ID,Label,Preferred label,Synonyms
C098107,CHEMICAL,flibanserin [Supplementary Concept],Flibanserin|Benzimidazoles
NEW00001,CHEMICAL,multifunctional serotonin receptor agonist,multifunctional serotonin receptor agonist
D063766,DISEASE,Pediatric Obesity,"Infantile Obesity|Obesity in Childhood|Child Obesity|Infant Obesity|Obesity, Childhood|Obesity, Childhood Onset|Overweight, Adolescent|Obesity, Child|Obesity, Infantile|Childhood Onset Obesity|Obesity|Obesity, Pediatric|Childhood Obesity|Overweight, Childhood|Adolescent Overweight|Infant Overweight|Obesity, Infant|Obesity, Adolescent|Obesity in Adolescence|Adolescent Obesity|Overweight, Infant|Childhood Overweight"
C093875,CHEMICAL,montelukast [Supplementary Concept],Quinolines|Sulfides|Cyclopropanes|Acetates|montelukast
D015525,NUTRITION,"Fatty Acids, Omega-3","n3 PUFA|Fatty Acid, n3|Fatty Acid, Omega-3|N-3 Fatty Acid|Omega-3 Fatty Acids|Acid, Omega-3 Fatty|N 3 Fatty Acid|n 3 Fatty Acids|Oil, n3|n3 Oils|Omega 3 Fatty Acid|n-3 Oil|n 3 Oils|n-3 Oils|n 3 Polyunsaturated Fatty Acid|n3 Polyunsaturated Fatty Acid|Oil, n-3|PUFA, n3|Omega 3 Fatty Acids|n3 Oil|Fatty Acid, N-3|PUFA, n-3|n-3 Fatty Acids|n-3 Polyunsaturated Fatty Acid|n3 Fatty Acid|Acid, N-3 Fatty|omega-3 fatty acids|n 3 Oil|n-3 PUFA|Omega-3 Fatty Acid|n 3 PUFA"
D015118,CHEMICAL,Eicosapentaenoic Acid,"Acid, Eicosapentanoic|5,8,11,14,17-Icosapentaenoic Acid|5,8,11,14,17-Eicosapentaenoic Acid|Icosapent|Eicosapentanoic Acid|omega 3 Eicosapentaenoic Acid|eicosapentaenoic acid|omega-3-Eicosapentaenoic Acid|Timnodonic Acid|EPA"
D001206,BIOCHEMICAL,Ascorbic Acid Deficiency,"Vitamin C Deficiencies|Deficiencies, Vitamin C|Ascorbic acid|Deficiency, Vitamin C|Deficiencies, Ascorbic Acid|Deficiency, Ascorbic Acid|Ascorbic Acid Deficiencies|Vitamin C Deficiency"
NEW00007,DISEASE,schizophrenic patients,schizophrenic patients
NEW00011,BIOCHEMICAL,lowered vitamin B6 levels,lowered vitamin B6 levels
D018164,DISEASE,"Hemorrhagic Disease Virus, Epizootic",hemorrhagic disease|Epizootic hemorrhagic disease virus
D064417,BIOCHEMICAL,Vitamin K Epoxide Reductases,"Reductase, Phylloquinone Epoxide|K Epoxidase, Vitamin|Vitamin K 2,3 Epoxide Reductase|Reductase, Menadione Epoxide|Epoxidase, Vitamin K|Vitamin K Epoxide Reductase|Vitamin K 2,3-Epoxide Reductase|Phylloquinone Epoxide Reductase|Reductase, Vitamin KO|Epoxide Reductase, Phylloquinone|Epoxide Reductase, Menadione|Vitamin K 1 Epoxidase|Vitamin KO Reductase|Vitamin K Epoxidase|Menadione Epoxide Reductase|Vitamin K1 Oxide Reductase|vitamin K"
NEW00013,BIOCHEMICAL,Riboflavin transporter deficiency,Riboflavin transporter deficiency
NEW00014,BIOCHEMICAL,folate deficiency,folate deficiency
NEW00015,DISEASE,psychiatric hospitalization,psychiatric hospitalization
NEW00016,DISEASE,psychiatric patients,psychiatric patients
NEW00018,DISEASE,B12 insufficiency,B12 insufficiency
NEW00019,CHEMICAL,Biotin-dependent carboxylases,Biotin-dependent carboxylases
C531633,BIOCHEMICAL,Biotin deficiency [Supplementary Concept],Biotinidase Deficiency|biotin deficiency
NEW00022,BIOCHEMICAL,folate levels,folate levels
NEW00024,BIOCHEMICAL,vitamin abnormalities,vitamin abnormalities
NEW00025,DISEASE,AD VaD patients,AD VaD patients
NEW00026,CHEMICAL,serotonin 5-HT1A/1B receptor agonist eltoprazine,serotonin 5-HT1A/1B receptor agonist eltoprazine
D058917,CHEMICAL,Adenosine A2 Receptor Antagonists,adenosine A2A receptor antagonists|Adenosine A2B Receptor Antagonists|Adenosine A2A Receptor Antagonists
C539997,CHEMICAL,"2-(2-furanyl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)-1-piperazinyl)ethyl)-7H-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidine-5-amine [Supplementary Concept]",Pyrimidines|Triazoles|preladenant
NEW00030,CHEMICAL,chronic subordinate colony housing,chronic subordinate colony housing|CSC
C108242,CHEMICAL,"1-aminocyclopentane-1,3,4-tricarboxylic acid [Supplementary Concept]",Tricarboxylic Acids|Cyclopentanes|ACPT-I
NEW00032,CHEMICAL,mGluR5 inverse agonist 2-methyl-6-(phenylethynyl)pyridine,mGluR5 inverse agonist 2-methyl-6-(phenylethynyl)pyridine|MPEP
D007980,CHEMICAL,Levodopa,"3-Hydroxy-L-tyrosine|3 Hydroxy L tyrosine|L-3,4-Dihydroxyphenylalanine|L 3,4 Dihydroxyphenylalanine|Dopaflex|L Dopa|L-Dopa|Larodopa|Dopar|Levopa|L-3,4-dihydroxyphenylalanine"
D010300,DISEASE,Parkinson Disease,"Lewy Body Parkinson Disease|Lewy Body Parkinson's Disease|Parkinson's Disease|Paralysis Agitans|Idiopathic Parkinson's Disease|Primary Parkinsonism|Idiopathic Parkinson Disease|Parkinson's Disease, Lewy Body|Parkinson Disease, Idiopathic|Parkinson's disease|Parkinsonism, Primary|Parkinson's Disease, Idiopathic"
NEW00034,CHEMICAL,"dopamine precursor L-3,4-dihydroxyphenylalanine","L-DOPA|dopamine precursor L-3,4-dihydroxyphenylalanine"
C111599,CHEMICAL,istradefylline [Supplementary Concept],Purines|KW-6002|Istradefylline
D002110,CHEMICAL,Caffeine,"Vivarin|QuickPep|Percoffedrinol N|Caffedrine|1,3,7-Trimethylxanthine|Dexitac|Quick-Pep|No Doz|Coffeinum Purrum|Coffeinum N|caffeine|Durvitan|Percutaféine|Quick Pep"
D011619,BIOCHEMICAL,Psychotropic Drugs,"Drug, Psychotropic|Psychoactive Agents|Psychoactive Drug|Agents, Psychoactive|Psychopharmaceuticals|Psychoactive Drugs|Psychopharmaceutical|Drug, Psychoactive|Psychotropic Drug|Agent, Psychoactive|Drugs, Psychoactive|Drugs, Psychotropic|Psychoactive Agent|psychoactive drug"
NEW00035,CHEMICAL,adenosine A2A antagonists,adenosine A2A antagonists
NEW00039,BIOCHEMICAL,A2A antagonists,A2A antagonists
D000077285,CHEMICAL,Rimonabant,"SR 141716|Zimulti|SR 141716A|Rimonabant Hydrochloride|SR141716|rimonabant|SR-141716A|Acomplia|N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide hydrochloride|SR141716A"
NEW00041,CHEMICAL,acid/kainate receptor-type neurotoxicity,acid/kainate receptor-type neurotoxicity
NEW00043,CHEMICAL,oxotremorine treatment,oxotremorine treatment
NEW00045,CHEMICAL,tramadol administration,tramadol administration
D003024,CHEMICAL,Clozapine,clozapine|Leponex|Clozaril
NEW00047,CHEMICAL,analgesic opioid prescription,analgesic opioid prescription|AOP
D009340,CHEMICAL,Nefopam,"Hydrochloride, Nefopam|Silentan Nefopam|Acupan|nefopam|Ajan|Nefopam Hydrochloride|Nefopam, Silentan|Fenazoxine"
D010098,CHEMICAL,Oxycodone,Theocodin|Oxycodone Hydrochloride|Pancodine|Oxycontin|Oxiconum|Dihydrohydroxycodeinone|Oxycone|Dihydrone|Dinarkon|Oxycodeinon|Eucodal|Oxycodone
D018847,CHEMICAL,Opioid Peptides,"Opiate Peptides|Opioid Peptide|Endogenous Opiates|Peptides, Opioid|Opiates, Endogenous|morphine|opioid|Peptide, Opioid|Peptides, Opiate"
NEW00057,MENTAL_HEALTH,CNS respiratory depression,CNS respiratory depression
D064829,CHEMICAL,Alcohol Abstinence,"alcohol|Ethanol Abstinence|Abstinence from Ethanols|Abstinence, Ethanol|Abstinence from Ethanol|Abstinence, Alcohol"
NEW00060,DISEASE,coma inadequate respirations,coma inadequate respirations
D018712,BIOCHEMICAL,"Analgesics, Non-Narcotic","Non-Opioid Analgesic|Analgesics, Non-Opioid|Analgesic, Nonopioid|Analgesics, Nonnarcotic|Non Opioid Analgesic|opioid analgesics|Non-Narcotic Analgesics|Nonnarcotic Analgesics|Analgesics, Nonopioid|Non-Opioid Analgesics|Non Opioid Analgesics|Analgesics, Non Narcotic|Opioid Analgesic, Non|Analgesic, Non-Opioid|Analgesic, Non Opioid|Nonopioid Analgesic|Nonopioid Analgesics"
D002047,CHEMICAL,Buprenorphine,"buprenorphine|Buprenex|RX 6029 M|6029-M|Temgésic|Buprex|Hydrochloride, Buprenorphine|Subutex|Prefin|RX-6029-M|RX6029M|6029M|6029 M|Buprenorphine Hydrochloride|Temgesic"
D013313,MENTAL_HEALTH,"Stress Disorders, Post-Traumatic","Neuroses, Post Traumatic|Posttraumatic Neuroses|Stress Disorder, Post-Traumatic|Moral Injury|Acute Post Traumatic Stress Disorder|Chronic Post-Traumatic Stress Disorder|Posttraumatic Stress Disorders|Post Traumatic Stress Disorders|Neuroses, Post-Traumatic|Injury, Moral|post-traumatic stress disorder|Posttraumatic Stress Disorder|Post-Traumatic Neuroses|Post-Traumatic Stress Disorders|Post-Traumatic Stress Disorder|Acute Post-Traumatic Stress Disorder|Stress Disorders, Posttraumatic|Chronic Post Traumatic Stress Disorder|Stress Disorder, Post Traumatic|Delayed Onset Post Traumatic Stress Disorder|Post Traumatic Stress Disorder|PTSD|Moral Injuries|Delayed Onset Post-Traumatic Stress Disorder|Neuroses, Posttraumatic|Stress Disorder, Posttraumatic"
NEW00065,MENTAL_HEALTH,chronic stress,chronic stress
NEW00066,CHEMICAL,antidepressant medications,antidepressant medications
NEW00067,BIOCHEMICAL,sialidase inhibitor oseltamivir,sialidase inhibitor oseltamivir
NEW00068,DISEASE,A. glehni extract,A. glehni extract
NEW00070,NUTRITION,phenylpropanoid moieties,phenylpropanoid moieties
NEW00072,CHEMICAL,water-ethanol extract,water-ethanol extract
C522975,CHEMICAL,p-coumaric acid glucoside [Supplementary Concept],p-coumaric acid|Coumaric Acids|Glucosides
D018726,MENTAL_HEALTH,Anti-Dyskinesia Agents,"Dyskinesia|Agents, Anti-Dyskinesia|Disorder Agents, Movement|Agents, Movement Disorder|Anti Dyskinesia Agents|Movement Disorder Agents"
D011899,CHEMICAL,Ranitidine,"AH-19065|Biotidin|ranitidine|N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine|Hydrochloride, Ranitidine|Ranitidin|Zantac|Sostril|Zantic|AH19065|Ranisen|AH 19065|Ranitidine Hydrochloride"
NEW00074,BIOCHEMICAL,histamine receptor blocker therapy,histamine receptor blocker therapy
NEW00075,CHEMICAL,ethanol E. senticosus root extract,ethanol E. senticosus root extract
C000713177,CHEMICAL,Siberian ginseng root [Supplementary Concept],Eleutherococcus|Eleutherococcus senticosus|Plant Extracts
D018763,MENTAL_HEALTH,Muscle Fatigue,"fatigue|Muscular Fatigue|Fatigue, Muscle|Fatigue, Muscular"
NEW00077,BIOCHEMICAL,Serotonergic antagonists,Serotonergic antagonists
NEW00078,BIOCHEMICAL,alpha-adrenoceptor antagonists,alpha-adrenoceptor antagonists
NEW00079,CHEMICAL,Phosphodiesterase isoenzymes 5 inhibitors,PDE5-Is|Phosphodiesterase isoenzymes 5 inhibitors
NEW00084,BIOCHEMICAL,alpha adrenoceptor antagonists,alpha adrenoceptor antagonists
NEW00086,BIOCHEMICAL,α1-adrenoceptor antagonists,α1-adrenoceptor antagonists
NEW00089,CHEMICAL,quinazoline based compounds,quinazoline based compounds
D064751,CHEMICAL,Ammonium Compounds,compounds|Ammonium|doxazosin
NEW00091,CHEMICAL,α-blockade,α-blockade
NEW00092,BIOCHEMICAL,Muscarinic receptor antagonists,Muscarinic receptor antagonists
D003583,CHEMICAL,Cytokinins,cytokinins|Cytokinin
D014968,CHEMICAL,Xanthine Dehydrogenase,"Oxidoreductase, Xanthine|Purine Hydroxylase I|Xanthine Oxidoreductase|Dehydrogenase, Xanthine|xanthine dehydrogenase"
D050876,CHEMICAL,Sulfite Oxidase,"Oxidase, Sulphite|sulphite oxidase|Sulphite Oxidase|Oxidase, Sulfite"
NEW00098,CHEMICAL,Activity-based anorexia,Activity-based anorexia|ABA
NEW00101,NUTRITION,Trans Fatty Acid TFA intake,Trans Fatty Acid TFA intake
D019967,DISEASE,Schizophrenia Spectrum and Other Psychotic Disorders,Schizophrenia and Disorders with Psychotic Features|psychotic disorders
NEW00102,CHEMICAL,MSUD metabolites,MSUD metabolites
NEW00104,CHEMICAL,brain kynurenic acid levels,brain kynurenic acid levels
NEW00105,CHEMICAL,kynurenic acid production,kynurenic acid production
NEW00106,CHEMICAL,kynurenine pathway,kynurenine pathway
D000597,CHEMICAL,"Amino Acids, Branched-Chain","BCAA|Acid, Branched-Chain Amino|Branched-chain amino acids|Amino Acid, Branched-Chain|Branched-Chain Amino Acids|Acids, Branched-Chain Amino|Branched-Chain Amino Acid|Amino Acids, Branched Chain|Branched Chain Amino Acid"
D050495,CHEMICAL,Vesicular Inhibitory Amino Acid Transport Proteins,"Transporter Proteins, VGAT|Vesicular Inhibitory Amino Acid Transporter Proteins|Vesicular GABA Glycine Transporter Proteins|Vesicular GABA-Glycine Transporter Proteins|Transporter Proteins, VIAAT|VIAAT Transporter Proteins|Vesicular GABA Glycine Transport Proteins|VGAT Transporter Proteins|Vesicular GABA-Glycine Transport Proteins|amino acid transport"
NEW00107,DISEASE,neurological sequelae,neurological sequelae
NEW00108,CHEMICAL,BCAA metabolism,BCAA metabolism
NEW00109,CHEMICAL,Objectives Valproic acid,Objectives Valproic acid|VPA
D016883,DISEASE,Diabetic Ketoacidosis,"Ketoacidosis, DKA Diabetic|Ketoses, Diabetic|Ketoacidosis, Diabetic|Acidosis, Diabetic|Diabetic Ketoses|Diabetic ketoacidosis|Diabetic Ketosis|Diabetic Acidosis|Ketoacidoses, Diabetic|DKA Diabetic Ketoacidoses|DKA Diabetic Ketoacidosis|Diabetic Ketoacidoses|Diabetic Ketoacidosis, DKA|Acidoses, Diabetic|Ketosis, Diabetic|Diabetic Acidoses"
D003922,DISEASE,"Diabetes Mellitus, Type 1","Diabetes Mellitus, Sudden-Onset|Type 1 Diabetes|Diabetes, Type 1|Diabetes Mellitus, Insulin-Dependent, 1|Diabetes Mellitus, Insulin Dependent|Diabetes, Autoimmune|Juvenile-Onset Diabetes|Diabetes Mellitus, Ketosis-Prone|Type 1 Diabetes Mellitus|Diabetes Mellitus, Juvenile-Onset|Insulin-Dependent Diabetes Mellitus 1|IDDM|Diabetes Mellitus, Insulin-Dependent|Brittle Diabetes Mellitus|Insulin-Dependent Diabetes Mellitus|Diabetes Mellitus, Type I|Ketosis-Prone Diabetes Mellitus|Diabetes Mellitus, Juvenile Onset|Insulin Dependent Diabetes Mellitus 1|Diabetes Mellitus, Brittle|Diabetes Mellitus, Sudden Onset|Diabetes, Juvenile-Onset|insulin-dependent diabetes mellitus|Juvenile-Onset Diabetes Mellitus|Diabetes Mellitus, Ketosis Prone|Autoimmune Diabetes|Juvenile Onset Diabetes|Sudden-Onset Diabetes Mellitus"
D010650,CHEMICAL,Phenylalanine Ammonia-Lyase,"Ammonia-lyase, Phenylalanine-Tyrosine|ammonia|Phenylalanine-Tyrosine Ammonia-lyase|Phenylalanine Tyrosine Ammonia lyase|Ammonia-Lyase, Phenylalanine|Phenylalanine Ammonia Lyase"
D056806,CHEMICAL,"Urea Cycle Disorders, Inborn","Disorder, Urea Cycle|Urea cycle disorders|Disorders, Urea Cycle|Urea Cycle Disorder|Urea Cycle Disorders|Inborn Urea Cycle Disorder"
D043202,DISEASE,"Steroid Metabolism, Inborn Errors","Congenital Errors of Steroid Metabolism|Inborn Errors of Steroid Metabolism|inborn errors|Steroid Metabolic Diseases, Inborn"
C075773,CHEMICAL,4-phenylbutyric acid [Supplementary Concept],Phenylbutyrates|Sodium 4-phenylbutyrate
NEW00118,CHEMICAL,BCAA/AAA molar ratio,BCAA/AAA molar ratio
D000592,CHEMICAL,"Amino Acid Metabolism, Inborn Errors","Amino Acid Metabolism Disorders, Inborn|Congenital Amino Acidopathy|Inherited Errors of Amino Acid Metabolism|Amino Acid Metabolism, Inherited Disorders|Amino Acidopathies, Inborn|amino acid metabolism|Inborn Amino Acidopathy|Inborn Errors, Amino Acid Metabolism|Inborn Amino Acidopathies|Amino Acid Metabolism, Inborn Error|Amino Acidopathy, Congenital|Amino Acidopathies, Congenital|Amino Acidopathy, Inborn|Congenital Amino Acidopathies"
D014635,CHEMICAL,Valproic Acid,"Depakine|Sodium Valproate|Valproic Acid, Sodium Salt (2:1)|Calcium Valproate|Valproate Sodium|Magnesium Valproate|Valproate|Depakene|2-Propylpentanoic Acid|Propylisopropylacetic Acid|Valproate Calcium|Depakote|2 Propylpentanoic Acid|Divalproex Sodium|Semisodium Valproate|Dipropyl Acetate|Convulsofin|Divalproex|Vupral|Ergenyl"
NEW00122,MENTAL_HEALTH,decreased anxiety,decreased anxiety
NEW00012,MENTAL_HEALTH,unlearned fear,unlearned fear|anxiety
D000374,DISEASE,Aggression,Aggression|Aggressions
NEW00130,CHEMICAL,plasma amino acid levels,plasma amino acid levels
D005222,MENTAL_HEALTH,Mental Fatigue,"Fatigue, Mental|mental fatigue"
D000544,MENTAL_HEALTH,Alzheimer Disease,"Senile Dementia, Acute Confusional|Dementia, Alzheimer-Type (ATD)|Familial Alzheimer Diseases (FAD)|Familial Alzheimer Disease (FAD)|Presenile Alzheimer Dementia|Alzheimer's Disease, Focal Onset|Alzheimer Sclerosis|Dementia, Presenile|Senile Dementia, Alzheimer Type|Dementia, Alzheimer Type|Alzheimer Type Senile Dementia|Dementia, Senile|Alzheimer Type Dementia|Alzheimer's Diseases|Presenile Dementia|Alzheimer Disease, Late Onset|Alzheimer Diseases|Alzheimers Diseases|Alzheimer Syndrome|Alzheimer-Type Dementia (ATD)|Focal Onset Alzheimer's Disease|Early Onset Alzheimer Disease|Alzheimer Type Dementia (ATD)|Primary Senile Degenerative Dementia|Acute Confusional Senile Dementia|Late Onset Alzheimer Disease|Dementia, Alzheimer|Sclerosis, Alzheimer|Alzheimer disease|Dementia, Primary Senile Degenerative|Alzheimer Disease, Early Onset|Alzheimer Disease, Familial (FAD)|Senile Dementia|Alzheimer's Disease|Alzheimer Dementias|Alzheimer Dementia"
D000755,DISEASE,"Anemia, Sickle Cell","Sickle Cell Disorder|Sickle Cell Anemias|Sickling Disorder Due to Hemoglobin S|Sickle Cell Disorders|Sickle Cell Diseases|Disease, Hemoglobin S|Hemoglobin S Disease|Cell Diseases, Sickle|Cell Disease, Sickle|Anemias, Sickle Cell|Sickle Cell Disease|Sickle Cell Anemia|Cell Disorder, Sickle|HbS Disease|Hemoglobin S Diseases|Cell Disorders, Sickle|s disease"
D000437,MENTAL_HEALTH,Alcoholism,"Alcohol Addiction|Intoxication, Chronic Alcoholic|Alcoholic Intoxication, Chronic|Abuse, Alcohol|alcohol dependence|Chronic Alcoholic Intoxication|Ethanol Abuse|Alcohol Use Disorders|Alcohol Abuse|Addiction, Alcohol|Use Disorders, Alcohol|Abuse, Ethanol|Alcohol Use Disorder|Dependence, Alcohol|Alcohol Dependence"
D000319,BIOCHEMICAL,Adrenergic beta-Antagonists,"beta Adrenoceptor Antagonists|Antagonists, beta-Adrenoceptor|Antagonist, beta-Adrenoceptor|Adrenergic beta-Receptor Blockader|Antagonist, beta-Adrenergic|beta-Adrenergic Blocking Agent|beta Adrenergic Blocking Agent|Blockader, beta-Adrenergic Receptor|Adrenergic beta-Antagonist|Agents, beta-Adrenergic Blocking|Blocker, beta-Adrenergic|beta-Adrenergic Antagonist|beta-Adrenergic Receptor Blockader|beta-Adrenoceptor Antagonists|beta Adrenoceptor Antagonist|Receptor Blockaders, beta-Adrenergic|beta-Receptor Blockader, Adrenergic|Blocking Agent, beta-Adrenergic|Adrenergic beta Antagonist|beta-Adrenergic Antagonists|beta-adrenoceptor antagonists|beta-Adrenergic Blocking Agents|beta-Adrenergic Blockers|Agent, beta-Adrenergic Blocking|beta-Antagonist, Adrenergic|Blockaders, beta-Adrenergic Receptor|Blockers, beta-Adrenergic|beta-Adrenergic Blocker|beta Adrenergic Receptor Blockader|beta-Antagonists, Adrenergic|Adrenergic beta-Receptor Blockaders|Blocking Agents, beta-Adrenergic|Blockader, Adrenergic beta-Receptor|beta Adrenergic Antagonists|beta Adrenergic Antagonist|Adrenergic beta Receptor Blockaders|Blockaders, Adrenergic beta-Receptor|beta-Blockers, Adrenergic|beta Blockers, Adrenergic|Antagonists, beta-Adrenergic|beta Adrenergic Blocking Agents|Adrenergic beta Antagonists|beta Adrenergic Blockers|beta-Adrenergic Receptor Blockaders|Adrenergic beta-Blockers|Receptor Blockader, beta-Adrenergic|beta Adrenergic Receptor Blockaders|Adrenergic beta Receptor Blockader|beta Adrenergic Blocker|beta-Adrenoceptor Antagonist|beta-Receptor Blockaders, Adrenergic"
D008790,CHEMICAL,Metoprolol,Spesicor|Beloc-Duriles|Beloc Duriles|Lopressor|Spesikor|H 93 26|Toprol|CGP-2175|Metoprolol Succinate|metoprolol|Betaloc-Astra|H 9326|CGP 2175|H 93-26|Toprol XL|Toprol-XL|Betalok|Metoprolol Tartrate|CGP2175|Betaloc|Betaloc Astra|Metoprolol CR XL|Metoprolol CR-XL|Seloken
D009248,CHEMICAL,Nadolol,Solgol|Corgard|SQ 11725|SQ11725|nadolol|SQ-11725
D011433,CHEMICAL,Propranolol,"Obsidan|Anaprilin|propranolol|Propanolol|AY20694|AY 20694|Betadren|Propranolol Hydrochloride|Avlocardyl|Rexigen|Dexpropranolol|Hydrochloride, Propranolol|Inderal|Anapriline|Obzidan|Dociton|AY-20694"
D065546,BIOCHEMICAL,Drug Liberation,"Dissolution, Drug|Liberation, Drug|drug|Drug Release|Release, Drug|Drug Dissolution"
NEW00137,BIOCHEMICAL,Mood stabilizers,Mood stabilizers
D050484,CHEMICAL,Norepinephrine Plasma Membrane Transport Proteins,"Sodium Dependent Noradrenaline Transporter|Transporter, Noradrenaline|Transporters, Noradrenaline-Specific Neurotransmitter|Noradrenaline Transporter|Norepinephrine Plasma Membrane Transporters|Neurotransmitter Transporters, Noradrenaline Specific|Noradrenaline-Specific Neurotransmitter Transporters|Transporter, Norepinephrine|Sodium-Dependent Noradrenaline Transporter|Noradrenaline Transporter, Sodium-Dependent|Noradrenaline Plasma Membrane Transport Proteins|NE|Neuronal NET Protein|Norepinephrine Transporter|norepinephrine|Transporter Protein, Norepinephrine|NET Protein, Neuronal|Norepinephrine Plasma Membrane Transporter Proteins|SLC6A2 Protein|Solute Carrier Family 6 Member 2|Neurotransmitter Transporters, Noradrenaline-Specific|Norepinephrine Transporter Protein"
D001569,CHEMICAL,Benzodiazepines,Benzodiazepine Compounds|benzodiazepines|Benzodiazepine
D020003,CHEMICAL,1-Octanol,"n-Octanol|Alcohol, n-Octyl|1-octanol|n-Octyl Alcohol|1 Octanol|n Octyl Alcohol|n Octanol"
NEW00141,CHEMICAL,dimethoxymethyl-diphenyl-barbituric acid,dimethoxymethyl-diphenyl-barbituric acid
D012978,CHEMICAL,Sodium Oxybate,"Oxybate Sodium|Xyrem|Oxybate, Sodium|Sodium gamma Hydroxybutyrate|Somsanit|sodium oxybate|gamma Hydroxybutyrate|Sodium Oxybutyrate|4 Hydroxybutyrate Sodium|Oxybutyrate, Sodium|gamma-Hydroxybutyrate|4-Hydroxybutyrate Sodium|Sodium gamma-Hydroxybutyrate"
D013956,BIOCHEMICAL,Antithyroid Agents,"Goitrogen|Drugs, Antithyroid|Antithyroid Drug|Goitrogens|Agents, Antithyroid|Antithyroid Effect|Effect, Antithyroid|Antithyroid Effects|Antithyroid Agent|Effects, Antithyroid|Antithyroid drugs|Drug, Antithyroid|Agent, Antithyroid|Thyroid Antagonists|Antithyroid Drugs|Antagonists, Thyroid"
D001523,DISEASE,Mental Disorders,"Mental Disorders, Severe|psychiatric disorders|Psychiatric Illnesses|Psychiatric Disorder|Psychiatric Disorders|Mental Illnesses|Diagnosis, Psychiatric|Psychiatric Illness|Illness, Mental|Mental Disorder|Psychiatric Diseases|Mental Disorder, Severe|Severe Mental Disorder|Psychiatric Diagnosis|Psychiatric Disease|Mental Illness|Behavior Disorders|Severe Mental Disorders"
D059411,DISEASE,Lower Urinary Tract Symptoms,Lower Urinary Tract Symptom|LUTS|lower urinary tract symptoms
D000068577,CHEMICAL,Nebivolol,"Hydrochloride, Nebivolol|Nebivolol Hydrochloride|67555, R|R67555|Alpha,Alpha'-(Iminobis(Methylene))bis(6-Fluoro-3,4-dihydro)-2H-1-benzopyran-2-methanol|Bystolic|Nebilet|R-67555|nebivolol|R 67555|Lobivon|Silostar"
NEW00145,DISEASE,male hypertensive patients,male hypertensive patients
D058669,CHEMICAL,Adrenergic alpha-2 Receptor Antagonists,"alpha(2)-antagonists|alpha2-Adrenergic Antagonists|Adrenergic alpha-2 Receptor Blockers|alpha2-Antagonists, Adrenergic|Antagonists, Adrenergic alpha-2|Adrenergic alpha 2 Receptor Blockers|alpha-2 Adrenergic Blocking Agents|Adrenergic alpha 2 Antagonists|Adrenergic alpha 2 Receptor Antagonists|Antagonists, alpha2-Adrenergic|Adrenergic alpha2-Antagonists|alpha-2 Antagonists, Adrenergic|Adrenergic alpha2 Antagonists|Adrenergic alpha-2 Antagonists|alpha2 Adrenergic Antagonists|alpha 2 Adrenergic Blocking Agents"
NEW00149,CHEMICAL,Nocturnal urinary melatonin excretion,Nocturnal urinary melatonin excretion
NEW00150,CHEMICAL,Nightly melatonin excretion,Nightly melatonin excretion
NEW00152,BIOCHEMICAL,alpha(2)-adrenoceptor agonists,alpha(2)-adrenoceptor agonists
D017367,CHEMICAL,Serotonin Uptake Inhibitors,"5 HT Uptake Inhibitor|5-HT Uptake Inhibitors|Inhibitors, 5-Hydroxytryptamine Uptake|Uptake Inhibitors, 5 Hydroxytryptamine|Selective Serotonin Reuptake Inhibitors|Uptake Inhibitors, 5 HT|Uptake Inhibitor, 5-HT|Inhibitor, Serotonin Uptake|Reuptake Inhibitor, Serotonin|Uptake Inhibitors, 5-Hydroxytryptamine|Uptake Inhibitor, Serotonin|5-Hydroxytryptamine Uptake Inhibitors|5-HT Uptake Inhibitor|Inhibitors, 5-HT Uptake|Inhibitors, 5 HT Uptake|Reuptake Inhibitors, Serotonin|Uptake Inhibitors, 5-HT|5 Hydroxytryptamine Uptake Inhibitor|Serotonin Reuptake Inhibitors|Uptake Inhibitor, 5-Hydroxytryptamine|Inhibitor, 5-Hydroxytryptamine Uptake|5 HT Uptake Inhibitors|Inhibitors, Serotonin Uptake|Inhibitors, Serotonin Reuptake|Uptake Inhibitors, Serotonin|5-Hydroxytryptamine Uptake Inhibitor|Serotonin Reuptake Inhibitor|Serotonin Uptake Inhibitor|Selective serotonin reuptake inhibitors|Selective Serotonin Reuptake Inhibitor|SSRIs|Inhibitors, 5 Hydroxytryptamine Uptake|Inhibitor, 5-HT Uptake|Inhibitor, Serotonin Reuptake|5 Hydroxytryptamine Uptake Inhibitors"
D019167,CHEMICAL,Appetite Stimulants,"Drugs, Appetite-Stimulating|Appetite Stimulating Drugs|Appetite-Stimulating Drugs|stimulants|Stimulants, Appetite"
D019964,MENTAL_HEALTH,Mood Disorders,"Disorders, Affective|Affective Disorder|Disorder, Mood|mood disorders|Affective Disorders|Disorders, Mood|Disorder, Affective|Mood Disorder"
D008803,CHEMICAL,Mianserin,"Hydrochloride, Mianserin|Mianserin Hydrochloride|Monohydrochloride, Mianserin|Org GB 94|mianserin|Lerivon|Tolvon|Mianserin Monohydrochloride"
NEW00154,CHEMICAL,atipemazole,atipemazole
D015016,CHEMICAL,Yohimbine,"Corynanthine|Hydrochloride, Yohimbine|Yohimbine Hydrochloride|Pluriviron|Yohimex|Yohimbine Houdé|Rauhimbine|Aphrodyne|Tartrate, Corynanthine|Yohimbin Spiegel|Hydrochloride, Aphrodine|Yocon|Corynanthine Tartrate|Yohimbine|Rauwolscine|Aphrodine Hydrochloride"
NEW00155,BIOCHEMICAL,selective alpha-2 adrenoceptor antagonists,selective alpha-2 adrenoceptor antagonists
D010883,CHEMICAL,Piperoxan,Forneau 933|piperoxan|Benodain|Benodaine|Piperoxane
D008774,CHEMICAL,Methylphenidate,"Equasym|methylphenidate|Ritalin-SR|Ritalin|Ritalin SR|Methylphenidate Hydrochloride|Hydrochloride, Methylphenidate|Methylin|Phenidylate|Metadate|Concerta|Ritaline|Tsentedrin|Centedrin|Daytrana"
D003913,CHEMICAL,Dextroamphetamine,"Dextro-Amphetamine Sulfate|d-Amphetamine|DextroStat|Curban|d Amphetamine|Dextroamphetamine Sulfate|Sulfate, Dextroamphetamine|d Amphetamine Sulfate|dextro Amphetamine|Dexamfetamine|d-Amphetamine Sulfate|Oxydess|Dexamphetamine|Dextro Amphetamine Sulfate|dextro-Amphetamine|Dexedrine"
NEW00157,DISEASE,orthostatic testing,orthostatic testing
NEW00159,CHEMICAL,lower pyruvate kinase activity,lower pyruvate kinase activity
D058832,CHEMICAL,Serotonin 5-HT4 Receptor Antagonists,"5-HT4 Antagonist|Serotonin|5-HT4 Antagonists|Antagonist, 5-HT4|5 HT4 Antagonist|Antagonists, 5-HT4|Serotonin 5 HT4 Receptor Antagonists|5 HT4 Antagonists"
C448763,NUTRITION,"calcification-associated peptide-1, crayfish [Supplementary Concept]",crayfish|Peptides
D018727,BIOCHEMICAL,Muscarinic Antagonists,"Antimuscarinics|Agent, Antimuscarinic|Antagonist, Cholinergic Muscarinic|Cholinergic Muscarinic Antagonist|Antagonists, Muscarinic|Antimuscarinic agents|Antimuscarinic|Muscarinic Antagonist, Cholinergic|Muscarinic Antagonist|Muscarinic Antagonists, Cholinergic|Antimuscarinic Agent|Antimuscarinic Agents|Agents, Antimuscarinic|Antagonists, Cholinergic Muscarinic|Antagonist, Muscarinic|Cholinergic Muscarinic Antagonists"
NEW00163,DISEASE,neuroleptic-induced akathisia,neuroleptic-induced akathisia
D011736,BIOCHEMICAL,Pyridoxine,Pyridoxol Hydrochloride|Rodex|vitamin B6|Pyridoxin|Pyridoxine Hydrochloride|Pyridoxine|Pyridoxol
NEW00167,DISEASE,schizoaffective inpatients,schizoaffective inpatients
NEW00170,CHEMICAL,heterocyclic antidepressants,heterocyclic antidepressants
D008996,CHEMICAL,Monoamine Oxidase Inhibitors,"Reversible Inhibitors of Monoamine Oxidase|MAO Inhibitors|Inhibitor, MAO|Reversible Inhibitor of Monoamine Oxidase|MAO Inhibitor|RIMA (Reversible Inhibitor of Monoamine Oxidase A)|Inhibitors, MAO|Inhibitors, Monoamine Oxidase|monoamine oxidase MAO inhibitors|Monoamine Oxidase Inhibitor|Inhibitor, Monoamine Oxidase"
NEW00178,BIOCHEMICAL,Antimuscarinic cholinergic drugs,Antimuscarinic cholinergic drugs
D001286,CHEMICAL,Atropine Derivatives,Atropines|atropine
D012602,CHEMICAL,Scopolamine Derivatives,"Derivatives, Scopolamine|scopolamine|Scopolamines"
D004244,DISEASE,Dizziness,Light Headedness|Orthostasis|Dizziness|Lightheadedness|Light-Headedness|Dizzyness
D065127,CHEMICAL,Dopamine D2 Receptor Antagonists,"dopamine|Antagonist, Dopamine D2|Antagonists, Dopamine D2|D2 Antagonists, Dopamine|Receptor Antagonists, Dopamine D2|Dopamine D2 Antagonists|Dopamine D2 Antagonist|Dopamine D2 Receptor Antagonist|D2 Antagonist, Dopamine"
D065101,BIOCHEMICAL,Chloride Channel Agonists,"Chloride Channel Activators|Activators, Chloride Channel|Agonists|Channel Agonists, Chloride|Stimulators, Chloride Channel|Chloride Channel Stimulators|Agonists, Chloride Channel|Channel Stimulators, Chloride|Channel Activators, Chloride"
NEW00185,BIOCHEMICAL,selective mGlu2/3 receptor agonists,selective mGlu2/3 receptor agonists
C007076,CHEMICAL,citral [Supplementary Concept],Acyclic Monoterpenes|Citral
NEW00187,BIOCHEMICAL,mGluR2 mGluR antagonists,mGluR2 mGluR antagonists
D065171,BIOCHEMICAL,Estrogen Receptor Antagonists,"Receptor Antagonists, Estradiol|Estrogen Receptor Antagonist|Antagonists, Estrogen Receptor|Receptor Antagonist, Estrogen|Antagonist, Estradiol Receptor|Antagonist, Estrogen Receptor|Receptor Antagonist, Estradiol|Estradiol Receptor Antagonists|antagonists|Estradiol Receptor Antagonist|Antagonists, Estradiol Receptor|Receptor Antagonists, Estrogen"
NEW00189,BIOCHEMICAL,group mGluR agonists,group mGluR agonists
NEW00190,CHEMICAL,glutamate activity,glutamate activity
NEW00191,CHEMICAL,gamma-aminobutyric acid GABA system,gamma-aminobutyric acid GABA system
D001008,MENTAL_HEALTH,Anxiety Disorders,"State, Neurotic Anxiety|Neurotic Anxiety States|Disorders, Anxiety|Neurotic Anxiety State|Neuroses, Anxiety|Disorder, Anxiety|Anxiety Disorder|Anxiety Neuroses|Anxiety State, Neurotic|Anxiety States, Neurotic|anxiety disorders|States, Neurotic Anxiety"
NEW00194,CHEMICAL,anticataplectic drugs,anticataplectic drugs|antidepressants
NEW00195,BIOCHEMICAL,insulin-sensitizing agent,insulin-sensitizing agent
NEW00196,CHEMICAL,Open-label rosiglitazone,Open-label rosiglitazone
C555357,CHEMICAL,3-((methylsulfonyl)amino)-2-phenyl-N-(1-phenylpropyl)quinolin-4-carboxamide [Supplementary Concept],AZD2624|Sulfonamides|Aminoquinolines
NEW00198,CHEMICAL,Pantothenate kinase deficiency,Pantothenate kinase deficiency
D009771,MENTAL_HEALTH,Obsessive-Compulsive Disorder,"Anankastic Personality|Obsessive-Compulsive Neurosis|Anankastic Personalities|Neuroses, Obsessive-Compulsive|Neurosis, Obsessive Compulsive|Obsessive-Compulsive Neuroses|Disorders, Obsessive-Compulsive|Disorder, Obsessive-Compulsive|Neurosis, Obsessive-Compulsive|Personalities, Anankastic|obsessive-compulsive disorder|Obsessive-Compulsive Disorders|Personality, Anankastic|Obsessive Compulsive Disorder"
NEW00201,MENTAL_HEALTH,dysexecutive syndromes,dysexecutive syndromes
D006211,DISEASE,Pantothenate Kinase-Associated Neurodegeneration,"Pigmentary Pallidal Degeneration|Neuroaxonal Dystrophy, Juvenile-Onset|Pigmentary Pallidal Atrophy|kinase-associated neurodegeneration|Degeneration, Pigmentary Pallidal|Neurodegeneration, Pantothenate Kinase-Associated|Dystrophies, Juvenile-Onset Neuroaxonal|Neurodegeneration With Brain Iron Accumulation 1|Neuroaxonal Dystrophies, Juvenile-Onset|Neurodegeneration with Brain Iron Accumulation Type 1|Pantothenate Kinase Associated Neurodegeneration|Pallidal Atrophy, Pigmentary|PKAN Neuroaxonal Dystrophy, Juvenile-Onset|Dystrophy, Juvenile-Onset Neuroaxonal|Juvenile-Onset Neuroaxonal Dystrophies|Juvenile-Onset Neuroaxonal Dystrophy|PKAN Neuroaxonal Dystrophy, Juvenile Onset|Hallervorden-Spatz Syndrome|Neuroaxonal Dystrophy, Juvenile Onset|Hallervorden Spatz Disease|Hallervorden-Spatz Disease|Hallervorden Spatz Syndrome"
NEW00203,DISEASE,Pantothenase kinase-associated neurodegeneration,Pantothenase kinase-associated neurodegeneration|PKAN
D020183,DISEASE,Nocturnal Paroxysmal Dystonia,"dystonia|Paroxysmal Dystonias, Hypnogenic|Paroxysmal Dystonia, Nocturnal|Dystonias, Nocturnal Paroxysmal|Dystonia, Hypnogenic Paroxysmal|Sleep-Related Dystonias|Nocturnal Paroxysmal Dystonias|Dystonias, Hypnogenic Paroxysmal|Dystonia, Sleep-Related|Sleep Related Dystonia|Dystonias, Sleep-Related|Dystonia, Nocturnal, Paroxysmal|Hypnogenic Paroxysmal Dystonia|Dystonia, Nocturnal Paroxysmal|Paroxysmal Dystonia, Hypnogenic|Paroxysmal Dystonias, Nocturnal|Hypnogenic Paroxysmal Dystonias|Sleep-Related Dystonia"
D000071516,CHEMICAL,Alpha-Ketoglutarate-Dependent Dioxygenase FTO,"Alpha Ketoglutarate Dependent Dioxygenase|Fat Mass and Obesity Associated Protein|alpha-ketoglutarate|Dioxygenase, Alpha-Ketoglutarate-Dependent|FTO, Alpha-Ketoglutarate-Dependent Dioxygenase|Alpha-Ketoglutarate-Dependent Dioxygenase|AlkB Homolog 9 Protein|Fat Mass and Obesity Associated (FTO) Protein|Alpha Ketoglutarate Dependent Dioxygenase FTO"
D051278,CHEMICAL,beta-Alanine-Pyruvate Transaminase,"pyruvate|beta-Alanine Pyruvate Aminotransferase|Transaminase, beta-Alanine-Pyruvate|Pyruvate Aminotransferase, beta-Alanine|beta Alanine Pyruvate Transaminase|Aminotransferase, beta-Alanine Pyruvate|beta Alanine Pyruvate Aminotransferase|beta-Alanine - Pyruvate Transaminase"
D045022,CHEMICAL,Lactate Dehydrogenases,"Dehydrogenases, Lactate|lactate"
NEW00208,CHEMICAL,L-Carnitine treatment,L-Carnitine treatment
NEW00211,DISEASE,congenital chronic hyperammonemia,congenital chronic hyperammonemia
NEW00209,CHEMICAL,spf/Y mice,spf/Y mice
D019189,CHEMICAL,Iron Metabolism Disorders,"Disorders, Iron Metabolism|Metabolism Disorder, Iron|iron metabolism|Metabolism Disorders, Iron|Disorder, Iron Metabolism|Iron Metabolism Disorder"
D000077205,CHEMICAL,Pioglitazone,"Pioglitazone|AD 4833|U72107A|U72,107A|AD-4833|AD4833|Actos|Pioglitazone Hydrochloride|U-72107A|U 72107A|5-(4-(2-(5-Ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione"
NEW00218,CHEMICAL,PPARγ agonist pioglitazone,PPARγ agonist pioglitazone
NEW00220,BIOCHEMICAL,PPARγ agonists,PPARγ agonists
D051023,BIOCHEMICAL,BH3 Interacting Domain Death Agonist Protein,Truncated Bid Protein|agonist|Bid Protein|tBid Protein
NEW00223,CHEMICAL,PPARγ thiazolidinedione,PPARγ thiazolidinedione
C000716087,BIOCHEMICAL,"8-(2-aminophenyl)-3-butyl-1,6,7-trimethyl-1H-imidazo(2,1-f)purine-2,4(3H,8H)-dione [Supplementary Concept]",PPARγ agonist|Purines|Imidazoles
NEW00225,CHEMICAL,GW1929 treatment,GW1929 treatment
NEW00230,DISEASE,IR injury,IR injury
NEW00232,CHEMICAL,thiazolidinedione PPARγ agonist,thiazolidinedione PPARγ agonist
NEW00234,CHEMICAL,N-(2-benzoylphenyl)-O-[2-(methyl-2-pyridinylamino)ethyl]-l-tyrosine,N-(2-benzoylphenyl)-O-[2-(methyl-2-pyridinylamino)ethyl]-l-tyrosine|GW1929
NEW00235,BIOCHEMICAL,PPARγ agonist treatment,PPARγ agonist treatment
NEW00237,MENTAL_HEALTH,excessive anxiety,excessive anxiety
C487473,CHEMICAL,17beta-estradiol platinum(II) [Supplementary Concept],17β-estradiol|E2|Estradiol/analogs  and  derivatives|Organoplatinum Compounds
NEW00240,BIOCHEMICAL,PPARγ agonist rosiglitazone,PPARγ agonist rosiglitazone
D000069499,CHEMICAL,"Ezetimibe, Simvastatin Drug Combination","Ezetimibe Simvastatin Combination|Ezetimibe-Simvastatin Drug Combination|Ezetimibe Simvastatin Drug Combination|Ezetimibe-Simvastatin Combination|Vytorin|Inegy|Ezetimibe|Combination, Ezetimibe-Simvastatin|Combination, Ezetimibe-Simvastatin Drug|Drug Combination, Ezetimibe-Simvastatin"
D066088,DISEASE,Infant Death,"Deaths, Infant|Infant Deaths|death|Death, Infant"
NEW00242,CHEMICAL,CCR(5 modulators,CCR(5 modulators
NEW00244,CHEMICAL,anesthetic premedication,anesthetic premedication
D064729,BIOCHEMICAL,Neurokinin-1 Receptor Antagonists,"Antagonist, Neurokinin-1 Receptor|Neurokinin 1 Receptor Antagonists|Substance P Receptor Blocker|Neurokinin 1 Receptor Blockers|neurokinin-1-receptor antagonists|Neuroleukin 1 Receptor Blockers|Receptor Blockers, Neuroleukin-1|Tachykinin Receptor 1 Antagonists|Tachykinin Receptor 1 Blockers|Tachykinin Receptor 1 Antagonist|Receptor Antagonists, Neurokinin-1|Neurokinin 1 Receptor Blocker|Blocker, Neurokinin-1 Receptor|Receptor Blockers, Neurokinin-1|Antagonists, Neurokinin-1 Receptor|Neurokinin-1 Receptor Blocker|Neuroleukin 1 Receptor Blocker|Neurokinin-1 Receptor Blockers|Receptor Blocker, Neuroleukin-1|Blockers, Neurokinin-1 Receptor|Neurokinin 1 Receptor Antagonist|Blockers, Neuroleukin-1 Receptor|Tachykinin Receptor 1 Blocker|Neuroleukin-1 Receptor Blockers|Neurokinin-1 Receptor Antagonist|Neuroleukin-1 Receptor Blocker|Substance P Receptor Antagonist|Substance P Receptor Antagonists|Receptor Antagonist, Neurokinin-1|Substance P Receptor Blockers|Receptor Blocker, Neurokinin-1|Blocker, Neuroleukin-1 Receptor"
NEW00248,CHEMICAL,Betaine Bet,Betaine Bet
NEW00249,CHEMICAL,sachet,sachet
C021822,CHEMICAL,myo-inositol-1 (or 4)-monophosphatase [Supplementary Concept],Phosphoric Monoester Hydrolases|Inositol monophosphatase
NEW00254,CHEMICAL,Environmental tobacco smoke exposure,Environmental tobacco smoke exposure
D053496,CHEMICAL,"Inositol 1,4,5-Trisphosphate Receptors","Receptor, INSP3|Type 1 Inositol 1,4,5-trisphosphate Receptor|Triphosphate Receptor, Inositol|Inositol-1,4,5-Triphosphate Receptor|Receptor, IP3|Inositol Triphosphate Receptor|INSP3 Receptor Type 3|Receptor, Inositol-1,4,5-triphosphate|Inositol 1,4,5-trisphosphate Receptor Type 3|Inositol 1,4,5-trisphosphate Receptor Subtype 3|INSP3 Receptor Type 2|Inositol 1,4,5-trisphosphate Receptor Type 2|IP3 Receptor|INSP3 Receptor Type 1|1,4,5-INTP Receptor|Inositol 1,4,5-Trisphosphate Receptor|Inositol 1,4,5-trisphosphate Receptor Type 1|Inositol 1,4,5-Triphosphate Receptor|inositol|Receptor, Inositol Triphosphate|INSP3 Receptor|Type 3 Inositol 1,4,5-trisphosphate Receptor|Inositol 1,4,5-Triphosphate Receptors"
D020250,DISEASE,Postoperative Nausea and Vomiting,"PONV|Nausea|Emeses, Postoperative|Nausea, Postoperative|Postoperative Emesis|Vomiting, Postoperative|Postoperative Vomiting|Nausea and Vomiting, Postoperative|Postoperative Nausea|Emesis, Postoperative|Postoperative Emeses"
NEW00255,DISEASE,tiredness,tiredness
NEW00256,NUTRITION,poly-unsaturated fatty acids,poly-unsaturated fatty acids
C067772,CHEMICAL,IdB 1016 [Supplementary Concept],Phosphatidylcholines|Silymarin|Silipide
D003865,DISEASE,"Depressive Disorder, Major","Depression, Involutional|Involutional Depression|Major Depressive Disorders|Major Depressive Disorder|Psychoses, Involutional|Involutional Melancholia|Involutional Paraphrenia|Involutional Paraphrenias|Paraphrenias, Involutional|Melancholia, Involutional|Major depressive disorders|Involutional Psychoses|Psychosis, Involutional|Depressive Disorders, Major|Paraphrenia, Involutional|Involutional Psychosis"
D005231,CHEMICAL,"Fatty Acids, Unsaturated","Unsaturated Fatty Acids|Polyunsaturated Fatty Acid|Acids, Polyunsaturated Fatty|PUFAs|Acid, Polyunsaturated Fatty|Fatty Acids, Polyunsaturated|Fatty Acid, Unsaturated|Polyunsaturated Fatty Acids|Acids, Unsaturated Fatty|Unsaturated Fatty Acid|Polyunsaturated fatty acids|Fatty Acid, Polyunsaturated|Acid, Unsaturated Fatty"
D051599,CHEMICAL,Glucose-1-Phosphate Adenylyltransferase,"ADP Glucose Synthetase|Synthase, ADP-Glucose|ADP Glucose Pyrophosphorylase|ADPGlucose Pyrophosphorylase|ADP-Glucose Pyrophosphorylase|Diphosphoglucose Pyrophosphorylase, Adenosine|Adenylyltransferase, Glucose-1-Phosphate|glucose|Pyrophosphorylase, ADP-Glucose|ADP-Glucose Synthetase|Pyrophosphorylase, ADPGlucose|ADP Glucose Synthase|Adenosine Diphosphoglucose Pyrophosphorylase|ADPG Synthetase|ADP-Glucose Synthase|Glucose 1 Phosphate Adenylyltransferase|Synthetase, ADPG|Synthetase, ADP-Glucose|Pyrophosphorylase, Adenosine Diphosphoglucose|Adenosine Diphosphate Glucose Pyrophosphorylase"
NEW00262,NUTRITION,n-3 long chain polyunsaturated fatty acids,n-3 long chain polyunsaturated fatty acids
NEW00264,CHEMICAL,n-3 long chain polyunsaturated fatty acids,n-3 long chain polyunsaturated fatty acids|n-3 LC-PUFA
NEW00265,DISEASE,seizure thresholds,seizure thresholds
C040048,CHEMICAL,caffeic acid [Supplementary Concept],Caffeic Acids|caffeic acid
NEW00268,CHEMICAL,weeks pioglitazone,weeks pioglitazone
NEW00271,BIOCHEMICAL,PPAR agonists,PPAR agonists
D045162,BIOCHEMICAL,Thiazolidinediones,Glitazones
NEW00273,CHEMICAL,serum alanine amino transferase concentrations,serum alanine amino transferase concentrations
D020790,DISEASE,"Diabetes Insipidus, Neurogenic","Diabetes Insipidus Cranial Type|Diabetes Insipidus, Neurohypophyseal|Diabetes Insipidus Secondary To Vasopressin Deficiency|Diabetes Insipidus, Primary Central|Neurogenic Diabetes Insipidus|Diabetes Insipidus, Cranial Type|Pituitary Diabetes Insipidus|Central Diabetes Insipidus|Diabetes Insipidus, Central|type diabetes|Vasopressin Deficiency|Neurohypophyseal Diabetes Insipidus|Diabetes Insipidus, Neurohypophyseal Type|Diabetes Insipidus Primary Central|Diabetes Insipidus, Pituitary|Vasopressin Defective Diabetes Insipidus"
D000077288,CHEMICAL,Troglitazone,"CS-045|CS 045|5-(4-((6-Hydroxy-2,5,7,8-tetramethylchroman-2-yl-methoxy)benzyl)-2,4-thiazolidinedione) - T|CS045|Rezulin|troglitazone|Prelay"
NEW00278,MENTAL_HEALTH,Improved insulin resistance,Improved insulin resistance
NEW00279,CHEMICAL,sulfonylurea use,sulfonylurea use
NEW00280,DISEASE,severe hypoglycemia,severe hypoglycemia
NEW00281,BIOCHEMICAL,peroxiproliferator-activated receptor gamma agonist pioglitazone,peroxiproliferator-activated receptor gamma agonist pioglitazone
NEW00282,DISEASE,familial AD-linked PSEN1 mutants,familial AD-linked PSEN1 mutants
NEW00283,MENTAL_HEALTH,fragile X mental retardation FMR1 gene,fragile X mental retardation FMR1 gene
NEW00285,BIOCHEMICAL,Endocrine changes,Endocrine changes
NEW00286,BIOCHEMICAL,GnRH agonists,GnRH agonists
D003277,CHEMICAL,"Contraceptives, Oral, Combined","Contraceptive, Combined Oral|Oral Contraceptives, Combined|Combined oral contraceptives|Contraceptive Agents, Female, Combined|Oral Contraceptive, Combined|Combined Oral Contraceptive|Contraceptives, Combined Oral|Combined Oral Contraceptives"
D055744,CHEMICAL,Invasive Pulmonary Aspergillosis,"Pulmonary Aspergilloses, Invasive|invasive pulmonary aspergillosis|Chronic Necrotizing Pulmonary Aspergillosis|Mycoses, Allergic Bronchopulmonary|Aspergillosis, Invasive Pulmonary|Allergic Bronchopulmonary Mycosis|Bronchopulmonary Mycoses, Allergic|Pulmonary Aspergillosis - Invasive|Pulmonary Aspergillosis Invasive|Pulmonary Aspergillosis, Invasive|Allergic Bronchopulmonary Mycoses|IPA|Mycosis, Allergic Bronchopulmonary|Bronchopulmonary Mycosis, Allergic"
D020230,DISEASE,Serotonin Syndrome,"Syndrome, Serotonin|Serotonin syndrome|Syndromes, Serotonin|toxicity|Serotonin Syndromes"
C051356,CHEMICAL,"isopropanol, phenol, salicylic acid drug combination [Supplementary Concept]",Salicylates|Drug Combinations|isopropanol
NEW00291,CHEMICAL,plasma corticosterone levels,plasma corticosterone levels
D050565,CHEMICAL,Benzoate 4-Monooxygenase,"4-Hydroxylase, Benzoate|Benzoate 4-Hydroxylase|4-Monooxygenase, Benzoate|Benzoate 4 Monooxygenase|Benzoate Para Hydroxylase|Benzoate-Para-Hydroxylase|Benzoate|Benzoate 4 Hydroxylase"
D020160,CHEMICAL,Sodium Benzoate,"Benzoate, Sodium|sodium benzoate"
NEW00293,MENTAL_HEALTH,Chronic stress,Chronic stress
NEW00294,BIOCHEMICAL,stress hormones,stress hormones
NEW00296,CHEMICAL,"pro-carcinogen 1,2-dimethylhydrazine","DMH|pro-carcinogen 1,2-dimethylhydrazine"
NEW00300,CHEMICAL,Fetal alcohol exposure,Fetal alcohol exposure
D034062,MENTAL_HEALTH,"Insomnia, Fatal Familial","insomnia|Fatal, Insomnia Familial|Familial Fatals, Insomnia|Insomnia Familial Fatals|Familial Fatal Insomnias|Insomnia, Familial Fatal|Familial Fatal Insomnia|Familial Fatal, Insomnia|Insomnias, Fatal Familial|Fatals, Insomnia Familial|Fatal Insomnia, Familial|Fatal Insomnias, Familial|Fatal Familial Insomnias|Insomnia Familial Fatal|Fatal Familial Insomnia|Insomnias, Familial Fatal"
C024025,CHEMICAL,"7,12-dimethylbenz(a)anthracene-5,6-dihydrodiol [Supplementary Concept]","7,12-dimethylbenz(a)anthracene|9,10-Dimethyl-1,2-benzanthracene/analogs  and  derivatives"
D020849,CHEMICAL,Raloxifene Hydrochloride,LY156758|raloxifene|LY139481|Raloxifene|Evista|LY-156758|LY 156758|Keoxifene|LY 139481|Raloxifene HCl|Keoxifene Hydrochloride|LY-139481
C057820,CHEMICAL,atrial natriuretic factor (7-23) [Supplementary Concept],Peptide Fragments|Alcohol|3.19|Atrial Natriuretic Factor
NEW00304,CHEMICAL,excessive alcohol intake,excessive alcohol intake
D054563,MENTAL_HEALTH,National Institute on Alcohol Abuse and Alcoholism (U.S.),alcohol abuse|National Institute on Alcohol Abuse and Alcoholism|NIAAA
D015197,BIOCHEMICAL,Carcinogenicity Tests,"Test, Carcinogenicity|Carcinogenic Activity Tests|Carcinogenic Potency Test|Carcinogenic Activity Test|Tests, Carcinogenic Potency|Test, Carcinogen|Carcinogen Test|Tests, Carcinogenicity|Tests, Carcinogen|Test, Carcinogenic Activity|Test, Tumorigenicity|Tests, Carcinogenic Activity|Potency Tests, Carcinogenic|Test, Carcinogenic Potency|Potency Test, Carcinogenic|Carcinogenesis Test|Test, Carcinogenesis|Tumorigenicity Test|Carcinogen Tests|Carcinogenicity Test|Tests, Carcinogenesis|Tests, Tumorigenicity|Tumorigenicity Tests|Carcinogenesis Tests|Carcinogenic Potency Tests|carcinogen"
NEW00307,MENTAL_HEALTH,binge alcohol abuse,binge alcohol abuse
D007538,CHEMICAL,Isoniazid,"Acid Vanillylidenehydrazide, Isonicotinic|Tubazide|Isoniazid|Hydrazide, Isonicotinic Acid|Phthivazid|Isonicotinic Acid Vanillylidenehydrazide|Ftivazide|Vanillylidenehydrazide, Isonicotinic Acid|Isonex|Phthivazide|Isonicotinic Acid Hydrazide"
D065819,CHEMICAL,Voriconazole,"UK 109,496|Voriconazole|Vfend|UK109,496|UK 109496|UK109496|UK-109496|UK-109,496"
D000072742,DISEASE,Invasive Fungal Infections,"Invasive Fungal Infection|Infection, Disseminated Fungal|Mycoses, Invasive|Fungal Infection, Invasive|Fungal Infection, Disseminated|Disseminated Fungal Infection|Invasive Mycoses|fungal infection|Infection, Invasive Fungal|Disseminated Fungal Infections"
NEW00315,CHEMICAL,single oral 4-mg rosiglitazone dose,single oral 4-mg rosiglitazone dose
D002176,DISEASE,Candida albicans,Myceloblastanon albicans|Syringospora albicans|Parasaccharomyces albicans|Mycotorula albicans|Procandida stellatoidea|Candida stellatoidea|Procandida albicans|Dematium albicans|Candida albicans var. stellatoidea|Candida albicans|Saccharomyces albicans|Monilia albicans
NEW00318,NUTRITION,icefish hearts,icefish hearts
NEW00320,CHEMICAL,Increased urine porphobilinogen excretion,Increased urine porphobilinogen excretion
D057233,CHEMICAL,Radio Frequency Identification Device,Radio Frequency Identification|•    Identification|RFID
D014914,CHEMICAL,Whole Blood Coagulation Time,"Activated Coagulation Time, Whole Blood|Blood Coagulation Time, Whole|Coagulation Time, Whole Blood|•    Whole blood"
NEW00322,CHEMICAL,chronic lead-exposure,chronic lead-exposure
NEW00323,MENTAL_HEALTH,Severe pain syndromes,Severe pain syndromes
D005198,DISEASE,Fanconi Syndrome,"Syndrome, Lignac-Fanconi|Adult Fanconi Syndrome|Pseudo-Phlorizin Diabetes|Fanconi Renotubular Syndrome|Syndrome, Adult Fanconi|Luder Sheldon Syndrome|Fanconi Bickel Syndrome|Proximal Renal Tubular Dysfunction|Renal Fanconi Syndrome|Fanconi Syndrome, Renal|Diabetes, Pseudo-Phlorizin|Fanconi Type Glycogenosis|De Toni-Debre-Fanconi Syndrome|Renotubular Syndrome, Fanconi|Glycogen Storage Disease XI|Syndrome, Fanconi|Syndrome, Fanconi Renotubular|Toni-Debre-Fanconi Syndrome|Pseudo Phlorizin Diabetes|Syndrome, Renal Fanconi|Fanconi-Bickel Syndromes|Luder-Sheldon Syndrome|Hepatorenal Glycogenosis with Renal Fanconi Syndrome|Fanconi Syndrome, Adult|Primary Toni-Debre-Fanconi Syndrome|Diabete, Pseudo-Phlorizin|Syndrome, Luder-Sheldon|Idiopathic De Toni-Debre-Fanconi Syndrome|Hepatic Glycogenosis with Amino Aciduria and Glucosuria|Syndrome, Fanconi Bickel|Glycogenosis, Fanconi Type|Pseudo-Phlorizin Diabete|Syndrome, Fanconi-Bickel|Lignac-Fanconi Syndrome|Fanconi Syndrome without Cystinosis|Bickel Syndrome, Fanconi|Hepatic Glycogenosis with Fanconi Nephropathy|Syndromes, Fanconi-Bickel|Fanconi Syndrome with Intestinal Malabsorption and Galactose Intolerance|Lignac Fanconi Syndrome|Fanconi-Bickel Syndrome|Neonatal De Toni-Debre-Fanconi Syndrome|tubular dysfunction"
D054818,CHEMICAL,Hexosaminidase A,beta-N-Acetylhexosaminidase A|beta N Acetylhexosaminidase A|Hex A
NEW00324,NUTRITION,fractionated porphyrins,fractionated porphyrins
NEW00325,DISEASE,acute hepatic porphyrias,acute hepatic porphyrias
D010383,DISEASE,Pellagra,Pellagras|pellagra
NEW00329,DISEASE,Skin photosensitivity,Skin photosensitivity
D036881,MENTAL_HEALTH,Long-Term Synaptic Depression,"Long-Term Depression, Physiological|Long-Term Depression, Neurophysiological|Depressions, Neurophysiological Long-Term|Depression, Homosynaptic|Homosynaptic Depression|Neurophysiologic Long-Term Depression|Long-Term Depressions, Physiological|Physiologic Long-Term Depression|Long-Term Depressions, Neurophysiological|Synaptic Depression, Long-Term|Long Term Depression, Neurophysiologic|Depression, Physiological Long-Term|Neurophysiological Long-Term Depressions|Long Term Synaptic Depression|Physiological Long-Term Depression|Long Term Depression, Physiological|Physiological Long-Term Depressions|Depression, Neurophysiological Long-Term|Depressions, Physiological Long-Term|Depotentiation|Depression|Long Term Depression, Neurophysiological|Long Term Depression, Physiologic|Long-Term Depression, Physiologic|Long-Term Depression, Neurophysiologic|Neurophysiological Long-Term Depression"
D060805,MENTAL_HEALTH,Performance Anxiety,"Performance Anxieties|Anxieties, Performance|Anxiety|Anxiety, Performance"
NEW00336,DISEASE,neurological disturbances,neurological disturbances
NEW00337,DISEASE,Alcoholic pellagra encephalopathy,Alcoholic pellagra encephalopathy
NEW00338,DISEASE,skin disturbances,skin disturbances
NEW00339,CHEMICAL,abnormal gamma-glutamyl transpeptidase,abnormal gamma-glutamyl transpeptidase
NEW00340,CHEMICAL,mean triglyceride values,mean triglyceride values
D017119,DISEASE,Porphyria Cutanea Tarda,Porphyria cutanea tarda|Porphyria (1966-1992)
NEW00341,CHEMICAL,direct-acting antivirals,direct-acting antivirals|DAA
D014575,CHEMICAL,Uroporphyrinogen Decarboxylase,"Decarboxylase, Uroporphyrinogen III|Uroporphyrinogen Carboxy Lyase|Decarboxylase, Uroporphyrinogen|Uroporphyrinogen III Decarboxylase|Carboxy-Lyase, Uroporphyrinogen|uroporphyrinogen decarboxylase|Uroporphyrinogen Carboxy-Lyase"
NEW00344,DISEASE,chronic viral infection,chronic viral infection
NEW00345,CHEMICAL,polyhalogenated cyclic hydrocarbons,polyhalogenated cyclic hydrocarbons
D011166,NUTRITION,Porphyrins,Porphyrin|porphyrins
NEW00347,CHEMICAL,fermentopathy,fermentopathy
NEW00349,DISEASE,motor neuropathy symptoms,motor neuropathy symptoms
D015746,DISEASE,Abdominal Pain,"Pains, Colicky|Pains, Abdominal|Colicky Pains|abdominal pain|Colicky Pain|Pain, Abdominal|Pain, Colicky|Abdominal Pains"
NEW00350,NUTRITION,Urinary porphyrins,Urinary porphyrins
NEW00352,DISEASE,severe ASDs,severe ASDs
NEW00355,NUTRITION,mercury intoxication,mercury intoxication
C546511,CHEMICAL,5-aminolevulinic acid heptyl ester [Supplementary Concept],5-ALA|5-aminolevulinic acid|Aminolevulinic Acid/antagonists  and  inhibitors
D054577,BIOCHEMICAL,National Institute on Drug Abuse (U.S.),Drug abuse|National Institute on Drug Abuse|NIDA (US)
D019965,DISEASE,Neurocognitive Disorders,"Organic Brain Syndrome, Nonpsychotic|Psychoses, Traumatic|cognitive disorders|Organic Mental Disorders|Delirium, Dementia, Amnestic, Cognitive Disorders|Disorder, Neurocognitive|Disorders, Neurocognitive|Nonpsychotic Organic Brain Syndrome|Disorders, Organic Mental|Mental Disorder, Organic|Traumatic Psychoses|Mental Disorders, Organic|Kandinsky Syndrome|Organic Mental Disorders, Psychotic|Neurocognitive Disorder|Clerambault Syndrome|Organic Mental Disorder"
D000082922,DISEASE,HIV Testing,"Testing, HIV|HIV infection|HIV-AIDS Testing|HIV AIDS Testing|Diagnosis, HIV Infection|HIV Infection Diagnosis|Testing, AIDS|AIDS Testing|Testing, HIV-AIDS"
NEW00359,CHEMICAL,CD14+CD16,CD14+CD16
NEW00361,DISEASE,HIV infected drug abusers,HIV infected drug abusers
NEW00363,CHEMICAL,elevated extracellular dopamine,elevated extracellular dopamine
D018491,BIOCHEMICAL,Dopamine Agonists,"Agonist, Dopamine Receptor|Agonists, Dopamine|Dopamine Receptor Agonist|Receptor Agonist, Dopamine|Dopaminergic Agonist|Agonist, Dopaminergic|Dopamine Receptor Agonists|Dopaminergic Agonists|Agonists, Dopaminergic|Agonist, Dopamine|dopamine agonist|Agonists, Dopamine Receptor|Receptor Agonists, Dopamine|Dopamine Agonist"
NEW00365,BIOCHEMICAL,D2 dopamine agonist,D2 dopamine agonist
C047508,CHEMICAL,rotigotine [Supplementary Concept],Tetrahydronaphthalenes|Rotigotine|Thiophenes
D001058,CHEMICAL,Apomorphine,"Apomorphin-Teclapharm|Apokinon|Apomorphin Teclapharm|Apomorphine Hydrochloride Anhydrous|Britaject|Apomorphine Hydrochloride, Hemihydrate|Apomorphine Chloride|Apomorphine Hydrochloride, Anhydrous|Apomorphine Hydrochloride|apomorphine"
D000077487,CHEMICAL,Pramipexole,"Sifrol|Pramipexol|2-Amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole|SND919CL2x|Pramipexole|4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazole-diamine|SND-919CL2x|SND 919CL2x|SND 919|Pramipexol Dihydrobromide, (+-)-isomer|6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydrochloride monohydrate|Mirapex|Dexpramipexole|Pramipexol, (R)-isomer|KNS-760704|Pramipexole Hydrochloride Monohydrate|Pramipexole Dihydrochloride Anhydrous|KNS 760704|2-Amino-6-propylaminotetrahydrobenzothiazole|Pramipexole Dihydrochloride|2 Amino 6 propylaminotetrahydrobenzothiazole|SND-919|KNS760704|Pramipexol, (+-)-isomer|Pramipexol Dihydrochloride, (S)-isomer"
D000077432,CHEMICAL,Tapentadol,"3-((1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl)phenol|Nucynta|Tapentadol|Tapentadol Hydrochloride"
C557247,CHEMICAL,oxycodone naloxone combination [Supplementary Concept],Drug Combinations|Targinact|Naloxone|Oxycodone
NEW00366,BIOCHEMICAL,opioid agonist oxycodone,opioid agonist oxycodone
NEW00367,BIOCHEMICAL,central-acting oral analgesic,central-acting oral analgesic
D000068760,CHEMICAL,Serotonin and Noradrenaline Reuptake Inhibitors,Serotonin and Norepinephrine Uptake Inhibitors|Serotonin and Noradrenaline Uptake Inhibitors|Serotonin and Norepinephrine Reuptake Inhibitors|SSRIs and NRIs|SNRI|NRIs and SSRIs|norepinephrine reuptake inhibitors|SNRIs
NEW00368,CHEMICAL,native dopamine D(2)-like receptors,native dopamine D(2)-like receptors
NEW00369,CHEMICAL,nonergoline dopamine receptor agonist,nonergoline dopamine receptor agonist
C046649,CHEMICAL,ropinirole [Supplementary Concept],Indoles|ropinirole
D020734,DISEASE,Parkinsonian Disorders,"Parkinsonian Syndromes|MPTP Induced Experimental Parkinsonism|Experimental Parkinsonism, MPTP-Induced|Parkinson Diseases, Experimental|Chromosome 6 Linked Autosomal Recessive Parkinsonism|Familial Parkinson Disease, Autosomal Recessive|Parkinson Disease 2, Autosomal Recessive Juvenile|Juvenile Parkinson Disease, Autosomal Dominant|Parkinsonism, Familial Juvenile|Autosomal Recessive Juvenile Parkinson Disease|Parkinsonism, Juvenile, Autosomal Dominant|Parkinsonism, Juvenile, Autosomal Recessive|Parkinsonian Diseases|Experimental Parkinson Diseases|Parkinson Disease, Juvenile, Autosomal Dominant|Parkinson Disease, Juvenile, Autosomal Recessive|Parkinson Disease, Juvenile|Chromosome 6-Linked Autosomal Recessive Parkinsonism|Parkinsonism, Experimental|Parkinsonism, Early Onset, with Diurnal Fluctuation|Parkinsonism|Parkinsonism, MPTP-Induced Experimental|Autosomal Dominant Parkinsonism|Juvenile Parkinsonisms|Dominant Parkinsonism, Autosomal|Autosomal Dominant Juvenile Parkinsonism|Juvenile Parkinson Disease, Autosomal Recessive|Parkinson Disease 2|Parkinsonism, Autosomal Dominant|Recessive Parkinsonism, Autosomal|Parkinson Disease Autosomal Recessive, Early Onset|Diseases, Experimental Parkinson|Parkinson Disease, Autosomal Dominant. Juvenile|Parkinsonism, Juvenile|Juvenile Parkinsonism, Autosomal Recessive|Autosomal Dominant Juvenile Parkinson Disease|Ramsay Hunt Paralysis Syndrome|Parkinson Disease, Experimental|Juvenile Parkinsonism|Juvenile Parkinson Disease|Familial Juvenile Parkinsonism|Autosomal Recessive Parkinsonism|Parkinsonisms, Experimental|Juvenile Parkinsonism, Familial|MPTP-Induced Experimental Parkinsonism|Experimental Parkinsonism, MPTP Induced|Parkinson Disease, Familial, Autosomal Recessive|Experimental Parkinson Disease|Experimental Parkinsonisms|Experimental Parkinsonism|Parkinsonism, Autosomal Recessive|Parkinsonisms, Juvenile|Juvenile Parkinsonism, Autosomal Dominant|Parkinsonian Syndrome|Autosomal Recessive Juvenile Parkinsonism|Parkinsonism, Early-Onset, With Diurnal Fluctuation"
D017265,CHEMICAL,Procaterol,"monohydrochloride|Procaterol Monohydrochloride, (R*,R*)-(+)-Isomer|CI-888|CI 888|CI888|OPC2009|Pro Air|Procaterol, (R*,S*)-(-)-Isomer|Procaterol Monohydrochloride, (R*,R*)-(+-)-Isomer|Hydrochloride, Procaterol|Procaterol, (R*,R*)-(+-)-Isomer|ProAir|(R*,S*)-(+-)-8-Hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)butyl)-2(1H)-quinolinone|OPC 2009|Procaterol Hydrochloride|OPC-2009|Procaterol Monohydrochloride, (R*,S*)-(+)-Isomer|Pro-Air|Monohydrochloride, Procaterol|Procaterol Monohydrochloride|Procaterol Monohydrochloride, (R*,S*)-(-)-Isomer|Procaterol Monohydrochloride, (R*,R*)-(-)-Isomer"
D050637,CHEMICAL,"Receptors, Dopamine D3","Dopamine D3 Receptors|Receptor, Dopamine-D3|dopamine D3 receptor|Dopamine-D3 Receptor|Dopamine D3 Receptor|Dopamine Receptor D3"
NEW00375,CHEMICAL,dopamine depletion,dopamine depletion
D007649,CHEMICAL,Ketamine,Ketamine|2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone|CI-581|Kalipsol|Calypsol|CI581|CI 581|Ketaset|Ketalar|Ketamine Hydrochloride|Ketanest|Calipsol
NEW00376,BIOCHEMICAL,non-competitive NMDA receptor antagonist,non-competitive NMDA receptor antagonist
D016194,CHEMICAL,"Receptors, N-Methyl-D-Aspartate","N Methyl D Aspartate Receptor|Receptors, N-Methylaspartate|NMDA Receptor|NMDA receptors|N Methylaspartate Receptors|Receptors, N Methyl D Aspartate|N-Methyl-D-Aspartate Receptors|N-Methylaspartate Receptors|Receptor, N-Methyl-D-Aspartate|Receptors, N Methylaspartate|Receptor, NMDA|N-Methyl-D-Aspartate Receptor|N Methyl D Aspartate Receptors|NMDA Receptors|Receptors, NMDA|NMDA Receptor-Ionophore Complex|NMDA Receptor Ionophore Complex"
NEW00377,DISEASE,tamoxifen-treated,tamoxifen-treated
NEW00379,CHEMICAL,17α-estradiol,17α-estradiol
D042724,BIOCHEMICAL,"Estrogens, Esterified (USP)",Esterified Estrogens (USP)|estrogens
D001971,CHEMICAL,Bromocriptine,"2-Bromoergocryptine|2 Bromoergocryptine Mesylate|2 Bromo alpha ergokryptine|Bromocriptin|CB 154|Mesylate, 2-Bromoergocryptine|CB154|2-Bromoergocryptine Methanesulfonate|CB-154|Parlodel|2-Bromo-alpha-ergocryptine|bromocriptine|2-Bromoergokryptine|2-Bromo-alpha-ergokryptine|Mesylate, Bromocriptine|2 Bromoergocryptine Methanesulfonate|Bromocriptine Mesylate|2 Bromoergokryptine|Bromocryptin|2-Bromoergocryptine Mesylate|2 Bromo alpha ergocryptine|Methanesulfonate, 2-Bromoergocryptine|2 Bromoergocryptine"
NEW00382,CHEMICAL,Low dopamine levels,Low dopamine levels
D000929,CHEMICAL,"Antidepressive Agents, Tricyclic","Tricyclic Antidepressive Agent|Agents, Tricyclic Antidepressive|Agent, Tricyclic Antidepressive|Antidepressant Drug, Tricyclic|Tricyclic Antidepressants|Tricyclic Antidepressant|Antidepressant Drugs, Tricyclic|Antidepressant, Tricyclic|Tricyclic Antidepressive Agents|Drugs, Tricyclic Antidepressant|Antidepressive Agent, Tricyclic|Antidepressants, Tricyclic|antidepressant|Tricyclic Antidepressant Drug|Drug, Tricyclic Antidepressant|Tricyclic Antidepressant Drugs"
D005473,CHEMICAL,Fluoxetine,Sarafem|N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine|Lilly110140|Fluoxetin|Fluoxetine Hydrochloride|Lilly 110140|Lilly-110140|Prozac|Fluoxetine
NEW00384,DISEASE,depressive-like behavior,depressive-like behavior
NEW00385,CHEMICAL,rotigotine-loaded microspheres,rotigotine-loaded microspheres|RoMS
NEW00386,DISEASE,Antipsychotic-induced hyperprolactinaemia,Antipsychotic-induced hyperprolactinaemia
NEW00387,MENTAL_HEALTH,Severe impulse control disorders,Severe impulse control disorders
NEW00391,CHEMICAL,Subcutaneous apomorphine,Subcutaneous apomorphine
C100146,CHEMICAL,trimethobenzamide [Supplementary Concept],trimethobenzamide|Benzamides
D004294,CHEMICAL,Domperidone,"Domperidon-TEVA|Novo-Domperidone|Péridys|R33,812|Monohydrochloride, Domperidone|R33812|Domperidone Monohydrochloride|Motilium|Apo-Domperidone|Domperidon|R-33812|Apo Domperidone|Gastrocure|Domperidon AL|Nu Domperidone|Stada, Domperidon|R-33,812|Ratio Domperidone|Domperidone Maleate|Domperidon TEVA|Domperidona Gamir|Domidon|Hexal, Domperidon|Domperidone Maleate (1:1)|PMS-Domperidone|Novo Domperidone|Domperidon Stada|Nu-Domperidone|Ratio-Domperidone|Gamir, Domperidona|Domperidone|Maleate, Domperidone|PMS Domperidone|Domperidon Hexal|Nauzelin"
NEW00395,DISEASE,nausea hypotension,nausea hypotension
D006212,MENTAL_HEALTH,Hallucinations,"Gustatory Hallucinations|Hallucinations, Organic|Sensory Hallucinations|Hallucinations, Elementary|Hallucination, Kinesthetic|Hallucination, Mood Incongruent|Hallucinations|Visual Hallucinations|Hallucinations, Auditory|Hallucinations, Internal Body Sensation|Tactile Hallucinations|Hallucinations, Sensory|Elementary Hallucination|Hallucinations, Visual, Formed|Hallucinations, Somatic|Olfactory Hallucinations|Verbal Auditory Hallucinations|Hallucination, Organic|Hypnagogic Hallucinations|Auditory Hallucination, Verbal|Reflex Hallucination|Hallucinations, Visual|Hallucination, Auditory|Mood Congruent Hallucination|Mood Incongruent Hallucinations|Dissociative Hallucinations|Hallucination, Gustatory|Hallucinations, Hypnapompic|Kinesthetic Hallucinations|Reflex Hallucinations|Hallucination, Somatic|Hallucination, Mood Congruent|Mood Congruent Hallucinations|Hallucination, Visual|Hallucination of Body Sensation|Hallucination, Dissociative|Auditory Hallucinations|Hallucination, Elementary|Hallucinations, Mood Incongruent|Tactile Hallucination|Hypnapompic Hallucination|Hallucination, Sensory|Auditory Hallucinations, Verbal|Hallucinations, Dissociative|Hallucinations, Gustatory|Mood Incongruent Hallucination|Elementary Hallucinations|Hallucinations, Visual, Unformed|Hallucinations, Verbal Auditory|Olfactory Hallucination|Visual Hallucination|Hallucination, Verbal Auditory|Hallucination, Reflex|Hypnagogic Hallucination|Kinesthetic Hallucination|Body Sensation Hallucinations|Hallucinations, Mood Congruent|Hallucinations, Kinesthetic|Somatic Hallucination|Organic Hallucinations|Sensory Hallucination|Verbal Auditory Hallucination|Gustatory Hallucination|Hallucination, Olfactory|Somatic Hallucinations|Organic Hallucination|Hallucination, Tactile|Hallucinations, Olfactory|Hallucinations, Hypnagogic|Hypnapompic Hallucinations|Hallucination|Hallucinations, Reflex|Dissociative Hallucination|Body Sensation Hallucination|Auditory Hallucination|Hallucination, Hypnagogic|Hallucinations, Formed, of People|Hallucinations, Tactile|Hallucination, Hypnapompic"
NEW00396,CHEMICAL,apomorphine test,apomorphine test
NEW00398,MENTAL_HEALTH,atypical parkinsonian syndromes,atypical parkinsonian syndromes
NEW00399,CHEMICAL,profile apomorphine,profile apomorphine
D000069445,CHEMICAL,Atomoxetine Hydrochloride,"N-methyl-gamma-(2-methylphenoxy)benzenepropanamine hydrochloride|Strattera|Tomoxetine Hydrochloride, (-)-isomer|Atomoxetine HCl|Tomoxetine Hydrochloride, (+)-isomer - T351671|HCl, Atomoxetine|Hydrochloride, Atomoxetine|139603, LY|Tomoxetine Hydrochloride, (+-)-isomer|LY 139603|Tomoxetine|Atomoxetine"
D052244,BIOCHEMICAL,Endocrine Disruptors,"endocrine disruptor|Disruptors, Endocrine|Chemical, Endocrine Disrupting|Endocrine Disrupting Chemicals|Disrupting Chemical, Endocrine|Disruptor, Endocrine|Endocrine Disruptor Effects|Chemicals, Endocrine Disrupting|Effect, Endocrine Disruptor|Disruptor Effects, Endocrine|Effects, Endocrine Disruptor|Endocrine Disruptor Effect|Disruptor Effect, Endocrine|Endocrine Disruptor|Endocrine Disrupting Chemical"
NEW00401,CHEMICAL,dopamine auto,dopamine auto
D000547,CHEMICAL,Amantadine,"Viregyt|Juventus, Amantadina|Amixx|Amantadin-ratiopharm|Infecto Flu|PMS-Amantadine|Infex|Midantan|Amanta Sulfate AZU|1 Aminoadamantane|Cerebramed|Amanta-HCI-AZU|Amantadin Stada|Hydrochloride, Amantadine|Symmetrel|Adamantylamine|AmantaSulfateAZU|AL, Amantadin|InfectoFlu|PMSAmantadine|Symadine|Adekin|Amantadin AZU|Amantadine Sulfate|Amantadin ratiopharm|Endantadine|AZU, Amantadin|Amantadinneuraxpharm|Wiregyt|1-Aminoadamantane|Amanta|Gen-Amantadine|tregor|Amantadin neuraxpharm|Amantadina Juventus|Sulfate, Amantadine|PMS Amantadine|Stada, Amantadin|Amanta-Sulfate-AZU|Amantadinratiopharm|Llorente, Amantadina|Amantadina Llorente|AmantaHCIAZU|Mantadix|Amantadine Hydrochloride|Amanta HCI AZU|Amantadin AL|GenAmantadine|Amantadin-neuraxpharm|Amantadine|Infecto-Flu|Aman|Gen Amantadine"
NEW00403,CHEMICAL,Intracellular amyloid β-protein,Intracellular amyloid β-protein
NEW00404,CHEMICAL,A147E,A147E|HbCLP2
NEW00406,CHEMICAL,α(2)-adrenergic agonist,clonidine|α(2)-adrenergic agonist
NEW00407,CHEMICAL,Stellate ganglion block,Stellate ganglion block|SGB
D019161,CHEMICAL,Hydroxymethylglutaryl-CoA Reductase Inhibitors,"Reductase Inhibitors, Hydroxymethylglutaryl-CoA|Hydroxymethylglutaryl-Coenzyme A Inhibitors|Hydroxymethylglutaryl CoA Reductase Inhibitor|Inhibitors, HMG CoA Reductase|Hydroxymethylglutaryl CoA Reductase Inhibitors|HMG CoA Reductase Inhibitors|Inhibitors, Hydroxymethylglutaryl-CoA Reductase|HMG-CoA Statins|Inhibitors, Hydroxymethylglutaryl Coenzyme A|HMG CoA Reductase Inhibitor|Inhibitors, Hydroxymethylglutaryl-Coenzyme A|HMG-CoA Reductase Inhibitor|Inhibitors, HMG-CoA Reductase|Statins|HMG-CoA Reductase Inhibitors|Inhibitors, Hydroxymethylglutaryl CoA|Statins, HMG-CoA|Statins, HMG CoA|Statin|Hydroxymethylglutaryl-CoA Inhibitors|Reductase Inhibitor, Hydroxymethylglutaryl-CoA|Reductase Inhibitors, HMG-CoA|Inhibitors, Hydroxymethylglutaryl-CoA|Hydroxymethylglutaryl-CoA Reductase Inhibitor"
NEW00409,BIOCHEMICAL,acting sympatholytics,acting sympatholytics
NEW00410,NUTRITION,alpha 2-adrenoceptor,alpha 2-adrenoceptor
D012735,MENTAL_HEALTH,"Sexual Dysfunction, Physiological","Sexual Dysfunctions, Physiological|sexual dysfunction|Physiological Sexual Dysfunction|Sexual Disorder, Physiological|Sexual Disorders, Physiological|Physiological Sexual Disorder|Sex Disorders|Physiological Sexual Disorders|Physiological Sexual Dysfunctions"
D000806,CHEMICAL,Angiotensin-Converting Enzyme Inhibitors,"Inhibitors, ACE|Enzyme Antagonists, Angiotensin-Converting|Angiotensin-Converting Enzyme Inhibitor|Kininase II Inhibitor|Angiotensin Converting Enzyme Inhibitor|Inhibitor, ACE|Inhibitors, Angiotensin Converting Enzyme|Inhibitors, Angiotensin-Converting Enzyme|ACE Inhibitor|Angiotensin I-Converting Enzyme Inhibitor|Angiotensin I-Converting Enzyme Inhibitors|Angiotensin I Converting Enzyme Inhibitor|Angiotensin Converting Enzyme Inhibitors|Angiotensin-Converting Enzyme Antagonists|Kininase II Antagonists|Kininase II Inhibitors|Inhibitor, Kininase II|Angiotensin I Converting Enzyme Inhibitors|Enzyme Inhibitors, Angiotensin-Converting|Antagonists, Angiotensin-Converting Enzyme|ACE Inhibitors|Inhibitor, Angiotensin-Converting Enzyme|Antagonists, Angiotensin Converting Enzyme|Inhibitors, Kininase II|Enzyme Inhibitor, Angiotensin-Converting|ACE inhibitors|Angiotensin Converting Enzyme Antagonists|II Inhibitor, Kininase|Antagonists, Kininase II"
NEW00413,DISEASE,hypertensive patient,hypertensive patient
NEW00414,BIOCHEMICAL,Antiarrhythmic drug therapy,Antiarrhythmic drug therapy
D000638,CHEMICAL,Amiodarone,"Trangorex|Amiodarona|Tachydaron|Amiodarex|Braxan|Amiodarone Hydrochloride|SKF 33134 A|L 3428|Amiohexal|L3428|SKF 33134A|Cordarex|Aratac|Cordarone|Amiobeta|Corbionax|Hydrochloride, Amiodarone|Amiodarone|Rytmarone|L-3428|SKF 33134-A|Ortacrone|Kordaron"
NEW00415,CHEMICAL,class III/IA agents,class III/IA agents
NEW00417,DISEASE,de pointes,de pointes
D016171,DISEASE,Torsades de Pointes,"Torsade de Pointes|Pointes, Torsade de|torsade|Pointes, Torsades de|de Pointes, Torsades|de Pointes, Torsade"
D059787,DISEASE,Acute Pain,"Pains, Acute|Pain, Acute|pain|Acute Pains"
D010698,MENTAL_HEALTH,Phobic Disorders,"Phobic Disorder|Claustrophobia|School Phobias|Phobias, School|Phobic Neuroses|Phobias|Disorder, Phobic|Neuroses, Phobic|Disorders, Phobic|Phobia|Phobia, School|School Phobia|Claustrophobias|claustrophobia"
NEW00419,BIOCHEMICAL,analgesic effects,analgesic effects
NEW00422,MENTAL_HEALTH,Perioperative anxiety,Perioperative anxiety
D000071257,MENTAL_HEALTH,Emergence Delirium,"Anesthesia Emergence Delirium|Emergence Excitement|Emergence Agitation|Agitated Emergence|Agitations, Emergence|Emergence Delirium, Anesthesia|Agitation, Emergence|Postanesthetic Excitement|Delirium, Emergence|Excitement, Emergence|Delirium, Anesthesia Emergence|Emergence, Agitated|Emergence agitation|Excitement, Postanesthetic"
D004414,MENTAL_HEALTH,Dyspareunia,Dyspareunia|Vulvar Vestibulitis
NEW00427,DISEASE,pain patients,pain patients
D002188,CHEMICAL,Cannabis,"Plant, Hemp|Hemps|Marijuana|Cannabi|Cannabis indica|cannabis|Hemp|Hemp Plant|Cannabis sativa|Hashishs|Ganja|Ganjas|Bhang|Hashish|Plants, Hemp|Marihuana|Hemp Plants|Bhangs"
NEW00430,CHEMICAL,cannabis smokers =,cannabis smokers =
NEW00432,CHEMICAL,Terminalia ivorensis A. Chev,Terminalia ivorensis A. Chev
C014215,CHEMICAL,tetrahydropalmatine [Supplementary Concept],Tetrahydropalmatine|THP|Berberine Alkaloids
D015667,CHEMICAL,Acupuncture Analgesia,"Analgesia, Acupuncture|Anesthesia, Acupuncture|Acupuncture Anesthesia|acupuncture anesthesia"
D020927,CHEMICAL,Dexmedetomidine,"MPV-1440|Dexmedetomidine Hydrochloride|dexmedetomidine|Precedex|Hydrochloride, Dexmedetomidine|MPV1440|MPV 1440"
D013312,MENTAL_HEALTH,"Stress, Physiological","Stress, Biotic|Physiological Stress Response|Biotic Stresses|Response, Metabolic Stress|Reaction, Abiotic Stress|Physiological Stress Reactions|Abiotic Stress Reaction|Physiological Stress|Abiotic Stress|Metabolic Stress Responses|Stress, Metabolic|Abiotic Stresses|stress reactions|Metabolic Stress|Abiotic Stress Reactions|Abiotic Stress Response|Stress Response, Physiological|Physiological Stress Reaction|Stress, Biological|Physiological Stress Reactivity|Biological Stress|Metabolic Stresses|Reactions, Abiotic Stress|Abiotic Stress Responses|Stress, Abiotic|Physiological Stresses|Metabolic Stress Response|Physiological Stress Responses|Response, Abiotic Stress|Biotic Stress|Stress Response, Metabolic|Biological Stresses|Stress Reaction, Physiological"
D000068882,CHEMICAL,Paliperidone Palmitate,"Palmitate, Paliperidone|9 Hydroxy risperidone|R-76477|Sustenna, Invega|9-Hydroxyrisperidone|R76477|3-(2-(4-(6-fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one|9-OH-risperidone|R 76477|9-Hydroxy-risperidone|Invega Sustenna|9 Hydroxyrisperidone|Invega|Paliperidone|9 OH risperidone"
NEW00245,MENTAL_HEALTH,preoperative anxiety,preoperative anxiety
NEW00440,CHEMICAL,thiocyanoacetamide,thiocyanoacetamide
NEW00441,BIOCHEMICAL,Analgesic activity,Analgesic activity
C052509,CHEMICAL,bulleyaconitine A [Supplementary Concept],Bulleyaconitine A|Aconitine/analogs  and  derivatives
NEW00445,DISEASE,chronic visceral pain,chronic visceral pain
NEW00450,BIOCHEMICAL,analgesic armamentarium,analgesic armamentarium
NEW00452,CHEMICAL,natural diallyl disulfide,natural diallyl disulfide
NEW00454,DISEASE,associated strength deficits,associated strength deficits
C028009,CHEMICAL,diallyl disulfide [Supplementary Concept],DADS|Disulfides|Allyl Compounds|diallyl disulfide
NEW00455,CHEMICAL,GYY4137 slow-releasing H2S donors,GYY4137 slow-releasing H2S donors
NEW00456,CHEMICAL,slow-releasing H2S donors,slow-releasing H2S donors
C529376,CHEMICAL,GYY 4137 [Supplementary Concept],Organothiophosphorus Compounds|GYY4137|Morpholines
C412584,CHEMICAL,DADS-C12 [Supplementary Concept],Benzenesulfonates|diallyl disulfide|DADS
NEW00457,CHEMICAL,H2S donors,H2S donors
D020950,CHEMICAL,Vitex,"Vitex agnus-castus|Chaste Tree|Chasteberries|Tree, Chasteberry|Chaste Trees|Vitex agnus castus|chaste tree|Chastetrees|Trees, Chaste|Vitex rotundifolia|Chasteberry|Chastetree|Chasteberry Tree|Trees, Chasteberry|Chasteberry Trees|Tree, Chaste"
NEW00459,BIOCHEMICAL,analgesic efficacy,analgesic efficacy
D017116,DISEASE,Low Back Pain,"Pain, Lower Back|Low Backache|Back Pains, Lower|Back Pain, Lower|Backaches, Low|Pains, Low Back|Low Back Pains|Ache, Low Back|Aches, Low Back|Low Back Pain, Posterior Compartment|Pain, Low Back|Mechanical Low Back Pain|Low Backaches|Low Back Aches|Low Back Ache|Back Aches, Low|Low Back Pain, Mechanical|Back Ache, Low|Back Pain, Low|Lower Back Pain|Postural Low Back Pain|Backache, Low|Back Pains, Low|Low Back Pain, Recurrent|back pain|Low Back Pain, Postural|Pains, Lower Back|Recurrent Low Back Pain|Lumbago|Lower Back Pains"
D026881,DISEASE,Acupuncture,Acupuncture|Pharmacopuncture
NEW00462,MENTAL_HEALTH,Anxiety conditions,Anxiety conditions
NEW00464,CHEMICAL,IDAZ,IDAZ
NEW00466,BIOCHEMICAL,selective α2C-AR antagonists,selective α2C-AR antagonists
D002185,CHEMICAL,Cannabidiol,"1,3-Benzenediol, 2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, (1R-trans)-|cannabidiol|CBD|Epidiolex"
D006992,DISEASE,"Hypnosis, Dental","Dental Hypnosis|Dental Hypnoses|Hypnoses, Dental|Hypnosis"
D055770,MENTAL_HEALTH,Interpleural Analgesia,"Interpleural Analgesias|Analgesia, Intrapleural|Analgesias, Interpleural|Intrapleural Analgesia|analgesia|Analgesia, Interpleural"
D000425,MENTAL_HEALTH,Alcohol Amnestic Disorder,"Alcohol-Induced Amnestic Psychosis|Psychosis, Alcohol-Induced Dysmnesic|Alcohol Induced Dysmnesic Syndrome|Alcohol-Induced Amnestic Syndromes|Alcohol-Induced Dysmnesic Syndrome|Psychoses, Alcohol-Induced Amnestic|Dysmnesic Psychosis, Alcohol-Induced|Dysmnesic Psychoses, Alcohol-Induced|Psychoses, Alcohol-Induced Dysmnesic|Dysmnesic Syndrome, Alcohol-Induced|Alcohol Amnestic Syndromes|Alcohol-Induced Persisting Amnestic Disorder|Amnestic Syndromes, Alcohol-Induced|Alcohol Amnestic Disorders|Alcohol Induced Amnestic Psychosis|Dysmnesic Syndromes, Alcohol-Induced|Alcohol-Induced Dysmnesic Syndromes|Alcohol Induced Amnestic Syndrome|Amnestic Disorder, Alcohol|Alcohol-Induced Amnestic Syndrome|Amnestic Syndrome, Alcohol-Induced|Amnestic Psychoses, Alcohol-Induced|Alcohol-Induced Amnestic Psychoses|psychosis|Alcohol-Induced Dysmnesic Psychoses|Alcohol Amnestic Syndrome|Psychosis, Alcohol-Induced Amnestic|Alcohol Induced Dysmnesic Psychosis|Alcohol Induced Persisting Amnestic Disorder|Amnestic Psychosis, Alcohol Induced|Alcohol-Induced Dysmnesic Psychosis|Amnestic Psychosis, Alcohol-Induced"
NEW00471,MENTAL_HEALTH,Butorphanol's postoperative analgesia,Butorphanol's postoperative analgesia
NEW00061,CHEMICAL,d)furan-5(6H)-one,d)furan-5(6H)-one|naloxone
D002077,CHEMICAL,Butorphanol,"butorphanol|17-(Cyclobutylmethyl)morphinan-3,14-diol|Moradol|Stadol|Dolorex|BC 2627|Torbugesic|BC2627|Beforal|Stadol NS|Apo-Butorphanol|BC-2627|Butorphanol Tartrate"
NEW00474,CHEMICAL,Medium concentration,Medium concentration
C068615,CHEMICAL,paracetamol sulfotransferase [Supplementary Concept],Paracetamol|Sulfotransferases
NEW00475,CHEMICAL,N-acetyl-p-benzo-quinone-imine,N-acetyl-p-benzo-quinone-imine
NEW00477,DISEASE,liver damage,liver damage
D010146,DISEASE,Pain,"Aches|Burning Pains|Crushing Pains|Sufferings, Physical|Splitting Pain|Pain, Radiating|Physical Sufferings|Radiating Pains|Radiating Pain|Pains, Burning|Pains, Migratory|Pains, Splitting|Migratory Pains|Ache|Migratory Pain|Pains, Radiating|Pain, Splitting|Suffering, Physical|Pain, Burning|Splitting Pains|physical pain|Pain, Crushing|Crushing Pain|Burning Pain|Pains, Crushing|Physical Suffering|Pain, Migratory"
NEW00478,BIOCHEMICAL,non-medical analgesic use,non-medical analgesic use
D016739,DISEASE,"Behavior, Addictive","addictive behaviors|Behaviors, Addictive|Addictive Behaviors|Addictive Behavior"
NEW00480,MENTAL_HEALTH,Anxiety scores,Anxiety scores
NEW00481,DISEASE,overall functional impairment,overall functional impairment
NEW00482,MENTAL_HEALTH,headache frequency,headache frequency
D060486,DISEASE,Ophthalmoplegic Migraine,"Ophthalmoplegic Migraine Syndrome|Migraine Syndromes, Ophthalmoplegic|Syndrome, Ophthalmoplegic Migraine|Ophthalmoplegic Migraines|Migraines, Ophthalmoplegic|Ophthalmoplegic Migraine Syndromes|migraine|Migraine Syndrome, Ophthalmoplegic|Migraine, Ophthalmoplegic|Syndromes, Ophthalmoplegic Migraine"
NEW00483,DISEASE,CBTs,CBTs
C499681,CHEMICAL,Ralfinamide [Supplementary Concept],Fluorobenzenes|Ralfinamide
NEW00485,BIOCHEMICAL,analgesic effect,analgesic effect
NEW00486,DISEASE,pain-related behavior,pain-related behavior
NEW00490,CHEMICAL,male sex hormone,testosterone|male sex hormone
NEW00492,BIOCHEMICAL,Stress-induced weak androgens,Stress-induced weak androgens
NEW00494,BIOCHEMICAL,estrogen depletion,estrogen depletion
NEW00499,CHEMICAL,pregabalin administration,pregabalin administration
NEW00500,DISEASE,chronic heart failure decompensation,chronic heart failure decompensation
NEW00501,BIOCHEMICAL,analgesic properties,analgesic properties
NEW00503,CHEMICAL,certain antidepressants,certain antidepressants
D000082002,DISEASE,Sexual Trauma,"Abuse Traumas, Sexual|Sexual Traumas|Abuse Trauma, Sexual|Trauma, Sexual|sexual abuse|Traumas, Sexual Abuse|Trauma, Sexual Abuse|Traumas, Sexual|Sexual Abuse Trauma|Sexual Abuse Traumas"
D011963,CHEMICAL,"Receptors, GABA-A","GABA-A Receptor rho Subunit|Muscimol Receptors|Receptor, Benzodiazepine|Benzodiazepine Receptors|GABA A Receptor gamma Subunit|GABA A Receptor|Receptor, Benzodiazepine-GABA|Diazepam Receptor|Receptors, Diazepam|Receptors, GABA Benzodiazepine|GABA Benzodiazepine Receptor|GABA A Receptors|benzodiazepine|GABA-A Receptor|gamma Aminobutyric Acid Subtype A Receptors|Receptor, Muscimol|delta Subunit, GABA A Receptor|GABA A Receptor delta Subunit|GABA A Receptor beta Subunit|Benzodiazepine-GABA Receptor|GABA(A) Receptor|Receptors, Benzodiazepine-GABA|GABA-Benzodiazepine Receptors|GABA A Receptor rho Subunit|delta Subunit, GABA-A Receptor|Receptors, Benzodiazepine GABA|GABA-Benzodiazepine Receptor|Receptors, GABA A|GABA A Receptor alpha Subunit|GABA-A Receptor alpha Subunit|Receptor, GABA-A|Receptors, Muscimol|Receptors, GABA-Benzodiazepine|gamma-Aminobutyric Acid Subtype A Receptors|epsilon Subunit, GABA A Receptor|Diazepam Receptors|GABA-A Receptor delta Subunit|Benzodiazepine GABA Receptor|Benzodiazepine-Gaba Receptors|GABA-A Receptor beta Subunit|GABA-A Receptors|Receptors, Benzodiazepine|Benzodiazepine Receptor|GABA-A Receptor gamma Subunit|Receptor, GABA-Benzodiazepine|GABA-A Receptor epsilon Subunit|Benzodiazepine Gaba Receptors|Muscimol Receptor|GABA A Receptor epsilon Subunit|GABA Benzodiazepine Receptors|Receptor, Diazepam|epsilon Subunit, GABA-A Receptor"
D059248,CHEMICAL,Chemoradiotherapy,"Synchronous Chemoradiotherapy|Chemoradiotherapy, Synchronous|Radiochemotherapies, Concurrent|Radiochemotherapy, Concomitant|Chemoradiotherapy, Concomitant|Concurrent Chemoradiotherapies|Chemoradiotherapies, Synchronous|concurrent chemoradiotherapy|Concurrent Radiochemotherapies|Concurrent Radiochemotherapy|Radiochemotherapies, Concomitant|Concomitant Radiochemotherapies|Concomitant Chemoradiotherapies|Concomitant Chemoradiotherapy|Synchronous Chemoradiotherapies|Chemoradiotherapies|Chemoradiotherapies, Concomitant|Chemoradiotherapies, Concurrent|Radiochemotherapy|Radiochemotherapies|Concomitant Radiochemotherapy|Chemoradiotherapy, Concurrent|Concurrent Chemoradiotherapy|Radiochemotherapy, Concurrent"
NEW00508,CHEMICAL,paracetamol poisoning,paracetamol poisoning
NEW00509,DISEASE,subsequent psychiatric disorder,subsequent psychiatric disorder
D018021,NUTRITION,Lithium Chloride,"Lithium|Chloride, Lithium"
D000077213,CHEMICAL,Lamotrigine,"3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine|Crisomet|BW-430C|BW430C|Lamotrigine|3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine|Lamictal|BW 430C|Lamiktal|Labileno"
NEW00512,MENTAL_HEALTH,bipolar disorder patients,bipolar disorder patients
D000078305,CHEMICAL,Zonisamide,"Zonisamide Monosodium|AD810|3-Sulfamoylmethyl-1,2-benzisoxazole|AD-810|CI912|AD 810|Zonegran|CI-912|CI 912|3 Sulfamoylmethyl 1,2 benzisoxazole|zonisamide"
D000077236,CHEMICAL,Topiramate,"McN 4853|topiramate|McN-4853|2,3-4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|USL255|McN4853|Topamax|Epitomax"
D000078330,CHEMICAL,Oxcarbazepine,"oxcarbazepine|Timox|Trileptal|10,11-Dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide|GP 47680"
D010672,CHEMICAL,Phenytoin,"Phenytoin|Difenin|Hydantol|Antisacer|Phenytoin Sodium|Phenhydan|Dihydan|Epamin|Sodium Diphenylhydantoinate|Dilantin|Fenitoin|5,5-diphenylimidazolidine-2,4-dione|Diphenylhydantoin|Epanutin|5,5-Diphenylhydantoin|Diphenylhydantoinate, Sodium"
D044123,CHEMICAL,"Receptor, Melatonin, MT2","melatonin|Melatonin 1b Receptor|Receptor, MT2|Receptor, Melatonin MT2|MT2 Receptor, Melatonin|Melatonin MT2 Receptor|Mel 1b Receptor|Receptor, Melatonin 1b|MT2 Receptor"
NEW00518,BIOCHEMICAL,bee venom acupuncture,bee venom acupuncture
NEW00520,CHEMICAL,cannabinoid receptor type 1,cannabinoid receptor type 1|CB1Rs
D066246,CHEMICAL,ErbB Receptors,"HER Family Receptor|NMDARs|Receptors, ErbB|Receptor, Transforming Growth Factor alpha|Receptor, Epidermal Growth Factor|Epidermal Growth Factor Receptor Protein Tyrosine Kinase|c-erbB-1 Protein|Receptor, Urogastrone|c-ErbB-1 Protein, Proto-oncogene|Receptors, EGF|Proto oncogene c ErbB 1 Protein|Proto-Oncogene Protein, erbB-1|Receptors, Epidermal Growth Factor Urogastrone|Proto-oncogene c-ErbB-1 Protein|Receptor, ErbB|Urogastrone Receptor|Receptor, HER Family|c erbB 1 Protein|Epidermal Growth Factor Receptor|TGF-alpha Receptor|Receptor, TGF-alpha|Family Receptor, HER|erbB-1 Proto-Oncogene Protein|ErbB Receptor|Transforming Growth Factor alpha Receptor|Epidermal Growth Factor Receptor Kinase|erbB 1 Proto Oncogene Protein|Receptors, Epidermal Growth Factor-Urogastrone|Receptor, ErbB 1|Receptor, TGF alpha|HER Family Receptors|Epidermal Growth Factor Receptor Family Protein|Epidermal Growth Factor Receptor Family Proteins|EGF Receptors|Epidermal Growth Factor Receptor Protein-Tyrosine Kinase|Receptor Tyrosine-protein Kinase erbB-1|Receptor, ErbB-1|Receptor, EGF|Receptors, Epidermal Growth Factor|ErbB-1 Receptor|receptors|Receptor Tyrosine protein Kinase erbB 1|Family Receptors, HER|EGF Receptor|Receptor, Transforming-Growth Factor alpha|Receptors, HER Family"
NEW00522,BIOCHEMICAL,Noncompetitive N-methyl-d-aspartate receptor antagonists,Noncompetitive N-methyl-d-aspartate receptor antagonists
NEW00523,CHEMICAL,NMDA receptor signaling,NMDA receptor signaling
C546030,CHEMICAL,"2-((1H-benzo(d)(1,2,3)triazol-5-ylamino)methyl)-4,6-dichlorophenol [Supplementary Concept]",Triazoles|Chlorophenols|IC87201
NEW00525,CHEMICAL,Elevated N-methyl-D-aspartate receptor activity,Elevated N-methyl-D-aspartate receptor activity
NEW00526,BIOCHEMICAL,glycine site agonists,glycine site agonists
NEW00531,DISEASE,Anti-N-methyl-D-aspartate receptor NMDAR encephalitis patients,Anti-N-methyl-D-aspartate receptor NMDAR encephalitis patients
NEW00532,DISEASE,glutamate/NMDAR system dysfunction,glutamate/NMDAR system dysfunction
NEW00534,BIOCHEMICAL,NMDAR antagonists,NMDAR antagonists
NEW00536,BIOCHEMICAL,human carriers,human carriers
NEW00538,DISEASE,stress-induced depressive-like behavior,stress-induced depressive-like behavior
NEW00540,DISEASE,depression/anxiety,depression/anxiety
NEW00541,CHEMICAL,Intravenous ketamine,Intravenous ketamine
NEW00543,BIOCHEMICAL,Oral N-methyl-D-aspartate receptor antagonists,Oral N-methyl-D-aspartate receptor antagonists
D008559,CHEMICAL,Memantine,"Memantin|1-Amino-3,5-dimethyladamantane|Memantine Hydrochloride|Axura|D145|1,3-Dimethyl-5-aminoadamantane|D 145|Ebixa|D-145|memantine|Namenda"
NEW00546,CHEMICAL,oral dextromethorphan,oral dextromethorphan
NEW00548,DISEASE,functional heterogeneity,functional heterogeneity
NEW00549,DISEASE,cortical microcircuit,cortical microcircuit
NEW00550,CHEMICAL,D-serine effects,D-serine effects
NEW00552,BIOCHEMICAL,N-methyl-D-aspartate NMDA receptor NMDAR antagonists,N-methyl-D-aspartate NMDA receptor NMDAR antagonists
D009609,CHEMICAL,Nitrous Oxide,"Gas, Laughing|nitrous oxide|Oxide, Nitrous|Laughing Gas|Nitrogen Protoxide"
NEW00555,CHEMICAL,NRG2 KOs,NRG2 KOs
D019969,CHEMICAL,Amphetamine-Related Disorders,"Disorder, Amphetamine-Related|Amphetamine Dependence|Abuse, Amphetamine|Disorders, Amphetamine-Related|Dependence, Amphetamine|Amphetamine Addiction|Addiction, Amphetamine|Amphetamine Related Disorders|amphetamine|Amphetamine Abuse"
D063926,DISEASE,Drug Hypersensitivity Syndrome,"Drug Hypersensitivity Syndromes|Syndromes, Drug Hypersensitivity|DRESS Syndrome|Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome|DRESS Syndromes|Hypersensitivity Syndromes, Drug|Drug Reaction with Eosinophilia and Systemic Symptoms|Hypersensitivity Syndrome, Drug|Drug Reaction With Eosinophilia And Systemic Symptom|Syndrome, Drug Hypersensitivity|hypersensitivity"
NEW00558,CHEMICAL,GABA(A)-BZD receptor formation,GABA(A)-BZD receptor formation
NEW00560,BIOCHEMICAL,Low serum vitamin D levels,Low serum vitamin D levels
D017114,DISEASE,"Liver Failure, Acute","ALF|Fulminant Liver Failure|Fulminating Hepatic Failures|Acute liver failure|Hepatic Failure, Fulminating|Fulminating Hepatic Failure|Acute Hepatic Failure|Acute Liver Failure|Fulminating Liver Failure|Fulminating Liver Failures|Fulminant Hepatic Failures|Failure, Acute Liver|Liver Failure, Fulminating|Liver Failure, Fulminant|Hepatic Failure, Acute|Hepatic Failure, Fulminant|Fulminant Liver Failures|Failure, Acute Hepatic|Fulminant Hepatic Failure"
C028921,CHEMICAL,hypotaurine aminotransferase [Supplementary Concept],Transaminases|hypotaurine
D013654,CHEMICAL,Taurine,"Taurine Zinc Salt (2:1)|Tauphon|Taufon|taurine|Taurine Hydrochloride|Taurine, Monopotassium Salt"
C104722,CHEMICAL,"glutamate receptor ionotropic, AMPA 2 [Supplementary Concept]","Receptors, AMPA|GluA2"
NEW00569,CHEMICAL,TREML2 rs3747742,TREML2 rs3747742
NEW00571,CHEMICAL,memantine treatment group,memantine treatment group
D019695,CHEMICAL,Glycyrrhizic Acid,"Glycyrrhizinate, Diammonium|Glycyrrhizin|Zinc Glycyrrhizate|Acid, Glycyrrhizinic|Glycyrrhizinic Acid|Diammonium Glycyrrhizinate|Glycyrrhizate, Zinc|Glycyrrhizinate, Dipotassium|Acid, Glycyrrhizic|glycyrrhizic acid|Dipotassium Glycyrrhizinate"
D029882,CHEMICAL,Glycyrrhiza uralensis,"Licorice, Chinese|Gan cao|Chinese Licorices|Gan zao|Gan caos|cao, Gan|zaos, Gan|Licorices, Chinese|Glycyrrhiza uralenses|uralenses, Glycyrrhiza|Glycyrrhiza uralensis|Gan zaos|Chinese Licorice"
NEW00574,BIOCHEMICAL,AhR antagonist,AhR antagonist
D020845,BIOCHEMICAL,Selective Estrogen Receptor Modulators,"Estrogen Receptor Modulator, Selective|Selective Estrogen Receptor Modulator|Selective Estrogen Receptor|SERM|SERMs|Estrogen Receptor Modulators, Selective"
NEW00577,BIOCHEMICAL,ongoing estrogen deficiency,ongoing estrogen deficiency
NEW00578,MENTAL_HEALTH,substance-induced psychotic disorder secondary,substance-induced psychotic disorder secondary
NEW00579,BIOCHEMICAL,cumulative estrogen exposure,cumulative estrogen exposure
D012110,CHEMICAL,Reserpine,Rausedil|Raunervil|Serpasil|Raupasil|V-Serp|Rausedyl|Serpivite|V Serp|Reserpine
NEW00583,BIOCHEMICAL,Estrogen levels,Estrogen levels
D012739,BIOCHEMICAL,Gonadal Steroid Hormones,"Steroid Hormones, Gonadal|Sex Steroid Hormone|Sex Hormones|gonadal steroid hormones|Steroid Hormone, Sex|Steroid Hormone, Gonadal|Sex Steroid Hormones|Hormone, Sex Steroid|Sex Hormone|Hormone, Gonadal Steroid|Gonadal Steroid Hormone|Hormone, Sex|Hormones, Gonadal Steroid|Steroid Hormones, Sex|Hormones, Sex Steroid"
NEW00586,CHEMICAL,"neurotoxins 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","neurotoxins 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|MPTP"
NEW00588,CHEMICAL,physiological estradiol,physiological estradiol
NEW00590,CHEMICAL,circulating estradiol,circulating estradiol
NEW00593,BIOCHEMICAL,estrogen level,estrogen level
NEW00515,CHEMICAL,DA receptor blocker,haloperidol|DA receptor blocker
D000067531,CHEMICAL,Alarmins,Damage-Associated Molecular Pattern Molecules|Alarmin Proteins|Danger-Associated Molecular Pattern Molecules|Alarmin|Danger Associated Molecular Pattern Molecules|alarmins|Damage Associated Molecular Pattern Molecules
NEW00596,CHEMICAL,gonadal steroids,gonadal steroids
NEW00597,BIOCHEMICAL,estrogen research,estrogen research
NEW00598,CHEMICAL,melatonin concentrations related,melatonin concentrations related
D011372,BIOCHEMICAL,Progestins,"Gestagens|Progestational Compounds|Compound, Progestational|Gestagen Effects|Progestin|Effect, Gestagenic|Effects, Gestagenic|Effects, Gestagen|Effect, Progestin|Gestagen|Gestagenic Effects|Agent, Progestagenic|Hormone, Progestational|Effect, Gestagen|Progestational Hormones|Gestagenic Agent|Progestogen Effects|Progestagen|Progestational Agent|Progestational Agents|Progestogen|Progestational Compound|Agent, Progestational|Gestagenic Agents|Progestagenic Agents|Gestagenic Effect|Effects, Progestogen|Progestin Effect|Progestagenic Agent|Progestogens|Progestogen Effect|Progestational Hormone|Effects, Progestin|Gestagen Effect|Effect, Progestogen|Agent, Gestagenic|progestin|Progestagens|Progestin Effects"
NEW00592,BIOCHEMICAL,hormone therapy,hormone therapy
NEW00602,CHEMICAL,adjunctive raloxifene treatment,adjunctive raloxifene treatment
NEW00604,CHEMICAL,oral adjunctive raloxifene treatment,oral adjunctive raloxifene treatment
D000081227,CHEMICAL,Neurosteroids,"Neurosteroid|Neuroactive Steroids|Neuroactive Steroid|Neuro Steroids|Neuro-Steroid|Steroid, Neuroactive|Neurosteroids|Neuro Steroid|Neuro-Steroids"
NEW00605,CHEMICAL,hormones testosterone,hormones testosterone
NEW00607,DISEASE,MAO-A VT,MAO-A VT
NEW00608,BIOCHEMICAL,ovariectomy-reduced hormones,ovariectomy-reduced hormones
NEW00609,MENTAL_HEALTH,depression symptom scores,depression symptom scores
D045166,CHEMICAL,Estradiol Congeners,"Synthetic Estrogen|Estrogen Analogue|Analogues, Estrogen|Analogue, Estrogen|Synthetic Estrogens|Congener, Estradiol|Estrogen Analogues|Analogs, Estrogen|Estrogen, Synthetic|Estradiol Congener|Estrogen Analog|Estrogens, Synthetic|Analog, Estrogen|Estrogen Analogs|estradiol"
NEW00610,MENTAL_HEALTH,Postmenopausal depression,Postmenopausal depression
NEW00612,DISEASE,depression-like behavior,depression-like behavior
C549840,CHEMICAL,"gper1 protein, zebrafish [Supplementary Concept]","Receptors, G-Protein-Coupled|GPER|G protein-coupled estrogen receptor|Zebrafish Proteins"
NEW00616,BIOCHEMICAL,Gender affirming hormone therapy,Gender affirming hormone therapy
NEW00617,DISEASE,Cholestasis indices,Cholestasis indices
NEW00619,DISEASE,BPD symptom exacerbations,BPD symptom exacerbations
NEW00611,BIOCHEMICAL,ovarian hormones,ovarian hormones
NEW00620,CHEMICAL,neuropeptide oxytocin,neuropeptide oxytocin
NEW00622,CHEMICAL,Oxytocin levels,Oxytocin levels
NEW00624,CHEMICAL,oxytocin system,oxytocin system
NEW00625,CHEMICAL,oxytocin concentrations,oxytocin concentrations
NEW00626,DISEASE,childhood traumata,childhood traumata
NEW00627,CHEMICAL,plasma oxytocin,plasma oxytocin
D000076783,DISEASE,Adverse Childhood Experiences,"Adverse Childhood Experience|Childhood Experiences, Traumatic|Traumas, Childhood|Childhood Experience, Traumatic|Trauma, Adolescent|Early Life Stress|Childhood Experience, Adverse|Stresses, Early Life|childhood trauma|Trauma, Childhood|Life Stress, Early|Childhood Trauma|Experience, Traumatic Childhood|Early Life Stresses|Stresses, Early-Life|Early-Life Stresses|Early-Life Stress|Stress, Early-Life|Childhood Traumas|Experiences, Traumatic Childhood|Traumatic Childhood Experiences|Adolescent Trauma|Adolescent Traumas|Stress, Early Life|Childhood Experiences, Adverse|Traumatic Childhood Experience|Traumas, Adolescent|Life Stresses, Early"
D001883,DISEASE,Borderline Personality Disorder,"Personality Disorders, Borderline|Disorder, Borderline Personality|Personality Disorder, Borderline|Disorders, Borderline Personality|Borderline Personality Disorders|BPD|borderline personality disorder"
NEW00629,NUTRITION,estrogen receptor alpha gene variants,estrogen receptor alpha gene variants
NEW00631,BIOCHEMICAL,estrogen levels,estrogen levels
NEW00634,DISEASE,residual psychotic symptoms,residual psychotic symptoms
NEW00635,CHEMICAL,saturated HFD,saturated HFD
NEW00637,CHEMICAL,HFDs,HFDs
NEW00639,CHEMICAL,Various antidepressants,Various antidepressants
D019314,CHEMICAL,Dehydroepiandrosterone Sulfate,"DHA Sulfate|DHEA Sulfate|Sulfate, Dehydroepiandrosterone|Sulfate, DHA|Sulfate, Dehydroisoandrosterone|DHEA|Prasterone Sulfate|dehydroepiandrosterone|Sulfate, Prasterone|Dehydroisoandrosterone Sulfate|Sulfate, DHEA"
D011085,DISEASE,Polycystic Ovary Syndrome,"Stein-Leventhal Syndrome|Polycystic ovary syndrome|Sclerocystic Ovarian Degeneration|Stein Leventhal Syndrome|Sclerocystic Ovary Syndrome|Polycystic Ovarian Syndrome|Polycystic Ovary Syndrome 1|Ovary, Sclerocystic|Syndrome, Stein-Leventhal|Syndrome, Polycystic Ovary|Sclerocystic Ovaries|Sclerocystic Ovary|Ovarian Syndrome, Polycystic|Ovarian Degeneration, Sclerocystic|Ovary Syndrome, Polycystic"
NEW00643,CHEMICAL,melatonin regulation,melatonin regulation
NEW00646,CHEMICAL,peptides growth hormone-releasing hormone,peptides growth hormone-releasing hormone|GHRH
D007319,MENTAL_HEALTH,Sleep Initiation and Maintenance Disorders,"Awakening, Early|Insomnia Disorder|Insomnia, Nonorganic|Rebound Insomnia|Insomnia, Primary|Psychophysiological Insomnia|Insomnia|Insomnia, Transient|Sleeplessness|Insomnia, Psychophysiological|Sleep Initiation Dysfunctions|Dysfunctions, Sleep Initiation|Disorders of Initiating and Maintaining Sleep|Insomnia Disorders|DIMS (Disorders of Initiating and Maintaining Sleep)|Insomnias|Early Awakening|primary insomnia|Insomnia, Secondary|Sleep Initiation Dysfunction|Chronic Insomnia|Secondary Insomnia|Nonorganic Insomnia|Dysfunction, Sleep Initiation|Primary Insomnia|Transient Insomnia|Insomnia, Rebound|Insomnia, Chronic"
D047748,DISEASE,Pituitary ACTH Hypersecretion,"Pituitary-Dependant Hypercortisolism Disorder|Cushing Disease|Cushing's Disease|Pituitary-Dependant Hypercortisolism Disorders|Cushing's disease|Pituitary-Dependant Cushing Syndrome|Hypersecretion, Pituitary ACTH|Pituitary Dependant Cushing Syndrome|Cushing Syndrome, Pituitary|Hypercortisolism, Pituitary-Dependant|Pituitary-Dependant Hypercortisolisms|Pituitary Dependant Hypercortisolism|Hypercortisolism Disorder, Pituitary-Dependant|Pituitary Cushing Diseases|Cushing Syndrome, Pituitary-Dependant|Pituitary Cushing Syndrome|Adrenocorticotropic Hormone, Inappropriate Secretion|Pituitary Cushing Disease|ACTH Hypersecretion, Pituitary|Cushing Disease, Pituitary|Pituitary Dependant Hypercortisolism Disorder|Inappropriate Adrenocorticotropic Hormone Secretion|Cushing Diseases, Pituitary|Disease, Cushing|Pituitary-Dependant Hypercortisolism|Inappropriate ACTH Secretion Syndrome"
D004393,DISEASE,"Dwarfism, Pituitary","Nanism, Pituitary|Isolated Growth Hormone Deficiency|Isolated HGH Deficiency|Isolated Human Growth Hormone Deficiency|Hyposomatotrophic Dwarfism|Hypophysial Dwarf|Isolated Somatotropin Deficiency|Pituitary Nanism|dwarfism|Pituitary Dwarf|Pituitary Dwarfism|Dwarfism, Growth Hormone Deficiency|Isolated GH Deficiency|Growth Hormone Deficiency Dwarfism|Isolated Somatotropin Deficiency Disorder"
D020181,MENTAL_HEALTH,"Sleep Apnea, Obstructive","Syndrome, Sleep Apnea, Obstructive|Sleep Apnea Hypopnea Syndrome|Apneas, Obstructive Sleep|Sleep Apneas, Obstructive|Syndrome, Obstructive Sleep Apnea|Upper Airway Resistance Sleep Apnea Syndrome|Syndrome, Upper Airway Resistance, Sleep Apnea|Sleep Apnea Syndrome, Obstructive|Obstructive Sleep Apnea Syndrome|OSAHS|Apnea, Obstructive Sleep|Obstructive Sleep Apneas|Obstructive Sleep Apnea|sleep apnea syndrome"
D000172,DISEASE,Acromegaly,"Somatotropin Hypersecretion Syndrome (Acromegaly)|Syndromes, Somatotropin Hypersecretion (Acromegaly)|acromegaly|Somatotropin Hypersecretion Syndromes (Acromegaly)|Hypersecretion Syndromes, Somatotropin (Acromegaly)|Hypersecretion Syndrome, Somatotropin (Acromegaly)|Syndrome, Somatotropin Hypersecretion (Acromegaly)|Inappropriate GH Secretion Syndrome (Acromegaly)|Inappropriate Growth Hormone Secretion Syndrome (Acromegaly)"
D020208,DISEASE,"Brain Injury, Chronic","brain injury|Brain Injuries, Chronic|Chronic Brain Injuries|Chronic Brain Injury"
NEW00647,DISEASE,drug-induced benign pituitary tumor,prolactinoma|drug-induced benign pituitary tumor
D016884,DISEASE,"Polyendocrinopathies, Autoimmune","Polyendocrinopathy, Autoimmune|Polyendocrinopathy-Candidiasis-Ectodermal-Dystrophy, Autoimmune|Schmidt's Syndrome|Polyendocrinopathy Candidiasis Ectodermal Dystrophy, Autoimmune|Polyglandular Autoimmune Syndrome, Type 3|Polyglandular Type III Autoimmune Syndrome|Autoimmune Syndrome Type III, Polyglandular|Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy|Polyglandular Type I Autoimmune Syndrome|Autoimmune Polyglandular Syndrome Type I|Autoimmune Polyglandular Syndrome, Type 1|Autoimmune Polyglandular Syndrome Type III|Polyglandular Type II Autoimmune Syndrome|Deficiency, AIRE|Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal-Dystrophy|Polyglandular Autoimmune Syndrome, Type 1|Polyglandular Autoimmune Syndrome, Type 2|Autoimmune Polyendocrine Syndrome, Type II|AIRE Deficiencies|Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy, Autoimmune|Autoimmune Polyglandular Syndrome, Type I|Diabetes Mellitus, Addison Disease, Myxedema|Autoimmune Polyendocrine Syndrome, Type 2|Polyglandular Deficiency Syndrome, Type 2|Addison's disease|Autoimmune Polyendocrinopathy Syndrome Type 1|Autoimmune Polyendocrinopathy|Polyglandular Autoimmune Syndrome, Type I|Autoimmune Polyglandular Syndrome Type II|Multiple Endocrine Deficiency Syndrome, Type 2|Autoimmune Syndrome Type I, Polyglandular|AIRE Deficiency|Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy|Autoimmune Syndrome Type II, Polyglandular|APS Type 1|Diabetes Mellitus, Addison's Disease, Myxedema|Autoimmune Polyendocrinopathy with Candidiasis and Ectodermal Dystrophy|Polyendocrine Autoimmune Syndrome, Type II|Schmidt Syndrome|Syndrome, Schmidt|APECED|Syndrome, Schmidt's|Autoimmune Polyglandular Syndrome, Type 3"
NEW00648,BIOCHEMICAL,corticotropin-releasing hormone neurons,corticotropin-releasing hormone neurons
NEW00649,CHEMICAL,oxytocin neurons,oxytocin neurons
D020641,CHEMICAL,"Polymorphism, Single Nucleotide","Polymorphisms, Single Nucleotide|SNPs|Nucleotide Polymorphisms, Single|single nucleotide polymorphisms|Nucleotide Polymorphism, Single|Single Nucleotide Polymorphisms|Single Nucleotide Polymorphism"
NEW00650,CHEMICAL,AGRP gene,AGRP gene
NEW00651,CHEMICAL,serum GPER level,serum GPER level
NEW00653,CHEMICAL,decreased serum GPER levels,decreased serum GPER levels
D042341,BIOCHEMICAL,Gonadal Hormones,"Gonadal Hormone|Hormones, Gonadal|Hormone, Gonadal|Gonadal hormones"
NEW00088,DISEASE,crucial etiological contributor to post-traumatic stress disorder,crucial etiological contributor to post-traumatic stress disorder|PTSD
NEW00657,DISEASE,CRF promoter,CRF promoter
NEW00661,CHEMICAL,ventromedial hypothalamus,ventromedial hypothalamus
NEW00663,DISEASE,winter SAD,winter SAD
NEW00664,MENTAL_HEALTH,Hypoactive desire disorder,Hypoactive desire disorder
D045167,CHEMICAL,Progesterone Congeners,"Synthetic Progestogens|Synthetic Progestagens|Progestational Hormone Analogs|Synthetic Progestins|Progestins, Synthetic|Progestin Analogues|Synthetic Progestational Hormones|progesterone|Progestin Analogs|Progestogens, Synthetic|Progestational Hormone Analogues|Progestin, Synthetic|Progestagens, Synthetic|Progestational Hormones, Synthetic|Synthetic Progestin"
NEW00667,BIOCHEMICAL,Endocrine therapy adherence,Endocrine therapy adherence
NEW00669,DISEASE,estrogen receptor positive ER+ breast cancer,estrogen receptor positive ER+ breast cancer
NEW00671,DISEASE,puerperal major depression,puerperal major depression
NEW00673,MENTAL_HEALTH,puerperal psychosis,puerperal psychosis
NEW00675,BIOCHEMICAL,sex hormone levels,sex hormone levels
NEW00676,MENTAL_HEALTH,Female sexual arousal disorder,Female sexual arousal disorder
NEW00678,CHEMICAL,Testosterone inhibitors,Testosterone inhibitors
NEW00680,DISEASE,cognitive circuits,cognitive circuits
NEW00682,BIOCHEMICAL,Endocrine organizational influences,Endocrine organizational influences
NEW00683,CHEMICAL,aromatase inactivator exemestane,aromatase inactivator exemestane
D000077289,CHEMICAL,Letrozole,"CGS-20267|4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile)|letrozole|Femara|CGS 20267|CGS20267|Fémara"
NEW00686,BIOCHEMICAL,sex hormone profile,sex hormone profile
D065086,CHEMICAL,Acetaldehyde Dehydrogenase Inhibitors,"Aldehyde Dehydrogenase Blockers|Acetaldehyde Dehydrogenase Antagonists|Dehydrogenase Antagonists, Acetaldehyde|Dehydrogenase Inhibitors, Acetaldehyde|acetaldehyde|Dehydrogenase Blockers, Aldehyde"
D000431,CHEMICAL,Ethanol,"Absolute Alcohol|Alcohol, Grain|Alcohol, Absolute|Ethyl Alcohol|ethanol|Alcohol, Ethyl|Grain Alcohol"
NEW00687,MENTAL_HEALTH,chronic alcohol abuse,chronic alcohol abuse
NEW00689,CHEMICAL,primary metabolite acetaldehyde,primary metabolite acetaldehyde
NEW00690,CHEMICAL,ethanol metabolism,ethanol metabolism
D010788,CHEMICAL,Photosynthesis,"Calvin Cycle|Photosynthetic Carbon Fixation|Calvin Benson Cycle|Calvin-Benson-Bassham Cycle|Carbon Fixation, Photosynthetic|Reductive Pentose Phosphate Cycle|Dark Reactions of Photosynthesis|Cycle, Calvin|Cycle, Calvin-Benson-Bassham|Cycle, Calvin-Benson|Photosynthesis Dark Reaction|Calvin Benson Bassham Cycle|Calvin-Benson Cycle|carbon fixation|Photosynthesis Dark Reactions"
NEW00693,CHEMICAL,Manganese toxicity,Manganese toxicity
NEW00695,DISEASE,autistic population,autistic population
NEW00698,DISEASE,autistic features,autistic features
NEW00699,CHEMICAL,Mn poisoning,Mn poisoning
NEW00701,CHEMICAL,Developmental manganese Mn exposure,Developmental manganese Mn exposure
NEW00704,CHEMICAL,Mn exposure,Mn exposure
C567628,DISEASE,"Spastic Paraplegia 18, Autosomal Recessive [Supplementary Concept]","Spastic Paraplegia, Hereditary|Intellectual Disability|Contracture|motor dysfunction"
D020149,CHEMICAL,Manganese Poisoning,"Nervous System Diseases, Manganese Induced|Syndrome, Manganese Neurotoxicity|manganese|Manganese Neurotoxicity Syndrome|Syndromes, Manganese Neurotoxicity|Neurotoxicity Syndrome, Manganese|Mn|Poisoning, Manganese|Nervous System Poisoning, Manganese|Manganese Neurotoxicity Syndromes|Nervous System Diseases, Manganese-Induced|Neurotoxicity Syndromes, Manganese"
NEW00708,CHEMICAL,bioavailable Mn,bioavailable Mn
NEW00709,CHEMICAL,chronic Mn exposure paradigm,chronic Mn exposure paradigm
NEW00710,DISEASE,Neuromotor deficits,Neuromotor deficits
NEW00712,CHEMICAL,chronic Mn exposure,chronic Mn exposure
NEW00652,DISEASE,ASD patients,ASD patients
NEW00714,DISEASE,depression-related behaviors,depression-related behaviors
D017633,CHEMICAL,Magnesium Silicates,"Mg|Silicates, Magnesium|magnesium"
NEW00717,CHEMICAL,Mn overexposure,Mn overexposure
D014028,CHEMICAL,Tobacco Smoke Pollution,"Air Pollution, Tobacco Smoke|Secondhand Smokes|Smokings, Passive|Pollution, Tobacco Smoke|Second Hand Smoke|Smoking, Involuntary|Smoking, Secondhand|Smoke, Second Hand|Environmental Smoke Pollution, Tobacco|Secondhand Smokings|tobacco smoke|Smoke Pollutions, Tobacco|Second Hand Smokes|Passive Smokings|Smoke Pollution, Tobacco|Hand Smoke, Second|Smokings, Involuntary|Involuntary Smoking|Hand Smokes, Second|Smokings, Secondhand|Secondhand Smoke|Environmental Tobacco Smoke Pollution|Passive Smoking|Smoke, Secondhand|Smokes, Second Hand|Environmental Pollution, Tobacco Smoke|Involuntary Smokings|Tobacco Smoke Pollutions|Smoking, Passive|Secondhand Smoking|Pollutions, Tobacco Smoke|Smokes, Secondhand"
NEW00722,BIOCHEMICAL,Dopamine agonist therapy,Dopamine agonist therapy
D020262,NUTRITION,"Mercury Poisoning, Nervous System","Poisoning, Mercury, Neurologic|Poisoning, Mercury, Nervous System|Nervous System Poisoning, Mercury|Mercury Poisoning, Neurologic|Organic Mercury Poisoning|Mercurial Psychosis|Nervous System Mercurialism|Mercurialism, Nervous System|Mercury Neurotoxicity Syndromes|Poisoning, Neurologic Mercury|Mercury Poisoning, Organic|Inorganic Mercury Poisoning|Nervous System Diseases, Mercury Induced|Mercury|Mercury Neurotoxicity Syndrome|Mad Hatter's Disease|Psychosis, Mercurial|Mercurialism, Neurologic|Syndrome, Mercury Neurotoxicity|Neuroanesthenia, Mercurial|Mercury Induced Nervous System Diseases|Neurologic Mercury Poisoning|Psychosis, Mercury|Nervous System Diseases, Mercury-Induced|Mercury Poisoning, Inorganic|Mad Hatter Disease|Mercurial Neuroanesthenia|Neurotoxicity Syndrome, Mercury|Mad Hatter Diseases|Syndromes, Mercury Neurotoxicity|Mercury Psychosis|Mercury-Induced Nervous System Diseases|Mad Hatters Disease|Minamata Disease|Poisoning, Inorganic Mercury|Mercury Encephalopathy|Neurotoxicity Syndromes, Mercury|Poisoning, Organic Mercury|Neurologic Mercurialism|Encephalopathy, Mercury|System Mercurialism, Nervous"
D008742,CHEMICAL,Methyl n-Butyl Ketone,"Hexan 2 one|Ketone, Methyl n-Butyl|n-Butyl Ketone, Methyl|Hexan-2-one|Butylmethyl Ketone|2-Hexanone|methyl n-butyl ketone|2 Hexanone|Ketone, Butylmethyl|Methyl n Butyl Ketone"
D014241,CHEMICAL,Trichloroethylene,"Trichloride, Ethinyl|Trilene|TCE|trichloroethylene|Trichloroethene|Ethinyl Trichloride|Trielina"
D064007,DISEASE,Ataxia Telangiectasia Mutated Proteins,"A-T Protein|ataxia|AT Mutated Protein|Protein, A-T|Protein, AT Mutated|A T Protein|Mutated Protein, AT|ATM Protein"
NEW00724,CHEMICAL,Dyshomeostasis,Dyshomeostasis
NEW00725,CHEMICAL,copper levels,copper levels
D019345,CHEMICAL,Zinc Acetate,"Zn|zinc|Zinc Acetate, Anhydrous|Zinc Acetate Anhydrous|Zinc Acetate Dihydrate|Galzin|Anhydrous Zinc Acetate"
NEW00727,CHEMICAL,excessive Mn,excessive Mn
NEW00729,DISEASE,MP density,MP density
D000068180,CHEMICAL,Aripiprazole,"OPC 14597|7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone|OPC-14597|Aripiprazol|Abilify|Aripiprazole"
NEW00731,BIOCHEMICAL,vitamin E supplementation,vitamin E supplementation
D014811,BIOCHEMICAL,Vitamin E Deficiency,"Deficiencies, Vitamin E|Vitamin E Deficiencies|vitamin E|Deficiency, Vitamin E"
NEW00733,CHEMICAL,IU all-rac-alpha-tocopheryl acetate,IU all-rac-alpha-tocopheryl acetate
NEW00734,BIOCHEMICAL,Antacids almagel,Antacids almagel
D064098,CHEMICAL,Esomeprazole,"esomeprazole|Esomeprazole Strontium|Esomeprazole Strontium Anhydrous|Esomeprazole Potassium|Strontium, Esomeprazole|Esomeprazole Sodium|Esomeprazole Magnesium|Nexium"
NEW00738,BIOCHEMICAL,over-the-counter antacids,over-the-counter antacids
NEW00740,DISEASE,hypokalaemia,hypokalaemia
D000863,BIOCHEMICAL,Antacids,"Agent, Alkalinizing|Alkalinizing Agent|Antacid|Alkalinizing Agents|antacids|Agents, Alkalinizing"
NEW00744,BIOCHEMICAL,traditional antihistamines,traditional antihistamines
NEW00746,CHEMICAL,CRF-related single nucleotide polymorphisms,CRF-related single nucleotide polymorphisms
NEW00748,DISEASE,hyperactive central corticotropin releasing factor CRF systems,hyperactive central corticotropin releasing factor CRF systems
NEW00749,DISEASE,neuronal hypersecretion,neuronal hypersecretion
NEW00751,DISEASE,synaptic CRF,synaptic CRF
NEW00752,CHEMICAL,N-methyl-D-aspartate NMDA receptor antagonists,N-methyl-D-aspartate NMDA receptor antagonists
NEW00753,CHEMICAL,R-ketamine,R-ketamine
NEW00755,CHEMICAL,MT-stabilizing compounds,MT-stabilizing compounds
C000620616,CHEMICAL,amyloid beta-peptide (1-30) [Supplementary Concept],Amyloid beta-Peptides|amyloid beta-peptide|Peptide Fragments
NEW00758,CHEMICAL,methadone poisoning,methadone poisoning
D002189,MENTAL_HEALTH,Marijuana Abuse,"Abuse, Hashish|Marihuana Abuse|Abuse, Cannabis|Dependence, Cannabis|Abuse, Marihuana|Disorder, Cannabis-Related|Cannabis Abuse|Marijuana Dependence|Dependence, Marijuana|Cannabis-Related Disorder|Cannabis Dependence|Abuse, Marijuana|Hashish Abuse|Cannabis Related Disorder|cannabis abuse"
NEW00760,DISEASE,truancy,truancy
NEW00761,DISEASE,type achalasia A3 motor pattern,type achalasia A3 motor pattern
NEW00763,CHEMICAL,adolescent morphine,adolescent morphine
D009294,BIOCHEMICAL,Narcotics,"Analgesics, Narcotic|Narcotic Effects|Effects, Narcotic|Effect, Narcotic|Narcotic Analgesics|narcotics|Narcotic|Narcotic Effect"
NEW00765,DISEASE,Many schizophrenic patients,Many schizophrenic patients
NEW00767,BIOCHEMICAL,Narcotic withdrawal,Narcotic withdrawal
NEW00769,DISEASE,EPP communication,EPP communication
NEW00771,BIOCHEMICAL,Narcotic-induced    androgen insufficiency,Narcotic-induced    androgen insufficiency
NEW00774,BIOCHEMICAL,narcotic analgesic use,narcotic analgesic use
D015212,DISEASE,Inflammatory Bowel Diseases,"inflammatory bowel disease|Bowel Diseases, Inflammatory|Inflammatory Bowel Disease"
NEW00777,MENTAL_HEALTH,schizophrenia-like psychosis,schizophrenia-like psychosis
D011605,DISEASE,"Psychoses, Substance-Induced","Substance Induced Psychoses|Drug Psychoses|Toxic Psychoses|Psychoses, Substance Induced|Substance-Induced Psychoses|Psychoses, Drug|psychoses|Psychoses, Toxic"
NEW00095,BIOCHEMICAL,drug classes,drug classes
NEW00779,CHEMICAL,SUD recovery,SUD recovery
NEW00781,DISEASE,trauma exposure,trauma exposure
NEW00783,BIOCHEMICAL,Estrogen treatment,Estrogen treatment
NEW00784,CHEMICAL,present antidepressants,present antidepressants
NEW00786,CHEMICAL,NMDAR-glycine site treatments,NMDAR-glycine site treatments
NEW00788,BIOCHEMICAL,Other drug groups,Other drug groups
D018663,BIOCHEMICAL,Adrenergic Agents,"Adrenergic Release Inhibitors|Inhibitors, Adrenergic Synthesis|Drugs, Adrenergic Neuron|Adrenergic|Synthesis Inhibitors, Adrenergic|Neuron Agents, Adrenergic|Adrenergic Drug|Effect, Adrenergic|Releasers, Sympathetic Transmitter|Neuron Drugs, Adrenergic|Adrenergic Neuron Agents|Drug, Adrenergic|Agents, Adrenergic|Adrenergic Synthesis Inhibitors|Neurohumor Depleters, Adrenergic|Adrenergic Neurohumor Depleters|Effects, Adrenergic|Adrenergics|Adrenergic Agent|adrenergic drugs|Inhibitors, Adrenergic Release|Agents, Adrenergic Neuron|Adrenergic Neuron Drugs|Adrenergic Drugs|Release Inhibitors, Adrenergic|Adrenergic Effects|Depleters, Adrenergic Neurohumor|Sympathetic Transmitter Releasers|Transmitter Releasers, Sympathetic|Agent, Adrenergic|Drugs, Adrenergic|Adrenergic Effect"
C566822,MENTAL_HEALTH,Perry Syndrome [Supplementary Concept],mental depression|Hypoventilation|Depression|Parkinsonian Disorders
NEW00793,CHEMICAL,digitalis toxicity,digitalis toxicity
D014700,CHEMICAL,Verapamil,"Falicard|Izoptin|Lekoptin|Calan|Finoptin|Verapamil Hydrochloride|Iproveratril|verapamil|Isoptin|Cordilox|Hydrochloride, Verapamil|Dexverapamil|Isoptine"
C537163,DISEASE,Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections [Supplementary Concept],Streptococcal Infections|Autoimmune Diseases|neuropsychiatric disorders|Obsessive-Compulsive Disorder
D020270,CHEMICAL,Alcohol Withdrawal Seizures,"Alcohol-Related Seizure|Alcohol Withdrawal-Induced Seizure|Seizures, Alcohol Withdrawal-Induced|Withdrawal-Induced Seizures, Alcohol|Alcohol Withdrawal Seizure|Seizure, Alcohol Withdrawal|Withdrawal-Induced Seizure, Alcohol|Seizure, Alcohol Withdrawal-Induced|Alcohol withdrawal|Seizures, Alcoholic|Status Epilepticus, Alcohol Withdrawal Induced|Alcohol Withdrawal Induced Seizure|Alcoholic Seizures|Major Motor Seizure, Alcohol Withdrawal-Induced|Alcohol Withdrawal-Induced Major Motor Seizure|Alcoholic Seizure|Seizures, Alcohol Withdrawal|Alcohol Withdrawal Induced Status Epilepticus|Seizure, Alcohol-Related|Alcohol Withdrawal-Induced Seizures|Alcohol Related Seizures|Alcohol Withdrawal-Induced Status Epilepticus|Alcohol Withdrawal Induced Major Motor Seizure|Seizures, Alcohol-Related|Status Epilepticus, Alcohol Withdrawal-Induced|Alcohol-Related Seizures|Seizure, Alcoholic"
NEW00795,CHEMICAL,BclI-SNP,BclI-SNP
NEW00800,DISEASE,psychiatric side effects,psychiatric side effects
D008750,CHEMICAL,Methyldopa,Sembrina|alpha Methyl L Dopa|Dopergit|alpha-Methyldopa|Aldomet|Nu Medopa|Apo-Methyldopa|Meldopa|methyldopa|Nu-Medopa|Dopegit|alpha Methyldopa|Methyldopate|alpha-Methyl-L-Dopa|Alphamethyldopa|Apo Methyldopa|Dopamet|Dopegyt|Hydopa
D016320,MENTAL_HEALTH,Substance Abuse Treatment Centers,"Drug Treatment Center|Treatment Centers, Substance Abuse|Drug Rehabilitation Centers|Drug Abuse Treatment Centers|Centers, Drug Treatment|Center, Drug Rehabilitation|Drug Treatment Centers|Rehabilitation Center, Drug|Drug Rehabilitation Center|Treatment Centers, Drug|Rehabilitation Centers, Drug|Treatment Center, Drug|Treatment Centers, Drug Abuse|Substance abuse|Centers, Drug Rehabilitation|Center, Drug Treatment"
D019970,CHEMICAL,Cocaine-Related Disorders,"Cocaine-Related Disorder|Abuse, Cocaine|Cocaine Abuse|Dependence, Cocaine|Addiction, Cocaine|Cocaine Dependence|Disorders, Cocaine-Related|Cocaine Related Disorders|Disorder, Cocaine-Related|Cocaine Addiction|Dependences, Cocaine|cocaine"
D009498,BIOCHEMICAL,Neurotoxins,"Neurotoxin|Excitatory Neurotoxin|Alpha-Neurotoxins|Excitotoxins|Alpha-Neurotoxin|Excitatory Neurotoxins|Alpha Neurotoxin|neurotoxins|Myotoxins|Neurotoxin, Excitatory|Alpha Neurotoxins|Neurotoxins, Excitatory|Excitotoxin|Myotoxin"
D047208,BIOCHEMICAL,Eosinophil-Derived Neurotoxin,"Neurotoxin, Eosinophil-Derived|Eosinophil Protein X|RNS2 Neurotoxin|s-EPX|neurotoxin|Serum Eosinophil Protein X|Neurotoxin, RNS2|Eosinophil Derived Neurotoxin"
NEW00805,DISEASE,drug-naïve schizophrenic patients,drug-naïve schizophrenic patients
NEW00807,DISEASE,neurotoxic events,neurotoxic events
NEW00808,DISEASE,Drug-naive schizophrenic patients,Drug-naive schizophrenic patients
D008538,MENTAL_HEALTH,Meige Syndrome,"Blepharospasm-Oromandibular Dystonia Syndrome, Idiopathic|Dystonia Syndromes, Blepharospasm-Oromandibular|orofacial dyskinesia|Syndrome, Blepharospasm-Oromandibular Dystonia|Blepharospasm-Oromandibular Dyskinesia|Blepharospasm Oromandibular Dystonia|Idiopathic Orofacial Dyskinesias|Blepharospasm-Oromandibular Dystonia Syndromes|Brueghel Syndrome|Orofacial Dyskinesia, Idiopathic|Idiopathic Orofacial Dyskinesia|Blepharospasm Oromandibular Dyskinesia|Blepharospasm-Oromandibular Dystonia Syndrome|Blepharospasm-Oromandibular Dyskinesias|Dystonia, Blepharospasm-Oromandibular|Dystonia Syndrome, Blepharospasm-Oromandibular|Blepharospasm-Oromandibular Dystonia|Dyskinesias, Blepharospasm-Oromandibular|Blepharospasm-Oromandibular Dystonias|Idiopathic Blepharospasm-Oromandibular Dystonia Syndrome|Orofacial Dyskinesias, Idiopathic|Dyskinesias, Idiopathic Orofacial|Dyskinesia, Idiopathic Orofacial|Dyskinesia, Blepharospasm-Oromandibular|Blepharospasm Oromandibular Dystonia Syndrome|Dystonias, Blepharospasm-Oromandibular|Idiopathic Blepharospasm Oromandibular Dystonia Syndrome|Blepharospasm Oromandibular Dystonia Syndrome, Idiopathic"
NEW00811,CHEMICAL,Catecholamine neurons,Catecholamine neurons
NEW00812,CHEMICAL,MPTP intoxication,MPTP intoxication
NEW00814,BIOCHEMICAL,Botulinum neurotoxin injections,Botulinum neurotoxin injections
NEW00656,DISEASE,Corticotrophin-releasing factor,CRF|Corticotrophin-releasing factor
NEW00817,CHEMICAL,Bilateral micro-applications,Bilateral micro-applications
C012102,CHEMICAL,DSP 4 [Supplementary Concept],DSP-4|Benzylamines
NEW00819,BIOCHEMICAL,NA neurotoxin,NA neurotoxin
NEW00823,CHEMICAL,neurotoxin methylazoxymethanol acetate,neurotoxin methylazoxymethanol acetate
NEW00824,CHEMICAL,central OXT,central OXT
NEW00826,CHEMICAL,VP systems,VP systems
NEW00827,DISEASE,Extrapyramidal side-effects,EPSE|Extrapyramidal side-effects
NEW00829,CHEMICAL,consumption DSP4 treatment,consumption DSP4 treatment
NEW00830,CHEMICAL,high sucrose consumption,high sucrose consumption
NEW00833,CHEMICAL,BOTOX ®,BOTOX ®
NEW00835,CHEMICAL,Chronic inorganic arsenic iAs exposure,Chronic inorganic arsenic iAs exposure
D002220,CHEMICAL,Carbamazepine,Finlepsin|Epitol|Neurotol|Carbamazepine L-Tartrate (4:1)|Carbamazepine Anhydrous|Carbazepin|Carbamazepine Hydrochloride|Carbamazepine Phosphate|Tegretol|Carbamazepine Dihydrate|Amizepine|carbamazepine|Carbamazepine Sulfate (2:1)|Carbamazepine Acetate
NEW00837,CHEMICAL,neuropeptide Y-like immunoreactivity NPY-LI concentrations,neuropeptide Y-like immunoreactivity NPY-LI concentrations
NEW00838,CHEMICAL,SP+CGRP relaxation curves,SP+CGRP relaxation curves
D022603,BIOCHEMICAL,Shiga Toxins,"Toxin, Vero|Vero Toxin|Verotoxins|Toxins, Vero|Cytotoxins, Vero Cell|Verotoxin|Shiga-Like Toxins|Shiga Like Toxins|toxins|Vero Cytotoxin|Vero Toxins|Vero Cell Cytotoxins|Cytotoxin, Vero|Cell Cytotoxins, Vero|Cytotoxin, Vero Cell|Toxins, Shiga-Like|Vero Cell Cytotoxin|Toxins, Shiga|Vero Cytoxins|Cytoxins, Vero"
D022124,DISEASE,Hyperammonemia,Ammonia (1966-2000)|hyperammonemia
NEW00841,DISEASE,mitochondrial impairment,mitochondrial impairment
NEW00843,CHEMICAL,neurotoxin ammonia,neurotoxin ammonia
NEW00845,DISEASE,neurotoxic properties,neurotoxic properties
C012301,CHEMICAL,domoic acid [Supplementary Concept],domoic acid|Kainic Acid/analogs  and  derivatives
D057096,CHEMICAL,Shellfish Poisoning,"Shellfish Poisonings, Diarrhetic|Poisonings, Shellfish|Poisoning, Amnesic Shellfish|Poisoning, Neurotoxic Shellfish|Shellfish Poisonings, Amnesic|Shellfish Poisonings, Neurotoxic|Poisonings, Paralytic Shellfish|Paralytic Shellfish Poisonings|ASP|Diarrhetic Shellfish Poisoning|Poisoning, Shellfish|Diarrhetic Shellfish Poisonings|Shellfish Poisoning, Diarrhetic|Amnesic Shellfish Poisonings|Shellfish Poisoning, Neurotoxic|Shellfish Poisoning, Amnesic|Neurotoxic Shellfish Poisoning|Poisoning, Diarrhetic Shellfish|Shellfish Poisoning, Paralytic|Poisoning, Paralytic Shellfish|Shellfish Poisonings|Poisonings, Amnesic Shellfish|Paralytic Shellfish Poisoning|Neurotoxic Shellfish Poisonings|Amnesic Shellfish Poisoning|Poisonings, Neurotoxic Shellfish|Poisonings, Diarrhetic Shellfish|Amnesic shellfish poisoning|Shellfish Poisonings, Paralytic"
NEW00846,CHEMICAL,dopamine levels,dopamine levels
D020267,CHEMICAL,MPTP Poisoning,"MPTP Neurotoxicity Syndrome|MPTP-Induced Parkinsonism|Poisoning, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine|MPTP Neurotoxicity Syndromes|Neurotoxicity Syndromes, MPTP|Poisoning, MPTP|MPTP Induced Parkinsonism|Parkinsonism, MPTP-Induced|MPTP Induced Degeneration of the Striatum|Neurotoxicity Syndrome, MPTP|1-methyl 4-phenyl 1,2,3,6 tetrahydropyridine|MPTP-Induced Degeneration of the Striatum"
NEW00848,BIOCHEMICAL,mitochondrial neurotoxin,mitochondrial neurotoxin
NEW00849,BIOCHEMICAL,MPTP-like toxin,MPTP-like toxin
C064498,CHEMICAL,mitochondrial processing peptidase [Supplementary Concept],Metalloendopeptidases|MPP+
NEW00851,DISEASE,neuronal death,neuronal death
NEW00519,CHEMICAL,cannabis plant,cannabis plant|Cannabis sativa
D006970,MENTAL_HEALTH,Disorders of Excessive Somnolence,"Hypersomnolence Disorders|Hypersomnia Disorder, Secondary|Hypersomnia, Recurrent|Excessive Daytime Sleepiness|Excessive Somnolence Disorders|excessive somnolence|Recurrent Hypersomnias|Secondary Hypersomnolence Disorder|Excessive Daytime Sleepinesses|Hypersomnolence Disorders, Primary|Hypersomnias|Hypersomnolence Disorder, Primary|Primary Hypersomnia Disorder|Somnolence Disorder, Excessive|Daytime Sleepinesses|Hypersomnolence|Daytime Sleepiness, Excessive|Secondary Hypersomnia Disorders|Primary Hypersomnolence Disorder|Hypersomnolence Disorder|Daytime Somnolences|Sleepiness, Excessive Daytime|Primary Hypersomnolence Disorders|Excessive Somnolence Disorder|Daytime Sleepiness|Daytime Somnolence|Hypersomnia|DOES (Disorders of Excessive Somnolence)|DOESs (Disorders of Excessive Somnolence)|Somnolence, Daytime|Hypersomnolence Disorders, Secondary|Hypersomnolence Disorder, Secondary|Hypersomnia Disorder, Primary|Recurrent Hypersomnia|Secondary Hypersomnolence Disorders|Primary Hypersomnia Disorders|Sleepiness, Daytime|Secondary Hypersomnia Disorder"
NEW00854,CHEMICAL,HCRT2/SAP-lesioned rats,HCRT2/SAP-lesioned rats
NEW00856,BIOCHEMICAL,neurotoxin HCRT2-SAP,neurotoxin HCRT2-SAP
NEW00857,CHEMICAL,hypocretin2-sap,hypocretin2-sap
D008767,CHEMICAL,Methylmercury Compounds,"Mercury Compounds, Methyl|Methyl Mercury Compounds|Compounds, Methylmercury|MeHg|Compounds, Methyl Mercury|Methylmercury"
NEW00858,CHEMICAL,neurotoxin methylmercury,neurotoxin methylmercury
D044183,BIOCHEMICAL,"Receptor, Parathyroid Hormone, Type 2","Receptor, PTH-2|Parathyroid Hormone Receptor 2|PTH-2 Receptor|Receptor, PTH2|PTH 2 Receptor|parathyroid hormone|PTH2 Receptor"
NEW00862,BIOCHEMICAL,Neurotoxin dosage,Neurotoxin dosage
NEW00863,DISEASE,high-incidence ALS,high-incidence ALS
NEW00864,DISEASE,severe hypomagnesemia,severe hypomagnesemia
NEW00866,CHEMICAL,kynurenine ratio,kynurenine ratio
NEW00869,CHEMICAL,reduced kynurenic acid,reduced kynurenic acid
NEW00871,CHEMICAL,unbalanced kynurenine metabolism,unbalanced kynurenine metabolism
NEW00873,NUTRITION,tryptophan degradation,tryptophan degradation
NEW00874,DISEASE,Excitotoxic damage,Excitotoxic damage
NEW00876,DISEASE,spontaneous daytime motor activity,spontaneous daytime motor activity
NEW00877,CHEMICAL,bilateral quinolinate+haloperidol rats,bilateral quinolinate+haloperidol rats
NEW00878,CHEMICAL,bilateral quinolinate group,bilateral quinolinate group
NEW00879,CHEMICAL,D-cycloserine,D-cycloserine
NEW00880,BIOCHEMICAL,partial N-methyl-D-aspartate receptor agonist,partial N-methyl-D-aspartate receptor agonist
D050601,CHEMICAL,Kynurenine 3-Monooxygenase,"Kynurenine 3-Hydroxylase|Kynurenine 3 Monooxygenase|3-Monooxygenase, Kynurenine|L-Kynurenine-3-Hydroxylase|Kynurenine 3 Hydroxylase|Kynurenine Hydroxylase|Kynurenine|L Kynurenine 3 Hydroxylase|3-Hydroxylase, Kynurenine|Hydroxylase, Kynurenine"
NEW00885,BIOCHEMICAL,CCR5-coreceptor antagonists,CCR5-coreceptor antagonists
D006397,BIOCHEMICAL,Hematinics,"Erythropoiesis Stimulating Agents|Hematopoietic Agents|Agent, Erythropoiesis Stimulating|erythropoiesis-stimulating agents|Stimulating Agent, Erythropoiesis|Hematinic|Erythropoiesis Stimulating Agent"
NEW00888,BIOCHEMICAL,Parathyroid hormone level,Parathyroid hormone level
NEW00889,CHEMICAL,chronic cortisol elevation,chronic cortisol elevation
NEW00891,NUTRITION,trout O.    mykiss,trout O.    mykiss
D015283,CHEMICAL,Citalopram,Celexa|Lu-10-171|Lu10171|Cytalopram|Seropram|Citalopram Hydrobromide|citalopram
NEW00893,CHEMICAL,stress hormone cortisol,stress hormone cortisol
NEW00895,NUTRITION,juvenile rainbow trout,Oncorhynchus mykiss|juvenile rainbow trout
C008757,CHEMICAL,palmitoleic acid [Supplementary Concept],"palmitoleic acid|Fatty Acids, Monounsaturated|POA"
C585684,CHEMICAL,TIC10 compound [Supplementary Concept],Pyridines|Compound (+)-7|Pyrimidines|MGS0008|Imidazoles
D005442,CHEMICAL,Flumazenil,Flumazenil|Anexate|Lanexat|Ro 15-1788|Romazicon|Ro 151788|Flumazepil|Ro 15 1788
C498829,CHEMICAL,"Hrh4 protein, mouse [Supplementary Concept]","Histamine H4 receptor|Receptors, Histamine H4"
NEW00897,BIOCHEMICAL,agonist activity,agonist activity
D000069348,CHEMICAL,Quetiapine Fumarate,"Quetiapine|Seroquel|2-(2-(4-dibenzo(b,f)(1,4)thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol|ICI204636|quetiapine|Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (E)-2-butenedioate (2:1) (salt)|ICI-204636|ICI 204,636|ICI 204636"
NEW00902,CHEMICAL,GLP-1 receptor stimulation,GLP-1 receptor stimulation
NEW00904,MENTAL_HEALTH,L-Dopa-induced dyskinesia,L-Dopa-induced dyskinesia
NEW00906,CHEMICAL,antiepileptic drug topiramate,antiepileptic drug topiramate
NEW00907,DISEASE,parkinsonian disability,parkinsonian disability
NEW00908,CHEMICAL,low-dose amantadine,low-dose amantadine
NEW00909,BIOCHEMICAL,D1R agonists,D1R agonists
NEW00910,BIOCHEMICAL,novel D1R agonists,novel D1R agonists
NEW00912,DISEASE,central nervous disorders,central nervous disorders
NEW00913,DISEASE,Acute myocardial ischemia,Acute myocardial ischemia
NEW00914,DISEASE,cocaine-induced myocardial infarction,cocaine-induced myocardial infarction
D058226,DISEASE,"Plaque, Atherosclerotic","Streak, Arterial Fatty|Arterial Fatty Streak|Fibroatheromatous Plaques|Atheromas|Plaques, Fibroatheromatous|Atheromatous Plaques|Plaques, Atheromatous|Atheroma|Plaques, Atherosclerotic|Streaks, Arterial Fatty|Fibroatheromas|Fibroatheroma|Atherosclerotic Plaque|Atherosclerotic Plaques|Arterial Fatty Streaks|Fibroatheromatous Plaque|Plaque, Fibroatheromatous|Atheromatous Plaque|Plaque, Atheromatous|Fatty Streaks, Arterial|atherosclerotic plaques|Fatty Streak, Arterial"
D004837,CHEMICAL,Epinephrine,"Epinephrine Bitartrate|Epinephrine|Epinephrine Hydrogen Tartrate|Medihaler-Epi|Epinephrine Hydrochloride|Adrenaline|Adrenaline Hydrochloride|Lyophrin|Epifrin|Epinephrine Acetate|Adrenaline Acid Tartrate|4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol|Epitrate|Adrenaline Bitartrate|Acetate, Epinephrine"
D007741,CHEMICAL,Labetalol,"Normodyne|R,R-Labetalol|Labetalol|SCH19927|ApoLabetalol|Hydrochloride, Labetalol|Dilevalol|Apo Labetalol|Labetalol Hydrochloride|Albetol|Presolol|AH 5158|Trandate|Labetolol|SCH 19927|R,R Labetalol|Labetalol, (R,R)-Isomer|SCH-19927|AH-5158|AH5158|Apo-Labetalol"
NEW00920,MENTAL_HEALTH,sluggishness sexual dysfunction,sluggishness sexual dysfunction
D007008,DISEASE,Hypokalemia,Hypokalemias|Hypopotassemia|Hypopotassemias|Hypokalemia
NEW00921,BIOCHEMICAL,nonselective beta-adrenergic blockers,nonselective beta-adrenergic blockers
D049993,CHEMICAL,Sodium Chloride Symporter Inhibitors,"Thiazide Sensitive NaCl Cotransporter Inhibitor|Sodium Chloride Symporter Inhibitor|Thiazide Sensitive NaCl Cotransporter Inhibitors|Thiazide Diuretics|Potassium Depleting Diuretic|Sodium Chloride Cotransporter Inhibitors|Diuretic, Benzothiadiazine|Potassium Depleting Diuretics|Diuretics, Benzothiadiazine|Diuretics, Potassium Depleting|Thiazide Diuretic|Sodium Chloride Cotransporter Inhibitor|Benzothiadiazine Diuretic|Benzothiadiazine Diuretics|Diuretics, Thiazide|Diuretic, Thiazide|Thiazide diuretics|Diuretic, Potassium Depleting|Depleting Diuretic, Potassium"
NEW00923,CHEMICAL,beta blocker,atenolol|beta blocker
D015220,CHEMICAL,Calcium Channels,"Calcium Channels, Voltage-Dependent|Calcium Channel Blocker Receptors|Voltage-Dependent Calcium Channel|Voltage Dependent Calcium Channel|Ion Channels, Calcium|Calcium Channel Blocker Receptor|calcium-channel blocker|Calcium Ion Channel|Voltage Dependent Calcium Channels|Ion Channel, Calcium|Channels, Voltage-Dependent Calcium|Calcium Channel Antagonist Receptor|Voltage-Dependent Calcium Channels|Calcium Channel|Receptors, Calcium Channel Antagonist|Calcium Channel, Voltage-Dependent|Receptors, Calcium Channel Blocker|Calcium Ion Channels|VDCC|Calcium Channel Antagonist Receptors|Channel, Voltage-Dependent Calcium"
NEW00925,CHEMICAL,blocker verapamil,blocker verapamil
NEW00927,CHEMICAL,psychostimulants,psychostimulants
NEW00928,CHEMICAL,Bupropion antidepressants,Bupropion antidepressants
D000316,BIOCHEMICAL,Adrenergic alpha-Agonists,"Agonists, alpha-Adrenergic Receptor|alpha-Adrenergic Agonist|Agonist, alpha-Adrenergic Receptor|Alpha adrenergic agonists|Adrenergic alpha-Agonist|alpha-Agonists, Adrenergic|Receptor Agonists, alpha Adrenergic|Agonists, alpha-Adrenergic|Receptor Agonist, alpha-Adrenergic|alpha-Agonist, Adrenergic|Adrenergic alpha-Receptor Agonists|alpha Adrenergic Agonists|Adrenergic alpha Receptor Agonists|Agonist, Adrenergic alpha-Receptor|alpha Adrenergic Receptor Agonist|alpha-Adrenergic Agonists|Agonists, Adrenergic alpha-Receptor|Agonist, alpha-Adrenergic|alpha Adrenergic Receptor Agonists|alpha-Receptor Agonists, Adrenergic|Receptor Agonists, Adrenergic alpha|Adrenergic alpha Agonists|Adrenergic alpha Receptor Agonist|Adrenergic alpha Agonist|alpha Adrenergic Agonist|alpha-Receptor Agonist, Adrenergic|alpha-Adrenergic Receptor Agonist|alpha-Adrenergic Receptor Agonists|Adrenergic alpha-Receptor Agonist|Receptor Agonists, alpha-Adrenergic"
D000077265,CHEMICAL,Donepezil,"Donepezilium Oxalate Trihydrate|Donepezil Hydrochloride|E-2020|Aricept|E2020|donepezil|E 2020|Eranz|1-Benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine hydrochloride"
NEW00931,BIOCHEMICAL,ABSTRACT beta-Adrenergic blockers,ABSTRACT beta-Adrenergic blockers
D051860,MENTAL_HEALTH,Fragile X Mental Retardation Protein,Fragile X Mental Retardation 1 Protein|FMRP Protein|Fragile X Mental Retardation-1 Protein|mental retardation
NEW00935,CHEMICAL,5-(2-Chlorophenoxy)-3-methyl-1-phenyl-1H-pyrazole-4-carbaldehyde,5-(2-Chlorophenoxy)-3-methyl-1-phenyl-1H-pyrazole-4-carbaldehyde
C042788,CHEMICAL,fluoren-9-ol [Supplementary Concept],9-hydroxyfluorene|Fluorenes
C562130,CHEMICAL,2-hydroxynaphthalene(dodecylo)-6-sulfonamide [Supplementary Concept],Naphthalenes|Sulfonamides|2-hydroxynaphthalene
NEW00937,CHEMICAL,3-hydroxyphenanthrene,3-hydroxyphenanthrene
C093851,CHEMICAL,1-hydroxypyrene-glucuronide [Supplementary Concept],Glucuronates|Pyrenes|1-hydroxypyrene
NEW00938,CHEMICAL,urinary polyaromatic hydrocarbons,urinary polyaromatic hydrocarbons
C477779,CHEMICAL,2-hydroxyfluorene [Supplementary Concept],Fluorenes|2-hydroxyfluorene
NEW00939,CHEMICAL,1-hydroxynaphthalene 1-naphthol,1-hydroxynaphthalene 1-naphthol
NEW00940,CHEMICAL,polar phenolic extract,polar phenolic extract
NEW00942,CHEMICAL,Dietary flavonoids,Dietary flavonoids
D000069503,CHEMICAL,Vilazodone Hydrochloride,"EMD 68843|2-benzofurancarboxamide, 5-(4-(4-(5-cyano-1H-indol-3-yl)butyl)-1-piperazinyl)-, hydrochloride (1:1)|EMB 68843|EMB68843|EMB-68843|Viibryd|Vilazodone HCl|68843, EMD|vilazodone|Vilazodone|5-(4-(4-(5-cyano-3-indolyl)butyl)-1-piperazinyl)benzofuran-2-carboxamide|HCl, Vilazodone|Hydrochloride, Vilazodone"
NEW00946,MENTAL_HEALTH,Obsessive-compulsive disorder patients,Obsessive-compulsive disorder patients
D050486,CHEMICAL,Serotonin Plasma Membrane Transport Proteins,"5HT Transporter|Neurotransmitter Transport Proteins, Serotonin-Specific|Transporter, Sodium-Dependent Serotonin|Sodium Dependent Serotonin Transporter|serotonin transporter|Sodium-Dependent Serotonin Transporter|Platelet Serotonin Transporter|Platelets Serotonin Transporter|Neurotransmitter Transport Proteins, Serotonin Specific|Serotonin Transporter|SERT Proteins|Serotonin Transporter, Platelets|Serotonin-Specific Neurotransmitter Transporters|Neurotransmitter Transporters, Serotonin-Specific|SLC6A4 Protein|Neurotransmitter Transporters, Serotonin Specific|Serotonin Transporter, Sodium-Dependent|5 Hydroxytryptamine Plasma Membrane Transport Protein|Serotonin Transporter, Platelet|Serotonin Plasma Membrane Transporter Proteins|Serotonectin|Solute Carrier Family 6, Member 4 Protein|5-Hydroxytryptamine Plasma Membrane Transport Protein"
NEW00949,CHEMICAL,NR4A1 Nur77 subfamily,NR4A1 Nur77 subfamily
D018160,BIOCHEMICAL,"Receptors, Cytoplasmic and Nuclear","Cytosol and Nuclear Receptors|Receptor, Nuclear Hormone|Receptors, Nuclear|Receptors, Intracellular Membrane|Nuclear Hormone Receptors|Cytosolic and Nuclear Receptors|Nuclear Receptor|Membrane Receptors, Intracellular|Receptors, Nuclear Hormone|Receptors, Cytoplasmic Hormone|nuclear hormone receptors|Hormone Receptor, Nuclear|Hormone Receptors, Nuclear|Cytoplasmic Hormone Receptors|Nuclear Receptors|Receptor, Nuclear|Cytoplasmic and Nuclear Receptors|Cytoplasmic Receptor|Hormone Receptors, Cytoplasmic|Nuclear and Cytoplasmic Receptors|Receptors, Cytosolic and Nuclear|Receptors, Cytoplasmic|Receptors, Nuclear and Cytoplasmic|Receptor, Cytoplasmic|Receptors, Cytosol and Nuclear|Nuclear Hormone Receptor|Intracellular Membrane Receptors|Cytoplasmic Receptors"
NEW00950,CHEMICAL,mM Li+ concentration,mM Li+ concentration
NEW00953,CHEMICAL,intracellular free-Ca2,intracellular free-Ca2
NEW00955,NUTRITION,inositol phospholipid second-messenger generating system,inositol phospholipid second-messenger generating system
NEW00954,DISEASE,manic-depressive disorder,manic-depressive disorder
NEW00956,DISEASE,early THC abuse,early THC abuse
C510793,CHEMICAL,pimavanserin [Supplementary Concept],Pimavanserin|Piperidines|Urea/analogs  and  derivatives
NEW00960,BIOCHEMICAL,partial agonist,partial agonist
NEW00961,BIOCHEMICAL,hormone dysregulation,hormone dysregulation
NEW00037,MENTAL_HEALTH,subscale D,depression|subscale D
NEW00967,CHEMICAL,first melatonergic antidepressant,first melatonergic antidepressant
NEW00968,CHEMICAL,agonists pramipexole,agonists pramipexole
NEW00969,CHEMICAL,dopamine modulator,dopamine modulator
NEW00970,CHEMICAL,modulator aripiprazole,modulator aripiprazole
D012753,MENTAL_HEALTH,Shared Paranoid Disorder,"Shared Psychotic Disorder|Folie a Deux|Shared Psychotic Disorders|Folie a Trois|Disorders, Shared Paranoid|Shared Paranoid Disorders|Paranoid Disorder, Shared|psychotic disorder|Disorder, Shared Paranoid|Paranoid Disorders, Shared|Psychotic Disorders, Shared|Disorders, Shared Psychotic|Disorder, Shared Psychotic|Psychotic Disorder, Shared"
NEW00972,CHEMICAL,K(+)-channel blocker 4-aminopyridine,K(+)-channel blocker 4-aminopyridine
NEW00973,CHEMICAL,glutamate release,glutamate release
NEW00974,CHEMICAL,AMPA infusion,AMPA infusion
D001640,CHEMICAL,Bicuculline,"bicuculline|6-(5,6,7,8-Tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)furo(3,4-e)1,3-benzodioxol-8(6H)one"
C000603040,CHEMICAL,gintonin [Supplementary Concept],Plant Extracts|Gintonin
NEW00978,BIOCHEMICAL,oestrogen depletion,oestrogen depletion
NEW00979,CHEMICAL,selective GPER agonist G1,selective GPER agonist G1
NEW00981,BIOCHEMICAL,novel oestrogen agonists,novel oestrogen agonists
D007213,CHEMICAL,Indomethacin,Indometacin|indomethacin|Indocid|Indomet 140|Metindol|Indocin|Osmosin|Indomethacin Hydrochloride|Amuno
NEW00983,CHEMICAL,KCZ,KCZ
NEW00985,CHEMICAL,KCZ effects,KCZ effects
NEW00987,DISEASE,chronic restraint stress,CRS|chronic restraint stress
D017294,CHEMICAL,Ondansetron,"Monohydrochloride Dihydrate, Ondansetron|Ondansetron Monohydrochloride|GR38032F|Ondansetron, (+,-)-Isomer|GR-38032F|GR 38032F|Ondansetron Hydrochloride|SN307|Dihydrate, Ondansetron Monohydrochloride|Ondansetron, (R)-Isomer|SN-307|Zofran|SN 307|4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-|Ondansetron Monohydrochloride Dihydrate|Monohydrochloride, Ondansetron|Ondansetron|Hydrochloride, Ondansetron|Ondansetron, (S)-Isomer"
NEW00989,BIOCHEMICAL,ondansetron 5HT3 antagonist,ondansetron 5HT3 antagonist
D000077526,CHEMICAL,Tropisetron,ICS-205-930|Indole-3-carboxylic Acid Tropine Ester|ICS-205930|ICS 205-930|ICS 205930|tropisetron|(3 alpha-Tropanyl)-1H-indole-3-carboxylic Acid Ester|Tropisetron Hydrochloride|ICS 205 930|Indole 3 carboxylic Acid Tropine Ester|Navoban
NEW00992,BIOCHEMICAL,Selective agonists,Selective agonists
NEW00993,CHEMICAL,M4 muscarinic acetylcholine receptors,M4 muscarinic acetylcholine receptors
C084711,CHEMICAL,agomelatine [Supplementary Concept],Agomelatine|Acetamides|Naphthalenes
NEW01003,CHEMICAL,antidepressant action,antidepressant action
C533287,CHEMICAL,cariprazine [Supplementary Concept],Piperazines|Cariprazine
NEW01006,CHEMICAL,increased cortisol levels,increased cortisol levels
C095476,CHEMICAL,"theophylline, salbutamol drug combination [Supplementary Concept]",Theophylline|Drug Combinations|Albuterol|salbutamol
NEW01011,CHEMICAL,miR-134 5p promoter,miR-134 5p promoter
C039979,CHEMICAL,gepirone [Supplementary Concept],gepirone|Pyrimidines
NEW01013,CHEMICAL,serotonin 1A receptor partial agonist ipsapirone hydrochloride,serotonin 1A receptor partial agonist ipsapirone hydrochloride
D014527,CHEMICAL,Uric Acid,"Sodium Acid Urate Monohydrate|Urate|Monosodium Urate Monohydrate|uric acid|Urate, Monosodium|Urate Monohydrate, Monosodium|Ammonium Acid Urate|Sodium Urate|Acid, Uric|Acid Urate, Ammonium|Monohydrate, Sodium Urate|Monohydrate, Monosodium Urate|Urate Monohydrate, Sodium|Urate, Sodium|Sodium Acid Urate|2,6,8-Trihydroxypurine|Urate, Sodium Acid|Sodium Urate Monohydrate|Monosodium Urate|Potassium Urate|Urate, Ammonium Acid|Urate, Potassium|Acid Urate, Sodium|Trioxopurine"
D000341,MENTAL_HEALTH,"Affective Disorders, Psychotic","Mood Disorders, Psychotic|Psychotic Affective Disorders|Disorders, Psychotic Affective|affective disorders|Psychotic Mood Disorder|Affective Disorder, Psychotic|Affective Psychoses|Psychotic Mood Disorders|Disorder, Psychotic Affective|Depression, Reactive, Psychotic|Mood Disorder, Psychotic|Psychotic Affective Disorder|Psychoses, Affective"
D006074,DISEASE,Gout Suppressants,"Antigout Agents|gout|Antihyperuricemics|Suppressants, Gout|Antihyperuricemic|Agents, Antigout"
NEW01017,BIOCHEMICAL,KOR antagonist treatment,KOR antagonist treatment
D006966,DISEASE,Hyperprolactinemia,"Syndrome, Prolactin Hypersecretion|Secretion Prolactin, Inappropriate|Hypersecretion Syndrome, Prolactin|Secretion, Inappropriate Prolactin|Inappropriate Prolactin Secretion Syndrome|Prolactin Hypersecretion Syndrome|Inappropriate Prolactin Secretion|Hyperprolactinemias|Prolactin, Inappropriate Secretion|Prolactin Secretion, Inappropriate|Inappropriate Secretion Prolactin|Hyperprolactinaemia|hyperprolactinemia"
D053578,DISEASE,Opsoclonus-Myoclonus Syndrome,"Dancing Eyes Dancing Feet Syndrome|Myoclonic Encephalopathy of Infants|Opsoclonus Myoclonus|Paraneoplastic Opsoclonus-Myoclonus Ataxia|Infants Myoclonic Encephalopathy|Infants Myoclonic Encephalopathies|Myoclonus, Opsoclonus|Kinsbourne Syndrome|Myoclonus|Dancing Eyes-Dancing Feet Syndrome|Paraneoplastic Opsoclonus Myoclonus Ataxia|Dancing Eyes, Dancing Feet Syndrome|Opsoclonus Myoclonus Syndrome|Opsoclonus Myoclonus Ataxia"
D000077206,CHEMICAL,Gabapentin,Novo-Gabapentin|Gabapentin|1-(Aminomethyl)cyclohexaneacetic Acid|ApoGabapentin|Convalis|NovoGabapentin|PMS-Gabapentin|Gabapentin Ratiopharm|GBP|Gabapentin Hexal|Apo-Gabapentin|Novo Gabapentin|Gabapentin-Ratiopharm|Gabapentin Stada|Neurontin|Apo Gabapentin
D014147,CHEMICAL,Tramadol,Tramadol Kern|Tradonal|Tramadol Heumann|Trama Dorsch|Tramadol Lindo|MTW-Tramadol|Zydol|Ultram|K315|Tramadol Stada|K 315|TramadolHameln|Tramadol-ratiopharm|Tramadol PB|Tramadol Lichtenstein|Jutadol|Tramadol Hydrochloride|TradolPuren|Contramal|Zumalgic|K-315|Nobligan|Tramadol Dolgit|Tramadol 1A|Trama KD|Zytram|Tradol Puren|Tramadol acis|MTWTramadol|Tramundin|Tramadol Ratiopharm|Trasedal|Trama 1A Pharma|Tramal|Tramadol Edigen|Tramadin|Zamudol|Tramadol Mabo|Tramake|Biokanol|Tramadol Bexal|Tramex|MTW Tramadol|Tramadol Bayvit|Tradol|Topalgic|Theradol|Biodalgic|Tramadol AL|Tramadol Asta Medica|Trama AbZ|Tramadol Hameln|Tralgiol|Tiral|Tramabeta|Adolonta|Takadol|Tramagit|Tramadolor|Tramadura|Tradol-Puren|Tramadoc|Tramadol Normon|TramaDorsch|Trama-Dorsch|tramadol|Tramadolratiopharm|Tramadol-Dolgit|TramadolDolgit|Tramagetic|Prontofort|Tramadol-Hameln|Tramadol Cinfa|Tramadol Basics|Ranitidin 1A Pharma|Amadol|Xymel 50
D001418,CHEMICAL,Baclofen,"Chlorophenyl GABA|Ba-34647|CIBA34,647BA|Gen Baclofen|Lebic|beta-(Aminomethyl)-4-chlorobenzenepropanoic Acid|GenBaclofen|NuBaclo|Ba34,647|Ba34647|Atrofen|Baclophen|Lioresal|Baclospas|Clofen|Baclofène-Irex|Baclofène Irex|Apo Baclofen|beta-(p-Chlorophenyl)-gamma-aminobutyric Acid|Nu-Baclo|PMS-Baclofen|Baclofen AWD|BaclofèneIrex|Liorésal|GABA, Chlorophenyl|Gen-Baclofen|CIBA-34,647-BA|ApoBaclofen|Genpharm|Ba-34,647|AWD, Baclofen|PCP-GABA|PMS Baclofen|PMSBaclofen|Apo-Baclofen|Baclofen|Nu Baclo"
C507711,CHEMICAL,4-(4-(2-(n-butoxy)ethoxy)-5-methylthiazol-2-yl)-2-fluorobenzoic acid [Supplementary Concept],Thiazoles|Benzoates|AC261066
NEW01030,CHEMICAL,retinoic acid RA receptor β2,retinoic acid RA receptor β2
NEW01031,CHEMICAL,cytochrome P450 4A,CYP4A|cytochrome P450 4A
NEW01033,BIOCHEMICAL,agonist SR9009,agonist SR9009
NEW01034,CHEMICAL,CYP4A antagonist,CYP4A antagonist
C000708209,CHEMICAL,HET0016 [Supplementary Concept],Amidines|HET0016
NEW01035,DISEASE,lithium-treated euthymic bipolar patients,lithium-treated euthymic bipolar patients
NEW01039,CHEMICAL,C-QUIP,C-QUIP
D017109,DISEASE,"Akathisia, Drug-Induced","akathisia|Akathisia, Drug Induced|Acathisia, Drug Induced|Drug-Induced Akathisia|Pseudoakathisia|Tardive Akathisia|Drug-Induced Acathisia|Acathisia, Drug-Induced|Akathisia, Tardive|Drug Induced Akathisia"
NEW01041,CHEMICAL,Partial dopamine agonism,Partial dopamine agonism
NEW01045,DISEASE,BPD patients,BPD patients
C516975,CHEMICAL,pitolisant [Supplementary Concept],Pitolisant|Piperidines
NEW01049,CHEMICAL,pimavanserin augmentation,pimavanserin augmentation
NEW01050,BIOCHEMICAL,agonist muscles,agonist muscles
D016750,DISEASE,Stiff-Person Syndrome,"Startle Syndromes|Congenital Stiff-Man Syndromes|Congenital Stiff-Person Syndromes|Syndrome, Stiffman|Syndrome, Stiff-Man|Syndromes, Stiff-Trunk|Stiffman Syndrome|Hereditary Hyperekplexias|Stiff-Person Syndrome, Congenital|Congenital Stiff-Man Syndrome|Startle Syndrome|Syndrome, Stiff-Trunk|Familial Hyperekplexias|Hyperekplexia, Familial|Syndrome, Stiff-Person|Hyperekplexia, Hereditary|Moersch Woltmann Syndrome|Stiff Trunk Syndrome|Familial Hyperekplexia|Stiff Man Syndrome|Stiff Person Syndrome|Stiff-Man Syndrome, Congenital|Stiff-Trunk Syndrome|Stiff-Baby Syndromes|Syndrome, Moersch-Woltmann|Hyperekplexias, Familial|Stiff-Person Syndromes, Congenital|Syndrome, Startle|Stiff-person syndrome|Syndrome, Stiff-Baby|Syndromes, Congenital Stiff-Person|Syndromes, Startle|Hyperekplexias, Hereditary|Syndrome, Congenital Stiff-Man|Stiff-Man Syndromes, Congenital|Stiff-Man Syndrome|Syndromes, Congenital Stiff-Man|Congenital Stiff-Person Syndrome|Stiff-Trunk Syndromes|Syndromes, Stiff-Baby|Hereditary Hyperekplexia|Moersch-Woltmann Syndrome|Syndrome, Congenital Stiff-Person|Stiff-Baby Syndrome|Congenital Stiff Man Syndrome"
D009293,DISEASE,Opioid-Related Disorders,"Dependence, Opioid|Opioid Use Disorder|Misuse, Prescription Opioid|Dependence, Opiate|Opioid Abuse|Abuse, Opiate|Addiction, Opioid|Opioid Misuses|Abuse, Prescription Opioid|Opioid Related Disorders|Opiate Addiction|Opiate Abuses|Prescription Opioid Abuses|OUD|Misuse, Opioid|Opioid Use Disorders|opioid use disorder|Opioid Dependence|Opioid Abuse, Prescription|Opioid Addictions|Prescription Opioid Abuse|Abuse, Opioid|Opiate Abuse|Disorder, Opioid Use|Opiate Dependence|Opioid Addiction|Prescription Opioid Misuses|Opioid Abuses|Prescription Opioid Misuse|Opioid-Related Disorder|Addiction, Opiate|Opioid Misuse|Opioid Dependences"
D009270,CHEMICAL,Naloxone,"MRZ 2593 Br|Dihydride, Naloxone Hydrochloride|Narcan|MRZ 2593|Abello, Naloxone|Naloxone Hydrochloride|Naloxon Ratiopharm|BuNa|MRZ-2593|Naloxon-Ratiopharm|Curamed, Naloxon|Hydrochloride, Naloxone|Nalone|Hydrobromide, Naloxone|Naloxone Hydrobromide|Hydrochloride Dihydride, Naloxone|MRZ 2593Br|Naloxone Hydrochloride Dihydride|Naloxone Abello|Naloxon Curamed|Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer|Narcanti|MRZ2593|Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer|MRZ 2593-Br|naloxone"
NEW01056,BIOCHEMICAL,opioid agonist treatment,opioid agonist treatment
NEW01058,BIOCHEMICAL,full μ-receptor agonists,full μ-receptor agonists
NEW01064,CHEMICAL,selective histamine receptor antagonist/inverse agonist,selective histamine receptor antagonist/inverse agonist
NEW01065,MENTAL_HEALTH,excessive sleepiness,excessive sleepiness
D014486,CHEMICAL,United States Food and Drug Administration,"Drug Administration|FDA|Food and Drug Administration|Food and Drug Administration (U.S.)|USFDA|United States Food, Drug Administration"
C507283,CHEMICAL,GLYX-13 peptide [Supplementary Concept],Oligopeptides|GLYX-13
D060426,CHEMICAL,Anti-N-Methyl-D-Aspartate Receptor Encephalitis,"Non paraneoplastic Anti NMDAR Encephalitis|Encephalitis, Anti-NMDAR|Anti-NMDAR Encephalitides, Paraneoplastic|Paraneoplastic Anti-NMDAR Encephalitides|Encephalitides, Paraneoplastic Anti-NMDAR|Anti-NMDAR Encephalitides|Paraneoplastic Anti NMDAR Encephalitis|Receptor Encephalitis, Anti-NMDA|Paraneoplastic Anti N Methyl D Aspartate Receptor Encephalitis|Receptor Encephalitides, Anti-NMDA|Paraneoplastic Anti-NMDAR Encephalitis|Encephalitides, Anti-N-Methyl-D-Aspartate Receptor|Encephalitis, Paraneoplastic Anti-NMDAR|Encephalitides, Non-paraneoplastic Anti-NMDAR|Non-paraneoplastic Anti-N-Methyl-D-Aspartate Receptor Encephalitis|Anti NMDA Receptor Encephalitis|Encephalitis, Non-paraneoplastic Anti-NMDAR|NMDA receptor|Encephalitides, Anti-NMDAR|Paraneoplastic Anti NMDA Receptor Encephalitis|Anti-NMDAR Encephalitides, Non-paraneoplastic|Encephalitis, Anti-NMDA Receptor|Anti-NMDAR Encephalitis, Non-paraneoplastic|Paraneoplastic Anti-NMDA Receptor Encephalitis|Paraneoplastic Anti-N-Methyl-D-Aspartate Receptor Encephalitis|Anti-NMDAR Encephalitis, Paraneoplastic|Non-paraneoplastic Anti-NMDAR Encephalitides|Anti-N-Methyl-D-Aspartate Receptor Encephalitides|Non-paraneoplastic Anti-NMDAR Encephalitis|Non paraneoplastic Anti N Methyl D Aspartate Receptor Encephalitis|Encephalitis, Anti-N-Methyl-D-Aspartate Receptor|Encephalitides, Anti-NMDA Receptor|Anti N Methyl D Aspartate Receptor Encephalitis|Non-paraneoplastic Anti-NMDA Receptor Encephalitis|Non paraneoplastic Anti NMDA Receptor Encephalitis|Anti-NMDAR Encephalitis|Anti-NMDA Receptor Encephalitides|Anti NMDAR Encephalitis|Anti-NMDA Receptor Encephalitis"
NEW01069,CHEMICAL,selective 5-HT2A antagonist M100907,selective 5-HT2A antagonist M100907
D006220,CHEMICAL,Haloperidol,Haldol|Haloperidol
D058830,BIOCHEMICAL,Serotonin 5-HT2 Receptor Antagonists,"5 HT2C Antagonist|Serotonin 5 HT2 Receptor Antagonists|5 HT2 Antagonist|Serotonin 5 HT2C Receptor Antagonists|Antagonist, 5-HT2B|5-HT2A receptor antagonists|Serotonin 5 HT2A Receptor Antagonists|Serotonin 5 HT2B Receptor Antagonists|Antagonist, 5-HT2A|5 HT2B Antagonist|Antagonist, 5-HT2|Serotonin 5-HT2C Receptor Antagonists|5 HT2A Antagonist|Antagonist, 5-HT2C|Serotonin 5-HT2A Receptor Antagonists|5-HT2C Antagonist|5-HT2B Antagonist|5-HT2A Antagonist|5-HT2 Antagonist|Serotonin 5-HT2B Receptor Antagonists"
NEW01074,CHEMICAL,dopamine agonist apomorphine,dopamine agonist apomorphine
NEW01076,BIOCHEMICAL,dopamine D2 receptor agonist,dopamine D2 receptor agonist
D003866,MENTAL_HEALTH,Depressive Disorder,"Depressions, Endogenous|Depression, Neurotic|Depression, Unipolar|Neurosis, Depressive|Melancholias|Endogenous Depressions|Neuroses, Depressive|Neurotic Depressions|Depressive Syndromes|Depressions, Neurotic|Syndromes, Depressive|Depression, Endogenous|Depressions, Unipolar|Unipolar Depressions|Unipolar Depression|Depressive Neuroses|Melancholia|Depressive Neurosis|Depressive Disorders|Endogenous Depression|Disorders, Depressive|Syndrome, Depressive|Disorder, Depressive|Neurotic Depression|endogenous depression|Depressive Syndrome"
C090499,CHEMICAL,salvinorin A [Supplementary Concept],"Diterpenes, Clerodane|Salvinorin A"
NEW01082,CHEMICAL,dextromethorphan dependence,dextromethorphan dependence
D007926,DISEASE,Lesch-Nyhan Syndrome,"Choreoathetosis Self Mutilation Hyperuricemia Syndrome|Deficiency of Guanine Phosphoribosyltransferase|X-Linked Primary Hyperuricemias|Hypoxanthine Phosphoribosyltransferase Deficiency|Syndromes, Juvenile Hyperuricemia|Complete Hypoxanthine Guanine Phosphoribosyltransferase Deficiency|Hyperuricemia, X-Linked Primary|Deficiencies, Hypoxanthine Phosphoribosyltransferase|Syndrome, Primary Hyperuricemia|Deficiency, Complete HPRT|Juvenile Hyperuricemia Syndromes|Deficiency Disease, Complete HGPRT|Deficiency, Hypoxanthine Phosphoribosyltransferase|Complete HPRT Deficiency|HPRT Deficiencies, Complete|Deficiencies, Complete HPRT|Hyperuricemias, X-Linked Primary|Syndromes, Primary Hyperuricemia|Deficiency of Hypoxanthine Phosphoribosyltransferase|Total HPRT Deficiency|Hyperuricemias, X-Linked|HGPRT Deficiency|HPRT Deficiency, Total|Hyperuricemia Syndromes, Primary|Choreoathetosis Self-Mutilation Syndrome|HPRT Deficiency, Complete|Syndrome, Choreoathetosis Self-Mutilation|Choreoathetosis Self-Mutilation Hyperuricemia Syndrome|Deficiency Diseases, Hypoxanthine-Phosphoribosyl-Transferase|X Linked Hyperuricemia|Complete Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency|HGPRT Deficiencies|Syndrome, Juvenile Hyperuricemia|Deficiency, HGPRT|Phosphoribosyltransferase Deficiency, Hypoxanthine|Lesch-Nyhan syndrome|Hyperuricemia Syndromes, Juvenile|Hypoxanthine Phosphoribosyl Transferase Deficiency Disease|Total Hypoxanthine Guanine Phosphoribosyl Transferase Deficiency|Syndromes, Choreoathetosis Self-Mutilation|Lesch Nyhan Syndrome|Deficiencies, HGPRT|HGPRT Deficiency Disease, Complete|Primary Hyperuricemia Syndrome|Primary Hyperuricemias, X-Linked|Hyperuricemia Syndrome, Primary|Deficiency Disease, Hypoxanthine-Phosphoribosyl-Transferase|Hypoxanthine-Phosphoribosyl-Transferase Deficiency Disease|X-Linked Hyperuricemia|Hypoxanthine Phosphoribosyltransferase Deficiencies|X-Linked Hyperuricemias|Guanine Phosphoribosyltransferase Deficiency|Juvenile Hyperuricemia Syndrome|Self-Mutilation Syndrome, Choreoathetosis|Phosphoribosyltransferase Deficiency, Guanine|Hyperuricemia Syndrome, Juvenile|Phosphoribosyltransferase Deficiencies, Guanine|Hypoxanthine Guanine Phosphoribosyltransferase Deficiency|Lesch Nyhan Disease|Complete HGPRT Deficiency Disease|X Linked Primary Hyperuricemia|HPRT Deficiencies, Total|Deficiencies, Total HPRT|Lesch-Nyhan Disease|Primary Hyperuricemia, X-Linked|Primary Hyperuricemia Syndromes|Deficiency Disease, Hypoxanthine Phosphoribosyl Transferase|Juvenile Gout, Choreoathetosis, Mental Retardation Syndrome|Complete HPRT Deficiencies|Hypoxanthine-Phosphoribosyl-Transferase Deficiency Diseases|Hyperuricemia, X-Linked|Deficiency, Total HPRT|Choreoathetosis Self-Mutilation Syndromes|X-Linked Primary Hyperuricemia|Self-Mutilation Syndromes, Choreoathetosis|Guanine Phosphoribosyltransferase Deficiencies|Hypoxanthine Guanine Phosphoribosyltransferase 1 Deficiency|Choreoathetosis Self Mutilation Syndrome|Phosphoribosyltransferase Deficiencies, Hypoxanthine|Total Hypoxanthine-Guanine Phosphoribosyl Transferase Deficiency|Total HPRT Deficiencies"
D016244,CHEMICAL,Guanosine 5'-O-(3-Thiotriphosphate),"gamma-Thio-GTP|guanosine|Guanosine 5'-(gamma-S)Triphosphate|GTP gamma S|Guanosine 5'-(3-O-Thio)Triphosphate|gamma Thio GTP|GTPgammaS|gamma S, GTP"
D009118,CHEMICAL,Muscimol,Agarin|Pantherine|Muscimol
D058785,BIOCHEMICAL,GABA-A Receptor Agonists,"Receptor Agonists, GABA-A|Agonist, GABA-A Receptor|Agonists, GABA-A|GABA-A Agonists|GABA A Receptor Agonists|GABA-a receptor agonist|Agonists, GABA-A Receptor|Receptor Agonist, GABA-A|GABA A Agonists|GABA A Receptor Agonist|GABA-A Receptor Agonist"
NEW01087,DISEASE,clonidine-induced aggressive behaviors,clonidine-induced aggressive behaviors
NEW01089,CHEMICAL,muscimol,muscimol
NEW01090,CHEMICAL,L-PIA,L-PIA
D007174,MENTAL_HEALTH,"Disruptive, Impulse Control, and Conduct Disorders","control disorders|Intermittent Explosive Disorders|Disorders, Impulse Control|Explosive Disorder, Intermittent|Impulse-Control Disorders|Impulse Control Disorders|Intermittent Explosive Disorder|Kleptomania|Disorders, Intermittent Explosive"
NEW01092,BIOCHEMICAL,D2/D3 agonists,D2/D3 agonists
NEW01094,CHEMICAL,mesocorticolimbic dopamine system,mesocorticolimbic dopamine system
NEW01095,BIOCHEMICAL,agonist therapy,agonist therapy
NEW01098,CHEMICAL,Melatonin agonists,Melatonin agonists
C476721,CHEMICAL,bremelanotide [Supplementary Concept],"Bremelanotide|alpha-MSH|Peptides, Cyclic"
NEW01100,BIOCHEMICAL,novel melanocortin receptor agonist,novel melanocortin receptor agonist
NEW01102,CHEMICAL,chronic CORT treatment,chronic CORT treatment
NEW01104,BIOCHEMICAL,Neurotensin receptor-1 agonist,Neurotensin receptor-1 agonist
NEW01108,CHEMICAL,excess KynA production,excess KynA production
D007736,CHEMICAL,Kynurenic Acid,"Acid, Kynurenic|kynurenic acid|Kynurenate|KynA"
NEW01110,MENTAL_HEALTH,comorbid major depressive disorder,comorbid major depressive disorder
C574027,CHEMICAL,lorcaserin N-carbamoyl glucuronide [Supplementary Concept],Benzazepines|lorcaserin|Glucuronides
NEW01116,BIOCHEMICAL,Drug classes,Drug classes
NEW01118,CHEMICAL,"4-(3-(3-fluoro-5-(trifluoromethyl)benzyl)-5-methyl-1H-1,2,4-triazol-1-yl)-2-methylbenzamide","4-(3-(3-fluoro-5-(trifluoromethyl)benzyl)-5-methyl-1H-1,2,4-triazol-1-yl)-2-methylbenzamide|FTBMT"
D065446,MENTAL_HEALTH,Premenstrual Dysphoric Disorder,"Syndrome, Premenstrual Dysphoric|Premenstrual Dysphoric Syndrome|premenstrual dysphoric disorder|Dysphoric Disorder, Premenstrual|Disorder, Premenstrual Dysphoric"
D011293,MENTAL_HEALTH,Premenstrual Syndrome,"premenstrual syndrome|Tensions, Premenstrual|Syndromes, Premenstrual|Syndrome, Premenstrual|Premenstrual Tension|Premenstrual Tensions|Tension, Premenstrual|Premenstrual Syndromes"
NEW01121,BIOCHEMICAL,various drug protocols,various drug protocols
D012044,MENTAL_HEALTH,Regression Analysis,"Regression analysis|Diagnostics, Regression|Regressions, Statistical|Analysis, Regression|Regression, Statistical|Statistical Regression|Analyses, Regression|Regression Analyses|Statistical Regressions|Regression Diagnostics"
NEW01123,BIOCHEMICAL,LXR agonists,LXR agonists
NEW01126,DISEASE,Atherosclerosis attenuation,Atherosclerosis attenuation
NEW01128,NUTRITION,fecal cholesterol counts,fecal cholesterol counts
NEW01130,BIOCHEMICAL,Ang-(1 agonists,Ang-(1 agonists
D000073879,CHEMICAL,Rice Bran Oil,"rice bran oil|Oil, Rice Bran|Bran Oil, Rice"
D010572,DISEASE,"Pest Control, Biological","controls|TD|Pest Control, Biologic|Biological Pest Control|Pest Controls, Biological|Biologic Pest Control|Biologic Pest Controls|Pest Controls, Biologic|Biological Pest Controls"
D000071057,MENTAL_HEALTH,Tardive Dyskinesia,"Tardive Dystonia|Dystonias, Tardive|Dyskinesias, Tardive|Tardive dyskinesia|Dyskinesia, Tardive|Tardive Dystonias|Tardive Dyskinesias|Dystonia, Tardive"
NEW01133,DISEASE,neurological deficits,neurological deficits
NEW01134,CHEMICAL,grain Zn concentrations,grain Zn concentrations
NEW01135,CHEMICAL,Fe concentrations,Fe concentrations
C013172,CHEMICAL,gamma-oryzanol [Supplementary Concept],γ-oryzanol|Phenylpropionates
D005680,CHEMICAL,gamma-Aminobutyric Acid,"gamma-Aminobutyric Acid, Calcium Salt (2:1)|Gammalon|gamma Aminobutyric Acid, Monolithium Salt|4-Aminobutyric Acid|Lithium GABA|4-Aminobutanoic Acid|Aminalone|gamma Aminobutyric Acid, Monosodium Salt|gamma Aminobutyric Acid|gamma-Aminobutyric Acid, Hydrochloride|gamma-Aminobutyric Acid, Monosodium Salt|Acid, Hydrochloride gamma-Aminobutyric|gamma Aminobutyric Acid, Hydrochloride|GABA|gamma-aminobutyric acid|4 Aminobutyric Acid|4 Aminobutanoic Acid|GABA, Lithium|Hydrochloride gamma-Aminobutyric Acid|Aminalon|gamma-Aminobutyric Acid, Zinc Salt (2:1)|gamma-Aminobutyric Acid, Monolithium Salt"
NEW01137,CHEMICAL,childhood separation anxiety,CSA|childhood separation anxiety
D003863,DISEASE,Depression,"Symptom, Depressive|Depression, Emotional|Depressive Symptom|Depressive Symptoms|Symptoms, Depressive|depressive symptoms|Emotional Depression"
D000067877,MENTAL_HEALTH,Autism Spectrum Disorder,"Autism Spectrum Disorders|Autistic Spectrum Disorder|Autistic Spectrum Disorders|autism spectrum disorder|Disorder, Autistic Spectrum"
NEW01142,CHEMICAL,CRWP nutritional intervention,CRWP nutritional intervention
NEW00374,DISEASE,L-DOPA-induced dyskinesia,LID|L-DOPA-induced dyskinesia
NEW01144,DISEASE,stable motor deficits,stable motor deficits
C095427,CHEMICAL,A 86929 [Supplementary Concept],Quinolones|A-86929|Thiophenes
NEW01146,BIOCHEMICAL,long-acting D1 agonist A-77636,long-acting D1 agonist A-77636
C079415,CHEMICAL,A 77636 [Supplementary Concept],A-77636|Benzopyrans|Adamantane/analogs  and  derivatives
NEW01149,BIOCHEMICAL,known D1-selective agonists,known D1-selective agonists
C061532,CHEMICAL,dihydrexidine [Supplementary Concept],Phenanthridines|Dihydrexidine
NEW01153,BIOCHEMICAL,D1 agonists,D1 agonists
D017447,CHEMICAL,"Receptors, Dopamine D1","Dopamine D1 Receptors|Dopamine D1 Receptor|D1 Receptors, Dopamine|D1- receptors|Receptor, Dopamine-D1|Dopamine-D1 Receptor"
C534628,CHEMICAL,SCH 23390 [Supplementary Concept],SCH23390|Benzazepines
NEW01155,BIOCHEMICAL,DA1/D1 agonists,DA1/D1 agonists
D015647,CHEMICAL,"2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine","SK and F-38393|R-SK and F 38393|SKF 38393A|RSK and F 38393|SKF 38393-A|SK and F38393|SK and F 38393|SKF-38393|SKF38393|1H-3-Benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-|SKF 38393|SKF 38393 A"
D010479,CHEMICAL,Pergolide,"Parkotil|Pharken|LY127,809|LY127809|LY-127,809|Pergolide Mesylate|Permax|pergolide|LY-127809|Mesylate, Pergolide|Celance"
NEW00392,CHEMICAL,levodopa therapy,levodopa therapy
D017478,CHEMICAL,"Receptors, Phencyclidine","Phencyclidine Receptors|PCP Receptors|Receptor, Phencylidine|phencyclidine|Receptor, PCP|Phencylidine Receptor|PCP Receptor|Receptors, PCP"
D018494,BIOCHEMICAL,Histamine Agents,"Histaminergic Effects|Agents, Histamine|Histaminergic Agents|Effect, Histamine|histamine agents|Effect, Histaminergic|Histamine Drugs|Histaminergic Effect|Histaminergic Drugs|Drugs, Histamine|Drugs, Histaminergic|Histamine Effects|Histamine Effect|Effects, Histamine|Effects, Histaminergic|Agents, Histaminergic"
NEW01162,CHEMICAL,histamine neuron system,histamine neuron system
D054828,CHEMICAL,Histamine H3 Antagonists,"Blockers, Histamine H3|Histamine H3 Receptor Antagonists|Antihistaminics, H3|H3 Antihistaminics|Antagonists, Histamine H3|H3 Blockers, Histamine|H3 Antagonists, Histamine|Histamine H3 Blockers|histamine"
D017442,BIOCHEMICAL,Histamine Agonists,"Histamine H2 Receptor Agonist|Agonist, H1|H1 Agonist|H2 Agonist|Histamine H3 Agonists|Agonist, H2|Histamine H1 Receptor Agonist|Agonists, H3|H1 Agonists|Agonist, H3|Agonist, Histamine H1|Histamine H1 Agonist|Agonists, Histamine H1|Histamine Agonist|H1 Agonist, Histamine|Agonist, Histaminergic|Agonist, Histamine H2|Agonist, Histamine|H3 Agonists|Agonists, Histamine H2|H3 receptor agonists|H3 Agonists, Histamine|Histamine H2 Agonists|Agonists, Histamine H3|Agonists, H2|Histaminergic Agonists|H2 Agonist, Histamine|H2 Agonists|H1 Agonists, Histamine|Histamine H1 Agonists|H2 Agonists, Histamine|Histamine H2 Agonist|Agonist, Histamine H3|Agonists, Histaminergic|H3 Agonist|Agonists, Histamine|Histamine H1 Receptor Agonists|Agonists, H1|Histamine H2 Receptor Agonists|H3 Agonist, Histamine|Histamine H3 Agonist|Histaminergic Agonist|Histamine H3 Receptor Agonists"
D006634,CHEMICAL,Histamine H1 Antagonists,"Antagonist, Histamine H1|Antihistaminics, Classical|Antihistamines, Classical|Histamine H1 Blockers|H1 Antagonist, Histamine|H1 Receptor Blockaders|Histamine H1 receptor antagonists|Classical Antihistamines|Antihistamines, Sedating|Antagonists, Histamine H1 Receptor|Classical Antihistaminics|Sedating Antihistamines|Blockaders, Histamine H1 Receptor|Antihistaminics, H1|Histamine H1 Receptor Antagonist|Antagonists, Histamine H1|Histamine H1 Antagonist|Histamine H1 Receptor Antagonists|H1 Antagonists, Histamine|Histamine H1 Receptor Blockaders|Receptor Blockaders, H1|First Generation H1 Antagonists|H1 Antihistaminics"
D002524,DISEASE,Cerebellar Ataxia,"Dysmetrias|Adiadochokineses|Ataxia, Cerebellar|Cerebellar Dysmetrias|Cerebellar Incoordination|Cerebellar ataxia|Hemiataxia, Cerebellar|Cerebellar Ataxias|Incoordinations, Cerebellar|Dysmetria|Hypermetrias|Cerebellar Hemiataxia|Ataxias, Cerebellar|Cerebellar Dysmetria|Dysmetria, Cerebellar|Hypermetria|Hemiataxias, Cerebellar|Cerebellar Incoordinations|Adiadochokinesis|Cerebellar Hemiataxias|Dysmetrias, Cerebellar|Incoordination, Cerebellar"
NEW01168,DISEASE,Alois Alzheimer,Alois Alzheimer
D018967,CHEMICAL,Risperidone,"Risperidal|risperidone|Consta, Risperdal|R64,766|R64766|R-64766|Risperdal Consta|R 64,766|R-64,766|R 64766"
NEW01170,MENTAL_HEALTH,Multivariable logistic regression,Multivariable logistic regression
NEW01174,CHEMICAL,iron deposition,iron deposition
NEW01176,CHEMICAL,above-mentioned bioelements,above-mentioned bioelements
D008124,MENTAL_HEALTH,Locomotion,"Activities, Locomotor|hyperactivity|Locomotor Activity|locomotor activity|Locomotor Activities|Activity, Locomotor"
NEW01179,CHEMICAL,zinc content,zinc content
NEW01181,CHEMICAL,magnesium supplementation,magnesium supplementation
D006527,DISEASE,Hepatolenticular Degeneration,"Degeneration, Hepatolenticular|Degeneration, Neurohepatic|Degeneration Syndromes, Hepatolenticular|Wilson's disease|Degeneration, Progressive Lenticular|Diseases, Kinnier-Wilson|Cerebral Pseudosclerosis|Wilsons Disease|Wilson Disease|Pseudosclerosis, Cerebral|Lenticular Degeneration, Progressive|Diseases, Copper Storage|Diseases, Hepato-Neurologic Wilson|Hepato-Neurologic Wilson Diseases|Kinnier Wilson Disease|Pseudoscleroses, Cerebral|Pseudosclerosis|Hepatocerebral Degeneration|Degenerations, Hepatocerebral|Wilson Diseases, Hepato-Neurologic|Storage Disease, Copper|Copper Storage Disease|Kinnier-Wilson Disease|Hepatolenticular Degeneration Syndromes|Syndromes, Hepatolenticular Degeneration|Degeneration Syndrome, Hepatolenticular|Cerebral Pseudoscleroses|Wilson's Disease|Degeneration, Hepatocerebral|Copper Storage Diseases|Progressive Lenticular Degeneration|Westphal-Strumpell Syndromes|Syndrome, Hepatolenticular Degeneration|Westphal Strumpell Syndrome|Degenerations, Neurohepatic|Kinnier-Wilson Diseases|Neurohepatic Degenerations|Hepato-Neurologic Wilson Disease|Hepatolenticular Degeneration Syndrome|Neurohepatic Degeneration|Hepato Neurologic Wilson Disease|Westphal-Strumpell Syndrome|Wilson Disease, Hepatic Form|Disease, Copper Storage|Hepatocerebral Degenerations|Storage Diseases, Copper|Wilson Disease, Hepato-Neurologic|Hepatic Form of Wilson Disease"
NEW01184,DISEASE,ophthalmologic disorder,ophthalmologic disorder
NEW01185,CHEMICAL,excess zinc,excess zinc
D007706,DISEASE,Menkes Kinky Hair Syndrome,"Copper Deficiencies, X-Linked|Syndromes, Menkea|Diseases, Menkes'|Deficiencies, X-Linked Copper|Hair Diseases, Kinky|Menkes' Disease|Syndrome, Menkea|X-Linked Copper Deficiency|X Linked Copper Deficiency|Diseases, Copper Transport|Menkes' Diseases|Transport Disease, Copper|Hair Diseases, Steely|Copper Transport Diseases|Transport Diseases, Copper|Menkea Syndrome|Copper deficiency|Deficiency, X-Linked Copper|Steely Hair Diseases|Steely Hair Disease|Menkes Syndrome|Disease, Steely Hair|Steely Hair Syndromes|Kinky Hair Diseases|Diseases, Steely Hair|Menkea Syndromes|Congenital Hypocupremias|Congenital Hypocupremia|X-Linked Copper Deficiencies|Syndrome, Steely Hair|Kinky Hair Syndrome|Menkes Disease|Hypocupremia, Congenital|Syndromes, Steely Hair|Kinky Hair Disease|Copper Transport Disease|Diseases, Kinky Hair|Copper Deficiency, X-Linked|Hypocupremias, Congenital|Steely Hair Syndrome|Disease, Copper Transport"
D061027,DISEASE,Programmed Cell Death 1 Ligand 2 Protein,"B7-DC Ligand|programmed cell death|CD273 Antigen|PD L2 Ligand|B7-DC Antigen|CD273 Antigens|Antigen, B7-DC|Antigens, CD273|Antigen, CD273|PD-L2 Ligand|Ligand, B7-DC|Ligand, PD-L2|B7 DC Antigen|B7 DC Ligand"
D003474,CHEMICAL,Curcumin,"Turmeric Yellow|Phytosome, Curcumin|1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-, (E,E)-|Curcumin Phytosome|Mervia|Diferuloylmethane|Curcumin|Yellow, Turmeric"
NEW01191,CHEMICAL,Curcumin co-treatment,Curcumin co-treatment
D003924,DISEASE,"Diabetes Mellitus, Type 2","Diabetes Mellitus, Maturity-Onset|Diabetes Mellitus, Slow-Onset|Non-Insulin-Dependent Diabetes Mellitus|Diabetes Mellitus, Adult Onset|Stable Diabetes Mellitus|Ketosis-Resistant Diabetes Mellitus|Maturity Onset Diabetes|MODY|Diabetes Mellitus, Ketosis-Resistant|Slow-Onset Diabetes Mellitus|Type 2 Diabetes|Diabetes Mellitus, Noninsulin Dependent|Diabetes Mellitus, Noninsulin-Dependent|Type 2 diabetes mellitus|Diabetes, Type 2|Maturity Onset Diabetes Mellitus|Adult-Onset Diabetes Mellitus|Diabetes Mellitus, Slow Onset|T2DM|Diabetes Mellitus, Stable|Diabetes Mellitus, Type II|Maturity-Onset Diabetes Mellitus|Diabetes Mellitus, Adult-Onset|Type 2 Diabetes Mellitus|NIDDM|Diabetes, Maturity-Onset|Diabetes Mellitus, Non-Insulin-Dependent|Diabetes Mellitus, Maturity Onset|Noninsulin Dependent Diabetes Mellitus|Maturity-Onset Diabetes|Noninsulin-Dependent Diabetes Mellitus|Diabetes Mellitus, Ketosis Resistant|Diabetes Mellitus, Non Insulin Dependent"
D000071739,CHEMICAL,Calcium Release Activated Calcium Channels,"Calcium Release Activated Channels|CRAC Channels|Calcium Release Activated Calcium Channel|Channel, CRAC|Calcium Release-Activated Calcium Channels|Calcium Release-Activated Channels|CRAC Channel|calcium"
C021343,CHEMICAL,haematoside synthetase [Supplementary Concept],lactosylceramide|Sialyltransferases|LacCer
NEW01193,DISEASE,Neurobehavioral abnormality,Neurobehavioral abnormality
NEW01199,DISEASE,neurobehavioral abnormalities,neurobehavioral abnormalities
D019327,CHEMICAL,Copper Sulfate,"Sulfate, Copper|Copper|Vitriol, Blue|Cupric Sulfate|Blue Vitriol|Sulfate, Cupric"
D000080445,DISEASE,Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome,"Asthma Chronic Obstructive Pulmonary Disease Overlap Syndrome|Asthma-COPD Overlap Syndrome|Overlap Syndrome, Asthma-COPD|obstructive pulmonary disease|Asthma COPD Overlap Syndrome|Asthma-COPD Overlap Syndromes"
NEW01203,DISEASE,reactive airway disease,reactive airway disease
NEW01204,MENTAL_HEALTH,pre-existing anxiety disorder,pre-existing anxiety disorder
NEW01205,CHEMICAL,high serum copper level,high serum copper level
D004221,CHEMICAL,Disulfiram,"Antabus|Anticol|Dicupral|Teturam|Tetraethylthiuram Disulfide|Disulfiram|Disulfide, Tetraethylthiuram|Antabuse|Bis(diethylthiocarbamoyl) Disulfide|Esperal|Alcophobin|Tetraethylthioperoxydicarbonic Diamide, ((H2N)C(S))2S2"
NEW01207,CHEMICAL,alcohol-abuse drug disulfiram,DSF|alcohol-abuse drug disulfiram
NEW01209,CHEMICAL,urea excretion,J urea|urea excretion
NEW01210,CHEMICAL,excessive cadmium burden,excessive cadmium burden
NEW01211,CHEMICAL,Zn supplementation,Zn supplementation
NEW01212,CHEMICAL,mean serum Zn levels,mean serum Zn levels
NEW01213,CHEMICAL,Zn/Cu ratio,Zn/Cu ratio
D053579,DISEASE,Gitelman Syndrome,"Tubular Hypomagnesemia-Hypokalemia with Hypocalcuria|Gitelman's Syndrome|Primary Renotubular, Hypokalemia-Hypomagnesemia with Hypocalciuria|Hypokalemia-Hypomagnesemia, Familial|Tubular Hypomagnesemia Hypokalemia with Hypocalcuria|Hypokalemia-Hypomagnesemia, Primary Renotubular, with Hypocalciuria|Syndrome, Gitelman's|Gitelman syndrome|Familial Hypokalemia-Hypomagnesemia|Primary Renotubular, Hypomagnesemia-Hypokalemia with Hypocalciuria|Familial Hypokalemia Hypomagnesemia|Syndrome, Gitelman|Hypomagnesemia-Hypokalemia, Primary Renotubular, with Hypocalciuria|Potassium and Magnesium Depletion"
NEW01214,DISEASE,autosomal recessive kidney disorder,autosomal recessive kidney disorder
D015430,DISEASE,Weight Gain,"Weight Gains|Weight gain|Gain, Weight|Gains, Weight"
NEW01217,CHEMICAL,polyP deficient strain,polyP deficient strain
D000927,BIOCHEMICAL,Anticonvulsants,"Drug, Anticonvulsant|Antiepileptics|Anticonvulsant Drugs|Drugs, Anticonvulsive|Antiepileptic Agent|Anticonvulsive Agents|Drugs, Anticonvulsant|Anticonvulsive Drug|Anticonvulsant|Anticonvulsive Agent|Anticonvulsant Drug|Drugs, Antiepileptic|Agent, Antiepileptic|Agents, Antiepileptic|Antiepileptic|Anticonvulsive Drugs|antiepileptic drug|Agents, Anticonvulsive|Drug, Antiepileptic|Antiepileptic Agents|Agent, Anticonvulsive|Antiepileptic Drug|Antiepileptic Drugs|Drug, Anticonvulsive"
NEW01221,MENTAL_HEALTH,atypical autism,atypical autism
D020938,DISEASE,"Epilepsy, Partial, Motor","Seizures, Versive|Epilepsy, Focal Motor|Versive Seizure|Seizure Disorder, Hemimotor|Partial Seizure Disorder, Motor|Seizure Disorder, Motor|Seizure Disorders, Motor|Tonic Seizure, Focal|Seizure, Versive|Hemimotor Seizure Disorders|Hemimotor Epilepsies|Focal Tonic Seizures|Clonic Seizures, Focal|Versive Seizures|Hemimotor Epilepsy|Hemimotor Seizure Disorder|Seizure Disorder, Partial, Motor|Seizure, Focal Clonic|Motor Partial Seizure Disorder|Epilepsy, Hemimotor|Focal Clonic Seizures|Motor Seizure Disorder|Partial Epilepsy, Motor|Focal Motor Epilepsy|Focal Clonic Seizure|Seizure Disorders, Hemimotor|Epilepsy, Motor Partial|Motor Seizure Disorders|Focal Tonic Seizure|epilepsy|Motor Epilepsy, Focal|Tonic Seizures, Focal"
NEW01222,DISEASE,nonbipolar patients,nonbipolar patients
D020529,DISEASE,"Multiple Sclerosis, Relapsing-Remitting","Remitting-Relapsing Multiple Sclerosis|Multiple Sclerosis, Remitting-Relapsing|multiple sclerosis|Relapsing Remitting Multiple Sclerosis|Acute Relapsing Multiple Sclerosis|Multiple Sclerosis, Relapsing Remitting|Relapsing-Remitting Multiple Sclerosis|Multiple Sclerosis, Acute Relapsing|Remitting Relapsing Multiple Sclerosis"
NEW01226,DISEASE,Cocaine-induced cardiotoxicity,Cocaine-induced cardiotoxicity
D005996,CHEMICAL,Nitroglycerin,"Nitroglyn|Anginine|Trinitrolong|Sustonit|Sustak|Nitro Bid|nitroglycerin|Nitro-Dur|Gilustenon|Transderm Nitro|Perlinganit|Nitrostat|Dynamite|Nitro Dur|Nitrolan|Glyceryl Trinitrate|Nitrospan|Nitroderm|Trinitrin|Nitro-Bid|Nitroderm TTS|Nitrangin|Nitrocard|Trinitrate, Glyceryl|Nitrol|NitroBid|Susadrin|Nitrong|NitroDur|Sustac|Tridil"
D053840,DISEASE,Brugada Syndrome,"Sudden Unexplained Nocturnal Death Syndrome (SUNDS)|Brugada Type ECG Pattern|ECG Pattern, Brugada|Sudden Unexplained Nocturnal Death Syndrome|Brugada ECG Pattern|Brugada syndrome|Right Bundle Branch Block, ST Segment Elevation, and Sudden Death Syndrome|Brugada Syndrome 1|Sudden Unexplained Death Syndrome"
NEW01229,CHEMICAL,lactate infusion,lactate infusion
NEW01231,MENTAL_HEALTH,childhood-onset Pervasive Developmental Disorders,childhood-onset Pervasive Developmental Disorders
NEW01232,CHEMICAL,inositol signaling,inositol signaling
D010042,CHEMICAL,Ouabain,Acolongifloroside K|G-Strophanthin|Ouabain|Acocantherin|G Strophanthin
D000087122,DISEASE,Mania,"Hypomanic Episodes|Hypomanias|Hypomania|Episode, Manic|Hypomanic Episode|Manic State|Manic Episode|Manic Episodes|Manias|manic episodes"
NEW01234,NUTRITION,lithium acid,lithium acid
D062708,CHEMICAL,Epithelial Sodium Channel Agonists,Epithelial Sodium Channel Activators|Epithelial Sodium Channel Stimulators|sodium-
NEW01237,CHEMICAL,nimodipine herbs,nimodipine herbs
D004213,MENTAL_HEALTH,Dissociative Disorders,"Dissociative Reaction|Disorder, Dissociative|Disorders, Dissociative|Hysterias, Dissociative|Reaction, Dissociative|Dissociative Disorder|Hysteria, Dissociative|Reactions, Dissociative|Fugue|Dissociative Hysteria|Dissociation|dissociative reaction|Dissociative Reactions"
NEW01238,DISEASE,ADP-induced platelet aggregation,ADP-induced platelet aggregation
D010975,DISEASE,Platelet Aggregation Inhibitors,"Platelet Antagonist|Antiaggregants, Blood Platelet|Platelet Aggregation Inhibitor|Blood Platelet Aggregation Inhibitor|Antiplatelet Agent|Drug, Antiplatelet|Inhibitor, Platelet Aggregation|Antiaggregant, Platelet|Aggregation Inhibitors, Platelet|platelet aggregation inhibitor|Platelet Antagonists|Inhibitors, Platelet|Antiplatelet Agents|Drugs, Antiplatelet|Inhibitor, Platelet|Platelet Inhibitors|Antagonists, Blood Platelet|Blood Platelet Antiaggregants|Blood Platelet Antagonist|Platelet Antiaggregant, Blood|Antagonists, Platelet|Blood Platelet Antagonists|Platelet Antiaggregants|Blood Platelet Aggregation Inhibitors|Platelet Inhibitor|Antiaggregants, Platelet|Blood Platelet Antiaggregant|Agent, Antiplatelet|Antagonist, Blood Platelet|Platelet Antiaggregant|Antagonist, Platelet|Inhibitors, Platelet Aggregation|Antiaggregant, Blood Platelet|Antiplatelet Drugs|Platelet Antagonist, Blood|Agents, Antiplatelet|Antiplatelet Drug|Aggregation Inhibitor, Platelet"
D020936,DISEASE,"Epilepsy, Benign Neonatal","Benign Familial Infantile Convulsions|Epilepsy, Benign Neonatal, Familial|Benign Infantile Familial Convulsions|Benign Neonatal Non-Familial Convulsions|Seizures, Benign Familial Neonatal-Infantile|Convulsions, Benign Neonatal, Non-Familial|Familial Benign Neonatal Convulsions|Epilepsy, Benign Neonatal, Nonfamilial|Benign Familial Neonatal Epilepsy|Familial Benign Neonatal Epilepsy|Benign Neonatal Epilepsy, Nonfamilial|Non-Familial Benign Neonatal Convulsions|Epilepsies, Benign Neonatal-Infantile|Epilepsies, Benign Neonatal|convulsions|Convulsions Benign Familial Neonatal|Benign Neonatal-Infantile Epilepsies|Benign Neonatal-Infantile Epilepsy|Benign Familial Neonatal-Infantile Seizures|Neonatal Convulsion, Benign|Neonatal Convulsions, Benign|Benign Neonatal Epilepsies|Benign Neonatal Epilepsy|Seizures, Benign Familial Infantile, 1|Seizures, Benign Familial Neonatal Infantile|Convulsions, Benign Neonatal, Familial|Benign Familial Infantile Convulsions Syndrome|Convulsions, Benign Neonatal|Neonatal Epilepsies, Benign|Convulsions, Benign Familial Infantile, 3|Benign Familial Neonatal Convulsions|Benign Neonatal Nonfamilial Epilepsy|Benign Neonatal Non Familial Convulsions|Benign Familial Neonatal Infantile Seizures|Benign Neonatal Convulsions|Benign Neonatal Convulsion|Benign Non Familial Neonatal Convulsions|Neonatal-Infantile Epilepsies, Benign|Epilepsy, Benign Neonatal, Non-Familial|Non-Familial Benign Neonatal Epilepsy|Convulsions, Benign Familial Infantile, 1|Benign Non-Familial Neonatal Convulsions|Epilepsy, Benign Neonatal Infantile|Epilepsy, Benign Neonatal-Infantile|Non Familial Benign Neonatal Convulsions|Neonatal-Infantile Epilepsy, Benign|Neonatal Epilepsy, Benign|Seizures, Benign Familial Infantile, 3|Non Familial Benign Neonatal Epilepsy|Convulsion, Benign Neonatal"
NEW01240,CHEMICAL,Phenytoin therapy,Phenytoin therapy
D000077287,CHEMICAL,Levetiracetam,"Ucb-L060|Etiracetam, R-isomer|R-isomer Etiracetam|Keppra|alpha-ethyl-2-oxo-1-Pyrrolidineacetamide|S-isomer Etiracetam|Ucb L060|Etiracetam, (R)-|alpha ethyl 2 oxo 1 Pyrrolidineacetamide|Etiracetam|Etiracetam, R isomer|Etiracetam, S isomer|Ucb L059|Ucb-L059|UcbL060|Levetiracetam|UCB 6474|UCB6474|Etiracetam, S-isomer|UCB-6474"
C005569,CHEMICAL,pipamperone [Supplementary Concept],pipamperone|Butyrophenones
D000090663,MENTAL_HEALTH,"Schizophrenia, Treatment-Resistant","Treatment Resistant Schizophrenia|Schizophrenia, Treatment Resistant|Refractory Schizophrenia|Treatment-Resistant Schizophrenia|refractory schizophrenia|Schizophrenia, Refractory"
NEW01242,BIOCHEMICAL,common food preservative,common food preservative
NEW01243,CHEMICAL,kinesin inhibition,kinesin inhibition
D050031,DISEASE,Hashimoto Disease,"Chronic Lymphocytic Thyroiditis|Hashimoto's Syndrome|Hashimoto's Syndromes|Hashimoto Struma|Chronic Lymphocytic Thyroiditides|Disease, Hashimoto's|Hashimoto Syndrome|Syndromes, Hashimoto's|Hashimoto Thyroiditides|Hashimoto's Struma|Disease, Hashimoto|Hashimotos Syndrome|Hashimotos Disease|Syndrome, Hashimoto's|Thyroiditides, Hashimoto|Lymphocytic Thyroiditides, Chronic|Thyroiditis, Hashimoto|Hashimoto's Disease|Hashimoto thyroiditis|Thyroiditis, Chronic Lymphocytic|Thyroiditides, Chronic Lymphocytic|Hashimoto Thyroiditis|Lymphocytic Thyroiditis, Chronic"
D013974,CHEMICAL,Thyroxine,"Levoxine|L-Thyroxine|Sodium Levothyroxine|L Thyroxine|Thyrax|sodium levothyroxine|Tiroxina Leo|Thyroid Hormone, T4|Novothyrox|3,5,3',5'-Tetraiodothyronine|O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine|O-(4-Hydroxy-3,5-diiodophenyl) 3,5-diiodo-L-tyrosine|Synthroid|Synthrox|Eutirox|L-Thyroxin beta|Levo-T|L Thyrox|Levo T|Levothroid|Levothyroxine Sodium|Lévothyrox|L-Thyroxin Henning|Eferox|Thevier|L Thyroxin Henning|Tiroidine|L Thyroxine Roche|Eltroxin|Oroxine|Levothyroid|Eltroxine|Novothyral|L-Thyroxine Roche|Euthyrox|L Thyroxin beta|T4 Thyroid Hormone|Dexnon|L-Thyrox|L-3,5,3',5'-Tetraiodothyronine|Berlthyrox|Levoxyl|Levothyroxine|Thyroxin|Levothyroxin Deladande|Levothyroxin Delalande|Unithroid"
D007037,DISEASE,Hypothyroidism,"Central Hypothyroidism|Deficiency, Thyroid-Stimulating Hormone|Primary Hypothyroidisms|Primary Hypothyroidism|Hormone Deficiency, Thyroid-Stimulating|TSH Deficiency|Hypothyroidism, Secondary|TSH Deficiencies|Secondary Hypothyroidisms|Hypothyroidism, Central|Thyroid-Stimulating Hormone Deficiency|Thyroid Stimulating Hormone Deficiency|Thyroid-Stimulating Hormone Deficiencies|hypothyroidism|Central Hypothyroidisms|Secondary Hypothyroidism|Hypothyroidisms|Hypothyroidism, Primary|Deficiency, TSH"
NEW01247,DISEASE,experimental colitis,experimental colitis
NEW01248,DISEASE,DSS-induced experimental colitis,DSS-induced experimental colitis
NEW01251,DISEASE,amnesic potential,amnesic potential
C095582,NUTRITION,"lebocin protein, Bombyx mori [Supplementary Concept]",Bombyx mori|Insect Proteins
D017382,CHEMICAL,Reactive Oxygen Species,"Pro Oxidant|Oxygen, Active|ROS|Pro Oxidants|Active Oxygen|reactive oxygen species|Pro-Oxidants|Oxygen Radical|Radical, Oxygen|Oxygen Radicals|Pro-Oxidant|Oxygen Species, Reactive"
D007052,CHEMICAL,Ibuprofen,"Ibuprofen-Zinc|Ibuprofen, Magnesium Salt|Ibuprofen, Sodium Salt|Ibuprofen, Zinc Salt|Salprofen|Ibuprofen, (R)-Isomer|Brufen|Trauma Dolgit Gel|Ibuprofen, Calcium Salt|Ibuprofen, Potassium Salt|Ibuprofen, (+-)-Isomer|Ibumetin|ibuprofen|Rufen|Ibuprofen Zinc|Trauma-Dolgit Gel|Motrin|alpha-Methyl-4-(2-methylpropyl)benzeneacetic Acid|Ibuprofen, Aluminum Salt|Ibuprofen, (S)-Isomer|Nuprin|Ibuprofen, Copper (2+) Salt"
D000530,BIOCHEMICAL,Alfaxalone Alfadolone Mixture,"CT1341|Glaxovet|Alfadolone Mixture, Alfaxalone|mixture|Saffan|CT-1341|CT 1341|Alphadione|Alphathesin|Alfatesine|Alfathesin|Althesin"
NEW01259,CHEMICAL,Sodium Voltage-Gated Channel Beta Subunit,Sodium Voltage-Gated Channel Beta Subunit
NEW01260,CHEMICAL,dopamine hypothesis,dopamine hypothesis
NEW01261,CHEMICAL,DA receptor D2,DA receptor D2
D016584,MENTAL_HEALTH,Panic Disorder,"Disorders, Panic|panic attack|Panic Attacks|Panic Attack|Disorder, Panic|Attack, Panic|Attacks, Panic|Panic Disorders"
NEW01263,DISEASE,valve collapse,valve collapse
D019354,CHEMICAL,Sodium Lactate,"Sodium lactate|Lactate, Sodium"
NEW01264,CHEMICAL,BACKGROUND Empagliflozin,BACKGROUND Empagliflozin
D001714,MENTAL_HEALTH,Bipolar Disorder,"Bipolar Disorders|Manic Disorder|Psychoses, Manic Depressive|Depression, Manic|Psychosis, Manic-Depressive|Mood Disorder, Bipolar|Manic Depressive Psychosis|bipolar disorder|Bipolar Mood Disorders|Bipolar Affective Psychosis|Bipolar Mood Disorder|Manic-Depressive Psychosis|Psychosis, Bipolar Affective|Psychosis, Manic Depressive|Depression, Bipolar|Manic Disorders|Depressions, Manic|Disorder, Manic|Disorder, Bipolar Mood|Disorder, Bipolar|Affective Psychosis, Bipolar|Psychoses, Manic-Depressive|Bipolar Depression|Manic Depression|Psychoses, Bipolar Affective"
NEW01268,NUTRITION,therapeutic lithium levels,therapeutic lithium levels
NEW01270,CHEMICAL,Fused-in-Sarcoma gene,Fused-in-Sarcoma gene
NEW01273,CHEMICAL,lateral amygdala,LA|lateral amygdala
NEW01275,CHEMICAL,buffered lidocaine,buffered lidocaine
NEW01278,CHEMICAL,lower-sodium oxybate,lower-sodium oxybate
NEW01279,CHEMICAL,Fluoride exposure,Fluoride exposure
NEW01281,DISEASE,Cancer Research ICR,Cancer Research ICR
NEW01287,DISEASE,sexual disturbances,sexual disturbances
D000078328,CHEMICAL,Felbamate,"Felbamyl|Taloxa|ADD-03055|2 Phenyl 1,3 propanediol dicarbamate|2-Phenyl-1,3-propanediol dicarbamate|W-554|W 554|ADD03055|W554|Felbatol|felbamate|(3-Carbamoyloxy-2-phenyl-propyl) carbamate|ADD 03055"
D010634,CHEMICAL,Phenobarbital,"Phenylethylbarbituric Acid|Phenobarbital Sodium|Gardenal|Sodium, Phenobarbital|Monosodium Salt Phenobarbital|Phenylbarbital|Phenemal|Acid, Phenylethylbarbituric|Luminal|phenobarbital|Hysteps|Phenobarbitone|Phenobarbital, Monosodium Salt"
NEW01289,CHEMICAL,chronic alcohol consumption,chronic alcohol consumption
NEW01291,CHEMICAL,A2AR‑mediated cAMP pathway,A2AR‑mediated cAMP pathway
D056487,DISEASE,"Chemical and Drug Induced Liver Injury, Chronic","Chemically-Induced Liver Injury, Chronic|Chemically Induced Liver Injury, Chronic|Drug-Induced Liver Injury, Chronic|Chemical Induced Liver Injury, Chronic|Chronic Drug-Induced Liver Injury|Liver Injury, Drug-Induced, Chronic|Chronic Drug Induced Liver Injury|liver injury|Hepatitis, Chronic, Drug-Related|Chemical-Induced Liver Injury, Chronic|Drug Induced Liver Injury, Chronic|Hepatitis, Chronic, Drug-Induced"
NEW01293,DISEASE,alcohol-associated hepatitis,alcohol-associated hepatitis
NEW01294,CHEMICAL,Elevated PAA,Elevated PAA
C538380,DISEASE,HHH syndrome [Supplementary Concept],"Ornithine/deficiency|Hyperammonemia|HHH syndrome|Urea Cycle Disorders, Inborn"
NEW01298,CHEMICAL,plasma amino acid profile,plasma amino acid profile
NEW01299,CHEMICAL,Amytal Sodium interviews,Amytal Sodium interviews
D002809,CHEMICAL,Chondroitin Sulfates,"Blutal|Chondroitin 6-Sulfate, Potassium Salt|Chondroitin Sulfate, Sodium|Chondroitin 4-Sulfate, Potassium Salt|Chondroitin 4 Sulfate, Potassium Salt|Chondroitin 4-Sulfate, Aluminum Salt|Chondroitin Sulfate, Sodium Salt|Chondroitin 6 Sulfate|Translagen|Chondroitin 4 Sulfate|Chondroitin 4-Sulfate|Chondroitin Sulfate, Potassium Salt|Chondroitin Sulfate A|Chondroitin Sulfate, Calcium Salt|Chonsurid|Chondroitin Sulfate|Chondroitin 4 Sulfate, Aluminum Salt|Chondroitin 6 Sulfate, Sodium Salt|Sulfate, Chondroitin|Sodium Chondroitin Sulfate|Chondroitin Sulfate, Iron Salt|sodium salt|Chondroitin Sulfate 4-Sulfate, Sodium Salt|Chondroitin 6 Sulfate, Potassium Salt|Chondroitin 6-Sulfate, Sodium Salt|Sulfate, Sodium Chondroitin|Chondroitin Sulfate, Iron (+3) Salt|Chondroitin Sulfate 4 Sulfate, Sodium Salt|Chondroitin Sulfate C|Chondroitin Sulfate, Zinc Salt|Chondroitin 6-Sulfate|Sulfates, Chondroitin"
NEW01301,CHEMICAL,sodium oxybate Alcover,sodium oxybate Alcover
NEW01302,DISEASE,psychiatric co-morbidity,psychiatric co-morbidity
D017723,BIOCHEMICAL,Drug Utilization Review,"Drug Use Review|Reviews, Drug-Use|Drug Utilization Reviews|drug review|Drug-Use Review|Review, Drug Utilization|Reviews, Drug Utilization|Evaluations, Drug Utilization|Evaluation, Drug Utilization|Review, Drug-Use|Review, Drug Use|Utilization Reviews, Drug|Utilization Evaluations, Drug|Drug Utilization Evaluations|Utilization Review, Drug|Drug Utilization Evaluation|Drug-Use Reviews|Utilization Evaluation, Drug"
D020155,CHEMICAL,3-Hydroxybutyric Acid,3 Hydroxybutyric Acid|hydroxybutyric acid|beta Hydroxybutyric Acid|beta-Hydroxybutyrate|beta Hydroxybutyrate|3-Hydroxybutyrate|(+ -)-3-Hydroxybutyric Acid|3 Hydroxybutyrate|beta-Hydroxybutyric Acid
NEW01308,CHEMICAL,Various antidepressant medications,Various antidepressant medications
NEW01309,CHEMICAL,norepinephrine serotonin reuptake inhibitors,norepinephrine serotonin reuptake inhibitors
D009290,MENTAL_HEALTH,Narcolepsy,"Gelineau Syndrome|Narcoleptic Syndromes|Narcolepsy-Cataplexy Syndrome|Gelineaus Syndrome|Syndrome, Narcoleptic|Syndrome, Narcolepsy-Cataplexy|Syndromes, Narcolepsy-Cataplexy|Syndromes, Gelineau's|Narcolepsy Cataplexy Syndrome|Syndromes, Narcoleptic|Paroxysmal Sleep|Gelineau's Syndrome|Gelineau's Syndromes|Sleep, Paroxysmal|Syndrome, Gelineau's|Narcolepsy-Cataplexy Syndromes|narcolepsy|Narcoleptic Syndrome|Syndrome, Gelineau"
D017291,CHEMICAL,Clarithromycin,TE-031|A 56268|Biaxin|6-O-Methylerythromycin|TE 031|clarithromycin|TE031|A-56268|A56268
NEW01313,BIOCHEMICAL,GABAA receptor agonists,GABAA receptor agonists
NEW01314,CHEMICAL,γ-amino butyric acid GABA modulation,γ-amino butyric acid GABA modulation
NEW01315,BIOCHEMICAL,Selective serotonin reuptake inhibitor antidepressants,Selective serotonin reuptake inhibitor antidepressants
D055013,DISEASE,"Osteoarthritis, Spine","Osteoarthritis of the Spine|Lumbar Osteoarthritis|Spine Osteoarthritis|osteoarthritis|Osteoarthritis of Spine|Osteoarthritis, Lumbar|Spinal Osteoarthritis|Osteoarthritis, Spinal"
NEW01316,CHEMICAL,Piperazine derivatives,Piperazine derivatives
NEW01318,CHEMICAL,piperazine derivative,piperazine derivative
D000086663,CHEMICAL,COVID-19 Vaccines,"2019 Novel Coronavirus Vaccine|Virus Vaccine, COVID-19|Virus Vaccines, COVID19|Vaccines, COVID-19 Virus|COVID 19 Vaccines|COVID19 Vaccine|coronavirus disease 2019|COVID 19 Virus Vaccine|COVID19 Vaccines|Vaccine, 2019-nCoV|COVID 19 Virus Vaccines|Coronavirus Disease 2019 Vaccine|COVID19 Virus Vaccine|2019-nCoV Vaccine|Virus Vaccine, COVID19|Vaccines, COVID-19|Coronavirus Disease 2019 Virus Vaccines|COVID-19 Virus Vaccines|Coronavirus Disease-19 Vaccines|SARS Coronavirus 2 Vaccines|Vaccine, SARS-CoV-2|SARS2 Vaccine|Vaccines, SARS2|2019 nCoV Vaccines|Vaccine, Coronavirus Disease-19|SARS-CoV-2 Vaccine|Vaccines, COVID19|COVID 19 Vaccine|COVID-19 Vaccine|Coronavirus Disease 2019 Vaccines|Vaccine, SARS2|COVID19 Virus Vaccines|Coronavirus Disease-19 Vaccine|SARS2 Vaccines|Vaccine, COVID-19 Virus|Vaccines, COVID19 Virus|Virus Vaccines, COVID-19|2019 nCoV Vaccine|Coronavirus Disease 2019 Virus Vaccine|Coronavirus Disease 19 Vaccines|Vaccines, 2019-nCoV|Coronavirus Disease 19 Vaccine|Vaccine, COVID19 Virus|SARS-CoV-2 Vaccines|Vaccine, COVID19|SARS CoV 2 Vaccines|COVID-19|Vaccines, SARS-CoV-2|Vaccines, Coronavirus Disease-19|Vaccine, COVID 19|SARS CoV 2 Vaccine|2019-nCoV Vaccines|Vaccine, COVID-19|2019 Novel Coronavirus Vaccines|COVID-19 Virus Vaccine"
NEW01320,DISEASE,behavioural deficits,behavioural deficits
D000069470,CHEMICAL,Venlafaxine Hydrochloride,"Venlafaxine|Sila-Venlafaxine|Sila Venlafaxine|Trevilor|Efexor|Wy-45030|Wy 45030|Wy45030|Wy 45,030|Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, hydrochloride|Dobupal|1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol HCl|Wy-45,030|Vandral|Wy45,030|Effexor|Hydrochloride, Venlafaxine"
D000078334,CHEMICAL,Lacosamide,Lacosamide|N-benzyl-2-acetamido-3-methoxypropionamide|N-benzyl-AcMeOPrNH2|N benzyl AcMeOPrNH2|N benzyl 2 acetamido 3 methoxypropionamide|Vimpat
D008376,CHEMICAL,Maprotiline,"Mirpan|Ba34,276|Mesylate, Maprotiline|Deprilept|Maprotilin|Maprotilin ratiopharm|maprotilin von ct|Maprotilin-ratiopharm|Maprotiline Hydrochloride|N-Methyl-9,10-ethanoanthracene-9(10H)-propylamine|Ba-34,276|Maprolu|Maprotilin-neuraxpharm|Maprotilin neuraxpharm|Novo Maprotiline|Maprotilin Holsten|Dibencycladine|maprotiline|Novo-Maprotiline|Hydrochloride, Maprotiline|Ludiomil|Psymion|Maprotilin-TEVA|Maprotilin TEVA|Maprotiline Mesylate"
D000078785,CHEMICAL,Mirtazapine,ORG3770|Norset|Org 50081|(N-Methyl-11C)mirtazapine|6 Azamianserin|ORG 3770|Rexer|6-Azamianserin|(S)-Mirtazapine|mirtazapine|Remeron|Zispin|Esmirtazapine|ORG-3770|Remergil
NEW01322,CHEMICAL,sodium valprote,sodium valprote
C567827,DISEASE,"Generalized Epilepsy With Febrile Seizures Plus, 7 [Supplementary Concept]","Seizures, Febrile|Epilepsy, Generalized|febrile seizures"
D004829,DISEASE,"Epilepsy, Generalized","Epilepsy, Tonic|Seizure Disorders, Generalized|Convulsive Epilepsy, Generalized|Epilepsies, Tonic|Epilepsies, Generalized Convulsive|Generalized Epilepsies|Convulsive Seizure Disorder, Generalized|Generalized Onset Seizure Disorder|Nonconvulsive Generalized Seizure Disorder|Seizure Disorder, Nonconvulsive Generalized|Seizure Disorder, Generalized|Generalized Seizure Disorders|Generalized Nonconvulsive Epilepsy|Generalized Epilepsy, Symptomatic|Symptomatic Generalized Epilepsy|Atonic Epilepsies|Atonic Epilepsy|Nonconvulsive Epilepsy, Generalized|Nonconvulsive Seizure Disorder, Generalized|Epilepsy, Atonic|Epilepsy, Generalized Nonconvulsive|Generalized Nonconvulsive Seizure Disorder|Generalized Epilepsy|Generalized Seizure Disorder|Tonic Epilepsies|Akinetic Epilepsies|Tonic Epilepsy|Epilepsy, Symptomatic Generalized|Seizure Disorder, Generalized Nonconvulsive|Seizure Disorder, Convulsive, Generalized|Akinetic Epilepsy|Generalized epilepsy|Generalized Seizure Disorder, Nonconvulsive|Convulsive Epilepsies, Generalized|Epilepsy, Generalized Convulsive|Epilepsy, Akinetic|Generalized Convulsive Epilepsies|Epilepsies, Generalized|Generalized Convulsive Epilepsy|Epilepsies, Atonic|Epilepsies, Akinetic|Seizure Disorder, Generalized Onset|Seizure Disorder, Generalized, Convulsive|Generalized Seizure Disorder, Convulsive|Convulsive Generalized Seizure Disorder"
D020663,DISEASE,ras Guanine Nucleotide Exchange Factors,rasGEF|ras GEF|ras-GEFs|ras GEFs|GEFS+|rasGEFs|ras Guanine Nucleotide Exchange Factor|ras-GEF
NEW01325,CHEMICAL,immunosuppressant drug rapamycin,immunosuppressant drug rapamycin
NEW01327,CHEMICAL,neurotransmitter serotonin 5-hydroxytryptamine,neurotransmitter serotonin 5-hydroxytryptamine
NEW00964,CHEMICAL,serotonin transporter gene,serotonin transporter gene
D016574,DISEASE,Seasonal Affective Disorder,"Affective Disorder, Seasonal|Mood Disorder, Seasonal|Disorder, Seasonal Affective|Seasonal Mood Disorders|Seasonal Affective Disorders|Seasonal affective disorder|Disorder, Seasonal Mood|SAD|Seasonal Mood Disorder|Depression, Winter|Winter Depression"
D000077408,CHEMICAL,Modafinil,2-((Diphenylmethyl)sulfinyl)acetamide|Sparlon|Modafinil|CRL-40476|Modiodal|Nuvigil|R-Modafinil|Vigil|R Modafinil|2-((R)-(Diphenylmethyl)sulfinyl)acetamide|Benzhydrylsulfinylacetamide|Alertec|CRL 40476|Armodafinil|Provigil
D008694,CHEMICAL,Methamphetamine,"methamphetamine|Deoxyephedrine|Madrine|Metamfetamine|Methylamphetamine|Desoxyn|Hydrochloride, Methamphetamine|N Methylamphetamine|Desoxyephedrine|Methamphetamine Hydrochloride|N-Methylamphetamine"
D012642,CHEMICAL,Selegiline,"Deprenalin|L-Deprenyl|E-250|Zelapar|Selegiline Hydrochloride, (S)-Isomer|Deprenyl|Humex|Selegiline Hydrochloride, (R,S)-Isomer|E 250|Selegiline, (S)-Isomer|Selegiline, (R)-Isomer|Selegiline Hydrochloride, (R)-Isomer|Selegiline Hydrochloride|E250|Deprenil|Selegiline, (R,S)-Isomer|Selegyline|Jumex|Eldepryl|Emsam|selegiline|Yumex"
NEW01333,CHEMICAL,acid-induced encephalopathy,acid-induced encephalopathy
NEW01338,CHEMICAL,plasma corticosterone,plasma corticosterone
D000074261,DISEASE,"Receptors, Enterotoxin","Receptors, Heat-Stable Enterotoxin|Heat-Stable Enterotoxin Receptor|Receptor, GC-C|Guanylyl Cyclase C|Cyclase-C Receptors, Guanyl|Guanylin-Uroguanylin Receptor|Cyclase C, Guanylyl|Receptor, Heat-Stable Enterotoxin|Enterotoxin Guanylin Receptors|Receptor, Guanyl Cyclase C|Enterotoxin-Guanylin Receptor|Enterotoxin Receptors|Enterotoxin-Guanylin Receptors|Guanyl Cyclase C Receptors|Guanylin-Uroguanylin Receptors|Guanyl Cyclase-C Receptors|Receptor, Guanylin-Uroguanylin|Heat-Stable Enterotoxin Receptors|GN|GC-C Receptor|Guanyl Cyclase-C Receptor|GC C Receptor|Receptors, Guanyl Cyclase C|Receptors, Enterotoxin-Guanylin|Receptors, Guanylin-Uroguanylin|Enterotoxin Guanylin Receptor|GC-C Receptors|Heat Stable Enterotoxin Receptor|Receptors, Guanyl Cyclase-C|guanylin|GC C Receptors|Receptor, Enterotoxin|Guanyl Cyclase C Receptor|Guanylin Uroguanylin Receptors|Heat Stable Enterotoxin Receptors|Receptor, Guanyl Cyclase-C|Enterotoxin Receptor|Enterotoxin Receptor, Heat-Stable|Receptors, GC-C|Enterotoxin Receptors, Heat-Stable|Guanylin Uroguanylin Receptor|Receptor, Enterotoxin-Guanylin"
NEW01343,MENTAL_HEALTH,Mixed mania,Mixed mania
NEW01344,MENTAL_HEALTH,secondary mania,secondary mania
D000077152,CHEMICAL,Olanzapine,"LY 170053|LY170052|Zyprexa|LY 170052|LY-170052|2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine|Zolafren|Olanzapine Pamoate|olanzapine"
D017590,CHEMICAL,"Myelinolysis, Central Pontine","Pontine Myelinolysis, Central|CPM|Myelinolyses, Extrapontine|Extrapontine Myelinoclases|Myelinoclases, Extrapontine|Myelinoclasis, Extrapontine|Extrapontine Myelinolysis|Central Pontine Myelinolysis|Central Pontine Myelinoclasis|Extrapontine Myelinoclasis|Myelinoclasis, Central Pontine|Central pontine myelinolysis|Extrapontine Myelinolyses|Myelinolysis, Extrapontine"
NEW01119,MENTAL_HEALTH,acute psychosis,acute psychosis
NEW01349,CHEMICAL,peripheral DAAO levels,peripheral DAAO levels
D005702,CHEMICAL,Galantamine,Galanthamine|Galanthamine Hydrobromide|Nivalin|Lycoremine|Galantamin|Nivaline|Reminyl|Galantamine|Razadyne
C561589,CHEMICAL,mangiferin heptasulfate [Supplementary Concept],Mangiferin|Sulfuric Acid Esters|Xanthones
NEW01352,CHEMICAL,H. perforatum L.,H. perforatum L.
NEW01354,DISEASE,Tovophyllin A,Tovophyllin A
D044004,NUTRITION,Xanthones,"Derivatives, Xanthone|Xanthone Derivatives|xanthones"
NEW01356,CHEMICAL,solids,solids
C074385,CHEMICAL,caldecrin [Supplementary Concept],Serum calcium|Serine Endopeptidases
NEW01357,CHEMICAL,Urinary phosphate excretion,Urinary phosphate excretion
NEW01362,CHEMICAL,severe phosphate diabetes,severe phosphate diabetes
NEW01365,BIOCHEMICAL,inverse agonist activity,inverse agonist activity
NEW01367,CHEMICAL,full mGlu5 NAM chemotypes,full mGlu5 NAM chemotypes
C541428,CHEMICAL,"3-((2-methyl-1,3-thiazol-4-yl)ethynyl)piperidine [Supplementary Concept]",Thiazoles|Piperidines|MTEP
NEW01368,BIOCHEMICAL,reported 5-HT2C selective agonists,reported 5-HT2C selective agonists
NEW01371,DISEASE,spasm activity,spasm activity
D026261,CHEMICAL,Diazepam Binding Inhibitor,"diazepam|Endozepine|Binding Inhibitor, Diazepam|Acyl CoA Binding Protein|Inhibitor, Diazepam Binding|Protein, Acyl-CoA-Binding|Peptide, DBI|DBI Peptide|EpDBI|Medium Chain Acyl CoA Binding Protein|Acyl-CoA-Binding Protein|Medium-Chain Acyl CoA-Binding Protein"
NEW01375,CHEMICAL,benzodiazepine agonist,benzodiazepine agonist
NEW01376,CHEMICAL,antimitotic agent methylazoxymethanol acetate,MAM|antimitotic agent methylazoxymethanol acetate
NEW01378,CHEMICAL,antimitotic agent methylazoxymethanol acetate,antimitotic agent methylazoxymethanol acetate
NEW01379,DISEASE,Schizophrenia-like deficits,Schizophrenia-like deficits
NEW01381,BIOCHEMICAL,adenosine receptor antagonist caffeine,adenosine receptor antagonist caffeine
NEW01382,BIOCHEMICAL,benzodiazepine receptor agonist N-methyl-beta-carboline-3-carboxamide,benzodiazepine receptor agonist N-methyl-beta-carboline-3-carboxamide
NEW01385,CHEMICAL,mono-amine reuptake,mono-amine reuptake
C092292,CHEMICAL,ziprasidone [Supplementary Concept],Thiazoles|Piperazines|ziprasidone
NEW01388,CHEMICAL,long-term ziprasidone therapy,long-term ziprasidone therapy
NEW01390,DISEASE,repeated chronic intermittent ethanol,repeated chronic intermittent ethanol
NEW01393,DISEASE,Stress-induced psychiatric disorders,Stress-induced psychiatric disorders
NEW01394,CHEMICAL,major protein Homer1,major protein Homer1
NEW01396,BIOCHEMICAL,selective mGluR5 inverse agonist,selective mGluR5 inverse agonist
NEW01398,BIOCHEMICAL,benzodiazepine inverse agonist,benzodiazepine inverse agonist
NEW01400,BIOCHEMICAL,CB1 antagonists,CB1 antagonists
NEW01401,BIOCHEMICAL,partial inverse agonist,partial inverse agonist
NEW01402,CHEMICAL,nonsedative anxiolytics,nonsedative anxiolytics
NEW01404,CHEMICAL,GABA hypothesis,GABA hypothesis
NEW01405,BIOCHEMICAL,inverse agonist,inverse agonist
NEW01406,CHEMICAL,adjunctive pimavanserin,adjunctive pimavanserin
D042782,CHEMICAL,"Estrogenic Steroids, Alkylated",steroids|Alkyl Estrogenic Steroids|Alkylated Estrogenic Steroids
NEW01409,CHEMICAL,nongenomic G-protein-coupled steroid receptors,nongenomic G-protein-coupled steroid receptors
NEW01410,BIOCHEMICAL,CB1R neutral antagonist,CB1R neutral antagonist
NEW01411,CHEMICAL,endomorphin analogs,endomorphin analogs
D053590,BIOCHEMICAL,Interleukin 1 Receptor Antagonist Protein,"Febrile Inhibitor, IL1|Urine IL-1 Inhibitor|Kineret|Urine Derived IL1 Inhibitor|Interleukin 1 Inhibitor, Urine|Antril|Anakinra|IL-1Ra|IL 1 Inhibitor, Urine|IL-1 Inhibitor, Urine|IL1 Febrile Inhibitor|IL1 Inhibitor, Urine-Derived|antagonist|Urine-Derived IL1 Inhibitor"
NEW01415,BIOCHEMICAL,oral 5-HT2A inverse agonist,oral 5-HT2A inverse agonist
C100419,CHEMICAL,ethyl octylphosphonofluoridate [Supplementary Concept],ethyl octylphosphonofluoridate|Organophosphorus Compounds|EOPF
NEW01418,DISEASE,EOPF-induced behaviors,EOPF-induced behaviors
NEW01420,DISEASE,H3 receptor inverse agonists,H3 receptor inverse agonists|IAs
NEW01422,CHEMICAL,SAR110894,SAR110894
NEW01423,CHEMICAL,SAR110894,SAR110894
C574738,CHEMICAL,MK-0249 [Supplementary Concept],MK-0249|Quinazolinones
NEW01425,CHEMICAL,histamine subtype receptor inverse agonists,histamine subtype receptor inverse agonists
NEW01426,BIOCHEMICAL,MPEP GABA(B)R orthosteric agonist R-baclofen,MPEP GABA(B)R orthosteric agonist R-baclofen
NEW01427,CHEMICAL,R-baclofen,R-baclofen
NEW01428,CHEMICAL,Negative allosteric modulators,NAMs|Negative allosteric modulators
NEW01429,CHEMICAL,metabotropic glutamate receptor subtype,metabotropic glutamate receptor subtype
NEW01430,CHEMICAL,metabotropic glutamate receptor subtype 5,mGlu5|metabotropic glutamate receptor subtype 5
C040653,NUTRITION,"boric acid, nitrofurazone, procaine drug combination [Supplementary Concept]",Nitrofurazone|Boric Acids|Drug Combinations|Procaine|boric acid
NEW01433,DISEASE,borated zirconia,borated zirconia
NEW01435,CHEMICAL,Dietary boron,Dietary boron
D003520,CHEMICAL,Cyclophosphamide,"Cyclophosphamide, (S)-Isomer|Neosar|Sendoxan|Cyclophosphamide Monohydrate|NSC 26271|Procytox|(+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate|Cytophosphan|Cyclophosphamide|Cyclophosphane|B 518|B-518|Cytoxan|Cyclophosphamide, (R)-Isomer|Cytophosphane|NSC26271|NSC-26271|Endoxan|B518|Cyclophosphamide Anhydrous"
NEW01437,CHEMICAL,anti-depressants,anti-depressants
D000084783,BIOCHEMICAL,Recreational Drug Use,"Drug Use|Drug Use, Recreational|Recreational Drug Uses"
NEW01440,DISEASE,Diverse behavioral disorders,Diverse behavioral disorders
D011596,DISEASE,Psychomotor Disorders,"Psychomotor impairment|Impairments, Psychomotor|Developmental Psychomotor Disorder|Psychomotor Disorders, Developmental|Psychomotor Impairment|Impairment, Psychomotor|Developmental Psychomotor Disorders|Psychomotor Impairments|Psychomotor Disorder, Developmental"
NEW01441,DISEASE,schizophrenic-like psychoses,schizophrenic-like psychoses
D000662,CHEMICAL,Amphetamines,amphetamines|Amphetamine (1966-1975)
D000088942,DISEASE,Technology Addiction,"Technology Addictions|Mobile Phone Addiction|Game Addiction, Video|Addiction|Cell Phone Addictions|Mobile Phone Addictions|Addiction, Mobile Phone|Addictions, Mobile Phone|Addiction, Cell Phone|Video Game Addictions|Video Game Addiction|Addictions, Video Game|Cell Phone Addiction|Phone Addiction, Mobile|Addiction, Video Game"
D003693,MENTAL_HEALTH,Delirium,"Delirium, Subacute|Delirium of Mixed Origin|delirium|Mixed Origin Deliriums|Subacute Deliriums|Deliriums, Subacute|Subacute Delirium|Mixed Origin Delirium"
NEW01444,DISEASE,bone pains,bone pains
NEW01445,CHEMICAL,Haloperidol treatment,Haloperidol treatment
NEW01447,BIOCHEMICAL,Chronic treatment lycopene,Chronic treatment lycopene
D000077276,BIOCHEMICAL,Lycopene,"Lycopene, (cis)-isomer|Lycopene, (7-cis,7'-cis,9-cis,9'-cis)-isomer -|Lycopene, (13-cis)-isomer|LYCOMATO|All trans Lycopene|All-trans-Lycopene|Prolycopene|Pro-Lycopene|Pro Lycopene|LYC-O-MATO|LYC O MATO|lycopene"
NEW01451,CHEMICAL,inhibitor SP600125,inhibitor SP600125
NEW01453,BIOCHEMICAL,lycopene consumption,lycopene consumption
D018950,CHEMICAL,Lipopolysaccharide Receptors,"CD14 Antigen, Soluble|Receptor, LPS|LPS Receptor|CD14 Antigens|Receptor, Lipoglycan|lipopolysaccharide|Receptors, Lipopolysaccharide|CD14 Monocyte Differentiation Antigen|Antigens, CD14|CD14 Antigen|CD14 Protein, Soluble|Soluble CD14|sCD14|Soluble CD14 Antigen|CD14, Soluble|Soluble CD14 Protein|Lipoglycan Receptor"
NEW01456,BIOCHEMICAL,lycopene supplementation,lycopene supplementation
C004999,CHEMICAL,ferulic acid [Supplementary Concept],ferulic acid|Coumaric Acids
D065730,CHEMICAL,Limonene Hydroxylases,"(S)-Limonene 6-Monooxygenase|limonene|Limonene Monooxygenases|Monooxygenases, Limonene|(R)-Limonene 6-Monooxygenase|(S)-Limonene 7-Monooxygenase|Hydroxylases, Limonene"
C009091,CHEMICAL,protocatechuic acid [Supplementary Concept],Hydroxybenzoates|protocatechuic acid
D002392,NUTRITION,Catechin,"KB-53|(+)-Catechin|Catechinic Acid|2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-cis)-|Cyanidanol-3|(2R,3R)-2-(3,4-Dihydroxyphenyl)-3,5,7-chromanetriol|Cianidanol|KB53|Cyanidanol 3|Epicatechin|(+)-Cyanidanol-3|(-)-Epicatechin|Catergen|(+)-Cyanidanol|Zyma|Catechuic Acid|KB 53|3,3',4',5,7-Flavanpentol|catechin|Z 7300"
D000077185,CHEMICAL,Resveratrol,"Resveratrol 3 sulfate|Resveratrol-3-sulfate|trans Resveratrol 3 O sulfate|3,5,4'-Trihydroxystilbene|Resveratrol, (Z)-|SRT-501|trans-Resveratrol-3-O-sulfate|resveratrol|SRT 501|trans Resveratrol|SRT501|trans-Resveratrol|cis Resveratrol|3,4',5-Stilbenetriol|cis-Resveratrol|3,4',5-Trihydroxystilbene"
D002726,CHEMICAL,Chlorogenic Acid,"chlorogenic acid|Acid, Chlorogenic|3 Caffeoylquinic Acid|3-Caffeoylquinic Acid|Acid, 3-Caffeoylquinic"
C515382,CHEMICAL,esculetin-4-carboxylic acid ethyl ester [Supplementary Concept],esculetin|Umbelliferones
C501718,CHEMICAL,3'-O-beta-D-glucopyranosyl rosmarinic acid [Supplementary Concept],Cinnamates|Monosaccharides|rosmarinic acid|Depsides
D011794,CHEMICAL,Quercetin,"Dikvertin|3,3',4',5,7-Pentahydroxyflavone|quercetin"
D005707,CHEMICAL,Gallic Acid,"gallic acid|3,4,5-Trihydroxybenzoic Acid|Acid, Gallic"
D004610,CHEMICAL,Ellagic Acid,"Acid, Benzoaric|Benzoaric Acid|Acid, Ellagic|ellagic acid"
C005274,CHEMICAL,naringin [Supplementary Concept],naringin|Flavanones
D002338,BIOCHEMICAL,Carotenoids,"Carotene|Carotenes|Derivatives, Tetraterpene|Carotenoid|carotenoids|Tetraterpene Derivatives|Tetraterpenes"
D005419,CHEMICAL,Flavonoids,2 Phenyl Chromenes|2-Phenyl-Benzopyrans|2-Phenyl-Chromene|2 Phenyl Benzopyran|2 Phenyl Benzopyrans|Bioflavonoid|2-Phenyl-Chromenes|Bioflavonoids|Flavonoid|2-Phenyl-Benzopyran|2 Phenyl Chromene|flavonoids
NEW01461,DISEASE,persistent hypercalcemia,persistent hypercalcemia
NEW01463,CHEMICAL,Associated aluminium intoxication,Associated aluminium intoxication
NEW01466,CHEMICAL,high plasma homocysteine concentration,high plasma homocysteine concentration
NEW01468,BIOCHEMICAL,D status,D status
NEW01470,CHEMICAL,elevated homocysteine Hcy level,elevated homocysteine Hcy level
NEW01471,CHEMICAL,Plasma Hcy,Plasma Hcy
D014899,DISEASE,Wernicke Encephalopathy,"Gayet-Wernicke Encephalopathy|Wernicke's Encephalopathy|Wernicke encephalopathy|Encephalopathy, Wernickes|Encephalopathy, Wernicke's|Wernicke Superior Hemorrhagic Polioencephalitis|Wernicke Disease|Encephalopathy, Gayet-Wernicke|Encephalopathies, Wernicke|Wernicke Encephalopathies|Gayet Wernicke Encephalopathy|Wernicke's Superior Hemorrhagic Polioencephalitis|Wernicke's Syndrome|Encephalopathy, Gayet Wernicke|Beriberi, Cerebral|Encephalopathy, Wernicke|Wernicke Polioencephalitis, Superior Hemorrhagic|Wernicke's Polioencephalitis, Superior Hemorrhagic|Wernicke's Disease|Cerebral Beriberi|Wernicke Syndrome"
D014815,BIOCHEMICAL,Vitamins,Vitamin|vitamins
NEW01475,DISEASE,severe hypertension,severe hypertension
D054972,DISEASE,Postural Orthostatic Tachycardia Syndrome,"Tachycardia Syndrome, Postural|Postural Tachycardia Syndrome|Tachycardia|Syndrome, Postural Tachycardia"
D065632,DISEASE,Chikungunya Fever,"Fever, Chikungunya|Chickungunya Fever|Chickungunya Fevers|fever|Infection, Chikungunya Virus|Fever, Chickungunya|Chikungunya Virus Infection|Chikungunya Virus Infections|Chikungunya Fevers"
D014808,BIOCHEMICAL,Vitamin D Deficiency,"Vitamin D Deficiencies|Deficiencies, Vitamin D|Deficiency, Vitamin D|Vitamin D deficiency"
D030181,BIOCHEMICAL,Vitamin D Response Element,"vitamin D|Response Element, Vitamin D"
NEW01476,DISEASE,post-MVC pain outcomes,post-MVC pain outcomes
NEW01477,BIOCHEMICAL,vitamin D insufficiency,vitamin D insufficiency
NEW01479,CHEMICAL,monoamines synthesis,monoamines synthesis
NEW01481,DISEASE,severe coagulopathy related,severe coagulopathy related
NEW01483,BIOCHEMICAL,vitamin K deficient proteins,vitamin K deficient proteins
D000066608,CHEMICAL,Underage Drinking,"Alcohol Consumption, Adolescent|Minimum Legal Drinking Age|Underage Alcohol Consumption|Alcohol Drinking, Adolescent|Legal Drinking Age|Adolescent Drinking|Minimum Drinking Ages|Drinking, Youth|Teen Drinking|Minimum Drinking Age|Adolescent Alcohol Consumption|Adolescent Alcohol Use|Drinking, Underage|Alcohol consumption|Alcohol Consumption, Youth|Drinking Ages, Legal|Alcohol Use, Adolescent|Adolescent Alcohol Intake|Youth Alcohol Consumption|Teenage Drinking|Drinking Ages, Minimum|Underage Alcohol Use|Drinking, Teenage|Youth Drinking|Drinking, Teen|Alcohol Use, Underage|Drinking, Adolescent|Alcohol Consumption, Underage|Drinking Age, Legal|Alcohol Intake, Adolescent|Drinking Age, Minimum|Legal Drinking Ages|Adolescent Alcohol Drinking"
NEW01485,BIOCHEMICAL,vitamin E administration,vitamin E administration
NEW01486,CHEMICAL,hypovitaminosis D,hypovitaminosis D
NEW01488,CHEMICAL,Hypovitaminosis D,Hypovitaminosis D
NEW01490,BIOCHEMICAL,vitamin B group,vitamin B group
D013838,BIOCHEMICAL,Thiamine Triphosphate,"thiamine|Triphosphate, Thiamin|Thiamin Triphosphate|Triphosphate, Thiamine"
D012141,DISEASE,Respiratory Tract Infections,"Upper Respiratory Tract Infections|respiratory infections|Respiratory Tract Infection|Upper Respiratory Infections|Infection, Respiratory Tract|Respiratory Infections|Infections, Upper Respiratory Tract|Infections, Respiratory|Infections, Respiratory Tract|Upper Respiratory Tract Infection|Infections, Upper Respiratory|Respiratory Infection, Upper"
D000080549,DISEASE,Autophagic Cell Death,"Death, Autophagy-Dependent Cell|deaths|Cell Deaths, Autophagic|Autophagy-Dependent Cell Deaths|Deaths, Autophagic Cell|Autophagic Programmed Cell Death|Autophagy Dependent Cell Death|Programmed Cell Death, Type II|Autophagic Cell Deaths|Cell Death, Autophagic|Deaths, Autophagy-Dependent Cell|Death, Autophagic Cell|Cell Death, Autophagy-Dependent|Autophagy-Dependent Cell Death|Cell Deaths, Autophagy-Dependent"
NEW01494,BIOCHEMICAL,vitamin D levels,vitamin D levels
NEW01495,MENTAL_HEALTH,factors anxiety,factors anxiety
NEW01496,DISEASE,incident TRD,incident TRD
D007011,DISEASE,Hypoparathyroidism,"Idiopathic Hypoparathyroidism|hypoparathyroidism|Hypoparathyroidism, Idiopathic"
D064149,CHEMICAL,"Influenza Pandemic, 1918-1919","1918-1919 Influenza Pandemics|H1N1 Influenza Pandemic, 1918-1919|pandemic|H1N1 Influenza Pandemic, 1918 1919|Influenza Pandemic, 1918 1919|Pandemics, 1918-1919 Influenza|1918-1919 Influenza Pandemic|Spanish Flu Pandemic, 1918-1919|Spanish Flu Pandemic, 1918 1919|Influenza Pandemics, 1918-1919"
NEW01500,DISEASE,depressed individuals,depressed individuals
D008687,CHEMICAL,Metformin,"Metformin|Hydrochloride, Metformin|Metformin HCl|HCl, Metformin|Glucophage|Dimethylbiguanidine|Dimethylguanylguanidine|Metformin Hydrochloride"
NEW01503,DISEASE,fasting hyperammonemia,fasting hyperammonemia
C536778,CHEMICAL,Systemic carnitine deficiency [Supplementary Concept],Carnitine/deficiency|Hyperammonemia|Muscular Diseases|Carnitine deficiency|Cardiomyopathies
NEW01508,CHEMICAL,Carnitine supplementation,Carnitine supplementation
C546380,CHEMICAL,N-(2-((2-mercapto-2-methylpropyl)amino)ethyl)-1-methylimidazole-2-carboxamido nickel(II) [Supplementary Concept],MMA|Organometallic Compounds
NEW01511,CHEMICAL,Nitrous oxide abuse,Nitrous oxide abuse
D014806,BIOCHEMICAL,Vitamin B 12 Deficiency,"Deficiency, Vitamin B12|Vitamin B12 Deficiency|Deficiencies, Vitamin B12|Vitamin B12 Deficiencies|Vitamin B12 deficiency|Deficiency, Vitamin B 12"
NEW01512,DISEASE,psychiatric symptoms,psychiatric symptoms
NEW01514,DISEASE,Hypercoagulability workup,Hypercoagulability workup
D012614,DISEASE,Scurvy,Hypoascorbemias|Hypoascorbemia|Scurvies|scurvy|Scorbutus
NEW01516,BIOCHEMICAL,D supplementation,D supplementation
D065668,BIOCHEMICAL,Vitamin D3 24-Hydroxylase,"CYP24A1, Cytochrome P-450|D3 24-Hydroxylase, 1,25-Dihydroxyvitamin|Cytochrome P-450 CYP24A1|1 alpha,25-Dihydroxyvitamin D(3)-24-Hydroxylase|1,25-Dihydroxyvitamin D3 24-Hydroxylase|25-Hydroxycholecalciferol-24-Hydroxylase|1 alpha,25-Dihydroxycholecalciferol-24-Hydroxylase|Vitamin D 24 Hydroxylase|1 alpha,25 Dihydroxycholecalciferol 24 Hydroxylase|Vitamin D 24-Hydroxylase|25 Hydroxycholecalciferol 24 Hydroxylase|Calcitriol 24-Hydroxylase|CYP24A1|Cytochrome P 450 CYP24A1|24-Hydroxylase, Vitamin D3|P-450 CYP24A1, Cytochrome|Calcitriol 24 Hydroxylase|1,25 Dihydroxyvitamin D3 24 Hydroxylase|vitamin D3|alpha,25-Dihydroxycholecalciferol-24-Hydroxylase, 1|Vitamin D3 24 Hydroxylase"
NEW01519,BIOCHEMICAL,vitamin B12 levels,vitamin B12 levels
NEW01520,BIOCHEMICAL,intravenous vitamin D analogs,intravenous vitamin D analogs
NEW01522,BIOCHEMICAL,serum vitamin B12 levels,serum vitamin B12 levels
NEW01523,MENTAL_HEALTH,Narcolepsy type,Narcolepsy type
D014802,BIOCHEMICAL,Vitamin A Deficiency,"Deficiency, Vitamin A|A deficiency|Vitamin A Deficiencies|Deficiencies, Vitamin A"
NEW01527,DISEASE,sleep disturbances,sleep disturbances
NEW01528,CHEMICAL,VA levels,VA levels
NEW01529,DISEASE,ASD subjects,ASD subjects
NEW01531,CHEMICAL,TC-II functional abnormality,TC-II functional abnormality
NEW01533,DISEASE,Aggressive behavior,Aggressive behavior
NEW01534,BIOCHEMICAL,Vitamin D/B12 supplementation,Vitamin D/B12 supplementation
C010549,BIOCHEMICAL,allantoin - escin - esculoside - hamamelis - methol - vitamin B1 - vitamin E [Supplementary Concept],vitamin B1|Esculin|Escin|Vitamin E|Rutin|Drug Combinations
NEW01536,DISEASE,alcoholic complaints,alcoholic complaints
D000430,MENTAL_HEALTH,Alcohol Withdrawal Delirium,"Delirium Tremens, Alcohol Withdrawal Induced|Alcohol Withdrawal-Induced Delirium Tremens|Autonomic Hyperactivity, Alcohol Withdrawal Associated|Hallucinosis, Alcohol Withdrawal|Alcohol Withdrawal Induced Delirium Tremens|Alcohol Withdrawal Associated Autonomic Hyperactivity|Alcohol Withdrawal Hallucinosis|delirium tremens|Delirium Tremens|Delirium, Alcohol Withdrawal"
NEW01537,BIOCHEMICAL,vitamin B1 absorption,vitamin B1 absorption
D014155,BIOCHEMICAL,Transcobalamins,"Cobalophilin|Vitamin B 12 Binding Proteins|Vitamin B12 Binding Protein|Protein, Vitamin B12-Binding|Protein, Cobalamin-Binding|Proteins, Cobalamin-Binding|Vitamin B12-Binding Proteins|Holo Transcobalamin II|Cobalamin Binding Proteins|Cobalamin Binding Protein|Vitamin B 12-Binding Protein|R Binder|Transcobalamin|Vitamin B12-Binding Protein|Vitamin B12 Binding Proteins|Transcobalamin I|R-Binder|Cobalamin-Binding Proteins|Transcobalamin III|Transcobalamin II|Vitamin B 12 Binding Protein|vitamin B12|Vitamin B 12 Binder|Cobalamin-Binding Protein|Transcobalamin (I)|B12-Binding Protein, Vitamin|Vitamin B 12-Binding Proteins|Holo-Transcobalamin II|Proteins, Vitamin B12-Binding|Haptocorrin"
NEW01538,BIOCHEMICAL,narcotic drug,narcotic drug
D006934,DISEASE,Hypercalcemia,"Hypercalcemias|hypercalcemia|Milk Alkali Syndrome|Syndrome, Milk-Alkali|Milk-Alkali Syndrome"
NEW01540,DISEASE,adverse psychiatric effects,adverse psychiatric effects
NEW01541,BIOCHEMICAL,vitamin D deficiency related,vitamin D deficiency related
NEW01543,DISEASE,avoidant/restrictive food intake disorder,ARFID|avoidant/restrictive food intake disorder
D001289,MENTAL_HEALTH,Attention Deficit Disorder with Hyperactivity,"Disorders, Attention Deficit-Hyperactivity|Disorders, Attention Deficit|Syndromes, Hyperkinetic|Deficit Disorder, Attention|Disorder, Attention Deficit-Hyperactivity|Attention Deficit Hyperactivity Disorder|Deficit Disorders, Attention|ADHD|deficit hyperactivity disorder|Attention Deficit Disorder|Attention Deficit Disorders|Attention Deficit-Hyperactivity Disorder|Deficit-Hyperactivity Disorder, Attention|Dysfunction, Minimal Brain|Deficit-Hyperactivity Disorders, Attention|Attention Deficit-Hyperactivity Disorders|Hyperkinetic Syndrome|ADDH|Minimal Brain Dysfunction|Brain Dysfunction, Minimal|Disorder, Attention Deficit|Attention Deficit Disorders with Hyperactivity|Attention Deficit Hyperactivity Disorders"
NEW01546,BIOCHEMICAL,lower vitamin D status,lower vitamin D status
NEW01547,BIOCHEMICAL,vitamin D status,vitamin D status
NEW01548,BIOCHEMICAL,perinatal suboptimal vitamin D concentrations,perinatal suboptimal vitamin D concentrations
D054586,DISEASE,National Institute of Diabetes and Digestive and Kidney Diseases (U.S.),NIDDK|Diabetes|National Institute of Diabetes and Digestive and Kidney Diseases
NEW01549,DISEASE,diabetic individuals,diabetic individuals
NEW01550,BIOCHEMICAL,vitamin D supplementation,vitamin D supplementation
NEW01551,BIOCHEMICAL,vitamin D receptor VDR gene polymorphisms,vitamin D receptor VDR gene polymorphisms
NEW01552,CHEMICAL,triptoreline,triptoreline
NEW01554,DISEASE,placentitis,placentitis
NEW01555,DISEASE,hormesis phenomenon,hormesis phenomenon
NEW01559,DISEASE,Hormone therapy,Hormone therapy|HT
NEW01560,CHEMICAL,allopregnanolone increase,allopregnanolone increase
NEW01561,BIOCHEMICAL,Exogenous oestrogens,Exogenous oestrogens
NEW01562,BIOCHEMICAL,estrogen deficiency,estrogen deficiency
NEW01563,DISEASE,cognitive disturbances,cognitive disturbances
NEW01564,BIOCHEMICAL,Estrogen administration,Estrogen administration
D059002,BIOCHEMICAL,Androgen Receptor Antagonists,"Antagonist, Androgen Receptor|Antagonists, Androgen Receptor|androgen|Androgen Receptor Antagonist|Receptor Antagonists, Androgen|Receptor Antagonist, Androgen"
NEW01567,DISEASE,Chronic fat malabsorption syndromes,Chronic fat malabsorption syndromes
NEW01568,BIOCHEMICAL,vitamin E levels,vitamin E levels
D011602,DISEASE,Psychophysiologic Disorders,Psychophysiological Disorder|Psychophysiologic Disorder|Psychosomatic Disorder|Psychosomatic Disorders|psychophysiological disorders|Psychophysiological Disorders
D050500,DISEASE,"Pancreatitis, Chronic",chronic pancreatitis|Chronic Pancreatitis
NEW01571,CHEMICAL,caudate putamen,caudate putamen|CP
D001851,DISEASE,"Bone Diseases, Metabolic","Osteopenias|Bone Disease, Metabolic|Metabolic Bone Diseases|Low Bone Densities|Metabolic Bone Disease|Low Bone Mineral Density|Bone Density, Low|bone disease|Osteopenia|Low Bone Density"
NEW01572,DISEASE,secondary osteoporosis,secondary osteoporosis
D015663,DISEASE,"Osteoporosis, Postmenopausal","Perimenopausal Bone Loss|Bone Loss, Postmenopausal|Osteoporoses, Post-Menopausal|Post-Menopausal Osteoporoses|Postmenopausal Osteoporosis|Postmenopausal Osteoporoses|Postmenopausal Bone Loss|Postmenopausal Bone Losses|Osteoporoses, Postmenopausal|Perimenopausal Bone Losses|Osteoporosis, Post Menopausal|Osteoporosis, Post-Menopausal|osteoporosis|Bone Losses, Postmenopausal|Bone Losses, Perimenopausal|Post-Menopausal Osteoporosis|Bone Loss, Perimenopausal"
NEW01579,DISEASE,pancreatic endocrine function,pancreatic endocrine function
D002780,DISEASE,"Cholestasis, Intrahepatic","Biliary Stasis, Intrahepatic|cholestasis|Intrahepatic Cholestasis|Intrahepatic Cholestases|Biliary Stases, Intrahepatic|Intrahepatic Biliary Stasis|Intrahepatic Biliary Stases|Bile Duct Obstruction, Intrahepatic|Cholestases, Intrahepatic"
C023336,CHEMICAL,trimethylamine [Supplementary Concept],trimethylamine|Methylamines
NEW01583,DISEASE,volatile trimethyl arsenic acid,volatile trimethyl arsenic acid|TMA
D001321,MENTAL_HEALTH,Autistic Disorder,"infantile autism|Kanner Syndrome|Kanners Syndrome|Autism, Early Infantile|Autism, Infantile|Infantile Autism|Disorders, Autistic|Infantile Autism, Early|Disorder, Autistic|Autism|Early Infantile Autism|Kanner's Syndrome"
D060825,DISEASE,Cognitive Dysfunction,"Decline, Cognitive|Cognitive Impairments|Mental Deteriorations|Deterioration, Mental|Impairments, Cognitive|Mental Deterioration|Cognitive Decline|Impairments, Mild Cognitive|Mild Neurocognitive Disorder|cognitive decline|Declines, Cognitive|Dysfunction, Cognitive|Cognitive Dysfunctions|Cognitive Impairments, Mild|Cognitive Declines|Disorder, Mild Neurocognitive|Neurocognitive Disorders, Mild|Impairment, Cognitive|Impairment, Mild Cognitive|Mild Cognitive Impairment|Cognitive Impairment, Mild|Cognitive Impairment|Dysfunctions, Cognitive|Neurocognitive Disorder, Mild|Deteriorations, Mental|Mild Neurocognitive Disorders|Mild Cognitive Impairments|Disorders, Mild Neurocognitive"
NEW01588,CHEMICAL,histidine supplementation,histidine supplementation
NEW01590,NUTRITION,native fish species,native fish species
NEW01591,CHEMICAL,SC09-Ysa,SC09-Ysa
NEW01594,MENTAL_HEALTH,Schizophrenia pathophysiology,Schizophrenia pathophysiology
D016291,CHEMICAL,Dizocilpine Maleate,MK 801|dizocilpine|MK-801|Dizocilpine|MK801
NEW01598,DISEASE,fear/anxiety behaviour,fear/anxiety behaviour
D003345,CHEMICAL,Corticosterone,corticosterone|Anti-Inflammatory Agents
NEW01602,CHEMICAL,highest ketamine concentration,highest ketamine concentration
D013482,CHEMICAL,Superoxide Dismutase,"Fe Superoxide Dismutase|Dismutase, Fe-Superoxide|Superoxide Dismutase, Fe-Zn|Dismutase, Fe-Zn Superoxide|Ag Zn Superoxide Dismutase|Superoxide Dismutase, Iron|Superoxide Dismutase, Ag-Zn|Cu-Superoxide Dismutase|Mn-Superoxide Dismutase|Mn SOD|Fe-Superoxide Dismutase|Cobalt Superoxide Dismutase|Dismutase, Superoxide|Mn-SOD|Dismutase, Cobalt Superoxide|Hemocuprein|Superoxide Dismutase, Cobalt|Fe Zn Superoxide Dismutase|Dismutase, Cu-Superoxide|Superoxide dismutase|Manganese Superoxide Dismutase|Fe-Zn Superoxide Dismutase|Erythrocuprein|Mn Superoxide Dismutase|Dismutase, Iron Superoxide|Superoxide Dismutase, Manganese|Dismutase, Manganese Superoxide|Ag-Zn Superoxide Dismutase|Iron Superoxide Dismutase|Cu Superoxide Dismutase|Dismutase, Mn-Superoxide|Dismutase, Ag-Zn Superoxide"
D050886,DISEASE,HSP20 Heat-Shock Proteins,"HSP20 Heat-Shock Protein|Heat-Shock Protein pp3|Heat Shock Proteins 20|Heat-Shock Proteins 20|Heat Shock Protein pp3|pp3, Heat-Shock Protein|HSP20 Heat Shock Protein|Heat-Shock Proteins, HSP20|heat shock protein|HSP20 Heat Shock Proteins|Heat-Shock Protein, HSP20"
NEW01605,CHEMICAL,Antidepressant fluoxetine,Antidepressant fluoxetine|FLX
NEW01608,DISEASE,hypocortisol phenotype,hypocortisol phenotype
NEW01610,DISEASE,HEA-mediated neurogenic impairment,HEA-mediated neurogenic impairment
NEW01611,CHEMICAL,ammonia poisoning,ammonia poisoning
NEW01612,CHEMICAL,DHA combinations,DHA combinations
D006816,DISEASE,Huntington Disease,"Huntington's Chorea|Huntington Disease, Juvenile-Onset|Progressive Chorea, Hereditary, Chronic (Huntington)|Huntington Disease, Juvenile|Akinetic-Rigid Variant of Huntington Disease|Chorea, Chronic Progressive Hereditary (Huntington)|Huntington Disease, Late-Onset|Huntington Chorea|Juvenile Onset Huntington Disease|Chronic Progressive Hereditary Chorea (Huntington)|Akinetic Rigid Variant of Huntington Disease|Huntington Disease, Akinetic-Rigid Variant|Huntington Disease, Akinetic Rigid Variant|Progressive Chorea, Chronic Hereditary (Huntington)|Chorea, Huntington's|Late Onset Huntington Disease|Juvenile Huntington Disease|Huntington's Disease|Late-Onset Huntington Disease|Chorea, Huntington|Huntington Disease, Juvenile Onset|Huntington Chronic Progressive Hereditary Chorea|Huntington Disease, Late Onset|Huntington disease|Juvenile-Onset Huntington Disease"
NEW01614,NUTRITION,omega-3 fatty acid treatment,omega-3 fatty acid treatment
NEW01615,CHEMICAL,Antidepressant AD drugs,Antidepressant AD drugs
NEW01616,CHEMICAL,flax oil,flax oil
NEW01617,NUTRITION,Low omega-3 polyunsaturated fatty acid levels,Low omega-3 polyunsaturated fatty acid levels
D004281,CHEMICAL,Docosahexaenoic Acids,"Acid, Docosahexaenoic|Docosahexenoic Acids|Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Potassium Salt|Docosahexaenoic Acid, Sodium Salt|DHA|docosahexaenoic acid|Docosahexaenoic Acid, 4,7,10,13,16,19-(Z,Z,Z,Z,Z,E-Isomer)|Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer, Sodium Salt|Docosahexaenoic Acid|Acids, Docosahexaenoic|Docosahexaenoate|Docosahexaenoic Acid, 3,6,9,12,15,18-Isomer|Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cesium Salt|Acids, Docosahexenoic|Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cerium Salt|Docosahexaenoic Acid (All-Z Isomer)|Docosahexaenoic Acid Dimer (All-Z Isomer)|Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer|Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer)"
NEW01618,CHEMICAL,selective dopamine,selective dopamine
NEW01619,CHEMICAL,low plasma DHA,low plasma DHA
NEW01620,NUTRITION,n-3 fatty acid supplementation,n-3 fatty acid supplementation
D002547,DISEASE,Cerebral Palsy,"Cerebral Palsy, Dystonic-Rigid|Infantile Cerebral Palsy, Diplegic|Infantile Cerebral Palsy, Quadriplegic|Monoplegic Cerebral Palsy|Cerebral Palsy, Dyskinetic|CP (Cerebral Palsy)|Mixed Cerebral Palsy|cerebral palsy|Cerebral Palsy, Monoplegic, Infantile|Cerebral Palsy, Atonic|Hypotonic Cerebral Palsy|Spastic Cerebral Palsies|Dystonic-Rigid Cerebral Palsy|Cerebral Palsy, Congenital|Cerebral Palsy, Quadriplegic, Infantile|Atonic Cerebral Palsy|Spastic Diplegias|Diplegia, Spastic|Cerebral Palsy, Rolandic Type|Rolandic Type Cerebral Palsy|Cerebral Palsies, Athetoid|Cerebral Palsy, Diplegic, Infantile|Congenital Cerebral Palsy|Mixed Cerebral Palsies|Quadriplegic Infantile Cerebral Palsy|Monoplegic Cerebral Palsies|Cerebral Palsy, Monoplegic|Spastic Cerebral Palsy|Diplegias, Spastic|Dyskinetic Cerebral Palsy|Cerebral Palsy, Hypotonic|Athetoid Cerebral Palsy|Little's Disease|Cerebral Palsy, Athetoid|Hypotonic Cerebral Palsies|Dystonic-Rigid Cerebral Palsies|Infantile Cerebral Palsy, Monoplegic|Cerebral Palsy, Dystonic Rigid|Monoplegic Infantile Cerebral Palsy|Diplegic Infantile Cerebral Palsy|Spastic Diplegia|Cerebral Palsies, Dyskinetic|Cerebral Palsies, Monoplegic|Cerebral Palsy, Spastic|Cerebral Palsies, Dystonic-Rigid|Cerebral Palsy, Mixed|Little Disease"
D003963,DISEASE,Diaper Rash,"Rash, Diaper|Diaper Rashes|Rashes, Diaper|rash"
D006854,CHEMICAL,Hydrocortisone,"Hydrocortisone|Cortifair|Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-|11 Epicortisol|Cortisol|Cortef|Cortril|Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer|11-Epicortisol|Hydrocortisone, (11 alpha)-Isomer|Epicortisol"
NEW01622,CHEMICAL,slow acting antidepressant,slow acting antidepressant
D033363,CHEMICAL,Neutron Diffraction,"n-3|Diffractions, Neutron|Diffraction, Neutron|Neutron Diffractions|neutron"
NEW01625,CHEMICAL,omega-3 supplementation,omega-3 supplementation
NEW01626,CHEMICAL,abnormal membrane prostaglandin production,abnormal membrane prostaglandin production
NEW01627,CHEMICAL,low omega-3 index,low omega-3 index
NEW01628,BIOCHEMICAL,niacin test,niacin test
NEW01630,CHEMICAL,NMDA antagonist-induced impairment,NMDA antagonist-induced impairment
D000069077,DISEASE,Memory Consolidation,"Memory Consolidations|Consolidation, Memory|memory consolidation|Consolidations, Memory"
C585473,NUTRITION,"theaflavin-3,3'-digallate [Supplementary Concept]",theaflavin|Biflavonoids|Catechin/analogs  and  derivatives
NEW01636,CHEMICAL,Theaflavins,Theaflavins
D013662,NUTRITION,Tea,"Green Teas|Green Tea|Teas, Green|Teas, Black|black tea|Tea, Green|Tea, Black|Black Teas|Black Tea"
NEW01637,CHEMICAL,pro-NMDA drugs,pro-NMDA drugs
NEW01641,CHEMICAL,N-methyl-D-aspartate NMDA receptors,N-methyl-D-aspartate NMDA receptors
NEW01644,CHEMICAL,Memantine treatment,Memantine treatment
NEW01646,BIOCHEMICAL,NMDA receptor antagonists,NMDA receptor antagonists
NEW01648,BIOCHEMICAL,Non-competitive N-methyl-D-aspartic acid NMDA receptor antagonists,Non-competitive N-methyl-D-aspartic acid NMDA receptor antagonists
NEW01649,CHEMICAL,endogenous NMDA receptor,endogenous NMDA receptor
NEW01650,DISEASE,anxiety-like behaviors,anxiety-like behaviors
NEW01655,CHEMICAL,NMDA pathway,NMDA pathway
NEW01657,CHEMICAL,GluN2A subunit-containing NMDA receptors,GluN2A subunit-containing NMDA receptors
C574512,CHEMICAL,TCN 201 [Supplementary Concept],Sulfonamides|TCN-201
NEW01660,CHEMICAL,N-methyl-d-aspartate receptor-ionophore complex,N-methyl-d-aspartate receptor-ionophore complex
D050487,CHEMICAL,Glycine Plasma Membrane Transport Proteins,"Neurotransmitter Transporters, Glycine-Specific|GLYT Proteins|Transporters, Glycine-Specific Neurotransmitter|Neurotransmitter Transport Proteins, Glycine-Specific|Glycine Transporter|Glycine Transporter 2|glycine transporter-1|Glycine Plasma Membrane Transporter Proteins|Neurotransmitter Transport Proteins, Glycine Specific|Glycine-Specific Neurotransmitter Transporters|Glycine Transporter 1|Neurotransmitter Transporters, Glycine Specific"
C101950,CHEMICAL,D-serine dehydratase [Supplementary Concept],D-serine|Hydro-Lyases
D051263,CHEMICAL,D-Alanine Transaminase,"D-alanine|D-Glutamate-D-Alanine Transaminase|Transaminase, D-Glutamate-D-Alanine|D Alanine Transaminase|D Glutamate D Alanine Transaminase|Transaminase, D-Alanine|D-Alanine Aminotransferase|D Alanine Aminotransferase|Aminotransferase, D-Alanine"
NEW01661,CHEMICAL,D-amino acid oxidase inhibitors,D-amino acid oxidase inhibitors
D050892,CHEMICAL,Sarcosine Dehydrogenase,"Sarcosine N Demethylase|Dehydrogenase, Sarcosine|N-Demethylase, Sarcosine|Dehydrogenase, Monomethylglycine|sarcosine|Monomethylglycine Dehydrogenase|Sarcosine N-Demethylase"
NEW01662,CHEMICAL,group metabotropic glutamate receptors,group metabotropic glutamate receptors
D051308,CHEMICAL,Glycine Transaminase,"Glycine-2-Oxoglutarate Aminotransferase|Transaminase, Glycine|Aminotransferase, Glycine|Glycine Aminotransferase|glycine|Aminotransferase, Glycine-2-Oxoglutarate|Glycine 2 Oxoglutarate Aminotransferase"
D000701,BIOCHEMICAL,"Analgesics, Opioid","Opioid Agonists, Full|Opioid Mixed Agonist-Antagonists|Opioid Analgesic|Agonists, Full Opioid|Opioids|Partial Agonists, Opioid|Analgesic, Opioid|Full Opioid Agonists|Agonists, Opioid Full|Opioid|Opioid Analgesics|Agonist-Antagonists, Opioid Mixed|Opioid Full Agonists|Opioid Partial Agonists|Agonists, Partial Opioid|Full Agonists, Opioid|Opioid Mixed Agonist Antagonists|Partial Opioid Agonists|Opioid Agonists, Partial|Mixed Agonist-Antagonists, Opioid|partial agonists|Agonists, Opioid Partial"
C095106,CHEMICAL,traxoprodil mesylate [Supplementary Concept],Piperidines|traxoprodil
NEW01663,BIOCHEMICAL,GluN2B subtype antagonists,GluN2B subtype antagonists
NEW01664,CHEMICAL,glycine site,glycine site
NEW01666,CHEMICAL,elevated ammonia concentrations,elevated ammonia concentrations
C020658,CHEMICAL,glutamine-synthetase adenylyltransferase [Supplementary Concept],glutamine synthetase|Nucleotidyltransferases
NEW01670,NUTRITION,synthetase inhibitor methionine sulfoximine MK-801,synthetase inhibitor methionine sulfoximine MK-801
NEW01671,CHEMICAL,urea cycle diseases,urea cycle diseases
NEW01675,CHEMICAL,ammonium exposure,ammonium exposure
D064529,CHEMICAL,"Receptor, Metabotropic Glutamate 5","Metabotropic Glutamate Receptor 5a|mGluR5a Protein|mGluR5 Protein|Metabotropic Glutamate Receptor 5b|mGluR5b Protein|Protein, mGluR5a|Receptor 5, Metabotropic Glutamate|Protein, mGluR5b|Glutamate|Protein, mGluR5|Metabotropic Glutamate Receptor 5"
NEW01682,CHEMICAL,NMDA antagonist-intake,NMDA antagonist-intake
NEW01596,CHEMICAL,NMDA receptor hypofunction,NMDA receptor hypofunction
C037078,CHEMICAL,MSH release inhibiting hormone receptor [Supplementary Concept],"Receptors, Pituitary Hormone-Regulating Hormone|glycinamide"
NEW01684,CHEMICAL,glutamate system,glutamate system
NEW01686,CHEMICAL,synapses/circuitry,synapses/circuitry
NEW01687,CHEMICAL,amygdala glutamate systems,amygdala glutamate systems
D018691,BIOCHEMICAL,Excitatory Amino Acid Antagonists,"Glutamate Antagonists|Antagonists, Glutamate Receptor|Antagonists, Glutamate|Glutamate Antagonist|Antagonists, Excitatory Amino Acid|Receptor Antagonist, Glutamate|Antagonists, EAA|Excitatory Amino Acid Antagonist|Amino Acids, Excitatory, Antagonists|Antagonist, Glutamate Receptor|Glutamate Receptor Antagonist|Glutamate Receptor Antagonists|Receptor Antagonists, Glutamate|Antagonist, Glutamate|Amino Acid Antagonists, Excitatory|EAA Antagonists|glutamate antagonists"
NEW01689,CHEMICAL,serotonin-enhancing agents,serotonin-enhancing agents
NEW01693,CHEMICAL,Boophone disticha,Boophone disticha
NEW01694,BIOCHEMICAL,beta Aβ oligomers,beta Aβ oligomers
NEW01696,CHEMICAL,theta burst stimulation,TBS|theta burst stimulation
D020269,DISEASE,Alcoholic Neuropathy,"Neuropathies, Alcohol-Induced Peripheral|Alcohol-Related Polyneuropathies|Polyneuropathy, Alcoholic|Alcoholic Polyneuropathy|Autonomic Polyneuropathy, Alcohol-Related|Alcoholic Axonal Neuropathy|Alcohol-Induced Peripheral Neuropathy|Alcohol Induced Polyneuropathy|Polyneuropathies, Alcohol-Related|Alcohol-Induced Peripheral Neuropathies|Axonal Neuropathies, Alcoholic|Peripheral Neuropathies, Alcohol-Induced|Polyneuropathies, Alcohol-Related Autonomic|Polyneuritides, Alcoholic|Alcohol-Induced Polyneuropathy|Alcoholic Polyneuritides|Polyneuropathies, Alcoholic|Alcohol-Related Autonomic Polyneuropathy|Peripheral Neuropathy, Alcohol Induced|Peripheral neuropathy|Alcohol Related Autonomic Polyneuropathy|Alcohol Related Polyneuropathy|Alcohol Induced Peripheral Neuropathy|Peripheral Neuropathy, Alcohol-Induced|Alcoholic Axonal Neuropathies|Alcoholic Polyneuropathies|Neuropathy, Alcohol-Induced Peripheral|Alcohol-Induced Polyneuropathies|Polyneuropathies, Alcohol-Induced|Alcoholic Polyneuritis|Polyneuropathy, Alcohol-Induced|Neuropathies, Alcoholic|Autonomic Polyneuropathies, Alcohol-Related|Polyneuropathy, Alcohol-Related Autonomic|Neuropathy, Alcoholic|Alcoholic Neuropathies|Alcohol-Related Polyneuropathy|Polyneuritis, Alcoholic|Neuropathies, Alcoholic Axonal|Axonal Neuropathy, Alcoholic|Alcohol-Related Autonomic Polyneuropathies|Neuropathy, Alcoholic Axonal|Polyneuropathy, Alcohol-Related"
C050147,CHEMICAL,"3-(2,2,2-trimethylhydrazine)propionate [Supplementary Concept]",Methylhydrazines|mildronate
D000068257,CHEMICAL,"Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination",efavirenz|Atripla
NEW01699,CHEMICAL,EVG-based ART regimen,EVG-based ART regimen
NEW01701,CHEMICAL,antiretrovirals,antiretrovirals
NEW01703,BIOCHEMICAL,first generation analogue reverse transcriptase inhibitor,first generation analogue reverse transcriptase inhibitor
NEW01704,CHEMICAL,non-nucleoside analogue,non-nucleoside analogue
D015215,CHEMICAL,Zidovudine,"3' Azido 2',3' Dideoxythymidine|zidovudine|AZT, Antiviral|BW A509U|AZT (Antiviral)|3'-Azido-2',3'-Dideoxythymidine|3'-Azido-3'-deoxythymidine|Retrovir|BWA 509U|BWA509U|Antiviral AZT|3' Azido 3' deoxythymidine|Azidothymidine|AZT Antiviral|BWA-509U"
NEW01706,BIOCHEMICAL,non-nucleoside reverse transcriptase inhibitor NNRTI efavirenz,non-nucleoside reverse transcriptase inhibitor NNRTI efavirenz
NEW01707,BIOCHEMICAL,GnRH agonist analogue,GnRH agonist analogue
NEW01709,BIOCHEMICAL,oestrogen signalling,oestrogen signalling
D012969,CHEMICAL,Sodium Fluoride,"Sodium Fluorides|Ossin|Fluoristats|Fluorides, Sodium|Zymafluors|Ossins|Zymafluor|fluoride|Fluoristat|Fluoride, Sodium"
D002994,CHEMICAL,Clofibrate,"Atromid S|Miskleron|Clofibric Acid, Ethyl Ester|clofibrate|Athromidin|Atromid|Miscleron|Chlorophenoxyisobutyrate, Ethyl|Ethyl Chlorophenoxyisobutyrate"
D017706,CHEMICAL,Lisinopril,Zestril|MK-521|Prinivil|lisinopril|Lisinopril Sulfate (1:2)|Lisinopril Maleate (1:1)|Lysinopril
NEW01716,DISEASE,idiopathic PAH,idiopathic PAH
D000081029,CHEMICAL,Pulmonary Arterial Hypertension,"PAH|pulmonary arterial hypertension|Arterial Hypertension, Pulmonary|Hypertension, Pulmonary Arterial"
NEW01717,CHEMICAL,severe COVID-19,severe COVID-19
D054990,DISEASE,Idiopathic Pulmonary Fibrosis,"Fibrocystic Pulmonary Dysplasias|pulmonary fibrosis|Usual Interstitial Pneumonia|Usual Interstitial Pneumonias|Pulmonary Fibrosis, Idiopathic|Cryptogenic Fibrosing Alveolitides|Idiopathic Pulmonary Fibrosis, Familial|Dysplasia, Fibrocystic Pulmonary|Pulmonary Dysplasia, Fibrocystic|Cryptogenic Fibrosing Alveolitis|Interstitial Pneumonitis, Usual|Idiopathic Fibrosing Alveolitis, Chronic Form|Idiopathic Pulmonary Fibroses|Fibrocystic Pulmonary Dysplasia|Fibrosing Alveolitis, Cryptogenic|Familial Idiopathic Pulmonary Fibrosis|Fibrosing Alveolitides, Cryptogenic|Pneumonitis, Usual Interstitial|Usual Interstitial Pneumonitides|Pulmonary Fibroses, Idiopathic|Usual Interstitial Pneumonitis|Pneumonitides, Usual Interstitial|Interstitial Pneumonia, Usual"
NEW01719,DISEASE,new HCV infections,new HCV infections
D019698,DISEASE,"Hepatitis C, Chronic",hepatitis C|Chronic Hepatitis C
NEW01721,DISEASE,acute viral illness,acute viral illness
C584156,DISEASE,"MIRN-H27 microRNA, herpes simplex virus 1 [Supplementary Concept]",oral herpes|MicroRNAs|HSV1
D000998,BIOCHEMICAL,Antiviral Agents,"Antivirals|Agent, Antiviral|Antiviral Agent|Antiviral Drug|Antiviral Drugs|Drugs, Antiviral|antiviral drugs|Drug, Antiviral|Antiviral|Agents, Antiviral"
NEW01724,DISEASE,HSV infections,HSV infections
NEW01726,CHEMICAL,self-administered female-sexual-function index FSFI questionnaire,self-administered female-sexual-function index FSFI questionnaire
D005767,DISEASE,Gastrointestinal Diseases,"Gastrointestinal Disorder, Functional|Gastrointestinal Disorders, Functional|gastrointestinal disorders|Cholera Infantum|Functional Gastrointestinal Disorders|Functional Gastrointestinal Disorder|Gastrointestinal Disorder|Disease, Gastrointestinal|Gastrointestinal Disease|Gastrointestinal Disorders|Diseases, Gastrointestinal"
NEW01727,CHEMICAL,haloperidol doses,haloperidol doses
NEW01730,BIOCHEMICAL,anti-coronavirus drug development,anti-coronavirus drug development
D060737,CHEMICAL,Reproductive Tract Infections,"Infection, Reproductive Tract|infections|Genital Tract Infection|Infection, Genital Tract|Genital Tract Infections|Infections, Reproductive Tract|Infections, Genital Tract|Reproductive Tract Infection"
NEW01731,DISEASE,Many psychiatric patients,Many psychiatric patients
D053480,NUTRITION,Cholesterol Ester Transfer Proteins,"Cholesterol Ester Transport Protein, CETP|Cholesteryl Ester Transfer Protein|Cholesteryl Ester Exchange Protein|Cholesterol Ester Transfer Protein|cholesterol"
D001218,CHEMICAL,Aspartame,"SC18862|Tri-Sweet|NutraSweet|Nozucar|Canderel|SC 18862|Hermesetas Gold|Aspartylphenylalanine Methyl Ester|Tri Sweet|TriSweet|SC-18862|Milisucre|aspartame|Methyl Aspartylphenylalanine|Goldswite|Methyl Ester, Aspartylphenylalanine|Aspartylphenylalanine, Methyl|Gold, Hermesetas"
C058272,CHEMICAL,norclozapine [Supplementary Concept],Clozapine/analogs  and  derivatives|N-Desmethylclozapine
NEW01736,CHEMICAL,µ1,µ1
D018045,CHEMICAL,"Receptors, Oxytocin","Oxytocin Receptor|Oxytocin Receptors|Receptor, Oxytocin|oxytocin receptor"
D050638,CHEMICAL,"Receptors, Dopamine D4","Dopamine D4 Receptors|D4 Receptors, Dopamine|D4 Receptor, Dopamine|dopamine D4 receptor|Receptor, Dopamine D4|Dopamine D4 Receptor"
NEW01737,CHEMICAL,Oxytocin Receptor G protein β3 subunit genes,Oxytocin Receptor G protein β3 subunit genes
NEW01743,CHEMICAL,Dopamine dysfunctions,Dopamine dysfunctions
NEW01746,MENTAL_HEALTH,profound dementia common,profound dementia common
D013759,CHEMICAL,Dronabinol,"delta-9-tetrahydrocannabinol|delta(1)-THC|9 ene Tetrahydrocannabinol|delta(9)-Tetrahydrocannabinol|Tetrahydrocannabinol, (6aS-cis)-Isomer|Tetrahydrocannabinol, Trans Isomer|Marinol|Tetrahydrocannabinol, (6aR-cis)-Isomer|delta(1)-Tetrahydrocannabinol|THC|Tetrahydrocannabinol, Trans-(+-)-Isomer|Tetrahydrocannabinol|9-ene-Tetrahydrocannabinol|Tetrahydrocannabinol, (6a-trans)-Isomer|delta(9)-THC|Tetrahydrocannabinol, Trans-Isomer"
NEW01749,CHEMICAL,THC exposure,THC exposure
NEW01752,DISEASE,patient's movement disorders,patient's movement disorders
NEW01753,CHEMICAL,novel Dlg2+/- rat,novel Dlg2+/- rat
NEW01756,DISEASE,p53-dependent neuron death,p53-dependent neuron death
D050417,BIOCHEMICAL,Insulin-Secreting Cells,"Pancreatic B Cells|B Cell, Pancreatic|Pancreatic beta Cells|beta Cell, Pancreatic|Insulin Secreting Cells|Pancreatic B Cell|pancreatic beta cells|Pancreatic beta Cell|B Cells, Pancreatic|beta Cells, Pancreatic|Cell, Insulin-Secreting|Cells, Insulin-Secreting|Insulin-Secreting Cell"
C019143,CHEMICAL,long-chain-fatty-acid-CoA ligase [Supplementary Concept],Coenzyme A Ligases|acyl-CoA synthetase long-chain family member
NEW01761,CHEMICAL,Higher CSF glucose,Higher CSF glucose
NEW01763,CHEMICAL,membrane phospholipids,MPL|membrane phospholipids
NEW01765,NUTRITION,N-3 polyunsaturated fatty acids,N-3 polyunsaturated fatty acids
D066300,CHEMICAL,Electronic Nicotine Delivery Systems,"E Cigarette|E-Cigarettes|Cigarette, Electronic|E Cig|E Cigs|Electronic Nicotine Delivery System|E Cigarettes|Electronic Cigarettes|E-Cigarette|E-Cig|Electronic Cigarette|Cigarettes, Electronic|Nicotine|E-Cigs"
NEW01769,DISEASE,SAD patients,SAD patients
NEW01770,BIOCHEMICAL,drug usage,drug usage
D005938,CHEMICAL,Glucocorticoids,"Effect, Glucocorticoid|GCs|Glucocorticoid|Effects, Glucorticoid|Glucocorticoid Effect|glucocorticoids|Glucorticoid Effects"
C024750,CHEMICAL,didrovaltrate [Supplementary Concept],Didrovaltrate|Iridoids
NEW01773,CHEMICAL,anterior corona radiata,ACR|anterior corona radiata
D020106,CHEMICAL,Acrylamide,Acrylamides (1982-1998)|Acrylamide
D000079403,CHEMICAL,Ferroptosis,Oxytosis|Ferroptosis
D017044,DISEASE,"Polycystic Kidney, Autosomal Recessive","Polycystic Kidney and Hepatic Disease 1|ARPKD|Hepatic disease|Polycystic Kidney Disease, Infantile, Type 1|Autosomal Recessive Polycystic Kidney Disease|Polycystic Kidney and Hepatic Disease 1 (Autosomal Recessive)|Kidney, Polycystic, Autosomal Recessive|Polycystic Kidney Disease, Autosomal Recessive|Autosomal Recessive Polycystic Kidney|Polycystic Kidney Disease, Infantile, Type I"
NEW01776,DISEASE,spike induced hepatitis,spike induced hepatitis
D000428,CHEMICAL,Alcohol Drinking,"Alcohol Intake|Alcohol Intakes|Alcohol Consumption|Drinking, Alcohol|Habits, Alcohol Drinking|Consumption, Alcohol|Drinking Habit, Alcohol|Alcohol Drinking Habit|Habit, Alcohol Drinking|alcohol drinking|Alcohol Drinking Habits|Intake, Alcohol"
NEW01780,NUTRITION,Lithium acid treatments,Lithium acid treatments
NEW01782,DISEASE,BD manic patients,BD manic patients
NEW01785,DISEASE,hyperinsulinism/hyperammonemia HI/HA syndrome,hyperinsulinism/hyperammonemia HI/HA syndrome
D044903,DISEASE,Congenital Hyperinsulinism,"Hyperinsulinisms, Neonatal|Hyperinsulinemic Hypoglycemia Due to Focal Adenomatous Hyperplasia|Hypoglycemias, Persistent Hyperinsulinemic|PHHI Hypoglycemias|Infancy Hyperinsulinemia Hypoglycemias|Hyperinsulinisms, Familial|Hyperinsulinemic Hypoglycemia, Persistent|Hyperinsulinemic Hypoglycemias, Persistent|Hypoglycemias, PHHI|Familial Hyperinsulinisms|Familial Hyperinsulinism|Hypoglycemia, Hyperinsulinemic, of Infancy|Hypoglycemia, PHHI|congenital hyperinsulinism|Hyperinsulinemic Hypoglycemia, Familial, 1|Hyperinsulinism, Familial|Persistent Hyperinsulinemia Hypoglycemia of Infancy|Hypoglycemia, Persistent Hyperinsulinemic|Infancy Hyperinsulinemia Hypoglycemia|Hyperinsulinisms, Congenital|Familial Hyperinsulinemic Hypoglycemia 1|Hyperinsulinism, Neonatal|Hyperinsulinemia Hypoglycemia of Infancy|Neonatal Hyperinsulinisms|Neonatal Hyperinsulinism|Persistent Hyperinsulinemic Hypoglycemia|Congenital Hyperinsulinisms|PHHI Hypoglycemia|Persistent Hyperinsulinemic Hypoglycemias|Hyperinsulinism, Congenital|Hyperinsulinemic Hypoglycemia, Familial, 2"
NEW01787,BIOCHEMICAL,drug reward,drug reward
D007175,DISEASE,Impulsive Behavior,"Impulsivities|Behavior, Impulsive|Behaviors, Impulsive|Impulsivity|Impulsive Behaviors"
D000077252,CHEMICAL,Dialectical Behavior Therapy,"Behavior Therapy, Dialectical|DBT|Dialectical Behavior Therapies|dialectical behavior therapy"
D057178,DISEASE,Primary Progressive Nonfluent Aphasia,"Nonfluent Aphasias, Progressive|Syndrome, PPA|Primary progressive aphasia|PPA Syndrome|Aphasias, Progressive Nonfluent|Progressive Nonfluent Aphasias|Non-fluent Primary Progressive Aphasia|Aphasia, Progressive Nonfluent|Non fluent Primary Progressive Aphasia|Syndromes, PPA|Progressive Nonfluent Aphasia|PPA Syndromes|Nonfluent Aphasia, Progressive"
D020961,MENTAL_HEALTH,Lewy Body Disease,"Lewy Body Disease, Diffuse|Lewy Body Disease, Cortical|Lewy Body Type Senile Dementia|Cortical Lewy Body Disease|Lewy body disease|Dementia, Lewy Body|Lewy Body Dementia|Diffuse Lewy Body Disease"
NEW01793,BIOCHEMICAL,KOR agonists,KOR agonists
NEW01794,CHEMICAL,glucuronate levels,glucuronate levels
D020723,CHEMICAL,Glucuronic Acid,"Glucuronate, Monosodium|Monosodium Glucuronate|Glucuronate, Monopotassium|Monopotassium Glucuronate|GlucA|Glucuronic Acid, Monopotassium Salt|glucuronate|Glucuronic Acid, 6-(14)C-labeled, (D)-isomer|Glucuronate|Glucuronic Acid, Monosodium Salt"
NEW01796,CHEMICAL,low-density HDLP lipoproteins,low-density HDLP lipoproteins
NEW01797,NUTRITION,HDLP cholesterol level,HDLP cholesterol level
NEW00027,DISEASE,Parkinson 's disease,Parkinson 's disease|PD
NEW01798,MENTAL_HEALTH,Drug-induced psychosis,Drug-induced psychosis
D065087,CHEMICAL,Acetylcholine Release Inhibitors,"Antagonists, Acetylcholine Release|Acetylcholine Release Blockers|acetylcholine|Release Blockers, Acetylcholine|Blockers, Acetylcholine Release|Inhibitors, Acetylcholine Release|Acetylcholine Release Antagonists"
NEW01800,CHEMICAL,3-(2-chloro-10H-phenothiazin-10-yl)-N-methyl-N-(4-(3-(piperidin-1-yl)propoxy)benzyl)propan-1-amine,3-(2-chloro-10H-phenothiazin-10-yl)-N-methyl-N-(4-(3-(piperidin-1-yl)propoxy)benzyl)propan-1-amine
NEW01803,CHEMICAL,glucose control medication,glucose control medication
NEW01805,MENTAL_HEALTH,ADHD aged,ADHD aged
NEW01807,NUTRITION,Abnormal fatty acid metabolism,Abnormal fatty acid metabolism
NEW00260,DISEASE,low-grade inflammation,low-grade inflammation
NEW01809,CHEMICAL,aluminium chloride,AlCl3|aluminium chloride
D048308,BIOCHEMICAL,Mitogen-Activated Protein Kinase 14,"MAPK14|SAPK2a|CSBP, Kinase|CSAID Binding Protein|MAX-Interacting Protein 2|Mitogen Activated Protein Kinase 14|Stress-activated protein kinase 2a|Cytokine Suppressive Anti-inflammatory Drug Binding Protein|CSAID-Binding Protein|MAX Interacting Protein 2|anti-inflammatory drug|Kinase CSBP|p38alphaMAPK|Mxi2 Protein|MAPK14 Mitogen-Activated Protein Kinase|p38alpha Mitogen Activated Protein Kinase|p38alpha Mitogen-Activated Protein Kinase|Stress activated protein kinase 2a|MAP Kinase, p38alpha|Cytokine Suppressive Anti inflammatory Drug Binding Protein|MAPK14 Mitogen Activated Protein Kinase|p38alpha MAP Kinase"
D009477,DISEASE,Hereditary Sensory and Autonomic Neuropathies,"Familial Dysautonomia, Type II|Neuropathies, Hereditary Sensory and Autonomic|Hereditary Sensory and Autonomic Neuropathy Type 1|Neuropathy, Hereditary Sensory And Autonomic, Type I|Hereditary Sensory and Autonomic Neuropathy, Type 5|Type I, HSAN|Pain Insensitivity with Anhidrosis, Congenital|HSANII|Type IV, HSAN|Familial Dysautonomia, Type 2|Insensitivity to Pain, Congenital, with Anhidrosis|Insensitivity to Pain with Anhidrosis, Congenital|Sensory Neuropathies, Congenital|Neuropathy, Hereditary Sensory Radicular, Autosomal Recessive|Sensory Neuropathies, Hereditary|Acroosteolyses, Neurogenic|Neuropathy, Progressive Sensory, Of Children|Hereditary Sensory Autonomic Neuropathy, Type 1|Neuropathy, Congenital Sensory, with Anhidrosis|HSAN2|Congenital Insensitivity to Pain with Anhidrosis|HSAN Type II|Hereditary Sensory Radicular Neuropathy|HSN Type I|Neuropathy, Hereditary Sensory Radicular, Autosomal Dominant|HSAN5|Hereditary Sensory and Autonomic Neuropathy Type V|HSAN I|Neurogenic Acroosteolysis|Sensory Neuropathy, Congenital|Neuropathy, Hereditary Sensory And Autonomic, Type V|HSAN (Hereditary Sensory Autonomic Neuropathy)|Hereditary Sensory And Autonomic Neuropathy IV|Hereditary Sensory and Autonomic Neuropathy Type IV|Hereditary Sensory Neuropathy Type Ia|HSN Type II|Hereditary Sensory Neuropathy|Neuropathy, Hereditary Sensory|CIPA|HSN Type IIs|HSAN Type V|Neuropathy Hereditary Sensory Radicular, Autosomal Dominant|HSAN 5|Neuropathies, Congenital Sensory|Hereditary Sensory Autonomic Neuropathy, Type 2|Hereditary Sensory and Autonomic Neuropathy, Type 4|HSAN V|HSAN 1|Acroosteolysis, Neurogenic|HSANs (Hereditary Sensory Autonomic Neuropathy)|HSAN Type IV|Hereditary Sensory Neuropathy Type I|Hereditary Sensory and Autonomic Neuropathy Type II|Neuropathy, Hereditary Sensory, Type I|Neuropathies, Hereditary Sensory|Hereditary Sensory Autonomic Neuropathy, Type 4|Congenital Sensory Neuropathies|Hereditary Sensory Radicular Neuropathy, Recessive Form|HSAN Type I|Type I, HSN|Neuropathy Hereditary Sensory and Autonomic Type 1|HSAN|Congenital Sensory Neuropathy|Hereditary Sensory Neuropathies|Giaccai Type Acroosteolysis|HSAN IV|Neuropathy, Congenital Sensory|Hereditary Sensory and Autonomic Neuropathy Type I|Sensory and Autonomic Neuropathies, Hereditary|Sensory Neuropathy, Hereditary|HSAN 4|Hereditary Sensory and Autonomic Neuropathy Type 2|Hereditary Sensory and Autonomic Neuropathy 4|Hereditary Sensory Neuropathy Type 1|Acroosteolysis, Giaccai Type|Neurogenic Acroosteolyses|Hereditary Sensory Autonomic Neuropathy, Type 5|anhidrosis"
NEW01818,DISEASE,autistic traits,autistic traits
D000072861,MENTAL_HEALTH,"Phobia, Social","Anxiety Disorder, Social|Disorders, Social Anxiety|Disorder, Social Anxiety|social anxiety|Anxiety Disorders, Social|Social Phobia|Social Anxiety Disorder|Social Anxiety Disorders|Social Phobias|Phobias, Social"
NEW01819,CHEMICAL,psychedelic drugs,psychedelic drugs
NEW01822,DISEASE,fear memory expression,fear memory expression
NEW01824,CHEMICAL,N-Acetylserotonin O-methyltransferase,N-Acetylserotonin O-methyltransferase|ASMT
D054648,DISEASE,Protein Phosphatase 2,"Protein Phosphatase 2, Regulatory Subunit B, gamma Isoform|Protein Phosphatase 2A|Protein Phosphatase-2A|Serine-Threonine-Protein Phosphatase 2A Catalytic Subunit alpha Isoform|Phosphatase, PPP2CB|Protein Phosphatase 2A, Regulatory Subunit B, alpha Isoform|Phosphatase, PPP2CA|Serine Threonine Protein Phosphatase 2A Catalytic Subunit alpha Isoform|Protein Phosphatase 2, Catalytic Subunit|Protein Phosphatase 2, Regulatory Subunit B, beta Isoform|Protein Phosphatase 2, Regulatory Subunit A, alpha Isoform|Protein Phosphatase 2A, Regulatory Subunit A, beta Isoform|Serine Threonine Protein Phosphatase 2A Catalytic Subunit beta Isoform|Protein Phosphatase 2, Regulatory Subunit|Protein Phosphatase 2, Regulatory Subunit B, delta Isoform|Protein Phosphatase 2, Regulatory Subunit B, alpha Isoform|PPP2CA Phosphatase|RII|Protein Phosphatase 2, Regulatory Subunit A, beta Isoform|Protein Phosphatase 2A, Catalytic Subunit, alpha Isoform|Protein Phosphatase 2A, Regulatory Subunit B, beta Isoform|Protein Phosphatase 2, Catalytic Subunit, alpha Isoform|Protein Phosphatase 2, Catalytic Subunit, beta Isoform|Protein Phosphatase 2A, Regulatory Subunit A , alpha Isoform|regulatory subunit|Protein Phosphatase 2A, Catalytic Subunit, beta Isoform|Protein Phosphatase 2A, Regulatory Subunit B, gamma Isoform|Protein Phosphatase 2A, Regulatory Subunit B, delta Isoform|PPP2CB Phosphatase"
NEW01827,CHEMICAL,morpholino-induced pgrmc1 knockdown,morpholino-induced pgrmc1 knockdown
NEW01830,CHEMICAL,c.757C T,c.757C T
NEW01831,CHEMICAL,chronic ketamine use,chronic ketamine use
NEW01833,CHEMICAL,beta-lactam ceftriaxone,beta-lactam ceftriaxone
NEW01836,BIOCHEMICAL,common environmental endocrine disrupters,common environmental endocrine disrupters
D017438,CHEMICAL,Bisphenol A-Glycidyl Methacrylate,"Concise White Sealant|Conclude Composite Resin|Enamel Bond, Concise|NuvaSeal|Bis-GMA Resin|Epoxylite9075|Composite Resins, Concise|Bis-GMA Resins|Resins, Concise Composite|Bis(Phenol A-Glycidyl Methacrylate), Homopolymer|Retroplast|Bis-GMA Polymers|BPA|Resin, Concise Composite|Bis(Phenol A-Glycydyl Methacrylate)|Bisphenol A-Glycidyl Methacrylate Polymer|Adaptic|Silux|Kerr Sealer|Bisphenol A Glycidyl Methacrylate Homopolymer|Epoxylite-9075|Nuva-Seal|2-Propenoic acid, 2-methyl-, (1-methylethylidene)bis(4,1-phenyleneoxy(2-hydroxy-3,1-propanediyl)) ester, homopolymer|Epoxylite 9075|Bisphenol A Glycidyl Methacrylate|Concise Composite Resin|Concise Enamel Bond System|Bisphenol A|Concise Composite Resins|Kerr Pit and Fissure Sealant|Delton|Bis(Phenol A-Glycidyl Methacrylate)|Resins, Bis-GMA|Bis GMA|Panavia Opaque|Resin, Conclude|Methacrylate, Bisphenol A-Glycidyl|Concise Resin|Composite Resin, Conclude|Polymer, Bis-GMA|Concise Resins|Opaque, Panavia|Bis GMA Polymer|Bis GMA Resin|Conclude Resin|Resin, Conclude Composite|Resins, Concise|Bond, Concise Enamel|Resin, Concise|Bisphenol A Glycidyl Methacrylate Polymer|Bisphenol A-Glycidyl Methacrylate Homopolymer|Nuva Seal|Concise Enamel Bond|Polymers, Bis-GMA|Poly(Bis-GMA)|Bis-GMA|Composite Resin, Concise|Resin, Bis-GMA|Bis-GMA Polymer"
NEW01838,CHEMICAL,Ala147Thr SNP,Ala147Thr SNP
NEW01839,CHEMICAL,steroids present,steroids present
NEW01841,BIOCHEMICAL,beta protein levels,beta protein levels
D020117,CHEMICAL,Cisapride,R51619|R 51619|cisapride|R-51619|Propulsid
D019274,CHEMICAL,"Botulinum Toxins, Type A","Meditoxin|Oculinum|Botulinum Toxin Type A|Toxin, Botulinum A|Vistabex|Onabotulinumtoxin A|Botox|Botulinum A Toxin|Clostridium botulinum A Toxin|Botulinum Neurotoxin A|Botulinum Neurotoxin Type A|Botulinum Toxin A|Neurotoxin A, Botulinum|BT|Botulinum toxin|Toxin A, Botulinum|OnabotulinumtoxinA|Clostridium Botulinum Toxin Type A|Vistabel|Neuronox"
NEW01844,CHEMICAL,educational DVD,educational DVD
NEW01846,CHEMICAL,circulating cortisol,circulating cortisol
NEW01848,CHEMICAL,oxygen consumption rate,oxygen consumption rate
NEW01853,CHEMICAL,de arginine synthesis,de arginine synthesis
C000623308,CHEMICAL,solriamfetol [Supplementary Concept],Carbamates|Phenylalanine/analogs  and  derivatives|Solriamfetol
C020611,CHEMICAL,cortisol 21-sulfate [Supplementary Concept],Hydrocortisone/analogs  and  derivatives|cortisol
NEW01859,MENTAL_HEALTH,Logistic regression analysis,Logistic regression analysis
NEW01862,CHEMICAL,Lower-brain glucose uptake,Lower-brain glucose uptake
NEW01864,CHEMICAL,MCTs,MCT-Es|MCTs
NEW01867,BIOCHEMICAL,stress hormone,stress hormone
C088327,CHEMICAL,plerixafor [Supplementary Concept],AMD3100|Cyclams|plerixafor|Benzylamines
NEW01869,CHEMICAL,anti-PD-1,αPD-1|anti-PD-1
D014411,DISEASE,Neoplastic Stem Cells,"Stem Cell, Neoplastic|Stem Cell, Cancer|Colony-Forming Unit, Neoplastic|Cancer stem cells|Stem Cell, Tumor|Initiating Cells, Tumor|Tumor Stem Cell|Cell, Tumor Initiating|Stem Cells, Cancer|Neoplastic Colony-Forming Unit|Neoplastic Stem Cell|Cells, Cancer Stem|Cancer Stem Cells|Cancer Stem Cell|Cells, Neoplastic Stem|Stem Cells, Neoplastic|Stem Cells, Tumor|Colony Forming Units, Neoplastic|Cell, Cancer Stem|Cell, Tumor Stem|Unit, Neoplastic Colony-Forming|Tumor Stem Cells|Cells, Tumor Initiating|Colony-Forming Units, Neoplastic|Cell, Neoplastic Stem|Units, Neoplastic Colony-Forming|Tumor Initiating Cells|Initiating Cell, Tumor|Tumor Initiating Cell|Neoplastic Colony-Forming Units|Neoplastic Colony Forming Units|Cells, Tumor Stem"
D062688,DISEASE,Buschke-Lowenstein Tumor,"Anogenital Type Verrucous Carcinoma|Lowenstein Tumor, Buschke|Condyloma Acuminatums, Giant|Buschke Lowenstein Tumor|Löwenstein Tumor, Buschke|Tumor, Buschke Lowenstein|Condyloma Acuminatum, Giant|Tumor, Buschke Löwenstein|Giant Condyloma of Buschke and Löwenstein|Tumor, Buschke-Lowenstein|Giant Condyloma of Buschke and Lowenstein|Tumor, Buschke-Löwenstein|Giant Condyloma Acuminatums|Buschke Löwenstein Tumor|Giant Condyloma Acuminatum|tumor|Buschke-Löwenstein Tumor"
C570280,CHEMICAL,"AP5B1 protein, human [Supplementary Concept]","AP-5|Adaptor Proteins, Vesicular Transport"
C104712,CHEMICAL,ACEA 1416 [Supplementary Concept],Quinoxalines|ACEA
NEW01872,CHEMICAL,NMDA antagonism,NMDA antagonism
D009271,CHEMICAL,Naltrexone,Celupan|Trexan|EN 1639A|Nemexin|ReVia|Naltrexone Hydrochloride|EN-1639A|naltrexone|Nalorex|Antaxone|EN1639A
NEW01875,BIOCHEMICAL,mu opioid antagonist,mu opioid antagonist
NEW01877,BIOCHEMICAL,delta opioid antagonist,delta opioid antagonist
NEW01879,CHEMICAL,ICI-154,ICI-154
D007981,CHEMICAL,Levorphanol,"Levo-Dromoran|3 Hydroxy N methylmorphinan|Levodroman|Levorphanol Tartrate|Tartrate, Levorphanol|Levorphan|levorphanol|Levo Dromoran|L-Dromoran|L Dromoran|LevoDromoran|3-Hydroxy-N-methylmorphinan"
NEW01881,BIOCHEMICAL,mu agonist,mu agonist
D008139,CHEMICAL,Loperamide,"Imodium|Loperamide Hydrochloride|R18553|Loperamide Monohydrochloride|loperamide|R-18553|Monohydrochloride, Loperamide|Hydrochloride, Loperamide|R 18553"
C041269,CHEMICAL,N-methylnaloxone [Supplementary Concept],Naloxone/analogs  and  derivatives|Quaternary Ammonium Compounds|methylnaloxone
NEW01884,CHEMICAL,μ-opioid receptor antagonist methylnaloxone,μ-opioid receptor antagonist methylnaloxone
C029167,CHEMICAL,ST 1435 [Supplementary Concept],Norprogesterones|Nestorone
NEW01888,BIOCHEMICAL,hormone treatments,hormone treatments
NEW01889,BIOCHEMICAL,selective oestrogen receptor modulators,selective oestrogen receptor modulators
NEW01890,CHEMICAL,Adjunctive MPA treatment,Adjunctive MPA treatment
D017258,CHEMICAL,Medroxyprogesterone Acetate,"Medroxyprogesterone|MPA|Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6alpha)-|6-alpha-Methyl-17alpha-hydroxyprogesterone Acetate|Gestapuran|Depo-Provera|DepoProvera|(6 alpha)-17-(Acetoxy)-6-methylpregn-4-ene-3,20-dione|6 alpha Methyl 17alpha hydroxyprogesterone Acetate|Medroxyprogesterone 17 Acetate|Depo Provera|Cycrin|Medroxyprogesterone 17-Acetate, (6 beta)-Isomer|Depo-Medroxyprogesterone Acetate|Curretab|Medroxyprogesterone 17-Acetate, (6 alpha,17 alpha)-Isomer|Perlutex|Depo Medroxyprogesterone Acetate|Medroxyprogesterone 17-Acetate|Veramix|Farlutal|Provera"
NEW01894,CHEMICAL,Oral contraceptive use,Oral contraceptive use
NEW01896,NUTRITION,Lithium antidepressants,Lithium antidepressants
NEW01901,CHEMICAL,Long-acting MPA,Long-acting MPA
D005201,MENTAL_HEALTH,Fantasy,"Dream, Day|Daydreams|Fantasies|Dreams, Day|Day Dreams|Day Dream|Daydream|fantasies"
NEW01902,CHEMICAL,progestin-only preparations,progestin-only preparations
NEW01904,CHEMICAL,estrogen-containing contraceptives,estrogen-containing contraceptives
D003276,CHEMICAL,"Contraceptives, Oral","Oral Contraceptives|Low-Dose Oral Contraceptives|Low-Dose Oral Contraceptive|oral contraceptives|Oral Contraceptives, Phasic|Contraceptive, Oral|Oral Contraceptive|Contraceptive, Low-Dose Oral|Phasic Oral Contraceptives|Contraceptives, Low-Dose Oral|Contraceptives, Phasic Oral|Oral Contraceptives, Low Dose|Oral Contraceptive, Low-Dose|Oral Contraceptives, Low-Dose|Low Dose Oral Contraceptive"
NEW01907,CHEMICAL,levonorgestrel implants,levonorgestrel implants
NEW01908,DISEASE,prolactinoma size,prolactinoma size
NEW01909,DISEASE,psychiatric benefits,psychiatric benefits
D008234,CHEMICAL,Lynestrenol,"19-Norpregn-4-en-20-yn-17-ol, (17alpha)-|Lynoestrenol|Lynestrenol, (9 beta, 10 alpha,17 alpha)-Isomer|lynestrenol|Exluton|Linestrenol|Linesterol|Ethinylestrenol"
NEW01913,NUTRITION,cholesterol transporter ABCA1,cholesterol transporter ABCA1
NEW01914,CHEMICAL,inhibitor RU486,inhibitor RU486
NEW01915,CHEMICAL,progesterone receptor inhibitor,progesterone receptor inhibitor
NEW01916,BIOCHEMICAL,estrogen therapy,estrogen therapy
NEW01918,CHEMICAL,higher BMI zinc levels,higher BMI zinc levels
NEW01919,BIOCHEMICAL,higher circulating vitamin D,higher circulating vitamin D
NEW01920,DISEASE,syndrome vitiligo,syndrome vitiligo
NEW01921,DISEASE,oxidative neuronal injury,oxidative neuronal injury
NEW01923,NUTRITION,membrane phospholipids,membrane phospholipids
C511402,CHEMICAL,Grape Seed Proanthocyanidins [Supplementary Concept],Proanthocyanidins|GSP|grape seed proanthocyanidins|Grape Seed Extract
D012838,CHEMICAL,Silymarin,Legalon|Carsil|Karsil|silymarin|Silimarin
D051549,CHEMICAL,Glutathione S-Transferase pi,"Glutathione Transferase P1-1|glutathione|GSTP1 Glutathione D Transferase|GSTP1 Glutathione D-Transferase|GSH|Transferase P1-1, Glutathione|GST Class-phi|Class-phi, GST|Glutathione S Transferase pi|Glutathione Transferase P1 1|GST Class phi|Glutathione D-Transferase, GSTP1|D-Transferase, GSTP1 Glutathione"
NEW01934,CHEMICAL,Erythrocyte glutathione,Erythrocyte glutathione
NEW01935,BIOCHEMICAL,antioxidants retinol,antioxidants retinol
NEW01936,DISEASE,hepatic injury,hepatic injury
NEW01937,BIOCHEMICAL,vitamin A poisoning secondary,vitamin A poisoning secondary
C538178,CHEMICAL,Acrodermatitis enteropathica [Supplementary Concept],Acrodermatitis|Zinc/deficiency|Zinc deficiency
D000995,BIOCHEMICAL,Antitubercular Agents,"Anti Tuberculosis Agent|Anti Tuberculosis Agents|Drug, Anti-Tuberculosis|Agent, Tuberculostatic|Antitubercular Drug|Drug, Antitubercular|Anti-Tuberculosis Drugs|Anti-Tuberculosis Agents|Agent, Anti-Tuberculosis|Anti-Tuberculosis Agent|Anti Tuberculosis Drug|Tuberculostatic Agent|Anti Tuberculosis Drugs|Tuberculostatic Agents|Agent, Antitubercular|Antitubercular Drugs|antitubercular drugs|Anti-Tuberculosis Drug|Antitubercular Agent"
NEW01943,BIOCHEMICAL,medical drug,medical drug
D017483,CHEMICAL,"Receptors, Vasopressin","V2 Receptors|Receptor, Arginine(8)-Vasopressin|V1a Vasopressin Receptor|Antidiuretic Hormone Receptors|Receptors, Antidiuretic Hormone|V2 Receptor|Hormone Receptors, Antidiuretic|Receptors, Argipressin|Arginine Vasopressin Receptor|Renal Type Arginine Vasopressin Receptor|Vascular Hepatic Type Arginine Vasopressin Receptor|Vasopressin V2 Receptor|Vasopressin V1b Receptor|Receptor, Antidiuretic Hormone|Vasopressin V3 Receptor|Vasopressin V1a Receptor|Vasopressin Receptors|V1 Receptor|Receptor, Vasopressin V1b|Renal-Type Arginine Vasopressin Receptor|Vasopressin Receptor 1|Antidiuretic Hormone Receptor 1b|Receptor, V2|vasopressin|Hormone Receptor, Antidiuretic|Argipressin Receptor|V1 Receptors|V1b Vasopressin Receptor|8 Arg Vasopressin Receptor|8-Arg-Vasopressin Receptor|Vascular-Hepatic Type Arginine Vasopressin Receptor|Argipressin Receptors|Receptor, Arginine Vasopressin|Vasopressin Receptor|V1b Receptor, Vasopressin|Receptor, Vasopressin V3|Vasopressin Receptor, V1b|Receptor, Vasopressin|Antidiuretic Hormone Receptor 1a|Vasopressin Type 1A Receptor|Receptors, V1|Receptor, Argipressin|Antidiuretic Hormone Receptor|Receptor, V1|Receptors, V2"
NEW01945,CHEMICAL,CA1 postsynaptic histamine H1,CA1 postsynaptic histamine H1
NEW01946,CHEMICAL,high-dose betahistine treatment,high-dose betahistine treatment
D001621,CHEMICAL,Betahistine,"Hydrochloride, Betahistine|Fidium|By-Vertin|Betaserc|Mersilon|Aequamen|Betahistine Hydrochloride|Ribrain|Extovyl|Betahistin Ratiopharm|Betavert|Betahistin Stada|Vasomotal|Betahistine Methanesulfonate|Lectil|Melopat|By Vertin|PT9|Serc|Vertigon|Dihydrobromide, Betahistine|Methanesulphonate, Betahistine|Betahistine Biphar|PT-9|PT 9|Betahistine Dihydrochloride|Betahistine Dihydrobromide|Betahistine Methanesulphonate|Betahistin AL|Betahistine|Betahistine Mesylate|Dihydrochloride, Betahistine|Betahistin-Ratiopharm|Mesylate, Betahistine|Methanesulfonate, Betahistine"
NEW01947,CHEMICAL,classic histamine receptors,classic histamine receptors
NEW01949,BIOCHEMICAL,H3 receptor antagonist,H3 receptor antagonist
C115705,CHEMICAL,ciproxifan [Supplementary Concept],Imidazoles|ciproxifan
NEW01951,CHEMICAL,histamine neurons,histamine neurons
NEW01952,CHEMICAL,H(3)-type histamine receptors,H(3)-type histamine receptors
NEW01953,BIOCHEMICAL,histamine H3 receptor antagonist,histamine H3 receptor antagonist
NEW01955,BIOCHEMICAL,histamine (H3)-receptor antagonist/inverse agonist,histamine (H3)-receptor antagonist/inverse agonist
D018687,CHEMICAL,"Antidepressive Agents, Second-Generation","Second Generation Antidepressive Agents|Antidepressants, Atypical|Atypical Antidepressants|Second-Generation Antidepressive Agents|Antidepressants|Antidepressive Drugs, Second-Generation|Drugs, Second-Generation Antidepressive|Antidepressive Drugs, Second Generation|Antidepressive Agents, Second Generation|Second-Generation Antidepressive Drugs|Agents, Second-Generation Antidepressive"
NEW01956,CHEMICAL,methylphenidate preparations,methylphenidate preparations
D018100,CHEMICAL,"Receptors, Histamine H3","Histamine H3 Receptor|H3 Receptors, Histamine|Receptor, H3|H3 Receptors|Receptor, Histamine H3|H3 Receptor, Histamine|H3 Receptor|Histamine H3 receptors|Histamine H3 Receptors|Receptors, H3"
C574166,CHEMICAL,bavisant [Supplementary Concept],Bavisant|JNJ-31001074|Benzamides|Piperazines
C052075,CHEMICAL,thioperamide [Supplementary Concept],thioperamide|Piperidines
NEW01960,CHEMICAL,histaminergic H1 receptor,histaminergic H1 receptor
NEW01962,BIOCHEMICAL,betahistine histaminergic H1R agonist,betahistine histaminergic H1R agonist
NEW01964,CHEMICAL,Betahistine co-treatment,Betahistine co-treatment
NEW01965,DISEASE,dizocilpine (DIZ)-induced memory deficits,dizocilpine (DIZ)-induced memory deficits
NEW01966,CHEMICAL,histamine H3 receptor antagonist E159,histamine H3 receptor antagonist E159
NEW01967,DISEASE,DIZ-induced amnesic model,DIZ-induced amnesic model
D020277,DISEASE,"Polyradiculoneuropathy, Chronic Inflammatory Demyelinating","Polyradiculopathies, Chronic Inflammatory|Polyradiculopathy, Chronic Inflammatory|Polyradiculoneuropathy, Chronic Inflammatory|Polyradiculoneuropathies, Chronic Inflammatory|Chronic Inflammatory Demyelinating Polyradiculoneuropathy|polyradiculoneuropathy|Inflammatory Polyradiculoneuropathies, Chronic|Inflammatory Polyradiculoneuropathy, Chronic|CIDP|Chronic Inflammatory Polyradiculoneuropathy|Inflammatory Polyradiculopathy, Chronic|Polyneuropathy, Inflammatory Demyelinating, Chronic|Inflammatory Polyradiculopathies, Chronic|Chronic Inflammatory Polyradiculopathy|Chronic Inflammatory Polyradiculoneuropathies|Chronic Inflammatory Polyradiculopathies"
NEW01971,CHEMICAL,free calcium,free calcium
NEW01973,DISEASE,Graves's disease,Graves's disease
NEW01975,DISEASE,liver disease due,liver disease due
NEW01976,DISEASE,euthyroid neonate,euthyroid neonate
NEW01977,DISEASE,fetal goitrous hypothyroidisms,fetal goitrous hypothyroidisms
NEW01979,CHEMICAL,brain dopamine,brain dopamine
NEW01980,CHEMICAL,PET dopamine measurements,PET dopamine measurements
NEW01981,BIOCHEMICAL,drugs levodopa,drugs levodopa
D002211,CHEMICAL,Capsaicin,NGX 4010|Capsidol|Zacin|NGX4010|Zostrix|capsaicin|Capsaicine|Gelcen|Capzasin|Capsin|Axsain|Antiphlogistine Rub A-535 Capsaicin|Katrum|Capsicum Farmaya|8 Methyl N Vanillyl 6 Nonenamide|NGX-4010|8-Methyl-N-Vanillyl-6-Nonenamide
NEW01984,CHEMICAL,LPS,LPS
NEW01985,CHEMICAL,dietary CAP,dietary CAP
NEW01987,CHEMICAL,Community-acquired pneumonia,CAP|Community-acquired pneumonia
NEW01989,BIOCHEMICAL,TRPV1 antagonists,TRPV1 antagonists
NEW01990,MENTAL_HEALTH,Specific phobias,Specific phobias
NEW01992,DISEASE,cannabis-dependent group,cannabis-dependent group
NEW01993,CHEMICAL,cocaine use,cocaine use
D004360,BIOCHEMICAL,"Drug Therapy, Computer-Assisted","Protocol Drug Therapy, Computer-Assisted|Drug Therapy, Computer Assisted|Therapy, Computer Assisted Drug|Computer Assisted Drug Therapy|Therapies, Computer-Assisted Drug|Therapy, Computer-Assisted Drug|Protocol Drug Therapy, Computer Assisted|Drug Therapies, Computer-Assisted|drug therapy|Computer-Assisted Drug Therapies|Computer-Assisted Drug Therapy"
NEW01994,CHEMICAL,Supplemental oxygen,Supplemental oxygen
NEW01995,MENTAL_HEALTH,specific mental disorders,specific mental disorders
NEW01997,MENTAL_HEALTH,anxiety problems,anxiety problems
D000342,MENTAL_HEALTH,Affective Symptoms,"Symptom, Affective|Symptoms, Affective|Affective Symptom|Disturbances, Emotional|Alexithymias|Disturbance, Emotional|Emotional Disturbance|alexithymia|Emotional Disturbances|Alexithymia"
D019973,CHEMICAL,Alcohol-Related Disorders,"Alcohol Related Disorders|alcohol problem|Alcohol Problems|Alcohol-Related Disorder|Disorder, Alcohol-Related|Alcohol Problem"
NEW01998,DISEASE,Attention-Deficit/Hyperkinetic Disorder,Attention-Deficit/Hyperkinetic Disorder
NEW01999,BIOCHEMICAL,hormone melatonin,hormone melatonin
D008903,DISEASE,Minerals,minerals|Mineral
D019287,CHEMICAL,Zinc Sulfate,"Zinc sulfate|Sulfate, Zinc|Zinc Sulfate, Heptahydrate|Zincteral"
NEW02001,MENTAL_HEALTH,ADHD therapy,ADHD therapy
NEW02003,CHEMICAL,zinc supplementation,zinc supplementation
NEW01182,MENTAL_HEALTH,ADHD children,ADHD children
NEW02004,MENTAL_HEALTH,ADHD treatment,ADHD treatment
NEW02005,CHEMICAL,Benzodiazepine dependence,Benzodiazepine dependence
NEW02006,CHEMICAL,Diazepam overdosage,Diazepam overdosage
D055963,CHEMICAL,"Asthma, Aspirin-Induced","NSAID-induced Asthmas|Aspirin-Induced Asthmas|Induced Asthma, Aspirin|Asthma Syndrome, Aspirin-Induced|Asthma Syndromes, Aspirin-Induced|Asthmas, Aspirin-Induced|Asthma, NSAID-induced|Asthmas, Aspirin Induced|Syndromes, Aspirin-Induced Asthma|aspirin|Syndrome, Aspirin-Induced Asthma|Aspirin Induced Asthmas|Asthma, Aspirin Induced|Asthmas, NSAID-induced|Aspirin-Induced Asthma|Aspirin-Induced Asthma Syndromes|Aspirin Induced Asthma Syndrome|Aspirin-Induced Asthma Syndrome|Asthma, NSAID induced|Aspirin Induced Asthma|Induced Asthmas, Aspirin|NSAID-induced Asthma"
NEW02010,MENTAL_HEALTH,character disorder,character disorder
NEW02011,DISEASE,European Cardiac Arrhythmia Society,ECAS|European Cardiac Arrhythmia Society
NEW02016,CHEMICAL,Inhaled loxapine,Inhaled loxapine
NEW02018,DISEASE,earlier sexual abuse,earlier sexual abuse
D063868,DISEASE,Patient Outcome Assessment,"Patient-Centered Outcomes Research|outcome|Research, Patient-Centered Outcomes|Outcome Assessment, Patient|Outcomes Assessments, Patient|Assessments, Patient Outcome|Patient Outcome Assessments|Assessment, Patient Outcomes|Outcome Assessments, Patient|polysubstance abuse|Assessment, Patient Outcome|Patient Outcomes Assessment|Patient Centered Outcomes Research"
NEW02019,MENTAL_HEALTH,pathological craving,pathological craving
NEW02021,CHEMICAL,cannabis preparations,cannabis preparations
NEW02023,CHEMICAL,cannabis indicators,cannabis indicators
D001010,MENTAL_HEALTH,"Anxiety, Separation","anxiety disorder|Separation Anxiety Disorder|Anxiety Disorder, Separation|Separation Anxiety"
NEW02025,CHEMICAL,Caine criteria,Caine criteria
NEW02028,MENTAL_HEALTH,Multiple regression,Multiple regression
NEW02031,DISEASE,sexual offenders,sexual offenders
NEW02032,CHEMICAL,smoked cocaine users,smoked cocaine users
C532690,CHEMICAL,"piracetam, vinpocetine drug combination [Supplementary Concept]",Drug Combinations|Vinca Alkaloids|Vinpocetine|Piracetam
NEW02034,BIOCHEMICAL,semisynthetic drug,semisynthetic drug
NEW02035,CHEMICAL,Excessive alcohol intake,Excessive alcohol intake
NEW02037,DISEASE,Hypersexuality,Hypersexuality
NEW02044,CHEMICAL,alcohol cues,alcohol cues
NEW02045,DISEASE,implicit attentional bias,implicit attentional bias
NEW02046,MENTAL_HEALTH,Univariable regression models,Univariable regression models
NEW02048,CHEMICAL,Sedative antidepressants,Sedative antidepressants
D014196,CHEMICAL,Trazodone,trazodone|Ratio-Trazodone|Molipaxin|Desyrel|Ratio Trazodone|Novo Trazodone|RatioTrazodone|Trazodone Hydrochloride|Gen Trazodone|AF 1161|PMS-Trazodone|Trazodon Neuraxpharm|Nu Trazodone|Deprax|PMS Trazodone|Gen-Trazodone|Apo-Trazodone|Apo Trazodone|AF-1161|Thombran|Novo-Trazodone|Trittico|Trazodon Hexal|Tradozone|TrazodonNeuraxpharm|Trazodon-Neuraxpharm|Trazon|Nu-Trazodone|AF1161
NEW02050,CHEMICAL,one LEP haplotype,one LEP haplotype|AB2H8
NEW02053,CHEMICAL,Chronic alcohol intake,Chronic alcohol intake
D059607,DISEASE,"Polydipsia, Psychogenic","Polydipsia, Primary|polydipsia|Psychogenic Polydipsias|Psychogenic Polydipsia|Polydipsias, Primary|Primary Polydipsias|Primary Polydipsia|Polydipsias, Psychogenic"
NEW02056,CHEMICAL,Antidepressant treatments,Antidepressant treatments
NEW02058,DISEASE,Antimanic treatments,Antimanic treatments
NEW02060,DISEASE,manic states,manic states
NEW02062,CHEMICAL,smoking intake,smoking intake
NEW02064,DISEASE,DSM-III sexual dysfunctions,DSM-III sexual dysfunctions
NEW02065,CHEMICAL,random forest-trees analysis,random forest-trees analysis
NEW02067,DISEASE,MDD patients,MDD patients
NEW02069,CHEMICAL,Co-use,Co-use
NEW02070,DISEASE,Alcohol Use Disorder Interview Schedule,Alcohol Use Disorder Interview Schedule
NEW02071,DISEASE,fifth edition,DSM-5|fifth edition
NEW02072,MENTAL_HEALTH,suicide attempts,suicide attempts
D016728,DISEASE,Self-Injurious Behavior,"Harm, Self|Self-Injurious Behaviors|Non Suicidal Self Injury|Behavior, Self-Destructive|Nonsuicidal Self Injury|Self Injury, Non-Suicidal|Deliberate Self-Harm|Non-Suicidal Self Injury|Non-Suicidal Self Injuries|Self Destructive Behavior|Self-Harm, Deliberate|Intentional Self Harm|Self-Destructive Behaviors|Self Harm, Intentional|Nonsuicidal Self Injuries|Intentional Self Injury|Self-Destructive Behavior|Self Injury, Nonsuicidal|Deliberate Self Harm|Self Harm|Intentional Self Injuries|Self Injurious Behavior|Self-Injury|self-harm|Behavior, Self-Injurious|Self Injury|Self Injury, Intentional"
NEW02074,MENTAL_HEALTH,psychosis determinants,psychosis determinants
NEW02077,CHEMICAL,lifetime cocaine use,lifetime cocaine use
NEW00521,DISEASE,psychotic symptoms,psychotic symptoms
C431546,CHEMICAL,hydroxybutyryl ethanolamide [Supplementary Concept],Gamma hydroxybutyric acid|gamma-Aminobutyric Acid/analogs  and  derivatives
D002385,MENTAL_HEALTH,Cataplexy,"Tonelessness Syndromes|Syndrome, Henneberg|Syndromes, Tonelessness|Tonelessness Syndrome|Syndrome, Tonelessness|Attacks, Cataleptic|Henneberg Syndrome|cataplexy|Status Cataplexicus|Attack, Cataleptic|Cataleptic Attacks|Cataleptic Attack"
NEW02079,CHEMICAL,diclofenac NSAIDs,diclofenac NSAIDs
D062787,BIOCHEMICAL,Drug Overdose,"drug overdose|Overdose, Drug|Drug Overdoses|Overdoses, Drug"
NEW02083,CHEMICAL,maternal alcohol consumption,maternal alcohol consumption
NEW02086,CHEMICAL,noradrenergic antidepressants,noradrenergic antidepressants
D003891,CHEMICAL,Desipramine,"Demethylimipramine|Pertrofran|Nu-Desipramine|Novo-Desipramine|Novo Desipramine|Ratio Desipramine|Pertofran|PMS Desipramine|Apo Desipramine|Norpramin|Ratio-Desipramine|PMS-Desipramine|Apo-Desipramine|Nu Desipramine|Hydrochloride, Desipramine|Pertofrane|Desipramine Hydrochloride|Desmethylimipramine|desipramine|Petylyl"
D017374,CHEMICAL,Paroxetine,"Paroxetine Hydrochloride Anhydrous|Aropax|Paroxetine Acetate|FG 7051|paroxetine|Paroxetine Hydrochloride, Hemihydrate|Paroxetine, trans-(+)-Isomer|Paxil|Paroxetine Hydrochloride|FG-7051|Paroxetine, cis-(-)-Isomer|Paroxetine, cis-(+)-Isomer|Seroxat|BRL-29060|BRL 29060|Paroxetine Maleate|Paroxetine Hydrochloride Hemihydrate|BRL29060|FG7051"
D063726,MENTAL_HEALTH,Delusional Parasitosis,"Parasitosis, Ekbom Delusional|Dermatozoic Delusions|Parasitoses, Ekbom Delusory|Parasitoses, Ekbom Delusional|Delusional Parasitoses|Ekbom Psychogenic Parasitosis|Parasitosis, Delusional|Parasitosis, Ekbom Delusory|Dermatozoic Delusions, Ekbom|Delusion, Dermatozoic|Delusory Parasitoses|Parasitoses, Delusory|Delusional Parasitosis, Ekbom|Delusions, Dermatozoic|Delusory Parasitoses, Ekbom|Delusions, Ekbom Dermatozoic|delusion|Parasitoses, Delusional|Ekbom Dermatozoic Delusions|Parasitosis, Delusory|Ekbom Delusory Parasitoses|Ekbom Delusional Parasitoses|Parasitosis, Ekbom Psychogenic|Parasitoses, Psychogenic|Ekbom Delusory Parasitosis|Ekbom Psychogenic Parasitoses|Dermatozoic Delusion, Ekbom|Psychogenic Parasitoses, Ekbom|Delusory Parasitosis, Ekbom|Psychogenic Parasitosis, Ekbom|Psychogenic Parasitosis|Dermatozoic Delusion|Ekbom Dermatozoic Delusion|Delusory Parasitosis|Delusional Parasitoses, Ekbom|Parasitosis, Psychogenic|Parasitoses, Ekbom Psychogenic|Psychogenic Parasitoses|Delusion, Ekbom Dermatozoic|Ekbom Delusional Parasitosis"
NEW02089,MENTAL_HEALTH,group manic-depressive psychosis,group manic-depressive psychosis
NEW02090,BIOCHEMICAL,toxin exposure,toxin exposure
D000987,MENTAL_HEALTH,Antisocial Personality Disorder,"Psychopathic Personalities|psychopathic personality|Antisocial Personality Disorders|Behaviors, Dyssocial|Personality Disorder, Antisocial|Personality, Psychopathic|Sociopathic Personality|Personality, Sociopathic|Sociopathic Personalities|Personalities, Antisocial|Behavior, Dyssocial|Antisocial Personality|Behavior, Antisocial|Dyssocial Behavior|Behaviors, Antisocial|Personality Disorders, Antisocial|Antisocial Behaviors|Personalities, Sociopathic|Disorders, Antisocial Personality|Psychopathic Personality|Personalities, Psychopathic|Antisocial Personalities|Dyssocial Behaviors|Disorder, Antisocial Personality|Antisocial Behavior|Personality, Antisocial"
NEW02093,CHEMICAL,problematic alcohol consumption,problematic alcohol consumption
NEW02094,CHEMICAL,psychopathy-focused Psychopathy Measure,psychopathy-focused Psychopathy Measure
NEW02098,CHEMICAL,Post-cocaine,Post-cocaine
NEW02100,CHEMICAL,Antidepressant pharmacotherapy,Antidepressant pharmacotherapy
D011239,CHEMICAL,Prednisolone,Predonine|Di Adreson F|DiAdresonF|Di-Adreson-F|Predate|prednisolone
D054319,CHEMICAL,Marchiafava-Bignami Disease,Marchiafava-Bignami Syndrome|MBD|Marchiafava-Bignami disease|Marchiafava Bignami Syndrome|Marchiafava Bignami Disease
NEW02104,DISEASE,disordered eating,disordered eating
NEW02105,MENTAL_HEALTH,adolescent anxiety,adolescent anxiety
NEW02107,DISEASE,Externalizing disorders,Externalizing disorders
NEW00156,DISEASE,attention-deficit/hyperactivity disorder,attention-deficit/hyperactivity disorder
D015035,CHEMICAL,Zinc Oxide-Eugenol Cement,"eugenol|Caryosan|Zinc Oxide Eugenol Cement|Cement, Zinc Oxide-Eugenol|Oxide-Eugenol Cement, Zinc"
C046412,CHEMICAL,benzyl acetate [Supplementary Concept],Benzyl acetate|Benzyl Compounds
NEW02109,CHEMICAL,heavy alcohol intake,heavy alcohol intake
NEW02110,DISEASE,Systemic diseases,Systemic diseases
D054144,DISEASE,"Heart Failure, Diastolic","heart failure|Diastolic Heart Failure|Heart Failure, Preserved Ejection Fraction|Heart Failure, Normal Ejection Fraction|Diastolic Heart Failures"
D057565,DISEASE,Apathy,Motivation (1966-2010)|Emotions (1966-2010)|Apathy
D010259,MENTAL_HEALTH,Paranoid Disorders,"Psychoses, Paranoid|Paranoias|Paranoia|Disorder, Paranoid|Paranoid Psychoses|Paranoid Disorder|paranoia|Disorders, Paranoid"
D001960,CHEMICAL,Bromazepam,"Bromazep Von Ct|Bromazepam Beta|Bromazepam-Ratiopharm|BromaLich|Gen Bromazepam|Lexotan|Von Ct, Bromazep|Lexomil|Bromazepam Heumann|Bromazepam-Neuraxpharm|Gen-Bromazepam|Apo-Bromazepam|Apo Bromazepam|Lexatin|Beta, Bromazepam|Bromazepam Ratiopharm|Ro 53350|Lexotanil|Bromazanil|Bromazepam|Durazanil|Bromazepam AL|Anxyrex|Bromazepam Neuraxpharm|Ro 5-3350|Bromaz 1A Pharma"
D010262,MENTAL_HEALTH,Paraphilic Disorders,"Sex Deviation|Paraphilia|Deviations, Sex|Disorders, Paraphilic|Sex Deviations|Disorder, Paraphilic|Paraphilic Disorder|Deviation, Sex|Paraphilias"
D052250,CHEMICAL,Nitric Oxide Synthase Type III,"Nitric Oxide Synthase, Type III|NO|Endothelial Nitric Oxide Synthase|ENOS Enzyme|ECNOS Enzyme|Endothelial Constitutive Nitric Oxide Synthase|nitric oxide"
D044062,CHEMICAL,Prostaglandins I,Prostaglandin I|Prostacyclins|prostaglandins
D000081025,CHEMICAL,Sphingosine-1-Phosphate Receptors,"Sphingosine 1 Phosphate Receptor|Sphingosine 1 Phosphate Receptor 3|AGR16 Protein|Sphingosine 1 Phosphate Receptor 2|H218 Protein|Sphingosine 1 Phosphate Receptors|S1P1 Receptor|Sphingosine-1-Phosphate Receptor 1|Sphingosine-1-Phosphate Receptor 4|Nrg 1 Receptor|Receptor, Sphingosine-1-Phosphate|Sphingosine-1-Phosphate Receptor 3|Sphingosine 1 Phosphate Receptor 5|G-Protein Coupled Receptor H218|Edg Receptors|Edg-5 Receptor|S1P|S1P4 Receptor|Sphingosine 1 Phosphate Receptor 1|Sphingosine-1-Phosphate Receptor 2|G Protein Coupled Receptor H218|S1P2 Receptor|Edg 5 Receptor|Sphingosine-1-Phosphate Receptor|S1P3 Receptor|EDG5 Protein|S1P5 Receptor|Sphingosine 1 Phosphate Receptor 4|Sphingosine 1-Phosphate Receptor|Sphingosine 1-phosphate|Nrg-1 Receptor|Sphingosine-1-Phosphate Receptor 5|S1P Receptor"
NEW02113,CHEMICAL,gamma-Hydroxybutyrate sodium oxybate,gamma-Hydroxybutyrate sodium oxybate
C037481,CHEMICAL,4-butyrolactone receptor [Supplementary Concept],"Receptors, GABA-A|gamma-butyrolactone"
NEW02115,DISEASE,Psychiatric problems,Psychiatric problems
NEW02118,CHEMICAL,Smoking cessation treatment,Smoking cessation treatment
NEW02120,CHEMICAL,Nicotine administration,Nicotine administration
NEW02122,DISEASE,schizophrenic families,schizophrenic families
NEW02123,CHEMICAL,caffeine users,caffeine users
NEW02125,DISEASE,Cannabis use disorder,CUD|Cannabis use disorder
NEW02129,CHEMICAL,passive tobacco smoke exposure,passive tobacco smoke exposure
D019256,CHEMICAL,Cadmium Chloride,"Chloride, Cadmium|CdCl2|Cadmium Dichloride|Dichloride, Cadmium|cadmium"
D056128,DISEASE,"Obesity, Abdominal","Central Obesity|Abdominal Obesities|Obesities, Central|Obesity, Visceral|Obesities, Visceral|Visceral Obesity|Visceral Obesities|Central Obesities|visceral obesity|Abdominal Obesity|Obesities, Abdominal|Obesity, Central"
C068282,CHEMICAL,"N-(2-O-(2-acetamido-1,2,3,5-tetradeoxy-1,5-iminoglucitol-3-yl)lactoyl)alanyl-isoglutamine [Supplementary Concept]",N(2)O|Acetylmuramyl-Alanyl-Isoglutamine/analogs  and  derivatives
NEW02134,CHEMICAL,d nicotine metabolite ratio,d nicotine metabolite ratio
NEW02136,DISEASE,Schedule DSM-5 Version,Schedule DSM-5 Version
NEW02138,DISEASE,Disorder Associated Disabilities,Disorder Associated Disabilities
NEW02139,CHEMICAL,Alcohol Use Disabilities Interview,Alcohol Use Disabilities Interview
D000067559,MENTAL_HEALTH,Specific Learning Disorder,"Learning Disorder, Specific|Specific Learning Disorders|Learning Disorders, Specific|specific learning disorders|Disorder, Specific Learning"
NEW02140,BIOCHEMICAL,environmental toxins,environmental toxins
NEW02141,MENTAL_HEALTH,anxiety behavior,anxiety behavior
NEW02142,CHEMICAL,opioid substitution treatment programmes,OSP|opioid substitution treatment programmes
D066229,DISEASE,Speech Sound Disorder,"Phonological Disorders|disorder|Disorder, Phonological|Disorders, Speech Sound|Disorder, Speech Sound|Phonological Disorder|Speech Sound Disorders|Disorders, Phonological"
NEW02143,DISEASE,cannabinoid hyperemesis,cannabinoid hyperemesis
NEW02144,DISEASE,Gastrointestinal complications,Gastrointestinal complications
NEW02147,CHEMICAL,cannabis use,cannabis use
NEW02149,DISEASE,allergic diseases,allergic diseases
NEW02150,MENTAL_HEALTH,ADHD symptoms,ADHD symptoms
NEW02152,MENTAL_HEALTH,probable ADHD,probable ADHD
D016642,CHEMICAL,Bupropion,"Zyntabac|Bupropion|Amfebutamone|Bupropion, (+-)-Isomer|Quomen|(+-)-1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone|Zyban (Anti-Smoking)|Zyban (Bupropion)|Bupropion Hydrochloride|Bupropion Hydrochloride, (+-)-Isomer|Wellbutrin"
C567288,DISEASE,Specific Language Impairment 4 [Supplementary Concept],Language Development Disorders|SLI|Specific Language Impairment
NEW02155,CHEMICAL,Smoking prevalence,Smoking prevalence
NEW02157,MENTAL_HEALTH,serious mental illness,serious mental illness
D016540,CHEMICAL,Smoking Cessation,"Smokings, Giving Up|Cessation, Smoking|Giving Up Smoking|Smoking Cessations|Smoking, Stopping|smoking|Up Smoking, Giving|Stopping Smoking|Smoking, Quitting|Quitting Smoking|Smoking, Giving Up"
NEW02158,CHEMICAL,smoking status,smoking status
D014029,CHEMICAL,Tobacco Use Disorder,"Tobacco Dependence|Nicotine Dependence|Dependence, Nicotine|Nicotine Use Disorder|Nicotine Addiction|Dependence, Tobacco|Tobacco-Use Disorder|Tobacco Use Disorders|Disorder, Tobacco-Use|Nicotine Addictions|Nicotine Use Disorders|Addiction, Nicotine|Disorder, Tobacco Use|Disorder, Nicotine Use|nicotine use"
D017831,DISEASE,"Diagnosis, Dual (Psychiatry)","Dual Diagnoses, Psychiatric|Diagnosis, Psychiatric Dual|psychiatric diagnosis|Dual Diagnoses|Dual Psychiatric Diagnoses|Psychiatric Diagnosis, Dual|Diagnosis, Dual|Dual Diagnoses (Psychiatry)|Diagnoses, Psychiatric Dual|Diagnoses, Dual (Psychiatry)|Dual Diagnosis|Psychiatric Dual Diagnoses|Diagnoses, Dual Psychiatric|Dual Diagnosis, Psychiatric|Dual Psychiatric Diagnosis|Dual Diagnosis (Psychiatry)|Psychiatric Dual Diagnosis|Diagnoses, Dual|Diagnosis, Dual Psychiatric|Psychiatric Diagnoses, Dual"
C506324,CHEMICAL,"2R-(n-butyl)-16-methyl-3S,5S,7S,9R,11R,13R,15S,26S, 27R-nonahydroxyoctacosa-16,18,20,22,24-pentaenoic acid, 27-lactone [Supplementary Concept]",Macrolides|TPU
NEW02164,CHEMICAL,cannabis rich,cannabis rich
D056829,DISEASE,Hereditary Angioedema Types I and II,"Angioedema, Hereditary, Types I and II|Angioedema, Hereditary, Type II|Deficiency of C1 Esterase Inhibitor|Hereditary Angioedema Type 1|Angioedema|Angioedema, Hereditary, Type I|Hereditary Angioedema Type I|C1 Esterase Inhibitor, Deficiency Of|Hereditary Angioedema Type II"
NEW02165,DISEASE,increased smoking behavior,increased smoking behavior
D000073869,CHEMICAL,Tobacco Smoking,"tobacco smoking|Smoking, Tobacco"
NEW02168,CHEMICAL,aberrant dopamine signaling,aberrant dopamine signaling
NEW02169,CHEMICAL,dopamine system function,dopamine system function
NEW02170,BIOCHEMICAL,major female sex hormone 17β-estradiol,major female sex hormone 17β-estradiol
D005283,CHEMICAL,Fentanyl,Fentanest|fentanyl|Fentora|Phentanyl|Fentanyl Citrate|R4263|Sublimaze|Duragesic|R 4263|R-4263|Durogesic|Transmucosal Oral Fentanyl Citrate
NEW02171,DISEASE,AAS abuse,AAS abuse
NEW02172,CHEMICAL,Mu-opioids morphine,Mu-opioids morphine
C572396,CHEMICAL,morphine-6-O-sulfate [Supplementary Concept],Morphine Derivatives|morphine-6-O-sulfate
NEW02173,CHEMICAL,Ketamine treatments,Ketamine treatments
NEW02175,BIOCHEMICAL,narcotic use,narcotic use
NEW02178,DISEASE,Pain sensitivity,Pain sensitivity
D000073222,MENTAL_HEALTH,Patient Health Questionnaire,GAD-2|Patient Health Questionnaire 9|Two-Item Generalised Anxiety Disorder Scale|PHQ-2|Patient Health Questionnaire 2|generalized anxiety disorder|PHQ Patient Health Questionnaire|Generalized Anxiety Disorder Scale|GAD-7|PHQ-ADS|Primary Care Evaluation of Mental Disorders|PRIME-MD|PHQ-9|Patient Health Questionnaire Anxiety and Depression Scale
NEW02181,MENTAL_HEALTH,Anxiety ratings,Anxiety ratings
D010302,DISEASE,"Parkinson Disease, Secondary","Symptomatic Parkinsonism|Parkinson Disease, Symptomatic|Parkinsonism, Secondary|Secondary Parkinson Disease|Symptomatic Parkinson Disease|Secondary Parkinsonism|Parkinsonism, Symptomatic|Parkinsonism, Atherosclerotic|Secondary Vascular Parkinson Disease|Parkinson Disease, Secondary Vascular|Atherosclerotic Parkinsonism|Parkinson disease"
NEW02183,DISEASE,cell toxicity,cell toxicity
NEW02185,CHEMICAL,Sodium dimethyldithiocarbamate,Sodium dimethyldithiocarbamate
D015039,CHEMICAL,Ziram,"ziram|Cuman L|Zinc Dimethyldithiocarbamate|Dimethyldithiocarbamate, Zinc|Milbam|Zerlate|Fuklasin"
NEW02190,CHEMICAL,pesticide neurotoxicity,pesticide neurotoxicity
C012864,CHEMICAL,dazomet [Supplementary Concept],Thiadiazines|dazomet
C008435,CHEMICAL,methyldithiocarbamate [Supplementary Concept],Metam|Thiocarbamates
NEW02194,MENTAL_HEALTH,known acute poisoning syndromes,known acute poisoning syndromes
D000071248,BIOCHEMICAL,Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha,Peroxisome Proliferator Activated Receptor Gamma Coactivator 1 alpha|PPARGC 1 alpha Protein|PPARGC1a Protein|PGC 1 alpha Protein|PPAR gamma|PPARGC-1-alpha Protein|PGC-1-alpha Protein|peroxisome proliferator-activated receptor gamma
NEW02196,BIOCHEMICAL,receptor-γ agonists,receptor-γ agonists
NEW02197,DISEASE,Memory impairment,Memory impairment
NEW02198,BIOCHEMICAL,PPAR-γ antagonist BADGE,PPAR-γ antagonist BADGE
NEW02200,BIOCHEMICAL,PPAR gamma agonists,PPAR gamma agonists
NEW02202,DISEASE,clozapine-treated patients,clozapine-treated patients
D007003,DISEASE,Hypoglycemia,"hypoglycemia|Fasting Hypoglycemia|Hypoglycemia, Postabsorptive|Postabsorptive Hypoglycemia|Postprandial Hypoglycemia|Hypoglycemia, Fasting|Hypoglycemia, Reactive|Hypoglycemia, Postprandial|Reactive Hypoglycemia"
C035100,CHEMICAL,nilvadipine [Supplementary Concept],Nifedipine/analogs  and  derivatives|Nilvadipine
D000077333,CHEMICAL,Telmisartan,"Micardis|BIBR 277|Pritor|BIBR-277|4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|telmisartan"
D016898,CHEMICAL,Interferon-alpha,"Lymphoblast Interferon|Interferon, Lymphoblastoid|Interferon alpha 7|Interferon alpha 88|Interferon alpha5|alpha-Interferon|Interferon alpha|Interferon alpha 17|Interferon, Leukocyte|Interferon alpha-J|Interferon alpha 1|Lymphoblastoid Interferon|Interferon alpha-T|Interferon alpha T|IFN alpha D|Interferon alpha-17|Leif D|LeIF I|IFN-alpha|IFN-alpha5|Interferon, Lymphoblast|Interferon Alfa|Interferon alpha-5|Interferon alpha-4|Interferon alpha J|Interferon alpha-1|IFN-alpha D|Interferon alpha4|Leukocyte Interferon|Interferon alpha-88|LeIF J|Interferon alpha 5|IFN alpha5|Interferon, alpha|Interferon alpha-7|Interferon alpha 4|alpha Interferon|Interferon-alpha"
NEW02205,CHEMICAL,oral erinaceus supplementation,oral erinaceus supplementation
NEW02206,CHEMICAL,erinaceus supplementation,erinaceus supplementation
C000679167,NUTRITION,Hericium erinaceus [Supplementary Concept],Hericium erinaceus|Hericium
C000607528,CHEMICAL,amycenone [Supplementary Concept],amycenone|Plant Extracts
NEW02209,CHEMICAL,H. erinaceus,H. erinaceus
NEW02210,CHEMICAL,MGS0274 besylate,MGS0274 besylate
D005600,MENTAL_HEALTH,Fragile X Syndrome,"Martin Bell Syndrome|Mar (X) Syndrome|Martin-Bell Syndrome|Syndrome, Marker X|Syndromes, FRAXE|Marker X Syndromes|Syndrome, Martin-Bell|Mental Retardation, X-Linked, Associated With Marxq28|Syndromes, FRAXA|Syndromes, Marker X|Syndrome, Fragile X|Fragile X Mental Retardation Syndrome|X Linked Mental Retardation and Macroorchidism|FRAXE Syndromes|Fra(X) Syndrome|FRAXA Syndromes|Marker X Syndrome|X-Linked Mental Retardation and Macroorchidism|fragile X syndrome|Syndrome, FRAXE|Fragile X Syndromes|Fragile X-F Mental Retardation Syndrome|FRAXE Syndrome|Mental Retardation, X-Linked, Associated With Fragile Site Fraxe|Syndrome, FRAXA|FRAXA Syndrome|Syndromes, Fragile X"
D019072,BIOCHEMICAL,Antibiotic Prophylaxis,"Premedication, Antibiotic|Antibiotic Premedication|antibiotic|Prophylaxis, Antibiotic|Antibiotic Premedications|Premedications, Antibiotic"
NEW02213,CHEMICAL,d-cycloserine,d-cycloserine
D018492,CHEMICAL,Dopamine Antagonists,"Dopamine Antagonist|Dopamine Blocker|Dopaminergic Antagonist|Antagonists, Dopamine|Blockers, Dopamine|Dopamine Receptor Antagonists|Antagonists, Dopaminergic|Blocker, Dopamine|Receptor Antagonists, Dopamine|Antagonist, Dopamine Receptor|Antagonists, Dopamine Receptor|Dopamine blockers|Receptor Antagonist, Dopamine|Dopamine Receptor Antagonist|Antagonist, Dopaminergic|Dopaminergic Antagonists|Dopamine Blockers|Antagonist, Dopamine"
NEW02215,MENTAL_HEALTH,pediatric anxiety disorders,pediatric anxiety disorders
NEW02216,CHEMICAL,selective serotonin norepinephrine reuptake inhibitors,SSNRIs|selective serotonin norepinephrine reuptake inhibitors
NEW02218,MENTAL_HEALTH,comorbid generalized anxiety disorder,comorbid generalized anxiety disorder
D000639,CHEMICAL,Amitriptyline,"Sarotex|Desitin, Amitriptylin|Endep|RPh, Amitriptylin|Laroxyl|Anapsique|Saroten|Apo-Amitriptyline|Triptafen|Amineurin|Amitrip|Amitriptyline hydrochloride|Domical|Syneudon|Amitriptylin Neuraxpharm|Amitriptylin Beta|Novoprotect|Amitriptylin RPh|Lentizol|Tryptizol|Elavil|Amitriptylin Desitin|Tryptanol|Amitriptylin-Neuraxpharm|Tryptine|Amitrol|Damilen|Apo Amitriptyline|Amitriptyline Hydrochloride"
D013629,CHEMICAL,Tamoxifen,"ICI 47699|Zitazonium|ICI 46474|tamoxifen|ICI-47699|Novaldex|ICI47699|Citrate, Tamoxifen|Tomaxithen|ICI46474|ICI-46,474|ICI46,474|Soltamox|ICI 46,474|Nolvadex|Tamoxifen Citrate|ICI-46474"
NEW02229,CHEMICAL,FEWP,FEWP
NEW00438,BIOCHEMICAL,mood stabilizers,mood stabilizers
D011285,CHEMICAL,Pregnenolone Carbonitrile,"PCN|Carbonitrile, Pregnenolone|Pregnenolone Carbonitrile, (3 beta)-Isomer|16 alpha-Carbonitrile, Pregnenolone|Pregnenolone 16 alpha-Carbonitrile|pregnenolone|Pregnenolone 16 alpha Carbonitrile|Pregnenolone Carbonitrile, (3 beta,16 beta)-Isomer"
NEW02230,CHEMICAL,lamotrogine,lamotrogine
NEW02232,DISEASE,Schizotypal disorders,Schizotypal disorders
NEW02234,BIOCHEMICAL,luteinizing hormone-releasing hormone agonists,luteinizing hormone-releasing hormone agonists
D048148,CHEMICAL,Casein Kinase Idelta,Casein Kinase I delta|Protein Kinase CK1delta|Casein Kinase 1 delta|CK1δ
NEW02237,BIOCHEMICAL,Middle-aged carriers,Middle-aged carriers
NEW02239,CHEMICAL,dopamine dysregulation syndrome,dopamine dysregulation syndrome
NEW02241,DISEASE,infarct rat brain regions,infarct rat brain regions
NEW02243,CHEMICAL,NO signaling pathway,NO signaling pathway
D000068677,CHEMICAL,Sildenafil Citrate,"UK 92480-10|Desmethylsildenafil|Acetildenafil|1-((3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate|NCX 911|Lactate, Sildenafil|UK-92,480-10|UK 9248010|Sildenafil|NCX911|Sildenafil Lactate|Revatio|Hydroxyhomosildenafil|UK 92,480 10|Nitrate, Sildenafil|UK 92480 10|Viagra|sildenafil|Sildenafil Nitrate|Homosildenafil|NCX-911|Citrate, Sildenafil|Desmethyl Sildenafil|Sildenafil, Desmethyl"
D000068581,CHEMICAL,Tadalafil,"IC-351|Cialis|IC351|tadalafil|IC 351|Pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione, 6-(1,3- benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R,12aR)-"
NEW02246,CHEMICAL,nitric oxide-system,nitric oxide-system
NEW00600,DISEASE,vascular occlusion disturbances,stroke|vascular occlusion disturbances
NEW02254,DISEASE,alleviated vascular occlusion disturbances,alleviated vascular occlusion disturbances
NEW02255,CHEMICAL,eplerenone treatment,eplerenone treatment
D000077545,CHEMICAL,Eplerenone,"9,11-Epoxy-7-(methoxycarbonyl)-3-oxo-17-pregn-4-ene-21,17-carbolactone|Eplerenon|Inspra|Eplerenone"
D013148,CHEMICAL,Spironolactone,"Ct, Spiro Von|Aldactone A|Espironolactona Mundogen|Duraspiron|Spirolang|Spirolactone|Espironolactona Alter|Novo Spiroton|Spirogamma|NovoSpiroton|SC 9420|Spiro Von Ct|Aquareduct|Spiractin|Spiro L.U.T.|spironolactone|Novo-Spiroton|Spirono Isis|Spirono-Isis|Jenaspiron|Practon|Aldactone|Spironone|Spirobeta|Flumach|SC-9420|Veroshpiron|Frumikal|Verospiron|SC9420|Von Ct, Spiro|Verospirone|Spirospare"
NEW02259,DISEASE,hypertension control,hypertension control
NEW02260,CHEMICAL,diuretic-based pharmacotherapy,diuretic-based pharmacotherapy
C102018,NUTRITION,fatty-acid amide hydrolase [Supplementary Concept],fatty acid amide hydrolase|Amidohydrolases
NEW02261,CHEMICAL,carbon dioxide CO2 inhalation,carbon dioxide CO2 inhalation
C529311,CHEMICAL,CTAP octapeptide [Supplementary Concept],Somatostatin|TCA|Peptide Fragments
NEW02263,MENTAL_HEALTH,chronic anxiety state,chronic anxiety state
NEW02264,CHEMICAL,to monoamine oxidase inhibitor,MAOI|to monoamine oxidase inhibitor
NEW02265,MENTAL_HEALTH,disorder receptor theory,disorder receptor theory
NEW02266,BIOCHEMICAL,action drug information,action drug information
NEW02267,NUTRITION,lithium intoxication,lithium intoxication
D011618,MENTAL_HEALTH,Psychotic Disorders,"Reactive Psychoses, Brief|Reactive Psychosis, Brief|Disorder, Schizophreniform|Schizoaffective Disorder|Schizophreniform Disorders|Disorder, Psychotic|schizoaffective disorder|Disorders, Schizophreniform|Schizoaffective Disorders|Psychosis, Brief Reactive|Psychosis|Psychotic Disorder|Disorders, Schizoaffective|Disorders, Psychotic|Schizophreniform Disorder|Brief Reactive Psychoses|Psychoses|Psychoses, Brief Reactive|Disorder, Schizoaffective|Brief Reactive Psychosis"
NEW02271,CHEMICAL,Second generation antipsychotics,Second generation antipsychotics|SGAs
D051958,CHEMICAL,Nuclear Receptor Coactivator 2,Glucocorticoid Receptor Interacting Protein 1|glucocorticoid receptor|Steroid Receptor Coactivator-2|Steroid Receptor Coactivator 2|Glucocorticoid Receptor-Interacting Protein 1|GR|Transcription Intermediary Factor 2|Steroid Receptor Coactivator SRC2
NEW02272,DISEASE,gastroesophageal reflux disease symptoms,gastroesophageal reflux disease symptoms
C058967,CHEMICAL,genipin 1-gentiobioside [Supplementary Concept],genipin|Iridoids
NEW02274,BIOCHEMICAL,HIV antigen,HIV antigen
D000077582,CHEMICAL,Amisulpride,Barnetil|N-(Ethyl-1-pyrrolidinyl- 2-methyl)methoxy-2-ethylsulfonyl-5-benzamide|LIN 1418|DAN-2163|Solian|Sultopride|LIN-1418|DAN 2163|Sultopride Hydrochloride|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide
NEW02276,CHEMICAL,ethanol extraction process,ethanol extraction process
NEW02279,CHEMICAL,divalproex ER,divalproex ER
NEW02280,CHEMICAL,peak ammonia levels,peak ammonia levels
NEW02283,CHEMICAL,Ammonia metabolism,Ammonia metabolism
NEW02284,CHEMICAL,acquired urea cycle dysfunction,acquired urea cycle dysfunction
C011941,CHEMICAL,nabilone [Supplementary Concept],Nabilone|Dronabinol/analogs  and  derivatives
NEW02288,BIOCHEMICAL,long-acting beta-adrenergic blocker,long-acting beta-adrenergic blocker
D015784,CHEMICAL,Betaxolol,"SL 75212|ALO140102|SL-75212|ALO 1401 02|Kerlon|SL75212|Betaxolol Hydrochloride|ALO-1401-02|Alcon, Betaxolol|Betoptima|Betoptic|Betaxolol Alcon|Hydrochloride, Betaxolol|Betaxolol|Kerlone|Oxodal"
D005715,MENTAL_HEALTH,Gambling,"Gamblings|Pathological gambling|Pathological Gambling|Gambling, Pathologic|Gambling, Pathological|Gamblings, Pathological|Pathological Gamblings"
NEW02293,CHEMICAL,n-3 polyunsaturated fatty acids,n-3 polyunsaturated fatty acids|n-3 PUFAs
NEW02294,CHEMICAL,Second-line choices,Second-line choices
D000077260,MENTAL_HEALTH,Sleepiness,Somnolence|Sleepiness
NEW02298,CHEMICAL,COVID-19 patients,COVID-19 patients
D008315,CHEMICAL,Malondialdehyde,"Malonaldehyde|Malondialdehyde, Sodium|Propanedial|Malonylaldehyde|malondialdehyde|Malonyldialdehyde|Sodium Malondialdehyde"
NEW02300,MENTAL_HEALTH,#NAME?,#NAME?
NEW02304,CHEMICAL,serotoninergic antidepressants,serotoninergic antidepressants
D064420,BIOCHEMICAL,Drug-Related Side Effects and Adverse Reactions,"Adverse Drug Event|Side Effects of Drugs|Drug Toxicities|Drug Events, Adverse|Drug Toxicity|Reactions, Adverse Drug|Drug Event, Adverse|Drug Side Effect|Drug-Related Side Effects and Adverse Reaction|Toxicity, Drug|Adverse Drug Reaction|Drug Reactions, Adverse|Toxicities, Drug|Adverse Drug Events|Effects, Drug Side|Side Effect, Drug|drug toxicity|Drug Reaction, Adverse|Drug Related Side Effects and Adverse Reactions|Side Effects, Drug|Adverse Drug Reactions|Drug Related Side Effects and Adverse Reaction|Drug Side Effects"
D005907,CHEMICAL,Gliclazide,Gen Gliclazide|Diaikron|Gen-Gliclazide|Diabrezide|S852|S-852|Diamicron|Glyclazide|Glyade|Gliklazid|Novo-Gliclazide|S 852|S1702|Novo Gliclazide|Diaglyk|S-1702|gliclazide|S 1702
NEW02306,DISEASE,hypoglycaemic seizures,hypoglycaemic seizures
NEW02307,BIOCHEMICAL,human antimicrobial peptide,human antimicrobial peptide
D059545,MENTAL_HEALTH,"Paraneoplastic Syndromes, Ocular","Paraneoplastic Disease, Ocular|Ocular Paraneoplastic Syndrome|Cancer-Associated Retinopathies|Disease, Ocular Paraneoplastic|Paraneoplastic Melanocytic Proliferations|Diseases, Ocular Paraneoplastic|Ocular Paraneoplastic Diseases|Bilateral Diffuse Uveal Melanocytic Proliferation, Paraneoplastic|Melanoma Associated Retinopathy|Ocular Paraneoplastic Syndromes|Retinopathies, Cancer-Associated|Ocular Paraneoplastic Disease|Cancer Associated Retinopathy|Paraneoplastic Syndrome, Ocular|syndromes|Cancer-Associated Retinopathy|Paraneoplastic Melanocytic Proliferation|Retinopathy, Cancer-Associated|Melanoma-Associated Retinopathies|Retinopathies, Melanoma-Associated|Syndrome, Ocular Paraneoplastic|Melanoma-Associated Retinopathy|Paraneoplastic Diseases, Ocular|Retinopathy, Melanoma-Associated|Melanocytic Proliferation, Paraneoplastic|Melanocytic Proliferations, Paraneoplastic|Syndromes, Ocular Paraneoplastic"
NEW02310,DISEASE,related hearing loss,related hearing loss
NEW02311,MENTAL_HEALTH,drug-related psychosis,drug-related psychosis
NEW00606,MENTAL_HEALTH,major depression,major depression
D055954,DISEASE,Corneal Endothelial Cell Loss,"Corneal Endothelial Cell Damage|Endothelial Cell Loss, Corneal|loss"
NEW01061,MENTAL_HEALTH,drug-induced psychosis,drug-induced psychosis
NEW02313,MENTAL_HEALTH,narcolepsy Human Leukocyte Antigen HLA risk allele,narcolepsy Human Leukocyte Antigen HLA risk allele
NEW01241,DISEASE,extrapyramidal adverse effects,extrapyramidal adverse effects
NEW02318,CHEMICAL,inhibitory transmitter GABA,inhibitory transmitter GABA
NEW02320,DISEASE,Repetitive behaviors,Repetitive behaviors
NEW02321,CHEMICAL,selective serotonin-receptive inhibitor fluvoxamine,selective serotonin-receptive inhibitor fluvoxamine
NEW02322,DISEASE,repetitive behaviors,repetitive behaviors
NEW02324,CHEMICAL,Low-dose liquid fluoxetine,Low-dose liquid fluoxetine
NEW02325,MENTAL_HEALTH,CY-BOCS compulsion scale,CY-BOCS compulsion scale
NEW02328,DISEASE,REM sleep abnormalities,REM sleep abnormalities
NEW02330,MENTAL_HEALTH,melancholic depression,melancholic depression
NEW02331,CHEMICAL,LC n-3 PUFAs,LC n-3 PUFAs
NEW02333,CHEMICAL,LC n-6,LC n-6
NEW02336,DISEASE,Psychotic symptoms,Psychotic symptoms
NEW02338,DISEASE,hereditary catalepsy,hereditary catalepsy
NEW02339,DISEASE,learning deficit,learning deficit
D003637,CHEMICAL,DEAE-Dextran,"Pulsar|DEAE Dextran|DEAE Sephadex|Sephadex, DEAE|Diethylaminoethyldextran|DEAE-Dextran"
NEW02342,DISEASE,dose day oral toxicity,dose day oral toxicity
D000505,DISEASE,Alopecia,"Alopecia, Male Pattern|Alopecia, Androgenic|Androgenic Alopecias|Baldness|Baldness, Male Pattern|Pseudopelade|Hair Loss|Baldness, Pattern|Loss, Hair|Alopecia Cicatrisatas|Pattern Baldness|Baldness, Female Pattern|Hair Losses|Male Pattern Baldness|Androgenic Alopecia|Alopecias, Androgenic|Losses, Hair|Androgenetic Alopecia|Alopecia Cicatrisata|hair loss|Male Pattern Alopecia|Alopecia, Androgenetic|Female Pattern Baldness"
NEW02345,BIOCHEMICAL,sexual hormones,sexual hormones
C005419,CHEMICAL,oxybutynin [Supplementary Concept],Mandelic Acids|oxybutynin
NEW02347,DISEASE,Etiopathogenic hypothesis,Etiopathogenic hypothesis
NEW02351,CHEMICAL,NMDAR-enhancing agents,NMDAR-enhancing agents
NEW02352,BIOCHEMICAL,drug free/ drug naïve patients,drug free/ drug naïve patients
NEW02353,BIOCHEMICAL,mGluR₂/₃ antagonists,mGluR₂/₃ antagonists
D016666,CHEMICAL,Fluvoxamine,"PMS-Fluvoxamine|DU23000|Fluvoxamina Geminis|Desiflu|ratio-Fluvoxamine|Floxyfral|DU-23000|Faverin|Dumirox|Fluvoxamin neuraxpharm|Fevarin|Novo-Fluvoxamine|Fluvoxamin beta|Fluvoxamine Maleate|Novo Fluvoxamine|Fluvoxamine Maleate, (E)-Isomer|PMS Fluvoxamine|Fluvoxamin-ratiopharm|Fluvoxamin AL|Fluvoxamine|Geminis, Fluvoxamina|Nu Fluvoxamine|DU 23000|Fluvoxamin-neuraxpharm|Fluvoxamin Stada|ratio Fluvoxamine|Nu-Fluvoxamine|Fluvoxadura|Fluvoxamine, (Z)-Isomer|Fluvoxamin ratiopharm|Luvox"
NEW00276,DISEASE,type diabetes mellitus,type diabetes mellitus
D065627,DISEASE,Familial Primary Pulmonary Hypertension,"Idiopathic Pulmonary Arterial Hypertension|Hypertension, Primary Pulmonary|Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia|Pulmonary Hypertension, Primary, Fenfluramine-Associated|Heritable Pulmonary Arterial Hypertension|Primary Pulmonary Hypertension|Idiopathic Pulmonary Hypertension|Hypertension, Idiopathic Pulmonary|Pph1 With Hht|hypertension|Pulmonary Hypertension, Idiopathic|Pulmonary Hypertension, Primary, Dexfenfluramine-Associated|Pulmonary Hypertension, Primary, 1|Pulmonary Hypertension, Primary"
NEW02356,DISEASE,nonsuppressed BPE,nonsuppressed BPE
NEW02357,DISEASE,BPE suppression,BPE suppression
D052656,NUTRITION,Ictalurivirus,"Channel Catfish Viruses|Channel Catfish Virus|Ictalurid herpesvirus 1|Ictaluriviruses|Virus, Channel Catfish|Viruses, Channel Catfish|Catfish"
D000904,BIOCHEMICAL,"Antibiotics, Antitubercular",antibiotics|Antitubercular Antibiotics
D063647,CHEMICAL,Fetal Alcohol Spectrum Disorders,"FAEs (Fetal Alcohol Effects)|Growth Retardation, Facial Abnormalities, and Central Nervous System Dysfunction|Fetal Alcohol Spectrum Disorder|FAE (Fetal Alcohol Effects)|Fetal alcohol syndrome|Fetal Alcohol Syndrome|Alcohol Related Birth Defects|FAS|Partial Fetal Alcohol Syndrome|Birth Defects, Alcohol-Related|Alcohol Related Neurodevelopmental Disorder|FASDs|Alcohol-Related Birth Defects|Syndrome, Fetal Alcohol|FASD"
NEW02362,CHEMICAL,bilirubin plasma concentrations,bilirubin plasma concentrations
D051556,DISEASE,"Hyperbilirubinemia, Neonatal","Neonatal Indirect Hyperbilirubinemia|Neonatal Direct Hyperbilirubinemia|Hyperbilirubinemia, Neonatal Direct|During Infancies, Hyperbilirubinemia|Neonatal Hyperbilirubinemia|Infancy, Hyperbilirubinemia During|Hyperbilirubinemia, Neonatal Indirect|Indirect Hyperbilirubinemia, Neonatal|Direct Hyperbilirubinemia, Neonatal|Hyperbilirubinemia During Infancy|hyperbilirubinemia"
NEW02363,MENTAL_HEALTH,schizophrenic psychosis,schizophrenic psychosis
NEW00228,DISEASE,cognitive deficits,cognitive deficits
NEW02364,CHEMICAL,chronic estradiol,chronic estradiol
C508230,CHEMICAL,soy isoflavone aglycone [Supplementary Concept],Isoflavones|beta-Glucans|soy isoflavone
D019833,CHEMICAL,Genistein,Genestein|genistein
NEW02369,CHEMICAL,phytoestrogen genistein,phytoestrogen genistein|GEN
D007006,DISEASE,Hypogonadism,"Hypogonadism, Hypergonadotropic|hypogonadism|Hypogonadism, Hypogonadotropic|Hypergonadotropic Hypogonadism|Hypogonadotropic Hypogonadism|Hypogonadism, Isolated Hypogonadotropic"
NEW02373,CHEMICAL,Excessive salt intake,Excessive salt intake
NEW02376,CHEMICAL,Estradiol treatment,Estradiol treatment
NEW02379,BIOCHEMICAL,peripheral sex hormones,peripheral sex hormones
NEW02380,CHEMICAL,Serotonin 1A receptors,Serotonin 1A receptors
D005070,CHEMICAL,Evans Blue,"C.I. Direct Blue 53|Evans blue|C.I. 23860|Evan Blue|EB|Blue, Azovan|Blue, Evan's|Azovan Blue|Evan's Blue|Blue, Evans"
NEW02382,CHEMICAL,Decreased serotonin function,Decreased serotonin function
C504569,NUTRITION,"tph2 protein, rat [Supplementary Concept]",tryptophan hydroxylase-2|Tryptophan Hydroxylase
NEW02384,BIOCHEMICAL,potent circulating estrogen,potent circulating estrogen
NEW02385,CHEMICAL,oral hormonal contraceptives,oral hormonal contraceptives
NEW02389,BIOCHEMICAL,new agents,new agents
NEW02391,CHEMICAL,low IGF1,low IGF1
NEW02392,DISEASE,brain masculinization due,brain masculinization due
NEW02396,CHEMICAL,HSD17B3 genes,HSD17B3 genes
D045165,CHEMICAL,Testosterone Congeners,"Analogues, Androgen|Steroid, Anabolic|Androgen, Synthetic|Androgen Analogues|Synthetic Androgen|Anabolic Steroid|Steroids, Anabolic|Analogs, Androgen|Synthetic Androgens|Testosterone|Androgens, Synthetic|Anabolic Steroids|Androgen Analogs"
D000735,CHEMICAL,Androstenedione,"4 Androstene 3,17 dione|4-Androstene-3,17-dione|delta 4 Androstenedione|Androstenedione|delta-4-Androstenedione"
NEW02399,BIOCHEMICAL,androgen excess markers,androgen excess markers
NEW02400,BIOCHEMICAL,conventional hormone therapy,conventional hormone therapy
NEW02401,BIOCHEMICAL,exogenous androgen,exogenous androgen
NEW02402,CHEMICAL,prolactin/oxytocin,prolactin/oxytocin
NEW02404,BIOCHEMICAL,estrogen receptor ESR1 gene,estrogen receptor ESR1 gene
NEW02405,CHEMICAL,eight-SNP haplotype,eight-SNP haplotype
NEW02406,BIOCHEMICAL,hormone medication,hormone medication
NEW02407,BIOCHEMICAL,endocrine anomalies,endocrine anomalies
NEW02410,DISEASE,isolated hypogonadotropic hypogonadism,isolated hypogonadotropic hypogonadism
D004966,BIOCHEMICAL,"Estrogens, Conjugated (USP)","Presomen|Progen|Equine Estrogen, Conjugated|Conjugated Estrogenic Hormones|Dagynil|Estro-Feminal|Premarin|Estro Feminal|Oestro-Feminal|Transannon|Conjugated Equine Estrogens|hormones estrogens|Estrogens, Conjugated|Femavit|Estrogen, Conjugated|Conjugated Equine Estrogen|Estrogenic Substances, Conjugated|Progens|Estrogen, Conjugated Equine|Oestro Feminal|Carentil|Oestrofeminal|Conjugated Estrogenic Substances|Congest|Climarest|Prelestrin|Conjugated Estrogens|Conjugated Estrogen|Equine Estrogens, Conjugated|Climopax|Estrogenic Hormones, Conjugated"
NEW02413,DISEASE,female affective behaviors,female affective behaviors
NEW02415,MENTAL_HEALTH,female depression,female depression
D059445,MENTAL_HEALTH,Anhedonia,"Social Anhedonia|Anhedonia, Physical|Physical Anhedonia|Physical Anhedonias|Social Anhedonias|Anhedonias|Anhedonias, Physical|Anhedonias, Social|Anhedonia, Social|anhedonia"
NEW02417,CHEMICAL,anti-inflammatory agent minocycline,anti-inflammatory agent minocycline
D015673,DISEASE,"Fatigue Syndrome, Chronic","Royal Free Disease|Chronic Fatigue Disorder|Chronic Fatigue Fibromyalgia Syndrome|Fatigue Disorder, Chronic|Chronic Fatigue Syndromes|Fatigue-Fibromyalgia Syndromes, Chronic|Fatigue Disorders, Chronic|Infectious Mononucleosis Like Syndrome, Chronic|Postviral Fatigue Syndrome|Encephalomyelitis, Myalgic|immune dysfunction|Chronic Fatigue and Immune Dysfunction Syndrome|Postviral Fatigue Syndromes|Chronic Fatigue Syndrome|Fatigue-Fibromyalgia Syndrome, Chronic|Chronic Fatigue-Fibromyalgia Syndrome|Chronic Fatigue-Fibromyalgia Syndromes|Systemic Exertion Intolerance Disease|Fatigue Syndromes, Chronic|Fatigue Syndrome, Postviral|Infectious Mononucleosis-Like Syndrome, Chronic|Chronic Fatigue Disorders|Myalgic Encephalomyelitis|Fatigue Syndromes, Postviral"
NEW02419,CHEMICAL,long-acting risperidone,long-acting risperidone
NEW02420,CHEMICAL,long-acting injectable risperidone,long-acting injectable risperidone
NEW02421,CHEMICAL,Hair cortisol measurement,Hair cortisol measurement
NEW02422,CHEMICAL,hair cortisol,hair cortisol
NEW02424,CHEMICAL,Alcohol biomarkers,Alcohol biomarkers
NEW02425,CHEMICAL,Chronic alcohol consumption,Chronic alcohol consumption
D014552,DISEASE,Urinary Tract Infections,"Tract Infections, Urinary|Infections, Urinary Tract|Urinary Tract Infection|urinary tract infection|Tract Infection, Urinary|Infection, Urinary Tract"
D056807,DISEASE,Argininosuccinic Aciduria,"Argininosuccinate Acidemias|Acidemias, Argininosuccinate|Deficiencies, Arginino Succinase|Aciduria, Argininosuccinic|Argininosuccinicaciduria|Argininosuccinic Acidurias|Argininosuccinicacidurias|Arginino Succinase Deficiencies|Deficiency, ASL|Deficiencies, Argininosuccinate Lyase|ASA Deficiency|Argininosuccinic Acidemia|Asauria|Inborn Error of Urea Synthesis, Arginino Succinic Type|Deficiency, Argininosuccinate Lyase|Acidemia, Argininosuccinate|Argininosuccinic aciduria|Argininosuccinate Lyase Deficiencies|Argininosuccinate Lyase Deficiency|Arginino Succinase Deficiency|Argininosuccinic Acid Lyase Deficiency|Deficiencies, ASA|Arginosuccinase Deficiency|ASA Deficiencies|Deficiencies, ASL|ASL Deficiencies|ASL Deficiency|Deficiency, ASA|Argininosuccinate Acidemia|Argininosuccinyl-Coa Lyase Deficiency|Urea Cycle Disorder, Arginino Succinase Type|Deficiency, Arginino Succinase|Acidurias, Argininosuccinic|Argininosuccinase Deficiency"
NEW02429,CHEMICAL,marble burying test,marble burying test|MBT
D061906,DISEASE,Advanced Trauma Life Support Care,Advanced Trauma Life Support|trauma
D000066511,CHEMICAL,Intimate Partner Violence,"Intimate Partner Abuse|Partner Abuse, Intimate|Abuse, Intimate Partner|IPV|Intimate partner violence|Partner Violence, Intimate|Dating Violence|Violence, Intimate Partner|Violence, Dating"
C476644,DISEASE,"mutacin III, Streptococcus mutans [Supplementary Concept]",S. mutans|Bacteriocins
NEW02431,BIOCHEMICAL,carbapenem antibiotic,carbapenem antibiotic
NEW02434,CHEMICAL,Doripenem monohydrate,Doripenem monohydrate
NEW02435,NUTRITION,Melissa officinalis L.,Melissa officinalis L.
NEW02437,BIOCHEMICAL,Antimicrobial drugs,Antimicrobial drugs
D005892,DISEASE,"Gingivitis, Necrotizing Ulcerative","Stomatitis, Ulcerative|Acute Necrotizing Ulcerative Gingivitis|Vincent's Gingivitis|Vincent's Stomatitis|Fusospirillary Gingivitis|NUG|Acute Membranous Gingivitis|Vincent Infection|Fusospirillosis|Trench Mouth|Ulcerative Gingivitis|Vincent's Infection|Vincent Angina|Phagedenic Gingivitis"
D050483,CHEMICAL,Dopamine Plasma Membrane Transport Proteins,"Neurotransmitter Transporters, Dopamine-Specific|Solute Carrier Family 6 (Neurotransmitter Transporter), Member 3 Protein|Transporter, Dopamine|Carriers, Dopamine|Transporter, DAT Dopamine|Dopamine Carriers|Transporters, Dopamine-Specific Neurotransmitter|Neurotransmitter Transporters, Dopamine Specific|SLC6A3 Protein|Dopamine Transporter, DAT|Dopamine-Specific Neurotransmitter Transporters|Protein, SLC6A3|Dopamine Plasma Membrane Transporter Proteins|dopamine transporter|Dopamine Transporter|Neurotransmitter Transport Proteins, Dopamine-Specific|Transporter Proteins, Dopamine|Dopamine Transporter Proteins|DAT Dopamine Transporter Proteins|Neurotransmitter Transport Proteins, Dopamine Specific|DAT Dopamine Transporter|Dopamine Uptake Complex"
NEW02442,CHEMICAL,low brain glutathione,low brain glutathione
NEW02443,BIOCHEMICAL,ascorbic acid levels,ascorbic acid levels
NEW02444,CHEMICAL,R)-sulfoximine,R)-sulfoximine|BSO
D018765,CHEMICAL,Dopamine Uptake Inhibitors,"Inhibitors, Dopamine Uptake|dopamine uptake|Reuptake Inhibitors, Dopamine|Dopamine Reuptake Inhibitors|Uptake Inhibitors, Dopamine|Inhibitors, Dopamine Reuptake"
NEW02446,CHEMICAL,brain glutathione synthesis,brain glutathione synthesis
NEW02447,CHEMICAL,low glutathione levels,low glutathione levels
NEW02450,CHEMICAL,FUB181,FUB181
NEW02452,CHEMICAL,GT2016,GT2016
NEW02453,BIOCHEMICAL,inverse histamine H3 receptor agonist pitolisant,inverse histamine H3 receptor agonist pitolisant
NEW02454,CHEMICAL,α2-adrenoceptor antagonist mirtazapine,α2-adrenoceptor antagonist mirtazapine
NEW02455,DISEASE,constipating,constipating
NEW02457,CHEMICAL,antihypertensive drug clonidine,antihypertensive drug clonidine
NEW02335,CHEMICAL,serotonin system,serotonin system
NEW02459,BIOCHEMICAL,Non-competitive N-methyl-d-aspartate receptor antagonists,Non-competitive N-methyl-d-aspartate receptor antagonists
NEW02461,CHEMICAL,Fra-2 immunoreactivity,Fra-2-IR|Fra-2 immunoreactivity
D020643,DISEASE,Anterior Thalamic Nuclei,"Nucleus, Anteroventral Thalamic|Nuclei, Anterior Thalamic|Anterior Thalamic Nucleus|Anterior Nuclear Group|ATN|Anterior Nucleus of Thalamus|Thalamus, Anterior|Anterodorsal Nucleus|Nucleus, Anterodorsal Thalamic|Anterior Thalamus|Nucleus, Anterodorsal|Anteroventral Nucleus|Anterodorsal Thalamic Nucleus|Anteroventral Thalamic Nucleus|Thalamus Anterior Nucleus|Nucleus, Anteromedial|Thalamic Nucleus, Anteroventral|Nucleus, Anteroventral|Anteromedial Nucleus|Thalamic Nucleus, Anteromedial|Anteromedial Thalamic Nucleus|Thalamic Nuclei, Anterior|anterior thalamic nuclei|Nucleus, Anteromedial Thalamic|Thalamic Nucleus, Anterodorsal"
C567439,DISEASE,Chromosome 15q13.3 Microdeletion Syndrome [Supplementary Concept],"Chromosome Disorders|Chromosome Deletion|Chromosomes, Human, Pair 15|Intellectual Disability|15q13.3 microdeletion syndrome|Seizures"
D001927,DISEASE,Brain Diseases,"Central Nervous System Disorders, Intracranial|Encephalon Diseases|Encephalopathy|CNS Disorder, Intracranial|Central nervous system disorders|Intracranial CNS Disorder|Brain Disorder|Intracranial Central Nervous System Disorders|Intracranial CNS Disorders|Encephalopathies|Central Nervous System Intracranial Disorders|Brain Disease|CNS Disorders, Intracranial|Brain Disorders|Encephalon Disease"
NEW02465,CHEMICAL,serotonergic systems ATPase activity,serotonergic systems ATPase activity
C499076,CHEMICAL,"ATP1A1 protein, human [Supplementary Concept]",Sodium-Potassium-Exchanging ATPase|K+ ATPase
D055495,DISEASE,Neurogenesis,neurogenesis|Neurogeneses
C000589472,CHEMICAL,gardenin A [Supplementary Concept],Gardenin A|GA|Flavones
NEW02468,CHEMICAL,intravenous anesthetic propofol,intravenous anesthetic propofol
D032341,CHEMICAL,Withania,"somniferas, Withania|Withania somniferas|Withanias|Withania somnifera"
NEW02471,CHEMICAL,PS episodes,PS episodes
D010852,CHEMICAL,Picrotoxin,picrotoxin|GABA Antagonists|Antidotes|Convulsants|Central Nervous System Stimulants
NEW02472,BIOCHEMICAL,GABAA receptor antagonist,GABAA receptor antagonist
NEW02475,BIOCHEMICAL,GABAA receptor antagonists,GABAA receptor antagonists
NEW02476,CHEMICAL,morphine-clonidine,morphine-clonidine
D058666,CHEMICAL,Adrenergic beta-2 Receptor Agonists,"Adrenergic beta-2 Agonists|Agonists, Adrenergic beta-2|Adrenergic beta-2 Receptor Agonist|Adrenergic beta2-Agonists|β2-agonists|beta2-Agonists, Adrenergic|Adrenergic beta 2 Receptor Agonist|Adrenergic beta 2 Agonists|beta-2 Agonists, Adrenergic|Adrenergic beta 2 Receptor Agonists|Adrenergic beta2 Agonists"
D003000,CHEMICAL,Clonidine,"Clonidine|Monohydrochloride, Clonidine|Dixarit|Clopheline|Hemiton|ST 155|Gemiton|Hydrochloride, Clonidine|Clonidine Hydrochloride|Catapresan|Isoglaucon|Clonidine Monohydrochloride|Monohydrobromide, Clonidine|Clofelin|Klofenil|M 5041T|Chlophazolin|Catapres|Clofenil|Clonidine Dihydrochloride|Klofelin|ST155|ST-155|Catapressan|M-5041T|Dihydrochloride, Clonidine|Clonidine Monohydrobromide|M5041T"
D016316,CHEMICAL,Guanfacine,"Lon798|BS 100 141|Guanfacine Hydrochloride|Monohydrochloride, Guanfacine|Hydrochloride, Guanfacine|Estulic|Guanfacine Monohydrochloride|Tenex|BS100141|Guanfacine|BS-100-141"
NEW02478,BIOCHEMICAL,alpha-2 agonist,alpha-2 agonist
NEW02480,BIOCHEMICAL,alpha-2A agonists,alpha-2A agonists
NEW02482,DISEASE,traumatic stress symptoms,traumatic stress symptoms
NEW02485,CHEMICAL,serotonergic 5-HT system,serotonergic 5-HT system
C071321,CHEMICAL,flerobuterol [Supplementary Concept],Albuterol/analogs  and  derivatives|flerobuterol
D004415,DISEASE,Dyspepsia,Indigestions|Indigestion|Dyspepsias|dyspepsia
NEW02488,CHEMICAL,serotonin/noradrenaline reuptake inhibitors,serotonin/noradrenaline reuptake inhibitors
D010433,CHEMICAL,Pentylenetetrazole,pentylenetetrazol|Metrazole|Pentetrazole|Korazole|Leptazole|Cardiazol|Pentamethylenetetrazole|Corasol|Korazol|Pentylenetetrazol|Corazole|Pentazol|Metrazol|Corazol
NEW02489,BIOCHEMICAL,alpha-2-adrenoceptor agonists,alpha-2-adrenoceptor agonists
NEW02490,BIOCHEMICAL,α₂-adrenoceptor agonists,α₂-adrenoceptor agonists
D058647,NUTRITION,Adrenergic alpha-2 Receptor Agonists,"alpha 2-agonists|Adrenergic alpha2 Agonists|Adrenergic alpha2-Agonists|Adrenergic alpha-2 Receptor Agonist|Adrenergic alpha-2 Agonists|Adrenergic alpha 2 Receptor Agonist|Agonists, Adrenergic alpha-2|Adrenergic alpha 2 Receptor Agonists|alpha2-Agonists, Adrenergic|alpha-2 Agonists, Adrenergic|Adrenergic alpha 2 Agonists"
D036361,BIOCHEMICAL,Peptide Hormones,"Hormone, Polypeptide|Hormones, Peptide|Polypeptide Hormones|Peptide hormones|Hormones, Polypeptide|Polypeptide Hormone|Hormone, Peptide|Peptide Hormone"
NEW02497,CHEMICAL,gas transfer,gas transfer
NEW02498,BIOCHEMICAL,multiple endocrine abnormalities,multiple endocrine abnormalities
NEW02502,BIOCHEMICAL,endocrine abnormalities,endocrine abnormalities
NEW02503,BIOCHEMICAL,endocrine perturbations,endocrine perturbations
NEW02504,DISEASE,Iatrogenic Creutzfeldt-Jakob disease,Iatrogenic Creutzfeldt-Jakob disease
NEW02507,CHEMICAL,Azaperon,Azaperon
NEW02508,DISEASE,Alcoholic encephalopathy,Alcoholic encephalopathy
NEW02509,CHEMICAL,glutamate metabolism,glutamate metabolism
D064799,DISEASE,Hypoxia-Inducible Factor-Proline Dioxygenases,"HIF Prolyl 4 Hydroxylase|Factor-Proline Dioxygenases, Hypoxia-Inducible|Hypoxia Inducible Factor Proline Dioxygenases|Dioxygenases, Hypoxia-Inducible Factor-Proline|Prolyl-4-Hydroxylases, HIF|HIF Prolyl 4 Hydroxylases|Hypoxia-Inducible Factor Prolyl Hydroxylase 2|Hypoxia-Inducible Factor Prolyl Hydroxylase 1|Dioxygenase, Hypoxia-Inducible Factor-Proline|Hypoxia Inducible Factor Prolyl Hydroxylase 2|Egl Nine Homolog 2 Protein|HIF Prolyl-4-Hydroxylases|Egl Nine Homolog 3 Protein|Factor-Proline Dioxygenase, Hypoxia-Inducible|Hypoxia-Inducible Factor-Proline Dioxygenase|Prolyl-4-Hydroxylase, HIF|Hypoxia Inducible Factor Proline Dioxygenase|Egl Nine Homolog 1 Protein|Hypoxia-Inducible Factor Prolyl Hydroxylase 3|Hypoxia Inducible Factor Prolyl Hydroxylase 3|Hypoxia Inducible Factor Prolyl Hydroxylase 1|hypoxia|HIF Prolyl-4-Hydroxylase"
NEW02512,CHEMICAL,ACh release,ACh release
D013832,BIOCHEMICAL,Thiamine Deficiency,"Thiamine Deficiencies|Deficiency, Thiamine|Deficiencies, Thiamine|thiamine deficiency"
NEW02510,CHEMICAL,thiamin deficiency,thiamin deficiency
NEW02514,BIOCHEMICAL,Vitamin abnormalities,Vitamin abnormalities
NEW02515,CHEMICAL,thiamin metabolism,thiamin metabolism
C501104,CHEMICAL,"17-cyclopropylmethyl-3-hydroxy-(5beta,7beta,3',5')-pyrrolidino-2'(S)-phenyl-7alpha-methyl-6,14-endoetheno morphinan [Supplementary Concept]",Bridged-Ring Compounds|BU74|Morphinans
D015819,BIOCHEMICAL,"Substance Abuse, Intravenous","Parenteral Drug Abuse|Intravenous Drug Abuse|intravenous drug abuse|Drug Abuse, Intravenous|Intravenous Substance Abuse|Drug Abuse, Parenteral"
D016183,DISEASE,Murine Acquired Immunodeficiency Syndrome,"AIDS|Murine Acquired Immuno-Deficiency Syndrome|AIDS, Murine|Murine AIDSs|Murine AIDS|Murine Acquired Immune Deficiency Syndrome|Murine Acquired Immuno Deficiency Syndrome|MAIDS|immune deficiency syndrome|AIDSs, Murine"
NEW00051,DISEASE,severe pain,severe pain
NEW02519,DISEASE,cocaine-induced anxiety- behaviors,cocaine-induced anxiety- behaviors
NEW02521,CHEMICAL,selective cholecystokinin B antagonists,selective cholecystokinin B antagonists
C065599,CHEMICAL,PD 134308 [Supplementary Concept],Meglumine/analogs  and  derivatives|CI-988|Indoles
C067110,CHEMICAL,enadoline [Supplementary Concept],Benzofurans|CI-977|Pyrrolidines
NEW02524,BIOCHEMICAL,high efficacy kappa opioid-receptor agonists,high efficacy kappa opioid-receptor agonists
NEW02525,BIOCHEMICAL,DOR agonists,DOR agonists
NEW02526,CHEMICAL,alcohol abstinence state,alcohol abstinence state
NEW02528,DISEASE,ethanol-withdrawal,ethanol-withdrawal
NEW02530,BIOCHEMICAL,GnRH agonist,GnRH agonist
D016729,CHEMICAL,Leuprolide,"Monoacetate, Leuprolide|A 43818|TAP-144|TAP144|Leuprolide, (DL-Leu)-Isomer|A43818|leuprolide|Enantone|Leuprolide Acetate|leuprolide acetate|Leuprolide, (L-Leu)-Isomer|TAP 144|Acetate, Leuprolide|A-43818|Leuprorelin|Leuprolide Monoacetate|Lupron"
NEW02532,CHEMICAL,Clomipramine treatment,Clomipramine treatment
NEW02533,CHEMICAL,deslorelin treatment,deslorelin treatment
NEW02534,BIOCHEMICAL,Gonadotropin-releasing hormone agonists,Gonadotropin-releasing hormone agonists
NEW02535,CHEMICAL,Androgen deprivation therapy,ADT|Androgen deprivation therapy
D050171,DISEASE,Dyslipidemias,Dyslipoproteinemias|Dyslipoproteinemia|Dyslipidemia|dyslipidemia
D006943,DISEASE,Hyperglycemia,"hyperglycemia|Hyperglycemias|Hyperglycemia, Postprandial|Hyperglycemias, Postprandial|Postprandial Hyperglycemias|Postprandial Hyperglycemia"
D007333,MENTAL_HEALTH,Insulin Resistance,"Sensitivity, Insulin|insulin resistance|Resistance, Insulin|Insulin Sensitivity"
NEW02537,DISEASE,clinical osteoporosis identification,clinical osteoporosis identification
NEW02541,DISEASE,Ovarian suppression,Ovarian suppression
NEW02543,DISEASE,Ovarian cyclicity,Ovarian cyclicity
NEW02545,CHEMICAL,free testosterone levels,free testosterone levels
NEW02547,DISEASE,Puberty suppression,Puberty suppression
NEW02548,BIOCHEMICAL,gonadotropin-releasing hormone agonists,gonadotropin-releasing hormone agonists
NEW02549,BIOCHEMICAL,androgen deprivation therapy,androgen deprivation therapy
NEW02550,MENTAL_HEALTH,subsequent dementia risk,subsequent dementia risk
C555622,CHEMICAL,ulipristal acetate [Supplementary Concept],ulipristal acetate|Norpregnadienes
NEW02552,BIOCHEMICAL,Gonadotropin Releasing Hormone (GnRH)-agonist,Gonadotropin Releasing Hormone (GnRH)-agonist
D016564,CHEMICAL,Amyloid beta-Protein Precursor,"amyloid beta-protein|Nexin 2, Protease|Amyloid beta Precursor Protein|Amyloid beta Protein Precursor|Nexin II, Protease|Amyloid A4 Protein Precursor|beta-Protein Precursor, Amyloid|Protease Nexin 2|beta Amyloid Protein Precursor|Protease Nexin II|beta-Amyloid Protein Precursor|Amyloid Protein Precursor"
D044402,CHEMICAL,"Receptor, Serotonin, 5-HT2A","Receptor, Serotonin 2A|Receptors, Serotonin 2A|Serotonin 2A Receptor|Serotonin 2A Receptors|5 HT2A Receptor|5-HT(2A) Receptor|5-HT(2A|5-HT2A Receptor|Receptor, 5-HT2A"
D044263,CHEMICAL,"Receptors, Serotonin, 5-HT1","Receptors, 5-HT1 Serotonin|Receptor, 5-HT1|5-HT1 Receptors|Serotonin, 5-HT1 Receptors|Serotonin, 5 HT1 Receptors|Serotonin 5-HT1 Receptors|serotonin receptors|Serotonin 5-HT1 Receptor|5 HT1 Receptors|Serotonin 5 HT1 Receptors|5 HT1 Receptor|5-HT1 Receptor, Serotonin|Receptor, Serotonin 5-HT1|Serotonin Receptors, 5 HT1|5-HT1 Receptors, Serotonin|5-HT1 Receptor|5-HT1 Receptors Serotonin|Serotonin Receptors, 5-HT1|Receptors, Serotonin 5-HT1|Serotonin 5 HT1 Receptor|Receptors Serotonin, 5-HT1|5-HT1 Serotonin Receptors|Receptors, 5-HT1"
D044405,CHEMICAL,"Receptor, Serotonin, 5-HT2C","Receptor, 5-HT2C|Receptor, 5-Hydroxytryptamine Type 2C|5 Hydroxytryptamine Type 2C Receptors|5 Hydroxytryptamine Type 2C Receptor|Receptor, Serotonin 2C|5-HT2C Receptor|Receptor, 5 Hydroxytryptamine Type 2C|Serotonin 2C Receptor|5-HT(2C) Receptor|5-Hydroxytryptamine Type 2C Receptors|5 HT2C Receptor|5-HT(2C|5-Hydroxytryptamine Type 2C Receptor"
C518685,CHEMICAL,"CP-809,101 [Supplementary Concept]","Piperazines|Pyrazines|CP-809,101"
NEW02557,CHEMICAL,5-HT(2C agonists,5-HT(2C agonists
NEW02558,DISEASE,taste aversions,taste aversions
NEW02560,CHEMICAL,effective antidepressant therapies,effective antidepressant therapies
NEW02562,DISEASE,psychiatric groups,psychiatric groups
C017783,CHEMICAL,"somatostatin, Trp(8)- [Supplementary Concept]",SRIF|Somatostatin/analogs  and  derivatives
NEW02563,BIOCHEMICAL,endocrine variables,endocrine variables
NEW02564,MENTAL_HEALTH,anxiety scores,anxiety scores
D010891,CHEMICAL,Piribedil,"Mono-hydrochloride, Piribedil|EU 4200|ET495|Piribedil Mesylate|EU4200|Piribedil Hydrochloride|ET 495|Trivastal|Piribedil|Mesylate, Piribedil|ET-495|Hydrochloride, Piribedil|Piribendyl|Piribedil Mono-hydrochloride|Piribedil Mono hydrochloride|EU-4200"
D011986,BIOCHEMICAL,"Receptors, Somatotropin","Somatotropin Receptors|Receptor, Growth Hormone|Hormone Receptors, Growth|Hormone Receptor, Growth|Growth Hormone Receptors|Receptors, Somatomammotropin|Receptors, Growth Hormone|Growth Hormone Receptor|Somatomammotropin Receptor|somatotropin|Somatomammotropin Receptors|Somatotropin Receptor"
NEW02568,MENTAL_HEALTH,Epidermal growth factor receptor EGFR tyrosine kinase inhibitor resistance,Epidermal growth factor receptor EGFR tyrosine kinase inhibitor resistance
NEW02571,MENTAL_HEALTH,chronic stress hormones,chronic stress hormones
NEW02573,BIOCHEMICAL,5-HT₃ antagonist studies,5-HT₃ antagonist studies
D018722,BIOCHEMICAL,Nicotinic Agonists,"Agonist, Nicotinic Cholinergic|Nicotinic Cholinergic Agonist|Agonists, Nicotinic Cholinergic|Cholinergic Agonists, Nicotinic|Agonist, Nicotinic|Cholinergic Agonist, Nicotinic|Nicotinic Cholinergic Agonists|Nicotinic Agonist|nicotinic agonists|Agonists, Nicotinic"
NEW02575,CHEMICAL,24-hour urinary beta-phenylethylamine,PEA|24-hour urinary beta-phenylethylamine
NEW02577,BIOCHEMICAL,5-HT(3 receptor antagonists,5-HT(3 receptor antagonists
NEW02578,BIOCHEMICAL,5-HT(1A agonists,5-HT(1A agonists
NEW01825,CHEMICAL,ethanol exposure,ethanol exposure
NEW02580,CHEMICAL,SIGNIFICANCE STATEMENT Ethanol consumption agents,SIGNIFICANCE STATEMENT Ethanol consumption agents
D000090862,DISEASE,Neuroinflammatory Diseases,"Neuroinflammatory Disorder|Neuroinflammation|Disorder, Neuroinflammatory|Disease, Neuroinflammatory|Neuroinflammatory Disease|Neuroinflammations|Neuroinflammatory Disorders"
NEW02583,DISEASE,Cognitive deficits,Cognitive deficits
NEW02585,BIOCHEMICAL,androgen receptor gene,androgen receptor gene
NEW02590,BIOCHEMICAL,Antiandrogen therapy,Antiandrogen therapy
NEW02591,CHEMICAL,Chronic pharmacologic testosterone treatment,Chronic pharmacologic testosterone treatment
NEW02593,CHEMICAL,testosterone levels,testosterone levels
NEW02595,CHEMICAL,pharmacologic testosterone treatment effects,pharmacologic testosterone treatment effects
NEW02600,BIOCHEMICAL,common endocrine disorder,common endocrine disorder
NEW02601,CHEMICAL,vasopresin,vasopresin
NEW02602,CHEMICAL,Prolactine,Prolactine
D012738,CHEMICAL,Sex Hormone-Binding Globulin,"sex-hormone-binding globulin|Sex Steroid-Binding Protein|Steroid-Binding Protein, Sex|Binding Globulin, Testosterone-Estradiol|Testosterone-Estradiol Binding Globulin|Globulin, Sex Hormone-Binding|Sex Hormone Binding Globulin|Testosterone Estradiol Binding Globulin|Globulin, Testosterone-Estradiol Binding|Sex Steroid Binding Protein|Hormone-Binding Globulin, Sex"
NEW02603,BIOCHEMICAL,Androgen deprivation therapy,Androgen deprivation therapy
NEW02605,BIOCHEMICAL,androgen deprivation,androgen deprivation
NEW02607,BIOCHEMICAL,Androgen excess,Androgen excess
NEW02609,BIOCHEMICAL,androgen excess,androgen excess
NEW02610,DISEASE,hyperandrogenic state,hyperandrogenic state
D057466,BIOCHEMICAL,Nonsteroidal Anti-Androgens,"androgens|AntiAndrogens, Nonsteroidal|Nonsteroidal Anti Androgens|Anti-Androgens, Nonsteroidal|Nonsteroidal Antiandrogens"
NEW02612,DISEASE,Depression-like behaviors,Depression-like behaviors
NEW02613,CHEMICAL,5-α reductase deficiency type,5-α reductase deficiency type
D013734,BIOCHEMICAL,Androgen-Insensitivity Syndrome,"Feminization Syndromes, Testicular|Male Pseudohermaphroditism Due to Androgen Insensitivity|Androgen Receptor Deficiency|Receptor Deficiency, Androgen|Deficiency, DHTR|Feminizations, Testicular|complete androgen insensitivity syndrome|Feminization Syndrome, Testicular|Androgen-Insensitivity Syndrome, Complete|Androgen Insensitivity Syndrome, Partial|Androgen Insensitivity Syndrome|Insensitivity Syndrome, Androgen|Androgen Resistance Syndromes|Partial Androgen Insensitivity|Androgen-Insensitivity Syndromes, Complete|Testicular Feminization|Dihydrotestosterone Receptor Deficiencies|Partial Androgen-Insensitivity Syndromes|Insensitivity Syndromes, Androgen|Reifenstein Syndrome|Deficiencies, AR|Deficiency, Dihydrotestosterone Receptor|Partial Androgen Insensitivities|Deficiency, Androgen Receptor|Deficiencies, Androgen Receptor|Androgen Insensitivity Syndromes|Reifensteins Syndrome|Androgen-Insensitivity Syndromes|Androgen Insensitivity, Partial|Insensitivities, Partial Androgen|Androgen Insensitivities, Partial|Testicular Feminizations|Receptor Deficiencies, Androgen|Testicular Feminization Syndromes|Androgen-Insensitivity Syndromes, Partial|Dihydrotestosterone Receptor Deficiency|Androgen Insensitivity Syndrome, Complete|Resistance Syndromes, Androgen|Partial Androgen-Insensitivity Syndrome|Deficiencies, Dihydrotestosterone Receptor|DHTR Deficiencies|Reifenstein's Syndrome|AR Deficiencies|Deficiency, AR|Resistance Syndrome, Androgen|Deficiencies, DHTR|Complete Androgen-Insensitivity Syndromes|Androgen Receptor Deficiencies|Complete Androgen-Insensitivity Syndrome|Testicular Feminization Syndrome|Insensitivity, Partial Androgen|Receptor Deficiencies, Dihydrotestosterone|Feminization, Testicular|AR Deficiency|Androgen Resistance Syndrome|Androgen-Insensitivity Syndrome, Partial|DHTR Deficiency|Receptor Deficiency, Dihydrotestosterone"
NEW02616,BIOCHEMICAL,short-term sex hormone deficiency,short-term sex hormone deficiency
NEW02617,BIOCHEMICAL,Long-term androgen deficiency,Long-term androgen deficiency
NEW02619,BIOCHEMICAL,exogenous sex hormones,exogenous sex hormones
NEW00080,DISEASE,prostate cancer patients,prostate cancer patients
NEW02620,CHEMICAL,Reduced testosterone levels,Reduced testosterone levels
NEW02621,CHEMICAL,high DHEA doses,high DHEA doses
NEW02622,CHEMICAL,DHEA therapy,DHEA therapy
NEW02624,CHEMICAL,CC abnormalities,CC abnormalities
NEW02627,MENTAL_HEALTH,major depressive episode,major depressive episode
NEW02628,BIOCHEMICAL,physiological androgen blood levels,physiological androgen blood levels
NEW02629,BIOCHEMICAL,elevated maternal androgens,elevated maternal androgens
D000079262,DISEASE,"Obesity, Maternal",Maternal Obesity|Obesity in Pregnancy|maternal obesity
NEW02630,DISEASE,psychiatric morbidity,psychiatric morbidity
NEW02632,DISEASE,17β-HSD3 deficiency,17β-HSD3 deficiency
D014770,DISEASE,Virilism,Virilization|Androgenization
NEW02633,MENTAL_HEALTH,purging type,purging type
NEW02638,DISEASE,Maternal polycystic ovary syndrome,Maternal polycystic ovary syndrome
D017588,DISEASE,Hyperandrogenism,Androgens (1966-1993)|hyperandrogenism
NEW02641,CHEMICAL,elevated prenatal testosterone exposure,elevated prenatal testosterone exposure
NEW02642,CHEMICAL,fetal testosterone,fetal testosterone
NEW02643,CHEMICAL,fT levels,fT levels
NEW02645,DISEASE,vibration disease patients,vibration disease patients
NEW02646,MENTAL_HEALTH,personal anxiety,personal anxiety
NEW02647,BIOCHEMICAL,androgen signaling,androgen signaling
NEW00623,DISEASE,aggressive behavior,aggressive behavior
NEW02635,CHEMICAL,5alpha-dihydrotestosterone,5alpha-dihydrotestosterone
NEW02649,CHEMICAL,5alpha-dihydrotestosterone,DHT|5alpha-dihydrotestosterone
D008914,CHEMICAL,Minoxidil,U 10858|Minoxidil|Loniten|Regaine|Rogaine
C041226,CHEMICAL,Terazosin [Supplementary Concept],Prazosin/analogs  and  derivatives|terazosin
D002121,CHEMICAL,Calcium Channel Blockers,"Blockader, Exogenous Calcium|Calcium Channel Blocking Drugs|Calcium Channel Blocking Drug|Antagonists, Calcium Channel|Calcium Inhibitors, Exogenous|Exogenous Calcium Blockaders|calcium channel blockers|Calcium Inhibitor, Exogenous|Calcium Channel Antagonists|Channel Blocker, Calcium|Calcium Antagonists, Exogenous|Exogenous Calcium Antagonists|Antagonists, Exogenous Calcium|Exogenous Calcium Blockader|Exogenous Calcium Inhibitor|Calcium Channel Antagonist|Channel Blockers, Calcium|Calcium Channel Blocker|Calcium Blockader, Exogenous|Blocker, Calcium Channel|Exogenous Calcium Inhibitors|Calcium Blockaders, Exogenous|Inhibitor, Exogenous Calcium|Channel Antagonist, Calcium|Antagonist, Calcium Channel|Blockers, Calcium Channel"
D049971,CHEMICAL,Thiazides,Thiazides|Thiazide
NEW02652,CHEMICAL,described anti-androgen side effects,described anti-androgen side effects
NEW02653,BIOCHEMICAL,hormone influences,hormone influences
NEW02656,BIOCHEMICAL,relative androgen deficiency,relative androgen deficiency
NEW01319,DISEASE,human behaviour,human behaviour
NEW00641,CHEMICAL,sex steroids,sex steroids
NEW02662,CHEMICAL,available oral contraceptives,available oral contraceptives
NEW02663,BIOCHEMICAL,Androgen receptor AR splice variants,Androgen receptor AR splice variants
D007021,DISEASE,Hypospadias,Hypospadia|hypospadias
C537243,DISEASE,"Prostate cancer, familial [Supplementary Concept]",Prostatic Neoplasms|prostate cancer
NEW02667,NUTRITION,Corylus avellana L.,Corylus avellana L.
NEW02668,DISEASE,Neuroleptic-induced acute akathisia,NIA|Neuroleptic-induced acute akathisia
NEW02569,DISEASE,advanced non-small cell lung cancer,advanced non-small cell lung cancer|NSCLC
NEW02671,DISEASE,diabetic diabetic animals,diabetic diabetic animals
NEW02673,DISEASE,traumatic memory,traumatic memory
NEW02674,BIOCHEMICAL,stress hormone effects,stress hormone effects
NEW02675,BIOCHEMICAL,intrathecal AMPA receptor antagonists,intrathecal AMPA receptor antagonists
NEW02677,CHEMICAL,intrathecal perampanel,intrathecal perampanel
C551441,CHEMICAL,perampanel [Supplementary Concept],perampanel|Pyridones|Nitriles
D019782,CHEMICAL,Riluzole,RP 54274|PK26124|riluzole|Rilutek|PK-26124|2-Amino-6-trifluoromethoxybenzothiazole|PK 26124|RP54274|2 Amino 6 trifluoromethoxybenzothiazole|RP-54274
NEW02680,BIOCHEMICAL,non-selective alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid AMPA receptor antagonists,non-selective alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid AMPA receptor antagonists
NEW02682,CHEMICAL,"2,3-benzodiazepine derivatives","2,3-benzodiazepine derivatives"
C119033,CHEMICAL,CFM 2 [Supplementary Concept],Benzodiazepinones|CFM-2
NEW02684,CHEMICAL,"novel 2,3-benzodiazepines","novel 2,3-benzodiazepines"
C110629,CHEMICAL,YM 872 [Supplementary Concept],Quinoxalines|YM872|Imidazoles
D018091,CHEMICAL,"Receptors, AMPA","AMPA Receptors|Receptor, AMPA|AMPA receptors|Receptor, Quisqualate|Quisqualate Receptor|AMPA Receptor|Quisqualate Receptors|Receptors, Quisqualate"
NEW02689,CHEMICAL,AMPA-type glutamate receptors,AMPA-type glutamate receptors
D012920,DISEASE,Social Behavior Disorders,"Disorders, Social Behavior|social behavior|Behavior Disorders, Social"
NEW02691,CHEMICAL,"active antagonist 2,3-dihydroxy-6-nitro-7-sulphamoyl-benzo(F)quinoxaline","active antagonist 2,3-dihydroxy-6-nitro-7-sulphamoyl-benzo(F)quinoxaline|NBQX"
NEW02694,BIOCHEMICAL,AMPA receptor antagonists,AMPA receptor antagonists
NEW02695,BIOCHEMICAL,potent toxin,potent toxin
NEW02697,CHEMICAL,Endogenous glutamate,Endogenous glutamate
NEW02700,CHEMICAL,hypoxia‑inducible factor (HIF)‑1α,hypoxia‑inducible factor (HIF)‑1α
NEW02703,CHEMICAL,suitable ethanol markers,suitable ethanol markers
NEW02705,CHEMICAL,interesting aroma,interesting aroma
C018961,CHEMICAL,hexamidine [Supplementary Concept],Benzamidines|Hexamidine Diisethionate
D012970,CHEMICAL,Sodium Glutamate,"Monosodium Glutamate|monosodium glutamate|MSG|Glutamate, Sodium|Accent|Vestin"
NEW02710,BIOCHEMICAL,neurotoxic agents,neurotoxic agents
D005503,BIOCHEMICAL,Food Additives,"Food Additive|Additive, Food|Additives, Food|food additives"
D015767,CHEMICAL,Mefloquine,"Ro215998001|WR-142,490|Lariam|WR177,602|WR 142,490|WR-177,602|mefloquine|WR142,490|Ro-21-5998-001|Ro 21 5998 001|Mephloquine|WR 177,602|Mefloquine Hydrochloride"
NEW02711,DISEASE,direct toxicity,direct toxicity
D044342,DISEASE,Malnutrition,Undernutrition|Malnourishments|nutritional deficiencies|Nutritional Deficiency|Malnourishment|Nutritional Deficiencies
NEW02712,BIOCHEMICAL,tocopherols supplementation,tocopherols supplementation
D018798,CHEMICAL,"Anemia, Iron-Deficiency","Iron-Deficiency Anemias|Iron Deficiency Anemias|Iron-Deficiency Anemia|Anemias, Iron-Deficiency|Iron Deficiency Anemia|Anemias, Iron Deficiency|Anemia, Iron Deficiency|iron deficiency"
NEW02715,CHEMICAL,Iron deficiency anaemia,Iron deficiency anaemia
D017613,CHEMICAL,Iodine Compounds,"iodine|Compounds, Iodine"
D020739,DISEASE,"Brain Diseases, Metabolic, Inborn","Familial Metabolic Disorders, Brain|Metabolic Disorders, CNS, Inborn|Metabolic Brain Syndrome, Inborn|Inborn Errors of Metabolism, Brain|Inborn Metabolic Disorders, Brain|Brain Syndrome, Metabolic, Inborn|Brain Diseases, Metabolic, Familial|Central Nervous System Inborn Metabolic Diseases|Metabolic Brain Diseases, Familial|Encephalopathies, Metabolic, Inborn|Metabolic Diseases, Inborn, Brain|Metabolic Brain Diseases, Inherited|CNS Metabolic Disorders, Inborn|Inborn Metabolic Brain Diseases|Familial Metabolic Brain Diseases|Metabolic Disorders, Brain, Inherited|Inherited Metabolic Brain Diseases|Brain diseases|Metabolic Brain Diseases, Inborn|Brain Diseases, Metabolic, Inherited|Metabolic Disorders, Familial, Brain|Inherited Metabolic Disorders, Brain|Central Nervous System Inborn Metabolic Disorders|Inborn Metabolic Brain Disorders|Metabolic Diseases, Inborn, Central Nervous System"
D024505,BIOCHEMICAL,Tocopherols,"Lasar|Dermorelle|Mowivit Vitamin E|Vitamin E, Mowivit|EUNOVA Vitamin E|E-ferol|Snow-E Muscle, Energy  and  Feritility|Spondyvit|Eplonat|VitaminE EVIMIRALE|Micorvit E|Bioweyxin|Aquasol E|Vitamine E GNR|Tocopharm|Auxina E|Dal E|Vitamin E, Vitagutt|Vitamin E Dragees|Vitazell|Malton E|E Mulsin|UnoVit|VitaE|E-Vitamin-Ratiopharm|Vitamin E AL|Biopto-E|Tocopherol Bayer|Evion|Vitamin E-mp|E Vicotrat|Tocovital|Vitamin-E EVI-MIRALE|Bio E|Eusovit|Vit E hydrosol|Detulin|Togasan Vitamin E|Ecoro|Richtavit E|Vitamin E EVI MIRALE|Ephynal|Uno-Vit|Vit. E Stada|Vita Plus E|Vitagutt Vitamin E|Vitamin E Suspension|Davitamon|Vitamin E, Togasan|E-Mulsin|Antioxidans E-Hevert|E-Vicotrat|Abortosan|Uno Vit|Vitamin Emp|Hydrovit E|Equivit E|Embial|Tocolion|E Vitamin E|Vita-E|Vita-Plus E|Vitamin E mp|Tocopa|Puncto E|tocopherols|Vita E|VitaPlus E|Sanavitan S|Elex Verla|Vitamin-E Dragees|Dal-E|Vitamin E Natur|Biosan|Unique E|Vitamin E Sanum|Vibolex|Tocopherol"
D063427,BIOCHEMICAL,Food Quality,"Quality, Food|Food Qualities|food|Qualities, Food|tocopherol"
D055985,DISEASE,Latent Tuberculosis,"Tuberculosis|Tuberculosis Infection, Latent|Latent Tuberculoses|Tuberculoses, Latent|Latent Tuberculosis Infections|Latent Tuberculosis Infection|Tuberculosis Infections, Latent|Infection, Latent Tuberculosis|Tuberculosis, Latent|Infections, Latent Tuberculosis"
NEW02723,MENTAL_HEALTH,induced psychosis,induced psychosis
C000590837,CHEMICAL,"lumbricusin peptide, Lumbricus terrestris [Supplementary Concept]",Helminth Proteins|Lumbricusin
NEW02725,CHEMICAL,Lumbricusin Analogue,Lumbricusin Analogue
C000713927,CHEMICAL,ginger extract [Supplementary Concept],Ginger|ginger extract|Plant Extracts
D023181,CHEMICAL,Antimicrobial Cationic Peptides,"Cationic Peptides, Antimicrobial|Microbicidal Cationic Proteins|Peptides, Cationic Antimicrobial|Amphipathic Cationic Antimicrobial Peptides|Antimicrobial Peptides, Cationic|Peptides, Host Defense|Antimicrobial Peptide, Cationic|Host Defense Peptides|Cationic Antimicrobial Peptide|AMP|Proteins, Microbicidal Cationic|Peptide, Cationic Antimicrobial|Defense Peptides, Host|Host Defense Peptide|Peptides, Antimicrobial Cationic|Cationic Antimicrobial Peptides|Peptide, Host Defense|Cationic antimicrobial peptides|Cationic Proteins, Microbicidal|Defense Peptide, Host|Cationic Host Defense Peptides"
NEW02730,CHEMICAL,Nutmegs,Nutmegs
NEW02732,CHEMICAL,proline metabolism,proline metabolism
NEW02734,NUTRITION,Salvia sclarea,clary sage|Salvia sclarea
D000077723,CHEMICAL,Cefepime,Quadrocef|BMY 28142|BMY-28142|Cefepim|Cefepime|Axépim|BMY28142|Maxipime|Cefepime Hydrochloride
NEW02737,CHEMICAL,Repeated cefepime treatment,Repeated cefepime treatment
D015643,CHEMICAL,Erythromycin Ethylsuccinate,"erythromycin|Succinate, Eyrthromycin Ethyl|EMycin E|Erythroped|Eyrthromycin Ethyl Succinate|EryPed|Pediamycin|E-Mycin E|Ethylsuccinate, Erythromycin|Wyamycin E|Ethyl Succinate, Eyrthromycin|Monomycin"
D015662,CHEMICAL,"Trimethoprim, Sulfamethoxazole Drug Combination",Eusaprim|Centrin|Centran|Trimethoprimsulfa|Metomide|Sulprim|Biseptol480|Kepinol Forte|Biseptol 480|Bactifor|Drylin|Sulfamethoxazole-Trimethoprim Combination|Trimedin|Septrin|TMP-SMX|Oriprim|Co-Trimoxazole|Sumetrolim|Sulfamethoxazole Trimethoprim Combination|Trimezole|Eslectin|Biseptol|Trimethoprim-Sulfamethoxazole Combination|Insozalin|Abactrim|Biseptol-480|Trimethoprim Sulfamethoxazole Combination|Kepinol|Trimosulfa|Trimethoprim-Sulfamethoxazole|Trimethoprim Sulfamethoxazole|Co Trimoxazole|Lescot|Septra|Cotrimoxazole|TMP SMX|Bactrim
D008795,CHEMICAL,Metronidazole,Satric|MetroGel|Trivazol|Trichopol|Metrodzhil|Metronidazole Hydrochloride|2-Methyl-5-nitroimidazole-1-ethanol|Metric|Danizol|Vagilen|Flagyl|Trichazol|Metronidazole Phosphoester|2 Methyl 5 nitroimidazole 1 ethanol|Metronidazole Monohydrochloride|metronidazole|Metrogyl|Clont|Bayer 5360|Metronidazole Phosphate|Gineflavir
D002045,CHEMICAL,Bupivacaine,"Bupivacaine Carbonate|Bupivacaina Braun|Carbostesin|Marcaine|Dolanaest|Bupivacaine|Buvacaina|Bupivacain-RPR|Bupivacaine Monohydrochloride, Monohydrate|Marcain|Bupivacaine Anhydrous|Bupivacain Janapharm|1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide|Sensorcaine|Bupivacaine Hydrochloride|Bupivacain RPR|Svedocain Sin Vasoconstr"
D045704,CHEMICAL,Mycoplasma genitalium,Mycoplasma genitalium|Mycoplasma (1981-2003)
NEW02739,DISEASE,particular Chlamydia trachomatis,particular Chlamydia trachomatis
NEW02740,DISEASE,Infections agents,Infections agents
C000629385,BIOCHEMICAL,ceragenins [Supplementary Concept],Steroids|Antimicrobials
NEW02741,BIOCHEMICAL,bactericidal antimicrobials,bactericidal antimicrobials
NEW02742,CHEMICAL,broad-spectrum penicillins,broad-spectrum penicillins
D011472,DISEASE,Prostatitis,"Inflammatory Prostatitis, Asymptomatic|Acute Bacterial Prostatitides|Chronic Bacterial Prostatitis|Prostatitides, Chronic Bacterial|Bacterial Prostatitides, Acute|Asymptomatic Inflammatory Prostatitis|Bacterial Prostatitides, Chronic|Asymptomatic Inflammatory Prostatitides|Chronic Prostatitis with Chronic Pelvic Pain Syndrome|Acute bacterial prostatitis|Acute Bacterial Prostatitis|Prostatitides|Bacterial Prostatitis, Acute|Chronic Bacterial Prostatitides|Bacterial Prostatitis, Chronic"
D000077731,CHEMICAL,Meropenem,Ronem|meropenem|Merrem|Penem|3-(5-Dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid|SM 7338|SM-7338|SM7338
D000077725,CHEMICAL,"Piperacillin, Tazobactam Drug Combination","Piperacillin-Tazobactam Combination Product|Piperacillin Tazobactam|Piperacillin Tazobactam Combination Product|Zosyn|Pipercillin Sodium - Tazobactam Sodium|Pipercillin Sodium Tazobactam Sodium|Tazocel|piperacillin-tazobactam|Pipercillin Sodium, Tazobactam Sodium Drug Combination|Piperacillin - Tazobactam|Tazobactam, Piperacillin -|Tazocin|Tazocillin"
NEW02719,BIOCHEMICAL,antibiotic treatment,antibiotic treatment
D018942,CHEMICAL,Macrolides,Macrolide|macrolides
D013754,CHEMICAL,Tetracyclines,tetracyclines
D000617,CHEMICAL,Aminoglycosides,Aminoglycosides|Aminoglycoside
D005578,CHEMICAL,Fosfomycin,"Phosphomycin|Tromethamine, Fosfomycin|Phosphonomycin|Fosfomycin Tromethamine|Monuril|fosfomycin|Fosfomycin Trometamol Salt"
NEW02747,CHEMICAL,alphablockers,alphablockers
D005436,CHEMICAL,Floxacillin,Fluorochloroxacillin|Flucloxacillin|flucloxacillin
D019475,CHEMICAL,Camphor 5-Monooxygenase,Camphor 5 Monooxygenase|camphor|Cytochrome P 450 cam|CYP101|Cytochrome P-450(cam)|Cytochrome P450(cam)|Cytochrome P 450 101|Cytochrome P-450-cam|P450cam|Camphor-5-Monooxygenase|Cytochrome P-450 101
NEW02755,CHEMICAL,naphthalene toxicity,naphthalene toxicity
NEW02757,BIOCHEMICAL,antimicrobial therapy,antimicrobial therapy
D000073358,CHEMICAL,Mycobacterium abscessus,Mycobacterium abscessus complex|Mycobacterium abscessus bolletii|Mycobacterium abscessus Complex|Mycobacterium bolletii|Mycobacterium abscessus subspecies bolletii|Mycobacterium massiliense|Mycobacterium chelonae abscessus|Mycobacteroides abscessus subsp. abscessus|Mycobacterium abscessus subspecies abscessus|Mycobacteroides abscessus|Mycobacterium abscessus abscessus|Mycobacterium abscessus subsp. bolletii|Mycobacteroides abscessus subsp. massiliense|Mycobacterium abscessus subsp. abscessus
D000069196,CHEMICAL,Gastrointestinal Microbiome,"Microflora, Gastrointestinal|Gastrointestinal Microflora|Gut Microbiotas|Flora, Intestinal|Intestinal Microbiotas|Enteric Bacteria|Gastrointestinal Microbiota|Gastrointestinal Microbial Community|Microbiome, Gut|Microbiota, Gastrointestinal|Gastric Microbiome|Gastric Microbiomes|Gastrointestinal Microbial Communities|Gut Microflora|Microflora, Intestinal|Gastrointestinal Microbiotas|Microbiome, Intestinal|Microbial Community, Gastrointestinal|Microbiota, Gut|Gastrointestinal Microbiomes|Intestinal Flora|gut microbiota|Microbiome, Gastrointestinal|Intestinal Microbiome|Gastrointestinal Flora|Microbiota, Intestinal|Intestinal Microflora|Microbiome, Gastric|Flora, Gut|Gut Microbiomes|Intestinal Microbiomes|Gut Microbiota|Bacteria, Enteric|Microflora, Gut|Gut Flora|GM|Intestinal Microbiota|Gut Microbiome|Flora, Gastrointestinal"
NEW02760,DISEASE,microbial dysbiosis,microbial dysbiosis
NEW02761,CHEMICAL,circulating catecholamines,circulating catecholamines
NEW02763,DISEASE,hypermetabolic response,hypermetabolic response
NEW02764,DISEASE,opportunistic nosocomial bacterial resistance,opportunistic nosocomial bacterial resistance
NEW02766,MENTAL_HEALTH,emerging resistance,emerging resistance
NEW02768,BIOCHEMICAL,newer antibiotics,newer antibiotics
D008933,DISEASE,Mitochondrial Swelling,"Swellings, Mitochondrial|Mitochondrial Swellings|Swelling, Mitochondrial|swelling"
NEW02770,CHEMICAL,sodium depletion,sodium depletion
D020852,DISEASE,Lyme Neuroborreliosis,"Encephalopathy, Lyme Disease|Lyme Disease, Central Nervous System|Mononeuritis Multiplex, Lyme Disease|Neuroborrelioses, Borrelia burgdorferi|Lyme Disease Encephalopathies|Neuroborreliosis, Lyme|lyme borreliosis|Lyme Polyradiculitides|Lyme Polyradiculopathy|Lyme Disease Encephalopathy|Lyme Polyradiculopathies|Neuroborreliosis, Borrelia burgdorferi|Lyme Meningoencephalitis|Polyradiculopathy, Lyme|Nervous System Lyme Borreliosis|Lyme Borreliosis, Nervous System|Borrelia burgdorferi Neuroborreliosis|Meningoencephalitis, Lyme|Polyradiculitis, Lyme|Lyme Polyradiculitis|Encephalopathies, Lyme Disease|Polyradiculopathies, Lyme|Lyme Disease Mononeuritis Multiplex|Peripheral Nervous System Lyme Disease|Polyradiculitides, Lyme|Central Nervous System Lyme Disease|Lyme Disease, Nervous System|Meningoradiculitis, Lyme|Lyme Meningoradiculitis|Nervous System Lyme Disease"
C000591922,CHEMICAL,brexpiprazole [Supplementary Concept],Thiophenes|Quinolones|Brexpiprazole
D005472,CHEMICAL,Fluorouracil,"5 HU Hexal|5-Fluorouracil|5-FU Medac|Carac|Fluorouracil Monosodium Salt|Fluracedyl|Onkofluor|Efudex|Fluorouracil GRY|Fluoruracil|5-FU|5 Fluorouracil Biosyn|Fluoro-Uracile ICN|Dakota, Fluorouracile|Fluorouracil Potassium Salt|Fluorouracile Dakota|Fluoro Uracile ICN|5-Fu|Fluoroplex|Efudix|Flurodex|Haemato FU|Fluorouracil Monopotassium Salt|Haemato-FU|5-FU Lederle|5 FU Lederle|Adrucil|5 FU Medac|Fluorouracil Mononitrate|5FU|Fluorouracilo Ferrer Far|Ribofluor|5-Fluorouracil-Biosyn|Neofluor|5-HU Hexal|Fluorouracil-GRY|5 Fluorouracil"
D002955,BIOCHEMICAL,Leucovorin,"5-Formyltetrahydropteroylglutamate|Leucovorin, Monosodium Salt|Leucovorin, (D)-Isomer|Folinic Acid-SF|Citrovorum Factor|Factor, Citrovorum|Leucovorin, Calcium|Leucovorin, Calcium (1:1) Salt|Leucovorin, Calcium (1:1) Salt, Pentahydrate|5 Formyltetrahydrofolate|Calcium Leucovorin|Folinic Acid SF|Leucovorin, (DL)-Isomer|Leukovorin|Leucovorin, (R)-Isomer|Calcium Folinate|Acid, Folinic|Leukovorum|Wellcovorin|5-Formyltetrahydrofolate|Folinate, Calcium|Leucovorin, Calcium (1:1) Salt, (DL)-Isomer|N(5)-Formyltetrahydrofolate|Folinic Acid|Monosodium Salt Leucovorin|5 Formyltetrahydropteroylglutamate|leucovorin"
NEW02774,MENTAL_HEALTH,high fatigue,high fatigue
D054316,BIOCHEMICAL,"Biomarkers, Pharmacological","drug response|Drug Safety Biomarkers|Pharmacological Biomarkers|Drug Dosing Biomarker|Drug Response Biomarkers|Dosing Biomarkers, Drug|Pharmacological Biological Markers|Markers, Pharmacological Biological|Response Biomarkers, Drug|Biological Markers, Pharmacological|Biomarkers, Drug Response|Drug Dosing Biomarkers|Biomarkers, Drug Dosing|Biomarker, Drug Dosing|Safety Biomarkers, Drug|Biomarkers, Drug Safety|Dosing Biomarker, Drug"
NEW02776,CHEMICAL,Arecoline responses,Arecoline responses
NEW02778,CHEMICAL,nicotine therapy,nicotine therapy
D002217,CHEMICAL,Carbachol,"Carbamylcholine|Carbamoylcholine|Doryl|Carboptic|Miostat|Carbachol, Isopto|carbachol|Carbacholine|Carbastat|Jestryl|Carbamann|Isopto Carbachol|Carbocholine"
NEW02780,BIOCHEMICAL,cholinergic agonist pilocarpine,cholinergic agonist pilocarpine
NEW02781,DISEASE,unfavorable lactation-induced malnutrition,unfavorable lactation-induced malnutrition
NEW02783,DISEASE,TgR mice,TgR mice
NEW02784,MENTAL_HEALTH,severe mania,severe mania
D000068797,CHEMICAL,Orexins,Orexin-B|Orexin B|Orexin A|Hypocretin|Hypocretins|Hypocretin 1|orexins|Orexin|Orexin-A|Hypocretin-2|Hypocretin 2|Hypocretin-1|ORX
C059240,CHEMICAL,cevimeline [Supplementary Concept],cevimeline|Quinuclidines|Thiophenes
NEW02787,MENTAL_HEALTH,mild-to-moderate Alzheimer disease,mild-to-moderate Alzheimer disease
NEW02790,CHEMICAL,acetylcholine synthesis,acetylcholine synthesis
NEW02791,NUTRITION,cytosolic choline,cytosolic choline
NEW02792,CHEMICAL,mint aroma,mint aroma
NEW02795,CHEMICAL,Eredményeink azt mutatják,Eredményeink azt mutatják
NEW02797,CHEMICAL,N-methyl-d-aspartate receptor hypofunction,N-methyl-d-aspartate receptor hypofunction
C496397,CHEMICAL,"benzonitrile, 4-(2-(2-((2r)-2-methyl-1-pyrrolidinyl)ethyl)-5-benzofuranyl)- [Supplementary Concept]",ABT-239|Benzofurans|Pyrrolidines
NEW02801,BIOCHEMICAL,Several histamine H3 receptor antagonists,Several histamine H3 receptor antagonists
NEW02803,CHEMICAL,c-hydroxybutyrate,c-hydroxybutyrate
NEW02804,BIOCHEMICAL,full antagonist,full antagonist
NEW02806,BIOCHEMICAL,H3 antagonist administration,H3 antagonist administration
D002974,CHEMICAL,Clemastine,Meclastine|clemastine|Tavist|HS-592|Mecloprodin|Clemastine Fumarate|HS 592|Tavegyl|2-(2-(1-(4-Chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidine|HS592
D016589,CHEMICAL,Astemizole,"Esmacen|Hubermizol|Ratiopharm, Astemizol|Hismanal|Laridal|Rifedot|Alonga, Astemizol|astemizole|Rimbol|Emdar|Astemizol Alonga|R 43 512|Astemizol Ratiopharm|Romadin|Retolen|R-43-512|Urdrim|Paralergin|Simprox|Astemina|Alermizol|Histaminos|Fustermizol|Astesen|R43512"
NEW02810,CHEMICAL,non-sedative histamine H1 receptor antagonist terfenadine mg/kg,non-sedative histamine H1 receptor antagonist terfenadine mg/kg
NEW02812,CHEMICAL,histamine H1 receptor antagonist terfenadine,histamine H1 receptor antagonist terfenadine
D016593,CHEMICAL,Terfenadine,"terfenadine|Terfenadin Ratiopharm|Terfenadin AL|Terfenadin Von Ct|alpha-(4-(1,1-Dimethylethyl)phenyl)-4-(hydroxydiphenylmethyl)-1-piperdinebutanol|Ternadin|Cyater|Teldane|Terfenadin-Ratiopharm|RMI 9918|Terfemundin|Triludan|Seldane|Rapidal|Terfenadin Stada|RMI-9918|RMI9918|Terfedura|Terfenidine|Balkis Saft Spezial|Terfenadin Heumann|Hisfedin"
NEW02813,CHEMICAL,selective histamine H1 receptor antagonist,selective histamine H1 receptor antagonist
NEW02814,CHEMICAL,h post-nicotine withdrawal time,h post-nicotine withdrawal time
NEW02816,CHEMICAL,μg/mouse,μg/mouse
D006635,BIOCHEMICAL,Histamine H2 Antagonists,"Receptor Blockader, H2|Antihistaminics, H2|Receptor Blockaders, H2|Antagonist, Histamine H2|Histamine H2 Receptor Blockader|Blockaders, H2 Receptor|Histamine H2 Receptor Blockaders|H2 Antagonists, Histamine|H2 Blocker, Histamine|Histamine H2 Antagonist|H2 Antihistaminics|Antagonists, Histamine H2|Blockers, Histamine H2|Histamine H2 Blockers|H2 Receptor Blockaders|H2 Blockers, Histamine|Blockaders, Histamine H2 Receptor|Histamine H2 Receptor Antagonist|H2 Receptor Blockader|Receptor Antagonists, Histamine H2|Histamine H2 Receptor Antagonists|H2 receptor antagonist|Blockader, H2 Receptor|Histamine H2 Blocker|H2 Antagonist, Histamine|Blocker, Histamine H2"
D017332,CHEMICAL,Cetirizine,"CetiLich|Ceti TAD|Reactine|Cetirlan|Zetir|P071|(2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)acetic Acid|Ceti-Puren|Dihydrochloride, Cetirizine|Ceterifug|P 071|Cetiderm|Cetirizine Dihydrochloride|P-071|Cetirizin AL|Cetirigamma|Virlix|Alerlisin|Cetidura|Zyrtec|Voltric|cetirizine|Cetirizin AZU|Cetalerg|Cetirizin Basics|Zirtek|Cetil von ct"
NEW02817,CHEMICAL,endogenous histamine,endogenous histamine
NEW00792,CHEMICAL,nicotine withdrawal,nicotine withdrawal
NEW02818,CHEMICAL,adenosine A1 receptor agonist N6-cyclopentyladenosine,adenosine A1 receptor agonist N6-cyclopentyladenosine|CPA
NEW01164,CHEMICAL,H1 receptor antagonist pyrilamine,H1 receptor antagonist pyrilamine
C021062,CHEMICAL,niaprazine [Supplementary Concept],Niaprazine|Niacinamide/analogs  and  derivatives
D020919,DISEASE,"Sleep Disorders, Intrinsic","Intrinsic Sleep Disorders|Hypersomnia, Post Traumatic|Hypersomnia, Post-Traumatic|sleep disorders|Post-Traumatic Hypersomnia|Hypersomnias, Posttraumatic|Posttraumatic Hypersomnia|Posttraumatic Hypersomnias|Post-Traumatic Hypersomnias|Intrinsic Sleep Disorder|Sleep State Misperceptions|Hypersomnia, Posttraumatic|Hypersomnias, Post-Traumatic|Sleep State Misperception|Sleep Disorder, Intrinsic"
NEW02822,CHEMICAL,Substance P NK1 receptor antagonists,Substance P NK1 receptor antagonists
NEW02824,BIOCHEMICAL,drug agreements,drug agreements
NEW02827,BIOCHEMICAL,unintentional drug overdoses,unintentional drug overdoses
D009437,DISEASE,Neuralgia,"Perineal Neuralgia|Neuralgia, Atypical|Atypical Neuralgias|Neuralgias, Iliohypogastric Nerve|Stump Neuralgia|Neuralgia, Supraorbital|Pains, Neuropathic|Neurodynia|Pain, Neuropathic|Stump Neuralgias|Nerve Pains|Pains, Nerve|Neuralgia, Ilioinguinal|Neuralgias, Ilioinguinal|Supraorbital Neuralgias|Supraorbital Neuralgia|Paroxysmal Nerve Pains|Ilioinguinal Neuralgias|Perineal Neuralgias|Iliohypogastric Nerve Neuralgia|Neuralgias, Supraorbital|Nerve Neuralgia, Iliohypogastric|Vidian Neuralgias|Ilioinguinal Neuralgia|Pain, Paroxysmal Nerve|Pains, Paroxysmal Nerve|Neuropathic Pain|neuropathic pain|Neuralgias, Stump|Neuralgia, Vidian|Atypical Neuralgia|Neurodynias|Nerve Pain|Neuralgias, Vidian|Neuralgias, Perineal|Nerve Pain, Paroxysmal|Pain, Nerve|Neuralgia, Iliohypogastric Nerve|Nerve Neuralgias, Iliohypogastric|Neuralgias|Iliohypogastric Nerve Neuralgias|Neuralgia, Stump|Neuropathic Pains|Neuralgias, Atypical|Nerve Pains, Paroxysmal|Neuralgia, Perineal|Paroxysmal Nerve Pain|Vidian Neuralgia"
NEW02832,BIOCHEMICAL,nonspecific GABAA receptor agonist muscimol,nonspecific GABAA receptor agonist muscimol
NEW02835,DISEASE,FXS adolescents,FXS adolescents
NEW02837,BIOCHEMICAL,GABAA receptor agonist,GABAA receptor agonist
D011280,CHEMICAL,Pregnanolone,"beta-pregnan-20-one, 3 alpha-Hydroxy-5|Pregnanolone, (3alpha)-isomer|3 Hydroxypregnan 20 one|Pregnanolone, (3beta, 5beta,14beta)-isomer|Allopregnanolone|3 alpha-Hydroxy-5 alpha-pregnan-20-one|Allopregnan-3 beta-ol-20-one|Pregnanolone, (3beta, 5beta, 17alpha)-isomer|Pregnanolone, (3alpha, 5beta, 17-alpha)-isomer|Pregnanolone, (3alpha,5alpha)-isomer|Pregnanolone, (5alpha)-isomer|Pregnanolone, (3beta)-isomer|Eltanolone|3 alpha Hydroxy 5 beta pregnan 20 one|alpha-Hydroxy-5 alpha-pregnan-20-one, 3|3beta-Hydroxy-5alpha-pregnan-20-one|Pregnanolone, (3beta, 5alpha, 8alpha, 17beta)-isomer|3 alpha, 5 beta-Tetrahydroprogesterone|Pregnanolone, (3beta, 5alpha)-isomer|3 alpha-Hydroxy-5 beta-pregnan-20-one|Pregnanolone, (3alpha,5beta)-isomer|Allopregnan 3 beta ol 20 one|alpha-pregnan-20-one, 3 alpha-Hydroxy-5|Pregnanolone, (3beta, 5beta)-isomer|Sepranolone|beta-ol-20-one, Allopregnan-3|Pregnanolone|Pregnan 3alpha ol 20 one|Epipregnanolone|Pregnan-3alpha-ol-20-one|alpha-Hydroxy-5 beta-pregnan-20-one, 3|3 alpha, 5 beta Tetrahydroprogesterone|3 alpha Hydroxy 5 alpha pregnan 20 one|3beta Hydroxy 5alpha pregnan 20 one|Pregnanolone, (3beta, 5alpha, 17alpha)-isomer|3-Hydroxypregnan-20-one"
D020941,CHEMICAL,"Myasthenia Gravis, Neonatal","Persistent Neonatal Myasthenia Gravis|Neonatal Myasthenia Gravis|Neonatal Myasthenia Gravis, Transient|Neonatal Myasthenia Gravis, Persistent|Antenatal Myasthenia Gravis|Myasthenia Gravis, Neonatal, Transient|Myasthenia Gravis, Neonatal, Persistent|Myasthenia Gravis, Persistent, Neonatal|MG|Transient Neonatal Myasthenia Gravis|Myasthenia Gravis, Antenatal|Myasthenia gravis|Myasthenia Gravis, Transient, Neonatal"
C432169,CHEMICAL,"6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyrido(3,4-b)indol-1-one [Supplementary Concept]",Pyrroles|SL651498|Indoles
NEW02842,CHEMICAL,"6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyrido[3,4-b]indol-1-one","6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyrido[3,4-b]indol-1-one"
C543979,CHEMICAL,artemisinin-naphthoquine combination [Supplementary Concept],Artemisinin|Naphthoquinones|Artemisinins
NEW02846,CHEMICAL,combined CO2-/O2-stunning,combined CO2-/O2-stunning
D002245,CHEMICAL,Carbon Dioxide,"CO2|carbon dioxide|Carbonic Anhydride|Dioxide, Carbon|Anhydride, Carbonic"
NEW02854,CHEMICAL,Creatine supplementation,Creatine supplementation
NEW02856,NUTRITION,omega-6 polyunsaturated fatty acids,omega-6 polyunsaturated fatty acids
NEW02857,CHEMICAL,dietary omega-3,dietary omega-3
NEW02858,DISEASE,dopaminergic abnormalities,dopaminergic abnormalities
NEW02860,CHEMICAL,Selective D1 dopamine agonists,Selective D1 dopamine agonists
C095428,CHEMICAL,adrogolide hydrochloride [Supplementary Concept],ABT-431|Pyridines|Tetrahydronaphthalenes
NEW02862,DISEASE,psychiatric history,psychiatric history
NEW02863,CHEMICAL,once-daily extended-release oral formulation,once-daily extended-release oral formulation
D064699,CHEMICAL,Dexmethylphenidate Hydrochloride,"XR, Focalin|Focalin|Focalin XR|Hydrochloride, Dexmethylphenidate|Dexmethylphenidate"
NEW02864,CHEMICAL,dexmethylphenidate XR,dexmethylphenidate XR
NEW02865,BIOCHEMICAL,AVP receptor agonists,AVP receptor agonists
NEW02866,CHEMICAL,Hypothalamic oxytocin,Hypothalamic oxytocin|OXT
D003894,CHEMICAL,Deamino Arginine Vasopressin,"AVP|Adiuretin|DDAVP|Acetate, Desmopressin|Desmogalen|Desmopressine Ferring|Apo-Desmopressin|Minurin|Vasopressin, 1-Desamino-8-arginine|1-Deamino-8-D-arginine Vasopressin|Desmopressin Acetate|Nocutil|Desmopressin|Desmospray|Desmotabs|Desmopressin Monoacetate, Trihydrate|Minirin|Vasopressin, 1-Deamino-8-D-arginine|Vasopressin, Deamino Arginine|Monoacetate, Trihydrate Desmopressin|Desmopressin Monoacetate|arginine vasopressin|Octostim|Monoacetate, Desmopressin|Adiuretin SD|1-Desamino-8-arginine Vasopressin|Trihydrate Desmopressin Monoacetate|Ferring, Desmopressine|Arginine Vasopressin, Deamino|Octim"
NEW02868,CHEMICAL,OXT transcripts,OXT transcripts
NEW02869,DISEASE,Stress-induced depression-like behaviors,Stress-induced depression-like behaviors
NEW02871,CHEMICAL,β-adrenergic blocker propranolol,β-adrenergic blocker propranolol
NEW02873,BIOCHEMICAL,glucocorticoid GR antagonist mifepristone,glucocorticoid GR antagonist mifepristone
NEW02874,DISEASE,Erythrocyte deformations,Erythrocyte deformations
D018019,BIOCHEMICAL,"Receptors, Corticotropin-Releasing Hormone","CRH Receptor|Corticotropin Releasing-Factor Receptor|Corticotropin-releasing hormone|Receptors, CRF|CRF Receptors|Corticotropin Releasing Hormone Receptors|Receptor, Corticotropin Releasing-Factor|Receptors, CRH|Corticotropin Releasing-Hormone Receptors|Receptor, CRF|Receptor, CRH|Receptors, Corticotropin Releasing-Factor|Receptors, Corticotropin Releasing-Hormone|Corticotropin Releasing-Factor Receptors|CRF Receptor|Releasing-Factor Receptors, Corticotropin|Corticotropin-Releasing Hormone Receptors|Corticotropin Releasing Factor Receptor|Releasing-Factor Receptor, Corticotropin|CRH Receptors|Releasing-Hormone Receptor, Corticotropin|Corticotropin Releasing-Hormone Receptor|Releasing-Hormone Receptors, Corticotropin|Hormone Receptors, Corticotropin-Releasing|Corticotropin Releasing Hormone Receptor|Receptor, Corticotropin Releasing-Hormone|Receptors, Corticotropin Releasing Hormone|Corticotropin Releasing Factor Receptors"
D051279,NUTRITION,Tryptophan Transaminase,"tryptophan|Aminotransferase, Tryptophan|Transaminase, Tryptophan|Tryptophan Aminotransferase|Aminotransferase, L-Tryptophan|L-Tryptophan Aminotransferase|L Tryptophan Aminotransferase"
NEW02878,CHEMICAL,Baseline indoxyl sulfate abundance,Baseline indoxyl sulfate abundance
D007200,CHEMICAL,Indican,"Monosodium Salt, Indican|indoxyl sulfate|Monopotassium Salt, Indican|Indican Monosodium Salt|1H-Indol-3-ol Hydrogen Sulfate Ester|Indoxyl Sulfate|Indican Monopotassium Salt|Sulfate, Indoxyl"
NEW02879,MENTAL_HEALTH,psychic anxiety,psychic anxiety
C408690,CHEMICAL,4-cresol sulfate [Supplementary Concept],Cresols|Sulfuric Acid Esters|P-cresol
D007676,DISEASE,"Kidney Failure, Chronic","End-Stage Renal Disease|End-Stage Kidney Disease|Renal Failure, End-Stage|Renal Disease, End-Stage|Chronic Kidney Failure|Renal Failure, Chronic|Renal Failure, End Stage|Disease, End-Stage Kidney|End Stage Renal Disease|Kidney Disease, End-Stage|Disease, End-Stage Renal|End Stage Kidney Disease|Chronic Renal Failure|end-stage renal disease|End-Stage Renal Failure|Renal Disease, End Stage|ESRD"
NEW02882,BIOCHEMICAL,aging toxins,aging toxins
D017366,BIOCHEMICAL,Serotonin Receptor Agonists,"5-HT Agonists|Agonists, 5-HT|Agonists, Serotonergic|5 HT Agonists|Receptor Agonists, Serotonin|Agonists, Serotonin|Serotonin Agonist|Agonist, Serotonin|5 HT Agonist|Agonist, Serotonin Receptor|Agonist, Serotonergic|5-Hydroxytryptamine Agonists|Serotonin Agonists|5 Hydroxytryptamine Agonists|Serotonergic Agonist|Agonist, 5-HT|Agonists, 5-Hydroxytryptamine|5 Hydroxytrytamine Agonist|5-Hydroxytrytamine Agonist|serotonergic agonist|Agonists, Serotonin Receptor|5-HT Agonist|Receptor Agonist, Serotonin|Serotonergic Agonists|Agonist, 5-Hydroxytrytamine|Serotonin Receptor Agonist"
C015068,CHEMICAL,1-(3-chlorophenyl)piperazine [Supplementary Concept],meta-chlorophenylpiperazine|Piperazines
NEW02883,CHEMICAL,nigrostriatal DA neurons,nigrostriatal DA neurons
NEW02886,BIOCHEMICAL,direct-acting postsynaptic serotonergic agonist,direct-acting postsynaptic serotonergic agonist
NEW02888,CHEMICAL,Oral metachlorophenylpiperazine,Oral metachlorophenylpiperazine
NEW02890,CHEMICAL,serotonin agonist meta-chlorophenylpiperazine,m-CPP|serotonin agonist meta-chlorophenylpiperazine
NEW02891,DISEASE,DSM-III-R chronic schizophrenic patients,DSM-III-R chronic schizophrenic patients
NEW02893,DISEASE,hostility factor,hostility factor
NEW02896,CHEMICAL,Meta-chloro-phenyl-piperazine,Meta-chloro-phenyl-piperazine
NEW02897,BIOCHEMICAL,nonspecific serotonergic agonist,nonspecific serotonergic agonist
NEW02899,CHEMICAL,5-HT agonist metachlorophenylpiperazine,mCPP|5-HT agonist metachlorophenylpiperazine
NEW02900,CHEMICAL,cocaine withdrawal,cocaine withdrawal
NEW02901,CHEMICAL,cocaine administration,cocaine administration
NEW02903,DISEASE,OCD symptoms,OCD symptoms
D008711,CHEMICAL,Metergoline,Liserdol|Methergoline|metergoline
NEW02904,CHEMICAL,intravenous mCPP,intravenous mCPP
NEW02906,BIOCHEMICAL,potent serotonin antagonist,potent serotonin antagonist
NEW02898,DISEASE,OCD patients,OCD patients
D011562,CHEMICAL,Psilocybin,psilocybin|Psilocybine|Psilocibin
NEW02908,DISEASE,GAS mice,GAS mice
NEW02910,BIOCHEMICAL,safe CRF antagonists,safe CRF antagonists
NEW02913,DISEASE,CRF system,CRF system
NEW02915,CHEMICAL,CRF/CRF1R unit,CRF/CRF1R unit
NEW02916,DISEASE,CRF peptide antagonists,CRF peptide antagonists
NEW02920,BIOCHEMICAL,lipophilic CRF antagonists,lipophilic CRF antagonists
NEW02922,DISEASE,CRF neuronal hyperactivity,CRF neuronal hyperactivity
NEW02923,BIOCHEMICAL,CRF(1 receptor antagonists,CRF(1 receptor antagonists
NEW02925,BIOCHEMICAL,CRF antagonists,CRF antagonists
NEW02927,BIOCHEMICAL,CRFR1 antagonists,CRFR1 antagonists
D011345,CHEMICAL,Fenofibrate,"Apo-Fenofibrate|Tricor|Novo-Fenofibrate|Procetofen|Fenofibrat Stada|Fenobeta|Lipidil-Ter|CiL|Hexal, Fenofibrat|Fenofibrat Hexal|Fénofibrate Debat|Normalip|Fenofibrat FPh|Fenofibrat AbZ|Micronized Procetofen, Antara|Fénofibrate MSD|Fenofibrate|Lipidil|Fenofibrat AL|Stada, Fenofibrat|Fenofibrat-ratiopharm|Fenofibrat Heumann|Lipanthyl|Debat, Fénofibrate|Liparison|AZU, Fenofibrat|Fenofibrat ratiopharm|Fenofanton|Lofibra|Procetofene|Supralip|Phenofibrate|MTW-Fenofibrat|durafenat|PMS Fenofibrate Micro|Lipidil Ter|Procetofen, Antara Micronized|Gen-Fenofibrate|Nu-Fenofibrate|Antara Micronized Procetofen|Controlip|Apo Fenofibrate|Apo Feno Micro|MTW Fenofibrat|Fenofibrat AZU|LF178|Lipantil|PMS-Fenofibrate Micro|fenofibrat von ct|Livesan|Novo Fenofibrate|Gen Fenofibrate|Heumann, Fenofibrat|Secalip|Nu Fenofibrate|LF 178|LF-178|Apo-Feno-Micro"
NEW02933,CHEMICAL,2-ethyl-3-methylpyrazine,2-ethyl-3-methylpyrazine
NEW02934,CHEMICAL,Aqueous katsuobushi,Aqueous katsuobushi|AK
NEW02935,BIOCHEMICAL,Kappa-opioid receptor antagonists,Kappa-opioid receptor antagonists
NEW02937,CHEMICAL,KOP agonists,KOP agonists
NEW02939,CHEMICAL,"U50,488","U50,488"
C040533,CHEMICAL,trimethyltin chloride [Supplementary Concept],TMT|Trimethyltin chloride|Trimethyltin Compounds
NEW02947,CHEMICAL,Non-dioxin-like NDL polychlorinated biphenyls,Non-dioxin-like NDL polychlorinated biphenyls
NEW02950,CHEMICAL,Cd exposure,Cd exposure
D001520,DISEASE,Behavior and Behavior Mechanisms,behavior|Behavior And Behavior Mechanism
NEW02956,BIOCHEMICAL,neurotoxicant,neurotoxicant
NEW02959,NUTRITION,Omega-3 polyunsaturated fatty acids,Omega-3 polyunsaturated fatty acids
NEW02960,BIOCHEMICAL,antifungal treatment,antifungal treatment
NEW02962,DISEASE,early infections,early infections
NEW02963,CHEMICAL,Sulfamate derivatives,Sulfamate derivatives
D042462,CHEMICAL,4-Quinolones,4 Oxoquinolines|Quinolones|4 Quinolones|4-Quinolinones|4-Oxoquinolines|4 Quinolinones|4-Quinolone|4 Quinolone|4 Quinolinone|4-Quinolinone|4-Oxoquinoline|4 Oxoquinoline
D015242,CHEMICAL,Ofloxacin,ORF 28489|Ru 43280|DL-8280|Hoe280|Ofloxacine|DR3355|DL8280|DR-3355|Ru43280|Hoe 280|Tarivid|Hoe-280|Ru-43280|ofloxacin|Ofloxacin Hydrochloride|ORF-28489|ORF28489|DL 8280|DR 3355
D002939,CHEMICAL,Ciprofloxacin,"Ciprofloxacin Hydrochloride|Ciprofloxacin Monohydrochloride Monohydrate|Ciprofloxacin|Monohydrochloride Monohydrate, Ciprofloxacin|Ciprofloxacin Hydrochloride Anhydrous|Bay09867|Anhydrous, Ciprofloxacin Hydrochloride|Hydrochloride, Ciprofloxacin|Bay 09867|Hydrochloride Anhydrous, Ciprofloxacin|Cipro|Monohydrate, Ciprofloxacin Monohydrochloride|Bay-09867|Ciprinol"
NEW02966,CHEMICAL,third-generation cephalosporin,third-generation cephalosporin
D026141,BIOCHEMICAL,"Drug Resistance, Multiple, Fungal","Multiple Antifungal Drug Resistance|drug resistance|Multidrug Resistance, Fungal"
NEW02969,BIOCHEMICAL,antibiotic treatments,antibiotic treatments
NEW02971,CHEMICAL,maternal supplemental iron,maternal supplemental iron
D044242,NUTRITION,Trans Fatty Acids,"Acids, Trans Fatty|Trans Fatty Acid|Acids, Trans-Fatty|fatty acids|Acid, Trans Fatty|Fatty Acid, Trans|Fatty Acids, Trans|Trans-Fatty Acids"
NEW02974,NUTRITION,mercury heavy metal,mercury heavy metal
D019636,DISEASE,Neurodegenerative Diseases,"Neurologic Degenerative Disease|Degenerative Condition, Neurologic|Neurodegenerative Disease|Degenerative Neurologic Disorder|neurodegenerative diseases|Nervous System Degenerative Diseases|Degenerative Diseases, Neurologic|Degenerative Neurologic Disease|Neurodegenerative Disorder|Neurologic Disease, Degenerative|Neurologic Degenerative Diseases|Neurologic Disorders, Degenerative|Degenerative Neurologic Disorders|Degenerative Diseases, Central Nervous System|Degenerative Diseases, Nervous System|Neurologic Degenerative Conditions|Neurologic Degenerative Condition|Degenerative Neurologic Diseases|Neurodegenerative Disorders|Degenerative Conditions, Neurologic|Neurologic Disorder, Degenerative|Degenerative Diseases, Spinal Cord|Neurologic Diseases, Degenerative"
C540355,CHEMICAL,fenamidone [Supplementary Concept],Strobilurins|Fenamidone
D010410,DISEASE,Penile Erection,"Penile Tumescence|Tumescence, Penile|Penile Tumescence, Nocturnal|Nocturnal Penile Tumescence|Erection, Penile|penile erection|Tumescence, Nocturnal Penile"
D003634,CHEMICAL,DDT,"4,4' Dichlorodiphenyltrichloroethane|DDT|TbisC ethane|1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane|p',p'-DDT|4,4'-Dichlorodiphenyltrichloroethane|Benzochloryl|4,4'-DDT|Chlorophenothane|TbisC-ethane|4,4' DDT"
NEW02981,CHEMICAL,cocaine,cocaine
C111212,CHEMICAL,TRK 820 [Supplementary Concept],Nalfurafine hydrochloride|Morphinans|Spiro Compounds
NEW02984,BIOCHEMICAL,kappa-opioid receptor agonist,kappa-opioid receptor agonist
NEW02986,CHEMICAL,alpha-1 adrenoceptor antagonist prazosin,alpha-1 adrenoceptor antagonist prazosin
NEW02988,CHEMICAL,"agonist U50,488H","agonist U50,488H"
C038981,CHEMICAL,nalmefene [Supplementary Concept],Naltrexone/analogs  and  derivatives|Nalmefene
C583636,CHEMICAL,eluxadoline [Supplementary Concept],Phenylalanine/analogs  and  derivatives|Imidazoles|eluxadoline
NEW02997,CHEMICAL,hallucinogen effects,hallucinogen effects
NEW03000,BIOCHEMICAL,κ-opioid receptor agonist,κ-opioid receptor agonist
NEW02999,DISEASE,central pruritus,central pruritus
NEW03001,DISEASE,uremic pruritus,uremic pruritus
NEW03006,BIOCHEMICAL,α₂-adrenoceptor agonist,α₂-adrenoceptor agonist
NEW03008,BIOCHEMICAL,5-HT2 antagonist ritanserin,5-HT2 antagonist ritanserin
NEW03009,CHEMICAL,Alektorophobia,Alektorophobia
NEW03010,CHEMICAL,Feather corticosterone concentration,Feather corticosterone concentration
NEW03015,CHEMICAL,PRSS1-mediated CP,PRSS1-mediated CP
NEW03016,DISEASE,autosomal dominant hereditary CP,autosomal dominant hereditary CP
NEW03017,MENTAL_HEALTH,process schizophrenia,process schizophrenia
NEW03019,BIOCHEMICAL,beta deposition,beta deposition
D000068796,BIOCHEMICAL,Orexin Receptor Antagonists,"Dual Orexin Receptor Antagonists|Orexin Receptor Antagonist|Antagonist, Orexin Receptor|Dual orexin receptor antagonists|Dual Orexin Receptor Antagonist|Orexin Receptor Blockers|Receptor Antagonist, Orexin"
NEW03021,BIOCHEMICAL,potent dual orexin receptor antagonists,potent dual orexin receptor antagonists
C000595055,CHEMICAL,dual orexin receptor antagonist 12 [Supplementary Concept],Azepines|Benzimidazoles|DORA-12
NEW03024,DISEASE,Mechanical hypersensitivity,Mechanical hypersensitivity
D013706,DISEASE,Temporomandibular Joint Dysfunction Syndrome,"Syndrome, Costen's|Costen's Syndrome|pain dysfunction|Syndrome, TMJ|TMJ Syndrome|Costens Syndrome|Temporomandibular Joint Syndrome|Syndrome, Temporomandibular Joint|Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint|Costen Syndrome|Joint Syndrome, Temporomandibular"
NEW03027,CHEMICAL,Cocaine users,Cocaine users
NEW03028,BIOCHEMICAL,pharmaceutical strategies,pharmaceutical strategies
NEW03029,MENTAL_HEALTH,anxiety levels,anxiety levels
C551624,CHEMICAL,suvorexant [Supplementary Concept],Azepines|suvorexant|Triazoles
NEW03031,DISEASE,Psychostimulants,Psychostimulants
NEW03033,CHEMICAL,5-HT-related compounds,5-HT-related compounds
NEW03034,BIOCHEMICAL,orexin antagonist,orexin antagonist
NEW03038,CHEMICAL,selective OX2R antagonists,SORA2s|selective OX2R antagonists
D041722,MENTAL_HEALTH,"Genes, Transgenic, Suicide","Suicide Genes, Transduced|Genes, Transgenic Apoptosis-Inducing|Genes, Transgenic Suicide|Transgenes, Apoptosis-Inducing|Apoptosis Inducing Transgenes|Transgene, Apoptosis-Inducing|Suicide Genes, Transgenic|Transgenic Suicide Genes|Suicide Gene, Transgenic|Gene, Transgenic Apoptosis-Inducing|Genes, Transduced Suicide|Apoptosis-Inducing Genes, Transgenic|Transgene, Suicide|Suicide Gene, Transduced|Suicide Transgene|Gene, Transduced Suicide|Transgenes, Suicide|Transduced Suicide Genes|suicide|Gene, Transgenic Suicide|Genes, Suicide, Metabolic, Transgenic|Apoptosis-Inducing Transgenes|Transgenic Apoptosis-Inducing Gene|Apoptosis-Inducing Transgene|Transgenic Metabolic Suicide Genes|Suicide Transgenes|Transgenic Apoptosis-Inducing Genes|Transduced Suicide Gene|Transgenic Suicide Gene|Genes, Transgenic Apoptosis Inducing|Apoptosis-Inducing Gene, Transgenic"
NEW03041,DISEASE,factitious thyrotoxicosis,factitious thyrotoxicosis
D017903,DISEASE,Bacteriophage T3,"Enterobacteria phage T3|Phages, T3|Phage T3|T3 Phage|Coliphage T3|T3 Phages|T3|Phage, T3"
NEW03046,CHEMICAL,inositol phospholipid metabolism,inositol phospholipid metabolism
D006980,DISEASE,Hyperthyroidism,"Primary Hyperthyroidism|Hyperthyroids|Hyperthyroidism|Hyperthyroidism, Primary|Hyperthyroid"
NEW03051,DISEASE,Febrile catatatony,Febrile catatatony
C487948,CHEMICAL,3-iodothyronamine [Supplementary Concept],Thyronines|T1AM|3-Iodothyronamine
D013963,BIOCHEMICAL,Thyroid Hormones,"Hormone, Thyroid|Thyroid Hormone|thyroid hormones|Hormones, Thyroid"
NEW03053,BIOCHEMICAL,thyroid hormone levels,thyroid hormone levels
NEW03055,DISEASE,non-attempters,non-attempters
NEW03056,MENTAL_HEALTH,suicide attempters,suicide attempters
NEW03058,DISEASE,Other carbamazepine-induced changes,Other carbamazepine-induced changes
D050564,CHEMICAL,Trans-Cinnamate 4-Monooxygenase,"4-Monooxygenase, Trans-Cinnamate|Trans-Cinnamic Acid 4-Hydroxylase|4-Monooxygenase CYP73, Trans-Cinnamate|CYP73, Trans-Cinnamate 4-Monooxygenase|Acid 4-Hydroxylase, Trans-Cinnamic|Trans Cinnamic Acid 4 Hydroxylase|Cinnamate 4-Hydroxylase|Cinnamate 4 Hydroxylase|4-Hydroxylase, Trans-Cinnamic Acid|4-Hydroxylase, Cinnamate|Trans Cinnamate 4 Monooxygenase CYP73|Trans Cinnamate 4 Monooxygenase|Trans-Cinnamate 4-Monooxygenase CYP73|trans-"
NEW03062,BIOCHEMICAL,low thyroid hormone secretion,low thyroid hormone secretion
NEW03063,CHEMICAL,FT3 levels,FT3 levels
NEW03065,CHEMICAL,free triiodothyronine,free triiodothyronine|FT3
D037042,BIOCHEMICAL,Thyroid Hormone Receptors beta,"c erbA beta|Thyroid Hormone Receptor beta-2|Thyroid Hormone Receptor beta|Thyroid Hormone Receptor beta 1|c-erbA beta|ERBA2 Gene Products|Gene Products, NR1A2|TR beta|Gene Products, THRB|THRB Gene Products|thyroid hormone|NR1A2 Gene Products|Thyroid Hormone Receptor beta-1|Thyroid Hormone Receptor beta 2|Gene Products, ERBA2|Receptors beta, Thyroid Hormone"
NEW03067,BIOCHEMICAL,plasma thyroid hormone concentrations,plasma thyroid hormone concentrations
NEW03069,CHEMICAL,daily ethanol consumption,daily ethanol consumption
NEW03070,DISEASE,HPT axis,HPT axis
NEW03073,CHEMICAL,NRA groups,NRA groups
NEW03074,DISEASE,TRH-induced TSH,TRH-induced TSH
C566501,DISEASE,Major Affective Disorder 3 [Supplementary Concept],bipolar affective disorder|Bipolar Disorder
NEW03075,BIOCHEMICAL,Thyroid hormone replacement,Thyroid hormone replacement
D012742,DISEASE,Sex Offenses,"Sex Offense|Sexual Assaults|Sexual Violences|Offense, Sex|Violence, Sexual|Sexual Abuses|Violences, Sexual|Abuse, Sexual|Assaults, Sexual|Offenses, Sex|Sexual Violence|Abuses, Sexual|sexual violence|Assault, Sexual|Sexual Assault|Sexual Abuse"
NEW03080,BIOCHEMICAL,thyroid hormone alterations,thyroid hormone alterations
NEW03081,DISEASE,severe hypothyroidism,severe hypothyroidism
NEW03082,MENTAL_HEALTH,patient's mania,patient's mania
NEW03083,BIOCHEMICAL,thyroid hormone signalling,thyroid hormone signalling
C000622662,CHEMICAL,"thyroid hormone receptor alpha, human [Supplementary Concept]",Thyroid Hormone Receptors alpha|TRαAMI/Cre3 mice|TRα
NEW03085,CHEMICAL,Glucocorticoid reproductive steroid levels,Glucocorticoid reproductive steroid levels
NEW03090,CHEMICAL,Exposure to perfluoroalkyl substances,PFAS|Exposure to perfluoroalkyl substances
NEW03091,DISEASE,maternal thyroid anomalies,maternal thyroid anomalies
NEW03092,CHEMICAL,levothyroxine treatment,levothyroxine treatment
NEW03094,BIOCHEMICAL,thyroid hormone regulation,thyroid hormone regulation
NEW03095,CHEMICAL,(IRMA)-and free-thyroid-hormone levels,(IRMA)-and free-thyroid-hormone levels
NEW03097,CHEMICAL,Baseline thyroid-secreting-hormone,Baseline thyroid-secreting-hormone
NEW03098,BIOCHEMICAL,thyroid hormone medication,thyroid hormone medication
NEW03101,BIOCHEMICAL,thyroid hormone abuse,thyroid hormone abuse
NEW03102,DISEASE,endogenous hyperthyroidism,endogenous hyperthyroidism
NEW00402,DISEASE,total body iron,total body iron|TBI
D000070642,DISEASE,"Brain Injuries, Traumatic","Brain Injury, Traumatic|Brain Trauma|Traumatic Encephalopathy|Encephalopathy, Traumatic|TBI (Traumatic Brain Injury)|TBI (Traumatic Brain Injuries)|Traumatic Brain Injuries|Encephalopathies, Traumatic|Trauma, Brain|TBIs (Traumatic Brain Injuries)|Traumatic Encephalopathies|Traumas, Brain|Brain Traumas|Injury, Brain, Traumatic|Traumatic Brain Injury|Traumatic brain injury"
NEW03103,BIOCHEMICAL,brain thyroid hormones,brain thyroid hormones
NEW03104,BIOCHEMICAL,thyroid-stimulating hormone TSH secretion,thyroid-stimulating hormone TSH secretion
D018025,BIOCHEMICAL,"Receptors, Thyrotropin-Releasing Hormone","thyrotropin releasing hormone|Thyrotropin-Releasing Hormone Receptors|TRH Receptors|Receptors, Thyrotropin Releasing Hormone|Receptors, Thyroliberin|Receptor, Protirelin|Thyrotropin Releasing Hormone Receptors|Receptors, Protirelin|Receptors, TRH|Receptor, TRH|TRH Receptor|Protirelin Receptors|Protirelin Receptor|Thyrotropin Releasing Hormone Receptor|Thyroliberin Receptors"
C575259,BIOCHEMICAL,"TRIP13 protein, human [Supplementary Concept]",thyroid hormone receptor interactor|ATPases Associated with Diverse Cellular Activities|Cell Cycle Proteins
NEW03106,BIOCHEMICAL,TRIP12 mutation carriers,TRIP12 mutation carriers
NEW03107,BIOCHEMICAL,altered thyroid hormone levels,altered thyroid hormone levels
NEW03108,CHEMICAL,serotonin 5-hydroxytryptamine levels,serotonin 5-hydroxytryptamine levels
NEW03109,DISEASE,hypothyroid rats,hypothyroid rats
D056825,CHEMICAL,Thyroxine-Binding Globulin,thyroxine|Thyropexin|Serpin A7|Thyroxine Binding Globulin
D000077273,DISEASE,"Thyroid Cancer, Papillary","Papillary Thyroid Carcinoma|Carcinoma, Papillary Thyroid|Familial Nonmedullary Thyroid Cancer|papillary thyroid carcinoma|Papillary Thyroid Carcinomas|Papillary Thyroid Cancer|Nonmedullary Thyroid Carcinoma|Thyroid Carcinomas, Papillary|Thyroid Carcinoma, Papillary|Carcinoma, Nonmedullary Thyroid|Thyroid Carcinomas, Nonmedullary|Cancers, Papillary Thyroid|Thyroid Cancers, Papillary|Papillary Carcinoma Of Thyroid|Cancer, Papillary Thyroid|Papillary Thyroid Cancers|Carcinomas, Nonmedullary Thyroid|Nonmedullary Thyroid Carcinomas|Carcinomas, Papillary Thyroid|Thyroid Carcinoma, Nonmedullary"
NEW03120,BIOCHEMICAL,insulin sensitizers,insulin sensitizers
NEW03121,CHEMICAL,metformin use,metformin use
NEW03123,DISEASE,Peripheral hyperinsulinemia,Peripheral hyperinsulinemia
NEW03125,CHEMICAL,sensitizers pioglitazone,sensitizers pioglitazone
NEW03127,BIOCHEMICAL,ORL-1 agonists,ORL-1 agonists
NEW03129,CHEMICAL,Endomorphins,Endomorphins
NEW03130,CHEMICAL,low subanalgesic doses,low subanalgesic doses
D000068116,MENTAL_HEALTH,Gender Dysphoria,"Identity Disorder, Gender|Gender Identity Disorders|Disorder, Gender Identity|dysphoria|Gender Identity Disorder"
NEW03133,BIOCHEMICAL,Full μ-opioid agonists,Full μ-opioid agonists
NEW03135,CHEMICAL,available antidepressants,available antidepressants
D018723,CHEMICAL,Bethanechol,"Urecholine|Myocholine|Duvoid|Bethanechol|Myotonine|Urocarb|PMS-Bethanechol Chloride|Bethanechol Chloride|Bethanecol|Chloride, Bethanechol|Hermes, Myo|Myotonachol|Myo Hermes|PMS Bethanechol Chloride"
D018678,BIOCHEMICAL,Cholinergic Agents,"Muscarinic Agents|Nicotinic Effect|Effect, Muscarinic|Agent, Muscarinic|Muscarinic Effect|Cholinomimetic|Effect, Nicotinic|Cholinergic Effect|Cholinergic Drugs|Acetylcholine Agent|Cholinomimetics|Agents, Acetylcholine|Effect, Cholinergic|Drugs, Cholinergic|Muscarinic Agent|Nicotinic Agent|cholinergic drug|Cholinergic|Cholinergic Agent|Nicotinic Agents|Agents, Muscarinic|Nicotinic Effects|Cholinergic Effects|Agents, Nicotinic|Effects, Nicotinic|Agent, Acetylcholine|Agent, Nicotinic|Muscarinics|Cholinergic Drug|Effects, Cholinergic|Effects, Muscarinic|Muscarinic Effects|Agent, Cholinergic|Muscarinic|Cholinergics|Drug, Cholinergic|Acetylcholine Agents|Agents, Cholinergic"
C052450,CHEMICAL,physostigmine heptyl [Supplementary Concept],Physostigmine/analogs  and  derivatives|Heptylphysostigmine
NEW03137,DISEASE,TD antigen,TD antigen
D008106,DISEASE,"Liver Cirrhosis, Experimental","Cirrhoses, Experimental Liver|Experimental Liver Cirrhoses|Cirrhosis, Experimental Liver|Experimental Liver Cirrhosis|cirrhosis|Experimental Hepatic Cirrhosis|Liver Cirrhoses, Experimental|Hepatic Cirrhosis, Experimental"
C567531,DISEASE,Major Affective Disorder 9 [Supplementary Concept],major affective disorder|Bipolar Disorder
NEW03141,BIOCHEMICAL,intracellular antigens,intracellular antigens
D000069283,CHEMICAL,Rituximab,"rituximab|IDEC C2B8 Antibody|Rituxan|CD20 Antibody, Rituximab|IDEC-C2B8 Antibody|IDEC-C2B8|Mabthera|Rituximab CD20 Antibody|GP2013|IDEC C2B8"
D020363,DISEASE,Limbic Encephalitis,"Paraneoplastic Limbic Encephalitis|Encephalitides, Paraneoplastic Limbic|Encephalitis, Limbic|Encephalitis, Paraneoplastic Limbic|Paraneoplastic limbic encephalitis|Limbic Encephalitis, Paraneoplastic"
NEW03145,CHEMICAL,brain-gut-microbiota axis,brain-gut-microbiota axis
NEW03148,BIOCHEMICAL,prostate antigens,prostate antigens
D006680,BIOCHEMICAL,HLA Antigens,"Human Leukocyte Antigen|Antigens, HLA|Human Leukocyte Antigens|HL-A Antigens|Antigens, Human Leukocyte|Leukocyte Antigens, Human|HL A Antigens|Antigen, Human Leukocyte|Antigens, HL-A|HLA antigens|Leukocyte Antigen, Human|Leukocyte Antigens|Antigens, Leukocyte"
NEW03151,CHEMICAL,synapsin (Ig)G serum antibody positive patients,synapsin (Ig)G serum antibody positive patients
NEW03153,CHEMICAL,anti-synapsin positive patients,anti-synapsin positive patients
NEW03155,CHEMICAL,Anti-synapsin positive patients,Anti-synapsin positive patients
NEW03157,BIOCHEMICAL,neuronal surface antigens,neuronal surface antigens
NEW03159,CHEMICAL,Monoclonal proteins,Monoclonal proteins|paraproteins
NEW03161,CHEMICAL,Yo antibodies,Yo antibodies
NEW03164,CHEMICAL,increased circulating catecholamines,increased circulating catecholamines
NEW03166,DISEASE,Hypercortisolaemia,Hypercortisolaemia
C434825,DISEASE,"Desrt protein, mouse [Supplementary Concept]",DNA-Binding Proteins|immune abnormalities|Transcription Factors
NEW03167,DISEASE,impaired cell-mediated immunity,CMI|impaired cell-mediated immunity
NEW03168,DISEASE,T- dysfunction,T- dysfunction
NEW03170,DISEASE,immunologic impairment indicative,immunologic impairment indicative
NEW03172,CHEMICAL,ex-methamphetamine abusers,ex-methamphetamine abusers
D059425,CHEMICAL,Interferon-gamma Release Tests,"Assays, Interferon-gamma Release|Interferon gamma Release Assays|Release Assay, Interferon-gamma|Interferon-gamma Release Assay|Tests, Interferon-gamma Release|interferon γ|Release Test, Interferon-gamma|Interferon gamma Release Tests|Interferon-gamma Release Assays|Release Tests, Interferon-gamma|Test, Interferon-gamma Release|Assay, Interferon-gamma Release|Interferon gamma Release Assay|Interferon-gamma Release Test|Release Assays, Interferon-gamma"
D000506,DISEASE,Alopecia Areata,Alopecia areata|Alopecia Circumscripta
NEW03174,DISEASE,immune-mediated encephalopathy/encephalitis,immune-mediated encephalopathy/encephalitis
D018334,DISEASE,Leishmania guyanensis,"viannia panamensis, Leishmania|guyanensis, Leishmania guyanensis|Leishmania brasiliensis guyanensis|guyanenses, Leishmania|guyanenses, Leishmania braziliensis|guyanensis, Leishmania braziliensis|Leishmania viannia guyanensis|Leishmania (Viannia) guyanensis|guyanensis guyanensis, Leishmania|guyanenses, Leishmania guyanensis|panamenses, Leishmania viannia|viannia guyanenses, Leishmania|viannia guyanensis, Leishmania|Leishmania braziliensis guyanenses|Leishmania guyanenses|braziliensis guyanenses, Leishmania|brasiliensis guyanensis, Leishmania|Leishmania guyanensis guyanenses|Leishmania|guyanensis, Leishmania viannia|guyanenses, Leishmania brasiliensis|guyanensis, Leishmania brasiliensis|Leishmania braziliensis guyanensis|Leishmania viannia panamenses|Leishmania viannia panamensis|Leishmania guyanensis guyanensis|Leishmania brasiliensis guyanenses|Leishmania (Viannia) panamensis|viannia panamenses, Leishmania|Leishmania viannia guyanenses"
NEW03177,CHEMICAL,LACK Leishmania analogue,LACK Leishmania analogue
NEW03179,CHEMICAL,Antimuscarinic acetylcholine receptor-3 m3AChR autoantibodies,Antimuscarinic acetylcholine receptor-3 m3AChR autoantibodies
NEW03181,BIOCHEMICAL,HERV-K env-su glycoprotein antigens,HERV-K env-su glycoprotein antigens
NEW03183,MENTAL_HEALTH,odor-induced anxiety,odor-induced anxiety
C073839,CHEMICAL,SR 48968 [Supplementary Concept],saredutant|Piperidines|Benzamides
C541361,CHEMICAL,3-trans-feruloyl maslinic acid [Supplementary Concept],maslinic acid|Triterpenes
NEW03190,DISEASE,MK-801-induced memory impairments,MK-801-induced memory impairments
NEW01107,BIOCHEMICAL,NMDA receptor antagonist,NMDA receptor antagonist
NEW03196,CHEMICAL,N-methyl-d-aspartate NMDA receptor hyperactivity,N-methyl-d-aspartate NMDA receptor hyperactivity
NEW03198,DISEASE,Excitotoxic injury,Excitotoxic injury
C059294,CHEMICAL,"3,3',4',5,6,7,8-heptamethoxyflavone [Supplementary Concept]","HMF|3,5,6,7,8,3',4'-heptamethoxyflavone|Flavonoids"
NEW03199,BIOCHEMICAL,NMDA receptor antagonist MK-801,NMDA receptor antagonist MK-801
NEW03202,CHEMICAL,Neonatal MK-801 exposure,Neonatal MK-801 exposure
C494553,CHEMICAL,"3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide [Supplementary Concept]",Pyrazoles|CDPPB|Benzamides
NEW03205,CHEMICAL,Ketamine-a noncompetitive glutamate N-methyl-d-aspartate NMDA receptor antagonist,Ketamine-a noncompetitive glutamate N-methyl-d-aspartate NMDA receptor antagonist
NEW03206,CHEMICAL,rapid-onset antidepressant effects,rapid-onset antidepressant effects
NEW03207,CHEMICAL,single-dose intravenous ketamine,single-dose intravenous ketamine
NEW01643,CHEMICAL,N-methyl-D-aspartate NMDA receptor antagonist,N-methyl-D-aspartate NMDA receptor antagonist
NEW03210,CHEMICAL,elevated corticosterone levels,elevated corticosterone levels
NEW03211,CHEMICAL,currents sEPSCs,currents sEPSCs
NEW03213,CHEMICAL,Repeated corticosterone administration,Repeated corticosterone administration
NEW03217,DISEASE,brief tail shock,brief tail shock
NEW03219,CHEMICAL,NMDA receptor agonism,NMDA receptor agonism
NEW03221,DISEASE,brief noxious tail shock,brief noxious tail shock
C109603,CHEMICAL,N-(1-(2-nitrophenyl)ethoxycarbonyl)-D-AP5 [Supplementary Concept],"Receptors, Serotonin|AP5"
C114144,CHEMICAL,neramexane [Supplementary Concept],neramexane|Cyclopentanes
NEW03227,BIOCHEMICAL,low-to-moderate affinity uncompetitive NMDA receptor antagonist,low-to-moderate affinity uncompetitive NMDA receptor antagonist
D001929,DISEASE,Brain Edema,"Brain Swellings|Edema, Cytotoxic Brain|Intracranial Edema|Brain Edema, Vasogenic|Edema, Brain|Edema, Cerebral|Edema, Intracranial|Cerebral Edemas, Vasogenic|Edema, Vasogenic Brain|Cytotoxic Brain Edema|Cerebral Edema, Vasogenic|Cerebral Edema, Cytotoxic|Edema, Vasogenic Cerebral|Cytotoxic Cerebral Edema|Swelling, Brain|Brain Edema, Cytotoxic|Cerebral Edema|Vasogenic Brain Edema|Vasogenic Cerebral Edema|Brain Swelling|brain edema|Edema, Cytotoxic Cerebral"
NEW03228,CHEMICAL,Furosemide agents,Furosemide agents
NEW03229,CHEMICAL,KP metabolite kynurenic acid,KYNA|KP metabolite kynurenic acid
NEW03234,CHEMICAL,noncompetitive NMDA-receptor antagonist memantine intraperitoneal,noncompetitive NMDA-receptor antagonist memantine intraperitoneal
NEW03237,CHEMICAL,glutamate N-methyl-D-aspartate NMDA receptor antagonist ketamine,glutamate N-methyl-D-aspartate NMDA receptor antagonist ketamine
NEW00797,DISEASE,PTSD symptoms,PTSD symptoms
NEW03238,CHEMICAL,noncompetitive glutamatergic N-methyl-d-aspartate NMDA receptor antagonist,noncompetitive glutamatergic N-methyl-d-aspartate NMDA receptor antagonist
NEW03240,CHEMICAL,rapid antidepressant responses,rapid antidepressant responses
NEW03241,BIOCHEMICAL,Several monoamine-based pharmacological drug classes,Several monoamine-based pharmacological drug classes
NEW03242,BIOCHEMICAL,noncompetitive NMDA receptor antagonist ketamine,noncompetitive NMDA receptor antagonist ketamine
NEW03243,CHEMICAL,non-competitive NMDA receptor antagonist ketamine,non-competitive NMDA receptor antagonist ketamine
NEW03244,CHEMICAL,ketamine's rapid antidepressant activity,ketamine's rapid antidepressant activity
NEW03246,CHEMICAL,non-competitive N-methyl-d-aspartate NMDA receptor antagonist ketamine,non-competitive N-methyl-d-aspartate NMDA receptor antagonist ketamine
NEW03247,DISEASE,treatment-resistant patients,treatment-resistant patients
NEW00754,CHEMICAL,rapid antidepressant effects,rapid antidepressant effects
D058468,CHEMICAL,"Receptors, Ionotropic Glutamate","Glutamate Receptor, Ionotropic|Ionotropic Glutamate Receptor|Glutamate Receptors, Ionotropic|glutamate receptors|Ionotropic Glutamate Receptors|Receptor, Ionotropic Glutamate"
NEW03249,CHEMICAL,T-type channel antagonists/blockers,T-type channel antagonists/blockers
NEW03250,CHEMICAL,N-methyl-D-aspartate NMDA receptor antagonist memantine,N-methyl-D-aspartate NMDA receptor antagonist memantine
NEW03252,BIOCHEMICAL,Current approved drug treatments,Current approved drug treatments
D016567,CHEMICAL,Nizatidine,"Axid|LY139037|LY-139037|nizatidine|LY 139037|N-(2-(((2-((Dimethylamino)methyl)-4-thiazolyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine"
D015738,CHEMICAL,Famotidine,famotidine|MK 208|MK208|YM11170|MK-208|Famotidine Hydrochloride|Pepcid|YM-11170|YM 11170
NEW03256,DISEASE,Paranoid disturbances,Paranoid disturbances
D002927,CHEMICAL,Cimetidine,"Eureceptor|SKF92334|Cimetidine HCl|SK and F 92334|Cimetidine|N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine|Histodil|SKF-92334|SKF 92334|Cimetidine Hydrochloride|SK and F-92334|Altramet|SK and F92334|Biomet400|HCl, Cimetidine|Hydrochloride, Cimetidine|Biomet|Tagamet"
NEW03258,CHEMICAL,drug-drug interaction,drug-drug interaction|DDI
NEW03260,DISEASE,major DDIs,major DDIs
NEW03261,CHEMICAL,Lycopodium alkaloids,Lycopodium alkaloids|LAs
NEW03262,NUTRITION,fresh onion juice,fresh onion juice
NEW03265,DISEASE,A. cepa bulb ethyl acetate fraction,A. cepa bulb ethyl acetate fraction
D000857,DISEASE,Olfaction Disorders,"phantosmia|Impairment, Olfactory|Cacosmia|Olfactory Impairment|Olfaction, Impaired|Cacosmias|Olfaction Disorder|Dysosmias|Phantosmia|Smell Disorder|Impaired Olfactions|Phantosmias|Dysfunction, Smell|Dysosmia|Smell Disorders|Olfactions, Impaired|Parosmias|Impaired Olfaction|Parosmia|Paraosmia|Paraosmias|Smell Dysfunction"
NEW03269,NUTRITION,quercetin-rich onion,quercetin-rich onion
NEW03270,BIOCHEMICAL,potent opioid receptor antagonists,potent opioid receptor antagonists
D000856,DISEASE,Anorexia Nervosa,"Nervosas, Anorexia|Anorexia Nervosas|anorexia|Nervosa, Anorexia"
NEW03271,DISEASE,sexual overstimulation,sexual overstimulation
NEW03276,BIOCHEMICAL,nonspecific antagonist,nonspecific antagonist
NEW03278,DISEASE,Parkinson's disease motor symptoms,Parkinson's disease motor symptoms
NEW03280,CHEMICAL,weeks morphine abstinence,weeks morphine abstinence
NEW03282,CHEMICAL,chronic escalating morphine regimen,chronic escalating morphine regimen
NEW03283,CHEMICAL,opioid receptor antagonist nor-Binaltorphimine,opioid receptor antagonist nor-Binaltorphimine
D009292,BIOCHEMICAL,Narcotic Antagonists,"Antagonists, Opioid|Opioid Reversal Agent|Receptor Antagonists, Opioid|Antagonists, Narcotic|Antagonists, Opioid Receptor|opioid receptor antagonists|Opioid Antagonists, Competitive|Reversal Agent, Opioid|Competitive Opioid Antagonists|Antagonist, Competitive Opioid|Opioid Reversal Agents|Antagonist, Narcotic|Opioid Receptor Antagonist|Agent, Opioid Reversal|Antagonists, Competitive Opioid|Opioid Antagonists|Opioid Antagonist|Competitive Opioid Antagonist|Receptor Antagonist, Opioid|Agents, Opioid Reversal|Antagonist, Opioid|Antagonist, Opioid Receptor|Narcotic Antagonist|Opioid Receptor Antagonists|Reversal Agents, Opioid|Opioid Antagonist, Competitive"
NEW02941,CHEMICAL,κ-receptor antagonist norbinaltorphimine,norBNI|κ-receptor antagonist norbinaltorphimine
NEW03287,CHEMICAL,KOR/dynorphin system,KOR/dynorphin system
NEW03289,BIOCHEMICAL,KOR antagonist nor-binaltorphimine,KOR antagonist nor-binaltorphimine
NEW03290,BIOCHEMICAL,KOR antagonists,KOR antagonists
NEW03293,BIOCHEMICAL,mixed μ-opioid antagonist,mixed μ-opioid antagonist
NEW03294,BIOCHEMICAL,non-selective opioid receptor antagonists,non-selective opioid receptor antagonists
NEW03296,DISEASE,prurigo nodularis therapy,prurigo nodularis therapy
NEW03299,DISEASE,Breast milk carotenoids,Breast milk carotenoids
D052248,CHEMICAL,Nitric Oxide Synthase Type I,"Neural Constitutive Nitric Oxide Synthase|nNOS Enzyme|neuronal nitric oxide synthase|NOS1 Protein|Neuronal Nitric Oxide Synthase|NCNOS Enzyme|Nitric Oxide Synthase, Type I"
NEW03300,CHEMICAL,nitric oxide NO system,nitric oxide NO system
NEW03301,CHEMICAL,central histamine systems,central histamine systems
D008635,CHEMICAL,Mescaline,"Mezcalin|Peyote|mescaline|Trimethoxyphenethylamine|3,4,5-Trimethoxyphenethylamine"
D032302,CHEMICAL,Datura,Daturas
C087658,CHEMICAL,levodopa receptor [Supplementary Concept],"Receptors, Neurotransmitter|L-Dopa"
NEW03303,CHEMICAL,Mucuna pruriens,Mucuna pruriens
NEW03304,DISEASE,diet-induced obesity,diet-induced obesity
C583676,CHEMICAL,"FNDC5 protein, rat [Supplementary Concept]",Fibronectins|Irisin
C535554,DISEASE,Abdominal obesity metabolic syndrome [Supplementary Concept],Metabolic Syndrome|abdominal obesity
NEW03307,CHEMICAL,pruriens seeds,pruriens seeds
D008012,CHEMICAL,Lidocaine,"Lidocaine Sulfate (1:1)|Lidocaine Carbonate (2:1)|Lidocaine Hydrocarbonate|Lidocaine Monohydrochloride, Monohydrate|Xylocaine|Lidocaine Hydrochloride|2-2EtN-2MePhAcN|lidocaine|Lidocaine Monoacetate|Octocaine|Lidocaine Carbonate|Dalcaine|Lidocaine Monohydrochloride|Xylocitin|Lignocaine|2-(Diethylamino)-N-(2,6-Dimethylphenyl)Acetamide|Xylesthesin|Xyloneural"
C087260,CHEMICAL,YM 022 [Supplementary Concept],YM022|Benzodiazepines
NEW03309,BIOCHEMICAL,5HT3 receptor antagonist,5HT3 receptor antagonist
NEW03310,BIOCHEMICAL,neurokinin NK1 receptor antagonists,neurokinin NK1 receptor antagonists
NEW03313,BIOCHEMICAL,common antibiotics,common antibiotics
NEW03314,CHEMICAL,dopamine regulation,dopamine regulation
NEW03315,CHEMICAL,severe aripiprazole hepatotoxicity,severe aripiprazole hepatotoxicity
D012258,BIOCHEMICAL,Riboflavin Synthase,"Synthase, Riboflavin|riboflavin"
D054069,DISEASE,Multiple Acyl Coenzyme A Dehydrogenase Deficiency,"ETFB Deficiencies|Multiple acyl-coA dehydrogenase deficiency|MADD (Multiple Acyl-CoA Dehydrogenase Deficiency)|Glutaric Aciduria Type II|Electron Transfer Flavoprotein Deficiency|Glutaric Aciduria IIA|ETFA Deficiency|ETFB Deficiency|Electron Transfer Flavoprotein Dehydrogenase Deficiency|Multiple FAD Dehydrogenase Deficiency|ETFA Deficiencies|Acidurias, Ethylmalonic-Adipic|MADDs (Multiple Acyl-CoA Dehydrogenase Deficiency)|Glutaric Aciduria II|ETFDH Deficiencies|Ethylmalonic-Adipicaciduria|Glutaric Acidemia Type II|Ethylmalonic-Adipic Acidurias|Glutaric Aciduria Type 2|Electron Transfer Flavoprotein Beta Subunit Deficiency|Glutaric Aciduria IIC|Aciduria, Ethylmalonic-Adipic|Ethylmalonic Adipic Aciduria|Ethylmalonic-Adipic Aciduria|MADD|Ethylmalonic Adipicaciduria|MADD (Multiple Acyl CoA Dehydrogenase Deficiency)|Multiple Acyl CoA Dehydrogenase Deficiency|Glutaric Aciduria IIB|Multiple Acyl-CoA Dehydrogenase Deficiency|Glutaric Aciduria, Type 2|ETFDH Deficiency|Glutaric Acidemia, Type 2|Electron Transfer Flavoprotein Alpha Subunit Deficiency"
NEW03317,BIOCHEMICAL,Higher nicotinamide level,Higher nicotinamide level
D026681,BIOCHEMICAL,Vitamin B 6 Deficiency,"B6 Deficiency, Vitamin|Vitamin Deficiencies, B6|Vitamin B6 Deficiency|Pyridoxine Deficiency|B6 Deficiencies, Vitamin|vitamin B6|Deficiencies, B6 Vitamin|Deficiency, Vitamin B6|B6 Vitamin Deficiency|Deficiency, Pyridoxine|Deficiencies, Vitamin B6|Vitamin Deficiency, B6|B6 Vitamin Deficiencies|pyridoxine|Deficiency, Vitamin B 6|Deficiency, B6 Vitamin|Vitamin B6 Deficiencies"
D014803,BIOCHEMICAL,Vitamin B Complex,"B Vitamin|Vitamin, B|Neurobion|B Vitamins"
NEW03318,CHEMICAL,Hepatic ammonia levels,Hepatic ammonia levels
NEW03320,DISEASE,Higher anxiety-like behavior,Higher anxiety-like behavior
C535306,DISEASE,2-Hydroxyglutaricaciduria [Supplementary Concept],"L-2-hydroxyglutaric aciduria|Brain Diseases, Metabolic, Inborn|L-2-HGA"
NEW03322,CHEMICAL,elevated L-2-hydroxyglutaric acid,elevated L-2-hydroxyglutaric acid|L-2-HG
NEW03324,CHEMICAL,fish-white meat,fish-white meat
NEW03325,CHEMICAL,blood zinc,blood zinc
NEW03326,CHEMICAL,kynurenines,kynurenines
NEW03327,CHEMICAL,kynurenine catabolism,kynurenine catabolism
NEW03329,DISEASE,rare neurological disorder,rare neurological disorder
C537111,DISEASE,Brown-Vialetto-Van Laere syndrome [Supplementary Concept],"Brown-Vialetto-Van Laere Syndrome|Hearing Loss, Sensorineural|Bulbar Palsy, Progressive"
NEW03331,CHEMICAL,Anabolic Androgenic Steroids,Anabolic Androgenic Steroids
NEW00128,CHEMICAL,anabolic-androgenic steroids,anabolic-androgenic steroids|AAS
NEW03332,CHEMICAL,oral contraceptive use,oral contraceptive use
NEW03333,CHEMICAL,chronic all-trans retinoic acid administration,chronic all-trans retinoic acid administration
D014212,CHEMICAL,Tretinoin,"Vesanoid|Potassium Salt, Tretinoin|Salt, Tretinoin Zinc|Retin A|Salt, Tretinoin Potassium|Sodium Salt, Tretinoin|trans Retinoic Acid|Zinc Salt, Tretinoin|Tretinoin Sodium Salt|Acid, Retinoic|trans-Retinoic Acid|Retinoic Acid|Tretinoin Potassium Salt|Acid, beta-all-trans-Retinoic|ATRA|all-trans-Retinoic Acid|Retin-A|beta-all-trans-Retinoic Acid|all trans Retinoic Acid|trans retinoic acid|Acid, trans-Retinoic|Salt, Tretinoin Sodium|Tretinoin Zinc Salt|Acid, Vitamin A|beta all trans Retinoic Acid|Acid, all-trans-Retinoic|Vitamin A Acid"
NEW03334,DISEASE,CRF neurons,CRF neurons
NEW03336,DISEASE,ATRA-induced CRF over-expression,ATRA-induced CRF over-expression
NEW03338,CHEMICAL,Chronic ATRA treatment,Chronic ATRA treatment
NEW03339,CHEMICAL,sex-hormone production,sex-hormone production
NEW03340,BIOCHEMICAL,oestrogen replacement therapy,oestrogen replacement therapy
NEW03344,DISEASE,first-episode SCZ patients,first-episode SCZ patients
NEW03345,CHEMICAL,serum progesterone levels,serum progesterone levels
D007172,MENTAL_HEALTH,Erectile Dysfunction,"Male Sexual Impotence|Male Impotence|sexual impotence|Impotence, Male|Impotence, Male Sexual|Sexual Impotence, Male|Impotence|Dysfunction, Erectile"
NEW03348,MENTAL_HEALTH,secondary sexual impotence,secondary sexual impotence
NEW03352,CHEMICAL,oestrogen-based therapies,oestrogen-based therapies
NEW03353,BIOCHEMICAL,selective oestrogen receptor modulator raloxifene,selective oestrogen receptor modulator raloxifene
NEW03355,BIOCHEMICAL,adrenal hormones,adrenal hormones
NEW03356,CHEMICAL,elevated testosterone,elevated testosterone
NEW03358,CHEMICAL,elevated estradiol,elevated estradiol
NEW03362,CHEMICAL,Higher cortisol levels,Higher cortisol levels
NEW03364,BIOCHEMICAL,most hormones,most hormones
NEW03365,CHEMICAL,lower testosterone concentrations,lower testosterone concentrations
NEW03367,DISEASE,higher depressive symptomatology,higher depressive symptomatology
D010226,CHEMICAL,Parabens,para-Hydroxybenzoic Acids|para-hydroxybenzoic acids|para Hydroxybenzoic Acids|4 Hydroxybenzoic Acids|4-Hydroxybenzoic Acids|Paraben
NEW03371,CHEMICAL,phthalates,phthalates
D004703,BIOCHEMICAL,Endocrine System,"Endocrine Systems|System, Endocrine|Endocrine systems|Systems, Endocrine"
NEW03373,MENTAL_HEALTH,ADHD n,ADHD n
NEW03377,CHEMICAL,Osmotic-release oral system methylphenidate treatment,Osmotic-release oral system methylphenidate treatment
NEW03380,CHEMICAL,DHEA-S levels,DHEA-S levels
NEW03382,CHEMICAL,SHBG levels,SHBG levels
NEW03384,CHEMICAL,endogenous oxytocin concentrations,endogenous oxytocin concentrations
NEW02414,CHEMICAL,estradiol levels,estradiol levels
NEW03386,CHEMICAL,high oxytocin,high oxytocin
NEW03389,BIOCHEMICAL,sex hormone differences,sex hormone differences
D020018,DISEASE,"Sexual Dysfunctions, Psychological","Disorders, Orgasmic|Dysfunctions, Psychosexual|Dysfunction, Psychological Sexual|Sexual Arousal Disorders|Sexual Dysfunction, Psychological|Dysfunctions, Psychological Sexual|Sexual Aversion Disorders|Orgasmic Disorder|Sexual Arousal Disorder|sexual disorders|Disorders, Psychosexual|Hypoactive Sexual Desire Disorder|Psychosexual Disorder|Sexual Aversion Disorder|Psychological Sexual Dysfunctions|Psychosexual Dysfunctions|Psychosexual Disorders|Dysfunction, Psychosexual|Frigidity|Psychosexual Dysfunction|Orgasmic Disorders|Arousal Disorders, Sexual|Psychological Sexual Dysfunction|Disorder, Psychosexual|Disorders, Sexual Arousal|Disorders, Sexual Aversion|Aversion Disorders, Sexual"
NEW03392,BIOCHEMICAL,intrauterine sex hormone exposure,intrauterine sex hormone exposure
D011218,MENTAL_HEALTH,Prader-Willi Syndrome,"Royers Syndrome|Willi Prader Syndrome|Syndrome, Labhart-Willi-Prader-Fanconi|Labhart-Willi Syndrome|Willi-Prader Syndrome|Prader Willi Syndrome|Prader-Willi Syndrome|Syndrome, Willi-Prader|Prader Labhart Willi Syndrome|Syndrome, Labhart-Willi|Labhart Willi Prader Fanconi Syndrome|Royer Syndrome|Labhart-Willi-Prader-Fanconi Syndrome|Syndrome, Prader-Willi|Prader-Labhart-Willi Syndrome|Labhart Willi Syndrome|Syndrome, Royer's|Syndrome, Prader-Labhart-Willi|Syndrome, Royer|Royer's Syndrome"
D039721,MENTAL_HEALTH,Diagnostic and Statistical Manual of Mental Disorders,DSM-II|DSM-V|mental disorders|DSM-IV|DSM-III
NEW03395,BIOCHEMICAL,female sex hormones,female sex hormones
NEW03399,BIOCHEMICAL,prenatal sex hormone exposure,prenatal sex hormone exposure
NEW03400,MENTAL_HEALTH,dementia diagnosis,dementia diagnosis
NEW03401,BIOCHEMICAL,non-NMDA N-methyl-D-aspartic acid receptor antagonist CNQX,non-NMDA N-methyl-D-aspartic acid receptor antagonist CNQX
NEW03403,CHEMICAL,intra-septal infusions,intra-septal infusions
NEW03404,BIOCHEMICAL,NMDA receptor antagonist AP-5,NMDA receptor antagonist AP-5
NEW03405,CHEMICAL,different EAA receptor types,different EAA receptor types
NEW03407,CHEMICAL,Certain D2 dopamine receptor Taq 1A genotypes,Certain D2 dopamine receptor Taq 1A genotypes
NEW02936,MENTAL_HEALTH,abuse disorders,abuse disorders
NEW03409,CHEMICAL,cortisol measures,cortisol measures
NEW03410,NUTRITION,blood cholesterol levels,blood cholesterol levels
NEW03411,CHEMICAL,increased cortisol secretion,increased cortisol secretion
D050528,CHEMICAL,"Diet, Carbohydrate-Restricted","Diets, Carbohydrate-Restricted|Carbohydrate Diet, Low|Carbohydrate-Restricted Diet|Carbohydrate Restricted Diet|Diet, Low-Carbohydrate|Diet, Low Carbohydrate|Low Carbohydrate Diets|Diet, Carbohydrate Restricted|Diets, Low Carbohydrate|Diets, Low-Carbohydrate|low-carbohydrate diets|Carbohydrate-Restricted Diets|Low-Carbohydrate Diet|Low Carbohydrate Diet|Low-Carbohydrate Diets|Carbohydrate Diets, Low"
C538646,NUTRITION,"High serum cholesterol, familial [Supplementary Concept]",High serum cholesterol|Hyperlipoproteinemia Type II
NEW03413,NUTRITION,long-chain polyunsaturated fatty acids,long-chain polyunsaturated fatty acids
NEW03415,NUTRITION,plasma phospholipids,plasma phospholipids
NEW03416,CHEMICAL,ascorbate concentrations,ascorbate concentrations
NEW03417,BIOCHEMICAL,TAAR1 agonists,TAAR1 agonists
NEW03419,BIOCHEMICAL,selective partial TAAR1 agonist,selective partial TAAR1 agonist
C000596180,CHEMICAL,"4-(3-fluoro-2-methylphenyl)-4,5-dihydrooxazol-2-ylamine [Supplementary Concept]",Oxazoles|RO5263397
NEW03420,CHEMICAL,Orx2 receptors,Orx2 receptors
NEW03422,CHEMICAL,azapirone anxiolytics,azapirone anxiolytics
D002065,CHEMICAL,Buspirone,"Bespar|MJ-9022-1|Buspar|Neurosine|buspirone|Gen Buspirone|Novo Buspirone|Apo-Buspirone|Buspirone Hydrochloride|Ratio-Buspirone|Lin-Buspirone|Nu-Buspirone|Apo Buspirone|Novo-Buspirone|MJ 9022 1|Lin Buspirone|Ratio Buspirone|Hydrochloride, Buspirone|MJ90221|Nu Buspirone|N-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-1-cyclopentanediacetamide|Busp|PMS-Buspirone|PMS Buspirone|Gen-Buspirone|Anxut"
D017371,CHEMICAL,8-Hydroxy-2-(di-n-propylamino)tetralin,"8-Hydroxy-2-(di-n-propylamino)tetralin Hydrochloride, (S)-Isomer|8-Hydroxy-2-(di-n-propylamino)tetralin Hydrobromide|8-Hydroxy-2-(di-n-propylamino)tetralin Hydrochloride, (R)-Isomer,|8-Hydroxy-2-(di-n-propylamino)tetralin Hydrobromide, (S)-Isomer,|8-Hydroxy-2-(di-n-propylamino)tetralin Hydrobromide, (+-)-Isomer|8-Hydroxy-2-(di-n-propylamino)tetralin, (R)-Isomer|8-Hydroxy-2-(di-n-propylamino)tetralin Hydrobromide, (R)-Isomer,|8-Hydroxy-2-(di-n-propylamino)tetralin, (+-)-Isomer|8-OH-DPAT|8-Hydroxy-2-(di-n-propylamino)tetralin, (S)-Isomer"
NEW03424,BIOCHEMICAL,nicotinic cholinergic drugs,nicotinic cholinergic drugs
NEW03427,DISEASE,motor habituation,motor habituation
D003566,CHEMICAL,Cytidine Diphosphate Choline,"Citicoline|Diphosphate Choline, Cytidine|citicoline|Cidifos|CDP Choline|Cytidine 5'-Diphosphocholine|Citicholine|Cytidine 5' Diphosphocholine|Cyticholine|5'-Diphosphocholine, Cytidine|Choline, CDP|Choline, Cytidine Diphosphate"
D057066,DISEASE,Low Tension Glaucoma,"Normal Tension Glaucomas|Normal Tension Glaucoma|Glaucoma, Normal Tension|glaucoma|Low Tension Glaucomas|Glaucoma, Low Tension"
NEW03429,CHEMICAL,ACh signaling,ACh signaling
D057180,MENTAL_HEALTH,Frontotemporal Dementia,"Familial Pick's Disease|FTLD with TDP-43 Pathology|Dementia, Frontotemporal, with Parkinsonism|FTLD-TDP|Frontotemporal Lobar Degeneration With Ubiquitin Positive Inclusions|Complices, Disinhibition-Dementia-Parkinsonism-Amyotrophy|Dementia, Frontotemporal Lobe (FLDEM)|Frontotemporal Lobe Dementias|Frontotemporal Dementia, Ubiquitin Positive|Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions|Disease, Familial Pick's|HDDD2|Ubiquitin-Positive Frontotemporal Dementias|Frontotemporal Dementias, Ubiquitin-Positive|Frontotemporal Lobe Dementia (FLDEM)|Semantic Dementia|Frontotemporal Dementia with Parkinsonism 17|Disinhibition Dementia Parkinsonism Amytrophy Complex|GRN-Related Frontotemporal Dementia|Dementias, GRN-Related Frontotemporal|Pick's Disease, Familial|HDDD1|Frontotemporal Lobe Dementia|FTDP-17|Disinhibition Dementia Parkinsonism Amyotrophy Complex|FTLD-17 GRN|Dementias, Semantic|Disinhibition-Dementia-Parkinsonism-Amyotrophy Complices|Lobe Dementias, Frontotemporal|Ubiquitin-Positive Frontotemporal Dementia|FTLD with TDP 43 Pathology|Complices, Disinhibition-Dementia-Parkinsonism-Amytrophy|Frontotemporal Dementia, Ubiquitin-Positive|dementia|Wilhelmsen-Lynch Diseases|Complex, Disinhibition-Dementia-Parkinsonism-Amytrophy|Disease, Wilhelmsen-Lynch|Frontotemporal Dementia with Parkinsonism|Dementia, Ubiquitin-Positive Frontotemporal|Hereditary Dysphasic Disinhibition Dementia|DDPAC|Pick's Diseases, Familial|Frontotemporal Dementias|Lobe Dementia, Frontotemporal|Disinhibition-Dementia-Parkinsonism-Amytrophy Complices|Wilhelmsen Lynch Disease|Dementias, Frontotemporal Lobe|Complex, Disinhibition-Dementia-Parkinsonism-Amyotrophy|Familial Pick Disease|Diseases, Wilhelmsen-Lynch|Frontotemporal Lobe Dementias (FLDEM)|Frontotemporal Dementia with Parkinsonism-17|FTD-PGRN|Multiple System Tauopathy with Presenile Dementia|Diseases, Familial Pick's|GRN Related Frontotemporal Dementia|Disinhibition-Dementia-Parkinsonism-Amyotrophy Complex|Dementia, Frontotemporal|Dementia, Hereditary Dysphasic Disinhibition|Familial Pick's Diseases|Dementias, Frontotemporal Lobe (FLDEM)|GRN-Related Frontotemporal Dementias|Disinhibition-Dementia-Parkinsonism-Amytrophy Complex|Dementia, Frontotemporal Lobe|Frontotemporal Dementias, GRN-Related|FTD-GRN|Dementias, Frontotemporal|Dementia, Semantic|Wilhelmsen-Lynch Disease|Dementia, GRN-Related Frontotemporal|Familial Picks Disease|Dementias, Ubiquitin-Positive Frontotemporal|Frontotemporal Dementia, GRN-Related|Semantic Dementias"
D000077924,DISEASE,Palonosetron,"RS 25233 198|Palonosetron, (S-(R*,S*))-isomer|Palonosetron, (R-(R*,S*))-isomer|RS25259198|RS 25259198|RS 25259-197|RS 25259|RS25259|Aloxi|RS 25233197|2-QHBIQO|RS 25233-198|2-(1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one|Palonosetron Hydrochloride|RS25233198|Palonosetron, (R-(R*,R*))-isomer|RS25233197|RS 25233-197|RS 25259 198|RS-25233-198|RS-25259-197|RS-25259-198|RS-25233-197|RS25259197|RS 25259 197|RS 25233 197|RS-25259|RS 25259197|RS 25233198|RS|RS 25259-198|Palonosetron, (3R)-"
D017202,DISEASE,Myocardial Ischemia,"Ischemic Heart Diseases|Myocardial Ischemias|Heart Disease, Ischemic|Ischemias, Myocardial|ischemic heart disease|Diseases, Ischemic Heart|Ischemic Heart Disease|Ischemia, Myocardial|Heart Diseases, Ischemic|Disease, Ischemic Heart"
NEW03431,DISEASE,geriatric age,geriatric age
NEW03432,DISEASE,Hcrt-r2 mutation,Hcrt-r2 mutation
NEW03434,DISEASE,narcoleptic canines,narcoleptic canines
D015140,DISEASE,"Dementia, Vascular","Dementias, Subcortical Vascular|Binswanger's Disease|Binswangers Disease|Binswanger's Encephalopathy|Encephalopathy, Subcortical Arteriosclerotic|Binswanger Disease|Subcortical Leukoencephalopathy|Encephalopathies, Subcortical Arteriosclerotic|Vascular Dementias|Subcortical Vascular Dementias|Subcortical Leukoencephalopathies|Vascular Dementia, Subcortical|Acute Onset Vascular Dementia|Binswanger Encephalopathy|Vascular Dementia, Acute Onset|Leukoencephalopathies, Subcortical|Disease, Binswanger|Arteriosclerotic Encephalopathy, Subcortical|Leukoencephalopathy, Subcortical|Encephalopathy, Binswangers|Dementia, Subcortical Vascular|Subcortical Encephalopathy, Chronic Progressive|Dementia, Arteriosclerotic|Chronic Progressive Subcortical Encephalopathy|Disease, Binswanger's|VaD|Dementias, Vascular|Vascular Dementia|Encephalopathy, Chronic Progressive Subcortical|Encephalopathy, Subcortical, Chronic Progressive|Arteriosclerotic Dementias|Subcortical Vascular Dementia|Dementias, Arteriosclerotic|Encephalopathy, Binswanger|vascular dementia|Subcortical Arteriosclerotic Encephalopathy|Encephalopathy, Binswanger's|Vascular Dementias, Subcortical|Arteriosclerotic Encephalopathies, Subcortical|Arteriosclerotic Dementia|Subcortical Arteriosclerotic Encephalopathies"
C032114,CHEMICAL,propentofylline [Supplementary Concept],propentofylline|Xanthines
C055448,CHEMICAL,posatirelin [Supplementary Concept],posatirelin|Thyrotropin-Releasing Hormone/analogs  and  derivatives
D009530,CHEMICAL,Nicergoline,"Nicergolin-TEVA|Nimergoline|Nicergolin Von Ct|Nicergobeta|Circo-Maren|Nicergolin-Neuraxpharm|Nicergolin TEVA|Fisifax|nicergoline|Ergobel|Von Ct, Nicergolin|Nicerium|Nicergolin Atid|Nicotergoline|Nicergolin Ratiopharm|F.I. 6714|Nicergolin-Ratiopharm|Circo Maren|Nicergolin Neuraxpharm|Nicergolin Lindo|Sermion"
D010431,CHEMICAL,Pentoxifylline,pentoxifylline|BL 191|BL191|BL-191|Trental|Torental|Oxpentifylline|Agapurin|Pentoxil
D013375,DISEASE,Substance Withdrawal Syndrome,"Substance Withdrawal Syndromes|withdrawal syndrome|Symptoms, Withdrawal|Symptoms, Drug Withdrawal|Drug Withdrawal Symptoms|Withdrawal Symptom, Drug|Syndrome, Substance Withdrawal|Symptom, Drug Withdrawal|Symptom, Withdrawal|Drug Withdrawal Symptom|Withdrawal Syndromes, Substance|Withdrawal Symptoms|Withdrawal Symptom|Withdrawal Symptoms, Drug|Syndromes, Substance Withdrawal|Withdrawal Syndrome, Substance"
NEW03437,BIOCHEMICAL,H(2)-receptor antagonists,H(2)-receptor antagonists
D019283,DISEASE,"Pancreatitis, Acute Necrotizing","Pancreatitis Necrotising|Necrotizing Pancreatitis, Acute|Pancreatic Necroses|Acute Necrotizing Pancreatitis|Pancreatic Necrosis|Necrosis, Pancreatic|Pancreatitis, Hemorrhagic Necrotic|Necrotic Pancreatitis, Hemorrhagic|acute pancreatitis|Hemorrhagic Necrotic Pancreatitides|Pancreatitis Necrotisings|Pancreatitis Necrotizings|Pancreatitis Necrotizing|Hemorrhagic Necrotic Pancreatitis"
NEW03438,CHEMICAL,ranitidine exposure,ranitidine exposure
NEW03439,CHEMICAL,cimetidine exposure,cimetidine exposure
NEW03443,CHEMICAL,rare ADR,rare ADR
NEW03445,CHEMICAL,ternatea L.,ternatea L.
NEW03446,DISEASE,chronic thromboembolic pulmonary hypertension,CTEPH|chronic thromboembolic pulmonary hypertension
NEW03448,CHEMICAL,blood/urine samples,blood/urine samples
NEW03450,CHEMICAL,Chaiyuwendan decoction,Chaiyuwendan decoction
NEW00768,MENTAL_HEALTH,atypical depression,atypical depression
NEW03454,CHEMICAL,lipid-derived messenger oleoylethanolamide,OEA|lipid-derived messenger oleoylethanolamide
NEW03456,BIOCHEMICAL,PPAR signalling system,PPAR signalling system
D064446,CHEMICAL,Orexin Receptors,"HCRT Receptor 1|Hypocretin-1 Receptor|Receptor, Hypocretin|HCRT Receptor 2|Receptor, Orexin-A|Orexin-A Receptor|Receptors, Orexin-A|Receptors 2, Hypocretin|Protein, HCTR2|Orexin Receptor|Receptor, Orexin B|OX1 Receptor|Receptor 1, HCRT|Orexin A Receptor|Hypocretin Receptor 2|OX1 Receptors|Receptors, Hypocretin|Receptors, Orexin|Orexin-B Receptor|Receptor, Hypocretin-2|Receptor 2, Hypocretin|Orexin A Receptors|Orexin B Receptor|Hypocretin 2 Receptor|Orexin-A Receptors|Receptor 2, HCRT|Orexin A|Orexin B Receptors|Hypocretin Receptors 2|Receptor, Orexin A|Orexin Receptor Type 2|Receptor 2, Orexin|OX2 Receptors|Hypocretin 1 Receptor|Receptors, OX2|Receptors, Orexin-B|Receptor, OX1|Receptors, OX1|Orexin Receptor 2|Hypocretin Receptors|OX2 Receptor|Receptor, Hypocretin-1|Hypocretin Receptor|Receptor, Orexin|Hypocretin-2 Receptor|Orexin Receptor Type 1|Receptor, Orexin-B|Receptor, OX2|HCTR2 Protein|Orexin-B Receptors"
NEW01288,DISEASE,narcoleptic patients,narcoleptic patients
C094503,CHEMICAL,glyceryl 2-arachidonate [Supplementary Concept],2-arachidonoylglycerol|Arachidonic Acids|Endocannabinoids|2-AG|Glycerides
C000596110,CHEMICAL,palmitoylethanolamide-succinamylgalactos-6'-yl ester [Supplementary Concept],Palmitates|Palmitoylethanolamide|Galactose/analogs  and  derivatives
NEW03462,DISEASE,PTSD patients,PTSD patients
NEW03463,CHEMICAL,related N-acyl-ethanolamides,related N-acyl-ethanolamides
D063388,CHEMICAL,Endocannabinoids,Endocannabinoid|Endocannabinoids
NEW03465,DISEASE,traumatic stress exposure,traumatic stress exposure
D008995,DISEASE,Monoamine Oxidase,"MAO A|MAO-B|Amine Oxidase (Flavin-Containing)|Oxidase, Tyramine|Type A Monoamine Oxidase|Monoamine Oxidase A|Monoamine Oxidase B|MAO|Type B Monoamine Oxidase|MAO-A|MAO B|Oxidase, Monoamine|Tyramine Oxidase"
NEW03468,CHEMICAL,MAO enzymatic activity,MAO enzymatic activity
NEW03469,DISEASE,severe depressive stress symptoms,severe depressive stress symptoms
NEW03471,DISEASE,Reported traumatic stress,Reported traumatic stress
NEW03473,CHEMICAL,ribonuclease H inhibitors,ribonuclease H inhibitors
C477074,DISEASE,"MYCT1 protein, human [Supplementary Concept]",cancer cells|Nuclear Proteins
NEW01698,BIOCHEMICAL,nucleoside reverse transcriptase inhibitors,nucleoside reverse transcriptase inhibitors
C451734,CHEMICAL,etravirine [Supplementary Concept],Nitriles|Pyrimidines|Etravirine
NEW03478,DISEASE,Extrapyramidal symptoms,EPS|Extrapyramidal symptoms
NEW03480,CHEMICAL,selective serotonin re-uptake inhibitors,selective serotonin re-uptake inhibitors
D058825,BIOCHEMICAL,Serotonin 5-HT1 Receptor Agonists,"Serotonin 5 HT1D Receptor Agonists|5-HT1D Agonist|Agonist, 5-HT1B|Serotonin 5-HT1D Receptor Agonists|5 HT1D Agonist|5-HT1B-D Agonist|5-HT1A agonist|Serotonin 5-HT1A Receptor Agonists|Serotonin 5-HT1B-D Agonists|5-HT1 Agonist|Serotonin 5 HT1 Receptor Agonists|Agonists, 5-HT1|Serotonin 5 HT1B Receptor Agonists|5-HT1B Agonist|Agonist, 5-HT1|Serotonin 5 HT1A Receptor Agonists|Agonist, 5-HT1B-D|5-HT1 Agonists|5 HT1 Agonists|5 HT1B Agonist|Serotonin 5-HT1B Receptor Agonists|Agonist, 5-HT1A|Agonists, Serotonin 5-HT1B-D|5-HT1A Agonist|Serotonin 5 HT1B D Agonists|5 HT1B D Agonist|Agonist, 5-HT1D|5 HT1A Agonist|5 HT1 Agonist|5-HT1B-D Agonists, Serotonin"
NEW03483,CHEMICAL,indorenate 5-methoxytryptamine beta-methyl carboxylate hydrochloride,indorenate 5-methoxytryptamine beta-methyl carboxylate hydrochloride
D018490,BIOCHEMICAL,Serotonin Agents,"Drugs, Serotonin|Serotoninergic Effect|Agents, Serotonin|Serotonergic Drugs|Effects, Serotoninergic|Serotonin Drugs|Effects, Serotonin|Agents, Serotonergic|serotonergic agents|Serotonin Effects|Serotoninergic Effects|Serotonin Effect|Serotonergic Agents|Effect, Serotonin|Drugs, Serotonergic|Effect, Serotoninergic"
NEW03484,CHEMICAL,Dysfunctional 5HT rhythms,Dysfunctional 5HT rhythms
NEW03486,CHEMICAL,5HT oscillations,5HT oscillations
C062720,CHEMICAL,mosapride [Supplementary Concept],Morpholines|Benzamides|mosapride
C406662,CHEMICAL,prucalopride [Supplementary Concept],prucalopride|Benzofurans
NEW03490,CHEMICAL,NO donors,NO donors
NEW03491,CHEMICAL,progesterone,progesterone
NEW03493,CHEMICAL,direct quipazine,direct quipazine
NEW03494,CHEMICAL,indirect fluoxetine,indirect fluoxetine
NEW03495,DISEASE,significant hypophagia,significant hypophagia
NEW03496,CHEMICAL,fluoxetine,fluoxetine
C046301,CHEMICAL,seganserin [Supplementary Concept],Piperidines|Seganserin
D011814,CHEMICAL,Quipazine,Quipazine Hydrochloride|MA1291|Quipazine Maleate (1:1)|Quipazine Maleate|2-(1-Piperazinyl)quinoline|MA-1291|quipazine|MA 1291
D020912,CHEMICAL,Moclobemide,"Moclobemide, GenRX|Moclobemid von ct|Moclobeta|Moclodura|Moclobemide, Healthsense|DBL Moclobemide|PMS-Moclobemide|Ro 11 1163|Nu Moclobemide|Healthsense Moclobemide|Deprenorm|Moclobemide|Moclobemid AZU|NovoMoclobemide|Moclobemid Stada|Moclobamide|Terry White Chemists Moclobemide|Moclobemid-Puren|Stada, Moclobemid|PMS Moclobemide|Moclix|Aurorex|Aurorix|Ro 11-1163|Novo Moclobemide|Moclobemid 1A Pharma|Ro-11-1163|NuMoclobemide|GenRX Moclobemide|Moclamine|Moclonorm|Manerix|Feraken|Moclobemid1A Pharma|Apo-Moclobemide|Moclobemid Puren|AZU, Moclobemid|Moclobemide, DBL|Moclobemide, Chem mart|Apo Moclobemide|von ct, Moclobemid|Novo-Moclobemide|Moclobemid-ratiopharm|Nu-Moclobemide|Moclobemid ratiopharm|Arima|Chem mart Moclobemide|Moclobemid-1A Pharma|Rimoc"
D061218,MENTAL_HEALTH,"Depressive Disorder, Treatment-Resistant","Refractory Depression|Depressions, Treatment Resistant|Depressive Disorder, Treatment Resistant|Therapy-Resistant Depression|Therapy-Resistant Depressions|refractory depression|Treatment-Resistant Depressive Disorders|Depression, Treatment Resistant|Disorder, Treatment-Resistant Depressive|Resistant Depression, Treatment|Refractory Depressions|Resistant Depressions, Treatment|Depression, Refractory|Depression, Therapy-Resistant|Depressions, Refractory|Depressive Disorders, Treatment-Resistant|Treatment Resistant Depressions|Treatment Resistant Depression|Treatment-Resistant Depressive Disorder|Therapy Resistant Depression|Disorders, Treatment-Resistant Depressive|Depressions, Therapy-Resistant"
D000084202,DISEASE,Chemotherapy-Related Cognitive Impairment,"Chemotherapy-Induced Cognitive Impairment|Cognitive Impairments, Chemotherapy-Induced|Chemotherapy Related Cognitive Dysfunction|Chemobrain|Chemotherapy-Induced Cognitive Impairments|Cognitive Impairments, Chemotherapy-Related|Chemo-Fog|Chemotherapy Induced Cognitive Impairment|Cognitive Dysfunction, Chemotherapy-Induced|Cognitive impairment|Chemotherapy Induced Cognitive Impairments|Chemotherapy-Induced Cognitive Dysfunction|Chemo Fog|Chemotherapy Induced Cognitive Dysfunction|Chemotherapy-Related Cognitive Dysfunction|Chemotherapy-Related Cognitive Dysfunctions|Cognitive Dysfunction, Chemotherapy-Related|Chemotherapy-Related Cognitive Impairments|Cognitive Impairment, Chemotherapy-Induced|Cognitive Impairment, Chemotherapy-Related|Chemotherapy Related Cognitive Impairment"
NEW03501,DISEASE,inappropriate antidiuretic hormone,inappropriate antidiuretic hormone|SIADH
NEW03503,DISEASE,panic patients,panic patients
NEW03505,CHEMICAL,Karoussi,Karoussi
NEW03507,DISEASE,affective instability abnormalities,affective instability abnormalities
NEW03510,CHEMICAL,azapirones,azapirones
NEW03512,BIOCHEMICAL,selective norepinephrine reuptake inhibitor,selective norepinephrine reuptake inhibitor
NEW03513,DISEASE,hyperactive mice,hyperactive mice
NEW03514,CHEMICAL,serotonin system genes,serotonin system genes
D000089983,CHEMICAL,Escitalopram,Lexapro|Escitalopram Oxalate|Escitalopram
NEW03516,MENTAL_HEALTH,generalized social phobia,generalized social phobia
NEW03519,CHEMICAL,serotonin systems,serotonin systems
NEW03520,CHEMICAL,serotonin-noradrenaline reuptake inhibitors,serotonin-noradrenaline reuptake inhibitors
NEW03521,CHEMICAL,noradrenaline reuptake inhibitor,SNRI|noradrenaline reuptake inhibitor
NEW02889,DISEASE,serotonergic dysfunction,serotonergic dysfunction
NEW03526,CHEMICAL,serotonin toxicity,serotonin toxicity
NEW03527,CHEMICAL,moderate serotonin toxicity,moderate serotonin toxicity
NEW03528,BIOCHEMICAL,novel KOP-r agonist MSB,novel KOP-r agonist MSB
D058918,CHEMICAL,Adenosine A3 Receptor Antagonists,"Receptor, Adenosine A3/antagonists and inhibitors (2004-2010)|adenosine"
NEW03533,BIOCHEMICAL,empirical antitubercular therapy,empirical antitubercular therapy
NEW03535,BIOCHEMICAL,Lithium mood stabilisers,Lithium mood stabilisers
NEW01159,DISEASE,advanced Parkinson's disease,advanced Parkinson's disease
NEW03539,BIOCHEMICAL,mood stabiliser,mood stabiliser
NEW03540,BIOCHEMICAL,drug treatments,drug treatments
NEW03541,BIOCHEMICAL,mood stabilisers,mood stabilisers
NEW03542,BIOCHEMICAL,mood stabiliser treatment,mood stabiliser treatment
NEW03543,MENTAL_HEALTH,bipolar mania,bipolar mania
C522667,CHEMICAL,asenapine [Supplementary Concept],Dibenzocycloheptenes|Asenapine
NEW03545,CHEMICAL,intravenous ascorbate,intravenous ascorbate|VitC
NEW03547,BIOCHEMICAL,Acute vitamin C administration,Acute vitamin C administration
D058979,BIOCHEMICAL,Proton-Coupled Folate Transporter,"Folate Transporter, Proton-Coupled|Solute Carrier Family 46, Member 1|Proton Coupled Folate Transporter|folate|Transporter, Proton-Coupled Folate|Folate Transporter, Proton Coupled"
D009525,BIOCHEMICAL,Niacin,"Nicotinic Acid|Niacin Magnesium Salt|Nicobid|Lithium Nicotinate|Nicolar|Nicotinate, Lithium|Nico 400|niacin|Nico400|Wampocap|Tosylate, Niacin|Niacin Calcium Salt|Enduracin|Niacin Lithium Salt, Hemihydrate|Niacin Cobalt (2+) Salt|Niacin Manganese (2+) Salt|3 Pyridinecarboxylic Acid|3-Pyridinecarboxylic Acid|Nicamin|Niacin Lithium Salt|Niacin Copper (2+) Salt|Tartrate, Niacin|Niacin Ammonium Salt|Nicotinate|Nicocap|Hydrochloride, Niacin|Niacin Potassium Salt|Niacin Aluminum Salt|Niacin Zinc Salt|Niacin Iron (2+) Salt|Niacin Tartrate|Niacin Sodium Salt|Niacin Hydrochloride|Induracin|Aluminum Salt, Niacin|Potassium Salt, Niacin|Sodium Salt, Niacin|Nico-400|Niacin Tosylate"
NEW03550,CHEMICAL,energy-adjusted DII,energy-adjusted DII|E-DII
NEW03551,BIOCHEMICAL,ascorbic acid supplementation,ascorbic acid supplementation
NEW03555,CHEMICAL,chronic stress-induced epinephrine,chronic stress-induced epinephrine
NEW03557,BIOCHEMICAL,LDHA-lowering agent vitamin C,LDHA-lowering agent vitamin C
D002395,CHEMICAL,Catecholamines,Catecholamine|Sympathins|catecholamines|Sympathin
NEW03559,CHEMICAL,abnormal early morning cortisol levels,abnormal early morning cortisol levels
NEW03560,NUTRITION,Low serum cholesterol levels,Low serum cholesterol levels
NEW03561,CHEMICAL,Prostaglandin (PG)E1,Prostaglandin (PG)E1
NEW03562,DISEASE,manic patients,manic patients
NEW03564,CHEMICAL,alcohol concentrations,alcohol concentrations
NEW03566,NUTRITION,Omega fatty acids,Omega fatty acids
NEW03568,CHEMICAL,Carbon dioxide laser technology,Carbon dioxide laser technology
NEW03569,CHEMICAL,Chronic ethanol exposure,Chronic ethanol exposure
NEW03570,CHEMICAL,Ethanol treatment,Ethanol treatment
D000872,NUTRITION,Anthocyanins,anthocyanins|Anthocyanidin|Anthocyanidins|Leucoanthocyanidins|Anthocyanin
NEW03572,BIOCHEMICAL,oral vitamin C supplementation,oral vitamin C supplementation
D006713,CHEMICAL,Homogentisic Acid,"Acid, Homogentisic|Homogentisic acid"
D017042,DISEASE,"Phenylketonuria, Maternal","Phenylalanine Hydroxylase Deficiency Disease, Maternal|PKU|Maternal Phenylketonuria|Pregnancy in Phenylketonuria|Phenylketonuria, Pregnancy in|Phenylketonuria|Maternal Phenylalanine Hydroxylase Deficiency Disease|Phenylalanine-Hydroxylase Deficiency Disease, Maternal|PKU, Maternal"
NEW03575,BIOCHEMICAL,vitamin C intake,vitamin C intake
NEW03576,CHEMICAL,short-chain EFA supplementation,short-chain EFA supplementation
D006333,DISEASE,Heart Failure,"Right Sided Heart Failure|Congestive Heart Failure|Heart Failure, Right Sided|Decompensation, Heart|Heart Failure, Left Sided|Heart Failure, Congestive|Heart Failure, Left-Sided|Heart Decompensation|Cardiac failure|Left-Sided Heart Failure|Right-Sided Heart Failure|Cardiac Failure|Myocardial Failure|Heart Failure, Right-Sided|Left Sided Heart Failure"
D002637,DISEASE,Chest Pain,"Syndrome, Precordial Catch|Precordial Catch|Chest Pains|Pains, Chest|Texidor Twinge|Pain, Chest|Precordial Catch Syndrome|chest pain|Texidor's Twinge"
D004418,DISEASE,"Dyspnea, Paroxysmal","Paroxysmal Dyspnea|Paroxysmal Dyspneas|Dyspnea, Paroxysmal Nocturnal|dyspnea|Dyspneas, Paroxysmal|Asthma, Cardiac"
D057774,DISEASE,Post-Exercise Hypotension,"Postexercise Hypotension|Hypotensions, Post Exercise|Hypotensions, Postexercise|Post-Exercise Hypotensions|Hypotension, Postexercise|hypotension|Hypotension, Post Exercise|Post Exercise Hypotension|Post Exercise Hypotensions|Postexercise Hypotensions|Hypotensions, Post-Exercise|Hypotension, Post-Exercise"
D058085,CHEMICAL,Iron Compounds,"iron|Compounds, Iron|Fe"
NEW03580,BIOCHEMICAL,higher vitamin C,higher vitamin C
NEW03582,BIOCHEMICAL,vitamin levels,vitamin levels
D050940,CHEMICAL,Betaine-Homocysteine S-Methyltransferase,"Betaine Homocysteine Methyltransferase|Methyltransferase, Betaine-Homocysteine|Betaine Homocysteine Methyltransferase 2|Methyltransferase, Betaine Homocysteine|Betaine-Homocysteine Methyltransferase-2|Methyltransferase-2, Betaine-Homocysteine|Betaine-Homocysteine Methyltransferase 2|Betaine-Homocysteine Methyltransferase|S-Methyltransferase, Betaine-Homocysteine|MTase, Bet-HCys|Methyltransferase 2, Betaine-Homocysteine|Betaine Homocysteine S Methyltransferase|homocysteine|Bet HCys MTase|Homocysteine Methyltransferase, Betaine|Bet-HCys MTase"
NEW03585,DISEASE,CONCLUSIONS Hyperhomocysteinemia,CONCLUSIONS Hyperhomocysteinemia
D002746,CHEMICAL,Chlorpromazine,"Contomin|chlorpromazine|Hydrochloride, Chlorpromazine|Largactil|Thorazine|Chlordelazine|Chlorpromazine Hydrochloride|Propaphenin|Chlorazine|Aminazine|Fenactil"
C104273,CHEMICAL,hydroxyglimepiride [Supplementary Concept],Sulfonylurea Compounds|glimepiride
D002446,DISEASE,Celiac Disease,"Sprue|Gluten-Sensitive Enteropathies|Celiac Disease|Nontropical Sprue|Sprue, Celiac|Enteropathy, Gluten|Gluten-Sensitive Enteropathy|Gluten Enteropathies|Enteropathies, Gluten-Sensitive|Enteropathy, Gluten-Sensitive|Disease, Celiac|Gluten Enteropathy|Sprue, Nontropical|Celiac Sprue|Enteropathies, Gluten|Gluten Sensitive Enteropathy"
NEW03591,BIOCHEMICAL,artificial non-nutritive sweeteners,artificial non-nutritive sweeteners
NEW03592,DISEASE,AN-B/P group,AN-B/P group
C016766,CHEMICAL,sulforaphane [Supplementary Concept],Isothiocyanates|sulforaphane|Sulfoxides
D000077157,CHEMICAL,Sorafenib,Sorafenib N Oxide|BAY 545 9085|Nexavar|BAY 5459085|4-(4-(3-(4-Chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxylic acid methyamide-4-methylbenzenesulfonate|Sorafenib|BAY 545-9085|BAY 673472|Sorafenib N-Oxide|BAY 43 9006|BAY-545-9085|BAY-673472|BAY 439006|Sorafenib Tosylate|BAY5459085|BAY 43-9006
C025457,CHEMICAL,2-ethylamino-1-(3-stearoylphenyl)ethanol [Supplementary Concept],stearic acid|Etilefrine/analogs  and  derivatives
D019301,CHEMICAL,Oleic Acid,Oleate|cis-9-Octadecenoic Acid|9-Octadecenoic Acid|9 Octadecenoic Acid|oleic acid|cis 9 Octadecenoic Acid
D019787,CHEMICAL,Linoleic Acid,"Linoleic Acid, (Z,Z)-Isomer|9,12-Octadecadienoic Acid|Linoleic Acid, Sodium Salt, (E,E)-Isomer|Linoleate|Linoelaidic Acid, (E,Z)-Isomer|Linoelaidic Acid|cis,cis-9,12-Octadecadienoic Acid|9 trans,12 trans Octadecadienoic Acid|9,12 Octadecadienoic Acid|9-trans,12-trans-Octadecadienoic Acid|Linoleic Acid, Calcium Salt, (Z,Z)-Isomer|Linoleic Acid, Sodium Salt, (Z,Z)-Isomer|trans,trans-9,12-Octadecadienoic Acid|Linolelaidic Acid|Acid, 9,12-Octadecadienoic|Linoleic Acid, (E,E)-Isomer|Linoleic Acid, Potassium Salt, (Z,Z)-Isomer|Linoleic Acid, (Z,E)-Isomer|linoleic acid|Linoleic Acid, (Z,Z)-Isomer, 14C-Labeled|Linoleic Acid, Ammonium Salt, (Z,Z)-Isomer"
D019308,CHEMICAL,Palmitic Acid,"Palmitate, Sodium|Acid, Hexadecanoic|Calcium Palmitate|Sodium Palmitate|palmitic acid|Hexadecanoic Acid|Acid, Palmitic|Palmitate, Calcium"
NEW03594,NUTRITION,selenium-rich Brazil nut,Bertholletia excelsa|selenium-rich Brazil nut
NEW03596,CHEMICAL,pioglitazone,pioglitazone
NEW03598,DISEASE,chronic thermal hyperalgesia,chronic thermal hyperalgesia
NEW03601,BIOCHEMICAL,Xenoestrogen endocrine disrupters,Xenoestrogen endocrine disrupters
NEW03602,BIOCHEMICAL,street drug use,street drug use
D020528,DISEASE,"Multiple Sclerosis, Chronic Progressive","Multiple Sclerosis, Primary Progressive|Secondary Progressive Multiple Sclerosis|Primary Progressive Multiple Sclerosis|SPMS|Multiple Sclerosis, Progressive Relapsing|secondary progressive multiple sclerosis|Multiple Sclerosis, Secondary Progressive|Chronic Progressive Multiple Sclerosis|Progressive Relapsing Multiple Sclerosis|Multiple Sclerosis, Remittent Progressive|Remittent Progressive Multiple Sclerosis"
NEW03604,DISEASE,Ovarian dysfunction,Ovarian dysfunction
NEW03608,CHEMICAL,melanopsin system responsible,melanopsin system responsible
D014820,DISEASE,Vitiligo,vitiligo
D059565,CHEMICAL,G2 Phase Cell Cycle Checkpoints,"G2 phase|Restriction Points, G2|Checkpoints, Antephase|G2 Cell Cycle Control|G2 Cell Cycle Checkpoints|Antephase Checkpoint|G2-M Cell Cycle Checkpoint|G2 Phase Checkpoint|G2 Restriction Points|Checkpoints, G2 Phase|Antephase Checkpoints|G2 Cell Cycle Arrest|G2 Phase Checkpoints|Checkpoint, Antephase|Checkpoint, G2 Phase|Restriction Point, G2|G2 Restriction Point|G2 M Cell Cycle Checkpoint"
C454300,CHEMICAL,estradiol valerate-dienogest [Supplementary Concept],Nandrolone/analogs  and  derivatives|Drug Combinations|Estradiol/analogs  and  derivatives|estradiol valerate
NEW03613,DISEASE,Abnormal anterior pituitary responsiveness,Abnormal anterior pituitary responsiveness
NEW02127,CHEMICAL,±,±
NEW03619,DISEASE,alopecic lesions,alopecic lesions
NEW03622,DISEASE,severe hair loss,severe hair loss
NEW03623,CHEMICAL,high DHEA level,high DHEA level
NEW03624,CHEMICAL,excess dopamine,excess dopamine
NEW03625,CHEMICAL,dexamethasone administration,dexamethasone administration
NEW03627,MENTAL_HEALTH,DSM-III melancholia,DSM-III melancholia
D009839,DISEASE,Oligomenorrhea,oligomenorrhea|Oligomenorrheas
NEW03632,CHEMICAL,D-amino acid oxidase inhibitor,D-amino acid oxidase inhibitor
NEW03634,CHEMICAL,cortical 5-HT(2A receptors,cortical 5-HT(2A receptors
NEW03635,DISEASE,Chronic restraint stress,Chronic restraint stress
NEW03636,BIOCHEMICAL,hormones epinephrine,hormones epinephrine
NEW03638,BIOCHEMICAL,selective ADRB1 antagonist atenolol,selective ADRB1 antagonist atenolol
NEW03640,BIOCHEMICAL,ADRB2 antagonists,ADRB2 antagonists
NEW03642,DISEASE,CRH hypersecretion,CRH hypersecretion
NEW03643,CHEMICAL,17beta-oestradiol,17beta-oestradiol
D028021,CHEMICAL,Sodium-Potassium-Chloride Symporters,"Cotransporter, NaCl-KCl|NaCl KCl Cotransporter|Na K Cl Transporter|SLC12A Transporters|Transporters, SLC12A|Na(+), K(+), Cl(-)-Cotransporter|Solute Carrier Family 12|KCl|Na-K-Cl-Transporter|Symporter, NaK2Cl|Sodium-Potassium-Chloride Cotransporter|Sodium, Potassium, Chloride-Cotransporter|Sodium Potassium Chloride Cotransporters|Na K Cl Symporter|Na-K-Cl-Symporter|Symporters, Sodium-Potassium-Chloride|Cotransporter, Sodium-Potassium-Chloride|NaK2Cl Symporter|Sodium-Potassium-Chloride Cotransporters|NaCl-KCl Cotransporter|Sodium Potassium Chloride Symporters|Cotransporters, Sodium-Potassium-Chloride|Sodium Potassium Chloride Cotransporter"
NEW02026,DISEASE,dietary deficiency,dietary deficiency
D017607,CHEMICAL,Aluminum Compounds,"aluminum|Compounds, Aluminum"
D000077410,CHEMICAL,Aluminum Chloride,"Drysol|aluminum chloride|AlCl3|Aluminum Chloride, Anhydrous|Aluminum Chloride Hexahydrate|Anhydrous Aluminum Chloride|Aluminum Trichloride"
C062088,CHEMICAL,ferric maltol [Supplementary Concept],maltol|Ferric Compounds|Pyrones
D002549,DISEASE,Diffuse Cerebral Sclerosis of Schilder,"Alpers Huttenlocher Syndrome|Alpers Diffuse Degeneration of Cerebral Gray Matter with Hepatic Cirrhosis|Alper's Syndrome|Encephalitis Periaxialis Diffusa|Myelinoclastic Diffuse Sclerosis|Neuronal Degeneration Of Childhood With Liver Disease, Progressive|Disease, Schilder|Alpers' Disease|Scleroses, Balo's Concentric|Cerebral Sclerosis, Diffuse|Sclerosis, Myelinoclastic Diffuse|Alpers-Huttenlocher Syndrome|Diffuse Sclerosis, Myelinoclastic|Concentric Sclerosis, Balo|Progressive Sclerosing Poliodystrophy|Syndrome, Alpers|Balo Concentric Sclerosis|Progressive Neuronal Degeneration of Childhood with Liver Disease|Schilder's Disease|neuronal degeneration|Diffuse Cerebral Sclerosis|Encephalitis Periaxialis Concentrica|Alpers Disease|Encephalitis Periaxialis|Diffuse Cerebral Scleroses|Alpers Syndrome|Diffuse Scleroses, Myelinoclastic|Alper Disease|Poliodystrophia Cerebri|Alpers Progressive Infantile Poliodystrophy|Disease, Schilder's|Disease, Alpers'|Sclerosis, Diffuse Cerebral|Schilder Disease|Sudanophilic Cerebral Sclerosis|Alper's Disease|Balo's Concentric Sclerosis|Myelinoclastic Diffuse Scleroses|Schilders Disease|Scleroses, Myelinoclastic Diffuse|Concentric Sclerosis, Balo's|Alpers' Syndrome|Progressive Sclerosing Poliodystrophies|Alper Syndrome|Syndrome, Alpers-Huttenlocher"
D018373,DISEASE,Peripheral Nervous System Agents,Peripheral Nervous System Drugs|peripheral nervous system|Peripheral Nervous System Effects|Peripheral Nervous System Effect
NEW03649,BIOCHEMICAL,drug olanzapine,drug olanzapine
D051296,CHEMICAL,Glucose Transporter Type 5,D-Fructose Transporter|SLC2A5 Protein|GLUT 5 Protein|GLUT5 Protein|glucose transporter|GLUT-5 Protein
D013212,DISEASE,Staphylococcus epidermidis,Staphylococcus epidermidis|Staphylococcus (1966-1983)
NEW03650,CHEMICAL,compound melatonin,compound melatonin
NEW03652,BIOCHEMICAL,stress hormone corticosterone,stress hormone corticosterone
NEW03654,CHEMICAL,short-term ATR exposure,short-term ATR exposure
NEW03659,CHEMICAL,Abeta42 levels,Abeta42 levels
D007665,CHEMICAL,Ketotifen,"Ketotiphen|ketotifen|Ketotiphene|4,9-Dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo(4,5)-cyclohepta(1,2-b)thiophen-10-one|Ketotifen Fumarate|Zaditen|Fumarate, Ketotifen|Ketotifene"
NEW03662,DISEASE,Sleep-wake behavior,Sleep-wake behavior
NEW03664,CHEMICAL,fluvoxamine treatment,fluvoxamine treatment
D027425,MENTAL_HEALTH,Multidrug Resistance-Associated Proteins,"Resistance-Associated Protein, Multidrug|ATP Binding Cassette, Sub Family C Proteins|Multidrug resistance|MOAT Protein|Multidrug Resistance Associated Proteins|Multidrug Resistance-Associated Protein|Multispecific Organic Anion Transporter|Multispecific Organic Anion Transport Proteins|ATP-Binding Cassette, Sub-Family C Proteins|Multidrug Resistance Associated Protein"
NEW03666,CHEMICAL,human doxorubicin,human doxorubicin|doxo
C021183,CHEMICAL,"1,7-dimethylxanthine [Supplementary Concept]",Paraxanthine|Theophylline
NEW03669,CHEMICAL,Chocolate intake,Chocolate intake
NEW03670,CHEMICAL,Piperaceae organic solvent-extract,Piperaceae organic solvent-extract
C452039,CHEMICAL,flavokawain B [Supplementary Concept],FKB|flavokawain B|Flavonoids
NEW03673,DISEASE,iron-overload disease,iron-overload disease
NEW03676,DISEASE,damage excess,damage excess
D008104,DISEASE,"Liver Cirrhosis, Alcoholic","alcoholic cirrhosis|Hepatic Cirrhosis, Alcoholic|Alcoholic Liver Cirrhosis|Alcoholic Hepatic Cirrhosis|Alcoholic Cirrhosis"
NEW03678,CHEMICAL,Hepatic ammonia detoxification,Hepatic ammonia detoxification
NEW03680,DISEASE,simple hyperammonemia,simple hyperammonemia
D006501,DISEASE,Hepatic Encephalopathy,"Coma, Hepatic|Encephalopathies, Portosystemic|Portosystemic Encephalopathy|Hepatic Stupors|Portal-Systemic Encephalopathies|Encephalopathy, Portosystemic|Encephalopathy, Portal Systemic|Encephalopathies, Hepatic|Encephalopathies, Portal-Systemic|Fulminant Hepatic Failure with Cerebral Edema|Portal-Systemic Encephalopathy|Encephalopathy, Portal-Systemic|Hepatocerebral Encephalopathy|Portosystemic Encephalopathies|Comas, Hepatic|Portal Systemic Encephalopathy|Encephalopathy, Hepatocerebral|Stupor, Hepatic|Hepatic Stupor|Hepatic Encephalopathies|Hepatic Comas|Hepatic Coma|Stupors, Hepatic|Encephalopathy, Hepatic|Hepatocerebral Encephalopathies|Encephalopathies, Hepatocerebral|hepatic encephalopathy"
NEW03682,BIOCHEMICAL,hepatotoxin,hepatotoxin
NEW03683,CHEMICAL,uracil moiety,uracil moiety
D037361,BIOCHEMICAL,Adenylate Cyclase Toxin,"Cyclase-Hemolysin, Adenylate|toxin|Ac Hly, Bordetella|Bordetella cyaA Protein|Pertussis Adenylate Cyclase-Haemolysin Bifunctional Protein|Bordetella pertussis Adenylate Cyclase Toxin|Bordetella AC Toxin|Cyclolysin|Bordetella Adenylate Cyclase Toxin|Adenylate Cyclase-Haemolysin Bifunctional Protein, B. pertussis|Bordetella Ac-Hly|Toxin, cyaA|cyaA Toxin|Ac-Hly, Bordetella|Toxin, Adenylate Cyclase|Pertussis Adenylate Cyclase Haemolysin Bifunctional Protein|Protein, Bordetella cyaA|AC Toxin, Bordetella|Adenylate Cyclase Haemolysin Bifunctional Protein, B. pertussis|Adenylate Cyclase Hemolysin|cyaA Gene Product, Bordetella|cyaA Protein, Bordetella|Adenylate Cyclase-Hemolysin|Toxin, Bordetella AC|Cyclase Toxin, Adenylate"
NEW03685,CHEMICAL,CACNA1C voltage-gated calcium channel gene,CACNA1C voltage-gated calcium channel gene
NEW03686,CHEMICAL,voltage-gated calcium channels,voltage-gated calcium channels
NEW03687,DISEASE,Most phaeochromocytomas,Most phaeochromocytomas
NEW03689,CHEMICAL,Neuronal NO synthase,Neuronal NO synthase
D058437,DISEASE,Hypertensive Retinopathy,"Hypertensive Retinopathies|hypertensive|Retinopathies, Hypertensive|Retinopathy, Hypertensive"
NEW03693,DISEASE,Ovarian function suppression,Ovarian function suppression
NEW03695,BIOCHEMICAL,Endocrine Society,Endocrine Society
NEW03696,DISEASE,puberty suppression,puberty suppression
NEW03697,DISEASE,hypogonadotropic hypogonadal state,hypogonadotropic hypogonadal state
D015914,CHEMICAL,Estrogen Replacement Therapy,"Therapy, Estrogen Replacement|Replacement Therapy, Estrogen|Estrogen Replacements|Replacements, Estrogen|Estrogen Replacement|Estrogen Progestin Replacement Therapy|Replacement, Estrogen|Estrogen Replacement Therapies|Hormone Replacement Therapy, Post Menopausal|Therapies, Estrogen Replacement|Postmenopausal Hormone Replacement Therapy|Estrogen Progestin Combination Therapy|Hormone Replacement Therapy, Post-Menopausal|Replacement Therapies, Estrogen|HRT|postmenopausal hormone replacement therapy"
NEW03699,CHEMICAL,estrogen/progesterone hormone replacement therapy,estrogen/progesterone hormone replacement therapy
NEW03702,BIOCHEMICAL,selective receptor agonists,selective receptor agonists
NEW03703,CHEMICAL,i.c microinfusion,i.c microinfusion
NEW03704,DISEASE,confusion/disorientation,confusion/disorientation
D004155,CHEMICAL,Diphenhydramine,"Diphenylhydramine|Benylin|Allerdryl|Hydrochloride, Diphenhydramine|Benzhydramine|Diphenhydramine Citrate|Citrate, Diphenhydramine|Dormin|Diphenhydramine Hydrochloride|Dimedrol|Benadryl|Benhydramin|diphenhydramine|Diphenylhydramin|2-Diphenylmethoxy-N,N-dimethylethylamine|Diphenhydramine Citrate (1:1)"
C010119,CHEMICAL,latrepirdine [Supplementary Concept],Dimebon|Indoles
D006919,CHEMICAL,Hydroxyzine,"Hydroxyzine|2-(2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)ethanol|Hydroxyzine Dihydrochloride|Pamoate, Hydroxyzine|Orgatrax|Hydroxyzine Hydrochloride|Hydroxyzine Pamoate|Durrax|Atarax|Vistaril"
NEW03712,CHEMICAL,Pheniramine abuse,Pheniramine abuse
NEW03713,DISEASE,Severe pruritus,Severe pruritus
NEW03715,CHEMICAL,weals,weals
NEW03718,CHEMICAL,Pitolisant brand name,Pitolisant brand name
D039563,BIOCHEMICAL,"Histamine H1 Antagonists, Non-Sedating","Second Generation Antihistamine|H1 Antihistamines, Non-Sedating|Second Generation Antihistamines|Third Generation H1 Antagonist|Third Generation H1 Antagonists|H1 Antihistamines, Non Sedating|Histamine H1 Antagonists, Non Sedating|Second Generation H1 Antagonist|Non-Sedating H1 Antihistamines|Antihistamines, Second Generation|Antihistamine, Second Generation|antihistamine|Second Generation H1 Antagonists|Generation Antihistamine, Second"
NEW00169,MENTAL_HEALTH,anxiety symptoms,anxiety symptoms
D018755,BIOCHEMICAL,GABA Agonists,"gamma-Aminobutyric Acid Agonist|Agonist, GABA Receptor|Agonists, GABA|Agonist, gamma-Aminobutyric Acid|Acid Agonists, gamma-Aminobutyric|GABA Agonist|Agonists, gamma-Aminobutyric Acid|Receptor Agonists, GABA|gamma Aminobutyric Acid Agonists|Acid Agonist, gamma-Aminobutyric|GABA Receptor Agonist|gamma-Aminobutyric Acid Agonists|GABA receptor agonists|gamma Aminobutyric Acid Agonist|Receptor Agonist, GABA|Agonists, GABA Receptor|Agonist, GABA|GABA Receptor Agonists"
D058786,BIOCHEMICAL,GABA-B Receptor Agonists,"GABA-B Agonists|Agonist, GABA-B Receptor|GABA-B Receptor Agonist|Agonists, GABA-B|GABA B Agonists|Receptor Agonist, GABA-B|GABA(B receptor agonist|Receptor Agonists, GABA-B|GABA B Receptor Agonists|Agonists, GABA-B Receptor|GABA B Receptor Agonist"
NEW03723,BIOCHEMICAL,Non-competitive NMDA receptor antagonists,Non-competitive NMDA receptor antagonists
NEW03724,DISEASE,approach-avoidance behavior,approach-avoidance behavior
NEW03726,BIOCHEMICAL,GABA receptor agonist progabide,GABA receptor agonist progabide
D007099,CHEMICAL,Imipramine,"4,4'-Methylenebis(3-hydroxy-2-naphthoic acid)-3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N,N-dimethyl-1-propanamine (1:2)|Imidobenzyle|Janimine|Imipramine Pamoate|Norchlorimipramine|Pryleugan|Imipramine Monohydrochloride|Imipramine Hydrochloride|imipramine|Melipramine|Imizin|Tofranil"
C017985,CHEMICAL,progabide [Supplementary Concept],gamma-Aminobutyric Acid/analogs  and  derivatives|progabide
D014511,DISEASE,Uremia,Uremias|uremia
D018017,BIOCHEMICAL,"Receptors, Pituitary Hormone-Regulating Hormone","hormone|Receptors, Hypothalamic Release Inhibiting Hormones|Pituitary Hormone-Releasing Hormone Receptors|Pituitary Hormone-Regulating Hormone Receptors|Receptors, Hypothalamic Release-Inhibiting Hormones|Hypothalamic Release Inhibiting Hormone Receptors|Receptors, Hypothalamic Releasing Hormones|Receptors, Pituitary Hormone Releasing Hormone|Pituitary Hormone Regulating Hormone Receptors|Receptors, Pituitary Hormone-Releasing Hormone|Receptors, Pituitary Hormone Release Inhibiting Hormones|Receptors, Pituitary Hormone Regulating Hormone|Pituitary Hormone Releasing Hormone Receptors|Hypothalamic Releasing Hormone Receptors|Hypothalamic Release-Inhibiting Hormone Receptors"
NEW03734,BIOCHEMICAL,Uraemic toxins,Uraemic toxins
D000087527,BIOCHEMICAL,Uremic Toxins,uremic toxins|Uremia Toxins|Uremic Retention Solutes
D049950,DISEASE,"Hyperparathyroidism, Primary","Primary Hyperparathyroidism|hyperparathyroidism|Hyperparathyroidisms, Primary|Primary Hyperparathyroidisms"
NEW03737,DISEASE,renal anemia,renal anemia
NEW03738,DISEASE,Cerebral uremic solute accumulation,Cerebral uremic solute accumulation
NEW03740,DISEASE,End-stage renal disease patients,End-stage renal disease patients
D052241,DISEASE,Fanconi Anemia Complementation Group G Protein,Fanconi Anemia Group G Protein|Fanconi Anemia Group G Complementing Protein|anemia|XRCC9 Protein|X Ray Repair Complementing Defective Repair In Chinese Hamster Cells 9 Protein|X-Ray Repair Complementing Defective Repair In Chinese Hamster Cells 9 Protein|FANCG Protein
NEW03742,BIOCHEMICAL,retinoid X receptor agonist,retinoid X receptor agonist
D000077610,CHEMICAL,Bexarotene,"LGD-1069|LG69 compound|Targretin|3-methyl-TTNEB|bexarotene|LGD 1069|4-(1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethenyl)benzoic acid|LGD1069"
NEW03745,CHEMICAL,Methamphetamine neurotoxicity,Methamphetamine neurotoxicity
D008691,CHEMICAL,Methadone,"Biodone|Methadose|Methadone Hydrochloride|Metadol|Phenadone|Amidone|methadone|Physeptone|Dolophine|Pinadone|Methaddict|Phymet|Hydrochloride, Methadone|Symoron|Methex|Metasedin"
NEW03747,CHEMICAL,agonists morphine,agonists morphine
D003061,CHEMICAL,Codeine,"Codeine Phosphate|Isocodeine|Ardinex|N-Methylmorphine|N Methylmorphine|Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-|codeine"
NEW03748,BIOCHEMICAL,D2-like receptor agonists,D2-like receptor agonists
NEW03751,BIOCHEMICAL,Pharmacological therapy leukotriene antagonists,Pharmacological therapy leukotriene antagonists
NEW03755,CHEMICAL,striatal alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA glutamate receptors,striatal alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA glutamate receptors
NEW03756,CHEMICAL,Ca(2+)-permeable AMPA receptors,Ca(2+)-permeable AMPA receptors
C550098,CHEMICAL,"TRIOBP protein, mouse [Supplementary Concept]",TRIO|Microfilament Proteins
NEW03757,DISEASE,matter alterations,matter alterations
NEW03759,CHEMICAL,PFOS exposure,PFOS exposure
NEW02838,DISEASE,behavioral abnormalities,behavioral abnormalities
D017239,CHEMICAL,Paclitaxel,"Paclitaxel, (4 alpha)-Isomer|Anzatax|Taxol A|Praxel|Onxol|NSC125973|NSC-125973|Paxene|Paclitaxel|NSC 125973|Taxol, Bris|7-epi-Taxol|Taxol|Bris Taxol|7 epi Taxol"
NEW03762,BIOCHEMICAL,cancer chemotherapeutic drug,cancer chemotherapeutic drug
D016190,CHEMICAL,Carboplatin,CBDCA|Ribocarbo|Blastocarb|Nealorin|NSC241240|JM 8|Carboplat|Platinwas|Paraplatine|Carbotec|Paraplatin|JM-8|Ercar|NSC 241240|Neocarbo|JM8|Carbosin|cis-Diammine(cyclobutanedicarboxylato)platinum II|Carboplatin|NSC-241240
NEW03763,BIOCHEMICAL,Androgen deficiency,Androgen deficiency
NEW03766,DISEASE,Bladder dysfunction,Bladder dysfunction
D012791,DISEASE,Shy-Drager Syndrome,"Progressive Autonomic Failure|Dysautonomia Orthostatic Hypotension Syndrome|Dysautonomic Orthostatic Hypotension|Hypotensions, Dysautonomic Orthostatic|Failure, Progressive Autonomic|Orthostatic Hypotension, Dysautonomic|Orthostatic hypotension|Autonomic Failures, Progressive|Syndrome, Dysautonomia Orthostatic Hypotension|Hypotension Syndrome, Dysautonomia-Orthostatic|Hypotension Syndromes, Dysautonomia-Orthostatic|Dysautonomic Orthostatic Hypotensions|Idiopathic Orthostatic Hypotension, Shy Drager Type|Syndrome, Dysautonomia-Orthostatic Hypotension|Orthostatic Hypotensions, Dysautonomic|Dysautonomia-Orthostatic Hypotension Syndrome|Idiopathic Orthostatic Hypotension, Shy-Drager Type|Syndrome, Shy-Drager|Dysautonomia-Orthostatic Hypotension Syndromes|Failures, Progressive Autonomic|Shy Drager Syndrome|Syndromes, Dysautonomia-Orthostatic Hypotension|Hypotension, Dysautonomic Orthostatic|Autonomic Failure, Progressive|Progressive Autonomic Failures"
NEW03768,CHEMICAL,due alcohol toxicity,due alcohol toxicity
NEW03771,CHEMICAL,AL    ±,AL    ±
NEW03772,CHEMICAL,Ammonia-scavenging transmembrane pH-gradient poly(styrene)-b-poly(ethylene oxide polymersomes,Ammonia-scavenging transmembrane pH-gradient poly(styrene)-b-poly(ethylene oxide polymersomes
NEW03774,DISEASE,neurologic complications,neurologic complications
NEW03775,DISEASE,impaired cognitive flexibility,impaired cognitive flexibility
NEW03776,CHEMICAL,glutamatergic mossy cells,glutamatergic mossy cells|MCs
D002540,CHEMICAL,Cerebral Cortex,"Cortical Plates|Periallocortices|Cortex Cerebri|Paleocortices|Cortical Plate|Periallocortex|Allocortex|Allocortices|Plate, Cortical|Cortex Cerebrus|Archipallium|Paleocortex|Cortex, Cerebral|CC|Archipalliums|cerebral cortex|Cerebral Cortices"
NEW03779,CHEMICAL,human DES gene,human DES gene
NEW03781,MENTAL_HEALTH,physical fatigue,physical fatigue
NEW03786,MENTAL_HEALTH,elevated thought disorder cluster scores,elevated thought disorder cluster scores
NEW03788,MENTAL_HEALTH,thought disorder,thought disorder
NEW03791,DISEASE,schizophrenic-like symptoms,schizophrenic-like symptoms
NEW03792,CHEMICAL,alpha(2)-adrenoreceptor agonist clonidine,alpha(2)-adrenoreceptor agonist clonidine|CLO
NEW03795,BIOCHEMICAL,agonist clonidine,agonist clonidine
NEW03798,BIOCHEMICAL,subsensitive neuroendocrine,growth hormone|subsensitive neuroendocrine
D002997,CHEMICAL,Clomipramine,"Clomipramine Monohydrochloride|Clomipramine Maleate (1:1)|Monohydrochloride, Clomipramine|Hydiphen|Chlorimipramine|Hydrochloride, Clomipramine|Chlomipramine|Anafranil|Clomipramine Hydrochloride|clomipramine"
NEW03801,NUTRITION,alpha 2-adrenergic receptor sensitivity,alpha 2-adrenergic receptor sensitivity
NEW03802,BIOCHEMICAL,dopamine agonist apomorphine APO hydrochloride,dopamine agonist apomorphine APO hydrochloride
NEW03804,CHEMICAL,extrahypothalamic corticotropin-releasing hormone,CRH|extrahypothalamic corticotropin-releasing hormone
NEW03805,BIOCHEMICAL,CRH antagonists,CRH antagonists
D015671,CHEMICAL,Electroacupuncture,Acupuncture (1966-1989)|Electroacupuncture
NEW03807,DISEASE,SI mice,SI mice
NEW03808,MENTAL_HEALTH,anxiety status,anxiety status
NEW03809,DISEASE,Depression-related phenotypes,Depression-related phenotypes
NEW03811,DISEASE,manic phase,manic phase
NEW03812,DISEASE,late-onset OTCD,late-onset OTCD
NEW03815,DISEASE,peripheral noradrenergic dysfunction,peripheral noradrenergic dysfunction
NEW03816,CHEMICAL,MG patients,MG patients
NEW03817,BIOCHEMICAL,Several endocrine abnormalities,Several endocrine abnormalities
NEW03820,DISEASE,attention-deficit/hyperactivity disorder stimulant medication,attention-deficit/hyperactivity disorder stimulant medication
NEW03169,CHEMICAL,dexamethasone suppression test,dexamethasone suppression test
NEW03823,CHEMICAL,serotonin 5-HT reuptake inhibitor clomipramine,serotonin 5-HT reuptake inhibitor clomipramine
NEW00246,DISEASE,depressed patients,depressed patients
NEW03827,CHEMICAL,intravenous morphine,intravenous morphine
D009022,CHEMICAL,Morphine Derivatives,Morphines|Morphine
NEW03829,CHEMICAL,chronic sulpiride therapy,chronic sulpiride therapy
NEW03832,BIOCHEMICAL,growth hormone GH secretion,growth hormone GH secretion
NEW03833,DISEASE,insulin-induced hypoglycemia,insulin-induced hypoglycemia
NEW03834,CHEMICAL,GABAB receptor function,GABAB receptor function
NEW03835,CHEMICAL,baclofen administration,baclofen administration
NEW03071,CHEMICAL,response to TSH releasing hormone,response to TSH releasing hormone|TRH
NEW03839,BIOCHEMICAL,Growth hormone responses,Growth hormone responses
NEW03840,CHEMICAL,clonidine stimulation,clonidine stimulation
NEW03841,CHEMICAL,presynaptic noradrenaline secretion,presynaptic noradrenaline secretion
NEW03842,CHEMICAL,methylphenidate challenge,methylphenidate challenge
D001615,CHEMICAL,beta-Endorphin,"beta-Endorphin (1-31)|beta-EP|beta-endorphin|Endorphin, beta|beta Endorphin"
NEW03844,CHEMICAL,single acute MPH administration,single acute MPH administration
NEW03846,CHEMICAL,beta-EP release,beta-EP release
NEW03370,CHEMICAL,MPH treatment,MPH treatment
NEW03847,BIOCHEMICAL,Growth hormone 3-methoxy-4-hydroxyphenelethylene glycol response,Growth hormone 3-methoxy-4-hydroxyphenelethylene glycol response
NEW03848,BIOCHEMICAL,plasma growth hormone,plasma growth hormone
NEW03850,DISEASE,ADD+H,ADD+H
NEW03851,BIOCHEMICAL,somatotropic axis growth hormone,somatotropic axis growth hormone
NEW03852,CHEMICAL,metformin administration,metformin administration
D012080,DISEASE,Chronic Kidney Disease-Mineral and Bone Disorder,"CKD-MBD|Renal Rickets|Chronic Kidney Disease Mineral and Bone Disorder|kidney disease|Osteodystrophy, Renal|Rickets, Renal|Renal Osteodystrophy|Osteodystrophies, Renal|Renal Osteodystrophies"
D015325,DISEASE,Pyruvate Dehydrogenase Complex Deficiency Disease,"Deficiency, Pyruvate Decarboxylase|PDHC Deficiency Disease|Pyruvate Decarboxylase Deficiency|Ataxia, Intermittent, with Abnormal Pyruvate Metabolism|Ataxia with Lactic Acidosis I|Deficiency, PDH|Pyruvate Dehydrogenase Complex Deficiency|Type I Ataxia with Lactic Acidosis|Lactic Acidosis with Ataxia, Type I|Deficiency, PDHC|Pyruvate Dehydrogenase Deficiency|Ataxia with Lactic Acidosis, Type I|Ataxia with Lactic Acidosis|Neonatal Pyruvate Dehydrogenase Complex Deficiency Disease|lactic acidosis|PDH Deficiency|Ataxia, Intermittent, with Pyruvate Dehydrogenase, or Decarboxylase, Deficiency|Pyruvate Dehydrogenase Complex Deficiency Disease, Neonatal|Deficiency, Pyruvate Dehydrogenase|Intermittent Ataxia with Pyruvate Dehydrogenase Deficiency|Pyruvate Dehydrogenase Complex Deficiency Disease, Juvenile|Juvenile Pyruvate Dehydrogenase Complex Deficiency Disease|PDHC Deficiency"
D000890,BIOCHEMICAL,Anti-Infective Agents,"Agents, Antiinfective|Antiinfective Agents|Anti Infective Agents|Anti Infective Agent|Antimicrobial Agents|Anti-Microbial Agent|antimicrobial agent|Agents, Antimicrobial|Agents, Anti-Infective|Antimicrobial Agent|Agent, Antimicrobial|Agent, Anti-Microbial|Anti Microbial Agents|Anti-Microbial Agents|Anti-Infective Agent|Anti Microbial Agent|Agent, Anti-Infective|Agents, Anti-Microbial|Microbicide|Microbicides"
D044882,CHEMICAL,Glucose Metabolism Disorders,"glucose metabolism|Glucose Metabolic Disorder|Metabolism Disorder, Glucose|Disorder, Glucose Metabolic|Glucose Metabolism Disorder|Disorder, Glucose Metabolism|Glucose Metabolic Disorders|Disorders, Glucose Metabolic|Metabolic Disorder, Glucose|Disorders, Glucose Metabolism|Metabolic Disorders, Glucose|Metabolism Disorders, Glucose"
C580174,DISEASE,Huntington Disease-Like Syndrome [Supplementary Concept],"Heredodegenerative Disorders, Nervous System|Huntington's disease"
D000077154,CHEMICAL,Rosiglitazone,"BRL 49653|RSG|5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate|rosiglitazone|Avandia|BRL-49653|BRL49653|Rosiglitazone Maleate"
NEW03857,CHEMICAL,PPAR-γ agonist,PPAR-γ agonist
NEW03859,BIOCHEMICAL,Peroxiproliferator-activated receptor gamma agonist,Peroxiproliferator-activated receptor gamma agonist
NEW03865,BIOCHEMICAL,insulin-sensitizing peroxiproliferator-activated receptor agonist,insulin-sensitizing peroxiproliferator-activated receptor agonist
NEW03867,DISEASE,Subacute myelo-optico-neuropathy,Subacute myelo-optico-neuropathy
NEW03869,CHEMICAL,cyclic depsipeptide teixobactin,cyclic depsipeptide teixobactin
NEW03871,CHEMICAL,betahistine group,betahistine group
NEW03874,BIOCHEMICAL,Naranjo adverse drug reaction probability scale,Naranjo adverse drug reaction probability scale
NEW03878,BIOCHEMICAL,mu-opioid receptor agonist,mu-opioid receptor agonist
D017974,CHEMICAL,Uranium Compounds,"uranium|U-47700|Compounds, Uranium"
NEW03880,DISEASE,depressed adult outpatients,depressed adult outpatients
NEW03882,CHEMICAL,μ-opioid receptor agonist loperamide,μ-opioid receptor agonist loperamide
D003248,DISEASE,Constipation,Colonic Inertia|Dyschezia|Constipation
NEW03883,BIOCHEMICAL,polymer patch delivery,polymer patch delivery
NEW03884,BIOCHEMICAL,polymer delivery system,polymer delivery system
NEW03885,BIOCHEMICAL,#NAME?,#NAME?
NEW03887,BIOCHEMICAL,"selective TRPV1 antagonist JTS-653 (3S)-3-(hydroxymethyl)-4-(5-methylpyridin-2-yl)-N-[6-(2,2,2-trifluoroethoxy)pyridin-3-yl]-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxamide","selective TRPV1 antagonist JTS-653 (3S)-3-(hydroxymethyl)-4-(5-methylpyridin-2-yl)-N-[6-(2,2,2-trifluoroethoxy)pyridin-3-yl]-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxamide"
D050051,CHEMICAL,Transient Receptor Potential Channels,"Cation Channel, TRP|Membrane Proteins, TRP|Transient Receptor Potential Cation Channel|Cation Channels, TRP|Channels, TRP Cation|Proteins, TRP Membrane|Transient Receptor Potential Cation Channels|Channel, TRP Cation|TRP channels|TRP Cation Channels|Transient Receptor Potential Channel|TRP Membrane Proteins|TRP Cation Channel"
NEW03890,CHEMICAL,Chronic alcohol use,Chronic alcohol use
NEW03892,CHEMICAL,adrenoreceptor antagonist prazosin,adrenoreceptor antagonist prazosin
D011224,CHEMICAL,Prazosin,"Prazosin Hydrochloride|Pratsiol|Furazosin|prazosin|HCL, Prazosin|Minipress|Hydrochloride, Prazosin|Prazosin HCL"
NEW03894,CHEMICAL,Antidepressant medications,Antidepressant medications
NEW03895,CHEMICAL,5-hydroxytryptamine reuptake,5-hydroxytryptamine reuptake
NEW03896,CHEMICAL,5-HT transport,5-HT transport
NEW03897,CHEMICAL,low-dose dopamine DA antagonists,low-dose dopamine DA antagonists
NEW03899,CHEMICAL,5-HT systems,5-HT systems
NEW03311,CHEMICAL,serotonin neurons,serotonin neurons
NEW03900,BIOCHEMICAL,toxin lesion,toxin lesion
NEW03901,CHEMICAL,serotonin tone,serotonin tone
NEW03903,CHEMICAL,serotonin precursor 5-hydroxy-tryptophan,serotonin precursor 5-hydroxy-tryptophan|5-HTP
NEW03904,CHEMICAL,5-HTP,5-HTP
NEW03909,CHEMICAL,neonatal citalopram exposure,neonatal citalopram exposure
NEW03911,DISEASE,lasting behavioral abnormalities,lasting behavioral abnormalities
D019966,BIOCHEMICAL,Substance-Related Disorders,"Related Disorder, Substance|Drug Use Disorders|Abuse, Prescription Drug|Habituation, Drug|Dependence, Substance|Substance Use|Dependence, Chemical|Prescription Drug Abuse|Use, Substance|Disorder, Substance Use|Substance Use Disorder|drug addiction|Addiction, Substance|Disorders, Substance Related|Substance Abuses|Dependence, Drug|Disorder, Drug Use|Drug Abuse, Prescription|Substance Dependence|Organic Mental Disorders, Substance-Induced|Abuse, Substance|Drug Abuse|Related Disorders, Substance|Drug Habituation|Abuse, Drug|Substance Addiction|Drug Dependence|Chemical Dependence|Substance Related Disorder|Drug Use Disorder|Substance Uses|Substance Abuse|Chemical Dependences|Substance Use Disorders|Addiction, Drug|Organic Mental Disorders, Substance Induced|Dependences, Chemical|Drug Addiction|Disorder, Substance Related"
NEW03913,CHEMICAL,atypical antipsychotic clozapine,atypical antipsychotic clozapine
NEW03914,CHEMICAL,melatonin agonist/5-HT(2C,melatonin agonist/5-HT(2C
NEW03915,CHEMICAL,cholinergic agents/SRIs,cholinergic agents/SRIs
NEW03917,CHEMICAL,newer cyclic antidepressants,newer cyclic antidepressants
NEW03920,CHEMICAL,maintenance antidepressant therapy,maintenance antidepressant therapy
C000712087,CHEMICAL,ACH-000029 [Supplementary Concept],ACH-000029|Piperazines|Quinazolines
NEW03923,BIOCHEMICAL,cannabinoid CB(1 receptor antagonists,cannabinoid CB(1 receptor antagonists
D012640,DISEASE,Seizures,"Motor Seizure|Visual Seizures|Seizure, Auditory|Somatosensory Seizures|Seizures, Generalized Tonic-Clonic|Complex Partial Seizure|Clonic Seizures|Seizure, Visual|Seizures, Vertiginous|Generalized Absence Seizures|Seizures, Clonic|Tonic Seizures|Seizures, Tonic|Vertiginous Seizures|Focal Seizure|Convulsion|Absence Seizure, Generalized|Absence Seizures, Atonic|Seizures, Tonic-Clonic|Seizure, Atonic Absence|Focal Seizures|Absence Seizure, Atonic|Generalized Seizure|Seizures, Vestibular|Tonic Seizure|Petit Mal Convulsion|Seizure, Convulsive|Seizure, Complex Partial|Convulsion, Non-Epileptic|Seizure, Partial|Seizure, Gustatory|Epileptic Seizures|Seizures, Generalized|Seizure, Tonic-Clonic|Somatosensory Seizure|Seizure, Olfactory|Convulsion, Non Epileptic|Seizure, Nonepileptic|Vertiginous Seizure|Absence Seizures, Generalized|Clonic Seizures, Tonic|Clonic Seizure|Tonic-Clonic Seizures, Generalized|Tonic Clonic Seizures|Seizure, Clonic|Seizure, Motor|Gustatory Seizure|Atonic Absence Seizures|Non-Epileptic Seizures|Vestibular Seizure|Seizure, Generalized|Myoclonic Seizures|Epileptic Seizure|Convulsions|Generalized Tonic-Clonic Seizures|Convulsive Seizure|Non-Epileptic Convulsions|Gustatory Seizures|Atonic Seizures|Seizures, Focal|Seizure|Myoclonic Seizure|Visual Seizure|Seizures, Convulsive|Atonic Seizure|Olfactory Seizures|Partial Seizures, Complex|Seizures, Gustatory|Non-Epileptic Convulsion|Generalized Tonic-Clonic Seizure|Single Seizure|Seizures, Motor|Partial Seizure, Complex|Sensory Seizure|Seizures, Epileptic|Seizures, Sensory|Seizure, Generalized Absence|Tonic-Clonic Seizures|Absence Seizure|Generalized Tonic Clonic Seizures|Seizure, Tonic|Vestibular Seizures|Complex Partial Seizures|Seizure, Somatosensory|Seizure, Sensory|Seizure, Jacksonian|Motor Seizures|Seizure, Vestibular|Tonic Clonic Seizure|Convulsions, Non-Epileptic|Partial Seizures|Seizure, Non-Epileptic|Auditory Seizure|Generalized Absence Seizure|Seizures, Nonepileptic|Generalized Seizures|Clonic Seizure, Tonic|Seizure, Atonic|Non Epileptic Seizure|Partial Seizure|Non Epileptic Seizures|Convulsion, Petit Mal|Sensory Seizures|Seizure, Single|Non-Epileptic Seizure|Seizures, Visual|Seizures, Auditory|Olfactory Seizure|Tonic-Clonic Seizure, Generalized|Seizure, Generalized Tonic-Clonic|Jacksonian Seizure|Seizure, Vertiginous|Seizure, Epileptic|Seizure, Focal|Atonic Absence Seizure|Seizure, Tonic Clonic|Convulsive Seizures|Nonepileptic Seizure|Tonic-Clonic Seizure|Nonepileptic Seizures|Seizure, Absence|Single Seizures|Seizure, Myoclonic|Auditory Seizures|Absence Seizures|Seizures, Somatosensory|Seizures, Olfactory"
NEW03926,DISEASE,Seizure risk,Seizure risk
D000317,NUTRITION,Adrenergic alpha-Antagonists,"Receptor Blockaders, alpha-Adrenergic|alpha Adrenergic Receptor Blockaders|Adrenergic alpha-Blockers|alpha-Adrenergic Antagonists|alpha-Adrenergic Blockers|alpha-Antagonists, Adrenergic|Blockaders, Adrenergic alpha-Receptor|alpha Adrenergic Blocking Agents|Adrenergic alpha Blockers|alpha-Adrenergic Blocking Agents|Blockers, alpha-Adrenergic|alpha-Blockers, Adrenergic|Agents, alpha-Adrenergic Blocking|Adrenergic alpha-Receptor Blockaders|alpha blockers|Adrenergic alpha Antagonists|Blocking Agents, alpha-Adrenergic|alpha Adrenergic Blockers|alpha-Adrenergic Receptor Blockaders|Antagonists, alpha-Adrenergic|alpha Adrenergic Antagonists|Blockaders, alpha-Adrenergic Receptor|Adrenergic alpha Receptor Blockaders|alpha-Receptor Blockaders, Adrenergic|alpha Blockers, Adrenergic"
NEW03927,CHEMICAL,calcium supplementation,calcium supplementation
NEW03929,MENTAL_HEALTH,Drug-induced sexual dysfunction,Drug-induced sexual dysfunction
D000077593,CHEMICAL,Reboxetine,Reboxetine|Vestra|2-((2-Ethoxyphenoxy)benzyl)morpholine methanesulfonate|Reboxetine Mesylate
NEW03934,CHEMICAL,SNRI duloxetine,SNRI duloxetine
NEW03936,DISEASE,DSM-IV-TR diagnosis,DSM-IV-TR diagnosis
D000068736,CHEMICAL,Duloxetine Hydrochloride,"LY 227942|N-methyl-3-(1-naphthalenyloxy)-3-(2-thiophene)propanamide|N-methyl-3-(1-naphthalenyloxy)-2-thiophenepropanamine|LY-227942|LY-248686|Duloxetine HCl|LY227942|Cymbalta|HCl, Duloxetine|LY248686|LY 248686|Hydrochloride, Duloxetine|Duloxetine|Duloxetine, (+)-isomer|duloxetine|Duloxetine Ethanedioate (1:1), (+-)-isomer - T353987"
NEW03939,CHEMICAL,available serotonin reuptake inhibitors,available serotonin reuptake inhibitors
NEW03940,DISEASE,hallucinatory-paranoid state,hallucinatory-paranoid state
NEW03942,CHEMICAL,serotonin-norepinephrine reuptake inhibitors,serotonin-norepinephrine reuptake inhibitors
NEW03925,CHEMICAL,newer antidepressants,newer antidepressants
NEW03943,CHEMICAL,serotonin-norepinephrine antidepressant,serotonin-norepinephrine antidepressant
NEW03947,CHEMICAL,Platelet 5HT2 receptor density,Platelet 5HT2 receptor density
NEW03948,DISEASE,orthostatic challenge test,orthostatic challenge test
NEW03949,CHEMICAL,Norepinephrine response,Norepinephrine response
NEW03950,CHEMICAL,low dopamine transporter site density,low dopamine transporter site density
NEW03951,CHEMICAL,benzodiazepines clonazepam,benzodiazepines clonazepam
NEW03954,CHEMICAL,neurotransmitters serotonin,neurotransmitters serotonin
C113970,CHEMICAL,dexaminoglutethimide [Supplementary Concept],Glutethimide|enantiomer|escitalopram
NEW03956,MENTAL_HEALTH,antenatal depression,antenatal depression
D052018,MENTAL_HEALTH,Bulimia Nervosa,"Nervosa, Bulimia|bulimia nervosa"
NEW03960,DISEASE,premenstrual syndrome/premenstrual dysphoric disorder,premenstrual syndrome/premenstrual dysphoric disorder
NEW03963,CHEMICAL,low iron level,low iron level
NEW03964,CHEMICAL,multiple micronutrient supplementation,MMS|multiple micronutrient supplementation
NEW03966,CHEMICAL,oral iron therapy,oral iron therapy
NEW03967,CHEMICAL,combined iron supplementation,combined iron supplementation
C038178,CHEMICAL,ammonium ferrous sulfate [Supplementary Concept],Ferrous Compounds|ferrous sulfate|Quaternary Ammonium Compounds
D002971,DISEASE,Cleft Lip,"Lips, Cleft|Harelips|Harelip|Cleft lip|Cleft Lips|Lip, Cleft"
D010547,DISEASE,Persistent Fetal Circulation Syndrome,"ACDMPV|Familial Persistent Pulmonary Hypertension of the Newborn|ACD MPV|Persistent Fetal Circulation|Alveolar Capillary Dysplasia With Misalignment Of Pulmonary Veins|Circulation, Persistent Fetal|Hypertension, Pulmonary, of Newborn, Persistent|Pulmonary Hypertension, Familial Persistent, of the Newborn|congenital anomalies|Misalignment of the Pulmonary Vessels|Fetal Circulation, Persistent|Alveolar Capillary Dysplasia With Misalignment Of Pulmonary Veins And Other Congenital Anomalies|ACD-MPV|Persistent Pulmonary Hypertension of Newborn"
NEW03970,CHEMICAL,female endogenous estradiol,female endogenous estradiol
NEW03971,DISEASE,Methaemoglobinaemia,Methaemoglobinaemia
NEW03972,DISEASE,methaemoglobinaemia,methaemoglobinaemia
D003622,CHEMICAL,Dapsone,"Dapson-Fatol|DADPS|Avlosulfone|Dapsoderm-X|dapsone|Disulone|Diaphenylsulfone|Sulfone, 4,4'-Diaminophenyl|Sulfonyldianiline|Sulfona|4,4' Diaminophenyl Sulfone|4,4'-Diaminophenyl Sulfone|Diaminodiphenylsulfone"
NEW03973,MENTAL_HEALTH,HO-1 hyperactivity,HO-1 hyperactivity
NEW03977,MENTAL_HEALTH,Glial HO-1 hyperactivity,Glial HO-1 hyperactivity
NEW03979,BIOCHEMICAL,related dopamine antagonist,related dopamine antagonist
NEW03983,CHEMICAL,Hair cortisol,Hair cortisol
NEW03984,CHEMICAL,± kg,± kg
NEW03986,DISEASE,obesity therapy,obesity therapy
C491208,CHEMICAL,"MCHR1 protein, rat [Supplementary Concept]","Receptors, Somatostatin|MCH|Melanin concentrating hormone"
NEW03987,CHEMICAL,lower blood glucose levels,lower blood glucose levels
NEW03988,CHEMICAL,thiazolidinedione pioglitazone,thiazolidinedione pioglitazone
C526140,BIOCHEMICAL,"GDF15 protein, human [Supplementary Concept]",non-steroidal anti-inflammatory drug|Growth Differentiation Factor 15
NEW03989,MENTAL_HEALTH,experimental anxiety,experimental anxiety
D006636,CHEMICAL,Histamine Release,Histamine Releases|Histamine Liberation|histamine release|Histamine Liberations
C564560,DISEASE,"Mental Retardation, X-Linked, Syndromic 10 [Supplementary Concept]","Mental Retardation, X-Linked|abnormal behavior|Dyskinesias"
NEW03991,CHEMICAL,phenomenon conditioning-specific reflex modification,CRM|phenomenon conditioning-specific reflex modification
D000322,BIOCHEMICAL,Adrenergic Agonists,"Agonists, Adrenergic|Agonist, Adrenergic|Agonists, Adrenergic Receptor|Adrenergic Agonist|Adrenergic Receptor Agonists|adrenergic agonists|Agonist, Adrenergic Receptor|Adrenergic Receptor Agonist|Adrenomimetics|Receptor Agonist, Adrenergic|Receptor Agonists, Adrenergic"
NEW03994,CHEMICAL,selective noradrenaline re-uptake inhibitor,selective noradrenaline re-uptake inhibitor
NEW03995,BIOCHEMICAL,agonists clonidine,agonists clonidine
NEW03996,CHEMICAL,Regionally-specific stimulant-induced elevations,Regionally-specific stimulant-induced elevations
NEW03999,DISEASE,tic severity,tic severity
NEW04001,MENTAL_HEALTH,uncomplicated ADHD,uncomplicated ADHD
NEW04003,CHEMICAL,methadone use,methadone use
NEW01019,CHEMICAL,methadone maintenance therapy,methadone maintenance therapy
NEW04007,CHEMICAL,Testosterone values,Testosterone values
NEW04010,CHEMICAL,Glutamate toxicity,Glutamate toxicity
C402107,CHEMICAL,2-(phosphonomethyl)pentanedioic acid [Supplementary Concept],Organophosphorus Compounds|2-(phosphonomethyl)-pentanedioic acid
NEW04013,CHEMICAL,environmental enrichment,EE|environmental enrichment
NEW04014,CHEMICAL,olfactory neuronal precursors,olfactory neuronal precursors|ONP
D056572,CHEMICAL,Histone Deacetylase Inhibitors,"Deacetylase Inhibitors, Histone|Deacetylase Inhibitor, Histone|Inhibitors, HDAC|Inhibitor, HDAC|HDAC inhibitors|Histone Deacetylase Inhibitor|Inhibitor, Histone Deacetylase|Inhibitors, Histone Deacetylase|HDAC Inhibitor|HDAC Inhibitors"
NEW01339,DISEASE,chronic social defeat stress,chronic social defeat stress|CSDS
NEW04018,MENTAL_HEALTH,Clock-induced repression,Clock-induced repression
NEW04019,CHEMICAL,reduced alcohol consumption,reduced alcohol consumption
NEW04020,CHEMICAL,alcohol administration,alcohol administration
D015740,CHEMICAL,Calcitonin Gene-Related Peptide,"Calcitonin Gene Related Peptide II|Calcitonin Gene-Related Peptide I|Gene-Related Peptide, Calcitonin|Calcitonin Gene-Related Peptide II|alpha-Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|beta-CGRP|CGRP|Calcitonin Gene Related Peptide I|beta Calcitonin Gene Related Peptide|alpha-CGRP|alpha Calcitonin Gene Related Peptide|Calcitonin Gene Related Peptide|beta-Calcitonin Gene-Related Peptide"
NEW04024,CHEMICAL,hepatic metabolised amphetamine prodrug Lisdexamfetamin,hepatic metabolised amphetamine prodrug Lisdexamfetamin
NEW04025,CHEMICAL,α(2)A-adrenoceptor-agonist Guanfacine,α(2)A-adrenoceptor-agonist Guanfacine
NEW04026,CHEMICAL,Intuniv ®,Intuniv ®
NEW01067,CHEMICAL,non-stimulant,non-stimulant
NEW04027,BIOCHEMICAL,MGlu5 receptor antagonists,MGlu5 receptor antagonists
NEW04028,CHEMICAL,mGlu5 receptor antagonists,mGlu5 receptor antagonists
NEW04030,BIOCHEMICAL,mGlu4/7/8 receptor agonists,mGlu4/7/8 receptor agonists
D029747,CHEMICAL,Opuntia,"Cactus, Cholla|Opuntia ficus-indica|Opuntia ficus|Cholla Cactus|Cactus, Prickly-pear|Prickly pear Cactus|Prickly-pear Cactus"
NEW04032,CHEMICAL,Air exposure,Air exposure
NEW04033,CHEMICAL,alcohol binge,alcohol binge
NEW04036,DISEASE,severe hyponatremia,severe hyponatremia
NEW04035,CHEMICAL,oolong tea,oolong tea
NEW04037,CHEMICAL,caffeine toxicity,caffeine toxicity
NEW04040,CHEMICAL,NAA concentration,NAA concentration
NEW04042,CHEMICAL,heavy ethanol exposure,heavy ethanol exposure
C036619,CHEMICAL,idebenone [Supplementary Concept],Ubiquinone/analogs  and  derivatives|idebenone
C000598329,CHEMICAL,hydroxy-alpha sanshool [Supplementary Concept],"Polyunsaturated Alkamides|Hydroxy-α-sanshool|Fatty Acids, Unsaturated"
NEW04046,CHEMICAL,serotonin neurotransmitter systems,serotonin neurotransmitter systems
NEW04047,MENTAL_HEALTH,disorder individuals,disorder individuals
NEW04048,NUTRITION,long-term lithium,long-term lithium
D007010,DISEASE,Hyponatremia,hyponatremia|Hyponatremias
NEW04052,BIOCHEMICAL,stress hormone system dysregulations,stress hormone system dysregulations
NEW04056,CHEMICAL,Rohypnol use,Rohypnol use
NEW04058,MENTAL_HEALTH,Rohypnol-induced sexual dysfunction,Rohypnol-induced sexual dysfunction
D005445,CHEMICAL,Flunitrazepam,"Flunizep Von Ct|Flunitrazepam-Ratiopharm|Rohipnol|Flunitrazepam Ratiopharm|Flunimerck|Fluni 1A Pharma|Flunitrazepam-Neuraxpharm|Narcozep|RO-5-4200|Rohypnol|Fluninoc|RO54200|Flunibeta|Flunitrazepam Neuraxpharm|Von Ct, Flunizep|Flunitrazepam-Teva|Fluridrazepam|Flunitrazepam Teva"
NEW04061,DISEASE,BPD group,BPD group
NEW04065,DISEASE,LD MP treatment,LD MP treatment
NEW04067,CHEMICAL,Agmatine treatment,Agmatine treatment
D000376,CHEMICAL,Agmatine,agmatine|1 Amino 4 guanidinobutane|4-(Aminobutyl)guanidine|1-Amino-4-guanidinobutane
NEW04069,CHEMICAL,unique exposure to nickel chloride,NiCl2|unique exposure to nickel chloride
NEW04072,CHEMICAL,antidepressant therapy,antidepressant therapy
D015742,CHEMICAL,Propofol,"Recofol|Propofol MCT|ICI35,868|Disoprivan|ICI 35,868|Propofol-Lipuro|ICI-35,868|Disoprofol|ICI-35868|2,6 Diisopropylphenol|ICI 35868|Diprivan|Propofol|Fresofol|2,6-Diisopropylphenol|2,6-Bis(1-methylethyl)phenol|ICI35868|Aquafol|Propofol Abbott|Propofol Rovi|Propofol Fresenius|Ivofol"
NEW04076,MENTAL_HEALTH,global mental illness,global mental illness
NEW04077,DISEASE,hypothyroidism group,hypothyroidism group
NEW02701,DISEASE,depressive behaviors,depressive behaviors
NEW04079,NUTRITION,to substrate,choline|to substrate
D005910,DISEASE,Glioma,"Mixed Glioma|Glioma, Malignant|Gliomas, Mixed|Malignant Glioma|Gliomas, Malignant|Gliomas|Glioma, Mixed|Mixed Gliomas|Glial Cell Tumor|Malignant Gliomas|Glial Cell Tumors|Tumors, Glial Cell|Tumor, Glial Cell"
NEW04081,DISEASE,grade gliomas,grade gliomas
NEW04085,CHEMICAL,choline/creatine elevation,choline/creatine elevation
C024894,CHEMICAL,tanshinone II A sodium sulfonate [Supplementary Concept],Phenanthrenes|tanshinone IIA
NEW04086,CHEMICAL,cocktail dopamine D2 receptor antagonist,cocktail dopamine D2 receptor antagonist
NEW04088,BIOCHEMICAL,drug cocktail,drug cocktail
NEW04090,DISEASE,sciatic MNCV,sciatic MNCV
NEW04092,CHEMICAL,nerve blood flow,nerve blood flow|NBF
NEW04093,CHEMICAL,Adenosine,Adenosine
NEW04096,MENTAL_HEALTH,hangover-induced anxiety,hangover-induced anxiety
D017448,CHEMICAL,"Receptors, Dopamine D2","dopamine D2 receptors|Dopamine D2 Receptor|D2 Receptors, Dopamine|Receptor, Dopamine-D2|Dopamine-D2 Receptor|Dopamine D2 Receptors"
D043705,CHEMICAL,"Receptor, Adenosine A2A","A2A Receptors, Adenosine|Adenosine A2A Receptors|A2A Receptor, Adenosine|Adenosine A2A Receptor|Adenosine A(2A) Receptor|adenosine A2A|Receptors, Adenosine A2A"
NEW04099,CHEMICAL,"3,4-metyhlenedioxymethamphetamine","3,4-metyhlenedioxymethamphetamine|MDMA"
NEW04100,CHEMICAL,chronic gestational stress,chronic gestational stress|CGS
NEW04104,BIOCHEMICAL,A2a agonist,A2a agonist
NEW04105,NUTRITION,yeast cells,yeast cells
D014439,CHEMICAL,Tyramine,para-Tyramine|4-(2-Aminoethyl)phenol|4 Hydroxyphenethylamine|tyramine|4-Hydroxyphenethylamine|p-Tyramine
C075222,CHEMICAL,amyloid beta-protein (1-42) [Supplementary Concept],Amyloid beta-Peptides|Aβ42|Peptide Fragments
D053485,DISEASE,Porcine epidemic diarrhea virus,diarrhea|Coronavirus (1988-2006)
NEW04106,DISEASE,coagulation abnormalities,coagulation abnormalities
D054098,DISEASE,"Thrombocytopenia, Neonatal Alloimmune","Alloimmune Thrombocytopenia, Neonatal|Neonatal Thrombocytopenias|Thrombocytopenias, Neonatal|Alloimmune Thrombocytopenias, Neonatal|Thrombocytopenias, Neonatal Alloimmune|Thrombocytopenia, Neonatal|Neonatal Alloimmune Thrombocytopenias|thrombocytopenia|Neonatal Alloimmune Thrombocytopenia|Neonatal Thrombocytopenia"
NEW04107,NUTRITION,yeast β-glucans,yeast β-glucans
NEW04109,MENTAL_HEALTH,human alcohol abuse,human alcohol abuse
NEW04112,CHEMICAL,NH4(+ toxicity,NH4(+ toxicity
C566555,DISEASE,Desmosterolosis [Supplementary Concept],"desmosterolosis|Abnormalities, Multiple|Lipid Metabolism, Inborn Errors"
NEW04115,DISEASE,gastrointestinal inflammation,gastrointestinal inflammation
NEW04118,BIOCHEMICAL,Anti-food antigen antibodies,Anti-food antigen antibodies
NEW04121,MENTAL_HEALTH,Familial Alzheimer disease mutations,Familial Alzheimer disease mutations
NEW04122,CHEMICAL,FAD mutations,FAD mutations
NEW04123,CHEMICAL,Ala substitution,Ala substitution
NEW04124,BIOCHEMICAL,deadly poisons,deadly poisons
NEW04127,NUTRITION,Fatty acid ethyl esters,Fatty acid ethyl esters
D011042,BIOCHEMICAL,Poisons,poisons|Poison
NEW04129,BIOCHEMICAL,metabolic poisons,metabolic poisons
C030290,CHEMICAL,malonic acid [Supplementary Concept],Malonates|malonic acid
C015392,CHEMICAL,3-nitropropionic acid [Supplementary Concept],Propionates|3-NP|3-nitropropionic acid|Nitro Compounds
NEW04130,CHEMICAL,systemic 3-NP,systemic 3-NP
D000077300,CHEMICAL,Bosentan,"Ro 47 0203|Bosentan Anhydrous|Ro 47-0203|Ro-47-0203|bosentan|Ro 470203|Bosentan Monohydrate|4-t-Butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide|Tracleer"
NEW04132,BIOCHEMICAL,endothelin receptor antagonist combination,endothelin receptor antagonist combination
NEW04136,BIOCHEMICAL,oral dual endothelin receptor antagonist,oral dual endothelin receptor antagonist
D051271,MENTAL_HEALTH,"Headache Disorders, Secondary","Headaches, Analgesic Overuse|Headache, Analgesic Rebound|Secondary Headache Disorders|Medication Overuse Headaches|Headache Disorder, Secondary|Disorders, Secondary Headache|Overuse Headache, Medication|Overuse Headaches, Medication|Medication overuse headache|Analgesic Rebound Headaches|Secondary Headache Disorder|Disorder, Secondary Headache|Analgesic Rebound Headache|Headache, Analgesic Overuse|Headache, Medication Overuse|Analgesic Overuse Headache|Analgesic Overuse Headaches|Headaches, Medication Overuse|Headaches, Analgesic Rebound|Medication Overuse Headache"
NEW04137,MENTAL_HEALTH,chronic pain disorder,chronic pain disorder
NEW04138,CHEMICAL,catecholamine neurotransmission,catecholamine neurotransmission
NEW04139,CHEMICAL,glutamate-glutamine shuttle mechanism,glutamate-glutamine shuttle mechanism
NEW04141,CHEMICAL,homocysteine levels,homocysteine levels
NEW04142,DISEASE,thyroid disorders,thyroid disorders
NEW04145,BIOCHEMICAL,high-dose vitamin B6,high-dose vitamin B6
NEW04147,BIOCHEMICAL,vitamin B6 levels,vitamin B6 levels
NEW04148,CHEMICAL,hepatic β-muricholic acid,βMCA|hepatic β-muricholic acid
NEW04150,NUTRITION,methionine Met levels,methionine Met levels
NEW04151,CHEMICAL,Methyl donor SAM,Methyl donor SAM
NEW04152,DISEASE,hypoactive Gln synthetase,hypoactive Gln synthetase|GS
D008717,NUTRITION,Methionine Sulfoximine,"methionine sulfoximine|Sulfoximine, Methionine"
NEW04154,CHEMICAL,Gln supplementation,Gln supplementation
C060234,CHEMICAL,magnesium-protoporphyrin methyltransferase [Supplementary Concept],Methyltransferases|S-adenosyl-L-methionine
NEW04156,CHEMICAL,Methyl donor micronutrient score,Methyl donor micronutrient score|MDMS
NEW04159,DISEASE,C677 T polymorphism,C677 T polymorphism
NEW04161,CHEMICAL,MTHFR gene,MTHFR gene
D066248,CHEMICAL,High Fructose Corn Syrup,"Isoglucose|Maize Syrup, High-Fructose|Glucose Fructose Syrup|Sugar, Corn|Syrup, Maize|Syrup, High-Fructose Maize|High-Fructose Maize Syrup|High Fructose Maize Syrup|Maize Syrup|Corn Sugar|Syrup, Glucose-Fructose|Glucose-Fructose Syrup|fructose"
NEW04163,NUTRITION,methionine Met polymorphism,methionine Met polymorphism
D050802,CHEMICAL,Valine Dehydrogenase (NADP+),"Valine Dehydrogenase, NADP Dependent|Valine Dehydrogenase, NADP-Dependent|Dehydrogenase, NADP-Dependent Valine|NADP-Dependent Valine Dehydrogenase|valine"
C007957,CHEMICAL,homocysteine thiolactone [Supplementary Concept],homocysteine thiolactone|Homocysteine/analogs  and  derivatives
D000082,CHEMICAL,Acetaminophen,Anacin 3|N-(4-Hydroxyphenyl)acetanilide|Acetaco|Anacin3|Panadol|p-Hydroxyacetanilide|Acephen|Paracetamol|Tylenol|Hydroxyacetanilide|Anacin-3|acetaminophen|Acetominophen|Acamol|N-Acetyl-p-aminophenol|Datril|APAP|Acetamidophenol|p-Acetamidophenol|Algotropyl
NEW04166,CHEMICAL,common single nucleotide polymorphism,common single nucleotide polymorphism
NEW04168,NUTRITION,methionine metabolism methionine adenosyltransferase MAT    A,methionine metabolism methionine adenosyltransferase MAT    A
NEW04170,NUTRITION,adequate methionine supplementation,adequate methionine supplementation
NEW04171,MENTAL_HEALTH,Increased narcolepsy incidence,Increased narcolepsy incidence
NEW04173,MENTAL_HEALTH,paired ADHD,paired ADHD
NEW04174,CHEMICAL,perinatal acetaminophen exposure,perinatal acetaminophen exposure
NEW04175,MENTAL_HEALTH,childhood attention-deficit hyperactivity disorder,childhood attention-deficit hyperactivity disorder
NEW04176,CHEMICAL,umbilical cord plasma amino acids,umbilical cord plasma amino acids
NEW04178,CHEMICAL,biomarker 8-hydroxy-deoxyguanosine,biomarker 8-hydroxy-deoxyguanosine
NEW04179,CHEMICAL,cord plasma acetaminophen,cord plasma acetaminophen
NEW04180,CHEMICAL,Cord unmetabolized acetaminophen,Cord unmetabolized acetaminophen
NEW04181,CHEMICAL,8-hydroxy-deoxyguanosine,8-hydroxy-deoxyguanosine
D058570,CHEMICAL,TOR Serine-Threonine Kinases,"Serine-Threonine Kinase, mTOR|Kinase, TOR|Mammalian Target of Rapamycin|TOR Serine-Threonine Kinase|serine|FK506 Binding Protein 12 Rapamycin Associated Protein 1|Kinase, mTOR Serine-Threonine|FKBP12 Rapamycin Associated Protein|Protein, RAFT-1|Protein, mTOR|Serine-Threonine Kinases, mTOR|mTOR Serine-Threonine Kinase|Protein Target, Rapamycin|Target of Rapamycin Proteins|FK506 Binding Protein 12-Rapamycin Associated Protein 1|FKBP12 Rapamycin Complex Associated Protein|Serine-Threonine Kinase, TOR|TOR Serine Threonine Kinases|FKBP12-Rapamycin Complex-Associated Protein|Rapamycin Protein Target|TOR Kinases|Target of Rapamycin Protein|Kinases, TOR Serine-Threonine|Rapamycin Target Protein|TOR Serine Threonine Kinase|Serine-Threonine Kinases, TOR|Mechanistic Target of Rapamycin Protein|mTOR Serine Threonine Kinase|FKBP12-Rapamycin Associated Protein|mTOR Serine-Threonine Kinases|Kinases, mTOR Serine-Threonine|TOR Kinase|mTOR Protein|RAFT 1 Protein|Kinase, TOR Serine-Threonine|mTOR Serine Threonine Kinases|RAFT-1 Protein"
NEW04183,NUTRITION,increasing cord methionine,increasing cord methionine
NEW04184,CHEMICAL,DA system,DA system
NEW04185,CHEMICAL,valine allele,valine allele
NEW04186,CHEMICAL,Val66Met amino acid polymorphism,Val66Met amino acid polymorphism
C023550,CHEMICAL,galactose-binding protein [Supplementary Concept],D-galactose|Periplasmic Binding Proteins|Calcium-Binding Proteins|Monosaccharide Transport Proteins
NEW04189,CHEMICAL,deserticola polysaccharides,deserticola polysaccharides
NEW04194,CHEMICAL,L-tryptophan acid,L-tryptophan acid
NEW04195,MENTAL_HEALTH,Depression rating scores,Depression rating scores
D015937,CHEMICAL,"Complement C5a, des-Arginine","des-Arginine, C5a|C5a des-Arginine|arginine|Complement C5a, des Arginine|des-Arginine C5 a|des-Arginine Complement 5a|C5a, des-Arginine Complement|des-Arg C5 a|C5a, des-Arg|C5 a, des Arginine|C5 a, des-Arg|des-Arg C5a|des-Arginine C5a|C5 a, des-Arginine|C5 a, des Arg|Complement 5a, des Arginine|Complement 5a, des-Arginine|C5a, des Arg|Complement 5a, de-Arginine|de-Arginine Complement 5a|des-Arg, C5a|des-Arginine Complement C5a|C5a, des Arginine|C5a, des-Arginine|C5a des Arginine|Complement 5a, de Arginine|C5a des-Arg"
NEW04196,NUTRITION,methionine Met cycle,methionine Met cycle
NEW04197,CHEMICAL,homocysteine ratio,homocysteine ratio
D051150,NUTRITION,Methionine Sulfoxide Reductases,"Reductases, Methionine-R-sulfoxide|Methionine R sulfoxide Reductases|Peptide-Methionine (S)-S-oxide Reductase|methionine|Peptide-Methionine (R)-S-oxide Reductase|Reductases, Methionine Sulfoxide|Reductase, Methionine-R-sulfoxide|Sulfoxide Reductases, Methionine|Methionine Sulfoxide Reductase A|Methionine R sulfoxide Reductase|Methionine-R-sulfoxide Reductases|Methionine Sulfoxide Reductase B|Selenoprotein R|SelR Protein|Methionine-R-sulfoxide Reductase"
NEW04200,DISEASE,consequent impairment,consequent impairment
D020138,DISEASE,Hyperhomocysteinemia,Hyperhomocysteinemias|hyperhomocysteinemia
D003908,CHEMICAL,Dexamethasone Isonicotinate,"Auxison|Isonicotinate, Dexamethasone|dexamethasone|HE 111|HE-111|HE111"
NEW04204,CHEMICAL,melatonin pretreatment,melatonin pretreatment
NEW04205,BIOCHEMICAL,peripheral glucocorticoid receptor agonist,peripheral glucocorticoid receptor agonist
NEW04207,CHEMICAL,UCR patients,UCR patients
NEW04211,CHEMICAL,depression-like behavior,depression-like behavior|DAB
NEW04214,CHEMICAL,Sutherlandia frutescens,Sutherlandia frutescens
NEW04215,CHEMICAL,Dexamethaone,Dexamethaone
NEW04217,CHEMICAL,GR inhibitor group,GR inhibitor group|RU486
NEW04218,DISEASE,male hypertensive rats,male hypertensive rats
NEW04220,CHEMICAL,GR agonist,GR agonist
NEW04222,DISEASE,POF disease stress model group,POF disease stress model group
NEW03203,CHEMICAL,sucrose preference,sucrose preference
NEW04226,CHEMICAL,glutamate kinase activity,GKA|glutamate kinase activity
NEW04228,CHEMICAL,guanine stacks,guanine stacks
D061626,CHEMICAL,Immunoreceptor Tyrosine-Based Inhibition Motif,Immune Receptor Tyrosine-Based Inhibition Motif|Immuno Receptor Tyrosine Based Inhibition Motif|Immune Receptor Tyrosine Based Inhibition Motif|Immunoreceptor Tyrosine Based Inhibition Motif|tyrosine|Immuno-Receptor Tyrosine-Based Inhibition Motif
NEW04232,CHEMICAL,Cerebral spinal fluid CSF magnesium,Cerebral spinal fluid CSF magnesium
NEW04234,CHEMICAL,magnesium treatment,magnesium treatment
NEW04237,CHEMICAL,Intravenous magnesium,Intravenous magnesium
NEW04239,CHEMICAL,inadequate brain magnesium,inadequate brain magnesium
D008708,DISEASE,Methemoglobinemia,Methemoglobinemias|Methemoglobinemia
NEW04241,DISEASE,Acquired methemoglobinemia,Acquired methemoglobinemia
NEW04242,CHEMICAL,Wide-scope target,Wide-scope target
NEW04243,CHEMICAL,Corticosterone administration,Corticosterone administration
NEW04244,CHEMICAL,Chronic corticosterone treatment,Chronic corticosterone treatment
NEW04245,CHEMICAL,adenosine A2A receptor antagonist,adenosine A2A receptor antagonist
NEW04247,CHEMICAL,β2-AR,β2-AR
NEW04249,CHEMICAL,cAMP signaling,cAMP signaling
NEW04250,MENTAL_HEALTH,baseline anxiety,baseline anxiety
D063487,BIOCHEMICAL,Prescription Drug Misuse,"Prescription Medicine Misuses|Medicine Misuse, Prescription|Non-Medical Use of Prescription Drugs|Prescription Medicine Misuse|Drug Misuse, Prescription|Misuse, Prescription Drug|Misuse, Prescription Medicine|Non Medical Use of Prescription Drugs|drug misuse|NMUPD"
NEW04253,CHEMICAL,central nervous system norepinephrine,central nervous system norepinephrine
NEW04254,DISEASE,neuronal injury,neuronal injury
NEW04256,CHEMICAL,medullary catecholamines,medullary catecholamines
NEW04257,CHEMICAL,Prolonged β-adrenergic blockade,Prolonged β-adrenergic blockade
D019337,DISEASE,Hematologic Neoplasms,"Hematologic Neoplasm|Hematological Malignancy|Hematologic Malignancies|Hematological Malignancies|Neoplasms, Hematological|Hematopoietic Neoplasm|Hematologic Malignancy|Malignancy, Hematological|Malignancies, Hematologic|hematological malignancies|Malignancy, Hematologic|Hematological Neoplasm|Hematopoietic Malignancy|Hematological Neoplasms|Hematopoietic Neoplasms|Neoplasm, Hematopoietic|Neoplasm, Hematological|Malignancies, Hematopoietic|Malignancy, Hematopoietic|Malignancies, Hematological|Hematopoietic Malignancies|Neoplasm, Hematologic|Neoplasms, Hematologic|Neoplasms, Hematopoietic"
NEW04260,CHEMICAL,specific serotonin uptake blocker fluoxetine,specific serotonin uptake blocker fluoxetine
NEW04262,MENTAL_HEALTH,experimental cataplexy,experimental cataplexy
NEW04263,CHEMICAL,alpha-adrenoreceptor blocker clonidine,alpha-adrenoreceptor blocker clonidine
NEW04264,CHEMICAL,dopamine receptor blocker pimozide,dopamine receptor blocker pimozide
NEW04266,CHEMICAL,melatonin secretion,melatonin secretion
D004071,CHEMICAL,Digitalis Glycosides,"Glycosides, Digitalis|digitalis"
D004110,CHEMICAL,Diltiazem,Cardil|Dilren|Aldizem|Dilacor XR|diltiazem|CRD-401|Diltiazem Hydrochloride|Tiazac|Dilzem|CRD401|CRD 401|Dilacor|Diltiazem Malate|Cardizem
D015764,CHEMICAL,Bepridil,"CERM 1978|Bepridil, alpha-Isomer|Bepridil, alpha Isomer|Bepridil Monohydrochloride, Monohydrate|bepridil|1978 CERM|Bepridil Monohydrochloride, alpha-Isomer|CERM-1978|1978CERM|Bepridil, (+-)-Isomer|Unicordium|1978-CERM|Cordium|Monohydrochloride, Bepridil|Bepridil, (+)-Isomer|Bepridil Monohydrochloride, alpha Isomer|Bepridil Monohydrochloride|Bepadin|Bepridil, (-)-Isomer|CERM1978|Bedapin|Monohydrochloride, alpha-Isomer Bepridil|Vascor"
D026941,CHEMICAL,Sodium Channel Blockers,"Sodium Channel Inhibitor|Blocker, Sodium Channel|Sodium Channel Blocker|Inhibitor, Sodium Channel|sodium channel blocker|Channel Inhibitors, Sodium|Channel Blocker, Sodium|Channel Inhibitor, Sodium|Channel Blockers, Sodium|Sodium Channel Inhibitors|Inhibitors, Sodium Channel"
NEW04269,CHEMICAL,GABAA-receptor agonist muscimol,GABAA-receptor agonist muscimol
D004958,CHEMICAL,Estradiol,"Estradiol, Sodium Salt|Estradiol, (+-)-Isomer|Estradiol Hemihydrate|17 beta Oestradiol|17 beta-Estradiol|17 beta Estradiol|Progynon-Depot|Oestradiol|Estradiol 17 alpha|Ovocyclin|Estraderm TTS|Estradiol, (16 alpha,17 beta)-Isomer|Estradiol, (9 beta,17 alpha)-Isomer|Estradiol, (16 alpha,17 alpha)-Isomer|Aerodiol|Estradiol, (-)-Isomer|oestradiol|Estradiol, (8 alpha,17 beta)-(+-)-Isomer|Estradiol 17beta|Estradiol Monohydrate|Estradiol Valeriante|Estradiol-17 alpha|Estradiol, Monosodium Salt|Delestrogen|Estradiol Anhydrous|Estradiol, (8 alpha,17 beta)-Isomer|Estradiol-17 beta|Estradiol 17 beta|17 beta-Oestradiol|Estradiol-17beta|Estrace|Progynon Depot|Estradiol, (9 beta,17 beta)-Isomer|Vivelle|Estradiol, (17-alpha)-Isomer|Estradiol Valerate|Progynova|Estradiol Hemihydrate, (17 alpha)-Isomer"
NEW04271,CHEMICAL,hippocampal serotonergic system,hippocampal serotonergic system
NEW04272,CHEMICAL,oestradiol treatment,oestradiol treatment
NEW04275,CHEMICAL,adjunctive oestradiol treatment,adjunctive oestradiol treatment
NEW04279,CHEMICAL,lower testosterone levels,lower testosterone levels
C107914,BIOCHEMICAL,estrogen receptor-related receptor beta [Supplementary Concept],"Receptors, Estrogen|oestrogen receptor"
NEW04281,MENTAL_HEALTH,Antenatal depression,Antenatal depression
NEW04286,DISEASE,DCI administration,DCI administration
NEW04287,DISEASE,DCI treatment,DCI treatment
D004715,DISEASE,Endometriosis,Endometrioses|Endometrioma|Endometriomas|endometriomas
NEW04289,CHEMICAL,dydrogesterone treatment,dydrogesterone treatment
D004394,CHEMICAL,Dydrogesterone,Isopregnenone|Dydrogesterone|6 Dehydro 9 beta 10 alpha progesterone|Dehydrogesterone|6-Dehydro-9 beta-10 alpha-progesterone|Duphaston
NEW04290,BIOCHEMICAL,topical oestrogens,topical oestrogens
NEW03342,BIOCHEMICAL,oestrogens,oestrogens
D019386,CHEMICAL,Alendronate,"Alendronate Sodium|MK 217|MK217|Alendronate Monosodium Salt, Trihydrate|MK-217|Alendronate|Aminohydroxybutane Bisphosphonate|4-Amino-1-Hydroxybutylidene 1,1-Biphosphonate|Fosamax"
D000068296,CHEMICAL,Risedronic Acid,"Bisphosphonate Risedronate Sodium|Risedronate|Atelvia|2-(3-pyridinyl)-1-hydroxyethylidenebisphosphonate|Actonel|Sodium, Bisphosphonate Risedronate|1-Hydroxy-2-(3-pyridyl)ethylidene diphosphonate|Risedronate Sodium, Bisphosphonate|2-(3-pyridinyl)-1-hydroxyethylidene-bisphosphonate|Risedronate Sodium|Risedronic Acid, Monosodium Salt"
NEW04295,NUTRITION,platelet alpha 2-adrenoceptors,platelet alpha 2-adrenoceptors
NEW04297,NUTRITION,platelet alpha capacity,platelet alpha capacity
NEW04300,CHEMICAL,GS/noMS mothers,GS/noMS mothers
NEW04303,CHEMICAL,Benzodiazepine dependency,Benzodiazepine dependency
NEW04305,DISEASE,Secondary PCOS,Secondary PCOS
NEW04306,DISEASE,Primary PCOS,Primary PCOS
NEW04308,BIOCHEMICAL,mild adrenal androgen,mild adrenal androgen
NEW04309,DISEASE,adrenal hyperresponsiveness,adrenal hyperresponsiveness
NEW04311,CHEMICAL,17-hydroxyprogesterone production,17-hydroxyprogesterone production
D000858,DISEASE,Anovulation,anovulation|Anovulations
NEW04313,BIOCHEMICAL,mild adrenal androgen excess,mild adrenal androgen excess
NEW04314,CHEMICAL,PACAP-PAC1 receptor pathway,PACAP-PAC1 receptor pathway
NEW04316,MENTAL_HEALTH,psychosexual orientation,psychosexual orientation
NEW04318,DISEASE,loss comorbidities,loss comorbidities
NEW04320,BIOCHEMICAL,Endocrine therapy,Endocrine therapy
D006065,CHEMICAL,"Gonadotropins, Pituitary",gonadotropins|Pituitary Gonadotropins
NEW04323,BIOCHEMICAL,Luteinising hormone-releasing hormone antagonists,Luteinising hormone-releasing hormone antagonists
NEW04328,BIOCHEMICAL,Selective antagonists,Selective antagonists
NEW04330,BIOCHEMICAL,Non-tissue selective antagonists,Non-tissue selective antagonists
NEW04331,DISEASE,deficiency revolve,deficiency revolve
NEW04332,CHEMICAL,Hypo/achloridia,Hypo/achloridia
NEW04336,BIOCHEMICAL,Vitamin B12 assay,Vitamin B12 assay
NEW04337,BIOCHEMICAL,MTHFR T allele carriers,MTHFR T allele carriers
NEW04339,DISEASE,MTHFR A1298C,MTHFR A1298C
NEW04340,NUTRITION,folate level,folate level
NEW04342,CHEMICAL,omega-3 treatments,omega-3 treatments
NEW04343,BIOCHEMICAL,Vitamin B(12 cobalamin deficiency,Vitamin B(12 cobalamin deficiency
NEW04344,CHEMICAL,nocturnal melatonin secretion,nocturnal melatonin secretion
NEW04345,CHEMICAL,low melatonin secretion,low melatonin secretion
NEW04346,CHEMICAL,metformin therapy,metformin therapy
D020820,DISEASE,Dyskinesias,"Dyskinesia, Orofacial|Hemiballism|Orofacial Dyskinesia|Lingual-Facial-Buccal Dyskinesia|Linguofacial Dyskinesias|Dyskinesia, Oral-Facial|Abnormal Movements|Dyskinesias, Lingual-Facial-Buccal|Movement, Abnormal|Asterixis|Lingual Facial Buccal Dyskinesia|Movement, Involuntary|Dyskinesias, Oral|Involuntary movements|Oral-Facial Dyskinesia|Oral Dyskinesias|Dyskinesias, Oral-Facial|Involuntary Movement|Abnormal Movement|Dyskinesia, Linguofacial|Dyskinesias, Orofacial|Dyskinesia|Tardive Oral Dyskinesia|Movements, Involuntary|Lingual-Facial-Buccal Dyskinesias|Dyskinesia, Oral|Oral Dyskinesia|Involuntary Movements|Orofacial Dyskinesias|Hemiballismus|Tardive Oral Dyskinesias|Dyskinesias, Linguofacial|Dyskinesia, Lingual-Facial-Buccal|Ballismus|Movements, Abnormal|Oral Facial Dyskinesia|Linguofacial Dyskinesia|Oral-Facial Dyskinesias"
NEW04349,CHEMICAL,elevated serum homocysteine,elevated serum homocysteine
NEW04350,BIOCHEMICAL,Serum vitamin B12,Serum vitamin B12
NEW04351,CHEMICAL,homocysteine concentrations,homocysteine concentrations
NEW04352,CHEMICAL,Homocysteine levels,Homocysteine levels
NEW04355,CHEMICAL,Cbl deficiency,Cbl deficiency
NEW04358,DISEASE,PKU patients,PKU patients
NEW04359,DISEASE,cardiovascular problems,cardiovascular problems
C023894,CHEMICAL,methylcobalamin-coenzyme M methyltransferase [Supplementary Concept],Archaeal Proteins|methyl-B12|Methyltransferases
NEW04360,BIOCHEMICAL,Maternal Vitamin B12 deficiency,Maternal Vitamin B12 deficiency
C046441,BIOCHEMICAL,"cyanocobalamin, pyridoxine, thiamine drug combination [Supplementary Concept]",Thiamine|cyanocobalamin|Vitamin B 12|Pyridoxine|Drug Combinations
NEW04367,BIOCHEMICAL,vitamin B12 serum levels,vitamin B12 serum levels
NEW04369,BIOCHEMICAL,addictive drug,addictive drug
D000752,DISEASE,"Anemia, Pernicious","Anemia, Addison|Anemia, Addisons|Addisons Anemia|Anemia, Addison's|pernicious anemia|Addison Anemia|Pernicious Anemia|Addison's Anemia"
D058972,BIOCHEMICAL,Folic Acid Transporters,"Folate Transporters|Transporters, Folic Acid|Proteins, Folate Transport|Folate Transport Proteins|Acid Transporters, Folic|folic acid|Transporters, Folate|Folic Acid Transport Proteins|Transport Proteins, Folate"
NEW04373,DISEASE,primary immune thrombocytopenia,ITP|primary immune thrombocytopenia
D065290,DISEASE,Acute-On-Chronic Liver Failure,"Liver Failure, Acute-On-Chronic|Acute-On-Chronic Liver Failures (ACLF)|liver failure|Failure, Acute-On-Chronic Liver|Acute On Chronic Liver Failure (ACLF)|Failures, Acute-On-Chronic Liver|Liver Failures, Acute-On-Chronic|Liver Failure, Acute-On-Chronic (ACLF)|Liver Failures, Acute-On-Chronic (ACLF)|Acute-On-Chronic Liver Failure (ACLF)|Liver Failure, Acute On Chronic|Failure, Acute-On-Chronic Liver (ACLF)|Acute On Chronic Liver Failure|Failures, Acute-On-Chronic Liver (ACLF)|Acute-On-Chronic Liver Failures"
C558827,CHEMICAL,N-acetyl cysteine proline cysteine amide [Supplementary Concept],Oligopeptides|N- Acetyl Cysteine|Sulfhydryl Compounds
C086501,CHEMICAL,N-acetylcysteine lysinate [Supplementary Concept],Acetylcysteine/analogs  and  derivatives|NAC|N-acetylcysteine|Lysine/analogs  and  derivatives
NEW04376,DISEASE,Serious toxicities,Serious toxicities
D006464,CHEMICAL,Hemoperfusion,Hemoperfusion|Hemosorption|Hemosorptions|Hemoperfusions
NEW04377,CHEMICAL,caffeine abuse,caffeine abuse
NEW04378,CHEMICAL,caffeine intake,caffeine intake
NEW04382,CHEMICAL,high caffeine users,high caffeine users
NEW04384,CHEMICAL,caffeine consumption,caffeine consumption
NEW04387,DISEASE,combat-stress reaction,combat-stress reaction
NEW04392,CHEMICAL,CLZ adverse reactions,CLZ adverse reactions
NEW04394,DISEASE,depressive effects,depressive effects
D000069956,CHEMICAL,Chocolate,"Cocoa Powders|Powder, Cocoa|Chocolates|cocoa|Cocoa Powder|Powders, Cocoa"
NEW04400,CHEMICAL,chronic caffeine exposure,chronic caffeine exposure
NEW04403,CHEMICAL,Synthetic caffeine,Synthetic caffeine
NEW04406,DISEASE,SGAP-induced weight gain,SGAP-induced weight gain
NEW04407,DISEASE,glucose dysregulation,glucose dysregulation
NEW04408,BIOCHEMICAL,glucagon-like peptide-1 receptor agonists,glucagon-like peptide-1 receptor agonists
NEW04410,CHEMICAL,Glucagon-like peptide-1 receptor agonists,GLP-1RAs|Glucagon-like peptide-1 receptor agonists
NEW04409,DISEASE,antipsychotic-associated body weight gain,antipsychotic-associated body weight gain
NEW04411,DISEASE,effective weight reduction interventions,effective weight reduction interventions
NEW04415,BIOCHEMICAL,Glucagon-like peptide-1 receptor agonists,Glucagon-like peptide-1 receptor agonists
NEW04418,BIOCHEMICAL,Peptide-1 Receptor Agonists,Peptide-1 Receptor Agonists
D053767,CHEMICAL,Glucagon-Like Peptide 2,Glucagon|Proglucagon (126-158)|Glucagon-Like Peptide-2 (1-33)|Glucagon Like Peptide 2
NEW04421,CHEMICAL,co- Transporter-2 inhibitors,co- Transporter-2 inhibitors
NEW04422,BIOCHEMICAL,Glucagon-like peptide-1 GLP-1 receptor agonists,Glucagon-like peptide-1 GLP-1 receptor agonists
NEW04424,CHEMICAL,GLP-1 receptor agonists,GLP-1 receptor agonists
NEW04425,CHEMICAL,oral semaglutide,oral semaglutide
D066249,MENTAL_HEALTH,Craving,craving|Cravings
NEW04426,BIOCHEMICAL,necessary drug intervention,necessary drug intervention
C534611,CHEMICAL,rGLP-1 protein [Supplementary Concept],Albiglutide|Glucagon-Like Peptide 1/analogs  and  derivatives
C479460,CHEMICAL,lixisenatide [Supplementary Concept],Lixisenatide|Peptides
NEW04432,CHEMICAL,glucagon-like peptide-1 receptor agonists,glucagon-like peptide-1 receptor agonists|GLP-1 RAs
NEW04434,CHEMICAL,metformin monotherapy,metformin monotherapy
NEW04435,BIOCHEMICAL,different antidiabetic drug monotherapies,different antidiabetic drug monotherapies
NEW04436,BIOCHEMICAL,glucagon-like peptide receptor agonists,glucagon-like peptide receptor agonists
NEW04437,CHEMICAL,Alcohol neurotoxicity,Alcohol neurotoxicity
NEW04438,DISEASE,Alcoholic organic brain disease,Alcoholic organic brain disease
NEW04442,CHEMICAL,alcohol dependents,alcohol dependents
NEW04443,DISEASE,Such cognitive disorders,Such cognitive disorders
NEW04446,DISEASE,profound anterograde memory deficit,profound anterograde memory deficit
D000076042,DISEASE,Alcoholic Korsakoff Syndrome,"Korsakoff Syndrome, Alcoholic|Alcohol-Induced Korsakoff Syndrome|Alcoholic Wernicke-Korsakoff Syndrome|Alcohol Induced Korsakoff Syndrome|Alcoholic Wernicke Korsakoff Syndrome|Wernicke-Korsakoff syndrome|Korsakoff Syndrome, Alcohol-Induced|Wernicke-Korsakoff Syndrome, Alcoholic"
NEW04449,CHEMICAL,phosphate esters,phosphate esters
NEW04452,DISEASE,neonatal congenital lactic acidosis,neonatal congenital lactic acidosis
NEW04453,DISEASE,Hyperlactacidemia,Hyperlactacidemia
NEW04456,CHEMICAL,pentose cycle,pentose cycle
D019289,CHEMICAL,Pyruvic Acid,"Acid, Pyruvic|Pyruvate|pyruvic acid"
NEW04457,DISEASE,send-out cerebrospinal fluid autoimmune encephalitis panel,send-out cerebrospinal fluid autoimmune encephalitis panel
D007069,CHEMICAL,Ifosfamide,"Isophosphamide|NSC-109,724|NSC 109724|NSC109,724|Iphosphamide|NSC 109,724|Iso Endoxan|NSC-109724|NSC109724|Asta Z 4942|Isofosfamide|Iso-Endoxan|Holoxan|Ifosfamide"
D012436,CHEMICAL,S-Adenosylmethionine,S Adenosyl L Methionine|S-adenosylmethionine|Samyr|SAM-e|AdoMet|Gumbaral|Ademetionine|S Adenosylmethionine|S-Adenosyl-L-Methionine|S Amet|S-Adenosylmethionine Sulfate Tosylate|FO-1561|FO 1561|S Adenosylmethionine Sulfate Tosylate|FO1561
NEW04459,BIOCHEMICAL,vitamin malnutrition,vitamin malnutrition
D046915,CHEMICAL,Penicillin-Binding Proteins,"Penicillin-Binding Protein 1A|Protein 1A, Penicillin-Binding|Penicillin Binding Protein 6|Penicillin Binding Protein 2a|Penicillin-Binding Protein 4|Penicillin-Binding Protein 6|Penicillin-Binding Protein 7|Synthetase, Peptidoglycan|Penicillin Binding Protein 7|Penicillin Binding Protein 2b|Penicillin Binding Protein 5|Penicillin-Binding Protein|Penicillin-Binding Protein 5|Penicillin Binding Proteins|Protein 1b, Penicillin-Binding|Penicillin-Binding Protein 2b|Penicillin Binding Protein 1|penicillin|Penicillin-Binding Protein 3|Penicillin-Binding Protein 1|Penicillin-Binding Protein 1b|Penicillin-Binding Protein 2a|Penicillin Binding Protein 3|Penicillin Binding Protein 2|Penicillin Binding Protein 4|Penicillin-Binding Protein 2|Penicillin Binding Protein 1A|Penicillin Binding Protein 1b|Proteins, Penicillin-Binding|Penicillin Binding Protein|Peptidoglycan Synthetase|Penicillin-Binding Protein-2a"
NEW04461,DISEASE,cerebral pellagra,cerebral pellagra
NEW04462,DISEASE,syphilitic general paralysis,syphilitic general paralysis
C021864,BIOCHEMICAL,nicotinate phosphoribosyltransferase [Supplementary Concept],nicotinic acid|Pentosyltransferases
D017674,DISEASE,Hypophosphatemia,Hypophosphatemias|hypophosphatemia
D020915,DISEASE,Korsakoff Syndrome,"Wernicke-Korsakoff Syndromes|Wernicke-Korsakoff Syndrome|Psychosis, Korsakoff|Psychoses, Korsakoff|Korsakoff Psychoses|Korsakoff Psychosis|Wernicke Korsakoff Syndrome|Korsakoff syndrome"
NEW04464,DISEASE,self-neglect abuse,self-neglect abuse
NEW04466,DISEASE,impaired consciousness,impaired consciousness
NEW04467,BIOCHEMICAL,thiamine pyrophosphate deficiency,thiamine pyrophosphate deficiency
NEW04468,CHEMICAL,subclinical Zn excess,subclinical Zn excess
NEW04470,DISEASE,TD deficits,TD deficits
NEW04472,DISEASE,mild TD,mild TD
NEW04474,NUTRITION,Reduced thiamine,Reduced thiamine
NEW04475,BIOCHEMICAL,"agonist (RS)-3,5-dihydroxyphenylglycine","agonist (RS)-3,5-dihydroxyphenylglycine"
NEW04479,CHEMICAL,Sodium benzoate therapy,Sodium benzoate therapy
C016030,CHEMICAL,pantogab [Supplementary Concept],Pantothenic Acid/analogs  and  derivatives|Calcium hopantenate|gamma-Aminobutyric Acid/analogs  and  derivatives
C536351,DISEASE,"Visceral Steatosis, Congenital [Supplementary Concept]",Fatty Liver|hepatic steatosis
NEW01337,DISEASE,acute encephalopathy,acute encephalopathy
NEW04482,CHEMICAL,selective receptor agonist lorcaserin,selective receptor agonist lorcaserin
NEW04483,CHEMICAL,serotonin releasers,serotonin releasers
D058826,BIOCHEMICAL,Serotonin 5-HT2 Receptor Agonists,"Serotonin 5-HT2B Receptor Agonists|Agonists, 5-HT2|Serotonin 5-HT2A Receptor Agonists|5-HT2A Agonist|Serotonin 5 HT2C Receptor Agonists|5-HT2C receptor agonists|Agonist, 5-HT2C|5-HT2 Agonist|5-HT2C Agonist|Serotonin 5-HT2C Receptor Agonists|Agonist, 5-HT2A|5 HT2C Agonist|5-HT2 Agonists|5 HT2 Agonists|5 HT2A Agonist|5 HT2B Agonist|5 HT2 Agonist|Agonist, 5-HT2B|Serotonin 5 HT2 Receptor Agonists|Serotonin 5 HT2B Receptor Agonists|5-HT2B Agonist|Agonist, 5-HT2|Serotonin 5 HT2A Receptor Agonists"
NEW04484,CHEMICAL,(dex)fenfluramine,(dex)fenfluramine
NEW04488,DISEASE,obsessive beliefs,obsessive beliefs
NEW04490,NUTRITION,alpha antagonist,alpha antagonist
D043887,CHEMICAL,"Receptor, Cholecystokinin B","CCK-B Receptor|CCK B Receptors|Receptors, CCK-B|Receptor, CKK-2|Cholecystokinin B Receptor|CCK B Receptor|Cholecystokinin|CKK 2 Receptor|Cholecystokinin 2 Receptor|CCK-B Receptors|Gastrin Receptor|Cholecystokinin-2 Receptor|Receptor, CCK-B|Receptor, Gastrin|B Receptor, Cholecystokinin|Receptor, CCK B|Receptors, Gastrin|Gastrin Receptors|Receptor, Cholecystokinin-2|Receptor, CCK2|CKK-2 Receptor|CCK2 Receptor"
NEW04491,BIOCHEMICAL,psycho-stimulant drug,psycho-stimulant drug
NEW04495,CHEMICAL,GABA genes,GABA genes
NEW04497,BIOCHEMICAL,SSRI treatment,SSRI treatment
NEW04498,DISEASE,cardiometabolic alterations,cardiometabolic alterations
NEW04499,BIOCHEMICAL,Perinatal SSRI exposure,Perinatal SSRI exposure
NEW04500,DISEASE,perinatal SSRI-induced behavioral abnormalities,perinatal SSRI-induced behavioral abnormalities
NEW04504,BIOCHEMICAL,SSRI paroxetine,SSRI paroxetine
NEW04505,CHEMICAL,circulating irisin levels,circulating irisin levels
NEW04509,CHEMICAL,Selective serotonin 5-hydroxytryptamine reuptake inhibitors,Selective serotonin 5-hydroxytryptamine reuptake inhibitors
NEW04510,DISEASE,UK CSM,UK CSM
NEW04511,CHEMICAL,Serotonin neurotransmission,Serotonin neurotransmission
NEW04512,DISEASE,Bipolar depressions,Bipolar depressions
NEW00390,CHEMICAL,Pathologic gambling,Pathologic gambling|PG
NEW04516,DISEASE,Behavioral addictions,Behavioral addictions
NEW04519,CHEMICAL,Fluvoxamine weeks,Fluvoxamine weeks
NEW03460,BIOCHEMICAL,SSRI antidepressants,SSRI antidepressants
NEW04520,CHEMICAL,central serotonin function,central serotonin function
NEW04521,CHEMICAL,acetylcholine systems,acetylcholine systems
NEW04523,BIOCHEMICAL,SSRI fluvoxamine,SSRI fluvoxamine
NEW04524,DISEASE,unipolar major depression,unipolar major depression|DSM-III-R
NEW04527,BIOCHEMICAL,dopamine reuptake inhibitor,dopamine reuptake inhibitor
NEW04528,BIOCHEMICAL,SSRI concomitant therapies,SSRI concomitant therapies
NEW04530,DISEASE,male ASD cases,male ASD cases
NEW04532,CHEMICAL,serotonin 5-HT reuptake,serotonin 5-HT reuptake
NEW04533,DISEASE,behavioral impairments,behavioral impairments
NEW04535,CHEMICAL,serotonin transmission,serotonin transmission
NEW04537,CHEMICAL,antidepressant citalopram,antidepressant citalopram|CIT
NEW04540,CHEMICAL,gamma-aminobutyric acid pathways,gamma-aminobutyric acid pathways
NEW04541,CHEMICAL,Haldol    Decanoate long-acting injectable,Haldol    Decanoate long-acting injectable
NEW04544,CHEMICAL,intranasal OXT,intranasal OXT
NEW04545,CHEMICAL,Oxytocin treatment,Oxytocin treatment
NEW04547,MENTAL_HEALTH,Acute anxiety,Acute anxiety
NEW04550,DISEASE,Premenstrual Disorders,Premenstrual Disorders
NEW04552,NUTRITION,cholesterol ATP-binding cassette transporter,cholesterol ATP-binding cassette transporter
NEW04553,CHEMICAL,Alpha-1-adrenergic antagonist prazosin,Alpha-1-adrenergic antagonist prazosin
D014409,DISEASE,Tumor Necrosis Factor-alpha,"Tumor Necrosis Factor alpha|Tumor Necrosis Factor|Cachectin Tumor Necrosis Factor|TNFalpha|Tumor Necrosis Factor Ligand Superfamily Member 2|tumor necrosis factor-α|Cachectin-Tumor Necrosis Factor|Cachectin|TNF Superfamily, Member 2|TNF-alpha"
NEW04556,BIOCHEMICAL,antagonist AM251,antagonist AM251
NEW04557,CHEMICAL,Chronic AM251,Chronic AM251
D002186,CHEMICAL,Cannabinoids,Cannabinoid|Cannabinoids
NEW04563,CHEMICAL,anandamide transport inhibitor N-(4-hydroxyphenyl)-arachidonamide,AM404|anandamide transport inhibitor N-(4-hydroxyphenyl)-arachidonamide
NEW04566,BIOCHEMICAL,CB1 cannabinoid receptor antagonist,CB1 cannabinoid receptor antagonist
NEW04568,BIOCHEMICAL,corelating hormone cortisol,corelating hormone cortisol
NEW01342,NUTRITION,lithium therapy,lithium therapy
NEW04569,CHEMICAL,Low melatonin levels,Low melatonin levels
NEW04570,CHEMICAL,Melatonin profiles,Melatonin profiles
NEW04573,BIOCHEMICAL,normalized thyroid hormones,normalized thyroid hormones
NEW04575,BIOCHEMICAL,exogenous thyroid hormones,exogenous thyroid hormones
NEW04577,CHEMICAL,Methadone maintenance therapy,Methadone maintenance therapy
NEW04578,CHEMICAL,Elevated T3 levels,Elevated T3 levels
NEW04579,CHEMICAL,T3 levels,T3 levels
NEW04580,DISEASE,violent/aggressive behavior,violent/aggressive behavior
NEW04582,CHEMICAL,ammonia secondary,ammonia secondary
NEW04584,DISEASE,hypothyroid myopathy,hypothyroid myopathy
NEW04585,CHEMICAL,ammonia secondary to,ammonia secondary to
NEW04586,DISEASE,Decreased liver ureagenesis,Decreased liver ureagenesis
NEW04587,NUTRITION,Circulating cholesterol,Circulating cholesterol
NEW04590,DISEASE,subtle thyroid dysfunction,subtle thyroid dysfunction
NEW04591,CHEMICAL,low triiodothyronine syndrome,low triiodothyronine syndrome
NEW04592,DISEASE,hypothyroidism treatment,hypothyroidism treatment
NEW04594,CHEMICAL,hormones fT3 TSH serum levels,hormones fT3 TSH serum levels
D005067,DISEASE,Euthyroid Sick Syndromes,"Syndrome, Sick Euthyroid|Low T3 Syndrome|Low T3 High T4 Syndrome|Low T3-Low T4 Syndrome|Syndromes, Non-Thyroidal Illness|Low T3 syndrome|Non Thyroidal Illness Syndrome|Sick Euthyroid Syndrome|Syndrome, Non-Thyroidal Illness|Low T3-High T4 Syndrome|Low T3 Low T4 Syndrome|Low T3 and Low T4 Syndrome|High T4 Syndrome|Euthyroid Sick Syndrome|Non-Thyroidal Illness Syndrome|High T4 Syndromes"
NEW04597,DISEASE,Subacute thyreoiditis,Subacute thyreoiditis
D058286,CHEMICAL,Calcitonin Receptor-Like Protein,"Receptor-Like Receptor, Calcitonin|Calcitonin Receptor-Like Receptor|Calcitonin Receptor Like Protein|Receptor-Like Protein, Calcitonin|Calcitonin Receptor Like Receptor|calcitonin"
D002291,DISEASE,"Carcinoma, Papillary","Carcinomas, Papillary|papillary carcinomas|Papillary Carcinomas|Papillary Carcinoma"
D064547,MENTAL_HEALTH,Myxovirus Resistance Proteins,"Protein Mx, Interferon Induced|Interferon-Induced Protein Mx|Mx, Interferon-Induced Protein|Resistance|Protein Mx|Mx, Protein|Protein Mx, Interferon-Induced"
NEW04601,BIOCHEMICAL,thyroid hormone beta,thyroid hormone beta
NEW04602,CHEMICAL,thyroid hormone-disrupting chemicals,thyroid hormone-disrupting chemicals
D007859,MENTAL_HEALTH,Learning Disabilities,"Developmental Disabilities of Scholastic Skills|Learning Disturbance|Adult Learning Disability|Developmental Academic Disabilities|Academic Disorders, Developmental|Developmental Academic Disorder|Learning Disabilities, Child|Developmental Disorders of Scholastic Skills|Learning Disorders, Adult|Adult Learning Disorder|Learning Disability, Adult|Learning Disorder|Developmental Academic Disorders|Adolescent Learning Disability|Academic Disability, Developmental|Disorder, Learning|Academic Disabilities, Developmental|Academic Disorder, Developmental|Learning Disabilities, Adolescent|Learning Disability, Child|Disturbances, Learning|Disability, Learning|Disabilities, Developmental Academic|Learning Disorders|Adult Learning Disabilities|Learning Disturbances|Learning Disability, Adolescent|Scholastic Skills Development Disorders|Disorders, Learning|Disabilities, Adult Learning|Learning Disabilities, Adult|Learning Disorder, Adult|Disabilities, Child Learning|Disability, Adult Learning|Adolescent Learning Disabilities|Child Learning Disabilities|Disability, Child Learning|Developmental Academic Disability|Disabilities, Adolescent Learning|Disorders, Adult Learning|Disability, Developmental Academic|Child Learning Disability|learning disorders|Learning Disability|Adult Learning Disorders|Disturbance, Learning|Disabilities, Learning|Disability, Adolescent Learning"
NEW04604,DISEASE,neurobehavioral disabilities,neurobehavioral disabilities
NEW04606,BIOCHEMICAL,thyroid hormones secretion,thyroid hormones secretion
NEW04607,CHEMICAL,TH supply,TH supply
NEW04609,BIOCHEMICAL,glucagon-like peptide-1 receptor agonist liraglutide,glucagon-like peptide-1 receptor agonist liraglutide
NEW04610,DISEASE,antidiabetic weight glucagon-like peptide-1 receptor agonist liraglutide,antidiabetic weight glucagon-like peptide-1 receptor agonist liraglutide
NEW04614,CHEMICAL,glucagon-like peptide-1 receptor agonist liraglutide treatment,glucagon-like peptide-1 receptor agonist liraglutide treatment
NEW04615,BIOCHEMICAL,glucagon-like peptide-1 GLP-1 receptor agonist,glucagon-like peptide-1 GLP-1 receptor agonist
NEW04617,CHEMICAL,GLP-1 analogue exenatide,GLP-1 analogue exenatide
D052216,CHEMICAL,Glucagon-Like Peptide 1,Glucagon-like peptide-1|GLP 1|GLP-1|Glucagon-Like Peptide-1|Glucagon Like Peptide 1
D008152,CHEMICAL,Loxapine,"Oxilapine|Loxapinsuccinate|CL 71,563|2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepine|Loxipine Succinate|Loxapine|Loxapine Succinate|Loxapine Hydrochloride|CL-71,563|CL71,563|Loxipine Maleate|Loxapine Monohydrochloride|Cloxazepine|Loxitane|Hydrochloride, Loxapine|Maleate, Loxipine|Succinate, Loxapine"
D011595,MENTAL_HEALTH,Psychomotor Agitation,"Restlessness, Psychomotor|Restlessness|Agitation, Psychomotor|Psychomotor Restlessness|Akathisia|Excitement, Psychomotor|Psychomotor Hyperactivity|Hyperactivity, Psychomotor|agitation|Psychomotor Excitement"
NEW04619,CHEMICAL,plasma glucose levels,plasma glucose levels
NEW04620,MENTAL_HEALTH,increased insulin resistance index,increased insulin resistance index
D000069450,CHEMICAL,Liraglutide,"NN2211|2211, NN|NN 2211|liraglutide|NN-2211|Saxenda|Victoza"
NEW04624,CHEMICAL,reboxetine-betahistine combination,reboxetine-betahistine combination
NEW04626,CHEMICAL,Histamine antagonism,Histamine antagonism
NEW04629,CHEMICAL,histamine enhancer,histamine enhancer
NEW04630,CHEMICAL,t.i.d,t.i.d
D058831,CHEMICAL,Serotonin 5-HT3 Receptor Antagonists,"5-HT3 Antagonist|Serotonin 5 HT3 Receptor Antagonists|Antagonist, 5-HT3|5 HT3 Antagonists|5 HT3 Antagonist|5-HT3 receptor|Antagonists, 5-HT3|5-HT3 Antagonists"
NEW04632,DISEASE,hepatitis C viral infection,hepatitis C viral infection
NEW04634,CHEMICAL,interferon-alpha IFN-alpha therapy,interferon-alpha IFN-alpha therapy
NEW04635,DISEASE,IFN-alpha-induced MDD,IFN-alpha-induced MDD
D015928,DISEASE,Cognitive Behavioral Therapy,"Therapies, Cognitive Behavior|Therapy, Cognitive Behaviour|Therapies, Cognitive Behavioral|Cognitive Behavior Therapies|Cognitive Behavior Therapy|Therapy, Cognitive Behavioral|Therapies, Cognitive|Therapy, Cognitive|cognitive behaviour therapy|Behavioral Therapy, Cognitive|Cognition Therapies|Behaviour Therapy, Cognitive|Cognitive Psychotherapy|Behavioral Therapies, Cognitive|Cognitive Behaviour Therapy|Therapy, Cognitive Behavior|Cognitive Behavioral Therapies|Psychotherapy, Cognitive|Cognition Therapy|Therapy, Cognition|Cognitive Psychotherapies|Behavior Therapy, Cognitive|Therapies, Cognition|Behaviour Therapies, Cognitive|Therapies, Cognitive Behaviour|Psychotherapies, Cognitive|Cognitive Therapy|Behavior Therapies, Cognitive|Cognitive Therapies|Cognitive Behaviour Therapies"
NEW04640,MENTAL_HEALTH,Depression Rating Scale response rate,Depression Rating Scale response rate
NEW04641,DISEASE,primary DSM-IV OCD diagnosis,primary DSM-IV OCD diagnosis
NEW04642,DISEASE,comorbid chronic tics,comorbid chronic tics
NEW04643,DISEASE,comorbid tics,comorbid tics
NEW04645,CHEMICAL,risperidone addition,risperidone addition
D011985,CHEMICAL,"Receptors, Serotonin","Receptors, 5 HT|Receptor, Tryptamine|5 HT Receptors|5-HT Receptors|Receptors, 5-Hydroxytryptamine|Receptor, 5-HT|Tryptamine Receptors|5 Hydroxytryptamine Receptors|serotonin 5-hydroxytryptamine|Receptor, 5-Hydroxytryptamine|5-Hydroxytryptamine Receptors|5-HT Receptor|Receptors, Tryptamine|Receptor, Serotonin|Tryptamine Receptor|5 Hydroxytryptamine Receptor|Receptors, 5 Hydroxytryptamine|Serotonin Receptors|Serotonin Receptor|5-Hydroxytryptamine Receptor|Receptors, 5-HT|5 HT Receptor"
NEW04648,DISEASE,early-life exposure,early-life exposure
NEW04649,DISEASE,early-life selective serotonin reuptake inhibitor exposure,early-life selective serotonin reuptake inhibitor exposure
NEW04652,CHEMICAL,amygdala serotonin reuptake,amygdala serotonin reuptake
NEW04655,BIOCHEMICAL,selective serotonin reuptake inhibitor medications,selective serotonin reuptake inhibitor medications
NEW03881,CHEMICAL,antidepressant treatment,antidepressant treatment
NEW04657,DISEASE,K´s manic symptoms,K´s manic symptoms
NEW04658,DISEASE,personality disordered patients,personality disordered patients
NEW04660,DISEASE,impulsive aggression,impulsive aggression
D010554,MENTAL_HEALTH,Personality Disorders,"Narcissistic Personality Disorder|Personality, Impulse-Ridden|As If Personality|Avoidant Personality Disorders|Personality Disorder|Personality, As If|Personality Disorder, Narcissistic|personality disorders|Impulse Ridden Personality|Personality, Inadequate|Inadequate Personality|Personality Disorders, Avoidant|Personality Disorder, Avoidant|Avoidant Personality Disorder|Impulse-Ridden Personality"
NEW04663,BIOCHEMICAL,SSRI treatment duration,SSRI treatment duration
NEW04667,CHEMICAL,serotonin reuptake-inhibitor fluoxetine,serotonin reuptake-inhibitor fluoxetine
NEW04668,CHEMICAL,serotonin precursor 5-hydroxytryptophan,serotonin precursor 5-hydroxytryptophan
NEW04669,CHEMICAL,extended-release methylphenidate,extended-release methylphenidate
D010869,CHEMICAL,Pindolol,Visken|LB-46|pindolol|LB 46|Prindolol|LB46
NEW04674,CHEMICAL,GABA type A receptor,GABAAR|GABA type A receptor
NEW04675,CHEMICAL,neuroactive steroid allopregnanolone,neuroactive steroid allopregnanolone
NEW04677,CHEMICAL,neuroactive steroid allopregnanolone,ALLO|neuroactive steroid allopregnanolone
NEW04678,DISEASE,mediated depression/anxiety,mediated depression/anxiety
NEW04680,BIOCHEMICAL,selective serotonin reuptake inhibitor sertraline,selective serotonin reuptake inhibitor sertraline
NEW04682,DISEASE,dexamethasone-induced neuronal damage,dexamethasone-induced neuronal damage
NEW04685,CHEMICAL,adjunctive quetiapine,adjunctive quetiapine
NEW04687,CHEMICAL,antidepressant use,antidepressant use
D020280,CHEMICAL,Sertraline,"Novo-Sertraline|ratio-Sertraline|Rhoxal-sertraline|Novo Sertraline|Apo-Sertraline|Hydrochloride, Sertraline|Gen-Sertraline|Besitran|Gen Sertraline|Sertraline Hydrochloride (1S-cis)-Isomer|Sertraline Hydrochloride|Aremis|ratio Sertraline|Lustral|Gladem|Apo Sertraline|Rhoxal sertraline|sertraline|Altruline|Zoloft|Sealdin"
NEW04689,CHEMICAL,agent amantadine,agent amantadine
NEW04691,CHEMICAL,Amantadine toxicity,Amantadine toxicity
NEW04692,DISEASE,Extrapyramidal symptoms,Extrapyramidal symptoms
NEW04694,DISEASE,BK virus encephalitis,BK virus encephalitis
D010269,CHEMICAL,Paraquat,"Gramoxone|paraquat|Methyl Viologen|Viologen, Methyl|Paragreen A"
NEW04696,CHEMICAL,Monoamine systems,Monoamine systems
NEW04698,CHEMICAL,systems serotonin,systems serotonin
NEW04699,DISEASE,KIV mice,KIV mice
NEW04701,CHEMICAL,Ginkgo biloba supplement,GB-S|Ginkgo biloba supplement
NEW04703,CHEMICAL,uroporphyrin characteristic,uroporphyrin characteristic
NEW04704,DISEASE,uroporphyria,uroporphyria
D004492,CHEMICAL,Edetic Acid,"Ethylenediaminetetraacetic Acid|Edetic Acid, Disodium Salt, Dihydrate|Edetic Acid, Monopotassium Salt|Tetracemate|EDTA, Chromium|Edetic Acid, Disodium Salt|Coprin|Calcitetracemate, Disodium|Edathamil|Edetic Acid, Magnesium Salt|EDTA, Dicobalt|Ethylenedinitrilotetraacetic Acid|EDTA|Disodium Calcitetracemate|Acid, Ethylenedinitrilotetraacetic|EDTA, Disodium|Edetic Acid, Sodium Salt|Ethylene Dinitrilotetraacetate|Edetic Acid, Monosodium Salt|N,N'-1,2-Ethanediylbis(N-(carboxymethyl)glycine)|Distannous EDTA|Chromium EDTA|Edetic Acid, Calcium Salt|ethylenediaminetetraacetic acid|Edetic Acid, Calcium, Sodium Salt|Gallium EDTA|EDTA, Copper|Versenate, Calcium Disodium|Versenate|Dicobalt EDTA|Edetic Acid, Potassium Salt|EDTA, Gallium|Magnesium Disodium EDTA|EDTA, Distannous|EDTA, Magnesium Disodium|EDTA, Stannous|Tetacine, Calcium|Chelaton 3|Stannous EDTA|Edetates|Edetate Disodium Calcium|Edetate, Calcium Disodium|Potassium EDTA|Calcium Disodium Edetate|Acid, Ethylenediaminetetraacetic|Disodium EDTA|Disodium Versenate, Calcium|Edetic Acid, Chromium Salt|Calcium Disodium Versenate|Acid, Edetic|Calcium Tetacine|Disodium Ethylene Dinitrilotetraacetate|Edetic Acid, Disodium, Magnesium Salt|Edetic Acid, Dipotassium Salt|Versene|Copper EDTA|EDTA, Potassium|Dinitrilotetraacetate, Disodium Ethylene|Ethylene Dinitrilotetraacetate, Disodium|Edetic Acid, Disodium, Monopotassium Salt|Dinitrilotetraacetate, Ethylene"
D007502,CHEMICAL,Iron Chelating Agents,"Iron Chelates|Chelates, Iron|Chelating Agents, Iron|Agents, Iron Chelating|iron chelates"
NEW04706,CHEMICAL,iron stores,iron stores
NEW03675,CHEMICAL,excess iron,excess iron
NEW04708,CHEMICAL,restricted Rg1,restricted Rg1
D020264,DISEASE,"Lead Poisoning, Nervous System, Childhood","Encephalopathy, Childhood Lead|Poisoning, Lead, Neurologic, Childhood|Nervous System Poisoning, Lead, Childhood|Poisoning, Lead, Nervous System, Childhood|Encephalopathy, Childhood Saturine|Saturnism, Childhood Neurologic|Lead encephalopathy|Neurotoxicity Syndrome, Lead, Childhood|Childhood Saturine Encephalopathy|Lead-Induced Nervous System Disease, Childhood|Saturine Encephalopathy, Childhood|Childhood Lead Encephalopathy|Neurologic Saturnism, Childhood|Lead Poisoning, Neurologic, Childhood|Plumbism, Neurologic, Childhood|Lead Induced Nervous System Disease, Childhood|Nervous System Disease, Lead-Induced, Childhood|Childhood Neurologic Saturnism|Lead Encephalopathy, Childhood"
D016015,MENTAL_HEALTH,Logistic Models,"Regressions, Logistic|Logistic Model|Models, Logit|Logit Models|Logistic regression|Logit Model|Logistic Regressions|Model, Logit|Models, Logistic|Model, Logistic|Logistic Regression|Regression, Logistic"
NEW04711,CHEMICAL,l-dopa therapy,l-dopa therapy
NEW04712,CHEMICAL,Hoffmann reflex H reflex,Hoffmann reflex H reflex
NEW04714,DISEASE,severe RLS,severe RLS
NEW04715,CHEMICAL,first-line therapy,first-line therapy
NEW04717,CHEMICAL,Background Methylphenidate hydrochloride,Background Methylphenidate hydrochloride
NEW03728,CHEMICAL,dopamine release,dopamine release
NEW04722,DISEASE,DLB patients,DLB patients
NEW04723,CHEMICAL,adjunctive amantadine,adjunctive amantadine
NEW04725,CHEMICAL,(R)-(-)-carvone,(R)-(-)-carvone
NEW04727,CHEMICAL,(S)-(+)-carvone,(S)-(+)-carvone
NEW04728,CHEMICAL,natural amino acid,natural amino acid
C000616255,CHEMICAL,ethyl 6-bromocoumarin-3-carboxylyl theanine [Supplementary Concept],L-THE|Glutamates|L-theanine|Coumarins
NEW04729,NUTRITION,Proprietary spearmint extract,Proprietary spearmint extract
NEW04730,BIOCHEMICAL,novel NMDAR glycine-site functional partial agonist,novel NMDAR glycine-site functional partial agonist
NEW04733,CHEMICAL,ketamine plasticity enhancement,ketamine plasticity enhancement
NEW04734,CHEMICAL,non-competitive N-methyl-D-aspartate receptor antagonist ketamine,non-competitive N-methyl-D-aspartate receptor antagonist ketamine
C000629870,CHEMICAL,Esketamine [Supplementary Concept],Ketamine|esketamine
NEW04736,CHEMICAL,D-serine levels,D-serine levels
NEW04738,DISEASE,auditory information processing,auditory information processing
NEW04739,CHEMICAL,N-methyl-d-aspartate receptor dysfunction,N-methyl-d-aspartate receptor dysfunction
NEW04743,BIOCHEMICAL,noncompetitive antagonist,noncompetitive antagonist
NEW04744,CHEMICAL,ketamine,ketamine
D003915,CHEMICAL,Dextromethorphan,"Racemethorphan|d-Methorphan|Levomethorphan|Dextromethorphan Hydrobromide, (+-)-Isomer|Delsym|dextromethorphan|Dextromethorphan, (+-)-Isomer|Dextromethorphan Hydrobromide|Dextromethorphan Hydrobromide, Monohydrate|Hydrobromide, Dextromethorphan|Dextromethorphan Hydrochloride|Hydrochloride, Dextromethorphan|l-Methorphan"
NEW04752,DISEASE,excitotoxicity-induced neuronal loss,excitotoxicity-induced neuronal loss
NEW04754,CHEMICAL,increased glutamate indicative,increased glutamate indicative
NEW04755,CHEMICAL,calcium increase,calcium increase
NEW04756,DISEASE,GluN2B activation,GluN2B activation
NEW04757,DISEASE,NMDAR antagonist PCP,NMDAR antagonist PCP
NEW04758,CHEMICAL,endogenous estradiol,endogenous estradiol
NEW04760,CHEMICAL,glutamate N-methyl-D-aspartate receptor hypofunction,glutamate N-methyl-D-aspartate receptor hypofunction
NEW04762,BIOCHEMICAL,noncompetitive NMDAR antagonist,noncompetitive NMDAR antagonist
NEW04763,BIOCHEMICAL,first nonstimulant drug,first nonstimulant drug
NEW04764,CHEMICAL,norepinephrine transporter inhibitor atomoxetine,norepinephrine transporter inhibitor atomoxetine
NEW04765,BIOCHEMICAL,NMDAR antagonist memantine,NMDAR antagonist memantine
NEW04767,BIOCHEMICAL,non-competitive NMDA receptor NMDAR antagonist,non-competitive NMDA receptor NMDAR antagonist
NEW04771,DISEASE,NMDAR blockade,NMDAR blockade
NEW00545,CHEMICAL,intravenous ketamine,intravenous ketamine
NEW03758,CHEMICAL,soy-derived phosphatidylserine,soy-derived phosphatidylserine|PS
C049058,CHEMICAL,amperozide [Supplementary Concept],Amperozide|Piperazines
NEW04772,DISEASE,DSM-III-defined major depression,DSM-III-defined major depression
NEW04773,CHEMICAL,sertraline group,sertraline group
NEW04775,CHEMICAL,amitriptyline group,amitriptyline group
NEW04776,CHEMICAL,TCA use,TCA use
D008103,DISEASE,Liver Cirrhosis,"liver fibrosis|Fibrosis, Liver|Cirrhosis, Hepatic|Cirrhosis, Liver|Hepatic Cirrhosis|Liver Fibrosis"
NEW04778,CHEMICAL,Venlafaxine dosage,Venlafaxine dosage
NEW04779,CHEMICAL,Nefazodone clearance,Nefazodone clearance
NEW04782,MENTAL_HEALTH,Liebowitz Anxiety Scale,Liebowitz Anxiety Scale
NEW04785,DISEASE,stereotyped repetitive behavior disorders,stereotyped repetitive behavior disorders
NEW04786,BIOCHEMICAL,serotonin uptake inhibitor clomipramine,serotonin uptake inhibitor clomipramine
NEW04787,CHEMICAL,Escitalopram treatment,Escitalopram treatment
NEW04789,CHEMICAL,acetylcholine esterase,acetylcholine esterase
NEW04790,CHEMICAL,novel dual-active ligand E100,novel dual-active ligand E100
C477020,CHEMICAL,Eudragit E100 [Supplementary Concept],Polymers|E100|Acrylates
NEW04793,BIOCHEMICAL,Drug relapse,Drug relapse
C000626969,CHEMICAL,poly(diol sebacate) [Supplementary Concept],Dicarboxylic Acids|sebacate|Decanoic Acids|Polymers|BTMPS
D059350,DISEASE,Chronic Pain,"Pain, Chronic|Chronic pain|Widespread Chronic Pains|Pain, Widespread Chronic|Pains, Chronic|Chronic Pain, Widespread|Widespread Chronic Pain|Chronic Pains, Widespread|Pains, Widespread Chronic|Chronic Pains"
NEW04796,CHEMICAL,α9α10 nicotinic acetylcholine receptor,α9α10 nicotinic acetylcholine receptor
NEW04797,BIOCHEMICAL,peptide antagonists,peptide antagonists
NEW04799,CHEMICAL,Dopamine signaling,Dopamine signaling
NEW01103,DISEASE,behavioral deficits,behavioral deficits
D008464,CHEMICAL,Mecamylamine,Mecamylamine|Antihypertensive Agents|Ganglionic Blockers|Nicotinic Antagonists|Inversine
NEW04802,CHEMICAL,psychotomimetic drug,psychotomimetic drug
NEW04804,CHEMICAL,neurotransmitter serotonin,neurotransmitter serotonin
NEW00161,DISEASE,anxiety-like behavior,anxiety-like behavior
NEW04806,CHEMICAL,relevant nicotine dosing regimens,relevant nicotine dosing regimens
NEW04807,CHEMICAL,Brain nicotinic acetylcholine receptors,Brain nicotinic acetylcholine receptors
NEW04811,CHEMICAL,α7 nicotinic acetylcholine receptor antagonist,α7 nicotinic acetylcholine receptor antagonist
NEW04812,BIOCHEMICAL,dopamine D1 receptor antagonist,dopamine D1 receptor antagonist
C054634,CHEMICAL,methyllycaconitine [Supplementary Concept],methyllycaconitine|Aconitine/analogs  and  derivatives
NEW04813,DISEASE,Shati/Nat8l-/- attentional impairment,Shati/Nat8l-/- attentional impairment
NEW04814,CHEMICAL,5-HT(2C receptors,5-HT(2C receptors
NEW04815,BIOCHEMICAL,preferential 5-HT(2C receptor agonist,preferential 5-HT(2C receptor agonist
NEW04816,CHEMICAL,5-HT receptor subtypes,5-HT receptor subtypes
NEW04817,CHEMICAL,serotonin receptor 2B agonist,serotonin receptor 2B agonist
C092430,CHEMICAL,1-(5-(2-thenyloxy)-1H-indol-3-yl)propan-2-amine [Supplementary Concept],BW723C86|Thiophenes|Indoles
NEW04818,BIOCHEMICAL,serotonin agonist BW723C86,serotonin agonist BW723C86
NEW04820,CHEMICAL,postsynaptic 5-HT(1A CGS 12066B DOI receptors,postsynaptic 5-HT(1A CGS 12066B DOI receptors
C056895,CHEMICAL,flesinoxan [Supplementary Concept],Piperazines|flesinoxan
C066304,CHEMICAL,sertindole [Supplementary Concept],Indoles|Imidazoles|sertindole
C060632,CHEMICAL,ICI 170809 [Supplementary Concept],"Quinolines|ICI-170,809"
D007650,CHEMICAL,Ketanserin,"R 41,468|R-41468|R 41468|R41,468|ketanserin|R-41,468|3-(2-(4-(4-Fluorobenzoyl)piperidinol)ethyl)-2,4(1H,3H)-quinazolinedione|R41468"
NEW04821,CHEMICAL,antagonists ritanserin,antagonists ritanserin
NEW04822,MENTAL_HEALTH,chronic primary insomnia,chronic primary insomnia
D016713,CHEMICAL,Ritanserin,"Ritanserin Tartrate|R-55667|6-(2-(4-(Bis(4-fluorophenyl)methylene)-1-piperidinyl)ethyl)-7-methyl-5H-thiazolo(3,2-a)pyrimidin-5-one|R 55667|Ritanserin Hydrochloride|ritanserin|R55667"
NEW04823,CHEMICAL,agonist APD-125,agonist APD-125
D000077310,DISEASE,"Sleep, Slow-Wave","Delta Sleep|Sleep, Delta|Slow-Wave Sleep|Sleep, N3|Deep Sleep|Stage 3, NREM|NREM Stage 3|Slow Wave Sleep|Sleep, Slow Wave|N3 Sleep|Sleep, Deep|SWS|slow wave sleep"
NEW04824,CHEMICAL,BZD hypnotics,BZD hypnotics
NEW04825,CHEMICAL,5-HT(2A antagonists,5-HT(2A antagonists
NEW04826,CHEMICAL,"2,5-Dimethoxy-4-ethylphenethylamine","2,5-Dimethoxy-4-ethylphenethylamine"
NEW04562,DISEASE,marble burying behavior,marble burying behavior
NEW04832,CHEMICAL,serotonin 5-HT releasers (+/-)-fenfluramine,serotonin 5-HT releasers (+/-)-fenfluramine
D005277,CHEMICAL,Fenfluramine,"(+)-fenfluramine|Fenfluramine Hydrochloride, R Isomer|Fenfluramine Hydrochloride, (+-)-Isomer|Isomeride|Pondimin|Fintepla|Fenfluramine, (+-)-Isomer|Fenfluramine, R-Isomer|Fenfluramine Hydrochloride, R-Isomer|Fenfluramine Hydrochloride|Fenfluramine, R Isomer|Hydrochloride, Fenfluramine"
NEW04835,DISEASE,patient's severe chronic intestinal pseudo-obstruction,patient's severe chronic intestinal pseudo-obstruction
NEW04837,DISEASE,significant weight loss,significant weight loss
NEW04838,BIOCHEMICAL,certain fat-soluble vitamins A,certain fat-soluble vitamins A
NEW04839,BIOCHEMICAL,mitochondrial solute carrier protein,mitochondrial solute carrier protein
NEW04840,CHEMICAL,βα1 domain,βα1 domain
NEW04843,DISEASE,maldigestion fat,maldigestion fat
NEW04844,BIOCHEMICAL,decreased vitamin D level,decreased vitamin D level
D015255,CHEMICAL,Idarubicin,"NSC-256439|IMI30|IMI|IMI-30|NSC256439|Hydrochloride, Idarubicin|IMI 30|4-Desmethoxydaunorubicin|NSC 256439|Idarubicin Hydrochloride|4 Demethoxydaunorubicin|4 Desmethoxydaunorubicin|4-Demethoxydaunorubicin"
NEW04845,CHEMICAL,dopamine DA agonists,dopamine DA agonists
NEW04849,BIOCHEMICAL,drug naïve,drug naïve
NEW04850,CHEMICAL,Nitric oxide (NO)/cGMP,Nitric oxide (NO)/cGMP
NEW04852,CHEMICAL,NO system,NO system
NEW04855,DISEASE,long-term hyperglycemia,long-term hyperglycemia
NEW04858,CHEMICAL,dopamine D4 receptor genotype/function,dopamine D4 receptor genotype/function
NEW04859,MENTAL_HEALTH,future alcohol abuse,future alcohol abuse
D015275,DISEASE,Tumor Lysis Syndrome,"Syndrome, Tumour Lysis|Syndrome, Tumor Lysis|Syndromes, Tumour Lysis|Tumour Lysis Syndromes|Tumor Lysis Syndromes|tumour|Tumour Lysis Syndrome|Syndromes, Tumor Lysis"
NEW04864,CHEMICAL,elevated oestradiol,elevated oestradiol
NEW04865,CHEMICAL,cortisol neurotrophic factor,cortisol neurotrophic factor
D017373,CHEMICAL,Cyproterone Acetate,"Androcur|Cyproterone acetate|Cyproterone Acetate, (1 alpha,2 alpha)-Isomer|Cyproterone Acetate, (1 alpha,2 alpha,9 beta,10 alpha)-Isomer|Cyproterone Acetate, (17 alpha)-Isomer"
NEW04868,DISEASE,paraphilic men,paraphilic men
NEW04869,DISEASE,sexual crimes,sexual crimes
NEW04870,BIOCHEMICAL,active drug,active drug
NEW04871,NUTRITION,tart cherry extracts,tart cherry extracts
NEW04874,NUTRITION,tart cherry anthocyanins,tart cherry anthocyanins
NEW04876,NUTRITION,anthocyanin production pathway,anthocyanin production pathway
D055731,DISEASE,Carbohydrate Biochemistry,"Biochemistry, Carbohydrate|carbohydrate"
NEW04880,CHEMICAL,sabdariffa Linne,sabdariffa Linne
NEW04881,CHEMICAL,sabdariffa aqueous extracts,sabdariffa aqueous extracts
NEW04883,DISEASE,aqueous extracts,HSE|aqueous extracts
NEW04885,DISEASE,polyphenol-rich extracts,HPE|polyphenol-rich extracts
NEW02273,CHEMICAL,irreversible monoamine oxidase inhibitors,irreversible monoamine oxidase inhibitors|MAOIs
NEW04887,CHEMICAL,caffeine poisoning,caffeine poisoning
NEW04888,BIOCHEMICAL,peripheral muscarinic antagonist,peripheral muscarinic antagonist
D019832,CHEMICAL,N-Methylscopolamine,"DD234|N Methylscopolamine Bromide|N-Methylscopolamine Bromide|N Methylscopolamine|Methylbromide, Scopolamine|N-Methylscopolamine Methylsulfate|Methylsulfate, Methylscopolammonium|Methylsulfate, N-Methylscine|DD 234|N-Methylscopolamine Iodide|N Methylscine Methylsulfate|Methylscopolammonium Methylsulfate|N Methylscopolamine Nitrate|Bromide, N-Methylscopolamine|Nitrate, N-Methylscopolamine|Methscopolamine|N-Methylscopolamine Nitrate|Nitrate, Methylscopolamine|Methylscopolamine|N Methylscopolamine Iodide|Hyoscine Methiodide|Hyoscine Methobromide|Ulix|N-Methylscine Methylsulfate|N Methylscopolamine Methylchloride|Methiodide, Hyoscine|Methobromide, Hyoscine|Scopolamine Methylbromide|DD-234|Methylsulfate, N-Methylscopolamine|Methylscopolamine Nitrate|Methylchloride, N-Methylscopolamine|Iodide, N-Methylscopolamine|N-Methylscopolamine Methylchloride|N Methylscopolamine Methylsulfate|Skopyl"
NEW04891,CHEMICAL,Chronic scopolamine,Chronic scopolamine
NEW04892,CHEMICAL,prostaglandin release,prostaglandin release
NEW04894,CHEMICAL,diisopropyl fluorophosphate,diisopropyl fluorophosphate|DFP
NEW04895,BIOCHEMICAL,beta-blocker prophylaxis,beta-blocker prophylaxis
NEW04901,BIOCHEMICAL,CNS beta receptors,CNS beta receptors
NEW04902,BIOCHEMICAL,beta-blocker medication,beta-blocker medication
NEW04903,DISEASE,Smoking abuse,Smoking abuse
NEW04904,BIOCHEMICAL,generation non selective vasodilating beta adrenergic blocking agent,generation non selective vasodilating beta adrenergic blocking agent
NEW04906,CHEMICAL,agent Carvedilol,agent Carvedilol
NEW04907,CHEMICAL,timolol drops,timolol drops
D014331,CHEMICAL,Tropicamide,"Ocu Tropic|OcuTropic|Mydrum|N-Ethyl-alpha-(hydroxymethyl)-N-(4-pyridinylmethyl)benzeneacetamide|Colircusi Tropicamida|Tropicamide, (+-)-Isomer|Mydriafair|Mydriaticum|Tropicacyl|Ocu-Tropic|Tropicamide|Minims Tropicamide|Tropicamide Monohydrochloride, (S)-Isomer|Tropicamide Minims|N-Ethyl-N-(4-pyridylmethyl)tropamide|Tropicamide Faure|Tropicamide, (S)-Isomer|Tropicamide Monohydrochloride, (R)-Isomer|Tropicamide Monofree|Tropicamide, (R)-Isomer|Mydral"
NEW04908,DISEASE,major anti-hypertensive AHT drug classes,major anti-hypertensive AHT drug classes
NEW04909,CHEMICAL,CCBs,CCBs
NEW04910,CHEMICAL,ACEIs,ACEIs
NEW04911,CHEMICAL,Adderall overdose,Adderall overdose
NEW04912,CHEMICAL,Adderall intoxication,Adderall intoxication
NEW04914,DISEASE,Cardiac tachyarrhythmias,Cardiac tachyarrhythmias
NEW04915,DISEASE,NA dysfunction,NA dysfunction
NEW04917,BIOCHEMICAL,additional beta-blocker use,additional beta-blocker use
NEW04919,BIOCHEMICAL,antiviral efficacy,antiviral efficacy
NEW04920,BIOCHEMICAL,antibiotic azithromycin,antibiotic azithromycin
NEW04921,CHEMICAL,supra-infections,supra-infections
D006886,CHEMICAL,Hydroxychloroquine,Hydroxychlorochin|Plaquenil|Hydroxychloroquine Sulfate (1:1) Salt|hydroxychloroquine|Oxychlorochin|Oxychloroquine|Hydroxychloroquine Sulfate
D011655,DISEASE,Pulmonary Embolism,"Embolism, Pulmonary|Pulmonary Thromboembolism|Thromboembolisms, Pulmonary|Embolisms, Pulmonary|Thromboembolism, Pulmonary|pulmonary embolism|Pulmonary Embolisms|Pulmonary Thromboembolisms"
D016757,DISEASE,"Death, Sudden, Cardiac","Sudden Cardiac Death|Cardiac Sudden Death|Cardiac Death, Sudden|Death, Cardiac Sudden|Cardiac Arrest, Sudden|sudden cardiac death|Sudden Cardiac Arrest|Death, Sudden Cardiac|Sudden Death, Cardiac|Arrest, Sudden Cardiac|Cardiac Arrests, Sudden"
C580047,DISEASE,Dmd-Associated Dilated Cardiomyopathy [Supplementary Concept],"Dilated cardiomyopathy|Cardiomyopathy, Dilated"
NEW04923,DISEASE,Carnitine deficiency-induced cardiomyopathy,Carnitine deficiency-induced cardiomyopathy
NEW04924,CHEMICAL,Carnitine deficiency-induced myopathy,Carnitine deficiency-induced myopathy
NEW04925,CHEMICAL,Atenololay,Atenololay
NEW04927,BIOCHEMICAL,heterozygous carriers,heterozygous carriers
D064386,DISEASE,Ankle Fractures,"Fracture, Bimalleolar Ankle|Fractures, Bimalleolar Equivalent|Bimalleolar Equivalent Fracture|Bimalleolar Fracture|Ankle Fracture, Bimalleolar|Equivalent Fractures, Bimalleolar|Fracture, Posterior Malleolus|Medial Malleolus Fracture|Ankle Fractures, Trimalleolar|Fracture, Trimalleolar Ankle|Medial Malleolus Fractures|Bimalleolar Fractures|Bimalleolar Equivalent Ankle Fractures|Ankle Fracture|Fracture, Medial Malleolus|Posterior Malleolus Fracture|Bimalleolar Equivalent Fractures|Ankle Fractures, Bimalleolar|Fracture, Lateral Malleolus|Trimalleolar Fracture|Fracture, Bimalleolar|Malleolus Fracture, Posterior|Fractures, Medial Malleolus|Trimalleolar Fractures|Malleolus Fractures, Posterior|Fracture, Trimalleolar|fractures|Ankle Fracture, Trimalleolar|Lateral Malleolus Fractures|Posterior Malleolus Fractures|Equivalent Fracture, Bimalleolar|Malleolus Fractures, Lateral|Fractures, Trimalleolar Ankle|Fracture, Ankle|Fractures, Lateral Malleolus|Fractures, Trimalleolar|Malleolus Fracture, Lateral|Bimalleolar Ankle Fracture|Lateral Malleolus Fracture|Fractures, Bimalleolar|Bimalleolar Ankle Fractures|Fractures, Ankle|Fractures, Posterior Malleolus|Malleolus Fractures, Medial|Trimalleolar Ankle Fractures|Trimalleolar Ankle Fracture|Fractures, Bimalleolar Ankle|Malleolus Fracture, Medial|Fracture, Bimalleolar Equivalent"
C529843,CHEMICAL,3beta-OH-tibolone [Supplementary Concept],Norpregnanes|Tibolone
D007562,DISEASE,Creutzfeldt-Jakob Syndrome,"Encephalopathies, Subacute Spongiform|New Variant Creutzfeldt Jakob Disease|Disease, Jakob-Creutzfeldt|Creutzfeldt-Jakob Disease, Variant|CJD (Creutzfeldt Jakob Disease)|New Variant Creutzfeldt-Jakob Disease|Spongiform Encephalopathies, Subacute|Familial Creutzfeldt Jakob Disease|Jakob-Creutzfeldt Disease|Jakob-Creutzfeldt Syndrome|Spongiform Encephalopathy, Subacute|Disease, Creutzfeldt Jacob|Creutzfeldt Jakob Disease, Familial|Familial Creutzfeldt-Jakob Disease|Familial Creutzfeldt-Jakob Diseases|Subacute Spongiform Encephalopathy|Subacute Spongiform Encephalopathies|Creutzfeldt-Jakob Diseases, Familial|Creutzfeldt Jacob Disease|Disease, Familial Creutzfeldt-Jakob|Variant Creutzfeldt Jakob Disease|Jacob Disease, Creutzfeldt|Creutzfeldt Jakob Syndrome|Creutzfeldt Jakob disease|Disease, Creutzfeldt-Jakob|Creutzfeldt-Jakob Disease, New Variant|Creutzfeldt-Jakob Disease|Syndrome, Jakob-Creutzfeldt|Jakob Creutzfeldt Syndrome|CJD (Creutzfeldt-Jakob Disease)|V-CJD (Variant-Creutzfeldt-Jakob Disease)|V CJD (Variant Creutzfeldt Jakob Disease)|Creutzfeldt Jakob Disease, Variant|Variant Creutzfeldt-Jakob Disease|Jakob Creutzfeldt Disease|Creutzfeldt Jakob Disease, New Variant|Creutzfeldt-Jakob Disease, Familial|Encephalopathy, Subacute Spongiform|Syndrome, Creutzfeldt-Jakob|Creutzfeldt Jakob Disease"
NEW04932,DISEASE,Chronic psycho-environmental stress,Chronic psycho-environmental stress
NEW04933,CHEMICAL,cortisol levels,cortisol levels
NEW04936,MENTAL_HEALTH,Psychological chronic stress,Psychological chronic stress
NEW04938,CHEMICAL,inadequate omega-3 levels,inadequate omega-3 levels
D019587,NUTRITION,Dietary Supplements,"Nutraceuticals|Food Supplementations|Supplements, Food|Supplements, Herbal|Food Supplement|Supplementations, Dietary|Nutriceuticals|Neutraceutical|Dietary Supplementations|Supplement, Food|Food Supplements|Herbal Supplements|Supplements, Dietary|Herbal Supplement|Neutraceuticals|Supplement, Herbal|food supplements|Nutraceutical|Nutriceutical|Dietary Supplement"
D002707,CHEMICAL,Chlordiazepoxide,"Hydrobromide, Chlordiazepoxide|Chlordiazepoxide Hydrobromide|7 Chloro 2 methylamino 5 phenyl 3H 1,4 benzodiazepine 4 oxide|Perchlorate, Chlordiazepoxide|7-Chloro-2-methylamino-5-phenyl-3H-1,4-benzodiazepine-4-oxide|7-Chloro-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-amine 4-oxide|Chlordiazepoxide Perchlorate|Chlordiazepoxide Monohydrochloride|Monohydrochloride, Chlordiazepoxide|Methaminodiazepoxide|Chlordiazepoxide Hydrochloride|7 Chloro N methyl 5 phenyl 3H 1,4 benzodiazepin 2 amine 4 oxide|Hydrochloride, Chlordiazepoxide|Chlozepid|Chlordiazepoxide|Elenium|Librium"
NEW04943,NUTRITION,Lithium antipsychotics,Lithium antipsychotics
NEW04944,DISEASE,behavioral dyscontrol,behavioral dyscontrol
D006677,MENTAL_HEALTH,Histrionic Personality Disorder,"Disorders, Histrionic Personality|Hysterical Personality|Histrionic Personality Disorder|Personality, Hysterical|Histrionic Personality Disorders|Personality Disorder, Histrionic|Disorder, Histrionic Personality|Hysterical Personalities|Personality Disorders, Histrionic|Personalities, Hysterical"
NEW04946,DISEASE,explosive behavior,explosive behavior
NEW04947,DISEASE,severe PD,severe PD
D012569,CHEMICAL,Schizotypal Personality Disorder,"Personality Disorder, Schizotypal|Schizophrenias, Pseudoneurotic|Borderline Schizophrenia|Schizophrenia, Borderline|Schizophrenia, Incipient|Schizophrenia, Latent|Incipient Schizophrenias|Schizotypal Personality Disorders|Borderline Schizophrenias|Pseudopsychopathic Schizophrenia|Incipient Schizophrenia|Schizophrenias, Pseudopsychopathic|Personality Disorders, Schizotypal|Disorder, Schizotypal Personality|Pseudoneurotic Schizophrenias|SPD|Latent Schizophrenia|Schizophrenia, Pseudopsychopathic|Schizophrenia, Pseudoneurotic|schizotypal personality disorder|Latent Schizophrenias|Schizophrenias, Incipient|Schizophrenias, Latent|Schizophrenias, Borderline|Pseudopsychopathic Schizophrenias|Disorders, Schizotypal Personality|Pseudoneurotic Schizophrenia"
NEW04948,DISEASE,Comorbid depression,Comorbid depression
NEW04949,MENTAL_HEALTH,Comorbid neurotic disorder,Comorbid neurotic disorder
NEW04950,MENTAL_HEALTH,Comorbid social phobia,Comorbid social phobia
D008148,CHEMICAL,Lovastatin,"Lovastatin, 1 alpha-Isomer|Lovastatin|Lovastatin, 1 alpha Isomer|Mevinolin|MK-803|alpha-Isomer Lovastatin, 1|6 Methylcompactin|1 alpha-Isomer Lovastatin|Lovastatin, (1 alpha(S*))-Isomer|MK 803|Mevacor|Monacolin K|MK803|6-Methylcompactin"
NEW04951,DISEASE,bipolar disorder-manic phase,bipolar disorder-manic phase
D003221,DISEASE,Confusion,"Confusional States|Disorientation|Bewilderment|Confusional State|confusion|Confusion, Post Ictal|State, Confusional|Post-Ictal Confusion|Confusion, Reactive|Reactive Confusion|States, Confusional|Confusion, Post-Ictal"
C000632444,DISEASE,"Aniridia, Partial, with Unilateral Renal Agenesis and Psychomotor Retardation [Supplementary Concept]",Aniridia|psychomotor retardation|Psychomotor Disorders
NEW04955,DISEASE,SUI-resistant patients,SUI-resistant patients
NEW04956,NUTRITION,chronic lithium treatment,chronic lithium treatment
NEW04958,MENTAL_HEALTH,generalized anxiety patients,generalized anxiety patients
NEW04548,CHEMICAL,benzodiazepine treatment,benzodiazepine treatment
NEW04960,CHEMICAL,benzodiazepines alprazolam,benzodiazepines alprazolam
NEW04963,CHEMICAL,triazolobenzodiazepine,triazolobenzodiazepine
D000525,CHEMICAL,Alprazolam,"Esparon|Ralozam|Alprazolam|Alprox|Nu-Alpraz|Tafil|Novo-Alprazol|Trankimazin|Apo Alpraz|Xanax|U31,889|D-65MT|Kalma|Novo Alprazol|Cassadan|Apo-Alpraz|U-31,889|Alprazolan|Nu Alpraz|D65MT"
D002998,CHEMICAL,Clonazepam,"Clonazepam|Antelepsin|2H-1,4-Benzodiazepin-2-one, 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-|Klonopin|Rivotril|Ro 54023|Ro 5-4023"
NEW04965,CHEMICAL,new potent benzodiazepine,new potent benzodiazepine
NEW04966,CHEMICAL,Low-dose repeated lipopolysaccharide pre-challenge,Low-dose repeated lipopolysaccharide pre-challenge
NEW04968,MENTAL_HEALTH,Bipolar Disorder PGBD Study,Bipolar Disorder PGBD Study
NEW04970,CHEMICAL,low-dose aspirin,low-dose aspirin
NEW04972,DISEASE,chronic social defeat stress,chronic social defeat stress
NEW04973,NUTRITION,Lithium therapy,Lithium therapy
D009404,DISEASE,Nephrotic Syndrome,"Nephrotic syndrome|Syndrome, Nephrotic|Syndromes, Nephrotic|Nephrotic Syndromes"
NEW04977,NUTRITION,lithium serum level,lithium serum level
D058924,CHEMICAL,Thienopyridines,"Derivatives, Thienopyridine|thienopyridine derivatives|Thienopyridine Derivatives"
D003374,CHEMICAL,Coumarins,"Coumarin|1,2 Benzo Pyrones|Derivatives, Coumarin|Coumarine|1,2-Benzo-Pyrones|Benzopyran 2 ones|Derivative, Coumarin|Benzopyran-2-ones|Coumarin Derivative|1,2-Benzopyrone Derivatives|Derivatives, 1,2-Benzopyrone|1,2 Benzopyrones|1,2 Benzopyrone Derivatives|1,2-Benzopyrones|Coumarin Derivatives|Coumarines"
NEW04981,CHEMICAL,Newer thienopyridine derivatives,Newer thienopyridine derivatives
D000068799,CHEMICAL,Prasugrel Hydrochloride,"Effient|640315, LY|prasugrel|Hydrochloride, Prasugrel|LY-640315|LY640315|747, CS|CS747|Efient|LY 640315|CS 747|Prasugrel|CS-747|HCl, Prasugrel|Prasugrel HCl"
D000077486,CHEMICAL,Ticagrelor,"ticagrelor|AZD 6140|AZD6140|Brilique|AZD-6140|3-(7-((2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-(1-3)-triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol|Brilinta"
NEW04984,CHEMICAL,PG subjects,PG subjects
D020329,DISEASE,Essential Tremor,"Familial Tremor|Tremor, Essential|Essential Tremors, Benign|Benign Essential Tremor|Familial Tremors|Tremor, Familial|Essential Tremor, Benign|Benign Essential Tremors|Tremor|Tremors, Benign Essential|Essential Tremors|Tremor, Benign Essential|Hereditary Essential Tremor|Tremors, Familial|Tremors, Essential"
NEW04985,CHEMICAL,Vaccine administration,Vaccine administration
C003402,CHEMICAL,sapropterin [Supplementary Concept],BH4|tetrahydrobiopterin|Biopterin/analogs  and  derivatives
NEW04987,CHEMICAL,antidepressant treatments,antidepressant treatments
NEW04989,DISEASE,manic switch,manic switch
NEW04990,DISEASE,Hyperammonemic encephalopathy,Hyperammonemic encephalopathy
NEW04991,CHEMICAL,plasma ammonia,plasma ammonia
NEW04993,CHEMICAL,NCG,NCG
D007792,CHEMICAL,Lactulose,Amivalex|Duphalac|Lactulose|Normase
NEW05000,DISEASE,cognitive peculiarities ideas,cognitive peculiarities ideas
NEW05001,CHEMICAL,major condition schizophrenia-BPD,major condition schizophrenia-BPD
NEW05002,MENTAL_HEALTH,Steroid-induced psychosis,Steroid-induced psychosis
NEW05006,BIOCHEMICAL,first line mood stabilizers,first line mood stabilizers
NEW05007,CHEMICAL,new antipsychotic quetiapine,new antipsychotic quetiapine
D008238,CHEMICAL,Lysergic Acid Diethylamide,"Acid Diethylamide, Lysergic|lysergic acid diethylamide|LSD-25|Lysergide|LSD 25|Lysergic Acid Diethylamide Tartrate|LSD|Diethylamide, Lysergic Acid"
NEW05011,DISEASE,hallucinatory experience,hallucinatory experience
D016651,NUTRITION,Lithium Carbonate,"Quilinorm retard|Dilithium Carbonate|Micalith|CP 15,467 61|CP15,46761|NSC16895|Lithium Bicarbonate|Lithonate|NSC 16895|Quilinormretard|Carbonate, Dilithium|NSC-16895|Eskalith|Lithobid|Carbonate, Lithium|Lithane|lithium carbonate|CP-15,467-61|Bicarbonate, Lithium|Quilinorm-retard|Priadel|Lithotabs"
NEW05014,BIOCHEMICAL,NOP agonists,NOP agonists
NEW05018,NUTRITION,lithium antipsychotics,lithium antipsychotics
NEW05019,CHEMICAL,atypical antipsychotics,atypical antipsychotics|AAPs
NEW05020,DISEASE,Total trauma scores,Total trauma scores
NEW05023,DISEASE,steroid-induced psychiatric symptoms,steroid-induced psychiatric symptoms
NEW05024,CHEMICAL,Extended-release venlafaxine,Extended-release venlafaxine
NEW05025,MENTAL_HEALTH,Sexual dysfunction related,Sexual dysfunction related
C488250,CHEMICAL,oleoylethanolamide [Supplementary Concept],Oleic Acids|oleoylethanolamide|Endocannabinoids
NEW05031,BIOCHEMICAL,endogenous peroxiproliferator-activated receptor-alpha PPAR-alpha agonist,endogenous peroxiproliferator-activated receptor-alpha PPAR-alpha agonist
NEW05032,CHEMICAL,OEA administration,OEA administration
NEW05033,BIOCHEMICAL,PPAR-α agonist,PPAR-α agonist
NEW05035,CHEMICAL,octadecylpropyl sulfamide,SUL|octadecylpropyl sulfamide
D019821,CHEMICAL,Simvastatin,MK 733|MK733|simvastatin|Zocor|Synvinolin|MK-733
NEW05037,CHEMICAL,Lipophilic statins,Lipophilic statins
NEW05039,CHEMICAL,Dopamine RSS,Dopamine RSS
NEW05041,DISEASE,hand dexterity,hand dexterity
NEW05042,CHEMICAL,Basal dopamine levels,Basal dopamine levels
NEW05044,BIOCHEMICAL,D1 agonist,D1 agonist
NEW05045,CHEMICAL,dopamine neurotransmitter,dopamine neurotransmitter
NEW05046,CHEMICAL,Dopamine system,Dopamine system
D016627,CHEMICAL,Oxidopamine,"6 Hydroxydopamine|Oxidopamine Hydrobromide|6-Hydroxydopamine|Oxidopamine Hydrochloride|Hydrobromide, Oxidopamine|6-OHDA|6-hydroxydopamine|Hydrochloride, Oxidopamine"
NEW05050,CHEMICAL,DA depletion,DA depletion
NEW05052,DISEASE,Chronic abuse,Chronic abuse
D011954,CHEMICAL,"Receptors, Dopamine","Dopamine Receptor|Dopamine Receptors|Dopamine receptors|Receptor, Dopamine"
NEW05055,CHEMICAL,different dopamine receptors,different dopamine receptors
NEW05057,BIOCHEMICAL,botanical drug,botanical drug
D008516,DISEASE,"Medicine, Chinese Traditional","Traditional Chinese medicine|Chung I Hsueh|Zhong Yi Xue|Chinese Traditional Medicine|Traditional Tongue Diagnoses|Traditional Medicine, Chinese|Hsueh, Chung I|Traditional Tongue Assessments|Tongue Diagnosis, Traditional|Tongue Assessment, Traditional|Traditional Tongue Diagnosis|Traditional Chinese Medicine|Tongue Diagnoses, Traditional|Chinese Medicine, Traditional|TCM|Traditional Tongue Assessment"
NEW05059,CHEMICAL,GAD activities,GAD activities
NEW05060,CHEMICAL,Gamma-aminobutyric acid GABA receptors,Gamma-aminobutyric acid GABA receptors
NEW05061,CHEMICAL,acid 13-cis-RA,acid 13-cis-RA
NEW05064,CHEMICAL,at-RA levels,at-RA levels
NEW05065,BIOCHEMICAL,vitamins A/D/E,vitamins A/D/E
NEW05067,CHEMICAL,hypovitaminosis,hypovitaminosis
NEW05068,DISEASE,RA signaling,RA signaling
D015474,CHEMICAL,Isotretinoin,"Isotretinoin|Roaccutane|Isotretinoin Zinc Salt, 13-cis-Isomer|13-cis-Retinoic Acid|Accutane|Isotretinoin Zinc Salt, 13 cis Isomer|Ro 4 3780|Ro 43780|13 cis Retinoic Acid|Ro 4-3780"
NEW05073,CHEMICAL,Ethanol exposure,Ethanol exposure
NEW05075,CHEMICAL,retinoic acid signaling pathway,retinoic acid signaling pathway
D054840,BIOCHEMICAL,"Retinol-Binding Proteins, Cellular","Retinol-Binding Protein 1, Cellular|Cellular Retinol-Binding Protein I|retinol|Retinol Binding Protein 1|Retinol Binding Protein 2|Retinol Binding Protein 1, Cellular|Cellular Retinol Binding Protein I|Retinol-Binding Protein (Type 2)|Retinol Binding Protein II, Cellular|Cellular Retinol Binding Protein|Retinol-Binding Protein 2, Cellular|Retinol-Binding Protein 1|Retinol Binding Protein 2, Cellular|Retinol-Binding Protein II, Cellular|Cellular Retinol-Binding Proteins|Retinol Binding Proteins, Cellular"
NEW05081,MENTAL_HEALTH,ADHD co-deficiency,ADHD co-deficiency
NEW05083,BIOCHEMICAL,Vitamins A,Vitamins A
NEW05084,NUTRITION,Omega-3 fatty acid supplementation,Omega-3 fatty acid supplementation
C115632,CHEMICAL,"COG5 protein, human [Supplementary Concept]","% GTC|Adaptor Proteins, Vesicular Transport"
NEW05087,CHEMICAL,baso-kisei,baso-kisei
C024070,CHEMICAL,pycnogenols [Supplementary Concept],Plant Extracts|French maritime pine|Flavonoids
NEW05088,CHEMICAL,1-month Pycnogenol administration,1-month Pycnogenol administration
C516941,CHEMICAL,peracetylated epigallocatechin-3-gallate [Supplementary Concept],Acetates|EGCG|Catechin/analogs  and  derivatives|(-)-Epigallocatechin-3-gallate
NEW05090,CHEMICAL,Tetrapleura tetraptera,Tetrapleura tetraptera
NEW05091,CHEMICAL,High-temperature-processed green tea extract,High-temperature-processed green tea extract|HTP-GTE
NEW05092,CHEMICAL,HTP-GTE intake,HTP-GTE intake
NEW05094,CHEMICAL,HTP-GTE supplementation,HTP-GTE supplementation
NEW05095,NUTRITION,Catechins,Catechins
NEW05096,NUTRITION,catechins,catechins
NEW05097,CHEMICAL,Amyloid-β Aβ production,Amyloid-β Aβ production
NEW05098,CHEMICAL,G single nucleotide polymorphism,G single nucleotide polymorphism
NEW05099,BIOCHEMICAL,important carriers,important carriers
NEW05101,CHEMICAL,serotonin transporter-linked polymorphic region,serotonin transporter-linked polymorphic region
NEW05102,MENTAL_HEALTH,Cannabis Abuse Screening Test,Cannabis Abuse Screening Test
NEW05105,CHEMICAL,Glutathione S-transferase A1*B polymorphism,Glutathione S-transferase A1*B polymorphism
D007343,BIOCHEMICAL,Insurance Carriers,"carriers|Carriers, Insurance|Insurance Provider|Providers, Insurance|Insurance Providers|Provider, Insurance|Insurer|Insurers|Insurance Carrier|Carrier, Insurance"
D008607,MENTAL_HEALTH,Intellectual Disability,"Mental Retardations, Psychosocial|Deficiency, Mental|Disorder, Intellectual Development|Disabilities, Intellectual|Development Disorder, Intellectual|Mental Retardation|Intellectual Development Disorder|Intellectual Development Disorders|Retardations, Psychosocial Mental|Mental Deficiency|Retardation, Psychosocial Mental|Psychosocial Mental Retardations|Intellectual Disabilities|Deficiencies, Mental|Psychosocial Mental Retardation|Retardation, Mental|Mental Deficiencies|Mental Retardation, Psychosocial|Development Disorders, Intellectual|Disorders, Intellectual Development|intellectual disability|Idiocy|Disability, Intellectual"
NEW05108,BIOCHEMICAL,Premutation carriers,Premutation carriers
NEW05109,BIOCHEMICAL,premutation carriers,premutation carriers
NEW05110,BIOCHEMICAL,FMR1 premutation carriers,FMR1 premutation carriers
NEW05111,CHEMICAL,common BDNF SNP,common BDNF SNP
NEW05113,DISEASE,DRD patients,DRD patients
C489843,DISEASE,"Map3k8 protein, mouse [Supplementary Concept]",MAP Kinase Kinase Kinases|Tumor progression|Proto-Oncogene Proteins
NEW05116,BIOCHEMICAL,STin2.12 repeat carrier,STin2.12 repeat carrier
NEW05118,BIOCHEMICAL,STin2.12 repeat carriers,STin2.12 repeat carriers
NEW03343,DISEASE,SCZ patients,SCZ patients
NEW05122,MENTAL_HEALTH,depression symptom severity,depression symptom severity
NEW05121,CHEMICAL,NOx- concentration,NOx- concentration
NEW05123,BIOCHEMICAL,unmodified modified based carriers,unmodified modified based carriers
C547076,CHEMICAL,tafamidis [Supplementary Concept],Benzoxazoles|tafamidis
NEW05127,MENTAL_HEALTH,anxiety traits,anxiety traits
NEW05128,BIOCHEMICAL,rs2146323 A- carriers,rs2146323 A- carriers
C000608144,CHEMICAL,"MCHR2-AS1 long non-coding RNA, human [Supplementary Concept]","RNA, Long Noncoding|MCHR2-AS1"
NEW05133,BIOCHEMICAL,female premutation carriers,female premutation carriers
C564105,DISEASE,Fragile X Tremor Ataxia Syndrome [Supplementary Concept],Fragile X Syndrome|fragile X-associated tremor ataxia syndrome|Tremor|FXTAS|Ataxia
NEW05134,DISEASE,CGG-repeats stretch,CGG-repeats stretch
NEW05137,MENTAL_HEALTH,Fragile X Mental Retardation FMR1 gene,Fragile X Mental Retardation FMR1 gene
NEW05138,CHEMICAL,serotonin transporter gene's,serotonin transporter gene's
NEW05139,DISEASE,early-life adversity,early-life adversity
NEW05141,CHEMICAL,Urea Cycle Rare disorders,Urea Cycle Rare disorders
D064507,BIOCHEMICAL,"Solute Carrier Family 12, Member 4","Protein, SLC12A4|carrier|Erythroid K-Cl Cotransporter 1|KCC1 Protein|SLC12A4 Protein|Solute Carrier Family 12 (Potassium Chloride Transporters), Member 4 Protein|Electroneutral Potassium-Chloride Cotransporter 1|Electroneutral Potassium Chloride Cotransporter 1|Protein, KCC1|Erythroid K Cl Cotransporter 1"
NEW05143,NUTRITION,fatty acid amide hydrolase FAAH C385A polymorphism,fatty acid amide hydrolase FAAH C385A polymorphism
D065886,DISEASE,Neurodevelopmental Disorders,"Disorder, Child Mental|neurodevelopmental disorders|Neurodevelopmental Disorders Usually Diagnosed in Infancy, Childhood or Adolescence|Mental Disorders Usually Diagnosed in Infancy, Childhood or Adolescence|Neurodevelopmental Disorder|Mental Disorders, Child|Mental Disorders Diagnosed in Childhood|Disorder, Neurodevelopmental|Child Mental Disorders|Mental Disorder, Child|Child Mental Disorder"
NEW05146,BIOCHEMICAL,older female FMR1 premutation carriers,older female FMR1 premutation carriers
NEW05147,BIOCHEMICAL,Female carriers,Female carriers
NEW05148,DISEASE,neurotoxic metals,neurotoxic metals
NEW05150,BIOCHEMICAL,external toxic agents,external toxic agents
NEW05151,BIOCHEMICAL,human leukocyte antigen HLA class allele,human leukocyte antigen HLA class allele
NEW05153,CHEMICAL,CPT1B carnitine palmitoyltransferase,CPT1B carnitine palmitoyltransferase
NEW05154,BIOCHEMICAL,human leukocyte antigen (HLA)-DRB1 15:01-DQB1 haplotype,human leukocyte antigen (HLA)-DRB1 15:01-DQB1 haplotype
NEW05155,CHEMICAL,CCR genes,CCR genes
NEW05156,DISEASE,Spanish DAS,Spanish DAS
NEW05158,MENTAL_HEALTH,death anxiety,death anxiety
NEW05160,DISEASE,common childhood-onset neurodevelopmental disorder,common childhood-onset neurodevelopmental disorder
NEW05159,CHEMICAL,first-line medicine,first-line medicine
NEW05161,CHEMICAL,functional intronic CDH13 SNP rs2199430,functional intronic CDH13 SNP rs2199430
D058978,CHEMICAL,Reduced Folate Carrier Protein,"Transporter, SLC19a1|Transporter 1, Folate|SLC19a1 Protein|Folate Transporter 1|Solute Carrier Family 19, Member 1|Folate Carrier, Reduced|SLC19a1 Transporter|Carrier, Reduced Folate|Protein, SLC19a1|Reduced Folate Carrier|SLC19A1"
NEW05163,CHEMICAL,NOS-I,NOS-I
NEW05166,CHEMICAL,Oxytocin receptor gene polymorphisms,Oxytocin receptor gene polymorphisms
NEW05167,DISEASE,Fragile X Associated Tremor Ataxia Syndrome FXTAS syndrome,Fragile X Associated Tremor Ataxia Syndrome FXTAS syndrome
NEW05168,BIOCHEMICAL,solute carrier transporters,solute carrier transporters
NEW05169,BIOCHEMICAL,Female S carriers,Female S carriers
NEW05170,CHEMICAL,serotonergic discrepancies,serotonergic discrepancies
NEW05171,CHEMICAL,OXTR SNP rs2254298,OXTR SNP rs2254298
NEW05173,CHEMICAL,particular Ser704Cys SNP,particular Ser704Cys SNP
C030284,CHEMICAL,3-methoxy-4-hydroxyphenylglycol sulfate [Supplementary Concept],Methoxyhydroxyphenylglycol/analogs  and  derivatives|3-methoxy-4-hydroxyphenylglycol
NEW05177,DISEASE,Psychiatric conditions,Psychiatric conditions
NEW05179,DISEASE,venous ammonemia,venous ammonemia
NEW05181,CHEMICAL,oral glucose administration,oral glucose administration
C072188,CHEMICAL,"vasopressin, 1-(beta-mercapto-beta,beta-cyclopentamethylene propionic acid)-(O-ethyl)Tyr(2)-Val(4)-Lys(8)-N(6)-carboxytetramethylrhodamine- [Supplementary Concept]",propionic acid|Lypressin/analogs  and  derivatives
NEW05183,CHEMICAL,propionic acid-treated,propionic acid-treated
NEW01607,CHEMICAL,antidepressant fluoxetine,antidepressant fluoxetine
NEW01392,CHEMICAL,glutamate transmission,glutamate transmission
NEW05188,CHEMICAL,glutamate-modulating mood-stabilizing drugs,glutamate-modulating mood-stabilizing drugs
NEW05191,DISEASE,hypocortisolism,hypocortisolism
D017608,CHEMICAL,Chromium Compounds,"Chromium|Compounds, Chromium"
D017668,CHEMICAL,Age of Onset,Age-at-onset|Age-at-Onset|Age at Onset|Onset Age
D020908,CHEMICAL,"Calcium Channels, R-Type","calcium channels|R Type Voltage Dependent Calcium Channels|R-Type Calcium Channels|R-Type Calcium Channel|Channel, R-Type Calcium|Calcium Channels, R Type|Calcium Channel, R-Type|VDCC, R-Type|R Type VDCC|R Type Calcium Channels|R-Type Voltage-Dependent Calcium Channels|R Type Calcium Channel|R-Type VDCC"
NEW05196,CHEMICAL,quetiapine therapy,quetiapine therapy
NEW01236,DISEASE,bipolar patients,bipolar patients
NEW05198,CHEMICAL,offending drug,methotrexate|offending drug
NEW05199,BIOCHEMICAL,cytotoxic drug,cytotoxic drug
NEW05200,BIOCHEMICAL,opiate antagonist treatment,opiate antagonist treatment
NEW05203,DISEASE,Nausea/vomiting,Nausea/vomiting
NEW05206,CHEMICAL,novel antipsychotic drug quetiapine,novel antipsychotic drug quetiapine
NEW05213,DISEASE,adolescent onset schizophrenic patients,adolescent onset schizophrenic patients
D000275,MENTAL_HEALTH,Adjustment Disorders,"Disorder, Adjustment|Disturbances, Transient Situational|Situational Disturbance, Transient|Reactive Depressions|Depressions, Reactive|Depression, Reactive|Anniversary Reactions|Adjustment Disorder|Transient Situational Disturbance|Disturbance, Transient Situational|Situational Disturbances, Transient|Disorders, Adjustment|Reactive Disorder|Reactive Disorders|Reactive Depression|Transient Situational Disturbances|Reactions, Anniversary|Reaction, Anniversary|Adjustment disorder =|Disorder, Reactive|Anniversary Reaction|Disorders, Reactive"
NEW05215,DISEASE,common psychiatric symptom,common psychiatric symptom
NEW05218,DISEASE,acute psychotic disorders,acute psychotic disorders
NEW05221,CHEMICAL,full D1 receptor agonist dihydrexidine,full D1 receptor agonist dihydrexidine|DHX
NEW05222,CHEMICAL,"(+/-)-trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine hydrochloride","(+/-)-trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine hydrochloride"
NEW05224,CHEMICAL,oleoylethanoloamide,oleoylethanoloamide
NEW05225,BIOCHEMICAL,PPARα agonists,PPARα agonists
NEW05226,CHEMICAL,"3,6'-dithioPom","3,6'-dithioPom|DP"
NEW05227,CHEMICAL,intensive naming therapy,INT|intensive naming therapy
NEW05229,CHEMICAL,REM sleep-induction-test,REM sleep-induction-test
D000068836,CHEMICAL,Rivastigmine,"ENA-713|Exelon|ENA713|ENA 713|SDZ ENA 713|RivastigmineTartrate|(S)-N-Ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate|713, ENA|ENA 713, SDZ|Tartrate, Rivastigmine Hydrogen|713, SDZ ENA|rivastigmine|Hydrogen Tartrate, Rivastigmine|Rivastigmine Hydrogen Tartrate"
NEW05232,DISEASE,Demented PD patients =,Demented PD patients =
NEW05238,MENTAL_HEALTH,self-limiting psychosis,self-limiting psychosis
NEW05240,CHEMICAL,nitric oxide (NO)-cyclic guanosine monophosphate cGMP cascade,nitric oxide (NO)-cyclic guanosine monophosphate cGMP cascade
D000962,BIOCHEMICAL,Antimalarials,"Agent, Antimalarial|Antimalarial Drugs|Antimalarial Drug|Anti Malarial|Antimalarial Agent|Anti-Malarials|Anti Malarials|Anti-Malarial|Antimalarial Agents|Agents, Antimalarial|Drugs, Antimalarial|Antimalarial|antimalarial agents|Drug, Antimalarial"
D002229,CHEMICAL,Carbenoxolone,"Glycyrrhetinic Acid 3-O-hemisuccinate|18alpha Glycyrrhetinic Acid 3beta O Hemisuccinate|18alpha-Glycyrrhetinic Acid 3beta-O-Hemisuccinate|Duogastrone|18alpha Carbenoxolone|Carbenoxolone Disodium Salt|18alpha-Carbenoxolone|3-O-hemisuccinate, Glycyrrhetinic Acid|Carbenoxolone Sodium|Acid 3beta-O-Hemisuccinate, 18alpha-Glycyrrhetinic|Carbosan|Sanodin|Glycyrrhetinic Acid 3 O hemisuccinate|Carbeneoxolone|Bioral|3beta-O-Hemisuccinate, 18alpha-Glycyrrhetinic Acid|Biogastrone|Carbenoxalone|Acid 3-O-hemisuccinate, Glycyrrhetinic|Pharmaxolon|carbenoxolone|CBX"
D043564,CHEMICAL,Inorganic Pyrophosphatase,"Inorganic Pyrophosphatase, Proton-Pumping|Proton-Pumping Inorganic Pyrophosphatase|H+-Pyrophosphatase|Proton-Translocating Pyrophosphatase|Pyrophosphatase, Pyrophosphate-Energized Inorganic|H(+)-PPase|Inorganic pyrophosphate|Inorganic Pyrophosphatase, Pyrophosphate-Energized|Proton Pumping Inorganic Pyrophosphatase|Pyrophosphatase, Proton-Pumping Inorganic|Proton Translocating Pyrophosphatase|Pyrophosphatase, Inorganic|Pyrophosphatase, Proton-Translocating|H+ Pyrophosphatase|Pyrophosphate-Energized Inorganic Pyrophosphatase|Pyrophosphate Energized Inorganic Pyrophosphatase"
D002738,CHEMICAL,Chloroquine,"Chloroquine Sulfate|Aralen|Arequin|Khingamin|Chlorochin|Nivaquine|Sulfate, Chloroquine|Chloroquine Sulphate|Arechine|Sulphate, Chloroquine|Chingamin|chloroquine"
NEW05242,CHEMICAL,camara,LCEO|camara
D011803,CHEMICAL,Quinine,"Sulphate, Quinine|Hydrochloride, Quinine|Quinine Sulfate|quinine|Quinine-Odan|Myoquin|Surquina|Quinbisul|Quindan|Quinine Bisulfate|Quinine Lafran|Quinine Sulphate|Quinamm|Biquinate|Bisulfate, Quinine|Quinine Hydrochloride|Legatrim|Quinimax|Quinsul|Quinson|Quinoctal|Quinbisan|Sulfate, Quinine|Strema"
D064687,CHEMICAL,Diarylquinolines,"Derivatives, Diarylquinoline|Quinoline derivatives|Derivative, Diaryl Quinoline|Quinoline Derivatives, Diaryl|Diaryl Quinoline Derivatives|Diarylquinoline Derivative|Diarylquinoline|Derivative, Diarylquinoline|Diaryl Quinoline Derivative|Quinoline Derivative, Diaryl|Derivatives, Diaryl Quinoline|Diarylquinoline Derivatives"
D019575,DISEASE,"Blindness, Cortical","Syndrome, Transient Anton's|Blindnesses, Reversible Cortical|Anton Syndrome|Blindness, Cortical, Transient|Syndrome, Anton's|Cortical Blindness, Reversible|Transient Anton's Syndrome|Antons Syndrome|Blindness, Cortical, Post-Ictal|Cortical Blindness|Reversible Cortical Blindness|Syndrome, Anton|Transient Antons Syndrome|Psychic Denial of Blindness|Transient Anton Syndrome|Syndrome, Anton-Babinski|Anton-Babinski Syndrome|Reversible Cortical Blindnesses|Anton's Syndrome, Transient|Cortical Blindnesses, Reversible|Anton Babinski Syndrome|Blindness, Reversible Cortical|Blindness|Anton's Syndrome"
D000655,CHEMICAL,Amodiaquine,"Amodiaquine|Amodiaquine Hydrochloride|Flavoquine|Amodiaquin|Hydrochloride, Amodiaquine|Amodiachin|Camoquin|Camoquine"
D011797,CHEMICAL,Quinacrine Mustard,"Acrichine Yperite|Yperite, Acrichine|Mustard, Quinacrine|quinacrine"
NEW05246,CHEMICAL,acridine derivative,acridine derivative
D020207,DISEASE,"Coma, Post-Head Injury","Post Head Injury Coma|coma|Post-Head Injury Comas|Coma, Post-Concussive|Coma, Post Concussive|Post-Head Injury Coma|Comas, Post-Head Injury|Coma, Post-Trauma|Post-Trauma Coma|Traumatic Coma|Post-Concussive Coma|Coma, Post Head Injury|Comas, Post-Concussive|Coma, Post Trauma|Post-Traumatic Coma|Comas, Post-Trauma|Post-Concussive Comas|Coma, Post Traumatic|Post-Trauma Comas|Coma, Post-Traumatic|Coma, Traumatic|Coma, Post-Traumatic, Prolonged"
D004830,DISEASE,"Epilepsy, Tonic-Clonic","Seizure Disorders, Tonic-Clonic|Disorders, Tonic-Clonic Convulsion|Epilepsy, Tonic Clonic|Epilepsy, Cryptogenic Tonic-Clonic|Epilepsies, Tonic-Clonic|Epilepsy, Tonic-Clonic, Cryptogenic|Epilepsy, Major|Seizure Syndromes, Tonic-Clonic|Epilepsies, Familial Tonic-Clonic|Convulsion Disorders, Tonic-Clonic|Tonic-Clonic Epilepsies|Syndromes, Tonic-Clonic Convulsion|Convulsions, Grand Mal|Convulsion, Grand Mal|Disorder, Tonic-Clonic Seizure|Tonic-Clonic Seizure Syndromes|Familial Tonic-Clonic Epilepsies|Disorders, Tonic-Clonic Seizure|Convulsion Disorder, Tonic-Clonic|Tonic-Clonic Convulsion Syndrome|Seizure Disorder, Major Motor|Grand Mal Convulsions|Tonic-Clonic Seizure Disorders|Convulsion Syndromes, Tonic-Clonic|Tonic-Clonic Seizure Syndrome|Symptomatic Tonic-Clonic Epilepsies|Syndrome, Tonic-Clonic Convulsion|Grand Mal Seizure Disorder|Syndrome, Tonic-Clonic Seizure|Convulsion Syndrome, Tonic-Clonic|Tonic-Clonic Seizure Disorder|Symptomatic Tonic-Clonic Epilepsy|Familial Tonic-Clonic Epilepsy|Tonic-Clonic Convulsion Disorder|Tonic-Clonic Convulsion Disorders|Seizure Disorder, Tonic-Clonic|Epilepsies, Cryptogenic Tonic-Clonic|Syndromes, Tonic-Clonic Seizure|Tonic-Clonic Epilepsies, Cryptogenic|Tonic-Clonic Epilepsy, Familial|Tonic-Clonic Epilepsies, Familial|Major Motor Seizure Disorder|Cryptogenic Tonic-Clonic Epilepsy|Convulsion|Epilepsy, Symptomatic Tonic-Clonic|Tonic-Clonic Epilepsy, Cryptogenic|Epilepsy, Tonic-Clonic, Symptomatic|Cryptogenic Tonic Clonic Epilepsy|Cryptogenic Tonic-Clonic Epilepsies|Tonic-Clonic Epilepsy|Symptomatic Tonic Clonic Epilepsy|Grand Mal Convulsion|Grand Mal Epilepsy|Tonic-Clonic Convulsion Syndromes|Tonic Clonic Convulsion Disorder|Epilepsies, Symptomatic Tonic-Clonic|Tonic-Clonic Epilepsy, Symptomatic|Convulsion, Tonic Clonic|Tonic Clonic Convulsion Syndrome|Major Epilepsies|Major Epilepsy|Tonic Clonic Convulsions|Epilepsy, Tonic-Clonic, Familial|Convulsions, Tonic Clonic|Seizure Syndrome, Tonic-Clonic|Seizure Disorder, Tonic Clonic|Epilepsy, Grand Mal|Tonic Clonic Seizure Disorder|Tonic-Clonic Epilepsies, Symptomatic|Familial Tonic Clonic Epilepsy|Tonic Clonic Seizure Syndrome|Disorder, Tonic-Clonic Convulsion|Epilepsy, Familial Tonic-Clonic|Seizure Disorder, Grand Mal|Tonic Clonic Convulsion"
D013413,CHEMICAL,Sulfadoxine,Sulformethoxine|Sulphormetoxin|Ro 44393|Sulforthomidine|Fanasil|Ro 4 4393|Sulphorthodimethoxine|Ro 4-4393|Sulfadoxine|Sulformetoxine
NEW05253,BIOCHEMICAL,antimalarial overdose,antimalarial overdose
NEW05255,BIOCHEMICAL,individual antimalarial drugs,individual antimalarial drugs
D014653,DISEASE,Vascular Headaches,"Cephalgia, Vascular|headaches|Cephalgias, Vascular|Vascular Cephalgias|Vascular Headache|Headache, Vascular|Vascular Cephalgia|Headaches, Vascular"
D017963,CHEMICAL,Azithromycin,"Toraseptol|azithromycin|Zitromax|Goxal|Vinzam|Azitrocin|Zithromax|CP62993|Azadose|Azythromycin|Azithromycin Dihydrate|Sumamed|Azithromycin Monohydrate|Dihydrate, Azithromycin|CP-62993|Zentavion|CP 62993|Monohydrate, Azithromycin|Ultreon"
D029862,DISEASE,Prosopis,Algarrobo|Mesquites|Algarrobos|Mesquite|Prosopis|Prosopi
D012216,DISEASE,Rheumatic Diseases,"rheumatic diseases|Disease, Rheumatic|Rheumatic Disease|Rheumatism|Diseases, Rheumatic"
NEW05259,MENTAL_HEALTH,initial depression,initial depression
D004723,CHEMICAL,Endorphins,endorphins|Endorphin
NEW01685,DISEASE,psychiatric pathology,psychiatric pathology
NEW05261,BIOCHEMICAL,opiate agonists,opiate agonists
NEW05262,CHEMICAL,L-alpha acetyl methadyl,LAAM|L-alpha acetyl methadyl
NEW05263,BIOCHEMICAL,2-adrenergic agonists,2-adrenergic agonists
NEW05267,BIOCHEMICAL,opiate antagonist,opiate antagonist
NEW05269,CHEMICAL,opiate agonist,opiate agonist|etonitazene
C096813,CHEMICAL,"Cep104 protein, rat [Supplementary Concept]",Nerve Tissue Proteins|TCP binding|Membrane Glycoproteins
NEW05270,CHEMICAL,SWA adenosine tone,SWA adenosine tone
NEW05272,CHEMICAL,chronic GUO treatment,chronic GUO treatment
NEW05275,BIOCHEMICAL,adenosine A1 receptor antagonist,adenosine A1 receptor antagonist
NEW05277,CHEMICAL,metabotropic glutamate2/3 mGlu2/3 receptor agonists,metabotropic glutamate2/3 mGlu2/3 receptor agonists
D000318,BIOCHEMICAL,Adrenergic beta-Agonists,"beta-Adrenergic Receptor Agonist|Agonist, beta-Adrenergic Receptor|beta-Receptor Agonist, Adrenergic|receptor agonist|Receptor Agonist, beta-Adrenergic|Adrenergic beta Agonist|beta Adrenergic Agonists|Adrenergic beta-Receptor Agonists|beta-Adrenergic Agonist|beta-Receptor Agonists, Adrenergic|Adrenergic beta Receptor Agonist|Receptor Agonists, beta-Adrenergic|beta Adrenergic Agonist|Agonists, beta-Adrenergic Receptor|Adrenergic beta-Agonist|Agonist, beta-Adrenergic|beta-Adrenergic Receptor Agonists|beta-Adrenergic Agonists|Agonists, beta-Adrenergic|Adrenergic beta-Receptor Agonist|beta-Agonists, Adrenergic|Receptor Agonists, beta Adrenergic|Adrenergic beta Receptor Agonists|Betamimetics|beta-Agonist, Adrenergic|Agonist, Adrenergic beta-Receptor|Adrenergic beta Agonists|beta Adrenergic Receptor Agonist|Receptors Agonists, Adrenergic beta|Agonists, Adrenergic beta-Receptor|beta Adrenergic Receptor Agonists"
D058915,CHEMICAL,Purinergic P1 Receptor Antagonists,"P1 Purinoceptor Antagonist|Purinoceptor Antagonists, P1|Adenosine Receptor Antagonists|Purinoceptor Antagonist, P1|Antagonists, Adenosine Receptor|Antagonists, P1 Purinoceptor|Purinergic P1 Receptor Antagonist|Antagonist, P1 Purinoceptor|Adenosine Receptor Antagonist|Receptor Antagonist, Adenosine|adenosine receptor|Receptor Antagonists, Adenosine|P1 Purinoceptor Antagonists|Antagonist, Adenosine Receptor"
C027513,CHEMICAL,N(6)-cyclohexyladenosine [Supplementary Concept],Adenosine/analogs  and  derivatives|N(6)-cyclohexyladenosine
C051360,CHEMICAL,"1,3-dipropyl-8-cyclopentylxanthine [Supplementary Concept]","8-cyclopentyl-1,3-dipropylxanthine|Xanthines"
NEW05282,CHEMICAL,adenosine receptor blockers,adenosine receptor blockers
NEW05284,CHEMICAL,novel adenosine A1 receptor antagonist,novel adenosine A1 receptor antagonist
NEW05286,CHEMICAL,alpha(1)-blockers,alpha(1)-blockers
C047638,CHEMICAL,alfuzosin [Supplementary Concept],alfuzosin|Quinazolines
D017311,CHEMICAL,Amlodipine,"Amlodipine Besylate|Astudal|Istin|Norvasc|Amlodis|Amlodipine Maleate|amlodipine|Amlodipine, (+-)-Isomer|Amlodipine, (S)-Isomer, Maleate (1:1)|Amlodipine, (R)-Isomer|Amlodipine Maleate (1:1)|Amlodipine, (+-)-Isomer, Maleate (1:1)|Amlor"
NEW05291,CHEMICAL,clonidine micrograms,clonidine micrograms
NEW05294,DISEASE,hyperactive micturition reflexes,hyperactive micturition reflexes
NEW05295,DISEASE,long-term paralysis,long-term paralysis
NEW05297,CHEMICAL,Clonidine pretreatment,Clonidine pretreatment
NEW00529,DISEASE,excitotoxic damage,excitotoxic damage
NEW05299,CHEMICAL,2-adrenergic receptor agonist clonidine,2-adrenergic receptor agonist clonidine
NEW05300,CHEMICAL,mafedine,mafedine
NEW05302,CHEMICAL,Baseline cortisol,Baseline cortisol
NEW05303,DISEASE,Depressed patients,Depressed patients
NEW05304,CHEMICAL,Guanfacine extended-release,Guanfacine extended-release
NEW02484,CHEMICAL,Extended-release guanfacine hydrochloride,GXR|Extended-release guanfacine hydrochloride
NEW05308,CHEMICAL,dobutamine stress magnetic resonance,dobutamine stress magnetic resonance
NEW05309,DISEASE,chronic migraine,chronic migraine|CM
NEW05310,BIOCHEMICAL,unselective beta blocker,unselective beta blockers
NEW05312,CHEMICAL,discharge ciprofloxacin mg tablet,discharge ciprofloxacin mg tablet
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Akathisia,DISEASE,akathisia,drug-drug-induced akathisia
D017298,CHEMICAL,Bisoprolol,"EMD33512|Fumarate, Bisoprolol|Bisoprolol Fumarate (1:1) Salt, (+-)-Isomer|Bisoprolol Hydrochloride|Bisoprolol Methanesulfonate Salt|Bisoprolol, (+-)-Isomer|Concor|bisoprolol|CL 297939|Bisoprolol Fumarate|Bisoprolol, Fumarate (2:1) Salt|Bisoprolol Fumarate (2:1) Salt, (+-)-Isomer|Bisoprolol, Fumarate (1:1) Salt|Bisoprolol, (-)-Isomer|EMD 33512|EMD-33512|CL-297939|CL297939|Hydrochloride, Bisoprolol"
NEW05314,CHEMICAL,β2-ar signaling,β2-AR signaling
NEW05316,DISEASE,lung cancer cell,lung cancer cells
NEW05317,CHEMICAL,endogenous catecholamine,Endogenous catecholamines
NEW05319,CHEMICAL,circulate epinephrine,circulating epinephrine
NEW05320,CHEMICAL,OR:1.34,OR:1.34
http://purl.obolibrary.org/obo/CHEBI_51080,CHEMICAL,nitrate ester,nitrate esters
NEW05321,DISEASE,or:0.85,OR:0.85
D003324,DISEASE,Coronary Artery Disease,"coronary artery disease|Left Main Coronary Disease|Coronary Arterioscleroses|Atherosclerosis, Coronary|Coronary Atheroscleroses|Left Main Diseases|Atheroscleroses, Coronary|Arterioscleroses, Coronary|Arteriosclerosis, Coronary|Artery Disease, Coronary|Artery Diseases, Coronary|Left Main Disease|CAD|Left Main Coronary Artery Disease|Coronary Arteriosclerosis|Coronary Artery Diseases|Coronary Atherosclerosis"
http://purl.obolibrary.org/obo/CHEBI_87631,CHEMICAL,statin,statins|statin OR:0.77
NEW05322,CHEMICAL,OR:1.58,OR:1.58
NEW05323,CHEMICAL,0.002,0.002
NEW05325,DISEASE,induce hyperammonemia,induced hyperammonemia
C025655,CHEMICAL,lofexidine [Supplementary Concept],Clonidine/analogs  and  derivatives|lofexidine
NEW05328,CHEMICAL,sirolimus conversion,sirolimus conversion
D020123,CHEMICAL,Sirolimus,I2190A|Rapamycin|sirolimus|AY 22-989|I-2190A|I 2190A|AY 22989|AY 22 989|Rapamune
NEW05329,CHEMICAL,non-amphetamine stimulant,non-amphetamine stimulant
NEW05330,CHEMICAL,its 's precursor gamma-butyrolactone,precursor gamma-butyrolactone
http://purl.obolibrary.org/obo/CHEBI_48407,CHEMICAL,antiparkinson drug,antiparkinson agent|anticataplectic drugs|antidepressants
NEW05332,BIOCHEMICAL,neuroleptic drug treatment,Neuroleptic drug treatments
NEW05335,DISEASE,severe axillary hyperhidrosis,severe axillary hyperhidrosis
NEW05337,BIOCHEMICAL,direct-acting antiviral,direct-acting antivirals
NEW05339,CHEMICAL,gt1a infection,GT1a infection
NEW05340,BIOCHEMICAL,direct-acting antiviral,Direct-acting antivirals
C087036,DISEASE,"NS-5 protein, hepatitis C virus [Supplementary Concept]",Hepatitis C virus|HCV|RNA-Dependent RNA Polymerase|Viral Nonstructural Proteins
NEW05343,BIOCHEMICAL,act antiviral,acting antivirals
NEW05350,CHEMICAL,successful daa treatment,successful DAA treatment
D010665,CHEMICAL,Phenylpropanolamine,"Propagest|Hydrochloride, Phenylpropanolamine|Phenylpropanolamine Hydrochloride|Prolamine|Triaminic DM|Phenylpropanolamine|Dexatrim|Norephedrine"
NEW05353,DISEASE,hypertensive crisis,Hypertensive crises
NEW05354,DISEASE,psychiatric symptom,Psychiatric symptoms
http://purl.obolibrary.org/obo/SYMP_0000412,MENTAL_HEALTH,anxiety,NTG-induced anxiety
NEW05357,CHEMICAL,(rs)-2-chloro-5-hydroxyphenylglycine,(RS)-2-chloro-5-hydroxyphenylglycine|CHPG
D008869,CHEMICAL,Microtubule-Associated Proteins,"MAP2 Microtubule-Associated Protein|MAP3 Microtubule-Associated Protein|microtubule-associated protein|Associated Protein, Microtubule|Protein, Microtubule-Associated|MAP2 Microtubule Associated Protein|Microtubule Associated Proteins|Microtubule-Associated Protein 1|Microtubule-Associated Protein 3|Microtubule Associated Protein 2|MAP3 Microtubule Associated Protein|Tau|Microtubule Associated Protein 1|Microtubule-Associated Protein, MAP2|Microtubule Associated Protein 3|Microtubule Associated Protein|Microtubule-Associated Protein, MAP1|MAP1 Microtubule Associated Protein|MAP1 Microtubule-Associated Protein|Microtubule-Associated Protein|Microtubule-Associated Protein, MAP3|Protein, Microtubule Associated|Microtubule-Associated Protein 2"
D003888,BIOCHEMICAL,"Desensitization, Immunologic","Immunologic Desensitization|Allergy Shots|Immunologic Desensitizations|Venom Immunotherapy|Immunotherapy, Venom|Immunotherapy, Allergen|Allergy Shot|Therapy, Hyposensitization|Allergen Immunotherapies|Desensitizations, Immunologic|Allergen immunotherapy|Shot, Allergy|Hyposensitization Therapies|Allergen Immunotherapy|Venom Immunotherapies|Hyposensitization Therapy"
D000069444,CHEMICAL,Omalizumab,Xolair|Omalizumab
NEW05360,CHEMICAL,recombinant humanize monoclonal anti-ige antibody,recombinant humanized monoclonal anti-IgE antibody
NEW05361,BIOCHEMICAL,allergen specific ige antibody,allergen specific IgE antibodies
NEW05362,BIOCHEMICAL,allergen exposure,allergen exposure
D006255,DISEASE,"Rhinitis, Allergic, Seasonal","Seasonal Allergic Rhinitis|Pollen Allergy|Pollen Allergies|Allergy, Pollen|Allergies, Pollen|Hayfever|allergic rhinitis|Allergic Rhinitis, Seasonal|Pollinosis|Hay Fever|Fever, Hay|Pollinoses|Allergic Rhinitides, Seasonal|Rhinitides, Seasonal Allergic|Seasonal Allergic Rhinitides|Rhinitis, Seasonal Allergic"
NEW05364,BIOCHEMICAL,long-term allergen exposure,long-term allergen exposure
NEW05365,DISEASE,so-called alcohol-induced disease,so-called alcohol-induced diseases
NEW05367,DISEASE,potential auto-immune disease,potential auto-immune diseases
NEW05368,DISEASE,neuroimmunologic disease,Neuroimmunologic diseases
D016269,DISEASE,Milk Hypersensitivity,"Cow Milk Allergy|Allergy, Milk|Milk Allergies|Cow's Milk Allergy|Milk Allergy, Cow's|Milk Allergy|Cow's Milk Protein Allergy|Hypersensitivity, Milk|Milk Hypersensitivities|Cow's Milk Allergies|Allergy, Cow's Milk|Cows Milk Allergy|milk allergy"
NEW05370,DISEASE,allergic cohort,allergic cohorts
D005512,DISEASE,Food Hypersensitivity,"food allergy|Food Allergy|Hypersensitivities, Food|Hypersensitivity, Food|Allergy, Food|Food Allergies|Allergies, Food|Food Hypersensitivities"
D019958,DISEASE,Attention Deficit and Disruptive Behavior Disorders,"Defiant Disorder, Oppositional|Behavior Disorder, Disruptive|Attention Deficit and Disruptive Behavioral Disorders|Behavioral Disorder, Disruptive|Oppositional Defiant Disorder|Disruptive Behavioral Disorder|behavioral disorders|Disruptive Behavioral Disorders|Disruptive Behavior Disorder|Disorder, Disruptive Behavioral"
D004597,DISEASE,Electroshock,"Electroconvulsive Shock|electroconvulsive shock|Electroshocks|Shock, Electroconvulsive|Electroconvulsive Shocks|Shocks, Electroconvulsive"
NEW05373,BIOCHEMICAL,opiate antagonist,opiate antagonists
NEW05374,MENTAL_HEALTH,post-ecs analgesia,post-ECS analgesia
NEW03134,DISEASE,various etiology,various etiologies
NEW05378,CHEMICAL,endorphin system,endorphin systems
NEW05379,BIOCHEMICAL,choose antiepileptic drug treatment,chosen antiepileptic drug treatment
NEW05383,DISEASE,primary alcoholism,primary alcoholism
NEW05385,CHEMICAL,naloxone injection,naloxone injection
NEW05387,BIOCHEMICAL,oral opiate antagonist drug,oral opiate antagonist drugs
D004341,BIOCHEMICAL,Drug Evaluation,"Study, Drug Evaluation|Evaluation Studies, Drug|drug studies|Studies, Drug Evaluation|Evaluation Study, Drug|Evaluation, Drug|Drug Evaluations|Evaluations, Drug|Drug Evaluation Studies|Drug Evaluation Study"
NEW05390,CHEMICAL,atypical neuroleptic risperidone,atypical neuroleptic risperidone
NEW05391,BIOCHEMICAL,serotonin 2a-dopamine d2 antagonist,serotonin 2A-dopamine D2 antagonist
NEW05393,DISEASE,postprandial fullness,Postprandial fullness
http://purl.obolibrary.org/obo/CHEBI_59282,BIOCHEMICAL,kappa-opioid receptor agonist,kappa-opioid receptor agonists|kappa-opioid agonist
http://purl.obolibrary.org/obo/CHEBI_60606,BIOCHEMICAL,opioid receptor agonist,opioid agonists|opiate agonists|opioid agonist|opioid receptor agonists|opiate agonist
http://purl.org/sig/ont/fma/fma67224,CHEMICAL,muscarinic acetylcholine receptor,muscarinic acetylcholine receptor M1 agonism
NEW05398,DISEASE,common behavioral impairment,common behavioral impairment
D000086882,CHEMICAL,Coronavirus Papain-Like Proteases,"Coronavirus Papain Like Proteases|PLP-2 Protein, Coronavirus|Papain-Like Proteinase 3, Coronavirus|Papain Like Proteinase 2, Coronavirus|Papain-Like Proteases, Coronavirus|Papain-Like Proteinase 2, Coronavirus|PLP-3 Protein, Coronavirus|Papain-Like Proteinase 1, Coronavirus|Coronavirus PLP-3 Protein|PLP 3 Protein, Coronavirus|Papain Like Proteinase 1, Coronavirus|Coronavirus PLP-1 Protein|PLP-1 Protein, Coronavirus|PLP|PLP 2 Protein, Coronavirus|Papain-Like Protease, Coronavirus|PLP 1 Protein, Coronavirus|Papain Like Proteinase 3, Coronavirus|Papain Like Protease, Coronavirus|Coronavirus PLP-2 Protein"
NEW05400,BIOCHEMICAL,classical estrogen receptor,classical estrogen receptors
C026777,CHEMICAL,ICI 118551 [Supplementary Concept],Propanolamines|ICI
NEW05402,CHEMICAL,Evans blue eb content,Evans blue EB contents
C043090,CHEMICAL,estradiol-bovine serum albumin [Supplementary Concept],"Estradiol|Serum Albumin, Bovine|E2-BSA"
NEW05404,BIOCHEMICAL,endogenous ovarian hormone,endogenous ovarian hormones
D063087,CHEMICAL,Noninvasive Ventilation,"Ventilations, Non-Invasive|Ventilations, Non Invasive|Non-invasive ventilation|Non-Invasive Ventilations|Noninvasive Ventilations|Non-Invasive Ventilation|Ventilation, Non-Invasive|Non Invasive Ventilation|Ventilation, Noninvasive|Ventilation, Non Invasive|Non Invasive Ventilations|Ventilations, Noninvasive|NIV"
NEW05406,CHEMICAL,Shire,Shire
NEW05410,CHEMICAL,berserk,berserks
NEW05412,MENTAL_HEALTH,antiepileptic drug-induced psychotic disorder,Antiepileptic drug-induced psychotic disorder
NEW05414,CHEMICAL,dopamine d2-receptor blockade,Dopamine D2-receptor blockade
D014747,CHEMICAL,Vinblastine,"Cellblastin|Vinblastin Hexal|Vinblastine|Lemblastine|Vinblastina Lilly|Vinblastine Sulfate|VBL|Velban|Vincaleukoblastine|Velbe|Sulfate, Vinblastine|Vinblastinsulfat-Gry"
NEW05415,CHEMICAL,agent ibuprofen,agent ibuprofen
C029036,CHEMICAL,crocin [Supplementary Concept],Carotenoids|crocin
NEW05417,CHEMICAL,strobilanthe crispus ethanol extract,Strobilanthes crispus ethanol extract
D051844,CHEMICAL,alpha-Synuclein,Non AB Component of AD Amyloid Protein|Non-AB Component of AD Amyloid Protein|Alpha-synuclein|alpha Synuclein
NEW01255,MENTAL_HEALTH,oxidative stress reaction,oxidative stress reactions
D008777,CHEMICAL,Methyltestosterone,methyltestosterone|Android-25|Oreton|17 Epimethyltestosterone|Mesteron|17-alpha-Methyltestosterone|17alpha-Methyl-Testosterone|17 beta-Methyltestosterone|17 beta Methyltestosterone|17 beta-Hydroxy-17-methyl-4-androsten-3-one|17alpha Methyl Testosterone|17beta Methyltestosterone|Android (Methyltestoterone)|Testred|Android 25|17beta-Hydroxy-17-methyl-4-androsten-3-one|17 beta Hydroxy 17 methyl 4 androsten 3 one|Mesterone|Methitest|17beta-Methyltestosterone|Metandren|Android 5|Android 10|17alpha-Methyltestosterone|Virilon|Android-5|17alpha Methyltestosterone|17 alpha Methyltestosterone|17-Epimethyltestosterone|Testoviron|Android-10|17beta Hydroxy 17 methyl 4 androsten 3 one
http://purl.obolibrary.org/obo/DOID_1470,MENTAL_HEALTH,major depressive disorder,recurrent major depression|single major depressive episode|major depressive disorder sample
NEW05422,CHEMICAL,demonstrable antidepressant efficacy,Demonstrable antidepressant efficacy
NEW05423,CHEMICAL,aed lamotrigine,AED lamotrigine
NEW05427,CHEMICAL,serotonergic agent meta-chlorophenylpiperazine,serotonergic agent meta-chlorophenylpiperazine
D009665,CHEMICAL,Noscapine,"Noscapine|Prikkelhoest, Librochin|Capval Tropfen|Noscapect|Capval|Noscapine Hydrochloride|Noscapine Hydrogen Embonate|Embonate, Noscapine Hydrogen|Librochin Prikkelhoest|Hydrochloride, Noscapine|Hydrogen Embonate, Noscapine|Narcotine|Tropfen, Capval|Tuscalman"
NEW05431,CHEMICAL,pb neurotoxicity,Pb neurotoxicity
NEW05433,CHEMICAL,avp release,AVP release
NEW05434,DISEASE,epithelial degeneration,epithelial degeneration
NEW05435,DISEASE,sustained dystonia,Sustained dystonia
NEW05436,CHEMICAL,choreoatheosis,choreoatheosis
D019956,DISEASE,Stereotypic Movement Disorder,"Stereotypic Movement Disorders|Movement Disorder, Stereotypic|Body Rocking|movement disorder|Head Banging"
NEW05437,CHEMICAL,to chlorpromazine,to chlorpromazine|CPZ
NEW05438,DISEASE,lactobacillus reuteri jbd400,Lactobacillus reuteri JBD400
http://purl.obolibrary.org/obo/DOID_14330,DISEASE,parkinson's disease,Parkinson disease|Parkinson 's disease|paralysis agitans|PD
C484876,CHEMICAL,scutellarin [Supplementary Concept],Scu|Glucuronates|Scutellarin|Apigenin
http://purl.obolibrary.org/obo/CHEBI_46634,CHEMICAL,carbapenemcarboxylic acid,acid (GABA)-mediated
http://purl.obolibrary.org/obo/CHEBI_22720,CHEMICAL,benzodiazepine,benzodiazepines|GABA-acting benzodiazepines
NEW05445,MENTAL_HEALTH,autism old,autism old
D020817,MENTAL_HEALTH,Asperger Syndrome,"Aspergers Disease|Diseases, Asperger's|Asperger's Disorder|Syndrome, Asperger|Asperger Disease|Disease, Asperger's|Disorder, Asperger's|Asperger's Diseases|Asperger Disorders|Asperger Diseases|Asperger syndrome|Disease, Asperger|Aspergers Syndrome|Disorder, Asperger|Asperger Disorder|Diseases, Asperger|Aspergers Disorder|Asperger's Syndrome|Disorders, Asperger|Asperger's Disease|Syndrome, Asperger's"
D002034,CHEMICAL,Bumetanide,Bumethanide|PF1593|Bumetanide|Miccil|Drenural|PF 1593|Burinex|Bumedyl|Fordiuran|PF-1593|Bumex
NEW05448,DISEASE,autistic symptomatology,autistic symptomatology
http://purl.obolibrary.org/obo/SYMP_0000666,DISEASE,abnormal behavior,abnormal behaviors
http://purl.obolibrary.org/obo/CHEBI_4530,CHEMICAL,diethylpropion,alpha-diethylaminopropiophenone|amfepramone|Amfepramone|alpha-benzoyltriethylamine|2-(diethylamino)-1-phenylpropan-1-one|1-phenyl-2-diethylamino-1-propanone|anfepramona|d-Fenfluramine|2-(diethylamino)-1-phenyl-1-propanone|amfepramonum|(+-)-diethylpropion|2-(diethylamino)propiophenone|Diethylpropion
NEW05450,CHEMICAL,specific serotonin (5-ht)-releasing agent,specific serotonin (5-HT)-releasing agent
C050504,CHEMICAL,tianeptine [Supplementary Concept],Thiazepines|Tianeptine
NEW05452,CHEMICAL,antidepressant efficacy,antidepressant efficacy
NEW05454,CHEMICAL,tianeptine therapy,tianeptine therapy
NEW05456,MENTAL_HEALTH,coexist depression,coexisting depression
http://purl.obolibrary.org/obo/SYMP_0000260,DISEASE,dry mouth,dry mouth
http://purl.obolibrary.org/obo/SYMP_0000024,MENTAL_HEALTH,drowsiness,drowsiness|drowsy|somnolence
http://purl.obolibrary.org/obo/SYMP_0000530,DISEASE,palpitation,dizziness/syncope|abnormal heart beats
NEW01105,BIOCHEMICAL,atypical antipsychotic drug,atypical antipsychotic drug
NEW05462,CHEMICAL,atypical antipsychotic quetiapine,atypical antipsychotic quetiapine
NEW05463,CHEMICAL,agomelatine augmentation,agomelatine augmentation
NEW05465,CHEMICAL,agomelatine augmentation,Agomelatine augmentation
C082372,CHEMICAL,T 588 [Supplementary Concept],Diethylamines|T-588|Thiophenes
NEW05471,CHEMICAL,synthetic glucocorticoid dexamethasone,synthetic glucocorticoid dexamethasone|DXM
NEW05473,CHEMICAL,hu211,HU211
C029892,CHEMICAL,cupric chloride [Supplementary Concept],Copper|cupric chloride
NEW05475,MENTAL_HEALTH,insomnia abnormality,insomnia abnormalities
NEW05476,CHEMICAL,oxytocin administration,oxytocin administration
D003471,CHEMICAL,Cuprizone,"Cuprizone|Oxaldihydrazone, Biscyclohexanone|Biscyclohexanone Oxaldihydrazone"
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Acute_Psychosis,MENTAL_HEALTH,acute psychosis,acute psychosis
NEW05480,BIOCHEMICAL,antibiotic exposure,antibiotic exposure
NEW05481,BIOCHEMICAL,tetracycline antibiotic minocycline,tetracycline antibiotic minocycline
D000069285,CHEMICAL,Infliximab,"Antibody cA2, Monoclonal|Inflectra|cA2, Monoclonal Antibody|Infliximab dyyb|Infliximab-dyyb|Remicade|Monoclonal Antibody cA2|Infliximab|Renflexis|MAb cA2|Infliximab abda|Infliximab-abda"
NEW05485,CHEMICAL,token-reward system,token-reward systems
NEW05486,CHEMICAL,short-term naloxone hydrochloride administration,short-term naloxone hydrochloride administration
NEW05489,CHEMICAL,endorphin involvement,endorphin involvement
NEW05491,BIOCHEMICAL,gut microbial toxin,gut microbial toxins
D008090,CHEMICAL,Lisuride,"Lysuride Hydrogen Maleate|Arolac|Lisuride Maleate, (8beta)-Isomer|Dopergine|Mesylate, Lisuride|Methylergol Carbamide|Lisuride|Lysurid|Lisuride Phosphate (1:1)|Revanil|Hydrochloride, Lisuride|Lisuride Maleate (1:1)|Cuvalit|Maleate, Lisuride|Lisuride, (8alpha)-(+-)-Isomer|Hydrogen Maleate, Lysuride|Lisuride Hydrochloride|Dopergin|Carbamide, Methylergol|Lisuride Mesylate|Lisuride Maleate|Lysenyl"
NEW05493,MENTAL_HEALTH,intrusive thought,Intrusive thoughts
NEW05495,DISEASE,stress-induced metabolic alteration,stress-induced metabolic alterations
NEW05497,DISEASE,skewed x-inactivation,Skewed X-inactivation
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Obsessive_Compulsive_Personality_Disorder,MENTAL_HEALTH,obsessive compulsive personality disorder,Obsessive compulsive personality disorder|OCPD
NEW05500,DISEASE,most psychogenic nonepileptic seizure,most psychogenic nonepileptic seizures|PNESs
D056805,DISEASE,Consciousness Monitors,"Consciousness Monitor|Index of Consciousness View Monitor|Monitors, Consciousness|Index of Consciousness-View Monitor|Bispectral Index Monitors|Monitor, Consciousness|consciousness|Bispectral Index Monitor|Cerebral State Index Monitor|Index of ConsciousnessView Monitor|Monitor, Bispectral Index|Monitors, Bispectral Index"
D000068356,CHEMICAL,Self-Control,"Control, Self|Self Regulation|Self Control|self-control|Self-Regulation|Regulation, Self"
NEW05504,MENTAL_HEALTH,high baseline adhd severity,higher baseline ADHD severity
NEW05507,CHEMICAL,cx-516,CX-516
http://purl.obolibrary.org/obo/CHEBI_64159,CHEMICAL,2-methyl-6-(phenylethynyl)pyridine,6-Methyl-2-(phenylethynyl)pyridine|2-methyl-6-(phenylethynyl)pyridine|AMPAkines|MPEP
D011558,DISEASE,"Herpesvirus 1, Suid","Pseudorabies Viruses|Virus, Pseudorabies|Herpesvirus 1 (alpha), Suid|Aujeszky's Disease Virus|Aujeszky's disease|Viruses, Pseudorabies|Suid Herpesvirus 1|Swine Herpesvirus 1|Aujeszky Disease Virus|Pseudorabies Virus|Herpesvirus 1, Swine|Herpesvirus Suis|Aujeszkys Disease Virus"
NEW05511,DISEASE,gambling disorder,gambling disorder
http://purl.obolibrary.org/obo/CHEBI_9288,CHEMICAL,streptozocin,streptozocinum|estreptozocina|N-D-Glucosyl-(2)-N&#39;-nitrosomethylharnstoff|Streptozotocin (STZ)-induced|streptozocin|Streptozocinium|2-Deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose|2-deoxy-2-{[methyl(nitroso)carbamoyl]amino}-alpha-D-glucopyranose|Zanosar|Streptozotocin|N-D-Glucosyl-(2)-N'-nitrosomethylurea|2-Deoxy-2-(((methylnitrosoamino)carbonyl)amino)-D-glucopyranose|streptozocine
http://purl.obolibrary.org/obo/SYMP_0000647,DISEASE,tache noire,(STZ)-induced diabetes
http://purl.obolibrary.org/obo/CHEBI_7009,CHEMICAL,moxonidine,Moxonidine|moxonidin|normoxocin|L-baclofen
http://purl.obolibrary.org/obo/CHEBI_68563,CHEMICAL,p2y12 receptor antagonist,ADP receptor subtype P2Y12 antagonist|purinergic receptor subtype P2Y12 antagonists|ADP receptor subtype P2Y12 antagonists|NK(1 receptor antagonists|purinergic receptor subtype P2Y12 antagonist|P2Y12 receptor antagonists
D013373,CHEMICAL,Substance P,"Substance P|Substance P, Euler-Gaddum|SP(1-11)|Hypothalamic Substance P|Euler Gaddum Substance P|Substance P, Hypothalamic|Euler-Gaddum Substance P"
NEW05517,DISEASE,vomit reflex,vomiting reflex
C518176,CHEMICAL,maropitant [Supplementary Concept],maropitant|Quinuclidines
NEW05522,CHEMICAL,human dopamine d2 receptor long isoform,human dopamine D2 receptor long isoform
D018998,NUTRITION,Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate,Wheat Germ Agglutinin Horseradish Peroxidase Conjugate|wheat germ|WGA-HRP
NEW05524,CHEMICAL,competitive non-nmda ampa/kainate receptor antagonist,competitive non-NMDA AMPA/kainate receptor antagonist
http://purl.obolibrary.org/obo/CHEBI_24866,CHEMICAL,salt,NBQX-disodium salt
http://purl.obolibrary.org/obo/CHEBI_60643,BIOCHEMICAL,nmda receptor antagonist,N-methyl-D-aspartate receptor antagonist|NMDAR antagonist|NMDA receptor antagonists|N-methyl-D-aspartate receptor antagonists|competitive NMDA receptor antagonist|NMDAR antagonists
NEW05526,CHEMICAL,systemic mk-801,Systemic MK-801
D006930,DISEASE,Hyperalgesia,"Thermal Allodynia|Hyperalgia, Mechanical|Hyperalgesic Sensations|Tactile Allodynia|Sensations, Hyperalgesic|Allodynia, Tactile|Hyperalgia, Primary|Hyperalgesia, Mechanical|Hyperalgia|Hyperalgesias|Secondary Hyperalgias|Hyperalgesic Sensation|Primary Hyperalgias|Mechanical Hyperalgia|Primary Hyperalgia|Hyperalgesia, Secondary|Allodynia, Thermal|Hyperalgesias, Thermal|Allodynia, Mechanical|Hyperalgesia, Primary|Secondary Hyperalgia|Mechanical Allodynia|Sensation, Hyperalgesic|Allodynia|mechanical allodynia|Thermal Hyperalgesia|Hyperalgesia, Tactile|Hyperalgia, Secondary|Mechanical Hyperalgias|Hyperalgesia, Thermal|Allodynias|Mechanical Hyperalgesia"
NEW05529,CHEMICAL,systemic nmda,systemic NMDA
C017069,CHEMICAL,bicuculline methiodide [Supplementary Concept],bicuculline methiodide|Bicuculline/analogs  and  derivatives
NEW05531,CHEMICAL,gamma-aminobutyric acid gabaa receptor,gamma-aminobutyric acid GABAA receptors
NEW05532,CHEMICAL,short-acting clonidine,Short-acting clonidine
NEW05537,CHEMICAL,acetate mmol/kg,acetate mmol/kg
C018824,CHEMICAL,ammonium acetate [Supplementary Concept],ammonium acetate|NH4Ac|Acetates
NEW05541,CHEMICAL,acetylcholine-induced catecholamine release,acetylcholine-induced catecholamine release
D010147,DISEASE,Pain Measurement,"Pain Questionnaire, McGill|Nociception Tests|Questionnaire, McGill Pain|Pain Scale, Analogue|Analgesia Tests|Nociception Test|Pain Intensities|Intensity, Pain|Severity, Pain|Analog Pain Scales|Scale, Analog Pain|Test, Formalin|Scale, McGill Pain|Pain Measurements|Tourniquet Pain Tests|McGill Pain Questionnaire|Pain Test, Tourniquet|Pain Severity|Pain Assessment|Test, Analgesia|Scale, Analogue Pain|Pain Assessments|Pain Scale, Analog|Tourniquet Pain Test|Visual Analog Pain Scale|Test, Tourniquet Pain|Pain Scale, McGill|McGill Pain Scale|Analogue Pain Scale|Measurement, Pain|Analog Pain Scale|Analogue Pain Scales|Pain Severities|pain assessment|Visual Analogue Pain Scale|Tests, Nociception|Analgesia Test|Assessment, Pain|Formalin Test|Formalin Tests|Test, Nociception|Pain Intensity"
NEW05546,CHEMICAL,hydromorphone pca,hydromorphone PCA
D001171,DISEASE,"Arthritis, Juvenile","Juvenile Oligoarthritis|Still's Disease, Juvenile-Onset|Juvenile Systemic Arthritis|Juvenile Rheumatoid Arthritis|Arthritis, Juvenile Chronic|Juvenile Onset Stills Disease|Polyarthritis, Juvenile, Rheumatoid Factor Negative|Enthesitis-Related Arthritis, Juvenile|rheumatoid arthritis|Arthritis, Juvenile Psoriatic|Stills Disease, Juvenile-Onset|Still Disease, Juvenile Onset|Chronic Arthritis, Juvenile|Psoriatic Arthritis, Juvenile|Systemic Arthritis, Juvenile|Oligoarthritis, Juvenile|Juvenile Arthritis|Arthritis, Juvenile Idiopathic|Arthritis, Juvenile Rheumatoid|Still's Disease, Juvenile Onset|Juvenile-Onset Still's Disease|Idiopathic Arthritis, Juvenile|Juvenile Enthesitis-Related Arthritis|Juvenile-Onset Stills Disease|Arthritis, Juvenile Systemic|Arthritis, Juvenile Enthesitis-Related|Juvenile Psoriatic Arthritis|Rheumatoid Arthritis, Juvenile|Juvenile-Onset Still Disease|Still Disease, Juvenile-Onset|Juvenile Idiopathic Arthritis|Juvenile Onset Still Disease|Polyarthritis, Juvenile, Rheumatoid Factor Positive|Enthesitis Related Arthritis, Juvenile|Juvenile Chronic Arthritis"
D010101,CHEMICAL,Oxygen Consumption,"oxygen consumption|Oxygen Consumptions|Consumption, Oxygen|Consumptions, Oxygen"
NEW05551,DISEASE,fatty acid-binding protein fabp3 knockout mouse,fatty acid-binding protein FABP3 knockout mice
NEW05554,CHEMICAL,ramelteon,ramelteon
http://purl.obolibrary.org/obo/CHEBI_79046,BIOCHEMICAL,melatonin receptor agonist,melatonin receptor agonists|melatonin receptor agonist
D027582,DISEASE,Humulus,Humulus lupulus|Hops
NEW05555,BIOCHEMICAL,nk-1 receptor antagonist,NK-1 receptor antagonists
D019733,CHEMICAL,Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor,Carbon Nitrogen Ligases with Glutamine as Amide N Donor|glutamine
NEW05558,CHEMICAL,potassium-evoked release,potassium-evoked release
NEW05559,DISEASE,elevated pain threshold,elevated pain thresholds
C036286,CHEMICAL,vitamin D2 glucosiduronate [Supplementary Concept],vitamin D2|Vit D2|Ergocalciferols
NEW05563,CHEMICAL,peripheral-cns interaction,peripheral-CNS interactions
NEW05565,CHEMICAL,fructose intake,fructose intake
NEW05566,DISEASE,hepatocellular carcinoma incidence,hepatocellular carcinoma incidence
NEW05569,CHEMICAL,increase acetaldehyde production,Increased acetaldehyde production
D065626,DISEASE,Non-alcoholic Fatty Liver Disease,"Steatohepatitides, Nonalcoholic|Nonalcoholic Fatty Liver Disease|NAFLD|Nonalcoholic Fatty Liver|Nonalcoholic Steatohepatitis|Fatty Livers, Nonalcoholic|Nonalcoholic steatohepatitis|Liver, Nonalcoholic Fatty|Livers, Nonalcoholic Fatty|Nonalcoholic Steatohepatitides|Non alcoholic Fatty Liver Disease|Nonalcoholic Fatty Livers|Steatohepatitis, Nonalcoholic|Fatty Liver, Nonalcoholic"
NEW02412,DISEASE,pain sensitivity,pain sensitivity
NEW05571,NUTRITION,choline availability,choline availability
NEW05572,CHEMICAL,acetylchyoline synthesis,acetylchyoline synthesis
http://purl.obolibrary.org/obo/CHEBI_26208,CHEMICAL,polyunsaturated fatty acid,PUFA|polyunsaturated fatty acids|PUFAs|n-3 LCPUFA|chain polyunsaturated fatty acids
NEW05573,CHEMICAL,omega-3 long     chain polyunsaturated fatty acid,omega-3 long    chain polyunsaturated fatty acids
D059551,DISEASE,"Toxicity Tests, Subacute","Subacute Toxicity Tests|Toxicity|Test, Subacute Toxicity|Toxicity Test, Subacute|Subacute Toxicity Test|Tests, Subacute Toxicity"
D013778,CHEMICAL,Tetrazolium Salts,"Tetrazolium Salt|salts|Salts, Tetrazolium|Salt, Tetrazolium"
C568831,CHEMICAL,alpha-((5-fluoro-2-methoxyphenyl)methyl)-alpha-(tetrahydro-2H-pyran-4-yl)-2-morpholinemethanol [Supplementary Concept],edivoxetine|Phenylethyl Alcohol/analogs  and  derivatives|Morpholines
D009949,MENTAL_HEALTH,Orientation,"Cognitive Orientations|Orientations|Mental Orientations|Orientation, Psychological|orientation|Orientations, Psychological|Orientation, Cognitive|Psychological Orientation|Mental Orientation|Orientations, Cognitive|Cognitive Orientation|Orientations, Mental|Psychological Orientations|Orientation, Mental"
http://purl.obolibrary.org/obo/CHEBI_39243,CHEMICAL,kinoprene,"prop-2-yn-1-yl (2E,4E)-3,7,11-trimethyldodeca-2,4-dienoate|(E,E)-3,7,11-trimethyl-2,4-dodecadienoic acid 2-propynyl ester|Kinoprene|(E,E)-2-propynyl 3,7,11-trimethyl-2,4-dodecadienoate|ng/bee|2-propynyl (E,E)-3,7,11-trimethyl-2,4-dodecadienoate"
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Chronic_Stress,MENTAL_HEALTH,chronic stress,Chronic stress
NEW05577,CHEMICAL,brain neurotrophin,brain neurotrophins
NEW05578,DISEASE,chronic unpredictable mild stress,chronic unpredictable mild stress|CUMS
C588289,CHEMICAL,chrysin 6-C-rutinoside [Supplementary Concept],Disaccharides|chrysin|Flavones
NEW05581,DISEASE,Mad Honey Disease,Mad Honey Disease
NEW01882,MENTAL_HEALTH,significant analgesia,significant analgesia
NEW05583,CHEMICAL,nonbromide counterpart,nonbromide counterparts
NEW05584,DISEASE,global pandemic lockdown,global pandemic lockdown
D017563,DISEASE,"Lung Diseases, Interstitial","Pneumonias, Interstitial|Pneumonitis, Interstitial|Diffuse Parenchymal Lung Disease|Interstitial Pneumonitis|Interstitial Lung Disease|Interstitial Pneumonias|Lung Disease, Interstitial|Pneumonia, Interstitial|Interstitial Pneumonia|Pneumonitides, Interstitial|Diffuse Parenchymal Lung Diseases|lung disease|Interstitial Pneumonitides|Interstitial Lung Diseases"
NEW05588,DISEASE,cancer health disparity,cancer health disparities
D061325,DISEASE,Hereditary Breast and Ovarian Cancer Syndrome,"HBOC Syndrome|HBOC Syndromes|Syndromes, HBOC|cancer|Syndrome, HBOC"
NEW05589,CHEMICAL,chronic alcohol comsumption,Chronic alcohol comsumption
D064129,DISEASE,"Prostatic Neoplasms, Castration-Resistant","Prostatic Cancer, Hormone Refractory|Androgen Independent Prostatic Neoplasms|Prostatic Neoplasms, Androgen Insensitive|Prostatic Neoplasms, Androgen-Independent|Prostatic Cancer, Androgen Resistant|Androgen-Independent Prostatic Cancer|Castration-Resistant Prostatic Cancer|Androgen-Resistant Prostatic Neoplasms|Prostatic Cancers, Androgen-Independent|Hormone Refractory Prostatic Neoplasms|cancers|Neoplasm, Castration-Resistant Prostatic|Prostatic Cancer, Androgen-Insensitive|Prostatic Cancer, Androgen Insensitive|Androgen-Insensitive Prostatic Neoplasms|Androgen Resistant Prostatic Neoplasms|Neoplasm, Androgen-Independent Prostatic|Prostatic Neoplasms, Androgen Independent|Castration-Resistant Prostatic Cancers|Prostatic Cancer, Androgen-Independent|Neoplasm, Androgen-Resistant Prostatic|Androgen-Independent Prostatic Neoplasm|Prostatic Neoplasm, Castration-Resistant|Neoplasm, Androgen-Insensitive Prostatic|Prostatic Neoplasm, Androgen-Insensitive|Androgen-Independent Prostatic Neoplasms|Cancer, Castration-Resistant Prostatic|Prostatic Cancers, Androgen-Resistant|Androgen Independent Prostatic Cancer|Neoplasms, Androgen-Independent Prostatic|Neoplasms, Castration-Resistant Prostatic|Androgen-Resistant Prostatic Neoplasm|Prostatic Neoplasm, Androgen-Independent|Prostatic Cancer, Castration Resistant|Castration Resistant Prostatic Neoplasms|Androgen-Insensitive Prostatic Cancer|Prostatic Cancer, Castration-Resistant|Prostatic Neoplasms, Androgen Resistant|Cancers, Androgen-Resistant Prostatic|Androgen Insensitive Prostatic Cancer|Cancers, Castration-Resistant Prostatic|Hormone Refractory Prostatic Cancer|Androgen-Resistant Prostatic Cancer|Androgen-Insensitive Prostatic Cancers|Prostatic Neoplasms, Androgen-Resistant|Neoplasms, Androgen-Insensitive Prostatic|Neoplasms, Androgen-Resistant Prostatic|Prostatic Neoplasms, Hormone Refractory|Androgen Insensitive Prostatic Neoplasms|Cancers, Androgen-Insensitive Prostatic|Prostatic Neoplasms, Castration Resistant|Prostatic Cancers, Androgen-Insensitive|Androgen-Resistant Prostatic Cancers|Cancer, Androgen-Resistant Prostatic|Prostatic Neoplasms, Androgen-Insensitive|Androgen-Independent Prostatic Cancers|Prostatic Cancer, Androgen Independent|Cancer, Androgen-Insensitive Prostatic|Castration Resistant Prostatic Cancer|Castration-Resistant Prostatic Neoplasm|Androgen-Insensitive Prostatic Neoplasm|Androgen Resistant Prostatic Cancer|Cancer, Androgen-Independent Prostatic|Prostatic Cancers, Castration-Resistant|Prostatic Neoplasm, Androgen-Resistant|Castration-Resistant Prostatic Neoplasms|Prostatic Cancer, Androgen-Resistant|Cancers, Androgen-Independent Prostatic"
D018733,BIOCHEMICAL,Nicotinic Antagonists,"Nicotinic antagonists|Antagonists, Nicotinic"
C403531,CHEMICAL,nicotinic receptor alpha4beta2 [Supplementary Concept],"Receptors, Nicotinic|α4β2"
http://purl.obolibrary.org/obo/CHEBI_48878,BIOCHEMICAL,nicotinic antagonist,nicotinic acetylcholine receptor antagonists|nicotinic acetylcholine receptor antagonist|agente antinicotinico|nicotinic cholinergic antagonist|antinicotinicos|agents antinicotiniques|agentes antinicotinicos|nicotinic antagonists|α7 nicotinic antagonists|nicotinic cholinergic antagonists
NEW05595,CHEMICAL,nicotine receptor,Nicotine receptors
NEW05597,CHEMICAL,transdermal nicotine,transdermal nicotine
NEW05598,DISEASE,e. hirta,E. hirta
http://purl.obolibrary.org/obo/PR_Q58G47,BIOCHEMICAL,protein tify 6a (arabidopsis thaliana),at-tify6a|t1n15.11|tify6a|jasmonate zim domain-containing protein 4 (arabidopsis thaliana)|jaz4|Jasmonates|at1g48500
C539351,CHEMICAL,elagolix [Supplementary Concept],"Pyrimidines|Elagolix|Hydrocarbons, Fluorinated"
D014103,DISEASE,Torticollis,"Spasmodic Torticollis|Dystonias, Cervical|Torticollis, Spasmodic|torticollis|Cervical Dystonias|Dystonia, Cervical|Torticollis, Intermittent|Torticollis, Psychogenic|Intermittent Torticollis|Cervical Dystonia|Psychogenic Torticollis|Wryneck"
C558368,CHEMICAL,argiotoxin-636 [Supplementary Concept],Polyamines|Indoleacetic Acids|AR636
D004546,BIOCHEMICAL,Elapid Venoms,"Sea Snake Venom|Elapidae Venom|Venom, Naja|Venoms, Sea Snake|King Cobra Venom|Venoms, Cobra|Hydrophid Venoms|Venom, King Cobra|Ophiophagus hannah Venom|Cobra Venom|Naja Venom|Naja Venoms|Sea Snake Venoms|venom|Venom, Elapid|Hydrophid Venom|Venoms, Naja|Venom, Cobra|Venom, Sea Snake|Elapid Venom|Venoms, Elapidae|Venom, Ophiophagus hannah|Venom, Hydrophid|Cobra Venoms|Venoms, Hydrophid|Venoms, Elapid|Venom, Elapidae|Elapidae Venoms"
NEW05603,BIOCHEMICAL,antihypertensive antibiotic antitumor class,antihypertensive antibiotic antitumor classes
NEW05605,CHEMICAL,conotoxin cyclization,conotoxin cyclization
D064666,NUTRITION,"Diapause, Insect",Insect Diapause|insect
NEW05610,NUTRITION,so-called toad vaccine,so-called toad vaccine
NEW05612,CHEMICAL,gamma-aminobutyric acid type b,gamma-aminobutyric acid type B
NEW05613,DISEASE,catatonic feature,catatonic features
NEW05615,BIOCHEMICAL,acetylcholine agonist carbachol,acetylcholine agonist carbachol
NEW05616,CHEMICAL,methyl glyoxal,methyl glyoxal
C530255,CHEMICAL,fluorodeoxyglucose F18-maleimidehexyloxime [Supplementary Concept],FDG|Maleimides|Oximes
NEW05617,CHEMICAL,moderate iodine deficiency,moderate iodine deficiency
NEW05622,BIOCHEMICAL,pharmaceutical treatment,Pharmaceutical treatments
NEW05623,BIOCHEMICAL,mglur antagonist,mGluR antagonists
NEW05624,CHEMICAL,reduce gaba neurotransmission,Reduced GABA neurotransmission
NEW05625,CHEMICAL,positive allosteric gaba modulator,i.e benzodiazepines|positive allosteric GABA modulators
D000091323,DISEASE,Psychogenic Nonepileptic Seizures,"Nonepileptic Seizure, Psychogenic|Pseudoseizure, Psychogenic|Psychogenic Nonepileptic Seizure|Psychogenic Pseudoseizure|Seizure, Psychogenic Nonepileptic|Psychogenic Pseudoseizures|psychogenic nonepileptic seizures"
NEW05632,CHEMICAL,descend serotonin,descending serotonin
NEW05633,CHEMICAL,chronic cannabis use,Chronic cannabis use
NEW05635,CHEMICAL,repeat ppx administration,repeated PPX administration
http://purl.obolibrary.org/obo/CHEBI_51065,BIOCHEMICAL,dopamine agonist,Dopaminergic agonist|Dopamine receptor agonist|Agonista dopaminergico|dopamine D3/D2 receptor-preferring agonist
D016688,DISEASE,"Mice, Inbred NOD","Diabetic Mouse, Nonobese|Mouse, Inbred NOD|Nonobese Diabetic Mouse|Non-Obese Diabetic Mouse|Mice, Non-Obese Diabetic|Mice, Nonobese Diabetic|Diabetic Mice, Non-Obese|Inbred NOD Mouse|Non Obese Diabetic Mouse|NOD Mice, Inbred|Mouse, Nonobese Diabetic|Diabetic Mouse, Non-Obese|Non Obese Diabetic Mice|Mice, NOD|Diabetic Mice, Nonobese|Inbred NOD Mice|NOD Mice|Mouse, Non-Obese Diabetic|Nonobese Diabetic Mice|Non-Obese Diabetic Mice|NOD Mouse|NOD Mouse, Inbred|Mouse, NOD|diabetic mice"
NEW05642,CHEMICAL,adenosine degradation product,adenosine degradation products
NEW05644,CHEMICAL,adenosine level,adenosine levels
NEW05645,DISEASE,experimental hyperammonemia,Experimental hyperammonemia
C440500,CHEMICAL,N-methyl D-aspartate receptor subtype 2A [Supplementary Concept],"NMDA glutamate receptor|Receptors, N-Methyl-D-Aspartate"
NEW01091,CHEMICAL,dopamine replacement therapy,dopamine replacement therapy
NEW05646,CHEMICAL,dopamine replacement therapy,Dopamine replacement therapy
NEW05648,BIOCHEMICAL,pineal gland hormone,pineal gland hormone
NEW05649,CHEMICAL,25i-nbome critical review,25I-NBOMe Critical Review
NEW05652,BIOCHEMICAL,specific cb1 receptor agonist,specific CB1 receptor agonist
http://purl.obolibrary.org/obo/OGMS_0000090,CHEMICAL,treatment,ACEA treatment
C090111,CHEMICAL,LEK 8829 [Supplementary Concept],Lysergic Acid/analogs  and  derivatives|LEK-8829
NEW05656,DISEASE,se animal,SE animals
NEW05657,DISEASE,shock exposure rat,shock exposure rats
NEW05658,CHEMICAL,endocannabinoid anandamide,endocannabinoid anandamide
NEW05660,CHEMICAL,intra-bla urb597,Intra-BLA URB597
NEW05664,CHEMICAL,suitable antidepressant,suitable antidepressant
NEW05667,CHEMICAL,specific 5-ht receptor subtype,specific 5-HT receptor subtypes
D043682,CHEMICAL,"Receptor, Adenosine A1","adenosine A1 receptors|Adenosine A1 Receptors|Adenosine A1 Receptor|Receptors, Adenosine A1"
NEW05670,CHEMICAL,standard analgesic pregabalin,standard analgesic pregabalin
NEW05672,BIOCHEMICAL,partial a1r agonist,partial A1R agonists
NEW05673,CHEMICAL,its 's metabotropic gabab receptor,metabotropic GABAB receptor
NEW05674,CHEMICAL,gabab receptor signaling,GABAB receptor signaling
NEW05677,CHEMICAL,baclofen efficacy,baclofen efficacy
NEW05678,CHEMICAL,aud patient,AUD patients
C465628,DISEASE,"LTO1 protein, human [Supplementary Concept]",Neoplasm Proteins|oral cancer
http://purl.obolibrary.org/obo/DOID_9854,DISEASE,lingual-facial-buccal dyskinesia,Oro-facial dyskinesia|Levodopa-induced dyskinesias
NEW05683,BIOCHEMICAL,other pharmaceutical therapy,Other pharmaceutical therapies
D018680,BIOCHEMICAL,Cholinergic Antagonists,"Antagonist, Acetylcholine|Cholinergic Receptor Antagonists|Antagonist, Cholinergic|Acetylcholine Antagonists|Acetylcholine Antagonist|Cholinergic Blocking Agent|Antagonists, Cholinergic|Agent, Cholinergic-Blocking|Cholinolytics|Anti Cholinergic|Anti-Cholinergic|Anticholinergic|anticholinergic agents|Cholinergic-Blocking Agents|Agents, Anticholinergic|Anti Cholinergics|Anti-Cholinergics|Receptor Antagonist, Cholinergic|Cholinergic Receptor Antagonist|Antagonists, Cholinergic Receptor|Anticholinergics|Cholinergic Antagonist|Agents, Cholinergic-Blocking|Cholinergic Blocking Agents|Cholinergic-Blocking Agent|Anticholinergic Agent|Cholinolytic|Receptor Antagonists, Cholinergic|Antagonists, Acetylcholine|Agent, Anticholinergic|Antagonist, Cholinergic Receptor|Anticholinergic Agents"
http://purl.obolibrary.org/obo/DOID_3669,DISEASE,intermittent claudication,Charcot's syndrome|Intermittent claudication|intermittent self-catheterisation
D034161,DISEASE,Pelvic Infection,"Pelvic Infections|Infection, Pelvic|infection|Infections, Pelvic"
NEW05689,BIOCHEMICAL,Delirium Drug scale,Delirium Drug Scale
D053201,DISEASE,"Urinary Bladder, Overactive","Overactive Detrusor Function|OAB|Overactive bladder|Overactive Bladder|Bladder, Overactive|Overactive Urinary Bladder|Overactive Detrusor|Detrusor Function, Overactive|Detrusor, Overactive"
D006024,CHEMICAL,Glycopyrrolate,"Glycopyrrolate|NVA 237|Pyrrolidinium, 3-((cyclopentylhydroxyphenylacetyl)oxy)-1,1-dimethyl-, bromide|NVA-237|Glycopyrronium Bromide|NVA237|Bromide, Glycopyrronium|Glycopyrronium"
NEW05694,BIOCHEMICAL,act cholinomimetic drug,acting cholinomimetic drugs
NEW05695,DISEASE,pelvic organ autonomic dysfunction,pelvic organ autonomic dysfunctions
NEW05697,DISEASE,radiation dermatitis,Radiation dermatitis
D017564,DISEASE,Radiation Pneumonitis,"Pneumonia, Radiation|Pneumonitis, Radiation|Radiation Pneumonia|Radiation pneumonitis"
NEW05699,DISEASE,radiation-induced emesis,Radiation-induced emesis
NEW05700,DISEASE,chronic radiation cystitis,chronic radiation cystitis
NEW05701,DISEASE,genitourinary autonomic dysfunction,genitourinary autonomic dysfunctions
NEW05703,DISEASE,neurodevelopmental disability,neurodevelopmental disabilities
http://purl.obolibrary.org/obo/SYMP_0000581,MENTAL_HEALTH,sleep apnea,Mild sleep apnea
http://purl.obolibrary.org/obo/MFOMD_0000105,CHEMICAL,enuresis,nonmonosymptomatic enuresis|NME
NEW05704,BIOCHEMICAL,central anticholinergic drug,central anticholinergic drug
NEW05705,CHEMICAL,serum corticosterone level,serum corticosterone levels
D014282,CHEMICAL,Trihexyphenidyl,Trihexyphenidyl Hydrochloride|Trihexyphenidyl Hydrochloride Elixir|Trihexane|Benzhexol|Trihexidyl Hydrochloride|Apo-Trihex|Apo Trihex|Artane|Hipokinon|Parkinane|ApoTrihex|trihexyphenidyl|Cyclodol|Parkopan
D014150,BIOCHEMICAL,Antipsychotic Agents,"Neuroleptic Drug|Major Tranquilizing Agents|Neuroleptic Agent|Neuroleptic Agents|Antipsychotic Medication|Antipsychotic Drug|Neuroleptic Drugs|Major Tranquillizing Agents|Antipsychotic|Antipsychotic Effect|Major Tranquilizers|Medication, Antipsychotic|Antipsychotic Effects|Effect, Antipsychotic|Neuroleptic|Antipsychotic Drugs|Antipsychotics|Tranquillizing Agents, Major|Antipsychotic Agent|Tranquilizer, Major|Agent, Neuroleptic|Major Tranquilizer|Drug, Neuroleptic|Tranquilizing Agents, Major|neuroleptic drug|Drug, Antipsychotic|Agent, Antipsychotic|Neuroleptics"
NEW05707,CHEMICAL,arginine vasopressin avp system,arginine vasopressin AVP system
NEW05708,CHEMICAL,selective vasopressin type 1a receptor agonist selepressin,selective vasopressin type 1a receptor agonist selepressin
NEW05711,CHEMICAL,"cyclic adenosine 3',5'-phosphate","cyclic adenosine 3',5'-phosphate"
NEW05712,CHEMICAL,intracellular calcium homeostasis,intracellular calcium homeostasis
NEW05713,CHEMICAL,arginine vasopressin v2 receptor antagonist,arginine vasopressin V2 receptor antagonists
http://purl.obolibrary.org/obo/CHEBI_37955,BIOCHEMICAL,h1-receptor antagonist,classical antihistaminics|H1-receptor blockers|H1 receptor blockaders|antagonists OPC-31260|H1-receptor antagonists|classical antihistamines|H1 antihistaminics|H1-receptor blocker|H1 receptor antagonists
NEW05714,BIOCHEMICAL,v2 receptor antagonist,V2 receptor antagonists
D000077602,CHEMICAL,Tolvaptan,"7-Chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1H-1-benzazepine|OPC41061|OPC 41061|Samsca|OPC-41061|tolvaptan"
NEW05716,CHEMICAL,arachis hypogaea l. peanut leaf,Arachis hypogaea L. peanut leaf
NEW05718,DISEASE,high frequency stimulation,high frequency stimulation|HFS
NEW05723,CHEMICAL,n-cadherin/β-catenin,N-cadherin/β-catenin
D053583,CHEMICAL,Interleukin-1beta,Interleukin 1beta|Interleukin-1 beta|IL-1 beta|interleukin-1β|Interleukin 1 beta|Catabolin
NEW05725,CHEMICAL,l-α-aminoadipate,l-α-aminoadipate
NEW05726,CHEMICAL,reserpine model,reserpine model
C023754,CHEMICAL,tizanidine [Supplementary Concept],Clonidine/analogs  and  derivatives|tizanidine
NEW05730,CHEMICAL,aliphatic halogenated hydrocarbon,aliphatic halogenated hydrocarbons
NEW05732,CHEMICAL,signal-transducing guanine nucleotide-binding g protein,signal-transducing guanine nucleotide-binding G proteins
NEW05733,CHEMICAL,reduce glutamate uptake activity,reduced glutamate uptake activity
NEW05735,BIOCHEMICAL,botulinum toxin therapy,botulinum toxin therapy
NEW05736,CHEMICAL,≤,≤
NEW05738,DISEASE,juvenile hd onset,juvenile HD onset
NEW05739,DISEASE,spider envenoming,spider envenoming
http://purl.obolibrary.org/obo/CL_0000540,CHEMICAL,neuron,glycine/GABA neurons
D012019,DISEASE,Reflex Sympathetic Dystrophy,"Reflex Sympathetic Dystrophies|Sympathetic Reflex Dystrophia|Sympathetic Reflex Dystrophias|Atrophy, Sudek|Complex regional pain syndrome|Atrophy, Sudek's|RSD (Reflex Sympathetic Dystrophy)|Reflex Dystrophia, Sympathetic|Pain Syndrome Type I, Regional, Complex|Cervical Sympathetic Dystrophies|Pain Syndrome Type I, Complex Regional|Atrophies, Sudek's|RSDs (Reflex Sympathetic Dystrophy)|Complex Regional Pain Syndrome, Type I|Shoulder-Hand Syndromes|Reflex Sympathetic Dystrophy Syndrome|Sudek's Atrophy|Syndrome, Shoulder-Hand|Dystrophies, Reflex Sympathetic|Shoulder Hand Syndrome|Sympathetic Dystrophy, Reflex|Sudek's Atrophies|Algodystrophy|Dystrophies, Cervical Sympathetic|Cervical Sympathetic Dystrophy|Algodystrophic Syndrome|Dystrophy, Cervical Sympathetic|Sudeks Atrophy|Syndrome, Algodystrophic|Shoulder-Hand Syndrome|CRPS Type Is|Type I, CRPS|Sympathetic Dystrophies, Cervical|Sympathetic Dystrophies, Reflex|CRPS|Syndromes, Shoulder-Hand|CRPS Type I|Dystrophy, Reflex Sympathetic|Sympathetic Dystrophy, Cervical|Sudek Atrophy|Type I Complex Regional Pain Syndrome|Algodystrophies|Syndrome, Reflex Sympathetic Dystrophy"
D020177,DISEASE,Idiopathic Hypersomnia,"Hypersomnolence, Idiopathic CNS|Idiopathic Hypersomnias|Hypersomnia, Idiopathic|Hypersomnias, Idiopathic|CNS Hypersomnolence, Idiopathic|Hypersomnolences, Idiopathic|Hypersomnolence, Idiopathic|Idiopathic Hypersomnolence|hypersomnia|Hypersomnolence, CNS, Idiopathic|Idiopathic Hypersomnolences|Hypersomnolences, Idiopathic CNS|Idiopathic Central Nervous System Hypersomnolence|Idiopathic CNS Hypersomnolence|Idiopathic CNS Hypersomnolences|CNS Hypersomnolences, Idiopathic"
D013747,CHEMICAL,Tetrabenazine,tetrabenazine|Nitoman|Xenazine
NEW05759,DISEASE,initial infection,initial infection
NEW05761,CHEMICAL,topical aluminum salt,topical aluminum salts
NEW05762,DISEASE,moderate hypertension,moderate hypertension
NEW05764,CHEMICAL,artificial food coloring,AFCs|artificial food colorings
NEW05765,BIOCHEMICAL,artificial food coloring,artificial food colorings
NEW05767,DISEASE,more punde patient,more punding patients
NEW00632,CHEMICAL,θ-band,θ-band|p<0.01
http://purl.obolibrary.org/obo/CHEBI_37886,BIOCHEMICAL,adrenergic agonist,Alpha-2 adrenergic agonists|adrenergic agonists|adrenomimetics|adrenoceptor agonists|adrenergic receptor agonist|adrenomimetic
D063386,BIOCHEMICAL,Cannabinoid Receptor Agonists,"Agonists, Cannabinoid|Activators, Cannabinoid Receptor|Receptor Agonists, Cannabinoid|Agonist, Cannabinoid|Agonists, Cannabinoid Receptor|Cannabinoid Receptor Agonist|Cannabinoid Receptor Activators|Cannabinoid Agonist|Cannabinoid Agonists|Receptor Agonist, Cannabinoid|Agonist, Cannabinoid Receptor|Receptor Activators, Cannabinoid|cannabinoid receptor agonists"
NEW05772,CHEMICAL,cannabis exposure,cannabis exposure
NEW05773,MENTAL_HEALTH,psychosis onset,psychosis onset
NEW05774,MENTAL_HEALTH,full schizophrenia,full schizophrenia
NEW05776,CHEMICAL,heptahelical serotonin 2a receptor,heptahelical serotonin 2A receptors
D055809,DISEASE,Illness Behavior,"Behaviors, Sickness|illness|Sickness Behavior|Behavior, Sickness|Illness Behaviors|Behaviors, Illness|Sickness Behaviors|Behavior, Illness"
NEW05779,BIOCHEMICAL,agonist infusion,agonists infusion
NEW05780,CHEMICAL,chronic bicuculline infusion,chronic bicuculline infusion
NEW05785,CHEMICAL,levodopa therapy,Levodopa therapy
NEW05787,DISEASE,hypocretin-ligand deficiency,hypocretin-ligand deficiency
NEW05788,CHEMICAL,dysregulate gabab receptor signaling,dysregulated GABAB receptor signaling
NEW05789,CHEMICAL,gabab receptor,GABAB receptor
NEW05790,BIOCHEMICAL,numerous agonist,Numerous agonists
NEW05791,CHEMICAL,endocannabinoid cannabinoid,endocannabinoids cannabinoids
NEW05792,CHEMICAL,aea signaling,AEA signaling
NEW05793,BIOCHEMICAL,chronic antipsychotic drug treatment,Chronic antipsychotic drug treatment
NEW05794,CHEMICAL,gamma-aminobutyric acid gaba agonist drug,Gamma-aminobutyric acid GABA agonist drugs
NEW05795,CHEMICAL,5-ht neuron,5-HT neurons
NEW05796,CHEMICAL,gabab receptor-based drug,GABAB receptor-based drugs
NEW05797,CHEMICAL,traditional antidepressant,traditional antidepressants
NEW05798,CHEMICAL,glucagon-like peptide functional agonist,glucagon-like peptide functional agonists
NEW05800,DISEASE,new hypoglycemic drug,New hypoglycemic drugs
NEW05801,CHEMICAL,glp-1 functional agonist,GLP-1 functional agonists
NEW05806,BIOCHEMICAL,synthetic agonist,synthetic agonists
NEW04515,CHEMICAL,dopamine function,dopamine function
NEW05809,MENTAL_HEALTH,bipolar depression imaging study,bipolar depression imaging studies
NEW05812,CHEMICAL,increase striatal dopamine transporter level,increased striatal dopamine transporter levels
NEW05813,MENTAL_HEALTH,mania dat blockade,mania DAT blockade
http://purl.obolibrary.org/obo/DOID_14761,DISEASE,greig cephalopolysyndactyly syndrome,polysyndactyly with peculiars skull shape|hyperinsulinism/hyperammonemia HI/HA syndrome
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Hypersexuality,DISEASE,hypersexuality,hypersexuality
http://purl.obolibrary.org/obo/DOID_10937,MENTAL_HEALTH,impulse control disorder,Impulse control disorder
NEW05815,DISEASE,impulsive aggression,Impulsive aggression
NEW05817,DISEASE,irresistible sleep episode,irresistible sleep episodes
http://purl.obolibrary.org/obo/DOID_3109,DISEASE,idiopathic cd4-positive t-lymphocytopenia,idiopathic SRED
NEW05818,DISEASE,rls-related sred,RLS-related SRED
NEW05819,BIOCHEMICAL,thyromimetic,thyromimetics
C526273,CHEMICAL,"3-((3,5-dibromo-4-(4-hydroxy-3-(1-methylethyl)phenoxy)phenyl)amino)-3-oxopropanoic acid [Supplementary Concept]",KB2115|Anilides
NEW05823,BIOCHEMICAL,orexin agonist,orexin agonists
NEW05824,CHEMICAL,5-ht receptor-mediated signal transduction system,5-HT receptor-mediated signal transduction systems
http://purl.obolibrary.org/obo/CHEBI_65254,BIOCHEMICAL,lrh-1 agonist,NR5A2 agonists|NR5A2 agonist|PPARs agonists|nuclear receptor subfamily 5 group A member 2 agonists|LRH-1 agonists|liver receptor homologue-1 agonist|liver receptor homologue-1 agonists|nuclear receptor subfamily 5 group A member 2 agonist
http://purl.obolibrary.org/obo/CHEBI_140535,CHEMICAL,trpv1 agonist,transient receptor potential vanilloid 1 agonists|AVP agonists|transient receptor potential cation channel subfamily V member 1 agonists|vanilloid receptor 1 agonist|capsaicin receptor agonist|capsaicin receptor agonists|TRPV1 agonists|vanilloid receptor 1 agonists|transient receptor potential vanilloid 1 agonist|transient receptor potential cation channel subfamily V member 1 agonist
NEW05830,BIOCHEMICAL,v1a receptor antagonist,V1a receptor antagonists
NEW05831,CHEMICAL,y2r agonist npy,Y2R agonist NPY
D020372,CHEMICAL,Dexfenfluramine,"Redux|Dexfenfluramine|Dexfenfluramine Hydrochloride|Hydrochloride, Dexfenfluramine"
NEW05832,CHEMICAL,dextrorotatory isomer,dextrorotatory isomer
NEW05833,BIOCHEMICAL,interventional drug trial,interventional drug trials
NEW05835,CHEMICAL,conclusion Cabergoline,Conclusions Cabergoline
NEW05837,BIOCHEMICAL,gut release hormone,gut released hormone
http://purl.obolibrary.org/obo/CHEBI_71196,CHEMICAL,glucagon-like peptide-1 receptor agonist,GLP-1RAs|GLP-1 receptor agonists|Glucagon-like peptide-1 receptor agonists|glucagon-like peptide-1 receptor agonists|GLP-1 receptor agonist
D000077270,CHEMICAL,Exenatide,"ITCA 650|Exendin 4|exenatide|Byetta|AC 2993|Ex4 Peptide|Peptide, Ex4|Bydureon|Exendin-4|AC 2993 LAR"
NEW05842,CHEMICAL,once-weekly extended-release subcutaneous exenatide n,once-weekly extended-release subcutaneous exenatide n
NEW05843,BIOCHEMICAL,glucagon peptide glp-1 receptor agonist,Glucagon peptide GLP-1 receptor agonists
NEW05844,CHEMICAL,exenatide group,exenatide group
NEW05847,BIOCHEMICAL,glucagon-like peptide glp-1 receptor agonist,Glucagon-like peptide GLP-1 receptor agonists
D000068900,CHEMICAL,Sitagliptin Phosphate,"Phosphate, Sitagliptin|Sitagliptin Monophosphate Monohydrate|MK 0431|Anhydrous, Sitagliptin Phosphate|Sitagliptin|Monophosphate Monohydrate, Sitagliptin|Monohydrate, Sitagliptin Monophosphate|Sitagliptin Phosphate Monohydrate|Monohydrate, Sitagliptin Phosphate|Phosphate Monohydrate, Sitagliptin|MK0431|MK-0431|Phosphate Anhydrous, Sitagliptin|Januvia|Sitagliptin Phosphate Anhydrous|sitagliptin|0431, MK|4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine"
NEW05849,BIOCHEMICAL,glp-1 agonist,GLP-1 agonists
NEW05850,CHEMICAL,gsh concentration,GSH concentrations
C116241,DISEASE,"MICU1 protein, human [Supplementary Concept]",Cation Transport Proteins|atopy|Mitochondrial Membrane Transport Proteins|Calcium-Binding Proteins
NEW05853,CHEMICAL,pyrrolidine group,pyrrolidine groups
NEW05854,BIOCHEMICAL,dop agonist,DOP agonists
C088464,CHEMICAL,"4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide [Supplementary Concept]",SNC80|Piperazines|Benzamides
NEW05856,BIOCHEMICAL,α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (ampa)/kainite receptor antagonist cnqx,α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainite receptor antagonist CNQX
C000610195,CHEMICAL,"17-cyclopropylmethyl-3-hydroxy-4,5-epoxy-7,8-en-6-((3'-iodo)benzamido)morphinan [Supplementary Concept]",Morphinans|MP1104
NEW05858,CHEMICAL,pyridomorphinan,pyridomorphinans
NEW05861,BIOCHEMICAL,dor agonist,DOR agonist
C555233,CHEMICAL,KNT 127 [Supplementary Concept],Morphinans|KNT-127
http://purl.obolibrary.org/obo/CHEBI_53115,CHEMICAL,8-(3-chlorostyryl)caffeine,"co-perfusion|8-[(E)-2-(3-chlorophenyl)ethenyl]-1,3,7-trimethyl-3,7-dihydro-1H-purine-2,6-dione|CSC"
http://purl.org/sig/ont/fma/fma276189,CHEMICAL,dorsolateral prefrontal cortex,DLPFC|PL-PFC|DL-PFC|prelimbic medial prefrontal cortex
C473195,CHEMICAL,(-)-alpha-pinene synthase [Supplementary Concept],Carbon-Oxygen Lyases|α-pinene
D004923,CHEMICAL,Erythrosine,"erythrosine|Erythrosine B|F D  and  C #3|FD  and  C Red No. 3|FDC Red No. 3|Erythrosin B|Erythrosin|2',4',5',7'-Tetraiodofluorescein"
D013645,CHEMICAL,Tartrazine,"Tartrazine Barium (2:3)|FD and C Yellow No. 5|Barium, Tartrazine|FD  and  C Yellow No. 5|Tartrazine Barium|tartrazine"
NEW05865,BIOCHEMICAL,nutraceutical coffee,nutraceutical coffee
NEW05867,BIOCHEMICAL,gut-derived uremic toxin,gut-derived uremic toxins
NEW05869,BIOCHEMICAL,biased cb1r inverse agonist,biased CB1R inverse agonists
NEW05871,BIOCHEMICAL,putative cb1r neutral antagonist,putative CB1R neutral antagonists
C515162,CHEMICAL,"5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole [Supplementary Concept]",LH-21|Triazoles
NEW05873,BIOCHEMICAL,hybrid cb1r/inos antagonist,hybrid CB1R/iNOS antagonist
NEW05875,BIOCHEMICAL,dual-target peripheral cb1r/inos antagonist,dual-target peripheral CB1R/iNOS antagonists
NEW05876,BIOCHEMICAL,generation cb1r antagonists/inverse agonist,generation CB1R antagonists/inverse agonists
C521311,CHEMICAL,N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide [Supplementary Concept],Pyridines|Amides|taranabant
http://purl.obolibrary.org/obo/CHEBI_90847,BIOCHEMICAL,inverse agonist,CB1R inverse agonists|inverse agonists
NEW05877,BIOCHEMICAL,neutral cb1r antagonist,neutral CB1R antagonists
NEW05878,BIOCHEMICAL,novel selective cb1 receptor antagonist,novel selective CB1 receptor antagonists
NEW05879,CHEMICAL,Combretum zeyheri,Combretum zeyheri
NEW05880,CHEMICAL,th target gene,TH target genes
NEW05882,BIOCHEMICAL,thyroid hormone transporter monocarboxylate transporter,thyroid hormone transporter monocarboxylate transporter
http://purl.obolibrary.org/obo/CHEBI_47958,BIOCHEMICAL,nicotinic acetylcholine receptor agonist,muscarinic agonists|Alpha7 nicotinic acetylcholine receptor agonists|nicotinic agonist|nicotinic agonists|nicotinic acetylcholine receptor agonists
C506289,CHEMICAL,"8-(4-(3-(5-fluoro-1H-indol-3-yl)propyl)piperazin-1-yl)-4H-benzo(1,4)oxazin-2-methyl-3-one [Supplementary Concept]",Benzoxazines|SLV314|Indoles
http://purl.obolibrary.org/obo/CHEBI_131787,CHEMICAL,dopamine receptor d2 antagonist,dopamine D2 receptor agonists|D2 receptor antagonist|D2R antagonist
NEW05886,CHEMICAL,l-dopa agonist,l-dopa agonists
NEW05887,DISEASE,l-dopa-induced enhancement,l-dopa-induced enhancement
NEW05889,BIOCHEMICAL,d2 agonist quinpirole,D2 agonist quinpirole
D011569,MENTAL_HEALTH,Psychiatric Status Rating Scales,Katz Adjustment Scales|Factor Construct Rating Scales (FCRS)|Edinburgh Postnatal Depression Scale|Wittenborn Scales|Mini International Neuropsychiatric Interview|Depression Scale|Lorr's Inpatient Multidimensional Psychiatric Rating Scale
NEW05894,CHEMICAL,levodopa equivalent daily dose,levodopa equivalent daily doses
NEW05896,DISEASE,postnatal forebrain,postnatal forebrain
NEW05898,MENTAL_HEALTH,transcriptional repression,Transcriptional repression
NEW05899,CHEMICAL,dopamine replacement,dopamine replacement
NEW05901,CHEMICAL,plasma testosterone,plasma testosterone
D035842,CHEMICAL,Research Subjects,"Subject, Human|MDMA users|Human Subject|Subjects, Human|subjects|Subject, Research|Research Subject|Subjects, Research|Human Subjects"
NEW05907,CHEMICAL,adjunctive rotigotine,adjunctive rotigotine
D012148,DISEASE,Restless Legs Syndrome,"Syndrome, Restless Leg|Syndrome, Wittmaack-Ekbom|Willis Ekbom Disease|Syndrome, Willis Ekbom|Syndrome, Willis-Ekbom|Disease, Willis Ekbom|Wittmaack Ekbom Syndrome|restless legs syndrome|Syndrome, Wittmaack Ekbom|Willis-Ekbom Syndrome|Restless Legs|Wittmaack-Ekbom Syndrome|Restless Leg Syndrome|Willis-Ekbom Disease|Willis Ekbom Syndrome|Disease, Willis-Ekbom"
NEW05910,MENTAL_HEALTH,dopaminergic-induced hallucination,dopaminergic-induced hallucinations
NEW05912,CHEMICAL,dl-mph,dl-MPH
NEW05913,DISEASE,depressive dose,depressive dose
NEW05916,CHEMICAL,mph-ethanol interaction,MPH-ethanol interactions
NEW05918,DISEASE,eph preclinical neuropharmacology,EPH preclinical neuropharmacology
NEW05919,CHEMICAL,dopamine system,dopamine system
NEW05920,CHEMICAL,dopamine d3 receptor gene,dopamine D3 receptor gene
NEW05921,BIOCHEMICAL,d3 antagonist,D3 antagonists
NEW05922,CHEMICAL,Camfetamine,Camfetamine
NEW05923,CHEMICAL,(phenylisopropyl)n-phenylcarbamoylsydnonimine,(phenylisopropyl)N-phenylcarbamoylsydnonimine
C083949,CHEMICAL,sydnogluton [Supplementary Concept],Sydnones|Drug Combinations|Glutamates|Sydnocarb
http://purl.obolibrary.org/obo/CHEBI_35499,DISEASE,hallucinogen,psychostimulants|hallucinogenic drugs|hallucinogenic agents|psychedelics|hallucinogens|psychedelic agents
NEW05926,DISEASE,acute neurotoxicity,acute neurotoxicity
NEW05927,BIOCHEMICAL,alpha-tocopherol level,alpha-tocopherol level
C490598,DISEASE,"SYD-2 protein, C elegans [Supplementary Concept]",Caenorhabditis elegans Proteins|Intercellular Signaling Peptides and Proteins|SYD
C082097,BIOCHEMICAL,"tocotrienol, delta [Supplementary Concept]",tocotrienol|Vitamin E/analogs  and  derivatives
NEW05931,CHEMICAL,acid l-tryptophan,acid L-tryptophan
NEW05932,CHEMICAL,nootropic agent piracetam,nootropic agent piracetam
D018038,CHEMICAL,Sodium Selenite,"Selenite, Sodium|Selenous Acid, Disodium Salt|Pentahydrate, Sodium Selenite|Sodium Biselenite|Biselenite, Sodium|Selenous Acid Disodium Salt|Disodium Selenite|Sodium Selenite Pentahydrate|Selenite Pentahydrate, Sodium|Selenite, Disodium|Monosodium Selenite|Selenite, Monosodium|sodium selenite"
NEW05933,NUTRITION,antioxidant alpha-tocopherol,antioxidants alpha-tocopherol
D041981,DISEASE,Gastrointestinal Tract,Digestive Tract|Digestive Tracts|Gastrointestinal Tracts|GI Tract|gastrointestinal tract|GI Tracts
NEW05935,BIOCHEMICAL,less drug transfer,less drug transfer
NEW05936,CHEMICAL,α2-adrenoblocker,α2-adrenoblockers
NEW05938,CHEMICAL,ethanol toxicity,ethanol toxicity
NEW05940,DISEASE,hyperornithinemia-hyperammonemia-homocitrullinuria hhh syndrome,Hyperornithinemia-hyperammonemia-homocitrullinuria HHH syndrome
C001352,CHEMICAL,homocitrulline [Supplementary Concept],Citrulline/analogs  and  derivatives|homocitrulline
D065108,CHEMICAL,Ornithine Decarboxylase Inhibitors,"Ornithine|Decarboxylase Inhibitors, Ornithine|Inhibitors, Ornithine Decarboxylase"
NEW05941,BIOCHEMICAL,tocopherol binder,tocopherol binders
NEW05943,BIOCHEMICAL,low-serum vitamin e,low-serum vitamin E
NEW05945,DISEASE,severe paraphilia,severe paraphilia
NEW05947,BIOCHEMICAL,antiandrogen treatment,antiandrogen treatment
NEW05948,DISEASE,secondary amenorrhea,secondary amenorrhea
NEW05952,CHEMICAL,central 5-ht,central 5-HT
D015813,BIOCHEMICAL,Substance Abuse Detection,"Drug Abuse Detection|Drug Abuse Testings|Substance Abuse Testing|Screenings, Drug Abuse|Detections, Illicit Drug|Detection, Substance Abuse|Testings, Substance Abuse|Testing, Street Drug|Illicit Drug Detection|Drug Testings, Illicit|Street Drug Detection|Street Drug Testing|Illicit Drug Detections|Drug Abuse Detections|Detection, Street Drug|Street Drug Testings|Testings, Drug Abuse|street drug|Drug Testing, Illicit|Detections, Street Drug|Street Drug Detections|Substance Abuse Testings|Drug Abuse Screenings|Testings, Street Drug|Substance Abuse Detections|Detections, Substance Abuse|Detection, Illicit Drug|Detections, Drug Abuse|Screening, Drug Abuse|Testing, Substance Abuse|Drug Abuse Testing|Detection, Drug Abuse|Drug Abuse Screening|Testing, Illicit Drug|Illicit Drug Testings|Testing, Drug Abuse|Illicit Drug Testing|Testings, Illicit Drug"
NEW05955,CHEMICAL,partial serotonin agonist meta-chlorophenylpiperazine,partial serotonin agonist meta-chlorophenylpiperazine
NEW05956,CHEMICAL,serotonin pathway,Serotonin pathways
NEW05958,CHEMICAL,serotonin 5-ht 2a receptor,serotonin 5-HT 2A receptor
NEW05961,MENTAL_HEALTH,headache response,headache responses
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Migraine_Headache,DISEASE,migraine headache,severe migraine-like headaches
NEW05963,CHEMICAL,5-ht pathway,5-HT pathways
NEW05964,DISEASE,hi insult,HI insult
NEW05965,DISEASE,Plinia trunciflora fruit extract,PTE|Plinia trunciflora fruit extract
NEW05967,NUTRITION,lithium clinic,lithium clinics
NEW05969,DISEASE,climacterium,Climacterium
NEW05971,CHEMICAL,Vitex fruit extract,Vitex fruit extract
http://purl.obolibrary.org/obo/CHEBI_35477,CHEMICAL,antimanic drug,anti-depressant drugs|antimanic agent|antimanics|antimanic drugs
NEW05974,CHEMICAL,excessive ammonia content,Excessive ammonia content
NEW05978,CHEMICAL,bergamot essential oil,Bergamot essential oil
http://purl.obolibrary.org/obo/DOID_14755,CHEMICAL,argininosuccinic aciduria,arginosuccinase deficiency|argininosuccinic acidemia|deficiency of argininosuccinate lyase|glutaric aciduria type I. Glutaric acid|Argininosuccinate lyase deficiency
NEW05980,CHEMICAL,gte fruit,GTE fruit
NEW05981,CHEMICAL,ethanol extract,ethanol extract
NEW05982,CHEMICAL,Grewia tenax,Grewia tenax
NEW05983,CHEMICAL,several Cecropiaceae specie,Several Cecropiaceae species
NEW05984,DISEASE,p. alata,P. alata
C000179,CHEMICAL,N-acetylaspartate [Supplementary Concept],Aspartic Acid/analogs  and  derivatives|NAA|N-acetyl aspartate
D010725,CHEMICAL,Phosphocreatine,"Phosphocreatine, Disodium Salt|Creatine Phosphate|phosphocreatine|Neoton|Phosphate, Creatine|Phosphorylcreatine|Disodium Salt Phosphocreatine|PCr"
http://purl.obolibrary.org/obo/DOID_890,DISEASE,mitochondrial encephalomyopathy,Mitochondrial neurogastrointestinal encephalomyopathy
D011741,CHEMICAL,Pyrimidine Nucleosides,"nucleosides|Nucleosides, Pyrimidine"
NEW05987,DISEASE,preexist psychiatric disorder,preexisting psychiatric disorders
NEW05991,CHEMICAL,aqueous virgin olive oil,aqueous virgin olive oil|VOO
NEW05993,CHEMICAL,its 's phenolic compound,phenolic compound
NEW05994,DISEASE,chronic unpredictable stressor,Chronic unpredictable stressors
NEW05996,CHEMICAL,mesb,MESB
NEW05997,CHEMICAL,mesb-treated mouse,MESB-treated mice
NEW05999,CHEMICAL,bilgeriana,bilgeriana|MESB
NEW06001,CHEMICAL,phenolic glycoside,phenolic glycoside
C583105,CHEMICAL,4-(4'-hydroxybenzyl)phenyl glucoside [Supplementary Concept],Gastrodin|Phenyl Ethers|Glucosides
C555358,CHEMICAL,PF 592379 [Supplementary Concept],Morpholines|Aminopyridines|PF-592379
D013729,CHEMICAL,Terpenes,Terpene|Isoprenoids|terpenes|Isoprenoid|Terpenoid|Terpenoids
http://purl.obolibrary.org/obo/CHEBI_166890,CHEMICAL,phenolic acid,phenolcarboxylic acids|phenolic acids
D035264,CHEMICAL,Flowers,"Bloom, Plant|Plant Styles|Ovary, Plant|Flower Filament|Plant Sepals|Plant Stigma|Blooms, Plant|Stamens, Plant|Plant Stamen|Ovaries, Plant|Calyx, Plant|Cannabis extracts|flowers|Plant Anthers|Plant Blooms|Styles, Plant|Plant Stigmas|Sepal, Plant|Petals, Plant|Anther, Plant|Calyxs, Plant|Plant Style|Flower Filaments|Stamen, Plant|Filament, Flower|Plant Ovaries|Flower|Blossom|Pistil|Pistils|Plant Calyxs|Style, Plant|Plant Carpal|Blossoms|Carpals, Plant|Plant Sepal|Plant Petal|Plant Calyx|Corollas, Plant|Carpal, Plant|Stigmas, Plant|Plant Bloom|Corolla, Plant|Plant Ovary|Anthers, Plant|Plant Anther|Petal, Plant|Filaments, Flower|Stigma, Plant|Plant Corolla|Sepals, Plant|Plant Petals|Plant Carpals|Plant Stamens|Plant Corollas"
D000069056,CHEMICAL,Lurasidone Hydrochloride,"SM 13496|SM13,496|13496, SM|SM-13,496|lurasidone|SM13496|SM-13496|SM 13,496|N-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl)-1-cyclohexylmethyl)-2,3-bicyclo(2.2.1)heptanedicarboximide|Latuda|Hydrochloride, Lurasidone|Lurasidone HCl|HCl, Lurasidone|Lurasidone"
NEW06006,CHEMICAL,sertindole effect,sertindole effect
NEW06012,CHEMICAL,brain histamine,brain histamine
NEW06013,CHEMICAL,histidine decarboxylase null,histidine decarboxylase null
NEW06019,CHEMICAL,serotonine agonist,serotonine agonist
C497736,BIOCHEMICAL,phytoalexin spirobrassinin [Supplementary Concept],Thiazoles|phytoalexin|Spiro Compounds
C044615,CHEMICAL,urodiolenone [Supplementary Concept],urodiolenone|Sesquiterpenes
NEW06024,DISEASE,cocaine-induced increase,cocaine-induced increases
NEW06027,BIOCHEMICAL,cb1 receptor-neutral antagonist,CB1 receptor-neutral antagonists
NEW06029,CHEMICAL,β-neurexin,β-neurexins
NEW06032,CHEMICAL,central cannabinoid cb(1 receptor,central cannabinoid CB(1 receptor
http://purl.obolibrary.org/obo/CHEBI_73416,BIOCHEMICAL,cb1 receptor antagonist,CB1R antagonist|type 1 cannabinoid receptor antagonists|CB1R antagonists|CB1 receptor agonists|CB1 receptor antagonist|type 1 cannabinoid receptor antagonist|cannabinoid receptor type 1 antagonist|CB1 receptor antagonists|cannabinoid receptor type 1 antagonists
NEW06033,BIOCHEMICAL,act antagonist,acting antagonists
NEW06035,BIOCHEMICAL,first-in-class cb1r antagonist/inverse agonist,first-in-class CB1R antagonist/inverse agonist
NEW06036,MENTAL_HEALTH,stress-induced analgesia,stress-induced analgesia
NEW06037,BIOCHEMICAL,endogenous cb1 receptor agonist,endogenous CB1 receptor agonists
D012702,CHEMICAL,Serotonin Antagonists,"Blocker, Serotonin Receptor|5 HT Antagonists|Receptor Blockers, Serotonin|Serotonin Receptor Antagonist|5-HT Antagonists|Blockers, Serotonin Receptor|Serotonin Receptor Blocker|Antiserotonergic Agent|Blockaders, Serotonin|Antagonist, Serotonin Receptor|Receptor Antagonist, Serotonin|Antagonists, 5-Hydroxytryptamine|Agents, Antiserotonergic|Antagonists, Serotonin Receptor|5 Hydroxytryptamine Antagonists|Antagonists, 5-HT|Antagonists, 5 HT|Antagonists, 5 Hydroxytryptamine|Serotonin Receptor Blockers|Antagonists, Serotonin|serotonin antagonist|Serotonin Blockaders|Antagonist, 5-HT|Serotonin Receptor Antagonists|Antiserotonergic Agents|Receptor Antagonists, Serotonin|Antagonist, 5-Hydroxytryptamine|Agent, Antiserotonergic|Receptor Blocker, Serotonin|5 HT Antagonist|5-Hydroxytryptamine Antagonist|5-HT Antagonist|5-Hydroxytryptamine Antagonists|Blockader, Serotonin|Antagonist, Serotonin|Serotonin Blockader|Serotonin Antagonist|5 Hydroxytryptamine Antagonist"
http://purl.obolibrary.org/obo/CHEBI_135470,CHEMICAL,indoramin,Wy 21901|Wy21901|Wy-21901|dl-Propranolol|indoramine
NEW06041,CHEMICAL,5meodmt,5MEODMT
NEW06045,BIOCHEMICAL,novel drug,novel drug
NEW06046,DISEASE,obsessive-compulsive symptom,obsessive-compulsive symptoms|OCS
NEW06049,BIOCHEMICAL,specific agonist,specific agonists
D020182,MENTAL_HEALTH,"Sleep Apnea, Central","Central Apneas|Sleep Apneas, Central|Central Sleep Apnea Syndrome|Central Sleep Apnea, Primary|Central Sleep Apnea, Secondary|Sleep-Disordered Breathings, Central|Ondine Syndrome|Apnea, Sleep, Central|Hypoventilations, Central Alveolar|Breathings, Central Sleep-Disordered|Central Sleep Disordered Breathing|Alveolar Hypoventilation, Central|Alveolar Hypoventilations, Central|Central Sleep-Disordered Breathing|Apneas, Central Sleep|Primary Sleep Apneas of Newborn|Sleep Apnea, Newborn, Primary|Primary Central Sleep Apnea|Apnea, Central|Sleep apnea|Sleep Apnea, Lethal Central|Central Alveolar Hypoventilation|Sleep Disordered Breathing, Central|Central Alveolar Hypoventilation Syndrome|Apnea, Central Sleep|Central Sleep Apnea|Newborn Primary Sleep Apneas|Central Apnea|Sleep-Disordered Breathing, Central|Central Sleep Apneas|Apneas, Central|Breathing, Central Sleep-Disordered|Secondary Central Sleep Apnea|Central Sleep-Disordered Breathings|Hypoventilation, Central Alveolar"
NEW06053,CHEMICAL,chronic intermittent hypoxia,chronic intermittent hypoxia|CIH
D000072656,DISEASE,Breast Cancer Lymphedema,"Lymphedema, Breast Cancer|Breast Cancer Lymphedemas|Post mastectomy Lymphedema|Breast Cancer Treatment Related Lymphedema|Postmastectomy Lymphedemas|Lymphedemas, Postmastectomy|Lymphedema, Postmastectomy|Breast Cancer Related Lymphedema|Breast Cancer-Related Arm Lymphedema|Breast Cancer Treatment-Related Lymphedema|breast cancer|Breast Cancer Related Arm Lymphedema|Lymphedema, Post-mastectomy|Post-mastectomy Lymphedemas|Postmastectomy Lymphedema|Post-mastectomy Lymphedema"
NEW06055,CHEMICAL,ai treatment,AI treatment
NEW06056,CHEMICAL,low testosterone level,Low testosterone levels
NEW06057,DISEASE,iatrogenic adrenal insufficiency secondary,Iatrogenic adrenal insufficiency secondary
NEW06060,DISEASE,female depressed patient,female depressed patients
NEW06061,DISEASE,female bipolar patient,female bipolar patients
NEW06062,DISEASE,mdd group,MDD group
NEW06064,MENTAL_HEALTH,stress-mediated affective disorder,stress-mediated affective disorders
C101530,BIOCHEMICAL,CRF receptor type 1 [Supplementary Concept],"Receptors, Corticotropin-Releasing Hormone|Corticotropin-releasing hormone receptor"
NEW06069,BIOCHEMICAL,increase androgen,increased androgens
D000153,DISEASE,Acne Keloid,"Keloidal Acne|Dermatitis Papillaris Capillitius|Folliculitis Keloidalis|Keloidal Acnes|Lichen Keloidalis Nuchae|Capillitii, Dermatitis Papillaris|Acne, Nuchal Keloid|Dermatitis Papillaris Capillitii|Papillaris Capillitii, Dermatitis|Acne Keloidalis|Keloids, Acne|Keloidalis Nuchae, Lichen|Nuchae, Lichen Keloidalis|Nuchal Keloid Acne|Acne, Keloidal|Acnes, Nuchal Keloid|Keloid, Acne|Keloidalis Nuchae, Folliculitis|Capillitius, Dermatitis Papillaris|Nuchal Keloid Acnes|Papillaris Capillitius, Dermatitis|Acne Keloids|Folliculitis Keloidalis Nuchae|Keloid Acnes, Nuchal|Keloid Acne, Nuchal|Nuchae, Folliculitis Keloidalis|acne"
NEW06070,CHEMICAL,novel d-amphetamine prodrug lisdexamfetamine,novel d-amphetamine prodrug lisdexamfetamine
http://purl.obolibrary.org/obo/DOID_11612,DISEASE,polycystic ovary syndrome,Polycystic ovaries|Stein-Leventhal syndrome|PCOS|Polycystic Ovarian disease|Stein-Leventhal synd.|polycystic ovary|Maternal polycystic ovary syndrome|Polycystic ovary syndrome|Multicystic ovaries
NEW06071,DISEASE,common metabolic disorder,common metabolic disorder
http://purl.obolibrary.org/obo/DOID_303,DISEASE,substance-related disorder,Many psychiatric disorders
NEW06073,DISEASE,psychiatric characteristic,psychiatric characteristics
NEW06074,DISEASE,idiopathic hirsutism,Idiopathic hirsutism
D012919,DISEASE,Social Behavior,"social behaviors|Behavior, Social|Behaviors, Social|Social Behaviors|Sociality"
http://purl.org/sig/ont/fma/fma54319,CHEMICAL,pubic hair,pubic hair
NEW06077,MENTAL_HEALTH,insulin resistance index,Insulin resistance index
D005247,MENTAL_HEALTH,Feeding Behavior,"Feeding Related Behavior|Feeding Patterns|Diet Habits|Habits, Diet|Eating Behaviors|Feeding-Related Behavior|Behavior, Feeding-Related|Habit, Food|Eating Behavior|Feeding Pattern|Feeding-Related Behaviors|Habit, Diet|Eating Habit|Pattern, Feeding|Habit, Eating|Food Habits|Eating Habits|Feeding Behaviors|Diet Habit|Behavior, Feeding|Food Habit|Dietary Habit|eating behaviors|Dietary Habits|Behavior, Eating|Habit, Dietary"
D000077339,CHEMICAL,Leflunomide,Leflunomide|N-(4-Trifluoromethyphenyl)-5-methylisoxazole-4-carboxamide|Arava|HWA-486|HWA 486|SU101|HWA486
http://purl.obolibrary.org/obo/CHEBI_50114,BIOCHEMICAL,estrogen,estrogenos|Oestrogen|oestrogene|estrogenes Hormon|oestrogenes|oestrogen|oestrogens|estrogene|Estrogene|estrogeno|Oestrogene|estrogenes|estrogens
NEW06081,CHEMICAL,long-term adt,Long-term ADT
NEW06082,CHEMICAL,dose- adt,dose- ADT
NEW06084,BIOCHEMICAL,complete androgen resistance,complete androgen resistance
NEW06085,BIOCHEMICAL,androgen therapy,androgen therapy
NEW06086,BIOCHEMICAL,androgen administration,androgen administration
NEW06090,CHEMICAL,vpa hepatotoxicity,VPA hepatotoxicity
NEW06093,DISEASE,direct neurotoxic effect,direct neurotoxic effect
NEW06094,BIOCHEMICAL,water-soluble vitamin,water-soluble vitamins
C022172,CHEMICAL,zotepine [Supplementary Concept],Dibenzothiepins|Zotepine
NEW06095,DISEASE,rs lps animal group,RS LPS animal groups
NEW06099,BIOCHEMICAL,leucocyte ascorbic acid level,leucocyte ascorbic acid level
C524644,CHEMICAL,Yi-Gan San [Supplementary Concept],"Yokukansan|YKS|Drugs, Chinese Herbal"
NEW06105,DISEASE,head-dipping behavior,head-dipping behaviors
http://purl.obolibrary.org/obo/CHEBI_64600,BIOCHEMICAL,c21-steroid hormone,corticoctropin-releasing hormone|C21-steroid hormones
NEW06108,BIOCHEMICAL,its 's endocrine mode,endocrine mode
NEW06113,CHEMICAL,water-soluble extract,HX106|water-soluble extracts
NEW06114,BIOCHEMICAL,excessive antibiotic,Excessive antibiotics
C074968,CHEMICAL,pentaacetyl geniposide [Supplementary Concept],geniposide|Iridoid Glucosides
NEW06116,DISEASE,non-celiac gluten sensitivity,Non-celiac gluten sensitivity
NEW06117,NUTRITION,wheat protein,wheat proteins
NEW06118,BIOCHEMICAL,food antigen,Food antigens
NEW06121,DISEASE,magnesium ion neuronal deficit,magnesium ion neuronal deficits
NEW06123,DISEASE,dietary deficiency,Dietary deficiencies
D008275,CHEMICAL,Magnesium Deficiency,"Deficiencies, Magnesium|magnesium deficiency|Deficiency, Magnesium|Magnesium Deficiencies"
NEW06124,DISEASE,non-celiac gluten sensitivity,non-celiac gluten sensitivity
D021182,NUTRITION,Wheat Hypersensitivity,"Wheat Allergy|Allergy, Wheat|Hypersensitivity, Wheat|Wheat Hypersensitivities|wheat|Wheat Allergies|Allergies, Wheat|Hypersensitivities, Wheat"
D008043,CHEMICAL,Linseed Oil,"Oil, Linseed|Oil, Flaxseed|flaxseed|Flaxseed Oil"
NEW06129,CHEMICAL,5α-reduced pregnane steroid,5α-reduced pregnane steroids
NEW06130,BIOCHEMICAL,pharmaceutical therapeutic,pharmaceutical therapeutic
NEW06132,BIOCHEMICAL,pharmaceutical pathway,pharmaceutical pathways
NEW06133,CHEMICAL,drospirenone/ethinylestradiol 3mg/20microg,Drospirenone/ethinylestradiol 3mg/20microg
NEW06135,DISEASE,psychosomatic health,psychosomatic health
NEW06137,BIOCHEMICAL,different progestogen,different progestogens
NEW06140,CHEMICAL,hrt hrt,HRT HRT
NEW06143,CHEMICAL,in ral,In RAL
D000535,CHEMICAL,Aluminum,Aluminium 27|Aluminum 27|Aluminium-27|Aluminum-27|aluminium
NEW06146,CHEMICAL,aluminium powder,aluminium powder
NEW06147,CHEMICAL,aluminium fume,aluminium fumes
NEW02975,BIOCHEMICAL,toxic agent,toxic agent
NEW06152,CHEMICAL,unregulated cytosolic dopamine,unregulated cytosolic dopamine
NEW06153,CHEMICAL,thallium poisoning,thallium poisoning
NEW02625,DISEASE,psychotic illness,psychotic illness
NEW06158,CHEMICAL,self-reported cannabis use,self-reported cannabis use
NEW06161,DISEASE,chemical poisoning,chemical poisoning
C034024,CHEMICAL,iodized salt [Supplementary Concept],"Sodium Chloride, Dietary|Iodine|iodized salt"
NEW06163,DISEASE,chronic cerebral hypoperfusion,chronic cerebral hypoperfusion
NEW06165,DISEASE,sciatic crush,sciatic crush
NEW06166,DISEASE,several nervous system injury model,Several nervous system injury models
NEW04094,DISEASE,diabetic rat,diabetic rats
NEW06167,NUTRITION,Angelica dahurica,Angelica dahurica
D001007,MENTAL_HEALTH,Anxiety,"Social Anxiety|Social Anxieties|Nervousness|Anxiousness|Anxieties, Social|nervousness|Angst|Hypervigilance|Anxiety, Social"
D010292,DISEASE,Paresthesia,"Painful Paresthesias|Paresthesia, Painful|Paresthesias|Paresthesias, Distal|Paresthesias, Painful|Formications|Paresthesia, Distal|Dysesthesias|Distal Paresthesia|Distal Paresthesias|Formication|Painful Paresthesia|Dysesthesia|paresthesia"
D065635,DISEASE,Benign Paroxysmal Positional Vertigo,"Recurrent Vertigos, Benign|Familial Vestibulopathy|Vertigo, Benign Recurrent|Recurrent Vertigo, Benign|Vertigo, Benign Paroxysmal Positional|Vestibulopathies, Familial|Benign Recurrent Vertigo|Benign Recurrent Vertigos|Familial Vestibulopathies|Vestibulopathy, Familial|Familial Benign Recurrent Vertigo|vertigo"
NEW04866,DISEASE,vaginal dryness,vaginal dryness
C574038,CHEMICAL,EstroG-100 [Supplementary Concept],Plant Extracts|EstroG-100
C532268,CHEMICAL,xiaoyaosan [Supplementary Concept],"XYS|Xiaoyaosan|Drugs, Chinese Herbal"
NEW00247,CHEMICAL,antidepressant effect,antidepressant effects
NEW06170,CHEMICAL,medicine Jangwonhwan,medicine Jangwonhwan
D015190,CHEMICAL,Blood Glucose Self-Monitoring,"Blood Sugar Self-Monitoring|Sugar Self-Monitoring, Blood|FBS|Home Blood Glucose Monitoring|Self Monitoring, Blood Glucose|Blood Glucose Self-Monitorings|Self-Monitoring, Blood Sugar|Blood Sugar Self Monitoring|Sugar Self-Monitorings, Blood|Glucose Self-Monitoring, Blood|Self-Monitorings, Blood Glucose|blood sugar|Self-Monitoring, Blood Glucose|Glucose Self-Monitorings, Blood|Glucose, Blood, Self-Monitoring|Blood Glucose Self Monitoring|Monitoring, Home Blood Glucose|Glucose, Blood, Self Monitoring|Blood Sugar Self-Monitorings|Self-Monitorings, Blood Sugar"
NEW06172,DISEASE,diabete animal model,diabetes animal model
NEW04513,BIOCHEMICAL,mood stabilizer,mood stabilizer
NEW06174,NUTRITION,combination     lithium,Combination    lithium
C000713787,DISEASE,rehmannia root [Supplementary Concept],Plant Extracts|Rehmannia|Radix Rehmanniae
NEW06178,CHEMICAL,lactulose pretreatment,lactulose pretreatment
C521955,CHEMICAL,"N,N-(2-methylnaphthylbenzyl)-2-aminoacetonitrile [Supplementary Concept]",LPI|Naphthalenes|Aminoacetonitrile/analogs  and  derivatives
http://purl.obolibrary.org/obo/DOID_12399,CHEMICAL,pathological gambling,Compulsive gambling|Pathological gambling|Pathologic gambling|PG
NEW06183,CHEMICAL,representation-mediated taste aversion,Representation-mediated taste aversion
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Distractibility,DISEASE,distractibility,hyperactivity/impulsivity
NEW06184,CHEMICAL,high-sugar/unhealthy food intake,high-sugar/unhealthy food intake
NEW06185,CHEMICAL,prenatal alcohol exposure,Prenatal alcohol exposure
NEW06187,CHEMICAL,prenatal alcohol exposure,prenatal alcohol exposure|PAE
NEW06188,DISEASE,metabolic disturbance,metabolic disturbance
NEW06190,CHEMICAL,hx106-treated OPAE,HX106-treated OPAE
NEW06193,CHEMICAL,ligasure,LigaSure
NEW06194,CHEMICAL,acetaminophen group,acetaminophen group
NEW06198,DISEASE,binge-like eat behavior,Binge-like eating behavior
C026285,CHEMICAL,trichlorosucrose [Supplementary Concept],Sucrose/analogs  and  derivatives|sucralose
NEW06201,CHEMICAL,novel synthetic glycolipids-disaccharide-based lipid a mimetic,DLAMs|novel synthetic glycolipids-disaccharide-based lipid A mimetics
NEW06204,CHEMICAL,disaccharide skeleton,disaccharide skeleton
NEW06206,DISEASE,ad patient,AD patients
NEW06208,DISEASE,due disc degeneration,due disc degeneration
D002976,CHEMICAL,Clenbuterol,clenbuterol|NAB-365|NAB365|Planipart|NAB 365
NEW06211,DISEASE,hypotensive property,hypotensive properties
C024763,CHEMICAL,talipexole [Supplementary Concept],Azepines|B-HT920
NEW06212,CHEMICAL,clonidine = b-ht920 great,clonidine = B-HT920 greater
NEW06214,CHEMICAL,nmda receptor hypofunction state,NMDA receptor hypofunction state
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Neurotoxicity,DISEASE,neurotoxicity,NRHypo neurotoxicity
http://purl.obolibrary.org/obo/CHEBI_48876,CHEMICAL,muscarinic antagonist,muscarinic antagonist scopolamine|muscarinic antagonists|agentes antimuscarinicos|antimuscarinicos|antimuscarinic agents|Antimuskarinikum|agents antimuscariniques|Antimuskarinika|agente antimuscarinico|muscarinic acetylcholine receptor antagonist
NEW06216,CHEMICAL,muscarinic glu agonist,muscarinic Glu agonists
C101562,CHEMICAL,"XenU1 protein, Xenopus [Supplementary Concept]","non-NMDA|Xenopus Proteins|Receptors, Glutamate"
NEW06218,CHEMICAL,5-ht releasing agent,5-HT releasing agents
D010133,CHEMICAL,p-Chloroamphetamine,p-chloroamphetamine|para Chloroamphetamine|LY-121860|Ly-123362|LY121860|p Chloroamphetamine|para-Chloroamphetamine|p Chloramphetamine|LY 121860|p-Chloramphetamine|Parachloroamphetamine|Ly123362|Ly 123362
NEW06221,DISEASE,neurotoxic dose,neurotoxic dose
NEW06222,DISEASE,hospitalize schizophrenic patient,hospitalized schizophrenic patients
NEW01733,CHEMICAL,atypical antipsychotic drug clozapine,atypical antipsychotic drug clozapine
NEW06224,CHEMICAL,stress-related catecholamine,stress-related catecholamine
C097869,CHEMICAL,"3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate [Supplementary Concept]",Propanolamines|SR59230A
NEW06226,CHEMICAL,peripheral 2-adrenergic agonist reproterol,peripheral 2-adrenergic agonist reproterol
NEW06227,CHEMICAL,ring-a-reduced progesterone derivative 5 alpha-pregnan-3 alpha-ol-20-one,tetrahydroprogesterone|ring-A-reduced progesterone derivative 5 alpha-pregnan-3 alpha-ol-20-one
http://purl.obolibrary.org/obo/MFOMD_0000191,CHEMICAL,anorgasmia,orgasm intensity/pleasure
D005039,CHEMICAL,Etilefrine,"Etilefrine Pivalate Hydrochloride|Bioflutin|Ethylphenylephrine|Circupon|Ethyladrianol|Phetanol|Effortil|Etilefrin|Eti Puren|Efortil|Pivalate Hydrochloride, Etilefrine|Etilefrine Hydrochloride|Etilefrin-ratiopharm|Ethyl Adrianol|etilefrine|Etilefrin AL|Adrianol, Ethyl|Adrenam|Etilefrin ratiopharm|Thomasin|etil von ct|Hydrochloride, Etilefrine Pivalate|Eti-Puren|Fetanol|Ethylnorphenylephrine|Cardanat|Hydrochloride, Etilefrine"
D054549,DISEASE,Takotsubo Cardiomyopathy,"Cardiomyopathy, Stress|Syndrome, Apical Ballooning|Tako tsubo Syndrome|Syndromes, Tako-tsubo|Syndrome, Tako-tsubo|Tako-tsubo Syndromes|Stress cardiomyopathy|Cardiomyopathy, Tako-tsubo|Stress Cardiomyopathy|Apical Ballooning Syndrome|Broken Heart Syndrome|Tako-tsubo Cardiomyopathy|Tako-tsubo Syndrome|Syndromes, Broken Heart|Syndrome, Broken Heart|Transient Apical Ballooning Syndrome|Takotsubo Syndrome|Cardiomyopathy, Takotsubo|Left Ventricular Apical Ballooning Syndrome|Tako tsubo Cardiomyopathy"
NEW06231,BIOCHEMICAL,alpha-2-adrenergic agonist,alpha-2-adrenergic agonist
NEW06234,CHEMICAL,second-line therapy,second-line therapies
NEW06236,DISEASE,report ingestion,reported ingestions
NEW06237,CHEMICAL,modafinil overdose,modafinil overdose
NEW06238,CHEMICAL,atomoxetine overdose,atomoxetine overdose
NEW06239,DISEASE,paradoxical hypertension,paradoxical hypertension
NEW06240,CHEMICAL,past alcohol use,past alcohol use
NEW06241,CHEMICAL,lofexidine recipient,lofexidine recipient
NEW06243,BIOCHEMICAL,alpha(2 adrenergic agonist clonidine,alpha(2 adrenergic agonist clonidine
NEW06244,BIOCHEMICAL,growth hormone gh response,growth hormone GH response
NEW06245,DISEASE,high crf concentration,high CRF concentrations
NEW06246,DISEASE,serial csf crf concentration,serial CSF CRF concentrations
NEW06254,CHEMICAL,enteral guanfacine therapy,Enteral guanfacine therapy
NEW06256,CHEMICAL,double-blind randomised-withdrawal study,double-blind randomised-withdrawal study
NEW06258,CHEMICAL,α2a-adrenergic agonist guanfacine,α2A-adrenergic agonist guanfacine
NEW06260,BIOCHEMICAL,its 's adrenergic agonist property,adrenergic agonist properties
C060897,CHEMICAL,ractopamine [Supplementary Concept],ractopamine|Phenethylamines
D004390,CHEMICAL,Chlorpyrifos,Lorsban|chlorpyrifos|Dursban|CPF
NEW06264,CHEMICAL,grape seed proanthocyanidin extract,GSPE|grape seed proanthocyanidins extracts
http://purl.obolibrary.org/obo/CHEBI_136044,CHEMICAL,fimasartan,fimasartan potassium|fimasartan potassium trihydrate|kanarb|fimasartan potassium hydrate|BR-A-657|clinidipine
D020108,CHEMICAL,Nicorandil,"nicorandil|SG-75|Nitrate, 2-Nicotinamidoethyl|SG75|Dancor|2-Nicotinamidoethyl Nitrate|2 Nicotinamidethyl Nitrate|2 Nicotinamidoethyl Nitrate|Nitrate, 2-Nicotinamidethyl|Ikorel|Adancor|2-Nicotinamidethyl Nitrate|SG 75"
C473739,NUTRITION,proanthocyanidin A1 [Supplementary Concept],Proanthocyanidins|proanthocyanidin
NEW06267,CHEMICAL,mixed dopamine da d1/d2 receptor agonist apomorphine,mixed dopamine DA D1/D2 receptor agonist apomorphine
NEW06269,CHEMICAL,dopamine releaser,dopamine releaser
NEW06270,DISEASE,pcp-induced cognitive deficit,PCP-induced cognitive deficits
http://purl.obolibrary.org/obo/CHEBI_55322,BIOCHEMICAL,mu-opioid receptor agonist,mu-opioid receptor agonists|mu opioid agonist|mu-opioid agonists|sigma-1 receptor agonists
NEW06277,CHEMICAL,"neurosteroid 3alpha,5alpha-thp","neurosteroid 3alpha,5alpha-THP"
NEW06279,BIOCHEMICAL,phenytoin-sensitive sigma1-receptor agonist,phenytoin-sensitive sigma1-receptor agonists
NEW06280,CHEMICAL,"(+)-skf-10,047","(+)-SKF-10,047"
http://purl.obolibrary.org/obo/DOID_1876,DISEASE,sexual dysfunction,SSRI-induced sexual dysfunction
NEW06284,BIOCHEMICAL,selective serotonin type 5-ht4 receptor agonist,selective serotonin type 5-HT4 receptor agonist
NEW06289,CHEMICAL,3xtg‑ad mouse,3xTg‑AD mice
NEW06292,MENTAL_HEALTH,schizophrenia antipsychotic,schizophrenia antipsychotics
NEW06294,CHEMICAL,monoamine deficiency,monoamines deficiency
NEW06295,CHEMICAL,ag nm,Ag NM
NEW06297,NUTRITION,chronic lithium nephrotoxicity,chronic lithium nephrotoxicity
NEW06298,NUTRITION,lithium time,lithium time
NEW06302,NUTRITION,low-dose lithium,low-dose lithium
NEW06304,CHEMICAL,binge ethanol exposure,Binge ethanol exposure
D000076226,CHEMICAL,Rapamycin-Insensitive Companion of mTOR Protein,RICTOR Protein|Rapamycin Insensitive Companion of mTOR Protein|rapamycin
C511993,CHEMICAL,kaempferol-3-O-(6-trans-caffeoyl)-beta-D-glucopyranosyl-(1- 2)-beta-D-glucopyranoside-7-O-beta-D-glucopyranoside [Supplementary Concept],KPF|Kaempferol|Kaempferols|Glycosides
NEW06307,CHEMICAL,csf t-tau level,CSF t-tau levels
NEW06308,CHEMICAL,nucleotide position,nucleotide position
D046350,DISEASE,"Porphyria, Variegate","Ppox Deficiency|Porphyria, South African Type|Porphyria Variegate|Protoporphyrinogen Oxidase Deficiency|Porphyria Variegata|Variegate porphyria|Deficiency, Ppox|Variegate Porphyria|Ppox Deficiencies"
D051778,CHEMICAL,Basic Helix-Loop-Helix Leucine Zipper Transcription Factors,"Transcription Factors, BHLHLZ|Basic Helix Loop Helix Leucine Zipper Transcription Factors|BHLH-Zip Transcription Factors|leucine|BHLH Zip Transcription Factors|Transcription Factors, BHLH-Zip|BHLHLZ Transcription Factors"
C551435,DISEASE,"CDKL5 protein, rat [Supplementary Concept]",Cyclin-dependent kinase-like 5|CDKL5|Protein Serine-Threonine Kinases
NEW06311,CHEMICAL,low‑dose injection,low‑dose injections
C487773,CHEMICAL,trans-sodium crocetinate [Supplementary Concept],Carotenoids|crocetin|Vitamin A/analogs  and  derivatives
D000666,CHEMICAL,Amphotericin B,Amphotericin B Cholesterol Dispersion|Amphotericin|amphotericin B|Fungizone|Amphocil|Amphotericin B Colloidal Dispersion
NEW06315,CHEMICAL,amphotericin b liposome,amphotericin B liposome
NEW06316,NUTRITION,Whortleberry extract,Whortleberry extract
NEW06317,CHEMICAL,dopamine homeostasis,dopamine homeostasis
NEW06319,CHEMICAL,dopamine transmodulational signaling,dopamine transmodulational signaling
NEW06322,BIOCHEMICAL,exaggerated beta,exaggerated beta
NEW06323,BIOCHEMICAL,twice-daily chronic dopamine antagonist treatment,Twice-daily chronic dopamine antagonist treatment
NEW06325,CHEMICAL,long-term aripiprazole therapy,Long-term aripiprazole therapy
NEW06327,BIOCHEMICAL,antiviral medication,antiviral medication
NEW06328,CHEMICAL,amantadine dosage,amantadine dosage
NEW06330,DISEASE,75-year-old depressed patient,75-year-old depressed patient
D009459,DISEASE,Neuroleptic Malignant Syndrome,"NMSs (Neuroleptic Malignant Syndrome)|Syndrome, Neuroleptic Malignant|neuroleptic malignant syndrome|Neuroleptic Malignant Syndrome, Neuroleptic Induced|Neuroleptic Malignant Syndromes|Neuroleptic Induced Neuroleptic Malignant Syndrome|Syndromes, Neuroleptic Malignant|Neuroleptic-Malignant Syndrome, Neuroleptic Induced|Neuroleptic-Induced Neuroleptic Malignant Syndrome|NMS (Neuroleptic Malignant Syndrome)"
D000077465,CHEMICAL,Cabergoline,1-((6-allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Dostinex|Galastop|FCE-21336|FCE 21336|Cabaser|Cabergoline|1-Ethyl-2-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta-carbonyl)urea diphosphate|Cabaseril|Cabergoline Diphosphate
D018721,BIOCHEMICAL,Muscarinic Agonists,"Muscarinic Cholinergic Agonists|Agonist, Muscarinic|Cholinergic Agonist, Muscarinic|Agonist, Muscarinic Cholinergic|Agonists, Muscarinic|muscarinic agonists|Agonists, Cholinergic Muscarinic|Agonists, Muscarinic Cholinergic|Muscarinic Cholinergic Agonist|Cholinergic Agonists, Muscarinic|Muscarinic Agonist|Cholinergic Muscarinic Agonists|Muscarinic Agonists, Cholinergic"
C075257,CHEMICAL,xanomeline [Supplementary Concept],xanomeline|Pyridines|Thiadiazoles
NEW06336,BIOCHEMICAL,combined agonist,combined agonist
NEW06337,BIOCHEMICAL,dopamine agonist apomorphine hydrochloride,dopamine agonist apomorphine hydrochloride
NEW06340,CHEMICAL,postsynaptic dopamine antagonism,Postsynaptic dopamine antagonism
NEW06342,BIOCHEMICAL,potent dopamine agonist,potent dopamine agonist
http://purl.obolibrary.org/obo/DOID_10936,DISEASE,schizoid personality disorder,schizotypal borderline personality disorders
http://purl.obolibrary.org/obo/CHEBI_131795,BIOCHEMICAL,dopamine receptor d1 agonist,dopamine D1 receptor agonists|D1-D2 dopamine agonist|dopamine D1 receptor agonist|D1 agonists|dopamine receptor D1 agonists|D1 agonist
NEW06350,CHEMICAL,adjunctive clozapine,adjunctive clozapine
NEW06351,BIOCHEMICAL,dopamine agonist discontinuation,Dopamine agonist discontinuation
NEW06352,CHEMICAL,hypothalamic dopamine d2 receptor,hypothalamic dopamine D2 receptors
NEW06353,DISEASE,sleep attack,Sleep attacks
C002474,CHEMICAL,tyrosine-4-azophenyltrimethylammonium chloride [Supplementary Concept],l-tyrosine|Tyrosine/analogs  and  derivatives
NEW06355,CHEMICAL,glutamate pathology,Glutamate pathology
NEW06356,CHEMICAL,ng muscimol,ng muscimol
NEW06358,CHEMICAL,serotonergic antidepressant,Serotonergic antidepressants
NEW06359,DISEASE,dsm-iv sand,DSM-IV SAnD
NEW06361,DISEASE,untreated sand subject,Untreated SAnD subjects
C027125,CHEMICAL,3-n-butylphthalide [Supplementary Concept],NBP|3-N-butylphthalide|Benzofurans
NEW06362,DISEASE,plasmodium falciparum proliferation,Plasmodium falciparum proliferation
NEW06364,MENTAL_HEALTH,dissociative reaction coordinate path,dissociative reaction coordinate path
D020945,DISEASE,"Lupus Vasculitis, Central Nervous System","Meningoencephalitis, Lupus|Meningoencephalitides, Lupus|Central Nervous System Lupus|systemic lupus erythematosus|Central Nervous System Lupus Vasculitis|Neuropsychiatric Systemic Lupus Erythematosus|Lupus Meningoencephalitis|Systemic Lupus Erythematosis, Central Nervous System|Lupus Meningoencephalitides|Central Nervous System Systemic Lupus Erythematosis"
NEW06367,CHEMICAL,mefloquine neurotoxicity,mefloquine neurotoxicity
NEW06369,MENTAL_HEALTH,bipolar disorder relapse,bipolar disorder relapse
NEW06370,CHEMICAL,intravenous cyclophosphamide,intravenous cyclophosphamide
D009173,CHEMICAL,Mycophenolic Acid,"Mycophenolate Sodium|Myfortic|RS61443|Mycophenolate, Sodium|Mycophenolate Mofetil|Mofetil, Mycophenolate|Sodium Mycophenolate|Mycophenolate mofetil|Mycophenolate Mofetil Hydrochloride|RS-61443|RS 61443|Cellcept|Mofetil Hydrochloride, Mycophenolate|Mycophenolic Acid Morpholinoethyl Ester"
NEW06372,CHEMICAL,inhibitor cyclosporine,inhibitors cyclosporine
C511911,CHEMICAL,belimumab [Supplementary Concept],"Antibodies, Monoclonal, Humanized|belimumab"
D011507,DISEASE,Proteinuria,Proteinurias|proteinuria
NEW06375,CHEMICAL,vasopressin 1a receptor,vasopressin 1A receptor
NEW06376,CHEMICAL,srx251,SRX251
NEW06378,DISEASE,stable chronic hyponatremia,Stable chronic hyponatremia
NEW06380,CHEMICAL,plasma sodium concentration,plasma sodium concentrations
NEW06383,BIOCHEMICAL,vasopressin v1b receptor antagonist,Vasopressin V1B receptor antagonists
NEW06385,CHEMICAL,avp infusion,AVP infusion
NEW06387,DISEASE,placental hypoxia,placental hypoxia
NEW06389,BIOCHEMICAL,avp receptor antagonist,AVP receptor antagonists
D018500,DISEASE,"Diabetes Insipidus, Nephrogenic","Diabetes Insipidus, Nephrogenic, Type 1|Nephrogenic Diabetes Insipidus, Type II|Congenital Nephrogenic Diabetes Insipidus|Diabetes Insipidus, Nephrogenic, Type I|Congenital nephrogenic diabetes insipidus|Nephrogenic Diabetes Insipidus, Type I|Diabetes Insipidus, Nephrogenic, Type II|Diabetes Insipidus Renalis|Nephrogenic Diabetes Insipidus|Acquired Nephrogenic Diabetes Insipidus|Diabetes Insipidus, Nephrogenic, X-Linked|ADH-Resistant Diabetes Insipidus|Diabetes Insipidus, Nephrogenic, Autosomal|Vasopressin-Resistant Diabetes Insipidus"
C564491,DISEASE,Nephrogenic Syndrome of Inappropriate Antidiuresis [Supplementary Concept],"Genetic Diseases, X-Linked|Inappropriate ADH Syndrome|NSIAD|inappropriate antidiuresis"
NEW06394,BIOCHEMICAL,indirect-acting muscarinic cholinergic agonist,indirect-acting muscarinic cholinergic agonists
NEW06395,BIOCHEMICAL,direct-acting muscarinic receptor agonist,direct-acting muscarinic receptor agonists
D018679,BIOCHEMICAL,Cholinergic Agonists,"Cholinergic Agonist|Acetylcholine Agonists|Agonists, Acetylcholine|Acetylcholine Agonist|cholinergic agonists|Agonist, Acetylcholine|Agonists, Cholinergic|Agonist, Cholinergic"
NEW06396,CHEMICAL,cyclosporine eye,cyclosporine eye
D013226,DISEASE,Status Epilepticus,"Non Convulsive Status Epilepticus|Status, Absence|Simple Partial Status Epilepticus|Status Epilepticus, Subclinical|Status Epilepticus, Electrographic|Generalized Status Epilepticus|Non-Convulsive Status Epilepticus|Status Epilepticus, Grand Mal|Status epilepticus|Grand Mal Status Epilepticus|Subclinical Status Epilepticus|Status Epilepticus, Non-Convulsive|Petit Mal Status|Absence Status|Status Epilepticus, Non Convulsive|Status, Petit Mal|Status Epilepticus, Simple Partial|Complex Partial Status Epilepticus|Generalized Convulsive Status Epilepticus|Status Epilepticus, Generalized Convulsive|Status Epilepticus, Generalized|Status Epilepticus, Complex Partial|Electrographic Status Epilepticus"
NEW06399,DISEASE,lithium/pilocarpine-induced status epilepticus,Lithium/pilocarpine-induced status epilepticus
D010095,CHEMICAL,Oxotremorine,oxotremorine|Oxytremorine
D065821,CHEMICAL,Pontine Tegmentum,"Tract, Central Tegmental|Accessory Abducens Nucleus|Paralemniscal Nucleus|Stria, Dorsal Acoustic|Reticular Formation of Pons|Tracts, Central Tegmental|Pontine Tegmentums|Tegmentum Ponti|Pons Dorsal Parts|Dorsal Part of Pons|Pons Tegmentums|Central Tegmental Tracts|Pons Dorsal Part|Protuberancials, Tegmentum|Pontine Reticular Formation|Reticular Formations, Pontine|Tegmental Tracts, Central|Tegmental Tract, Central|Acoustic Stria, Dorsal|Tegmentum Protuberancial|Tegmentums, Pontine|Dorsal Acoustic Strias|Pars Dorsalis Pontis|Pons Reticular Formations|Pontine Reticular Formations|Nuclei of the Lateral Lemniscus|Nucleus, Accessory Abducens|Nucleus Subceruleus|Reticular Formation, Pontine|Tegmentum Pontis|pontine reticular formation|Formation, Pontine Reticular|Tegmentum, Pontine|Central Tegmental Tract|Acoustic Strias, Dorsal|Ponti, Tegmentum|Tegmentum of Pons|Nucleus, Paralemniscal|Formations, Pontine Reticular|Dorsal Acoustic Stria|Abducens Nucleus, Accessory|Strias, Dorsal Acoustic|Protuberancial, Tegmentum|Tegmentum Protuberancials|Pons Tegmentum|Pons Reticular Formation|Pontis, Tegmentum|Subceruleus, Nucleus"
NEW06403,BIOCHEMICAL,inhibitory gabaergic receptor agonist muscimol,inhibitory GABAergic receptor agonist muscimol
D014236,CHEMICAL,Trichlorfon,Chlorofos|Dylox|Dipterex|Metrifonate|Trichlorphon|Chlorophos|Neguvon|Foschlor|Bilarcil|Ricifon|Metriphonate
D008401,CHEMICAL,Gas Chromatography-Mass Spectrometry,"Spectrometry-Gas Chromatography, Mass|Spectrum Analysis, Mass-Gas Chromatography|Chromatography, Gas-Mass Spectrometry|Chromatography-Mass Spectrometry, Gas-Liquid|Chromatography, Gas Mass Spectrometry|Mass Spectrometry-Gas Chromatography|Spectrometries, Mass-Gas Chromatography|Chromatography, Gas-Liquid-Mass Spectrometry|Gas-Liquid Chromatography-Mass Spectrometry|gas chromatography-mass spectrometry|Gas Liquid Chromatography Mass Spectrometry|GCMS|Gas Chromatography Mass Spectrometry|Chromatography, Gas Liquid Mass Spectrometry|Spectrometry, Mass-Gas Chromatography|Chromatography, Mass Spectrometry-Gas|Chromatography-Mass Spectrometry, Gas|Spectrometry, Gas-Liquid Chromatography-Mass|Mass Spectrometry Gas Chromatography|Spectrometry, Mass Gas Chromatography|Spectrum Analysis, Mass Gas Chromatography|Spectrometry, Gas Chromatography-Mass"
NEW06407,NUTRITION,free cholesterol,free cholesterol
http://purl.obolibrary.org/obo/CHEBI_132501,NUTRITION,fatty acid 17:2,polyunsaturates fatty acids|free fatty acid 17:2|FA 17:2
NEW06408,NUTRITION,severe mercury intoxication,Severe mercury intoxication
NEW06410,DISEASE,glutamatergic neurochemical dysfunction,glutamatergic neurochemical dysfunction
NEW06411,CHEMICAL,long-term chronic hgcl2 intoxication,long-term chronic HgCl2 intoxication
NEW06415,NUTRITION,egg White Hydrolysate,Egg White Hydrolysate
NEW06417,BIOCHEMICAL,toxin level,toxin levels
NEW06418,DISEASE,early-life exposure,Early-life exposures
NEW06419,NUTRITION,mercury study,MERCURY study
NEW06421,NUTRITION,mercury exposure,mercury exposure
D014202,DISEASE,Tremor,"Tremor, Passive|Saturnine Tremor|Neonatal Tremor|Tremors, Limb|Quiver, Involuntary|Tremor, Nerve|Tremor, Muscle|Tremor, Neonatal|Tremor, Pill Rolling|Darkness Tremors|Tremor, Resting|Tremor, Fine|Saturnine Tremors|Semirhythmic Tremors|Tremor, Coarse|Fine Tremor|Static Tremors|Muscle Tremor|Action Tremor|Senile Tremors|Tremors, Action|Tremor, Intermittent|Passive Tremor|Tremor, Intention|Tremor, Continuous|Tremor, Limb|Intention Tremors|Coarse Tremors|Tremors, Rest|Tremors, Intermittent|Involuntary Quivers|Tremor, Action|Nerve Tremors|Persistent Tremor|Tremors, Pill Rolling|Resting Tremor|Tremors, Persistent|Action Tremors|Fine Tremors|Tremors, Senile|Static Tremor|Darkness Tremor|Semirhythmic Tremor|Perioral Tremors|Tremor, Saturnine|Tremors, Fine|Tremors, Muscle|Rest Tremor|Tremor, Senile|Continuous Tremor|Coarse Tremor|Tremors, Intention|Perioral Tremor|Tremors, Semirhythmic|Tremors, Nerve|Tremor, Perioral|Tremor, Static|Passive Tremors|Tremors|Tremors, Saturnine|Tremors, Neonatal|Tremor, Persistent|Rolling Tremors, Pill|tremors|Massive Tremor|Intention Tremor|Tremors, Static|Tremors, Continuous|Pill Rolling Tremors|Tremor, Darkness|Muscle Tremors|Limb Tremors|Persistent Tremors|Continuous Tremors|Intermittent Tremors|Tremors, Passive|Tremors, Coarse|Involuntary Quiver|Quivers, Involuntary|Resting Tremors|Tremors, Massive|Tremors, Resting|Tremor, Rest|Tremors, Perioral|Tremor, Semirhythmic|Tremors, Darkness|Massive Tremors|Intermittent Tremor|Rest Tremors|Tremor, Massive|Rolling Tremor, Pill|Nerve Tremor|Senile Tremor|Limb Tremor|Neonatal Tremors|Pill Rolling Tremor"
NEW06423,MENTAL_HEALTH,increase anxiety,Increasing anxiety
D058066,DISEASE,Digital Dermatitis,"Papillomatosis, Digital|Bovine Hairy Footwarts|Digital Dermatitis, Bovine|Ovine Digital Dermatitides|Ovine Digital Dermatitis|Papillomatous Digital Dermatitis|Digital Papillomatosis|Papillomatous Digital Dermatitides|Hairy Footwart, Bovine|Digital Dermatitides, Papillomatous|Hairy Footwarts, Bovine|Bovine Hairy Footwart|Digital Papillomatoses|Warts, Bovine Foot|Bovine Foot Wart|Dermatitis, Bovine Digital|Bovine Digital Dermatitis|Footwart, Bovine Hairy|Foot Warts, Bovine|Digital Dermatitides|Bovine Foot Warts|Digital Dermatitis, Ovine|Dermatitides, Digital|Digital Dermatitis, Papillomatous|Wart, Bovine Foot|dermatitis|Dermatitides, Bovine Digital|Bovine Digital Dermatitides|Digital Dermatitides, Bovine|Digital Dermatitides, Ovine|Dermatitis, Digital|Papillomatoses, Digital|Footwarts, Bovine Hairy|Foot Wart, Bovine"
NEW06426,CHEMICAL,methylmercury exposure,methylmercury exposure
NEW06427,CHEMICAL,mehg exposure,MeHg exposure
NEW06429,CHEMICAL,decrease triglyceride level,decreased triglyceride levels
NEW06431,NUTRITION,mercury concentration,mercury concentrations
NEW06433,MENTAL_HEALTH,chronic alcohol abuse,Chronic alcohol abuse
D010842,MENTAL_HEALTH,Pica,pica|Allotriophagy|Geophagia
NEW06436,CHEMICAL,often-potassium zinc deficiency,often-potassium zinc deficiency
NEW06439,MENTAL_HEALTH,toluene-induced partial insomnia,toluene-induced partial insomnia
C029261,CHEMICAL,phenethylamine [Supplementary Concept],2-phenylethylamine|Phenethylamines
C025136,NUTRITION,phenylacetic acid [Supplementary Concept],Phenylacetates|phenylacetic acid
NEW06440,CHEMICAL,high urinary pea excretion,high urinary PEA excretion
NEW06441,CHEMICAL,post-synaptic dopamine receptor,post-synaptic dopamine receptor
NEW06442,CHEMICAL,neuromodulator phenylethylamine,neuromodulator phenylethylamine
NEW06444,CHEMICAL,5-ht turnover,5-HT turnover
NEW06446,CHEMICAL,hange-koboku-to-mediated reduction,Hange-koboku-to-mediated reduction
NEW06447,DISEASE,offence history/institutional behavior,offence history/institutional behavior
NEW06448,CHEMICAL,neonatal urea cycle disorder,Neonatal Urea cycle disorders
C570223,CHEMICAL,glycerol phenylbutyrate [Supplementary Concept],Glycerol/analogs  and  derivatives|Phenylbutyrates|glycerol phenylbutyrate
NEW04451,CHEMICAL,urea metabolism,urea metabolism
D010652,CHEMICAL,Phenylalanine-tRNA Ligase,"Phenylalanyl T RNA Synthetase|Phe-tRNA Ligase|Ligase, Phe-tRNA|Ligase, Phenylalanine-tRNA|Phenylalanyl-tRNA Synthetase|Phe|Synthetase, Phenylalanyl-tRNA|phenylalanine|Phe tRNA Ligase|Phenylalanyl tRNA Synthetase|Phenylalanine tRNA Ligase"
D019805,CHEMICAL,alpha-Methyltyrosine,"Demser|Hydrochloride, alpha-Methyltyrosine|p-tyrosine|alpha Methyl para tyrosine|Metyrosine|alpha Methyltyrosine Hydrochloride|alpha Methyltyrosine|alpha-Methyltyrosine, (L)-Isomer|alpha-methyl- DL-Tyrosine|alpha-Methyltyrosine Hydrochloride|alpha-Methyltyrosine, (D,L)-Isomer|alpha-Methyltyrosine, (+,-)-Isomer|alpha-Methyl-para-tyrosine|Metirosine|alpha Methyl p tyrosine|alpha MPT|Racemetirosine|DL-Tyrosine, alpha-methyl-|Tyr|alpha-MPT|alpha-Methyl-p-tyrosine"
D013197,CHEMICAL,Stanozolol,Winstrol|Stromba|Androstanazol|Stanazolol|stanozolol|Methylstanazol
D010862,CHEMICAL,Pilocarpine,"pilocarpine|Pilocarpine Mononitrate, (3S-cis)-Isomer|Salagen|Pilocarpine, Monohydrochloride, (3S-cis)-Isomer|Pilocarpine Hydrochloride|Nitrate, Pilocarpine|Pilocarpine Nitrate|Isoptocarpine|Isopilocarpine|Hydrochloride, Pilocarpine|Ocusert"
http://purl.obolibrary.org/obo/CHEBI_68992,CHEMICAL,nantenine,"Domestine|6a-alpha-Aporphine, 1,2-dimethoxy-9,10-(methylenedioxy)-|o-Methyldomesticine|AF102B FSK-508 cis-2-methylspiro|(6aS)-1,2-dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-benzo[de][1,3]benzodioxolo[5,6-g]quinoline"
http://purl.obolibrary.org/obo/CHEBI_38324,BIOCHEMICAL,cholinergic agonist,acetylcholine agonists|acetylcholine agonist|cholinergic muscarinic agonist|cholinomimetic|cholinergic agonists|cholinomimetics|acetylcholine receptor agonist
NEW06459,CHEMICAL,patient xanomeline,patients xanomeline
NEW01305,MENTAL_HEALTH,narcolepsy patient,narcolepsy patients
NEW06464,BIOCHEMICAL,muscarinic agonist pilocarpine,muscarinic agonist pilocarpine
C088566,CHEMICAL,carboxyebselen [Supplementary Concept],ebselen|Organoselenium Compounds
http://purl.obolibrary.org/obo/CHEBI_38325,BIOCHEMICAL,muscarinic agonist,muscarinic cholinergic agonists|muscarinic cholinergic agonist|muscarinic agonists|muscarinic acetylcholine receptor agonist|muscarinic agonist carbachol
D017255,CHEMICAL,Acitretin,"Ro-10-1670|Acitretin, (Z,E,E,E)-Isomer|Ro 101670|13-cis-Acitretin|Neotigason|Ro-13-7652|Ro 137652|Ro137652|Isoacitretin|Ro 13-7652|Soriatane|Etretin|acitretin|Ro 10-1670|Isoetretin|Ro101670"
http://purl.obolibrary.org/obo/DOID_0060018,DISEASE,cd3gamma deficiency,GRK5 deficiency
NEW06469,CHEMICAL,af267b administration,AF267B administration
D020551,BIOCHEMICAL,"Pulse Therapy, Drug","Pulse Drug Therapies|Therapies, Drug Pulse|Therapy, Pulse Drug|Therapy, Drug Pulse|Therapies, Pulse Drug|drug therapies|Pulse Therapies, Drug|Pulse Drug Therapy|Drug Therapy, Pulse|Drug Pulse Therapies|Drug Pulse Therapy|Drug Therapies, Pulse"
NEW06471,CHEMICAL,sligrl-amide,SLIGRL-amide
NEW06473,CHEMICAL,glu(k5 kainate receptor subunit,GLU(K5 kainate receptor subunits
NEW06474,CHEMICAL,glu(k5 kainate receptor subtype,GLU(K5 kainate receptor subtype
http://purl.obolibrary.org/obo/CHEBI_83821,CHEMICAL,amino acid derivative,amino acid compounds
NEW06476,CHEMICAL,non-peptide kinin receptor antagonist,non-peptide kinin receptor antagonists
NEW06478,CHEMICAL,capsaicin microinjection,capsaicin microinjections
NEW06482,CHEMICAL,intracortical iron injection,intracortical iron injection
NEW06484,NUTRITION,buckthorn seed oil,buckthorn seed oil
NEW06486,CHEMICAL,low high testosterone level,Low high testosterone levels
NEW06487,BIOCHEMICAL,high androgen level,high androgen levels
NEW06488,DISEASE,hypoandrogenic postmenopausal woman,hypoandrogenic postmenopausal women
NEW06489,CHEMICAL,testosterone replacement therapy,Testosterone replacement therapy
NEW06490,BIOCHEMICAL,long-acting agonist analogue,long-acting agonist analogue
D007987,BIOCHEMICAL,Gonadotropin-Releasing Hormone,"Gn-RH|Gonadorelin Hydrochloride|GnRH|Kryptocur|LHFSH Releasing Hormone|FSH-Releasing Hormone|Releasing Hormone, LHFSH|LH-Releasing Hormone|Cystorelin|Gonadorelin|Luteinizing Hormone-Releasing Hormone|LH-RH|LHFSHRH|Factrel|Gonadoliberin|LHRH|gonadotropin-releasing hormone|Luteinizing Hormone Releasing Hormone|LH Releasing Hormone|FSH Releasing Hormone|Luliberin|Dirigestran|LFRH|Gonadotropin Releasing Hormone|LH FSH Releasing Hormone|Gonadorelin Acetate|LH-FSH Releasing Hormone"
NEW06493,DISEASE,numerous psychiatric disorder,Numerous psychiatric disorders
NEW06495,DISEASE,due vaginal dryness,due vaginal dryness
NEW06496,CHEMICAL,responsive to estrogen replacement therapy,ERT|responsive to estrogen replacement therapy
NEW06497,DISEASE,sexual difficulty,sexual difficulties
NEW06499,BIOCHEMICAL,new progestin,new progestins
NEW06501,CHEMICAL,excess serotonin,Excess serotonin
NEW06503,CHEMICAL,serotonin toxicity,Serotonin toxicity
NEW02799,CHEMICAL,mam rat,MAM rats
NEW06507,CHEMICAL,late gestational mam injection,late gestational MAM injection
NEW06508,BIOCHEMICAL,mitotic inhibitor methylazoxymethanol,mitotic inhibitor methylazoxymethanol
NEW06510,DISEASE,platinum-refractory ovarian cancer,platinum-refractory ovarian cancer
NEW06511,BIOCHEMICAL,stress hormone,Stress hormones
NEW06514,CHEMICAL,nasal cannabidiol inclusion complex temperature-sensitive hydrogel,nasal cannabidiol inclusion complex temperature-sensitive hydrogels|CBD TSGs
NEW06515,NUTRITION,chronic cholesterol depletion,chronic cholesterol depletion
C056599,CHEMICAL,icariin [Supplementary Concept],Icariin|Flavonoids
NEW04676,CHEMICAL,gaba type a receptor,GABA type A receptor
D060789,CHEMICAL,Prostatein,"Prostatic Steroid Binding Protein|Prostatic Steroid-Binding Protein|steroid binding|Steroid-Binding Protein, Prostatic"
NEW06517,CHEMICAL,allopregnanolone action,allopregnanolone action
C038369,CHEMICAL,hirsutine [Supplementary Concept],Alkaloids|Hirsutine
NEW06518,CHEMICAL,hp-cd microsphere,HP-CD microspheres
NEW06519,NUTRITION,neuron-derived cholesterol content similar,neuron-derived cholesterol content similar
D015259,BIOCHEMICAL,Dopamine Agents,"Drugs, Dopaminergic|Dopaminergic Drugs|Dopamine Drugs|Dopaminergic Agents|Dopaminergic Effects|Agents, Dopamine|Agents, Dopaminergic|Dopamine Effect|Effects, Dopaminergic|Dopamine Effects|Effect, Dopaminergic|Effect, Dopamine|Drugs, Dopamine|Dopaminergic Effect|dopaminergic agents|Effects, Dopamine"
NEW06522,CHEMICAL,chronic 071031b treatment,Chronic 071031B treatment
NEW06528,CHEMICAL,Levomilnacipran LVM,Levomilnacipran LVM
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Atypical_Depression,MENTAL_HEALTH,atypical depression,atypical depression
NEW03957,BIOCHEMICAL,selective norepinephrine reuptake inhibitor,selective norepinephrine reuptake inhibitors
NEW06531,CHEMICAL,new maoi,newer MAOI
NEW06533,DISEASE,mau inhibition,MAU inhibition
NEW06534,CHEMICAL,reserpine reversal,reserpine reversal
NEW06536,DISEASE,depressed 48-year-old woman,depressed 48-year-old woman
NEW06538,BIOCHEMICAL,multifunctional serotonin agonist,multifunctional serotonin agonist
D000069583,CHEMICAL,Pregabalin,"(S+)-3-isobutyl GABA|CI 1008|CI-1008|Lyrica|pregabalin|1008, CI|CI1008|(R-)-3-isobutyl GABA|3-(aminomethyl)-5-methylhexanoic acid|GABA, 3-isobutyl|(S)-3-(aminomethyl)-5-methylhexanoic acid|3-isobutyl GABA|3 isobutyl GABA"
NEW06539,CHEMICAL,non-fda,Non-FDA
D020188,DISEASE,Sleep Paralysis,"Paralysis, Sleep|Sleep paralysis"
NEW06541,CHEMICAL,lc ne neuron,LC NE neurons
http://purl.obolibrary.org/obo/SYMP_0000408,MENTAL_HEALTH,cataplexy,narcolepsy hypersomnia
NEW06546,MENTAL_HEALTH,cataplexy treatment,Cataplexy treatment
NEW06547,DISEASE,newborn heart defect,newborn heart defects
NEW06549,DISEASE,main psychosomatic treatment,main psychosomatic treatment
NEW06552,CHEMICAL,covid-19 community,COVID-19 community
NEW06553,DISEASE,subthreshold psychotic symptom,subthreshold psychotic symptoms
D020271,DISEASE,"Heredodegenerative Disorders, Nervous System","Neurodegenerative Diseases, Hereditary|Diseases, Neurodegenerative Hereditary|Disease, Hereditary Neurodegenerative|Hereditary Disease, Neurodegenerative|Degenerative Hereditary Disorders, Nervous System|Hereditary Neurodegenerative Diseases|Nervous System Diseases, Degenerative, Hereditary|Disease, Neurodegenerative Hereditary|Degenerative Disease, Nervous System, Hereditary|Neurodegenerative Disease, Hereditary|Nervous System Degenerative Hereditary Diseases|Neurodegenerative Hereditary Disease|Degenerative Hereditary Diseases, Nervous System|Diseases, Hereditary Neurodegenerative|Hereditary-Degenerative Disorders, Nervous System|Neurodegenerative Hereditary Diseases|Hereditary Neurodegenerative Disease|Hereditary Degenerative Disorders, Nervous System|Hereditary Diseases, Neurodegenerative|hereditary diseases|Nervous System Hereditary Degenerative Diseases"
D000069279,DISEASE,Drug Resistant Epilepsy,"Drug Refractory Epilepsies|Epilepsy, Intractable|Intractable Epilepsy|Epilepsies, Drug Refractory|Resistant Epilepsy, Drug|Refractory Epilepsy, Drug|Drug Resistant Epilepsies|Epilepsy, Medication Resistant|Epilepsy, Drug Resistant|Medication Resistant Epilepsy|Epilepsy, Drug Refractory|Resistant Epilepsies, Medication|Epilepsies, Refractory|Medication Resistant Epilepsies|Epilepsy, Refractory|Resistant Epilepsies, Drug|Intractable Epilepsies|Refractory Epilepsy|Epilepsies, Intractable|Epilepsies, Medication Resistant|Refractory Epilepsies, Drug|Drug Refractory Epilepsy|refractory epilepsy|Epilepsies, Drug Resistant|Refractory Epilepsies|Resistant Epilepsy, Medication"
NEW06556,DISEASE,brain infection,brain infections
http://purl.obolibrary.org/obo/DOID_12858,DISEASE,huntington's disease,Huntington's chorea|HD|Huntington disease|Huntington 's disease
D000108,CHEMICAL,Acetylcarnitine,"ALCAR|Medosan|Acetyl L Carnitine|acetyl-L-carnitine|Levocarnitine Acetyl|Acetyl Carnitine|Branigen|Acetylcarnitine, (R)-Isomer|Acetyl-L-Carnitine|Carnitine, Acetyl|Alcar"
C539260,CHEMICAL,"alpha-lipoic acid, 4-aminobenzoic acid, aniline, benfotiamine, thioctic Acid, vitamin E drug combination [Supplementary Concept]",Thioctic Acid|Alpha-lipoic acid|ALA|Thiamine/analogs  and  derivatives|4-Aminobenzoic Acid|Vitamin E|Drug Combinations|Folic Acid
D016718,CHEMICAL,Arachidonic Acid,"Arachidonic Acid, Ammonium Salt, (all-Z)-Isomer|arachidonic acid|Arachidonic Acid, (all-Z)-isomer, 3H-Labeled|Arachidonic Acid, Sodium Salt, (all-Z)-Isomer|Arachidonic Acid, Potassium Salt, (all-Z)-Isomer|Sodium Arachidonate|Arachidonic Acid, Lithium Salt, (all-Z)-Isomer|Arachidonic Acid, Sodium Salt|Arachidonic Acid, Cerium Salt, (all-Z)-Isomer|Arachidonate, Sodium|Arachidonic Acid, (all-Z)-Isomer, 1-(14)C-Labeled|Vitamin F|(all-Z)-5,8,11,14-Eicosatetraenoic acid|Arachidonic Acid, Cesium Salt, (all-Z)-Isomer|Arachidonic Acid, Zinc Salt, (all-Z)-Isomer"
D007862,CHEMICAL,Phosphatidylcholine-Sterol O-Acyltransferase,"Phosophatidylcholine Sterol Acyltransferase|phosphatidylcholine|Acyltransferase, Lecithin Cholesterol|Cholesterol Acyltransferase, Lecithin|Acyltransferase, Phosophatidylcholine-Sterol|Lecithin Cholesterol Acyltransferase|Acyltransferase, Lecithin|Phosophatidylcholine-Sterol Acyltransferase|Lecithin Acyltransferase|O-Acyltransferase, Phosphatidylcholine-Sterol|Cholesterol Ester Lysolecithin Acyltransferase|Phosphatidylcholine Sterol O Acyltransferase"
NEW06560,CHEMICAL,omega-3 ps,omega-3 PS
NEW06564,DISEASE,resultant ssri-induced apoptosis,Resultant SSRI-induced apoptosis
http://purl.obolibrary.org/obo/CHEBI_48593,BIOCHEMICAL,benzocycloheptapyridine,benzocycloheptapyridines|SSRI class
NEW06565,BIOCHEMICAL,charge drug molecule,charged drug molecules
D010717,NUTRITION,CDPdiacylglycerol-Serine O-Phosphatidyltransferase,"Phosphatidylserine Synthetase|Phosphatidylserine Synthase|Synthetase, Phosphatidylserine|CDP Diglyceride Serine O-Phosphatidyltransferase|Synthase, CDP-DG|phosphatidylserine|O-Phosphatidyltransferase, CDP Diacylglycerol-Serine|Diacylglycerol-Serine O-Phosphatidyltransferase, CDP|CDP DG Synthase|Synthase, Phosphatidylserine|CDPdiacylglycerol Serine O Phosphatidyltransferase|CDP Diglyceride Serine O Phosphatidyltransferase|CDP Diacylglycerol Serine O Phosphatidyltransferase|CDP-DG Synthase|O-Phosphatidyltransferase, CDPdiacylglycerol-Serine|CDP Diacylglycerol-Serine O-Phosphatidyltransferase"
NEW06567,NUTRITION,soy-derived phosphatidylserine,soy-derived phosphatidylserine
D049294,NUTRITION,Phospholipid Transfer Proteins,"Phospholipid Transfer Protein|Phosphatidylinositol Transfer Protein beta|Translocase, Aminophospholipid|Aminophospholipid Translocator|Phospholipid Scramblase|Phosphatidylserine Translocase|Phosphatidylinositol Transfer Protein|Aminophospholipid Flippase|Phospholipid Exchange Proteins|Phosphatidylinositol Transfer Proteins|Phosphatidylinositol Transfer Protein alpha|Aminophospholipid Transporter|Translocator, Aminophospholipid|Aminophospholipid Translocase|Phosphatidylcholine Exchange Protein|Aminophospholipid Transfer Proteins|Lecithin Transfer Protein|Phosphatidyl Transfer Protein|Nonspecific Phospholipid Transfer proteins|Phosphatidylinositol Exchange Protein|Phosphatidylcholine Transfer Proteins|Transporter, Aminophospholipid|Transfer Proteins, Phospholipid|Phospholipid Exchange Protein|Scramblase, Phospholipid|Phospholipid Translocating Protein|Phosphatidylcholine Transfer Protein|Translocase, Phosphatidylserine|phospholipid"
C498493,DISEASE,"Cln8 protein, mouse [Supplementary Concept]",CLN8|Membrane Proteins
NEW06570,CHEMICAL,tea polyphenol,tea polyphenols
NEW00040,DISEASE,neuronal loss,neuronal loss
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Tourette_Syndrome,MENTAL_HEALTH,tourette syndrome,Tourette syndrome symptoms
NEW06574,MENTAL_HEALTH,japanese schizophrenia patient,Japanese schizophrenia patients
NEW06577,CHEMICAL,caffeine,caffeine
D056344,DISEASE,Executive Function,"Executive Functions|executive functions|Executive Control|Functions, Executive|Function, Executive|Executive Controls"
NEW06580,CHEMICAL,da transmission,DA transmission
NEW06582,CHEMICAL,vac extract,VAC extract
NEW06583,CHEMICAL,abeta42 production,Abeta42 production
NEW06584,CHEMICAL,Healthy Foods North,HFN|Healthy Foods North
NEW06587,MENTAL_HEALTH,cam dissociation,CaM dissociation
http://purl.obolibrary.org/obo/CHEBI_171887,CHEMICAL,acrimarine n,"1-hydroxy-3,5,6-trimethoxy-2-[1-(7-methoxy-2-oxochromen-6-yl)-3-methylbut-2-enyl]-10-methylacridin-9-one|N N-trimethylglycine"
NEW06593,CHEMICAL,aldosterone level,aldosterone levels
D000451,CHEMICAL,Mineralocorticoid Receptor Antagonists,"Mineralocorticoid Antagonists|Aldosterone Receptor Antagonists|Receptor Antagonist, Aldosterone|Aldosterone Antagonists|Antagonists, Aldosterone Receptor|Antagonist, Aldosterone Receptor|Mineralocorticoid Antagonist|Antagonist, Aldosterone|Antagonists, Mineralocorticoid Receptor|Mineralocorticoid Receptor Antagonist|Aldosterone Antagonist|Antagonist, Mineralocorticoid|Receptor Antagonist, Mineralocorticoid|Antagonists, Mineralocorticoid|Antagonists, Aldosterone|Receptor Antagonists, Mineralocorticoid|Aldosterone Receptor Antagonist|Receptor Antagonists, Aldosterone|Antagonist, Mineralocorticoid Receptor|Aldosterone antagonists"
http://purl.obolibrary.org/obo/CHEBI_50844,BIOCHEMICAL,aldosterone antagonist,selective aldosterone antagonist
NEW06599,BIOCHEMICAL,mineral corticoid antagonist,mineral corticoid antagonist
NEW06601,CHEMICAL,sr58611a,SR58611A
NEW06602,MENTAL_HEALTH,primary depression,primary depression
C462679,CHEMICAL,SMP 500 [Supplementary Concept],Naphthyridines|SMP|Urea/analogs  and  derivatives
NEW06606,BIOCHEMICAL,primary analgesic,primary analgesic
D000077769,CHEMICAL,Rilmenidine,2-(N-(Dicyclopropylmethyl)amino)oxazoline Phosphate Salt|Oxaminozoline|S 3341|rilmenidine|S 3341 3|2-(N-(Dicyclopropylmethyl)amino)oxazoline|Hyperium|S3341|S33413|Rilmenidine Phosphate|S-3341|S-3341-3
NEW06608,BIOCHEMICAL,particular sympatholytic property,particular sympatholytic properties
NEW06609,DISEASE,neurogenic disorder,neurogenic disorders
NEW06611,CHEMICAL,act moxonidine metoprolol sympatholytic agent,acting moxonidine metoprolol sympatholytic agents
NEW06612,DISEASE,hypertensive man,hypertensive men
http://purl.obolibrary.org/obo/CHEBI_167165,BIOCHEMICAL,kappa-opioid receptor antagonist,kappa-opioid receptor antagonists|kappa-opioid antagonists|kappa-opioid antagonist
NEW06614,BIOCHEMICAL,aberrant glycosylate muc1 neoantigen,aberrant glycosylated MUC1 neoantigen
C545823,CHEMICAL,"soybean oil, phospholipid emulsion [Supplementary Concept]",Soybean Oil|Intralipid|Phospholipids|Emulsions
NEW06618,CHEMICAL,high ca/mg ratio,high Ca/Mg ratio
NEW06620,CHEMICAL,mg supplementation,Mg supplementation
NEW06622,CHEMICAL,psychostimulant caffeine,psychostimulant caffeine
NEW06623,CHEMICAL,magnesium status,Magnesium status
NEW06625,CHEMICAL,magnesium level,magnesium levels
NEW06626,CHEMICAL,serum zinc,Serum zinc
NEW06628,CHEMICAL,low serum zinc level,low serum zinc levels
NEW06629,DISEASE,severe rapid cycling manic-depressive patient,severe rapid cycling manic-depressive patients
D001224,CHEMICAL,Aspartic Acid,"Monopotassium Aspartate|Aspartate, Monopotassium|Aspartic Acid, Monopotassium Salt|Aspartate, Monosodium|Aspartate, Ammonium|L Aspartate|Aspartic Acid, Ammonium Salt|(R,S)-Aspartic Acid|Mg-5-Longoral|Dipotassium Aspartate|Aspartic Acid, Hydrochloride|Magnesium Aspartate|Aspartate Magnesium Hydrochloride|Aspartate, Calcium|Aspartic Acid, Magnesium (2:1) Salt|Aspartic Acid, Potassium Salt|Aspartate|Potassium Aspartate|L-Aspartate|Aspartate, Disodium|Monosodium Aspartate|Aspartic Acid, Magnesium-Potassium (2:1:2) Salt|Sodium Aspartate|Aspartic Acid, Hydrobromide|Aspartic Acid, Disodium Salt|Aspartate, Dipotassium|Calcium Aspartate|L Aspartic Acid|Aspartic Acid, Monosodium Salt|Disodium Aspartate|L-Aspartic Acid|Aspartic Acid, Calcium Salt|Aspartic Acid, Dipotassium Salt|Aspartate, Sodium|Magnesiocard|Aspartic Acid, Magnesium (1:1) Salt, Hydrochloride, Trihydrate|Aspartate, Magnesium|Aspartate, Potassium|(+-)-Aspartic Acid|Ammonium Aspartate|Aspartic Acid, Sodium Salt"
D008278,CHEMICAL,Magnesium Sulfate,"Sulfate, Magnesium|magnesium sulfate|Magnesium Sulfate, Heptahydrate|Heptahydrate Magnesium Sulfate"
NEW06633,DISEASE,hypermagnesemia,hypermagnesemia
NEW06636,CHEMICAL,over-the-counter magnesium chloride,over-the-counter magnesium chloride
D015636,CHEMICAL,Magnesium Chloride,"MgCl2|magnesium chloride|Chloride, Magnesium"
C004454,BIOCHEMICAL,"dicyclomine, doxylamine, pyridoxine drug combination [Supplementary Concept]",Dicyclomine|Doxylamine|Pyridoxine hydrochloride|Pyridoxine|Drug Combinations
D055030,BIOCHEMICAL,Drug Users,"Drug Abuser|Abusers, Drug|User, Intravenous Drug|Drug User, IV|Addicts, Drug|drug addicts|Drug Addicts|User, Drug|Intravenous Drug Users|People Who Inject Drugs|Drug User|Intravenous Drug User|Addict, Drug|Drug Abusers|Users, Intravenous Drug|Drug Users, Intravenous|Users, Drug|Drug User, Intravenous|IV Drug User|Users, IV Drug|Drug Users, IV|Drug Addict|User, IV Drug|Abuser, Drug|IV Drug Users"
NEW06638,CHEMICAL,serum mg++ level,serum Mg++ levels
NEW06640,DISEASE,genomovar isolate,genomovar isolates
NEW06642,CHEMICAL,serum magnesium level,serum magnesium levels
NEW06644,CHEMICAL,endocrine-disrupting chemical bisphenol a,endocrine-disrupting chemicals bisphenol A
C543008,CHEMICAL,bis(4-hydroxyphenyl)sulfone [Supplementary Concept],bisphenol S|Sulfones|Phenols
NEW06646,CHEMICAL,contaminant bpa,contaminants BPA
NEW06648,DISEASE,human neuroblastoma cell line sk-n-be,human neuroblastoma cell line SK-N-BE
NEW06649,CHEMICAL,brain high-energy phosphate metabolism,brain high-energy phosphate metabolism
http://purl.obolibrary.org/obo/DOID_0060481,DISEASE,goldberg-shprintzen syndrome,Fahr syndrome|Goldberg-Shprintzen megacolon syndrome
http://purl.org/sig/ont/fma/fma83374,BIOCHEMICAL,parathyroid hormone,excess parathyroid hormone
NEW06651,DISEASE,preexist chronic renal failure,preexisting chronic renal failure
NEW06653,NUTRITION,phosphorus spectroscopy,phosphorus spectroscopy
NEW06406,MENTAL_HEALTH,schizophrenia subject,schizophrenia subjects
NEW06656,DISEASE,bipolar subject,bipolar subjects
NEW06658,DISEASE,depressive state,depressive state
NEW06660,CHEMICAL,high-energy phosphate neuropsychological performance,high-energy phosphate neuropsychological performance
D019761,NUTRITION,Phosphorus-Oxygen Lyases,"Phosphorus|Phosphorus Oxygen Lyases|Lyases, Phosphorus-Oxygen"
NEW06664,CHEMICAL,"1,25-dihydroxyvitamin D. symptom","1,25-dihydroxyvitamin D. Symptoms"
D018167,CHEMICAL,"Receptors, Calcitriol","Vitamin D 3 Receptors|1,25 Dihydroxyvitamin D3 Receptor|Receptor, Vitamin D|Vitamin D 3 Receptor|1,25-Dihydroxyvitamin D3 Receptors|D Receptor, Vitamin|D3 Receptor, 1,25-Dihydroxyvitamin|Vitamin D3 Receptors|Cholecalciferol Receptors|Receptors, 1,25-Dihydroxycholecalciferol|D3 Receptors, 1,25-Dihydroxyvitamin|Calcitriol Receptor|1,25-Dihydroxyvitamin D 3 Receptor|1,25-Dihydroxycholecalciferol Receptor|Receptors, Vitamin D3|Receptors, Vitamin D 3|1,25-Dihydroxycholecalciferol Receptors|Calcitriol Receptors|Vitamin D Receptor|Receptors, Vitamin D|Receptors, 1,25-Dihydroxyvitamin D3|D Receptors, Vitamin|Receptors, Cholecalciferol|1,25 Dihydroxyvitamin D3 Receptors|1,25-Dihydroxyvitamin D3 Receptor|D3 Receptors, Vitamin|Vitamin D Receptors|Receptor, 1,25-Dihydroxyvitamin D3|calcitriol|1,25 Dihydroxyvitamin D 3 Receptor|Vitamin D3 Receptor|1,25 Dihydroxycholecalciferol Receptor|Receptors, 1,25-Dihydroxyvitamin D 3|Receptor, 1,25-Dihydroxycholecalciferol|Receptor, Vitamin D3|Receptor, Calcitriol|1,25 Dihydroxycholecalciferol Receptors|D3 Receptor, Vitamin"
NEW06666,BIOCHEMICAL,vitamin d compound,vitamin D compounds
NEW06667,BIOCHEMICAL,new vitamin d analogue,new vitamin D analogue
NEW06670,CHEMICAL,crp μg/ml age,CRP μg/ml age
http://purl.obolibrary.org/obo/CHEBI_35471,BIOCHEMICAL,psychotropic drug,psychoactive drugs|psychoactive agent|psychopharmaceuticals|well-known psychotropic drug|psychotropic drugs
D012206,DISEASE,Rhabdomyolysis,Rhabdomyolyses|rhabdomyolysis
NEW06675,DISEASE,psychotic patient,psychotic patients
D002309,DISEASE,Cardiology,"Specialty, Cardiovascular Disease|Disease Specialty, Cardiovascular|Medicine, Vascular|Angiology|Cardiovascular Disease Specialty|cardiovascular disease|Vascular Medicine"
C535858,DISEASE,HEM dysplasia [Supplementary Concept],ectopic calcification|Osteochondrodysplasias
NEW06676,DISEASE,myocardial infarction-induced inflammatory response,myocardial infarction-induced inflammatory response
NEW06678,BIOCHEMICAL,vitamin d signalling,vitamin D signalling
D006962,DISEASE,"Hyperparathyroidism, Secondary","Secondary Hyperparathyroidisms|Secondary Hyperparathyroidism|Hyperparathyroidisms, Secondary|secondary hyperparathyroidism"
D065386,CHEMICAL,Historically Controlled Study,"Studies, Historically Controlled|Historical Control Studies|Study, Historical Controlled|Historical Controlled Study|Studies, Historical Controlled|Historical Controlled Studies|Historically Controlled Studies|Study, Historically Controlled|Historical Control Study|Study, Historical Control|• study|Studies, Historical Control"
NEW06680,CHEMICAL,insecticide synergist pbo,insecticide synergist PBO
D018846,CHEMICAL,Excitatory Amino Acids,"Excitatory amino acids|Acid, Excitatory Amino|EAA|Amino Acids, Excitatory|Amino Acid, Excitatory|Excitatory Amino Acid|Acids, Excitatory Amino"
http://purl.obolibrary.org/obo/CHEBI_71014,BIOCHEMICAL,ampa receptor antagonist,AMPA antagonist|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist|AMPA receptor antagonists|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonists
NEW06685,DISEASE,several neurodegenerative disorder,Several neurodegenerative disorders
NEW06686,CHEMICAL,glutamate pathway,glutamate pathways
NEW06687,CHEMICAL,extracellular atp,Extracellular ATP
NEW06688,BIOCHEMICAL,muscarinic receptor partial agonist,muscarinic receptor partial agonists
NEW06692,CHEMICAL,brain histamine system,brain histamine system
NEW06693,BIOCHEMICAL,antimitotic compound methylazoxymethanol,antimitotic compound methylazoxymethanol
NEW00821,DISEASE,schizophrenia-like phenotype,schizophrenia-like phenotype
NEW06697,CHEMICAL,peripubertal cannabidiol treatment,peripubertal cannabidiol treatment
D050256,BIOCHEMICAL,Antimitotic Agents,"Drug, Antimitotic|Agent, Antimitotic|Antimitotics|Antimitotic Drugs|Drugs, Antimitotic|Antimitotic Drug|Antimitotic Agent|Agents, Antimitotic|antimitotic agent|Antimitotic"
NEW06701,DISEASE,advanced pretraite relapsed soft tissue sarcoma,advanced pretraited relapsed soft tissue sarcoma
NEW06702,DISEASE,global brain injury,Global brain injury
NEW06704,CHEMICAL,antimitotic drug temozolomide,antimitotic drug temozolomide|TMZ
http://purl.obolibrary.org/obo/CHEBI_3396,CHEMICAL,carbidopa-levodopa,levodopa/benserazide|Carbidopa-levodopa
C088383,CHEMICAL,3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole [Supplementary Concept],Isoxazoles|ABT-418|Pyrrolidines
NEW02809,DISEASE,epileptic patient,epileptic patients
NEW04810,DISEASE,attentional impairment,attentional impairment
NEW06707,CHEMICAL,ns9775,NS9775
D064569,CHEMICAL,alpha7 Nicotinic Acetylcholine Receptor,"Receptors, alpha-Bungarotoxin|alpha7 Subunit, nAChR|Receptor, alpha-Bungarotoxin|nAChR alpha7 Subunit|alpha7-nicotinic acetylcholine receptor|alpha Bungarotoxin Receptors|alpha-Bungarotoxin Receptor|Nicotinic Acetylcholine Receptor alpha7|alpha-Bungarotoxin Receptors|Subunit, nAChR alpha7|Receptor, alpha Bungarotoxin|alpha7nAChR"
http://purl.org/sig/ont/fma/fma61796,CHEMICAL,nicotinic acetylcholine receptor,alpha7-nicotinic acetylcholine receptor-deficiency
NEW06710,CHEMICAL,cholinomimetic galantamine,cholinomimetics galantamine
NEW04012,NUTRITION,choline acetyltransferase activity,choline acetyltransferase activity
NEW06711,CHEMICAL,Betel nut alkaloid,Betel nut alkaloids
NEW06713,DISEASE,tbi patient,TBI patients
C420685,CHEMICAL,CS 932 [Supplementary Concept],Isoxazoles|CS-932|Quinuclidines
D040701,MENTAL_HEALTH,"Stress Disorders, Traumatic, Acute","Acute Stress Disorder|Stress Disorders, Acute|Acute Stress Disorders|acute stress|Stress Disorder, Acute"
NEW06718,DISEASE,p. flavus isolate,P. flavus isolates
D002957,CHEMICAL,Citrus,"Trees, Citron|Pomelo Trees|Trees, Bitter Orange|Tree, Sour Orange|Pummelo Trees|Citron Tree|Trees, Lemon|Citrus grandis|Tangerine Tree|Trees, Sour Orange|Orange Tree, Seville|Citrus maxima|Sour Orange Tree|Trees, Pummelo|bergamia, Citrus|Tree, Pomelo|Citrus grandi|Orange Trees, Mandarin|medicas, Citrus|Citrus medicas|Tree, Pummelo|Seville Orange Trees|Lemon Trees|Tree, Tangerine|hystrices, Citrus|Trees, Mandarin Orange|Orange Tree, Sour|Citrus reticulatas|Citrus bergamias|Trees, Pomelo|Citrus hystrices|Mandarin Orange Trees|Bitter Orange Tree|Tree, Lemon|Citrus medica|Orange Trees, Seville|Citrus hystrix|Orange Trees, Bitter|Tree, Mandarin Orange|Trees, Seville Orange|Orange Trees, Sour|Citrus limon|Citrus bergamia|reticulata, Citrus|Citrus aurantium|aurantium, Citrus|Orange Tree, Mandarin|Citrus reticulata|Tangerine Trees|Bitter Orange Trees|Citrus aurantiums|Lemon Tree|Kaffir Lime|Orange Tree, Bitter|Pomelo Tree|Pummelo Tree|Citrus Fruit|Tree, Bitter Orange|Seville Orange Tree|maxima, Citrus|Fruit, Citrus|Citron Trees|Sour Orange Trees|Tree, Citron|Mandarin Orange Tree|Lime, Kaffir|Trees, Tangerine|Tree, Seville Orange"
D031162,NUTRITION,Achillea,"Achillea millefolium|Achillea millefoliums|Yarrow|millefolium, Achillea|Yarrows|Achilleas"
http://purl.obolibrary.org/obo/CHEBI_166595,BIOCHEMICAL,yessotoxin,"[(1R,3S,5R,7S,9R,11S,13R,14S,16R,18S,20R,22S,25R,27S,30S,31R,33S,34R,35R,37S,40S,42R,44S,46R,48S)-34-hydroxy-40-[(2R,3E)-2-hydroxy-5-methylideneocta-3,7-dien-2-yl]-13,25,27,30,35-pentamethyl-39-methylidene-13-(2-sulooxyethyl)-4,8,12,17,21,26,32,36,41,45,49-undecaoxaundecacyclo[25.22.0.03,25.05,22.07,20.09,18.011,16.031,48.033,46.035,44.037,42]nonatetracontan-14-yl] hydrogen sulate|cyanotoxin"
NEW06721,MENTAL_HEALTH,Kernel Machine regression,Kernel Machine Regression
D000077261,CHEMICAL,Carvedilol,"Carvedilol, (+)|Carvedilol, (-)|Carvedilol, (+)-isomer|Dilatrend|Carvedilol, (S)-isomer|Coropres|Eucardic|Carvedilol, (+-)-isomer|Carvedilol Hydrochloride|BM14190|Carvedilol, (-)-isomer|Coreg|Carvedilol, (R)-isomer|Carvedilol, 14C labeled|BM-14190|Querto|14C-labeled Carvedilol|Carvedilol, 14C-labeled|carvedilol|BM 14190|Kredex"
NEW06728,DISEASE,mesial temporal sclerosis,mesial temporal sclerosis
NEW06729,DISEASE,pure TLE,pure TLE
NEW06730,DISEASE,seizure frequency,Seizure frequency
NEW06732,CHEMICAL,increase mda,Increased MDA
D004833,DISEASE,"Epilepsy, Temporal Lobe","Epilepsies, Temporal Lobe|TLE|Epilepsy, Benign Psychomotor, Childhood|Epilepsies, Lateral Temporal|Uncinate Epilepsies|Uncinate Epilepsy|Childhood Benign Psychomotor Epilepsy|Epilepsy, Lateral Temporal|Lateral Temporal Epilepsies|Lateral Temporal Epilepsy|Benign Psychomotor Epilepsy, Childhood|Epilepsies, Uncinate|Epilepsy, Uncinate|Temporal Lobe Epilepsies|Temporal Lobe Epilepsy|temporal lobe epilepsy"
NEW06735,DISEASE,oxidative stress toxicity protein oxidation,oxidative stress toxicity protein oxidation
NEW06737,NUTRITION,dietary omega-3 fatty acid supplementation,dietary omega-3 fatty acid supplementation
NEW06738,BIOCHEMICAL,safe analgesic,safe analgesic
NEW06740,CHEMICAL,chronic ethanol intoxication,Chronic ethanol intoxication
NEW06743,CHEMICAL,continuous ethanol intoxication,continuous ethanol intoxication
D000069059,CHEMICAL,Atorvastatin,"Liptonorm|Lipitor|Atorvastatin Calcium|(3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid|Atorvastatin Calcium Anhydrous|Atorvastatin, Calcium Salt|Atorvastatin Calcium Hydrate|CI 981|CI-981|CI981|Atorvastatin Calcium Trihydrate|atorvastatin"
http://purl.obolibrary.org/obo/DOID_9971,CHEMICAL,hypervitaminosis d,hypovitaminosis D
NEW06745,BIOCHEMICAL,d adequacy,D adequacy
NEW06748,NUTRITION,low cholesterol,Low cholesterol
NEW06749,CHEMICAL,clozapine titration,clozapine titration
http://purl.obolibrary.org/obo/CHEBI_25681,NUTRITION,omega-3 fatty acid,omega-3 fatty acids|omega-3 fatty acid|n-3 fatty acids|omega-3 fatty acid docosahexaenoic acid|n-3 fatty acid
NEW06752,CHEMICAL,myristoleic acid concentration,myristoleic acid concentration
NEW06753,CHEMICAL,triacylglycerol alpha-linolenic acid concentration,Triacylglycerol alpha-linolenic acid concentration
NEW06755,CHEMICAL,1-stearyl-2-docosahexaenoyl-sn-glycero-3-phosphoethanolamine,1-stearyl-2-docosahexaenoyl-sn-glycero-3-phosphoethanolamine
NEW06756,CHEMICAL,cholesteryl ester oleic acid,cholesteryl ester oleic acid
NEW00023,MENTAL_HEALTH,adhd patient,ADHD patients
NEW06758,MENTAL_HEALTH,comorbid affective disorder,comorbid affective disorders
NEW06760,MENTAL_HEALTH,multivariable regression model,multivariable regression models
NEW06762,DISEASE,eighty-three manic patient,Eighty-three manic patients
D002331,CHEMICAL,Carnitine,Vitamin BT|Bicarnesine|Levocarnitine|L-Carnitine|l-carnitine|L Carnitine
NEW06768,CHEMICAL,mets prevalence,MetS prevalence
D024821,DISEASE,Metabolic Syndrome,"Cardiovascular Syndrome, Metabolic|MetS|Syndrome, Metabolic|Metabolic X Syndrome|Syndromes, Metabolic|Metabolic Syndrome X|Syndromes, Cardiometabolic|Syndrome X, Metabolic|Syndrome X, Insulin Resistance|Dysmetabolic Syndrome X|Syndrome, Metabolic X|Syndrome X, Dysmetabolic|Metabolic Syndrome|Cardiometabolic Syndromes|X Syndrome, Metabolic|Metabolic Cardiovascular Syndrome|Metabolic Syndromes|Syndrome X, Reaven|Reaven Syndrome X|Cardiometabolic Syndrome|Cardiovascular Syndromes, Metabolic|Syndrome, Metabolic Cardiovascular|Insulin Resistance Syndrome X|Syndrome, Cardiometabolic"
D063425,CHEMICAL,Binge Drinking,"Binge Alcohol Consumption|Binge alcohol consumption|Alcohol Consumption, Binge|Drinking, Binge"
NEW06771,CHEMICAL,eicosapentaenoic acid supplementation,Eicosapentaenoic acid supplementation
NEW06772,CHEMICAL,epa metabolite,EPA metabolites
D000072376,CHEMICAL,Oxysterols,oxysterols|Oxysterol
NEW06774,CHEMICAL,altered oxysterol level,Altered oxysterol levels
C044563,CHEMICAL,24-hydroxycholesterol [Supplementary Concept],24-hydroxycholesterol|Hydroxycholesterols
C041324,CHEMICAL,prostaglandin E2 methyl ester [Supplementary Concept],Prostaglandin E2|PGE2|Dinoprostone/analogs  and  derivatives
NEW06780,CHEMICAL,monoamine catabolism,monoamines catabolism
NEW06781,NUTRITION,low cholesterol level,lower cholesterol levels
D001925,DISEASE,"Brain Damage, Chronic","Encephalopathy, Chronic|Chronic Encephalopathy|brain damage|Chronic Brain Damage"
NEW06783,NUTRITION,total cholesterol,Total cholesterol
NEW06786,CHEMICAL,enzyme superoxide dismutase activity level,enzymes superoxide dismutase activity levels
D006937,DISEASE,Hypercholesterolemia,"Elevated Cholesterol|Hypercholesterolemias|Cholesterol Level, High|Levels, High Cholesterol|Cholesterol, Elevated|Cholesterol Levels, High|Hypercholesteremias|Elevated Cholesterols|High Cholesterol Level|Level, High Cholesterol|High Cholesterol Levels|Hypercholesteremia|hypercholesterolemia|Cholesterols, Elevated"
NEW06789,NUTRITION,low cholesterol level,low cholesterol levels
NEW06790,NUTRITION,abnormal membrane phospholipid metabolism,abnormal membrane phospholipid metabolism
NEW06791,CHEMICAL,reduce n-3 content,Reduced n-3 content
NEW06792,CHEMICAL,antidepressant potential,antidepressant potentials
D002318,DISEASE,Cardiovascular Diseases,"Diseases, Cardiovascular|Cardiovascular Disease|Disease, Cardiovascular|Cardiovascular diseases"
NEW06794,DISEASE,serious mental illness,serious mental illness|SMI
NEW06796,NUTRITION,phospholipid deficit,phospholipid deficits
NEW06797,CHEMICAL,cannabis consumption,cannabis consumption
D008385,CHEMICAL,Marijuana Smoking,"Blunt, Smoking|Smoking Blunt|Blunts Smokings|Cannabis smoking|Smoking, Cannabis|Smoking, Marihuana|Blunts, Smoking|Hashish Smoking|Smoking, Blunts|Blunts Smoking|Cannabis Smoking|Smoking Blunts|Smokings, Blunts|Smoking, Hashish|Marihuana Smoking|Smoking, Marijuana"
NEW06799,DISEASE,mean weight loss,Mean weight loss
NEW06800,DISEASE,corticotropin-releasing factor crf mrna level,corticotropin-releasing factor CRF mRNA levels
NEW06802,DISEASE,adult attention-deficit hyperactivity disorder,A-ADHD|adult attention-deficit hyperactivity disorder
NEW06803,CHEMICAL,adipoko mouse,adipoKO mice
D017270,CHEMICAL,Lipoprotein(a),Lipoprotein (a-)|Lipoprotein Lp(a)|lipoprotein(a|Lipoprotein a|Lipoprotein (a)
http://purl.obolibrary.org/obo/CHEBI_62754,BIOCHEMICAL,glycine receptor antagonist,Glycine receptor antagonists|glycine receptor antagonists
C111401,CHEMICAL,hemoglobin Strasbourg [Supplementary Concept],"Hemoglobins, Abnormal|Strasbourg|GAERS"
NEW06807,BIOCHEMICAL,agonist r-n6(phenylisopropyl)adenosine mg/kg,agonist R-N6(phenylisopropyl)adenosine mg/kg
NEW06810,CHEMICAL,"adenosine a1 antagonist 1,3-dipropyl-8-cyclopentylxanthine mg/kg","adenosine A1 antagonist 1,3-dipropyl-8-cyclopentylxanthine mg/kg"
NEW06812,CHEMICAL,endogenous modulator adenosine,endogenous modulator adenosine
NEW06813,MENTAL_HEALTH,anergia lack,anergia lack
NEW06815,CHEMICAL,caffeine adenosine antagonist,caffeine adenosine antagonists
http://purl.obolibrary.org/obo/CHEBI_71232,CHEMICAL,adenosine receptor antagonist,caffeine adenosine receptor antagonists|adenosine receptor antagonists
NEW06816,DISEASE,motivational dysfunction,motivational dysfunction
D013806,CHEMICAL,Theophylline,"Theo 24|Constant-T|Lodrane|Synophylate|Theophylline Sodium Glycinate|SloPhyllin|Theovent|Anhydrous, Theophylline|Theophyllinate, Glycine|Monospan|Somophyllin T|Uniphylline|Aerolate|Glycine Theophyllinate|Nuelin S.A.|Nuelin|Ct, Theo Von|Theocin|Theobid|Theo Dur|Euphylong|Theolix|Quibron TSR|Theo Von Ct|Slo Phyllin|Theospan|3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione|Aerobin|Theo-24|1,3 Dimethylxanthine|theophylline|Uniphyllin|Theolair|Somophyllin-T|Aquaphyllin|Sodium Glycinate, Theophylline|Armophylline|Theostat|Uniphyl|ConstantT|Von Ct, Theo|Theo-Dur|Theodur|Quibron T-SR|Theo24|Theonite|Afonilum Retard|Slo-Phyllin|Bronchoparat|Accurbron|SomophyllinT|Theon|1,3-Dimethylxanthine|Glycinate, Theophylline Sodium|Theophylline Anhydrous|Bronkodyl|Sustaire|Theopek|Elixophyllin|Theoconfin Continuous|Quibron T SR|Constant T"
NEW01458,DISEASE,learn impairment,learning impairments
http://purl.obolibrary.org/obo/CHEBI_48279,BIOCHEMICAL,serotonergic antagonist,5-HT antagonists|serotonin antagonists|serotonin blockaders|5-hydroxytryptamine antagonists|antiserotonergic agents|adenosinergic antagonists
NEW06819,BIOCHEMICAL,broad-spectrum antifungal,broad-spectrum antifungal
NEW06822,MENTAL_HEALTH,patient 's auditory hallucination,patient's auditory hallucinations
NEW06827,BIOCHEMICAL,pfizer drug safety datum,Pfizer drug safety data
NEW06828,DISEASE,monogenic disease autoimmune polyendocrine syndrome type,monogenic disease autoimmune polyendocrine syndrome type
D002178,CHEMICAL,"Candidiasis, Chronic Mucocutaneous","Candidiases, Chronic Mucocutaneous|Chronic Mucocutaneous Candidiasis|Mucocutaneous Candidiasis, Chronic|Chronic Mucocutaneous Candidiases|chronic mucocutaneous candidiasis|Mucocutaneous Candidiases, Chronic|CMC"
NEW06830,BIOCHEMICAL,topical antifungal treatment,Topical antifungal treatments
NEW06831,DISEASE,c. japonicum,C. japonicum
http://purl.obolibrary.org/obo/DOID_2272,DISEASE,vulvovaginal candidiasis,Candidiasis of vulva and vagina|Vulvovaginal Candidiasis|Candidal vulvovaginitis|Monilial vulvovaginitis|Candidal: cervix|recurrent vulvovaginal candidiasis
NEW06834,BIOCHEMICAL,antifungal activity,Antifungal activity
NEW06837,DISEASE,fungi aspergillus niger,fungi Aspergillus niger
NEW06839,CHEMICAL,galanthus nivalis L.,Galanthus nivalis L.
NEW06842,DISEASE,kainate-induced epilepsy,kainate-induced epilepsy
NEW06845,CHEMICAL,glp-1 receptor agonist,GLP-1 receptor agonist
NEW06848,CHEMICAL,glp-1 analog,GLP-1 analogs
C089946,CHEMICAL,"2,4-thiazolidinedione [Supplementary Concept]",Thiazolidinediones|thiazolidinedione
NEW06849,CHEMICAL,nucleos(t)ide analogue,nucleos(t)ide analogues|NUCs
http://purl.obolibrary.org/obo/CHEBI_91016,CHEMICAL,gabaa receptor agonist,receptor agonist (S)-AMPA|GABAA receptor agonists
NEW06853,CHEMICAL,omega-3 deficiency,omega-3 deficiency
NEW06855,DISEASE,tbi animal,TBI animals
NEW06856,BIOCHEMICAL,trkb receptor agonist,TrkB receptor agonist
C485383,CHEMICAL,"6,7-dihydroxyflavone [Supplementary Concept]","7,8-dihydroxyflavone|Flavones"
NEW06857,CHEMICAL,omega-3 deficiency,Omega-3 deficiency
NEW06858,BIOCHEMICAL,"agonist 7,8-dihydroxyflavone dhf h","agonist 7,8-dihydroxyflavone DHF h"
http://purl.obolibrary.org/obo/CHEBI_50137,CHEMICAL,mu-opioid receptor antagonist,selective NK(3 receptor antagonist osanetant|mu-opioid antagonists|mu-opioid antagonist|mu-opioid receptor antagonists
C091554,CHEMICAL,SR 142801 [Supplementary Concept],Piperidines|Osanetant
NEW06865,DISEASE,mild hypertension,mild hypertension
http://purl.obolibrary.org/obo/CHEBI_35469,CHEMICAL,antidepressant,antidepressants|thymoleptics|thymoleptic drugs|non-SSRI antidepressants|antidepressant drugs|thymoanaleptics
NEW06867,CHEMICAL,stimulant methylphenidate,stimulants methylphenidate
NEW06868,CHEMICAL,nonstimulant entity,nonstimulant entities
C586534,CHEMICAL,(1-(5-hydropentyl)indol-3-yl)-(1-naphthyl)methanone [Supplementary Concept],JWH|Naphthalenes|Indoles
NEW06870,DISEASE,ethanol-induced motor impairment,ethanol-induced motor impairments
http://purl.obolibrary.org/obo/CHEBI_140971,CHEMICAL,lysophosphatidylcholine 22:5-omega-3,LPC 22:5-w3|LPC(22:5-w3)|phosphatidylinosites
NEW06874,DISEASE,che tg class,ChE TG classes
NEW06878,CHEMICAL,drug valproic acid,drugs valproic acid
NEW06879,DISEASE,nhale patient,NHALE patients
NEW06881,CHEMICAL,oseltamivir intake,oseltamivir intake
NEW06882,DISEASE,adverse behavior,adverse behaviors
D022261,DISEASE,Respiratory Syncytial Virus Vaccines,"RSV Vaccines|RSV Vaccine|Respiratory Syncytial Virus Vaccine|respiratory syncytial virus|Vaccines, RSV|Vaccine, RSV"
NEW06885,BIOCHEMICAL,vr1 antagonist capsazepine,VR1 antagonist capsazepine
NEW06887,CHEMICAL,inject capsaicin,injected capsaicin
NEW06888,CHEMICAL,latent inhibition,LI|latent inhibition
NEW06892,BIOCHEMICAL,direct act antiviral agent,direct acting antiviral agents
NEW06893,CHEMICAL,hippocampal NSC,hippocampal NSC
D004671,DISEASE,"Encephalitis, Arbovirus","Encephalitides, Arthropod-Borne Viral|Epidemic Encephalitides|Encephalitides, Epidemic|Arthropod Borne Viral Encephalitis|Mosquito Borne Encephalitis|Encephalitides, Mosquito-Borne|Encephalitides, Arboviral|Mosquito-Borne Encephalitides|Encephalitis, Arthropod-Borne Viral|viral encephalitis|Arthropod-Borne Viral Encephalitides|Arbovirus Encephalitis|Arthropod Borne Encephalitis|Mosquito-Borne Encephalitis|Arthropod-Borne Encephalitis|Encephalitides, Arthropod-Borne|Epidemic Encephalitis|Viral Encephalitis, Arthropod-Borne|Encephalitides, Arbovirus|Encephalitis, Epidemic|Encephalitis, Mosquito Borne|Viral Encephalitis, Arthropod Borne|Arthropod-Borne Encephalitides|Arbovirus Encephalitides|Encephalitis, Mosquito-Borne|Viral Encephalitides, Arthropod-Borne|Encephalitis, Arthropod-Borne|Encephalitis, Arthropod Borne|Encephalitis, Arboviral|Arboviral Encephalitis|Arboviral Encephalitides|Arthropod-Borne Viral Encephalitis"
NEW06897,BIOCHEMICAL,former intravenous drug abuse,former intravenous drug abuse
D053633,CHEMICAL,"Receptor, Interferon alpha-beta","Type I Interferon Receptor|Interferon alpha beta Receptor 2|Receptor-2, Interferon alpha-beta|Interferon alpha-beta Receptor-2|Interferon alpha beta Receptor 1|Receptors, Interferon alpha|IFN-alphabetaR|alpha Receptor, Interferon|Receptor, Interferon alpha beta|Interferon alpha-beta Receptor IFNAR1 Subunit|IFNAR2.1 Subunit, Interferon alpha-beta Receptor|IFNAR1 Subunit, Interferon alpha beta Receptor|Interferon alpha beta Receptor IFNAR2 Subunit|Interferon alpha-beta Receptor Chain 2|alpha Receptors, Interferon|IFNAR2.2 Subunit, Interferon alpha beta Receptor|Interferon alpha Receptors|IFNAR1 Subunit, Interferon alpha-beta Receptor|Interferon alphabeta Receptors|alpha-beta Receptor-1, Interferon|IFNAR2.1 Subunit, Interferon alpha beta Receptor|interferon-alpha receptor|IFNAR2 Subunit, Interferon alpha beta Receptor|alpha-beta Receptor-2, Interferon|Interferon alpha-beta Receptor Chain 1|IFNAR2.2 Subunit, Interferon alpha-beta Receptor|Interferon alpha beta Receptor Chain 1|Interferon alpha-beta Receptor IFNAR2 Subunit|Interferon alpha-beta Receptor-1|Interferon alpha Receptor|Receptors, Interferon alphabeta|IFNAR2 Subunit, Interferon alpha-beta Receptor|Interferon alpha-beta Receptor|Interferon alpha beta Receptor Chain 2|IFN alphabetaR|Interferon alpha beta Receptor|Receptor-1, Interferon alpha-beta|IFN-alphaR|Receptor, Interferon alpha|Interferon alpha beta Receptor IFNAR1 Subunit"
NEW06898,BIOCHEMICAL,antiviral effect,Antiviral effects
NEW06899,CHEMICAL,daa therapy,DAA therapy
C567088,DISEASE,"Angiopathy, Hereditary, With Nephropathy, Aneurysms, And Muscle Cramps [Supplementary Concept]",muscle cramps|Raynaud Disease|Muscle Cramp
D012254,CHEMICAL,Ribavirin,Rebetol|Ribamide|Viramide|Tribavirin|Vilona|ribavirin|ICN 1229|Ribovirin|Ribamidyl|Ribamidil|Ribasphere|ICN-1229|ICN1229|Virazide|Virazole
NEW06903,DISEASE,pandemic outbreak,pandemic outbreak
C000718127,CHEMICAL,COVID-19 breakthrough infections [Supplementary Concept],COVID-19 Vaccines|COVID-19|COVID-19 infection
http://purl.obolibrary.org/obo/NCBITaxon_10407,DISEASE,hepatitis b virus,hepatitis C virus infection
NEW06904,CHEMICAL,psychiatric-risk patient,psychiatric-risk patients
NEW06907,DISEASE,acute lung damage,acute lung damage
NEW06909,CHEMICAL,buprenorphine maintenance,buprenorphine maintenance
NEW06911,CHEMICAL,intramuscular im naltrexone,intramuscular IM naltrexone
NEW06912,CHEMICAL,tc-5214,TC-5214
D058365,DISEASE,"Candidiasis, Invasive","Invasive Candidiasis|Candidiases, Invasive|Invasive Candidiases|candidiasis"
NEW06913,CHEMICAL,mg deficit,Mg deficit
NEW06914,BIOCHEMICAL,prolonged antibiotic exposure,prolonged antibiotic exposure
D009617,DISEASE,Nocardia Infections,"Nocardioses, Cerebral|Primary Cutaneous Nocardiosis|Nocardia asteroides Infections|Nocardiosis|Nocardiosis, Primary Cutaneous|Cutaneous Nocardiosis, Primary|Nocardia Infection|Pulmonary Nocardioses|Nocardioses, Pulmonary|Cerebral Nocardiosis|Nocardioses, Primary Cutaneous|Nocardioses|Pulmonary Nocardiosis|Nocardia asteroides Infection|Nocardiosis, Cerebral|Cerebral Nocardioses|Infections, Nocardia asteroides|Primary Cutaneous Nocardioses|Nocardiosis, Pulmonary|Infection, Nocardia|Infections, Nocardia|Cutaneous Nocardioses, Primary|Infection, Nocardia asteroides"
C433236,CHEMICAL,N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide [Supplementary Concept],Benzamides|Aminoquinolines|JTC-801
NEW06921,CHEMICAL,monoamine dopamine,monoamines dopamine
NEW06923,DISEASE,skin damage,Skin damage
NEW02699,MENTAL_HEALTH,chronic stress condition,chronic stress conditions
C402565,CHEMICAL,glutamate decarboxylase 1 [Supplementary Concept],glutamic acid decarboxylase|Glutamate Decarboxylase
NEW06925,DISEASE,maternal inflammation,maternal inflammation
NEW06927,CHEMICAL,tau intermediate aggregate aggregate,Tau intermediate aggregate aggregates
NEW06929,CHEMICAL,full-length abeta,full-length Abeta
NEW06931,CHEMICAL,mutant superoxide dismutase,mutant superoxide dismutase
NEW06933,CHEMICAL,endogenous amino acid l-cysteine,endogenous amino acid L-cysteine
NEW06101,DISEASE,alcohol-induced damage,alcohol-induced damage
D000077557,CHEMICAL,Ibandronic Acid,"Bondronat|Boniva|BM-210955|RPR 102289A|1-Hydroxy-3-(methylpentylamino)propylidenebisphosphonate|RPR102289A|BM210955|BM 21.0955|ibandronate|BM21.0955|RPR-102289A|Ibandronic Acid, Sodium Salt, Monohydrate|Bonviva|Ibandronate Sodium|Ibandronate Sodium Anhydrous|Ibandronate|BM-21.0955|(1-Hydroxy-3-(methylpentylamino)propylidene)bisphosphonate|BM 210955"
NEW06935,CHEMICAL,microg ibandronate,microg ibandronate
NEW06937,DISEASE,alcohol-induced tibial bone loss,alcohol-induced tibial bone loss
NEW06942,DISEASE,infertility treatment,infertility treatment
NEW06944,NUTRITION,alpha syn pathology,alpha Syn pathology
NEW06946,CHEMICAL,neurology 65:1863,Neurology 65:1863
NEW06947,DISEASE,untreated mild essential hypertension,untreated mild essential hypertension
http://purl.obolibrary.org/obo/CHEBI_184908,CHEMICAL,"2-methyl-3-(2-methylphenyl)-3,4-dihydroquinazolin-4-one [2-(diphenylmethoxy)ethyl]dimethylamine hydrochloride","LY3038404 HCl|2-benzhydryloxy-N,N-dimethylethanamine;2-methyl-3-(2-methylphenyl)quinazolin-4-one;hydrochloride"
NEW06950,BIOCHEMICAL,novel selective cb2 receptor agonist,novel selective CB2 receptor agonist
http://purl.obolibrary.org/obo/CHEBI_67072,CHEMICAL,cannabinoid receptor agonist,"non-selective cannabinoid receptor agonist WIN55,212|cannabinoid receptor agonists"
NEW06953,CHEMICAL,win mg/kg,WIN mg/kg
NEW06957,BIOCHEMICAL,gp 1a,GP 1a|selective CB2 receptor agonist
NEW06960,CHEMICAL,intra-vh microinjection,intra-VH microinjection
http://purl.obolibrary.org/obo/CHEBI_73413,BIOCHEMICAL,cannabinoid receptor antagonist,cannabinoid CB1 receptor antagonist/inverse agonist|cannabinoid receptor antagonists
C103505,CHEMICAL,AM 251 [Supplementary Concept],Pyrazoles|AM-251|Piperidines
NEW06961,CHEMICAL,morphine administration,morphine administration
NEW06964,CHEMICAL,"win55,212 mg/kg","WIN55,212 mg/kg"
NEW06965,CHEMICAL,subchronic apomorphine treatment,subchronic apomorphine treatment
NEW06967,CHEMICAL,dri score,DRI scores
NEW06969,CHEMICAL,dynamic risk indicator,DRI|Dynamic Risk Indicators
NEW06970,DISEASE,measurement violent patient,measurements violent patients
NEW06971,BIOCHEMICAL,histaminergic h3 receptor antagonist,histaminergic H3 receptor antagonists
NEW06972,BIOCHEMICAL,betahistine histaminergic h1 receptor agonist,betahistine histaminergic H1 receptor agonist
NEW06974,CHEMICAL,low-dose risperidone,low-dose risperidone
NEW06975,CHEMICAL,oral chronic exposure to ovalbumin,OVA|oral chronic exposure to ovalbumin
http://purl.org/sig/ont/fma/fma23873,BIOCHEMICAL,stabilizer,3ε stabilizer FC-A
NEW06978,BIOCHEMICAL,mood stabilizer treatment,mood stabilizer treatment
NEW06981,NUTRITION,term low dose lithium,term low dose lithium
NEW06985,DISEASE,clinical hypothyroidism,Clinical hypothyroidism
NEW06989,CHEMICAL,long-term vpa therapy,Long-term VPA therapy
NEW06990,DISEASE,psychiatric adult patient,psychiatric adult patients
NEW06991,CHEMICAL,serum vpa level,serum VPA level
D002334,CHEMICAL,Carnitine O-Palmitoyltransferase,"Palmitoylcarnitine Transferase|Acyltransferase I, Carnitine|Palmitoyltransferase I, Carnitine|Carnitine Palmitoyltransferase I|II, Carnitine Palmitoyltransferase|Carnitine Palmitoyltransferase II|Transferase, Palmitoylcarnitine|Palmitylcarnitine Acyltransferase|Acyltransferase, Palmitylcarnitine|Palmitoyltransferase II, Carnitine|Carnitine Acyltransferase I|O-Palmitoyltransferase, Carnitine|Carnitine Palmitoyltransferase|Palmitoyltransferase, Carnitine|CPT II|carnitine|Carnitine O Palmitoyltransferase"
NEW06992,CHEMICAL,ammonia level,ammonia levels
NEW06993,DISEASE,anti-nmda receptor nmdar encephalitis,Anti-NMDA receptor NMDAR encephalitis
NEW06994,CHEMICAL,serotonergic antidepressant medication,Serotonergic antidepressant medications
NEW01079,CHEMICAL,antidepressant use,Antidepressant use
NEW06995,BIOCHEMICAL,mood stabilizer therapy,Mood stabilizer therapy
NEW06997,CHEMICAL,benzodiazepine medication,benzodiazepine medications
D003291,MENTAL_HEALTH,Conversion Disorder,"Neurological Disorders, Functional|Conversion Reaction|Astasia-Abasia|Functional Movement Disorders|Movement Disorders, Functional|Conversion Disorder|Disorder, Functional Movement|Neurosis, Conversion|Conversion Neurosis|Conversion Neuroses|Disorder, Functional Neurological|Functional Movement Disorder|Movement Disorder, Functional|Astasia Abasia|Conversion Disorders|Neuroses, Conversion|Neurological Disorder, Functional|Functional Neurological Disorders|Functional Neurological Disorder|Hysteria, Conversion|Conversion Hysteria"
NEW07001,CHEMICAL,adjunctive modafinil,adjunctive modafinil
NEW07003,BIOCHEMICAL,antidepressant stabilizer treatment,antidepressant stabilizer treatments
http://purl.obolibrary.org/obo/CHEBI_65191,CHEMICAL,second generation antipsychotic,atypical antipsychotic|Second generation antipsychotics|atypical antipsychotic drug|atypical antipsychotic drugs|second generation antipsychotic agent|atypical antipsychotic agents|atypical antipsychotics|second generation antipsychotic drug|SGAs|second generation antipsychotic agents|atypical antipsychotic agent|second generation antipsychotic drugs|second generation antipsychotics
NEW07005,BIOCHEMICAL,safe monoamine stabilizer,safe monoamine stabilizer
NEW07007,CHEMICAL,anticonvulsant oxcarbazepine,anticonvulsant oxcarbazepine
NEW07008,CHEMICAL,substituted amphetamine,Substituted amphetamines
NEW07012,DISEASE,lithium-induced hyperparathyroidism,lithium-induced hyperparathyroidism
D052139,CHEMICAL,Intracellular Calcium-Sensing Proteins,"Calcium-Sensing Peptides, Intracellular|Intracellular Calcium Sensing Proteins|Calcium Sensing Peptides, Intracellular|Calcium Sensing Proteins, Intracellular|Intracellular Calcium Sensing Peptides|Intracellular Calcium-Sensing Peptides|Peptides, Intracellular Calcium-Sensing|intracellular calcium|Calcium-Sensing Proteins, Intracellular"
NEW00431,CHEMICAL,smoke cannabis,smoked cannabis
C536275,DISEASE,Fahr's disease [Supplementary Concept],Fahr's syndrome|Calcinosis|Basal Ganglia Diseases|Neurodegenerative Diseases
NEW07018,CHEMICAL,other bisphosphonate,Other bisphosphonates
D012968,CHEMICAL,Etidronic Acid,"Dicalcium Etidronate|Didronel|1-Hydroxyethylene Diphosphonate, Disodium|Xidiphon|Salt Etidronate, Tetrapotassium|Etidronate Disodium|Hydroxyethylidene Diphosphonic Acid|EHDP|Etidronate|Diphosphonic Acid, Hydroxyethylidene|Etidronate, Tetrapotassium Salt|1,1 hydroxyethylenediphosphonate|HEDSPA|Tetrapotassium Salt Etidronate|etidronate|Disodium Etidronate|Disodium 1-Hydroxyethylene Diphosphonate|Etidronate, Disodium|1-Hydroxyethane-1,1-Diphosphonate|Etidronate, Dicalcium|HEDP|EHDP, Dicalcium|1 Hydroxyethylidene 1,1 Bisphosphonate|Phosphonic acid, (1-hydroxyethylidene)bis-, disodium salt|1,1-hydroxyethylenediphosphonate|(1-hydroxyethylene)diphosphonic acid|Xydiphone|Diphosphonate, Disodium 1-Hydroxyethylene|Xidifon|Dicalcium EHDP|Disodium 1 Hydroxyethylene Diphosphonate|Ethanehydroxyphosphate|Ethanehydroxydiphosphonate|(1-hydroxyethylene)diphosphonic acid, Tetrapotassium Salt|1 Hydroxyethane 1,1 Diphosphonate|Etidronate, Sodium|Sodium Etidronate|Hydroxyethanediphosphonate|1-Hydroxyethylidene-1,1-Bisphosphonate"
D000077268,CHEMICAL,Pamidronate,"(3-Amino-1-hydroxypropylidene)-1,1-biphosphonate|1-Hydroxy-3-aminopropane-1,1-diphosphonic acid|AHPrBP|Amino 1 hydroxypropane 1,1 diphosphonate|Pamidronate Calcium|Aminopropanehydroxydiphosphonate|1 Hydroxy 3 aminopropane 1,1 diphosphonic acid|Amino-1-hydroxypropane-1,1-diphosphonate|Aminohydroxypropylidene Diphosphonate|Pamidronic Acid|Aredia|Amidronate|Pamidronate Disodium|pamidronate|Pamidronate Monosodium"
NEW07019,CHEMICAL,only benzodiazepine,only benzodiazepines
C000719193,DISEASE,Arachnophobia [Supplementary Concept],arachnophobia|Phobic Disorders
NEW07022,DISEASE,chronic spinal cord injury,Chronic spinal cord injury|CSCI
D000069448,CHEMICAL,Denosumab,Prolia|Xgeva|Denosumab|AMG 162
NEW07024,DISEASE,lactate-induced panic-like response,lactate-induced panic-like response
NEW07026,CHEMICAL,gamma aminobutyric acid gaba neuron-related marker,gamma aminobutyric acid GABA neuron-related markers
NEW07027,CHEMICAL,gaba-synthesizing enzyme gad67,GABA-synthesizing enzyme GAD67
NEW07028,CHEMICAL,calcium-binding protein parvalbumin,calcium-binding protein parvalbumin
NEW07031,CHEMICAL,elevated free intracellular calcium ion concentration,elevated free intracellular calcium ion concentrations
NEW07032,NUTRITION,mm lithium,mM lithium
D000073296,DISEASE,Noncommunicable Diseases,"Noninfectious Disease|Chronic Disease, Non-communicable|chronic diseases|Noncommunicable Disease|Non-infectious Disease|Disease, Non-communicable|Non-communicable Chronic Disease|Non communicable Chronic Diseases|Non-infectious Diseases|Non-communicable Diseases|Non-communicable Disease|Non communicable Diseases|Non-communicable Chronic Diseases|Non infectious Diseases|Noninfectious Diseases"
NEW07034,CHEMICAL,dysregulate ammonia metabolism,Dysregulated ammonia metabolism
NEW07035,CHEMICAL,BabaoDan,BabaoDan
NEW07038,CHEMICAL,(5-ht)-stimulated platelet intracellular calcium ca mobilization,(5-HT)-stimulated platelet intracellular calcium Ca mobilization
NEW07040,CHEMICAL,intra-vmpfc administration prior,Intra-vmPFC administration prior
C000601471,CHEMICAL,"1,1,1,3,3,3-hexafluoropropan-2-yl 4-(bis(benzo(d)(1,3)dioxol-5-yl)(hydroxy)methyl)piperidine-1-carboxylate [Supplementary Concept]",Benzodioxoles|KML29|Piperidines
http://purl.obolibrary.org/obo/CHEBI_185741,CHEMICAL,brosimacutin h,"KML29    h|1-[3-(2,3-dihydroxy-3-methylbutyl)-2,4-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one"
NEW07042,BIOCHEMICAL,vitamin d insufficiency,Vitamin D insufficiency
http://purl.obolibrary.org/obo/CHEBI_30351,CHEMICAL,"2,2'-bipyridine","bpy|2,2'-dipyridine|2,2'-bipyridine|5-HT-induced Ca2|alpha,alpha'-dipyridyl|2,2'-dipyridyl|alpha,alpha'-dipyridine|alpha,alpha'-bipyridyl|2,2'-bipyridyl|2,2'-Bipyridin|alpha,alpha'-bipyridine|2-(2-pyridyl)pyridine"
NEW07045,DISEASE,psychotic sign,psychotic signs
NEW07046,DISEASE,convulsive component,convulsive component
NEW07048,NUTRITION,acidic phospholipid,acidic phospholipids
D051360,CHEMICAL,Cyclin-Dependent Kinase 5,"Protein Kinase, Cdk5|PSSALRE Protein|Cdk5 Protein|Neuronal Cdc2-Like Protein Kinase|Cdk5 Protein Kinase|PSSALRE, Cdc2-Related Kinase|Cyclin Dependent Kinase 5|Neuronal Cdc2 Like Protein Kinase|Cyclin-dependent kinase 5|CDK5|Cdc2-Related Kinase PSSALRE|Cdc2 Related Kinase PSSALRE"
NEW07050,CHEMICAL,high calcium level,High calcium levels
NEW07054,CHEMICAL,Aqueously,Aqueously
NEW07057,CHEMICAL,covid-19 situation,COVID-19 situation
NEW07058,CHEMICAL,pure kavalactone,pure kavalactones
NEW07060,CHEMICAL,d-kawain,D-kawain
D020901,CHEMICAL,Kava,"Piper methysticums|Kawas, Kawa|Kava Kavas|Kawa Kawa|Kava Kava|methysticums, Piper|Kavas, Kava|Piper methysticum|kava|Kava, Kava|Kawa|Kawas|Kavas|Kawa, Kawa|Kawa Kawas"
NEW07061,DISEASE,toxic ingestion,Toxic ingestions
NEW07063,MENTAL_HEALTH,chronic fatigue group,Chronic fatigue group
NEW07066,CHEMICAL,egcg administration,EGCG administration
C062817,CHEMICAL,N-hydroxy-N'-aminoguanidine [Supplementary Concept],Guanidines|AG|aminoguanidine
D018086,CHEMICAL,Glutamate Dehydrogenase (NADP+),"NADP-Specific Glutamate Dehydrogenase|Dehydrogenase, NADPH-Dependent Glutamate|Dehydrogenase, NADP+-Dependent Glutamate|NADP+-Dependent Glutamate Dehydrogenase|NADP-Dependent Glutamate Dehydrogenase|Glutamate Dehydrogenase, NADPH-Dependent|NADP Specific Glutamate Dehydrogenase|Glutamate Dehydrogenase, NADP+-Dependent|NADPH Dependent Glutamate Dehydrogenase|NADPH-Dependent Glutamate Dehydrogenase|GDH|Dehydrogenase, NADP-Dependent Glutamate|Glutamate Dehydrogenase, NADP-Specific|Glutamate Dehydrogenase, NADP-Dependent|NADP+ Dependent Glutamate Dehydrogenase|Glutamate dehydrogenase|Dehydrogenase, NADP-Specific Glutamate|NADP Dependent Glutamate Dehydrogenase"
NEW07070,CHEMICAL,glutamine catabolism,glutamine catabolism
NEW07072,CHEMICAL,gdh inhibitor,GDH inhibitors
D051960,CHEMICAL,"GTP-Binding Protein alpha Subunit, Gi2","GTP|GTP Binding Protein alpha Subunit, Gi2|G Protein Subunit alpha I2|Galphai2 Protein|Gi2-alpha Protein|Gi2 alpha Protein|Galpha(i2) Protein"
D004352,BIOCHEMICAL,"Drug Resistance, Microbial","Antibiotic resistance|Antibiotic Resistance|Resistance, Antibiotic|Antimicrobial Drug Resistance|Drug Resistances, Microbial|Antibiotic Resistance, Microbial|Antimicrobial Drug Resistances"
NEW07073,MENTAL_HEALTH,resistance mutation,resistance mutations
D018168,CHEMICAL,"Receptors, Retinoic Acid","Retinoic Acid-Binding Proteins|Proteins, Retinoic Acid-Binding|retinoic acid|Retinoic Acid Receptors|Receptor, Retinoic Acid|Retinoic Acid Binding Proteins|Retinoic Acid Receptor"
NEW07075,DISEASE,ra resistance,RA resistance
NEW07078,BIOCHEMICAL,ha filler,HA fillers
http://purl.org/sig/ont/fma/fma86578,CHEMICAL,interleukin,Interleukins (IL)-8
NEW07083,BIOCHEMICAL,il-1 receptor antagonist,IL-1 receptor antagonist
NEW07086,CHEMICAL,analogue lurasidone,analogue lurasidone
NEW07087,CHEMICAL,ziprasidone analogue,ziprasidone analogue
NEW07088,DISEASE,autoimmune encephalitis,Autoimmune encephalitis
D065166,DISEASE,Sepsis-Associated Encephalopathy,"Deliriums, Sepsis Associated|Associated Delirium, Sepsis|Deliriums, Sepsis-Associated|Sepsis Associated Delirium|Encephalopathy, Sepsis Associated|Sepsis Associated Deliriums|Encephalopathies, Sepsis-Associated|Encephalopathies, Sepsis Associated|Sepsis Associated Encephalopathies|Sepsis Associated Encephalopathy|Sepsis-Associated Encephalopathies|Sepsis-Associated Deliriums|Associated Deliriums, Sepsis|Delirium, Sepsis-Associated|Associated Encephalopathy, Sepsis|Sepsis-Associated Delirium|Associated Encephalopathies, Sepsis|Encephalopathy, Sepsis-Associated|Delirium, Sepsis Associated|sepsis"
NEW07092,DISEASE,endothelial injury,endothelial injury
NEW07093,CHEMICAL,excessive alcohol consumption,excessive alcohol consumption
http://purl.obolibrary.org/obo/DOID_12930,DISEASE,dilated cardiomyopathy,Familial dilated cardiomyopathy|nonischemic dilated cardiomyopathy|Congestive cardiomyopathy|primary dilated cardiomyopathy|Idiopathic dilation cardiomyopathy
NEW07094,DISEASE,hypertension account,hypertension accounts
NEW07095,DISEASE,unintentional ingestion,unintentional ingestions
D062025,DISEASE,Organophosphate Poisoning,"Organothiophosphonate Poisoning|Organothiophosphate Poisoning|Poisonings, Organothiophosphate|Poisoning, Organothiophosphonate|Poisonings, Organothiophosphonate|Poisoning, Organophosphate|Organothiophosphonate Poisonings|Organothiophosphate Poisonings|Organophosphorus Poisoning|Poisonings, Organophosphate|poisoning|Poisoning, Organothiophosphate|Organophosphate Poisonings"
NEW07099,NUTRITION,omega fatty acid,omega fatty acids
NEW07101,NUTRITION,tart cherry extract,tart cherry extract
NEW07102,NUTRITION,Cherry concentrate,Cherry concentrate
NEW07105,CHEMICAL,natalizumab therapy,Natalizumab therapy
NEW07106,DISEASE,recurrent/chronic dermatophytosis,recurrent/chronic dermatophytosis
NEW07108,CHEMICAL,intravenous voriconazole,Intravenous voriconazole
D003480,DISEASE,Cushing Syndrome,"Cushing's Syndrome|Syndrome, Cushing's|Syndrome, Cushing|Cushing's syndrome|Hypercortisolism"
NEW07111,DISEASE,hypercortisolemia,hypercortisolemia
D017088,DISEASE,AIDS-Related Opportunistic Infections,"Opportunistic Infections, HIV-Related|HIV-Related Opportunistic Infections|opportunistic infections|AIDS-Related Opportunistic Infection|AIDS Related Opportunistic Infections|Infections, HIV-Related Opportunistic|Opportunistic Infection, HIV-Related|Infection, HIV-Related Opportunistic|Opportunistic Infection, AIDS-Related|Opportunistic Infections, AIDS Related|HIV-Related Opportunistic Infection|Opportunistic Infections, AIDS-Related|HIV Related Opportunistic Infections|Opportunistic Infections, HIV Related"
NEW07112,CHEMICAL,tau proteolysis,Tau proteolysis
http://purl.obolibrary.org/obo/CHEBI_132554,CHEMICAL,oligomer,oligomers|Amyloid-β Aβ oligomers
D064430,CHEMICAL,NAD (+) and NADP (+) Dependent Alcohol Oxidoreductases,"Alchohol Oxidoreductases, NAD (+) and NADP (+) Dependent|NAD+"
D009249,BIOCHEMICAL,NADP,"Triphosphopyridine Nucleotide|Nicotinamide-Adenine Dinucleotide Phosphate|Nicotinamide Adenine Dinucleotide Phosphate|Phosphate, Nicotinamide-Adenine Dinucleotide|Nucleotide, Triphosphopyridine|Dinucleotide Phosphate, Nicotinamide-Adenine|Coenzyme II|nicotinamide adenine dinucleotide|NADPH"
D009537,CHEMICAL,Nicotinamide Mononucleotide,"NMN|Nicotinamide mononucleotide|Mononucleotide, Nicotinamide"
http://purl.obolibrary.org/obo/CHEBI_37694,CHEMICAL,o-phospho peptide,amyloid-β Aβ peptide|O-phospho peptides
NEW07116,BIOCHEMICAL,toxic agent,toxic agents
D051299,MENTAL_HEALTH,Post-Dural Puncture Headache,"Headaches, Postdural Puncture|Post-Lumbar Puncture Headache|Post-Dural Puncture Headaches|Headaches, Post-Dural Puncture|Post Dural Puncture Headache|Postdural Puncture Headache|Postdural Puncture Headaches|Headache, Postdural Puncture|headache|Headache, Post-Dural Puncture"
NEW07118,DISEASE,ari group,ARI group
NEW01262,MENTAL_HEALTH,schizophrenia patient,schizophrenia patients
NEW07120,BIOCHEMICAL,vitamin b6 therapy,vitamin B6 therapy
D020078,DISEASE,Neurogenic Inflammation,"Inflammation, Neurogenic|Inflammations, Neurogenic|Inflammation|Neurogenic Inflammations"
NEW07124,DISEASE,ringed sideroblastic anemia,ringed sideroblastic anemia
D005494,BIOCHEMICAL,Folic Acid Deficiency,"Deficiencies, Folic Acid|Acid Deficiencies, Folic|Deficiency, Folic Acid|Folic Acid Deficiencies|folic acid deficiency|Acid Deficiency, Folic"
C536510,DISEASE,Thiamine responsive megaloblastic anemia syndrome [Supplementary Concept],"Anemia, Megaloblastic|Megaloblastic anemia|Diabetes Mellitus|Thiamine Deficiency/congenital|Hearing Loss, Sensorineural"
C535323,DISEASE,Chromosome 5q Deletion Syndrome [Supplementary Concept],"Anemia, Macrocytic|Chromosome Deletion|Chromosomes, Human, Pair 5|macrocytic anemia"
http://purl.obolibrary.org/obo/SYMP_0000272,DISEASE,myoclonic seizure,Pyridoxine-dependent seizure
NEW07127,DISEASE,idiopathic hyperoxaluria,idiopathic hyperoxaluria
D002129,CHEMICAL,Calcium Oxalate,"Monohydrate, Calcium Oxalate|Calcium Oxalate Dihydrate (1:1)|Calcium Oxalate Monohydrate|Calcium Oxalate Dihydrate|Calcium Oxalate Trihydrate|Trihydrate, Calcium Oxalate|oxalate|Oxalate, Calcium|Calcium Oxalate Monohydrate (1:1)|Calcium Oxalate (1:1)|Dihydrate, Calcium Oxalate"
NEW07128,DISEASE,mild hyperhomocysteimenia,mild hyperhomocysteimenia
NEW07129,BIOCHEMICAL,folate system genetic variant,folate system genetic variants
NEW07130,MENTAL_HEALTH,isoniazid-related psychosis,isoniazid-related psychosis
NEW07133,CHEMICAL,antituberculosis,antituberculosis
NEW07134,CHEMICAL,serum homocysteine,serum homocysteine
NEW07135,BIOCHEMICAL,vitamin b supplementation,vitamin B supplementation
NEW07136,BIOCHEMICAL,b vitamin supplementation,B vitamin supplementation
NEW07138,CHEMICAL,serum pyridoxal level,serum pyridoxal levels
http://purl.obolibrary.org/obo/CHEBI_176842,BIOCHEMICAL,vitamin b9,vitamin B9 vitamer|folate vitamers|folate vitamer|vitamins B6|vitamin B9|vitamins B9|vitamin B9 vitamers|vitamin B-9
NEW07139,CHEMICAL,vasopressin v(1b receptor,vasopressin V(1b receptor
D004412,DISEASE,Dysmenorrhea,"Painful Menstruations|Menstrual Pain|Menstruation, Painful|Pains, Menstrual|Menstrual Pains|Painful Menstruation|Menstruations, Painful|Pain, Menstrual|Dysmenorrheas|dysmenorrhea"
D012964,CHEMICAL,Sodium,"Sodium-23|Sodium 23|Level, Sodium Ion|Ion Level, Sodium|sodium level|Sodium Ion Level"
NEW07142,NUTRITION,cholesterol catabolism,cholesterol catabolism
NEW07144,DISEASE,primary bile acid,primary bile acids
NEW07145,CHEMICAL,abu-genes,abu-genes
D010612,DISEASE,Pharyngitis,"Pharyngitides|Sore Throats|Sore Throat|pharyngitis|Throat, Sore"
NEW07147,CHEMICAL,tsen54 gene,Tsen54 gene
NEW07150,BIOCHEMICAL,nk1 receptor antagonist,NK1 receptor antagonists
NEW07151,BIOCHEMICAL,non-peptide nk1 receptor antagonist,non-peptide NK1 receptor antagonists
NEW07153,BIOCHEMICAL,nk3 receptor antagonist,NK3 receptor antagonists
NEW07154,CHEMICAL,substance p-neurokinin-1 nk1 receptor pathway,Substance P-neurokinin-1 NK1 receptor pathways
NEW07155,BIOCHEMICAL,selective nk1 receptor antagonist,selective NK1 receptor antagonist
NEW07157,CHEMICAL,neuraminidase inhibitor 3r 5s]-4-acetamide-5-amino-3-(1-ethylpropyl)-1-cyclohexene-1-carboxylate phosphate,neuraminidase inhibitor 3R 5S]-4-Acetamide-5-amino-3-(1-ethylpropyl)-1-cyclohexene-1-carboxylate phosphate
D053139,CHEMICAL,Oseltamivir,GS 4104|GS4104|GS4071|GS-4071|GS-4104|GS 4071|Tamiflu|Oseltamivir
NEW07160,CHEMICAL,conyza canadensis,Conyza canadensis
C026166,CHEMICAL,theanine [Supplementary Concept],theanine|Glutamates
NEW07162,CHEMICAL,tea consumption,tea consumption
NEW07163,CHEMICAL,mg/kg nicotine,mg/kg nicotine
NEW07167,MENTAL_HEALTH,clear dissociation,clear dissociation
D007050,CHEMICAL,Ibogaine,NIH 10567|12-Methoxyibogamine|NIH10567|Endabuse|12 Methoxyibogamine|NIH-10567|Ibogaine
NEW07168,CHEMICAL,ibogaine pretreatment,Ibogaine pretreatment
NEW07171,BIOCHEMICAL,nmda antagonist action,NMDA antagonist actions
NEW07172,BIOCHEMICAL,kappa agonist,kappa agonist
NEW07173,CHEMICAL,morphine self-administration,morphine self-administration
D058908,BIOCHEMICAL,Adenosine A2 Receptor Agonists,Adenosine A2A Receptor Agonists|adenosine A2A receptor agonists|Adenosine A2B Receptor Agonists
NEW05885,DISEASE,motor deficit,motor deficits
C021053,NUTRITION,mangostin [Supplementary Concept],Xanthones|alpha mangostin
NEW07179,BIOCHEMICAL,cariprazine d2 receptor partial agonist,Cariprazine D2 receptor partial agonist
NEW07181,CHEMICAL,metabotropic eaa receptor,metabotropic EAA receptors
NEW01600,DISEASE,severe psychiatric disorder,severe psychiatric disorders
NEW06956,CHEMICAL,mptp administration,MPTP administration
http://purl.obolibrary.org/obo/MFOMD_0000179,MENTAL_HEALTH,suicidal behavior,suicidal behavior
D011611,CHEMICAL,Psychosomatic Medicine,"Medicine, Psychosomatic|APM|Psychosomatic Medicine"
NEW07187,BIOCHEMICAL,alpha 1/alpha agonist clonidine,alpha 1/alpha agonist clonidine
NEW06043,MENTAL_HEALTH,chronic schizophrenia,chronic schizophrenia
NEW07193,CHEMICAL,combined oral contraceptive use,Combined oral contraceptive use
NEW07194,CHEMICAL,coc user,COC users
NEW01558,DISEASE,adverse mood,adverse mood
NEW07195,CHEMICAL,add-back hormone replacement therapy,add-back hormone replacement therapy
http://purl.obolibrary.org/obo/CHEBI_41922,CHEMICAL,diethylstilbestrol,"diethylstilbestrol|trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|Distilbene|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|diethylstilbestrolum|alpha,alpha'-diethyl-(E)-4,4'-stilbenediol|4,4'-(3E)-hex-3-ene-3,4-diyldiphenol|(E)-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|diethylstilboestrol|DES|trans-Diethylstilboesterol|4,4'-dihydroxy-alpha,beta-diethylstilbene|trans-Diethylstilbesterol|Diethylstilbestrol|dietilestilbestrol|trans-Diethylstilbestrol"
NEW07196,CHEMICAL,prenatal exposure to diethylstilboestrol,Prenatal exposure to diethylstilboestrol|DES
D020249,BIOCHEMICAL,Hormone Replacement Therapy,"Hormone Replacement Therapies|Replacement Therapies, Hormone|Therapies, Hormone Replacement|Replacement Therapy, Hormone|hormone replacement therapy|Therapy, Hormone Replacement"
NEW07197,CHEMICAL,selective nicotinic partial agonist varenicline,selective nicotinic partial agonist varenicline
C490152,CHEMICAL,ispronicline [Supplementary Concept],Pyridines|TC-1734
D011978,CHEMICAL,"Receptors, Nicotinic","Receptors, Nicotinic Acetylcholine|Nicotinic Acetylcholine Receptors|Receptor, Nicotinic|nicotinic acetylcholine receptors|Acetylcholine Receptor, Nicotinic|Acetylcholine Receptors, Nicotinic|Nicotinic Acetylcholine Receptor|Receptor, Nicotinic Acetylcholine|Nicotinic Receptors|Nicotinic Receptor"
NEW07201,NUTRITION,nicotinic acetylcholine alpha receptor gene,nicotinic acetylcholine alpha receptor gene
D016878,DISEASE,POEMS Syndrome,"Syndrome, Takatsuki's|Polyneuropathy Organomegalies|Organomegaly, Polyneuropathy|Crow-Fukase Syndrome|Crow-Fukase syndrome|Polyneuropathy, Organomegaly, Endocrinopathy, M Protein, and Skin Changes Syndrome|Takatsuki's Syndrome|Syndrome, POEMS|Takatsuki Syndrome|Syndrome, Crow-Fukase|Organomegalies, Polyneuropathy|Crow Fukase Syndrome|Polyneuropathy Organomegaly"
D013792,CHEMICAL,Thalidomide,Thalomid|Sedoval|Thalidomide
NEW07208,DISEASE,spinal pain processing receptor,spinal pain processing receptors
NEW07209,CHEMICAL,intrathecal hypotaurine,intrathecal hypotaurine
C094635,CHEMICAL,L 701324 [Supplementary Concept],"L-701,324|Quinolones"
C058083,CHEMICAL,eliprodil [Supplementary Concept],eliprodil|Piperidines
NEW07211,CHEMICAL,certain nmda receptor subunit,certain NMDA receptor subunits
NEW07213,CHEMICAL,third trimester ethanol exposure,third trimester ethanol exposure
NEW07214,CHEMICAL,oxaliplatin treatment,oxaliplatin treatment
NEW07215,BIOCHEMICAL,selective pparγ agonist,selective PPARγ agonists
NEW07216,BIOCHEMICAL,synthetic agonist,synthetic agonist
C541917,CHEMICAL,INT 131 [Supplementary Concept],Quinolines|Sulfonamides|INT-131
NEW07217,BIOCHEMICAL,act m1 muscarinic agonist,acting m1 muscarinic agonists
NEW07218,CHEMICAL,antisense oligonucleotide technology,antisense oligonucleotide technology
NEW07221,DISEASE,b. cereus SW7,B. cereus SW7
NEW02536,DISEASE,cardiovascular event,cardiovascular events
NEW07224,DISEASE,p. aeruginosa tat mutant,P. aeruginosa tat mutants
NEW07226,CHEMICAL,cytotoxin-associated gene a,CagA|cytotoxin-associated gene A
NEW07228,CHEMICAL,copenhagen prospective study,COpenhagen Prospective Study
NEW07234,MENTAL_HEALTH,multiple linear regression model,multiple linear regression model
NEW07236,DISEASE,metabolic dysfunction,Metabolic dysfunction
C527551,CHEMICAL,LY686017 [Supplementary Concept],Triazoles|Pyridines|LY686017
NEW07239,CHEMICAL,with/without estradiol replacement,with/without estradiol replacement
NEW07242,CHEMICAL,intranasal oxytocin,intranasal oxytocin
NEW07244,DISEASE,emotional disorder,emotional disorders
NEW07245,BIOCHEMICAL,corticotropin releasing hormone arginine vasopressin avp concentration,Corticotropin releasing hormone arginine vasopressin AVP concentrations
NEW07246,CHEMICAL,dopamine transporter inhibitor,Dopamine transporter inhibitors
NEW07247,DISEASE,chronic hyperammonemia,Chronic hyperammonemia
NEW07249,DISEASE,chronic hyperammonemia similar,chronic hyperammonemia similar
NEW07250,MENTAL_HEALTH,heterotypic chronic stress,heterotypic chronic stress
NEW07252,BIOCHEMICAL,synthetic hormone,synthetic hormone
NEW07253,DISEASE,new-onset hypothyroidism,new-onset hypothyroidism
NEW07254,CHEMICAL,leuprorelin administration,Leuprorelin administration
NEW07255,CHEMICAL,leuprorelin injection,leuprorelin injection
NEW07256,BIOCHEMICAL,gonadotrophin-releasing hormone analog,Gonadotrophin-Releasing Hormone analogs
NEW07257,CHEMICAL,central glutamate,central glutamate
NEW07258,BIOCHEMICAL,plasma hpa axis hormone,Plasma HPA axis hormones
NEW07260,BIOCHEMICAL,long-term hormone replacement therapy,long-term hormone replacement therapy
D013036,DISEASE,"Spasms, Infantile","Hypsarrhythmias|Jackknife Seizure|infantile spasms|West Syndrome, Cryptogenic|Nodding Spasm|Spasms, Nodding|Infantile Spasm|Spasm, Nodding|Infantile Spasms|Infantile Spasms, Cryptogenic|Infantile Spasm, Cryptogenic|West Syndrome, Symptomatic|West Syndrome|Attacks, Lightning|Cryptogenic Infantile Spasms|Attacks, Salaam|Spasm, Cryptogenic Infantile|Spasmus Nutans|Lightning Attack|Spasms, Symptomatic Infantile|Spasm, Symptomatic Infantile|Spasms, Cryptogenic Infantile|Symptomatic Infantile Spasm|Seizure, Jackknife|Attack, Lightning|Syndrome, Cryptogenic West|Syndrome, West|Salaam Seizures|Syndrome, Symptomatic West|Jackknife Seizures|Seizures, Jackknife|Lightning Attacks|Salaam Attacks|Cryptogenic West Syndrome|Cryptogenic Infantile Spasm|Nodding Spasms|Symptomatic Infantile Spasms|Infantile Spasm, Symptomatic|Symptomatic West Syndrome|Seizures, Salaam|Infantile Spasms, Symptomatic|Hypsarrhythmia"
NEW07261,MENTAL_HEALTH,static encephalopathy,static encephalopathy
NEW01893,MENTAL_HEALTH,severe depression,severe depression
NEW07264,CHEMICAL,trh stimulation,TRH stimulation
NEW07265,DISEASE,mood symptom,mood symptoms
NEW07267,CHEMICAL,cortisol plasma level,cortisol plasma levels
NEW07268,DISEASE,dopamine-related gene,dopamine-related genes
NEW07269,CHEMICAL,gonadal hormone testosterone,gonadal hormone testosterone
NEW07271,MENTAL_HEALTH,stress associate mental disorder,stress associated mental disorders
D020187,MENTAL_HEALTH,REM Sleep Behavior Disorder,"Behavior Disorder, REM|Behavior Disorders, REM|Rapid Eye Movement Sleep Behavior Disorder|Behavior Disorder, Rapid Eye Movement Sleep|REM Behavior Disorders|REM sleep behavior disorder|REM Behavior Disorder"
NEW07274,CHEMICAL,nesfatin-1-hormone,nesfatin-1-hormone
NEW07275,DISEASE,bpd symptomatology,BPD symptomatology
NEW07276,CHEMICAL,serum oxt,serum OXT
D007041,CHEMICAL,Hypoxanthine Phosphoribosyltransferase,"Pyrophosphorylase, IMP|Phosphoribosyltransferase, Hypoxanthine-Guanine|HPRTase|IMP Pyrophosphorylase|hypoxanthine phosphoribosyltransferase|Phosphoribosyltransferase, Hypoxanthine|Hypoxanthine Guanine Phosphoribosyltransferase|Phosphoribosyltransferase, Guanine|Guanine Phosphoribosyltransferase|HGPRT|HPRT|Hypoxanthine-Guanine Phosphoribosyltransferase"
NEW07280,CHEMICAL,phosphorylate fty720,Phosphorylated FTY720
C542743,CHEMICAL,((E)-3-amino-5-(4-heptylphenyl)-3-(hydroxymethyl)pent-1-enyl)phosphonic acid [Supplementary Concept],FTY720|FTY720-P|Organophosphonates
NEW07284,BIOCHEMICAL,major metabolism-regulating hormone,major metabolism-regulating hormone
NEW07285,CHEMICAL,exogenous melatonin,Exogenous melatonin
NEW07288,BIOCHEMICAL,hormone fluctuation,hormone fluctuation
NEW07289,DISEASE,thyroid autoimmunity,thyroid autoimmunity
NEW07291,BIOCHEMICAL,hypothalamic-pituitary-thyroid axis hormone,hypothalamic-pituitary-thyroid axis hormones
NEW07292,MENTAL_HEALTH,postnatal psychosis,postnatal psychosis
NEW07295,BIOCHEMICAL,mood stabiliser,Mood stabilisers
http://purl.obolibrary.org/obo/MF_0000203,MENTAL_HEALTH,personality trait,personality traits
NEW07297,CHEMICAL,cortisol reactivity,cortisol reactivity
http://purl.obolibrary.org/obo/DOID_13351,DISEASE,pedophilia,psychopathy|Paedophilia
NEW07299,DISEASE,psychopathic trait,psychopathic traits
NEW07301,CHEMICAL,low progesterone,low progesterone
NEW07303,CHEMICAL,deficient cortisol production,deficient cortisol production
NEW07304,MENTAL_HEALTH,myxedema psychosis,Myxedema psychosis
NEW07306,DISEASE,depressive symptomology,Depressive symptomology
NEW07308,CHEMICAL,cdk4/6 inhibitor,CDK4/6 inhibitor
NEW07311,CHEMICAL,brain renin-angiotensin system,brain renin-angiotensin system
NEW07312,CHEMICAL,angiotensin receptor ligand,angiotensin receptor ligands
NEW07313,NUTRITION,egg white hydrolysate,egg white hydrolysate
NEW07317,DISEASE,dispar larva,dispar larvae
http://purl.obolibrary.org/obo/DOID_3044,DISEASE,food allergy,IgE-mediated food allergy|food hypersensitivity
NEW07320,CHEMICAL,oral immunotherapy,OIT|Oral immunotherapy
D002096,CHEMICAL,C-Peptide,"C-Peptide, Proinsulin|C-peptide|C Peptide, Proinsulin|C Peptide|Proinsulin C Peptide|Proinsulin C-Peptide|Connecting Peptide"
D019727,MENTAL_HEALTH,Proxy,"Agents, Patient|Patient Agent|proxy|Agent, Patient|Proxies"
http://purl.obolibrary.org/obo/CHEBI_63963,CHEMICAL,metabotropic glutamate receptor antagonist,mGluR antagonist|metabotropic glutamate receptor antagonists|metabotropic glutamate subtype mGlu5 receptor|mGluR antagonists
NEW07322,CHEMICAL,metabotropic glutamate subtype activity,metabotropic glutamate subtype activity
NEW07323,DISEASE,corticotropin-releasing factor crf receptor,corticotropin-releasing factor CRF receptors
NEW07325,DISEASE,effective crf receptor antagonist,effective CRF receptor antagonists
NEW07329,MENTAL_HEALTH,dysfunctional family situation,dysfunctional family situation
NEW07331,CHEMICAL,caffeine consumption,Caffeine consumption
NEW07332,CHEMICAL,zolpidem concentration,Zolpidem concentrations
NEW07335,CHEMICAL,pretreatment hva level,pretreatment HVA levels
NEW07336,CHEMICAL,acute arecoline treatment,acute arecoline treatments
NEW01705,DISEASE,mitochondrial dysfunction,mitochondrial dysfunction
NEW07338,CHEMICAL,adenosine a2a receptor function,adenosine A2A receptor function
NEW07343,CHEMICAL,clozapine level,clozapine levels
NEW07345,CHEMICAL,caffeine use,caffeine use
C077059,CHEMICAL,"1,3,7,9-tetramethyluric acid [Supplementary Concept]",Uric Acid/analogs  and  derivatives|theacrine
NEW07352,CHEMICAL,green rooibo,green rooibos
NEW07353,CHEMICAL,low omega-3 index,low Omega-3 Index
NEW07354,CHEMICAL,Omega-3 index,Omega-3 Index
NEW07355,CHEMICAL,acute caffeine intake,acute caffeine intake
NEW07356,CHEMICAL,caffeine response,caffeine response
NEW07357,MENTAL_HEALTH,idiopathic rem sleep behavior disorder,idiopathic REM sleep behavior disorder
D051760,DISEASE,Xeroderma Pigmentosum Group A Protein,Xeroderma Pigmentosum Group A Complementing Protein|Xeroderma Pigmentosum-A Protein|XPA Repair Protein|Xeroderma Pigmentosum A Protein|xeroderma pigmentosum|XPA Nucleotide Excision Repair Protein
NEW07359,DISEASE,pd trait,PD traits
NEW07362,CHEMICAL,moderate caffeine intake,moderate caffeine intake
NEW07366,MENTAL_HEALTH,performance anxiety disorder,performance anxiety disorder
NEW07367,DISEASE,neurotransmitter abnormality,neurotransmitter abnormality
NEW07369,CHEMICAL,striatal presynaptic dopamine transporter,striatal presynaptic dopamine transporter
NEW07370,DISEASE,female pd patient,female PD patients
NEW07372,BIOCHEMICAL,putative cck receptor antagonist,putative CCK receptor antagonist
D011377,CHEMICAL,Proglumide,Xylamide|Milid|proglumide|Xilamide
NEW07373,CHEMICAL,cck relative,CCK relative
NEW07380,CHEMICAL,particular nimodipine,particular nimodipine
NEW07381,CHEMICAL,sofosbuvir/velpatasvir combination regiman,sofosbuvir/velpatasvir combination regimen
C571889,CHEMICAL,asunaprevir [Supplementary Concept],Isoquinolines|Asunaprevir|Sulfonamides
NEW07383,CHEMICAL,interferon-free combination,interferon-free combinations
NEW07384,CHEMICAL,dopamine compromise,dopamine compromise
NEW07387,CHEMICAL,plasma amino acid level,Plasma amino acid levels
NEW06581,CHEMICAL,premenstrual tension syndrome,PMS|premenstrual tension syndrome
NEW07390,CHEMICAL,low serotonin level,low serotonin levels
D005505,BIOCHEMICAL,Food Coloring Agents,"Coloring Agents, Food|Agents, Food Coloring|food coloring|Food Colorants|Colorants, Food"
NEW07391,CHEMICAL,α7 isoform,α7 isoform
NEW07392,CHEMICAL,pam pnu120596,PAM PNU120596
D011220,DISEASE,Pralidoxime Compounds,"Compounds, Pralidoxime|2 PAM Compounds|Compounds, 2-PAM|Pyridine Aldoxime Methyl Compounds|PAM|2-PAM Compounds"
D000521,CHEMICAL,alpha-MSH,"Desacetyl alpha MSH|Desacetyl alpha-Melanocyte-Stimulating Hormone|alpha Melanocyte Stimulating Hormone|alphaMSH|(Des-Acetyl)-alpha-MSH|ACTH(1-13)|Desacetyl alpha-MSH|Des-Acetyl MSH|alpha-Melanotropin|alpha Melanotropin|Adrenocorticotropin (1-13)NH2|Acetylated ACTH (1-13)NH2|Hormone, alpha-Melanocyte-Stimulating|Intermedin, alpha|alpha-Melanocyte-Stimulating Hormone, Desacetyl|Desacetyl alpha Melanocyte Stimulating Hormone|Hormone, Desacetyl alpha-Melanocyte-Stimulating|alpha-melanocyte stimulating hormone|ACTH (1-13)|alpha-Melanocyte-Stimulating Hormone|alpha Intermedin|(Desacetyl)alpha-MSH|MSH, Des-Acetyl|MSH, (Desacetyl)alpha-|ACTH (1-13)NH2|DE-alpha-MSH|MSH, alpha|alpha MSH|alpha-MSH, Desacetyl"
NEW07395,CHEMICAL,erythromycin dopamine antagonist,erythromycin dopamine antagonists
D011949,CHEMICAL,"Receptors, Cholecystokinin","Octapeptide Receptors, Cholecystokinin|Receptors, Cholecystokinin Octapeptide|Receptors, Pancreozymin|Receptor, CCK|Cholecystokinin Octapeptide Receptors|Sincalide Receptors|CCK 8 Receptors|CCK|Receptors, CCK 4|Cholecystokinin Receptor|CCK-4 Receptors|CCK Receptors|Pancreozymin Receptors|Caerulein Receptors|Receptors, Sincalide|Receptors, Caerulein|Cholecystokinin Receptors|Receptors, CCK 8|CCK Receptor|Receptors, CCK-8|Receptors, CCK-4|Receptor, Cholecystokinin|CCK-8 Receptors|CCK 4 Receptors|Receptors, CCK"
NEW07398,MENTAL_HEALTH,saccadic distractibility,Saccadic distractibility
C055334,CHEMICAL,iso THIP [Supplementary Concept],Isoxazoles|Pyridines|THIP
NEW07401,DISEASE,shr impulsivity,SHR impulsivity
NEW07404,CHEMICAL,gaba biology,GABA biology
C097222,CHEMICAL,"glutamate receptor ionotropic, AMPA 1 [Supplementary Concept]","glutamate receptor|Receptors, AMPA"
NEW07406,CHEMICAL,glutamate receptor biology,glutamate receptor biology
NEW07407,CHEMICAL,corticolimbic circuitry,Corticolimbic circuitry
D000078308,CHEMICAL,Tiagabine,"NO 329|(R)-(4,4-bis(3-Methyl-2-thienyl)-3-butenyl)-3-piperidinecarboxylic acid, Hydrochloride|N-(4,4-di(3-Methylthien-2-yl)but-3-enyl)nipecotic acid|NO 328|NO-328|Gabitril|Tiagabine, (S)-isomer|NO-329|Tiagabine|Tiagabine Hydrochloride"
NEW07408,BIOCHEMICAL,selective gamma-aminobutyric acid gaba reuptake inhibitor,selective gamma-aminobutyric acid GABA reuptake inhibitor
http://purl.obolibrary.org/obo/CHEBI_85384,BIOCHEMICAL,gaba reuptake inhibitor,GABA reuptake inhibitors|gamma-aminobutyric acid reuptake inhibitors|selective GABA reuptake inhibitor|gamma-aminobutyric acid reuptake inhibitor|GABA re-uptake inhibitor|gamma-aminobutyric acid re-uptake inhibitors|gamma-aminobutyric acid re-uptake inhibitor|GABA re-uptake inhibitors
NEW07411,BIOCHEMICAL,novel gaba reuptake inhibitor antiepileptic drug,novel GABA reuptake inhibitor antiepileptic drug
http://purl.obolibrary.org/obo/CHEBI_131800,CHEMICAL,(r)-skf 38393,"R-(+)-SKF-38393|(1R)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol|(1R)-2,3,4,5-tetrahydro-1-phenyl-1H-3-benzazepine-7,8-diol|(R)-SKF-38393|D2-agonist quinpirole"
C441128,CHEMICAL,"3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate [Supplementary Concept]",Cholestanes|trodusquemine|Spermine/analogs  and  derivatives
NEW07413,CHEMICAL,vdm-11,VDM-11
C062018,CHEMICAL,HU 211 [Supplementary Concept],HU-210|Dronabinol/analogs  and  derivatives
C067515,CHEMICAL,eicosapentaenoic omega 3-epoxygenase [Supplementary Concept],ω3|Cytochrome P-450 Enzyme System
NEW07415,BIOCHEMICAL,cb1 receptor antagonist sr,CB1 receptor antagonist SR
NEW07416,BIOCHEMICAL,psychostimulant drug amphetamine,psychostimulant drug amphetamine
NEW07419,DISEASE,trauma history,trauma histories
NEW07420,CHEMICAL,cortisol level,Cortisol levels
NEW07423,CHEMICAL,area vta dopamine neuron,area VTA dopamine neurons
NEW07426,BIOCHEMICAL,cb1 receptor neutral antagonist,CB1 receptor neutral antagonist
D065146,BIOCHEMICAL,Zeaxanthins,"Zeaxanthin|3R,3'R-Zeaxanthin|Beta Carotene 3,3' Diol|zeaxanthin|Beta-Carotene-3,3'-Diol|3R,3'R Zeaxanthin"
NEW07428,NUTRITION,long-term zeaxanthin treatment,long-term zeaxanthin treatment
NEW07430,BIOCHEMICAL,zeaxanthin equivalent,Zeaxanthin equivalents
NEW07431,CHEMICAL,isocitric acid level,isocitric acid levels
C034219,CHEMICAL,isocitric acid [Supplementary Concept],isocitric acid|isocitrate|Isocitrates
C010661,CHEMICAL,surfagon [Supplementary Concept],Gonadotropin-Releasing Hormone/analogs  and  derivatives|surfagon
NEW07434,BIOCHEMICAL,gonadotropin-releasing hormone agonist treatment,gonadotropin-releasing hormone agonist treatment
NEW07435,CHEMICAL,progesterone treatment,progesterone treatments
NEW07436,BIOCHEMICAL,hormone transition,hormone transition
NEW07438,BIOCHEMICAL,estrogen signaling,estrogen signaling
NEW07440,CHEMICAL,gnrha model work,GnRHa model work
NEW07442,BIOCHEMICAL,abolish luteinizing hormone,abolishing luteinizing hormone
NEW07445,DISEASE,cold- pain,cold- pain
D012131,MENTAL_HEALTH,Respiratory Insufficiency,"Depressions, Ventilatory|Respiratory Failure, Hypoxemic|Hypoxemic Respiratory Failure|Ventilatory Depression|Hypercapnic Respiratory Failure|Acute Hypercapnic Respiratory Failure|Acute Hypoxemic Respiratory Failure|Hypoxemic Acute Respiratory Failure|Failure, Hypercapnic Respiratory|Respiratory Failure, Hypercapnic|Failure, Hypoxemic Respiratory|Respiratory Failures|respiratory depression|Hypercapnic Acute Respiratory Failure|Hypoxemic Respiratory Failures|Respiratory Failure|Hypercapnic Respiratory Failures|Respiratory Depression|Failure, Respiratory"
NEW07447,DISEASE,organophosphate-induced delay neuropathy,Organophosphate-induced delayed neuropathy
NEW07449,DISEASE,cardiac inflammation,Cardiac inflammation
NEW07451,CHEMICAL,c56bl/6n mouse,C56BL/6N mice
http://purl.obolibrary.org/obo/CHEBI_134834,CHEMICAL,pivagabine,3-hydropxypyridine emoxipine|tonerg|pivagabin
C009820,CHEMICAL,6-methyl-2-ethyl-3-hydroxypyridine [Supplementary Concept],Picolines|emoxipine
C549374,CHEMICAL,Reamberin [Supplementary Concept],reamberin|Meglumine/analogs  and  derivatives|Succinates
C070020,CHEMICAL,emoxypine succinate [Supplementary Concept],Picolines|mexidol
NEW07455,NUTRITION,tryptophan breakdown,tryptophan breakdown
D005909,DISEASE,Glioblastoma,"Grade IV Astrocytomas|Astrocytoma, Grade IV|Glioblastoma Multiforme|Glioblastomas|Grade IV Astrocytoma|Giant Cell Glioblastoma|Glioblastoma, Giant Cell|Glioblastomas, Giant Cell|Astrocytomas, Grade IV|Giant Cell Glioblastomas|glioblastomas"
D003542,CHEMICAL,Cystathionine gamma-Lyase,"gamma Cystathionase|Cystathionine|Cystine Desulfohydrolase|Cystine Desulfhydrase|Deaminase, Homoserine|Dehydratase, Homoserine|Desulfhydrase, Cysteine|Cystathionine gamma Lyase|Desulfhydrase, Cystine|Cystathionase|Cysteine Desulfhydrase|gamma-Cystathionase|Homoserine Dehydratase|Desulfohydrolase, Cystine|gamma-Lyase, Cystathionine|Homoserine Deaminase"
NEW07460,CHEMICAL,over-the-counter supplement,Over-the-counter supplements
NEW07462,CHEMICAL,fatal caffeine overdose,Fatal caffeine overdoses
NEW07464,CHEMICAL,uranium toxicity threshold,uranium toxicity threshold
NEW07465,CHEMICAL,intake ≥0.25 kg,intake ≥0.25 kg
D005955,CHEMICAL,Glucosephosphate Dehydrogenase Deficiency,"G6PD Deficiencies|Deficiency, GPD|Deficiencies, G6PD|Glucose-6-phosphate dehydrogenase deficiency|Dehydrogenase Deficiencies, Glucosephosphate|Deficiency, G6PD|GPD Deficiency|Deficiencies, Glucosephosphate Dehydrogenase|GPD Deficiencies|Dehydrogenase Deficiency, Glucose-6-Phosphate|Deficiency, Glucose-6-Phosphate Dehydrogenase|Deficiency, Glucosephosphate Dehydrogenase|Deficiency of Glucose-6-Phosphate Dehydrogenase|G6PD Deficiency|Deficiency of Glucose 6 Phosphate Dehydrogenase|Glucosephosphate Dehydrogenase Deficiencies|Deficiencies, Glucose-6-Phosphate Dehydrogenase|Dehydrogenase Deficiency, Glucosephosphate|Hemolytic Anemia Due to G6PD Deficiency|Deficiencies, GPD|Glucose-6-Phosphate Dehydrogenase Deficiency|Dehydrogenase Deficiencies, Glucose-6-Phosphate|Glucose 6 Phosphate Dehydrogenase Deficiency|Glucose-6-Phosphate Dehydrogenase Deficiencies"
NEW07466,DISEASE,acute hemolysis,acute hemolysis
NEW07468,CHEMICAL,food iodization program,food iodization programs
C000588741,CHEMICAL,saroglitazar [Supplementary Concept],Saroglitazar|Phenylpropionates|Pyrroles
NEW07474,BIOCHEMICAL,rise serum prostate-specific antigen psa level,rising serum prostate-specific antigen PSA level
NEW07475,BIOCHEMICAL,nonsteroidal antiandrogen,nonsteroidal antiandrogen
NEW07476,BIOCHEMICAL,androgen suppression therapy,androgen suppression therapy
NEW07477,CHEMICAL,bicalutamide mg,Bicalutamide mg
NEW07479,CHEMICAL,bicalutamide monotherapy,Bicalutamide monotherapy
NEW07480,DISEASE,ovarian follicular atresia,Ovarian follicular atresia
NEW07481,CHEMICAL,high serum estradiol concentration,higher serum estradiol concentrations
NEW07483,CHEMICAL,suppress testosterone,suppressed testosterone
NEW07484,CHEMICAL,adt treatment,ADT treatment
NEW07489,CHEMICAL,sulfite consumption,sulfite consumption
D050902,CHEMICAL,Sulfite Dehydrogenase,"Dehydrogenase, Sulfite|sulfite|Sulphite Dehydrogenase|Dehydrogenase, Sulphite|Sulphite Cytochrome C Reductase|Sulfite Cytochrome C Reductase"
http://purl.obolibrary.org/obo/CHEBI_8188,CHEMICAL,physovenine,µM galanthamine|Physovenine
C058254,CHEMICAL,sibutramine [Supplementary Concept],sibutramine|Cyclobutanes
D010645,CHEMICAL,Phentermine,"Phentermine Hydrochloride|AdipexP|Adipex P|Hydrochloride, Phentermine|Ionamine|Adipex-P|phentermine|Duromine"
NEW07494,DISEASE,obesity trial,obesity trials
D018094,CHEMICAL,"Receptors, Metabotropic Glutamate","Glutamate Receptor, Metabotropic|Metabotropic Glutamate Receptor|Receptors, Glutamate, Metabotropic|Metabotropic Glutamate Receptors|Receptor, Metabotropic Glutamate|Glutamate Receptors, Metabotropic|Metabotropic glutamate receptors"
NEW07495,BIOCHEMICAL,partial 5ht agonist meta-chlorophenylpiperazine,partial 5HT agonist meta-chlorophenylpiperazine
NEW07497,CHEMICAL,partial 5ht agonist meta-chlorophenylpiperazine,MCPP|partial 5HT agonist meta-chlorophenylpiperazine
NEW07498,BIOCHEMICAL,novel serotonin agonist,novel serotonin agonists
D004157,CHEMICAL,Diphenoxylate,"Hydrochloride, Diphenoxylate|Monohydrochloride, Diphenoxylate|Diphenoxylate Hydrochloride|Diphenoxylate Monohydrochloride|diphenoxylate"
NEW07502,CHEMICAL,antipsychotic/ssri combination,antipsychotic/SSRI combination
C022197,CHEMICAL,N-acetyl-5-hydroxytryptophyl-5-hydroxytryptophanamide [Supplementary Concept],5-Hydroxytryptophan/analogs  and  derivatives|(-)5HTP
NEW07504,CHEMICAL,5ht precursor,5HT precursor
NEW07505,DISEASE,head shake,head shakes
NEW07506,BIOCHEMICAL,non-competitive antagonist,non-competitive antagonists
NEW07508,CHEMICAL,glutamate deficiency,glutamate deficiency
C400939,CHEMICAL,methylone [Supplementary Concept],Methamphetamine/analogs  and  derivatives|methylone
NEW07512,BIOCHEMICAL,psychedelic serotonin agonist,psychedelic serotonin agonists
NEW07513,CHEMICAL,different antidepressant,Different antidepressants
NEW07516,DISEASE,esophageal disorder,esophageal disorders
NEW07514,DISEASE,pain modulator,pain modulators
D004087,CHEMICAL,Dihydroergotamine,"DHE Ratiopharm|Erganton|D-Tamin Retard L.U.T.|DHE45|Migranal|Ergomimet|Seglor|D Tamin Retard L.U.T.|Agit|Ergotam Von Ct|DET MS|Methanesulfonate, Dihydroergotamine|Orstanorm|Von Ct, Ergotam|Verladyn|Angionorm|Ergont|Clavigrenin|Ikaran|DHE Puren|DHE-Puren|Dihydroergotamin AL|Dihytamin|Dihydroergotamine Sandoz|Dihydergot|Dihydroergotamine Mesylate|DHE 45|Dihydroergotamine|DHE-45|DHE-Ratiopharm|Tamik|Dihydroergotamine Methanesulfonate|D.H.E. 45|Mesylate, Dihydroergotamine|Dihydroergotamine-Sandoz"
http://purl.obolibrary.org/obo/CHEBI_4821,CHEMICAL,ergocristine,"Ergocristine|ergots|ergocristine|5'alpha-benzyl-12'-hydroxy-3',6',18-trioxo-2'-(propan-2-yl)ergotaman|ergocrystine"
NEW07519,CHEMICAL,benzodiazepine receptor sensitivity,benzodiazepine receptor sensitivity
NEW07521,DISEASE,postinfectious olfactory dysfunction,Postinfectious olfactory dysfunction
NEW07523,CHEMICAL,postinfectious olfactory dysfunction,Postinfectious olfactory dysfunction|PIOD
NEW07522,DISEASE,olfactory dysfunction,olfactory dysfunction
NEW07524,CHEMICAL,neurokinin nk1 receptor,Neurokinin NK1 receptors
NEW05516,DISEASE,pain transmission,pain transmission
D000077608,CHEMICAL,Aprepitant,"(1-(3,5-bis(Trifluoromethyl)phenyl)ethoxy)-3-(fluoro)phenyl-4-(3-oxo-1,2,4-triazol-5-yl)methylmorpholine|L 754,030|L-754,030|Emend|L-754030|L754,030|MK0869|MK-869|MK869|MK0517|MK-0869|MK 869|L754030|MK-0517|L 754030|MK 0869|MK 0517|(2R)-(1R)-3,5-bis(Trifluoromethylphenyl)ethoxy)-(3S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazole)methyl-morpholine"
NEW07526,BIOCHEMICAL,oral vitamin k antagonist,Oral vitamin K antagonists
NEW07528,DISEASE,ttr measurement,TTR measurement
D000077144,CHEMICAL,Clopidogrel,"SC 25990C|Clopidogrel Besilate|clopidogrel|SR 25989|Clopidogrel Napadisilate|Clopidogrel Besylate|Clopidogrel, (+)(S)-isomer|Clopidogrel-Mepha|SC 25989C|PCR-4099|Plavix|Clopidogrel Mepha|Clopidogrel Bisulfate|Iscover|PCR 4099|Clopidogrel Sandoz|Clopidogrel Hydrochloride"
NEW07530,CHEMICAL,non-vitamin k antagonist oral anticoagulation agent,non-vitamin K antagonist oral anticoagulation agents
NEW07532,CHEMICAL,oral anticoagulation agent,NOAC|oral anticoagulation agents
http://purl.obolibrary.org/obo/CHEBI_55347,BIOCHEMICAL,vitamin k antagonist,vitamin K antagonists
D014859,CHEMICAL,Warfarin,"4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one|Apo-Warfarin|warfarin|Aldocumar|Sodium, Warfarin|Warfant|Coumadin|Warfarin Potassium|Potassium, Warfarin|Warfarin Sodium|Tedicumar|Coumadine|Gen-Warfarin|Marevan"
D014813,BIOCHEMICAL,Vitamin K Deficiency,"Deficiency, Vitamin K|Vitamin K Deficiencies|Deficiencies, Vitamin K|Vitamin K deficiency"
NEW07538,CHEMICAL,ammonium glycyrrhizate,Ammonium Glycyrrhizate
NEW07543,DISEASE,little short-term toxicity,Little short-term toxicity
D006034,CHEMICAL,Glycyrrhetinic Acid,"Jintan|Enoxolone|Arthrodont|Acid, Rhetinic|Glyciram|Rhetinic Acid|Glycyrrhetic Acid|Acid, Glycyrrhetinic|Acid, Uralenic|Po 12|Glycyrrhetinic Acid|Uralenic Acid|12, Po|Acid, Glycyrrhetic|Glycyram"
NEW07546,BIOCHEMICAL,serotoninergic-dopaminergic antagonist,serotoninergic-dopaminergic antagonist
NEW07547,DISEASE,similar cognitive impairment,Similar cognitive impairments
NEW07549,BIOCHEMICAL,dopaminergic antagonist antipsychotic,dopaminergic antagonist antipsychotics
NEW07550,CHEMICAL,domperidone treatment,Domperidone treatment
NEW05717,BIOCHEMICAL,endocrine dysfunction,endocrine dysfunction
D007027,DISEASE,Hypothalamic Diseases,"Disorders, Hypothalamic-Neurohypophyseal|Syndromes, Pituitary Diencephalic|Froehlichs Syndrome|Hypothalamic Disease|Syndrome, Hypothalamic Dysinhibition|Syndrome, Hypothalamic Overactivity|Froehlich's Syndrome|Syndromes, Hypothalamic Overactivity|Hypothalamic Pseudopuberties|Syndromes, Hypothalamic Dysfunction|Disorder, Hypothalamic-Neurohypophyseal|Hypothalamic Dysfunction Syndromes|Diencephalic Syndrome, Pituitary|Diencephalic Syndromes, Pituitary|Hypothalamic Pseudopuberty|Pituitary Diencephalic Syndromes|Hypothalamic Dysinhibition Syndrome|Hypothalamic Dysinhibition Syndromes|Hypothalamic-Neurohypophyseal Disorders|Overactivity Syndrome, Hypothalamic|Disease, Hypothalamic|Dysinhibition Syndromes, Hypothalamic|Hypothalamic-Adenohypophyseal Disorders|Disorders, Hypothalamic-Adenohypophyseal|hypothalamic dysfunction|Overactivity Syndromes, Hypothalamic|Hypothalamic-Adenohypophyseal Disorder|Hypothalamic-Neurohypophyseal Disorder|Disorder, Hypothalamic-Adenohypophyseal|Syndrome, Froehlich's|Hypothalamic Dysfunction Syndrome|Pseudopuberty, Hypothalamic|Hypothalamic Adenohypophyseal Disorders|Dysinhibition Syndrome, Hypothalamic|Dysfunction Syndromes, Hypothalamic|Pseudopuberties, Hypothalamic|Hypothalamic Neurohypophyseal Disorders|Diseases, Hypothalamic|Froehlich Syndrome|Hypothalamic Overactivity Syndrome|Dysfunction Syndrome, Hypothalamic|Pituitary Diencephalic Syndrome|Hypothalamic Overactivity Syndromes|Syndromes, Hypothalamic Dysinhibition|Syndrome, Hypothalamic Dysfunction"
NEW07557,CHEMICAL,culture hydrocortisone,cultures hydrocortisone
NEW07558,DISEASE,folliculotropic lymphoma,Folliculotropic lymphoma
NEW01525,DISEASE,different etiology,different etiologies
D006521,DISEASE,"Hepatitis, Chronic","Chronic Persistent Hepatitides|Cryptogenic Chronic Hepatitis|Chronic Hepatitis|Hepatitis, Chronic Persistent|Hepatitis, Chronic, Cryptogenic|chronic hepatitis|Hepatitis, Chronic Active|Chronic Persistent Hepatitis|Chronic Hepatitis, Cryptogenic|Hepatitis, Cryptogenic Chronic|Chronic Active Hepatitis"
http://purl.obolibrary.org/obo/DOID_9351,DISEASE,diabetes mellitus,overt diabetes mellitus
D001219,CHEMICAL,Aspartate Aminotransferases,"Aminotransferases, Aspartate|Aspartate Transaminase|Transaminase, Glutamate-Aspartate|Glutamate-Aspartate Transaminase|Serum Glutamic-Oxaloacetic Transaminase|SGOT|Aspartate Apoaminotransferase|Aspartate Aminotransferase|aspartate aminotransferases|Glutamic Oxaloacetic Transaminase|Glutamic-Oxaloacetic Transaminase, Serum|Transaminase, Aspartate|Glutamic-Oxaloacetic Transaminase|Apoaminotransferase, Aspartate|L-Aspartate-2-Oxoglutarate Aminotransferase|Aminotransferase, Aspartate|L Aspartate 2 Oxoglutarate Aminotransferase|Serum Glutamic Oxaloacetic Transaminase|Aminotransferase, L-Aspartate-2-Oxoglutarate|Transaminase, Glutamic-Oxaloacetic|Glutamate Aspartate Transaminase|Transaminase, Serum Glutamic-Oxaloacetic"
D016207,DISEASE,Cytokines,Cytokines|Cytokine
NEW07560,CHEMICAL,serum sex-hormone-binding globulin ceruloplasmin concentration,Serum sex-hormone-binding globulin ceruloplasmin concentrations
NEW07561,CHEMICAL,serum shbg concentration,serum SHBG concentrations
NEW07562,BIOCHEMICAL,multiple antibiotic,multiple antibiotics
NEW07563,CHEMICAL,chlorisondamine pretreatment,chlorisondamine pretreatment
NEW07565,BIOCHEMICAL,nicotinic partial agonist,nicotinic partial agonists
NEW07568,MENTAL_HEALTH,schizophrenia self-administer nicotine,schizophrenia self-administer nicotine
NEW07570,BIOCHEMICAL,nicotine nicotinic agonist,nicotine nicotinic agonists
NEW07572,CHEMICAL,neuronal nicotinic acetylcholine receptor nnr system,neuronal nicotinic acetylcholine receptor NNR system
NEW07573,CHEMICAL,α7 receptor,α7 receptors
NEW07574,DISEASE,cognitive dysfunction relevant,cognitive dysfunction relevant
NEW02735,DISEASE,endothelial dysfunction,endothelial dysfunction
NEW07578,DISEASE,early endothelial damage,early endothelial damage
NEW07580,DISEASE,motor complete SCI,motor complete SCI
NEW07584,CHEMICAL,va patient,VA patients
D050197,DISEASE,Atherosclerosis,Atherogenesis|atherosclerosis|Atheroscleroses
NEW07585,MENTAL_HEALTH,depression characteristic,Depression characteristics
NEW07586,DISEASE,depressed person,Depressed persons
NEW07589,BIOCHEMICAL,solute carrier slc6 family member,solute carrier SLC6 family members
NEW07591,CHEMICAL,dm zebrafish,DM zebrafish
NEW07593,NUTRITION,serum cholesterol level,serum cholesterol levels
NEW07594,CHEMICAL,abnormal sphingolipid metabolism,abnormal sphingolipid metabolism
D056627,DISEASE,Peritoneal Fibrosis,"Sclerosis, Encapsulating Peritoneal|Sclerosis, Peritoneal|Encapsulating Peritoneal Scleroses|Scleroses, Encapsulating Peritoneal|Peritoneal Scleroses|Encapsulating Peritoneal Sclerosis|Syndrome, Peritoneal Fibrosing|Peritoneal Scleroses, Encapsulating|Peritoneal Fibroses|Scleroses, Peritoneal|Fibrosing Syndrome, Peritoneal|Peritoneal Fibrosing Syndrome|Peritoneal Sclerosis, Encapsulating|Peritoneal Sclerosis|Syndromes, Peritoneal Fibrosing|Fibroses, Peritoneal|Fibrosing Syndromes, Peritoneal|fibrosis|Fibrosis, Peritoneal|Peritoneal Fibrosing Syndromes"
C579867,DISEASE,3-Methylglutaconic Aciduria [Supplementary Concept],"3-methylglutaconic aciduria|Metabolism, Inborn Errors"
NEW07597,CHEMICAL,high-cholesterol diet,high-cholesterol diet
http://purl.obolibrary.org/obo/NCBITaxon_400053,DISEASE,sylvaemus group,NASH group
NEW07598,DISEASE,cbz-induced increase,CBZ-induced increases
NEW07604,CHEMICAL,nbp treatment,NBPs treatment
C537769,DISEASE,Anophthalmos with limb anomalies [Supplementary Concept],limb anomalies|Waardenburg Syndrome
D019082,DISEASE,Smith-Lemli-Opitz Syndrome,"Smith Lemli Opitz Syndrome|7-Dehydrocholesterol Reductase Deficiencies|Syndromes, RSH|Syndrome, RSH|Syndrome, Lethal Acrodysgenital|Deficiencies, 7-Dehydrocholesterol Reductase|Smith Lemli Opitz syndrome, type 1|Hyperotosis Corticalis Generalisata Familiaris|Polydactyly, Sex Reversal, Renal Hypoplasia, And Unilobar Lung|RSH-SLO Syndrome|Syndromes, SLO|Reductase Deficiencies, 7-Dehydrocholesterol|Smith-Lemli-Opitz syndrome|7-Dehydrocholesterol Reductase Deficiency|RSH Syndrome|Rutledge Lethal Multiple Congenital Anomaly Syndrome|Syndrome, SLO|Lethal Acrodysgenital Syndrome|RSH-SLO Syndromes|Lethal Acrodysgenital Syndromes|Smith Lemli Opitz Syndrome, Type I|Rutledge Friedman Harrod Syndrome|Reductase Deficiency, 7-Dehydrocholesterol|Deficiency, 7-Dehydrocholesterol Reductase|Smith-Lemli-Opitz Syndrome, Type 1|Smith Lemli Opitz Syndrome, Type II|RSH Syndromes|Smith-Lemli-Opitz Syndrome, Type 2|Smith Lemli Opitz Syndrome, Type 2|RSH SLO Syndrome|Acrodysgenital Syndromes, Lethal|SLO Syndrome|Acrodysgenital Syndrome, Lethal|Smith-Lemli-Opitz Syndrome, Type I|Smith-Lemli-Opitz Syndrome, Type II|SLO Syndromes"
NEW07606,CHEMICAL,pregnanolone-neurosteroid,pregnanolone-neurosteroids
NEW07609,DISEASE,attentional impulsivity,attentional impulsivity
D013186,CHEMICAL,Farnesyl-Diphosphate Farnesyltransferase,"Farnesyl Transferase, FPP-FPP|Synthetase, Squalene|Farnesyldiphosphate Farnesyldiphosphate Farnesyltransferase|squalene synthase|Farnesyltransferase, Farnesyl-Diphosphate|Transferase, FPP-FPP Farnesyl|Presqualene Diphosphate Synthase|FPP FPP Farnesyl Transferase|Presqualene-Diphosphate Synthase|FPP-FPP Farnesyl Transferase|Synthase, Squalene|Farnesyl Diphosphate Farnesyltransferase|Squalene Synthetase|Farnesyldiphosphate-Farnesyldiphosphate Farnesyltransferase|Synthase, Presqualene-Diphosphate|Squalene Synthase|Farnesyltransferase, Farnesyldiphosphate-Farnesyldiphosphate"
C075117,CHEMICAL,squalestatin 1 [Supplementary Concept],"Bridged Bicyclo Compounds, Heterocyclic|Tricarboxylic Acids|zaragozic acid"
NEW07614,MENTAL_HEALTH,depression scale,depression scales
C495910,CHEMICAL,ramelteon [Supplementary Concept],ramelteon|Indenes
NEW07616,CHEMICAL,prenatal valproic acid,prenatal valproic acid|Pre-VPA
NEW07619,CHEMICAL,low nocturnal melatonin production,Low nocturnal melatonin production
D017387,BIOCHEMICAL,Investigational New Drug Application,Investigational New Drug Applications|new drug
NEW07622,CHEMICAL,use antidepressant,used antidepressants
NEW07623,CHEMICAL,exogenous melatonin,exogenous melatonin
D002375,DISEASE,Catalepsy,"Flexibilitas, Cerea|Catalepsy|Anochlesias|Flexibilities, Waxy|Cerea Flexibilitas|Waxy Flexibility|Flexibility, Waxy|Catalepsies|Waxy Flexibilities|Anochlesia"
D010096,CHEMICAL,Oxprenolol,"Hydrochloride, Oxprenolol|oxprenolol|Tevacor|Coretal|Slow Trasicor|Oxprenolol Hydrochloride|Trasicor, Slow|Trasicor|Koretal"
D000526,CHEMICAL,Alprenolol,Aptina|H-56-28|H5628|1-(o-Allylphenoxy)-3-(isopropylamino)-2-propanol|AptinDuriles|Alpheprol|Alfeprol|Aptine|H 56 28|Aptin Duriles|Aptin|Aptin-Duriles|alprenolol|Alprenolol Hydrochloride
D001250,DISEASE,"Asthma, Exercise-Induced","Exercise-Induced Asthmas|bronchospasm|Exercise-Induced Bronchospasms|Asthmas, Exercise-Induced|Exercise-Induced Asthma|Exercise Induced Bronchospasm|Bronchospasm, Exercise-Induced|Bronchospasms, Exercise-Induced|Exercise-Induced Bronchospasm|Asthma, Exercise Induced|Bronchospasm, Exercise Induced|Exercise Induced Asthma"
NEW07628,CHEMICAL,chlortalidone diuretic,chlortalidone diuretics
NEW07631,BIOCHEMICAL,nonselective lipophilic beta-adrenoceptor antagonist,Nonselective lipophilic beta-adrenoceptor antagonists
NEW07632,BIOCHEMICAL,hair androgen concentration,hair androgen concentrations
NEW07634,BIOCHEMICAL,non-competitive nnr antagonist,non-competitive NNR antagonists
NEW07635,BIOCHEMICAL,non-selective nnr antagonist,non-selective NNR antagonist
NEW07636,CHEMICAL,chronic fluoxetine,Chronic fluoxetine
NEW07637,CHEMICAL,impaired glutathione gsh synthesis,Impaired glutathione GSH synthesis
NEW07639,CHEMICAL,corticosterone treatment,Corticosterone treatment
NEW07641,CHEMICAL,bupropion sr treatment,bupropion SR treatment
D008140,CHEMICAL,Lorazepam,"Somagerol|Donix|Temesta|Novo Lorazem|Tolid|WY 4036|Wyeth, Orfidal|Duralozam|lorazepam|Idalprem|Nu-Loraz|Témesta|Lorazepam Medical|Sinestron|WY4036|Medical, Lorazepam|Sedicepan|Von Ct, Lorazep|Lorazepam Ratiopharm|Durazolam|Apo Lorazepam|Lorazepam-Ratiopharm|Orfidal Wyeth|Lorazep Von Ct|Lorazepam-Neuraxpharm|Apo-Lorazepam|Laubeel|WY-4036|Ativan|Novo-Lorazem|Nu Loraz|Lorazepam Neuraxpharm"
NEW07644,CHEMICAL,bath salt,bath salts
D058186,DISEASE,Acute Kidney Injury,"Renal Insufficiency, Acute|Acute Kidney Failures|Renal Injury, Acute|Acute Renal Injuries|Kidney Injury, Acute|Renal Injuries, Acute|acute kidney injury|Acute Renal Insufficiencies|Acute Kidney Failure|Acute Kidney Injuries|Renal Failures, Acute|Kidney Insufficiencies, Acute|Kidney Failure, Acute|Acute Renal Insufficiency|Kidney Insufficiency, Acute|Acute Kidney Insufficiency|Acute Renal Injury|Acute Renal Failure|Kidney Injuries, Acute|Acute Kidney Insufficiencies|Acute Renal Failures|Renal Failure, Acute|Kidney Failures, Acute|Renal Insufficiencies, Acute"
NEW07648,DISEASE,coronary spasm,Coronary spasm
NEW07652,DISEASE,hand tremor,hand tremors
NEW07655,CHEMICAL,norepinephrine-dopamine reuptake inhibitor bupropion,norepinephrine-dopamine reuptake inhibitor bupropion
NEW07656,CHEMICAL,chronic nicotine,chronic nicotine
D059290,CHEMICAL,Dopaminergic Neurons,"Neurons, Dopaminergic|Dopamine Neuron|Neuron, Dopamine|Dopamine Neurons|Neurons, Dopamine|Neuron, Dopaminergic|Dopaminergic Neuron|dopamine neurons"
NEW07659,DISEASE,chronic decrease,chronic decrease
D015260,CHEMICAL,Neprilysin,"Antigen, CD10|Kidney-Brush-Border Neutral Proteinase|Enkephalinase|YGG-Forming Enzyme|Antigens, Leukemia, Common Acute Lymphoblastic|Neutral Endopeptidase|Metallo-Endopeptidase, Membrane|Carboxypeptidase, Enkephalin Dipeptidyl|Neutral Proteinase, Kidney-Brush-Border|CD10 Antigen|Antigens, CD10|Kidney Brush Border Neutral Proteinase|Atriopeptidase|Enzyme, YGG-Forming|NEP|neprilysin|Dipeptidyl Carboxypeptidase, Enkephalin|Enkephalin Dipeptidyl Carboxypeptidase|Thermolysin-Like Metalloendopeptidase|CD10 Antigens|Thermolysin Like Metalloendopeptidase|Endopeptidase 24.11|Endopeptidase, Neutral|Membrane Metallo-Endopeptidase|Endopeptidase 24.11, Neutral|CALLA Antigen|Metalloendopeptidase, Thermolysin-Like|YGG Forming Enzyme|Common Acute Lymphoblastic Leukemia Antigens|Neutral Endopeptidase 24.11|Enkephalinase-24.11|Enkephalinase 24.11|Endopeptidase-24.11|Membrane Metallo Endopeptidase"
http://purl.obolibrary.org/obo/CHEBI_81568,CHEMICAL,luteinizing hormone,Interstitial cell stimulating hormone|LH|hypothalamic luteinizing hormone releasing hormone|ICSH|LHRH
NEW07663,CHEMICAL,ethanol dependence,ethanol dependence
NEW00495,DISEASE,hyperexcitability,hyperexcitability
NEW07672,CHEMICAL,central gamma-aminobutyric acid gaba system,central gamma-aminobutyric acid GABA system
NEW07674,DISEASE,chronic cerebral hypoperfusion model,chronic cerebral hypoperfusion model
NEW07678,BIOCHEMICAL,agonist baclofen/muscimol,agonists baclofen/muscimol
NEW07680,CHEMICAL,pfc nmda receptor,PFC NMDA receptors
NEW07681,CHEMICAL,prefrontal cortex gaba transmission,prefrontal cortex GABA transmission
NEW07682,CHEMICAL,n-methyl-d-aspartate (nmdar)-mediated glutamatergic pathway,N-methyl-d-aspartate (NMDAR)-mediated glutamatergic pathways
NEW07683,CHEMICAL,protract alcohol withdrawal,Protracted alcohol withdrawal
NEW07686,CHEMICAL,zopiclone dose,Zopiclone doses
D000077334,CHEMICAL,Zolpidem,"SL-800750-23-N|Zolpi Lich|Ambien|Imidazo(1,2-a)pyridine-3-acetamide, N,N,6-trimethyl-2-(4-methylphenyl)-|Zodormdura|SL 80.0750|Zolpimist|Zolpidem 1A Pharma|Stilnoct|Zolpi-Lich|Zoldem|zolpidem|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2a)pyridine-3-acetamide hemitartrate|Zolpidem Hemitartrate|Amsic|Dalparan|Zolpidem Tartrate|Bikalm|Zolpidem AbZ|Zolirin|Stilnox|Zolpinox|SL 800750 23 N"
NEW07687,BIOCHEMICAL,various subtype selective partial gaba-a agonist,Various subtype selective partial GABA-A agonists
C105051,CHEMICAL,ganaxolone [Supplementary Concept],ganaxolone|Pregnanolone/analogs  and  derivatives
D016572,CHEMICAL,Cyclosporine,CsA-Neoral|Ciclosporin|CsA|Cyclosporin|Neoral|Sandimmun Neoral|Sandimmun|CsA Neoral|OL 27-400|CyA-NOF|Sandimmune|Cyclosporine A|OL 27 400|CyA NOF|OL 27400|CsANeoral|Cyclosporine-A|Cyclosporin A
NEW02054,DISEASE,hepatotoxicity,hepatotoxicity
NEW01926,DISEASE,nephrotoxicity,nephrotoxicity
NEW07689,CHEMICAL,blood alcohol level,blood alcohol levels
NEW07690,BIOCHEMICAL,estrogen deprivation,estrogen deprivation
NEW07691,BIOCHEMICAL,long-term endocrine treatment,Long-term endocrine treatment
C000614027,DISEASE,huangqi decoction [Supplementary Concept],"Decoction|Drugs, Chinese Herbal|SHD"
D055423,CHEMICAL,"Diet, Ketogenic","Ketogenic Diet|Ketogenic diets|Ketogenic Diets|Diets, Ketogenic"
NEW02546,DISEASE,depressed mood,depressed mood
C536398,CHEMICAL,Neonatal-onset citrullinemia type 2 [Supplementary Concept],Citrin deficiency|Citrullinemia
http://purl.obolibrary.org/obo/DOID_0070342,DISEASE,adult-onset type ii citrullinemia,Adult-onset type citrullinemia|citrin deficiency
NEW07693,CHEMICAL,simultaneous glycine-plus-sucrose,simultaneous glycine-plus-sucrose
NEW07695,CHEMICAL,gly       suc administration,Gly      Suc administration
C538260,DISEASE,Atresia of small intestine [Supplementary Concept],"Intestine, Small/abnormalities|small intestine|Intestinal Atresia"
NEW07697,CHEMICAL,aspartate-to-alanine conversion,Aspartate-to-alanine conversion
http://purl.obolibrary.org/obo/DOID_0080543,DISEASE,hyperprolinemia type 2,hyperprolinemia type II|Hyperprolinemia type
NEW07699,CHEMICAL,harman level,harman levels
D002243,CHEMICAL,Carbolines,"Beta-Carbolines|beta-carbolines|Carboline|Pyrido(4,3-b)Indole|Beta Carbolines|Pyrido(4,3-b)Indoles"
NEW07700,CHEMICAL,norharman level,norharman levels
C010262,CHEMICAL,norharman [Supplementary Concept],norharman|Carbolines
NEW07701,CHEMICAL,low-carbohydrate high-fat diet,Low-carbohydrate high-fat diets
D014531,CHEMICAL,Uridine Diphosphate Galactose,"galactose|UDP Galactose|Uridine Diphosphogalactose|UDPGal|Galactose, UDP|Diphosphogalactose, Uridine|Galactose, Uridine Diphosphate|Pyrophosphogalactose, Uridine|Diphosphate Galactose, Uridine|Uridine Pyrophosphogalactose"
D058619,CHEMICAL,Maltose-Binding Proteins,maltose|Maltose Binding Proteins|Maltose-Binding Protein|Maltose Binding Protein
D007789,CHEMICAL,Lactose Tolerance Test,"Tolerance Tests, Lactose|Tests, Lactose Tolerance|Tolerance Test, Lactose|Lactose Tolerance Tests|lactose %|Test, Lactose Tolerance"
NEW07704,NUTRITION,protein-source tryptophan,Protein-source tryptophan
NEW04455,CHEMICAL,lactate/pyruvate ratio,lactate/pyruvate ratio
NEW07709,CHEMICAL,pyruvate level,pyruvate levels
D018981,DISEASE,Congenital Disorders of Glycosylation,"Syndrome, Carbohydrate-Deficient Glycoprotein|Carbohydrate-Deficient Glycoprotein Syndromes|Carbohydrate-Deficient Glycoprotein Syndrome|CDGs|glycosylation|Glycoprotein Syndrome, Carbohydrate-Deficient|Carbohydrate Deficient Glycoprotein Syndrome|Syndromes, Carbohydrate-Deficient Glycoprotein"
NEW07711,DISEASE,anchor-related congenital disorder,anchor-related congenital disorders
NEW07712,DISEASE,chronic ketosis,chronic ketosis
NEW00745,DISEASE,functional impairment,functional impairment
D013469,CHEMICAL,Sulpiride,Arminol|Dolmatil|Vertigo-Meresa|Lebopride|Eglonyl|Dogmatil|neogama|Pontiride|Deponerton|Sulperide|Digton|vertigo-neogama|vertigo neogama|Ekilid|Guastil|Sulpiride|Sulpor|Synédil|Meresa|Tepavil|Psicocen|Sulpivert|Aiglonyl|Sulp|Vertigo Meresa|Sulpitil|Desisulpid
NEW07716,CHEMICAL,fo group,FO group
NEW07720,CHEMICAL,high pufa ratio,high PUFA ratio
NEW07722,CHEMICAL,salivary cortisol,salivary cortisol
D053380,DISEASE,Tumor Necrosis Factor Ligand Superfamily Member 15,"tumor necrosis factor|Ligand, TL1A|VEGI (Vascular Endothelial Growth Inhibitor) Protein|TL1A Ligand|Ligand, TL1|TL1 Ligand"
NEW07727,DISEASE,a. glycine,A. glycines
http://purl.obolibrary.org/obo/CHEBI_65057,CHEMICAL,adenosine a1 receptor agonist,adenosine A1 receptor agonist N6-cyclopentyladenosine|adenosine A1 receptor agonists|CPA
D019954,DISEASE,Neurobehavioral Manifestations,"Cognitive Manifestation|Manifestations, Cognitive|Cognitive Manifestations|Neurobehavioral Signs and Symptoms|cognitive symptoms|Manifestation, Cognitive|Cognitive Symptoms|Symptom, Cognitive|Manifestations, Neurobehavioral|Neurobehavioral Manifestation|Symptoms, Cognitive|Cognitive Symptom|Manifestation, Neurobehavioral|Signs and Symptoms, Neurobehavioral"
NEW07730,CHEMICAL,medicine yokukansan,medicine yokukansan
NEW07731,MENTAL_HEALTH,disorder combat veteran,disorder combat veterans
NEW07733,BIOCHEMICAL,opiate antagonist naltrexone,opiate antagonist naltrexone
NEW07734,CHEMICAL,naltrexone mg/kg s.c,naltrexone mg/kg s.c
NEW07735,DISEASE,frequent hyperserotonemia,frequent hyperserotonemia
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Alcohol_Abuse,MENTAL_HEALTH,alcohol abuse,long-term alcohol abuse
NEW03826,DISEASE,female psychiatric inpatient,female psychiatric inpatients
NEW07740,CHEMICAL,Pizotifene,Pizotifene
NEW07742,CHEMICAL,opiate antagonist naloxone,opiate antagonist naloxone
NEW07745,CHEMICAL,"12-allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-(4ah)-(8,9-c)-iminoethanophenanthro(4,5-b","12-allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-(4aH)-(8,9-c)-iminoethanophenanthro(4,5-b"
NEW07746,BIOCHEMICAL,specific opiate antagonist,specific opiate antagonist
NEW07750,CHEMICAL,naloxone-related miosis,naloxone-related miosis
NEW07751,BIOCHEMICAL,optimal vitamin d status,optimal vitamin D status
D019694,DISEASE,"Hepatitis B, Chronic","Chronic hepatitis B virus infection|Hepatitis B Virus Infection, Chronic|Chronic Hepatitis B|Chronic Hepatitis B Virus Infection"
NEW07753,CHEMICAL,contraceptive steroid,contraceptive steroids
D003278,CHEMICAL,"Contraceptives, Oral, Hormonal","Hormonal Oral Contraceptive Agents|Hormonal Oral Contraceptive Agent|Hormonal Oral Contraceptive|Oral Contraceptives, Hormonal|Estrogen Contraceptive Agents|Contraceptive Agents, Oral, Hormonal|hormonal contraceptives|Contraceptives, Hormonal Oral|Contraceptive Agents, Estrogen|Oral Contraceptive, Hormonal|Contraceptive, Hormonal Oral|Hormonal Oral Contraceptives|Oral Contraceptive Agents, Hormonal"
C020681,CHEMICAL,glycine amidinotransferase [Supplementary Concept],Amidinotransferases|L-arginine
C099630,CHEMICAL,"3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine [Supplementary Concept]","Pyrroles|Pyridines|L-745,870"
NEW07755,DISEASE,severe parkinsonian motor oscillation,severe Parkinsonian motor oscillations
NEW07756,CHEMICAL,dopamine receptor antagonist domperidone,dopamine receptor antagonist domperidone
NEW07759,CHEMICAL,stabilizer aripiprazole,stabilizer aripiprazole
NEW07760,DISEASE,morphine-induced hyperlocomotion,Morphine-induced hyperlocomotion
NEW07762,BIOCHEMICAL,dopamine receptor antagonist fluphenazine,dopamine receptor antagonist fluphenazine
D029771,CHEMICAL,Rhodiola,Roseroot|Rhodiola crenulata|Roseroots|Rhodiola rosea
http://purl.obolibrary.org/obo/NCBITaxon_72171,CHEMICAL,ziziphus,Atractylodes macrocephala Koidz
C532132,CHEMICAL,cinnamomi cortex [Supplementary Concept],"cinnamon bark|Drugs, Chinese Herbal|Cinnamomum zeylanicum"
NEW07768,CHEMICAL,acheis,AChEIs
NEW07769,CHEMICAL,apoeɛ4,ApoEɛ4
D007520,CHEMICAL,Isocarboxazid,Monoamine Oxidase Inhibitors|Isocarboxazid|Antidepressive Agents
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Major_Depression,MENTAL_HEALTH,major depression,major depression
NEW07770,DISEASE,dysthymic patient,Dysthymic patients
NEW07772,BIOCHEMICAL,nonselective ff1/ff2 agonist,nonselective FF1/FF2 agonist
NEW07774,BIOCHEMICAL,ff1 antagonist,FF1 antagonists
Q000187,BIOCHEMICAL,drug effects [Subheading],drug effects|pharmacologic effects|effect of drugs
NEW07776,CHEMICAL,thalamic gaba level,thalamic GABA levels
NEW07780,DISEASE,l-dopa-induced surge,l-DOPA-induced surge
C473959,CHEMICAL,befiradol [Supplementary Concept],Piperidines|Pyridines|NLX-112
C443680,CHEMICAL,"N-(3-furylmethyl)eicosa-5,8,11,14-tetraenamide [Supplementary Concept]",Arachidonic Acids|UCM707|Furans|Polyunsaturated Alkamides
NEW07782,CHEMICAL,parvalbumin (pv)-positive γ-aminobutyric acid gaba interneuron,parvalbumin (PV)-positive γ-aminobutyric acid GABA interneurons
http://purl.obolibrary.org/obo/CHEBI_142184,BIOCHEMICAL,5-hydroxytryptamine 2b receptor agonist,5-hydroxytryptamine receptor 2B agonist|5-hydroxytryptamine 2B receptor agonists|5-HT2B agonist|5-HT2B receptor agonist|serotonin receptor 2B agonists|serotonin 5-HT 1A receptor agonist|5-HT2B agonists|5-hydroxytryptamine receptor 2B agonists|5-HT2B receptor agonists|serotonin receptor 2B agonist
C503102,CHEMICAL,1-(3-(2-(1-benzothiophen-5-yl) ethoxy) propyl)-3-azetidinol maleate [Supplementary Concept],Maleates|T-817MA|Thiophenes
NEW07785,CHEMICAL,t-817ma 1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl azetidin-3-ol maleate,T-817MA 1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl azetidin-3-ol maleate
NEW07788,CHEMICAL,pregnenolone administration,pregnenolone administration
NEW07789,CHEMICAL,pregnenolone level,pregnenolone levels
NEW07790,CHEMICAL,adjunctive pregnenolone,adjunctive pregnenolone
NEW07792,CHEMICAL,novel gaba uptake inhibitor anticonvulsant,novel GABA uptake inhibitor anticonvulsant
NEW07793,CHEMICAL,gamma-amino butyric acid gaba type a gaba(a receptor,gamma-amino butyric acid GABA type A GABA(A receptor
http://purl.org/sig/ont/fma/fma83354,DISEASE,corticotropin-releasing factor,CRF|Corticotrophin-releasing factor
NEW07794,BIOCHEMICAL,major adrenocorticotropic hormone acth secretagogue,major adrenocorticotropic hormone ACTH secretagogue
NEW07795,CHEMICAL,antiepileptic drug valproic acid,antiepileptic drug valproic acid
NEW07797,CHEMICAL,valproate active moiety,Valproate active moiety
NEW07798,CHEMICAL,severe alcohol withdrawal,Severe alcohol withdrawal
NEW07799,CHEMICAL,adjunctive pregabalin,Adjunctive pregabalin
NEW07800,CHEMICAL,adjunctive pregabalin,adjunctive pregabalin
NEW07802,DISEASE,narcoleptic teenager,narcoleptic teenagers
NEW07803,MENTAL_HEALTH,epworth Sleepiness scale,Epworth Sleepiness Scale
NEW07804,DISEASE,Pediatric Daytime Sleepiness scale,Pediatric Daytime Sleepiness Scale
NEW07805,CHEMICAL,ghb use,GHB use
NEW07809,CHEMICAL,stimulant prodrug lisdexamfetamine,stimulant prodrug lisdexamfetamine
NEW07812,BIOCHEMICAL,analgesic agent,analgesic agent
NEW07814,MENTAL_HEALTH,effective analgesia,effective analgesia
http://purl.obolibrary.org/obo/CHEBI_35623,CHEMICAL,anticonvulsant,anti-convulsive agents|Antikonvulsivum|anticonvulsive agent|Antikonvulsiva|antiepileptics|antiepileptique|anti-convulsant|anti-convulsive agent|anticonvulsive agents|anticonvulsants|antiepileptic|Antiepileptikum|Antiepileptika|anti-convulsants|antiepileptiques
NEW07817,CHEMICAL,gabapentin dependence,gabapentin dependence
NEW07821,CHEMICAL,csf glu level,CSF Glu levels
NEW07822,DISEASE,pain processing,pain processing
NEW07824,BIOCHEMICAL,selective agonist activity,selective agonist activity
NEW07825,CHEMICAL,common anesthetic isoflurane,common anesthetic isoflurane
NEW07828,CHEMICAL,high histamine concentration,high histamine concentrations
NEW07830,CHEMICAL,low histamine level,Low histamine levels
NEW07831,CHEMICAL,neuronal histamine,Neuronal histamine
D050492,CHEMICAL,Vesicular Biogenic Amine Transport Proteins,"Vesicular Amine Transporter|Biogenic Amine Transporters, Vesicular|Amine Transporter, Vesicular|amine|Vesicular Amine Transport Proteins|Vesicular Amine Transporter Proteins|Vesicular Biogenic Amine Transporters"
D015306,CHEMICAL,Biogenic Monoamines,"Monoamines|Monoamines, Biogenic"
NEW07833,BIOCHEMICAL,other analgesic drug,Other analgesic drugs
NEW07835,CHEMICAL,endothelial cell atp diphosphohydrolase,Endothelial cell ATP diphosphohydrolases
NEW07839,CHEMICAL,ammonium sensitivity,ammonium sensitivity
NEW07841,BIOCHEMICAL,cobra venom ngf,cobra venom NGF
NEW07472,DISEASE,male pattern hair loss,male pattern hair loss
D018120,CHEMICAL,Finasteride,Propecia|Chibro Proscar|MK 906|Eucoprost|Chibro-Proscar|Propeshia|MK-906|finasteride|MK906|Proscar
NEW07842,MENTAL_HEALTH,potential irreversible sexual dysfunction,potential irreversible sexual dysfunction
NEW07843,CHEMICAL,da transporter,DA transporter
NEW07844,CHEMICAL,two-single-nucleotide-polymorphism haplotype,two-single-nucleotide-polymorphism haplotype
NEW07845,BIOCHEMICAL,gene carrier,gene carriers
NEW07847,DISEASE,viral hepatitis c. patient,viral hepatitis C. patient
NEW07849,DISEASE,cognitive alteration,cognitive alterations
NEW07850,CHEMICAL,commercial motor vehicle driver,CMVDs|commercial motor vehicle drivers
NEW02955,CHEMICAL,dopamine neurotransmission,dopamine neurotransmission
NEW07852,CHEMICAL,5-ht transporter gene-linked polymorphic region,5-HT transporter gene-linked polymorphic region
NEW07853,CHEMICAL,human serotonin transporter sert gene polymorphism,human serotonin transporter SERT gene polymorphism
D000255,CHEMICAL,Adenosine Triphosphate,"ATP-MgCl2|Striadyne|Adenosine Triphosphate, Magnesium Salt|CaATP|ATP MgCl2|Adenosine Triphosphate, Calcium Salt|CrATP|ATP|MgATP|adenosine triphosphate|Cr(H2O)4 ATP|Magnesium Adenosine Triphosphate|Adenosine Triphosphate, Chromium Salt|Adenosine Triphosphate, Magnesium Chloride|Manganese Adenosine Triphosphate|Adenosine Triphosphate, Manganese Salt|Atriphos|MnATP|Chromium Adenosine Triphosphate|Adenosine Triphosphate, Chromium Ammonium Salt|Adenylpyrophosphate"
NEW07859,CHEMICAL,atp generation,ATP generation
NEW07860,DISEASE,mobility loss,mobility losses
D006719,CHEMICAL,Homovanillic Acid,"4 Hydroxy 3 Methoxyphenylacetic Acid|Acid, 3-Methoxy-4-Hydroxyphenylacetic|4-Hydroxy-3-Methoxyphenylacetic Acid|3 Methoxy 4 Hydroxyphenylacetic Acid|Acid, 4-Hydroxy-3-Methoxyphenylacetic|homovanillic acid|3-Methoxy-4-Hydroxyphenylacetic Acid|Acid, Homovanillic"
D008734,CHEMICAL,Methoxyhydroxyphenylglycol,"Methoxyhydroxyphenylglycol, (+)-Isomer|4 Hydroxy 3 methoxyphenylethyleneglycol|4 Hydroxy 3 methoxyphenylethylene Glycol|Methoxyhydroxyphenylglycol, (+-)-Isomer|4-Hydroxy-3-methoxyphenylethyleneglycol|Hydroxymethoxyphenylglycol|4-Hydroxy-3-methoxyphenylglycol|4 Hydroxy 3 methoxyphenylglycol|Vanylglycol|Methoxyhydroxyphenylglycol, (-)-Isomer|MOPEG|4-Hydroxy-3-methoxyphenylethylene Glycol|MHPG|4-hydroxy-3-methoxyphenylglycol"
NEW07862,CHEMICAL,platelet serotonin uptake,platelet serotonin uptake
NEW07863,CHEMICAL,5-hydroxyindoleacetic acid,5-hydroxyindoleacetic acid
NEW07864,DISEASE,axis disorder,Axis disorders
NEW07870,CHEMICAL,seasonal serotonin transporter fluctuation,seasonal serotonin transporter fluctuations
NEW07872,CHEMICAL,serotonin transporter binding,serotonin transporter binding
NEW07875,CHEMICAL,antidepressant drug amitriptyline hydrochloride,AMT|antidepressant drug amitriptyline hydrochloride
NEW07876,BIOCHEMICAL,c9orf72 mutation carrier,C9orf72 mutation carriers
NEW07878,DISEASE,binge-eating behavior,binge-eating behavior
NEW07880,MENTAL_HEALTH,mixed-effects regression model,Mixed-effects regression models
NEW07882,CHEMICAL,hypoglycemic treatment,Hypoglycemic treatments
D015431,DISEASE,Weight Loss,"Weight Reduction|Reduction, Weight|Reductions, Weight|Weight Losses|Weight loss|Losses, Weight|Loss, Weight|Weight Reductions"
http://purl.obolibrary.org/obo/CHEBI_9907,CHEMICAL,ursodeoxycholic acid,"3alpha,7beta-dihydroxy-5beta-cholan-24-oic acid|urodeoxycholic acid|Ursodeoxycholate|Actigall|(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid|3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid|Ursodiol|Ursodeoxycholic acid"
C417086,CHEMICAL,"5-(4-N,N-dimethylaminophenylmethylene)-4-hydroxy-2-(1-methylimidazol-2-ylthio)-4-(4-phenylbutyl)-2-cyclopentenone [Supplementary Concept]",cyclopentenone|Prostaglandins A
NEW01350,DISEASE,neuronal damage,neuronal damage
NEW01734,CHEMICAL,sepscs,sEPSCs
NEW07887,MENTAL_HEALTH,nicotine-induced long-lasting depression,nicotine-induced long-lasting depression
NEW07890,CHEMICAL,neuroleptic flupenthixol,neuroleptic flupenthixol
NEW07893,CHEMICAL,potent combined serotonin,potent combined serotonin
NEW07894,CHEMICAL,dopamine system dysfunction,Dopamine system dysfunction
NEW07895,BIOCHEMICAL,potent dopamine da d2 receptor antagonist,potent dopamine DA D2 receptor antagonists
NEW07896,BIOCHEMICAL,potent d2 antagonist,potent D2 antagonists
NEW07898,CHEMICAL,preserved 5-ht transmission,Preserved 5-HT transmissions
NEW07905,CHEMICAL,dopamine excess,dopamine excess
NEW07907,CHEMICAL,atypical antipsychotic lek-8829,atypical antipsychotic LEK-8829
NEW07908,DISEASE,activity-based anorexia,Activity-based anorexia
NEW07911,BIOCHEMICAL,antagonist eticlopride,antagonists eticlopride
NEW07912,DISEASE,retinal alteration,retinal alterations
NEW07914,CHEMICAL,mdrtb patient,MDRTB patients
NEW07920,DISEASE,most Parkinson 's disease patient,most Parkinson's disease patients
NEW07921,CHEMICAL,protein-gated inwardly rectify k+ girk channel,protein-gated inwardly rectifying K+ GIRK channels
NEW07922,BIOCHEMICAL,act mor agonist,acting MOR agonist
NEW07924,CHEMICAL,antipsychotic olanzapine,antipsychotic olanzapine
http://purl.obolibrary.org/obo/CHEBI_60605,CHEMICAL,opioid receptor antagonist,opioid receptor antagonists|opiate antagonist|opioid receptor antagonist samidorphan|opiate antagonists|opioid antagonists|opioid antagonist
C000606131,CHEMICAL,3-carboxamido-4-hydroxynaltrexone [Supplementary Concept],samidorphan|Naltrexone/analogs  and  derivatives
NEW07926,BIOCHEMICAL,second antipsychotic drug,second antipsychotic drug
NEW07929,CHEMICAL,5ht2,5HT2
NEW07930,MENTAL_HEALTH,somnolence effect,Somnolence effects
D045602,DISEASE,Steatorrhea,steatorrhea|Celiac Disease (1964-2003)
NEW07932,NUTRITION,tree damage,tree damage
NEW07934,CHEMICAL,paopa-loaded snp-cmch hydrogel,PAOPA-loaded SNP-CMCh hydrogels
NEW07935,CHEMICAL,conventional paopa administration,conventional PAOPA administration
D000084922,NUTRITION,Resistant Starch,resistant starch|Dietary Fiber (1984-2020)|Starch (1984-2020)
NEW07938,CHEMICAL,prolonged benzodiazepine administration,prolonged benzodiazepine administration
D005951,CHEMICAL,Glucose Tolerance Test,"Intravenous Glucose Tolerance Test|Glucose Tolerance, Oral|Intravenous Glucose Tolerance|OGTT|Glucose Tolerance Tests|glucose tolerance|Oral Glucose Tolerance Test|Oral Glucose Tolerance"
C000713387,CHEMICAL,peony root extract [Supplementary Concept],"Plant Extracts|Paeonia|Drugs, Chinese Herbal|root extract"
NEW07941,DISEASE,type hyperammonemia,type hyperammonemia
NEW07943,CHEMICAL,main intestinal fructose transporter protein,main intestinal fructose transporter proteins
D000072056,CHEMICAL,Transcription Factor HES-1,"HES|Hairy and Enhancer of Split 1 Protein|Hairy-Like Transcription Factor|Transcription Factor, Hairy-Like|Transcription Factor HES 1|Hairy Like Transcription Factor|HES-1, Transcription Factor"
D006895,NUTRITION,Hydroxyethyl Starch Derivatives,"Pentaspan|Hemohes|Hydroxyethyl Starch 130 0.4|Hespan|Plasmasteril|Hydroxyethyl Starch (130 KD-0.4 Substitution)|HAES-steril|Pentafraction|Starches, 2-Hydroxyethyl|Starch Derivatives, Hydroxyethyl|Derivatives, Hydroxyethyl Starch|Hydroxyethylated Starches|Hetastarch|Hydroxyethyl Starch 130-0.4|Starches, 2 Hydroxyethyl|2-Hydroxyethyl Starches|Starches, Hydroxyethylated|Pentastarch|Hydroxyethyl starch|Elohes"
NEW07945,DISEASE,cerebral hypoperfusion,cerebral hypoperfusion
NEW07946,CHEMICAL,phenolic compound myricetin,Myr|phenolic compounds myricetin
NEW07948,DISEASE,hepatic abnormality,hepatic abnormalities
NEW07950,BIOCHEMICAL,gut hormone,gut hormones
NEW07951,CHEMICAL,glp-1 analogue,GLP-1 analogues
NEW07952,NUTRITION,serum folate,serum folate
NEW07955,DISEASE,anti- tuberculosis medication,anti- tuberculosis medication
NEW07956,CHEMICAL,medication rifampicin,medication rifampicin
NEW07957,CHEMICAL,thalidomide embryopathy,thalidomide embryopathy
NEW07960,DISEASE,thalidomide-induced cognitive dysfunction,thalidomide-induced cognitive dysfunctions
NEW07962,CHEMICAL,10mg/kg,10mg/kg
NEW07963,BIOCHEMICAL,anti-tubercular drug pharmacokinetic,anti-tubercular drug pharmacokinetics
NEW07964,CHEMICAL,sedative/hypnotic thalidomide,sedative/hypnotic thalidomide
D000069286,CHEMICAL,Bortezomib,"LDP-341|PS341|Velcade|PS 341|LDP 341|PS-341|LDP341|341, PS|bortezomib"
NEW07969,CHEMICAL,nicotine administration,nicotine administration
NEW07971,DISEASE,non-adhd subject,non-ADHD subjects
NEW07973,BIOCHEMICAL,antiparkinsonian dopaminergic agent,antiparkinsonian dopaminergic agents
http://purl.obolibrary.org/obo/DOID_0090123,CHEMICAL,aromatic l-amino acid decarboxylase deficiency,AADC|AADC deficiency|enzyme aromatic L-amino acid decarboxylase
NEW07975,CHEMICAL,dopamine storage,dopamine storage
NEW07977,CHEMICAL,active dopamine,active dopamine
NEW07978,CHEMICAL,glutamate homeostasis,glutamate homeostasis
NEW07980,CHEMICAL,levodopa preparation,Levodopa preparations
http://purl.org/sig/ont/fma/fma70958,CHEMICAL,erythromelanin granule,Zishenpingchan granules
NEW07981,DISEASE,affective level disorder patient,affective level disorder patients
NEW07984,DISEASE,many behavioural abnormality,Many behavioural abnormalities
NEW07988,CHEMICAL,nigrostriatal dopamine,nigrostriatal dopamine
NEW07991,MENTAL_HEALTH,movement REM sleep behaviour disorder,movement REM sleep behaviour disorder
NEW07994,DISEASE,periodic leg-movement disorder,periodic leg-movement disorder
D003702,MENTAL_HEALTH,Delusions,Delusion|delusions
NEW07997,DISEASE,stress/anxiety rating,stress/anxiety ratings
NEW08000,DISEASE,acute non-biliary pancreatitis,acute non-biliary pancreatitis
NEW08001,CHEMICAL,intravenous heparin,Intravenous heparin
NEW08002,CHEMICAL,dha level,DHA levels
NEW08003,NUTRITION,lcn-3 fatty acid deficiency,LCn-3 fatty acid deficiency
C044894,CHEMICAL,ethylcholine aziridinium [Supplementary Concept],"2,4,6-trinitrobenzenesulfonic acid|Aziridines|Choline/analogs  and  derivatives"
NEW08007,CHEMICAL,trinitrobenzene sulfonic acid,TNBS|trinitrobenzene sulfonic acid
D019342,CHEMICAL,Acetic Acid,"Glacial Acetic Acid|Acetic Acid, Glacial|Acetic Acid Glacial|acetic acid|Vinegar|Glacial, Acetic Acid"
NEW08009,DISEASE,hypersensitive visceral motor response,hypersensitive visceral motor response|VMR
C500065,CHEMICAL,4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide [Supplementary Concept],Piperazines|Aminopyridines|JNJ-17203212
NEW08012,BIOCHEMICAL,selective trpv1 antagonist,selective TRPV1 antagonist
D055589,DISEASE,"Pancreatitis, Graft",Graft Pancreatitis|pancreatitis
http://purl.obolibrary.org/obo/CHEBI_82891,BIOCHEMICAL,glucocorticoid receptor antagonist,glucocorticoid receptor GR antagonist RU486 antagonist|glucocorticoid receptor antagonists
C071423,CHEMICAL,capsazepine [Supplementary Concept],Capsaicin/analogs  and  derivatives|capsazepine
NEW08017,CHEMICAL,cox2 inhibitor ns-398,COX2 inhibitor NS-398
D009599,CHEMICAL,Nitroprusside,"Disodium Salt Nitroprusside|Nitropress|Nitroferricyanide|Nitroprussiat Fides|Nitriate|Nitroprusside, Disodium Salt|Nitroprusside, Sodium|Ketostix|Nipruton|sodium nitroprusside|Sodium Nitroprusside|Nipride|Nitroprusside, Disodium Salt, Dihydrate|Naniprus|Cyanonitrosylferrate"
D026423,CHEMICAL,S-Nitroso-N-Acetylpenicillamine,"N2-Acetyl-S-Nitroso-D,L-Penicillinaminamide|NO donor|S-Nitrosylacetylpenicillamine|SNAP (NO donor)|N-Acetyl-S-Nitrosopenicillamine|S-NONAP"
C053402,CHEMICAL,"(N-(4-amino-4-deoxy-N(10)-methylpteroyl)amino)-3-chloro-4,5-dihydro-5-isoxazoleacetic acid [Supplementary Concept]",Acivicin|Methotrexate/analogs  and  derivatives|Isoxazoles
NEW08023,CHEMICAL,l-glutamine antagonist,L-glutamine antagonist
NEW01190,DISEASE,cns toxicity,CNS toxicity
NEW08025,DISEASE,advanced malignancy,advanced malignancies
D051046,CHEMICAL,Amino-Acid N-Acetyltransferase,"Acetyl CoA Glutamate N Acetyltransferase|Acetyltransferase, Amino-Acid|N-Acetylglutamate Synthetase|N Acetylglutamate Synthetase|N-Acetyl-L-Glutamate Synthetase|Acetyl Coenzyme A Glutamate N-Acetyltransferase|N Acetyl L Glutamate Synthetase|Synthetase, N-Acetylglutamate|Amino Acid N Acetyltransferase|Synthase, N-Acetylglutamate|Synthetase, N-Acetyl-L-Glutamate|Acetyl CoA Glutamate N-Acetyltransferase|N-Acetyltransferase, Amino-Acid|N-Acetylglutamate Synthase|Amino Acid Acetyltransferase|Acetyl Coenzyme A Glutamate N Acetyltransferase|amino acid|Acetyltransferase, Amino Acid|Amino-Acid Acetyltransferase|N Acetylglutamate Synthase|Acid Acetyltransferase, Amino"
NEW08027,CHEMICAL,miltiorrhiza Bge,miltiorrhiza Bge
C571351,CHEMICAL,danshensu bingpian zhi [Supplementary Concept],Phenylpropionates|Danshensu|Camphanes
C085278,CHEMICAL,hydroxysafflor yellow A [Supplementary Concept],hydroxysafflor yellow A|Quinones|HSYA|Chalcone/analogs  and  derivatives
C513882,CHEMICAL,nicotiflorin [Supplementary Concept],Nicotiflorin|Flavonoids|Phenols
NEW08033,NUTRITION,defective fatty acid oxidation,Defective fatty acid oxidation
C565304,DISEASE,Multiple Mitochondrial Dysfunctions Syndrome [Supplementary Concept],mitochondrial dysfunctions|Mitochondrial Diseases
NEW08036,CHEMICAL,da hypothesis,DA hypotheses
NEW08040,DISEASE,psychotic action,psychotic actions
NEW04801,CHEMICAL,kynurenine acid,kynurenine acid
NEW08042,CHEMICAL,antidepressant fluoxetine,Antidepressant fluoxetine
NEW08043,CHEMICAL,FLX administration,FLX administration
NEW08045,CHEMICAL,fluoxetine administration,Fluoxetine administration
C520797,DISEASE,GB-115 [Supplementary Concept],GB-115|Dipeptides
NEW08046,NUTRITION,neuroactive tryptophane,neuroactive tryptophane
NEW08047,CHEMICAL,kynurenine metabolite,kynurenine metabolite
NEW08049,CHEMICAL,defective phenylalanine metabolism,defective phenylalanine metabolism
D010661,DISEASE,Phenylketonurias,"Hyperphenylalaninemia, BH4-Deficient, C|DHPR Deficiency|Deficiency, DHPR|Phenylalanine Hydroxylase Deficiency Disease|Phenylketonuria I|Deficiency, QDPR|Phenylketonuria|QDPR Deficiency|PAH Deficiency|Deficiency, Tetrahydrobiopterin|Phenylketonuria, Classical|Tetrahydrobiopterin Deficiency|Deficiency Disease, Dihydropteridine Reductase|Deficiency, PAH|Hyperphenylalaninemia, Non-Phenylketonuric|Non Phenylketonuric Hyperphenylalaninemia|Phenylketonuria Type 2|Dihydropteridine Reductase Deficiency Disease|Non-Phenylketonuric Hyperphenylalaninemia|HPABH4C|BH4 Deficiency|Atypical PKU|Disease, Folling|Folling's Disease|Deficiency Disease, Phenylalanine Hydroxylase, Severe|Oligophrenia Phenylpyruvica|Hyperphenylalaninemia, Non Phenylketonuric|Hyperphenylalaninemia Caused by a Defect in Biopterin Metabolism|Phenylketonuria II|Folling Disease|Deficiency, Dihydropteridine Reductase|Disease, Folling's|Hyperphenylalaninaemia|Deficiency, BH4|Atypical Phenylketonuria|Hyperphenylalaninemia, Tetrahydrobiopterin-Deficient, Due To DHPR Deficiency|Deficiency, Phenylalanine Hydroxylase|Phenylalanine Hydroxylase Deficiency|hyperphenylalaninemia|Quinoid Dihydropteridine Reductase Deficiency|PKU, Atypical|Classical Phenylketonuria|Deficiency Disease, Phenylalanine Hydroxylase|Non-Phenylketonuric Hyperphenylalaninemias|Phenylalanine Hydroxylase Deficiency Disease, Severe|Phenylketonuria, Atypical|Dihydropteridine Reductase Deficiency"
D017780,DISEASE,Malaria Vaccines,"malaria|Vaccines, Malaria|Vaccines, Malarial|Malaria Vaccine|Vaccine, Malarial|Malarial Vaccines|Malarial Vaccine|Vaccine, Malaria"
NEW08053,NUTRITION,tryptophane hydroxylase gene polymorphism,tryptophane hydroxylase gene polymorphism
NEW08055,CHEMICAL,human metabotropic glutamate receptor subtype,human metabotropic glutamate receptor subtype
D020364,DISEASE,Paraneoplastic Polyneuropathy,"Paraneoplastic Peripheral Neuropathies|Paraneoplastic Peripheral Neuropathy|Polyneuropathy, Paraneoplastic|Neuropathy, Paraneoplastic|Neuropathies, Paraneoplastic|Peripheral Neuropathies, Paraneoplastic|Paraneoplastic Neuropathies|Paraneoplastic Polyneuropathies|Neuropathies, Paraneoplastic Peripheral|polyneuropathy|Peripheral Neuropathy, Paraneoplastic|Neuropathy, Paraneoplastic Peripheral|Polyneuropathies, Paraneoplastic|Paraneoplastic Neuropathy"
NEW08056,CHEMICAL,aromatic alcohol phenol,aromatic alcohol phenol
NEW08057,CHEMICAL,n-alcohols methanol,n-alcohols methanol
D002722,CHEMICAL,Chlorobenzenes,chlorobenzenes
NEW08058,CHEMICAL,several antidepressant,Several antidepressants
NEW08059,NUTRITION,lithium prophylaxis,lithium prophylaxis
D011629,DISEASE,"Puberty, Precocious","Precocious Puberties|puberty|Central Precocious Puberty|Male-Limited Precocious Puberty|Familial Precocious Puberty|Praecox, Pubertas|Sexual Precocities, Idiopathic|Precocious Puberties, Central|Precocious Puberties, Familial|Precocious Puberty|Male-Limited Precocious Puberties|Sexual Precocity, Idiopathic|Sexual Precocity|Precocities, Idiopathic Sexual|Precocious Puberties, Male-Limited|Idiopathic Sexual Precocity|Familial Precocious Puberties|Central Precocious Puberties|Precocious Puberty, Male Limited|Precocious Puberty, Central|Puberty, Male-Limited Precocious|Precocities, Sexual|Puberties, Male-Limited Precocious|Precocity, Sexual|Puberty, Central Precocious|Precocity, Idiopathic Sexual|Precocious Puberty, Familial|Puberty, Familial Precocious|Precocious Puberty, Male-Limited|Testotoxicosis|Puberties, Precocious|Idiopathic Sexual Precocities|Puberties, Familial Precocious|Sexual Precocities|Puberties, Central Precocious|Pubertas Praecox"
D005764,DISEASE,Gastroesophageal Reflux,"Gastro-Esophageal Reflux Disease|Reflux, Gastro-oesophageal|Acid Reflux, Gastric|Reflux, Gastro-Esophageal|GERD|Gastro-Esophageal Reflux Diseases|gastro-esophageal reflux|Reflux, Gastric Acid|Gastro-oesophageal Reflux|Gastric Acid Reflux Disease|Gastro-Esophageal Reflux|Reflux Disease, Gastro-Esophageal|Gastro Esophageal Reflux Disease|Gastric Acid Reflux|Reflux, Gastroesophageal|Gastro oesophageal Reflux|Gastro Esophageal Reflux|Gastroesophageal Reflux Disease|Esophageal Reflux"
NEW08063,MENTAL_HEALTH,pathological gambling similar,pathological gambling similar
NEW08066,DISEASE,whose be neurotoxic effect,neurotoxic effects
http://purl.org/sig/ont/fma/fma71132,DISEASE,gastrointestinal tract,Gastrointestinal system|human gastrointestinal tract|Gastro-intestinal system
NEW08069,CHEMICAL,lfao oligomeric strain,LFAO oligomeric strain
D008076,NUTRITION,"Cholesterol, HDL","HDL Cholesterol|Cholesterol, HDL3|HDL(3) Cholesterol|HDL2 Cholesterol|high-density lipoprotein cholesterol|HDL(2) Cholesterol|alpha Lipoprotein Cholesterol|HDL3 Cholesterol|Cholesterol, HDL2|High Density Lipoprotein Cholesterol|alpha-Lipoprotein Cholesterol|Cholesterol, alpha-Lipoprotein"
D007863,BIOCHEMICAL,Lecithin Cholesterol Acyltransferase Deficiency,"Fish-Eye Disease|Corneal Dystrophy, Dyslipoproteinemic|Norum Disease|alpha LCAT Deficiency|LCATA Deficiencies|Lecithin:Cholesterol Acyltransferase Deficiency|Acyltransferase Deficiency, Lecithin:Cholesterol|Deficiency, LCAT|alpha-Lecithin:Cholesterol Acyltransferase Deficiency|Fish Eye Disease|LCAT Deficiency|Dyslipoproteinemic Corneal Dystrophy|Deficiency, alpha-LCAT|LCATA Deficiency|lecithin|alpha-LCAT Deficiency|alpha-Lecithin-Cholesterol Acyltransferase Deficiency"
NEW08073,DISEASE,viral liver disease,viral liver disease
NEW08074,CHEMICAL,platelet mao,platelet MAO
D056732,CHEMICAL,Prolidase Deficiency,"Prolidase Deficiencies|Deficiencies, Imidodipeptidase|Imidodipeptidase Deficiency|Hyperimidodipeptiduria|deficiency|FLD|Deficiency, Prolidase|Hyperimidodipeptidurias|Deficiency, Imidodipeptidase|Imidodipeptidase Deficiencies|Deficiencies, Prolidase"
NEW08076,NUTRITION,familial lecithin cholesterol acyltransferase lcat deficiency,familial lecithin cholesterol acyltransferase LCAT deficiency
NEW08077,DISEASE,several inborn error,Several inborn errors
D015211,DISEASE,Zellweger Syndrome,"Cerebrohepatorenal Syndrome|Spectrum, Zellweger|Zellweger-Like Syndrome|Zellweger Syndrome Spectrum|Zellweger Disease|Zellweger Like Syndrome|Zellweger Spectrum|Cerebro Hepato Renal Syndrome|PBD, ZSS|Cerebro-Hepato-Renal Syndrome|Zellweger's syndrome|Peroxisome Biogenesis Disorders, Zellweger Syndrome Spectrum|Zellweger's Syndrome"
D019294,DISEASE,"Xanthomatosis, Cerebrotendinous","Cerebral Cholesterinoses|Cerebrotendinous Xanthomatoses|Cerebrotendinous Xanthomatosis|Disease, Van Bogaert-Scherer-Epstein|Van Bogaert Scherer Epstein Disease|Xanthomatoses, Cerebrotendinous|Cerebral Cholesterinosis|Bogaert-Scherer-Epstein Disease, Van|cerebrotendinous xanthomatosis|Van Bogaert-Scherer-Epstein Disease"
D010743,NUTRITION,Phospholipids,Phosphatides|Phospholipid|phospholipids
NEW08080,NUTRITION,soy lecithin,soy lecithin
NEW08081,MENTAL_HEALTH,early alzheimer disease,early Alzheimer disease
D010830,CHEMICAL,Physostigmine,Eserine|physostigmine
D013619,CHEMICAL,Tacrine,"Tenakrin|Tetrahydroaminoacridine|1,2,3,4-Tetrahydroaminoacridine|Tacrine Hydrochloride|1,2,3,4-Tetrahydro-9-acridinamine|tetrahydroaminoacridine|THA|9-Amino-1,2,3,4-Tetrahydroacridine|Romotal|Cognex"
NEW08086,CHEMICAL,gaba(a)-receptor alpha-reduced neuroactive steroid,GABA(A)-receptor alpha-reduced neuroactive steroids
NEW08087,CHEMICAL,glucocorticoid receptor gr antagonist ru38486,glucocorticoid receptor GR antagonist RU38486
NEW08088,CHEMICAL,specific mineralocorticoid receptor mr antagonist ru28318,specific mineralocorticoid receptor MR antagonist RU28318
D018028,CHEMICAL,"Receptors, Neurotensin","neurotensin|Neurotensin Receptors|Neurotensin Receptor|Receptor, Neurotensin"
NEW08090,CHEMICAL,neurotensin agonist neurotensin peptide fragment,neurotensin agonist neurotensin peptide fragment
C513736,CHEMICAL,"(Trp3, Arg5)-ghrelin(1-5) [Supplementary Concept]",Arg5|Ghrelin
NEW08091,CHEMICAL,antioxidant defense system glutathione,antioxidant defense system glutathione
C016837,CHEMICAL,zinc chloride [Supplementary Concept],Chlorides|Zinc Compounds|zinc chloride|ZnCl₂
NEW08094,CHEMICAL,high dietary zinc,high dietary zinc
http://purl.obolibrary.org/obo/DOID_9279,DISEASE,hyperhomocysteinemia,hyperzincuria
NEW08096,DISEASE,mechanical pain,mechanical pain
NEW08098,DISEASE,mouse conditioned avoidance response,CAR|mouse conditioned avoidance response
NEW08100,CHEMICAL,low serum zinc,low serum zinc
NEW08102,DISEASE,skeletal muscle mass,skeletal muscle mass
NEW08103,CHEMICAL,bcaa zinc preparation,BCAA zinc preparation
NEW08105,CHEMICAL,antidepressant agent,antidepressant agents
NEW08107,CHEMICAL,zinc supplementation,Zinc supplementation
D005742,CHEMICAL,Gasoline,"Fuels, Diesel|Fuel, Diesel|Diesel Fuel|gasoline|Gasolines|Diesel Fuels"
NEW08108,DISEASE,physio-somatic symptom,physio-somatic symptoms
NEW08109,DISEASE,postnatal depressive symptom,Postnatal depressive symptoms
NEW08112,CHEMICAL,dietary zinc,dietary zinc
NEW08113,CHEMICAL,hair copper level,hair copper levels
NEW08115,CHEMICAL,zinc ratio,zinc ratio
D000090463,CHEMICAL,Iron Deficiencies,"Sideropenias|Deficiency, Latent Iron|Iron Deficiencies, Latent|Iron Deficiency|Latent Iron Deficiencies|Deficiencies, Iron|Iron Deficiency, Latent|Sideropenia|Hypoferritinemia|Hypoferritinemias|Deficiencies, Latent Iron|Deficiency, Iron|Latent Iron Deficiency|iron deficiencies"
NEW08117,DISEASE,major depressed subject,Major depressed subjects
NEW08119,CHEMICAL,chronic high-level alcohol consumption,chronic high-level alcohol consumption
NEW08120,DISEASE,increase inflammation,increased inflammation
NEW08121,CHEMICAL,cortisol pathway dysregulation,cortisol pathway dysregulation
NEW08122,CHEMICAL,dietary zinc intake,Dietary zinc intake
NEW08124,CHEMICAL,dietary zinc intake,dietary zinc intake
D003533,CHEMICAL,Cyproheptadine,Viternum|cyproheptadine|Antergan|Dihexazin|Periactin|Peritol
D012563,DISEASE,"Schizophrenia, Paranoid","Paranoid Schizophrenias|Disorders, Delusional|delusional disorders|Paranoid Schizophrenia|Schizophrenias, Paranoid|Delusional Disorders|Disorder, Delusional|Delusional Disorder"
NEW08125,MENTAL_HEALTH,refractory obsessive-compulsive disorder,refractory obsessive-compulsive disorder
NEW08126,CHEMICAL,bl-3912,BL-3912
C051752,CHEMICAL,nefazodone [Supplementary Concept],Piperazines|Triazoles|nefazodone
NEW08129,BIOCHEMICAL,daily prenatal vitamin,daily prenatal vitamin
http://purl.obolibrary.org/obo/CHEBI_82663,CHEMICAL,elemental iron,elemental iron
D009767,DISEASE,"Obesity, Morbid","Severe Obesity|Obesity, Severe|Obesities, Severe|morbid obesity|Morbid Obesities|Severe Obesities|Obesities, Morbid|Morbid Obesity"
NEW08131,CHEMICAL,kava hepatotoxicity,kava hepatotoxicity
D014761,DISEASE,Viral Hepatitis Vaccines,"Vaccines, Viral Hepatitis|Hepatitis Vaccines, Viral|Hepatitis, Viral, Vaccines|Viral hepatitis"
NEW08132,CHEMICAL,hepatic iron transporter,hepatic iron transporters
NEW08134,CHEMICAL,iron toxicity,Iron toxicity
NEW08136,DISEASE,hepatotoxic potential,hepatotoxic potential
D004211,DISEASE,Disseminated Intravascular Coagulation,"Coagulopathy, Consumption|coagulopathy|Coagulation, Disseminated Intravascular|Disseminated Coagulations, Intravascular|Coagulations, Intravascular Disseminated|Coagulations, Disseminated Intravascular|Disseminated Coagulation, Intravascular|Intravascular Coagulation, Disseminated|Disseminated Intravascular Coagulations|Consumption Coagulopathies|Intravascular Disseminated Coagulations|Intravascular Coagulations, Disseminated|Coagulation, Intravascular Disseminated|Coagulopathies, Consumption|Consumption Coagulopathy|Intravascular Disseminated Coagulation"
NEW08139,DISEASE,depressed people,depressed people
NEW08140,CHEMICAL,adenosine 2a a2a receptor hyperactivation,adenosine 2A A2A receptor hyperactivation
NEW08141,CHEMICAL,acetylcholine depletion,acetylcholine depletion
NEW08142,BIOCHEMICAL,microtubule stabiliser,microtubule stabilisers
NEW08143,NUTRITION,lithium relapse prevention effect,lithium relapse prevention effects
NEW08145,CHEMICAL,antidepressant prescription,antidepressant prescriptions
NEW08146,BIOCHEMICAL,low carotenoid status,Low carotenoid status
D014975,BIOCHEMICAL,Lutein,"Lutein F|Lutein, gamma|beta,epsilon-Carotene-3,3'-diol, (3S,3'R,6'S)-|beta,epsilon-Carotene-3, 3'-Diol, (3R,3'R,6'S)-|gamma Lutein|Lutein G|lutein"
NEW08150,NUTRITION,prolonged lithium intoxication,Prolonged lithium intoxication
D012402,CHEMICAL,Rotenone,Uncoupling Agents|Insecticides|Rotenone
D004178,CHEMICAL,Diquat,"diquat|Dibromide, Diquat|Diquat Dibromide"
NEW08152,DISEASE,impairment swimming score,impairment swimming score
NEW08154,BIOCHEMICAL,multiple toxin,multiple toxins
NEW08155,BIOCHEMICAL,clostridial neurotoxin,Clostridial neurotoxins
NEW08156,BIOCHEMICAL,botulinum neurotoxin bont family,botulinum neurotoxin BoNT family
D009209,DISEASE,Myofascial Pain Syndromes,"Pain Syndrome, Myofascial|myofascial pain|Myofascial Pain Syndrome|Myofascial Trigger Point Pain|Syndromes, Myofascial Pain|Pain Syndromes, Myofascial|Trigger Point Pain, Myofascial|Syndrome, Myofascial Pain"
NEW08157,CHEMICAL,soluble amyloid oligomer,Soluble amyloid oligomers
NEW08159,NUTRITION,prenatal choline supplementation,prenatal choline supplementation
NEW08161,CHEMICAL,plasma corticosterone,Plasma corticosterone
http://purl.obolibrary.org/obo/CHEBI_16240,CHEMICAL,hydrogen peroxide,Hydrogen peroxide|dihydrogen peroxide|dihydrogen(peroxide)|perhydrol|hydrogen peroxide|dihydrogen dioxide|HYDROGEN PEROXIDE|bis(hydridooxygen)(O--O)|H2O2|[OH(OH)]|Oxydol|dioxidane|hydrogen peroxide production|HOOH
NEW02275,MENTAL_HEALTH,psychiatric syndrome,psychiatric syndromes
NEW08166,BIOCHEMICAL,uraemic neurotoxin,uraemic neurotoxins
D008911,CHEMICAL,Minocycline,"Minocycline Monohydrochloride|Akne-Puren|Minocin|Minomycin|Akamin|Mestacine|Minotab|Apo Minocycline|Mynocine|Apo-Minocycline|Minox 50|Minocycline Hydrochloride|Minoplus|Dynacin|Cyclomin|Blemix|Minakne|Aknin-Mino|Monohydrochloride, Minocycline|Icht Oral|Icht-Oral|Minoclir|minocycline|Lederderm|Cyclops|Mino Wolff|Minocin MR|Minolis|Klinomycin|Akne Puren|Dentomycin|Arestin|Aknosan|Aknin Mino|Mino-Wolff|Aknemin|Minocycline, (4R-(4 alpha,4a beta,5a beta,12a beta))-Isomer|Hydrochloride, Minocycline"
NEW08169,DISEASE,only infection,only infections
NEW08171,DISEASE,neonatal infection,neonatal infections
NEW08172,DISEASE,death toll,death toll
NEW08174,MENTAL_HEALTH,insomnia treatment,Insomnia treatment
NEW08175,BIOCHEMICAL,new dual orexin receptor antagonist,new dual orexin receptor antagonist
http://purl.obolibrary.org/obo/SYMP_0000462,DISEASE,symptom,SRS-induced PTSD-like symptoms
NEW08177,CHEMICAL,nonselective orexin receptor antagonist suvorexant,nonselective orexin receptor antagonist suvorexant
NEW08178,BIOCHEMICAL,ox1 receptor antagonist,OX1 receptor antagonist
NEW08180,BIOCHEMICAL,orexin receptor oxr antagonist,orexin receptor OXR antagonists
http://purl.obolibrary.org/obo/CHEBI_83296,CHEMICAL,orexin receptor antagonist,orexin receptor antagonist suvorexant|orexin receptor antagonists
NEW08181,BIOCHEMICAL,oxr antagonist,OXR antagonists
http://purl.obolibrary.org/obo/DOID_10652,DISEASE,alzheimer's disease,severe Alzheimer's disease|Alzheimers dementia|Alzheimer disease
NEW08185,CHEMICAL,serotonin alteration,serotonin alterations
NEW08187,BIOCHEMICAL,drug dopaminergic agonist,drugs dopaminergic agonists
http://purl.obolibrary.org/obo/DOID_10939,MENTAL_HEALTH,antisocial personality disorder,impulsive personality disorders|Psychopathic personality|Dissocial personality disorder|Asocial personality|sociopathic personality|Psychopath.personality|Psychopathic personality disorder
NEW08189,BIOCHEMICAL,circulate oestrogen,circulating oestrogens
NEW08190,BIOCHEMICAL,oestrogen therapy,Oestrogen therapy
D020258,DISEASE,Neurotoxicity Syndromes,"Neurotoxicity|Nervous System Poisonings|Toxic Encephalitides|Encephalitis, Toxic|Neurotoxin Disorders|Encephalopathy, Toxic|Neurotoxin Disorder|Toxic Encephalopathies|Encephalopathies, Toxic|Syndromes, Neurotoxicity|Neurotoxicity Syndrome|Nervous System Poisoning|Neurotoxin Disease|Poisonings, Nervous System|Syndrome, Neurotoxicity|Neurotoxic Disorders|Poisoning, Nervous System|Neurotoxin Diseases|Toxic Encephalitis|Encephalitides, Toxic|Neurotoxic Disorder|Toxic Encephalopathy"
http://purl.org/sig/ont/fma/fma67440,CHEMICAL,claustrum,caudate putamen|CP|Dorsal claustrum|Dorsal portion of claustrum
NEW08192,BIOCHEMICAL,lipophilic anticholinergic,Lipophilic anticholinergics
NEW08195,DISEASE,sinus arrhythmia measurement,Sinus arrhythmia measurements
NEW08196,CHEMICAL,mirabegron use,mirabegron use
NEW08198,DISEASE,acute dystonia,Acute dystonia
NEW08202,MENTAL_HEALTH,pediatric nocturnal enuresis,pediatric nocturnal enuresis
NEW08205,MENTAL_HEALTH,toxic delirium,Toxic delirium
NEW01750,DISEASE,psychiatric manifestation,psychiatric manifestations
C073145,CHEMICAL,S-adenosylmethionine-dependent phosphate methyltransferase [Supplementary Concept],AdoMet|Methyltransferases
C558116,CHEMICAL,"8-ethynyl-6-(2'-pyridine)-4H-2,5,10b-triazabenzo(e)azulene-3-carboxylic acid ethyl ester [Supplementary Concept]",HZ166|Imidazoles|Benzodiazepines
NEW08208,MENTAL_HEALTH,chronic stress aqp5 expressing cell,chronic stress AQP5 expressing cells
C500889,CHEMICAL,"Ara h 1 protein, Arachis hypogaea [Supplementary Concept]","ARA|Plant Proteins|Membrane Proteins|Antigens, Plant"
NEW08210,MENTAL_HEALTH,static encephalopathy,Static encephalopathy
D018244,NUTRITION,"Chromosomes, Artificial, Yeast","Artificial Chromosome, Yeast|Yeast Artificial Chromosome|Yeast Artificial Chromosomes|Chromosome, Yeast Artificial|YAC (Chromosome)|yeast artificial chromosome|Chromosomes, Yeast Artificial|YACs (Chromosomes)|Artificial Chromosomes, Yeast"
http://purl.obolibrary.org/obo/CHEBI_53121,CHEMICAL,adenosine a2a receptor antagonist,adenosine A2A receptor antagonists|adenosine A2A receptor antagonist
NEW08215,CHEMICAL,istradefylline increase on-time,istradefylline increased on-time
D008569,DISEASE,Memory Disorders,"Age-Related Memory Disorder|Memory Losses|Semantic Memory Disorders|Memory Disorder, Age-Related|Spatial Memory Disorder|Memory Disorders, Age-Related|Memory Disorders, Semantic|Cognitive Retention Disorders|Memory Disorder, Semantic|Deficit, Memory|Deficits, Memory|Memory Deficits|memory deficits|Memory Deficit|Age Related Memory Disorders|Memory Loss|Memory Disorder|Memory Disorders, Age Related|Spatial Memory Disorders|Memory Disorder, Spatial|Semantic Memory Disorder|Age-Related Memory Disorders|Retention Disorders, Cognitive|Memory Disorders, Spatial|Cognitive Retention Disorder|Retention Disorder, Cognitive"
NEW08219,CHEMICAL,uric acid neurological problem,uric acid neurological problems
NEW08221,CHEMICAL,aicaribosid,AICAR breakdown product|AICAribosid
NEW08222,CHEMICAL,metabolite 5'-methylthioadenosine,metabolite 5'-methylthioadenosine|MTA
NEW08224,BIOCHEMICAL,anthrax lethal toxin,anthrax lethal toxin
NEW08225,CHEMICAL,non-vitamin k antagonist oral anticoagulant,Non-vitamin K antagonist oral anticoagulants
NEW08228,CHEMICAL,Hypericum perforatum L.,Hypericum perforatum L.
NEW08230,CHEMICAL,kg(-1,kg(-1
NEW08232,CHEMICAL,hypericin content,hypericin content
NEW08233,CHEMICAL,zinc (zn)-deficiency,zinc (Zn)-deficiency
NEW08234,CHEMICAL,h. triquetrifolium,H. triquetrifolium
NEW08235,CHEMICAL,rat to chronic unpredictable stress,rats to chronic unpredictable stress|CUS
NEW08238,CHEMICAL,ud extract,UD extract
NEW08240,DISEASE,hypersomnia item,hypersomnia items
C422326,CHEMICAL,Hypericum extract LI 160 [Supplementary Concept],Hypericum|Plant Extracts|LI160
NEW02921,CHEMICAL,antidepressant activity,antidepressant activity
NEW08242,CHEMICAL,non-fda-approved over-the-counter OTC herbal supplement,non-FDA-approved over-the-counter OTC herbal supplement
C559745,CHEMICAL,hyperforin dicyclohexylammonium [Supplementary Concept],Terpenes|Hyperforin
NEW08245,CHEMICAL,hypericum extract,HpE|hypericum extracts
NEW08247,BIOCHEMICAL,nutraceutical treatment,nutraceutical treatments
NEW08248,DISEASE,menstruous dysfunction,menstruous dysfunction
NEW08250,CHEMICAL,2a-selective agonist guanfacine,2a-selective agonist guanfacine
http://purl.org/sig/ont/fma/fma67255,NUTRITION,alpha adrenergic receptor,post-junctional alpha receptors
NEW08251,CHEMICAL,"drug dopamine da precursor l-3,4-dihydroxy phenylamine","drugs dopamine DA precursor L-3,4-dihydroxy phenylamine"
NEW08253,CHEMICAL,da releaser amantadine,DA releaser amantadine
NEW08254,CHEMICAL,serum ni concentration,serum Ni concentrations
http://purl.obolibrary.org/obo/DOID_0060042,MENTAL_HEALTH,atypical autism,PDD|atypical autism
D064588,CHEMICAL,Selenium Oxides,"Oxides, Selenium|Trioxide, Selenium|Selenium Oxide|selenium|Selenium Trioxide|Oxide, Selenium|Selenium Monoxide|Monoxide, Selenium|Dioxide, Selenium|Selenium Dioxide"
NEW08258,CHEMICAL,serum selenium concentration,serum selenium concentrations
NEW05864,DISEASE,hd mouse,HD mice
NEW08261,CHEMICAL,selenium metabolism,selenium metabolism
NEW08262,DISEASE,d-gal-induced anxiety- symptom,D-gal-induced anxiety- symptoms
NEW08263,DISEASE,d-gal-induced dysfunction,D-gal-induced dysfunction
NEW08264,BIOCHEMICAL,specific vitamin b-12,specific vitamins B-12
NEW08265,CHEMICAL,mineral calcium,minerals calcium
NEW08266,CHEMICAL,vitamin-like nutrient,vitamin-like nutrients
D051137,CHEMICAL,Selenium-Binding Proteins,"Protein, Se-Binding|Protein, Selenium-Binding|Selenium Binding Protein|Binding Protein, Selenium|Selenium Binding Proteins|Se Binding Protein|Se-Binding Proteins|Se Binding Proteins|Selenium binding protein|Protein, Selenium Binding|Selenium-Binding Protein|Se-Binding Protein"
C459607,CHEMICAL,"Zhf1 protein, S pombe [Supplementary Concept]",zinc homeostasis|Schizosaccharomyces pombe Proteins|Membrane Transport Proteins
NEW08268,CHEMICAL,selenium exposure,Selenium exposure
NEW08270,CHEMICAL,elevated plasma selenium level,elevated plasma selenium levels
NEW08271,CHEMICAL,increase plasma selenium level,increased plasma selenium level
NEW08272,CHEMICAL,blood plasma selenium,blood plasma selenium
C008493,CHEMICAL,methylselenic acid [Supplementary Concept],Methylseleninic acid|Organoselenium Compounds
NEW08276,CHEMICAL,selenium nanoparticle,Selenium nanoparticles
NEW08278,DISEASE,hyperlipidaemia,hyperlipidaemia
NEW08280,CHEMICAL,maternal rbc se level,maternal RBC Se levels
NEW08281,CHEMICAL,maternal se,maternal Se
NEW08283,DISEASE,diabetic people,diabetic people
NEW08284,CHEMICAL,desipramine mg/kg,desipramine mg/kg
D018756,BIOCHEMICAL,GABA Antagonists,"GABA Receptor Antagonists|gamma Aminobutyric Acid Antagonists|Antagonist, GABA|Receptor Antagonists, GABA|Antagonists, GABA|GABA antagonist|Antagonists, gamma-Aminobutyric Acid|GABA Antagonist|Antagonists, GABA Receptor|Acid Antagonists, gamma-Aminobutyric|gamma-Aminobutyric Acid Antagonists"
NEW08286,BIOCHEMICAL,gaba antagonist drug,GABA antagonist drugs
NEW08289,CHEMICAL,kainate-type glutamate receptor,kainate-type glutamate receptors
NEW08290,CHEMICAL,glucosamine hydrochloride,Glucosamine hydrochloride
D002511,CHEMICAL,Cephalosporins,"Cephalosporanic Acid|Antibiotics, Cephalosporin|Acids, Cephalosporanic|Cephalosporanic Acids|Cephalosporin Antibiotics|Acid, Cephalosporanic|Antibiotic, Cephalosporin|Cephalosporin|Cephalosporin Antibiotic|cephalosporins"
NEW08292,CHEMICAL,la classification,LA classification
NEW04043,DISEASE,motor impairment,motor impairments
NEW08295,DISEASE,register gerd,registered GERD
NEW08296,DISEASE,due facial palsy,due facial palsy
D024841,CHEMICAL,Fluoroquinolones,Fluoroquinolone|fluoroquinolones
NEW08302,BIOCHEMICAL,antibiotic exposure,Antibiotics exposure
NEW08304,BIOCHEMICAL,antibiotic exposure,antibiotics exposure
NEW08306,CHEMICAL,long-term azi treatment,Long-term AZI treatment
http://purl.obolibrary.org/obo/CHEBI_34974,CHEMICAL,sennoside,"Senna-lax|5,5'-bis(beta-D-glucopyranosyloxy)-4,4'-dihydroxy-10,10'-dioxo-9,9',10,10'-tetrahydro-9,9'-bianthracene-2,2'-dicarboxylic acid|sennaglucosides|Liuwei Dihuang Pills/Yougui"
D057919,CHEMICAL,Biological Oxygen Demand Analysis,"Oxygen Demand, Chemical|Chemical Oxygen Demand|Chemical Oxygen Demand Analyses|Oxygen|Biological Oxygen Demand Analyses|Chemical Oxygen Demand Analysis|Oxygen Demand, Biological|Demand, Chemical Oxygen|Biological Oxygen Demand"
D001993,CHEMICAL,Bronchodilator Agents,"Bronchial-Dilating Agents|Broncholytic Agents|Agents, Bronchodilator|Bronchodilator Effects|Bronchodilator Agent|Broncholytic Agent|Agent, Bronchodilator|bronchodilators|Bronchodilator Effect|Effects, Bronchodilator|Broncholytic Effects|Agents, Bronchial-Dilating|Effect, Bronchodilator|Effect, Broncholytic|Agent, Broncholytic|Effects, Broncholytic|Bronchodilators|Agents, Broncholytic|Broncholytic Effect|Bronchial Dilating Agents|Bronchodilator"
http://purl.obolibrary.org/obo/SYMP_0000413,DISEASE,catatonia,Antibiomania
D015780,DISEASE,Carbapenems,"Antibiotics, Carbapenem|Carbapenems|Carbapenem|Carbapenem Antibiotics"
D004405,DISEASE,"Dysentery, Bacillary","shigellosis|Shigella sonnei Dysenteries|Dysenteries, Shigella sonnei|Dysentery, Shigella sonnei|Shigella boydii Dysentery|Dysentery, Shigella|Shigella flexneri Dysentery|Bacillary Dysentery|Shigella sonnei Dysentery|Dysentery, Shigella boydii|Shigella dysenteriae Dysentery|Shigella Infections|Dysenteries, Shigella boydii|Shigella Infection|Shigellosis|Dysentery, Shigella dysenteriae|Shigella Dysenteries|Dysenteries, Shigella|Shigella flexneri Dysenteries|Infections, Shigella|Infection, Shigella|Shigella boydii Dysenteries|Dysenteries, Shigella dysenteriae|Dysentery, Shigella dysenteriae type 1|Dysenteries, Shigella flexneri|Shigella dysenteriae Dysenteries|Shiga bacillus Dysentery|Dysentery, Shigella flexneri|Dysentery, Shiga bacillus|Shigella Dysentery"
NEW08316,BIOCHEMICAL,late antibiotic treatment,Late antibiotic treatment
NEW08317,DISEASE,early childhood shigellosis,early childhood shigellosis
NEW08318,BIOCHEMICAL,late antibiotic treatment,late antibiotic treatment
D014647,DISEASE,Varicose Ulcer,"Venous Ulcers|Ulcer, Venous|Ulcer, Venous Hypertension|ulcers|Venous Stasis Ulcer|Venous Hypertension Ulcers|Stasis Ulcer, Venous|Venous Ulcer|Ulcers, Varicose|Venous Hypertension Ulcer|Varicose Ulcers|Stasis Ulcer|Venous Stasis Ulcers|Ulcer, Venous Stasis|Stasis Ulcers, Venous|Ulcer, Varicose|Ulcers, Venous Hypertension|Stasis Ulcers|Hypertension Ulcer, Venous|Ulcers, Venous Stasis|Ulcers, Stasis|Ulcers, Venous|Hypertension Ulcers, Venous|Ulcer, Stasis"
D004318,CHEMICAL,Doxycycline,"Alpha-6-Deoxyoxytetracycline|Doryx|Doxycycline Monohydrate|Doxycycline Calcium|BU3839T|Hydramycin|Vibravenos|BMY-28689|Doxycycline Monohydrochloride, 6 epimer|Doxycycline Monohydrochloride, 6-epimer|2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))-|Oracea|Alpha 6 Deoxyoxytetracycline|BU-3839T|Vibramycin Novum|Vibra-Tabs|Vibra Tabs|BU 3839T|Doxycycline Calcium Salt (1:2)|Doxycycline|Vibramycin|Doxycycline Chinoin|Atridox|Doxycycline-Chinoin|Doxycycline Monohydrochloride, Dihydrate|BMY28689|Periostat|Doxycycline Phosphate (1:1)|Doxycycline Hyclate|Doxycycline Hemiethanolate|BMY 28689"
NEW08321,DISEASE,gut microbiome dysbiosis,gut microbiome dysbiosis
NEW08322,CHEMICAL,isotretinoin user,isotretinoin users
NEW08323,DISEASE,moderate acne,moderate acne
NEW08324,DISEASE,community-acquired pneumonia,Community-acquired pneumonia
D002945,CHEMICAL,Cisplatin,"cis-Diamminedichloroplatinum|Platinum Diamminodichloride|Platino|Platidiam|Dichlorodiammineplatinum|cis-Dichlorodiammineplatinum(II)|cis-Platinum|NSC-119875|Cisplatin|Diamminodichloride, Platinum|Biocisplatinum|cis Platinum|Platinol|cis Diamminedichloroplatinum|cis-Diamminedichloroplatinum(II)"
D018946,DISEASE,Chemokine CCL5,"CCL5 Chemokine|T-Cell RANTES Protein|RANTES Protein, T Cell|RANTES|CCL5, Chemokine|Chemokine, CCL5|RANTES Protein, T-Cell"
NEW08326,CHEMICAL,aspirin activity,Aspirin activity
D007529,CHEMICAL,Isoflavones,"3-Benzylidene-4-Chromanone|3-Benzylidene-4-Chromanones|3 Benzylchroman 4 Ones|3 Benzylchroman 4 One|Homoisoflavone|3-Benzylchroman-4-One|Derivative, Isoflavone|Isoflavone Derivatives|Isoflavone Derivative|3 Benzylidene 4 Chromanone|3-Benzylchroman-4-Ones|Homoisoflavones|isoflavones|Derivatives, Isoflavone|3 Benzylidene 4 Chromanones|Isoflavone"
D013025,NUTRITION,Soybeans,"Glycine max|Soy Bean|soybeans|Soy Beans|Beans, Soy|Soybean|Bean, Soy"
NEW08328,NUTRITION,soybean consumption,soybeans consumption
NEW08329,DISEASE,alcoholic organic brain syndrome,alcoholic organic brain syndrome
NEW08332,DISEASE,tic-related neurophysiologic dysfunction,tic-related neurophysiologic dysfunction
NEW08333,BIOCHEMICAL,blood pressure-enhancing alpha-adrenergic agonist,blood pressure-enhancing alpha-adrenergic agonist
D008879,CHEMICAL,Midodrine,"Midodrine Hydrochloride|Monohydrochloride, Midodrine|Midon|Midodrine Monohydrochloride|Amatine|ST-1085|midodrine|ProAmatine|Midodrin|ST1085|Gutron|ST 1085"
http://purl.obolibrary.org/obo/CHEBI_73966,CHEMICAL,nitric oxide synthase activator,NOS activator|nitric oxide synthase gene|NOS activators|nitric oxide synthase activators
NEW08336,CHEMICAL,nitric oxide-mediated,nitric oxide-mediated
NEW08338,CHEMICAL,antisense nucleotide,antisense nucleotides
D063387,BIOCHEMICAL,Cannabinoid Receptor Antagonists,"Blockers, Cannabinoid Receptor|Cannabinoid Receptor Blockers|Antagonist, Cannabinoid|Cannabinoid Antagonist|Cannabinoid Blocker|Cannabinoid Blockers|Receptor Blockers, Cannabinoid|Antagonists, Cannabinoid Receptor|Blocker, Cannabinoid Receptor|Blocker, Cannabinoid|Receptor Antagonist, Cannabinoid|cannabinoid receptor antagonists|Cannabinoid Antagonists|Blockers, Cannabinoid|Cannabinoid Receptor Blocker|Antagonists, Cannabinoid|Receptor Antagonists, Cannabinoid|Antagonist, Cannabinoid Receptor|Cannabinoid Receptor Antagonist|Receptor Blocker, Cannabinoid"
NEW08339,BIOCHEMICAL,selective agonist,selective agonists
NEW08341,CHEMICAL,cannabinoid cb(2 receptor activation,Cannabinoid CB(2 receptor activation
NEW08343,CHEMICAL,trpv1 antagonist 5'-iodoresiniferatoxin,TRPV1 antagonist 5'-Iodoresiniferatoxin
NEW08345,BIOCHEMICAL,trpv1 agonist capsaicin,TRPV1 agonist capsaicin
NEW08346,CHEMICAL,intra-vlpag administration,Intra-VLPAG administration
NEW08348,CHEMICAL,intra-lpag administration,Intra-LPAG administration
NEW08351,CHEMICAL,structural different receptor inverse agonist ciproxifan,structural different receptor inverse agonists ciproxifan
NEW08353,CHEMICAL,trigeminal cgrp release,trigeminal CGRP release
NEW08355,BIOCHEMICAL,channel v1 agonist capsaicin,channel V1 agonist capsaicin
NEW08356,BIOCHEMICAL,photoswitchable trpa1 agonist,photoswitchable TRPA1 agonists
NEW08358,CHEMICAL,local capsaicin,local capsaicin
NEW08360,CHEMICAL,capsaicin potentiation,Capsaicin potentiation
NEW08362,MENTAL_HEALTH,gbp depression,GBP depression
NEW08365,CHEMICAL,central apelin,Central apelin
http://purl.obolibrary.org/obo/CHEBI_88295,BIOCHEMICAL,g-protein-coupled receptor antagonist,G-protein-coupled receptor antagonists|GPCR antagonist|APJ receptor antagonist F13A|GPCR antagonists
NEW08367,DISEASE,central corticotrophin releasing-factor crf signalling pathway,Central corticotrophin releasing-factor CRF signalling pathways
NEW08369,DISEASE,early trauma,early trauma
NEW08372,DISEASE,crf transgenic animal,CRF transgenic animals
NEW08373,CHEMICAL,nociceptin/orphanin fq,Nociceptin/orphanin FQ
NEW08378,BIOCHEMICAL,gaba(a)α1-preferring benzodiazepine-site agonist,GABA(A)α1-preferring benzodiazepine-site agonist
NEW08379,CHEMICAL,crf-gaba(a)α1 ko,CRF-GABA(A)α1 KO
NEW08380,DISEASE,endogenous crf,endogenous CRF
http://purl.org/sig/ont/fma/fma72478,CHEMICAL,locus ceruleus,Locus coeruleus|Nucleus of locus caeruleus|locus coeruleus (LC)-norepinephrine system|Caerulean nucleus
NEW08382,DISEASE,crf receptor antagonist d-phe crf,CRF receptor antagonist d-Phe CRF
NEW08383,CHEMICAL,alcohol seek,alcohol seeking
NEW08385,CHEMICAL,isoproterenol treatment,isoproterenol treatment
D008070,CHEMICAL,Lipopolysaccharides,lipopolysaccharides|Lipoglycans|Lipopolysaccharide
NEW08388,CHEMICAL,repeat lps administration,repeated LPS administration
NEW08389,BIOCHEMICAL,repeat nmdar agonist administration,repeated NMDAR agonist administration
NEW08390,DISEASE,nmdar dysfunction,NMDAR dysfunction
NEW08391,CHEMICAL,tryptophan catabolite,TRYCATs|Tryptophan catabolites
NEW08393,CHEMICAL,other trycats,Other TRYCATS
NEW08395,CHEMICAL,d-aspartate level,D-aspartate levels
NEW08396,DISEASE,temporal reduction,Temporal reduction
NEW08397,CHEMICAL,increase d-aspartate level,increased D-aspartate levels
NEW08398,CHEMICAL,d-aspartate content,D-aspartate content
NEW08399,CHEMICAL,elevated quinolinic acid concentration,elevated quinolinic acid concentrations
http://purl.obolibrary.org/obo/CHEBI_135649,CHEMICAL,alpidem,ananxyl|D-cycloserine
NEW08400,BIOCHEMICAL,partial nmda-receptor agonist,partial NMDA-receptor agonist
NEW08401,CHEMICAL,selective crf1 corticotropin releasing factor type receptor antagonist ssr125543,selective CRF1 corticotropin releasing factor type receptor antagonist SSR125543
NEW08403,NUTRITION,tryptophan metabolite,tryptophan metabolites
NEW08404,CHEMICAL,kynurenine metabolite,kynurenine metabolites
http://purl.obolibrary.org/obo/CHEBI_16946,CHEMICAL,l-kynurenine,(2S)-2-amino-4-(2-aminophenyl)-4-oxobutanoic acid|3-(2-aminobenzoyl)-L-alanine|3-Anthraniloyl-L-alanine|L-Kynurenine|KYNURENINE|kynurenines
NEW08406,CHEMICAL,nmda modulator,NMDA modulators
NEW08408,CHEMICAL,dl-ap5,DL-AP5
D010208,CHEMICAL,Papaverine,"Pavabid|Hydrochloride, Papaverine|Papaverine|Papaverine Hydrochloride|Cerespan|Pavatym"
NEW08409,CHEMICAL,"its 's intracellular signal inositol 1,4,5 trisphosphate concentration","intracellular signal inositol 1,4,5 trisphosphate concentrations"
NEW08411,BIOCHEMICAL,long-term pertussis toxin treatment,Long-term pertussis toxin treatment
NEW08415,CHEMICAL,secondary thalamic neurodegeneration,secondary thalamic neurodegeneration|STND
C114781,BIOCHEMICAL,"endothelial barrier antigen, rat [Supplementary Concept]","endothelial barrier antigen|Antigens, Surface"
C039123,CHEMICAL,fucosyl GM1 ganglioside [Supplementary Concept],G(M1) Ganglioside/analogs  and  derivatives|GM1 ganglioside
NEW08418,CHEMICAL,serum igm binding to gm1 ganglioside,Serum IgM binding to GM1 ganglioside|GM1
NEW08420,DISEASE,prostate volume median mean,prostate volume Median mean
D018809,BIOCHEMICAL,Proliferating Cell Nuclear Antigen,"PCNA|proliferating cell nuclear antigen|Antigen, Proliferating Cell Nuclear"
NEW08422,CHEMICAL,tnf-α system,TNF-α system
NEW08423,CHEMICAL,cd19 chimeric antigen receptor car t cell,CD19 chimeric antigen receptor CAR T cells
NEW08425,CHEMICAL,high-dose treatment,high-dose treatment
D003975,CHEMICAL,Diazepam,"Sibazon|Relanium|Diazemuls|7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Stesolid|Valium|Apaurin|Seduxen|Faustan"
C558166,DISEASE,"Shh protein, Xenopus [Supplementary Concept]",Shh|Hedgehog Proteins|Xenopus Proteins
NEW08431,DISEASE,autoimmune thyroid disorder,autoimmune thyroid disorder
D024483,CHEMICAL,Vitamin K 3,"2-Methyl-1,4-naphthalenedione|Sodium Bisulfite, Menadione|Vitamin K3 Sodium Bisulfite|Bisulfite, Menadione Sodium|Menadione Bisulfite|Vikasol|Menadione Sodium Bisulfite, Trihydrate|2-Methyl-1,4-naphthoquinone|Bisulfite, Menadione|Vitamin K3|2-Methylnaphthoquinone|Menadione Sodium Bisulfite|Menadione|Sodium bisulfite|Vicasol"
NEW08434,DISEASE,antigen positive asd,antigen positive ASD
NEW08435,DISEASE,td maternal sample,TD maternal samples
NEW08436,DISEASE,bipolar affective illness,bipolar affective illness
NEW08437,NUTRITION,high lithium ratio,high lithium ratio
NEW08438,DISEASE,severe gbv,Severe GBV
NEW08439,DISEASE,sexual GBV,Sexual GBV
NEW08440,BIOCHEMICAL,human leukocyte antigen hla locus,Human leukocyte antigen HLA loci
D017593,MENTAL_HEALTH,Kleine-Levin Syndrome,"Periodic Hypersomnia|Kleine Levin Critchley Syndrome|Kleine-Levin syndrome|Periodic Hypersomnias|Kleine-Levin Hibernation Syndrome|Hypersomnia, Periodic|Familial Kleine Levin Syndrome|Kleine Levin Syndrome|Kleine-Levin-Critchley Syndrome|Familial Hibernation (Kleine-Levin) Syndrome|Familial Kleine-Levin Syndrome|Kleine Levin Hibernation Syndrome|Syndrome, Kleine-Levin-Critchley|Syndrome, Kleine-Levin Hibernation|Syndrome, Familial Kleine-Levin|Syndrome, Kleine-Levin|Kleine-Levin Syndrome, Familial|Hibernation Syndrome, Kleine-Levin"
C536209,DISEASE,Congenital central hypoventilation syndrome [Supplementary Concept],"Sleep Apnea, Central|central hypoventilation|Hypoventilation/congenital"
NEW03175,DISEASE,prominent psychiatric symptom,prominent psychiatric symptoms
NEW08442,DISEASE,encephalitis decrease,encephalitis decrease
NEW08443,CHEMICAL,anti-n-methyl-d-aspartate nmda receptor encephalitis,anti-N-methyl-d-aspartate NMDA receptor encephalitis
D008731,CHEMICAL,Methoxychlor,"Dianisyl Trichloroethane|Trichloroethane, Dianisyl|Metox|DMDT|Methoxychlor"
http://purl.obolibrary.org/obo/CHEBI_76988,BIOCHEMICAL,xenoestrogen,xenoestrogens
http://purl.obolibrary.org/obo/CHEBI_38657,CHEMICAL,organochlorine acaricide,organochlorine acaricides|organochlorine insecticide Methoxychlor|MXC|organochloride acaricides|chlororganische Akarizide|organochloride acaricide
NEW08447,CHEMICAL,prenatal nicotine exposure,prenatal nicotine exposure
NEW08448,CHEMICAL,selective nri,selective NRIs
NEW08451,CHEMICAL,dopaminergic anti-depressant,dopaminergic anti-depressant
NEW08452,CHEMICAL,noradrenergic ne system,noradrenergic NE system
D014745,CHEMICAL,Viloxazine,"Viloxazine Hydrochloride, (R)-Isomer|ICI58,834|ICI-58,834|Viloxazine, (+-)-Isomer|Viloxazine Hydrochloride, (S)-Isomer|Viloxazine Oxalate (1:1)|Viloxazine, (S)-Isomer|Viloxazine, (R)-Isomer|Vivalan|viloxazine|Viloxazine Hydrochloride|Emovit"
NEW08454,MENTAL_HEALTH,adhd medication,ADHD medications
NEW08455,DISEASE,seizure-induced respiratory arrest,seizure-induced respiratory arrest
NEW08457,BIOCHEMICAL,norepinephrine reuptake inhibitor,norepinephrine reuptake inhibitor
NEW08458,CHEMICAL,clinical relevant nri,clinical relevant NRIs
C081732,CHEMICAL,iloperidone [Supplementary Concept],Isoxazoles|Piperidines|iloperidone
NEW08464,CHEMICAL,paliperidone combination,paliperidone combination
NEW08466,CHEMICAL,venlafaxine treatment,venlafaxine treatment
NEW08467,CHEMICAL,serotonin reuptake blockade,Serotonin reuptake blockade
NEW08468,CHEMICAL,chronic milnacipran treatment,chronic milnacipran treatment
D000078764,CHEMICAL,Milnacipran,F 2207|1-Phenyl-1-diethylaminocarbonyl-2-aminomethylcyclopropane HCl|Savella|milnacipran|1 Phenyl 1 diethylaminocarbonyl 2 aminomethylcyclopropane HCl|F-2207|F2207|Ixel|Midalcipran|Milnacipran Hydrochloride
NEW08472,CHEMICAL,brand antidepressant,branded antidepressants
D000078784,CHEMICAL,Vortioxetine,"Lu AA21004|LuAA21004|Lu-AA21004|Vortioxetine|1-(2-(2,4-Dimethylphenylsulfanyl)phenyl)piperazine|Brintellix|Vortioxetine Hydrobromide"
NEW08474,CHEMICAL,levomilnacipran er,Levomilnacipran ER
NEW08475,CHEMICAL,serotonin norepinephrine reuptake inhibitor,serotonin norepinephrine reuptake inhibitor
NEW08480,CHEMICAL,γ-aminobutyric acid b gabab receptor,γ-aminobutyric acid B GABAB receptors
NEW08481,BIOCHEMICAL,selective serotonin reuptake inhibitor ssri medication,selective serotonin reuptake inhibitor SSRI medication
NEW08482,CHEMICAL,desipramine treatment,desipramine treatment
http://purl.obolibrary.org/obo/DOID_3324,MENTAL_HEALTH,mood disorder,comorbid mood disorder|episodic mood disorder
NEW08486,CHEMICAL,immediate-release formulation,immediate-release formulation
NEW08489,CHEMICAL,serotonin release,serotonin release
NEW08490,NUTRITION,lithium exposure,Lithium exposure
NEW08492,CHEMICAL,suprathreshold duloxetine,suprathreshold duloxetine
NEW08495,CHEMICAL,levomilnacipran extended-release,Levomilnacipran extended-release
C509981,CHEMICAL,bifeprunox [Supplementary Concept],Benzoxazoles|DU-127090|Piperazines
NEW00124,CHEMICAL,serotonin function,serotonin function
NEW08499,BIOCHEMICAL,act 5-ht1c/5-ht2 agonist,acting 5-HT1C/5-HT2 agonist
NEW08500,CHEMICAL,6-chloro-2-(1-piperaziny)pyrazine,MK-212|6-chloro-2-(1-piperaziny)pyrazine
NEW08501,DISEASE,autistic patient,autistic patients
NEW08502,DISEASE,poisoning due,poisoning due
NEW08503,DISEASE,loudness dependence,loudness dependence
NEW08506,CHEMICAL,phosphodiesterase-5 inhibitor drug,phosphodiesterase-5 inhibitor drugs
NEW08510,DISEASE,baseline depressive symptom rating,baseline depressive symptom rating
NEW08511,CHEMICAL,whole-blood serotonin content,whole-blood serotonin content
NEW08512,DISEASE,eating-disorder patient,eating-disorder patients
http://purl.obolibrary.org/obo/CHEBI_73296,BIOCHEMICAL,cholecystokinin antagonist,CCK antagonist|cholecystokinin antagonists|CCK antagonists
NEW08517,CHEMICAL,cck receptor system,CCK receptor systems
D010418,CHEMICAL,Pentagastrin,"Pentapeptide, Gastrin|Gastrin Pentapeptide|Pentagastrin|Peptavlon|Acignost"
D013758,CHEMICAL,Tetragastrin,"Cholecystokinin (30-33)|AOC-Tetrapeptide|AOC Tetragastrin|CCK-4|CKK-4|Cholecystokinin-Tetrapeptide|AOC Tetrapeptide|Cholecystokinin-tetrapeptide|Gastrin Tetrapeptide|CCK (30-33)|Cholecystokinin Tetrapeptide|AOC-Tetragastrin|Cholecystokinin 4|Tetrapeptide, Gastrin"
D006569,NUTRITION,Hesperidin,"Hesperetin|Hesperetin 7-Rhamnoglucoside|2S, Hesperidin|Hesperetin 7 Rhamnoglucoside|Hesperidin 2S|4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (S)-|7-Rhamnoglucoside, Hesperetin|Hesperetin 7 Rutinoside|Hesperetin-7-Rutinoside"
NEW08522,CHEMICAL,prenatal valproic acid-exposed rat,Prenatal valproic acid-exposed rat
NEW08523,NUTRITION,hesperetin treatment,Hesperetin treatment
NEW08524,NUTRITION,its 's aglycone hesperetin,aglycone hesperetin
NEW08525,CHEMICAL,constituent hesperidin,constituents hesperidin
NEW08527,CHEMICAL,moderate ethanol feeding,moderate ethanol feeding
NEW08531,CHEMICAL,adolescent cee,adolescent CEE
D000078306,CHEMICAL,Clobazam,"1-Phenyl-5-methyl-8-chloro-1,2,4,5- tetrahydro-2,4-diketo-3H-1,5-benzodiazepine|LM 2717|HR 376|LM2717|Onfi|Urbanyl|Frisium|LM-2717|clobazam"
NEW08537,CHEMICAL,ketamine metabolite,ketamine metabolite
C000592340,DISEASE,yuan zhi [Supplementary Concept],"Polygalae extract|Drugs, Chinese Herbal"
NEW08540,CHEMICAL,l-lactate level,l-lactate levels
NEW08542,CHEMICAL,mct inhibitor 4-cin,MCT inhibitor 4-CIN
NEW08543,CHEMICAL,long-term alcohol exposure,Long-term alcohol exposure
C056723,CHEMICAL,FG 9041 [Supplementary Concept],DNQX|Quinoxalines
NEW08546,DISEASE,post-natal dietary deficit,Post-natal dietary deficits
NEW08548,CHEMICAL,gsh depletion,GSH depletion
NEW08549,CHEMICAL,beta-casein a1,beta-casein A1
http://purl.obolibrary.org/obo/CHEBI_134765,CHEMICAL,isometheptene,isometheptene mucate|6-Methylamino-2-methylheptene|isomethepten|gabapentinoids|isometeptene|octinum
NEW08554,CHEMICAL,5 mg intravenous delta-9-tetrahydrocannabinol,Delta-9-THC|5 mg intravenous delta-9-tetrahydrocannabinol
NEW08556,BIOCHEMICAL,potential endocrine,potential endocrine
NEW08557,CHEMICAL,high evening cortisol,high evening cortisol
NEW08558,CHEMICAL,morning dhea,morning DHEA
NEW08560,BIOCHEMICAL,specific endocrine disturbance,specific endocrine disturbances
NEW08561,MENTAL_HEALTH,strong posttraumatic stress reaction,stronger posttraumatic stress reactions
NEW08563,BIOCHEMICAL,adjuvant endocrine therapy,adjuvant endocrine therapy
NEW08565,CHEMICAL,ovarian function suppression,OFS|ovarian function suppression
NEW08566,BIOCHEMICAL,antipsychotic drug therapy,Antipsychotic drug therapy
NEW08568,CHEMICAL,tailor phospholipid-enriched buttermilk,tailored phospholipid-enriched buttermilk
C565974,DISEASE,Familial Glucocorticoid Deficiency 1 [Supplementary Concept],"Steroid Metabolism, Inborn Errors|glucocorticoid deficiency|Adrenal Insufficiency"
http://purl.obolibrary.org/obo/CHEBI_65311,BIOCHEMICAL,corticotropin-releasing hormone,corticotropin-releasing factor|CRH|directed corticotropin-releasing hormones
NEW08570,BIOCHEMICAL,endocrine stress signaling pathway,endocrine stress signaling pathways
NEW08577,BIOCHEMICAL,endocrine system insulin resistance,endocrine system insulin resistance
C538167,CHEMICAL,"Acidemia, isovaleric [Supplementary Concept]","isovaleric acidemia|Isovaleryl-CoA Dehydrogenase/deficiency|Amino Acid Metabolism, Inborn Errors"
D018783,MENTAL_HEALTH,"Impotence, Vasculogenic","Vasculogenic Impotence|Impotence, Arteriogenic|Impotence, Venogenic|impotence|Arteriogenic Impotence|Venogenic Impotence|Penile Venous Leakage|Leakage, Penile Venous|Venous Leakage, Penile"
NEW08582,BIOCHEMICAL,endocrine alteration,endocrine alterations
NEW08583,BIOCHEMICAL,hypothalamus-regulated endocrine axis hypothalamic pituitary-gonadal,hypothalamus-regulated endocrine axes hypothalamic pituitary-gonadal
NEW08584,CHEMICAL,new antidepressant,new antidepressants
C000705749,CHEMICAL,lumateperone [Supplementary Concept],"Lumateperone|Heterocyclic Compounds, 4 or More Rings"
NEW08587,BIOCHEMICAL,abnormal growth hormone,Abnormal growth hormones
NEW08589,BIOCHEMICAL,endocrine marker,endocrine markers
NEW08590,BIOCHEMICAL,endocrine change,endocrine changes
NEW08592,BIOCHEMICAL,low serum calcidiol concentration,Low serum calcidiol concentrations
NEW08593,BIOCHEMICAL,vitamin insufficiency,vitamin insufficiency
NEW08594,CHEMICAL,calcipherol system,calcipherol system
NEW08596,CHEMICAL,5-ht function,5-HT functions
NEW08597,NUTRITION,dietary tryptophan supplementation,dietary tryptophan supplementation
NEW08598,NUTRITION,tryptophan supplementation,tryptophan supplementation
NEW08599,MENTAL_HEALTH,depression unrelated,depression unrelated
NEW08601,CHEMICAL,reproductive steroid level,reproductive steroid levels
NEW08604,BIOCHEMICAL,common endocrine disorder,common endocrine disorders
http://purl.obolibrary.org/obo/CHEBI_139503,BIOCHEMICAL,vitamin d receptor agonist,Vitamin D receptor VDR agonists|calcitriol receptor agonist|vitamin D nuclear receptor agonist|vitamin D receptor agonists|calcitriol receptor agonists|vitamin D nuclear receptor agonists|VDR agonist|VDR agonists
NEW08607,DISEASE,established uremia,established uremia
C570781,CHEMICAL,"5-(2-(1-(1-(3-hydroxy-2,3-dimethylbutoxy)ethyl)-7alpha-methyldihydro-1H-inden-4(2H,5H,6H,7H,7alphaH)-ylidene)ethylidene)-2-methylenecyclohexane-1,3-diol [Supplementary Concept]",VS-105|Calcitriol/analogs  and  derivatives
NEW08611,DISEASE,induce hypoparathyroidism,induced hypoparathyroidism
D043782,CHEMICAL,"Receptor, Bradykinin B2","Bradykinin Type 2 Receptor|Receptor, Bradykinin Type 2|B2 Receptors, Bradykinin|B2 Receptor, Bradykinin|Bradykinin B2 Receptors|Receptors, Bradykinin B2|Bradykinin receptors|Bradykinin B2 Receptor"
NEW08613,CHEMICAL,kinin receptor deficiency,kinin receptor deficiency
http://purl.obolibrary.org/obo/CHEBI_50888,CHEMICAL,fluoroarene,3-Pyridyl 4-(phenylcarbamoyl)piperidine-1-carboxylate|ASP8477|fluoroarenes|aryl fluorides|aryl fluoride
NEW08619,CHEMICAL,faah inhibitor urb597,FAAH inhibitor URB597
NEW08622,CHEMICAL,cannabidiol combination,cannabidiol combination
C587251,CHEMICAL,nabiximols [Supplementary Concept],Dronabinol|Drug Combinations|Cannabidiol|Sativex
http://purl.obolibrary.org/obo/CHEBI_23888,BIOCHEMICAL,drug,drug Epidiolex
NEW08625,CHEMICAL,cannabis use,Cannabis use
NEW08626,CHEMICAL,cannabis variant,cannabis variants
NEW08628,MENTAL_HEALTH,psychosis condition,Psychosis conditions
NEW08629,CHEMICAL,5-ht(2a receptor,5-HT(2A receptors
NEW08630,MENTAL_HEALTH,nps toxicity syndrome,NPS toxicity syndromes
NEW08633,CHEMICAL,different naag peptidase inhibitor,different NAAG peptidase inhibitors
http://purl.obolibrary.org/obo/CHEBI_61966,CHEMICAL,metabotropic glutamate receptor agonist,group metabotropic glutamate receptors|mGluRs agonist|metabotropic glutamate receptor agonists
NEW04679,CHEMICAL,glutamate neurotransmission,glutamate neurotransmission
NEW08635,BIOCHEMICAL,group mglu receptor agonist,group mGlu receptor agonists
NEW08636,DISEASE,toxic leukoencephalopathy,Toxic leukoencephalopathy
C026385,CHEMICAL,n-hexane [Supplementary Concept],Hexane|Hexanes
NEW08640,DISEASE,obvious demyelination,Obvious demyelination
NEW08641,DISEASE,behavioral disturbance,Behavioral disturbance
NEW08642,DISEASE,inborn deficiency,Inborn deficiencies
NEW01505,CHEMICAL,ammonia detoxification,ammonia detoxification
NEW08646,DISEASE,acute toxicity,acute toxicities
NEW08648,CHEMICAL,cellular differentiate agent hexamethylene bisacetamide,cellular differentiating agent hexamethylene bisacetamide
NEW08649,CHEMICAL,mao inhibitor isocarboxazid,MAO inhibitor isocarboxazid
NEW08650,CHEMICAL,high blood ua level,High blood UA level
NEW08651,CHEMICAL,sulphur amino acid metabolism,sulphur amino acid metabolism
NEW08652,CHEMICAL,endogenous sulphite,Endogenous sulphite
http://purl.obolibrary.org/obo/DOID_0111270,CHEMICAL,isolated sulfite oxidase deficiency,sulphite oxidase deficiency|sulfocysteinuria
NEW08653,CHEMICAL,sulphite radical,Sulphite radicals
http://purl.obolibrary.org/obo/CHEBI_60798,BIOCHEMICAL,excitatory amino acid antagonist,EAA receptor antagonist|EAA receptor antagonists|selective excitatory amino acid antagonists|excitatory amino acid receptor antagonist|excitatory amino acid receptor antagonists|excitatory amino acid antagonists
D000069446,CHEMICAL,Atazanavir Sulfate,"BMS 232632|Reyataz|BMS-232632|BMS232632|CGP-73547|CGP|BMS 232632 05|CGP-75136|CGP73547|CGP-75176|BMS23263205|CGP75176|CGP 75355|CGP 75136|CGP75136|CGP 73547|232632, BMS|3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester|BMS-232632-05|CGP75355|CGP-75355|CGP 75176|Atazanavir"
C031231,CHEMICAL,2-amino-7-phosphonoheptanoic acid [Supplementary Concept],2-Amino-5-phosphonovalerate/analogs  and  derivatives|AP7
C106106,CHEMICAL,sigma-1 receptor [Supplementary Concept],"sigma-1 receptor|Receptors, sigma"
NEW08654,CHEMICAL,dopamine blocking property,dopamine blocking properties
C042709,CHEMICAL,tiospirone [Supplementary Concept],tiaspirone|Spiro Compounds
NEW08656,DISEASE,Kingdom National OCD Inpatient Service,Kingdom National OCD Inpatient Service
NEW08657,CHEMICAL,functional snp located,functional SNP located
NEW08658,CHEMICAL,bradykinin receptor b2 gene,bradykinin receptor B2 gene
NEW08659,CHEMICAL,dexamethasone suppression,dexamethasone suppression
http://purl.obolibrary.org/obo/DOID_2468,MENTAL_HEALTH,psychotic disorder,mental or behavioural disorder|neuroleptic-responsive psychotic disorder
NEW08661,MENTAL_HEALTH,drug-responsive psychotic disorder,drug-responsive psychotic disorder
D000745,DISEASE,"Anemia, Hemolytic, Congenital","Hemolytic Anemia, Congenital|Hemolytic Anemia, Hereditary|Hereditary Hemolytic Anemia|Hereditary Hemolytic Anemias|anemias|Anemia, Hereditary Hemolytic|Congenital Hemolytic Anemia|Anemia, Congenital Hemolytic|Anemias, Congenital Hemolytic|Congenital Hemolytic Anemias|Anemias, Hereditary Hemolytic|Hemolytic Anemias, Hereditary|Hemolytic Anemias, Congenital|Anemia, Hemolytic, Hereditary"
C537149,BIOCHEMICAL,"Hypogammaglobulinemia and Isolated growth hormone deficiency, X-linked [Supplementary Concept]","Genetic Diseases, X-Linked|Dwarfism, Pituitary|Growth hormone deficiency|Agammaglobulinemia"
NEW02501,CHEMICAL,elevated cortisol,elevated cortisol
NEW08665,CHEMICAL,crh administration,CRH administration
http://purl.obolibrary.org/obo/DOID_656,DISEASE,adrenal adenoma,adrenal adenoma|adenoma of the Adrenal gland
NEW08667,BIOCHEMICAL,human growth hormone hgh response,human growth hormone HGH response
NEW08668,CHEMICAL,dextroamphetamine sulfate dose,dextroamphetamine sulfate doses
NEW08669,CHEMICAL,ghrh analog,GHRH analogs
NEW08670,CHEMICAL,stress-related hormone cortisol,stress-related hormone cortisol
NEW08673,DISEASE,muscle loss,muscle loss
NEW08674,BIOCHEMICAL,early treatment growth hormone,Early treatment growth hormone
NEW08677,CHEMICAL,severe zinc deficiency,severe zinc deficiency
NEW08680,MENTAL_HEALTH,personality disorder patient,personality disorder patients
NEW08683,MENTAL_HEALTH,States depression,States depression
NEW08684,DISEASE,depressive response,depressive response
NEW08681,CHEMICAL,physostigmine challenge,physostigmine challenge
NEW08685,DISEASE,acute depressive response,acute depressive responses
C536560,NUTRITION,Chanarin-Dorfman Syndrome [Supplementary Concept],"Lipid Metabolism, Inborn Errors|Ichthyosiform Erythroderma, Congenital|Muscular Diseases|long-chain fatty acid oxidation"
NEW08691,CHEMICAL,drug.1 sodium salt,drug.1 Sodium salt
D058247,DISEASE,Loose Anagen Hair Syndrome,"Syndromes, Loose Anagen|Anagen Syndrome, Loose|loose anagen hair|Anagen Syndromes, Loose|Loose Anagen Syndromes|Loose Anagen Syndrome|Syndrome, Loose Anagen"
D009634,DISEASE,Noonan Syndrome,"Pseudo-Ullrich-Turner Syndrome|Noonan Syndrome 1|Noonan-Ehmke Syndrome|Male Turner's Syndrome|Noonan Ehmke Syndrome|Ullrich-Noonan Syndrome|Turner's Phenotype, Karyotype Normal|Ullrich Noonan Syndrome|Turner Syndrome, Male|Female Pseudo-Turner Syndrome|Turner's Syndrome, Male|Female Pseudo Turner Syndrome|Turner Like Syndrome|Turner Syndrome, Familial|Pseudo Ullrich Turner Syndrome|Pseudo-Turner Syndrome, Female|Male Turner Syndrome|Noonan syndrome|Turner-Like Syndrome|Familial Turner Syndrome|Turner Phenotype with Normal Karyotype"
NEW08694,DISEASE,bipolar patient,Bipolar patients
NEW08695,BIOCHEMICAL,numerous endocrine abnormality,Numerous endocrine abnormalities
C000610980,CHEMICAL,paeoniflorin-6'-O-benzenesulfonate [Supplementary Concept],paeoniflorin|Glucosides|Monoterpenes
NEW08699,DISEASE,twenty-four-hour hypersecretion,Twenty-four-hour hypersecretion
NEW08700,DISEASE,enzyme ghrelin o-acyltransferase,enzyme ghrelin O-acyltransferase|GOAT
C581708,CHEMICAL,cyclic des-acyl ghrelin (6-13) [Supplementary Concept],"des-acyl-ghrelin|Ghrelin|DAG|Peptide Fragments|Peptides, Cyclic"
NEW08705,CHEMICAL,mk-0677-treated 5xfad mouse,MK-0677-treated 5XFAD mice
C094817,CHEMICAL,ibutamoren mesylate [Supplementary Concept],Spiro Compounds|Indoles|MK-0677
NEW08708,CHEMICAL,c-amp dependent protein kinase protein kinase a,c-AMP dependent protein kinase protein kinase A
C532492,CHEMICAL,"apelin-13, Ala(13)- [Supplementary Concept]",apelin-13|Intercellular Signaling Peptides and Proteins
NEW08711,CHEMICAL,ana-12 injection,ANA-12 injection
NEW08713,CHEMICAL,trkb receptor antagonist,ANA-12|TrkB receptor antagonist
D020539,CHEMICAL,"Sequence Analysis, Protein","Analysis, Peptide Sequence|Sequence Analyses, Peptide|Analyses, Peptide Sequence|Sequencing, Amino Acid|Sequence Analysis, Amino Acid|Sequence Analyses, Amino Acid|Sequencing, Protein|Sequence Determination, Peptide|Amino Acid Sequence Determination|Peptide Sequence Determinations|Sequence Determination, Amino Acid|Protein Sequence Analyses|Protein Sequence Determinations|amino acid peptide|Amino Acid Sequencing|Acid Sequencing, Amino|Sequence Determinations, Peptide|Sequence Analysis, Peptide|Protein Sequence Determination|Analysis, Protein Sequence|Peptide Sequence Analyses|Protein Sequencing|Sequence Determinations, Amino Acid|Amino Acid Sequence Analysis|Peptide Sequence Analysis|Amino Acid Sequence Determinations|Protein Sequence Analysis|Analyses, Protein Sequence|Sequence Determinations, Protein|Sequence Analyses, Protein|Sequence Determination, Protein|Peptide Sequence Determination|Amino Acid Sequence Analyses"
NEW06112,MENTAL_HEALTH,disorder patient,disorder patients
NEW08717,DISEASE,dpag-evoked panic-like behaviour,DPAG-evoked panic-like behaviours
NEW08719,DISEASE,recent-onset psychotic patient,recent-onset psychotic patients
NEW08721,DISEASE,se female,SE females
NEW08723,CHEMICAL,at1 receptor blocker,AT1 receptor blocker|ARB
NEW08724,CHEMICAL,corticosterone response,corticosterone response
NEW08726,MENTAL_HEALTH,schizophrenia inpatient,schizophrenia inpatients
NEW08727,CHEMICAL,prescribe clozapine dosage,prescribed clozapine dosage
NEW08728,CHEMICAL,plasma clozapine concentration,plasma clozapine concentrations
NEW08729,MENTAL_HEALTH,repeat chronic stress,Repeated chronic stress
C548016,DISEASE,Hypermanganesemia with Dystonia Polycythemia and Cirrhosis [Supplementary Concept],Chronic liver disease|Metabolic Diseases
NEW08730,BIOCHEMICAL,hormone supplement,hormone supplements
D047508,DISEASE,Massive Hepatic Necrosis,"Submassive Hepatic Necrosis|Acute Yellow Atrophies|Acute Yellow Atrophy|Fulminant Hepatitis|Necrosis, Drug-induced Hepatic|Necrosis, Submassive Hepatic|fulminant hepatitis|Hepatic Necrosis, Massive|Acute Yellow Atrophy of Liver|Hepatic Necrosis, Drug-induced|Fulminant Hepatitides|Hepatitis, Fulminant|Yellow Atrophy, Acute|Hepatic Necrosis, Submassive|Submassive Hepatic Necroses|Drug-induced Hepatic Necroses|Drug induced Hepatic Necrosis|Drug-induced Hepatic Necrosis"
NEW08732,BIOCHEMICAL,hypothalamic peptide hormone,hypothalamic peptide hormones
NEW08735,BIOCHEMICAL,glucocorticoid hormone,Glucocorticoid hormones
NEW08736,BIOCHEMICAL,glucocorticoid hormone,glucocorticoid hormones
D051247,CHEMICAL,Sodium-Glucose Transport Proteins,"Sodium Glucose Transport System|SGLT Protein|Transporter, Sodium-Sugar|SGLT Proteins|Glucose Transporter, Sodium|Glucose Sodium Transport System|Sodium Glucose Transport Protein|Protein, SGLT|Sodium-Sugar Transporter|Glucose-Sodium Transport System|Sodium Glucose Transporter|Sodium Glucose Transport Proteins|Sodium-Glucose Transport System|Sodium Glucose Transporters|Sodium Sugar Transporter|Sodium Glucose Cotransporters|Protein, Sodium-Glucose Transport|Glucose Cotransporters, Sodium|Sodium-Glucose Transport Protein|Glucose Cotransporter, Sodium|Transport Protein, Sodium-Glucose|glucose transporters|Transporter, Sodium Glucose|Sodium Glucose Cotransporter|Glucose Transporters, Sodium|Cotransporter, Sodium Glucose"
NEW08739,DISEASE,cluster b,cluster B
NEW08741,DISEASE,pd s,PD s
NEW08744,MENTAL_HEALTH,seasonal affective disorder scale,seasonal affective disorder scale
NEW08746,BIOCHEMICAL,target hormone,target hormones
NEW08749,CHEMICAL,derive biogenic amine,derived biogenic amines
NEW08752,CHEMICAL,neurotransmitter precursor amino acid level,neurotransmitter precursor amino acid levels
NEW08753,CHEMICAL,kynurenine/tryptophan,Kynurenine/tryptophan
http://purl.obolibrary.org/obo/CHEBI_25500,CHEMICAL,neopterins,KYN/TRP
http://purl.obolibrary.org/obo/CHEBI_18257,CHEMICAL,ornithine,"Ornithine|phenylalanine/tyrosine|PHE/TYR|2,5-diaminopentanoic acid|ornithine|2,5-Diaminovaleric acid|2,5-Diaminopentanoic acid|Orn|DL-Ornithine"
NEW08761,CHEMICAL,serotonergic receptor activity,serotonergic receptor activity
NEW05268,CHEMICAL,inhibitor tranylcypromine,inhibitor tranylcypromine|TCP
NEW08766,CHEMICAL,tcp treatment,TCP treatment
NEW08773,CHEMICAL,serotonin dysregulation,serotonin dysregulation
NEW08774,CHEMICAL,available antidepressant medication,available antidepressant medications
NEW08775,CHEMICAL,5-ht(1a)-r full agonist (r)-(+)-8-hydroxy-2-(di-n-propylamino)tetralin,5-HT(1A)-R full agonist (R)-(+)-8-hydroxy-2-(di-n-propylamino)tetralin
NEW08777,CHEMICAL,5-ht neurotransmission,5-HT neurotransmission
NEW08778,DISEASE,aberrant emotional behavior,aberrant emotional behaviors
NEW08783,CHEMICAL,conventional irreversible maoi,conventional irreversible MAOIs
NEW08785,CHEMICAL,selective mao-a inhibitor,selective MAO-A inhibitors
NEW08786,CHEMICAL,conventional irreversible maoi,conventional irreversible MAOI
NEW08787,CHEMICAL,selective maoi-a inhibitor,selective MAOI-A inhibitors
NEW08788,DISEASE,nps intake,NPS intake
NEW04827,DISEASE,several new psychoactive substance,NPS|several new psychoactive substances
NEW08790,BIOCHEMICAL,synthetic cannabinoid agonist win,synthetic cannabinoid agonist WIN
NEW07906,DISEASE,positive psychotic symptom,positive psychotic symptoms
NEW08794,CHEMICAL,benzodiazepine class,benzodiazepine class
NEW08795,CHEMICAL,clonazepam tablet,clonazepam tablets
NEW08796,CHEMICAL,coadministrate 5-ht1a agonistic psychotropic,coadministrating 5-HT1A agonistic psychotropics
NEW08797,CHEMICAL,severe serotonin excess,severe serotonin excess
NEW08799,CHEMICAL,dopamine reward substrate,dopamine reward substrate
NEW08800,BIOCHEMICAL,dopamine antagonist treatment,dopamine antagonist treatment
NEW08802,BIOCHEMICAL,serotonin-dopamine antagonist,serotonin-dopamine antagonist
NEW08805,BIOCHEMICAL,potent dopamine d2-like receptor antagonist,potent dopamine D2-like receptor antagonist
NEW08807,CHEMICAL,dopamine impairment,Dopamine impairments
D000078262,CHEMICAL,Rifaximin,"Redactiv|L 105|Rifaximin|L-105|L105|Xifaxan|4-Deoxy-4'-methylpyrido(1',2'-1,2)imidazo(5,4C)rifamycin"
D000348,CHEMICAL,Aflatoxins,Aflatoxin|aflatoxins
C555344,CHEMICAL,deoxynivalenol sulfonate [Supplementary Concept],DON|Trichothecenes|Deoxynivalenol
NEW08812,CHEMICAL,low don exposure,lower DON exposure
D009183,BIOCHEMICAL,Mycotoxins,"Fungal Toxins|Toxins, Fungal|Mycotoxin|mycotoxins"
D016308,CHEMICAL,"Enkephalin, Leucine-2-Alanine","Leucine Enkephalin 2 Alanine|Leucine-2-Alanine Enkephalin|5-Leucine-2-Alanine Enkephalin|BW180C|2 Alanyl Leucine Enkephalin|Leu Enkephalin 2 Ala|Enkephalin, Leucine 2 Alanine|BW-180C|DADLE|Enkephalin, 5-Leucine-2-Alanine|Enkephalin-2-Alanine, Leucine|Leucine Enkephalin-2-Alanine|2-Alanyl-Leucine Enkephalin|Enkephalin, 2-Alanyl-Leucine|D-Ala(2)-D-Leu(5)-Enkephalin|Enkephalin-Leu,Ala(2)|Leu-Enkephalin-2-Ala|5 Leucine 2 Alanine Enkephalin|BW 180C"
NEW08816,CHEMICAL,oseltamivir treatment,oseltamivir treatment
NEW08817,DISEASE,childhood bpd,Childhood BPD
D010389,CHEMICAL,Pemoline,"Tradon|Pemoline Compounds|Compounds, Pemoline|Magnesium, Pemoline|Phenylisohydantoin|Pemoline Magnesium|Phenoxazole|PemADD|Pemoline|Cylert"
NEW08818,CHEMICAL,adenosine reuptake inhibitor,adenosine reuptake inhibitors
D004176,CHEMICAL,Dipyridamole,Antistenocardin|dipyridamole|Novo-Dipiradol|Dipyramidole|Persantin|Miosen|Cléridium|Kurantil|Apo Dipyridamole|Persantine|Curantyl|Curantil|Novo Dipiradol|Apo-Dipyridamole|Cerebrovase
NEW08820,BIOCHEMICAL,anticonvulsant drug pregabalin,anticonvulsant drug pregabalin
NEW08821,DISEASE,drug-induced dependency,drug-induced dependency
http://purl.obolibrary.org/obo/MFOMD_0000188,DISEASE,dysphoria,paruresis
http://purl.obolibrary.org/obo/DOID_10933,DISEASE,obsessive-compulsive disorder,obsessive compulsive disorder|Overanxious disorder|Anancastic neurosis
NEW08825,CHEMICAL,clozapine therapy,clozapine therapy
D009365,MENTAL_HEALTH,"Neoplasm Regression, Spontaneous","spontaneous regression|Regression, Spontaneous Neoplasm|Spontaneous Neoplasm Remission|Remission, Spontaneous Neoplasm|Spontaneous Neoplasm Regression|Neoplasm Remission, Spontaneous"
NEW08829,CHEMICAL,sucrose consumption,sucrose consumption
C527076,CHEMICAL,Avlimil [Supplementary Concept],Plant Extracts|Avlimil
C524675,NUTRITION,formic acid 4-(3-oxobutyl)phenyl ester [Supplementary Concept],Raspberry ketone|Formates
NEW08832,DISEASE,selective hyposmia,selective hyposmia
NEW08833,CHEMICAL,mesolimbic dopamine innervation,mesolimbic dopamine innervation
NEW08834,BIOCHEMICAL,muscarinic cholinergic antagonist quinuclidinyl benzilate,muscarinic cholinergic antagonist quinuclidinyl benzilate
C515421,CHEMICAL,SB-699551-A [Supplementary Concept],SB-699551|Biphenyl Compounds
NEW08836,CHEMICAL,mecamylamine nachrs antagonist,mecamylamine nAChRs antagonists
C029617,CHEMICAL,ethyl loflazepate [Supplementary Concept],Loflazepate|Benzodiazepines
C004858,CHEMICAL,diphenidol [Supplementary Concept],Piperidines|Diphenidol
NEW08839,DISEASE,alzheimers s disease patient,Alzheimers s disease patients
D044945,NUTRITION,Proanthocyanidins,"Anthocyanidin Polymers|Tannins, Condensed|Procyanidins|Condensed Tannins|proanthocyanidins|Condensed Tannin|Polymers, Anthocyanidin|Tannin, Condensed"
D056604,CHEMICAL,Grape Seed Extract,"seed extract|Seed Extract, Grape|Extract, Grape Seed"
D059808,CHEMICAL,Polyphenols,Polyphenol|polyphenols|Provinols
NEW08841,BIOCHEMICAL,isoflavonoid phytoestrogen,isoflavonoid phytoestrogen
NEW08843,CHEMICAL,genistein supplementation,Genistein supplementation
NEW08846,CHEMICAL,bps-exposed NODEF mouse,BPS-exposed NODEF mice
D048789,BIOCHEMICAL,Phytoestrogens,"Plant Estrogen|Phytoestrogen|Estrogen-Like Plant Extracts|Estrogen Like Plant Extracts|Plant Extracts, Estrogen-Like|Extracts, Estrogen-Like Plant|Estrogen, Plant|Plant Estrogens|Phyto Estrogen|Phyto-Estrogen|Phytoestrogens|Estrogens, Plant"
C576978,CHEMICAL,7-(O)-carboxymethyl daidzein N-t-Boc-hexylenediamine conjugate [Supplementary Concept],Isoflavones|daidzein
NEW08848,DISEASE,diet-induced obese male mouse,diet-induced obese male mice
NEW08850,CHEMICAL,s-equol,S-equol
NEW08851,CHEMICAL,s-equol individual,S-equol individuals
NEW08852,CHEMICAL,sutaehwan,Sutaehwan
NEW08854,CHEMICAL,sth_kp17001,STH_KP17001
D062485,DISEASE,Breath Holding,"Holdings, Breath|Holding, Breath|breath|Breath Holdings"
NEW08858,CHEMICAL,Flax seed,Flax seed
NEW08860,DISEASE,mature oligodendrocyte,mature oligodendrocytes
NEW08864,CHEMICAL,"l655,708","L655,708"
NEW08868,DISEASE,profound hypogonadism,profound hypogonadism
NEW08869,CHEMICAL,isoflavone intake,isoflavone intake
http://purl.obolibrary.org/obo/CHEBI_36005,CHEMICAL,docosahexaenoic acid,docosahexaenoic acid|acids docosahexaenoic acid|DHA|docosahexaenoic acids
D006950,DISEASE,"Hyperlipidemia, Familial Combined","Hyperlipidemias, Familial Combined|Combined Hyperlipidemia, Familial|Multiple Lipoprotein-Type Hyperlipidemia|Lipoprotein-Type Hyperlipidemia, Multiple|Hyperlipidemia, Multiple Lipoprotein-Type|Lipoprotein-Type Hyperlipidemias, Multiple|Hyperlipidemias, Multiple Lipoprotein-Type|Multiple Lipoprotein-Type Hyperlipidemias|Combined Hyperlipidemias, Familial|Familial Combined Hyperlipidemia|Hyperlipidemia, Multiple Lipoprotein Type|Familial Combined Hyperlipidemias|hyperlipidemia"
NEW08871,DISEASE,advanced aids abuse,advanced AIDS abuse
NEW03477,CHEMICAL,non-nucleoside reverse transcriptase inhibitor,non-nucleoside reverse transcriptase inhibitors
D019829,CHEMICAL,Nevirapine,"BIRG587|BI-RG-587|nevirapine|BI RG 587|Hemihydrate, Nevirapine|Nevirapine Hemihydrate|Viramune"
http://purl.obolibrary.org/obo/CHEBI_31781,CHEMICAL,lopinavir,"(2S)-N-[(2S,4S,5S)-5-{[(2,6-dimethylphenoxy)acetyl]amino}-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide|Lopinavir|ritonavir-boosted lopinavir"
D000069545,CHEMICAL,"Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination","Elvitegravir-Cobicistat-Emtricitabine-Tenofovir Disoproxil Fumarate Drug Combination|tenofovir disoproxil fumarate|Pill, Quad|Genvoya|Elvitegravir Cobicistat Emtricitabine Tenofovir Disoproxil Fumarate Drug Combination|Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate Drug Combination|Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate|TDF|Quad Pill|Stribild"
http://purl.obolibrary.org/obo/CHEBI_37924,CHEMICAL,atazanavir,"ritonavir-boosted atazanavir|atazanavir|atazanavirum|ATZ|dimethyl (3S,8S,9S,12S)-9-benzyl-3,12-di-tert-butyl-8-hydroxy-4,11-dioxo-6-[4-(2-pyridyl)benzyl]-2,5,6,10,13-pentaazatetradecanedioate"
NEW08873,DISEASE,human immunodeficiency virus/acquired immunodeficiency syndrome chemotherapy,human immunodeficiency virus/acquired immunodeficiency syndrome chemotherapies
NEW08877,CHEMICAL,co-formulated bictegravir,Co-formulated bictegravir
C000654125,CHEMICAL,"bictegravir, emtricitabine, tenofovir alafenamide, drug combination [Supplementary Concept]",tenofovir alafenamide|Piperazines|Emtricitabine|Tenofovir|Alanine|Drug Combinations|Pyridones
C042080,CHEMICAL,diisodecyl phthalate [Supplementary Concept],DIDP|Phthalic Acids|Diisodecyl phthalate
D059409,DISEASE,"Stroke, Lacunar","Lacunar Infarctions|Syndrome, Lacunar|Infarctions, Lacunar|Strokes, Lacunar|Stroke|Lacunar Syndrome|Lacunar Syndromes|Infarcts, Lacunar|Syndromes, Lacunar|Infarction, Lacunar|Lacunar Stroke|Lacunar Infarcts|Lacunar Infarction|Lacunar Infarct|Lacunar Strokes|Infarct, Lacunar"
NEW08879,DISEASE,Disease Disorders Association,Disease Disorders Association
NEW08880,BIOCHEMICAL,adjunctive vitamin,adjunctive vitamin
NEW08882,BIOCHEMICAL,antioxidant vitamin,antioxidant vitamins
NEW08883,DISEASE,k. anthotheca,K. anthotheca
NEW08884,MENTAL_HEALTH,treatment-resistant recurrent depression,treatment-resistant recurrent depression
NEW08886,CHEMICAL,intracellular gsh,intracellular GSH
NEW08887,DISEASE,cytotoxic brain edema due,Cytotoxic brain edema due
NEW08888,DISEASE,astrocyte swelling,astrocyte swelling
NEW08889,CHEMICAL,astrocytic glutamate uptake,astrocytic glutamate uptake
NEW08891,BIOCHEMICAL,vitamin e family,vitamin E family
NEW08892,DISEASE,chronic neurological disease,chronic neurological diseases
NEW08895,CHEMICAL,• Health authority,• Health authorities
NEW08898,CHEMICAL,background citrin deficiency,Background Citrin deficiency
NEW08901,MENTAL_HEALTH,pneumonia-related anxiety,pneumonia-related anxiety
NEW08902,CHEMICAL,gad sample,GAD sample
http://purl.obolibrary.org/obo/CHEBI_75253,CHEMICAL,phenylarsine oxide,Phenyl arsine oxide|oxo(phenyl)arsine|Arsenosobenzene|endogenous nitric oxide|Phenylarsenoxide|Oxophenylarsine|PhAsO
http://purl.obolibrary.org/obo/CHEBI_50786,CHEMICAL,anabolic androgenic steroid,anabolic-androgenic steroids|AAS|Anabolic steriod
NEW08906,CHEMICAL,elevated hcy level,Elevated Hcy levels
NEW08907,CHEMICAL,hcy metabolism,Hcy metabolism
D009963,CHEMICAL,Orotic Acid,"Acid, Orotic|Sodium Orotate|Orotic acid|Orotate, Sodium|Orotate, Potassium|Orotate, Zinc|Potassium Orotate|Zinc Orotate"
http://purl.obolibrary.org/obo/DOID_0080361,DISEASE,trimethylaminuria,CblD disorder|fish-odor syndrome
NEW08911,MENTAL_HEALTH,attention-deficit/hyperactivity Disorder adhd category,Attention-Deficit/Hyperactivity Disorder ADHD category
NEW08913,DISEASE,multiple rare abnormality discovery,multiple rare abnormalities discovery
NEW08915,CHEMICAL,serotonin depletion,serotonin depletion
NEW08919,BIOCHEMICAL,niacin skin flush test,niacin skin flush test
NEW08922,CHEMICAL,dietary na supplementation,dietary NA supplementation
NEW08929,DISEASE,serum tg,serum TG
NEW08930,DISEASE,undiagnosed encephalopathy,undiagnosed encephalopathies
NEW08932,DISEASE,chronic alcoholic patient,chronic alcoholic patients
NEW03508,CHEMICAL,serotonin level,serotonin levels
NEW08936,BIOCHEMICAL,vasodilator niacin,vasodilator niacin
NEW08937,CHEMICAL,topical methylnicotinate,topical methylnicotinate
D054409,BIOCHEMICAL,Nicotinamide Phosphoribosyltransferase,"Pre B Cell Colony Enhancing Factor|Visfatin|NAmPRTase|NAMPT Protein|NMN Pyrophosphorylase|nicotinamide|Pre-B-Cell Colony-Enhancing Factor|Colony-Enhancing Factor, Pre-B-Cell|Phosphoribosyltransferase, Nicotinamide"
NEW08942,CHEMICAL,statin treatment,statin treatment
http://purl.org/sig/ont/fma/fma67372,CHEMICAL,serotonin receptor,serotonin 5-HT(2A receptor
NEW08945,CHEMICAL,glutamate mglu2 receptor,glutamate mGlu2 receptors
http://purl.obolibrary.org/obo/CHEBI_28790,CHEMICAL,serotonin,5-Hydroxytryptamine|5-HT|Serotonin|serotonin 5-HT(2A|3-(2-Aminoethyl)-1H-indol-5-ol|thrombocytin|Enteramine|serotonine|3-(2-aminoethyl)-1H-indol-5-ol|thrombotonin|SEROTONIN
NEW08950,NUTRITION,dietary thiamine deficiency,dietary thiamine deficiency
NEW08952,CHEMICAL,nmda n-methyl-d-aspartate receptor antagonist ketamine,NMDA N-methyl-D-aspartate receptor antagonist ketamine
NEW08954,CHEMICAL,its 's 5-ht(2a,5-HT(2A
http://purl.obolibrary.org/obo/DOID_10507,DISEASE,dressler's syndrome,Hoigne's syndrome|Dressler syndrome|Postmyocardial infarction syndrome
NEW08957,DISEASE,tbi-induced impulsivity,TBI-induced impulsivity
D015500,CHEMICAL,Chloramphenicol O-Acetyltransferase,"O-Acetyltransferase, Chloramphenicol|Chloramphenicol Acetyltransferase|Transacetylase, Chloramphenicol|chloramphenicol|Acetyltransferase, Chloramphenicol|Chloramphenicol O Acetyltransferase|Chloramphenicol Transacetylase|CAT Enzyme|Enzyme, CAT"
D007412,DISEASE,Intestinal Fistula,"Fistula, Cholecystoduodenal|Fistula, Intestinal|enterocutaneous fistula|Fistula, Enterocutaneous|Cholecystoduodenal Fistula|Enterocutaneous Fistula|Fistula, Colovesical|Colovesical Fistula"
C030880,CHEMICAL,gentamicin A [Supplementary Concept],Gentamicins|gentamicin
NEW08961,BIOCHEMICAL,injection drug,injection drug
NEW08962,CHEMICAL,low-dose methotrexate,low-dose methotrexate
NEW08965,CHEMICAL,rifaximin treatment,Rifaximin treatment
NEW08968,DISEASE,lesion pituitary abscess,lesion pituitary abscess
NEW08970,BIOCHEMICAL,antibiotic therapy,Antibiotic therapy
NEW08973,BIOCHEMICAL,offend drug,offending drug
NEW08974,BIOCHEMICAL,broad spectrum carbapenem antibiotic,broad spectrum carbapenem antibiotic
NEW08976,CHEMICAL,context ertapenem,Context Ertapenem
D010878,CHEMICAL,Piperacillin,"Monosodium Salt, Piperacillin|Piperacillin Hexal|Piperacillin Monosodium Salt|Cl227193|Pipcil|Pipera Hameln|Pipercillin|Curasan, Piperacillin|Piperacillin Curasan|T1220|Salt, Piperacillin Monosodium|Pipril|Piperacillin Sodium|Piperacillin Fresenius|Pipracil|Sodium, Piperacillin|T 1220|AB-Piperacillin|Piperacillin Ratiopharm|AB Piperacillin|Pipera-Hameln|Cl-227193|Cl 227193|piperacillin|Piperacillin-Ratiopharm|T-1220"
D000077727,CHEMICAL,Ertapenem,Ertapenem Sodium|Invanz|ertapenem|Invanoz
NEW08977,BIOCHEMICAL,antibiotic treatment,Antibiotic treatment
NEW08979,BIOCHEMICAL,neurological adverse drug reaction,neurological adverse drug reactions
D002442,CHEMICAL,Ceftazidime,"ceftazidime|Fortum|GR 20263|Tazidime|GR-20263|Ceftazidime Pentahydrate|Fortaz|LY-139381|Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))-|GR20263|Ceftazidime Anhydrous|LY 139381|LY139381"
NEW08981,BIOCHEMICAL,antibiotic drug exposure,antibiotic drug exposure
NEW08984,CHEMICAL,chronic minocycline treatment,chronic minocycline treatment
NEW08985,CHEMICAL,gaba signaling,GABA signaling
C431671,CHEMICAL,tertiary amine N-oxide reductase [Supplementary Concept],trimethylamine-N-oxide reductase|Cytochrome P-450 Enzyme System
NEW08989,DISEASE,human gut bacterial na(+)-transporting nadh ubiquinone reductase nqr sequence,Human gut bacterial Na(+)-transporting NADH ubiquinone reductase NQR sequence
D046948,CHEMICAL,Secologanin Tryptamine Alkaloids,"Alseroxylon|Alkaloids, Secologanin Tryptamine|Alkaloids, Rauwolfia|Derivatives, Strictosidine|Rauvolfia Alkaloids|Terpenoid Indole Alkaloids|Monoterpenoid Indole Alkaloids|Indole Alkaloids, Monoterpenoid|Tryptamine|Rauwolfia Alkaloids|Tryptamine Alkaloids, Secologanin|Alkaloids, Secologanin Indole|Alkaloids, Rauvolfia|Alkaloids, Terpenoid Indole|Alkaloids, Monoterpenoid Indole|Indole Alkaloids, Secologanin|Strictosidine Derivatives|Yohimbans|Indole Alkaloids, Terpenoid|Secologanin Indole Alkaloids"
NEW08991,CHEMICAL,tryptamine treatment,tryptamine treatment
NEW08992,DISEASE,myoclonic status epilepticus,Myoclonic status epilepticus
http://purl.obolibrary.org/obo/CHEBI_35481,BIOCHEMICAL,non-narcotic analgesic,synthetic narcotic analgesic
D010423,CHEMICAL,Pentazocine,"Hydrochloride, Pentazocine|Fortral|Pentazocine Lactate|Lactate, Pentazocine|Pentazocine|Lexir|Talwin|Pentazocine Hydrochloride"
D058986,CHEMICAL,Phosphodiesterase 5 Inhibitors,"PDE-5 Inhibitors|Phosphodiesterase Type 5 Inhibitors|PDE 5 Inhibitor|Inhibitors, PDE-5|Inhibitor, PDE5|Inhibitor, Phosphodiesterase 5|5 Inhibitor, Phosphodiesterase|Phosphodiesterase Type 5 Inhibitor|PDE5 Inhibitor|Inhibitor, PDE-5|PDE 5 Inhibitors|Phosphodiesterase 5 Inhibitor|Phosphodiesterase-5 inhibitors|PDE-5 Inhibitor|Inhibitors, Phosphodiesterase 5|Inhibitors, PDE5|PDE5 Inhibitors"
NEW08996,CHEMICAL,fentanyl overdose,Fentanyl overdose
D010889,CHEMICAL,Piracetam,Piracetam-RPh|Piracetam RPh|Pyracetam|Avigilen|UCB 6215|nootropil|Piracetrop|Cerepar N|2-Pyrrolidone-N-Acetamide|Sinapsan|Memo-Puren|Pyramem|Dinagen|Piracebral|Ciclofalina|Normabraïn|Nootropyl|Memo Puren|Piracetam AbZ|UCB6215|Axonyl|Cuxabrain|Geram|UCB-6215|Pirazetam|Nootropil|Gabacet|Nootrop|Cerebroforte
D009020,CHEMICAL,Morphine,"SDZ 202250|SDZ202-250|SDZ202 250|SDZ 202-250|SDZ202250|morphine sulfate|SDZ 202 250|MS Contin|Chloride, Morphine|Morphia|Oramorph SR|Morphine Sulfate|Contin, MS|Morphine Sulfate (2:1), Anhydrous|Morphine Chloride|Duramorph|Sulfate, Morphine|Morphine Sulfate (2:1), Pentahydrate"
NEW08999,CHEMICAL,central avp,Central AVP
NEW09001,CHEMICAL,term central avp antagonism,term central AVP antagonism
NEW09003,BIOCHEMICAL,n-methyl-d-aspartate nmda antagonist,N-methyl-D-aspartate NMDA antagonists
C456029,CHEMICAL,"1-(5-chloro-1-((2,4-dimethoxyphenyl)sulfonyl)-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl)-4-hydroxy-N,N-dimethyl-2-pyrrolidinecarboxamide [Supplementary Concept]",Pyrrolidines|SSR149415|Indoles
http://purl.org/sig/ont/fma/fma275560,CHEMICAL,corticospinal-corticobulbar pathway,AVP/V(3 pathway
NEW09007,CHEMICAL,corticotrophin releasing factor,corticotrophin releasing factor
NEW09008,CHEMICAL,vasopressin antagonism,vasopressin antagonism
NEW09010,CHEMICAL,central arginine vasopressin,central arginine vasopressin
NEW09012,CHEMICAL,ssr149415 mg/kg,SSR149415 mg/kg
D008305,DISEASE,Malignant Hyperthermia,"Hyperthermia, Malignant|Hyperthermia, Anesthesia Related|Hyperpyrexia, Malignant|Hyperthermia of Anesthesia|Malignant Hyperpyrexia|Malignant Hyperpyrexias|hyperthermia|Anesthesia Related Hyperthermia|Anesthesia Hyperthermia"
NEW09014,CHEMICAL,arginine vasopressin avp receptor,arginine vasopressin AVP receptors
NEW09018,CHEMICAL,intranasal avp receptor antagonist-d(ch2)5tyr(et)davp,intranasal AVP receptor antagonist-D(CH2)5Tyr(ET)DAVP
NEW09019,CHEMICAL,avp level,AVP levels
NEW09022,CHEMICAL,cerebral avp receptor,cerebral AVP receptor
NEW09024,DISEASE,lumbar sympathetic nerve activity,lumbar sympathetic nerve activity
NEW09026,BIOCHEMICAL,neuraminidase inhibitor,neuraminidase inhibitors
C518601,CHEMICAL,polysialic acid DP5 [Supplementary Concept],Oligosaccharides|Sialic Acids|polysialic acid
NEW09029,CHEMICAL,chronic corticosterone,Chronic corticosterone
NEW09030,CHEMICAL,elevated corticosterone concentration,elevated corticosterone concentrations
D020925,DISEASE,"Hypoxia-Ischemia, Brain","Brain Ischemia-Hypoxias|Anoxia Ischemia, Cerebral|Encephalopathy, Anoxic Ischemic|Ischemia-Hypoxias, Cerebral|Cerebral Hypoxia Ischemia|Anoxia-Ischemia, Cerebral|Encephalopathies, Hypoxic-Ischemic|Brain Ischemia Hypoxia|Ischemia Hypoxia, Brain|Ischemic Hypoxic Encephalopathy|Brain Hypoxia Ischemia|Ischemic-Hypoxic Encephalopathies|Encephalopathies, Anoxic-Ischemic|Hypoxia-Ischemias, Cerebral|Cerebral Anoxia-Ischemia|Hypoxic-Ischemic Encephalopathy|Hypoxia-Ischemia, Cerebral|Ischemia-Anoxia, Brain|Ischemia-Anoxia, Cerebral|cerebral ischemia|Brain Hypoxia-Ischemia|Encephalopathy, Hypoxic-Ischemic|Encephalopathies, Ischemic-Hypoxic|Anoxic Ischemic Encephalopathy|Anoxia-Ischemias, Cerebral|Ischemic-Hypoxic Encephalopathy|Brain Ischemia-Anoxias|Anoxia Ischemia, Brain|Ischemia-Anoxias, Brain|Cerebral Ischemia-Anoxias|Brain Anoxia-Ischemias|Encephalopathy, Anoxic-Ischemic|Hypoxia Ischemia, Cerebral|Brain Anoxia-Ischemia|Ischemia-Hypoxia, Brain|Brain Ischemia Anoxia|Ischemia Hypoxia, Cerebral|Ischemia Anoxia, Cerebral|Ischemia-Hypoxia, Cerebral|Hypoxic-Ischemic Encephalopathies|Cerebral Ischemia-Hypoxia|Hypoxic Ischemic Encephalopathy|Anoxia-Ischemia, Brain|Cerebral Ischemia-Hypoxias|Ischemia-Hypoxias, Brain|Anoxic-Ischemic Encephalopathy|Cerebral Anoxia Ischemia|Hypoxia-Ischemias, Brain|Cerebral Hypoxia-Ischemia|Cerebral Ischemia Hypoxia|Brain Hypoxia-Ischemias|Ischemia Anoxia, Brain|Encephalopathy, Ischemic-Hypoxic|Brain Anoxia Ischemia|Brain Ischemia-Anoxia|Anoxia-Ischemias, Brain|Cerebral Ischemia Anoxia|Cerebral Anoxia-Ischemias|Encephalopathy, Hypoxic Ischemic|Hypoxia Ischemia, Brain|Anoxic-Ischemic Encephalopathies|Cerebral Ischemia-Anoxia|Cerebral Hypoxia-Ischemias|Ischemia-Anoxias, Cerebral|Brain Ischemia-Hypoxia"
NEW09033,CHEMICAL,elevated corticosterone,elevated corticosterone
NEW09035,CHEMICAL,cus exposure,CUS exposure
NEW09038,CHEMICAL,net mrna level,NET mRNA levels
NEW09039,BIOCHEMICAL,glucocorticoid receptor antagonist mifepristone,glucocorticoid receptor antagonist mifepristone
NEW00917,DISEASE,autonomous cortisol secretion,ACS|autonomous cortisol secretion
NEW09041,CHEMICAL,mifepristone treatment,mifepristone treatment
NEW09043,CHEMICAL,mifepristone treatment,Mifepristone treatment
http://purl.obolibrary.org/obo/SYMP_0000719,DISEASE,memory impairment,IL-1beta-induced memory impairment
D015735,CHEMICAL,Mifepristone,RU-486|R-38486|ZK 98296|RU38486|R38486|RU-38486|RU 38486|Mifegyne|R 38486|ZK98296|Mifeprex|Mifégyne|RU 486|ZK-98296|RU486
NEW09048,CHEMICAL,blunted cortisol response,Blunted cortisol responses
NEW08462,CHEMICAL,alcohol preference,alcohol preference
NEW09052,DISEASE,acute organic schizophreniform disorder,acute organic schizophreniform disorder
D011241,CHEMICAL,Prednisone,"Cutason|Predni Tablinen|Prednison Acsis|Rectodelt|Sterapred|Liquid Pred|Deltasone|Sone|Prednison Hexal|Orasone|Dacortin|Kortancyl|Enkortolon|Ultracorten|Encorton|Prednidib|delta-Cortisone|Panasol|Acsis, Prednison|Cortancyl|Decortisyl|Encortone|Winpred|Panafcort|Meticorten|Pronisone|Apo-Prednisone|Predniment|Prednison Galen|Decortin|Cortan|Dehydrocortisone|prednisone"
NEW09053,NUTRITION,long-term lithium therapy,Long-term lithium therapy
http://purl.obolibrary.org/obo/CHEBI_135441,BIOCHEMICAL,metipamide,beta-blocker|metipamid|hypotylin
NEW09060,DISEASE,high rate hypothyroidism,higher rated hypothyroidism
NEW09062,DISEASE,antipsychotic-induced constipation,antipsychotic-induced constipation
NEW09067,CHEMICAL,bupropion therapy,Bupropion therapy
NEW09068,CHEMICAL,available antidepressant,available antidepressant
NEW09071,CHEMICAL,first selective serotonin 5-hydroxytryptamine reuptake inhibitor,first selective serotonin 5-hydroxytryptamine reuptake inhibitor
NEW09072,CHEMICAL,oral paroxetine,Oral paroxetine
NEW09075,CHEMICAL,profile buspirone,profile buspirone
http://purl.obolibrary.org/obo/CHEBI_64356,CHEMICAL,pregabalin,3-Isobutyl GABA|Lyrica|(3S)-3-(aminomethyl)-5-methylhexanoic acid|pregabalin|(S)-3-Isobutyl GABA|pregabaline
NEW09078,BIOCHEMICAL,selective histamine receptor agonist,selective histamine receptor agonists
NEW09080,CHEMICAL,histamine neuron,Histamine neurons
NEW09081,CHEMICAL,brain histamine,Brain histamine
C545612,CHEMICAL,LASSBio-873 [Supplementary Concept],Pyrazoles|LASSBio-873|Pyridines|Pyrroles
NEW09083,CHEMICAL,due biperiden,due biperiden
NEW09084,BIOCHEMICAL,parasympatholytic scopolamine similar,parasympatholytic scopolamine similar
D064692,CHEMICAL,Hyoscyamine,"hyoscyamine|Anaspaz|Hyoscyamine Hydrochloride|Atropine Sulfate, 3(S)-endo-Isomer|Hyoscyamine Sulfate Anhydrous|Atropine, 3(S)-endo-Isomer|Hyoscyamine Hydrobromide|Hyoscyamine Sulfate|Cytospaz"
NEW09085,CHEMICAL,atropine racemate,atropine racemate
NEW09086,CHEMICAL,post-weaning social isolation,ISO|post-weaning social isolation
NEW09087,CHEMICAL,iso mouse,ISO mice
NEW09089,DISEASE,comorbid developmental disorder,comorbid developmental disorder
NEW09092,CHEMICAL,actiamide,actiamide
NEW09093,BIOCHEMICAL,non-selective muscarinic antagonist scopolamine,non-selective muscarinic antagonist scopolamine
NEW09094,DISEASE,scopolamine-induced memory deficit,scopolamine-induced memory deficit
NEW09097,CHEMICAL,direct oral anticoagulant,Direct oral anticoagulants|DOACs
NEW09098,DISEASE,pediatric antiphospholipid syndrome,Pediatric antiphospholipid syndrome|APS
NEW09103,NUTRITION,plasma phospholipid fatty acid,plasma phospholipid fatty acids
NEW09104,CHEMICAL,dysfunctional serotonergic turnover,dysfunctional serotonergic turnover
C556353,CHEMICAL,3-carba cyclic-phosphatidic acid [Supplementary Concept],cPA|Cyclic phosphatidic acid|Phosphatidic Acids
NEW09107,CHEMICAL,bioavailable atx inhibitor pf-8380,bioavailable ATX inhibitor PF-8380
D056889,DISEASE,Barth Syndrome,"MGA Type 2|3-Methylglutaconicaciduria Type 2s|Type 2s, MGA|Type II, MGA|3-Methylglutaconicaciduria Type II|MGA Type II|MGA Type IIs|Type IIs, MGA|3-Methylglutaconic Aciduria, Type II|MGA Type 2s|Barth syndrome|3-Methylglutaconicaciduria Type 2|3 Methylglutaconicaciduria Type 2|3-Methylglutaconicaciduria Type IIs|Syndrome, Barth|3 Methylglutaconic Aciduria, Type II|Type 2, 3-Methylglutaconicaciduria|Type 2, MGA|Cardioskeletal Myopathy with Neutropenia and Abnormal Mitochondria"
NEW09111,NUTRITION,essential fatty acid aberration,essential fatty acid aberrations
http://purl.obolibrary.org/obo/CHEBI_171868,CHEMICAL,"11,12-epoxyeicosatrienoic acid","14C-labeled arachidonic acid|(5E,8E)-10-[3-[(E)-oct-2-enyl]oxiran-2-yl]deca-5,8-dienoic acid"
NEW09113,DISEASE,stress-induced pain prolongation,stress-induced pain prolongation
NEW09116,CHEMICAL,n-3 fatty acid deficient mouse,n-3 fatty acid deficient mice
NEW09117,DISEASE,stress-induced persistent mechanical allodynia,stress-induced persistent mechanical allodynia
NEW09120,CHEMICAL,right pwm mi/cr ratio,right PWM mI/Cr ratios
NEW09121,CHEMICAL,right mi/cr ratio,right mI/Cr ratios
http://purl.obolibrary.org/obo/DOID_9271,CHEMICAL,ornithine carbamoyltransferase deficiency,ornithine transcarbamylase deficiency|deficiency of citrulline phosphorylase|X-linked ornithine transcarbamylase deficiency
NEW09125,CHEMICAL,hepatic triglyceride concentration,Hepatic triglyceride concentrations
NEW09127,CHEMICAL,epa/dha supplementation,EPA/DHA supplementation
NEW09128,CHEMICAL,brain tcr,brain tCr
NEW09130,NUTRITION,phospholipid hypothesis,phospholipid hypothesis
NEW09131,CHEMICAL,low erythrocyte n-3 pufa concentration,low erythrocyte n-3 PUFA concentrations
NEW09132,CHEMICAL,n-3 pufa supplementation,n-3 PUFA supplementation
NEW09134,NUTRITION,plasma fatty acid composition,plasma fatty acid composition
NEW09136,NUTRITION,plasma fatty acid level,plasma fatty acid levels
NEW09137,CHEMICAL,sigmaomega-6/ sigmaomega-3 ratio,Sigmaomega-6/ Sigmaomega-3 ratio
http://purl.obolibrary.org/obo/CHEBI_85778,CHEMICAL,4beta-hydroxycholesterol,"cholest-5-en-3beta,4beta-diol|4beta-hydroxycholesterol|plasma Sigmaomega-3|cholest-5-ene-3beta,4beta-diol|(3beta,4beta)-cholest-5-ene-3,4-diol"
NEW09139,CHEMICAL,plasma dha,plasma DHA
NEW09140,NUTRITION,plasma sigmaomega-3 fatty acid,plasma Sigmaomega-3 fatty acids
NEW09143,BIOCHEMICAL,fluctuate estrogen level,fluctuating estrogen levels
NEW09145,BIOCHEMICAL,estrogen-containing hormone treatment,estrogen-containing hormone treatment
D011960,BIOCHEMICAL,"Receptors, Estrogen","Estrogen Receptor Type I|Receptors, Estrogen, Type II|Estrogen Receptors Type I|Estrogen Nuclear Receptor|Estrogen Receptor|Estrogen Receptor Type II|Estrogen Receptors|Estrogen Receptors Type II|Nuclear Receptor, Estrogen|Receptors, Estrogen, Type I|Receptor, Estrogen|Receptor, Estrogen Nuclear|estrogen receptors"
NEW09147,BIOCHEMICAL,estrogen receptor polymorphism,estrogen receptor polymorphisms
NEW09148,MENTAL_HEALTH,depression-related mood disorder,depression-related mood disorders
NEW09149,BIOCHEMICAL,specific estrogen receptor polymorphism,specific estrogen receptor polymorphisms
D000380,DISEASE,Agranulocytosis,Granulocytopenias|Granulocytopenia|Agranulocytoses|agranulocytosis
C536227,DISEASE,Cyclic neutropenia [Supplementary Concept],Leucopenia|Neutropenia
D010198,DISEASE,Pancytopenia,pancytopenia|Pancytopenias
D054517,DISEASE,Orbital Cellulitis,"Cellulitis, Orbital|cellulitis|Orbital Cellulitides|Cellulitides, Orbital"
D046290,DISEASE,"Liver Abscess, Pyogenic","Abscess, Pyogenic Hepatic|Pyogenic Liver Abscesses|Hepatic Abscesses, Pyogenic|Pyogenic Hepatic Abscess|Liver Abscesses, Pyogenic|Abscesses, Pyogenic Hepatic|Abscesses, Pyogenic Liver|Pyogenic Liver Abscess|Abscess, Pyogenic Liver|abscess|Pyogenic Hepatic Abscesses|Hepatic Abscess, Pyogenic"
D012532,DISEASE,Scabies,"Sarcoptic Mange|Mange, Sarcoptic|Scabies"
NEW09155,BIOCHEMICAL,various antibiotic,Various antibiotics
NEW09156,DISEASE,pcp effect,PCP effects
NEW09159,CHEMICAL,n-methyl-d-aspartate receptor function,N-methyl-D-aspartate receptor function
NEW09160,DISEASE,glun2b protein level,GluN2B protein levels
NEW09162,CHEMICAL,grin2b+/c456y mouse,Grin2b+/C456Y mice
NEW09164,CHEMICAL,glun2b-c456y haploinsufficiency,GluN2B-C456Y haploinsufficiency
NEW09166,BIOCHEMICAL,postpartum estrogen withdrawal,Postpartum estrogen withdrawal
http://purl.obolibrary.org/obo/CHEBI_64571,BIOCHEMICAL,nmda receptor agonist,NMDAr agonist NMDA|NMDAR agonists|NMDA receptor agonists|N-methyl-D-aspartate receptor agonist|N-methyl-D-aspartate receptor agonists|NMDAR agonist
NEW09168,CHEMICAL,ro25 inhibitor dasatinib,Ro25 inhibitor dasatinib
NEW09170,CHEMICAL,trkb receptor inhibitor k252a,TrkB receptor inhibitor K252a
D017378,CHEMICAL,Quinolinic Acid,"Quinolinic Acid, Disodium Salt|Quinolinic Acid, Copper(2+) Salt|quinolinic acid|Quinolinic Acid, Strontium Salt|Quinolinate"
http://purl.obolibrary.org/obo/CHEBI_64102,BIOCHEMICAL,ampa receptor agonist,endogenous N-methyl-d-aspartate receptor agonist|quisqualate receptor agonist|AMPAR agonist|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor agonist|AMPA receptor agonists
NEW09171,CHEMICAL,microglial quin content,microglial QUIN content
NEW09172,CHEMICAL,nmda depression,NMDA depression
NEW09174,CHEMICAL,accumbal dopamine release,accumbal dopamine release
NEW09175,CHEMICAL,blocker phencyclidine,blockers phencyclidine
NEW09176,CHEMICAL,n-methyl-d-aspartate nmda receptor open channel blocker,N-methyl-D-aspartate NMDA receptor open channel blockers
NEW09177,DISEASE,ptsd-related behavioral trait,PTSD-related behavioral traits
D000071518,CHEMICAL,Liver X Receptors,"LXR-Alpha Protein|NR1H3 Protein|Oxysterol Receptors, Nuclear|LXR-Alpha, Oxysterols Receptor|Oxysterols Receptor LXR-Alpha|Liver X Receptor-Alpha|Liver X Receptor|NR1H2 Protein|Oxysterols Receptor LXR Alpha|Nuclear Receptor Subfamily 1, Group H, Member 3|LXRalpha Protein|LXRβ|Oxysterols Receptor LXR-Beta|LXR-Beta, Oxysterols Receptor|Liver X Receptor Alpha|Nuclear Orphan Receptor LXR Alpha|Liver X Receptor Beta|Oxysterols Receptor LXR Beta|Nuclear Receptor Subfamily 1, Group H, Member 2|Nuclear Oxysterol Receptors|Liver X Receptor-Beta|LXRbeta Protein|LXR Alpha Protein|Nuclear Orphan Receptor LXR-Alpha"
NEW09178,CHEMICAL,serotonin 5-ht system,serotonin 5-HT system
NEW09179,CHEMICAL,brain serotonin,brain serotonin
NEW09180,MENTAL_HEALTH,amphetamine-induced hyperactivity,amphetamine-induced hyperactivity
NEW09183,CHEMICAL,kyna exposure,KYNA exposure
NEW09184,DISEASE,birth variation,birth variations
D014365,NUTRITION,Tryptophan Hydroxylase,"tryptophan hydroxylase|Monooxygenase, Tryptophan|Hydroxylase, Tryptophan|Tryptophan Monooxygenase"
NEW09186,CHEMICAL,kynurenine pathway metabolite,kynurenine pathway metabolites
NEW09187,NUTRITION,plasma tryptophan,Plasma tryptophan
NEW00965,NUTRITION,tryptophan hydroxylase gene,tryptophan hydroxylase gene
NEW09188,CHEMICAL,serotonin biosynthesis,serotonin biosynthesis
NEW09189,CHEMICAL,inhale oxygen,inhaled oxygen
NEW09190,CHEMICAL,monoamine receptor,monoamine receptors
NEW09191,CHEMICAL,elevated neurotoxic kynurenine,elevated neurotoxic kynurenines
C005045,CHEMICAL,3-hydroxykynurenine [Supplementary Concept],3-hydroxykynurenine|Kynurenine/analogs  and  derivatives
NEW09194,DISEASE,chronic enteropathy,chronic enteropathies
NEW09195,DISEASE,chronic enteropathy,chronic enteropathy
NEW09196,MENTAL_HEALTH,neuro-cognitive psychosis,Neuro-Cognitive psychosis
NEW09197,CHEMICAL,major neuro-cognitive psychosis,MNP|Major Neuro-Cognitive psychosis
NEW09198,CHEMICAL,ginseng saponin,ginseng saponins
D050503,CHEMICAL,"Indoleamine-Pyrrole 2,3,-Dioxygenase","Indoleamine 2,3-Dioxygenase|indoleamine 2,3-dioxygenase|Indolamine-2,3-Dioxygenase|Dioxygenase, IDO|Indolamine 2,3 Dioxygenase|Indoleamine 2,3 Dioxygenase|IDO Dioxygenase|Indoleamine-Oxygen 2,3-Oxidoreductase (Decyclizing)"
NEW09201,NUTRITION,lowered plasma tryptophan,Lowered plasma tryptophan
NEW09203,CHEMICAL,ky/ka ratio,KY/KA ratio
NEW09206,CHEMICAL,tryptophan-kynurenine pathway,tryptophan-kynurenine pathway
NEW09207,CHEMICAL,low prenatal kyn level,lower prenatal Kyn levels
NEW09209,CHEMICAL,kyn biomarker,Kyn biomarkers
NEW00188,CHEMICAL,antidepressant property,antidepressant properties
NEW09211,CHEMICAL,subsequent prolonged elevated cortisol concentration,subsequent prolonged elevated cortisol concentrations
NEW09212,CHEMICAL,pic/quin,PIC/QUIN
C030614,CHEMICAL,picolinic acid [Supplementary Concept],Picolinic Acids|picolinic acid
NEW09213,CHEMICAL,kp metabolite,KP metabolites
NEW09214,CHEMICAL,l-tryptophan loading,L-tryptophan loading
NEW09217,CHEMICAL,xanthurenic acid xa flow,xanthurenic acid XA flow
NEW09218,CHEMICAL,efficacious antidepressant,efficacious antidepressants
NEW09220,CHEMICAL,brain serotonin system,Brain serotonin systems
NEW09221,NUTRITION,tryptophan depletion,tryptophan depletion
NEW09223,NUTRITION,tryptophan (trp)-kynurenine kyn pathway,tryptophan (Trp)-kynurenine Kyn pathway
NEW09225,CHEMICAL,fear-cascade modulation,fear-cascade modulation
D051817,CHEMICAL,Butyrate Response Factor 1,Early Response Factor Berg36|butyrate
NEW09227,NUTRITION,tryptophan hydroxylase gene allele variant,Tryptophan hydroxylase gene allele variants
NEW09228,CHEMICAL,serotonin transporter promoter allele,serotonin transporter promoter allele
D002956,CHEMICAL,Citrulline,citrulline
NEW09231,DISEASE,chronic schizophrenic patient,chronic schizophrenic patients
NEW09233,NUTRITION,tryptophan hydroxylase tph1 gene,tryptophan hydroxylase TPH1 gene
NEW05911,DISEASE,pd patient,PD patients
D016603,CHEMICAL,Eosinophilia-Myalgia Syndrome,"L-Tryptophan-Related Eosinophilia-Myalgia Syndromes|Syndrome, Eosinophilia-Myalgia|Syndromes, L-Tryptophan-Related Eosinophilia-Myalgia|L-tryptophan|Eosinophilia Myalgia Syndrome|Eosinophilia-Myalgia Syndrome, L-Tryptophan-Related|Syndromes, Eosinophilia-Myalgia|Eosinophilia-Myalgia Syndromes, L-Tryptophan-Related|Syndrome, L-Tryptophan-Related Eosinophilia-Myalgia|Syndrome, Eosinophilia-Myalgia, L-Tryptophan-Related|L-Tryptophan-Related Eosinophilia-Myalgia Syndrome|Eosinophilia-Myalgia Syndromes"
NEW09234,DISEASE,example eosinophilia-myalgia syndrome,examples eosinophilia-myalgia syndrome
NEW09238,DISEASE,tumor necrosis factor-alpha system,tumor necrosis factor-alpha system
NEW09239,NUTRITION,serotonin-synthesizing tryptophan hydroxylase-2 tph2-/- gene,serotonin-synthesizing tryptophan hydroxylase-2 Tph2-/- gene
NEW09240,CHEMICAL,tryptophan metabolic pathway,tryptophan metabolic pathway|TMP
NEW09241,CHEMICAL,serum 3-hydroxykynurenine level,serum 3-hydroxykynurenine levels
NEW09243,CHEMICAL,serum kynurenine level,serum kynurenine levels
NEW09244,CHEMICAL,serum 3-hydroxykynurenine/kynurenine ratio,serum 3-hydroxykynurenine/kynurenine ratio
NEW09245,CHEMICAL,serum kynurenic acid/kynurenine ratio,serum kynurenic acid/kynurenine ratio
http://purl.obolibrary.org/obo/MFOMD_0000143,MENTAL_HEALTH,major depressive episode,major depressive episode
NEW09248,CHEMICAL,baseline cortisol,baseline cortisol
NEW09249,DISEASE,dsm-iii-r melancholic subtype,DSM-III-R melancholic subtype
NEW09250,CHEMICAL,fenfluramine cortisol level,fenfluramine cortisol levels
NEW09251,CHEMICAL,baseline cortisol level,baseline cortisol levels
NEW09255,NUTRITION,tryptophan hydroxylase-2 gene,tryptophan hydroxylase-2 gene
NEW09257,CHEMICAL,synaptic serotonin availability,synaptic serotonin availability
NEW09259,NUTRITION,acute tryptophan depletion,acute tryptophan depletion
NEW09261,CHEMICAL,central serotonin transmission,central serotonin transmission
NEW09263,NUTRITION,tryptophan hydroxylase-2 tph2 g-703 t polymorphism,tryptophan hydroxylase-2 TPH2 G-703 T polymorphism
NEW09264,CHEMICAL,elevated neural serotonin synthesis rate,elevated neural serotonin synthesis rate
NEW09265,CHEMICAL,kynurenine-tryptophan ratio,kynurenine-tryptophan ratios
NEW09266,CHEMICAL,increase plasma kynurenine level,Increased plasma kynurenine levels
D014364,NUTRITION,Tryptophan,L-Tryptophan|ratio Tryptophan|Tryptophan Metabolism Alterations|PMS Tryptophan|Naturruhe|Ardeytropin|Tryptacin|PMS-Tryptophan|Optimax|tryptophan metabolism|Lyphan|L-Tryptophan-ratiopharm|Ardeydorm|Levotryptophan|L Tryptophan|Tryptan|Trofan|ratio-Tryptophan|L Tryptophan ratiopharm
NEW09270,CHEMICAL,exogenous l-tryptophan,exogenous l-tryptophan
NEW09271,CHEMICAL,5-ht synthesis,5-HT synthesis
NEW09273,CHEMICAL,kyn pathway,Kyn pathway
NEW09275,NUTRITION,tryptophan breakdown,Tryptophan breakdown
NEW09276,NUTRITION,serum tryptophan,Serum tryptophan
NEW09279,CHEMICAL,glun2a subunit,GluN2A subunits
NEW09280,CHEMICAL,5-ht neuronal modulation,5-HT neuronal modulation
NEW09281,CHEMICAL,lowered brain serotonin neurotransmission,lowered brain serotonin neurotransmission
NEW09282,DISEASE,dietary-induced impairment,dietary-induced impairment
NEW02486,CHEMICAL,5-ht system,5-HT system
NEW09284,CHEMICAL,5-ht signaling,5-HT signaling
NEW09286,CHEMICAL,kyn/trp index,KYN/TRP index
NEW09287,MENTAL_HEALTH,depression value,depression values
http://purl.obolibrary.org/obo/CHEBI_18053,CHEMICAL,1-aminocyclopropanecarboxylic acid,1-aminocyclopropane-1-carboxylic acid|1-Aminocyclopropane-1-carboxylic acid|Kynurenic acid levels|ACC|1-AMINOCYCLOPROPANECARBOXYLIC ACID
NEW09290,NUTRITION,phospholipid metabolism,Phospholipid metabolism
NEW09291,CHEMICAL,atypical antipsychotic drug,AAPDs|Atypical antipsychotic drugs
NEW09293,CHEMICAL,ampa administration,AMPA administration
NEW09295,CHEMICAL,citalopram administration,Citalopram administration
NEW09297,DISEASE,hashimoto's-related hypothyroidism stable,Hashimoto's-related hypothyroidism stable
NEW09299,CHEMICAL,th insufficiency,TH insufficiency
D002231,CHEMICAL,Carbimazole,Neo-Thyreostat|Carbimazole|Neomercazole|Carbimazole Henning|Neo-Mercazole|Neo Tomizol
NEW09301,NUTRITION,herbal food supplement,Herbal food supplements
NEW09303,CHEMICAL,nonselective n-methyl-d-aspartate receptor antagonist ketamine,nonselective N-methyl-D-aspartate receptor antagonist ketamine
NEW09306,MENTAL_HEALTH,stn-hfs-evoked forelimb dyskinesia,STN-HFS-evoked forelimb dyskinesia
NEW09308,MENTAL_HEALTH,stn-hfs-induced forelimb dyskinesia,STN-HFS-induced forelimb dyskinesia
NEW09311,CHEMICAL,excessive glutamate transmission,Excessive glutamate transmission
NEW09313,MENTAL_HEALTH,schizophrenia subgroup,schizophrenia subgroup
C000712971,BIOCHEMICAL,N-methyl-d-aspartate receptor antagonist MN-08 [Supplementary Concept],N-methyl-D-aspartate receptor antagonist|Adamantane/analogs  and  derivatives
C000626862,CHEMICAL,D-methadone [Supplementary Concept],d-methadone|Methadone
D019263,MENTAL_HEALTH,Dysthymic Disorder,"Disorder, Dysthymic|Dysthymia and Chronic Depression|Neurotic Depression, Persistent Depressive Disorder|Dysthymic Disorders|chronic depression|Persistent Depressive Disorder, Dysthymia|Dysthymia"
NEW09320,CHEMICAL,monoaminergic neurotransmitter serotonin mechanism,Monoaminergic neurotransmitter serotonin mechanisms
NEW09321,CHEMICAL,n-methyl-d-aspartate receptor antagonist ketamine,N-methyl-D-aspartate receptor antagonist ketamine
NEW09323,CHEMICAL,translational ketamine model,translational ketamine models
NEW09325,MENTAL_HEALTH,prodromal schizophrenia,prodromal schizophrenia
NEW09326,CHEMICAL,h. cumulative morphine consumption,h. Cumulative morphine consumption
NEW09327,DISEASE,postoperative pain intensity,postoperative pain intensity
NEW09333,CHEMICAL,commercial isoflavone,commercial isoflavones
NEW09334,CHEMICAL,isoflavone treatment,isoflavones treatment
C561945,CHEMICAL,"2'', 3'', 4'', 6''-tetraacetyl puerarin [Supplementary Concept]",Isoflavones|Puerarin
NEW09337,DISEASE,rsv group,RSV group
NEW09339,CHEMICAL,lps group,LPS group
NEW09340,CHEMICAL,estradiol level,estradiol level
D004960,CHEMICAL,Estradiol Dehydrogenases,"17-beta Estradiol|17 beta-Dehydrogenase, Estradiol|Dehydrogenases, Estradiol|17 beta Estradiol Dehydrogenase|Dehydrogenase, 17 beta-Estradiol|Estradiol 17 beta-Dehydrogenase|Dehydrogenase, Estradiol|Estradiol 17 beta Dehydrogenase|Estradiol 17 alpha-Dehydrogenase|Estradiol Dehydrogenase|17 alpha-Dehydrogenase, Estradiol|17 beta-Estradiol Dehydrogenase|Estradiol 17 alpha Dehydrogenase"
http://purl.obolibrary.org/obo/CHEBI_3160,BIOCHEMICAL,botulinum toxin type a,Botulinum toxin type A|Botulin A|Botulinum toxin type A BoNT-A injection
NEW09342,CHEMICAL,oxygen production,oxygen production
NEW09344,CHEMICAL,dopamine neuron glutamate cotransmission,dopamine neuron glutamate cotransmission
NEW09345,CHEMICAL,cortisol content,cortisol contents
NEW09347,CHEMICAL,hair cortisol content,hair cortisol contents
NEW06197,DISEASE,metabolic derangement,metabolic derangements
NEW09354,BIOCHEMICAL,environmental toxin,environmental toxin
NEW09356,MENTAL_HEALTH,hyperactivity disorder model,hyperactivity disorder model
NEW09357,DISEASE,ptsd diagnosis,PTSD diagnosis
D001427,BIOCHEMICAL,Bacterial Toxins,"bacterial toxins|Toxin, Bacterial|Bacterial Toxin|Toxins, Bacterial"
NEW09359,DISEASE,thalamic infarction,thalamic infarction
NEW09361,CHEMICAL,elevated taurine level,elevated taurine level
NEW09363,CHEMICAL,taurine level,taurine levels
NEW09364,CHEMICAL,quercetin mg/kg,quercetin mg/kg
NEW09366,CHEMICAL,afb1-intoxicated mouse,AFB1-intoxicated mice
C075477,CHEMICAL,ochratoxin A hydroxylase [Supplementary Concept],ochratoxin A|Cytochrome P-450 Enzyme System
NEW09367,BIOCHEMICAL,ota mycotoxin,OTA mycotoxin
http://purl.obolibrary.org/obo/CHEBI_35569,BIOCHEMICAL,alpha-adrenergic agonist,Alpha2-adrenergic agonists|alpha-adrenergic receptor agonist|alpha-adrenergic agonists|alpha-adrenoceptor agonists
NEW09371,NUTRITION,nerve terminal alpha autoreceptor,nerve terminal alpha autoreceptors
NEW09373,DISEASE,subsensitivity,subsensitivity
NEW09374,BIOCHEMICAL,chlorthalidone agonist,chlorthalidone agonists
NEW09375,BIOCHEMICAL,non-cardioselective beta blocker,non-cardioselective beta blockers
NEW09376,CHEMICAL,propranolol thiazide diuretic,propranolol thiazide diuretics
NEW09377,CHEMICAL,clonidine ceruleus lesion,Clonidine ceruleus lesions
NEW09378,DISEASE,alcohol dependency,alcohol dependency
NEW09379,CHEMICAL,nonpsychostimulant medication,nonpsychostimulant medications
NEW09380,CHEMICAL,opioid antagonist naltrexone,opioid antagonist naltrexone|XR-NTX
NEW09382,MENTAL_HEALTH,placebo analgesia,placebo analgesia
C113902,CHEMICAL,"D-glucose, O-D-glucopyranosyl-(1-4)-O-D-mannopyranosyl-(1-4) [Supplementary Concept]",D-glucose|Trisaccharides
NEW08791,CHEMICAL,chronic morphine treatment,chronic morphine treatment
NEW09386,DISEASE,severe renal impairment,Severe renal impairment
NEW09388,DISEASE,moderate hepatic impairment,moderate hepatic impairment
D028642,DISEASE,Mentally Ill Persons,"ill|Person, Mentally Ill|Mental Patients|Mentally Ill|Persons, Mentally Ill|Mentally Ill Person|Ill, Mentally"
NEW09393,BIOCHEMICAL,delta subtype-selective agonist,delta subtype-selective agonists
NEW09394,CHEMICAL,naltrexone therapy,Naltrexone therapy
NEW09396,CHEMICAL,context/expectation,context/expectation
NEW09397,MENTAL_HEALTH,context/expectation-driven relative relief-related analgesia,Context/expectation-driven relative relief-related analgesia
NEW09398,DISEASE,dry ejaculate,dry ejaculate|aspermia
NEW09400,MENTAL_HEALTH,self-reported delusion,self-reported delusions
D064086,CHEMICAL,Medical Marijuana,"Marijuana, Medicinal|Dispensaries, Marijuana|marijuana|Marijuana Dispensaries|Marijuana, Medical|Medicinal Marijuana|Marijuana Treatment|Medicinal Cannabis|Cannabis, Medicinal|Treatment, Marijuana|Cannabis, Medical|Medical Cannabis"
NEW09402,DISEASE,psychotic experience,psychotic experiences
D013566,BIOCHEMICAL,Sympathomimetics,"Sympathomimetic Effect|Agent, Sympathomimetic|Agents, Sympathomimetic|Effect, Sympathomimetic|Sympathomimetic Agent|Effects, Sympathomimetic|Sympathomimetic Drugs|Sympathomimetic|Amines, Sympathomimetic|Sympathomimetics|Sympathomimetic Agents|Sympathomimetic Drug|Sympathomimetic Amines|Drug, Sympathomimetic|Sympathomimetic Effects|Drugs, Sympathomimetic"
D015320,CHEMICAL,Tachykinins,tachykinins|Tachykinin
NEW09407,BIOCHEMICAL,nk2 receptor antagonist,NK2 receptor antagonists
D017347,DISEASE,Brucella melitensis,Brucella (1966-1992)|Brucella melitensis
D009561,CHEMICAL,Nisin,nisin|Antibiotics (1966-1972)
NEW09410,CHEMICAL,mt2 receptor agonist,MT2 receptor agonist
NEW09412,CHEMICAL,ω3 lcpufa supplementation,ω3 LCPUFA supplementation
NEW09414,CHEMICAL,fabp3－/－ mouse,Fabp3－/－ mice
NEW09415,DISEASE,neurotoxic protein,neurotoxic proteins
NEW09416,DISEASE,gc-induced deterioration,GC-induced deterioration
C581609,CHEMICAL,N-(2-(5-methoxy-indol-3-yl)-ethyl)-4-oxo-4H-pyran-2-carboxamide [Supplementary Concept],piromelatine|Pyrans|Indoles
NEW09418,CHEMICAL,gr mrna down-regulation,GR mRNA down-regulation
NEW09419,DISEASE,gr-i mouse,GR-i mice
NEW09423,BIOCHEMICAL,newly-developed orexin antagonist,newly-developed orexin antagonists
D000212,CHEMICAL,Acyclovir,"Virmen|ViraxPuren|Zovirax|Zyclir|Cicloferon|aciclovir von ct|Alonga, Aciclovir|Solutab, Acipen|Viclovir|Aci-Sanorania|Cusiviral|Avirax|Virax Puren|Supraviran|Virupos|Opthavir|Aciclovir-Sanorania|acyclovir|Activir|Wellcome 248U|Genvir|Herpetad|Maynar|Acipen Solutab|Zoliparin|Aciclostad|Virherpes|Antiherpes Creme|Mapox|9-((2-Hydroxyethoxy)methyl)guanine|Aciclovir Sanorania|Vipral|Virzin|Aci Sanorania|Acic|Aciclovir|Clonorax|Herpotern|Acycloguanosine|Wellcome-248U|Acifur|Acivir|Herpoviric|Aciclobeta|Milavir|Sodium, Acyclovir|Acyclo V|Acyclo-V|Virolex|Acyclovir Sodium|Aciclovir Alonga|Herpofug|Laciken|Wellcome248U|Isavir|Virax-Puren"
NEW09427,CHEMICAL,interferon-based treatment,interferon-based treatments
D013000,DISEASE,Psychiatric Somatic Therapies,"Therapy, Psychiatric Somatic|Therapies, Psychiatric Somatic|Somatic Therapy, Psychiatric|psychiatric|Somatic Therapies, Psychiatric|Psychiatric Somatic Therapy"
NEW09430,CHEMICAL,"dopamine precursor l-3,4-dihydroxyphenylalanine","dopamine precursor L-3,4-dihydroxyphenylalanine"
C070417,CHEMICAL,"(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone [Supplementary Concept]","Naphthalenes|Benzoxazines|Morpholines|WIN-55,212"
NEW09432,CHEMICAL,young-adult cannabis use,young-adult cannabis use
NEW09433,DISEASE,early neurodevelopmental disruption,early neurodevelopmental disruptions
C118149,NUTRITION,UDP-glucose anthocyanin 5-O-glucosyltransferase [Supplementary Concept],anthocyanin|Glucosyltransferases
NEW09435,CHEMICAL,5&#8242;-chloro-5&#8242;-deoxy-(&#177;)-enba mg/kg,5&#8242;-chloro-5&#8242;-deoxy-(&#177;)-ENBA mg/kg
D009288,CHEMICAL,Naproxen,"Naprosin|Anaprox|Naprosyn|Aleve|Naproxen Sodium|Sodium, Naproxen|Sodium Naproxenate|Naproxenate, Sodium|Proxen|Methoxypropiocin|Synflex|naproxen"
NEW09442,BIOCHEMICAL,selective a1-receptor antagonist,Selective A1-receptor antagonists
NEW09443,CHEMICAL,endogenous adenosine,endogenous adenosine
C571818,CHEMICAL,4-hydroxyospemifene [Supplementary Concept],Tamoxifen/analogs  and  derivatives|Ospemifene
NEW09451,BIOCHEMICAL,post-menopausal estrogen therapy,Post-menopausal estrogen therapy
D051603,BIOCHEMICAL,Recoverin,Sensitivity-Modulating Protein|Sensitivity Modulating Protein|Cancer Associated Retinopathy Antigen|S-Modulin|Cancer-Associated Retinopathy Antigen|S Modulin|antigen sensitivity
NEW09453,CHEMICAL,Cannabis sativa L.,Cannabis sativa L.
D064704,CHEMICAL,Levofloxacin,"Anhydrous, Levofloxacin|Ofloxacin, (S)-Isomer|Levofloxacin Anhydrous|levofloxacin|Levaquin|Quixin"
NEW01416,MENTAL_HEALTH,acute anxiety,acute anxiety
NEW09458,CHEMICAL,average postmortem caffeine concentration,average postmortem caffeine concentration
NEW09461,CHEMICAL,agonist naïve patient,agonist naïve patients
NEW09463,DISEASE,pd treatment,PD treatment
NEW09465,MENTAL_HEALTH,chronic anxiety disorder,chronic anxiety disorders
NEW09466,CHEMICAL,antipsychotic aripiprazole,antipsychotics aripiprazole
D050493,CHEMICAL,Vesicular Monoamine Transport Proteins,"Vesicular Monoamine Transporter 1|Chromaffin Granule Amine Transporter|Monoamine Transporter, Vesicular|Monoamine Vesicular Transport Proteins|VMAT-1 Vesicular Monoamine Transporter|Vesicular Transporter, Monoamine|Vesicular Monoamine Transporters|VMAT 1 Vesicular Monoamine Transporter|Vesicular Monoamine Transporter 2|Monoamine Vesicular Transporter|VMAT2 Vesicular Monoamine Transporter|Vesicular Monoamine Transporter Proteins|Monoamine Transporters, Vesicular|Monoamine transporters|Vesicular Monoamine Transporter"
NEW09468,BIOCHEMICAL,central d2 antagonist,central D2 antagonists
NEW09471,CHEMICAL,dl-threo-Methylphenidate,dl-threo-Methylphenidate
D000928,CHEMICAL,Antidepressive Agents,"Antidepressant medication|Agent, Antidepressive|Drug, Antidepressant|Antidepressant Drugs|Antidepressants|Antidepressant Medication|Antidepressive Agent|Antidepressant Drug|Medication, Antidepressant|Thymoanaleptic|Thymoleptics|Thymoleptic|Thymoanaleptics|Antidepressant"
D045202,DISEASE,Porphyromonas endodontalis,Porphyromonas|Porphyromonas (1993-2003)
D000252,CHEMICAL,Calcium-Transporting ATPases,"Calcium-ATPase|Triphosphatase, Calcium Adenosine|ATPases, Calcium-Transporting|Calcium Adenosine Triphosphatase|ATPase, Calcium|Calcium ATPase|Calcium Adenosinetriphosphatase|Ca(2+)-Transporting ATPase|ATPase, Ca2+|Ca2+ ATPase|Adenosine Triphosphatase, Calcium|calcium Ca(2|Calcium Transporting ATPases|Adenosinetriphosphatase, Calcium"
NEW09474,DISEASE,bacterial cns infection,bacterial CNS infections
NEW09476,CHEMICAL,serotonin neuronal system,serotonin neuronal systems
D013732,MENTAL_HEALTH,Test Anxiety Scale,"Questionnaires, Test Anxiety|Test Anxiety Scales|anxiety test|Scale, Test Anxiety|Questionnaire, Test Anxiety|Scales, Test Anxiety|Test Anxiety Questionnaire|Test Anxiety Questionnaires"
NEW09478,BIOCHEMICAL,5-ht(2a/2c agonist doi,5-HT(2A/2C agonist DOI
NEW09480,BIOCHEMICAL,peripheral 5-ht(2a/2c antagonist xylamidine,peripheral 5-HT(2A/2C antagonist xylamidine
NEW09483,CHEMICAL,5-ht(2a receptor antagonist ketanserin,5-HT(2A receptor antagonist ketanserin
C550631,CHEMICAL,"(4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl)(5-methanesulfonyl-2-(2,2,2-trifluoro-1-methylethoxy)phenyl)methanone [Supplementary Concept]",bitopertin|Piperazines|Sulfones
NEW09485,CHEMICAL,early antiandrogen,Earlier antiandrogens
D058748,DISEASE,Pain Perception,"Perception, Pain|Pain perception|Pain Perceptions|Perceptions, Pain"
NEW09489,DISEASE,crf nmol/mouse,CRF nmol/mouse
NEW09490,CHEMICAL,atypical neuroleptic clozapine,atypical neuroleptic clozapine
D016631,DISEASE,Lewy Bodies,"DLB|Lewy Neurites|Lewy Body|Lewy bodies|Lewy Neurite|Neurite, Lewy"
NEW09496,DISEASE,delusional misidentification,delusional misidentification
NEW09497,NUTRITION,cortical alpha nicotinic receptor,cortical alpha nicotinic receptors
NEW09498,NUTRITION,choline administration,choline administration
D002798,CHEMICAL,Diacylglycerol Cholinephosphotransferase,"Phosphorylcholine Glyceride Transferase|Phosphocholinetransferase|CDP Diacylglycerol Synthase|Cholinephosphotransferase|CDP-choline|Diacylglycerol CDP Choline Phosphotransferase|CDP-Choline 1,2-Diglyceride Choline Phosphotransferase|Diacylglycerol-CDP Choline Phosphotransferase|1-alkyl-2-Acetylglycerol Cholinephosphotransferase|CDP-Choline Cholinephosphotransferase|Choline Phosphotransferase, Diacylglycerol-CDP|Phosphorylcholineglyceride Transferase|Synthase, CDP-Diacylglycerol|Phosphorylcholine-Glyceride Transferase|PAF Phosphocholinetransferase|Phosphocholinetransferase, PAF|Cholinephosphotransferase, Diacylglycerol|CDP-Diacylglycerol Synthase|Phosphotransferase, Diacylglycerol-CDP Choline|CDP Choline 1,2 Diglyceride Choline Phosphotransferase|CDP Choline Cholinephosphotransferase|Cholinephosphotransferase, CDP-Choline|Transferase, Phosphorylcholineglyceride|Cholinephosphotransferase, 1-alkyl-2-Acetylglycerol|Transferase, Phosphorylcholine-Glyceride"
NEW09503,CHEMICAL,decrease naa concentration,Decreased NAA concentrations
NEW09505,CHEMICAL,methyl donor choline,Ch|methyl donor choline
NEW09507,NUTRITION,altered brain choline level,altered brain choline levels
NEW09509,CHEMICAL,risperidone treatment,risperidone treatment
NEW09511,NUTRITION,choline concentration,Choline concentration
NEW09513,NUTRITION,low choline concentration,low choline concentrations
NEW09516,NUTRITION,rbc choline uptake system,RBC choline uptake system
D008109,DISEASE,"Liver Diseases, Parasitic","Disease, Parasitic Liver|Parasitic Liver Disease|Liver Disease, Parasitic|liver diseases|Parasitic Liver Diseases|Diseases, Parasitic Liver"
NEW09519,CHEMICAL,increase glutamate/glutamine,increased Glutamate/glutamine
NEW09520,DISEASE,function deficit,functioning deficits
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Emotional_Abuse,DISEASE,emotional abuse,childhood emotional abuse
D000080103,DISEASE,Emotional Regulation,"Emotion Self Regulation|Self-Regulation, Emotional|Emotional Self Regulation|emotional regulation|Emotional Self-Regulations|Regulation, Emotion|Emotion Regulation|Emotional Regulations|Self-Regulation, Emotion|Self-Regulations, Emotional|Emotional Self-Regulation|Regulations, Emotional|Regulation, Emotional|Emotion Self-Regulation|Emotion Self-Regulations|Self-Regulations, Emotion"
NEW09523,CHEMICAL,snp located,SNP located
C542592,CHEMICAL,"CHKB protein, human [Supplementary Concept]",Choline Kinase|CHKB
NEW09527,CHEMICAL,adhd+pae,ADHD+PAE
http://purl.obolibrary.org/obo/DOID_0090019,CHEMICAL,sitosterolemia,phytosterolemia|familial ADHD-PAE
NEW09528,DISEASE,familial etiology,familial etiologies
NEW09529,DISEASE,behavior memory formation,behavior memory formation
NEW01472,MENTAL_HEALTH,untreated psychosis,untreated psychosis
NEW09535,CHEMICAL,on-line game addiction,PGA|on-line game addiction
NEW09536,MENTAL_HEALTH,internet Addiction scale,Internet Addiction Scale
NEW09537,CHEMICAL,PGA cohort,PGA cohort
NEW09538,DISEASE,depressive Inventory score,Depressive Inventory scores
NEW09540,DISEASE,ptsd comorbidity,PTSD comorbidity
NEW09542,CHEMICAL,prenatal micronutrient,Prenatal micronutrients
NEW09544,NUTRITION,choline supplementation,Choline supplementation
NEW09545,NUTRITION,maternal choline,maternal choline
C031906,CHEMICAL,bifemelane [Supplementary Concept],MCI-2016|Benzhydryl Compounds
NEW09547,BIOCHEMICAL,cholinomimetic drug,cholinomimetic drugs
NEW09548,BIOCHEMICAL,cholinomimetic convulsant pilocarpine,cholinomimetic convulsant pilocarpine
NEW09549,DISEASE,neuronal damage,Neuronal damage
NEW09551,BIOCHEMICAL,cholinomimetic drug physostigmine,cholinomimetic drug physostigmine
NEW09553,CHEMICAL,serum epinephrine level,serum epinephrine levels
NEW09557,CHEMICAL,levodopa drug,levodopa drugs
D015103,CHEMICAL,Droxidopa,"threo-DOPS|DL threo 3,4 Dihydroxyphenylserine|3,4-threo-DOPS|3,4 threo DOPS|erythro 3,4 Dihydroxyphenylserine|Droxidopa|DL-threo-3,4-Dihydroxyphenylserine|threo DOPS|Droxidopa, (DL-Tyr)-Isomer|3,4 Dihydroxyphenylserine|3,4-Dihydroxyphenylserine|erythro-3,4-Dihydroxyphenylserine"
NEW09558,BIOCHEMICAL,cholinomimetic therapy,Cholinomimetic therapy
NEW09559,DISEASE,psychotic manifestation,psychotic manifestations
D011729,CHEMICAL,Pyridostigmine Bromide,"Bromide, Pyridostigmine|Pyridostigmine|Mestinon|pyridostigmine"
D000073943,CHEMICAL,Neonicotinoids,neonicotinoids|Neonicotinoid
NEW09560,BIOCHEMICAL,cholinomimetic drug responsiveness,cholinomimetic drug responsiveness
NEW01386,MENTAL_HEALTH,schizophrenia disorder,schizophrenia disorder
NEW09562,CHEMICAL,ntx group,NTX group
C000609675,CHEMICAL,curzerene [Supplementary Concept],Curzerene|Sesquiterpenes
D000448,DISEASE,Aldicarb,"UC21149|UC-21,149|ENT 27,093|ENT27,093|UC-21149|UC 21,149|UC21,149|Temik|UC 21149|ENT-27,093|UC"
NEW09564,DISEASE,anger out-hidden aggression,anger out-hidden aggression
NEW09569,MENTAL_HEALTH,hallucination score,Hallucinations scores
D053442,CHEMICAL,"High-Density Lipoproteins, Pre-beta","PreBeta-HDL|Pre-beta High-Density Lipoproteins|Pre beta1 HDL|Pre-beta HDL Lipoprotein|Pre beta HDL|Nascent HDL|Lipoprotein, Pre beta HDL|High-Density Lipoprotein, Pre-beta1|High Density Lipoproteins, Pre beta|HDL, Pre-beta1|Pre-beta1 HDL|Pre beta1 High Density Lipoprotein|Lipoproteins, Pre-beta High-Density|High-Density Lipoprotein, Pre-beta|Lipoprotein, Pre-beta HDL|HDL Lipoprotein, Pre-beta|Pre beta High Density Lipoprotein|lipoproteins|High Density Lipoprotein, Pre beta1|PreBeta HDL|HDL, Nascent|Pre-beta High-Density Lipoprotein|Pre-beta1 High-Density Lipoprotein|HDL, Pre-beta|Pre-beta HDL"
NEW09572,CHEMICAL,sphingomyelin sm molecular specie,sphingomyelin SM molecular species
NEW09575,BIOCHEMICAL,niacin flush,niacin flush
D002855,CHEMICAL,"Chromatography, Thin Layer","Thin Layer Chromatography|Chromatographies, Thin-Layer|Thin Layer Chromatographies|Thin-Layer Chromatography|Thin layer chromatography|Chromatography, Thin-Layer|Thin-Layer Chromatographies|Chromatographies, Thin Layer"
NEW09577,NUTRITION,membrane phospholipid,Membrane phospholipids
NEW09578,CHEMICAL,"platelet membrane phosphatidylinositol-4,5-bisphosphate","platelet membrane phosphatidylinositol-4,5-bisphosphate"
NEW09579,CHEMICAL,liposome-supported peritoneal dialysis,Liposome-supported peritoneal dialysis
NEW09582,CHEMICAL,mg different lipoprotein concentration,Mg different lipoprotein concentration
NEW09585,CHEMICAL,dha-enriched membrane phospholipid,DHA-enriched membrane phospholipids
NEW09590,BIOCHEMICAL,non-competitive nmdar n-methyl-d-aspartate receptor antagonist,Non-competitive NMDAR N-Methyl-d-aspartate receptor antagonists
NEW09592,CHEMICAL,presurgery memantine,presurgery memantine
NEW09596,CHEMICAL,single subanesthetic dose,Single subanesthetic doses
NEW09598,DISEASE,stroke patient,stroke patients
D016903,BIOCHEMICAL,Drug Monitoring,"Monitoring, Therapeutic Drug|Therapeutic Drug Monitoring|Drug Monitoring, Therapeutic|drug monitoring|Monitoring, Drug"
NEW09599,DISEASE,gastrointestinal tract no,gastrointestinal tract NO
NEW09603,CHEMICAL,numerous no-donor drug,Numerous NO-donor drugs
NEW09605,CHEMICAL,nitrate derivative,nitrate derivatives
NEW09607,CHEMICAL,ne neuron,NE neurons
NEW09608,CHEMICAL,large na system,largest NA system
D006948,MENTAL_HEALTH,Hyperkinesis,"motor hyperactivity|Hyperkinesia, Generalized|Hyperkinesia|Hyperkinesias, Generalized|Hyperkinetic Movement|Hyperkinetic Movements|Generalized Hyperkinesia|Motor Hyperactivity|Movement, Hyperkinetic|Hyperactivity, Motor|Movements, Hyperkinetic|Generalized Hyperkinesias"
NEW09613,CHEMICAL,d-Methylphenidate,d-Methylphenidate
NEW09614,CHEMICAL,catecholamine dysregulation,catecholamine dysregulation
NEW09619,CHEMICAL,alphabetameatp,alphabetaMeATP
NEW09621,DISEASE,post-transplantation abnormal movement,post-transplantation abnormal movements
http://purl.obolibrary.org/obo/SYMP_0000594,DISEASE,abnormal involuntary movement,Abnormal involuntary movements
C544831,CHEMICAL,GSK 1363089 [Supplementary Concept],Quinolines|Foretinib|Anilides
D018341,CHEMICAL,"Receptors, Adrenergic, alpha-2","Adrenergic alpha-2D Receptors|Adrenergic alpha-2B Receptors|Receptor, alpha-2C Adrenergic|Receptors, Adrenergic alpha-2|Receptors, Adrenergic, alpha-2D|alpha-2A Adrenergic Receptor|Adrenergic alpha-2A Receptors|alpha-2 Adrenergic Receptors|Adrenergic alpha 2 Receptors|Receptors, Adrenergic alpha-2D|Adrenergic alpha 2D Receptors|alpha 2A Adrenergic Receptor|Adrenergic Receptor, alpha-2|Adrenergic Receptor, alpha-2A|Receptor, Adrenergic, alpha-2B|Receptor alpha-2C, Adrenergic|alpha-2B Receptors, Adrenergic|alpha-2 Adrenergic Receptor|Receptor, Adrenergic, alpha-2D|Receptors, alpha-2 Adrenergic|Receptor, alpha-2A Adrenergic|Adrenergic Receptor alpha-2b|Adrenergic alpha 2B Receptors|Receptors, Adrenergic alpha-2C|Receptor, Adrenergic, alpha-2A|Receptors, Adrenergic alpha-2B|alpha 2 Adrenergic Receptors|Adrenergic Receptors, alpha-2|alpha-2C, Adrenergic Receptor|Receptor, alpha-2 Adrenergic|alpha-2B Adrenergic Receptor|Receptor, alpha-2D Adrenergic|alpha 2C Adrenergic Receptor|Adrenergic Receptor, alpha 2|Receptor, Adrenergic, alpha-2C|alpha-2 Receptors, Adrenergic|Adrenergic alpha-2C Receptors|Adrenergic alpha 2C Receptors|Receptors, Adrenergic alpha-2A|alpha-2D Receptors, Adrenergic|alpha-2A Receptors, Adrenergic|Receptor, alpha-2B Adrenergic|alpha-2b, Adrenergic Receptor|Receptor, Adrenergic, alpha-2|Adrenergic Receptor alpha 2C|alpha 2D Adrenergic Receptor|Adrenergic alpha 2A Receptors|Adrenergic Receptor, alpha-2B|Receptors, alpha 2 Adrenergic|Adrenergic Receptor, alpha-2C|alpha-2C Receptors, Adrenergic|Receptors, Adrenergic, alpha-2B|Adrenergic Receptor alpha-2C|Adrenergic Receptor, alpha-2D|Adrenergic Receptor alpha 2b|Receptors, Adrenergic, alpha-2A|alpha-2D Adrenergic Receptor|alpha 2B Adrenergic Receptor|Adrenergic Receptor alpha(2d)|alpha-2C Adrenergic Receptor|α-2 adrenergic receptors|Receptor alpha-2b, Adrenergic|Adrenergic alpha-2 Receptors|Adrenergic Receptor alpha(2C)"
NEW09628,CHEMICAL,"muscarinic ligand (5r,6r)-6-(3-butylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane","BuTAC|muscarinic ligand (5R,6R)-6-(3-butylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane"
D007464,CHEMICAL,Clioquinol,Iodochloroxyquinoline|Clioquinol|Entero-Septol|Entero Septol|Enteroquinol|EnteroSeptol|Entero Vioform|Iodochlorhydroxyquin|Chloroiodoquine|5-Chloro-7-iodo-8-quinolinol|5 Chloro 7 iodo 8 quinolinol|CQ|Chinoform|Vioform|Entero-Vioform|EnteroVioform
NEW09633,CHEMICAL,abnormal iron metabolism,Abnormal iron metabolism
NEW09636,CHEMICAL,iron homeostasis,iron homeostasis
NEW09637,CHEMICAL,increase iron,Increased iron
NEW09640,CHEMICAL,psychosis-its hallmark characteristic-can,psychosis-its hallmark characteristic-can
NEW09642,CHEMICAL,rs3811655 polymorphism,rs3811655 polymorphism
NEW09643,CHEMICAL,low serum iron level,low serum iron levels
NEW09645,CHEMICAL,ask1 inhibitor gs-4997,ASK1 inhibitor GS-4997
D054038,DISEASE,Posterior Leukoencephalopathy Syndrome,"leukoencephalopathy|Leukoencephalopathy Syndromes, Posterior|Leukoencephalopathy Syndrome, Posterior|Posterior Reversible Encephalopathy Syndrome|Syndromes, Posterior Leukoencephalopathy|Reversible Posterior Leukoencephalopathy Syndrome|Syndrome, Posterior Leukoencephalopathy"
NEW09650,DISEASE,inherit neurologic disorder,inherited neurologic disorders
D019943,CHEMICAL,Amino Acid Substitution,"Substitutions, Amino Acid|Amino acid substitutions|Amino Acid Substitutions|Substitution, Amino Acid"
NEW09656,MENTAL_HEALTH,narcolepsy prs,Narcolepsy PRS
NEW09659,CHEMICAL,serum iron level,serum iron levels
NEW09660,MENTAL_HEALTH,adhd symptom severity,ADHD symptom severity
NEW09661,CHEMICAL,low serum iron ferritin level,Low serum iron ferritin levels
NEW09668,DISEASE,hfe gene,HFE gene
D006556,MENTAL_HEALTH,Heroin Dependence,"heroin dependence|Abuse, Heroin|Heroin Smoking|Heroin Smokings|Dependence, Heroin|Addiction, Heroin|Heroin Addiction|Heroin Abuse|Smoking, Heroin"
NEW03341,DISEASE,comorbid schizophrenia spectrum disorder,SSD|comorbid schizophrenia spectrum disorders
NEW09675,DISEASE,previous psychiatric hospitalization,Previous psychiatric hospitalization
NEW09676,DISEASE,schizophrenic illness,schizophrenic illness
C482678,CHEMICAL,7-hydroxymitragynine [Supplementary Concept],7-Hydroxymitragynine|Secologanin Tryptamine Alkaloids
D061686,MENTAL_HEALTH,Premature Ejaculation,"Ejaculatio Praecoxs|Praecox, Ejaculatio|premature ejaculation|Premature Ejaculations|Praecoxs, Ejaculatio|Ejaculations, Premature|Ejaculatio Praecox|Ejaculation, Premature"
NEW09681,BIOCHEMICAL,synthetic kappa-opioid agonist,synthetic kappa-opioid agonists
NEW09683,DISEASE,nocturnal eating behavior,nocturnal eating behaviors
NEW09684,DISEASE,slc16a2 gene mutation,SLC16A2 gene mutations
NEW09687,CHEMICAL,levamisole toxicosis,levamisole toxicosis
C496352,CHEMICAL,"7-(N,N-dimethylpiperazinium)-7-oxo-8,8-dicyanoquinodimethane [Supplementary Concept]",Piperazines|dimethylpiperazinium
NEW03849,DISEASE,scallop flesh extract,SE|scallop flesh extract
D000077182,CHEMICAL,Polylactic Acid-Polyglycolic Acid Copolymer,"Acids, PLGA|Copolymers, PL-PG|Poly(L-lactide)-co-glycolide|Poly-L-lactic-polyglycolic Acids|PLG Polymers|PLGA Acid|Polymer, PLG|Poly L lactic polyglycolic Acid|PL-PG Copolymers|Poly(DL-lactide-co-glycolic Acid)|Polylactic Acid Polyglycolic Acid Copolymer|PL PG Copolymer|Copolymer, Polylactic-co-glycolic Acid|Polylactic-co-glycolic Acid Copolymers|PLG Polymer|acid|Polylactic-co-glycolic Acid Copolymer|RG 502|Copolymers, Polylactic-co-glycolic Acid|Acid, PLGA|Poly (D,L-lactic-co-glycolic Acid)|PLGA Acids|Poly(Lactic-co-glycolic Acid)|PLGA Compound|Poly(D,L-lactide-co-glycolide)|Copolymer, PL-PG|Poly(Glycolide-co-lactide)|LactoSorb|PLGA Compounds|Polymers, PLG|Polylactic co glycolic Acid Copolymer|Poly (Lactic-co-glycolic Acid) -|PL-PG Copolymer|Poly-L-lactic-polyglycolic Acid"
NEW09693,CHEMICAL,dopamine transmission,dopamine transmission
NEW09694,DISEASE,selective cognitive impairment,Selective cognitive impairments
NEW09695,CHEMICAL,mitogen-activated protein kinase/extracellular signal-related kinase kinase inhibitor pd-0325901,mitogen-activated protein kinase/extracellular signal-related kinase kinase inhibitor PD-0325901
NEW09697,CHEMICAL,selective norepinephrine ne α2a-adrenoceptor α2a-ar agonist,selective norepinephrine NE α2A-adrenoceptor α2A-AR agonist
NEW09701,CHEMICAL,ouabain administration,ouabain administration
NEW09702,CHEMICAL,potassium supplementation,potassium supplementation
http://purl.obolibrary.org/obo/CHEBI_38999,CHEMICAL,gaba-gated chloride channel antagonist,potassium channel antagonist|GABA-gated chloride channel antagonists
D015761,CHEMICAL,4-Aminopyridine,"VMI 103|4-Aminopyridine|4-Aminopyridine Sustained Release|Fampridine SR|VMI-103|Pymadine|4 Aminopyridine Sustained Release|Fampridine-SR|VMI103|4 Aminopyridine|Dalfampridine|Sustained Release, 4-Aminopyridine|4AP"
C548134,CHEMICAL,4-aminopyridine-3-methanol [Supplementary Concept],Aminopyridines|4-AP
D055551,DISEASE,HSP27 Heat-Shock Proteins,"Heat-Shock Proteins, HSP27|Heat Shock Protein beta 1|Heat-Shock Protein 27|HSP27 Protein|HSP27 Heat Shock Proteins|Heat-Shock Proteins 27|Heat Shock Protein beta-1|Protein 27, Heat-Shock|Heat Shock Proteins 27|Heat Shock Protein 27|HSP27 Proteins|heat shock"
NEW09709,CHEMICAL,glucose metabolism impairment,glucose metabolism impairment
NEW09711,CHEMICAL,non-competitive nmda receptor antagonist ketamine,non-competitive NMDA receptor antagonist ketamine|KET
C067662,CHEMICAL,glibenclamide receptor [Supplementary Concept],"Glibenclamide|Receptors, Drug|Potassium Channels"
NEW09714,CHEMICAL,glibenclamide mg/kg,glibenclamide mg/kg
D013224,DISEASE,Status Asthmaticus,"Crises, Asthmatic|Crisis, Asthmatic|Asthmatic Shock|Asthmatic Shocks|Status asthmaticus|Asthmatic Crises|Asthmatic Crisis|Shock, Asthmatic|Asthmaticus, Status|Shocks, Asthmatic"
NEW09717,CHEMICAL,serial potassium monitoring,serial potassium monitoring
NEW09718,DISEASE,comorbidity migraine-epilepsy,comorbidity migraine-epilepsy
NEW08376,CHEMICAL,5-ht level,5-HT levels
http://purl.obolibrary.org/obo/DOID_3650,DISEASE,lactic acidosis,Metformin-associated lactic acidosis|MALA
NEW09723,CHEMICAL,urinary cortisol level,urinary cortisol level
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Dexamethasone_Suppression_Test,CHEMICAL,dexamethasone suppression test,dexamethasone suppression test
NEW09725,CHEMICAL,individual sex- control,individual sex- controls
NEW09730,NUTRITION,mood stabilizer lithium,mood stabilizer lithium
C000719301,CHEMICAL,anti-Kv1.4 autoantibody [Supplementary Concept],Autoantibodies|Anti-voltage-gated potassium channel
NEW09733,DISEASE,channel anti-vgkc antibody encephalitis,channel anti-VGKC antibody encephalitis
NEW09734,CHEMICAL,kir6.1+/- mouse,Kir6.1+/- mice
NEW09741,CHEMICAL,nucleotide change,nucleotide change
D001030,CHEMICAL,Apamin,Bees (1966-1977)|Venoms (1966-1977)|apamin
NEW09743,DISEASE,mitochondrial dysfunction,Mitochondrial dysfunction
NEW03158,DISEASE,autoimmune encephalitis,autoimmune encephalitis
NEW09747,CHEMICAL,5-hydroxytryptamine 5-ht type 2a receptor,5-hydroxytryptamine 5-HT type 2A receptors
C514172,CHEMICAL,"(4-bromo-3,6-dimethoxybenzocyclobuten-1-yl)methylamine [Supplementary Concept]",TCB-2|Bridged Bicyclo Compounds|Methylamines
NEW09749,CHEMICAL,tcb-2 administration,TCB-2 administration
NEW09753,DISEASE,myelinogenesis,myelinogenesis
NEW09754,CHEMICAL,carbon source,carbon source
NEW09756,NUTRITION,catechol o-methyltransferase comt gene,catechol O-methyltransferase COMT gene
NEW09759,DISEASE,severe ptsd,severe PTSD
D000077867,CHEMICAL,Tolcapone,"Ro-40-7592|Ro 40-7592|3,4 Dihydroxy 5' methyl 5 nitrobenzophenone|tolcapone|Ro407592|Ro 407592|Ro 40 7592|3,4-Dihydroxy-5'-methyl-5-nitrobenzophenone|SOM0226|Tasmar"
NEW09764,CHEMICAL,5-ht brain system,5-HT brain systems
NEW09765,CHEMICAL,ObjectiveaaWe,ObjectiveaaWe
NEW09767,CHEMICAL,early life stress serotonin transporter promoter variant,early life stress serotonin transporter promoter variant
NEW09768,CHEMICAL,sex-genotype interaction,Sex-genotype interactions
NEW09769,CHEMICAL,puberty e2 replacement,puberty E2 replacement
NEW09770,CHEMICAL,inhibitory serotonin-1a receptor,inhibitory serotonin-1A receptor
D004062,DISEASE,DiGeorge Syndrome,"Deletion 22q11.2 Syndrome|VCF Syndrome|Syndrome, DiGeorge|Shprintzen Syndrome|Velocardiofacial Syndrome|Shprintzen VCF Syndrome|Syndrome, VCF|Third and Fourth Pharyngeal Pouch Syndrome|Conotruncal Anomaly Face Syndrome (CTAF)|Velo Cardio Facial Syndrome|22q11.2 Deletion Syndrome|22q11.2DS|Pharyngeal Pouch Syndrome|Hypoplasia of Thymus and Parathyroids|DiGeorge Anomaly|Deletion Syndrome, 22q11.2|Familial Third and Fourth Pharyngeal Pouch Syndrome|Syndrome, Velocardiofacial|Syndrome, Shprintzen|Autosomal Dominant Opitz G-Bbb Syndrome|Catch22|Autosomal Dominant Opitz G Bbb Syndrome|DiGeorge Sequence|Syndrome, Velo-Cardio-Facial|Sedlackova Syndrome|Velo-Cardio-Facial Syndrome|Syndrome, Sedlackova|Thymic Aplasia Syndrome|Conotruncal Anomaly Face Syndrome"
NEW09773,DISEASE,orexin/hypocretin deficiency,orexin/hypocretin deficiency
NEW09774,DISEASE,woman narcoleptic,women narcoleptics
NEW09775,CHEMICAL,impaired dopamine activity,Impaired dopamine activity
NEW09776,CHEMICAL,mesolimbic dopamine sensitization,Mesolimbic dopamine sensitization
NEW09778,MENTAL_HEALTH,untreated psychosis,Untreated Psychosis
NEW09780,DISEASE,dup duration,DUP Duration
NEW09781,CHEMICAL,cannabis-comt interaction,cannabis-COMT interaction
NEW09782,CHEMICAL,neurotransmitter dopamine,neurotransmitter dopamine
NEW09786,BIOCHEMICAL,met allele carrier,Met allele carriers
NEW09788,CHEMICAL,42-residue amyloid β-protein,42-residue amyloid β-protein
NEW09789,CHEMICAL,numerous flavonoid,Numerous flavonoids
C009288,CHEMICAL,metaperiodate [Supplementary Concept],sodium periodate|Periodic Acid
C067156,CHEMICAL,taxifolin-3-glucopyranoside [Supplementary Concept],(+)-taxifolin|Quercetin/analogs  and  derivatives|Glucosides
D000292,DISEASE,Pelvic Inflammatory Disease,"Pelvic Disease, Inflammatory|Diseases, Inflammatory Pelvic|Disease, Pelvic Inflammatory|Inflammatory Pelvic Disease|Adnexitis|Inflammatory Disease, Pelvic|Pelvic Inflammatory Diseases|Diseases, Pelvic Inflammatory|Inflammatory Pelvic Diseases|Inflammatory Diseases, Pelvic|Pelvic Diseases, Inflammatory|inflammatory diseases|Disease, Inflammatory Pelvic"
D008108,DISEASE,"Liver Diseases, Alcoholic","alcoholic liver disease|Alcoholic Liver Diseases|Liver Disease, Alcoholic|ALD|Alcoholic Liver Disease"
NEW09794,CHEMICAL,new nontricyclic antidepressant,newer nontricyclic antidepressants
NEW09795,MENTAL_HEALTH,autism patient,Autism patients
C538385,DISEASE,Hyperprolinemia type 2 [Supplementary Concept],"hyperprolinemia|1-Pyrroline-5-Carboxylate Dehydrogenase/deficiency|Amino Acid Metabolism, Inborn Errors"
NEW09801,BIOCHEMICAL,new direct-acting antiviral,New direct-acting antivirals
D000142,DISEASE,"Acidosis, Respiratory","Respiratory Acidosis|Respiratory acidosis|Respiratory Acidoses|Acidoses, Respiratory"
NEW09804,DISEASE,acute hyperammonemia,Acute hyperammonemia
NEW09807,MENTAL_HEALTH,patient 's hallucination,patient's hallucinations
D013255,CHEMICAL,Steroid 21-Hydroxylase,"P-450 c21, Cytochrome|Cytochrome P-450 CYP21|Cytochrome P-450 21-Hydroxylase|Cytochrome P 450 21 Hydroxylase|Steroid 21 Hydroxylase|21-Hydroxylase|Cytochrome P-450(c-21)|Steroid 21 Monooxygenase|steroid 21-hydroxylase|Cytochrome P-450 c21|Progesterone 21 Hydroxylase|Cytochrome P 450 CYP21|Steroid-21-Hydroxylase|Steroid 21-Monooxygenase|21 Hydroxylase|Cytochrome P450c21|Cytochrome P 450 c21|Progesterone 21-Hydroxylase"
D048550,DISEASE,Hepatic Insufficiency,"Insufficiency, Hepatic|Liver Insufficiency|Insufficiency, Liver|hepatic insufficiency"
NEW09811,CHEMICAL,once- atomoxetine,Once- atomoxetine
NEW09812,DISEASE,stimulant-naive patient,Stimulant-naive patients
NEW09817,MENTAL_HEALTH,adhd symptom score,ADHD symptom score
NEW09819,MENTAL_HEALTH,Wender-Reimherr Adult Attention Deficit Disorder scale,Wender-Reimherr Adult Attention Deficit Disorder Scale
NEW09821,CHEMICAL,mesolimbic dopamine,mesolimbic dopamine
NEW09826,CHEMICAL,5-hydroxytryptamine mechanism,5-hydroxytryptamine mechanism
NEW09829,CHEMICAL,β-adrenergic receptor antagonist pindolol,β-adrenergic receptor antagonist pindolol
D009127,DISEASE,Muscle Rigidity,"Rigidity, Muscular|Rigidity, Catatonic|Cogwheel Rigidities|Rigidity, Cogwheel|Extensor Rigidity|Rigidities, Cogwheel|Nuchal Rigidity|Extrapyramidal Rigidity|Muscular Rigidity|Gegenhalten|Catatonic Rigidity|Cogwheel Rigidity|Gegenhaltens|Rigidity, Nuchal|Rigidity, Muscle|muscle rigidity|Rigidity, Extensor|Rigidity, Extrapyramidal"
NEW09831,CHEMICAL,mdma metabolism,MDMA metabolism
NEW09836,CHEMICAL,noradrenaline reuptake inhibitor reboxetine,noradrenaline reuptake inhibitor reboxetine
NEW09837,BIOCHEMICAL,serotonin-selective reuptake inhibitor ssri agent,serotonin-selective reuptake inhibitor SSRI agents
NEW09838,CHEMICAL,endogenous ne signaling,endogenous NE signaling
NEW09842,CHEMICAL,ne transmission,NE transmission
NEW09844,CHEMICAL,prenatal op exposure,prenatal OP exposure
NEW09848,DISEASE,related stay-at-home sah order,related stay-at-home SAH orders
NEW09849,DISEASE,drug/alcohol abuse,drug/alcohol abuse
NEW09851,BIOCHEMICAL,drug prevention,Drug prevention
NEW04172,CHEMICAL,pandemrix ®,Pandemrix ®
NEW09853,BIOCHEMICAL,immunoregulatory human leukocyte antigen hla complex,immunoregulatory human leukocyte antigen HLA complex
NEW09854,CHEMICAL,high gestational dap concentration,Higher gestational DAP concentrations
NEW09855,CHEMICAL,maternal tdap vaccination,maternal Tdap vaccination
NEW09856,BIOCHEMICAL,maternal folic acid,Maternal folic acid
NEW09857,DISEASE,adult psychiatric admission,adult psychiatric admissions
NEW09859,CHEMICAL,extrahypothalamic oxytocin neuron,extrahypothalamic oxytocin neurons
NEW09861,CHEMICAL,"inositol 1,4,5-trisphosphate receptor gene","inositol 1,4,5-trisphosphate receptor gene"
NEW09863,CHEMICAL,gsk3β signaling,GSK3β signaling
NEW09864,CHEMICAL,aberrant nmda receptor function,Aberrant NMDA receptor functions
NEW09865,CHEMICAL,non-synonymous single nucleotide polymorphism,non-synonymous single nucleotide polymorphisms
NEW09866,DISEASE,threat-induced reduction,threat-induced reduction
NEW09868,CHEMICAL,clonidine treatment,clonidine treatment
NEW09872,BIOCHEMICAL,selective inhibitor ssri fluoxetine,selective inhibitor SSRI fluoxetine
NEW09873,BIOCHEMICAL,high affinity selective agonist,high affinity selective agonists
C032412,CHEMICAL,Ro 22-1319 [Supplementary Concept],Isoquinolines|Ro
C080864,CHEMICAL,N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea [Supplementary Concept],Urea/analogs  and  derivatives|SB-200646A|Indoles
http://purl.obolibrary.org/obo/CHEBI_73319,CHEMICAL,adenosine a3 receptor agonist,A3 receptor agonists|A3 receptor agonist|A3 agonists|adenosine A3 receptor agonists|A3 adenosine receptor|A3 agonist
NEW09877,CHEMICAL,a3 adenosine receptor expression/function,A3 adenosine receptor expression/function
http://purl.obolibrary.org/obo/CHEBI_36204,CHEMICAL,12-hydroxylaurate,omega-hydroxy laurate|R-PIA nmol|12-hydroxydodecanoate|12-OH dodecanoate|omega-OH dodecanoate|omega-hydroxydodecanoate|12-OH laurate
http://purl.obolibrary.org/obo/CHEBI_17985,CHEMICAL,"adenosine 3',5'-bismonophosphate","3'-Phosphoadenylate|R-PIA|3'-phosphoadenylate|R-phenylisopropyl adenosine|adenosine 3',5'-bis(dihydrogen phosphate)|Adenosine 3',5'-bisphosphate|Phosphoadenosine phosphate|PAP"
NEW09878,CHEMICAL,adenosine receptor stimulation,adenosine receptor stimulation
NEW09880,DISEASE,immunosuppressed patient,immunosuppressed patients
NEW09882,DISEASE,primary nociceptor,Primary nociceptors
C050426,CHEMICAL,huperzine A [Supplementary Concept],huperzine A|Alkaloids|Sesquiterpenes
NEW09887,CHEMICAL,l. clavatum extract,L. clavatum extract
NEW09888,CHEMICAL,result quercetin,Results Quercetin
C478032,CHEMICAL,"8,15-dehydro-5,6-dihydrolycopodine [Supplementary Concept]",Alkaloids|Lycopodine|Quinolizines
NEW09890,DISEASE,various liver ailment,various liver ailments
http://purl.obolibrary.org/obo/NCBITaxon_51030,CHEMICAL,necator,Lyocopodium clavatum
NEW09894,BIOCHEMICAL,potentize homeopathic drug,potentized homeopathic drug
NEW09895,CHEMICAL,Lycopodium-30,Lycopodium-30
D002274,BIOCHEMICAL,"Carcinogens, Environmental",Environmental Carcinogens|carcinogens
NEW09897,DISEASE,H. dichotoma,H. dichotoma
NEW09898,CHEMICAL,Qiancengta,Qiancengta
http://purl.obolibrary.org/obo/CHEBI_44785,CHEMICAL,peroxide,Superoxide-hydrogen peroxide|dioxidanediide|dioxide(2-)|PEROXIDE ION|O2(2-)|[O2](2-)|peroxide
NEW09899,DISEASE,fetida earthworm,fetida earthworms
D001705,CHEMICAL,Bioprosthesis,"Xenograft Bioprosthesis, Porcine|Porcine Xenograft Bioprostheses|Bioprosthesis, Porcine Xenograft|Porcine Xenograft Bioprosthesis|Xenograft Bioprostheses|Glutaraldehyde Stabilized Grafts|Glutaraldehyde-Stabilized Grafts|glutaraldehyde|Xenograft Bioprosthesis|Xenograft Bioprostheses, Porcine|Bioprostheses, Porcine Xenograft|Heterograft Bioprostheses|Graft, Glutaraldehyde-Stabilized|Bioprostheses, Xenograft|Bioprostheses, Heterograft|Bioprosthesis, Heterograft|Bioprostheses|Glutaraldehyde-Stabilized Graft|Heterograft Bioprosthesis|Bioprosthesis, Xenograft|Grafts, Glutaraldehyde-Stabilized"
D020265,CHEMICAL,"Lead Poisoning, Nervous System, Adult","Neurotoxicity Syndrome, Lead, Adult|Poisoning, Lead, Neurologic, Adult|Saturnism, Adult Neurologic|Lead-Induced Polyneuropathy|Nervous System Toxicity, Lead, Adult|Nervous System Poisoning, Lead, Adult|Pb|Polyneuropathy, Lead|Lead Induced Polyneuropathy|Neurologic Saturnism, Adult|Polyneuropathy, Lead Induced|Adult Neurologic Saturnism|Lead Induced Nervous System Diseases, Adult|Lead Poisoning, Neurologic, Adult|Lead Polyneuropathy|Nervous System Diseases, Lead Induced, Adult|lead|Lead-Induced Polyneuropathies|Plumbism, Neurologic, Adult|Polyneuropathies, Lead-Induced|Polyneuropathy, Lead-Induced|Poisoning, Lead, Nervous System, Adult"
NEW09906,NUTRITION,earthworm Eisenia fetida,earthworm Eisenia fetida
NEW09907,NUTRITION,earthworm Eisenia andrei,earthworm Eisenia andrei
NEW09910,DISEASE,paper contact toxicity test,paper contact toxicity test
NEW09914,DISEASE,soil toxicity test,soil toxicity test
NEW09915,CHEMICAL,fusarium plant,Fusarium plant
NEW09917,CHEMICAL,fusarium biomass,Fusarium biomass
NEW09919,CHEMICAL,don concentration,DON concentration
NEW09920,NUTRITION,earthworm P. excavate,earthworm P. excavates
NEW09922,NUTRITION,earthworm activity,earthworm activity
NEW09923,CHEMICAL,total ag measurement,Total Ag measurements
NEW09925,CHEMICAL,Mylabris phalerata Pallas,Mylabris phalerata Pallas
C475247,NUTRITION,"immotilin, earthworm [Supplementary Concept]",earthworm|Proteins
C423572,MENTAL_HEALTH,"Oxr1 protein, mouse [Supplementary Concept]",oxidation resistance|Mitochondrial Proteins
NEW09932,DISEASE,emblica extract,emblica extract
NEW09934,DISEASE,serotonergic hyperstimulation,serotonergic hyperstimulation
NEW09935,NUTRITION,Platichthys stellatu,Platichthys stellatus
D012772,DISEASE,"Shock, Septic","Endotoxin Shocks|Shock, Toxic|Shock Syndrome, Toxic|septic shock|Septic Shock|Toxic Shock|Shock, Endotoxin|Shocks, Endotoxin|Endotoxin Shock|Shock, Endotoxic|Toxic Shock Syndromes|Toxic Shock Syndrome"
NEW09938,MENTAL_HEALTH,depression severity,Depression severity
NEW09939,CHEMICAL,low ft3,low FT3
NEW09941,CHEMICAL,ft3 reduction,FT3 reduction
NEW09944,NUTRITION,systemic folate deficiency,systemic folate deficiency
NEW09948,NUTRITION,folate receptor alpha autoimmunity,Folate receptor alpha autoimmunity
NEW09950,CHEMICAL,low csf N(5)-methyl-tetrahydrofolate,low CSF N(5)-methyl-tetrahydrofolate
NEW09951,CHEMICAL,bind propidium,bound propidium
D044149,DISEASE,Vibrio alginolyticus,Pseudomonas creosotensis|Vibrio alginolyticus|Beneckea alginolytica|Oceanomonas alginolytica
NEW09954,BIOCHEMICAL,cis carotenoid isomer,cis carotenoid isomers
NEW09956,DISEASE,m. wisconsensis,M. wisconsensis
NEW09959,DISEASE,esbl isolate,ESBL isolates
D013753,CHEMICAL,Tetracycline Resistance,"Tetracycline (1966-1987)|tetracycline|Drug Resistance, Microbial (1966-1987)"
D010403,CHEMICAL,Penicillin Resistance,"penicillin resistance|Resistances, Penicillin|Penicillin Resistances|Resistance, Penicillin"
D010406,CHEMICAL,Penicillins,"penicillins|Antibiotics, Penicillin|Penicillin Antibiotics|Penicillin"
NEW09961,MENTAL_HEALTH,tetracycline resistance,tetracyclines resistance
http://purl.obolibrary.org/obo/CHEBI_48539,BIOCHEMICAL,alpha-adrenergic drug,alpha-adrenergic drugs
NEW09963,DISEASE,moderate hirsutism,moderate hirsutism
http://purl.obolibrary.org/obo/CHEBI_35530,CHEMICAL,beta-adrenergic antagonist,BBs|beta-blockers|beta-adrenergic blockers|beta-adrenergic receptor blockaders|Beta1-receptor antagonists|beta-adrenergic antagonists|beta-adrenergic blocker|beta-blocker|beta-adrenoceptor antagonists
http://purl.obolibrary.org/obo/CHEBI_26666,CHEMICAL,short-chain fatty acid,short-chain fatty acids|microbe-derived short-chain fatty acids|SCFA|SCFAs
NEW09966,CHEMICAL,d-amino acid,D-amino acids
D005693,DISEASE,Galactosemias,"GALE Deficiency|Galactosemia 2|Galactokinase Deficiency, Hereditary|Deficiency Disease, UDPglucose 4 Epimerase|Deficiency, GALT|Hereditary Galactokinase Deficiencies|Deficiency, UDP-Galactose-4-Epimerase|UTP Hexose 1 Phosphate Uridylyltransferase Deficiency|Epimerase Deficiency Galactosemia|Uridylyltransferase Deficiencies, Galactose-1-Phosphate|UDPGlucose Hexose-1-Phosphate Uridylyltransferase Deficiency|Deficiencies, GALT|UDPglucose 4-Epimerase Deficiency Disease|Deficiency Disease, Galactose-1-Phosphate Uridyl-Transferase|Galactose Epimerase Deficiency|Deficiency Disease, UDP Galactose 4 Epimerase|Galactose 1 Phosphate Uridyltransferase Deficiency|Deficiency, Hereditary Galactokinase|Classic Galactosemia|Galactosemias, Epimerase Deficiency|Deficiencies, Galactokinase|Deficiency Galactosemias, Epimerase|UDPglucose 4 Epimerase Deficiency Disease|GALT Deficiencies|UTP Hexose-1-Phosphate Uridylyltransferase Deficiency|GALK Deficiency|Deficiencies, Galactose Epimerase|UDP-Galactose-4-Epimerase Deficiency Disease|Galactosemia, Classic|GALK Deficiencies|Deficiency Galactosemia, Epimerase|Deficiency Disease, UDP-Galactose-4-Epimerase|Deficiency Disease, UDPglucose 4-Epimerase|Galactose 1 Phosphate Uridylyltransferase Deficiency|Classic Galactosemias|Galactokinase Deficiencies, Hereditary|Deficiency Disease, Galactokinase|UTP Hexose 1 Phosphate Uridylyltransferase Deficiency Disease|Uridyltransferase Deficiencies, Galactose-1-Phosphate|Deficiencies, Galactose-1-Phosphate Uridyltransferase|UTP-Hexose-1-Phosphate Uridylyltransferase Deficiency Disease|Galactokinase Deficiency|UDP Galactose 4 Epimerase Deficiency Disease|Deficiency, GALK|Deficiency, Galactose Epimerase|Galactose Epimerase Deficiencies|Deficiencies, UDP-Galactose-4-Epimerase|Galactosemias, Classic|UDP-Galactose-4-Epimerase Deficiency|UDP Galactose 4 Epimerase Deficiency|Galactosemia 3s|Uridyltransferase Deficiency, Galactose-1-Phosphate|Deficiencies, GALK|Galactosemia 2s|UDP-Galactose-4-Epimerase Deficiency Diseases|UDPGlucose Hexose 1 Phosphate Uridylyltransferase Deficiency|Deficiency, Galactose-1-Phosphate Uridylyltransferase|Uridylyltransferase Deficiency, Galactose-1-Phosphate|Deficiencies, Galactose-1-Phosphate Uridylyltransferase|UDP-Galactose-4-Epimerase Deficiencies|Deficiency, GALE|Galactose-1-Phosphate Uridyltransferase Deficiencies|Deficiency, Galactokinase|Deficiency Disease, Galactose 1 Phosphate Uridyl Transferase|Galactosemia, Epimerase Deficiency|Epimerase Deficiency Galactosemias|GALE Deficiencies|Galactosemia|Galactosemia 3|Hereditary Galactokinase Deficiency|Galactose-1-Phosphate Uridylyltransferase Deficiency|Deficiency, Galactose-1-Phosphate Uridyltransferase|Galactokinase Deficiency Diseases|Deficiencies, GALE|Galactose-1-Phosphate Uridyltransferase Deficiency|Galactose 1 Phosphate Uridyl Transferase Deficiency Disease|Galactosemia IIIs|Galactokinase Deficiencies|Deficiency Diseases, UDP-Galactose-4-Epimerase|Galactose-1-Phosphate Uridylyltransferase Deficiencies|Galactose-1-Phosphate Uridyl-Transferase Deficiency Disease|Galactosemia III|Galactokinase Deficiency Disease|GALT Deficiency|Classic galactosemia|Deficiencies, Hereditary Galactokinase"
NEW09969,CHEMICAL,biogenic amine hypothesis,biogenic amine hypothesis
NEW09970,CHEMICAL,adenosine system,Adenosine systems
NEW09972,DISEASE,spontaneous hypertensive rat,Spontaneous Hypertensive Rats
NEW09976,MENTAL_HEALTH,alcohol syndrome patient,Alcohol syndrome patients
NEW09978,DISEASE,rat clonal pheochromocytoma cell line,rat clonal pheochromocytoma cell line
NEW09980,CHEMICAL,exogenous alphat,exogenous alphaT
D024502,CHEMICAL,alpha-Tocopherol,"Tocopherol, d-alpha|d-alpha-Tocopheryl Acetate|alpha-Tocopherol Acetate|Tocopherol Succinate|alpha Tocopherol Succinate|alpha Tocopheryl Calcium Succinate|d alpha Tocopheryl Acetate|Vitamin E Succinate|alphaT|Tocopheryl Acetate|Tocopherol Acetate|alpha Tocopherol Hemisuccinate|alpha Tocopherol|alpha-Tocopherol Succinate|d-alpha Tocopherol|alpha Tocopherol Acetate|alpha-Tocopheryl Calcium Succinate|3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-ol|Acetate, Tocopherol|alpha-tocopherol|alpha-Tocopherol Hemisuccinate|d alpha Tocopherol|R,R,R-alpha-Tocopherol"
NEW09985,DISEASE,crf effect,CRF effects
NEW09987,DISEASE,crf receptor concentration,CRF receptor concentration
NEW09989,CHEMICAL,cbd-rich medical cannabis,CBD-rich medical cannabis
D008078,NUTRITION,"Cholesterol, LDL","LDL cholesterol|Cholesteryl Linoleate, LDL|LDL Cholesteryl Linoleate|Low Density Lipoprotein Cholesterol|Cholesterol, beta-Lipoprotein|LDL Cholesterol|beta-Lipoprotein Cholesterol|beta Lipoprotein Cholesterol"
NEW09991,DISEASE,estrogen receptor-positive er+ metastatic tumor,Estrogen receptor-positive ER+ metastatic tumors
NEW07310,CHEMICAL,er+ metastatic breast cancer,MBC|ER+ metastatic breast cancer
NEW09994,DISEASE,er+ metastatic liver tumor,ER+ metastatic liver tumors
NEW09996,CHEMICAL,mbc cell,MBC cells
NEW09995,CHEMICAL,glucose metabolism enzyme,glucose metabolism enzymes
NEW09997,CHEMICAL,increase glucose metabolism,increased glucose metabolism
NEW09999,MENTAL_HEALTH,anthelmintic resistance,anthelmintic resistance
NEW10000,BIOCHEMICAL,drug efflux,drug efflux
NEW10001,DISEASE,nematode parasite infection,nematode parasite infections
D007978,CHEMICAL,Levamisole,"Levotetramisole|Dekaris|Solaskil|levamisole|Hydrochloride, Levamisole|Decaris|Levamisole Hydrochloride|L-Tetramisole"
D011717,CHEMICAL,Pyrantel Tartrate,"Banminth|pyrantel|Tartrate, Pyrantel"
NEW10002,BIOCHEMICAL,drug target site,drug target site
NEW10004,DISEASE,dopaminergic deficit,dopaminergic deficits
http://purl.obolibrary.org/obo/SYMP_0000099,DISEASE,pain,PD-related pain
NEW10006,CHEMICAL,50 mg/kg berberine,BBR|50 mg/kg berberine
NEW10008,DISEASE,hepatic lipoprotein lipase,hepatic lipoprotein lipase
NEW10010,CHEMICAL,atp citrate lyase acly mrna expression,ATP citrate lyase ACLY mRNA expression
D051782,CHEMICAL,Sterol Regulatory Element Binding Protein 2,SRE 2 Binding Protein|SRE-2 Binding Protein|Sterol-Regulatory Element-Binding Protein 2|SREBP2 Protein|sterol regulatory element-binding protein
NEW10011,BIOCHEMICAL,vitamin     d level,vitamin    D levels
NEW10013,BIOCHEMICAL,serum calcidiol,serum calcidiol
NEW10014,BIOCHEMICAL,low serum calcidiol,low serum calcidiol
NEW10017,DISEASE,impulsive pd patient,impulsive PD patients
NEW10019,CHEMICAL,dopamine treatment,dopamine treatment
http://purl.obolibrary.org/obo/DOID_9063,DISEASE,ritter's disease,"Scalded skin syndrome|Pemphigus neonatorum|Ritter disease|Staphylococcal scalded skin syndrome|Dermatitis exfoliativa neonatorum|Biermers's disease|Toxic epidermal necrolysis, subcorneal type"
D020721,DISEASE,"Nervous System Autoimmune Disease, Experimental","Autoimmune Disease Models, Nervous System|autoimmune disease|Experimental Autoimmune Myositis|Autoimmune Myositis, Experimental|Disease Models, Autoimmune, Nervous System|Nervous System Autoimmune Disease Models|Autoimmune Experimental Myositis|Myositis, Experimental Autoimmune|Experimental Myositis, Autoimmune|Myositis, Autoimmune Experimental"
NEW10022,CHEMICAL,Conclusion-We,Conclusion-We
NEW10024,BIOCHEMICAL,nicotine agonist,nicotine agonists
NEW10027,BIOCHEMICAL,potent dopamine blocker,potent dopamine blocker
D015243,NUTRITION,"Cholesterol, VLDL","Cholesterol, Pre-beta-Lipoprotein|Pre-beta-Lipoprotein Cholesterol|Pre beta Lipoprotein Cholesterol|low-density lipoprotein cholesterol|Prebetalipoprotein Cholesterol|VLDL Cholesterol|Cholesterol, Prebetalipoprotein|Very Low Density Lipoprotein Cholesterol"
http://purl.obolibrary.org/obo/CHEBI_70565,CHEMICAL,"(-)-(4s,5s,10r,20r)-12,18-dihydroxy-7-oxo-abieta-8,11,13-trien-20-aldehyde 18,20-ethyl acetal","diallyl thiosulfinate|(20R)-20-ethoxy-12-hydroxy-19,20-epoxyabieta-8,11,13-trien-7-one"
NEW10030,BIOCHEMICAL,hormone change,hormone changes
NEW10033,CHEMICAL,reduce oestrodiol,reduced oestrodiol
NEW05085,DISEASE,autistic child,autistic children
NEW10035,BIOCHEMICAL,postnatal sex hormone level,postnatal sex hormone levels
NEW02639,BIOCHEMICAL,prenatal androgen exposure,prenatal androgen exposure
NEW10036,BIOCHEMICAL,measure hormone,measured hormones
NEW10038,CHEMICAL,cyproterone acetate agonist,cyproterone acetate agonist
C570497,BIOCHEMICAL,"MEDA-7 protein, mouse [Supplementary Concept]",Cytokines|oestrogen
C053541,CHEMICAL,bicalutamide [Supplementary Concept],Nitriles|Tosyl Compounds|bicalutamide|Anilides
NEW10039,DISEASE,neonatal pulmonary hypertension,Neonatal pulmonary hypertension
http://purl.obolibrary.org/obo/CHEBI_5854,CHEMICAL,ibotenic acid,Ibotenic acid|excitotoxin quinolinic acid
NEW10041,DISEASE,d/1/california,D/1/California
D017470,CHEMICAL,"Receptors, Glutamate","excitatory amino acid receptors|Glutamate Receptor|Excitatory Amino Acid Receptor|Glutamate Receptors|Excitatory Amino Acid Receptors|Receptors, Excitatory Amino Acid|Receptor, Glutamate"
http://purl.obolibrary.org/obo/IDO:0000586,DISEASE,infection,D/1/California infection
NEW10047,BIOCHEMICAL,pharmacological drug treatment,pharmacological drug treatments
D059408,DISEASE,Pain Management,"pain management|Managements, Pain|Pain Managements|Management, Pain"
D001602,DISEASE,Beriberi,beriberi
http://purl.obolibrary.org/obo/CHEBI_15890,CHEMICAL,"5,6-dimethylbenzimidazole","Dimezol|5,6-Dimethylbenzimidazole|5,6-dimethylbenzimidazole|Dimesol|Dimethylbenzimidazole|Dimedazole|Dimedazol|5,6-dimethyl-1H-benzimidazole|5,6-DIMETHYLBENZIMIDAZOLE|Thiamin Thiamin"
D012441,NUTRITION,Saccharomyces cerevisiae,"Baker's Yeast|brewer's yeast|Baker's Yeasts|Saccharomyces italicus|Yeast, Baker's|Yeast, Baker|Saccharomyces uvarum var. melibiosus|Candida robusta|Brewer's Yeast|Saccharomyces capensis|Yeast, Brewer's|Saccharomyces oviformis|Baker Yeast|S cerevisiae|S. cerevisiae"
NEW10050,BIOCHEMICAL,vitamin fortification,Vitamin fortification
D009436,DISEASE,Neural Tube Defects,"Neuroenteric Cysts|Craniorachischises|Cyst, Neuroenteric|Tethered Spinal Cord Syndrome|Neural Tube Developmental Defects|Tethered Cord Syndrome|Dysraphism, Occult Spinal|Cyst, Neurenteric|Occult Spinal Dysraphism|Acrania|Occult Spinal Dysraphism Sequence|Developmental Defects, Neural Tube|Diastematomyelia|Spinal Dysraphism, Occult|Dysraphisms, Occult Spinal|Cysts, Neuroenteric|Cysts, Neurenteric|Defect, Neural Tube|Spinal Cord Myelodysplasias|Exencephaly|Neurenteric Cysts|Developmental Neural Tube Defects|Diastematomyelias|Neural Tube Defect|Neurenteric Cyst|Spinal Dysraphisms, Occult|Exencephalies|Tethered Cord Syndromes|Occult Spinal Dysraphisms|Acranias|Myelodysplasias, Spinal Cord|tube defects|Spinal Cord Myelodysplasia|Myelodysplasia, Spinal Cord|Neuroenteric Cyst|Defects, Neural Tube|Iniencephaly|Craniorachischisis|Iniencephalies"
NEW10056,BIOCHEMICAL,folate deficiency,Folate deficiency
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Wernicke's_Syndrome,DISEASE,wernicke's syndrome,Wernicke's encephalopathy-Korsakoff syndrome
D000079689,DISEASE,Opioid-Induced Constipation,"Dysfunction, Opioid-Induced Bowel|Opiate Induced Constipation|Opiate-Induced Constipations|Bowel Syndrome, Narcotic|Constipation, Opiate-Induced|Opioid-Induced Constipations|Constipation, Opioid-Induced|Narcotic Bowel Syndromes|Bowel Dysfunction, Opioid-Induced|Narcotic Bowel Syndrome|Opioid Induced Bowel Dysfunction|Opioid-Induced Bowel Dysfunction|Opioid-Induced Bowel Dysfunctions|Opiate-Induced Constipation|Opioid Induced Constipation|Opioid-induced-constipation|OIC"
D051572,CHEMICAL,Proto-Oncogene Proteins c-hck,"Proto Oncogene Protein hck|c hck Proteins|c-hck, Proto-Oncogene Protein|Hematopoietic Cell Kinase|c hck Proto Oncogene Proteins|hck Proto-Oncogene Proteins|Tyrosine-Protein Kinase HCK|Proto Oncogene Protein c hck|c-hck Proteins|c-hck Proto-Oncogene Proteins|hck Proto Oncogene Proteins|Proto-Oncogene Proteins, c-hck|Hck|Proto-Oncogene Protein hck|Proto-Oncogene Protein c-hck|Tyrosine Protein Kinase HCK|Proto Oncogene Proteins c hck|Proto-Oncogene Proteins, hck"
D051076,CHEMICAL,Proto-Oncogene Proteins c-fyn,"Proto Oncogene Proteins c fyn|p60(fyn) Protein|Protein-Tyrosine Kinase p59(fyn)|Fyn Tyrosine Kinase|Proto Oncogene Protein c fyn|Proto-Oncogene Protein p72(fyn)|p72(fyn) Protein|Proto-Oncogene Protein p60(fyn)|Proto Oncogene Protein c syn|c-fyn Protein, p59|c-fyn Proto-Oncogene Proteins|fyn Proto-Oncogene Proteins|Fyn|p59 c-fyn Protein|Proto-Oncogene Proteins, c-fyn|Proto-Oncogene Protein p59(fyn)|p72 c-fyn Protein|fyn Proto Oncogene Proteins|c-fyn Protein|p59 c fyn Protein|c fyn Proto Oncogene Proteins|c-syn, Proto-Oncogene Protein|Tyrosine Kinase, Fyn|p72 c fyn Protein|Proto-Oncogene Proteins, fyn|p60 c-fyn Protein|p60 c fyn Protein|c-fyn, Proto-Oncogene Protein|Proteins c-fyn, Proto-Oncogene|c-fyn, Proto-Oncogene Proteins|Proto-Oncogene Protein c-fyn|c-fyn Protein, p60|Proto-Oncogene Protein c-syn|p59(fyn) Protein"
http://purl.obolibrary.org/obo/CHEBI_60004,BIOCHEMICAL,mixture,xanthine-catechin mixture|XC mixture
NEW10059,BIOCHEMICAL,selective alpha adrenal receptor α2-ar agonist,selective alpha adrenal receptor α2-AR agonist
NEW10061,NUTRITION,increase cholesterol level,increased cholesterol levels
D004410,MENTAL_HEALTH,Dyslexia,"Dyslexia, Developmental|Developmental Dyslexias|Word Blindnesses|Disability, Developmental Reading|Alexia|Dyslexias|Word Blindness|Alexias|Blindness, Word|Reading disorder|Developmental Reading Disorders|Dyslexias, Developmental|Reading Disabilities, Developmental|Developmental Reading Disability|Disorders, Reading|Blindnesses, Word|Reading Disability, Developmental|Disabilities, Developmental Reading|Disorders, Developmental Reading|Reading Disorder, Developmental|Reading Disorders, Developmental|Reading Disorders|Developmental Reading Disorder|Reading Disorder|Disorder, Reading|Disorder, Developmental Reading|Developmental Reading Disabilities|Developmental Dyslexia"
NEW10063,MENTAL_HEALTH,surface dyslexia,Surface dyslexia
NEW10064,CHEMICAL,methadone program,methadone program
C061277,BIOCHEMICAL,"Cor a I protein, hazel [Supplementary Concept]",Plant Proteins|major allergen
C054649,CHEMICAL,"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol [Supplementary Concept]","CP-55,940|Cyclohexanols"
D032065,CHEMICAL,Mitragyna,Mitragyna speciosas|Mitragynas|Kratoms|Mitragyna speciosa|Kratom
NEW10080,BIOCHEMICAL,inappropriate antidiuretic hormone,inappropriate antidiuretic hormone
C105254,CHEMICAL,pramlintide [Supplementary Concept],Pramlintide|Islet Amyloid Polypeptide
NEW10084,DISEASE,aspergillus flavus infection,Aspergillus flavus infection
NEW10089,DISEASE,specimen toxicity,specimen toxicity
NEW10092,CHEMICAL,intracellular atp content,intracellular ATP content
NEW10093,CHEMICAL,plasma phosphate level,Plasma phosphate levels
NEW10094,CHEMICAL,red cell organic phosphate ester fraction,red cell organic phosphate ester fractions
NEW10095,CHEMICAL,membrane atp pool,membrane ATP pool
D028061,CHEMICAL,Phosphate Transport Proteins,"inorganic phosphate|Inorganic Phosphate Transporters|Phosphate Transporters, Inorganic|Transporter, Phosphate|Phosphate Transporter|Phosphate Carriers|Inorganic Phosphate Transporter|Phosphate Transporters|Transporters, Inorganic Phosphate|Carriers, Phosphate|Transporters, Phosphate"
NEW10097,CHEMICAL,passive phosphate transport,passive phosphate transport
NEW10098,CHEMICAL,plasma cell inorganic phosphate level,Plasma cell inorganic phosphate levels
NEW10099,CHEMICAL,serum-free fatty acid level,FFA|serum-free fatty acid levels
NEW10100,NUTRITION,fast serum-free fatty acid level,Fasting serum-free fatty acid levels
NEW10101,CHEMICAL,ffa responsiveness,FFA responsiveness
NEW10103,CHEMICAL,increase ffa,increased FFA
NEW01903,DISEASE,depressive patient,depressive patients
http://purl.obolibrary.org/obo/CHEBI_156001,CHEMICAL,scb2,CBD µg/mL|SCB2
NEW10107,CHEMICAL,sacubitril/valsartan,Sacubitril/valsartan
NEW04576,DISEASE,depressive state,depressive states
C529765,CHEMICAL,AM4113 [Supplementary Concept],Pyrazoles|AM4113
http://purl.obolibrary.org/obo/CHEBI_17780,CHEMICAL,5-hydroxy-l-tryptophan,Levothym|oxitriptan|5-Hydroxy-L-tryptophan|Oxitriptan|5-hydroxytryptophan L-form|5-hydroxy-L-tryptophan|(2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoic acid|Tript-OH|L-5-hydroxytryptophan|Cincofarm
D050545,NUTRITION,Choline Dehydrogenase,"Choline|Dehydrogenase, Choline"
NEW10112,CHEMICAL,hippocampal glutamate,hippocampal glutamate
NEW10114,DISEASE,dopaminergic deficiency,Dopaminergic deficiency
http://purl.obolibrary.org/obo/MFOMD_0000141,MENTAL_HEALTH,rem sleep behaviour disorder,REM sleep behaviour disorder
NEW10117,MENTAL_HEALTH,preferential transmembrane orientation,preferential transmembrane orientation
D031786,NUTRITION,Saccharum,Saccharum officinarum L.|Saccharum officinarum|Saccharum spontaneum|Sugarcanes|sugarcane|Sugarcane
http://purl.obolibrary.org/obo/SO_0000704,CHEMICAL,gene,CEMB-GTGene genes
D007154,DISEASE,Immune System Diseases,"Diseases of Immune System|Immunologic Diseases|Immunological Diseases|Immune Disorders|Disorder, Immune System|immune disorder|Disease, Immune|Immune System Disease|Immune Disorder|Immune Disease|Disease, Immunological|Disease, Immunologic|Disease, Immune System|Immune Diseases|Immunologic Disease|Immunological Disease|Immune System Disorder|Immune System Disorders"
NEW10125,DISEASE,adult type diabete,adult type diabetes
NEW10126,MENTAL_HEALTH,ntf dissociation,NTF dissociation
NEW10128,NUTRITION,alpha power,alpha power
D053501,CHEMICAL,Arsenite Transporting ATPases,"Arsenite-Translocating ATPase|ATPase, Arsenite-Transporting|Arsenite Transporting ATPase|ATPase, Arsenite-Translocating|ATPases, Arsenite Transporting|Arsenite-Transporting ATPase|Arsenite Translocating ATPase|Arsenite|Transporting ATPases, Arsenite"
NEW10130,CHEMICAL,periconceptional folic acid,periconceptional folic acid
http://purl.obolibrary.org/obo/CHEBI_176839,BIOCHEMICAL,vitamin b3,vitamin B3 vitamers|vitamin B-3|vitamin B3 vitamer|vitamins B3|vitamin B3|vitamin B11
NEW10134,BIOCHEMICAL,water-soluble vitamin b,water-soluble vitamins B
NEW10136,DISEASE,bipolar family,bipolar family
NEW10137,DISEASE,suppose unipolar illness,supposed unipolar illness
C553458,CHEMICAL,apatinib [Supplementary Concept],apatinib|Pyridines
D029481,DISEASE,"Bronchitis, Chronic",Chronic Bronchitis|bronchitis
NEW10142,DISEASE,epileptic manifestation,epileptic manifestation
NEW10143,CHEMICAL,t. goniospermum extract,T. goniospermum extracts
D054821,CHEMICAL,beta-Hexosaminidase beta Chain,"beta-N-Acetylhexosaminidase beta Chain|beta Hexosaminidase beta Chain|beta Chain, beta-Hexosaminidase|Hexosaminidase B, beta Chain|β|beta N Acetylhexosaminidase beta Chain|beta Chain, beta-N-Acetylhexosaminidase|Hexosaminidase A, beta Chain"
D015386,BIOCHEMICAL,Hazardous Substances,"Toxic Environmental Substance|Chemicals, Hazardous|Materials, Hazardous|Substance, Hazardous|Hazardous Chemicals|Hazardous Chemical|Toxic Environmental Substances|toxic substances|Toxic Substances, Environmental|Environmental Toxic Substances|Substances, Environmental Toxic|Environmental Substances, Toxic|Hazardous Material|Substances, Toxic Environmental|Environmental Substance, Toxic|Substance, Toxic Environmental|Hazardous Materials|Hazardous Substance|Material, Hazardous|Biohazard|Biohazards|Chemical, Hazardous|Substances, Hazardous"
D015658,DISEASE,HIV Infections,"Infection, HTLV-III-LAV|Infections, HTLV-III-LAV|HIV infections|Coinfections, HIV|Infection, HTLV-III|T-Lymphotropic Virus Type III Infections, Human|Infections, HIV|HIV Infection|Infection, HIV|HTLV-III-LAV Infections|HTLV III LAV Infections|HTLV-III Infection|HTLV-III-LAV Infection|HIV Coinfections|Infections, HTLV-III|HTLV-III Infections|Coinfection, HIV|T Lymphotropic Virus Type III Infections, Human|HIV Coinfection|HTLV III Infections"
NEW10147,DISEASE,acquire molybdenum deficiency,acquired molybdenum deficiency
NEW10149,CHEMICAL,acetate complex,acetate complex
NEW10151,CHEMICAL,monomeric Al material,monomeric Al materials
NEW10153,CHEMICAL,oral Al hydroxide,Oral Al hydroxide
NEW10154,CHEMICAL,chronic al toxicity,chronic Al toxicity
D009141,DISEASE,Musculoskeletal System,"System, Musculoskeletal|Musculoskeletal Systems|Systems, Musculoskeletal|musculoskeletal system"
NEW10156,CHEMICAL,chronic Al toxicity,Chronic Al toxicity
NEW10157,CHEMICAL,al toxicity,Al toxicity
C021080,CHEMICAL,pyrogastrone [Supplementary Concept],Al(OH)(3|Aluminum Hydroxide|Alginates|Carbenoxolone|Silicates|Drug Combinations|Bicarbonates
NEW10160,CHEMICAL,mg/kg-day Al,mg/kg-day Al
NEW10161,DISEASE,current cancer therapy,Current cancer therapy
C526732,CHEMICAL,SALLRSIPA [Supplementary Concept],Nerve Tissue Proteins|SALLRSIPA|Peptide Fragments|SAL
D055098,BIOCHEMICAL,Endocrine Cells,"Endocrine Cell|endocrine|Cells, Endocrine|Cell, Endocrine"
http://purl.obolibrary.org/obo/NCBITaxon_7509,CHEMICAL,siphonaptera,KOH
NEW10166,CHEMICAL,airway-centric pattern,Airway-centric pattern
NEW10168,DISEASE,pediatric stroke case,pediatric stroke cases
D016908,DISEASE,Gram-Positive Bacterial Infections,"Gram-Positive Bacterial Infection|Infections, Gram-Positive Bacterial|Bacterial Infections, Gram Positive|bacterial infection|Gram Positive Bacterial Infections|Infection, Gram-Positive Bacterial|Infections, Gram Positive Bacterial|Bacterial Infections, Gram-Positive|Bacterial Infection, Gram-Positive"
NEW10173,BIOCHEMICAL,drug regiman,drug regimen
NEW10175,CHEMICAL,initial regimen isoniazid,initial regimen isoniazid
NEW10177,BIOCHEMICAL,common environmental xenoestrogen,common environmental xenoestrogen
NEW10178,MENTAL_HEALTH,orientation selectivity,orientation selectivity
NEW10180,CHEMICAL,acute bpa exposure,acute BPA exposure
D019382,CHEMICAL,Human Growth Hormone,"CryoTropin|Nutropin|Norditropin|hGH (Human Growth Hormone)|recombinant human growth hormone|Recombinant Human Growth Hormone (Mammalian)|Norditropine|Somatropin|Omnitrope|Genotonorm|Maxomat|Zomacton|Growth Hormone, Human|Umatrope|rhGH|Somatotropin (Human)|Serostim|r-hGH(m)|r-hGH-M|Norditropin Simplexx|Cryo-Tropin|Cryo Tropin|Genotropin|Somatropin (Human)|Humatrope|Saizen"
NEW10183,CHEMICAL,gonadotropin-releasing hormone analog,gonadotropin-releasing hormone analog|GnRHa
C011896,CHEMICAL,lephetamine [Supplementary Concept],lefetamine|Phenethylamines
C585977,CHEMICAL,AZD6765 [Supplementary Concept],Pyridines|lanicemine|Phenethylamines
C067553,CHEMICAL,remacemide [Supplementary Concept],Acetamides|remacemide
NEW10184,CHEMICAL,dissociative agent diphenidine,DPH|dissociative agents diphenidine
D002064,CHEMICAL,Buserelin,"Tiloryth|Bigonist|HOE-766|Suprefact|Buserelin Acetate|HOE766|HOE 766|Suprecur|Profact|Acetate, Buserelin|Buserelin|Receptal"
NEW10188,CHEMICAL,methotrexate mg.kg-1,methotrexate mg.kg-1
D009543,CHEMICAL,Nifedipine,"Nifedipine Monohydrochloride|BAY a 1040|Korinfar|Nifangin|Cordipine|BAYa1040|Cordipin|Bay1040|Bay-1040|Corinfar|Procardia|Bay 1040|BAY-a-1040|nifedipine|Fenigidin|Vascard|Nifedipine-GTIS|Nifedipine GTIS|Monohydrochloride, Nifedipine|Procardia XL|Adalat"
NEW10189,CHEMICAL,reserpine mg.kg-1,reserpine mg.kg-1
NEW10193,DISEASE,epileptic seizure discharge,Epileptic seizure discharges
NEW10195,CHEMICAL,syringyl unit,syringyl units
NEW10198,MENTAL_HEALTH,leptin resistance,leptin resistance
D000935,BIOCHEMICAL,Antifungal Agents,"Antifungal Antibiotics|Therapeutic Fungicides|Antifungal Agent|Antibiotics, Antifungal|Agent, Antifungal|antifungal agents|Agents, Antifungal|Fungicides, Therapeutic"
NEW10202,CHEMICAL,serotonin 1a receptor,serotonin 1A receptors
NEW10200,CHEMICAL,serotonergic agent,fluoxetine|serotonergic agent
NEW10205,BIOCHEMICAL,combined histamine antagonist activity,combined histamine antagonist activities
NEW10207,CHEMICAL,glutamic acid decarboxylase gad65 autoantibody,glutamic acid decarboxylase GAD65 autoantibodies
D058975,NUTRITION,Folate Receptor 1,"Receptor 1, Folate|folate receptor alpha|Ovarian Tumor Associated Antigen MOv18|Ovarian Tumor-Associated Antigen MOv18|Receptor alpha, Folate|Folate Receptor alpha"
NEW10209,MENTAL_HEALTH,acoustic hallucination,Acoustic hallucinations
NEW10210,BIOCHEMICAL,low serum folate level,low serum folate levels
NEW10211,CHEMICAL,different alkali metal,different alkali metals
NEW10212,MENTAL_HEALTH,fragmentation pathway,fragmentation pathways
http://purl.obolibrary.org/obo/CHEBI_73730,BIOCHEMICAL,pparbeta/delta agonist,"PPARD receptor agonist|PPAR-beta agonist|nuclear receptor subfamily 1, group C, member 2 agonist|PPARbeta agonists|nuclear receptor subfamily 1, group C, member 2 agonists|PPARbeta agonist|PPARbeta/delta agonist|PPAR(beta/delta) agonists|PPAR(beta/delta) agonist|NR1C2 agonist|peroxisome proliferator-activated receptor-delta agonist|PPARD receptor agonists|peroxisome proliferator-activated receptor-beta agonists|PPARD agonist|peroxisome proliferator-activated receptor-delta agonists|PPAR-beta/delta agonist|NR1C2 agonists|PPAR-beta/delta agonists|PPAR-beta agonists|5-HT1A agonists|PPARdelta agonist|peroxisome proliferator-activated receptor-beta agonist|PPAR-delta agonist|PPARbeta/delta agonists|PPAR-delta agonists|PPARdelta agonists|PPARD agonists"
NEW10214,CHEMICAL,noradrenergic re-uptake inhibitor methylphenidate,noradrenergic re-uptake inhibitor methylphenidate
D000088282,CHEMICAL,Corticobasal Degeneration,CBD|corticobasal degeneration|Cortico basal Degeneration|Cortico-basal Degeneration|Corticobasal Syndrome|Cortico-basal Ganglionic Degeneration|Cortico basal Ganglionic Degeneration
NEW10218,CHEMICAL,cannabis consumption,Cannabis consumption
NEW10219,DISEASE,wild-type p. furiosus,wild-type P. furiosus
NEW10220,CHEMICAL,3hp titer,3HP titers
NEW10223,CHEMICAL,copro-porphyrin,copro-porphyrins
D028441,CHEMICAL,F2-Isoprostanes,F2 Isoprostanes|isoprostanes|F2 Isoprostane|F2-Isoprostane
NEW10224,CHEMICAL,transfer-purge chamber,transfer-purge chamber
NEW10225,CHEMICAL,count k cells/µL,count K cells/µL
NEW10226,DISEASE,cytopenia hemoglobin,cytopenia hemoglobin
NEW10227,CHEMICAL,copper nanoparticle,copper nanoparticles
NEW10228,CHEMICAL,copper nanoparticle,Cu-NPs|copper nanoparticles
NEW10230,BIOCHEMICAL,lipophilic beta-blocker propranolol,lipophilic beta-blocker propranolol
NEW10231,DISEASE,p. kudriavzevii,P. kudriavzevii
NEW10232,CHEMICAL,ca ascorbate,Ca ascorbate
NEW10233,CHEMICAL,cacl2,CaCl2
NEW10234,DISEASE,severe adrenal insufficiency,severe adrenal insufficiency
NEW10235,CHEMICAL,b (-)deprenyl,b (-)Deprenyl
D020144,DISEASE,Basal Ganglia Cerebrovascular Disease,"Lenticulostriate Vasculopathies|Vasculopathies, Lenticulostriate|Lenticulostriate Vascular Disease|Basal Ganglia Vascular Disease|cerebrovascular disease|Vascular Disease, Lenticulostriate|Lenticulostriate Vasculopathy|Vascular Lenticulostriate Diseases|Vasculopathy, Lenticulostriate|Vascular Diseases, Lenticulostriate|Lenticulostriate Diseases, Vascular|Cerebrovascular Disease, Basal Ganglia|Lenticulostriate Vascular Diseases|Vascular Diseases, Basal Ganglia|Vascular Disease, Basal Ganglia"
NEW10237,DISEASE,convulsive activity,convulsive activity
D006945,DISEASE,Hyperhidrosis,Hyperidrosis|hyperhidrosis
NEW10241,CHEMICAL,btx treatment,BTX treatment
NEW10243,BIOCHEMICAL,mr antagonist treatment,MR antagonist treatment
NEW10247,BIOCHEMICAL,androgen receptor ar antagonist,Androgen receptor AR antagonists
NEW10248,CHEMICAL,ethanol extract,Ethanol extracts
NEW10250,CHEMICAL,prinoide ethanol extract,prinoides ethanol extracts
NEW10252,CHEMICAL,long chain omega-3 polyunsaturated fatty acid,LC omega-3 PUFA|long chain omega-3 polyunsaturated fatty acids
NEW10253,CHEMICAL,low omega-3 intake,low Omega-3 intake
NEW10256,CHEMICAL,cellular nad+ level,cellular NAD+ levels
NEW10258,CHEMICAL,orally-administered antipsychotic,Orally-administered antipsychotics
NEW10259,CHEMICAL,administer 3h-morphine,administered 3H-morphine
D020555,MENTAL_HEALTH,GTP-Binding Protein Regulators,"G-Protein Regulating Factors|G-Protein Signaling Regulators|Regulators, GTP-Binding Protein|G Protein Signaling Regulators|GTP Binding Protein Regulators|Regulators, G-Protein Signaling|G-protein signaling|Regulators, G Protein Signaling|analgesia|Regulating Factors, GTP Binding Protein|Regulating Factors, G-Protein|G Protein Regulating Factors|Signaling Regulators, G-Protein|Regulating Factors, GTP-Binding Protein"
NEW10262,CHEMICAL,spinal cord grain density,spinal cord grain density
NEW10263,BIOCHEMICAL,impaired circulate estrogen level,Impaired circulating estrogen levels
NEW10264,BIOCHEMICAL,folate supplementation,folate supplementation
NEW10265,BIOCHEMICAL,folate supplement,folate supplement
C005984,CHEMICAL,5-methyltetrahydrofolate [Supplementary Concept],Tetrahydrofolates|l-methylfolate
D014256,DISEASE,Trichotillomania,Trichotillomania|Trichotillomanias|TTM
D019565,CHEMICAL,"Metals, Light",Light Metals|metals
http://purl.obolibrary.org/obo/PR_Q9V4P1,DISEASE,anillin (fruit fly),protein scraps (fruit fly)|cg2092|fly-scra|scra|ani|abp8 (fruit fly)|actin-binding protein 8 (fruit fly)|SCRA
NEW10272,CHEMICAL,adh aldh alcohol metabolizing gene,ADH ALDH alcohol metabolizing genes
C090840,CHEMICAL,alosetron [Supplementary Concept],Carbolines|Alosetron
NEW10275,CHEMICAL,low-level pfoa,low-level PFOA
C553090,CHEMICAL,Vitex agnus castus extract [Supplementary Concept],"Agnus Castus Fruit|Vitex|Drugs, Chinese Herbal"
NEW10277,CHEMICAL,food-grade titanium dioxide,Food-grade titanium dioxide
D000068258,CHEMICAL,Bevacizumab,Bevacizumab awwb|Mvasi|Avastin|Bevacizumab-awwb|bevacizumab
http://purl.obolibrary.org/obo/DOID_3498,DISEASE,pancreatic ductal adenocarcinoma,ductal adenocarcinoma of the pancreas|metastatic pancreatic ductal adenocarcinoma
NEW10281,CHEMICAL,pemetrexed pharmacokinetic,pemetrexed pharmacokinetics
NEW10282,BIOCHEMICAL,high-dose folinic acid,high-dose folinic acid
NEW10285,CHEMICAL,traditional herbal medicine yokukansan,YKS|traditional herbal medicines yokukansan
NEW10286,MENTAL_HEALTH,perioral dyskinesia,perioral dyskinesia
NEW10287,CHEMICAL,38393 0.1,38393 0.1
NEW10288,BIOCHEMICAL,subsequent toxin production,subsequent toxin production
NEW10290,CHEMICAL,dopamine d₃-preferring d₃/d₂ receptor partial agonist,dopamine D₃-preferring D₃/D₂ receptor partial agonist
NEW10291,BIOCHEMICAL,serotonin 5-ht1a receptor partial agonist,serotonin 5-HT1A receptor partial agonist
NEW10292,DISEASE,matter lesion,matter lesions
D054890,CHEMICAL,"Fatty Acid Synthase, Type I","fatty acid synthase|FAS|Fatty Acid Synthase, Animal Form|Fatty Acid Synthase, Mammalian"
NEW10294,MENTAL_HEALTH,dissociation constant kd,dissociation constant KD
NEW10296,CHEMICAL,anti-aβ40,anti-aβ40
D013539,CHEMICAL,Simian virus 40,SV40 Viruses|aβ40|Polyomavirus macacae|SV40 Virus|SV 40 Viruses|40|Vacuolating Agents|Vacuolating Agent|SV 40 Virus
D000069347,CHEMICAL,Erlotinib Hydrochloride,"CP 358,774|CP-358,774|11C-erlotinib|CP 358774|Hydrochloride, Erlotinib|N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine|Erlotinib|11C erlotinib|Erlotinib HCl|OSI 774|358774, CP|CP-358774|CP358774|OSI-774|OSI774|CP358,774|Tarceva|HCl, Erlotinib|358,774, CP"
NEW10297,DISEASE,inferior ventricular nerve,inferior ventricular nerve
NEW10298,CHEMICAL,thuja occidentalis l.,Thuja occidentalis L.
NEW10301,BIOCHEMICAL,low csf amyloid beta,low CSF amyloid beta
C478603,CHEMICAL,N-palmitoylethanolamine-selective acid amidase [Supplementary Concept],PEA|N-palmitoylethanolamine|Amidohydrolases
NEW10306,DISEASE,behavioral deficit,behavioral deficit
NEW10308,CHEMICAL,skin methylnicotinate stimulation,Skin methylnicotinate stimulation
NEW10309,CHEMICAL,omega-3 pufa,omega-3 PUFA
NEW10310,CHEMICAL,decrease pufa level,Decreased PUFA levels
NEW10311,BIOCHEMICAL,niacin skin,niacin skin
NEW10312,MENTAL_HEALTH,depression severity,depression severity
NEW10315,CHEMICAL,low dha level,low DHA levels
NEW10319,MENTAL_HEALTH,Epizelus 's psychogenic mutism,Epizelus's psychogenic mutism
NEW10320,BIOCHEMICAL,carrier Epizelus 's,carrier Epizelus's
NEW10323,CHEMICAL,intravenous levothyroxine replacement,Intravenous levothyroxine replacement
NEW10325,DISEASE,nephrotoxic effect,nephrotoxic effect
NEW10327,DISEASE,uraemic encephalopathy secondary,uraemic encephalopathy secondary
NEW10329,BIOCHEMICAL,folate receptor fr1,folate receptor FR1
NEW10331,BIOCHEMICAL,to topical tocopherol,vitamin E|to topical tocopherol
NEW10332,BIOCHEMICAL,q10 ubiquinol vitamin,Q10 ubiquinol vitamins
NEW10333,DISEASE,severe self-injury,severe self-injury
NEW10334,CHEMICAL,methadone treatment,methadone treatment
NEW10335,CHEMICAL,dexmedetomidine infusion,dexmedetomidine infusions
D011539,DISEASE,Pruritus Vulvae,pruritus
NEW10336,CHEMICAL,slow dissociation kinetic,buprenorphine|slow dissociation kinetics
NEW10337,DISEASE,malformation risk,malformation risk
C028938,CHEMICAL,methyl acetylsalicylic acid [Supplementary Concept],acetylsalicylic acid|Aspirin/analogs  and  derivatives
D011550,DISEASE,Pseudomonas aeruginosa,Micrococcus pyocyaneus|Bacillus aeruginosus|Bacterium pyocyaneum|Bacterium aeruginosum|Pseudomonas pyocyanea|Pseudomonas polycolor|Pseudomonas aeruginosa|Bacillus pyocyaneus
NEW10340,BIOCHEMICAL,novel putative virulence factor,novel putative virulence factor
D016360,DISEASE,Clostridioides difficile,difficile|Clostridium difficile
D048373,DISEASE,Treponema denticola,Spirochaeta dentium|Spirochaeta microdentium|Spironema dentium|Treponema dentium-stenogyratum|Spirochaeta comandonii|Spirochaete denticola|Spirochaete dentium|Treponema dentium|Treponema orthodontum|Treponema comandonii|Spirochaeta orthodonta|Spirochaeta ambigua|Treponema denticola|Spirillum dentium|Treponema ambiguum|Treponema microdentium
http://purl.obolibrary.org/obo/CHEBI_149711,BIOCHEMICAL,chemokine receptor 2 antagonist,chemokine receptor antagonists|CKR-2B antagonist|CD192 antagonist|CCR2 antagonists|CCR-2 antagonist|C-C chemokine receptor type 2 antagonists|CKR-2B antagonists|chemokine receptor 2 antagonists|CCR2 antagonist|C-C chemokine receptor type 2 antagonist|CD192 antagonists|CCR-2 antagonists
NEW10347,CHEMICAL,sub-analgesic dose,sub-analgesic doses
NEW10349,CHEMICAL,serum homovanillic acid,HVA|serum homovanillic acid
NEW10351,CHEMICAL,plasma hva concentration,plasma HVA concentration
C565393,DISEASE,3-Methylglutaconic Aciduria Type IV [Supplementary Concept],"3-Methylglutaconic aciduria type|Abnormalities, Multiple|Metabolism, Inborn Errors"
NEW10354,CHEMICAL,single nucleotide polymorphism array analysis,single nucleotide polymorphism array analysis
NEW10355,BIOCHEMICAL,female fmr1 premutation carrier,Female FMR1 premutation carriers
NEW10356,CHEMICAL,tca cycle,TCA cycle
NEW10357,CHEMICAL,nadh generation,NADH generation
NEW10358,CHEMICAL,multivitamin intake,multivitamins intake
D043371,NUTRITION,"Fatty Acids, Omega-6","Acid, N-6 Fatty|Fatty Acid, Omega-6|N-6 Fatty Acid|N-6 Fatty Acids|Fatty Acids, N-6|Acid, Omega-6 Fatty|n-6 fatty acids|Omega-6 Fatty Acids|N 6 Fatty Acids|Omega 6 Fatty Acid|Omega-6 Fatty Acid|N 6 Fatty Acid|Fatty Acids, Omega 6|Omega 6 Fatty Acids|Acids, N-6 Fatty|Acids, Omega-6 Fatty|Fatty Acid, N-6"
NEW10359,CHEMICAL,arachidonic acid metabolite,arachidonic acid metabolites
NEW10361,CHEMICAL,pge1/dgla ratio,PGE1/DGLA ratio
NEW10362,DISEASE,violent suicidal,violent suicidal
NEW10364,NUTRITION,serum cholesterol fasting concentration,Serum cholesterol fasting concentrations
NEW10366,DISEASE,habitually violent tendency,habitually violent tendency
C024524,CHEMICAL,beta-funaltrexamine [Supplementary Concept],Naltrexone/analogs  and  derivatives|Beta-funaltrexamine
D057136,CHEMICAL,"Nuclear Receptor Subfamily 6, Group A, Member 1",Retinoid Receptor Related Testis Associated Receptor|Retinoid Receptor-Related Testis-Associated Receptor|group A|naltrexone|Retinoid Receptor Related Testis Specific Receptor|Germ Cell Nuclear Factor|Neuronal Cell Nuclear Factor|Nuclear Receptor NR6A1
NEW10367,NUTRITION,phenylacetic acid concentration,phenylacetic acid concentrations
NEW10368,MENTAL_HEALTH,0.001).multiple linear regression analysis,0.001).Multiple linear regression analysis
NEW10372,CHEMICAL,solanum torvum Sw,Solanum torvum Sw
C552171,CHEMICAL,edoxaban [Supplementary Concept],Thiazoles|edoxaban|Pyridines
D009357,MENTAL_HEALTH,Neonatal Abstinence Syndrome,"Syndrome, Neonatal Withdrawal|Syndrome, Neonatal Abstinence|Neonatal Abstinence Syndromes|Substance Withdrawal, Neonatal|Abstinence Syndrome, Neonatal|Neonatal Withdrawal Syndromes|Substance Withdrawals, Neonatal|Neonatal Substance Withdrawal|Abstinence Syndromes, Neonatal|Passive Addictions, Neonatal|Neonatal abstinence syndrome|Addiction, Neonatal Passive|Neonatal Passive Addiction|Passive Addiction, Neonatal|Syndromes, Neonatal Abstinence|Withdrawal Syndromes, Neonatal|Neonatal Substance Withdrawals|Addictions, Neonatal Passive|Syndromes, Neonatal Withdrawal|Withdrawal, Neonatal Substance|Neonatal Passive Addictions|Withdrawal Syndrome, Neonatal|Neonatal Withdrawal Syndrome"
NEW10378,CHEMICAL,chronic l-dopa treatment,chronic L-DOPA treatment
C033595,CHEMICAL,N-oleoylethanolamine [Supplementary Concept],OEA|N-oleoylethanolamine|Oleic Acids|Ethanolamines|Endocannabinoids
NEW10380,DISEASE,local prostate cancer recurrence,local prostate cancer recurrence
D001052,CHEMICAL,Apoferritins,"Ferritin Light Chain|ferritin heavy chain|L Subunit, Ferritin|Heavy Chain, Ferritin|Ferritin H Subunit|L-Ferritin|Apoferritin|H Ferritin|Ferritin Heavy Chain|FTH|Ferritin, H|H Subunit, Ferritin|Light Chain, Ferritin|L Ferritin|H-Ferritin|Ferritin L Subunit"
NEW01348,BIOCHEMICAL,effective drug treatment,effective drug treatment
NEW10384,DISEASE,combined tbi,combined TBI
NEW10386,MENTAL_HEALTH,asperger 's autism study,Asperger's autism study
NEW10387,DISEASE,syndrome/high function autism,syndrome/high functioning autism
D010840,CHEMICAL,Phytosterols,"Steroid, Plant|Sterol, Plant|Plant Steroid|Plant Steroids|phytosterols|Phytosteroids|Plant Sterol|Phytosteroid|Sterols, Plant|Plant Sterols|Steroids, Plant|Phytosterol"
D064429,NUTRITION,Fatty Acid Synthases,"Fatty Acid Synthase|Acid Synthase, Fatty|Synthetases, Fatty Acid|fatty acid|Acid Synthases, Fatty|Fatty Acid Synthetases|Synthase, Fatty Acid"
D050603,CHEMICAL,Squalene Monooxygenase,"Squalene Epoxidase|squalene|Monooxygenase, Squalene|Epoxidase, Squalene|Squalene Monooxygenase (2,3-Epoxidizing)"
NEW10393,CHEMICAL,3-hydroxy-3methyl glutaryl coenzyme a reductase,3-hydroxy-3methyl glutaryl Coenzyme A reductase
D051779,CHEMICAL,Sterol Regulatory Element Binding Proteins,"SREBP Proteins|Sterol Regulatory Element Binding Protein|sterol regulatory element binding proteins|Protein, SREBP|SREBP Protein"
D060492,NUTRITION,Low Density Lipoprotein Receptor-Related Protein-5,Low Density Lipoprotein Receptor-Related Protein 5|Lipoprotein Receptor Related Protein 5|low density lipoprotein receptor|Lipoprotein Receptor-Related Protein 5|Low Density Lipoprotein Receptor Related Protein 5
NEW06777,NUTRITION,cholesterol metabolism,cholesterol metabolism
NEW10396,BIOCHEMICAL,trkb agonist,TrkB agonist
C571746,BIOCHEMICAL,alpha-tocotrienol quinone [Supplementary Concept],Ubiquinone/analogs  and  derivatives|alpha- tocotrienol
C082089,BIOCHEMICAL,"tocotrienol, beta [Supplementary Concept]",beta-tocotrienol|Vitamin E/analogs  and  derivatives
NEW10398,DISEASE,volume overload,Volume overload
D012652,DISEASE,Self Mutilation,"Mutilation, Self|Self Mutilating Behavior|Autotomy Humans|Self Mutilating Behaviors|Autotomy Human|Mutilating Behavior, Self|self-mutilation|Behavior, Self Mutilating"
NEW10402,CHEMICAL,ooeo administration,OOEO administration
D055646,NUTRITION,"Killer Factors, Yeast","Factors, Yeast Killer|Killer Toxin, Yeast|yeast|Yeast Killer Factor|Killer Factor, Yeast|Factor, Yeast Killer|Yeast Killer Toxin|Yeast Killer Factors|Toxin, Yeast Killer"
NEW10403,MENTAL_HEALTH,salvage resistance,salvage resistance
NEW10404,DISEASE,drug-resistant mycobacterium tuberculosis isolate,drug-resistant Mycobacterium tuberculosis isolates
NEW10407,CHEMICAL,nicotinic acid derivative bgp-15,nicotinic acid derivative BGP-15
http://purl.obolibrary.org/obo/CHEBI_35875,CHEMICAL,imidazopyrimidine,(3-piperidine-2-hydroxy-1-propyl)-nicotinic amidoxime
D002389,DISEASE,Catatonia,"Catatonias|Organic Catatonic Disorder|Catatonias, Malignant|Catatonic Disorders, Organic|Schizophreniform Catatonia|Organic Catatonic Disorders|Catatonia, Schizophreniform|Catatonias, Schizophreniform|Lethal Catatonias|Catatonias, Organic|Catatonic Disorder, Organic|Catatonia, Malignant|Catatonia|Organic Catatonia|Organic Catatonias|Catatonia, Lethal|Malignant Catatonia|Malignant Catatonias|Catatonia, Organic|Catatonias, Lethal|Schizophreniform Catatonias|Lethal Catatonia"
NEW10409,DISEASE,relative deficiency,relative deficiency
C047182,CHEMICAL,3-hydroxynortropane-8-spiro-1'-pyrrolidinium [Supplementary Concept],trospium|Nortropanes
NEW10412,CHEMICAL,gabaergic benzodiazepine,clonazepam|GABAergic benzodiazepines
NEW10413,CHEMICAL,photosensitizer hypericin,photosensitizers hypericin
C029752,NUTRITION,branched-chain amino acid-binding proteins [Supplementary Concept],branched chain amino acid|Carrier Proteins
NEW10418,BIOCHEMICAL,alpha-adrenergic blocker,alpha-adrenergic blocker
D010643,CHEMICAL,Phenoxybenzamine,"Phenoxybenzamine Hydrochloride|Dibenylene|Dibenzyline|Dibenziran|Dibenyline|phenoxybenzamine|Dibenzylin|Dibenzyran|Hydrochloride, Phenoxybenzamine"
NEW10421,DISEASE,neurogenic bladder dysfunction,neurogenic bladder dysfunction
D053202,DISEASE,"Urinary Incontinence, Urge","Incontinence, Urinary Reflex|Urinary Reflex Incontinence|Urinary Urge Incontinence|incontinence|Incontinence, Urge|Urge Incontinence"
NEW10422,BIOCHEMICAL,alpha-adrenoceptor agonist phenylpropanolamine,alpha-adrenoceptor agonist phenylpropanolamine
NEW10423,BIOCHEMICAL,alpha 1-adrenoceptor antagonist,Alpha 1-Adrenoceptor antagonists
D010656,CHEMICAL,Phenylephrine,"Neo-Synephrine|Metaoxedrin|(R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol|Phenylephrine Tannate|Tannate, Phenylephrine|Neo Synephrine|phenylephrine|Metasympatol|Mezaton|Neosynephrine|Phenylephrine Hydrochloride"
http://purl.obolibrary.org/obo/CHEBI_37890,BIOCHEMICAL,alpha-adrenergic antagonist,alpha-adrenergic blocker|alpha-adrenoceptor antagonists|alpha-adrenergic blockers|alpha-adrenergic receptor blockaders|alpha-adrenergic antagonists
NEW10426,CHEMICAL,withdrawal phentolamine,Withdrawal phentolamine
NEW10427,CHEMICAL,elevated systemic bilirubin concentration,elevated systemic bilirubin concentrations
D005878,DISEASE,Gilbert Disease,"Meulengracht Syndrome|Hyperbilirubinemia, Arias Type|Gilbert-Lereboullet Syndrome|Familial Nonhemolytic Jaundice|Gilbert's Disease|Gilbert's Syndrome|Gilberts Syndrome|Syndrome, Gilbert|Unconjugated Benign Bilirubinemia|Hyperbilirubinemia I|Gilbert syndrome|Gilbert Syndrome|Constitutional Liver Dysfunction|Arias Type Hyperbilirubinemia|Arias Type Hyperbilirubinemias|Hyperbilirubinemia 1s|Disease, Gilbert|Disease, Gilbert's|Hyperbilirubinemias, Arias Type|Gilberts Disease|Syndrome, Gilbert's|Hyperbilirubinemia 1"
http://purl.obolibrary.org/obo/DOID_9352,DISEASE,type 2 diabetes mellitus,NIDDM|type 2 diabetes|insulin resistance|non-insulin-dependent diabetes mellitus|type II diabetes mellitus|type diabetes mellitus
NEW10429,CHEMICAL,high lactate level,high lactate levels
NEW10433,CHEMICAL,high benzene concentration,high benzene concentrations
NEW10435,DISEASE,parkinsonian feature,parkinsonian features
NEW10436,DISEASE,hypocalcemia secondary,hypocalcemia secondary
NEW10441,NUTRITION,low folate,low folate
NEW10443,BIOCHEMICAL,low-activity comt met158 variant carrier,low-activity COMT Met158 variant carriers
NEW00706,CHEMICAL,mph efficacy,MPH efficacy
D013262,DISEASE,Stevens-Johnson Syndrome,"Drug-Induced Stevens-Johnson Syndromes|Lyell's Syndrome|Toxic Epidermal Necrolysis Stevens Johnson Syndrome|Drug Induced Stevens Johnson Syndrome|Stevens-Johnson Syndromes, Drug-Induced|Drug-Induced Stevens Johnson Syndrome|Toxic Epidermal Necrolysis Stevens Johnson Syndrome Spectrum|Toxic Epidermal Necrolyses|Toxic epidermal necrolysis|Stevens Johnson Syndrome|Mycoplasma-Induced Stevens-Johnson Syndrome|Stevens-Johnson Syndrome, Drug-Induced|Nonstaphylococcal Scalded Skin Syndrome|Mycoplasma Induced Stevens Johnson Syndrome|Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum|Stevens Johnson Syndrome Toxic Epidermal Necrolysis|Epidermal Necrolysis, Toxic|Mycoplasma-Induced Stevens Johnson Syndrome|Necrolysis, Toxic Epidermal|Toxic Epidermal Necrolysis Stevens-Johnson Syndrome Spectrum|Drug-Induced Stevens-Johnson Syndrome|Epidermal Necrolyses, Toxic|Toxic Epidermal Necrolysis|Lyell Syndrome|Scalded Skin Syndrome, Nonstaphylococcal|Stevens Johnson Syndrome Toxic Epidermal Necrolysis Spectrum|Syndrome, Mycoplasma-Induced Stevens-Johnson|Stevens-Johnson Syndrome Toxic Epidermal Necrolysis|Lyell's Syndromes|Stevens-Johnson Syndrome, Mycoplasma-Induced|Syndrome, Lyell's|Syndromes, Lyell's|Toxic Epidermal Necrolysis Stevens-Johnson Syndrome|Necrolyses, Toxic Epidermal"
NEW10444,DISEASE,adverse cutaneous drug reaction,adverse cutaneous drug reactions
NEW10447,CHEMICAL,Carphedon,Carphedon
NEW10449,MENTAL_HEALTH,dimer inos dissociation,dimer iNOS dissociation
NEW10451,CHEMICAL,μm hocl,μM HOCl
NEW10452,CHEMICAL,melatonin supplementation,Melatonin supplementation
NEW10457,CHEMICAL,gsh redox ratio,GSH redox ratio
NEW10460,CHEMICAL,acid metabolic pathway,acids metabolic pathways
http://purl.obolibrary.org/obo/NCBITaxon_8030,NUTRITION,salmo salar,trout Salmo trutta
NEW10464,NUTRITION,winter cherry plant,winter cherry plant
NEW10466,DISEASE,autosomal dominant elovl4 mutation,autosomal dominant ELOVL4 mutations
NEW10467,MENTAL_HEALTH,cerebral resistance arteriole,cerebral resistance arterioles
NEW10469,CHEMICAL,synthetic thc dronabinol,synthetic THC dronabinol
D000086,CHEMICAL,Acetazolamide,"Diuramide|Ak Zol|Glaupax|HumaZolamide|ApoAcetazolamide|Diacarb|Huma Zolamide|Défiltran|Edemox|Glauconox|Huma-Zolamide|Acetadiazol|Ak-Zol|Acetazolam|Apo-Acetazolamide|Apo Acetazolamide|acetazolamide|AkZol|Acetazolamide Sodium, (Sterile)|Acetazolamide, Monosodium Salt|Diamox"
D012509,DISEASE,Sarcoma,"soft tissue sarcomas|Sarcomas, Spindle Cell|Sarcoma, Spindle Cell|Epithelioid Sarcomas|Sarcomas|Soft Tissue Sarcomas|Sarcomas, Epithelioid|Sarcomas, Soft Tissue|Epithelioid Sarcoma|Spindle Cell Sarcomas|Sarcoma, Soft Tissue|Soft Tissue Sarcoma|Sarcoma, Epithelioid|Spindle Cell Sarcoma"
D008727,CHEMICAL,Methotrexate,"Amethopterin|Methotrexate, (D)-Isomer|Sodium, Methotrexate|Mexate|Methotrexate|Methotrexate Hydrate|Methotrexate, Dicesium Salt|MTX|Hydrate, Methotrexate|Dicesium Salt Methotrexate|Methotrexate Sodium|Methotrexate, Disodium Salt|Methotrexate, Sodium Salt|Methotrexate, (DL)-Isomer"
NEW10474,BIOCHEMICAL,somatotrophic hormone,somatotrophic hormone
NEW10477,BIOCHEMICAL,n-methyl-d-aspartate receptor antagonist magnesium sulfate,N-methyl-D-aspartate receptor antagonist magnesium sulfate
D009494,DISEASE,Neurosyphilis,"Neurosyphilis, Secondary|Neurosyphilis, Asymptomatic|Neurosyphilis, Symptomatic|Central Nervous System Syphilis|Secondary Neurosyphilis|General Paresis|General Paresis of the Insane|Neurosyphilis, Juvenile|Juvenile Paresis|neurosyphilis|Paretic Neurosyphilis|Paralysis, General|Syphilis, Central Nervous System|General Paralysis|Neurosyphilis, Gummatous|General Paralysis of the Insane|Syphilis, CNS"
NEW10479,MENTAL_HEALTH,narcolepsy type incidence,Narcolepsy type incidence
NEW10483,CHEMICAL,"brain d2 3,4-dihydroxyphenylethylamine","dopamine|brain D2 3,4-dihydroxyphenylethylamine"
NEW10484,BIOCHEMICAL,d1 receptor agonist,D1 receptor agonists
NEW00720,DISEASE,parkinsonian patient,parkinsonian patients
NEW10486,DISEASE,initial dose p. odocoilei,initial dose P. odocoilei
NEW10487,CHEMICAL,angiotensin converting enzyme ace inhibitor,angiotensin converting enzyme ACE inhibitors
NEW10489,BIOCHEMICAL,non-vitamin k antagonist oral anticoagulant noac drug,Non-vitamin K antagonist oral anticoagulant NOAC drugs
NEW10490,DISEASE,ischemic stroke prevention,ischemic stroke prevention
NEW10491,CHEMICAL,poly(I c challenge,poly(I C challenge
NEW10493,BIOCHEMICAL,antiviral defense mechanism,antiviral defense mechanism
NEW10495,CHEMICAL,nmda receptor activation,NMDA receptor activation
NEW10500,CHEMICAL,prolonged etoh exposure,Prolonged EtOH exposure
NEW10501,CHEMICAL,gas homeostatic change,gas homeostatic changes
http://purl.obolibrary.org/obo/CHEBI_26349,CHEMICAL,proteochondroitin sulfate,p-cresyl sulfate
D000072458,MENTAL_HEALTH,"Orientation, Spatial","Spatial Orientations|Orientations, Spatial|spatial orientation|Spatial Orientation"
NEW10505,DISEASE,cardiovascular comorbiditie,cardiovascular comorbidities
NEW10506,CHEMICAL,active oxybate moiety,active oxybate moiety
NEW10509,BIOCHEMICAL,flexible dopamine reuptake inhibitor,flexible dopamine reuptake inhibitor
NEW10510,CHEMICAL,hf/6 31g(d level,HF/6 31G(d levels
NEW10512,DISEASE,molecular orbital calculation,Molecular orbital calculations
NEW10513,BIOCHEMICAL,indirect agonist therapy,indirect agonist therapy
NEW10514,DISEASE,cholestatic pruritus,cholestatic pruritus
NEW10516,DISEASE,itch pathophysiology,itch pathophysiology
NEW10518,MENTAL_HEALTH,collision-induced dissociation,Collision-induced dissociation
NEW10520,CHEMICAL,human adenosine receptor,human adenosine receptors
NEW10523,CHEMICAL,3-(2-pyridinyl)isoquinoline derivative,3-(2-pyridinyl)isoquinoline derivatives
D000584,CHEMICAL,Amiloride,"Amiduret Trom|Amidal|Midoride|Anhydrous Amiloride Hydrochloride|Trom, Amiduret|Hydrochloride, Anhydrous Amiloride|Amiloberag|Midamor|Hydrochloride, Amiloride|Kaluril|Modamide|Amiloride Hydrochloride, Anhydrous|amiloride|Amiloride Hydrochloride"
NEW10524,CHEMICAL,biphosphonate,biphosphonates
NEW10525,CHEMICAL,one central,one central|moxonidine
http://purl.obolibrary.org/obo/CHEBI_66991,BIOCHEMICAL,sympatholytic agent,sympatholytics|Centrally-acting sympatholytic agents|sympatholytic agents|sympatholytic|sympatholytic drugs|sympatholytic drug
NEW10528,DISEASE,nocturnal pd model,nocturnal PD models
NEW10529,CHEMICAL,modafinil co-administration,modafinil co-administration
C008842,CHEMICAL,4-amino-3-phenylbutyric acid [Supplementary Concept],Phenibut|gamma-Aminobutyric Acid/analogs  and  derivatives
NEW10534,BIOCHEMICAL,fda-approved drug memantine,FDA-approved drug memantine
D000077443,CHEMICAL,Acamprosate,"N-Acetylhomotaurine|N-Acetylhomotaurine, Zinc (2:1) Salt|N-Acetylhomotaurine, Magnesium (2:1) Salt|Calcium Acetylhomotaurinate|N Acetylhomotaurine, Monopotassium Salt|N Acetylhomotaurine, Monolithium Salt|Calcium Acetylhomotaurine|Acamprosate Calcium|N-Acetylhomotaurine, Calcium (2:1) Salt|N Acetylhomotaurine|N-Acetylhomotaurine, Monopotassium Salt|N Acetylhomotaurine, Monosodium Salt|Aotal|Sodium Acetylhomotaurine|N-Acetylhomotaurine, Monolithium Salt|Zulex|Acetylhomotaurinate, Calcium|Acetylhomotaurine, Sodium|Campral|Acamprostate|Calcium Acetyl Homotaurinate|Acamprosate|Campral EC|N-Acetylhomotaurine, Monosodium Salt|Acetylhomotaurine, Calcium|Acetyl Homotaurinate, Calcium|Regtect"
NEW10538,CHEMICAL,propofol anesthesia,propofol anesthesia
NEW10542,BIOCHEMICAL,neoantigen neoag peptide,Neoantigen NeoAg peptides
NEW10546,CHEMICAL,lowered atp production,lowered ATP production
C053737,CHEMICAL,loxiglumide [Supplementary Concept],Proglumide/analogs  and  derivatives|loxiglumide
NEW03552,CHEMICAL,antidepressant effect,antidepressant effect
NEW10548,CHEMICAL,antiphospholipid,Antiphospholipids|aPLAs
NEW10550,CHEMICAL,cholinergic-dopaminergic-serotinergic balance,cholinergic-dopaminergic-serotinergic balance
C442200,CHEMICAL,"9,10-dehydroepothilone D [Supplementary Concept]",Epothilone D|Epothilones
NEW00231,MENTAL_HEALTH,apoptotic dna fragmentation,apoptotic DNA fragmentation
http://purl.obolibrary.org/obo/CHEBI_59229,BIOCHEMICAL,gnrh antagonist,gonadotrophin-releasing hormone antagonists|GnRH antagonists|GnRH antagonist|gonadotrophin-releasing hormone antagonist
NEW10552,BIOCHEMICAL,estrogen withdrawal,Estrogen withdrawal
NEW10555,CHEMICAL,natural glucocorticoid hydrocortisone,Natural glucocorticoid hydrocortisone
NEW10556,BIOCHEMICAL,hormone treatment,Hormone treatment
NEW10561,BIOCHEMICAL,dietary folic acid augmentation,Dietary folic acid augmentation
NEW10563,BIOCHEMICAL,excess maternal folic acid fortification,Excess maternal folic acid fortification
NEW10564,DISEASE,stroke-prone hypertensive rat,stroke-prone hypertensive rats
NEW10566,DISEASE,ad/hd animal model,AD/HD animal model
NEW10567,CHEMICAL,d-serine/d-serine,D-serine/D-serine
D006624,CHEMICAL,Hippocampus,"Collaterals, Schaffer|Formations, Hippocampal|Ammon Horn|Cornu Ammonis|Hippocampal Formation|Horn, Ammon|hippocampus|Hippocampal Formations|Propers, Hippocampus|HIP|Horn, Ammon's|Ammon's Horn|Ammons Horn|Subiculum|Collateral, Schaffer|Schaffer Collateral|Schaffer Collaterals|Formation, Hippocampal|Proper, Hippocampus|Subiculums|Hippocampus Propers|Hippocampus Proper"
D020303,DISEASE,"Rats, Inbred Dahl","Salt-Sensitive Rats, Dahl|Hypertensive Rats, Dahl|Rats, Dahl Hypertensive|Dahl Salt-Resistant Rats|hypertensive rats|Inbred Dahl Rats|Dahl Salt-Sensitive Rats|Rats, Dahl Salt-Resistant|Dahl Salt Sensitive Rats|Rat, Dahl|Dahl Rat|Dahl Salt-Sensitive Rat|Salt-Resistant Rats, Dahl|Dahl Hypertensive Rats|Dahl Salt Resistant Rats|SHRSP/Ezo|Dahl Rats, Inbred|Rats, Dahl|Rats, Dahl Salt-Sensitive|Dahl Rats|Rat, Dahl Salt-Sensitive|Salt-Sensitive Rat, Dahl|Dahl Salt Sensitive Rat"
http://purl.obolibrary.org/obo/CHEBI_167633,CHEMICAL,cpsf3 inhibitor,DAAO inhibitor|CPSF-73 inhibitors|cleavage and polyadenylation specificity factor subunit 3 inhibitor|CPSF73 inhibitor|CPSF73 inhibitors|cleavage and polyadenylation specificity factor subunit 3 inhibitors|CPSF-73 inhibitor|CPSF3 inhibitors|cleavage and polyadenylation specific factor 3 inhibitor|cleavage and polyadenylation specificity factor 73 KDa subunit inhibitors|cleavage and polyadenylation specific factor 3 inhibitors|cleavage and polyadenylation specificity factor 73 KDa subunit inhibitor
http://purl.obolibrary.org/obo/GO_0007610,CHEMICAL,behavior,AD/HD-like behaviors
NEW10569,CHEMICAL,major pl class,major PL classes
NEW10570,CHEMICAL,monounsaturated fatty acid-containing phosphatidylcholine,monounsaturated fatty acid-containing phosphatidylcholine
NEW10573,MENTAL_HEALTH,equilibrium dissociation constant,Equilibrium dissociation constants
NEW10575,BIOCHEMICAL,synthetic inverse agonist,synthetic inverse agonists
NEW10576,MENTAL_HEALTH,basal repression,basal repression
NEW10578,NUTRITION,California bobwhite quail lysozyme,California bobwhite quail lysozymes
NEW10580,CHEMICAL,deficient acmsd activity,deficient ACMSD activity
NEW10581,MENTAL_HEALTH,suicide attempter,Suicide attempters
NEW10583,CHEMICAL,SNP rs2121337,SNP rs2121337
http://purl.obolibrary.org/obo/CHEBI_10211,CHEMICAL,alpha-aminoadipoyl-s-acyl enzyme,alpha-Aminoadipoyl-S-acyl enzyme|Aminoadip.-S|ACMSD|enzyme amino-β-carboxymuconate-semialdehyde-decarboxylase
http://purl.obolibrary.org/obo/CHEBI_176811,CHEMICAL,8-methyl nonanoic acid,8-methylnonanoic acid|5-trimethoxy cinnamic acid|TMCA
NEW10587,DISEASE,major disturbance,major disturbance
D062145,CHEMICAL,Maternal Serum Screening Tests,testosterone|Maternal Serum Triple Test|serum
NEW10589,DISEASE,neurotoxic metabolite quinolinic acid,neurotoxic metabolite quinolinic acid
NEW10592,CHEMICAL,naringin supplementation,naringin supplementation
NEW10595,BIOCHEMICAL,lycopene treatment,lycopene treatment
NEW10599,CHEMICAL,extended-release naltrexone,Extended-release naltrexone
NEW10600,CHEMICAL,daily oral naltrexone tablet,daily oral naltrexone tablets
NEW10601,CHEMICAL,alcohol relapse,Alcohol relapse
NEW10605,CHEMICAL,alginate coat,Alginate coating
NEW10606,DISEASE,significant hypoglycemic effect,significant hypoglycemic effect
NEW10608,NUTRITION,yeast saccharomyces cerevisiae,yeast Saccharomyces cerevisiae
D061986,CHEMICAL,MCF-7 Cells,"Cell, MCF-7|MCF7 Cell|MCF-7 Cell|MCF7 Cells|Cells, MCF-7|Michigan Cancer Foundation 7 Cells|MCF 7 Cells|Cells, MCF7|MCF-7 cells|Cell, MCF7"
NEW10612,DISEASE,autistic behaviour,autistic behaviour
NEW10614,CHEMICAL,abnormal gaba production,abnormal GABA production
NEW10616,DISEASE,excessive sleep disorder,excessive sleep disorders
http://purl.obolibrary.org/obo/CHEBI_188583,CHEMICAL,indiplon,"Ramelteon Z-drugs|N-methyl-N-[3-[3-(thiophene-2-carbonyl)pyrazolo[1,5-a]pyrimidin-7-yl]phenyl]acetamide"
NEW10619,DISEASE,allergic angioedema,Allergic angioedema
C096997,CHEMICAL,histidine N-acetyltransferase [Supplementary Concept],Acetyltransferases|L-Histidine
NEW10164,BIOCHEMICAL,second compound,antagonist|second compound
NEW10622,CHEMICAL,serotonin-norepinephrine reuptake inhibitor,Serotonin-norepinephrine reuptake inhibitors
NEW10623,CHEMICAL,dopamine-norepinephrine reuptake inhibitor bupropion,dopamine-norepinephrine reuptake inhibitor bupropion
NEW10624,CHEMICAL,norepinephrine-serotonin modulator,norepinephrine-serotonin modulators
NEW08768,DISEASE,hypertensive crisis,hypertensive crisis
D013494,DISEASE,"Supranuclear Palsy, Progressive","Progressive Supranuclear Palsies|Richardson Syndrome|Steele-Richardson-Olszewski Disease|Steele Richardson Olszewski Syndrome|Steele-Richardson-Olszewski Syndrome|Progressive Supranuclear Palsy 1|Supranuclear Ophthalmoplegia, Progressive|Ophthalmoplegia, Progressive Supranuclear|progressive supranuclear palsy|Progressive Supranuclear Ophthalmoplegia|Richardson's Syndrome|Palsy, Progressive Supranuclear|Steele Richardson Olszewski Disease|Supranuclear Palsy, Progressive, 1|Supranuclear Palsies, Progressive|Progressive Supranuclear Palsy|PSP"
NEW10627,CHEMICAL,AcMYB123,AcMYB123
NEW10629,MENTAL_HEALTH,rna interference repression,RNA interference repression
C082748,CHEMICAL,epibatidine [Supplementary Concept],"Bridged Bicyclo Compounds, Heterocyclic|Pyridines|epibatidine"
NEW10632,CHEMICAL,5-iodo-a-85380,A-85380|5-iodo-A-85380
NEW10266,DISEASE,amenable,psychiatric disorders|amenable
C484549,CHEMICAL,"SLC33A1 protein, human [Supplementary Concept]",AT(1|Membrane Transport Proteins
NEW10640,CHEMICAL,sex steroid deficiency,sex steroid deficiency
NEW10643,CHEMICAL,adenosine receptor ligand,adenosine receptor ligands
NEW10648,BIOCHEMICAL,oral antibiotic,oral antibiotics
NEW10650,MENTAL_HEALTH,catecholaminergic hyperactivity,catecholaminergic hyperactivity
NEW10652,BIOCHEMICAL,serum antioxidant vitamin,Serum antioxidant vitamins
D013011,CHEMICAL,Sorbic Acid,"Propenylacrylic Acid|Hexadienoic Acid|sorbic acid|Sorbate, Sodium|Sodium Sorbate|Acid, Propenylacrylic|Acid, Hexadienoic|Sorbate, Potassium|Acid, Sorbic|Potassium Sorbate"
D013406,MENTAL_HEALTH,"Suicide, Attempted","Attempt, Suicide|Parasuicides|Attempted Suicide|Parasuicide|Suicide Attempt|suicide attempt"
C117359,CHEMICAL,P-glycoprotein 2 [Supplementary Concept],"P-glycoprotein|ATP Binding Cassette Transporter, Subfamily B"
NEW10660,CHEMICAL,two-year fluoxetine administration,Two-year fluoxetine administration
C101425,CHEMICAL,posaconazole [Supplementary Concept],Triazoles|posaconazole
NEW10663,CHEMICAL,dopamine d1 receptor agent,dopamine D1 receptor agents
NEW10664,BIOCHEMICAL,micromolar canthaxanthin,micromolar canthaxanthin
NEW10667,BIOCHEMICAL,epsilon carrier status,epsilon carrier status
NEW10668,CHEMICAL,dopamine hypofunction,dopamine hypofunction
NEW10672,CHEMICAL,cgj,CGJ
NEW10673,CHEMICAL,animal tissue-derived gelatin,animal tissue-derived gelatins
NEW10675,CHEMICAL,pica::lacz fusion,picA::lacZ fusion
D058607,CHEMICAL,Fibric Acids,"Fibrates|2 Phenoxy Isobutyric Acids|Acid Derivatives, Fibric|2-Phenoxy-2-Methylpropionic Acid Derivatives|fibrates|Methyl 2 Phenoxypropanoic Acid Derivatives|Methyl-2-Phenoxypropanoic Acid Derivatives|2-Phenoxy Isobutyric Acids|Fibrate|2 Phenoxy 2 Methylpropionic Acid Derivatives|Fibric Acid Derivatives|Isobutyric Acids, 2-Phenoxy"
NEW10678,BIOCHEMICAL,peroxiproliferator-activated receptor-delta agonist,peroxiproliferator-activated receptor-delta agonists
NEW10680,MENTAL_HEALTH,erectile dysfunction drug,erectile dysfunction drugs
D001919,DISEASE,Bradycardia,Bradycardias|bradyarrhythmias|Bradyarrhythmia|Bradyarrhythmias
D006963,DISEASE,Hyperphagia,Polyphagia|Polyphagias|hyperphagia|Overeating
http://purl.obolibrary.org/obo/CHEBI_86029,BIOCHEMICAL,liver x receptor agonist,liver X receptor agonists|Selective liver X receptor agonists|LXR agonist|LXR agonists
NEW10686,BIOCHEMICAL,specific lxr agonist,specific LXR agonist
NEW10687,CHEMICAL,transient outward potassium current,transient outward potassium current
NEW10688,DISEASE,malignant ventricular arrhythmia,malignant ventricular arrhythmias
NEW04926,CHEMICAL,propranolol therapy,propranolol therapy
NEW10690,CHEMICAL,propranolol treatment,propranolol treatment
NEW10693,BIOCHEMICAL,dietary sweetener,dietary sweetener
NEW10695,CHEMICAL,non-invasive l. plant,non-invasive L. plants
NEW10697,DISEASE,studied-the invasive lupinus polyphyllus Lindl,studied-the invasive Lupinus polyphyllus Lindl
NEW10698,CHEMICAL,prolactin/prlr antibody,prolactin/PRLR antibodies
NEW10700,CHEMICAL,agent atropine,agents atropine
D008916,BIOCHEMICAL,Miotics,"miotics|Miotic Effect|Effect, Miotic|Miotic Effects|Effects, Miotic"
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Nicotine_Withdrawal,CHEMICAL,nicotine withdrawal,nicotine withdrawal
NEW10706,DISEASE,chronic viral Illness Service,Chronic Viral Illness Service
NEW10709,DISEASE,hypercytokinaemia,hypercytokinaemia
D000309,DISEASE,Adrenal Insufficiency,"Adrenal Gland Hypofunction|Adrenal insufficiency|Hypoadrenalism|Hypofunction, Adrenal Gland|Adrenal Insufficiencies"
NEW10713,DISEASE,emotional abnormality,emotional abnormality
NEW10714,DISEASE,human-like bile acid composition,human-like bile acid composition
NEW10716,BIOCHEMICAL,steroidal ba-like fxr agonist,steroidal BA-like FXR agonist
C464660,CHEMICAL,obeticholic acid [Supplementary Concept],Chenodeoxycholic Acid/analogs  and  derivatives|Obeticholic acid
D007024,DISEASE,"Hypotension, Orthostatic","postural hypotension|Postural Hypotension|Orthostatic Hypotension|Hypotension, Postural"
NEW10720,BIOCHEMICAL,dietary vitamin b12,dietary vitamin B12
NEW10723,BIOCHEMICAL,vitamin b12 supplementation,Vitamin B12 supplementation
D014227,CHEMICAL,Triazines,triazines|Benzotriazines|Triazine
D014366,NUTRITION,Tryptophan Oxygenase,"Oxygenase, Tryptophan|2,3-Dioxygenase, Tryptophan|Dioxygenase, TDO|Tryptophan Pyrrolase|tryptophan 2,3-dioxygenase|Tryptophan 2,3-Dioxygenase|TDO Dioxygenase|Tryptophan 2,3 Dioxygenase|Pyrrolase, Tryptophan"
D011908,MENTAL_HEALTH,Rationalization,rationalization
NEW10731,MENTAL_HEALTH,opiate abstinence syndrome,opiate abstinence syndrome
D019900,CHEMICAL,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer","U 50488|U50,488H|3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(+-)-Isomer|3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monohydrochloride, (trans)-(+-)-Isomer,|U-50,488H|U-50488|U50488|U 50488H|trans-3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide|3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monomethanesulfonate, (trans)-Isomer|trans-3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide Hydrochloride|3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(-)-Isomer|U 50,488H|U-50488H|3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monomethanesulfonate, (trans)-(+-)-Isomer|3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Mesylate, (trans)-(+)-Isomer|U50488H|3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monomethanesulfonate, (trans)-(+)-Isomer|3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (1S-cis)-Isomer|Benzeneacetamide, 3,4-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-, (trans)-Isomer|3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Mesylate, (trans)-(+-)-Isomer|3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (1R-cis)-Isomer"
D050499,DISEASE,Adrenarche,"Adrenal Glands (1973-2005)|Adrenarche|Puberty, Precocious (1966-2005)"
NEW10735,BIOCHEMICAL,adrenarchal androgen,Adrenarchal androgens
NEW10737,DISEASE,premature adrenarche,Premature adrenarche
D033022,CHEMICAL,Vicia sativa,"Vetchs, Common|Vicia sativas|Common Vetchs|Common Vetch|sativa, Vicia|Vetch, Common|sativa"
NEW10739,BIOCHEMICAL,several psychotropic drug class,Several psychotropic drug classes
NEW10740,DISEASE,lv infection,LV infection
D004295,CHEMICAL,Dihydroxyphenylalanine,"3-Hydroxy-DL-tyrosine|beta Hydroxytyrosine|3,4-Dihydroxyphenylalanine|beta-Hydroxytyrosine|L-dopa|Dihydroxyphenylalanine Hydrochloride, (2:1)|3,4-dihydroxyphenylalanine|3,4 Dihydroxyphenylalanine|Dopa|3 Hydroxy DL tyrosine"
NEW10742,CHEMICAL,low ly303870,low LY303870
NEW10743,CHEMICAL,low sp receptor antagonist,low SP receptor antagonists
C096759,CHEMICAL,1-(N-(2-methoxybenzyl)acetylamino)-3-(1H-indol-3-yl)-2-(N-(2-(4-(piperidin-1-yl)piperidin-1-yl)acetyl)amino)propane [Supplementary Concept],LY303870|Piperidines|Indoles
D065809,DISEASE,Respiratory Sinus Arrhythmia,"Sinus Arrhythmia, Respiratory|Arrhythmia, Respiratory Sinus|arrhythmia"
NEW10745,DISEASE,lung edema clearance,lung edema clearance
NEW10746,DISEASE,edema clearance,edema clearance
NEW10750,DISEASE,neurotoxic process,Neurotoxic processes
NEW10753,DISEASE,patient 's seizure,patient's seizures
C004651,CHEMICAL,dipropylacetamide [Supplementary Concept],VPD|Valproic Acid/analogs  and  derivatives|Valpromide
NEW10755,CHEMICAL,valproate blood concentration,Valproate blood concentration
NEW10756,NUTRITION,integument enriched fatty acid elongase gene,integument enriched fatty acid elongase gene
D010937,BIOCHEMICAL,Plant Growth Regulators,"Plant Hormones|Phytohormone|Regulator, Plant Growth|Plant Hormone|Hormone, Plant|Growth Regulators, Plant|Plant Growth Regulator|Regulators, Plant Growth|Hormones, Plant|Phytohormones|Growth Regulator, Plant|phytohormones"
NEW10758,DISEASE,oral allergy syndrome,Oral allergy syndrome
NEW10761,BIOCHEMICAL,dopamine receptor agonist drug,Dopamine receptor agonist drugs
NEW10762,CHEMICAL,edema dopamine agonist,edema dopamine agonists
D008939,CHEMICAL,Mitotane,"Lysodren|ortho,para DDD|Chloditan|ortho,para-DDD|o,p-DDD|Mitotane|Mytotan|Chlodithane|Khloditan"
D005045,CHEMICAL,Etomidate,Etomidate|Hypnomidate|R 26490|R-26490|Radenarkon|R26490|Ethomidate
NEW10765,CHEMICAL,intracellular hydrogen peroxide,intracellular hydrogen peroxide
D006861,CHEMICAL,Hydrogen Peroxide,"Hydrogen Peroxide (H2O2)|Hydroperoxide|hydrogen peroxide|Peroxide, Hydrogen|Superoxol|H2O2|Oxydol|Perhydrol"
NEW10767,CHEMICAL,HLAB*15:02,HLAB*15:02
D000077209,CHEMICAL,Decitabine,"Dacogen|Decitabine|5-Aza-2'-deoxycytidine|2'-Deoxy-5-azacytidine|DAC|5 Aza 2' deoxycytidine|Decitabine Mesylate|5-AzadC|5AzadC|5-Deoxyazacytidine|NSC127716|5 Deoxyazacytidine|2' Deoxy 5 azacytidine|NSC 127716|NSC-127716|Compound, AzadC|Mesylate, Decitabine|5 Azadeoxycytidine|AzadC Compound|5-Azadeoxycytidine"
NEW10772,CHEMICAL,gaba synthesis,GABA synthesis
NEW10773,CHEMICAL,l-allyglycine,l-allyglycine
NEW10775,CHEMICAL,glutamate mechanism,glutamate mechanism
NEW10778,CHEMICAL,nalac challenge,NaLac challenge
NEW10781,CHEMICAL,nalac dose,NaLac dose
NEW10782,CHEMICAL,cbipes,CBiPES
NEW10783,CHEMICAL,chronic l-methionine administration,Chronic L-methionine administration
C094930,CHEMICAL,"arginine, L-methionine, zinc drug combination [Supplementary Concept]",Arginine|Methionine|L-methionine|Drug Combinations|Zinc
C034364,CHEMICAL,ozagrel [Supplementary Concept],ozagrel|Methacrylates
C117600,CHEMICAL,enterostatin receptor [Supplementary Concept],"Enterostatin|Receptors, Cell Surface|VPDPR"
NEW10786,CHEMICAL,intracavernosal injection,ICI|Intracavernosal injections
NEW10787,BIOCHEMICAL,female premutation carrier,Female premutation carriers
D031337,NUTRITION,Mentha spicata,"Mentha spicata|Spearmints|spicata, Mentha|Spearmint|Mentha spicatas"
NEW10789,DISEASE,primary hypoparathyroidism,Primary hypoparathyroidism
NEW10791,DISEASE,primary organic disorder,Primary organic disorders
NEW09059,CHEMICAL,free thyroxine,free thyroxine
NEW05230,DISEASE,depressive,depressives
NEW10795,BIOCHEMICAL,water-soluble vitamin e,water-soluble vitamin E
C550427,CHEMICAL,trolox-L-carnosine [Supplementary Concept],Carnosine/analogs  and  derivatives|Trolox
NEW10796,CHEMICAL,vilazodone poisoning,Vilazodone poisoning
D016267,MENTAL_HEALTH,External Fixators,"External Fixation Device|Fixation Devices, External|External Fixator|external fixation|Fixator, External|Devices, External Fixation|External Fixation Devices|Fixation Device, External|Fixators, External|Device, External Fixation"
D006620,DISEASE,Hip Fractures,"Intertrochanteric Fractures|Subtrochanteric Fractures|Fractures, Intertrochanteric|Trochanteric Fractures|Fractures, Subtrochanteric|Fractures, Trochanteric|intertrochanteric fractures|Fractures, Hip"
NEW10803,BIOCHEMICAL,s carrier,s carriers
NEW10805,CHEMICAL,gaba activity,GABA activity
http://purl.obolibrary.org/obo/CHEBI_51373,BIOCHEMICAL,gaba agonist,GABA agonists|gamma-aminobutyric acid receptor agonists|GABA receptor agonist|gamma-aminobutyric acid receptor agonist|GABA receptor agonists|selective GABA agonist
NEW10808,CHEMICAL,allopregnanalone,allopregnanalone
NEW10809,BIOCHEMICAL,antimicrobial efficacy,antimicrobial efficacy
NEW10811,BIOCHEMICAL,synergistic antimicrobial effect,synergistic antimicrobial effect
NEW10812,CHEMICAL,specific oxygen uptake rate,specific oxygen uptake rates
NEW10814,DISEASE,eps content,EPS contents
NEW10815,CHEMICAL,specific ammonium oxidation rate,specific ammonium oxidation rates
NEW10816,DISEASE,high osa risk,high OSA risk
NEW10819,CHEMICAL,serotonin pathway,serotonin pathways
NEW10820,CHEMICAL,quaternary tetramethylammonium tetrafluoroborate tma bf4 salt,quaternary tetramethylammonium tetrafluoroborate TMA BF4 salt
NEW10822,CHEMICAL,polyamide molecule,polyamide molecules
NEW10823,CHEMICAL,aliphatic polyamide nylon fibre,aliphatic polyamide nylon fibres
http://purl.obolibrary.org/obo/CHEBI_61950,BIOCHEMICAL,microtubule-stabilising agent,microtubule stabilizing role|microtubule stabilizing agents|microtubule stabilising role|microtubule stabilising agent|microtubule-stabilising agents|microtubule-stabilizing agent|microtubule stabilizing agent
NEW10824,CHEMICAL,natural epothilone b,natural epothilone B
C430592,CHEMICAL,ixabepilone [Supplementary Concept],Ixabepilone|Epothilones
D043823,CHEMICAL,Taxoids,Taxoid|Taxanes|taxanes
NEW10826,BIOCHEMICAL,microtubule stabilize agent,microtubule stabilizing agent
NEW10828,CHEMICAL,potent non-taxane microtubule,potent non-taxane microtubule
C093788,CHEMICAL,epothilone B [Supplementary Concept],epothilone B|Epothilones|Patupilone
D000072482,CHEMICAL,Retinoic Acid Receptor alpha,"alpha 1, RAR|Retinoic acid receptor|RAR alpha 1|RAR alpha 2|alpha 2, RAR|Retinoic Acid Receptor alpha 1|Retinoic Acid Receptor alpha 2"
NEW10830,MENTAL_HEALTH,hpa axis hyperactivity,HPA axis hyperactivity
C071721,CHEMICAL,Ro 41-0960 [Supplementary Concept],Ro41|Benzophenones
NEW10835,DISEASE,parkinson 's disease-model rat,Parkinson's disease-model rats
NEW10841,MENTAL_HEALTH,late-life depression,Late-life depression
NEW10843,BIOCHEMICAL,androgen receptor (ar)-regulated gene,androgen receptor (AR)-regulated genes
http://purl.obolibrary.org/obo/CHEBI_28121,CHEMICAL,harmine,"astragalosides|7-methoxy-1-methyl-9H-beta-carboline|Telepathine|Leucoharmine|CGA|7-methoxy-1-methyl-9H-pyrido[3,4-b]indole|Yageine|Banisterine|6-Methoxyharman|Harmine|Yajeine"
D011738,CHEMICAL,Pyrilamine,"Mepyramine Maleate|Pyranisamine|Boots Bite  and  Sting Relief|Mepyramine|Maleate, Mepyramine|Anthisan|mepyramine|Pyrilamine Maleate|Kriptin|Maleate, Pyrilamine"
NEW10847,CHEMICAL,extraneous carbon,extraneous carbon
NEW10849,CHEMICAL,pin2/terf1 interacting telomerase inhibitor,PIN2/TERF1 interacting telomerase inhibitor
D000077208,CHEMICAL,Remifentanil,Remifentanil Hydrochloride|remifentanil|3-(4-Methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic Acid Methyl Ester|Ultiva|GI87084B|GI-87084B|Remifentanil Monohydrochloride|GI 87084B
D003921,CHEMICAL,"Diabetes Mellitus, Experimental","Streptozocin Diabetes|Diabete, Streptozocin|Alloxan Diabetes|streptozotocin|Streptozotocin Diabetes|Experimental Diabetes Mellitus|Diabetes, Alloxan|Diabetes, Streptozotocin|Streptozocin Diabete|Diabetes, Streptozocin"
NEW10853,BIOCHEMICAL,"nonselective cb1/cb2 receptor agonist win55,212","nonselective CB1/CB2 receptor agonist WIN55,212"
D015082,CHEMICAL,"2,2'-Dipyridyl","Dipyridyl, 2,2|Dipyridyl, 2,2'|Bipyridyl|2,2 Dipyridyl|2,2 Bipyridyl|alpha,alpha Dipyridyl|2,2-Dipyridyl|2|WIN|2,2' Bipyridine|2,2'-Bipyridine|2,2-Bipyridyl|2,2 Bipyridine|2,2' Dipyridyl|2,2-Bipyridine|alpha,alpha-Dipyridyl"
NEW10855,CHEMICAL,nmda μg/rat,NMDA μg/rat
http://purl.obolibrary.org/obo/CHEBI_144132,CHEMICAL,caperatic acid,docosahexaenoic acid C22:6 n-3
NEW10856,DISEASE,dietary deficiency,Dietary deficiency
NEW10859,BIOCHEMICAL,sympatholytic medication,sympatholytic medications
NEW10863,CHEMICAL,preoperative gabapentin,Preoperative gabapentin
NEW10865,BIOCHEMICAL,dopaminergic agonist group,dopaminergic agonist group
NEW10866,CHEMICAL,peripheral a1 adenosine receptor signaling,Peripheral A1 adenosine receptor signaling
NEW10869,DISEASE,acute animal pain model,acute animal pain models
NEW10871,BIOCHEMICAL,combination antibacterial,Combination antibacterials
NEW10872,BIOCHEMICAL,antiandrogen cyproterone acetate,antiandrogen cyproterone acetate
D002613,DISEASE,Cheilitis,Cheilitides|Cheilitis
NEW10874,DISEASE,angular stomatitis,angular stomatitis
D002710,CHEMICAL,Chlorhexidine,"Novalsan|MK412A|MK-412A|Sebidin A|Hydrochloride, Chlorhexidine|Chlorhexidine Hydrochloride|Chlorhexidine|Chlorhexidine Acetate|MK 412A|Acetate, Chlorhexidine|Tubulicid"
NEW10875,BIOCHEMICAL,antibiotic policy,Antibiotic policies
NEW10876,CHEMICAL,elevated mao-a level,elevated MAO-A levels
NEW10879,MENTAL_HEALTH,systemic resistance,Systemic resistance
NEW10884,CHEMICAL,baseline vasopressin release,baseline vasopressin release
NEW10885,CHEMICAL,crown rot,crown rot
C045246,DISEASE,"PAEP protein, human [Supplementary Concept]",human pregnancy|Glycodelin
D000444,CHEMICAL,Aldehyde Dehydrogenase,"D-Glucuronolactone Dehydrogenase|Dehydrogenase, Aldehyde|Aldehyde Dehydrogenase E1|Aldehyde-NAD Oxidoreductase|Aldehyde Dehydrogenase E2|D Glucuronolactone Dehydrogenase|Aldehyde NAD Oxidoreductase|aldehyde dehydrogenase|Aldehyde Dehydrogenase (NAD(+))|Dehydrogenase, D-Glucuronolactone"
NEW10887,MENTAL_HEALTH,excitation dissociation,excitation dissociation
NEW10888,MENTAL_HEALTH,capture dissociation,capture dissociation
NEW10889,MENTAL_HEALTH,collision-induced dissociation,collision-induced dissociation
NEW10890,MENTAL_HEALTH,dissociation method,dissociation methods
C005790,CHEMICAL,beta-thujone [Supplementary Concept],thujone|Bicyclic Monoterpenes
D014500,CHEMICAL,Uracil Nucleotides,"Nucleotides|Phosphates, Uridine|Uridine Nucleotides|Nucleotides, Uridine|Uridine Phosphates|Nucleotides, Uracil"
NEW10897,CHEMICAL,portunus trituberculatus,Pt-egg oil|Portunus trituberculatus
NEW10898,DISEASE,atoxigenic aspergillus flavus isolate,atoxigenic Aspergillus flavus isolates
D016607,CHEMICAL,Aflatoxin M1,"4 Hydroxyaflatoxin B1|aflatoxin|Aflatoxin M(1)|4-Hydroxyaflatoxin B1|Aflatoxin M|Aflatoxin M1, cis(+-)-Isomer"
NEW10900,DISEASE,atoxigenic a. flavus genotype,atoxigenic A. flavus genotypes
NEW10901,DISEASE,atoxigenic a. flavus,atoxigenic A. flavus
NEW10903,MENTAL_HEALTH,competitive displacement,competitive displacement
NEW10905,CHEMICAL,schisandra chinensis extract,Schisandra chinensis extract
NEW10908,BIOCHEMICAL,low vitamin d level,low vitamin D levels
NEW10909,BIOCHEMICAL,hormone therapy,Hormone therapy
NEW10911,DISEASE,decrease sexual desire,Decreased sexual desire
NEW10913,BIOCHEMICAL,h2 antagonist activity,H2 antagonist activity
NEW10916,CHEMICAL,bind ferulic acid,bound ferulic acid
http://purl.obolibrary.org/obo/DOID_9362,DISEASE,status asthmaticus,Severe asthma attack|nonconvulsive status epilepticus|Asthma with status asthmaticus
NEW10917,CHEMICAL,carbamazepine treatment,Carbamazepine treatment
NEW10919,CHEMICAL,amyloid positron emission tomography,amyloid positron emission tomography
NEW10921,CHEMICAL,glyphosate-grown culture,glyphosate-grown cultures
http://purl.obolibrary.org/obo/DOID_2575,MENTAL_HEALTH,barbiturate dependence,Barbiturate dependence
NEW10926,CHEMICAL,intraoperative adenosine,Intraoperative adenosine
C562325,CHEMICAL,dolutegravir [Supplementary Concept],"Heterocyclic Compounds, 3-Ring|dolutegravir|Piperazines|Pyridones|Oxazines"
D000068898,CHEMICAL,Raltegravir Potassium,"Isentress|MK-0518|Potassium, Raltegravir|MK 0518|MK0518|0518, MK|Raltegravir"
NEW10931,CHEMICAL,peritraumatic ketamine,peritraumatic ketamine
D031581,CHEMICAL,Banisteriopsis,Ayahuascas|ayahuasca|Ayahuasca|Banisteriopses
NEW10933,CHEMICAL,high arachidonic acid level,high arachidonic acid levels
NEW10937,BIOCHEMICAL,noncompetitive n-methyl-d-aspartate/glutamate receptor antagonist,Noncompetitive N-methyl-D-aspartate/glutamate receptor antagonists
NEW10941,CHEMICAL,transdermal testosterone,transdermal testosterone
C035514,CHEMICAL,"N-2-diazo-3,3,3-trifluoropropionyl-3,5,3'-triiodothyronine [Supplementary Concept]",Triiodothyronine/analogs  and  derivatives|L-T3|Diazonium Compounds
NEW10943,CHEMICAL,rbc l-t3 uptake,RBC L-T3 uptake
NEW10944,BIOCHEMICAL,translocation carrier,translocation carriers
D003620,CHEMICAL,Dantrolene,"Dantrolene Sodium|Dantrium|Sodium, Dantrolene|Dantrolene"
D008874,CHEMICAL,Midazolam,"Versed|Maleate, Midazolam|Dormicum|midazolam|Ro 21-3981|Hydrochloride, Midazolam|Midazolam Hydrochloride|Ro 21 3981|Ro 213981|Midazolam Maleate"
D013874,CHEMICAL,Thiopental,Thiopental Nycomed|Thiopentone|Sodipental|Tiobarbital Braun|Trapanal|Pentothal|Thionembutal|Thiopental Sodium|Pentothal Sodico|Bomathal|thiopental|Nesdonal|Penthiobarbital|Thiopentobarbital|Thiomebumal
NEW10948,CHEMICAL,intravenous oxycodone analgesia,Intravenous oxycodone analgesia
NEW10950,BIOCHEMICAL,new oral gonadotropin-releasing hormone antagonist,new oral gonadotropin-releasing hormone antagonist
NEW10952,CHEMICAL,modulator bazedoxifene,modulators bazedoxifene
NEW10954,CHEMICAL,persistent testosterone,Persistent testosterone
NEW10956,CHEMICAL,neuronal histamine,neuronal histamine
http://cbmi.med.harvard.edu/asdphenotype#Class_386,CHEMICAL,perinatal exposures,perinatal DEHP exposure
NEW10960,CHEMICAL,plasma ne value,plasma NE values
NEW10961,BIOCHEMICAL,appetite hormone,appetite hormones
NEW10962,CHEMICAL,steroidogenic inhibitor finasteride,steroidogenic inhibitor finasteride
NEW10964,CHEMICAL,RES     mg/kg/day,RES    mg/kg/day
NEW10967,CHEMICAL,monoamine-depleting agent reserpine,monoamine-depleting agent reserpine
NEW10968,DISEASE,botrytis sp.,Botrytis sp.
NEW10971,MENTAL_HEALTH,resistance conferring mutation,Resistance conferring mutations
NEW10973,CHEMICAL,galantamine treatment,galantamine treatment
NEW10977,CHEMICAL,positive allosteric modulator benzyl quinolone carboxylic acid,positive allosteric modulator benzyl quinolone carboxylic acid
NEW10978,CHEMICAL,acetylcholine action,acetylcholine action
D023382,DISEASE,"Toxicity Tests, Acute","Test, Acute Toxicity|Acute Toxicity Tests|acute toxicity|Tests, Acute Toxicity|Acute Toxicity Test|Toxicity Test, Acute"
NEW10987,CHEMICAL,nad precursor,NAD precursors
http://purl.obolibrary.org/obo/CHEBI_89871,CHEMICAL,"2,2,4-trimethyl-1,3-pentadienol diisobutyrate","2,2,4-trimethyl-1-[(2-methylpropanoyl)oxy]pentan-3-yl 2-methylpropanoate|R-enantiomer"
NEW10989,BIOCHEMICAL,life-threatening adverse drug reaction,life-threatening adverse drug reaction
NEW10990,MENTAL_HEALTH,second resistance mechanism,second resistance mechanism
C000602893,CHEMICAL,ribocil [Supplementary Concept],Pyrimidines|ribocil
NEW10992,CHEMICAL,ribocil binding,ribocil binding
NEW10995,CHEMICAL,low dopamine level,lower dopamine levels
D017292,CHEMICAL,Doxazosin,"Doxazosin Monohydrochloride|Cardular|Doxa-Puren|Doxazosin findusFit|UK33274|Doxazosin Klast|Apo-Doxazosin|Doxazosina Ratiopharm|Doxazosin Mesylate|Doxazosin Heumann|Doxazosina Geminis|Cardura|Doxa Puren|Doxazosin Stada|Doxazosin-ratiopharm|Doxazosina Ur|Novo Doxazosin|Ratiopharm, Doxazosina|Doxazosin-Wolff|Carduran Neo|UK 33274|Doxazomerck|Doxamax|ratio-Doxazosin|Neo, Carduran|doxazosin|1 (4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)piperazine|Von Ct, Doxazosin|Doxazosina Combino Pharm|Gen Doxazosin|Uriduct|Novo-Doxazosin|Alfamedin|Doxazosin beta|Gen-Doxazosin|ratio Doxazosin|Zoxan|Doxazosin Wolff|UK-33274|Diblocin|Doxazosin Apogepha|Doxazosina Normon|Mesylate, Doxazosin|Monohydrochloride, Doxazosin|Doxazosin Von Ct|MTW-Doxazosin|Doxazosin AZU|Doxatensa|Doxazosin ratiopharm|Carduran|Doxazosina Cinfa|MTW Doxazosin|Jutalar|Progandol Neo|Doxacor|Doxagamma|Doxazosina Alter|Ct, Doxazosin Von|Doxazosin AL|Apo Doxazosin|DoxaUro|Doxazosina Pharmagenus"
NEW10997,CHEMICAL,α1 -adrenergic antagonist,α1 -adrenergic antagonist
http://purl.obolibrary.org/obo/DOID_1510,MENTAL_HEALTH,personality disorder,DSM-III-R personality disorders|character disorder
NEW11003,DISEASE,intermittent explosive disorder-revised,intermittent explosive disorder-revised
NEW11005,DISEASE,intermittent explosive disorder-revised,IED-R|intermittent explosive disorder-revised
NEW11007,CHEMICAL,menopausal transition,MT|menopausal transition
NEW11008,DISEASE,osteolytic disease,Osteolytic disease
NEW11010,MENTAL_HEALTH,orthogonal projection,orthogonal projection
NEW11012,NUTRITION,branched-chain amino acid degradation pathway,branched-chain amino acid degradation pathways
NEW11017,MENTAL_HEALTH,chronic opioid abuse,Chronic opioid abuse
C052714,CHEMICAL,rhyncophylline [Supplementary Concept],Oxindoles|isorhynchophylline
NEW11019,CHEMICAL,apomorphine mg/kg,apomorphine mg/kg
NEW11021,MENTAL_HEALTH,pain analgesia,pain analgesia
NEW11022,MENTAL_HEALTH,significant analgesia,Significant analgesia
NEW11023,CHEMICAL,one parenteral dopamine agonist,one parenteral dopamine agonist|apomorphine
NEW11025,CHEMICAL,cannabis toxicity,Cannabis toxicity
NEW11027,CHEMICAL,cannabis law,cannabis laws
NEW11032,DISEASE,significant cad,significant CAD
NEW11034,CHEMICAL,se nanoparticle,Se nanoparticles
NEW11035,DISEASE,aeromonas hydrophila infection,Aeromonas hydrophila infection
D064147,DISEASE,Febrile Neutropenia,"Febrile Neutropenias|Neutropenia, Febrile|Neutropenia|Neutropenias, Febrile"
NEW11038,CHEMICAL,peginterferon/ribavirin therapy,Peginterferon/Ribavirin therapy
NEW11039,BIOCHEMICAL,folinic acid supplementation,folinic acid supplementation
NEW11040,DISEASE,female rett patient,female Rett patients
NEW11041,CHEMICAL,sam level,SAM levels
NEW11042,CHEMICAL,PtDIR11,PtDIR11
NEW11043,CHEMICAL,acute cannabis exposure,Acute cannabis exposure
NEW11047,BIOCHEMICAL,thiamine repressible promoter,thiamine repressible promoter
NEW11049,CHEMICAL,protein synthesis inhibitor cycloheximide,protein synthesis inhibitor cycloheximide
NEW10410,CHEMICAL,inhibitory neurotransmitter γ-aminobutyric acid,GABA|inhibitory neurotransmitter γ-aminobutyric acid
http://purl.obolibrary.org/obo/CHEBI_75228,CHEMICAL,sodium lactate,"sodium 2-hydroxypropanoate|2-Hydroxypropanoic acid, monosodium salt|sodium hydroxybutyrate|E325|Mediject L|Lactic acid, monosodium salt|Monosodium lactate|Lactic acid sodium salt|Monosodium 2-hydroxypropanoate|Sodium alpha-hydroxypropionate"
NEW11051,DISEASE,tumor cavity,tumor cavity
NEW11054,BIOCHEMICAL,prenatal progestin exposure,prenatal progestin exposure
NEW11057,DISEASE,acute dystonia,acute dystonia
NEW11058,NUTRITION,tree cart analysis,tree CART analysis
NEW11060,NUTRITION,daily food intake,Daily food intake
NEW11062,BIOCHEMICAL,daily vitamin b1,daily vitamin B1
NEW11064,DISEASE,increase talkativeness,Increased talkativeness
NEW11066,BIOCHEMICAL,various carotenoid present,various carotenoids present
NEW11067,DISEASE,prostate cancer cell,prostate cancer cells
C011947,BIOCHEMICAL,neoxanthin [Supplementary Concept],Xanthophylls|Neoxanthin
D061146,CHEMICAL,Chlorophyll Binding Proteins,"Chlorophyll a Proteins|Chlorophyll a c Binding Proteins|fucoxanthin|Proteins, Fucoxanthin Chlorophyll|Chlorophyll a-c Binding Proteins|Chlorophyll a Binding Proteins|Fucoxanthin Chlorophyll a-c Binding Proteins|Chlorophyll Proteins, Fucoxanthin|Chlorophyll Protein Complexes|Chlorophyll a b Binding Proteins|Chlorophyll ac Proteins|Chlorophyll ab Proteins|Fucoxanthin Chlorophyll Proteins|Fucoxanthin Chlorophyll a c Binding Proteins|Chlorophyll ac-Proteins|Chlorophyll ab-Proteins|Fucoxanthin Chlorophyll Binding Proteins|Chlorophyll a-Proteins|Chlorophyll a-b Binding Proteins"
NEW11069,MENTAL_HEALTH,fiber orientation,fiber orientation
NEW11071,CHEMICAL,spermine synthase gene,spermine synthase gene
NEW11073,CHEMICAL,excessive aspartame ingestion,excessive aspartame ingestion
NEW11075,DISEASE,rhabdovirus viral hemorrhagic septicemia virus vhsv genogroup iva,rhabdovirus Viral hemorrhagic septicemia virus VHSV genogroup IVa
NEW11076,NUTRITION,pacific herring,Pacific herring
NEW11077,DISEASE,floor muscle spasm,floor muscle spasm
NEW11079,CHEMICAL,amygdala faah density,amygdala FAAH density
D008406,DISEASE,Masseter Muscle,"Muscle, Masseter|Masseter Muscles|Muscles, Masseter|masseter muscle"
NEW11080,DISEASE,temporary paralysis,Temporary paralysis
NEW11081,DISEASE,digestive gland-associated microbiota,digestive gland-associated microbiota
NEW11087,NUTRITION,spanish version,Spanish version
NEW11088,NUTRITION,spanish patient,Spanish patients
NEW11090,DISEASE,cobra naja melanoleuca venom,cobra Naja melanoleuca venom
http://purl.obolibrary.org/obo/CHEBI_137376,CHEMICAL,long-chain fatty acyl-amp,long-chain α-neurotoxins|long-chain fatty acyl-adenylate|long-chain fatty acyl-adenosine-5-monophosphate
NEW11092,BIOCHEMICAL,modifier toxin,modifier toxins
D001180,BIOCHEMICAL,Arthropod Venoms,"Arachnid Venoms|Insect Venoms|Toxin, Arachnid|arthropod venoms|Arachnid Toxin|Venom, Arachnid|Arthropod Venom|Arachnid Venom|Insect Venom|Hymenoptera Venom|Venoms, Arachnid|Arachnid Toxins|Hymenoptera Venoms|Venoms, Insect|Venom, Hymenoptera|Venom, Insect|Venom, Arthropod|Venoms, Arthropod|Toxins, Arachnid|Venoms, Hymenoptera"
C026013,CHEMICAL,fenproporex [Supplementary Concept],fenproporex|Amphetamines
NEW11094,BIOCHEMICAL,drug concentration,drug concentrations
NEW11096,CHEMICAL,oxygen scavenging,oxygen scavenging
C501162,CHEMICAL,"FLT1 protein, human [Supplementary Concept]",Vascular Endothelial Growth Factor Receptor-1|sFlt-1
C075750,CHEMICAL,8-epi-prostaglandin F2alpha [Supplementary Concept],Dinoprost/analogs  and  derivatives|isoprostane
NEW11098,DISEASE,alport mouse,Alport mice
http://purl.obolibrary.org/obo/CHEBI_135810,CHEMICAL,atrasentan,atrasentan hydrochloride|atrasentan HCl|sitaxentan
NEW11099,NUTRITION,receptor-related orphan receptor alpha,receptor-related orphan receptor alpha
NEW11101,NUTRITION,dysregulate phospholipid metabolism,Dysregulated phospholipid metabolism
NEW11102,NUTRITION,phospholipid metabolism,phospholipid metabolism
NEW11104,DISEASE,lucidum stimulation,lucidum stimulation
NEW11106,CHEMICAL,neuroimmunological kynurenine pathway,neuroimmunological kynurenine pathway
NEW11107,DISEASE,depressed adolescent,depressed adolescents
D065766,DISEASE,Atypical Hemolytic Uremic Syndrome,"Non Stx Hus|atypical hemolytic uremic syndrome|Nonenteropathic HUSs|HUS, Non-Shiga-Like Toxin-Associated|Atypical Hemolytic-Uremic Syndromes|Nonenteropathic HUS|Hemolytic Uremic Syndrome, Atypical|HUSs, Non-Shiga-Like Toxin-Associated|Non-Shiga-Like Toxin-Associated HUS|HUS, Nonenteropathic|HUSs, Nonenteropathic|Syndromes, Atypical Hemolytic-Uremic|Syndrome, Atypical Hemolytic-Uremic|Non-Stx-Hus|Toxin-Associated HUSs, Non-Shiga-Like|Hemolytic-Uremic Syndrome, Atypical|Toxin-Associated HUS, Non-Shiga-Like|Atypical Hemolytic-Uremic Syndrome|Non Shiga Like Toxin Associated HUS|Hemolytic-Uremic Syndromes, Atypical|Non-Shiga-Like Toxin-Associated HUSs"
D044348,CHEMICAL,"Receptors, Serotonin, 5-HT2","Receptors, 5 HT 2|Serotonin 5-HT2 Receptors|Receptors, 5-HT2 Serotonin|Receptors, Serotonin-2|Serotonin-2 Receptors|Serotonin 5 HT2 Receptors|Receptors, Serotonin 2|5-HT2 receptors|5 HT 2 Receptors|S2 Receptors, Serotonin|Receptors, 5-HT-2|5-HT2 Receptors, Serotonin|Receptors, Serotonin 5-HT2|Receptors, Serotonin S2|Serotonin 2 Receptors|Serotonin Receptors, 5-HT2|Serotonin S2 Receptors|Serotonin Receptors, 5 HT2|5-HT-2 Receptors|5-HT2 Serotonin Receptors"
NEW11112,CHEMICAL,leuprolide pretreatment,Leuprolide pretreatment
NEW04671,CHEMICAL,mg/day,mg/day
NEW11117,CHEMICAL,omega-3 hufa,omega-3 HUFAs
NEW11119,DISEASE,neonatal hypoxia-ischemia,Neonatal hypoxia-ischemia
NEW10374,CHEMICAL,12 day post infection,12 day post infection|DPI
NEW11122,DISEASE,cardiometabolic factor,cardiometabolic factors
http://purl.obolibrary.org/obo/CHEBI_178076,CHEMICAL,caffeic acid-13c9,"dinophysistoxins|(E)-3-(3,4-dihydroxy(1,2,3,4,5,6-13C6)cyclohexa-1,3,5-trien-1-yl)(1,2,3-13C3)prop-2-enoic acid"
NEW11123,BIOCHEMICAL,diarrhetic shellfish-poisoning toxin,Diarrhetic shellfish-poisoning toxins
D019319,CHEMICAL,Okadaic Acid,Ocadaic Acid|okadaic acid
NEW11124,CHEMICAL,quinolone action,quinolone action
NEW11126,DISEASE,multiple mass spectrometry experiment,multiple mass spectrometry experiments
NEW11129,CHEMICAL,gepirone er,gepirone ER
NEW11131,CHEMICAL,pi3 k pathway activation,PI3 K pathway activation
http://purl.obolibrary.org/obo/MFOMD_0000133,MENTAL_HEALTH,resistance,WFT resistance
D011763,CHEMICAL,Pyrrolizidine Alkaloids,"pyrrolizidine alkaloid|Pyrrolizidine Alkaloid|Alkaloid, Pyrrolizidine|Alkaloids, Pyrrolizidine|Senecio Alkaloid|Alkaloids, Senecio|Senecio Alkaloids|Alkaloid, Senecio"
NEW11133,MENTAL_HEALTH,displacement reaction,displacement reaction
NEW11137,MENTAL_HEALTH,same compressive displacement,same compressive displacement
NEW11138,CHEMICAL,15wt% PVA boric acid,15wt% PVA boric acid
NEW11140,MENTAL_HEALTH,lateral head displacement,lateral head displacement
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Perceptual_Disturbances,DISEASE,perceptual disturbances,perceptual disturbances
NEW00822,MENTAL_HEALTH,schizophrenia symptom,schizophrenia symptoms
NEW11142,DISEASE,c-treated dn-disc1 mouse,C-treated DN-DISC1 mice
NEW11143,DISEASE,atopic child,atopic children
D057985,DISEASE,"Multi-Ingredient Cold, Flu, and Allergy Medications","Cold Medications, Multi-Ingredient|Cold, Flu, and Allergy Medications, Multi-Ingredient|Medications, Multi-Ingredient Flu|Multi Ingredient Flu Medications|Medications, Multi-Ingredient Cold|Flu Medications, Multi-Ingredient|Multi Ingredient Cold Medications|Remedies, Multi-Ingredient Cold|Cold and Flu Medications, Multi-Ingredient|Cold Remedies, Multi-Ingredient|Multi-Ingredient Allergy Medications|Multi-Ingredient Cold Medications|Allergy Medications, Multi-Ingredient|Multi-Ingredient Cold Remedies|Multi Ingredient Allergy Medications|Medications, Multi-Ingredient Allergy|Multi-Ingredient Flu Medications|Multi Ingredient Cold and Flu Medications|Multi Ingredient Cold Remedies|Cold and Flu Medications, Multi Ingredient|Multi-Ingredient Cold and Flu Medications|allergy"
NEW11145,BIOCHEMICAL,gradual antipsychotic drug discontinuation,gradual antipsychotic drug discontinuation
http://purl.obolibrary.org/obo/CHEBI_3360,CHEMICAL,cannabinol,CBDV|Cannabinol|phytocannabinoid cannabidivarin
NEW11148,CHEMICAL,symptomatic cbdv,symptomatic CBDV
D000073116,DISEASE,Cancer Survivors,"Cancer Survivors, Childhood|Childhood Cancer Survivor|Survivor, Long-Term Cancer|Survivorship, Cancer|Cancer Survivor|Cancer Survivorship|Cancer Survivor, Long-Term|Cancer Survivors, Long-Term|Childhood Cancer Survivors|Long-Term Cancer Survivors|cancer survivors|Survivors, Cancer|Cancer Survivor, Childhood|Survivors, Long-Term Cancer|Survivors of Childhood Cancer|Long-Term Cancer Survivor|Long Term Cancer Survivors"
NEW11154,DISEASE,mild methemoglobinemia,mild methemoglobinemia
http://purl.obolibrary.org/obo/SYMP_0000510,DISEASE,pallor,paleness
NEW11155,BIOCHEMICAL,old drug,old drug
C533284,CHEMICAL,"Ffar4 protein, rat [Supplementary Concept]","FFAR1/GPR40|Receptors, G-Protein-Coupled|fatty acid receptor 1"
C519853,NUTRITION,"FFAR4 protein, human [Supplementary Concept]","Receptors, G-Protein-Coupled|fatty acid receptor"
NEW11158,CHEMICAL,zly032,ZLY032
NEW11163,BIOCHEMICAL,dual ffa1/pparδ agonist,dual FFA1/PPARδ agonists
NEW11164,NUTRITION,methionine intoxication,methionine intoxication
C015816,CHEMICAL,dihydroguaiaretic acid [Supplementary Concept],Lignans|Guaiacol/analogs  and  derivatives|meso-dihydroguaiaretic acid
D050859,CHEMICAL,Betacyanins,Betanins|betacyanins|Betanidins|Betanidin|Betacyanin
http://purl.obolibrary.org/obo/CHEBI_22888,CHEMICAL,biphenyls,dioxin-like polychlorinated biphenyls|dl-PCBs
C067940,CHEMICAL,"2,3,3',4,4'-pentachlorobiphenyl [Supplementary Concept]",Polychlorinated Biphenyls|PCB
NEW11168,BIOCHEMICAL,vitamin b. vitamin b,vitamin B. Vitamin B
D014804,BIOCHEMICAL,Vitamin B Deficiency,"Deficiencies, Vitamin B|Deficiency, Vitamin B|Vitamin B Deficiencies|vitamin B deficiency"
NEW11169,CHEMICAL,33-kda cysteine protease,33-kDa cysteine protease
NEW11172,CHEMICAL,b-vitamin status,B-vitamin status
NEW11174,CHEMICAL,induce vad. l-methionone,induced VaD. l-methionone
NEW11176,CHEMICAL,l-methionine treated animal,L-methionine treated animals
D011623,CHEMICAL,gamma-Glutamyl Hydrolase,folacin|Pteroyl Polyglutamate Hydrolase|gamma Glutamyl Hydrolase|Folate Hydrolyzing Enzyme|Carboxypeptidase G1|Folyl Conjugate Synthetase|Folyl Poly-gamma-Glutamate Carboxypeptidase|Carboxypeptidase G|Folate Conjugase|Folacin Conjugase|Conjugase|Carboxypeptidase G2|Folylpolyglutamate Hydrolase|Folyl Polyglutamate Cleavage Enzyme
NEW11181,CHEMICAL,cr ratio,Cr ratios
NEW11182,MENTAL_HEALTH,orientation bias,orientation bias
NEW11183,CHEMICAL,brain 5-ht functional activity,brain 5-HT functional activity
http://purl.obolibrary.org/obo/DOID_4543,MENTAL_HEALTH,retrograde amnesia,ECS-induced retrograde amnesia
NEW11185,CHEMICAL,mrn-lesioned rat,MRN-lesioned rats
NEW11186,DISEASE,choreiform limb,choreiform limb
NEW11188,DISEASE,limb dyskinesia,limb dyskinesias
NEW11190,BIOCHEMICAL,essential vitamin,essential vitamin
NEW11191,DISEASE,metabolism deficit,metabolism deficit
NEW01474,BIOCHEMICAL,folate metabolism,folate metabolism
C483078,DISEASE,"BREVIS RADIX protein, Arabidopsis [Supplementary Concept]",Arabidopsis Proteins|brevis radix
D000450,CHEMICAL,Aldosterone,"aldosterone|Aldosterone, (+-)-Isomer|Aldosterone, (11 beta,17 alpha)-Isomer"
NEW11193,DISEASE,cardiac damage,cardiac damage
NEW11194,DISEASE,cardiovascular damage,cardiovascular damage
NEW11198,MENTAL_HEALTH,high dissociation rate,high dissociation rate
NEW11200,MENTAL_HEALTH,rapid dissociation,rapid dissociation
NEW11201,CHEMICAL,insufficient brain dha,Insufficient brain DHA
NEW11202,CHEMICAL,optimal brain dha status,optimal brain DHA status
D057265,CHEMICAL,Site-Specific DNA-Methyltransferase (Cytosine-N4-Specific),cytosine|N(4)-Cytosine-Specific DNA Methylase|Site-Specific DNA-Methyltransferase (Cytosine-N(4)-Specific)
C519817,CHEMICAL,"1-(1-methylethyl)-4-((1-(6-(trifluoromethyl)-3-pyridinyl)-4-piperidinyl)carbonyl)hexahydro-1H-1,4-diazepine [Supplementary Concept]",Azepines|Pyridines|GSK334429
NEW11205,BIOCHEMICAL,novel receptor antagonist,Novel receptor antagonists
C519816,CHEMICAL,"5-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-2-pyrazinecarboxamide [Supplementary Concept]",Benzazepines|GSK207040|Pyrazines
NEW11207,CHEMICAL,ca2 entry,Ca2 entry
NEW11210,CHEMICAL,large spine abductor,large spine abductor
NEW11211,CHEMICAL,oral propranolol,oral propranolol
NEW11214,CHEMICAL,low-frequency electroacupuncture,Low-frequency electroacupuncture
NEW11216,CHEMICAL,low-frequency electroacupuncture,low-frequency electroacupuncture
NEW11217,CHEMICAL,elevated homocysteine level,Elevated homocysteine levels
NEW11218,DISEASE,non-cardiac vascular disease,non-cardiac vascular diseases
NEW04146,CHEMICAL,hcy level,Hcy levels
C100406,CHEMICAL,albocycline K3 [Supplementary Concept],Albocycline|Lactones
NEW11220,MENTAL_HEALTH,work-related fatigue,work-related fatigue
NEW11222,CHEMICAL,omega (n)-3,Omega (n)-3
NEW11223,BIOCHEMICAL,obsessive compulsive Drug Use scale,Obsessive Compulsive Drug Use Scale
NEW11225,CHEMICAL,5-hydroxytryptamine receptor 3b,5-hydroxytryptamine receptor 3B
NEW11226,CHEMICAL,d2 dopamine receptor gene -141c ins/del polymorphism,D2 dopamine receptor gene -141C Ins/Del polymorphism
NEW11229,MENTAL_HEALTH,activate defense mechanism,Activated defense mechanism
NEW11230,CHEMICAL,extent casein glycomacropeptide,extent casein glycomacropeptide|CGMP
NEW02137,DISEASE,psychiatric condition,psychiatric conditions
NEW11234,DISEASE,microscopic esophagitis,microscopic esophagitis
NEW11236,DISEASE,functional esophagus,functional esophagus
NEW11238,DISEASE,panic symptom,panic symptoms
NEW09222,CHEMICAL,brain serotonin function,brain serotonin function
NEW11239,CHEMICAL,5-ht availability,5-HT availability
D029588,CHEMICAL,Moringa oleifera,"oleifera, Moringa|Drumsticktrees|Moringa oleifera|Moringa oleiferas|Drumsticktree"
C037144,CHEMICAL,mifamurtide [Supplementary Concept],Phosphatidylethanolamines|mifamurtide|Acetylmuramyl-Alanyl-Isoglutamine/analogs  and  derivatives
NEW11241,CHEMICAL,combination chemotherapy doxorubicin,combination chemotherapy doxorubicin
NEW11243,CHEMICAL,adjuvant postoperative mifamurtide,adjuvant postoperative mifamurtide
NEW11244,CHEMICAL,mifamurtide administration,Mifamurtide administration
NEW11246,CHEMICAL,four-layered microgyria,Four-layered microgyria
http://purl.obolibrary.org/obo/CHEBI_176783,BIOCHEMICAL,vitamin c,vitamins C|vitaminum C|vitamine C|Vitamin C|vitamina C|vitamin C vitamers|vitamin C vitamer
NEW11248,BIOCHEMICAL,carotenoid beta-carotene,carotenoids beta-carotene
NEW11249,DISEASE,old autistic subject,Older autistic subjects
NEW11251,BIOCHEMICAL,high plasma vitamin concentration,high plasma vitamin concentrations
NEW11254,CHEMICAL,donor sodium nitroprusside,SNP|donor Sodium Nitroprusside
NEW11257,NUTRITION,elevated cytoplasmic trehalose level,elevated cytoplasmic trehalose levels
NEW11258,DISEASE,host infection,host infection
NEW11259,BIOCHEMICAL,progestogen contraception,progestogen contraception
http://purl.obolibrary.org/obo/CHEBI_86324,BIOCHEMICAL,quinolone antibiotic,quinolone antibiotics
NEW11263,MENTAL_HEALTH,medication-induced psychotic disorder,Medication-induced psychotic disorder
NEW11266,CHEMICAL,n-6 family,n-6 families
NEW11267,MENTAL_HEALTH,multiple linear regression analysis,multiple linear regression analysis
NEW11270,DISEASE,obstructive Sleep Apnea Hypopnea Syndrome,Obstructive Sleep Apnea Hypopnea Syndrome|OSAHS
NEW11271,NUTRITION,particular fatty acid ratio,particular fatty acid ratio
NEW11275,CHEMICAL,dhbetae,DHbetaE
NEW11277,MENTAL_HEALTH,fluorescence displacement assay,fluorescence displacement assay
NEW11279,CHEMICAL,sulfonate acid group,sulfonate acid group
NEW11281,CHEMICAL,remimazolam tosilate,Remimazolam tosilate
D020299,DISEASE,"Intracranial Hemorrhage, Hypertensive","intracranial hemorrhage|Hemorrhage, Intracranial Hypertensive|Hypertensive Hemorrhages, Cerebral|Hypertensive Intracranial Hemorrhages|Hypertensive Hemorrhage, Cerebral|Intracranial Hemorrhages, Hypertensive|Hypertensive Intracerebral Hemorrhage|Hemorrhage, Hypertensive Intracranial|Intracranial Hypertensive Hemorrhages|Cerebral Hemorrhages, Hypertensive|Cerebral Hemorrhage, Hypertensive|Hemorrhage, Hypertensive Cerebral|Hemorrhages, Intracranial Hypertensive|Cerebral Hypertensive Hemorrhage|Cerebral Hypertensive Hemorrhages|Hemorrhages, Cerebral Hypertensive|Hypertensive Hemorrhage, Intracranial|Hypertensive Cerebral Hemorrhage|Hemorrhages, Hypertensive Intracerebral|Hemorrhage, Cerebral Hypertensive|Hypertensive Intracranial Hemorrhage|Hemorrhages, Hypertensive Cerebral|Hemorrhages, Hypertensive Intracranial|Hypertensive Intracerebral Hemorrhages|Intracranial Hypertensive Hemorrhage|Intracerebral Hemorrhages, Hypertensive|Hemorrhage, Hypertensive Intracerebral|Intracerebral Hemorrhage, Hypertensive|Hypertensive Cerebral Hemorrhages|Hypertensive Hemorrhages, Intracranial"
NEW11288,DISEASE,hepatitis b infection,hepatitis B infection
http://purl.obolibrary.org/obo/CHEBI_50908,BIOCHEMICAL,hepatotoxic agent,hepatoxicant|hepatotoxin|hepatoxic agent|hepatotoxicant|agente hepatotoxico|hepatotoxins|hepatotoxic agents|hepatotoxicants
NEW11293,BIOCHEMICAL,vitamin e. a deficiency,vitamin E. A deficiency
http://purl.obolibrary.org/obo/SYMP_0000336,DISEASE,neurological dysfunction,Neurological dysfunction
NEW11296,BIOCHEMICAL,serum vitamin e,serum vitamin E
D008728,CHEMICAL,Methotrimeprazine,Levomeprazin|Tizercine|levomepromazine|Levomepromazine|Tizertsin|Levopromazine|Tisercin
NEW11298,DISEASE,severe exhibitionist,severe exhibitionist
NEW11302,BIOCHEMICAL,androgen blockade,androgen blockade
D005084,MENTAL_HEALTH,Exhibitionism,Exhibitionisms|exhibitionism
NEW11304,CHEMICAL,pilocarpine administration,pilocarpine administration
NEW11306,CHEMICAL,repeat donepezil treatment,repeated donepezil treatments
NEW11307,MENTAL_HEALTH,morphine i.c.v analgesia,morphine i.c.v analgesia
NEW11310,CHEMICAL,agent 5-aza-2'-deoxycytidine,agent 5-aza-2'-deoxycytidine
NEW11312,DISEASE,hyperoxia-induced pulmonary fibrosis,hyperoxia-induced pulmonary fibrosis
http://purl.obolibrary.org/obo/DOID_5585,DISEASE,ferguson-smith tumor,NNK-induced tumors|Multiple self-healing epithelioma of Ferguson-Smith
NEW11315,MENTAL_HEALTH,nicotine-induced hyperactivity,nicotine-induced hyperactivity
C096097,CHEMICAL,4-((hydroxymethyl)nitrosamino)-1-(3-pyridyl)-1-butanone [Supplementary Concept],NNK|Nitrosamines
http://purl.obolibrary.org/obo/CHEBI_39026,DISEASE,low-density lipoprotein,beta-lipoproteins|Elevated low-density lipoproteins|low-density lipoproteins|LDL
NEW11316,NUTRITION,acid ratio,acids ratio
NEW11317,NUTRITION,fatty acid unsaturation,fatty acid unsaturation
http://purl.obolibrary.org/obo/CHEBI_39025,DISEASE,high-density lipoprotein,elevated high-density lipoproteins|alpha-lipoproteins|HDL|high-density lipoproteins
NEW11318,CHEMICAL,elevated linoleic acid,Elevated linoleic acid
NEW11319,NUTRITION,n-6 fatty acid ratio,n-6 fatty acid ratios
NEW11320,NUTRITION,elevated saturated fatty acid ratio,elevated saturated fatty acid ratio
NEW11321,MENTAL_HEALTH,hierarchical multiple regression,Hierarchical multiple regression
NEW11322,DISEASE,p. infestan,P. infestans
http://purl.obolibrary.org/obo/CHEBI_1391,CHEMICAL,"3,4-methylenedioxymethamphetamine","MDMA|DL-(3,4-Methylenedioxy)methamphetamine|(RS)-3,4-(methylenedioxy)methamphetamine|3,4-Methylenedioxymethamphetamine|1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine|1-(1,3-Benzodioxol-5-yl)-N-methyl-2-propanamine|ecstasy|N,alpha-dimethyl-1,3-benzodioxole-5-ethanamine|N-Methyl-3,4-methylenedioxyamphetamine"
NEW11323,BIOCHEMICAL,carrier youth,carrier youth
C106812,CHEMICAL,adefovir dipivoxil [Supplementary Concept],Organophosphonates|Adenine/analogs  and  derivatives|ADV|adefovir
D057911,CHEMICAL,Angiotensin Receptor Antagonists,"Receptor Antagonists, Angiotensin|Angiotensin Receptor Blockers|Angiotensin II Receptor Blockers|Receptor Blockers, Angiotensin|Antagonist, Angiotensin Receptor|Antagonists, Angiotensin Receptor|Blocker, Angiotensin Receptor|Receptor Antagonist, Angiotensin|Angiotensin II Receptor Blocker|Angiotensin Receptor Blocker|Angiotensin II Receptor Antagonists|angiotensin receptor|Angiotensin II Receptor Antagonist|Angiotensin Receptor Antagonist|Receptor Blocker, Angiotensin"
D008407,CHEMICAL,Mast Cells,"Cells, Mast|Basophils, Tissue|Tissue Basophil|Mast cells|Tissue Basophils|Mast Cell|Basophil, Tissue|MCs|Cell, Mast"
NEW11326,BIOCHEMICAL,membrane stabilizer sodium cromoglycate,membrane stabilizer sodium cromoglycate
http://purl.obolibrary.org/obo/CHEBI_61016,CHEMICAL,angiotensin receptor antagonist,angiotensin receptor antagonist Valsartan|angiotensin receptor antagonists
NEW11327,CHEMICAL,mc membrane stabilizer sodium cromoglycate,SCG|MCs membrane stabilizer sodium cromoglycate
NEW11328,CHEMICAL,adv accumulation,ADV accumulation
NEW11331,DISEASE,lung cancer treatment,lung cancer treatments
NEW11332,DISEASE,cancer present,Cancer present
D066066,DISEASE,Response Evaluation Criteria in Solid Tumors,RECIST|tumors
D059630,CHEMICAL,Mesenchymal Stem Cells,"Wharton's Jelly Cells|Multipotent Mesenchymal Stromal Cell|Mesenchymal Stromal Cell|Multipotent Mesenchymal Stromal Cells|Bone Marrow Stromal Cell|stem cells|Mesenchymal Progenitor Cell|Mesenchymal Stem Cells, Adipose Derived|Stromal Cells, Mesenchymal|Adipose Tissue Derived Mesenchymal Stromal Cell|Adipose Derived Mesenchymal Stem Cell|Whartons Jelly Cells|Progenitor Cells, Mesenchymal|Wharton Jelly Cells|Wharton's Jelly Cell|Bone Marrow Stromal Stem Cells|Adipose-Derived Mesenchymal Stem Cell|Adipose Tissue Derived Mesenchymal Stromal Cells|Progenitor Cell, Mesenchymal|Multipotent Bone Marrow Stromal Cells|Bone Marrow Stromal Cells|Stromal Cell, Mesenchymal|Adipose-Derived Mesenchymal Stem Cells|Mesenchymal Stem Cells, Adipose-Derived|Multipotent Bone Marrow Stromal Cell|Adipose Tissue-Derived Mesenchymal Stromal Cell|Mesenchymal Stromal Cells|Adipose Tissue-Derived Mesenchymal Stem Cells|Stem Cells, Mesenchymal|CSCs|Mesenchymal Stem Cell|Bone Marrow Mesenchymal Stem Cell|Adipose Tissue-Derived Mesenchymal Stromal Cells|Adipose Tissue Derived Mesenchymal Stem Cells|Adipose Tissue Derived Mesenchymal Stem Cell|Bone Marrow Mesenchymal Stem Cells|Mesenchymal Progenitor Cells|Stem Cell, Mesenchymal|Adipose-Derived Mesenchymal Stromal Cells|Adipose Derived Mesenchymal Stem Cells|Adipose Tissue-Derived Mesenchymal Stem Cell|Adipose Derived Mesenchymal Stromal Cells|Mesenchymal Stromal Cells, Multipotent|Bone Marrow Stromal Cells, Multipotent"
NEW00158,DISEASE,hypertensive patient,hypertensive patients
D001600,CHEMICAL,Berberine Alkaloids,"Berbines|berberine|Alkaloids, Berberine"
NEW11334,DISEASE,self-assembled thermosensitive in-situ hydrogel,self-assembled thermosensitive in-situ hydrogel
NEW11335,CHEMICAL,different add-back regimen,different add-back regimens
NEW11336,BIOCHEMICAL,primary carotenoid,primary carotenoids
NEW11337,CHEMICAL,hiv-1 rt dna polymerase/rnase h activity,HIV-1 RT DNA polymerase/RNase H activities
http://purl.obolibrary.org/obo/CHEBI_31919,NUTRITION,norgalanthamine,Norgalanthamine|aegyptiaca L. Delile|N-Demethylgalanthamine
NEW11339,DISEASE,neuronal brain damage,neuronal brain damage
NEW11341,BIOCHEMICAL,endogenous nmda receptor agonist other,endogenous NMDA receptor agonist other
NEW08618,BIOCHEMICAL,analgesic activity,analgesic activity
NEW11342,CHEMICAL,chf3381,CHF3381
NEW11344,CHEMICAL,anti-synaptophysin reactivity,anti-synaptophysin reactivity
NEW11346,MENTAL_HEALTH,equilibrium dissociation constant,equilibrium dissociation constant
NEW11348,CHEMICAL,m. suaveolen,M. suaveolens
NEW11350,BIOCHEMICAL,conventional antimicrobial therapy,conventional antimicrobial therapy
NEW11352,CHEMICAL,reduce gamma-aminobutyric acid gaba concentration,Reduced gamma-aminobutyric acid GABA concentrations
NEW11354,BIOCHEMICAL,usage inhibitor/angiotensin ⅱ receptor antagonist,usage inhibitor/Angiotensin Ⅱ receptor antagonist
NEW11355,CHEMICAL,bicarbonate OR=0.89,bicarbonate OR=0.89
NEW11356,CHEMICAL,acei/arb,ACEI/ARB
NEW11357,CHEMICAL,serum bicarbonate,serum bicarbonate
D027521,CHEMICAL,Nepeta,"Nepeta cataria|cataria, Nepeta|Catnips|Nepeta catarias|Nepetas|Catnip"
NEW11360,CHEMICAL,Crataegus sp.,Crataegus sp.
D031205,CHEMICAL,Taraxacum,Dandelion|Taraxacum officinale|Dandelions
D031168,CHEMICAL,Matricaria,"Mayweed, Crown|Matricaria matricarioide|Crown Mayweed|Chamomilla recutitas|matricarioide, Matricaria|recutitas, Chamomilla|Crown Mayweeds|Matricaria recutitas|German Camomile|recutitas, Matricaria|Chamomilla recutita|chamomilla, Matricaria|Weeds, Pineapple|Matricarias|German Chamomile|Matricaria recutita|Pineapple Weeds|Camomile, German|Pineapple Weed|Matricaria chamomillas|Matricaria matricarioides|Chamomile, German|Weed, Pineapple|Mayweeds, Crown|Matricaria chamomilla"
http://purl.obolibrary.org/obo/NCBITaxon_523089,NUTRITION,haemaphysalis concinna,Helichrysum arenarium
NEW11361,BIOCHEMICAL,Fat-Soluble vitamin,Fat-Soluble Vitamins
D020013,CHEMICAL,Calcium Signaling,"Signaling, Calcium|Wave, Calcium|Waves, Calcium|Oscillation, Calcium|Calcium Spark|Calcium Puffs|Calcium Signalings|Spikes, Calcium|Calcium Waves|Puffs, Calcium|Calcium Sparks|Sparks, Calcium|Calcium Wave|calcium signaling|Puff, Calcium|Calcium Spike|Calcium Puff|Spark, Calcium|Oscillations, Calcium|Calcium Oscillations|Spike, Calcium|Calcium Spikes|Signalings, Calcium|Calcium Oscillation"
NEW11362,BIOCHEMICAL,vitamin d Endocrine system,Vitamin D Endocrine System
NEW11364,DISEASE,P. Quinn,P. Quinn
NEW11365,CHEMICAL,sex-hormone level,sex-hormone levels
NEW11367,CHEMICAL,serotonin signaling,serotonin signaling
NEW05698,CHEMICAL,oral prednisone,oral prednisone
NEW11197,MENTAL_HEALTH,dissociation constant,dissociation constant
NEW11374,CHEMICAL,melatonin treatment,Melatonin treatment
C084656,CHEMICAL,paricalcitol [Supplementary Concept],Pari|Paricalcitol|Ergocalciferols
NEW11376,CHEMICAL,pari administration,Pari administration
D012726,DISEASE,"Sexual Behavior, Animal","Sex Behavior, Animal|Animal Sexual Behavior|Sexual Behaviors, Animal|Sex Behaviors, Animal|sexual behavior|Animal Mating Behaviors|Animal Mating Behavior|Animal Sexual Behaviors|Mating Behavior, Animal|Animal Sex Behavior|Mating Behaviors, Animal|Animal Sex Behaviors"
D011133,CHEMICAL,Polysaccharide-Lyases,"Polysaccharide Lyase|Lyase, Polysaccharide|Polysaccharide Lyases|Polysaccharide-Lyase|polysaccharide|ASP"
NEW11381,DISEASE,sub-lethal tl toxicity effect,sub-lethal Tl toxicity effects
D009586,MENTAL_HEALTH,Nitrogen Fixation,"Activity, Diazotrophic|Fixation, Dinitrogen|Diazotrophy|Dinitrogen Fixation|N2 Fixation|nitrogen fixation|Fixation, Nitrogen|Fixation, N2|Diazotrophic Activities|Activities, Diazotrophic|Diazotrophic Activity"
http://cbmi.med.harvard.edu/asdphenotype#Class_471,DISEASE,depressive disorder,bipolar depressive disorders
C088990,CHEMICAL,"N-(1,3-dimethyl-2-butenyl)adenosine [Supplementary Concept]",S-enantiomer|esketamine|Isopentenyladenosine/analogs  and  derivatives
NEW11383,CHEMICAL,melatonin treatment,melatonin treatment
NEW11384,BIOCHEMICAL,estrogen pathway,estrogen pathways
C000646209,CHEMICAL,Komagataeibacter hansenii [Supplementary Concept],Komagataeibacter|Acetobacteraceae
NEW11385,DISEASE,surgical Infection Society 's,Surgical Infection Society's
C062878,CHEMICAL,L-rhamnose isomerase [Supplementary Concept],L-rhamnose|Aldose-Ketose Isomerases
D056730,CHEMICAL,Silver-Russell Syndrome,"Russell Silver Syndrome|Silver Russell Dwarfism|Syndrome, Silver-Russell|Silver-Russell Dwarfism|Dwarfism, Silver Russell|Syndrome, Russell Silver|silver|Silver Russell Syndrome|Russell-Silver Syndrome|Dwarfism, Silver-Russell"
D060887,BIOCHEMICAL,B7 Antigens,"Antigens|B 7 Antigen|Antigens, B7|B-7 Antigen|Antigen, B-7|B7 Costimulatory Molecules|Costimulatory Molecules, B7|B7 Antigen|Antigen, B7|B7 Molecules|Molecules, B7"
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Dementia_with_Lewy_Bodies,DISEASE,dementia with lewy bodies,Lewy body-associated dementias
NEW11393,BIOCHEMICAL,neuronal- antigen,neuronal- antigens
D016643,CHEMICAL,"Encephalopathy, Bovine Spongiform","Mad Cow Diseases|BSE (Bovine Spongiform Encephalopathy)|Bovine spongiform encephalopathy|Spongiform Encephalopathy, Bovine|Bovine Spongiform Encephalitis|Bovine Spongiform Encephalopathy|BSE|Mad Cow Disease|BSEs (Bovine Spongiform Encephalopathy)|Encephalitis, Bovine Spongiform"
NEW11394,CHEMICAL,certain amino acid residue,certain amino acid residues
C108475,CHEMICAL,pitavastatin [Supplementary Concept],Pitavastatin|Quinolines
C107067,NUTRITION,"2,4,6-trihydroxyacetophenone [Supplementary Concept]",Acetophenones|acetophenone
NEW11397,BIOCHEMICAL,vitamin b6 supplementation,vitamin B6 supplementation
NEW11399,BIOCHEMICAL,environmental oestrogen,Environmental oestrogens
D020511,DISEASE,Neuromuscular Junction Diseases,"Neuromuscular Junction Disease|Neuromuscular Junction Toxic Disorders|Toxic Disorders, Neuromuscular Junction|Neuromuscular Transmission Disorders|Neuromuscular Transmission Disorder|Neuromuscular Junction Disorder|Neuromuscular Junction Disorders|neuromuscular junction"
NEW11402,CHEMICAL,da receptor,DA receptors
NEW11403,CHEMICAL,postsynaptic da receptor,postsynaptic DA receptors
NEW11405,CHEMICAL,dope ZnO,doped ZnO
NEW11407,CHEMICAL,chronic aicar administration,Chronic AICAR administration
NEW11408,CHEMICAL,chronic aicar treatment,chronic AICAR treatment
NEW11410,CHEMICAL,adenosine monophosphate-activated protein kinase agonist 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside,AICAR|adenosine monophosphate-activated protein kinase agonist 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside
NEW11415,BIOCHEMICAL,new female androgen patch,new female androgen patch
NEW11416,CHEMICAL,l. fruit,L. fruits
NEW11418,CHEMICAL,da agonist,DA agonist|lisuride
NEW11419,CHEMICAL,dopaminergic da response,dopaminergic DA response
NEW11420,DISEASE,behavioral aggression,Behavioral aggression
D062646,BIOCHEMICAL,Acid Sensing Ion Channel Blockers,"Blockers, ASIC Channel|ASIC Channel Antagonists|Proton-Gated Sodium Channel Blockers|Acid Sensing Ion Channel Inhibitors|ASIC Channel Blockers|channel antagonists|ASIC Blockers|Channel Blockers, ASIC|ASIC Inhibitors|Channel Antagonists, ASIC|Proton Gated Sodium Channel Blockers|Antagonists, ASIC Channel"
D014363,CHEMICAL,Tryptamines,triptan|Triptan|Triptans|Indolylethylamines
NEW11428,BIOCHEMICAL,prophylactic treatment beta-adrenoceptor antagonist,prophylactic treatment beta-adrenoceptor antagonists
NEW01910,CHEMICAL,d2 dopamine receptor,D2 dopamine receptors
D020315,DISEASE,Latex Hypersensitivity,"Allergy, Rubber Latex|Allergy, Rubber|Rubber Allergy|Rubber Latex Allergy|Hypersensitivity, Latex|Allergies, Latex|Latex Allergy|Allergies, Rubber|Allergies, Rubber Latex|Rubber Allergies|Natural Rubber Latex Allergy|Latex Allergies|Hypersensitivities, Latex|Allergy, Latex|allergies|Rubber Latex Allergies|Latex Hypersensitivities"
NEW11432,DISEASE,coloboma mouse,coloboma mice
NEW11433,BIOCHEMICAL,alpha(2)-adrenergic receptor antagonist yohimbine,alpha(2)-adrenergic receptor antagonist yohimbine
NEW11434,CHEMICAL,serotonin 5-ht system activity,serotonin 5-HT system activity
NEW11438,CHEMICAL,pre-synaptic 5-ht function,pre-synaptic 5-HT function
D016137,CHEMICAL,Spina Bifida Cystica,"SB|Spina Bifida Aperta|Spina Bifida Manifesta|Open Spina Bifida|Spina bifida|Spina Bifida, Open"
NEW11442,CHEMICAL,polyene-loaded ergosterol-immobilized slab,polyene-loaded ergosterol-immobilized slabs
NEW11445,CHEMICAL,mir-330 3p target site snp,miR-330 3p target site SNP
NEW11446,CHEMICAL,Rs41305272,Rs41305272
NEW11447,BIOCHEMICAL,rs41305272*t carrier frequency,Rs41305272*T carrier frequency
NEW11448,CHEMICAL,predict mir-330 3p target gene,Predicted miR-330 3p target genes
NEW11449,DISEASE,treatment-emergent nausea,treatment-emergent nausea
NEW11450,NUTRITION,cerebral folate deficiency,Cerebral folate deficiency
C548696,CHEMICAL,"FOLR1 protein, human [Supplementary Concept]",FOLR1|Folate Receptor 1
NEW11452,NUTRITION,folr1-related folate deficiency present,FOLR1-related folate deficiency present
NEW11453,DISEASE,early childhood.(2 Seizures,early childhood.(2 Seizures
NEW11456,BIOCHEMICAL,platelet glycoprotein gp iib/iiia receptor antagonist,Platelet glycoprotein Gp IIb/IIIa receptor antagonists
NEW11457,MENTAL_HEALTH,non-st-segment elevation acute coronary syndrome,non-ST-segment elevation acute coronary syndromes
NEW11458,CHEMICAL,anticonvulsive agent gabapentin,anticonvulsive agent gabapentin
D000071442,MENTAL_HEALTH,Taxis Response,"Taxis Responses|Avoidance, Thermal|Compass orientation|Thermal Avoidance|Compass Orientation|Response, Taxis|Thermotaxis|Galvanotaxis|Avoidance, Heat|Orientation, Compass|Heat Avoidance|Tropotaxis|Responses, Taxis"
NEW11460,CHEMICAL,serum ua elevation,serum UA elevation
NEW11461,CHEMICAL,serum creatinine,serum creatinine
D016604,CHEMICAL,Aflatoxin B1,"Aflatoxin B(1)|HSDB3453|NSC 529592|Aflatoxin B1, cis(+,-)-Isomer|Aflatoxin B1 Dihydrochloride, (6aR-cis)-Isomer|Aflatoxin B1, (6aR-cis)-Isomer, 14C-Labeled|Aflatoxin B|NSC-529592|Aflatoxin B1, (6aR-cis)-Isomer, 2H-Labeled|HSDB 3453|NSC529592|aflatoxin B1|Aflatoxin B1, (6aR-cis)-Isomer, 3H-Labeled|HSDB-3453"
http://purl.obolibrary.org/obo/MFOMD_0000174,MENTAL_HEALTH,regression,Regression algorithms-that
NEW11466,BIOCHEMICAL,potent paf antagonist,potent PAF antagonist
C103289,CHEMICAL,lexipafant [Supplementary Concept],lexipafant|Leucine/analogs  and  derivatives|Imidazoles
NEW11467,DISEASE,"5,10-methylenetetrahydrofolate reductase mthfr deficiency","5,10-methylenetetrahydrofolate reductase MTHFR deficiency"
NEW11468,DISEASE,various snps/mutation,various SNPs/mutations
NEW11470,DISEASE,x-linked gene sts,X-linked gene STS
NEW00504,CHEMICAL,methadone maintenance treatment,methadone maintenance treatment
NEW11473,DISEASE,alternaria toxin reduction,Alternaria toxins reduction
http://purl.obolibrary.org/obo/DOID_0060436,DISEASE,chromosome 22q11.2 microduplication syndrome,duplication 22q11.2|trisomy 22q11.2|22q11.2 microduplication syndrome|22q11.2 microdeletion
NEW11475,CHEMICAL,clozapine treatment,clozapine treatment
NEW11476,NUTRITION,bobwhite quail,bobwhite quail
C035598,DISEASE,"enterotoxin, Clostridium [Supplementary Concept]",Clostridium perfringens type A|Enterotoxins
NEW11479,DISEASE,ulcerative enteritis-like disease,Ulcerative enteritis-like disease
http://purl.obolibrary.org/obo/NCBITaxon_10278,DISEASE,molluscipoxvirus,A/chicken/Hong Kong/220/97 HK/220 HPAI virus
NEW11480,BIOCHEMICAL,b-cell maturation antigen bcma,B-cell maturation antigen BCMA
NEW11481,BIOCHEMICAL,antigen expression,antigen expression
D001555,CHEMICAL,Benzene Derivatives,"Benzene|Derivatives, Benzene"
D020926,CHEMICAL,Medetomidine,"medetomidine|Medetomidine Hydrochloride|Hydrochloride, Medetomidine|MPV785|Levomedetomidine|MPV 785|MPV-785"
NEW11486,CHEMICAL,transmucosal route,transmucosal routes
NEW11487,DISEASE,obesity-related chronic pain,Obesity-related chronic pain
NEW11488,CHEMICAL,conjugate bilirubin,conjugated bilirubin
NEW11489,MENTAL_HEALTH,final logistic regression model,final logistic regression model
D060467,MENTAL_HEALTH,Disease Resistance,"disease resistance|Resistance, Disease|Disease Resistances|Resistances, Disease"
D000089882,CHEMICAL,Antimicrobial Peptides,"Peptide, Antimicrobial|AMP|antimicrobial peptides|Antimicrobial Peptide"
D000068579,CHEMICAL,Celecoxib,Celecoxib|SC 58635|4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide|SC-58635|Celebrex|SC58635
D000080702,DISEASE,Edible Insects,"Insects As Food|Edible Insect|Insects As Foods|Food, Insects As|insects|Insect, Edible|Insects, Edible|As Foods, Insects|As Food, Insects|Foods, Insects As"
D007023,DISEASE,"Hypotension, Controlled","Hypotension, Induced|Induced Hypotension|controlled hypotension|Controlled Hypotension"
NEW11497,CHEMICAL,agent isoflurane,agents isoflurane
NEW11498,DISEASE,reward-related eat behavior,reward-related eating behavior
C453360,CHEMICAL,"6-O-(2'', 4''-diacetyl-3'' -O-p-methoxycinnamoyl)-rhamnopyranosyl catalpol [Supplementary Concept]",Cinnamates|Iridoid Glycosides|catalpol
NEW11500,CHEMICAL,lonchocarpus cyanescen,Lonchocarpus cyanescens
NEW11501,CHEMICAL,pb exposure,Pb exposure
NEW11503,NUTRITION,pacific oyster mortality syndrome,Pacific oyster mortality syndrome
NEW11505,BIOCHEMICAL,mollusc-derived antiviral,Mollusc-derived antivirals
NEW11507,NUTRITION,pacific oyster,Pacific oyster
NEW11509,NUTRITION,Pacific Oyster Mortality Syndrome,Pacific Oyster Mortality Syndrome
NEW11510,CHEMICAL,γ-aminobutyric acid gaba analogue,γ-aminobutyric acid GABA analogues
NEW11512,NUTRITION,plasma alpha-tocopherol,Plasma alpha-tocopherol
NEW11513,NUTRITION,novel wheat adp-ribosylation factor-like protein 6-interacting protein gene,novel wheat ADP-ribosylation factor-like protein 6-interacting protein gene
NEW11516,CHEMICAL,taarl6ip4,TaArl6ip4
NEW11517,CHEMICAL,taarl6ip4 expression,TaArl6ip4 expression
NEW11520,CHEMICAL,taarl6ip4,TaARL6IP4
http://purl.obolibrary.org/obo/CHEBI_65423,CHEMICAL,ardimerin digallate,"ardimerin 6,6'-digallate|theaflavins"
C063843,CHEMICAL,insulin gene enhancer binding protein Isl-1 [Supplementary Concept],ISL|LIM-Homeodomain Proteins|Transcription Factors
NEW11530,CHEMICAL,morphine plasma concentration,morphine plasma concentration
NEW11537,CHEMICAL,conventional monoaminergic antidepressant,conventional monoaminergic antidepressants
NEW11538,CHEMICAL,modulator ketamine,modulator ketamine
http://purl.obolibrary.org/obo/DOID_602,MENTAL_HEALTH,cancerophobia,Fear of getting cancer|cancer phobia|compulsion
NEW11542,CHEMICAL,ng tube,NG tube
NEW11543,DISEASE,functional intestinal obstruction,functional intestinal obstruction
NEW11544,BIOCHEMICAL,alpha-2 agonist use,alpha-2 agonist use
C018152,CHEMICAL,sucrose monolaurate [Supplementary Concept],sucrose laurate|Sucrose/analogs  and  derivatives
http://purl.obolibrary.org/obo/CHEBI_140431,CHEMICAL,cis-phytol,FO/flaxseed oil
NEW11548,DISEASE,arg-induced nephrotoxicity,ARG-induced nephrotoxicity
NEW11550,MENTAL_HEALTH,antioxidant defense mechanism,antioxidant defense mechanism
http://purl.obolibrary.org/obo/CHEBI_135892,CHEMICAL,acetyldigoxin,PUFA-enriched FO|novodigal|beta acetyldigoxin|beta-Acetyldigoxin
C028521,CHEMICAL,lanthanum chloride [Supplementary Concept],Lanthanum|lanthanum chloride
D018281,DISEASE,Cholangiocarcinoma,"cholangiocarcinoma|Carcinomas, Cholangiocellular|Extrahepatic Cholangiocarcinoma|Extrahepatic Cholangiocarcinomas|Carcinoma, Cholangiocellular|Intrahepatic Cholangiocarcinoma|Cholangiocellular Carcinoma|Cholangiocellular Carcinomas|Cholangiocarcinoma, Intrahepatic|Cholangiocarcinomas, Intrahepatic|Cholangiocarcinomas|Cholangiocarcinomas, Extrahepatic|Intrahepatic Cholangiocarcinomas|Cholangiocarcinoma, Extrahepatic"
C000648425,DISEASE,Flavobacterium columnare [Supplementary Concept],Flavobacterium columnare|Flavobacterium
NEW11556,CHEMICAL,lyase-deficient δcsla δcslb mutant,lyase-deficient ΔcslA ΔcslB mutant
C103308,DISEASE,"VAH1 protein, Listonella anguillarum [Supplementary Concept]",Hemolysin Proteins|Listonella anguillarum|Bacterial Proteins
C431071,DISEASE,"cml protein, Xenopus [Supplementary Concept]",Acetyltransferases|Xenopus Proteins|CML
http://purl.obolibrary.org/obo/CHEBI_38215,CHEMICAL,calcium channel blocker,calcium channel antagonists|calcium channel blockers|calcium channels blocker|calcium channel antagonist
NEW11565,CHEMICAL,glutamate complex receptor,glutamate complex receptor
NEW11568,CHEMICAL,sex steroid,Sex steroids
NEW03398,BIOCHEMICAL,cross-sex hormone therapy,cross-sex hormone therapy
D050582,CHEMICAL,Excitatory Amino Acid Transporter 5,"SLC1A7 Transporter|Transporter, SLC1A7|EAA|excitatory amino acid|EAAT 5 Excitatory Amino Acid Transporter|EAAT-5 Excitatory Amino Acid Transporter"
NEW11570,CHEMICAL,excitatory amino acid pathway,excitatory amino acid pathways
NEW11571,MENTAL_HEALTH,lc hyperactivity,LC hyperactivity
NEW11573,DISEASE,social phobic patient,social phobic patients
C586085,CHEMICAL,perfluoroundecanoic acid [Supplementary Concept],PFA|Fatty Acids|Fluorocarbons
NEW11577,CHEMICAL,"environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin","environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin|TCDD"
D051786,CHEMICAL,Cyclic AMP Response Element Modulator,"CREM Protein, epsilon Isoform|ICERIIgamma|cyclic AMP response|CREM Protein, alpha Isoform|cAMP Responsive Element Modulator|Inducible cAMP Early Regulator|ICERIgamma|CREM Protein, gamma Isoform|CREM Protein, tau Isoform|cAMP-Responsive Element Modulator"
http://purl.obolibrary.org/obo/CHEBI_48540,BIOCHEMICAL,beta-adrenergic drug,beta-adrenergic drugs
D015269,CHEMICAL,Mycobacterium avium Complex,Mycobacterium avium complex|Mycobacterium intracellulare|Nocardia intracellularis|MAIC|Mycobacterium avium-intracellulare Complex|Mycobacterium avium-intracellulare|Battey Bacillus
NEW11579,DISEASE,erector spinae plane block,ESPB|Erector spinae plane block
C007287,BIOCHEMICAL,"dexon (fungicide), sodium salt [Supplementary Concept]",Benzenesulfonates|fungicide
NEW11582,NUTRITION,wheat host plant,wheat host plants
NEW11584,DISEASE,b. graminis infection,B. graminis infection
NEW11587,CHEMICAL,pms common,PMS common
NEW11590,DISEASE,nocturnal hypoxemia,nocturnal hypoxemia
D012892,MENTAL_HEALTH,Sleep Deprivation,"Sleep fragmentation|Syndrome, Insufficient Sleep|Deprivation, REM Sleep|Insufficiencies, Sleep|Sleep, Inadequate|Sleep Deprivation, REM|Sleep Insufficiencies|Insufficient Sleep|Sleep Debt|Insufficiency, Sleep|Insufficient Sleep Syndrome|Sleep Insufficiency|Sleep, Insufficient|Fragmentation, Sleep|Insufficient Sleep Syndromes|REM Sleep Deprivation|Inadequate Sleep|Deprivation, Sleep|Sleep Fragmentation"
NEW11595,CHEMICAL,dab staining,DAB staining
NEW11597,DISEASE,mildew infection,mildew infection
C523462,CHEMICAL,benzyloxycarbonyl-leucyl-leucyl-norleucinal [Supplementary Concept],Oligopeptides|GSI|TLnp/D&G
NEW11600,DISEASE,derive hdl,derived HDL
NEW11603,CHEMICAL,iv amphotericin b,IV Amphotericin B
NEW11604,BIOCHEMICAL,antifungal therapy,Antifungal therapy
D020235,MENTAL_HEALTH,Gait Apraxia,"Gait Dyspraxias|Apraxias, Bruns' Gait|Bruns' Gait Apraxia|Gait Apraxia, Bruns'|gait apraxia|Apraxia, Bruns' Gait|Dyspraxia of Gait|Apraxia, Gait|Apraxias, Gait|Frontal Gait Apraxias|Bruns' Gait Apraxias|Bruns' Apraxia, Gait|Apraxias, Frontal Gait|Gait Apraxias, Bruns'|Gait Apraxias|Gait Dyspraxia|Bruns Apraxia, Gait|Bruns Gait Apraxia|Bruns' Apraxia of Gait|Gait Apraxia, Frontal|Apraxia of Gait|Frontal Gait Apraxia|Apraxia, Frontal Gait|Gait Apraxias, Frontal"
NEW11606,DISEASE,therapy-resistant parkinsonism,therapy-resistant parkinsonism
NEW11607,CHEMICAL,Acetaminophen misuse,Acetaminophen misuse
NEW11608,MENTAL_HEALTH,structure-activity rationalization,structure-activity rationalization
NEW11611,CHEMICAL,inherited amino acid substitution,Inherited amino acid substitutions
D000080662,NUTRITION,Phospholipid Hydroperoxide Glutathione Peroxidase,"PHGPx Enzyme|GPX4 Phospholipid Hydroperoxide Glutathione Peroxidase|PH-GPeroxidase|Phospholipid-Hydroperoxide Glutathione Peroxidase|Phospholipid Hydroperoxide Glutathione Peroxidase GPX4|phospholipid hydroperoxide|Selenium-Dependent Glutathione Peroxidase Type-4|Selenium Dependent Glutathione Peroxidase Type 4|Glutathione Peroxidase 4|PH GPeroxidase|Glutathione Peroxidase, Phospholipid-Hydroperoxide"
NEW11612,BIOCHEMICAL,toad toxin,toad toxins
NEW11613,DISEASE,neuropsychiatric disease secondary,neuropsychiatric diseases secondary
C487049,CHEMICAL,BXL628 [Supplementary Concept],Elocalcitol|Calcitriol/analogs  and  derivatives
NEW11619,CHEMICAL,sim-9 microglia cell,SIM-9 microglia cells
NEW11622,CHEMICAL,β(1)ar,β(1)AR
NEW11623,DISEASE,body-focused repetitive behavior disorder,Body-focused repetitive behavior disorders
D024504,CHEMICAL,gamma-Tocopherol,"3,4-Dihydro-2,7,8-trimethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-ol|gamma-tocopherol|GTF"
NEW11626,BIOCHEMICAL,vitamin toxicity,vitamin toxicity
NEW11627,DISEASE,non-union,non-union
NEW11630,BIOCHEMICAL,serum sex hormone,serum sex hormones
NEW11631,DISEASE,severe psychiatric condition,severe psychiatric conditions
NEW11634,DISEASE,high-functioning adult male subject,high-functioning adult male subjects
C000598571,CHEMICAL,"(6-chloro-1-(2-(dimethylamino)ethyl)indol-3-yl)-spiro(1H-isobenzofuran-3,4'-piperidine)-1'-yl-methanone [Supplementary Concept]",RO5028442|Spiro Compounds|Indoles
NEW11637,DISEASE,ptsd-like sequela,PTSD-like sequelae
NEW11639,BIOCHEMICAL,US Drug Administration,US Drug Administration
NEW11640,BIOCHEMICAL,low level carcinogen,low level carcinogens
NEW11642,CHEMICAL,primary hepatic angiosarcoma,PHA|Primary hepatic angiosarcoma
http://purl.obolibrary.org/obo/MFOMD_0000167,MENTAL_HEALTH,defense mechanism,defense mechanism
C099641,NUTRITION,"PRS3S protein, Papaver rhoeas [Supplementary Concept]",Plant Proteins|Papaver rhoeas
D064233,CHEMICAL,Sulfonylurea Receptors,"Sulfonylurea Receptor|Receptor, Sulfonylurea|Receptors, Sulfonylurea|sulfonylurea"
NEW11645,CHEMICAL,tribenuron resistant,tribenuron resistant|R
NEW11646,CHEMICAL,non-sulfonylurea als-inhibiting herbicide,non-sulfonylurea ALS-inhibiting herbicides
C471341,DISEASE,"29-kDa outer membrane protein, Acinetobacter baumannii [Supplementary Concept]",A. baumannii|Bacterial Proteins
NEW11648,CHEMICAL,importance rifabutin,IMPORTANCE Rifabutin
NEW11650,NUTRITION,lipogenic enzyme fatty acid synthase,lipogenic enzyme fatty acid synthase
NEW11651,MENTAL_HEALTH,fas hyperactivity,FAS hyperactivity
NEW11653,CHEMICAL,slow-binding fas inhibitor,slow-binding FAS inhibitor
NEW11655,CHEMICAL,pr- fas up-regulation,PR- FAS up-regulation
NEW11658,CHEMICAL,anti-estrogen ici,anti-estrogen ICI
C536300,DISEASE,Partington X-linked mental retardation syndrome [Supplementary Concept],"dystonia|dystonic movements|Mental Retardation, X-Linked|Ataxia|Seizures"
NEW11663,BIOCHEMICAL,neurobiological hormone sensitivity,neurobiological hormone sensitivities
NEW11667,DISEASE,rat trigeminal ganglia,rat trigeminal ganglia|TG
C006606,CHEMICAL,anti-thyroglobulin [Supplementary Concept],anti-thyroglobulin|Autoantibodies|A-TG
NEW04050,MENTAL_HEALTH,suicide risk,suicide risk
D051667,CHEMICAL,Kv1.6 Potassium Channel,"Potassium channel|Potassium Channel, HBK2|HBK2 Potassium Channel|KCNA6 Potassium Channel|Potassium Channel, KCNA6|Potassium Channel, Kv1.6|RCK2 Potassium Channel|Potassium Channel, RCK2"
C546026,CHEMICAL,"2-(2-methyl-1H-indol-3-yl)-1H-imidazol(4,5-f)(1,10)phenanthroline [Supplementary Concept]",Phenanthrolines|ML133|Imidazoles
NEW11675,CHEMICAL,levodopa administration,levodopa administration
C505239,CHEMICAL,amyloid beta-protein (1-6) [Supplementary Concept],Amyloid beta-Peptides|Peptide Fragments|Aβ1
NEW11677,NUTRITION,brain fatty acid metabolism,brain fatty acid metabolism
NEW11679,BIOCHEMICAL,high carotenoid,High carotenoid
http://purl.obolibrary.org/obo/CHEBI_23044,BIOCHEMICAL,carotenoid,xanthophyll carotenoid|carotenoids|carotenes and carotenoids|carotenoid
D000072743,CHEMICAL,Beta-Cryptoxanthin,β-cryptoxanthin|Beta Cryptoxanthin
NEW11681,NUTRITION,platelet alpha 2-receptor,platelet alpha 2-receptors
http://purl.obolibrary.org/obo/CHEBI_36413,BIOCHEMICAL,anabolic agent,anabolic agent
http://purl.obolibrary.org/obo/DOID_4337,DISEASE,tinea capitis,Dermatophytosis of scalp|dermatophytosis of scalp or beard|Scalp ringworm|Trichophyton rubrum tinea capitis|Molds-induced Tinea capitis|tinea capitis due to Trichophyton rubrum
NEW11683,DISEASE,behavioral damage,behavioral damage
NEW11684,CHEMICAL,high thc content,high THC content
NEW11687,CHEMICAL,pro dopamine regulation,pro dopamine regulation
D000069447,CHEMICAL,Tiotropium Bromide,"679 BR, BA|BA679 BR|tiotropium|Spiriva|BA 679 BR|BA-679 BR|BR, BA 679|Tiotropium|7-((hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane bromide|Bromide, Tiotropium"
NEW11690,BIOCHEMICAL,long-acting muscarinic antagonist,Long-acting muscarinic antagonists
NEW11693,BIOCHEMICAL,postmenopausal estrogen replacement therapy,postmenopausal estrogen replacement therapy
NEW11695,CHEMICAL,dopamine receptor blocking agent,dopamine receptor blocking agents
NEW11430,DISEASE,tremor dominant,TD|Tremor Dominant
NEW11698,CHEMICAL,vaccine-induced immune thrombotic thrombocytopenia,Vaccine-induced immune thrombotic thrombocytopenia|VITT
NEW11700,CHEMICAL,apixaban immunoglobulin ivig infusion,apixaban immunoglobulin IVIG infusion
NEW11701,CHEMICAL,platelet mao activity,platelet MAO activity
NEW11702,CHEMICAL,haloperidol administration,haloperidol administrations
NEW11704,CHEMICAL,acute reserpine,acute reserpine
NEW11705,CHEMICAL,approve antiseizure medication,approved antiseizure medications
http://purl.obolibrary.org/obo/DOID_2842,DISEASE,jervell-lange nielsen syndrome,Jervell and Lange-Nielson syndrome|SCN1A-related Dravet syndrome
NEW11706,CHEMICAL,sex steroid receptor,sex steroid receptors
NEW11707,CHEMICAL,fibrate medication,Fibrate medications
NEW11709,CHEMICAL,ppar-α ly518674,PPAR-α LY518674
NEW02794,BIOCHEMICAL,potent agonist,potent agonist
NEW11710,CHEMICAL,a derivative retinoic acid,A derivative retinoic acid
NEW11712,DISEASE,bladder inflammation,bladder inflammation
NEW11716,DISEASE,bladder hypersensitivity,bladder hypersensitivity
D018674,BIOCHEMICAL,Adrenergic Antagonists,"Agents, Adrenergic-Blocking|Adrenergic Antagonist|Receptor Antagonists, Adrenergic|Blockaders, Adrenergic Receptor|Blocker, Adrenergic|Antagonist, Adrenergic|Anti-Adrenergics|Adrenergic Blockers|Adrenolytics|Anti Adrenergics|Adrenolytic Agents|Blockers, Adrenergic|Drugs, Adrenolytic|Blockaders, Adrenergic|Antiadrenergic Agents|Adrenolytic Drugs|adrenergic blockers|Adrenergic Blocker|Antiadrenergics|Antagonists, Adrenergic Receptor|Antagonists, Adrenergic|Adrenergic Receptor Blockaders|Adrenergic-Blocking Agents|Adrenergic Receptor Antagonists|Adrenergic Blockaders|Receptor Blockaders, Adrenergic|Agents, Adrenolytic|Agents, Antiadrenergic|Adrenergic Blocking Agents"
NEW11721,DISEASE,cerebral disease,cerebral diseases
NEW11722,BIOCHEMICAL,rt inhibitor,RT inhibitor
D012365,CHEMICAL,"RNA, Transfer, Tyr","Tyr|Tyrosine Specific tRNA|tRNATyr|tRNA(Tyr)|tRNA, Tyrosine-Specific|Tyrosine-Specific tRNA|RNA, Tyr Transfer|Tyr Transfer RNA|Transfer RNA, Tyr"
NEW11723,CHEMICAL,n348i mutation,N348I mutation
NEW11726,CHEMICAL,n348i,N348I
NEW11728,CHEMICAL,rnase h activity,RNase H activity
NEW01517,MENTAL_HEALTH,withdrawal-induced anxiety,withdrawal-induced anxiety
NEW11731,CHEMICAL,paracetamol dose,Paracetamol dose
NEW11733,CHEMICAL,histamine system,histamine system
NEW04673,DISEASE,traumatic event,traumatic events
NEW11736,CHEMICAL,prepare clonidine admixture,prepared clonidine admixture
NEW11737,NUTRITION,fatty acid supplementation,Fatty acid supplementation
NEW11738,BIOCHEMICAL,adequate folate intake,adequate folate intake
C008922,CHEMICAL,piperine [Supplementary Concept],Alkaloids|piperine|Polyunsaturated Alkamides|Piperidines|Benzodioxoles
D016640,DISEASE,"Diabetes, Gestational","Diabetes, Pregnancy-Induced|Diabetes Mellitus, Gestational|Gestational Diabetes|Diabetes, Pregnancy Induced|gestational diabetes mellitus|Pregnancy-Induced Diabetes|Gestational Diabetes Mellitus"
NEW11740,DISEASE,pregnancy-specific disorder,Pregnancy-specific disorders
D006939,DISEASE,Hyperemesis Gravidarum,Pregnancy Pernicious Vomiting|hyperemesis gravidarum|Pernicious Vomiting of Pregnancy
NEW11741,CHEMICAL,tumor necrosis factor-alpha inhibitor thalidomide,tumor necrosis factor-alpha inhibitor thalidomide
NEW11742,CHEMICAL,abnormal myo-inositol metabolism,Abnormal myo-inositol metabolism
NEW11744,CHEMICAL,lepidagathis hyalina Nees,Lepidagathis hyalina Nees
D020324,MENTAL_HEALTH,"Amnesia, Anterograde","Anterograde Memory Losses|Amnesias, Anterograde|Anterograde Amnesias|Post-Ictal Memory Losses|Amnesias, Post-Ictal|Amnesia, Post Ictal|Anterograde Amnesia|Post Ictal Memory Loss|Post-Ictal Amnesias|Anterograde Memory Loss|Amnesia, Post-Ictal|Memory Loss, Anterograde|Memory Loss, Post-Ictal|Memory Losses, Post-Ictal|anterograde amnesia|Post-Ictal Amnesia|Post-Ictal Memory Loss|Losses, Post-Ictal Memory|Loss, Post-Ictal Memory|Memory Losses, Anterograde"
NEW11747,BIOCHEMICAL,selective serotonergic agonist fluoxetine,selective serotonergic agonist fluoxetine
NEW11748,MENTAL_HEALTH,major depressive disorder alcohol dependence,major depressive disorder alcohol dependence
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Diagnosis,DISEASE,diagnosis,DSM-III-R diagnoses
http://purl.obolibrary.org/obo/DOID_224,DISEASE,transient cerebral ischemia,Transient cerebral ischaemia|Transient ischemic attacks|TIA - Transient ischaemic attack|TRANSIENT ISCHEMIC ATTACK|global transient cerebral ischemia|Transient cerebral ischemia|TIA|transient ischemic attack
NEW11751,MENTAL_HEALTH,analytical projection model,analytical projection model
NEW11753,NUTRITION,benthic-oriented brown bullhead,Benthic-oriented brown bullhead
NEW11754,NUTRITION,white sucker,white sucker
NEW11755,NUTRITION,brown bullhead,brown bullhead
NEW11758,CHEMICAL,acute antidepressant efficacy,acute antidepressant efficacy
D006820,CHEMICAL,Hyaluronic Acid,"Sodium Hyaluronate|Etamucine|Luronit|Hyaluronate, Sodium|Hyaluronate Sodium|Healon|hyaluronic acid|Amo Vitrax|Vitrax, Amo|Biolon|Hyaluronan|Hyvisc|Amvisc|Acid, Hyaluronic"
D011225,DISEASE,Pre-Eclampsia,"Hypertension Edema Proteinuria Gestosis|Gestosis, Hypertension-Edema-Proteinuria|Pregnancies, Toxemia Of|EPH Toxemias|EPH Toxemia|Proteinuria-Edema-Hypertension Gestosis|Preeclampsia Eclampsia 1s|Eclampsia 1s, Preeclampsia|Of Pregnancies, Toxemia|Toxemia, EPH|Gestosis, Edema-Proteinuria-Hypertension|Edema-Proteinuria-Hypertension Gestosis|Toxemia Of Pregnancies|1s, Preeclampsia Eclampsia|Edema Proteinuria Hypertension Gestosis|Pregnancy, Toxemia Of|Toxemia, Pregnancy|Pre Eclampsia|Gestosis, EPH|EPH Complex|EPH Gestosis|Hypertension-Edema-Proteinuria Gestosis|Gestosis, Proteinuria-Edema-Hypertension|Pregnancy Toxemia|Of Pregnancy, Toxemia|Toxemias, Pregnancy|Proteinuria Edema Hypertension Gestosis|Toxemia Of Pregnancy|1, Preeclampsia Eclampsia|Preeclampsia Eclampsia 1|Pregnancy Toxemias|Toxemias, EPH|Eclampsia 1, Preeclampsia|Preeclampsia|PE"
D015799,DISEASE,Gyrate Atrophy,"Ornithine Aminotransferase Deficiency|Ornithine Keto Acid Aminotransferase Deficiency|OKT Deficiency|Hyperornithinemia with Gyrate Atrophy of Choroid and Retina|Ornithine Ketoacid Aminotransferase Deficiency|Deficiency, OAT|Ornithinemia with Gyrate Atrophy|Deficiency, Ornithine-Delta-Aminotransferase|Ornithine Delta Aminotransferase Deficiency|Atrophy, Gyrate|Deficiency, Ornithine Aminotransferase|Deficiency, OKT|gyrate atrophy|Gyrate Atrophy of Choroid and Retina|Gyrate Atrophy of the Choroid and Retina|OAT Deficiency|Ornithine-Delta-Aminotransferase Deficiency"
NEW11764,BIOCHEMICAL,partial opioid agonist,partial opioid agonist
NEW11765,BIOCHEMICAL,kappa opioid antagonist property,kappa opioid antagonist properties
C576986,CHEMICAL,morin-5'-sulfonic acid [Supplementary Concept],morin|Sulfonic Acids|Flavonoids
NEW11767,DISEASE,behavioral deficit,Behavioral deficits
NEW11771,CHEMICAL,polyinosinic polycytidylic acid poly(i,polyinosinic polycytidylic acid poly(I
NEW11772,CHEMICAL,novel antidepressant (r)-ketamine,novel antidepressant (R)-ketamine
NEW11774,CHEMICAL,(r)-ketamine,(R)-ketamine
NEW11776,BIOCHEMICAL,trkb antagonist weekly,TrkB antagonist weekly
C559317,CHEMICAL,ANA 12 compound [Supplementary Concept],Azepines|ANA-12|Benzamides
NEW11779,MENTAL_HEALTH,ramble accumulation pattern,rambling accumulation pattern
NEW11782,CHEMICAL,oral antidepressant,oral antidepressants|ADs
NEW11783,CHEMICAL,esketamine nasal spray,Esketamine nasal spray
NEW11784,CHEMICAL,esketamine nasal spray,esketamine nasal spray
NEW11785,CHEMICAL,intravenous ketamine augmentation,intravenous ketamine augmentation
NEW11787,CHEMICAL,dopamine receptor agonist apomorphine hydrochloride)-stimulate growth hormone release,dopamine receptor agonist apomorphine hydrochloride)-stimulated growth hormone release
NEW09960,CHEMICAL,trimethoprim/sulfamethoxazole,trimethoprim/sulfamethoxazole
NEW11789,CHEMICAL,selective gamma-amino-butyric acid type b gabab receptor agonist,selective gamma-amino-butyric acid type B GABAB receptor agonist
D013693,CHEMICAL,Temazepam,"Temazep Von Ct|Norkotral Tema|Tema, Norkotral|Nu Temazepam|3 Hydroxydiazepam|Methyloxazepam|PMS-Temazepam|Hydroxydiazepam|Ro 5 5345|Euhypnos|Gen Temazepam|Oxydiazepam|SaH 47603|Dasuen|Levanxol|Normitab|Novo Temazepam|Normison|Nu-Temazepam|WY-3917|temazepam|Planum|Apo-Temazepam|Remestan|Restoril|Signopam|Von Ct, Temazep|Temaze|SaH 47 603|Apo Temazepam|Pronervon T|Ro-5-5345|Temtabs|Ro55345|SaH 47-603|Novo-Temazepam|3-Hydroxydiazepam|Tenox|PMS Temazepam|WY3917|WY 3917|Gen-Temazepam|Nortem|Nocturne"
C003466,CHEMICAL,thymoquinone [Supplementary Concept],Benzoquinones|thymoquinone
NEW11795,CHEMICAL,N. sativa,N. sativa
NEW11800,BIOCHEMICAL,opioid agonist therapy,Opioid agonist therapies
NEW11801,DISEASE,phobic symptom,phobic symptoms
NEW11803,CHEMICAL,acetylcholine level,acetylcholine levels
D004734,CHEMICAL,Energy Metabolism,"Metabolism, Energy|Energy Expenditure|Expenditure, Energy|EE|Energy Metabolisms|Bioenergetics|energy expenditure|Expenditures, Energy|Bioenergetic|Metabolisms, Energy|Energy Expenditures"
NEW11807,CHEMICAL,ethanol neurotoxicity,Ethanol neurotoxicity
D020197,DISEASE,"Head Injuries, Penetrating","Penetrating Cranial Traumas|Head Injuries, Penetrating, Missile|head trauma|Cranial Traumas, Penetrating|Trauma, Penetrating Craniocerebral|Head Trauma, Penetrating|Penetrating Missile Injuries, Head|Missile Injuries, Penetrating, Head|Injuries, Penetrating Head|Penetrating Cranial Trauma|Cranial Trauma, Penetrating|Penetrating Craniocerebral Trauma|Penetrating Head Traumas|Trauma, Penetrating Cranial|Penetrating Head Trauma|Craniocerebral Trauma, Penetrating|Brain Injuries, Penetrating|Brain Injury, Penetrating|Craniocerebral Traumas, Penetrating|Injury, Penetrating Head|Head Traumas, Penetrating|Traumas, Penetrating Cranial|Traumas, Penetrating Craniocerebral|Trauma, Penetrating Head|Penetrating Brain Injuries|Traumas, Penetrating Head|Penetrating Craniocerebral Traumas|Penetrating Head Injuries|Penetrating Brain Injury|Penetrating Head Injury|Head Injury, Penetrating"
NEW11810,BIOCHEMICAL,kor agonist,KOR agonist
NEW09673,CHEMICAL,methadone maintenance,Methadone maintenance
NEW06910,CHEMICAL,methadone maintenance,methadone maintenance
NEW11814,BIOCHEMICAL,selective antagonist sb-242084,selective antagonist SB-242084
NEW11816,CHEMICAL,carbon side chain,carbon side chain
http://purl.obolibrary.org/obo/CHEBI_52846,CHEMICAL,cycloalkane ring,cycloalkane rings|thiophene ring
C000611824,DISEASE,"EPS long non-coding RNA, mouse [Supplementary Concept]","RNA, Long Noncoding|EPS|extrapyramidal symptoms"
http://purl.obolibrary.org/obo/CHEBI_85834,CHEMICAL,triacylglycerol 51:4,TAG(51:4)|TG(51:4)|triacylglycerol (TG)-
http://purl.obolibrary.org/obo/CHEBI_77391,BIOCHEMICAL,trimyristin,"Tracylglycerol(42:0)|lecithin (PC)-enriched|TG 14:0/14:0/14:0|1,2,3-Propanetriol tritetradecanoate|TG(14:0/14:0/14:0)|propane-1,2,3-triyl tritetradecanoate|Glycerol trimyristate|1,2,3-tritetradecanoylglycerol|Glyceryl tritetradecanoate|1,2,3-trimyristoylglycerol|Myristic triglyceride|TG(42:0)|TAG(42:0)|Myristic acid triglyceride|trimyristoylglycerol|Tetradecanoic acid, 1,2,3-propanetriyl ester|TAG(14:0/14:0/14:0)|Myristin|Glyceryl trimyristate|Tracylglycerol(14:0/14:0/14:0)|tritetradecanoylglycerol"
NEW11821,NUTRITION,brain cholesterol,brain cholesterol
D051152,CHEMICAL,Clusterin,"SGP-2 Protein|Complement Lysis Inhibitor|TRPM-2 Protein|Complement-Associated Protein SP-40,40|X-Ray-Inducible Protein 8|ApoJ Protein|Testosterone Repressed Prostate Message 2 Protein|MAC393 Antigen|Testosterone-Repressed Prostate Message-2 Protein|Apolipoprotein J|Complement Associated Protein SP 40,40|SP-40,40, Complement-Associated Protein|SGP 2 Protein|apoJ|Ionizing Radiation-Induced Protein-8|Radiation-Induced Protein-8, Ionizing|Sulfated Glycoprotein-2|TRPM 2 Protein|X Ray Inducible Protein 8|XIP8 Protein|SP 40,40 Protein|Sulfated Glycoprotein 2|Ionizing Radiation Induced Protein 8"
NEW11824,MENTAL_HEALTH,freeze point depression,freezing point depression
NEW11825,MENTAL_HEALTH,mla12 resistance pathway,Mla12 resistance pathways
NEW11827,CHEMICAL,barley leave,barley leaves
D000076107,DISEASE,"Diet, High-Protein Low-Carbohydrate","High-Protein Low-Carbohydrate Diets|South Beach Diet|Diets, High-Protein Low-Carbohydrate|Diet, Low-Carbohydrate High-Protein|Diets high|Carbohydrate-Restricted Diet, High-Protein|High-Protein Diet, Low-Carbohydrate|High-Protein Diet, Carbohydrate-Restricted|High-Protein Diets, Carbohydrate-Restricted|Low Carbohydrate High Protein Diet|High Protein Carbohydrate Restricted Diets|Diet, High Protein Low Carbohydrate|Diets, Low-Carbohydrate High-Protein|Low Carbohydrate High Protein Diets|Diet, South Beach|High Protein Low Carbohydrate Diets|Diet, Atkins|High Protein Carbohydrate Restricted Diet|Atkins Diet|High Protein Low Carbohydrate Diet|High-Protein Carbohydrate-Restricted Diets|Carbohydrate Restricted High Protein Diet|Low-Carbohydrate Diet, High-Protein|Low-Carbohydrate High-Protein Diet|Carbohydrate-Restricted High-Protein Diets|High-Protein Low-Carbohydrate Diet|High-Protein Diets, Low-Carbohydrate|Diets, High-Protein Carbohydrate-Restricted|High-Protein Carbohydrate-Restricted Diet|Carbohydrate-Restricted Diets, High-Protein|Low-Carbohydrate Diets, High-Protein|Diet, Carbohydrate-Restricted High-Protein|Carbohydrate-Restricted High-Protein Diet|Low-Carbohydrate High-Protein Diets|Diet, High-Protein Carbohydrate-Restricted|Carbohydrate Restricted High Protein Diets|Diets, Carbohydrate-Restricted High-Protein"
D005227,NUTRITION,Fatty Acids,"Esterified Fatty Acids|Acid, Saturated Fatty|Fatty Acid, Saturated|Saturated Fatty Acids|Saturated Fatty Acid|Aliphatic Acids|Fatty Acid, Esterified|Esterified Fatty Acid|Acid, Esterified Fatty|Acid, Aliphatic|Aliphatic Acid|Fatty Acid|saturated fatty acids|Fatty Acids, Esterified|Fatty Acids, Saturated"
NEW11829,NUTRITION,plasma cholesterol level,plasma cholesterol levels
NEW11830,CHEMICAL,sphingomyelin sm specie,sphingomyelin SM species
NEW11831,DISEASE,severe respiratory impairment,Severe respiratory impairment
NEW11832,CHEMICAL,lipid-lowering fluvastatin,lipid-lowering fluvastatin
http://purl.obolibrary.org/obo/CHEBI_61670,CHEMICAL,oroxylin a 7-o-beta-d-glucuronide,"5,7-dihydroxy-6-methoxyflavone 7-O-beta-D-glucuronide|oroxylin 7-O-beta-D-glucuronide|5-hydroxy-6-methoxy-4-oxo-2-phenyl-4H-chromen-7-yl beta-D-glucopyranosiduronic acid|5-hydroxy-6-methoxy-flavone-7-yl beta-D-glucopyranosiduronic acid|Tanshinone A"
NEW11834,CHEMICAL,tanshinoneⅱa,TanshinoneⅡA
NEW11835,CHEMICAL,porcine brain enzyme hydrolysate,porcine brain enzyme hydrolysate|PBEH
NEW11836,BIOCHEMICAL,non-nucleoside reverse transcriptase inhibitor,non-nucleoside reverse transcriptase inhibitor
NEW11838,CHEMICAL,akt/mapk-related constitutive hyperactivation,AKT/MAPK-related constitutive hyperactivation
NEW11840,MENTAL_HEALTH,her2-driven endocrine resistance,HER2-driven endocrine resistance
NEW11842,CHEMICAL,substance p sp level,Substance P SP levels
http://purl.obolibrary.org/obo/CHEBI_55351,BIOCHEMICAL,substance p receptor antagonist,substance P receptor antagonist MK-869|substance P receptor antagonists
NEW11844,CHEMICAL,rs28836840 SNP,rs28836840 SNP
NEW11845,CHEMICAL,rs28386840 snp,rs28386840 SNP
NEW11848,CHEMICAL,cd to 5-fluorouracil,CD to 5-fluorouracil|5FU
C532843,CHEMICAL,coronarin D [Supplementary Concept],coronarin D|Diterpenes
C538346,DISEASE,Naxos disease [Supplementary Concept],"Arrhythmogenic cardiomyopathy|Keratoderma, Palmoplantar|Hair Diseases|Arrhythmogenic Right Ventricular Dysplasia"
NEW11852,CHEMICAL,acm heart,ACM heart
NEW11853,CHEMICAL,forebrain dopamine activity,forebrain dopamine activity
NEW11857,DISEASE,online hemodiafiltration,HDF|Online hemodiafiltration
NEW08320,MENTAL_HEALTH,severe mental illness,severe mental illness
NEW11860,BIOCHEMICAL,partial dopamine agonist,partial dopamine agonists
NEW10966,CHEMICAL,dopamine d3 receptor-preferential agonist pramipexole,dopamine D3 receptor-preferential agonist pramipexole|PPX
NEW11861,BIOCHEMICAL,b group vitamin,B group vitamins
NEW10659,BIOCHEMICAL,androgen level,androgen levels
NEW11862,NUTRITION,steroid hormone level,steroid hormone levels
NEW11863,CHEMICAL,testosterone precursor,testosterone precursors
NEW11864,CHEMICAL,precursor dehydroepiandrosterone,precursors dehydroepiandrosterone
NEW11865,BIOCHEMICAL,high androgen activity,higher androgen activity
NEW11866,CHEMICAL,many p450-derived lipid,Many p450-derived lipids
NEW11869,BIOCHEMICAL,narcotic addict,Narcotic addicts
NEW11871,DISEASE,cannabinoid hyperemesis syndrome,Cannabinoid Hyperemesis Syndrome
C037036,CHEMICAL,cannabigerol [Supplementary Concept],cannabigerol|Cannabinoids
C536228,DISEASE,Familial cyclic vomiting syndrome [Supplementary Concept],Vomiting|Cyclic Vomiting Syndrome
http://purl.org/sig/ont/fma/fma61811,BIOCHEMICAL,dopamine receptor,D2/D3 dopamine receptor agonist
NEW11877,CHEMICAL,naloxone challenge,Naloxone challenge
NEW11881,CHEMICAL,17α-ethinylestradiol,17α-ethinylestradiol|EE2
C000605449,CHEMICAL,Kai-Xin-San [Supplementary Concept],"KXS|Kai-Xin-San|Drugs, Chinese Herbal"
NEW11888,CHEMICAL,ghb-/gabab-receptor,GHB-/GABAB-receptors
D010188,DISEASE,Exocrine Pancreatic Insufficiency,"Insufficiencies, Pancreatic|Pancreatic Insufficiencies, Exocrine|Pancreatic Insufficiency, Exocrine|Exocrine pancreatic insufficiency|Pancreatic Insufficiency|Insufficiency, Exocrine Pancreatic|Insufficiencies, Exocrine Pancreatic|Exocrine Pancreatic Insufficiencies|Insufficiency, Pancreatic|Pancreatic Insufficiencies"
NEW11890,CHEMICAL,background benzodiazepine,Background Benzodiazepines
D054058,DISEASE,Acute Coronary Syndrome,"Coronary Syndrome, Acute|acute coronary syndromes|Syndrome, Acute Coronary|Acute Coronary Syndromes|Coronary Syndromes, Acute|ACS|Syndromes, Acute Coronary"
D062706,DISEASE,Prodromal Symptoms,"Sign, Prodromal|Symptoms, Prodromal|Period, Prodromal|Signs, Prodromal|Stages, Prodromal|Prodromal Stage|Prodromal State|Prodromal Syndromes|Characteristics, Prodromal|Periods, Prodromal|Syndromes, Prodromal|Prodromal Characteristic|States, Prodromal|Syndrome, Prodromal|Prodromal Signs|Prodromal Characteristics|Characteristic, Prodromal|State, Prodromal|Prodromal Sign|Prodromal Symptom|Prodromal Periods|Prodromal Period|Prodromal Syndrome|Prodromal States|PTSS|symptoms|Prodromal Stages|Symptom, Prodromal|Stage, Prodromal"
NEW11894,CHEMICAL,benzodiazepine use,benzodiazepine use
NEW11897,MENTAL_HEALTH,drought resistance,drought resistance
NEW11899,CHEMICAL,hexagonal mgo nanoparticle,hexagonal MgO nanoparticles
NEW11902,CHEMICAL,mgo nanoparticle,MgO nanoparticles
D053831,MENTAL_HEALTH,Surgical Fixation Devices,"Device, Surgical Fixation|Surgical Fastener|Surgical Fasteners|Fasteners, Surgical|fixation|Fastener, Surgical|Devices, Surgical Fixation|Fixation Device, Surgical|Surgical Fixation Device|Fixation Devices, Surgical"
NEW11906,BIOCHEMICAL,antigen a. method,Antigen A. methods
D014280,CHEMICAL,Triglycerides,Triglyceride|Triacylglycerol|Triacylglycerols|triacylglycerols
C473373,NUTRITION,"RFC3 protein, Arabidopsis [Supplementary Concept]",Arabidopsis Proteins|Fatty acid composition|Ribosomal Proteins
http://purl.obolibrary.org/obo/CHEBI_68565,CHEMICAL,tuberculostearic acid,10-methylstearic acid|docosatrienoic acid|10-methyloctadecanoic acid
C026219,CHEMICAL,docosapentaenoic acid [Supplementary Concept],"docosapentaenoic acid|Fatty Acids, Unsaturated"
NEW11908,DISEASE,3-year-old boy,3-year-old boy
NEW11909,DISEASE,alexithymic subject,Alexithymic subjects
NEW11910,CHEMICAL,hypothalamus-pituitary-adrenal (hpa)-axis,hypothalamus-pituitary-adrenal (HPA)-axis
NEW11911,NUTRITION,functionalize calcium phosphate,functionalized calcium phosphates
NEW11912,MENTAL_HEALTH,OCPd,OCPd
NEW11914,CHEMICAL,l. rhamnosus,L. rhamnosus
NEW11917,DISEASE,invasive mucormycosis,Invasive mucormycosis
D009091,DISEASE,Mucormycosis,"mucormycosis|Infection, Mucorales|Mucormycose|Mucorales Infection|Mucorales Infections|Mucormycoses"
NEW11921,DISEASE,slight hyperprolactinemia,slight hyperprolactinemia
D019257,CHEMICAL,Quinpirole,quinpirole|Quinpirole Hydrochloride|Quinpirole Monohydrochloride
D016202,CHEMICAL,N-Methylaspartate,"N Methyl D aspartate|N Methyl D aspartic Acid|N-Methyl-D-aspartic Acid|NMDA|N Methylaspartate|N-Methyl-D-aspartate|Acid, N-Methyl-D-aspartic|N-methyl-d-aspartic acid"
NEW11931,CHEMICAL,add-on memantine,add-on memantine
NEW11932,NUTRITION,trifolium pratense L.,Red Clover|Trifolium pratense L.
http://purl.obolibrary.org/obo/CHEBI_37667,CHEMICAL,sesquiterpene lactone,new sesquiterpene lactones
D000081207,DISEASE,Primary Immunodeficiency Diseases,"Primary Antibody Deficiency Disorder|Immunodeficiency Syndrome, Congenital|Primary Immune Deficiency Syndrome|Immune Deficiency, Primary|Immunodeficiency Disorder, Congenital|Primary Immunodeficiency Syndrome|Immunodeficiency Disease, Inherited|Congenital Immunodeficiency Syndrome|Primary Immune Deficiency Disorders|Immunodeficiency Disease, Congenital|Immunodeficiency Diseases, Inherited|Primary Immunodeficiency Disorders|Immunodeficiency Syndromes, Inherited|Congenital Immunodeficiency Disorder|Antibody Deficiency, Primary|Inherited Immunodeficiency Diseases|Inherited Immunodeficiency Disorder|Congenital Immunodeficiency Diseases|Immunodeficiency Syndrome, Primary|Congenital Immunodeficiency Disease|Primary Immunodeficiency Syndromes|Inherited Immunodeficiency Syndrome|Inherited Immunodeficiency Disease|Primary Immune Deficiency Disorder|Immunodeficiency Disorder, Inherited|Primary Antibody Deficiencies|Primary Antibody Deficiency Disorders|Primary Immune Deficiency Syndromes|Primary Immune Deficiency Diseases|Inherited Immunodeficiency Syndromes|Immunodeficiency Disorders, Inherited|Primary Immune Deficiency|Primary Immune Deficiencies|Primary Immune Deficiency Disease|Congenital Immunodeficiency Syndromes|Immunodeficiency Syndromes, Primary|Primary Immunodeficiency Disorder|Primary Antibody Deficiency|Immunodeficiency Disorder, Primary|Primary Immunodeficiency Disease|Immunodeficiency Syndrome, Inherited|Inherited Immunodeficiency Disorders|Immunodeficiency Diseases, Primary|Primary Antibody Deficiency Syndromes|Immunodeficiency Diseases, Congenital|deficiency disorder|Immunodeficiency Disorders, Congenital|Deficiency, Primary Immune|Immunodeficiency Disease, Primary|Immunodeficiency Syndromes, Congenital|Primary Antibody Deficiency Syndrome|Congenital Immunodeficiency Disorders"
NEW11936,CHEMICAL,acetyl zingerone,acetyl zingerone|AZ
D007383,DISEASE,Intermittent Claudication,"intermittent claudication|Claudication, Intermittent"
D000077407,CHEMICAL,Cilostazol,"OPC 13013|OPC-13013|Pletal|6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone|cilostazol"
D010693,CHEMICAL,Phloretin,Phloretin|PHL
NEW11939,CHEMICAL,gli3 zinc finger transcription factor,GLI3 zinc finger transcription factor
NEW11940,CHEMICAL,selective norepinephrine,selective norepinephrine
NEW11943,CHEMICAL,covid-19 case,COVID-19 cases
D029424,DISEASE,"Pulmonary Disease, Chronic Obstructive","Chronic Obstructive Pulmonary Disease|Chronic Obstructive Lung Disease|Airflow Obstructions, Chronic|COPD|chronic obstructive pulmonary disease|Chronic Airflow Obstruction|Airflow Obstruction, Chronic|Chronic Airflow Obstructions|Chronic Obstructive Pulmonary Diseases|Chronic Obstructive Airway Disease|COAD"
NEW11945,BIOCHEMICAL,bone morphogenic protein bmp antagonist,bone morphogenic protein BMP antagonist
NEW11947,DISEASE,pseudomonas putida kt2440,Pseudomonas putida KT2440
http://purl.obolibrary.org/obo/DOID_3083,DISEASE,chronic obstructive pulmonary disease,COLD|chronic obstructive lung disease|COPD|stable chronic obstructive pulmonary disease|chronic obstructive airway disease
NEW11950,CHEMICAL,inhaled corticosteroid,Inhaled corticosteroids|ICS
http://purl.obolibrary.org/obo/CHEBI_35522,BIOCHEMICAL,beta-adrenergic agonist,beta-adrenergic receptor agonist|beta-2-adrenoceptor agonists|beta-adrenergic agonists|beta-adrenoceptor agonists
NEW11953,CHEMICAL,don exposure,DON exposure
http://purl.obolibrary.org/obo/CHEBI_187010,CHEMICAL,19-phenyl nonadecanoic acid,excess palmitic acid|19-phenylnonadecanoic acid
C091910,CHEMICAL,acridine mustard [Supplementary Concept],ICR-170|Nitrogen Mustard Compounds|Aminoacridines
NEW11958,DISEASE,chronic intermittent hypoxia,Chronic intermittent hypoxia
http://purl.obolibrary.org/obo/DOID_0050848,DISEASE,obstructive sleep apnea,obstructive sleep apnea syndrome|OSA|moderate obstructive sleep apnea
NEW11962,CHEMICAL,Lewy body Dementia Association,LBDA|Lewy Body Dementia Association
NEW10217,BIOCHEMICAL,to muscarinic m4 cholinergic antagonist,anticholinergics|to muscarinic M4 cholinergic antagonists
NEW11969,DISEASE,neuroleptic-induced eps,neuroleptic-induced EPS
NEW11970,CHEMICAL,inhalational anesthetic,Desflurane|inhalational anesthetic
NEW11971,CHEMICAL,maternal FLX,Maternal FLX
NEW11972,CHEMICAL,acerf2 induce transcript accumulation,AcERF2 induced transcript accumulation
NEW06405,DISEASE,neuroblastoma cell,neuroblastoma cells
D017380,DISEASE,"Hypertrophy, Right Ventricular","Hypertrophies, Right Ventricular|Right Ventricular Hypertrophies|hypertrophy|Ventricular Hypertrophies, Right|Right Ventricular Hypertrophy|Ventricular Hypertrophy, Right"
NEW11975,CHEMICAL,camp inducing agent,cAMP inducing agents
NEW11976,BIOCHEMICAL,agonist clenbuterol,agonist clenbuterol
D013805,NUTRITION,Theobromine,Bronchodilator Agents|Vasodilator Agents|theobromine
NEW11978,CHEMICAL,cmrtf2h,CmRTF2h
NEW11979,CHEMICAL,various flavonoid,various flavonoids
NEW11981,DISEASE,idiopathic calcinosis cutis,Idiopathic calcinosis cutis
NEW11982,DISEASE,calcinosis cutis,Calcinosis cutis
NEW11983,BIOCHEMICAL,novel norepinephrine reuptake inhibitor,novel norepinephrine reuptake inhibitor
D047494,BIOCHEMICAL,PPAR delta,Peroxisome Proliferator-Activated Receptor delta|PPARD protein|PPAR δ|Peroxisome Proliferator Activated Receptor delta|PPARdelta
C000713688,CHEMICAL,seladelpar [Supplementary Concept],MBX-8025|Acetates|Seladelpar
NEW11990,BIOCHEMICAL,selective ppar-δ agonist,Selective PPAR-δ agonists
NEW11993,DISEASE,a. cepa meristem cell,A. cepa meristem cells
NEW11995,CHEMICAL,17β-oestradiol,E2|17β-oestradiol
NEW11999,CHEMICAL,oxidase mao-a,oxidases MAO-A
NEW12000,DISEASE,autosomal dominant calpainopathy,Autosomal dominant calpainopathy
C014896,CHEMICAL,6-chloro-2-(1-piperazinyl)pyrazine [Supplementary Concept],Pyrazines|MK-212
NEW12007,CHEMICAL,benzodiazepine agonist,benzodiazepine agonists
NEW12008,CHEMICAL,benzodiazepine derivative,Benzodiazepine derivatives
NEW12009,BIOCHEMICAL,gaba-a receptor agonist hypnotic,GABA-A receptor agonist hypnotics
D017576,CHEMICAL,Daptomycin,"Daptomycin, 9 L beta Aspartic Acid|LY 146032|Daptomycin, 9-L beta-Aspartic Acid|Deptomycin|LY-146032|LY146032|Daptomycin|Cubicin"
NEW12011,CHEMICAL,zinc cluster transcription factor,zinc cluster transcription factors
D003882,DISEASE,Dermatomyositis,"Myositis, Juvenile|Childhood Type Dermatomyositis|Polymyositis-Dermatomyositis|dermatomyositis|Juvenile Dermatomyositis|Adult Type Dermatomyositis|Dermatomyositis, Adult Type|Dermatomyositis, Juvenile|Polymyositis Dermatomyositis|Juvenile Myositis|Dermatopolymyositis|Dermatomyositis, Childhood Type"
NEW12014,DISEASE,simple constipation,simple constipation
NEW12016,DISEASE,low incisor,lower incisors
NEW12017,CHEMICAL,naocl,NaOCl
NEW12021,CHEMICAL,serotonin 5ht agonist,serotonin 5HT agonist
D009166,DISEASE,Mycobacterium leprae,Mycobacterium leprae|Leprostatic Agents
D058345,DISEASE,Asymptomatic Infections,"Colonization, Asymptomatic|Subclinical Infections|Asymptomatic Colonizations|Presymptomatic Infection|Infection, Presymptomatic|Infection, Subclinical|Infection, Inapparent|Presymptomatic Infections|Asymptomatic Infection|Inapparent Infection|Subclinical Infection|Inapparent Infections|Infection, Asymptomatic|Subclinical infection|Asymptomatic Colonization"
NEW12028,DISEASE,male-to-female transsexual,male-to-female transsexuals
NEW12030,MENTAL_HEALTH,slow dissociation,slow dissociation
D018009,CHEMICAL,"Receptors, Glycine","Strychnine-Insensitive Glycine Receptor|Strychnine Sensitive Glycine Receptor|Glycine Receptor, Strychnine-Sensitive|Glycine Receptor alpha1|Receptor, Strychnine-Insensitive Glycine|Glycine Receptor, Strychnine-Insensitive|Strychnine Insensitive Glycine Receptor|Receptors, GlyB|Strychnine-Sensitive Glycine Receptor|Receptor, Glycine|Inhibitory Glycine Receptor|SIG Receptor|glycine receptors|Excitatory Glycine Receptors|Receptor, Inhibitory Glycine|Glycine B Receptors|Glycine A Receptors|GlyB Receptors|Glycine Receptor|Receptor, Strychnine-Sensitive Glycine|Glycine Receptors|GlyA Receptors|Glycine Receptor, Inhibitory|Receptor, SIG"
http://purl.org/sig/ont/fma/fma67906,CHEMICAL,protein complex,Bmi1/Ring1 protein complex
http://purl.obolibrary.org/obo/DOID_0060014,DISEASE,cd45 deficiency,Bmi1 deficiency
NEW12033,MENTAL_HEALTH,autism group,autism group
NEW12036,CHEMICAL,choline/creatine ratio,Choline/Creatine ratios
NEW12038,CHEMICAL,ficus deltoidea L.,Ficus deltoidea L.
D011552,DISEASE,Pseudomonas Infections,"aeruginosa infections|Infection, Pseudomonas|Infections, Pseudomonas|Pseudomonas aeruginosa Infections|Pseudomonas aeruginosa Infection|Pseudomonas Infection"
D019779,DISEASE,Salmonella enterica,Salmonella enterica|Salmonella (1980-1997)
NEW12040,NUTRITION,ounce,ounce
NEW12041,CHEMICAL,average daily ethanol intake,average daily ethanol intake
http://purl.obolibrary.org/obo/DOID_0050741,MENTAL_HEALTH,alcohol dependence,DSM-IV alcohol dependence|alcoholism
NEW06162,CHEMICAL,ethanol consumption,ethanol consumption
D017828,CHEMICAL,Rifabutin,Ansamycin|Ansatipin|Rifabutin|Mycobutin|LM427|Rifabutine|Ansatipine|LM 427|Alfacid|LM-427
D015867,DISEASE,"Uveitis, Intermediate","Intermediate Uveitis|Cyclitis, Chronic|Uveitis|Chronic Cyclitis"
NEW12043,CHEMICAL,disseminated mycobacterium avium infection,Disseminated Mycobacterium avium infection
http://purl.obolibrary.org/obo/CHEBI_65751,CHEMICAL,"3,5-di-o-caffeoyl quinic acid","3,5-DCQA|3,5-Dicaffeoylquinic acid|(3R,5R)-3,5-bis{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-1,4-dihydroxycyclohexanecarboxylic acid|Sinapic acid treatment|(1S,3R,4S,5R)-1,3,4,5-tetrahydroxy-1-carboxycyclohexane3,5-di-3-(3,4-dihydroxyphenyl)propenoate|Isochlorogenic acid a|Quinic acid 3,5-di-O-caffeate"
C073734,CHEMICAL,sinapinic acid [Supplementary Concept],Sinapic acid|Coumaric Acids
D051127,NUTRITION,"Scavenger Receptors, Class E","Oxidized Low-Density Lipoprotein Receptor 1|Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1|Oxidized Low Density Lipoprotein Receptor 1|lectin-like oxidized low-density lipoprotein receptor-1|SR EI Proteins|OLR1 Protein|Scavenger Receptors, Class E, Type I|SR-E Proteins|SR-EI Proteins|Lectin Like Oxidized Low Density Lipoprotein Receptor 1"
NEW12047,CHEMICAL,β1-β2 loop,β1-β2 loop
NEW12048,CHEMICAL,excessive ethanol consumption,Excessive ethanol consumption
C025910,CHEMICAL,dimethyl sulfone [Supplementary Concept],Methylsulfonylmethane|Dimethyl Sulfoxide|MSM|Sulfones
D022681,DISEASE,Diphtheria-Tetanus-acellular Pertussis Vaccines,"Vaccine, DTaP|Tetanus|Pertussis Vaccine, Diphtheria-Tetanus-acellular|Vaccine, Diphtheria-Tetanus-acellular Pertussis|ACEL-IMUNE|ACEL IMUNE|Infanrix|Diphtheria Tetanus acellular Pertussis Vaccine|DTaP Vaccines|DTaP Vaccine|Diphtheria-Tetanus-acellular Pertussis Vaccine|Tripedia|Pertussis Vaccines, Diphtheria-Tetanus-acellular|Diphtheria Tetanus acellular Pertussis Vaccines|Vaccines, DTaP|ACELIMUNE|Vaccines, Diphtheria-Tetanus-acellular Pertussis"
D002349,DISEASE,Carpal Tunnel Syndrome,"Entrapment Neuropathy, Carpal Tunnel|Carpal Tunnel Syndromes|Syndromes, Carpal Tunnel|Median Neuropathy, Carpal Tunnel|carpal tunnel syndrome|Amyotrophy, Thenar, Of Carpal Origin|Compression Neuropathy, Carpal Tunnel|CTS|Syndrome, Carpal Tunnel"
NEW12054,BIOCHEMICAL,serum vitamin d level,Serum vitamin D levels
NEW12057,DISEASE,chocolate reformulation,chocolate reformulation
NEW12059,DISEASE,plantarum 299v,plantarum 299v
NEW12060,DISEASE,lactobacillus acidophilus la3,Lactobacillus acidophilus La3
C119572,CHEMICAL,"bearberry, bladderwrack, borage oil, centella, fatty acid, fish oil, ginkgo biloba, melilotus, soya lecithin drug combination [Supplementary Concept]",FO|fish oil|Drug Combinations|Plant Extracts
NEW12061,CHEMICAL,Morus alba L.,Morus alba L.
NEW12062,DISEASE,apnea/hypopnea index,apnea/hypopnea index
NEW12064,DISEASE,rodent head-shake,Rodent head-shakes
D012450,NUTRITION,Safflower Oil,"Oil, Safflower|Safflower Oils|Carthamus tinctorius L.|Safflower|Oils, Safflower"
D004652,DISEASE,Empty Sella Syndrome,"Secondary Empty Sella Syndrome|Empty sella syndrome|Primary Empty Sella Syndrome|Empty Sella Turcica Syndrome|Sella Turcica, Empty|Empty Sella Turcicas|Sella Turcicas, Empty|Empty Sella Syndromes|Empty Sella Turcica|Empty Sella Syndrome, Secondary|Empty Sella Syndrome, Primary"
NEW12068,NUTRITION,quantitative fatty acid composition,Quantitative fatty acid compositions
http://purl.obolibrary.org/obo/CHEBI_166968,CHEMICAL,trans-fatty acid,monounsaturated acids
NEW12070,CHEMICAL,serotonin reuptake blocker,serotonin reuptake blocker
D004875,CHEMICAL,Ergosterol,"ergosterol|Pro-Vitamin D2|Lumisterol|D2, Pro-Vitamin|Provitamin D 2|Pro Vitamin D2"
NEW12071,CHEMICAL,c1-thf synthase activity,C1-THF synthase activity
D063185,MENTAL_HEALTH,Epigenetic Repression,"Repression|Repression, Epigenetic"
D004331,DISEASE,Drosophila melanogaster,"Drosophila melanogaster|D. melanogaster|melanogaster, Drosophila|Drosophila melanogasters"
NEW12073,CHEMICAL,hdmse-ms/ms,HDMSE-MS/MS
NEW12075,BIOCHEMICAL,specific serotonin reuptake inhibitor,specific serotonin reuptake inhibitor
D005659,BIOCHEMICAL,"Fungicides, Industrial",fungicides|Industrial Fungicides
NEW12078,CHEMICAL,cytochrome p450-dependent sterol 14α-demethylase cyp51 gene,cytochrome P450-dependent sterol 14α-demethylase Cyp51 gene
NEW12080,BIOCHEMICAL,d-2 receptor antagonist,D-2 receptor antagonist
NEW12081,BIOCHEMICAL,partial agonist agent,partial agonist agents
C000609690,CHEMICAL,deutetrabenazine [Supplementary Concept],Tetrabenazine/analogs  and  derivatives|Deutetrabenazine
NEW12082,CHEMICAL,increase dopamine level,increased dopamine levels
NEW12084,CHEMICAL,moderate prenatal alcohol exposure,Moderate prenatal alcohol exposure
NEW12085,DISEASE,opioid-related seizure,opioid-related seizure
NEW12086,DISEASE,schizophrenic proband,schizophrenic probands
NEW12088,BIOCHEMICAL,prophylactic beta-blocker therapy,prophylactic beta-blocker therapy
NEW12091,CHEMICAL,aemab,AEMAb
D019422,CHEMICAL,Dietary Sucrose,"Table Sugar|sucrose|Table Sugars|Sugars, Table|Sucroses, Dietary|Sucrose, Dietary|Dietary Sucroses"
NEW12092,CHEMICAL,excessive fructose intake,Excessive fructose intake
C506936,DISEASE,"levoglucosan kinase, Aspergillus niger [Supplementary Concept]",Phosphotransferases|A. niger
NEW12094,BIOCHEMICAL,pubertal hormone,pubertal hormones
D043266,CHEMICAL,Steryl-Sulfatase,"Steroid Sulphatase|Steroid Sulfatase|Sulfatase, Cholesterol Sulfate|Sulfohydrolase, Estrone Sulfate|3 Beta-Hydroxysteroid Sulfate Sulfatase|Sulfatase, DHEA|Arylsulfatase C|Cholesterol Sulfate Sulfatase|Sulfate Sulfohydrolase, Estrone|Estrone Sulfate Sulfatase|Sulfatase, Sterol|Sulfate Sulfatase, Dehydroepiandrosterone|Sulfatase, Steroid|Sulfatase, Cholesterol|Steryl Sulfatase|Sulfatase, Estrone Sulfate|3 Beta Hydroxysteroid Sulfate Sulfatase|DHEA|Sulfate Sulfatase, Estrone|Sterol Sulfatase|Sulfatase, Dehydroepiandrosterone Sulfate|Sulphatase, Steroid|Sterylsulfatase|Sulfohydrolase, Steroid|DHEA Sulfatase|Steroid Sulfohydrolase|Estrone Sulfate Sulfohydrolase|Sulfate Sulfatase, Cholesterol|Arylsulphatase C|Cholesterol Sulfatase|Dehydroepiandrosterone Sulfate Sulfatase"
NEW12096,CHEMICAL,increase salivary dhea concentration,Increased salivary DHEA concentrations
NEW12099,MENTAL_HEALTH,generalize disorder symptom,generalized disorder symptoms
NEW12101,CHEMICAL,dhea concentration,DHEA concentrations
D060053,CHEMICAL,Transplant Donor Site,"Donor Site, Transplant|Donor Sites, Transplant|Sites, Transplant Donor|donor|Site, Transplant Donor|DETA NONOate|Transplant Donor Sites"
NEW12102,CHEMICAL,homovanillic acid hva,homovanillic acid HVA
NEW12103,DISEASE,aeromonas infection,Aeromonas infection
NEW12104,CHEMICAL,cortisol concentration,cortisol concentrations
D001764,DISEASE,Blepharospasm,blepharospasm|Blepharospasms
NEW12107,NUTRITION,microbiota-derived tryptophan metabolite,microbiota-derived tryptophan metabolites
NEW12108,DISEASE,intestinal mucosal immunity,intestinal mucosal immunity
C425043,CHEMICAL,jasmonic acid carboxyl methyltransferase [Supplementary Concept],Jasmonic acid|Methyltransferases
NEW12111,CHEMICAL,exogenous meja,exogenous MeJA
C503359,DISEASE,"hang protein, Drosophila [Supplementary Concept]",Drosophila Proteins|Hangover
NEW12113,CHEMICAL,anti-hangover aho product,anti-hangover AHO product
NEW12115,DISEASE,incident exocrine pancreatic cancer case,incident exocrine pancreatic cancer cases
NEW12117,DISEASE,pancreatic cancer risk,pancreatic cancer risk
http://purl.obolibrary.org/obo/DOID_9972,BIOCHEMICAL,hypervitaminosis a,vitamins A
D020803,DISEASE,"Encephalitis, Herpes Simplex","Herpes Simplex Meningoencephalitis|Acute Necrotizing Encephalitis, Herpetic|Encephalitides, Herpetic|Meningoencephalitides, Herpes Simplex|Encephalitis, Herpes|Herpetic Meningoencephalitides|Encephalitides, Herpes Simplex|Herpetic Meningoencephalitis|Meningoencephalitides, Herpetic|Meningoencephalitis, Herpes Simplex Virus|Encephalitis, Herpetic|Herpetic Encephalitis|Herpetic Encephalitides|Herpes Simplex Encephalitis|Herpes Simplex Meningoencephalitides|herpes simplex encephalitis|Herpes Simplex Encephalitides|Herpes Encephalitis|Herpetic Acute Necrotizing Encephalitis|Meningoencephalitis, Herpetic|Meningoencephalitis, Herpes Simplex"
NEW12126,DISEASE,psychiatric ramification,psychiatric ramifications
NEW12127,CHEMICAL,zlt,ZLT
NEW12128,CHEMICAL,sterol profile,sterol profiles
D016633,CHEMICAL,Apolipoprotein A-II,Apo A-2|Proapolipoprotein A II|Proapolipoprotein A-II|Apolipoprotein A-II Isoproteins|Apolipoprotein A II|apolipoprotein AII|Apo AII|Pro Apolipoprotein A II|Apolipoprotein A 2|Apolipoprotein A II Isoproteins|Apo A-II|Apolipoprotein AII|Apolipoprotein A-2|Pro Apo A II|Pro-Apo A-II|Apo A2|ApoA-2|Apolipoprotein A2|ApoA-II|Apo A II Isoproteins|Pro-Apolipoprotein A-II|Apo A-II Isoproteins
NEW12133,BIOCHEMICAL,niacin test oral administration,niacin test oral administration
NEW12135,CHEMICAL,nicotine acid,nicotine acid
NEW12136,MENTAL_HEALTH,beer craving,beer craving
NEW12138,MENTAL_HEALTH,drug resistance mutation,drug resistance mutations
D015124,CHEMICAL,8-Bromo Cyclic Adenosine Monophosphate,"8 Bromo Cyclic Adenosine Monophosphate|8-Bromo Cyclic Adenosine Monophosphate, Sodium Salt|8 Bromo Cyclic Adenosine Monophosphate, Monosodium Salt|8 Bromo Cyclic Adenosine Monophosphate, Sodium Salt|8-Bromo Cyclic AMP|8 Bromo Cyclic AMP|8-Bromo Cyclic Adenosine Monophosphate, Monosodium Salt|8 Bromoadenosine 3',5' Cyclic Monophosphate|Br Cycl AMP|8 Bromo cAMP|AMP, Br Cycl|8-Br Cyclic AMP|Cyclic AMP, 8-Br|Cyclic AMP, 8-Bromo|cyclic adenosine monophosphate|8-Bromoadenosine 3',5'-Cyclic Monophosphate|8 Br Cyclic AMP|8-Bromo-cAMP"
NEW12140,CHEMICAL,y. pseudotuberculosis lipopolysaccharide,Y. pseudotuberculosis lipopolysaccharide
C042744,CHEMICAL,N-methylacetamide-oxotremorine M [Supplementary Concept],oxotremorine-M|Oxotremorine/analogs  and  derivatives
NEW12143,NUTRITION,cortical chat activity,cortical ChAT activity
D062626,CHEMICAL,Degenerin Sodium Channels,"sodium channels|Degenerin Ion Channels|Degenerins|Ion Channels, Degenerin|Degenerin|Degenerin Sodium Ion Channels|Sodium Channels, Degenerin"
NEW12144,CHEMICAL,large-scale isoniazid exposure,large-scale isoniazid exposure
NEW12145,CHEMICAL,pi transport,Pi transport
http://purl.obolibrary.org/obo/CHEBI_176350,CHEMICAL,sinapoyl glucose,"PGG|(E,5R,6S,7R,8R)-5,6,7,8,9-pentahydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)non-1-ene-3,4-dione|pentagalloyl glucose"
http://purl.obolibrary.org/obo/CHEBI_70868,BIOCHEMICAL,antileishmanial agent,antitrypanosomal agents|antileishmanial agents|antileishmanial drug|antileishmanial drugs
NEW12152,DISEASE,rapid hydrophilic interaction liquid chromatography-tandem spectrometry method,rapid hydrophilic interaction liquid chromatography-tandem spectrometry method
NEW12153,CHEMICAL,mecp2 protein-either,MeCP2 protein-either
http://purl.obolibrary.org/obo/MFOMD_0000082,DISEASE,sexual arousal disorder,Female sexual arousal disorder|FSAD
NEW12158,CHEMICAL,ne level,NE levels
D013726,CHEMICAL,Terbutaline,Monovent|Terbutalin-ratiopharm|Brethine|Brethaire|Arubendol|terbutalin von ct|Butaliret|Terbutalin Stada|Butalitab|Taziken|Contimit|Terbasmin|Terbuturmant|Terbutaline Sulfate|Bricanyl SA|KWD-2019|Tedipulmo|KWD 2019|Terbutalin AL|Terbutalin ratiopharm|Terbul|Asthmoprotect|KWD2019|Bricanyl|terbutaline
NEW12159,BIOCHEMICAL,beta2-adrenergic agonist medication,Beta2-adrenergic agonist medications
D000420,CHEMICAL,Albuterol,Salbutamol|albuterol|Ventolin|Sultanol|Albuterol Sulfate|2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol|Proventil
NEW12160,BIOCHEMICAL,beta2-adrenergic agonist,beta2-adrenergic agonists
NEW12161,CHEMICAL,selenium deficiency,Selenium deficiency
NEW12166,CHEMICAL,glutamate system,glutamate systems
NEW12167,CHEMICAL,methanolic Blighia sapida leaf extract,methanolic Blighia sapida leaf extract
NEW12168,CHEMICAL,vpa toxicity,VPA toxicity
NEW12171,CHEMICAL,medicine yokukansan,medicines yokukansan
D000087124,DISEASE,COVID-19 Serological Testing,"Antigen Testings, SARS-COV-2|Serodiagnosis, COVID19|Testing, COVID19 Antibody|COVID-19 Serological Testings|Testing, COVID-19 Antibody|COVID-19 Serodiagnoses|SARS-COV-2 Antigen Testing|Serodiagnosis, COVID-19|Serological Testing, COVID19|SARS-CoV-2 Infection Antibody Testing|Antibody Testing, COVID19|Serological Testing, COVID-19|COVID-19 Serodiagnosis|COVID19 Serodiagnosis|COVID19 Antibody Testing|COVID 19 Antibody Testing|COVID19 Antibody Testings|COVID19 Serological Testing|COVID-19 Antibody Testings|SARS COV 2 Antigen Testing|SARS CoV 2 Infection Antibody Testing|Testing, SARS-COV-2 Antigen|COVID 19 Serodiagnosis|SARS-CoV-2 Infection Serological Testing|SARS-CoV-2 infection|COVID-19 Antibody Testing|COVID 19 Serological Testing|Testing, COVID19 Serological|Serology Testing for COVID 19|COVID19 Serological Testings|Antibody Testing, COVID-19|Serology Testing for COVID-19|Testing, COVID-19 Serological|SARS-COV-2 Antigen Testings|SARS CoV 2 Infection Serological Testing|COVID19 Serodiagnoses"
http://purl.obolibrary.org/obo/MFOMD_0000102,MENTAL_HEALTH,apprehension,apprehension
D037521,BIOCHEMICAL,Virulence Factors,"virulence factors|Factors, Virulence|Factors, Pathogenicity|Pathogenicity Factors|Pathogenicity Factor|Factor, Virulence|Virulence Factor|Factor, Pathogenicity"
NEW12175,CHEMICAL,low-fat whole-food vegan diet,low-fat whole-food vegan diet
C080710,CHEMICAL,policosanol [Supplementary Concept],Fatty Alcohols|policosanol
NEW12177,NUTRITION,fatty acid class,fatty acid class
C097824,CHEMICAL,23-(O-ribofuranosyl)rifampicin [Supplementary Concept],Rifampicin|Rifampin/analogs  and  derivatives
NEW12182,BIOCHEMICAL,riboflavin biosynthetic pathway,riboflavin biosynthetic pathway
C581655,BIOCHEMICAL,"SLC52A3 protein, rat [Supplementary Concept]","riboflavin transporter|Membrane Transport Proteins|Receptors, G-Protein-Coupled"
NEW12184,BIOCHEMICAL,riboflavin analog,riboflavin analogs
NEW12186,DISEASE,hexa)-inactivate poliomyelitis-absorbe conjugate haemophilus influenzae type b vaccine,hexa)-inactivated poliomyelitis-absorbed conjugated Haemophilus influenzae type b vaccine
NEW12188,DISEASE,diphtheria-tetanus-acellular pertussis-hepatitis b recombinant poliomyelitis-adsorbed conjugate haemophilus influenzae type b vaccine,diphtheria-tetanus-acellular pertussis-hepatitis B recombinant poliomyelitis-adsorbed conjugated Haemophilus influenzae type b vaccine
NEW12189,CHEMICAL,positive allosteric nicotinic acetylcholine receptor nachr modulator,positive allosteric nicotinic acetylcholine receptor nAChR modulators
NEW12190,CHEMICAL,approve nucleos(t)ide analog,approved nucleos(t)ide analogs
NEW12192,CHEMICAL,carbamate moiety,carbamate moiety
NEW12194,DISEASE,sixty-five psychotic proband,Sixty-five psychotic probands
NEW12195,DISEASE,apple replant disease,Apple replant disease
NEW12197,DISEASE,spontaneous seizure,Spontaneous seizures
NEW12198,CHEMICAL,pilocarpine model,pilocarpine model
NEW12200,MENTAL_HEALTH,dose fixation study,dose fixation studies
NEW12202,BIOCHEMICAL,novel nonstimulant wakefulness-promoting drug,novel nonstimulant wakefulness-promoting drug
NEW12203,CHEMICAL,l-kainate,L-kainate
NEW12206,BIOCHEMICAL,vitamin d administration,vitamin D administration
http://purl.obolibrary.org/obo/CHEBI_33237,CHEMICAL,vitamin d4,"1α,25(OH)2 Vitamin D3|(3S,5Z,7E)-9,10-secoergosta-5,7,10(19)-trien-3-ol|vitamin D4|(5Z,7E)-(3S)-9,10-Seco-5,7,10(19)-ergostatrien-3-ol|(3beta,5Z,7E)-9,10-secoergosta-5,7,10(19)-trien-3-ol|22,23-dihydroergocalciferol|Vitamin D4|1,25-D3|22,23-dihydroercalciol|(5Z,7E)-(3S)-9,10-secoergosta-5,7,10(19)-trien-3-ol|(3S)-9,10-seco-5Z,7E,10(19)-ergostatrien-3-ol|22-Dihydroergocalciferol|24S-methylcalciol|(24S)-methylcalciol"
D004809,CHEMICAL,Ephedrine,"Ephedrine Hydrochloride|SalPhedrine|Sal Phedrine|Ephedrine Sulfate|ephedrine|Renaudin, Ephedrine|Hydrochloride, Ephedrine|Sulfate, Ephedrine|Ephedrine Renaudin|Ephedrine Erythro Isomer|Erythro Isomer of Ephedrine|Sal-Phedrine"
http://purl.obolibrary.org/obo/CHEBI_48278,BIOCHEMICAL,serotonergic drug,serotonergic agents|serotonergic drug|serotonin drugs|serotonergic drugs
NEW12208,CHEMICAL,dipalmitate astaxanthin,dipalmitate astaxanthin
D053938,MENTAL_HEALTH,DNA Fragmentation,"Fragmentation|Apoptotic DNA Degradation|Fragmentation, DNA|DNA Degradation, Apoptotic"
NEW12210,MENTAL_HEALTH,distinctive mass spectrometry fragmentation pattern,distinctive mass spectrometry fragmentation pattern
NEW12214,DISEASE,full-length g glycoprotein,full-length G glycoprotein|RABV-G
NEW12215,CHEMICAL,pure pms group,Pure PMS group
NEW12218,DISEASE,polyketide lasiodiplodin,polyketides lasiodiplodin
NEW12221,CHEMICAL,14-membered ral homologue,14-membered RAL homologues
http://purl.obolibrary.org/obo/CHEBI_25212,CHEMICAL,metabolite,secondary metabolites|RAL12 metabolites|metabolites|primary metabolites|metabolite
C447119,CHEMICAL,bazedoxifene [Supplementary Concept],Bazedoxifene|Indoles
NEW12225,BIOCHEMICAL,selective estrogene receptor modulator available,selective estrogene receptor modulator available
NEW07692,DISEASE,breast cancer patient,breast cancer patients
D018567,DISEASE,"Breast Neoplasms, Male","Breast Neoplasm, Male|Breast Cancer, Male|Neoplasms, Male Breast|Neoplasms, Breast, Male|Tumor, Male Breast|Breast Tumor, Male|Neoplasm, Male Breast|Male Breast Tumor|Male Breast Carcinoma|Male Breast Tumors|Tumors, Breast, Male|Cancer, Male Breast|Carcinoma, Male Breast|breast tumors|Breast Tumors, Male|Breast Carcinoma, Male|Male Breast Cancer|Male Breast Neoplasm|Tumors, Male Breast|Male Breast Neoplasms"
NEW12228,DISEASE,heritable peroxisomal disorder,heritable peroxisomal disorders
NEW12230,DISEASE,peroxisomal impairment,peroxisomal impairment
NEW12232,DISEASE,significant erythrocyte dha deficit,significant erythrocyte DHA deficits
NEW12235,BIOCHEMICAL,cannabinoid cb1 receptor antagonist rimonabant,cannabinoid CB1 receptor antagonist rimonabant
D002725,CHEMICAL,Chloroform,Trichloromethane|Chloroform
NEW12239,BIOCHEMICAL,forget poison,forgotten poison
NEW08147,CHEMICAL,methamphetamine use,methamphetamine use
NEW12241,DISEASE,severe apicomplexan infection,severe apicomplexan infection
NEW12243,CHEMICAL,h(2)s,H(2)S
NEW12245,CHEMICAL,perturb h(2)s synthesis,perturbed H(2)S synthesis
NEW12246,CHEMICAL,microm glutamate,microM glutamate
NEW12248,CHEMICAL,selective noradrenaline reuptake inhibitor atomoxetine,selective noradrenaline reuptake inhibitor atomoxetine
NEW12250,BIOCHEMICAL,drug plasma level,drug plasma level
NEW12251,CHEMICAL,cannabis compound,cannabis compounds
D031171,NUTRITION,Artemisia absinthium,"Artemisia absinthiums|Artemisia absinthium|absinthiums, Artemisia"
NEW12253,CHEMICAL,Congo red staining,Congo red staining
NEW12254,CHEMICAL,murine amino terminal peptide sequence,murine amino terminal peptide sequence
NEW12255,CHEMICAL,serum alanine aminotransferase level,serum alanine aminotransferase levels
D005229,NUTRITION,"Fatty Acids, Monounsaturated","Monounsaturated Fatty Acid|Acid, Monounsaturated Fatty|Acids, Monounsaturated Fatty|Monounsaturated Fatty Acids|monounsaturated fatty acids|Fatty Acid, Monounsaturated"
NEW12256,DISEASE,ald group,ALD group
D000326,DISEASE,Adrenoleukodystrophy,"X-Linked Adrenoleukodystrophy|Adrenoleukodystrophy, X-Linked|Bronze Schilder Disease|X ALD|X ALD (X Linked Adrenoleukodystrophy)|X-ALD (X-Linked Adrenoleukodystrophy)|ALD (Adrenoleukodystrophy)|Addison Disease and Cerebral Sclerosis|Siemerling Creutzfeldt Disease|Siemerling-Creutzfeldt Disease|Adrenomyeloneuropathy|Melanodermic Leukodystrophy|Schilder Addison Complex|Leukodystrophies, Melanodermic|adrenoleukodystrophy|X Linked Adrenoleukodystrophy|Leukodystrophy, Melanodermic|Schilder-Addison Complex|ALD|X-ALD"
C013147,CHEMICAL,nervonic acid [Supplementary Concept],"nervonic acid|Fatty Acids, Monounsaturated"
NEW12260,DISEASE,male xald mouse,male XALD mice
NEW12261,DISEASE,x-linked hypophosphataemia,X-linked hypophosphataemia
NEW12263,BIOCHEMICAL,active vitamin d metabolite,active vitamin D metabolites
NEW12265,CHEMICAL,phosphate supplement,phosphate supplements
D008737,CHEMICAL,Methyl Chloride,"Chloride, Methyl|Chloromethane|methyl chloride"
NEW12267,BIOCHEMICAL,m1 receptor agonist,M1 receptor agonists
NEW12269,CHEMICAL,n-arylthiourea,N-arylthioureas
NEW12276,DISEASE,immunological abnormality,immunological abnormalities
NEW12279,NUTRITION,mushroom Hericium erinaceus,mushroom Hericium erinaceus
NEW12281,DISEASE,anti-gastric ulcer activity,anti-gastric ulcer activity
NEW12283,MENTAL_HEALTH,metal-complex dissociation constant,metal-complex dissociation constants
NEW12284,MENTAL_HEALTH,grazer resistance,grazer resistance
http://purl.obolibrary.org/obo/CHEBI_140954,NUTRITION,fatty acid 20:3-omega-3omega-6,FA(20:3-w3w6)|FA 20:3-w3w6|fatty acid metabolism
NEW12287,BIOCHEMICAL,estrogen deficit,Estrogen deficit
NEW12289,DISEASE,drug-induced tremor,Drug-induced tremor
NEW12290,DISEASE,drug-induced tremor,drug-induced tremor
D000077291,CHEMICAL,Terbinafine,"SF 86-327|DA 5505|SF 86 327|Lamisil|Terbinafine, (Z)-isomer|(E)-N-(6,6-Dimethyl-2-heptenynyl)-N-methyl-1-naphthalenementhamin hydrochloride|TDT067|SF 86327|TDT 067|Terbinafine|TDT-067|Terbinafine Hydrochloride|SF86327|Terbinafine, (Z)-|SF-86-327"
NEW12292,DISEASE,more sfa,more SFAs
NEW12293,CHEMICAL,as-needed use,as-needed use
NEW12294,DISEASE,infection risk,infection risk
D001249,DISEASE,Asthma,"Asthma, Bronchial|Asthmas|bronchial asthma|Bronchial Asthma"
NEW12298,CHEMICAL,glucagon-like peptide receptor agonist,Glucagon-like peptide receptor agonists
NEW12299,MENTAL_HEALTH,elevated conditioned response level,Elevated conditioned response levels
NEW12300,CHEMICAL,​0.81,​0.81
NEW12301,BIOCHEMICAL,low vitamin e,Lower vitamin E
NEW12302,BIOCHEMICAL,low a level,Lower A levels
NEW12303,CHEMICAL,bupropion overdose,bupropion overdose
NEW12305,MENTAL_HEALTH,noradrenaline-induced depression,noradrenaline-induced depression
D000068438,CHEMICAL,Brimonidine Tartrate,"UK14304|UK 14,304|Brimonidine Tartrate (1:1), (S-(R*,R*))-Isomer|UK 14,304-18|UK14,308|Ratio-Brimonidine|UK14,30418|Brimonidine Purite|Alphagan P|5-bromo-6-(imidazolidinylideneamino)quinoxaline|UK-14,308|UK 14308|AGN-190342|Alphagan|Brimonidine Tartrate (1:1)|Bromoxidine|AGN 190342|UK-14,304-18|UK 14,308|5-bromo-6-(imidazolin-2-ylamino)quinoxaline|Ratio Brimonidine|5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate|UK 14304|Brimonidine|Brimonidine Tartrate, (R-(R*,R*))-Isomer|UK 14,30418|AGN190342|UK-14304|UK 14,304 18|Sanrosa|Mirvaso"
NEW12307,BIOCHEMICAL,alpha-2 adrenergic receptor agonist,alpha-2 adrenergic receptor agonist
D008304,DISEASE,Malignant Catarrh,"Malignant Catarrhs|Malignant catarrhal fever|Malignant Catarrhal Fevers|Catarrhal Fever, Malignant|Fever, Malignant Catarrhal|Fevers, Malignant Catarrhal|Catarrhs, Malignant|Malignant Catarrhal Fever|Catarrhal Fevers, Malignant|Catarrh, Malignant"
NEW12309,BIOCHEMICAL,phytoestrogen exposure,phytoestrogen exposure
NEW12311,BIOCHEMICAL,m-chlorophenylbiguanide 5-ht3 receptor agonist,m-chlorophenylbiguanide 5-HT3 receptor agonist
NEW03721,DISEASE,aβ toxicity,Aβ toxicity
http://purl.obolibrary.org/obo/CHEBI_81507,CHEMICAL,"1,2,3,7,8-pentachlorodibenzofuran","A1254|1,2,3,7,8-PeCDF|PCDF 94|Aroclor1254"
NEW12312,BIOCHEMICAL,hla class-1 antigen,HLA class-1 antigens
NEW12313,DISEASE,glial abnormality,glial abnormalities
D005232,CHEMICAL,"Fatty Acids, Volatile","Short-Chain Fatty Acid|Short Chain Fatty Acid|Fatty Acids, Short-Chain|Acid, Volatile Fatty|SCFA|Fatty Acids, Short Chain|Short-chain fatty acids|Volatile Fatty Acids|Acid, Short-Chain Fatty|Volatile Fatty Acid|Fatty Acid, Volatile|Fatty Acid, Short-Chain|Short-Chain Fatty Acids"
NEW12315,CHEMICAL,anabolic-androgenic steroid use,Anabolic-androgenic steroid use
NEW12316,DISEASE,various psychotic symptom,Various psychotic symptoms
NEW12319,CHEMICAL,appz exposure,APPZ exposure
NEW12322,DISEASE,viral infection coronavirus disease,viral infection coronavirus disease
NEW12321,BIOCHEMICAL,promising drug candidate,promising drug candidate
http://purl.obolibrary.org/obo/CHEBI_32460,CHEMICAL,cysteine residue,cysteine acid residue|cysteinyl|cysteine residues|cysteine residue
NEW12323,DISEASE,topical vaginal lubricant,topical vaginal lubricants
NEW12324,DISEASE,vaginal atrophy,Vaginal atrophy
NEW12326,NUTRITION,bombyx mori silk,Bombyx mori silk
C520571,CHEMICAL,tideglusib [Supplementary Concept],Tideglusib|Thiadiazoles
NEW12330,CHEMICAL,dapt duration,DAPT duration
NEW12334,CHEMICAL,mild-to-moderate covid-19 symptom,Mild-to-moderate COVID-19 symptoms
D012128,DISEASE,Respiratory Distress Syndrome,"Human ARDS|Shock Lung|Respiratory Distress Syndrome, Pediatric|Lung, Shock|Respiratory Distress Syndrome, Acute|ARDS, Human|Respiratory Distress Syndromes|Acute Respiratory Distress Syndrome|Distress Syndromes, Respiratory|Adult Respiratory Distress Syndrome|acute respiratory distress syndrome|Distress Syndrome, Respiratory|Respiratory Distress Syndrome, Adult|Pediatric Respiratory Distress Syndrome|ARDS|Syndrome, Respiratory Distress"
C000716082,BIOCHEMICAL,ICH3 alpha7 nicotinic acetylcholine receptor agonist [Supplementary Concept],Spiro Compounds|Fumarates|nicotinic acetylcholine receptor agonist
C000605814,CHEMICAL,N-(7-chloro-N-quinuclidin-3-yl)benzo(b)thiophene-2-carboxamide [Supplementary Concept],Encenicline|Quinuclidines|Thiophenes
NEW12338,MENTAL_HEALTH,pd dementia,PD dementia
NEW12339,DISEASE,fhp nonalcoholic man,FHP nonalcoholic men
D019205,NUTRITION,"GTP-Binding Protein alpha Subunits, Gs","Stimulatory GTP Binding Protein, alpha Subunit|Gs alpha GTP-Binding Protein Subunits|Gs, Stimulatory G-Protein|G-Protein, Gs alpha Family|G(s)alpha|Gs Stimulatory G-Proteins|alpha Gs|G-Protein Gs, Stimulatory|G-Protein, Stimulatory Gs|G Protein, Gs alpha Family|G Protein, Stimulatory Gs|Stimulatory Gs G-Protein|Stimulatory GTP-Binding Protein, alpha Subunit|Ns Protein, Regulatory|Stimulatory G-Protein Gs|Gs G-Protein, Stimulatory|Gs alpha|G-Proteins, Gs Stimulatory|alpha-Gs|Gs, Stimulatory G Protein|G(s), alpha Subunit|Gs alpha GTP Binding Protein Subunits|GTP Binding Protein alpha Subunits, Gs|Stimulatory G-Proteins, Gs|Regulatory Ns Protein|Gs Stimulatory G Proteins"
NEW12340,DISEASE,periodontal pathogen porphyromonas gingivalis,periodontal pathogen Porphyromonas gingivalis
NEW12341,CHEMICAL,omega-3 enriched dietary supplement,omega-3 enriched dietary supplements
NEW12343,BIOCHEMICAL,ngf stimulator,NGF stimulators
NEW12344,CHEMICAL,linc00511,LINC00511
NEW12345,CHEMICAL,er-negative-associated linc00511,ER-negative-associated LINC00511
NEW12346,DISEASE,high-risk human papillomavirus hr‑hpv infection,high-risk human papillomavirus HR‑HPV infection
NEW12348,CHEMICAL,hsp-inducing compound geranylgeranylacetone,HSP-inducing compound geranylgeranylacetone
http://purl.obolibrary.org/obo/CHEBI_52647,DISEASE,organoiridium compound,organoiridium compounds|TCM compounds
http://purl.obolibrary.org/obo/CHEBI_16494,CHEMICAL,lipoic acid,"Biletan|Lipoic acid|Thioctansaeure|alpha-Lipoic acid|alpha-Liponsaeure|5-(dithiolan-3-yl)valeric acid|Thioctsaeure|6,8-thiotic acid|β -lipoic acid|1,2-dithiolane-3-valeric acid|1,2-dithiolane-3-pentanoic acid|Acetate-replacing factor|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioktsaeure|6-thioctic acid|6,8-thioctic acid|5-(1,2-dithiolan-3-yl)pentanoic acid|alpha-lipoic acid|liponic acid|5-(1,2-dithiolan-3-yl)valeric acid|Thioctic acid|6-thiotic acid"
C000469,CHEMICAL,diazobenzenesulfonic acid [Supplementary Concept],Sulfanilic Acids|sulfanilic acid|Diazonium Compounds
NEW12352,CHEMICAL,α2a-ar activation,α2A-AR activation
NEW12353,MENTAL_HEALTH,chronic cocaine abuse,chronic cocaine abuse
NEW12356,DISEASE,lung infection,lung infection
NEW12359,CHEMICAL,slow-growing ntm specie mycobacterium chimaera,slow-growing NTM species Mycobacterium chimaera
NEW12361,NUTRITION,cholesterol serum level,cholesterol serum levels
C000591640,CHEMICAL,omadacycline [Supplementary Concept],Omadacycline|Tetracyclines
C029738,CHEMICAL,tertiapin [Supplementary Concept],tertiapin|Bee Venoms
NEW12365,CHEMICAL,drug cloperastine,drugs cloperastine
D000996,CHEMICAL,Antitussive Agents,"antitussives|Agents, Antitussive|Drugs, Antitussive|Antitussive Drugs|Cough Suppressant|Suppressant, Cough|Antitussive|Cough Suppressants|Suppressants, Cough|Drug, Antitussive|Antitussive Drug|Antitussives|Agent, Antitussive|Antitussive Agent"
NEW12368,DISEASE,high trait hostility male volunteer,high trait hostility male volunteers
NEW12370,DISEASE,autistic boy,autistic boys
D012605,DISEASE,Scorpions,Scorpion|scorpions
NEW12372,NUTRITION,pecten,pectines
NEW12373,CHEMICAL,non-ergot dopamine agonist,NEDA|Non-ergot dopamine agonist
NEW12374,CHEMICAL,long-acting dopamine agonist,Long-acting dopamine agonists
NEW12375,CHEMICAL,cabergoline co-treatment,Cabergoline co-treatment
NEW12377,CHEMICAL,mg/kg nab,mg/kg NaB
http://purl.obolibrary.org/obo/CHEBI_50836,CHEMICAL,zinc oxide nanoparticle,Zinc oxide nanoparticles|ZnO-NPs
C109513,CHEMICAL,OSU 6162 [Supplementary Concept],OSU-6162|Piperidines
NEW12380,NUTRITION,blue honeysuckle,blue honeysuckle
NEW12382,DISEASE,fop mouse model,FOP mouse models
NEW12385,DISEASE,wearing-off responder,wearing-off responders
NEW12387,MENTAL_HEALTH,glutamate hyperactivity,glutamate hyperactivity
NEW12389,DISEASE,flaccid state,flaccid state
NEW12391,CHEMICAL,relaxant yohimbine activity,relaxant yohimbine activity
NEW12393,DISEASE,pheochromocytoma cell,pheochromocytoma cells
C018919,CHEMICAL,"3,3'-diethyloxadicarbocyanine [Supplementary Concept]","3,3'-diethyloxadicarbocyanine|Carbocyanines"
NEW12395,CHEMICAL,oligodeoxynucleotide ttaggg,oligodeoxynucleotide TTAGGG
NEW12396,CHEMICAL,long term lom therapy,long term LOM therapy
NEW12398,NUTRITION,charr Salvelinus fontinalis,charr Salvelinus fontinalis
NEW12399,CHEMICAL,severe hypovitaminosis d3,severe hypovitaminosis D3
D052439,DISEASE,Lipid Metabolism Disorders,"Metabolism Disorders, Lipid|lipid metabolism disorder|Metabolism Disorder, Lipid|Lipid Metabolism Disorder"
D020939,CHEMICAL,Ginger,"Zingiber officinale|Zingiber officinales|ginger|Gingers|officinales, Zingiber"
D020441,CHEMICAL,Ginkgo biloba,"Maidenhair Tree|Ginkgo bilobas|Gingkos|Maidenhair Trees|Ginkos|Trees, Maidenhair|bilobas, Ginkgo|Ginkgo|Gingko|Gingko bilobas|gingko biloba|bilobas, Gingko|Ginko|Gingko biloba|Ginkgophyta|Ginkgos|Tree, Maidenhair|Ginkgophytas"
NEW12402,BIOCHEMICAL,systemic drug therapy,Systemic drug therapies
NEW12403,MENTAL_HEALTH,other syndrome,Other syndromes
NEW12404,DISEASE,m74,M74
NEW12405,DISEASE,rbd patient,RBD patients
NEW12407,DISEASE,resistant arterial hypertension,HTN|resistant arterial hypertension
NEW12409,DISEASE,s. terebinthifolius,S. terebinthifolius
C049449,CHEMICAL,mepiquat [Supplementary Concept],Mepiquat chloride|Piperidines
NEW12411,NUTRITION,anthocyanidin cyanidin,anthocyanidins cyanidin
http://purl.obolibrary.org/obo/CHEBI_71507,NUTRITION,anthocyanidin 5-o-beta-d-glucoside 3-o-beta-d-sambubioside,anthocyanidin 5-O-beta-D-glucoside 3-O-[beta-D-xylosyl-(1->2)-beta-D-glucoside]s|anthocyanidin 5-O-beta-D-glucoside 3-O-[beta-D-xylosyl-(1->2)-beta-D-glucoside]|anthocyanidin 5-O-beta-D-glucoside 3-O-beta-D-sambubiosides|bilberry-derived anthocyanidins
NEW12415,NUTRITION,alpha diversity,Alpha diversity
NEW12417,CHEMICAL,peripheral sstr,peripheral SSTRs
NEW12419,DISEASE,monoamine neurotransmitter disorder,monoamine neurotransmitter disorders
http://purl.obolibrary.org/obo/CHEBI_81173,DISEASE,akeboside stf,PD PD
NEW12422,DISEASE,contractile dysfunction,Contractile dysfunction
NEW12424,DISEASE,obesity-induced endothelial dysfunction,Obesity-induced endothelial dysfunction
NEW12429,CHEMICAL,"model conjugate s-(1,2-dichlorovinyl)-l-cysteine","model conjugate S-(1,2-dichlorovinyl)-L-cysteine"
NEW12430,CHEMICAL,"model conjugate s-(1,2-dichlorovinyl)-l-cysteine","model conjugate S-(1,2-dichlorovinyl)-L-cysteine|DCVC"
NEW12432,CHEMICAL,"s-(1,2-dichlorovinyl)-l-homocysteine","DCVHC|S-(1,2-dichlorovinyl)-L-homocysteine"
NEW12436,MENTAL_HEALTH,suicide substrate,suicide substrate
C009055,CHEMICAL,propargylglycine [Supplementary Concept],propargylglycine|Alkynes|Glycine/analogs  and  derivatives
NEW12438,CHEMICAL,gen male,GEN males
NEW12439,NUTRITION,oral choline supplementation,oral choline supplementation
http://purl.obolibrary.org/obo/DOID_8689,DISEASE,anorexia nervosa,AN-R|restrictive-type anorexia nervosa
NEW12440,CHEMICAL,purging behavior,purging behaviors|BPB
NEW12442,CHEMICAL,zykr1,ZYKR1
NEW12447,DISEASE,intramyelinic edema,intramyelinic edema
C546258,CHEMICAL,"Gabra3 protein, mouse [Supplementary Concept]","gamma-aminobutyric acid A receptor|Receptors, GABA-A|GABAAR"
NEW12450,CHEMICAL,arsenic exposure,Arsenic exposure
NEW12451,CHEMICAL,arsenic exposure,arsenic exposure
http://purl.obolibrary.org/obo/SYMP_0000566,DISEASE,sleep disturbance,sleep disturbance
NEW12452,BIOCHEMICAL,opioid agonist treatment patient,opioid agonist treatment patients
NEW12453,DISEASE,ten-week-old male diabetic gk rat,Ten-week-old male diabetic GK rats
NEW12456,MENTAL_HEALTH,dementia disease,dementia diseases
NEW12457,CHEMICAL,various standard antidepressant drug,various standard antidepressant drugs
D003807,DISEASE,Dentin Sensitivity,"Dentin Hypersensitivities|Sensitivities, Dentin|Dentine Sensitivities|Sensitivities, Dentine|Hypersensitivities, Dentin|Tooth Sensitivity|Dentine Sensitivity|dentine|Dentine Hypersensitivities|Dentin Hypersensitivity|Sensitivities, Tooth|Sensitivity, Tooth|Tooth Sensitivities|Dentine Hypersensitivity|Sensitivity, Dentin|Hypersensitivities, Dentine|Sensitivity, Dentine|Dentin Sensitivities|Hypersensitivity, Dentin|Hypersensitivity, Dentine"
NEW12458,CHEMICAL,dentine to ca(oh)2,dentine to Ca(OH)2|pH12.6
C013572,CHEMICAL,"acetic acid, calcium hydroxide (Ca(OH)2), calcium salt (2:1), mercapto-, strontium hydroxide (Sr(OH)2) drug combination [Supplementary Concept]",Calcium Hydroxide|Thioglycolates|Ca(OH)2|Drug Combinations|Strontium
NEW12460,NUTRITION,yellow corn meal-based diet,yellow corn meal-based diet
http://purl.obolibrary.org/obo/DOID_14323,DISEASE,marfan syndrome,Marfan's syndrome|pale-bird syndrome
NEW12463,NUTRITION,brain choline acetyltransferase activity,Brain choline acetyltransferase activity
D002795,NUTRITION,Choline O-Acetyltransferase,"Choline Acetylase|Choline O Acetyltransferase|Choline Acetyltransferase|choline acetyltransferase|O-Acetyltransferase, Choline|Acetyltransferase, Choline|Acetylase, Choline|ChAT"
NEW12466,DISEASE,late-onset mthfr deficiency,late-onset MTHFR deficiency
NEW12467,BIOCHEMICAL,secondary cerebral folate deficiency,secondary cerebral folate deficiency
http://purl.obolibrary.org/obo/CHEBI_33232,CHEMICAL,application,Kocide applications
NEW12475,CHEMICAL,excessive alcohol consumption,Excessive alcohol consumption
NEW12477,NUTRITION,host fatty acid,host fatty acids
NEW12479,NUTRITION,fatty acid biosynthesis fasii enzyme,Fatty acid biosynthesis FASII enzymes
NEW12482,BIOCHEMICAL,selective serotonin reuptake inhibitor ssri fluoxetine,selective serotonin reuptake inhibitor SSRI fluoxetine
D065008,DISEASE,Scorpion Stings,"Scorpionisms|Scorpion Sting|Scorpion Envenoming|Sting, Scorpion|Scorpionism|envenoming|Envenoming, Scorpion|Envenomings, Scorpion|Scorpion Envenomation|Scorpion Envenomings|Envenomation, Scorpion|Scorpion Envenomations|Stings, Scorpion"
C541254,DISEASE,"hellerase, Crotalus oreganus helleri [Supplementary Concept]",Crotalus oreganus helleri|Crotalid Venoms|Metalloproteases
NEW12484,BIOCHEMICAL,various adrenergic agent,various adrenergic agents
NEW12488,CHEMICAL,f115 bulge f88,F115 bulge F88
NEW12489,BIOCHEMICAL,preoperative endocrine stress test,preoperative endocrine stress tests
NEW12491,DISEASE,osteoporosis disorder,osteoporosis disorder
D028243,DISEASE,"Cerebral Amyloid Angiopathy, Familial","Amyloidosis VIs|Cerebral Hemorrhage, Hereditary, With Amyloidosis|Cerebral Amyloid Angiopathy, Genetic|Icelandic Type Amyloidosis|HCHWA|Familial Cerebral Amyloid Angiopathy|Cerebral Amyloid Angiopathy, Cst3-Related|Amyloidosis, Icelandic Type|Autosomal Dominant Cerebrovascular Amyloidosis|Amyloidosis VI|Hereditary Cerebral Amyloid Angiopathy, Icelandic Type|Amyloidosis, Cerebroarterial, Icelandic Type|Icelandic Type Hereditary Cerebral Amyloid Angiopathy|Cerebral amyloid angiopathy|Hereditary Cerebral Hemorrhage With Amyloidosis|Cerebral Amyloid Angiopathy, Cst3 Related|Cerebral Amyloid Angiopathy, Hereditary|Hereditary Cerebral Amyloid Angiopathy"
http://purl.obolibrary.org/obo/DOID_0050544,DISEASE,hypermethioninemia,Hyperammonaemia
NEW12495,CHEMICAL,anaplerosis,Anaplerosis
NEW12498,NUTRITION,typical phospholipid lamella structure,Typical phospholipid lamella structures
NEW12500,DISEASE,wheat embryo albumin,WEA|wheat embryo albumin
NEW12503,BIOCHEMICAL,natural drug extract,natural drug extracts
NEW12505,CHEMICAL,gb energy,GB energy
D013750,CHEMICAL,Tetrachloroethylene,PERC|Perchloroethylene|Tetrachlorethylene|Tetrachloroethene|Perchlorethylene|perchloroethylene
NEW12509,CHEMICAL,Comorbidty,Comorbidty
NEW12510,CHEMICAL,ay001,AY001
NEW12512,BIOCHEMICAL,know renal toxin,known renal toxins
C430864,DISEASE,"DLC-1 (deleted in liver cancer) protein, mouse [Supplementary Concept]",GTPase-Activating Proteins|liver cancer|Tumor Suppressor Proteins
C517734,CHEMICAL,roflumilast N-oxide [Supplementary Concept],Roflumilast|Aminopyridines|Benzamides|Cyclopropanes
http://purl.obolibrary.org/obo/CHEBI_35472,BIOCHEMICAL,anti-inflammatory drug,anti-inflammatory drugs|antiinflammatory drugs|antiinflammatory agent|antiinflammatory drug
NEW11760,CHEMICAL,plant hormone gibberellin,GA|plant hormone gibberellin
NEW12517,DISEASE,prove mitochondrial disease,proven mitochondrial disease
NEW12518,CHEMICAL,most gas,most GAs
C042496,BIOCHEMICAL,ARK 62-62 [Supplementary Concept],Organoplatinum Compounds|L-ascorbic acid
NEW12523,DISEASE,hydropic vacuolation,HYDVAC|hydropic vacuolation
NEW12526,NUTRITION,wheat gluten,wheat glutens
NEW12527,DISEASE,gastrointestinal gi tract,gastrointestinal GI tract
D012435,DISEASE,S-Adenosylhomocysteine,"S Adenosylhomocysteine|S-adenosylhomocysteine|Adenosylhomocysteine, S|SAH"
D012604,CHEMICAL,Scorpion Venoms,"Scorpion Toxin|Venom Peptide, Scorpion|Venom, Tityus serrulatus|alpha Scorpion Toxin|gamma-Scorpion Toxin|Venom, Scorpion|Toxin, alpha-Scorpion|Scorpion Toxins|Toxin, beta-Scorpion|beta Scorpion Toxin|Scorpion Venom Peptide|Toxin, Scorpion|Tityus serrulatus Venom|PESV|beta-Scorpion Toxin|alpha-Scorpion Toxin|scorpion venom|gamma Scorpion Toxin|Peptide, Scorpion Venom|Scorpion Venom"
NEW12529,CHEMICAL,polypeptide extract,Polypeptide extract
NEW12531,BIOCHEMICAL,venom arsenal,venom arsenal
NEW12533,CHEMICAL,trocarin d,Trocarin D|TroD
NEW12535,BIOCHEMICAL,venom prothrombin activator,venom prothrombin activator
NEW12536,DISEASE,tropidechis carinatu,Tropidechis carinatus
NEW12537,BIOCHEMICAL,low maternal vitamin d level,low maternal vitamin D levels
NEW12538,CHEMICAL,Dimu Ningshen,Dimu Ningshen
NEW12540,DISEASE,leishmania major ptr1,Leishmania major PTR1
NEW12542,MENTAL_HEALTH,crave drug-seeking,craving drug-seeking
NEW12545,BIOCHEMICAL,traditional antihistamine chlorpheniramine,traditional antihistamine chlorpheniramine
NEW12546,CHEMICAL,hamlet human alpha-lactalbumin,HAMLET human alpha-lactalbumin
NEW12547,CHEMICAL,agent ticagrelor,agent ticagrelor
NEW12549,DISEASE,heart failure patient,heart failure patient
NEW12552,DISEASE,hypercapnic copd patient,hypercapnic COPD patients
NEW12553,CHEMICAL,clenbuterol overdosing,clenbuterol overdosing
D000067251,DISEASE,Symptom Flare Up,"Symptom Flare-ups|exacerbations|Symptom Exacerbations|Acute Symptom Flare|Increase, Symptom|Flareups, Symptom|Symptom Worsening|Flare-up, Symptom|Flareup, Symptom|Symptom Exaggeration|Flare Up, Symptom|Flare Ups, Symptom|Symptom Flare, Acute|Symptom Increase|Symptom Exacerbation|Symptom Flaring Up|Exaggeration, Symptom|Symptom Flareup|Symptom Magnifications|Magnification, Symptom|Symptom Flare Ups|Flaring Up, Symptom|Flare-ups, Symptom|Symptom Flare-up|Acute Symptom Flares|Symptom Flareups|Exacerbation, Symptom|Worsening, Symptom|Symptom Exaggerations|Symptom Magnification"
NEW12555,DISEASE,similar cardiovascular dysfunction,Similar cardiovascular dysfunctions
NEW12557,MENTAL_HEALTH,myocardial depression,myocardial depression
C543531,CHEMICAL,arbaclofen placarbil [Supplementary Concept],Baclofen/analogs  and  derivatives|Arbaclofen
NEW09502,DISEASE,neuronal dysfunction,neuronal dysfunction
NEW12560,MENTAL_HEALTH,violent hyperactivity,violent hyperactivity
NEW12561,DISEASE,abnormal limb movement,contralateral ballism|Abnormal limb movements
D050644,CHEMICAL,Succinate-Semialdehyde Dehydrogenase,"Semialdehyde Dehydrogenase, Succinate|Dehydrogenase, Succinate Semialdehyde|Dehydrogenase, Succinate-Semialdehyde|Succinate Semialdehyde Dehydrogenase|Semialdehyde Dehydrogenase, Succinic|succinate|Dehydrogenase, Succinic Semialdehyde|Succinic Semialdehyde Dehydrogenase|NAD(+)-Dependent Succinic Semialdehyde Dehydrogenase"
NEW12566,BIOCHEMICAL,backbone endocrine therapy,backbone endocrine therapy
NEW12569,BIOCHEMICAL,endocrine side effect,Endocrine side effect
NEW12571,CHEMICAL,non potassium-sparing diuretic,Non potassium-sparing diuretics
NEW12572,DISEASE,allergy score,allergy scores
D003663,NUTRITION,Decision Trees,"Decision Tree|Trees, Decision|decision tree|Tree, Decision"
NEW12574,MENTAL_HEALTH,associate synaptic depression,associated synaptic depression
NEW12576,CHEMICAL,[14c]leucine,[14C]leucine
NEW12577,CHEMICAL,[14c]iodoantipyrine,[14C]iodoantipyrine
NEW12578,CHEMICAL,[3h]naloxone binding,[3H]naloxone binding
NEW12580,MENTAL_HEALTH,agonist displacement,agonist displacement
http://purl.obolibrary.org/obo/CHEBI_43000,CHEMICAL,guanosine 5'-[gamma-thio]triphosphate,gamma-Thio-GTP|5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE|GTP-gamma-S|guanosine 5'-(tetrahydrogen 5-thiotriphosphate)|GTP gamma S|guanosine 5'-[gamma-thio]triphosphate|Guanosine 5'-O-(3-thiotriphosphate)|Guanosine 5'-(gamma-S)triphosphate
C535800,MENTAL_HEALTH,"Amyloidosis, Cerebral, with Spongiform Encephalopathy [Supplementary Concept]",Prion Diseases|Progressive dementia|Dementia
D002336,CHEMICAL,Carnosine,"beta-Alanylhistidine|beta Alanylhistidine|L-Carnosine|Carnosine|Hydrochloride, Carnosine|L Carnosine|Carnosine, (D-His)-Isomer|Carnosine Hydrochloride"
NEW12582,CHEMICAL,serotonin receptor gene polymorphism,Serotonin receptor gene polymorphism
NEW12583,DISEASE,diabetes patient,diabetes patients
NEW12586,CHEMICAL,ZT bromocriptine treatment,ZT bromocriptine treatment
NEW12587,CHEMICAL,circadian-timed bromocriptine treatment,circadian-timed bromocriptine treatment
NEW12591,CHEMICAL,glucose uptake,Glucose uptake
NEW12592,CHEMICAL,3h-serotonin uptake,3H-serotonin uptake
D015518,DISEASE,Rett Syndrome,"Rett's Disorder|Cerebroatrophic Hyperammonemia|Syndrome, Rett's|Autism Dementia Ataxia Loss of Purposeful Hand Use Syndrome|Autism, Dementia, Ataxia, and Loss of Purposeful Hand Use|Hyperammonemia, Cerebroatrophic|Rett Disorder|Cerebroatrophic Hyperammonemias|Rett's Syndrome|Retts Syndrome|Hyperammonemias, Cerebroatrophic|Syndrome, Rett|RS|Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome|Rett syndrome"
NEW12594,BIOCHEMICAL,widespread fungicide use,widespread fungicide use
NEW12595,CHEMICAL,noncompetitive n-methyl-d-aspartate receptor nmdar antagonist,noncompetitive N-methyl-D-aspartate receptor NMDAr antagonist
NEW12596,CHEMICAL,levodopa response,levodopa response
NEW12598,DISEASE,fhb resistance type,FHB resistance types
NEW12600,CHEMICAL,avp-induced water retention,AVP-induced water retention
NEW12602,DISEASE,dilutional hyponatremia,dilutional hyponatremia
D004347,BIOCHEMICAL,Drug Interactions,"Interaction, Drug|Drug Interaction|Interactions, Drug|drug interactions"
D048668,DISEASE,Lactobacillus delbrueckii,Lactobacillus bulgaricus|Lactobacillus delbrueckii subspecies bulgaricus|Lactobacillus delbrueckii subsp. bulgaricus
NEW12607,CHEMICAL,berberine treatment,berberine treatment
NEW12610,CHEMICAL,pre-administration,Pre-administration
NEW12614,CHEMICAL,pregnane x receptor expression,Pregnane X receptor expression
NEW12617,BIOCHEMICAL,ir-like state high beta cell activity index,IR-like state high beta cell activity indices
NEW12619,CHEMICAL,low testosterone level,low testosterone levels
NEW12621,DISEASE,dystonia patient,dystonia patients
NEW12623,DISEASE,experimental autoimmune prostatitis persistent inflammatory immune response,Experimental autoimmune prostatitis persistent inflammatory immune response
NEW12625,CHEMICAL,injectable paliperidone palmitate,injectable paliperidone palmitate
D015228,DISEASE,Hypertriglyceridemia,Hypertriglyceridemias|hypertriglyceridemia
NEW12628,DISEASE,severe anemia,severe anemia
NEW12630,CHEMICAL,5-fu metabolism,5-FU metabolism
NEW12633,CHEMICAL,n-3 index,n-3 index
http://purl.obolibrary.org/obo/DOID_10581,DISEASE,metachromatic leukodystrophy,deficiency of cerebroside-sulfatase|MLD|Metachromatic leucodystrophy|sulfatide lipoidosis|arylsulfatase A deficiency|Scholz cerebral sclerosis
NEW12635,BIOCHEMICAL,nitroimidazole drug,nitroimidazole drug
D002181,DISEASE,"Candidiasis, Vulvovaginal","Vaginal Yeast Infection|Genital Vulvovaginal Candidiasis|Vulvovaginal Candidiasis|Vulvovaginal Candidiasis, Genital|Vaginitis, Monilial|Monilial Vaginitis|Candidiasis, Genital|Infection, Vaginal Yeast|Yeast Infection, Vaginal|Moniliasis, Vulvovaginal|Candidiasis, Genital Vulvovaginal|Yeast Infections, Vaginal|Infections, Vaginal Yeast|Vulvovaginal Moniliasis|vulvovaginal candidiasis|Vaginal Yeast Infections|Genital Candidiasis"
D059268,DISEASE,Atrophic Vaginitis,"Atrophic vaginitis|Atrophic Vaginitides|Vaginitis, Atrophic|Vaginitides, Atrophic"
NEW12639,MENTAL_HEALTH,male rat resistance,male rat resistance
NEW12641,CHEMICAL,testosterone effect,Testosterone effect
NEW12642,CHEMICAL,Muntingia calabura,Elaecoparceae|Muntingia calabura
NEW12644,CHEMICAL,ketamine compound,ketamine compound
NEW12645,BIOCHEMICAL,available antitubercular drug,available antitubercular drugs
NEW12646,CHEMICAL,caffeine metabolite,caffeine metabolites
NEW12647,CHEMICAL,caffeine caffeine metabolite,caffeine caffeine metabolites
http://purl.obolibrary.org/obo/CL_0002077,CHEMICAL,ecto-epithelial cell,PDAC cells
NEW12649,CHEMICAL,thiazolidinedione class,thiazolidinedione class
NEW12650,DISEASE,transient forebrain ischemia,transient forebrain ischemia
NEW12651,CHEMICAL,pioglitazone treatment,pioglitazone treatment
NEW12653,DISEASE,abeta-induced cell death,Abeta-induced cell death
D000077466,CHEMICAL,Tirofiban,"Aggrastat|L 700,462|L-700462|Agrastat|L-700,462|N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine|tirofiban|MK 383|Tirofiban Hydrochloride Monohydrate|MK-383|Tirofiban Hydrochloride|L700,462|L 700462"
D000077284,CHEMICAL,Abciximab,"CentoRx|ReoPro|Clotinab|Chimeric 7E3 Fab|Fab, Chimeric 7E3|c7E3 Fab|Abciximab"
NEW12656,DISEASE,ischaemic adverse cardiovascular event,ischaemic adverse cardiovascular events
NEW12657,DISEASE,traumatic event exposure,traumatic event exposure
NEW12658,BIOCHEMICAL,long-acting β2-adrenergic receptor agonist,long-acting β2-adrenergic receptor agonist
NEW12659,BIOCHEMICAL,long-acting anticholinergic agent,long-acting anticholinergic agents
NEW12661,CHEMICAL,laac,LAAC
NEW12662,CHEMICAL,long-acting β2-adrenergic receptor agonist,long-acting β2-adrenergic receptor agonist|LABA
NEW08702,BIOCHEMICAL,estrogen exposure,estrogen exposure
NEW12663,BIOCHEMICAL,traditional menopausal hormone therapy,Traditional menopausal hormone therapy
D017312,CHEMICAL,Toremifene,"Fareston|FC1157a|Citrate, Toremifene|FC-1157a|toremifene|Toremifene Citrate|FC 1157a|Toremifene, (E)-Isomer|Toremifene Citrate (1:1)"
NEW12664,CHEMICAL,selective estrogen receptor degrader fulvestrant,selective estrogen receptor degrader fulvestrant
NEW12667,CHEMICAL,nile tilapia skin,Nile tilapia skin
NEW12669,CHEMICAL,dha intake,DHA intake
NEW12670,CHEMICAL,high dha intake,high DHA intake
NEW12671,CHEMICAL,dietary dha,dietary DHA
NEW12672,DISEASE,autistic pup,Autistic pups
D000077149,CHEMICAL,Sevoflurane,"Ultane|Sevorane|BAX 3084|Fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethyl Ether|Fluoromethyl Hexafluoroisopropyl Ether|sevoflurane"
NEW12676,CHEMICAL,corylifolia l.,corylifolia L.
D005688,CHEMICAL,Galactosamine,Hexosamines (1966-1970)|galactosamine
D001089,CHEMICAL,Arabinose,L-Arabinose|L Arabinose|arabinose
NEW12680,DISEASE,Prunus fermentation extract,Prunus fermentation extract
C084809,CHEMICAL,lergotrile mesylate [Supplementary Concept],Ergolines|lergotrile mesylate
D013001,DISEASE,Somatoform Disorders,"Medically Unexplained Syndromes|Disorder, Somatoform|Somatoform Disorder|Unexplained Syndrome, Medically|Medically Unexplained Syndrome|Syndrome, Briquet|Somatization Disorders|Syndrome, Medically Unexplained|somatoform disorders|Pain Disorder|Briquet Syndrome|Somatization Disorder"
NEW12688,NUTRITION,wheat diet,wheat diets
NEW12691,MENTAL_HEALTH,severe premenstrual depression,severe premenstrual depression
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Premenstrual_Syndrome,MENTAL_HEALTH,premenstrual syndrome,severe premenstrual syndrome
D019052,MENTAL_HEALTH,"Depression, Postpartum","Post Natal Depression|Postnatal depression|Post-Natal Depression|Depression, Postnatal|Post Partum Depression|Depression, Post-Natal|Post-Partum Depression|Postnatal Depression|Depression, Post-Partum|Postpartum Depression"
NEW12693,DISEASE,chronic crf release,chronic CRF release
NEW12695,BIOCHEMICAL,ketamine ionotropic glutamatergic nmdar n-methyl-d-aspartate receptor antagonist,ketamine ionotropic glutamatergic NMDAR N-methyl-D-aspartate receptor antagonist
NEW12698,CHEMICAL,non-starch polysaccharide,NSPs|Non-starch polysaccharides
http://purl.obolibrary.org/obo/CHEBI_6628,DISEASE,macrozamin,Puerariae Lobatae Radix(YHG|Macrozamin
C027492,DISEASE,Huang Qi [Supplementary Concept],"Astragalus propinquus|Drugs, Chinese Herbal|Astragali Radix"
http://purl.obolibrary.org/obo/CHEBI_7714,CHEMICAL,obamegine,Epimedii Folium|Obamegine|(+)-Obamegine
NEW12702,CHEMICAL,oral contraceptive user,oral contraceptive users
C006952,CHEMICAL,cerebrolysin [Supplementary Concept],Amino Acids|Cerebrolysin
NEW12705,DISEASE,new neurodevelopmental syndrome responsive,new neurodevelopmental syndrome responsive
D006916,CHEMICAL,5-Hydroxytryptophan,"5-hydroxytryptophan|Oxytryptophan|5-HTP|Oxitriptan|Hydroxytryptophan|5 Hydroxytryptophan|Tryptophan, 5 Hydroxy|5-Hydroxy- Tryptophan|Tryptophan, 5-Hydroxy-"
D020881,CHEMICAL,"Enkephalin, D-Penicillamine (2,5)-","Enkephalin, Pen(2,5)-|Bis-Pen-Enkephalin|Bis Pen Enkephalin|d-Penicillamine|DPDPE|D-Pen2, L-Pen5-Enkephalin|DPDPE(SH)2|Bis Penicillamine Enkephalin|Enkephalin, Penicillamine (2,5)-|D-Pen5-Enkephalin D-Pen2|DPLPE|D Pen2, D Pen5 Enkephalin|L-Pen5-Enkephalin D-Pen2|Bis-Penicillamine-Enkephalin|D-Pen2, D-Pen5-Enkephalin|D-Penicillamine (2,5)-Enkephalin|D Pen2, L Pen5 Enkephalin"
D009021,MENTAL_HEALTH,Morphine Dependence,"Morphine Addiction|Morphine dependence|Morphine Abuse|Dependence, Morphine|Addiction, Morphine|Abuse, Morphine"
NEW12708,CHEMICAL,excitatory amino acid system,excitatory amino acid systems
http://purl.obolibrary.org/obo/PR_Q54N47,CHEMICAL,branched-chain-amino-acid aminotransferase (dictyostelium discoideum),ddb_g0285509|bcaa|dicty-ilve|BCAAs
NEW12712,CHEMICAL,air spora,Air spora
NEW12714,CHEMICAL,pinene emission,Pinene emissions
NEW12717,CHEMICAL,shsvct2,shSVCT2
NEW12719,CHEMICAL,atrx-dependent svct2 signal,ATRX-dependent SVCT2 signal
NEW12721,MENTAL_HEALTH,adhd trial,ADHD trial
NEW12722,MENTAL_HEALTH,adhd pharmacotherapy,ADHD pharmacotherapy
NEW12724,DISEASE,psychophysiological stress-induced chronic sleep disorder,CSD|psychophysiological stress-induced chronic sleep disorder
NEW12727,CHEMICAL,raise plasma homocysteine,Raised plasma homocysteine
NEW12728,CHEMICAL,hp/g-bw film,HP/G-BW film
NEW12731,BIOCHEMICAL,preferable dopamine receptor antagonist,preferable dopamine receptor antagonist
NEW12732,CHEMICAL,haloperidol mg/kg,haloperidol mg/kg
NEW12735,CHEMICAL,gaba(a)-benzodiazepine receptor,GABA(A)-benzodiazepine receptor
NEW12736,BIOCHEMICAL,endogenous inverse agonist,endogenous inverse agonist
NEW12737,CHEMICAL,gamma-aminobutyric acid type a gabaa receptor subunit gene,gamma-Aminobutyric acid type A GABAA receptor subunit genes
NEW12738,CHEMICAL,benzodiazepine agonist,Benzodiazepine agonists
NEW12739,NUTRITION,probe-sonicated achiote extract,probe-sonicated achiote extract
NEW12741,CHEMICAL,high δ-tocotrienol content,highest δ-tocotrienol content
NEW12742,NUTRITION,achiote lipophilic extract,Achiote lipophilic extract
C004588,BIOCHEMICAL,bixin [Supplementary Concept],Carotenoids|bixin
NEW12743,NUTRITION,achiote seed extract,achiote seed extract
NEW12745,CHEMICAL,acute lsd administration,acute LSD administration
NEW12746,CHEMICAL,repeat lsd,repeated LSD
NEW12748,CHEMICAL,clinical-stage therapeutic vatiquinone,clinical-stage therapeutic vatiquinone
NEW12750,DISEASE,lithium neurotoxicity,Lithium neurotoxicity
NEW12752,CHEMICAL,dopamine d2 antagonism,dopamine D2 antagonism
D058976,BIOCHEMICAL,Folate Receptor 2,"Protein, Placental Folate-Binding|Fetal Folate Receptor|Placental Folate Receptor|beta, Folate Receptor|Folate Receptor, Placental|Folate Receptor beta|Receptor, Placental Folate|Folate Receptor, Fetal|Folate-Binding Protein, Placental|Receptor 2, Folate|Placental Folate-Binding Protein|Placental Folate Binding Protein|Receptor, Fetal Folate|Folic Acid Receptor beta|Receptor beta, Folate|folate receptor-β"
NEW12755,CHEMICAL,developmental ethanol exposure,Developmental ethanol exposure
NEW12757,CHEMICAL,developmental etoh,developmental EtOH
NEW12759,DISEASE,neuroteratogen alcohol spectrum disorder,neuroteratogen alcohol spectrum disorders
NEW12762,CHEMICAL,high dose methotrexate infusion,High dose methotrexate infusion
D053626,CHEMICAL,Atovaquone,"566C80|2-(4-(4'-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|Wellvone|hydroxynaphthoquinone 566C80|hydroxynaphthoquinone, 566C80|2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|atovaquone|compound 566|Mepron|566C80 hydroxynaphthoquinone|566C"
NEW12763,CHEMICAL,papaverine prostaglandin e1,papaverine prostaglandin E1
NEW12765,DISEASE,traumatic paraplegic,traumatic paraplegics
NEW12767,CHEMICAL,sodium nitrite toxicity,Sodium nitrite toxicity
C000603935,CHEMICAL,aripiprazole lauroxil [Supplementary Concept],Aripiprazole lauroxil|Aripiprazole
D017330,CHEMICAL,Remoxipride,"Remoxipride Hydrochloride|FLA-731|Monohydrochloride, Remoxipride|Anhydrous, Remoxipride Hydrochloride|remoxipride|Remoxipride Monohydrochloride|Remoxipride Monohydrochloride, (R)-Isomer|Monohydrochloride Monohydrate, Remoxipride|(S)-3-Bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxybenzamide|Hydrochloride, Remoxipride|Remoxipride Hydrochloride Anhydrous|Remoxipride Monohydrochloride Monohydrate|Remoxipride, (R)-Isomer|Hydrochloride Anhydrous, Remoxipride|FLA731"
NEW12773,MENTAL_HEALTH,positive anxiety,positive anxiety
D004411,MENTAL_HEALTH,"Dyslexia, Acquired","Disability, Acquired Reading|Dyslexia, Acquired Global|Reading Disability, Acquired|Reading Disabilities, Acquired|Acquired Reading Disabilities|Dyslexia, Acquired Spelling|Acquired Dyslexia|Acquired Word Blindnesses|Acquired Spelling Dyslexia|Blindnesses, Acquired Word|dyslexia|Acquired Reading Disability|Acquired Alexia|Acquired Word Blindness|Disabilities, Acquired Reading|Acquired Global Dyslexia|Alexia, Acquired|Spelling Dyslexia, Acquired|Word Blindnesses, Acquired|Global Dyslexia, Acquired|Blindness, Acquired Word|Word Blindness, Acquired"
http://purl.obolibrary.org/obo/DOID_0050589,DISEASE,inflammatory bowel disease,concurrent inflammatory bowel disease
NEW12776,CHEMICAL,non-menthol cooling agent,non-menthol cooling agents
NEW12781,CHEMICAL,mske,MSKE
D020190,DISEASE,"Myoclonic Epilepsy, Juvenile","Petit Mal, Impulsive, Janz|Myoclonic Epilepsy, Juvenile, 1|Epilepsy, Myoclonic, Juvenile|JMEs (Juvenile Myoclonic Epilepsy)|myoclonic epilepsy|JME (Juvenile Myoclonic Epilepsy)|Epilepsy, Adolescent Myoclonic|Myoclonic Epilepsy, Adolescent|Epilepsy, Juvenile Myoclonic|Impulsive Petit Mal Epilepsy|Janz Syndrome|Impulsive Petit Mal, Janz|Juvenile Myoclonic Epilepsy|Adolescent Myoclonic Epilepsy|Juvenile Epilepsy, Myoclonic|Juvenile Myoclonic Epilepsy of Janz|Petit Mal, Impulsive|Janz Juvenile Myoclonic Epilepsy|Myoclonic Juvenile Epilepsy|Janz Impulsive Petit Mal|Epilepsy, Myoclonic Juvenile"
NEW12783,DISEASE,global brain ischemia,global brain ischemia
NEW12785,CHEMICAL,lipopolysaccharide structure,lipopolysaccharide structures
NEW12787,MENTAL_HEALTH,partial dissociation,partial dissociation
NEW12788,CHEMICAL,c = o ester carbonyl stretch,C = O ester carbonyl stretch
NEW12789,CHEMICAL,hap nanoparticle,HAp nanoparticles
NEW12791,DISEASE,druginduced diabete,druginduced diabetes
NEW12795,NUTRITION,total cholesterol,Total Cholesterol
NEW12796,CHEMICAL,intracavernosal alpha-adrenergic agent,intracavernosal alpha-adrenergic agents
NEW12798,CHEMICAL,GLOBIOM-Brazil scenario,GLOBIOM-Brazil scenarios
NEW12801,CHEMICAL,supra-therapeutic dose,supra-therapeutic doses
NEW12803,CHEMICAL,rho-kinase 2,Rho-kinase 2|ROCK-II
NEW12804,DISEASE,facial cellulitis,Facial cellulitis
NEW12805,BIOCHEMICAL,ttr tetramer stabilizer,TTR tetramer stabilizers
NEW12807,BIOCHEMICAL,stabilizer concentration,stabilizer concentration
NEW12809,DISEASE,associate arrhythmia,associated arrhythmias
NEW12812,CHEMICAL,isotope labeling experiment,isotope labeling experiments
NEW12816,CHEMICAL,procyanidin oligomer,procyanidin oligomers
D051304,CHEMICAL,Profilins,Profilin 3|Profilin-3|Profilin|Profilin Proteins|Profilin 4|Profilin 1|profilin|Profilin-4|Profilin I|Profilin-1|Profilin-2|Profilin 2
NEW12820,DISEASE,behavioural deficit,Behavioural deficits
NEW12823,CHEMICAL,nmda receptor-mediated glutamate transmission,NMDA receptor-mediated glutamate transmission
NEW12825,MENTAL_HEALTH,bipolar disorder patient,Bipolar disorder patients
NEW12827,CHEMICAL,low-dose resveratrol,low-dose resveratrol
NEW12830,NUTRITION,dietary raspberry,dietary raspberry
D020806,DISEASE,Central Nervous System Bacterial Infections,"Bacterial Infections, Central Nervous System|Infections, Bacterial, Central Nervous System|bacterial infections"
D054631,DISEASE,"Receptor-Like Protein Tyrosine Phosphatases, Class 3","Stomach Cancer Associated Protein Tyrosine Phosphatase|Receptor Like Protein Tyrosine Phosphatases, Class 3|Protein Tyrosine Phosphatase, Receptor Type H|Phosphatase, SAP-1|PTPRQ Phosphatase|Receptor Like Protein Tyrosine Phosphatases, Class III|Phosphatase, PTPRV|Protein Tyrosine Phosphatase, Receptor Type O|Protein Tyrosine Phosphatase Receptor omicron|Vascular Endothelial Protein Tyrosine Phosphatase|Protein Tyrosine Phosphatase eta|Glomerular Epithelial Protein 1|Density-Enhanced Phosphatase 1|Protein Tyrosine Phosphatase, Receptor Type V|Phosphatase, PTPRO|Phosphatase, GLEPP1|Protein Tyrosine Phosphatase, Receptor Type Q|DEP1 Phosphatase|Phosphatase, PTPRJ|PTPRV Phosphatase|Phosphatase, PTPRH|VE-PTP Phosphatase|Phosphatase, PTPRB|Protein-Tyrosine Phosphatase eta|SAP 1 Phosphatase|PTPRB Phosphatase|Receptor-Like Protein Tyrosine Phosphatases, Class III|Stomach Cancer-Associated Protein-Tyrosine Phosphatase|Protein Tyrosine Phosphatase, Receptor Type J|GLEPP1 Phosphatase|PTPRJ Phosphatase|VE PTP Phosphatase|Phosphatase eta, Protein-Tyrosine|SAP-1 Phosphatase|Density Enhanced Phosphatase 1|PTPRH Phosphatase|PTPRO Phosphatase|Protein Tyrosine Phosphatase, Receptor Type B|Phosphatase, PTPRQ|stomach cancer"
D018698,CHEMICAL,Glutamic Acid,"Potassium Glutamate|D-Glutamate|L Glutamic Acid|L-Glutamate, Aluminum|Glutamic acid|Aluminum L-Glutamate|Aluminum L Glutamate|Glutamate, Potassium|D Glutamate|Glutamate|L-Glutamate|L Glutamate|L-Glutamic Acid|Glutamic Acid, (D)-Isomer"
NEW12833,CHEMICAL,phenylalanine value,phenylalanine values
NEW12834,NUTRITION,maximum likelihood tree,maximum likelihood tree
C121465,CHEMICAL,6-methyl-2-(phenylethynyl)pyridine [Supplementary Concept],Pyridines|MPEP
C117789,CHEMICAL,7-(hydroxyimino)cyclopropan(b)chromen-1a-carbxoylic acid ethyl ester [Supplementary Concept],CPCCOEt|Chromones
NEW12838,BIOCHEMICAL,group mglur agonist,group mGluR agonist
C114785,CHEMICAL,2-amino-4-phosphono-propinate [Supplementary Concept],Propionates|L-AP4
C120942,CHEMICAL,"1,4-diaminopyrrolidine-2,4-dicarboxylic acid [Supplementary Concept]",APDC|Proline
NEW12840,CHEMICAL,opioid antagonist naltrexone,opioid antagonist naltrexone
NEW12842,MENTAL_HEALTH,hyperactivity disorder-like symptom,hyperactivity disorder-like symptoms
http://purl.obolibrary.org/obo/CHEBI_67194,CHEMICAL,cannabinoid,cannabinoids|cannabinoids Δ9-tetrahydrocannabinol
NEW12843,CHEMICAL,adenosine a1 a2a receptor,Adenosine A1 A2A receptors
C079215,CHEMICAL,"3,5-dihydroxyphenylglycine [Supplementary Concept]",Resorcinols|DHPG|Glycine/analogs  and  derivatives
NEW12846,CHEMICAL,mt chloride,MT chloride
NEW12849,CHEMICAL,monoamine oxidase b inhibitor,Monoamine oxidase B inhibitors
NEW12851,DISEASE,reversible mao-a inhibitor,reversible MAO-A inhibitors
NEW12852,BIOCHEMICAL,pharmaceutical class,pharmaceutical class
NEW12855,CHEMICAL,rapid-acting antidepressant,rapid-acting antidepressants
NEW12856,CHEMICAL,inappropriate metalaxyl usage,inappropriate metalaxyl usage
D057910,DISEASE,Implant Capsular Contracture,"Capsular Contracture, Implant|Contracture, Implant Capsular|contracture"
D010646,CHEMICAL,Phentolamine,"Regitine|Mesylate, Phentolamine|Mesilate, Phentolamine|Phentolamine Methanesulfonate|Rogitine|Regityn|Fentolamin|Methanesulfonate, Phentolamine|Phentolamine Mesylate|Phentolamine Mesilate|Phentolamine Mono-hydrochloride|phentolamine|Z-Max|Phentolamine Mono hydrochloride|Mono-hydrochloride, Phentolamine"
C010616,CHEMICAL,normorphine [Supplementary Concept],normorphine|Morphine Derivatives
NEW12860,CHEMICAL,glutamatergic nmda,glutamatergic NMDA
NEW12863,CHEMICAL,da function,DA function
NEW12864,MENTAL_HEALTH,idiopathic impotence,idiopathic impotence
NEW12867,CHEMICAL,vpa model mouse,VPA model mice
NEW12870,MENTAL_HEALTH,autism symptom,autism symptoms
NEW12871,BIOCHEMICAL,gabab receptor agonist administration,GABAB receptor agonist administration
NEW12873,DISEASE,metabolic impairment,Metabolic impairments
NEW12875,DISEASE,mild hypoxia,mild hypoxia
NEW12877,CHEMICAL,metformin treatment,metformin treatment
NEW12879,NUTRITION,scl27a4 solute family fatty acid transporter,SCL27A4 solute family fatty acid transporter
NEW12880,CHEMICAL,palmitate oxidation,palmitate oxidation
NEW12882,DISEASE,platelet aggregation,Platelet aggregations
NEW12883,BIOCHEMICAL,selective antagonist available,selective antagonist available
NEW12884,DISEASE,pure menstrual migraine,Pure menstrual migraine
NEW12885,CHEMICAL,medium fertilizer-medium water treatment,medium fertilizer-medium water treatment
NEW12887,CHEMICAL,f2w3,F2W3
http://purl.obolibrary.org/obo/DOID_10127,DISEASE,cerebral artery occlusion,acute cerebral artery occlusion
NEW12890,CHEMICAL,mt treatment,MT treatment
NEW12891,BIOCHEMICAL,combination antimicrobial therapy,Combination antimicrobial therapy
D000583,CHEMICAL,Amikacin,"Amikacin Sulfate|Oprad|BBK 8|Gamikal|BB K 8|Amikin|Amikalem|Medical, Amikacina|Sulfate, Amikacin|Amikason's|BBK8|A.M.K|Amukin|BB-K 8|Amikafur|amikacin|Yectamid|BB K8|Amikacina Medical|Amiklin|Biclin|Biklin|BB-K8|Normon, Amikacina|Kanbine|Amikayect|Amikacina Normon"
NEW12893,DISEASE,a. baumannii isolate,A. baumannii isolates
http://purl.obolibrary.org/obo/CHEBI_5138,BIOCHEMICAL,fluvoxamine,fluvoxamina|SSRI fluvoxamine|O-(2-aminoethyl)-N-{(1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}hydroxylamine|fluvoxaminum|Fluvoxamine|2-{[(E)-{5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}amino]oxy}ethan-1-amine|(1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one O-(2-aminoethyl)oxime|fluvoxamine
NEW12895,DISEASE,ibs patient,IBS patients
NEW12898,BIOCHEMICAL,apoe ε4 genotype carrier,APOE ε4 genotype carriers
NEW12901,MENTAL_HEALTH,regression model,regression models
NEW12904,CHEMICAL,restricted cubic spline,Restricted cubic splines
NEW12905,CHEMICAL,Langmuir equation model,Langmuir equation model
D064695,CHEMICAL,Enclomiphene,"trans-Clomiphene|Citrate, Enclomiphene|trans Clomiphene Citrate|Citrate, trans-Clomiphene|clomiphene citrate|(E)-2-(p-(2-Chloro-1,2-Diphenylvinyl)phenoxy)triethylamine Citrate|trans-Clomiphene Citrate|trans Clomiphene|Androxal|Enclomiphen|CC|Enclomifene|(E)-2-(p-(2-Chloro-1,2-Diphenylvinyl)phenoxy)triethylamine|En-Clomiphene|Enclomiphene Citrate"
NEW12907,NUTRITION,cholesterol saturation,cholesterol saturation
NEW12909,DISEASE,disease morbidity,diseases morbidity
NEW12912,CHEMICAL,valproic acid vpa intake,Valproic acid VPA intake
NEW12914,CHEMICAL,vpa-induced embriotoxicity,VPA-induced embriotoxicity
NEW12916,CHEMICAL,nac treatment,NAC treatment
NEW12917,BIOCHEMICAL,nonsteroidal estrogenic mycotoxin,nonsteroidal estrogenic mycotoxin
D015025,CHEMICAL,Zearalenone,"F 2 Toxin|Toxin, F2|Toxin, F-2|F-2 Toxin|Zearalenone|F2 Toxin"
NEW12920,DISEASE,b. amyloliquefacien ln,B. amyloliquefaciens LN
NEW12921,CHEMICAL,zen concentration,ZEN concentration
NEW12927,CHEMICAL,dopamine dysregulation,dopamine dysregulation
NEW01539,DISEASE,psychiatric treatment,psychiatric treatment
D000861,CHEMICAL,Anserine,anserine|Ophidine|Beta-Alanyl-3-Methylhistidine|Balanine|Beta Alanyl 3 Methylhistidine
NEW12929,CHEMICAL,imidazole dipeptide,imidazole dipeptides
NEW08227,DISEASE,stroke prevention,stroke prevention
NEW12931,MENTAL_HEALTH,displacement rate,Displacement rate
D014151,CHEMICAL,Anti-Anxiety Agents,"Anxiolytics|Anti Anxiety Effects|Tranquillizing Agents, Minor|anxiolytics|Anti Anxiety Effect|Anxiolytic Agent|Minor Tranquillizing Agents|Drug, Anti-Anxiety|Anti-Anxiety Effects|Effects, Anti-Anxiety|Effect, Anti-Anxiety|buspirone|Anxiolytic Agents|Anxiolytic Effect|Anti-Anxiety Drugs|Effects, Anxiolytic|Minor Tranquilizing Agents|Anxiolytic|Agents, Minor Tranquilizing|Agent, Anti-Anxiety|Antianxiety Effect|Anti-Anxiety Effect|Anti-Anxiety Drug|Agents, Anxiolytic|Anti Anxiety Agents|Anti Anxiety Drugs|Anti Anxiety Agent|Anti-Anxiety Agent|Agent, Anxiolytic|Anxiolytic Effects|Effects, Antianxiety|Antianxiety Effects|Agents, Anti-Anxiety|Effect, Anxiolytic|Agents, Minor Tranquillizing|Drugs, Anti-Anxiety|Effect, Antianxiety|Anti Anxiety Drug|Tranquilizing Agents, Minor"
NEW12933,NUTRITION,yeast homolog,yeast homolog
http://purl.obolibrary.org/obo/CHEBI_183050,BIOCHEMICAL,neoantigen,neoantigens|Neoantigens
NEW12935,DISEASE,major congenital anomaly,major congenital anomalies
NEW12937,DISEASE,insomniac,insomniacs
NEW12938,CHEMICAL,treatment ° C/24 h,treatments ° C/24 h
NEW12939,NUTRITION,amorphous calcium phosphate nanoplatform,amorphous calcium phosphate nanoplatform
NEW12942,DISEASE,tumor intracellular environment,tumor intracellular environment
NEW12945,CHEMICAL,nicotinamide adenine dinucleotide phosphate nadph oxidase,Nicotinamide adenine dinucleotide phosphate NADPH oxidase
NEW12946,CHEMICAL,chronic pentylenetetrazole treatment,chronic pentylenetetrazole treatment
C056165,CHEMICAL,acetovanillone [Supplementary Concept],apocynin|Acetophenones
http://purl.obolibrary.org/obo/CHEBI_166857,CHEMICAL,3-acetylpyridine adenine dinucleotide,"(3-acetylpyridine)AD|3-acetyl NAD|3-acetylpyridine-DPN|3-acetyl-1-[(2R,3R,4S,5R)-5-{[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphorylphosphonato)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-1lambda(5)-pyridin-1-ylium|3-acetylpyridine NAD|3-acetylpyridineadenine dinucleotide|nicotinamide adenine dinucleotide NAD+ precursors|acetylpyridine-adenine dinucleotide|3-acetylpyridine-NAD"
NEW12949,BIOCHEMICAL,dietary nicotinamide,dietary nicotinamide
NEW12951,MENTAL_HEALTH,hierarchical linear regression model,hierarchical linear regression model
NEW12954,BIOCHEMICAL,daily dietary nicotinamide intake,Daily dietary nicotinamide intake
NEW06641,CHEMICAL,≥,≥
http://purl.obolibrary.org/obo/SYMP_0019183,MENTAL_HEALTH,hyperactivity,CRH-induced hyperactivity
NEW12960,CHEMICAL,membrane arachidonic acid level,membrane arachidonic acid levels
C543485,CHEMICAL,"EPHX1 protein, mouse [Supplementary Concept]",microsomal epoxide hydrolase|Epoxide Hydrolases
NEW12961,DISEASE,severe ss,Severe SS
NEW12963,CHEMICAL,serotonergic toxicity,serotonergic toxicity
http://purl.obolibrary.org/obo/CHEBI_34324,BIOCHEMICAL,"3,4-dihydro-3-hydroxy-4-s-glutathionyl bromobenzene","hepatotoxicants|3,4-Dihydro-3-hydroxy-4-S-glutathionyl bromobenzene"
NEW07995,DISEASE,rbd symptom,RBD symptoms
NEW12965,NUTRITION,essential fatty acid status,essential fatty acid status
NEW12967,CHEMICAL,vitamin-k-antagonist,Vitamin-K-antagonists
D016632,DISEASE,Apolipoprotein A-I,Apolipoprotein A 1|Apolipoprotein A-I Isoprotein-4|Apo AI|Apolipoprotein AI|Apolipoprotein A-I|Apo A1|ApoA-1|Apolipoprotein A I Isoprotein 2|Apolipoprotein A-I Isoproteins|Apolipoprotein A-I Isoprotein-2|Apo A I Isoproteins|Apolipoprotein A I Isoproteins|Apolipoprotein A I Isoprotein 4|Pro-Apo A-I|ApoA-I|Apolipoprotein A I|Apolipoprotein A1|Apolipoprotein AI Propeptide|apoA-I|Apo A-I|Apolipoprotein A-1|Apo A-1|Apo A-I Isoproteins|Pro Apolipoprotein A I|Pro Apo A I|Proapolipoprotein AI|Pro-Apolipoprotein A-I
C536274,DISEASE,"Ichthyosis, mental retardation, dwarfism, and renal impairment [Supplementary Concept]",Intellectual Disability|renal impairment|Dwarfism|Kidney Diseases|Ichthyosis
NEW12972,NUTRITION,circulate esterify cholesterol,circulating esterified cholesterol
NEW12973,NUTRITION,unesterified cholesterol,unesterified cholesterol
NEW12974,NUTRITION,tryptophan addition,Tryptophan addition
C523360,CHEMICAL,astaxanthin-lysine conjugate Asly [Supplementary Concept],Carotenoids|Lysine/analogs  and  derivatives|Astaxanthin
NEW12978,DISEASE,pathological disorder,Pathological disorder
NEW12979,CHEMICAL,fast antidepressant effect,fast antidepressant effect
NEW12980,CHEMICAL,n-methyl-d-aspartate receptor antagonist ketamine,N-methyl-d-aspartate receptor antagonist ketamine
NEW12981,BIOCHEMICAL,antimicrobial treatment,antimicrobial treatment
D013530,DISEASE,Surgical Wound Infection,"Infections, Surgical Wound|Infection, Surgical Wound|Infection, Surgical Site|Infections, Postoperative Wound|Wound Infection, Postoperative|Surgical Site Infections|Postoperative Wound Infections|Postoperative Wound Infection|site infections|Surgical Wound Infections|Wound Infections, Postoperative|Wound Infections, Surgical|Wound Infection, Surgical|Surgical Site Infection|Infection, Postoperative Wound|Infections, Surgical Site"
D019344,CHEMICAL,Lactic Acid,"lactic acid|Ammonium Lactate|Propanoic Acid, 2-Hydroxy-, (2S)-|L-Lactic Acid|LA|Sarcolactic Acid|2-Hydroxypropionic Acid|2 Hydroxypropionic Acid|D-Lactic Acid|D Lactic Acid|Propanoic Acid, 2-Hydroxy-, (2R)-|Lactate|2 Hydroxypropanoic Acid|2-Hydroxypropanoic Acid|Lactate, Ammonium|L Lactic Acid"
NEW12984,CHEMICAL,la infiltration,LA infiltration
NEW12986,CHEMICAL,mg/ml lidocaine,mg/mL Lidocaine
NEW12990,BIOCHEMICAL,in antimicrobial effect,in antimicrobial effects
NEW12991,CHEMICAL,mg/ml mupirocine,mg/mL mupirocine
C520851,CHEMICAL,"4'-(2-furyl)-N-pyridin-3-yl-4,5'-bipyrimidin-2'-amine [Supplementary Concept]",Pyrimidines|Furans|LAs
NEW12993,NUTRITION,local brown rice,Local brown rice
NEW12994,NUTRITION,brown rice,brown rice
NEW12995,CHEMICAL,utilize nalfurafine,utilized nalfurafine
NEW12997,CHEMICAL,pericyte-mediated capillary constriction,Pericyte-mediated capillary constriction
D063806,DISEASE,Myalgia,"Muscle Pain|Muscle Soreness|Tenderness, Muscle|tenderness|Muscle Tenderness|Pain, Muscle|Pains, Muscle|Muscle Sorenesses|Soreness, Muscle"
http://purl.obolibrary.org/obo/CHEBI_80661,CHEMICAL,"dna 2,6-diamino-5-formamido-3,4-dihydro-4-oxopyrimidine",DNA fragmentation/integrity
NEW13000,DISEASE,sperm visual motility,sperm visual motility
NEW13001,DISEASE,chronic inflammatory disease,chronic inflammatory disease
D010510,DISEASE,Periodontal Diseases,"Pyorrhea Alveolaris|Periodontal disease|Diseases, Periodontal|Disease, Periodontal|Parodontoses|Periodontal Disease|Parodontosis"
NEW13003,BIOCHEMICAL,known hepatotoxin,known hepatotoxins
NEW13005,CHEMICAL,omega-3 pufa supplement,omega-3 PUFA supplements
NEW13007,CHEMICAL,gnrha intervention,GnRHa intervention
NEW13009,CHEMICAL,depot form,depot form
NEW13010,BIOCHEMICAL,gonadotropin-releasing hormone agonist,Gonadotropin-releasing hormone agonist
D010281,CHEMICAL,Parathyroid Hormone,"PTH(1-34)|PTH|Parathyroid Hormone Peptide (1-34)|Parathyroid Hormone (1-34)|Parathormone|Hormone, Parathyroid|Parathyroid Hormone (1-84)|parathormone|PTH (1-84)|Natpara|Parathyrin"
NEW13013,CHEMICAL,n-diethyl-benzamide,SNC80|N-diethyl-benzamide
NEW13015,MENTAL_HEALTH,relative resistance,relative resistance
NEW13016,BIOCHEMICAL,thyroid hormone inhibition,thyroid hormone inhibition
NEW13017,DISEASE,wolman 's disease fibroblast,Wolman's disease fibroblasts
D010205,NUTRITION,Pantothenic Acid,"Vitamin B 5|Calcium Pantothenate|Dexol|Pantothenate, Calcium|Pantothenate, Zinc|B5, Vitamin|Zinc Pantothenate|Vitamin B5|pantothenic acid|B 5, Vitamin"
NEW13018,BIOCHEMICAL,cerebral vitamin b5 deficiency,cerebral vitamin B5 deficiency
NEW13020,CHEMICAL,robust antidepressant action,robust antidepressant actions
NEW13021,CHEMICAL,ketamine-like antidepressant action,ketamine-like antidepressant actions
http://purl.org/sig/ont/fma/fma12520,CHEMICAL,axis,C2 vertebra|Axis (CII)|brain-spleen axis|Second cervical vertebra
NEW13022,CHEMICAL,non-competitive n-methyl-d-aspartate/glutamate receptor antagonism,Non-competitive N-methyl-D-aspartate/glutamate receptor antagonism
NEW13023,CHEMICAL,repeat ketamine intake,repeated ketamine intake
D015343,BIOCHEMICAL,"DNA Probes, HLA","DNA Probes, HLA-C|HLA C DNA Probes|HLA DR DNA Probes|DNA Probes, HLA-DR|DNA Probes, HLA-D|DNA Probes, Histocompatibility Antigen|HLA A DNA Probes|human leukocyte antigen|HLA-Dw DNA Probes|Probes, HLA DNA|HLA-C DNA Probes|Probes, HLA-C DNA|HLA-D DNA Probes|DNA Probes, HLA-Dw|DNA Probes, HLA-A|HLA DNA Probes|Probes, HLA-B DNA|Probes, HLA-DR DNA|Probes, HLA-A DNA|HLA-B DNA Probes|HLA-A DNA Probes|Probes, HLA-D DNA|Histocompatibility Antigen DNA Probes|Human Leukocyte Antigen DNA Probes|HLA D DNA Probes|HLA B DNA Probes|HLA-DR DNA Probes|DNA Probes, HLA-B|Probes, HLA-Dw DNA|HLA Dw DNA Probes"
D022641,BIOCHEMICAL,Shiga Toxin 2,"Verotoxin 2|VT2 Cytotoxin|Vero Cytotoxin VT2|Stx2 protein|Shiga toxin|Shiga Toxin 2, Escherichia coli|Shiga-Like Toxin II|SLT-II|Cytotoxin, VT2|SLTII|SLT II|Shiga Like Toxin II"
D006463,DISEASE,Hemolytic-Uremic Syndrome,"Syndrome, Hemolytic-Uremic|Gasser's Syndrome|hemolytic uremic syndrome|Gasser Syndrome|Gassers Syndrome|HUS|Hemolytic Uremic Syndrome"
NEW13027,CHEMICAL,urinary potassium,urinary potassium
NEW13029,DISEASE,lps/stx2-induced kidney injury model,LPS/Stx2-induced kidney injury model
D010636,NUTRITION,Phenols,phenols
NEW13032,CHEMICAL,n-buoh extract,n-BuOH extract
NEW13034,DISEASE,human breast cancer tissue,human breast cancer tissue
D000069584,DISEASE,Unilateral Breast Neoplasms,"Left Sided Breast Neoplasm|Breast Neoplasm, Unilateral|Left Sided Breast Neoplasms|Breast Cancers, Right-Sided|Right-Sided Breast Cancers|Breast Cancers, Left-Sided|Breast Neoplasms, Right-Sided|Breast Neoplasm, Left-Sided|Breast Neoplasms, Left-Sided|Left-Sided Breast Neoplasms|Breast Cancer, Right-Sided|Right-Sided Breast Neoplasms|Left-Sided Breast Neoplasm|Breast Cancer, Unilateral|Right-Sided Breast Cancer|Right Sided Breast Cancer|Left-Sided Breast Cancers|Right Sided Breast Neoplasms|Left Sided Breast Cancer|Right Sided Breast Neoplasm|Breast Neoplasms, Unilateral|Unilateral Breast Cancer|Breast Cancers, Unilateral|Unilateral Breast Cancers|breast cancers|Breast Neoplasm, Right-Sided|Left-Sided Breast Cancer|Breast Cancer, Left-Sided|Right-Sided Breast Neoplasm"
NEW13036,MENTAL_HEALTH,music hallucination,Music hallucinations
NEW13039,CHEMICAL,[3h]prazosin binding,[3H]prazosin binding
NEW13041,MENTAL_HEALTH,displacement potency,displacement potencies
NEW13043,BIOCHEMICAL,1-adrenergic antagonist,1-adrenergic antagonists
NEW13045,DISEASE,adolescent mdd,adolescent MDD
http://purl.obolibrary.org/obo/CHEBI_34910,CHEMICAL,pentetrazol,"pentetrazol|Coranormol|Cardiazole|Kardiazol|Cenazol|Pentetrazol|pentamethylene-1,5-tetrazole|Cardifortan|Korazol|Cardosal|6,7,8,9-tetrahydro-5H-tetrazolo[1,5-a]azepine|Coratoline|Deumacard|1,5-pentamethylenetetrazole|KYN|Cardiazol|Phrenazol|Gewazol|Diovascole|Corazol|pentylenetetrazol|pentetrazolum|1-kynurenine|alpha,beta-cyclopentamethylenetetrazole|Coryvet|Cenalene-M|Pentylenetetrazole|Corazole|Metrazol|Ventrazol|6,7,8,9-tetrahydro-5-azepotetrazole|7,8,9,10-tetrazabicyclo[5.3.0]-8,10-decadiene|Corvasol|Cardiotonicum|Cardosan"
NEW13049,NUTRITION,american chestnut,American chestnut
NEW13051,CHEMICAL,bc3f2 tree 's,BC3F2 trees's
NEW13050,MENTAL_HEALTH,blight resistance,blight resistance
NEW13052,NUTRITION,chestnut backcross,chestnut backcross
NEW13053,DISEASE,p. cinnamomi,P. cinnamomi
NEW13054,DISEASE,grave BC3F3,Graves BC3F3
http://purl.obolibrary.org/obo/CHEBI_64344,CHEMICAL,"2',4',6'-trihydroxyacetophenone","acetylphloroglucinol|phloroacetophenone|2',4',6'-trihydroxyacetophenone|monoacetylphloroglucinol|2-acetylphloroglucinol|THAP|1-(2,4,6-trihydroxyphenyl)ethanone|phloracetophenone|acetophloroglucine|2,4,6-trihydroxyacetophenone"
C583588,CHEMICAL,2-acetylcyclopentanone [Supplementary Concept],2-acetylcyclopentanone|Ketones
NEW11661,CHEMICAL,intrathecal baclofen,intrathecal baclofen
D006996,DISEASE,Hypocalcemia,Hypocalcemia|Hypocalcemias
NEW13057,CHEMICAL,intravenous magnesium loading,intravenous magnesium loading
NEW13060,CHEMICAL,intracellular magnesium deficiency,Intracellular magnesium deficiency
NEW12889,CHEMICAL,malondialdehyde content,malondialdehyde content
C025451,CHEMICAL,sodium bisulfide [Supplementary Concept],Sulfides|NaHS
C068637,CHEMICAL,"calcium D-pantothenate, L-cysteine drug combination [Supplementary Concept]",CYS|Cysteine|L-cysteine|Pantothenic Acid|Drug Combinations
http://purl.org/sig/ont/fma/fma321004,DISEASE,corpus cavernosum,human corpus cavernosum|HCC
NEW13064,CHEMICAL,exogenous h2s,Exogenous H2S
NEW13066,CHEMICAL,meq/l bicarbonate,mEq/L bicarbonate
D011084,CHEMICAL,Polycyclic Aromatic Hydrocarbons,"Hydrocarbons, Polycyclic Aromatic|Aromatic Hydrocarbons, Polynuclear|Polycyclic Aromatic Hydrocarbon|Polycyclic Hydrocarbons, Aromatic|polycyclic aromatic hydrocarbons|Hydrocarbon, Polycyclic Aromatic|Aromatic Hydrocarbons, Polycyclic|Aromatic Hydrocarbon, Polynuclear|Aromatic Polycyclic Hydrocarbons|Hydrocarbon, Polynuclear Aromatic|Hydrocarbons, Polynuclear Aromatic|Polynuclear Aromatic Hydrocarbons|Hydrocarbons, Aromatic Polycyclic|Polynuclear Aromatic Hydrocarbon|Aromatic Hydrocarbon, Polycyclic"
NEW13070,BIOCHEMICAL,α7 nicotinic receptor partial agonist,α7 nicotinic receptor partial agonist
C543642,CHEMICAL,"spiro(1-azabicyclo(2.2.2)octane-3,2'(3H)-furo(2,3-b)pyridine) [Supplementary Concept]",AZD0328|Quinuclidines|Furans
NEW13071,CHEMICAL,chronic nicotine treatment,Chronic nicotine treatment
NEW13072,CHEMICAL,striatal presynaptic α6β2 receptor,striatal presynaptic α6β2 receptors
NEW00723,CHEMICAL,l-dopa therapy,L-dopa therapy
D000068580,CHEMICAL,Varenicline,"6,7,8,9-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)benzazepine|Champix|Varenicline Tartrate|varenicline|Chantix"
NEW13077,BIOCHEMICAL,limited vitamin c intake,limited vitamin C intake
NEW13079,DISEASE,experimental anemia,experimental anemia
C014758,CHEMICAL,plumbagin [Supplementary Concept],Naphthoquinones|plumbagin
C103490,CHEMICAL,dexloxiglumide [Supplementary Concept],dexloxiglumide|Pentanoic Acids
NEW13082,CHEMICAL,amiglumide,amiglumide
C048181,CHEMICAL,lorglumide [Supplementary Concept],lorglumide|Proglumide/analogs  and  derivatives
NEW13084,CHEMICAL,1-aminoanthraquinone-2-sulfonate,1-aminoanthraquinone-2-sulfonate
NEW13087,CHEMICAL,low hexcer,low HexCer
NEW13089,DISEASE,high tg,High TG
NEW13090,NUTRITION,photodynamic therapy porphyrin,Photodynamic therapy porphyrins
NEW13093,CHEMICAL,glutamatergic n-methyl-d-aspartate nmda receptor,glutamatergic N-methyl-D-aspartate NMDA receptor
NEW13094,DISEASE,particular impairment,particular impairments
NEW13095,MENTAL_HEALTH,increase distractibility,increased distractibility
NEW13096,DISEASE,endogenous psychosis,endogenous psychoses
NEW13097,CHEMICAL,ketamine effect,ketamine effects
C100708,CHEMICAL,oritavancin [Supplementary Concept],Lipoglycopeptides|Oritavancin
NEW13099,CHEMICAL,common fq-related adverse effect,common FQ-related adverse effects
NEW13100,MENTAL_HEALTH,chelate agent picolinic acid,PICA|chelating agent picolinic acid
C521977,CHEMICAL,"poly-2,6-pyridinedicarboxylic acid [Supplementary Concept]","Pyridines|2,6-pyridinedicarboxylic acid|Carboxylic Acids"
C086107,CHEMICAL,"6-(4-hydroxybutyl)-2,3,5-trimethyl-1,4-benzoquinone [Supplementary Concept]","Benzoquinones|6-(4-hydroxybutyl)-2,3,5-trimethyl-1,4- benzoquinone|TMQ"
http://purl.obolibrary.org/obo/CHEBI_72294,BIOCHEMICAL,nerve growth factor stimulator,nerve growth factor stimulators|NGF stimulators|NGF stimulator
NEW13103,MENTAL_HEALTH,decrease forearm vascular resistance,decreased forearm vascular resistance
NEW13104,CHEMICAL,naoxintong capsule,NXTC|Naoxintong capsule
NEW13106,NUTRITION,adipocyte-derived saturated fatty acid,adipocyte-derived saturated fatty acids
NEW13109,CHEMICAL,serum uric acid,serum uric acid
NEW13110,BIOCHEMICAL,vitamin b3 nicotinic acid niacin deficiency,Vitamin B3 nicotinic acid niacin deficiency
NEW13114,BIOCHEMICAL,vitamin b3 deficiency,Vitamin B3 deficiency
NEW13115,CHEMICAL,ethanol consumption,Ethanol consumption
NEW13119,CHEMICAL,gold nanorod,AuNRs|gold nanorods
NEW13120,CHEMICAL,pendant ciprofloxacin,pendant ciprofloxacin|Cip
NEW13123,CHEMICAL,nucleotide metabolic pathway,nucleotide metabolic pathways
NEW13125,CHEMICAL,de purine biosynthesis,de purine biosynthesis
NEW13126,CHEMICAL,gdhr,gdhR
NEW13128,CHEMICAL,gdhr,GdhR
D016210,CHEMICAL,Methacholine Chloride,"2-(Acetyloxy)-N,N,N-trimethyl-1-propanaminium Chloride|Acetyl-beta-methylcholine|Acetyl beta methylcholine|Mecholyl|Methacholine|Acetyl 2 methylcholine Chloride|Acetyl-beta-methacholine Chloride|Acetyl beta methacholine Chloride|Provokit|Acetyl-2-methylcholine Chloride|Mecholine|Chloride, Methacholine|methacholine|Provocholine"
D008355,CHEMICAL,Mannitol Phosphates,"mannitol|Phosphates, Mannitol"
NEW13134,CHEMICAL,h1 r expression,H1 R expression
NEW13135,CHEMICAL,m. genitalium,M. genitalium
D008594,DISEASE,"Menopause, Premature",menopause|Premature Menopause
NEW13137,BIOCHEMICAL,vaginal vitamin e,vaginal vitamin E
NEW13139,CHEMICAL,daily glucose rhythm,daily glucose rhythm
NEW13140,CHEMICAL,elevated glutamate,Elevated glutamate
NEW13142,CHEMICAL,elevated lactate response,elevated lactate responses
NEW13143,CHEMICAL,increase glutamine/glutamate ratio,increased glutamine/glutamate ratio
NEW13145,CHEMICAL,hippocampal naa/cr,hippocampal NAA/Cr
NEW13148,BIOCHEMICAL,vitamin vitamin,vitamins vitamins
NEW13151,BIOCHEMICAL,bixin aldehyde,bixin aldehyde
NEW13153,CHEMICAL,spirodiclofen administration,Spirodiclofen administration
NEW13154,BIOCHEMICAL,lycopene application,Lycopene application
C508135,CHEMICAL,spirodiclofen [Supplementary Concept],4-Butyrolactone/analogs  and  derivatives|spirodiclofen|Spiro Compounds
D004280,CHEMICAL,Dobutamine,"Dobutamine, (-)-Isomer|Dobuject|Dobutamine Tartrate (1:1), (R-(R*,R*))-Isomer|Dobutamine (+)-Isomer|Dobutamin Solvay|Dobutamine Hydrobromide|Dobutamine Tartrate|Dobutamina Rovi|Hydrochloride, Dobutamine|Dobutamine Hydrochloride|Dobutamina Inibsa|Posiject|Tartrate, Dobutamine|Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer|Dobutamin Hexal|Dobutamin-ratiopharm|Dobutrex|Dobutamine Phosphate (1:1) Salt, (-)-Isomer|Lilly 81929|Dobutamine, Phosphate (1:1) Salt (+)-Isomer|Dobutamin ratiopharm|dobutamine|Dobutamine Lactobionate|Dobucor|Dobutamin Fresenius|Lactobionate, Dobutamine|Hydrobromide, Dobutamine|Oxiken"
NEW13156,DISEASE,osmoregulatory dysfunction,osmoregulatory dysfunction
NEW13157,BIOCHEMICAL,serum carotenoid,Serum carotenoids
NEW13160,CHEMICAL,serum α-carotene,Serum α-carotene
D013705,DISEASE,Temporomandibular Joint Disorders,"Diseases, TMJ|Disorders, Temporomandibular|Disorders, TMJ|Temporomandibular Joint Disorder|Diseases, Temporomandibular Joint|Disorder, Temporomandibular|Disorders, Temporomandibular Joint|Temporomandibular disorder|TMJ Disorder|Joint Disorders, Temporomandibular|Temporomandibular Disorder|TMJ Diseases|TMJ Disorders|Joint Diseases, Temporomandibular|Temporomandibular Joint Disease|Temporomandibular Disorders|Temporomandibular Joint Diseases|TMJ Disease|TMD|Disorder, TMJ|Joint Disease, Temporomandibular|Disease, TMJ|Disorder, Temporomandibular Joint|Joint Disorder, Temporomandibular|Disease, Temporomandibular Joint"
D050482,CHEMICAL,Catecholamine Plasma Membrane Transport Proteins,"Neurotransmitter Transporters, Catecholamine-Specific|Transport Protein, Catecholamine|Catecholamine Carrier|Catecholamine Plasma Membrane Transporters|Neurotransmitter Transport Proteins, Catecholamine Specific|Catecholamine Transport Protein|Neurotransmitter Transport Proteins, Catecholamine-Specific|Neurotransmitter Transporters, Catecholamine Specific|Catecholamine-Specific Neurotransmitter Transporters|Transporters, Catecholamine-Specific Neurotransmitter|Catecholamine Plasma Membrane Transporter Proteins|catecholamine"
NEW13166,DISEASE,infantile-onset pompe disease,infantile-onset Pompe disease|IOPD
D014003,NUTRITION,Tin Polyphosphates,"Polyphosphates, Stannous|Polyphosphates, Tin|Tin Pyrophosphates|Stannous Polyphosphates|Stannous Pyrophosphates|Pyrophosphates, Tin|Pyrophosphates, Stannous|Polyphosphates"
NEW13170,CHEMICAL,ai therapy,AIs therapy
http://purl.obolibrary.org/obo/CHEBI_22315,CHEMICAL,alkaloid,Rhoeadine alkaloids
NEW13173,CHEMICAL,oral amantadine,oral amantadine
C583037,CHEMICAL,URMC-099 [Supplementary Concept],Pyridines|URMC-099|Pyrroles
NEW13176,BIOCHEMICAL,brain-penetrant anti-inflammatory neuroprotective drug,brain-penetrant anti-inflammatory neuroprotective drug
NEW13178,CHEMICAL,fungi metarhizium robertsii dopamine,fungi Metarhizium robertsii dopamine
NEW13180,CHEMICAL,relative da concentration,relative DA concentrations
NEW13182,CHEMICAL,l-dopa preparation,L-dopa preparations
NEW13183,BIOCHEMICAL,selective β3 adrenoceptor agonist,selective β3 adrenoceptor agonists
NEW13185,DISEASE,cispt-induced pharyngeal injury,CisPt-induced pharyngeal injury
NEW13190,DISEASE,bipolar spectrum,bipolar spectrum
NEW13192,CHEMICAL,clonazepam improvement,Clonazepam improvement
D020805,DISEASE,Central Nervous System Viral Diseases,"Viral Diseases, CNS|Disease, CNS Viral|Infection, Viral CNS|Diseases, CNS Viral|CNS Infections, Viral|CNS Viral Diseases|CNS Infection, Viral|Viral CNS Infections|Central Nervous System Viral Infections|Viral Infections, Central Nervous System|Infections, CNS, Viral|viral infections|Viral CNS Infection|CNS Viral Disease|Infections, Viral CNS|Viral Diseases, Central Nervous System|Viral Disease, CNS"
NEW13194,CHEMICAL,azt resistance,AZT resistance
NEW13196,CHEMICAL,engineer active tmpk,engineered active TMPK
NEW13198,DISEASE,hiv-infected t cell,HIV-infected T cells
D012049,DISEASE,Rehabilitation of Speech and Language Disorders,Speech and Language Disorder Rehabilitation|Language and Speech Disorder Rehabilitation|language disorders
NEW13203,DISEASE,hypotensive activity,hypotensive activity
NEW13205,CHEMICAL,low-calorie ketogenic diet,Low-calorie ketogenic diets|LCKDs
NEW13206,CHEMICAL,pre-bs lckd,pre-BS LCKD
NEW13208,CHEMICAL,LCKD,LCKD
NEW13210,NUTRITION,low folate level,low folate level
NEW13211,BIOCHEMICAL,folate increase,folate increase
NEW13212,DISEASE,cobalamin cbl c deficiency,cobalamin cbl C deficiency
D050683,CHEMICAL,R-SNARE Proteins,"Vesicle-Associated Membrane Proteins|R SNARE Proteins|Membrane Proteins, Vesicle-Associated|R-SNARES|Vesicle-Associated Membrane Protein|Synaptobrevins|Membrane Protein, Vesicle-Associated|Proteins, R-SNARE|Vesicle Associated Membrane Protein|RACT|Synaptobrevin|R|R SNARES|Vesicle Associated Membrane Proteins"
NEW13216,CHEMICAL,mir-132 expression,miR-132 expression
C011626,CHEMICAL,adenosine 5'-triphosphate 3'-diphosphate [Supplementary Concept],Adenine Nucleotides|adenosine 5'-triphosphate|ATP
NEW13219,CHEMICAL,excitotoxic glutamate,excitotoxic glutamate
NEW13220,BIOCHEMICAL,pharmacological antagonist,pharmacological antagonists
NEW13222,BIOCHEMICAL,brain penetrant p2x7r antagonist,brain penetrant P2X7R antagonists
NEW13223,CHEMICAL,rapid kinetic,fentanyl|rapid kinetics
NEW13227,CHEMICAL,spd screening questionnaire,SPD screening questionnaire
NEW13228,NUTRITION,dietary fibre intake,dietary fibre intake
D008797,CHEMICAL,Metyrapone,Methopyrapone|Metopirone|Metopiron|metyrapone|Methbipyranone|SU 4885|Métopirone
NEW13234,DISEASE,tissue fibrosis,tissue fibrosis
D001546,BIOCHEMICAL,Bentonite,Montmorrillonite|Montmorillonite|bentonite
NEW13236,DISEASE,colorectal motility,colorectal motility
NEW13241,CHEMICAL,oxygen barrier,oxygen barrier
NEW05216,MENTAL_HEALTH,insomnia symptom,insomnia symptoms
NEW13247,CHEMICAL,magnesium- melatonin-vitamin b complex supplementation,Magnesium- melatonin-vitamin B complex supplementation
NEW13249,CHEMICAL,physostigmine administration,physostigmine administration
NEW13250,BIOCHEMICAL,dietary vitamin intake,dietary vitamin intakes
NEW13252,DISEASE,euglycemic hyperinsulinemia,euglycemic hyperinsulinemia
D055191,DISEASE,Delayed Emergence from Anesthesia,"Post-Procedural Delayed Awakening|Blockades, Residual Neuromuscular|Neuromuscular Blocks, Residual|Residual Paralyses, Post-Anesthesia|neuromuscular block|Residual Paralysis, Post Anesthesia|Residual Neuromuscular Blocks|Blocks, Residual Neuromuscular|Residual Blocks|Neuromuscular Block, Residual|Residual Curarization, Postoperative|Residual Curarisation, Postoperative|Neuromuscular Blockades, Residual|Delayed Awakening, Post Procedural|Post-Anesthesia Residual Paralysis|Block, Residual Neuromuscular|Curarization, Postoperative Residual|Residual Block|Postoperative Residual Curarization|Residual Neuromuscular Blockade|Delayed Awakening, Post-Procedural|Weakness, Postoperative Residual|Paralysis, Post-Anesthesia Residual|Post-Procedural Delayed Awakenings|Residual Curarizations, Postoperative|Postoperative Residual Weaknesses|Residual Weaknesses, Postoperative|Delayed Awakenings, Post-Anesthesia|Residual Neuromuscular Block|Postoperative Residual Curarizations|Delayed Awakening, Post-Anesthesia|Awakening, Post-Anesthesia Delayed|Awakenings, Post-Anesthesia Delayed|Delayed Awakening, Post Anesthesia|Delayed Recovery from Anesthesia|Delayed Return of Consciousness|Post-Anesthesia Residual Paralyses|Blocks, Residual|Blockade, Residual Neuromuscular|Post-Anesthesia Delayed Awakening|Residual Weakness, Postoperative|Postoperative Residual Curarisations|Neuromuscular Blockade, Residual|Residual Neuromuscular Blockades|Postoperative Residual Curarisation|Postoperative Residual Weakness|Delayed Awakening from Anesthesia|Weaknesses, Postoperative Residual|Residual Paralysis, Post-Anesthesia|Delayed Awakenings, Post-Procedural|Post-Anesthesia Delayed Awakenings|Block, Residual|Curarizations, Postoperative Residual|Paralyses, Post-Anesthesia Residual|Delayed Regaining of Consciousness|Residual Curarisations, Postoperative"
NEW13255,CHEMICAL,inject hexamethonium,injected hexamethonium
D010197,CHEMICAL,Pancuronium,"Bromide, Pancuronium|pancuronium|Pancuronium Curamed|Pancuronium Bromide|Pavulon|Pancuronium Organon"
D018696,BIOCHEMICAL,Neuroprotective Agents,"Effects, Neuroprotective|Neuroprotectant|Neuroprotective Drugs|neuroprotective drug|Neuroprotectants|Drug, Neuroprotective|Neuroprotective Effects|Neuroprotective Effect|Drugs, Neuroprotective|Neuroprotective Drug|Agent, Neuroprotective|Neuroprotective Agent|Effect, Neuroprotective|Agents, Neuroprotective"
NEW13258,DISEASE,excitotoxic neuronal cell damage,Excitotoxic neuronal cell damage
NEW13261,DISEASE,excitotoxic neuronal cell death,Excitotoxic neuronal cell death
NEW13263,NUTRITION,main oil 's monounsaturated fatty acid,main oil's monounsaturated fatty acid
NEW13265,CHEMICAL,oleic acid oa,oleic acid OA
NEW13266,NUTRITION,steroid hormone signaling,steroid hormone signaling
NEW13267,BIOCHEMICAL,serum sexual hormone level,serum sexual hormone levels
NEW13268,BIOCHEMICAL,serum sexual hormone measurement,serum sexual hormone measurements
NEW12408,DISEASE,severe osa,severe OSA
NEW13270,DISEASE,severe osa patient,Severe OSA patients
D006177,DISEASE,Gynecomastia,"Enlargement, Male Breast|Gynecomastia, Adolescent|Gynecomastia, Infant|Newborn Gynecomastia|Infant Gynecomastia|Gynecomastia, Newborn|Breast Enlargement, Male|Male Breast Enlargement|Adolescent Gynecomastia|gynecomastia"
NEW13272,CHEMICAL,anti-pd-1/anti-ctla-4 antibody,anti-PD-1/anti-CTLA-4 antibodies
http://purl.obolibrary.org/obo/CHEBI_65207,BIOCHEMICAL,vascular endothelial growth factor receptor antagonist,VEGF receptor inhibitor|VEGFR inhibitors|vascular endothelial growth factor receptor inhibitors|VEGFR inhibitor|vascular endothelial growth factor receptor inhibitor|vascular endothelial growth factor receptor antagonists|VEGF receptor inhibitors
D000077784,CHEMICAL,Axitinib,axitinib|AG013736|AG-013736|AG 013736|Inlyta
NEW13277,MENTAL_HEALTH,multivariable linear regression model,multivariable linear regression model
NEW01589,DISEASE,metabolic dysfunction,metabolic dysfunction
NEW13280,CHEMICAL,endocannabinoid 2-arachidonylglycerol degradation,endocannabinoid 2-arachidonylglycerol degradation
NEW13281,CHEMICAL,serotonin gene-linked polymorphic region polymorphism,serotonin gene-linked polymorphic region polymorphisms
NEW13283,MENTAL_HEALTH,phosphorylation modification,phosphorylation modification|pICA
NEW13284,CHEMICAL,dietary NA supplementation,Dietary NA supplementation
NEW13286,CHEMICAL,optimal dietary na supplementation,optimal dietary NA supplementation
NEW13288,MENTAL_HEALTH,tamoxifen resistance,Tamoxifen resistance
C000720887,BIOCHEMICAL,EGFR inhibitor SP101 [Supplementary Concept],Piperazines|Quinazolines|EGFR inhibitor
D000077156,CHEMICAL,Gefitinib,N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide|ZD 1839|Iressa|ZD1839|gefitinib
NEW13291,BIOCHEMICAL,fgfr inhibitor,FGFR inhibitors
NEW13294,CHEMICAL,mm nac,mM NAC
NEW13296,CHEMICAL,z-vad-fmk caspase inhibitor,z-VAD-FMK caspase inhibitor
NEW13297,CHEMICAL,cycloheximide protein synthesis inhibitor,Cycloheximide protein synthesis inhibitor
NEW13298,MENTAL_HEALTH,nuclear fragmentation,nuclear fragmentation
NEW13302,DISEASE,tumor immunocombination therapy,tumor immunocombination therapy
NEW13304,DISEASE,immunogenic cell death effect,immunogenic cell death effect
NEW13305,BIOCHEMICAL,antagonist (don)-loaded nanocarrier,antagonist (DON)-loaded nanocarrier
C471253,CHEMICAL,L-glutamine 2-deoxy-scyllo-inosose aminotransferase [Supplementary Concept],Transaminases|L-glutamine
NEW13312,BIOCHEMICAL,drug injection,Drug injection
NEW11026,MENTAL_HEALTH,acute neurological symptom,acute neurological symptoms|stupor
D012214,DISEASE,Rheumatic Heart Disease,"Disease, Bouillaud's|Bouillaud Disease|Bouillaud's Disease|Bouillauds Disease|rheumatic heart disease|Heart Diseases, Rheumatic|Diseases, Rheumatic Heart|Disease, Rheumatic Heart|Heart Disease, Rheumatic|Rheumatic Heart Diseases|Disease, Bouillaud"
NEW13314,BIOCHEMICAL,antibiotic therapy,antibiotic therapy
NEW13315,CHEMICAL,oxytocin receptor gene allele,oxytocin receptor gene alleles
NEW13318,NUTRITION,sucker rod,sucker rods
NEW13320,MENTAL_HEALTH,fatigue datum,fatigue data
NEW13321,CHEMICAL,ultra-high-strength hl,ultra-high-strength HL
NEW13322,MENTAL_HEALTH,fitting result fatigue test value,fitting result fatigue test value
NEW13324,CHEMICAL,untreated mets rat,untreated MetS rats
NEW13325,DISEASE,behavioral abnormality,behavioral abnormality
NEW13327,BIOCHEMICAL,antibiotic combination,Antibiotic combinations
NEW13329,MENTAL_HEALTH,fos resistance,FOS resistance
NEW13331,CHEMICAL,pep flux,PEP flux
C499823,CHEMICAL,"5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid [Supplementary Concept]",Resolvin E1|Eicosapentaenoic Acid/analogs  and  derivatives|RvE1
NEW13332,CHEMICAL,PSL     mg/kg,PSL    mg/kg
NEW13334,DISEASE,repeat psl-induced increase,repeated PSL-induced increase
NEW13337,CHEMICAL,dha content,DHA content
NEW13339,CHEMICAL,omega-3 pufa,Omega-3 PUFAs
D062950,MENTAL_HEALTH,rho Guanine Nucleotide Dissociation Inhibitor gamma,rho GDI gamma|rhoGDI3|rho Guanine Nucleotide Dissociation Inhibitor 3|rhoGDI gamma|rho GDP-Dissociation Inhibitor 3|rho GDP Dissociation Inhibitor (GDI) gamma|rhoGDIgamma|Dissociation
NEW13342,BIOCHEMICAL,antimicrobial intervention,antimicrobial interventions
NEW13344,DISEASE,infarct volume,Infarct volume
NEW13346,BIOCHEMICAL,glutamate n-methyl-d-aspartate nmda receptor antagonist ketamine,glutamate N-methyl-d-aspartate NMDA receptor antagonist ketamine
NEW13348,CHEMICAL,preferential d2 dopamine antagonist haloperidol,preferential D2 dopamine antagonist haloperidol
D013786,CHEMICAL,Thalamic Diseases,"Thalamic Syndromes|Dejerine Roussy Syndrome|Syndrome, Dejerine-Roussy|Syndromes, Thalamic|Déjerine-Roussy syndrome|Thalamic Syndrome|Diseases, Thalamic|Dejerine-Roussy Syndrome|Thalamic Disease|Syndrome, Thalamic|Disease, Thalamic"
NEW13353,DISEASE,immunotoxicity disorder,immunotoxicity disorder
NEW13354,BIOCHEMICAL,maternal vitamin b12 status,maternal vitamin B12 status
NEW13357,DISEASE,bipolar patient,bipolar patient
NEW13358,CHEMICAL,carbidopa intestinal gel,Duodopa|carbidopa intestinal gel
D013616,DISEASE,"Tachycardia, Sinus","Sinus Tachycardia|sinus tachycardia|Sinus Tachycardias|Tachycardias, Sinus"
NEW13359,MENTAL_HEALTH,sufficient analgesia,sufficient analgesia
NEW13360,DISEASE,surgical trauma,surgical trauma
NEW13361,BIOCHEMICAL,infant carrier,Infant carriers
NEW13362,CHEMICAL,prenatal ethanol exposure,Prenatal ethanol exposure
C435731,CHEMICAL,fluoro jade [Supplementary Concept],Fluoresceins|Fluoro-jade-B
http://purl.obolibrary.org/obo/CHEBI_51240,CHEMICAL,propidium iodide,"propidium diiodide|3,8-diamino-5-{3-[diethyl(methyl)ammonio]propyl}-6-phenylphenanthridinium diiodide|3,8-diamino-5-(3-(diethylmethylammonio)propyl)-6-phenylphenanthridinium diiodide|propidium iodide staining"
NEW13364,CHEMICAL,gaba(b)r,GABA(B)R
NEW13366,MENTAL_HEALTH,regression slope,regression slopes
NEW13368,CHEMICAL,grain weight,grain weight
http://purl.obolibrary.org/obo/CHEBI_22527,CHEMICAL,aminopurine,DON|6-diazo-5-oxo-norleucine
D002953,CHEMICAL,Citrinin,citrinin|Benzopyrans (1969-1974)|CIT
NEW13371,CHEMICAL,aunp dimers/mxene,AuNP dimers/MXenes
C009166,CHEMICAL,retinol acetate [Supplementary Concept],9-cis-retinyl acetate|QLT091001|Retinyl Esters|Diterpenes
D008268,DISEASE,Macular Degeneration,"Macular Dystrophy|Maculopathy, Age Related|Maculopathy|Age-Related Macular Degeneration|Maculopathies, Age-Related|Macular Degeneration, Age Related|Maculopathy, Age-Related|Dystrophy, Macular|Age-Related Macular Degenerations|age-related macular degeneration|Age Related Maculopathy|Macular Dystrophies|Age Related Macular Degeneration|Degeneration, Macular|Macular Degenerations|Maculopathies|Macular Degeneration, Age-Related|Age Related Maculopathies|Age-Related Maculopathies|Age-Related Maculopathy"
NEW13372,DISEASE,neuropsychological impairment,neuropsychological impairments
NEW13377,CHEMICAL,cholecystokinin cck receptor,Cholecystokinin CCK receptors
NEW13379,CHEMICAL,1mm,1mM
NEW13381,CHEMICAL,fatty acid oxidation defect,FAOD|Fatty acid oxidation defects
NEW01668,CHEMICAL,urea cycle defect,urea cycle defects
NEW13383,CHEMICAL,marked hprl,marked HPRL
D029863,NUTRITION,Cicer,"Chickpea|Cicers|Cicer arietinum|arietinum, Cicer|Garbanzos|chickpea|Chickpeas|Garbanzo|Cicer arietinums"
NEW13386,CHEMICAL,fosfomycin removal,Fosfomycin removal
D015378,CHEMICAL,Imipenem,"Anhydrous, Imipenem|N-Formimidoylthienamycin|Imipenem Anhydrous|Imipenem|Imipenem, Anhydrous|MK 0787|MK-0787|MK0787|Anhydrous Imipenem|Imipemide|N Formimidoylthienamycin"
NEW13389,DISEASE,heteroresistance subpopulation,heteroresistance subpopulation
NEW13390,DISEASE,maternal infection,maternal infections
NEW13391,CHEMICAL,vta dopamine neuron,VTA dopamine neurons
NEW00048,MENTAL_HEALTH,abuse disorder,abuse disorder
NEW13393,DISEASE,several hypertension guideline,Several hypertension guidelines
NEW13395,CHEMICAL,antagonist ketamine,antagonists ketamine
C057884,CHEMICAL,diclazuril [Supplementary Concept],Nitriles|Triazines|diclazuril
NEW13398,CHEMICAL,amine template,amine templates
NEW13400,BIOCHEMICAL,pre-polymerization mixture,pre-polymerization mixture
NEW13401,CHEMICAL,sucrose inhibition,Sucrose inhibition
NEW13402,CHEMICAL,guajava Linnaeus,guajava Linnaeus
NEW13404,CHEMICAL,guava leaf-made medicine,guava leaf-made medicines
D002719,CHEMICAL,Chlormethiazole,Distraneurin|clomethiazole|Clomethiazole
NEW13406,MENTAL_HEALTH,alcohol dependence long-lasting benzodiazepine,alcohol dependence long-lasting benzodiazepines
NEW13407,BIOCHEMICAL,beta diversity,beta diversity
NEW13408,MENTAL_HEALTH,antimicrobial resistance,Antimicrobial resistance
C000621805,CHEMICAL,derazantinib [Supplementary Concept],Aniline Compounds|Quinazolines|derazantinib
NEW13409,CHEMICAL,myocellular h+ accumulation,Myocellular H+ accumulation
NEW13410,CHEMICAL,skeletal muscle atp-sensitive k+ katp channel,skeletal muscle ATP-sensitive K+ KATP channel
NEW09988,BIOCHEMICAL,crf antagonist,CRF antagonist
http://purl.obolibrary.org/obo/CHEBI_62215,CHEMICAL,allelochemical,allelochemicals|fluazinam-treated plants
NEW12110,MENTAL_HEALTH,plant defense mechanism,plant defense mechanism
NEW13414,CHEMICAL,resistance activator benzothiadiazole,resistance activator benzothiadiazole|BTH
NEW13416,CHEMICAL,systemic acquire resistance activator benzothiadiazole,systemic acquired resistance activator benzothiadiazole
NEW13417,CHEMICAL,hepatic cytosolic glutathione s-transferase,hepatic cytosolic glutathione S-transferases
NEW13418,CHEMICAL,overall gst-cdnb activity,overall GST-CDNB activity
D005015,CHEMICAL,Ethoxyquin,"Santoquin|1,2-Dihydro-6-Ethoxy-2,2,4-Trimethylquinoline|6-ethoxy-2,2,4-trimethyl-1,2-dihydroquinoline|ethoxyquin|6-ETMDQ"
NEW13420,NUTRITION,bullhead gst isoform,bullhead GST isoforms
NEW13422,MENTAL_HEALTH,potential repression,potential repression
D064791,CHEMICAL,Desoxycorticosterone Acetate,"Deoxycorticosterone-21-acetate|DOC-21-acetate|acetate|DOCA|Syncortyl|DOC 21 acetate|Desoxycorticosterone-21-acetate|Deoxycorticosterone 21 acetate|Desoxycorticosterone 21 acetate|Acetate, Desoxycortone|Desoxycortone Acetate"
NEW13425,NUTRITION,hair follicle stem/progenitor cell differentiation,hair follicle stem/progenitor cell differentiation
http://purl.obolibrary.org/obo/PR_000004112,CHEMICAL,ap-4 complex subunit epsilon-1,ap-4 adapter complex subunit epsilon|ap4e1|epsilon subunit of ap-4|ap-4 adaptor complex subunit epsilon|AP4E1|epsilon-adaptin|adaptor-related protein complex 4 subunit epsilon-1|adapter-related protein complex 4 subunit epsilon-1
NEW13427,MENTAL_HEALTH,persistent stuttering,persistent stuttering
C476123,CHEMICAL,"HEXIM1 protein, human [Supplementary Concept]",RNA-Binding Proteins|hexamethylene bisacetamide|Transcription Factors
NEW13430,CHEMICAL,activated-hydrochar,Activated-hydrochar
NEW13431,DISEASE,activated-hydrochar,Activated-hydrochar|AHC
D015900,MENTAL_HEALTH,"Radiography, Dual-Energy Scanned Projection","Dual-Energy Scanned Projection Radiography|Dual Energy Scanned Projection Radiography|Radiography, Dual Energy Scanned Projection|Digital Scan Projection Radiography, Dual Energy|projection|Digital Scanned Projection Radiography, Dual-Energy|Digital Scanned Projection Radiography, Dual Energy|Digital Scan Projection Radiography, Dual-Energy"
NEW13432,NUTRITION,first whale,first whale
NEW13434,NUTRITION,second whale,second whale
NEW13435,CHEMICAL,aa/epa,AA/EPA
NEW13436,CHEMICAL,tissue pufa change,tissue PUFA change
NEW10670,BIOCHEMICAL,promising drug candidate,promising drug candidates
D047310,CHEMICAL,Apigenin,apigenin|Flavonoids (1967-2004)
NEW13441,CHEMICAL,Zoloft trade mark,Zoloft trade mark
NEW13443,CHEMICAL,precoproporhyrin,precoproporhyrin
NEW13447,CHEMICAL,tianeptine selective serotonin reuptake enhancer,Tianeptine selective serotonin reuptake enhancer
NEW13448,CHEMICAL,aripiprazole adjunctive therapy,aripiprazole adjunctive therapy
NEW13450,CHEMICAL,gamma aminobutyric acid gaba receptor agonist,Gamma aminobutyric acid GABA receptor agonists
NEW13453,MENTAL_HEALTH,fragmentation regularity,fragmentation regularity
NEW13454,NUTRITION,stg fatty acid composition,STG fatty acid composition
NEW13456,DISEASE,certain ejaculatory disorder,certain ejaculatory disorders
NEW13457,CHEMICAL,specific serotonin receptor antagonist,specific serotonin receptor antagonists
http://purl.obolibrary.org/obo/CHEBI_24870,CHEMICAL,ion,Ag+ ion
C419664,CHEMICAL,udenafil [Supplementary Concept],Pyrimidines|Sulfonamides|Udenafil
NEW13458,DISEASE,pulmonary vascular resistance index,pulmonary vascular resistance index
NEW13460,CHEMICAL,tadalafil cialis ®,tadalafil Cialis ®
http://purl.obolibrary.org/obo/CHEBI_9139,CHEMICAL,sildenafil,"sildenafil Viagra ®|1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine|sildenafil|5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one"
D009566,CHEMICAL,Nitrates,Nitrate|nitrates
NEW13462,CHEMICAL,natural antioxidant sulforaphane,natural antioxidant sulforaphane
http://purl.org/sig/ont/fma/fma74639,CHEMICAL,adrenocorticotropin,ACTH|adrenocorticotrophin
NEW12605,CHEMICAL,μg/ml,μg/mL
C046641,CHEMICAL,juglone hydroxylase [Supplementary Concept],juglone|Oxidoreductases
NEW13470,DISEASE,cerebral hypoperfusion,Cerebral hypoperfusion
NEW13471,DISEASE,impaired bioavailability,impaired bioavailability
NEW13472,CHEMICAL,succinate dehydrogenase inhibitor,SDHIs|succinate dehydrogenase inhibitors
NEW13474,MENTAL_HEALTH,double resistance,double resistance
NEW13475,CHEMICAL,serotonin 5-hydroxytryptamine system,serotonin 5-hydroxytryptamine system
NEW13476,DISEASE,in gastrointestinal digestion,in gastrointestinal digestion
C085734,CHEMICAL,rhamnopyranosyl-3-hydroxydecanoyl-3-hydroxydecanoate [Supplementary Concept],Rhamnose/analogs  and  derivatives|Decanoates|rhamnolipid|Rha
C036604,CHEMICAL,esmolol [Supplementary Concept],Propanolamines|esmolol
NEW13478,BIOCHEMICAL,selective beta antagonist,Selective beta antagonists
NEW13480,BIOCHEMICAL,alpha adrenergic antagonist,alpha adrenergic antagonist
D011942,NUTRITION,"Receptors, Adrenergic, alpha","Receptor, Adrenergic, alpha|Adrenergic alpha-Receptors|alpha-Adrenergic Receptor|alpha-Receptors, Adrenergic|Receptors, alpha-Adrenergic|Adrenergic alpha Receptors|Adrenergic alpha-Receptor|alpha-Adrenergic Receptors|Adrenergic alpha Receptor|alpha-Receptor, Adrenergic|alpha receptors|Receptors, alpha Adrenergic|Receptor, alpha-Adrenergic|alpha Adrenergic Receptors|alpha Adrenergic Receptor"
D052240,CHEMICAL,Fanconi Anemia Complementation Group L Protein,PHD Finger Protein 9|Group L|Ubiquitin Ligase Protein PHF9|Fanconi Anemia Group L Complementing Protein|Fanconi Anemia Group L Protein|FANCL Protein|Lidocaine
D019569,DISEASE,Hemifacial Spasm,"Spasm, Hemifacial|Spasm, Unilateral Facial|Spasms, Hemifacial|Facial Spasms, Unilateral|Spasms, Unilateral Facial|Hemifacial Myokymia|Unilateral Facial Spasms|Spasm|Myokymia, Hemifacial|Hemifacial Spasms|Facial Spasm, Unilateral|Unilateral Facial Spasm"
NEW13484,MENTAL_HEALTH,adhd comorbidity,ADHD comorbidity
D000080223,DISEASE,Chronic Urticaria,"Idiopathic Urticaria, Chronic|CIndU|Idiopathic Chronic Urticarias|Chronic Urticarias|Chronic Inducible Urticaria|Urticaria, Chronic Autoimmune|Idiopathic Chronic Urticaria|Autoimmune Urticaria, Chronic|Urticaria, Chronic Spontaneous|Urticaria, Chronic|Chronic Autoimmune Urticaria|Chronic Urticaria, Idiopathic|Chronic Autoimmune Urticarias|Spontaneous Urticaria, Chronic|Urticaria, Chronic Idiopathic|Autoimmune Urticaria|Chronic Idiopathic Urticaria|Inducible Urticaria, Chronic|Chronic Inducible Urticarias|Urticaria, Chronic Inducible|Chronic Idiopathic Urticarias|Urticaria, Autoimmune|Autoimmune Urticarias|Chronic Spontaneous Urticaria|Chronic Spontaneous Urticarias|Urticaria, Idiopathic Chronic|Chronic urticaria"
NEW13487,BIOCHEMICAL,human growth hormone intron,human growth hormone intron
NEW13489,CHEMICAL,alpha- lipoic acid supplementation,alpha- lipoic acid supplementation
NEW13490,CHEMICAL,metabolite 3-methoxy-4-hydroxyphenylglycol,metabolite 3-methoxy-4-hydroxyphenylglycol|MHPG
C092797,CHEMICAL,safinamide [Supplementary Concept],Safinamide|Alanine/analogs  and  derivatives|Benzylamines
D004079,CHEMICAL,Dihydro-beta-Erythroidine,"Dihydro beta Erythroidine|dihydro-beta-erythroidine|Erythroidine, Dihydro beta|beta Erythroidine, Dihydro"
NEW13494,DISEASE,chronic facial musculoskeletal pain,chronic facial musculoskeletal pain
NEW13495,CHEMICAL,za therapy,ZA therapy
D020913,CHEMICAL,Perindopril,"Perindopril Erbumine|Erbumine, Perindopril|S 9490-3|S 94903|perindopril|S9490|S-9490|Pirindopril|S 9490|S 9490 3|Perstarium"
NEW13498,CHEMICAL,bpa exposure,BPA exposure
NEW13500,DISEASE,bdnf-induced platelet aggregation,BDNF-induced platelet aggregation
NEW13501,MENTAL_HEALTH,worldwide antimicrobial resistance,Worldwide antimicrobial resistance
NEW13502,DISEASE,hiv rt mutation,HIV RT mutations
NEW13505,CHEMICAL,cysteinyl leukotriene receptor antagonist,Cysteinyl leukotrienes receptor antagonists
D020024,BIOCHEMICAL,Leukotriene Antagonists,"Antagonists, Leukotriene Receptor|Receptor Antagonists, Leukotriene|Receptor Antagonist, Leukotriene|Antagonist, Leukotriene Receptor|leukotriene receptor antagonists|Antagonists, Leukotriene|Leukotriene Antagonist|Leukotriene Receptor Antagonists|Antagonist, Leukotriene|Leukotriene Receptor Antagonist"
NEW13506,CHEMICAL,iron-chelated aspartate,Fe-Asp|iron-chelated aspartate
NEW13508,CHEMICAL,eef2 k,eEF2 K
NEW13510,CHEMICAL,eef2 k inhibitor,eEF2 K inhibitors
NEW13515,MENTAL_HEALTH,side-chain orientation,side-chain orientation
NEW13517,BIOCHEMICAL,prototypical kor agonist,prototypical KOR agonists
NEW13519,DISEASE,dopamine agonist withdrawal syndrome,DAWS|dopamine agonist withdrawal syndrome
C031967,CHEMICAL,rasagiline [Supplementary Concept],Indans|rasagiline
NEW13521,CHEMICAL,hebt,HEBT
NEW13522,NUTRITION,brown rice extract,brown rice extracts
NEW13526,DISEASE,melas phenotype,MELAS phenotype
D020521,DISEASE,Stroke,"Brain Vascular Accidents|Acute Strokes|Stroke, Cerebrovascular|Acute Stroke|Strokes|Vascular Accident, Brain|CVAs (Cerebrovascular Accident)|Strokes, Cerebral|Cerebral Stroke|Acute Cerebrovascular Accidents|Cerebrovascular Apoplexy|Brain Vascular Accident|Cerebrovascular Strokes|Cerebrovascular Accidents|Strokes, Cerebrovascular|Acute Cerebrovascular Accident|Cerebrovascular Accident|Cerebral Strokes|Apoplexy|Stroke, Acute|Cerebrovascular Accident, Acute|Cerebrovascular Stroke|Apoplexy, Cerebrovascular|Stroke, Cerebral|Strokes, Acute|Vascular Accidents, Brain|Cerebrovascular Accidents, Acute|cerebral stroke|CVA (Cerebrovascular Accident)"
NEW13529,DISEASE,renal function,renal function
NEW13531,CHEMICAL,creatine supplementation,creatine supplementation
C076799,CHEMICAL,interferon-alpha 8 [Supplementary Concept],Interferon-alpha|IFN alpha
NEW13535,MENTAL_HEALTH,alpha-induced depression,alpha-induced depression
NEW13538,CHEMICAL,two-step acid pickling,Two-step acid pickling
NEW13542,CHEMICAL,bpa degradation pathway,BPA degradation pathway
C536830,DISEASE,Glut1 Deficiency Syndrome [Supplementary Concept],"Monosaccharide Transport Proteins/deficiency|GLUT1-DS|Carbohydrate Metabolism, Inborn Errors|GLUT1 Deficiency Syndrome"
NEW13543,CHEMICAL,very-long-chain acyl-coa dehydrogenase vlcad deficiency,Very-long-chain acyl-CoA dehydrogenase VLCAD deficiency
NEW13545,CHEMICAL,n-methyl-d-aspartate nmda antagonist drug model,N-methyl-d-aspartate NMDA antagonist drug models
NEW13546,CHEMICAL,acute nicotine exposure,acute nicotine exposure
D065128,BIOCHEMICAL,Endothelin Receptor Antagonists,"Endothelin Antagonists|Endothelin Receptor Antagonist|Endothelin Antagonist|Antagonist, Endothelin|endothelin receptor antagonists|Antagonist, Endothelin Receptor|Receptor Antagonist, Endothelin|Antagonists, Endothelin Receptor|Antagonists, Endothelin"
D000068877,CHEMICAL,Imatinib Mesylate,"STI-571|Glivec|CGP 57148|ST1571|STI 571|Imatinib Methanesulfonate|Methanesulfonate, Imatinib|CGP57148B|Imatinib|Imatinib mesylate|CGP57148|Mesylate, Imatinib|STI571|ST 1571|CGP-57148|Alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide|Gleevec"
D017545,DISEASE,"Aortic Aneurysm, Thoracic","Aortic Aneurysms, Thoracic|Aneurysm, Thoracoabdominal Aortic|Aortic Aneurysm, Thoracoabdominal|Thoracoabdominal Aortic Aneurysms|Aneurysms, Thoracoabdominal Aortic|Aortic Aneurysms, Thoracoabdominal|Aneurysm, Thoracic Aortic|Thoracoabdominal Aortic Aneurysm|Thoracic Aortic Aneurysms|Thoracic Aortic Aneurysm|Aortic aneurysms"
NEW13551,CHEMICAL,co-occurre ad,co-occurring ADs
NEW11843,DISEASE,depressed outpatient,depressed outpatients
NEW13556,MENTAL_HEALTH,projection cortex,projection cortex
NEW13559,CHEMICAL,serotonin transporter expression,serotonin transporter expression
NEW13561,DISEASE,functional hypersensitivity,functional hypersensitivity
NEW13562,CHEMICAL,postsynaptic dopamine d2-receptor,postsynaptic dopamine D2-receptors
D013893,CHEMICAL,Thiram,"Nobecutan|Sadoplon 75|TMTD|thiram|Thiuram D|TMT Disulfide|Disulfide, TMT|Tetramethylthiuram Disulfide|Disulfide, Tetramethylthiuram|Thiuram|Bacteriostat"
C092282,BIOCHEMICAL,"PSMC5 protein, human [Supplementary Concept]",Proteasome Endopeptidase Complex|ATPases Associated with Diverse Cellular Activities|thyroid hormone receptor
http://purl.obolibrary.org/obo/DOID_0080909,DISEASE,castration-resistant prostate carcinoma,castration-resistant prostate cancer|CRPC
NEW13566,BIOCHEMICAL,non-selective muscarinic receptor agonist pilocarpine,non-selective muscarinic receptor agonist pilocarpine
NEW13569,MENTAL_HEALTH,clinical depression,Clinical depression
NEW13570,CHEMICAL,dopamine d2/3 receptor agonist,dopamine D2/3 receptor agonist
C028458,CHEMICAL,tipepidine [Supplementary Concept],tipepidine|Piperidines
NEW13571,DISEASE,sp. rm,sp. RM
C033955,CHEMICAL,glucose dehydrogenase (pyrroloquinoline-quinone) [Supplementary Concept],Glucose Dehydrogenases|quinoprotein glucose dehydrogenase
D044169,CHEMICAL,"Receptors, Calcium-Sensing","Receptor, Calcium-Sensing|Receptor, Parathyroid Calcium-Sensing|Extracellular Calcium-Ion Sensing Receptor|Extracellular Calcium Ion Sensing Receptor|Calcium-Sensing Receptor, Parathyroid|Receptors, Ca-Sensing|Calcium Sensing Receptor|Calcium Receptors|Receptors, Calcium|Ca2+ Sensing Receptor|Receptor, Ca-Sensing|Calcium-Sensing Receptor Protein|Receptors, Calcium Sensing|Receptor Protein, Calcium-Sensing|Parathyroid Calcium-Sensing Receptor|Ca2+-Sensing Receptor|Ca-Sensing Receptors|Calcium Sensing Receptor Protein|CASR Protein|Receptor, Ca2+-Sensing|Calcium ion|Calcium-Sensing Receptors|Ca Sensing Receptors|Calcium Sensing Receptors|Parathyroid Calcium Sensing Receptor|Ca-Sensing Receptor|Calcium-Sensing Receptor|Receptor, Ca Sensing"
NEW13574,DISEASE,age-related cognitive deficit,age-related cognitive deficits
NEW13575,CHEMICAL,low α-tocopherol level,lower α-tocopherol levels
NEW13576,CHEMICAL,prenatal flutamide,Prenatal flutamide
NEW13577,CHEMICAL,hfn2,HFn2
NEW13578,CHEMICAL,excess alcohol consumption,excess alcohol consumption
NEW13579,DISEASE,hippocampal dysfunction,Hippocampal dysfunction
NEW13580,CHEMICAL,oral transmucosal fentanyl citrate,Oral transmucosal fentanyl citrate
NEW13584,BIOCHEMICAL,prame tumour antigen,PRAME tumour antigen
D000069552,CHEMICAL,Rivaroxaban,"BAY 59-7939|Xarelto|BAY 597939|5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide|Rivaroxaban|BAY 59 7939"
NEW13588,DISEASE,thrombotic antiphospholipid syndrome,thrombotic antiphospholipid syndrome
http://purl.obolibrary.org/obo/CHEBI_28675,NUTRITION,dextrin,retrograded starch
NEW13594,MENTAL_HEALTH,associate clinical syndrome,associated clinical syndromes
NEW13596,CHEMICAL,elevated co2,Elevated CO2
NEW13598,DISEASE,trauma patient,Trauma patients
NEW13600,DISEASE,trauma phase,trauma phase
NEW13601,DISEASE,metabolic product,metabolic product
http://purl.obolibrary.org/obo/DOID_1561,DISEASE,cognitive disorder,HAND|cognitive disease|Organic Mental disorder|HIV-associated neurocognitive disorder
C000664111,DISEASE,Botrytis pseudocinerea [Supplementary Concept],Botrytis|Botrytis pseudocinerea
D065692,BIOCHEMICAL,Cytochrome P-450 CYP3A Inhibitors,"Cytochrome P-450 CYP3A7 Inhibitors|Inhibitors, CYP3A|CYP3A7 Inhibitors|CYP3A Inhibitors|Inhibitor, CYP3A5|Cytochrome P 450 CYP3A5 Inhibitor|Cytochrome P-450 CYP3A7 Inhibitor|Inhibitors, P450 CYP3A4|P450 CYP3A Inhibitors|Cytochrome P 450 CYP3A7 Inhibitor|Cytochrome P-450 CYP3A5 Inhibitor|P450 CYP3A7 Inhibitors|Inhibitors, P450 CYP3A|P450 CYP3A5 Inhibitors|Cytochrome P 450 CYP3A7 Inhibitors|CYP3A4 Inhibitor, P450|Inhibitor, P450 CYP3A5|Inhibitor, P450 CYP3A|inhibitors|CYP3A7 Inhibitor, P450|Inhibitors, CYP3A5|Cytochrome P-450 CYP3A4 Inhibitor|Inhibitor, P450 CYP3A7|CYP3A Inhibitor, P450|Inhibitors, CYP3A7|P450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A Inhibitor|Inhibitors, CYP3A4|Inhibitor, CYP3A|Inhibitor, P450 CYP3A4|Inhibitor, CYP3A7|Cytochrome P-450 CYP3A4 Inhibitors|CYP3A5 Inhibitors|CYP3A Inhibitor|Cytochrome P 450 CYP3A5 Inhibitors|Cytochrome P 450 CYP3A4 Inhibitors|P450 CYP3A4 Inhibitor|P450 CYP3A5 Inhibitor|Cyp3A4 Inhibitor|CYP3A5 Inhibitor|P450 CYP3A Inhibitor|Cytochrome P 450 CYP3A Inhibitors|Cytochrome P 450 CYP3A Inhibitor|P450 CYP3A7 Inhibitor|Cytochrome P 450 CYP3A4 Inhibitor|CYP3A5 Inhibitor, P450|Inhibitors, P450 CYP3A7|Cytochrome P-450 CYP3A5 Inhibitors|CYP3A4 Inhibitors|Inhibitor, Cyp3A4|CYP3A5 Inhibitors, P450|CYP3A7 Inhibitors, P450|CYP3A7 Inhibitor"
NEW13605,CHEMICAL,mirtazapine use,mirtazapine use
NEW13606,DISEASE,hypothyroxinaemia,hypothyroxinaemia
NEW13609,NUTRITION,yeast prion,Yeast prions
NEW13610,CHEMICAL,memantine pretreatment,Memantine pretreatment
NEW13614,CHEMICAL,morphine dose,morphine dose
NEW13615,NUTRITION,american pokeweed plant,American pokeweed plant
D007405,MENTAL_HEALTH,Intervertebral Disc Displacement,"Disc, Protruded|Herniation, Intervertebral Disc|Intervertebral Disk Herniations|Intervertebral Disk Protrusion|Herniation, Intervertebral Disk|Intervertebral Disk Displacements|Prolapsed Disc|Protrusion, Intervertebral Disk|Disk Displacement, Intervertebral|Intervertebral Disc Protrusions|Disc Protrusion|Prolapses, Disk|Disc Herniation|Disc Protrusion, Intervertebral|Intervertebral Disc Displacements|Disk, Protruded|Protruded Disc|Protruded Disks|Herniation, Disc|Herniated Disc|Disk, Prolapsed|Herniated Discs|Prolapsed Disks|Disk, Herniated|Disk Protrusion, Intervertebral|Intervertebral Disc Protrusion|Disc, Slipped|Protrusion, Disc|Intervertebral Disk Protrusions|Protrusion, Intervertebral Disc|Intervertebral Disk Herniation|Prolapsed Discs|Disk, Slipped|Disc Protrusions|Disk Prolapse|Herniated Disk|Protruded Disk|Disk Protrusion|Protruded Discs|Disc Displacement, Intervertebral|Disc, Prolapsed|Intervertebral Disc Herniations|Slipped Disc|Slipped Discs|Disk Prolapses|displacement|Protrusions, Intervertebral Disk|Herniated Disks|Disk Herniation|Slipped Disk|Prolapse, Disk|Disc Herniations|Slipped Disks|Herniation, Disk|Intervertebral Disk Displacement|Disk Protrusions|Intervertebral Disc Herniation|Prolapsed Disk|Discs, Protruded|Disc, Herniated|Protrusion, Disk|Disk Herniations|Disc Protrusions, Intervertebral"
NEW13620,CHEMICAL,nitric oxide/asymmetric dimethylarginine/dimethylarginine dimethylaminohydrolase no/adma/ddah pathway,nitric oxide/asymmetric dimethylarginine/dimethylarginine dimethylaminohydrolase NO/ADMA/DDAH pathway
NEW13621,CHEMICAL,wu-ling-shen,Wu-Ling-Shen
NEW13622,CHEMICAL,polymorphism arg16,polymorphism Arg16
NEW13623,CHEMICAL,conventional antidepressant,Conventional antidepressants
NEW13627,CHEMICAL,standard antidepressant,standard antidepressants
NEW13629,CHEMICAL,several glutamate receptor-modulating agent,Several glutamate receptor-modulating agents
D065092,BIOCHEMICAL,Antidiuretic Hormone Receptor Antagonists,"Antidiuretic Hormone Antagonists|Vasopressin Receptor Antagonists|Antagonist, Vasopressin|Antagonists, Vasopressin|Antagonist, Antidiuretic Hormone|Receptor Antagonists, Vasopressin|Vasopressin Receptor Antagonist|Antidiuretic Hormone Receptor Antagonist|Antagonist, Vasopressin Receptor|vasopressin-receptor antagonists|Hormone Antagonist, Antidiuretic|Antagonists, Antidiuretic Hormone|Hormone Antagonists, Antidiuretic|Vasopressin Antagonist|Receptor Antagonist, Vasopressin|Antidiuretic Hormone Antagonist|Antagonists, Vasopressin Receptor|Vasopressin Antagonists"
C445659,CHEMICAL,bilastine [Supplementary Concept],bilastine|Piperidines|Benzimidazoles
NEW13631,BIOCHEMICAL,non-carboxylated carboxylate antihistamine doxepin,non-carboxylated carboxylated antihistamines doxepin
NEW13632,DISEASE,rtt subject,RTT subjects
C538724,CHEMICAL,HhAntag691 [Supplementary Concept],vismodegib|Pyridines|Anilides
http://purl.obolibrary.org/obo/CHEBI_66908,BIOCHEMICAL,smo receptor antagonist,smoothened receptor antagonists|SMO antagonists|SMO receptor antagonists|smoothened antagonist|smoothened antagonists|smoothened receptor antagonist
NEW13634,BIOCHEMICAL,smoothen antagonist,Smoothened antagonist
NEW13635,CHEMICAL,shh pathway inhibitor,SHH pathway inhibitor|Vismodegib
NEW13636,CHEMICAL,social deficit score,SOCDEF|Social deficit scores
C435779,CHEMICAL,A-DP2 doxorubicin albumin conjugate [Supplementary Concept],Oligopeptides|Doxorubicin/analogs  and  derivatives|DP2
NEW11615,MENTAL_HEALTH,organic psychosis,organic psychosis
NEW13641,CHEMICAL,antimalarial chloroquine,antimalarials chloroquine|CQ
http://purl.obolibrary.org/obo/CHEBI_33288,CHEMICAL,rodenticide,HCQ poisoning|rodenticides
NEW13649,CHEMICAL,oxytocin neuron,Oxytocin neurons
NEW13652,CHEMICAL,oc individual,OC individuals
NEW13656,CHEMICAL,CA192-CsA,CA192-CsA
NEW13658,CHEMICAL,intravitreal bevacizumab,intravitreal bevacizumab
NEW04091,DISEASE,diabetic animal,diabetic animals
NEW13659,DISEASE,diabetic neuropathic pain,diabetic neuropathic pain
NEW13660,CHEMICAL,systemic win,Systemic WIN
D060347,BIOCHEMICAL,Sodium-Coupled Vitamin C Transporters,"Sodium-Dependent Vitamin C Transporter|Sodium Dependent Vitamin C Transporter 1|vitamin C|Sodium Coupled Vitamin C Transporters|SVCT 1, Ascorbic Acid Transporter|SLC23A1 Transporter|Transporter, SLC23A1|Sodium-Dependent Vitamin C Transporter 2|Solute Carrier Family 23 (Nucleobase Transporters), Member 1|SVCT 2, Ascorbic Acid Transporter|Transporter, SLC23A2|Sodium-Dependent Vitamin C Transporter 1|Solute Carrier Family 23 (Nucleobase Transporters), Member 2|Sodium Dependent Vitamin C Transporter|SLC23A2 Transporter|Sodium Dependent Vitamin C Transporter 2"
NEW13661,DISEASE,severe tbi,severe TBI
C101470,CHEMICAL,25-hydroxyvitamin D3-bromoacetate [Supplementary Concept],Calcifediol/analogs  and  derivatives|25(OH)D3
NEW13664,MENTAL_HEALTH,depression symptom,depression symptom
NEW13665,BIOCHEMICAL,vitamin d metabolite,vitamin D metabolites
NEW13669,CHEMICAL,antagonist rimonabant,antagonist rimonabant
NEW13671,CHEMICAL,Hipoadiponectynemia,Hipoadiponectynemia
NEW13673,CHEMICAL,bilirubin removal,bilirubin removal
NEW13675,NUTRITION,fatty acid mixture infusion prefilter,fatty acid mixtures infusion prefilter
NEW13677,CHEMICAL,biloba l.,biloba L.
NEW13678,MENTAL_HEALTH,moderate dementia,moderate dementia
NEW13679,CHEMICAL,abnormal brain serotonin turnover,abnormal brain serotonin turnover
NEW13680,BIOCHEMICAL,folate receptor alpha FRα autoimmunity,folate receptor alpha FRα autoimmunity
NEW13681,BIOCHEMICAL,maternal vitamin d deficiency,maternal vitamin D deficiency
http://purl.obolibrary.org/obo/CHEBI_176799,CHEMICAL,glytoucan g03183mg,Ritaline mg
D053207,MENTAL_HEALTH,Diurnal Enuresis,"Daytime Urinary Incontinence|Enuresis, Diurnal|Incontinence, Daytime Urinary|enuresis|Wetting, Daytime|Urinary Incontinence, Daytime|Daytime Wetting"
NEW13689,MENTAL_HEALTH,organic mania,organic mania
NEW13691,CHEMICAL,tts malignancies:- patient,TTS malignancies:- patients
NEW13693,BIOCHEMICAL,next drug target,next drug targets
http://purl.obolibrary.org/obo/CHEBI_59662,CHEMICAL,colistimethate,Meropenam
http://purl.obolibrary.org/obo/CHEBI_27933,BIOCHEMICAL,beta-lactam antibiotic,beta-lactam antibiotic
C038366,CHEMICAL,ibudilast [Supplementary Concept],Pyridines|ibudilast
NEW13698,BIOCHEMICAL,opioid analgesic requirement,opioid analgesic requirements
D000111,CHEMICAL,Acetylcysteine,"MPectil|NAC, Bisolvon|Acetylcystein, mentopin|mentopin Acetylcystein|durabronchal|Alveolex|Acetylin|Airbron|Acetylcysteine, (D)-Isomer|Broncho Fips|Dampo Mucopect|Genac|Muco Sanigen|Lindocetyl|M Pectil|Fluimucil|Bisolvon NAC|Eurespiran|Acetylcystein AL|Acétylcystéine GNR|Acetylcysteine Hydrochloride|N-acetyl-L-cysteine|Mucosol|Cystamucil|NAC AL|Solmucol|Zambon, NAC|Acid, Mercapturic|Hoestil|N Acetylcysteine|Siccoral|Acetylcysteine, (DL)-Isomer|Frekatuss|Acetylcysteine Zinc|BronchoFips|Lantamed|Codotussyl|N Acetyl L cysteine|Mucopect, Dampo|Optipect Hustengetränk|Mucosil|Larylin NAC|Fabrol|Bromuc|M-Pectil|N-Acetylcysteine|N-Acetyl-L-cysteine|Zinc, Acetylcysteine|acebraus|Sodium, Acetylcysteine|Acetylcystein Atid|Acetylcystein Trom|Acetylcysteine Sodium|Jenapharm|Broncholysin|Monoammonium Salt Acetylcysteine|NAC Zambon|Acemuc|Acetylcysteine, Monosodium Salt|Mucomyst|Exomuc|Broncoclar|Hydrochloride, Acetylcysteine|Fluprowit|Mercapturic Acid|Ilube|Acetylcysteine, Monoammonium Salt|Acetabs|Muciteran|Siran|Sanigen, Muco|Acetylcystein Heumann|Broncho-Fips|Acetyst|Azubronchin|Hustengetränk, Optipect|Mucosolvin|Jenacystein|Monosodium Salt Acetylcysteine"
NEW13700,CHEMICAL,angiotensin-ii receptor blocker losartan,angiotensin-II receptor blocker losartan
NEW13701,BIOCHEMICAL,beta-3 adrenergic receptor agonist mirabegron,beta-3 adrenergic receptor agonist mirabegron
D019808,CHEMICAL,Losartan,"Losartan Monopotassium Salt|2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol|MK954|DuP 753|Monopotassium Salt, Losartan|DuP-753|DuP753|Losartan|Losartan Potassium|Cozaar|Salt, Losartan Monopotassium|Potassium, Losartan|MK-954|MK 954"
C520025,CHEMICAL,mirabegron [Supplementary Concept],Mirabegron|Thiazoles|Acetanilides
C492923,CHEMICAL,"Cacnb1 protein, mouse [Supplementary Concept]","Calcium Channels, L-Type|L-type calcium channel"
NEW13707,CHEMICAL,cytochrome p450 ethanol metabolism,Cytochrome P450 ethanol metabolism
NEW13708,CHEMICAL,due to familial ad,FAD|due to familial AD
C045855,CHEMICAL,"3-N-butyl-4,5-dihydrophthalide [Supplementary Concept]",Benzofurans|senkyunolide A
NEW13712,DISEASE,vital energy deficiency,vital energy deficiency
NEW13714,BIOCHEMICAL,peroxiproliferator-activated receptor gamma agonist,Peroxiproliferator-activated receptor gamma agonists
C044361,CHEMICAL,M-VAC protocol [Supplementary Concept],Vinblastine|Methotrexate|Doxorubicin|VAC|Cisplatin|Antineoplastic Combined Chemotherapy Protocols
NEW13719,NUTRITION,VAC food supplement,VAC food supplements
D008599,DISEASE,Menstruation Disturbances,"Menstruation Disorder|Menstruation Disturbance|Disturbance, Menstruation|Menstrual Irregularity|Disturbances, Menstruation|Irregular Menstruation|Menstruation, Irregular|Polymenorrhea|Menstrual irregularities|Menses, Irregular|Disorder, Menstruation|Retrograde Menstruation|Menstrual Irregularities|Menstruation, Retrograde|Disorders, Menstruation|Menstruation Disorders|Hypomenorrhea|Irregularity, Menstrual|Irregular Menses"
NEW13721,CHEMICAL,whi-studie,WHI-studies
D004164,CHEMICAL,Diphosphonates,Bisphosphonate|Bisphosphonates|bisphosphonates
C010739,CHEMICAL,ifenprodil [Supplementary Concept],ifenprodil|Piperidines
NEW13726,BIOCHEMICAL,inversion carrier,inversion carriers
C480551,CHEMICAL,benzylaminopurine [Supplementary Concept],Purines|6-benzylaminopurine|Benzyl Compounds|6-BA
NEW13729,CHEMICAL,nonpigmented epithelia,NPE|nonpigmented epithelia
NEW13730,BIOCHEMICAL,androgen therapy,Androgen therapy
NEW13731,BIOCHEMICAL,gender-affirming hormone therapy,Gender-Affirming Hormone Therapy
NEW13732,CHEMICAL,pip2 signaling,PIP2 signaling
NEW13733,DISEASE,hypoxic hypoxidosis,hypoxic hypoxidosis
D001784,CHEMICAL,Blood Gas Analysis,"Gas Analysis, Blood|Analyses, Blood Gas|Blood Gas Analyses|Blood gas analysis|Gas Analyses, Blood|Analysis, Blood Gas"
NEW13736,CHEMICAL,Adult Anxiety Related disorder,SCAARED|Adult Anxiety Related Disorders
NEW13739,DISEASE,psychotic child aged,psychotic children aged
NEW13743,CHEMICAL,t-588 administration,T-588 administration
D015725,CHEMICAL,Fluconazole,Fluconazol Isis|Fluconazol AbZ|Fluconazol von ct|UK 49858|Fluconazol ratiopharm|fluconazole|Fluconazol-ratiopharm|UK49858|Fluconazol Stada|Béagyne|Lavisa|Flucobeta|Fluconazol AL|Solacap|Oxifungol|Neofomiral|Zonal|Fluc Hexal|Loitin|Diflucan|Apo Fluconazole|Apo-Fluconazole|UK-49858|Fluconazol-Isis|Fungata|Flunazul|Triflucan|FlucoLich
NEW13745,CHEMICAL,oral protexin,oral protexin
NEW13747,CHEMICAL,substitutive therapy,substitutive therapy
NEW13750,DISEASE,neuroleptic-induced purposeless,Neuroleptic-induced purposeless
D001590,CHEMICAL,Benztropine,"Cogentinol|Mesylate, Benztropine|Benzatropine Methanesulfonate, Hydrochloride, (endo)-Isomer|N Methylbenztropine|Methanesulfonate, Hydrobromide Benzatropine|Cogentin|Benzatropine Methanesulfonate, Hydrobromide, (endo)-Isomer|Benztropine Mesylate|Apo-Benztropine|PMS-Benztropine|Benzatropine|Bensylate|N-Methylbenztropine|Benzatropine Methanesulfonate|Hydrobromide Benzatropine Methanesulfonate|benztropine|Methanesulfonate, Benzatropine|Benzatropine Mesylate|Apo Benztropine|Mesylate, Benzatropine|Benzatropine Methanesulfonate, Hydrobromide|PMS Benztropine"
NEW13753,DISEASE,acute dyskinetic syndrome,acute dyskinetic syndrome
NEW13758,CHEMICAL,cannabidiol fumarate,cannabidiol fumarate
NEW13761,CHEMICAL,risperidone user,risperidone users
NEW13762,DISEASE,mucus hypersecretion,mucus hypersecretion
NEW13763,BIOCHEMICAL,agonist bronchodilator,agonist bronchodilators
NEW13764,NUTRITION,rockfish,rockfish
NEW13766,BIOCHEMICAL,estrogen inactivating sulfotransferase,estrogen inactivating sulfotransferase
NEW13768,BIOCHEMICAL,estrogen inactivation,estrogen inactivation
NEW13769,CHEMICAL,syndrome alcohol,syndromes alcohol
NEW13772,BIOCHEMICAL,unique d3-preferring partial agonist pharmacology,unique D3-preferring partial agonist pharmacology
D000071698,CHEMICAL,Latent Autoimmune Diabetes in Adults,"adults|Type 1.5 Diabetes|Diabetes, Type 1.5|LADA, Latent Autoimmune Diabetes in Adults|Type 1.5 Diabetes Mellitus|MIS-A|Latent Autoimmune Diabetes of Adults|Diabetes Mellitus Type 1.5"
C000705967,DISEASE,"pediatric multisystem inflammatory disease, COVID-19 related [Supplementary Concept]",COVID-19/complications|Multisystem inflammatory syndrome|Systemic Inflammatory Response Syndrome
NEW13778,DISEASE,ASD complexity,ASD complexity
NEW13779,CHEMICAL,gaba imbalance,GABA imbalance
NEW13781,CHEMICAL,ppa treatment,PPA treatment
NEW13783,DISEASE,scorpion Androctonus australi,scorpion Androctonus australis
NEW13785,NUTRITION,crayfish Procambarus clarkii,crayfish Procambarus clarkii
NEW13788,BIOCHEMICAL,a. australis venom,A. australis venom
NEW13790,DISEASE,a. australis,A. australis
NEW13791,BIOCHEMICAL,present mixture,present mixture
NEW13792,DISEASE,p. viteana,P. viteana
C026971,CHEMICAL,coproporphyrin III [Supplementary Concept],Coproporphyrins|Zincphyrin
NEW13795,BIOCHEMICAL,carrier status,carrier status
NEW13799,BIOCHEMICAL,erbeta selective agonist,ERbeta selective agonists
NEW13800,DISEASE,elasticum (pxe)-like syndrome,elasticum (PXE)-like syndrome
NEW13802,CHEMICAL,phenolic antioxidant resveratrol,Phenolic antioxidant resveratrol
C109473,CHEMICAL,"orange carotenoid protein, Synechocystis [Supplementary Concept]",OCP|orange carotenoid protein|Bacterial Proteins
C553237,CHEMICAL,paeonol oxime [Supplementary Concept],paeonol|Oximes
NEW13805,BIOCHEMICAL,novel ppar agonist,Novel PPAR agonists
http://purl.obolibrary.org/obo/CHEBI_35941,BIOCHEMICAL,serotonergic agonist,serotonergic agonists|serotonin agonists|5-hydroxytryptamine agonist|noradrenergic agonists|5-HT agonist|serotonin agonist
NEW13808,BIOCHEMICAL,glutamatergic antagonist,glutamatergic antagonists
NEW13809,CHEMICAL,clonidine microl,clonidine microl
C011266,CHEMICAL,ST 91 [Supplementary Concept],ST-91|Clonidine/analogs  and  derivatives
NEW13810,CHEMICAL,melatonin level,melatonin levels
NEW13812,CHEMICAL,adjunctive trazodone,adjunctive trazodone
NEW13814,CHEMICAL,gaba system gene,GABA system genes
NEW13817,MENTAL_HEALTH,% amphetamine-induced psychotic disorder patient,% amphetamine-induced psychotic disorder patients
NEW13815,MENTAL_HEALTH,amphetamine-induced psychotic disorder,amphetamine-induced psychotic disorder
D007989,DISEASE,Libido,"Decreased Libido|Libido, Decreased|Libido, Increased|libido|Increased Libido"
NEW13822,DISEASE,sugar addiction,sugar addiction
D000079524,BIOCHEMICAL,Narcotic-Related Disorders,"Abuses, Narcotic|Narcotic-Related Disorder|Disorder, Narcotic-Related|narcotic dependence|Narcotic Related Disorders|Narcotic Addictions|Narcotic Abuses|Narcotic Abuse|Addiction, Narcotic|Narcotic Addiction|Dependence, Narcotic|Narcotic Dependence|Abuse, Narcotic"
NEW13824,MENTAL_HEALTH,regression coefficient,regression coefficients
NEW13827,DISEASE,high-energy diet,HED|high-energy diet
D031324,CHEMICAL,Juglans,"Walnuts, English|Walnuts, Black|Walnuts|Juglans regia|Juglans nigra|English Walnuts|Black Walnut|Walnut|Walnut, English|Black Walnuts|Walnut, Black|English Walnut"
NEW13829,NUTRITION,tree nut consumption,tree nut consumption
NEW13831,MENTAL_HEALTH,vectorial displacement,vectorial displacement
D006860,CHEMICAL,Hydrogen Bonding,"Hydrogen Bonds|hydrogen bond|Hydrogen Bond|Bond, Hydrogen"
NEW13836,CHEMICAL,gamma-aminobutyric acid gaba neurotransmitter system,gamma-aminobutyric acid GABA neurotransmitter system
http://purl.obolibrary.org/obo/DOID_0050587,DISEASE,trichotillomania,cothymia
NEW13837,DISEASE,general neurotic syndrome,general neurotic syndrome
NEW13838,BIOCHEMICAL,most drug treatment,most drug treatments
D020382,CHEMICAL,Interleukin-18,"IFN-gamma Inducing Factor|IFN gamma Inducing Factor|IFN-gamma-Inducing Factor|Interferon-gamma Inducing Factor|Inducing Factor, Interferon-gamma|Interleukin 18|IL18|Interferon gamma Inducing Factor|Interferon-gamma-Inducing Factor|IL-18|IFN-|Inducing Factor, IFN-gamma"
NEW13844,BIOCHEMICAL,nk1 antagonist activity,NK1 antagonist activities
NEW13847,DISEASE,primary familial brain calcification,Primary familial brain calcification
NEW13851,DISEASE,α-syn fibrillation,α-syn fibrillation
NEW13853,MENTAL_HEALTH,anxiety group,anxiety group
NEW13854,BIOCHEMICAL,specific neurotoxin,specific neurotoxin
NEW13855,CHEMICAL,oxygen contain medium,oxygen containing medium
http://purl.obolibrary.org/obo/DOID_12402,MENTAL_HEALTH,pyromania,MMPI-2 hysteria|firesetting behavior|Pathological firesetting
NEW00957,DISEASE,neuropsychological deficit,neuropsychological deficits
NEW13858,BIOCHEMICAL,charge micro-hydrated pantothenate [ca(panto-h)(h2o)]+ adduct,charged micro-hydrated pantothenate [Ca(panto-H)(H2O)]+ adduct
C066444,CHEMICAL,cocaethylene [Supplementary Concept],Cocaethylene|Cocaine/analogs  and  derivatives
D012765,NUTRITION,Shikimic Acid,"Acid, Shikimic|shikimic acid"
NEW11664,CHEMICAL,enzymatic hydrolysate,glucose|enzymatic hydrolysate
C030691,BIOCHEMICAL,gluconic acid [Supplementary Concept],Gluconates|gluconic acid
D043524,CHEMICAL,Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase,"N-Glycanase, Peptide|N Glycosidase F|Peptide-N(4)-(acetyl-beta-glucosaminyl)Asparagine Amidase|Peptide N glycohydrolase F|N-Glycosidase, Peptide|Peptide N-glycohydrolase F|Glycopeptide N glycosidase|Peptide N Glycosidase|N-glycohydrolase F, Peptide|Peptide N-Glycanase|asparagine|PNGase F|Glycopeptidase A|N-glycosidase, Glycopeptide|Glycopeptidase, N-Oligosaccharide|N Oligosaccharide Glycopeptidase|Glycopeptidase F|Peptide N Glycanase|N-Oligosaccharide Glycopeptidase|N-Glycosidase F|Glycopeptidase|Peptide-N-Glycanase|PNGase A|Glycopeptide N-glycosidase|N Glycosidase A|N-Glycosidase A|N-Glycanase|Peptide N-Glycosidase|N Glycanase"
NEW13863,CHEMICAL,gabbr2 gamma-aminobutyric acid type b receptor subunit gene,GABBR2 Gamma-Aminobutyric acid Type B Receptor Subunit gene
NEW13865,DISEASE,mecp2-mediated mitochondrial dysfunction,MeCP2-mediated mitochondrial dysfunction
NEW13867,CHEMICAL,arterioradionecrosis,arterioradionecrosis
http://purl.obolibrary.org/obo/CHEBI_116931,CHEMICAL,nipecotic acid,gamma-aminobutyric acid γ-aminobutyric acid|3-piperidinecarboxylic acid|piperidine-3-carboxylic acid|Piperidine-3-carboxylic acid|hexahydronicotinic acid
NEW13869,CHEMICAL,menthol cigarette,menthol cigarettes
http://purl.obolibrary.org/obo/PR_Q63563,CHEMICAL,atp-binding cassette sub-family c member 9 (rat),Sulfonylureas|sur2|rabcc9|sulfonylurea receptor 2 (rat)|abcc9
D014044,CHEMICAL,Tolbutamide,Apo-Tolbutamide|Diaval|Diabetol|tolbutamide|Tolbutamid R.A.N.|Orinase|Artosin|Dolipol|Rastinon|Orabet
D049912,BIOCHEMICAL,Growth Hormone-Secreting Pituitary Adenoma,"growth hormone|GH-Secreting Pituitary Adenomas|Pituitary Adenoma, Growth Hormone-Secreting|Pituitary Adenomas, GH-Secreting|GH-Secreting Pituitary Adenoma|Somatotroph Adenomas|Somatotropinoma, Familial Isolated|Pituitary Adenoma, GH-Secreting|Adenomas, Somatotroph|Pituitary Growth Hormone-Secreting Adenoma|Adenoma, Somatotroph|Pituitary Growth Hormone Secreting Adenoma|Pituitary Adenoma, Growth Hormone Secreting|Acromegaly Due To Pituitary Adenoma|Pituitary Adenoma, GH Secreting|Isolated Familial Somatotropinoma|Somatotrophinoma, Familial|GH Secreting Pituitary Adenoma|Somatotroph Adenoma"
NEW13875,MENTAL_HEALTH,schizoaffective mania,schizoaffective mania
NEW13876,CHEMICAL,plasma cortisol,Plasma cortisol
D009481,CHEMICAL,Neurophysins,"Neurophysin I|Neurophysin, Oxytocin-Associated|neurophysins|Oxytocin-Associated Neurophysin|Neurophysin|Vasopressin Associated Neurophysin|Oxytocin Associated Neurophysin|Neurophysin, Vasopressin-Associated|Neurophysin II|Neurophysin III|Vasopressin-Associated Neurophysin"
NEW13878,DISEASE,vascular damage,Vascular damage
NEW13883,DISEASE,inflammatory disorder,Inflammatory disorder
NEW13886,BIOCHEMICAL,selective agonist,selective agonist
NEW13887,CHEMICAL,intrathecal neostigmine,Intrathecal neostigmine
NEW13889,CHEMICAL,transdermal nitroglycerine,transdermal nitroglycerine
NEW13891,CHEMICAL,cocaine use,Cocaine use
NEW13892,DISEASE,cntnap2 ko mouse,Cntnap2 KO mice
NEW13893,CHEMICAL,vpa mouse,VPA mice
C074369,CHEMICAL,thiocyanate hydrolase [Supplementary Concept],Hydrolases|thiocyanate
NEW13896,CHEMICAL,antenatal omega-3 supplementation,antenatal omega-3 supplementation
NEW13900,CHEMICAL,well-known olive polyphenol,well-known olive polyphenol
NEW13901,BIOCHEMICAL,gabaa receptor antagonist picrotoxin,GABAA receptor antagonist picrotoxin
NEW13902,BIOCHEMICAL,nonsymmetric a carotenoid α-carotene,nonsymmetric A carotenoid α-carotene
NEW13904,BIOCHEMICAL,true vitamin a.,true vitamin A.
http://purl.obolibrary.org/obo/CHEBI_35701,CHEMICAL,ester,α-retinyl esters
C022521,DISEASE,retinol-palmitate esterase [Supplementary Concept],Retinyl palmitate|Carboxylic Ester Hydrolases|RP
NEW13906,DISEASE,human skin jurkat t-cell,human skin Jurkat T-cells
D012176,BIOCHEMICAL,Retinoids,Retinoids|vitamin A|Retinoid
NEW13907,BIOCHEMICAL,n-methyl-d-aspartate receptor agonist quinolinate,N-methyl-d-aspartate receptor agonist quinolinate
http://purl.obolibrary.org/obo/CHEBI_1547,CHEMICAL,3-hydroxykynurenine,3-Hydroxy-DL-kynurenine|quinolinic (QUIN)-induced|3-(2-amino-3-hydroxybenzoyl)alanine|2-amino-4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid|3-(3-hydroxyanthraniloyl)alanine|3-Hydroxykynurenine
NEW13913,BIOCHEMICAL,first-line drug therapy,first-line drug therapy
NEW13915,CHEMICAL,guanylate cyclase-c agonist linaclotide,guanylate cyclase-C agonist linaclotide
NEW13919,CHEMICAL,serotonin-norepinephrine noradrenaline reuptake inhibitor,serotonin-norepinephrine noradrenaline reuptake inhibitors
D018880,DISEASE,Atrial Premature Complexes,"Atrial Beat, Premature|Supraventricular Beat, Premature|Premature Atrial Beat|Premature Atrial Contraction|Premature Supraventricular Beats|Premature Atrial Contractions|Premature Complexes, Atrial|Premature Supraventricular Beat|Atrial Contractions, Premature|Atrial Ectopic Beats|Atrial Extrasystole|Atrial Contraction, Premature|Atrial Premature Complices|Atrial Beats, Premature|Atrial Complices, Premature|Premature Complex, Atrial|Ectopic Beat, Atrial|Atrial Ectopic Beat|Atrial Extrasystoles|Extrasystoles, Atrial|Ectopic Beats, Atrial|Premature Atrial Complices|Premature Atrial Beats|Supraventricular Beats, Premature|Premature Atrial Complex|Atrial Complex, Premature|Premature Complices, Atrial|Extrasystole, Atrial|extrasystole|Atrial Premature Complex"
C552597,CHEMICAL,1-pentyl-3-(1-naphthoyl)indole [Supplementary Concept],Naphthalenes|Naphthalen-1-yl-(1-pentylindol-3-yl)methanone|JWH-018|Indoles
NEW13921,CHEMICAL,jwh-018 administration,JWH-018 administration
http://purl.obolibrary.org/obo/SYMP_0000758,DISEASE,neurological alteration,neurological alterations
http://purl.obolibrary.org/obo/CHEBI_9424,CHEMICAL,tecomine,Tecomine|bauchiense
NEW13923,CHEMICAL,selective na reuptake inhibitor,selective NA reuptake inhibitors
NEW13928,CHEMICAL,cyproheptadine therapy,cyproheptadine therapy
NEW13932,CHEMICAL,arachidonic acid aa dha ratio,arachidonic acid AA DHA ratio
D009532,CHEMICAL,Nickel,Ni(2|nickel|Trace Elements
D000072283,CHEMICAL,A549 Cells,"A549 Cell Lines|A549 Cell|Cell Line, A549|Cells, A549|Cell, A549|A549 cells|Cell Lines, A549|A549 Cell Line"
NEW13934,BIOCHEMICAL,organotropic carcinogen,Organotropic carcinogens
C045718,CHEMICAL,lavender oil [Supplementary Concept],"Lavandula|Plant Oils|Oils, Volatile|Silexan"
NEW13936,CHEMICAL,glutamate nmda-receptor antagonist,glutamate NMDA-receptor antagonist
NEW13938,BIOCHEMICAL,indirect serotonergic agonist,indirect serotonergic agonist
NEW13942,DISEASE,alpha(1)-antitrypsin alpha(1)-at deficiency,alpha(1)-antitrypsin alpha(1)-AT deficiency
NEW13943,BIOCHEMICAL,drug intervention,Drug intervention
NEW13946,CHEMICAL,hydrogen sulfide h2s deficiency,Hydrogen sulfide H2S deficiency
NEW13948,BIOCHEMICAL,antioxidative carotenoid,antioxidative carotenoid
NEW13951,CHEMICAL,elevated corticosteroid level,elevated corticosteroid levels
NEW13953,BIOCHEMICAL,cyanocobalamin vitamin b12 deficiency,Cyanocobalamin vitamin B12 deficiency
NEW13954,CHEMICAL,caspr2-igg,Caspr2-IgG
NEW13956,CHEMICAL,meoh h2o extract,MeOH H2O extracts
D003048,DISEASE,Coccidiosis,Coccidioses|Besnoitiasis|Besnoitioses|coccidiosis|Besnoitiases|Besnoitiosis
NEW13959,DISEASE,plasmolysis,plasmolysis
C000611893,CHEMICAL,"2-(3,5-dimethyl-1H-pyrazol-1-yl)-5-methylphenol [Supplementary Concept]",Pyrazoles|ME1111|Phenols
NEW13961,BIOCHEMICAL,effective antifungal agent,effective antifungal agent
C431707,CHEMICAL,efinaconazole [Supplementary Concept],efinaconazole|Triazoles
C512998,CHEMICAL,tavaborole [Supplementary Concept],"Tavaborole|Boron Compounds|Bridged Bicyclo Compounds, Heterocyclic"
NEW13963,CHEMICAL,concurrent thc treatment,concurrent THC treatment
NEW13964,DISEASE,transient global uterine ischemia,transient global uterine ischemia
NEW13966,CHEMICAL,polyvinyl alcohol particle,polyvinyl alcohol particles
C496735,BIOCHEMICAL,trisacryl gelatin microspheres [Supplementary Concept],Gelatin|tris-acryl gelatin microspheres|Acrylic Resins
D011142,CHEMICAL,Polyvinyl Alcohol,"Polyviol|Polyvinyl alcohol|Liquifilm Tears|Alcohol, Polyvinyl|Tears, Liquifilm"
D013922,DISEASE,Thrombocytosis,Thrombocythemia|Thrombocytoses|Thrombocytosis|Thrombocythemias
NEW13972,BIOCHEMICAL,plasmapheresis agonist,plasmapheresis agonist
NEW13975,CHEMICAL,N. fruit extract,N. fruit extract
NEW13976,DISEASE,persistent babesiosis,Persistent babesiosis
NEW13978,DISEASE,chronic infectious disease,chronic infectious disease
D056006,DISEASE,"Leprosy, Multibacillary","leprosy|Lepromatous, Midborderline|Multibacillary Leprosy|Multibacillary Leprosies|Midborderline Lepromatous|Borderline Lepromatous|Leprosies, Multibacillary|Lepromatous, Borderline"
NEW13980,CHEMICAL,multidrug therapy,multidrug therapy|MDT
NEW13982,BIOCHEMICAL,t allele carrier,T allele carriers
NEW13983,CHEMICAL,combination olanzapine,Combination olanzapine
C107773,CHEMICAL,pterostilbene [Supplementary Concept],pterostilbene|Stilbenes
NEW13984,CHEMICAL,bccao mouse,BCCAO mice
NEW13986,DISEASE,hippocampal neuronal death,hippocampal neuronal death
NEW04697,CHEMICAL,current antidepressant,current antidepressants
NEW13990,CHEMICAL,ep2 receptor,EP2 receptor
NEW13992,CHEMICAL,self-supplying oxygen nanotherapeutic,Self-supplying oxygen nanotherapeutics
D000069479,CHEMICAL,"Buprenorphine, Naloxone Drug Combination","Drug Combination, Buprenorphine-Naloxone|Buprenorphine Naloxone|Buprenorphine-Naloxone|buprenorphine-naloxone combination|Buprenorphine Naloxone Drug Combination|Buprenorphine-Naloxone Drug Combination|Buprenorphine-Naloxone Combination|Combination, Buprenorphine-Naloxone|Combination, Buprenorphine-Naloxone Drug|Naloxone, Buprenorphine|Suboxone|Buprenorphine Naloxone Combination"
D002249,CHEMICAL,Carbon Monoxide Poisoning,"Poisoning, Carbon Monoxide|Illuminating Gas Poisonings|Carbon Monoxide Poisonings|Poisonings, Illuminating Gas|Gas Poisoning, Illuminating|Monoxide Poisoning, Carbon|Poisoning, Illuminating Gas|Monoxide Poisonings, Carbon|carbon monoxide|Illuminating Gas Poisoning|Gas Poisonings, Illuminating|Poisonings, Carbon Monoxide"
D008752,CHEMICAL,Methylene Chloride,"Dichloromethane|Methylene Dichloride|Solaesthin|Bichloride, Methylene|Dichloride, Methylene|Chloride, Methylene|methylene chloride|Methylene Bichloride"
NEW13995,DISEASE,non-inflammatory condition,non-inflammatory condition
D016585,DISEASE,"Vaginosis, Bacterial","Bacterial Vaginosis|Vaginitides, Bacterial|Bacterial vaginosis|Bacterial Vaginitides|Nonspecific Vaginitis|Vaginitis, Nonspecific|Vaginitis, Bacterial|Bacterial Vaginitis|Bacterial Vaginoses|Vaginoses, Bacterial"
NEW13996,BIOCHEMICAL,gut microbiota-derived vitamin,gut microbiota-derived vitamins
NEW13997,CHEMICAL,elevated homocysteine,Elevated homocysteine
NEW13998,DISEASE,diet (hfd)-induced obesity,diet (HFD)-induced obesity
NEW13999,NUTRITION,reverse Cholesterol Transport,Reverse Cholesterol Transport
NEW14000,CHEMICAL,increase plasma malondialdehyde level,increased plasma malondialdehyde level
NEW14002,BIOCHEMICAL,wild-type oprm1-aa genotype carrier,Wild-type OPRM1-AA genotype carriers
http://purl.obolibrary.org/obo/DOID_14756,DISEASE,vascular type ehlers-danlos syndrome,vascular Ehlers-Danlos syndrome|autosomal dominant type IV Ehlers-Danlos syndrome
NEW14005,CHEMICAL,perennial ryegrass toxicosis,PRGT|perennial ryegrass toxicosis
NEW14006,MENTAL_HEALTH,elevated social anxiety,elevated social anxiety
NEW14008,NUTRITION,plasma choline phosphoglyceride,plasma choline phosphoglycerides
NEW14009,CHEMICAL,erythrocyte ethanolamine phosphoglyceride,erythrocyte ethanolamine phosphoglycerides
NEW14010,NUTRITION,long chain polyunsaturated fatty acid,long chain polyunsaturated fatty acids
NEW14011,BIOCHEMICAL,gamma aminobutyric acid gaba receptor agonist,gamma aminobutyric acid GABA receptor agonist
NEW14014,CHEMICAL,low dose naltrexone,low dose naltrexone
NEW14015,CHEMICAL,statin therapy,statin therapy
NEW14016,CHEMICAL,statin therapy,Statin therapy
NEW14017,NUTRITION,fatty acid signalling,fatty acid signalling
http://purl.obolibrary.org/obo/CHEBI_76977,BIOCHEMICAL,corticotropin-releasing factor receptor antagonist,CRF antagonist|Corticotrophin-releasing factor antagonists|CRF antagonists|corticotropin-releasing factor receptor antagonists
NEW14019,DISEASE,severe ocd,severe OCD
NEW14022,CHEMICAL,glutamate-modulating agent,glutamate-modulating agents
NEW14023,DISEASE,colonic motility,colonic motility
NEW14025,DISEASE,chronic constipation refractory,chronic constipation refractory
NEW14026,BIOCHEMICAL,thyroid hormone therapy,thyroid hormone therapy
NEW14029,DISEASE,renal failure patient,renal failure patients
NEW14030,CHEMICAL,acacia drepanolobium,Acacia drepanolobium
NEW14031,CHEMICAL,morphine consumption,Morphine consumption
NEW14034,CHEMICAL,chronic ethanol feeding,chronic ethanol feeding
NEW14035,DISEASE,hepatotoxicity,Hepatotoxicity
NEW14037,DISEASE,nutritional deficit,nutritional deficits
NEW14038,CHEMICAL,gem/clf co-loaded liposome,GEM/CLF co-loaded liposomes
NEW14040,CHEMICAL,gem/clf co-loaded liposomal delivery system,GEM/CLF co-loaded liposomal delivery system
C085058,CHEMICAL,"alpha-cobratoxin cyclic peptide Cys-23,40 (23-40) [Supplementary Concept]","Peptide Fragments|Peptides, Cyclic|α-cobratoxin|Cobra Neurotoxin Proteins"
NEW14043,CHEMICAL,intracellular calcium measurement,intracellular calcium measurement
D019755,CHEMICAL,Carbon-Carbon Lyases,"Lyases, Carbon-Carbon|Carbon Carbon Lyases|° C|carbon"
NEW14053,BIOCHEMICAL,ln retinol binding protein,ln retinol binding protein
D005971,CHEMICAL,Glutamates,Glutamic Acid Derivatives|Glutamic Acids|glutamic acids|Glutaminic Acids
D013853,DISEASE,Thioacetamide,TAA|Thiacetamid|thioacetamide|Thioacetamid
D003980,CHEMICAL,Diazooxonorleucine,6-Diazo-5-oxo-L-norleucine|6 Diazo 5 oxo L norleucine
NEW14056,CHEMICAL,reversible defunctionalisation,Reversible defunctionalisation
NEW14057,CHEMICAL,trpv1 receptor agonist olvanil,TRPV1 receptor agonist olvanil
NEW14058,CHEMICAL,rapid carbon dioxide retention,rapid carbon dioxide retention
NEW14063,CHEMICAL,phosphate binder,Phosphate binders
D054559,DISEASE,Hyperphosphatemia,Hyperphosphatemias|hyperphosphatemia
NEW14068,CHEMICAL,Dcycloserine,Dcycloserine
NEW14070,CHEMICAL,glycine modulatory site,glycine modulatory site
NEW14073,CHEMICAL,rna nanoparticle,RNA nanoparticles
NEW14075,CHEMICAL,covid-19 vaccination campaign,COVID-19 vaccination campaign
C478745,CHEMICAL,tasimelteon [Supplementary Concept],Cyclopropanes|Benzofurans|tasimelteon
D000324,BIOCHEMICAL,Adrenocorticotropic Hormone,"Adrenocorticotropin|Hormone, Adrenocorticotropic|Corticotropin|ACTH|Adrenocorticotrophic Hormone|Corticotrophin|Corticotropin (1-39)|1-39 ACTH|ACTH (1-39)|Corticotrophin (1-39)|Adrenocorticotropic hormone|Hormone, Adrenocorticotrophic"
http://purl.obolibrary.org/obo/CHEBI_70782,BIOCHEMICAL,pparalpha agonist,PPARalpha agonist|PPARgamma agonists|PPAR-alpha agonists|peroxisome proliferator-activated receptor-alpha agonist|PPARalpha agonists|PPAR-alpha agonist|peroxisome proliferator-activated receptor-alpha agonists
NEW14077,CHEMICAL,label fructan oligomer,labeled fructan oligomers
NEW14078,MENTAL_HEALTH,order ms fragmentation pattern,order MS fragmentation patterns
D003192,DISEASE,Compulsive Behavior,"Behaviors, Compulsive|compulsive behaviors|Compulsive Behaviors|Behavior, Compulsive"
NEW14080,CHEMICAL,dorsomedial striatal dopamine depletion,dorsomedial striatal dopamine depletion
NEW14082,CHEMICAL,intranasal corticoid,Intranasal corticoids
NEW14084,CHEMICAL,Myricitrin     mg/kg,Myricitrin    mg/kg
NEW14085,BIOCHEMICAL,blood carotenoid,blood carotenoids
NEW14087,DISEASE,hyperactive bladder refractory,hyperactive bladder refractory
NEW14088,NUTRITION,many chromone,Many chromones
http://purl.obolibrary.org/obo/CHEBI_135580,CHEMICAL,theodrenaline,(+/-)-Theodrenaline|0.04mg/kg
NEW14092,DISEASE,dmba-induced oral precancerous lesion,DMBA-induced oral precancerous lesions
NEW14094,CHEMICAL,vaccine thimerosal exposure,vaccine thimerosal exposure
NEW02659,DISEASE,common psychiatric condition,common psychiatric condition
D003042,CHEMICAL,Cocaine,"Hydrochloride, Cocaine|Cocaine hydrochloride|Cocaine HCl|HCl, Cocaine|Cocaine Hydrochloride"
NEW14096,MENTAL_HEALTH,potentiate opiate analgesia,Potentiated opiate analgesia
NEW14098,CHEMICAL,systemic clonidine,Systemic clonidine
D013565,BIOCHEMICAL,Sympatholytics,"Sympatholytic Effects|Effects, Sympatholytic|Agent, Sympatholytic|Agents, Sympathetic-Blocking|Sympathetic Blocking Agents|Sympatholytic Drugs|Effect, Sympatholytic|Sympatholytic Drug|Drug, Sympatholytic|Sympatholytic Agent|Agents, Sympatholytic|Sympatholytic drugs|Sympatholytic Effect|Sympatholytic Agents|Sympathetic-Blocking Agents|Drugs, Sympatholytic|Sympatholytic"
http://purl.obolibrary.org/obo/DOID_11634,DISEASE,myxedema,Amiodarone-induced thyrotoxicosis
D000077150,CHEMICAL,Oxaliplatin,"Oxalato-(1,2-cyclohexanediamine)platinum II|1,2-Diaminocyclohexane Platinum Oxalate|Eloxatine|1,2-Diamminocyclohexane(trans-1)oxolatoplatinum(II)|Eloxatin|Oxaliplatin, (SP-4-2-(1S-trans))-isomer|oxaliplatin|1,2 Diaminocyclohexane Platinum Oxalate|L-OHP Cpd|Oxaliplatin, (SP-4-2-(1R-trans))-isomer|ACT-078|Oxaliplatine|ACT078|Cis-oxalato-(trans-l)-1,2-diaminocyclohexane-platinum(II)|Platinum(II)-1,2-cyclohexanediamine Oxalate|Platinum(2+) ethanedioate (1R,2R)-1,2-cyclohexanediamine (1:1:1)|ACT 078|Oxaliplatin, (SP-4-3-(cis))-isomer"
C520255,CHEMICAL,130-nm albumin-bound paclitaxel [Supplementary Concept],Nab-paclitaxel|Albumins|Paclitaxel
C056507,CHEMICAL,gemcitabine [Supplementary Concept],gemcitabine|Deoxycytidine/analogs  and  derivatives
D000077146,CHEMICAL,Irinotecan,SN 38|Irinotecan hydrochloride|SN-38|NK012 Compound|7-Ethyl-10-hydroxycamptothecin|Irrinotecan|SN3811|Irinotecan Hydrochloride|7 Ethyl 10 hydroxycamptothecin|Camptothecin-11|CPT-11|CPT11|CPT 11|Camptothecin 11|Camptosar|SN-38-11|SN 38 11|irinotecan
NEW14103,BIOCHEMICAL,folate depletion,Folate depletion
NEW14104,CHEMICAL,ropi treatment,ROPI treatment
NEW14105,CHEMICAL,agonist ropinirole,ROPI|agonist Ropinirole
D001463,CHEMICAL,Barbiturates,"Anesthetics, Intravenous|Anticonvulsants|barbiturates|Hypnotics and Sedatives"
C111960,CHEMICAL,baicalin 6-O-sulfate [Supplementary Concept],baicalin|Flavonoids
http://purl.obolibrary.org/obo/CHEBI_87211,CHEMICAL,fluoroquinolone antibiotic,Fluoroquinolone antibiotics|fluoroquinolone antibiotics
NEW14111,CHEMICAL,fluoroquinolone use,fluoroquinolone use
http://purl.obolibrary.org/obo/DOID_9952,DISEASE,acute lymphoblastic leukemia,acute lymphoblastic leukemia|acute lymphocytic leukaemia|acute lymphoblastic leukaemia|ALL|childhood acute lymphoblastic leukemia|precursor lymphoblastic lymphoma/leukemia
NEW08061,DISEASE,precancerous lesion,precancerous lesions
D062556,DISEASE,NAV1.7 Voltage-Gated Sodium Channel,Voltage Gated Sodium Channel Type 9 Subunit alpha|Voltage Gated Sodium Channel Type 9|NAV1.7 Voltage Gated Sodium Channel|Type 9 Voltage Gated Sodium Channel|SCN9A Sodium Channel alpha Subunit|Peripheral Sodium Channel 1|SCN9A|Voltage-Gated Sodium Channel Type 9 Subunit alpha|Type 9 Voltage-Gated Sodium Channel|Voltage-Gated Sodium Channel Type 9
NEW14118,CHEMICAL,sterol metabolism,sterol metabolism
NEW14119,CHEMICAL,ketone ketogenic medium-chain triglyceride,ketones ketogenic medium-chain triglyceride
NEW14120,DISEASE,arterial damage,arterial damage
NEW14121,CHEMICAL,high homocysteine level,High homocysteine levels
D003494,CHEMICAL,Cyclamates,"Cyclamate|Cyclamate Calcium (2:1) Salt|Cyclamate, Sodium|Cyclamate, Sodium Salt|Cyclamate, Calcium|Calcium Cyclamate|Cyclamic Acid|Potassium Cyclamate|Sodium cyclamate|Cyclamate, Calcium (2:1) Salt, Dihydrate|Sodium Cyclamate|Cyclamate, Potassium"
C006068,CHEMICAL,propylparaben [Supplementary Concept],propylparaben|Parabens
D010892,CHEMICAL,Pirinitramide,piritramide|Piritramide|Dipydolor|Dipidolor|Piritramid
NEW14125,CHEMICAL,readmission troponin,readmission troponins
D009705,CHEMICAL,Nucleosides,"nucleoside analogs|Analogs, Nucleoside|Nucleoside|Nucleoside Analogs|Nucleoside Analog|Analog, Nucleoside"
D054556,DISEASE,Venous Thromboembolism,"venous thromboembolism|Thromboembolism, Venous"
NEW14128,DISEASE,clozapine-induced allergic vasculitis,clozapine-induced allergic vasculitis
NEW14130,DISEASE,osa subject,OSA subjects
C444427,NUTRITION,"RSAD2 protein, human [Supplementary Concept]",S-Adenosyl methionine|Oxidoreductases Acting on CH-CH Group Donors
D000432,CHEMICAL,Methanol,"Wood Alcohol|Methyl Alcohol|Alcohol, Wood|Methanol|Alcohol, Methyl|Carbinol|Sodium Methoxide|Methoxide, Sodium"
NEW14136,CHEMICAL,ethyl acetate leaf extract,ethyl acetate leaf extracts
http://purl.org/sig/ont/fma/fma67310,MENTAL_HEALTH,projection neuron,projection neurons
C480564,CHEMICAL,coumaryl gamma-amino-butyric acid diazopyruvate [Supplementary Concept],Aminobutyrates|γ-amino butyric acid|Coumarins|Pyruvates
NEW14140,CHEMICAL,dorsal anterior cingulate cortex dacc glutamate,Dorsal anterior cingulate cortex dACC glutamate
NEW14141,BIOCHEMICAL,ovarian hormone,Ovarian hormones
NEW14143,CHEMICAL,heroin crosse,Heroin crosses
NEW14146,CHEMICAL,mirtazapine augmentation,Mirtazapine augmentation
NEW14147,MENTAL_HEALTH,mixed depression,Mixed depression
NEW14151,DISEASE,gba mutation,GBA mutations
NEW14152,DISEASE,parkinson disease functional score,Parkinson disease functional scores
D005776,DISEASE,Gaucher Disease,"Gaucher Disease Type 1|Acid beta-Glucosidase Deficiency|Gaucher Disease, Subacute Neuronopathic Type|Gauchers Disease|thesaurismoses, Kerasin|Deficiency Disease, Glucocerebrosidase|Gaucher Disease, Infantile|Glucosyl Cerebroside Lipidosis|Diseases, Glucocerebrosidase Deficiency|Gaucher Disease, Type 1|Gauchers Diseases|Gaucher Splenomegaly|Gaucher Disease, Subacute Neuronopathic Form|Lipidoses, Glucosylceramide|Glucosylceramidase Deficiency|Glucocerebrosidase Deficiency Diseases|Gaucher Disease, Type I|Gaucher Disease Type 3|Gaucher Disease, Type III|Diseases, Gauchers|Gaucher Disease, Type 3|Lipoidosis, Kerasin|Kerasin thesaurismoses|Deficiency, Glucocerebrosidase|Cerebroside Lipidosis, Glucosyl|Gaucher Disease, Juvenile|Gaucher Disease, Chronic|Gaucher Disease, Type II|Histiocytosis, Lipoid (Kerasin Type)|Lipoid Histiocytoses (Kerasin Type)|Gaucher Disease, Non-Neuronopathic Form|Kerasin Lipoidoses|Disease, Glucocerebrosidase Deficiency|Gaucher Disease Type 2|Disease, Non-Neuronopathic Gaucher|Lipidosis Syndromes, Cerebroside|Type 1 Gaucher Disease|Gaucher disease|Gaucher's Disease|Non-Neuronopathic Gaucher Disease|Kerasin thesaurismosis|GBA Deficiency|Deficiencies, Glucocerebrosidase|Glucosylceramide Lipidoses|Syndromes, Cerebroside Lipidosis|Glucocerebrosidosis|Gaucher Disease, Infantile Cerebral|Cerebroside Lipidoses, Glucosyl|Gaucher Disease, Chronic Neuronopathic Type|Gaucher Disease, Juvenile and Adult, Cerebral|Disease, Neuronopathic Gaucher|Deficiencies, GBA|Disease, Juvenile Gaucher|Glucocerebrosidase Deficiency Disease|Cerebroside Lipidosis Syndrome|Syndrome, Cerebroside Lipidosis|Disease, Infantile Gaucher|Disease, Gaucher|Glucosylceramide Beta-Glucosidase Deficiency Disease|Lipoid Histiocytosis (Kerasin Type)|Glucosylceramide Beta-Glucosidase Deficiency|Glucocerebrosidoses|Gaucher Disease, Neuronopathic|Glucocerebrosidase Deficiency|Kerasin Histiocytoses|Acute Neuronopathic Gaucher Disease|Glucocerebrosidase Deficiencies|Lipidosis Syndrome, Cerebroside|Deficiency, GBA|Gaucher Disease, Non Neuronopathic Form|Type 3 Gaucher Disease|Infantile Gaucher Disease|Glucosyl Cerebroside Lipidoses|Juvenile Gaucher Disease|Splenomegaly, Gaucher|Subacute Neuronopathic Gaucher Disease|Histiocytosis, Kerasin|Histiocytoses, Lipoid (Kerasin Type)|Acid beta-Glucosidase Deficiency Disease|Glucosylceramide Lipidosis|thesaurismosis, Kerasin|Neuronopathic Gaucher Disease|Histiocytoses, Kerasin|Gaucher Syndrome|Type 2 Gaucher Disease|Cerebroside Lipidosis Syndromes|Gaucher Disease, Type 2|Disease, Gaucher's|Chronic Gaucher Disease|GBA Deficiencies|Lipidosis, Glucosyl Cerebroside|Gaucher Disease, Non-Neuronopathic|Non Neuronopathic Gaucher Disease|Gaucher Disease, Acute Neuronopathic|Gaucher Disease, Noncerebral Juvenile|Deficiency Diseases, Glucocerebrosidase|Gaucher Disease, Acute Neuronopathic Type|Lipidoses, Glucosyl Cerebroside|Syndrome, Gaucher|Kerasin Lipoidosis|Lipoidoses, Kerasin|Lipidosis, Glucosylceramide|Kerasin Histiocytosis|Disease, Chronic Gaucher|Disease, Gauchers"
NEW14155,BIOCHEMICAL,phytohormone Abscisic Acid,phytohormone Abscisic Acid
D058486,CHEMICAL,"Receptors, Purinergic P2X7","P2X7 Receptor, Purinergic|Purinergic P2X7 Receptor|Purinoceptors, P2X7|P2X7 Receptor|Purinergic P2X7 Receptors|P2X7 Receptors, Purinergic|Purinergic Receptor P2X, Ligand-Gated Ion Channel, 7|Purinoceptor P2Z|P2X7 Purinoceptors|Purinoceptor, P2X7|P2X7 receptor|P2Z, Purinoceptor|P2Z Receptor|P2X7 Purinoceptor|Receptor, Purinergic P2X7"
D051270,MENTAL_HEALTH,"Headache Disorders, Primary","Hypnic Headache Syndrome|Headache, Benign Exertional|Headaches, Alarm Clock|Headache, Thunderclap|Primary Headache Disorders|Headache, Primary Exertional|Exertional Headache, Benign|Primary Thunderclap Headache|Clock Headaches, Alarm|Headache, Primary Cough|Headache Syndromes, Hypnic|Headache Disorder, Primary|Ice-Pick Headache|Headaches, Benign Exertional|Primary Cough Headache|Primary Exertional Headache|Primary Headache Disorder|Benign Cough Headache|Headache, Primary Stabbing|Headaches, Ice-Pick|Cough Headache|Benign Exertional Headache|Cough Headaches, Benign|Benign Exertional Headaches|Cough Headache, Benign|Benign Cough Headaches|Disorder, Primary Headache|Disorders, Primary Headache|Ice Pick Headache|Clock Headache, Alarm|Alarm Clock Headaches|Thunderclap Headache|Alarm Clock Headache|Exertional Headaches, Benign|Headache, Ice-Pick|Headache, Hypnic|primary headache|Ice-Pick Headaches|Headache, Cough|Headaches, Benign Cough|Headache, Benign Cough|Headache, Primary Thunderclap|Primary Stabbing Headache|Headache, Stabbing|Headache Syndrome, Hypnic|Hypnic Headache Syndromes|Stabbing Headache|Hypnic Headache|Headache, Alarm Clock"
NEW14158,BIOCHEMICAL,nutraceutical ingredient,nutraceutical ingredients
C575860,NUTRITION,"fatty acid 2-hydroxylase 2, Arabidopsis [Supplementary Concept]",Mixed Function Oxygenases|Arabidopsis Proteins|fatty acid 2-hydroxylase
http://purl.obolibrary.org/obo/DOID_13282,DISEASE,intestinal tuberculosis,intestinal tuberculosis|tuberculosis of intestine
C517803,CHEMICAL,"4-aminho-2-thiabicyclo(3.1.0)hexane-4,6-dicarboxylic acid [Supplementary Concept]","Bridged Bicyclo Compounds, Heterocyclic|LY404039|Cyclic S-Oxides"
NEW14161,NUTRITION,geometry witch,geometry witch
NEW14163,CHEMICAL,ethanol-exposed ncc,ethanol-exposed NCCs
NEW14165,CHEMICAL,dca specimen,DCA specimens
NEW14167,CHEMICAL,smoking group,smoking group
NEW14168,DISEASE,chronic hypoxia,chronic hypoxia
NEW14170,MENTAL_HEALTH,synthetic auxin herbicide resistance,synthetic auxin herbicide resistance
NEW14172,CHEMICAL,ja signal,JA signal
NEW14176,BIOCHEMICAL,ppar‑γ agonist pioglitazone,PPAR‑γ agonist pioglitazone
NEW14178,DISEASE,sev‑induced cognitive decline,SEV‑induced cognitive decline
NEW14180,CHEMICAL,ape treatment,APE treatment
NEW14183,DISEASE,hepatic centrilobular hypertrophy,Hepatic centrilobular hypertrophy
NEW14184,CHEMICAL,vd(o,VD(O
NEW14186,BIOCHEMICAL,bind agonist,bound agonist
NEW04231,DISEASE,hyperactive symptom,hyperactive symptoms
NEW14188,CHEMICAL,anticonvulsant topiramate,anticonvulsant topiramate
NEW14189,MENTAL_HEALTH,displacement study,Displacement studies
NEW14191,CHEMICAL,glun2a_k879r knock-in mouse,GluN2A_K879R knock-in mice
NEW14193,MENTAL_HEALTH,high resistance,high resistance
D010131,CHEMICAL,Aminosalicylic Acid,"Alumino 4 Aminosalicylic Acid|4 Aminosalicylic Acid|Acid, Aminosalicylic|4-Aminosalicylic Acid|p-Aminosalicylic Acid Monopotassium Salt|p Aminosalicylic Acid Monosodium Salt|para-Aminosalicylic Acid|p-Aminosalicylic Acid Monolithium Salt|para Aminosalicylic Acid|p-Aminosalicylic Acid, Calcium (2:1) Salt|p-Aminosalicylic Acid, Aluminum (2:1) Salt|p Aminosalicylic Acid Monolithium Salt|Alumino-4-Aminosalicylic Acid|Rezipas|p-Aminosalicylic Acid Monosodium Salt|p-Aminosalicylic Acid, Monosodium Salt, Dihydrate|p Aminosalicylic Acid|p Aminosalicylic Acid Monopotassium Salt|p-Aminosalicylic Acid|Pamisyl|p-aminosalicylic acid"
D053700,CHEMICAL,"Receptors, Interleukin-8","IL-8 Receptors|Receptors, IL-8|IL 8 Receptors|Receptors, Interleukin 8|IL8 Receptors|IL-8|Interleukin-8 Receptors|Receptors, IL8|Interleukin 8 Receptors"
NEW14195,CHEMICAL,tropomyosin receptor kinase b,tropomyosin receptor kinase B
NEW14197,CHEMICAL,5-hydroxytryptamine 5-ht receptor 1a,5-hydroxytryptamine 5-HT receptor 1A
D014446,CHEMICAL,Tyrosine 3-Monooxygenase,"Tyrosine 3 Monooxygenase|tyrosine hydroxylase|3-Monooxygenase, Tyrosine|Hydroxylase, Tyrosine|Tyrosine Hydroxylase"
http://purl.obolibrary.org/obo/CHEBI_187455,CHEMICAL,dihomo-gamma-linolenoyl dopamine,"dopamine 5-HTR1A|(8Z,11Z,14Z)-N-[2-(3,4-dihydroxyphenyl)ethyl]icosa-8,11,14-trienamide"
C006923,CHEMICAL,carvone [Supplementary Concept],Cyclohexane Monoterpenes|carvone
NEW14199,CHEMICAL,alkalinized bupivacaine,Alkalinized bupivacaine
NEW14200,MENTAL_HEALTH,globe akinesia,globe akinesia
NEW14202,CHEMICAL,alkalinized bupivacaine group,alkalinized bupivacaine group
NEW14204,CHEMICAL,bupivacaine-lidocaine group,bupivacaine-lidocaine group
NEW14205,CHEMICAL,lidocaine-bupivacaine group,lidocaine-bupivacaine group
NEW14206,CHEMICAL,ph-adjusted bupivacaine group,pH-adjusted bupivacaine group
NEW14210,DISEASE,non-suicide attempter,non-suicide attempters
NEW14212,MENTAL_HEALTH,pain-related depression,Pain-related depression
NEW14215,CHEMICAL,ketoprofen effect,ketoprofen effects
NEW14216,BIOCHEMICAL,kappa opioid receptor antagonist jdtic,kappa opioid receptor antagonist JDTic
NEW14217,BIOCHEMICAL,semi-parametric group-based mixture model,semi-parametric group-based mixture model
NEW14218,CHEMICAL,low-dose combination,low-dose combination
NEW14219,BIOCHEMICAL,antiandrogen drug,antiandrogen drug
NEW14220,BIOCHEMICAL,antimineralocorticoid activity,antimineralocorticoid activity
NEW14221,BIOCHEMICAL,antimineralocorticoid effect,antimineralocorticoid effects
D011743,CHEMICAL,Pyrimidines,pyrimidines
D011687,CHEMICAL,Purines,Purines
NEW14222,CHEMICAL,amino acid level,amino acid level
NEW14223,CHEMICAL,nucleotide metabolite,nucleotides metabolite
NEW14224,CHEMICAL,metabolite amino acid pattern,metabolite amino acid pattern
NEW14226,CHEMICAL,nucleotide metabolite,nucleotide metabolite
NEW14227,CHEMICAL,itc measurement,ITC measurements
NEW14228,BIOCHEMICAL,sulpiride d-2 antagonist,sulpiride D-2 antagonist
NEW14231,CHEMICAL,aba model,ABA model
NEW14233,CHEMICAL,aba rat,ABA rats
NEW14234,CHEMICAL,treat aba rat,Treated ABA rats
NEW14235,BIOCHEMICAL,gonadotropin-releasing hormone pulse,gonadotropin-releasing hormone pulses
D000568,DISEASE,Amenorrhea,"Postpartum Amenorrheas|amenorrhea|Amenorrhea, Postpartum|Postpartum Amenorrhea"
NEW14237,DISEASE,responsive psychogenic amenorrhea patient,Responsive psychogenic amenorrhea patients
NEW14238,DISEASE,non-responsive psychogenic amenorrhea group,non-responsive psychogenic amenorrhea group
NEW14240,CHEMICAL,elevated cortisol level,elevated cortisol levels
NEW14241,MENTAL_HEALTH,severe akinesia,Severe akinesia
C537921,MENTAL_HEALTH,"Fetal akinesia syndrome, X-linked [Supplementary Concept]","Genetic Diseases, X-Linked|Limb Deformities, Congenital|Akinesia|Pterygium|Fetal Growth Retardation"
NEW14243,CHEMICAL,deoxyglucose study,Deoxyglucose studies
NEW14247,DISEASE,peripheral ulcerative keratitis,peripheral ulcerative keratitis|PUK
NEW14249,BIOCHEMICAL,intravenous drug abuser,Intravenous drug abusers
NEW02390,DISEASE,hcv infection,HCV infection
http://purl.obolibrary.org/obo/CHEBI_121846,CHEMICAL,3-benzamido-3-oxopropanethioic acid s-methyl ester,"benzo-1,2,3-thiadiazole-7-car ioic acid S-methyl ester"
C005073,CHEMICAL,ethephon [Supplementary Concept],Organophosphorus Compounds|ethephon
C072239,CHEMICAL,methyl jasmonate [Supplementary Concept],methyl jasmonate|Cyclopentanes|Acetates|Oxylipins
NEW14253,CHEMICAL,type pufa,type PUFAs
NEW14255,CHEMICAL,omega-3 type,omega-3 type
NEW14256,CHEMICAL,dietary dha uptake,dietary DHA uptake
NEW01577,BIOCHEMICAL,fat-soluble vitamin,fat-soluble vitamins
NEW14260,CHEMICAL,pilocarpine treatment,Pilocarpine treatment
NEW14261,BIOCHEMICAL,muscarinic cholinergic agonist carbachol,muscarinic cholinergic agonist carbachol
NEW14262,CHEMICAL,calcium ionophore a23187,Calcium ionophore A23187
http://purl.obolibrary.org/obo/CHEBI_31410,CHEMICAL,clenbuterol hydrochloride,"(+-)-clenbuterol monohydrochloride|4-amino-3,5-dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol monohydrochloride|(+-)-clenbuterol hydrochloride|4-amino-3,5-dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol hydrochloride|clenbuterol HCl|1-(4-amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethanol hydrochloride|clenbuterol monohydrochloride|4-amino-alpha-((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol monohydrochloride|4-amino-alpha-((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol hydrochloride|clenbuterol clorhidrato|zilpaterol hydrochloride"
NEW14264,DISEASE,apparent bruise,apparent bruises
D016861,CHEMICAL,Cyclooxygenase Inhibitors,"Inhibitors, Prostaglandin-Endoperoxide Synthase|Inhibitors, Prostaglandin Endoperoxide Synthase|Inhibitors, Cyclo Oxygenase|Antagonists, Prostaglandin Synthesis|prostaglandin inhibitors|Prostaglandin Synthesis Antagonist|Prostaglandin Synthase Inhibitors|Inhibitors, Cyclooxygenase|Cyclo Oxygenase Inhibitor|Prostaglandin Synthesis Antagonists|Cyclo-Oxygenase Inhibitor|Prostaglandin Synthase Inhibitor|Inhibitors, Prostaglandin Synthase|Synthase Inhibitor, Prostaglandin|Synthesis Antagonist, Prostaglandin|Prostaglandin Endoperoxide Synthase Inhibitors|Cyclo Oxygenase Inhibitors|Cyclo-Oxygenase Inhibitors|Inhibitor, Cyclooxygenase|Inhibitor, Cyclo-Oxygenase|Inhibitors, Cyclo-Oxygenase|Inhibitor, Prostaglandin Synthase|Cyclooxygenase Inhibitor|Prostaglandin Endoperoxide Synthase Inhibitor|Antagonist, Prostaglandin Synthesis"
D008787,CHEMICAL,Metoclopramide,"Metaclopramide|Primperan|Reglan|Rimetin|Maxolon|Cerucal|metoclopramide|Metoclopramide Dihydrochloride|Hydrochloride, Metoclopramide|Metoclopramide Monohydrochloride, Monohydrate|Metoclopramide Monohydrochloride|Dihydrochloride, Metoclopramide|4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide|Metoclopramide Hydrochloride|Monohydrochloride, Metoclopramide"
NEW14269,DISEASE,nephrotoxicity,Nephrotoxicity
D011192,CHEMICAL,Potassium Dichromate,"Bichromate, Potassium|Potassium dichromate|K2Cr2O7|Potassium Bichromate|Dichromate, Potassium"
C534676,CHEMICAL,"S-(1,2-dichlorovinyl)-L-cysteine sulfoxide [Supplementary Concept]","S-(1,2- dichlorovinyl l-cysteine|Cysteine/analogs  and  derivatives"
C026729,CHEMICAL,4-aminophenol [Supplementary Concept],Aminophenols|p-aminophenol
NEW14274,DISEASE,dyspnea attack,Dyspnea attack
C092435,NUTRITION,"ventricular natriuretic factor, rainbow trout [Supplementary Concept]",rainbow trout|Atrial Natriuretic Factor
D013788,DISEASE,Thalamus,thalamus|Thalamencephalon|Thalamencephalons|PVT
NEW14278,DISEASE,paedophilic disorder,PeD|paedophilic disorder
NEW14280,CHEMICAL,prophylactic ketamine administration,prophylactic ketamine administration
NEW14282,CHEMICAL,ketamine administration,ketamine administration
NEW14284,CHEMICAL,prophylactic ketamine,prophylactic ketamine
NEW14285,BIOCHEMICAL,specific δ-receptor antagonist,specific δ-receptor antagonist
C469346,CHEMICAL,N1'-fluoroethyl-(14-formylamino)naltrindole [Supplementary Concept],Naltrexone/analogs  and  derivatives|naltrindole
NEW14287,CHEMICAL,rice husk powder,rice husk powder
NEW14288,CHEMICAL,cu/zn ratio,Cu/Zn ratio
NEW14289,BIOCHEMICAL,antioxidant vitamin e,antioxidant vitamin E
NEW14290,NUTRITION,impaired tryptophan catabolite pathway,impaired tryptophan catabolites pathway
NEW14292,CHEMICAL,abnormal nitric oxidative production,Abnormal nitric oxidative production
NEW14293,NUTRITION,tryptophan catabolite pathway,tryptophan catabolites pathway
D017984,CHEMICAL,Enoxaparin,"PK10,169|EMT967|PK-10169|EMT-966|PK 10169|PK10169|PK 10,169|EMT-967|EMT966|EMT 967|Enoxaparin|Enoxaparine|Clexane|EMT 966|Lovenox|PK-10,169"
D056989,DISEASE,Inferior Wall Myocardial Infarction,"Infarction, Inferior Myocardial|Myocardial Infarctions, Diaphragmatic|Inferior Myocardial Infarction|Myocardial Infarctions, Inferior|Infarction, Diaphragmatic Myocardial|Inferior Myocardial Infarctions|Diaphragmatic Myocardial Infarction|Infarctions, Inferior Myocardial|Infarctions, Diaphragmatic Myocardial|Myocardial Infarction, Inferior|Myocardial Infarction, Diaphragmatic|myocardial infarction|Myocardial Infarction, Inferior Wall|Acute Inferior Myocardial Infarction|Diaphragmatic Myocardial Infarctions"
D000090542,CHEMICAL,Homozygous Familial Hypercholesterolemia,"FH|Recessive Hypercholesterolemia, Autosomal|Hypercholesterolemias, Homozygous Familial|Autosomal Recessive Hypercholesterolemia|familial hypercholesterolemia|Hypercholesterolemias, Autosomal Recessive|Recessive Hypercholesterolemias, Autosomal|Autosomal Recessive Hypercholesterolemias|HoFH"
NEW14296,BIOCHEMICAL,Most narcotic,Most narcotics
NEW14298,DISEASE,Key pointscyberchondria,Key pointsCyberchondria
NEW14299,CHEMICAL,health anxiety/hypochondriasis,Health anxiety/hypochondriasis
D020920,MENTAL_HEALTH,Dyssomnias,"Sleep Disorders, Adjustment|Syndromes, Nocturnal Eating-Drinking|Sleep Disorders, Environmental|Adjustment Sleep Disorder|Nocturnal Eating Drinking Syndrome|Environmental Sleep Disorder|Sleep Disorder, Adjustment|Sleep Disorder, Environmental|Limit-Setting Sleep Disorders|Nocturnal Eating-Drinking Syndrome|Sleep Disorders, Limit-Setting|Syndrome, Nocturnal Eating-Drinking|Limit-Setting Sleep Disorder|Sleep Disorder, Limit-Setting|Extrinsic Sleep Disorder|Nocturnal Eating-Drinking Syndromes|Sleep Disorder, Limit Setting|Eating-Drinking Syndromes, Nocturnal|sleep disorder|Sleep Disorders, Extrinsic|Limit Setting Sleep Disorder|Eating-Drinking Syndrome, Nocturnal|Environmental Sleep Disorders|Dyssomnia|Sleep Disorder, Extrinsic|Adjustment Sleep Disorders|Extrinsic Sleep Disorders"
C061050,CHEMICAL,bimakalim [Supplementary Concept],Benzopyrans|Dihydropyridines|bimakalim
NEW14304,CHEMICAL,single oral dose bimakalim,single oral dose bimakalim
C059921,CHEMICAL,tedisamil [Supplementary Concept],"Bridged Bicyclo Compounds, Heterocyclic|Cyclopropanes|tedisamil"
NEW14307,CHEMICAL,lactate concentration,lactate concentrations
http://purl.obolibrary.org/obo/DOID_3389,DISEASE,papillon-lefevre disease,Papillon Lefevre syndrome|Papillon-Lefvre syndrome|PKAN disease
NEW14312,DISEASE,intestinal dysbacteriosis due,intestinal dysbacteriosis due
NEW14314,CHEMICAL,sodium (na+):multivitamin transporter,sodium (Na+):multivitamin transporter
C119981,DISEASE,biotin transporter [Supplementary Concept],human SMVT|Symporters
D064306,BIOCHEMICAL,Non-Nutritive Sweeteners,"Non-Nutritive Artificial Sweeteners|Sweeteners, Non-Nutritive|Sweeteners, High-Intensity|artificial sweeteners|High-Intensity Sweeteners|Artificial Sweeteners, Non Nutritive|Artificial Sweeteners, Non-Nutritive|High Intensity Sweeteners|Non Nutritive Sweeteners"
http://purl.obolibrary.org/obo/SYMP_0000403,DISEASE,weight gain,body weight gain
NEW14322,CHEMICAL,sucrose seek,sucrose seeking
NEW14326,MENTAL_HEALTH,craving generalize,craving generalizes
NEW14327,CHEMICAL,reagent 2-keto-3-butynoic acid,reagent 2-keto-3-butynoic acid
NEW14329,CHEMICAL,pcb congener,PCB congeners
NEW14330,CHEMICAL,high pcb concentration,higher PCB concentrations
C105260,CHEMICAL,4-tert-octylphenol [Supplementary Concept],4-tert-octylphenol|Phenols
NEW14334,CHEMICAL,carbonic anhydrase inhibitor dorzolamide,carbonic anhydrase inhibitor dorzolamide
NEW14335,BIOCHEMICAL,alpha-adrenergic agonist brimonidine,alpha-adrenergic agonist brimonidine
D000379,MENTAL_HEALTH,Agoraphobia,Agoraphobias|agoraphobia
C000606999,BIOCHEMICAL,"EGOT lncRNA, human [Supplementary Concept]","vitamin B6|RNA, Long Noncoding|EGOT"
NEW14339,DISEASE,hypotensive action,hypotensive actions
D058906,BIOCHEMICAL,Purinergic P1 Receptor Agonists,"Purinoceptor Agonists, P1|Agonists, P1 Purinoceptor|Adenosine Receptor Agonists|Receptor Agonists, Adenosine|adenosine receptor agonists|Agonists, Adenosine Receptor|P1 Purinoceptor Agonists"
NEW14340,DISEASE,several etiology,Several etiologies
NEW14341,CHEMICAL,cocaine abuser,cocaine abusers
NEW14343,DISEASE,cocaine-abuse depressed alcoholic,cocaine-abusing depressed alcoholics
NEW14347,CHEMICAL,calcium-dependent ne release,calcium-dependent NE release
NEW14348,CHEMICAL,brain ne concentration,brain NE concentrations
NEW14350,CHEMICAL,ne regulation,NE regulation
NEW14351,CHEMICAL,specific quencher,specific quencher
NEW14353,CHEMICAL,generate hydroxyl radical,generated hydroxyl radical
NEW14352,CHEMICAL,us/chlorine system,US/chlorine system
NEW01958,BIOCHEMICAL,selective antagonist,selective antagonist
NEW14357,BIOCHEMICAL,blunted plasma growth hormone response,Blunted plasma growth hormone responses
NEW03828,CHEMICAL,plasma cortisol,plasma cortisol
NEW14361,MENTAL_HEALTH,paranoia trait,Paranoia traits
http://purl.obolibrary.org/obo/CHEBI_7799,CHEMICAL,oseltamivir phosphate,"Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (1:1)|(3R-(3alpha,4beta,5alpha))-Ethyl 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (1:1)|ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate phosphate|Tamiflu|Oseltamivir phosphate|oseltamivir phosphate"
NEW14368,CHEMICAL,crh neuron,CRH neurons
NEW14371,CHEMICAL,gaba concentration,GABA concentrations
NEW04225,CHEMICAL,glutamate level,glutamate levels
D000087623,DISEASE,Insular Cortex,"Gustatory Cortex, Primary|Brodmann Area 13|Brodmann's Area 15|Area 16, Brodmann's|Brodmanns Area 14|Area 15, Brodmann's|Brodmann's Area 16|Cortex, Visceral|Brodmanns Area 16|Area 16, Brodmann|Region, Insular|Visceral Cortex|Area 15, Brodmann|Brodmann's Area 14|Brodmann Area 14|Brodmanns Area 15|Insular Regions|Area 13, Brodmann|Cortex, Insular|Gyrus, Insular|Insula of Reil|Central Lobes|Insular Region|Brodmann Area 15|Brodmanns Area 43|Central Lobe|Visceral Cortices|Area 14, Brodmann's|Lobe, Central|Cortex, Primary Gustatory|Cortex, Opercular|Cortex, Gustatory|Brodmann's Area 13|Area 13, Brodmann's|Gustatory Cortex|Lobus Insularis|Area 43, Brodmann's|Area 43, Brodmann|Insular Cortices|Insular Gyrus|Brodmanns Area 13|Brodmann Area 43|Brodmann's Area 43|Brodmann Area 16|insula|Primary Gustatory Cortices|Primary Gustatory Cortex|Opercular Cortex|Area 14, Brodmann"
NEW14374,CHEMICAL,saohya,SaOhyA
NEW14375,NUTRITION,fingerle rainbow trout =,Fingerling rainbow trout =
NEW14380,CHEMICAL,morphine min,morphine min
NEW14382,NUTRITION,fatty acid level,fatty acid levels
NEW14383,NUTRITION,dietary fatty acid level,dietary fatty acid levels
C560532,DISEASE,"Omg protein, rat [Supplementary Concept]",GPI-Linked Proteins|Myelin Proteins|OMG
NEW14388,DISEASE,ibs-d therapeutic option,IBS-D therapeutic options
NEW14390,CHEMICAL,eluxadoline treatment,eluxadoline treatment
C574694,CHEMICAL,"CIC-DUX4 fusion protein, human [Supplementary Concept]","Oncogene Proteins, Fusion|DUX4"
D000083242,DISEASE,Ischemic Stroke,"Cryptogenic Ischemic Strokes|Embolism Stroke, Cryptogenic|Ischaemic Strokes|Cryptogenic Stroke|Cryptogenic Strokes|Stroke, Ischemic|Wake-up Stroke|Cryptogenic Embolism Stroke|Ischemic Strokes|Ischemic Stroke, Cryptogenic|Acute Ischemic Strokes|Stroke, Cryptogenic Embolism|Stroke, Wake-up|Ischemic stroke|Ischemic Stroke, Acute|Stroke, Acute Ischemic|Acute Ischemic Stroke|Stroke, Cryptogenic|Cryptogenic Ischemic Stroke|Wake-up Strokes|Stroke, Ischaemic|Stroke, Cryptogenic Ischemic|Ischaemic Stroke|Wake up Stroke|Cryptogenic Embolism Strokes"
NEW14391,BIOCHEMICAL,non-peptidic δ-opioid receptor agonist,non-peptidic δ-opioid receptor agonist
NEW14393,CHEMICAL,n-methyl-d -aspartate nmda glutamate receptor,N-methyl-D -aspartate NMDA glutamate receptor
NEW14395,CHEMICAL,nmda receptor site,NMDA receptor site
C535803,CHEMICAL,succinic semialdehyde dehydrogenase deficiency [Supplementary Concept],"Succinate-Semialdehyde Dehydrogenase/deficiency|Succinic semialdehyde dehydrogenase deficiency|Amino Acid Metabolism, Inborn Errors|Developmental Disabilities"
NEW14397,CHEMICAL,nes-wdr45(fl/y mouse,Nes-Wdr45(fl/Y mice
NEW14398,DISEASE,elevated apnea-hypopnea index,elevated apnea-hypopnea index
NEW14399,DISEASE,nocturnal hypoxemia,Nocturnal hypoxemia
NEW14400,DISEASE,narcotic pain management,Narcotic pain management
NEW00850,DISEASE,idiopathic parkinsonism,idiopathic parkinsonism
NEW14403,CHEMICAL,odd sum carbon number,odd summed carbon number
NEW14404,CHEMICAL,large-conductance k⁺ channel kca1.1,large-conductance K⁺ channel KCa1.1
NEW14406,BIOCHEMICAL,vdr agonist,VDR agonists
D053701,CHEMICAL,"Receptors, Interleukin-10","Interleukin-10 Receptor|Receptor, Interleukin-10|IL 10 Receptor|Receptors, Interleukin 10|Interleukin 10 Receptor|IL-10 Receptors|Interleukin 10 Receptors|Receptor, IL-10|Receptors, IL-10|IL-10 Receptor|Receptors, IL 10|interleukin-10|Interleukin-10 Receptors|Receptor, Interleukin 10"
NEW14408,MENTAL_HEALTH,stuttering severity,stuttering severity
NEW14411,CHEMICAL,acute perampanel overdose,acute perampanel overdose
NEW14412,CHEMICAL,perampanel overdose,perampanel overdose
D002698,CHEMICAL,Chloralose,Glucochloralose|Anhydroglucochloral|alpha-Chloralose|beta-Chloralose|alpha Chloralose|beta Chloralose|Alpha-chloralose|Glucochloral
NEW14414,DISEASE,hypoxia intoxication,Hypoxia intoxications
NEW09123,DISEASE,depressed subject,depressed subjects
NEW14418,DISEASE,depressed future attempter,depressed future attempters
NEW08470,CHEMICAL,cortisol response,cortisol response
NEW14419,CHEMICAL,garlic chive-derived vln,GC-VLNs|garlic chive-derived VLNs
NEW14422,DISEASE,chronic inflammation,chronic inflammation
C030514,CHEMICAL,hippuric acid [Supplementary Concept],hippuric acid|Hippurates
D019271,CHEMICAL,Hypoxanthine,Hypoxanthines (1981-1996)|hypoxanthine
D000083682,DISEASE,Opiate Overdose,"Opiate Overdoses|Overdose, Opioid|Opioid Overdose|Overdose, Opiate|Opioid Overdoses|opioid overdose"
NEW14424,BIOCHEMICAL,restricted kor agonist,restricted KOR agonists
NEW14425,CHEMICAL,combined gem,combined Gem
NEW14428,BIOCHEMICAL,non-specific fgfr inhibitor,non-specific FGFR inhibitors
C531958,CHEMICAL,lenvatinib [Supplementary Concept],Phenylurea Compounds|Quinolines|lenvatinib
C500007,CHEMICAL,4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one [Supplementary Concept],dovitinib|Quinolones|Benzimidazoles
D009582,CHEMICAL,Nitrofurantoin,"Furadoine|Furadantine|Furantoin|Furadonine|Nitrofurantoin|Furadantin|Macrodantin|Nitrofurantoin, Monohydrate|Nitrofurantoin Sodium Salt"
D052978,BIOCHEMICAL,Disk Diffusion Antimicrobial Tests,"Test, Epsilometer|Disk-Diffusion Method, Bauer-Kirby|Disk-Diffusion Method, Kirby-Bauer|Kirby Bauer Disk Diffusion Method|Kirby-Bauer Disk-Diffusion Method|Bauer Kirby Disk Diffusion Method|Bauer-Kirby Disk-Diffusion Method|Tests, Epsilometer|Etests|Etest|Epsilometer Test|antimicrobial|Epsilometer Tests"
D009547,CHEMICAL,Nifurtimox,Bayer 2502|nifurtimox|Lampit
NEW14430,CHEMICAL,nitrofurantoin analog,nitrofurantoin analog
D014354,DISEASE,"Trypanosomiasis, Bovine","Bovine Trypanosomiases|Bovine Trypanosomiasis|Trypanosomiases, Bovine|Trypanosomiasis"
D024361,CHEMICAL,"Amino Acids, Basic","Basic Amino Acids|Basic Amino Acid|amino acids|Amino Acid, Basic"
NEW14433,BIOCHEMICAL,antimicrobial peptide hepcidin,antimicrobial peptide hepcidin
D002762,BIOCHEMICAL,Cholecalciferol,"Vitamin D 3|cholecalciferol|(3 beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol|Vitamin D3|Cholecalciferols|Calciol"
NEW14435,DISEASE,high weight gain,highest weight gain
NEW14438,NUTRITION,total fish intake,Total fish intake
NEW14439,NUTRITION,black carp,black carp
D002347,CHEMICAL,Carps,"Grass Carp|Cyprinus|silver carp|Carassius carassius|Crucian Carp|Carp, Silver|Carps, Grass|Hypophthalmichthys molitrix|Carps, Crucian|Koi Carp|Grass Carps|Carps, Silver|Carp, Grass|Silver Carps|Carp, Crucian|Carp|Cyprinus carpio|Ctenopharyngodon idellus|Carp, Koi|Silver Carp|Crucian Carps"
NEW11555,NUTRITION,freshwater fish,freshwater fish
NEW14441,NUTRITION,fish intake,fish intake
NEW14442,CHEMICAL,antidepressant treatment,Antidepressant treatment
C031140,CHEMICAL,antheraxanthin [Supplementary Concept],Xanthophylls|antheraxanthin
http://purl.obolibrary.org/obo/CHEBI_27547,CHEMICAL,zeaxanthin,"Zeaxanthin|all-trans-beta-carotene-3,3'-diol|all-trans-zeaxanthin|(3R,3'R)-beta,beta-carotene-3,3'-diol|(3R,3'R)-dihydroxy-beta,beta-carotene|loroxanthin|anchovyxanthin|beta,beta-carotene-3,3'-diol"
D011700,CHEMICAL,Putrescine,"1,4-Diaminobutane|Tetramethylenediamine|putrescine|1,4 Butanediamine|1,4 Diaminobutane|1,4-Butanediamine"
C023290,BIOCHEMICAL,violaxanthin de-epoxidase [Supplementary Concept],violaxanthin|Oxidoreductases
D013095,CHEMICAL,Spermidine,Amines (1966-1970)|spermidine
D013097,CHEMICAL,Spermine Synthase,"Synthetase, Spermine|Spermine Synthetase|Spermidine Aminopropyltransferase|spermine|Aminopropyltransferase, Spermidine|Synthase, Spermine"
NEW14446,NUTRITION,aged brown bear,aged brown bear
NEW14447,NUTRITION,aged polar bear,aged polar bear
NEW14449,CHEMICAL,calcium (ca2+)-permeable ampa receptor,Calcium (Ca2+)-permeable AMPA receptors
NEW14450,CHEMICAL,nmda receptor-independent seizure,NMDA receptor-independent seizures
NEW13174,DISEASE,synapse loss,synapse loss
NEW14452,DISEASE,behavioural impairment,behavioural impairments
D018382,DISEASE,Thyroid Hormone Resistance Syndrome,"Generalized Resistance to Thyroid Hormone|resistance to thyroid hormone|Syndrome, Refetoff|Resistance, Thyroid Hormone|Hormone Resistance, Thyroid|Refetoff-DeWind-DeGroot Syndrome|Refetoff Syndrome|Thyroid Hormone Resistance|Generalized Thyroid Hormone Resistance|RTH|Refetoff DeWind DeGroot Syndrome|Syndrome, Refetoff-DeWind-DeGroot"
D009266,CHEMICAL,Nalbuphine,Nalbuphine Hydrochloride|Nalbuphine|EN 2234A|EN-2234A|EN2234A|Nubain|Nalbuphine Serb
NEW14456,CHEMICAL,ingest fk,ingested FK
D020109,CHEMICAL,Devazepide,"L364,718|MK-329|MK329|L 364,718|L-364,718|devazepide|MK 329"
D002078,CHEMICAL,Butoxamine,"Butoxamine Hydrochloride|Hydrochloride, Butoxamine|Butoxamine|Butaxamine"
D058668,BIOCHEMICAL,Adrenergic alpha-1 Receptor Antagonists,"alpha1-Adrenoceptor Blocker|Adrenergic alpha-1 Antagonists|alpha 1 Adrenergic Blocking Agents|α1-adrenergic antagonists|Adrenergic alpha1 Antagonists|Adrenergic alpha 1 Antagonists|alpha1 Adrenoceptor Blocker|alpha-1 Antagonists, Adrenergic|alpha1 Adrenergic Antagonists|Adrenergic alpha-1 Receptor Blockers|Adrenergic alpha1-Antagonists|alpha-1 Adrenergic Blocking Agents|alpha1-Adrenergic Antagonists|Antagonists, alpha1-Adrenergic|Adrenergic alpha 1 Receptor Blockers|Adrenergic alpha 1 Receptor Antagonists|alpha1-Antagonists, Adrenergic"
NEW14458,DISEASE,intermittent hypercapnia,intermittent hypercapnia
NEW14460,CHEMICAL,5-ht receptor activation,5-HT receptor activation
NEW14464,CHEMICAL,non-ache-inhibiting dose,non-AChE-inhibiting dose
NEW14466,BIOCHEMICAL,adequate vitamin d status,Adequate vitamin D status
NEW14468,BIOCHEMICAL,inadequate vitamin d status,inadequate vitamin D status
NEW14469,BIOCHEMICAL,excess dietary vitamin a due,excess dietary vitamin A due
NEW14471,DISEASE,acne treatment,acne treatment
C535670,CHEMICAL,Accutane embryopathy [Supplementary Concept],"Accutane|Isotretinoin/adverse effects|Abnormalities, Drug-Induced"
NEW14472,CHEMICAL,accutane use,Accutane use
NEW05995,MENTAL_HEALTH,clinical depression,clinical depression
NEW14473,CHEMICAL,gsh amount,GSH amount
NEW14475,DISEASE,hepatic cat,hepatic CAT
NEW14476,CHEMICAL,csf alpha-synuclein assay,CSF Alpha-synuclein assay
NEW14478,DISEASE,second important psychiatric use,second important psychiatric use
http://purl.obolibrary.org/obo/DOID_12700,DISEASE,hyperprolactinemia,Pregnancy-related A-G syndrome|hyperprolactinaemia|Chiari-Frommel syndrome|hyperestrogenism
NEW14482,BIOCHEMICAL,synthetic auxin resistance,synthetic auxin resistance
NEW14483,CHEMICAL,resistance-endowing iaa16 mutation,resistance-endowing IAA16 mutation
NEW14485,BIOCHEMICAL,hormone system,hormone systems
NEW14486,DISEASE,p. alata P. foetida,P. alata P. foetida
C011991,BIOCHEMICAL,phytoalexins [Supplementary Concept],phytoalexins|Sesquiterpenes
C102405,CHEMICAL,camalexin [Supplementary Concept],Thiazoles|Camalexin|Indoles
NEW14489,BIOCHEMICAL,phytoalexin deficient4,PHYTOALEXIN DEFICIENT4
NEW14490,CHEMICAL,loh1 inhibitor fumonisin b1,LOH1 inhibitor fumonisin B1
NEW14493,BIOCHEMICAL,agonist damgo microg,agonist DAMGO microg
NEW14494,CHEMICAL,n-iminoethyl-l-ornithine,N-Iminoethyl-L-ornithine
D008751,CHEMICAL,Methylene Blue,"Basic Blue 9|Blue N, Methylene|Chromosmon|Methylthionine Chloride|Blue, Methylene|Methylene Blue N|Urolene Blue|Methylthioninium Chloride|Swiss Blue|Blue, Urolene|Blue 9, Basic|methylene blue|Blue, Swiss"
NEW13061,CHEMICAL,no synthase inhibitor,NO synthase inhibitor
NEW14495,CHEMICAL,cgmp activation,cGMP activation
NEW14497,CHEMICAL,bh4 defect,BH4 defects
NEW14498,DISEASE,neuropsychiatric comorbiditie,neuropsychiatric comorbidities
NEW14500,DISEASE,cinnamomi cassiae,Cinnamomi cassiae
D002292,DISEASE,"Carcinoma, Renal Cell","Tumor, Grawitz|Carcinomas, Collecting Duct|Collecting Duct Carcinoma (Kidney)|Collecting Duct Carcinomas (Kidney)|Renal Cell Cancer|Cancer, Renal Cell|Papillary Renal Cell Carcinoma|Collecting Duct Carcinoma|Clear Cell Renal Carcinoma|Renal Carcinoma|Nephroid Carcinoma|Adenocarcinoma Of Kidneys|Carcinoma, Hypernephroid|Clear Cell Renal Cell Carcinoma|Carcinoma, Collecting Duct (Kidney)|Adenocarcinomas, Renal Cell|Renal Collecting Duct Carcinoma|Renal Cell Cancers|Renal Cell Carcinoma, Papillary|Clear cell renal cell carcinoma|Carcinomas, Renal Cell|Chromophil Renal Cell Carcinoma|Adenocarcinoma Of Kidney|Hypernephroid Carcinomas|Kidney, Adenocarcinoma Of|Hypernephroma|Grawitz Tumor|Renal Cell Carcinoma|Carcinoma, Nephroid|Carcinoma, Collecting Duct|Adenocarcinoma, Renal|Renal Adenocarcinoma|Hypernephromas|Collecting Duct Carcinomas|Collecting Duct Carcinoma of the Kidney|Hypernephroid Carcinoma|Renal Carcinomas|Nephroid Carcinomas|Renal Cell Adenocarcinoma|Sarcomatoid Renal Cell Carcinoma|Carcinomas, Collecting Duct (Kidney)|Chromophobe Renal Cell Carcinoma|Renal Cell Carcinomas|Renal Adenocarcinomas|Adenocarcinoma, Renal Cell|Renal Cell Adenocarcinomas|Carcinoma, Renal"
NEW14501,DISEASE,diet-induced obesity,Diet-induced obesity
NEW14502,BIOCHEMICAL,vitamin d receptor agonist doxercalciferol,vitamin D receptor agonist doxercalciferol
NEW14503,BIOCHEMICAL,vdr agonist,VDR agonist
NEW14506,DISEASE,thyroid disorder,Thyroid disorders
NEW14509,BIOCHEMICAL,unopposed estrogen,unopposed estrogens
NEW14510,BIOCHEMICAL,add progestogen,Added progestogen
http://purl.obolibrary.org/obo/DOID_2870,DISEASE,endometrial adenocarcinoma,adenocarcinoma of uterus|adenocarcinoma of endometrium|endometrial endometrioid adenocarcinoma|endometrioid carcinoma of Endometrium|endometrioid adenomas and carcinomas|endometrioid adenoma or carcinoma|endometrial adenoacanthoma|endometrial endometrioid adenocarcinoma with squamous differentiation|adenocarcinoma of the Endometrium|endometrial adenocarcinoma
D000073496,DISEASE,Frailty,Debility|Debilities|Frailness|frailty syndrome|Frailties|Frailty Syndrome
C527126,CHEMICAL,green tea extract polyphenone E [Supplementary Concept],Catechin/analogs  and  derivatives|green tea
http://purl.obolibrary.org/obo/CHEBI_36044,BIOCHEMICAL,antiviral drug,chemical-synthesized antiviral drugs|antiviral drugs|anti-virus drug|anti-viral drug
NEW14514,BIOCHEMICAL,effective antiviral drug,effective antiviral drugs
D047628,CHEMICAL,Estrogen Receptor alpha,"Estrogen Receptors alpha|alpha, Estradiol Receptor|estrogen receptor-α|Receptor alpha, Estradiol|Receptor alpha, Estrogen|Estrogen Receptor 1|ERα|ERalpha|Estradiol Receptor alpha"
NEW14516,MENTAL_HEALTH,downward orientation,downward orientation
D051479,DISEASE,Plant Infertility,"Sterility, Reproductive, Plants|Reproductive Sterility in Plants|infertility|Infertility, Plant|Reproductive Sterility, Plants"
NEW14519,CHEMICAL,glutamate excitatory amino acid,glutamate excitatory amino acids
C104517,CHEMICAL,Gluk1 kainate receptor [Supplementary Concept],"Receptors, Kainic Acid|Kainate"
NEW14523,CHEMICAL,calcium radical,calcium radicals
NEW14525,CHEMICAL,Allium fistulosum,Allium fistulosum
NEW14529,CHEMICAL,glutamate neural transmission,glutamate neural transmission
NEW14532,CHEMICAL,baicalensis Georgi,baicalensis Georgi
NEW14533,CHEMICAL,catecholamine deficiency hypothesis,catecholamine deficiency hypothesis
NEW14534,DISEASE,non-alcoholic wernicke Encephalopathy,Non-alcoholic Wernicke Encephalopathy
NEW14536,CHEMICAL,whole body cortisol,Whole body cortisol
NEW14538,NUTRITION,whitefish embryo,whitefish embryos
NEW14539,BIOCHEMICAL,t-type calcium channel antagonist mk-8998,T-type calcium channel antagonist MK-8998
http://purl.obolibrary.org/obo/DOID_0040088,DISEASE,autoimmune uveitis,autoimmune uveitis
D010320,CHEMICAL,Parvalbumins,Parvalbumin|parvalbumin|Parvalbumin B
NEW14541,CHEMICAL,phthalate concentration,phthalate concentrations
NEW14542,CHEMICAL,short-term phthalate exposure,short-term phthalate exposure
NEW14545,CHEMICAL,ng-nitro-l-arginine-methylester,NG-nitro-L-arginine-methylester
NEW14546,CHEMICAL,fortify juice,fortified juice
NEW14548,CHEMICAL,riboflavin-fortified cloudy apple juice,riboflavin-fortified cloudy apple juice
NEW14550,MENTAL_HEALTH,cis fatigue score,CIS fatigue score
NEW14552,MENTAL_HEALTH,subjective fatigue subscale,subjective fatigue subscale
NEW14553,BIOCHEMICAL,vitamin b2 fortified-cloudy apple juice,vitamin B2 fortified-cloudy apple juice
NEW14554,CHEMICAL,serum calcium level,serum calcium level
NEW14556,CHEMICAL,triiodothyronine level,triiodothyronine levels
NEW14557,BIOCHEMICAL,circulate maternal thyroid hormone,circulating maternal thyroid hormones
NEW14559,BIOCHEMICAL,subtle thyroid hormone insufficiency,subtle thyroid hormone insufficiency
NEW14560,DISEASE,significant liver disease,significant liver disease
NEW14562,CHEMICAL,nitrogen to ammonia,nitrogen to ammonia|NH3
NEW14564,MENTAL_HEALTH,photocatalytic fixation,Photocatalytic fixation
NEW14565,CHEMICAL,oxygen vacancie,oxygen vacancies
NEW14566,BIOCHEMICAL,low endogenous androgen production,low endogenous androgen production
C526145,CHEMICAL,Phellinus linteus extract [Supplementary Concept],Phellinus linteus|Phellinus|Plant Extracts
NEW02217,CHEMICAL,vpa monotherapy,VPA monotherapy
NEW14568,CHEMICAL,pethidine addiction,pethidine addiction
NEW14569,MENTAL_HEALTH,abstinent syndrome,abstinent syndromes
NEW14573,CHEMICAL,propoli ethanolic extract,propolis ethanolic extract|PEE
NEW14574,BIOCHEMICAL,propoli extract,propolis extract
NEW06734,CHEMICAL,mda level,MDA levels
NEW14577,CHEMICAL,no level,NO levels
NEW14578,CHEMICAL,amino-acid sequence identity,amino-acid sequence identity
C082925,CHEMICAL,retinoic acid receptor beta [Supplementary Concept],"Receptors, Retinoic Acid|retinoic acid receptor beta"
NEW14580,CHEMICAL,rarβ-/- spmsns,Rarβ-/- spMSNs
NEW14584,CHEMICAL,dntp metabolism,dNTP metabolism
D054306,CHEMICAL,Dideoxynucleotides,"Dideoxynucleotide Triphosphates|ddNTPs|Triphosphates, Dideoxynucleotide|dNTPs|triphosphates"
NEW14586,CHEMICAL,charge anion,charged anions
NEW14589,DISEASE,mineral disorder,mineral disorders
NEW14592,BIOCHEMICAL,unusual filler usage,unusual filler usage
NEW14593,CHEMICAL,salt loading,salt loading
C080234,DISEASE,ATN 10 [Supplementary Concept],ATN|Deuteroporphyrins
NEW14594,DISEASE,cerebrovascular dysfunction,cerebrovascular dysfunction
NEW14595,DISEASE,abeta(25 35)-induced amnesic mouse,Abeta(25 35)-induced amnesic mice
D047311,CHEMICAL,Luteolin,"Luteoline|luteolin|3',4',5,7-Tetrahydroxy-Flavone|3',4',5,7-Tetrahydroxyflavone"
NEW14597,DISEASE,depressive polarity,Depressive polarity
NEW14598,CHEMICAL,AimsThis study,AimsThis study
NEW14599,CHEMICAL,characterise scl32 gene,characterised SCL32 gene
NEW14601,BIOCHEMICAL,antihistamine clemastine,antihistamine clemastine
NEW14606,BIOCHEMICAL,first-generation antihistamine usage,first-generation antihistamine usage
D061565,NUTRITION,Cycloaddition Reaction,"Technique, Cycloaddition Reaction|Reaction, Cycloaddition|Cycloaddition Reactions|Angelica sinensis|Reaction Technique, Cycloaddition|Diels|Reaction Techniques, Cycloaddition|Cycloaddition Reaction Technique|Techniques, Cycloaddition Reaction|Reactions, Cycloaddition|Cycloaddition Reaction Techniques|Cycloaddition|Diels Alder Reaction|Diels-Alder Reaction|Reaction, Diels-Alder"
NEW14609,CHEMICAL,graveolen L.,graveolens L.
NEW14610,CHEMICAL,Zingiber officinale Roscoe,Zingiber officinale Roscoe
NEW14611,DISEASE,poisoning case,poisoning case
C536742,DISEASE,Woodhouse Sakati syndrome [Supplementary Concept],"Alopecia|Woodhouse-Sakati syndrome|Diabetes Mellitus|Intellectual Disability|Hypogonadism|Arrhythmias, Cardiac|Basal Ganglia Diseases"
http://purl.obolibrary.org/obo/CHEBI_38637,CHEMICAL,tyrosine kinase inhibitor,TKI inhibitor|tyrphostins|tyrphostin|tyrosine kinase inhibitors|protein tyrosine kinase inhibitors|TKI inhibitors|protein tyrosine kinase inhibitor
NEW14618,CHEMICAL,inhibitor vandetanib,inhibitors vandetanib
C558660,CHEMICAL,cabozantinib [Supplementary Concept],Pyridines|cabozantinib|Anilides
NEW14619,CHEMICAL,mtc patient,MTC patients
NEW14622,CHEMICAL,type 5-ht3 serotonin receptor,type 5-HT3 serotonin receptors
http://purl.obolibrary.org/obo/CHEBI_7916,BIOCHEMICAL,pantothenic acid,"Synthetic folic acid|N-(2,4-dihydroxy-3,3-dimethylbutanoyl)-beta-alanine|Pantothenic acid|3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanoic acid"
NEW14626,CHEMICAL,neutral methyl stearate,neutral methyl stearate
NEW14627,NUTRITION,fatty acid ester ion,fatty acid ester ions
NEW14629,MENTAL_HEALTH,main dissociation channel,main dissociation channels
NEW14630,CHEMICAL,methyl stearate molecule,methyl stearate molecule
D027961,CHEMICAL,Potassium-Hydrogen Antiporters,"Potassium Hydrogen Exchanger|Antiporter, Potassium-Hydrogen|Potassium-Hydrogen Exchanger|Potassium Hydrogen Antiporters|K(+)-H(+)-Exchanger|Potassium Hydrogen Antiporter|Antiporters, Potassium-Hydrogen|H|hydrogen|Potassium-Hydrogen Antiporter"
D008672,CHEMICAL,"Metals, Alkali","1 Element, Group|Metal, Alkali|Group 1 Element|Alkali Metals|Group 1 Elements|alkali metal|Element, Group 1|Alkali Metal|Elements, Group 1"
NEW14633,MENTAL_HEALTH,limb apraxia,Limb apraxia
C029878,CHEMICAL,"hlb protein, Staphylococcus aureus [Supplementary Concept]",Bacterial Toxins|Hemolysin Proteins|Sphingomyelin Phosphodiesterase|HLB
NEW14637,NUTRITION,plant anthocyanin synthesis,plant anthocyanin synthesis
NEW08743,MENTAL_HEALTH,stress resistance,stress resistance
C506691,CHEMICAL,"FoxO1 protein, Xenopus [Supplementary Concept]",Forkhead Box Protein O1|Xenopus Proteins|• FOXO1
D064209,CHEMICAL,Phytochemicals,"Chemical, Plant-Derived|Plant Biologically Active Compound|Compounds, Plant Bioactive|Plant Derived Chemicals|Plant-Derived Compound|Plant Bioactive Compounds|Plant Derived Compounds|Compounds, Plant-Derived|• Phytochemicals|Dietary Phytochemical|Biologically Active Coumpounds, Plant|Plant Bioactive Compound|Plant Bioactive Coumpounds|Bioactive Coumpounds, Plant|Plant-Derived Compounds|Phytochemical|Plant-Derived Chemical|Phytonutrients|Compound, Plant-Derived|Chemicals, Plant-Derived|Plant Derived Chemical|Bioactive Compounds, Plant|Compound, Plant Bioactive|Bioactive Compound, Plant|Dietary Phytochemicals|Phytochemicals, Dietary|Plant Biologically Active Compounds|Phytochemical, Dietary|Coumpounds, Plant Bioactive|Phytonutrient|Plant-Derived Chemicals|Plant Derived Compound"
C012552,CHEMICAL,alpha-tocopherol phosphate [Supplementary Concept],α-tocopheryl phosphate|alpha-Tocopherol/analogs  and  derivatives
NEW14640,CHEMICAL,myocardial nad level,myocardial NAD levels
D005047,CHEMICAL,Etoposide,"Vépéside Sandoz|Riboposid|Toposar|Eto-GRY|Vepesid|Etoposide, alpha-D-Glucopyranosyl Isomer|Eto GRY|etoposide|VP 16213|Celltop|Lastet|Etopos|Etoposide Teva|NSC-141540|Etomedac|Eposin|Demethyl Epipodophyllotoxin Ethylidine Glucoside|Vépéside-Sandoz|Etoposide, (5S)-Isomer|Onkoposid|Etoposido Ferrer Farma|Exitop|VP 16|Etoposide, alpha D Glucopyranosyl Isomer|Etoposide, (5a alpha,9 alpha)-Isomer|Teva, Etoposide|VP-16|Eposide|Etoposide, (5a alpha)-Isomer|alpha-D-Glucopyranosyl Isomer Etoposide|NSC141540|VP16|VP 16-213|Etoposide Pierre Fabre|VP 16 213|NSC 141540"
NEW14641,CHEMICAL,p-tau181,p-tau181
D002991,CHEMICAL,Clofazimine,"B 663|N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-2-phenazinamine|G30,320|clofazimine|B-663|Lamprene|G 30,320|G-30,320|B663"
NEW14645,CHEMICAL,clofazimine crystal,Clofazimine crystals
NEW14647,CHEMICAL,phloroglucinol treatment,phloroglucinol treatment
NEW14650,CHEMICAL,corticosterone secretion,corticosterone secretion
NEW14651,CHEMICAL,egfr-directed inhibitor cetuximab,EGFR-directed inhibitor cetuximab
NEW14652,CHEMICAL,cetuximab sensitivity,cetuximab sensitivity
D000077195,DISEASE,Squamous Cell Carcinoma of Head and Neck,"OSCC|Oral Squamous Cell Carcinoma|Carcinoma, Squamous Cell of Head and Neck|Oral Squamous Cell Carcinomas|Squamous Cell Carcinoma of the Head and Neck|Squamous Cell Carcinoma of the Nasal Cavity|Head And Neck Squamous Cell Carcinomas|Oral Tongue Squamous Cell Carcinoma|Head and Neck Squamous Cell Carcinoma|Oral Cavity Squamous Cell Carcinoma|HNSCC|Squamous Cell Carcinoma, Head And Neck|Squamous Cell Carcinoma of the Mouth|Hypopharyngeal Squamous Cell Carcinoma|oral squamous cell carcinoma|Laryngeal Squamous Cell Carcinoma|Squamous Cell Carcinoma of Larynx|Oropharyngeal Squamous Cell Carcinoma|Squamous Cell Carcinoma of the Larynx"
NEW14656,CHEMICAL,human mesencephalic da neuron,human mesencephalic DA neurons
NEW14660,CHEMICAL,persistent methotrexate concentration,persistent methotrexate concentrations
NEW14661,NUTRITION,associate folate deficiency,associated folate deficiency
NEW14662,BIOCHEMICAL,drug donepezil,drug donepezil
http://purl.obolibrary.org/obo/CHEBI_59059,CHEMICAL,methyl isocyanate,methyl mercaptan
C033479,CHEMICAL,sodium sulfide [Supplementary Concept],Sulfides|sodium sulfide
NEW14664,CHEMICAL,pollutant hydrogen sulfide,pollutants hydrogen sulfides
NEW14666,BIOCHEMICAL,selective ppar-δ agonist,selective PPAR-δ agonist
NEW14669,DISEASE,breast cancer cell line,breast cancer cell lines
NEW14670,MENTAL_HEALTH,treatment refractory depression,treatment refractory depression
NEW14672,CHEMICAL,ketamine treatment,Ketamine treatment
C522201,CHEMICAL,remimazolam [Supplementary Concept],remimazolam|Benzodiazepines
NEW14674,CHEMICAL,voltage-gated potassium channel vgkc complex,voltage-gated potassium channel VGKC complex
NEW14675,DISEASE,gad autoantibody,GAD autoantibodies
NEW14678,CHEMICAL,argyrophilic grain disease,Argyrophilic grain disease|AGD
NEW14682,DISEASE,psp pathology,PSP pathologies
NEW14683,CHEMICAL,coexist agd,coexisting AGD
NEW14684,CHEMICAL,soluble egcg/hst5 complex,Soluble EGCG/Hst5 complexes
NEW14685,CHEMICAL,antiarrhythmic amiodarone,antiarrhythmic amiodarone
NEW14687,CHEMICAL,metabolite desethylamiodarone,metabolite desethylamiodarone
NEW14688,CHEMICAL,metabolite desethylamiodarone,metabolite desethylamiodarone|Des
D000066553,DISEASE,Problem Behavior,"Behavior, Problem|Behavioral Problem|Psychology Dysfunctional Behaviors|Disruptive Behaviors|Problem Behaviors|Dysfunctional Behavior, Psychology|Behavior, Psychology Dysfunctional|Behaviors, Disruptive|Behavior, Disruptive|Problem, Behavioral|Behaviors, Psychology Dysfunctional|Behavioral Problems|Problems, Behavioral|Behaviors, Problem|Disruptive Behavior|Psychology Dysfunctional Behavior|Dysfunctional Behaviors, Psychology|disruptive behaviors"
NEW14692,CHEMICAL,acute cocaine toxicity,acute cocaine toxicity
NEW14694,CHEMICAL,uroselective alpha1-adrenoceptor antagonist sanofi-aventis,uroselective alpha1-adrenoceptor antagonist Sanofi-Aventis
NEW14697,CHEMICAL,high histamine concentration,high histamine concentration
NEW14698,CHEMICAL,brain t-meha level,brain t-MeHA levels
NEW14148,CHEMICAL,antidepressant monotherapy,antidepressant monotherapy
NEW04672,CHEMICAL,antidepressant response,antidepressant responses
NEW14700,CHEMICAL,exogenous T1AM,exogenous T1AM
NEW14701,CHEMICAL,serotonin (5-ht)(1a)-receptor ligand,serotonin (5-HT)(1A)-receptor ligands
NEW14702,CHEMICAL,l-acetyl-carnitine,L-acetyl-carnitine|LAC
NEW14704,CHEMICAL,cadmium resistance,cadmium resistance
NEW14705,BIOCHEMICAL,diverse antiviral,diverse antivirals
C088115,CHEMICAL,anacardic acid [Supplementary Concept],anacardic acid|Anacardic Acids
NEW05970,DISEASE,diabetic group,diabetic group
NEW06428,CHEMICAL,triglyceride level,triglyceride levels
D001656,DISEASE,Biliary Atresia,"Biliary Atresia, Extrahepatic|Atresia, Biliary|biliary atresia|Intrahepatic Biliary Atresia|Atresia, Intrahepatic Biliary|Idiopathic Extrahepatic Biliary Atresia|Biliary Atresia, Intrahepatic|Atresia, Extrahepatic Biliary|Familial Extrahepatic Biliary Atresia|Extrahepatic Biliary Atresia"
D000090124,DISEASE,Intestinal Failure,"intestinal failure|Failure, Intestinal"
NEW14709,BIOCHEMICAL,sex hormone imbalance,sex hormone imbalances
NEW03853,DISEASE,infectious agent,infectious agents
NEW14714,DISEASE,abnormal aggregation,Abnormal aggregation
NEW14715,DISEASE,caspase mediated cell death,caspase mediated cell death
NEW14718,CHEMICAL,panicogenic agent cholecystokinin-tetrapeptide,panicogenic agent cholecystokinin-tetrapeptide
NEW14719,CHEMICAL,acylcarnitine level,acylcarnitine levels
NEW14720,CHEMICAL,oral l-carnitine,oral L-carnitine
NEW14721,BIOCHEMICAL,aforementioned toxin,aforementioned toxins
D000078304,CHEMICAL,Tigecycline,GAR-936|tigecycline|GAR936|GAR 936|Tygacil|9-(tert-Butylglycylamido)minocycline|TBG-MINO
NEW09486,CHEMICAL,testosterone therapy,testosterone therapy
NEW14725,CHEMICAL,testosterone therapy,Testosterone therapy
NEW14727,CHEMICAL,serotonin na reuptake,serotonin NA reuptake
NEW14728,DISEASE,stress urinary incontinence,SUI|stress urinary incontinence
NEW14730,CHEMICAL,5-ht na reuptake inhibitor snri duloxetine,5-HT NA reuptake inhibitor SNRI duloxetine
D000688,CHEMICAL,Amylose,amylose
D024941,NUTRITION,Starch Phosphorylase,"Starch Phosphorylase b|Starch Phosphorylase a|Phosphorylase a, Starch|Phosphorylase b, Starch|Amylophosphorylase|Phosphorylase, Starch|starch"
NEW14733,BIOCHEMICAL,specific sialidase inhibitor,Specific sialidase inhibitors
D000086382,CHEMICAL,COVID-19,"COVID-19 Pandemic|Coronavirus Disease 19|2019-nCoV Disease|Disease, 2019-nCoV|Pandemic, COVID-19|Infection, 2019-nCoV|COVID-19 Virus Diseases|COVID-19 virus|Infection, SARS-CoV-2|COVID 19|2019-nCoV Diseases|2019 Novel Coronavirus Infection|COVID-19 Virus Infection|Virus Disease, COVID-19|COVID19|Coronavirus Disease-19|Coronavirus Disease 2019|COVID 19 Virus Disease|COVID-19 Virus Infections|SARS-CoV-2 Infection|Virus Infection, COVID-19|COVID 19 Pandemic|Severe Acute Respiratory Syndrome Coronavirus 2 Infection|2019 nCoV Disease|Disease 2019, Coronavirus|COVID-19 Virus Disease|2019-nCoV Infection|SARS Coronavirus 2 Infection|Disease, COVID-19 Virus|2019 nCoV Infection|SARS-CoV-2 Infections|2019 Novel Coronavirus Disease|2019-nCoV Infections|COVID 19 Virus Infection|SARS CoV 2 Infection|COVID-19 Pandemics|Infection, COVID-19 Virus"
NEW14736,CHEMICAL,l-alphahydrazinomethyldopa,MK-486|L-alphahydrazinomethyldopa
NEW14737,CHEMICAL,l-dopa effect,L-dopa effect
NEW14738,CHEMICAL,plasma dopa level,Plasma dopa levels
NEW14740,NUTRITION,chronic lithium therapy,chronic lithium therapy
NEW14745,DISEASE,avoidant personality trait,Avoidant personality traits
C000711527,DISEASE,hikikomori [Supplementary Concept],"hikikomori|Shame|Phobia, Social"
NEW14748,CHEMICAL,% ethanol extract,% ethanol extract
NEW14753,CHEMICAL,interleukin-1β expression,interleukin-1β expression
NEW14756,BIOCHEMICAL,drug modafinil,drug modafinil
NEW14758,CHEMICAL,perturb glutamate,perturbed glutamate
NEW02698,DISEASE,neurological disease,neurological diseases
NEW14760,MENTAL_HEALTH,resistance level,resistance levels
NEW14761,DISEASE,inflammatory lesion,inflammatory lesions
D019159,CHEMICAL,Nonheme Iron Proteins,"Iron Proteins, Nonheme|heme iron|Iron Proteins, Non-Heme|Iron Proteins, Non Heme|Proteins, Non-Heme Iron|Non-Heme Iron Proteins|Non Heme Iron Proteins|Proteins, Nonheme Iron"
NEW14764,CHEMICAL,amino acid homocysteine,amino acid homocysteine
NEW14766,CHEMICAL,inhibitor rivaroxaban,inhibitor rivaroxaban
NEW14768,CHEMICAL,sex-microbiota-brain interaction,sex-microbiota-brain interactions
NEW14769,DISEASE,s. acmella,S. acmella
NEW14770,CHEMICAL,selective group i mglur antagonist (s)4-carboxyphenylglycine,4-CPG|selective group I mGluR antagonist (S)4-carboxyphenylglycine
C117595,CHEMICAL,methyl-CpG DNA demethylase [Supplementary Concept],"Oxidoreductases, O-Demethylating|MCPG"
C561247,CHEMICAL,"5alpha,10beta,13beta-triacetoxy-2 alpha,7beta-dihydroxy-2(3-20) abeotaxa-4(20),11-dien-9-one [Supplementary Concept]",tADA|Taxoids
NEW14773,MENTAL_HEALTH,suicide inhibitor alpha-difluoromethyl-lysine,suicide inhibitor alpha-difluoromethyl-lysine
D029681,DISEASE,Arabidopsis Proteins,"Thale Cress Proteins|thaliana Proteins, Arabidopsis|Arabidopsis thaliana Proteins|Proteins, Arabidopsis thaliana|Arabidopsis"
NEW14775,BIOCHEMICAL,auxin glycosyltransferase ugt84a2,auxin glycosyltransferase UGT84A2
NEW14777,CHEMICAL,synthetic benzodiazepine,Synthetic benzodiazepines
NEW14778,CHEMICAL,bac-containing eye drop,BAC-containing eye drops
C532038,CHEMICAL,10-(6'-plastoquinonyl)decyltriphenylphosphonium [Supplementary Concept],Plastoquinone/analogs  and  derivatives|SkQ1
NEW14781,CHEMICAL,second-generation antidepressant,second-generation antidepressants
NEW10982,DISEASE,elevated triiodothyronine,T3|elevated triiodothyronine
NEW14783,DISEASE,tbev replication,TBEV replication
D053060,DISEASE,West Nile Virus Vaccines,WNV|Viral Vaccines (2000-2006)|West Nile virus
NEW14786,MENTAL_HEALTH,chronic ethanol abuse,Chronic ethanol abuse
NEW14788,CHEMICAL,green-synthesized ag np,green-synthesized Ag NPs
NEW14791,CHEMICAL,second-generation tetracycline,second-generation tetracycline
NEW14792,DISEASE,lupus b cell,Lupus B cells
NEW14793,BIOCHEMICAL,growth hormone secretagogue receptor type a,growth hormone secretagogue receptor type A
NEW14795,DISEASE,non-autoimmune hyperthyroidism,non-autoimmune hyperthyroidism
NEW14796,CHEMICAL,crh receptor 1,CRH receptor 1|CRHR1
http://purl.obolibrary.org/obo/MFOMD_0000168,MENTAL_HEALTH,repression,CRISPR-mediated repression
NEW14798,CHEMICAL,cortisol secretion,cortisol secretion
D007034,DISEASE,"Hypothalamus, Posterior","Commissure, Supramammillary|Posterior, Area Hypothalamica|Nucleus, Supramammillary|Hypothalamic Region, Posterior|Posteriors, Hypothalamus|Region, Mammillary|Region, Posterior Hypothalamic|Nucleus, Premammillary|Hypothalamica Posteriors, Area|Posterior Periventricular Nucleus|Hypothalamus Posteriors|Premammillary Nucleus|Posterior Hypothalamic Regions|Hypothalamica Posterior, Area|Hypothalamus Posterior|Hypothalamic Regions, Posterior|Regions, Mammillary|HYPO|Posterior Hypothalamic Region|Mammillary Region|Periventricular Nucleus, Posterior|Nucleus, Posterior Periventricular|Supramammillary Commissures|Commissures, Supramammillary|Supramammillary Commissure|Supramammillary Nucleus|Area Hypothalamica Posteriors|Posterior Hypothalamus|Posterior, Hypothalamus|Mammillary Regions|hypothalamus|Regions, Posterior Hypothalamic|Posteriors, Area Hypothalamica|Area Hypothalamica Posterior"
NEW14800,MENTAL_HEALTH,male hyperactivity,Male hyperactivity
NEW14801,CHEMICAL,comprehensive two-dimensional gas chromatography,comprehensive two-dimensional gas chromatography
C535466,DISEASE,Convulsions benign familial neonatal dominant form [Supplementary Concept],"Epilepsy, Benign Neonatal|neonatal seizures"
NEW14803,CHEMICAL,n-6/n-3 pufa,n-6/n-3 PUFA
C032257,CHEMICAL,methylnaltrexone [Supplementary Concept],Naltrexone/analogs  and  derivatives|Quaternary Ammonium Compounds|methylnaltrexone
NEW14805,DISEASE,crf signaling,CRF signaling
NEW14807,CHEMICAL,last morphine injection,last morphine injection
NEW14808,BIOCHEMICAL,gabaa agonist muscimol,GABAA agonist muscimol
NEW14809,CHEMICAL,gabab agonist baclofen bac,GABAB agonist baclofen BAC
NEW14812,DISEASE,pathologic aggression,pathologic aggression
NEW14814,CHEMICAL,pparγ thiazolidinedione tzd drug,PPARγ thiazolidinedione TZD drugs
C016299,CHEMICAL,chelerythrine [Supplementary Concept],Benzophenanthridines|chelerythrine
NEW14816,CHEMICAL,telmisartan treatment,Telmisartan treatment
D024508,BIOCHEMICAL,Tocotrienols,tocotrienols|Tocotrienol
NEW14819,BIOCHEMICAL,a2-adrenergic receptor agonist clonidine,a2-adrenergic receptor agonist clonidine
NEW07125,CHEMICAL,alcohol abuser,alcohol abusers
NEW14822,BIOCHEMICAL,drug effect,drug effect
NEW14824,CHEMICAL,aluminum balance,aluminum balance
NEW14827,BIOCHEMICAL,many antibacterial drug,Many antibacterial drugs
NEW14828,NUTRITION,BlackThorn Therapeutics,BlackThorn Therapeutics
NEW14831,CHEMICAL,preferred carbon source,preferred carbon sources
NEW14832,BIOCHEMICAL,amyloid beta abeta protein,Amyloid beta Abeta protein
http://purl.obolibrary.org/obo/SYMP_0000022,MENTAL_HEALTH,depression,42)-evoked depression
NEW14835,DISEASE,life-threatening invasive fungal infection,Life-threatening invasive fungal infections
NEW14836,CHEMICAL,mycobacterium tuberculosis h37rv genome,Mycobacterium tuberculosis H37Rv genome
D007654,CHEMICAL,Ketoconazole,"R41,400|ketoconazole|R-41400|R 41400|R41400|Nizoral"
NEW14837,CHEMICAL,novel nlr-like gene,LvNLRPL2|novel NLR-like gene
D004878,CHEMICAL,Ergotamine,"Gynergen|Lingraine|Tartrate, Ergotamine|Ergo Sanol|Ergotamine Tartrate (2:1)|Mono, Ergodryl|Ergotaminine|Ergo-Kranit|Ergostat|ergotamine|Ergotamine Tartrate|Ergodryl Mono|Ergomar|Ergo Kranit|Cornutamine"
NEW14839,CHEMICAL,pro-serotonin effect,pro-serotonin effect
D008784,CHEMICAL,Methysergide,"Methysergide Dimaleate|Dimethylergometrin|Désernil Sandoz|UML-491|Sansert|Deseril|Methylmethylergonovine|UML 491|Dimaleate, Methysergide|UML491|Methysergide Maleate|Désernil-Sandoz|methysergide|Maleate, Methysergide|Desril"
NEW14840,CHEMICAL,psbma-gelatin-mxene-glycerol pgmg organohydrogel,PSBMA-gelatin-MXene-glycerol PGMG organohydrogel
NEW14842,BIOCHEMICAL,monoaminergic stabilizer,monoaminergic stabilizer
NEW14844,CHEMICAL,d-trp6-pro9-n-ethylamide-lhrh,D-Trp6-Pro9-N-ethylamide-LHRH|LHRHA
D062550,CHEMICAL,NAV1.1 Voltage-Gated Sodium Channel,"Type 1 Voltage-Gated Sodium Channel|Nav1.1|NAV1.1 Voltage Gated Sodium Channel|Voltage Gated Sodium Channel Type 1|Type 1 Voltage Gated Sodium Channel|NAV1.1 alpha Subunit|Voltage-Gated Sodium Channel Type 1 alpha Subunit|alpha Subunit, NAV1.1|Sodium Channel, Voltage-Gated, Type I, alpha Protein|SCN1A Sodium Channel alpha Subunit|Voltage Gated Sodium Channel Type 1 Subunit alpha|Voltage-Gated Sodium Channel Type 1|Voltage Gated Sodium Channel Type 1 alpha Subunit|Voltage-Gated Sodium Channel Type 1 Subunit alpha"
NEW14847,CHEMICAL,Celery Seed extract,CSE|Celery Seed Extract
NEW14849,CHEMICAL,low-dose ketamine,Low-dose ketamine
NEW14851,CHEMICAL,low-dose ketamine continuous infusion,low-dose ketamine continuous infusion
NEW14853,CHEMICAL,adjuvant ketamine use,adjuvant ketamine use
NEW14854,CHEMICAL,low-dose ketamine infusion,low-dose ketamine infusion
NEW14856,CHEMICAL,selective norepinephrine reuptake inhibitor reboxetine,selective norepinephrine reuptake inhibitor reboxetine
http://purl.obolibrary.org/obo/DOID_3717,DISEASE,gastric adenocarcinoma,stomach adenocarcinoma|gastric adenocarcinoma|adenocarcinoma of stomach
NEW14858,CHEMICAL,lactulose mannitol test,lactulose mannitol test
http://purl.obolibrary.org/obo/MFOMD_0000012,DISEASE,hypomanic mood episode,mood episodes
NEW14861,CHEMICAL,lamotrigine treatment,lamotrigine treatment
NEW14862,DISEASE,serious rash,serious rash
C535739,DISEASE,Congenital disorder of glycosylation type 1A [Supplementary Concept],Congenital Disorders of Glycosylation|Phosphotransferases (Phosphomutases)/deficiency|carbohydrate-deficient glycoprotein syndrome
D006830,CHEMICAL,Hydralazine,"Nepresol|Hydrallazin|mono-Hydrochloride, Hydralazine|Hydralazine Hydrochloride|Apresoline|Hydralazine mono-Hydrochloride|Hydrazinophthalazine|Hydralazine mono Hydrochloride|Apressoline|Hydralazine|Hydrochloride, Hydralazine|Apressin"
D006145,CHEMICAL,Guanethidine,"Monosulfate, Guanethidine|Guanethidine Sulfate (1:1)|Oktadin|((2-Hexahydro-1(2H)-azocinyl)ethyl)guanidine|Guanethidine|Isobarin|Guanethidine Sulfate (2:1), 14C-Labeled|Guanethidine Monosulfate|Guanethidine Sulfate|Ismelin|Guanethidine Sulfate (1:2)|Sulfate, Guanethidine|Octadine|Guanethidine Sulfate (2:1)"
D010640,CHEMICAL,Phenothiazines,Antipsychotic Agents|phenothiazines
NEW14873,CHEMICAL,cp extract,CP extract
NEW14877,BIOCHEMICAL,increase growth hormone response,increased growth hormone response
NEW14879,CHEMICAL,calcium antagonist,calcium antagonist
NEW14881,BIOCHEMICAL,mean vitamin B(12,mean vitamin B(12
NEW14884,CHEMICAL,gas chromatography- mass spectroscopy,gas chromatography- mass spectroscopy
NEW14885,DISEASE,urinary organic acid analysis,Urinary organic acid analysis
NEW14887,CHEMICAL,chronic ethanol,chronic ethanol
NEW14888,CHEMICAL,histidine ligand,histidine ligands
NEW14891,DISEASE,recurrent malignant astrocytoma,recurrent malignant astrocytomas
C083585,CHEMICAL,"cholesteryl ester transfer protein inhibitor, baboon [Supplementary Concept]",cholesteryl ester transfer protein inhibitor|Apolipoproteins C|Peptide Fragments
NEW14894,MENTAL_HEALTH,phase agitation,phase agitation
http://purl.obolibrary.org/obo/CHEBI_60247,CHEMICAL,silver ion,silver ions
NEW14896,CHEMICAL,combined monophasic contraceptive,combined monophasic contraceptives
NEW14898,CHEMICAL,ovocept-ld,Ovocept-LD
NEW14899,BIOCHEMICAL,gamma-aminobutyric acid-a gabaa receptor agonist alprazolam,gamma-aminobutyric acid-A GABAA receptor agonist alprazolam
D000377,MENTAL_HEALTH,Agnosia,"Anosognosias|Topographical Agnosias|Developmental Agnosias|Body-Image Agnosia|Agnosia, Body-Image|Agnosia, Ideational|Finger Agnosia|Syndromes, Visual Disorientation|Agnosias, Auditory|Agnosias, Time|Agnosia, Tactile|Agnosia, Congenital Auditory|Time Agnosia|Agnosias, Position|Visual Agnosias|Congenital Auditory Agnosias|Agnosias, Sensory|Agnosia, Gustatory|Visual Agnosia for Objects|Body-Image Agnosias|Olfactory Agnosias|Anosognosia|Position Agnosias|Agnosia, Topographical|Agnosia, Finger|Agnosia for Smell|Visual Disorientation Syndrome|Sensory Agnosias|Agnosia, Olfactory|Agnosias, Congenital Auditory|Agnosia, Developmental|Agnosia for Tastes|Agnosias, Somatosensory|Agnosia, Auditory|Ideational Agnosia|Auditory Agnosia|Finger Agnosias|Auditory Agnosias, Congenital|Agnosia, Visual|Olfactory Agnosia|Body Image Agnosia|Agnosias, Ideational|Agnosia for Taste|Syndrome, Visual Disorientation|Agnosias, Topographical|Congenital Auditory Agnosia|Visuospatial Agnosia|Agnosias, Body-Image|Time Agnosias|Visuospatial Agnosias|Position Agnosia|Ideational Agnosias|Gustatory Agnosia|Auditory Agnosias|Somatosensory Agnosias|Agnosia, Visuospatial|Agnosia, Somatosensory|Agnosias, Tactile|Agnosia for Pain|Tactile Agnosia|Agnosias, Visual|Agnosias, Olfactory|Agnosia, Position|Agnosias, Visuospatial|Tactile Agnosias|Sensory Agnosia|Developmental Agnosia|Topographical Agnosia|Agnosia, Time|Agnosias, Developmental|anosognosia|Agnosias, Finger|Agnosia, Sensory|Somatosensory Agnosia|Auditory Agnosia, Congenital|Agnosias|Agnosia for Temperature|Visual Agnosia|Visual Disorientation Syndromes"
NEW14902,BIOCHEMICAL,tlr5 agonist,TLR5 agonist
NEW14903,DISEASE,nonadjuvante Tetanus Toxoid,nonadjuvanting Tetanus Toxoid
http://purl.obolibrary.org/obo/DOID_9976,CHEMICAL,heroin dependence,Crack-cocaine dependence
NEW14910,CHEMICAL,grow chloramphenicol,growing chloramphenicol
C533194,CHEMICAL,SiO2-CaO-P2O5-Ag2O [Supplementary Concept],Ceramics|Ag2O
NEW14911,CHEMICAL,mibg imaging,MIBG imaging
NEW14913,DISEASE,postoperative hypoventilation,postoperative hypoventilation
NEW14914,CHEMICAL,rvmat2,rVMAT2
NEW14917,CHEMICAL,amino acid replacement,amino acid replacements
D000071421,DISEASE,Life History Traits,"Life History Characteristic|Life History Strategy|Life History Characteristics|traits|Life History Strategies|Life History Variations|Life History Theory|Life History Variation|Strategy, Life History|Life History Trait|Strategies, Life History"
D064106,MENTAL_HEALTH,Human Coprophagia,"coprophagia|Coprophagy, Human|Cecotrophy, Human|Human Coprophagy|Coprophagia, Human|Human Cecotrophy"
NEW14918,MENTAL_HEALTH,bipolar disorder effect,Bipolar disorder effects
D020233,DISEASE,"Gait Disorders, Neurologic","Rapid Fatigue of Gait|Gait, Broadened|Neurologic Ambulation Disorder|Hemiplegic Gait|Sensorimotor Gait Disorders|Hysterical Gait|Gait, Scissors|Athetotic Gait|Stumbling Gait|Unsteady Gait|Ambulation Disorder, Neurologic|Sensorimotor Gait Disorder|Festinating Gait|Frontal Gait|Gait, Unsteady|Charcot Gaits|Gait, Drop Foot|Charcots Gait|Locomotion Disorders, Neurologic|Gait, Shuffling|Gait, Charcot|Gaits, Charcot|Gait, Duck|Duck Gait|Reeling Gait|Scissors Gait|Neurologic Gait Dysfunction|Gait Disorder, Neurologic|Neurologic Locomotion Disorders|Broadened Gait|Neurologic Gait Disorders|Gait, Stumbling|Rigid Gait|Gait, Frontal|Spastic Gait|Drop Foot Gait|Gait, Festinating|gait disorders|Gait Dysfunctions, Neurologic|Neurologic Gait Dysfunctions|Shuffling Gaits|Gait, Charcot's|Widebased Gait|Gait, Reeling|Gait, Rigid|Charcot's Gait|Neurologic Gait Disorder|Ambulation Disorders, Neurologic|Gait, Widebased|Gait Disorders, Sensorimotor|Foot Gait, Drop|Gait, Hemiplegic|Neurologic Locomotion Disorder|Marche a Petit Pas|Gait Dysfunction, Neurologic|Gait Disorder, Sensorimotor|Gait, Hysterical|Gait, Spastic|Locomotion Disorder, Neurologic|Charcot Gait|Gait, Athetotic|Neurologic Ambulation Disorders|Shuffling Gait"
NEW14921,BIOCHEMICAL,primary stabilizer,primary stabilizer
http://purl.org/sig/ont/fma/fma22315,DISEASE,gluteus medius,Gluteus medius muscle|gluteus medius muscle
NEW14923,CHEMICAL,dilinoleoyl specie,DLPC|dilinoleoyl species
NEW09905,MENTAL_HEALTH,significant depression,significant depression
NEW14927,CHEMICAL,high-mg2,high-Mg2
NEW14929,CHEMICAL,inhibitor phenelzine,inhibitors phenelzine
NEW14930,CHEMICAL,antidepressant maprotiline,antidepressants maprotiline
NEW14931,NUTRITION,lithium agent,lithium agents
NEW14932,BIOCHEMICAL,serum drug concentration,serum drug concentrations
NEW14934,MENTAL_HEALTH,machine regression,machine regression
NEW14937,CHEMICAL,lopinavir/ritonavir-based combination,lopinavir/ritonavir-based combination
NEW14940,DISEASE,agitation-assisted extraction,AAE|Agitation-assisted extraction
NEW14941,BIOCHEMICAL,tumor necrosis factor tnf antagonist infliximab,tumor necrosis factor TNF antagonist infliximab
NEW14943,DISEASE,high inflammation,high inflammation
NEW14945,CHEMICAL,ethanol dependence phase,ethanol dependence phase
NEW14948,CHEMICAL,acetyl-l-carnitine treatment,Acetyl-L-carnitine treatment
NEW14952,DISEASE,schizophrenia/schizoaffective disorder,schizophrenia/schizoaffective disorders
http://purl.obolibrary.org/obo/CHEBI_131587,CHEMICAL,12-ethyl-8-propyl-3-vinylbacteriochlorophyllide d,"{3-[(3S,4S)-9-ethenyl-18-ethyl-4,8,13-trimethyl-20-oxo-14-propylphorbin-3-yl-kappa(4)N(23),N(24),N(25),N(26)]propanoato(2-)}magnesium|prevalent-hypovitaminosis D"
D015090,BIOCHEMICAL,25-Hydroxyvitamin D3 1-alpha-Hydroxylase,"25-Hydroxyvitamin D 1-alpha-Hydroxylase|CYP27B1|25-Hydroxyvitamin D2 1-hydroxylase|25 Hydroxycholecalciferol 1 Hydroxylase|25 Hydroxyergocalciferol 1 alpha Hydroxylase|25-Hydroxyergocalciferol 1-alpha-Hydroxylase|1-alpha-Hydroxylase, 25-Hydroxyergocalciferol|25-Hydroxycholecalciferol 1-Hydroxylase|Calcidiol 1-Monooxygenase|Cytochrome P-450 CYP27B1|25 Hydroxyvitamin D 1 alpha Hydroxylase|25-Hydroxycholecalciferol-1-Hydroxylase|Calcidiol 1 Monooxygenase|25 Hydroxyvitamin D2 1 hydroxylase|1-alpha-Hydroxylase, 25-Hydroxyvitamin D|calcidiol|25 Hydroxyvitamin D3 1 alpha Hydroxylase|25-Hydroxyvitamin D(3) 1 alpha-Hydroxylase|1-hydroxylase, 25-Hydroxyvitamin D2|Cytochrome P 450 CYP27B1"
NEW12969,CHEMICAL,direct oral anticoagulant,DOAC|direct oral anticoagulants
D020111,CHEMICAL,Chlorodiphenyl (54% Chlorine),Aroclor 1254|Chlorine|Aroclor-1254
NEW14956,BIOCHEMICAL,acute ssri treatment,Acute SSRI treatment
NEW14957,DISEASE,death scene,death scene
NEW14960,CHEMICAL,msa case,MSA cases
NEW14962,BIOCHEMICAL,thorough endocrine evaluation,thorough endocrine evaluation
NEW14963,CHEMICAL,ssri-tca combination,SSRI-TCA combination
D062865,CHEMICAL,"Diuretics, Potassium Sparing",potassium|Potassium Sparing Diuretics|K
NEW14966,CHEMICAL,alpha-linolenic acid pathway,alpha-linolenic acid pathway
D003428,DISEASE,Cross Infection,"nosocomial infections|Infections, Nosocomial|Infections, Hospital|Infection, Nosocomial|Infection, Cross|Nosocomial Infection|Nosocomial Infections|Hospital Infections|Infection, Healthcare Associated|Healthcare Associated Infection|Health Care Associated Infections|Hospital Infection|Infections, Healthcare Associated|Cross Infections|Health Care Associated Infection|Healthcare Associated Infections|Infections, Cross|Infection, Hospital"
D003091,CHEMICAL,Colistin,"Totazina|Coly-Mycin|Sulfate, Colistin|Colimycin|Colisticin|Polymyxin E|Colistin|Colistin Sulfate"
NEW14970,CHEMICAL,methylprednisolone therapy,methylprednisolone therapies
NEW14972,DISEASE,thromboembolic event,thromboembolic event
NEW14973,NUTRITION,phospholipid antibody,phospholipid antibodies
C034504,CHEMICAL,digoxin-like factors [Supplementary Concept],Saponins|endogenous digoxin|Cardenolides
C013785,CHEMICAL,4-amino-5-hexynoic acid [Supplementary Concept],Alkynes|gamma-acetylenic GABA|Aminocaproates
http://purl.obolibrary.org/obo/CHEBI_165543,CHEMICAL,n-oleoyl gaba,gamma-vanylic GABA|4-[[(Z)-octadec-9-enoyl]amino]butanoic acid
C535407,CHEMICAL,Gamma aminobutyric acid transaminase deficiency [Supplementary Concept],"GABA transaminase|4-Aminobutyrate Transaminase/deficiency|Amino Acid Metabolism, Inborn Errors"
NEW14975,CHEMICAL,sucrose tolerance,sucrose tolerance
NEW14977,BIOCHEMICAL,d3 agonist therapy,D3 agonist therapy
NEW03273,CHEMICAL,dopamine precursor,dopamine precursor
NEW14979,MENTAL_HEALTH,reversible somnolence,Reversible somnolence
NEW14981,DISEASE,folate b12 insufficiency,Folate B12 insufficiencies
NEW14982,CHEMICAL,tamarillo pvy isolate,tamarillo PVY isolates
NEW14984,CHEMICAL,tam17,Tam17
NEW14987,CHEMICAL,low oxygen consumption,Lower oxygen consumption
NEW14988,DISEASE,lactobacillus level,Lactobacillus levels
NEW14990,BIOCHEMICAL,classical androgen,classical androgens
NEW14992,BIOCHEMICAL,11-oxygenated androgen,11-oxygenated androgens
NEW14997,CHEMICAL,pcstat isoform,PcSTAT isoforms
NEW14999,NUTRITION,crayfish group,crayfish groups
D012276,CHEMICAL,Ricin,"Ricinus Toxin|Ricinus Lectin|Toxin, Ricinus|Ricin Toxin|RCA 60|RCA60|Toxin, Ricin|Castor Bean Lectin|Ricin A Chain|A Chain, Ricin|Ricin|Ricin B Chain|B Chain, Ricin|Ricin D|Lectin, Ricinus|Lectin, Castor Bean|Ricin I"
NEW15002,DISEASE,pathological pain,pathological pain
C072823,CHEMICAL,delta9-tetrahydrocannabinol hemisuccinate [Supplementary Concept],delta9-THC|delta9-tetrahydrocannabinol|Dronabinol/analogs  and  derivatives
NEW15004,CHEMICAL,delta9-thc antinociception,delta9-THC antinociception
NEW15005,BIOCHEMICAL,cannabinoid analgesic system,cannabinoid analgesic system
NEW15007,BIOCHEMICAL,c(50 beta-cyclic carotenoid synthesis gene cluster,C(50 beta-cyclic carotenoid synthesis gene cluster
D017261,NUTRITION,Glycosylphosphatidylinositols,"Glycosylphosphatidylinositol Anchor|Phosphatidylinositol, Glycosylated|PI Glycan|Membrane Anchor, GPI|phospholipid membrane|Glycosyl-Phosphatidylinositol Membrane Protein Anchor|Glycosylphosphatidylinositol Anchors|Glycosyl Phosphatidylinositol Membrane Protein Anchor|Phosphatidylinositol Glycan|Glycosylated Phosphatidylinositol|Glycosyl-Phosphatidylinositol|Glycan, Phosphatidylinositol|PI-Glycan|GPI Membrane Anchor|Glycosylated Phosphatidylinositols|Anchors, Glycosylphosphatidylinositol|Glycosylphosphatidylinositol Linkage|Anchors, GPI Membrane|Gly-PtdIns|Glycosyl-Phosphatidylinositol Membrane Protein Anchors|Glycoinositol Phospholipid Membrane Anchor|Phosphatidylinositols, Glycosylated|Glycosylphosphatidylinositol|Anchor, GPI Membrane|Membrane Anchors, GPI|Linkage, Glycosylphosphatidylinositol|Anchor, Glycosylphosphatidylinositol|GPI Membrane Anchors|Glycosyl Phosphatidylinositol Membrane Protein Anchors|Glycosyl Phosphatidylinositol"
NEW15009,DISEASE,otological vertigo,Otological vertigo
NEW15011,CHEMICAL,vestibular suppressant,vestibular suppressants
NEW15013,BIOCHEMICAL,agent l-channel channel antagonist,agents L-channel channel antagonists
NEW15014,DISEASE,parkinsonian patient,parkinsonian patient
NEW10005,CHEMICAL,l-dopa administration,L-dopa administration
NEW15015,CHEMICAL,"3,4-dihydroxyphenylacetic acid/l-dopa","3,4-dihydroxyphenylacetic acid/L-dopa"
NEW15024,CHEMICAL,oral benzodiazepine,oral benzodiazepine
NEW15025,DISEASE,tumor vasculature,tumor vasculature
NEW15027,CHEMICAL,hydroxide anion,hydroxide anion
NEW15028,CHEMICAL,hydroxide anion,pyridinium group
NEW15030,BIOCHEMICAL,vitamin k2 deficiency,vitamin K2 deficiency
D009466,CHEMICAL,Neuromuscular Blocking Agents,"Blockers, Neuromuscular|Agent, Neuromuscular Blocking|Neuromuscular Blocking Agent|Agents, Neuromuscular Blocking|Neuromuscular blockers|Blocker, Neuromuscular|Neuromuscular Blockers|Blocking Agents, Neuromuscular|Neuromuscular Blocker|NMBs|Blocking Agent, Neuromuscular"
D000077122,CHEMICAL,Sugammadex,6-Perdeoxy-6-per(2-carboxyethyl)thio-gamma-cyclodextrin sodium salt|Sugammadex Sodium|Bridion|Sugammadex|Org 25969
NEW15033,CHEMICAL,er hydrocodone,ER hydrocodone
NEW15035,DISEASE,coital dysfunction,Coital dysfunction
NEW15038,DISEASE,intracorporeal fibrosis,intracorporeal fibrosis
NEW15041,CHEMICAL,gonadal steroid,Gonadal steroids
NEW03372,CHEMICAL,free testosterone,free testosterone
NEW15042,MENTAL_HEALTH,free testosterone,schizophrenia groups
NEW15043,MENTAL_HEALTH,mania group,mania group
NEW15045,CHEMICAL,free testosterone level,free testosterone level
NEW15046,MENTAL_HEALTH,input resistance peak,input resistance peak
NEW15047,NUTRITION,spanish acronym,Spanish acronym
D009421,DISEASE,Nervous System Malformations,"Nervous System Anomalies|Nervous System Malformation|Nervous System Congenital Abnormalities|Congenital Malformations, Nervous System|Nervous System Abnormality|Abnormality, Nervous System|Nervous System Abnormalities|Congenital Malformations|Congenital Abnormalities, Nervous System|Nervous System Congenital Malformations|Malformations, Nervous System|Malformations, Nervous System, Congenital|Abnormalities, Nervous System|Cranioschises|Nervous System Anomaly|Anomaly, Nervous System|Congenital Anomalies, Nervous System|Nervous System Malformations, Congenital|Abnormalities, Congenital, Nervous System|Cranioschisis|Anomalies, Nervous System|Malformation, Nervous System"
NEW15049,BIOCHEMICAL,folic acid supplementation,folic acid supplementation
NEW15050,BIOCHEMICAL,early folic acid supplementation,early folic acid supplementation
NEW15051,DISEASE,serotonergic dysfunction,Serotonergic dysfunction
NEW15052,CHEMICAL,21-gene expression assay,21-gene expression assay
NEW15054,BIOCHEMICAL,active environmental friendly antimicrobial alternative,active environmental friendly antimicrobial alternatives
http://purl.obolibrary.org/obo/CHEBI_50853,CHEMICAL,quantum dot,ZnO QDs|point quantique|punto cuantico|ZnO quantum dots|QD|Quantenpunkt
NEW15055,CHEMICAL,ofin vitrotest,ofin vitrotests
D059147,DISEASE,HIV Serosorting,"YLPHIV|HIV|Serosorting, HIV"
NEW15057,CHEMICAL,cask gene,CASK gene
D005978,CHEMICAL,Glutathione,"gamma L Glu L Cys Gly|gamma-L-Glu-L-Cys-Gly|reduced glutathione|gamma-L-Glutamyl-L-Cysteinylglycine|Reduced Glutathione|gamma L Glutamyl L Cysteinylglycine|Glutathione, Reduced"
NEW15059,MENTAL_HEALTH,oxidative stress dna fragmentation,oxidative stress DNA fragmentation
NEW15060,CHEMICAL,LIGER,LIGER
http://purl.obolibrary.org/obo/NCBITaxon_151340,CHEMICAL,papillomaviridae,family Akkermansiaceae
NEW15061,DISEASE,Genus Akkermansia,Genus Akkermansia
D040941,DISEASE,Heredity,Heredity
http://purl.obolibrary.org/obo/DOID_13328,DISEASE,diabetic cataract,diabetic cataract|Cataract - diabetic
NEW15066,CHEMICAL,selenium vitamin e,selenium vitamin E
NEW15068,BIOCHEMICAL,vitamin e status,vitamin E status
NEW15069,MENTAL_HEALTH,disorder intervention,disorder interventions
NEW15070,CHEMICAL,intermediate etoh concentration,Intermediate EtOH concentrations
NEW15072,CHEMICAL,high etoh concentration,High EtOH concentrations
NEW15074,MENTAL_HEALTH,crayfish hyperactivity,crayfish hyperactivity
NEW15076,CHEMICAL,cortisol alteration,cortisol alterations
NEW15078,CHEMICAL,cortisol stress measure,cortisol stress measures
D017152,CHEMICAL,"Antibodies, Antiphospholipid","Antiphospholipid Antibodies|APLA|Antibody, Antiphospholipid|Antiphospholipid Antibody|antiphospholipid antibodies"
D000077409,CHEMICAL,Tamsulosin,Tamsulosin Hydrochloride|YM 617|Tamsulosin hydrochloride|LY 253352|LY-253352|YM-617|5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|Flomax
D011317,DISEASE,Priapism,Priapisms|priapism
NEW15081,CHEMICAL,chr mrna,CHR mRNA
NEW15086,CHEMICAL,amino-acid analogue tracer,amino-acid analogue tracers
NEW15089,CHEMICAL,fixed-dose formulation,fixed-dose formulation
NEW07810,MENTAL_HEALTH,eat episode,eating episodes
http://purl.obolibrary.org/obo/CHEBI_9123,CHEMICAL,sertraline,"(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine|(1S,4S)-sertraline|SSRIs sertaline|sertraline|Sertraline|sertralina|(1S-cis)-1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(+)-sertraline|sertralinum|CP 51974|cis-(+)-sertraline"
NEW15093,CHEMICAL,plasma amino acid,plasma amino acid
NEW15094,DISEASE,urinary organic acid profile,urinary organic acid profile
NEW15097,NUTRITION,anthocyanin-rich wheat,anthocyanin-rich wheat
NEW15098,DISEASE,accidental poisoning,accidental poisoning
NEW15100,BIOCHEMICAL,ec inverse agonist,EC inverse agonists
C031927,CHEMICAL,hydroquinone [Supplementary Concept],hydroquinone|MBEH|Hydroquinones
http://purl.obolibrary.org/obo/CHEBI_77161,BIOCHEMICAL,toll-like receptor 2 agonist,Toll-like receptor 2 agonists|Toll-like Receptor agonists|TLR-2 agonist|TLR-2 agonists|TLR 2 agonists|TLR 2 agonist|Toll-like receptor-2 agonists|Toll-like receptor-2 agonist
D000077271,CHEMICAL,Imiquimod,"R-837|Aldara|R 837|S 26308|S-26308|R837|imiquimod|1-Isobutyl-1H-imidazo(4,5-c)quinolin-4-amine|Zyclara"
NEW15104,BIOCHEMICAL,endocrine factor,endocrine factors
NEW15106,NUTRITION,ω-6 fish oil fatty acid,ω-6 fish oil fatty acids
D013024,NUTRITION,Soybean Oil,"Soybean Oils|Oil, Soya|Oils, Soy Bean|Oil, Soybean|Soy Bean Oils|Oil, Soy Bean|Soy Bean Oil|Soya Oil|Oils, Soybean|soybean oil|Soya Oils|Oils, Soya"
NEW15107,NUTRITION,acid consumption,acids consumption
NEW15108,NUTRITION,ficus sycomorus stem bark,Ficus sycomorus stem bark
NEW15109,BIOCHEMICAL,tnf-α antagonist therapy,TNF-α antagonist therapy
NEW15112,CHEMICAL,ethanol metabolism,Ethanol metabolism
http://purl.obolibrary.org/obo/DOID_12361,CHEMICAL,graves' disease,Grave's disease|Graves ' Disease|Basedow's disease|exophthalmic goiter|GD|Graves disease
NEW15125,DISEASE,pattern daughter loss method,pattern Daughter Loss methods
NEW15127,MENTAL_HEALTH,ms/ms fragmentation pattern,MS/MS fragmentation pattern
NEW15132,CHEMICAL,guanylate cyclase-c guanosine monophosphate agonist,Guanylate cyclase-C guanosine monophosphate agonists
NEW15134,BIOCHEMICAL,synthetic gc-c agonist,synthetic GC-C agonist
C584575,CHEMICAL,plecanatide [Supplementary Concept],Plecanatide|Natriuretic Peptides
NEW15135,BIOCHEMICAL,oral poison,oral poisons
NEW15142,MENTAL_HEALTH,reward crave,reward craving
NEW15143,MENTAL_HEALTH,relief craving,relief craving
http://purl.obolibrary.org/obo/CHEBI_15939,CHEMICAL,glycyrrhizinic acid,"(3beta,20beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl-2-O-beta-D-glucopyranuronosyl-alpha-D-glucopyranosiduronic acid|Glycyrrhizin|Glycyrrhizic acid|Protocatechuic acids|glycyrrhizic acid|30-hydroxy-11,30-dioxoolean-12-en-3beta-yl (2-O-beta-D-glucopyranosyluronic acid)-alpha-D-glucopyranosiduronic acid"
NEW10748,DISEASE,neuropathic pain syndrome,neuropathic pain syndromes
NEW15145,CHEMICAL,glp-1 system,GLP-1 system
NEW15147,CHEMICAL,glp-1r agonist liraglutide,GLP-1R agonist liraglutide|LIRA
NEW15149,CHEMICAL,fo metabolite,FO metabolites
NEW15150,CHEMICAL,fo treatment,FO treatment
NEW15153,BIOCHEMICAL,specific antibiotic group,specific antibiotic groups
D018528,CHEMICAL,ATP-Binding Cassette Transporters,"Transporter, ABC|Transporters, ABC|ATP-Binding Cassette Transporter|Transporters, ATP-Binding Cassette|Transporter, ATP-Binding Cassette|ABC Transporters|ABC Transporter|ATP Binding Cassette Transporter|ATP binding|ATP Binding Cassette Transporters|Cassette Transporter, ATP-Binding"
NEW15157,DISEASE,arthritis symptom,arthritis symptoms
NEW15158,BIOCHEMICAL,vitamin alternation,Vitamin alternations
NEW15160,CHEMICAL,potent dopamine receptor antagonistic antipsychotic,potent dopamine receptor antagonistic antipsychotics
D015175,DISEASE,Prolactinoma,"Pituitary Adenoma, Prolactin-Secreting|Pituitary Adenomas, PRL-Secreting|Prolactin-Producing Pituitary Adenomas|PRL Secreting Pituitary Adenoma|Prolactinoma, Familial|Lactotroph Adenoma|Adenoma, Lactotroph|Pituitary Adenomas, Prolactin-Producing|Prolactin-Producing Pituitary Adenoma|Prolactinomas|Prolactin Secreting Pituitary Adenoma|prolactinoma|Adenoma, Prolactin-Secreting, Pituitary|Lactotroph Adenomas|Macroprolactinomas|Prolactin Producing Pituitary Adenoma|Pituitary Adenoma, PRL-Secreting|Prolactin-Secreting Pituitary Adenomas|Microprolactinomas|Macroprolactinoma|Microprolactinoma|Prolactin-Secreting Pituitary Adenoma|Pituitary Adenoma, Prolactin-Producing|Pituitary Adenoma, Prolactin Secreting|PRL-Secreting Pituitary Adenomas|PRL-Secreting Pituitary Adenoma|Pituitary Adenomas, Prolactin-Secreting|Adenomas, Lactotroph"
NEW15162,CHEMICAL,single amino acid mutation,single amino acid mutation
NEW15164,CHEMICAL,histone deacetylase inhibitor phenylbutyrate,histone deacetylase inhibitor phenylbutyrate
NEW15166,CHEMICAL,phenylbutyrate treatment,phenylbutyrate treatment
NEW15169,DISEASE,idiopathic overactive bladder,OAB|Idiopathic overactive bladder
C087371,CHEMICAL,"11beta,17alpha,21-trihydroxypregn-4-ene-20-one-3-(O-(N-propargyl)carbamoylmethyl)oxime hexacarbonyldicobalt [Supplementary Concept]",cort|Hydrocortisone/analogs  and  derivatives|Organometallic Compounds
C071482,CHEMICAL,calpeptin [Supplementary Concept],calpeptin|Dipeptides
NEW15172,CHEMICAL,EtOH vapor inhalation,EtOH vapor inhalation
NEW15173,CHEMICAL,penicillin injection,penicillin injections
NEW15178,BIOCHEMICAL,lycopene concentration,lycopene concentration
NEW15179,BIOCHEMICAL,maternal serum lycopene concentration,Maternal serum lycopene concentrations
NEW09784,MENTAL_HEALTH,food craving,food craving
NEW15184,BIOCHEMICAL,opiate agonist therapy,opiate agonist therapy
D000083083,DISEASE,Laminopathies,"Disease, LMNA-Associated|LMNA Linked Diseases|LMNA Associated Diseases|LMNA-Associated Diseases|LMNA-Linked Diseases|Disease, LMNA-Linked|LMNA-Associated Disease|LMNA-Linked Disease|Laminopathy|LMNA"
NEW15189,CHEMICAL,cannabis constituent,Cannabis constituent
http://purl.obolibrary.org/obo/SYMP_0019187,DISEASE,repetitive behavior,stimming|THC-induced repetitive behavior
NEW15195,NUTRITION,sonchus asper,Sonchus asper
NEW15196,DISEASE,chronic social defeat exposure,Chronic social defeat exposure
NEW15198,CHEMICAL,nonstimulant atomoxetine formulation,nonstimulants atomoxetine formulations
http://purl.obolibrary.org/obo/CHEBI_48295,CHEMICAL,alpha-methylserotonin,(+/-)-cyclazocine|alpha-methyl-5-HT|alpha-methyl-5-hydroxytryptamine|3-(2-aminopropyl)-1H-indol-5-ol
NEW15199,DISEASE,reversible ph,reversible PH
NEW15200,DISEASE,stress-related psychiatric disorder,Stress-related psychiatric disorders
NEW15202,CHEMICAL,salsalate treatment,salsalate treatment
NEW15203,CHEMICAL,nuclear inhibitor salsalate,nuclear inhibitor salsalate
NEW15205,CHEMICAL,phenolic glycoside,phenolic glycosides
NEW15208,CHEMICAL,5-hydroxytryptamine 5-ht2 receptor antagonist,5-hydroxytryptamine 5-HT2 receptor antagonists
NEW15209,CHEMICAL,serum homocysteine level,Serum homocysteine level
NEW15210,CHEMICAL,hh signaling,Hh signaling
C585734,CHEMICAL,SAHA-PIP-delta [Supplementary Concept],SAHA|Nylons|Pyrroles
D011292,CHEMICAL,Premedication,premedication|Premedications
C413749,CHEMICAL,"CRT-1 protein, Carybdea rastoni [Supplementary Concept]",Cnidarian Venoms|CrTX-B|Proteins
NEW15215,DISEASE,suspect acute coronary syndrome,suspected acute coronary syndrome
NEW15217,BIOCHEMICAL,beta blocker administration,beta blocker administration
C519562,CHEMICAL,imetelstat [Supplementary Concept],Oligonucleotides|imetelstat
NEW15219,NUTRITION,pear Opuntia ficus-indica,pear Opuntia ficus-indica
NEW15220,DISEASE,brown alga Padina pavonica,brown alga Padina pavonica|EPP
D015060,CHEMICAL,"1,2-Dipalmitoylphosphatidylcholine","glycerophosphocholine|1,2 Dipalmitoyl Glycerophosphocholine|Dipalmitoylglycerophosphocholine|Dipalmitoyllecithin|1,2 Dihexadecyl sn Glycerophosphocholine|Dipalmitoyl Phosphatidylcholine|1,2 Dipalmitoylphosphatidylcholine|1,2-Dihexadecyl-sn-Glycerophosphocholine|Phosphatidylcholine, Dipalmitoyl|1,2-Dipalmitoyl-Glycerophosphocholine|Dipalmitoylphosphatidylcholine"
NEW15225,NUTRITION,maternal folate intake,Maternal folate intake
NEW15227,BIOCHEMICAL,maternal vitamin b6 intake,Maternal vitamin B6 intake
D051765,BIOCHEMICAL,Early Growth Response Transcription Factors,"Transcription Factors, EGR|EGR|EGR Transcription Factors|vitamin B2"
NEW15231,DISEASE,a. alata,A. alata
D003027,MENTAL_HEALTH,Cluster Headache,"Migraine, Neuralgic|Cluster Headache, Episodic|Cluster Headaches|Ciliary Neuralgia|Histamine Cephalgias|Cluster Headaches, Episodic|Neuralgias, Ciliary|Cluster Headache Syndromes|Headache Syndromes, Cluster|Episodic Cluster Headaches|Chronic Cluster Headache|Cluster Headaches, Atypical|Headache, Episodic Cluster|Cluster Headache, Chronic|Atypical Cluster Headache|Cluster Headache, Atypical|Syndrome, Horton|Headache, Chronic Cluster|Episodic Cluster Headache|Neuralgia, Ciliary|Cephalgia, Histamine|Horton's Syndrome|Chronic Cluster Headaches|Cluster Headaches, Chronic|Headache, Cluster|Headaches, Chronic Cluster|Atypical Cluster Headaches|Syndrome, Cluster Headache|Headaches, Atypical Cluster|Horton Syndrome|Headache, Atypical Cluster|cluster headache|Headaches, Cluster|Neuralgic Migraine|Syndrome, Horton's|Migraines, Neuralgic|Hortons Syndrome|Cluster Headache Syndrome|Headache Syndrome, Cluster|Neuralgic Migraines|Histamine Cephalgia|Cephalgias, Histamine|Headaches, Episodic Cluster|Ciliary Neuralgias|Syndromes, Cluster Headache"
NEW15232,CHEMICAL,catecholamine mobilization,catecholamine mobilization
D053243,CHEMICAL,Zanamivir,"2,3-Didehydro-2,4-Dideoxy-4-Guanidino-N-Acetyl-D-Neuraminic Acid|2,3-Didehydro-2,4-Dideoxy-4-Guanidinyl-N-Acetylneuraminic Acid|4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic Acid|Acid, 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic|5-Acetylamino-2,6-Anhydro-4-Guanidino-3,4,5-Trideoxy-D-Galacto-Non-Enoic Acid|4 Guanidino 2 Deoxy 2,3 Didehydro N Acetylneuraminic Acid|4 Guanidino Neu5Ac2en|4-Guanidino-2,4-Dideoxy-2,3-Didehydro-N-Acetylneuraminic Acid|Relenza|GG167|4-Guanidino-Neu5Ac2en|GG 167|GG-167|Zanamivir"
NEW15239,DISEASE,document infection,documented infections
C004262,CHEMICAL,pleuromutilin [Supplementary Concept],pleuromutilin|Diterpenes|Polycyclic Compounds
NEW15241,CHEMICAL,background     pregabalin,Background    Pregabalin
NEW15242,CHEMICAL,piperazine h1-receptor antagonist,piperazine H1-receptor antagonist
C034808,CHEMICAL,ecdysteroid receptor [Supplementary Concept],"Receptors, Steroid|20-hydroxyecdysone"
NEW15247,BIOCHEMICAL,akh hormone,AKH hormone
C023166,CHEMICAL,pyroglutamyl-peptidase II [Supplementary Concept],Pyrrolidonecarboxylic Acid/analogs  and  derivatives|Aminopeptidases|thyroliberin
NEW15249,BIOCHEMICAL,pituitary hormone secretion,pituitary hormone secretion
NEW15250,BIOCHEMICAL,somatotropin secretion,somatotropin secretion
NEW15253,BIOCHEMICAL,somatotropin stimulation maximum,Somatotropin stimulation maxima
NEW03612,DISEASE,depressive phase,depressive phase
C070499,CHEMICAL,1-(1-phenyl-2-methylcyclohexyl)piperidine [Supplementary Concept],Phencyclidine/analogs  and  derivatives|piperidine|TCP
D014191,CHEMICAL,Tranylcypromine,"Sulfate, Tranylcypromine|Tranylcypromine|Parnate|trans-2-Phenylcyclopropylamine|Tranylcypromine Sulfate|Jatrosom|Transamine|trans 2 Phenylcyclopropylamine"
NEW15255,DISEASE,hypertensive crisis,Hypertensive crisis
NEW15257,CHEMICAL,cyp1a2-ko mouse,Cyp1a2-KO mice
D056486,DISEASE,Chemical and Drug Induced Liver Injury,"Drug-Induced Hepatitides|Drug-Induced Acute Liver Injury|Liver Diseases, Drug-Induced|Toxicity, Chemically-Induced Liver|Liver Injury, Drug-Induced|Acute Liver Injury, Drug-Induced|Hepatitis, Drug-Induced|Drug-Induced Liver Injury|Hepatitis, Toxic|Liver Injury, Drug-Induced, Acute|Hepatitis, Drug Induced|Liver Toxicities, Chemically-Induced|Diseases, Drug-Induced Liver|Liver Disease, Drug-Induced|Drug-Induced Liver Injuries|Drug-Induced Liver Diseases|Liver Injuries, Drug-Induced|Chemically-Induced Liver Toxicities|Acute Liver Injury, Drug Induced|Drug Induced Liver Disease|Toxic Hepatitis|Injury, Drug-Induced Liver|Chemically Induced Liver Toxicity|Hepatitides, Toxic|Chemically-Induced Liver Toxicity|Hepatitides, Drug-Induced|Drug-Induced Liver Disease|Liver Injury, Drug Induced|Toxicities, Chemically-Induced Liver|Drug-Induced Hepatitis|Disease, Drug-Induced Liver|Injuries, Drug-Induced Liver|liver toxicity|Drug Induced Acute Liver Injury|Drug Induced Liver Injury|Toxic Hepatitides|Liver Toxicity, Chemically-Induced"
NEW15260,NUTRITION,Delicious 's winter squash c. maximum,Delicious's winter squash C. maxima
NEW15262,CHEMICAL,hand-pollinated fruit,Hand-pollinated fruit
NEW15265,DISEASE,fasd spectrum,FASD spectrum
NEW15267,BIOCHEMICAL,current antifungal drug,Current antifungal drugs
NEW15269,BIOCHEMICAL,fungicide use,fungicide use
http://purl.obolibrary.org/obo/CHEBI_32483,CHEMICAL,glutamic acid residue,glutamic residue|glutamyl|glutamic acid residues|glutamic acid residue
NEW15274,CHEMICAL,microm cch,microM CCh
NEW15276,BIOCHEMICAL,cholinergic antagonist scopolamine,cholinergic antagonist scopolamine
NEW15278,CHEMICAL,active cholinergic antagonist methscopolamine,active cholinergic antagonist methscopolamine
NEW15280,BIOCHEMICAL,folate-related b vitamin,folate-related B vitamins
NEW15281,DISEASE,vascular dysfunction,vascular dysfunction
NEW15285,CHEMICAL,ERβ agonist diarylpropionitrile,ERβ agonist diarylpropionitrile|DPN
NEW15287,CHEMICAL,dilute pilocarpine test,dilute pilocarpine test
NEW15289,CHEMICAL,neuroprotective steroid,neuroprotective steroids
D000086402,CHEMICAL,SARS-CoV-2,"Virus, SARS-CoV-2|Virus, COVID19|2019 Novel Coronaviruses|2019 Novel Coronavirus|SARS CoV 2 Virus|Coronavirus, Wuhan|2019-nCoV|SARS-CoV-2|Wuhan Seafood Market Pneumonia Virus|Viruses, COVID19|SARS-CoV-2 Viruses|Coronavirus Disease 2019 Virus|COVID 19 Virus|SARS Coronavirus 2|COVID-19 Viruses|COVID19 Virus|COVID-19 Virus|Virus, COVID-19|Wuhan Coronavirus|SARS-CoV-2 Virus|Coronavirus, 2019 Novel|Novel Coronavirus, 2019|COVID19 Viruses|Coronavirus 2, SARS|Severe Acute Respiratory Syndrome Coronavirus 2"
NEW15291,CHEMICAL,intratracheal i.t hydrochloric acid 0.1n hcl instillation,intratracheal i.t hydrochloric acid 0.1N HCl instillation
D014407,DISEASE,"Tumor Cells, Cultured","Tumor Cell, Cultured|Cell, Cultured Neoplastic|Neoplastic Cell, Cultured|Cell, Cultured Tumor|Cultured Neoplastic Cell|Cells, Cultured Tumor|Cultured Tumor Cells|Neoplastic Cells, Cultured|Cultured Tumor Cell|Cells, Cultured Neoplastic|Cultured Neoplastic Cells|tumor cells"
NEW15297,CHEMICAL,grin2-variant patient alteration,GRIN2-variant patients alterations
D013092,DISEASE,Spermatogenesis-Blocking Agents,"Spermatogenesis Blocking Agents|spermatogenesis|Agents, Spermatogenesis Blocking|Agents, Spermatogenesis-Blocking"
NEW15301,DISEASE,brain infarct area,Brain infarct area
D015853,CHEMICAL,Cysteine Proteinase Inhibitors,"Inhibitor, Cysteine Proteinase|Cysteine Proteinase Inhibitor|Cysteine Proteinase Inhibitors, Exogenous|alpha Cysteine Protease Inhibitor|Cysteine Proteinase Antagonist|Protease Inhibitor, Cysteine|Inhibitors, Cysteine Proteinase|Inhibitor, alpha-Cysteine Protease|Inhibitors, alpha-Cysteine Protease|Protease Inhibitors, Cysteine|alpha-Cysteine Protease Inhibitors|Cysteine Proteinase Inhibitors, Endogenous|Acid Cysteine Proteinase Inhibitors|Proteinase Inhibitors, Cysteine|Proteinase Antagonists, Cysteine|Proteinase Inhibitor, Cysteine|Inhibitor, Cysteine Protease|Protease Inhibitor, alpha-Cysteine|Acid Cysteine Proteinase Inhibitor|Antagonist, Cysteine Proteinase|Proteinase Antagonist, Cysteine|Inhibitors, Cysteine Protease|alpha Cysteine Protease Inhibitors|alpha-Cysteine Protease Inhibitor|Cysteine Proteinase Antagonists|Cysteine Protease Inhibitors|Antagonists, Cysteine Proteinase|cysteine Proteinase|Protease Inhibitors, alpha-Cysteine|Cysteine Protease Inhibitor"
D029686,CHEMICAL,Lepidium,"Lepidium meyenii|meyenii, Lepidium|Macas|maca|Lepidiums|Lepidium meyenius|WFWRM|Maca"
NEW15305,CHEMICAL,dietary nitrate,dietary nitrate
NEW15310,MENTAL_HEALTH,epidural local analgesia,epidural local analgesia
NEW10915,CHEMICAL,traditional antidepressant,traditional antidepressants|serotonin re-uptake inhibitors
NEW12502,BIOCHEMICAL,toxin gene,toxin genes
C573540,CHEMICAL,N-(N-benzoyl-O-(2-dimethylaminoethyl)tyrosyl)phenylalaninol [Supplementary Concept],Bentysrepinine|Benzamides|Dipeptides
NEW15322,CHEMICAL,repensine,repensine
NEW15323,DISEASE,c. australi,C. australis
NEW15325,BIOCHEMICAL,β-adrenoreceptor blocking drug β-blocker prescription,β-adrenoreceptor blocking drug β-blocker prescription
NEW15327,DISEASE,central pain pathway,central pain pathways
NEW15330,DISEASE,cuff pressure pain stimulation,Cuff pressure pain stimulation
NEW15333,BIOCHEMICAL,implication analgesic effect,Implications Analgesic effects
NEW15336,MENTAL_HEALTH,thermal resistance,thermal resistance
NEW15338,BIOCHEMICAL,intraseptal muscarinic agonist,Intraseptal muscarinic agonists
D032383,DISEASE,"Myocytes, Cardiac","Cardiac Muscle Cells|Cardiac Myocytes|Muscle Cell, Cardiac|Cardiac Myocyte|Heart Muscle Cell|Muscle Cells, Heart|Myocyte, Cardiac|cardiac muscle|Cells, Heart Muscle|Cardiomyocytes|Cardiomyocyte|Muscle Cells, Cardiac|Cardiac Muscle Cell|Cell, Cardiac Muscle|Cells, Cardiac Muscle|Cell, Heart Muscle|Heart Muscle Cells|Muscle Cell, Heart"
NEW15340,CHEMICAL,hip fracture,Hip fracture
C560743,CHEMICAL,menatetrenone epoxide [Supplementary Concept],Epoxy Compounds|MK-4|Vitamin K 2/analogs  and  derivatives
NEW15343,CHEMICAL,calcium supplement,calcium supplements
C019396,CHEMICAL,formyltetrahydrofolate dehydrogenase [Supplementary Concept],10-Formyltetrahydrofolate dehydrogenase|Oxidoreductases Acting on CH-NH Group Donors
NEW15348,CHEMICAL,children-between year,children-between years
NEW15350,CHEMICAL,eserine sulfate,Eserine sulfate
D010767,NUTRITION,Phosphorylcholine,"Phosphate, Choline|Choline chloride|Chloride, Phosphorylcholine|Chloride, Choline Phosphate|Phosphocholine|Choline Chloride Dihydrogen Phosphate|Choline Phosphate Chloride|Phosphate Chloride, Choline|Choline Phosphate|Phosphorylcholine Chloride"
NEW15351,CHEMICAL,ginger constituent,Ginger constituents
NEW15353,CHEMICAL,estrogenic terpene,estrogenic terpenes
http://purl.obolibrary.org/obo/MFOMD_0000209,MENTAL_HEALTH,mood swing,mood swing
NEW15358,DISEASE,cancer patient,Cancer patients
NEW15360,CHEMICAL,background cisplatin/5-fluorouracil therapy,BACKGROUND Cisplatin/5-fluorouracil therapy
NEW15362,CHEMICAL,cisplatin-based chemotherapy,Cisplatin-based chemotherapy
NEW15363,DISEASE,advanced esophageal cancer,advanced esophageal cancer
NEW15364,CHEMICAL,advanced esophageal cancer,cisplatin/5-fluorouracil therapy
NEW15366,BIOCHEMICAL,lycopene administration,lycopene administration
D004834,DISEASE,"Epilepsy, Post-Traumatic","Disorders, Post-Traumatic Seizure|Post-Traumatic Seizure Disorder|Early Post-Traumatic Seizure|Post-traumatic seizures|Post-Traumatic Seizure, Late|Traumatic Epilepsies|Epilepsies, Post-Traumatic|Epilepsies, Traumatic|Convulsion, Concussive|Seizure Disorders, Post-Traumatic|Concussive Convulsions|Late Post Traumatic Seizures|Post-Traumatic Seizure Disorders|Seizure Disorder, Post Traumatic|Seizures, Early Post-Traumatic|Seizure, Early Post-Traumatic|Convulsions, Concussive|Seizure Disorder, Post-Traumatic|Impact Seizure|Post-Traumatic Epilepsies|Impact Seizures|Post-Traumatic Epilepsy|Seizure, Late Post-Traumatic|Post Traumatic Seizure Disorder|Disorder, Post-Traumatic Seizure|Seizures, Late Post-Traumatic|Traumatic Epilepsy|Concussive Convulsion|Post-Traumatic Seizures, Late|Late Post-Traumatic Seizures|Epilepsy, Post Traumatic|Post-Traumatic Seizure, Early|Early Post-Traumatic Seizures|Post-Traumatic Seizures, Early|Epilepsy, Traumatic|Early Post Traumatic Seizures|Late Post-Traumatic Seizure"
NEW15369,CHEMICAL,purmorphamine treatment,purmorphamine treatment
C470893,CHEMICAL,purmorphamine [Supplementary Concept],Purines|Morpholines|purmorphamine
NEW15371,DISEASE,tbi phenotype,TBI phenotypes
NEW15372,CHEMICAL,water-soluble diacyl arsenosugar phospholipid,As-PL|Water-soluble diacyl arsenosugar phospholipids
NEW15374,DISEASE,high neuroticism,higher neuroticism
NEW15378,NUTRITION,methionine restriction,methionine restriction
NEW15379,DISEASE,higher-fat diet,higher-fat diets
NEW15381,NUTRITION,red onion,Red onion
NEW15383,CHEMICAL,carbon onion,carbon onions
C047505,CHEMICAL,R 59022 [Supplementary Concept],Thiazoles|R59022|Pyrimidinones
C095370,CHEMICAL,3-methyl-8-(2-deoxyribofuranosyl)isoxanthopterin [Supplementary Concept],Xanthopterin/analogs  and  derivatives|Deoxyguanosine/analogs  and  derivatives|isoxanthopterin
NEW15389,CHEMICAL,serotonin reuptake blocker,Serotonin reuptake blockers
NEW15391,DISEASE,serotonin reuptake blocker,sexual obsessions
NEW15392,DISEASE,serotonin reuptake blocker,compulsions
NEW15393,BIOCHEMICAL,androgen receptor blockade,androgen receptor blockade
D005485,CHEMICAL,Flutamide,FlutaGRY|Apimid|Fluta cell|Flutamide|ApoFlutamide|Cytamid|Novo Flutamide|Fluta-cell|Testotard|Flutacell|Flutexin|Flutaplex|Novo-Flutamide|Niftolide|SCH13521|Fluta 1A Pharma|SCH 13521|Drogenil|PMS-Flutamide|SCH-13521|Chimax|Flutamin|NovoFlutamide|Prostica|Fluta-GRY|Prostacur|Prostogenat|Apo-Flutamide|Eulexine|Grisetin|PMS Flutamide|Apo Flutamide|Niftolid|Fluta GRY|Flutandrona|Fluken|Fugerel|Euflex|Oncosal|Flulem|Eulexin|Flumid
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Dyskinesia,DISEASE,dyskinesia,LID|#NAME?
NEW15396,DISEASE,lid nasal gel,LID nasal gel
D011808,CHEMICAL,Quinone Reductases,"Reductases, Quinone|menaquinone|Menaquinone Reductases|Reductases, Menaquinone"
NEW15399,CHEMICAL,receptor protein tyrosine phosphatase β/ζ,receptor protein tyrosine phosphatase β/ζ
NEW15402,CHEMICAL,dopac level,DOPAC levels
NEW15403,BIOCHEMICAL,safe antimicrobial peptide,safe antimicrobial peptide
NEW15405,CHEMICAL,IMPORTANCE Nisin,IMPORTANCE Nisin
C489810,CHEMICAL,"type 2A protein serine-threonine phosphatase 55 kDa B, Arabidopsis [Supplementary Concept]",Arabidopsis Proteins|SMAPs|PP2A|Protein Phosphatase 2
NEW15410,MENTAL_HEALTH,opioid-induced respiratory depression,Opioid-induced respiratory depression
NEW15414,CHEMICAL,diazeniumdiolate amidine,diazeniumdiolated amidines
NEW10896,CHEMICAL,[3h]rauwolscine,[3H]rauwolscine
D000077212,CHEMICAL,Ropivacaine,"LEA 103|LEA-103|AL381|Ropivacaine Hydrochloride|AL-381|Ropivacaine Monohydrochloride|Naropeine|1 Propyl 2',6' pipecoloxylidide|AL 381|Ropivacaine Monohydrochloride, (S)-isomer|Naropin|1-Propyl-2',6'-pipecoloxylidide|ropivacaine|LEA103"
D019796,NUTRITION,"15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid","(15S)-Hydroxy-11 alpha, 9 alpha-(epoxymethano)prosta-5Z, 13E-dienoic Acid|U 46619|9,11-Dideoxy-11 alpha,9-alpha-epoxymethano-PGF2 alpha|11 alpha,9 alpha-Epoxymethano PGH2|(15S)hydroxy-9alpha,11alpha-(epoxymethano)prosta-5,13-dienoic acid|9,11-Dideoxy-11 alpha,9 alpha-epoxymethanoprostaglandin F2 alpha|U46619|alpha|U 44619|U44619|9,11 epoxymethano PGH2|U-44619|11 alpha,9 alpha Epoxymethano PGH2|U-46619|9,11-epoxymethano-PGH2"
C084825,CHEMICAL,thioproperazine [Supplementary Concept],Thioproperazine|Phenothiazines
NEW15418,DISEASE,alcoholic liver injury,Alcoholic liver injury
NEW15421,CHEMICAL,skf injection,SKF injection
NEW15422,CHEMICAL,significant xanthine oxidase inhibition,significant xanthine oxidase inhibition
C496347,CHEMICAL,"DHC-1, herbal formulation [Supplementary Concept]",herbal formulation|Urinil B|Plant Extracts
NEW15426,CHEMICAL,5-ht network,5-HT network
NEW15428,CHEMICAL,increase serum triglyceride level,Increased serum triglyceride levels
NEW15429,DISEASE,er-positive breast cancer cell,ER-positive breast cancer cells
NEW15430,CHEMICAL,nmda glutamatergic neurotransmission,NMDA glutamatergic neurotransmission
NEW15431,BIOCHEMICAL,uncompetitive nmda receptor antagonist,uncompetitive NMDA receptor antagonist
NEW15432,CHEMICAL,drug-induced parkinsonism,Drug-induced parkinsonism|DIP
NEW15437,CHEMICAL,irreversible dip,Irreversible DIP
NEW15439,DISEASE,bona endometrial precancer,bona endometrial precancers
NEW15442,DISEASE,hair loss prevention,hair loss prevention
NEW15443,CHEMICAL,VitD. current study,VitD. Current studies
NEW15444,DISEASE,escherichia coli mastitis,Escherichia coli mastitis
NEW15445,NUTRITION,escherichia coli mastitis,dairy cattle
C089242,CHEMICAL,"S100A7 protein, human [Supplementary Concept]",Psoriasin|S100 Calcium Binding Protein A7
NEW15447,DISEASE,genital staphylococcal infection,genital staphylococcal infections
NEW15448,BIOCHEMICAL,gaseous antigen,gaseous antigen
NEW15450,DISEASE,hyper-sensitivity,hyper-sensitivity
C095252,CHEMICAL,A'-neogammacer-22(29)-en-3-ol [Supplementary Concept],DYRK1A|Triterpenes|A
D000081015,DISEASE,Ototoxicity,"Ototoxicity, Drug-Induced|Drug Induced Ototoxicity|Ototoxicities, Drug-Related|Drug-Induced Ototoxicity|Drug-Induced Cochlear Toxicity|Drug-Related Cochleotoxicity|Drug-Induced Vestibular Toxicity|Otological Toxicity, Drug-Induced|Ototoxicities|Drug Related Otological Toxicity|Drug-Induced Vestibulotoxicity|Drug Induced Cochlear Toxicity|Ototoxicity, Drug-Related|Drug-Related Ototoxicity|Drug-Related Cochlear Toxicity|Otological Toxicity, Drug-Related|Drug-Related Cochlear Toxicities|Vestibulotoxicity, Drug-Induced|Cochlear Toxicity, Drug-Related|Drug Related Ototoxicity|Cochleotoxicity, Drug-Induced|Cochlear Toxicities, Drug-Related|Cochleotoxicities, Drug-Related|Drug-Induced Cochlear Toxicities|Drug Related Cochleotoxicity|Drug Related Cochlear Toxicity|Drug Induced Vestibular Toxicity|Drug-Induced Cochleotoxicity|Drug-Related Ototoxicities|Drug-Induced Otological Toxicity|Drug Induced Otological Toxicity|Cochlear Toxicity, Drug-Induced|Cochleotoxicity, Drug-Related|Drug Induced Vestibulotoxicity|Drug Induced Cochleotoxicity|Drug-Related Otological Toxicity|toxicities|Drug-Induced Otological Toxicities|Vestibular Toxicity, Drug-Induced|Drug-Related Otological Toxicities"
NEW15452,CHEMICAL,elevated homocysteine concentration,elevated homocysteine concentrations
D062966,CHEMICAL,Ozone Depletion,"ozone|Ozone Hole|Holes, Ozone|Depletion, Ozone Layer|Ozone Layer Depletion|Ozone Holes|Hole, Ozone|Layer Depletion, Ozone|Depletion, Ozone"
D061329,CHEMICAL,Oil and Gas Fields,"oil|Gas Reservoirs|Well, Oil|Gas Well|Gas Fields|Gas Reservoir|Oil Field|Fields, Oil|Wells, Oil|Reservoir, Oil|Oil Wells|Field, Oil|Oil Well|Fields, Gas|Oil and Gas Wells|Reservoirs, Gas|Wells, Gas|Oil Fields|Oil Reservoir|Well, Gas|Reservoir, Gas|Oil and Gas Reservoirs|Gas Field|Field, Gas|ODSO|Gas Wells|Oil Reservoirs|Reservoirs, Oil"
NEW15460,DISEASE,alcohol abuser,micronutrient deficiency
NEW15461,CHEMICAL,moderate alcohol consumption,moderate alcohol consumption
http://purl.obolibrary.org/obo/CHEBI_38218,CHEMICAL,isophthalonitrile,"3-Cyanobenzonitrile|1,3-Benzenedicarbonitrile|benzene-1,3-dicarbonitrile|(E)-N-[17-(cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6beta-yl]-3-(furan-3-yl)-N-methylprop-2-enamide monohydrochloride|m-Dicyanobenzene|Isophthalodinitrile|1,3-Dicyanobenzene|IPN"
NEW15467,NUTRITION,distal tracheobronchial tree,distal tracheobronchial tree
NEW15469,BIOCHEMICAL,female reproductive hormone cycle event,female reproductive hormone cycle events
NEW15470,MENTAL_HEALTH,incident depression,Incident depression
NEW15471,BIOCHEMICAL,non-selective beta-blocker related,non-selective beta-blockers related
NEW15475,BIOCHEMICAL,pleiotrope alpha-melanophore stimulating hormone,pleiotrope alpha-melanophore stimulating hormone
NEW15476,CHEMICAL,cy-3-g,Cy-3-g
NEW15477,DISEASE,2-year-old asthmatic boy,2-year-old asthmatic boy
NEW15480,BIOCHEMICAL,thyroid hormone alpha,thyroid hormone alpha
NEW15483,BIOCHEMICAL,specific ppardelta agonist,specific PPARdelta agonist
NEW15486,CHEMICAL,ppardelta-mediated mir-15a inhibition,PPARdelta-mediated miR-15a inhibition
NEW15488,BIOCHEMICAL,estrogen mimic,estrogen mimics
NEW15489,CHEMICAL,dopamine receptor activation,dopamine receptor activation
NEW15493,BIOCHEMICAL,antiviral factor,antiviral factors
NEW15495,CHEMICAL,subanesthetic dose,Subanesthetic dose
NEW15496,CHEMICAL,dose intravenous ketamine,dose intravenous ketamine
D005228,NUTRITION,"Fatty Acids, Essential","essential fatty acids|Essential Fatty Acids|Acids, Essential Fatty"
NEW15497,DISEASE,alcohol-induced tissue damage,alcohol-induced tissue damage
NEW15500,BIOCHEMICAL,pellagra erythaema,niacin supplementation
NEW15502,DISEASE,pellagra erythaema,non-specific erythaema
NEW15503,MENTAL_HEALTH,hazard regression,hazards regression
NEW15504,CHEMICAL,excessive alcohol user,Excessive alcohol users
NEW15508,DISEASE,e. amylovora,E. amylovora
C525624,CHEMICAL,"D-tagatose 3-epimerase, Pseudomonas cichorii [Supplementary Concept]",d-tagatose|Carbohydrate Epimerases
NEW15511,CHEMICAL,increase brain kyna level,increased brain KYNA levels
NEW15512,DISEASE,antilipolysacchride factor,ALF|antilipolysacchride factor
NEW15513,CHEMICAL,brain kyna level,Brain KYNA levels
http://purl.obolibrary.org/obo/SYMP_0000296,DISEASE,hepatic dysfunction,hepatic dysfunction
NEW15515,CHEMICAL,imipramine administration,Imipramine administration
NEW15517,CHEMICAL,ccl4 ml,CCl4 ml
NEW15519,CHEMICAL,long-term ethanol treatment,Long-term ethanol treatment
NEW15523,MENTAL_HEALTH,behavioral agitation,behavioral agitation
NEW15525,DISEASE,psychotic thinking,psychotic thinking
NEW15528,CHEMICAL,"mg/kg l-365,031 l-365,260","mg/kg L-365,031 L-365,260"
NEW15529,BIOCHEMICAL,non-peptide cck antagonist,non-peptide CCK antagonists
NEW15531,CHEMICAL,zidovudine monotherapy,zidovudine monotherapy
NEW15532,DISEASE,hiv disease,HIV disease
NEW15534,CHEMICAL,mek inhibitor pd184352,MEK inhibitor PD184352
NEW10647,MENTAL_HEALTH,bacterial resistance,bacterial resistance
NEW15536,CHEMICAL,multiple inhaler type,multiple inhaler types
NEW15537,BIOCHEMICAL,primary drug treatment,primary drug treatment
NEW15538,CHEMICAL,nonselective sri clomipramine,nonselective SRI clomipramine
NEW15542,DISEASE,related dyslipidemia,related dyslipidemia
NEW11986,DISEASE,related dyslipidemia,hepatic fatty acids|steatosis
NEW15543,CHEMICAL,omega-oxidation cytochrome p450 cyp4a gene expression,omega-oxidation cytochrome P450 CYP4A gene expression
NEW15544,NUTRITION,cyp4a fatty acid omega-hydroxylase p450s,CYP4A fatty acid omega-hydroxylase P450s
http://purl.obolibrary.org/obo/CHEBI_59554,NUTRITION,medium-chain fatty acid,MCFA|medium-chain fatty acids|medium-chain fatty acid MCFA CYP4A LCFA CYP4Fomega-hydroxylase genes|MCFAs
NEW15545,DISEASE,nutritional alteration,nutritional alterations
NEW15547,CHEMICAL,natural actomyosin,NAM|natural actomyosin
NEW15549,DISEASE,jellyfish stinging cell,jellyfish stinging cells
D003064,BIOCHEMICAL,Cnidarian Venoms,"Venom, Jellyfish|Venoms, Jellyfish|Venom, Sea Anemone|Sea Anemone Venoms|Cnidarian Venom|Chironex Venoms|Venoms, Sea Anemone|Venom, Cnidarian|Portuguese Man-of-War Venom|Sea Anemone Venom|Venoms, Cnidarian|Venom, Portuguese Man-of-War|Venom, Chironex|Venoms, Nematocyst|Venoms, Chironex|Nematocyst Venoms|Chironex Venom|Jellyfish Venom|Jellyfish venoms|Portuguese Man of War Venom|Jellyfish Venoms"
NEW15553,BIOCHEMICAL,venom component,venom components
http://purl.obolibrary.org/obo/CHEBI_166993,NUTRITION,callicarpenal,"2-[(1S,2R,4aR,8aR)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]acetaldehyde|diamondback moth"
C554435,CHEMICAL,4'-amino-4'-avermectin B1 benzoate [Supplementary Concept],emamectin benzoate|Ivermectin/analogs  and  derivatives
C415329,CHEMICAL,spinosad [Supplementary Concept],Macrolides|Drug Combinations|spinosad
NEW15558,CHEMICAL,superoxide level,superoxide level
NEW15561,BIOCHEMICAL,hiv drug regiment,HIV drug regiment
D053307,DISEASE,"Hyper-IgM Immunodeficiency Syndrome, Type 1","X-Linked Hyper-IgM Immunodeficiency|Immunodeficiencies, X-Linked Hyper-IgM|Hyper-IgM Syndrome 1|Hyper IgM Immunodeficiency Syndrome, Type 1|Immunodeficiency, X-Linked Hyper-IgM|HIGM1 Syndromes|Hyper IgM Syndrome 1|immunodeficiency syndrome|Immunodeficiency with Hyper IgM, Type 1|Hyper-IgM Immunodeficiencies, X-Linked|X-Linked Hyper-IgM Immunodeficiencies|X-Linked Hyper IgM Syndrome|AIDS|Hyper IgM Immunodeficiency, X Linked|HIGM1 Syndrome|X Linked Hyper IgM Syndrome|HIGM1|Immunodeficiency with Hyper-IgM, Type 1|Hyper-IgM Immunodeficiency, X-Linked"
NEW15564,BIOCHEMICAL,mutation-induced drug resistance problem,mutation-induced drug resistance problems
C121001,DISEASE,NR2B NMDA receptor [Supplementary Concept],"GluN2B|Receptors, N-Methyl-D-Aspartate"
NEW15567,BIOCHEMICAL,antimicrobial use,antimicrobial use
NEW15569,MENTAL_HEALTH,resistance phenotype,resistance phenotypes
NEW15571,MENTAL_HEALTH,craving response,craving response
NEW15576,CHEMICAL,gamma aminobutyric acid agonist specific,gamma aminobutyric acid agonist specific
NEW15577,CHEMICAL,α-1 receptor subtype,α-1 receptor subtype
NEW15579,CHEMICAL,infusion muscimol,Infusion muscimol
D003336,CHEMICAL,Tectum Mesencephali,"Quadrigemina, Corpora|Colliculus Commissures, Inferior|Quadrigeminal Plates|Inferior Colliculus Commissures|Corpora Quadrigemina|superior colliculus|Commissure of Superior Colliculus|Plates, Quadrigeminal|Colliculus Commissure, Superior|Quadrigemina, Lamina|Lamina Quadrigemina|Inferior Colliculus Commissure|Tectum Mesencephalus|Commissure of Inferior Colliculus|MRF-DLSC|Colliculus Commissures, Superior|Quadrigeminal Plate|Plate, Quadrigeminal|Superior Colliculus Commissure|Colliculus Commissure, Inferior|Mesencephalus, Tectum|Superior Colliculus Commissures"
NEW15582,CHEMICAL,various eet product,Various EET products
NEW15585,DISEASE,persistent hyperglycaemia,Persistent hyperglycaemia
NEW15586,BIOCHEMICAL,ppar-gamma agonist,PPAR-gamma agonists
NEW15588,BIOCHEMICAL,ppar-gamma agonist rosiglitazone,PPAR-gamma agonist rosiglitazone
NEW15590,DISEASE,ppar-gamma agonist rosiglitazone,hyperplastic endometrial lesions
NEW15592,CHEMICAL,gstm1 gene,GSTM1 gene
D000073942,DISEASE,T-Cell Acute Lymphocytic Leukemia Protein 1,"T Cell Acute Lymphocytic Leukemia Protein 1|TAL 1 Protein|TAL-1 Protein|acute lymphocytic leukemia|TAL1 Transcription Factor|Transcription Factor, TAL1"
D004314,MENTAL_HEALTH,Down Syndrome,"Downs Syndrome|Down's Syndrome|Down Syndrome, Partial Trisomy 21|Syndrome, Down's|Trisomy 21|Trisomy 21, Meiotic Nondisjunction|47,XX,+21|Mongolism|Down syndrome|47,XY,+21|Trisomy 21, Mitotic Nondisjunction|Syndrome, Down|Partial Trisomy 21 Down Syndrome|Trisomy G"
NEW15593,CHEMICAL,mumol/l,mumol/L
NEW15594,CHEMICAL,42-hour mtx concentration,42-hour MTX concentration
NEW15595,CHEMICAL,average mtx clearance,average MTX clearance
NEW15596,CHEMICAL,altered mtx pharmacokinetic,altered MTX pharmacokinetics
NEW15597,DISEASE,altered mtx pharmacokinetic,MTX-induced toxicity
NEW15598,BIOCHEMICAL,indirectly-acting sympathomimetic amine,indirectly-acting sympathomimetic amines
NEW15600,CHEMICAL,exogenous surfactant,exogenous surfactants
http://purl.obolibrary.org/obo/CHEBI_35816,BIOCHEMICAL,leprostatic drug,leprostatic agent|Antifungal drugs|leprostatic drugs|leprostatic
NEW15601,NUTRITION,blue rockfish,blue rockfish
NEW15602,NUTRITION,copper rockfish,copper rockfish
C464966,CHEMICAL,VX-745 [Supplementary Concept],Pyrimidines|VX-745|Pyridazines
NEW15606,CHEMICAL,acute vx-745 application,acute VX-745 application
NEW15608,DISEASE,common chronic liver disease,common chronic liver disease
C043425,CHEMICAL,vanoxerine [Supplementary Concept],GBR-12909|Piperazines|Vanoxerine
NEW15612,CHEMICAL,pb(ac)2 exposure,Pb(Ac)2 exposure
NEW15614,CHEMICAL,ape administration,APE administration
D000682,CHEMICAL,Amyloid,"amyloid fibrils|Amyloid Substance|Fibril, Amyloid|Amyloid Fibril|Fibrils, Amyloid|Substance, Amyloid|Amyloid Fibrils"
NEW15616,CHEMICAL,specie glycoursodeoxycholic acid,species glycoursodeoxycholic acid|GUDCA
C031655,CHEMICAL,ursodoxicoltaurine [Supplementary Concept],TUDCA|tauroursodeoxycholic acid|Taurochenodeoxycholic Acid
D014580,CHEMICAL,Ursodeoxycholic Acid,"Ursogal|Delursan|3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic Acid|ursodeoxycholic acid|Ursodiol|Sodium Ursodeoxycholate|Urso Heumann|3 alpha,7 beta Dihydroxy 5 beta cholan 24 oic Acid|Destolit|Urdox|Ursofalk|Acid, Ursodeoxycholic|Ursacholic Acid|Ursochol|Ursobilane|Ursodeoxycholate, Sodium|Cholofalk|Acid, Deoxyursocholic|Ursolvan|Ursolite|Urso|Cholit-Ursan|UDCA|Deoxyursocholic Acid|Acid, Ursacholic"
C000600266,CHEMICAL,aducanumab [Supplementary Concept],"Aducanumab|Antibodies, Monoclonal, Humanized"
NEW15620,CHEMICAL,bivalent cation,bivalent cations
NEW15622,NUTRITION,lanthane,lanthane
NEW15624,NUTRITION,long chain polyunsaturated fatty acid level,Long chain polyunsaturated fatty acid levels
NEW15627,CHEMICAL,high-frequency tens,high-frequency TENS
NEW15628,CHEMICAL,functional single nucleotide polymorphism present,functional single nucleotide polymorphism present
NEW15630,CHEMICAL,val allele,Val allele
NEW15633,CHEMICAL,periconceptional use,periconceptional use
NEW15634,BIOCHEMICAL,folic acid fortification,folic acid fortification
NEW15640,DISEASE,due respiratory viral infection,due respiratory viral infections
NEW15641,CHEMICAL,iron supplementation,Iron supplementation
NEW15646,CHEMICAL,phase-high performance chromatography method,phase-high performance chromatography method
http://purl.obolibrary.org/obo/SYMP_0000309,CHEMICAL,loss of appetite,inappetence|lack of appetite|appetite loss
D008468,CHEMICAL,Meclizine,"Meclizine Monohydrochloride|meclizine|Antivert|Bonine|D Vert|Parachloramine|Dihydrochloride, Meclizine|Bonamine|Hydrochloride, Meclizine|Meclozine|Chiclida|Monohydrochloride, Meclizine|Ru-Vert-M|Histametizyn|D-Vert|Agyrax|DVert|Meclizine Hydrochloride|Meclizine Dihydrochloride|Ru Vert M"
NEW15651,CHEMICAL,rifampicin-treate alcl3-rat,Rifampicin-treated AlCl3-rats
NEW15653,DISEASE,lysinibacillus sp. btku3 strain,Lysinibacillus sp. BTKU3 strain
NEW11855,DISEASE,gut microbiota dysbiosis,gut dysbiosis|gut microbiota dysbiosis
NEW15654,DISEASE,postnatal gut dysbiosis,Postnatal gut dysbiosis
NEW15655,DISEASE,extensive gut dysbiosis,extensive gut dysbiosis
NEW15658,CHEMICAL,neuroprotectant kynurenic acid,neuroprotectant kynurenic acid
NEW15659,CHEMICAL,dose mg/kg,dose mg/kg
NEW15661,CHEMICAL,catecholamine level,catecholamine levels
D006862,CHEMICAL,Hydrogen Sulfide,"Hydrogen Sulfide (H2S2)|Hydrogen sulfide|Hydrogen Sulfide (H2S3)|Sulfide, Hydrogen|Hydrogen Sulfide (H2(Sx))"
NEW15664,DISEASE,s. platensis,S. platensis
NEW15667,DISEASE,capsaicin-mediated bradycardia,capsaicin-mediated bradycardia
NEW01950,DISEASE,chronic restraint stress,chronic restraint stress
http://purl.obolibrary.org/obo/CHEBI_25029,CHEMICAL,leukotriene,leucotriene|leukotriene|Leukotrien|leukotrienes|Leukotriene|leucotrienes
NEW15670,DISEASE,death due,death due
NEW15672,DISEASE,alcohol liver disease,Alcohol liver disease
NEW15674,CHEMICAL,conyza bonariensis,Conyza bonariensis
D011815,MENTAL_HEALTH,R Factors,"Resistance factors|R Plasmids|Factors, Resistance|Plasmids, R|Factor, R|R Factor|Resistance Factor|Resistance Factors|Factors, R|R Plasmid|Plasmid, R|Factor, Resistance"
NEW15675,MENTAL_HEALTH,resistance mechanism,resistance mechanism
NEW15676,MENTAL_HEALTH,high-level resistance,high-level resistance
NEW15678,CHEMICAL,3'-azido-3'-deoxythymidine azt,3'-azido-3'-deoxythymidine AZT
NEW15681,CHEMICAL,3'-azido-3'-deoxythymidine azt,norepinephrine substrates
NEW15682,BIOCHEMICAL,apoe4 carrier,ApoE4 carriers
NEW15684,CHEMICAL,apoe3 carrier,ApoE3 carriers
NEW15685,CHEMICAL,dha+epa level,DHA+EPA levels
NEW15686,BIOCHEMICAL,apoe-ε4 allele carrier,APOE-ε4 allele carriers
NEW15687,CHEMICAL,covid-19 survivor,COVID-19 survivors
NEW15688,BIOCHEMICAL,selective taar1 full agonist,selective TAAR1 full agonist
NEW15689,CHEMICAL,ro5256390,RO5256390
NEW15690,BIOCHEMICAL,kappa receptor antagonist,kappa receptor antagonists
C480351,CHEMICAL,astodrimer [Supplementary Concept],SPL7013|Polylysine|Dendrimers
NEW15691,BIOCHEMICAL,allergene,allergene
NEW15693,CHEMICAL,high serum uric acid ua level,higher serum uric acid UA levels
D006947,DISEASE,Hyperkalemia,Hyperkalemias|hyperkalemia|Hyperpotassemias|Hyperpotassemia
NEW15696,DISEASE,frailty score,Frailty score
NEW15698,BIOCHEMICAL,second-generation factor-related apoptosis-inducing ligand receptor agonist,second-generation factor-related apoptosis-inducing ligand receptor agonist
NEW15699,MENTAL_HEALTH,steroid phobia,steroid phobia
D000077216,DISEASE,"Carcinoma, Ovarian Epithelial","Epithelial Ovarian Cancer|Cancers, Ovarian Epithelial|Ovarian Carcinoma, Epithelial|ovarian carcinoma|Carcinomas, Epithelial Ovarian|Ovarian Epithelial Carcinomas|Epithelial Cancers, Ovarian|Epithelial Ovarian Cancers|Epithelial Cancer, Ovarian|Ovarian Epithelial Carcinoma|Cancers, Epithelial Ovarian|Epithelial Ovarian Carcinoma|Epithelial Carcinoma, Ovarian|Cancer, Epithelial Ovarian|Cancer, Ovarian Epithelial|Carcinoma, Epithelial Ovarian|Ovarian Cancers, Epithelial|Ovarian Epithelial Cancers|Carcinomas, Ovarian Epithelial|Ovarian Cancer, Epithelial|Ovarian Carcinomas, Epithelial|Epithelial Ovarian Carcinomas|Epithelial Carcinomas, Ovarian|Ovarian Epithelial Cancer"
D018908,DISEASE,Muscle Weakness,"Muscle Weaknesses|Weaknesses, Muscular|Muscular Weaknesses|muscle weakness|Weakness, Muscle|Muscular Weakness|Weaknesses, Muscle|Weakness, Muscular"
NEW15701,CHEMICAL,acid analysis,acids analysis
NEW15703,CHEMICAL,circulate serotonin,circulating serotonin
NEW15704,MENTAL_HEALTH,newborn olfactory projection neuron,newborn olfactory projection neurons
NEW15705,CHEMICAL,uro-s,URO-S
NEW15707,CHEMICAL,lipopolysaccharide lps level,Lipopolysaccharide LPS levels
NEW15708,CHEMICAL,trna3lys,tRNA3Lys
NEW15710,BIOCHEMICAL,vitamin k status,vitamin K status
D003876,DISEASE,"Dermatitis, Atopic","Neurodermatitides, Atopic|Disseminated Neurodermatitis|Eczema, Atopic|Atopic Dermatitides|Dermatitides, Atopic|Atopic dermatitis|Neurodermatitis, Atopic|Infantile Eczema|Atopic Dermatitis|Atopic Eczema|Eczema, Infantile|Neurodermatitis, Disseminated|Disseminated Neurodermatitides|Atopic Neurodermatitides|Atopic Neurodermatitis|Neurodermatitides, Disseminated"
NEW15711,CHEMICAL,plasma adrenaline,Plasma adrenaline
D005230,NUTRITION,"Fatty Acids, Nonesterified","Acid, Free Fatty|Acids, Free Fatty|free fatty acids|Nonesterified Fatty Acids|NEFA|Free Fatty Acid|Acids, Nonesterified Fatty|Fatty Acid, Free|Free Fatty Acids|Fatty Acids, Free"
D016854,MENTAL_HEALTH,Dental Anxiety,"Dental Anxieties|Phobia, Dental|Dental Fears|Anxiety, Dental|Dental Phobias|Odontophobia|Dental Phobia|Fear, Dental|Phobias, Dental|Fears, Dental|dental phobia|Dental Fear|Odontophobias|Anxieties, Dental"
NEW15715,CHEMICAL,increase plasma homocysteine,Increased plasma homocysteine
D008244,CHEMICAL,Lysophosphatidylcholines,Lysolecithins|LPC|Lysophosphatidylcholine|lysophosphatidylcholines|Lysolecithin
http://purl.obolibrary.org/obo/CHEBI_26523,CHEMICAL,reactive oxygen species,ROS|reactive oxygen species production
NEW15717,CHEMICAL,copper ammunition,Copper ammunitions
NEW15719,CHEMICAL,thymidine derivative,thymidine derivative
http://purl.obolibrary.org/obo/CHEBI_33838,CHEMICAL,nucleoside,"2',3'-dideoxynucleoside|Nucleoside|nucleosides|a nucleoside"
NEW15721,CHEMICAL,a. indica,MeOH-AI|A. indica
NEW15723,CHEMICAL,alcohol amblyopia,alcohol amblyopia
NEW15725,CHEMICAL,berberis aristata dc,Berberis aristata DC
NEW15727,CHEMICAL,aristata extract,aristata extract
D011718,CHEMICAL,Pyrazinamide,pyrazinamide|Tisamid
NEW15732,BIOCHEMICAL,bmp antagonist,BMP antagonists
NEW15734,DISEASE,folie à double forme,folie à double forme
NEW15737,CHEMICAL,serotonin abnormality,serotonin abnormalities
NEW15740,MENTAL_HEALTH,least-square regression model,least-squares regression model
NEW15743,CHEMICAL,homozygous sip1 mouse,Sip1fI/fI|homozygous Sip1 mice
NEW15745,DISEASE,significant multi-morbidity,significant multi-morbidity
NEW15746,BIOCHEMICAL,vital endocrine organ,vital endocrine organ
NEW08303,DISEASE,gut microbiota dysbiosis,gut microbiota dysbiosis
NEW15423,DISEASE,significant xanthine oxidase inhibition,visceral hypersensitivity
NEW01784,NUTRITION,lithium treatment,lithium treatment
NEW15755,DISEASE,bipolar adolescent,bipolar adolescents
NEW15757,CHEMICAL,selenium status,selenium status
D064702,MENTAL_HEALTH,"International Classification of Functioning, Disability and Health",disability|Disability Evaluation (2002-2013)
NEW15759,BIOCHEMICAL,correspond endocrine syndrome,corresponding endocrine syndromes
C493962,CHEMICAL,"Cdkn1b protein, rat [Supplementary Concept]",p27(kip1|Cyclin-Dependent Kinase Inhibitor p27
NEW15762,CHEMICAL,other non-short-stature indication,Other non-short-stature indications
NEW15764,MENTAL_HEALTH,postoperative delirium,postoperative delirium
NEW15765,DISEASE,levodopa-treated parkinson patient,levodopa-treated Parkinson patients
C005466,CHEMICAL,ursolic acid [Supplementary Concept],ursolic acid|UA|Triterpenes
D002333,CHEMICAL,Carnitine Acyltransferases,"Carnitine Translocase|Translocase, Carnitine-Acetylcarnitine|acylcarnitine|Translocase, Carnitine-Acylcarnitine|Carnitine Acetylcarnitine Translocase|Carnitine-Acylcarnitine Translocase|Translocase, Carnitine|Carnitine Acylcarnitine Translocase|Acylcarnitine Translocase|Acyltransferases, Carnitine|Translocase, Acylcarnitine|Carnitine-Acetylcarnitine Translocase"
http://purl.obolibrary.org/obo/CHEBI_35478,NUTRITION,lithium salt,Lithium salts|Lithiumsalze|Lithiumsalz|lithium salts
NEW15768,CHEMICAL,clopyralid sensitivity,clopyralid sensitivity
http://purl.obolibrary.org/obo/CHEBI_85012,BIOCHEMICAL,thrombopoietin receptor agonist,thrombopoietin receptor agonists|thrombopoietin TPO receptor agonist lusutrombopag|TPO receptor agonists|TPO receptor agonist
NEW15769,DISEASE,non-ischemic heart failure,non-ischemic heart failure
NEW15771,DISEASE,heart failure entity,heart failure entities
D000069287,CHEMICAL,Capecitabine,Capecitabine|Xeloda|N(4)-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine
NEW15773,CHEMICAL,5-methyltetrahydrofolate specie,5-methyltetrahydrofolate species
NEW15774,BIOCHEMICAL,contraceptive microbicide,Contraceptive microbicides
D058458,CHEMICAL,Nitrogen Cycle,"N-9|Ammonification|Nitrogen Cycles|Cycle, Nitrogen|nitrogen"
NEW15775,CHEMICAL,sco mg/kg,Sco mg/kg
NEW15776,CHEMICAL,g-protein-activated inwardly rectifying potassium girk channel,G-protein-activated inwardly rectifying potassium GIRK channels
NEW15781,CHEMICAL,histamine h1-receptor blocker,Histamine H1-receptor blockers
NEW15782,CHEMICAL,imipramine- drug,imipramine- drugs
NEW06445,CHEMICAL,various antidepressant,various antidepressants
D056508,DISEASE,Sleep Medicine Specialty,"Specialties, Sleep Medicine|Sleep Medicine Specialties|Medicine Specialties, Sleep|sleep|catalepsy|Medicine Specialty, Sleep|Specialty, Sleep Medicine"
NEW15783,DISEASE,histamine-induced catalepsy,Histamine-induced catalepsy
NEW15784,CHEMICAL,α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid ampa receptor glua1 subunit-deficient glua1-/- mouse,α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA receptor GluA1 subunit-deficient GluA1-/- mice
D010713,CHEMICAL,Phosphatidylcholines,"Choline, Phosphatidyl|Choline Glycerophospholipids|Phosphatidyl Choline|Phosphoglycerides, Choline|Cholines, Phosphatidyl|Choline Phosphoglycerides|Phosphatidyl Cholines|phosphatidylcholines|Phosphatidylcholine|Glycerophospholipids, Choline"
NEW15787,DISEASE,cognition loss,cognition loss
D003983,CHEMICAL,Dibenzylchlorethamine,"Chlorethylamine, Dibenzyl|Dibenzyl Chlorethylamine|dibenamine|Dibenamine"
NEW15789,BIOCHEMICAL,combined nutraceutical supplement,combined nutraceutical supplement
NEW14440,DISEASE,breast cancer risk,breast cancer risk
NEW15792,BIOCHEMICAL,base antacid,based antacid
NEW15793,CHEMICAL,significant quick-eze use,significant Quick-Eze use
NEW15796,CHEMICAL,hypomethylating agent azacitidine,AZA|hypomethylating agent azacitidine
NEW15798,CHEMICAL,hypomethylating agent azacitidine,hypomethylating agent azacitidine
NEW15800,CHEMICAL,aza-7,AZA-7
NEW15803,CHEMICAL,gamma-aminobutyric acid gaba metabolism,Gamma-aminobutyric acid GABA metabolism
NEW15804,CHEMICAL,gaba alteration,GABA alterations
NEW15806,CHEMICAL,gaba signal,GABA signal
NEW15807,CHEMICAL,rsno,RSNO
D026403,CHEMICAL,S-Nitrosothiols,S-Nitrosothiol|Nitrosothiols
NEW15809,BIOCHEMICAL,nitric oxide releasing polymer hexagon,nitric oxide releasing polymer hexagons
NEW15810,BIOCHEMICAL,novel antibacterial agent,novel antibacterial agent
D019803,CHEMICAL,Glutathione Disulfide,"Disulfide, Glutathione|Glutathione Disulfide, Ion(1-)|disulfide|Oxidized Glutathione|Glutathione, Oxidized|GSSG"
NEW15812,DISEASE,elderly hypertensive male patient,elderly hypertensive male patient
NEW15814,CHEMICAL,serotonin synthesis production,serotonin synthesis production
NEW15816,DISEASE,aqueous nymphaea lotus extract,aqueous Nymphaea lotus extract|ANL
D018092,CHEMICAL,"Receptors, Kainic Acid","Receptor, Kainic Acid|Receptor, Kainate|Kainic Acid Receptor|Kainate Receptors|Kainic Acid Receptors|Kainic acid|Kainate Receptor|Receptors, Kainate"
D030721,CHEMICAL,Nymphaea,"Lily, Water|Nymphaea lotus|Waterlily|Water Lily"
D019331,CHEMICAL,NG-Nitroarginine Methyl Ester,"NG Nitroarginine Methyl Ester, D Orn Isomer|NG-Nitroarginine Methyl Ester, D-Orn-Isomer|Methyl Ester, NG-Nitroarginine|NG-Nitroarginine Methyl Ester, L-Orn-Isomer, Monohydrochloride|N(omega)-Nitro-L-arginine Methyl Ester|N(G)-Nitro-L-arginine Methyl Ester|Methyl Ester, NG-Nitro-L-Arginine|N omega-Nitro-L-arginine Methyl Ester|N(G)-Nitroarginine Methyl Ester|N omega Nitro L arginine Methyl Ester|L-NAME|NG-Nitro-L-Arginine Methyl Ester|NG Nitroarginine Methyl Ester|NG Nitro L Arginine Methyl Ester"
NEW15821,CHEMICAL,l-name chronic intake,L-NAME chronic intake
NEW15823,CHEMICAL,nymphea lotus,Nymphea lotus
D017334,CHEMICAL,Teicoplanin,Teicoplanin|Targocid|Teichomycin A2|Teichomycin
C449179,CHEMICAL,N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide [Supplementary Concept],Pyrimidines|YM598|Sulfonamides
NEW15825,DISEASE,human melanoma cell line skmel-,human melanoma cell line SKMel-
NEW15826,BIOCHEMICAL,novel endothelin-a eta receptor antagonist,novel endothelin-A ETA receptor antagonist
NEW15827,BIOCHEMICAL,selective nk1 receptor antagonist,selective NK1 receptor antagonists
D000116,CHEMICAL,Acetylgalactosamine,2 Acetamido 2 D galactopyranose|2 Acetamido 2 Deoxygalactose|2-Acetamido-2-D-galactopyranose|2-Acetamido-2-Deoxy-D-Galactose|N Acetyl D Galactosamine|N-Acetyl-D-Galactosamine|d-galactosamine|2 Acetamido 2 Deoxy D Galactose|2-Acetamido-2-Deoxygalactose
NEW15828,CHEMICAL,acetaminophen toxicity,acetaminophen toxicity
D054596,CHEMICAL,"Protein Tyrosine Phosphatase, Non-Receptor Type 22","PTPN-22 Protein|Tyrosine Protein Phosphatase, Non-Receptor Type 22|protein-tyrosine phosphatase|PTPase, Lyp2|Lymphoid Phosphatase|Protein-Tyrosine Phosphatase Lyp|Lyp2 PTPase|Tyrosine Protein Phosphatase, Non Receptor Type 22|Protein Tyrosine Phosphatase Lyp|PTPase Lyp|PTPN 22 Protein|PTPase, Lyp1|Protein Tyrosine Phosphatase, Non Receptor Type 22|Lyp1 PTPase"
D014222,CHEMICAL,Triamcinolone Acetonide,"Tricort-40|Azmacort|triamcinolone|Acetonide, Triamcinolone|Tricort 40|Cinonide|Tricort40|Kenalog 40|Kenacort A|Kenalog"
NEW15830,CHEMICAL,such pns sow,Such PNS sows
NEW15833,DISEASE,sympathomimetic toxidrome,sympathomimetic toxidrome
NEW15834,MENTAL_HEALTH,excited delirium syndrome,Excited delirium syndrome
NEW15837,DISEASE,excited delirium syndrome,ExDS|Excited delirium syndrome
NEW15838,CHEMICAL,prehospital ketamine,Prehospital ketamine
NEW15840,BIOCHEMICAL,adrenocorticotrophic hormone rat model,Adrenocorticotrophic hormone rat model
NEW15842,BIOCHEMICAL,hpg axis hormone,HPG axis hormones
C472067,CHEMICAL,levocetirizine [Supplementary Concept],Cetirizine|levocetirizine
NEW15843,CHEMICAL,simple well histamine receptor,simpler better histamine receptor
NEW15844,BIOCHEMICAL,lithium mood stabilizer,lithium mood stabilizers
NEW15847,BIOCHEMICAL,selective da-1 agonist,Selective DA-1 agonists
D052684,DISEASE,Thyrotrophs,"TSH|TSH-Producing Cell, Pituitary|Pituitary TSH-Secreting Cells|TSH-Secreting Cells, Pituitary|TSH Cells|Cell, TSH|Pituitary TSH Secreting Cells|Pituitary TSH-Producing Cell|TSH-Producing Cells, Pituitary|Pituitary TSH-Producing Cells|Thyrotroph|Pituitary TSH-Secreting Cell|TSH Cell|Pituitary TSH Producing Cells|TSH-Secreting Cell, Pituitary|IST"
NEW15849,BIOCHEMICAL,peripheral thyroid hormone action compatible,peripheral thyroid hormone action compatible
NEW15852,MENTAL_HEALTH,respiration depression,respiration depression
NEW15854,CHEMICAL,dibenzazepine mg/kg,dibenzazepine mg/kg
C004822,CHEMICAL,"10,11-dihydro-10,11-dihydroxy-5H-dibenzazepine-5-carboxamide [Supplementary Concept]",Carbamazepine/analogs  and  derivatives|dibenzazepine
D008659,DISEASE,Metabolic Diseases,"Thesaurismosis|Thesaurismoses|Metabolic Disease|Disease, Metabolic|metabolic disease|Diseases, Metabolic"
http://purl.obolibrary.org/obo/DOID_857,DISEASE,multiple carboxylase deficiency,Multiple carboxylases deficiency
NEW15858,CHEMICAL,trinitrate ointment,trinitrate ointment
NEW15860,CHEMICAL,myrtus communis,Mc-80ME|Myrtus communis
NEW15861,BIOCHEMICAL,antibiotic resistant,Antibiotic resistant
NEW15863,MENTAL_HEALTH,5-fu resistance,5-FU resistance
NEW15865,MENTAL_HEALTH,certain resistance mechanism,Certain resistance mechanisms
NEW15866,MENTAL_HEALTH,severe alcohol withdrawal syndrome,severe alcohol withdrawal syndromes
NEW15867,CHEMICAL,thyrotoxic periodic paralysis,Thyrotoxic periodic paralysis|TPP
D018943,CHEMICAL,Anthracyclines,Anthracyclines|Anthracycline
D004317,CHEMICAL,Doxorubicin,"Adriblastina|Doxorubicina Tedec|Doxorubicine Baxter|Adriablastine|Hydrochloride, Doxorubicin|Onkodox|Urokit Doxo cell|Rubex|Urokit Doxo-cell|Adriblastine|Doxorubicin NC|Doxotec|Doxorubicin Hydrochloride|Doxorubicin Hexal|Doxorubicina Ferrer Farm|Doxolem|Adriamycin|Adrimedac|DOXO-cell|doxorubicin|Adriblastin|Adriablastin|Farmiblastina|Doxorubicina Funk|Myocet|Ribodoxo|DOXO cell"
D064730,CHEMICAL,Dexrazoxane,"Cardioxan|ICRF-187|Razoxane, (S)-Isomer|Zinecard|NSC 169780|ADR 529|dexrazoxane|NSC169780|ADR-529|ADR529|Hydrochloride, Dexrazoxane|Cardioxane|Dexrazoxane Hydrochloride|NSC-169780|Razoxane, (S)-Isomer, Hydrochloride|ICRF 187|ICRF187"
NEW15870,CHEMICAL,class statin,classes statins
NEW15872,DISEASE,severe mood episode,severe mood episodes
NEW15874,CHEMICAL,nicotinic acetylcholine receptor subtype inhibitor,Nicotinic acetylcholine receptor subtype inhibitors
NEW15879,DISEASE,overt hyperthyroidism,Overt hyperthyroidism
NEW15881,DISEASE,subclinical hyperthyroidism,subclinical hyperthyroidism
NEW15883,DISEASE,ensue inflammation,ensuing inflammation
NEW15887,CHEMICAL,nad+ metabolism,NAD+ metabolism
NEW15889,CHEMICAL,host 's nad+ salvage pathway,host's NAD+ salvage pathway
NEW00405,BIOCHEMICAL,antifungal activity,antifungal activity
NEW15891,NUTRITION,simple oxygenated xanthone,simple oxygenated xanthones
NEW15895,MENTAL_HEALTH,erythropoietin resistance index,erythropoietin resistance index
NEW15897,CHEMICAL,cerebral regional oxygen saturation,cerebral regional oxygen saturation
D013960,BIOCHEMICAL,Thyroid Function Tests,"Secretory Capacity of the Thyroid Gland|Jostel TSH Index|Thyrotroph Thyroid Hormone Sensitivity Index|Thyroid Function Test|Protein-Bound Iodine Test|SPINA-GT|hormone sensitivity|Thyroid Gland Function Tests|Jostels Thyrotropin Index|Function Test, Thyroid|Protein Bound Iodine Test|Protein-Bound Iodine Tests|Jostels TSH Index|Iodine Test, Protein-Bound|Jostel Thyrotropin Index|Jostel's TSH Indices|Jostel's TSH Index|Test, Protein-Bound Iodine|Sum Activity of Peripheral Deiodinases|TSH Index, Jostel's|Thyrotropin Index, Jostel's|Test, Thyroid Function|SPINA-GD|Jostel's Thyrotropin Index"
NEW08890,DISEASE,abnormal cholesterol synthesis,abnormal cholesterol synthesis
NEW15900,BIOCHEMICAL,adjuvant vitamin d supplementation therapy,adjuvant vitamin D supplementation therapy
NEW01576,BIOCHEMICAL,low vitamin d,low vitamin D
D050901,CHEMICAL,Nitrate Reductase,"nitrate reductase|Nitrate Reductase, Respiratory|Quinol Nitrate Oxidoreductase|Reductase, Respiratory Nitrate|Oxidoreductase, Quinol-Nitrate|Quinol-Nitrate Oxidoreductase|Reductase, Nitrate|Respiratory Nitrate Reductase"
D050790,CHEMICAL,Glutamate Synthase (NADH),"NADH Dependent Glutamate Synthase|Synthetase, L-Glutamate|L-Glutamate Synthetase|NADH Glutamate Synthase|Glutamate Synthase, NADH-Dependent|NADH-Dependent Glutamate Synthase|NADH-Glutamate Synthase|NADH-GOGAT|Synthase, NADH-Dependent Glutamate|L Glutamate Synthetase|NADH GOGAT|glutamate synthase"
NEW15904,CHEMICAL,Montmorency tart cherry juice,Montmorency tart cherry juice
NEW15906,CHEMICAL,adjunctive tiagabine,adjunctive tiagabine
NEW15908,DISEASE,adjunctive tiagabine,disinhibited behaviors
NEW15910,DISEASE,diet-induced obese,Diet-induced obese
NEW15911,DISEASE,cardiovascular autonomic neuropathy,cardiovascular autonomic neuropathy|CAN
NEW15918,CHEMICAL,atypical vesicular glutamate transporter type 3,atypical vesicular glutamate transporter type 3|VGLUT3
NEW15921,CHEMICAL,dietary flavonoid,dietary flavonoids
NEW15922,BIOCHEMICAL,specific carotenoid,specific carotenoids
http://purl.obolibrary.org/obo/CHEBI_38077,CHEMICAL,polypyrrole,polypyrroles|PPys|poly(pyrrole)s|Polyaniline nanoparticles
D045730,CHEMICAL,Soy Foods,"Texturized Soy Protein|Bean Curd, Soy|Sauce, Soy|Soy Proteins, Texturized|Soy Bean Curds|Tofu|Bean Curds, Soy|Protein, Texturized Soy|Miso|Curd, Soy Bean|Soy Protein, Texturized|Vegetable Protein, Texturized|Soy Food|Cheeses, Soy|Food, Soy|Texturized Soy Proteins|Natto|soy|Curds, Soy Bean|Protein, Texturized Vegetable|Tempeh|Soy Cheeses|Cheese, Soy|Soy Bean Curd|Soy Cheese|Foods, Soy|Soy-PL|Proteins, Texturized Soy|Vegetable Proteins, Texturized|Soy Sauce|Texturized Vegetable Protein"
D058867,CHEMICAL,Lipoprotein Lipase Activators,"Activators, Lipoprotein Lipase|Lipase Activators, Lipoprotein|Lipoprotein Lipase Activating Agents|lipase"
NEW15924,CHEMICAL,endogenous acetylcholine,endogenous acetylcholine
NEW15926,CHEMICAL,endogenous ach,endogenous ACh
NEW15928,CHEMICAL,glutamate receptor dysfunction,Glutamate receptor dysfunction
NEW15930,BIOCHEMICAL,nmdar antagonist administration,NMDAR antagonist administration
D004345,BIOCHEMICAL,Drug Industry,"Pharmaceutic Industry|Industries, Pharmaceutic|Drug Industries|Industry, Pharmaceutic|Pharmaceutical Industry|Industries, Pharmaceutical|Industry, Drug|Industry, Pharmaceutical|Pharmaceutical Industries|pharmaceutical industry|Industries, Drug|Pharmaceutic Industries"
NEW15935,DISEASE,central neurogenic hypoventilation,central neurogenic hypoventilation
NEW15937,CHEMICAL,combined serotonin,combined serotonin
NEW15939,CHEMICAL,h(1)-histamine receptor blocker,H(1)-histamine receptor blockers
C014742,CHEMICAL,quifenadine [Supplementary Concept],Benzhydryl Compounds|Quifenadine
NEW15941,CHEMICAL,Quifanidine,Quifanidine
NEW15943,NUTRITION,low cholesterol,low cholesterol
http://purl.obolibrary.org/obo/CHEBI_84071,NUTRITION,c22-c26 saturated fatty acid,saturated fatty acid diet|C22-C26 saturated fatty acids
NEW15945,DISEASE,hematopathologic finding,hematopathologic findings
NEW15947,CHEMICAL,valproic acid vpa injection,Valproic acid VPA injection
NEW15948,CHEMICAL,vpa rat,VPA rats
D066255,CHEMICAL,EGF Family of Proteins,"Ligands, EGF Receptor|DEPs|Receptor Ligands, EGF|EGF Receptor Ligands|Epidermal Growth Factor Like Proteins|proteins|Epidermal Growth Factor-Like Proteins|Epidermal Growth Factors|Proteins EGF Family"
NEW15949,CHEMICAL,prazosin addition,prazosin addition
NEW15951,CHEMICAL,clinical trial prazosin,clinical trial Prazosin
NEW15952,BIOCHEMICAL,acridinecarboxamide topoisomerase poison,acridinecarboxamide topoisomerase poisons
NEW15954,BIOCHEMICAL,appropriate antimicrobial medication,appropriate antimicrobial medications
NEW15955,CHEMICAL,odorata Cav,odorata Cav
NEW15956,CHEMICAL,nmdar-dependent bursting activity,NMDAR-dependent bursting activity
NEW15959,DISEASE,functional fragile x mental retardation protein,functional Fragile X mental retardation protein
NEW15961,CHEMICAL,pi3 k signaling,PI3 K signaling
D002697,CHEMICAL,Chloral Hydrate,"Chloral hydrate|Noctec|Hydrate, Chloral"
NEW15966,CHEMICAL,high baclofen dose,higher baclofen doses
NEW11009,CHEMICAL,to oseltamivir carboxylate,to oseltamivir carboxylate|OC
NEW15968,DISEASE,androgenetic alopecia aga management,Androgenetic alopecia AGA management
NEW15973,CHEMICAL,gas sensor,gas sensors
NEW15975,BIOCHEMICAL,transient receptor potential vanilloid type1 agonist,transient receptor potential vanilloid type1 agonist
NEW15977,CHEMICAL,mitochondrial calcium homeostasis,mitochondrial calcium homeostasis
NEW15978,CHEMICAL,low-dose dietary capsaicin,low-dose dietary capsaicin
NEW15979,MENTAL_HEALTH,erectile dysfunction present,erectile dysfunction present
NEW15981,CHEMICAL,frog wsc,frog WSC
NEW15983,DISEASE,catalepsy homologue,catalepsy homologue
NEW05202,NUTRITION,brain phospholipid,brain phospholipids
NEW15986,MENTAL_HEALTH,negative schizophrenia,negative schizophrenia
NEW15992,CHEMICAL,podophyllin reaction,podophyllin reaction
NEW15993,DISEASE,organic skin disease,organic skin disease
NEW15996,CHEMICAL,weak n-methyl-d-aspartate nmda receptor-antagonist,weak N-Methyl-D-Aspartate NMDA receptor-antagonists
NEW14967,BIOCHEMICAL,alpha-linolenic acid pathway,antibiotic overuse
NEW15997,CHEMICAL,blood aba level,Blood ABA levels
NEW16001,BIOCHEMICAL,serum thyroid hormone concentration,serum thyroid hormone concentrations
NEW16002,BIOCHEMICAL,serum thyroid hormone concentration,hormone function
NEW16003,MENTAL_HEALTH,somatic anxiety,somatic anxiety
http://purl.obolibrary.org/obo/CHEBI_6121,CHEMICAL,ketamine,Ketamine|2-(2-chlorophenyl)-2-(methylamino)cyclohexanone|DL-ketamine|ketaminum|ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|dl-ketamine|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|ketamina|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|special K|NMDA|KETAMINE|small-dose ketamine|(+-)-ketamine
NEW16005,DISEASE,depressed mood,Depressed mood
http://purl.obolibrary.org/obo/CHEBI_8411,CHEMICAL,primidolol,beta-adrenoblocker|Primidolol
NEW11856,MENTAL_HEALTH,transepithelial electrical resistance,transepithelial electrical resistance
D007545,CHEMICAL,Isoproterenol,"Isadrin|Euspiran|Izadrin|isadrine|Norisodrine|4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol|Isopropyl Noradrenaline|Novodrin|Noradrenaline, Isopropyl|Isoproterenol Sulfate|Isoprenaline|Isoproterenol Hydrochloride|Isopropylnoradrenaline|Sulfate, Isoproterenol|Isadrine|Isopropylnorepinephrine|Isopropylarterenol|Isuprel|Hydrochloride, Isoproterenol"
NEW16008,CHEMICAL,membrane-impermeant no scavenger cptio,membrane-impermeant NO scavenger cPTIO
NEW16009,CHEMICAL,nos inhibitor l-name,NOS inhibitor L-NAME
C095284,CHEMICAL,"1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one [Supplementary Concept]",Quinoxalines|ODQ|Oxadiazoles
C096240,CHEMICAL,"cyclosporin A, MeAla(3)-Phe(7)-Ser(8)- [Supplementary Concept]",cyclosporin A|Cyclosporins
NEW16010,CHEMICAL,transmitter release,transmitter release
NEW16012,MENTAL_HEALTH,long-lasting depression,long-lasting depression
NEW16013,BIOCHEMICAL,gabaa agonist midazolam,GABAA agonist midazolam
NEW16016,BIOCHEMICAL,nmdar antagonist s-ketamine,NMDAR antagonist s-ketamine
NEW16018,NUTRITION,primary root growth promotion,primary root growth promotion
NEW16021,BIOCHEMICAL,ppar-γ agonist pioglitazone,PPAR-γ agonist pioglitazone
D007711,DISEASE,Klebsiella pneumoniae,Klebsiella pneumoniae aerogenes|Klebsiella rhinoscleromatis|Hyalococcus pneumoniae|Bacillus pneumoniae|Bacterium pneumoniae crouposae|Klebsiella pneumoniae
D013837,CHEMICAL,Thiamin-Triphosphatase,thiamin|Thiamine Triphosphatase|Thiamin Triphosphatase
NEW16023,CHEMICAL,14n nuclear quadrupole coupling hyperfine structure,14N nuclear quadrupole coupling hyperfine structure
C523273,CHEMICAL,"NrdR protein, E coli [Supplementary Concept]",NrdR|Escherichia coli Proteins
NEW16030,BIOCHEMICAL,glycoprotein iib/iiia receptor antagonist,Glycoprotein IIb/IIIa receptor antagonists
C046817,CHEMICAL,cefteram pivoxil [Supplementary Concept],Tomiron|Cefmenoxime/analogs  and  derivatives
NEW16032,DISEASE,schizophrenia abnormal gene,schizophrenia abnormal gene
D000076722,BIOCHEMICAL,Drug Development,"Development, Pharmaceutical|drug development|Drug Target Predictions|Prediction, Drug Target|Drug Target Prediction|Pharmaceutical Development|Development, Medication|Computational Prediction of Drug-Target Interactions|Development, Drug|Target Prediction, Drug|Medication Development"
D002692,DISEASE,Chlamydia trachomatis,Chlamydia trachomatis|Chlamydia (1966-1975)
NEW16034,NUTRITION,serum folate level,serum folate levels
NEW01895,MENTAL_HEALTH,serum folate level,suicidal behavior
NEW16035,NUTRITION,serum folate level,Serum folate levels
NEW16038,BIOCHEMICAL,reduce serum folate level,Reduced serum folate levels
NEW16041,BIOCHEMICAL,lxr agonist treatment,LXR agonist treatment
NEW16042,DISEASE,intrauterine growth retardation iugr neonatus,intrauterine growth retardation IUGR neonatus
D050792,DISEASE,"Circulatory Arrest, Deep Hypothermia Induced",Deep Hypothermic Circulatory Arrest|hypothermia
NEW16046,MENTAL_HEALTH,resistance test,resistance test
NEW16047,BIOCHEMICAL,ssri initiation,SSRI initiation
NEW16048,BIOCHEMICAL,flexible 32-channel polymer microelectrode array,flexible 32-channel polymer microelectrode arrays
http://purl.obolibrary.org/obo/DOID_2228,DISEASE,thrombocytosis,hyperviscosity|Thrombocythaemia
NEW16051,CHEMICAL,testosterone supplementation,Testosterone supplementation
NEW16053,CHEMICAL,srs-4,SRS-4
NEW16054,CHEMICAL,serum homocysteine,Serum homocysteine
NEW16056,BIOCHEMICAL,vitamin intervention,Vitamin Intervention
NEW16058,CHEMICAL,fxrα,fxrα
NEW16059,CHEMICAL,high-carbohydrate diet,High-carbohydrate diet
NEW16061,CHEMICAL,high carbohydrate level,High carbohydrate levels
NEW16063,BIOCHEMICAL,characterize virulence factor,characterized virulence factor
C000625557,CHEMICAL,roluperidone [Supplementary Concept],Roluperidone|Indoles
NEW16065,DISEASE,mda-mb-231 breast cancer cell,MDA-MB-231 breast cancer cells
NEW16073,BIOCHEMICAL,estrogen molecule,estrogen molecules
NEW06690,MENTAL_HEALTH,input resistance peak,input resistance
NEW16076,CHEMICAL,4-(4-hydroxyphenyl)-2-butanone,4-(4-hydroxyphenyl)-2-butanone
http://purl.obolibrary.org/obo/CHEBI_39093,CHEMICAL,organophosphorus pesticide,OPPs|Organophosphorus pesticides|organophosphorus pesticides
NEW16080,NUTRITION,phospholipid vesicle,Phospholipid vesicles
NEW16083,CHEMICAL,antibiotic-resistant iturin c,Antibiotic-resistant Iturin C
NEW16085,CHEMICAL,first rrr pattern,first RRR pattern
C583443,CHEMICAL,technetium 99m diethylenetriaminepentaacetic acid neolactosyl human serum albumin [Supplementary Concept],Serum Albumin|Organotechnetium Compounds|[99mTc]DTPA
NEW16087,DISEASE,various brain tumor,Various brain tumors
NEW16089,DISEASE,recurrent tumor,recurrent tumors
NEW16090,DISEASE,radiation necrosis,radiation necrosis
NEW16091,CHEMICAL,[11c]methylmethionine,[11C]methylmethionine
http://purl.obolibrary.org/obo/CHEBI_50949,BIOCHEMICAL,serotonin uptake inhibitor,SSRI|selective serotonin uptake inhibitor|serotonin reuptake inhibitor
NEW16093,CHEMICAL,tacrolimus treatment,tacrolimus treatment
D022061,CHEMICAL,Tacrolimus Binding Protein 1A,FK506 Binding Protein 1|FKBP-12|Tacrolimus|FK506-Binding Protein 1A|FK506-Binding Protein 1|FKBP 12|FK506 Binding Protein 1A|FKBP12|Macrophilin 12|Macrophilin-12
NEW16096,CHEMICAL,betel nut abuse,betel nut abuse
D012907,DISEASE,Smoking,"smoking behavior|Smoking Habits|Smoking Habit|Behaviors, Smoking|Habits, Smoking|Behavior, Smoking|Smoking Behavior|Habit, Smoking|Smoking Behaviors"
NEW16097,CHEMICAL,asai-mutant,asaI-mutant
NEW16099,CHEMICAL,exogenous c4-hsl,exogenous C4-HSL
NEW16100,CHEMICAL,asai/c4-hsl,AsaI/C4-HSL
NEW16101,DISEASE,deficit patient,deficit patients
NEW16103,BIOCHEMICAL,antiviral drug toxicity,antiviral drug toxicity
NEW16105,DISEASE,goal-oriented behavior,goal-oriented behavior
NEW16106,DISEASE,minimal facial acne,minimal facial acne
NEW16107,MENTAL_HEALTH,dysmorphophobia related,dysmorphophobia related
NEW16108,DISEASE,primary dysthymic patient,primary dysthymic patients
NEW16109,DISEASE,p. pedunculata,P. pedunculata
D009119,DISEASE,Muscle Contraction,"muscle contractions|Contractions, Muscular|Contraction, Muscle|Muscular Contraction|Inotropism|Muscle Contractions|Muscular Contractions|Contractions, Muscle|Inotropisms|Contraction, Muscular"
D000069476,CHEMICAL,Linagliptin,"1356, BI|BI 1356|(R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione|Trajenta|BI-1356|Tradjenta|1H-purine-2,6-dione, 8-((3r)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-|BI1356|linagliptin"
NEW16114,BIOCHEMICAL,prenatal folic acid supplementation,prenatal folic acid supplementation
NEW16116,MENTAL_HEALTH,autism symptomatology,autism symptomatology
NEW16117,CHEMICAL,pufa treatment,PUFA treatments
NEW16118,BIOCHEMICAL,ghrelin receptor inverse agonist,ghrelin receptor inverse agonist
NEW16119,CHEMICAL,KbFwLL-NH2,KbFwLL-NH2
NEW16120,DISEASE,vulvovaginal atrophy,Vulvovaginal atrophy
NEW16121,MENTAL_HEALTH,dissociation energy,dissociation energies
NEW16127,NUTRITION,largemouth bass ranavirus,Largemouth bass ranavirus
NEW16131,CHEMICAL,gaba pathway,GABA pathway
NEW16135,DISEASE,severe hypoxia group,severe hypoxia group
NEW16137,CHEMICAL,serum ft3 level ng/l,serum FT3 level ng/L
NEW16138,CHEMICAL,serum ft3,serum FT3
NEW16139,DISEASE,osahs patient,OSAHS patients
NEW12878,DISEASE,severe hypoxia,severe hypoxia
NEW16142,DISEASE,osahs child,OSAHS children
NEW16143,MENTAL_HEALTH,population fragmentation,population fragmentation
NEW16146,CHEMICAL,glucose response,Glucose response
NEW16150,NUTRITION,intestinal yeast cyclic dipeptide,intestinal yeast cyclic dipeptides
NEW16151,CHEMICAL,glutamate receptor activation,glutamate receptor activation
NEW16152,CHEMICAL,ampa receptor activation,AMPA receptor activation
NEW16153,DISEASE,cerebellar overactivity,cerebellar overactivity
http://purl.obolibrary.org/obo/DOID_1837,DISEASE,diabetic ketoacidosis,"severe diabetic ketoacidosis|ketosis-prone diabetes mellitus|DIABETES MELLITUS, KETOSIS-PRONE"
NEW16156,NUTRITION,inorganic potassium phosphate,inorganic potassium phosphates
NEW16157,MENTAL_HEALTH,oxyhemoglobin dissociation curve,oxyhemoglobin dissociation curve
D010710,CHEMICAL,Phosphates,"Phosphate|Phosphate, Inorganic|inorganic phosphates|Inorganic Phosphates|Orthophosphate|Inorganic Phosphate|Phosphates, Inorganic"
NEW16161,CHEMICAL,dpg level,DPG level
NEW16165,BIOCHEMICAL,folate substituion,folate substituion
NEW16166,CHEMICAL,mri-voxel-based specific regional analysis system,MRI-voxel-based specific regional analysis system
NEW16167,DISEASE,low urinary tract symptom,LUTS|lower urinary tracts symptoms
NEW16171,CHEMICAL,Background risperidone,Background Risperidone
NEW16172,CHEMICAL,chronic ethanol consumption,Chronic ethanol consumption
NEW16178,MENTAL_HEALTH,bio-based disease resistance inducer able,bio-based disease resistance inducers able
NEW16180,CHEMICAL,superoxide dismutase glutathione s-transferase,superoxide dismutase glutathione S-transferase
NEW16182,DISEASE,necrotic mechanism,necrotic mechanisms
http://purl.obolibrary.org/obo/CHEBI_170865,CHEMICAL,"13,14-dihydro pgf2a","resolvins RvD1|(E)-7-[3,5-dihydroxy-2-(3-hydroxyoctyl)cyclopentyl]hept-5-enoic acid"
NEW16183,CHEMICAL,numerous antidepressant,Numerous antidepressants
D020150,DISEASE,Chorea Gravidarum,"Chorea|Pregnancy-Induced Chorea|Gravidarum, Chorea|Pregnancy-Associated Choreoathetosis|Choreoathetosis, Pregnancy Associated|Choreoathetoses, Pregnancy-Associated|Choreoathetosis, Pregnancy-Associated|Chorea, Pregnancy Induced|Pregnancy-Induced Choreas|Chorea Gravidarums|Chorea, Pregnancy-Induced|Choreas, Pregnancy-Induced|Pregnancy-Associated Choreoathetoses"
D009655,CHEMICAL,Octopamine,para-Octopamine|4-Octopamine|octopamine|Norsympatol|p-Octopamine|alpha-(Aminoethyl)-4-hydroxybenzenemethanol|Norsynephrine
NEW16187,DISEASE,urogenital infection,urogenital infections
D005460,CHEMICAL,"Fluorides, Topical","Fluoride Varnishes|Topical Fluorides|topical fluorides|Varnishes, Fluoride"
NEW16191,BIOCHEMICAL,gastric acid-neutralizing antacid rinse,gastric acid-neutralizing antacid rinses
NEW16194,CHEMICAL,polydatin treatment,polydatin treatment
NEW16197,DISEASE,adult coeliac disease,adult coeliac disease
NEW16198,DISEASE,adult coeliac disease,concomitant depressive symptoms
NEW16200,BIOCHEMICAL,San Filippo Neri Hospital,San Filippo Neri Hospital
NEW16201,BIOCHEMICAL,non-competitive n-methyl-d-aspartate receptor antagonist,non-competitive N-methyl-d-aspartate receptor antagonist
NEW16202,CHEMICAL,organophosphorus anticholinesterase,organophosphorus anticholinesterases
NEW16204,DISEASE,abnormal sexual behavior,abnormal sexual behavior
C537345,DISEASE,Sitosterolemia [Supplementary Concept],"Lipid Metabolism, Inborn Errors|sitosterolemia|Intestinal Diseases|Phytosterols/adverse effects|Hypercholesterolemia"
D029842,NUTRITION,Phyllanthus emblica,"Emblica officinali|embilicas, Mirobalanus|Emblica officinalis|officinali, Emblica|Amla|Amlas|Mirobalanus embilica|Mirobalanus embilicas|Phyllanthus emblicas|emblica, Phyllanthus|Phyllanthus emblica"
NEW16210,CHEMICAL,intravenous iron therapy,Intravenous iron therapy
NEW16211,CHEMICAL,intravenous iron use,Intravenous iron use
NEW16214,CHEMICAL,permethrin susceptibility screening,permethrin susceptibility screening
NEW02823,CHEMICAL,conventional antidepressant,conventional antidepressants
NEW16221,CHEMICAL,dopamine level,Dopamine levels
NEW16222,CHEMICAL,inhibitor tolcapone,inhibitor tolcapone
C491010,CHEMICAL,ZJ-17 compound [Supplementary Concept],Urea/analogs  and  derivatives|ZJ-17
C491011,CHEMICAL,ZJ-11 compound [Supplementary Concept],Urea/analogs  and  derivatives|ZJ-11
NEW16225,CHEMICAL,extracellular naag,extracellular NAAG
NEW16228,CHEMICAL,class antagonist xv459,Class antagonist XV459
C118235,CHEMICAL,roxifiban [Supplementary Concept],Amidines|Isoxazoles|roxifiban
NEW16239,CHEMICAL,auranofin af,Auranofin AF
NEW16241,CHEMICAL,oral indomethacin,oral indomethacin
NEW16242,DISEASE,combined dama action,combined DAMA actions
NEW16244,DISEASE,antidyskinetic effect,Antidyskinetic effects
NEW16246,MENTAL_HEALTH,establish l-dopa-induced dyskinesia,established L-dopa-induced dyskinesia
NEW16247,DISEASE,parkinsonian monkey,Parkinsonian monkeys
NEW16245,CHEMICAL,antidyskinetic effect,ADL5510
NEW16248,DISEASE,winter depressive patient,winter depressive patients
NEW16250,DISEASE,hypersomnia common,hypersomnia common
D014284,CHEMICAL,Triiodothyronine,"liothyronine|Liothyronine Sodium|Liothyronine|Cytomel|Thyroid Hormone, T3|triiodothyronine|T3 Thyroid Hormone|3,3',5-Triiodothyronine"
NEW16251,MENTAL_HEALTH,fluoxetine-induced mania,Fluoxetine-induced mania
NEW16252,CHEMICAL,kynurenine metabolism,kynurenine metabolism
D013496,CHEMICAL,Suprofen,suprofen|TN-762|TN762|R-25061|R25061|TN 762|R 25061
NEW16254,NUTRITION,erythrocyte ghost phospholipid datum,Erythrocyte ghost phospholipid data
NEW16255,CHEMICAL,"2r,4r-apdc","2R,4R-APDC"
NEW16258,CHEMICAL,beta-2 adrenergic agonist salbutamol,beta-2 adrenergic agonist salbutamol
NEW07444,MENTAL_HEALTH,depression score,depression scores
C078452,CHEMICAL,ziconotide [Supplementary Concept],ziconotide|omega-Conotoxins
NEW16261,BIOCHEMICAL,Pocock scorpion venom,Pocock scorpion venom
NEW16263,DISEASE,venom poisoning,venom poisoning
D031881,CHEMICAL,Nigella sativa,"Cumin, Black|Cumins, Black|Black Cumin|Nigella sativas|Nigella sativa|Kalonji|Black Cumins|Kalonjus|sativa, Nigella"
D063246,CHEMICAL,"Organogenesis, Plant","Development, Plant Organ|Formations, Plant Organ|Plant Organ Developments|Plant Organogeneses|Plant Organ Formations|plant|Plant Organ Formation|Plant Organogenesis|Organ Formation, Plant|Plant Organ Development|Organogeneses, Plant|Organ Development, Plant|Organ Developments, Plant|Organ Formations, Plant|Formation, Plant Organ|Developments, Plant Organ"
NEW16265,CHEMICAL,ethanol aqueous extract,Ethanol aqueous extract
NEW16266,MENTAL_HEALTH,displacement average,displacement averages
NEW16268,MENTAL_HEALTH,complete dissociation,Complete dissociation
NEW16272,DISEASE,depressed individual,Depressed individuals
NEW16275,CHEMICAL,atypical dopamine da transport blocker,Atypical dopamine DA transport blockers
NEW16276,CHEMICAL,agent tetrabenazine,agent tetrabenazine
D017094,DISEASE,"Porphyrias, Hepatic","porphyrias|Porphyria, Hepatic|Hepatic Porphyrias|Hepatic Porphyria"
NEW16279,CHEMICAL,endogenous acetylcholine degradation,endogenous acetylcholine degradation
D005997,NUTRITION,Glycerylphosphorylcholine,"L alpha Glycerylphosphorylcholine|L-alpha-Glycerylphosphorylcholine|Glycerol 3 Phosphocholine|3-Phosphocholine, Glycerol|Glycerol 3-Phosphocholine|choline alphoscerate|Alphoscerate, Choline|Choline Alfoscerate|Alfoscerate, Choline|Choline Glycerophosphate|Choline Alphoscerate|Glycerophosphorylcholine|Glycerophosphate, Choline"
NEW16282,CHEMICAL,aspartame intake,aspartame intake
NEW16284,DISEASE,basic furnace sludge,basic furnace sludge
NEW16285,DISEASE,basic oxygen furnace sludge,BOFS|basic oxygen furnace sludge
D004688,MENTAL_HEALTH,Encopresis,encopresis
C483757,CHEMICAL,"2-amino-3-(3,4-dichlorobenzyloxy)-6-fluorobicyclo(3.1.0)hexane-2,6-dicarboxylic acid [Supplementary Concept]",MGS0039|Bridged Bicyclo Compounds|Dicarboxylic Acids
NEW16287,BIOCHEMICAL,group mglu receptor antagonist,group mGlu receptor antagonist
C114624,CHEMICAL,LY 341495 [Supplementary Concept],LY341495|Xanthenes|Amino Acids
NEW16289,DISEASE,fearful memory,fearful memories
NEW16291,CHEMICAL,impaired da transmission,impaired DA transmission
NEW16295,BIOCHEMICAL,soft polymer nanoparticle,Soft polymer nanoparticles
NEW16297,BIOCHEMICAL,controlled release analgesic system,Controlled release analgesic systems
NEW16300,CHEMICAL,bupivacaine/meloxicam pr,bupivacaine/meloxicam PR
NEW16302,BIOCHEMICAL,novel polymer technology,novel polymer technology
NEW16304,NUTRITION,spanish cohort,Spanish cohort
NEW16306,MENTAL_HEALTH,autism trio,autism trios
NEW16307,CHEMICAL,polygenic risk score,polygenic risk scores|PRS
NEW16310,CHEMICAL,s-predixcan,S-Predixcan
NEW16311,DISEASE,maternal pre-pregnancy obesity,maternal pre-pregnancy obesity
NEW16313,MENTAL_HEALTH,multivariate linear regression model,multivariate linear regression models
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Pathology,DISEASE,pathology,CJD pathology
C000645105,DISEASE,Lactobacillus collinoides [Supplementary Concept],Lactobacillus collinoides|Lactobacillus
D052196,DISEASE,Lactobacillus brevis,Lactobacillus brevis|Lactobacillus (1967-2005)
D048191,DISEASE,Lactobacillus plantarum,Lactobacillus plantarum|Lactobacillus (1965-2004)
NEW16320,CHEMICAL,alkyl catechol,alkyl catechols
NEW16322,DISEASE,artificial fever,artificial fever
D001729,NUTRITION,Bismuth,Bismuth|Antacids
D001115,CHEMICAL,Arecoline,Methylarecaidin|arecoline|Arecolin|Arecholin|Arecholine|Arecaline
NEW16325,CHEMICAL,adaboost+dt,Adaboost+DT
NEW16326,CHEMICAL,metabolite 3-methoxy-4-hydroxyphenyglycol,metabolites 3-methoxy-4-hydroxyphenyglycol
NEW16327,CHEMICAL,5-hiaa psychopathological variable,5-HIAA psychopathological variables
NEW16328,CHEMICAL,glutathione function,glutathione function
NEW16329,CHEMICAL,single-nucleotide polymorphism snp diagnostic marker,Single-nucleotide polymorphism SNP diagnostic markers
NEW16332,CHEMICAL,Q.Yr.bisa-2D,Q.Yr.bisa-2D
D000069478,CHEMICAL,Lisdexamfetamine Dimesylate,"Vyvanse|Lis-dexamfetamine Dimesylate|Lis dexamfetamine Dimesylate|Dimesylate, Lis-dexamfetamine|Lisdexamfetamine|lisdexamfetamine|Dimesylate, Lisdexamfetamine|NRP 104|Elvanse|NRP-104|NRP104"
NEW16334,CHEMICAL,dopamine neurotransmission,Dopamine neurotransmission
NEW16336,DISEASE,p. elegan,P. elegans
NEW16338,CHEMICAL,stress-induced corticosterone,Stress-induced corticosterone
NEW16337,BIOCHEMICAL,p. elegan,carotenoid supplementation
NEW16341,CHEMICAL,naltrexone mg/kg,Naltrexone mg/kg
NEW16344,CHEMICAL,elevated plasma homocysteine,Elevated plasma homocysteine
NEW06141,DISEASE,fracture prevention,fracture prevention
NEW16347,CHEMICAL,phthalate mixture risk assessment,phthalate mixture risk assessments
C563551,DISEASE,"Myeloproliferative Syndrome, Transient [Supplementary Concept]",transient abnormal myelopoiesis|Leukemoid Reaction|Down Syndrome
http://purl.obolibrary.org/obo/DOID_5425,DISEASE,ovarian hyperstimulation syndrome,severe ovarian hyperstimulation syndrome|OHSS|secondary Meig's syndrome
http://purl.obolibrary.org/obo/DOID_594,MENTAL_HEALTH,panic disorder,comorbid panic disorder|panic anxiety syndrome
NEW16354,CHEMICAL,comt snp rs4818 allele,COMT SNP rs4818 allele
NEW16355,CHEMICAL,gene-gene interaction effect,Gene-gene interaction effect
NEW16356,CHEMICAL,[³h]-domperidone,[³H]-domperidone
C031815,BIOCHEMICAL,"toxB protein, Clostridium difficile [Supplementary Concept]",Bacterial Toxins|Clostridium difficile toxin B|Bacterial Proteins
NEW16358,CHEMICAL,bifidobacterium longum strain,Bifidobacterium longum strains
NEW16360,BIOCHEMICAL,high-dose intravenous vitamin c,High-dose intravenous vitamin C
NEW16362,BIOCHEMICAL,supplementary vitamin c,supplementary vitamin C
D002216,CHEMICAL,Captopril,"SQ 14,534|SQ14534|SQ14225|SQ14,225|SQ-14225|captopril|Lopirin|Capoten|SQ-14,225|SQ 14,225|SQ-14,534|SQ 14534|SQ-14534|(S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline|SQ14,534|SQ 14225"
D012710,CHEMICAL,"Serum Albumin, Bovine","Albumin, Bovine Serum|Bovine Serum Albumin|Serum, Fetal Bovine|fetal calf serum|Albumin Bovine|Calf Serum, Fetal|Fetal Bovine Serum|Bovine, Albumin|Bovine Albumin|Serum, Fetal Calf|FCS|Albumin, Bovine|Bovine Serum, Fetal|Fetal Calf Serum"
NEW16367,CHEMICAL,traditional prescription kyung-ok-ko,traditional prescription Kyung-Ok-Ko
D000070660,CHEMICAL,Wolfiporia,"Fungus, Tuckahoe|Wolfiporia cocos|Fuling|Fu-Ling|Poria cocos|Fu Ling|Tuckahoe Fungus|Wolfiporia extensa"
D032305,NUTRITION,Lycium,"Plant, Goji Berry|Goji Berry Plants|Wolfberries|Plants, Goji Berry|Berry Plants, Goji|Berry Plant, Goji|Goji Berry Plant|Lycium barbarum|Goji Berry|Berry, Goji|Goji Berries|Wolfberry|Berries, Goji|Lycium chinense"
NEW16370,DISEASE,pcos induction,PCOS induction
NEW16373,NUTRITION,chinense Miller,chinense Miller
NEW16374,NUTRITION,Lycium chinense Miller,Lycium chinense Miller
NEW16375,CHEMICAL,low-dose clozapine treatment,low-dose clozapine treatment
NEW16376,DISEASE,behavioural disturbance,behavioural disturbances
NEW16381,DISEASE,various cancer cell,various cancer cells
http://purl.obolibrary.org/obo/CHEBI_182917,CHEMICAL,tryptophan conjugated cholic acid,"N-methyltaurine conjugated cholic acid|3-(1H-indol-3-yl)-2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propanoic acid"
NEW16386,CHEMICAL,novel n-acyl amidated bile acid,novel N-acyl amidated bile acids
NEW16387,NUTRITION,angelfish,angelfish
NEW16389,DISEASE,biliary bile acid,biliary bile acids
D003840,CHEMICAL,Deoxycholic Acid,"Deoxycholate, Sodium|Deoxycholic Acid, Monosodium Salt|Choleic Acid|Deoxycholic Acid, 12beta-Isomer|Deoxycholate|Deoxycholic Acid, 5alpha-Isomer|Deoxycholic Acid, 3beta Isomer|Deoxycholic Acid, Disodium Salt|Desoxycholic Acid|Deoxycholic Acid, Magnesium (2:1) Salt|Deoxycholic Acid, 3beta-Isomer|Deoxycholic Acid, Monoammonium Salt|Sodium Deoxycholate|Lagodeoxycholic Acid|5alpha-Isomer Deoxycholic Acid|Dihydroxycholanoic Acid|deoxycholic acid|3beta-Isomer Deoxycholic Acid|12beta-Isomer Deoxycholic Acid|Kybella|Deoxycholic Acid, Sodium Salt, 12beta-Isomer|Deoxycholic Acid, Monopotassium Salt|Deoxycholic Acid, 12beta Isomer|Deoxycholic Acid, 5alpha Isomer"
NEW16391,CHEMICAL,hydropinic therapy,hydropinic therapy
D066150,DISEASE,Organisation for Economic Co-Operation and Development,OECD|development|Organization for Economic Cooperation and Development
NEW16393,CHEMICAL,alcohol exposure,Alcohol exposure
D011419,CHEMICAL,Propidium,"Diiodide, Propidium|Propidium Diiodide|Propidium Iodide|Iodide, Propidium|propidium iodide"
NEW16394,CHEMICAL,suvorexant treatment,suvorexant treatment
NEW16396,CHEMICAL,l. paracasei hm1,L. paracasei HM1
NEW16398,CHEMICAL,hiv protease inhibitor saquinavir,Saq-NO|HIV protease inhibitor saquinavir
NEW16402,DISEASE,depressive symptomatology,Depressive symptomatology
NEW16403,CHEMICAL,low serum testosterone level,low serum testosterone levels
NEW16404,BIOCHEMICAL,specific antigen fixation,specific antigen fixation
C569455,CHEMICAL,theabrownin [Supplementary Concept],theabrownin|Catechin/analogs  and  derivatives
C036658,CHEMICAL,acrylic acid [Supplementary Concept],acrylic acid|Acrylates
D019826,CHEMICAL,Cholic Acid,Cholbam|cholic acid
C030737,CHEMICAL,indoleacetic acid [Supplementary Concept],Indoleacetic Acids|1H-indole-3-acetic acid
C090905,CHEMICAL,homoserine hydroxamic acid [Supplementary Concept],Homoserine/analogs  and  derivatives|l-homoserine
NEW16408,CHEMICAL,theophylline administration,theophylline administration
NEW16411,CHEMICAL,faah level,FAAH levels
NEW16412,BIOCHEMICAL,sr agonist,SR agonists
NEW16414,CHEMICAL,increase intracellular cyclic adenosine monophosphate camp level,increased intracellular cyclic adenosine monophosphate cAMP level
NEW16416,CHEMICAL,chronic morphine injection,Chronic morphine injection
NEW16417,DISEASE,precipitate opioid withdrawal syndrome,precipitated opioid withdrawal syndrome
NEW16419,CHEMICAL,acute inorganic arsenic,Acute inorganic arsenic|iAs
NEW16423,CHEMICAL,gl-iv-03,GL-IV-03
NEW16425,CHEMICAL,gl-iv-03,nonsedative drug candidates
NEW12558,CHEMICAL,gaba agonist muscimol,GABA agonist muscimol
C523483,CHEMICAL,linaclotide [Supplementary Concept],linaclotide|Peptides
C402769,CHEMICAL,tipifarnib [Supplementary Concept],Quinolones|OPC-21268|1H)- quinolinone
C028052,CHEMICAL,phenothiazine receptor [Supplementary Concept],"Receptors, Dopamine|phenothiazine"
NEW16438,CHEMICAL,immunosuppressant tacrolimus,immunosuppressant tacrolimus
C000588757,CHEMICAL,BAL27862 [Supplementary Concept],BAL27862|Oxadiazoles|Benzimidazoles
D004565,DISEASE,Electroconvulsive Therapy,"electric shock|Electric Convulsive Therapy|Therapies, Electric Convulsive|Electroshock Therapy|Therapy, Electric Convulsive|Electric Shock Therapies|Electroconvulsive Therapies|Shock Therapies, Electric|Electroshock Therapies|Convulsive Therapy, Electric|Therapies, Electroshock|Therapy, Electroconvulsive|ECT (Psychotherapy)|Electric Shock Therapy|Shock Therapy, Electric|Therapy, Electric Shock|Therapies, Electroconvulsive|Therapy, Electroshock|Convulsive Therapies, Electric|Electric Convulsive Therapies|Therapies, Electric Shock"
D064133,DISEASE,Sports Nutritional Physiological Phenomena,"Sports Nutritional Physiology|Exercise Nutritional Physiological Phenomena|Nutritional Physiology, Exercise|Sports Nutrition Physiology|Sports Nutritional Physiology Phenomenon|Nutrition Physiology, Sports|Exercise Nutritional Physiology Phenomena|Physiology, Sports Nutritional|Exercise Nutritional Physiology|Nutritional Physiology, Sports|Nutrition Physiology, Exercise|anorexia|Physiology, Exercise Nutrition|Exercise Nutritional Physiological Phenomenon|Exercise Nutrition Physiology|Sports Nutritional Physiological Phenomenon|nutritional|Exercise Nutritional Physiology Phenomenon|Physiology, Sports Nutrition|Sports Nutritional Physiology Phenomena|Physiology, Exercise Nutritional"
NEW16444,MENTAL_HEALTH,oxygen repression,oxygen repression
NEW16448,CHEMICAL,carotenogenesis repressor gene,carotenogenesis repressor gene
NEW16450,BIOCHEMICAL,carotenoid biosynthesis,Carotenoid biosynthesis
NEW16452,CHEMICAL,al exposure,Al exposure
C501277,CHEMICAL,Mangifera indica extract [Supplementary Concept],Mangifera|Mangifera indica|Plant Extracts
NEW16454,CHEMICAL,thymus kotschyanus extract,Thymus kotschyanus extract
C537365,DISEASE,Ichthyosis and male hypogonadism [Supplementary Concept],"male hypogonadism|Intellectual Disability|Hypogonadism|Ichthyosis, X-Linked|Cryptorchidism"
NEW16455,BIOCHEMICAL,bisphosphonate drug,bisphosphonate drug
NEW16456,CHEMICAL,dppc vehicle,DPPC vehicle
NEW16457,CHEMICAL,dry powder inhalation,dry powder inhalation|NPDPIs
NEW16459,CHEMICAL,smoke exposure,smoke exposure
NEW16464,NUTRITION,chronic lithium ingestion,Chronic lithium ingestion
D011530,CHEMICAL,Protriptyline,"Hydrochloride, Protriptyline|protriptyline|Vivactil|Protriptyline Hydrochloride"
NEW16467,CHEMICAL,selective norepinephrine reuptake inhibitor atomoxetine,selective norepinephrine reuptake inhibitor atomoxetine
NEW16468,BIOCHEMICAL,menopausal hormone therapy,menopausal hormone therapy
NEW16469,CHEMICAL,moderate alcohol use,moderate alcohol use
NEW16470,CHEMICAL,diacylglycerol kinase (dgkη)-knockout mouse,diacylglycerol kinase (DGKη)-knockout mice
NEW16472,CHEMICAL,acid (pufa)-containe phosphatidic acid pa molecular specie,acid (PUFA)-containing phosphatidic acid PA molecular species
C558154,CHEMICAL,xanthohumol D [Supplementary Concept],XN|Xanthohumol|Flavonoids
NEW16475,DISEASE,significant allodynia,Significant allodynia
D000096,CHEMICAL,Acetone,Solvents|acetone
NEW16476,CHEMICAL,n-(2-chloroethyl)-n-ethyl-2-bromobenzylamine dsp-4,N-(2-Chloroethyl)-N-ethyl-2-bromobenzylamine DSP-4
NEW16477,CHEMICAL,noradrenaline depletion,Noradrenaline depletion
http://purl.obolibrary.org/obo/CHEBI_134825,CHEMICAL,guanacline,para-chlorophenylalanine PCPA|cyclazenine|guanacline sulfate
NEW16478,CHEMICAL,idazoxan 5-ht₃ receptor antagonist bemesetron,idazoxan 5-HT₃ receptor antagonist bemesetron
C042253,CHEMICAL,bemesetron [Supplementary Concept],MDL-72222|Tropanes
NEW16480,CHEMICAL,maternal catecholamine,maternal catecholamines
D058496,DISEASE,Smith-Magenis Syndrome,"Smith-Magenis syndrome|Smith Magenis Syndrome|17p11.2 Monosomy|Chromosome 17p11.2 Deletion Syndrome|Syndrome, Smith-Magenis"
D057094,CHEMICAL,"Nuclear Receptor Subfamily 1, Group F, Member 1","Retinoid Related Orphan Receptor alpha4|Nuclear Receptor RZR-alpha|Retinoid Related Orphan Receptor alpha1|Receptor NR1F1, Nuclear|Retinoid-Related Orphan Receptor-alpha1|Nuclear Receptor NR1F1|Retinoid Related Orphan Receptor alpha|Nuclear Receptor ROR-alpha|RAR Related Orphan Receptor A|hENT1|Retinoid-Related Orphan Receptor-alpha3|Retinoid-Related Orphan Receptor-alpha4|RZR-alpha, Nuclear Receptor|Nuclear Receptor RZR alpha|1|RAR-Related Orphan Receptor A|Nuclear Receptor ROR alpha|Retinoid Related Orphan Receptor alpha2|NR1F1, Nuclear Receptor|Retinoid-Related Orphan Receptor-alpha|Retinoid Related Orphan Receptor alpha3|Retinoid-Related Orphan Receptor-alpha2"
NEW16481,CHEMICAL,7-deazapurine nucleoside antibiotic tubercidin,7-deazapurine nucleoside antibiotic tubercidin
NEW16484,CHEMICAL,"2',3',5'-o-acetyladenosine","2',3',5'-O-acetyladenosine"
NEW16486,MENTAL_HEALTH,nucleophillic displacement,Nucleophillic displacement
http://purl.obolibrary.org/obo/CHEBI_52473,CHEMICAL,triflate ester,triflate esters|trifluoromethanesulfonate ester|trifluoromethanesulphonate esters|trifluoromethanesulfonate esters|triflate ester moiety|trifluoromethanesulphonate ester
NEW16488,CHEMICAL,toyocamycin analogue,toyocamycin analogues
D005126,DISEASE,Eye Burns,"Eye Burn|Burn, Eye|Burns, Eye|burns"
NEW16490,CHEMICAL,pseudomonas(p. aeruginosa,Pseudomonas(P. aeruginosa
NEW16491,CHEMICAL,leucine catabolite beta-hydroxy-beta-methylbutyrate,leucine catabolite beta-hydroxy-beta-methylbutyrate|HMB
C018091,CHEMICAL,maduramicin [Supplementary Concept],Lactones|maduramicin
NEW16493,CHEMICAL,maduramicin residue,maduramicin residues
D003410,DISEASE,Cri-du-Chat Syndrome,"Chromosome 5p Deletion Syndrome|Chromosome 5 Short Arm Deletion Syndrome|Syndrome, Cat Cry|Syndrome, Crying Cat|Crying Cat Syndromes|Cat Cry Syndromes|5p Deletion Syndrome|Syndromes, 5p Deletion|5p Minus Syndrome|Syndrome, 5p-|Deletion of Short Arm of Chromosome 5 Syndrome|5p- Syndrome|Syndrome, Cri-du-Chat|5p Syndrome|Minus Syndromes, 5p|5p Deletion Syndromes|5p- Syndromes, Chromosome|Deletion Syndrome, 5p|du chat syndrome|Crying Cat Syndrome|Syndromes, 5p Minus|Syndromes, Crying Cat|5p Minus Syndromes|Cri-du-Chat Syndromes|Deletion Syndromes, 5p|Chromosome 5p- Syndromes|Syndrome, 5p Minus|5p- Syndromes|Syndromes, Chromosome 5p-|Cri du Chat Syndrome|Syndrome, 5p Deletion|Syndromes, Cat Cry|Syndrome, Chromosome 5p-|5p- Syndrome, Chromosome|Chromosome 5p- Syndrome|Syndromes, Cri-du-Chat|Cat Cry Syndrome|Minus Syndrome, 5p"
C579167,CHEMICAL,"Chrna7 protein, human [Supplementary Concept]",CHRFAM7A|alpha7 Nicotinic Acetylcholine Receptor
D063268,CHEMICAL,Sialic Acid Binding Ig-like Lectin 3,"Antigen, CD33|gp67, Glycoprotein|CD33 Antigens|sialic acid|Glycoprotein gp67|Antigens, CD33|Siglec-3|CD33 Antigen|Sialic Acid Binding Ig like Lectin 3"
NEW16498,MENTAL_HEALTH,stress-induced motivational anhedonia,stress-induced motivational anhedonia
NEW16500,DISEASE,improve luts,improved LUTS
NEW16503,BIOCHEMICAL,potential adverse drug event,Potential adverse drug events
NEW16504,CHEMICAL,pde-5 inhibitor tadalafil,PDE-5 inhibitor tadalafil
http://purl.obolibrary.org/obo/CHEBI_3176,CHEMICAL,brinzolamide,"Brinzolamide|timolol-pilocarpine|Azopt|(4R)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide"
NEW16506,BIOCHEMICAL,β-adrenergic antagonist toxicity,β-Adrenergic antagonist toxicity
NEW16508,CHEMICAL,high-dose insulin,High-dose insulin
NEW16510,MENTAL_HEALTH,suicide group,suicide group
NEW16513,CHEMICAL,propranolol overdose,propranolol overdose
NEW16514,DISEASE,persistent hypotension,persistent hypotension
NEW16516,CHEMICAL,serum propranolol level,serum propranolol level
NEW16518,BIOCHEMICAL,chronic drug exposure,chronic drug exposure
NEW16520,CHEMICAL,dopamine da system,dopamine DA system
NEW16521,DISEASE,da defect,DA defects
C046785,CHEMICAL,bryostatin 1 [Supplementary Concept],Bryostatins|Bryostatin-1
NEW16523,BIOCHEMICAL,anesthetic drug agent,Anesthetic drug agents
NEW16525,MENTAL_HEALTH,repetitive sleep fragmentation,repetitive sleep fragmentation
NEW16527,DISEASE,intermittent hypoxemia,intermittent hypoxemia
NEW16528,MENTAL_HEALTH,long-term alcohol abuse,long-term alcohol abuse
NEW16529,CHEMICAL,serum histamine,serum histamine
NEW16530,BIOCHEMICAL,antihistamine release,antihistamine release
NEW16531,CHEMICAL,cysteinyl leukotriene,Cysteinyl leukotrienes
NEW16533,MENTAL_HEALTH,left-right orientation,left-right orientation
D005862,MENTAL_HEALTH,Gerstmann Syndrome,"finger agnosia|Gerstmann, Syndrome de|de Gerstmann, Syndrome|Acquired Gerstmann's Syndrome|Syndrome, Developmental Gerstmann|Acquired Gerstmann Syndrome|Finger-Agnosia-Left-Right-Confusion-Acalculia-Agraphias|Syndrome, Gerstmann-Badal|Syndrome de Gerstmann|Gerstmann Syndrome 2|Gerstmann's Syndrome, Developmental|Gerstmann's Syndrome|Developmental Gerstmann's Syndrome|Finger-Agnosia-Left-Right-Confusion-Acalculia-Agraphia|Syndrome, Acquired Gerstmann|Gerstmann's Syndrome, Acquired|Gerstmann-Badal Syndrome|Gerstmann Syndrome, Developmental|Gerstmann Badal Syndrome|Gerstmann Syndrome, Acquired|Syndrome, Acquired Gerstmann's|Syndrome, Gerstmann|Developmental Gerstmanns Syndrome|Developmental Gerstmann Syndrome"
NEW16536,BIOCHEMICAL,antibiotic treatment,antibiotics treatment
NEW16537,NUTRITION,phospholipid profile,phospholipid profile
NEW16538,CHEMICAL,maternal ethanol consumption,maternal ethanol consumption
D054811,CHEMICAL,Phytochelatins,Phytochelatin|Phytochelatins
NEW16540,DISEASE,pbc patient,PBC patients
NEW16542,DISEASE,pbc-aih overlap syndrome,PBC-AIH overlap syndrome
D011537,DISEASE,Pruritus,pruritis|Itching|Pruritis
NEW16543,CHEMICAL,n-methyl d-aspartate receptor nmdar antagonist gas nitrous oxide,N-methyl d-aspartate receptor NMDAR antagonist gas nitrous oxide
NEW16544,BIOCHEMICAL,same common drug therapy,same common drug therapy
NEW16548,CHEMICAL,six-herb medicine formula,six-herb medicine formula
NEW16554,DISEASE,prolonged qtc interval,prolonged QTc interval|LQT
NEW16555,CHEMICAL,channel blocker phenytoin,channel blocker phenytoin
NEW16557,CHEMICAL,drowsiness/lethargy,Drowsiness/lethargy
NEW16560,DISEASE,major depressive disorder pathogenesis,microcytic anaemias
NEW16561,CHEMICAL,cytoplasmic luminal mutation,cytoplasmic luminal mutations
C030720,CHEMICAL,triacetic acid lactone [Supplementary Concept],triacetic acid lactone|Pyrones
NEW16563,CHEMICAL,stnfr60 level,sTNFR60 levels
NEW16566,CHEMICAL,uplc-qtofms-based metabolomic method,UPLC-QTOFMS-based metabolomic method
NEW16568,CHEMICAL,uplc-qtofms-based metabolomic method,YGS|Traditional Chinese medicine Yi-Gan San
NEW16569,DISEASE,vad rat,VaD rats
NEW16571,DISEASE,2-vo-induced VaD,2-VO-induced VaD
NEW16574,BIOCHEMICAL,several hepatotoxic agent,Several hepatotoxic agents
NEW16575,CHEMICAL,toxicity acetaminophen,toxicity acetaminophen
NEW16578,BIOCHEMICAL,anticonvulsant drug valproic acid,anticonvulsant drug valproic acid
NEW16579,CHEMICAL,particular 4-en-valproate,particular 4-en-valproate
http://purl.obolibrary.org/obo/CHEBI_63794,BIOCHEMICAL,retinoid x receptor agonist,retinoid X receptor agonist|retinoid X receptor agonists
NEW16590,CHEMICAL,δ-tocotrienol,δ-tocotrienols
NEW16592,BIOCHEMICAL,antimicrobial protein,Antimicrobial proteins
D008600,DISEASE,Menstruation-Inducing Agents,Menstruation|Emmenagogues|Menstruation Inducing Agents
NEW16596,DISEASE,ischaemic priapism,ischaemic priapism
NEW16598,MENTAL_HEALTH,exacerbated postparturient insulin resistance,Exacerbated postparturient insulin resistance
NEW16599,BIOCHEMICAL,vitamin e supplementation,Vitamin E supplementation
NEW16600,NUTRITION,dl-alpha-tocopheryl acetate,dl-alpha-tocopheryl acetate
D043183,DISEASE,Irritable Bowel Syndrome,"Irritable Colon|IBS|Colitis, Mucous|Mucous Colitis|Irritable bowel syndrome|Syndrome, Irritable Bowel|Irritable Bowel Syndromes|Colon, Irritable|Syndromes, Irritable Bowel|Mucous Colitides|Colitides, Mucous"
D050559,BIOCHEMICAL,"beta-Carotene 15,15'-Monooxygenase","beta, beta-Carotene-15,15'-Dioxygenase|beta Carotene Cleaving Enzyme|15,15'-Monooxygenase, beta-Carotene|beta-carotene|Carotene Dioxygenase|Dioxygenase, Carotene|beta-Carotene Cleaving Enzyme|beta Carotene 15,15' Dioxygenase|15,15'-Dioxygenase, beta-Carotene|beta, beta-Carotene-15,15'-Monooxygenase|beta-Carotene 15,15'-Dioxygenase|beta Carotene 15,15' Monooxygenase|Cleaving Enzyme, beta-Carotene"
C495008,CHEMICAL,N-(3-oxo-hexahydrocyclopenta(b)furan-3a-yl)acylamide [Supplementary Concept],Furans|Amides|Cyclopentanes|FAA
NEW16605,CHEMICAL,five-factor borderline inventory-short form,Five-Factor Borderline Inventory-Short Form|FFBI-SF
NEW16606,DISEASE,polycystic ovary pco phenotype model,polycystic ovary PCO phenotype model
NEW16607,DISEASE,ne-induced polycystic condition,NE-induced polycystic condition
NEW16609,DISEASE,ss patient,SS patients
D008167,DISEASE,Lumpy skin disease virus,lumpy skin disease|Neethling Virus
C098825,BIOCHEMICAL,"HIV-1 immunogen, incomplete Freund's adjuvant [Supplementary Concept]",AIDS Vaccines|immunogen
NEW16617,MENTAL_HEALTH,hypoxic depression,hypoxic depression
NEW16620,NUTRITION,elevated plasma very-long-chain fatty acid,elevated plasma very-long-chain fatty acids
NEW16622,CHEMICAL,gut tryptamine increase,Gut tryptamine increase
NEW16625,DISEASE,viral infection-induced dysbiosis,viral infection-induced dysbiosis
NEW16627,CHEMICAL,ns structural arrangement,NSs structural arrangements
NEW16630,DISEASE,catatonic sign,catatonic signs
NEW16631,CHEMICAL,multiple-voxel h-mrs,Multiple-voxel H-MRS
NEW16633,MENTAL_HEALTH,behavioral depression,behavioral depression
C038193,CHEMICAL,4-hydroxybenzoic acid [Supplementary Concept],Para-hydroxybenzoic acid|Parabens|PHBA
NEW10810,DISEASE,fungal strain,Candida albicans|fungal strain
NEW16634,BIOCHEMICAL,antiviral medication,antiviral medications
NEW16636,BIOCHEMICAL,high luteinizing hormone concentration,high luteinizing hormone concentrations
NEW16638,MENTAL_HEALTH,evoke agitation,evoked agitation
NEW16639,CHEMICAL,cyclic metaphosphate structure,cyclic metaphosphate structure
NEW16642,CHEMICAL,p-glycoprotein inhibitor,P-glycoprotein inhibitors
NEW16643,CHEMICAL,α1-adrenergic antagonist prazosin,α1-adrenergic antagonist prazosin
NEW16645,DISEASE,patient allergic,patient allergic
NEW16647,CHEMICAL,bell/chili pepper cedar pollen,bell/chili pepper cedar pollen
NEW16648,CHEMICAL,pufa supplement,PUFA supplements
NEW16649,CHEMICAL,pufa treatment,PUFA treatment
NEW16650,CHEMICAL,serine/threonine kinase glycogen synthase kinase-3,serine/threonine kinase glycogen synthase kinase-3|GSK-3
http://purl.org/sig/ont/fma/fma24890,CHEMICAL,arm,PAPD5/7 arm|Brachial region|Proximal segment of free upper limb
NEW16652,DISEASE,alzheimer degenerative deficiency,Alzheimer degenerative deficiency
NEW16653,CHEMICAL,omega-3 pufas arachidonic acid,ARA|omega-3 PUFAs arachidonic acid
C420120,BIOCHEMICAL,gamma-aminobutyryl-2-methyltryptophyl-2-methyltryptophyl-2-methyltryptophyl-lysinamide [Supplementary Concept],Oligopeptides|growth hormone releasing peptide
NEW16654,MENTAL_HEALTH,arsenic resistance operon,arsenic resistance operon
NEW16656,MENTAL_HEALTH,importance antimicrobial resistance,IMPORTANCE Antimicrobial resistance
D029821,CHEMICAL,"Enterovirus A, Human","Human Enterovirus A|EV-A71|Human Enterovirus 71|A71|Enterovirus 71, Human"
NEW16659,DISEASE,bone metastasis,bone metastases
NEW16661,DISEASE,acid-induced adipocyte inflammation,acid-induced adipocyte inflammation
NEW16662,CHEMICAL,saturated free,Saturated free
D002083,CHEMICAL,Butylated Hydroxyanisole,"Tenox BHA|Nipantiox 1F|Embanox|Methoxyphenol, Butyl|AMIF 72|Nipantiox 1 F|Butylhydroxyanisole|BHA|AMIF72|(1,1-Dimethylethyl)-4-methoxyphenol|AMIF-72|Nipantiox 1-F|Hydroxyanisole, Butylated|Butyl Methoxyphenol"
NEW15494,BIOCHEMICAL,antiviral factor,non-competitive N-methyl-D-aspartate receptor antagonist
NEW16666,CHEMICAL,striatal n-methyl-d-aspartate receptor function,striatal N-methyl-D-aspartate receptor function
NEW16668,CHEMICAL,oxidize β-cyclodextrin,oxidized β-cyclodextrin
NEW16670,DISEASE,organization pain relief,Organization pain relief
NEW16671,DISEASE,rapid pain relief,Rapid pain relief
NEW16673,MENTAL_HEALTH,psychological resistance,psychological resistance
NEW16672,BIOCHEMICAL,rapid pain relief,opioid analgesic use
NEW16674,DISEASE,psychological resistance,pain amelioration
NEW16675,CHEMICAL,p97/vcp valosin,p97/VCP Valosin
NEW16677,DISEASE,human disease mutation,human disease mutations
D015526,DISEASE,AIDS Dementia Complex,"Encephalopathies, HIV|Complex, AIDS-Related Dementia|HIV-1 Cognitive and Motor Complex|related dementia|AIDS-Related Dementia Complex|Encephalopathy, AIDS|Dementias, HIV|HIV Dementias|HIV Dementia|ADRD|HIV Encephalopathy|Dementia, HIV|HIV Encephalopathies|Encephalopathy, HIV|AIDS Encephalopathy|Dementia Complex, AIDS Related|AIDS Related Dementia Complex|Acquired-Immune Deficiency Syndrome Dementia Complex|Dementia Complex, AIDS-Related|HIV Associated Cognitive Motor Complex|HIV-Associated Cognitive Motor Complex|HIV-1-Associated Cognitive Motor Complex|AIDS Encephalopathies|HIV 1 Cognitive and Motor Complex|HIV 1 Associated Cognitive Motor Complex|Complex, AIDS Dementia|Dementia Complex, AIDS|Encephalopathies, AIDS|Dementia Complex, Acquired Immune Deficiency Syndrome"
NEW16678,BIOCHEMICAL,human disease mutation,analgesic use
NEW16679,CHEMICAL,recombinant pegylated human ifn alpha,recombinant pegylated human IFN alpha
NEW16681,CHEMICAL,soya isoflavone,soya isoflavones
NEW16683,BIOCHEMICAL,vitamin d skeleton,vitamin D skeleton
NEW16689,CHEMICAL,nicotine abstinence,nicotine abstinence
NEW16691,CHEMICAL,nicotine abstinent patient,nicotine abstinent patients
NEW16692,DISEASE,abstinence-induced pain sensitivity,abstinence-induced pain sensitivity
NEW16693,CHEMICAL,nicotine abstinence duration,nicotine abstinence duration
http://purl.obolibrary.org/obo/CHEBI_28313,CHEMICAL,nornicotine,nicotine dependence/abstinence|3-[(2S)-pyrrolidin-2-yl]pyridine|Nornicotine|S-(-)-nornicotine|l-nor-nicotine|(-)-nornicotine|1'-demethyl nicotine|(S)-1'-demethylnicotine
NEW16694,BIOCHEMICAL,unopposed estrogen use,Unopposed estrogen use
http://purl.obolibrary.org/obo/CHEBI_50811,CHEMICAL,carbon nanohorn,CNH|Carbon nanohorns
NEW16696,CHEMICAL,oxcnh-cap-ibn composite nanoparticle,OxCNH-CaP-IBN composite nanoparticles
NEW16698,CHEMICAL,dissolve phosphate ion,dissolved phosphate ions
NEW16699,CHEMICAL,composite,composites
NEW05296,BIOCHEMICAL,2-adrenergic receptor agonist,2-adrenergic receptor agonist
NEW16706,CHEMICAL,active alpha-2 adrenergic receptor agonist clonidine,active alpha-2 adrenergic receptor agonist clonidine
NEW16711,DISEASE,APEC isolate,APEC isolates
NEW16712,DISEASE,APEC strain,APEC strains
NEW16714,DISEASE,pneumonia onset,pneumonia onset
D008713,CHEMICAL,Methimazole,"Thyrozol|Tirodril|Merkazolil|Methylmercaptoimidazole|Tiamazol|Tapazole|Mercazole|Metisol|Henning, Thiamazol|Methizol|Thiamazol Hexal|Thiamazole|Methymazol|Hexal, Thiamazol|1-Methyl-2-mercaptoimidazole|Favistan|Thiamazol Henning|Strumazol|Thimazol|1 Methyl 2 mercaptoimidazole|Mercazol|thiamazole|Mercazolyl|Mercasolyl|Metizol"
D011441,CHEMICAL,Propylthiouracil,6 Propyl 2 Thiouracil|propylthiouracil|6-Propyl-2-Thiouracil
NEW16718,CHEMICAL,addon administration,addon administration
NEW16720,CHEMICAL,serotonin-dopamine activity modulator,serotonin-dopamine activity modulator
NEW16722,BIOCHEMICAL,second partial agonist,second partial agonist
NEW16725,CHEMICAL,brexpiprazole target dosing,Brexpiprazole target dosing
NEW16727,CHEMICAL,57co-cyanocobalamin,57Co-cyanocobalamin
NEW16729,NUTRITION,uninterrupted folate cycle,uninterrupted folate cycle
NEW16732,CHEMICAL,depression antidepressant,depression antidepressants
NEW16735,CHEMICAL,chronic ven treatment,Chronic VEN treatment
NEW16740,CHEMICAL,serotonin hypersensitivity,serotonin hypersensitivity
NEW16743,MENTAL_HEALTH,severe dementia,severe dementia
NEW16744,CHEMICAL,da metabolism,DA metabolism
NEW02511,CHEMICAL,da release,DA release
NEW16745,CHEMICAL,dopamine innervation,dopamine innervation
NEW16748,CHEMICAL,p-cresol circulating concentration,p-cresol circulating concentrations
D009553,CHEMICAL,Nimodipine,"Nimodipino Bayvit|Nimodipin Hexal|Bay e 9736|Nimodipin ISIS|Nimotop|Kenesil|Remontal|Admon|Calnit|Nimodipin-ISIS|Modus|nimodipine|Bayvit, Nimodipino|Brainal|Hexal, Nimodipin|e 9736, Bay|Nymalize"
C060285,CHEMICAL,lacidipine [Supplementary Concept],Lacidipine|Dihydropyridines
http://purl.obolibrary.org/obo/CHEBI_4110,CHEMICAL,cathinone,Cathinone|amphetamine (AMPH)-type|cathinonum|(2S)-2-amino-1-phenylpropan-1-one|cathinone|catinona|Norephedrone|D-Cathinone
NEW16753,DISEASE,pkc-mediated mitochondrial dysfunction,PKC-mediated mitochondrial dysfunction
D061213,DISEASE,"Mortality, Premature","Premature Deaths|Death, Premature|Premature Death|Deaths, Premature|Mortalities, Premature|Premature Mortality|Premature Mortalities|premature death"
NEW16758,MENTAL_HEALTH,ms-ms fragmentation pattern,MS-MS fragmentation pattern
C046131,BIOCHEMICAL,"auxin receptor, plant [Supplementary Concept]","auxin|Plant Proteins|Receptors, Cell Surface"
NEW16760,CHEMICAL,low dose intravenous ketamine,low dose intravenous ketamine
NEW16761,NUTRITION,phosphorus metabolite level,phosphorus metabolite levels
NEW16762,DISEASE,leave temporal lobe,left temporal lobe
NEW16764,NUTRITION,membrane phospholipid abnormality,Membrane phospholipid abnormalities
NEW16766,MENTAL_HEALTH,topographical disorientation,topographical disorientation
http://purl.obolibrary.org/obo/CHEBI_80298,BIOCHEMICAL,gonadotropin-releasing hormone ii,GnRH-II|gonadotropin-releasing hormone (GnRH)-agonists|Gonadoliberin-II
D008994,CHEMICAL,Monoacylglycerol Lipases,"Glycerol Monoester Hydrolases|Hydrolase, Glycerol Monoester|Monoglyceride Esterases|Monoester Hydrolase, Glycerol|Monoglyceride Lipases|Monoglyceride Lipase|Esterases, Monoglyceride|Esterase, Monoglyceride|Monoacylglycerol Lipase|Glycerol Monoester Hydrolase|Lipases, Monoglyceride|Hydrolase, Monoglyceride|Monoglyceride Esterase|Hydrolases, Glycerol Monoester|Lipase, Monoacylglycerol|Monoglyceride Hydrolase|Lipases, Monoacylglycerol|Lipase, Monoglyceride|Monoester Hydrolases, Glycerol|monoacylglycerol lipase"
NEW16767,NUTRITION,primary endocannabinoid enzyme fatty acid amide hydrolase,primary endocannabinoid enzymes fatty acid amide hydrolase
NEW16768,CHEMICAL,high bpa level,higher BPA levels
C000624641,CHEMICAL,"2,3-dihydro-3beta-methoxy withaferin-A [Supplementary Concept]",Withaferin A|Withanolides|WFA
NEW16770,CHEMICAL,lactate accumulation,lactate accumulation
NEW16772,CHEMICAL,oxygen uptake,oxygen uptake
C548078,DISEASE,Mungan Syndrome [Supplementary Concept],Cardiac abnormalities|Barrett Esophagus|Intestinal Pseudo-Obstruction
NEW16777,DISEASE,dengue infection,dengue infection
NEW16778,DISEASE,aids pandemic,AIDS pandemic
NEW16780,CHEMICAL,vif-a3f,Vif-A3F
D052556,DISEASE,"Niemann-Pick Disease, Type C","Niemann-Pick Type C Disease|Niemann-Pick Disease, Nova Scotian|Niemann Pick Disease, Type C|Niemann-Pick disease, Subacute Juvenile Form|Nova Scotia (Type D) Form of Niemann-Pick Disease|Niemann Pick Disease Type C|Niemann Pick Type D Disease|Niemann-Pick Type D Disease|Niemann Pick Disease, Type C1|Niemann Pick's Disease Type D|Nova Scotia Niemann Pick Disease (Type D)|Niemann Pick Disease without Sphingomyelinase Deficiency|Niemann Pick Disease, Chronic Neuronopathic Form|Niemann-Pick Disease Type D|Niemann-Pick Disease without Sphingomyelinase Deficiency|Niemann Pick Disease, Type D|Niemann Pick Disease with Cholesterol Esterification Block|Niemann-Pick Disease, Type C1|Niemann-Pick Disease Type C|Niemann-Pick Disease, Type D|Niemann-Pick's Disease Type C|Niemann-Pick Disease, Chronic Neuronopathic Form|Niemann-Pick disease type C|Niemann Pick Disease, Nova Scotian|Niemann Pick Type C Disease|Niemann Pick's Disease Type C|Niemann-Pick's Disease Type D|Nova Scotia Niemann-Pick Disease (Type D)|Niemann-Pick Disease with Cholesterol Esterification Block|Niemann Pick disease, Subacute Juvenile Form|Niemann Pick Disease Type D|Neurovisceral Storage Disease with Vertical Supranuclear Ophthalmoplegia"
NEW16783,CHEMICAL,tisafp8,TisAFP8
NEW16786,BIOCHEMICAL,"5-ht2 agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane","5-HT2 agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane"
NEW16788,DISEASE,behavioral syndrome,behavioral syndrome
NEW16791,DISEASE,pain-like behavioral syndrome,pain-like behavioral syndrome
NEW16792,CHEMICAL,isomer-specific fragment,Isomer-specific fragments
NEW16793,CHEMICAL,deregulate acrolein metabolism,deregulated acrolein metabolism
NEW16794,CHEMICAL,dietary soy isoflavone intervention,dietary soy isoflavone intervention
NEW16799,BIOCHEMICAL,rar antagonist,RAR antagonist
NEW16801,BIOCHEMICAL,indolic antimicrobial metabolite,indolic antimicrobial metabolite
C494598,CHEMICAL,glucosyl jasmonate [Supplementary Concept],Oxylipins|Cyclopentanes|Glucosides|jasmonate
NEW16807,CHEMICAL,conclusion dexamethasone,Conclusion Dexamethasone
C001520,CHEMICAL,lanthionine [Supplementary Concept],Sulfides|lanthionine|Alanine/analogs  and  derivatives
NEW16810,CHEMICAL,fty720 administration,FTY720 administration
NEW16813,DISEASE,mesocorticolimbic dopamine system,severe medical disorder
NEW16814,CHEMICAL,catechu l. treatment,catechu L. treatment
NEW16815,MENTAL_HEALTH,locomotion hyperactivity phenotype,locomotion hyperactivity phenotypes
NEW16818,BIOCHEMICAL,adipose-produce hormone leptin,adipose-produce hormone leptin
NEW16823,BIOCHEMICAL,bile sequestrant,bile sequestrants
NEW16826,MENTAL_HEALTH,chromosome autistic psychotic rett syndrome child,Chromosomes autistic psychotic Rett syndrome children
NEW16828,DISEASE,psychotic child,psychotic children
NEW16829,CHEMICAL,5-hydroxy-indoleacetic acid,5-hydroxy-indoleacetic acid
NEW16833,CHEMICAL,glucolipid metabolism disorder,glucolipid metabolism disorders
NEW16837,BIOCHEMICAL,range phytotoxin,range phytotoxin
http://purl.obolibrary.org/obo/DOID_6088,MENTAL_HEALTH,acute stress disorder,Acute stress disorder symptoms|traumatic stress disorder
NEW16839,CHEMICAL,cortisol awakening response,cortisol awakening responses
NEW16840,CHEMICAL,cortisol awakening response,cortisol awakening response
NEW16841,BIOCHEMICAL,Drug Commission,Drug Commission
NEW16844,DISEASE,blood cell formation,blood cell formation
NEW16845,CHEMICAL,cadmium treatment,Cadmium treatments
NEW16848,CHEMICAL,cd toxicity symptom,Cd toxicity symptoms
NEW16849,CHEMICAL,prophylactic pregabalin,prophylactic pregabalin
NEW11699,DISEASE,heparin-induced thrombocytopenia,heparin-induced thrombocytopenia
NEW16850,MENTAL_HEALTH,clinical syndrome,Clinical syndromes
NEW16855,CHEMICAL,nascent pf4-ahit-igg complex,nascent PF4-aHIT-IgG complexes
NEW16857,CHEMICAL,"new p(1),p(4)-di(adenosine-5 tetraphosphate ap4a derivative","new P(1),P(4)-di(adenosine-5 tetraphosphate Ap4A derivatives"
NEW16859,CHEMICAL,(ml)-based decision algorithm,(ML)-based decision algorithms
NEW16860,CHEMICAL,acid content,acids contents
NEW16863,DISEASE,ralstonia spp,Ralstonia spp
NEW16865,BIOCHEMICAL,vitamin pyridoxine deficiency,vitamin pyridoxine deficiency
NEW16866,CHEMICAL,plasma homocysteine level,Plasma homocysteine levels
NEW16868,CHEMICAL,plasma homocysteine concentration,plasma homocysteine concentration
NEW16869,NUTRITION,spot seal pup,spotted seal pups
NEW16871,DISEASE,circadian disruption-induced metabolic syndrome,Circadian disruption-induced metabolic syndrome
D003692,CHEMICAL,Delayed-Action Preparations,"Controlled Release Formulation|Release Formulation, Controlled|Delayed Action Preparation|Delayed-Action Preparation|Prolonged-Action Preparations|Formulation, Controlled Release|Timed-Release Preparations|Delayed Action Preparations|Controlled-Release Preparation|Controlled Release Formulations|Extended Release Formulations|Depot Preparations|Timed Release Preparation|Prolonged Action Preparation|Timed Release Preparations|Sustained Release Formulations|Controlled-Release Formulation|Controlled-Release Preparations|Sustained Release Formulation|Extended Release Preparations|Sustained-Release Preparations|extended-release formulation|Controlled Release Preparations|Sustained-Release Preparation|Slow Release Formulation|Prolonged-Action Preparation|Extended Release Formulation|Release Formulations, Controlled|Extended Release Preparation|Controlled Release Preparation|Controlled-Release Formulations|Sustained Release Preparation|Depot Preparation|Formulations, Controlled Release|Timed-Release Preparation"
C449521,CHEMICAL,SLI381 [Supplementary Concept],Adderall|Amphetamines
NEW16873,NUTRITION,fatty acid peroxide,fatty acid peroxides
D016893,DISEASE,Carotid Stenosis,"Stenosis, Carotid|Narrowings, Carotid Artery|Artery Stenoses, Carotid|Artery Stenosis, Carotid|Carotid Artery Ulcerating Plaque|External Carotid Artery Stenosis|Artery Plaque, Carotid|Stenoses, Carotid|Carotid Stenoses|Ulcerating Plaque, Carotid Artery|Common Carotid Artery Stenosis|Carotid Ulcer|Artery Plaques, Carotid|Carotid Artery Narrowing|Carotid Artery Plaques|Plaque, Carotid Artery|Carotid Ulcers|Ulcers, Carotid|Stenosis, Common Carotid Artery|Carotid Artery Narrowings|Carotid Artery Plaque|Internal Carotid Artery Stenosis|Stenosis, External Carotid Artery|Plaque, Ulcerating, Carotid Artery|Stenosis, Carotid Artery|carotid artery stenosis|Artery Narrowings, Carotid|Carotid Artery Stenosis|Narrowing, Carotid Artery|Ulcer, Carotid|Stenoses, Carotid Artery|Artery Narrowing, Carotid|Carotid Artery Stenoses|Plaques, Carotid Artery"
NEW16874,CHEMICAL,serum thiobarbituric acid reactive substance,Serum thiobarbituric acid reactive substances
NEW16876,DISEASE,strain p. diazotrophicus,strain P. diazotrophicus
NEW16877,NUTRITION,prenylflavonoid xanthohumol,prenylflavonoids xanthohumol
NEW02852,DISEASE,aristata extract,chronic alcoholism
NEW16880,BIOCHEMICAL,subclinical vitamin deficiency other,subclinical vitamin deficiencies other
NEW16885,CHEMICAL,coumestrol binding,coumestrol binding
D003375,CHEMICAL,Coumestrol,Coumarins (1972-1974)|coumestrol|Benzofurans (1972-1974)
D016660,CHEMICAL,NAD(P)H Dehydrogenase (Quinone),"Reductase, Quinone|Vitamin K Reductase|Reductase, Phylloquinone|Reductase, Vitamin K|Diaphorase, DT|Reductase, Menadione|quinone reductase|Phylloquinone Reductase|DT Diaphorase|Quinone Reductase|Menadione Reductase"
NEW16891,NUTRITION,crayfish muscle,crayfish muscle
NEW16894,CHEMICAL,molecule vegfr1/2/3 inhibitor,molecule VEGFR1/2/3 inhibitors
D000077210,CHEMICAL,Sunitinib,"SU 11248|sunitinib|SU011248|SU 011248|SU-11248|Sutent|Sunitinib Malate|5-(5-Fluoro-2-oxo-1,2-dihydroindolylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide|SU11248|SU-011248"
C516667,CHEMICAL,pazopanib [Supplementary Concept],Indazoles|Pyrimidines|pazopanib|Sulfonamides
NEW16895,CHEMICAL,nivolumab immune checkpoint inhibitor,nivolumab immune checkpoint inhibitor
D014403,CHEMICAL,Tubocurarine,Tubocurarine Chloride|d-Tubocurare|d-tubocurarine|Tubocurare|d-Tubocurarine
NEW16898,BIOCHEMICAL,promising drug molecule,promising drug molecules
NEW16901,DISEASE,morbid vasospasm,morbid vasospasm
D015652,CHEMICAL,25-Hydroxyvitamin D 2,"25-Hydroxyergocalciferol|25 Hydroxycalciferol|25-Hydroxycalciferol|25 Hydroxyergocalciferol|25 Hydroxyvitamin D2|25-Hydroxyvitamin D2|Ercalcidiol|9,10-Secoergosta-5,7,10(19),22-tetraene-3 beta,25-diol|25 Hydroxyvitamin D 2|25-hydroxyvitamin D"
NEW16905,BIOCHEMICAL,cholecalciferol deficiency,Cholecalciferol deficiency
NEW16906,MENTAL_HEALTH,multiple regression analysis,Multiple regression analysis
NEW16907,CHEMICAL,foh-monofaes,FOH-monoFAEs
NEW16908,BIOCHEMICAL,carotenoid standard,carotenoid standards
NEW16911,MENTAL_HEALTH,multiple linear regression,multiple linear regression
C536911,DISEASE,Familial medullary thyroid carcinoma [Supplementary Concept],"Carcinoma, Medullary/congenital|Medullary thyroid cancer|Multiple Endocrine Neoplasia Type 2a|Thyroid Neoplasms"
NEW16914,CHEMICAL,metastatic mtc,metastatic MTC
NEW16916,CHEMICAL,sodium nitrite intoxication,sodium nitrite intoxication
NEW16918,CHEMICAL,Chilto powder,Chilto powder
NEW16921,DISEASE,human aggression,human aggression
D017282,DISEASE,Tick-Borne Diseases,"Infections, Tick Borne|Tick-Borne Infection|Infections, Tick-Borne|Borne Diseases, Tick|Diseases, Tick Borne|Tick Borne Infections|Disease, Tick-Borne|Borne Disease, Tick|tick-borne diseases|Disease, Tick Borne|Tick-Borne Infections|Tick Borne Diseases|Tick-Borne Disease|Infection, Tick-Borne|Tick Borne Disease|Diseases, Tick-Borne|Tick Borne Infection"
D006850,DISEASE,"Hydrocephalus, Normal Pressure","Hakim's Syndrome|normal pressure hydrocephalus|Hakim Syndrome|NPH (Normal Pressure Hydrocephalus)|Syndromes, Hakim|Syndromes, Hakim's|Normal Pressure Hydrocephalus|Hydrocephalus, Normal-Pressure|Hakim Syndromes|NPHs (Normal Pressure Hydrocephalus)|Syndrome, Hakim|Hakim's Syndromes|Hakims Syndrome|Syndrome, Hakim's"
http://purl.obolibrary.org/obo/CHEBI_24712,CHEMICAL,hydroxymethyl group,hydroxymethyl|-CH2-OH|serine side-chain|alpha-hydroxyl group
D058646,CHEMICAL,Adrenergic alpha-1 Receptor Agonists,"Adrenergic alpha-1 Agonists|Adrenergic alpha 1 Receptor Agonists|Adrenergic alpha 1 Receptor Agonist|Adrenergic alpha 1 Agonists|Agonists, Adrenergic alpha-1|alpha1-Agonists, Adrenergic|Adrenergic alpha1-Agonists|Adrenergic alpha1 Agonists|Adrenergic alpha-1 Receptor Agonist|α1-agonists"
NEW16926,BIOCHEMICAL,systemic antifungal drug,systemic antifungal drugs
NEW16928,CHEMICAL,h2s metabolism,H2S metabolism
NEW16929,CHEMICAL,cerebral h2s metabolism,cerebral H2S metabolism
NEW16931,CHEMICAL,tyrosine analog,tyrosine analog
NEW16933,MENTAL_HEALTH,drug-induced delirium,Drug-induced delirium
NEW16935,CHEMICAL,anabolic androgen steroid user,Anabolic androgen steroid users
NEW16937,CHEMICAL,vinyl phosphonate,vinyl phosphonates
NEW16938,CHEMICAL,vinyl phosphonate,vinylated nucleosides
http://purl.obolibrary.org/obo/CHEBI_175971,CHEMICAL,pteroside p,"p ≤|(2S)-5-(hydroxymethyl)-2,7-dimethyl-6-[2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]-2,3-dihydroinden-1-one"
NEW16940,CHEMICAL,acute cocaine intoxication,acute cocaine intoxication
NEW16942,DISEASE,acute cocaine intoxication,myocardial damage
NEW16943,DISEASE,similar death,similar deaths
C522181,CHEMICAL,apixaban [Supplementary Concept],apixaban|Pyridones|Pyrazoles
D011968,CHEMICAL,"Receptors, Histamine","Histamine Binding Sites|Binding Sites, Histamine|Sites, Histamine Binding|Histamine Receptors|histamine receptors|Histamine Receptor|Receptor, Histamine"
http://purl.obolibrary.org/obo/CHEBI_6413,CHEMICAL,letrozole,"Letrozol|Letrozole|4,4'-(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile|letrozole|Femara|aromatase-inhibitor letrozole"
D002128,CHEMICAL,Calcium Metabolism Disorders,"Disorders, Calcium Metabolism|Calcium Metabolism Disorder|calcium metabolism|Disorder, Calcium Metabolism"
NEW16949,CHEMICAL,letrozole stimulation,letrozole stimulation
NEW16951,CHEMICAL,biscationic quaternary phosphonium compound,Biscationic quaternary phosphonium compounds
NEW16952,DISEASE,structural rigidity,structural rigidity
NEW16953,DISEASE,neurometabolic factor,Neurometabolic factors
D050538,CHEMICAL,Malate Dehydrogenase (NADP+),"malate|Malate Dehydrogenase (NADP)|NADP Malate Dehydrogenase|Dehydrogenase, NADP-Malate|NADP-Malate Dehydrogenase"
NEW16955,CHEMICAL,impaired striatal phasic dopamine release,impaired striatal phasic dopamine release
NEW16956,DISEASE,hippocampal-dependent behavior,hippocampal-dependent behavior
NEW16961,CHEMICAL,oestradiol level,oestradiol levels
NEW16962,CHEMICAL,final oocyte maturation,FOM|final oocyte maturation
NEW16964,BIOCHEMICAL,estrogen therapy,Estrogen therapy
http://purl.obolibrary.org/obo/CHEBI_92458,CHEMICAL,"4-fluorobenzoic acid 4-[[5-(2-methoxyphenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester",Phthalic acid ester
NEW16970,CHEMICAL,phthalate metabolite level,phthalate metabolite levels
NEW16971,CHEMICAL,phthalate metabolite concentration,phthalate metabolite concentrations
D000090702,DISEASE,Constitutive Androstane Receptor,"CAR|CAR Nuclear Receptor|Androstane Receptor, Constitutive|CAR Orphan Nuclear Receptor|Receptor, CAR Nuclear|Constitutive Active Receptor|Nuclear Receptor, CAR|Active Receptor, Constitutive|constitutive androstane receptor|Constitutive Androstane Receptor beta|Receptor, Constitutive Active"
NEW16973,BIOCHEMICAL,xenobiotic agonist,Xenobiotic agonists
NEW16975,DISEASE,brain tumour stem cell,Brain tumour stem cells
NEW16977,MENTAL_HEALTH,medium-sized projection neuron,medium-sized projection neurons
NEW04900,DISEASE,cancer therapy,cancer therapies
NEW16982,BIOCHEMICAL,class cxcr4 antagonist,class CXCR4 antagonist
NEW16983,BIOCHEMICAL,class cxcr4 antagonist,partial mu-opiate agonist
NEW16984,BIOCHEMICAL,female androgen insufficiency syndrome,female androgen insufficiency syndrome
NEW16992,MENTAL_HEALTH,fragmentation scheme,Fragmentation schemes
NEW16993,DISEASE,tourette patient,Tourette patients
NEW16995,CHEMICAL,urinary beta-phenylethylamine level,urinary beta-phenylethylamine levels
D019469,CHEMICAL,Indinavir,"L735 524|L735,524|L 735,524|Crixivan|Indinavir, Sulfate (1:1)|L-735,524|L-735 524|MK639|Sulfate, Indinavir|L 735 524|indinavir|MK 639|Indinavir Sulfate|MK-639"
NEW16999,CHEMICAL,dietary gaba,dietary GABA
NEW17000,MENTAL_HEALTH,regression equation,regression equations
C000610981,CHEMICAL,"MTNR1A protein, human [Supplementary Concept]","MTNR1A|Receptor, Melatonin, MT1"
C425931,CHEMICAL,GW 501516 [Supplementary Concept],Thiazoles|GW501516
NEW17006,CHEMICAL,cytoplasmic human uterine progesterone receptor,cytoplasmic human uterine progesterone receptor
NEW17008,CHEMICAL,3h-dihydrospirorenone,3H-dihydrospirorenone
NEW17009,CHEMICAL,label steroid,labeled steroid
NEW17011,CHEMICAL,80-gene molecular subtyping profile,80-Gene Molecular Subtyping Profile
NEW17013,DISEASE,pericardial edema,Pericardial edema
C451427,CHEMICAL,zoxamide [Supplementary Concept],Amides|zoxamide
NEW03725,CHEMICAL,mesolimbic dopamine da system,mesolimbic dopamine DA system
NEW17016,DISEASE,mesolimbic dopamine da system,hypersomniac episodes
D021902,DISEASE,Enterobacter aerogenes,Klebsiella mobilus|Aerobacter aerogenes|Klebsiella mobilis|Enterobacter %|Klebsiella aerogenes
D041121,DISEASE,Klebsiella oxytoca,Klebsiella|Bacillus oxytocus perniciosus
D044082,DISEASE,Citrobacter rodentium,Citrobacter freundii Biotype 4280|Citrobacter
NEW17017,DISEASE,strain e13 t (= dsm t,strain E13 T (= DSM T
C406452,CHEMICAL,"(7-methoxycoumarin-4-yl)methyl-caged 8-bromoadenosine cyclic 3',5'-monophosphate [Supplementary Concept]",Coumarins|8-Br-cAMP|Cyclic AMP/analogs  and  derivatives
C085974,CHEMICAL,forskolin receptor [Supplementary Concept],"Receptors, Cell Surface|forskolin"
http://purl.obolibrary.org/obo/CHEBI_38634,CHEMICAL,voltage-gated sodium channel blocker,Nav channel blockers|voltage-dependent sodium channel blockers|Nav channel blocker|Voltage-gated KCNQ/Kv7 potassium channels
NEW17025,CHEMICAL,conotoxin family,conotoxin family
D020916,CHEMICAL,Conotoxins,mu-Conotoxin|alpha-Conotoxins|alpha-Conotoxin|mu-Conotoxins|Conotoxin|alpha Conotoxin|mu Conotoxin|alpha Conotoxins|α-conotoxins|mu Conotoxins
NEW17026,CHEMICAL,α5/5 conotoxin isomer,α5/5 conotoxin isomers
NEW17029,DISEASE,erythroleukemia cell line,erythroleukemia cell lines
NEW17033,NUTRITION,cherax destructor hemocyanin,Cherax destructor hemocyanin
D016553,DISEASE,"Purpura, Thrombocytopenic, Idiopathic","Werlhof's Disease|Disease, Werlhof's|Purpura, Immune Thrombocytopenic|Thrombocytopenic Purpuras, Idiopathic|Purpura, Thrombocytopenic, Autoimmune|Werlhof Disease|Disease, Werlhof|Purpuras, Autoimmune Thrombocytopenic|Thrombocytopenia, Autoimmune|Immune Thrombocytopenic Purpura|Immune Thrombocytopenias|Autoimmune Thrombocytopenia|Autoimmune Thrombocytopenic Purpuras|Thrombocytopenic Purpuras, Immune|Idiopathic Thrombocytopenic Purpuras|Thrombocytopenias, Immune|Purpuras, Idiopathic Thrombocytopenic|Purpura, Idiopathic Thrombocytopenic|Thrombocytopenic Purpura, Autoimmune|Purpura, Autoimmune Thrombocytopenic|ITP|Autoimmune Thrombocytopenias|Immune Thrombocytopenic Purpuras|Werlhofs Disease|immune thrombocytopenia|Thrombocytopenic Purpura, Idiopathic|Immune Thrombocytopenia|Thrombocytopenias, Autoimmune|Purpuras, Immune Thrombocytopenic|Idiopathic Thrombocytopenic Purpura|Thrombocytopenia, Immune|Thrombocytopenic Purpura, Immune|Autoimmune Thrombocytopenic Purpura"
D019916,CHEMICAL,Choline-Phosphate Cytidylyltransferase,"CDP Choline Synthetase|Phosphocholine Cytidylyltransferase, CTP|Choline Phosphate Cytidylyltransferase|Phosphocholine Cytidylyl-Transferase, CTP|CTP Phosphocholine Cytidylyl Transferase|Phosphorylcholine Cytidyl Transferase|Transferase, Phosphorylcholine Cytidyl|Phosphorylcholine Cytidyltransferase, CTP|Phosphocholine Cytidyltransferase|CTP Phosphorylcholine Cytidyltransferase|Cytidylyltransferase, CTP Phosphocholine|Cytidylyl-Transferase, CTP Phosphocholine|Synthetase, CDP-Choline|Cytidyltransferase, CTP Phosphorylcholine|CTP Phosphocholine Cytidylyltransferase|CTP Phosphocholine Cytidylyl-Transferase|CDP-Choline Synthetase|Cytidyl Transferase, Phosphorylcholine|CTP|Cytidylyltransferase, Choline-Phosphate|Cytidyltransferase, Phosphocholine"
D005957,CHEMICAL,UTP-Glucose-1-Phosphate Uridylyltransferase,"Pyrophosphorylase, UDP Glucose|Uridylyltransferase, UTP-Glucose-1-Phosphate|Pyrophosphorylase, UDPG|Uridylyltransferase, Glucosephosphate|UDP Glucose Pyrophosphorylase|UDPG Pyrophosphorylase|UTP|UTP Glucose 1 Phosphate Uridylyltransferase|Glucosephosphate Uridylyltransferase"
NEW17035,DISEASE,peripheral blood carbonyl stress marker,peripheral blood carbonyl stress markers
NEW17036,CHEMICAL,advanced product age pentosidine,advanced product AGE pentosidine
D017127,DISEASE,"Glycation End Products, Advanced","Products, Maillard|Maillard Product|Glycation Endproduct, Advanced|Reaction Product, Maillard|Reaction Products, Maillard|Endproducts, Advanced Glycation|Maillard Reaction End Product|Product, Maillard|Product, Maillard Reaction|Advanced Glycation Endproduct|Advanced Maillard Reaction End Products|Endproduct, Advanced Glycation|Maillard Reaction End Products|Advanced Glycation End Products|Products, Maillard Reaction|Maillard Reaction Products|Advanced Glycation End Product|Endproducts, Advanced Glycosylation|Maillard Reaction Product|Maillard Products|Advanced Glycosylation End Product|Advanced Maillard Reaction End Product|Glycation Endproducts, Advanced|Glycosylation Endproducts, Advanced|Advanced Glycosylation Endproducts|Advanced Glycation Endproducts|Glycosylation End Products, Advanced|Advanced Glycosylation End Products|glycation end product"
NEW17037,CHEMICAL,reactive carbonyl-detoxifying b6 vitamin pyridoxal,reactive carbonyl-detoxifying B6 vitamin pyridoxal
NEW17038,CHEMICAL,glyceraldehyde-derived ages,Glyceraldehyde-derived AGEs
http://cbmi.med.harvard.edu/asdphenotype#Class_148,CHEMICAL,exposures,Over-exposure
D019551,BIOCHEMICAL,Dental Disinfectants,"disinfectants|Disinfectants, Dental"
NEW17040,BIOCHEMICAL,peroxiproliferator-activated receptor alpha agonist,peroxiproliferator-activated receptor alpha agonists
http://purl.obolibrary.org/obo/DOID_807,DISEASE,carotid artery occlusion,Occlusion and stenosis of carotid artery|unilateral common carotid artery occlusion
NEW17044,CHEMICAL,third-generation fibric acid derivative,third-generation fibric acid derivative
NEW17047,CHEMICAL,fenofibrate therapy,fenofibrate therapy
D013779,CHEMICAL,Tetrodotoxin,"Toxin, Fugu|Tetradotoxin|Tarichatoxin|Fugu Toxin|Tetrodotoxin"
C092427,DISEASE,CM 178-78 [Supplementary Concept],Diamines|CM
NEW17052,CHEMICAL,ingredient osthole,ingredient osthole
NEW17053,CHEMICAL,pectin receptor,pectin receptors
NEW17055,MENTAL_HEALTH,somatotopic projection,somatotopic projection
NEW17058,BIOCHEMICAL,rt inhibitor,RT inhibitors
D058008,CHEMICAL,Xenotropic murine leukemia virus-related virus,"Xenotropic murine leukemia virus related virus|Viruses, XMRV|Xenotropic MuLV-related viruses|XMRV|xenotropic murine leukemia virus-related virus|Xenotropic MuLV-related virus|XMRV Viruses|Xenotropic MuLV related virus|MuLV-related viruses, Xenotropic|Virus, XMRV|MuLV-related virus, Xenotropic|XMRV Virus"
NEW17060,NUTRITION,pacific mackerel Trachurus symmetricus,Pacific mackerel Trachurus symmetricus
NEW17061,DISEASE,crypt cell,Crypt cells
D048271,CHEMICAL,Chitosan,Poliglusam|chitosan
NEW17063,CHEMICAL,increase salicylic acid,Increased salicylic acid
C534740,CHEMICAL,betulinic acid methyl ester [Supplementary Concept],Triterpenes|betulinic acid
NEW17066,CHEMICAL,long-term liquorice ingestion,Long-term liquorice ingestion
D000077489,CHEMICAL,Piperazine,"piperazine|Piperazinium Oleate|Piperazine Dihydrochloride|Piperazine Sulfate|Piperazine Hydrobromide|Piperazine Hydrochloride|Piperazine Monohydrochloride|Piperazine Tartrate|Piperazine Phosphate (1:1)|Piperazine Phosphate Anhydrous|Piperazine Hydrate|Piperazine Hexahydrate|Piperazine Salt|NAN-190|Piperazine Tartrate (1:1), (R-(R*,R*))-isomer|Piperazine Phosphate|1,4-Diazacyclohexane|Piperazine Tartrate, (R-(R*,R*))-isomer|1,4 Piperazine|Pripsen|Piperazine Diacetate|1,4-Piperazine|1,4 Diazacyclohexane"
NEW17069,CHEMICAL,serotonin 5-ht1a receptor antagonist butyl piperazine,serotonin 5-HT1A receptor antagonist butyl piperazine
NEW17071,DISEASE,brain crf system,brain CRF systems
NEW17072,DISEASE,olb,OLB
NEW17073,CHEMICAL,ee/ln ee/drsp coc treatment,EE/LN EE/DRSP COC treatment
NEW17078,DISEASE,consecutive hypertensive patient,consecutive hypertensive patients
D000077405,CHEMICAL,Irbesartan,"SR47436|BMS 186295|2-N-Butyl-3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1,3-diazaspiro(4,4)non-1-en-4-one|BMS-186295|irbesartan|Karvea|SR-47436|Avapro|Aprovel|SR 47436"
D006852,CHEMICAL,Hydrochlorothiazide,HCTZ|HydroDIURIL|Esidrix|Sectrazide|Esidrex|hydrochlorothiazide|Hypothiazide|Oretic|Dihydrochlorothiazide|Dichlothiazide
NEW17080,DISEASE,gastrointestinal bacterial community,gastrointestinal bacterial communities
NEW17083,DISEASE,anti-gamma aminobutyric acid b receptor encephalitis,Anti-gamma aminobutyric acid B receptor encephalitis
NEW17085,CHEMICAL,metoclopramide poisoning,metoclopramide poisoning
NEW17086,BIOCHEMICAL,poison gland mucus,Poison gland mucus
NEW17088,BIOCHEMICAL,crf1 receptor antagonist,CRF1 receptor antagonists
NEW17089,BIOCHEMICAL,basal thyroid-stimulating hormone,Basal thyroid-stimulating hormone
NEW17090,CHEMICAL,combined estrogen-progestin regiman,combined estrogen-progestin regimen
NEW17091,BIOCHEMICAL,potent estrogen,potent estrogens
NEW12568,BIOCHEMICAL,endocrine therapy,endocrine therapy
NEW17094,CHEMICAL,anti-progestin capable,anti-progestins capable
NEW17095,DISEASE,steroid-induced growth factor,steroid-induced growth factors
NEW17096,DISEASE,early breast cancer,early breast cancer
NEW17098,BIOCHEMICAL,new endocrine agent,newer endocrine agents
NEW17099,CHEMICAL,nbm ch neuron,NBM Ch neurons
NEW17102,MENTAL_HEALTH,glutamatergic corticostriatal projection,glutamatergic corticostriatal projection
D002541,DISEASE,Cerebral Decortication,"Cortex Decortications, Cerebral|cerebral decortication|Cerebral Decortications|Decortication, Cerebral|Cortex Decortication, Cerebral|Cerebral Cortex Decortication|Decortications, Cerebral Cortex|Cerebral Cortex Decortications|Decortications, Cerebral|Decortication, Cerebral Cortex"
NEW03647,DISEASE,neurotoxic effect,neurotoxic effect
NEW17104,DISEASE,hepatocellular hypertrophy,hepatocellular hypertrophy
NEW17105,CHEMICAL,pronamide administration,pronamide administration
NEW05825,CHEMICAL,purine metabolism,purine metabolism
C023666,CHEMICAL,pyridine [Supplementary Concept],Pyridines|pyridine
D011686,CHEMICAL,"Purine-Pyrimidine Metabolism, Inborn Errors","purine|Purine Pyrimidine Metabolism, Inborn Errors"
NEW17109,BIOCHEMICAL,decrease plasma nicotinamide concentration,Decreased plasma nicotinamide concentrations
NEW17110,CHEMICAL,photoadduct,photoadducts
http://purl.obolibrary.org/obo/CHEBI_166646,CHEMICAL,dihydrorotenone,"(1R,6S,13R)-16,17-dimethoxy-6-propan-2-yl-2,7,20-trioxapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-3(11),4(8),9,14,16,18-hexaen-12-one|[(3)H]tamsulosin"
NEW17113,BIOCHEMICAL,certain β-adrenoceptor antagonists/inverse agonist,certain β-adrenoceptor antagonists/inverse agonists
NEW17114,BIOCHEMICAL,peroxiproliferator activate receptor γ agonist pioglitazone AK Scientific,peroxiproliferator activated receptor γ agonist pioglitazone AK Scientific
D000071070,DISEASE,Familial Multiple Lipomatosis,"Familial Multiple Lipomas|Lipomatoses, Familial Multiple|Adiposis Dolorosa Type III|Multiple Lipoma, Familial|Familial Multiple Lipoma|Dercum's Disease Type III|Lipomatosis, Familial Multiple|Lipoma Dolorosa|Multiple Lipomas, Familial|multiple lipomas|Familial Multiple Lipomatoses"
D008067,DISEASE,Lipoma,"Lipomas|lipomas|Lipomas, Atypical|Fatty Tumor|Atypical Lipomas|Lipomata|Pleomorphic Lipoma|Fatty Tumors|Lipomatosis, Multiple|Lipomas, Pleomorphic|Lipoma, Atypical|Lipomatoses, Multiple|Tumors, Fatty|Hibernomas|Lipomatas|Hibernoma|Multiple Lipomatosis|Atypical Lipoma|Tumor, Fatty|Pleomorphic Lipomas|Multiple Lipomatoses|Lipoma, Pleomorphic"
D018902,CHEMICAL,"Chondrodysplasia Punctata, Rhizomelic","CDP|Chondrodysplasia punctata|Chondrodysplasia Punctatas, Rhizomelic|Rhizomelic Chondrodysplasia Punctatas|Chondrodysplasia Punctata, Rhizomelic Form|Rhizomelic Chondrodysplasia Punctata|Punctatas, Rhizomelic Chondrodysplasia|Punctata, Rhizomelic Chondrodysplasia"
NEW17120,DISEASE,maternal hepatic lesion,maternal hepatic lesions
NEW17122,BIOCHEMICAL,prevalent xenoestrogen,prevalent xenoestrogen
NEW17124,CHEMICAL,bpa treatment,BPA treatment
NEW17127,BIOCHEMICAL,pervasive xenoestrogen,pervasive xenoestrogen
C105101,CHEMICAL,"FPR2 protein, human [Supplementary Concept]","formyl peptide receptor|FPR|Receptors, Formyl Peptide|Receptors, Lipoxin"
NEW17130,MENTAL_HEALTH,cholinergic projection,cholinergic projection
NEW17132,BIOCHEMICAL,cholinergic projection,BZR agonists
NEW01373,BIOCHEMICAL,cholinergic projection,inverse agonists
NEW17133,BIOCHEMICAL,recent vitamin d intervention study,recent vitamin D intervention studies
NEW17134,BIOCHEMICAL,iodine-rich drug,iodine-rich drug
NEW17138,MENTAL_HEALTH,sevoflurane-induced pica,sevoflurane-induced pica
NEW17139,CHEMICAL,leukotriene pathway,leukotriene pathway
NEW17141,CHEMICAL,cynanchi atrati,Cynanchi atrati
NEW10394,DISEASE,rtt patient,RTT patients
C024989,CHEMICAL,coenzyme Q10 [Supplementary Concept],coenzyme Q10|Ubiquinone/analogs  and  derivatives|CoQ10
NEW17145,BIOCHEMICAL,vitamin e-derivative trolox,vitamin E-derivative Trolox
NEW17147,CHEMICAL,in trolox treatment,in Trolox treatment
NEW17152,MENTAL_HEALTH,augmented mglur-induced long-term depression,Augmented mGluR-induced long-term depression
http://purl.obolibrary.org/obo/CHEBI_33709,CHEMICAL,amino acid,various amino acids
NEW17154,DISEASE,young-onset mouse,young-onset mice
NEW17156,CHEMICAL,dta-induced orexin neurodegeneration,DTA-induced orexin neurodegeneration
C553414,CHEMICAL,avanafil [Supplementary Concept],Avanafil|Pyrimidines
C579978,DISEASE,Catsper1-Related Nonsyndromic Male Infertility [Supplementary Concept],"Infertility, Male|male infertility"
NEW17161,BIOCHEMICAL,pharmaceutical manipulation,pharmaceutical manipulation
NEW17162,CHEMICAL,α7 nachr,α7 nAChRs
NEW17163,CHEMICAL,diacylglycerol kinase dgk δ,Diacylglycerol kinase DGK δ
NEW17167,BIOCHEMICAL,anticholinergic drug category,anticholinergic drug categories
NEW17168,DISEASE,bacillus sp. b87,Bacillus sp. B87
NEW17170,NUTRITION,soybean gall midge,Soybean gall midge
NEW17171,BIOCHEMICAL,immunogenic neoantigen,immunogenic neoantigens
http://purl.obolibrary.org/obo/CHEBI_35479,CHEMICAL,alkali metal salt,metal salts
NEW17173,DISEASE,differential ion mobility spectrometry,DIMS|Differential ion mobility spectrometry
NEW15118,CHEMICAL,ethanol metabolism,prenatal alcohol exposure
NEW17175,BIOCHEMICAL,selective serotonin uptake inhibitor citalopram,selective serotonin uptake inhibitor citalopram
NEW17176,MENTAL_HEALTH,Montgomery-Asberg depression rating scale,Montgomery-Asberg Depression Rating Scale
NEW17177,CHEMICAL,serotonin-norepinephrine uptake inhibitor desipramine,serotonin-norepinephrine uptake inhibitor desipramine
NEW17179,CHEMICAL,Background Bromodihydrochlorophenylbenzodiazepine,Background Bromodihydrochlorophenylbenzodiazepine
NEW17180,DISEASE,trauma anxiety disorder,trauma anxiety disorders
NEW17183,CHEMICAL,serotonin metabolism,serotonin metabolism
NEW17185,CHEMICAL,opium cure,opium cure
NEW08538,CHEMICAL,possible antidepressant action,possible antidepressant action
NEW17187,CHEMICAL,opiate partial agonist buprenorphine,opiate partial agonist buprenorphine
D001985,BIOCHEMICAL,Bronchial Provocation Tests,"Challenge Test, Bronchial|Endobronchial Challenge Test|Challenges, Bronchial Allergen|Test, Bronchial Provocation|Bronchial Challenge Test|Provocation Tests, Bronchial|Test, Inhalation Provocation|Bronchial Challenge Tests|Challenge, Endobronchial Allergen|Tests, Bronchial Challenge|Endobronchial Allergen Challenges|Challenge Tests, Bronchial|Inhalation Provocation Test|allergen|Allergen Challenge, Bronchial|Challenge Tests, Endobronchial|Challenges, Endobronchial Allergen|Allergen Challenges, Endobronchial|Test, Endobronchial Challenge|Challenge, Bronchial Allergen|Endobronchial Challenge Tests|Provocation Tests, Inhalation|Bronchial Allergen Challenges|Allergen Challenges, Bronchial|Challenge Test, Endobronchial|Inhalation Provocation Tests|Allergen Bronchial Provocation Tests|Bronchial Allergen Challenge|Allergen Challenge, Endobronchial|Bronchial Provocation Test|Test, Bronchial Challenge|Provocation Test, Bronchial|Endobronchial Allergen Challenge|Antigen Bronchial Provocation Tests|Tests, Bronchial Provocation|Tests, Endobronchial Challenge|Tests, Inhalation Provocation|Provocation Test, Inhalation"
NEW17190,DISEASE,catatonic episode,catatonic episode
NEW17191,DISEASE,usher syndrome type ib,Usher syndrome type IB
NEW17192,DISEASE,combined blindness,combined blindness
D000081412,CHEMICAL,Myosin VIIa,"Myosin-VIIa|myosin VIIA|VIIa, Unconventional Myosin|Myosin VIIa, Unconventional|protein, MYO7A|MYO7A protein|VIIa, Myosin|Unconventional Myosin VIIa"
NEW17195,DISEASE,ovarian section,Ovarian sections
http://purl.obolibrary.org/obo/CHEBI_27705,CHEMICAL,delta-carotene,"epsilon,psi-carotene|lycopenes|delta-carotene"
C000645456,CHEMICAL,Lachnoclostridium edouardi [Supplementary Concept],Lachnoclostridium|Clostridiales
NEW17200,NUTRITION,tryptophan intervention,tryptophan interventions
NEW17202,NUTRITION,tryptophan modulation,tryptophan modulation
NEW17203,CHEMICAL,central anandamide level,central anandamide levels
NEW17204,CHEMICAL,selective kappa-opioid receptor agonist spiradoline mesylate,selective kappa-opioid receptor agonist spiradoline mesylate
C051272,CHEMICAL,spiradoline [Supplementary Concept],spiradoline|Pyrrolidines
NEW17205,CHEMICAL,estradiol replacement therapy,Estradiol replacement therapy
NEW17206,CHEMICAL,tryptophan-kynurenine metabolic pathway,tryptophan-kynurenine metabolic pathway
NEW17207,DISEASE,neurotoxic pathway,neurotoxic pathway
C514283,CHEMICAL,oligonol [Supplementary Concept],Oligonol|Catechin/analogs  and  derivatives|Phenols
NEW17209,CHEMICAL,tg-ad mouse,Tg-AD mice
NEW17210,CHEMICAL,continuous oligonol treatment,continuous Oligonol treatment
D000074924,DISEASE,Nut and Peanut Hypersensitivity,Peanut and Tree Nut Allergy|Peanut and Nut Allergies|Peanut and Tree Nut Allergies|peanut allergy|Peanut and Tree Nut Hypersensitivity|Peanut and Nut Allergy|Tree Nut and Peanut Allergy|Nut and Peanut Allergy|Nut and Peanut Allergies
NEW17214,NUTRITION,low serum cholesterol level,low serum cholesterol level
NEW17215,CHEMICAL,5-ht vomiting network,5-HT vomiting network
C467566,CHEMICAL,pomalidomide [Supplementary Concept],Thalidomide/analogs  and  derivatives|Pomalidomide
D009190,DISEASE,Myelodysplastic Syndromes,"Syndrome, Dysmyelopoietic|Myelodysplastic Syndrome|Dysmyelopoietic Syndrome|Myelodysplasia, Hematopoetic|Syndromes, Dysmyelopoietic|Dysmyelopoietic Syndromes|Syndromes, Myelodysplastic|Myelodysplasias, Hematopoetic|Syndrome, Myelodysplastic|Myelodysplastic syndrome|Hematopoetic Myelodysplasias|Hematopoetic Myelodysplasia"
NEW17218,DISEASE,p450c17 deficiency,P450c17 deficiencies
NEW17220,BIOCHEMICAL,cry1a toxin,Cry1A toxins
NEW17223,CHEMICAL,NEKY,NEKY
NEW17224,CHEMICAL,3-hydroxykyn,3HKYN|3-hydroxyKYN
NEW17225,CHEMICAL,excitatory NEKY,excitatory NEKY
NEW17226,CHEMICAL,opposite neuroactivitie,opposite neuroactivities
D005670,CHEMICAL,Fusarium,Fusarium|Fusariums
NEW17230,DISEASE,don contamination level,DON contamination levels
NEW17232,CHEMICAL,Columbia Take-Home Naloxone thn program,Columbia Take-Home Naloxone THN program
NEW17233,MENTAL_HEALTH,bayesian logistic regression,Bayesian logistic regression
NEW17236,DISEASE,allergic response,allergic response
NEW17237,NUTRITION,soybean protoplast,soybean protoplasts
NEW17242,CHEMICAL,leucine incorporation,leucine incorporation
http://purl.obolibrary.org/obo/CHEBI_3216,CHEMICAL,buprenorphine,"buprenorphine|17-cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|buprenorphinum|(-)-buprenorphine|Buprenorphine|(5alpha,6beta,14beta,18R)-17-(cyclopropylmethyl)-18-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol|21-cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine|2-[3-cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|buprenorfina|2-(N-cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|ED-initiated buprenorphine"
D006712,DISEASE,Homocystinuria,"Homocystinuria|CBS Deficiency|Deficiency, CBS|Cystathionine beta Synthase Deficiency Disease|Cystathionine Beta Synthase Deficiency|Cystathionine beta-Synthase Deficiency Disease|Deficiency Disease, Cystathionine beta Synthase|CBS Deficiencies|Deficiencies, CBS|Deficiency Disease, Cystathionine beta-Synthase"
NEW17245,CHEMICAL,zinc deficiency,Zinc deficiencies
NEW17247,CHEMICAL,glutamic acid decarboxylase isoform,glutamic acid decarboxylase isoform
NEW17250,CHEMICAL,thiobarbituric acid reactive product,thiobarbituric acid reactive products
D008063,CHEMICAL,Thioctic Acid,"Acid, alpha-Lipoic|Thiogamma Injekt|Pleomix-Alpha|biomo lipon|Pleomix Alpha N|PleomixAlpha|AlphaLipon Stada|Injekt, Thiogamma|MTWAlphaliponsaure|Lipoic Acid|Verla-Lipon|Thioctacid|Alpha Lipogamma|Pleomix-Alpha N|alpha Liponsaure von ct|MTW Alphaliponsaure|alphaVibolex|AlphaLiponsaure Sofotec|Alpha Liponsaure Sofotec|Alpha-Liponsaure Sofotec|Juthiac|duralipon|Pleomix Alpha|alpha Liponaure Heumann|espa lipon|Tromlipon|AlphaLipogamma|Thioctacide T|biomolipon|alpha Vibolex|VerlaLipon|alpha-Vibolex|biomo-lipon|Alpha-Lipogamma|alphaLiponsaure von ct|MTW-Alphaliponsaure|Thiogamma oral|Alpha Lippon AL|Fenint|AlphaLippon AL|Verla Lipon|Alphaflam|alphaLiponaure Heumann|espalipon|Liponsaure-ratiopharm|Liponsaureratiopharm|alpha-Lipoic Acid|Alpha Lipon Stada|alpha Lipoic Acid|espa-lipon|Azulipont|alpha-Liponsaure von ct|lipoic acid|alpha-Liponaure Heumann|Alpha-Lipon Stada|PleomixAlpha N|Neurium|Alpha-Lippon AL|Liponsaure ratiopharm"
NEW17251,CHEMICAL,ala supplementation,ALA supplementation
NEW17254,CHEMICAL,metabolite dihydro lipoic acid,metabolite dihydro lipoic acid
D016576,CHEMICAL,Fleroxacin,Ro 23 6240|AM833|AM 833|Ro 23-6240|FLRX|AM-833|Fleroxacin|Ro 236240|Quinodis
NEW17256,CHEMICAL,sex-hormone signaling,sex-hormone signaling
C509671,DISEASE,"voltage-sensor-containing phosphatase, Ciona intestinalis [Supplementary Concept]",Phosphoric Monoester Hydrolases|C. intestinalis
NEW17259,BIOCHEMICAL,unique venom proteome,unique venom proteome
NEW17260,DISEASE,bite envenoming,bite envenoming
NEW17262,DISEASE,bite envenoming,moderate pain
NEW17263,CHEMICAL,serum creatine kinase level,serum creatine kinase level
NEW17264,DISEASE,x-linked disorder,X-linked disorder
NEW17265,DISEASE,schisandrae lignan,Schisandrae lignans
NEW17267,CHEMICAL,schisandrae lignan,endocannabinoids system
NEW04875,DISEASE,gl-iv-03,inflammatory pain
NEW17268,DISEASE,hepatotoxic metabolite,hepatotoxic metabolites
NEW17271,CHEMICAL,docosahexaenoic acid dha,docosahexaenoic acid DHA
NEW17272,DISEASE,gray matter volume reduction,gray matter volume reductions
NEW17273,CHEMICAL,pufa composition,PUFA composition
NEW17275,DISEASE,age-related reduction,age-related reduction
C000618185,CHEMICAL,"SMXL2 protein, Arabidopsis [Supplementary Concept]",Arabidopsis Proteins|smxl2|Intracellular Signaling Peptides and Proteins
D000956,BIOCHEMICAL,"Antigens, Viral","viral antigen|Viral Antigens|Antigen, Viral|Viral Antigen"
http://purl.obolibrary.org/obo/CHEBI_80008,CHEMICAL,bila 2185bs,acupuncture/acupressure
NEW17278,CHEMICAL,de adnp mutation,de ADNP mutations
NEW17281,CHEMICAL,calcium sulfate bead,Calcium sulfate beads
D059245,DISEASE,Transient Tachypnea of the Newborn,Newborn Transient Tachypnea|newborn|PPHN|Transient Tachypnea of Newborn|Newborn Transient Tachypneas
NEW17286,DISEASE,lung mitochondrial dysfunction present,lung mitochondrial dysfunction present
NEW17289,CHEMICAL,proline content,proline contents
C512397,CHEMICAL,thienorphine [Supplementary Concept],thienorphine|Buprenorphine/analogs  and  derivatives
D006946,DISEASE,Hyperinsulinism,"Compensatory Hyperinsulinemia|Exogenous Hyperinsulinism|Hyperinsulinism, Endogenous|Hyperinsulinism, Exogenous|Endogenous Hyperinsulinism|Hyperinsulinemia|compensatory hyperinsulinemia|Hyperinsulinemia, Compensatory"
NEW17294,CHEMICAL,ester-rich fasting,ester-rich fasting
NEW17296,CHEMICAL,serum ua concentration,serum UA concentrations
NEW17298,DISEASE,first-episode bpd,first-episode BPD
NEW17304,CHEMICAL,% grje dietary supplementation,% GRJE dietary supplementation
NEW17306,CHEMICAL,SsCCL25,SsCCL25
NEW17308,CHEMICAL,endothelium-dependent challenge,endothelium-dependent challenge
NEW17309,CHEMICAL,elagolix exposure,Elagolix exposures
NEW17312,CHEMICAL,elagolix dose,elagolix dose
C401888,CHEMICAL,pyrithiobac sodium [Supplementary Concept],Benzoates|pyrithiobac
NEW17315,BIOCHEMICAL,high vitamin e intake,Higher vitamin E intake
D024882,BIOCHEMICAL,"Drug Resistance, Viral","Antiviral Drug Resistance|Antiviral Drug Resistances|antiviral drug|Drug Resistances, Viral"
NEW17316,CHEMICAL,report acyclovir,report acyclovir
NEW17318,CHEMICAL,pure compound 2-phenylchromone,pure compound 2-phenylchromone
NEW17319,BIOCHEMICAL,agonist medication,agonist medications
NEW17320,CHEMICAL,sanocrysin,sanocrysin
NEW17323,CHEMICAL,sanocrysin therapy,Sanocrysin therapy
NEW17324,BIOCHEMICAL,h. current analgesic regime,h. Current analgesic regimes
NEW17325,BIOCHEMICAL,beta adrenoreceptor agonist,beta adrenoreceptor agonists
NEW17327,BIOCHEMICAL,act μ-opioid receptor antagonist,acting μ-opioid receptor antagonist
C000620491,CHEMICAL,naldemedine [Supplementary Concept],Naltrexone/analogs  and  derivatives|naldemedine
NEW17329,DISEASE,constipation-induced reduction,constipation-induced reduction
NEW17331,DISEASE,pantoea ananatis brt175,Pantoea ananatis BRT175
NEW17334,CHEMICAL,importance formylaminooxyvinylglycine,IMPORTANCE formylaminooxyvinylglycine
C088137,CHEMICAL,aminoethoxyvinylglycine [Supplementary Concept],aminoethoxyvinylglycine|Glycine/analogs  and  derivatives
NEW17336,CHEMICAL,l-arginine transporter,l-arginine transporter
NEW17337,CHEMICAL,l-asparagine transporter,l-asparagine transporter
NEW17338,CHEMICAL,dietary proanthocyanidin,dietary proanthocyanidins|PAC
D000069349,CHEMICAL,Linezolid,"U-100766|U 100766|N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide|100766, U|Linezolide|Linezolid|Zyvox|PNU100766|PNU-100766|U100766|PNU 100766"
NEW17340,CHEMICAL,linezolid therapy,linezolid therapy
NEW09912,CHEMICAL,oral conjugated equine estrogen,CEE|Oral conjugated equine estrogens
NEW17344,CHEMICAL,melatonin mt(1 receptor,melatonin MT(1 receptors
http://purl.obolibrary.org/obo/IAO_0000409,CHEMICAL,denotator type,type    HSV-I
C048621,DISEASE,"glycoprotein E, herpes simplex-virus type 2 [Supplementary Concept]",herpes simplex virus type|Viral Envelope Proteins
NEW17348,DISEASE,recurrent hsv-i infection hsv-i,recurrent HSV-I infection HSV-I
C477373,DISEASE,"MON1B protein, human [Supplementary Concept]",Intracellular Signaling Peptides and Proteins|HSV-I
D017789,DISEASE,"Granuloma, Pyogenic","Lobular Capillary Hemangioma|Hemangioma, Lobular Capillary|pyogenic granuloma|Pyogenic Granuloma|Angiogranulomas|Granuloma Pyogenicum|Angiogranuloma|Capillary Hemangioma, Lobular|Granuloma Telangiecticum"
NEW17349,DISEASE,recurrent hsv-i infection hsv-i,chronic HSV-I infection
NEW17351,BIOCHEMICAL,antagonist muscle,antagonist muscles
D064830,DISEASE,Temperance Movement,"Women's Christian Temperance Union|Temperance Movements|Movement, Temperance|Movements, Temperance|movement"
NEW17354,CHEMICAL,neuro-transmitter serotonin,neuro-transmitter serotonin
NEW17356,BIOCHEMICAL,nervosa serotonin agonist,Nervosa serotonin agonists
C100640,CHEMICAL,8-cyclopentyl-3-(3-((4-(fluorosulfonyl)benzoyl)oxy)propyl)-1-propylxanthine [Supplementary Concept],Xanthines|FSCPX
http://purl.obolibrary.org/obo/CHEBI_3095,BIOCHEMICAL,biguanide,"imidodicarbonimidic diamide|Hbig|biguanide|Thiazolidinediones TZDs|H2N-C(=NH)-NH-C(=NH)-NH2|1,2,3-triimidodicarbonic diamide|Biguanide"
NEW17361,CHEMICAL,fly gd model,fly GD model
NEW17363,MENTAL_HEALTH,dissociation constant,Dissociation constants
C565390,DISEASE,Methylmalonic Aciduria due to Methylmalonyl-CoA Mutase Deficiency [Supplementary Concept],"Methylmalonyl-CoA Mutase/deficiency|Amino Acid Metabolism, Inborn Errors|methylmalonic aciduria"
NEW17365,DISEASE,cobalamin-responsive patient,cobalamin-responsive patients
NEW17366,CHEMICAL,exist antidepressant drug,existing antidepressant drugs
NEW17367,CHEMICAL,glucose catabolism,glucose catabolism
D015323,CHEMICAL,"Pyruvate Metabolism, Inborn Errors","Carbohydrate Metabolism, Inborn Errors (1966-1988)|pyruvate metabolism|Pyruvates (1966-1988)"
NEW17368,CHEMICAL,metabolism pentose phosphate pathway,metabolism pentose phosphate pathways
NEW17369,CHEMICAL,lipopolysaccharide injection,Lipopolysaccharide injection
NEW17370,CHEMICAL,high-carbohydrate level,High-carbohydrate levels
http://purl.obolibrary.org/obo/CHEBI_8764,CHEMICAL,mycophenolate mofetil,"2-(morpholin-4-yl)ethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate|RS 61443|MMF|mycophenolic acid morpholinoethyl ester|Tacrolimus (FK506)/mycophenolate mofetil|Cellcept|2-morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate"
NEW17374,CHEMICAL,tn crt2,Tn CRT2
NEW17376,DISEASE,average daily weight gain,average daily weight gain
NEW17377,NUTRITION,finisher herd,Finisher herds
NEW17380,DISEASE,migraine patient,Migraine patients
NEW17381,DISEASE,meningeal inflammation,meningeal inflammation
NEW17383,BIOCHEMICAL,conventional μ-opioid receptor agonist,conventional μ-opioid receptor agonists
NEW07773,DISEASE,neuropathic rat,neuropathic rats
NEW17386,BIOCHEMICAL,selective μ-opioid receptor antagonist ctap,selective μ-opioid receptor antagonist CTAP
NEW17387,CHEMICAL,microglial inhibitor minocycline,microglial inhibitor minocycline
NEW17388,CHEMICAL,low frequency electroacupuncture,low frequency electroacupuncture
NEW17390,DISEASE,plp deficiency,PLP deficiency
C097250,NUTRITION,betaine reductase [Supplementary Concept],Amino Acid Oxidoreductases|trimethylglycine
D015456,DISEASE,"Leukemia, Biphenotypic, Acute","Acute Leukemia, Biphenotypic|Acute Leukemias, Mixed-Lineage|Acute Biphenotypic Leukemias|Hybrid Acute Leukemia|Acute Leukemias, Biphenotypic|Mixed-Cell Leukemia|Lymphocytic Leukemia, Acute, B and T Cell|Acute Leukemia, Hybrid|Acute Biphenotypic Leukemia|Leukemia, Mixed, B- and T-Cell|Acute Leukemias, Hybrid|Mixed-Lineage Acute Leukemia|B and T Cell Leukemia, Acute|Leukemia, Mixed-Lineage Acute|Leukemia, Mixed Cell|B- and T-Cell Leukemia, Acute|Leukemias, Biphenotypic Acute|Leukemias, Mixed-Cell|B- and T-Cell Acute Lymphoblastic Leukemia|Acute Leukemia, Mixed-Lineage|Mixed-Lineage Acute Leukemias|Leukemias, Mixed-Lineage Acute|B and T Cell Acute Lymphoblastic Leukemia|Leukemia, Lymphocytic, Acute, Mixed-Cell|Mixed Lineage Acute Leukemias|Biphenotypic Acute Leukemias|Leukemias, Hybrid Acute|Leukemias, Acute Biphenotypic|Leukemia, Lymphocytic, Acute, Mixed Cell|Lymphocytic Leukemia, Acute, B- and T-Cell|Biphenotypic Acute Leukemia|Mixed-Cell Leukemias|Leukemia, Mixed-Cell|T cell acute lymphoblastic leukemia|Biphenotypic Leukemias, Acute|Leukemia, Hybrid Acute|Leukemia, Acute Biphenotypic|Leukemia, Biphenotypic Acute|Biphenotypic Leukemia, Acute|Hybrid Acute Leukemias|Leukemia, Mixed, B and T Cell"
NEW17394,CHEMICAL,faah gene,FAAH gene
NEW17396,MENTAL_HEALTH,gene cannabis dependence,gene cannabis dependence
NEW17397,BIOCHEMICAL,selective a2a receptor antagonist,selective A2A receptor antagonist
http://purl.obolibrary.org/obo/CHEBI_51052,CHEMICAL,lucanthone,lucanthone|indenoisoquinolines|1-diethylaminoethylethylamino-4-methyl-thioxanthenone|1-{[2-(diethylamino)ethyl]amino}-4-methyl-9H-thioxanthen-9-one|1-((2-(diethylamino)ethyl)amino)-4-methylthioxanthen-9-one|lucanthonum|lucantona|Lucanthone|1-{[2-(diethylamino)ethyl]amino}-4-methylthioxanthen-9-one
NEW17399,BIOCHEMICAL,non-camptothecinic base topoisomerase poison,non-camptothecinic based topoisomerase poisons
NEW17400,CHEMICAL,intravenous apomorphine,intravenous apomorphine
NEW17403,CHEMICAL,avp action,AVP action
NEW02919,BIOCHEMICAL,endocrine response,endocrine responses
NEW17410,DISEASE,depressed participant,Depressed participants
NEW17414,MENTAL_HEALTH,alogia SANSS,Alogia SANSS
NEW17415,CHEMICAL,mixed μ/κ opioid,mixed μ/κ opioid
NEW17416,BIOCHEMICAL,mixed micro-/kappa-opioid analgesic,mixed micro-/kappa-opioid analgesic
NEW17418,CHEMICAL,epinephrine dose-response curve,epinephrine dose-response curve
NEW17419,DISEASE,ser-the aggression,SER-the aggression
C050232,CHEMICAL,"1,3-ditolylguanidine [Supplementary Concept]","Guanidines|1,3-Di-o-tolylguanidine|DTG"
NEW17421,MENTAL_HEALTH,l-dopa hyperactivity,L-DOPA hyperactivity
http://purl.obolibrary.org/obo/CHEBI_7936,CHEMICAL,paroxetine,"DTG paroxetine|Paroxetine|(-)-(3S,4R)-4-(p-fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine|paroxetinum|paroxetina|(3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine"
NEW17423,DISEASE,importance gut bacterial infection,IMPORTANCE Gut bacterial infections
D003969,DISEASE,Vipoma,"Watery Diarrhea with Hypokalemic Alkalosis|Syndrome, Vipoma|Watery Diarrhea Syndrome|VIPomas, Pancreatic|WDHA|Vasoactive Intestinal Peptide-Producing Tumor|Tumors, Diarrheogenic|Pancreatic VIPoma|Tumors, VIP-Secreting (VIPoma)|Verner Morrison Syndrome|VIP-Secreting Tumors (VIPoma)|WDHH|Tumor, Diarrheogenic|watery diarrhea|Diarrheogenic Tumors|Pancreatic VIPomas|VIP-Secreting Tumor (VIPoma)|WDHA Syndromes|VIPoma, Pancreatic|Vasoactive Intestinal Peptide Producing Tumor|Tumor, VIP-Secreting (VIPoma)|Cholera, Pancreatic|Syndrome, Verner-Morrison|Pancreatic Cholera|Diarrheogenic Tumor|VIP Secreting Tumor (VIPoma)|Vipoma Syndrome|WDHA Syndrome|Watery Diarrhea, Hypokalemia, and Achlorhydria Syndrome|Verner-Morrison Syndrome|Vipomas|Vasoactive Intestinal Peptide (VIP) Tumor|Diarrheogenic Islet Cell Tumor"
NEW17424,CHEMICAL,low-dose ttx,low-dose TTX
D002024,NUTRITION,Bufo marinus,"Toads, Giant|Marine Toads|toad|Giant Toads|Toads, Marine|Rhinella marina|Giant Toad|Toad, Giant|Toad, Marine|Marine Toad"
NEW02057,DISEASE,breast cancer patient,manic symptoms
NEW17431,MENTAL_HEALTH,treatment-emergent mania,treatment-emergent mania
D057465,MENTAL_HEALTH,Catabolite Repression,"Catabolite Repressions|Repressions, Carbon Catabolite|Carbon Catabolite Repression|Catabolite repression|Repression, Carbon Catabolite|Repression, Catabolite|Repressions, Catabolite|Carbon Catabolite Repressions|Catabolite Repressions, Carbon|Catabolite Repression, Carbon"
NEW17440,CHEMICAL,resveratrol dimer,Resveratrol dimer
D046930,DISEASE,Thymus Plant,"Thyme|Thymus vulgari|Plant, Thymus|Thymus Plants|vulgaris, Thymus|Plants, Thymus|Thymus vulgaris|Thymes"
D004078,CHEMICAL,Dihydralazine,"Dihydrallazine|Dihydrazinophthalazin|dihydralazine|Depressan|Sulfate, Dihydralazine|Dihydralazine Sulfate"
NEW17443,CHEMICAL,day minoxidil,day minoxidil
NEW17445,CHEMICAL,nasal steroid,Nasal steroids
NEW17449,DISEASE,fatty liver disease secondary,fatty liver disease secondary
NEW17453,DISEASE,hepatic sensitivity,hepatic sensitivity
NEW17454,CHEMICAL,fernblock ® ifc,Fernblock ® IFC
NEW17456,DISEASE,Melasma quality,Melasma Quality
NEW17459,CHEMICAL,oral PLE aqueous extract product,oral PLE aqueous extract product
NEW17461,CHEMICAL,doxylamine/dicyclomine/pyridoxine combination,doxylamine/dicyclomine/pyridoxine combination
NEW17463,CHEMICAL,dha 22:6n-3,DHA 22:6n-3
NEW17464,MENTAL_HEALTH,syndrome ds trisomy cell,syndrome DS trisomy cells
D014199,NUTRITION,Trehalose,Trehalose
NEW17468,CHEMICAL,cholesterol-lowering agent,cholesterol-lowering agents
NEW17469,CHEMICAL,kynurenine pathway metabolite,kynurenine pathway metabolite
NEW17471,CHEMICAL,neuroactive kynurenine pathway metabolite,neuroactive kynurenine pathway metabolites
NEW17474,CHEMICAL,kynurenine pathway metabolism,kynurenine pathway metabolism
NEW17475,CHEMICAL,nimodipine pre-treatment,nimodipine pre-treatment
NEW17477,NUTRITION,various alpha 2-adrenoceptor,Various alpha 2-adrenoceptor
C534368,CHEMICAL,fipronil sulfone [Supplementary Concept],Pyrazoles|fipronil
NEW17482,CHEMICAL,acetylcholinesterase inhibitor soman,acetylcholinesterase inhibitor soman
NEW17484,CHEMICAL,[3h]mtx,[3H]MTX
NEW17229,DISEASE,opposite neuroactivitie,DON|6-diazo-5-oxo-norleucine
C043077,CHEMICAL,ipsapirone [Supplementary Concept],Pyrimidines|ipsapirone
NEW10591,MENTAL_HEALTH,alcohol craving,alcohol craving
NEW17490,CHEMICAL,nicotine replacement therapy,Nicotine replacement therapies
NEW17493,DISEASE,differentiated thyroid cancer,Differentiated thyroid cancer
NEW17495,CHEMICAL,vegf receptor inhibitor pazopanib,VEGF receptor inhibitor pazopanib
NEW17497,CHEMICAL,mek inhibitor trametinib,MEK inhibitor trametinib
C003915,CHEMICAL,diminazene aceturate [Supplementary Concept],DIZE|Diminazene/analogs  and  derivatives|Diminazene aceturate
NEW17500,DISEASE,lethal inflammatory disorder,lethal inflammatory disorder
NEW17502,CHEMICAL,high plasma homocysteine,High plasma homocysteine
NEW17505,CHEMICAL,flc-like,CiMFL|FLC-like
NEW17507,DISEASE,formalin-induced inflammatory pain,formalin-induced inflammatory pain
NEW17509,BIOCHEMICAL,novel benzodiazepine receptor partial inverse agonist,novel benzodiazepine receptor partial inverse agonist
NEW17511,CHEMICAL,alpha-adrenergic agonist midodrine,alpha-adrenergic agonist midodrine
NEW17512,CHEMICAL,5-hydroxytryptamine agonist/antagonist dihydroergotamine,5-hydroxytryptamine agonist/antagonist dihydroergotamine
NEW17513,BIOCHEMICAL,5-ht antagonist cyproheptadine,5-HT antagonist cyproheptadine
NEW17514,DISEASE,precede viral infection,preceding viral infection
NEW17516,BIOCHEMICAL,chronic opioid analgesic use,chronic opioid analgesic use
NEW17517,MENTAL_HEALTH,postoperative analgesia,Postoperative analgesia
http://purl.obolibrary.org/obo/NCBITaxon_6687,NUTRITION,penaeus monodon,shrimp Litopenaeus
NEW17519,MENTAL_HEALTH,migraine dialysis headache subgroup,migraine dialysis headache subgroups
NEW17520,CHEMICAL,boron substitution,boron substitution
NEW17521,CHEMICAL,exocyclic b-o-n linkage,exocyclic B-O-N linkage
NEW17524,CHEMICAL,plasma oxytocin level,plasma oxytocin level
NEW17525,MENTAL_HEALTH,plasma oxytocin level,heroin craving
NEW17526,CHEMICAL,ttx level,TTX levels
NEW17528,BIOCHEMICAL,nicotine agonist,Nicotine agonists
NEW17529,CHEMICAL,nmda receptor agonist quinolinic acid,NMDA receptor agonist quinolinic acid
D018869,DISEASE,Heat-Shock Response,"Heat shock response|Stress, Heat Shock|Heat Stress|Heat Shock|Heat-Shock Reaction|Shock, Heat|Heat Shock Response|Heat-Stress Responses|Heat Shocks|Stress, Heat|Heat Shock Reaction|Heat Stress Response|Heat Shock Stress|Heat-Shock Reactions|Heat-Stress Reaction|Heat Stresses|Heat-Stress Response|Heat-Stress Reactions|Heat Stress Reaction|Heat Shock Stresses|Heat-Shock Responses"
C529323,CHEMICAL,"Naxe protein, mouse [Supplementary Concept]",APOA1BP|NAXE|Phosphoproteins|Racemases and Epimerases
NEW17533,CHEMICAL,glutamatergic n-methyl-d-aspartate receptor antagonist ketamine,glutamatergic N-methyl-D-aspartate receptor antagonist ketamine
NEW17534,DISEASE,moderate accidental trauma,moderate accidental trauma
D015651,DISEASE,Mycotoxicosis,"Poisonings, Fungus|Fungus Poisoning|Fungus Poisonings|Mycotoxicoses|Poisoning, Fungus|mycotoxicosis"
D000071438,DISEASE,Fatty Acid-Binding Protein 7,"Brain Lipid-Binding Protein|Fatty Acid-Binding Protein, Brain|Fatty Acid Binding Protein, Brain|Fatty Acid Binding Protein 7|Mammary-Derived Growth Inhibitor Related Protein|Lipid-Binding Protein, Brain|Brain Lipid Binding Protein|fatty acid-binding protein|Mammary Derived Growth Inhibitor Related Protein"
NEW17539,BIOCHEMICAL,intracellular fatty acid carrier protein,intracellular fatty acid carrier protein
NEW17540,CHEMICAL,electroacupuncture treatment,electroacupuncture treatment
NEW17542,CHEMICAL,maternal tobacco smoking,Maternal tobacco smoking
NEW17544,CHEMICAL,alpha-5 nicotinic acetylcholine receptor subunit,alpha-5 nicotinic acetylcholine receptor subunit
http://purl.obolibrary.org/obo/CHEBI_15857,CHEMICAL,5-l-glutamyl amino acid,N(alpha)-(L-gamma-glutamyl) amino acid|L-gamma-glutamyl amino acid|5-L-Glutamyl amino acid|L-gamma-Glutamyl amino acid|amino acid position
D057055,CHEMICAL,Aspartic Acid Proteases,"Proteinases, Aspartic Acid|Acid Protease, Aspartic|Aspartic Proteinase|Aspartyl Proteinase|Aspartic Acid Proteinases|Aspartyl Proteases|Acid Proteinase, Aspartic|Protease, Aspartyl|Aspartic Acid Protease|Acid Proteases, Aspartic|Protease, Aspartic Acid|Proteases, Aspartic Acid|Proteases, Aspartyl|Proteinases, Aspartic|Proteinases, Aspartyl|Proteinase, Aspartic Acid|Aspartyl Proteinases|Proteinase, Aspartyl|Aspartic Acid Proteinase|Aspartyl Protease|Proteinase, Aspartic|aspartic acid|Aspartic Proteinases"
NEW17546,CHEMICAL,asparagine substitution,asparagine substitution
NEW17547,CHEMICAL,chrna5 single nucleotide polymorphism snp rs16969968,CHRNA5 single nucleotide polymorphism SNP rs16969968
NEW10057,MENTAL_HEALTH,dissociation constant,dissociation constants
C011639,CHEMICAL,ADTN [Supplementary Concept],Tetrahydronaphthalenes|ADTN
NEW17552,BIOCHEMICAL,act μ-opiate antagonist,acting μ-opiate antagonists
NEW17553,CHEMICAL,rapid antidepressant effect,Rapid antidepressant effects
NEW17554,CHEMICAL,n-methyl-d-aspartate glutamate-receptor antagonist,N-methyl-D-aspartate glutamate-receptor antagonists
NEW17556,CHEMICAL,glx glutamate,Glx glutamate
NEW17557,CHEMICAL,glx glutamate,ketamine dose
NEW17558,BIOCHEMICAL,other endocrine abnormality,Other endocrine abnormalities
NEW17560,DISEASE,hypothalamic-pituitary abnormality,hypothalamic-pituitary abnormalities
NEW17563,DISEASE,peritoneal metastasis,peritoneal metastasis
D001285,CHEMICAL,Atropine,"atropine|Sulfate, Atropine|atropine sulfate|Anhydrous, Atropine Sulfate|Atropin Augenöl|Atropine Sulfate|Atropinol|Sulfate Anhydrous, Atropine|AtroPen|Augenöl, Atropin|Atropine Sulfate Anhydrous"
D006986,CHEMICAL,Hypervitaminosis A,Vitamin A (1966-1986)|hypervitaminosis A
NEW17567,CHEMICAL,corrected calcium,corrected calcium
NEW17571,DISEASE,accelerate liver fibrosis,Accelerated liver fibrosis
NEW17573,DISEASE,frequent hepatic decompensation event,frequent hepatic decompensation events
NEW17574,DISEASE,Protocadherin female limited epilepsy,Protocadherin female limited epilepsy
NEW17576,CHEMICAL,PCDH19-FE mim300088,PCDH19-FE MIM300088
http://purl.obolibrary.org/obo/CHEBI_35482,BIOCHEMICAL,opioid analgesic,opioid analgesic drugs|narcotic analgesic|opioid analgesics|narcotic analgesics|narcotics|narcotic
D000090983,CHEMICAL,2019-nCoV Vaccine mRNA-1273,"Moderna COVID 19 Vaccine|M1273|COVID-19 Vaccine Moderna|Moderna COVID-19 Vaccine RNA|TAK-919|COVID 19 Vaccine Moderna|TAK 919|Elasomeran|Vaccine, Moderna COVID-19|mRNA-1273|2019 nCoV Vaccine mRNA 1273|mRNA-1273.211|Moderna, COVID-19 Vaccine|M-1273|Moderna COVID-19 Vaccine|mRNA-1273, 2019-nCoV Vaccine|COVID-19 Vaccine, Moderna|TAK919|mRNA 1273|M 1273|mRNA 1273.211|Moderna COVID 19 Vaccine RNA"
D001905,BIOCHEMICAL,Botulinum Toxins,"Botulin|Toxins, Botulinum|Toxins, Clostridium botulinum|Neurotoxins, Botulinum|Botulinum Neurotoxins|Toxin, Botulinum|Clostridium botulinum Toxins|Botulinum Neurotoxin|Botulinum neurotoxins|Neurotoxin, Botulinum|Botulinum Toxin"
D013119,DISEASE,Spinal Cord Injuries,"Cord Transection, Spinal|Cord Contusions, Spinal|Cord Traumas, Spinal|Spinal Cord Laceration|Cord Injuries, Spinal|Injuries, Spinal Cord|Cord Transections, Spinal|Spinal Cord Traumas|Spinal Cord Contusion|Contusion, Spinal Cord|Cord Injury, Spinal|Cord Trauma, Spinal|Injury, Spinal Cord|Post-Traumatic Myelopathy|Spinal Cord Transections|Traumatic Myelopathies|Myelopathy, Traumatic|Myelopathy, Post-Traumatic|Post-Traumatic Myelopathies|Lacerations, Spinal Cord|Traumatic Myelopathy|Myelopathies, Traumatic|Laceration, Spinal Cord|Cord Laceration, Spinal|Spinal Cord Transection|Myelopathies, Post-Traumatic|Trauma, Spinal Cord|Spinal cord injury|Spinal Cord Trauma|Spinal Cord Injury|Traumas, Spinal Cord|Cord Lacerations, Spinal|Spinal Cord Contusions|Cord Contusion, Spinal|Transections, Spinal Cord|Post Traumatic Myelopathy|Contusions, Spinal Cord|Transection, Spinal Cord|Spinal Cord Lacerations"
NEW17582,DISEASE,hypocapnic central apnea,hypocapnic central apnea
D054020,CHEMICAL,"Lasers, Gas","CO2 Laser|Gas Lasers|Vapor Lasers, Gold|HeNe Laser|Vapor Laser, Metal|Ion Laser, Argon|Laser, Gas|Lasers, Xenon Ion|Helium Neon Gas Lasers|Vapor Laser, Gold|Lasers, HeNe|Lasers, CO2|Laser, Carbon Dioxide|Nitrogen Lasers|Helium Laser|Lasers, Metal Vapor|CO2|Carbon Dioxide Lasers|Lasers, Copper Vapor|Lasers, Helium|Helium Lasers|Gold Vapor Laser|Laser, Gold Vapor|Laser, Metal Vapor|Laser, Argon Ion|Argon Ion Lasers|Metal Vapor Laser|Laser, Xenon Ion|Lasers, Carbon Dioxide|Laser, CO2|Gold Vapor Lasers|Dioxide Laser, Carbon|Laser, Nitrogen|Copper Vapor Laser|Laser, Helium|Lasers, Gold Vapor|Lasers, Nitrogen|Metal Vapor Lasers|Laser, Copper Vapor|Nitrogen Laser|Ion Lasers, Xenon|Laser, HeNe|CO2 Lasers|Vapor Laser, Copper|Lasers, Argon Ion|Argon Ion Laser|Vapor Lasers, Copper|Ion Laser, Xenon|Ion Lasers, Argon|Copper Vapor Lasers|Gas Laser|Xenon Ion Lasers|Xenon Ion Laser|Dioxide Lasers, Carbon|Lasers, Helium Neon Gas|Vapor Lasers, Metal|Carbon Dioxide Laser|HeNe Lasers"
NEW17588,CHEMICAL,high-dose acetazolamide,high-dose acetazolamide
NEW17590,DISEASE,high-dose acetazolamide,central SDB
NEW17591,BIOCHEMICAL,endocrine factor,Endocrine factors
NEW17592,CHEMICAL,eulophia macrobulbon,Eulophia macrobulbon
NEW17593,CHEMICAL,oral myo-inositol,Oral myo-inositol
NEW17597,CHEMICAL,repetitive ethanol intoxication,repetitive ethanol intoxication
C537889,CHEMICAL,Pfeiffer Palm Teller syndrome [Supplementary Concept],"Joint Diseases|Facies|Teller|Abnormalities, Multiple|Growth Disorders|Dental Enamel Hypoplasia"
D058225,CHEMICAL,"Plaque, Amyloid","amyloid plaques|Amyloid Deposit|Plaque, Senile|Senile Plaques|Neuritic Plaque|Amyloid Plaque|Plaque, Neuritic|Senile Plaque|Plaques, Amyloid|Deposit, Amyloid|Plaques, Senile|Neuritic Plaques|Plaques, Neuritic|Deposits, Amyloid|Amyloid Deposits|Amyloid Plaques"
NEW17603,DISEASE,idiopathic short stature,idiopathic short stature
NEW17604,CHEMICAL,injectable recombinant human (rh)igf-i,Injectable recombinant human (rh)IGF-I|mecasermin
NEW17607,CHEMICAL,exogenous atp,exogenous ATP
D013498,CHEMICAL,Suramin,"Salt Suramin, Monosodium|Suramin, Hexasodium Salt|Germanin|suramin|Naganin|Naganol|Suramin Sodium|Salt Suramin, Hexasodium|Suramin, Monosodium Salt|Monosodium Salt Suramin|Sodium, Suramin|Moranil|Hexasodium Salt Suramin|Naphuride"
C007768,CHEMICAL,formononetin [Supplementary Concept],Formononetin|Isoflavones
NEW17612,BIOCHEMICAL,gonadotropin-releasing hormone analogue,Gonadotropin-releasing hormone analogues
NEW17614,BIOCHEMICAL,conventional gnrh antagonist protocol,Conventional GnRH antagonist protocols
NEW17616,DISEASE,p. plecoglossicida,P. plecoglossicida
NEW17618,DISEASE,spleen granuloma,spleen granulomas
D015675,CHEMICAL,Osteocalcin,"Bone 4-Carboxyglutamic Protein|Bone gamma-Carboxyglutamic Acid Protein|Vitamin K-Dependent Bone Protein|Calcium Binding Protein, Vitamin K Dependent|Vitamin K Dependent Bone Protein|ucOC|Gla Protein, Bone|Protein, Bone 4-Carboxyglutamic|osteocalcin|Bone Gla Protein|Bone gamma Carboxyglutamic Acid Protein|4-Carboxyglutamic Protein, Bone|4 Carboxyglutamic Protein, Bone|Protein, Bone Gla|Calcium-Binding Protein, Vitamin K-Dependent"
C482445,DISEASE,"Npc1l1 protein, mouse [Supplementary Concept]",Membrane Transport Proteins|C1-like
NEW17624,BIOCHEMICAL,hormone hypothalamic-pituitary-adrenal axis hormone,hormones hypothalamic-pituitary-adrenal axis hormones
NEW17626,MENTAL_HEALTH,multiple regression analysis,Multiple regression analyses
NEW05640,BIOCHEMICAL,multiple regression analysis,hormone levels
NEW17627,MENTAL_HEALTH,multiple regression analysis,ADHD severity
NEW17628,CHEMICAL,cortisol diurnal slope,cortisol diurnal slope
NEW17629,BIOCHEMICAL,hpa axis hormone level,HPA axis hormone levels
NEW17630,BIOCHEMICAL,estrogen metabolite,estrogen metabolites
NEW17632,BIOCHEMICAL,estrogen hydroxylation pathway,estrogen hydroxylation pathway
NEW11502,BIOCHEMICAL,endocrine hormone,endocrine hormones
NEW17635,DISEASE,ra derivative,RA derivatives
http://purl.obolibrary.org/obo/CHEBI_9512,CHEMICAL,thalidasine,Thalidasine|Salvia miltiorrhiza Bunge
NEW17637,CHEMICAL,cystine importer-overexpressing strain,cystine importer-overexpressing strain
NEW17638,DISEASE,s. platensis extract,S. platensis extract
NEW17639,DISEASE,endophyte nitrogen-fixing p. stutzeri,endophyte nitrogen-fixing P. stutzeri
NEW17640,CHEMICAL,asmsrb-rnai hairy root,AsMsrB-RNAi hairy roots
NEW17642,CHEMICAL,asmsrb,AsMsrB
NEW01631,CHEMICAL,subeffective dose,subeffective doses
NEW17643,DISEASE,premature adrenarche,premature adrenarche
C536845,BIOCHEMICAL,Familial hypersecretion of adrenal androgens [Supplementary Concept],adrenal androgens|Adrenocortical Hyperfunction
NEW17646,CHEMICAL,striatal dopamine d5 receptor,striatal dopamine D5 receptor
NEW17647,BIOCHEMICAL,partial d5 receptor agonist,partial D5 receptor agonist
C080703,CHEMICAL,SK and F 83959 [Supplementary Concept],"2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/analogs  and  derivatives|SKF-83959"
NEW17650,CHEMICAL,metoclopramide side effect related,Metoclopramide side effects related
NEW17651,MENTAL_HEALTH,resistance exercise,Resistance exercise
NEW17653,BIOCHEMICAL,flavour enhancer,flavour enhancer
NEW17654,CHEMICAL,excessive food additive monosodium glutamate,Excessive food additives Monosodium glutamate|MSG
NEW17657,MENTAL_HEALTH,resistance quantitative trait locus,resistance quantitative trait locus
NEW17658,CHEMICAL,gabrg2 gaba a receptor subunit gamma2 polymorphism,GABRG2 GABA A receptor subunit gamma2 polymorphism
NEW17659,CHEMICAL,rs7713917 a g snp,rs7713917 A G SNP
NEW17661,CHEMICAL,high-dose trimethoprim-sulfamethoxazole,high-dose trimethoprim-sulfamethoxazole
NEW17663,CHEMICAL,analog n-oleoylalanine,analog N-Oleoylalanine|OlAla
NEW17664,CHEMICAL,endogenous amide n-oleoylglycine,OlGly|endogenous amide N-Oleoylglycine
http://purl.obolibrary.org/obo/DOID_0090070,DISEASE,hypogonadotropic hypogonadism,congenital idiopathic hypogonadotropic hypogonadism|isolated congenital gonadotropin deficiency|hypogonadotropism|isolated hypogonadotropic hypogonadism
D008303,DISEASE,Malignant Carcinoid Syndrome,"Carcinoid Syndrome, Malignant|Malignant Carcinoid Syndromes|Carcinoid Syndromes, Malignant|carcinoid syndrome|Syndrome, Malignant Carcinoid|Syndromes, Malignant Carcinoid"
NEW17667,CHEMICAL,excessive dietary leucine intake,excessive dietary leucine intake
C565923,DISEASE,"Aural Atresia, Multiple Congenital Anomalies, and Mental Retardation [Supplementary Concept]","multiple congenital anomalies|Intellectual Disability|Ear Canal/abnormalities|Abnormalities, Multiple"
NEW17669,BIOCHEMICAL,dose thyroid hormone,dosing thyroid hormone
D017313,CHEMICAL,Fenretinide,"4-HPR|4-Hydroxyphenylretinamide|Fenretinide, 13-cis-Isomer|MCN R 1967|4 Hydroxyphenylretinamide|Fenretinimide|N-(4-Hydroxyphenyl)retinamide|MCN-R-1967|MCNR1967|Fenretinide, 13 cis Isomer|13-cis-Isomer Fenretinide|N-(4-Hydroxyphenyl)-trans-Retinamide"
NEW17674,DISEASE,forestomach carcinoma,forestomach carcinomas
NEW17675,CHEMICAL,c3h-a(vy mouse,C3H-A(vy mice
D054580,DISEASE,National Institute of Arthritis and Musculoskeletal and Skin Diseases (U.S.),National Institute of Arthritis and Musculoskeletal and Skin Diseases|NIAMS|arthritis
http://purl.obolibrary.org/obo/CHEBI_135598,CHEMICAL,tetrofosmin,99m-technetium methoxyisobutylisonitrile
C085911,CHEMICAL,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one [Supplementary Concept],LY294002|Morpholines|Chromones
NEW17681,CHEMICAL,n-6/3 pufa ratio,n-6/3 PUFA ratio
NEW17682,CHEMICAL,pufa ratio,PUFA ratio
NEW17686,CHEMICAL,tension-frequency relationship,tension-frequency relationship
NEW17438,MENTAL_HEALTH,fatigue resistance,fatigue resistance
NEW17687,CHEMICAL,cel treatment,CEL treatment
NEW04296,BIOCHEMICAL,endogenous oestrogen,endogenous oestrogen
NEW17692,CHEMICAL,cannabis product,Cannabis products
NEW17693,CHEMICAL,s-oxazepam,S-oxazepam
NEW17694,MENTAL_HEALTH,low peripheral resistance,low peripheral resistance
NEW17696,CHEMICAL,hypoglycemic activity,Hypoglycemic activity
NEW17699,BIOCHEMICAL,addition estrogen deficiency,addition estrogen deficiency
NEW02644,BIOCHEMICAL,androgen deficiency,androgen deficiency
NEW17703,DISEASE,diabetic sponge cake,diabetic sponge cakes
NEW17704,DISEASE,brain matter myelin abnormality,Brain matter myelin abnormalities
NEW17705,NUTRITION,cell membrane fatty acid abnormality,cell membrane fatty acid abnormalities
NEW17706,BIOCHEMICAL,certain b vitamin,certain B vitamins
NEW17707,BIOCHEMICAL,il-4 agonist administration,IL-4 agonist administration
D053662,CHEMICAL,Interleukin-4 Receptor alpha Subunit,"CD124 Antigens|IL-4|CD124 Antigen|Receptor, Interleukin-4, alpha Subunit|Receptors alpha, Interleukin-4|Interleukin-4 Receptors alpha|Interleukin 4 Receptor alpha Chain|Interleukin 4 Receptors alpha|Interleukin-4 Receptor alpha Chain|Interleukin 4 Receptor alpha Subunit|alpha-subunit, Receptor, Interleukin-4|Antigens, CD124|Antigen, CD124|interleukin-4"
NEW17710,NUTRITION,circulate lecithin,circulating lecithin
D041603,CHEMICAL,Pinus taeda,"taeda, Pinus|loblolly pine|Pinus taedas|Pines, Loblolly|Loblolly Pines|Pine, Loblolly|Loblolly Pine"
NEW17713,CHEMICAL,• anionic molecule inhibitory,• anionic molecule inhibitory
NEW17714,CHEMICAL,• exact mass,• Exact mass
NEW17715,MENTAL_HEALTH,mass spectrometry ms-ms fragmentation,mass spectrometry MS-MS fragmentation
NEW17716,BIOCHEMICAL,potent act nachr antagonist,potent acting nAChR antagonist
NEW07685,DISEASE,mass spectrometry ms-ms fragmentation,mood instability
C511383,CHEMICAL,"2,6-dihydroxy-3,4-dimethylbenzoic acid methyl ester [Supplementary Concept]","Hydroxybenzoates|3,4-dimethylbenzoic acid"
C001317,CHEMICAL,gamma-guanidinobutyric acid [Supplementary Concept],Guanidines|4-guanidinobutyric acid
NEW17720,CHEMICAL,serine acid,Serine acids
D050918,NUTRITION,Phosphatidylethanolamine N-Methyltransferase,"Methyltransferase II, Phospholipid|Phosphatidylethanolamine-Methyltransferase II|Cephalin N Methyltransferase|Phosphatidylethanolamine N-Methyltransferase, S-Adenosylmethionine|Phosphatidylethanolamine Phosphatidylcholine N Methyltransferase|Phospholipid Methyltransferase II|phosphatidylethanolamine|N-Methyltransferase, S-Adenosylmethionine Phosphatidylethanolamine|S Adenosylmethionine Phosphatidylethanolamine N Methyltransferase|Methyltransferase, Phosphatidylethanolamine|N-Methyltransferase, Phosphatidylethanolamine|Phosphatidylethanolamine N Methyltransferase|Phosphatidylethanolamine N Methyltransferase 2|Methyltransferase II, PHET|Phosphatidylethanolamine Methyltransferase|Phosphatidylethanolamine-Phosphatidylcholine N-Methyltransferase|S-Adenosylmethionine Phosphatidylethanolamine N-Methyltransferase|N-Methyltransferase-2, Phosphatidylethanolamine|Cephalin N-Methyltransferase|N-Methyltransferase, Phosphatidylethanolamine-Phosphatidylcholine|N-Methyltransferase, Cephalin|Phosphatidylethanolamine Methyltransferase II|Phosphatidylethanolamine N-Methyltransferase-2|PHET Methyltransferase II"
NEW17723,DISEASE,abnormal lipoprotein,abnormal lipoprotein
NEW17724,CHEMICAL,aluminum exposure,aluminum exposure
NEW17725,CHEMICAL,dopaminergic d2 antagonist haloperidol,dopaminergic D2 antagonist haloperidol
http://purl.obolibrary.org/obo/PR_Q9XZT6,CHEMICAL,deoxynucleoside kinase (fruit fly),dnk|deoxynucleosides|fly-tk2|cg5452|multispecific deoxynucleoside kinase (fruit fly)|dm-dnk|deoxyribonucleoside kinase (fruit fly)
C535979,DISEASE,Congenital adrenal hyperplasia due to 21 hydroxylase deficiency [Supplementary Concept],"CAH|congenital adrenal hyperplasia|Adrenal Hyperplasia, Congenital"
NEW17729,NUTRITION,methionine positron emission tomography,Methionine positron emission tomography
NEW17733,NUTRITION,tryptophan level,tryptophan levels
NEW17734,NUTRITION,kg-1 trehalose,kg-1 trehalose
NEW17738,CHEMICAL,cqkpi,CqKPI
NEW17740,NUTRITION,typha angustifolia,Typha angustifolia
D020260,CHEMICAL,"Heavy Metal Poisoning, Nervous System","heavy metals|Poisoning, Heavy Metals, Nervous System"
NEW17742,NUTRITION,typha angustifolia L.,Typha angustifolia L.
NEW17746,BIOCHEMICAL,selective estrogen receptor er modulator,selective estrogen receptor ER modulator
C055492,CHEMICAL,4-hydroxy-N-desmethyltamoxifen [Supplementary Concept],Z-endoxifen|Tamoxifen/analogs  and  derivatives
D001441,DISEASE,Bacteroides fragilis,Bacteroides fragilis|Bacteroides (1966-1975)
NEW17749,DISEASE,selective estrogen receptor er modulator,MDD microbiome
NEW17750,CHEMICAL,cerebral serotonin,cerebral serotonin
NEW17751,CHEMICAL,heartland bandavirus,Heartland bandavirus
NEW17752,CHEMICAL,IMPORTANCE Heartland bandavirus,HRTV|IMPORTANCE Heartland bandavirus
D000085142,DISEASE,Severe Fever with Thrombocytopenia Syndrome,"severe fever|Infection, SFTS Virus|Severe Fever with Thrombocytopenia Syndrome Bunyavirus Infection|SFTS Virus Infections|Virus Infection, SFTS|SFTS Virus Infection"
C053539,CHEMICAL,penciclovir [Supplementary Concept],Guanine|penciclovir
NEW17755,CHEMICAL,Acyclovir 's main metabolite 9-carboxymethoxymethylguanine,Acyclovir's main metabolite 9-carboxymethoxymethylguanine
D006967,DISEASE,Hypersensitivity,"Reaction, Allergic|Allergies|Allergy|Hypersensitivities|Allergic Reaction|Allergic Reactions|Reactions, Allergic|allergic reactions"
NEW17760,DISEASE,schizophrenia pathophysiology,hypersensitivity reactions
D011146,DISEASE,"Eczema, Dyshidrotic","Eczemas, Vesicular Palmoplantar|eczema|Eczema, Vesicular Palmoplantar|Eczemas, Dyshydrotic|Dyshydrotic Eczemas|Eczemas, Dyshidrotic|Dyshydrotic Eczema|Palmoplantar Eczemas, Vesicular|Palmoplantar Eczema, Vesicular|Vesicular Palmoplantar Eczemas|Dyshidrotic Eczema|Eczema, Dyshydrotic|Dyshidrotic Eczemas|Vesicular Palmoplantar Eczema|Pompholyx"
D014582,DISEASE,Urticaria Pigmentosa,"urticaria|Maculopapular Cutaneous Mastocytoses|Cutaneous Mastocytosis, Maculopapular|Cutaneous Mastocytoses, Maculopapular|Maculopapular Cutaneous Mastocytosis"
D065631,DISEASE,"Rhinitis, Allergic","Allergic Rhinitis|rhinitis|Allergic Rhinitides|Rhinitides, Allergic"
NEW17761,DISEASE,atopic child,allergenic adverse reactions
D064427,BIOCHEMICAL,Nutritive Sweeteners,"Artificial Sweeteners, Nutritive|Sweeteners, Nutritive|sweeteners"
NEW17762,DISEASE,spleen t cell function,Spleen T cell function
NEW17764,CHEMICAL,long-acting beta2-agonist,long-acting beta2-agonists
D000068299,CHEMICAL,Salmeterol Xinafoate,"Xinafoate, Salmeterol|Serevent|Salmeterol"
NEW17767,CHEMICAL,lysine methylation,lysine methylation
NEW17771,CHEMICAL,memory-enhancing acute potential,Memory-enhancing acute potentials
NEW17772,BIOCHEMICAL,mixture b. monnieri,mixture B. monnieri
NEW17774,BIOCHEMICAL,dopamine agonist agent,dopamine agonist agent
NEW17775,DISEASE,nutritional dermatosis,Nutritional dermatoses
C030069,CHEMICAL,"spore-specific proteins, Bacillus [Supplementary Concept]",CSK22|Bacterial Proteins
D000075384,DISEASE,Neuroticism,Neuroticism Trait|neuroticism|Neuroticism Traits
NEW17780,DISEASE,baseline neuroticism,baseline neuroticism
NEW17782,DISEASE,questionnaire neuroticism,questionnaire neuroticism
NEW17788,CHEMICAL,gal-3 gene deletion,Gal-3 gene deletion
NEW17790,CHEMICAL,gal-3 deficiency,Gal-3 deficiency
NEW17791,CHEMICAL,n-ethyl-2-(1-ethyl-2-hydroxy-2-nitrosohydrazino)-ethanamine,N-ethyl-2-(1-ethyl-2-hydroxy-2-nitrosohydrazino)-ethanamine|NOC12
D030421,CHEMICAL,Peroxynitrous Acid,"Peroxynitrous Acid, Potassium Salt|Peroxynitrous Acids|Acids, Peroxynitrous|Peroxonitrites|Peroxynitrite|Peroxynitrites|Peroxonitrite|peroxynitrite|Acid, Peroxynitrous"
C002385,CHEMICAL,linsidomine [Supplementary Concept],3-morpholinosydnonimine|Molsidomine/analogs  and  derivatives
D020030,CHEMICAL,Nitric Oxide Donors,"nitric oxide donor|Oxide Donor, Nitric|Nitric Oxide Donor|Donors, Nitric Oxide|Donor, Nitric Oxide|Oxide Donors, Nitric"
NEW17797,DISEASE,dietary-induced binge,dietary-induced binge
http://purl.obolibrary.org/obo/CHEBI_73311,CHEMICAL,adenosine receptor agonist,adenosine receptor agonist|Adenosine A(2A receptors
NEW17803,DISEASE,tremulous jaw movement,Tremulous jaw movements
C098657,CHEMICAL,"5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine [Supplementary Concept]",Pyrimidines|Triazoles|SCH58261
NEW17807,DISEASE,maladaptive personality symptom,maladaptive personality symptoms
NEW11935,NUTRITION,whole plant,whole plant
NEW17812,CHEMICAL,aluminium dust,aluminium dust
D017135,CHEMICAL,Desogestrel,"desogestrel|Org 2969|Org-2969|Org2969|18,19-Dinorpregn-4-en-20-yn-17-ol, 13-ethyl-11-methylene-, (17alpha)-|alpha-pregn-4-en-20-yn-17-ol, 13-Ethyl-11-methylene-18,19-dinor-17|Cerazette|13 Ethyl 11 methylene 18,19 dinor 17 alpha pregn 4 en 20 yn 17 ol|Marvelon|13-Ethyl-11-methylene-18,19-dinor-17 alpha-pregn-4-en-20-yn-17-ol"
C033273,CHEMICAL,Gestodene [Supplementary Concept],Norpregnenes|gestodene
C421822,CHEMICAL,7-methyl-norethisterone [Supplementary Concept],Norethindrone/analogs  and  derivatives|norethisterone
D016912,CHEMICAL,Levonorgestrel,"D-Norgestrel|Norplant 2|18,19-dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(-)-|l-Norgestrel|Vikela|Cerazet|levonorgestrel|Norgeston|Norplant|Plan B|l Norgestrel|Capronor|D Norgestrel|NorLevo|Norplant2|Norplant-2|Mirena|Microval|Microlut|duofem"
NEW17818,CHEMICAL,different progestogen,acetylenic steroids
NEW17821,CHEMICAL,nabiximol thc combination,Nabiximols THC combination
C008577,CHEMICAL,myricitrin [Supplementary Concept],myricitrin|Flavonoids
NEW17822,MENTAL_HEALTH,pathological gambling patient,pathological gambling patients
NEW17823,MENTAL_HEALTH,arnd characteristic,ARND characteristics
D009015,CHEMICAL,Morantel,"Paratect|Tartrate, Morantel|Morantel Tartrate|morantel"
NEW17827,CHEMICAL,intraoral sucrose,intraoral sucrose
NEW17830,DISEASE,soilborne oomycete phytophthora cinnamomi-which,soilborne oomycete Phytophthora cinnamomi-which
NEW17831,NUTRITION,chestnut hybrid,chestnut hybrid
NEW17833,CHEMICAL,thyroid-abs,thyroid-Abs
NEW17834,CHEMICAL,acd/logp,ACD/LogP
NEW17836,CHEMICAL,copper solution,copper solution
NEW17839,CHEMICAL,thiourea group,thiourea group
NEW17841,MENTAL_HEALTH,compounds12a c displacement,compounds12a c displacement
http://purl.obolibrary.org/obo/CHEBI_16526,CHEMICAL,carbon dioxide,CARBON DIOXIDE|[CO2]|CO2|methanedione|E290|carbon dioxide|E 290|R-744|carbon dioxide inhalation|Carbon dioxide|carbonic anhydride|dioxidocarbon|E-290
NEW17843,CHEMICAL,isoproterenol infusion,Isoproterenol infusions
NEW17844,BIOCHEMICAL,several dopaminergic agonist,Several dopaminergic agonists
NEW17845,CHEMICAL,ml417,ML417
NEW17849,DISEASE,abnormal mental behavior,abnormal mental behavior
NEW17851,DISEASE,dysregulate depressed function,dysregulated depressed function
NEW17854,CHEMICAL,3-(4-hydroxyphenyl)pyruvate,3-(4-hydroxyphenyl)pyruvate
C583815,CHEMICAL,"methyl 3, 4-dihydroxyphenylacetate [Supplementary Concept]","Phenylacetates|3,4-dihydroxyphenylacetate|DOPAC"
D007014,DISEASE,Hypophosphatasia,HPP|Hypophosphatasia|Hypophosphatasias
NEW17855,BIOCHEMICAL,sympathomimetic decongestant,sympathomimetic decongestants
NEW17857,BIOCHEMICAL,non-selective alpha-adrenoceptor agonist,non-selective alpha-adrenoceptor agonists
NEW17860,BIOCHEMICAL,selective alpha(2)-adrenoceptor agonist,selective alpha(2)-adrenoceptor agonist
NEW17864,NUTRITION,fatty acid class,fatty acid classes
NEW17869,DISEASE,parkinson 's syndrome,Parkinson's syndrome
D009101,DISEASE,Multiple Myeloma,"multiple myeloma|Plasma-Cell Myelomas|Myelomas, Plasma-Cell|Kahler Disease|Myelomatoses|Disease, Kahler|Myeloma, Plasma-Cell|Cell Myeloma, Plasma|Plasma-Cell Myeloma|Plasma Cell Myelomas|Myeloma, Plasma Cell|Cell Myelomas, Plasma|Myeloma, Multiple|Myelomas, Multiple|Plasma Cell Myeloma|Multiple Myelomas|Myeloma-Multiples|Myeloma-Multiple|Myelomas, Plasma Cell|MM|Myeloma Multiple|Myelomatosis"
D016123,DISEASE,Campylobacter jejuni,Vibrio hepaticus|C. jejuni|Campylobacter fetus subsp. jejuni|Vibrio jejuni|jejuni
NEW17873,CHEMICAL,pimavanserin inverse agonist,Pimavanserin inverse agonist
NEW17877,CHEMICAL,combustion value,combustion values
NEW17880,NUTRITION,lr cholesterol,LR cholesterol
NEW17883,NUTRITION,lrs cholesterol,LRs cholesterol
C039671,CHEMICAL,ciglitazone [Supplementary Concept],ciglitazone|Thiazolidinediones
D059585,DISEASE,G1 Phase Cell Cycle Checkpoints,"Checkpoint, G1 Phase|G1-S Phase Cell Cycle Checkpoint|G1 Phase Restriction Point|G1 Restriction Point|G1 S Phase Cell Cycle Checkpoint|G1 Phase Checkpoint|START Cell Cycle Checkpoint|Checkpoints, G1 Phase|G1 Cell Cycle Checkpoints|G1 Restriction Points|G1 Cell Cycle Arrest|Cell-cycle arrest|Restriction Point, G1|Restriction Points, G1|G1 Phase Checkpoints"
NEW17887,CHEMICAL,thiazolidinedione tzd family,thiazolidinedione TZD family
NEW17888,DISEASE,due concomitant tonic pain,due concomitant tonic pain
NEW17890,DISEASE,phasic pain relief,phasic pain relief
NEW17892,CHEMICAL,da toxicosis,DA toxicosis
http://purl.obolibrary.org/obo/CHEBI_37887,BIOCHEMICAL,adrenergic antagonist,adrenergic antagonists|adrenergic blocker|adrenergic antagonists propranolol|adrenergic blockaders|adrenergic receptor blockaders|adrenergic blockers|adrenoceptor antagonists
NEW17894,NUTRITION,Background lithium,Background Lithium
NEW17899,DISEASE,inflammation level,Inflammation levels
NEW17900,BIOCHEMICAL,allergen binding,allergen binding
D008133,DISEASE,Long QT Syndrome,Electrocardiogram QT Prolonged|long QT syndrome
NEW17902,MENTAL_HEALTH,dolutegravir resistance,dolutegravir resistance
NEW17904,NUTRITION,lithium administration,lithium administration
NEW17906,CHEMICAL,up state,UP states
NEW17907,CHEMICAL,cholinergic-induced increase,cholinergic-induced increase
NEW17908,CHEMICAL,carbachol-induced csd inhibition,carbachol-induced CSD inhibition
NEW17910,CHEMICAL,preferential m1 muscarinic agonist mcn-a-343,preferential M1 muscarinic agonist McN-A-343
NEW17911,NUTRITION,tree oil ρ-cymene,tree oil ρ-cymene
NEW17914,CHEMICAL,asp goal,ASP goals
NEW13944,DISEASE,severe hyperhomocysteinemia,HHcy|severe hyperhomocysteinemia
NEW17916,BIOCHEMICAL,recent b vitamin supplementation trial,Recent B vitamin supplementation trials
NEW17917,BIOCHEMICAL,vitamin supplementation,vitamins supplementation
D065666,DISEASE,Mesenteric Ischemia,"Vascular Insufficiencies, Mesenteric|ischemia|Mesenteric Venous Thromboses|Venous Thromboses, Mesenteric|Occlusive Mesenteric Arterial Ischemia|Insufficiency, Mesenteric Vascular|Ischemias, Nonocclusive Mesenteric|Ischemia, Mesenteric|Acute Mesenteric Arterial Embolus|Nonocclusive Mesenteric Ischemia|Mesenteric Ischemia, Nonocclusive|Nonocclusive Mesenteric Ischemias|Mesenteric Vascular Insufficiency|Mesenteric Ischemias|Mesenteric Ischemias, Nonocclusive|Thrombosis, Mesenteric Venous|Mesenteric Venous Thrombosis|Mesenteric Vascular Insufficiencies|Insufficiencies, Mesenteric Vascular|Thromboses, Mesenteric Venous|Ischemia, Nonocclusive Mesenteric|Venous Thrombosis, Mesenteric|Acute Mesenteric Arterial Thrombosis|Ischemias, Mesenteric|Vascular Insufficiency, Mesenteric"
NEW17921,CHEMICAL,uncycle n-methyl scaffold,uncycled N-methyl scaffold
NEW17922,CHEMICAL,side chain procaine,side chain procaine
NEW17923,CHEMICAL,n-methyl scaffold,N-methyl scaffold
D013134,CHEMICAL,Spiperone,Spiroperidol|Spiroperone|spiperone
NEW17926,BIOCHEMICAL,selective serotonergic drug,selective serotonergic drugs
C018855,CHEMICAL,2-tert-butylhydroquinone [Supplementary Concept],tBHQ|Tert-butylhydroquinone|Hydroquinones
NEW09122,CHEMICAL,inositol metabolism,inositol metabolism
NEW17929,BIOCHEMICAL,novel cholinomimetic,novel cholinomimetics
NEW17931,MENTAL_HEALTH,resistance heritability,Resistance heritability
NEW17934,MENTAL_HEALTH,neocortical projection neuron,neocortical projection neurons
NEW17936,CHEMICAL,ppar-α agonist fenofibrate,PPAR-α agonist fenofibrate
NEW17937,CHEMICAL,mdma challenge,MDMA challenge
D065148,DISEASE,Nicolau Syndrome,"Nicolau's Syndrome|Dermatitis, Nicolau Livedoid|Nicolau's syndrome|Livedo-like Dermatitides|Nicolau Livedoid Dermatitis|Nicolaus Syndrome|Livedo-like Dermatitis|Livedoid Syndrome, Nicolau's|Nicolau's Livedoid Syndrome|Syndrome, Nicolau's Livedoid|Syndrome, Nicolau's|Dermatitides, Livedo-like|Nicolaus Livedoid Syndrome|Cutis Medicamentosa, Embolia|Syndrome, Nicolau|Medicamentosa, Embolia Cutis|Dermatitis, Livedo-like|Livedoid Dermatitis, Nicolau|Livedo like Dermatitis|Nicolau Livedoid Syndrome|Embolia Cutis Medicamentosa"
D004008,CHEMICAL,Diclofenac,"GP45,840|SR38|Orthofen|Diclofenac, Sodium|Voltarol|Diclophenac|Diclonate P|Voltaren|diclofenac sodium|Orthophen|Sodium Diclofenac|Diclofenac Potassium|Ortofen|Dichlofenal|Dicrofenac|SR 38|GP-45,840|Feloran|GP 45,840|SR-38|Novapirina|Diclofenac Sodium"
NEW17942,BIOCHEMICAL,lipophilic drug,lipophilic drug
NEW17943,BIOCHEMICAL,carotenoid degradation,carotenoid degradation
NEW17945,CHEMICAL,pah metabolite,PAH metabolites
NEW17948,DISEASE,induce aggregation/fibrillation,induced aggregation/fibrillation
NEW17949,NUTRITION,croceine croaker,croceine croaker
NEW17951,CHEMICAL,swim bladder peptide fraction,swim bladder peptide fraction|SBP-III-3
D007772,CHEMICAL,Lactate dehydrogenase-elevating virus,Lactate Dehydrogenase Viruses|Lactic Dehydrogenase Viruses|Lactate dehydrogenase elevating virus|Lactate dehydrogenase-elevating viruses|Lactate Dehydrogenase Virus|Lactic Dehydrogenase Virus|lactic dehydrogenase|Riley Virus
http://purl.obolibrary.org/obo/CHEBI_36808,CHEMICAL,duloxetine hydrochloride,Dapoxetine HCl|N-methyl-3-(naphthalen-1-yloxy)-3-(2-thienyl)propan-1-amine hydrochloride|N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine hydrochloride
NEW17955,CHEMICAL,low-level developmental mehg,low-level developmental MeHg
NEW17958,NUTRITION,mean mercury ingestion,mean mercury ingestion
NEW17962,CHEMICAL,serum na level,serum Na level
NEW17964,MENTAL_HEALTH,transient mutism,Transient mutism
NEW17968,DISEASE,relative toxicity,relative toxicities
NEW17971,DISEASE,visual function loss,visual function loss
NEW17973,DISEASE,b. aegyptiaca gall,B. aegyptiaca galls
NEW17975,MENTAL_HEALTH,intrathecal analgesia,intrathecal analgesia
NEW17976,CHEMICAL,capsaicin-sensitive adenosine release,capsaicin-sensitive adenosine release
NEW17977,CHEMICAL,extracellular adenosine availability,extracellular adenosine availability
NEW17980,CHEMICAL,adenosine analog,Adenosine analogs
NEW17982,CHEMICAL,tritium label cyproterone acetate,tritium labeled cyproterone acetate
NEW17984,CHEMICAL,beta-estradiol oophorectomized animal,beta-estradiol oophorectomized animals
NEW17986,DISEASE,tumor cytosol,Tumor cytosol
NEW17988,CHEMICAL,cortical gaba content,cortical GABA content
NEW17991,MENTAL_HEALTH,transendothelial electrical resistance,transendothelial electrical resistance
NEW17993,DISEASE,human pulmonary artery endothelial cell,human pulmonary artery endothelial cells
C532507,CHEMICAL,"GPER1 protein, mouse [Supplementary Concept]","Receptors, G-Protein-Coupled|GPER|Receptors, Estrogen"
NEW17995,CHEMICAL,selective gper agonist g-1,selective GPER agonist G-1
C105482,CHEMICAL,allergen Bla g 1 [Supplementary Concept],G-1|Allergens
D004872,BIOCHEMICAL,Ergocalciferols,"Vitamin D2|D2, Vitamin|Vitamin D 2|Calciferols|Ergocalciferol|ergocalciferol"
NEW18004,BIOCHEMICAL,vitamin k supplementation,vitamin K supplementation
D016058,MENTAL_HEALTH,"Analgesia, Patient-Controlled","Patient-Controlled Analgesia|patient-controlled analgesia|Analgesia, Patient Controlled|Patient Controlled Analgesia"
NEW18005,CHEMICAL,ampa receptor potentiator,AMPA receptor potentiators
C539313,CHEMICAL,"Cnih2 protein, rat [Supplementary Concept]","CNIH-2|Receptors, AMPA"
NEW18007,BIOCHEMICAL,multimodal serotonergic drug,multimodal serotonergic drug
NEW18008,CHEMICAL,nhe rat,NHE rats
NEW18011,NUTRITION,southeast asian tree,Southeast Asian tree
NEW18014,DISEASE,ibs-d patient,IBS-D patients
NEW18016,CHEMICAL,fibro-scan,fibro-scan
NEW18020,DISEASE,in amyloid-β Aβ fibrillation diagnosis,in amyloid-β Aβ fibrillation diagnosis
NEW18021,CHEMICAL,glutamate dysfunction,Glutamate dysfunction
NEW18022,CHEMICAL,ota level,OTA levels
D052201,CHEMICAL,Lactobacillus rhamnosus,Culturelle|Lactobacillus GG|Lactobacillus
C477279,CHEMICAL,danggui buxue decoction [Supplementary Concept],"Drugs, Chinese Herbal|Buxue Tang"
NEW18025,CHEMICAL,dialectical behavioral therapy,DBT|Dialectical behavioral therapy
NEW18026,DISEASE,traditional medicine TCM formula,traditional medicine TCM formula
NEW18027,CHEMICAL,small-molecule selective gsk3β inhibitor,small-molecule selective GSK3β inhibitor
NEW18032,BIOCHEMICAL,act muscarinic agonist,acting muscarinic agonist
NEW18033,MENTAL_HEALTH,motor conversion disorder,motor conversion disorder
NEW18035,CHEMICAL,approve antidepressant medication,approved antidepressant medications
NEW18036,CHEMICAL,noncompetitive n-methyl-d-aspartate nmda receptor antagonist ketamine,noncompetitive N-methyl-D-aspartate NMDA receptor antagonist ketamine
NEW18037,CHEMICAL,single subanesthetic dose infusion,single subanesthetic dose infusion
D055118,DISEASE,Medication Adherence,"Nonadherence, Medication|Drug Adherence|Compliance, Medication|Medication Non-Adherence|Nonadherence|Medication Non Compliance|Medication Compliance|Medication Persistence|Adherence, Medication|Compliance, Drug|Medication Noncompliance|Drug Compliance|Persistence, Medication|Non-Compliance, Medication|Noncompliance, Medication|Medication Non-Compliance|Medication Nonadherence|Medication Non Adherence|Adherence, Drug|Non-Adherence, Medication"
NEW18041,CHEMICAL,postsynaptic da receptor supersensitivity,Postsynaptic DA receptor supersensitivity
NEW18043,DISEASE,ginseng total saponin,GTS|ginseng total saponin
NEW18047,CHEMICAL,novel three-zone ionization source,novel three-zones ionization source
D001657,MENTAL_HEALTH,Biliary Dyskinesia,"Biliary Dyskinesias|Gallbladder Dyskinesias|Gallbladder Dyskinesia|Dyskinesia, Gallbladder|Dyskinesias, Gallbladder|Dyskinesias, Biliary|Dyskinesia, Biliary|biliary dyskinesia"
NEW18052,NUTRITION,cholesterol stone,Cholesterol stones
NEW18056,MENTAL_HEALTH,drug-receptor dissociation constant,drug-receptor dissociation constant
NEW18057,CHEMICAL,plasma catecholamine,plasma catecholamines
NEW18058,CHEMICAL,Pseudarcobacter,Pseudarcobacter
NEW18060,CHEMICAL,Aliarcobacter,Aliarcobacter
NEW18061,CHEMICAL,low la content,low LA content
D004083,CHEMICAL,Cholestanol,"beta-Cholestan-3 beta-ol, 5|5 beta-Cholestan-3 beta-ol|5 alpha-Cholestan-3 alpha-ol|5 beta Cholestan 3 beta ol|Coprostanol|Dihydrocholesterol|5 alpha-Cholestan-3 beta-ol|beta Cholestanol|Cholestan 3 ol|cholestanol|5 alpha Cholestan 3 beta ol|Coprosterol|5 alpha Cholestan 3 alpha ol|Cholestanol, (3alpha, 5beta)-Isomer|beta-ol, 5 beta-Cholestan-3|beta-Cholestanol|5 beta-Cholestan-3 alpha-ol|Cholestan-3-ol"
NEW18062,DISEASE,unexpected stroke,unexpected stroke
C479581,CHEMICAL,procyanidin B3 [Supplementary Concept],Biflavonoids|Proanthocyanidins|procyanidin B3|Catechin
NEW18066,NUTRITION,catechin molecule,catechin molecule
NEW18068,BIOCHEMICAL,systemic oestrogen replacement,systemic oestrogen replacement
C019984,CHEMICAL,cytokinin oxidase [Supplementary Concept],CKX|Oxidoreductases|cytokinin dehydrogenase
NEW18070,BIOCHEMICAL,novel antimicrobial agent,novel antimicrobial agents
C073340,CHEMICAL,ranitidine bismuth citrate [Supplementary Concept],ranitidine bismuth citrate|Bismuth|Ranitidine/analogs  and  derivatives
NEW18074,CHEMICAL,Chrysanthemum × grandiflora,Chrysanthemum × grandiflora
NEW18076,DISEASE,c. grandiflora,C. grandiflora
NEW18078,CHEMICAL,nacl imposition,NaCl imposition
NEW18079,CHEMICAL,mg-3zn substrate,Mg-3Zn substrate
NEW18082,NUTRITION,phosphate coating,phosphate coating
NEW18083,DISEASE,heat shock protein gene,heat shock protein gene
NEW18085,CHEMICAL,csltl-2,CsLTL-2
D017829,CHEMICAL,Granisetron,"BRL-43694|granisetron|Monohydrochloride, Granisetron|BRL43694|BRL-43694A|1-Methyl-N-(endo-9-Methyl-9-Azabicyclo(3.3.1)non-3-yl)-1H-Indazole-3-Carboxamide|BRL 43694|BRL 43694A|Kytril|Granisetron Monohydrochloride|Hydrochloride, Granisetron|BRL43694A|Granisetron Hydrochloride"
NEW18086,CHEMICAL,nitrogen equilibrium,nitrogen equilibrium
NEW18088,BIOCHEMICAL,selective npr agonist,selective nPR agonists
NEW05271,DISEASE,sleep loss,sleep loss
NEW18091,BIOCHEMICAL,intact opioid drug product,intact opioid drug products
NEW18093,BIOCHEMICAL,n-methyl-d-aspartate antagonist s-ketamine,N-methyl-D-aspartate antagonist S-ketamine
NEW18094,CHEMICAL,raclopride bp,raclopride BP
NEW18096,CHEMICAL,glutamatergic nmda receptor,glutamatergic NMDA receptor
NEW18098,BIOCHEMICAL,circulate estrogen,circulating estrogen
NEW18101,DISEASE,age-related loss,age-related loss
NEW18102,DISEASE,premature neonate,premature neonate
NEW18105,BIOCHEMICAL,neuropsychiatric adverse drug reaction,neuropsychiatric adverse drug reactions
NEW18106,MENTAL_HEALTH,publish soil-to-small mammal bioaccumulation regression model,Published soil-to-small mammal bioaccumulation regression models
C533772,CHEMICAL,thiophene-3-boronic acid [Supplementary Concept],thiophene-3-boronic acid|Boronic Acids|Thiophenes
NEW18109,MENTAL_HEALTH,paratope orientation controller,paratope orientation controller
http://purl.obolibrary.org/obo/CHEBI_26375,CHEMICAL,pterins,Albumin-bound 25OHD
NEW18110,DISEASE,esbl strain,ESBL strains
NEW18112,BIOCHEMICAL,double mixture disc,double mixture discs
C013841,CHEMICAL,benzotript [Supplementary Concept],Benzamides|benzotript
NEW18113,CHEMICAL,cyclohexane-cyclohexane pair,cyclohexane-cyclohexane pairs
D019749,CHEMICAL,Sulfur-Sulfur Bond Isomerases,"Isomerases, S-S Bond|S-S Bond Isomerases|Bond Isomerases, S-S|sulfur|Isomerases, Sulfur-Sulfur Bond|S44819|Sulfur Sulfur Bond Isomerases|Bond Isomerases, Sulfur-Sulfur"
NEW18118,DISEASE,amnestic effect,amnestic effect
NEW05028,DISEASE,psychiatric medication,psychiatric medications
NEW11050,BIOCHEMICAL,same drug,same drug
http://purl.obolibrary.org/obo/CHEBI_35473,BIOCHEMICAL,tranquilizing drug,tranquilising drug|tranquilizing drugs|tranquillizing agents|antidepressive drug|ataractics|tranquillising agent
NEW18120,CHEMICAL,sodium pump activity,sodium pump activity
NEW18122,DISEASE,bipolar group,bipolar group
NEW14229,MENTAL_HEALTH,"mg/kg l-365,031 l-365,260",morphine analgesia
NEW18132,CHEMICAL,antiopioid n-methyl-d-aspartate receptor system,antiopioid N-methyl-D-aspartate receptor system
NEW18135,MENTAL_HEALTH,lesion orientation,lesion orientation
NEW18138,CHEMICAL,glutathione gsh precursor,glutathione GSH precursor
http://purl.obolibrary.org/obo/CHEBI_142185,CHEMICAL,5-hydroxytryptamine 2c receptor agonist,5-hydroxytryptamine receptor 2C agonist|5-HT2C receptor agonists|serotonin receptor 2C agonist|5-HT2c agonists|serotonin 2C receptor agonists|serotonin receptor 2C agonists|5-HT2C receptor agonist|5-HT2c agonist|5-hydroxytryptamine 2C receptor agonists|5-hydroxytryptamine receptor 2C agonists
NEW18141,MENTAL_HEALTH,comorbid insomnia,comorbid insomnia
C085665,CHEMICAL,zaleplon [Supplementary Concept],Acetamides|zaleplon|Pyrimidines
NEW18142,MENTAL_HEALTH,insomnia severity,insomnia severity
NEW18144,CHEMICAL,eb diet,EB diet
NEW18146,CHEMICAL,intracerebroventricular stz,Intracerebroventricular STZ
NEW18147,BIOCHEMICAL,established 3d gelatin scaffold model,established 3D gelatin scaffold model
http://purl.obolibrary.org/obo/DOID_0110445,DISEASE,dilated cardiomyopathy 1kk,early dilated cardiomyopathy|CMD1KK
NEW18149,CHEMICAL,triac therapy,TRIAC therapy
NEW18151,CHEMICAL,cortisol infusion,cortisol infusion
NEW18152,CHEMICAL,csf 5-hydroxyindoleacetic acid,CSF 5-hydroxyindoleacetic acid
NEW18153,DISEASE,serious ocular complication,serious ocular complications
NEW18156,BIOCHEMICAL,soy phytoestrogen,soy phytoestrogens
NEW18159,CHEMICAL,soy-based infant formula,soy-based infant formula
D012439,CHEMICAL,Saccharin,"Saccharin Calcium|Calcium, Saccharin|Saccharin Sodium|Saccharin"
NEW18162,CHEMICAL,saccharin/sucralose consumption,Saccharin/sucralose consumption
NEW18164,CHEMICAL,metformin supplementation,Metformin supplementation
D007064,CHEMICAL,L-Iditol 2-Dehydrogenase,"L Iditol 2 Dehydrogenase|2-Dehydrogenase, L-Iditol|Dehydrogenase, Iditol|polyol|Polyol Dehydrogenase|Dehydrogenase, Polyol|Dehydrogenase, Sorbitol|Iditol Dehydrogenase|Sorbitol Dehydrogenase"
D014993,CHEMICAL,Xylitol,Sweetening Agents|Xylitol
D014502,CHEMICAL,Uranyl Nitrate,"Uranium nitrate|Uranium Nitrate|Nitrate, Uranyl|Nitrate, Uranium"
NEW02637,CHEMICAL,serum testosterone,serum testosterone
NEW18171,DISEASE,hyperactive psd,hyperactive PSD
http://purl.obolibrary.org/obo/CHEBI_72730,CHEMICAL,flavanone glycoside,flavanone glycosides|flavonoid glycosides
NEW18173,DISEASE,neurological dementia,Neurological dementias
NEW18174,BIOCHEMICAL,systemic narcotic administration,systemic narcotic administration
NEW18175,DISEASE,anticholinergic poisoning,anticholinergic poisoning
D006246,CHEMICAL,Harmaline,"Harmaline|Harmidine|Dihydroharmine|3H-Pyrido(3,4-b)indole, 4,9-dihydro-7-methoxy-1-methyl-"
NEW18176,CHEMICAL,phyllanthus tenellus Roxb,Phyllanthus tenellus Roxb
C049096,CHEMICAL,corilagin [Supplementary Concept],Corilagin|Glucosides|Hydrolyzable Tannins
NEW18179,BIOCHEMICAL,% drug loading,% drug loading
D059038,CHEMICAL,Black Sea,SEA
NEW18181,CHEMICAL,serum testosterone level,Serum testosterone levels
NEW18185,CHEMICAL,testosterone level,testosterone level
NEW18188,BIOCHEMICAL,nicotinic acid niacin stimulation,nicotinic acid niacin stimulation
NEW18189,CHEMICAL,well-studied kynurenine pathway upregulation,well-studied kynurenine pathway upregulation
C000589289,CHEMICAL,"6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine [Supplementary Concept]",Spiro Compounds|Cebranopadol|Indoles
NEW18190,CHEMICAL,act acetylcholinesterase inhibitor neostigmine,acting acetylcholinesterase inhibitor neostigmine
NEW18191,MENTAL_HEALTH,scop amnesia,SCOP amnesia
NEW18195,CHEMICAL,zeylanicus plant powder,zeylanicus plant powder
C497232,CHEMICAL,balaglitazone [Supplementary Concept],Balaglitazone|Thiazolidinediones|Quinazolines
http://purl.obolibrary.org/obo/CHEBI_135535,CHEMICAL,etofibrate,ethofibrate|tricerol|MBX-102 acid/JNJ39659100|etofibrate hydrochloride|etofibrate HCl
NEW18201,BIOCHEMICAL,free drug level,free drug levels
NEW18203,DISEASE,diabetic ob/ob mouse,diabetic ob/ob mouse
NEW18205,CHEMICAL,clone α-like bioctr,cloned α-like BiOctR
NEW18206,DISEASE,glaucoma surgery,glaucoma surgery
D014130,CHEMICAL,Trabeculectomy,Trabeculoplasties|Goniotomies|Goniotomy|Trabeculoplasty|Trabeculectomies|Trabeculotomies|trabeculectomy|Trabeculotomy
NEW18208,BIOCHEMICAL,gelatin stent,gelatin stents
NEW18211,NUTRITION,adjunctive folate,adjunctive folate
NEW18212,CHEMICAL,chronic cort exposure,chronic CORT exposure
D002402,CHEMICAL,Cathepsin D,cathepsin D|Cathepsins (1966-1984)
NEW18216,CHEMICAL,ors structure,ORS structure
D018753,CHEMICAL,"Diet, Protein-Restricted","Low-Protein Diet|Diet, Protein Restricted|Protein-Restricted Diet|Diet, Low-Protein|Low-Protein Diets|protein-restricted diet|Low Protein Diet|Diets, Protein-Restricted|Diets, Low-Protein|Diet, Low Protein|Diet, Protein-Free|Diet, Protein Free|Protein-Free Diets|Protein-Free Diet|Protein Restricted Diet|Diets, Protein-Free|Protein-Restricted Diets"
http://purl.obolibrary.org/obo/CHEBI_150866,CHEMICAL,gs-441524 monophosphate,"RDV-MP|GS-441524 monophosphate|[4,3-b]pyridine monophosphate|[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen phosphate|remdesivir monophosphate"
D006566,DISEASE,Herpesviridae Infections,"Herpesvirus Infection|Infections, Herpesvirus|Herpesviridae Infection|Infections, B Virus|herpesvirus infections|B Virus Infection|Infections, Herpesviridae|Herpesvirus Infections|Infection, B Virus|Infection, Herpesvirus|B Virus Infections|Infection, Herpesviridae"
NEW18220,CHEMICAL,gabapentin toxicity,gabapentin toxicity
NEW18221,CHEMICAL,tyrosine hydroxylase rate-limiting enzyme,tyrosine hydroxylase rate-limiting enzyme
NEW18222,CHEMICAL,norepinephrine biosynthesis,norepinephrine biosynthesis
NEW18224,CHEMICAL,capsaicin administration,Capsaicin administration
NEW05208,CHEMICAL,serotonin hypothesis,serotonin hypothesis
D044302,CHEMICAL,"Receptor, Serotonin, 5-HT1B","Serotonin 1Dbeta Receptors|Receptor, 5-HT1B|1B Receptors, 5-Hydroxytryptamine|1B Receptor, 5-Hydroxytryptamine|5-HT-1B receptor|Receptor, Serotonin Type 1Dbeta|5 HT1B Receptor|Receptors, Serotonin 1Dbeta|5-HT1B Receptor|Receptor, Serotonin 1B|Receptor, 5 Hydroxytryptamine 1B|5-Hydroxytryptamine 1B Receptors|5 Hydroxytryptamine 1B Receptor|Serotonin 1D Beta Receptor|5 HT1Dbeta Receptor|Serotonin 1B Receptor|Receptor, Serotonin 1Dbeta|5 Hydroxytryptamine 1B Receptors|5-Hydroxytryptamine 1B Receptor|Serotonin 1Dbeta Receptor|Receptor, 5-HT1Dbeta|Receptors, 5-Hydroxytryptamine 1B|5-HT(1B) Receptor|5-HT1Dbeta Receptor|5-HT(1Dbeta) Receptor|Receptor, 5-Hydroxytryptamine 1B"
NEW18228,CHEMICAL,5-ht-1b receptor,5-HT-1B receptors
C089750,CHEMICAL,zolmitriptan [Supplementary Concept],Tryptamines|Oxazolidinones|Zolmitriptan
NEW18230,DISEASE,lactobacillus family,Lactobacillus family
C040968,CHEMICAL,seglitide [Supplementary Concept],"Peptides, Cyclic|MK-678|seglitide"
NEW18232,BIOCHEMICAL,major carotenoid,major carotenoids
NEW18233,DISEASE,alzheimer 's multi-infarct dementia patient,Alzheimer's multi-infarct dementia patients
NEW11609,BIOCHEMICAL,fxr agonist,FXR agonists
NEW16219,MENTAL_HEALTH,multimodal analgesia,multimodal analgesia
NEW18234,CHEMICAL,gsh/gssg ratio,GSH/GSSG ratio
NEW18235,DISEASE,recent zika fever epidemic,recent Zika fever epidemic
C418604,DISEASE,"TRIM8 protein, human [Supplementary Concept]",Nerve Tissue Proteins|Carrier Proteins|human glioblastoma
NEW18236,CHEMICAL,ozone therapy,ozone therapy
http://purl.obolibrary.org/obo/GENO_0000149,DISEASE,x-linked recessive inheritance,X-linked semidominant inheritance|X-linked recessive inheritance
NEW18238,CHEMICAL,biperiden abuser,biperiden abusers
NEW18240,CHEMICAL,intra-articular ia hyaluronic acid injection,Intra-articular IA hyaluronic acid injections
NEW18242,DISEASE,intra-articular ia hyaluronic acid injection,mandibular mobility
NEW18243,MENTAL_HEALTH,cholinergic projection system,Cholinergic projection systems
NEW18249,CHEMICAL,gemfibrozil preincubation,gemfibrozil preincubation
D013392,CHEMICAL,Sucralfate,"Sucralfate|Ulsanic|Ulcerban|Sulfate, Aluminum Sucrose|Aluminum Sucrose Sulfate|Basic Aluminum Sucrose Sulfate|Ulcogant|Antepsin|Carafate"
NEW18254,CHEMICAL,mglu1 pam,mGlu1 PAM
NEW18257,DISEASE,depressive symptom,depressive symptoms
NEW18264,BIOCHEMICAL,low carotenoid,lower carotenoids
NEW18266,BIOCHEMICAL,sigma agonist fluvoxamine,sigma agonist fluvoxamine
NEW18270,CHEMICAL,"unlabelled 1,25(oh)2d3","unlabelled 1,25(OH)2D3"
http://purl.obolibrary.org/obo/CHEBI_35209,CHEMICAL,label,"labelled 1,25(OH)2D3|label"
NEW18271,DISEASE,postpartum depressive symptom,postpartum depressive symptoms
C579116,CHEMICAL,"2-(2,6-diisopropylphenyl)-5-amino-1H-isoindole-1,3-dione [Supplementary Concept]",TC11|Phthalimides
NEW18277,CHEMICAL,cytosolic tag accumulation,cytosolic TAG accumulation
NEW08067,DISEASE,cognitive development,cognitive development
NEW06075,BIOCHEMICAL,circulate androgen,circulating androgens
NEW18280,CHEMICAL,high-dose chemotherapy,high-dose chemotherapy
NEW18281,CHEMICAL,bicyclam molecule,bicyclam molecule
NEW18282,CHEMICAL,topical nifedipine,topical nifedipine
NEW18283,DISEASE,avian mycoplasma,Avian mycoplasmas
NEW18284,DISEASE,mycoplasma gallisepticum infection,Mycoplasma gallisepticum infection
NEW18287,BIOCHEMICAL,melatonin-receptor agonist,melatonin-receptor agonists
NEW01012,CHEMICAL,novel antidepressant,novel antidepressant
NEW18291,DISEASE,frequent CAE,frequent CAE
NEW18293,DISEASE,polyposis registry clinician,Polyposis registry clinicians
NEW18295,DISEASE,increase polyp number,increased polyp number
NEW18296,CHEMICAL,aspirin group,aspirin groups
NEW18299,CHEMICAL,metabolise phytanic acid,metabolised phytanic acid
C002844,CHEMICAL,pristanic acid [Supplementary Concept],Fatty Acids|pristanic acid
NEW17645,CHEMICAL,premature adrenarche,dopamine precursor levodopa
D018980,DISEASE,Williams Syndrome,"Hypercalcemia-Supravalvar Aortic Stenoses|Williams Contiguous Gene Syndrome|Contiguous Gene Syndrome, Williams|Aortic Stenosis, Hypercalcemia-Supravalvar|Williams Beuren Syndrome|Aortic Stenoses, Hypercalcemia-Supravalvar|Beuren Syndrome|Hypercalcemia-Supravalvar Aortic Stenosis|Chromosome 7q11.23 Deletion Syndrome|Syndrome, Williams-Beuren|Syndrome, Williams|Hypercalcemia Supravalvar Aortic Stenosis|Syndrome, Beuren|Stenosis, Hypercalcemia-Supravalvar Aortic|contiguous gene syndrome|Supravalvar Aortic Stenosis Syndrome|Stenoses, Hypercalcemia-Supravalvar Aortic|Williams-Beuren Syndrome"
NEW18301,DISEASE,tumor tissue,tumor tissue
NEW18302,DISEASE,breast cancer tissue,breast cancer tissue
NEW18304,CHEMICAL,natural coumarin,Natural coumarins
C569370,DISEASE,"PRRT2 protein, human [Supplementary Concept]",PRRT2|Nerve Tissue Proteins|Membrane Proteins
NEW18308,DISEASE,increase prostate index,increased prostate index
NEW18311,NUTRITION,seahorse extract,Seahorse extracts
NEW18313,CHEMICAL,Suicidegene therapy,Suicidegene therapy
D015774,CHEMICAL,Ganciclovir,"BIOLF-62|BW-759|RS-21592|Cytovene|Ganciclovir, Monosodium Salt|Gancyclovir|ganciclovir|Ganciclovir Sodium"
NEW18316,BIOCHEMICAL,cationic peptide carrier,cationic peptide carriers
NEW18318,CHEMICAL,cubic spline,cubic splines
NEW18321,CHEMICAL,xylose consumer,xylose consumer
NEW18322,DISEASE,sp. strain jdr-2,sp. strain JDR-2
NEW18328,CHEMICAL,low serum glucose level,low serum glucose levels
C009105,CHEMICAL,psilocin [Supplementary Concept],psilocin|Psilocybin/analogs  and  derivatives
NEW18330,CHEMICAL,active hallucinogen,active hallucinogen
NEW18332,CHEMICAL,prefrontal oxygen consumption rate,Prefrontal oxygen consumption rate
NEW18333,DISEASE,malignant pain,malignant pain
NEW18334,NUTRITION,captive adult snow leopard,captive adult snow leopard
NEW18336,CHEMICAL,oral fluoxetine,oral fluoxetine
NEW18338,DISEASE,e. ictaluri,E. ictaluri
NEW18340,DISEASE,pathophysiology septicemia,pathophysiology septicemia
NEW18341,CHEMICAL,atypical antipsychotic ziprasidone,atypical antipsychotic ziprasidone
NEW18343,CHEMICAL,selegiline treatment,selegiline treatment
NEW18344,CHEMICAL,camp signaling pathway,cAMP signaling pathway
NEW18348,CHEMICAL,ketamine anaesthesia,ketamine anaesthesia
NEW18349,BIOCHEMICAL,antiviral pf74,Antiviral PF74
NEW18352,DISEASE,g. sabinae,G. sabinae
NEW18356,MENTAL_HEALTH,fatigue resistance,Fatigue resistance
NEW18358,CHEMICAL,cd tolerance,Cd tolerance
NEW18359,DISEASE,a. auriculiformis,A. auriculiformis
NEW18361,CHEMICAL,aggregated cd toxicity,aggregated Cd toxicity
http://purl.obolibrary.org/obo/MFOMD_0000189,MENTAL_HEALTH,premenstrual dysphoric disorder,Premenstrual dysphoric disorder symptoms
NEW18365,CHEMICAL,pulsatile levodopa administration,Pulsatile levodopa administration
NEW18366,CHEMICAL,plasma agrp elevation,plasma AGRP elevation
NEW18370,CHEMICAL,mg741,MG741
C000712990,CHEMICAL,(E)-5-hydroxy-7-methoxy-3-(2'-hydroxybenzyl)-4-chromanone [Supplementary Concept],(E)-5-hydroxy-7-methoxy-3-(2-hydroxybenzyl)-4-chromanone|Flavonoids
NEW18373,BIOCHEMICAL,thyroid hormone signaling regulation,thyroid hormone signaling regulation
NEW18375,CHEMICAL,potent serotonin reuptake inhibiting property,potent serotonin reuptake inhibiting properties
NEW18376,CHEMICAL,potent serotonin reuptake inhibition,potent serotonin reuptake inhibition
NEW18378,BIOCHEMICAL,brain vitamin k,brain vitamin K
NEW18379,CHEMICAL,high brain mk4 concentration,Higher brain MK4 concentrations
NEW18382,BIOCHEMICAL,high brain mk4 concentration,pyridoxine responsive individuals
NEW18384,BIOCHEMICAL,folate transporter deficiency,folate transporter deficiency
D008746,CHEMICAL,Methylazoxymethanol Acetate,"methylazoxymethanol|Acetate, Methylazoxymethanol|(Methyl-ONN-azoxy)methanol Acetate"
NEW18387,BIOCHEMICAL,pharmaceutical campaign,pharmaceutical campaign
NEW18390,MENTAL_HEALTH,d1 agonist,oro-facial dyskinesia
NEW18391,DISEASE,ovarian cancer 3d culture,ovarian cancer 3D cultures
NEW18393,BIOCHEMICAL,estrogen pathway activation,estrogen pathway activation
NEW18394,DISEASE,estrogen pathway activation,incessant ovulation
NEW18395,DISEASE,estrogen pathway activation,ovarian carcinogenesis
NEW03054,CHEMICAL,free triiodothyronine,free triiodothyronine
NEW18398,DISEASE,free triiodothyronine,athyreotic patients
NEW18400,BIOCHEMICAL,peroxiproliferation-activated receptor gamma agonist medication,peroxiproliferation-activated receptor gamma agonist medications
NEW18401,CHEMICAL,antidiabetic glitazone GTZ drug,antidiabetic glitazone GTZ drugs
NEW07421,DISEASE,total cholesterol,total cholesterol|TC
D017498,CHEMICAL,Adenovirus E1 Proteins,"E1|Proteins, Adenovirus E1|E1 Proteins, Adenovirus"
NEW18405,CHEMICAL,finite-temperature k spectrum,finite-temperature K spectra
NEW18408,CHEMICAL,catecholaminergic amp system,Catecholaminergic AMP systems
D029774,CHEMICAL,Gynostemma,"Gynostemmas|pentaphyllum, Gynostemma|Gynostemma pentaphyllums|Gynostemma pentaphyllum"
NEW18412,BIOCHEMICAL,bee venom therapy,Bee venom therapy
NEW18413,CHEMICAL,2=0.52,2=0.52
D055397,DISEASE,Ventilator-Induced Lung Injury,"Lung Injury, Ventilator-Induced|Lung Injury, Ventilator Induced|Lung Injuries, Ventilator-Induced|Ventilator-Induced Lung Injuries|Ventilator Induced Lung Injury|lung injury"
D020823,CHEMICAL,ADP-Ribosylation Factor 1,"ARF 1 Protein|ADP ribosylation factor|ADP Ribosylation Factor 1|Protein, ARF1|ARF1p|ARF1 Protein"
D003453,DISEASE,Cryptococcosis,"Cryptococcus neoformans Infections|cryptococcus infection|Infection, Cryptococcus gattii|C gattii Infection|Infection, Cryptococcus neoformans|C neoformans Infection|Cryptococcus neoformans Infection|Infection, C. gattii|Cryptococcus gattii Infection|Cryptococcus Infections|Torulosis|Infection, C neoformans|Infection, C. neoformans|C. neoformans Infections|Infection, C gattii|Infections, C gattii|C. gattii Infections|C neoformans Infections|Cryptococcoses|Toruloses|C gattii Infections|C. gattii Infection|Infections, C. neoformans|C. neoformans Infection|Cryptococcus gattii Infections|Cryptococcus Infection|Infection, Cryptococcus"
D003078,CHEMICAL,Colchicine,"colchicine|Colchicine, (R)-Isomer|Colchicine, (+-)-Isomer"
NEW11514,DISEASE,suppression subtractive hybridization,suppression subtractive hybridization|SSH
NEW18428,CHEMICAL,oseltamivir resistance,oseltamivir resistance
C570114,CHEMICAL,CCL 34 [Supplementary Concept],Serine/analogs  and  derivatives|CCl|Glycolipids
NEW18432,CHEMICAL,ccl exposure,CCl exposures
NEW18435,CHEMICAL,acute ccl exposure,acute CCl exposure
NEW18437,CHEMICAL,anit feeding,ANIT feeding
D020381,CHEMICAL,Interleukin-17,"Interleukin-17E|Interleukin-17C|Interleukin-17A|CTLA-8|Interleukin 17|IL-17|Cytotoxic T lymphocyte-Associated Antigen 8|IL-17F|Interleukin 25|Cytokine ML-1|IL 17E|Interleukin-17B|Interleukin-25|IL-17E|IL-17B|Interleukin 17A|Interleukin 17B|Interleukin 17F|Cytotoxic T lymphocyte Associated Antigen 8|IL-17A|Interleukin-17F|Cytokine ML 1|CX2, Cytokine|IL-17C|Interleukin 17E|Interleukin 17C|CTLA8|Cytokine CX2"
NEW18443,DISEASE,puccinia striiformis f. sp. tritici,Puccinia striiformis f. sp. tritici
NEW18444,NUTRITION,transgenic wheat,Transgenic wheat
NEW18445,CHEMICAL,pst27791,Pst27791
NEW18447,DISEASE,TaRaf46,TaRaf46
NEW18449,CHEMICAL,serotonin neuronal system,Serotonin neuronal systems
NEW18450,CHEMICAL,5-ht(3 receptor antagonist ondansetron,5-HT(3 receptor antagonist ondansetron
NEW18452,CHEMICAL,5-ht(3 receptor antagonist ondansetron,cortico-mesolimbic dopamine release
NEW18453,CHEMICAL,low-dose ondansetron,low-dose ondansetron
NEW18456,DISEASE,vasoplegic profile,vasoplegic profile
http://purl.obolibrary.org/obo/DOID_535,MENTAL_HEALTH,sleep disorder,Non-organic sleep disorder|sleep behaviour disorder
NEW18461,BIOCHEMICAL,abnormal thyroid hormone system function,Abnormal thyroid hormone system function
NEW18465,BIOCHEMICAL,circulate thyroid hormone,circulating thyroid hormones
NEW18466,CHEMICAL,fas child,FAS children
NEW18467,CHEMICAL,progesterone treatment,progesterone treatment
NEW18468,CHEMICAL,serotonin 5-hydroxytryptamine type receptor,serotonin 5-hydroxytryptamine type receptor
NEW18470,BIOCHEMICAL,otsuka Pharmaceutical Co. Ltd.,Otsuka Pharmaceutical Co. Ltd.
NEW18474,CHEMICAL,inhibitor flurbiprofen,inhibitor flurbiprofen
NEW18475,DISEASE,interstitial thickening,Interstitial thickening
NEW18476,BIOCHEMICAL,human pxr agonist,human PXR agonists
http://purl.obolibrary.org/obo/NCBITaxon_6843,DISEASE,chelicerata,Reynoldsia sandwicensis
D053829,DISEASE,Amyloid Precursor Protein Secretases,"gamma Secretase|amyloid precursor protein|APP Secretase|beta Secretase|Secretase, APP|gamma-Secretase|Amyloid Precursor Protein Secretase|alpha Secretase|beta-Secretase|Secretases|APP|alpha-Secretase|Secretase"
C005356,CHEMICAL,sphingosine phosphorylcholine [Supplementary Concept],lysosphingomyelin|Phosphorylcholine/analogs  and  derivatives|Sphingosine/analogs  and  derivatives
NEW18480,BIOCHEMICAL,group metabotropic glutamate receptor mglur agonist,Group metabotropic glutamate receptor mGluR agonist
NEW18482,DISEASE,synchronized 1a9 ovarian carcinoma cell,Synchronized 1A9 ovarian carcinoma cells
NEW18484,CHEMICAL,tubulin heterodimer,tubulin heterodimers
NEW18486,DISEASE,stress-induced ibs,stress-induced IBS
http://purl.obolibrary.org/obo/CHEBI_22587,BIOCHEMICAL,antiviral agent,Anti-viral agents|antiviral agents|anti-viral agents|antivirals|anti-viral agent|antiviral
NEW18491,BIOCHEMICAL,beta gamma secretase,beta gamma secretase
D017405,CHEMICAL,Herpes Simplex Virus Protein Vmw65,"Herpes Simplex Virus Protein VP16|Factor, alpha-Trans Inducing|Herpes Simplex Virus Type 2 Protein VP16|HSV-1|alpha TIF HSV 1|alpha Trans Inducing Factor, Herpes Simplex Virus 1|alpha-Trans-Inducing Factor, Herpes Simplex Virus 1|Protein, Vmw65|HSV-1 Protein VP-16|HSV 1 Protein VP 16|Protein VP16, HSV-1|Protein, VP16|HSV-1 Protein VP16|Herpes Simplex Virus Transcriptional Activator Vmw65|Protein VP-16, HSV-1|VP-16, HSV-1 Protein|alpha Trans Inducing Factor|HSV 1 Protein VP16|Herpes Simplex Virus Trans-Activator Vmw65|Vmw65 Protein|alpha-TIF HSV-1|HSV-1, alpha-TIF|Herpes Simplex Virus Protein VP 16|VP16, HSV-1 Protein|Inducing Factor, alpha-Trans|VP16 Protein|alpha-Trans Inducing Factor|Herpes Simplex Virus Trans Activator Vmw65"
NEW18493,CHEMICAL,retinoic acid signaling defect,retinoic acid signaling defects
NEW11875,CHEMICAL,cannabinoid hyperemesis syndrome,Cannabinoid Hyperemesis Syndrome|CHS
NEW18495,CHEMICAL,pee group,PEE group
NEW18498,DISEASE,hypertension higher,hypertension higher
NEW18501,DISEASE,disorder pathology,Disorder pathology
NEW18503,CHEMICAL,doxazosin therapy,doxazosin therapy
NEW18504,CHEMICAL,norepinephrine system,norepinephrine system
NEW18505,CHEMICAL,nb atom,Nb atoms
NEW18507,MENTAL_HEALTH,premenstrual depression,Premenstrual depression
NEW18511,DISEASE,mtf ts,MtF TS
NEW18513,DISEASE,endocrinopathy occurence,endocrinopathy occurence
NEW18517,CHEMICAL,progesterone increase,progesterone increase
NEW18518,MENTAL_HEALTH,progesterone increase,CL regression
NEW18522,DISEASE,rage-dependent neuronal death,RAGE-dependent neuronal death
NEW18523,CHEMICAL,rage-dependent neuronal death,AGE-albumin
NEW18524,DISEASE,adipose inflammation,Adipose inflammation
C496221,CHEMICAL,"Adgre1 protein, rat [Supplementary Concept]","Receptors, Cell Surface|Adgre1"
NEW18526,DISEASE,hypoleptinemia,hypoleptinemia
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Aphagia,DISEASE,aphagia,hypercorticosteronemia
NEW18527,CHEMICAL,impaired glucose homeostasis,impaired glucose homeostasis
http://purl.obolibrary.org/obo/DOID_0060041,MENTAL_HEALTH,autism spectrum disorder,child autism spectrum disorder
NEW18529,CHEMICAL,large-scale dm/q trial,large-scale DM/Q trials
NEW18531,CHEMICAL,dm/q 30/30,DM/Q 30/30
NEW18532,CHEMICAL,subanesthetic dose,subanesthetic dose
NEW18533,CHEMICAL,dissociative anesthetic ketamine,dissociative anesthetic ketamine
NEW18534,BIOCHEMICAL,nonselective opioid antagonist naltrexone,nonselective opioid antagonist naltrexone
NEW18536,DISEASE,cci-tbi,CCI-TBI
NEW18538,CHEMICAL,dexamethasone treatment,dexamethasone treatment
NEW18539,CHEMICAL,lysine+dextroamphetamine formulation,lysine+dextroamphetamine formulation
NEW18540,DISEASE,cannabinoid hyperemesis syndrome patient,cannabinoid hyperemesis syndrome patients
NEW18542,DISEASE,cannabinoid hyperemesis syndrome patient,antipsychotic-induced akathisia
D015026,CHEMICAL,Zeatin,Amino Alcohols (1973-1974)|zeatin|Purines (1973-1974)
http://purl.obolibrary.org/obo/CHEBI_8228,CHEMICAL,pioglitazone,"Pioglitazone|pioglitazonum|TZD pioglitazone|pioglitazona|(+-)-5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|pioglitazone|Actos|5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione"
NEW18546,CHEMICAL,sub-cus week exposure,sub-CUS week exposure
NEW18547,CHEMICAL,cus 6-week exposure,CUS 6-week exposure
NEW18548,CHEMICAL,sub-cus,sub-CUS
NEW00640,DISEASE,sub-cus week exposure,depression-like behaviors
NEW18550,MENTAL_HEALTH,widespread antibiotic resistance,Widespread antibiotic resistance
NEW18552,CHEMICAL,chronic pbz exposure,chronic PBZ exposure
D002289,DISEASE,"Carcinoma, Non-Small-Cell Lung","Carcinoma, Non Small Cell Lung|Carcinoma, Non-Small Cell Lung|Non-Small Cell Lung Carcinoma|Lung Carcinoma, Non-Small-Cell|Non-Small Cell Lung Cancer|Lung Carcinomas, Non-Small-Cell|Carcinomas, Non-Small-Cell Lung|Non Small Cell Lung Carcinoma|Nonsmall Cell Lung Cancer|Non-Small-Cell Lung Carcinomas|Non-Small-Cell Lung Carcinoma|Non-small cell lung cancer|NSCLC"
NEW14477,DISEASE,manic recurrence,manic recurrences
NEW18554,NUTRITION,lithium-treate excellent lithium responder,lithium-treated excellent lithium responders
NEW18556,NUTRITION,lithium monotherapy,lithium monotherapy
NEW18557,DISEASE,hyperthymic temperament,hyperthymic temperament
NEW18558,DISEASE,cognitive disorganization,cognitive disorganization
NEW18559,NUTRITION,Lithium Genetics,Lithium Genetics
D000077267,CHEMICAL,Fulvestrant,"ZM182780|ICI182780|ZM-182780|ICI 182,780|ZM 182780|ICI-182780|Faslodex|7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol|Fulvestrant|ICI 182780"
D000077384,CHEMICAL,Anastrozole,"ZD1033|Arimidex|ICI D1033|anastrozole|2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile)|ZD-1033|ZD 1033|Zeneca ZD 1033|Anastrazole"
NEW18564,BIOCHEMICAL,stable mood stabilizer,stable mood stabilizer
NEW18566,BIOCHEMICAL,selective beta-adrenoceptor agonist,Selective beta-adrenoceptor agonists
NEW18568,CHEMICAL,red rice extract,red rice extract
C420323,CHEMICAL,"UL37 protein, Human herpesvirus 5 [Supplementary Concept]",Immediate-Early Proteins|vMIA
C050767,CHEMICAL,hydroxypropyl distarch phosphate [Supplementary Concept],Hydroxyethyl Starch Derivatives/analogs  and  derivatives|hydroxypropyl distarch phosphate|HDP
NEW18573,NUTRITION,low folate status,low folate status
NEW18574,NUTRITION,low folate intake,low folate intake
NEW18575,CHEMICAL,interferon-based regimen,Interferon-based regimens
NEW18576,CHEMICAL,cyclase inhibitor tripropylamine,cyclase inhibitor tripropylamine|TPA
NEW18581,BIOCHEMICAL,combined vitamin preparation,Combined vitamin preparations
NEW18582,CHEMICAL,stress-induced cortisol secretion,stress-induced cortisol secretion
D000074361,CHEMICAL,Sleep Latency,"Sleep Latency, REM|Latency, Sleep Onset|Onset Latencies, Sleep|preSO|sleep onset|Sleep Onset Latencies|REM Sleep Latencies|Latency, REM Sleep|Sleep Onset Latency|Sleep Latencies|REM Sleep Latency|Latency, Sleep"
NEW18586,CHEMICAL,hydrophobic property,hydrophobic property
NEW18590,CHEMICAL,nmda treatment,NMDA treatment
NEW18591,DISEASE,viral nervous necrosis,viral nervous necrosis|VNN
C572289,CHEMICAL,eicosenoic acid [Supplementary Concept],"cis-11-eicosenoic acid|Fatty Acids, Monounsaturated"
NEW18593,BIOCHEMICAL,hormone regulation,hormone regulation
NEW18595,MENTAL_HEALTH,cue-induced craving,Cue-induced craving
D065348,DISEASE,Macular Pigment,"Macular pigment|MP|Pigment, Macular"
NEW18599,CHEMICAL,gaba agonist 3-aminopropane sulphonic acid,GABA agonist 3-aminopropane sulphonic acid|3-APS
NEW18601,CHEMICAL,gaba uptake system,GABA uptake systems
NEW18604,CHEMICAL,gaba uptake blockade,GABA uptake blockade
NEW18606,MENTAL_HEALTH,hyperactivity model,hyperactivity model
NEW18306,CHEMICAL,natural coumarin,DA neurons
NEW18608,BIOCHEMICAL,drd1 antagonist,DRD1 antagonist
D000071071,DISEASE,Microaneurysm,"Miliary Aneurysm|Microaneurysms|Retinal Microaneurysm|Aneurysm, Miliary|Aneurysms, Miliary|Aneurysms, Charcot-Bouchard|Charcot Bouchard Aneurysms|Microaneurysm, Retinal|microaneurysms|Microaneurysms, Retinal|Retinal Microaneurysms|Miliary Aneurysms|Charcot-Bouchard Aneurysms|Charcot-Bouchard Aneurysm|Aneurysm, Charcot-Bouchard|Charcot Bouchard Aneurysm"
NEW18613,DISEASE,early retinopathy,early retinopathy
NEW18614,CHEMICAL,adjuvant coq10,adjuvant CoQ10
NEW18615,MENTAL_HEALTH,syn orientation,syn orientation
C539275,CHEMICAL,"CHRNG protein, human [Supplementary Concept]","Receptors, Nicotinic|AchR"
NEW18622,DISEASE,induce enteritis model,induced enteritis model
NEW18625,CHEMICAL,estradiole,estradiole
NEW18626,CHEMICAL,pyruvate dehydrogenase pdh deficiency,Pyruvate dehydrogenase PDH deficiency
NEW18628,CHEMICAL,sialic-acid dosage,sialic-acid dosage
D015160,DISEASE,Hydrops Fetalis,"Hydrops Fetalis, Non-Immune|Familial Non Immune Hydrops Fetalis|Fetal Hydrops|Non-Immune Hydrops Fetalis|Fetalis Nonimmune, Hydrops|Hydrops, Fetal|Fetalis, Idiopathic Hydrops|Edema, Fetal|hydrops fetalis|Nonimmune Hydrops Fetalis|Nonimmune Hydrops Fetali|Hydrops Fetalis Nonimmune|Idiopathic Hydrops Fetali|Immune Hydrops Fetalis|Fetalis Nonimmunes, Hydrops|Hydrops Fetalis, Idiopathic|Idiopathic Hydrops Fetalis|Familial Non-Immune Hydrops Fetalis|Nonimmunes, Hydrops Fetalis|Fetali, Idiopathic Hydrops|Hydrops Fetali, Idiopathic|Fetal Edema|Hydrops Fetali, Nonimmune|Hydrops Fetalis, Immune|Nonimmune, Hydrops Fetalis|Hydrops Fetalis Nonimmunes|Hydrops Fetalis, Nonimmune"
NEW01037,BIOCHEMICAL,first drug,first drug
NEW18630,BIOCHEMICAL,antagonist [11C]raclopride,antagonist [11C]raclopride
C536254,DISEASE,Pyridoxine-dependent epilepsy [Supplementary Concept],Pyridoxine-dependent epilepsy|Epilepsy
NEW18636,CHEMICAL,mao b ko mouse,MAO B KO mice
NEW18637,DISEASE,altered brain injury gene,Altered brain injury genes
NEW18639,CHEMICAL,mao b knockout mouse,MAO B knockout mice
NEW18640,NUTRITION,tree algorithm,tree algorithms
NEW18642,DISEASE,srg suppression,SRG suppression
NEW18646,DISEASE,ruminal lactic acidosis,ruminal lactic acidosis
NEW18649,DISEASE,hallucinogen persist perception disorder,Hallucinogen persisting perception disorder
NEW18650,DISEASE,veris L.,veris L.
D004229,CHEMICAL,Dithiothreitol,"DTT|Cleland's Reagent|Reagent, Cleland|Cleland Reagent|Clelands Reagent|Sputolysin|Dithiothreitol|Reagent, Cleland's"
D000726,BIOCHEMICAL,Androgen Antagonists,"Effect, Anti-Androgen|Antiandrogen|Effects, Antiandrogen|Anti Androgen Effects|Anti-Androgen Effects|Antiandrogens|Antiandrogen Effects|Antiandrogen Effect|Anti Androgen Effect|Androgen Antagonist|Effects, Anti-Androgen|Effect, Antiandrogen|antiandrogen|Antagonists, Androgen|Anti-Androgen Effect|Antagonist, Androgen"
C031423,BIOCHEMICAL,osmotic shock released antigen [Supplementary Concept],released antigen|Blood Proteins
NEW18655,MENTAL_HEALTH,astrovirus projection domain,astrovirus projection domain
NEW18657,CHEMICAL,dopamine da depletion,Dopamine DA depletion
NEW15933,MENTAL_HEALTH,rapid movement sleep behavior disorder,rapid movement sleep behavior disorder
D005133,DISEASE,Eye Movements,"Eye Movement|Movements, Eye|eye movements|Movement, Eye"
NEW18661,MENTAL_HEALTH,exercise fatigue,Exercise fatigue
NEW18663,CHEMICAL,norepinephrine-dopamine reuptake inhibition,Norepinephrine-dopamine reuptake inhibition
NEW18664,CHEMICAL,norepinephrine-dopamine reuptake inhibition,norepinephrine-dopamine reuptake inhibition
NEW18667,CHEMICAL,coal combustion emission,Coal combustion emissions|CCE
NEW18669,CHEMICAL,bismuth-containing quadruple therapy,Bismuth-containing quadruple therapy
NEW18671,BIOCHEMICAL,ip3 receptor antagonist heparin,IP3 receptor antagonist heparin
NEW18673,CHEMICAL,ryanodine-dependent ca2 mobilization inhibitor dantrolene,ryanodine-dependent Ca2 mobilization inhibitor dantrolene
NEW18674,BIOCHEMICAL,ip3 receptor agonist inositol triphosphate,IP3 receptor agonist inositol triphosphate
NEW18675,CHEMICAL,"1,4,5-inositol trisphosphate-linked subtype","1,4,5-inositol trisphosphate-linked subtypes"
NEW18677,CHEMICAL,serotonergic anxiolytic buspirone,serotonergic anxiolytic buspirone
NEW18678,DISEASE,migraine remission,migraine remissions
NEW18680,CHEMICAL,herbicide paraquat,PQ|herbicide paraquat
NEW10646,BIOCHEMICAL,fungicide maneb,fungicide maneb
NEW18683,CHEMICAL,pq       mb exposure,PQ      MB exposure
NEW18684,MENTAL_HEALTH,multiple regression analysis,multiple regression analyses
NEW18685,CHEMICAL,desensitization propertiesat,desensitization propertiesat
NEW18686,BIOCHEMICAL,a supplementation,A supplementation
D051142,BIOCHEMICAL,Retinol O-Fatty-Acyltransferase,"Retinol Ester Synthetase|O-Fatty-Acyltransferase, Retinol|retinol palmitate|Fatty Acyl Coenzyme A Retinol Acyltransferase|Synthetase, Retinol-Palmitate|Synthetase, Retinol Stearate|Retinol Fatty-Acyltransferase|Retinol O Fatty Acyltransferase|Retinol Fatty Acyltransferase|Ester Synthetase, Retinol|Fatty Acyl Coenzyme A-Retinol Acyltransferase|CoA-Retinol Acyltransferase, Acyl|Retinol Stearate Synthetase|Fatty-Acyltransferase, Retinol|Synthetase, Retinol Ester|Stearate Synthetase, Retinol|Acyl CoA-Retinol Acyltransferase|Acyl CoA Retinol Acyltransferase|Acyltransferase, Acyl CoA-Retinol|Retinol Palmitate Synthetase|Retinol-Palmitate Synthetase"
NEW18687,CHEMICAL,glutathione metabolic process,glutathione metabolic process
NEW18688,CHEMICAL,serotonin-uptake blocker fluvoxamine maleate,serotonin-uptake blocker fluvoxamine maleate
NEW18689,DISEASE,episodic memory failure,episodic memory failure
http://purl.obolibrary.org/obo/CHEBI_35716,CHEMICAL,c-nitro compound,specifically-acting compounds
D005207,DISEASE,Fasciculation,"Fasciculation, Benign|Fasciculation, Skeletal Muscle|Tongue Fasciculations|Muscular Fasciculation|Fasciculations, Tongue|Fasciculations, Skeletal Muscle|Fasciculations|Muscle fasciculation|Muscle Fasciculations, Skeletal|Fasciculations, Benign|Fasciculations, Muscular|Benign Fasciculations|Skeletal Muscle Fasciculation|Muscular Fasciculations|Benign Fasciculation|Fasciculation, Muscular|Fasciculation, Tongue|Tongue Fasciculation|Muscle Fasciculation, Skeletal|Skeletal Muscle Fasciculations"
D011654,DISEASE,Pulmonary Edema,"Lung, Wet|pulmonary edema|Edemas, Pulmonary|Edema, Pulmonary|Wet Lungs|Wet Lung|Lungs, Wet|Pulmonary Edemas"
D015877,DISEASE,Miosis,"Persistent Mioses|Pupillary Mioses|Miosis, Persistent|Pupils, Small|Constricted Pupil|miosis|Pupil, Constricted|Persistent Miosis|Miosis, Pupillary|Constricted Pupils|Pupils, Constricted|Small Pupil|Mioses|Mioses, Pupillary|Pupil, Small|Mioses, Persistent|Small Pupils|Pupillary Miosis"
NEW18693,CHEMICAL,swainsonine concentration,swainsonine concentrations
NEW18695,BIOCHEMICAL,vitamin k-dependent protein osteocalcin,vitamin K-dependent protein osteocalcin
NEW18696,BIOCHEMICAL,low vitamin k intake,Low vitamin K intake
NEW18697,MENTAL_HEALTH,Schizophrenia spectrum Disorders,Schizophrenia Spectrum Disorders
D013342,MENTAL_HEALTH,Stuttering,"Stuttering, Developmental|Developmental Stuttering|Adult Stuttering|Stuttering, Familial Persistent 1|Childhood Stuttering|stuttering|Stuttering, Acquired|Stuttering, Childhood|Stuttering, Adult|Acquired Stuttering|Stammering"
NEW18699,BIOCHEMICAL,old generation dopamine antagonist medication,older generation dopamine antagonist medications
D002272,BIOCHEMICAL,Carcinoembryonic Antigen,"CD66e Antigens|carcinoembryonic antigen|Antigen, CD66e|Antigen, Carcinoembryonic|Antigens, CD66e|CD66e Antigen"
NEW18704,NUTRITION,impaired cholesterol,impaired cholesterol
NEW18705,CHEMICAL,sphingolipid catabolism,sphingolipid catabolism
NEW18706,DISEASE,subclinical atherosclerosis,subclinical atherosclerosis
NEW18708,DISEASE,gremlin-1-silenced mesothelioma cell,gremlin-1-silenced mesothelioma cells
NEW18709,MENTAL_HEALTH,gremlin-1-silenced mesothelioma cell,adolescent ethanol abuse
NEW18711,NUTRITION,arctic charr,Arctic charr
NEW18713,CHEMICAL,most steroid metabolite,most steroid metabolites
D000738,CHEMICAL,Androsterone,androsterone|5 alpha-Androstan-3 alpha-ol-17-one|Epiandrosterone|3-alpha-Hydroxy-5-alpha-Androstan-17-One|5 alpha Androstan 3 alpha ol 17 one|3 alpha Hydroxy 5 alpha Androstan 17 One
NEW18715,CHEMICAL,oral montelukast,Oral montelukast
C018562,CHEMICAL,guggulu extract [Supplementary Concept],guggulipid|Commiphora|Plant Gums|Plant Extracts
NEW18718,DISEASE,inflammatory t helper cell,inflammatory T helper cells
NEW18721,CHEMICAL,cxcl12/cxcr4-cxcr7 receptor,CXCL12/CXCR4-CXCR7 receptors
NEW18722,BIOCHEMICAL,gabab agonist baclofen,GABAB agonist baclofen
D009128,DISEASE,Muscle Spasticity,"Spasticity, Clasp-Knife|Spasticity, Muscle|spasticity|Clasp Knife Spasticity|Spastic|Clasp-Knife Spasticity"
NEW18723,MENTAL_HEALTH,microbial resistance,microbial resistance
NEW18725,BIOCHEMICAL,classical antimicrobial agent,classical antimicrobial agents
NEW18728,CHEMICAL,da symptom,DA symptoms
D009388,CHEMICAL,Neostigmine,"Neostigmine Methylsulfate|Prozerin|Prostigmin|Syntostigmine|Bromide, Neostigmine|Neostigmine Bromide|Prostigmine|neostigmine|Synstigmin|Methylsulfate, Neostigmine|Polstigmine|Proserine"
NEW18733,BIOCHEMICAL,peripheral nicotinic antagonist,peripheral nicotinic antagonist
NEW18734,CHEMICAL,low nicotine concentration,lower nicotine concentration
NEW18736,DISEASE,ndv infected cell,NDV infected cells
NEW18737,DISEASE,anxiety-like behavior,Anxiety-like behavior
NEW18739,CHEMICAL,brainstem-acting drug cloperastine,brainstem-acting drug cloperastine|CPS
NEW18742,DISEASE,sarcoma cell,sarcoma cells
NEW18744,BIOCHEMICAL,liver-specific thyromimetic,Liver-specific thyromimetics
NEW18747,NUTRITION,tea catechin,tea catechins
NEW18748,CHEMICAL,cpt1a1 sirna knockdown,CPT1A1 siRNA knockdown
NEW18750,CHEMICAL,transcript variant 4,transcript variants 4|ATF3-T4
NEW18753,DISEASE,brain microvascular inflammation,brain microvascular inflammation
NEW18754,DISEASE,program cell death signalling pathway,programmed cell death signalling pathways
NEW18756,CHEMICAL,gel sample,GEL samples
NEW18758,DISEASE,antitumor immunity,antitumor immunity
NEW18762,CHEMICAL,high alcohol intake,high alcohol intake
D045724,DISEASE,"Diverticulosis, Stomach","Gastric Diverticulosis|diverticulosis|Diverticulosis, Gastric|Stomach Diverticulosis"
NEW18766,CHEMICAL,smoking rate,Smoking rates
NEW18768,CHEMICAL,bergamot polyphenolic formulation,BPF99|Bergamot polyphenolic formulation
NEW18769,BIOCHEMICAL,vitamin d deficiency serum,Vitamin D deficiency serum
NEW18771,BIOCHEMICAL,25-oh vitamin d level,25-OH vitamin D levels
NEW18772,BIOCHEMICAL,extended-release calcifediol,Extended-release calcifediol
NEW18774,CHEMICAL,nmdar antagonist apv,NMDAR antagonist APV
NEW18778,CHEMICAL,Trp98Stop,Trp98Stop
NEW18780,CHEMICAL,nicotine seek,Nicotine seeking
NEW18782,CHEMICAL,rapid-acting antidepressant property,rapid-acting antidepressant properties
D006331,DISEASE,Heart Diseases,Cardiac Disease|Heart Disorders|Cardiac Disorders|Cardiac Disorder|Heart Disorder|Cardiac Diseases|heart disorders|Heart Disease
NEW18784,DISEASE,comorbid condition,Comorbid conditions
NEW17769,CHEMICAL,lysine methylation,DADLE|delta-opioid receptor-preferring agonist D-Ala2-D-Leu2-enkephalin
NEW18785,CHEMICAL,cb(1 antagonist rimonabant,CB(1 antagonist rimonabant
NEW18787,DISEASE,beta-hemolytic spirochete,beta-hemolytic spirochetes
NEW16335,BIOCHEMICAL,dopamine neurotransmission,pharmaceutical agents
NEW18791,NUTRITION,plant-derived phenylpropanoid,plant-derived phenylpropanoid
NEW18792,CHEMICAL,levodopa l-dopa therapy,Levodopa L-dopa therapy
NEW18794,CHEMICAL,camp signaling cascade,cAMP signaling cascade
NEW18796,CHEMICAL,dopamine precursor l-3,dopamine precursor L-3
NEW17140,DISEASE,leukotriene pathway,abnormal involuntary movements
C517782,CHEMICAL,pasireotide [Supplementary Concept],Somatostatin/analogs  and  derivatives|Pasireotide
NEW18798,BIOCHEMICAL,intramuscular botulinum toxin,intramuscular botulinum toxin
NEW14950,CHEMICAL,acetyl-l-carnitine treatment,ethanol intake
C000627118,DISEASE,"MMAB protein, human [Supplementary Concept]",Alkyl and Aryl Transferases|cobalamin deficiency
NEW18799,CHEMICAL,± sd serum level,± SD serum levels
NEW18801,CHEMICAL,chocolate consumption,chocolate consumption
NEW18802,CHEMICAL,facl4 gene mutation,FACL4 gene mutations
NEW18804,CHEMICAL,available antidepressant agent,available antidepressant agents
NEW18805,BIOCHEMICAL,glucagon-like peptide receptor agonist,Glucagon-like peptides receptor agonists
NEW18807,BIOCHEMICAL,selective adrenergic blocker,selective adrenergic blocker
NEW18809,CHEMICAL,oral labetalol,oral labetalol
D019806,CHEMICAL,Cromakalim,"BRL 38227|cromakalim|Cromakalim, (trans)-Isomer|Lemakalim|Cromakalim, (3S-cis)-Isomer|BRL38227|BRL38226|BRL-38226|BRL 38226|Cromakalim, (3R-cis)-Isomer|Levcromakalim|Cromakalim, (3S-trans)-Isomer|BRL-38227|Cromakalim, (3R-trans)-Isomer|BRL-34915"
NEW18811,CHEMICAL,blocker doxazosin,blocker doxazosin
NEW18812,CHEMICAL,adenosine reuptake,adenosine reuptake
NEW18813,CHEMICAL,serotonergic interaction,serotonergic interactions
NEW18814,CHEMICAL,3-hydroxy-3-methylglutaryl coenzyme a hmg-coa reductase inhibitor,3-hydroxy-3-methylglutaryl coenzyme A HMG-CoA reductase inhibitors
D000068558,CHEMICAL,"Amlodipine Besylate, Olmesartan Medoxomil Drug Combination","Amlodipine Besylate-Olmesartan Medoxomil Drug Combination|olmesartan|Amlodipine Besylate Olmesartan Medoxomil Drug Combination|Amlodipine Besylate, Olmesartan Medoxomil|Amlodipine Besylate-Olmesartan Medoxomil|Azor|Amlodipine Besylate Olmesartan Medoxomil|Besylate-Olmesartan Medoxomil, Amlodipine|Medoxomil, Amlodipine Besylate-Olmesartan"
D017035,CHEMICAL,Pravastatin,"SQ-31000|Pravastatin tert Octylamine Salt|Pravastatin Sodium Salt|Pravasin|SQ 31000|Apo-Pravastatin|Apo Pravastatin|Vasten|Lipostat|Sodium Salt, Pravastatin|Pravastatin tert-Octylamine Salt|CS514|Lin Pravastatin|Lipemol|RMS-431|Nu Pravastatin|CS-514|SQ31000|Pravachol|SQ31,000|Lin-Pravastatin|Pravastatin Sodium|RMS431|pravastatin|CS 514|Elisor|Liplat|Nu-Pravastatin|Pravastatin Monosodium Salt, (6 beta)-Isomer|RMS 431|Prareduct|Pravacol|SQ-31,000|Bristacol|Pravastatin, (6 beta)-Isomer|Eptastatin|Mevalotin|SQ 31,000|Selektine"
NEW18816,CHEMICAL,pravastatin administration,Pravastatin administration
NEW17045,DISEASE,third-generation fibric acid derivative,cardiomyocyte hypertrophy
C582420,CHEMICAL,methyl-2-ethoxy-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-benzimidazole-7-carboxylate [Supplementary Concept],Tetrazoles|candesartan|Benzimidazoles
NEW09952,MENTAL_HEALTH,dissociation rate,dissociation rate
D004409,MENTAL_HEALTH,"Dyskinesia, Drug-Induced","Dyskinesias, Medication-Induced|induced dyskinesia|Dyskinesia, Medication Induced|Drug-Induced Dyskinesias|Medication-Induced Dyskinesia|Dyskinesia, Drug Induced|Drug-Induced Dyskinesia|Dyskinesia, Medication-Induced|Medication-Induced Dyskinesias|Dyskinesias, Drug-Induced|Medication Induced Dyskinesia"
NEW18821,DISEASE,tumor patient,Tumor patients
NEW18822,MENTAL_HEALTH,ischemia-induced retrograde amnesia,Ischemia-induced retrograde amnesia
D015669,CHEMICAL,Acupuncture Points,"Acupoints|acupuncture points|Acupoint|Acupuncture Point|Point, Acupuncture|Points, Acupuncture"
NEW18826,NUTRITION,southern flounder,southern flounder
NEW18829,NUTRITION,spanish first-grade,Spanish first-grade
NEW01252,DISEASE,dietary nitrate,memory impairment
NEW18831,BIOCHEMICAL,calculate antagonist dissociation constant,calculated antagonist dissociation constants
NEW18834,CHEMICAL,mibg scintigraphy,MIBG scintigraphy
NEW18836,BIOCHEMICAL,low ascorbic acid level,low ascorbic acid levels
NEW18839,DISEASE,salmonella typhimurium cecal colonization,Salmonella typhimurium cecal colonization
NEW18841,DISEASE,cecal microflora,cecal microflora
NEW18842,CHEMICAL,dietary lactose,dietary lactose
C419502,CHEMICAL,alvimopan [Supplementary Concept],Alvimopan|Piperidines
NEW18850,CHEMICAL,one extra carbon,α-PHP|one extra carbon
NEW18853,CHEMICAL,o2 stimulus,O2 stimuli
NEW18855,CHEMICAL,testosterone supplementation,testosterone supplementation
NEW18856,CHEMICAL,acute testosterone supplementation,acute testosterone supplementation
NEW18857,CHEMICAL,testosterone administration,testosterone administration
NEW02305,DISEASE,hyperglycaemia,hyperglycaemia
NEW18859,CHEMICAL,camp production,cAMP production
NEW18866,DISEASE,second encouraging psychiatric use,second encouraging psychiatric use
NEW07004,MENTAL_HEALTH,mood disorder patient,mood disorder patients
C071475,CHEMICAL,methyl bensulfuron [Supplementary Concept],bensulfuron-methyl|Sulfonylurea Compounds
NEW18871,CHEMICAL,subpopulation bc1,subpopulation BC1
NEW18874,CHEMICAL,bc1 population,BC1 population
C065631,CHEMICAL,phosducin [Supplementary Concept],Phosphoproteins|Eye Proteins|GTP-Binding Protein Regulators|ivD-pDC|pDC
C062485,CHEMICAL,bredinin 5'-monophosphate [Supplementary Concept],Ribonucleotides|Bredinin
NEW18883,DISEASE,crf action,CRF action
D007984,DISEASE,Leydig Cell Tumor,"Leydig cell|Tumors, Interstitial Cell|Interstitial Cell Tumor|Tumor, Leydig Cell|Interstitial Cell Tumors|Tumor, Interstitial Cell"
NEW18888,CHEMICAL,high ps level,higher PS level
NEW18891,CHEMICAL,norepinephrine ne transporter,norepinephrine NE transporters
C000617044,CHEMICAL,Roentgenium [Supplementary Concept],roentgenium|Transactinide Series Elements|Rg1
C035054,CHEMICAL,ginsenoside Rg1 [Supplementary Concept],Ginsenosides|Ginsenoside Rg1
NEW18895,DISEASE,CPu dopamine level,CPu dopamine levels
NEW18896,DISEASE,astrocytic hypertrophy,astrocytic hypertrophy
NEW18900,BIOCHEMICAL,other drug option,Other drug options
NEW18901,CHEMICAL,iron supplement,iron supplements
D010624,CHEMICAL,Phenelzine,"beta-Phenylethylhydrazine|Fenelzin|Nardelzine|2-Phenethylhydrazine|phenelzine|Phenelzine Sulfate|Sulfate, Phenelzine|Phenethylhydrazine|beta Phenylethylhydrazine|Nardil|2 Phenethylhydrazine"
D009770,MENTAL_HEALTH,Obsessive Behavior,"Behaviors, Obsessive|Obsession|Obsessive Behaviors|Obsessions|Behavior, Obsessive"
NEW18906,DISEASE,patient 's thrombocytopenia,patient's thrombocytopenia
NEW18907,DISEASE,profound thrombocytopenia,Profound thrombocytopenia
NEW18908,CHEMICAL,intravenous eptifibatide,intravenous eptifibatide
D000077542,CHEMICAL,Eptifibatide,"7H-Pyrrolo(2,1-g)(1,2,5,8,11,14,17,20)dithiahexaazacyclotricosine-17-acetic acid, 3-(aminocarbonyl)-11-(4-((aminoiminomethyl)amino)butyl)docosahydro-20-(1H-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxo-, (3R,11S,17S,20S,25aS)-|Epifibratide|Epifibatide|eptifibatide|Integrilin|Integrelin"
NEW18912,MENTAL_HEALTH,acute untreated schizophrenia,acute untreated schizophrenia
NEW18914,MENTAL_HEALTH,disorganized type schizophrenia,disorganized type schizophrenia
NEW18911,MENTAL_HEALTH,induce psychosis,paranoid type schizophrenia
NEW18916,CHEMICAL,central serotonin 5ht system,central serotonin 5HT system
NEW18919,DISEASE,primary bilateral macronodular adrenal hyperplasia,Primary bilateral macronodular adrenal hyperplasia
C054597,CHEMICAL,garcinol [Supplementary Concept],Terpenes|Garcinol
NEW18925,DISEASE,toxicity,toxicity
NEW18927,BIOCHEMICAL,appropriate adrenergic agent,appropriate adrenergic agent
NEW18929,DISEASE,whose be hepatotoxicity,hepatotoxicity
NEW18933,DISEASE,hepatotoxic dose,hepatotoxic doses
C043067,CHEMICAL,"bromobenzene 3,4-oxide [Supplementary Concept]",Bromobenzenes|bromobenzene
NEW18934,CHEMICAL,elevated catecholamine,elevated catecholamines
NEW18945,CHEMICAL,adenosine A2AR,adenosine A2AR
NEW18947,MENTAL_HEALTH,e3 adhd subunit,E3 AdhD subunit
D008733,CHEMICAL,Methoxyflurane,Anecotan|Methoxyflurane|Pentrane|Penthrane|Methofluranum
NEW18951,CHEMICAL,7-ni,7-NI
NEW18952,CHEMICAL,renin-angiotensin-aldosterone blockade,Renin-angiotensin-aldosterone blockade
NEW18954,DISEASE,an-induced cognitive deficit,AN-induced cognitive deficits
NEW18958,CHEMICAL,free levothyroxine,free levothyroxine
NEW18959,MENTAL_HEALTH,quantile regression,Quantile regression
NEW18961,DISEASE,hyperprolactinemic serum,hyperprolactinemic sera
C014225,CHEMICAL,tocophersolan [Supplementary Concept],poly-ethylene-glycol|PEG|Vitamin E
NEW18963,BIOCHEMICAL,specific egfr inhibitor osimertinib mesylate,specific EGFR inhibitor osimertinib mesylate
D020186,MENTAL_HEALTH,Sleep Bruxism,"Adult Sleep Bruxism|Bruxisms, Sleep-Related|Sleep-Related Bruxisms|Nocturnal Bruxism|Childhood Sleep Bruxisms|Adult Sleep Bruxisms|Nocturnal Teeth Grinding Disorder|Sleep Bruxisms, Adult|Bruxisms, Sleep|Sleep-Related Bruxism|Sleep Bruxism, Adult|Teeth Grinding Disorder, Nocturnal|Sleep Bruxisms, Childhood|Sleep bruxism|Nocturnal Bruxisms|Bruxisms, Nocturnal|Sleep Bruxism, Childhood|Bruxism, Nocturnal|Bruxism, Sleep|Sleep Bruxisms|Sleep Related Bruxism|Bruxism, Sleep-Related|Childhood Sleep Bruxism"
NEW18967,MENTAL_HEALTH,bruxism episode,bruxism episodes
NEW18970,MENTAL_HEALTH,post-partum mental illness,post-partum mental illness
D008228,DISEASE,"Lymphoma, Non-Hodgkin","Lymphoma, Intermediate-Grade|Non-Cleaved-Cell Lymphoma, Small|Lymphoma, Mixed-Cell, Diffuse|Diffuse Mixed Cell Lymphoma|Mixed-Cell Lymphomas|Mixed Lymphomas|non-Hodgkin lymphoma|Lymphoma, Diffuse Undifferentiated|Lymphoma, Low Grade|Non-Hodgkins Lymphoma|Sarcoma, Lymphatic|Pleomorphic Lymphomas|Lymphoma, Diffuse|Lymphatic Sarcoma|Reticulosarcoma|Small Noncleaved-Cell Lymphomas|Lymphoma, Mixed Lymphocytic-Histiocytic|Lymphoma, Non Hodgkin|Undifferentiated Lymphoma|Lymphoma, Non Hodgkins|Low-Grade Lymphomas|Diffuse Undifferentiated Lymphoma|Diffuse Lymphomas|Mixed-Cell Lymphoma|Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic|Lymphoma, Mixed|Lymphoma, Atypical Diffuse Small Lymphoid|Non-Hodgkin's Lymphoma|Small Noncleaved Cell Lymphoma|Non-Hodgkin Lymphoma|Small Non Cleaved Cell Lymphoma|Diffuse Lymphoma|Lymphoma, Undifferentiated|Lymphoma, Nonhodgkin's|Reticulosarcomas|Mixed-Cell Lymphoma, Diffuse|Mixed Cell Lymphoma|Diffuse Mixed Small and Large Cell Lymphoma|Non Hodgkin's Lymphoma|Lymphoma, Undifferentiated, Diffuse|Nonhodgkin's Lymphoma|High-Grade Lymphomas|Mixed Lymphoma|Intermediate-Grade Lymphomas|Small Cleaved Cell Lymphoma, Diffuse|Lymphoma, Non-Hodgkin's|Undifferentiated Lymphoma, Diffuse|Lymphoma, Small Non Cleaved Cell|Lymphoma, Intermediate Grade|Lymphoma, Mixed Small and Large Cell, Diffuse|Diffuse Small Cleaved Cell Lymphoma|Mixed Lymphocytic-Histiocytic Lymphoma|Lymphoma, Mixed-Cell|Reticulum Cell Sarcoma|Lymphoma, Nonhodgkins|Reticulum Cell Sarcomas|Lymphosarcomas|Intermediate-Grade Lymphoma|Lymphoma, Small Cleaved Cell, Diffuse|Lymphoma, Small Noncleaved Cell|Diffuse Mixed-Cell Lymphomas|Lymphoma, Small and Large Cleaved-Cell, Diffuse|Sarcoma, Reticulum Cell|Reticulum-Cell Sarcomas|Lymphoma, Small Non-Cleaved-Cell|Lymphoma, Non-Hodgkin, Familial|Lymphoma, Small Noncleaved-Cell|Lymphoma, High-Grade|Small Non-Cleaved-Cell Lymphoma|Mixed Small and Large Cell Lymphoma, Diffuse|Mixed Lymphocytic-Histiocytic Lymphomas|Pleomorphic Lymphoma|High-Grade Lymphoma|Small Non-Cleaved-Cell Lymphomas|Low-Grade Lymphoma|Lymphoma, Non Hodgkin's|Lymphoma, Non-Hodgkins|Sarcoma, Reticulum-Cell|Lymphocytic-Histiocytic Lymphomas, Mixed|Nonhodgkins Lymphoma|Lymphoma, Small Cleaved-Cell, Diffuse|Lymphoma, Mixed Lymphocytic Histiocytic|Diffuse Mixed-Cell Lymphoma|Undifferentiated Lymphomas|Lymphoma, Mixed Cell|Reticulum-Cell Sarcoma|Lymphoma, Mixed Cell, Diffuse|Non Hodgkin Lymphoma|Lymphoma, Diffuse Mixed-Cell|Mixed Cell Lymphoma, Diffuse|Diffuse Small Cleaved-Cell Lymphoma|Lymphosarcoma|Lymphoma, Nonhodgkin|Lymphatic Sarcomas|Lymphoma, Pleomorphic|Small Noncleaved-Cell Lymphoma|Lymphoma, Low-Grade|Diffuse Undifferentiated Lymphomas|Lymphocytic-Histiocytic Lymphoma, Mixed|Small Cleaved-Cell Lymphoma, Diffuse|Lymphoma, High Grade|Noncleaved-Cell Lymphoma, Small"
NEW18972,CHEMICAL,uva light,UVA light
NEW18973,CHEMICAL,Psoralea corylifolia L. seed,Psoralea corylifolia L. seed
NEW18976,BIOCHEMICAL,prenatal vitamin d,Prenatal vitamin D
NEW18978,CHEMICAL,prenatal dexamethasone,Prenatal dexamethasone
NEW18980,BIOCHEMICAL,serum vitamin d level,serum vitamin D level
D004964,CHEMICAL,Estriol,"estriol|Ovestin|16alpha,17beta-Estriol|16alpha,17beta Estriol|16beta Hydroxy Estradiol|16-alpha-Hydroxy-Estradiol|Epiestriol|(16alpha,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol|16beta-Hydroxy-Estradiol|(16beta,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol|Estra-1,3,5(10)-Triene-3,16beta,17beta-Triol|16 alpha Hydroxy Estradiol"
NEW18981,NUTRITION,concurrent lithium therapy,concurrent lithium therapy
NEW18982,MENTAL_HEALTH,refractory early onset schizophrenia,refractory early onset schizophrenia
C500350,CHEMICAL,"N,N'-dibenzoylcystine [Supplementary Concept]",Cystine/analogs  and  derivatives|DBC
D000293,CHEMICAL,Adolescent,"Teen|Youth|Teenagers|Adolescents, Female|Adolescent, Female|Adolescents, Male|Youths|Adolescent, Male|Teens|Teenager|Female Adolescent|Female Adolescents|Male Adolescent|Adolescents|Adolescence|Male Adolescents|ESS-CHAD"
http://purl.obolibrary.org/obo/CHEBI_7494,CHEMICAL,nefazodone,"1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|nefazodona|mirtazapine α2|2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-5-ethyl-4-(2-phenoxyethyl)-2,4-dihydro-3H-1,2,4-triazol-3-one|Nefazodone|nefazodone|nefazodonum"
NEW18988,CHEMICAL,multiple 5-ht receptor,multiple 5-HT receptors
NEW18990,BIOCHEMICAL,dopamine receptor antagonist haloperidol,dopamine receptor antagonist haloperidol
NEW18991,DISEASE,dopamine receptor antagonist haloperidol,catalepsy sensitization
NEW18994,BIOCHEMICAL,new selective norepinephrine reuptake inhibitor,new selective norepinephrine reuptake inhibitor
D013981,DISEASE,Tic Disorders,"Tic Disorder, Post Traumatic|Post-Traumatic Tic Disorders|Tic Disorders, Post-Traumatic|Tic Disorders, Childhood|Transient Tic Disorders|Tic Disorder, Vocal|Chronic Motor or Vocal Tic Disorder|Post-Traumatic Tic Disorder|Tic Disorder, Chronic Motor or Vocal|Vocal Tic Disorder|Tic Disorders, Vocal|Tic Disorder, Post-Traumatic|Motor Tic Disorders|Tic Disorder|Childhood Tic Disorders|motor tic|Tic Disorders, Transient|Tic Disorder, Transient|Motor Tic Disorder|Tic Disorders, Motor|Tic Disorder, Childhood|Motor or Vocal Tic Disorder, Chronic|Childhood Tic Disorder|Vocal Tic Disorders|Transient Tic Disorder|Post Traumatic Tic Disorder|Tic Disorder, Motor"
D004733,CHEMICAL,Enema,Enemata|Enematas|Enemas
D000069462,CHEMICAL,Dimethyl Fumarate,"FAG201|compound, BG12|12 compound, BG|Fumarate, Dimethyl|Dimethylfumarate|BG 12 compound|2-butenedioic acid, (2E)-, dimethyl ester|compound, BG 12|Fumaderm|00012, BG|BG12 compound|BG 00012|201, FAG|BG-00012|BG00012|Tecfidera|FAG-201|FAG 201|BG-12 compound|Dimethyl fumarate"
NEW19000,NUTRITION,aegerita lectin,aegerita lectin
NEW19003,NUTRITION,synthetic calcium phosphate,synthetic calcium phosphates
NEW19005,CHEMICAL,multinuclear three-dimensional solid-state mri,Multinuclear three-dimensional solid-state MRI
NEW19006,MENTAL_HEALTH,three-dimensional projection reconstruction mri,Three-dimensional projection reconstruction MRI
NEW19007,DISEASE,minimal thyroid abnormality,Minimal thyroid abnormalities
NEW19010,CHEMICAL,norepinephrine level,norepinephrine level
NEW00127,CHEMICAL,serotonin synthesis,serotonin synthesis
NEW19014,MENTAL_HEALTH,antibiotic phobia,antibiotic phobia
NEW19015,BIOCHEMICAL,antibiotic intervention mouse,antibiotic intervention mice
NEW19017,DISEASE,bovine mycotoxicosis,Bovine mycotoxicosis
D001906,DISEASE,Botulism,"Botulism|Clostridium botulinum Infections|Wound Botulism|Infant Botulism|Toxico-Infectious Botulism|Botulism, Wound|Botulism, Infantile|Botulism, Toxico-Infectious|Botulism, Infant|Foodborne Botulism|Wound Botulisms|Infantile Botulism|Foodborne Botulisms|Toxico Infectious Botulism|Infant Botulisms|Botulism, Foodborne|Clostridium botulinum Infection|Botulism, Toxico Infectious|Infection, Clostridium botulinum"
NEW19019,DISEASE,persistent dizziness,persistent dizziness
NEW19020,NUTRITION,cholesterol determination,Cholesterol determination
NEW19021,NUTRITION,standard cholesterol,standard cholesterol
NEW19023,NUTRITION,prepare cholesterol biosensor,prepared cholesterol biosensor
NEW19024,CHEMICAL,csa array,CSA array
D016984,CHEMICAL,Enterococcus faecium,Enterococcus faecium|Streptococcus faecium
NEW19026,CHEMICAL,iron deprivation,iron deprivation
NEW19029,CHEMICAL,5-fluorocytosine therapy,5-Fluorocytosine therapy
NEW19030,CHEMICAL,guanine biosynthesis,guanine biosynthesis
NEW19031,CHEMICAL,inosine monophosphate dehydrogenase inhibitor,inosine monophosphate dehydrogenase inhibitor
C402104,CHEMICAL,5-formyl-2'-deoxycytidine [Supplementary Concept],Deoxycytidine/analogs  and  derivatives|5-FC
NEW19033,DISEASE,compulsive behaviour present,Compulsive behaviour present
NEW09302,DISEASE,different psychiatric disorder,different psychiatric disorders
NEW19035,CHEMICAL,mineral bone disorder,MBD|mineral bone disorders
NEW19036,DISEASE,aki mouse,AKI mice
NEW19038,DISEASE,contractile dysfunction,contractile dysfunction
NEW19039,CHEMICAL,ca2 transient,Ca2 transients
NEW19040,DISEASE,tumor necrosis factor (tnf)-α,tumor necrosis factor (TNF)-α
http://purl.obolibrary.org/obo/CHEBI_53576,CHEMICAL,pyrimidine-2-thiol,2-Mercaptopyrimidine|2-Thiopyrimidine|CaNa2 EDTA|pyrimidine-2-thiol|MPY|2-Pyrimidinethiol
NEW19044,BIOCHEMICAL,sympathomimetic stimulant,sympathomimetic stimulants
NEW19046,DISEASE,xp-associated neoplasia,XP-associated neoplasia
NEW19048,DISEASE,ocular surface,ocular surface
NEW19049,MENTAL_HEALTH,transient mental depression,Transient mental depression
D005894,CHEMICAL,Panax,"Korean red ginseng|Ginseng|Korean Red Ginseng|Shinseng|Korean Red Ginsengs|Korean Ginsengs|Schinsengs|Jen Shens|Ninjin|Korean Ginseng|Shinsengs|KRG|Ninjins|Shen, Jen|Ginsengs|Renshens|Schinseng|Red Ginseng, Korean|Renshen|Panax ginseng|Ginseng, Korean|Ginseng, Korean Red|Jen Shen"
NEW19051,CHEMICAL,Viola odorata l,Viola odorata L
NEW19053,CHEMICAL,peroxiproliferator-activated receptor gamma agonist ciglitazone,peroxiproliferator-activated receptor gamma agonist ciglitazone
NEW19055,NUTRITION,brain omega-3 fatty acid concentration,brain omega-3 fatty acid concentrations
NEW19058,DISEASE,ocd dominant patient,OCD dominant patients
D057215,DISEASE,Body Dysmorphic Disorders,"Image Disfunctions, Body|Body Image Disorders|Dysmorphic Disorders, Body|Body Image Disfunction|Disorder, Body Dysmorphic|Disorders, Body Dysmorphic|Body Image Disorder|Disfunction, Body Image|Image Disorders, Body|Disorders, Body Image|Disfunctions, Body Image|Dysmorphic Disorder, Body|Image Disfunction, Body|Body Dysmorphic Disorder|BDD|Body Image Disfunctions|body dysmorphic disorder"
D000073602,BIOCHEMICAL,Antimicrobial Stewardship,"Stewardship, Antimicrobial|Stewardship, Antibiotic|Antibiotic Stewardship|antimicrobial stewardship"
NEW19060,CHEMICAL,4-ethylphenylsulfate,4-ethylphenylsulfate
NEW19064,DISEASE,crf group,CRF group
http://purl.obolibrary.org/obo/SYMP_0000178,DISEASE,weight loss,Epigallocathechin-3-gallate-induced weight loss
D013831,BIOCHEMICAL,Thiamine,"Aneurin|Thiamin|Mononitrate, Thiamine|vitamin B-1|Thiamine Mononitrate|Vitamin B 1|Vitamin B1"
D018651,NUTRITION,Chicory,chicory|Cichorium intybus
NEW05349,BIOCHEMICAL,antiviral treatment,antiviral treatment
NEW19072,DISEASE,antiseizure medication,antiseizure medication
http://purl.obolibrary.org/obo/CHEBI_9937,CHEMICAL,vasopressin,Inyectable de vasopresina|VP|AVP|d(CH2)5Tyr(Me)arginine vasopressin|Antidiuretic hormone|Vasopressini injectio|ADH|argipressin|Vasopressin|beta-Hypophamine|Solute injectable de vasopressine|arginine vasopressin
NEW19074,BIOCHEMICAL,arginine vasopressin antagonist,arginine vasopressin antagonist
NEW19075,CHEMICAL,nmda receptor antagonist amino phosphono valeric acid,NMDA receptor antagonist amino phosphono valeric acid
NEW19076,CHEMICAL,nmda receptor antagonist amino phosphono valeric acid,NMDA receptor ligands
NEW19077,BIOCHEMICAL,drug group,drug groups
C029130,CHEMICAL,nitrogenase reductase [Supplementary Concept],Oxidoreductases|nitrogenase Fe protein
NEW19080,NUTRITION,plasma methionine level,plasma methionine levels
NEW19081,CHEMICAL,plasma homocysteine,plasma homocysteine
NEW19082,CHEMICAL,high intensity ultrasound,high intensity ultrasound|HIU
NEW19086,BIOCHEMICAL,hormone use status,Hormone use status
NEW19088,CHEMICAL,free amino acid level,Free amino acid levels
NEW19091,CHEMICAL,high alanine tyrosine level,higher alanine tyrosine levels
NEW19092,CHEMICAL,high glycine level,higher glycine levels
D058999,DISEASE,Drug-Seeking Behavior,"Drug-seeking behavior|Drug Seeking Behavior|Behaviors, Drug-Seeking|Drug-Seeking Behaviors|Behavior, Drug-Seeking"
http://purl.obolibrary.org/obo/CHEBI_5118,CHEMICAL,fluoxetine,"fluoxetine|(+-)-N-methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine|rac-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine|fluoxetinum|SSRIs fluoxetine|(+-)-N-methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine|fluoxetina|Prozac"
NEW19096,CHEMICAL,imipramine antidepressant,Imipramine antidepressants
NEW19097,DISEASE,oseltamivir-susceptible b/brisbane/60/2008,oseltamivir-susceptible B/Brisbane/60/2008
NEW19099,BIOCHEMICAL,new antimicrobial peptide,new antimicrobial peptide
NEW19101,CHEMICAL,etoh concomitant,EtOH concomitant
NEW19104,CHEMICAL,high dopamine degradation,higher dopamine degradation
D020156,CHEMICAL,Salicylic Acid,"Acid, o-Hydroxybenzoic|ortho Hydroxybenzoic Acid|2 Hydroxybenzoic Acid|2-Hydroxybenzoic Acid|o Hydroxybenzoic Acid|ortho-Hydroxybenzoic Acid|Acid, 2-Hydroxybenzoic|o-Hydroxybenzoic Acid|Acid, ortho-Hydroxybenzoic|salicylic acid|Acid, Salicylic"
NEW17332,BIOCHEMICAL,pantoea ananatis brt175,antibiotic activity
NEW19108,CHEMICAL,lactic acid release,lactic acid release
NEW19109,CHEMICAL,metabolic acid lactic,metabolic acid lactic
NEW19111,DISEASE,sleep dysfunction,sleep dysfunction
NEW19114,CHEMICAL,sleep dysfunction,M3OMG|methyl-3-O-methyl gallate
http://purl.obolibrary.org/obo/CHEBI_69284,CHEMICAL,suvanine,"(E)-{(8alpha,13E,14alpha)-14-[2-(3-Furyl)ethyl]-8-methylpodocarpan-13-ylidene}methyl hydrogen sulfate - 1,1-dimethylguanidine (1:1)|synthetic antidepressants-"
NEW19115,DISEASE,depressed mood-may,depressed mood-may
NEW19119,BIOCHEMICAL,telomerase inhibitor,telomerase inhibitors
NEW19121,CHEMICAL,acetylcholinesterase inhibitor pyridostigmine,acetylcholinesterase inhibitor pyridostigmine
NEW19123,CHEMICAL,cholinergic agent pyridostigmine,cholinergic agent pyridostigmine
C516458,CHEMICAL,isorhamnetin 3-O-rhamnopyranosyl-1-6-glucopyranoside [Supplementary Concept],Disaccharides|Iso|Isorhamnetin|Flavones
http://purl.obolibrary.org/obo/CHEBI_67461,NUTRITION,clerodin,"3-Deoxycaryoptinol|{(1R,4aR,5S,6R,8S,8aR)-8-(acetyloxy)-5,6-dimethyl-5-[(2S,3aS,6aS)-2,3,3a,6a-tetrahydrofuro[2,3-b]furan-2-yl]octahydro-8aH-spiro[naphthalene-1,2'-oxiran]-8a-yl}methyl acetate|eckol-type phlorotannins"
NEW19130,NUTRITION,brown seaweed phlorotannin,brown seaweed phlorotannin
NEW19131,MENTAL_HEALTH,hyperactive delirium,Hyperactive delirium
NEW19132,CHEMICAL,serum glucose level,serum glucose levels
D003022,CHEMICAL,Clotrimazole,FB b 5097|Canesten|clotrimazole|Lotrimin|Bay b 5097|Klotrimazole|Mycelex|Kanesten
NEW19134,CHEMICAL,au year,Au years
NEW19136,CHEMICAL,16:1n7 t,16:1n7 t
NEW19139,NUTRITION,abnormal fatty acid metabolism,abnormal fatty acid metabolism
NEW19143,MENTAL_HEALTH,current apprehension,current apprehension
NEW19144,CHEMICAL,fecal spermidine level,fecal spermidine levels
NEW19146,CHEMICAL,daily spermidine intake,daily spermidine intake
NEW19147,CHEMICAL,spermidine supplementation,Spermidine supplementation
C490486,DISEASE,"NcpI-S protein, T. gondii [Supplementary Concept]",Recombinant Proteins|T. gondii
NEW19151,DISEASE,Most infection,Most infections
C449302,CHEMICAL,GW 6471 [Supplementary Concept],GW6471|Oxazoles|Tyrosine/analogs  and  derivatives
NEW19153,CHEMICAL,l-carnitine supplementation,L-carnitine supplementation
C106641,CHEMICAL,"DEFB4A protein, human [Supplementary Concept]",beta-Defensins|β-defensin
NEW19158,CHEMICAL,-3347,-3347
NEW19160,MENTAL_HEALTH,such differential repression,Such differential repression
NEW19163,CHEMICAL,such differential repression,iron status
NEW19164,CHEMICAL,progestin-only contraceptive,progestin-only contraceptive
NEW19165,CHEMICAL,dha consumption,DHA consumption
NEW19167,CHEMICAL,hif1-α,HIF1-α
NEW19170,MENTAL_HEALTH,plasma agitation,plasma agitation
NEW19174,MENTAL_HEALTH,competitive displacement assay,Competitive displacement assay
NEW19176,DISEASE,alzheimer 's disease-like symptom,Alzheimer's disease-like symptoms
C000711707,BIOCHEMICAL,kappa-opioid agonist JT09 [Supplementary Concept],kappa-opioid agonist|Peptides
NEW19180,BIOCHEMICAL,antimicrobial activity,antimicrobial activities
http://purl.org/sig/ont/fma/fma72655,CHEMICAL,right middle frontal gyrus,MFG|right middle frontal gyrus
D019947,DISEASE,"Receptors, Interleukin-6","IL-6 Receptor|IL 6 Receptor|Interleukin 6 Receptor|IL-6 Receptors|Receptor, Interleukin-6|IL6 Receptors|Interleukin-6 Receptor|IL 6 Receptors|Receptors, IL6|interleukin-6|IL6 Receptor|Receptors, IL-6|Receptor, IL-6|Receptor, IL6|Receptors, Interleukin 6|Interleukin 6 Receptors|Interleukin-6 Receptors|Receptors, IL 6|Receptor, Interleukin 6"
NEW19186,CHEMICAL,fenofibrate treatment,Fenofibrate treatment
NEW19189,CHEMICAL,long-term steroid use,long-term steroid use
http://purl.obolibrary.org/obo/SYMP_0000682,DISEASE,altered mental status,Altered mental status|AMS
NEW19191,BIOCHEMICAL,combined androgen blockade,Combined androgen blockade
NEW19193,CHEMICAL,dopamine type receptor,Dopamine type receptors
NEW19197,DISEASE,aml cell line,AML cell lines
http://purl.obolibrary.org/obo/DOID_809,CHEMICAL,cocaine abuse,METH abuse
NEW15726,DISEASE,berberis aristata dc,testicular toxicity
NEW19200,MENTAL_HEALTH,psychotic mania symptom,Psychotic mania symptoms
NEW19202,DISEASE,diabetic tissue,diabetic tissues
NEW19203,MENTAL_HEALTH,displacement curve,Displacement curves
NEW19204,CHEMICAL,post-burst afterhyperpolarization,AHP|post-burst afterhyperpolarization
NEW19206,MENTAL_HEALTH,Stroke Aphasia Quality,Stroke Aphasia Quality
NEW19207,CHEMICAL,Life-39 scale,Life-39 scale
NEW19208,CHEMICAL,maintenance antidepressant,Maintenance antidepressant
NEW19212,DISEASE,standard candida albicans strain,Standard Candida albicans strains
NEW19214,BIOCHEMICAL,partial μ-opioid receptor agonist buprenorphine,partial μ-opioid receptor agonist buprenorphine
NEW19217,DISEASE,gastric motility,gastric motility
NEW19219,CHEMICAL,dynamic cysteine s-acylation,dynamic cysteine S-acylation
NEW19221,MENTAL_HEALTH,source dissociation,source dissociation
NEW11347,CHEMICAL,receptor content,receptor content|Ro
NEW19223,NUTRITION,unsaturated phosphatidyl choline,unsaturated phosphatidyl cholines
C006065,CHEMICAL,We 201 [Supplementary Concept],lysoPC|1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine|Lysophosphatidylcholines
C000706771,CHEMICAL,levonadifloxacin [Supplementary Concept],Levonadifloxacin|Quinolones|Quinolizines
http://purl.obolibrary.org/obo/NCBITaxon_1502,DISEASE,clostridium perfringens,Clostridium butyricum MIYAIRI
D010890,CHEMICAL,Pirenzepine,"Ulgescum|Pyrenzepine|Dihydrochloride, Pirenzepine|LS-519|Gastrozepin|LS519|Ulcoprotect|Piren Basan|Pirenzepin-Ratiopharm|pirenzepine|Pirenzepine Dihydrochloride|Pirenzepin Ratiopharm|Piren-Basan|Pirenzepin Von Ct|Pirenzepin|Von Ct, Pirenzepin|Gastrotsepin|LS 519|L-S 519"
NEW19229,CHEMICAL,pkr inhibitor c16,PKR inhibitor C16
D000069501,CHEMICAL,Abiraterone Acetate,"abiraterone|Zytiga|17-(3-pyridyl)-5,16-androstadien-3beta-acetate|CB-7630|CB7630|CB 7630"
NEW19232,CHEMICAL,downstream plasma dhea-sulfate level,downstream plasma DHEA-sulfate levels
NEW19234,MENTAL_HEALTH,acute global amnesia,Acute global amnesia
NEW19241,CHEMICAL,5-mthf formulation,5-MTHF formulation
NEW19244,BIOCHEMICAL,adjunctive folinic acid,Adjunctive folinic acid
NEW00831,CHEMICAL,no production,NO production
NEW19245,DISEASE,no production,P. leucopus
NEW19247,NUTRITION,mercury accumulation,Mercury accumulation
NEW16181,MENTAL_HEALTH,superoxide dismutase glutathione s-transferase,defense mechanism
NEW19248,NUTRITION,wild boar liver,wild boar liver
NEW19249,NUTRITION,boar closest,boar closest
NEW19250,CHEMICAL,se concentration,Se concentrations
NEW19253,CHEMICAL,l. plantarum 8p-a3-clr-amx strain,L. plantarum 8p-a3-Clr-Amx strain
NEW19254,CHEMICAL,l. plantarum,L. plantarum
NEW19256,BIOCHEMICAL,correspond antimicrobial drug,corresponding antimicrobial drugs
D050536,CHEMICAL,Glycerol-3-Phosphate Dehydrogenase (NAD+),G3P Dehydrogenase (NAD+)|alpha Glycerol-3-Phosphate Dehydrogenase (NAD+)|Glycerol 3-Phosphate Dehydrogenase (NAD+)|alphaGPDH|glycerol
NEW19258,DISEASE,ovarian membrane,Ovarian membranes
NEW19260,CHEMICAL,borate treatment,borate treatment
NEW19267,CHEMICAL,nmda antagonist-induced model,NMDA antagonist-induced model
NEW19268,DISEASE,so-called parkinson-plus syndrome,so-called Parkinson-plus syndromes
NEW19271,DISEASE,P. maximus,P. maximus
NEW19273,DISEASE,lipid metabolic abnormality,lipid metabolic abnormality
NEW10922,CHEMICAL,co2 fixation,CO2 fixation
NEW19275,CHEMICAL,plasma octanoate,plasma octanoate
NEW19279,CHEMICAL,α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor activation,α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor activations
NEW07176,DISEASE,tissue damage,tissue damage
NEW19282,CHEMICAL,radical scavenger melatonin,radical scavenger melatonin
NEW19283,CHEMICAL,melatonin/memantine combination,melatonin/memantine combination
NEW02366,DISEASE,pcp treatment,PCP treatment
NEW19288,CHEMICAL,i-extract,i-Extract
C030693,CHEMICAL,Ashwagandha [Supplementary Concept],Ashwagandha|Plant Extracts|Withania somnifera
NEW19289,NUTRITION,proanthocyanidin b2,Proanthocyanidin B2
D005911,DISEASE,Gliosis,"Astrocytosis|Glial Scar|Astrocytoses|Glial Scars|Astrogliosis|Scar, Glial|gliosis"
D060387,CHEMICAL,Ascorbate Peroxidases,"Ascorbate Peroxidase|Peroxidase, Ascorbate|Acid Peroxidase, L-Ascorbic|L-Ascorbic Acid Peroxidase|L Ascorbic Acid Peroxidase|Peroxidases, Ascorbate|Peroxidase, L-Ascorbic Acid|ascorbate"
NEW19291,CHEMICAL,functional mthfr snp rs1801133,functional MTHFR SNP rs1801133
NEW19292,BIOCHEMICAL,intelligent premutation carrier,intelligent premutation carriers
D066257,CHEMICAL,Heparin-binding EGF-like Growth Factor,"Short Form HB EGF|Heparin-binding Epidermal Growth Factor-like Growth Factor Precursor Protein|HB-EGF, Short Form|HB EGF|SF HB EGF|HB-EGF|SF HB-EGF|Heparin-binding EGF-like Growth-Factor|HB EGF Precursor|Toxin Receptor, Diphtheria|Toxin Receptors, Diphtheria|Receptor, Diphtheria Toxin|Diphtheria Toxin Receptors|heparin|Short Form HB-EGF|Heparin binding EGF like Growth Factor|Heparin binding Epidermal Growth Factor like Growth Factor Precursor Protein|HB-EGF Precursor|Receptors, Diphtheria Toxin|Diphtheria Toxin Receptor"
C075005,CHEMICAL,"GNLY protein, human [Supplementary Concept]","Antigens, Differentiation, T-Lymphocyte|granulysin"
NEW19296,DISEASE,serious rot disease,serious rot disease
D003130,MENTAL_HEALTH,Combat Disorders,"Combat Neurosis|Shell Shocks|Combat Stress Disorder|Shock, Shell|Combat Disorder|Stress Disorder, Combat|War Neuroses|Stress Disorders, Combat|Disorder, Combat Stress|Neurosis, War|Disorders, Combat Stress|Shocks, Shell|Neuroses, War|War Neurosis|neurosis|Combat Neuroses|Disorder, Combat|Shell Shock|Combat Stress Disorders|Disorders, Combat|Neurosis, Combat|Neuroses, Combat"
D010378,MENTAL_HEALTH,Pedophilia,Pederasties|pedophilia|Pederasty|Pedophilias
D005879,DISEASE,Tourette Syndrome,"Tourette Disorder|Tourette's Syndrome|Tourette Disease|Combined Vocal and Multiple Motor Tic Disorder|Tourettes Syndrome|Multiple Motor and Vocal Tic Disorder, Combined|Chronic Motor and Vocal Tic Disorder|Gilles De La Tourette's Syndrome|Tourette's Disease|Gilles de la Tourette Disorder|Tourette's Disorder|Tourette's syndrome|Gilles de la Tourette's Disease|Tic Disorder, Combined Vocal and Multiple Motor|Tourettes Disease|Syndrome, Tourette|Gilles de la Tourette Syndrome|Combined Multiple Motor and Vocal Tic Disorder|Tourettes Disorder"
NEW19299,DISEASE,cognition decline,cognition decline
NEW19300,CHEMICAL,acei,ACEI
D000077204,CHEMICAL,Temozolomide,"Methazolastone|TMZA-HE|Temodar|TMZ Bioshuttle|M and B 39831|NSC 362856|Temozolomide Hexyl Ester|CCRG 81045|NSC362856|CCRG81045|NSC-362856|M and B-39831|8-Carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one|Temodal|CCRG-81045|M and B39831|Temozolomide|TMZ-Bioshuttle"
NEW19304,CHEMICAL,dopamine type agonist,Dopamine type agonists
NEW19305,NUTRITION,generalize insect herbivore,generalized insect herbivores
NEW19307,NUTRITION,wild parsnip plant,Wild parsnip plants
NEW19309,CHEMICAL,monoamine serotonin,monoamines serotonin
NEW19310,CHEMICAL,epidermal growth factor receptor egfr tyrosine kinase inhibitor osimertinib,epidermal growth factor receptor EGFR tyrosine kinase inhibitor osimertinib
NEW19313,DISEASE,ra receptor,RA receptors
NEW19314,MENTAL_HEALTH,genetic repression,genetic repression
NEW19316,BIOCHEMICAL,niacin sensitivity,niacin sensitivity
NEW19317,CHEMICAL,m1r/m4r agonist xanomeline,M1R/M4R agonist xanomeline
D016488,NUTRITION,"Medicine, African Traditional","Witch Doctors, African|Medicine, Traditional African|African Witch Doctor|Doctors, African Witch|Doctor, African Witch|witch|African Witch Doctors|African Traditional Medicine|Traditional African Medicine|African Medicine|Traditional Medicine, African|Medicine, African|Witch Doctor, African|African Medicine, Traditional"
NEW19319,DISEASE,mc38 tumor,MC38 tumor
NEW19320,DISEASE,private psychiatric patient,private psychiatric patients
NEW19321,CHEMICAL,high serum homocysteine,Higher serum homocysteine
NEW19322,DISEASE,serotonergic overstimulation,serotonergic overstimulation
NEW19324,CHEMICAL,sb exposure,Sb exposure
NEW19326,BIOCHEMICAL,rat poison,rat poison
NEW19328,BIOCHEMICAL,unexpected drug finding,unexpected drug findings
NEW19329,CHEMICAL,[3h]batrachotoxin,[3H]batrachotoxin
D016907,BIOCHEMICAL,Adverse Drug Reaction Reporting Systems,"Adverse Drug Reaction Reporting System|Drug Reaction Reporting Systems, Adverse|adverse drug reaction"
NEW19331,BIOCHEMICAL,folic acid trial,folic acid trials
NEW19333,DISEASE,increase cognitive impairment,increased cognitive impairment
NEW19335,DISEASE,v. cholerae o395,V. cholerae O395
NEW19337,CHEMICAL,defensin gene cluster,defensin gene cluster
NEW19340,CHEMICAL,chronic intrathecal baclofen therapy,Chronic intrathecal baclofen therapy
NEW19341,CHEMICAL,sterilized pei microparticle,Sterilized PEI microparticles
D013971,DISEASE,Thyrotoxicosis,Thyrotoxicosis|Thyrotoxicoses
NEW19343,DISEASE,thyrotoxicosis case,thyrotoxicosis cases
NEW19344,CHEMICAL,thalidomide gavage,Thalidomide gavage
D000077269,CHEMICAL,Lenalidomide,"CC 5013|lenalidomide|3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione|CC-5013|Revlimid|2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H- isoindol-2-yl)-|Revimid|IMiD3 Cpd|CC5013"
D014908,NUTRITION,Triticum,"Wheat Triticum|Triticum durum|Triticum turgidum subsp. durum|Durum Wheat|Durum Wheats|Wheat, Durum|Triticum turgidum|Triticum spelta|Triticum aestivum|Triticum vulgare|Wheat"
NEW19348,CHEMICAL,carrot Daucus carota L.,carrots Daucus carota L.
NEW19349,CHEMICAL,tagetes patula L.,Tagetes patula L.
NEW19350,CHEMICAL,ceramide metabolism,ceramide metabolism
NEW19352,CHEMICAL,unsolved amyloid fibril,unsolved amyloid fibril
NEW19354,MENTAL_HEALTH,high resistance level,highest resistance levels
NEW19355,BIOCHEMICAL,important antimicrobial,important antimicrobials
NEW19357,CHEMICAL,amphetamine-induced li disruption,Amphetamine-induced LI disruption
NEW19358,DISEASE,scopolamine-induced li disruption,Scopolamine-induced LI disruption
NEW19359,DISEASE,cholinergic-related positive symptom,cholinergic-related positive symptoms
NEW19360,CHEMICAL,antidepressant medication,antidepressants medication
NEW03523,CHEMICAL,tumor necrosis factor tnf antagonist infliximab,antidepressant response
NEW19364,CHEMICAL,oxygen molecule,oxygen molecules|oxygen transport parameter
NEW19366,CHEMICAL,all-trans isomer,all-trans isomer
NEW19368,NUTRITION,zeaxanthin similar,zeaxanthin similar
NEW19370,CHEMICAL,zeaxanthin-dppc monolayer,zeaxanthin-DPPC monolayers
NEW19372,CHEMICAL,repeat corticosterone injection,repeated corticosterone injections
NEW19374,BIOCHEMICAL,lactogenic hormone,lactogenic hormones
NEW19376,MENTAL_HEALTH,peripheral insulin resistance,peripheral insulin resistance
NEW19378,BIOCHEMICAL,transdermal estrogen,Transdermal estrogens
NEW19381,BIOCHEMICAL,b vitamin requirement,B vitamin requirements
NEW19386,CHEMICAL,selenium only group,selenium only group
http://purl.obolibrary.org/obo/DOID_679,DISEASE,basal ganglia disease,Biotin-thiamine-responsive basal ganglia disease
D000068437,CHEMICAL,Pemetrexed,"LY-231514|MTA|N-(4-(2-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid|LY231514|LY 231,514|231,514, LY|LY 231514|Pemetrexed Disodium|LY-231,514|231514, LY|Pemetrexed|Disodium, Pemetrexed|Alimta"
D009888,CHEMICAL,Opipramol,"Opipramol Hydrochloride|Insidon|Hydrochloride, Opipramol|Opipramol"
NEW19393,CHEMICAL,saccharin exposure,saccharin exposure
NEW19395,CHEMICAL,stimulant drug methylphenidate,stimulant drug methylphenidate
NEW19397,BIOCHEMICAL,sweetener intake,sweetener intake
NEW19398,DISEASE,cortical eeg hyperarousal,cortical EEG hyperarousal
NEW19400,DISEASE,cardiotoxic agent due,cardiotoxic agents due
C031626,CHEMICAL,ribose-5-phosphate [Supplementary Concept],Ribosemonophosphates|D-ribose
D042963,CHEMICAL,Electron Transport Complex II,"coenzyme-Q|Succinate Dehydrogenase-Coenzyme Q Reductase|Reductase, Succinate Dehydrogenase-CoQ|Dehydrogenase-CoQ Reductase, Succinate|Succinate-Ubiquinone Oxidoreductase|Succinate Ubiquinone Oxidoreductase|Succinate-Coenzyme Q Reductase|Succinate-Quinone Oxidoreductase|Succinate Quinone Oxidoreductase|Succinate Coenzyme Q Reductase|Succinate Dehydrogenase Coenzyme Q Reductase|Succinate Dehydrogenase CoQ Reductase|Succinate-Q Oxidoreductase|Succinate-Ubiquinone Reductase|Succinate Dehydrogenase-CoQ Reductase|Succinate Dehydrogenase (Ubiquinone)|Succinate Q Oxidoreductase|Oxidoreductase, Succinate-Quinone|Oxidoreductase, Succinate-Ubiquinone|Succinate Ubiquinone Reductase|Oxidoreductase, Succinate-Q"
D020195,DISEASE,"Epilepsy, Reflex","Eating Induced Epilepsy|Eating-Induced Epilepsy|Reflex Epilepsy, Audiogenic|Photosensitive Epilepsy|Reflex Epilepsy, Photosensitive|Epilepsies, Immersion Related|Epilepsies, Photosensitive Reflex|Reflex Epilepsies, Reading|Epilepsies, Photosensitive|Epilepsies, Eating-Induced Reflex|Reflex Epilepsies, Tactile|Reflex Epilepsy, Musicogenic|Epilepsy, Eating-Induced|Musicogenic Epilepsy|Immersion Related Epilepsy|Musicogenic Epilepsies|Tactile Reflex Epilepsies|Epilepsies, Reading|Epilepsy, Audiogenic Reflex|Immersion Related Epilepsies|Photosensitive Reflex Epilepsy|Reflex Epilepsy, Cursive (Running)|Reading Epilepsies|Reading Reflex Epilepsy|Reflex Epilepsies, Cursive (Running)|Epilepsies, Eating-Induced|Epilepsy, Reading Reflex|Reading Reflex Epilepsies|Cursive Reflex Epilepsies (Running)|Audiogenic Epilepsy|Reflex Epilepsies, Photosensitive|Reading Epilepsy|Cursive Epilepsy|Reflex Epilepsy, Tactile|Writing Induced Reflex Epilepsy|Eating-Induced Reflex Epilepsy|Epilepsy, Reading|Reflex Epilepsy|Reflex Epilepsies|Epilepsies, Reflex|Reflex Epilepsy, Visual Pattern|Reflex Epilepsy, Eating-Induced|Epilepsy, Eating-Induced Reflex|Epilepsy, Writing-Induced Reflex|reflex epilepsy|Audiogenic Epilepsies|Reflex Epilepsies, Eating-Induced|Epilepsy, Cursive|Reflex Epilepsy, Eating Induced|Tactile Reflex Epilepsy|Epilepsy, Photogenic|Epilepsies, Musicogenic|Epilepsy, Musicogenic|Decision Making Reflex Epilepsy|Epilepsies, Musicogenic Reflex|Epilepsies, Reading Reflex|Reflex Epilepsy, Reading|Epilepsy, Immersion Related|Epilepsy, Musicogenic Reflex|Epilepsies, Cursive|Writing-Induced Reflex Epilepsies|Musicogenic Reflex Epilepsy|Epilepsies, Tactile Reflex|Reflex Epilepsies, Musicogenic|Photosensitive Reflex Epilepsies|Audiogenic Reflex Epilepsy|Reflex Epilepsy, Writing-Induced|Photosensitive Epilepsies|Epilepsies, Writing-Induced Reflex|Epilepsy, Photosensitive Reflex|Reflex Epilepsies, Audiogenic|Epilepsy, Cursive Reflex (Running)|Musicogenic Reflex Epilepsies|Epilepsy, Tactile Reflex|Visual Pattern Reflex Epilepsy|Reflex Epilepsies, Writing-Induced|Epilepsy, Photosensitive|Cursive Reflex Epilepsy (Running)|Audiogenic Reflex Epilepsies|Writing-Induced Reflex Epilepsy|Eating-Induced Reflex Epilepsies|Epilepsy, Audiogenic|Eating-Induced Epilepsies|Epilepsies, Audiogenic Reflex"
NEW19407,DISEASE,epetraborole,EPT|epetraborole
C045571,CHEMICAL,cyclosporin G [Supplementary Concept],norvaline|Cyclosporine
NEW19412,CHEMICAL,asparate-314,asparate-314
NEW19413,CHEMICAL,cleavage-resistant d314e mutant,cleavage-resistant D314E mutant
NEW19419,CHEMICAL,first paclitaxel injection,first paclitaxel injection
D000069604,CHEMICAL,Dabigatran,"BIBR 1048|Mesylate, Dabigatran Etexilate|N-((2-(((4-(aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)-N-2-pyridinyl-beta-alanine|Dabigatran Etexilate Mesylate|Etexilate Mesylate, Dabigatran|Dabigatran Etexilate|dabigatran|Etexilate, Dabigatran|Pradaxa"
NEW07535,DISEASE,non-vitamin k antagonist oral anticoagulant,systemic embolism
NEW19423,DISEASE,dabigatran-induced anticoagulation,dabigatran-induced anticoagulation
C000594745,CHEMICAL,idarucizumab [Supplementary Concept],"Antibodies, Monoclonal, Humanized|idarucizumab"
NEW19425,CHEMICAL,unlabeled conantokin-g,unlabeled conantokin-G
NEW19427,BIOCHEMICAL,n-methyl-d-aspartate receptor agonist binding site,N-methyl-D-aspartate receptor agonist binding site
NEW19428,CHEMICAL,n-methyl-d-aspartate receptor agonist binding site,polyamine modulatory site
NEW19431,CHEMICAL,oxygen generation datum,oxygen generation data
NEW19432,MENTAL_HEALTH,compulsion zone,compulsion zone
D019957,MENTAL_HEALTH,Motor Skills Disorders,"Developmental Coordination Disorder|Coordination Disorder, Developmental|Developmental Coordination Disorders|developmental coordination disorder|Motor Skills Disorder"
NEW19436,NUTRITION,membrane phospholipid metabolism,membrane phospholipid metabolism
http://purl.obolibrary.org/obo/SYMP_0000293,DISEASE,hemiparesis,hemichorea
NEW05540,BIOCHEMICAL,drug action,drug action
NEW19442,CHEMICAL,2-deoxyglucose metabolic mapping technique,2-deoxyglucose metabolic mapping technique
NEW19444,CHEMICAL,escitalopram treatment,escitalopram treatment
C065533,CHEMICAL,perospirone [Supplementary Concept],Thiazoles|perospirone|Isoindoles
C001945,DISEASE,syringic acid [Supplementary Concept],Gallic Acid/analogs  and  derivatives|SA|Syringic acid
NEW19449,DISEASE,neurological complication,Neurological complications
NEW19451,DISEASE,Chen Tea,Chen Tea
NEW19452,CHEMICAL,chinese green tea,Chinese green tea
NEW19454,BIOCHEMICAL,natural delta-tocotrienol,natural delta-tocotrienol
C005023,CHEMICAL,fulvic acid [Supplementary Concept],Benzopyrans|Fulvic acid
D029503,DISEASE,"Anemia, Diamond-Blackfan","Red Cell Aplasia, Pure, Hereditary|hypoplastic anemia|Inherited Erythroblastopenia|Congenital Anemias, Hypoplastic|Anemia, Hypoplastic Congenital|Hypoplastic Congenital Anemias|Chronic Congenital Agenerative Anemia|Erythroblastopenias, Inherited|Erythroblastopenia, Inherited|Anemias, Hypoplastic Congenital|Erythrogenesis Imperfectas|Hypoplastic Congenital Anemia|Anemia, Diamond Blackfan Type|Congenital Hypoplastic Anemia of Blackfan and Diamond|Congenital Anemia, Hypoplastic|Blackfan-Diamond Disease|Congenital Pure Red Cell Aplasia|Imperfecta, Erythrogenesis|Blackfan Diamond Disease|Anemia, Diamond-Blackfan Type|Congenital Erythroid Hypoplastic Anemia|Disease, Blackfan-Diamond|Congenital Pure Red Cell Anemia|Pure Hereditary Red Cell Aplasia|Diamond Blackfan Anemia|Inherited Erythroblastopenias|Anemia, Diamond Blackfan|Blackfan-Diamond Syndrome|Imperfectas, Erythrogenesis|Diamond-Blackfan Type Anemia|Anemia, Blackfan Diamond|Blackfan Diamond Syndrome|Erythrogenesis Imperfecta|Blackfan Diamond Anemia|Diamond-Blackfan Anemia|Anemia, Congenital Hypoplastic, Of Blackfan And Diamond|Diamond Anemia, Blackfan"
NEW19460,CHEMICAL,imipramine treatment,imipramine treatment
D000493,CHEMICAL,Allopurinol,Apurin|Pureduct|Novopurol|Jenapurinol|Zygout|Uripurinol|Purinol|Urosin|Progout|Allohexan|Suspendol|Xanturic|Lysuron|Tipuric|Roucol|Uridocid|Pan Quimica|Caplenal|Zyloric|Urtias|Lopurin|Rimapurinol|Cellidrin|Hamarin|Remid|Allural|Zyloprim|Allpargin|Allopurin|Xanthomax|allopurinol|Milurite|Atisuril|Alloprin|Uribenz|Embarin|Allohexal|Allorin|Capurate|Milurit|Bleminol|Foligan|Apulonga
D014292,CHEMICAL,Trimetazidine,"Vastarel|Trimétazidine Irex|Dihydrochloride, Trimetazidine|Trimetazidine Dihydrochloride|Idaptan|Centrophène|Trimetazidine|Vasartel"
C039984,CHEMICAL,Bretschneider cardioplegic solution [Supplementary Concept],Potassium Chloride|Histidine-tryptophan-ketoglutarate|Mannitol|Glucose|Procaine
NEW19464,CHEMICAL,popular phytochemical-rich beverage,popular phytochemical-rich beverage
NEW19468,DISEASE,5-fu-sensitive ht29 colorectal cancer cell,5-FU-sensitive HT29 colorectal cancer cells
NEW19470,CHEMICAL,yap/rar-rxr cross-talk,YAP/RAR-RXR cross-talk
NEW19472,DISEASE,colorectal cancer cell,colorectal cancer cells
NEW19475,DISEASE,various human disease,various human diseases
NEW19476,MENTAL_HEALTH,syndrome ds risk,syndrome DS risk
NEW19478,CHEMICAL,folate-homocysteine metabolic pathway gene polymorphism,folate-homocysteine metabolic pathway gene polymorphism
NEW19479,NUTRITION,maternal choline supplementation,Maternal choline supplementation
C480398,CHEMICAL,atraric acid [Supplementary Concept],Hydroxybenzoates|Atraric acid
http://purl.obolibrary.org/obo/DOID_1612,DISEASE,breast cancer,malignant tumor of the breast|breast tumor|mammary neoplasm|mammary tumor|mammary cancer|primary breast cancer|breast cancer tumors|malignant neoplasm of breast
NEW19484,CHEMICAL,dopamine loss,Dopamine loss
NEW19487,CHEMICAL,da input,DA inputs
NEW19489,CHEMICAL,new-generation antidepressant,New-generation antidepressants
NEW19490,CHEMICAL,adjunctive n-acetylcysteine,adjunctive N-acetylcysteine
NEW19491,DISEASE,cdg treatment,CDG treatment
NEW19494,CHEMICAL,polyphenol dhc,polyphenol DHC
NEW19496,CHEMICAL,dxa/piximus,Dxa/Piximus
NEW19502,CHEMICAL,dopamine replacement approach,dopamine replacement approach
NEW19503,DISEASE,dui substitution,DUI substitution
NEW19504,DISEASE,hypoxia group,hypoxia group
NEW19506,CHEMICAL,xenon treatment,xenon treatment
NEW19509,CHEMICAL,memantine treatment model,memantine treatment models
http://purl.obolibrary.org/obo/CHEBI_82784,CHEMICAL,pvp38-ag np,polyvinylpyrrolidone (38 nm) coated-Ag nanoparticle|polyvinylpyrrolidone (38 nm) coated-Ag nanoparticles|Cu2-x S@Ru NPs|PVP38-Ag NPs
D050858,CHEMICAL,Betalains,Betalains|Betalain Pigments|Betalain
NEW19513,BIOCHEMICAL,kappa opiate agonist,kappa opiate agonists
NEW19515,CHEMICAL,sibulelo,Sibulelo
NEW19517,MENTAL_HEALTH,mixed mania,mixed mania
C103016,CHEMICAL,antalarmin [Supplementary Concept],Pyrimidines|antalarmin|Pyrroles
NEW19519,BIOCHEMICAL,act crf antagonist,acting CRF antagonist
NEW19521,CHEMICAL,levodopa treatment,Levodopa treatment
C000629164,CHEMICAL,"Htr1a protein, mouse [Supplementary Concept]","serotonin receptor 1A|Receptor, Serotonin, 5-HT1A"
NEW19523,BIOCHEMICAL,azole antifungal,Azole antifungals
D001393,CHEMICAL,Azoles,Azole|azoles
NEW19526,BIOCHEMICAL,folate supplement,Folate supplements
D010301,DISEASE,"Parkinson Disease, Postencephalitic","Postencephalitic Parkinson Disease|Parkinson Disease, Post Encephalitic|Parkinsonian Syndrome, Postencephalitis|Economo-Type Parkinsonism, Postencephalitic|Encephalitis Lethargica Type Parkinsonism|parkinsonian syndrome|Parkinsonism, Postencephalitic Economo-Type|Meningoencephalitic Parkinsonism, Viral|Parkinsonisms, Viral Meningoencephalitic|Viral Meningoencephalitic Parkinsonism|Parkinsonism, Postencephalitic|Parkinson Disease, Post-Encephalitic|Parkinsonism, Viral Meningoencephalitic|Post-Encephalitic Parkinson Disease|von Economo Encephalitis Type Parkinsonism|Post Encephalitic Parkinson Disease|Postencephalitic Economo-Type Parkinsonism|Postencephalitic Economo Type Parkinsonism|Postencephalitic Parkinsonism|Postencephalitis Parkinsonian Syndrome"
NEW19528,CHEMICAL,mets component,MetS components
NEW19529,MENTAL_HEALTH,multivariable regression model,Multivariable regression model
NEW19530,CHEMICAL,SNP rs3776362,SNP rs3776362
NEW13811,MENTAL_HEALTH,moderate depression,moderate depression
D061217,DISEASE,Weight Reduction Programs,"Weight reduction|Reduction Program, Weight|Weight Loss Programs|Programs, Weight Loss|Loss Program, Weight|Program, Weight Loss|Weight Loss Program|Program, Weight Reduction|Weight Reduction Program|Programs, Weight Reduction|Reduction Programs, Weight|Loss Programs, Weight"
NEW19533,DISEASE,marmoset wasting syndrome,Marmoset wasting syndrome|MWS
NEW19535,DISEASE,dyt1 early-onset primary dystonia,DYT1 early-onset primary dystonia
NEW19537,CHEMICAL,small molecule 4-phenylbutyrate,4-PBA|small molecule 4-phenylbutyrate
D016881,DISEASE,Microsporidiosis,"Infection, Microspora|Microsporidioses|Microspora Infection|Infections, Microspora|Microspora Infections|Infections, Microsporidia|microsporidiosis|Infection, Microsporidia|Microsporidia Infections|Microsporidia Infection"
D015766,CHEMICAL,Albendazole,"albendazole|Metiazol|Lurdex|Digezanol|Zentel|Albendoral|Monohydrochloride, Albendazole|Albendazole Monohydrochloride|Disthelm|Mediamix V Disthelm|SK and F-62979|SK and F 62979|SKF-62979|Gascop|SKF62979|Valbazen|Bendapar|Bilutac|Eskazole|SKF 62979|Andazol|Albenza|SK and F62979|Endoplus"
D020192,DISEASE,Lafora Disease,"Lafora Body Disease|Lafora disease|Lafora Type Progressive Myoclonic Epilepsy|Lafora Progressive Myoclonic Epilepsy|Epilepsy Progressive Myoclonic 2|Lafora Body Disease, Late Onset|Progressive Myoclonic Epilepsy, Lafora|Myoclonic Epilepsy of Lafora|Progressive Myoclonic Epilepsy, Lafora Type|Lafora Progressive Myoclonus Epilepsy|Lafora Myoclonic Epilepsy|Epilepsy, Progressive Myoclonic 2A|Late Onset Lafora Body Disease|Progressive Myoclonic Epilepsy Type 2|Progressive Myoclonus Epilepsy, Lafora Type|Lafora Body Disorder|Epilepsy, Progressive Myoclonic, Lafora|Lafora-Body Disease, Late Onset"
NEW19546,BIOCHEMICAL,major analgesic effect,major analgesic effect
NEW19547,DISEASE,mild hypercortisolism,Mild hypercortisolism
NEW19549,CHEMICAL,late-night salivary cortisol,late-night salivary cortisol
NEW19551,CHEMICAL,24-h urinary free cortisol,24-h urinary free cortisol
NEW19555,DISEASE,neurotoxic side-effect,Neurotoxic side-effects
NEW19556,DISEASE,tuberculosis chemotherapy,tuberculosis chemotherapy
NEW19557,DISEASE,postinfective IBS,Postinfective IBS
C538206,DISEASE,Deal Barratt Dillon syndrome [Supplementary Concept],Jaundice|diarrhoea|Congenital Abnormalities|Fanconi Syndrome|Ichthyosis
C000628501,CHEMICAL,"HTR2B protein, human [Supplementary Concept]","Receptor, Serotonin, 5-HT2B|serotonin receptor 2B"
NEW19561,CHEMICAL,tph2 gene,TPH2 gene
NEW19564,NUTRITION,strawberry packaging,strawberry packaging
NEW19566,CHEMICAL,combined estrogen/progestogen therapy,Combined estrogen/progestogen therapy
NEW19567,DISEASE,moderate-to-severe dysmenorrhea,moderate-to-severe dysmenorrhea
NEW19569,CHEMICAL,n-6:n-3 ratio,n-6:n-3 ratio
NEW19572,MENTAL_HEALTH,general anxiety,general anxiety
D010653,CHEMICAL,Phenylbutazone,Butapyrazole|Butadion|Butacote|Butapirazol|Diphenylbutazone|Fenilbutazon|Butazolidin|Phenylbutazone|Butadione
NEW19574,CHEMICAL,first modern antidepressant,first modern antidepressant
NEW19578,DISEASE,dukes c colon carcinoma,Dukes C colon carcinoma
NEW19581,CHEMICAL,circulate gonadal steroid,circulating gonadal steroids
NEW19583,NUTRITION,reduce gonadal steroid hormone concentration,reduced gonadal steroid hormone concentrations
NEW19585,DISEASE,atypical partial lipodystrophy,atypical partial lipodystrophy
NEW19586,CHEMICAL,low dose morphine,low dose morphine
NEW11567,CHEMICAL,morphine tolerance,morphine tolerance
D015289,CHEMICAL,Leukotrienes,Leukotriene|leukotrienes
NEW19588,MENTAL_HEALTH,headache pain,headache pain
NEW19590,CHEMICAL,g14f mutant peptide,G14F mutant peptide
D003681,DISEASE,Dehydration,"dehydration|Water Stress|Stress, Water"
D006955,DISEASE,Hypernatremia,Hypernatremias|hypernatremia
C029311,CHEMICAL,serum sodium transport inhibitor [Supplementary Concept],serum sodium|Peptides
NEW19595,CHEMICAL,extracellular neuroactive amino acid,extracellular neuroactive amino acids
C586842,CHEMICAL,((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine [Supplementary Concept],Oliceridine|Thiophenes|Spiro Compounds
D000069058,CHEMICAL,Vardenafil Dihydrochloride,"1-(((3-(3,4-dihydro-5-methyl)-4-oxo-7-propylimidazo(5,1-f)-as-triazin-2-yl)-4-ethoxyphenyl)sulfonyl)-4-ethylpiperazine|Vardenafil hydrochloride|Dihydrochloride, Vardenafil|Levitra|Trihydrate, Vardenafil Hydrochloride|Vardenafil Hydrochloride|Hydrochloride, Vardenafil|Vardenafil Hydrochloride Anhydrous|Anhydrous, Vardenafil Hydrochloride|Vardenafil|Vardenafil Hydrochloride Trihydrate|Hydrochloride Trihydrate, Vardenafil|Hydrochloride Anhydrous, Vardenafil"
C080598,CHEMICAL,dapoxetine [Supplementary Concept],Naphthalenes|Dapoxetine hydrochloride|Benzylamines
C043482,CHEMICAL,moxonidine [Supplementary Concept],Moxonidine|Imidazoles
NEW10075,MENTAL_HEALTH,"unlabelled 1,25(oh)2d3",apparent dissociation constant
NEW19600,MENTAL_HEALTH,pregnancy-induced analgesia,Pregnancy-induced analgesia
NEW19601,CHEMICAL,high estradiol high progesterone state indicative,high estradiol high progesterone state indicative
NEW19602,DISEASE,high estradiol high progesterone state indicative,pain experience
NEW19603,CHEMICAL,high progesterone level,high progesterone levels
C580335,DISEASE,Nonsyndromic Holoprosencephaly [Supplementary Concept],Holoprosencephaly|non-syndromic
NEW19606,CHEMICAL,previous oc,Previous OC
C536215,DISEASE,Pediatric Crohn's disease [Supplementary Concept],Crohn Disease|Crohn's disease
NEW19608,DISEASE,pandemic due sars-cov-2 infection,pandemic due SARS-CoV-2 infection
NEW19610,DISEASE,traumatic memory formation,traumatic memory formation
http://purl.obolibrary.org/obo/DOID_0111860,CHEMICAL,amme complex,chromosome Xq22.3 telomeric deletion syndrome|Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome|Ca(2+)-catecholate complexes|ATS-MR|AMME syndrome
http://purl.obolibrary.org/obo/CHEBI_60272,CHEMICAL,aluminium ion,aluminum ion|aluminum ions
NEW19613,CHEMICAL,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor,Alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors
NEW19615,CHEMICAL,intra-nac injection,intra-NAc injection
http://purl.obolibrary.org/obo/MFOMD_0000212,MENTAL_HEALTH,derailment,derailment
NEW19618,CHEMICAL,mg ha-1,Mg ha-1
NEW19619,DISEASE,mg ha-1,ha-1 poultry manure
NEW19620,CHEMICAL,npk fertilizer biochar manure,NPK fertilizer biochar manure
NEW19623,CHEMICAL,npk fertilizer,NPK fertilizer
NEW19624,CHEMICAL,biochar manure,biochar manure
NEW08325,DISEASE,stress-induced corticosterone,pain due to chemotherapy-induced peripheral neuropathy|CIPN
NEW19627,DISEASE,oxaliplatin-induced mechanical allodynia,oxaliplatin-induced mechanical allodynia
NEW19629,BIOCHEMICAL,orexin type-1 receptor agonist,Orexin type-1 receptor agonists
NEW14230,CHEMICAL,morphine-dependent mouse,morphine-dependent mice
NEW19634,DISEASE,percent weight loss,percent weight loss
NEW19635,BIOCHEMICAL,current gaba agonist therapy,current GABA agonist therapies
NEW19636,DISEASE,other metabolic disturbance,Other metabolic disturbances
NEW19637,BIOCHEMICAL,low affinity nmda receptor antagonist,low affinity NMDA receptor antagonists
NEW19638,NUTRITION,long chain omega-3 fatty acid,long chain omega-3 fatty acids
NEW19639,CHEMICAL,w-3 pufa intake,w-3 PUFA intake
NEW19640,CHEMICAL,Cil/Val,Cil/Val
NEW19642,BIOCHEMICAL,sympatholytic action,sympatholytic actions
NEW19644,BIOCHEMICAL,female sex hormone cycle,female sex hormone cycle
NEW19645,CHEMICAL,hormone-based contraceptive,Hormone-based contraceptives
NEW19646,CHEMICAL,progestin-only contraceptive,progestin-only contraceptives
D010002,DISEASE,Osteitis Fibrosa Cystica,"Recklinghausens Disease, Bone|Recklinghausen Disease, Bone|Recklinghausen Disease of Bone|Osteitis|Recklinghausen's Disease of Bone"
NEW19647,BIOCHEMICAL,pyridoxine nutritional status,Pyridoxine nutritional status
NEW19648,BIOCHEMICAL,high-dose pyridoxine,high-dose pyridoxine
NEW19650,CHEMICAL,vaginal progesterone,vaginal progesterone
NEW19653,CHEMICAL,bacterial endotoxin lipopolysaccharide,bacterial endotoxin lipopolysaccharide
C006018,CHEMICAL,RC-12 [Supplementary Concept],Ethylenediamines|RC-12
NEW04095,CHEMICAL,acute ethanol exposure,acute ethanol exposure
NEW19656,CHEMICAL,embryonic ethanol exposure,embryonic ethanol exposure
NEW19658,CHEMICAL,sag treatment,SAG treatment
NEW19661,CHEMICAL,combined ethanol exposure,combined ethanol exposure
NEW19664,CHEMICAL,target folic acid-conjugated oxidize mesoporous carbon nanosphere,targeted folic acid-conjugated oxidized mesoporous carbon nanospheres
NEW19667,CHEMICAL,chronic glu output,chronic GLU output
NEW19668,CHEMICAL,potentiate cortical/limbic cstc subcircuit afferent,potentiated cortical/limbic CSTC subcircuit afferents
NEW19669,CHEMICAL,mouse 's chronic glu-excited str,mice's chronic GLU-excited STR
D066328,CHEMICAL,Ventral Striatum,"striatum|Striatum, Ventral|STR"
NEW19673,DISEASE,ocd-like mouse,OCD-like mice
NEW19676,CHEMICAL,cortical-limbic Neuron neuronal circuit model,Cortical-limbic Neuron neuronal circuit model
NEW19682,CHEMICAL,antidepressant psychoactive drug,antidepressant psychoactive drugs
NEW19684,DISEASE,combined disorder,combined disorder
NEW19685,CHEMICAL,casein kinase i epsilon,CKIepsilon|casein kinase I epsilon
D020918,DISEASE,Complex Regional Pain Syndromes,"CRPS (Complex Regional Pain Syndromes)|pain syndromes|Complex Regional Pain Syndrome|Pain Syndromes, Regional Complex"
NEW19690,DISEASE,adenomatous polyposis coli apc gene,adenomatous polyposis coli APC gene
NEW19695,MENTAL_HEALTH,fast dissociation,Fast dissociation
D012997,CHEMICAL,Solvents,Solvent|solvents
NEW19701,CHEMICAL,nmdar memantine-as,NMDARs memantine-as
NEW19703,NUTRITION,red wheat bran,red wheat bran
NEW19707,MENTAL_HEALTH,phs resistance,PHS resistance
C417722,CHEMICAL,"SNP protein, lizard [Supplementary Concept]",SNP|SNP-222|Nuclear Proteins|Reptilian Proteins
NEW19711,CHEMICAL,entacapone addition,entacapone addition
D002800,CHEMICAL,Cholinesterase Inhibitors,"Anti Cholinesterases|Agent, Anticholinesterase|Anti Cholinesterase|Acetylcholinesterase inhibitors|Anti-Cholinesterases|Drugs, Anticholinesterase|Cholinesterase Inhibitors, Irreversible|AChEIs|Drug, Anticholinesterase|Acetylcholinesterase Inhibitor|Anticholinesterase Drug|Anti-Cholinesterase|Anticholinesterase Agent|Inhibitors, Cholinesterase|Inhibitors, Acetylcholinesterase|Inhibitors, Reversible Cholinesterase|Anticholinesterases|Cholinesterase Inhibitors, Reversible|Irreversible Cholinesterase Inhibitors|Anticholinesterase Drugs|Cholinesterase Inhibitor|Agents, Anticholinesterase|Anticholinesterase|Inhibitors, Irreversible Cholinesterase|Inhibitor, Cholinesterase|Anticholinesterase Agents|Inhibitor, Acetylcholinesterase|Acetylcholinesterase Inhibitors|Reversible Cholinesterase Inhibitors"
NEW19713,BIOCHEMICAL,plant-based food flavoring agent,plant-based food flavoring agents
NEW19715,BIOCHEMICAL,opioid receptor mor selective antagonist,opioid receptor MOR selective antagonists
NEW19716,CHEMICAL,reboxetine dose,Reboxetine doses
NEW19722,CHEMICAL,glutamate modulation,glutamate modulation
NEW19724,DISEASE,functional impairment,Functional impairments
NEW19726,CHEMICAL,congenital nicotinamide adenine dinucleotide nad deficiency disorder,Congenital nicotinamide adenine dinucleotide NAD deficiency disorders
NEW19729,CHEMICAL,improve ach level,Improved ACh levels
NEW19730,CHEMICAL,decrease nad+ production,decreased NAD+ production
NEW19734,BIOCHEMICAL,pharmaceutical dosage,pharmaceutical dosage
C018523,CHEMICAL,4-dimethylaminocinnamaldehyde [Supplementary Concept],Cinnamates|cinnamaldehyde
NEW19740,CHEMICAL,elagolix treatment,elagolix treatment
D014991,CHEMICAL,Xylazine,BAY Va 1470|Xylazine Phosphate (1:1)|Xylazin|Rompun|BAYVa 1470|Xylazine Hydrochloride|Xylaxine|BAY-Va 1470|xylazine|Xylazine Monohydrochloride
NEW19742,CHEMICAL,mp135,MP135
NEW19744,DISEASE,opiate use disorder,opiate use disorder
NEW19745,DISEASE,mouse ecohiv infection,mouse EcoHIV infection
NEW19746,CHEMICAL,buprenorphine treatment prior,buprenorphine treatment prior
http://purl.obolibrary.org/obo/NCBITaxon_3655,CHEMICAL,cucumis,Kathetostoma giganteum
http://purl.obolibrary.org/obo/NCBITaxon_137207,NUTRITION,oligoryzomys longicaudatus,Hoplostethus atlanticus
NEW19747,DISEASE,Methicillin-resistant s. aureus isolate,Methicillin-resistant S. aureus isolates
D016106,MENTAL_HEALTH,Methicillin Resistance,"Resistance, Methicillin|methicillin resistance|Methicillin Resistant|Methicillin-Resistant"
http://purl.obolibrary.org/obo/PR_000022301,DISEASE,cytidylate kinase,MSSA|mssa|protein mssa|cmk|p25|cmp kinase|ycag|ycaf|cytidine monophosphate kinase|ck
NEW19750,CHEMICAL,cysteine uptake,cysteine uptake
C493400,CHEMICAL,"SLC1A1 protein, human [Supplementary Concept]",excitatory amino acid carrier 1|Excitatory Amino Acid Transporter 3|EAAC1
C000598618,CHEMICAL,mirogabalin [Supplementary Concept],Bridged Bicyclo Compounds|Mirogabalin
C515728,CHEMICAL,thrombopoietin mimetic peptide [Supplementary Concept],Peptides|● thrombopoietin mimetic peptide
C028208,CHEMICAL,metkephamid [Supplementary Concept],"metkephamid|Enkephalin, Methionine/analogs  and  derivatives"
C033453,NUTRITION,"enkephalin-Met, Arg(6)-Gly(7)-Leu(8)- [Supplementary Concept]","methionine enkephalin|Enkephalin, Methionine/analogs  and  derivatives"
NEW19758,DISEASE,second degree burn,second degree burns
NEW19760,DISEASE,grubii fungemia,grubii fungemia
NEW19761,CHEMICAL,no synthesis,NO synthesis
NEW19762,MENTAL_HEALTH,purging-type bulimia,purging-type bulimia
NEW19767,DISEASE,great baseline depressive severity,greater baseline depressive severity
NEW19769,CHEMICAL,altered gamma-aminobutyric acid signaling,Altered gamma-aminobutyric acid signaling
NEW04433,DISEASE,t2dm patient,T2DM patients
NEW19771,BIOCHEMICAL,drug Latrodectus,drug Latrodectus
C049985,CHEMICAL,staurosporine aglycone [Supplementary Concept],Carbazoles|K252a|Indole Alkaloids
NEW19776,BIOCHEMICAL,anti-inflammatory drug celecoxib,anti-inflammatory drug celecoxib
NEW19777,BIOCHEMICAL,trpa1 endogenous agonist,TRPA1 endogenous agonists
NEW19779,DISEASE,non-psychotic non-remitting depression,non-psychotic non-remitting depression
NEW19781,DISEASE,aeromonas molluscorum av27,Aeromonas molluscorum Av27
NEW19783,BIOCHEMICAL,few virulence factor,Few virulence factors
NEW19788,CHEMICAL,rat msg exposure,rats MSG exposure
NEW19791,MENTAL_HEALTH,bipolar manic episode,bipolar manic episode
NEW01062,MENTAL_HEALTH,rat msg exposure,psychotic mania
NEW19792,MENTAL_HEALTH,religious delusion,religious delusions
NEW19793,DISEASE,ovarian tumor otu deubiquitinase,ovarian tumor OTU deubiquitinase
NEW19794,CHEMICAL,otud7a/cezanne2,OTUD7A/CEZANNE2
NEW19796,CHEMICAL,high activity val158 h allele,high activity Val158 H allele
NEW19801,CHEMICAL,% fishmeal cp,% fishmeal CP
NEW19802,NUTRITION,dietary methionine,dietary methionine
NEW19804,CHEMICAL,taurine content,taurine content
NEW19805,DISEASE,juvenile lmb,juvenile LMB
NEW16835,NUTRITION,glucolipid metabolism disorder,largemouth bass
NEW19803,DISEASE,dietary methionine,black skin syndrome
NEW19807,DISEASE,rhinosinusitis,rhinosinusitis
NEW19814,NUTRITION,wheat ingestion,Wheat ingestion
NEW19817,DISEASE,postprandial regurgitation,Postprandial regurgitation
NEW19818,NUTRITION,wheat noodle,Wheat noodle
NEW19821,CHEMICAL,[2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine mesdopetam,[2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine mesdopetam
NEW19823,DISEASE,motor disability,motor disabilities
http://purl.obolibrary.org/obo/SYMP_0000090,CHEMICAL,encephalitis,Covid-19-related encephalitis
NEW19824,DISEASE,retroculus,Retroculus
NEW19828,MENTAL_HEALTH,retroculus,autism spectrum conditions
NEW19829,BIOCHEMICAL,prenatal androgen level,Prenatal androgen levels
NEW19830,CHEMICAL,androgen-related condition,androgen-related conditions
NEW19831,CHEMICAL,anti-histamine drug,Anti-histamine drugs
NEW19833,CHEMICAL,stimulant-like medication,stimulant-like medications
NEW19835,DISEASE,idiopathic premature ovarian failure,idiopathic premature ovarian failure
NEW16963,DISEASE,final oocyte maturation,normal premature ovarian failure|POF
NEW19837,MENTAL_HEALTH,daytime eat disorder,daytime eating disorders
NEW19839,MENTAL_HEALTH,sleep-related eat disorder distinct,Sleep-related eating disorders distinct
NEW19840,DISEASE,sleep-related eating,sleep-related eating
NEW19842,NUTRITION,particular brain phospholipid,particular brain phospholipids
NEW19843,BIOCHEMICAL,hybrid factor mixture model,hybrid factor mixture models
NEW19846,CHEMICAL,protein kinase dyrk1a,protein kinase DYRK1A
NEW19847,CHEMICAL,leucettine,Leucettines
NEW19850,CHEMICAL,tag concentration,TAG concentrations
NEW19851,DISEASE,cancer Cell line encyclopedia ccle datum,Cancer Cell Line Encyclopedia CCLE data
NEW19852,DISEASE,ongoing coronavirus disease pandemic,ongoing coronavirus disease pandemic
NEW19855,CHEMICAL,novel 3-cyanopyridine derivative,novel 3-cyanopyridine derivatives
NEW19857,BIOCHEMICAL,potent survivin modulator,potent survivin modulators
NEW19860,BIOCHEMICAL,neurotoxic n-methyl-d-aspartate nmda glutamate agonist quinolinic acid,neurotoxic N-methyl-d-aspartate NMDA glutamate agonist quinolinic acid
NEW19861,CHEMICAL,plasma acylcarnitine profile,plasma acylcarnitine profiles
NEW19864,CHEMICAL,mood stabilizer,mood stabilizers|MSs
NEW19867,CHEMICAL,statin use,statin use
http://purl.obolibrary.org/obo/CHEBI_172843,CHEMICAL,casomorphin,2-[[1-[2-[[2-[[2-[[1-[2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoic acid|endomorphins
NEW18939,MENTAL_HEALTH,primary depression,acute schizophrenia
NEW19872,CHEMICAL,cytochrome c oxidase 2,SCO2|cytochrome c oxidase 2
NEW19874,CHEMICAL,dfz exposure,DFZ exposure
C115058,CHEMICAL,difenoconazole [Supplementary Concept],Difenoconazole|Triazoles|Dioxolanes|DFZ
NEW19877,MENTAL_HEALTH,developmental phonagnosia,developmental phonagnosia
NEW19879,DISEASE,equine neuroaxonal dystrophy/equine degenerative myeloencephalopathy,Equine neuroaxonal dystrophy/equine degenerative myeloencephalopathy
NEW19882,BIOCHEMICAL,purify skin toxin,purified skin toxin
NEW19883,BIOCHEMICAL,skin toxin,skin toxin
D020275,DISEASE,Guillain-Barre Syndrome,"Familial Guillain-Barre Syndrome|Polyneuropathy, Inflammatory Demyelinating, Acute|Guillain Barre Syndrome, Familial|Guillain-Barré Syndromes|Guillaine Barre Syndrome|Guillain-Barré syndrome|Autoimmune Neuropathy, Acute|Acute Infectious Polyneuritis|Syndrome, Guillain-Barré|Neuropathies, Acute Autoimmune|Guillain-Barre Syndromes, Familial|Syndrome, Landry-Guillain-Barre|Polyneuropathy Acute, Inflammatory|Syndrome, Guillaine-Barre|Inflammatory Polyradiculoneuropathies, Acute|Inflammatory Polyneuropathy Acute|Syndrome, Familial Guillain-Barre|Autoimmune Neuropathies, Acute|Polyneuritis, Acute Infectious|Acute Inflammatory Polyradiculoneuropathy|Guillain-Barré Syndrome|Demyelinating Polyradiculoneuropathy, Acute Inflammatory|Polyradiculoneuropathies, Acute Inflammatory|Inflammatory Polyneuropathy, Acute|Polyradiculoneuropathy, Acute Inflammatory|Polyneuropathy, Acute Inflammatory|Guillain Barré Syndrome|Inflammatory Polyneuropathies, Acute|Acute Autoimmune Neuropathy|Acute Inflammatory Demyelinating Polyradiculoneuropathy|Landry-Guillain-Barre Syndrome|Acute Inflammatory Polyneuropathy|Acute Autoimmune Neuropathies|Guillain-Barre Syndrome, Familial|Guillaine-Barre Syndrome|Polyneuropathies, Acute Inflammatory|Landry Guillain Barre Syndrome|Acute Inflammatory Polyradiculoneuropathies|Syndromes, Guillain-Barré|Syndromes, Familial Guillain-Barre|Guillain Barre Syndrome|Familial Guillain-Barre Syndromes|GBS|Acute Inflammatory Demyelinating Polyneuropathy|Acute Inflammatory Polyneuropathies|Neuropathy, Acute Autoimmune|Polyradiculoneuropathy, Acute Inflammatory Demyelinating|Infectious Polyneuritis, Acute|Inflammatory Demyelinating Polyradiculoneuropathy, Acute|Syndrome, Guillain-Barre"
NEW19886,BIOCHEMICAL,bee toxin,bee toxin
NEW19888,BIOCHEMICAL,surface-exposed antigen,surface-exposed antigens
NEW19889,CHEMICAL,nc001,NC001
NEW19891,BIOCHEMICAL,increase androgen signaling,Increased androgen signaling
NEW07212,CHEMICAL,chronic ethanol exposure,chronic ethanol exposure
NEW19892,DISEASE,antique pandemic,antique pandemic
NEW19893,CHEMICAL,kir6.2 mutant mouse,Kir6.2 mutant mice
NEW19896,MENTAL_HEALTH,therapeutic impotence,Therapeutic impotence
NEW19899,MENTAL_HEALTH,uncomfortable treat adhd,uncomfortable treating ADHD
NEW19900,CHEMICAL,tobacco smoke toxin,tobacco smoke toxins
NEW19904,CHEMICAL,intravaginal dehydroepiandrosterone,Intravaginal dehydroepiandrosterone
NEW19906,CHEMICAL,bergenin derivative,bergenin derivatives
D000075244,CHEMICAL,Apelin Receptors,"Receptor, Apelin|Angiotensin Receptor Like 1 Protein|Angiotensin Receptor-Like 1 Protein|APLNR|Apelin|Apelin Receptor|Receptors, Apelin"
NEW19908,DISEASE,hyperketonemia,Hyperketonemia
http://purl.obolibrary.org/obo/CHEBI_31538,CHEMICAL,enprostil,fundyl|sucralphate|gardrine|Enprostil|gardrin|camleed|RS-84135|RS84135
D003543,CHEMICAL,Cysteamine,"Cystagon|Cysteamine Hydrobromide|beta Mercaptoethylamine|Cysteamine Dihydrochloride|Dihydrochloride, Cysteamine|Cysteamine Hydrochloride|Mercaptoethylamine|Cysteamine Bitartrate|35S-Labeled Cysteamine|Hydrochloride, Cysteamine|2-Aminoethanethiol|Tosylate, Cysteamine|2 Aminoethanethiol|Mercaptamine|Cysteamine, 35S-Labeled|beta-Mercaptoethylamine|Becaptan|Cysteamine Tosylate|Hydrobromide, Cysteamine|Tartrate, Cysteamine|Cysteamine|Mercamine|Cysteinamine|Cysteamine, 35S Labeled|Cysteamine Maleate (1:1)|Bitartrate, Cysteamine|Cysteamine Tartrate (1:1)|Cysteamine Tartrate"
D006209,DISEASE,Halitosis,Halitosis|Halitoses
C504810,CHEMICAL,scarlet lightning extract [Supplementary Concept],Silene|Plant Extracts|L. extract
NEW19913,CHEMICAL,symptomatic propylthiouracil hepatic injury,symptomatic propylthiouracil hepatic injury
NEW02540,CHEMICAL,ovarian steroid,ovarian steroids
NEW19917,DISEASE,overnight hypoxemia,overnight hypoxemia
NEW14434,CHEMICAL,mao activity,MAO activity
NEW19918,CHEMICAL,platelet mao activity,Platelet MAO activity
NEW19920,BIOCHEMICAL,oestrogen serum level,oestrogen serum levels
NEW19921,CHEMICAL,progesterone serum level,progesterone serum levels
NEW19923,DISEASE,tumor neovascularization,Tumor neovascularization
NEW19924,DISEASE,hormone therapy ht trial,Hormone therapy HT trials
NEW19925,CHEMICAL,vitagene,Vitagenes
NEW19926,BIOCHEMICAL,available kappa opioid receptor antagonist,available kappa opioid receptor antagonist
D007317,CHEMICAL,"Insemination, Artificial, Homologous","Artificial Insemination, Husband|Artificial insemination|Insemination, Artificial, Husband|Insemination, Homologous|Insemination, Husband Artificial|Husband Artificial Insemination|AIH|AI|Homologous Insemination"
NEW19929,NUTRITION,modify high amylopectin cornstarch,modified high amylopectin cornstarch
NEW19932,DISEASE,average path velocity,VAP|average path velocity
NEW19933,MENTAL_HEALTH,displacement hypothesis,displacement hypothesis
NEW19935,BIOCHEMICAL,cxc chemokine receptor cxcr4 antagonist,CXC chemokine receptor CXCR4 antagonists
http://purl.obolibrary.org/obo/DOID_0060180,DISEASE,colitis,DSS-induced colitis
NEW19937,DISEASE,clostridium acetobutylicum cell,Clostridium acetobutylicum cells
C104753,CHEMICAL,eglumetad [Supplementary Concept],Bridged Bicyclo Compounds|LY354740
NEW19944,BIOCHEMICAL,crustacean hyperglycemia hormone,crustacean hyperglycemia hormones
D019446,DISEASE,Endotoxemia,endotoxemia|Endotoxemias
NEW19947,CHEMICAL,mef2-reporter mouse,MEF2-reporter mice
NEW19950,DISEASE,herpes simplex virus thymidine kinase,Herpes simplex virus thymidine kinase
NEW19952,BIOCHEMICAL,agent aciclovir,agent aciclovir
NEW17925,MENTAL_HEALTH,n-methyl scaffold,displacement curves
NEW19957,MENTAL_HEALTH,mixed-effects regression model,mixed-effects regression models
NEW19959,CHEMICAL,past-year nutrition,Past-year nutrition
NEW19961,CHEMICAL,glucocorticoid-induced tumor necrosis factor receptor gitr agonistic antibody,glucocorticoid-induced tumor necrosis factor receptor GITR agonistic antibody
NEW19962,CHEMICAL,agonistic antibody,agonistic antibody|DTA-1
C000712933,BIOCHEMICAL,TLR4 agonist GSK1795091 [Supplementary Concept],TLR4 agonist|Glycolipids
NEW19963,MENTAL_HEALTH,central insulin resistance,Central insulin resistance
NEW19964,CHEMICAL,icv-stz administration,ICV-STZ administration
NEW19966,CHEMICAL,norepinephrine dosage,norepinephrine dosage
NEW19968,NUTRITION,soybean root,soybean roots
C540014,CHEMICAL,GA3 compound [Supplementary Concept],Xanthones|GA3
C052949,CHEMICAL,alkylglycerophosphoethanolamine phosphodiesterase [Supplementary Concept],Autotaxin|Phosphoric Diester Hydrolases
NEW19972,CHEMICAL,atx expression,ATX expression
NEW19974,BIOCHEMICAL,sp. venom fraction,sp. venom fraction
NEW19975,MENTAL_HEALTH,stepwise regression analysis,Stepwise regression analysis
NEW19978,CHEMICAL,rna m6a regulator,RNA m6A regulators
NEW19979,CHEMICAL,increase aspartate release,increased aspartate release
NEW19980,CHEMICAL,mgso4,MgSO4
NEW19981,DISEASE,ulcer patient,ulcer patients
NEW19982,CHEMICAL,cold sdf-1alpha,cold SDF-1alpha
NEW19985,CHEMICAL,bicyclam amd3100,bicyclam AMD3100
NEW19988,CHEMICAL,cxcr4-specific antibody,CXCR4-specific antibody
D020888,CHEMICAL,Vigabatrin,gamma-Vinyl-GABA|gamma Vinyl gamma Aminobutyric Acid|Vigabatrin|gamma-Vinyl-gamma-Aminobutyric Acid|VGB|Sabrilex|Sabril|gamma Vinyl GABA
NEW19992,DISEASE,plasmolysis process,plasmolysis process
NEW19994,NUTRITION,label-free living onion cell membrane,Label-free living onion cell membranes
NEW19996,DISEASE,thirty-five lbw infant,Thirty-five LBW infants
NEW06011,DISEASE,cancer patient,cancer patients
NEW20000,CHEMICAL,central sympathetic blocker clonidine hydrochloride,central sympathetic blocker clonidine hydrochloride
D000074042,DISEASE,Cerebral Intraventricular Hemorrhage,"Intraventricular Haemorrhage, Cerebral|Haemorrhage, Cerebral Intraventricular|haemorrhage|Intraventricular Hemorrhage, Cerebral|Intraventricular Haemorrhages, Cerebral|Cerebral Intraventricular Haemorrhage|Cerebral Intraventricular Hemorrhages|Hemorrhage, Cerebral Intraventricular|Cerebral Intraventricular Haemorrhages"
http://purl.obolibrary.org/obo/CHEBI_31918,CHEMICAL,norfenefrine hydrochloride,Norfenefrine hydrochloride|alpha(2)-blocker clonidine hydrochloride
NEW20004,CHEMICAL,intact pth level,intact PTH levels
NEW20006,CHEMICAL,cinacalcet treatment,cinacalcet treatment
NEW00887,DISEASE,hd patient,HD patients
NEW20007,CHEMICAL,cinacalcet response,cinacalcet response
NEW20008,BIOCHEMICAL,target gpcr antagonist,targeted GPCR antagonists
NEW20010,BIOCHEMICAL,biased agonist,Biased agonists
NEW20011,CHEMICAL,µ-opioid receptor,µ-opioid receptors
NEW20013,DISEASE,urinary homovanillic acid,urinary homovanillic acid
D010649,CHEMICAL,Phenylalanine,"Phenylalanine, L Isomer|L-Phenylalanine|Phenylalanine, L-Isomer|L-phenylalanine|Endorphenyl|L-Isomer Phenylalanine"
C026979,CHEMICAL,6-O-monoacetylmorphine [Supplementary Concept],Morphine Derivatives|6-acetylmorphine
NEW20016,CHEMICAL,histamine production,histamine production
NEW20018,CHEMICAL,histamine decarboxylase hdc gene,histamine decarboxylase HDC gene
D011540,CHEMICAL,Prussian Blue Reaction,"Ferrocyanide Reactions|Reaction, Ferrocyanide|Ferrocyanide Reaction|Reactions, Ferrocyanide|Prussian blue|Reactions, Prussian Blue|Prussian Blue Reactions|Blue Reaction, Prussian|Blue Reactions, Prussian|Reaction, Prussian Blue"
NEW20022,CHEMICAL,brain 5-ht,Brain 5-HT
NEW20024,BIOCHEMICAL,[3h]5 alpha-androstane-3 beta,[3H]5 alpha-androstane-3 beta
D046848,DISEASE,White spot syndrome virus 1,White Spot Syndrome Virus|WSSV|White spot syndrome virus
NEW20026,NUTRITION,native crayfish population,native crayfish populations
NEW20028,BIOCHEMICAL,antihistamine chlorpheniramine,antihistamines chlorpheniramine
NEW20029,DISEASE,induce hypocortisolism,induced hypocortisolism
NEW20031,CHEMICAL,n-methyl-d-aspartate glutamate receptor subunit,N-methyl-D-aspartate glutamate receptor subunits
NEW20032,BIOCHEMICAL,gut neurotoxin p-cresol,gut neurotoxin p-cresol
NEW20036,BIOCHEMICAL,selective agonist 2-[4-(2-p-carboxy ethyl)phenylamino]-5'-n-ethylcarboxamido adenosine,selective agonist 2-[4-(2-p-carboxy ethyl)phenylamino]-5'-N-ethylcarboxamido adenosine
NEW20037,DISEASE,HCC strip,HCC strips
NEW20040,DISEASE,p. staminea,P. staminea
NEW20041,NUTRITION,germinate brown rice,germinated brown rice
NEW20042,CHEMICAL,dopaminergic da cell death,dopaminergic DA cell death
NEW20044,NUTRITION,ubiquitous trimethylxanthine,ubiquitous trimethylxanthine
NEW20047,CHEMICAL,Illumina Cotton SNP k,Illumina Cotton SNP K
NEW20049,CHEMICAL,valine (val)66-to-methionine met variant located,valine (Val)66-to-methionine Met variant located
NEW20051,BIOCHEMICAL,drug exposure,drug exposures
NEW20053,MENTAL_HEALTH,diurnal somnolence,Diurnal somnolence
D016066,DISEASE,"Pleural Effusion, Malignant","Effusion, Malignant Pleural|Effusions, Malignant Pleural|Pleural effusions|Malignant Pleural Effusions|Pleural Effusions, Malignant|Malignant Pleural Effusion"
NEW20054,MENTAL_HEALTH,somnolence report,Somnolence reports
NEW20055,CHEMICAL,population benzodiazepine,populations benzodiazepines
NEW20057,DISEASE,patient 's extrahepatic biliary tree,patient's extrahepatic biliary tree
D054407,CHEMICAL,Chemokine CCL4,"Chemokine CCL4L2|Chemokine, CCL4|Chemokine, CCL4L1|Chemokine CCL4L1|CCL4 Chemokine|Macrophage Inflammatory Protein-1beta2|Macrophage Inflammatory Protein 1 beta|CCL4L1 Chemokine|Chemokine, CCL4L2|MIP-1beta|CCl4|CCL4L1, Chemokine|Inflammatory Protein-1beta2, Macrophage|MIP 1beta|Macrophage Inflammatory Protein 1beta2|CCL4, Chemokine|CCL4L2 Chemokine|Macrophage Inflammatory Protein 1-beta|CCL4L2, Chemokine"
C403304,CHEMICAL,zerumbone [Supplementary Concept],Zerumbone|ZER|Sesquiterpenes
NEW20058,DISEASE,associate fibrogenesis,associated fibrogenesis
D016644,BIOCHEMICAL,Canthaxanthin,Carophyll Red|Orobronze|Food Orange 8|C.I. 40850|Canthaxanthine|Roxanthin Red 10|canthaxanthin
http://purl.obolibrary.org/obo/UBERON_0002048,DISEASE,lung,AFP-producing lung HAC
NEW20063,CHEMICAL,increase homocysteine,increased homocysteine
NEW20064,NUTRITION,serum folate,Serum folate
NEW20065,NUTRITION,serum folate value,Serum folate values
NEW20066,NUTRITION,tryptophan (trp)-kynurenine pathway,tryptophan (TRP)-kynurenine pathway
NEW20068,DISEASE,migraine-associated ca2,migraine-associated Ca2
NEW20071,CHEMICAL,in-tcpp surface-coordinated mof thin film,In-TCPP surface-coordinated MOF thin films
NEW20073,CHEMICAL,porphyrinic mof thin film,porphyrinic MOF thin film
D009528,CHEMICAL,Nicarbazin,Nicarbazine|Nicarbazin
D016503,BIOCHEMICAL,Drug Delivery Systems,"drug delivery|Targeting, Drug|System, Drug Delivery|Drug Delivery System|Drug Targeting|Delivery Systems, Drug|Targetings, Drug|Systems, Drug Delivery|Delivery System, Drug|Drug Targetings"
NEW20079,CHEMICAL,rbp1-/- mouse,Rbp1-/- mice
NEW20080,BIOCHEMICAL,synthetic rxr agonist,synthetic RXR agonist
NEW20082,CHEMICAL,"9-cis-13,14-dihydroretinol","9-cis-13,14-dihydroretinol"
NEW20083,CHEMICAL,dapsone hypersensitivity syndrome,Dapsone hypersensitivity syndrome
C521531,CHEMICAL,API 1252 [Supplementary Concept],Pyrones|AFN-1252|Benzofurans
NEW20085,MENTAL_HEALTH,camv 35s-driven rnai repression,CaMV 35S-driven RNAi repression
NEW20087,DISEASE,Opioid dependency,Opioid dependency
NEW20089,DISEASE,deposition-induced loss,deposition-induced loss
NEW20091,BIOCHEMICAL,prototypical beta blocker propranolol,prototypical beta blocker propranolol
NEW20097,DISEASE,large bipolar pedigree,large bipolar pedigrees
NEW20098,DISEASE,mild small vessel disease phenotype,mild small vessel disease phenotypes
NEW20101,CHEMICAL,nitric oxide no donor sodium nitroprusside,nitric oxide NO donor Sodium Nitroprusside
http://purl.obolibrary.org/obo/CHEBI_64584,BIOCHEMICAL,uremic toxin,uremic toxins|uremic toxin
NEW20110,CHEMICAL,subacute mtx neurotoxicity,Subacute MTX neurotoxicity
NEW20112,DISEASE,transient neurological dysfunction,transient neurological dysfunction
NEW20115,DISEASE,psychiatric disturbance,psychiatric disturbances
NEW20116,DISEASE,transduce tumor cell,transduced tumor cells
D057947,DISEASE,Parenteral Nutrition Solutions,"Nutrition|NIN|Intravenous Feeding Solutions|Solutions, Intravenous Feeding|Feeding Solutions, Intravenous"
NEW20121,CHEMICAL,transduce tumor cell,national vitamin A|Vit-A
NEW20123,CHEMICAL,elevated local e2 level,elevated local E2 levels
NEW20126,BIOCHEMICAL,nucleoside analogue reverse transcriptase inhibitor,Nucleoside analogue reverse transcriptase inhibitors
NEW20127,CHEMICAL,folfox chemotherapy,FOLFOX chemotherapy
NEW20128,MENTAL_HEALTH,neuroleptic-induced oral dyskinesia,neuroleptic-induced oral dyskinesia
http://purl.obolibrary.org/obo/CHEBI_60649,BIOCHEMICAL,glucagon receptor antagonist,glucagon receptor antagonists
NEW20129,CHEMICAL,twincretin,twincretins
NEW20130,BIOCHEMICAL,triple glp-1 agonist,triple GLP-1 agonists
NEW20131,NUTRITION,tryptophan depletion,Tryptophan depletion
NEW20132,NUTRITION,tryptophan degrade enzyme,tryptophan degrading enzyme
D000078862,CHEMICAL,Levomilnacipran,Levomilnacipran Hydrochloride|Fetzima|Levomilnacipran
D061566,CHEMICAL,Voltage-Gated Sodium Channels,"Channel, Voltage-Gated Sodium|Sodium Channels, Voltage Gated|Channels, Voltage-Gated Sodium|Sodium Channels, Voltage-Gated|Voltage-Gated Sodium Channel|Sodium Channel, Voltage-Gated|Voltage Gated Sodium Channels|Voltage-gated sodium channels|Voltage Gated Sodium Channel"
NEW20141,CHEMICAL,Zingiber zerumbet L. Smith,Zingiber zerumbet L. Smith
NEW20142,MENTAL_HEALTH,zerumbone-induced analgesia,zerumbone-induced analgesia
NEW20143,CHEMICAL,atp-sensitive k+ channel,ATP-sensitive K+ channel
NEW20144,BIOCHEMICAL,sur1-katp channel subtype agonist,SUR1-KATP channel subtype agonists
NEW20145,CHEMICAL,intraperitoneal ellagic acid,Intraperitoneal ellagic acid
NEW20147,DISEASE,p. fluorescens subgroup,P. fluorescens subgroup
NEW20149,MENTAL_HEALTH,simple linear regression analysis,Simple linear regression analysis
NEW20151,MENTAL_HEALTH,low trait anxiety,low trait anxiety
C105109,NUTRITION,TSA-Direct BlueFISH [Supplementary Concept],Bluefish|Tyrosine/analogs  and  derivatives
NEW20153,BIOCHEMICAL,growth hormone releasing hormone antagonist,Growth hormone releasing hormone antagonists
http://purl.obolibrary.org/obo/CHEBI_138015,BIOCHEMICAL,endocrine disruptor,Many endocrine disruptors|endocrine disrupting compound|hormonally active agents|endocrine disruptors|endocrine-disrupting chemicals|endocrine disrupting compounds|endocrine disrupting chemical|hormonally active agent|endocrine disrupting chemicals|endocrine-disrupting chemical
NEW20156,CHEMICAL,μm. ziram,μM. Ziram
NEW20159,CHEMICAL,dopamine da concentration,dopamine DA concentration
NEW20160,CHEMICAL,bacillus siamensis strain b44v,Bacillus siamensis strain B44v
NEW20164,CHEMICAL,serotonin turnover,serotonin turnover
NEW20165,CHEMICAL,serum gln concentration,serum Gln concentrations
NEW20166,DISEASE,rtt hippocampus,RTT hippocampus
NEW20168,MENTAL_HEALTH,hyperarousal symptom,Hyperarousal symptoms
NEW20171,MENTAL_HEALTH,fragmentation mechanism,fragmentation mechanism
http://purl.obolibrary.org/obo/CHEBI_176307,CHEMICAL,pelargonidin 3-sophoroside 5-glucoside,"flavonol aglycone|2-[4,5-dihydroxy-2-[7-hydroxy-2-(4-hydroxyphenyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromenylium-3-yl]oxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol"
D044948,CHEMICAL,Flavonols,flavonols|2 Phenyl 3 Hydroxy Benzopyran 4 Ones|3 hydroxy 4 keto Flavonoids|2-Phenyl-3-Hydroxy-Benzopyran-4-Ones|3-hydroxy-4-keto-Flavonoids
NEW15738,BIOCHEMICAL,serotonin abnormality,antibody carriers
NEW20179,CHEMICAL,locomotor-enhancing effect,locomotor-enhancing effects
NEW20182,DISEASE,morphine-dependent diabetic mouse,morphine-dependent diabetic mice
NEW20183,BIOCHEMICAL,serotonergic antagonist mirtazapine,serotonergic antagonist mirtazapine
D059326,CHEMICAL,Serotonergic Neurons,"Serotonergic Neuron|Neurons, Serotonergic|Serotoninergic Neurons|Neuron, Serotoninergic|Serotoninergic Neuron|serotonergic neurons|Neurons, Serotoninergic|Neuron, Serotonergic"
NEW20188,DISEASE,depressed pregnant woman,depressed pregnant women
NEW20191,DISEASE,dysthymic group,Dysthymic group
NEW20194,CHEMICAL,multifunctional silica bead,multifunctional silica beads
NEW20196,MENTAL_HEALTH,novel invertase enzymatic hydrolysate-triggered displacement reaction strategy,novel invertase enzymatic hydrolysate-triggered displacement reaction strategy
NEW20197,MENTAL_HEALTH,competitive-type displacement reaction,competitive-type displacement reaction
NEW20200,CHEMICAL,ige sensitization,IgE sensitization
NEW20204,BIOCHEMICAL,cross-reactive allergen component,cross-reactive allergen components
NEW20206,CHEMICAL,inhale allergen,inhaled allergens
D057912,CHEMICAL,Angiotensin II Type 2 Receptor Blockers,Angiotensin 2 Receptor Antagonists|Type 2 Angiotensin Receptor Antagonists|Angiotensin II Type 2 Receptor Antagonists|Type 2 Angiotensin Receptor Blockers|angiotensin receptor blockers
C539977,CHEMICAL,perphenazine GABA ester [Supplementary Concept],Perphenazine/analogs  and  derivatives|gamma-Aminobutyric Acid/analogs  and  derivatives|BL-1020
D005520,BIOCHEMICAL,Food Preservatives,"Preservatives, Food|food preservatives"
NEW20209,DISEASE,most candida albican,most Candida albicans
NEW20211,DISEASE,acute alcohol hallucinosis,acute alcohol hallucinosis
NEW20214,DISEASE,S. nigriventris,S. nigriventris
NEW20216,NUTRITION,cholesterol guideline,Cholesterol guidelines
NEW20217,NUTRITION,erythrocyte lithium influx,Erythrocyte lithium influx
NEW20219,CHEMICAL,nefazodone weak,nefazodone weak
NEW20222,BIOCHEMICAL,selective serotonin-2 antagonist,selective serotonin-2 antagonist
NEW20221,MENTAL_HEALTH,syndrome related,syndromes related
NEW20223,DISEASE,non-epithelial neuroendocrine neoplasm,non-epithelial neuroendocrine neoplasms
NEW20228,DISEASE,jaundice syndrome,Jaundice Syndrome
NEW20230,CHEMICAL,male daily cannabis smoker,male daily cannabis smokers
NEW20233,DISEASE,vibrio cholerae neuraminidase,Vibrio cholerae neuraminidase
NEW20237,NUTRITION,american bullfrog,American bullfrog
NEW20241,BIOCHEMICAL,alpha7 nicotinic agonist,alpha7 nicotinic agonist
NEW20242,NUTRITION,haliotis tuberculata mortality,Haliotis tuberculata mortality
NEW20246,CHEMICAL,pentafluorobenzyl ester,Pentafluorobenzyl esters
NEW20247,DISEASE,isolate ovarian follicular cell dna,isolated ovarian follicular cell DNA
C000659190,DISEASE,Magnusiomyces clavatus [Supplementary Concept],Saccharomycetales|Magnusiomyces clavatus
NEW20252,NUTRITION,cortical choline acetyl transferase activity,cortical choline acetyl transferase activity
http://purl.obolibrary.org/obo/CHEBI_182239,BIOCHEMICAL,antibiotic ab3217a,"(1R,3S,4S,7R,8R,11R,12R,13R)-8-(4-methoxyphenyl)-2,9,14-trioxa-6-azatricyclo[9.2.1.03,7]tetradecane-4,12,13-triol|β-lactam antibiotics"
D015624,DISEASE,Lambert-Eaton Myasthenic Syndrome,"Myasthenic-Myopathic Syndrome of Eaton-Lambert|Myasthenic Myopathic Syndrome of Lambert Eaton|Lambert Eaton Myasthenic Syndrome|Lambert-Eaton Myasthenic-Myopathic Syndromes|Eaton-Lambert Myopathic-Myasthenic Syndromes|Myasthenic Syndrome, Eaton-Lambert|Eaton Lambert Myasthenic Syndrome|Myasthenic-Myopathic Syndrome of Lambert-Eaton|Myopathic-Myasthenic Syndrome of Lambert-Eaton|Eaton-Lambert Syndrome|Myasthenic Syndrome, Lambert Eaton|Lambert-Eaton Syndrome|Syndrome, Lambert-Eaton|Eaton-Lambert Myasthenic-Myopathic Syndrome|Syndrome, Eaton-Lambert Myasthenic|Myopathic Myasthenic Syndrome of Eaton Lambert|Eaton-Lambert Myasthenic Syndrome|Eaton Lambert Syndrome|Lambert-Eaton Myasthenic-Myopathic Syndrome|Lambert-Eaton myasthenic syndrome|Lambert-Eaton Myopathic-Myasthenic Syndrome|Eaton-Lambert Myopathic-Myasthenic Syndrome|Syndrome, Eaton-Lambert|Lambert Eaton Syndrome|Syndrome, Lambert-Eaton Myasthenic|Myasthenic Myopathic Syndrome of Eaton Lambert|Myasthenic Syndrome, Lambert-Eaton|Myopathic-Myasthenic Syndrome of Eaton-Lambert|Lambert-Eaton Myopathic-Myasthenic Syndromes"
NEW20254,DISEASE,junctional disorder,junctional disorder
NEW20256,BIOCHEMICAL,specific ar antagonist,specific AR antagonist
NEW20259,BIOCHEMICAL,preserve vitamin e levels?vitamin e,preserved vitamin E levels?Vitamin E
http://purl.obolibrary.org/obo/SYMP_0000187,DISEASE,tiredness,tiredness
NEW20261,CHEMICAL,typical cannabis side effect,typical cannabis side effects
NEW20262,CHEMICAL,th deficit,TH deficit
NEW20264,DISEASE,grow pituitary adenoma,growing pituitary adenoma
NEW20266,CHEMICAL,n-3 pufa dha,n-3 PUFA DHA
NEW01647,DISEASE,schizophrenia-like symptom,schizophrenia-like symptoms
NEW20269,CHEMICAL,bdnf snp,BDNF SNP
NEW20272,CHEMICAL,self-control dimension,self-control dimensions
NEW20274,BIOCHEMICAL,liver-type mitochondrial aspartate-glutamate carrier,liver-type mitochondrial aspartate-glutamate carrier
NEW20275,DISEASE,niccd patient,NICCD patients
NEW20277,DISEASE,many ctln2 patient,Many CTLN2 patients
NEW20281,CHEMICAL,levothyroxine therapy,Levothyroxine therapy
http://purl.obolibrary.org/obo/CHEBI_32940,CHEMICAL,hexacosane,alkylresorcinol 5-methylresorcinol|CH3-[CH2]24-CH3|n-hexacosane|hexacosane
NEW20284,DISEASE,average pain score,average pain score
NEW20286,CHEMICAL,mglu5 receptor,mGlu5 receptors
NEW20287,DISEASE,dht-induced tec-secreted apoptotic factor,DHT-induced TEC-secreted apoptotic factors
NEW20289,CHEMICAL,dht priming,DHT priming
NEW08209,DISEASE,active disease,active disease
NEW20294,DISEASE,undifferentiated small cell lung cancer,Undifferentiated small cell lung cancer
NEW20300,CHEMICAL,low blood omega-3 lc-pufa,Low blood Omega-3 LC-PUFA
NEW20302,CHEMICAL,pufa metabolism,PUFA metabolism
NEW20303,CHEMICAL,omega-6 long-chain pufa,LC-PUFA|omega-6 long-chain PUFA
NEW20305,DISEASE,less smoking-related symptomatology,less smoking-related symptomatology|SRS
NEW20308,MENTAL_HEALTH,narcolepsy mouse,narcolepsy mice
NEW20309,DISEASE,effective pain management,effective pain management
NEW20311,DISEASE,μg/day transdermal testosterone patch,μg/day transdermal testosterone patch|TTP
NEW20314,DISEASE,severe psychiatric side effect,Severe psychiatric side effects
NEW20316,CHEMICAL,mefloquine intoxication,mefloquine intoxication
NEW20317,BIOCHEMICAL,high-affinity trkb receptor agonist,high-affinity TrkB receptor agonist
NEW20318,CHEMICAL,anti-ischemic compound,anti-ischemic compounds
NEW20320,DISEASE,Cattle encephalon glycoside,Cattle encephalon glycoside
NEW20322,MENTAL_HEALTH,cluster headache patient,cluster headache patients
NEW20324,CHEMICAL,l-(u-14c)serine,L-(U-14C)serine
NEW20325,BIOCHEMICAL,intravaginal oestrogen,intravaginal oestrogen
NEW20326,DISEASE,posttraumatic disorder,posttraumatic disorder
NEW20329,BIOCHEMICAL,folate status indicator,folate status indicators
NEW06864,DISEASE,diabetic patient,diabetic patients
NEW20331,DISEASE,hypertensive noninsulin-dependent patient,hypertensive noninsulin-dependent patients
NEW20332,MENTAL_HEALTH,innate disease resistance,Innate disease resistance
NEW20334,CHEMICAL,nano‑selenium,Nano‑selenium
NEW20335,CHEMICAL,nano-se supplementation,nano-Se supplementation
NEW20338,CHEMICAL,nano‑selenium,Nano‑selenium|Nano-Se
NEW20340,DISEASE,cea crf neuron,CeA CRF neurons
http://purl.obolibrary.org/obo/CHEBI_65255,BIOCHEMICAL,food preservative,food preservatives|food preservative
NEW05775,CHEMICAL,cannabis user,cannabis users
NEW20344,CHEMICAL,unilateral 6-hydroxydopamine lesion,unilateral 6-hydroxydopamine lesions
NEW20345,CHEMICAL,cheonwangbosim-dan,Cheonwangbosim-dan
NEW20348,CHEMICAL,zinc level,zinc level
NEW20349,CHEMICAL,reduce vesicular glutamate,reduced vesicular glutamate
NEW20350,CHEMICAL,acamprosate administration,acamprosate administration
NEW20352,CHEMICAL,normal histamine,normal histamine
NEW20354,CHEMICAL,histone h3 lysine n-methyltransferase,histone H3 lysine N-methyltransferase
NEW20356,CHEMICAL,in morin,In morin
NEW20358,NUTRITION,important tree specie,important tree species
NEW20359,CHEMICAL,hrtcp20 transcription factor,HrTCP20 transcription factor
NEW20360,NUTRITION,aaa tryptophan,AAAs tryptophan
http://purl.obolibrary.org/obo/CHEBI_31293,NUTRITION,bismuth subnitrate,Bismuth subsalicylate preparations|Bismuth subnitrate|Bismuth hydroxide nitrate oxide
NEW20362,MENTAL_HEALTH,in-source fragmentation,In-source fragmentation
NEW20364,DISEASE,positive tpo antibody,Positive TPO antibodies
NEW20366,BIOCHEMICAL,pro-opiomelanocortin alpha-melanocyte-stimulating hormone,pro-opiomelanocortin alpha-melanocyte-stimulating hormone
NEW20368,NUTRITION,wild turkey population,wild turkey population
NEW20370,CHEMICAL,ja biosynthesis,JA biosynthesis
NEW20372,DISEASE,arf transcription factor,ARF transcription factor
NEW20374,MENTAL_HEALTH,tumour repression,tumour repression
NEW20377,BIOCHEMICAL,mutation carrier,mutation carriers
NEW20379,BIOCHEMICAL,human loss-of-function allele carrier,human loss-of-function allele carriers
NEW20383,BIOCHEMICAL,fat soluble vitamin deficiency,vitamin D|fat soluble vitamin deficiencies
NEW20384,DISEASE,psychrophilum molecular serotype,psychrophilum molecular serotypes
NEW20386,CHEMICAL,utero ethanol exposure,utero ethanol exposure
NEW20388,DISEASE,chronic loss,chronic loss
NEW20390,CHEMICAL,gaba inhibition,GABA inhibition
NEW20393,CHEMICAL,serum sodium level,serum sodium level
NEW20395,CHEMICAL,natremia,natremia
NEW20397,DISEASE,hypoglycemic condition,hypoglycemic condition
NEW20399,CHEMICAL,low self-control,low self-control
NEW20400,BIOCHEMICAL,decrease serum vitamin b12 level,Decreased serum vitamin B12 levels
NEW20402,CHEMICAL,FU(OX,FU(OX
NEW20404,DISEASE,mptp-induced massive oxidative damage,MPTP-induced massive oxidative damage
NEW20409,CHEMICAL,cocaine effect,cocaine effects
NEW20411,NUTRITION,trout larvae,trout larvae
NEW20413,DISEASE,pediatric/young adult,pediatric/young adult
NEW20415,CHEMICAL,serum chromium,Serum chromium
NEW20417,DISEASE,congenital long qt syndrome experience,congenital long QT syndrome experience
NEW20419,DISEASE,congenital long qt syndrome,congenital long QT syndrome|LQTS
NEW20420,BIOCHEMICAL,amphipathic toxin candidalysin,amphipathic toxin candidalysin
NEW20422,CHEMICAL,jef-279,JEF-279
NEW20425,DISEASE,transient gut dysbiosis,transient gut dysbiosis
NEW20427,CHEMICAL,partial opiate agonist buprenorphine,partial opiate agonist buprenorphine
NEW20429,CHEMICAL,hydroxyl moiety,hydroxyl moiety
NEW20430,NUTRITION,seaweed extract,seaweed extract
NEW20431,CHEMICAL,abnormal dopamine neurotransmission,Abnormal dopamine neurotransmission
NEW20433,CHEMICAL,d1- d2-like dopamine receptor antagonist,D1- D2-like dopamine receptor antagonists
NEW20435,CHEMICAL,d2-dopamine receptor,D2-dopamine receptors
NEW20437,MENTAL_HEALTH,adhd adult,ADHD adults
NEW20439,CHEMICAL,Glabralactone,Glabralactone
NEW20441,CHEMICAL,wilfordii genus preparation,wilfordii genus preparations
NEW20442,CHEMICAL,catecholamine synthesis inhibitor,catecholamine synthesis inhibitors
http://purl.obolibrary.org/obo/CHEBI_59132,BIOCHEMICAL,antigen,antigen (TIA)-1|antigens
NEW20446,NUTRITION,finite ovarian follicle pool,finite ovarian follicle pool
NEW20448,DISEASE,left-sided frontal alpha,left-sided frontal alpha
NEW20450,CHEMICAL,exogenous taurine,exogenous taurine
NEW20452,CHEMICAL,high ammonia level,high ammonia level
NEW20454,MENTAL_HEALTH,enkephalin-positive projection neuron,Enkephalin-positive projection neurons
NEW20456,CHEMICAL,nmda receptor expression,NMDA receptor expression
NEW20457,CHEMICAL,un-competitive nmda antagonist,un-competitive NMDA antagonists
NEW20458,NUTRITION,germ-tube positive yeast,Germ-tube positive yeast
NEW20461,CHEMICAL,g. (+)-alpha-pinene,g. (+)-alpha-pinene
NEW20463,CHEMICAL,seed oil rich,seed oil rich
NEW09216,DISEASE,depressive mood,depressive mood
NEW05244,DISEASE,gastrointestinal symptom,gastrointestinal symptoms
NEW20464,NUTRITION,soybean transphosphatidylated phosphatidylserine,Soybean transphosphatidylated phosphatidylserine
NEW20466,CHEMICAL,soybean lecithin transphosphatidylated phosphatidylserine,SB-tPS|Soybean lecithin transphosphatidylated phosphatidylserine
NEW20467,NUTRITION,acid composition,acids composition
NEW20471,NUTRITION,high-affinity choline uptake process,high-affinity choline uptake process
NEW20473,CHEMICAL,(3h)hemicholinium-3,(3H)Hemicholinium-3
NEW20474,NUTRITION,cranberry phytochemical,cranberry phytochemicals
NEW20475,CHEMICAL,atypical antipsychotic agent aripiprazole,atypical antipsychotic agent aripiprazole
NEW20477,DISEASE,dermatological disorder,dermatological disorders
NEW20480,DISEASE,low cardiotoxicity,lower cardiotoxicity
NEW20483,DISEASE,idiopathic heritable related,idiopathic heritable related
NEW20485,BIOCHEMICAL,antagonist sch58261 mg/kg,antagonist SCH58261 mg/kg
NEW20486,CHEMICAL,caffeine administration,caffeine administration
NEW20488,BIOCHEMICAL,caffeine receptor antagonist,caffeine receptor antagonists
NEW20491,CHEMICAL,generate cu+ ion,generated Cu+ ions
NEW20493,CHEMICAL,laser-assisted uvulopalatoplasty,Laser-assisted uvulopalatoplasty|LAUP
NEW20495,BIOCHEMICAL,gestagen supplementation,Gestagen supplementation
NEW20496,DISEASE,pms patient,PMS patients
http://purl.obolibrary.org/obo/DOID_12257,DISEASE,medulloadrenal hyperfunction,NMDAR hypofunction
NEW20500,CHEMICAL,sildenafil potent phosphodiesterase-5 inhibitor,sildenafil potent phosphodiesterase-5 inhibitor
NEW20502,BIOCHEMICAL,selective 5-ht(2a receptor antagonist eplivanserin,selective 5-HT(2A receptor antagonist eplivanserin
NEW20504,CHEMICAL,nonselective serotonin 5-ht(2a/2c receptor antagonist,nonselective serotonin 5-HT(2A/2C receptor antagonists
NEW20505,CHEMICAL,macrophage-activation stimulus,Macrophage-activation stimuli
NEW20507,BIOCHEMICAL,cb2 agonist,CB2 agonist
NEW20509,CHEMICAL,chemical chaperone 4-phenylbutyrate,chemical chaperones 4-phenylbutyrate
NEW20512,CHEMICAL,inhibitor BRAFi,inhibitors BRAFi
NEW20514,BIOCHEMICAL,ahr antagonist,AhR antagonists
NEW20515,CHEMICAL,n-methyl-d-aspartate nmda receptor antagonist ketamine,N-methyl-D-aspartate NMDA receptor antagonist ketamine
NEW20517,CHEMICAL,transient antidepressant effect,transient antidepressant effects
NEW20518,CHEMICAL,monoamine reuptake inhibitor,Monoamine reuptake inhibitors
NEW20519,CHEMICAL,endothelin (et)-1,endothelin (ET)-1
NEW20520,DISEASE,debilitating neurocognitive deficit,Debilitating neurocognitive deficits
NEW20521,NUTRITION,giant freshwater prawn,giant freshwater prawn
http://purl.obolibrary.org/obo/CHEBI_26908,CHEMICAL,tetrahydrofolyl glutamate,L-(3H glutamate
NEW02156,DISEASE,comorbid diabete,comorbid diabetes
NEW20527,BIOCHEMICAL,nmda receptor glycine site agonist d-cycloserine,NMDA receptor glycine site agonist d-cycloserine
NEW20531,DISEASE,compulsive buying disorder,Compulsive buying disorder
NEW20533,DISEASE,compulsive buying disorder,compulsive buying disorder
NEW20535,CHEMICAL,pg patient,PG patients
NEW20537,NUTRITION,cholesterol fraction,cholesterol fractions
NEW20538,BIOCHEMICAL,ppar alpha agonist,PPAR alpha agonists
NEW20541,BIOCHEMICAL,ppar alpha agonist,PPAR alpha agonist
NEW20542,CHEMICAL,spontaneous calcium elevation,spontaneous calcium elevations
NEW20543,DISEASE,insulin-induced hypoglycemia,Insulin-induced hypoglycemia
NEW20546,DISEASE,mm moderate hypoglycemia,mM moderate hypoglycemia
NEW14582,CHEMICAL,plasma glucose,plasma glucose
NEW20548,DISEASE,moderate hypoglycemia,Moderate hypoglycemia
NEW20551,CHEMICAL,impaired acetylcholine metabolism,impaired acetylcholine metabolism
NEW20554,BIOCHEMICAL,synthetic lxr agonist,synthetic LXR agonists
NEW20556,CHEMICAL,galloylated oligo- pac,Galloylated oligo- PACs
NEW20558,CHEMICAL,alcohol fetal exposure,alcohol fetal exposure
http://purl.obolibrary.org/obo/CHEBI_10302,CHEMICAL,alpha-methyl-m-tyramine,d-alpha-Methyl-m-tyramine|Gepefrine|alpha-Methyl-m-tyramine|5-HT releasers
NEW20560,NUTRITION,short chain fatty acid profile,short chain fatty acid profiles
NEW20562,DISEASE,persistent crps,persistent CRPS
NEW20566,BIOCHEMICAL,peptidic agonist,Peptidic agonists
NEW20569,CHEMICAL,antidepressant prescribing pattern,Antidepressant prescribing patterns
NEW20572,BIOCHEMICAL,gamma-aminobutyric acid a receptor gabaar agonist,Gamma-aminobutyric acid A receptor GABAAR agonists
NEW20574,CHEMICAL,adjunctive aripiprazole,adjunctive aripiprazole
NEW20575,DISEASE,arboviral disease,Arboviral diseases
NEW20586,BIOCHEMICAL,excessive estrogen influence,Excessive estrogen influence
NEW20587,CHEMICAL,excessive progesterone influence,Excessive progesterone influence
NEW20588,CHEMICAL,significant ketamine prescribing experience,significant ketamine prescribing experience
NEW20590,MENTAL_HEALTH,disorder specialist,disorder specialists
NEW20591,CHEMICAL,cpe strain,CPE strains
NEW20595,CHEMICAL,enoxaparin therapy,Enoxaparin therapy
NEW20597,CHEMICAL,inflammation myeloperoxidase activity-mpo,inflammation myeloperoxidase activity-MPO
NEW20600,CHEMICAL,il-1β thiobarbituric acid reactive substances-tbars,IL-1β thiobarbituric acid reactive substances-TBARS
NEW20601,CHEMICAL,bmi β=0.148,BMI β=0.148
NEW20604,CHEMICAL,β=0.130,β=0.130
NEW20605,MENTAL_HEALTH,multidrug resistance mechanism,multidrug resistance mechanisms
NEW20608,CHEMICAL,(+)-9'-allyl-ABA,(+)-9'-allyl-ABA
NEW20301,MENTAL_HEALTH,attention-deficit/hyperactivity disorder,ADHD|Attention-deficit/hyperactivity disorder
NEW20610,CHEMICAL,uvb dose,UVB dose
NEW20613,MENTAL_HEALTH,patient 's psychosis,patient's psychosis
NEW20616,BIOCHEMICAL,receptor-alpha agonist,receptor-alpha agonists
NEW20617,NUTRITION,fatty acid amide hydrolase inhibitor,Fatty acid amide hydrolase inhibitors
NEW20618,CHEMICAL,monoacylglycerol lipase inhibitor,monoacylglycerol lipase inhibitors
NEW20619,CHEMICAL,cb(2 receptor,CB(2 receptors
NEW20621,CHEMICAL,cb receptor agonist,CB receptor agonists
NEW20622,CHEMICAL,real-time lamp,Real-time LAMP
NEW20624,DISEASE,associate wet-dog shake,associated wet-dog shakes
NEW20625,DISEASE,epileptoid eeg,epileptoid EEG
NEW20627,CHEMICAL,4-ethyloxalacetate,4-ethyloxalacetate
NEW20629,CHEMICAL,brucine base,Brucine base
NEW20630,DISEASE,systemic toxicity,systemic toxicity
NEW20632,CHEMICAL,Phetholamine,Phetholamine
NEW20634,NUTRITION,therapeutic range lithium treatment,therapeutic range lithium treatment
NEW20635,CHEMICAL,∆9-tetrahydrocannabinol,THC|∆9-tetrahydrocannabinol
NEW20636,CHEMICAL,alpha t3 cell,alpha T3 cells
NEW20638,BIOCHEMICAL,receptor-bound antagonist,receptor-bound antagonist
NEW20640,CHEMICAL,doxepin mouthwash,doxepin mouthwash
NEW20644,MENTAL_HEALTH,insomnia symptomatology,insomnia symptomatology
NEW20646,CHEMICAL,dopamine neurotransmitter system,dopamine neurotransmitter system
NEW20647,BIOCHEMICAL,selective α2a-adrenoceptor agonist,selective α2A-adrenoceptor agonist
NEW20649,MENTAL_HEALTH,regression modeling,regression modeling
NEW20651,NUTRITION,sea bass fpies,sea bass FPIES
NEW20654,MENTAL_HEALTH,generic dsm-iv-tr substance dependence criterion,generic DSM-IV-TR substance dependence criteria
NEW20655,DISEASE,mandibular condyle bone scintigraphy,mandibular condyle bone scintigraphy
NEW20660,BIOCHEMICAL,carotenoid pigment,carotenoid pigments
NEW20663,DISEASE,tomato mottle mosaic virus,Tomato mottle mosaic virus
NEW20665,DISEASE,iron-overload mouse,iron-overload mice
NEW20667,CHEMICAL,high-affinity anti-cocaine monoclonal antibody,high-affinity anti-cocaine monoclonal antibody
NEW20669,DISEASE,male ftm transsexual,male FTM transsexuals
NEW20671,CHEMICAL,am80 administration,Am80 administration
NEW20673,CHEMICAL,genus Sceletium,genus Sceletium
NEW20675,MENTAL_HEALTH,multiple linear regression,Multiple linear regression
NEW20678,DISEASE,gonadal neoplasm,gonadal neoplasms
NEW20342,CHEMICAL,high nitrite level,high nitrite levels
NEW12613,CHEMICAL,inducible no synthase,inducible NO synthase
NEW20681,CHEMICAL,no pathway,NO pathway
NEW20683,DISEASE,p. peruviana juice supplementation,P. peruviana juice supplementation
NEW20686,CHEMICAL,hepatotoxicant carbon tetrachloride,CCl4|hepatotoxicant carbon tetrachloride
http://purl.obolibrary.org/obo/NCBITaxon_27458,NUTRITION,chrysops,largemouth bass
NEW20689,DISEASE,liver cell death,liver cell death
NEW20690,DISEASE,many bipolar patient,Many bipolar patients
NEW20691,CHEMICAL,"methyl 5,5-diphenyl-1-(thiazol-2-yl)pyrrolidine-2-carboxylate derivative","methyl 5,5-diphenyl-1-(thiazol-2-yl)pyrrolidine-2-carboxylate derivatives"
NEW20693,BIOCHEMICAL,antimicrobial screening,antimicrobial screening
NEW20695,DISEASE,diet (hfd)-induced mets,diet (HFD)-induced MetS
NEW20697,CHEMICAL,hfd-related mets feature,HFD-related MetS features
NEW20700,CHEMICAL,autophagic inhibitor 3-methyladenine,Autophagic inhibitor 3-methyladenine
NEW20702,CHEMICAL,Byur dMar Nyer lNga Ril Bu,Byur dMar Nyer lNga Ril Bu
NEW20704,CHEMICAL,naltrindole hydrochloride,naltrindole hydrochloride|NTI
NEW20706,CHEMICAL,nti microgram,NTI micrograms
NEW20707,MENTAL_HEALTH,multiple linear regression analysis,Multiple linear regression analysis
NEW20709,CHEMICAL,half dose hormone replacement therapy,HRT|half dose hormone replacement therapy
http://purl.obolibrary.org/obo/CHEBI_35474,BIOCHEMICAL,anxiolytic drug,anti-anxiety drugs|anxiolytic agents|minor tranquilizing agents|anxiolytics|minor tranquilisers|anxiolytic drug|anti-anxiety agents|minor tranquilizers
NEW20712,CHEMICAL,single snp association,single SNP association
NEW20714,BIOCHEMICAL,α7nachr agonist pnu,α7nAChR agonist PNU
NEW20716,CHEMICAL,biotin-dependent mitochondrial enzyme,biotin-dependent mitochondrial enzyme
NEW20718,CHEMICAL,excessive da dose,excessive DA dose
NEW20719,CHEMICAL,release guanfacine,release Guanfacine
NEW20721,DISEASE,cardiogenic pulmonary edema,cardiogenic pulmonary edema
NEW20723,MENTAL_HEALTH,inadequate analgesia,inadequate analgesia
NEW20727,CHEMICAL,miniature excitatory postsynaptic current,miniature excitatory postsynaptic currents|EPSCs
NEW20729,CHEMICAL,no scavenger,NO scavenger
NEW20730,BIOCHEMICAL,estrogen level,estrogens levels
NEW20732,BIOCHEMICAL,short-acting beta-adrenergic agonist,Short-acting beta-adrenergic agonists
NEW20734,DISEASE,cognitive peculiarity idea,cognitive peculiarities ideas
NEW20735,CHEMICAL,hcy reduction,Hcy reduction
NEW20736,BIOCHEMICAL,vitamin b complex supplement,vitamin B complex supplements
NEW20737,DISEASE,diet-induced hhcy,Diet-induced HHcy
NEW20738,BIOCHEMICAL,vitamin b intake,vitamin B intake
NEW20740,DISEASE,diet-induced hhcy,diet-induced HHcy
NEW20741,NUTRITION,disorder fatty acid metabolism,disordered fatty acid metabolism
NEW20743,DISEASE,C. thermophilum sp. nov.,C. thermophilum sp. nov.
NEW20744,CHEMICAL,plasma leu-enk,Plasma Leu-enk
http://purl.obolibrary.org/obo/DOID_7148,DISEASE,rheumatoid arthritis,"Arthritis or polyarthritis, rheumatic|atrophic Arthritis|Rheumatoid arthritis patients"
NEW08804,MENTAL_HEALTH,hyperactivity behavior,hyperactivity behavior
NEW20747,BIOCHEMICAL,carrier medium,carrier medium
NEW20748,CHEMICAL,α2δ calcium-channel ligand,α2δ calcium-channel ligand
NEW20750,MENTAL_HEALTH,membrane orientation active-layer [al]-face fs,membrane orientation active-layer [AL]-facing FS
NEW20752,BIOCHEMICAL,clinical antimalarial,clinical antimalarials
NEW20754,CHEMICAL,oral mq regiman,oral MQ regimen
NEW20756,BIOCHEMICAL,high-efficacy cannabinoid cb1 receptor agonist,high-efficacy cannabinoid CB1 receptor agonist
NEW20758,CHEMICAL,septal spur,SS|septal spur
NEW20761,DISEASE,collateral injury,collaterals injury
NEW05744,BIOCHEMICAL,botulinum toxin injection,botulinum toxin injections
NEW14033,BIOCHEMICAL,partial dopamine agonist,partial dopamine agonist
NEW20766,CHEMICAL,plasma calcium,plasma calcium
NEW20768,CHEMICAL,fix k,fixed K
NEW20772,MENTAL_HEALTH,machine regression analysis,machine regression analysis
NEW20776,CHEMICAL,lpa signaling,LPA signaling
NEW20778,NUTRITION,drug/drug contaminant fatty acid cosmetic msi approach,drug/drug contaminant fatty acid cosmetics MSI approach
NEW20779,CHEMICAL,ros scavenger,ROS scavengers
NEW20781,CHEMICAL,scavenger resveratrol,scavengers resveratrol
NEW20782,DISEASE,autoimmune-associated avb,Autoimmune-associated AVB
NEW20784,DISEASE,hyper-inflammatory reaction,Hyper-inflammatory reaction
NEW20786,CHEMICAL,tcdd exposure,TCDD exposure
NEW20788,MENTAL_HEALTH,nrf2-keap antioxidative defense mechanism,Nrf2-Keap antioxidative defense mechanism
NEW20790,MENTAL_HEALTH,panic disorder,panic disorder
NEW20792,CHEMICAL,glutamate dysregulation,Glutamate dysregulation
NEW20793,CHEMICAL,ly354740     mg/kg,LY354740    mg/kg
NEW19375,BIOCHEMICAL,counterregulatory hormone,counterregulatory hormones
NEW20796,BIOCHEMICAL,antifungal chemotherapy,antifungal chemotherapy
NEW10912,CHEMICAL,testosterone concentration,testosterone concentrations
NEW12076,DISEASE,gts patient,GTS patients
NEW20798,DISEASE,voluntary tic suppression,voluntary tic suppression
NEW20800,CHEMICAL,rhodiola rosea L.,Rhodiola rosea L.
http://purl.obolibrary.org/obo/CHEBI_169010,CHEMICAL,isorientin 4'-o-glucoside 2''-o-p-hydroxybenzoagte,"rosavins|[(2S,4S,5S)-2-[5,7-dihydroxy-2-[3-hydroxy-4-[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-4-oxochromen-6-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] 4-hydroxybenzoate"
NEW20802,CHEMICAL,arsenic toxicity,arsenic toxicity
NEW20804,CHEMICAL,hagsto1,HaGSTO1
NEW20805,CHEMICAL,cation ca2,cation Ca2
NEW20806,NUTRITION,croaker zip9 protein,Croaker ZIP9 protein
NEW20809,NUTRITION,recombinant croaker zip9,Recombinant croaker ZIP9
NEW20810,NUTRITION,wheat powdery mildew,Wheat powdery mildew
NEW20813,DISEASE,b. graminis f. sp. tritici isolate,B. graminis f. sp. tritici isolates
http://purl.obolibrary.org/obo/CHEBI_17750,NUTRITION,glycine betaine,"choline glycine betaine|Trimethylaminoacetate|Trimethylammonioacetate|abromine|Betaine|glycine betaine|2-N,N,N-trimethylammonio acetate|N,N,N-trimethylammonioacetate|(trimethylammoniumyl)acetate|trimethylglycine|Glycine betaine|(trimethylammonio)acetate|1-carboxy-N,N,N-trimethylmethanaminium inner salt|trimethylglycocoll|N,N,N-Trimethylglycine|acidol|Bet"
NEW20815,DISEASE,chemogenetic suppression,Chemogenetic suppression
NEW20817,DISEASE,food-borne pathogen,food-borne pathogens
NEW20818,CHEMICAL,amyloid hypothesis,amyloid hypothesis
NEW20821,DISEASE,leishmania cell,Leishmania cells
NEW20824,CHEMICAL,dietary pufa docosahexaenoic acid,dietary PUFA docosahexaenoic acid
NEW20825,BIOCHEMICAL,exist ad drug research target,Existing AD drug research targets
NEW20827,BIOCHEMICAL,v1b receptor antagonist ts-121,V1B receptor antagonists TS-121
NEW20828,BIOCHEMICAL,v1b receptor antagonist,V1B receptor antagonists
NEW20829,DISEASE,allergic response,allergic responses
NEW19230,DISEASE,hippocampal damage,hippocampal damage
NEW20833,CHEMICAL,glucocorticoid dexamethasone,glucocorticoid dexamethasone
NEW20836,MENTAL_HEALTH,symptom akinesia related,symptoms akinesia related
NEW20837,CHEMICAL,phenylalanine exposure,phenylalanine exposure
http://purl.org/sig/ont/fma/fma67251,CHEMICAL,acetylcholine receptor,acetylcholine receptor desensitization
NEW20840,NUTRITION,bismuth drug,bismuth drugs
NEW20842,CHEMICAL,glucagon biology,glucagon biology
NEW20844,CHEMICAL,bup-hcl,Bup-HCl
NEW20845,BIOCHEMICAL,beta-2 adrenergic agonist,beta-2 adrenergic agonist
http://purl.obolibrary.org/obo/CHEBI_32570,CHEMICAL,mycosamine,"Mycosamin|3-amino-3,6-dideoxy-D-mannose|3-Amino-3-desoxy-D-rhamnose|N-butylphenol moiety"
NEW20849,CHEMICAL,bacl2 superfusion,BaCl2 superfusion
NEW20851,CHEMICAL,prolonged response,prolonged responses|PRs
NEW20855,BIOCHEMICAL,recombinant gelatin,recombinant gelatin
NEW20858,CHEMICAL,(1)h spectrum,(1)H spectra
NEW20861,CHEMICAL,censusADHD study,censusADHD Study
NEW20862,CHEMICAL,glutamate treatment,glutamate treatment
NEW20864,NUTRITION,tumour necrosis factor alpha,tumour necrosis factor alpha
NEW20865,DISEASE,chronic low grade inflammation,chronic low grade inflammation
NEW20867,CHEMICAL,kainic acid i.t,kainic acid i.t
NEW20869,CHEMICAL,da signaling,DA signaling
NEW20873,DISEASE,rhizoctonia solani viability,Rhizoctonia solani viability
NEW20874,CHEMICAL,carnobacterium maltaromaticum sm-2,Carnobacterium maltaromaticum sm-2
NEW20876,CHEMICAL,tbt exposure,TBT exposure
NEW20878,CHEMICAL,tyrosine kinase domain,tyrosine kinase domain
NEW06398,DISEASE,depressive symptomatology,depressive symptomatology
http://purl.obolibrary.org/obo/CHEBI_81884,CHEMICAL,zinc phosphide,to zinc phosphide|Zn3P2
NEW20881,CHEMICAL,topical ketamine,topical ketamine
NEW20883,CHEMICAL,topical amitriptyline increase,topical amitriptyline increase
NEW20886,BIOCHEMICAL,dopamine antagonist medication,dopamine antagonist medications
NEW20887,NUTRITION,phlorotannin supplement,phlorotannin supplement
NEW16466,DISEASE,respiratory disturbance index,respiratory disturbance index
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Amnesia,MENTAL_HEALTH,amnesia,Cyt-4-induced amnesia
NEW20891,CHEMICAL,serum pth level,serum PTH levels
NEW20893,CHEMICAL,catechin-in-cyclodextrin-in-phospholipid liposome,catechin-in-cyclodextrin-in-phospholipid liposome|CCPL
NEW20895,CHEMICAL,encapsulate amphotericin b Constantinides,encapsulated amphotericin B Constantinides
NEW20897,CHEMICAL,encapsulate amb drug,encapsulated AmB drugs
NEW20899,CHEMICAL,nanoencapsulation amb,nanoencapsulation AmB
NEW20900,CHEMICAL,excessive sucrose consumption,Excessive sucrose consumption
NEW20902,CHEMICAL,gliquidone micrograms/mouse,gliquidone micrograms/mouse
NEW20904,CHEMICAL,k+ katp channel blocker,K+ KATP channel blocker
NEW08084,CHEMICAL,total elbow arthroplasty,total elbow arthroplasty|TEA
NEW20908,BIOCHEMICAL,combined hormone therapy,combined hormone therapy
NEW20910,CHEMICAL,high atp level,high ATP levels
NEW20913,DISEASE,toxic fmr1 mrna,toxic FMR1 mRNA
http://purl.obolibrary.org/obo/SYMP_0000619,DISEASE,tetany,Carotenemia
NEW20916,CHEMICAL,serotonin gene-linked polymorphic region,serotonin gene-linked polymorphic region
NEW20924,CHEMICAL,interface-oriented grain boundary,interface-oriented grain boundary
NEW20926,BIOCHEMICAL,certain vitamin,certain vitamins
NEW20928,BIOCHEMICAL,serotonin 5-ht2a/2c antagonist mianserin,serotonin 5-HT2A/2C antagonist mianserin
NEW20931,BIOCHEMICAL,ssri administration,SSRI administration
NEW20933,BIOCHEMICAL,water-soluble vitamin,Water-soluble vitamins
NEW20935,DISEASE,cirrhotic patient,Cirrhotic patients
NEW20938,CHEMICAL,anti-pd-1 therapy,anti-PD-1 therapy
NEW20940,DISEASE,low tumor hypoxia,Lower tumor hypoxia
NEW04589,DISEASE,subclinical hypothyroidism,subclinical hypothyroidism
NEW20941,MENTAL_HEALTH,main nutritional syndrome,main nutritional syndromes
NEW20944,CHEMICAL,neurotransmitter acetylcholine,neurotransmitter acetylcholine
http://purl.obolibrary.org/obo/DOID_11949,DISEASE,creutzfeldt-jakob disease,CJD|Jakob-Creutzfeldt disease|Creutzfeldt Jacob syndrome|Creutzfeldt Jakob disease|Subacute spongiform encephalopathy|Transmissible virus dementia|sporadic Creutzfeldt-Jakob disease|Creutzfeldt-Jacob disease
NEW20946,BIOCHEMICAL,antagonist effect,antagonists effects
NEW20948,DISEASE,locomotor behavior,locomotor behavior
NEW20951,CHEMICAL,poly(hamam-b-hepoman,poly(HAMAm-b-HEPOMAn
NEW20953,CHEMICAL,tryptophan/nicotinic acid pathway,tryptophan/nicotinic acid pathway
NEW20955,CHEMICAL,gamma-aminobutyric acid gaba antagonist,gamma-Aminobutyric acid GABA antagonists
NEW20957,DISEASE,severe odontogenic infection,severe odontogenic infection
NEW20958,NUTRITION,tree seedling,tree seedlings
NEW18015,BIOCHEMICAL,bile acid sequestrant,bile acid sequestrants
NEW20961,DISEASE,impaired rate-dependent depression,RDD|Impaired rate-dependent depression
NEW20962,BIOCHEMICAL,gabab receptor agonist baclofen,GABAB receptor agonist baclofen
NEW20965,CHEMICAL,ppm ab113 concentration,ppm AB113 concentration
NEW20966,BIOCHEMICAL,analgesic prescription,analgesic prescription
NEW20967,DISEASE,hepatotoxic dosage,hepatotoxic dosages
NEW20969,CHEMICAL,domoic acid poisoning,domoic acid poisoning
NEW20971,CHEMICAL,domoic acid toxicity,Domoic acid toxicity
NEW20973,DISEASE,differential toxicity,differential toxicity
NEW20975,MENTAL_HEALTH,dyskinesia performance,Dyskinesia performance
NEW20977,CHEMICAL,(3-ethyl-2-methyl-quinolin-6-yl)-(4-methoxy-cyclohexyl)-methanone methane sulfonate,(3-ethyl-2-methyl-quinolin-6-yl)-(4-methoxy-cyclohexyl)-methanone methane sulfonate|EMQMCM
NEW20980,CHEMICAL,"1r,4r,5s,6r-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate","LY379268|1R,4R,5S,6R-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate"
NEW20981,DISEASE,delusional theme,Delusional themes
NEW20984,CHEMICAL,6f-tricin,6F-tricin
NEW20985,CHEMICAL,lectin griffithsin,GRFT|lectin griffithsin
NEW20990,CHEMICAL,Cinnamon polyphenol extract,Cinnamon polyphenol extract|CPE
NEW20991,BIOCHEMICAL,antibiotic e. coli,antibiotic E. coli
NEW20992,BIOCHEMICAL,dopamine agonist treatment,Dopamine agonist treatment
NEW20993,BIOCHEMICAL,plant nephrotoxin,plant nephrotoxin
http://purl.obolibrary.org/obo/CHEBI_61015,BIOCHEMICAL,nephrotoxin,nephrotoxins|nephrotoxin
NEW20997,CHEMICAL,prostaglandin h synthase cyclooxygenase,Prostaglandin H synthase cyclooxygenase
NEW20999,CHEMICAL,amphetamine derivative,amphetamine derivatives
NEW21000,CHEMICAL,guanfacine xr,Guanfacine XR
NEW21001,BIOCHEMICAL,gamma-aminobutyric acid type b gabab receptor agonist,gamma-aminobutyric acid type B GABAB receptor agonist
NEW21004,CHEMICAL,gabab receptor positive modulator approach,GABAB receptor positive modulator approach
NEW21005,CHEMICAL,cell-membrane fluidity,Cell-membrane fluidity
NEW21008,BIOCHEMICAL,antibiotic usage,antibiotics usage
NEW21011,BIOCHEMICAL,dual co-receptor antagonist,dual co-receptor antagonists
NEW21013,CHEMICAL,chemotherapeutic agent gemcitabine,chemotherapeutic agent gemcitabine
NEW21016,CHEMICAL,aldh1a1 inhibitor disulfiram,ALDH1A1 inhibitor disulfiram
http://purl.obolibrary.org/obo/CHEBI_156386,NUTRITION,asperlactone,"(5R)-5-[(1S)-1-hydroxyethyl]-3-[(2S,3S)-3-methyloxiran-2-yl]furan-2(5H)-one|phenylpropanoids|5R-[(1S)-1-hydroxyethyl]-3-[(2S,3S)-3-methyl-2-oxiranyl]-2(5H)-furanone"
NEW21019,CHEMICAL,theoretical 2h-distribution,theoretical 2H-distribution
NEW21020,CHEMICAL,plasma oxalic acid,plasma oxalic acid
NEW21021,BIOCHEMICAL,erythrocyte vitamin b6,erythrocyte vitamin B6
NEW07097,CHEMICAL,atp concentration,ATP concentrations
NEW21023,DISEASE,J. regia,J. regia
NEW21025,NUTRITION,adjuvant thiamine,adjuvant thiamine
NEW21026,DISEASE,mdd adjuvant thiamine,MDD adjuvant thiamine
NEW21027,CHEMICAL,eaa receptor antagonist d-2-amino-5-phosphonovalerate,EAA receptor antagonist D-2-amino-5-phosphonovalerate|D-APV
NEW21030,NUTRITION,ecto-5'-nucleotidase inhibitor alpha,ecto-5'-nucleotidase inhibitor alpha
NEW21032,CHEMICAL,beta-methylene-ADP,beta-methylene-ADP
http://purl.obolibrary.org/obo/CHEBI_20725,CHEMICAL,6-hydroxydopa,"2-amino-3-(2,4,5-trihydroxyphenyl)propanoic acid|2,4,5-trihydroxyphenylalanine|2,5-dihydroxytyrosine|3,4,6-trihydroxyphenylalanine|6-OHdopa|3,4,6-topa|6-hydroxy-dopamine (6-OHDA)-induced"
NEW21034,MENTAL_HEALTH,specific fragmentation reaction,specific fragmentation reaction
http://purl.obolibrary.org/obo/CHEBI_53756,BIOCHEMICAL,hiv-1 reverse transcriptase inhibitor,HIV-1 reverse transcriptase inhibitors|reverse transcriptase inhibitor|reverse transcriptase inhibitors|HIV reverse transcriptase inhibitors
NEW21037,DISEASE,purulent meningitis,purulent meningitis
NEW21040,DISEASE,cytokine-induced death,cytokine-induced death
NEW21041,DISEASE,inflammatory stimulation-induced corneal epithelial cell death,Inflammatory stimulation-induced corneal epithelial cell death
NEW21042,NUTRITION,peroxiproliferator-activated receptor alpha,peroxiproliferator-activated receptor alpha
NEW21044,DISEASE,short- aas abuse,short- AAS abuse
NEW21045,CHEMICAL,aas dependence,AAS dependence
NEW21048,MENTAL_HEALTH,neural hyperactivity,neural hyperactivity
NEW21050,BIOCHEMICAL,gene sting agonist capable,genes STING agonists capable
NEW21054,CHEMICAL,central serotonin activity,central serotonin activity
NEW21058,DISEASE,spt-modulated program cell death,SPT-modulated programmed cell death
NEW21060,BIOCHEMICAL,melanocortin receptor agonist,melanocortin receptor agonists
NEW10326,CHEMICAL,oxalate deposition,oxalate deposition
http://purl.obolibrary.org/obo/NCBITaxon_3977,CHEMICAL,euphorbiaceae,Gaultheria procumbens
NEW21068,CHEMICAL,fdopa PET,FDOPA PET
NEW21069,CHEMICAL,glutamate synthesis,glutamate synthesis
NEW21071,CHEMICAL,copper nanoparticle,copper nanoparticles|CuNPs
http://purl.obolibrary.org/obo/CHEBI_52522,CHEMICAL,bimetallic nanoparticle,Intermetallic nanoparticles
http://purl.obolibrary.org/obo/CHEBI_78954,NUTRITION,(omega-1)-hydroxy fatty acid,straight-chain fatty acids|(omega-1)-hydroxy fatty acids
NEW21074,CHEMICAL,chronic etoh exposure,Chronic EtOH exposure
NEW21075,DISEASE,most necrosis,most necrosis
http://purl.obolibrary.org/obo/DOID_4481,DISEASE,allergic rhinitis,Perenial allergic rhinitis|seasonal allergic rhinitis|hay fever|pollenosis|atopic rhinitis|perennial allergic rhinitis|Non-seasonal allergic rhinitis
NEW13394,NUTRITION,european sea bass,European sea bass
NEW21079,CHEMICAL,gamma-aminobutyric acidergic gabaergic interneuron,gamma-aminobutyric acidergic GABAergic interneurons
NEW21080,CHEMICAL,serotonin synthesis inhibitor,serotonin synthesis inhibitor
http://purl.obolibrary.org/obo/CHEBI_64946,CHEMICAL,anti-hiv agent,diazepam|anti-AIDS agent|benzodiazepine-GABAergic agent|anti-AIDS agents|anti-HIV agents
NEW21081,CHEMICAL,bzt analog,BZT analogs
http://purl.obolibrary.org/obo/CHEBI_63431,CHEMICAL,2-deoxyhexitol derivative,2-deoxyhexitol derivatives|BZT derivative
NEW21084,DISEASE,osteoporosis androgen suppression,Osteoporosis androgen suppression
NEW21085,BIOCHEMICAL,regioisomeric mixture,regioisomeric mixture
NEW21087,CHEMICAL,long-acting dihydropyridine dosage,long-acting dihydropyridine dosage
NEW21090,NUTRITION,marine omega-3 fatty acid supplement,Marine omega-3 fatty acid supplements
NEW13670,DISEASE,aids patient,AIDS patients
NEW21092,DISEASE,cranial mri abnormality,cranial MRI abnormalities
NEW21097,NUTRITION,insufficient folate activity,Insufficient folate activity
NEW21099,BIOCHEMICAL,folic acid artificial chemical analogue,folic acid artificial chemical analogue
NEW21101,CHEMICAL,altered testosterone level,Altered testosterone level
NEW21102,DISEASE,post-weaning multisystemic wasting syndrome,Post-weaning multisystemic wasting syndrome
NEW21106,DISEASE,sporadic cjd case,sporadic CJD cases
NEW21108,DISEASE,human prion disease,human prion disease
NEW21109,NUTRITION,shipworm symbiotic bacterium,shipworm symbiotic bacterium
NEW21111,BIOCHEMICAL,non-selective serotonin agonist,non-selective serotonin agonist
NEW21113,DISEASE,mediate neuroinflammation,mediated neuroinflammation
NEW21114,DISEASE,johnson grass,Johnson grass
NEW21118,DISEASE,retrieve thrombi,retrieved thrombi
NEW21123,CHEMICAL,natural sepiolite,natural sepiolite
NEW21125,CHEMICAL,Pgr_tv4,Pgr_tv4
NEW21127,DISEASE,primary ovarian explant,primary ovarian explants
NEW21130,BIOCHEMICAL,recombinant piscine follicle-stimulating hormone,recombinant piscine follicle-stimulating hormone
NEW21131,CHEMICAL,dissociative-hypnotic compound ketamine,dissociative-hypnotic compound ketamine
NEW21134,CHEMICAL,[(3)h]-clonidine binding,[(3)H]-clonidine binding
NEW21136,CHEMICAL,melatonin release,Melatonin release
NEW21137,CHEMICAL,phosphate release,Phosphate release
NEW21139,MENTAL_HEALTH,phosphate fixation,phosphate fixation
NEW01414,MENTAL_HEALTH,psychosis related,psychosis related
NEW21142,DISEASE,qat abuse,qat abuse
NEW21143,CHEMICAL,methanol extract,Methanol extracts
NEW21144,DISEASE,stz-diabetic group,STZ-diabetic groups
NEW21149,CHEMICAL,extensive tramadol intake,Extensive tramadol intake
NEW21150,CHEMICAL,Pleuropterus multiflorus,Pleuropterus multiflorus
NEW21152,CHEMICAL,similar gabapentin dose,similar gabapentin doses
NEW21155,CHEMICAL,selective hedgehog antagonist pf-04449913,selective Hedgehog antagonist PF-04449913
NEW21157,NUTRITION,Starch s,Starch S
NEW21159,DISEASE,gdm dam,GDM dams
NEW21162,CHEMICAL,kyn/trp ratio,Kyn/Trp ratio
http://purl.obolibrary.org/obo/NCBITaxon_1485,DISEASE,clostridium,Clostridium XlVa
NEW21165,BIOCHEMICAL,lecithin therapy,lecithin therapy
NEW21166,CHEMICAL,cocaine sensitization,Cocaine sensitization
NEW21168,DISEASE,homocystinuria nonresponsive,homocystinuria nonresponsive
NEW21170,DISEASE,induce obesity,induced obesity
NEW21171,CHEMICAL,Urtica dioica L.,Urtica dioica L.
http://purl.obolibrary.org/obo/PR_000001452,CHEMICAL,free fatty acid receptor,FFAs|fam:ffa_r
NEW21174,BIOCHEMICAL,drug concentration,drug concentration
http://purl.obolibrary.org/obo/CHEBI_38656,CHEMICAL,organochlorine pesticide,organochloride pesticides|Chlororganische Pestizide|Organochlorpestizid|organochlorine pesticides|organochlorine pesticide Kepone|organochloride pesticide
http://purl.obolibrary.org/obo/SYMP_0000133,DISEASE,severe necrosis,severe necrosis
NEW21178,DISEASE,peripheral vasculitis/vasculopathy,Peripheral vasculitis/vasculopathy
NEW21179,CHEMICAL,sr)-i-bu hcl crystal structure,SR)-i-Bu HCl crystal structure
NEW21181,CHEMICAL,human ether go-go herg potassium channel,human ether go-go HERG potassium channels
NEW21183,CHEMICAL,aromatic chalcone,aromatic chalcones
NEW21185,BIOCHEMICAL,α2 -adrenoceptor agonist,α2 -adrenoceptor agonists
NEW21188,BIOCHEMICAL,adrenoceptor agonist,adrenoceptor agonist
NEW21190,BIOCHEMICAL,progestin agonist,progestin agonist
NEW21192,BIOCHEMICAL,m. surinamensis venom,M. surinamensis venom
NEW21194,MENTAL_HEALTH,additional depression,additional depression
NEW21196,CHEMICAL,elevated cr,Elevated Cr
NEW21199,MENTAL_HEALTH,early age-of-onset schizophrenia,early age-of-onset schizophrenia
NEW21201,DISEASE,alcohol-related brain damage,Alcohol-related brain damage
NEW21204,CHEMICAL,other pioglitazone,others pioglitazone
NEW21207,CHEMICAL,kynurenine pathway,kynurenine pathways
NEW21208,CHEMICAL,kynurenine pathway,Kynurenine pathway
NEW21209,BIOCHEMICAL,selective s2 serotonergic antagonist,selective S2 serotonergic antagonist
http://purl.obolibrary.org/obo/CHEBI_68557,BIOCHEMICAL,bradykinin receptor antagonist,Histamine receptor antagonists|bradykinin receptor antagonists
http://purl.obolibrary.org/obo/CHEBI_23116,CHEMICAL,chlorine atom,chlore|17Cl|chlorine|cloro|Chlor|chlorine atoms|chlorum|Cl
NEW21214,BIOCHEMICAL,folate profile,Folate profile
NEW21216,MENTAL_HEALTH,adjust regression model,adjusted regression model
NEW21218,BIOCHEMICAL,high-dose cholecalciferol,high-dose cholecalciferol
NEW21220,DISEASE,Scombroid poisoning,Scombroid poisoning
NEW21222,CHEMICAL,Conclusions- α2δ-1,Conclusions- α2δ-1
NEW15604,DISEASE,disulfiram-ethanol reaction,disulfiram-ethanol reaction
NEW21226,CHEMICAL,trolox pretreatment,Trolox pretreatment
NEW21228,MENTAL_HEALTH,traditional syndrome,traditional syndromes
NEW21230,CHEMICAL,cyp6dc1,CYP6DC1
NEW21232,DISEASE,PTSD+ individual,PTSD+ individuals
NEW21236,DISEASE,sensory impairment,sensory impairments
NEW21238,MENTAL_HEALTH,alcohol craving,Alcohol craving
NEW21240,DISEASE,ocd symptom severity,OCD symptom severity
NEW21242,CHEMICAL,first-line treatment,first-line treatments
NEW21243,DISEASE,OCD ssri,OCD SSRI
NEW13073,DISEASE,antidyskinetic effect,antidyskinetic effect
NEW21250,NUTRITION,low-dose lithium carbonate,low-dose lithium carbonate
NEW21252,NUTRITION,black abalone,black abalone
http://purl.obolibrary.org/obo/SYMP_0000504,MENTAL_HEALTH,headache,cephalalgia|Hypnic headache patients
NEW05285,MENTAL_HEALTH,dementia disorder,dementia disorders
NEW21256,CHEMICAL,antiparkinsonian drug amantadine hcl,antiparkinsonian drug amantadine HCl
NEW21257,BIOCHEMICAL,preoperative serum vitamin d,preoperative serum vitamin D
NEW21258,MENTAL_HEALTH,postoperative cognitive disorder,postoperative cognitive disorder
NEW21259,MENTAL_HEALTH,multiple regression analysis,multiple regression analysis
NEW21261,CHEMICAL,rapa L.,rapa L.
NEW16397,MENTAL_HEALTH,agitation speed,agitation speed
NEW21265,DISEASE,Flavobacterium sp.,Flavobacterium sp.
NEW21267,CHEMICAL,human recombinant interleukin-2,human recombinant interleukin-2|IL-2
http://purl.org/sig/ont/fma/fma85272,CHEMICAL,capsule,zuranolone capsules
NEW21271,DISEASE,rna toxicity,RNA toxicity
NEW21272,MENTAL_HEALTH,schizophrenia scale,schizophrenia scale
NEW21274,DISEASE,gastric cancer pathogenesis,Gastric cancer pathogenesis
NEW21276,CHEMICAL,standard madopar,standard Madopar
NEW21278,CHEMICAL,high sucrose/fructose consumption,high sucrose/fructose consumption
NEW21281,CHEMICAL,iron increase,iron increase
NEW21283,BIOCHEMICAL,mixture modeling,Mixture modeling
NEW21285,CHEMICAL,high corticosterone level,high corticosterone levels
NEW21288,DISEASE,wt parkinsonian mouse,WT parkinsonian mice
NEW21291,DISEASE,eyelid opening,eyelid opening
NEW21293,NUTRITION,anthocyanin extraction,anthocyanin extraction
NEW21294,MENTAL_HEALTH,dominate fragmentation channel,dominating fragmentation channels
NEW21295,MENTAL_HEALTH,dna fragmentation analysis,DNA fragmentation analysis
NEW21296,CHEMICAL,odoratissimus Linn,odoratissimus Linn
NEW21298,BIOCHEMICAL,topical vaginal estrogen therapy,Topical vaginal estrogen therapy
NEW21301,CHEMICAL,apple cider vinegar,apple cider vinegar|ACV
NEW21302,CHEMICAL,synthetic flavonoid,synthetic flavonoid|Chrysin
NEW21303,CHEMICAL,anti-alzheimer 's drug,anti-Alzheimer 's drug|Rivastigmine
NEW21306,CHEMICAL,methyl donor betaine,methyl donor betaine
http://purl.obolibrary.org/obo/CHEBI_22918,NUTRITION,branched-chain amino acid,Branched-chain amino acid BCAA metabolism|branched chain amino acids
NEW21313,CHEMICAL,colecystokinin receptor b,colecystokinin receptor B
NEW21315,MENTAL_HEALTH,adhd co-morbid condition,ADHD co-morbid conditions
NEW21316,BIOCHEMICAL,cxcr3 antagonist,CXCR3 antagonists
NEW21317,CHEMICAL,excessive glutamate neurotransmission,Excessive glutamate neurotransmission
http://purl.obolibrary.org/obo/CHEBI_80256,CHEMICAL,neuropeptide w-30,NAAG|neuropeptide N-acetylaspartylglutamate
NEW21319,CHEMICAL,metabolite aminomethylphosphonic acid,metabolite aminomethylphosphonic acid
NEW21320,CHEMICAL,5-f quinazolinone,5-F quinazolinone
NEW21321,BIOCHEMICAL,egfr inhibitor,EGFR inhibitors
NEW21323,CHEMICAL,5-iodo-3-[2(s)-2-azetidinylmethoxy]pyridine,5-Iodo-3-[2(S)-2-azetidinylmethoxy]pyridine|5-I-A-85380
NEW02327,MENTAL_HEALTH,childhood autism,childhood autism
NEW21326,BIOCHEMICAL,dopamine agonist levodopa,dopamine agonist levodopa
NEW04412,CHEMICAL,aripiprazole augmentation,aripiprazole augmentation
NEW21329,CHEMICAL,e. faecium isolate,E. faecium isolates
NEW21331,CHEMICAL,intramuscular nbqx,intramuscular NBQX
NEW21335,MENTAL_HEALTH,schizophrenia patient,Schizophrenia patients
NEW21338,CHEMICAL,morphine compound,morphine compounds
NEW21339,CHEMICAL,bu group,BU group
NEW21343,CHEMICAL,epidural butorphanol,epidural butorphanol|BU
NEW21345,CHEMICAL,epidural morphine,Epidural morphine
NEW21346,MENTAL_HEALTH,specific syndrome,Specific syndromes
NEW02702,CHEMICAL,sucrose preference test,sucrose preference test
NEW21349,DISEASE,ethanol-associated fetotoxicity,ethanol-associated fetotoxicity
NEW21351,CHEMICAL,ethanol-exposed infant monkey,ethanol-exposed infant monkeys
NEW21353,CHEMICAL,ongoing antidepressant therapy,ongoing antidepressant therapy
NEW21354,CHEMICAL,nac supplementation,NAC supplementation
NEW21356,CHEMICAL,high-dose nr,high-dose NR
NEW21358,CHEMICAL,na regulatory circuit,NA regulatory circuit
http://purl.obolibrary.org/obo/CHEBI_35748,NUTRITION,fatty acid ester,fatty acid esters|a fatty acid ester|Saturated fatty acid esters|FAEE
NEW21362,DISEASE,aae force,AAE forces
NEW21366,BIOCHEMICAL,selective serotonin reuptake inhibitor agent,selective serotonin reuptake inhibitor agents
NEW21365,MENTAL_HEALTH,lsd flashback syndrome,LSD flashback syndrome
NEW21368,DISEASE,early-life inflammation,Early-life inflammation
NEW21370,DISEASE,bulimic patient,bulimic patients
NEW21372,CHEMICAL,betae2,betaE2
NEW21377,MENTAL_HEALTH,mean maximum lateral displacement,mean maximum lateral displacement
NEW21379,CHEMICAL,ge-ti-π textile,Ge-Ti-π textile
NEW21381,MENTAL_HEALTH,resistance development,resistance development
NEW21382,CHEMICAL,blood cd level,blood Cd levels
NEW21383,DISEASE,fibroid tumor size,fibroid tumor size
NEW21384,DISEASE,fibroid cell,fibroid cells
NEW21386,BIOCHEMICAL,selective serotonin reuptake inhibitor ssri treatment,selective serotonin reuptake inhibitor SSRI treatment
NEW21387,CHEMICAL,elevated monoamine,elevated monoamines
NEW21388,CHEMICAL,atfdh1 mutant,Atfdh1 mutants
NEW21392,CHEMICAL,hypothalamic-pituitary-adrenal (hpa)-axis activity,hypothalamic-pituitary-adrenal (HPA)-axis activity
NEW21393,MENTAL_HEALTH,frequent resistance mechanism,frequent resistance mechanism
NEW21395,MENTAL_HEALTH,unadjusted regression analysis,Unadjusted regression analyses
NEW21397,BIOCHEMICAL,gut microbial uremic toxin,gut microbial uremic toxins
NEW21399,DISEASE,anoxic depolarization,Anoxic depolarization
NEW21401,DISEASE,staphylococcus aureus fads,Staphylococcus aureus FADS
NEW21403,CHEMICAL,prediabete baseline fasting glucose aged,prediabetes baseline fasting glucose aged
NEW21405,DISEASE,Saudis,Saudis
NEW21406,CHEMICAL,p2x3 atp receptor,P2X3 ATP receptor
NEW21409,BIOCHEMICAL,idiosyncratic drug hepatotoxicity,Idiosyncratic drug hepatotoxicity
NEW21411,DISEASE,hepatotoxicity subset,hepatotoxicity subset
NEW21413,CHEMICAL,biospheric molecular oxygen,biospheric molecular oxygen
NEW21416,CHEMICAL,liquid chromatography/high tandem mass spectrometry,Liquid chromatography/high tandem mass spectrometry
NEW21418,CHEMICAL,crispr-directed mutagenesis,CRISPR-directed mutagenesis
NEW21419,DISEASE,potent tumour suppressor,potent tumour suppressor
NEW21420,CHEMICAL,bind [14c]inosine,bound [14C]inosine
NEW21422,CHEMICAL,gas hydrate,gas hydrates
NEW21424,CHEMICAL,amino acid kinetic promoter,amino acid kinetic promoters
NEW19482,DISEASE,opportunistic pathogen,opportunistic pathogens
NEW21425,DISEASE,opportunistic pulmonary infection,opportunistic pulmonary infections
NEW21427,CHEMICAL,polynucleotide kinase 3'-phosphatase pnkp gene,polynucleotide kinase 3'-phosphatase PNKP gene
NEW21429,CHEMICAL,gtn ointment,GTN ointment
NEW21430,CHEMICAL,diltiazem ointment,Diltiazem ointment
NEW21432,CHEMICAL,dietary gmp,dietary GMP
NEW21434,CHEMICAL,dietary amp supplementation,dietary AMP supplementation
NEW18331,CHEMICAL,antidepressant action,antidepressant actions
NEW21437,CHEMICAL,phosphorylate cyclic amp response element binding protein,phosphorylated cyclic AMP response element binding protein
NEW21438,DISEASE,curcumin-induced increase,curcumin-induced increase
NEW21439,BIOCHEMICAL,estrogen blockade,estrogen blockade
NEW21440,DISEASE,patient 's manic symptom,patient's manic symptoms
NEW21442,DISEASE,serious psychiatric disorder,serious psychiatric disorders
NEW21443,CHEMICAL,representative polyphenol,representative polyphenol
NEW21445,DISEASE,veteran ptsd group,Veteran PTSD group
NEW21447,BIOCHEMICAL,estrogen receptor alpha gene rs2234693,estrogen receptor alpha gene rs2234693
NEW21449,BIOCHEMICAL,c allele carrier,C allele carriers
NEW21451,DISEASE,combat-related ptsd,combat-related PTSD
NEW21452,DISEASE,combat-related ptsd comorbid,combat-related PTSD comorbid
http://purl.obolibrary.org/obo/CHEBI_66567,CHEMICAL,lespeflorin g5,"(6aR,11aR)-8-methyl-4,10-bis(3-methylbut-2-en-1-yl)-6a,11a-dihydro-6H-[1]benzofuro[3,2-c]chromene-3,9-diol|X. sorbifolium"
NEW21454,DISEASE,appetite disturbance,appetite disturbance
NEW10192,MENTAL_HEALTH,dose-related analgesia,dose-related analgesia
NEW21456,BIOCHEMICAL,drug tamoxifen,drug tamoxifen
NEW21458,CHEMICAL,nonsteroidal antiestrogen drug,nonsteroidal antiestrogen drug
NEW21460,DISEASE,diabetic rodent,diabetic rodents
NEW12032,MENTAL_HEALTH,transcriptional repression,transcriptional repression
NEW21462,CHEMICAL,iron chelation,Iron chelation
NEW21465,DISEASE,acquire osmotolerance,Acquired osmotolerance
NEW21467,CHEMICAL,jasmonate pathway,jasmonate pathway
NEW21469,CHEMICAL,catalepsy-like immobility,catalepsy-like immobility
NEW21471,DISEASE,parkinsonian animal,parkinsonian animals
NEW21470,CHEMICAL,bar test,BT|bar test
NEW21472,DISEASE,nanocrystalline cellulose,nanocrystalline cellulose|NCC
NEW21474,CHEMICAL,steroid aldosterone,steroids aldosterone
NEW21475,CHEMICAL,sigma-1 receptor agonist igmesine,sigma-1 receptor agonist igmesine
NEW21476,NUTRITION,mercury intoxication,Mercury intoxication
NEW21478,NUTRITION,mercury level,mercury levels
NEW21479,CHEMICAL,ala treatment,ALA treatment
NEW21482,BIOCHEMICAL,sub-optimal vitamin d level,Sub-optimal vitamin D levels
NEW21487,CHEMICAL,avp analgesia,AVP analgesia
NEW21489,CHEMICAL,dopamine ratio,dopamine ratio
NEW21491,CHEMICAL,phosphorus calcium Survey,Phosphorus Calcium Survey
NEW21493,BIOCHEMICAL,nonselective muscarinic agonist xanomeline,nonselective muscarinic agonist xanomeline
NEW21495,CHEMICAL,steroid responsiveness,steroid responsiveness
NEW21496,DISEASE,quetiapine-induced elevation,quetiapine-induced elevations
http://purl.obolibrary.org/obo/NCBITaxon_12721,DISEASE,human immunodeficiency virus,human immunodeficiency virus infection
NEW21499,DISEASE,seizure score,seizure score
NEW21500,CHEMICAL,des placement,DES placement
NEW21502,DISEASE,type cardiorenal syndrome,type cardiorenal syndrome
NEW21505,BIOCHEMICAL,progestin action,progestin actions
NEW21507,DISEASE,mw2 swap variant,MW2 swap variants
NEW21509,CHEMICAL,atg18-retromer,Atg18-retromer
NEW21511,CHEMICAL,creatine deficiency disorder,Creatine deficiency disorders
NEW21513,CHEMICAL,guanidinoacetic acid gaa toxicity,guanidinoacetic acid GAA toxicity
NEW21516,MENTAL_HEALTH,motor restlessness,motor restlessness
NEW21518,DISEASE,age attention deficit score,age attention deficit scores
NEW21519,MENTAL_HEALTH,stress-associated suicide risk,stress-associated suicide risk
NEW21521,DISEASE,t-allele carrier,T-allele carriers
NEW21523,CHEMICAL,day/night serum tac,day/night serum TAC
NEW21525,DISEASE,cardiovascular mortality,cardiovascular mortality
NEW21527,CHEMICAL,alpha-2-delta ligand,alpha-2-delta ligands
NEW21529,DISEASE,epilepsy drug,Epilepsy drugs
NEW21532,CHEMICAL,rapid nicotine metabolism,rapid nicotine metabolism
NEW21533,MENTAL_HEALTH,suicide thought,suicide thoughts
NEW21536,CHEMICAL,gaba transmission,GABA transmission
http://purl.obolibrary.org/obo/CHEBI_73641,CHEMICAL,rac-methyl lactate,"methyl RS-lactate|2-hydroxypropanoic acid methyl ester|RS-methyl lactate|methyl alpha-hydroxypropionate|lactic acid, methyl ester|(+-)-methyl 2-hydroxypropanoate|rac-methyl 2-hydroxypropanoate|(+-)-methyl 2-hydroxypropionate|DL-methyl lactate|(+-)-methyl lactate|methyl DL-lactate|lactate clearance(LC|methyl 2-hydroxypropionate"
NEW21541,DISEASE,cums-induced microglial activation,CUMS-induced microglial activation
NEW21543,MENTAL_HEALTH,nuclear displacement,nuclear displacement
http://purl.obolibrary.org/obo/CHEBI_135869,CHEMICAL,iopronic acid,oravue|triac|bilimiro|triiodothyroacetic acid
NEW21545,DISEASE,early-stage ad patient,early-stage AD patients
NEW21547,CHEMICAL,simulated gastric hcl,simulated gastric HCl
NEW21549,BIOCHEMICAL,modify sodium bentonite geosynthetic clay liner,modified sodium bentonite geosynthetic clay liner
NEW21551,DISEASE,modify fluid loss test,modified fluid loss test
NEW21553,BIOCHEMICAL,4-aminoquinoline-based antimalarial,4-aminoquinoline-based antimalarials
NEW21555,CHEMICAL,abnormal glucose metabolism,abnormal glucose metabolism
NEW21556,DISEASE,hyperglycaemia,Hyperglycaemia
NEW21557,DISEASE,hyperinsulinaemia,hyperinsulinaemia
NEW21558,NUTRITION,low hdl cholesterol,low HDL cholesterol
NEW21561,BIOCHEMICAL,antiandrogen treatment,Antiandrogen treatments
NEW21564,DISEASE,copd pharmacotherapy guideline,COPD pharmacotherapy guidelines
NEW12660,DISEASE,copd patient,COPD patients
NEW21567,MENTAL_HEALTH,fatigue level,fatigue levels
http://purl.obolibrary.org/obo/PR_Q9LVZ7,DISEASE,phosphatidylcholine:diacylglycerol cholinephosphotransferase 1 (arabidopsis thaliana),desaturation|at-rod1|atpdct1|msj11.22|rod1|at3g15820|protein reduced oleate desaturation 1 (arabidopsis thaliana)
NEW21571,DISEASE,carcinosin-tumor-derived breast cancer tissue,Carcinosin-tumor-derived breast cancer tissue
NEW21574,DISEASE,rcc risk,RCC risk
NEW21575,CHEMICAL,pangenotypic direct-acting antiviral agent,Pangenotypic direct-acting antiviral agents
NEW21577,CHEMICAL,sof/vel combination ± ribavirin,SOF/VEL combination ± ribavirin
NEW21579,DISEASE,hcv patient,HCV patients
NEW21582,CHEMICAL,Ashitaba powder,Ashitaba powder
NEW13464,DISEASE,liver tumor,liver tumors
NEW21584,CHEMICAL,be mouse,BE mice
NEW21585,NUTRITION,phospholipid liposome,phospholipid liposomes
http://purl.org/sig/ont/fma/fma84050,CHEMICAL,cytokine,Th17/Treg-related cytokine
NEW21590,BIOCHEMICAL,anticonvulsant mood stabilizer,anticonvulsant mood stabilizers
NEW21591,CHEMICAL,insp6 non-treated group,InsP6 non-treated group
NEW21593,CHEMICAL,calcium content,calcium content
NEW21595,CHEMICAL,iron starvation,Iron starvation
NEW21596,MENTAL_HEALTH,morphine-conditioned hyperactivity,morphine-conditioned hyperactivity
NEW21597,BIOCHEMICAL,agonist levorphanol,agonist levorphanol
NEW21598,CHEMICAL,agonist dissociation constant,KA|agonist dissociation constants
NEW21600,CHEMICAL,"drug 3,4-methylenedioxymethamphetamine","drug 3,4-methylenedioxymethamphetamine"
NEW21603,CHEMICAL,zn uptake,Zn uptake
NEW21605,CHEMICAL,salicylic acid content,salicylic acid contents
NEW21607,CHEMICAL,jasmonate acid,jasmonate acid
http://purl.obolibrary.org/obo/CHEBI_84194,CHEMICAL,hydroxytryptophan,hydroxytryptophans|5-hydroxytryptophan 5-HTP
NEW21608,CHEMICAL,glutamate neurotoxicity,glutamate neurotoxicity
NEW21611,BIOCHEMICAL,reaction mixture,reaction mixture
NEW21613,MENTAL_HEALTH,(14)co(2 fixation product,(14)CO(2 fixation products
NEW21615,CHEMICAL,fix carbon atom,fixed carbon atom
NEW21617,NUTRITION,short-chain fatty acid production pathway,short-chain fatty acid production pathways
NEW21618,BIOCHEMICAL,supraphysiologic hormone supplementation,supraphysiologic hormone supplementation
NEW21620,DISEASE,increase muscle mass,increased muscle mass
NEW21621,BIOCHEMICAL,ascorbic acid content,Ascorbic acid content
NEW21624,CHEMICAL,paf receptor antagonist,PAF receptor antagonists
NEW21625,NUTRITION,thrombocytic phospholipid,thrombocytic phospholipids
NEW21626,MENTAL_HEALTH,alcoholic abstinence syndrome,alcoholic abstinence syndrome
NEW21628,CHEMICAL,salbutamol treatment,Salbutamol treatment
NEW21631,CHEMICAL,β2-adrenergic agonist salbutamol,β2-adrenergic agonist salbutamol
NEW21634,BIOCHEMICAL,hypophysis-thyroid hormone,hypophysis-thyroid hormones
NEW21635,BIOCHEMICAL,hormone sth,hormones STH
NEW21636,MENTAL_HEALTH,tumor neurosis factor homolog april,tumor neurosis factor homolog APRIL
NEW21638,DISEASE,Albright 's hereditary osteodystrophy,Albright's hereditary osteodystrophy
NEW21639,CHEMICAL,objectivevon hippel-lindau disease,OBJECTIVEVon Hippel-Lindau disease
NEW21641,CHEMICAL,0.0004).conclusionspropranolol,0.0004).CONCLUSIONSPropranolol
NEW21643,BIOCHEMICAL,paf antagonist,PAF antagonist
NEW21644,DISEASE,tha microm,THA microM
NEW21647,CHEMICAL,paf 1-o-alkyl-2-acetyl-sn-glycero-3-phosphocholine,PAF 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine
NEW21649,CHEMICAL,prenatal acetaminophen exposure due,prenatal acetaminophen exposure due
NEW21651,DISEASE,localized provoke vulvodynia,Localized provoked vulvodynia
NEW21653,DISEASE,acute concomitant poisoning,acute concomitant poisoning
NEW21655,DISEASE,acute poisoning,Acute poisoning
NEW21661,BIOCHEMICAL,poor vitamin k status,Poor vitamin K status
http://purl.obolibrary.org/obo/DOID_11476,DISEASE,osteoporosis,CKD-associated osteoporosis
NEW21663,NUTRITION,american bison,American bison
NEW21665,CHEMICAL,inhale budesonide,inhaled budesonide
NEW21667,CHEMICAL,intranasal corticosteroid,intranasal corticosteroids|INSs
NEW21668,BIOCHEMICAL,cysteinyl leukotriene receptor antagonist,cysteinyl leukotriene receptor antagonist
NEW21669,CHEMICAL,muscarinic cholinergic antagonist atropine,muscarinic cholinergic antagonist atropine
NEW21675,CHEMICAL,high glutamate,higher glutamate
NEW06452,CHEMICAL,psychostimulant methylphenidate,psychostimulant methylphenidate
NEW21677,DISEASE,radicular pain,radicular pain
NEW21679,CHEMICAL,δ8-thc effect,Δ8-THC effects
NEW21681,CHEMICAL,ethinyl estradiol ee concentration,ethinyl estradiol EE concentrations
NEW21683,CHEMICAL,microg ee,microg EE
NEW21686,CHEMICAL,alkalien phosphatase activity,enzymorrhea|alkalien phosphatase activity
NEW21688,DISEASE,glutamic antibody-associated encephalitis,Glutamic antibody-associated encephalitis
NEW21689,CHEMICAL,new adp antagonist,new ADP antagonists
NEW21691,BIOCHEMICAL,increase dopaminergic agent,Increased dopaminergic agents
NEW21694,CHEMICAL,antidepressant therapy,Antidepressant therapy
NEW21696,CHEMICAL,synthetic sulfone,synthetic sulfone
NEW21698,DISEASE,advanced rheumatoid arthritis,advanced rheumatoid arthritis
NEW21699,BIOCHEMICAL,botulinus toxin,botulinus toxin
NEW21701,CHEMICAL,inositol monophosphatase impa1 gene,inositol monophosphatase IMPA1 gene
NEW21703,CHEMICAL,testosterone increase,testosterone increase
NEW21705,DISEASE,low-flow veno-occlusive priapism,Low-flow veno-occlusive priapism
NEW21707,DISEASE,diabetic animal,Diabetic animals
NEW21709,MENTAL_HEALTH,p linear regression model,p linear regression models
NEW21711,CHEMICAL,low-dose ketamine infusion,Low-dose ketamine infusion
NEW21713,BIOCHEMICAL,alpha-tocopherol antioxidant,alpha-Tocopherol antioxidant
NEW21715,DISEASE,twitch response,twitch responses
NEW21716,BIOCHEMICAL,cb agonist,CB agonists
NEW21717,BIOCHEMICAL,inhaled β2-adrenergic agonist,Inhaled β2-adrenergic agonists
NEW21718,DISEASE,toxicity assessment,toxicity assessment
NEW21720,DISEASE,linteus fruiting body hot water extract,linteus fruiting body hot water extract|PLE
NEW08526,DISEASE,stz-induced oxidative stress,STZ-induced oxidative stress
NEW21722,CHEMICAL,ba5,BA5
NEW21724,DISEASE,sepsis-induced hyperlactatemia,sepsis-induced hyperlactatemia
NEW21726,CHEMICAL,selective mao-a-inhibitor moclobemide,selective MAO-A-inhibitor moclobemide
NEW21728,NUTRITION,alpha responsivity,alpha responsivity
NEW21729,BIOCHEMICAL,norepinephrine reuptake inhibitor maprotiline,norepinephrine reuptake inhibitor maprotiline
NEW21730,CHEMICAL,elevated cortisol level,elevated cortisol level
NEW21731,CHEMICAL,chronic oea treatment,chronic OEA treatment
NEW21734,CHEMICAL,isoflavone daidzein,isoflavones daidzein
NEW21736,DISEASE,sunflower wrky transcription factor,sunflower WRKY transcription factor
NEW21738,CHEMICAL,hawrky76,HaWRKY76
http://purl.obolibrary.org/obo/DOID_10600,DISEASE,chronic tic disorder,CMT|chronic motor tic disorder|chronic motor or vocal tic disorder
NEW17946,MENTAL_HEALTH,multivariate regression model,multivariate regression models
NEW21741,BIOCHEMICAL,antibiotic sequence therapy,antibiotic sequence therapy
NEW21743,NUTRITION,chat level,CHAT levels
NEW21744,BIOCHEMICAL,administer steroid/gel mixture,administered steroid/gel mixture
NEW21748,MENTAL_HEALTH,hepatic antioxidant defense mechanism,hepatic antioxidant defense mechanism
NEW21750,DISEASE,nitrosodiethylamine-induced carcinoma change,Nitrosodiethylamine-induced carcinoma changes
NEW21751,CHEMICAL,hydrophilic ascorbic acid,hydrophilic ascorbic acids
NEW21753,CHEMICAL,intravenous same,intravenous SAMe
NEW21756,CHEMICAL,synthetic gestagen levonorgestrel,synthetic gestagen levonorgestrel|LNG
NEW21760,DISEASE,npsle patient,NPSLE patients
NEW21761,CHEMICAL,fxs,FXS|Fmr1 KO2 mice
NEW21762,CHEMICAL,extrasynaptic gaba receptor,extrasynaptic GABA receptors
NEW21765,CHEMICAL,[cl-]i level,[Cl-]i levels
NEW21767,CHEMICAL,crh concentration,CRH concentrations
NEW21770,NUTRITION,sea urchin lesion syndrome,Sea urchin lesion syndrome
NEW21773,DISEASE,persistent hyperosmolality,Persistent hyperosmolality
NEW21775,CHEMICAL,oestrogen-stimulated neurophysin,oestrogen-stimulated neurophysin
NEW21778,DISEASE,AVH Group,AVH Group
http://purl.obolibrary.org/obo/CHEBI_16987,CHEMICAL,1-piperideine-6-carboxylate,"ACC-recorded Glu|2,3,4,5-tetrahydropyridine-2-carboxylate|delta-1-Piperideine-6-carboxylate|1-piperideine-6-carboxylate"
http://purl.obolibrary.org/obo/CHEBI_38757,CHEMICAL,isoflavones,isoflavones|soy-derived phytoestrogen|an isoflavone
NEW21779,CHEMICAL,genistein treatment,genistein treatment
NEW21780,CHEMICAL,promoter SbaP,promoter SbaP
NEW21783,BIOCHEMICAL,vitamin a toxicity,vitamin A toxicity
NEW21786,NUTRITION,folate receptor alpha autoantibody,folate receptor alpha autoantibodies
NEW21788,CHEMICAL,l-leucovorin,l-leucovorin
NEW21792,MENTAL_HEALTH,fungal hyphae fragmentation assay,fungal hyphae fragmentation assay
NEW21793,BIOCHEMICAL,potential antifungal activity,Potential antifungal activity
NEW21795,CHEMICAL,exenatide therapy,Exenatide therapy
NEW21797,CHEMICAL,serum gamma-glutamyl transpeptidase,Serum gamma-glutamyl transpeptidase
NEW21800,BIOCHEMICAL,novel peroxiproliferator-activated receptor ppar modulator,novel peroxiproliferator-activated receptor PPAR modulator
NEW21802,CHEMICAL,epidural morphine,epidural morphine
NEW21804,CHEMICAL,catecholamine receptor activity,catecholamine receptor activity
NEW21806,DISEASE,contracture tension,Contracture tension
http://purl.obolibrary.org/obo/SYMP_0000213,DISEASE,agraphia,impersistence|inability to write
NEW21809,DISEASE,nhcap patient,NHCAP patients
NEW21811,CHEMICAL,auricular electroacupuncture,auricular electroacupuncture
NEW21812,CHEMICAL,Metalaxyl-M. Maxim ® xl exposure,Metalaxyl-M. Maxim ® XL exposure
NEW21815,CHEMICAL,intrathecal fentanyl injection,intrathecal fentanyl injection
NEW21816,CHEMICAL,drug prazosin,drugs prazosin
NEW21818,DISEASE,experimental seizure model,experimental seizure models
NEW21820,MENTAL_HEALTH,predictive regression relationship,predictive regression relationship
NEW21822,CHEMICAL,Neu_LR,Neu_LR
NEW21824,BIOCHEMICAL,… drug trafficking,… Drug trafficking
NEW21826,CHEMICAL,scopolamine patch,scopolamine patches
NEW21828,CHEMICAL,da d2 receptor antagonism,DA D2 receptor antagonism
NEW21829,CHEMICAL,nonergot dopamine agonist,Nonergot dopamine agonists
NEW21830,BIOCHEMICAL,sedative-hypnotic drug,sedative-hypnotic drug
http://purl.obolibrary.org/obo/CHEBI_60027,BIOCHEMICAL,polymer,Kunststoff|Polymer|(SNAP)-doped polymer
NEW21833,DISEASE,fmr1-knockout mouse,Fmr1-knockout mice
NEW21834,CHEMICAL,fmr1-knockout mouse,FMR1-knockout mice
NEW21836,CHEMICAL,carnosine-stimulated/mediated neuronal histamine system,carnosine-stimulated/mediated neuronal histamine system
NEW21837,BIOCHEMICAL,cyanocobalamin supplementation,cyanocobalamin supplementation
NEW21839,CHEMICAL,superoxide anion,superoxide anions
NEW21840,DISEASE,visceral leishmaniasis patient,visceral leishmaniasis patients
NEW21708,CHEMICAL,gsh level,GSH levels
NEW21842,CHEMICAL,patient 's creatine kinase level,patient's creatine kinase levels
NEW21844,DISEASE,head shake,Head shakes
NEW21847,CHEMICAL,shikimate pathway,shikimate pathway
NEW21849,CHEMICAL,his-tagged recombinant microbacterium esterase,his-tagged recombinant Microbacterium esterase
NEW21852,CHEMICAL,single-site cuii,single-site CuII
NEW21854,NUTRITION,officinarum Hance,officinarum Hance
NEW21855,CHEMICAL,FTG,FTG
NEW21859,CHEMICAL,cd distribution,Cd distribution
NEW21862,DISEASE,rice leave,rice leaves
NEW21863,NUTRITION,blueberry anthocyanin,Blueberry anthocyanin
NEW21865,CHEMICAL,mg/kg cd stress,mg/kg Cd stress
NEW21867,NUTRITION,g/l blueberry anthocyanin,g/L blueberry anthocyanin
NEW21860,NUTRITION,blueberry anthocyanin,blueberry anthocyanin
NEW03938,CHEMICAL,serotonin norepinephrine reuptake inhibitor,serotonin norepinephrine reuptake inhibitors
http://cbmi.med.harvard.edu/asdphenotype#Class_297,DISEASE,compulsive behavior,impulsive-compulsive behaviours
NEW21871,DISEASE,severe psychiatric disorder,severe psychiatric disorder
NEW09965,BIOCHEMICAL,endocrine disorder,endocrine disorder
NEW21872,CHEMICAL,congener norfluoxetine,congener norfluoxetine
NEW21874,CHEMICAL,allo biosynthesis,ALLO biosynthesis
NEW21875,DISEASE,severe graft-versus-host disease,severe graft-versus-host disease
NEW21878,BIOCHEMICAL,drug amitriptyline,drug amitriptyline
NEW21880,CHEMICAL,ketamine self-administration,ketamine self-administration
NEW21882,DISEASE,subclinical hyperthyroidism,Subclinical hyperthyroidism
NEW21884,BIOCHEMICAL,effective 5-ht(1b/1d agonist,effective 5-HT(1B/1D agonists
NEW21886,MENTAL_HEALTH,PLS regression,PLS regression
NEW21889,CHEMICAL,gl wine treatment,GL wine treatments
NEW21890,CHEMICAL,gold-fleshed kiwifruit,gold-fleshed kiwifruit
NEW21891,CHEMICAL,glycine/valine,glycine/valine
NEW21893,BIOCHEMICAL,progestogen activity,progestogen activity
NEW21895,CHEMICAL,low dose thyroxine,low dose thyroxine
NEW21896,DISEASE,respiratory defect,respiratory defects
NEW21898,CHEMICAL,self-administered ici,self-administered ICI
NEW21901,CHEMICAL,adenylic nucleotide atp,adenylic nucleotides ATP
NEW21903,CHEMICAL,injectable contraceptive medroxyprogesterone acetate,MPA|injectable contraceptive medroxyprogesterone acetate
NEW21908,CHEMICAL,levamisole level,levamisole levels
NEW21910,CHEMICAL,use dexmedetomidine,use dexmedetomidine
NEW21912,CHEMICAL,ndn-mutated mouse,Ndn-mutated mice
http://purl.obolibrary.org/obo/CHEBI_178059,CHEMICAL,myristic acid-13c3,"(1,2,3-13C3)tetradecanoic acid|L-acetylcarnitine|LAC"
NEW21916,CHEMICAL,long-acting mph,long-acting MPH
NEW21918,DISEASE,huge overdose,huge overdose
NEW21919,NUTRITION,xp-endo finisher instrument,XP-Endo Finisher instruments
NEW02317,BIOCHEMICAL,toxin injection,toxin injections
NEW21922,DISEASE,significant structural disorder,significant structural disorder
NEW21925,CHEMICAL,intravenous tramadol,intravenous tramadol
NEW21930,CHEMICAL,fluoroethylnormemtantine,FENM|fluoroethylnormemtantine
NEW21932,MENTAL_HEALTH,increase analgesia,Increased analgesia
NEW21934,BIOCHEMICAL,electroacupuncture ampa/ka receptor antagonist,electroacupuncture AMPA/KA receptor antagonists
NEW21935,CHEMICAL,low-dose testosterone,Low-dose testosterone
NEW21936,CHEMICAL,adjunctive low-dose transdermal testosterone,adjunctive low-dose transdermal testosterone
NEW21938,CHEMICAL,lpa receptor-null mouse,LPA receptor-null mice
NEW21939,DISEASE,officinalis tr,officinalis TR
NEW21941,NUTRITION,Bear suppression,Bear Suppression
NEW21943,DISEASE,prolonged hyperammonemia,prolonged hyperammonemia
http://purl.obolibrary.org/obo/CHEBI_65259,CHEMICAL,gaba antagonist,gamma-aminobutyric acid receptor antagonists|GABA antagonists|radiolabeled GABA receptor antagonist|gamma-aminobutyric acid receptor antagonist
NEW21946,CHEMICAL,Qisheng Wan formula,QWF|Qisheng Wan formula
NEW21947,CHEMICAL,Bajitianwan,BJTW|Bajitianwan
NEW21949,DISEASE,type dystonia,Type dystonia
NEW21951,NUTRITION,acid supplementation,acids supplementation
NEW21953,CHEMICAL,wild-type nlg-1,wild-type NLG-1
NEW21954,MENTAL_HEALTH,organic impotence,organic impotence
NEW21957,CHEMICAL,halobenzoquinone,Halobenzoquinones
NEW21959,BIOCHEMICAL,beta ra,beta RA
NEW21961,CHEMICAL,absent alphara,absent alphaRA
NEW21962,BIOCHEMICAL,sympatholytic antihypertensive,Sympatholytic antihypertensives
NEW21964,CHEMICAL,continuous glucose monitoring,continuous glucose monitoring
NEW21966,DISEASE,cholinergic mesopontine neuron,cholinergic mesopontine neurons
NEW21967,DISEASE,secondary gain,secondary gain
NEW21969,BIOCHEMICAL,endothelin-a eta receptor antagonist,endothelin-A ETA receptor antagonists
NEW21970,CHEMICAL,to serotonin reuptake inhibitor,SRIs|to serotonin reuptake inhibitors
NEW21972,CHEMICAL,duloxetine group,duloxetine group
NEW21973,CHEMICAL,doxazosin group,doxazosin group
NEW21974,MENTAL_HEALTH,headache severity,headache severity
NEW21976,BIOCHEMICAL,use disinfectant,used disinfectants
NEW21977,MENTAL_HEALTH,unusual resistance,unusual resistance
NEW21978,CHEMICAL,da d2 receptor antagonist raclopride,DA D2 receptor antagonist raclopride
NEW21981,DISEASE,ventral gland,ventral glands
NEW21984,CHEMICAL,gaba level,GABA level
NEW21986,CHEMICAL,naloxone stigma,naloxone stigma
NEW21988,DISEASE,oud stigma,OUD stigma
NEW21989,CHEMICAL,systemic modafinil treatment,Systemic modafinil treatment
NEW21991,CHEMICAL,second-line augmentation,second-line augmentation
NEW21992,CHEMICAL,active tens,Active TENS
NEW21994,CHEMICAL,Navafenterol,Navafenterol
NEW21997,DISEASE,osas patient-derived mdsc,OSAS patient-derived MDSC
NEW22003,CHEMICAL,taurine glutamine level,Taurine glutamine levels
NEW22005,DISEASE,injury due pellet,injuries due pellets
http://purl.obolibrary.org/obo/CHEBI_36043,BIOCHEMICAL,antimicrobial drug,antimicrobial drugs
NEW22011,MENTAL_HEALTH,dissociation enthalpy,dissociation enthalpies
NEW22013,CHEMICAL,characteristic lignin subunit,characteristic lignin subunits
NEW22014,CHEMICAL,imidazolium functionalized bipyridine ligand,imidazolium functionalized bipyridine ligands
http://purl.obolibrary.org/obo/CHEBI_16322,CHEMICAL,"myo-inositol 1,3,4,5,6-pentakisphosphate","1D-myo-Inositol 1,3,4,5,6-pentakisphosphate|inositols myo-inositol|Inositol 1,3,4,5,6-pentakisphosphate|D-myo-Inositol 1,3,4,5,6-pentakisphosphate|myo-inositol 1,3,4,5,6-pentakis(dihydrogen phosphate)"
NEW22017,BIOCHEMICAL,prophylactic vitamin c administration,prophylactic vitamin C administration
NEW22018,BIOCHEMICAL,vitamin c administration,vitamin C administration
NEW22019,CHEMICAL,sustained antidepressant effect,sustained antidepressant effect
NEW22020,DISEASE,strict lifelong gfd,strict lifelong GFD
NEW22022,DISEASE,paraphiliac disorder,paraphiliac disorders
NEW09813,CHEMICAL,atomoxetine treatment,atomoxetine treatment
NEW22024,DISEASE,poststroke statin,poststroke statin
NEW22026,CHEMICAL,several nq,Several NQs
NEW22028,CHEMICAL,intravenous corticoid,intravenous corticoids
http://purl.obolibrary.org/obo/CHEBI_61697,NUTRITION,fatty acid derivative,FA derivatives|fatty acid derivatives|FA derivative
NEW22031,NUTRITION,low cholesterol,lower cholesterol
NEW22032,DISEASE,high impulsivity,higher impulsivity
NEW22033,CHEMICAL,indole g,indole g
NEW19721,CHEMICAL,lactate level,lactate levels
NEW22036,BIOCHEMICAL,antiandrogenic progestogen,antiandrogenic progestogens
NEW22038,CHEMICAL,serotonin neural pathway,serotonin neural pathways
NEW22039,DISEASE,obesity treatment,Obesity treatment
NEW22040,CHEMICAL,novel RSC11 k locus gene,novel RSC11 K locus genes
NEW22042,CHEMICAL,l-dopa/benserazide,L-DOPA/benserazide
NEW22044,CHEMICAL,nsd1015,NSD1015
NEW10719,CHEMICAL,mm.,mM.
NEW22046,CHEMICAL,brain dopamine function,brain dopamine function
NEW22050,DISEASE,ams domain scale score,AMS domain scale scores
NEW22053,MENTAL_HEALTH,pyrabactin resistance,pyrabactin resistance
NEW22055,CHEMICAL,soy isoflavone,Soy isoflavones
NEW22057,CHEMICAL,soy isoflavone extract,soy isoflavone extract
NEW22059,NUTRITION,soybean cake,soybean cake
NEW05115,CHEMICAL,acute toxic-metabolic encephalopathy,Acute toxic-metabolic encephalopathy|TME
NEW22063,DISEASE,ptsd prevalence,PTSD prevalence
NEW22066,BIOCHEMICAL,female t allele carrier,female T allele carriers
NEW22069,NUTRITION,insect cuticle,Insect cuticle
NEW22072,DISEASE,polyuria dysfunction,polyuria dysfunction
NEW22074,DISEASE,physical disturbance,physical disturbance
NEW22075,DISEASE,Rosaceae allergy,Rosaceae allergy
NEW22080,DISEASE,tooth trait,tooth traits
NEW22081,MENTAL_HEALTH,dissociative identity disorder patient,dissociative identity disorder patients
NEW22082,MENTAL_HEALTH,suicide behavior,suicide behavior
NEW22084,DISEASE,acute poisoning,acute poisonings
http://purl.obolibrary.org/obo/CHEBI_4460,CHEMICAL,devazepide,"MK-329|devazepidum|sulpride|devazepida|3(S)-(-)-1,3-Dihydro-3-(2-indolecarbonylamino)-1-methyl-5-phenyl-2H-(1,4)benzodiazepin-2-one|N-[(3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide|L 364718|(S)-N-(2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)indole-2-carboxamide|devazepide"
NEW22086,CHEMICAL,tolterodine ir,tolterodine IR
NEW22087,DISEASE,allergy symptom,allergy symptoms
NEW22089,BIOCHEMICAL,water-soluble vitamin intake,water-soluble vitamin intake
NEW22092,CHEMICAL,glutamate exposure,glutamate exposure
NEW22093,BIOCHEMICAL,apolipoprotein-e ε4 allele carrier,Apolipoprotein-E ε4 allele carriers
NEW22095,DISEASE,sylvian fissure,Sylvian fissure
NEW22098,BIOCHEMICAL,hla antigen association,HLA antigen associations
NEW22101,CHEMICAL,various antidepressant agent,various antidepressant agents
NEW22102,NUTRITION,wheat variety,wheat variety
NEW22104,MENTAL_HEALTH,leaf rust resistance gene,leaf rust resistance gene
NEW22106,MENTAL_HEALTH,durable resistance cultivar,durable resistance cultivars
NEW22108,CHEMICAL,conserve lysine,conserved lysine
NEW22109,DISEASE,b. subtilis strain,B. subtilis strain
NEW22111,BIOCHEMICAL,mixture analysis,Mixture analysis
NEW22114,CHEMICAL,csf 5-hydroxyindoleacetic acid 5-hiaa measurement,CSF 5-hydroxyindoleacetic acid 5-HIAA measurements
NEW22116,DISEASE,peripheral vascular impairment,peripheral vascular impairment
NEW22118,DISEASE,arthritic deformity,arthritic deformities
NEW22119,DISEASE,distal joint,distal joints
NEW22123,CHEMICAL,serotonin noradrenaline reuptake inhibitor,serotonin noradrenaline reuptake inhibitor
NEW22125,CHEMICAL,antidepressant venlafaxine,antidepressant venlafaxine
NEW22128,CHEMICAL,kp modulation,KP modulation
NEW22130,DISEASE,similar age-dependent injury,similar age-dependent injury
http://purl.obolibrary.org/obo/CHEBI_10554,CHEMICAL,epinine,Deoxyepinephrine|catecholamine norepinephrine|Epinine
NEW22133,CHEMICAL,fenugreek Trigonella foenum-graecum seed,fenugreek Trigonella foenum-graecum seeds
http://cbmi.med.harvard.edu/asdphenotype#Class_163,DISEASE,primary diagnosis,primary DSM-III-R diagnosis
NEW22137,CHEMICAL,formicamycin biosynthetic gene cluster,formicamycin biosynthetic gene cluster
NEW22141,MENTAL_HEALTH,deficiency-induced female depression,deficiency-induced female depression
NEW22146,CHEMICAL,chimeric antigen receptor car t cell therapy,Chimeric antigen receptor CAR T cell therapy
NEW22148,CHEMICAL,adenosine adenosine uptake blocker,Adenosine adenosine uptake blockers
NEW22150,CHEMICAL,chronic ptz treatment,Chronic PTZ treatment
NEW22152,BIOCHEMICAL,nutraceutical supplementation,Nutraceutical supplementation
NEW09322,DISEASE,treatment-resistant mdd patient,treatment-resistant MDD patients
NEW22155,NUTRITION,anticipatory alpha oscillation,anticipatory alpha oscillations
NEW22156,BIOCHEMICAL,inadequate estrogen stimulation,inadequate estrogen stimulation
NEW22157,CHEMICAL,bazibushen formula,BaZiBuShen formula
NEW22160,CHEMICAL,serum malondialdehyde level,serum malondialdehyde levels
NEW22162,CHEMICAL,extracellular adenosine signaling,extracellular adenosine signaling
NEW22164,CHEMICAL,pharmacologic ent inhibitor dipyridamole,pharmacologic ENT inhibitor dipyridamole
NEW22167,CHEMICAL,high acid epa supplement,high acid EPA supplements
NEW22168,NUTRITION,onion stalk,Onion Stalk
NEW22174,CHEMICAL,altered glutamate neurotransmission,altered glutamate neurotransmission
NEW22175,DISEASE,monoamine deficiency hypothesis,monoamine deficiency hypothesis
NEW22176,NUTRITION,plasma omega-6:omega-3 fatty acid ratio,plasma omega-6:omega-3 fatty acid ratio
NEW22179,CHEMICAL,acaricide resistance,Acaricide resistance
NEW22181,CHEMICAL,excessive caffeine consumption,Excessive caffeine consumption
NEW22182,BIOCHEMICAL,selective pparδ agonist,selective PPARδ agonist
NEW22186,CHEMICAL,objectively-measured plasma tfa concentration,objectively-measured plasma TFA concentrations
NEW22187,NUTRITION,mature bombyx mori silkworm,mature Bombyx mori silkworm
http://purl.obolibrary.org/obo/BFO_0000034,CHEMICAL,function,PtrMYB120 function
NEW22191,CHEMICAL,ppwrky46,PpWRKY46
NEW22192,BIOCHEMICAL,antimalarial medication,antimalarial medications
NEW22194,DISEASE,associate hyperpyrexia,associated hyperpyrexia
NEW22197,CHEMICAL,serum glutathione level,serum glutathione levels
NEW22199,CHEMICAL,gd phenotype,GD phenotype
NEW22202,MENTAL_HEALTH,resistance level,resistance level
NEW22007,MENTAL_HEALTH,resistance rate,resistance rate
NEW22204,BIOCHEMICAL,antimicrobial residue,antimicrobial residues
NEW22206,DISEASE,thyroid hemorrhage,thyroid hemorrhage
NEW22208,CHEMICAL,nsaid ketoprofen,NSAID ketoprofen|KETO
NEW22211,DISEASE,noxious electrical shock,Noxious electrical shock
NEW04388,CHEMICAL,caffeine withdrawal,caffeine withdrawal
NEW22214,MENTAL_HEALTH,ultra-treatment resistant schizophrenia,ultra-treatment resistant schizophrenia
NEW22215,CHEMICAL,dopamine receptor supersensitivity,dopamine receptor supersensitivity
NEW22217,CHEMICAL,amphetamine sensitization,amphetamine sensitization
NEW22219,NUTRITION,vitamin folate,vitamins folate
NEW22220,CHEMICAL,s1p inhibitor,S1P inhibitor
NEW22221,NUTRITION,rosmarinus officinalis L.,Rosmarinus officinalis L.
NEW22223,DISEASE,successful intraoperative ovarian venous sampling,Successful intraoperative ovarian venous sampling
NEW22225,CHEMICAL,strychnine seizure,strychnine seizures
NEW22228,CHEMICAL,secretory luminal membrane,secretory luminal membrane
NEW22230,CHEMICAL,erinaceus polysaccharide,erinaceus polysaccharides
NEW22233,BIOCHEMICAL,serotonin 1a 5-ht1a receptor agonist,serotonin 1A 5-HT1A receptor agonists
NEW22234,DISEASE,nmda receptor agonist dcs,NMDA receptor agonist DCS
NEW22235,BIOCHEMICAL,5-ht1a receptor agonist,5-HT1A receptor agonist
NEW22236,BIOCHEMICAL,a2ar antagonist istradefylline,A2AR antagonist istradefylline
NEW22237,MENTAL_HEALTH,bipolar type bp major depressive episode,bipolar type BP major depressive episode
NEW22238,DISEASE,manic switch rate,manic switch rate
NEW22239,CHEMICAL,dopamine synapse activity,dopamine synapse activity
http://purl.obolibrary.org/obo/CHEBI_78206,NUTRITION,fatty acid ethyl ester,Fatty acid ethyl esters|a fatty acid ethyl ester
NEW22241,CHEMICAL,nonoxidative ethanol metabolite present,nonoxidative ethanol metabolites present
NEW18403,DISEASE,possible toxicity,possible toxicity
NEW22243,CHEMICAL,monoclonal antibody mab cetuximab,monoclonal antibody mAb cetuximab
NEW22245,DISEASE,Salicornia herbacea,Salicornia herbacea
NEW22248,CHEMICAL,pure cortisol exposure,pure cortisol exposure
NEW22249,BIOCHEMICAL,anabolic growth hormone,anabolic growth hormone
NEW22251,MENTAL_HEALTH,final multivariate logistic regression analysis,final multivariate logistic regression analysis
NEW17146,DISEASE,hypoxia tolerance,hypoxia tolerance
NEW22255,CHEMICAL,benzamide metoclopramide,benzamides metoclopramide
NEW22256,DISEASE,brachiocephalic trunk injury,brachiocephalic trunk injury
NEW22260,DISEASE,depressed subject,Depressed subjects
NEW22262,MENTAL_HEALTH,increase peak pulmonary vascular resistance,increased peak pulmonary vascular resistance
NEW22265,CHEMICAL,serotonin/norepinephrine reuptake inhibitor,serotonin/norepinephrine reuptake inhibitors
NEW22266,BIOCHEMICAL,prenatal androgen,prenatal androgens
NEW22269,CHEMICAL,nmda function,NMDA function
NEW22270,CHEMICAL,adenosine analog cordycepin,adenosine analog cordycepin
NEW22272,MENTAL_HEALTH,enhance resistance,enhanced resistance
NEW22274,CHEMICAL,ethanol content,ethanol content
NEW10511,CHEMICAL,°,°
NEW22277,DISEASE,small intestinal bacterial overgrowth,SIBO|small intestinal bacterial overgrowth
NEW22280,DISEASE,late thrombotic event,late thrombotic events
NEW22281,CHEMICAL,amygdala GM volume,amygdala GM volume
NEW22282,NUTRITION,invertase activity,invertase activity
NEW22284,MENTAL_HEALTH,severe drug dependence,severe drug dependence
NEW22286,DISEASE,delay qt prolongation,Delayed QT prolongation
NEW22288,CHEMICAL,fingerprint-efficacy relationship,fingerprint-efficacy relationship
NEW22289,CHEMICAL,antidepressant response,Antidepressant response
NEW22290,NUTRITION,blood mercury,blood mercury
NEW22291,MENTAL_HEALTH,depression risk,depression risk
NEW22292,DISEASE,neurological memory impairment,neurological memory impairment
NEW22294,BIOCHEMICAL,adjuvant sympatholytic,Adjuvant sympatholytics
NEW22296,DISEASE,leishmania donovani promastigote,Leishmania donovani promastigotes
http://purl.obolibrary.org/obo/CHEBI_29515,CHEMICAL,ansamitocin p3,"Maytansinol isobutyrate|Antibiotic C15003P3|ansamitocin P-3|(1S,2R,3S,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1(10,14).0(3,5)]hexacosa-10(26),11,13,16,18-pentaen-6-yl 2-methylpropanoate|2'-De(acetylmethylamino)-2'-methylmaytansine|ansamitocin P3|C15003P3"
NEW22298,CHEMICAL,steroid profile,Steroid profile
NEW22299,CHEMICAL,5'-terminal guanine,5'-terminal guanine
NEW22301,CHEMICAL,2'-terminal pyrimidine,2'-terminal pyrimidines
NEW22303,DISEASE,skv therapy,SKV therapy
http://purl.obolibrary.org/obo/CHEBI_83192,CHEMICAL,glycerophosphoinositol trisphosphate,inositol trisphosphate receptor
NEW22305,CHEMICAL,dietary n-3 pufa deficiency,dietary n-3 PUFA deficiency
NEW22307,BIOCHEMICAL,d2r antagonist,D2r antagonist
NEW22308,CHEMICAL,cannabinoid nabilone,cannabinoid nabilone
NEW22310,DISEASE,musculoskeletal disorder,musculoskeletal disorder
NEW22312,DISEASE,chronic intermittent hypoxia cih exposure,chronic intermittent hypoxia CIH exposure
NEW22315,CHEMICAL,native loricariid common pleco,native loricariid common pleco|Hypostomus punctatus
NEW22317,CHEMICAL,α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor,α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor
NEW22318,CHEMICAL,rapamycin signaling,rapamycin signaling
NEW22319,CHEMICAL,fractional co2 laser,fractional CO2 laser
NEW22320,CHEMICAL,% terbinafine cream,% terbinafine cream
NEW22322,CHEMICAL,conclusion fractional co2 laser,Conclusion Fractional CO2 laser
NEW22323,CHEMICAL,levosimendan key pathology,levosimendan key pathology
NEW22325,CHEMICAL,α2δ-1-bound n-methyl-d-aspartate receptor,α2δ-1-bound N-methyl-D-aspartate receptors
NEW22327,CHEMICAL,oral antiplatelet,oral antiplatelets
NEW22328,CHEMICAL,serum sphingosine,serum sphingosine
NEW22330,DISEASE,alcohol/substance dependence,alcohol/substance dependence
NEW22332,BIOCHEMICAL,fast beta power,fast beta power
NEW22334,DISEASE,chronic obesity,chronic obesity
NEW22336,CHEMICAL,thrombopoietin receptor agonist eltrombopag,thrombopoietin receptor agonist eltrombopag
NEW22337,CHEMICAL,varenicline/ethanol co-treatment,Varenicline/ethanol co-treatment
NEW22338,BIOCHEMICAL,c. bolteae ps immunogen,C. bolteae PS immunogen
NEW22339,CHEMICAL,gpc+pc,GPC+PC
NEW22340,MENTAL_HEALTH,rapid cycling bipolar disorder,rapid cycling bipolar disorder
NEW22342,CHEMICAL,intravenous m-cpp,intravenous m-CPP
NEW22345,CHEMICAL,purine metabolism transcript,purine metabolism transcripts
NEW22347,CHEMICAL,serum uric acid level,serum uric acid level
NEW22349,MENTAL_HEALTH,disorder narcolepsy,disorder narcolepsy
NEW22351,CHEMICAL,∆9-tetrahydrocannabinol,∆9-tetrahydrocannabinol
NEW22352,BIOCHEMICAL,antigen pertussis toxin,antigens pertussis toxin
http://purl.obolibrary.org/obo/SYMP_0000607,MENTAL_HEALTH,hallucination,Medicationrelated hallucinations
NEW03499,CHEMICAL,specific serotonin reuptake inhibitor,specific serotonin reuptake inhibitors
NEW22356,CHEMICAL,serotonin transporter,Serotonin transporters
NEW22357,CHEMICAL,prostacyclin analogue drug,Prostacyclin analogue drugs
NEW22360,BIOCHEMICAL,opioid receptor mor agonist,opioid receptor MOR agonists
NEW22361,MENTAL_HEALTH,maximal hyperactivity,Maximal hyperactivity
NEW22363,MENTAL_HEALTH,opioid-induced hyperactivity,opioid-induced hyperactivity
NEW22365,MENTAL_HEALTH,agonist-induced hyperactivity,agonist-induced hyperactivity
NEW22367,CHEMICAL,mosapride citrate tablet,mosapride citrate tablets
NEW22369,CHEMICAL,% conﬁdence interval,% conﬁdence intervals
NEW22370,CHEMICAL,drug halothane,drugs halothane
NEW22371,CHEMICAL,5-mg group,5-mg group
NEW22375,DISEASE,concomitant low grade fever suggestive,concomitant low grade fever suggestive
NEW22378,CHEMICAL,atypical dopamine-uptake inhibitor,Atypical dopamine-uptake inhibitors
NEW22380,CHEMICAL,sprinkle,sprinkle
NEW22384,CHEMICAL,novel flat-panel photobioreactor,novel flat-panel photobioreactor|FPP
NEW22385,CHEMICAL,Jonkheer van Tets,Jonkheer van Tets
NEW22387,NUTRITION,red currant tomato,red currant tomato
NEW22389,BIOCHEMICAL,adenosine a2b agonist adenosine a1 agonist,adenosine A2B agonist adenosine A1 agonist
NEW22391,BIOCHEMICAL,specific antagonist,specific antagonist
NEW22393,BIOCHEMICAL,selective antagonist,selective antagonists
NEW22395,CHEMICAL,low-dose daily niacin supplementation,low-dose daily niacin supplementation
NEW22397,CHEMICAL,oral fucose,oral fucose
NEW22402,DISEASE,active metabolic transformation,active metabolic transformation
NEW22404,CHEMICAL,active se form,active Se forms
NEW22407,CHEMICAL,modern antidepressant,modern antidepressants
NEW22408,CHEMICAL,scale id-pain,scales ID-pain
NEW22409,MENTAL_HEALTH,cox regression analysis,Cox regression analysis
NEW22411,BIOCHEMICAL,drug driving,drug driving
NEW22412,BIOCHEMICAL,yolk lecithin,yolk lecithin
NEW05626,MENTAL_HEALTH,depression symptom,depression symptoms
NEW22415,BIOCHEMICAL,bacterial toxin cnf1,bacterial toxin CNF1
NEW22417,DISEASE,protein toxin cytotoxic necrotizing factor 1,protein toxin cytotoxic necrotizing factor 1|CNF1
http://purl.obolibrary.org/obo/CHEBI_22901,CHEMICAL,bisphenol,bisphenols
NEW22420,DISEASE,adult diabete,adult diabetes
NEW22423,BIOCHEMICAL,act μ-opioid receptor antagonist,acting μ-opioid receptor antagonists
NEW22425,CHEMICAL,catecholamine depletion,catecholamine depletion
NEW22426,BIOCHEMICAL,drug category,drug category
NEW22427,DISEASE,ethanol-induced hepatic inflammation,ethanol-induced hepatic inflammation
NEW22428,CHEMICAL,gaba mimetic,GABA mimetics
NEW22430,DISEASE,established tumor,established tumors
NEW22433,CHEMICAL,galantamine treatment,Galantamine treatment
NEW22434,CHEMICAL,brimonidine 0.2 % fixed combination,brimonidine 0.2 % fixed combination|BBFC
NEW22437,DISEASE,midline destructive lesion,midline destructive lesions
NEW22438,BIOCHEMICAL,active antibiotic,active antibiotic
NEW22440,CHEMICAL,enantiomer esketamine,enantiomer esketamine
NEW22441,CHEMICAL,depolarize dopamine response,depolarizing dopamine response
NEW22443,BIOCHEMICAL,h3r antagonist pitolisant,H3R antagonist pitolisant
NEW22447,BIOCHEMICAL,different toxic substance,different toxic substances
NEW22449,DISEASE,perinatal hypothyroidism,perinatal hypothyroidism
NEW22451,DISEASE,nutritional dermatosis,nutritional dermatoses
NEW22452,DISEASE,active vitamin a metabolite retinoic acid,RA|active vitamin A metabolite retinoic acid
NEW22455,MENTAL_HEALTH,major depressive episode unresponsive,major depressive episode unresponsive
NEW22456,BIOCHEMICAL,neuropituitary hormone,neuropituitary hormones
NEW22457,NUTRITION,polar xanthophyll,polar xanthophylls
NEW22458,CHEMICAL,wild type α-synuclein,α-syn-140|wild type α-synuclein
NEW22459,CHEMICAL,α-syn-112,α-Syn-112
NEW22461,MENTAL_HEALTH,antibiotic resistance enzyme,antibiotic resistance enzyme
NEW22463,CHEMICAL,ne inhibitor sivelestat,NE inhibitor Sivelestat
NEW22465,CHEMICAL,angelica gigas extract,Angelica gigas extract
NEW22467,NUTRITION,angelica gigas,Angelica gigas
NEW22470,DISEASE,inescapable foot shock,inescapable foot shock
NEW22472,DISEASE,only foot shock,only foot shock
NEW22475,BIOCHEMICAL,iv high dose vitamin c,iv high dose vitamin C
NEW22476,CHEMICAL,e2 ubiquitin ligase,E2 ubiquitin ligases
D049994,CHEMICAL,Sodium Potassium Chloride Symporter Inhibitors,"Diuretics, Loop|Sodium Potassium Chloride Cotransporter Inhibitors|Inhibitors, Na-K-CL Symporter|Symporter Inhibitors, Na-K-CL|potassium chloride|Diuretic, Loop|Na-K-CL Symporter Inhibitors|Loop Diuretics|High Ceiling Diuretics|Diuretics, High Ceiling|Loop Diuretic|Bumetanide Sensitive Na K Cl Transporter Inhibitors|Bumetanide Sensitive Na-K-Cl-Transporter Inhibitors|Na K CL Symporter Inhibitors|Ceiling Diuretics, High"
C031866,NUTRITION,de-epoxy rosamicin [Supplementary Concept],potassium dihydrogen phosphate|Leucomycins
NEW22483,MENTAL_HEALTH,fixation rate,fixation rate
C051042,CHEMICAL,dansyl undecanoic acid [Supplementary Concept],Fatty Acids|undecanoic acid|Dansyl Compounds
NEW22487,BIOCHEMICAL,cck2 selective antagonist,CCK2 selective antagonist
NEW14175,DISEASE,chronic intermittent hypoxia,chronic intermittent hypoxia
NEW22489,CHEMICAL,ftdp-17 model,FTDP-17 model
NEW22491,CHEMICAL,ftdp-17 human mutant tau over-expression,FTDP-17 human mutant tau over-expression
NEW22077,DISEASE,histamine intolerance,HIT|Histamine Intolerance
NEW22495,MENTAL_HEALTH,suicide inactivation,suicide inactivation
NEW22499,CHEMICAL,potassium intake,potassium intake
NEW22500,NUTRITION,raspberry juice,Raspberry juice
NEW22501,CHEMICAL,increase central nervous system norepinephrine outflow,Increased central nervous system norepinephrine outflow
NEW22502,BIOCHEMICAL,brain-accessible alpha1-adrenergic antagonist prazosin,brain-accessible alpha1-adrenergic antagonist Prazosin
NEW22504,CHEMICAL,elevated serum testosterone,Elevated serum testosterone
C422364,DISEASE,inhibin B [Supplementary Concept],inhibin B|Inhibins
C546535,CHEMICAL,Palovarotene [Supplementary Concept],Palovarotene|Stilbenes|Pyrazoles
NEW22507,CHEMICAL,nuclear retinoic acid receptor,nuclear retinoic acid receptor
NEW22508,CHEMICAL,RARγ agonist-loaded poly-lactic acid nanoparticle,RARγ agonist-loaded poly-lactic acid nanoparticles
NEW22509,BIOCHEMICAL,RARγ agonist treatment,RARγ agonist treatment
D004338,BIOCHEMICAL,Drug Combinations,"Drug Combination|Combination, Drug|Drug combinations|Combinations, Drug"
NEW22511,CHEMICAL,poultry feces-may,poultry feces-may
NEW22513,DISEASE,avian coccidiosis,avian coccidiosis
D065906,DISEASE,Hyperlactatemia,Hyperlactatemias|hyperlactatemia
NEW22516,CHEMICAL,human flavin,human flavin
NEW22518,CHEMICAL,acetaminophen metabolite am,acetaminophen metabolite AM
NEW22520,NUTRITION,fatty acid amide hydrolase faah inhibitor cyclohexylcarbamic acid ester,fatty acid amide hydrolase FAAH inhibitor Cyclohexylcarbamic acid ester
NEW22521,NUTRITION,common buckwheat,Common buckwheat
NEW22523,CHEMICAL,analog ketamine,analog ketamine
NEW22524,CHEMICAL,glutamate hypofunction,glutamate hypofunction
http://purl.obolibrary.org/obo/PR_Q9R1M7,CHEMICAL,"glutamate receptor ionotropic, nmda 3a (rat)",NMDARs|nmdar-l (rat)|nr3a (rat)|nmdar-l1 (rat)|n-methyl-d-aspartate receptor (rat)|rgrin3a|n-methyl-d-aspartate receptor subtype 3a (rat)|grin3a|glun3a (rat)|nmdar3a (rat)|glutamate receptor chi-1 (rat)
NEW22530,CHEMICAL,gamma-aminobutyric acid gaba analogue anticonvulsant,gamma-aminobutyric acid GABA analogue anticonvulsant
NEW22532,MENTAL_HEALTH,disorder diagnosis,disorder diagnoses
NEW22533,CHEMICAL,cb₁ receptor,CB₁ receptors|CB₁Rs
NEW22535,CHEMICAL,kinin b(1)r,kinin B(1)R
D054714,CHEMICAL,Echinocandins,Echinocandins|Mulundocandins|Aculeacins|Pneumocandin|Pneumocandins|Aculeacin|Echinocandin
NEW22539,DISEASE,disorder mouse model,disorder mouse model
D019578,CHEMICAL,Multiple System Atrophy,"Atrophy, Multiple System|Atrophies, Multisystemic|Multisystemic Atrophies|Multisystem Atrophy|Multiple System Atrophy Syndrome|Multisystemic Atrophy|Multiple system atrophy|Atrophy, Multisystemic|Atrophies, Multisystem|MSA|Atrophy, Multisystem|Multiple System Atrophies|Multisystem Atrophies"
NEW22544,BIOCHEMICAL,mixture per,mixture Pers
NEW22545,NUTRITION,hericium erinaceus administration,Hericium erinaceus administration
D013390,CHEMICAL,Suxamethonium,"Dibromide, Succinylcholine|Succinylcholine Diperchlorate|Succinylcholine Diiodide|Suxamethonium|Dichloride, Succinylcholine|Bromide, Suxamethonium|Succinylcholine Dibromide|Myorelaxin|Suxamethonium Bromide|Quelicin|Succinylcholine Chloride|Ditilin|Lysthenon|Anectine|Succinylcholine Dichloride|Diiodide, Succinylcholine|Succinate, Dicholine|Succinylcholine Dichloride, Di-H2O|Succinylcholine Iodide|Succicuran|Succinyldicholine|Succinylcholine Dichloride, Di H2O|Diperchlorate, Succinylcholine|Suxamethonium Chloride|Listenon|Dicholine Succinate|Celocurine"
D012601,CHEMICAL,scopolamine,scopolamine
D008094,CHEMICAL,lithium,lithium
D005672,CHEMICAL,fusidic acid,fusidic acid
D003676,CHEMICAL,desferrioxamine,desferrioxamine
D008274,CHEMICAL,magnesium,magnesium
C004656,CHEMICAL,Chloroacetaldehyde,Chloroacetaldehyde
C084599,CHEMICAL,Clotiazepam,Clotiazepam
D014148,CHEMICAL,tranexamic acid,tranexamic acid
D005481,CHEMICAL,hexafluorodiethyl ether,hexafluorodiethyl ether|Flurotyl|Indoklon|Fluorothyl
D010615,CHEMICAL,phenacetin,phenacetin
D014229,CHEMICAL,Triazolam,Triazolam
D013999,CHEMICAL,timolol,"Timolol Hemihydrate|MK950|Optimol|2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (S)-|MK-950|Timolol Maleate, (1:1) Salt|Timoptol|(S)-1-((1,1-Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadazol-3-yl)oxy)-2-propanol|timolol|Timoptic|L-714,465|L714,465|L 714,465|Timolol Maleate|Blocadren|MK 950|Timacar"
D012256,CHEMICAL,riboflavin,riboflavin
D005200,CHEMICAL,N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide,N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide
D004054,CHEMICAL,diethylstilbestrol,diethylstilbestrol
D014223,CHEMICAL,Triamterene,Triamterene
D013307,CHEMICAL,streptomycin,Streptomycine Panpharma|Estreptomicina Clariana|Strepto Hefa|Streptomycin Sulphate|Estreptomicina Normon|Strepto-Hefa|Estreptomicina CEPA|Streptomycin Sulfate|streptomycin|Streptomycin Sulfate (2:3) Salt|Strepto Fatol|Streptomycin Grünenthal|Strepto-Fatol
D012293,CHEMICAL,rifampin,rifampin
D011692,CHEMICAL,puromycin aminonucleoside,puromycin aminonucleoside
D009538,CHEMICAL,AN,AN
C007112,CHEMICAL,coniine,coniine
D014294,CHEMICAL,trimethaphan,trimethaphan
D000527,CHEMICAL,prostaglandin E1,prostaglandin E1
D002443,CHEMICAL,ceftriaxone,"Ceftriaxone Sodium|Ceftriaxon Curamed|Ceftriaxone, Disodium Salt, Hemiheptahydrate|Rocefalin|Ceftriaxona LDP Torlan|Anhydrous Ceftriaxone Sodium|Ro139904|ceftriaxone|Ro13-9904|Ro 13 9904|Longaceph|Tacex|Benaxona|Ceftrex|Lendacin|Ro 13-9904|Rocefin|Longacef|Ceftriaxon Hexal|Ro-13-9904|Rocephine|Terbac|Ro 139904|Ceftriaxone, Disodium Salt|Ceftriaxona Andreu|Ceftriaxone Irex|Cefatriaxone|Ro13 9904|Cefaxona|Ceftriaxone Sodium, Anhydrous|Rocephin|Ceftriaxon"
C030852,CHEMICAL,vinorelbine,vinorelbine
D019259,CHEMICAL,lamivudine,lamivudine
C065046,CHEMICAL,CP 93129,CP 93129
D013988,CHEMICAL,Ticlopidine,Ticlopidine
D009569,CHEMICAL,NO,NO
D018817,CHEMICAL,MDMA,"Methylenedioxymethamphetamine|MDMA|Ecstasy (Drug)|Hydrochloride, N-Methyl-3,4-methylenedioxyamphetamine|N Methyl 3,4 methylenedioxyamphetamine Hydrochloride|N-Methyl-3,4-methylenedioxyamphetamine Hydrochloride|N Methyl 3,4 methylenedioxyamphetamine"
C102006,CHEMICAL,citrate,citrate
D006493,CHEMICAL,heparin,heparin
D002996,CHEMICAL,clomiphene,"Gravosan|clomiphene|Clomid|Hydrochloride, Clomiphene|Klostilbegit|Serophene|Clomide|Dyneric|Clomiphene Citrate|Citrate, Clomiphene|Clomiphene Hydrochloride|Chloramiphene|Clostilbegit|Clomifen|Clomifene"
D002784,CHEMICAL,cholesterol,cholesterol
C031942,CHEMICAL,argatroban,argatroban
C110904,CHEMICAL,capecitabine,capecitabine
D009638,CHEMICAL,norepinephrine,norepinephrine
D001241,CHEMICAL,aspirin,aspirin
D007548,CHEMICAL,isosorbide dinitrate,isosorbide dinitrate
D005905,CHEMICAL,Glyburide,Glyburide
D007530,CHEMICAL,isoflurane,isoflurane
D012460,CHEMICAL,sulphasalazine,Azulfidine|Salicylazosulfapyridine|Salazopyrin|Colo-Pleon|Sulfasalazine FNA|Pleon|Salazosulfapyridine|Sulfasalazin Heyl|Colo Pleon|Sulfasalazin-Heyl|Azulfadine|ratio-Sulfasalazine|Ulcol|Asulfidine|ratio Sulfasalazine|Ucine|Sulfasalazin medac|sulphasalazine|Pyralin EN|Azulfidine EN|Sulphasalazine
D003606,CHEMICAL,dacarbazine,dacarbazine
D002066,CHEMICAL,Busulfan,Busulfan
D006221,CHEMICAL,halothane,halothane
C036006,CHEMICAL,oxcarbazepine,oxcarbazepine
D000667,CHEMICAL,ampicillin,ampicillin
D000658,CHEMICAL,amoxicillin,amoxicillin
D001279,CHEMICAL,atracurium,atracurium
D014673,CHEMICAL,vecuronium bromide,vecuronium bromide
D013311,CHEMICAL,streptozotocin,Streptozotocine|2-Deoxy-2-((methylnitrosoamino)carbonyl)amino-D-glucose|streptozotocin|Zanosar|Streptozotocin
C085788,CHEMICAL,MFL,MFL
D008619,CHEMICAL,mepivacaine,mepivacaine
D016559,CHEMICAL,tacrolimus,tacrolimus
C098725,CHEMICAL,S-(-)-ET-126,S-(-)-ET-126
C047426,CHEMICAL,venlafaxine,venlafaxine
C010637,CHEMICAL,terodiline,terodiline
D014750,CHEMICAL,vincristin,vincristin
D011346,CHEMICAL,prochlorperazine,"Prochlorperazine Edisylate Salt|Compazine|Salt, Prochlorperazine Edisylate|Edisylate Salt, Prochlorperazine|Edisylate, Prochlorperazine|Prochlorperazine Maleate|Prochlorperazine Edisylate|Maleate, Prochlorperazine|prochlorperazine"
D010396,CHEMICAL,D-penicillamine,D-penicillamine
D003907,CHEMICAL,RD,RD
D004997,CHEMICAL,ethinyl estradiol,ethinyl estradiol
D007531,CHEMICAL,diisopropylfluorophosphate,diisopropylfluorophosphate
C032302,CHEMICAL,rilmenidine,rilmenidine
C030262,CHEMICAL,triamcinolone diacetate,triamcinolone diacetate
D013739,CHEMICAL,Testosterone,Testosterone
D012906,CHEMICAL,smoking,smoking
C026098,CHEMICAL,levetiracetam,levetiracetam
C417083,CHEMICAL,pegylated interferon,pegylated interferon
C094645,CHEMICAL,aripiprazole,aripiprazole
C076029,CHEMICAL,olanzapine,olanzapine
D000661,CHEMICAL,amphetamine,amphetamine
D008454,CHEMICAL,mazindol,Mazanor|Mazindole|Solucaps|Sanorex|Teronak|Teronac|AN448|Sanjorex|mazindol|AN-448|Diestet
D015760,CHEMICAL,alfentanil,alfentanil
D005480,CHEMICAL,Flurbiprofen,Flurbiprofen
C005238,CHEMICAL,mipafox,mipafox
D001379,CHEMICAL,azathioprine,"azathioprine|Imuran|Azathioprine Sodium|Sodium, Azathioprine|Azothioprine|Immuran|Azathioprine Sodium Salt|Azathioprine Sulfate|Imurel"
D002330,CHEMICAL,BCNU,BCNU
D002251,CHEMICAL,carbon tetrachloride,carbon tetrachloride
D015282,CHEMICAL,octreotide,SMS 201-995|SAN 201 995|Compound 201995|SM 201 995|SAN 201995|Octreotide Acetate Salt|octreotide|Sandoz 201 995|SAN 201-995|Sandoz 201995|Sandoz 201-995|Compound 201 995|Sandostatin|Sandostatine|Compound 201-995|SM 201-995|SMS 201995|Octreotide Acetate|SM 201995|SMS 201 995
C072959,CHEMICAL,"1-chloro-1,2,2,2-tetrafluoroethane","1-chloro-1,2,2,2-tetrafluoroethane"
C067411,CHEMICAL,"1,1-dichloro-2,2,2-trifluoroethane","1,1-dichloro-2,2,2-trifluoroethane"
D011318,CHEMICAL,prilocaine,prilocaine
D008614,CHEMICAL,Pethidine,Demerol|Dolcontral|Meperidine Hydrochloride|Lidol|Lydol|Isonipecain|Dolsin|Dolantin|Dolargan|Dolin|Operidine EPJ-I|Operidine EPJ I|Pethidine|Dolosal
D001067,CHEMICAL,appetite suppressants,"Appetite Depressing Drugs|Drugs, Anorexigenic|Appetite-Depressing Drugs|Anorectic|Appetite-Suppressant Drug|Anorexigenic Drugs|Depressants, Appetite|Anorexigenic Drug|Appetite-Depressing Drug|Agent, Anorectic|Anorexic Drug|Depressant, Appetite|Appetite Suppressant|appetite suppressants|Drug, Appetite-Suppressant|Drugs, Anorexic|Suppressant, Appetite|Agents, Anorectic|Suppressants, Appetite|Anorectic Agents|Drug, Appetite-Depressing|Anorectics|Appetite Suppressant Drug|Appetite-Suppressant Drugs|Drug, Anorexic|Appetite Depressant|Appetite Suppressant Drugs|Appetite Depressing Drug|Drugs, Appetite-Depressing|Drug, Anorexigenic|Anorectic Agent|Drugs, Appetite-Suppressant|Appetite Suppressants|Anorexic Drugs"
D005839,CHEMICAL,gentamicin,gentamicin
D008775,CHEMICAL,methylprednisolone,methylprednisolone
C044834,CHEMICAL,iodixanol,iodixanol
D003287,CHEMICAL,contrast medium,contrast medium
D007479,CHEMICAL,iopamidol,iopamidol
D006514,CHEMICAL,HBsAg,HBsAg
D015632,CHEMICAL,MPTP,MPTP
C558899,CHEMICAL,lopinavir/ritonavir,lopinavir/ritonavir
D010424,CHEMICAL,pentobarbital,"Nembutal|Monosodium Salt Pentobarbital|Etaminal|Ethaminal|Pentobarbital, Monosodium Salt|Pentobarbital Sodium|Pentobarbitone|Mebumal|pentobarbital|Diabutal|Mebubarbital|Sagatal"
C492458,CHEMICAL,Simvastatin-ezetimibe,Simvastatin-ezetimibe
D003484,CHEMICAL,hydrogen cyanamide,hydrogen cyanamide
D014299,CHEMICAL,trimipramine,trimipramine
D001556,CHEMICAL,lindane,lindane
C068820,CHEMICAL,8-[(4-amino-l-methylbutyl)amino]- 5-(l-hexyloxy)-6-methoxy-4-methylquinoline,8-[(4-amino-l-methylbutyl)amino]- 5-(l-hexyloxy)-6-methoxy-4-methylquinoline
D005665,CHEMICAL,furosemide,furosemide
D007612,CHEMICAL,kanamycin,kanamycin
D018170,CHEMICAL,sumatriptan,sumatriptan
C067311,CHEMICAL,docetaxel,docetaxel
D003613,CHEMICAL,danazol,Danol|Danazol Ratiopharm|Danoval|danazol|Danazant|Azol|Danazol-Ratiopharm|Norciden|Ladogal|Cyclomen|Panacrine|Danocrine|Danatrol
D019980,CHEMICAL,combination of amoxicillin and clavulanic acid,"Co amoxiclav|Amoxi Clavulanate|Amoxicillin Clavulanic Acid|Amoxycillin, Clavulanate Potentiated|Clavulin|Spektramox|Synulox|Co-amoxiclav|BRL 25000|Coamoxiclav|Clavulanate Potentiated Amoxycillin|Amoxicillin-Clavulanic Acid|Amoxycillin Clavulanic Acid|Amoxicillin Potassium Clavulanate Combination|combination of amoxicillin and clavulanic acid|Amox clav|Amox-clav|Potassium Clavulanate-Amoxicillin Combination|Amoxi-Clavulanate|BRL25000|Amoxycillin-Clavulanic Acid|Potassium Clavulanate Amoxicillin Combination|Augmentin|BRL-25000"
D011342,CHEMICAL,Procainamide,Procainamide
D015073,CHEMICAL,2-acetylaminofluorene,2-acetylaminofluorene
D001564,CHEMICAL,benzo[a]-pyrene,benzo[a]-pyrene
D001374,CHEMICAL,5-azacytidine,5-azacytidine
D019813,CHEMICAL,"1,2-dimethylhydrazine","1,2-dimethylhydrazine"
D008770,CHEMICAL,N-methyl-N-nitrosourea,N-methyl-N-nitrosourea
C413408,CHEMICAL,atazanavir,atazanavir
C016986,CHEMICAL,aponidine hydrochloride,aponidine hydrochloride
C017367,CHEMICAL,Carmofur,Carmofur
D008801,CHEMICAL,mexiletine,mexiletine
D008972,CHEMICAL,molindone,"Molindone Monohydrochloride|Molindone Hydrochloride|Hydrochloride, Molindone|molindone|Monohydrochloride, Molindone|Moban"
D020748,CHEMICAL,Ro 40-5967,Ro 40-5967
D006513,CHEMICAL,hepatitis B virus e antigen,hepatitis B virus e antigen
D014031,CHEMICAL,tobramycin,tobramycin
C476217,CHEMICAL,cinacalcet HCl,cinacalcet HCl
D010248,CHEMICAL,paramethasone,paramethasone
D013395,CHEMICAL,sucrose,sucrose
D003630,CHEMICAL,daunorubicin,daunorubicin
D013449,CHEMICAL,Sulfonamides,Sulfonamides
D000477,CHEMICAL,alkylating agents,alkylating agents
C034818,CHEMICAL,"methyl 6,7-dimethoxy-4-ethyl-B-carboline-3-carboxylate","methyl 6,7-dimethoxy-4-ethyl-B-carboline-3-carboxylate"
D013331,CHEMICAL,strychnine,strychnine
D015097,CHEMICAL,3-mercaptopropionic acid,3-mercaptopropionic acid
C042315,CHEMICAL,CI-921,CI-921
C426686,CHEMICAL,Ximelagatran,Ximelagatran
C021341,CHEMICAL,cefazedone,cefazedone
D015790,CHEMICAL,cefonicid,cefonicid
C121249,CHEMICAL,NRA0160,NRA0160
D014217,CHEMICAL,troleandomycin,troleandomycin
D015248,CHEMICAL,gemfibrozil,gemfibrozil
D009567,CHEMICAL,nitrazepam,nitrazepam
D011405,CHEMICAL,propafenone,propafenone
D002512,CHEMICAL,cephalothin,cephalothin
D003401,CHEMICAL,creatine,creatine
D010894,CHEMICAL,piroxicam,piroxicam
C106876,CHEMICAL,DFU,DFU
C007789,CHEMICAL,fucoidan,fucoidan
C106791,CHEMICAL,telithromycin,telithromycin
C004616,CHEMICAL,2-chloroprocaine-CE,2-chloroprocaine-CE
D013467,CHEMICAL,sulindac,sulindac
D012312,CHEMICAL,ritodrine,ritodrine
D004967,CHEMICAL,estrogen,estrogen
C009265,CHEMICAL,levodopa/carbidopa,levodopa/carbidopa
C005618,CHEMICAL,benzoylecgonine,benzoylecgonine
D002122,CHEMICAL,calcium chloride,"calcium chloride|Calcium Chloride, Anhydrous|Calcium Chloride Dihydrate"
D017673,CHEMICAL,dietary sodium chloride,dietary sodium chloride
D019438,CHEMICAL,ritonavir,ritonavir
C021650,CHEMICAL,Hydrocortisone acetate,Hydrocortisone acetate
D002794,CHEMICAL,choline,choline
D008755,CHEMICAL,methylergonovine,methylergonovine
D000628,CHEMICAL,aminophylline,aminophylline
C093622,CHEMICAL,rizatriptan,rizatriptan
D001761,CHEMICAL,bleomycin,bleomycin
D014748,CHEMICAL,vinca alkaloid,vinca alkaloid
C104457,CHEMICAL,nelarabine,nelarabine
D007208,CHEMICAL,indocyanine green,indocyanine green
D009853,CHEMICAL,omeprazole,"Omeprazole Sodium|Prilosec|H 16868|H 168 68|Magnesium, Omeprazole|Sodium, Omeprazole|omeprazole|Omeprazole Magnesium|H 168-68"
D016049,CHEMICAL,didanosine,didanosine
C471405,CHEMICAL,sorafenib,sorafenib
C473478,CHEMICAL,sunitinib,sunitinib
D004025,CHEMICAL,dicyclomine,dicyclomine
C010882,CHEMICAL,chlorhexidine-digluconate,chlorhexidine-digluconate
D011206,CHEMICAL,povidone-iodine,povidone-iodine
C006820,CHEMICAL,bromperidol,bromperidol
C036150,CHEMICAL,beta-carboline,beta-carboline
D009568,CHEMICAL,nitrendipine,nitrendipine
C023470,CHEMICAL,Perhexiline maleate,Perhexiline maleate
D009943,CHEMICAL,organophosphorus (OP) poisons,organophosphorus (OP) poisons
D006170,CHEMICAL,gum Arabic,gum Arabic
C022189,CHEMICAL,zonisamide,zonisamide
D003513,CHEMICAL,cycloheximide,cycloheximide
D000641,CHEMICAL,ammonia,ammonia
D004491,CHEMICAL,edrophonium,edrophonium
D015119,CHEMICAL,epsilon-aminocaproic acid,epsilon-aminocaproic acid
D010400,CHEMICAL,benzylpenicillin,benzylpenicillin
C047781,CHEMICAL,lamotrigine,lamotrigine
D000305,CHEMICAL,corticosteroids,corticosteroids
D008794,CHEMICAL,metrizoate,metrizoate
C107135,CHEMICAL,everolimus,everolimus
D001498,CHEMICAL,BAY k-8644,BAY k-8644
D011374,CHEMICAL,progesterone,progesterone
D008353,CHEMICAL,mannitol,mannitol
C045645,CHEMICAL,cilostazol,cilostazol
C048081,CHEMICAL,beraprost,beraprost
C422649,CHEMICAL,etoricoxib,etoricoxib
C025541,CHEMICAL,Tri-ortho-tolyl phosphate,Tri-ortho-tolyl phosphate
D004656,CHEMICAL,enalapril,enalapril
D004232,CHEMICAL,diuretic,diuretic
D015080,CHEMICAL,mesna,mesna
C038192,CHEMICAL,iopromide,iopromide
D007472,CHEMICAL,iohexol,iohexol
D004977,CHEMICAL,ethambutol,ethambutol
D004041,CHEMICAL,fat,fat
D004876,CHEMICAL,ergot,ergot
D007505,CHEMICAL,iron dextran,iron dextran
D002701,CHEMICAL,chloramphenicol,chloramphenicol
D004917,CHEMICAL,erythromycins,erythromycins
D009428,CHEMICAL,netilmicin,netilmicin
C044946,CHEMICAL,benazapril,benazapril
D017392,CHEMICAL,thiobarbituric acid reactive substances,thiobarbituric acid reactive substances|TBARs
D008054,CHEMICAL,lipid hydroperoxides,lipid hydroperoxides
C012052,CHEMICAL,amisulpride,amisulpride
D063325,CHEMICAL,tiapride,tiapride
D001539,CHEMICAL,bendrofluazide,bendrofluazide
C059262,CHEMICAL,cidofovir,cidofovir
D014640,CHEMICAL,vancomycin,vancomycin
C418563,CHEMICAL,tenofovir disoproxil fumarate,tenofovir disoproxil fumarate
D007372,CHEMICAL,interferon,interferon
C019248,CHEMICAL,pamidronate,pamidronate
D002119,CHEMICAL,Calcium carbonate,"Vaterite|Carbonate, Calcium|Chalk|Limestone|Marble|Calcite|Milk of Calcium|Calcium Milk|Calcium carbonate|Aragonite"
D008550,CHEMICAL,melatonin,melatonin
D012701,CHEMICAL,serotonin,serotonin
D004298,CHEMICAL,dopamine,dopamine
C020976,CHEMICAL,azelastine,azelastine
D017693,CHEMICAL,Sodium bicarbonate,Sodium bicarbonate
D003473,CHEMICAL,nondepolarizing neuromuscular blocking agents,nondepolarizing neuromuscular blocking agents
D015232,CHEMICAL,Prostaglandin E2,Prostaglandin E2
D002752,CHEMICAL,chlorthalidone,chlorthalidone
D015230,CHEMICAL,Prostaglandin D2,Prostaglandin D2
D009643,CHEMICAL,norfloxacin,norfloxacin
D008942,CHEMICAL,mitoxantrone,"NSC-301739|CL232325|Mitoxantrone Hydrochloride|Onkotrone|NSC 287836|NSC 299195|NSC279836|NSC 301739|DHAQ|CL-232325|NSC301739|NSC301739D|NSC-287836|Mitozantrone|Novantrone|mitoxantrone|Ralenova|Novantron|Mitroxone|NSC-279836|Mitoxantrone Acetate|NSC299195|NSC 301739D|NSC287836|Hydrochloride, Mitoxantrone|NSC-299195|CL 232325|Acetate, Mitoxantrone|NSC 279836|Pralifan|NSC-301739D"
D018818,CHEMICAL,fenoldopam,fenoldopam
D006495,CHEMICAL,Low-molecular-weight heparin,Low-molecular-weight heparin
C052342,CHEMICAL,topiramate,topiramate
D007608,CHEMICAL,kainic acid,kainic acid
D005492,CHEMICAL,folate,folate
D000643,CHEMICAL,NH4CL,"Ammoniac, Sal|Sal Ammoniac|Chloride, Ammonium|NH4CL"
D013256,CHEMICAL,steroid,steroid
D004329,CHEMICAL,droperidol,Dehydrobenzperidol|Inapsine|Droleptan|Dehidrobenzperidol|droperidol
D004077,CHEMICAL,digoxin,digoxin
D014042,CHEMICAL,tolazamide,tolazamide
C014282,CHEMICAL,cirazoline,cirazoline
C056299,CHEMICAL,Abbott-53693,Abbott-53693
C476513,CHEMICAL,levobupivacaine,levobupivacaine
C037663,CHEMICAL,ropivacaine,ropivacaine
C051883,CHEMICAL,22-oxacalcitriol,22-oxacalcitriol
D002117,CHEMICAL,Calcitriol,"MC-1288|Silkis|Sitriol|1,25-Dihydroxyvitamin D3|1,25-dihydroxy-20-epi-Vitamin D3|1 alpha,25-Dihydroxycholecalciferol|Bocatriol|Osteotriol|1,25 Dihydroxyvitamin D3|1,25 dihydroxy 20 epi Vitamin D3|Decostriol|Calcitriol|Calcitriol-Nefro|Soltriol|1 alpha, 25-dihydroxy-20-epi-Vitamin D3|D3, 1 alpha,25-Dihydroxyvitamin|MC 1288|Calcitriol KyraMed|Renatriol|1,25(OH)2-20epi-D3|1,25 Dihydroxycholecalciferol|D3, 1,25-Dihydroxyvitamin|1, 25-(OH)2D3|1,25-Dihydroxycholecalciferol|1 alpha,25 Dihydroxyvitamin D3|Calcijex|Tirocal|D3, 1,25-dihydroxy-20-epi-Vitamin|Calcitriol Nefro|20-epi-1alpha,25-dihydroxycholecaliferol|MC1288|KyraMed, Calcitriol|1 alpha,25-Dihydroxyvitamin D3|Rocaltrol"
D013881,CHEMICAL,Mellaril,Mellaril
D009661,CHEMICAL,Aventyl,Aventyl
C117268,CHEMICAL,pimecrolimus,pimecrolimus
D000157,CHEMICAL,aconitine,aconitine
C076946,CHEMICAL,E-2020,E-2020
C049860,CHEMICAL,NIK-247,NIK-247
D004308,CHEMICAL,dothiepin hydrochloride,"Prothiaden|dothiepin hydrochloride|Dothiepin Hydrochloride|Dosulepin|Hydrochloride, Dothiepin"
D006046,CHEMICAL,gold,gold
C004504,CHEMICAL,2-bromoethylamine,2-bromoethylamine
C001335,CHEMICAL,hexachloro-1:3-butadiene,hexachloro-1:3-butadiene
C012655,CHEMICAL,nimesulide,nimesulide
D000894,CHEMICAL,NSAID,NSAID
C027278,CHEMICAL,Renografin 76%,Renografin 76%
C099041,CHEMICAL,tolterodine,tolterodine
D007854,CHEMICAL,lead,lead
D016685,CHEMICAL,Mitomycin C,Mitomycin C
C015173,CHEMICAL,dipivalyl epinephrine,dipivalyl epinephrine
D001205,CHEMICAL,Vitamin C,Vitamin C
D002747,CHEMICAL,Chlorpropamide,Chlorpropamide
D015313,CHEMICAL,Cefotetan,Cefotetan
C005177,CHEMICAL,L-DOPA/benserazide,L-DOPA/benserazide
D008130,CHEMICAL,CCNU,CCNU
C059896,CHEMICAL,N-butyl-deoxynojirimycin,N-butyl-deoxynojirimycin
C031662,CHEMICAL,"N10-propargyl-5,8-dideazafolic acid","N10-propargyl-5,8-dideazafolic acid"
C017610,CHEMICAL,fluphenazine enanthate,fluphenazine enanthate
D014221,CHEMICAL,triamcinolone,triamcinolone
C045894,CHEMICAL,lometrexol,lometrexol
C090450,CHEMICAL,anastrozole,anastrozole
D014667,CHEMICAL,vasopressin,vasopressin
D020105,CHEMICAL,milrinone,milrinone
D004737,CHEMICAL,enflurane,enflurane
D003561,CHEMICAL,cytosine arabinoside,cytosine arabinoside
D002351,CHEMICAL,carrageenan,carrageenan
D007660,CHEMICAL,ketoprofen,"RP 19583|RP19583|Alrheumat|2-(3-Benzoylphenyl)propionic Acid|Orudis|Profenid|Alrheumum|Benzoylhydratropic Acid|RP, 19,583|ketoprofen|19,583 RP|RP-19583"
D004052,CHEMICAL,diethylnitrosamine,diethylnitrosamine
C033457,CHEMICAL,Quinidine phenylethylbarbiturate,Quinidine phenylethylbarbiturate
D011802,CHEMICAL,Quinidine,"Quinidine|Chinidin|Quinora|Quinidine Sulfate|Adaquin|Apo-Quinidine|Quinidex|Sulfate, Quinidine|Apo Quinidine|Quincardine"
C400082,CHEMICAL,bortezomib,bortezomib
C084178,CHEMICAL,telmisartan,telmisartan
D010068,CHEMICAL,oxacillin,oxacillin
D000171,CHEMICAL,acrolein,acrolein
D005476,CHEMICAL,fluphenazine,fluphenazine
C081489,CHEMICAL,Valsartan,Valsartan
C061282,CHEMICAL,CGS 21680,CGS 21680
D008729,CHEMICAL,methoxamine,methoxamine
D009627,CHEMICAL,nomifensine,nomifensine
D008625,CHEMICAL,Tiopronin,Tiopronin
D015237,CHEMICAL,prostaglandin F2 alpha,prostaglandin F2 alpha
D013866,CHEMICAL,6-thioguanine,6-thioguanine
D043343,CHEMICAL,testosterone propionate,testosterone propionate
D009074,CHEMICAL,MSH,MSH
C044650,CHEMICAL,imipenem/cilastatin,imipenem/cilastatin
D010121,CHEMICAL,oxytocin,oxytocin
D005446,CHEMICAL,fluocinolone acetonide,fluocinolone acetonide
D010419,CHEMICAL,pentamidine,pentamidine
D004456,CHEMICAL,echothiophate iodide,echothiophate iodide
D000728,CHEMICAL,androgen,androgen
C033706,CHEMICAL,tiazofurin,tiazofurin
C055162,CHEMICAL,clopidogrel,clopidogrel
C006780,CHEMICAL,Bisphenol A,Bisphenol A
C467567,CHEMICAL,RD,RD
C098010,CHEMICAL,Linezolid,Linezolid
D003976,CHEMICAL,diazinon,diazinon
C051890,CHEMICAL,irinotecan,irinotecan
C086816,CHEMICAL,desvenlafaxine,desvenlafaxine
C065180,CHEMICAL,fluvastatin,fluvastatin
D015251,CHEMICAL,epirubicine,epirubicine
D010758,CHEMICAL,phosphorus,phosphorus
C069541,CHEMICAL,quetiapine,quetiapine
C002752,CHEMICAL,norpethidine,norpethidine
C042288,CHEMICAL,Pilsicainide,Pilsicainide
C106487,CHEMICAL,S-53482,S-53482
C083440,CHEMICAL,S-23121,S-23121
C041359,CHEMICAL,terbinafine,terbinafine
C067431,CHEMICAL,letrozole,letrozole
C486464,CHEMICAL,telaprevir,telaprevir
C049430,CHEMICAL,mivacurium,mivacurium
C039726,CHEMICAL,artesunate,artesunate
C030272,CHEMICAL,maleate,maleate
D052638,CHEMICAL,particulate matter,particulate matter
D010126,CHEMICAL,ozone,ozone
C031763,CHEMICAL,"1,3-Butadiene","1,3-Butadiene"
C051786,CHEMICAL,metolachlor,metolachlor
D001152,CHEMICAL,inorganic arsenic,inorganic arsenic
C024986,CHEMICAL,BaCl2,BaCl2
D008696,CHEMICAL,Dianabol,Dianabol
D014810,CHEMICAL,vitamin E,vitamin E
D017275,CHEMICAL,Isradipine,Isradipine
D003035,CHEMICAL,cobalt,cobalt
C020731,CHEMICAL,carbetocin,carbetocin
D008558,CHEMICAL,melphalan,melphalan
D016578,CHEMICAL,crack cocaine,crack cocaine
D003932,CHEMICAL,heroine,heroine
D009278,CHEMICAL,naphazoline,naphazoline
C009695,CHEMICAL,xylometazoline,xylometazoline
D002228,CHEMICAL,carbenicillin,carbenicillin
D005280,CHEMICAL,fenoterol-hydrobromide,fenoterol-hydrobromide
C000873,CHEMICAL,methylprednisolone acetate,methylprednisolone acetate
D013752,CHEMICAL,tetracycline,tetracycline
D004976,CHEMICAL,Ethacrynic acid,Ethacrynic acid
D004049,CHEMICAL,diethylcarbamazine,diethylcarbamazine
D016595,CHEMICAL,misoprostol,misoprostol
D013852,CHEMICAL,thiotepa,thiotepa
D020110,CHEMICAL,pinacidil,pinacidil
D008528,CHEMICAL,mefenamic acid,mefenamic acid
C048279,CHEMICAL,chlorhexidine diphosphanilate,chlorhexidine diphosphanilate
D001712,CHEMICAL,biperiden,"Biperiden Hydrochloride|Akineton|Biperiden, 1R-(1 alpha,2 alpha(R*),4 alpha)-Isomer|Biperidene|alpha-Bicyclo(2.2.1)hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|biperiden|Hydrochloride, Biperiden|Biperiden, 1S-(1 alpha,2 alpha(R*),4 alpha)-Isomer"
D019793,CHEMICAL,fluorescein,fluorescein
D013327,CHEMICAL,strophanthidin,strophanthidin
D010567,CHEMICAL,pertussis vaccine,pertussis vaccine
D012980,CHEMICAL,sodium salicylate,"sodium salicylate|Salicylate, Sodium"
D013827,CHEMICAL,thiabendazole,thiabendazole
D001507,CHEMICAL,beclomethasone dipropionate,beclomethasone dipropionate
D005479,CHEMICAL,flurazepam,flurazepam
D003900,CHEMICAL,deoxycorticosterone,deoxycorticosterone
D011796,CHEMICAL,quinacrine hydrochloride,"Acrichine|Atabrine|Quinacrine Monohydrochloride|Hydrochloride, Quinacrine|Quinacrine Dihydrochloride, Dihydrate|Dihydrochloride, Quinacrine|Quinacrine Dimesylate|Quinacrine Hydrochloride|Quinacrine, (R)-Isomer|Quinacrine, (+-)-Isomer|Monohydrochloride, Quinacrine|Quinacrine, (S)-Isomer|Mepacrine|Monomesylate, Quinacrine|Dimesylate, Quinacrine|Quinacrine Monoacetate|Quinacrine Dihyrochloride, (R)-Isomer|Atebrin|Monoacetate, Quinacrine|Quinacrine Dihydrochloride|Quinacrine Monomesylate|Quinacrine Dihyrochloride, (S)-Isomer|quinacrine hydrochloride"
C034868,CHEMICAL,CPDD,CPDD
C006753,CHEMICAL,Endografine,Endografine
C025504,CHEMICAL,Dimer-X,Dimer-X
D014295,CHEMICAL,trimethoprim,trimethoprim
D002506,CHEMICAL,cephalexin,cephalexin
D001534,CHEMICAL,bemegride,bemegride
D001127,CHEMICAL,arginine vasopressin,arginine vasopressin
D002118,CHEMICAL,Calcium,Calcium
D000468,CHEMICAL,alkali,Alkalis|Alkali|alkali
D013015,CHEMICAL,"d,l-sotalol","d,l-sotalol"
D004053,CHEMICAL,diethylpropion,diethylpropion
D000109,CHEMICAL,acetylcholine,acetylcholine
C040442,CHEMICAL,helodermin,helodermin
C065757,CHEMICAL,Meloxicam,Meloxicam
D001554,CHEMICAL,benzene,benzene
C059765,CHEMICAL,amphotericin B-sodium deoxycholate,amphotericin B-sodium deoxycholate
D013411,CHEMICAL,sulfadiazine,sulfadiazine
C027429,CHEMICAL,veralipride,veralipride
D019888,CHEMICAL,Viracept,Viracept
C057837,CHEMICAL,DMPX,DMPX
C451780,CHEMICAL,niacin extended-release/lovastatin,niacin extended-release/lovastatin
C105934,CHEMICAL,celecoxib,celecoxib
C035133,CHEMICAL,mirtazapine,mirtazapine
D011188,CHEMICAL,potassium,potassium
D004365,CHEMICAL,Chinese herbal,Chinese herbal
C116926,CHEMICAL,rofecoxib,rofecoxib
D052246,CHEMICAL,COX-2 inhibitors,"Inhibitor, COX-2|Inhibitor, COX2|COX2 Inhibitors|Inhibitors, COX-2|2 Inhibitor, Cyclooxygenase|Inhibitors, COX2|Inhibitors, Cyclooxygenase 2|COX 2 Inhibitor|Coxib|COX-2 Inhibitors|COX2 Inhibitor|Cyclooxygenase-2 Inhibitor|COX-2 inhibitors|Cyclooxygenase 2 Inhibitor|Coxibs|COX-2 Inhibitor|Inhibitor, Cyclooxygenase 2|COX 2 Inhibitors|Inhibitors, Cyclooxygenase-2|Inhibitor, Cyclooxygenase-2|Cyclooxygenase-2 Inhibitors"
D010100,CHEMICAL,oxygen,oxygen
C042705,CHEMICAL,PEG-asparaginase,PEG-asparaginase
D004113,CHEMICAL,Succimer,Succimer
C085143,CHEMICAL,Piperacillin/tazobactam,Piperacillin/tazobactam
D018119,CHEMICAL,d4T,d4T
D019772,CHEMICAL,Topotecan,Topotecan
C071741,CHEMICAL,Remifentanil,Remifentanil
D005424,CHEMICAL,flecainide,flecainide
C542870,CHEMICAL,botox,botox
C401859,CHEMICAL,temsirolimus,temsirolimus
D017257,CHEMICAL,ramipril,ramipril
D009254,CHEMICAL,nafcillin,nafcillin
D005947,CHEMICAL,glucose,glucose
D005690,CHEMICAL,galactose,galactose
http://purl.obolibrary.org/obo/DOID_0040102,DISEASE,"N,N'-diethylthiourea allergic contact dermatitis","N,N'-diethylthiourea allergic contact dermatitis"
http://purl.obolibrary.org/obo/DOID_251,DISEASE,alcohol-induced mental disorder,alcohol-induced mental disorder
http://purl.obolibrary.org/obo/DOID_252,DISEASE,alcoholic psychosis,alcoholic psychosis
http://purl.obolibrary.org/obo/DOID_0040010,DISEASE,mepivacaine allergy,mepivacaine allergy
http://purl.obolibrary.org/obo/DOID_0040103,DISEASE,cefotiam allergy,cefotiam allergy
http://purl.obolibrary.org/obo/DOID_0040079,DISEASE,"2,4-dinitrophenyl allergic contact dermatitis","2,4-dinitrophenyl allergic contact dermatitis"
http://purl.obolibrary.org/obo/DOID_0090047,DISEASE,paroxysmal nonkinesigenic dyskinesia 2,paroxysmal nonkinesigenic dyskinesia 2
http://purl.obolibrary.org/obo/DOID_0060505,DISEASE,apricot allergy,apricot allergy
http://purl.obolibrary.org/obo/DOID_0040020,DISEASE,cefotaxime allergy,cefotaxime allergy
http://purl.obolibrary.org/obo/DOID_0040011,DISEASE,phenobarbital allergy,phenobarbital allergy
http://purl.obolibrary.org/obo/DOID_8680,DISEASE,alcoholic gastritis,alcoholic gastritis
http://purl.obolibrary.org/obo/DOID_4377,DISEASE,egg allergy,egg allergy
http://purl.obolibrary.org/obo/DOID_0040001,DISEASE,shrimp allergy,shrimp allergy
http://purl.obolibrary.org/obo/DOID_0040002,DISEASE,aspirin allergy,aspirin allergy
http://purl.obolibrary.org/obo/DOID_0060495,DISEASE,shellfish allergy,shellfish allergy
http://purl.obolibrary.org/obo/DOID_0060506,DISEASE,cherry allergy,cherry allergy
http://purl.obolibrary.org/obo/DOID_0060523,DISEASE,mollusc allergy,mollusc allergy
http://purl.obolibrary.org/obo/DOID_0040033,DISEASE,piperacillin allergy,piperacillin allergy
http://purl.obolibrary.org/obo/DOID_0040016,DISEASE,sulfamethoxazole allergy,sulfamethoxazole allergy
http://purl.obolibrary.org/obo/DOID_0060510,DISEASE,peach allergy,peach allergy
http://purl.obolibrary.org/obo/DOID_0040006,DISEASE,carbamazepine allergy,carbamazepine allergy
http://purl.obolibrary.org/obo/DOID_0080949,DISEASE,alcoholic ketoacidosis,alcoholic ketoacidosis
http://purl.obolibrary.org/obo/DOID_0040024,DISEASE,ceftazidime allergy,ceftazidime allergy
http://purl.obolibrary.org/obo/DOID_0040043,DISEASE,toluene meta-diisocyanate allergic asthma,toluene meta-diisocyanate allergic asthma
http://purl.obolibrary.org/obo/DOID_0040026,DISEASE,chlorhexidine allergy,chlorhexidine allergy
http://purl.obolibrary.org/obo/DOID_0040034,DISEASE,rocuronium allergy,rocuronium allergy
http://purl.obolibrary.org/obo/DOID_0040051,DISEASE,hexahydrophthalic anhydride allergic asthma,hexahydrophthalic anhydride allergic asthma
http://purl.obolibrary.org/obo/DOID_0040042,DISEASE,"diphenylmethane-4,4'-diisocyanate allergic asthma","diphenylmethane-4,4'-diisocyanate allergic asthma"
http://purl.obolibrary.org/obo/DOID_0040025,DISEASE,cefuroxime allergy,cefuroxime allergy
http://purl.obolibrary.org/obo/DOID_0060524,DISEASE,crustacean allergy,crustacean allergy
http://purl.obolibrary.org/obo/DOID_0040007,DISEASE,abacavir allergy,abacavir allergy
http://purl.obolibrary.org/obo/DOID_0060515,DISEASE,Atlantic salmon allergy,Atlantic salmon allergy
http://purl.obolibrary.org/obo/DOID_0040015,DISEASE,sulfonamide allergy,sulfonamide allergy
http://purl.obolibrary.org/obo/DOID_12935,DISEASE,alcoholic cardiomyopathy,alcoholic cardiomyopathy
http://purl.obolibrary.org/obo/DOID_0040052,DISEASE,"diphenylmethane-4,4'-diisocyanate allergic contact dermatitis","diphenylmethane-4,4'-diisocyanate allergic contact dermatitis"
http://purl.obolibrary.org/obo/DOID_0040035,DISEASE,sulfasalazine allergy,sulfasalazine allergy
http://purl.obolibrary.org/obo/DOID_0060519,DISEASE,beta-lactam allergy,beta-lactam allergy
http://purl.obolibrary.org/obo/DOID_0040047,DISEASE,trimellitic anhydride allergic asthma,trimellitic anhydride allergic asthma
http://purl.obolibrary.org/obo/DOID_0060516,DISEASE,carp allergy,carp allergy
http://purl.obolibrary.org/obo/DOID_0040070,DISEASE,co-trimoxazole allergy,co-trimoxazole allergy
http://purl.obolibrary.org/obo/DOID_0040053,DISEASE,cobalt allergic contact dermatitis,cobalt allergic contact dermatitis
http://purl.obolibrary.org/obo/DOID_0040057,DISEASE,benzoic acid allergic contact dermatitis,benzoic acid allergic contact dermatitis
http://purl.obolibrary.org/obo/DOID_0070334,DISEASE,vegetable allergy,vegetable allergy
http://purl.obolibrary.org/obo/DOID_0040080,DISEASE,patent blue V allergy,patent blue V allergy
http://purl.obolibrary.org/obo/DOID_0040048,DISEASE,phthalic anhydride allergic asthma,phthalic anhydride allergic asthma
http://purl.obolibrary.org/obo/DOID_4988,DISEASE,alcoholic pancreatitis,alcoholic pancreatitis
http://purl.obolibrary.org/obo/DOID_0040038,DISEASE,meropenem allergy,meropenem allergy
http://purl.obolibrary.org/obo/DOID_0040071,DISEASE,sodium aurothiomalate allergy,sodium aurothiomalate allergy
http://purl.obolibrary.org/obo/DOID_0040029,DISEASE,trimethoprim allergy,trimethoprim allergy
http://purl.obolibrary.org/obo/DOID_0040044,DISEASE,methyl isocyanate allergic asthma,methyl isocyanate allergic asthma
http://purl.obolibrary.org/obo/DOID_0040061,DISEASE,remazole black respiratory allergy,remazole black respiratory allergy
http://purl.obolibrary.org/obo/DOID_0040049,DISEASE,maleic anhydride allergic asthma,maleic anhydride allergic asthma
http://purl.obolibrary.org/obo/DOID_0040062,DISEASE,chloramine T respiratory allergy,chloramine T respiratory allergy
http://purl.obolibrary.org/obo/DOID_0040076,DISEASE,phthalyl group allergy,phthalyl group allergy
http://purl.obolibrary.org/obo/DOID_0040066,DISEASE,melphalan allergy,melphalan allergy
http://purl.obolibrary.org/obo/DOID_0050667,DISEASE,alcohol-related neurodevelopmental disorder,alcohol-related neurodevelopmental disorder
http://purl.obolibrary.org/obo/DOID_12351,DISEASE,alcoholic hepatitis,acute alcoholic liver disease|Alcoholic Hepatitis|acute alcoholic hepatitis|Alcoholic hepatitis|acute Alcoholic Hepatitis|alcoholic hepatitis
http://purl.obolibrary.org/obo/DOID_0060001,DISEASE,withdrawal disorder,withdrawal disorder
http://purl.obolibrary.org/obo/DOID_0050668,DISEASE,alcohol-related birth defect,alcohol-related birth defect
http://purl.obolibrary.org/obo/DOID_0070335,DISEASE,celery allergy,celery allergy
http://purl.obolibrary.org/obo/DOID_0040058,DISEASE,"1,4-phenylenediamine allergic contact dermatitis","1,4-phenylenediamine allergic contact dermatitis"
http://purl.obolibrary.org/obo/DOID_0040075,DISEASE,benzo[d]isothiazol-3-one allergic contact dermatitis,benzo[d]isothiazol-3-one allergic contact dermatitis
http://purl.obolibrary.org/obo/DOID_14018,DISEASE,alcoholic liver cirrhosis,alcoholic liver cirrhosis
http://purl.obolibrary.org/obo/DOID_0040003,DISEASE,benzylpenicillin allergy,benzylpenicillin allergy
http://purl.obolibrary.org/obo/DOID_0040030,DISEASE,cefixime allergy,cefixime allergy
http://purl.obolibrary.org/obo/DOID_0040013,DISEASE,ranitidine allergy,ranitidine allergy
http://purl.obolibrary.org/obo/DOID_0050696,DISEASE,fetal alcohol spectrum disorder,fetal alcohol spectrum disorder
http://purl.obolibrary.org/obo/DOID_0060504,DISEASE,apple allergy,apple allergy
http://purl.obolibrary.org/obo/DOID_0040004,DISEASE,amoxicillin allergy,amoxicillin allergy
http://purl.obolibrary.org/obo/DOID_0040021,DISEASE,cephalosporin allergy,cephalosporin allergy
http://purl.obolibrary.org/obo/DOID_0040012,DISEASE,phenytoin allergy,phenytoin allergy
http://purl.obolibrary.org/obo/DOID_0040104,DISEASE,"toluene 2,4-diisocyanate allergic asthma","toluene 2,4-diisocyanate allergic asthma"
http://purl.obolibrary.org/obo/DOID_0060511,DISEASE,plum allergy,plum allergy
http://purl.obolibrary.org/obo/DOID_0090044,DISEASE,dystonia 9,dystonia 9
http://purl.obolibrary.org/obo/DOID_0040022,DISEASE,amodiaquine allergy,amodiaquine allergy
http://purl.obolibrary.org/obo/DOID_0040005,DISEASE,ceftriaxone allergy,ceftriaxone allergy
http://purl.obolibrary.org/obo/DOID_0060512,DISEASE,tomato allergy,tomato allergy
http://purl.obolibrary.org/obo/DOID_0060530,DISEASE,snail allergy,snail allergy
http://purl.obolibrary.org/obo/DOID_0060513,DISEASE,fish allergy,fish allergy
http://purl.obolibrary.org/obo/DOID_14183,DISEASE,alcoholic neuropathy,alcoholic neuropathy
http://purl.obolibrary.org/obo/DOID_0040017,DISEASE,suprofen allergy,suprofen allergy
http://purl.obolibrary.org/obo/DOID_0060503,DISEASE,fruit allergy,fruit allergy
http://purl.obolibrary.org/obo/DOID_0060520,DISEASE,penicillin allergy,penicillin allergy
http://purl.obolibrary.org/obo/DOID_0060492,DISEASE,chicken egg allergy,chicken egg allergy
http://purl.obolibrary.org/obo/DOID_0090049,DISEASE,paroxysmal nonkinesigenic dyskinesia 1,paroxysmal nonkinesigenic dyskinesia 1
http://purl.obolibrary.org/obo/DOID_0040023,DISEASE,cefaclor allergy,cefaclor allergy
http://purl.obolibrary.org/obo/DOID_0040040,DISEASE,hexamethylene diisocyanate allergic asthma,hexamethylene diisocyanate allergic asthma
http://purl.obolibrary.org/obo/DOID_4376,DISEASE,milk allergy,milk allergy
http://purl.obolibrary.org/obo/DOID_0040027,DISEASE,cyclophosphamide allergy,cyclophosphamide allergy
http://purl.obolibrary.org/obo/DOID_0040018,DISEASE,thiopental allergy,thiopental allergy
http://purl.obolibrary.org/obo/DOID_0040050,DISEASE,tetrachlorophthalic anhydride allergic asthma,tetrachlorophthalic anhydride allergic asthma
http://purl.obolibrary.org/obo/DOID_0040041,DISEASE,isocyanates allergic asthma,isocyanates allergic asthma
http://purl.obolibrary.org/obo/DOID_0040008,DISEASE,isoniazide allergy,isoniazide allergy
http://purl.obolibrary.org/obo/DOID_0060508,DISEASE,orange allergy,orange allergy
http://purl.obolibrary.org/obo/DOID_0040014,DISEASE,corticosteroid allergy,corticosteroid allergy
http://purl.obolibrary.org/obo/DOID_0040031,DISEASE,diclofenac allergy,diclofenac allergy
http://purl.obolibrary.org/obo/DOID_0040032,DISEASE,carbapenem allergy,carbapenem allergy
http://purl.obolibrary.org/obo/DOID_0060518,DISEASE,rainbow trout allergy,rainbow trout allergy
http://purl.obolibrary.org/obo/DOID_0040019,DISEASE,D-mannitol allergy,D-mannitol allergy
http://purl.obolibrary.org/obo/DOID_0060509,DISEASE,melon allergy,melon allergy
http://purl.obolibrary.org/obo/DOID_0040009,DISEASE,lidocaine allergy,lidocaine allergy
http://purl.obolibrary.org/obo/DOID_0040063,DISEASE,4-vinylcyclohexene dioxide respiratory allergy,4-vinylcyclohexene dioxide respiratory allergy
http://purl.obolibrary.org/obo/DOID_0040046,DISEASE,nickel allergic contact dermatitis,nickel allergic contact dermatitis
http://purl.obolibrary.org/obo/DOID_0040036,DISEASE,tubocurarine allergy,tubocurarine allergy
http://purl.obolibrary.org/obo/DOID_0040054,DISEASE,cobalt allergic asthma,cobalt allergic asthma
http://purl.obolibrary.org/obo/DOID_0040073,DISEASE,disodium cromoglycate allergy,disodium cromoglycate allergy
http://purl.obolibrary.org/obo/DOID_0040056,DISEASE,chromium allergic contact dermatitis,chromium allergic contact dermatitis
http://purl.obolibrary.org/obo/DOID_0060904,DISEASE,legume allergy,legume allergy
http://purl.obolibrary.org/obo/DOID_0040081,DISEASE,acid anhydride respiratory allergy,acid anhydride respiratory allergy
http://purl.obolibrary.org/obo/DOID_0040064,DISEASE,carvone allergic contact dermatitis,carvone allergic contact dermatitis
http://purl.obolibrary.org/obo/DOID_0040055,DISEASE,palladium allergic contact dermatitis,palladium allergic contact dermatitis
http://purl.obolibrary.org/obo/DOID_0040072,DISEASE,parthenolide allergic contact dermatitis,parthenolide allergic contact dermatitis
http://purl.obolibrary.org/obo/DOID_0040037,DISEASE,aztreonam allergy,aztreonam allergy
http://purl.obolibrary.org/obo/DOID_0040045,DISEASE,nickel allergic asthma,nickel allergic asthma
http://purl.obolibrary.org/obo/DOID_0040028,DISEASE,succinylcholine allergy,succinylcholine allergy
http://purl.obolibrary.org/obo/DOID_0040065,DISEASE,quinidine allergy,quinidine allergy
http://purl.obolibrary.org/obo/DOID_0040082,DISEASE,oxirane allergy,oxirane allergy
http://purl.obolibrary.org/obo/DOID_0050665,DISEASE,fetal alcohol syndrome,fetal alcohol syndrome
http://purl.obolibrary.org/obo/DOID_0040069,DISEASE,"1-chloro-2,4-dinitrobenzene allergic contact dermatitis","1-chloro-2,4-dinitrobenzene allergic contact dermatitis"
http://purl.obolibrary.org/obo/DOID_0040077,DISEASE,alcuronium bromide allergy,alcuronium bromide allergy
http://purl.obolibrary.org/obo/DOID_14081,DISEASE,toxic labyrinthitis,toxic labyrinthitis
http://purl.obolibrary.org/obo/DOID_0050666,DISEASE,partial fetal alcohol syndrome,partial fetal alcohol syndrome
http://purl.obolibrary.org/obo/DOID_0040101,DISEASE,"N,N'-diphenylthiourea allergic contact dermatitis","N,N'-diphenylthiourea allergic contact dermatitis"
http://purl.obolibrary.org/obo/DOID_0040078,DISEASE,gallamine allergy,gallamine allergy
http://purl.obolibrary.org/obo/DOID_0040068,DISEASE,4-tert-butylphenol allergic contact dermatitis,4-tert-butylphenol allergic contact dermatitis
http://purl.obolibrary.org/obo/DOID_0040059,DISEASE,potassium dichromate allergic contact dermatitis,potassium dichromate allergic contact dermatitis
http://purl.obolibrary.org/obo/DOID_0040074,DISEASE,formaldehyde allergic contact dermatitis,formaldehyde allergic contact dermatitis
NEW00000,MENTAL_HEALTH,acquired generalized hypoactive sexual desire disorder,acquired generalized hypoactive sexual desire disorder
NEW00002,CHEMICAL,reduced testosterone,reduced testosterone
NEW00003,DISEASE,erectile function,erectile function
NEW00004,BIOCHEMICAL,safe drug,safe drug
NEW00005,DISEASE,psychiatric adverse events,psychiatric adverse events
NEW00006,DISEASE,cognitive functioning =,cognitive functioning =
D000690,DISEASE,Amyotrophic Lateral Sclerosis,"Dementia With Amyotrophic Lateral Sclerosis|Disease, Guam|Gehrig Disease|Motor Neuron Disease, Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis|Lou Gehrig's Disease|Gehrigs Disease|Charcot Disease|Amyotrophic Lateral Sclerosis With Dementia|Lou-Gehrigs Disease|ALS Amyotrophic Lateral Sclerosis|Sclerosis, Amyotrophic Lateral|ALS - Amyotrophic Lateral Sclerosis|Gehrig's Disease|Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam|Guam Disease|Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1|Disease, Lou-Gehrigs|Lou Gehrig Disease|Guam Form of Amyotrophic Lateral Sclerosis|Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam|Amyotrophic Lateral Sclerosis, Guam Form|Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1"
NEW00008,CHEMICAL,high plasma pentosidine levels,high plasma pentosidine levels
NEW00009,DISEASE,idiopathic carbonyl stress,idiopathic carbonyl stress
NEW00010,CHEMICAL,high pentosidine levels,high pentosidine levels
NEW00017,BIOCHEMICAL,low serum folate values,low serum folate values
D027982,CHEMICAL,Sodium-Bicarbonate Symporters,"SLC4A4 Protein|Sodium Coupled Bicarbonate Transporters|Transporters, Sodium-Coupled Bicarbonate|Sodium Bicarbonate Symport|Solute Carrier Family 4 Member 10|Protein, NBCe2|Protein, SLC4A10|Solute Carrier Family 4, Sodium Bicarbonate Cotransporter, Member 10|Solute Carrier Family 4 Member 5|Solute Carrier Family 4 Member 7|Solute Carrier Family 4, Sodium Bicarbonate Cotransporter, Member 4|Symport, Na-HCO3|Sodium-Bicarbonate Cotransporter|NBCn2 Protein|Protein, NBC1|Na-HCO3 Symport|Protein, NBC3|Sodium Bicarbonate Cotransporter 2|Protein, NBCE1|k NBC3 Protein|SLC4A8 Protein|Bicarbonate Transporters, Sodium-Coupled|Symporters, Sodium-Bicarbonate|Electroneutral Na(+)-Driven Cl-HCO3 Exchanger|Electrogenic Sodium Bicarbonate Cotransporter 4|Protein, NBCn2|NBCE1 Protein|Protein, k-NBC3|SLC4A5 Protein|Sodium Bicarbonate Cotransporter|SLC4A7 Protein|Sodium Bicarbonate Cotransporter 3|bicarbonate|Na HCO3 Symport|Sodium-Coupled Bicarbonate Transporters|Sodium driven chloride bicarbonate exchanger|NBCe2 Protein|NCBE Protein|Solute Carrier Family 4 Member 8|Solute Carrier Family 4, Sodium Bicarbonate Cotransporter, Member 8|Protein, SLC4A4|NBC3 Protein|Bicarbonate Symport, Sodium|Protein, SLC4A8|Solute Carrier Family 4, Sodium Bicarbonate Cotransporter, Member 7|SLC4A10 Protein|Protein, NBC4|Sodium-driven chloride bicarbonate exchanger|Sodium Bicarbonate Symporters|Symport, Sodium Bicarbonate|Electroneutral Sodium Bicarbonate Exchanger 1|NBC4 Protein|Electrogenic Sodium Bicarbonate Cotransporter 1|Protein, SLC4A7|Protein, SLC4A5|Cotransporter, Sodium-Bicarbonate|NBC1 Protein|k-NBC3 Protein|Solute Carrier Family 4 Member 4|Solute Carrier Family 4, Sodium Bicarbonate Cotransporter, Member 5"
D009123,DISEASE,Muscle Hypotonia,"Hypotonias, Unilateral|Tone Poor, Muscle|Muscles, Floppy|Muscle Tone Atonic|hypotonia|Muscle Hypotony|Muscle Tone, Flaccid|Muscular Flaccidity|Neonatal Hypotonia|Muscular Hypotonia|Tone Atonic, Muscle|Floppy Muscle|Muscle Tone Poor|Flaccid Muscle Tone|Floppy Muscles|Muscle Flaccidity|Flaccidity, Muscular|Hypotonia, Muscle|Muscle Tone, Decreased|Muscle, Floppy|Hypomyotonia|Neonatal Hypotonias|Hypotonias, Neonatal|Hypotonia|Hypotonia, Unilateral|Hypotonia, Neonatal|Flaccidity, Muscle|Muscle Tone Atonics|Hypotony, Muscle|Hypotonia, Muscular|Unilateral Hypotonia|Muscular Flaccidities|Decreased Muscle Tone"
NEW00020,DISEASE,organic aciduria,organic aciduria
NEW00021,DISEASE,ketolactic acidosis,ketolactic acidosis
NEW00028,DISEASE,dyskinetic-like behavior,dyskinetic-like behavior
NEW00029,CHEMICAL,l-dopa efficacy,l-dopa efficacy
NEW00031,DISEASE,haloperidol-induced catalepsy,haloperidol-induced catalepsy
NEW00033,DISEASE,parkinsonian rats,parkinsonian rats
NEW00036,BIOCHEMICAL,agonist drugs,agonist drugs
NEW00038,BIOCHEMICAL,drug class,drug class
NEW00042,CHEMICAL,voltage sensitive calcium channels,voltage sensitive calcium channels
NEW00044,DISEASE,chronic stress-induced cognitive deficits,chronic stress-induced cognitive deficits
NEW00046,DISEASE,neurodegeneration effect,neurodegeneration effect
NEW00049,CHEMICAL,age ≤ old female gender,age ≤ old female gender
NEW00050,DISEASE,electric seizure threshold,electric seizure threshold
NEW00052,CHEMICAL,opioid-naive patients,opioid-naive patients
NEW00053,DISEASE,renal impairment due,renal impairment due
D000072716,DISEASE,Cancer Pain,"Pain, Cancer-Associated|Pains, Oncological|Pain, Tumor-Related|Neoplasm Associated Pain|Pains, Neoplasm-Related|Pains, Cancer-Associated|Oncological Pain|Tumor-Related Pains|Pains, Cancer-Related|Pain, Oncological|Neoplasm-Associated Pains|Cancer Related Pain|Oncological Pains|Tumor Related Pain|Pain, Tumor-Associated|cancer pain|Neoplasm-Associated Pain|Pain, Cancer-Related|Cancer Pains|Pains, Oncology|Neoplasm-Related Pains|Tumor-Related Pain|Pain, Oncology|Cancer-Associated Pains|Oncology Pains|Tumor-Associated Pains|Tumor-Associated Pain|Oncology Pain|Cancer-Related Pains|Cancer-Related Pain|Pains, Tumor-Associated|Cancer-Associated Pain|Pain, Neoplasm-Associated|Pain, Neoplasm-Related|Pains, Tumor-Related|Neoplasm-Related Pain|Pains, Neoplasm-Associated|Pains, Cancer|Pain, Cancer|Neoplasm Related Pain|Tumor Associated Pain|Cancer Associated Pain"
NEW00054,DISEASE,severe postoperative pain,severe postoperative pain
NEW00055,DISEASE,cerebral oedema,cerebral oedema
NEW00056,DISEASE,cardiac conduction abnormalities,cardiac conduction abnormalities
NEW00058,DISEASE,deep coma,deep coma
NEW00059,DISEASE,recurrent seizures,recurrent seizures
NEW00062,MENTAL_HEALTH,new depression episodes,new depression episodes
NEW00063,DISEASE,co-occurring pain,co-occurring pain
D001492,NUTRITION,Bass,"Basses, Temperate|Micropterus|sea bass|Basses, Sea|Bass, Sea|Morone americana|Dicentrarchus|Serranidae|Perch, White|Moronidae|Sea Bass|Temperate Basses|Morone|Sea Basses|White Perch"
NEW00069,CHEMICAL,kaempferol glycosides,kaempferol glycosides
NEW00071,DISEASE,pentylenetetrazole-induced mice,pentylenetetrazole-induced mice
NEW00073,DISEASE,ulcer prophylaxis,ulcer prophylaxis
NEW00076,DISEASE,nosemosis,nosemosis
NEW00081,DISEASE,urinary tract calculi,urinary tract calculi
D010411,DISEASE,Penile Induration,"Cavernitis, Fibrous|Cavernitides, Fibrous|Peyronie's Disease|Fibrous Cavernitides|Penile Fibromatosis|Fibrous Cavernitis|Peyronies Disease|Peyronie Disease|Peyronie's disease|Plastic Induration of the Penis|Fibromatosis, Penile"
NEW00082,MENTAL_HEALTH,female sexual dysfunction,female sexual dysfunction
NEW00083,DISEASE,urinary illnesses,urinary illnesses
NEW00085,DISEASE,benign prostatic hyperplasia sufferers,benign prostatic hyperplasia sufferers
NEW00087,DISEASE,prostate tumor growth,prostate tumor growth
NEW00090,DISEASE,prostate tumors,prostate tumors
NEW00093,DISEASE,overactive bladder syndrome,overactive bladder syndrome
NEW00094,DISEASE,benign prostatic enlargement/benign prostatic obstruction,benign prostatic enlargement/benign prostatic obstruction
NEW00096,CHEMICAL,purine catabolism,purine catabolism
NEW00097,CHEMICAL,excess sulphite,excess sulphite
NEW00099,CHEMICAL,second messenger cyclic ADP-ribose,second messenger cyclic ADP-ribose
NEW00100,DISEASE,tumor factor-alpha production,tumor factor-alpha production
D003327,DISEASE,Coronary Disease,"Coronary Heart Disease|Disease, Coronary|Disease, Coronary Heart|Coronary Heart Diseases|Heart Diseases, Coronary|Coronary Diseases|Diseases, Coronary Heart|Diseases, Coronary|Heart Disease, Coronary|coronary heart diseases"
NEW00103,CHEMICAL,pyruvate dehydrogenase activity,pyruvate dehydrogenase activity
D001928,DISEASE,"Brain Diseases, Metabolic","Metabolic Disorder, CNS|Brain Diseases, Metabolic, Acquired|Metabolic Diseases, Acquired, Nervous System|Encephalopathy, Metabolic, Acquired|Brain Disorders, Metabolic|Encephalopathies, Acquired Metabolic|Metabolic Disorders, Brain|Metabolic Brain Diseases|Nervous System Acquired Metabolic Diseases|Encephalopathy, Acquired Metabolic|CNS Metabolic Disorders|Acquired Metabolic Diseases, Nervous System|Encephalopathy, Metabolic|Brain Metabolic Disorders|Brain Syndrome, Metabolic|Brain Metabolic Disorder|Metabolic Encephalopathy, Acquired|Metabolic Brain Diseases, Acquired|Metabolic Encephalopathy|Metabolic Brain Syndrome|Encephalopathies, Metabolic|Metabolic Encephalopathies, Acquired|Brain Syndrome, Metabolic, Acquired|Metabolic Disorders, CNS|Brain Disorders, Metabolic, Acquired|Acquired Metabolic Diseases, Brain|Metabolic Brain Disease|brain disorders|Acquired Metabolic Encephalopathy|Metabolic Brain Syndrome, Acquired|Acquired Metabolic Encephalopathies|Metabolic Disorders, CNS, Acquired|Metabolic Brain Disorders|Central Nervous System Metabolic Disorders|Metabolic Brain Disorder|CNS Metabolic Disorder|Metabolic Disorder, Central Nervous System, Acquired|Brain Disease, Metabolic|Brain Disorder, Metabolic|CNS Metabolic Disorders, Acquired|Metabolic Encephalopathies|Metabolic Brain Syndromes, Acquired|Metabolic Disorders, Central Nervous System|Metabolic Brain Syndromes|Metabolic Disorder, Brain"
D055825,DISEASE,National Institute of Neurological Disorders and Stroke (U.S.),neurological disorders|National Institute of Neurological Disorders and Stroke|NINDS
D008375,CHEMICAL,Maple Syrup Urine Disease,"Maple Syrup Urine Disease, Classic|MSUD (Maple Syrup Urine Disease)|Maple Syrup Urine Disease, Classical|Branched Chain alpha Keto Acid Dehydrogenase Deficiency|Branched-Chain alpha-Keto Acid Dehydrogenase Deficiency|Branched Chain Ketoaciduria|Branched-Chain Ketoaciduria|Intermediate Maple Syrup Urine Disease|Thiamine Responsive Maple Syrup Urine Disease|BCKD Deficiency|Ketoacidurias, Branched-Chain|Maple Syrup Urine Disease, Thiamine Responsive|Classic Maple Syrup Urine Disease|Intermittent Maple Syrup Urine Disease|Classical Maple Syrup Urine Disease|Branched-Chain Ketoacidurias|Keto Acid Decarboxylase Deficiency|MSUD|Maple Syrup Urine Disease, Intermittent|Ketoaciduria, Branched-Chain|Maple Syrup Urine Disease, Thiamine-Responsive|Maple Syrup Urine Disease, Intermediate|Maple syrup urine disease"
NEW00110,CHEMICAL,essential amino acid tryptophan,TRP|essential amino acid tryptophan
NEW00112,NUTRITION,plasma tryptophan,plasma tryptophan
NEW00113,DISEASE,rare inherited metabolic diseases,rare inherited metabolic diseases
NEW00114,DISEASE,neurocognitive deficits,neurocognitive deficits
NEW00115,CHEMICAL,glutamine consumption,glutamine consumption
NEW00117,DISEASE,Huntington 's disease,HD|Huntington 's disease
NEW00119,MENTAL_HEALTH,transient hallucinations,transient hallucinations
NEW00120,CHEMICAL,alcohol withdrawal syndrome,alcohol withdrawal syndrome
NEW00121,DISEASE,dose-limited absorption,dose-limited absorption
NEW00123,CHEMICAL,"estrogen-mediated liver Trp 2,3-dioxygenase","estrogen-mediated liver Trp 2,3-dioxygenase"
NEW00125,CHEMICAL,albumin-bound Trp,albumin-bound Trp
NEW00126,CHEMICAL,cerebral serotonin synthesis,cerebral serotonin synthesis
D009752,DISEASE,Nutritional Status,"Status, Nutrition|Status, Nutritional|nutritional status|Nutrition Status"
NEW00129,DISEASE,neuropsychiatric abnormalities,neuropsychiatric abnormalities
NEW00131,CHEMICAL,corticosterone concentrations,corticosterone concentrations
NEW00132,CHEMICAL,norepinephrine systems,norepinephrine systems
NEW00133,MENTAL_HEALTH,acute stress reactions,acute stress reactions
D000788,DISEASE,"Angina Pectoris, Variant","Prinzmetals Angina|Angina, Prinzmetal|Prinzmetal Angina|Prinzmetal's Angina|Angina, Prinzmetal's|angina pectoris|Variant Angina Pectoris"
D001145,DISEASE,"Arrhythmias, Cardiac","Dysrhythmia, Cardiac|Arrhythmia|arrhythmias|Cardiac Arrhythmias|Arrythmia|Cardiac Dysrhythmia|Arrhythmia, Cardiac|Cardiac Arrhythmia"
NEW00134,CHEMICAL,specific anti-hostility effect,specific anti-hostility effect
NEW00135,DISEASE,persistent aggressive behaviour,persistent aggressive behaviour
NEW00136,DISEASE,poor impulsivity,poor impulsivity
NEW00138,DISEASE,drug- withdrawal syndromes,drug- withdrawal syndromes
NEW00139,DISEASE,advanced pancreatic cancer,advanced pancreatic cancer
NEW00140,MENTAL_HEALTH,associated anxiety,associated anxiety
NEW00142,DISEASE,euthyroidism,euthyroidism
NEW00143,DISEASE,medication-induced sexual adverse effects,medication-induced sexual adverse effects
NEW00144,BIOCHEMICAL,long-term beta-adrenoceptor antagonist therapy,long-term beta-adrenoceptor antagonist therapy
NEW00146,BIOCHEMICAL,cardioselective beta(1)-adrenoceptor antagonists,cardioselective beta(1)-adrenoceptor antagonists
NEW00147,BIOCHEMICAL,antihypertensive drug treatment,antihypertensive drug treatment
NEW00151,DISEASE,nightly CNS-symptoms,nightly CNS-symptoms
C565201,DISEASE,"Prostate Cancer, Hereditary, 7 [Supplementary Concept]",Prostatic Neoplasms|aggressiveness
NEW00153,DISEASE,aggressive behaviour,aggressive behaviour
NEW00160,MENTAL_HEALTH,possible metabolic depression,possible metabolic depression
NEW00162,DISEASE,extrapyramidal symptoms,extrapyramidal symptoms
NEW00164,DISEASE,acute akathisia,acute akathisia
NEW00165,CHEMICAL,mianserin,mianserin
NEW00166,CHEMICAL,vitamin,vitamin
NEW00168,DISEASE,neuroleptic-induced movement disorders,neuroleptic-induced movement disorders
NEW00171,DISEASE,paraesthesias,paraesthesias
NEW00172,DISEASE,rhinorrhoea,rhinorrhoea
D011000,DISEASE,"Pleurodynia, Epidemic","Myalgia, Epidemic|Epidemic Myalgias|myalgias|Pleurodynias, Epidemic|Bornholm Disease|Epidemic Myalgia|Epidemic Pleurodynias|Epidemic Pleurodynia|Myalgias, Epidemic"
NEW00173,DISEASE,diaphoresis,diaphoresis
NEW00174,DISEASE,persecution,persecution
NEW00175,MENTAL_HEALTH,severe anxiety,severe anxiety
NEW00176,MENTAL_HEALTH,drowsiness,drowsiness
NEW00177,DISEASE,suicidality,suicidality
NEW00179,MENTAL_HEALTH,characteristic hyperactivity,characteristic hyperactivity
NEW00180,MENTAL_HEALTH,dream-like hallucinations,dream-like hallucinations
NEW00181,CHEMICAL,tolterodine users,tolterodine users
C015586,CHEMICAL,propiverine [Supplementary Concept],propiverine|Benzilates
NEW00182,BIOCHEMICAL,schizophrenia drug abuse,schizophrenia drug abuse
D055808,BIOCHEMICAL,Drug Discovery,"Discovery, Drug|Drug Prospecting|drug discovery|Prospecting, Drug"
NEW00183,DISEASE,GI motility,GI motility
NEW00184,BIOCHEMICAL,potential analgesic agents,potential analgesic agents
NEW00186,DISEASE,chronic regional pain syndrome,chronic regional pain syndrome
NEW00192,MENTAL_HEALTH,anxiety interventions,anxiety interventions
NEW00193,BIOCHEMICAL,partial benzodiazepine-GABA receptor antagonists,partial benzodiazepine-GABA receptor antagonists
NEW00197,BIOCHEMICAL,NK3 receptor antagonist,NK3 receptor antagonist
NEW00199,DISEASE,progressive extrapyramidal dysfunction,progressive extrapyramidal dysfunction
NEW00200,DISEASE,McLeod's syndrome,McLeod's syndrome
D054546,DISEASE,Neuroacanthocytosis,"chorea-acanthocytosis|Chorea Acanthocytosis Syndrome|Acanthocytosis with Neurologic Disorder|Choreoacanthocytoses|Chorea Acanthocytosis|Acanthocytoses, Chorea|Acanthocytosis, Chorea|Chorea-Acanthocytosis|Choreoacanthocytosis|Chorea Acanthocytoses|Chorea Acanthocytosis Syndromes|Chorea-Acanthocytoses|Levine Critchley Syndrome|Levine-Critchley Syndrome"
NEW00202,CHEMICAL,brain iron accumulation diseases,brain iron accumulation diseases
NEW00204,DISEASE,severe progressive dystonia,severe progressive dystonia
NEW00205,MENTAL_HEALTH,rare neuropsychiatric syndromes,rare neuropsychiatric syndromes
NEW00206,CHEMICAL,intrathecal baclofen infusion,intrathecal baclofen infusion
NEW00207,CHEMICAL,mmol L-carnitine/kg BW,mmol L-carnitine/kg BW
D048828,CHEMICAL,beta-N-Acetyl-Galactosaminidase,N Acetyl beta Galactosaminidase|acetyl|beta N Acetyl Galactosaminidase|beta-N-Acetylgalactosaminidase|N-Acetyl-beta-Galactosaminidase|beta N Acetylgalactosaminidase
NEW00210,CHEMICAL,triphosphate CoA levels,triphosphate CoA levels
NEW00212,CHEMICAL,L-carnitine administration,L-carnitine administration
NEW00214,DISEASE,rare disorder PKAN,rare disorder PKAN
NEW00215,DISEASE,common neurodegenerative diseases,common neurodegenerative diseases
NEW00216,DISEASE,neurobehavioral impairments,neurobehavioral impairments
NEW00217,DISEASE,LPS-induced dopaminergic neuronal loss,LPS-induced dopaminergic neuronal loss
NEW00219,MENTAL_HEALTH,Nrf2/ARE-dependent HO-1 pathway defense mechanism,Nrf2/ARE-dependent HO-1 pathway defense mechanism
NEW00221,DISEASE,experimental PD,experimental PD
NEW00222,DISEASE,progressive weight loss,progressive weight loss
NEW00224,DISEASE,mHTT-evoked energy deficiency,mHTT-evoked energy deficiency
NEW00226,DISEASE,IR induced neurological symptoms,IR induced neurological symptoms
NEW00227,DISEASE,hippocampal neuronal damage,hippocampal neuronal damage
NEW00229,DISEASE,hyperlocomotion,hyperlocomotion
NEW00233,DISEASE,global cerebral IR injury,global cerebral IR injury
NEW00236,DISEASE,pain-related behaviors,pain-related behaviors
NEW00238,CHEMICAL,pioglitazone microinjection,pioglitazone microinjection
NEW00239,DISEASE,anxiety- behaviors,anxiety- behaviors
NEW00241,DISEASE,NAFLD/NASH patients,NAFLD/NASH patients
NEW00243,BIOCHEMICAL,CXCR(4 antagonist development,CXCR(4 antagonist development
NEW00250,DISEASE,diarrhea prominent irritable bowel syndrome,diarrhea prominent irritable bowel syndrome
NEW00251,DISEASE,human lumbar cerebrospinal fluid,human lumbar cerebrospinal fluid
NEW00252,CHEMICAL,phosphatidyl-inositol-4-kinase-catalytic-alpha,phosphatidyl-inositol-4-kinase-catalytic-alpha
NEW00253,DISEASE,22q11.2 region,22q11.2 region
D013398,DISEASE,Sudden Infant Death,"Sudden Infant Death Syndrome|Cot Death|SID|Death, Cot|Crib Death|Infant Death, Sudden|Death, Crib|Death, Sudden Infant|Cot Deaths|SIDS|sudden infant death syndrome"
NEW00257,DISEASE,related weight loss,related weight loss
NEW00258,CHEMICAL,ethanol-derived radicals,ethanol-derived radicals
NEW00259,NUTRITION,long-chain omega-3 polyunsaturated fatty acids,long-chain omega-3 polyunsaturated fatty acids
NEW00261,DISEASE,compulsive disorders,compulsive disorders
NEW00263,DISEASE,desaturation,desaturation
D005234,DISEASE,Fatty Liver,"Liver Steatosis|liver steatosis|Visceral Steatoses|Steatosis, Liver|Steatoses, Visceral|Steatoses, Liver|Steatosis, Visceral|Visceral Steatosis|Steatosis of Liver|Steatohepatitis|Steatohepatitides|Liver Steatoses|Liver, Fatty"
NEW00267,DISEASE,chronic fatigue-like condition,chronic fatigue-like condition
NEW00269,MENTAL_HEALTH,fatigue animals,fatigue animals
NEW00272,CHEMICAL,sulfonlyureas,sulfonlyureas
NEW00274,CHEMICAL,fasting plasma glucose,fasting plasma glucose
NEW00275,DISEASE,sustained chronic hyperglycemia,sustained chronic hyperglycemia
NEW00277,MENTAL_HEALTH,peripheral vascular resistance,peripheral vascular resistance
NEW00284,CHEMICAL,gonadotrophins,gonadotrophins
NEW00287,DISEASE,endometriosis symptoms,endometriosis symptoms
NEW00288,BIOCHEMICAL,Toxic Substances Control,Toxic Substances Control
NEW00289,MENTAL_HEALTH,transient central nervous system depression,transient central nervous system depression
NEW00290,DISEASE,rodent toxicity endpoints,rodent toxicity endpoints
NEW00292,DISEASE,tumor growth enhancement,tumor growth enhancement
NEW00295,DISEASE,oral carcinogenesis,oral carcinogenesis
NEW00297,DISEASE,colon inflammation,colon inflammation
NEW00298,CHEMICAL,plasmatic corticosterone,plasmatic corticosterone
NEW00299,DISEASE,colon carcinogenesis,colon carcinogenesis
NEW00301,DISEASE,carcinogen-induced mammary cancer progression,carcinogen-induced mammary cancer progression
D010903,DISEASE,"Pituitary Gland, Anterior","Anterior Pituitary Glands|Lobus Anterior|Anterior Pituitary Gland|pituitary glands|Pituitary Anterior Lobe|Anterior, Lobus|Lobus Anteriors|Pituitary Glands, Anterior|Adenohypophysis|Anterior Lobe of Pituitary|Anteriors, Lobus|Pars Distalis of Pituitary|Pituitary Pars Distalis|Adenohypophyses"
NEW00302,DISEASE,carcinogen-induced tumors,carcinogen-induced tumors
NEW00303,BIOCHEMICAL,Group carcinogen,Group carcinogen
C537258,DISEASE,Fibrolamellar hepatocellular carcinoma [Supplementary Concept],"Carcinoma, Hepatocellular|hepatocellular carcinoma"
NEW00305,DISEASE,acute/chronic hepatitis,acute/chronic hepatitis
NEW00306,DISEASE,studies tumors,studies tumors
NEW00308,CHEMICAL,TNF-alpha treatment,TNF-alpha treatment
NEW00309,DISEASE,Club cell mitogenesis,Club cell mitogenesis
NEW00310,DISEASE,necrotic changes,necrotic changes
NEW00312,DISEASE,leukemia patients,leukemia patients
D020953,DISEASE,Neuroaspergillosis,"Nervous System Invasive Aspergillosis|invasive aspergillosis|Aspergillosis, Nervous System Invasive|Neuroaspergilloses"
NEW00313,BIOCHEMICAL,primary antifungal agent,primary antifungal agent
NEW00316,CHEMICAL,once-daily 750-mg SCY-078 dose,once-daily 750-mg SCY-078 dose
NEW00317,BIOCHEMICAL,higher toxin levels,higher toxin levels
NEW00319,DISEASE,higher maximum stroke volume,higher maximum stroke volume
NEW00321,DISEASE,National Acute Porphyria Service,National Acute Porphyria Service
D046351,DISEASE,"Protoporphyria, Erythropoietic","Erythropoietic Protoporphyria|Protoporphyrias, Erythropoietic|Erythropoietic Protoporphyrias|Deficiencies, Heme Synthetase|Heme Synthetase Deficiencies|Synthetase Deficiency, Heme|Deficiencies, Ferrochelatase|Deficiency, Ferrochelatase|Deficiency, Heme Synthetase|Synthetase Deficiencies, Heme|Ferrochelatase Deficiencies|Ferrochelatase Deficiency|Heme Synthetase Deficiency|protoporphyria|Erythrohepatic Protoporphyria"
D059345,DISEASE,Cerebral Small Vessel Diseases,"Cerebral Small Vessel Disease|Microangiopathies, Cerebral|Cerebral Microangiopathies|Cerebral Microangiopathy|Microangiopathy, Cerebral|diseases"
NEW00326,DISEASE,rare porphyria,rare porphyria
D046349,DISEASE,"Coproporphyria, Hereditary","hereditary coproporphyria|Hereditary Coproporphyria|Coproporphyrinogen Oxidase Deficiency|Deficiency, Coproporphyrinogen Oxidase"
NEW00327,CHEMICAL,ALA dehydratase,ADP|ALA dehydratase
D017118,DISEASE,"Porphyria, Acute Intermittent","Deficiency, Porphobilinogen Deaminase|Porphobilinogen Deaminase Deficiencies|Porphyrias, Acute Intermittent|Deaminase Deficiency, Porphobilinogen|Deficiency, Uroporphyrinogen Synthase|Synthase Deficiencies, Hydroxymethylbilane|Deaminase Deficiencies, Porphobilinogen|PBGD Deficiencies|Intermittent Porphyrias, Acute|Porphobilinogen Deaminase Deficiency|Swedish Type Porphyrias|Acute Intermittent Porphyrias|Synthase Deficiency, Uroporphyrinogen|UPS Deficiency|acute intermittent porphyria|PBGD Deficiency|Intermittent Porphyria, Acute|Deficiencies, Uroporphyrinogen Synthase|Type Porphyria, Swedish|Porphyrias, Acute|Synthase Deficiencies, Uroporphyrinogen|Deficiency, UPS|Deficiencies, UPS|UPS Deficiencies|Deficiencies, PBGD|Swedish Type Porphyria|Deficiencies, Porphobilinogen Deaminase|Acute Porphyria|Hydroxymethylbilane Synthase Deficiencies|Hydroxymethylbilane Synthase Deficiency|Deficiencies, Hydroxymethylbilane Synthase|Porphyria, Acute|Porphyria, Swedish Type|Acute Intermittent Porphyria|Uroporphyrinogen Synthase Deficiencies|Synthase Deficiency, Hydroxymethylbilane|Acute Porphyrias|Type Porphyrias, Swedish|Uroporphyrinogen Synthase Deficiency|Deficiency, Hydroxymethylbilane Synthase|Deficiency, PBGD|Porphyrias, Swedish Type"
NEW00330,CHEMICAL,Trp metabolite picolinic acid,Trp metabolite picolinic acid
NEW00331,CHEMICAL,haem precursor 5-aminolaevulinic acid,haem precursor 5-aminolaevulinic acid
NEW00332,NUTRITION,photo-reactive porphyrins,photo-reactive porphyrins
NEW00333,CHEMICAL,histidine metabolite urocanic acid,histidine metabolite urocanic acid
NEW00334,CHEMICAL,serotonin deficiency,serotonin deficiency
NEW00335,CHEMICAL,5-ALA Trp metabolite kynurenic acid,5-ALA Trp metabolite kynurenic acid
D054506,DISEASE,Chloracne,"Acne, Chlorine|Chlorine Acne|Chlorine Acnes|Acnes, Chlorine|chloracne|Chloracnes"
D015828,DISEASE,"Eye Infections, Viral","Infections, Viral Eye|Viral Eye Infection|Eye Infection, Viral|Infections, Viral Ocular|viral infection|Viral Eye Infections|Viral Ocular Infections|Infection, Viral Eye|Ocular Infections, Viral|Infection, Viral Ocular|Ocular Infection, Viral|Viral Ocular Infection"
NEW00342,DISEASE,phototoxic skin reaction,phototoxic skin reaction
NEW00343,NUTRITION,poly-carboxylated porphyrins,poly-carboxylated porphyrins
NEW00346,DISEASE,chronic HCV infection,chronic HCV infection
NEW00348,DISEASE,relevant porphyria,relevant porphyria
NEW00351,DISEASE,Sociability,Sociability
C513117,CHEMICAL,precoproporphyrin [Supplementary Concept],Porphyrins|precoproporphyrin
C034350,CHEMICAL,pentacarboxylic porphyrin [Supplementary Concept],Porphyrins|pentacarboxyporphyrin
NEW00353,NUTRITION,intoxication-associated urinary porphyrins,intoxication-associated urinary porphyrins
NEW00354,DISEASE,mild ASDs,mild ASDs
NEW00356,DISEASE,autistic symptoms,autistic symptoms
C538258,DISEASE,ATR-X syndrome [Supplementary Concept],"Mental Retardation, X-Linked|alpha-Thalassemia|ATR-X syndrome"
NEW00357,DISEASE,ATR-X syndrome patient,ATR-X syndrome patient
NEW00358,DISEASE,ATR-X syndrome model,ATR-X syndrome model
NEW00360,DISEASE,HIV neuropathogenesis,HIV neuropathogenesis
NEW00362,CHEMICAL,dopamine rich brain regions,dopamine rich brain regions
NEW00364,DISEASE,PD-associated pain,PD-associated pain
NEW00370,DISEASE,MPTP-treated marmosets,MPTP-treated marmosets
NEW00371,MENTAL_HEALTH,akinesia movement,akinesia movement
NEW00372,MENTAL_HEALTH,obvious dyskinesia,obvious dyskinesia
NEW00378,DISEASE,receptor-mediated psychosis-like behaviours,receptor-mediated psychosis-like behaviours
NEW00380,DISEASE,hyperprolactinemia movement disorders,hyperprolactinemia movement disorders
NEW00381,DISEASE,psychotic illnesses,psychotic illnesses
NEW00383,MENTAL_HEALTH,moderate sexual dysfunction,moderate sexual dysfunction
NEW00388,BIOCHEMICAL,dopamine receptor agonist drugs,dopamine receptor agonist drugs
NEW00389,MENTAL_HEALTH,impulse control disorders secondary,impulse control disorders secondary
NEW00393,CHEMICAL,apomorphine treatment,apomorphine treatment
NEW00394,DISEASE,advanced Parkinson disease,advanced Parkinson disease
NEW00397,CHEMICAL,apomorphine bolus,apomorphine bolus
NEW00400,DISEASE,off-phases dyskinesias,off-phases dyskinesias
C096258,DISEASE,"ALTA1 protein, Alternaria alternata [Supplementary Concept]",Allergens|Fungal Proteins|Alternaria alternata
NEW00408,DISEASE,new psychiatric disorders,new psychiatric disorders
D000077550,CHEMICAL,Ivabradine,"S-16257|S-16257-2|Corlanor|ivabradine|S 16257|S 16257 2|S 162572|S162572|S16257|S 16257-2|S-16260-2|S 16260-2|S 162602|7,8-Dimethoxy-3-(3-(((4,5-dimethoxybenzocyclobutan-1-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-2H-benzazepin-2-one|S 16260 2|S162602"
NEW00411,BIOCHEMICAL,beta-blocker,beta-blocker
NEW00412,DISEASE,concomitant congestive heart failure,concomitant congestive heart failure
C067192,CHEMICAL,ibutilide [Supplementary Concept],ibutilide|Sulfonamides
D054141,DISEASE,Ventricular Flutter,flutter|Ventricular Flutters
D014693,DISEASE,Ventricular Fibrillation,"fibrillation|Fibrillations, Ventricular|Fibrillation, Ventricular|Ventricular Fibrillations"
NEW00416,DISEASE,impaired cell contact,impaired cell contact
NEW00418,CHEMICAL,ongoing NIMV,ongoing NIMV
NEW00420,MENTAL_HEALTH,high anxiety,high anxiety
NEW00421,MENTAL_HEALTH,deafferentation syndromes,deafferentation syndromes
D014313,DISEASE,Trismus,"Masseter Muscle Spasms|Spasms, Masseter|Lockjaw|Muscle Spasms, Masseter|Spasms, Masseter Muscle|Spasm, Masseter|Masseter Spasms|muscle spasm|Masseter Muscle Spasm|Muscle Spasm, Masseter|Spasm, Masseter Muscle|Lock Jaw|Masseter Spasm"
NEW00423,CHEMICAL,desflurane anesthesia,desflurane anesthesia
NEW00424,DISEASE,breast cancer survivors,breast cancer survivors
NEW00425,BIOCHEMICAL,low estrogen,low estrogen
NEW00428,MENTAL_HEALTH,greater analgesia,greater analgesia
NEW00429,CHEMICAL,low dose oxycodone,low dose oxycodone
NEW00433,CHEMICAL,tyrosine kinase receptor B (TrkB)/calmodulin,tyrosine kinase receptor B (TrkB)/calmodulin
NEW00434,DISEASE,MA-induced neurotoxicity,MA-induced neurotoxicity
NEW00435,DISEASE,neurotoxic diseases related,neurotoxic diseases related
NEW00437,BIOCHEMICAL,better analgesic effect,better analgesic effect
NEW00439,BIOCHEMICAL,pain analgesic consumption,pain analgesic consumption
NEW00442,DISEASE,rodent aphthous ulcer pain,rodent aphthous ulcer pain
D059265,DISEASE,Visceral Pain,"Visceral Pains|Pains, Visceral|visceral pain|Pain, Visceral"
NEW00444,DISEASE,significant antivisceral pain effect,significant antivisceral pain effect
NEW00446,MENTAL_HEALTH,heterotypic intermittent chronic stress protocol,heterotypic intermittent chronic stress protocol
NEW00447,CHEMICAL,"2,4,6-trinitrobenzene sulfonic acid","2,4,6-trinitrobenzene sulfonic acid"
NEW00448,DISEASE,antivisceral pain mechanism,antivisceral pain mechanism
NEW00449,DISEASE,marked pain effects,marked pain effects
NEW00451,DISEASE,comorbid psychiatric condition,comorbid psychiatric condition
NEW00453,DISEASE,chronic osteoarthritic pain,chronic osteoarthritic pain
NEW00458,CHEMICAL,Kv7 potassium channels,Kv7 potassium channels
D059373,DISEASE,Mastodynia,"Pain, Breast|Breast Pains|Mammalgia|Mammalgias|Mastalgias|Pains, Breast|Mastodynias|mastalgia|Mastalgia|Breast Pain"
NEW00460,DISEASE,acute pain conditions,acute pain conditions
D004361,BIOCHEMICAL,Drug Tolerance,"Tolerance, Drug|Drug Tolerances|Tolerances, Drug|drug tolerance"
NEW00461,BIOCHEMICAL,analgesic effect,analgesic effect
NEW00463,CHEMICAL,α2-AR modulation,α2-AR modulation
NEW00465,CHEMICAL,NA p    2C-AR antagonism,NA p    2C-AR antagonism
D000068099,DISEASE,Trauma and Stressor Related Disorders,Trauma and Stress Related Disorders|stress-related disorders
NEW00467,DISEASE,gastrointestinal damage,gastrointestinal damage
NEW00468,DISEASE,traumatic skeletal injuries,traumatic skeletal injuries
NEW00469,DISEASE,needle-related procedural pain,needle-related procedural pain
NEW00470,BIOCHEMICAL,adjunct analgesic therapies,adjunct analgesic therapies
NEW00472,DISEASE,postoperative respiratory depression,postoperative respiratory depression
NEW00473,MENTAL_HEALTH,postoperative intravenous analgesia,postoperative intravenous analgesia
D048949,DISEASE,Labor Pain,"Pain, Obstetric|labor pain|Pain, Labor|Obstetric Pain"
NEW00476,DISEASE,hepatic toxicity threshold,hepatic toxicity threshold
NEW00479,BIOCHEMICAL,analgesic medication,analgesic medication
NEW00484,DISEASE,stimulus-evoked chronic pain,stimulus-evoked chronic pain
NEW00487,DISEASE,Nav1.8,Nav1.8
NEW00488,CHEMICAL,NMDA receptor antagonism,NMDA receptor antagonism
NEW00489,CHEMICAL,Cav2.2 channels,Cav2.2 channels
D020222,DISEASE,Abducens Nerve Injury,"Traumatic Sixth-Nerve Palsy|Injury, Sixth Cranial Nerve|Traumatic Sixth-Nerve Palsies|Nerve Trauma, Abducens|Nerve Traumas, Abducens|Sixth Cranial Nerve Injury|Traumatic Sixth Nerve Palsy|Sixth Nerve Trauma|Sixth Nerve Palsy, Traumatic|Sixth-Nerve Traumas|Sixth-Nerve Palsies, Traumatic|Sixth-Nerve Palsy, Traumatic|Injuries, Abducens Nerve|Abducens Neuropathy, Traumatic|nerve injury|Traumatic Abducens Neuropathies|Abducens Nerve Injuries|Trauma, Abducens Nerve|Traumas, Sixth-Nerve|Abducens Nerve Traumas|Traumatic Abducens Neuropathy|Cranial Nerve VI Injury|Nerve Injury, Abducens|Trauma, Sixth-Nerve|Abducens Nerve Trauma|Sixth Cranial Nerve Injuries|Injury, Cranial Nerve VI|Injury, Abducens Nerve|Sixth-Nerve Trauma|Abducens Neuropathies, Traumatic|Traumas, Abducens Nerve|Nerve Injuries, Abducens"
NEW00493,CHEMICAL,mature GABA,mature GABA
NEW00496,CHEMICAL,insufficient maternal oxytocin,insufficient maternal oxytocin
NEW00497,DISEASE,white matter asymmetry,white matter asymmetry
NEW00498,DISEASE,diabetic peripheral neuropathy,diabetic peripheral neuropathy
D051474,DISEASE,"Neuralgia, Postherpetic",postherpetic neuralgia|Postherpetic Neuralgia
NEW00502,DISEASE,intractable pruritus,intractable pruritus
NEW00505,DISEASE,pain indices,pain indices
NEW00506,DISEASE,higher pain thresholds,higher pain thresholds
D000077274,DISEASE,Nasopharyngeal Carcinoma,"Carcinoma, Nasopharyngeal|nasopharyngeal carcinoma|Carcinomas, Nasopharyngeal|Nasopharyngeal Carcinomas"
NEW00510,DISEASE,classic bipolar disorders,classic bipolar disorders
NEW00511,DISEASE,treatment-refractory rapid cycling,treatment-refractory rapid cycling
NEW00513,MENTAL_HEALTH,bulimia alcohol dependence,bulimia alcohol dependence
NEW00514,MENTAL_HEALTH,acute mania,acute mania
NEW00516,MENTAL_HEALTH,adjunctive mania efficacy,adjunctive mania efficacy
NEW00517,DISEASE,thermal pain threshold,thermal pain threshold
C535531,DISEASE,Intervertebral disc disease [Supplementary Concept],Intervertebral Disc Displacement|intervertebral disc disease|Intervertebral Disc Degeneration
D059352,DISEASE,Musculoskeletal Pain,"musculoskeletal pain|Pains, Musculoskeletal|Pain, Musculoskeletal|Musculoskeletal Pains"
NEW00524,DISEASE,2A pain behavior,2A pain behavior
NEW00527,CHEMICAL,chronic high-dose glycine nutritional supplementation,chronic high-dose glycine nutritional supplementation
NEW00528,CHEMICAL,preliminary D-serine trial,preliminary D-serine trial
NEW00530,DISEASE,antipsychotic-induced parkinsonian symptoms,antipsychotic-induced parkinsonian symptoms
D009069,DISEASE,Movement Disorders,Movement Disorder Syndrome|Dyskinesia Syndromes|Status Marmoratus|Movement Disorder|movement disorders|Movement Disorder Syndromes|Dyskinesia Syndrome|Etat Marbre
NEW00533,BIOCHEMICAL,drug withdrawal syndrome,drug withdrawal syndrome
NEW00535,DISEASE,near-death experiences,near-death experiences
NEW00537,CHEMICAL,glutamate signals,glutamate signals
NEW00539,BIOCHEMICAL,NMDAR1-AB carriers,NMDAR1-AB carriers
NEW00542,DISEASE,severe neuropathic pain,severe neuropathic pain
NEW00544,CHEMICAL,ketamine infusions,ketamine infusions
D018710,DISEASE,Pain Clinics,"Multidisciplinary Pain Centers|Multidisciplinary Pain Clinics|Pain Clinic, Multidisciplinary|Center, Multidisciplinary Pain|Service, Acute Pain|Centers, Multidisciplinary Pain|Clinics, Pain|Acute Pain Services|Services, Acute Pain|Unit, Pain Relief|Pain Relief Unit|Pain Center, Multidisciplinary|Pain Relief Units|pain relief|Center, Pain|Pain Center|Pain Services, Acute|Pain Centers, Multidisciplinary|Pain Service, Acute|Units, Pain Relief|Pain Centers|Pain Clinics, Multidisciplinary|Clinic, Multidisciplinary Pain|Acute Pain Service|Multidisciplinary Pain Clinic|Pain Clinic|Centers, Pain|Clinic, Pain|Clinics, Multidisciplinary Pain|Multidisciplinary Pain Center"
NEW00547,CHEMICAL,psychotomimetic effects,psychotomimetic effects
NEW00551,MENTAL_HEALTH,established schizophrenia,established schizophrenia
NEW00553,DISEASE,such treatment-resistant depressed patients,TRD|such treatment-resistant depressed patients
NEW00554,DISEASE,ill TRD patients,ill TRD patients
NEW00556,CHEMICAL,dopamine dysbalance,dopamine dysbalance
NEW00557,CHEMICAL,higher extracellular dopamine levels,higher extracellular dopamine levels
NEW00559,DISEASE,cocaine-related behavioral disturbances,cocaine-related behavioral disturbances
NEW00561,MENTAL_HEALTH,schizophrenia studies,schizophrenia studies
NEW00562,DISEASE,ovarian cancer cells,ovarian cancer cells
NEW00563,DISEASE,ovarian tumor tissues,ovarian tumor tissues
NEW00564,DISEASE,tumor tissue arrays,tumor tissue arrays
NEW00565,DISEASE,serous EOC,serous EOC
NEW00566,DISEASE,abdominal tumor burden,abdominal tumor burden
NEW00567,CHEMICAL,high-energy phosphor-nucleotides,high-energy phosphor-nucleotides
NEW00568,CHEMICAL,glycolysis pentose phosphate pathways,glycolysis pentose phosphate pathways
NEW00570,CHEMICAL,CSF total-tau levels,CSF total-tau levels
NEW00572,DISEASE,Severe Impairment Battery,Severe Impairment Battery
NEW00573,CHEMICAL,scopolamine-induced cognitive impairment,scopolamine-induced cognitive impairment
NEW00575,DISEASE,AOAH-deficient depressive phenotype,AOAH-deficient depressive phenotype
NEW00576,DISEASE,clinical psychiatric practice,clinical psychiatric practice
NEW00580,MENTAL_HEALTH,new psychotic disorder,new psychotic disorder
NEW00581,DISEASE,involuntary oral movements,involuntary oral movements
NEW00582,DISEASE,progressive catalepsy,progressive catalepsy
NEW00584,DISEASE,catalepsy duration,catalepsy duration
NEW00585,CHEMICAL,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model","1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model"
NEW00587,DISEASE,subtle sexually-dimorphic impairments,subtle sexually-dimorphic impairments
NEW00589,MENTAL_HEALTH,stress-related memory disorders,stress-related memory disorders
NEW00591,DISEASE,HTLV scores,HTLV scores
NEW00594,DISEASE,extrapyramidal motor disorders,extrapyramidal motor disorders
NEW00595,DISEASE,sterile brain inflammation,sterile brain inflammation
NEW00599,DISEASE,mood vasomotor symptoms,mood vasomotor symptoms
NEW00601,DISEASE,cognitive improvements,cognitive improvements
NEW00603,CHEMICAL,thirteen-week,thirteen-week
NEW00613,BIOCHEMICAL,GPER agonist,GPER agonist
NEW00614,MENTAL_HEALTH,estrogen deficiency-related affective disorders,estrogen deficiency-related affective disorders
D012004,DISEASE,Rectal Neoplasms,"Rectal Tumors|Rectal Cancers|Neoplasm, Rectal|Neoplasms, Rectal|Cancer, Rectum|Cancer of the Rectum|Rectum Cancer|Rectum Neoplasm|Cancer, Rectal|Rectal Neoplasm|Rectal Cancer|Cancer of Rectum|Rectum Cancers|Tumor, Rectal|rectal cancer|Neoplasm, Rectum|Rectal Tumor|Rectum Neoplasms"
NEW00615,MENTAL_HEALTH,postoperative sexual dysfunction,postoperative sexual dysfunction
NEW00618,BIOCHEMICAL,synthetic hormone therapy,synthetic hormone therapy
NEW00621,DISEASE,affiliative behaviors,affiliative behaviors
NEW00628,DISEASE,suicidal behaviors,suicidal behaviors
NEW00630,DISEASE,anger- behaviors,anger- behaviors
NEW00633,DISEASE,BPD symptoms,BPD symptoms
NEW00636,BIOCHEMICAL,plasma estrogen,plasma estrogen
NEW00638,DISEASE,metabolic impairments,metabolic impairments
NEW00642,BIOCHEMICAL,abnormal hormone levels,abnormal hormone levels
NEW00644,BIOCHEMICAL,androgen production,androgen production
NEW00645,DISEASE,antioxidative damage,antioxidative damage
NEW00654,MENTAL_HEALTH,analgesia responses,analgesia responses
NEW00655,DISEASE,anxiety-related behaviors,anxiety-related behaviors
NEW00658,BIOCHEMICAL,estrogen response elements,estrogen response elements
NEW00662,MENTAL_HEALTH,increased daytime sleepiness,increased daytime sleepiness
NEW00665,MENTAL_HEALTH,sexual fantasies,sexual fantasies
NEW00666,DISEASE,Text Revision,DSM-IV-TR|Text Revision
NEW00668,DISEASE,optimal estrogen receptor-positive breast cancer outcomes,optimal estrogen receptor-positive breast cancer outcomes
NEW00670,BIOCHEMICAL,endocrine therapies,endocrine therapies
NEW00672,CHEMICAL,high-dose oral estrogen,high-dose oral estrogen
NEW00674,BIOCHEMICAL,estrogen withdrawal,estrogen withdrawal
NEW00677,DISEASE,vaginal lubricants,vaginal lubricants
NEW00679,DISEASE,cognitive functioning,cognitive functioning
NEW00681,MENTAL_HEALTH,sex-specific hormone-dependent mood disorder,sex-specific hormone-dependent mood disorder
NEW00684,DISEASE,metastatic breast cancer,metastatic breast cancer
NEW00685,DISEASE,social distress,social distress
D000087523,CHEMICAL,Endotoxin Tolerance,"Endotoxin Desensitization|Tolerance, Endotoxin|endotoxin|Desensitization, Endotoxin"
NEW00688,DISEASE,hepatotoxic,hepatotoxic
NEW00691,MENTAL_HEALTH,chronic ethanol abuse,chronic ethanol abuse
NEW00692,CHEMICAL,atmospheric carbon dioxide,atmospheric carbon dioxide
NEW00694,DISEASE,levodopa-resistant akinetic-rigid syndrome,levodopa-resistant akinetic-rigid syndrome
NEW00696,CHEMICAL,sex- controls,sex- controls
NEW00697,CHEMICAL,calcium higher levels,calcium higher levels
D003037,CHEMICAL,Cobalt Radioisotopes,"Radioisotopes, Cobalt|cobalt"
NEW00700,MENTAL_HEALTH,early psychotic disorder,early psychotic disorder
NEW00702,CHEMICAL,chronic postnatal Mn exposure,chronic postnatal Mn exposure
NEW00703,DISEASE,fine motor dysfunction due,fine motor dysfunction due
NEW00705,CHEMICAL,brain extracellular dopamine,brain extracellular dopamine
NEW00707,DISEASE,neurotoxic effects,neurotoxic effects
NEW00711,CHEMICAL,manganese Mn toxicity,manganese Mn toxicity
NEW00713,DISEASE,dopaminergic neuron loss,dopaminergic neuron loss
D001608,CHEMICAL,Beryllium,beryllium
D009414,CHEMICAL,Nerve Growth Factors,"Neurotrophic Factor|Neurotrophic Proteins|Growth-Associated Proteins, Neuronal|Neuronal Growth-Associated Proteins|Factor, Neurite Outgrowth|Neurite Outgrowth Factors|Neuronal Growth Associated Protein|neurotrophins|Growth-Associated Protein, Neuronal|Outgrowth Factors, Neurite|Factors, Neuronotrophic|Neuronal Growth-Associated Protein|Neuronotrophic Factors|Neuronal Growth Associated Proteins|Factors, Neurite Outgrowth|Neurotrophic Factors|Neurotrophin|Neurotrophins|Neuronotrophic Factor|Factors, Neurotrophic|Factors, Nerve Growth|Growth Associated Proteins, Neuronal|Protein, Neuronal Growth-Associated|Neurotrophic Protein|Factor, Neuronotrophic|Proteins, Neuronal Growth-Associated|Outgrowth Factor, Neurite|Factor, Neurotrophic|Neurite Outgrowth Factor"
NEW00715,CHEMICAL,immobilization stress-1 group,immobilization stress-1 group
NEW00716,MENTAL_HEALTH,anxiety behaviors,anxiety behaviors
NEW00718,DISEASE,atypical parkinsonian syndrome,manganism|atypical parkinsonian syndrome
NEW00719,DISEASE,oesophageal carcinogenesis,oesophageal carcinogenesis
NEW00726,DISEASE,severe neuronal damage,severe neuronal damage
NEW00728,DISEASE,irreversible mild cognitive impairment,irreversible mild cognitive impairment
D065852,DISEASE,Spatial Memory,"Memories, Spatial|memory|Memory, Spatial|Spatial Memories"
NEW00730,BIOCHEMICAL,brain lutein,brain lutein
NEW00732,MENTAL_HEALTH,anxiety increase,anxiety increase
NEW00735,DISEASE,concomitant duodenitis,concomitant duodenitis
D006356,DISEASE,Heartburn,Pyroses|heartburn|Pyrosis
D064747,CHEMICAL,Lansoprazole,"lansoprazole|Zoton|AG 1749|Lanzor|Lansoprazole Sodium|Opiren|Prezal|Lansol|Promeco|Lansoprazol|Ulpax|Ogast|AG-1749|Prevacid|Bamalite|2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole|Ogastro|Lansoprazoles|Pro Ulco|Monolitum|Takepron|Sodium, Lansoprazole|Agopton|AG1749"
NEW00736,DISEASE,esophagitis higher healing rates,esophagitis higher healing rates
NEW00737,DISEASE,gastric mucosal injury,gastric mucosal injury
NEW00739,DISEASE,pregnancy-associated heartburn,pregnancy-associated heartburn
NEW00741,DISEASE,uterine irritability,uterine irritability
NEW00742,DISEASE,threatened preterm labour,threatened preterm labour
NEW00743,CHEMICAL,fluoride application,fluoride application
NEW00747,MENTAL_HEALTH,anxiety depressive disorders,anxiety depressive disorders
NEW00750,DISEASE,excessive central CRF neurotransmission,excessive central CRF neurotransmission
NEW00756,DISEASE,related tauopathies,related tauopathies
NEW00757,DISEASE,neuronal injuries,neuronal injuries
NEW00759,DISEASE,poisoning referral wards,poisoning referral wards
NEW00762,CHEMICAL,high-dose opioids,high-dose opioids
NEW00764,CHEMICAL,acute morphine analgesia,acute morphine analgesia
NEW00766,BIOCHEMICAL,self-medication drug abuse,self-medication drug abuse
NEW00770,BIOCHEMICAL,preoperative narcotic use,preoperative narcotic use
NEW00772,DISEASE,chronic C infection,chronic C infection
NEW00773,DISEASE,hepatitis C virus disease progression,hepatitis C virus disease progression
NEW00775,BIOCHEMICAL,oral narcotics,oral narcotics
NEW00776,DISEASE,existing psychiatric comorbidity,existing psychiatric comorbidity
NEW00778,DISEASE,chronic alcoholism nosological differentiation,chronic alcoholism nosological differentiation
D003644,DISEASE,Death Certificates,"Death Records|Death Certificate|Certificate, Death|Records, Death|Death Record|Record, Death|Certificates, Death|death certificate"
NEW00780,DISEASE,serious physical injuries,serious physical injuries
NEW00782,DISEASE,co-occurring psychiatric disorders,co-occurring psychiatric disorders
NEW00785,DISEASE,Late-life depression,LLD|Late-life depression
NEW00787,DISEASE,specific psychiatric entities,specific psychiatric entities
NEW00789,CHEMICAL,NMDA antagonists,NMDA antagonists
NEW00790,DISEASE,young Parkinson patients,young Parkinson patients
NEW00791,BIOCHEMICAL,beta-adrenergic drugs,beta-adrenergic drugs
D062686,BIOCHEMICAL,Epithelial Sodium Channel Blockers,"ENaC Channel Blockers|Epithelial Sodium Ion Channel Blockers|blockers|Epithelial Sodium Channel Antagonists|Renal Epithelial Sodium Channel Blockers|Channel Blockers, ENaC|Epithelial Sodium Channel Inhibitors|Renal Epithelial Sodium Channel Inhibitors"
D000075222,DISEASE,Essential Hypertension,"essential hypertension|Hypertension, Essential"
NEW00794,MENTAL_HEALTH,alcohol dependence syndrome,alcohol dependence syndrome
NEW00796,DISEASE,traumatic memories,traumatic memories
NEW00798,CHEMICAL,lower basal cortisol levels,lower basal cortisol levels
NEW00799,BIOCHEMICAL,methyldopa peripheral adrenergic drugs,methyldopa peripheral adrenergic drugs
NEW00801,DISEASE,neuronal impairments,neuronal impairments
NEW00802,DISEASE,immune dysfunctions,immune dysfunctions
NEW00803,DISEASE,neurocognitive impairments,neurocognitive impairments
NEW00804,DISEASE,schizophrenic brains,schizophrenic brains
NEW00806,MENTAL_HEALTH,previous long-term cannabis abuse,previous long-term cannabis abuse
NEW00809,CHEMICAL,cannabis controls,cannabis controls
NEW00810,CHEMICAL,second-line immunotherapy,second-line immunotherapy
NEW00813,DISEASE,comparable neuronal loss,comparable neuronal loss
NEW00815,DISEASE,focal spasticity,focal spasticity
C568481,DISEASE,"C19orf12 protein, human [Supplementary Concept]",human neurodegeneration|Mitochondrial Proteins
NEW00816,DISEASE,restraint-induced gastric mucosal lesions,restraint-induced gastric mucosal lesions
NEW00818,DISEASE,ulcer pathology,ulcer pathology
NEW00825,CHEMICAL,MAM model,MAM model
NEW00828,CHEMICAL,co-occurring methamphetamine,co-occurring methamphetamine
NEW00832,CHEMICAL,months,months
NEW00834,MENTAL_HEALTH,anxiety oxidative stress,anxiety oxidative stress
NEW00836,DISEASE,hypomanic switches,hypomanic switches
NEW00839,NUTRITION,M lithium,M lithium
NEW00840,DISEASE,neurologic injury,neurologic injury
NEW00842,CHEMICAL,NH4 neurotoxicity,NH4 neurotoxicity
C000631768,DISEASE,Pediatric acute-onset neuropsychiatric syndrome [Supplementary Concept],Autoimmune Diseases|Obsessive-Compulsive Disorder|neuropsychiatric syndrome
NEW00847,DISEASE,PD mouse model,PD mouse model
NEW00852,DISEASE,SC degeneration,SC degeneration
NEW00853,DISEASE,narcoleptic-like behavior,narcoleptic-like behavior
NEW00855,DISEASE,narcoleptic-like sleep behavior,narcoleptic-like sleep behavior
NEW00865,CHEMICAL,intravenous magnesium replacement,intravenous magnesium replacement
NEW00867,CHEMICAL,interferon-α treated patients,interferon-α treated patients
NEW00868,DISEASE,bipolar manic-depressive disorder,bipolar manic-depressive disorder
NEW00870,DISEASE,major psychiatric disorders,major psychiatric disorders
NEW00872,DISEASE,human brain diseases,human brain diseases
NEW00875,DISEASE,hypoglycaemic brain damage,hypoglycaemic brain damage
NEW00883,DISEASE,demonstrated neurotoxic effects,demonstrated neurotoxic effects
NEW00884,BIOCHEMICAL,potent N-methyl-D-aspartate receptor agonist,potent N-methyl-D-aspartate receptor agonist
NEW00886,DISEASE,infected individuals,infected individuals
NEW00890,NUTRITION,subordinate trout,subordinate trout
NEW00892,MENTAL_HEALTH,chronic stress status,chronic stress status
NEW00894,DISEASE,memory retention,memory retention
NEW00896,DISEASE,CRF expression,CRF expression
C453300,CHEMICAL,isocoumarin NM-3 [Supplementary Concept],Isocoumarins|nM
C102718,CHEMICAL,metabotropic glutamate receptor 3 [Supplementary Concept],"Receptors, Metabotropic Glutamate|mGluR3"
NEW00898,CHEMICAL,phencyclidine (PCP)-induced hyperactivity,phencyclidine (PCP)-induced hyperactivity
NEW00899,DISEASE,clozapine-induced hematopoietic toxicity,clozapine-induced hematopoietic toxicity
NEW00901,DISEASE,levodopa-induced motor complications,levodopa-induced motor complications
NEW00903,CHEMICAL,acute cocaine self-administration,acute cocaine self-administration
NEW00905,CHEMICAL,N-methyl-D-aspartate glutamate receptors,N-methyl-D-aspartate glutamate receptors
D024741,DISEASE,"Cardiomyopathy, Hypertrophic, Familial","Hypertrophy, Hereditary Ventricular|Familial Hypertrophic Cardiomyopathy|Ventricular Hypertrophies, Familial|Hypertrophic Cardiomyopathy, Familial|Familial Hypertrophic Cardiomyopathies|Hypertrophies, Hereditary Ventricular|Familial Ventricular Hypertrophy|ventricular hypertrophy|Hereditary Ventricular Hypertrophies|Familial Ventricular Hypertrophies|Hypertrophic Subaortic Stenosis, Idiopathic|Ventricular Hypertrophy, Familial|Ventricular Hypertrophies, Hereditary|Ventricular Hypertrophy, Hereditary|Cardiomyopathy, Familial Hypertrophic|Hypertrophy, Familial Ventricular|Hypertrophic Cardiomyopathies, Familial|Hereditary Ventricular Hypertrophy|Cardiomyopathies, Familial Hypertrophic|Obstructive Asymmetric Septal Hypertrophy|Asymmetric Septal Hypertrophy, Familial"
D003329,DISEASE,Coronary Vasospasm,"Coronary Vasospasms|Artery Vasospasm, Coronary|Coronary Artery Vasospasms|Vasospasms, Coronary|Vasospasm, Coronary|Vasospasm, Coronary Artery|Vasospasms, Coronary Artery|coronary vasospasm|Artery Vasospasms, Coronary|Coronary Artery Vasospasm"
NEW00915,DISEASE,chronic assaultiveness,chronic assaultiveness
D010323,DISEASE,Passive Cutaneous Anaphylaxis,"PCA|Anaphylaxis, Passive Cutaneous|Cutaneous Anaphylaxis, Passive|anaphylaxis"
NEW00916,DISEASE,syndrome medications,syndrome medications
NEW00918,DISEASE,hypertensive emergencies,hypertensive emergencies
D008881,MENTAL_HEALTH,Migraine Disorders,"Variant, Migraine|Migraines, Acute Confusional|Abdominal Migraine|Hemicrania Migraine|Headache, Sick|Acute Confusional Migraines|Headache, Migraine|Migraine Headache|migraine headache|Disorder, Migraine|Migraine Syndromes, Cervical|Sick Headaches|Acute Confusional Migraine|Migraines|Cervical Migraine Syndromes|Variants, Migraine|Disorders, Migraine|Migraine Headaches|Migraines, Abdominal|Headaches, Sick|Migraine|Status Migrainosus|Migraine, Abdominal|Cervical Migraine Syndrome|Hemicrania Migraines|Abdominal Migraines|Sick Headache|Migraine Variants|Migraine, Acute Confusional|Migraines, Hemicrania|Migraine Disorder|Migraine Variant|Migraine, Hemicrania|Headaches, Migraine|Migraine Syndrome, Cervical"
NEW00919,DISEASE,palpitations,palpitations
NEW00922,MENTAL_HEALTH,craving levels,craving levels
NEW00924,DISEASE,psychocardiac disorders,psychocardiac disorders
NEW00926,MENTAL_HEALTH,anxiety neurosis,anxiety neurosis
NEW00929,DISEASE,managing cognitive symptoms,managing cognitive symptoms
NEW00930,MENTAL_HEALTH,core ADHD symptoms,core ADHD symptoms
NEW00932,DISEASE,verbal aggression,verbal aggression
NEW00933,DISEASE,physical aggression,physical aggression
NEW00934,DISEASE,peripheral blockade,peripheral blockade
NEW00936,CHEMICAL,carbaldehyde group,carbaldehyde group
NEW00941,DISEASE,human neuroblastoma SK-N-SH cells,human neuroblastoma SK-N-SH cells
NEW00943,DISEASE,various chronic diseases,various chronic diseases
NEW00945,DISEASE,Adult Separation Anxiety Disorder,ASAD|Adult Separation Anxiety Disorder
NEW00947,DISEASE,glia restricted progenitor GRP cells,glia restricted progenitor GRP cells
NEW00948,CHEMICAL,NSC production,NSC production
NEW00951,CHEMICAL,"Ins(1,4,5)P3","Ins(1,4,5)P3"
NEW00952,CHEMICAL,"mass inositol 1,4,5-trisphosphate","mass inositol 1,4,5-trisphosphate"
NEW00958,CHEMICAL,dopamine imbalances,dopamine imbalances
NEW00959,MENTAL_HEALTH,schizophrenia related,schizophrenia related
NEW00962,CHEMICAL,D-amino-acid-oxidase activator/G30 gene complex,D-amino-acid-oxidase activator/G30 gene complex
NEW00963,CHEMICAL,dopamine transporter gene,dopamine transporter gene
D020514,DISEASE,Hypokalemic Periodic Paralysis,"Periodic Paralysis Hypokalemic|Hypokalemic Periodic Paralysis, Familial|paralysis|Periodic Paralysis- Hypokalemics|Periodic Paralysis- Hypokalemic|Primary Hypokalemic Periodic Paralysis|Westphall Disease|Periodic Paralysis, Hypokalemic|HYPOPP|HOKPP|HYPOKPP|Familial Hypokalemic Periodic Paralysis|Paralysis, Hypokalemic Periodic"
NEW00975,DISEASE,MN death,MN death
NEW00976,DISEASE,hyperexcitation,hyperexcitation
NEW00977,DISEASE,neuroinflammation- neurodegeneration,neuroinflammation- neurodegeneration
NEW00980,DISEASE,iron- impairments,iron- impairments
NEW00982,CHEMICAL,prostaglandins synthesis,prostaglandins synthesis
NEW00984,DISEASE,stress (CRS)-induced ulcer formation,stress (CRS)-induced ulcer formation
NEW00986,CHEMICAL,naltrexone pretreatment,naltrexone pretreatment
NEW00994,DISEASE,rheumathoid arthritis,rheumathoid arthritis
NEW00995,MENTAL_HEALTH,conditions sexual impotence,conditions sexual impotence
NEW00996,DISEASE,haemorrhagic shock,haemorrhagic shock
NEW00997,DISEASE,toxic neuropathies,toxic neuropathies
D002100,DISEASE,Cachexia,HIV Wasting Syndrome|Wasting Syndrome|cachexia
D058639,DISEASE,Cold-Shock Response,"Cold Shock|Cold-Stress Responses|Cold-Stress Response|shock|Stresses, Cold Shock|Stress, Cold Shock|Cold Stress Response|Stress, Cold|Cold Shock Response|Shock Stress, Cold|Cold Stress Reaction|Cold Stress|Cold Shock Stress|Cold Shock Stresses|Response, Cold-Stress|Cold-Stress Reactions|Responses, Cold-Stress|Cold Shocks|Shock Stresses, Cold|Cold-Shock Responses|Cold-Stress Reaction"
NEW00998,DISEASE,ischemia/reperfusion-induced brain damage,ischemia/reperfusion-induced brain damage
D003929,DISEASE,Diabetic Neuropathies,"Neuropathies, Diabetic|Diabetic Asymmetric Polyneuropathies|Mononeuropathy, Diabetic|Diabetic Neuropathy|Diabetic Polyneuropathies|Painful Diabetic Neuropathy|Neuropathy, Diabetic Autonomic|Polyneuropathy, Diabetic|Neuralgia, Diabetic|Symmetric Diabetic Proximal Motor Neuropathy|Diabetic Neuropathies, Painful|Simplex, Diabetic Mononeuropathy|Diabetic Polyneuropathy|Diabetic Mononeuropathy Simplices|Autonomic Neuropathies, Diabetic|Asymmetric Polyneuropathies, Diabetic|Diabetic Mononeuropathy Simplex|Simplices, Diabetic Mononeuropathy|Diabetic Asymmetric Polyneuropathy|Neuropathies, Diabetic Autonomic|Mononeuropathies, Diabetic|diabetic neuropathy|Painful Diabetic Neuropathies|Amyotrophies, Diabetic|Diabetic Neuropathy, Painful|Diabetic Neuralgias|Diabetic Mononeuropathy|Amyotrophy, Diabetic|Mononeuropathy Simplex, Diabetic|Autonomic Neuropathy, Diabetic|Polyneuropathies, Diabetic Asymmetric|Diabetic Amyotrophies|Asymmetric Polyneuropathy, Diabetic|Diabetic Mononeuropathies|Diabetic Autonomic Neuropathies|Asymmetric Diabetic Proximal Motor Neuropathy|Polyneuropathies, Diabetic|Diabetic Neuralgia|Neuropathies, Painful Diabetic|Polyneuropathy, Diabetic Asymmetric|Mononeuropathy Simplices, Diabetic|Neuropathy, Diabetic|Diabetic Amyotrophy|Neuralgias, Diabetic|Diabetic Autonomic Neuropathy|Neuropathy, Painful Diabetic"
NEW00999,DISEASE,novelty-induced hypophagia,novelty-induced hypophagia
NEW01000,CHEMICAL,KCl-evoked serotonin,KCl-evoked serotonin
NEW01001,CHEMICAL,KCl-evoked 5-HT release,KCl-evoked 5-HT release
NEW01002,CHEMICAL,5-HT release,5-HT release
NEW01004,MENTAL_HEALTH,type depression,type depression
NEW01007,DISEASE,epilepsy patients,epilepsy patients
NEW01008,BIOCHEMICAL,behavior hormone levels,behavior hormone levels
D025521,DISEASE,Tumor Suppressor Proteins,"Protein, Metastasis Suppressor|Metastasis Suppressor Protein|Suppressor Protein, Tumor|Growth Suppressor Proteins|Protein, Tumor Suppressor|Proteins, Tumor Suppressor|Proteins, Metastasis Suppressor|Metastasis Suppressor Proteins|Suppressor Protein, Metastasis|Proteins, Growth Suppressor|Tumor Suppressor Protein|tumor growth"
NEW01009,DISEASE,transplanted tumor tissue,transplanted tumor tissue
NEW01010,MENTAL_HEALTH,conclusion chronic stress model,conclusion chronic stress model
NEW01015,CHEMICAL,nucleotide receptors,nucleotide receptors
NEW01016,CHEMICAL,adenosine P1 receptors,adenosine P1 receptors
D064428,CHEMICAL,Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels,"Channel, HCN4|Cation Channel, Hyperpolarization-Activated|Hyperpolarization Cyclic Nucleotide Gated Cation Channel 1|Hyperpolarization Activated Cyclic Nucleotide Gated Channels|Channel, HCN1|HCN Pacemaker Channels|Hyperpolarization Cyclic-Nucleotide Gated Cation Channel 1|I(h) Cation Channels|Hyperpolarization Activated Cation Channel|HCN2 Potassium Channel|Channel, Hyperpolarization-Activated Cation|HCN4 Channel|Hyperpolarization Cyclic Nucleotide Gated Ion Channels|Potassium Channel, HCN2|Hyperpolarization-Activated Cation Channel|Potassium-Sodium Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel 2|Hyperpolarization Activated Cyclic Nucleotide-Gated Potassium Channel 2|Channel, HCN2 Potassium|Channels, HCN Pacemaker|Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 2|Channel, HCN3|I(h) Channels|HCN2 Channel|Ih Cation Channels|Channels, Ih Cation|Potassium Sodium Hyperpolarization Activated Cyclic Nucleotide Gated Channel 2|HCN1 Channel|Hyperpolarization Cyclic-Nucleotide Gated Cation Channel 4|nucleotide|Cation Channels, Ih|Hyperpolarization Cyclic Nucleotide Gated Cation Channel 3|Pacemaker Channels, HCN|Hyperpolarization Cyclic-Nucleotide Gated Cation Channel 3|Hyperpolarization Cyclic Nucleotide Gated Cation Channel 4|Hyperpolarization Cyclic-Nucleotide Gated Ion Channels|HCN3 Channel|Channel, HCN2"
NEW01018,DISEASE,anxiogenic affective-like behaviors,anxiogenic affective-like behaviors
NEW01020,MENTAL_HEALTH,improved anxiety,improved anxiety
NEW01022,DISEASE,diffuse brain damage,diffuse brain damage
NEW01023,DISEASE,preexisting myoclonus,preexisting myoclonus
NEW01024,MENTAL_HEALTH,chronic static encephalopathy,chronic static encephalopathy
NEW01025,DISEASE,myoclonic potential,myoclonic potential
NEW01026,CHEMICAL,GBP discontinuation,GBP discontinuation
NEW01027,DISEASE,spastic muscle activity,spastic muscle activity
NEW01028,BIOCHEMICAL,hepatic vitamin A,hepatic vitamin A
NEW01029,DISEASE,alcohol-driven hepatic retinoid losses,alcohol-driven hepatic retinoid losses
NEW01032,DISEASE,ALD pathogenesis,ALD pathogenesis
NEW01036,BIOCHEMICAL,agonist activation,agonist activation
NEW01038,MENTAL_HEALTH,dysfunction hypoactive sexual desire disorder,dysfunction hypoactive sexual desire disorder
D000068105,CHEMICAL,Bipolar and Related Disorders,related disorders|ICRDs
NEW01042,BIOCHEMICAL,partial dopamine agonist activity,partial dopamine agonist activity
NEW01043,MENTAL_HEALTH,pathological gambling due,pathological gambling due
NEW01044,CHEMICAL,fludrocortisone,fludrocortisone
D005438,CHEMICAL,Fludrocortisone,"Astonin Merck|9 Fluorocortisol|Astonin|FCOL|9-Fluorohydrocortisone|9 Fluorohydrocortisone|fludrocortisone|9 alpha-Fluoro-17-Hydroxycorticosterone|9 alpha Fluoro 17 Hydroxycorticosterone|9-Fluoro-17-Hydroxycortisone|9 alpha Fludrohydrocortisone|9 Fluoro 17 Hydroxycortisone|9 alpha-Fluorohydrocortisone|9 alpha Fluorohydrocortisone|Astonin-H|9-Fluorocortisol|Merck, Astonin|Astonin H"
NEW01047,MENTAL_HEALTH,cataplexy rate,cataplexy rate
NEW01051,DISEASE,gait disturbance,gait disturbance
NEW01052,BIOCHEMICAL,full mu-receptor agonist opioid,full mu-receptor agonist opioid
NEW01053,CHEMICAL,mean morphine equivalent dose,mean morphine equivalent dose
NEW01054,MENTAL_HEALTH,opioid craving,opioid craving
NEW01055,DISEASE,co-occurring psychiatric symptoms,co-occurring psychiatric symptoms
NEW01057,BIOCHEMICAL,full μ-receptor agonist opioids,full μ-receptor agonist opioids
NEW01059,DISEASE,lower self-reported pain,lower self-reported pain
NEW01060,DISEASE,higher pain tolerance,higher pain tolerance
NEW01063,BIOCHEMICAL,inverse agonist effect,inverse agonist effect
NEW01066,CHEMICAL,serotonin-norepinephrine viloxazine,serotonin-norepinephrine viloxazine
NEW01068,CHEMICAL,extended-release capsule,extended-release capsule|viloxazine ER
NEW01070,MENTAL_HEALTH,different psychosis models,different psychosis models
NEW01071,CHEMICAL,NMDA antagonist-,NMDA antagonist-
NEW01072,MENTAL_HEALTH,antagonist- hyperactivity spontaneous locomotion,antagonist- hyperactivity spontaneous locomotion
NEW01073,DISEASE,behavioural anomalies,behavioural anomalies
NEW01075,MENTAL_HEALTH,defined melancholia,defined melancholia
D009483,DISEASE,Neuropsychological Tests,"cognitive function|Tower of London Test|Aphasia Tests|Cognitive Test|Test, Neuropsychological|Continuous Performance Task|Testing, Cognitive|CANTAB|Clock Test|Cognitive Tests|Behavioral Assessment of Dysexecutive Syndrome|Cognitive Testing|Paced Auditory Serial Addition Test|Rey-Osterrieth Complex Figure|Cognitive Function Scanner|Neuropsychologic Tests|Tests, Neuropsychological|Neuropsychological Testing|Test, Cognitive|Symbol Digit Modalities Test|AX-CPT|Neuropsychologic Test|Tests, Cognitive|Memory for Designs Test|Testing, Neuropsychological|Neuropsychological Test|NEPSY|Hooper Visual Organization Test|Controlled Oral Word Association Test|Cambridge Neuropsychological Test Automated Battery|Test of Everyday Attention|Repeatable Battery for the Assessment of Neuropsychological Status|Developmental Neuropsychological Assessment|Delis-Kaplan Executive Function System"
NEW01077,CHEMICAL,oral fenfluramine,oral fenfluramine
NEW01078,DISEASE,non-endogenous subjects,non-endogenous subjects
NEW01081,DISEASE,gastrointestinal disturbances,gastrointestinal disturbances
NEW01083,DISEASE,cough medicine,cough medicine
NEW01084,DISEASE,possible excitotoxic damage,possible excitotoxic damage
NEW01085,DISEASE,irritability,irritability
NEW01086,DISEASE,i.p.)-induced aggressive behaviors,i.p.)-induced aggressive behaviors
NEW01093,DISEASE,risk-taking behaviour,risk-taking behaviour
NEW01096,DISEASE,risk-taking behavior,risk-taking behavior
NEW01099,DISEASE,acquired generalized HSDD,acquired generalized HSDD
NEW01106,CHEMICAL,3-hydroxykynurenine branch,3-hydroxykynurenine branch
NEW01109,MENTAL_HEALTH,affective psychosis group relative,affective psychosis group relative
NEW01111,CHEMICAL,antidepressant medicines,antidepressant medicines
NEW01112,CHEMICAL,tablet baclofen,tablet baclofen
NEW01113,DISEASE,intake gain,intake gain
NEW01114,DISEASE,pain activity,pain activity
NEW01115,DISEASE,seizure-like,seizure-like
D019440,DISEASE,Anti-Obesity Agents,"Drugs, Weight-Loss|Weight-Loss Drug|Antiobesity Drug|Weight Loss Agents|Antiobesity Drugs|Agent, Antiobesity|Drugs, Antiobesity|Drug, Antiobesity|Anti Obesity Drug|Anti-Obesity Agent|Anti Obesity Agents|Drug, Anti-Obesity|Weight-Loss Agents|Weight Loss Drugs|Weight Loss Drug|Anti-Obesity Drug|Agents, Antiobesity|Anti-Obesity Drugs|Anti Obesity Drugs|Agent, Anti-Obesity|weight loss agents|Weight-Loss Drugs|Agents, Weight-Loss|Anti Obesity Agent|Drug, Weight-Loss|Drugs, Anti-Obesity|Agents, Anti-Obesity|Antiobesity Agent|Antiobesity Agents"
NEW01117,MENTAL_HEALTH,food intermittent binge eating model,food intermittent binge eating model
NEW01120,MENTAL_HEALTH,MK-801-induced hyperactivity,MK-801-induced hyperactivity
NEW01122,NUTRITION,fecal cholesterol,fecal cholesterol
NEW01124,NUTRITION,body cholesterol,body cholesterol
NEW01125,NUTRITION,fecal cholesterol content,fecal cholesterol content
NEW01127,NUTRITION,increased fecal cholesterol,increased fecal cholesterol
NEW01129,CHEMICAL,aortic cholesteryl ester content,aortic cholesteryl ester content
NEW01131,CHEMICAL,HF-saline treated mice,HF-saline treated mice
D011597,DISEASE,Psychomotor Performance,"Visual Motor Coordination|Performance, Perceptual Motor|Performance, Sensory Motor|Motor Coordinations, Visual|Motor Performance, Perceptual|Motor Performances, Perceptual|Motor Performance, Sensory|Coordination, Visual Motor|Perceptual Motor Performances|Performances, Perceptual Motor|Sensory Motor Performance|Sensory Motor Performances|Visual Motor Coordinations|Performances, Psychomotor|Coordinations, Visual Motor|Performances, Sensory Motor|Perceptual Motor Performance|Motor Performances, Sensory|motor coordination|Psychomotor Performances|Performance, Psychomotor|Motor Coordination, Visual"
NEW01132,BIOCHEMICAL,D2 antagonist haloperidol,D2 antagonist haloperidol
NEW01136,DISEASE,stress-induced hypoadiponectinemia,stress-induced hypoadiponectinemia
NEW01138,CHEMICAL,mild/moderate alcohol use,mild/moderate alcohol use
NEW01141,CHEMICAL,glutathione levels,glutathione levels
NEW01143,CHEMICAL,supersensitive D1 dopamine receptors located,supersensitive D1 dopamine receptors located
NEW01145,DISEASE,dose-dependent dyskinesias,dose-dependent dyskinesias
NEW01147,CHEMICAL,twice-daily L-dopa dosing locomotion,twice-daily L-dopa dosing locomotion
NEW01148,DISEASE,prominent dystonia,prominent dystonia
D002908,DISEASE,Chronic Disease,"chronic illness|Chronic Diseases|Condition, Chronic|Illness, Chronic|Chronic Illnesses|Chronic Illness|Chronic Conditions|Chronically Ill|Disease, Chronic|Chronic Condition"
NEW01150,DISEASE,dlPFC pyramidal cell dendritic atrophy,dlPFC pyramidal cell dendritic atrophy
NEW01151,CHEMICAL,cortical dopamine,cortical dopamine
NEW01152,DISEASE,fear/anxiety,fear/anxiety
NEW01154,DISEASE,experimental gastroduodenal lesions,experimental gastroduodenal lesions
NEW01156,DISEASE,experimental gastric mucosal injury,experimental gastric mucosal injury
NEW01157,CHEMICAL,term levodopa monotherapy,term levodopa monotherapy
NEW01158,CHEMICAL,levodopa dosage,levodopa dosage
NEW01160,BIOCHEMICAL,potent drug,potent drug
NEW01161,MENTAL_HEALTH,schizophrenia histamine release,schizophrenia histamine release
NEW01163,DISEASE,extradopaminergic brain dysfunction,extradopaminergic brain dysfunction
NEW01165,BIOCHEMICAL,H3 antagonist thioperamide,H3 antagonist thioperamide
NEW01166,CHEMICAL,histamine turnovers,histamine turnovers
NEW01167,CHEMICAL,MeHg levels,MeHg levels
C083889,CHEMICAL,hemoglobin Tubingen [Supplementary Concept],"Hemoglobins, Abnormal|Tübingen"
NEW01169,DISEASE,unusual brain disease,unusual brain disease
NEW01171,BIOCHEMICAL,antimalarial drug categories,antimalarial drug categories
NEW01175,DISEASE,atherosclerotic plaque instability,atherosclerotic plaque instability
NEW01177,DISEASE,hyperactive children,hyperactive children
D009155,MENTAL_HEALTH,Mutism,"Voluntary Mutism|Organic Mutisms|Aphasia, Kussmaul|Kussmaul's Aphasia|Mutism, Conversion|Organic Mutism|Mutism, Elective|Mutism, Voluntary|Mutisms, Conversion|Conversion Mutism|Mutisms, Organic|selective mutism|Conversion Mutisms|Kussmauls Aphasia|Aphasia, Kussmaul's|Kussmaul Aphasia|Mutisms, Elective|Mutism, Organic|Voluntary Mutisms|Mutism, Selective|Elective Mutism|Mutisms, Voluntary|Selective Mutism|Mutisms|Elective Mutisms"
D020323,DISEASE,Tics,"Vocal Tic|Habit Choreas|Tic, Motor|Tic, Transient|Vocal Tics|Tics, Vocal|Motor Tic|Choreas, Habit|Transient Tics|Transient Tic|Chorea, Habit|Spasm, Habituation|Spasm, Habit|Spasms, Habituation|Tics, Motor|Tic, Gestural|Habituation Spasm|Motor Tics|Habit Spasm|Gestural Tic|Tics, Gestural|Habit Spasms|tics|Habituation Spasms|Tic, Vocal|Tics, Transient|Habit Chorea|Tic|Spasms, Habit|Gestural Tics"
NEW01178,DISEASE,disruptive behaviour disorders,disruptive behaviour disorders
NEW01180,DISEASE,behaviour disorder,behaviour disorder
C583283,CHEMICAL,"COMMD9 protein, rat [Supplementary Concept]","copper metabolism|Adaptor Proteins, Signal Transducing"
D053360,DISEASE,"Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive","Ectodermal Dysplasia, Hypohydrotic, Autosomal Recessive|Anhidridic Ectodermal Dysplasia, Autosomal Recessive|Anhidrotic Ectodermal Dysplasia, Autosomal Recessive|autosomal recessive|Autosomal Recessive Anhidrotic Ectodermal Dysplasia|Anhydridic Ectodermal Dysplasia, Autosomal Recessive|Autosomal Recessive Anhydrotic Ectodermal Dysplasia|Ectodermal Dysplasia, Anhidrotic, Autosomal Recessive"
D017301,CHEMICAL,Ca(2+) Mg(2+)-ATPase,"ATPase, Calcium Magnesium|Mg2+-ATPase|Ca2+ Mg2+ ATPase|Magnesium Adenosine Triphosphatase|Adenosinetriphosphatase, Calcium, Magnesium|Calcium Magnesium Adenosinetriphosphatase|Ca Mg ATPase|ATPase, Magnesium|ATPase, Ca2+-Mg2+|ATPase, Mg2+-Dependent|Adenosine Triphosphatase, Calcium, Magnesium|Adenosinetriphosphatase, Magnesium|Calcium Magnesium Adenosine Triphosphatase|Adenosine Triphosphatase, Magnesium|Ca Mg-ATPase|Mg2+ ATPase|Mg2+-Dependent ATPase|Magnesium Adenosinetriphosphatase|adenosine triphosphatase|Calcium Magnesium ATPase|Adenosinetriphosphatase, Calcium Magnesium|Mg2+ Dependent ATPase|Ca2+-Mg2+ ATPase|Magnesium ATPase"
D003315,DISEASE,Cornea,Corneas|cornea
NEW01186,DISEASE,concurrent anaemia,concurrent anaemia
NEW01187,DISEASE,dorsal column syndrome,dorsal column syndrome
NEW01188,DISEASE,pre-existing cognitive impairment,pre-existing cognitive impairment
NEW01189,CHEMICAL,to hydrogen peroxide,H2O2|to hydrogen peroxide
NEW01192,MENTAL_HEALTH,Cu-induced anxiety,Cu-induced anxiety
NEW01194,MENTAL_HEALTH,being agitation,being agitation
NEW01195,DISEASE,night abnormal behavior,night abnormal behavior
NEW01196,CHEMICAL,%,%
NEW01197,DISEASE,aberrant motor behavior,aberrant motor behavior
NEW01198,DISEASE,elation,elation
NEW01200,CHEMICAL,glutamate level,glutamate level
NEW01201,DISEASE,pandemic syndrome,pandemic syndrome
NEW01202,CHEMICAL,chi2=171,chi2=171
NEW01208,DISEASE,impaired biliary excretion,impaired biliary excretion
D020886,DISEASE,Somatosensory Disorders,"Thermal Sensation Disorders|Sensation Disorders, Thermal|Diminished, Pinprick Sensation|Thermal Sensation Disorder|Impairment, Light Touch Sensation|Somatic Sensation Disorder|Pain Sensation Diminished|Diminisheds, Pain Sensation|Pinprick Sensation Diminisheds|Sensation Disorder, Somatic|Somatic Sensation Disorders|Sensation Disorder, Thermal|Diminished, Pain Sensation|Sensation Diminisheds, Pinprick|Position Sense Disorder|Sense Disorders, Position|Sensation Disorders, Somatic|Proprioceptive Disorders|Proprioceptive Disorder|Light Touch Sensation Impairment|Somatosensory Disorder|Sense Disorder, Position|Pain Sensation Diminisheds|Diminisheds, Pinprick Sensation|Pinprick Sensation Diminished|Sensation Diminished, Pinprick|Sensation Diminisheds, Pain|Position Sense Disorders|pain sensation|Sensation Diminished, Pain"
NEW01215,CHEMICAL,contraceptive depot medroxyprogesterone acetate,contraceptive depot medroxyprogesterone acetate|DMPA
NEW01216,CHEMICAL,depot medroxyprogesterone acetate,depot medroxyprogesterone acetate
NEW01218,CHEMICAL,copper resistance systems,copper resistance systems
NEW01219,DISEASE,low hypozincemia detection,low hypozincemia detection
NEW01223,DISEASE,aggressive behaviors,aggressive behaviors
NEW01224,MENTAL_HEALTH,treatment refractory schizophrenia,treatment refractory schizophrenia
NEW01225,DISEASE,severe cardiac adverse events,severe cardiac adverse events
D009205,DISEASE,Myocarditis,myocarditis|Myocarditides|Carditis
NEW01227,CHEMICAL,catecholamine uptake,catecholamine uptake
NEW01228,DISEASE,cocaine-associated chest pain,cocaine-associated chest pain
NEW01230,MENTAL_HEALTH,Claustrophobia Questionnaire,Claustrophobia Questionnaire
NEW01233,CHEMICAL,sodium-potassium adenosine triphosphatase,sodium-potassium adenosine triphosphatase
NEW01235,DISEASE,ouabain-induced neurotoxicity,ouabain-induced neurotoxicity
D014012,DISEASE,Tinnitus,"Tinnitus, Tensor Tympani Induced|Pulsatile Tinnitus|Tinnitus, Clicking|Clicking Tinnitus|Subjective Tinnitus|Tinnitus, Noise Induced|Tensor Tympani Induced Tinnitus|Leudet Tinnitus|Tinnitus, Spontaneous Oto-Acoustic Emission|Leudet's Tinnitus|Induced Tinnitus, Noise|Spontaneous Oto Acoustic Emission Tinnitus|Tinnitus, Pulsatile|Tensor Palatini Induced Tinnitus|Spontaneous Oto-Acoustic Emission Tinnitus|Tinnitus, Leudets|Ringing Buzzing Tinnitus|Tinnitus, Tensor Palatini Induced|Tinnitus, Vascular Origin|Tinnitus, Leudet|Objective Tinnitus|tinnitus|Ringing-Buzzing-Tinnitus|Tinnitus, Subjective|Noise Induced Tinnitus|Tinnitus, Spontaneous Oto Acoustic Emission|Vascular Origin Tinnitus|Tinnitus, Objective|Tinnitus of Vascular Origin|Tinnitus, Leudet's"
NEW01239,DISEASE,cardiac rhythm impairment,cardiac rhythm impairment
NEW01244,CHEMICAL,microg/day,microg/day
NEW01245,DISEASE,persistent hypothyroidism,persistent hypothyroidism
NEW01246,DISEASE,multinodular atoxic goiter,multinodular atoxic goiter
D016264,CHEMICAL,Dextran Sulfate,"DSS|Dextran Sulfate Sodium|Sulfate, Dextran|Sodium Dextran Sulfate|Sulfate, Sodium Dextran|Dextran Sulfate, Sodium|Sulfate Sodium, Dextran|dextran sulfate sodium"
NEW01249,CHEMICAL,continuous curcumin,continuous curcumin
D053655,CHEMICAL,"Receptors, Interleukin-21","IL-21 Receptors|Receptor, Interleukin 21|IL-21 Receptor|Receptors, Interleukin 21|Receptor, IL-21|Interleukin 21 Receptors|Interleukin 21 Receptor|IL-21|IL21R|Receptor, Interleukin-21|Interleukin-21 Receptors|IL 21 Receptor|Interleukin-21 Receptor|Receptors, IL-21|IL 21 Receptors"
NEW01250,DISEASE,colonic mucosal ulceration,colonic mucosal ulceration
NEW01253,CHEMICAL,BDNF Arc promoter,BDNF Arc promoter
NEW01254,DISEASE,induced reproductive toxicity,induced reproductive toxicity
NEW01258,CHEMICAL,metallothioneins,metallothioneins
NEW01265,DISEASE,diabetic management,diabetic management
NEW01266,CHEMICAL,glucose reabsorption,glucose reabsorption
NEW01267,CHEMICAL,sodium excretion,sodium excretion
D050608,CHEMICAL,Sodium-Phosphate Cotransporter Proteins,"Sodium Phosphate Transporters|Sodium Phosphate Cotransporter|Phosphate Transporter, Sodium|Sodium-Phosphate Symporters|Transporters, Sodium Phosphate|Sodium Phosphate Cotransporter Proteins|Sodium-Phosphate Cotransporter|Symporters, Sodium-Phosphate|Cotransporter Proteins, Sodium-Phosphate|Sodium Phosphate Symporters|Phosphate Transporters, Sodium|sodium transporters|Sodium Phosphate Transporter"
NEW01269,CHEMICAL,inpatient blood glucose measurements,inpatient blood glucose measurements
NEW01271,DISEASE,juvenile-onset Amyotrophic Lateral Sclerosis,juvenile-onset Amyotrophic Lateral Sclerosis
NEW01272,MENTAL_HEALTH,CVS-induced anxiety level,CVS-induced anxiety level
NEW01274,DISEASE,pain patient anxiety,pain patient anxiety
NEW01280,DISEASE,anxiety- behavior,anxiety- behavior
NEW01282,CHEMICAL,exercise fluoride group,exercise fluoride group
NEW01283,CHEMICAL,NaF,NaF
NEW01284,CHEMICAL,fluoride group,fluoride group
NEW01285,CHEMICAL,sodium fluoride,sodium fluoride
NEW01286,MENTAL_HEALTH,bipolar affective disorders,bipolar affective disorders
NEW01290,DISEASE,LPS‑induced lung injury,LPS‑induced lung injury
NEW01292,CHEMICAL,recent alcohol consumption,recent alcohol consumption
NEW01295,DISEASE,reversible neurological toxicity,reversible neurological toxicity
NEW01296,CHEMICAL,deficient mitochondrial ornithine transporter,deficient mitochondrial ornithine transporter
NEW01300,DISEASE,obsessive patients,obsessive patients
NEW01303,MENTAL_HEALTH,residual sleepiness,residual sleepiness
NEW01304,BIOCHEMICAL,drug chemistry,drug chemistry
NEW01306,MENTAL_HEALTH,narcolepsy symptoms,narcolepsy symptoms
NEW01310,CHEMICAL,JZP-386,JZP-386
NEW01311,CHEMICAL,FT extended-release formulation,FT extended-release formulation
NEW01312,CHEMICAL,deuterated sodium oxybate oral suspension,deuterated sodium oxybate oral suspension
NEW01317,MENTAL_HEALTH,various mental illness,various mental illness
NEW01321,CHEMICAL,sodium salt valproate,sodium salt valproate
D017029,DISEASE,"Epilepsy, Complex Partial","Epilepsy, Psychomotor|Complex Partial Seizure Disorder|Symptomatic Partial Complex Epilepsy|Disorder, Complex Partial Seizures|Partial Epilepsy, Complex|Cryptogenic Partial Complex Epilepsy|Partial Complex Epilepsy, Cryptogenic|Complex Partial Epilepsy|Epilepsy, Psychic Equivalent|Psychomotor Epilepsy|Psychic Equivalent Epilepsy|Partial Complex Epilepsy, Symptomatic|partial epilepsy|Epilepsy, Symptomatic, Partial Complex|Epilepsy, Cryptogenic, Partial Complex|Seizure Disorder, Complex Partial"
NEW01323,CHEMICAL,cerebral sodium channels,cerebral sodium channels
NEW01324,CHEMICAL,DSS colitis,DSS colitis
NEW01326,DISEASE,aging disorders,aging disorders
NEW01328,CHEMICAL,TRP depletion,TRP depletion
NEW01329,DISEASE,transient depressive relapse,transient depressive relapse
NEW01330,DISEASE,short-term depressive relapse,short-term depressive relapse
NEW01331,DISEASE,paraphilic sexual disorders,paraphilic sexual disorders
NEW01332,MENTAL_HEALTH,sleepiness due,sleepiness due
NEW01334,DISEASE,hyperammonemia enzyme dysfunction,hyperammonemia enzyme dysfunction
NEW01335,CHEMICAL,urea cycle enzyme,urea cycle enzyme
NEW01336,CHEMICAL,L-carnitine deficiency,L-carnitine deficiency
NEW01340,DISEASE,CSDS group,CSDS group
NEW01341,MENTAL_HEALTH,pure mania,pure mania
NEW01345,MENTAL_HEALTH,extreme psychosis,extreme psychosis
D004401,DISEASE,Dysarthria,"Scanning Dysarthria|Hypokinetic Dysarthria|Scanning Dysarthrias|dysarthria|Flaccid Dysarthrias|Dysarthrias, Spastic|Scanning Speech|Mixed Dysarthrias|Dysarthria, Hypokinetic|Guttural Dysarthria|Guttural Dysarthrias|Hypokinetic Dysarthrias|Dysarthria, Hyperkinetic|Dysarthoses|Dysarthria, Spastic|Dysarthrias, Hyperkinetic|Dysarthria, Scanning|Speechs, Scanning|Dysarthria, Guttural|Hyperkinetic Dysarthria|Dysarthrias, Scanning|Dysarthria, Flaccid|Dysarthrias, Guttural|Dysarthrias, Flaccid|Spastic Dysarthria|Flaccid Dysarthria|Spastic Dysarthrias|Dysarthrias, Mixed|Dysarthrias, Hypokinetic|Dysarthosis|Dysarthrias|Dysarthria, Mixed|Hyperkinetic Dysarthrias|Mixed Dysarthria|Scanning Speechs"
D020828,DISEASE,Pseudobulbar Palsy,"Bulbar Palsies, Spastic|Mutism, Pseudobulbar|Pseudobulbar Paralysis|Bulbar Palsy, Spastic|Syndrome, Pseudobulbar|Pareses, Pseudobulbar|Pseudobulbar Mutism|Pseudobulbar Pareses|Paralyses, Pseudobulbar|pseudobulbar palsy|Palsy, Spastic Bulbar|Palsies, Spastic Bulbar|Pseudobulbar Syndromes|Pseudobulbar Mutisms|Pseudobulbar Palsies|Pseudobulbar Dysarthrias|Pseudobulbar Syndrome|Palsy, Pseudobulbar|Dysarthrias, Pseudobulbar|Spastic Bulbar Palsies|Pseudobulbar Paralyses|Dysarthria, Pseudobulbar|Syndromes, Pseudobulbar|Pseudobulbar Dysarthria|Spastic Bulbar Palsy|Paralysis, Pseudobulbar|Palsies, Pseudobulbar|Paresis, Pseudobulbar|Pseudobulbar Paresis|Mutisms, Pseudobulbar"
D011782,DISEASE,Quadriplegia,"Flaccid Tetraplegia|Quadriplegias, Spastic|Tetraplegia|Quadriparesis|Quadriplegias|Tetraplegia, Spastic|Paralysis, Spinal, Quadriplegic|Flaccid Quadriplegias|Quadriplegia, Spastic|Quadripareses|Tetraplegias|Tetraplegias, Spastic|Spastic Tetraplegias|spastic quadriparesis|Flaccid Quadriplegia|Spastic Quadriplegia|Tetraplegias, Flaccid|Spastic Quadriplegias|Tetraplegia, Flaccid|Quadriplegias, Flaccid|Flaccid Tetraplegias|Spastic Tetraplegia|Quadriplegia, Flaccid"
NEW01347,DISEASE,various degrees coma,various degrees coma
D054795,CHEMICAL,Incretins,"incretins|Effects, Incretin|Incretin|Incretin Effects|Effect, Incretin|Incretin Effect|Insulin-Releasing Hormone, Glucose-Dependent|Hormone, Glucose-Dependent Insulin-Releasing|Glucose Dependent Insulin Releasing Hormone|Glucose-Dependent Insulin-Releasing Hormone"
D005749,CHEMICAL,Gastric Inhibitory Polypeptide,"Glucose-Dependent Insulinotropic Peptide|Peptide, Glucose-Dependent Insulinotropic|Inhibitory Polypeptide, Gastric|Polypeptide, Gastric-Inhibitory|glucose-dependent insulinotropic peptide|Polypeptide, Gastric Inhibitory|Peptide, Glucose-Dependent Insulin-Releasing|Gastric-Inhibitory Polypeptide|Glucose Dependent Insulinotropic Peptide|Glucose-Dependent Insulin-Releasing Peptide|Insulin-Releasing Peptide, Glucose-Dependent|Glucose Dependent Insulin Releasing Peptide|Insulinotropic Peptide, Glucose-Dependent"
D002544,DISEASE,Cerebral Infarction,"Cerebral, Right Hemisphere, Infarction|Cerebral Infarcts|Posterior Choroidal Artery Infarction|Infarction, Cerebral, Left Hemisphere|Subcortical Infarction|Left Hemisphere, Infarction, Cerebral|Infarctions, Cerebral|Infarcts, Cerebral|cerebral infarction|Cerebral Infarction, Right Hemisphere|Cerebral Infarction, Left Hemisphere|Right Hemisphere, Infarction, Cerebral|Subcortical Infarctions|Infarction, Cerebral|Cerebral Infarct|Cerebral Infarctions|Infarction, Left Hemisphere, Cerebral|Right Hemisphere, Cerebral Infarction|Infarct, Cerebral|Infarction, Subcortical|Left Hemisphere, Cerebral Infarction|Infarctions, Subcortical|Cerebral, Left Hemisphere, Infarction|Anterior Choroidal Artery Infarction|Infarction, Cerebral, Right Hemisphere|Infarction, Right Hemisphere, Cerebral"
NEW01351,DISEASE,various neurological disorders,various neurological disorders
NEW01353,MENTAL_HEALTH,moderate mental depression,moderate mental depression
NEW01355,DISEASE,proven duodenitis,proven duodenitis
NEW01358,BIOCHEMICAL,antacid use,antacid use
D008286,DISEASE,Malabsorption Syndromes,"Syndromes, Malabsorption|malabsorption|Syndrome, Malabsorption|Malabsorption Syndrome"
NEW01359,CHEMICAL,serum phosphate level,serum phosphate level
NEW01360,CHEMICAL,urinary phosphate excretion,urinary phosphate excretion
NEW01361,CHEMICAL,normal serum calcium level,normal serum calcium level
NEW01363,DISEASE,spinal pain,spinal pain
NEW01364,MENTAL_HEALTH,chronic fatigue ascribable,chronic fatigue ascribable
D018771,DISEASE,Arthralgia,"Polyarthralgias|Polyarthralgia|Joint Pains|Joint Pain|Pain, Joint|Pains, Joint|Arthralgias|polyarthralgia"
NEW01366,DISEASE,psychotomimetic-like effects,psychotomimetic-like effects
NEW01369,BIOCHEMICAL,mixed-action serotonergic drugs,mixed-action serotonergic drugs
NEW01370,MENTAL_HEALTH,abuse pharmacotherapy,abuse pharmacotherapy
NEW01372,BIOCHEMICAL,neutral antagonist,neutral antagonist
NEW01374,DISEASE,memory deficits similar,memory deficits similar
NEW01377,MENTAL_HEALTH,schizophrenia long-lasting behavioral alterations,schizophrenia long-lasting behavioral alterations
NEW01380,BIOCHEMICAL,CB1 antagonist/inverse agonist AM251,CB1 antagonist/inverse agonist AM251
NEW01383,DISEASE,treatment resistant psychotic symptoms,treatment resistant psychotic symptoms
NEW01384,MENTAL_HEALTH,refractory hallucinations,refractory hallucinations
NEW01387,DISEASE,affective abnormalities,affective abnormalities
NEW01389,DISEASE,cognitive benefits,cognitive benefits
NEW01391,CHEMICAL,male alcohol use,male alcohol use
NEW01395,DISEASE,psychopathologies,psychopathologies
NEW01397,DISEASE,behavioral alterations,behavioral alterations
NEW01399,DISEASE,seizure activity,seizure activity
NEW01403,BIOCHEMICAL,antidepressant drug development,antidepressant drug development
NEW01407,CHEMICAL,unconventional steroid signaling,unconventional steroid signaling
NEW01408,DISEASE,alcohol-induced behaviors,alcohol-induced behaviors
NEW01412,CHEMICAL,naloxone- withdrawal syndromes,naloxone- withdrawal syndromes
NEW01413,CHEMICAL,naltrexone-elicited,naltrexone-elicited
NEW01417,DISEASE,ADHD-like behaviors,ADHD-like behaviors
NEW01419,BIOCHEMICAL,agonist SLV-319,agonist SLV-319
NEW01421,CHEMICAL,ethanol addiction,ethanol addiction
NEW01424,DISEASE,selective attention deficit,selective attention deficit
NEW01431,DISEASE,experimental acute sciatic nerve injury,experimental acute sciatic nerve injury
D020833,DISEASE,Diffuse Axonal Injury,"DAIs (Diffuse Axonal Injury)|Axonal Injuries, Diffuse|Axonal Injury, Diffuse|Injury, Diffuse Axonal|axonal injury|DAI (Diffuse Axonal Injury)|Diffuse Axonal Injuries|Injuries, Diffuse Axonal"
NEW01432,DISEASE,injured sciatic nerve,injured sciatic nerve
NEW01434,CHEMICAL,phosphate ion competition,phosphate ion competition
D065098,NUTRITION,Catechol O-Methyltransferase Inhibitors,"O-Methyltransferase Inhibitors, Catechol|Catechol O Methyltransferase Inhibitors|catechol"
NEW01436,DISEASE,uncontrolled pain management,uncontrolled pain management
NEW01438,BIOCHEMICAL,month illicit drug users,month illicit drug users
D000063,DISEASE,"Accidents, Traffic","Collision, Traffic|Accident, Traffic|Crashes, Traffic|Traffic Collisions|crashes|Collisions, Traffic|Traffic Accidents|Traffic Crashes|Traffic Collision|Traffic Accident"
NEW01439,DISEASE,more deaths,more deaths
D011396,CHEMICAL,Promedol,Trimeperidine|Dimethylmeperidine|promedol|Isopromedol
NEW01442,DISEASE,psychotic state,psychotic state
NEW01443,BIOCHEMICAL,pre-existing drug abuse,pre-existing drug abuse
NEW01446,DISEASE,orofacial dyskinetic movements,orofacial dyskinetic movements
NEW01448,CHEMICAL,colchicine treated rats,colchicine treated rats
NEW01449,DISEASE,mito-oxidative damage parameters,mito-oxidative damage parameters
NEW01450,DISEASE,memory dysfunction,memory dysfunction
NEW01452,DISEASE,CRS-induced hippocampal mitochondrial dysfunction,CRS-induced hippocampal mitochondrial dysfunction
NEW01454,DISEASE,diseases prostate cancer,diseases prostate cancer
NEW01455,DISEASE,colitis mice,colitis mice
NEW01457,DISEASE,learning impairment,learning impairment
NEW01459,DISEASE,SMZ-induced brain injury,SMZ-induced brain injury
NEW01460,DISEASE,ischemic-induced injury,ischemic-induced injury
NEW01462,BIOCHEMICAL,apparent extrarenal vitamin D synthesis,apparent extrarenal vitamin D synthesis
NEW01464,DISEASE,adynamic uremic osteodystrophy,adynamic uremic osteodystrophy
NEW01465,CHEMICAL,desferrioxamine challenge,desferrioxamine challenge
NEW01467,DISEASE,large vessel disease,large vessel disease
NEW01469,DISEASE,deficit symptoms,deficit symptoms
NEW01473,BIOCHEMICAL,vitamin B1 deficiency,vitamin B1 deficiency
NEW01478,DISEASE,pain outcomes,pain outcomes
NEW01480,DISEASE,cognitive abilities,cognitive abilities
NEW01482,BIOCHEMICAL,vitamin K antagonists,vitamin K antagonists
NEW01484,DISEASE,persistent physical abnormalities,persistent physical abnormalities
NEW01487,DISEASE,stress-associated metabolic disorders,stress-associated metabolic disorders
NEW01489,DISEASE,bone injury,bone injury
NEW01491,DISEASE,Ang II-related cognitive impairment,Ang II-related cognitive impairment
NEW01492,DISEASE,pathogenic Candida strains,pathogenic Candida strains
NEW01493,DISEASE,acute respiratory infection,acute respiratory infection
NEW01497,MENTAL_HEALTH,broad depression phenotypes,broad depression phenotypes
NEW01498,DISEASE,MDD subtypes,MDD subtypes
NEW01499,CHEMICAL,calcium medication,calcium medication
NEW01501,DISEASE,multistrain probiotic,multistrain probiotic
D001710,BIOCHEMICAL,Biotin,"Biokur|Gelfert, Biotin|Rombellin|Deacura|Gabunat|Biotin Ratiopharm|Biotin Gelfert|biotin|Biotine Roche|Biodermatin|Vitamin H|Medebiotin|Medobiotin|Biotin Hermes|Biotin-Ratiopharm|Roche, Biotine|Hermes, Biotin"
NEW01502,DISEASE,modest weight reduction,modest weight reduction
NEW01504,DISEASE,renal azotemia,renal azotemia
D034141,DISEASE,Hypoalbuminemia,Hypoproteinemia (1965-2002)|hypoalbuminemia|Serum Albumin (1965-2002)
NEW01506,NUTRITION,fatty acid metabolism,fatty acid metabolism
D055948,DISEASE,Sarcopenia,Sarcopenias|sarcopenia
NEW01507,DISEASE,liver cirrhotic patients,liver cirrhotic patients
NEW01509,DISEASE,chronic tubulointerstitial nephritis,chronic tubulointerstitial nephritis
NEW01510,MENTAL_HEALTH,alcoholic delirium,alcoholic delirium
NEW01513,CHEMICAL,nitrous oxide use,nitrous oxide use
NEW01515,CHEMICAL,elevated homocysteine level,elevated homocysteine level
NEW01518,MENTAL_HEALTH,withdrawal-induced anxiety related,withdrawal-induced anxiety related
NEW01524,DISEASE,immune-mediated disease,immune-mediated disease
NEW01526,MENTAL_HEALTH,unexplained fatigue,unexplained fatigue
NEW01530,BIOCHEMICAL,vitamin B6 level,vitamin B6 level
NEW01532,BIOCHEMICAL,tissue vitamin B12 deficiency,tissue vitamin B12 deficiency
NEW01535,DISEASE,Wernicke-Korsakov syndrome,Wernicke-Korsakov syndrome
D000077211,CHEMICAL,Zoledronic Acid,"Zoledronate|CGP42'446|CGP-42446|CGP 42'446|Zometa|Zoledronic Acid Anhydrous|CGP42446|CGP 42446|zoledronic acid|2-(Imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid|CGP 42446A|CGP-42'446"
NEW01542,DISEASE,bone damage related,bone damage related
NEW01544,BIOCHEMICAL,most vitamins,most vitamins
NEW01545,MENTAL_HEALTH,acute manic episode,acute manic episode
NEW01553,DISEASE,aggressive hypersexual patients,aggressive hypersexual patients
NEW01556,CHEMICAL,female sexual steroids,female sexual steroids
NEW01557,BIOCHEMICAL,sequential hormone therapy,sequential hormone therapy
D002560,DISEASE,Cerebrovascular Circulation,"Circulation, Cerebral|Flow, Brain Blood|Circulation, Cerebrovascular|Cerebral Circulation|Perfusion Pressure, Cerebral|Pressure, Cerebral Perfusion|Flow, Cerebral Blood|Cerebral Blood Flow|Cerebral Circulations|Brain Blood Flow|Blood Flow, Brain|Cerebral Blood Flows|Regional Cerebral Blood Flow|Blood Flow, Cerebral|Cerebral Perfusion Pressures|Cerebral Perfusion Pressure|cerebral blood flow|Brain Blood Flows"
NEW01565,CHEMICAL,cerebral glucose administration,cerebral glucose administration
NEW01566,DISEASE,neurological disease,neurological disease
C048016,BIOCHEMICAL,"fatty acid, fat-soluble vitamin and phospholipid emulsion [Supplementary Concept]",Vitamin D|Phospholipids|fat-soluble vitamin|Emulsions|Vitamin A|Fatty Acids
NEW01569,DISEASE,spinal-cerebral diseases,spinal-cerebral diseases
NEW01570,DISEASE,digestive disorders,digestive disorders
NEW01573,DISEASE,sitophobia,sitophobia
NEW01574,DISEASE,maldigestion due,maldigestion due
NEW01575,MENTAL_HEALTH,smoking abuse,smoking abuse
NEW01578,CHEMICAL,pancreatic enzyme replacement therapy,PERT|pancreatic enzyme replacement therapy
D019005,DISEASE,Cystic Fibrosis Transmembrane Conductance Regulator,"cystic fibrosis|Chloride channels, ATP gated CFTR|Protein, CFTR|CFTR Protein|Chloride channels, ATP-gated CFTR"
NEW01580,DISEASE,hyperglycaemia overt diabetes mellitus,hyperglycaemia overt diabetes mellitus
NEW01581,BIOCHEMICAL,fat soluble vitamin deficiencies,fat soluble vitamin deficiencies
C537706,DISEASE,Kaler Garrity Stern syndrome [Supplementary Concept],"Hair Diseases|osteopenia|Bone Diseases, Metabolic|Intellectual Disability"
D063730,DISEASE,"Rickets, Hypophosphatemic","Rickets, Vitamin D Resistant|Vitamin D-Resistant Rickets|Hypophosphatemic Rickets|Acquired Vitamin D Resistant Rickets|Ricket, Hypophosphatemic|rickets|Hypophosphatemic Vitamin D Resistant Rickets|Acquired Vitamin D-Resistant Rickets|Hypophosphatemic Ricket|Hypophosphatemic Vitamin D-Resistant Rickets|Rickets, Vitamin D-Resistant|Hypophosphatemia, Vitamin D-Resistant Rickets"
C536561,DISEASE,Trimethylaminuria [Supplementary Concept],"trimethylaminuria|Metabolism, Inborn Errors|Methylamines/urine"
NEW01584,CHEMICAL,Omega-3 brain-food,Omega-3 brain-food
NEW01585,DISEASE,dietary deficit,dietary deficit
NEW01586,CHEMICAL,deficient brain-food,deficient brain-food|Omega-3
NEW01592,DISEASE,Salmonella enterica pathogenicity island,Salmonella enterica pathogenicity island
NEW01593,DISEASE,various brain disorders,various brain disorders
NEW01595,MENTAL_HEALTH,dopaminergic hyperactivity,dopaminergic hyperactivity
NEW01597,MENTAL_HEALTH,schizophrenia features,schizophrenia features
NEW01599,CHEMICAL,alarm pheromone,alarm pheromone
D004316,CHEMICAL,Doxepin,"Quitaxon|Espadox|Mareen|Desidox|Sinequan|ApoDoxepin|Sinquan|Deptran|Novo Doxepin|Doxepin-RPh|Prudoxin|Doxepin RPh|Doxepin beta|∼1 %|Doxepia|Zonalon|Aponal|Novo-Doxepin|Xepin|Apo-Doxepin|Apo Doxepin|Doneurin|Doxepin Hydrochloride|Hydrochloride, Doxepin|Doxepin Hydrochloride, Cis-Trans Isomer Mixture (approximately 1:5)"
NEW01601,DISEASE,dendritic atrophy,dendritic atrophy
NEW01603,DISEASE,slight memory impairment,slight memory impairment
NEW01604,CHEMICAL,µM cyclophosphamide exposure,µM cyclophosphamide exposure
NEW01609,DISEASE,CRF type receptor selective antagonist antalarmin,CRF type receptor selective antagonist antalarmin
D005979,CHEMICAL,Glutathione Peroxidase,"Selenoglutathione Peroxidase|Peroxidase, Selenoglutathione|Glutathione Peroxidase, Cytosolic|Peroxidase, Glutathione|Lipoperoxidase, Glutathione|glutathione peroxidase|Glutathione Lipoperoxidase|Cytosolic Glutathione Peroxidase"
NEW01613,DISEASE,attention deficit/hyperactivity disorder,attention deficit/hyperactivity disorder
D001072,MENTAL_HEALTH,Apraxias,"Speech-Language Disorder 1|Developmental Verbal Apraxia|Oral Dyspraxia|Speech-Language Disorder 1s|Apraxias, Verbal|Verbal Apraxias|Phonation Apraxias|Dyspraxias, Developmental Verbal|Apraxia, Verbal|Apraxia|Verbal Apraxia|Dyspraxias, Verbal|Speech Language Disorder 1|Apraxia, Developmental Verbal|Dyspraxias|Verbal Apraxias, Developmental|Motor Apraxias|Oral Dyspraxias|Apraxias, Gestural|1s, Speech-Language Disorder|Verbal Dyspraxia, Developmental|Apraxias, Dressing|Phonation Apraxia|Dressing Apraxia|Apraxia, Gestural|Apraxias, Ideational|Dyspraxia, Oral|Oral Apraxias|Apraxia, Articulatory|Dressing Apraxias|Apraxias, Articulatory|Apraxia, Dressing|Apraxia, Ideational|Ideational Apraxia|Speech And Language Disorder With Orofacial Dyspraxia|Apraxia, Oral|Apraxias, Oral|Verbal Apraxia, Developmental|Disorder 1s, Speech-Language|Apraxia, Facial-Oral|Developmental Verbal Apraxias|Motor Apraxia|Apraxia of Phonation|Developmental Verbal Dyspraxias|Articulatory Apraxias|Developmental Verbal Dyspraxia|Apraxias, Motor|Articulatory Apraxia|Verbal Dyspraxias, Developmental|dyspraxia|Oral Apraxia|Gestural Apraxia|Dyspraxia|Verbal Dyspraxia|Gestural Apraxias|Dyspraxias, Articulatory|Articulatory Dyspraxias|Disorder 1, Speech-Language|Dyspraxia, Articulatory|Dyspraxia, Verbal|Articulatory Dyspraxia|Dyspraxia, Developmental Verbal|Facial-Oral Apraxia|Dyspraxias, Oral|Apraxia, Facial Oral|Verbal Dyspraxias|Facial-Oral Apraxias|Apraxia, Motor|Apraxias, Developmental Verbal|Ideational Apraxias|Apraxias, Facial-Oral"
NEW01621,CHEMICAL,SMOF group,SMOF group
C093230,CHEMICAL,fexofenadine [Supplementary Concept],Terfenadine/analogs  and  derivatives|fexofenadine
NEW01629,CHEMICAL,arachidonic acid levels,arachidonic acid levels
NEW01632,BIOCHEMICAL,neurotoxin 1-methyl-4-phenyl-1,neurotoxin 1-methyl-4-phenyl-1
NEW01633,CHEMICAL,6-tetrahydropyridine,6-tetrahydropyridine
NEW01634,CHEMICAL,nigral tyrosine hydroxylase,nigral tyrosine hydroxylase
NEW01635,DISEASE,progressive neurodegenerative diseases,progressive neurodegenerative diseases
NEW01639,CHEMICAL,NMDA receptor function,NMDA receptor function
NEW01638,DISEASE,schizophrenic people,schizophrenic people
NEW01640,CHEMICAL,NMDA receptor complex,NMDA receptor complex
NEW01642,DISEASE,pain pathways,pain pathways
NEW01645,CHEMICAL,corticosterone levels,corticosterone levels
NEW01651,DISEASE,stress-induced depression/anxiety,stress-induced depression/anxiety
NEW01652,MENTAL_HEALTH,neurogenic stress-induced depression,neurogenic stress-induced depression
NEW01653,DISEASE,behavioral despair,behavioral despair
NEW01654,CHEMICAL,melatonin pathway,melatonin pathway
NEW01656,DISEASE,neurogenic stress-induced depressive behaviors,neurogenic stress-induced depressive behaviors
NEW01658,MENTAL_HEALTH,parallel orientation,parallel orientation
C097015,CHEMICAL,oxazole yellow [Supplementary Concept],Quinolines|oxazole|Benzoxazoles
NEW01659,DISEASE,seizure burden,seizure burden
NEW01665,DISEASE,ischaemia,ischaemia
NEW01667,DISEASE,neuro-cognitive deficits,neuro-cognitive deficits
NEW01669,DISEASE,hyperammonemic fish,hyperammonemic fish
NEW01672,CHEMICAL,ammonium elimination,ammonium elimination
NEW01673,CHEMICAL,urea cycle deficiencies,urea cycle deficiencies
NEW01674,DISEASE,organic acidemias,organic acidemias
NEW01676,CHEMICAL,amino acid pathways,amino acid pathways
NEW01677,CHEMICAL,nitric oxide synthesis,nitric oxide synthesis
NEW01678,CHEMICAL,ATP levels,ATP levels
NEW01679,DISEASE,addiction-like behaviors,addiction-like behaviors
NEW01680,DISEASE,hypersynchronization,hypersynchronization
NEW01681,BIOCHEMICAL,psychotomimetic N-methyl-D-aspartic acid NMDA receptor antagonists,psychotomimetic N-methyl-D-aspartic acid NMDA receptor antagonists
NEW01683,CHEMICAL,increasing extrasynaptic glycine concentrations,increasing extrasynaptic glycine concentrations
NEW01688,MENTAL_HEALTH,clinical anxiety disorders,clinical anxiety disorders
NEW01691,MENTAL_HEALTH,MK-801-induced amnesia,MK-801-induced amnesia
NEW01692,MENTAL_HEALTH,major mental disorders,major mental disorders
NEW01695,MENTAL_HEALTH,Alzheimer disease patients,Alzheimer disease patients
NEW01697,DISEASE,TBS-induced LTP,TBS-induced LTP
C052873,CHEMICAL,zidovudine triphosphate [Supplementary Concept],azidothymidine|Zidovudine/analogs  and  derivatives
NEW01700,DISEASE,improved PTSD symptoms,improved PTSD symptoms
NEW01702,DISEASE,HIV-associated neurocognitive disorder,HIV-associated neurocognitive disorder
NEW01708,DISEASE,ovarian suppression,ovarian suppression
NEW01710,BIOCHEMICAL,peripartum sex-steroid hormone fluctuations,peripartum sex-steroid hormone fluctuations
NEW01711,DISEASE,neurodevelopmental toxicity,neurodevelopmental toxicity
NEW01712,DISEASE,developmental neurotoxicity,developmental neurotoxicity
D000068079,DISEASE,Motor Disorders,motor disorders|Motor Skills Disorders (1998-2015)
NEW01713,DISEASE,neuronal inflammation,neuronal inflammation
NEW01714,DISEASE,neurodegeneration motor disorders,neurodegeneration motor disorders
NEW01715,BIOCHEMICAL,novel drug candidate,novel drug candidate
C106276,CHEMICAL,sitaxsentan [Supplementary Concept],Isoxazoles|sitaxsentan|Thiophenes
NEW01718,DISEASE,significant pulmonary fibrosis,significant pulmonary fibrosis
NEW01720,BIOCHEMICAL,Direct Antiviral Agents,Direct Antiviral Agents
C462182,CHEMICAL,favipiravir [Supplementary Concept],Pyrazines|Amides|favipiravir
NEW01722,CHEMICAL,amyloid beta-protein Aβ aggregation,amyloid beta-protein Aβ aggregation
NEW01723,DISEASE,peripheral HSV infection,peripheral HSV infection
NEW01725,MENTAL_HEALTH,dementia risk,dementia risk
NEW01728,MENTAL_HEALTH,longer delirium duration,longer delirium duration
NEW01729,DISEASE,Conclusions,Conclusions
D018352,DISEASE,Coronavirus Infections,"Coronavirus Infection|Middle East Respiratory Syndrome|Infections, Coronavirus|MERS (Middle East Respiratory Syndrome)|coronavirus infections|Infection, Coronavirus"
NEW01732,MENTAL_HEALTH,therapy-resistant schizophrenia,therapy-resistant schizophrenia
NEW01735,CHEMICAL,spontaneous glutamate release,spontaneous glutamate release
NEW01738,CHEMICAL,β/γ dimer-mediated signaling,β/γ dimer-mediated signaling
NEW01739,MENTAL_HEALTH,adult separation anxiety,adult separation anxiety
NEW01740,CHEMICAL,glutamate signaling,glutamate signaling
NEW01744,CHEMICAL,K+ sheep,K+ sheep
NEW01745,CHEMICAL,volume-sensitive K+-Cl- COT,volume-sensitive K+-Cl- COT
NEW01747,BIOCHEMICAL,overall beta-amyloid protein,overall beta-amyloid protein|beta AP
NEW01748,DISEASE,retina damage,retina damage
NEW01751,DISEASE,mutant DISC1,mutant DISC1
NEW01754,CHEMICAL,N-Methyl-D-aspartic acid receptor antagonist phencyclidine,N-Methyl-D-aspartic acid receptor antagonist phencyclidine
NEW01755,DISEASE,psychiatric endophenotypes,psychiatric endophenotypes
NEW01757,DISEASE,SMA mice,SMA mice
NEW01758,BIOCHEMICAL,date drug treatment,date drug treatment
NEW01759,CHEMICAL,verapamil treatment,verapamil treatment
NEW01760,MENTAL_HEALTH,nonsyndromic X-linked mental retardation,nonsyndromic X-linked mental retardation
NEW01762,BIOCHEMICAL,Standardized beta =,Standardized beta =
NEW01764,CHEMICAL,testosterone synthesis,testosterone synthesis
NEW01766,MENTAL_HEALTH,CMS+MS-induced depression models,CMS+MS-induced depression models
NEW01767,DISEASE,CMS+MS-induced postmenopausal bone loss,CMS+MS-induced postmenopausal bone loss
D016301,DISEASE,Alveolar Bone Loss,"Alveolar Bone Atrophies|Resorption, Periodontal|Alveolar Resorption|Bone Loss, Periodontal|Periodontal Bone Losses|Periodontal Resorptions|Bone Atrophy, Alveolar|Alveolar Process Atrophy|Resorptions, Alveolar|bone loss|Bone Losses, Periodontal|Periodontal Resorption|Periodontal Bone Loss|Bone Loss, Alveolar|Resorption, Alveolar|Alveolar Resorptions|Bone Atrophies, Alveolar|Alveolar Process Atrophies|Alveolar Bone Losses|Alveolar Bone Atrophy"
NEW01768,CHEMICAL,brain serotonin secretion,brain serotonin secretion
NEW01771,DISEASE,skeletal muscle atrophy,skeletal muscle atrophy
NEW01772,DISEASE,DEX-induced myotube atrophy,DEX-induced myotube atrophy
NEW01774,MENTAL_HEALTH,male sexual dysfunction,male sexual dysfunction
NEW01775,DISEASE,non-apoptotic oxidative death,non-apoptotic oxidative death
NEW01777,CHEMICAL,pre-existing AUD,pre-existing AUD
NEW01778,DISEASE,SARS-CoV2 infection,SARS-CoV2 infection
NEW01779,DISEASE,severe liver disease,severe liver disease
NEW01781,DISEASE,stimulus-induced PKC translocations,stimulus-induced PKC translocations
NEW01783,CHEMICAL,lithium acid treatments,lithium acid treatments
NEW01786,CHEMICAL,mitochondrial enzyme glutamate dehydrogenase,mitochondrial enzyme glutamate dehydrogenase
NEW01788,CHEMICAL,PI3 K pathway,PI3 K pathway
NEW01790,DISEASE,maladaptive behavior,maladaptive behavior
NEW01791,MENTAL_HEALTH,somnolence sleep attacks,somnolence sleep attacks
D007815,DISEASE,Larva Migrans,"Eruptions, Creeping|Ground Itchs|Larva Migrans, Ocular|Dew Itch|itch|Creeping Eruptions|Larva Migrans, Cutaneous|Itchs, Ground|Eruption, Creeping|Ground Itch|Itch, Dew|Itch, Ground|Itchs, Dew|Dew Itchs|Creeping Eruption|Cutaneous Larva Migrans|Ocular Larva Migrans"
NEW01795,MENTAL_HEALTH,drug-resistant schizophrenia,drug-resistant schizophrenia
NEW01799,CHEMICAL,mesolimbic-cortical dopamine receptors,mesolimbic-cortical dopamine receptors
NEW01801,DISEASE,repetitive/compulsive behaviors,repetitive/compulsive behaviors
NEW01802,DISEASE,social deficits,social deficits
NEW01804,BIOCHEMICAL,first-line drug,first-line drug
NEW01806,BIOCHEMICAL,G allele carrier group,G allele carrier group
NEW01808,DISEASE,increased depressive,increased depressive
NEW01810,BIOCHEMICAL,nuclear factor- k beta,nuclear factor- k beta
NEW01811,CHEMICAL,Al activity,Al activity
NEW01812,CHEMICAL,ionized calcium binding adaptor molecule,ionized calcium binding adaptor molecule
NEW01813,CHEMICAL,acetyl cholinesterase,acetyl cholinesterase
D052247,CHEMICAL,Nitric Oxide Synthase Type II,"Nitric Oxide Synthase, Type II|Inducible Nitric Oxide Synthase|NOS-II|Nitric Oxide Synthase II|inducible nitric oxide synthase|Inducible NOS Protein|NOS II|INOS Enzyme"
NEW01814,DISEASE,brain impairment,brain impairment
NEW01815,CHEMICAL,neurotrophic tyrosine kinase receptor type gene,neurotrophic tyrosine kinase receptor type gene
NEW01816,CHEMICAL,purine salvage enzyme,purine salvage enzyme
NEW01817,CHEMICAL,enzyme hypoxanthine phosphoribosyltransferase,enzyme hypoxanthine phosphoribosyltransferase
NEW01820,MENTAL_HEALTH,disorder anxiety disorder,disorder anxiety disorder
NEW01821,CHEMICAL,SB impairments,SB impairments
NEW01823,BIOCHEMICAL,CGRP receptor antagonist BIBN4096,CGRP receptor antagonist BIBN4096
D010871,DISEASE,Pinealoma,"Pineoblastomas|Pineal Tumors|Neoplasm, Pineal|Pineocytoma-Pineoblastoma, Mixed|Pineoblastoma|Mixed Pineocytoma-Pineoblastoma|Mixed Pineocytoma Pineoblastoma|Neoplasms, Pineal|Pineocytomas|Pinealomas|Pineal Tumor|Pineal Neoplasm|Pineal Neoplasms|Pineocytoma|Pineal Parenchymal Tumors|Tumors, Pineal|Pinealocytoma|Tumor, Pineal|Mixed Pineocytoma-Pineoblastomas|Pineal Gland Tumor|Tumors, Pineal Gland|Pineal Parenchymal Tumor|Tumor, Pineal Parenchymal|Pineal Gland Tumors|pineal parenchymal tumors|Pinealocytomas|Pineocytoma-Pineoblastomas, Mixed|Tumor, Pineal Gland|Tumors, Pineal Parenchymal"
NEW01826,CHEMICAL,"CNS 3',5'-cyclic adenosine monophosphate","CNS 3',5'-cyclic adenosine monophosphate|cyclic AMP"
NEW01828,DISEASE,cataract formation,cataract formation
NEW01829,DISEASE,significant cataract formation,significant cataract formation
NEW01832,DISEASE,impairments years,impairments years
NEW01834,DISEASE,memory impairments,memory impairments
NEW01835,DISEASE,early brain injury,early brain injury
D020206,DISEASE,"Subarachnoid Hemorrhage, Traumatic","subarachnoid hemorrhage|Post Traumatic Subarachnoid Hemorrhage|Hemorrhage, Traumatic Subarachnoid|Post-Traumatic Subarachnoid Hemorrhage|Subarachnoid Hemorrhages, Post-Traumatic|Subarachnoid Hemorrhage, Post-Traumatic|Traumatic Subarachnoid Hemorrhages|Hemorrhages, Post-Traumatic Subarachnoid|Hemorrhage, Post-Traumatic Subarachnoid|Subarachnoid Hemorrhages, Traumatic|Traumatic Subarachnoid Hemorrhage|Post-Traumatic Subarachnoid Hemorrhages"
NEW01837,DISEASE,developmental toxicity,developmental toxicity
NEW01840,DISEASE,Parkinson's diseases,Parkinson's diseases
NEW01842,DISEASE,serious cardiac arrhythmias,serious cardiac arrhythmias
NEW01843,DISEASE,functional disability scores,functional disability scores
NEW01845,MENTAL_HEALTH,anxiety glycaemic control,anxiety glycaemic control
NEW01847,CHEMICAL,meal cortisol reactions,meal cortisol reactions
NEW01849,MENTAL_HEALTH,non-seasonal depression,non-seasonal depression
NEW01850,DISEASE,depressed women,depressed women
NEW01851,MENTAL_HEALTH,various affective disorders,various affective disorders
NEW01854,DISEASE,arterial hyperammonemia,arterial hyperammonemia
NEW01855,BIOCHEMICAL,drug absorption,drug absorption
NEW01856,CHEMICAL,mumols/l,mumols/l
NEW01857,DISEASE,stuporous states,stuporous states
NEW01858,MENTAL_HEALTH,subjective sleepiness,subjective sleepiness
NEW01860,CHEMICAL,parental smoking status,parental smoking status
NEW01861,MENTAL_HEALTH,Addiction score,Addiction score
NEW01863,DISEASE,cognitive deterioration,cognitive deterioration
NEW01865,CHEMICAL,plasma medium-chain fatty acids,plasma medium-chain fatty acids
NEW01866,CHEMICAL,ketogenesis,ketogenesis
NEW01868,DISEASE,tumor types,tumor types
NEW01870,DISEASE,glioblastoma GBM development,glioblastoma GBM development
NEW01871,DISEASE,agitation/allodynia,agitation/allodynia
NEW01873,DISEASE,tonic pain,tonic pain
NEW01874,CHEMICAL,hypoanalgesic response,hypoanalgesic response
NEW01876,DISEASE,defeat-induced analgesia,defeat-induced analgesia
NEW01878,MENTAL_HEALTH,nondefeat-induced analgesia,nondefeat-induced analgesia
NEW01880,DISEASE,defeat-induced increases,defeat-induced increases
NEW01883,MENTAL_HEALTH,animal anxiety,animal anxiety
NEW01885,DISEASE,first submersion,first submersion
D004681,DISEASE,"Encephalomyelitis, Autoimmune, Experimental","Autoimmune Encephalomyelitis, Experimental|experimental autoimmune encephalomyelitis|Experimental Allergic Encephalomyelitides|Experimental Autoimmune Encephalomyelitis|Encephalomyelitis, Allergic|Encephalomyelitis, Experimental Allergic|Experimental Encephalomyelitis, Autoimmune|Allergic Encephalomyelitis, Experimental|Autoimmune Experimental Encephalomyelitis|EAE|Encephalomyelitis, Experimental Autoimmune|Allergic Encephalomyelitis|Experimental Allergic Encephalomyelitis|Encephalomyelitis, Autoimmune Experimental"
NEW01886,DISEASE,experimental encephalomyelitis model,experimental encephalomyelitis model
NEW01887,DISEASE,hippocampus abnormalities,hippocampus abnormalities
NEW01891,MENTAL_HEALTH,mania symptoms,mania symptoms
NEW01892,MENTAL_HEALTH,persistent mania,persistent mania
NEW01897,DISEASE,ovarian hormone-linked upsets,ovarian hormone-linked upsets
NEW01898,MENTAL_HEALTH,antidepressants hyperactivity,antidepressants hyperactivity
NEW01899,CHEMICAL,brain monoamines,brain monoamines
NEW01900,DISEASE,childhood attention-deficit/hyperactivity disorder,childhood attention-deficit/hyperactivity disorder
NEW01905,DISEASE,menstruation-related symptoms,menstruation-related symptoms
NEW01906,DISEASE,favorable bleeding patterns,favorable bleeding patterns
NEW01911,DISEASE,human CCF-STTG1 astrocytoma cells,human CCF-STTG1 astrocytoma cells
NEW01912,DISEASE,CCF-STTG1 astrocytoma cells,CCF-STTG1 astrocytoma cells
NEW01917,BIOCHEMICAL,anti-TB drug,anti-TB drug
NEW01922,BIOCHEMICAL,vitamins E,vitamins E
NEW01924,CHEMICAL,EPUFAs,EPUFAs
NEW01925,DISEASE,chemical-induced hepatotoxicity,chemical-induced hepatotoxicity
NEW01927,BIOCHEMICAL,diverse drug,diverse drug
D066126,DISEASE,Cardiotoxicity,"Cardiac Toxicities|Toxicity, Cardiac|Cardiac Toxicity|cardiotoxicity|Cardiotoxicities"
NEW01928,DISEASE,selected human cancer cells,selected human cancer cells
NEW01929,DISEASE,DMN-induced liver carcinogenesis,DMN-induced liver carcinogenesis
NEW01930,CHEMICAL,ethanol,ethanol
NEW01931,DISEASE,hepatic damage,hepatic damage
D017455,CHEMICAL,"Receptors, IgE","Fc epsilon Receptors|IgE Receptor|Receptors, Fc epsilon|Fc epsilon RII|Fc Receptors, epsilon|epsilon Receptors, Fc|Receptor, epsilon Fc|Receptor, Immunoglobulin E|Receptor, IgE|Antigens, CD23|Receptor, Fc epsilon|epsilon Fc Receptors|Immunoglobulin E Receptor|Fc Receptor, epsilon|Fc epsilon Receptor|epsilon RI, Fc|Receptors, epsilon Fc|epsilon Fc Receptor|IgE|IgE Receptors|epsilon RII, Fc|CD23 Antigens|Antigens, CD 23|Antigen, CD23|CD23 Antigen|Fc epsilon RI|CD 23 Antigens|epsilon Receptor, Fc"
NEW01932,CHEMICAL,urinary 8-hydroxy-2'deoxyguanosine,urinary 8-hydroxy-2'deoxyguanosine
D053649,CHEMICAL,"Receptors, Interleukin-5","Receptors, IL-5|Receptor, Interleukin 5|IL 5 Receptors|IL-5 Receptors|Receptor, IL5|Receptor, Il-5|Interleukin 5 Receptor|Interleukin 5 Receptors|Interleukin-5 Receptor|Il 5 Receptor|IL5 Receptor|Interleukin-5 Receptors|Receptor, Interleukin-5|Il-5 Receptor|Receptors, Interleukin 5|IL-5"
NEW01933,CHEMICAL,plasma malondialdehyde,plasma malondialdehyde
C545682,DISEASE,"M-sec protein, mouse [Supplementary Concept]",tumour necrosis factor|Tumor Necrosis Factors
D056912,MENTAL_HEALTH,Binge-Eating Disorder,"Disorder, Binge-Eating|Binge-Eating Disorders|Disorders, Binge-Eating|Binge Eating Disorder|eating disorder"
NEW01938,BIOCHEMICAL,vitamin E components,vitamin E components
NEW01939,DISEASE,hepato-splenomegaly,hepato-splenomegaly
NEW01940,DISEASE,severe iron deficiency anemia,severe iron deficiency anemia
D063465,DISEASE,Skin Cream,"Lotions, Skin|Creams, Dermal|Creams, Skin|Cream, Dermal|Dermal Creams|Cream, Skin|Skin Lotion|Lotion, Skin|Skin Lotions|Skin Creams|Dermal Cream|skin"
NEW01941,DISEASE,tuberculosis ward,tuberculosis ward
NEW01942,DISEASE,elevated mood,elevated mood
D001037,DISEASE,Aphasia,"Discriminatory Aphasia, Auditory|aphasias|Intellectual Aphasias|Post-Ictal Aphasia|Post-Ictal Aphasias|Graphomotor Aphasia|Aphasia, Ageusic|Dysphasia|Dejerine Lichtheim Phenomenon|Aphasia, Intellectual|Auditory Discriminatory Aphasias|Logagnosias|Progressive Aphasias|Aphasia, Graphomotor|Aphasia, Syntactical|Logagnosia|Dejerine-Lichtheim Phenomenon|Lichtheims Sign|Aphasia, Functional|Ageusic Aphasia|Anepias|Functional Aphasias|Post-Traumatic Aphasia|Aphasia, Commisural|Global Aphasias|Deafness, Word|Lichtheim's Sign|Aphasia, Global|Semantic Aphasias|Alogia|Ageusic Aphasias|Mixed Aphasia|Global Aphasia|Sign, Lichtheim's|Mixed Aphasias|Aphasia, Mixed|Logamnesia|Syntactical Aphasias|Logasthenias|Acquired Aphasia|Anepia|Commisural Aphasia|Auditory Discriminatory Aphasia|Commisural Aphasias|Global Dysphasias|Intellectual Aphasia|Lichtheim Sign|Dysphasia, Global|Aphasia, Acquired|Word Deafness|Aphasia, Progressive|Discriminatory Aphasias, Auditory|Graphomotor Aphasias|Semantic Aphasia|Aphasias, Commisural|Aphasia, Post-Traumatic|Alogias|Syntactical Aphasia|Progressive Aphasia|Logasthenia|Aphasia, Auditory Discriminatory|Aphasia, Semantic|Global Dysphasia|Phenomenon, Dejerine-Lichtheim|Aphasia, Post Ictal|Aphasia, Post-Ictal|Logamnesias|Aphasia, Post Traumatic|Post-Traumatic Aphasias|Functional Aphasia"
NEW01944,DISEASE,efferent motor aphasias,efferent motor aphasias
D013276,DISEASE,Stomach Ulcer,"Gastric Ulcer|gastric ulcer|Ulcer, Stomach|Ulcers, Stomach|Gastric Ulcers|Ulcers, Gastric|Stomach Ulcers|Ulcer, Gastric"
NEW01948,BIOCHEMICAL,drug targets,drug targets
NEW01954,DISEASE,potential syndrome,potential syndrome
NEW01957,CHEMICAL,non-histamine neurons,non-histamine neurons
NEW01959,BIOCHEMICAL,multifunctional drug able,multifunctional drug able
NEW01961,DISEASE,weight gain/obesity side-effects,weight gain/obesity side-effects
NEW01963,DISEASE,SGA-induced weight gain/obesity,SGA-induced weight gain/obesity
NEW01968,CHEMICAL,H2R antagonist zolantidine,H2R antagonist zolantidine
NEW01969,CHEMICAL,H1R antagonist pyrilamine,H1R antagonist pyrilamine
NEW01970,BIOCHEMICAL,antithyroid drug treatment,antithyroid drug treatment
NEW01972,BIOCHEMICAL,increased thyroid hormone levels,increased thyroid hormone levels
NEW01974,BIOCHEMICAL,thyroid hormone values,thyroid hormone values
NEW01978,DISEASE,fetal dyshormonogenesis,fetal dyshormonogenesis
NEW01982,DISEASE,hypersexual behaviours,hypersexual behaviours
NEW01983,CHEMICAL,neuromodulator dopamine,neuromodulator dopamine
D020278,DISEASE,"Demyelinating Autoimmune Diseases, CNS","Autoimmune Diseases, Demyelinating, Brain|Spinal Cord Demyelinating Autoimmune Diseases|Demyelinating Autoimmune Diseases, Brain|Autoimmune Demyelinating Diseases, Central Nervous System|Autoimmune Demyelinating Disorders, CNS|Autoimmune Demyelinating Diseases, CNS|Demyelinating Autoimmune Diseases, Central Nervous System|Autoimmune Demyelinating Diseases, Cerebral|Cerebral Demyelinating Diseases, Autoimmune|CNS Autoimmune Demyelinating Disorders|Demyelinating Autoimmune Disorders, CNS|Demyelinating Autoimmune Diseases, Cerebral|Autoimmune Demyelinating Diseases, Spinal Cord|Demyelinating Disease, Autoimmune, CNS|autoimmune diseases|CNS Demyelinating Autoimmune Diseases|Brain Autoimmune Demyelinating Diseases|Demyelinating Autoimmune Diseases, Spinal Cord"
NEW01986,CHEMICAL,behavior sucrose preference test,behavior sucrose preference test
NEW01988,DISEASE,depression-related microbiota,depression-related microbiota
C000638160,DISEASE,Sutterella parvirubra [Supplementary Concept],Sutterella|Burkholderiales
C000648698,DISEASE,Allobaculum stercoricanis [Supplementary Concept],Allobaculum|Firmicutes
D045243,DISEASE,Prevotella ruminicola,Prevotella (1992-2003)|Prevotella
C000643374,DISEASE,Oscillospira guilliermondii [Supplementary Concept],Oscillospira|Clostridiales
NEW01991,CHEMICAL,higher alcohol consumption,higher alcohol consumption
D066235,CHEMICAL,Fluorine-19 Magnetic Resonance Imaging,"Fluorine 19 Magnetic Resonance Imaging|19F MRI|fluorine|F[2,23 ="
NEW01996,DISEASE,phobias/separation anxiety/autism spectrum deficit hyperactivity disorder/social anxiety,phobias/separation anxiety/autism spectrum deficit hyperactivity disorder/social anxiety
NEW02000,MENTAL_HEALTH,hyperkinetic disorder,hyperkinetic disorder
NEW02002,CHEMICAL,zinc deficit,zinc deficit
NEW02007,CHEMICAL,barbiturate overdosage,barbiturate overdosage
NEW02008,DISEASE,overdose situations,overdose situations
NEW02009,BIOCHEMICAL,common drug,common drug
D058687,DISEASE,Out-of-Hospital Cardiac Arrest,"Out of Hospital Cardiac Arrest|Out-of-Hospital Heart Arrests|Out-of-Hospital Cardiac Arrests|Heart Arrests, Out-of-Hospital|Out-of-Hospital Heart Arrest|cardiac arrest|Heart Arrest, Out-of-Hospital|Cardiac Arrests, Out-of-Hospital|Out of Hospital Heart Arrest|Cardiac Arrest, Out-of-Hospital"
NEW02012,DISEASE,life-threatening arrhythmias,life-threatening arrhythmias
NEW02013,DISEASE,impaired driving,impaired driving
NEW02014,DISEASE,increased risk-taking behaviors,increased risk-taking behaviors
NEW02015,MENTAL_HEALTH,caffeine intoxication,caffeine intoxication
NEW02017,MENTAL_HEALTH,mild-to-moderate agitation,mild-to-moderate agitation
NEW02020,CHEMICAL,alcohol drugs,alcohol drugs
NEW02022,CHEMICAL,increased tetrahydrocannabinol content,increased tetrahydrocannabinol content
NEW02024,DISEASE,self-reported psychotic disorders,self-reported psychotic disorders
NEW02027,DISEASE,low general cognitive functioning abnormalities,low general cognitive functioning abnormalities
D002526,DISEASE,Cerebellar Diseases,"Disease, Cerebellar|Cerebellar Syndrome|Cerebellar Disease|Cerebellum Disease|Cerebellar Syndromes|Cerebellar Disorders|Cerebellar Dysfunction|Cerebellar Dysfunctions|Cerebellar Disorder|Dysfunction, Cerebellar|Cerebellum Diseases|Disorder, Cerebellar|cerebellar dysfunction|Disease, Cerebellum|Syndrome, Cerebellar"
NEW02029,NUTRITION,low whole blood thiamine level consistent,low whole blood thiamine level consistent
NEW02030,DISEASE,violent offense,violent offense
NEW02033,MENTAL_HEALTH,Canadian Pathological Gambling Index,Canadian Pathological Gambling Index
D002561,MENTAL_HEALTH,Cerebrovascular Disorders,"Occlusion, Cerebrovascular|Diseases, Cerebrovascular|Cerebrovascular Insufficiencies|Cerebrovascular Insufficiency|Vascular Disease, Intracranial|cerebrovascular disorders|Vascular Disorders, Brain|Occlusions, Cerebrovascular|Disease, Cerebrovascular|Insufficiency, Cerebrovascular|Vascular Disorder, Brain|Brain Vascular Disorder|Cerebrovascular Diseases|Cerebrovascular Occlusions|Intracranial Vascular Diseases|Intracranial Vascular Disorder|Brain Vascular Disorders|Intracranial Vascular Disorders|Vascular Diseases, Intracranial|Cerebrovascular Disease|Vascular Disorder, Intracranial|Cerebrovascular Disorder|Vascular Disorders, Intracranial|Cerebrovascular Occlusion|Insufficiencies, Cerebrovascular|Intracranial Vascular Disease"
NEW02036,CHEMICAL,melatonin suppression,melatonin suppression
NEW02038,DISEASE,hypersexuality,hypersexuality
NEW02039,DISEASE,resistant hypersexuality,resistant hypersexuality
NEW02042,MENTAL_HEALTH,anxiety level,anxiety level
NEW02043,MENTAL_HEALTH,depression level,depression level
NEW02047,MENTAL_HEALTH,log-linear regression,log-linear regression
NEW02049,MENTAL_HEALTH,sleep onset insomnia,sleep onset insomnia
NEW02051,MENTAL_HEALTH,Dependence FTND scores,Dependence FTND scores
NEW02052,CHEMICAL,lower Fagerström Test,lower Fagerström Test
NEW02055,MENTAL_HEALTH,upcoming manic episode,upcoming manic episode
NEW02059,BIOCHEMICAL,genuine mood stabiliser,genuine mood stabiliser
NEW02061,NUTRITION,lithium due,lithium due
NEW02063,CHEMICAL,liver-gut axis,liver-gut axis
D011604,MENTAL_HEALTH,"Psychoses, Alcoholic",alcoholic psychoses|Alcoholic Psychoses
NEW02066,DISEASE,low conscientiousness,low conscientiousness
NEW02068,DISEASE,overdose risk,overdose risk
NEW02073,CHEMICAL,major tranquillisers,major tranquillisers
NEW02075,CHEMICAL,COVID-19 era,COVID-19 era
NEW02076,DISEASE,paroxysmal neurological diseases,paroxysmal neurological diseases
NEW02078,MENTAL_HEALTH,narcolepsy withdrawal,narcolepsy withdrawal
NEW02080,DISEASE,comatose state,comatose state
NEW02082,BIOCHEMICAL,date-rape drug,date-rape drug
NEW02084,MENTAL_HEALTH,childhood autism spectrum disorders,childhood autism spectrum disorders
NEW02085,DISEASE,violent crimes,violent crimes
NEW02087,DISEASE,PTSD comorbid groups,PTSD comorbid groups
NEW02088,MENTAL_HEALTH,depression group,depression group
NEW02091,MENTAL_HEALTH,severe intellectual disability,severe intellectual disability
NEW02092,MENTAL_HEALTH,symptom sleepiness,symptom sleepiness
NEW02095,CHEMICAL,self-control seeking,self-control seeking
NEW02096,CHEMICAL,intercellular dopamine,intercellular dopamine
NEW02097,CHEMICAL,norepinephrine levels,norepinephrine levels
NEW02099,MENTAL_HEALTH,depression craving,depression craving
NEW02101,CHEMICAL,cocaine abstinence,cocaine abstinence
NEW02102,CHEMICAL,general antidepressant action,general antidepressant action
D058545,MENTAL_HEALTH,Inhalant Abuse,"Abuse, Glue|Abuses, Inhalant|Glue Abuses|Abuse, Inhalant|abuse|Inhalant Abuses|Glue Abuse|Glue Sniffing|Glue Sniffings|Abuses, Glue"
NEW02106,CHEMICAL,later alcohol use,later alcohol use
D054062,MENTAL_HEALTH,Deaf-Blind Disorders,"Deaf-Blindness Disorder|Disorders, Deaf-Blind|Disorders, Deaf-Mutism-Blind|Deaf-Blind Syndromes|Prelingual Deaf Blind Disorders|Disorders, Blind-Deaf|Prelingual Deafness-Blindness|Syndromes, Deaf-Blind|Deaf Blind Syndromes|Vision and Hearing Loss|Disorder, Deaf-Blindness|Deafness-Blindnesses, Prelingual|Deaf-Mutism-Blind Disorder|Disorders, Deaf-Blindness|Hearing and Vision Loss|Deaf-Mutism-Blind Disorders|Deaf-Blind Disorder, Prelingual|Disorder, Prelingual Deaf-Blind|disorder disorder|Deaf Mutism Blind Disorders|Deafness Blindness|Blind-Deaf Disorder|Deaf-Blind Disorders, Prelingual|Deafness-Blindness, Prelingual|Syndrome, Deaf-Blind|Deaf-Blindness Disorders|Blind-Deaf Disorders|Deafness-Blindness|Disorder, Deaf-Blind|Blind Deaf Disorders|Blindness-Deafness|Blindness Deafness|Deaf Blindness Disorders|Prelingual Deaf-Blind Disorder|Deaf-Blind Disorder|Prelingual Deafness Blindness|Disorder, Deaf-Mutism-Blind|Prelingual Deaf-Blind Disorders|Deaf-Blind Syndrome|Deaf Blind Disorders|Prelingual Deafness-Blindnesses|Disorders, Prelingual Deaf-Blind|Disorder, Blind-Deaf"
NEW02108,DISEASE,mume floral scent,mume floral scent
NEW02111,CHEMICAL,low dose clozapine,low dose clozapine
NEW02112,BIOCHEMICAL,dopaminergic agent dose reduction,dopaminergic agent dose reduction
D020214,DISEASE,Cerebrovascular Trauma,"Vascular Brain Injury|Brain Vascular Trauma|Vascular Injury, Brain|Brain Vascular Injury|Brain Injuries, Vascular|Injury, Brain Vascular|Vascular Trauma, Brain|Injuries, Brain Vascular|Vascular Brain Injuries|Injury, Vascular, Brain|Brain Injury, Vascular|vascular injury|Vascular Traumas, Brain|Trauma, Cerebrovascular"
NEW02114,DISEASE,overdose treatment approaches,overdose treatment approaches
NEW02116,MENTAL_HEALTH,organic brain syndromes,organic brain syndromes
NEW02117,DISEASE,terminal illness,terminal illness
NEW02119,MENTAL_HEALTH,profound depression,profound depression
NEW02121,DISEASE,sensory-processing deficits,sensory-processing deficits
C416186,NUTRITION,H-2O antigen [Supplementary Concept],alpha locus|Histocompatibility Antigens Class II
D063992,NUTRITION,"Mitochondrial Trifunctional Protein, alpha Subunit",Multienzyme Complexes (1994-2013)|alpha subunit
NEW02124,MENTAL_HEALTH,hunger craving postcessation,hunger craving postcessation
NEW02126,MENTAL_HEALTH,Abuse Screening Test,Abuse Screening Test
NEW02128,CHEMICAL,mean ± interactions,mean ± interactions
NEW02130,DISEASE,neuromuscular junction degeneration consistent,neuromuscular junction degeneration consistent
NEW02131,DISEASE,cognitive function disorders,cognitive function disorders
NEW02132,BIOCHEMICAL,multiple endocrine disturbances,multiple endocrine disturbances
NEW02133,DISEASE,alcohol tobacco withdrawal syndrome,alcohol tobacco withdrawal syndrome
NEW02135,CHEMICAL,nicotine metabolism,nicotine metabolism
NEW02145,DISEASE,schizophrenic crises,schizophrenic crises
D009105,DISEASE,Dissociative Identity Disorder,"Disorder, Multiple Personality|dissociative|Personality Disorder, Multiple|Dual Personality|Personality, Multiple|Disorder, Multiple Identity|Personalities, Multiple|Identity Disorder, Dissociative|Multiple Personality Disorders|Personalities, Dual|Multiple Identity Disorders|Multiple Identity Disorder|Personality Disorders, Multiple|Multiple Personalities|Identity Disorder, Multiple|Personality, Dual|Multiple Personality|Multiple Personality Disorder|Disorder, Dissociative Identity"
NEW02146,CHEMICAL,clinical high risk,CHR|clinical high risk
NEW02148,CHEMICAL,CHR sample,CHR sample
NEW02151,DISEASE,allergic participants,allergic participants
NEW02153,DISEASE,metabolic transformation,metabolic transformation
NEW02154,BIOCHEMICAL,SSRI drugs,SSRI drugs
D001942,DISEASE,Breast Feeding,"Breast Feeding, Exclusive|breast feeding|Breastfeeding, Exclusive|Breastfeeding|Exclusive Breastfeeding|Milk Sharing|Breast Fed|Sharing, Milk|Exclusive Breast Feeding|Wet Nursing|Breastfed"
NEW02159,MENTAL_HEALTH,non-affective psychosis,non-affective psychosis
NEW02160,CHEMICAL,nicotine consumption,nicotine consumption
NEW02161,NUTRITION,e.g. gummy bear,e.g. gummy bear
NEW02162,DISEASE,hedonic flavors,hedonic flavors
NEW02163,CHEMICAL,suppressant effects,suppressant effects
D012878,DISEASE,Skin Neoplasms,"Cancer of the Skin|Skin Cancer|Skin Cancers|Cancers, Skin|Cancer of Skin|Neoplasm, Skin|Neoplasms, Skin|skin cancer|Skin Neoplasm|Cancer, Skin"
NEW02166,DISEASE,tumor size,tumor size
NEW02167,DISEASE,tumor stages,tumor stages
D014599,DISEASE,Uterus,"Cornua, Uterine|Fundus Uteri|Wombs|Uteri|Uterine Fundus|Womb|Uterus Cornua|Uteri, Fundus|uterus|Fundus Uterus|Uterine Cornua|Fundus, Uterine"
NEW02174,DISEASE,altered pain sensitivity,altered pain sensitivity
NEW02176,DISEASE,neuropsychiatric illness,neuropsychiatric illness
NEW02177,DISEASE,cold pressor pain models,cold pressor pain models
NEW02179,BIOCHEMICAL,drug liking,drug liking
NEW02180,CHEMICAL,mg oxycodone,mg oxycodone
NEW02182,CHEMICAL,GAD group,GAD group
NEW02184,BIOCHEMICAL,NeuN antigen,NeuN antigen
NEW02186,CHEMICAL,striatal TH staining,striatal TH staining
NEW02187,DISEASE,nigral cell loss,nigral cell loss
NEW02188,DISEASE,persistent motor deficits,persistent motor deficits
NEW02189,DISEASE,selective dopaminergic cell damage,selective dopaminergic cell damage
NEW02191,DISEASE,mild cognitive dysfunction,mild cognitive dysfunction
NEW02192,DISEASE,mouse liver microsomes,mouse liver microsomes
NEW02193,CHEMICAL,S-methyl metam,S-methyl metam
NEW02195,DISEASE,depressed red blood cell cholinesterase levels,depressed red blood cell cholinesterase levels
NEW02199,DISEASE,β-amyloid-induced memory dysfunction due,β-amyloid-induced memory dysfunction due
NEW02201,DISEASE,learning deficits,learning deficits
NEW02203,DISEASE,harmaline-induced locomotor,harmaline-induced locomotor
D019986,DISEASE,Persons With Hearing Impairments,"Hearing Impaired Person|Hard of Hearing Persons|Hearing Disabled Person|impairments|Disabled Persons, Hearing|Person, Deaf|Deaf Person|Deaf Persons|Persons, Deaf|Persons, Hearing Disabled|Person, Hearing Impaired|Hearing Impaired Persons|Hearing Disabled Persons|Person, Hearing Disabled|Persons, Hearing Impaired"
NEW02204,DISEASE,depressive- behaviour,depressive- behaviour
NEW02207,DISEASE,depressive-anxious nature,depressive-anxious nature
NEW02208,DISEASE,LPS-induced inflammation model,LPS-induced inflammation model
D005106,DISEASE,Exploratory Behavior,"Behaviors, Novelty-Seeking|novelty-seeking behavior|Exploratory Behaviors|Curiosities|Behavior, Novelty-Seeking|Novelty Seeking Behavior|Curiosity|Novelty-Seeking Behavior|Behaviors, Exploratory|Novelty-Seeking Behaviors|Behavior, Exploratory"
NEW02211,BIOCHEMICAL,mGlu3 receptor agonist MGS0008,mGlu3 receptor agonist MGS0008
NEW02214,DISEASE,tetanic spasms,tetanic spasms
NEW02219,CHEMICAL,VPA group,VPA group
NEW02220,MENTAL_HEALTH,intrusive thoughts,intrusive thoughts
NEW02221,DISEASE,acute PTSD symptoms,acute PTSD symptoms
NEW02222,DISEASE,emotional numbing,emotional numbing
NEW02223,DISEASE,flashbacks,flashbacks
NEW02224,MENTAL_HEALTH,hyperarousal,hyperarousal
NEW02225,DISEASE,numbing symptoms,numbing symptoms
NEW02226,DISEASE,chronic PTSD symptoms,chronic PTSD symptoms
D006167,DISEASE,Guilt,Guilts|guilt
NEW02227,CHEMICAL,serotonin neurotransmission,serotonin neurotransmission
NEW02228,MENTAL_HEALTH,acute bipolar depression,acute bipolar depression
NEW02231,MENTAL_HEALTH,depression symptom improvement relative,depression symptom improvement relative
NEW02233,CHEMICAL,low-dose antipsychotic drugs,low-dose antipsychotic drugs
NEW02235,DISEASE,paraphilic patients,paraphilic patients
NEW02236,MENTAL_HEALTH,familial advanced sleep phase syndrome,familial advanced sleep phase syndrome
NEW02238,DISEASE,fragile X-associated tremor/ataxia syndrome,fragile X-associated tremor/ataxia syndrome
NEW02240,DISEASE,non-Parkinson's disease patients,non-Parkinson's disease patients
NEW02242,CHEMICAL,triphenyltetrazolium chloride staining technique,triphenyltetrazolium chloride staining technique
D009461,DISEASE,Neurologic Manifestations,"Manifestation, Neurologic|Neurological Manifestations|Dysfunction, Neurologic|Neurologic Manifestation|Neurologic Dysfunctions|Neurologic Signs and Symptoms|Neurologic Finding|Neurologic Deficit, Focal|Manifestations, Neurological|Neurologic Deficits, Focal|Sign, Neurologic|Dysfunctions, Neurologic|Neurologic Symptoms|Signs, Neurologic|Focal Neurologic Deficits|Manifestation, Neurological|Deficits, Neurologic|Deficits, Focal Neurologic|Manifestations, Neurologic|Focal Neurologic Deficit|Finding, Neurologic|Deficit, Neurologic|Symptoms, Neurologic|Neurologic Deficit|Neurologic Signs|Neurological Manifestation|Deficit, Focal Neurologic|deficits|Neurologic Dysfunction|Findings, Neurologic|Symptom, Neurologic|Neurologic Symptom|Neurologic Deficits|Neurologic Sign|Neurologic Findings"
NEW02244,DISEASE,arterial pulmonary hypertension,arterial pulmonary hypertension
NEW02245,MENTAL_HEALTH,erectile dysfunction due,erectile dysfunction due
NEW02247,CHEMICAL,vesicles depletion nitric oxide-system disturbances,vesicles depletion nitric oxide-system disturbances
NEW02248,CHEMICAL,receptors blockade,receptors blockade
NEW02249,CHEMICAL,non-responsive L-arginine responsive,non-responsive L-arginine responsive
NEW02250,DISEASE,nigrostriatal damage,nigrostriatal damage
NEW02251,CHEMICAL,L-arginine responsive,L-arginine responsive
NEW02252,CHEMICAL,L-NAME responsive,L-NAME responsive
NEW02253,CHEMICAL,dopamine disturbances,dopamine disturbances
NEW02256,DISEASE,abnormal vaginal bleeding,abnormal vaginal bleeding
NEW02257,DISEASE,renal retention,renal retention
NEW02258,CHEMICAL,antikaliuretic,antikaliuretic
NEW02262,MENTAL_HEALTH,distinct syndromes,distinct syndromes
NEW02268,DISEASE,myxedema coma,myxedema coma
NEW02269,DISEASE,cumulative seizure risk,cumulative seizure risk
NEW02270,CHEMICAL,bupropion SR,bupropion SR
D010434,CHEMICAL,Pepsin A,pepsin|Pepsin 3|Pepsin|Pepsin 1
D020178,DISEASE,"Sleep Disorders, Circadian Rhythm","Sleep Wake Schedule Disorder|Sleep Disorder, Shift-Work|Sleep Wake Cycle Disorder|Sleep-Wake Cycle Disorder|Nyctohemeral Rhythms, Disturbed|Advanced Sleep Phase Syndrome|Circadian Rhythm Sleep Disorder|Delayed Sleep Phase Syndrome|Sleep-Wake Schedule Disorder|Sleep Disorder, Shift Work|Circadian Rhythm Sleep Disorders|Sleep Wake Disorder, Non 24 Hour|Delayed Sleep-Phase Syndrome|Disturbed Nyctohemeral Rhythms|Sleep-Wake Cycle Disorders|Sleep-Wake Schedule Disorders|shift-work sleep disorders|Nonorganic Sleep Wake Cycle Disorder|Disturbed Nyctohemeral Rhythm|Sleep Wake Schedule Disorders|Non-24 Hour Sleep-Wake Disorder|Sleep Wake Cycle Disorders|Shift Work Sleep Disorder|Sleep-Wake Disorder, Non-24 Hour|Delayed Sleep-Phase Syndromes|Nonorganic Sleep Wake Cycle Disorders|Sleep Disorders, Shift-Work|Non 24 Hour Sleep Wake Disorder|Shift-Work Sleep Disorder|Nyctohemeral Rhythm, Disturbed|Shift-Work Sleep Disorders"
C564108,DISEASE,Major Affective Disorder 2 [Supplementary Concept],"Genetic Diseases, X-Linked|manic depressive illness|Bipolar Disorder"
NEW02277,CHEMICAL,rutin agents,rutin agents
NEW02278,BIOCHEMICAL,pharmaceutical companies,pharmaceutical companies
NEW02281,DISEASE,Ureaplasma colonization,Ureaplasma colonization
NEW02285,DISEASE,adult-onset NCH,adult-onset NCH
NEW02286,DISEASE,severe gastrointestinal toxicity,severe gastrointestinal toxicity
NEW02287,CHEMICAL,difficult therapeutic area-those patients,difficult therapeutic area-those patients
NEW02289,MENTAL_HEALTH,persistent anxiety,persistent anxiety
NEW02290,CHEMICAL,smoking inactivity,smoking inactivity
NEW02291,DISEASE,psychotic naive patients,psychotic naive patients
NEW02292,BIOCHEMICAL,dopamine agonist use,dopamine agonist use
NEW02295,CHEMICAL,selective serotonin reuptake inibitors,selective serotonin reuptake inibitors
NEW02296,DISEASE,postural abnormalities,postural abnormalities
NEW02297,BIOCHEMICAL,multiple serotonergic agents,multiple serotonergic agents
NEW02299,MENTAL_HEALTH,fear-related anxiety disorders,fear-related anxiety disorders
NEW02301,DISEASE,disorders indication,disorders indication
NEW02302,DISEASE,hypersomnia due sleep apnea,hypersomnia due sleep apnea
NEW02303,DISEASE,parasomnia related,parasomnia related
D020184,DISEASE,Night Terrors,"Secondary Night Terror|Childhood Pavor Nocturnus|Nocturnus, Childhood Pavor|Terror, Secondary Night|Night Terrors, Secondary|Terror, Adult Night|Adult Night Terror|Sleep Terror Disorder|Sleep Terrors|Terrors, Primary Night|Night Terrors, Adult|Terror, Childhood Night|Pavor Nocturnus, Childhood|Terrors, Sleep|Primary Night Terror|Night Terrors, Primary|Primary Night Terrors|Nocturnus, Adult Pavor|Night Terror, Primary|Pavor Nocturnus|Terror, Sleep|Terrors, Secondary Night|night terrors|Terrors, Adult Night|Adult Night Terrors|Night Terror, Childhood|Secondary Night Terrors|Adult Pavor Nocturnus|Pavor Nocturnus, Adult|Sleep Terror|Terror, Primary Night|Night Terrors, Childhood|Night Terror, Adult|Terrors, Childhood Night|Night Terror, Secondary|Childhood Night Terrors|Childhood Night Terror"
D005356,DISEASE,Fibromyalgia,"Fibromyositis-Fibromyalgia Syndrome|Rheumatism, Muscular|Muscular Rheumatism|Primary Fibromyalgias|Fibromyalgias, Primary|Secondary Fibromyalgia|Fibromyositis-Fibromyalgia Syndromes|Fibromyalgias, Secondary|Fibromyalgia Fibromyositis Syndrome|Fibrositis|Fibromyalgia, Primary|Fibromyalgia, Secondary|Fibromyalgias|Diffuse Myofascial Pain Syndrome|Myofascial Pain Syndrome, Diffuse|Syndrome, Fibromyositis-Fibromyalgia|Fibromyositis Fibromyalgia Syndrome|Fibromyalgia-Fibromyositis Syndromes|Syndrome, Fibromyalgia-Fibromyositis|fibromyalgia|Primary Fibromyalgia|Fibrositides|Fibromyalgia-Fibromyositis Syndrome|Secondary Fibromyalgias|Syndromes, Fibromyositis-Fibromyalgia|Syndromes, Fibromyalgia-Fibromyositis"
NEW02308,MENTAL_HEALTH,battle fatigue,battle fatigue
D009449,MENTAL_HEALTH,Neurocirculatory Asthenia,"Neurocirculatory Asthenias|Asthenia, Neurocirculatory|Phobia, Cardiac|Syndrome, Hyperkinetic Heart|Effort Syndrome|Cardiac Phobia|Cardiac Neuroses|Cardiac Neurosis|Neurosis, Cardiac|neurocirculatory asthenia|Heart Syndrome, Hyperkinetic|Syndrome, Effort|Hyperkinetic Heart Syndrome"
C531763,DISEASE,Irritable heart [Supplementary Concept],Orthostatic Intolerance|irritable heart
NEW02309,CHEMICAL,Da Costa,Da Costa
NEW02312,CHEMICAL,amphetamine users,amphetamine users
NEW02314,CHEMICAL,antiseizure medications,antiseizure medications
NEW02315,DISEASE,obstructive sleep apnea/hypopnea syndrome,OSAS|obstructive sleep apnea/hypopnea syndrome
NEW02316,CHEMICAL,iron-dopamine hypothesis,iron-dopamine hypothesis
D010868,CHEMICAL,Pimozide,pimozide|R-6238|Orap forte|Antalon|R6238|Orap
NEW02319,DISEASE,infantile autistic syndrome,infantile autistic syndrome
NEW02323,CHEMICAL,liquid fluoxetine,liquid fluoxetine
NEW02329,BIOCHEMICAL,cholinomimetic agents,cholinomimetic agents
NEW02332,DISEASE,aggressive behaviours,aggressive behaviours
NEW02334,DISEASE,psychiatric samples,psychiatric samples
D006791,DISEASE,Hostility,Hostilities|hostility
NEW02337,CHEMICAL,clozapine group,clozapine group
NEW02341,CHEMICAL,OECD-407,OECD-407
NEW02343,DISEASE,sub-acute toxicity,sub-acute toxicity
D065104,BIOCHEMICAL,Cystine Depleting Agents,"Depleting Agents, Cystine|Cystine Disulfide Reducers|agents|Disulfide Reducers, Cystine|Reducers, Cystine Disulfide|Agents, Cystine Depleting|Cystine Disulfide Reducing Agents"
NEW02348,DISEASE,hydroxychloroquine lethal illness,hydroxychloroquine lethal illness
NEW02349,CHEMICAL,glucocorticosteroids,glucocorticosteroids
NEW02350,DISEASE,antiphospholipide,antiphospholipide
NEW02354,DISEASE,disease pneumonia,disease pneumonia
NEW02355,DISEASE,acute hypoxic respiratory failure secondary,acute hypoxic respiratory failure secondary
NEW02358,DISEASE,HR-positive cohort,HR-positive cohort
NEW02359,DISEASE,depressed HLP-1 levels,depressed HLP-1 levels
NEW02360,NUTRITION,channel catfish skin,channel catfish skin
NEW02361,CHEMICAL,ammonia group,ammonia group
D011566,DISEASE,Psychiatric Aides,"Hospital Orderlies, Psychiatric|Psychiatric Hospital|Aide, Psychiatric|Ward Attendant, Psychiatric|Attendants, Psychiatric Ward|Psychiatric Aide|Orderlies, Psychiatric Hospital|Orderly, Psychiatric Hospital|Psychiatric Ward Attendant|Psychiatric Hospital Orderlies|Attendant, Psychiatric Ward|Psychiatric Hospital Orderly|Ward Attendants, Psychiatric|Psychiatric Ward Attendants|Hospital Orderly, Psychiatric|Aides, Psychiatric"
NEW02365,CHEMICAL,sub-chronic PCP-induced cognitive deficits,sub-chronic PCP-induced cognitive deficits
NEW02368,DISEASE,ALS pathogenesis,ALS pathogenesis
NEW02370,DISEASE,short-term hypogonadism,short-term hypogonadism
NEW02371,DISEASE,long-term hypogonadism,long-term hypogonadism
NEW02372,DISEASE,tissue loss,tissue loss
NEW02374,DISEASE,hypertension rats,hypertension rats
NEW02375,CHEMICAL,typical increased sodium preference,typical increased sodium preference
NEW02377,MENTAL_HEALTH,trauma resistance,trauma resistance
NEW02378,DISEASE,body weight gain,body weight gain
NEW02381,DISEASE,various neuropsychiatric disorders,various neuropsychiatric disorders
NEW02383,DISEASE,cognitive behaviors,cognitive behaviors
NEW02386,BIOCHEMICAL,psychiatric adverse drug reactions,psychiatric adverse drug reactions
NEW02387,DISEASE,hepatic deficiency,hepatic deficiency
D013034,CHEMICAL,Sparteine,"alpha Isosparteine|Sparteine, (-)-Isomer|Depasan Retard|Sulfate Anhydrous, Sparteine|Sparteine, (7S-(7alpha,7abeta,14alpha,14abeta))-Isomer|Sparteine, (7R-(7alpha,7abeta,14alpha,14abeta))-Isomer|Sparteine Monohydrochloride, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer|Anhydrous, Sparteine Sulfate|Sparteine Hydrochloride, (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer|beta Isosparteine|Sparteine Hydrochloride, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer|beta-Isosparteine|L-Sparteine|Sparteine, (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer|alpha-Isosparteine|Sparteine, (+)-Isomer|Pachycarpine|Genisteine Alkaloid|Sparteine, (7S-(7alpha,7aalpha,14alpha,14aalpha))-Isomer|Sparteine Sulfate|Pachycarpine Sulfate (1:1), Pentahydrate, (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer|Sparteine, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer|Sparteine Sulfate Anhydrous|Sparteine Hydroiodide, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer|D-sparteine|Sparteine Sulfate (1:1), (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer|7α-|Sparteine Sulfate (1:1), (7S-(7alpha,7aalpha,14alpha,14aalpha))-Isomer|Sparteine Monohydroiodide, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer"
NEW02393,CHEMICAL,C19 Δ5 steroids,C19 Δ5 steroids
NEW02394,CHEMICAL,free isopregnanolone,free isopregnanolone
NEW02395,CHEMICAL,5α/β-reduced pregnane steroids,5α/β-reduced pregnane steroids
D046468,DISEASE,Sexual Development,"Development, Sex|Development, Sexual|46,XY DSD|sexual development|Sex Development"
NEW02397,DISEASE,low T production,low T production
C562567,DISEASE,Leydig Cell Hypoplasia [Supplementary Concept],"46,XY disorder|Disorder of Sex Development, 46,XY|Testis/abnormalities"
NEW02398,DISEASE,PCOS women,PCOS women
NEW02403,MENTAL_HEALTH,glucocorticoid hyperactivity,glucocorticoid hyperactivity
NEW02408,BIOCHEMICAL,hormone axis,hormone axis
NEW02409,DISEASE,amenorrhea/oligomenorrhea delayed puberty,amenorrhea/oligomenorrhea delayed puberty
NEW02411,BIOCHEMICAL,growth hormone axis,growth hormone axis
NEW02416,CHEMICAL,saccharin preference test,saccharin preference test
NEW02418,CHEMICAL,clozapine refractory schizophrenia,clozapine refractory schizophrenia
D001924,DISEASE,Brain Concussion,"Concussion, Severe|Severe Concussions|Mild Traumatic Brain Injury|Concussion, Mild|Brain Concussions|Cerebral Concussions|mild traumatic brain injury|Mild Concussions|Concussion, Intermediate|Intermediate Concussion|Intermediate Concussions|Mild Concussion|Cerebral Concussion|Concussion, Cerebral|Severe Concussion|Commotio Cerebri|Concussion, Brain"
NEW02426,DISEASE,cortical bone fractures,cortical bone fractures
NEW02427,DISEASE,uropathy fistula,uropathy fistula
NEW02428,DISEASE,hyperammonemic encephalopathy,hyperammonemic encephalopathy
C562342,CHEMICAL,"alanyl-phosphatidylglycerol synthase, Pseudomonas aeruginosa [Supplementary Concept]",PGs|Aminoacyltransferases|Bacterial Proteins
NEW02430,DISEASE,caries prevention agents,caries prevention agents
NEW02432,DISEASE,complicated urinary tract infections,complicated urinary tract infections
NEW02433,DISEASE,complicated intra-abdominal infections,complicated intra-abdominal infections|cIAIs
NEW02436,DISEASE,traditional medicine psychiatric conditions,traditional medicine psychiatric conditions
NEW02438,DISEASE,selective toxicity,selective toxicity
NEW02439,DISEASE,dopaminergic toxicity,dopaminergic toxicity
NEW02440,MENTAL_HEALTH,L-DOPA-induced dyskinesia,L-DOPA-induced dyskinesia
NEW02441,CHEMICAL,cerebral glutathione deficit,cerebral glutathione deficit
C536868,DISEASE,"Spastic paraplegia 9, autosomal dominant [Supplementary Concept]","Cataract|Bone and Bones/abnormalities|Spastic Paraplegia, Hereditary|cataracts|Growth Disorders"
NEW02445,DISEASE,long-term cognitive deficits,long-term cognitive deficits
NEW02449,DISEASE,neurobehavioral disorders,neurobehavioral disorders
NEW02451,DISEASE,deficit hyperactive disorder,deficit hyperactive disorder
NEW02456,CHEMICAL,inhibitory α2-adrenoceptors,inhibitory α2-adrenoceptors
NEW02458,DISEASE,stress-related psychiatric disorders,stress-related psychiatric disorders
NEW02460,DISEASE,psychotomimetic-like behaviors,psychotomimetic-like behaviors
NEW02462,DISEASE,ATN disinhibition,ATN disinhibition
NEW02463,CHEMICAL,Df[h15q13]/+,Df[h15q13]/+
NEW02464,MENTAL_HEALTH,postpartum anxiety,postpartum anxiety
C515179,CHEMICAL,caryophyllene oxide [Supplementary Concept],β-caryophyllene|Polycyclic Sesquiterpenes
C051622,CHEMICAL,"9-amino-6-methyl-5,6,6a,7-tetrahydro-4H-benzo-(de)thiazolo(4,5-g)quinoline [Supplementary Concept]",Thiazoles|Quinolines|4-PSQ|quinoline
NEW02466,DISEASE,pentobarbital-induced sleep test,pentobarbital-induced sleep test
NEW02467,DISEASE,strychnine-induced seizure test,strychnine-induced seizure test
NEW02469,DISEASE,sexual disinhibition,sexual disinhibition
NEW02470,DISEASE,nervous exhaustion,nervous exhaustion
NEW02473,DISEASE,episodic memory impairments,episodic memory impairments
NEW02474,DISEASE,plasticity deficits,plasticity deficits
C537723,DISEASE,Lubs X-linked mental retardation syndrome [Supplementary Concept],"Mental Retardation, X-Linked|MECP2 duplication syndrome"
NEW02477,DISEASE,cross-sensitivity effect,cross-sensitivity effect
NEW02479,CHEMICAL,dopamine efflux,dopamine efflux
NEW02481,BIOCHEMICAL,good analgesic action,good analgesic action
NEW02483,MENTAL_HEALTH,comorbid ADHD symptoms,comorbid ADHD symptoms
NEW02487,DISEASE,abnormal endoscopy,abnormal endoscopy
NEW02491,BIOCHEMICAL,5-hydroxytryptamine-2A antagonists,5-hydroxytryptamine-2A antagonists
NEW02492,BIOCHEMICAL,growth hormone agonists,growth hormone agonists
D006633,BIOCHEMICAL,Histamine Antagonists,"Antagonists, Histamine|histamine antagonists|Antihistamine|Antagonist, Histamine|Antihistamines|Histamine Antagonist"
NEW02493,BIOCHEMICAL,ghrelin agonists,ghrelin agonists
NEW02494,BIOCHEMICAL,beta3-adrenoceptor agonists,beta3-adrenoceptor agonists
NEW02495,BIOCHEMICAL,corticotropin-releasing factor receptor antagonists,corticotropin-releasing factor receptor antagonists
NEW02496,BIOCHEMICAL,melanocortin receptor antagonists,melanocortin receptor antagonists
NEW02499,DISEASE,depots,depots
NEW02500,BIOCHEMICAL,hormone secretions,hormone secretions
C567328,BIOCHEMICAL,"Coloboma, Ocular, And Ichthyosis, Brain Malformations, And Endocrine Abnormalities [Supplementary Concept]",endocrine abnormalities|Congenital Disorders of Glycosylation
D000015,DISEASE,"Abnormalities, Multiple",Multiple Abnormalities|multiple abnormalities
NEW02505,BIOCHEMICAL,human growth hormones,human growth hormones
NEW02506,DISEASE,insufficient pain sedating effect,insufficient pain sedating effect
D009536,CHEMICAL,Niacinamide,"Nicotinamide|B3, Vitamin|Vitamin PP|Nicotinsäureamid Jenapharm|Enduramide|3 Pyridinecarboxamide|niacinamide|Nicobion|Vitamin B 3|Jenapharm, Nicotinsäureamid|Vitamin B3|B 3, Vitamin|3-Pyridinecarboxamide|Papulex"
NEW02513,DISEASE,alcohol-related cortical neuronal loss,alcohol-related cortical neuronal loss
NEW02516,BIOCHEMICAL,delayed antagonist actions,delayed antagonist actions
NEW02517,BIOCHEMICAL,common mu opioid receptor agonists,common mu opioid receptor agonists
NEW02518,MENTAL_HEALTH,increased anxiety,increased anxiety
NEW02520,BIOCHEMICAL,delta opioid receptor agonist SNC80,delta opioid receptor agonist SNC80
NEW02522,CHEMICAL,tricyclo[3.3.1.1.3.1]dec-2-yloxy)carbonyl]amino]propyl]ami no]-1-phenethyl]amino-4-oxobutanoic acid,tricyclo[3.3.1.1.3.1]dec-2-yloxy)carbonyl]amino]propyl]ami no]-1-phenethyl]amino-4-oxobutanoic acid
NEW02523,CHEMICAL,selective B antagonists,selective B antagonists
NEW02527,DISEASE,obsessive-compulsive behavior,obsessive-compulsive behavior
NEW02529,DISEASE,marble-burying behavior,marble-burying behavior
NEW02531,DISEASE,ethanol-withdrawal-induced changes,ethanol-withdrawal-induced changes
NEW02538,DISEASE,fragility fractures,fragility fractures
NEW02539,BIOCHEMICAL,hormone agonist exposure,hormone agonist exposure
NEW02542,CHEMICAL,gonadotropin-releasing hormone (GnRH)-agonist,gonadotropin-releasing hormone (GnRH)-agonist|Lupron
NEW02544,MENTAL_HEALTH,premenstrual dysphoria,premenstrual dysphoria
NEW02551,BIOCHEMICAL,progesterone receptor antagonist,progesterone receptor antagonist
D008796,DISEASE,Metrorrhagia,"Intermenstrual Bleeding|Dysfunctional Uterine Bleedings|Spotting|uterine bleeding|Breakthrough Bleeding|Dysfunctional Uterine Bleeding|Bleeding Between Periods|Bleeding, Breakthrough|Uterine Bleeding, Dysfunctional"
NEW02553,CHEMICAL,"second-messenger inositol 1,4,5-trisphosphate","second-messenger inositol 1,4,5-trisphosphate"
NEW02554,MENTAL_HEALTH,disease attractive therapeutic strategy,disease attractive therapeutic strategy
NEW02555,CHEMICAL,typical APDs,typical APDs
NEW02556,MENTAL_HEALTH,PCP- hyperactivity,PCP- hyperactivity
NEW02559,BIOCHEMICAL,antagonists cyproheptadine,antagonists cyproheptadine
C084642,CHEMICAL,2-bromolysergic acid diethylamide [Supplementary Concept],bromo-LSD|Lysergic Acid Diethylamide/analogs  and  derivatives
NEW02561,DISEASE,CRF hypersecretion,CRF hypersecretion
NEW02565,DISEASE,unipolar endogenous depressed,unipolar endogenous depressed
NEW02566,DISEASE,depressed man,depressed man
NEW02567,MENTAL_HEALTH,alcoholic hallucinosis,alcoholic hallucinosis
NEW02570,DISEASE,NSCLC cells,NSCLC cells
NEW02572,CHEMICAL,EGFR TKI resistance,EGFR TKI resistance
NEW02574,MENTAL_HEALTH,stable schizophrenia patients,stable schizophrenia patients
NEW02576,BIOCHEMICAL,standard anxiolytic drug,standard anxiolytic drug
NEW02579,DISEASE,similar behavioral disturbances,similar behavioral disturbances
NEW02581,BIOCHEMICAL,maternal CCR2 antagonist,maternal CCR2 antagonist
NEW02582,CHEMICAL,ethanol drinking,ethanol drinking
NEW02584,BIOCHEMICAL,gonadotropins sex hormone biosynthesis,gonadotropins sex hormone biosynthesis
NEW02586,CHEMICAL,lower peripheral testosterone levels,lower peripheral testosterone levels
NEW02587,CHEMICAL,testosterone system,testosterone system
NEW02588,DISEASE,child sexual offenders,child sexual offenders
NEW02589,DISEASE,sexual offenses,sexual offenses
NEW02592,NUTRITION,acetyltransferase ChAT mRNA levels,acetyltransferase ChAT mRNA levels
NEW02594,DISEASE,sexual symptoms,sexual symptoms
NEW02596,DISEASE,testosterone-induced temporal fluctuations,testosterone-induced temporal fluctuations
NEW02597,DISEASE,chronic anovulation,chronic anovulation
NEW02598,BIOCHEMICAL,androgen hypersecretion,androgen hypersecretion
NEW02599,DISEASE,hirsuitism,hirsuitism
NEW02604,DISEASE,advanced prostate cancer,advanced prostate cancer
NEW02606,MENTAL_HEALTH,social impotence,social impotence
C488187,CHEMICAL,"FRS2alpha protein, mouse [Supplementary Concept]",tyrosine phosphorylated|Membrane Proteins
NEW02608,DISEASE,obesity states,obesity states
NEW02611,BIOCHEMICAL,sex hormone balance,sex hormone balance
NEW02614,DISEASE,DSM-IV Axis I,DSM-IV Axis I
D001368,DISEASE,"Axis, Cervical Vertebra","Cervical Vertebra Axis|Os Odontoideum|C2 Vertebra|Vertebra Axis, Cervical|Axis|Epistropheus|C2 Vertebras"
NEW02615,BIOCHEMICAL,different sex hormone milieu,different sex hormone milieu
NEW02618,MENTAL_HEALTH,anxiety open field,anxiety open field
NEW02623,MENTAL_HEALTH,inhibited sexual desire,inhibited sexual desire
NEW02626,DISEASE,daily psychiatric evaluation,daily psychiatric evaluation
NEW02631,DISEASE,premature ovarian insufficiency,premature ovarian insufficiency|POI
D037101,BIOCHEMICAL,"Luteinizing Hormone, beta Subunit","Lutropin, beta Subunit|Lutropin beta|Luteinizing Hormone, beta Chain|Lutropin-beta|Luteinizing Hormone, beta Polypeptide Chain|LH, beta Subunit|ICSH, beta Subunit|luteinizing hormone|LH-beta|LH beta"
NEW02634,DISEASE,ovarian morphology,ovarian morphology
NEW02636,CHEMICAL,deyhydroepiahndrosterone sulfate,deyhydroepiahndrosterone sulfate
NEW02640,DISEASE,severe ASD,severe ASD
NEW02648,DISEASE,human aggressive behavior,human aggressive behavior
D011944,BIOCHEMICAL,"Receptors, Androgen","Receptors, Androgens|Receptor, 5 alpha-Dihydrotestosterone|androgen receptors|alpha-Dihydrotestosterone Receptor, 5|Receptor, Stanolone|Androgens Receptors|Receptor, Androgen|Stanolone Receptor|Androgen Receptor|5 alpha Dihydrotestosterone Receptor|Dihydrotestosterone Receptors|Androgen Receptors|Receptors, Stanolone|Receptor, Testosterone|Testosterone Receptor|Stanolone Receptors|5 alpha-Dihydrotestosterone Receptor|Receptors, Dihydrotestosterone"
D006628,DISEASE,Hirsutism,Hypertrichosis|hirsutism
NEW02650,DISEASE,systemic hypertension,systemic hypertension
NEW02651,DISEASE,ureteric calculi,ureteric calculi
D000152,DISEASE,Acne Vulgaris,acne vulgaris|Acne
NEW02654,CHEMICAL,amine neurotransmitter systems,amine neurotransmitter systems
NEW02655,DISEASE,disorder due to partial,disorder due to partial|PAIS
NEW02657,MENTAL_HEALTH,greater depression,greater depression
NEW02658,MENTAL_HEALTH,anxiety symptom severity,anxiety symptom severity
D020204,DISEASE,"Skull Fracture, Depressed","Skull Fractures, Compound Depressed|Compound Depressed Skull Fractures|Fracture, Depressed Skull|Skull Fracture, Compound Depressed|Fractures, Depressed Skull|depressed|Depressed Skull Fracture|Skull Fractures, Depressed|Compound Depressed Skull Fracture|Depressed Skull Fractures"
NEW02660,MENTAL_HEALTH,perimenopausal dysphoria,perimenopausal dysphoria
NEW02661,MENTAL_HEALTH,postpartum psychosis,postpartum psychosis
NEW02664,DISEASE,lethal castration-resistant prostate cancer,lethal castration-resistant prostate cancer
NEW02665,DISEASE,"other 46,XY","DSD|other 46,XY"
NEW02666,DISEASE,metastatic prostate cancer,metastatic prostate cancer
NEW02669,CHEMICAL,dopamine enhancers,dopamine enhancers
NEW02670,DISEASE,female schizophrenic patients,female schizophrenic patients
NEW02672,CHEMICAL,higher blood glucose levels,higher blood glucose levels
D011943,BIOCHEMICAL,"Receptors, Adrenergic, beta","beta-Receptors, Adrenergic|Receptor, Adrenergic, beta|Receptors, beta Adrenergic|beta-Receptor, Adrenergic|Adrenergic beta-Receptors|Receptor, beta Adrenergic|beta-Adrenergic Receptor|beta-Adrenergic Receptors|beta Adrenergic Receptor|beta adrenergic receptors|Adrenergic Receptor, beta|Receptor, beta-Adrenergic|Adrenergic beta-Receptor|Adrenergic beta Receptors|Receptors, beta-Adrenergic|Adrenergic beta Receptor|beta Adrenergic Receptors"
NEW02676,DISEASE,various pain states,various pain states
NEW02678,DISEASE,neuropathic inflammatory pain,neuropathic inflammatory pain
NEW02679,DISEASE,pain conditions,pain conditions
NEW02681,DISEASE,audiogenic seizures,audiogenic seizures
NEW02683,CHEMICAL,pentylentetrazole,pentylentetrazole
NEW02685,DISEASE,thermal pain,thermal pain
NEW02686,DISEASE,thermal nociceptions,thermal nociceptions
NEW02687,BIOCHEMICAL,rats analgesic effects,rats analgesic effects
NEW02688,DISEASE,psychiatric comorbidities,psychiatric comorbidities
NEW02690,CHEMICAL,GluR-A subunit-containing AMPA receptors,GluR-A subunit-containing AMPA receptors
NEW02692,DISEASE,ambivalent aggression,ambivalent aggression
NEW02693,DISEASE,TNA mice,TNA mice
NEW02696,DISEASE,limbic seizures,limbic seizures
D045468,DISEASE,Fallopia japonica,"Japanese Knotweeds|Knotweeds, Japanese|cuspidatum, Polygonum|Fallopia japonicas|Japanese knotweed|Polygonum cuspidatum|Polygonum cuspidatums|Knotweed, Japanese|japonicas, Fallopia|Japanese Knotweed"
NEW02704,MENTAL_HEALTH,chronic abuse control,chronic abuse control
C119846,DISEASE,"HST7 protein, Candida albicans [Supplementary Concept]",C. albicans|Fungal Proteins|Mitogen-Activated Protein Kinase Kinases
D055624,DISEASE,Methicillin-Resistant Staphylococcus aureus,MRSA|Methicillin Resistant Staphylococcus aureus|Staphylococcus aureus
NEW02706,BIOCHEMICAL,antimicrobial activity,antimicrobial activity
NEW02707,DISEASE,slight erythema,slight erythema
NEW02708,DISEASE,slight edema,slight edema
NEW02709,DISEASE,neurotoxicity brain damage,neurotoxicity brain damage
NEW02713,MENTAL_HEALTH,premenstrual depression,premenstrual depression
NEW02714,DISEASE,cerebral functions,cerebral functions
NEW02716,DISEASE,severe cerebral dysfunction,severe cerebral dysfunction
D003409,DISEASE,Congenital Hypothyroidism,"Myxedema, Congenital|Cretinism|cretinism|Endemic Cretinism|Cretinism, Endemic|Hypothyroidism, Congenital|Fetal Iodine Deficiency Disorder"
NEW02717,DISEASE,dietary deficiencies,dietary deficiencies
NEW02718,BIOCHEMICAL,outpatient parenteral antimicrobial therapy,outpatient parenteral antimicrobial therapy
NEW02720,DISEASE,severe injection-related infections,severe injection-related infections
NEW02721,CHEMICAL,buprenorphine induction,buprenorphine induction
NEW02722,MENTAL_HEALTH,antimicrobial resistance,antimicrobial resistance
NEW02724,DISEASE,clinical syndrome,clinical syndrome
NEW02726,MENTAL_HEALTH,various memory disorders,various memory disorders
NEW02727,BIOCHEMICAL,memory enhancing drug,memory enhancing drug
NEW02728,DISEASE,congenital immunity,congenital immunity
NEW02729,BIOCHEMICAL,antimicrobial action,antimicrobial action
NEW02731,CHEMICAL,stimulant psychotomimetic agents,stimulant psychotomimetic agents
NEW02733,DISEASE,secondary bacterial infections,secondary bacterial infections
NEW02736,DISEASE,severe infections,severe infections
NEW02738,DISEASE,pain control,pain control
D019868,CHEMICAL,Kanamycin Kinase,"Neomycin Phosphotransferase II|Phosphate Transferase, Kanamycin-Neomycin|Aminoglycoside 3'-Phosphotransferases (I and II)|APT 3' I and II|aphVII Gene Product|3'-Phosphotransferase, Amikacin|Phosphotransferase, Aminoglycoside|Aminoglycoside Phosphotransferase Type III|Phosphotransferase II, Neomycin|Kanamycin-Neomycin Phosphate Transferase|Kanamycin Neomycin Phosphate Transferase|Neomycin Phosphotransferase|Aminocyclitol Phosphotransferase|Phosphotransferase, Aminocyclitol|aminoglycoside|Aminoglycoside 3'-Phosphotransferase Type VIII|APH(3')-IIb|APHVII|Phosphotransferase, Neomycin|Aminoglycoside 3' Phosphotransferase Type VIII|Transferase, Kanamycin-Neomycin Phosphate|APH(3')-IIIa|APT-3'-I and II|Kinase, Kanamycin|Aminoglycoside Phosphotransferase|Amikacin 3' Phosphotransferase|Amikacin 3'-Phosphotransferase"
NEW02743,DISEASE,urosepsis,urosepsis
NEW02744,DISEASE,serious infection,serious infection
NEW02745,DISEASE,multiresistant gramnegative pathogens,multiresistant gramnegative pathogens
NEW02746,DISEASE,resistant prostatitis,resistant prostatitis
NEW02748,DISEASE,prostatitis symptoms,prostatitis symptoms
NEW02749,BIOCHEMICAL,single drug treatment,single drug treatment
NEW02753,DISEASE,serious toxicity,serious toxicity
NEW02754,CHEMICAL,camphor toxicity,camphor toxicity
NEW02756,DISEASE,acute intravascular hemolysis,acute intravascular hemolysis
D006457,DISEASE,"Hemoglobinuria, Paroxysmal","Cold Paroxysmal Hemoglobinuria|hemoglobinuria|Marchiafava-Micheli Syndrome|Paroxysmal Hemoglobinuria|Paroxysmal Cold Hemoglobinuria|Paroxysmal Nocturnal Hemoglobinuria|Syndrome, Marchiafava-Micheli|Hemoglobinuria, Cold Paroxysmal|Hemoglobinuria, Nocturnal Paroxysmal|Paroxysmal Hemoglobinuria, Cold|Marchiafava Micheli Syndrome|Hemoglobinuria, Paroxysmal Nocturnal|Paroxysmal Hemoglobinuria, Nocturnal|Hemoglobinuria, Paroxysmal Cold|Nocturnal Paroxysmal Hemoglobinuria"
D008585,DISEASE,"Meningitis, Meningococcal","Meningococcal Meningitis, Serogroup W135|Meningitis, Meningococcal, Serogroup Y|Meningococcal Meningitis, Serogroup B|Serogroup W-135, Meningococcal Meningitis|Serogroup A Meningococcal Meningitis|Meningococcal Meningitis, Serogroup Y|Meningitis, Meningococcal, Serogroup A|Meningococcal Meningitis, Serogroup W 135|Meningococcal Meningitis, Serogroup C|Meningitis, Meningococcal, Serogroup W-135|Serogroup C Meningococcal Meningitis|Serogroup Y, Meningococcal Meningitis|Meningitis, Meningococcal, Serogroup B|Serogroup W 135, Meningococcal Meningitis|meningococcal meningitis|Serogroup B Meningococcal Meningitis|Meningitis, Meningococcal, Serogroup W135|Meningococcal Meningitis|Meningococcal Meningitis, Serogroup W-135|Meningococcal Meningitis, Serogroup A|Meningitis, Meningococcal, Serogroup C|Meningitis, Meningococcic|Serogroup W135, Meningococcal Meningitis"
NEW02759,DISEASE,pulmonary nontuberculous mycobacteria infections,pulmonary nontuberculous mycobacteria infections
NEW02762,DISEASE,peripheral lipolysis,peripheral lipolysis
NEW02765,DISEASE,severe burns,severe burns
NEW02767,BIOCHEMICAL,antibiotic armamentarium,antibiotic armamentarium
NEW02769,DISEASE,large burns,large burns
D006987,DISEASE,Hypesthesia,"Hypesthesia, Thermal|Reduced Sensations|Numbness|Impaired Sensation|Thermal Hypesthesia|Hypesthesias, Tactile|Hypoesthesias|numbness|Sensations, Reduced|Reduced Sensation|Thermal Hypesthesias|Hypesthesias, Thermal|Sensation, Reduced|Hypesthesias|Hypoesthesia|Tactile Hypesthesia|Hypesthesia, Tactile|Tactile Hypesthesias|Sensation, Impaired|Sensations, Impaired|Impaired Sensations"
NEW02771,DISEASE,severe vomiting,severe vomiting
NEW02772,BIOCHEMICAL,unnecessary antimicrobial treatments,unnecessary antimicrobial treatments
NEW02773,MENTAL_HEALTH,advanced dementia,advanced dementia
D003123,DISEASE,"Colorectal Neoplasms, Hereditary Nonpolyposis","Colon Cancer, Familial Nonpolyposis, Type 1|Lynch Syndrome|Hereditary Nonpolyposis Colorectal Neoplasms|Hereditary Nonpolyposis Colon Cancer|Lynch Cancer Family Syndrome I|Hereditary Nonpolyposis Colorectal Cancer Type 1|Hereditary Nonpolyposis Colorectal Cancer|Colon Cancer, Familial Nonpolyposis|Lynch Syndrome I|colorectal cancer|Syndrome, Lynch|Familial Nonpolyposis Colon Cancer|Colorectal Cancer, Hereditary Nonpolyposis, Type 1|Familial Nonpolyposis Colon Cancer Type 1|Colorectal Cancer Hereditary Nonpolyposis"
NEW02775,BIOCHEMICAL,H1 antagonist drug doxepin hydrocholoride,H1 antagonist drug doxepin hydrocholoride
NEW02777,DISEASE,well-state bipolar patients,well-state bipolar patients
NEW02779,DISEASE,acute post-stroke period,acute post-stroke period
NEW02782,CHEMICAL,pilocarpine effects,pilocarpine effects
NEW02785,DISEASE,muscle atonia,muscle atonia
NEW02786,DISEASE,narcolepsy/cataplexy,narcolepsy/cataplexy
NEW02788,CHEMICAL,transdermal xanomeline,transdermal xanomeline
NEW02789,BIOCHEMICAL,M1-selective cholinergic agonist,M1-selective cholinergic agonist
NEW02796,CHEMICAL,károsodás negatív,károsodás negatív
D007184,DISEASE,Incontinentia Pigmenti,"Syndrome, Bloch-Sulzberger|Bloch-Siemens Syndrome|Bloch Sulzberger Syndrome|Bloch-Siemens-Sulzberger Syndrome|Bloch-Sulzberger Syndrome|incontinentia"
NEW02798,DISEASE,neurodevelopmental model,neurodevelopmental model
NEW02800,DISEASE,spontaneous alternation impairments,spontaneous alternation impairments
NEW02802,MENTAL_HEALTH,narcolepsy deficits,narcolepsy deficits
NEW02805,DISEASE,neonatal habenula lesion,NHL|neonatal habenula lesion
NEW02807,DISEASE,NHL-induced hyperlocomotion,NHL-induced hyperlocomotion
D015123,DISEASE,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide","7,8-Dihydroxy-9,10-Epoxy-7,8,9,10-Tetrahydrobenzo(a)pyrene|7,8-BaP-9,10-Diol Epoxide|Anti-BaPDE|Benzo(a)pyrene-7,8-diol 9,10-Epoxide|Benzo(a)pyrene 7,8-Dihydrodiol 9,10-Epoxide|Anti BaPDE|BPDE|7"
NEW02808,DISEASE,progressive neurodegenerative disease,progressive neurodegenerative disease
NEW02811,CHEMICAL,terfenadine treatment,terfenadine treatment
NEW02815,DISEASE,somatic behavior,somatic behavior
NEW02819,DISEASE,impaired emotional memory,impaired emotional memory
NEW02820,CHEMICAL,lorazepam,lorazepam
NEW02821,CHEMICAL,L-759274,L-759274
NEW02825,DISEASE,drug-induced impairments,drug-induced impairments
NEW02826,DISEASE,sleep deficits,sleep deficits
NEW02828,BIOCHEMICAL,opioid agents,opioid agents
NEW02829,DISEASE,injury death,injury death
NEW02830,DISEASE,burn pain management,burn pain management
NEW02831,BIOCHEMICAL,drug arm,drug arm
NEW02833,MENTAL_HEALTH,various mental disorders,various mental disorders
NEW02836,CHEMICAL,OV101    mg QD,OV101    mg QD
NEW02839,CHEMICAL,NMDA receptor activation enhancer,NMDA receptor activation enhancer
NEW02840,CHEMICAL,tetrahydrodeoxy-corticosterone,THDOC|tetrahydrodeoxy-corticosterone
NEW02841,BIOCHEMICAL,drug development candidate,drug development candidate
NEW02843,DISEASE,drugs muscle weakness,drugs muscle weakness
C584145,DISEASE,"SZT2 protein, human [Supplementary Concept]",seizure threshold|Nerve Tissue Proteins
NEW02844,DISEASE,intestinal tract helminthosis,intestinal tract helminthosis
NEW02847,MENTAL_HEALTH,new stress reactions,new stress reactions
NEW02853,BIOCHEMICAL,niacin cures,niacin cures
NEW02855,DISEASE,muscular myopathies,muscular myopathies
NEW02859,DISEASE,working memory impairments,working memory impairments
NEW02861,DISEASE,inpatient psychiatric unit,inpatient psychiatric unit
NEW02867,DISEASE,stress-induced depressive behaviors,stress-induced depressive behaviors
NEW02870,CHEMICAL,OXT promoters,OXT promoters
NEW02872,DISEASE,subsequent traumatic imagery,subsequent traumatic imagery
NEW02876,DISEASE,central nervous system toxicity,central nervous system toxicity
NEW02880,CHEMICAL,corticosterone element-1 silencing factor REST regulators,corticosterone element-1 silencing factor REST regulators
NEW02881,BIOCHEMICAL,accumulative uremic toxin,accumulative uremic toxin
NEW02884,MENTAL_HEALTH,dyskinesia expression,dyskinesia expression
NEW02885,CHEMICAL,ionotropic N-methyl-D -aspartate receptors,ionotropic N-methyl-D -aspartate receptors
NEW02887,MENTAL_HEALTH,treatment-refractory chronic schizophrenia,treatment-refractory chronic schizophrenia
NEW02892,CHEMICAL,oral m-CPP,oral m-CPP
NEW02894,CHEMICAL,m-CPP condition,m-CPP condition
NEW02895,CHEMICAL,smaller cortisol response,smaller cortisol response
C000628274,CHEMICAL,"HTR2C protein, human [Supplementary Concept]","Receptor, Serotonin, 5-HT2C|5HT2C"
NEW02902,MENTAL_HEALTH,cocaine-induced anxiety,cocaine-induced anxiety
NEW02905,CHEMICAL,oral mCPP,oral mCPP
NEW02907,DISEASE,sleep-related neuroplasticity,sleep-related neuroplasticity
NEW02909,BIOCHEMICAL,agonist infiltrates,agonist infiltrates
NEW02911,DISEASE,human diseases,human diseases
D010437,DISEASE,Peptic Ulcer,"Ulcers, Gastroduodenal|Peptic Ulcers|Ulcer, Gastroduodenal|Gastroduodenal Ulcer|Marginal Ulcers|Marginal Ulcer|Ulcer, Marginal|Gastroduodenal Ulcers|Ulcers, Marginal|Ulcers, Peptic|Ulcer, Peptic|peptic ulcers"
NEW02914,CHEMICAL,standard CRF antagonist drug antalarmin,standard CRF antagonist drug antalarmin
NEW02917,DISEASE,stress/anxiety,stress/anxiety
NEW02918,BIOCHEMICAL,hormone mediator,hormone mediator
NEW02924,DISEASE,CRF release,CRF release
NEW02926,DISEASE,PFC cognitive dysfunction,PFC cognitive dysfunction
NEW02928,BIOCHEMICAL,CRFR1 antagonist,CRFR1 antagonist
NEW02929,DISEASE,kindling seizure,kindling seizure
NEW02930,DISEASE,seizure latency,seizure latency
NEW02931,DISEASE,latency behaviors,latency behaviors
NEW02932,DISEASE,PTZ-induced kindling seizure,PTZ-induced kindling seizure
NEW02938,BIOCHEMICAL,strong analgesic effect,strong analgesic effect
NEW02940,CHEMICAL,systemic nicotine,systemic nicotine
NEW02942,MENTAL_HEALTH,stress-induced anxiety responses,stress-induced anxiety responses
NEW02943,MENTAL_HEALTH,anxiety responses,anxiety responses
NEW02946,MENTAL_HEALTH,related mental disorders,related mental disorders
NEW02948,DISEASE,neuropsychological dysfunction,neuropsychological dysfunction
NEW02952,CHEMICAL,acute carbon disulfide exposure,acute carbon disulfide exposure
NEW02957,DISEASE,neurotoxicity,neurotoxicity
NEW02958,CHEMICAL,elevated BHg levels,elevated BHg levels
NEW02961,DISEASE,primary illness,primary illness
NEW02964,DISEASE,hormone-dependent tumors,hormone-dependent tumors
D020728,DISEASE,Transurethral Resection of Prostate,"prostate|Prostate Transurethral Vaporesection|Transurethral Radiofrequency Thermal Ablation|Prostate Transurethral Electrovaporization|Microwave Thermotherapy, Transurethral|Transurethral Prostatectomy|VLAP|Transurethral Thermotherapy|Prostatectomy, Transurethral|Transurethral Thermotherapies|Transurethral Prostatectomies|Contact Laser Ablation of Prostate|Prostate Transurethral Electroresections|Prostate Transurethral Resection|Transurethral Vaporesection of Prostate|Prostate Transurethral Vaporesections|Prostate Transurethral Electroresection|Prostate Resections, Transurethral|Transurethral Prostate Resection|Transurethral Needle Ablation of Prostate|Prostate Resection, Transurethral|TURP|Thermotherapies, Transurethral|Transurethral Electroresection of Prostate|Prostatectomies, Transurethral|Thermotherapy, Transurethral Microwave|Resections, Transurethral Prostate|Transurethral Prostate Resections|Resection, Transurethral Prostate|TURPs|Transurethral Electrovaporization of Prostate|Prostate Transurethral Electrovaporizations|Transurethral Ultrasound-Guided Laser-Induced Prostatectomy|Transurethral Microwave Thermotherapy|Transurethral Ultrasound Guided Laser Induced Prostatectomy|Thermotherapy, Transurethral|Transurethral Visual Laser Ablation of Prostate|TUVP|Prostate Transurethral Resections"
D016889,DISEASE,Endometrial Neoplasms,"Cancer of the Endometrium|Carcinoma, Endometrial|Neoplasm, Endometrial|Endometrial Cancer|Endometrial Carcinomas|Carcinoma of Endometrium|Endometrial Cancers|Cancer, Endometrium|Neoplasms, Endometrial|Endometrium Carcinoma|Cancer, Endometrial|Endometrium Carcinomas|Carcinomas, Endometrial|Endometrial Carcinoma|Cancers, Endometrial|Endometrial Neoplasm|Cancers, Endometrium|Endometrium Cancers|endometrial cancers|Cancer of Endometrium|Endometrium Cancer"
NEW02965,CHEMICAL,calcium sensing receptor agonists,calcium sensing receptor agonists
D054579,DISEASE,National Institute of Allergy and Infectious Diseases (U.S.),National Institute of Allergy and Infectious Diseases|infectious diseases|NIAID
D000900,BIOCHEMICAL,Anti-Bacterial Agents,"Agents, Bacteriocidal|Bacteriocidal Agents|Agent, Anti-Mycobacterial|Anti-Bacterial Agent|Antimycobacterial Agents|antibacterial agents|Bacteriocide|Agent, Anti-Bacterial|Anti Bacterial Agent|Antibacterial Agents|Agents, Antibacterial|Antimycobacterial Agent|Antibiotic|Anti Bacterial Compound|Anti-Mycobacterial Agent|Agent, Antibacterial|Anti Bacterial Compounds|Bacteriocides|Bacteriocidal Agent|Anti Bacterial Agents|Anti-Bacterial Compounds|Agent, Antimycobacterial|Anti-Mycobacterial Agents|Agents, Anti-Bacterial|Anti-Bacterial Compound|Compound, Anti-Bacterial|Agents, Anti-Mycobacterial|Anti Mycobacterial Agent|Agent, Bacteriocidal|Compounds, Anti-Bacterial|Agents, Antimycobacterial|Antibacterial Agent|Anti Mycobacterial Agents|Antibiotics"
NEW02967,DISEASE,community-acquired brain abscess,community-acquired brain abscess
NEW02968,BIOCHEMICAL,traditional antibiotic therapy,traditional antibiotic therapy
NEW02970,DISEASE,satiation weight loss,satiation weight loss
NEW02972,DISEASE,ASD prevention strategies,ASD prevention strategies
D000074242,DISEASE,Sunflower Oil,"Sunflower Seed Oil|Oil, Sunflower Seed|Oil, Sunflower|sunflower oil|Seed Oil, Sunflower"
NEW02976,NUTRITION,possible mercury involvement,possible mercury involvement
NEW02977,DISEASE,yolk sac edema,yolk sac edema
NEW02978,DISEASE,pericardial edema,pericardial edema
D013121,DISEASE,Spinal Curvatures,"Curvatures, Spinal|Spinal Curvature|Curvature, Spinal|spinal curvature"
NEW02979,CHEMICAL,μM. Fenamidone,μM. Fenamidone
NEW02980,BIOCHEMICAL,mixture rabbits,mixture rabbits
D050033,DISEASE,Thyroid Dysgenesis,"Dysgenesis, Thyroid|Ectopic Thyroids|Thyroid Agenesis|dysgenesis|Agenesis, Thyroid|Thyroid, Ectopic|Thyroid Hypoplasia|Hypoplasia, Thyroid|Ectopic Thyroid|Thyroids, Ectopic"
D003456,DISEASE,Cryptorchidism,"cryptorchidism|Cryptorchidism, Inguinal|Testes, Undescended|Inguinal Cryptorchidism|Cryptorchidism, Unilateral|Abdominal Cryptorchidism|Testis, Undescended|Cryptorchidism, Unilateral Or Bilateral|Unilateral Cryptorchidism|Undescended Testes|Bilateral Cryptorchidism|Cryptorchidism, Bilateral|Undescended Testis|Cryptorchism|Cryptorchidism, Abdominal"
NEW02982,CHEMICAL,REMITCH CAPSULES microg,REMITCH CAPSULES microg
NEW02983,BIOCHEMICAL,Torii Pharmaceutical Co.,Torii Pharmaceutical Co.
NEW02985,DISEASE,abnormal behaviors related,abnormal behaviors related
NEW02987,MENTAL_HEALTH,chronic stress disorders,chronic stress disorders
NEW02989,DISEASE,mechanical hypersensitivity,mechanical hypersensitivity
NEW02991,BIOCHEMICAL,antipruritus drug,antipruritus drug
NEW02992,DISEASE,biliary duct obstruction,biliary duct obstruction
NEW02993,DISEASE,known mechanical gastrointestinal obstruction,known mechanical gastrointestinal obstruction
NEW02994,DISEASE,known pancreatic duct obstruction,known pancreatic duct obstruction
NEW02995,MENTAL_HEALTH,active alcohol abuse,active alcohol abuse
NEW02996,DISEASE,severe hepatic impairment,severe hepatic impairment
D046628,DISEASE,Sphincter of Oddi Dysfunction,Oddi dysfunction|Sphincter of Oddi Stenosis|Sphincter of Oddi Dyskinesia
NEW02998,CHEMICAL,neoclerodane diterpene Salvinorin A,neoclerodane diterpene Salvinorin A
NEW03002,CHEMICAL,kappa-opioid-receptor agonist,kappa-opioid-receptor agonist
NEW03003,CHEMICAL,topical capsaicin cream,topical capsaicin cream
NEW03004,CHEMICAL,oral activated charcoal,oral activated charcoal
NEW03005,CHEMICAL,ultraviolet B phototherapy,ultraviolet B phototherapy
NEW03007,MENTAL_HEALTH,patients ADHD symptoms,patients ADHD symptoms
NEW03011,MENTAL_HEALTH,depression treatment,depression treatment
NEW03014,CHEMICAL,hereditary CP,hereditary CP
D010190,DISEASE,Pancreatic Neoplasms,"Neoplasm, Pancreas|Cancer of the Pancreas|Pancreas Cancer|Cancer, Pancreas|Cancers, Pancreas|Cancers, Pancreatic|Pancreas Cancers|Neoplasms, Pancreas|Pancreas Neoplasms|Pancreatic Cancer|Pancreas Neoplasm|Cancer of Pancreas|Cancer, Pancreatic|Neoplasms, Pancreatic|pancreatic cancer|Pancreatic Neoplasm|Neoplasm, Pancreatic|Pancreatic Cancers"
NEW03018,CHEMICAL,glyphosate-based herbicides,glyphosate-based herbicides
NEW03020,DISEASE,Alzheimer brains,Alzheimer brains
NEW03022,DISEASE,mouse formalin pain model,mouse formalin pain model
NEW03023,DISEASE,pain responses,pain responses
C581638,CHEMICAL,DORA-22 [Supplementary Concept],Triazoles|DORA-22|Piperidines
NEW03025,CHEMICAL,DORA-2,DORA-2
NEW03026,CHEMICAL,nitroglycerin rat model,nitroglycerin rat model
D006935,DISEASE,Hypercapnia,hypercapnia
NEW03030,BIOCHEMICAL,drug challenge,drug challenge
NEW03032,MENTAL_HEALTH,human narcolepsy,human narcolepsy
NEW03035,MENTAL_HEALTH,cataplexy sudden episodes,cataplexy sudden episodes
NEW03036,CHEMICAL,lemborexant-treated WT mice,lemborexant-treated WT mice
NEW03037,CHEMICAL,non-benzodiazepine,non-benzodiazepine
NEW03039,BIOCHEMICAL,additional pharmaceutical option,additional pharmaceutical option
NEW03040,BIOCHEMICAL,poisonous substance,poisonous substance
NEW03042,CHEMICAL,thyroglobulin antibodies,thyroglobulin antibodies
NEW03043,DISEASE,callous personality traits,callous personality traits
NEW03044,CHEMICAL,peripheral deiodination,peripheral deiodination
NEW03045,MENTAL_HEALTH,bipolar depressive disorder,bipolar depressive disorder
NEW03047,MENTAL_HEALTH,unit due delusions,unit due delusions
NEW03048,BIOCHEMICAL,normal serum thyroid hormone levels,normal serum thyroid hormone levels
NEW03049,DISEASE,malignant neuroleptic syndrome,malignant neuroleptic syndrome
NEW03050,DISEASE,drug-induced hypothyroidism,drug-induced hypothyroidism
NEW03052,DISEASE,psychotic phenomena,psychotic phenomena
NEW03057,BIOCHEMICAL,existing drug regimen,existing drug regimen
NEW03059,NUTRITION,cholesterol concentrations,cholesterol concentrations
NEW03060,BIOCHEMICAL,cortisol hormones,cortisol hormones
NEW03061,DISEASE,thyroid dysfunction,thyroid dysfunction
NEW03064,DISEASE,somatoform factor score,somatoform factor score
NEW03068,CHEMICAL,chronic daily ethanol consumption,chronic daily ethanol consumption
NEW03072,BIOCHEMICAL,thyroid-stimulating hormone response,thyroid-stimulating hormone response
C106996,CHEMICAL,NRA 0045 [Supplementary Concept],Thiazoles|NRA|Pyrrolidines
NEW03076,DISEASE,hepatic decompensation,hepatic decompensation
NEW03077,CHEMICAL,elevated ammonia level,elevated ammonia level
NEW03078,DISEASE,consciousness disturbance,consciousness disturbance
NEW03079,DISEASE,hyperammonemia portal-systemic encephalopathy,hyperammonemia portal-systemic encephalopathy
NEW03084,MENTAL_HEALTH,heightened anxiety,heightened anxiety
NEW03086,BIOCHEMICAL,sex hormone secretion disorders,sex hormone secretion disorders
NEW03087,CHEMICAL,triiodothyronine conversion,triiodothyronine conversion
NEW03088,BIOCHEMICAL,classic thyroid hormone disruptor,classic thyroid hormone disruptor
NEW03089,CHEMICAL,polybrominated diphenyl ether,polybrominated diphenyl ether
NEW03093,DISEASE,neurodevelopmental impairments,neurodevelopmental impairments
NEW03096,DISEASE,depressed females,depressed females
NEW03099,DISEASE,goiter recurrence,goiter recurrence
NEW03100,BIOCHEMICAL,suppressive thyroid hormone therapy,suppressive thyroid hormone therapy
D013954,DISEASE,Thyroglobulin,thyroglobulin
NEW03105,DISEASE,mild central hypothyroidism,mild central hypothyroidism
NEW03110,CHEMICAL,central serotonin system,central serotonin system
NEW03111,CHEMICAL,cretins,cretins
NEW03112,MENTAL_HEALTH,permanent mental retardation,permanent mental retardation
NEW03113,DISEASE,MMI-treated hypothyroid rats,MMI-treated hypothyroid rats
NEW03114,CHEMICAL,D(2)-like dopamine receptors,D(2)-like dopamine receptors
NEW03115,MENTAL_HEALTH,depression refractory,depression refractory
NEW03116,CHEMICAL,elective radioactive iodine treatment,elective radioactive iodine treatment
D038263,DISEASE,Auditory Brain Stem Implantation,"Implantation, Auditory Brainstem|auditory|Auditory Brainstem Implantation|Brainstem Implantation, Auditory|Auditory Brainstem Implantations|Brainstem Implantations, Auditory"
NEW03117,MENTAL_HEALTH,paranoid delusion,paranoid delusion
NEW03118,MENTAL_HEALTH,flat affect,flat affect
NEW03119,DISEASE,euthyroid patients,euthyroid patients
NEW03122,DISEASE,diabetes risk,diabetes risk
NEW03124,DISEASE,tau hyperphosphorylation,tau hyperphosphorylation
NEW03126,MENTAL_HEALTH,mild Alzheimer disease,mild Alzheimer disease
NEW03128,CHEMICAL,mesolimbic dopamine release,mesolimbic dopamine release
NEW03131,DISEASE,traumatic event,traumatic event
NEW03132,CHEMICAL,morphine CPP,morphine CPP
NEW03138,DISEASE,addictive diseases,addictive diseases
NEW03139,DISEASE,multiple hepatic injuries,multiple hepatic injuries
C052746,CHEMICAL,adriamycin-cardiolipin complex [Supplementary Concept],cardiolipin|Cardiolipins|Doxorubicin
NEW03140,CHEMICAL,HEp2-substrate,HEp2-substrate
D013945,DISEASE,Thymoma,"thymoma|Thymic Carcinomas|Thymic Carcinoma|Thymomas|Carcinoma, Thymic|Carcinomas, Thymic"
NEW03142,DISEASE,AntiMa2,testicular tumor|AntiMa2
NEW03143,DISEASE,ANNA3,ANNA3|bronchial small cell carcinoma
D020274,DISEASE,Autoimmune Diseases of the Nervous System,"autoimmune disorders|Nervous System Autoimmune Diseases|Nervous System Immune Diseases|Immune Diseases, Nervous System|Autoimmune Disease, Neurologic|Nervous System Immune Disorders|Autoimmune Diseases, Nervous System|Autoimmune Nervous System Diseases|Autoimmune Disorders, Nervous System|Neurologic Autoimmune Diseases|Neurologic Autoimmune Disease|Disease, Neurologic Autoimmune|Autoimmune Diseases, Neurologic|Diseases, Neurologic Autoimmune|Immune Disorders, Nervous System|Autoimmune Disorders of the Nervous System"
NEW03146,BIOCHEMICAL,indiscriminate antibiotic use,indiscriminate antibiotic use
NEW03147,CHEMICAL,environmental chemicals,environmental chemicals
NEW03149,DISEASE,CP/CPPS patients,CP/CPPS patients
NEW03150,DISEASE,Japanese narcoleptic patients,Japanese narcoleptic patients
NEW03152,DISEASE,acute psychiatric care,acute psychiatric care
NEW03154,CHEMICAL,anti-synapsin negative patients,anti-synapsin negative patients
NEW03156,MENTAL_HEALTH,higher agitation scores,higher agitation scores
NEW03160,DISEASE,paraproteinemic multifocal motor neuropathy,paraproteinemic multifocal motor neuropathy
NEW03163,DISEASE,hypersensitivity DTH skin responses,hypersensitivity DTH skin responses
NEW03165,DISEASE,severe depressive disorders,severe depressive disorders
NEW03171,BIOCHEMICAL,neural antigens,neural antigens
C037709,DISEASE,HLA-A9 antigen [Supplementary Concept],HLA-A9|HLA-A Antigens
NEW03173,DISEASE,partial noncicatricial hair loss,partial noncicatricial hair loss
NEW03176,BIOCHEMICAL,antigen formulation,antigen formulation
NEW03178,DISEASE,genus Leishmania,genus Leishmania
NEW03180,DISEASE,primary Sjögren 's syndrome,primary Sjögren 's syndrome|pSS
NEW03182,DISEASE,Alzheimer's disease patients,Alzheimer's disease patients
NEW03184,BIOCHEMICAL,orexin receptor antagonist SB-334867,orexin receptor antagonist SB-334867
C520475,CHEMICAL,"CHIC1 protein, human [Supplementary Concept]",DNA-Binding Proteins|Transcription Factors|hydrophobic domain
NEW03185,BIOCHEMICAL,noncompetitive NMDA receptor antagonist,noncompetitive NMDA receptor antagonist
NEW03186,BIOCHEMICAL,fact antagonist effect,fact antagonist effect
NEW03188,DISEASE,schizophrenia-like behaviors,schizophrenia-like behaviors
NEW03189,DISEASE,behavior deficits,behavior deficits
NEW03191,DISEASE,interaction deficits,interaction deficits
NEW03192,DISEASE,chronic pain states,chronic pain states
NEW03193,DISEASE,hypersensitivity attention,hypersensitivity attention
NEW03194,DISEASE,hemiparkinsonian,hemi-PD|hemiparkinsonian
NEW03195,DISEASE,akinetic motor deficit,akinetic motor deficit
NEW03197,DISEASE,epilepsy-related memory dysfunction,epilepsy-related memory dysfunction
NEW03200,MENTAL_HEALTH,experimental schizophrenia model,experimental schizophrenia model
NEW03201,CHEMICAL,NMDA receptor blockade,NMDA receptor blockade
NEW03204,MENTAL_HEALTH,profound motor hyperactivity,profound motor hyperactivity
NEW03208,DISEASE,chronic PTSD,chronic PTSD
NEW03209,DISEASE,impaired neural connectivity,impaired neural connectivity
NEW03212,MENTAL_HEALTH,DRN projection cells,DRN projection cells
NEW03214,CHEMICAL,sIPSC frequency,sIPSC frequency
NEW03215,CHEMICAL,rapid antidepressant response,rapid antidepressant response
NEW03216,DISEASE,depressed-like anhedonic behavior,depressed-like anhedonic behavior
NEW03218,CHEMICAL,μg/side,μg/side
NEW03220,DISEASE,pain behaviors,pain behaviors
NEW03222,CHEMICAL,CNQX .5,CNQX .5
NEW03223,CHEMICAL,NMDA receptor antagonist D-2-amino-5-phosphonovalerate,NMDA receptor antagonist D-2-amino-5-phosphonovalerate
NEW03224,CHEMICAL,"non-NMDA receptor antagonist 6-Cyano-7-nitroquinoxaline-2,3-dione disodium","non-NMDA receptor antagonist 6-Cyano-7-nitroquinoxaline-2,3-dione disodium"
NEW03225,DISEASE,unilaterality,unilaterality
NEW03226,DISEASE,ethanol dependence,withdrawal-associated audiogenic seizures|ethanol dependence
D053145,DISEASE,Cell Nucleus Size,"Cell Nuclear Size|Nuclear Size, Cell|cell volume|Volume, Cell Nucleus|Size, Cell Nucleus|Cell Nuclear Volume|Nucleus Size, Cell|Nucleus Volumes, Cell|Cell Nuclear Sizes|Nuclear Sizes, Cell|Volumes, Cell Nuclear|Sizes, Cell Nucleus|Cell Nucleus Volume|Cell Nucleus Sizes|Cell Nucleus Volumes|Size, Cell Nuclear|Nuclear Volume, Cell|edema|Cell Nuclear Volumes|Nuclear Volumes, Cell|Volumes, Cell Nucleus|Volume, Cell Nuclear|Nucleus Volume, Cell|Sizes, Cell Nuclear|Nucleus Sizes, Cell"
NEW03230,CHEMICAL,glycine site,glycine site
NEW03232,CHEMICAL,GSH consumption,GSH consumption|decreased GSH/GSSG ratio
NEW03233,CHEMICAL,GSH synthesis,GSH synthesis
NEW03235,CHEMICAL,amino acid concentrations,amino acid concentrations
NEW03236,CHEMICAL,plasma ammonia concentrations,plasma ammonia concentrations
NEW03239,DISEASE,treatment-resistant major depressive disorder,treatment-resistant major depressive disorder
NEW03245,DISEASE,treatment-resistant MDD,treatment-resistant MDD
NEW03248,DISEASE,food-seeking behavior,food-seeking behavior
NEW03251,DISEASE,dependent memory deficits,dependent memory deficits
NEW03253,BIOCHEMICAL,NMDA receptor antagonist memantine,NMDA receptor antagonist memantine
NEW03254,DISEASE,reducing/limiting weight gain,reducing/limiting weight gain
NEW03255,DISEASE,our's treatment-resistant patients,our's treatment-resistant patients
NEW03257,CHEMICAL,famotidine augmentation,famotidine augmentation
C576143,CHEMICAL,G6 stilbenoid tyrosine kinase inhibitor [Supplementary Concept],Stilbenes|TKI|tyrosine-kinase inhibitor
NEW03259,DISEASE,advanced non-small-cell cancer aNSCLC patients,advanced non-small-cell cancer aNSCLC patients
NEW03263,CHEMICAL,serum testosterone levels,serum testosterone levels
NEW03264,MENTAL_HEALTH,paroxetine-induced sexual dysfunction,paroxetine-induced sexual dysfunction
NEW03266,CHEMICAL,paroxetine-induced male rats,paroxetine-induced male rats
NEW03267,DISEASE,postinfectious anosmia,postinfectious anosmia
NEW03268,DISEASE,age-related cognitive decline,age-related cognitive decline
NEW03272,DISEASE,severe locomotor deficits,severe locomotor deficits
NEW03274,CHEMICAL,precursor L-DOPA,precursor L-DOPA
NEW03275,DISEASE,LID severity,LID severity
NEW03277,DISEASE,LIDs,LIDs
NEW03279,BIOCHEMICAL,brain nucleus-targeted µ receptor agonists,brain nucleus-targeted µ receptor agonists
NEW03281,DISEASE,depressive-like behaviors,depressive-like behaviors
NEW03284,DISEASE,moderate-to-severe pain constipation,moderate-to-severe pain constipation
NEW03285,DISEASE,chronic constipation,chronic constipation
NEW03286,DISEASE,postoperative ileus,postoperative ileus
NEW03288,DISEASE,multiple neuropsychological disorders,multiple neuropsychological disorders
NEW03291,CHEMICAL,novel antidepressants,novel antidepressants
NEW03295,DISEASE,short-term weight loss,short-term weight loss
NEW03297,BIOCHEMICAL,μ-opioid receptor antagonists,μ-opioid receptor antagonists
NEW03298,CHEMICAL,topical steroids,topical steroids
NEW03302,CHEMICAL,atropine content,atropine content
NEW03305,CHEMICAL,ss-endorphins,ss-endorphins
NEW03306,MENTAL_HEALTH,antipsychotic drug-induced insulin resistance,antipsychotic drug-induced insulin resistance
NEW03308,DISEASE,withdrawal-induced hyperalgesia,withdrawal-induced hyperalgesia
NEW03316,DISEASE,motor disability,motor disability
NEW03319,DISEASE,secondary hyperammonemia,secondary hyperammonemia
NEW03321,CHEMICAL,KCl-induced CSDs,KCl-induced CSDs
NEW03323,DISEASE,striatal damage,striatal damage
C000603057,CHEMICAL,"L2HGDH protein, mouse [Supplementary Concept]",Alcohol Oxidoreductases|L-2-hydroxyglutarate dehydrogenase
NEW03328,MENTAL_HEALTH,Norwegian adult ADHD patients,Norwegian adult ADHD patients
NEW03330,BIOCHEMICAL,defective riboflavin transporters,defective riboflavin transporters
C562465,MENTAL_HEALTH,"Phobia, Specific [Supplementary Concept]",Phobic Disorders|specific phobia
NEW03335,BIOCHEMICAL,sex hormone receptors,sex hormone receptors
NEW03337,CHEMICAL,arginine-vasopressin up-regulation,arginine-vasopressin up-regulation
D046790,DISEASE,"Pancreas, Exocrine",pancreas|Exocrine Pancreas
NEW03346,BIOCHEMICAL,blood hormone levels,blood hormone levels
D006931,CHEMICAL,Hyperbaric Oxygenation,"Hyperbaric Oxygen Therapy|Therapies, Hyperbaric Oxygen|Oxygen Therapy, Hyperbaric|Hyperbaric Oxygen Therapies|oxygen therapy|Oxygenation, Hyperbaric|Oxygenations, Hyperbaric|Therapy, Hyperbaric Oxygen|Hyperbaric Oxygenations|Oxygen Therapies, Hyperbaric"
NEW03349,CHEMICAL,microng LHRH,microng LHRH
NEW03350,CHEMICAL,2.39+/-0.4 mu/ml,2.39+/-0.4 mu/ml
NEW03351,MENTAL_HEALTH,schizophrenia relative,schizophrenia relative
NEW03354,BIOCHEMICAL,sex hormone depletion,sex hormone depletion
NEW03357,MENTAL_HEALTH,elevated anxiety scores,elevated anxiety scores
NEW03359,MENTAL_HEALTH,elevated depression,elevated depression
NEW03360,BIOCHEMICAL,difference/10 % hormone increase,difference/10 % hormone increase
NEW03361,CHEMICAL,β=0.42,β=0.42
D016014,MENTAL_HEALTH,Linear Models,"Model, Log-Linear|Log Linear Models|Regression, Linear|Linear Model|Linear Regression|Models, Linear|Models, Log-Linear|Log-Linear Models|Linear Regressions|Log-Linear Model|Model, Linear|linear regression|Regressions, Linear"
NEW03363,MENTAL_HEALTH,depression association,depression association
NEW03366,DISEASE,more fractures,more fractures
NEW03368,DISEASE,higher depressive,higher depressive
NEW03369,BIOCHEMICAL,endogenous gonadal hormones,endogenous gonadal hormones
D043373,BIOCHEMICAL,"Follicle Stimulating Hormone, Human","FSH, Human|Anthrogon|FSH, human (follicle stimulating hormone)|follicle-stimulating hormone|Human Follicle Stimulating Hormone|Human FSH|hFSH"
C012313,CHEMICAL,ethyl-p-hydroxybenzoate [Supplementary Concept],Parabens|ethylparaben|EP
NEW03374,CHEMICAL,lower SHBG,lower SHBG
NEW03375,CHEMICAL,bioavailable testosterone,bioavailable testosterone
NEW03376,MENTAL_HEALTH,ADHD measures,ADHD measures
NEW03378,BIOCHEMICAL,abnormal sex hormone levels,abnormal sex hormone levels
NEW03379,CHEMICAL,lower DHEA-S levels,lower DHEA-S levels
NEW03381,DISEASE,impulsivity performance,impulsivity performance
NEW03383,MENTAL_HEALTH,ADHD behavior symptoms,ADHD behavior symptoms
NEW03385,MENTAL_HEALTH,lower Liebowitz Anxiety Score,lower Liebowitz Anxiety Score
NEW03387,BIOCHEMICAL,individual sex hormone levels,individual sex hormone levels
NEW03388,MENTAL_HEALTH,basal anxiety levels,basal anxiety levels
NEW03390,DISEASE,PTSD symptomology,PTSD symptomology
NEW03391,DISEASE,subsequent post-traumatic stress symptoms,subsequent post-traumatic stress symptoms
NEW03393,MENTAL_HEALTH,moderate intellectual disability,moderate intellectual disability
NEW03394,MENTAL_HEALTH,cycle-related mood disorders,cycle-related mood disorders
NEW03396,MENTAL_HEALTH,major depression disorder,major depression disorder
NEW03397,MENTAL_HEALTH,certain mental disorders,certain mental disorders
NEW03402,DISEASE,burying behavior,burying behavior
NEW03406,DISEASE,different anxiety-related behaviors,different anxiety-related behaviors
NEW03408,MENTAL_HEALTH,obesity substance abuse,obesity substance abuse
NEW03412,DISEASE,diabetes management,diabetes management
NEW03414,MENTAL_HEALTH,ADHD group,ADHD group
NEW03418,DISEASE,schedule-induced polydipsia,schedule-induced polydipsia
NEW03421,DISEASE,anxious behavior,anxious behavior
NEW03423,DISEASE,experiments polydipsia,experiments polydipsia
C414463,DISEASE,"SIP protein, Streptococcus group B [Supplementary Concept]","SIP|Antigens, Bacterial"
NEW03425,CHEMICAL,alpha7-N-receptors,alpha7-N-receptors
NEW03426,DISEASE,cortical circuits,cortical circuits
D000089502,DISEASE,Antiglaucoma Agents,"Drug, Anti-Glaucoma|Drugs, Anti-Glaucoma|Antiglaucoma Drugs|Antiglaucoma Medications|Anti-Glaucoma Drug|Anti-Glaucoma Medications|Anti-Glaucoma Drugs|Anti Glaucoma Medications|Anti-Glaucoma Agents|glaucoma medications|Medications, Antiglaucoma|Anti-Glaucoma Agent|Medications, Anti-Glaucoma"
NEW03428,DISEASE,glaucomatous damages,glaucomatous damages
D012133,DISEASE,Respiratory Paralysis,"Paralysis, Diaphragmatic|Paralysis, Respiratory|Respiratory Muscle Paralysis|Muscle Paralyses, Respiratory|Paralysis, Respiratory Muscle|Muscle Paralysis, Respiratory|Diaphragmatic Paralysis|muscle paralysis"
NEW03430,BIOCHEMICAL,direct cholinergic agonist,direct cholinergic agonist
NEW03433,MENTAL_HEALTH,drug-induced cataplexy,drug-induced cataplexy
NEW03436,MENTAL_HEALTH,schizophrenia research,schizophrenia research
NEW03440,DISEASE,ulcer surgery,ulcer surgery
NEW03441,BIOCHEMICAL,central adverse drug reactions,central adverse drug reactions
NEW03442,DISEASE,slurred speech,slurred speech
NEW03444,DISEASE,E-mediated anaphylaxis,E-mediated anaphylaxis
NEW03447,CHEMICAL,high energy phosphate,high energy phosphate
NEW03449,MENTAL_HEALTH,non-MD/SZ suicide group,non-MD/SZ suicide group
NEW03451,DISEASE,depressed rats,depressed rats
NEW03452,CHEMICAL,methadone withdrawal,methadone withdrawal
NEW03453,DISEASE,comparison TLR3-induced hyperthermia,comparison TLR3-induced hyperthermia
NEW03455,DISEASE,hyperthermia-related genes,hyperthermia-related genes
NEW03457,DISEASE,psychiatric population,psychiatric population
NEW03458,DISEASE,cataplexies,cataplexies
NEW03459,MENTAL_HEALTH,comorbid ADHD,comorbid ADHD
C565342,MENTAL_HEALTH,Macrocephaly Autism Syndrome [Supplementary Concept],autism syndrome|Autistic Disorder|Facies|Megalencephaly
NEW03461,CHEMICAL,GABA action,GABA action
NEW03464,MENTAL_HEALTH,anxiety memories,anxiety memories
D051298,DISEASE,Post-Traumatic Headache,"Post-Traumatic Headaches|Post Traumatic Headache|Cervicogenic Headaches|Headaches, Post-Traumatic|Headache, Cervicogenic|Headaches, Cervicogenic|traumatic|Headache, Post-Traumatic|Cervicogenic Headache"
C441623,CHEMICAL,"3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide [Supplementary Concept]",NAE|Benzopyrans
NEW03466,CHEMICAL,hydrochloride sulfate,hydrochloride sulfate
NEW03467,CHEMICAL,indoleamines,indoleamines
NEW03470,CHEMICAL,2-AG concentrations,2-AG concentrations
C466089,CHEMICAL,stearoylethanolamide [Supplementary Concept],stearoylethanolamide|SEA|Stearic Acids
NEW03472,DISEASE,behavioral impairments,behavioral impairments
NEW03474,CHEMICAL,polyphenol (-)-epigallocatechin-3-gallate,EGCg|polyphenol (-)-epigallocatechin-3-gallate
NEW03475,CHEMICAL,various quinone site inhibitors,various quinone site inhibitors
NEW03476,DISEASE,hepatosteatosis,hepatosteatosis
NEW03481,MENTAL_HEALTH,serotonin-related mental disorders,serotonin-related mental disorders
NEW03482,DISEASE,chronic spinal cord injury,chronic spinal cord injury
NEW03485,CHEMICAL,5HT mechanisms,5HT mechanisms
D015154,DISEASE,Esophageal Motility Disorders,"esophageal motility|Esophageal Dysmotility|Dysmotilities, Esophageal|Dysmotility, Esophageal|Nutcracker Esophagus|Motility Disorders, Esophageal|Disorders, Esophageal Motility|Esophageal Dysmotilities|Esophagus, Nutcracker|Esophageal Motility Disorder|Disorder, Esophageal Motility|Motility Disorder, Esophageal"
NEW03487,CHEMICAL,1-[2-[(methyl sulfonyl)-amino]-ethyl]-4-piperidinyl-methyl-5-fluoro-2-methoxy-1H-indole-3-carboxylate i.p,1-[2-[(methyl sulfonyl)-amino]-ethyl]-4-piperidinyl-methyl-5-fluoro-2-methoxy-1H-indole-3-carboxylate i.p
NEW03488,BIOCHEMICAL,selective 5-HT4 receptor antagonist GR,selective 5-HT4 receptor antagonist GR
NEW03489,BIOCHEMICAL,GABA-ergic agents,GABA-ergic agents
NEW03492,DISEASE,significant hyperphagia,significant hyperphagia
NEW03497,DISEASE,progesterone-induced hyperphagia,progesterone-induced hyperphagia
NEW03498,CHEMICAL,quipazine-induced hypophagia,quipazine-induced hypophagia
NEW03500,BIOCHEMICAL,SSRI therapy,SSRI therapy
NEW03502,MENTAL_HEALTH,severe anxiety symptoms,severe anxiety symptoms
NEW03504,DISEASE,depressive problems,depressive problems
NEW03506,CHEMICAL,low-dose neuroleptics,low-dose neuroleptics
NEW03509,DISEASE,hippocampus-dependent behaviors,hippocampus-dependent behaviors
NEW03515,CHEMICAL,normal brain serotonin function,normal brain serotonin function
NEW03517,CHEMICAL,reduced serotonin transporter binding,reduced serotonin transporter binding
NEW03518,CHEMICAL,3-methoxy-4-hydrophenylglycol,3-methoxy-4-hydrophenylglycol
NEW03522,MENTAL_HEALTH,premenstrual dysphoric disorder efficacy,premenstrual dysphoric disorder efficacy
NEW03524,CHEMICAL,intra-synaptic central nervous system serotonin,intra-synaptic central nervous system serotonin
NEW03525,BIOCHEMICAL,adverse drug effects,adverse drug effects
NEW03529,DISEASE,alcoholism treatment models,alcoholism treatment models
NEW03530,DISEASE,tuberculous meningitis patients,tuberculous meningitis patients
NEW03531,DISEASE,tachy-brady arrhythmias,tachy-brady arrhythmias
NEW03532,DISEASE,SAN dysfunction,SAN dysfunction
D016921,DISEASE,"Meningitis, Fungal","Fungal Pachymeningitides|fungal meningitis|Pachymeningitides, Fungal|Pachymeningitis, Fungal|Fungal Meningitis|Fungal Meningitides|Fungal Pachymeningitis|Meningitides, Fungal"
C051038,CHEMICAL,"Inositol 1,4,5-trisphosphate 3-kinase [Supplementary Concept]",IP(3|Phosphotransferases (Alcohol Group Acceptor)
NEW03534,CHEMICAL,"(1,4,5)-trisphosphate signalling","(1,4,5)-trisphosphate signalling"
NEW03536,CHEMICAL,intracellular inositol,intracellular inositol
NEW03537,DISEASE,stimulation-related manic state,stimulation-related manic state
NEW03544,MENTAL_HEALTH,uncomplicated BD depression,uncomplicated BD depression
NEW03546,MENTAL_HEALTH,neuromuscular fatigue resistance,neuromuscular fatigue resistance
NEW03548,MENTAL_HEALTH,fatigue development,fatigue development
NEW03549,CHEMICAL,higher E-DII scores,higher E-DII scores
NEW03553,MENTAL_HEALTH,anxiety spectrum disorders,anxiety spectrum disorders
NEW03554,DISEASE,low toxicity,low toxicity
NEW03556,CHEMICAL,lactate metabolic rewiring,lactate metabolic rewiring
NEW03558,DISEASE,stress-associated breast cancer,stress-associated breast cancer
NEW03563,CHEMICAL,more PGE1,more PGE1
NEW03565,CHEMICAL,PGE1 concentrations,PGE1 concentrations
NEW03567,MENTAL_HEALTH,chemotherapy resistance,chemotherapy resistance
NEW03571,DISEASE,ethanol-induced neuronal cell death,ethanol-induced neuronal cell death
NEW03573,MENTAL_HEALTH,modest anxiety disorders,modest anxiety disorders
NEW03574,DISEASE,biomolecular damage,biomolecular damage
NEW03578,BIOCHEMICAL,B-complex vitamins,B-complex vitamins
NEW03579,BIOCHEMICAL,vitamin C. athletes,vitamin C. athletes
NEW03581,DISEASE,greater confusion,greater confusion
NEW03587,CHEMICAL,Freeman AA,Freeman AA
NEW03588,CHEMICAL,Rye DB,Rye DB
NEW03589,DISEASE,hypersomnia patients,hypersomnia patients
D013549,BIOCHEMICAL,Sweetening Agents,"Artificial Sweetener|Sweetener|Artificial Sweeteners|sweetener|Sweeteners, Artificial|Sugar Substitute|Sweetener, Artificial|Agent, Sweetening|Sweetening Agent|Substitutes, Sugar|Sugar Substitutes|Sweeteners|Substitute, Sugar|Agents, Sweetening"
NEW03593,DISEASE,body-weight gain,body-weight gain
NEW03595,DISEASE,MCI patients,MCI patients
D063309,CHEMICAL,"2',3'-Cyclic Nucleotide 3'-Phosphodiesterase","2',3'-CN Phosphodiesterase|2',3' CN Phosphodiesterase|2',3' Cyclic Nucleotide 3' Phosphodiesterases|3-|Cyclic CMP Phosphodiesterase|2',3' CNPase|3'-Phosphodiesterase, 2',3'-Cyclic Nucleotide|2',3' Cyclic Nucleotide 3' Phosphodiesterase|2',3'-CNPase|2',3'-Cyclic Nucleotide 3'-Phosphodiesterases"
NEW03599,CHEMICAL,pioglitazone group,pioglitazone group
NEW03600,DISEASE,neuroprotective heat shock proteins,neuroprotective heat shock proteins
NEW03603,BIOCHEMICAL,reproductive hormones,reproductive hormones
C051774,CHEMICAL,neurofilament protein H [Supplementary Concept],neurofilament-H+|Neurofilament Proteins
D003711,DISEASE,Demyelinating Diseases,"Demyelination|Clinically Isolated Syndrome, CNS Demyelinating|demyelination|Demyelinating Disorder|Clinically Isolated CNS Demyelinating Syndrome|Demyelinating Disease|Demyelinating Disorders|Demyelinations"
NEW03605,NUTRITION,abnormal follicle counts,abnormal follicle counts
C548904,CHEMICAL,"insulin-like growth factor-1, rat [Supplementary Concept]",Insulin-Like Growth Factor I|insulin-like growth factor 1|IGF1
NEW03606,CHEMICAL,increased serum corticosterone levels,increased serum corticosterone levels
NEW03607,MENTAL_HEALTH,chronic stress HFSC quiescence,chronic stress HFSC quiescence
NEW03609,DISEASE,photosensitive dermal melanophores,photosensitive dermal melanophores
D001679,CHEMICAL,Biogenic Amines,"Amines, Biogenic|Biogenic Amine|Amine, Biogenic|biogenic amines"
NEW03610,BIOCHEMICAL,serum sex hormone levels,serum sex hormone levels
NEW03611,MENTAL_HEALTH,primary affective disorders,primary affective disorders
NEW03614,DISEASE,schizoaffective patients,schizoaffective patients
NEW03615,DISEASE,schizoaffective subject,schizoaffective subject
NEW03616,CHEMICAL,high testosterone levels,high testosterone levels
NEW03617,DISEASE,hypoprolactinemia,hypoprolactinemia
NEW03618,DISEASE,abnormal FSH,abnormal FSH
NEW03620,NUTRITION,hair follicle structures,hair follicle structures
D057092,DISEASE,Geographic Atrophy,"Atrophy, Geographic|Degeneration, Dry Macular|Macular Degenerations, Dry|Geographic Atrophies|Dry Macular Degeneration|Dry Macular Degenerations|Degenerations, Dry Macular|Atrophies, Geographic|atrophy|Macular Degeneration, Dry"
NEW03621,DISEASE,severe inflammation,severe inflammation
NEW03626,BIOCHEMICAL,hormone concentrations,hormone concentrations
NEW03628,CHEMICAL,post-LHRH,post-LHRH
NEW03629,DISEASE,psychiatric presentation,psychiatric presentation
NEW03630,DISEASE,cardiovascular fitness,cardiovascular fitness
NEW03631,BIOCHEMICAL,lower estrogen levels,lower estrogen levels
NEW03633,MENTAL_HEALTH,early-phase Alzheimer disease,early-phase Alzheimer disease
NEW03637,DISEASE,tumour growth,tumour growth
NEW03639,DISEASE,tumour cell proliferation,tumour cell proliferation
D009362,DISEASE,Neoplasm Metastasis,"Metastases|metastasis|Neoplasm Metastases|Metastase|Metastasis, Neoplasm|Metastases, Neoplasm|Metastasis"
NEW03641,DISEASE,tumour tissue,tumour tissue
NEW03644,NUTRITION,alpha oestrogen receptors,alpha oestrogen receptors
NEW03645,DISEASE,age-related diseases,age-related diseases
NEW03646,DISEASE,AP-1 antagonist A-Fos,AP-1 antagonist A-Fos
NEW03648,CHEMICAL,Al chloride,Al chloride
C495677,CHEMICAL,"SLC2A1 protein, human [Supplementary Concept]",Glucose Transporter Type 1|human glucose transporter
NEW03651,DISEASE,CPZ-induced liver disease,CPZ-induced liver disease
NEW03653,DISEASE,colonic hyperalgesia,colonic hyperalgesia
NEW03655,DISEASE,motor cognitive functions,motor cognitive functions
NEW03656,DISEASE,behavioral abnormalities suggestive,behavioral abnormalities suggestive
NEW03657,DISEASE,human mental health,human mental health
NEW03658,BIOCHEMICAL,stress hormone due,stress hormone due
NEW03660,MENTAL_HEALTH,disease mutations,disease mutations
NEW03661,CHEMICAL,electroconvulsions,electroconvulsions
NEW03663,CHEMICAL,central histamine studies,central histamine studies
NEW03665,DISEASE,effective cancer chemotherapy,effective cancer chemotherapy
NEW03667,DISEASE,resistant cancer cells,resistant cancer cells
NEW03668,DISEASE,lower toxicity,lower toxicity
NEW03671,MENTAL_HEALTH,moderate anxiety,moderate anxiety
NEW03672,DISEASE,severe liver damage,severe liver damage
NEW03674,DISEASE,alcohol-induced liver damage,alcohol-induced liver damage
NEW03677,DISEASE,primary hepatic carcinoma,primary hepatic carcinoma
D019190,CHEMICAL,Iron Overload,"iron overload|Overload, Iron"
NEW03679,DISEASE,hyperammonemia neurological damage,hyperammonemia neurological damage
NEW03681,CHEMICAL,Tau content,Tau content
NEW03684,CHEMICAL,catalytic site(s,catalytic site(s
NEW03688,BIOCHEMICAL,alpha-adrenergic antagonist,alpha-adrenergic antagonist
NEW03690,MENTAL_HEALTH,resistance vasculature,resistance vasculature
NEW03691,CHEMICAL,SMTC 0.05,SMTC 0.05
NEW03692,CHEMICAL,selective nNOS inhibitor S-methyl-l-thiocitrulline,selective nNOS inhibitor S-methyl-l-thiocitrulline
NEW03694,DISEASE,metastasis breast cancer,metastasis breast cancer
NEW03698,CHEMICAL,pseudomenopause,pseudomenopause
NEW03700,CHEMICAL,benzodiazepine binding sites,benzodiazepine binding sites
NEW03701,MENTAL_HEALTH,anxiety due occupancy,anxiety due occupancy
NEW03705,CHEMICAL,cyclizine ingestions,cyclizine ingestions
NEW03706,DISEASE,varicella-zoster lesions,varicella-zoster lesions
NEW03707,DISEASE,concurrent angioedema due,concurrent angioedema due
NEW03708,CHEMICAL,risperidone BID,risperidone BID
NEW03709,DISEASE,hand tremor,hand tremor
NEW03710,CHEMICAL,voltage-gate Ca+2 channels,voltage-gate Ca+2 channels
NEW03714,MENTAL_HEALTH,dysfunction limitations,dysfunction limitations
NEW03716,CHEMICAL,Zyprexatrade mark,Zyprexatrade mark
C121345,CHEMICAL,desloratadine [Supplementary Concept],desloratadine|Loratadine/analogs  and  derivatives
NEW03717,CHEMICAL,histamine central nervous system,histamine central nervous system
NEW03719,MENTAL_HEALTH,paradoxical hyperarousal,paradoxical hyperarousal
D010632,CHEMICAL,Pheniramine,"Bimaleate, Pheniramine|Histapyridamine|Maleate, Pheniramine|Propheniramine|Avil|Daneral|Prophenpyridamine|Pheniramine Maleate|pheniramine|Pheniramine Bimaleate"
NEW03720,MENTAL_HEALTH,disease patients,disease patients
NEW03722,DISEASE,recognition memory impairment,recognition memory impairment
NEW03727,MENTAL_HEALTH,major affective disorders,major affective disorders
NEW03729,DISEASE,neuroleptic-induced increase,neuroleptic-induced increase
NEW03730,CHEMICAL,dopamine turnover,dopamine turnover
NEW03731,DISEASE,neuroleptic-induced up-regulation,neuroleptic-induced up-regulation
NEW03732,CHEMICAL,adenine diet,adenine diet
NEW03733,DISEASE,colon motility,colon motility
NEW03735,DISEASE,CKD-associated symptom burden,CKD-associated symptom burden
NEW03736,DISEASE,chronic disease (CKD)-related complications,chronic disease (CKD)-related complications
NEW03739,DISEASE,uremic encephalopathy,uremic encephalopathy
NEW03741,CHEMICAL,cerebral oxygen extraction fraction,cerebral oxygen extraction fraction
NEW03743,MENTAL_HEALTH,Alzheimer disease (AD)-transgenic mice,Alzheimer disease (AD)-transgenic mice
NEW03744,CHEMICAL,soluble amyloid-β,soluble amyloid-β
NEW03746,DISEASE,peripheral neuropathic pain,peripheral neuropathic pain
NEW03749,BIOCHEMICAL,μ-opioid receptor agonists,μ-opioid receptor agonists
NEW03750,BIOCHEMICAL,analgesic targets,analgesic targets
NEW03752,DISEASE,associated allergic diseases,associated allergic diseases
NEW03753,DISEASE,haloperidol-induced locomotor hypoactivity,haloperidol-induced locomotor hypoactivity
NEW03754,BIOCHEMICAL,H3-receptor antagonists/inverse agonists,H3-receptor antagonists/inverse agonists
C000719052,CHEMICAL,"GRM1 protein, human [Supplementary Concept]","glutamate metabotropic receptor|Receptors, Metabotropic Glutamate"
NEW03760,CHEMICAL,increased dorsal striatum dopamine release,increased dorsal striatum dopamine release
C410218,CHEMICAL,serogroup C meningococcal conjugate vaccine [Supplementary Concept],Meningococcal Vaccines|MNC
NEW03761,DISEASE,breast ovarian cancer patients,breast ovarian cancer patients
D064706,DISEASE,Vocal Cord Dysfunction,"Dysfunction, Vocal Cord|Paradoxical Vocal Fold Motion|Exercise-Induced Vocal Cord Dysfunction|dysfunction|Vocal Cord Dysfunctions|Exercise Induced Vocal Cord Dysfunction|Paradoxical Vocal Fold Motion Disorder|Dysfunctions, Vocal Cord"
NEW03764,DISEASE,genitourinary syndrome,genitourinary syndrome
NEW03765,DISEASE,vulvovaginal atrophy,vulvovaginal atrophy
NEW03767,BIOCHEMICAL,mirabegron agonist,mirabegron agonist
NEW03769,DISEASE,white-matter abnormalities,white-matter abnormalities
NEW03770,CHEMICAL,± old,± old
NEW03773,DISEASE,hyperammonemia condition,hyperammonemia condition
NEW03777,MENTAL_HEALTH,autism research,autism research
NEW03778,DISEASE,TD children,TD children
D058065,DISEASE,Diabetic Cardiomyopathies,"cardiomyopathies|Diabetic Cardiomyopathy|Cardiomyopathy, Diabetic|Cardiomyopathies, Diabetic"
NEW03780,DISEASE,hereditary myopathies,hereditary myopathies
NEW03782,CHEMICAL,COVID-19 long-haulers,COVID-19 long-haulers
NEW03783,MENTAL_HEALTH,persistent hyperactivity,persistent hyperactivity
NEW03784,DISEASE,functional pituitary adenomas,functional pituitary adenomas
NEW03785,DISEASE,distinct psychotic symptom clusters,distinct psychotic symptom clusters
NEW03787,CHEMICAL,central DA receptor supersensitivity,central DA receptor supersensitivity
NEW03789,CHEMICAL,DA receptor blocker,DA receptor blocker
NEW03790,CHEMICAL,impaired iron metabolism,impaired iron metabolism
NEW03793,DISEASE,SAD n=16,SAD n=16
NEW03794,MENTAL_HEALTH,DSM-IV schizophrenia,DSM-IV schizophrenia
NEW03796,DISEASE,paranoid SCZ patients,paranoid SCZ patients
NEW03797,DISEASE,young male psychotic patients,young male psychotic patients
NEW03799,DISEASE,neuroleptic-free psychotic patients,neuroleptic-free psychotic patients
NEW03800,BIOCHEMICAL,hormone GH response,hormone GH response
NEW03803,MENTAL_HEALTH,DSM-III-R schizophrenia =,DSM-III-R schizophrenia =
NEW03806,MENTAL_HEALTH,chronic anxiety,chronic anxiety
C511689,CHEMICAL,(N)-methanocarba-2MeSADP [Supplementary Concept],Adenosine Diphosphate/analogs  and  derivatives|MRS2365
NEW03810,BIOCHEMICAL,desipramine-induced hormone stimulation,desipramine-induced hormone stimulation
NEW03813,CHEMICAL,arginine treatment,arginine treatment
NEW03814,CHEMICAL,urea cycle function,urea cycle function
NEW03818,DISEASE,hypogonadotrophic hypogonadism,hypogonadotrophic hypogonadism
NEW03819,CHEMICAL,altered GHRH circadian rhythm,altered GHRH circadian rhythm
NEW03821,BIOCHEMICAL,hormone treatment,hormone treatment
NEW03822,MENTAL_HEALTH,non-psychotic depression,non-psychotic depression
NEW03824,MENTAL_HEALTH,Major Depression,Major Depression
NEW03825,CHEMICAL,GHRH curve,GHRH curve
NEW03830,MENTAL_HEALTH,anxiety reactions,anxiety reactions
D007046,MENTAL_HEALTH,Hysteria,"Hysterical Neuroses|hysteria|Neuroses, Hysterical"
NEW03831,DISEASE,childhood psychoses,childhood psychoses
NEW03836,DISEASE,SAD controls,SAD controls
NEW03837,DISEASE,experimental spinal cord injury,experimental spinal cord injury
NEW03838,DISEASE,shock states,shock states
NEW03843,CHEMICAL,weeks MPH treatment,weeks MPH treatment
NEW03845,DISEASE,ADDH children,ADDH children
D000083123,DISEASE,Vancomycin-Resistant Staphylococcus aureus,Glycopeptide-Intermediate Staphylococcus aureus|Vancomycin-Intermediate S. aureus|Vancomycin-Resistant S. aureus|S.    aureus|Glycopeptide-Intermediate S. aureus|Vancomycin-Intermediate Staphylococcus aureus|Glycopeptide-Resistant Staphylococcus aureus|Glycopeptide-Resistant S. aureus
C476155,DISEASE,"beta-lactamase SPM-1, Pseudomonas aeruginosa [Supplementary Concept]",P.    aeruginosa|beta-Lactamases
D017919,DISEASE,"Hepatitis B Virus, Woodchuck","Virus, Woodchuck Hepatitis|Woodchuck Hepatitis Viruses|Woodchuck Hepatitis B Virus|Woodchuck Hepatitis Virus|hepatitis B virus|Hepatitis Viruses, Woodchuck|Viruses, Woodchuck Hepatitis|Hepatitis Virus, Woodchuck"
NEW03854,DISEASE,multiple infectious diseases,multiple infectious diseases
NEW03855,DISEASE,CAG trinucleotide expansion,CAG trinucleotide expansion
NEW03856,DISEASE,mutant HTT-induced toxicity,mutant HTT-induced toxicity
NEW03858,DISEASE,HD mouse brain,HD mouse brain
NEW03860,DISEASE,metabolic disorder-related depression,metabolic disorder-related depression
NEW03861,DISEASE,astrocytic deficits,astrocytic deficits
NEW03862,DISEASE,HFD-induced glucose-metabolic dysfunctions,HFD-induced glucose-metabolic dysfunctions
NEW03863,DISEASE,depressive phenotypes,depressive phenotypes
NEW03864,MENTAL_HEALTH,associated depression,associated depression
NEW03866,MENTAL_HEALTH,bipolar depression symptom severity,bipolar depression symptom severity
NEW03868,DISEASE,fatal bacterial infections,fatal bacterial infections
NEW03870,CHEMICAL,antipsychotic-associated weight gain,antipsychotic-associated weight gain
NEW03872,DISEASE,less weight gain,less weight gain
NEW03873,DISEASE,osteoporotic hip fracture,osteoporotic hip fracture
NEW03875,DISEASE,acute hearing loss,acute hearing loss
D010111,CHEMICAL,Oxymorphone,oxymorphone|Numorphan|Oxymorphone Hydrochloride|Opana|Oxymorphone HCl
NEW03876,CHEMICAL,cocaine self-administration,cocaine self-administration
NEW03877,DISEASE,cocaine-induced behaviors,cocaine-induced behaviors
D059026,DISEASE,Diagnostic Self Evaluation,"Complaints, Subjective Health|Health Complaints, Subjective|Self-Appraisals|Subjective Health|Subjective Health Complaint|Health, Subjective|Subjective Health Complaints|Self Evaluations, Diagnostic|Self Evaluation|Complaint, Subjective Health|Self-Appraisal|Subjective Healths|Diagnostic Self Evaluations|Complaints|Self Evaluation, Diagnostic|Self-Evaluations|Evaluations, Diagnostic Self|Self Appraisal|Health Complaint, Subjective|Self-Evaluation"
NEW03879,DISEASE,clinical neurotoxicity,clinical neurotoxicity
NEW03886,DISEASE,heat pain,heat pain
NEW03888,DISEASE,formalin-induced pain,formalin-induced pain
NEW03889,DISEASE,NSAID-refractory chronic pain,NSAID-refractory chronic pain
NEW03891,DISEASE,increased pain perception,increased pain perception
NEW03893,CHEMICAL,noradrenaline effects,noradrenaline effects
NEW03898,MENTAL_HEALTH,comorbid chronic tic disorder,comorbid chronic tic disorder
NEW03902,DISEASE,LID therapeutic effect,LID therapeutic effect
NEW03905,DISEASE,L-DOPA-primed dyskinetic rats,L-DOPA-primed dyskinetic rats
NEW03906,DISEASE,behavioral disturbances,behavioral disturbances
NEW03907,CHEMICAL,prototypic antidepressant,prototypic antidepressant
NEW03908,CHEMICAL,adult antidepressant treatment,adult antidepressant treatment
NEW03910,DISEASE,male sexual behavior,male sexual behavior
NEW03912,CHEMICAL,relevant antidepressant treatments,relevant antidepressant treatments
NEW03916,BIOCHEMICAL,concurrent drug therapy,concurrent drug therapy
NEW03918,DISEASE,nausea arrhythmias,nausea arrhythmias
NEW03921,MENTAL_HEALTH,recurrent depression,recurrent depression
NEW03924,DISEASE,pain regulation,pain regulation
D014550,DISEASE,"Urinary Incontinence, Stress","Urinary Stress Incontinence|Incontinence, Urinary Stress|stress incontinence|Stress Incontinence, Urinary"
D016055,DISEASE,Urinary Retention,"Retention, Urinary|urinary retention"
D007669,DISEASE,Kidney Calculi,"Stones, Kidney|Kidney Stones|Calculus, Kidney|Nephrolith|Kidney Calculus|renal calculi|Stone, Kidney|Calculi, Kidney|Renal Calculus|Calculus, Renal|Renal Calculi|Kidney Stone|Calculi, Renal"
NEW03928,CHEMICAL,triamterene inhibitors,triamterene inhibitors
NEW03930,BIOCHEMICAL,beta adrenoceptor blockers,beta adrenoceptor blockers
NEW03931,DISEASE,neuropsychiatric complications,neuropsychiatric complications
NEW03932,MENTAL_HEALTH,anxiety due,anxiety due
NEW00860,CHEMICAL,noradrenaline reuptake inhibitor,noradrenaline reuptake inhibitor
NEW03933,DISEASE,impulsive behavioural dyscontrol symptoms,impulsive behavioural dyscontrol symptoms
NEW03935,DISEASE,somatic complaints,somatic complaints
NEW03937,CHEMICAL,open-label duloxetine,open-label duloxetine
NEW03941,CHEMICAL,amphetamine-like stimulants,amphetamine-like stimulants
NEW03944,CHEMICAL,cholecystokinin/pentagastrin,cholecystokinin/pentagastrin
NEW03945,MENTAL_HEALTH,similar anxiety reactions,similar anxiety reactions
NEW03946,CHEMICAL,5HT1A serotonin receptor subtypes,5HT1A serotonin receptor subtypes
NEW03952,DISEASE,dry mouth,dry mouth
NEW03953,MENTAL_HEALTH,comorbid alcohol dependence,comorbid alcohol dependence
NEW03955,MENTAL_HEALTH,seasonal depression,seasonal depression
NEW03958,MENTAL_HEALTH,purging episodes,purging episodes
NEW03959,MENTAL_HEALTH,severe premenstrual syndrome,severe premenstrual syndrome
NEW03961,DISEASE,cataract development,cataract development
NEW03962,DISEASE,abnormal uterine bleeding,abnormal uterine bleeding
D000073396,DISEASE,Metal-Organic Frameworks,"Porous Coordination Polymers|Organic Framework, Covalent|Covalent Organic Framework|Porous Coordination Networks|Framework, Covalent Organic|Metal-Organic Framework|Networks, Porous Coordination|Metal Organic Frameworks|Framework, Metal-Organic|Frameworks, Metal-Organic|Metal Organic Framework|Framework, Metal Organic|Coordination Networks, Porous|Organic Framework, Metal|frameworks|Coordination Polymers, Porous|Polymers, Porous Coordination|Polymer, Porous Coordination|Porous Coordination Polymer|Coordination Polymer, Porous"
NEW03965,DISEASE,anemia rates,anemia rates
NEW03968,DISEASE,maternal hypoxia,maternal hypoxia
NEW03969,CHEMICAL,ferrous citrate (FC)-infusion,ferrous citrate (FC)-infusion
NEW03974,CHEMICAL,pathological iron deposition,pathological iron deposition
NEW03975,DISEASE,bioenergetic failure,bioenergetic failure
NEW03976,CHEMICAL,non-transferrin iron,non-transferrin iron
NEW03978,DISEASE,fescue toxicosis,fescue toxicosis
NEW03980,DISEASE,depressed concentrations,depressed concentrations
NEW03981,MENTAL_HEALTH,weight Chronic stress,weight Chronic stress
NEW03982,CHEMICAL,BW dexamethasone,BW dexamethasone
NEW03985,DISEASE,beef cattle,beef cattle
D000071220,BIOCHEMICAL,Pharmaceutical Research,"Research, Pharmaceutical|pharmaceutical research"
NEW03990,BIOCHEMICAL,anticholinergic drug,anticholinergic drug
NEW03992,DISEASE,milder tics persons,milder tics persons
NEW03993,DISEASE,chronic spinal catheters,chronic spinal catheters
NEW03997,MENTAL_HEALTH,pediatric ADHD,pediatric ADHD
NEW04000,CHEMICAL,catecholamine pathway dysfunction,catecholamine pathway dysfunction
NEW04002,BIOCHEMICAL,different drug therapies,different drug therapies
NEW04004,CHEMICAL,recent nonmedical buprenorphine use,recent nonmedical buprenorphine use
NEW04005,CHEMICAL,recent methadone maintenance treatment = =,recent methadone maintenance treatment = =
NEW04006,MENTAL_HEALTH,multivariate logistic regression analysis,multivariate logistic regression analysis
NEW04008,MENTAL_HEALTH,ASEX dysfunction scores,ASEX dysfunction scores
NEW04011,DISEASE,chronic glutamate-mediated neuron degeneration,chronic glutamate-mediated neuron degeneration
NEW04015,BIOCHEMICAL,high-throughput drug screening,high-throughput drug screening
NEW04016,CHEMICAL,repeated imipramine,repeated imipramine
NEW04017,CHEMICAL,phosphorylated form,phosphorylated form|p-Hdac5
NEW04021,DISEASE,permanent behavioral abnormality,permanent behavioral abnormality
NEW04022,DISEASE,traumatic fear,traumatic fear
NEW04023,CHEMICAL,stimulant methylphenidate,stimulant methylphenidate
NEW04029,DISEASE,chronic neurodegenerative disorders,chronic neurodegenerative disorders
NEW04031,CHEMICAL,type DM,type DM
NEW04034,DISEASE,intestinal dysbiosis,intestinal dysbiosis
D006944,DISEASE,Hyperglycemic Hyperosmolar Nonketotic Coma,"Hyperglycemic Syndromes, Hyperosmolar|Nonketotic Hyperglycemic Coma|Coma, Hyperglycemic Hyperosmolar Nonketotic|Nonketotic Hyperosmolar Comas|Hyperosmolar Hyperglycemic Syndrome|Coma, Nonketotic Hyperglycemic|Hyperosmolar Coma, Nonketotic|Hyperosmolar Hyperglycemic States|hyperosmolar coma|Comas, Hyperosmolar Nonketotic|Nonketotic Comas, Hyperosmolar|Hyperosmolar Comas, Nonketotic|Coma, Nonketotic Hyperosmolar|Coma, Hyperosmolar Nonketotic|Hyperglycemic Syndrome, Hyperosmolar|Nonketotic Coma, Hyperosmolar|Hyperosmolar Hyperglycemic Nonketotic Coma|Hyperosmolar Nonketotic Coma|Syndrome, Hyperosmolar Hyperglycemic|Nonketotic Hyperosmolar Coma|Hyperosmolar Hyperglycemic Syndromes|Hyperglycemic Coma, Nonketotic|Syndromes, Hyperosmolar Hyperglycemic|Hyperosmolar Hyperglycemic State|Hyperosmolar Nonketotic Comas|Hyperglycemic States, Hyperosmolar|Comas, Nonketotic Hyperosmolar|Hyperglycemic State, Hyperosmolar"
NEW04038,DISEASE,severe rhabdomyolysis,severe rhabdomyolysis
NEW04039,CHEMICAL,cannabis cessation,cannabis cessation
NEW04041,MENTAL_HEALTH,chronic psychosis patients,chronic psychosis patients
D018476,DISEASE,Hypokinesia,"Bradykinesia|Bradykinesias|Antiorthostatic Hypokinesias|bradykinesia|Hypodynamia|Hypokinesias, Antiorthostatic|Hypokinesia, Antiorthostatic|Antiorthostatic Hypokinesia"
NEW04044,DISEASE,long-lasting cerebellar degeneration,long-lasting cerebellar degeneration
NEW04045,CHEMICAL,radium poisoning,radium poisoning
NEW04049,NUTRITION,short-term lithium,short-term lithium
NEW04051,BIOCHEMICAL,third-generation antipsychotic drug,third-generation antipsychotic drug
NEW04053,DISEASE,sleeping-related disorders,sleeping-related disorders
NEW04054,DISEASE,certain cancers,certain cancers
NEW04055,DISEASE,neurological conditions,neurological conditions
NEW04057,DISEASE,sexual behaviour,sexual behaviour
NEW04059,BIOCHEMICAL,circulatory follicle-stimulating hormone,circulatory follicle-stimulating hormone
NEW04060,BIOCHEMICAL,luteinising hormone,luteinising hormone
NEW04063,MENTAL_HEALTH,withdrawal excessive daytime sleepiness,withdrawal excessive daytime sleepiness
NEW04064,DISEASE,attention-deficit hyperactive disorder,attention-deficit hyperactive disorder
NEW04066,CHEMICAL,brain glucose metabolism,BGluM|brain glucose metabolism
NEW04068,DISEASE,olfactory impairments,olfactory impairments
NEW04070,MENTAL_HEALTH,anxiety tests,anxiety tests
NEW04071,CHEMICAL,oxide lipid peroxidation,oxide lipid peroxidation
NEW04073,CHEMICAL,ASM-ceramide system,ASM-ceramide system
NEW04074,DISEASE,post-traumatic stress disease,post-traumatic stress disease
NEW04075,DISEASE,disease pandemic,disease pandemic
NEW04078,CHEMICAL,exposure to 0.05 % propylthiouracil,PTU|exposure to 0.05 % propylthiouracil
NEW04080,NUTRITION,choline elevation,choline elevation
NEW04082,CHEMICAL,choline/creatine ratios,choline/creatine ratios
NEW04083,CHEMICAL,myoinositol/creatine ratio,myoinositol/creatine ratio
NEW04084,NUTRITION,elevated choline levels,elevated choline levels
NEW04087,DISEASE,repetitive behavior,repetitive behavior
NEW04089,DISEASE,repetitive motor behavior,repetitive motor behavior
NEW04097,CHEMICAL,ethanol administration,ethanol administration
NEW04098,DISEASE,human neuroblastoma cells,human neuroblastoma cells
NEW04101,BIOCHEMICAL,antagonist effects,antagonist effects
NEW04102,DISEASE,MDMA hippocampal neurotoxic effects,MDMA hippocampal neurotoxic effects
NEW04103,CHEMICAL,contrast to A2a antagonist,SCH|contrast to A2a antagonist
NEW04108,DISEASE,intestinal inflammation,intestinal inflammation
NEW04110,CHEMICAL,cellular acetaldehyde pools,cellular acetaldehyde pools
NEW04111,CHEMICAL,inositol synthesis,inositol synthesis
NEW04113,CHEMICAL,specific essential amino acid,specific essential amino acid
NEW04114,CHEMICAL,cholesterol precursor desmosterol,cholesterol precursor desmosterol
NEW04116,BIOCHEMICAL,food antigens,food antigens
NEW04117,CHEMICAL,gluten exorphins,gluten exorphins
NEW04119,CHEMICAL,intestinally-infectious pathogen,intestinally-infectious pathogen
C417762,DISEASE,"H4 protein, Toxoplasma gondii [Supplementary Concept]",Immunodominant Epitopes|Protozoan Proteins|Toxoplasma gondii
NEW04120,MENTAL_HEALTH,recent onset schizophrenia,recent onset schizophrenia
D011039,BIOCHEMICAL,Poison Control Centers,"Centers, Poison Control|poison|Poison Control Center|Center, Poison Control|Control Centers, Poison"
NEW04125,MENTAL_HEALTH,widespread public anxiety,widespread public anxiety
NEW04126,CHEMICAL,≥12<17 years age group,≥12<17 years age group
NEW04128,DISEASE,factitial disease,factitial disease
NEW04131,DISEASE,malonate-induced neuronal damage,malonate-induced neuronal damage
NEW04133,MENTAL_HEALTH,General Fatigue,General Fatigue
NEW04134,MENTAL_HEALTH,Physical Fatigue,Physical Fatigue
NEW04135,MENTAL_HEALTH,fatigue dimensions,fatigue dimensions
NEW04140,DISEASE,orofacial motor dysfunction,orofacial motor dysfunction
NEW04143,CHEMICAL,prolactin-serotonin-dopamine interactions,prolactin-serotonin-dopamine interactions
NEW04144,DISEASE,debilitating disorder,debilitating disorder
NEW04149,DISEASE,NAFLD therapy,NAFLD therapy
NEW04153,CHEMICAL,Glu levels,Glu levels
NEW04155,MENTAL_HEALTH,mild-to-moderate depression,mild-to-moderate depression
NEW04157,CHEMICAL,0·60,0·60
NEW04158,CHEMICAL,0·31,0·31
NEW04160,DISEASE,idiopathic male infertility,idiopathic male infertility
NEW04162,CHEMICAL,homocysteine plasma concentration,homocysteine plasma concentration
NEW04164,MENTAL_HEALTH,increased alcohol abuse,increased alcohol abuse
NEW04165,MENTAL_HEALTH,significant schizophrenia,significant schizophrenia
NEW04167,NUTRITION,methionine substitution,methionine substitution
NEW04169,DISEASE,fibrosis carcinoma,fibrosis carcinoma
D010625,CHEMICAL,Phenylethanolamine N-Methyltransferase,"Phenethanolamine N-Methyltransferase|Norepinephrine N Methyltransferase|noradrenalin|Phenylethanolamine N Methyltransferase|Noradrenaline N-Methyltransferase|Norepinephrine Methyltransferase|Noradrenalin N Methyltransferase|Phenethanolamine N Methyltransferase|Noradrenaline N Methyltransferase|Methyltransferase, Norepinephrine|Norepinephrine N-Methyltransferase|Noradrenalin N-Methyltransferase"
NEW04177,CHEMICAL,antioxidant glutathione,antioxidant glutathione
NEW04182,MENTAL_HEALTH,childhood ADHD,childhood ADHD
NEW04187,DISEASE,gut microbial dysbiosis,gut microbial dysbiosis
NEW04188,DISEASE,peripheral inflammation,peripheral inflammation
NEW04190,DISEASE,age-related decline cognitive function,age-related decline cognitive function
NEW04191,CHEMICAL,natural killer cell activity,natural killer cell activity|NKCA
NEW04192,CHEMICAL,taurochenodesoxycholic acid,taurochenodesoxycholic acid
NEW04193,CHEMICAL,L-acetylcarnitine,L-acetylcarnitine
D012695,CHEMICAL,L-Serine Dehydratase,"L Serine Dehydratase|Serine Dehydratase|Dehydratase, L-Serine|Deaminase, Serine|Dehydratase, Serine-Threonine|Serine-Threonine Dehydratase|L-Serine Ammonia-Lyase|L Serine Ammonia Lyase|Serine Deaminase|Ammonia-Lyase, L-Serine|Serine Threonine Dehydratase|Dehydratase, Serine|L-serine"
D007296,CHEMICAL,Myo-Inositol-1-Phosphate Synthase,"Cyclase, Inositol|Synthase, Inositol-1-Phosphate|Inositol 1 Phosphate Synthase|Myo Inositol 1 Phosphate Synthase|Inositol-1-Phosphate Synthase|Inositol Cyclase|Synthase, Myo-Inositol-1-Phosphate|Cycloaldolase|myo-inositol"
C018524,CHEMICAL,"N,N-dimethylarginine [Supplementary Concept]",Arginine/analogs  and  derivatives|asymmetric dimethylarginine
D001216,CHEMICAL,Asparagine,L-Asparagine|L-asparagine
C031570,CHEMICAL,2-hydroxybutyric acid [Supplementary Concept],2-hydroxybutyric acid|Hydroxybutyrates
D003404,CHEMICAL,Creatinine,"Salt, Creatinine Sulfate|creatinine|Krebiozen|Sulfate Salt, Creatinine|Creatinine Sulfate Salt"
C420324,CHEMICAL,nangibotide [Supplementary Concept],Oligopeptides|Rhodamines|Lauric Acids|dodecanoic acid
NEW04198,MENTAL_HEALTH,incident dementia,incident dementia
NEW04199,CHEMICAL,reactive oxygen species synthesis,reactive oxygen species synthesis
NEW04201,BIOCHEMICAL,nicotinamide adenine dinucleotide phosphate-oxidase,nicotinamide adenine dinucleotide phosphate-oxidase
NEW04202,CHEMICAL,oxide reactive oxygen species synthesis,oxide reactive oxygen species synthesis
NEW04203,DISEASE,memory motor coordination,memory motor coordination
NEW04206,DISEASE,stress-related behavioral deficits,stress-related behavioral deficits
NEW04208,MENTAL_HEALTH,greater anxiety,greater anxiety
NEW04209,MENTAL_HEALTH,chronic stress levels,chronic stress levels
NEW04210,DISEASE,systemic low-grade inflammation,systemic low-grade inflammation
NEW04212,CHEMICAL,fludrocortisone test,fludrocortisone test
NEW04213,MENTAL_HEALTH,essential relative resistance,essential relative resistance
NEW04216,MENTAL_HEALTH,disorder rats,disorder rats
NEW04219,BIOCHEMICAL,GR agonist group,GR agonist group
NEW04221,CHEMICAL,DA levels,DA levels
NEW04223,CHEMICAL,low-drug,low-drug
NEW04224,MENTAL_HEALTH,CIS-induced depression animal models,CIS-induced depression animal models
NEW04227,MENTAL_HEALTH,maximum resistance,maximum resistance
NEW04229,CHEMICAL,consecutive nucleotides,consecutive nucleotides
NEW04230,MENTAL_HEALTH,pain depression,pain depression
NEW04233,MENTAL_HEALTH,treatment-resistant suicidal depression,treatment-resistant suicidal depression
NEW04235,MENTAL_HEALTH,agitated depression,agitated depression
NEW04236,CHEMICAL,anti-depressant imipramine,anti-depressant imipramine
NEW04240,CHEMICAL,oxygen transfer,oxygen transfer
NEW04246,DISEASE,breast cells,breast cells
NEW04248,DISEASE,prostate cancer metastasis formation,prostate cancer metastasis formation
NEW04251,MENTAL_HEALTH,context-specific anxiety,context-specific anxiety
NEW04252,BIOCHEMICAL,drug cues,drug cues
NEW04255,MENTAL_HEALTH,Alzheimer disease neuropathology,Alzheimer disease neuropathology
NEW04258,CHEMICAL,β-blockade,β-blockade
NEW04261,MENTAL_HEALTH,extent cataplexy,extent cataplexy
NEW04265,CHEMICAL,anticholinesterase physostigmine,anticholinesterase physostigmine
NEW04267,CHEMICAL,antidepressant effects,antidepressant effects
D001281,DISEASE,Atrial Fibrillation,"Atrial Fibrillations|Atrial Fibrillation, Persistent|Atrial Fibrillation, Familial|Familial Atrial Fibrillations|Atrial Fibrillation, Paroxysmal|Atrial Fibrillations, Persistent|Fibrillations, Persistent Atrial|atrial fibrillation|Fibrillations, Atrial|Fibrillation, Atrial|Fibrillation, Auricular|Fibrillations, Paroxysmal Atrial|Fibrillation, Familial Atrial|Paroxysmal Atrial Fibrillations|Persistent Atrial Fibrillations|Fibrillations, Auricular|Fibrillation, Persistent Atrial|Familial Atrial Fibrillation|Fibrillation, Paroxysmal Atrial|Auricular Fibrillation|Persistent Atrial Fibrillation|Atrial Fibrillations, Paroxysmal|Auricular Fibrillations|Atrial Fibrillations, Familial|Paroxysmal Atrial Fibrillation|Fibrillations, Familial Atrial"
NEW04268,CHEMICAL,µatm CO2,µatm CO2
NEW04270,CHEMICAL,altered Cl(- flux,altered Cl(- flux
NEW04273,DISEASE,comorbid depressive symptoms,comorbid depressive symptoms
NEW04274,MENTAL_HEALTH,comorbid depression,comorbid depression
NEW04276,CHEMICAL,brain sex steroid receptors,brain sex steroid receptors
NEW04277,CHEMICAL,circulating sex steroid levels,circulating sex steroid levels
NEW04278,CHEMICAL,testosterone relative,testosterone relative
NEW04280,DISEASE,impaired cognition,impaired cognition
D001111,CHEMICAL,Arcuate Nucleus of Hypothalamus,"Arcuate Nucleus|ARC|Nucleus, Infundibular|Infundibular Nucleus|arcuate nucleus|Hypothalamus Arcuate Nucleus|Nucleus, Arcuate"
NEW04282,CHEMICAL,reduced cortisol levels,reduced cortisol levels
NEW04283,CHEMICAL,cortisol withdrawal,cortisol withdrawal
NEW04285,DISEASE,various chronic liver diseases,various chronic liver diseases
NEW04288,CHEMICAL,mg dydrogesterone tablets,mg dydrogesterone tablets
NEW04291,DISEASE,oestrogen/progesterone receptor positive breast cancer,oestrogen/progesterone receptor positive breast cancer
NEW04292,DISEASE,TG secretion,TG secretion
NEW04293,DISEASE,wrist fractures,wrist fractures
NEW04294,DISEASE,spine fractures,spine fractures
NEW04298,MENTAL_HEALTH,maternity blues,maternity blues
NEW04299,BIOCHEMICAL,rational drug development,rational drug development
NEW04301,CHEMICAL,noGS/noMS,noGS/noMS
NEW04302,CHEMICAL,lower serum 17-beta-oestradiol levels,lower serum 17-beta-oestradiol levels
NEW04304,DISEASE,sleep disturbance,sleep disturbance
NEW04307,BIOCHEMICAL,adrenal androgen status,adrenal androgen status
NEW04310,CHEMICAL,increased cortisol clearance,increased cortisol clearance
NEW04312,BIOCHEMICAL,oestrogen levels,oestrogen levels
NEW04315,DISEASE,human male sexual behaviour,human male sexual behaviour
NEW04317,BIOCHEMICAL,global endocrine dysregulation,global endocrine dysregulation
NEW04319,DISEASE,premenstrual syndrome-type symptoms,premenstrual syndrome-type symptoms
NEW04321,DISEASE,oestrogen receptor positive ER+ breast cancer,oestrogen receptor positive ER+ breast cancer
NEW04322,CHEMICAL,microg ethinylestradiol/3 drospirenone,microg ethinylestradiol/3 drospirenone
NEW04324,CHEMICAL,rapid testosterone suppression,rapid testosterone suppression
NEW04325,CHEMICAL,radioiodine,radioiodine
NEW04326,CHEMICAL,thionamides,thionamides
D018149,CHEMICAL,Glucose Intolerance,"Impaired Glucose Tolerance|Glucose Intolerances|Glucose Tolerance, Impaired|Tolerance, Impaired Glucose|Impaired Glucose Tolerances|impaired glucose tolerance|Glucose Tolerances, Impaired|Intolerance, Glucose|Tolerances, Impaired Glucose|Intolerances, Glucose"
D007752,DISEASE,"Obstetric Labor, Premature","Premature Labor|Preterm Labor|preterm labor|Labor, Preterm|Labor, Premature Obstetric|Labor, Premature|Premature Obstetric Labor"
NEW04329,DISEASE,inflammatory disorders,inflammatory disorders
D018358,DISEASE,Neuroendocrine Tumors,"Tumors, Neuroendocrine|Tumor, Neuroendocrine|Neuroendocrine Tumor|neuroendocrine tumors"
NEW04333,CHEMICAL,serum gastrin levels,serum gastrin levels
D000082742,DISEASE,Heart Disease Risk Factors,"Score, Cardiovascular Risk|Cardiovascular Risk Score|Cardiovascular Risk Factor|cardiovascular risk|Risk Factors for Cardiovascular Disease|Risk Factor, Cardiovascular|Residual Cardiovascular Risk|Risk, Cardiovascular|Cardiovascular Risk|Risk Score, Cardiovascular|Risk, Residual Cardiovascular|Cardiovascular Risk, Residual|Cardiovascular Risk Factors|Factor, Cardiovascular Risk|Cardiovascular Risk Scores|Residual Cardiovascular Risks|Cardiovascular Risks|Risk Factors for Heart Disease"
NEW04334,DISEASE,spinal cord demyelination,spinal cord demyelination
NEW04335,DISEASE,sensory-motor abnormalities,sensory-motor abnormalities
NEW04338,CHEMICAL,677CC genotype,677CC genotype
NEW04341,DISEASE,SCZ groups,SCZ groups
NEW04347,DISEASE,incident peripheral neuropathy,incident peripheral neuropathy
NEW04348,BIOCHEMICAL,parenteral vitamin B12 supplementation,parenteral vitamin B12 supplementation
NEW04353,MENTAL_HEALTH,Yale-Brown compulsion,Yale-Brown compulsion
NEW04354,CHEMICAL,higher homocysteine levels,higher homocysteine levels
NEW04356,CHEMICAL,certain amino acids,certain amino acids
NEW04357,CHEMICAL,phenylalanine hydroxylase enzyme,phenylalanine hydroxylase enzyme
NEW04361,DISEASE,offspring neuropsychiatric disorders,offspring neuropsychiatric disorders
NEW04362,MENTAL_HEALTH,offspring ADHD,offspring ADHD
NEW04363,NUTRITION,n-6/n-3 fatty acid ratio,n-6/n-3 fatty acid ratio
NEW04364,NUTRITION,serum saturated fatty acids,serum saturated fatty acids
NEW04365,CHEMICAL,inorganic phosphorous concentration,inorganic phosphorous concentration
NEW04366,MENTAL_HEALTH,winter seasonal affective disorder,winter seasonal affective disorder
NEW04368,DISEASE,impairment symptoms,impairment symptoms
NEW04370,MENTAL_HEALTH,diagnosed depression,diagnosed depression
NEW04371,BIOCHEMICAL,high-dosage folic acid,high-dosage folic acid
NEW04372,BIOCHEMICAL,low vitamin B12 status,low vitamin B12 status
NEW04374,CHEMICAL,working life/studies,working life/studies
NEW04375,CHEMICAL,acetaminophen overdose,acetaminophen overdose
NEW04379,MENTAL_HEALTH,major depression patients,major depression patients
NEW04380,DISEASE,diagnostic groups,DSM-III-R criteria|diagnostic groups
NEW04381,MENTAL_HEALTH,anxiety patients,anxiety patients
NEW04383,MENTAL_HEALTH,factor depression,factor depression
NEW04385,CHEMICAL,excessive caffeine consumption,excessive caffeine consumption
NEW04386,MENTAL_HEALTH,reactions gene expression,reactions gene expression
NEW04389,DISEASE,humans caffeinism,humans caffeinism
NEW04390,MENTAL_HEALTH,refractory psychosis,refractory psychosis
NEW04391,CHEMICAL,concomitant alcohol intake,concomitant alcohol intake
NEW04393,MENTAL_HEALTH,short-lasting hyperactivity,short-lasting hyperactivity
NEW04395,MENTAL_HEALTH,anxiety breaks,anxiety breaks
NEW04396,MENTAL_HEALTH,anxiety attacks,anxiety attacks
NEW04398,CHEMICAL,week alcohol problems,week alcohol problems
NEW04399,MENTAL_HEALTH,dependence risk,dependence risk
NEW04401,DISEASE,French psychiatric patients,French psychiatric patients
NEW04402,MENTAL_HEALTH,anxiety disturbance,anxiety disturbance
NEW04404,DISEASE,cardiovascular function,cardiovascular function
NEW04405,CHEMICAL,greater caffeine intake,greater caffeine intake
NEW04413,CHEMICAL,d-fenfluramine,d-fenfluramine
NEW04414,CHEMICAL,glucose levels,glucose levels
NEW04416,DISEASE,diabetes studies,diabetes studies
NEW04417,DISEASE,obesity treatment,obesity treatment
NEW04419,DISEASE,NAFLD/NASH,NAFLD/NASH
NEW04420,DISEASE,Cardiovascular Disease CVD morbidity,Cardiovascular Disease CVD morbidity
NEW04423,DISEASE,favorable psychiatric adverse event profiles,favorable psychiatric adverse event profiles
C570240,CHEMICAL,empagliflozin [Supplementary Concept],Benzhydryl Compounds|empagliflozin|Glucosides
NEW04427,DISEASE,loss potential,loss potential
NEW04428,DISEASE,MACE infarction events,MACE infarction events
NEW04429,CHEMICAL,once-weekly semaglutide,once-weekly semaglutide
NEW04430,DISEASE,stroke events,stroke events
NEW04431,DISEASE,cardiovascular deaths,cardiovascular deaths
NEW04439,CHEMICAL,ethanol neurotoxicity,ethanol neurotoxicity
NEW04440,BIOCHEMICAL,nutritional thiamine deficiency,nutritional thiamine deficiency
NEW04441,DISEASE,alcoholism-associated dysfunction,alcoholism-associated dysfunction
NEW04444,CHEMICAL,controlled alcohol consumption,controlled alcohol consumption
NEW04445,DISEASE,alcohol-related cognitive deficits,alcohol-related cognitive deficits
NEW04447,MENTAL_HEALTH,unrecognized schizophrenia,unrecognized schizophrenia
NEW04448,MENTAL_HEALTH,malnourishment due poisoning delusions,malnourishment due poisoning delusions
NEW04450,BIOCHEMICAL,vitamin deficit,vitamin deficit
D012202,DISEASE,Reye Syndrome,"Reye Syndrome, Adult|Reye-Johnson Syndrome|Fatty Liver with Encephalopathy|Adult Reye Syndrome|Reye's Like Syndrome|Reye Johnson Syndrome|Reye Like Syndrome|Reye's Syndrome|Adult Reye's Syndrome|Reye's Syndrome, Adult|Reye's syndrome|Reye-Like Syndrome|Reye's-Like Syndrome"
D015324,CHEMICAL,Pyruvate Carboxylase Deficiency Disease,"Ataxia with Lactic Acidosis II|Ataxia with Lactic Acidosis, Type II|Type II Ataxia with Lactic Acidosis|Lactic Acidosis with Ataxia, Type II|Pyruvate Carboxylase Deficiency|Ataxia with Lactic Acidosis 2|Deficiency, Pyruvate Carboxylase|pyruvate carboxylase deficiency|Deficiency Disease, Pyruvate Carboxylase"
NEW04454,BIOCHEMICAL,decreased beta hydroxybutyrate/acetoacetate ratio,decreased beta hydroxybutyrate/acetoacetate ratio
NEW04458,CHEMICAL,neuronal inositol triphosphate receptor,neuronal inositol triphosphate receptor
NEW04460,BIOCHEMICAL,vitamin deficiency syndromes,vitamin deficiency syndromes
D006778,DISEASE,"Hospitals, Psychiatric","Mental Institutions|Psychiatric Hospital|Institutions, Mental|Hospital, Psychiatric|Hospitals, Mental|Institution, Mental|Mental Hospital|Mental Institution|Psychiatric Hospitals|Mental Hospitals|psychiatric hospitals|Hospital, Mental"
D055677,DISEASE,Refeeding Syndrome,"Syndrome, Refeeding|refeeding syndrome"
D000308,DISEASE,Adrenocortical Hyperfunction,"Hyperadrenalism|Hypercorticism|Hyperfunction, Adrenal Gland|hypercorticism|Hyperfunction, Adrenocortical|Adrenal Gland Hyperfunction|Hyperadrenocorticism"
NEW04463,BIOCHEMICAL,hormone status,hormone status
NEW04465,BIOCHEMICAL,immediate vitamin replacement,immediate vitamin replacement
D007655,CHEMICAL,Ketoglutarate Dehydrogenase Complex,"Dehydrogenase, 2-Keto-4-Hydroxyglutarate|2-Oxoglutarate Dehydrogenase|Oxoglutarate Dehydrogenase|2 Keto 4 Hydroxyglutarate Dehydrogenase|2 Oxoglutarate Dehydrogenase|Dehydrogenase Complex, Ketoglutarate|Complex, alpha-Ketoglutarate Dehydrogenase|Dehydrogenase Complex, 2-Oxoglutarate|2-Keto-4-Hydroxyglutarate Dehydrogenase|alpha-Ketoglutarate Dehydrogenase Complex|2-Oxoglutarate Dehydrogenase Complex|Dehydrogenase Complex, alpha-Ketoglutarate|Dehydrogenase, Oxoglutarate|alpha-Ketoglutarate Dehydrogenase|Complex, 2-Oxoglutarate Dehydrogenase|Complex, Ketoglutarate Dehydrogenase|alpha Ketoglutarate Dehydrogenase Complex|Dehydrogenase, alpha-Ketoglutarate|Dehydrogenase, 2-Oxoglutarate|ketoglutarate dehydrogenase|2 Oxoglutarate Dehydrogenase Complex|alpha Ketoglutarate Dehydrogenase"
D030481,CHEMICAL,Pyruvate Dehydrogenase (Lipoamide),Pyruvate Dehydrogenase-E1|Pyruvate Decarboxylase (Lipoamide)|Pyruvate Dehydrogenase E1|Pyruvate Dehydrogenase Component E1|pyruvate dehydrogenase
NEW04469,DISEASE,overt neuronal impairment,overt neuronal impairment
NEW04471,CHEMICAL,acetyl-CoA/acetylcholine metabolism,acetyl-CoA/acetylcholine metabolism
NEW04473,CHEMICAL,non-harmful border-line Zn excitotoxic signals,non-harmful border-line Zn excitotoxic signals
NEW04476,DISEASE,NMDAR-dependent long-term depression,NMDAR-dependent long-term depression|LTD
NEW04477,MENTAL_HEALTH,mGluR-dependent long-term depression,mGluR-dependent long-term depression
NEW04478,DISEASE,specific deficiency syndrome,specific deficiency syndrome
D005348,DISEASE,Fibrocystic Breast Disease,"fibrocystic breast disease|Fibrocystic Changes of Breast|Adenosis, Microglandular|Cystic Breast Disease|Breast Disease, Fibrocystic|Breast Fibrocystic Changes|Fibrocystic Mastopathy|Cystic Mastitis, Chronic|Breast Cystic Diseases|Microglandular Adenoses|Breast Fibrocystic Disease|Breast Fibrocystic Change|Microglandular Adenosis|Adenoses, Microglandular|Breast Adenosis|Breast Dysplasia|Dysplasia, Breast|Breast Disease, Cystic|Disease, Cystic Breast|Disease, Fibrocystic Breast|Fibrocystic Disease of Breast|Dysplasia, Mammary|Chronic Cystic Mastitis|Adenosis of Breast|Cystic Disease of Breast|Mastopathy, Fibrocystic|Breast Cystic Disease|Mammary Dysplasia"
NEW04480,DISEASE,behavior abnormalities,behavior abnormalities
NEW04481,NUTRITION,pantothenic acid antagonist,pantothenic acid antagonist
NEW04485,DISEASE,feeding weight gain,feeding weight gain
NEW04486,MENTAL_HEALTH,pediatric depression,pediatric depression
NEW04487,MENTAL_HEALTH,multiple different anxiety disorders,multiple different anxiety disorders
NEW04489,CHEMICAL,noradrenaline nervous system,noradrenaline nervous system
NEW04492,DISEASE,vivid psychotic,vivid psychotic
NEW04493,MENTAL_HEALTH,cataplexy production,cataplexy production
NEW04494,DISEASE,neuropsychiatric diseases,neuropsychiatric diseases
NEW04496,CHEMICAL,surprising NMDA receptor downregulation,surprising NMDA receptor downregulation
NEW04502,MENTAL_HEALTH,seasonal winter depression,seasonal winter depression
NEW04503,CHEMICAL,escitalopram mg,escitalopram mg
NEW04508,MENTAL_HEALTH,instance sexual dysfunction,instance sexual dysfunction
D000083302,DISEASE,Hemorrhagic Stroke,"Subarachnoid Hemorrhagic Strokes|Intracerebral Hemorrhagic Strokes|Hemorrhagic Strokes|Hemorrhage Stroke, Intracerebral|Stroke, Intracerebral Hemorrhage|hemorrhagic stroke|Stroke, Subarachnoid Hemorrhagic|Intracerebral Hemorrhagic Stroke|Hemorrhagic Stroke, Intracerebral|Intracerebral Hemorrhage Strokes|Subarachnoid Hemorrhagic Stroke|Stroke, Intracerebral Hemorrhagic|Hemorrhagic Stroke, Subarachnoid|Stroke, Hemorrhagic|Intracerebral Hemorrhage Stroke"
D006475,DISEASE,Vitamin K Deficiency Bleeding,bleeding|Hemorrhagic Disease of Newborn|Newborn Hemorrhagic Diseases|Newborn Hemorrhagic Disease
NEW04514,CHEMICAL,carbamazapine,carbamazapine
NEW04517,CHEMICAL,SSRIs paroxetine,SSRIs paroxetine
NEW04518,DISEASE,OCD similar efficacy,OCD similar efficacy
NEW04525,DISEASE,status cataplecticus,status cataplecticus
NEW04526,MENTAL_HEALTH,cataplexy attacks due,cataplexy attacks due
NEW04529,DISEASE,MP misuse,MP misuse
NEW04531,CHEMICAL,higher platelet 5-HT content,higher platelet 5-HT content
NEW04534,DISEASE,behavioral dysfunctions,behavioral dysfunctions
NEW04536,DISEASE,multiple depressive phenotypes,multiple depressive phenotypes
NEW04538,MENTAL_HEALTH,various phobias,various phobias
NEW04539,MENTAL_HEALTH,central nervous system affective disorders,central nervous system affective disorders
NEW04542,DISEASE,refractory PE,refractory PE
NEW04546,MENTAL_HEALTH,comorbid unipolar depression,comorbid unipolar depression
NEW04549,MENTAL_HEALTH,pediatric anxiety,pediatric anxiety
NEW04551,CHEMICAL,Syst Rev 2:CD001396,Syst Rev 2:CD001396
C536595,MENTAL_HEALTH,Alzheimer disease type 2 [Supplementary Concept],Alzheimer Disease|late-onset Alzheimer disease
D053661,CHEMICAL,Interleukin-13 Receptor alpha1 Subunit,"Interleukin 13 Receptor alpha1 Chain|Antigens, CD213a1|Interleukin 13 Receptor alpha1 Subunit|IL-13Ralpha1|CD213a1 Antigens|Interleukin 4, 13 Receptor Shared Subunit|Interleukin-4, 13 Receptor Shared Subunit|Antigen, CD213a1|CD213a1 Antigen|Interleukin-13 Receptor alpha1 Chain|α1"
NEW04554,MENTAL_HEALTH,anxiety disorders related,anxiety disorders related
NEW04555,CHEMICAL,catecholamine secretion,catecholamine secretion
NEW04558,DISEASE,chronic PCP,chronic PCP
NEW04559,DISEASE,excessive weight gain,excessive weight gain
NEW04560,CHEMICAL,antidepressant effectiveness,antidepressant effectiveness
NEW04561,CHEMICAL,JZL184 MAGL inhibitor,JZL184 MAGL inhibitor
NEW04564,DISEASE,mild hypokinesia,mild hypokinesia
NEW04565,DISEASE,juvenile hypertensive rats,juvenile hypertensive rats
NEW04567,CHEMICAL,catecholamine determinations,catecholamine determinations
D060545,DISEASE,Pudendal Neuralgia,"Entrapment, Pudendal Nerve|Entrapments, Pudendal Nerve|Pudendal Neuropathy|Neuralgias, Pudendal|Nerve Entrapment, Pudendal|Nerve Entrapments, Pudendal|Pudendal Nerve Entrapments|Pudendal Canal Entrapment Syndrome|Pudendal Neuropathies|Pudendal Neuralgias|Pudendal Nerve Entrapment|Neuropathy, Pudendal|Neuralgia, Pudendal|Neuropathies, Pudendal|Pudendal Nerve Entrapment Syndrome|neuralgia"
NEW04571,MENTAL_HEALTH,autism spectrum disorder diagnosis,autism spectrum disorder diagnosis
NEW04572,DISEASE,autism-like traits,autism-like traits
NEW04574,BIOCHEMICAL,thyroid hormone elevation,thyroid hormone elevation
NEW04581,NUTRITION,lithium controls,lithium controls
NEW04583,CHEMICAL,ammonia load,ammonia load
NEW04588,MENTAL_HEALTH,Eating Disorder Inventory-2,Eating Disorder Inventory-2
NEW04593,BIOCHEMICAL,synthetic T4 hormone,synthetic T4 hormone
NEW04595,DISEASE,thyroid gland disorder,thyroid gland disorder
NEW04596,CHEMICAL,inactive triiodothyronine,inactive triiodothyronine
NEW04598,DISEASE,hyperthyreosis,hyperthyreosis
NEW04599,CHEMICAL,normal anti-TPO,normal anti-TPO
NEW04600,DISEASE,medullar carcinoma,medullar carcinoma
C101203,DISEASE,IQ motif containing GTPase activating protein 1 [Supplementary Concept],IQ|ras GTPase-Activating Proteins
NEW04603,BIOCHEMICAL,fetal endocrine disruption,fetal endocrine disruption
NEW04605,DISEASE,manic phases,manic phases
NEW04608,DISEASE,various neurological dysfunctions,various neurological dysfunctions
D000077403,CHEMICAL,Orlistat,Tetrahydrolipstatin|Tetrahydrolipastatin|THLP|Alli|Xenical|1-((3-Hexyl-4-oxo-2-oxetanyl)methyl)dodecyl-2-formamido-4-methylvalerate|Ro-18-0647|Ro 18 0647|orlistat
D019987,DISEASE,Visually Impaired Persons,"Impaired Person, Visually|Blind Person|Impaired Persons, Visually|Persons, Blind|Visually Impaired Person|Blind Persons|Persons, Visually Impaired|impaired|Person, Blind|Person, Visually Impaired"
NEW04611,CHEMICAL,overweight glucose tolerance,overweight glucose tolerance
NEW04612,DISEASE,prediabetic overweight/obese schizophrenia-spectrum disorder patients,prediabetic overweight/obese schizophrenia-spectrum disorder patients
NEW04613,DISEASE,glucometabolic disturbances,glucometabolic disturbances
NEW04616,DISEASE,cardiovascular injury,cardiovascular injury
NEW04618,DISEASE,prevalent multi-factorial functional bowel disorder,prevalent multi-factorial functional bowel disorder
D005769,DISEASE,Gastrointestinal Motility,"Intestinal Motilities|Motility, Intestinal|Motility, Gastrointestinal|gastrointestinal motility|Motilities, Gastrointestinal|Gastrointestinal Motilities|Motilities, Intestinal|Intestinal Motility"
C027576,CHEMICAL,4-hydroxy-2-nonenal [Supplementary Concept],4-HNE|Aldehydes
NEW04621,CHEMICAL,4-hydroxynonenal marker,4-hydroxynonenal marker
NEW04622,BIOCHEMICAL,glucagon-like peptide-1 receptor agonist,glucagon-like peptide-1 receptor agonist
NEW04623,DISEASE,T2DM rats,T2DM rats
NEW04625,DISEASE,olanzapine-induced weight gain,olanzapine-induced weight gain
NEW04627,DISEASE,antipsychotic drug-induced weight gain,antipsychotic drug-induced weight gain
NEW04628,MENTAL_HEALTH,first-episode schizophrenia patients,first-episode schizophrenia patients
NEW04631,MENTAL_HEALTH,similar depression remission rates,similar depression remission rates
NEW04633,MENTAL_HEALTH,Depression Inventory,Depression Inventory
NEW04636,CHEMICAL,IFN-alpha therapy,IFN-alpha therapy
NEW04637,BIOCHEMICAL,selective serotonin reuptake inhibitor agent,selective serotonin reuptake inhibitor agent
NEW04638,MENTAL_HEALTH,treatment resistance,treatment resistance
NEW04639,MENTAL_HEALTH,Depression Rating Scale,Depression Rating Scale
NEW04644,CHEMICAL,SRI treatment response,SRI treatment response
NEW04646,DISEASE,OCD refractory,OCD refractory
D012565,DISEASE,Schizophrenic Psychology,"Psychology, Schizophrenic|schizophrenic"
NEW04647,CHEMICAL,inhibitor antidepressants,inhibitor antidepressants
NEW04650,CHEMICAL,threat-elicited negative emotions,threat-elicited negative emotions
NEW04651,CHEMICAL,amygdala serotonin transporter,amygdala serotonin transporter
NEW04653,MENTAL_HEALTH,maternal mental illness,maternal mental illness
NEW04654,MENTAL_HEALTH,numerous affective disorders,numerous affective disorders
NEW04656,DISEASE,cerebellar symptoms,cerebellar symptoms
D019462,DISEASE,"Syncope, Vasovagal","Faint, Neurally Mediated|Syncope, Cerebral|Syncopes, Neurocardiogenic|Syncopes, Malignant Neurocardiogenic|Syncopes, Vasovagal|Neurocardiogenic Syncope|Neurocardiogenic Syncope, Malignant|Neurocardiogenic Syncopes, Malignant|Vasovagal Syncopes|Supine Syncope|Syncopes, Vasodepressor|Supine Syncopes|Neurogenic Syncope|Neurally Mediated Faints|Syncope, Neurocardiogenic|Neurally Mediated Faint|Vasodepressor Syncopes|Neurocardiogenic Syncopes|Malignant Neurocardiogenic Syncope|Vasodepressor Syncope|Syncope, Supine|Syncope, Neurogenic|Cerebral Syncopes|Syncope, Vasodepressor|Neurogenic Syncopes|Syncope, Malignant Neurocardiogenic|Cerebral Syncope|Syncope, Vasovagal, Neurally-Mediated|Syncopes, Supine|Syncopes, Cerebral|Syncopes, Neurogenic|Vasovagal Syncope|Malignant Neurocardiogenic Syncopes|syncope|Faints, Neurally Mediated"
NEW04659,CHEMICAL,relative glucose metabolism,relative glucose metabolism
NEW04661,BIOCHEMICAL,selective inhibitor SSRI treatment,selective inhibitor SSRI treatment
D001930,DISEASE,Brain Injuries,"Focal Brain Injury|Injuries, Acute Brain|Brain Injuries, Acute|brain injuries|Brain Injuries, Focal|Injuries, Focal Brain|Acute Brain Injuries|Injury, Brain|Injury, Acute Brain|Injury, Focal Brain|Brain Lacerations|Brain Laceration|Laceration, Brain|Injuries, Brain|Brain Injury, Acute|Lacerations, Brain|Brain Injury, Focal|Focal Brain Injuries|Brain Injury|Acute Brain Injury"
NEW04662,DISEASE,impulsive aggressive behavior,impulsive aggressive behavior
NEW04664,CHEMICAL,simultaneous BZD initiation,simultaneous BZD initiation
NEW04665,CHEMICAL,BZD treatment,BZD treatment
NEW04670,DISEASE,SSRI-refractory patients,SSRI-refractory patients
D011790,CHEMICAL,Quarantine,"Lockdowns, Health|Health Lockdowns|quarantine|Stay at Home Orders|Lockdown, Health|Self Quarantine|Quarantines|Health Lockdown|Cordon Sanitaire|Self-Quarantine"
NEW04681,DISEASE,sublethal neuronal damage,sublethal neuronal damage
NEW04683,DISEASE,dexamethasone-associated neuronal damage,dexamethasone-associated neuronal damage
NEW04684,CHEMICAL,chronic antidepressant medication,chronic antidepressant medication
NEW04686,DISEASE,PMS/PMDD,PMS/PMDD
NEW04688,DISEASE,Alzheimer's Disease Study-2,Alzheimer's Disease Study-2
NEW04690,DISEASE,levodopa-induced dyskinesias,levodopa-induced dyskinesias
D051437,DISEASE,Renal Insufficiency,"Kidney Failure|Failure, Kidney|Failure, Renal|Failures, Renal|Kidney Insufficiencies|Renal Failures|Insufficiency, Kidney|Renal Failure|Failures, Kidney|Kidney Failures|Kidney Insufficiency|renal insufficiency|Renal Insufficiencies"
NEW04693,CHEMICAL,anti-NMDA receptor antibodies,anti-NMDA receptor antibodies
NEW04695,BIOCHEMICAL,direct antiviral therapy,direct antiviral therapy
NEW04700,CHEMICAL,serotonin synthesizing enzyme,serotonin synthesizing enzyme
D018340,NUTRITION,"Receptors, Adrenergic, alpha-1","Adrenergic alpha 1A Receptors|Receptors, Adrenergic alpha-1A|alpha 1a|Adrenergic Receptors, alpha-1|alpha-1B Adrenergic Receptor|Receptor, Adrenergic, alpha-1A|Adrenergic Receptor, alpha-1A|Adrenergic alpha-1D Receptors|alpha 1 Adrenergic Receptors|Adrenergic Receptor, alpha-1C|Receptors, Adrenergic alpha-1B|Receptor, Adrenergic, alpha-1|Receptors, Adrenergic, alpha-1A|Adrenergic Receptor, alpha-1B|Adrenergic alpha 1 Receptors|Receptor, Adrenergic, alpha-1D|Adrenergic Receptor, alpha 1|Receptor, alpha-1 Adrenergic|alpha-1D Adrenergic Receptor|Adrenergic alpha-1A Receptors|alpha 1B Adrenergic Receptor|Adrenergic alpha-1 Receptors|Adrenergic alpha-1B Receptors|alpha-1 Receptors, Adrenergic|alpha-1D Receptors, Adrenergic|alpha-1A Receptors, Adrenergic|Receptor, alpha-1B Adrenergic|Adrenergic alpha 1D Receptors|Receptors, Adrenergic, alpha-1B|alpha 1C Adrenergic Receptor|Receptors, Adrenergic alpha-1|Adrenergic Receptor, alpha-1D|Receptors, alpha-1 Adrenergic|alpha 1 Adrenergic Receptor|alpha 1A Adrenergic Receptor|alpha 1D Adrenergic Receptor|Receptor, alpha-1C Adrenergic|alpha-1B Receptors, Adrenergic|alpha-1 Adrenergic Receptor|alpha-1A Adrenergic Receptor|alpha-1C Adrenergic Receptor|Receptor, Adrenergic, alpha-1B|Receptor, alpha-1D Adrenergic|Receptors, Adrenergic alpha-1D|Receptor, alpha-1A Adrenergic|Adrenergic Receptor, alpha-1|alpha-1 Adrenergic Receptors|Receptors, alpha 1 Adrenergic|Adrenergic alpha 1B Receptors|Receptors, Adrenergic, alpha-1D"
NEW04702,CHEMICAL,chronic binge-pattern alcohol consumption,chronic binge-pattern alcohol consumption
D014576,CHEMICAL,Uroporphyrinogen III Synthetase,"Synthetase, Uroporphyrinogen III|Uroporphyrinogen III Cosynthetase|Isomerase, Uroporphyrinogen|Cosynthetase, Uroporphyrinogen III|Uroporphyrinogen III Synthase|Uroporphyrinogen-III Synthase|uroporphyrinogen|Cosynthase|Uroporphyrinogen Isomerase|Synthase, Uroporphyrinogen-III"
NEW04705,CHEMICAL,hydrogen peroxide-dependent oxidation,hydrogen peroxide-dependent oxidation
D008862,DISEASE,"Microsomes, Liver","Microsome, Liver|Liver Microsome|Liver Microsomes|liver microsomes"
NEW04707,CHEMICAL,DES treatment,DES treatment
NEW04709,NUTRITION,calcium disodium ethylenediaminetetraacetic acid,calcium disodium ethylenediaminetetraacetic acid
D004112,CHEMICAL,Dimercaprol,"Anti-Lewisite Agent, British|2,3-Dimercaptopropanol, Cadmium|2,3 Dithiopropan 1 o1|British Anti Lewisite Agent|British Anti-Lewisite Agent|Anti-Lewisite, British|B.A.L.|BAL in Oil|British Anti-Lewisite|Cadmium 2,3 Dimercaptopropanol|Dicaptol|2,3 Dimercaptopropanol|Cadmium 2,3-Dimercaptopropanol|British Anti Lewisite|dimercaprol|2,3-Dimercaptopropanol|Oil, BAL in|in Oil, BAL|2,3-Dithiopropan-1-o1"
NEW04710,CHEMICAL,higher-dose ESA,higher-dose ESA
NEW04713,DISEASE,depressed type,depressed type
C493250,CHEMICAL,1-(((alpha-isobutanoyloxyethoxy)carbonyl)aminomethyl)-1-cyclohexaneacetic acid [Supplementary Concept],Carbamates|gabapentin enacarbil|gamma-Aminobutyric Acid/analogs  and  derivatives
NEW04716,DISEASE,impaired balance,impaired balance
NEW04718,CHEMICAL,dopamine similar,dopamine similar
NEW04719,CHEMICAL,myopic shifts,myopic shifts
D047728,DISEASE,"Myopia, Degenerative","Myopias, Pathological|Myopias, Progressive|Progressive Myopias|Progressive Myopia|myopia|Degenerative Myopias|Pathological Myopias|Pathological Myopia|Degenerative Myopia|Myopia, Progressive|Myopias, Degenerative|Myopia, Pathological"
NEW04720,DISEASE,unipolar depressed patients,unipolar depressed patients
NEW04721,MENTAL_HEALTH,double controlled bipolar depression treatment studies,double controlled bipolar depression treatment studies
D065768,DISEASE,Lennox Gastaut Syndrome,Lennox Gastaut Syndromes|Lennox-Gastaut Syndrome|Lennox-Gastaut syndrome
NEW04724,DISEASE,refractory absence seizures,refractory absence seizures
NEW04726,MENTAL_HEALTH,methylphenidate-induced hyperactivity,methylphenidate-induced hyperactivity
NEW04731,DISEASE,Porsolt hypophagia,Porsolt hypophagia
NEW04732,BIOCHEMICAL,muscle relaxant effect,muscle relaxant effect|drug discrimination
NEW04735,DISEASE,substance abuse disorders,substance abuse disorders|SUD
NEW04737,DISEASE,sporadic ALS,sporadic ALS
NEW04740,MENTAL_HEALTH,hypothalamic-pituitary-adrenal axis hyperactivity,hypothalamic-pituitary-adrenal axis hyperactivity
NEW04741,BIOCHEMICAL,corticotrophin-releasing hormone (CRH)-expressing neurons,corticotrophin-releasing hormone (CRH)-expressing neurons
NEW04742,DISEASE,cognitive flexibility,cognitive flexibility
NEW04745,DISEASE,stress-induced cognitive inflexibility,stress-induced cognitive inflexibility
NEW04746,DISEASE,ataxic effects,ataxic effects
NEW04747,BIOCHEMICAL,prototypical NMDAR antagonist MK-801,prototypical NMDAR antagonist MK-801
NEW04748,DISEASE,sedation/hypnosis,sedation/hypnosis
NEW04749,DISEASE,ethanol-induced ataxia,ethanol-induced ataxia
NEW04750,DISEASE,ethanol-induced sedation/hypnosis,ethanol-induced sedation/hypnosis
NEW04751,MENTAL_HEALTH,chronic stress exposure,chronic stress exposure
NEW04753,CHEMICAL,ethanol withdrawal symptoms,ethanol withdrawal symptoms
NEW04759,CHEMICAL,NMDAr-dependent mechanisms,NMDAr-dependent mechanisms
NEW04761,CHEMICAL,glutamate burst,glutamate burst
NEW04766,DISEASE,stress-induced depression-like behaviors,stress-induced depression-like behaviors
NEW04768,DISEASE,pronounced neuroinflammation,pronounced neuroinflammation
NEW04769,DISEASE,peripheral infections,peripheral infections
NEW04770,MENTAL_HEALTH,e.g. delirium,e.g. delirium
NEW04774,DISEASE,gastrointestinal complaints,gastrointestinal complaints
NEW04777,DISEASE,fibrosis progression,fibrosis progression
NEW04780,DISEASE,hepatic impairment,hepatic impairment
NEW04781,CHEMICAL,reversible monoamine oxidase type A inhibitor brofaromine,reversible monoamine oxidase type A inhibitor brofaromine
C038213,CHEMICAL,brofaromine [Supplementary Concept],Piperidines|brofaromine
NEW04784,MENTAL_HEALTH,alcohol craving relative,alcohol craving relative
C565506,MENTAL_HEALTH,"Muscular Dystrophy, Congenital, associated with Calf Hypertrophy, Microcephaly, and Severe Mental Retardation [Supplementary Concept]","Intellectual Disability|Muscle, Skeletal/abnormalities|Microcephaly|Muscular Dystrophies|severe mental retardation"
NEW04788,DISEASE,autism-like neurobehavioral defects,autism-like neurobehavioral defects
NEW04791,BIOCHEMICAL,high H3R antagonist affinity,high H3R antagonist affinity
NEW04792,DISEASE,repetitive compulsive behaviors,repetitive compulsive behaviors
NEW04794,DISEASE,anxiety depressive states,anxiety depressive states
NEW04795,DISEASE,cocaine-induced anxiety-like behaviors,cocaine-induced anxiety-like behaviors
D000700,BIOCHEMICAL,Analgesics,"Analgesic Agents|Drugs, Analgesic|Analgesic Drugs|Agents, Analgesic|analgesic drugs|Anodynes|Agents, Antinociceptive|Antinociceptive Agents|Analgesic"
NEW04800,CHEMICAL,γ-aminobutyric acid GABA dysregulation,γ-aminobutyric acid GABA dysregulation
D058788,CHEMICAL,GABA-B Receptor Antagonists,"GABA B Antagonists|GABA-B Receptor Antagonist|GABA-B Antagonists|GABA B Receptor Antagonist|Receptor Antagonist, GABA-B|GABA B Receptor Antagonists|Antagonist, GABA-B Receptor|Antagonists, GABA-B Receptor|Antagonists, GABA-B|GABA-B|Receptor Antagonists, GABA-B"
NEW04803,MENTAL_HEALTH,mood disorder aetiology,mood disorder aetiology
NEW04805,CHEMICAL,nicotine withdrawal syndrome,nicotine withdrawal syndrome
NEW04808,DISEASE,adult neurogenesis,adult neurogenesis
NEW04819,DISEASE,skin hyperpigmentation disorders,skin hyperpigmentation disorders
NEW04829,CHEMICAL,5-HT2 receptor blockade,5-HT2 receptor blockade
NEW04830,CHEMICAL,dopamine D2 partial agonism,dopamine D2 partial agonism
NEW04831,CHEMICAL,serotonin 5-HT1A agonism,serotonin 5-HT1A agonism
D006349,DISEASE,Heart Valve Diseases,"Heart Valvular Disease|Disease, Heart Valvular|Heart Valvular Diseases|Valve Disease, Heart|Valvular Heart Diseases|Heart Valve Disease|valvular heart disease|Valvular Heart Disease|Valvular Disease, Heart|Heart Disease, Valvular"
NEW04833,CHEMICAL,H(2)-histamine antagonists,H(2)-histamine antagonists
NEW04834,DISEASE,system reactions,system reactions
NEW04836,DISEASE,brown bowel syndrome,brown bowel syndrome
D005943,CHEMICAL,Gluconeogenesis,gluconeogenesis
NEW04841,DISEASE,intestinal lipid malabsorption,intestinal lipid malabsorption
NEW04842,DISEASE,severe hypobetalipoproteinemia,severe hypobetalipoproteinemia
NEW04846,DISEASE,TBI females,TBI females
NEW04847,CHEMICAL,DA metabolisms,DA metabolisms
NEW04848,MENTAL_HEALTH,first episode untreated schizophrenia,first episode untreated schizophrenia
NEW04851,MENTAL_HEALTH,anxiety modulation,anxiety modulation
NEW04853,BIOCHEMICAL,ovarian sex hormones,ovarian sex hormones
C485949,DISEASE,"Mass1 protein, mouse [Supplementary Concept]","Receptors, G-Protein-Coupled|seizure susceptibility"
NEW04854,DISEASE,sex-specific pain hypersensitivity,sex-specific pain hypersensitivity
NEW04856,DISEASE,diabetic vascular neuropathy,diabetic vascular neuropathy
D018384,DISEASE,Oxidative Stress,"Oxidative Stress Injuries|DNA Damage, Oxidative|Stress, Nitro-Oxidative|Stress, Oxidative|Stress, Oxidative Nitrative|Oxidative DNA Damages|Oxidative Injury|Oxidative Stress Injury|Cleavage, Oxidative|Damage, DNA Oxidative|Oxidative Damage|Antioxidative Stress|Injury, Oxidative Stress|Nitro Oxidative Stress|Nitro-Oxidative Stress|Stresses, Nitro-Oxidative|Anti-oxidative Stresses|Oxidative Cleavages|Oxidative Nitrative Stress|Stress Injury, Oxidative|Oxidative Stresses|Oxidative DNA Damage|Oxidative Damage, DNA|Stress, Anti-oxidative|Oxidative Cleavage|Stress, Antioxidative|Oxidative Injuries|Damage, Oxidative DNA|Oxidative Nitrative Stresses|Anti oxidative Stress|Oxidative and Nitrosative Stress|Anti-oxidative Stress|DNA Oxidative Damage|DNA Oxidative Damages|Antioxidative Stresses|Damage, Oxidative|Nitro-Oxidative Stresses|Nitrative Stress, Oxidative|oxidative stress injury|Oxidative Damages|Injury, Oxidative"
NEW04857,CHEMICAL,abnormal zinc metabolism,abnormal zinc metabolism
NEW04860,DISEASE,tumour burden,tumour burden
NEW04861,DISEASE,non-advanced tumours,non-advanced tumours
NEW04862,DISEASE,cirrhotic HCC,cirrhotic HCC
NEW04863,DISEASE,extinction recall,extinction recall
NEW04867,DISEASE,vaginal lubrication,vaginal lubrication
NEW04872,DISEASE,paw edema,paw edema
NEW04873,DISEASE,inflammation-induced thermal hyperalgesia,inflammation-induced thermal hyperalgesia
NEW04877,MENTAL_HEALTH,nitrogen chronic stress conditions,nitrogen chronic stress conditions
NEW04878,DISEASE,crispa W. Deane,crispa W. Deane
NEW04879,CHEMICAL,HFHC-diet protein,HFHC-diet protein
NEW04882,CHEMICAL,H. sabdariffa L.,H. sabdariffa L.
NEW04884,DISEASE,atherosclerosis chemopreventive agents,atherosclerosis chemopreventive agents
NEW04886,DISEASE,STZ-induced SDAT,STZ-induced SDAT
NEW04889,DISEASE,DFP-induced bradycardia,DFP-induced bradycardia
NEW04890,DISEASE,DFP-induced hypothermia,DFP-induced hypothermia
NEW04893,DISEASE,DFP-induced hyperthermia,DFP-induced hyperthermia
NEW04896,CHEMICAL,oxytocine,oxytocine
NEW04897,BIOCHEMICAL,beta blocker,beta blocker
NEW04898,DISEASE,clozapine-induced tachycardia,clozapine-induced tachycardia
NEW04899,CHEMICAL,catecholamine dysfunction,catecholamine dysfunction
D047368,DISEASE,Tumor Burden,"Weights, Tumor|Volume, Tumor|Tumor Load|Tumor Volume|Tumor Weights|Burden, Tumor|Load, Tumor|Weight, Tumor|Loads, Tumor|Tumor Weight|Tumor Loads|tumor burden"
D053609,DISEASE,Lethargy,lethargy|Sleep Stages (1977-2006)
NEW04905,NUTRITION,alpha adrenoceptor,alpha adrenoceptor
D065346,CHEMICAL,Lubricant Eye Drops,"Eye Drop, Lubricant|Drops, Lubricant Eye|Lubricating Eye Drops|Eye Drops, Lubricant|Drops, Lubricating Eye|eye-drops|Lubricating Eye Drop|Lubricant Eye Drop|Drop, Lubricant Eye|Tears, Artificial|Eye Drops, Lubricating|Drop, Lubricating Eye|Artificial Tear|Tear, Artificial|Artificial Tears|Eye Drop, Lubricating"
D059246,DISEASE,Tachypnea,tachypnea|Tachypneas
D015878,DISEASE,Mydriasis,mydriasis|Pupil (1967-1989)
C566014,DISEASE,Undritz Anomaly [Supplementary Concept],Leukocyte Disorders|hypersegmentation
NEW04913,DISEASE,mild thrombocytopenia,mild thrombocytopenia
NEW04916,DISEASE,neuropsychiatric illnesses,neuropsychiatric illnesses
NEW04918,DISEASE,hypertensive response,hypertensive response
NEW04922,BIOCHEMICAL,ischemic toxins,ischemic toxins
NEW04928,DISEASE,hand movements,hand movements
NEW04929,DISEASE,clumsiness,clumsiness
NEW04930,BIOCHEMICAL,known carcinogens,known carcinogens
D017096,DISEASE,Prion Diseases,"Encephalopathy, Transmissible Spongiform|Prion Induced Disorder|Transmissible Dementias|Inherited Human Transmissible Spongiform Encephalopathies|Spongiform Encephalopathy, Transmissible|Dementias, Transmissible|Human Transmissible Spongiform Encephalopathies, Inherited|Prion-Induced Disorders|transmissible spongiform encephalopathies|Disorder, Prion-Induced|Prion-Associated Disorders|Spongiform Encephalopathies, Transmissible|Prion Protein Diseases|Prion Disease|Dementia, Transmissible|Transmissible Dementia|Prion Protein Disease|Prion-Induced Disorder|Encephalopathies, Transmissible Spongiform|Transmissible Spongiform Encephalopathies|Encephalopathies, Spongiform, Transmissible|Transmissible Spongiform Encephalopathy|Disorders, Prion-Induced"
NEW04931,CHEMICAL,CJres,CJres
NEW04934,DISEASE,neurological dysfunction due,neurological dysfunction due
NEW04935,DISEASE,chronic psycho-environmental stress,chronic psycho-environmental stress
C536653,DISEASE,Penttinen-Aula syndrome [Supplementary Concept],"Acro-Osteolysis|Progeria|Limb Deformities, Congenital|premature aging"
NEW04937,CHEMICAL,psychiatric CNTDs,psychiatric CNTDs
NEW04939,CHEMICAL,chronic cortisol exposure,chronic cortisol exposure
NEW04940,DISEASE,psychiatric drug investigators,psychiatric drug investigators
NEW04941,NUTRITION,our's sample lithium,our's sample lithium
NEW04942,MENTAL_HEALTH,associated organic brain syndromes,associated organic brain syndromes
NEW04945,CHEMICAL,depot antipsychotic drug,depot antipsychotic drug
D010076,CHEMICAL,Oxazepam,oxazepam|Adumbran|Tazepam|Serax
NEW04952,CHEMICAL,lovastatin group,lovastatin group
NEW04953,CHEMICAL,melatonin metabolism,melatonin metabolism
NEW04954,DISEASE,concurrent psychotic spectrum disorders,concurrent psychotic spectrum disorders
NEW04957,DISEASE,motor impulsivity,motor impulsivity
NEW04959,MENTAL_HEALTH,rebound anxiety state,rebound anxiety state
NEW04961,CHEMICAL,classical benzodiazepines,classical benzodiazepines
NEW04962,DISEASE,novel psychiatric indications,novel psychiatric indications
NEW04964,CHEMICAL,medium potency benzodiazepines,medium potency benzodiazepines
NEW04967,DISEASE,general depressive symptoms,general depressive symptoms
NEW04969,NUTRITION,lithium response,lithium response
NEW04971,CHEMICAL,LLD-Li therapy,LLD-Li therapy
NEW04974,BIOCHEMICAL,lifesaving drug,lifesaving drug
NEW04975,DISEASE,hyperosmolar state,hyperosmolar state
NEW04978,DISEASE,AKI development,AKI development
NEW04979,NUTRITION,lithium therapy duration,lithium therapy duration
NEW04980,DISEASE,vasculogenic priapism,vasculogenic priapism
D013009,DISEASE,Somnambulism,"Sleep Walking Disorders|Sleep Walking Disorder|Nocturnal Wandering|Wandering, Nocturnal|Sleep Walking|Sleepwalking|somnambulism"
NEW04982,MENTAL_HEALTH,childhood depression,childhood depression
NEW04983,DISEASE,bipolar spectrum comorbidity,bipolar spectrum comorbidity
NEW04986,DISEASE,low mood,low mood
NEW04988,CHEMICAL,LPS-induced microglia/macrophage M1-polarization,LPS-induced microglia/macrophage M1-polarization
NEW04992,DISEASE,bacterial sepsis,bacterial sepsis
NEW04994,DISEASE,neonatal hyperammonemia,neonatal hyperammonemia
NEW04995,DISEASE,neurological toxicity,neurological toxicity
NEW04996,DISEASE,skin disorders,skin disorders
D008107,DISEASE,Liver Diseases,"Liver Disease|Dysfunction, Liver|liver dysfunction|Liver Dysfunctions|Disease, Liver|Diseases, Liver|Liver Dysfunction|Dysfunctions, Liver"
NEW04997,DISEASE,severe skin disorders,severe skin disorders
NEW04998,MENTAL_HEALTH,disorder behaviors,disorder behaviors
NEW04999,CHEMICAL,"genetic condition-""borderline","genetic condition-""borderline"
D011307,BIOCHEMICAL,Drug Prescriptions,"Drug Prescribing|Prescribing, Drug|drug prescriptions|Prescribings, Drug|Drug Prescription|Drug Prescribings"
NEW05003,CHEMICAL,corticosteroid therapy,corticosteroid therapy
NEW05004,MENTAL_HEALTH,disorders comorbidity,disorders comorbidity
NEW05005,DISEASE,alcohol-substance use,alcohol-substance use
NEW05008,MENTAL_HEALTH,paranoid psychosis,paranoid psychosis
NEW05009,MENTAL_HEALTH,simple hallucinations,simple hallucinations
NEW05010,DISEASE,pseudohallucinations,pseudohallucinations
NEW05012,DISEASE,minimal neurocognitive impairments,minimal neurocognitive impairments
NEW05013,DISEASE,recurrent manic-depressive disorders,recurrent manic-depressive disorders
NEW05015,DISEASE,innovative psychiatric drugs,innovative psychiatric drugs
NEW05016,DISEASE,hypersomnia attacks,hypersomnia attacks
NEW05017,MENTAL_HEALTH,chronic mental illness,chronic mental illness
NEW05021,DISEASE,comorbid psychiatric disorders,comorbid psychiatric disorders
NEW05022,CHEMICAL,lifetime antidepressant use,lifetime antidepressant use
NEW05026,DISEASE,Tourette symptoms,Tourette symptoms
NEW05027,DISEASE,bipolar symptomatology,bipolar symptomatology
NEW05029,NUTRITION,lithium antagonists,lithium antagonists
NEW05030,DISEASE,MDMA-induced deficits,MDMA-induced deficits
NEW05034,DISEASE,stroke models,stroke models
NEW05036,DISEASE,lipid-related cardiovascular diseases,lipid-related cardiovascular diseases
NEW05038,MENTAL_HEALTH,autism disorders,autism disorders
NEW05040,CHEMICAL,DA denervation,DA denervation
NEW05043,DISEASE,NQO1 deficiency,NQO1 deficiency
NEW05047,CHEMICAL,dopamine content,dopamine content
NEW05048,CHEMICAL,tyrosine hydroxylase immunoreactivity,tyrosine hydroxylase immunoreactivity
NEW05049,DISEASE,impaired motor functions,impaired motor functions
NEW05051,CHEMICAL,D1- behaviors,D1- behaviors
NEW05053,DISEASE,long-lasting cognitive impairment,long-lasting cognitive impairment
NEW05054,DISEASE,drug-driven behavior,drug-driven behavior
NEW05056,DISEASE,heroin-induced cognitive impairment,heroin-induced cognitive impairment
NEW05058,BIOCHEMICAL,ethical drug,ethical drug
D051245,DISEASE,Retinal Bipolar Cells,"Cell, Retinal Bipolar|Bipolar Cells, Retinal|Retinal Bipolar Cell|retinal bipolar cells|Cells, Retinal Bipolar|Bipolar Cell, Retinal"
NEW05062,DISEASE,severe acne,severe acne
NEW05063,DISEASE,RA catabolism,RA catabolism
NEW05066,MENTAL_HEALTH,schizophrenia vital neuroprotective roles,schizophrenia vital neuroprotective roles
NEW05069,DISEASE,acne patient,acne patient
NEW05070,DISEASE,psychiatric effects,psychiatric effects
NEW05071,CHEMICAL,Isotretinoin use,Isotretinoin use
NEW05072,DISEASE,stress neuro inflammation,stress neuro inflammation
D013401,CHEMICAL,Sugar Alcohol Dehydrogenases,"Dehydrogenases, Sugar Alcohol|Alcohol Oxidoreductases, Sugar|Alcohol Dehydrogenases, Sugar|Oxidoreductases, Sugar Alcohol|Sugar Alcohol Oxidoreductases|alcohol dehydrogenases"
NEW05074,BIOCHEMICAL,antiviral function,antiviral function
NEW05076,DISEASE,depression-related behavior,depression-related behavior
NEW05077,CHEMICAL,retinoic acid signaling,retinoic acid signaling
D051739,DISEASE,Microphthalmia-Associated Transcription Factor,"MITF Transcription Factor|microphthalmia|Microphthalmia Associated Transcription Factor|MITF Protein|Transcription Factor, Microphthalmia-Associated|Microphthalmia, Transcription Factor|Transcription Factor Microphthalmia"
D000074122,DISEASE,Short Stature Homeobox Protein,SHOX Protein|SHOXY Protein|short stature|GCFX Protein|PHOG Protein
NEW05078,DISEASE,microcephally dysmorphogenesis,microcephally dysmorphogenesis
NEW05079,BIOCHEMICAL,antagonistic to retinol,Vitamin A|antagonistic to retinol
NEW05080,CHEMICAL,osmotic-release oral-system methylphenidate remission rate,osmotic-release oral-system methylphenidate remission rate
NEW05082,MENTAL_HEALTH,ADHD inattention subscale,ADHD inattention subscale
NEW05086,CHEMICAL,more VA deficiencies,more VA deficiencies
NEW05093,CHEMICAL,cognitive-decline phenotypes,cognitive-decline phenotypes
NEW05100,DISEASE,neurological pathologies,neurological pathologies
NEW05103,BIOCHEMICAL,hepatic virus carriers,hepatic virus carriers
NEW05106,MENTAL_HEALTH,schizophrenia diagnosis,schizophrenia diagnosis
NEW05107,BIOCHEMICAL,non-B carriers,non-B carriers
NEW05112,DISEASE,stroke recovery,stroke recovery
NEW05114,CHEMICAL,single l-dopa dose,single l-dopa dose
NEW05117,MENTAL_HEALTH,schizophrenia occurrence,schizophrenia occurrence
NEW05119,MENTAL_HEALTH,schizophrenia cases,schizophrenia cases
NEW05120,CHEMICAL,higher peripheral NO metabolite,higher peripheral NO metabolite
NEW05124,DISEASE,malignancies glioblastomas,malignancies glioblastomas
NEW05125,DISEASE,tetrameric TTR,tetrameric TTR
NEW05126,BIOCHEMICAL,5-HTTLPR/rs25531 LALA genotype carriers,5-HTTLPR/rs25531 LALA genotype carriers
NEW05129,MENTAL_HEALTH,fewer hallucinations,fewer hallucinations
NEW05130,DISEASE,non-psychotic psychiatric disorder,non-psychotic psychiatric disorder
NEW05131,BIOCHEMICAL,C-allele carriers,C-allele carriers
NEW05132,DISEASE,amyloid pathologies,amyloid pathologies
NEW05135,DISEASE,late-onset neurodegenerative disorder Fragile X-associated tremor-ataxia syndrome,late-onset neurodegenerative disorder Fragile X-associated tremor-ataxia syndrome
NEW05136,MENTAL_HEALTH,neurodevelopmental Fragile X syndrome,neurodevelopmental Fragile X syndrome
NEW05140,MENTAL_HEALTH,recurrent depressive disorder,recurrent depressive disorder
NEW05145,BIOCHEMICAL,duplication carriers,duplication carriers
D013959,DISEASE,Thyroid Diseases,"Disease, Thyroid|thyroid disease|Diseases, Thyroid|Thyroid Disease"
D016649,DISEASE,Primary Ovarian Insufficiency,"Ovarian Insufficiency, Primary|Hypergonadotropic Ovarian Failure, X-Linked|Premature Ovarian Failure, X Linked|Primary Ovarian Insufficiency, Fragile X Associated|Fragile X-Associated Primary Ovarian Insufficiency|Premature Ovarian Failure 1|Gonadotropin Resistant Ovary Syndrome|primary ovarian insufficiency|Fragile X Associated Primary Ovarian Insufficiency|Fragile X Premature Ovarian Failure|Gonadotropin-Resistant Ovary Syndrome|Resistant Ovary Syndrome|FMR1-Related Primary Ovarian Insufficiency|Hypergonadotropic Ovarian Failure, X Linked|X Linked Hypergonadotropic Ovarian Failure|Ovarian Failure, Premature|X-Linked Hypergonadotropic Ovarian Failure|Premature Ovarian Failure, X-Linked|Premature Ovarian Failure|FMR1 Related Primary Ovarian Insufficiency|Primary Ovarian Insufficiency, Fragile X-Associated"
NEW05149,BIOCHEMICAL,human leukocyte antigen class DQB1 allele,human leukocyte antigen class DQB1 allele
NEW05152,MENTAL_HEALTH,narcolepsy onset,narcolepsy onset
NEW05157,NUTRITION,Spanish HIV/AIDS patients,Spanish HIV/AIDS patients
NEW05162,DISEASE,childhood ASD,childhood ASD
NEW05164,DISEASE,hyperactive/impulsive phenotypes,hyperactive/impulsive phenotypes
NEW05165,DISEASE,self-directed aggression relative,self-directed aggression relative
NEW05172,MENTAL_HEALTH,nervosa neural responses,nervosa neural responses
NEW05174,MENTAL_HEALTH,Phobic anxiety,Phobic anxiety
NEW05175,DISEASE,Paranoid ideation,Paranoid ideation
NEW05176,DISEASE,drug-free psychiatric patients,drug-free psychiatric patients
NEW05178,CHEMICAL,peripheral melatonin levels,peripheral melatonin levels
NEW05180,CHEMICAL,arterio-venous ammonia difference,arterio-venous ammonia difference
NEW05182,DISEASE,peripheral muscular ammonia uptake,peripheral muscular ammonia uptake
NEW05184,CHEMICAL,thiobarbituric acid reactive species,thiobarbituric acid reactive species
NEW05185,CHEMICAL,postnatal acid-induced social impairment,postnatal acid-induced social impairment
NEW05186,DISEASE,prenatal VPA-induced social impairment,prenatal VPA-induced social impairment
NEW05187,DISEASE,VPA-induced autistic phenotypes,VPA-induced autistic phenotypes
NEW05189,DISEASE,female manic patients,female manic patients
NEW05190,MENTAL_HEALTH,cycloid psychosis,cycloid psychosis
NEW05192,CHEMICAL,cortisol long-term stress,cortisol long-term stress
NEW05193,DISEASE,dendritic hypertrophy,dendritic hypertrophy
NEW05194,MENTAL_HEALTH,anorgasmia,anorgasmia
NEW05195,BIOCHEMICAL,drug mechanism,drug mechanism
NEW05197,DISEASE,comorbid alcoholism,comorbid alcoholism
NEW05201,CHEMICAL,acid turnover,acid turnover
NEW05204,DISEASE,sedation gain,sedation gain
NEW05205,CHEMICAL,anti-ADHD medications,anti-ADHD medications
NEW05207,DISEASE,severe self-mutilation,severe self-mutilation
NEW05209,MENTAL_HEALTH,pervasive developmental disorder,pervasive developmental disorder
NEW05210,MENTAL_HEALTH,adolescent onset schizophrenia,adolescent onset schizophrenia
NEW05211,BIOCHEMICAL,useful drug,useful drug
NEW05212,MENTAL_HEALTH,resistant childhood schizophrenia,resistant childhood schizophrenia
NEW05214,CHEMICAL,COVID-19 group,COVID-19 group
NEW05217,DISEASE,psychiatric inpatient settings,psychiatric inpatient settings
NEW05220,DISEASE,WMC errors,WMC errors
NEW05223,CHEMICAL,ethanol self-administration,ethanol self-administration
D018887,MENTAL_HEALTH,Landau-Kleffner Syndrome,"Aphasia, Epileptic, Acquired|Aphasia, Acquired, With Convulsive Disorder|Landau Kleffner Acquired Epileptiform Aphasia|Acquired Aphasia with Convulsive Disorder|Acquired Epileptic Aphasias|Epileptic Aphasia, Acquired|Acquired Epileptic Aphasia|Epileptiform Aphasias, Acquired|Landau-Kleffner Acquired Epileptiform Aphasia|Landau Kleffner Syndrome|Epileptiform Aphasia, Acquired|Aphasia, Acquired Epileptic|Acquired Epileptiform Aphasias|Syndrome, Landau-Kleffner|Acquired Childhoood Aphasia with Convulsive Disorder|acquired aphasia|Acquired Epileptiform Aphasia|Epileptic Aphasias, Acquired"
NEW05228,DISEASE,related cognitive posttraumatic deficits,related cognitive posttraumatic deficits
NEW05231,DISEASE,tremor features,tremor features
NEW05233,CHEMICAL,rivastigmine mean dose,rivastigmine mean dose
NEW05234,DISEASE,demented PD patients,demented PD patients
NEW05236,DISEASE,chloroquine-resistant areas,chloroquine-resistant areas
NEW05237,DISEASE,malaria prophylaxis,malaria prophylaxis
NEW05239,BIOCHEMICAL,antimalarial mefloquine,antimalarial mefloquine
D008179,DISEASE,"Lupus Erythematosus, Discoid","Lupus Erythematosus, Cutaneous, Chronic|Discoid Lupus Erythematosus|discoid lupus|Lupus Erythematosus, Chronic Cutaneous"
NEW05241,DISEASE,chloroquine-resistant malaria,chloroquine-resistant malaria
NEW05243,CHEMICAL,quinine overdose,quinine overdose
D035923,DISEASE,Hepatitis delta Antigens,"Antigen, delta|Hepatitis delta Antigen|HDAg|Hepatitis D Antigen|Antigen, Hepatitis delta|Antigens, Hepatitis D|delta Antigens, Hepatitis|delta Antigen|Antigens, Hepatitis delta|Antigen, Hepatitis D|hepatitis|Hepatitis D Antigens|delta Antigen, Hepatitis"
NEW05247,CHEMICAL,pyrimethamine overdose,pyrimethamine overdose
NEW05248,DISEASE,Lyell syndromes,Lyell syndromes
NEW05251,CHEMICAL,artemesinine,artemesinine
NEW05252,BIOCHEMICAL,new antimalarial,new antimalarial
NEW05254,CHEMICAL,lavage treatment.(ABSTRACT,lavage treatment.(ABSTRACT
NEW05256,CHEMICAL,to 42.7 %,amodiaquine|to 42.7 %
NEW05257,DISEASE,acute malaria studies,acute malaria studies
C001205,CHEMICAL,"fanasil, pyrimethamine drug combination [Supplementary Concept]",sulphadoxine|Drug Combinations|Pyrimethamine|Sulfadoxine
NEW05258,MENTAL_HEALTH,anxiety mental distress,anxiety mental distress
NEW05260,CHEMICAL,b.i.d,b.i.d
D011431,CHEMICAL,Dextropropoxyphene,"Propoxyphene Hydrochloride, (S-(R*,R*))-Isomer|D Propoxyphene|Propoxyphene Hydrochloride, (R*,R*)-(+-)-Isomer|Propoxyphene Maleate, (+)-Isomer|Propoxyphene Phosphate, (S-(R*,S*))-Isomer|Darvon|Propoxyphene Hydrochloride, (R-(R*,S*))-Isomer|D-Propoxyphene|Propoxyphene Hydrochloride|Propoxyphene|Propoxyphene Sulfate, (S-(R*,S*))-Isomer|propoxyphene|Propoxyphene Hydrochloride, (R-(R*,R*))-Isomer|Hydrochloride, Propoxyphene"
NEW05264,MENTAL_HEALTH,adrenergic hyperarousal,adrenergic hyperarousal
NEW05265,CHEMICAL,arylcyclohexylamine class,arylcyclohexylamine class
NEW05273,DISEASE,mood dysfunction,mood dysfunction
NEW05274,DISEASE,our's previous study clonic/tonic seizures,our's previous study clonic/tonic seizures
NEW05276,DISEASE,NMDA-evoked seizures,NMDA-evoked seizures
NEW05278,DISEASE,diverse neuropsychiatric illness,diverse neuropsychiatric illness
NEW05279,CHEMICAL,"phenethylamine hallucinogen (+/-)-2,5-dimethoxy-4-iodoamphetamine hydrochloride","phenethylamine hallucinogen (+/-)-2,5-dimethoxy-4-iodoamphetamine hydrochloride"
NEW05280,BIOCHEMICAL,adenosine receptor agonist,adenosine receptor agonist
NEW05281,DISEASE,DOI-induced head shakes,DOI-induced head shakes
NEW05283,MENTAL_HEALTH,anxiety task,anxiety task
D011470,DISEASE,Prostatic Hyperplasia,"Prostatic Hyperplasia, Benign|Benign Prostatic Hypertrophy|Hypertrophy, Prostatic|Prostatic Hyperplasias, Benign|Hyperplasia, Prostatic|Hyperplasia, Benign Prostatic|Hypertrophies, Prostatic|Hypertrophy, Benign Prostatic|Prostatic Hypertrophy|Hyperplasias, Benign Prostatic|benign prostatic hyperplasia|Benign Prostatic Hyperplasias|Prostatic Hypertrophies|Benign Prostatic Hyperplasia|Prostatic Hypertrophy, Benign|Prostatic Adenomas|Adenoma, Prostatic|Adenomas, Prostatic|Prostatic Adenoma"
NEW05287,DISEASE,human prostate tissue,human prostate tissue
NEW05288,DISEASE,human detrusor muscle,human detrusor muscle
D014655,MENTAL_HEALTH,Vascular Resistance,"Vascular Resistance, Pulmonary|Systemic Vascular Resistance|Pulmonary Vascular Resistance|Resistance, Vascular|Resistance, Total Peripheral|Vascular Resistance, Systemic|Resistance, Peripheral|Total Peripheral Resistance|Resistance, Pulmonary Vascular|peripheral resistance|Peripheral Resistance, Total|Resistance, Systemic Vascular|Peripheral Resistance"
NEW05289,CHEMICAL,baseline norepinephrine levels,baseline norepinephrine levels
NEW05290,CHEMICAL,COVID-19 knowledge,COVID-19 knowledge
NEW05292,DISEASE,suprasacral spinal cord lesions,suprasacral spinal cord lesions
NEW05293,DISEASE,chronic spinal lesions,chronic spinal lesions
NEW05298,DISEASE,drug-induced deficits,drug-induced deficits
NEW05301,CHEMICAL,zebrafish-a sensitive vertebrate aquatic model,zebrafish-a sensitive vertebrate aquatic model
NEW05305,MENTAL_HEALTH,adult ADHD,adult ADHD
NEW05306,DISEASE,VTE laps,VTE laps
NEW05307,DISEASE,diverse etiologies,diverse etiologies
D005444,CHEMICAL,Flunarizine,"R 14950|Flunarizine Hydrochloride|Flunarizine Dihydrochloride|R-14950|Hydrochloride, Flunarizine|Sibelium|R14950|Dihydrochloride, Flunarizine|Flunarizin|flunarizine"
NEW05311,CHEMICAL,profound catecholamine stimulation,profound catecholamine stimulation
NEW05313,DISEASE,barnes akathisia rating scale,Barnes akathisia rating scale
NEW05315,MENTAL_HEALTH,apoptosis resistance,apoptosis resistance
NEW05318,MENTAL_HEALTH,chronic stress norepinephrine,chronic stress norepinephrine
NEW05326,CHEMICAL,ammonia clearance,ammonia clearance
NEW05327,MENTAL_HEALTH,chronic subpanic anxiety,chronic subpanic anxiety
NEW05331,DISEASE,obsessive-compulsive dimension,obsessive-compulsive dimension
NEW05333,MENTAL_HEALTH,severe agitation,severe agitation
NEW05334,DISEASE,severe extrapyramidal reaction,severe extrapyramidal reactions
NEW05336,MENTAL_HEALTH,anxiety hallmark,anxiety hallmarks
NEW05338,CHEMICAL,dasabuvir (obv/ptv/r+dsv)±ribavirin,dasabuvir (OBV/PTV/r+DSV)±ribavirin|RBV
NEW05341,BIOCHEMICAL,antibacterial,antibacterials
NEW05342,BIOCHEMICAL,direct-acting antiviral medication,direct-acting antiviral medications
NEW05344,DISEASE,extrahepatic hcv disease,extrahepatic HCV diseases
NEW05345,DISEASE,global pandemic,global pandemic
NEW05346,MENTAL_HEALTH,pandemic-related anxiety,pandemic-related anxiety
NEW05347,BIOCHEMICAL,multiple drug use,multiple drug use
NEW05348,MENTAL_HEALTH,mental disorder secondary,mental disorders secondary
http://purl.obolibrary.org/obo/DOID_1229,MENTAL_HEALTH,paranoid schizophrenia,Paraphrenia - late|paranoid type schizophrenia subchronic state|Paranoid type schizophrenia|chronic paranoid schizophrenia|paranoid psychosis|Paraphrenic schizophrenia
NEW05352,DISEASE,hypertensive crisis,hypertensive crises
NEW05355,MENTAL_HEALTH,marked anxiety,marked anxiety
NEW05356,CHEMICAL,sb334867,SB334867
NEW05358,DISEASE,mild-to-moderate allergic asthma,mild-to-moderate allergic asthma
NEW05359,DISEASE,persistent moderate-to-severe allergic asthma,persistent moderate-to-severe allergic asthma
http://purl.obolibrary.org/obo/DOID_417,DISEASE,autoimmune disease,hypersensitivity reaction type II disease|autoimmune hypersensitivity disease|auto-immune diseases
NEW05366,CHEMICAL,repeat alcohol withdrawal,repeated alcohol withdrawals
NEW05369,DISEASE,anxiety-like behavior level,anxiety-like behavior levels
NEW05371,CHEMICAL,population(s,population(s
NEW05372,MENTAL_HEALTH,post-ictal analgesia,post-ictal analgesia
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Catalepsy,DISEASE,catalepsy,post-ECS catalepsy
NEW05375,DISEASE,chronic right hemiplegia effective,chronic right hemiplegia effective
D007977,CHEMICAL,Levallorphan,Lorfan|Naloxiphan|levallorphan
NEW05376,CHEMICAL,endorphin unclear,endorphins unclear
NEW05377,MENTAL_HEALTH,schizophrenia syndrome,schizophrenia syndromes
NEW05380,DISEASE,lesional epilepsy,lesional epilepsy
NEW05381,DISEASE,frontal-cortical behavioral control,frontal-cortical behavioral control
NEW05382,CHEMICAL,negative affect-anxiety,negative affect-anxiety
NEW05384,CHEMICAL,serotonin 5-hydroxytryptamine reuptake inhibitor,serotonin 5-hydroxytryptamine reuptake inhibitors
NEW05386,DISEASE,pain response,pain response
NEW05388,DISEASE,life-threatening disorder,life-threatening disorder
D016465,MENTAL_HEALTH,Bone Marrow Purging,"Hematopoietic Stem Cell Purging|Purging, Bone Marrow|purging"
NEW05389,MENTAL_HEALTH,retardation autism disorder,retardation autism disorders
NEW05392,DISEASE,recurrent maladaptive gambling behavior,recurrent maladaptive gambling behavior
http://purl.org/sig/ont/fma/fma85813,CHEMICAL,solid,solids
NEW05394,DISEASE,functional dyspepsia,functional dyspepsia
NEW05395,MENTAL_HEALTH,functional digestive syndrome,functional digestive syndromes
NEW05396,MENTAL_HEALTH,robust analgesia,robust analgesia
NEW05399,BIOCHEMICAL,pre-test drug,pre-test drug
NEW05401,DISEASE,long-term behavioral disorder,long-term behavioral disorders
NEW05403,DISEASE,cognitive deficiency,cognitive deficiency
NEW05405,DISEASE,niv failure,NIV failure
NEW05407,DISEASE,acute repetitive seizure,acute repetitive seizures
NEW05408,DISEASE,migraine prophylaxis,migraine prophylaxis
NEW05409,CHEMICAL,SPD-421,SPD-421
NEW05411,DISEASE,character trait,character traits
NEW05413,BIOCHEMICAL,iatrogenic drug reaction,iatrogenic drug reaction
NEW05416,DISEASE,acute intermittent hypoxia,Acute intermittent hypoxia|AIH
NEW05418,CHEMICAL,azoxymethane (aom)-induced colonic aberrant crypt focus,azoxymethane (AOM)-induced colonic aberrant crypt foci
NEW05419,DISEASE,abnormal aggregation,abnormal aggregation
NEW05420,DISEASE,low weight gain,low weight gain
NEW05421,DISEASE,disorder population,disorder population
NEW05424,CHEMICAL,lamotrigine monotherapy,lamotrigine monotherapy
NEW05425,CHEMICAL,lamotrigine adjunctive therapy,lamotrigine adjunctive therapy
NEW05426,CHEMICAL,valproate monotherapy,valproate monotherapy
NEW05428,CHEMICAL,bradykinin histaminergic system,bradykinin histaminergic systems
NEW05429,DISEASE,Disease Lateral Sclerosis,Disease Lateral Sclerosis
NEW05430,DISEASE,ischemic brain damage,ischemic brain damage
http://purl.obolibrary.org/obo/CHEBI_2721,CHEMICAL,angoline,methyl-noscapine|Angoline
NEW05432,CHEMICAL,vasopressin staining,vasopressin staining
NEW05439,CHEMICAL,intestinal ammonia,intestinal ammonia
NEW05440,DISEASE,prehospital pain control,prehospital pain control
NEW05442,DISEASE,stress-related neuropsychological disorder,stress-related neuropsychological disorders
NEW05443,DISEASE,prepsychotic condition,prepsychotic condition
NEW05444,MENTAL_HEALTH,autism paradoxical effect,autism paradoxical effects
NEW05446,MENTAL_HEALTH,Childhood autism rating scale,Childhood Autism Rating Scale
NEW05447,CHEMICAL,D90-D0,D90-D0
NEW05449,MENTAL_HEALTH,unipolar major depression,unipolar major depression
NEW05451,DISEASE,stress-induced behavioural deficit,stress-induced behavioural deficits
NEW05453,MENTAL_HEALTH,major depression similar,major depression similar
http://purl.obolibrary.org/obo/DOID_3312,MENTAL_HEALTH,bipolar disorder,Manic bipolar I disorder|bipolar depression|manic depression|Depressive-manic psych.|depressed bipolar disorder|Manic Bipolar Affective disorder|manic disorder|bipolar disorder manic phase|Manic Depressive disorder|mixed bipolar disorder
NEW05455,CHEMICAL,post-alcohol-withdrawal,post-alcohol-withdrawal
NEW05457,MENTAL_HEALTH,primary anxiety,primary anxiety
NEW05458,CHEMICAL,amitriptyline recipient,amitriptyline recipients
NEW05459,CHEMICAL,more tianeptine,more tianeptine
NEW05461,MENTAL_HEALTH,treatment-resistant insomnia,treatment-resistant insomnia
NEW05464,DISEASE,treatment-resistant ocd,treatment-resistant OCD
NEW05466,MENTAL_HEALTH,its 's obsession,obsession
NEW05467,MENTAL_HEALTH,compulsion subscale,compulsion subscales
NEW05468,DISEASE,difficult-to-treat illness,difficult-to-treat illness
NEW05469,CHEMICAL,scopolamine-induced memory impairment,scopolamine-induced memory impairments
NEW05472,MENTAL_HEALTH,dextromethorphan-induced psychotic disorder,dextromethorphan-induced psychotic disorder
http://purl.obolibrary.org/obo/DOID_8646,MENTAL_HEALTH,substance-induced psychosis,substance-induced psychosis
NEW05474,DISEASE,severe autotomy,severe autotomy
NEW05477,MENTAL_HEALTH,so-called mask depression,so-called masked depression
http://purl.obolibrary.org/obo/DOID_11328,MENTAL_HEALTH,schizophreniform disorder,schizo-affective psychosis
NEW05478,CHEMICAL,substrain,substrains
NEW05479,DISEASE,similar weight loss,similar weight loss
NEW05482,DISEASE,various autoimmune disorder,various autoimmune disorders
NEW05483,CHEMICAL,albendazole monotherapy,albendazole monotherapy
NEW05484,CHEMICAL,sertraline percent,sertraline percent
NEW05487,DISEASE,schizophrenic population,schizophrenic population
NEW05488,CHEMICAL,naloxone-associated improvement,naloxone-associated improvement
NEW05490,CHEMICAL,cannabis risk,cannabis risks
D017615,DISEASE,Enteric Nervous System,"ENS|Nervous System, Enteric|Systems, Enteric Nervous|enteric nervous system|Nervous Systems, Enteric|System, Enteric Nervous|Enteric Nervous Systems"
NEW05492,DISEASE,akinetic crisis,akinetic crisis
NEW05494,DISEASE,obsessive-compulsive symptom,obsessive-compulsive symptoms
D006259,DISEASE,Craniocerebral Trauma,"Minor Head Injury|Head Injury, Minor|Superficial Head Injuries|Open Head Injuries|Head Injury, Multiple|head injury|Head Traumas|Injuries, Open Head|Region Traumas, Occipital|Traumas, Frontal Region|Region Trauma, Occipital|Occipital Traumas|Craniocerebral Traumas|Traumas, Head|Injury, Multiple Head|Trauma, Frontal Region|Occipital Region Trauma|Head Injury|Minor Head Injuries|Region Trauma, Parietal|Craniocerebral Injuries|Temporal Region Traumas|Injury, Open Head|Parietal Region Trauma|Trauma, Parietal Region|Traumas, Occipital|Crushing Skull Injuries|Head Injuries, Open|Trauma, Head|Skull Injury, Crushing|Injuries, Multiple Head|Injury, Head|Head Injury, Superficial|Forehead Traumas|Head Trauma|Head Injuries, Minor|Craniocerebral Injury|Crushing Skull Injury|Open Head Injury|Trauma, Temporal Region|Head Injuries, Superficial|Head Injuries|Injury, Minor Head|Traumas, Craniocerebral|Temporal Region Trauma|Trauma, Occipital|Trauma, Craniocerebral|Multiple Head Injuries|Traumas, Parietal Region|Injury, Craniocerebral|Injuries, Superficial Head|Region Trauma, Frontal|Injury, Superficial Head|Traumas, Forehead|Injuries, Minor Head|Injuries, Craniocerebral|Multiple Head Injury|Frontal Region Traumas|Head Injuries, Multiple|Skull Injuries, Crushing|Traumas, Occipital Region|Injuries, Head|Parietal Region Traumas|Region Traumas, Frontal|Superficial Head Injury|Occipital Trauma|Trauma, Occipital Region|Frontal Region Trauma|Trauma, Forehead|Traumas, Temporal Region|Region Traumas, Parietal|Occipital Region Traumas|Head Injury, Open|Forehead Trauma"
NEW05496,CHEMICAL,glucose uptake,glucose uptake
NEW05498,BIOCHEMICAL,carrier mother,carrier mother
D015897,DISEASE,Comorbidity,Diagnosis Related Groups (1986-1989)|Length of Stay (1986-1989)|comorbidity|specific disease/complications (1977-1989)
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Obsessive_Compulsive_Disorder,DISEASE,obsessive compulsive disorder,compulsive disorders
NEW05499,MENTAL_HEALTH,anxiety spectrum disorder,anxiety spectrum disorder
NEW05501,DISEASE,epilepsy great conscious awareness,epilepsy greater conscious awareness
NEW05502,DISEASE,accidental overdose,accidental overdose
NEW05503,NUTRITION,teddy bear,teddy bear
NEW05505,CHEMICAL,osmotic-release oral system methylphenidate,OROS-MPH|osmotic-release oral system methylphenidate
NEW05506,DISEASE,obsessional character,obsessional character
NEW05508,CHEMICAL,Val di non,Val di Non
NEW05509,DISEASE,raw pork,raw pork
NEW05510,DISEASE,new dsm-5 system,new DSM-5 system
NEW05512,DISEASE,post-traumatic stress symptom,post-traumatic stress symptoms
NEW05513,CHEMICAL,gd grubbs,GD Grubbs
NEW05514,MENTAL_HEALTH,brief disorder,brief disorder
NEW05518,BIOCHEMICAL,nk-1 antagonist,NK-1 antagonists
NEW05519,DISEASE,opioid-induced vomiting,opioid-induced vomiting
NEW05521,CHEMICAL,buffer stz,buffered STZ
NEW05523,NUTRITION,g wheat germ,g wheat germ
NEW05525,DISEASE,thermal allodynia behavior,thermal allodynia behavior
NEW05527,BIOCHEMICAL,analgesic dose,analgesic doses
NEW05528,DISEASE,severe motor impairment,severe motor impairment
NEW05530,DISEASE,chronic allodynia-like response,chronic allodynia-like response
NEW05533,DISEASE,rebound hypertension,rebound hypertension
NEW05538,BIOCHEMICAL,drug response,drug responses
NEW05539,BIOCHEMICAL,impaired drug metabolism,impaired drug metabolism
NEW05542,CHEMICAL,mm nh4ac,mM NH4Ac
http://purl.obolibrary.org/obo/CHEBI_17303,CHEMICAL,morphine,"(5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|(5alpha,6alpha)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol|(5R,6S,9R,13S,14R)-4,5-epoxy-N-methyl-7-morphinen-3,6-diol|morfina|(-)-morphine|(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL|morphine analgesia-|Morphia|morphium|morphinum|Morphin|Morphine|17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol"
NEW05543,DISEASE,analgesia- muscular incoordination,analgesia- muscular incoordination
NEW05544,DISEASE,nociceptive pain component,nociceptive pain component
http://purl.obolibrary.org/obo/SYMP_0000832,DISEASE,neuropathic pain,new neuropathic pain
NEW05545,MENTAL_HEALTH,adequate analgesia,adequate analgesia
NEW05547,DISEASE,pain treatment,pain treatment
NEW05548,DISEASE,end-stage cancer patient,end-stage cancer patients
NEW05549,NUTRITION,toadfish,toadfish
NEW05550,DISEASE,hyperammonemic condition,hyperammonemic conditions
NEW05552,DISEASE,antagonist-induced catalepsy behavior,antagonist-induced catalepsy behaviors
NEW05553,DISEASE,abnormal dopamine-related behavior,abnormal dopamine-related behaviors
NEW05556,DISEASE,tumour cell,tumour cells
NEW05557,DISEASE,tumour cell death,tumour cell death
NEW05560,CHEMICAL,naltrexone pretreatment,naltrexone pretreatment
NEW05561,MENTAL_HEALTH,anxiety evaluation,anxiety evaluation
NEW05562,DISEASE,behavioral dysfunction,behavioral dysfunction
NEW05564,DISEASE,diet-induced function,diet-induced function
NEW05567,CHEMICAL,aflatoxin exposure,aflatoxin exposure
NEW05568,DISEASE,hepatocellular carcinoma risk factor,hepatocellular carcinoma risk factors
D016031,DISEASE,Liver Transplantation,"liver liver|Transplantation, Liver|Transplant, Liver|Liver Grafting|Liver Transplants|Hepatic Transplantations|Liver Transplantations|Liver Transplant|Transplantation, Hepatic|Grafting, Liver|Hepatic Transplantation"
NEW05570,DISEASE,alcoholic liver injury,alcoholic liver injury
D059333,DISEASE,Central Nervous System Sensitization,"Sensitizations, Central|Central Sensitizations|Sensitization, Central|Central Sensitization|central nervous system"
http://purl.obolibrary.org/obo/SYMP_0000681,DISEASE,aggressive behavior,aggressive behaviour
NEW05574,CHEMICAL,mg ion,Mg ions
NEW05575,MENTAL_HEALTH,alzheimer disease development,Alzheimer disease development
NEW05576,DISEASE,severe atypical parkinsonian syndrome,severe atypical parkinsonian syndrome
NEW05579,DISEASE,depressive status,depressive status
NEW05580,CHEMICAL,non-protein thiol,NPSH|non-protein thiol
D004801,CHEMICAL,Eosine Yellowish-(YS),"Eosine Yellowish-(YS), Dipotassium Salt|Eosine|Eosin Y|eosin|Eosin|C.I. Acid Red 87|Tetrabromofluorescein|Eosin (yellowish) (free acid)|Eosine Yellowish-(YS), Potassium, Sodium Salt|Eosine Yellowish|Acid Red 87"
C497274,CHEMICAL,grayanotoxin XXI [Supplementary Concept],grayanotoxin|Diterpenes
NEW05582,MENTAL_HEALTH,chronic pain syndrome,chronic pain syndromes
D011514,DISEASE,Proteus vulgaris,Proteus vulgaris|Proteus (1966-1971)
NEW05585,BIOCHEMICAL,humidifier disinfectant,humidifier disinfectants
C092153,CHEMICAL,microsomal ethanol-oxidizing system [Supplementary Concept],Alcohol Oxidoreductases|microsomal ethanol oxidizing system|Cytochrome P-450 Enzyme System
C420272,CHEMICAL,"ADH1C protein, human [Supplementary Concept]",human-alcohol dehydrogenase|Alcohol Dehydrogenase
NEW05590,DISEASE,pancreas damage,pancreas damage
D049310,DISEASE,Distal Myopathies,"Muscular Dystrophies, Distal|Finnish Markesbery Muscular Dystrophy|Myopathy, Udd|Udd Distal Myopathy|Laing Early-Onset Distal Myopathy|Distal Myopathy 1|Tibial Muscular Dystrophy, Tardive|Distal Myopathy, Welander|Muscular Dystrophy, Distal|Muscular Dystrophies, Tibial|Myopathy, Distal 1|Udd Markesbery Muscular Dystrophy|Myopathy, Udd Distal|Distal 1 Myopathy|Muscular Dystrophy, Tibial|Muscular Dystrophy, Udd-Markesbery|Welander Distal Myopathy|Distal Myopathy Markesbery-Griggs Type|Distal Muscular Dystrophies|Udd Myopathy|Myopathy 1s, Distal|Myopathies, Distal|Myopathy, Distal|Distal Myopathy, Laing|Laing Early Onset Distal Myopathy|Myopathy, Distal, Swedish|Tibial Muscular Dystrophy|Myopathy, Distal, Early-Onset, Autosomal Dominant|Distal 1 Myopathies|Distal Myopathy Markesbery Griggs Type|Udd-Markesbery Muscular Dystrophy|Distal Myopathy, Udd|Distal Myopathy 1s|Distal Myopathy|myopathies|Myopathy 1, Distal|Muscular Dystrophy, Distal, Late-Onset, Autosomal Dominant|Distal Muscular Dystrophy|Myopathy, Laing Distal|Tardive Tibial Muscular Dystrophy|Laing Distal Myopathy|Muscular Dystrophy, Finnish-Markesbery|Myopathies, Distal 1|Finnish-Markesbery Muscular Dystrophy|Myopathy, Late Distal Hereditary"
NEW05591,DISEASE,lipid damage,lipid damage
NEW05592,DISEASE,different pain model,different pain models
NEW05593,DISEASE,amnestic effect,amnestic effects
NEW05594,CHEMICAL,α4β2 receptor expression,α4β2 receptor expression
NEW05596,CHEMICAL,muscarinic ach,muscarinic ACh
NEW05599,CHEMICAL,flavonoid content,flavonoids contents
NEW05600,MENTAL_HEALTH,development reaction,development reactions
NEW05601,CHEMICAL,catecholamine metabolism,catecholamine metabolism
D001480,MENTAL_HEALTH,Basal Ganglia Diseases,Lenticulostriate Disorders|Lenticulostriate Disorder|Extrapyramidal Disorders|Basal Ganglia Disease|Basal Ganglia Disorder|Extrapyramidal Disorder|extrapyramidal disorders|Basal Ganglia Disorders
NEW05602,DISEASE,human breast adenocarcinoma cell line,human breast adenocarcinoma cell line
NEW05604,DISEASE,b. jararaca venom,B. jararaca venom
NEW05606,CHEMICAL,α- conotoxin class,α- conotoxin classes
http://purl.obolibrary.org/obo/CHEBI_16737,CHEMICAL,creatinine,"Creatinine|creatinine|Creatine anhydride|1-methylglycocyamidine|creatinina|2-amino-1,5-dihydro-1-methyl-4H-Imidazol-4-one|1-Methylglycocyamidine|2-Amino-1-methylimidazolin-4-one|Kreatinin|1-Methylhydantoin-2-imide|creatinine concentration-are|2-imino-1-methylimidazolidin-4-one"
NEW05607,MENTAL_HEALTH,focal fragmentation,focal fragmentation
D000744,DISEASE,"Anemia, Hemolytic, Autoimmune","Hemolytic Anemia, Autoimmune|anaemia|Cold Antibody Disease|Autoimmune Haemolytic Anaemias|Idiopathic Autoimmune Hemolytic Anemia|Anemia, Hemolytic, Cold Antibody|Cold Agglutinin Diseases|Anaemia, Autoimmune Haemolytic|Acquired Autoimmune Hemolytic Anemia|Anemia, Autoimmune Hemolytic|Haemolytic Anaemia, Autoimmune|Autoimmune Hemolytic Anemia|Cold Antibody Diseases|Autoimmune Hemolytic Anemias|Agglutinin Disease, Cold|Cold Antibody Hemolytic Anemia|Cold Agglutinin Disease|Autoimmune Haemolytic Anaemia|Anemia, Hemolytic, Idiopathic Acquired"
http://purl.obolibrary.org/obo/SYMP_0000081,DISEASE,low grade fever,low grade fever
NEW05608,DISEASE,bloat,bloating
NEW05609,MENTAL_HEALTH,its 's effective projection,effective projection
NEW05611,MENTAL_HEALTH,States abuse treatment,States abuse treatment
NEW05614,DISEASE,spastic han-wistar rat,spastic Han-Wistar rat
C117902,CHEMICAL,vanadocene dithiocyanate [Supplementary Concept],Organometallic Compounds|VDS
D025341,MENTAL_HEALTH,Principal Component Analysis,"Analyses, Principal Component|component analysis|Analysis, Principal Component|Principal Component Analyses|pICA"
NEW05618,DISEASE,transient maternal hypothyroidism,transient maternal hypothyroidism
NEW05619,DISEASE,impaired mental development,impaired mental development
NEW05620,NUTRITION,lithium receptor mglur antagonist,lithium receptor mGluR antagonists
D025542,DISEASE,Neurofibromin 1,NF1 Protein|NF1 GRP|NF1 GAP Related Protein|NF1|Neurofibromatosis Type 1 Protein|NF-1 Protein|Neurofibromin|NF1-GAP-Related Protein|NF 1 Protein|Neurofibromatosis Type 1 Gene Product
NEW05621,CHEMICAL,hmg-coa reductase inhibitor lavastatin,HMG-CoA reductase inhibitor lavastatin
NEW05628,DISEASE,tertiary epilepsy center,tertiary epilepsy centers
NEW05629,NUTRITION,10-month-old Argentine Dogo,10-month-old Argentine Dogo
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Extrapyramidal_Symptoms,DISEASE,extrapyramidal symptoms,EPS|Extrapyramidal symptoms
NEW05630,CHEMICAL,striatal dopamine activity,striatal dopamine activity
NEW05631,MENTAL_HEALTH,specific phobia anxiolytic effect,specific phobia anxiolytic effect
NEW05634,DISEASE,psychotic state,psychotic states
NEW05636,DISEASE,type diabetic mouse,type diabetic mice
NEW05637,CHEMICAL,npy-npy y1 receptor system,NPY-NPY Y1 receptor system
NEW05638,MENTAL_HEALTH,troubledyskinesia,troubledyskinesia
NEW05639,MENTAL_HEALTH,forepaw akinesia,forepaw akinesia
NEW05641,DISEASE,female sexual desire,female sexual desire
NEW05643,CHEMICAL,adenosine release,adenosine release
D018388,DISEASE,"Codon, Terminator","Codon, Termination|Codons, Termination|Stop Codons, Amber|Codons, UAG|Codon, Stop|UAG Codons|Codon, TAA|Stop Codon, Opal|Terminator Codons, Amber|Termination Codon|UAG, Stop Codon|Codon, Ochre Stop|TGA Codons|Ochre Stop Codon|Amber Codon|UAA Codons|Stop Codon, UGA|Codon, Amber|Stop Codon UAA|Opal Stop Codons|UGA, Stop Codon|Opal Codon|Amber Stop Codon|Codon, UAG Stop|Codons, TAA|TAG Codon|Stop Codon, Ochre|Codon, Opal Stop|Ochre Codons|TAA Codon|Codons, UGA Stop|Stop Codons, Opal|Codons, UAA Stop|Terminator Codons|Stop Codon, Amber|UGA Codon|UGA Stop Codons|Terminator Codon|Opal Codons|Codons, Ochre|Stop Codon, UAA|Codons, Opal|UAA, Stop Codon|Stop Codons|Codon, Opal|UAA Codon|Opal Stop Codon|Codon, UAG|Stop Codons, UAA|Codon, UAA|Stop Codons, UAG|Codon UGA, Stop|UAG Codon|Stop Signal, Translation|UAA Stop Codons|TAA|TAA Codons|Codon, TGA|Stop Codon UGA|Translation Stop Signal|Codons, Amber|Codons, Opal Stop|Codon, Ochre|UAG Stop Codons|Translation Stop Signals|Codons, Amber Terminator|Stop Codon, UAG|Stop Codon UGAs|Stop Codons, Ochre|Codons, Amber Stop|Codons, TAG|Codon UAG, Stop|Stop Signals, Translation|UAG Stop Codon|TGA Codon|TAG Codons|Codon, TAG|Stop Codons, UGA|Amber Stop Codons|Amber Codons|UGA Codons|Stop Codon UAG|Codons, Stop|Termination Codons|Codons, TGA|Codon, Amber Stop|Codon, UGA Stop|Terminator Codon, Amber|Codons, Ochre Stop|UGA Stop Codon|Codon, UAA Stop|Amber Terminator Codons|Codons, Terminator|Codons, UGA|Ochre Codon|Ochre Stop Codons|Codon, UGA|Codons, UAA|Stop Codon|Amber Terminator Codon|Codons, UAG Stop|Codon, Amber Terminator|Codon UAA, Stop|UAA Stop Codon"
NEW05647,BIOCHEMICAL,dopamine agonist action,dopamine agonist action
NEW05650,DISEASE,ars group,ARS group
NEW05651,DISEASE,ars-induced anxiety-like behavior,ARS-induced anxiety-like behavior
NEW05653,MENTAL_HEALTH,mutilation effect,mutilation effect
NEW05654,DISEASE,treatment-resistant psychiatric disorder,treatment-resistant psychiatric disorders
NEW05655,BIOCHEMICAL,future drug development,future drug developments
NEW05659,CHEMICAL,"npy1 receptor agonist leu31,pro34-npy","NPY1 receptor agonist Leu31,Pro34-NPY"
NEW05661,CHEMICAL,depression-behavior,depression-behaviors
NEW05662,DISEASE,social impairment,social impairments
NEW05663,CHEMICAL,melatonin secretion rhythm,melatonin secretion rhythm
NEW05665,BIOCHEMICAL,antipsychotic drug action,antipsychotic drug actions
NEW05666,MENTAL_HEALTH,schizophrenia pathophysiology,schizophrenia pathophysiology
NEW05668,MENTAL_HEALTH,hormone-induced depression,hormone-induced depression
NEW05669,DISEASE,spare nerve injury,spared nerve injury
NEW05671,DISEASE,pain behavior,pain behavior
http://purl.obolibrary.org/obo/MFOMD_0000004,MENTAL_HEALTH,mental disorder,various mental disorders
NEW05675,DISEASE,fxs improvement,FXS improvement
NEW05679,DISEASE,disorder vs.,disorders vs.
NEW05680,BIOCHEMICAL,exogenic carcinogenic agent,exogenic carcinogenic agents
NEW05681,CHEMICAL,chronic dopamine agonism,chronic dopamine agonism
NEW05682,DISEASE,striatal dopamine-receptor hypersensitivity,striatal dopamine-receptor hypersensitivity
NEW05684,CHEMICAL,mesocorticolimbic dopamine receptor,mesocorticolimbic dopamine receptors
NEW05685,DISEASE,tardive parkinsonism,tardive parkinsonism
NEW05686,MENTAL_HEALTH,extrapyramidal syndrome,extrapyramidal syndromes
NEW05687,DISEASE,bladder dysfunction,bladder dysfunction
NEW05688,BIOCHEMICAL,low-dose antibiotic,low-dose antibiotics
NEW05690,BIOCHEMICAL,drug burden,drug burden
NEW05691,BIOCHEMICAL,intravesical botulinum toxin,intravesical botulinum toxin
NEW05692,DISEASE,compensatory hyperhidrosis,compensatory hyperhidrosis
NEW05693,DISEASE,affective disorder patient,affective disorder patients
http://purl.obolibrary.org/obo/MFOMD_0000131,MENTAL_HEALTH,anergia,anergia
NEW05696,CHEMICAL,levodopa treatment,levodopa treatment
http://purl.obolibrary.org/obo/CHEBI_38706,CHEMICAL,pediculicide,pediculicides|emollient creams
D010621,CHEMICAL,Phenazopyridine,"Phenazopyridine Hydrochloride|Azo-Natural|Re-Azo|Azo Natural|ReAzo|UTI Relief|Urogesic|Azo Dine|Azo-Gesic|Azo Gesic|Phenazo|Pyridiate|Baridium|AzoNatural|Azo Standard|AzoGesic|Azo-Dine|AzoStandard|Prodium|Re Azo|phenazopyridine|Geridium|Azo-Standard|Pyridium|AzoDine|Hydrochloride, Phenazopyridine"
http://purl.obolibrary.org/obo/MFOMD_0000113,DISEASE,flashback,(PTSD)-related flashbacks
NEW05706,DISEASE,trauma associated-behavioral change,trauma associated-behavioral changes
NEW05709,CHEMICAL,mixed vasopressin type 1a receptor/vasopressin v2 receptor agonist vasopressor hormone arginine vasopressin,mixed vasopressin type 1a receptor/vasopressin V2 receptor agonist vasopressor hormone arginine vasopressin
NEW05710,DISEASE,pseudomonas aeruginosa pneumonia-induced severe sepsis,Pseudomonas aeruginosa pneumonia-induced severe sepsis
D016891,DISEASE,"Polycystic Kidney, Autosomal Dominant","Polycystic Kidney Disease, Type 2|Adult Polycystic Kidney Disease|ADPKD|Polycystic Kidney, Type 2 Autosomal Dominant Disease|Adult Polycystic Kidney Disease Type 2|Polycystic Kidney Disease, Autosomal Dominant|Kidney, Polycystic, Autosomal Dominant|Polycystic Kidney Disease 2|Polycystic Kidney, Type 1 Autosomal Dominant Disease|Polycystic Kidney Disease, Adult Type 2|Adult Polycystic Kidney Disease Type 1|Polycystic Kidney Disease, Adult, Type II|Polycystic Kidney Disease, Adult|Autosomal Dominant Polycystic Kidney|polycystic kidney disease"
http://purl.obolibrary.org/obo/DOID_0110861,DISEASE,autosomal recessive polycystic kidney disease,"Polycystic Kidney and Hepatic Disease 1|human autosomal recessive polycystic kidney disease|Pkhd1|Polycystic Kidney Disease, Infantile, Type I|Arpkd"
NEW05715,DISEASE,hypertension chronic kidney disease progression,hypertension chronic kidney disease progression
C537699,DISEASE,"Nephronophthisis, familial juvenile [Supplementary Concept]","nephronophthisis|Kidney Diseases, Cystic/congenital"
NEW05719,CHEMICAL,drug dysport,abobotulotoxin|drug dysport
NEW05720,CHEMICAL,guanosine triphosphate (gtp)-binding protein,guanosine triphosphate (GTP)-binding protein
NEW05721,CHEMICAL,mal quality,MAL quality
NEW05722,MENTAL_HEALTH,severe memory disorder,severe memory disorders
NEW05724,CHEMICAL,ziprasidone treatment,ziprasidone treatment
NEW05727,DISEASE,current pd treatment,current PD treatments
NEW05728,BIOCHEMICAL,adjuvant botulinum toxin a.,adjuvant botulinum toxin A.
NEW05729,DISEASE,genetic defect,genetic defects
NEW05731,DISEASE,life-threatening liver injury,life-threatening liver injury
C095470,CHEMICAL,"Grp protein, Zymomonas mobilis [Supplementary Concept]",DNA-Binding Proteins|glutamate uptake|Transcription Factors|Bacterial Proteins
NEW05734,DISEASE,neuropsychiatric alteration,neuropsychiatric alterations
NEW05737,DISEASE,motoric symptom,motoric symptoms
NEW05740,CHEMICAL,ketamine     mg,ketamine    mg
NEW05741,CHEMICAL,mg intravenous ketamine,mg intravenous ketamine
NEW05742,MENTAL_HEALTH,standard analgesia,standard analgesia
NEW05743,DISEASE,additional pain relief,additional pain relief
D020923,DISEASE,REM Sleep Parasomnias,"Parasomnias, REM Sleep|Erection, Sleep-Related Painful|Sleep-Related Painful Erection|Sleep, REM, Parasomnias|Parasomnia, REM Sleep|Sleep-Related Painful Erections|REM-atonia|Painful Erections, Sleep Related|Sinus Arrest, REM Sleep Related|Sleep Related Painful Erections|REM Sleep Related Sinus Arrest|Painful Erections, Sleep-Related|REM sleep|REM Sleep-Related Sinus Arrest|Erections, Sleep-Related Painful|REM Sleep Parasomnia|Rapid Eye Movement Sleep Parasomnias|Painful Erection, Sleep-Related|Sinus Arrest, REM Sleep-Related"
NEW05746,CHEMICAL,enzyme hypoxanthine-guanine phosphoribosyltransferase,enzyme hypoxanthine-guanine phosphoribosyltransferase
NEW05747,CHEMICAL,purine metabolism due,purine metabolism due
NEW05748,CHEMICAL,enzyme hypozanthine-guanine phosphoribosyltransferase,enzyme hypozanthine-guanine phosphoribosyltransferase
NEW05751,DISEASE,crps-i,CRPS-I
NEW05752,CHEMICAL,crps-ii,CRPS-II
NEW05753,CHEMICAL,ge;30,ge;30
NEW05754,DISEASE,probable ptsd symptom,probable PTSD symptoms
NEW05755,MENTAL_HEALTH,toxin-dependent sleepiness,toxin-dependent sleepiness
NEW05756,MENTAL_HEALTH,hypersomnic syndrome,hypersomnic syndromes
NEW05760,DISEASE,axillary hyperhidrosis,axillary hyperhidrosis
NEW05763,CHEMICAL,± 3(sd,± 3(SD
NEW05766,MENTAL_HEALTH,hyperactive syndrome,hyperactive syndromes
NEW05768,CHEMICAL,high da agonist,higher DA agonists
NEW05769,CHEMICAL,levodopa equivalent daily dose,levodopa equivalent daily dose
NEW05770,CHEMICAL,da agonist,DA agonists
NEW05771,CHEMICAL,antidepressant substance,antidepressant substances
NEW05777,MENTAL_HEALTH,drug-induced hallucination,drug-induced hallucinations
NEW05778,MENTAL_HEALTH,depression rating score,depression rating scores
NEW05781,DISEASE,ipsilateral gait alteration,ipsilateral gait alterations
NEW05782,DISEASE,significant neuron loss,significant neuron loss
NEW05783,DISEASE,phalange flaccidity,phalange flaccidity
C564593,DISEASE,"Gaze Palsy, Familial Horizontal, with Progressive Scoliosis [Supplementary Concept]","Scoliosis|Ophthalmoplegia, Chronic Progressive External|bilateral paralysis"
NEW05786,BIOCHEMICAL,effective drug,effective drug
NEW05799,CHEMICAL,potential antidepressant,potential antidepressants
NEW05802,MENTAL_HEALTH,depression rating scale,depression rating scales
NEW05803,CHEMICAL,glutamate receptor expression,glutamate receptor expression
NEW05804,DISEASE,steroid-independent sexual behavior,steroid-independent sexual behavior
NEW05805,DISEASE,neuroinflammation decrease,neuroinflammation decrease
NEW05807,CHEMICAL,voluntary alcohol consumption,voluntary alcohol consumption
NEW05808,CHEMICAL,α-msh mc4r signaling,α-MSH MC4R signaling
NEW05810,CHEMICAL,dopamine transporter level,dopamine transporter levels
NEW05811,DISEASE,bipolar depressive symptom,bipolar depressive symptoms
NEW05814,CHEMICAL,da therapy,DA therapy
C010169,CHEMICAL,glucose utilization inhibitor [Supplementary Concept],Peptides|glucose utilization
D006897,CHEMICAL,Hydroxyindoleacetic Acid,"Acid, 5-Hydroxy-3-Indoleacetic|Acetic Acid, 5-Hydroxyindolamine|5-Hydroxy-3-Indoleacetic Acid|Acid, 5-Hydroxyindolamine Acetic|Acid, Hydroxyindoleacetic|5-Hydroxyindolamine Acetic Acid|5 Hydroxy 3 Indoleacetic Acid|5 Hydroxyindolamine Acetic Acid|5-HIAA"
NEW05816,CHEMICAL,l fenfluramine,l fenfluramine
D049268,CHEMICAL,Positron-Emission Tomography,"Tomography, Positron-Emission|PET Imaging|Tomography Imaging, Positron-Emission|PET Imagings|PET Scan|Positron Emission Tomography Imaging|Positron-Emission Tomography Imaging|Positron Emission Tomography|positron-emission tomography|Positron-Emission Tomography Imagings|PET Scans|Imaging, Positron-Emission Tomography|Imaging, PET|Tomography, Positron Emission|Scan, PET"
NEW05820,DISEASE,parkinsonian side effect,parkinsonian side effects
NEW05822,DISEASE,pd motor function,PD motor function
NEW05826,CHEMICAL,dopamine deficiency,dopamine deficiency
NEW05827,DISEASE,ptsd-like manner,PTSD-like manner
NEW05828,DISEASE,rodent behavior,rodents behavior
NEW05829,CHEMICAL,avp signaling,AVP signaling
NEW05834,DISEASE,effective weight loss,effective weight loss
NEW05836,DISEASE,tumour mass,tumour mass
NEW05838,DISEASE,metabolic impairment,metabolic impairment
NEW05839,DISEASE,cerebral infarct area,cerebral infarct area
NEW05840,DISEASE,neurological deficit,neurological deficit
D002545,DISEASE,Brain Ischemia,"Cerebral Ischemia|Ischemia, Cerebral|Encephalopathy, Ischemic|brain ischemia|Ischemic Encephalopathies|Brain Ischemias|Ischemic Encephalopathy|Ischemias, Cerebral|Ischemia, Brain|Cerebral Ischemias"
NEW05841,DISEASE,great weight loss,greater weight loss
NEW05845,DISEASE,great mean weight loss,greater mean weight loss
NEW05846,CHEMICAL,fast glucose,fasting glucose
NEW05848,CHEMICAL,its 's antidepressant effect,antidepressant effect
NEW05851,DISEASE,reduce genotoxic damage,reduced genotoxic damage
NEW05852,DISEASE,throat tighten,throat tightening
NEW05855,DISEASE,convulsive-like behavior,convulsive-like behaviors
NEW05857,DISEASE,tremor-like behavior,tremor-like behaviors
NEW05859,BIOCHEMICAL,non-selective potent antagonist,non-selective potent antagonists
NEW05860,DISEASE,normal pain state,normal pain state
NEW05862,DISEASE,schizophrenia-like behavioural abnormality,schizophrenia-like behavioural abnormalities
NEW05863,DISEASE,behavioural abnormality,behavioural abnormalities
NEW05866,DISEASE,anti-inflammatory type-2 diabetes mellitus,anti-inflammatory type-2 diabetes mellitus
NEW05868,DISEASE,systemic inflammation,systemic inflammation
NEW05870,DISEASE,related cardiometabolic complication,related cardiometabolic complications
NEW05872,DISEASE,convulsive behavior,convulsive behavior
NEW05874,CHEMICAL,cb1r antagonist rimonabant,CB1R antagonist rimonabant
D061387,DISEASE,Chlamydial Pneumonia,"Pneumonia, Chlamydial|Chlamydophila Pneumonia|Chlamydophila Pneumonias|Pneumonias, Chlamydial|Chlamydial Pneumonias|Pneumonias, Chlamydophila|pneumonia|Pneumonia, Chlamydophila"
NEW05881,DISEASE,thyrotoxic state,thyrotoxic state
NEW05883,BIOCHEMICAL,inhibition ssri functionality,inhibition SSRI functionality
NEW05884,CHEMICAL,selective serotonin reuptake inhibition,selective serotonin reuptake inhibition
NEW05888,BIOCHEMICAL,d2r antagonist eticlopride,D2R antagonist eticlopride
NEW05890,DISEASE,levodopa-treated animal,levodopa-treated animals
NEW05891,CHEMICAL,dopamine producing cell,dopamine producing cells
NEW05892,DISEASE,abnormal degeneration,abnormal degeneration
NEW05893,DISEASE,chinese pd patient,Chinese PD patients
NEW05895,DISEASE,associate periodic leg movement,associated periodic leg movements
NEW05897,BIOCHEMICAL,stimulant agonist drug,stimulant agonist drugs
NEW05900,DISEASE,ten normoprolactinemic,ten normoprolactinemic
NEW05902,DISEASE,hyperprolactinemic patient,hyperprolactinemic patients
NEW05903,DISEASE,normoprolactinemic,normoprolactinemic
NEW05904,DISEASE,hyperprolactinemic group,hyperprolactinemic group
NEW05905,DISEASE,Buss Hostility Inventory,Buss Hostility Inventory
NEW05906,MENTAL_HEALTH,Hamilton Depression rating scale,Hamilton Depression Rating Scale
NEW05908,DISEASE,advanced pd,advanced PD
D000082882,DISEASE,Bicuspid Aortic Valve Disease,"valve disease|Aortic Valve, Bicuspid|Valve, Bicuspid Aortic|Bicuspid Aortic Valves|Aortic Valve Disease 1|Bicuspid Aortic Valve"
NEW05914,CHEMICAL,dl-mph stimulation,dl-MPH stimulation
NEW05915,CHEMICAL,urinary d-mph,urinary d-MPH
http://purl.obolibrary.org/obo/CHEBI_82181,CHEMICAL,perfluidone,l-EPH
NEW05917,MENTAL_HEALTH,adhd personalized medicine,ADHD personalized medicine
NEW05924,BIOCHEMICAL,psychostimulant drug,psychostimulant drug
NEW05925,CHEMICAL,oxide generation,oxide generation
NEW05928,DISEASE,few neurotoxic property,fewer neurotoxic properties
NEW05929,DISEASE,selective neuronal damage,selective neuronal damage
D010024,DISEASE,Osteoporosis,"Osteoporoses, Age-Related|Bone Losses, Age-Related|Osteoporosis, Senile|Osteoporosis, Post Traumatic|Age-Related Osteoporosis|Senile Osteoporoses|age-related|Age Related Osteoporosis|Bone Loss, Age Related|Osteoporoses|Osteoporosis, Post-Traumatic|Post-Traumatic Osteoporosis|Osteoporosis, Age Related|Post-Traumatic Osteoporoses|Age-Related Osteoporoses|Osteoporoses, Senile|Age-Related Bone Losses|Senile Osteoporosis|Osteoporosis, Age-Related|Osteoporosis, Involutional|Bone Loss, Age-Related|Age-Related Bone Loss"
NEW05930,MENTAL_HEALTH,cerebrovascular memory disorder,cerebrovascular memory disorders
NEW05934,CHEMICAL,oral clozapine administration,oral clozapine administration
NEW05937,CHEMICAL,high caffeine intake,high caffeine intake
NEW05939,DISEASE,hepatic siderosis,hepatic siderosis
C488998,CHEMICAL,"SLC25A2 protein, human [Supplementary Concept]","Amino Acid Transport Systems, Basic|mitochondrial ornithine transporter"
NEW05944,MENTAL_HEALTH,severe alzheimer disease,severe Alzheimer disease
NEW05946,CHEMICAL,long-acting gonadotrophin hormone releasing hormone analogue,long-acting gonadotrophin hormone releasing hormone analogue
NEW05949,BIOCHEMICAL,gnrh-a program,GnRH-a program
NEW05950,DISEASE,cardiovascular disorder,cardiovascular disorders
NEW05951,CHEMICAL,extracellular serotonin,extracellular serotonin
NEW05953,BIOCHEMICAL,5-ht agonist metachlorophenylpiperazine,5-HT agonist metachlorophenylpiperazine
NEW05954,DISEASE,various addiction disorder,various addiction disorders
NEW05957,DISEASE,cranial nerve neuralgias,cranial nerve neuralgias
NEW05959,CHEMICAL,5-ht tone,5-HT tone
NEW05960,DISEASE,behavioral impulsiveness,behavioral impulsiveness
NEW05962,CHEMICAL,high peak m-cpp level,higher peak m-CPP levels
NEW05966,DISEASE,spatial memory impairment,spatial memory impairment
NEW05968,NUTRITION,today 's lithium therapy,today's lithium therapy
NEW05972,DISEASE,stz-induced diabete,STZ-induced diabetes
D020165,CHEMICAL,Carbamoyl-Phosphate Synthase I Deficiency Disease,"Carbamyl Phosphate Synthetase (CPS) Deficiency|Carbamyl-Phosphate Synthetase I Deficiency Disease|Carbamoyl-Phosphate Synthetase I Deficiency Disease|Carbamyl-Phosphate Synthetase 1 Deficiency Disease|Carbamyl Phosphate Synthetase I Deficiency Disease|CPS I Deficiencies|Carbamyl Phosphate Synthetase Deficiency Disease|Carbamoyl Phosphate Synthetase I Deficiency Disease|CPS I Deficiency|Carbamoyl Phosphate Synthase 1 Deficiency Disease|CPS 1 Deficiencies|Hyperammonemia Due to Carbamoyl Phosphate Synthetase 1 Deficiency|Carbamoyl Phosphate Synthase 1 Deficiency|Carbamoylphosphate Synthetase 1 Deficiency Disease -|Carbamoylphosphate Synthetase 1 Deficiency Disease|Carbamoyl Phosphate Synthetase I Deficiency, Hyperammonemia Due To|Carbamyl Phosphate Synthetase 1 Deficiency Disease|Carbamoylphosphate Synthetase I Deficiency Disease|CPS 1 Deficiency|Carbamoyl Phosphate Synthase (Ammonia) Deficiency Disease|Carbamoyl-Phosphate Synthase 1 Deficiency Disease (Ornithine Carbamoyl Phosphate Deficiency)|Carbamoyl-Phosphate Synthase I Deficiency Disease (Ornithine Carbamoyl Phosphate Deficiency)|carbamoyl phosphate synthase|Carbamoyl Phosphate Synthase 1 Deficiency Disease (Ornithine Carbamoyl Phosphate Deficiency)|Carbamoyl Phosphate Synthetase I Deficiency|Carbamoyl-Phosphate Synthase 1 Deficiency Disease"
D020163,CHEMICAL,Ornithine Carbamoyltransferase Deficiency Disease,"Deficiencies, OTC|Deficiency Disease, Ornithine Transcarbamylase|OTC Deficiencies|Ornithine Carbamoyltransferase Deficiency|Deficiencies, Ornithine Transcarbamylase|ornithine transcarbamylase|Deficiency, Ornithine Transcarbamylase|Deficiency Disease, Ornithine Carbamoyltransferase|Ornithine Transcarbamylase Deficiencies|Ornithine Transcarbamylase Deficiency|Deficiency, OTC|OTC Deficiency|Ornithine Transcarbamylase Deficiency Disease|Ornithine Transcarbamylase Deficiency, Hyperammonemia Due To"
NEW05975,CHEMICAL,urea cycle enzyme,urea cycle enzymes
NEW05979,MENTAL_HEALTH,stress-induced anxiety,stress-induced anxiety
D002252,CHEMICAL,Carbon Tetrachloride Poisoning,"CCl4 Poisoning|Carbon Tetrachloride Poisonings|CCl4 Poisonings|Poisoning, CCl4|carbon tetrachloride|Poisonings, Carbon Tetrachloride|Poisoning, Carbon Tetrachloride"
D013939,CHEMICAL,Thymidine Phosphorylase,thymidine phosphorylase|Platelet Derived Endothelial Cell Growth Factor|Gliostatin|Platelet-Derived Endothelial Cell Growth Factor|PD-ECGF
NEW05985,CHEMICAL,mitochondrial dna mtdna deoxyribonucleoside triphosphate,mitochondrial DNA mtDNA deoxyribonucleoside triphosphates
http://purl.obolibrary.org/obo/CHEBI_17972,CHEMICAL,ribonucleoside triphosphate,Ribonucleoside triphosphate|dNTPs|deoxyribonucleoside triphosphates|ribonucleoside triphosphates
NEW05986,CHEMICAL,purine salvage pathway,purine salvage pathway
NEW05988,CHEMICAL,covid-19 outbreak,COVID-19 outbreak
NEW05989,CHEMICAL,peroxynitrite- apoptosis,peroxynitrite- apoptosis
NEW05990,CHEMICAL,striatal superoxide dismutase,striatal superoxide dismutase
C485766,DISEASE,"Ero1a protein, rat [Supplementary Concept]",global ischemia|Membrane Glycoproteins
http://purl.obolibrary.org/obo/DOID_11119,MENTAL_HEALTH,gilles de la tourette syndrome,Guinon's disease|Psychogenic tics|Tourette syndrome|motor-verbal tic disorder|Gille de la Tourette syndrome
NEW05992,DISEASE,chronic degenerative disease,chronic degenerative diseases
NEW05998,CHEMICAL,capsaicin test,capsaicin test
NEW06000,DISEASE,unregulated inflammation,unregulated inflammation
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Female_Sexual_Dysfunction,MENTAL_HEALTH,female sexual dysfunction,female sexual dysfunction
NEW06002,MENTAL_HEALTH,male erectile dysfunction,male erectile dysfunction
NEW06003,DISEASE,micro-element,micro-elements
NEW06004,CHEMICAL,second-choice approach,second-choice approach
NEW06005,BIOCHEMICAL,hormone due,hormones due
NEW06007,DISEASE,schizophrenic patient intolerant,schizophrenic patients intolerant
NEW06008,CHEMICAL,conclusion second-line choice,conclusion second-line choice
NEW06009,DISEASE,intractable vomiting,intractable vomiting
NEW06010,DISEASE,refractory vomiting,refractory vomiting
NEW06014,DISEASE,csds initiation,CSDS initiation
NEW06015,DISEASE,behavior impairment,behavior impairments
NEW06016,CHEMICAL,serotonin neuronal activity,serotonin neuronal activity
NEW06017,BIOCHEMICAL,potential spinal analgesic action,potential spinal analgesic action
NEW06020,DISEASE,sleep confusion,sleeping confusions
NEW06021,CHEMICAL,pro-inflammatory cytokine,pro-inflammatory cytokines
NEW06022,DISEASE,labile hypertension,labile hypertension
NEW06023,DISEASE,hypertensive subject,hypertensive subjects
NEW06025,CHEMICAL,2-ag signaling,2-AG signaling
NEW06026,BIOCHEMICAL,cb1 receptor antagonists/inverse agonist,CB1 receptor antagonists/inverse agonists
NEW06028,BIOCHEMICAL,prototype cb1 receptor antagonists/inverse agonist,prototype CB1 receptor antagonists/inverse agonists
NEW06030,DISEASE,psychotic reaction,psychotic reactions
NEW06031,CHEMICAL,delta(9)-tetrahydrocannabinol characteristic psychomotor effect,Delta(9)-Tetrahydrocannabinol characteristic psychomotor effects
NEW06034,DISEASE,serious psychiatric side effect,serious psychiatric side effects
NEW04522,MENTAL_HEALTH,pathological anxiety,pathological anxiety
NEW06038,BIOCHEMICAL,drug intake,drug intake
C531600,BIOCHEMICAL,Growth hormone excess [Supplementary Concept],Acromegaly|hormone excess
NEW06039,CHEMICAL,universal somatostatin receptor agonist pasireotide,universal somatostatin receptor agonist pasireotide
NEW06040,DISEASE,behavioural syndrome,behavioural syndrome
NEW06042,DISEASE,myoclonic jerking movement,myoclonic jerking movements
NEW06047,DISEASE,distinct schizophrenic subgroup,distinct schizophrenic subgroup
NEW06048,MENTAL_HEALTH,oc schizophrenia,OC schizophrenia
NEW06050,DISEASE,human narcoleptic patient,human narcoleptic patients
NEW06051,MENTAL_HEALTH,worldwide abuse problem,worldwide abuse problem
NEW06052,CHEMICAL,testosterone dysregulation,testosterone dysregulation
NEW06054,DISEASE,significant spatial memory impairment,significant spatial memory impairment
D047072,CHEMICAL,Aromatase Inhibitors,"Inhibitors, Aromatase|aromatase inhibitors|Inhibitor, Aromatase|AI|Aromatase Inhibitor"
NEW06058,DISEASE,systematic rheumatic disease,systematic rheumatic diseases
NEW06059,DISEASE,astrocytic atrophy,astrocytic atrophy
NEW06063,DISEASE,bipolar woman,bipolar women
NEW06065,CHEMICAL,serotonin circuit,serotonin circuits
NEW06066,BIOCHEMICAL,gonadal hormone influence,gonadal hormone influence
NEW06067,DISEASE,anxiety-type behavior,anxiety-type behaviors
NEW06068,DISEASE,mood behavior,mood behaviors
C537436,DISEASE,Aromatase deficiency [Supplementary Concept],"Metabolism, Inborn Errors|Aromatase/deficiency|Gynecomastia|46, XX Disorders of Sex Development|Infertility, Male|placental aromatase deficiency"
NEW06072,BIOCHEMICAL,androgen androgen sensitivity,androgens androgen sensitivity
http://purl.obolibrary.org/obo/DOID_1414,DISEASE,ovarian dysfunction,ovarian dysfunctions
D024282,CHEMICAL,"Genes, sry","Sex-Related Gene On Y|Sex-Related Y Gene|Gene, sry|sry Genes|Gene, Sex Determining Region Y|Gene, Sex-Related Y|Sex-Related Y Genes|Sex-Determining Region Gene On Y|sry Gene|Sry|Y Gene, Sex-Related|Genes, Sex-Related Y|Sex Related Gene On Y|Sex Determining Region Gene On Y|Gene, Sex-Determining Region Y|Genes, Sex Related Y|Y Genes, Sex-Related"
C567552,DISEASE,Spondylodysplasia And Premature Pubarche [Supplementary Concept],"Osteochondrodysplasias|premature pubarche|Puberty, Precocious|Spine/abnormalities"
NEW06078,CHEMICAL,2.09±1.42,2.09±1.42
NEW06079,DISEASE,insulin instability,insulin instability
http://www.semanticweb.org/ontologies/2015/0/disorderscluster.owl#Symptomology,DISEASE,symptomology,PCOS symptomatology
NEW06080,DISEASE,ra patient,RA patients
NEW06083,BIOCHEMICAL,hormone sex chromosome,hormones sex chromosomes
NEW06087,DISEASE,als motoneuron recovery,ALS motoneuron recovery
NEW06088,DISEASE,anticonvulsant reversible hepatic dysfunction,anticonvulsant reversible hepatic dysfunction
NEW06089,DISEASE,irreversible hepatic failure,irreversible hepatic failure
NEW06091,DISEASE,additional neurological disease,additional neurological disease
NEW06092,CHEMICAL,enzyme-inducing drug,enzyme-inducing drugs
NEW06096,CHEMICAL,atp level,ATP level
NEW06097,CHEMICAL,deplete monoamine,depleted monoamines
NEW06098,DISEASE,alcohol-related illness,alcohol-related illness
C016470,BIOCHEMICAL,"ascorbic acid, B2, B6, bendazol, caffeine, citric acid, distilled H2O, ethanol, gelatin, glutamic acid, KCl, MgCl2, NaCl, sorbitol, sucrose, vitamins B1 drug combination [Supplementary Concept]",vitamins B1|Drug Combinations|Glutamates|Hexoses
NEW06100,CHEMICAL,gamma-glutamyl transferase,gamma-glutamyl transferase
NEW06102,DISEASE,group 3-without extensive liver cell damage,group 3-without extensive liver cell damage
NEW06103,DISEASE,group cirrhosis,group cirrhosis
NEW06104,DISEASE,group 2-with extensive liver cell damage,group 2-with extensive liver cell damage
http://purl.obolibrary.org/obo/SYMP_0000654,DISEASE,irritability,Inconsolability|irritability
NEW06106,CHEMICAL,benzodiazepine receptor antagonist flumazenil,benzodiazepine receptor antagonist flumazenil
NEW06109,CHEMICAL,stress-hormone system,stress-hormone system
NEW06111,CHEMICAL,network 's dopamine system,network's dopamine system
NEW06115,DISEASE,stz-induced learning deficit,STZ-induced learning deficit
NEW06119,CHEMICAL,food(s,food(s
NEW06120,DISEASE,intestinal symptom,intestinal symptoms
NEW06122,CHEMICAL,excessive dietary calcium,excessive dietary calcium
NEW06125,MENTAL_HEALTH,disease-related fatigue,disease-related fatigue
NEW06126,MENTAL_HEALTH,conclusion mental fatigue,conclusion mental fatigue
NEW06127,CHEMICAL,neuroprotective steroid,neuroprotective steroid
NEW06128,DISEASE,tat-related behavioral impairment,Tat-related behavioral impairments
NEW06131,DISEASE,female sexual disorder,female sexual disorders
NEW06134,DISEASE,moderate acne vulgaris,moderate acne vulgaris
D011980,CHEMICAL,"Receptors, Progesterone","Receptor, Progestin|Progesterone Receptors|progesterone receptors|Receptors, Progestin|Progestin Receptor|Receptor, Progesterone|Progestin Receptors|Progesterone Receptor"
NEW06136,DISEASE,heavy bleeding,heavy bleeding
NEW06138,CHEMICAL,term hrt,term HRT
NEW06139,DISEASE,low fracture incidence,lower fracture incidence
NEW06142,DISEASE,cardiovascular disease prevention,cardiovascular disease prevention
NEW06144,DISEASE,estrogen-dependent breast adenocarcinoma cell,estrogen-dependent breast adenocarcinoma cells
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Respiratory_Tract_Disorders,DISEASE,respiratory tract disorders,respiratory tract disorders
NEW06148,DISEASE,severe neuron damage,severe neuron damage
NEW06149,DISEASE,early pd,early PD
NEW06150,CHEMICAL,midbrain dopamine neuron,midbrain dopamine neurons
NEW06151,DISEASE,profound neurodegeneration,profound neurodegeneration
NEW06154,DISEASE,digestive complaint,digestive complaints
NEW06157,DISEASE,depressive thought,depressive thoughts
NEW06159,DISEASE,acute psychotic decompensation,acute psychotic decompensation
NEW06160,BIOCHEMICAL,main toxic agent,main toxic agent
NEW06164,NUTRITION,angelica injection,angelica injection
D029971,NUTRITION,Angelica sinensis,"Angelica sinenses|sinenses, Angelica|angelica"
NEW06168,DISEASE,pre- peri- woman,pre- peri- women
NEW06169,CHEMICAL,corticosterone cort model,corticosterone CORT model
NEW06171,DISEASE,neurogenic pulmonary edema,neurogenic pulmonary edema
NEW06173,CHEMICAL,fasting blood glucose,mg/dl fasting blood glucose|fasting blood glucose
NEW06175,CHEMICAL,rehmannia glutionsa Libosch,Rehmannia glutionsa Libosch
NEW06176,DISEASE,inflammatory injury,inflammatory injury
NEW06177,DISEASE,hyperammonemia generation,hyperammonemia generation
NEW06179,DISEASE,decrease blood ammonia,decreased blood ammonia
NEW06180,DISEASE,meth-induced neurotoxicity,METH-induced neurotoxicity
NEW06181,DISEASE,protein malnutrition,protein malnutrition
NEW06182,DISEASE,persistent maladaptive gambling behavior,persistent maladaptive gambling behavior
NEW06186,DISEASE,adhd-like hyperactive behavior,ADHD-like hyperactive behavior
NEW06189,MENTAL_HEALTH,adhd neuropathology,ADHD neuropathology
NEW06191,DISEASE,hyperactive behavior,hyperactive behavior
NEW06192,CHEMICAL,vehicle-treated OPAE,vehicle-treated OPAE
NEW06195,MENTAL_HEALTH,low social anxiety,lower social anxiety
NEW06196,DISEASE,social pain,social pain
NEW06199,CHEMICAL,low-calorie food,low-calorie foods
NEW06200,DISEASE,animal cancer bioassay,animal cancer bioassays
NEW06202,DISEASE,exceptional conformational rigidity,exceptional conformational rigidity
C044283,DISEASE,lipid X [Supplementary Concept],E. coli lipid A.|Glycolipids
NEW06203,CHEMICAL,sugar scaffold,sugar scaffold
NEW06205,MENTAL_HEALTH,bind orientation,binding orientation
NEW06207,MENTAL_HEALTH,resistance homa-ir index,Resistance HOMA-IR index
NEW06209,DISEASE,parkinsonian phenotype,parkinsonian phenotype
NEW06210,DISEASE,reserpine-induced hypothermia,reserpine-induced hypothermia
NEW06213,CHEMICAL,b-ht920 great,B-HT920 greater
NEW06215,CHEMICAL,non-nmda glutamate antagonist,non-NMDA glutamate antagonists
NEW06217,DISEASE,neurotoxic reaction,neurotoxic reaction
NEW06219,DISEASE,auditory prepulse inhibition,auditory prepulse inhibition
NEW06220,CHEMICAL,cortical 5-ht,cortical 5-HT
NEW06223,DISEASE,stress-induced lung metastasis,stress-induced lung metastasis
NEW06225,DISEASE,swim-induced hyperalgesia,swim-induced hyperalgesia
NEW06228,MENTAL_HEALTH,corticotropin-releasing hormone-induced anxiety,corticotropin-releasing hormone-induced anxiety
NEW06229,DISEASE,month hypertension,months hypertension
NEW06230,DISEASE,ventricular arrhythmia,ventricular arrhythmia
NEW06232,DISEASE,stress-induced cardiomyopathy,stress-induced cardiomyopathy
NEW06233,CHEMICAL,excessive extracellular dopamine,excessive extracellular dopamine
NEW06235,BIOCHEMICAL,central alpha-adrenoreceptor agonist,central alpha-adrenoreceptor agonists
NEW06242,MENTAL_HEALTH,due transient hallucination,due transient hallucinations
NEW06247,DISEASE,high csf crf,high CSF CRF
NEW06248,DISEASE,system crf activity,system CRF activity
NEW06249,BIOCHEMICAL,neonatal narcotic addiction,neonatal narcotic addiction
NEW06250,CHEMICAL,alcohol detoxification,alcohol detoxification
NEW06253,BIOCHEMICAL,α2-adrenergic agonist medication,α2-adrenergic agonist medications
D000074022,DISEASE,"Anesthesia, Cardiac Procedures","Cardiac Anesthesia|Anesthesia, Cardiothoracic|Cardiac Procedures Anesthesia|Anesthesias, Cardiac Procedures|Cardiac Anaesthesia|Anesthesia, Cardiovascular|Cardiac Procedures Anesthesias|Anesthesia, Cardiac|Anaesthesia, Cardiothoracic|Cardiac Anaesthesias|Cardiovascular Anesthesia|cardiac procedures|Cardiothoracic Anaesthesia|Cardiothoracic Anesthesia"
NEW06255,DISEASE,maladaptive behavior,maladaptive behaviors
NEW06257,CHEMICAL,gxr efficacy,GXR efficacy
NEW06259,DISEASE,chf patient,CHF patients
NEW06262,DISEASE,article neurodegeneration,article neurodegeneration
NEW06263,CHEMICAL,reduce acetylcholine esterase,reduced acetylcholine esterase
NEW06265,CHEMICAL,subacute cpf,subacute CPF
NEW06266,DISEASE,lps-induced depressive-like behavior,LPS-induced depressive-like behaviors
NEW06268,BIOCHEMICAL,dopamine d1/d2 receptor agonist,dopamine D1/D2 receptor agonist
NEW06271,BIOCHEMICAL,selective sigma-1 receptor antagonist ne-100,selective sigma-1 receptor antagonist NE-100
NEW06272,CHEMICAL,neurosteroid dehydroepiandrosterone 3-sulfate,neurosteroid dehydroepiandrosterone 3-sulfate
NEW06273,CHEMICAL,selective sigma-1 receptor agonist sa4503,selective sigma-1 receptor agonist SA4503
NEW06274,CHEMICAL,dhea-s,DHEA-S
NEW06275,MENTAL_HEALTH,contrary high anxiety,contrary higher anxiety
NEW06276,MENTAL_HEALTH,caffeine-induced anxiety,caffeine-induced anxiety
NEW06278,DISEASE,depressive animal model,depressive animal model
NEW06281,DISEASE,decrease sexual motivation,decreased sexual motivation
NEW06282,DISEASE,orgasm difficulty,orgasm difficulties
NEW06283,CHEMICAL,5-ht1a receptor agonist buspirone,5-HT1A receptor agonist buspirone
NEW06285,BIOCHEMICAL,endocrine tissue,endocrine tissues
NEW06286,DISEASE,increase neoplasia incidence,increased neoplasia incidence
NEW06287,BIOCHEMICAL,prolactin receptor-expressing endocrine tissue,prolactin receptor-expressing endocrine tissues
C537716,DISEASE,Macrocephaly mesodermal hamartoma spectrum [Supplementary Concept],Proteus Syndrome|macrocephaly
NEW06288,DISEASE,axonal remodeling,axonal remodeling
C491521,CHEMICAL,"CPI-17 protein, Oryctolagus cuniculus [Supplementary Concept]",CPI-17|Muscle Proteins|Phosphoproteins
NEW06290,DISEASE,cognitive competence,cognitive competence
NEW06293,CHEMICAL,dopamine receptor subtype,dopamine receptor subtypes
NEW06296,DISEASE,its 's toxicity,toxicity
D011141,DISEASE,Polyuria,polyuria|Polyurias
D005923,DISEASE,"Glomerulosclerosis, Focal Segmental","Glomerulonephritis, Focal Sclerosing|Hyalinosis, Segmental Glomerular|Sclerosing Glomerulonephritides, Focal|Focal Segmental Glomerulosclerosis|focal glomerulosclerosis|Sclerosing Glomerulonephritis, Focal|Focal Glomerulosclerosis|Glomerular Hyalinosis, Segmental|Segmental Hyalinosis|Focal Sclerosing Glomerulonephritis|Segmental Glomerular Hyalinosis|Hyalinosis, Segmental|Focal Sclerosing Glomerulonephritides|Glomerulosclerosis, Focal|Glomerulonephritides, Focal Sclerosing|Segmental Glomerulosclerosis, Focal"
D009395,DISEASE,"Nephritis, Interstitial","Tubulointerstitial Nephritides|Nephritides, Interstitial|Tubulointerstitial Nephritis|Interstitial Nephritis|Nephritis, Tubulointerstitial|Interstitial Nephritides|Nephritides, Tubulointerstitial|interstitial nephritis"
NEW06299,DISEASE,glomerular disease,glomerular disease
NEW06303,DISEASE,acute kidney disease,acute kidney disease
NEW06306,CHEMICAL,beta-amyloid protein inhibition,beta-amyloid protein inhibition
http://purl.obolibrary.org/obo/DOID_705,DISEASE,leber hereditary optic neuropathy,Leber 's hereditary optic neuropathy|Leber's hereditary optic neuropathy|LHON|Leber's optic atrophy
D050768,CHEMICAL,Protoporphyrinogen Oxidase,"Protoporphyrinogen Dehydrogenase|Dehydrogenase, Protoporphyrinogen|Protoporphyrinogen IX Oxidase|Oxidase, Protoporphyrinogen|protoporphyrinogen oxidase|Oxidase, Protoporphyrinogen IX|Protoporphyrinogenase|Protox"
NEW06309,CHEMICAL,extracellular dopamine,extracellular dopamine
NEW06310,CHEMICAL,phosphorylate dopamine transporter,phosphorylated dopamine transporter
D017102,DISEASE,Fracture Healing,"Healing, Fracture|fracture healing|Healings, Fracture|Fracture Healings"
NEW06313,DISEASE,obvious depression-like behavior,obvious depression-like behaviors
NEW06314,CHEMICAL,interleukin-6 level,interleukin-6 levels
NEW06318,DISEASE,neurogenetic change,neurogenetic changes
NEW06320,BIOCHEMICAL,dopamine agonist treatment,dopamine agonist treatment
NEW06321,DISEASE,emotional deficit,emotional deficits
NEW06324,CHEMICAL,hz power/coherence,Hz power/coherence
NEW06326,DISEASE,drug-induced extrapyramidal reaction,drug-induced extrapyramidal reactions
NEW06329,DISEASE,severe withdrawal syndrome,severe withdrawal syndrome
NEW06331,MENTAL_HEALTH,case catatonic delirium,case catatonic delirium
NEW06332,CHEMICAL,outpatient amantadine,outpatient amantadine
D065606,DISEASE,Metabolic Side Effects of Drugs and Substances,Metabolic Side Effects of Substances|Substance Effects on Metabolism|effects|Drug Effects on Metabolism|Metabolic Side Effects of Drugs
NEW06334,DISEASE,cardinal motor parkinsonian symptom,cardinal motor parkinsonian symptoms
NEW06335,DISEASE,conditioned-avoidance respond behavior,conditioned-avoidance responding behaviors
NEW06338,DISEASE,functional psychosis,functional psychoses
NEW06339,CHEMICAL,risperidone classical antipsychotic,risperidone classical antipsychotics
NEW06341,MENTAL_HEALTH,antipsychotic-induced sexual dysfunction,antipsychotic-induced sexual dysfunction
NEW06343,DISEASE,invasive giant prolactinoma,invasive giant prolactinoma
NEW06344,MENTAL_HEALTH,abuse tobacco,abuse tobacco
NEW06345,CHEMICAL,nicotine replacement therapy,nicotine replacement therapy
NEW06346,DISEASE,reward dependence,reward dependence
NEW06347,CHEMICAL,amphetamine administration,amphetamine administration
NEW06349,MENTAL_HEALTH,parkinson disease psychosis,Parkinson disease psychosis
NEW06354,DISEASE,dependent depression,dependent depressions
NEW06357,DISEASE,self-mutilation behavior,self-mutilation behavior
NEW06360,CHEMICAL,pramipexole mg,pramipexole mg
NEW06363,CHEMICAL,purine salvage,purine salvage
NEW06365,CHEMICAL,immobile purine base,immobile purine base
NEW06366,DISEASE,lupus patient,lupus patients
NEW06368,DISEASE,adverse neuropsychiatric event,adverse neuropsychiatric events
NEW06371,DISEASE,lupus nephritis class,lupus nephritis classes
D008181,DISEASE,Lupus Nephritis,"Glomerulonephritides, Lupus|lupus nephritis|Lupus Glomerulonephritides|Lupus Nephritides|Lupus Glomerulonephritis|Glomerulonephritis, Lupus|Nephritides, Lupus|Nephritis, Lupus"
NEW06373,DISEASE,refractory lupus nephritis patient,refractory lupus nephritis patients
NEW06374,CHEMICAL,inhibitor use,inhibitor use
NEW06377,BIOCHEMICAL,v1a antagonist,V1a antagonists
NEW06379,CHEMICAL,continuous vasopressin v(2 receptor stimulation,continuous vasopressin V(2 receptor stimulation
NEW06381,DISEASE,hyponatremic rat,hyponatremic rats
NEW06382,CHEMICAL,avp receptor modulator,AVP receptor modulators
NEW06384,CHEMICAL,arginine vasopressin (avp)-receptor antagonist,arginine vasopressin (AVP)-receptor antagonists
NEW06386,DISEASE,renal glomerular endotheliosis,renal glomerular endotheliosis
NEW06388,CHEMICAL,placental fms-like tyrosine kinase-1,placental fms-like tyrosine kinase-1
NEW06390,DISEASE,renal pathology,renal pathologies
NEW06391,BIOCHEMICAL,arginine vasopressin hormone responsible,arginine vasopressin hormone responsible
NEW06392,CHEMICAL,low plasma arginine vasopressin hormone level,low plasma arginine vasopressin hormone levels
NEW06393,CHEMICAL,v(2)-receptor due,V(2)-receptor due
NEW06397,DISEASE,ocular symptom,ocular symptoms
NEW06400,CHEMICAL,h. kainic acid,h. Kainic acid
NEW06401,CHEMICAL,kainate administration,kainate administration
NEW06402,MENTAL_HEALTH,food-elicite Cataplexy Test,Food-Elicited Cataplexy Test
C042375,CHEMICAL,"4-diphenylacetoxy-1,1-dimethylpiperidinium [Supplementary Concept]",4-DAMP|Piperidines
D005703,CHEMICAL,Gallamine Triethiodide,"Gallamonium Iodide|Gallamine Triethochloride|gallamine|Flaxedil|Iodide, Gallamonium|Iodide, Gallamine Triethyl|Triethyl Iodide, Gallamine|Gallamine|Triethochloride, Gallamine|Triethiodide, Gallamine|Gallamine Triethyl Iodide"
NEW06404,DISEASE,related neurodegenerative dementia,related neurodegenerative dementias
C500712,DISEASE,"NOP53 protein, human [Supplementary Concept]",Tumor Suppressor Proteins|human glioma
NEW06409,MENTAL_HEALTH,volatile substance abuse,volatile substance abuse
NEW06412,DISEASE,functional damage,functional damage
NEW06413,DISEASE,overall brain damage,overall brain damage
NEW06414,DISEASE,motor damage,motor damage
NEW06416,MENTAL_HEALTH,recognition memory disorder,recognition memory disorders
http://purl.obolibrary.org/obo/DOID_9191,CHEMICAL,diabetic macular edema,diabetic macular oedema|DME
NEW06420,DISEASE,impaired visual acuity,impaired visual acuity
NEW06422,DISEASE,impaired memory,impaired memory
NEW06424,NUTRITION,inorganic mercury compound,inorganic mercury compounds
NEW06430,MENTAL_HEALTH,suicide gesture,suicide gesture
http://purl.obolibrary.org/obo/CHEBI_35113,NUTRITION,elemental mercury,elemental mercury
NEW06432,MENTAL_HEALTH,multiple regression model,multiple regression models
NEW06434,DISEASE,cardiovascular system hypertension,cardiovascular system hypertension
NEW06435,NUTRITION,chronic mercury intoxication,chronic mercury intoxication
D000077215,DISEASE,Clay,Clays|Halloysites|Halloysite|clay
NEW06437,DISEASE,gastrointestinal obstruction,gastrointestinal obstructions
NEW06438,NUTRITION,starch ingestion,starch ingestion
NEW06443,DISEASE,drug-free psychiatric inpatient,drug-free psychiatric inpatients
D000786,DISEASE,Anger,anger|Angers
NEW06449,DISEASE,severe hyperammonemia,severe hyperammonemia
NEW06450,CHEMICAL,phenylacetylglutamine rare genetic disorder,phenylacetylglutamine rare genetic disorders
NEW06451,CHEMICAL,urinary phenylacetylglutamine,urinary phenylacetylglutamine|PAGN
NEW06453,MENTAL_HEALTH,adhd subject,ADHD subjects
NEW06454,CHEMICAL,aas abuser,AAS abusers
NEW06455,BIOCHEMICAL,m1-type novel m1 agonist,M1-type novel M1 agonist
NEW06456,MENTAL_HEALTH,experimental amnesia,experimental amnesia
NEW06457,DISEASE,stress-induced cognitive impairment,stress-induced cognitive impairment
http://cbmi.med.harvard.edu/asdphenotype#Class_218,DISEASE,impatience,suspiciousness
NEW06460,DISEASE,behavioral disturbance,behavioral disturbance
NEW06461,DISEASE,vocal outburst,vocal outbursts
NEW06462,CHEMICAL,various dopamine model,various dopamine models
NEW06463,CHEMICAL,formulation xanomeline adverse effect,formulation xanomeline adverse effects
NEW06465,DISEASE,pilocarpine-induced seizure,pilocarpine-induced seizures
NEW06466,DISEASE,pilocarpine-induced tremor,pilocarpine-induced tremor
NEW06467,CHEMICAL,fyn kinase,Fyn kinase
NEW06468,CHEMICAL,hippocampal ach release,hippocampal ACh release
NEW06470,DISEASE,various neuropathic pain syndrome,various neuropathic pain syndromes
NEW06472,DISEASE,a infection,A infection
NEW06475,DISEASE,persistent pain,persistent pain
NEW06477,DISEASE,cutaneous inflammation model,cutaneous inflammation models
NEW06479,DISEASE,persistent tachypnoea,persistent tachypnoea
NEW06480,CHEMICAL,5-ht serum level,5-HT serum levels
NEW06481,CHEMICAL,perforin b,perforin B
NEW06483,CHEMICAL,mm fecl3,mM FeCl3
NEW06485,MENTAL_HEALTH,depression management,depression management
NEW06491,CHEMICAL,testosterone secretion,testosterone secretion
NEW06492,DISEASE,deviant sexual behavior,deviant sexual behavior
NEW06494,CHEMICAL,mesocortical dopamine pathway,mesocortical dopamine pathway
NEW06498,DISEASE,preexist psychiatric illness,preexisting psychiatric illness
NEW06500,CHEMICAL,combination contraceptive,combination contraceptives
NEW06502,CHEMICAL,toxicity-serotonin toxicity,toxicity-serotonin toxicity
D020211,DISEASE,Autonomic Dysreflexia,"Dysreflexias, Autonomic|Spinal Autonomic Dysreflexias|Hyperreflexias, Autonomic|Autonomic Dysreflexias|Hyperreflexia, Autonomic|Autonomic Dysreflexia, Spinal|Autonomic Dysreflexias, Spinal|Autonomic Hyperreflexia|Dysreflexia, Autonomic|hyperreflexia|Spinal Autonomic Dysreflexia|Dysreflexia, Spinal Autonomic|Autonomic Hyperreflexias|Dysreflexias, Spinal Autonomic"
NEW06504,DISEASE,hyperthermia flush,hyperthermia flushing
NEW06506,DISEASE,dramatic gross brain abnormality,dramatic gross brain abnormalities
NEW06509,MENTAL_HEALTH,female postpartum anxiety,females postpartum anxiety
D008425,DISEASE,Maternal Behavior,"Care Patterns, Maternal|Maternal Patterns of Care|Patterns, Maternal Care|Maternal Care Patterns|Maternal Behaviors|Care Pattern, Maternal|Behaviors, Maternal|Maternal Care Pattern|maternal behavior|Behavior, Maternal|Pattern, Maternal Care"
C072383,CHEMICAL,canertinib dihydrochloride [Supplementary Concept],Carbamates|CI-980|Pyrazines|Pyridines
NEW06512,MENTAL_HEALTH,depression model,depression model
NEW06513,DISEASE,depressive behaviour,depressive behaviours
D019208,CHEMICAL,Brain-Derived Neurotrophic Factor,"Neurotrophic Factor, Brain-Derived|Brain Derived Neurotrophic Factor|Factor, Brain-Derived Neurotrophic|proBDNF|BDNF|brain-derived neurotrophic factor"
NEW06516,MENTAL_HEALTH,radial displacement,radial displacement
C087631,CHEMICAL,gou-teng [Supplementary Concept],"Drugs, Chinese Herbal|Uncaria rhynchophylla"
NEW06520,MENTAL_HEALTH,comorbid substance abuse,comorbid substance abuse
NEW06521,MENTAL_HEALTH,comorbid chronic pain syndrome,comorbid chronic pain syndromes
NEW06523,CHEMICAL,reduce sucrose preference,reduced sucrose preference
NEW06529,CHEMICAL,tyramine-restricted diet,tyramine-restricted diets
NEW06530,CHEMICAL,mao substrate,MAO substrates
NEW06532,CHEMICAL,old maoi,older MAOIs
NEW06535,DISEASE,vocal impairment,vocal impairment
C536334,DISEASE,Polymorphic catecholergic ventricular tachycardia [Supplementary Concept],"ventricular tachycardia|Tachycardia, Ventricular"
NEW06537,MENTAL_HEALTH,less sexual dysfunction,less sexual dysfunction
NEW06540,CHEMICAL,benzodiazepine hypnotic,benzodiazepine hypnotics
NEW06542,DISEASE,narcolepsy/cataplexy symptom,narcolepsy/cataplexy symptoms
NEW06543,CHEMICAL,lc ne dysregulation,LC NE dysregulation
NEW06544,CHEMICAL,dextroamphetamine preparation,dextroamphetamine preparations
NEW06545,CHEMICAL,modafinil/armodafinil,modafinil/armodafinil
NEW06548,BIOCHEMICAL,individualized drug management,individualized drug management
NEW06550,CHEMICAL,serotonin-norepinephrine reuptake,serotonin-norepinephrine reuptake
NEW06551,CHEMICAL,inhibitors(SNRIs,inhibitors(SNRIs
NEW06554,CHEMICAL,plant Cannabis sativa,plant Cannabis sativa
NEW06555,DISEASE,chronic brain inflammation,chronic brain inflammation
D013385,CHEMICAL,Succinate Dehydrogenase,"succinate dehydrogenase|Dehydrogenase, Succinic|Succinic Dehydrogenase|Dehydrogenase, Succinate|Oxidase, Succinic|Succinic Oxidase|Fumarate Reductase|Reductase, Fumarate"
NEW06557,DISEASE,brain hypoperfusion,brain hypoperfusion
NEW06558,DISEASE,psychotic episode,psychotic episode
NEW06559,MENTAL_HEALTH,chronic stress response,chronic stress response
NEW06561,MENTAL_HEALTH,chronic stress level,chronic stress level
NEW06562,DISEASE,anxiety-related disorder,anxiety-related disorders
http://purl.obolibrary.org/obo/DOID_0080779,DISEASE,plasmablastic lymphoma,Burkitt lymphoma cells
NEW06563,CHEMICAL,calcium flux,calcium flux
C099490,CHEMICAL,Dyrk kinase [Supplementary Concept],Protein-Tyrosine Kinases|Protein Serine-Threonine Kinases|tyrosine phosphorylation
D053078,DISEASE,"Membrane Potential, Mitochondrial","DeltaPsi M|DeltapsiM|Mitochondrial Transmembrane Potentials|Membrane Potentials, Mitochondrial|Mitochondrial Membrane Potential|mitochondrial membrane potential|M, DeltaPsi|Delta Psi M|Transmembrane Potentials, Mitochondrial|Mitochondrial Membrane Potentials|Transmembrane Potential, Mitochondrial|Mitochondrial Transmembrane Potential"
NEW06566,NUTRITION,phosphatidylserine membrane,phosphatidylserine membranes
NEW06568,DISEASE,cln8 domain,CLN8 domain
NEW06569,DISEASE,cognitive impairment due,cognitive impairment due
NEW06571,DISEASE,excitotoxicity,excitotoxicity
NEW06572,CHEMICAL,partial agonist-like aripiprazole,partial agonist-like aripiprazole
NEW06573,DISEASE,odd behavior,odd behavior
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Magical_Thinking,MENTAL_HEALTH,magical thinking,magical thinking
NEW06575,DISEASE,treatment-resistant td,treatment-resistant TD
NEW06576,DISEASE,young treatment-resistant schizophrenic patient,young treatment-resistant schizophrenic patients
NEW06578,DISEASE,si-induced latent learning deficit,SI-induced latent learning deficit
NEW06579,DISEASE,si-induced attention deficit,SI-induced attention deficit
NEW06585,DISEASE,chronic disease risk factor,chronic disease risk factors
NEW06586,DISEASE,classroom deficit/hyperactivity disorder,classroom deficit/hyperactivity disorder
NEW06588,CHEMICAL,tau phosphorylation,TAU phosphorylation
NEW06589,CHEMICAL,appnl-g-f mouse,AppNL-G-F mice
NEW06590,DISEASE,neuronal cell loss,neuronal cell loss
NEW06591,DISEASE,diabetic symptom,diabetic symptoms
NEW06592,MENTAL_HEALTH,disease animal,disease animals
NEW06594,DISEASE,mild-to-moderate hypertension,mild-to-moderate hypertension
NEW06595,DISEASE,resistant hypertension,resistant hypertension
NEW06596,BIOCHEMICAL,androgen adverse event,androgen adverse events
NEW06597,DISEASE,mild-to-moderate hypertension similar,mild-to-moderate hypertension similar
NEW06598,DISEASE,hypertensive population,hypertensive population
NEW06600,MENTAL_HEALTH,nervosa symptom,nervosa symptoms
NEW06603,CHEMICAL,secondary aud,secondary AUD
NEW06604,DISEASE,pain state,pain states
NEW06605,CHEMICAL,clonidine intervention,clonidine interventions
NEW06607,DISEASE,aberrant behavior,aberrant behavior
D009102,DISEASE,Multiple Organ Failure,"organ failure|Multiple Organ Dysfunction Syndrome|Failure, Multiple Organ|Organ Dysfunction Syndrome, Multiple|Multiple Organ Failures|MODS|Organ Failure, Multiple"
D020361,DISEASE,"Paraneoplastic Syndromes, Nervous System","autonomic dysfunction|Paraneoplastic Encephalomyelitis|Neurologic Syndrome, Paraneoplastic|Paraneoplastic Encephalomyelitides|Paraneoplastic Autonomic Dysfunction|Autonomic Dysfunctions, Paraneoplastic|Encephalomyelitis, Paraneoplastic|Autonomic Dysfunction, Paraneoplastic|Nervous System Paraneoplastic Syndromes|Neurologic Syndromes, Paraneoplastic|Syndrome, Paraneoplastic Neurologic|Paraneoplastic Autonomic Dysfunctions|Syndromes, Paraneoplastic Neurologic|Paraneoplastic Neurologic Syndrome|Paraneoplastic Neurologic Syndromes"
NEW06610,DISEASE,neurological symptom,neurological symptoms
NEW06613,CHEMICAL,moxonidine monotherapy,moxonidine monotherapy
NEW06615,DISEASE,various cancer,various cancers
NEW06616,CHEMICAL,caffeine concentration,caffeine concentration
NEW06617,DISEASE,depressed heart,depressed heart
D025861,DISEASE,"Blood Coagulation Disorders, Inherited","Coagulation Disorders, Inherited|Hereditary Coagulation Disorders|Inherited Coagulation Disorder|Coagulation Disorder, Inherited|Inherited Blood Coagulation Disorders|Hereditary Coagulation Disorder|Coagulation Disorders, Hereditary|Inherited Coagulation Disorders|Coagulation Disorder, Hereditary|blood coagulation|Hereditary Blood Coagulation Disorders"
NEW06619,DISEASE,acth-evoked cardiac fibrosis,ACTH-evoked cardiac fibrosis
NEW06621,DISEASE,acth-induced hpa axis hyperactivity,ACTH-induced HPA axis hyperactivity
NEW06624,MENTAL_HEALTH,subjective anxiety,subjective anxiety
NEW06627,DISEASE,middle aged hypertensive man,middle aged hypertensive men
NEW06630,CHEMICAL,magnesium preparation,magnesium preparation
NEW06631,CHEMICAL,magnesiocard meq/day,Magnesiocard mEq/day
NEW06632,DISEASE,eclampsia edema,eclampsia edema
NEW06634,CHEMICAL,glutamate aquaporin-4 expression,glutamate aquaporin-4 expression
NEW06635,MENTAL_HEALTH,well control hallucination,better control hallucinations
NEW06637,DISEASE,psychiatric comorbidity,psychiatric comorbidity
NEW06639,CHEMICAL,clozapine user,clozapine users
C574608,DISEASE,"Sab protein, E coli [Supplementary Concept]",Membrane Transport Proteins|biofilm formation|Escherichia coli Proteins
NEW06643,MENTAL_HEALTH,all-cause dementia,all-cause dementia
NEW06645,DISEASE,childhood neurodevelopmental disorder,childhood neurodevelopmental disorders
NEW06647,MENTAL_HEALTH,anxiety time,anxiety time
NEW06650,DISEASE,motor nerve conduction velocity,motor nerve conduction velocity
NEW06652,CHEMICAL,mncv calcium content,MNCV calcium content
NEW06654,MENTAL_HEALTH,schizophrenia altered metabolism,schizophrenia altered metabolism
NEW06655,DISEASE,premorbid neurodevelopmental abnormality,premorbid neurodevelopmental abnormality
NEW06657,CHEMICAL,high-energy phosphate metabolite,high-energy phosphate metabolites
NEW06659,CHEMICAL,high mpl precursor level,higher MPL precursor levels
D013702,DISEASE,Temporal Lobe,"Brodmann's Area 21|Sulcus, Temporal|Temporal Sulcus|Temporal Gyrus|Area 38, Brodmann's|Brodmanns Area 52|Area 38, Brodmann|Brodmann's Area 37|Gyrus, Fusiform|Occipito-Temporal Gyrus, Lateral|Brodmann's Area 22|Fusiform Gyrus|Temporal Horns|Brodmanns Area 20|Gyrus, Superior Temporal|Temporal Horn of the Lateral Ventricle|Brodmanns Area 21|Area 37, Brodmann|Temporal Lobes, Anterior|Brodmann's Area 38|Area 20, Brodmann|Brodmann's Area 20|Area 21, Brodmann's|Occipitotemporal Gyrus|Area 52, Brodmann|Brodmann Area 20|Gyrus, Temporal|Gyrus, Occipitotemporal|Area 22, Brodmann|Parainsular Area|Temporal Region|Gyrus, Inferior Temporal|Lobe, Anterior Temporal|Brodmann Area 37|Brodmanns Area 38|Brodmann Area 52|Temporal Horn|Brodmann Area 22|Region, Temporal|Temporal Cortex|Temporal Gyrus, Middle|Area 37, Brodmann's|Inferior Temporal Gyrus|Anterior Temporal Lobe|Occipitotemporal Gyrus, Lateral|Temporal Operculum|Cortex, Temporal|Brodmanns Area 22|Area 52, Brodmann's|Temporal Regions|Horn, Temporal|Area, Parainsular|Lateral Occipito-Temporal Gyrus|temporal regions|Parainsular Areas|Anterior Temporal Lobes|Superior Temporal Gyrus|Area 22, Brodmann's|Middle Temporal Gyrus|Area 21, Brodmann|Lateral Occipitotemporal Gyrus|Brodmann Area 38|Lobe, Temporal|Inferior Horn of Lateral Ventricle|Operculum, Temporal|Inferior Horn of the Lateral Ventricle|Areas, Parainsular|Gyrus, Lateral Occipitotemporal|Gyrus Fusiformis|Temporal Cortices|Planum Polare|Temporal Lobes|Area 20, Brodmann's|Gyrus, Lateral Occipito-Temporal|Brodmann's Area 52|Temporal Lobe, Anterior|Brodmanns Area 37|Gyrus, Middle Temporal|Temporal Gyrus, Inferior|Temporal Gyrus, Superior|Lateral Occipito Temporal Gyrus|Brodmann Area 21|Gyrus Temporalis Superior"
D017241,DISEASE,MELAS Syndrome,"Mitochondrial Myopathy, Lactic Acidosis, Stroke-Like Episode|Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes|mitochondrial encephalopathy|Myopathy, Mitochondrial-Encephalopathy-Lactic Acidosis-Stroke|MELAS|Syndrome, MELAS|Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes"
D051436,DISEASE,"Renal Insufficiency, Chronic","Diseases, Chronic Kidney|Kidney Insufficiencies, Chronic|Chronic Renal Insufficiency|Kidney Disease, Chronic|Chronic Renal Diseases|Chronic Kidney Disease|Disease, Chronic Renal|Chronic Kidney Insufficiency|Renal Insufficiencies, Chronic|Disease, Chronic Kidney|Chronic Kidney Diseases|Chronic Renal Disease|Renal Diseases, Chronic|Chronic Kidney Insufficiencies|Diseases, Chronic Renal|Kidney Insufficiency, Chronic|chronic renal diseases|Chronic Renal Insufficiencies|Renal Disease, Chronic|Kidney Diseases, Chronic"
NEW06661,BIOCHEMICAL,kidney estrogen,kidneys estrogens
NEW06662,BIOCHEMICAL,vitamin d fibroblast growth factor,vitamin D fibroblast growth factor
NEW06663,DISEASE,chronic alcohol-abuse,chronic alcohol-abuse
NEW06665,DISEASE,bone pain,bone pain
NEW06668,CHEMICAL,calcium level,calcium levels
NEW06669,CHEMICAL,paricalcitol therapy,paricalcitol therapy
NEW06671,DISEASE,substantial hyponatremia,substantial hyponatremia
NEW06672,CHEMICAL,elevated glucose,elevated glucose
D003444,DISEASE,Crush Syndrome,"Crush Syndromes|Syndromes, Crush|crush syndrome|Syndrome, Crush"
NEW06673,DISEASE,acute arterial occlusion,acute arterial occlusion
NEW06674,DISEASE,diabetic nonketotic coma,diabetic nonketotic coma
C028815,CHEMICAL,salmon calcitonin [Supplementary Concept],synthetic salmon calcitonin|Calcitonin
NEW06677,BIOCHEMICAL,vitamin d receptor mutant,vitamin D receptor mutants
NEW06679,BIOCHEMICAL,normocalcaemic vitamin d receptor mutant,normocalcaemic vitamin D receptor mutants
http://purl.obolibrary.org/obo/DOID_5844,DISEASE,myocardial infarction,heart attack|Myocardial infarct|function post-myocardial infarction
NEW06681,CHEMICAL,top chemical,top chemicals
NEW06682,DISEASE,neurotoxic substance,neurotoxic substances
NEW06683,DISEASE,postischemic damage,postischemic damage
NEW06684,CHEMICAL,electrical activity felbamate,electrical activity felbamate
NEW06689,DISEASE,great exploratory behavior,greater exploratory behaviors
NEW06691,CHEMICAL,tetrodotoxin ttx tmn neuron,tetrodotoxin TTX TMN neurons
http://purl.obolibrary.org/obo/MF_0000012,DISEASE,arousal,TRH-induced arousal
NEW06694,DISEASE,dose-dependent atrophy,dose-dependent atrophy
NEW06695,CHEMICAL,non-psychotropic phytocannabinoid cannabidiol,non-psychotropic phytocannabinoid cannabidiol
NEW06698,CHEMICAL,mam insult,MAM insult
NEW06699,DISEASE,schizophrenia-like deficit,schizophrenia-like deficits
NEW06700,DISEASE,schizophrenic symptome,schizophrenic symptomes
http://purl.obolibrary.org/obo/CHEBI_31824,CHEMICAL,mesna,g/m2/cycle ifosfamide|Mesna
NEW06703,MENTAL_HEALTH,childhood hyperactivity,childhood hyperactivity
D001932,DISEASE,Brain Neoplasms,"Malignant Brain Neoplasms|Recurrent Brain Tumors|Brain Tumors|Benign Brain Neoplasms|Brain Malignant Neoplasm|Brain Cancer|Brain Tumors, Recurrent|Neoplasms, Brain|Cancer, Brain|Malignant Primary Brain Neoplasms|Neoplasm, Intracranial|Tumor, Brain|Brain Tumor, Primary|Neoplasms, Intracranial|Malignant Neoplasms, Brain|Brain Neoplasms, Primary Malignant|Cancer of Brain|Brain Neoplasms, Primary|Recurrent Brain Tumor|Brain Neoplasm|Brain Metastases|Brain Neoplasms, Benign|brain cancer|Brain Neoplasm, Benign|Brain Neoplasm, Primary|Benign Neoplasm, Brain|Primary Malignant Brain Neoplasms|Brain Tumor|Brain Tumor, Recurrent|Brain Malignant Neoplasms|Brain Neoplasm, Malignant|Benign Brain Neoplasm|Benign Neoplasms, Brain|Brain Benign Neoplasm|Brain Benign Neoplasms|Neoplasms, Brain, Primary|Brain Neoplasms, Malignant|Neoplasms, Brain, Malignant|Brain Neoplasms, Malignant, Primary|Primary Brain Neoplasms|Intracranial Neoplasm|Malignant Neoplasm, Brain|Primary Brain Neoplasm|Primary Brain Tumor|Intracranial Neoplasms|Malignant Primary Brain Tumors|Primary Malignant Brain Tumors|Neoplasm, Brain|Brain Metastase|Cancer of the Brain|Malignant Brain Neoplasm|Primary Brain Tumors|Neoplasms, Brain, Benign|Brain Cancers"
NEW06705,BIOCHEMICAL,dopaminergic neurotoxin,dopaminergic neurotoxin
NEW06706,CHEMICAL,levodopa dose necessary,levodopa dose necessary
NEW06708,DISEASE,y-maze learning deficit,Y-maze learning deficits
NEW06709,MENTAL_HEALTH,mild-to-moderate alzheimer 's dementia,mild-to-moderate Alzheimer's dementia
NEW06712,BIOCHEMICAL,potent muscarinic cholinomimetic,potent muscarinic cholinomimetics
NEW06714,DISEASE,severe traumatic brain injury patient,severe traumatic brain injury patients
NEW06715,DISEASE,noncognitive behavior,noncognitive behaviors
NEW06716,DISEASE,severe gad,severe GAD
NEW06717,DISEASE,subsyndromal depressive symptom,subsyndromal depressive symptoms
NEW06719,CHEMICAL,hydrocarbon substrate,hydrocarbons substrates
NEW06720,DISEASE,sporadic neurodegenerative disease,sporadic neurodegenerative diseases
NEW06722,BIOCHEMICAL,high quartile mixture level,higher quartile mixture levels
NEW06723,CHEMICAL,ccr5 inhibitor maraviroc,CCR5 inhibitor Maraviroc
NEW06724,MENTAL_HEALTH,neuroleptic-induced orofacial dyskinesia,neuroleptic-induced orofacial dyskinesia
NEW06725,CHEMICAL,basal phosphate accumulation,basal phosphate accumulations
NEW06726,BIOCHEMICAL,stimulant drug,stimulant drug
NEW06731,CHEMICAL,increase mda,increased MDA
NEW06733,CHEMICAL,low mda level,lower MDA levels
NEW06736,CHEMICAL,tle/mts,TLE/MTS
NEW06739,DISEASE,long-term nervous system damage,long-term nervous system damage
NEW06741,DISEASE,significant motor deficit,significant motor deficits
NEW06742,CHEMICAL,nitrite peroxidation,nitrite peroxidation
NEW06744,DISEASE,neurobehavioral damage,neurobehavioral damage
D000077962,DISEASE,Body-Weight Trajectory,"Trajectory, Body-Weight|Loss Trajectories, Weight|Body Weight Trajectory|Weight Loss Trajectories|Weight Change Trajectory|Weight Trajectory|Trajectories, Body-Weight|Trajectory, Weight|Change Trajectories, Weight|Weight Change Trajectories|Trajectory, Weight Loss|Weight Trajectories|Trajectory, Weight Gain|Trajectories, Weight Loss|Change Trajectory, Weight|weight change|Trajectories, Weight|Weight Gain Trajectory|Loss Trajectory, Weight|Trajectories, Weight Change|Weight Loss Trajectory|Body-Weight Trajectories|Gain Trajectories, Weight|Trajectories, Weight Gain|Trajectory, Weight Change|Gain Trajectory, Weight|Weight Gain Trajectories"
NEW06746,DISEASE,acute dyslipidemia independent,acute dyslipidemia independent
NEW06747,CHEMICAL,antidepressant anti-stress effect,antidepressant anti-stress effects
http://purl.obolibrary.org/obo/MFOMD_0000178,DISEASE,assaultive behavior,violent behaviour
NEW06750,DISEASE,psychiatric exacerbation,psychiatric exacerbation
NEW06751,NUTRITION,low high-density lipid cholesterol,lower high-density lipid cholesterol
NEW06754,DISEASE,summer-fall euthymia,summer-fall euthymia
NEW06757,CHEMICAL,il-1β related,IL-1β related
C060504,CHEMICAL,dihydrosphingosine 1-phosphate [Supplementary Concept],Sphingosine/analogs  and  derivatives|sphinganine-1-phosphate
NEW06759,CHEMICAL,cer22:0,Cer22:0
NEW06761,CHEMICAL,neurolipidome,neurolipidome
NEW06763,NUTRITION,regular lithium carbonate,regular lithium carbonate
NEW06764,DISEASE,hyperammonemia cramp,hyperammonemia cramps
NEW06765,DISEASE,cirrhotic liver,cirrhotic liver
NEW06766,DISEASE,conclusion hepatocellular damage,conclusion hepatocellular damage
NEW06767,DISEASE,human chronic liver disease,human chronic liver diseases
NEW06769,CHEMICAL,individual mets criterion,individual MetS criteria
NEW06770,CHEMICAL,benzodiazepine dependency,benzodiazepine dependency
NEW06773,DISEASE,memory-related disorder,memory-related disorders
D020765,DISEASE,Intracranial Arterial Diseases,"Arterial Disease, Intracranial|Arterial Disorders, Intracranial|Brain Arterial Disease|Brain Disorder, Arterial|Intracranial Arterial Disorder|Brain Disorders, Arterial|Arterial Brain Disease|Arterial Diseases, Intracranial|Brain Diseases, Arterial|Intracranial Arterial Disorders|Arterial Diseases, Brain|Brain Arterial Diseases|brain disorder|Arterial Brain Disorder|Arterial Brain Disorders|Arterial Brain Diseases|Intracranial Arterial Disease|Arterial Disease, Brain|Arterial Disorder, Intracranial"
NEW06775,DISEASE,alzheimer 's disease amyotrophic,Alzheimer's disease Amyotrophic
NEW06776,DISEASE,numerous neuropsychiatric disorder,numerous neuropsychiatric disorders
NEW06778,CHEMICAL,circulate oxysterol,circulating oxysterols
NEW06779,CHEMICAL,pge2 pathway,PGE2 pathway
NEW06782,CHEMICAL,hematoxylin-eosin,hematoxylin-eosin
NEW06784,DISEASE,3-month post-discharge violent behaviour,3-month post-discharge violent behaviour
NEW06785,DISEASE,inpatient violent behaviour,inpatient violent behaviour
NEW06787,CHEMICAL,malondialdehyde level,malondialdehyde levels
NEW06788,DISEASE,SAD group,SAD group
NEW06793,DISEASE,high syndrome prevalence,high syndrome prevalence
NEW06795,CHEMICAL,comorbidities.7 mental health training,comorbidities.7 Mental health training
NEW06798,DISEASE,related metabolic alteration,related metabolic alterations
NEW06801,DISEASE,binge-like eat behavior,binge-like eating behavior
D000419,DISEASE,Albuminuria,albuminuria|Albuminurias
NEW06804,DISEASE,premature coronary heart disease,premature coronary heart disease
NEW06805,BIOCHEMICAL,specific antagonist,specific antagonists
C473669,CHEMICAL,"dynorphin A-(1-11)amide, cyclo(N,5)(Trp(3)-Trp(4)-Glu(5))-- [Supplementary Concept]","A(1|Peptides, Cyclic|Dynorphins"
NEW06806,DISEASE,spike-and-wave discharge,spike-and-wave discharges|SWDs
NEW06808,DISEASE,withdrawal diarrhea,withdrawal diarrhea
NEW06809,DISEASE,dog shake,dog shakes
NEW06811,BIOCHEMICAL,a2 antagonist,A2 antagonist
NEW06817,DISEASE,minor psychostimulant,minor psychostimulants
NEW06818,CHEMICAL,a1 a2a adenosine receptor,A1 A2A adenosine receptors
NEW06821,CHEMICAL,toxic voriconazole blood level,toxic voriconazole blood levels
NEW06823,CHEMICAL,voriconazole treatment,voriconazole treatment
NEW06824,CHEMICAL,high voriconazole level,high voriconazole levels
NEW06826,DISEASE,reversible visual disturbance,reversible visual disturbances
NEW06829,BIOCHEMICAL,multiple endocrine organ,multiple endocrine organs
NEW06832,CHEMICAL,sertraline therapy,sertraline therapy
NEW06833,CHEMICAL,Tresleen,Tresleen
NEW06835,DISEASE,candida specie,Candida species
NEW06838,BIOCHEMICAL,antifungal assay,antifungal assay
NEW06840,CHEMICAL,galanthamine content,galanthamine content
NEW06841,CHEMICAL,"1-methyl-4-phenyl-1,2,3,6-tetrahydropypridine MPTP mouse model","1-methyl-4-phenyl-1,2,3,6-tetrahydropypridine MPTP mouse model"
NEW06843,DISEASE,behavioural alteration,behavioural alterations
NEW06844,CHEMICAL,weight gain/hyperglycaemia side-effect,weight gain/hyperglycaemia side-effects
NEW06846,DISEASE,genetic absence epileptic glaxo/rijswijk rat,genetic absence epileptic Glaxo/Rijswijk rats
NEW06847,DISEASE,metabolic disturbance,metabolic disturbances
NEW06850,DISEASE,fibrosis advanced fibrosis,fibrosis advanced fibrosis
NEW06852,DISEASE,behavior symptom,behavior symptoms
NEW06854,CHEMICAL,adenosine monophosphate-activated protein kinase,adenosine monophosphate-activated protein kinase
NEW06859,DISEASE,ptsd-like effect,PTSD-like effect
NEW06860,BIOCHEMICAL,selective nk3 antagonist,selective NK3 antagonists
NEW06861,MENTAL_HEALTH,slow dissociation kinetic,slower dissociation kinetics
NEW06866,DISEASE,trauma symptom,trauma symptoms
NEW06869,CHEMICAL,dopamine neuron loss,dopamine neuron loss
C000606289,CHEMICAL,N-(1-(aminocarbonyl)-2-methylpropyl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide [Supplementary Concept],Indazoles|AB-CHMINACA|Valine/analogs  and  derivatives
NEW06871,DISEASE,ethanol-induced motor impairment,ethanol-induced motor impairment
NEW06872,CHEMICAL,extracellular glutamate level,extracellular glutamate levels
NEW06873,DISEASE,neurocirculatory dystonia,neurocirculatory dystonia
NEW06875,CHEMICAL,ChE-PICALM,ChE-PICALM
C569957,CHEMICAL,"Slc24a4 protein, mouse [Supplementary Concept]",Antiporters|SLC24A4
NEW06876,CHEMICAL,acid level,acid levels
NEW06877,DISEASE,motor impairment,motor impairment
C564004,DISEASE,"Macrocytosis, Familial [Supplementary Concept]","Erythrocytes, Abnormal|Hematologic Diseases|macrocytosis"
NEW06880,CHEMICAL,ovarian-teratoma-related anti-n-methyl-d-aspartate receptor,ovarian-teratoma-related anti-N-methyl-D-aspartate receptor
NEW06883,DISEASE,behavioural disorder,behavioural disorders
D001990,DISEASE,"Bronchiolitis, Viral","Bronchiolitides, Viral|bronchiolitis|Viral Bronchiolitis|Viral Bronchiolitides"
NEW06886,DISEASE,persistent pain state,persistent pain states
NEW06889,DISEASE,attentional deficit,attentional deficit
NEW06890,DISEASE,paradoxical pain,paradoxical pain
NEW06891,DISEASE,thermal hypersensitivity,thermal hypersensitivity
NEW06894,CHEMICAL,NSC progeny,NSC progeny
NEW06895,DISEASE,learn defect,learning defects
D011484,CHEMICAL,Protein-Arginine N-Methyltransferases,"Myelin Basic Protein (Arginine) Methyltransferase|Type II Protein Arginine Methyltransferase|Protein Arginine N Methyltransferases|Protein-Arginine N-Methyltransferase|Type I Protein Arginine N-Methyltransferase|arginine methyltransferase|Arginine Methylase|Arginine Methyltransferase, Protein|Protein Methyltransferase I|Protein Arginine Methyltransferase|Methyltransferase, Protein Arginine|Protein Arginine N Methyltransferase|(Myelin Basic Protein)-Arginine N-Methyltransferase|Protein Methylase I|Type I Protein Arginine Methyltransferase|Type I Protein Arginine N Methyltransferase"
NEW06900,DISEASE,hcv infection sexual function,HCV infection sexual function
C535382,DISEASE,Arthrogryposis renal dysfunction cholestasis syndrome [Supplementary Concept],Renal Insufficiency|renal dysfunction|Cholestasis|Arthrogryposis
NEW06901,DISEASE,hepatitis c virus chronic liver disease,hepatitis C virus chronic liver disease
NEW06902,MENTAL_HEALTH,global anxiety,global anxiety
D012903,DISEASE,Smell,smell|Olfaction|Smell Sense|Sense of Smell
http://purl.obolibrary.org/obo/SYMP_0000480,DISEASE,nervous system symptom,central nervous system symptoms
NEW06905,CHEMICAL,pegylated interferon alpha,pegylated interferon alpha
NEW06906,CHEMICAL,pegylated interferon alpha,pegylated interferon alpha|pegIFN-alpha
NEW06908,DISEASE,chronic impairment,chronic impairment
D000082424,DISEASE,Internet Addiction Disorder,"Gaming Disorder, Internet|Smartphone Addiction|Addiction Disorder, Internet|Addictions, Internet|Internet Addiction|Addiction, Social Media|Disorders, Internet Gaming|Media Addictions, Social|Internet Gaming Disorders|Addiction, Internet|Disorder, Internet Gaming|Addiction Disorders, Internet|Addictions, Smartphone|Internet Addiction Disorders|Gaming Disorders, Internet|Smartphone Addictions|Internet Gaming Disorder|Disorders, Internet Addiction|Social Media Addiction|Disorder, Internet Addiction|Social Media Addictions|Addiction, Smartphone|addiction disorders|Addictions, Social Media|Internet Addictions|Media Addiction, Social"
NEW06915,BIOCHEMICAL,oral antifungal therapy,oral antifungal therapy
NEW06916,DISEASE,candida desensitization,candida desensitization
NEW06917,CHEMICAL,oral co-trimoxazole treatment,oral co-trimoxazole treatment
NEW06919,DISEASE,human osteosarcoma cell,human osteosarcoma cells
NEW06920,DISEASE,cancer-associated death,cancer-associated death
NEW06922,DISEASE,different acute stressor,different acute stressors
NEW06924,CHEMICAL,hdwgut12     h fish,HDWgut12    h fish
D005880,DISEASE,Gills,gills|Gill
http://purl.obolibrary.org/obo/CHEBI_60974,CHEMICAL,cyanoamino acid,acids catabolism|cyanoamino acids
NEW06926,CHEMICAL,gad67 expression,GAD67 expression
NEW06928,DISEASE,neurodegeneration impairment,neurodegeneration impairment
NEW06930,CHEMICAL,cerebral abeta level,cerebral Abeta levels
C531617,DISEASE,Amyotrophic lateral sclerosis 1 [Supplementary Concept],familial amyotrophic lateral sclerosis|Amyotrophic Lateral Sclerosis
NEW06932,DISEASE,acetaminophen poison,acetaminophen poisoning
D065227,DISEASE,Transfusion Reaction,"Hemolytic Transfusion Reactions|Acute Hemolytic Transfusion Reaction|Transfusion-Associated Circulatory Overload|Posttransfusion Purpura|allergic reaction|Purpura, Posttransfusion|Blood Transfusion Associated Adverse Reactions|Reactions, Hemolytic Transfusion|Delayed Serologic Transfusion Reaction|Transfusion Reactions, Hypotensive|TAGHD|Transfusion-Associated Allergic Reaction|Transfusion-Transmitted Infections|Delayed Hemolytic Transfusion Reaction|Transfusion Transmitted Infection|Post-Transfusion Purpura|Transfusion-Transmitted Infection|Purpura, Post-Transfusion|Hypotensive Transfusion Reaction|Transfusion Reactions|Blood Transfusion-Associated Adverse Reactions|Allergic Reaction, Transfusion-Associated|Hemolytic Transfusion Reaction|Transfusion Associated Circulatory Overload|Transfusion-Associated Circulatory Overloads|Circulatory Overloads, Transfusion-Associated|Transfusion Reactions, Hemolytic|Transfusion Associated Graft Vs. Host Disease|Infection, Transfusion-Transmitted|Transfusion Reaction, Hemolytic|Circulatory Overload, Transfusion-Associated|Post Transfusion Purpura|Posttransfusion Purpuras|Transfusion Associated Dyspnea|Reaction, Hypotensive Transfusion|Febrile Non Hemolytic Transfusion Reaction|Transfusion-Associated Graft Vs. Host Disease|Febrile Non-Hemolytic Transfusion Reaction|Reaction, Hemolytic Transfusion|Dyspnea, Transfusion-Associated|Transfusion-Associated Dyspnea|Transfusion Associated Allergic Reaction|Transfusion Reaction, Hypotensive"
NEW06934,DISEASE,intermittent parathyroid hormone,intermittent parathyroid hormone
NEW06936,DISEASE,alcohol-induced bone loss,alcohol-induced bone loss
NEW06938,DISEASE,narcolepsy disorder,narcolepsy disorders
NEW06939,DISEASE,high turnover bone loss,high turnover bone loss
NEW06940,CHEMICAL,serum type 1 pro-collagen n-terminal protein,P1NP|serum type 1 pro-collagen N-terminal protein
NEW06941,CHEMICAL,collagen type 1 cross-linked c-telopeptide,CTX-1|collagen type 1 cross-linked C-telopeptide
NEW06943,BIOCHEMICAL,endocrine disturbance,endocrine disturbances
NEW06945,CHEMICAL,transitional/limbic,transitional/limbic
NEW06948,CHEMICAL,nitrendipine mg,nitrendipine mg
NEW06949,CHEMICAL,alcohol/high fat ahf diet,alcohol/high fat AHF diet
NEW06951,DISEASE,chronic pancreatitis pain model,chronic pancreatitis pain model
NEW06952,CHEMICAL,nigrostriatal dopamine neuron,nigrostriatal dopamine neurons
NEW06954,CHEMICAL,tyrosine hydroxylase-positive neuron,tyrosine hydroxylase-positive neurons
NEW06955,DISEASE,mptp-induced loss,MPTP-induced loss
NEW06958,CHEMICAL,5-ht(2a receptor mrna,5-HT(2A receptor mRNA
NEW06959,DISEASE,stress-induced memory formation impairment,stress-induced memory formation impairment
NEW06962,DISEASE,stress-induced memory impairment,stress-induced memory impairment
NEW06963,CHEMICAL,gr level,GR levels
http://purl.obolibrary.org/obo/MFOMD_0000170,MENTAL_HEALTH,projection,collateral-CA1 projection
NEW06966,CHEMICAL,dopamine d2 receptor sensitization,dopamine D2 receptor sensitization
NEW06968,DISEASE,pain group,pain groups
http://purl.obolibrary.org/obo/DOID_302,MENTAL_HEALTH,substance abuse,DSM-IV substance abuse
NEW06973,DISEASE,olanzapine-induced weight gain/obesity,olanzapine-induced weight gain/obesity
http://purl.obolibrary.org/obo/SYMP_0000311,DISEASE,intestinal hypermotility,intestinal hypermotility
NEW06976,DISEASE,depressed mouse,depressed mice
NEW06977,DISEASE,subdiagnostic transition,subdiagnostic transitions
NEW06982,DISEASE,cardiac surgery associated acute kidney injury,CSA-AKI|Cardiac surgery associated acute kidney injury
NEW06983,CHEMICAL,dopamine stabilizer antipsychotic,dopamine stabilizer antipsychotic
NEW06984,MENTAL_HEALTH,acute bipolar mania,acute bipolar mania
NEW06986,CHEMICAL,thyroxine replacement,thyroxine replacement
NEW06988,CHEMICAL,monoamine transport inhibitor,monoamine transport inhibitors
NEW06996,MENTAL_HEALTH,comorbid bd disorder,comorbid BD disorder
NEW06998,DISEASE,canmat task force,CANMAT task force
NEW06999,CHEMICAL,third-line therapy,third-line therapy
NEW07000,CHEMICAL,megadose,Megadose
NEW07006,DISEASE,dopaminergic dysfunction,dopaminergic dysfunction
NEW07009,CHEMICAL,calcium signaling protein,calcium signaling proteins
http://purl.obolibrary.org/obo/DOID_9651,DISEASE,systolic heart failure,chronic systolic heart failure
NEW07010,DISEASE,episodic ataxia type lethargic,episodic ataxia type lethargic
C000589038,CHEMICAL,"PMCA4 protein, mouse [Supplementary Concept]",plasma-membrane Ca2|Calcium-Transporting ATPases
D020754,CHEMICAL,Spinocerebellar Ataxias,"Ataxia 4, Spinocerebellar|Spinocerebellar Atrophy 2|Olivopontocerebellar Atrophy IIs|Olivopontocerebellar Atrophy I|Atrophy, Spinocerebellar|Schut-Haymaker Type OPCA|SCA1s|Spinocerebellar Ataxia 7s|Type 4 Spinocerebellar Ataxia|Spinocerebellar Ataxia 1s|Spinocerebellar Ataxia 4s|Spinocerebellar Ataxia 6s|Cerebellar Degeneration with Slow Eye Movements|Olivopontocerebellar Atrophy IVs|Ataxias, Dominantly-Inherited Spinocerebellar|Spinocerebellar Atrophy|Spinocerebellar Atrophies|Ataxia, Dominantly-Inherited Spinocerebellar|Type 7 Spinocerebellar Ataxia|Ataxia 5, Spinocerebellar|Dominantly-Inherited Spinocerebellar Ataxia|Type 1 Spinocerebellar Ataxia|Schut Haymaker Type OPCA|Spinocerebellar Ataxia Type 2|OPCA, Schut-Haymaker Type|Atrophy III, Olivopontocerebellar|Wadia-Swami Syndrome|Ataxia 1, Spinocerebellar|Syndrome, Wadia-Swami|Atrophy 2, Spinocerebellar|Spinocerebellar Atrophy Is|Dominantly Inherited Spinocerebellar Ataxias|OPCA with Retinal Degeneration|Spinocerebellar Degeneration with Slow Eye Movements|Spinocerebellar Ataxia 6|Spinocerebellar Ataxia-1|Spinocerebellar Ataxias, Dominantly Inherited|Spinocerebellar Ataxia, Autosomal Dominant, with Sensory Axonal Neuropathy|Olivopontocerebellar Atrophy 2s|Autosomal Dominant Cerebellar Ataxia, Type II|Atrophy II, Olivopontocerebellar|Spinocerebellar Ataxia-7|Atrophy IIs, Spinocerebellar|Atrophy IV, Olivopontocerebellar|OPCA with Macular Degeneration and External Ophthalmoplegia|Spinocerebellar Ataxia with Slow Eye Movements|Syndrome, Wadia Swami|Spinocerebellar Ataxia Type 1|Spinocerebellar Atrophy 2s|Spinocerebellar Ataxia Type 6|Atrophy 2s, Spinocerebellar|Spinocerebellar Ataxia-2|Spinocerebellar Ataxia Type 5|Olivopontocerebellar Atrophy, Holguin Type|Ataxias, Spinocerebellar|Olivopontocerebellar Atrophy 2|Cerebelloparenchymal Disorder I|Olivopontocerebellar Atrophy IIIs|Swami Syndrome, Wadia|Spinocerebellar Ataxia Type 4|Spinocerebellar Ataxias, Dominantly-Inherited|Olivopontocerebellar Atrophy Is|Cerebelloparenchymal Disorder Is|Spinocerebellar Ataxia, Cuban Type|Atrophy I, Spinocerebellar|Spinocerebellar Ataxia 5s|Ataxia 6, Spinocerebellar|spinocerebellar ataxia type|Ataxia 2, Spinocerebellar|Atrophy 2, Olivopontocerebellar|SCA1|Spinocerebellar Ataxia-5|OPCA, Menzel Type|Olivopontocerebellar Atrophy II|Wadia Swami Syndrome|Spinocerebellar Ataxia 4|Atrophy IVs, Olivopontocerebellar|Spinocerebellar Atrophy I|Spinocerebellar Ataxia 1|Type 5 Spinocerebellar Ataxia|Spinocerebellar Ataxia|Type 6 Spinocerebellar Ataxia|Spinocerebellar Ataxia 2s|Menzel Type OPCA|Spinocerebellar Ataxia Type 7|Olivopontocerebellar Atrophy III|Olivopontocerebellar Atrophy IV|Spinocerebellar Atrophy IIs|Spinocerebellar Ataxia-4|Atrophies, Spinocerebellar|Spinocerebellar Ataxia-6|Spinocerebellar Ataxia 5|Dominantly-Inherited Spinocerebellar Ataxias|Atrophy 2s, Olivopontocerebellar|Spinocerebellar Ataxia 7|Atrophy I, Olivopontocerebellar|Spinocerebellar Ataxia, Dominantly-Inherited|Spinocerebellar Ataxia 2|Spinocerebellar Atrophy II|Ataxia 7, Spinocerebellar|Ataxia, Spinocerebellar|Type 2 Spinocerebellar Ataxia"
D020325,DISEASE,Migraine with Aura,"Familial Hemiplegic Migraine|Typical Aura without Headache|Basilar Type Migraine|Migraine, Classic|Migraine, Basilar Artery|familial hemiplegic migraine|Migraine with Typical Aura|Migraine, Basilar-Type|Migraine, Classical|Migraine with Prolonged Aura|Hemiplegic Migraine, Familial|Classical Migraine|Hemiplegic-Ophthalmoplegic Migraine|Prolonged Aura Migraine|Basilar Migraine|Basilar Artery Migraine|Complicated Migraine|Classic Migraine|Migraine with Auras|Migraine Aura without Headache|Migraine with Acute Onset Aura|Basilar-Type Migraine|Migraine, Prolonged Aura|Basilar Migraines|Migraine, Basilar|Acute Onset Aura Migraine|Migraine, Complicated|Familial Hemiplegic Migraines"
NEW07011,CHEMICAL,glutamate excitotoxicity,glutamate excitotoxicity
D053040,DISEASE,Nephrolithiasis,nephrolithiasis|Kidney Calculi (1965-2006)
NEW07013,CHEMICAL,normal urinary cyclic adenosine monophosphate excretion,normal urinary cyclic adenosine monophosphate excretion
NEW07014,CHEMICAL,normal plasma inorganic phosphate,normal plasma inorganic phosphate
NEW07015,CHEMICAL,low urinary calcium excretion,low urinary calcium excretion
NEW07016,BIOCHEMICAL,increase drug accessibility,increased drug accessibility
NEW07017,CHEMICAL,bilateral intracranial calcium deposition,bilateral intracranial calcium deposition
D066208,DISEASE,Olfactory Tubercle,"Olfactorium, Tuberculum|Olfactory Tubercles|Anterior Perforated Substances|Anterior Perforated Space|Substances, Anterior Perforated|Tuberculum Olfactorium|Perforated Substances, Anterior|olfactory|Tubercle, Olfactory|Olfactoriums, Tuberculum|Tuberculum Olfactoriums|Perforated Substance, Anterior|Anterior Perforated Substance|Tubercles, Olfactory|Substance, Anterior Perforated"
NEW07020,MENTAL_HEALTH,anxiety immediate anxiolytic effect,anxiety immediate anxiolytic effect
NEW07021,CHEMICAL,quetiapine xr,quetiapine XR
NEW07023,CHEMICAL,neurological severity score,NSS|neurological severity scores
D064594,DISEASE,Bone-Patellar Tendon-Bone Grafts,GCTB|bone|Bone Patellar Tendon Bone Grafts|Bone-Patellar Tendon-Bone Graft
D018212,DISEASE,Giant Cell Tumor of Bone,Giant Cell Tumors (1966-1993)|Bone Neoplasms (1966-1993)|giant cell tumor
NEW07025,CHEMICAL,angiotensin-ii mediated activation,angiotensin-II mediated activation
NEW07029,CHEMICAL,cus mouse,CUS mice
NEW07030,CHEMICAL,calcium-phosphate balance,calcium-phosphate balance
D007970,DISEASE,Leukopenia,Leukocytopenias|leukopenia|Leukocytopenia|Leukopenias
NEW07033,DISEASE,hyperammonemic stress response,hyperammonemic stress response
NEW07036,DISEASE,tcm clinic,TCM clinics
NEW07037,CHEMICAL,calcium pth level,calcium PTH levels
NEW07039,DISEASE,unmedicated depressive patient,unmedicated depressive patients
NEW07041,DISEASE,generalize disorder,generalized disorder
NEW07043,DISEASE,cardiovascular cv disease,cardiovascular CV disease
NEW07044,MENTAL_HEALTH,cns hyperactivity,CNS hyperactivity
NEW07047,CHEMICAL,glucose consumption,glucose consumption
NEW07049,DISEASE,cns hyperexcitability,CNS hyperexcitability
NEW07052,CHEMICAL,dopaminergic da neuron,dopaminergic DA neurons
NEW07053,CHEMICAL,α-synuclein (α-syn)-containing neuronal protein aggregate,α-synuclein (α-syn)-containing neuronal protein aggregates
NEW07056,CHEMICAL,extraneuronal amyloid plaque,extraneuronal amyloid plaques
D000067073,DISEASE,Psychological Trauma,"Trauma, Psychological|psychological trauma"
NEW07059,DISEASE,l5178y mouse lymphoma cell,L5178Y mouse lymphoma cells
NEW07062,DISEASE,peculiar tissue-specific microwave oven burn,peculiar tissue-specific microwave oven burns
NEW07064,CHEMICAL,tnf-α level,TNF-α level
NEW07065,DISEASE,significant behavioral alteration,significant behavioral alterations
NEW07067,DISEASE,neurodegenerative disease animal model,neurodegenerative disease animal models
D010264,DISEASE,Paraplegia,"Paraplegias, Flaccid|Spastic Paraplegias|Paralysis, Lower Limbs|Paraplegias, Spastic|Ataxic Paraplegia|Paraplegia, Cerebral|Cerebral Paraplegia|Paraplegia, Spinal|Ataxic Paraplegias|Spinal Paraplegia|Paraplegias, Ataxic|Paraplegia, Ataxic|Cerebral Paraplegias|Paralysis, Legs|Paraplegias, Spinal|Paralysis, Lower Extremities|Flaccid Paraplegias|Paraplegias, Cerebral|Paraplegia, Flaccid|Paraplegias|Paraplegia, Spastic|Spinal Paraplegias|Spastic Paraplegia|Flaccid Paraplegia|ataxic"
NEW07068,DISEASE,nmda antagonist-stimulated motoric behavior,NMDA antagonist-stimulated motoric behavior
NEW07069,CHEMICAL,cortical glutamate eﬄux,cortical glutamate eﬄux
D002490,DISEASE,Central Nervous System,"Systems, Central Nervous|Central Nervous Systems|Nervous Systems, Central|central systems|Nervous System, Central|Axis, Cerebrospinal|Cerebrospinal Axi|Axi, Cerebrospinal|Cerebrospinal Axis"
http://purl.obolibrary.org/obo/DOID_6680,DISEASE,capgras syndrome,hyperinsulinism/hyperammonemia syndrome|Capgras delusion theory|HHS
NEW07071,DISEASE,various tumor,various tumors
NEW07074,DISEASE,human tumor,human tumors
NEW07076,DISEASE,ra-regulated tumor suppressor gene,RA-regulated tumor suppressor gene
NEW07077,CHEMICAL,retinoic acid receptor beta2 gene,retinoic acid receptor beta2 gene
NEW07079,BIOCHEMICAL,non-hyalouronic filler,non-hyalouronic filler
NEW07080,CHEMICAL,silicon agents-in case,silicon agents-in cases
D000067548,BIOCHEMICAL,Dermal Fillers,"Fillers, Dermal|Fillers, Skin|Filler, Skin|filler|Skin Fillers|Skin Filler|Filler, Dermal|Dermal Filler"
NEW07081,DISEASE,typical Language Development,TLD|Typical Language Development
NEW07082,DISEASE,vaginal inflammation,vaginal inflammation
NEW07084,DISEASE,pain addiction management,pain addiction management
NEW07085,DISEASE,synergistic neurotoxicity,synergistic neurotoxicity
NEW07089,DISEASE,neuronal atrophy,neuronal atrophy
NEW07090,CHEMICAL,plasma glutamate level,plasma glutamate levels
NEW07091,CHEMICAL,heparan fragment,heparan fragments
NEW07096,DISEASE,acute overdose,acute overdose
NEW07098,DISEASE,human neuroblastoma sh-sy5y cell,human neuroblastoma SH-SY5Y cells
NEW07100,DISEASE,ad-like deficit,AD-like deficits
NEW07103,CHEMICAL,serum urate,SU|serum urate
NEW07104,CHEMICAL,urate flare,urate flares
D005761,DISEASE,"Gastroenteritis, Transmissible, of Swine","Swine Transmissible Gastroenteritis|Transmissible Gastroenteritides, Swine|Transmissible Gastroenteritides, Porcine|Transmissible Porcine Gastroenteritides|Swine Transmissible Gastroenteritides|Transmissible Gastroenteritis of Swine|Gastroenteritides, Swine Transmissible|Porcine Transmissible Gastroenteritides|gastroenteritis|Gastroenteritis, Transmissible, Porcine|Gastroenteritis, Swine Transmissible|Gastroenteritis, Porcine Transmissible|Gastroenteritides, Transmissible Porcine|Transmissible Gastroenteritis, Swine|Gastroenteritis, Transmissible Porcine|Gastroenteritides, Porcine Transmissible|Transmissible Gastroenteritis, Porcine|Porcine Transmissible Gastroenteritis|Transmissible Porcine Gastroenteritis|Porcine Gastroenteritis, Transmissible|Porcine Gastroenteritides, Transmissible"
D007968,DISEASE,"Leukoencephalopathy, Progressive Multifocal","progressive multifocal leukoencephalopathy|Encephalitis, JC Polyomavirus|Leukoencephalopathies, Progressive Multifocal|Progressive Multifocal Leukoencephalopathies|JC Polyomavirus Encephalopathy|Progressive Multifocal Leukoencephalopathy|Encephalopathy, JC Polyomavirus|Multifocal Leukoencephalopathy, Progressive|JC Polyomavirus Encephalitis|Multifocal Leukoencephalopathies, Progressive|Encephalopathies, JC Polyomavirus"
D020773,DISEASE,Headache Disorders,"Intractable Headaches|Chronic Headache|Headache, Intractable|Headache Syndromes|Headaches, Chronic|Headaches, Chronic Daily|Chronic Headaches|Headache, Chronic Daily|Chronic Daily Headache|cephalgia|Daily Headaches, Chronic|Daily Headache, Chronic|Cephalgia Syndrome|Headache, Chronic|Headache Syndrome|Intractable Headache|Syndrome, Headache|Headache Disorder|Cephalgia Syndromes|Headaches, Intractable|Chronic Daily Headaches"
D009304,DISEASE,Nasopharyngitis,Nasopharyngitides|nasopharyngitis
http://purl.obolibrary.org/obo/CHEBI_35718,BIOCHEMICAL,antifungal agent,antifungal drug|antifungal drugs|antifungal agents|newer antifungal agents|antifungals|antifungal
NEW07107,DISEASE,haematological disease,haematological diseases
NEW07109,DISEASE,visual disturbance,visual disturbances
NEW07110,CHEMICAL,excessive cortisol,excessive cortisol
NEW07113,DISEASE,neurodegenerative damage,neurodegenerative damage
NEW07114,CHEMICAL,lmw ≤10 k proteolytic peptide,LMW ≤10 K proteolytic peptides
NEW07115,BIOCHEMICAL,major neurotoxic agent,major neurotoxic agents
NEW07117,DISEASE,widespread amyloid deposition,widespread amyloid deposition
NEW07119,CHEMICAL,± μg/l,± μg/L
D036102,DISEASE,Peripheral Blood Stem Cell Transplantation,"Transplantation, Peripheral Stem Cell|Peripheral Stem Cell Transplantation|Stem Cell Transplantation, Peripheral|peripheral blood"
NEW07121,DISEASE,stress-induced gastritis,stress-induced gastritis
NEW07122,CHEMICAL,vb6 supplementation,VB6 supplementation
NEW07123,DISEASE,low magnesemia,low magnesemia
http://purl.obolibrary.org/obo/DOID_13382,DISEASE,megaloblastic anemia,recessive hereditary megaloblastic anemia 1|Grasbeck-Imerslund syndrome|RH-MGA1|Imerslund-Grasbeck syndrome|recessive hereditary megaloblastic anaemia 1|MGA1 Norwegian type|microcytic anemia|IGS|megaloblastic anaemia
http://purl.obolibrary.org/obo/SYMP_0000634,DISEASE,leukocytosis,anisocytosis
NEW07126,DISEASE,hyperammonemic patient,hyperammonemic patients
C019635,CHEMICAL,Alanine-glyoxylate transaminase [Supplementary Concept],Transaminases|glyoxylate
D006960,DISEASE,"Hyperoxaluria, Primary","Primary Hyperoxaluria|hyperoxalurias|Oxaloses, Primary|Primary Oxaluria|Oxaluria, Primary|Hyperoxalurias, Primary|Primary Oxalurias|Primary Oxalosis|Primary Hyperoxalurias|Oxalosis, Primary|Primary Oxaloses|Oxalurias, Primary"
NEW07131,CHEMICAL,powerful imao,powerful IMAO
D007490,CHEMICAL,Iproniazid,iproniazid|Iprazid
NEW07132,CHEMICAL,author pyridoxin deficiency isoniazid toxicity,authors pyridoxin deficiency isoniazid toxicity
NEW07137,DISEASE,cognitive decline secondary,cognitive decline secondary
NEW07140,CHEMICAL,excessive vasopressin function,excessive vasopressin function
D011928,DISEASE,Raynaud Disease,"Raynaud's Disease|Raynaud Phenomenon|Raynaud's disease|Cold Fingers, Hereditary|Raynauds Disease"
NEW07141,DISEASE,due hyperproteinemia,due hyperproteinemia
NEW07143,MENTAL_HEALTH,dementia pathogenesis,dementia pathogenesis
NEW07146,MENTAL_HEALTH,virus tobacco abuse,virus tobacco abuse
D005750,DISEASE,Gastric Juice,"gastric juices|Juices, Gastric|Gastric Juices|Juice, Gastric"
NEW07148,DISEASE,mental deficit,mental deficits
NEW07149,DISEASE,severe neurodegenerative disorder,severe neurodegenerative disorders
C548069,DISEASE,Pontocerebellar Hypoplasia Type 1 [Supplementary Concept],pontocerebellar hypoplasia|Olivopontocerebellar Atrophies
NEW07152,DISEASE,clinical pain condition,clinical pain conditions
http://purl.obolibrary.org/obo/MFOMD_0000197,MENTAL_HEALTH,substance-induced anxiety disorder,anxiety depressive disorders
NEW07158,DISEASE,influenza infection,influenza infections
NEW07159,DISEASE,hepatic ultra-structural damage,hepatic ultra-structural damage
NEW07161,CHEMICAL,caffeine catechin,caffeine catechins
NEW07164,MENTAL_HEALTH,significant locomotor depression,significant locomotor depression
NEW07165,MENTAL_HEALTH,significant hyperactivity,significant hyperactivity
NEW07166,CHEMICAL,mdma pretreated group,MDMA pretreated groups
D020644,DISEASE,Midline Thalamic Nuclei,"Reunien, Nucleus|Paraventricular Nucleus of Thalamus|Thalamic Nucleus, Midline|Rhomboidal Nucleus|Midline Nuclear Group|Thalamic Nuclei, Midline|Thalamus Periventricular Nuclei|Reuniens, Nucleus|Nucleus, Parataenial|Nucleus, Paraventricular Thalamic|Nucleus Reuniens|Reuniens Thalami, Nucleus|Parataenial Nucleus|Paratenial Nucleus|Thalamus, Nucleus Reuniens|Nuclei, Midline Thalamic|Nucleus, Rhomboidal|Thalamus Midline Nucleus|Nucleus, Rhomboid Thalamic|Nucleus, Reuniens Thalamic|Nuclear Group, Midline|Midline Thalamic Nucleus|Thalamic Nucleus, Reuniens|Nucleus, Subfascular|Thalamic Nucleus, Rhomboid|paraventricular thalamic nucleus|Nucleus Reuniens Thalami|Nucleus, Midline Thalamic|Nucleus Reuniens Thalamus|Nucleus, Paratenial|Reuniens Nucleus|Periventricular Nuclei of Thalamus|Midline Nuclei of Thalamus|Nucleus, Rhomboid|Nucleus, Paratenial Thalamic|Reuniens Thalamic Nucleus|Thalami, Nucleus Reuniens|Nucleus Reunien|Thalamic Nucleus, Paratenial|Nucleus, Subfascular Thalamic|Rhomboid Thalamic Nucleus|Reuniens Thalamus, Nucleus|Paratenial Thalamic Nucleus|Paraventricular Thalamic Nucleus|Nucleus, Reuniens|Thalamus Midline Nuclei|Thalamic Nucleus, Paraventricular|Subfascular Nucleus|Thalamus Paraventricular Nucleus|Rhomboid Nucleus|Subfascular Thalamic Nucleus|Thalamic Nucleus, Subfascular|PVT"
NEW07169,MENTAL_HEALTH,morphine-induced locomotor hyperactivity,morphine-induced locomotor hyperactivity
NEW07170,CHEMICAL,morphine-induced dopamine release,morphine-induced dopamine release
NEW07174,DISEASE,its 's developmental neurotoxicity,developmental neurotoxicity
NEW07175,MENTAL_HEALTH,initial locomotor hyperactivity,initial locomotor hyperactivity
NEW07177,DISEASE,locomotor dysfunction,locomotor dysfunction
NEW07178,CHEMICAL,rotenone treated animal,rotenone treated animals
NEW07180,CHEMICAL,night-time levodopa,night-time levodopa
NEW07182,CHEMICAL,nmda receptor-ion channel complex,NMDA receptor-ion channel complexes
NEW07183,DISEASE,cardiovascular disease related,cardiovascular disease related
NEW07184,BIOCHEMICAL,toxic substance mixture,toxic substance mixtures
NEW07185,DISEASE,comorbid psychiatric medical condition,comorbid psychiatric medical conditions
NEW07186,DISEASE,remarkable cell apoptosis tumor elimination,remarkable cell apoptosis tumor elimination
NEW07188,MENTAL_HEALTH,reserpine akinesia,reserpine akinesia
NEW07189,CHEMICAL,clozapine non-clozapine group,clozapine non-clozapine groups
NEW07190,CHEMICAL,catecholamine agent,catecholamine agents
NEW07191,MENTAL_HEALTH,stress-induced craving,stress-induced craving
NEW07192,CHEMICAL,prazosin effect,prazosin effects
NEW07198,DISEASE,acute oral toxicity study,acute oral toxicity studies
NEW07199,DISEASE,adult attention-deficit/hyperactivity disorder,adult attention-deficit/hyperactivity disorder
D000073865,DISEASE,Cigarette Smoking,"cigarette smoking|Smoking, Cigarette"
NEW07200,CHEMICAL,dopamine b significant risk factor,dopamine b significant risk factor
NEW07202,MENTAL_HEALTH,adhd criterion,ADHD criteria
NEW07203,MENTAL_HEALTH,adhd parent-proband,ADHD parent-proband
NEW07204,DISEASE,invasive infection,invasive infections
NEW07205,DISEASE,cidp refractory,CIDP refractory
NEW07206,MENTAL_HEALTH,canine cataplexy,canine cataplexy
NEW07207,DISEASE,tumor necrosis factor-alpha production,tumor necrosis factor-alpha production
http://purl.obolibrary.org/obo/CHEBI_187805,CHEMICAL,"(25r)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-27-oyl taurine","2-[[(2R,6R)-2-methyl-6-[(3R,5S,7R,10S,12S,13R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoyl]amino]ethanesulonic acid|μg hypotaurine"
NEW07210,CHEMICAL,nmdar1 subunit,NMDAR1 subunits
D012021,DISEASE,"Reflex, Abnormal","Reflex, Biceps, Absent|Reflex, Hoffman's|Pendular Reflex|Decreased Bulbocavernosus Reflex|Reflex, Corneal, Decreased|Decreased Reflex|Bulbocavernousus Reflex Absent|Reflex, Triceps, Abnormal|Reflex, Palmo-Mental|Reflex, Acoustic, Abnormal|Abnormal Reflex|Hyporeflexia|Reflex, Triceps, Absent|Reflex, Absent|Reflex, Corneal, Absent|Reflex, Gag, Absent|Reflex, Knee, Decreased|Reflex, Decreased|Reflex, Decreased Bulbocavernosus|Reflex, Moro, Asymmetric|Hoffman's Reflex|Reflex, Ankle, Decreased|Palmo-Mental Reflex|Bulbocavernosus Reflex, Decreased|Reflex, Pendular|Palmo Mental Reflex|Reflexes, Abnormal|Reflex, Triceps, Decreased|Reflex, Gag, Decreased|Reflex, Anal, Absent|Reflex, Ankle, Absent|Reflex, Biceps, Decreased|Reflex, Knee, Abnormal|Reflex Absent, Bulbocavernousus|Abnormal Deep Tendon Reflex|Abnormal Reflexes|Reflex, Biceps, Abnormal|Absent Reflex|Hyperreflexia|Reflex, Ankle, Abnormal|hyporeflexia|Reflex, Anal, Decreased|Reflex, Deep Tendon, Abnormal|Reflex, Deep Tendon, Absent"
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Mental_Confusion,MENTAL_HEALTH,mental confusion,mental confusion
D012859,DISEASE,Sjogren's Syndrome,"Sjögren's syndrome|Sicca Syndrome|Sjogren Syndrome|Syndrome, Sjogren's|Syndrome, Sicca|Sjogrens Syndrome"
NEW01173,DISEASE,psychotic episode,psychotic episodes
NEW07219,DISEASE,neuroregeneration,neuroregeneration
NEW07220,DISEASE,gene-related brain damage,gene-related brain damage
NEW07222,BIOCHEMICAL,virulence factor gene,virulence factor genes
NEW07223,CHEMICAL,pneumococcal cap,pneumococcal CAP
NEW07225,CHEMICAL,2-alkyl-4-quinolone production,2-alkyl-4-quinolone production
NEW07227,CHEMICAL,selenium supplementation,selenium supplementation
NEW07229,MENTAL_HEALTH,Neuropsychiatric Schizophrenia,Neuropsychiatric Schizophrenia
NEW07230,DISEASE,ASD symptom,ASD symptoms
NEW07231,BIOCHEMICAL,d concentration,D concentrations
NEW07232,MENTAL_HEALTH,autism behavior checklist,Autism Behavior Checklist
NEW07233,MENTAL_HEALTH,Autism Diagnostic Observation Schedule-Second Edition,Autism Diagnostic Observation Schedule-Second Edition
NEW07235,BIOCHEMICAL,vitamin d concentration,vitamin D concentration
NEW07237,CHEMICAL,alcohol reward,alcohol reward
NEW07238,MENTAL_HEALTH,preclinical anxiety model,preclinical anxiety models
http://purl.obolibrary.org/obo/CHEBI_4315,CHEMICAL,danazol,"danazol|danazolum|[1,2]oxazolo[4',5':2,3]-17alpha-pregn-4-en-20-yn-17-ol|50mg/d LY686017|Cyclomen|Danocrine"
NEW07240,CHEMICAL,amphetamine treatment,amphetamine treatment
NEW07241,DISEASE,attentional set-shifting,attentional set-shifting
NEW07243,MENTAL_HEALTH,canine separation anxiety,canine separation anxiety
NEW07248,CHEMICAL,cortisol present,cortisol present
http://purl.obolibrary.org/obo/CHEBI_36699,BIOCHEMICAL,corticosteroid hormone,corticosteroid hormones|adrenal cortex hormones
NEW07251,DISEASE,impairment disability,impairment disability
NEW07259,DISEASE,cancer cell line culture,cancer cell line cultures
C000719212,MENTAL_HEALTH,Pathophobia [Supplementary Concept],Phobic Disorders|cancer phobia
NEW07262,BIOCHEMICAL,tsh releasing hormone,TSH releasing hormone
NEW07263,BIOCHEMICAL,hormone response,hormone response
NEW07266,DISEASE,substance-related addictive disorder,substance-related addictive disorders
NEW07270,CHEMICAL,basal testosterone metabolism,basal testosterone metabolism
NEW07272,DISEASE,abnormal rem sleep manifestation,abnormal REM sleep manifestations
NEW07273,DISEASE,major orexin impairment,major orexin impairment
NEW07277,DISEASE,drug-facilitated sexual assault,drug-facilitated sexual assault
NEW07278,DISEASE,sexual predator,sexual predators
NEW07279,DISEASE,x-linked neurological disorder,X-linked neurological disorder
NEW07281,CHEMICAL,to sphingosine-1-phosphate receptor,to sphingosine-1-phosphate receptors|S1PRs
D066253,DISEASE,Vascular Remodeling,"Remodeling, Vascular|Arterial Remodeling, Pulmonary|Remodelings, Vascular|vascular remodeling|Pulmonary Arterial Remodelings|Remodeling, Pulmonary Arterial|Pulmonary Arterial Remodeling|Remodelings, Pulmonary Arterial|Vascular Remodelings|Arterial Remodelings, Pulmonary"
NEW07282,CHEMICAL,down-regulating gr expression,down-regulating GR expression
NEW07283,DISEASE,adolescent stress-induced ptsd-like behavior,adolescent stress-induced PTSD-like behaviors
NEW07286,MENTAL_HEALTH,peri-surgical anxiety,peri-surgical anxiety
NEW07287,DISEASE,functional dyspeptic syndrome,functional dyspeptic syndrome
NEW07290,MENTAL_HEALTH,early psychosis,early psychosis
NEW07293,MENTAL_HEALTH,imminent psychosis,imminent psychosis
NEW07294,BIOCHEMICAL,preventive drug therapy,preventive drug therapy
NEW07296,DISEASE,postnatal psychotic episode,postnatal psychotic episodes
NEW07298,CHEMICAL,cortisol blunting,cortisol blunting
NEW07300,CHEMICAL,low cortisol secretion,lower cortisol secretion
NEW07302,DISEASE,psychopathy group,psychopathy group
NEW07305,BIOCHEMICAL,hypothyroidism-a common endocrine disorder,hypothyroidism-a common endocrine disorder
NEW07307,CHEMICAL,glutamate glu level,glutamate Glu levels
NEW07309,DISEASE,her2-negative her2- metastatic breast cancer,HER2-negative HER2- metastatic breast cancer
D021541,NUTRITION,Sea Bream,"Gilthead Seabreams|Seabream, Gilthead|Sea Breams, Gilthead|gilthead sea bream|Gilthead Seabream|Gilthead Bream|Gilthead Breams|Sparus aurata|Seabream|Seabreams|Sea Bream, Gilthead|Sparus auratus|Gilthead Sea Bream|Gilthead Sea Breams|Seabreams, Gilthead|Sea Breams"
NEW07314,DISEASE,neuropathic disorder,neuropathic disorders
NEW07315,DISEASE,associate corrosive gastritis,associated corrosive gastritis
NEW07318,CHEMICAL,dietary cadmium,dietary cadmium
NEW07319,CHEMICAL,specific ige-antibodie,specific IgE-antibodies
D021181,DISEASE,Egg Hypersensitivity,"Hypersensitivity, Egg|Egg Allergy|Egg Allergies|Allergy, Egg|egg allergy|Hypersensitivities, Egg|Allergies, Egg|Egg Hypersensitivities"
NEW07321,DISEASE,devastate heart damage,devastating heart damage
NEW07324,BIOCHEMICAL,potential drug target,potential drug targets
NEW07326,BIOCHEMICAL,different agonist,different agonists
NEW07327,CHEMICAL,ip1,IP1
NEW07328,CHEMICAL,camp accumulation,cAMP accumulation
NEW07330,DISEASE,migraine onset,migraine onset
D014822,DISEASE,Vitreous Body,"Humor, Vitreous|Bodies, Vitreous|Humors, Vitreous|Vitreous Humor|vitreous humor|Body, Vitreous|Vitreous Humors|Vitreous Bodies"
NEW07333,CHEMICAL,acute zolpidem overdose,acute zolpidem overdose
NEW07334,CHEMICAL,high-dose caffeine ingestion,high-dose caffeine ingestions
NEW07337,DISEASE,overt anxiolytic-like behavior,overt anxiolytic-like behavior
NEW07339,DISEASE,induce neurotoxicity,induced neurotoxicity
NEW07340,DISEASE,dose panic state,dose panic states
NEW07341,NUTRITION,alpha frequency,alpha frequency
NEW07342,BIOCHEMICAL,beta power,beta power
NEW07344,CHEMICAL,heavy caffeine consumption,heavy caffeine consumption
NEW07346,CHEMICAL,abnormal 5-hydroxytryptamine metabolism,abnormal 5-hydroxytryptamine metabolism
NEW07347,DISEASE,chronic stress-induced depression-like disorder,chronic stress-induced depression-like disorders
NEW07348,CHEMICAL,neuronal adenosine a2a receptor,neuronal adenosine A2A receptors
NEW07349,DISEASE,stress-induced mood dysfunction,stress-induced mood dysfunction
NEW07350,DISEASE,memory deterioration,memory deterioration
NEW07351,DISEASE,sensory contact model,sensory contact model|SCM
http://purl.obolibrary.org/obo/CHEBI_140133,CHEMICAL,demethoxyisogemichalcone c,C rooibos
D010469,DISEASE,Perceptual Distortion,"Distortions, Perceptual|Distortion, Perceptual|perceptual distortions|Perceptual Distortions"
http://purl.obolibrary.org/obo/MF_0000003,DISEASE,alertness,alertness
D051876,CHEMICAL,Sex-Determining Region Y Protein,Testis Determining Factor|Testis-Determining Factor|SRY Sex Determining Region Protein|SRY Sex-Determining Region Protein|y|Sex Determining Region Y Protein
NEW07358,MENTAL_HEALTH,drowsiness time,drowsiness time
NEW07360,CHEMICAL,caffeine variable,caffeine variable
NEW07361,MENTAL_HEALTH,mild dependence benefit,mild dependence benefits
NEW07363,DISEASE,cognitive failure,cognitive failures
NEW07364,MENTAL_HEALTH,symptom anxiety,symptoms anxiety
NEW07365,DISEASE,rare case psychotic,rare cases psychotic
NEW07368,CHEMICAL,postsynaptic serotonin receptor,postsynaptic serotonin receptors
NEW07371,DISEASE,oxidative/nitrative damage,oxidative/nitrative damage
NEW07374,CHEMICAL,dopamine hyperactivity hypothesis,dopamine hyperactivity hypothesis
NEW07375,DISEASE,pain increase,pain increase
http://purl.obolibrary.org/obo/SYMP_0000209,DISEASE,ischemia,ischaemia
C572578,CHEMICAL,"SARAF protein, human [Supplementary Concept]",calcium entry|Membrane Proteins|Intracellular Calcium-Sensing Proteins
NEW07376,BIOCHEMICAL,various nephrotoxin,various nephrotoxins
NEW07377,DISEASE,renal insufficiency due,renal insufficiency due
NEW07378,DISEASE,renal reperfusion,renal reperfusion
NEW07379,DISEASE,subarachnoid haemorrhage,subarachnoid haemorrhage
D020301,DISEASE,"Vasospasm, Intracranial","Cerebrovascular Spasms|Spasms, Cerebral Artery|Angiospasm, Intracranial|Intracranial Vasospasm|Angiospasms, Cerebral|Cerebral Angiospasm|Vascular Spasms, Intracranial|Angiospasms, Intracranial|Spasm, Cerebrovascular|Cerebral Angiospasms|Spasm, Cerebral Artery|Vasospasms, Intracranial|Spasms, Cerebrovascular|Vasospasms, Cerebral|vasospasm|Cerebral Vasospasms|Spasm, Intracranial Vascular|Cerebrovascular Spasm|Artery Spasms, Cerebral|Vasospasm, Cerebral|Cerebral Vasospasm|Cerebral Artery Spasms|Spasms, Intracranial Vascular|Intracranial Vasospasms|Vascular Spasm, Intracranial|Intracranial Angiospasm|Intracranial Angiospasms|Angiospasm, Cerebral|Artery Spasm, Cerebral|Intracranial Vascular Spasm|Intracranial Vascular Spasms|Cerebral Artery Spasm"
http://purl.obolibrary.org/obo/DOID_3526,DISEASE,cerebral infarction,acute cerebral infarction|Cerebral infarction|CVA - Cerebral infarction|Cerebral infarct
NEW07382,DISEASE,hcv genotype,HCV genotypes
NEW07385,CHEMICAL,alcohol dependent patient,alcohol dependent patients
NEW07386,MENTAL_HEALTH,depression power,depression power
NEW07388,MENTAL_HEALTH,carbohydrate craving,carbohydrate craving
NEW07389,MENTAL_HEALTH,increase fatigue,increased fatigue
C502443,DISEASE,"Trib3 protein, rat [Supplementary Concept]",neuronal cell death|Protein Serine-Threonine Kinases/antagonists  and  inhibitors
NEW07393,CHEMICAL,calcium current,calcium current
C527835,CHEMICAL,"N-(6-Chloropyridin-3-yl)-3,4-difluorobenzamide [Supplementary Concept]",ICa|Pyridines|Benzamides
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Anhedonia,DISEASE,anhedonia,fear/anxiety
NEW07394,MENTAL_HEALTH,anxiety abuse,anxiety abuse
NEW07396,DISEASE,acute severe exacerbation,acute severe exacerbations
NEW07397,CHEMICAL,cck level,CCK levels
NEW07399,CHEMICAL,mg muscimol,mg muscimol
NEW07400,BIOCHEMICAL,active drug treatment,active drug treatment
NEW07402,BIOCHEMICAL,da antagonist,DA antagonist
C477966,CHEMICAL,baicalein-6-O-glucopyranuronoside [Supplementary Concept],Glucuronates|Flavonoids|baicalein
NEW07403,DISEASE,experimental myopia,experimental myopia
NEW07405,BIOCHEMICAL,gaba agonist drug action,GABA agonist drug action
NEW07409,CHEMICAL,open-label tiagabine,open-label tiagabine
http://purl.obolibrary.org/obo/DOID_2030,MENTAL_HEALTH,anxiety disorder,different anxiety disorders|anxiety|anxiety state
NEW07410,DISEASE,generalize onset seizure,generalized onset seizures
NEW07412,DISEASE,impaired retention,impaired retention
http://purl.obolibrary.org/obo/CHEBI_188730,CHEMICAL,ifetroban,"co-infusion|3-[2-[[(1S,2R,3S,4R)-3-[4-(pentylcarbamoyl)-1,3-oxazol-2-yl]-7-oxabicyclo[2.2.1]heptan-2-yl]methyl]phenyl]propanoic acid"
NEW07414,CHEMICAL,carbachol-evoked ipsc,carbachol-evoked IPSCs
NEW07417,DISEASE,attention-deficit/hyperactivity Disorder,Attention-Deficit/Hyperactivity Disorder
NEW07418,BIOCHEMICAL,cb1 receptor antagonist radiotracer,CB1 receptor antagonist radiotracer
NEW07422,DISEASE,ptsd group relative,PTSD groups relative
NEW07424,MENTAL_HEALTH,dependent long-term depression,dependent long-term depression
NEW07425,DISEASE,cognitive deficit,cognitive deficit
NEW07427,DISEASE,novel object-recognition memory deficit,novel object-recognition memory deficit
C116653,CHEMICAL,"HGRG-14 protein, human [Supplementary Concept]",high glucose|Phosphoproteins|Carrier Proteins
NEW07429,MENTAL_HEALTH,diabetes-associated anxiety,diabetes-associated anxiety
NEW07432,MENTAL_HEALTH,multivariate logistic regression,multivariate logistic regression
NEW07433,DISEASE,mitochondrial dysfunction hypothesis,mitochondrial dysfunction hypothesis
NEW07437,DISEASE,severe depressive episode,severe depressive episodes
NEW07439,NUTRITION,sex steroid hormone fluctuation,sex steroid hormone fluctuations
NEW07441,NUTRITION,sex steroid hormone milieu,sex steroid hormone milieu
NEW07443,CHEMICAL,potent gonadotropin-lowering gonadotropin-releasing hormone agonist,potent gonadotropin-lowering gonadotropin-releasing hormone agonist
NEW07446,DISEASE,depressed group,depressed group
NEW07448,CHEMICAL,op compound capable,OP compounds capable
D000080044,CHEMICAL,Ado-Trastuzumab Emtansine,Trastuzumab-DM1 Conjugate|Trastuzumab DM1 Conjugate|Trastuzumab DM1|huN901DM1|huN901-DM1|huN901 DM1|Kadcyla|Trastuzumab-DM1|Ado Trastuzumab Emtansine|trastuzumab|Trastuzumab Emtansine
NEW07450,CHEMICAL,to trastuzumab,herceptin|to trastuzumab
NEW07452,DISEASE,lumbal disc hen,lumbal disc hen
http://purl.obolibrary.org/obo/SYMP_0000006,DISEASE,backache,dorsalgia|back pain
D059226,DISEASE,Nociceptive Pain,"Pain, Tissue|Tissue Pain|Pains, Tissue|Pain, Somatic|Pains, Somatic|Nociceptive Pains|Pain, Nociceptive|Pains, Nociceptive|Somatic Pain|Tissue Pains|nociceptive pain|Somatic Pains"
NEW07453,DISEASE,pathic pain,pathic pain
NEW07454,CHEMICAL,most pron antidepressant effect,most pron antidepressant effect
NEW07456,MENTAL_HEALTH,certain human disorder,certain human disorders
http://purl.obolibrary.org/obo/CHEBI_90199,CHEMICAL,c-met tyrosine kinase inhibitor,"EGFR tyrosine kinase inhibitors|MET inhibitors|c-Met tyrosine kinase inhibitors|MET inhibitor|MET proto-oncogene, receptor tyrosine kinase inhibitor|c-Met inhibitor|c-Met inhibitors|MET proto-oncogene, receptor tyrosine kinase inhibitors"
NEW07457,DISEASE,notable toxicity,notable toxicity
C418782,CHEMICAL,alpha-ketobutyrate oxidase [Supplementary Concept],Ketone Oxidoreductases|α-ketobutyrate
D058466,CHEMICAL,Cysteine Loop Ligand-Gated Ion Channel Receptors,"Cysteine Loop Ligand Gated Ion Channel Receptor|cysteine|Cys Loop Receptor|Cys-Loop Receptor Superfamily|Cysteine Loop Ligand-Gated Ion Channel Receptor|Cys-Loop Receptors|Cys-Loop Receptor|Cys Loop Receptors|Receptors, Cys-Loop|Receptor Superfamily, Cys-Loop|Superfamily, Cys-Loop Receptor|Cys Loop Receptor Superfamily|Receptor, Cys-Loop|Cysteine Loop Ligand Gated Ion Channel Receptors"
NEW07458,DISEASE,acute tubular necrosis,acute tubular necrosis
NEW07461,BIOCHEMICAL,prescription drug mixture,prescription drug mixtures
NEW07463,CHEMICAL,mg/l caffeine,mg/L caffeine
C061510,DISEASE,"alpha-amylase inhibitor, Phaseolus vulgaris [Supplementary Concept]",Plant Lectins|P. vulgaris
D013542,DISEASE,Sweat,sweats|Sweats
NEW07467,BIOCHEMICAL,oxidative drug,oxidative drug
D031307,CHEMICAL,Vicia faba,"Bean, Horse|Faba Beans|Faba Bean|fava beans|Beans, Fava|Horsebean|Bean, Fava|Horse Bean|Horse Beans|Horsebeans|Fava Bean|Beans, Faba|Fava Beans|fabas, Vicia|Vicia fabas|Beans, Horse|Bean, Faba"
NEW07469,DISEASE,id disorder,ID disorders
NEW07470,DISEASE,diabetic dyslipidemia,diabetic dyslipidemia
C493232,CHEMICAL,"Slc6a4 protein, rat [Supplementary Concept]",Serotonin Plasma Membrane Transport Proteins|serotonin reuptake transporter
NEW07473,DISEASE,female pattern hair loss,female pattern hair loss
http://purl.obolibrary.org/obo/DOID_12698,DISEASE,gynecomastia,gynaecomastia
NEW07478,BIOCHEMICAL,antiandrogen monotherapy,antiandrogen monotherapy
http://purl.obolibrary.org/obo/DOID_10283,DISEASE,prostate cancer,"tumor of the prostate|hereditary prostate cancer|prostatic cancer|prostatic neoplasm|prostate neoplasm|prostate cancer, familial|advanced prostate cancer|malignant tumor of the prostate|NGP - new growth of prostate"
NEW07482,DISEASE,breast development,breast development
NEW07485,DISEASE,neurocognitive dysfunction,neurocognitive dysfunction
NEW07488,MENTAL_HEALTH,sulfite-induced anxiety,sulfite-induced anxiety
NEW07490,DISEASE,stimulant-induced hypertensive reaction,stimulant-induced hypertensive reactions
NEW07491,CHEMICAL,endogenous ach,endogenous Ach
NEW07492,DISEASE,4d toxicity,4D toxicity
NEW07493,CHEMICAL,depression-inducing effect,depression-inducing effect
NEW07496,DISEASE,trait hostility,trait hostility
C105050,CHEMICAL,tegaserod [Supplementary Concept],Indoles|tegaserod
NEW07499,DISEASE,constipated ibs patient,constipated IBS patients
NEW07500,DISEASE,diarrhea-predominant ibs,diarrhea-predominant IBS
NEW07501,DISEASE,negative symptom,negative symptoms
D012559,DISEASE,Schizophrenia,"Disorders, Schizophrenic|schizophrenic disorders|Schizophrenias|Dementia Praecox|Disorder, Schizophrenic|Schizophrenic Disorders|Schizophrenic Disorder"
NEW07503,CHEMICAL,non-competitive n-methyl-d-aspartate nmda antagonist dizocilpine,non-competitive N-methyl-D-aspartate NMDA antagonist dizocilpine
NEW07507,BIOCHEMICAL,competitive antagonist expression,competitive antagonists expression
NEW07509,CHEMICAL,pindolol group,pindolol group
NEW07510,BIOCHEMICAL,mixed indirect dopamine-serotonin agonist,mixed indirect dopamine-serotonin agonists
NEW07511,CHEMICAL,"3,4-metyhlenedioxymethamphetamine","3,4-metyhlenedioxymethamphetamine"
NEW07515,DISEASE,aforementioned esophageal disorder,aforementioned esophageal disorders
NEW07517,BIOCHEMICAL,visceral analgesic effect,visceral analgesic effect
NEW07518,DISEASE,convulsive ergotism,convulsive ergotism
C408447,CHEMICAL,"neurokinin A (4-10), Trp(7)-beta-Ala(8)- [Supplementary Concept]",Neurokinin A/analogs  and  derivatives|Peptide Fragments|NKA
http://purl.obolibrary.org/obo/CHEBI_80311,CHEMICAL,neurokinin a,Neuromedin L|Substance K|neurokinins A
NEW07525,DISEASE,fundamental psychiatric research,fundamental psychiatric research
NEW07527,DISEASE,thromboembolic disease,thromboembolic disease
NEW07529,CHEMICAL,warfarin exposure,warfarin exposure
D065427,CHEMICAL,Factor Xa Inhibitors,"Factor Xa Inhibitor|Direct Factor Xa Inhibitor|Inhibitor, Factor Xa|Direct Acting Oral Anticoagulant|Oral Anticoagulant, Direct-Acting|Direct-Acting Oral Anticoagulant|Direct Acting Oral Anticoagulants|OAC|Direct Factor Xa Inhibitors|Anticoagulant, Direct-Acting Oral|oral anticoagulants|Anticoagulants, Direct-Acting Oral|Oral Anticoagulants, Direct-Acting|Direct-Acting Oral Anticoagulants|Xa Inhibitor, Factor"
http://purl.obolibrary.org/obo/SYMP_0000226,DISEASE,atrial fibrillation,non-valvular atrial fibrillation|auricular fibrillation|AF|a-fib
NEW07531,DISEASE,thrombo-embolic prophylaxis,thrombo-embolic prophylaxis
NEW07533,BIOCHEMICAL,multiple drug interaction,multiple drug interactions
NEW07534,DISEASE,bleed risk,bleeding risk
NEW07536,DISEASE,high thromboembolic risk factor,high thromboembolic risk factor
NEW07537,DISEASE,intestinal tract,intestinal tract
D000472,DISEASE,"Alkalosis, Respiratory","Respiratory Alkalosis|Respiratory Alkaloses|alkalosis|Alkaloses, Respiratory"
NEW07539,CHEMICAL,potassium excretion,potassium excretion
NEW07540,CHEMICAL,renin-angiotensis-aldosterone system,renin-angiotensis-aldosterone system
NEW07541,CHEMICAL,sodium retention,sodium retention
NEW07542,DISEASE,muscular paralysis,muscular paralysis
D064753,CHEMICAL,Ammonium Hydroxide,"ammonium|Hydroxide, Ammonium"
D003009,CHEMICAL,Clorazepate Dipotassium,Tranxene|Chlorazepate|Clorazepate|Clorazepate Monopotassium|Tranxilium|Clorazepic Acid|4306-CB|Dipotassium Chlorazepate|dipotassium
C104670,CHEMICAL,disodium cocoamphodipropionate [Supplementary Concept],Propionates|beta-Alanine/analogs  and  derivatives|disodium salts
NEW07548,BIOCHEMICAL,dopaminergic antagonist drug,dopaminergic antagonist drugs
NEW07551,DISEASE,lps-induced tumor necrosis factor,LPS-induced tumor necrosis factor
NEW07552,DISEASE,inflammation subsequent inflammatory injury,inflammation subsequent inflammatory injury
NEW07553,MENTAL_HEALTH,severe mood disorder,severe mood disorder
NEW07554,BIOCHEMICAL,abnormal endocrine,abnormal endocrine
NEW07555,MENTAL_HEALTH,endogenomorphic depression,endogenomorphic depression
NEW07556,DISEASE,obesity resistance,obesity resistance
http://purl.org/sig/ont/fma/fma70549,CHEMICAL,epithelial cell of choroid plexus,choroid plexus epithelial cells|CPEC
http://purl.obolibrary.org/obo/DOID_8691,CHEMICAL,mycosis fungoides,mycosis fungoides lymphoma|fungoid mycosis|Mycosis fungoides
D057112,DISEASE,Corneal Perforation,"Corneal Perforations|Perforations, Corneal|corneal perforation|Perforation, Corneal"
D020909,CHEMICAL,Acarbose,acarbose|Prandase|Precose|Glucor|Bay g 5421|Glumida|Glucobay
http://purl.obolibrary.org/obo/DOID_784,DISEASE,chronic kidney disease,chronic kidney failure|chronic renal failure syndrome|renal failure - chronic|CKD|chronic liver diseases|CRF|chronic renal disease
NEW07559,CHEMICAL,acarbose treatment due,acarbose treatment due
D017714,DISEASE,Community-Acquired Infections,"Community Acquired Infections|Acquired Infections, Community|Infections, Community-Acquired|Infections, Community Acquired|Infection, Community-Acquired|Community Acquired Infection|Acquired Infection, Community|community-acquired infection|Infection, Community Acquired|Community-Acquired Infection"
http://purl.obolibrary.org/obo/IDO:0000630,DISEASE,hospital-acquired infection,hospital-acquired infection
NEW07564,DISEASE,acute pain model,acute pain models
NEW07566,DISEASE,chronic pain disorder,chronic pain disorders
NEW07567,DISEASE,rodent tonic pain model,rodent tonic pain model
NEW07569,DISEASE,synergistic hypolocomotion,synergistic hypolocomotion
NEW07571,BIOCHEMICAL,effective nachr agonist,effective nAChR agonists
NEW07575,BIOCHEMICAL,drug development target,drug development target
NEW07576,BIOCHEMICAL,recreational drug abuse,recreational drug abuse
NEW07577,DISEASE,early endothelial dysfunction,early endothelial dysfunction
NEW07579,CHEMICAL,chronic cannabis use,chronic cannabis use
NEW07581,CHEMICAL,BMI     ±,BMI    ±
NEW07582,CHEMICAL,index bmi     ±,index BMI    ±
NEW07583,CHEMICAL,loi c4-t11,LOI C4-T11
NEW07587,CHEMICAL,low glucose level,lower glucose levels
NEW07588,CHEMICAL,high triglyceride level,higher triglyceride levels
D019948,CHEMICAL,"Receptors, Interleukin-4","Interleukin-4 Receptor|Receptors, IL4|Receptor, Interleukin 4|Receptors, IL-4|Receptor, IL4|Receptor, Interleukin-4|IL-4 Receptors|IL-4|IL-4 Receptor|Interleukin 4 Receptor|Interleukin-4 Receptors|IL 4 Receptor|IL4 Receptors|Receptor, IL-4|Receptors, IL 4|IL 4 Receptors|Interleukin 4 Receptors|IL4 Receptor|Receptors, Interleukin 4"
NEW07592,CHEMICAL,elevated whole-body cortisol,elevated whole-body cortisol
NEW07595,DISEASE,ketogenesis disorder,ketogenesis disorders
NEW07596,CHEMICAL,leucine oxidation,leucine oxidation
NEW07599,NUTRITION,baseline cholesterol,baseline cholesterol
NEW07600,CHEMICAL,cbz level,CBZ levels
NEW07601,NUTRITION,National Cholesterol Education Adult,National Cholesterol Education Adult
NEW07602,DISEASE,different psychiatric diagnosis,different psychiatric diagnoses
NEW07605,NUTRITION,cholesterol biosynthesis defect,cholesterol biosynthesis defect
NEW07607,DISEASE,neurotrauma,neurotrauma
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Premenstrual_Dysphoric_Disorder,DISEASE,premenstrual dysphoric disorder,pre-menstrual dysphoric disorder
NEW07610,DISEASE,impaired dendritic development similar,impaired dendritic development similar
NEW07615,MENTAL_HEALTH,relapse due depression,relapse due depression
D000073039,CHEMICAL,Nitrosative Stress,"Stress, Nitrosative|Nitrosative Stresses|nitrite/nitrate|Stresses, Nitrosative|nitrosative stress"
NEW07617,CHEMICAL,brain calcium level,brain calcium levels
NEW07618,DISEASE,exploratory activity intestinal motility,exploratory activity intestinal motility
NEW07620,DISEASE,elderly insomniac,elderly insomniacs
NEW07621,BIOCHEMICAL,novel melatonergic drug,novel melatonergic drug
NEW07624,DISEASE,comorbid neurological,comorbid neurological
NEW07625,DISEASE,airway beta2-adrenoceptor blockade,airway beta2-adrenoceptor blockade
NEW07626,CHEMICAL,endogenous catecholamine response,endogenous catecholamine responses
NEW07629,DISEASE,erectile problem,erectile problems
NEW07630,DISEASE,memory function,memory function
NEW07633,DISEASE,chronic blockade,chronic blockade
NEW07638,DISEASE,stress-induced anxiety/depression-like behavior,stress-induced anxiety/depression-like behaviors
NEW07640,DISEASE,marked adrenal atrophy,marked adrenal atrophy
NEW07642,MENTAL_HEALTH,emergent sexual dysfunction,emergent sexual dysfunction
NEW07643,CHEMICAL,bupropion xr,bupropion XR
NEW07645,DISEASE,dopamine-induced vasoconstriction,dopamine-induced vasoconstriction|renal ischemia
NEW07646,DISEASE,volume contraction,volume contraction
NEW07647,BIOCHEMICAL,direct drug effect,direct drug effects
NEW07649,CHEMICAL,norepinephrine-dopamine reuptake inhibitor,norepinephrine-dopamine reuptake inhibitor
NEW07651,DISEASE,drug-induced altered mental status,drug-induced altered mental status
NEW07653,CHEMICAL,bupropion use,bupropion use
NEW07654,CHEMICAL,bupropion mg,bupropion mg
NEW07657,DISEASE,d2r-antagonist-induced aberrant motor learning,D2R-antagonist-induced aberrant motor learning
NEW07658,DISEASE,d2r-mediated aberrant motor learning,D2R-mediated aberrant motor learning
NEW07660,DISEASE,aberrant motor learning,aberrant motor learning
NEW07661,BIOCHEMICAL,d2r antagonist,D2R antagonist
NEW07662,CHEMICAL,dvl-gsk3β-β-catenin signalling,Dvl-GSK3β-β-catenin signalling
NEW07664,CHEMICAL,ethanol liquid diet,ethanol liquid diet
NEW07665,CHEMICAL,ethanol withdrawal state,ethanol withdrawal state
NEW07666,CHEMICAL,ethanol withdrawal,ethanol withdrawal
NEW07667,BIOCHEMICAL,depot gonadotrophin luteinizing releasing hormone analogue,depot gonadotrophin luteinizing releasing hormone analogue
NEW07668,CHEMICAL,triptorelin intramuscularly,triptorelin intramuscularly
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Antisocial_Behavior,DISEASE,antisocial behavior,paraphilic behavior
NEW07669,DISEASE,human SCI,human SCI
NEW07670,CHEMICAL,cortical gabab neuronal pathway,cortical GABAB neuronal pathways
NEW07671,DISEASE,reflexive behavior,reflexive behavior
NEW07673,DISEASE,schizophrenia-like behavioral deficit,schizophrenia-like behavioral deficits
NEW07675,CHEMICAL,2vo,2VO
NEW07676,DISEASE,two-vessel occlusion,two-vessel occlusion
D020191,DISEASE,"Myoclonic Epilepsies, Progressive","Epilepsies, Progressive Myoclonus|May White Syndrome|Naito-Oyanagi Diseases|Epilepsy, Progressive Myoclonus|Atrophy, Dentatorubral-Pallidoluysian|Dentatorubral Pallidoluysian Atrophy|Haw River Syndromes|Progressive Myoclonus Epilepsies|Haw River Syndrome|Encephalopathy, Biotin-Responsive|Action Myoclonus-Renal Failure Syndrome|River Syndromes, Haw|Epilepsy, Progressive Myoclonic|Progressive Myoclonus Epilepsy|Atypical Inclusion-Body Diseases|Myoclonus Nephropathy Syndrome|Atypical Inclusion-Body Disease|Ataxia, Chorea, Seizures, And Dementia|Dentatorubral-Pallidoluysian Atrophy|Biotin Responsive Encephalopathy|Myoclonic Epilepsy, Progressive|epilepsies|Progressive Myoclonic Epilepsy|Myoclonus-Nephropathy Syndrome|Naito Oyanagi Disease|Atrophies, Dentatorubral-Pallidoluysian|Epilepsies, Progressive Myoclonic|Myoclonus Epilepsies, Progressive|Inclusion-Body Disease, Atypical|Action Myoclonus Renal Failure Syndrome|Encephalopathies, Biotin-Responsive|Syndromes, Myoclonus-Nephropathy|Myoclonus-Nephropathy Syndromes|Progressive Myoclonic Epilepsies|Dentatorubral-Pallidoluysian Atrophies|Inclusion-Body Diseases, Atypical|Biotin-Responsive Encephalopathy|Biotin-Responsive Encephalopathies|Naito-Oyanagi Disease|May-White Syndrome|Familial Progressive Myoclonic Epilepsy|Atypical Inclusion Body Disease"
NEW07677,CHEMICAL,sedating antidepressant,sedating antidepressants
NEW07679,DISEASE,rat delay-independent deficit,rats delay-independent deficits
NEW07684,MENTAL_HEALTH,anxiety common,anxiety common
NEW07688,CHEMICAL,csa dosing regimen,CsA dosing regimens
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Traumatic_Brain_Injury,DISEASE,traumatic brain injury,traumatic injury
C537398,DISEASE,Pili torti developmental delay neurological abnormalities [Supplementary Concept],Growth Disorders|Hair Diseases|neurological abnormalities
NEW07694,DISEASE,severe hyperammonemic state,severe hyperammonemic state
NEW07696,DISEASE,conclusion severe hyperammonemic state,conclusion severe hyperammonemic state
NEW07698,CHEMICAL,inter-organ aspartate metabolism,inter-organ aspartate metabolism
D011394,CHEMICAL,Proline Oxidase,"Proline Dehydrogenase|Dehydrogenase, Proline|Oxidase, Proline|proline oxidase"
NEW07702,CHEMICAL,glycolysis pathway,glycolysis pathway
NEW07703,DISEASE,hospitalize psychiatric patient,hospitalized psychiatric patients
D012528,DISEASE,Satiety Response,"satiety|Satiety Responses|Responses, Satiety|Response, Satiety"
NEW07705,DISEASE,mood alleviation,mood alleviation
NEW07706,DISEASE,pentetrazole convulsion,pentetrazole convulsions
NEW07707,CHEMICAL,tranquilizer treatment,tranquilizer treatment
NEW07708,CHEMICAL,atropine coma,atropine coma
NEW07710,DISEASE,early onset severe seizure disorder,early onset severe seizure disorders
C536594,CHEMICAL,Alzheimer disease type 1 [Supplementary Concept],Alzheimer Disease|early-onset familial form|FAD
NEW07713,DISEASE,neurodegenerative condition,neurodegenerative conditions
NEW07714,CHEMICAL,blood glucose achievable,blood glucose achievable
http://purl.obolibrary.org/obo/DOID_0050456,DISEASE,buruli ulcer disease,Mossman ulcer|Searl ulcer|Searle's ulcer|Bairnsdale ulcer|peptic ulcer disease|Daintree ulcer
NEW07715,DISEASE,drug-induced parkinsonism,drug-induced parkinsonism
NEW07717,CHEMICAL,n-3 polyunsaturated-fa,n-3 polyunsaturated-FA
NEW07718,CHEMICAL,tfa incorporation,TFA incorporation
NEW07719,CHEMICAL,gr expression,GR expression
NEW07721,CHEMICAL,significant antidepressant property,significant antidepressant properties
NEW07723,CHEMICAL,curcumin treatment,curcumin treatment
NEW07724,MENTAL_HEALTH,17-item Hamilton Depression rating scale,17-item Hamilton Depression Rating Scale
NEW07725,CHEMICAL,significant antidepressant behavioral response,significant antidepressant behavioral response
NEW07726,CHEMICAL,salivary cortisol concentration,salivary cortisol concentrations
D062559,CHEMICAL,NAV1.8 Voltage-Gated Sodium Channel,"PN3 Sodium Channel|Type 10 Voltage-Gated Sodium Channel|NAV1.8 Voltage Gated Sodium Channel|Voltage Gated Sodium Channel Type 10 Subunit alpha|Voltage-Gated Sodium Channel Type 10 Subunit alpha|Voltage-Gated Sodium Channel Type 10|Voltage Gated Sodium Channel Type 10|voltage-gated sodium channel|Sodium Channel Protein Type 10 Subunit alpha|SCN10A Sodium Channel alpha Subunit|Sodium Channel Protein Type X|Peripheral Nerve Sodium Channel 3|Sodium Channel, PN3|Type 10 Voltage Gated Sodium Channel"
http://purl.obolibrary.org/obo/PR_P10997,DISEASE,islet amyloid polypeptide (human),dap (human)|insulinoma amyloid peptide (human)|iapp|amylin (human)|diabetes-associated peptide (human)|hIAPP|hiapp
NEW07728,CHEMICAL,different amyloid peptide,different amyloid peptides
NEW07729,DISEASE,chronic inflammatory pain,chronic inflammatory pain
NEW07732,CHEMICAL,high nalmefene dosage,higher nalmefene dosages
NEW07736,DISEASE,epilepsy disorder,epilepsy disorders
NEW07737,DISEASE,useful psychiatric disorder,useful psychiatric disorders
NEW07738,CHEMICAL,saccharin solution,saccharin solutions
C563835,BIOCHEMICAL,"Drug Metabolism, Poor, CYP2D6-Related [Supplementary Concept]","Metabolism, Inborn Errors|Cytochrome P-450 CYP2D6/deficiency|drug metabolism"
NEW07739,MENTAL_HEALTH,disorder alcohol abuse,disorder alcohol abuse
NEW07741,DISEASE,trh-induced tsh response,TRH-induced TSH response
NEW07743,DISEASE,male chronic schizophrenic patient,male chronic schizophrenic patients
NEW07744,CHEMICAL,naloxone administration,naloxone administration
NEW07747,DISEASE,catatonic state,catatonic states
NEW07748,DISEASE,psychotic symptomatology,psychotic symptomatology
NEW07749,DISEASE,narcoleptic subject,narcoleptic subjects
http://purl.obolibrary.org/obo/DOID_8986,DISEASE,narcolepsy,"paroxysmal sleep|narcoleptics|Narcolepsy, without cataplexy"
NEW07752,DISEASE,few depressive symptom,fewer depressive symptoms
NEW07754,DISEASE,ischemia-induced neural cell damage,ischemia-induced neural cell damage
NEW07757,CHEMICAL,intramuscular diphenhydramine,intramuscular diphenhydramine
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Premorbidity,DISEASE,premorbidity,treatment-resistance
NEW07758,DISEASE,morphine-induced dopamine-related action,morphine-induced dopamine-related actions
NEW07761,CHEMICAL,dopamine receptor antagonist prochlorperazine,dopamine receptor antagonist prochlorperazine
NEW07763,BIOCHEMICAL,indirect agonist,indirect agonists
NEW07764,DISEASE,fetal irritability,fetal irritability
NEW07765,DISEASE,gastrointestinal dysfunction,gastrointestinal dysfunction
NEW07766,DISEASE,chinese hamster ovarian cho cell,Chinese hamster ovarian CHO cells
NEW07767,CHEMICAL,aβ40 production,Aβ40 production
NEW07775,DISEASE,establish mechanical allodynia,established mechanical allodynia
D003071,DISEASE,Cognition,"Function, Cognitive|cognitive functions|Cognitive Functions|Functions, Cognitive|Cognitions|Cognitive Function"
NEW07777,CHEMICAL,mn deposition,Mn deposition
NEW07778,DISEASE,past-12-month exposure level,past-12-months exposure levels
NEW07779,CHEMICAL,NLX-112 administration,NLX-112 administration
NEW07781,CHEMICAL,specific gamma-aminobutyric acid(A,specific gamma-aminobutyric acid(A
D059330,CHEMICAL,GABAergic Neurons,"GABA Neuron|Neuron, GABAergic|GABAergic Neuron|GABA neurons|GABA Cell|GABA Neurons|Neuron, GABA|Cell, GABA|GABA Cells|Cells, GABA|Neurons, GABA|Neurons, GABAergic"
NEW07783,MENTAL_HEALTH,schizophrenia consistent,schizophrenia consistent
NEW07784,CHEMICAL,pv-positive gaba neuron,PV-positive GABA neurons
NEW07786,CHEMICAL,gaba neurotransmitter system,GABA neurotransmitter system
NEW07791,DISEASE,bipolar type,bipolar type
NEW07796,DISEASE,crf production,CRF production
NEW07801,DISEASE,drug-resistant ocd,drug-resistant OCD
NEW07806,MENTAL_HEALTH,narcolepsy-associated cataplexy,narcolepsy-associated cataplexy
NEW07807,DISEASE,obesity mild weight loss,obesity mild weight loss
NEW07808,CHEMICAL,glucose regulation,glucose regulation
D056768,DISEASE,Giant Axonal Neuropathy,"Axonal Neuropathy, Giant|Neuropathy, Giant Axonal|Neuropathy, Giant Axonal (GAN)|Giant Axonal Neuropathy 1 (GAN1)|Axonal Neuropathy, Giant (GAN)|neuropathy|Giant Axonal Neuropathy 1|Neuropathy, Giant Axonal, Autosomal Recessive|Giant Axonal Neuropathy (GAN)"
NEW07811,DISEASE,chemotherapy-induced neuropathic pain,chemotherapy-induced neuropathic pain
NEW07813,BIOCHEMICAL,opioid dependence potential drug interaction,opioid dependence potential drug interactions
NEW07815,CHEMICAL,slow dose up-titration,slow dose up-titration
NEW07816,DISEASE,epilepsy post-herpetic neuralgia,epilepsy post-herpetic neuralgia
NEW07818,MENTAL_HEALTH,toxic delirium,toxic delirium
NEW07819,DISEASE,prolonged post-withdrawal confusional state reminiscent,prolonged post-withdrawal confusional state reminiscent
NEW07820,CHEMICAL,benzodiazepine withdrawal,benzodiazepine withdrawal
NEW07823,BIOCHEMICAL,h3 receptor inverse agonist,H3 receptor inverse agonists
NEW07826,BIOCHEMICAL,disease-associated amyloid beta protein,disease-associated amyloid beta protein
NEW07827,MENTAL_HEALTH,opioid-induced analgesia,opioid-induced analgesia
D012893,DISEASE,Sleep Wake Disorders,"Long Sleeper Syndromes|Phenotype, Short Sleep|Subwakefullness Syndrome|Tachypneas, Sleep-Related Neurogenic|Disorders, Sleep|Disorder, Sleep|Sleeper Syndrome, Long|Sleep Related Neurogenic Tachypnea|Subwakefullness Syndromes|Neurogenic Tachypnea, Sleep-Related|Syndromes, Subwakefullness|Sleeper Syndrome, Short|Syndrome, Short Sleeper|Sleep Wake Disorder|sleep-wake disorders|Syndrome, Subwakefullness|Wake Disorders, Sleep|Long Sleeper Syndrome|Disorders, Sleep Wake|Short Sleep Phenotypes|Wake Disorder, Sleep|Short Sleep Phenotype|Sleep Disorder|Sleeper Syndromes, Short|Sleep-Related Neurogenic Tachypneas|Short Sleeper Syndromes|Syndromes, Long Sleeper|Sleeper Syndromes, Long|Disorder, Sleep Wake|Syndrome, Long Sleeper|Sleep-Related Neurogenic Tachypnea|Phenotypes, Short Sleep|Tachypnea, Sleep-Related Neurogenic|Syndromes, Short Sleeper|Neurogenic Tachypneas, Sleep-Related|Short Sleeper Syndrome|Sleep Phenotypes, Short|Sleep Disorders"
NEW07829,DISEASE,disease schizophrenic patient,disease schizophrenic patients
NEW07832,DISEASE,endogenous pain system,endogenous pain system
NEW07834,DISEASE,pain inhibition,pain inhibition
NEW07836,DISEASE,platelet thrombi,platelet thrombi
NEW07837,CHEMICAL,Hoeeum,Hoeeum
NEW07838,CHEMICAL,sbv pharmacopuncture,SBV pharmacopuncture
NEW07840,DISEASE,neuronal disorder,neuronal disorders
C029899,CHEMICAL,imidazole [Supplementary Concept],imidazole|Imidazoles
NEW07846,MENTAL_HEALTH,unwanted intrusive thought,unwanted intrusive thoughts
NEW07848,DISEASE,psychiatric clinical,Psychiatric Clinical
NEW07851,DISEASE,respiratory dysfunction,respiratory dysfunction
http://purl.obolibrary.org/obo/DOID_12883,DISEASE,hypochondriasis,Hypochondriacal disorder|depressivity|hypochondriacal neurosis|Hypochondria
NEW07854,DISEASE,multiple psychiatric disorder,multiple psychiatric disorders
NEW07855,CHEMICAL,tca cycle dysfunction,TCA cycle dysfunction
NEW07856,CHEMICAL,elevated pyruvate level,elevated pyruvate levels
NEW07857,DISEASE,[hypo]manic mood state,[hypo]manic mood state
NEW07858,DISEASE,depressed state,depressed state
C498532,CHEMICAL,"Atp1a2 protein, rat [Supplementary Concept]",Sodium-Potassium-Exchanging ATPase|Na K-ATPase
C542800,BIOCHEMICAL,"Slc25a47 protein, rat [Supplementary Concept]",Mitochondrial Carrier Protein|Mitochondrial Membrane Transport Proteins
NEW07861,BIOCHEMICAL,carrier concentration,carrier concentration
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Patient_Abuse,MENTAL_HEALTH,patient abuse,abuse patients
NEW07865,BIOCHEMICAL,Carrier Foundation,Carrier Foundation
NEW07866,DISEASE,axis psychiatric comorbidity,Axis psychiatric comorbidity
NEW07868,CHEMICAL,enzyme hypoxanthin-guanine phosphorribosyl transferase,enzyme hypoxanthin-guanine phosphorribosyl transferase
NEW07869,CHEMICAL,acid disorder,acid disorder
NEW07871,CHEMICAL,winter high serotonin transporter,winter higher serotonin transporter
NEW07873,DISEASE,depressive symptom severity,depressive symptom severity
NEW07874,CHEMICAL,affective disorders.media-1vid110.1093/brain/aww043_video_abstractaww043_video_abstract,affective disorders.media-1vid110.1093/brain/aww043_video_abstractaww043_video_abstract
NEW07877,MENTAL_HEALTH,diverse clinical syndrome,diverse clinical syndromes
NEW07879,BIOCHEMICAL,obese carrier,obese carriers
NEW07881,DISEASE,cognitive diagnosis,cognitive diagnosis
NEW07883,DISEASE,hepatitis component,hepatitis component
NEW07884,DISEASE,depressive illness,depressive illness
NEW07885,DISEASE,retinoblastoma protein phosphorylation,retinoblastoma protein phosphorylation
NEW07886,DISEASE,cancer heart disease,cancer heart disease
D017965,CHEMICAL,gamma-Linolenic Acid,"gamma Linolenic Acid, Cerium Salt|gamma Linolenic Acid, Lithium Salt|gamma-Linolenic Acid, Zinc Salt|Gamolenic Acid|gamma Linolenic Acid, Zinc Salt|gamma Linolenic Acid, Ammonium Salt|gamma-Linolenic Acid, Ammonium Salt|gamma Linolenic Acid|gamma-Linolenic Acid, Cerium Salt|gamma-Linolenic Acid, Sodium Salt|Acid, Gamolenic|gamma-Linolenic acid|gamma Linolenic Acid, Indium Salt|gamma-Linolenic Acid, Lithium Salt|gamma-Linolenic Acid, Indium Salt|Acid, gamma-Linolenic|gamma Linolenic Acid, Sodium Salt|gamma-Linolenic Acid, Potassium Salt|gamma Linolenic Acid, Potassium Salt"
NEW07888,CHEMICAL,neuroadaptation,neuroadaptations
NEW07889,CHEMICAL,vesicular da content,vesicular DA content
NEW07891,BIOCHEMICAL,possible anti-craving drug,possible anti-craving drug
NEW07892,CHEMICAL,cocaine addict,cocaine addicts
NEW07897,CHEMICAL,reward-enhancing effect,reward-enhancing effects
NEW07899,DISEASE,p. edulis,P. edulis
NEW07900,CHEMICAL,dopamine antagonism,dopamine antagonism
NEW07901,MENTAL_HEALTH,schizophrenia aged,schizophrenia aged
NEW07902,CHEMICAL,dopamine transmission abnormality,dopamine transmission abnormalities
NEW07903,CHEMICAL,particular dopamine d2-receptor deficiency,particular dopamine D2-receptor deficiency
NEW07904,DISEASE,cognitive distortion,cognitive distortions
D003006,CHEMICAL,Clopenthixol,alpha Clopenthixol|zuclopenthixol|Cisordinol|Zuclopenthixol|alpha-Clopenthixol
NEW07909,DISEASE,loss restricted food access,loss restricted food access
NEW07910,MENTAL_HEALTH,paradoxical hyperactivity,paradoxical hyperactivity
NEW07913,DISEASE,gastrointestinal injury,gastrointestinal injury
D018501,CHEMICAL,Antirheumatic Agents,"Anti-Rheumatic Agents, Non-Steroidal|Anti-Rheumatic Agent|Anti Rheumatic Agents, Non Steroidal|Anti Rheumatic Drugs|Anti Rheumatic Drug|Antirheumatic Drug, Disease-Modifying|Disease Modifying, Antirheumatic Second Line Drugs|Agent, Anti-Rheumatic|Antirheumatic Disease-Modifying Second-Line Drug|Antirheumatic Drugs|Drug, Anti-Rheumatic|Drug, Disease-Modifying Antirheumatic|Disease Modifying Antirheumatic Drug|DMARD|Antirheumatic Disease Modifying Second Line Drugs|Non-Steroidal Anti-Rheumatic Agents|Drug, Antirheumatic|Antirheumatic Drugs, Disease-Modifying|Disease-Modifying Antirheumatic Drugs|Anti-Rheumatic Drugs|Anti-Rheumatic Drug|Agent, Antirheumatic|second-line drug|Anti Rheumatic Agents|Antirheumatic Disease-Modifying Second-Line Drugs|Anti Rheumatic Agent|Disease Modifying Antirheumatic Drugs|Antirheumatic Agent|Antirheumatic Drug|Disease-Modifying, Antirheumatic Second-Line Drugs|Anti-Rheumatic Agents|Antirheumatic Drugs, Disease Modifying|Antirheumatic Disease Modifying Second Line Drug|Disease-Modifying Antirheumatic Drug"
NEW07915,CHEMICAL,MDRTB,MDRTB
NEW07916,MENTAL_HEALTH,additional resistance,additional resistance
NEW07917,CHEMICAL,pre-xdrtb,pre-XDRTB
NEW07918,CHEMICAL,second-line injectable,second-line injectable
NEW07919,CHEMICAL,MDRTB acquisition,MDRTB acquisition
NEW07923,DISEASE,heat hypersensitivity,heat hypersensitivity
NEW07925,DISEASE,metabolic dysregulation,metabolic dysregulation
NEW07927,DISEASE,olz-induced mass gain,OLZ-induced mass gain
NEW07928,CHEMICAL,alcohol ethanol consumption,alcohol ethanol consumption
NEW07931,DISEASE,alcoholism dependence,alcoholism dependence
D015551,DISEASE,Autoimmunity,Autoimmune Responses|autoimmunity|Autoimmune Response|Autoimmunities
NEW07933,DISEASE,premature senescence,premature senescence
NEW07936,CHEMICAL,paopa dose,PAOPA dose
NEW07937,DISEASE,obesity regulation,obesity regulation
NEW07939,CHEMICAL,normal glucose tolerance,normal glucose tolerance
NEW07940,DISEASE,glucose-induced insulin release,glucose-induced insulin release
NEW07942,CHEMICAL,plasma citrulline,plasma citrulline
NEW07944,DISEASE,fructose malabsorption,fructose malabsorption
NEW07947,DISEASE,cellular toxicity,cellular toxicity
NEW07949,CHEMICAL,glp-1 receptor,GLP-1 receptors
D000067758,CHEMICAL,Glucagon-Like Peptide-2 Receptor,"GLP2R Protein|GLP 2 Receptor|Receptor, GLP-2R|Glucagon Like Peptide 2 Receptor|Peptide-2 Receptor, Glucagon-Like|GLP-2|Receptor, Glucagon-Like Peptide-2|GLP-2 Receptor|GLP-2R Receptor|Protein, GLP2R|Glucagon-Like Peptide 2 Receptor|GLP 2R Receptor|Receptor, GLP-2"
C502483,DISEASE,"Ana o 3 protein, Anacardium occidentale [Supplementary Concept]","Antigens, Plant|Plant Proteins|ANA"
NEW07953,CHEMICAL,twohour,twohour
NEW07954,CHEMICAL,post prandial blood sugar,post prandial blood sugar
C565618,DISEASE,DK Phocomelia Syndrome [Supplementary Concept],"Urogenital Abnormalities|Thrombocytopenia|phocomelia|Encephalocele|Abnormalities, Multiple|Ectromelia"
C536498,DISEASE,Tetra-amelia autosomal recessive [Supplementary Concept],amelia|Ectromelia
NEW07958,DISEASE,reversible memory loss,reversible memory loss
NEW07961,CHEMICAL,paxilline treatment,paxilline treatment
http://purl.obolibrary.org/obo/DOID_0080750,DISEASE,erythema nodosum,erythema nodosum leprosum|ENL
NEW07965,DISEASE,severe birth defect,severe birth defects
NEW07966,CHEMICAL,second-line therapy,second-line therapy
NEW07967,DISEASE,severe aggressive behavior,severe aggressive behavior
NEW07968,BIOCHEMICAL,endocrine response,endocrine response
NEW07970,DISEASE,formalin-induced pain response,formalin-induced pain response
C537658,DISEASE,"Basal ganglia disease, biotin-responsive [Supplementary Concept]",basal ganglia disease|Basal Ganglia Diseases
NEW07972,DISEASE,psychotic condition,psychotic conditions
NEW07974,DISEASE,parkinsonian rat striata,parkinsonian rat striata
NEW07976,CHEMICAL,l-dopa therapy,L-DOPA therapy
NEW07979,DISEASE,numerous neurological disorder,numerous neurological disorders
D055824,BIOCHEMICAL,Formulary [Publication Type],"preferred drug|Essential Medicines List|Formularies|Drug Formularies|Formularies, Drug|Preferred Drug List"
NEW07982,BIOCHEMICAL,dopaminergic agent l-dopa,dopaminergic agents L-dopa
NEW07983,DISEASE,antidepressant-induced sexual dysfunction,antidepressant-induced sexual dysfunction
NEW07985,CHEMICAL,dopamine da producing cell,dopamine DA producing cells
NEW07986,DISEASE,specific cortico-subcortical extrapyramidal circuit,specific cortico-subcortical extrapyramidal circuits
NEW07987,MENTAL_HEALTH,dopaminergic projection area,dopaminergic projection areas
NEW07989,DISEASE,subtle cognitive disturbance,subtle cognitive disturbances
NEW07990,DISEASE,progressive motor dysfunction,progressive motor dysfunction
NEW07992,CHEMICAL,clonazepam agent,clonazepam agents
NEW07993,BIOCHEMICAL,levodopa-carbidopa new dopamine agonist,levodopa-carbidopa newer dopamine agonists
NEW07996,DISEASE,different neuropathologie,different neuropathologies
NEW07998,CHEMICAL,cortisol basal level,cortisol basal levels
NEW07999,DISEASE,severe hypertriglyceridaemia,severe hypertriglyceridaemia
http://purl.obolibrary.org/obo/DOID_1387,DISEASE,hypolipoproteinemia,hypertriglyceridaemia|Lipoprotein deficiencies|Hypolipoproteinaemia
http://purl.obolibrary.org/obo/DOID_4989,DISEASE,pancreatitis,hypertriglyceridaemia-induced pancreatitis
NEW08004,DISEASE,neuroinflammation decline,neuroinflammation decline
NEW08005,CHEMICAL,marble-burying behavior,marble-burying behavior|MBB
NEW08006,DISEASE,model chronic post-inflammatory colonic hypersensitivity,model chronic post-inflammatory colonic hypersensitivity
NEW08008,DISEASE,increase vmr,increased VMR
NEW08010,DISEASE,colonic hypersensitivity,colonic hypersensitivity
NEW08011,CHEMICAL,luminal distension,luminal distension
NEW08013,DISEASE,functional bowel disorder,functional bowel disorders
C500530,CHEMICAL,"3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide [Supplementary Concept]","Bridged Bicyclo Compounds, Heterocyclic|AMG9810|Acrylamides"
NEW08014,BIOCHEMICAL,trpv1 antagonist drug,TRPV1 antagonist drug
NEW08015,DISEASE,alcohol-induced pancreatitis,alcohol-induced pancreatitis
NEW08016,DISEASE,prolonged sensitization pain,prolonged sensitization pain
NEW08018,CHEMICAL,acid-induced gastric ulcer,acid-induced gastric ulcer
NEW08019,DISEASE,inflammatory cell infiltration,inflammatory cell infiltration
NEW08020,DISEASE,ulcer area,ulcer area
NEW08021,DISEASE,chronic colitis,chronic colitis
NEW08022,DISEASE,refractory advanced solid tumor,refractory advanced solid tumors
NEW08024,CHEMICAL,plasma acivicin level,plasma acivicin levels
NEW08026,DISEASE,acivicin-induced cns toxicity,acivicin-induced CNS toxicity
NEW08028,DISEASE,stroke treatment,stroke treatment
NEW08029,MENTAL_HEALTH,pro-inflammatory reaction,pro-inflammatory reactions
NEW08030,DISEASE,neurological defect,neurological defects
NEW08031,NUTRITION,Carthamus tinctorius L.,Carthamus tinctorius L.
NEW08032,DISEASE,cerebral i/r injury,cerebral I/R injury
NEW08034,DISEASE,neurodegeneration deficit,neurodegeneration deficits
NEW08037,CHEMICAL,d2-n-methyl-d-aspartate mglu5 heteroreceptor complex,D2-N-methyl-d-aspartate mGlu5 heteroreceptor complexes
NEW08038,CHEMICAL,a2a-d2-metabotropic glutamate receptor,A2A-D2-metabotropic glutamate receptor
NEW08039,BIOCHEMICAL,biased agonist action,biased agonist action
NEW08041,CHEMICAL,schizophrenic and-due,schizophrenics and-due
NEW08044,CHEMICAL,5-ht increment,5-HT increment
NEW08048,CHEMICAL,low phenylalanine phe diet,low phenylalanine Phe diet
NEW08050,CHEMICAL,tetrahydrobiopterin bh4 cofactor,tetrahydrobiopterin BH4 cofactor
NEW08051,CHEMICAL,tetrahydrobiopterin deficiency,tetrahydrobiopterin deficiencies
NEW08052,CHEMICAL,quinoline derive substance,quinoline derived substances
NEW08054,CHEMICAL,serotonin transporter promoter gene,serotonin transporter promoter gene
D020268,DISEASE,"Alcohol-Induced Disorders, Nervous System","Nervous System Disorders, Ethanol Induced|Ethanol Induced Disorders, Nervous System|Alcohol Abuse, Nervous System|Alcohol Induced Disorders, Nervous System|Nervous System Disorders, Ethanol-Induced|nervous system disorders|Ethanol-Induced Nervous System Disorders|Ethanol Induced Nervous System Disorders|Ethyl Alcohol Abuse Neurologic Syndromes|Ethanol-Induced Disorders, Nervous System"
NEW08062,CHEMICAL,smoke consumption,smoking consumption
NEW08064,DISEASE,abnormal regional grey matter volume,abnormal regional grey matter volumes
NEW08065,DISEASE,severe neurological disorder,severe neurological disorder
NEW08068,DISEASE,chronic mental stress,chronic mental stresses
D016480,DISEASE,Helicobacter pylori,Helicobacter pylori|Helicobacter nemestrinae|Campylobacter pylori subsp. pylori|Campylobacter pyloridis|Campylobacter pylori
http://purl.obolibrary.org/obo/DOID_0070027,CHEMICAL,cst3-related cerebral amyloid angiopathy,"HCHWA|Hereditary Cerebral Hemorrhage with Amyloidosis, Icelandic Variant|Amyloidosis VI|Cerebral Hemorrhage, Hereditary, with Amyloidosis, Icelandic Variant|CAA|Amyloidosis, Cerebroarterial, Icelandic Type|acute cerebral amyloid angiopathy"
NEW08070,DISEASE,atherosclerotic heart disease,atherosclerotic heart disease
NEW08071,DISEASE,levodopa-induced abnormal movement,levodopa-induced abnormal movements
NEW08072,DISEASE,liver fibrogenesis,liver fibrogenesis
NEW08075,CHEMICAL,brain mao,brain MAO
C563921,DISEASE,"Congenital Corneal Opacities, Cornea Guttata, and Corectopia [Supplementary Concept]","corneal opacities|Pupil Disorders|Corneal Dystrophies, Hereditary"
C536835,CHEMICAL,Glutathione synthetase deficiency [Supplementary Concept],"pyroglutamic aciduria|Glutathione Synthase/deficiency|Amino Acid Metabolism, Inborn Errors"
C537359,DISEASE,Methylmalonic acidemia with homocystinuria [Supplementary Concept],methylmalonic acidemia|Homocystinuria|Vitamin B 12 Deficiency/congenital
NEW08078,DISEASE,n-acetyl aspartic aciduria,N-acetyl aspartic aciduria
NEW08079,DISEASE,norway familial lecithin-cholesterol acyltransferase deficiency,Norway familial lecithin-cholesterol acyltransferase deficiency
NEW08082,BIOCHEMICAL,supplemental lecithin,supplemental lecithin
NEW08083,CHEMICAL,oral physostigmine,oral physostigmine
NEW08085,CHEMICAL,elevated crh concentration,elevated CRH concentrations
NEW08089,CHEMICAL,gaba release,GABA release
C114036,CHEMICAL,neurotensin type 1 receptor [Supplementary Concept],"Receptors, Neurotensin|neurotensin receptor"
NEW08092,CHEMICAL,acetylcholine activity,acetylcholine activity
NEW08093,DISEASE,zncl₂. neurotoxic effect,ZnCl₂. Neurotoxic effects
NEW08095,CHEMICAL,zinc concentration enzyme activity,zinc concentration enzyme activity
D000086582,DISEASE,Anosmia,Loss of Smell|Smell Loss|hyposmia|Hyposmia
D000370,DISEASE,Ageusia,"Hysterical Ageusia|Ageusia, Hysterical|Taste Loss|Taste Blindness|hypogeusia|Taste-Blindness|Hysterical Ageusias|Loss of Taste|Hypogeusia|Hypogeusias|Ageusias, Hysterical"
NEW08097,CHEMICAL,zinc sulfate nasal irrigation,zinc sulfate nasal irrigation
NEW08099,CHEMICAL,factor nuclear factor-κb,factor nuclear factor-κB
NEW08101,CHEMICAL,high aspartate aminotransferase/alanine aminotransferase ratio,higher aspartate aminotransferase/alanine aminotransferase ratio
NEW08106,DISEASE,chronic bulimic symptom,chronic bulimic symptoms
http://cbmi.med.harvard.edu/asdphenotype#Class_58,DISEASE,self-injurious behavior,delinquent behavior
NEW08110,MENTAL_HEALTH,prenatal depression,prenatal depression
NEW08111,DISEASE,prenatal depressive symptom,prenatal depressive symptoms
NEW08114,CHEMICAL,spot urine creatinine,spot urine creatinine
NEW08118,CHEMICAL,low serum Fe,lower serum Fe
D033901,CHEMICAL,Bacterial Transferrin Receptor Complex,"Transferrin Binding Protein Complex, Bacterial|Tf|transferrin|Transferrin-Binding Protein Complex, Bacterial"
NEW08123,DISEASE,daytime dysfunction,daytime dysfunction
NEW08127,CHEMICAL,lsd-trained rat,LSD-trained rats
NEW08128,BIOCHEMICAL,potent postsynaptic serotonergic antagonist,potent postsynaptic serotonergic antagonist
NEW08130,DISEASE,neurologic fetal development,neurologic fetal development
http://purl.obolibrary.org/obo/DOID_3985,DISEASE,ostertagiasis,aflatoxicosis
NEW08133,CHEMICAL,hereditary iron overload disease,hereditary iron overload diseases
D006432,DISEASE,Hemochromatosis,"Pigmentary Cirrhosis|Syndromes, Troisier-Hanot-Chauffard|Disorder, Iron Storage|Bronzed Cirrhoses|Familial Hemochromatoses|Hemochromatoses|Recklenhausen-Applebaum Diseases, Von|Hemochromatoses, Familial|Troisier Hanot Chauffard Syndrome|Genetic Hemochromatoses|Hemochromatosis, Familial|Von Recklenhausen-Applebaum Diseases|Pigmentary Cirrhoses|Syndrome, Troisier-Hanot-Chauffard|Disorders, Iron Storage|Storage Disorder, Iron|Storage Disorders, Iron|Hemochromatose|Bronzed Cirrhosis|Troisier-Hanot-Chauffard Syndrome|Troisier-Hanot-Chauffard Syndromes|Haemochromatoses|Cirrhoses, Bronzed|Von Recklenhausen Applebaum Disease|Bronze Diabetes|Haemochromatosis|hemochromatosis|Von Recklenhausen-Applebaum Disease|Diabetes, Bronze|Cirrhosis, Pigmentary|Cirrhosis, Bronzed|Iron Storage Disorders|Familial Hemochromatosis|Recklenhausen-Applebaum Disease, Von|Iron Storage Disorder|Cirrhoses, Pigmentary|Primary Hemochromatosis|Hemochromatoses, Genetic|Genetic Hemochromatosis|Hemochromatosis, Genetic|Diseases, Von Recklenhausen-Applebaum|Disease, Von Recklenhausen-Applebaum"
NEW08135,DISEASE,trigger organelle dysfunction,triggering organelle dysfunction
NEW08137,DISEASE,difficult-to-treat subtype,difficult-to-treat subtypes
NEW08138,DISEASE,bipolar illness,bipolar illness
NEW08144,DISEASE,manic relapse,manic relapses
D056785,DISEASE,"Medicine, Mongolian Traditional","Mongolian Traditional Medicine|Mongolian Medicine|Medicines, Mongolian Traditional|Mongolian Medicines|Folk Medicines, Mongolian|Mongolian Folk Medicine|Medicines, Mongolian Folk|Mongolian Traditional Medicines|Medicines, Mongolian|Medicines|Folk Medicine, Mongolian|Medicine, Mongolian Folk|CSM|Traditional Medicines, Mongolian|Medicine, Mongolian|Mongolian Folk Medicines|Traditional Medicine, Mongolian"
NEW08148,DISEASE,granulocytosis,granulocytosis
D008231,DISEASE,Lymphopenia,Lymphocytopenias|Lymphopenias|Lymphocytopenia|lymphopenia
D066187,DISEASE,Basal Forebrain,"Forebrain Area, Basal|Area, Basal Forebrain|Basal Forebrains|Forebrain, Basal|Forebrain Areas, Basal|Telencephalus, Pars Basalis|Basalis Telencephali, Pars|forebrain|Telencephali, Pars Basalis|Pallidum, Ventral|Pars Basalis Telencephalus|Basal Forebrain Areas|Basal Forebrain Area|Areas, Basal Forebrain|Pallidums, Ventral|Ventral Pallidum|Forebrains, Basal|Pars Basalis Telencephali|Basalis Telencephalus, Pars|Ventral Pallidums"
D058953,DISEASE,Neural Stem Cells,"Cells, Neural Stem|Cell, Neural Stem|neural stem cells|Stem Cell, Neural|Neural Stem Cell|Stem Cells, Neural"
NEW08149,CHEMICAL,glutamate due,glutamate due
NEW08151,DISEASE,permanent brain damage,permanent brain damage
NEW08153,DISEASE,mild nigrostriatal neurodegeneration,mild nigrostriatal neurodegeneration
http://purl.obolibrary.org/obo/DOID_4675,DISEASE,uremic neuropathy,uraemic neuropathy
http://purl.obolibrary.org/obo/NCBITaxon_1491,DISEASE,clostridium botulinum,bacterium Clostridium botulinum
NEW08158,MENTAL_HEALTH,damage disorder,damage disorders
D000069338,DISEASE,Neuropathology,Neuropathologist|Neuropathologies|Neuropathologists|neuropathologies
NEW08160,CHEMICAL,high-dose mk-801 rat,high-dose MK-801 rats
D059865,CHEMICAL,Endoplasmic Reticulum Stress,"Reticulum Stress, Endoplasmic|Stresses, Endoplasmic Reticulum|Endoplasmic Reticulum Stresses|Reticulum Stresses, Endoplasmic|stress|Stress, Endoplasmic Reticulum"
NEW08162,CHEMICAL,its 's oxidize product 1-methyl-4-phenylpyridinium,oxidized product 1-methyl-4-phenylpyridinium
NEW08163,DISEASE,parkinsonian symptom,parkinsonian symptoms
C549047,CHEMICAL,amyloid beta-peptide (9-42) [Supplementary Concept],Amyloid beta-Peptides|beta-amyloid peptide|Peptide Fragments
NEW08164,DISEASE,which be infectious disease,which's infectious disease
NEW08165,BIOCHEMICAL,environmental neurotoxin,environmental neurotoxins
NEW08167,DISEASE,mci pathogenesis,MCI pathogenesis
NEW08168,DISEASE,oligomer-induced cognitive impairment,oligomer-induced cognitive impairment
NEW08170,DISEASE,amyloid-β-induce toxicity,amyloid-β-induced toxicity
NEW08173,CHEMICAL,resistant mycobacterium tuberculosis,resistant Mycobacterium tuberculosis
NEW08176,MENTAL_HEALTH,Karolinska Sleepiness scale,Karolinska Sleepiness Scale
NEW08179,MENTAL_HEALTH,Binge eat Anxiety Disorders,Binge Eating Anxiety Disorders
NEW08182,DISEASE,cocaine-evoked impulsivity,cocaine-evoked impulsivity
NEW08183,DISEASE,psychostimulant-induced motor impulsivity,psychostimulant-induced motor impulsivity
NEW08184,DISEASE,advanced pd stage,advanced PD stages
NEW08186,CHEMICAL,psychotogenic effect,psychotogenic effects
NEW08188,CHEMICAL,psychotomimetic state,psychotomimetic states
NEW08191,DISEASE,peri- woman,peri- women
http://purl.obolibrary.org/obo/CHEBI_52550,BIOCHEMICAL,theopalauamide,"C(3.1),C(3.7)-[3-(beta-D-galactopyranosyl)-1H-imidazolium-4,1-diyl]-1,12-anhydro[L-alanyl-L-allothreonyl-L-seryl-L-phenylalanyl-(3S,4S,5E,7E)-3-amino-4-hydroxy-6-methyl-8-phenylocta-5,7-dienoyl-L-seryl-D-alanyl-L-asparaginyl-(3R)-3-hydroxy-L-asparaginyl-(betaS)-4-bromo-beta-methyl-L-phenylalanyl-(2R)-2-hydroxy-beta-alanyl-(5S)-5-amino-5-carboxylatopentanoyl]|antifungals|(1S,7S,10R,14S,17S,20S,23R,26S,30S,33S,36S,39S)-17-[(1R)-2-amino-1-hydroxy-2-oxoethyl]-20-(2-amino-2-oxoethyl)-33-benzyl-14-[(1S)-1-(4-bromophenyl)ethyl]-44-(beta-D-galactopyranosyl)-10-hydroxy-39-[(1S)-1-hydroxyethyl]-26,36-bis(hydroxymethyl)-30-[(1S,2E,4E)-1-hydroxy-3-methyl-5-phenylpenta-2,4-dien-1-yl]-3,9,13,16,19,22,25,28,32,35,38,41-dodecaoxo-2,8,12,15,18,21,24,27,31,34,37,40,44-tridecaaza-46-azoniatricyclo[21.18.6.1(43,46)]octatetraconta-43(48),45-diene-7-carboxylate"
http://purl.obolibrary.org/obo/CHEBI_80841,BIOCHEMICAL,kakuol,antimycobacterials|Kakoul
NEW08193,DISEASE,mnesic,mnesic
NEW08194,MENTAL_HEALTH,Disease Psychosis,Disease Psychosis
NEW08197,DISEASE,uui,UUI
NEW08199,CHEMICAL,strychnine poison,strychnine poisoning
NEW08200,DISEASE,localized tetanus,localized tetanus
D020937,DISEASE,"Epilepsy, Partial, Sensory","Sensory Seizure Disorders|Seizure, Visual Partial|Partial Seizures, Gustatory|Partial Seizure, Olfactory|Vertiginous Partial Seizure|Sensory Seizure Disorder|Gustatory Partial Seizure|partial seizures|Sensory Seizures, Partial|Visual Partial Seizure|Seizure Disorders, Sensory|Seizures, Partial Sensory|Sensory Epilepsy|Seizure Disorder, Sensory, Focal|Seizure, Partial Sensory|Sensory Seizure, Focal|Partial Seizure, Gustatory|Partial Seizures, Vertiginous|Seizure, Focal Sensory|Seizures, Olfactory Partial|Seizure, Olfactory Partial|Gustatory Partial Seizures|Vertiginous Partial Seizures|Partial Seizures, Visual|Partial Seizures, Olfactory|Seizures, Vertiginous Partial|Simple Partial Seizures, Special Sensory Symptoms|Sensory Partial Epilepsy|Partial Seizure, Vertiginous|Focal Sensory Seizures|Epilepsy, Sensory Partial|Olfactory Partial Seizures|Seizures, Focal Sensory|Seizure Disorder, Partial, Sensory|Partial Sensory Seizures|Sensory Partial Seizure Disorder|Olfactory Partial Seizure|Visual Partial Seizures|Sensory Focal Seizure Disorder|Seizures, Simple Partial, Special Sensory Symptoms|Focal Sensory Seizure|Seizure Disorder, Sensory|Partial Seizure, Visual|Epilepsy, Sensory|Sensory Seizures, Focal|Seizure, Vertiginous Partial|Focal Seizure Disorder, Sensory|Partial Sensory Seizure|Seizure, Gustatory Partial|Partial Epilepsy, Sensory|Sensory Seizure, Partial"
D008306,MENTAL_HEALTH,Malingering,malingering
D020814,DISEASE,"Meningitis, Escherichia coli","Escherichia coli Meningitides|Meningitides, Escherichia coli|meningitis|Escherichia coli Meningitis"
NEW08201,DISEASE,attention-deficit/hyperactivity disorder medication,attention-deficit/hyperactivity disorder medications
NEW08203,BIOCHEMICAL,antidiuretic hormone analog,antidiuretic hormone analogs
NEW08204,MENTAL_HEALTH,enuresis alarm,enuresis alarms
C026718,CHEMICAL,physostigmine salicylate [Supplementary Concept],physostigmine salicylate|Physostigmine/analogs  and  derivatives
NEW08206,BIOCHEMICAL,neuroleptic anticholinergic,neuroleptics anticholinergics
NEW08207,DISEASE,sedation motor impairment,sedation motor impairment
NEW08211,CHEMICAL,amyloid evolvability,amyloid evolvability
NEW08212,DISEASE,parkinsonian motor symptom,parkinsonian motor symptoms
NEW08213,CHEMICAL,"gold-standard 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","gold-standard 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"
NEW08214,DISEASE,postural deficit,postural deficits
NEW08216,CHEMICAL,optimal l-dopa treatment dose,optimal l-DOPA treatment dose
NEW08217,CHEMICAL,istradefylline administration,istradefylline administration
NEW08220,DISEASE,compulsive self-mutilation,compulsive self-mutilation
NEW08223,DISEASE,melanoma cell,melanoma cells
NEW08226,DISEASE,non-valvular Atrial Fibrillation,non-valvular Atrial Fibrillation
NEW08229,CHEMICAL,clear antidepressant action,clear antidepressant action
NEW08231,DISEASE,non-spatial memory impairment due,non-spatial memory impairments due
NEW08236,DISEASE,associative memory impairment,associative memory impairment
NEW08237,DISEASE,body weight loss,body weight loss
D011490,CHEMICAL,Protein Disulfide Reductase (Glutathione),"Insulin Transhydrogenase, Glutathione|Oxidoreductase, Thiol-Disulfide|thiol|Thiol-Disulfide Oxidoreductase|Thiol Disulfide Oxidoreductase|Thiol Protein Disulfide Oxidoreductase|Disulfide Oxidoreductase, Thiol-Protein|Glutathione Insulin Transhydrogenase|Transhydrogenase, Glutathione Insulin|Thiol-Protein Disulfide Oxidoreductase|Oxidoreductase, Thiol-Protein Disulfide|Glutathione Protein Disulfide Oxidoreductase"
NEW08239,DISEASE,mediate neurological disorder,mediated neurological disorders
NEW08241,DISEASE,structural cardiac abnormality,structural cardiac abnormality
D020244,DISEASE,"Infarction, Middle Cerebral Artery","Stroke, Middle Cerebral Artery|Embolus, Middle Cerebral Artery|Middle Cerebral Artery Thrombosis|Middle Cerebral Artery Embolic Infarction|MCA Infarction|Thrombotic Infarction, Middle Cerebral Artery|MCA Infarct|middle cerebral artery occlusion|MCA Infarcts|Middle Cerebral Artery Infarction|Infarcts, MCA|Middle Cerebral Artery Occlusion|Infarct, MCA|Thrombosis, Middle Cerebral Artery|Embolic Infarction, Middle Cerebral Artery|Left Middle Cerebral Artery Infarction|Cerebral Infarction, Middle Cerebral Artery|Middle Cerebral Artery Embolus|Middle Cerebral Artery Stroke|Occlusion, Middle Cerebral Artery|Middle Cerebral Artery Circulation Infarction|Middle Cerebral Artery Syndrome|Right Middle Cerebral Artery Infarction|Middle Cerebral Artery Thrombotic Infarction"
NEW08243,DISEASE,edema formation,edema formation
NEW08244,DISEASE,neuronal cell injury,neuronal cell injury
NEW08246,MENTAL_HEALTH,classical adhd drug,classical ADHD drugs
NEW08249,DISEASE,5-htp-induced dog shake behavior,5-HTP-induced dog shake behavior
NEW08252,DISEASE,induce catalepsy,induced catalepsy
NEW08255,CHEMICAL,serum Al,serum Al
NEW08259,DISEASE,chronic neurodegeneration,chronic neurodegeneration
NEW08260,CHEMICAL,brain oxidize glutathione level,brain oxidized glutathione levels
C506812,DISEASE,"Htt protein, mouse [Supplementary Concept]",mouse HD|Huntingtin Protein
Q000150,DISEASE,complications [Subheading],sequelae|coexistent disease|coexistent conditions|sequels|associated conditions|concomitant conditions|associated disease|concomitant disease
NEW08267,DISEASE,secondary hypogonadism,secondary hypogonadism
NEW08269,MENTAL_HEALTH,liver insulin resistance,liver insulin resistance
D000072657,DISEASE,ST Elevation Myocardial Infarction,ST-elevation|STEMI|ST Segment Elevation Myocardial Infarction|ST Elevated Myocardial Infarction
NEW08273,DISEASE,myocardial infarction deficiency,myocardial infarction deficiency
NEW08274,DISEASE,induce methemoglobinemia,induced methemoglobinemia
NEW08275,DISEASE,hematological disorder,hematological disorder
NEW08277,BIOCHEMICAL,chronic disease long-term drug therapy,chronic disease long-term drug therapy
NEW08279,CHEMICAL,low-dose senps aggravated atherosclerotic lesion,low-dose SeNPs aggravated atherosclerotic lesions
NEW08282,DISEASE,autistic subject,autistic subjects
NEW08285,DISEASE,picrotoxin-induced locomotor stimulation,picrotoxin-induced locomotor stimulation
NEW08287,DISEASE,motor incoordination,motor incoordination
D007222,DISEASE,Inert Gas Narcosis,"Nitrogen Narcosis|Depth Intoxication|Narcosis, Nitrogen|narcosis|Narcoses, Inert Gas|Inert Gas Narcoses|Nitrogen Narcoses|Intoxications, Depth|Narcoses, Nitrogen|Depth Intoxications|Intoxication, Depth|Narcosis, Inert Gas"
http://purl.obolibrary.org/obo/DOID_11723,DISEASE,duchenne muscular dystrophy,"Muscular dystrophy, Duchenne|Duchenne muscular dystrophy patients"
NEW08291,DISEASE,antagonist- behavioral alteration,antagonist- behavioral alterations
NEW08293,DISEASE,esophageal damage,esophageal damage
NEW08294,DISEASE,hepatotoxic effect,hepatotoxic effect
NEW08297,DISEASE,eyelid swelling,eyelid swelling
D058568,DISEASE,Necrolytic Migratory Erythema,"erythema|Pseudoglucagonoma Syndrome|Migratory Erythema, Necrolytic|Syndrome, Pseudoglucagonoma|Migratory Erythemas, Necrolytic|Necrolytic Migratory Erythemas|Erythemas, Necrolytic Migratory|Erythema, Necrolytic Migratory|Pseudoglucagonoma Syndromes|Syndromes, Pseudoglucagonoma"
NEW08298,CHEMICAL,ros neutralize antioxidative defense mechanism,ROS neutralizing antioxidative defense mechanisms
NEW08299,DISEASE,neurotoxic adverse event,neurotoxic adverse events
NEW08300,MENTAL_HEALTH,schizophrenia behavior,schizophrenia behavior
NEW08301,MENTAL_HEALTH,persistent psychosis,persistent psychosis
NEW08305,DISEASE,gut microbiome disturbance,gut microbiome disturbance
NEW08307,DISEASE,anxious behavior,anxious behaviors
NEW08308,DISEASE,chronic prostatitis/chronic pelvic pain syndrome,CP/CPPS|chronic prostatitis/chronic pelvic pain syndrome
NEW08310,DISEASE,infection failure,infection failure
NEW08311,BIOCHEMICAL,new antibiotic,new antibiotics
NEW08312,CHEMICAL,cephalosporin family,cephalosporin family
NEW08313,DISEASE,suspect aspiration pneumonia,suspected aspiration pneumonia
NEW08314,MENTAL_HEALTH,addition antibiotic resistance,addition antibiotic resistance
NEW08315,MENTAL_HEALTH,long-term adhd rate,long-term ADHD rates
NEW08319,BIOCHEMICAL,appropriate antibiotic,appropriate antibiotics
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Suicidal_Ideation,MENTAL_HEALTH,suicidal ideation,pre-existing suicidal ideations
NEW08327,DISEASE,platelet aggregation platelet release,platelet aggregation platelet release
NEW08330,DISEASE,idiopathic hypersomniac,idiopathic hypersomniacs
NEW08331,DISEASE,noradrenergic deficit,noradrenergic deficits
NEW08334,DISEASE,hypotensive person,hypotensive persons
http://purl.obolibrary.org/obo/UBERON_0001621,DISEASE,coronary artery,coronary artery spasm
NEW08335,DISEASE,enzyme myocardial infarction,enzyme myocardial infarction
NEW08337,MENTAL_HEALTH,resistance vessel,resistance vessels
D028227,DISEASE,"Amyloid Neuropathies, Familial","Amyloid Polyneuropathies, Familial|Familial Portuguese Polyneuritic Amyloidosis|Amyloid Polyneuropathy, Iowa Type|Hereditary Neuropathic Amyloidosis|Polyneuritic Amyloidoses, Portuguese|Iowa Type Amyloid Polyneuropathy|Neuropathic Amyloidoses, Hereditary|Amyloid Syndrome, Neuropathic|Familial Amyloid Polyneuropathy, Type II|Type I Familial Amyloid Polyneuropathy|Neuropathy, Familial Amyloid|Amyloid Neuropathy Type 1|Neuropathic Amyloidosis, Hereditary|Familial Amyloid Neuropathy, Finnish Type|British Type Amyloid Polyneuropathy|Familial Amyloid Polyneuropathy, Type IV|Appalachian Type Familial Amyloid Polyneuropathy|Type II Familial Amyloid Polyneuropathy|Wohlwill Andrade Syndrome|Familial Amyloid Polyneuropathy, Type I|Type IV Familial Amyloid Polyneuropathy|Familial Amyloid Polyneuropathy, Jewish Type|Polyneuritic Amyloidosis, Portuguese|Familial Amyloid Polyneuropathy, Type VI|Amyloidosis, Portuguese Polyneuritic|Familial Amyloid Neuropathies|Wohlwill-Corino Andrade Syndrome|Portuguese Type Familial Amyloid Neuropathy|Finnish Type Familial Amyloid Neuropathy|Polyneuropathy, Familial Amyloid|Familial Amyloid Neuropathy, Andrade Type|Neuropathic Amyloid Syndromes|Swiss Type Amyloid Polyneuropathy|neuropathic|Familial Amyloid Polyneuropathy|Familial Amyloid Polyneuropathy, Type III|Jewish Type Familial Amyloid Polyneuropathy|Amyloid Neuropathy, Familial|Polyneuropathies, Familial Amyloid|Type III Familial Amyloid Polyneuropathy|Neuropathies, Familial Amyloid|Wohlwill Corino Andrade Syndrome|Cerebral Amyloid Angiopathy, British Type|Familial Amyloid Polyneuropathies|Hereditary Neuropathic Amyloidoses|Amyloid Polyneuropathy, British Type|Portuguese Polyneuritic Amyloidosis|Familial Amyloid Polyneuropathy, Appalachian Type|Familial Amyloid Polyneuropathy, Type V|Amyloid Polyneuropathy, Swiss Type|Familial Amyloid Neuropathy, Portuguese Type|Type V Familial Amyloid Polyneuropathy|Type VI Familial Amyloid Polyneuropathy|Familial Amyloid Neuropathy|Wohlwill-Andrade Syndrome|Neuropathic Amyloid Syndrome|Amyloid Polyneuropathy, Familial|Portuguese Polyneuritic Amyloidoses|Amyloidoses, Portuguese Polyneuritic|Amyloidosis, Hereditary Neuropathic|Amyloidoses, Hereditary Neuropathic|Amyloid Syndromes, Neuropathic"
NEW08340,DISEASE,inflammatory bone cancer pain,inflammatory bone cancer pain
C445383,CHEMICAL,"4,4'-bis-methyl-5,5'-((1-methyltrimethylene)di)methylnicotinate [Supplementary Concept]",Niacin/analogs  and  derivatives|methylnicotinate
NEW08342,DISEASE,effective durable pain relief,effective durable pain relief
NEW08344,DISEASE,formalin-evoked nociceptive behaviour,formalin-evoked nociceptive behaviour
NEW08347,DISEASE,nociceptive behaviour,nociceptive behaviour
NEW08350,DISEASE,nerve injury model,nerve injury model
NEW08354,DISEASE,preclinical pain model,preclinical pain models
NEW08357,DISEASE,pain signaling,pain signaling
NEW08359,DISEASE,early axon loss,early axon loss
NEW08361,BIOCHEMICAL,drug permeation,drug permeation
NEW08363,DISEASE,pain mediator,pain mediators
NEW08364,DISEASE,damage impairment,damage impairment
NEW08366,DISEASE,chronic homotypic stress,chronic homotypic stress
NEW08368,BIOCHEMICAL,endocrine behavioural response,endocrine behavioural responses
NEW08370,DISEASE,intestinal mucosal dysfunction,intestinal mucosal dysfunction
NEW08371,BIOCHEMICAL,its 's endocrine function,endocrine functions
NEW08374,BIOCHEMICAL,functional antagonist,functional antagonist
NEW08375,CHEMICAL,5-hiaa content,5-HIAA content
NEW08377,BIOCHEMICAL,crf antagonist r121919,CRF antagonist R121919
NEW08381,DISEASE,defense behavior,defense behaviors
NEW08384,CHEMICAL,yohimbine toxicity,yohimbine toxicity
NEW08386,DISEASE,high-fructose rat,high-fructose rats
NEW08387,DISEASE,depressive- behavior,depressive- behaviors
NEW08392,DISEASE,neuro-inflammatory disease,neuro-inflammatory disease
NEW08394,CHEMICAL,synaptic d-aspartate nmda receptor,synaptic D-Aspartate NMDA receptors
D050804,CHEMICAL,D-Aspartate Oxidase,"Oxidase, D-Aspartate|Oxidase, Aspartic|Aspartic Oxidase|D-aspartic Oxidase|D Aspartate Oxidase|Oxidase, D-aspartic|D-aspartate oxidase|D aspartic Oxidase"
D065767,DISEASE,"Activation, Metabolic","Drug Activation|activation|Metabolic Activation|Activation, Drug"
D003605,CHEMICAL,D-Amino-Acid Oxidase,"Oxidase, dextro-Amino Acid|Acid Oxidase, dextro-Amino|D Amino Acid Oxidase|dextro Amino Acid Oxidase|D-amino acid|D-Amino Acid Dehydrogenase|Acid Dehydrogenase, D-Amino|Oxidase, D-Amino-Acid|Dehydrogenase, D-Amino Acid|dextro-Amino Acid Oxidase|D Amino Acid Dehydrogenase"
NEW08402,DISEASE,long-term cognitive deficit,long-term cognitive deficit
NEW08405,MENTAL_HEALTH,unipolar treatment-resistant depression,unipolar treatment-resistant depression
NEW08407,DISEASE,morphine-induced memory impairment,morphine-induced memory impairment
NEW08410,BIOCHEMICAL,standardized antipsychotic drug treatment,standardized antipsychotic drug treatment
D020339,DISEASE,Optic Nerve Glioma,"Optic Glioma|Glioma, Optic Nerve|Malignant Optic Nerve Astrocytoma|Gliomas, Optic|Optic Nerve Glioma, Childhood|Optic Nerve Glioma, Adult|Glioma, Optic Nerve, Childhood|Glioma, Optic|Gliomas, Optic Nerve|Astrocytoma, Malignant, Optic Nerve|Adult Optic Nerve Glioma|Optic Nerve, Malignant Astrocytoma|Childhood Optic Nerve Glioma|Optic Gliomas|Malignant Astrocytoma, Optic Nerve|glioma|Optic Nerve Gliomas|Glioma, Optic Nerve, Adult"
NEW08413,CHEMICAL,microglial structural reorganization,microglial structural reorganization|Iba-1
NEW08414,CHEMICAL,iba-1 positive cell,Iba-1 positive cells
NEW08416,DISEASE,blood-brain barrier damage,blood-brain barrier damage
NEW08417,DISEASE,chronic acquire motor neuropathy,chronic acquired motor neuropathies
D006918,CHEMICAL,Hydroxyurea,Hydroxycarbamid|hydroxyurea|Oncocarbide|Hydrea
NEW08419,DISEASE,vascular damage,vascular damage
D006461,DISEASE,Hemolysis,"Extravascular Hemolysis|Hemolyses, Extravascular|Extravascular Hemolyses|Hemolyses, Intravascular|Hemolysis, Intravascular|Haemolyses|Intravascular Hemolyses|Intravascular Hemolysis|hemolysis|Haemolysis|Hemolysis, Extravascular"
NEW08421,MENTAL_HEALTH,low sexual dysfunction,lower sexual dysfunction
NEW08424,DISEASE,relapsed/refractory diffuse large b cell lymphoma,relapsed/refractory diffuse large B cell lymphoma
NEW08426,DISEASE,acute graft-versus-host disease,acute graft-versus-host disease
D004931,DISEASE,Esophageal Achalasia,"Achalasia, Esophageal|Achalasias, Esophageal|Achalasias|Megaesophagus|Cardiospasm|megaesophagus|Cardiospasms|Esophageal Achalasias|Achalasia"
NEW08427,DISEASE,muscle development disorder,muscle development disorder
NEW08428,DISEASE,Zhu S.,Zhu S.
NEW08429,DISEASE,sonic hedgehog gene,sonic hedgehog gene
NEW08430,CHEMICAL,mice.-Jia X.,mice.-Jia X.
NEW08432,BIOCHEMICAL,thyroid-stimulating hormone receptor antibody,thyroid-stimulating hormone receptor antibody
NEW08433,DISEASE,bipolar disease patient,bipolar disease patients
http://purl.obolibrary.org/obo/DOID_1574,CHEMICAL,alcohol use disorder,Ethanol abuse|alcohol abuse|disordered alcohol use
D064532,BIOCHEMICAL,Histocompatibility Antigen H-2D,"H-2D(p) Antigen|Histocompatibility Antigen H-2D(b)|H-2D(q)|H-2D(b) Glycoprotein|H-2D(d) Antigen|H-2D(b) Antigen|H-2L(d)s Self Peptide Complex|H-2D(d)-Q10(b) Histocompatibility Antigen|H-2L(d) Antigen|H-2D, Histocompatibility Antigen|antigen|H-2D(k) Antigen|Histocompatibility Antigen H 2D|H-2D(q) Histocompatibility Antigen|Antigen H-2D, Histocompatibility"
NEW08441,DISEASE,ovarian teratoma,ovarian teratomas
NEW08444,DISEASE,dimorphic behavioral alteration,dimorphic behavioral alterations
NEW08445,DISEASE,fertility behavior,fertility behaviors
NEW08446,DISEASE,emotional behavior,emotional behaviors
NEW08449,CHEMICAL,serotonin reuptake inhibiting property,serotonin reuptake inhibiting properties
NEW08450,DISEASE,depressive pd,depressive PD
NEW08453,CHEMICAL,exogenous norepinephrine administration,exogenous Norepinephrine administration
NEW08456,DISEASE,sudep case,SUDEP cases
D012129,DISEASE,Respiratory Function Tests,"Pulmonary Function Test|Function Tests, Pulmonary|respiratory function|Pulmonary Function Tests|Lung Function Tests|Lung Function Test|Function Test, Respiratory|Function Test, Pulmonary|Function Tests, Lung|Function Test, Lung|Tests, Pulmonary Function|Tests, Respiratory Function|Test, Lung Function|Test, Pulmonary Function|Tests, Lung Function|Test, Respiratory Function|Function Tests, Respiratory|Respiratory Function Test"
http://purl.obolibrary.org/obo/MFOMD_0000214,MENTAL_HEALTH,perseveration,perseveration
NEW08459,DISEASE,traumatic brain damage,traumatic brain damage
D014911,DISEASE,Whiplash Injuries,"Whiplash Injury|Injury, Whiplash|Injuries, Whiplash|whiplash"
NEW00859,CHEMICAL,selective noradrenaline reuptake inhibitor,selective noradrenaline reuptake inhibitor
NEW08461,DISEASE,seizure phenomenon,seizure phenomena
NEW08463,CHEMICAL,chronic alcohol intake,chronic alcohol intake
NEW08465,CHEMICAL,pparα blockade,PPARα blockade
NEW08469,DISEASE,cognitive set-shifting,cognitive set-shifting
NEW08471,CHEMICAL,impaired norepinephrine system,impaired norepinephrine system
NEW08473,DISEASE,placebo depressive symptom,placebo depressive symptoms
NEW08476,CHEMICAL,first-line treatment levomilnacipran due,first-line treatment levomilnacipran due
NEW08477,CHEMICAL,second-line treatment,second-line treatments
NEW08478,MENTAL_HEALTH,sleep-related hallucination,sleep-related hallucinations
NEW08479,MENTAL_HEALTH,cataplexy attack,cataplexy attacks
NEW08483,CHEMICAL,urinary catecholamine,urinary catecholamines
http://purl.obolibrary.org/obo/CHEBI_135925,CHEMICAL,lisdexamfetamine,lisdexamphetamine|non-stimulant|vyvanse|lisdexamfetamine dimesylate
NEW08484,CHEMICAL,Supernus Pharmaceuticals,Supernus Pharmaceuticals
NEW08485,CHEMICAL,extended-release form,extended-release form
NEW08487,CHEMICAL,e.g. tricyclic antidepressant,e.g. tricyclic antidepressants
NEW08488,CHEMICAL,first-generation antidepressant,first-generation antidepressants
NEW08491,DISEASE,fetal cardiac malformation,fetal cardiac malformations
NEW08493,MENTAL_HEALTH,co-morbid anorexia nervosa binge-purging type,co-morbid anorexia nervosa binge-purging type
NEW08494,CHEMICAL,5-ht reuptake,5-HT reuptake
NEW08497,CHEMICAL,dopamine d2 receptor partial agonist,dopamine D2 receptor partial agonist
C006737,CHEMICAL,1-benzylpiperazine [Supplementary Concept],BZP|Benzylpiperazine|Piperazines
NEW08504,NUTRITION,prophylactic lithium treatment,prophylactic lithium treatment
NEW08505,CHEMICAL,overactive serotonin activity,overactive serotonin activity
NEW08507,MENTAL_HEALTH,dysfunction account,dysfunction accounts
D003861,MENTAL_HEALTH,Depersonalization,"Depersonalization Disorder|Disorders, Depersonalization|Depersonalization Disorders|Derealization|depersonalization|Depersonalizations|Derealizations|Disorder, Depersonalization"
NEW08508,MENTAL_HEALTH,panic anxiety,panic anxiety
NEW08509,DISEASE,agoraphobic patient,agoraphobic patients
NEW08513,CHEMICAL,fenfluramine challenge,fenfluramine challenge
D018589,DISEASE,Gastroparesis,"Gastric Stases|Stases, Gastric|Gastric Stasis|Stasis, Gastric|Gastropareses|gastroparesis"
NEW08514,DISEASE,bowel disorder,bowel disorders
NEW08515,DISEASE,pancreatic disorder,pancreatic disorders
NEW08516,MENTAL_HEALTH,human anxiety,human anxiety
NEW08518,DISEASE,spontaneous panic attack,spontaneous panic attacks
C565557,CHEMICAL,"Gamma-Glutamylcysteine Synthetase Deficiency, Hemolytic Anemia due to [Supplementary Concept]","Anemia, Hemolytic|γ-glutamylcysteine synthetase|Glutamate-Cysteine Ligase/deficiency"
NEW08519,DISEASE,glucose-induced neuronal damage,glucose-induced neuronal damages
NEW08520,MENTAL_HEALTH,summary diabetes-associated anxiety,summary diabetes-associated anxiety
NEW08521,CHEMICAL,gsh level,GSH level
NEW08528,DISEASE,ccl₄-induced liver injury,CCl₄-induced liver injury
NEW08529,DISEASE,frank fibrosis,frank fibrosis
NEW08530,CHEMICAL,ethanol feeding,ethanol feeding
NEW08532,CHEMICAL,ss activity,SS activity
NEW08533,DISEASE,seizure phase,seizure phases
NEW08534,DISEASE,epilepsy prone rat,epilepsy prone rats
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Audiogenic_Seizures,DISEASE,audiogenic seizures,audiogenic seizures
NEW08535,DISEASE,lidocaine-induced,lidocaine-induced
NEW08536,DISEASE,chronic stress-induced depression-like behavior,chronic stress-induced depression-like behavior
NEW08539,CHEMICAL,n-methyl d-aspartate nmda neurotoxicity,N-methyl D-aspartate NMDA neurotoxicity
NEW08541,DISEASE,stz-induced diabetic mouse,STZ-induced diabetic mice
NEW08544,DISEASE,withdrawal-related anxiety-like behavior,withdrawal-related anxiety-like behavior
NEW08545,BIOCHEMICAL,possible drug target,possible drug targets
NEW08550,DISEASE,ischaemic heart disease,ischaemic heart disease
NEW08551,DISEASE,various psychiatric condition,various psychiatric conditions
NEW08552,BIOCHEMICAL,drug discrimination procedure,drug discrimination procedures
NEW08553,DISEASE,paw tremor,paw tremors
D000071896,DISEASE,Medically Unexplained Symptoms,"Somatic Symptom|Symptoms, Somatic|Medically Unexplained Symptom|Unexplained Symptoms, Medically|Symptom, Somatic|Symptoms, Medically Unexplained|Unexplained Symptom, Medically|Somatic Symptoms|Symptom, Medically Unexplained|somatic symptoms"
NEW08555,DISEASE,increase nervous system stress-reactivity,increased nervous system stress-reactivity
NEW08559,BIOCHEMICAL,endocrine abnormality,endocrine abnormality
NEW08562,CHEMICAL,within-individual cortisol dysregulation,within-individual cortisol dysregulation
NEW08564,DISEASE,chinese young breast cancer patient old,Chinese young breast cancer patients old
NEW08567,DISEASE,drug-induced benign pituitary tumor,drug-induced benign pituitary tumor
NEW08569,CHEMICAL,preferential responsiveness to monoamine oxidase inhibitor,preferential responsiveness to monoamine oxidase inhibitors|MAO-I
D011565,DISEASE,Psoriasis,Palmoplantaris Pustulosis|Pustular Psoriasis of Palms and Soles|Pustulosis of Palms and Soles|Psoriases|Pustulosis Palmaris et Plantaris|psoriasis
D002310,DISEASE,"Cardiomyopathy, Alcoholic",Alcoholic Cardiomyopathy|alcoholic cardiomyopathy
NEW08571,DISEASE,alcoholic hypertension,alcoholic hypertension
C536575,BIOCHEMICAL,Borjeson-Forssman-Lehmann syndrome [Supplementary Concept],"endocrine disorders|Epilepsy|Fingers/abnormalities|Hypogonadism|Mental Retardation, X-Linked|Face/abnormalities|Growth Disorders|Obesity"
D019512,DISEASE,"Pancreatitis, Alcoholic",Alcoholic Pancreatitis|alcoholic pancreatitis
NEW08572,DISEASE,vascular lesion,vascular lesions
NEW08573,DISEASE,consequent metabolic disease,consequent metabolic diseases
NEW08574,DISEASE,alcohol injury,alcohol injury
NEW08575,DISEASE,cancer risk,cancer risk
NEW08576,DISEASE,promise hepato- due,promising hepato- due
NEW08578,DISEASE,muscle mass,muscle mass
NEW08579,DISEASE,non-anion metabolic acidosis,non-anion metabolic acidosis
NEW08580,DISEASE,glucose disturbance,glucose disturbances
NEW08581,BIOCHEMICAL,endocrine screening,endocrine screening
D058533,CHEMICAL,Sex Chromosome Disorders of Sex Development,"DSDs, Sex Chromosome|Sex Chromosome DSD|sex-|Chromosome DSD, Sex|DSD, Sex Chromosome|Sex Chromosome DSDs|Chromosome DSDs, Sex"
http://purl.obolibrary.org/obo/CHEBI_135889,CHEMICAL,sorbinicate,gammahydroxybutyrate|glucitol hexanicotinate
NEW08585,CHEMICAL,serotonin key neurotransmitter,serotonin key neurotransmitters
NEW08586,DISEASE,maladaptive bodily behavior,maladaptive bodily behavior
NEW08588,CHEMICAL,high mehp level,higher MEHP levels
NEW08591,DISEASE,first-time trauma,first-time trauma
http://purl.obolibrary.org/obo/GO_0061744,DISEASE,motor behavior,motor behavior
NEW08595,BIOCHEMICAL,endocrine regulation,endocrine regulation
NEW08600,CHEMICAL,low dehydroepiandrosterone sulfate level,lower dehydroepiandrosterone sulfate levels
NEW08602,MENTAL_HEALTH,reproductive mood disorder,reproductive mood disorders
NEW08605,DISEASE,small ovarian cyst,small ovarian cysts
NEW08606,DISEASE,hyperparathyroidism secondary to chronic kidney disease,CKD|hyperparathyroidism secondary to chronic kidney disease
NEW08608,BIOCHEMICAL,elevated serum parathyroid hormone,elevated serum parathyroid hormone
NEW08609,DISEASE,abnormal cardiac function,abnormal cardiac function
NEW08610,DISEASE,cardiac fibrosis,cardiac fibrosis
NEW08612,CHEMICAL,phosphate wasting,phosphate wasting
NEW08614,DISEASE,endotoxin-induced hypotension,endotoxin-induced hypotension
NEW08616,DISEASE,chronic constriction nerve injury rat,chronic constriction nerve injury rats
NEW08617,DISEASE,cold allodynia,cold allodynia
NEW08620,DISEASE,inflammatory pain state,inflammatory pain states
NEW08621,MENTAL_HEALTH,receptor-mediated analgesia,receptor-mediated analgesia
NEW08623,DISEASE,spasticity due,spasticity due
NEW08624,DISEASE,childhood seizure,childhood seizures
NEW08627,DISEASE,few psychotic experience,fewer psychotic experiences
NEW08631,DISEASE,psychiatric inpatient,psychiatric inpatient
NEW08632,CHEMICAL,d-amphetamine nmda receptor blocker,d-amphetamine NMDA receptor blockers
D043425,CHEMICAL,Glutamate Carboxypeptidase II,"N Acetylaspartylglutamate Peptidase|Hydrolase I, Folate|NAALADase II|glutamate carboxypeptidase|N Acetylated alpha Linked Acidic Dipeptidase|Carboxypeptidase II, Glutamate|FOLH1 Protein|Peptidase, N-Acetylaspartylglutamate|NAALADase L|Acidic Dipeptidase, N-Acetylated-alpha-Linked|N-Acetylaspartylglutamate Peptidase|NAAG Peptidase|N-Acetylated-alpha-Linked Acidic Dipeptidase|Dipeptidase, N-Acetylated-alpha-Linked Acidic|NAALADase|Folate Hydrolase I"
NEW08634,CHEMICAL,dopamine model,dopamine models
D056784,DISEASE,Leukoencephalopathies,"white matter disease|Vanishing White Matter Leukodystrophy|Myelinosis Centralis Diffusas|Diffusa, Myelinosis Centralis|Leukoencephalopathy with Vanishing White Matter|Cree Leukoencephalopathy|Syndrome, CACH VWM|Diffusas, Myelinosis Centralis|Myelinosis Centralis Diffusa|White Matter Diseases|Childhood Ataxia with Diffuse Central Nervous System Hypomyelination|CACH Syndrome|CACH Syndromes|Childhood Ataxia with Central Nervous System Hypomyelinization|Leukoencephalopathy, Cree|Centralis Diffusa, Myelinosis|Vanishing White Matter Disease|CACH VWM Syndrome|Childhood Ataxia with Central Nervous System Hypomyelination|VWM Syndrome, CACH|Leukoencephalopathy|Cree Leukoencephalopathies|White Matter Disease|CACH VWM Syndromes"
NEW08638,DISEASE,neuronal dysfunction,neuronal dysfunctions
NEW08639,DISEASE,central system,central system
D066271,DISEASE,External Capsule,"Capsules, External|Capsula Externas|External Capsules|external capsule|Externa, Capsula|Externas, Capsula|Capsule, External|Capsula Externa"
D054561,DISEASE,National Institute on Aging (U.S.),National Institute on Aging|NIA (US)|aging
NEW08643,CHEMICAL,intestinal ammonia production,intestinal ammonia production
NEW08644,CHEMICAL,ammonia generation,ammonia generation
NEW08645,CHEMICAL,ammoniagenic amino acid,ammoniagenic amino acids
NEW08647,DISEASE,anion-gap metabolic,anion-gap metabolic
http://purl.obolibrary.org/obo/CHEBI_26834,CHEMICAL,sulfur-containing amino acid,sulfur-containing amino acids|sulphur-containing amino acids
C567856,DISEASE,"Growth Retardation, Developmental Delay, Coarse Facies, And Early Death [Supplementary Concept]","Facies|Dwarfism|early death|Abnormalities, Multiple|Failure to Thrive|Developmental Disabilities"
NEW08655,CHEMICAL,d2 dopamine receptor,D2 dopamine receptor
NEW08660,BIOCHEMICAL,growth hormone response,growth hormone response
NEW08662,BIOCHEMICAL,excessive growth hormone response,excessive growth hormone response
http://purl.obolibrary.org/obo/CHEBI_37845,BIOCHEMICAL,growth hormone,Wachstumshormon|growth hormones|growth hormone (GH)-insulin|Somatotropin|GH
NEW08663,MENTAL_HEALTH,verbal memory disorder,verbal memory disorders
C567209,DISEASE,"Mental Retardation, Joint Hypermobility, And Skin Laxity, With Or Without Metabolic Abnormalities [Supplementary Concept]",Joint Instability/congenital|metabolic abnormalities|Intellectual Disability|Skin Diseases
D010900,DISEASE,Pituitary Diseases,"Pituitary Disorder|Disease, Neurohypophyseal|Pituitary Diseases, Posterior|Pituitary Gland Disease|Diseases, Pituitary|Disease, Pituitary|Posterior Pituitary Disease|pituitary disease|Posterior Pituitary Diseases|Adenohypophyseal Disease|Pituitary Disease, Anterior|Neurohypophyseal Diseases|Neurohypophyseal Disease|Disorder, Pituitary|Pituitary Diseases, Anterior|Adenohypophyseal Diseases|Disorder, Hypophyseal|Pituitary Disease|Disease, Pituitary Gland|Pituitary Disease, Posterior|Diseases, Pituitary Gland|Anterior Pituitary Disease|Diseases, Posterior Pituitary|Disorders, Hypophyseal|Anterior Pituitary Diseases|Diseases, Adenohypophyseal|Disorders, Pituitary|Pituitary Disorders|Hypophyseal Disorders|Disease, Posterior Pituitary|Diseases, Neurohypophyseal|Disease, Anterior Pituitary|Pituitary Gland Diseases|Hypophyseal Disorder|Diseases, Anterior Pituitary|Disease, Adenohypophyseal"
NEW08664,DISEASE,secondary adrenal failure,secondary adrenal failure
NEW08666,NUTRITION,ovarian follicle maturation,ovarian follicle maturation
NEW08671,DISEASE,issnhl patient,ISSNHL patients
NEW08672,DISEASE,body compositionand hypotony,body compositionand hypotony
D063305,DISEASE,Organ Dysfunction Scores,"Score, Organ Dysfunction|Organ Failure Score|organ dysfunction|Scores, Organ Dysfunction|Scores, SOFAS|Organ Dysfunction Score|Scores, Organ Failure|Organ Failure Scores|Sequential Organ Failure Assessment Scores|Score, Organ Failure|Scores, MODS|MODS Scores|SOFAS Score|SOFAS Scores|Score, MODS|Multiple Organ Dysfunction Score|Score, SOFAS|MODS Score|Sequential Organ Failure Assessment Score"
NEW08675,DISEASE,extensive burn,extensive burns
NEW08676,DISEASE,chronic debilitating disorder,chronic debilitating disorders
NEW08678,DISEASE,emotional disorder,emotional disorder
http://purl.obolibrary.org/obo/DOID_2723,DISEASE,dermatitis,skin inflammation|bullous-pustular dermatitis|eczema
NEW08679,DISEASE,intercurrent infection,intercurrent infections
NEW08682,DISEASE,non-borderline,non-borderline
NEW08686,DISEASE,upd group,UPD group
D024182,DISEASE,Uniparental Disomy,"Heterodisomies, Uniparental|Disomy, Uniparental|Uniparental Isodisomy|UPD|Uniparental Disomies|Isodisomies, Uniparental|Heterodisomy, Uniparental|Uniparental Heterodisomy|uniparental disomy|Uniparental Isodisomies|Disomies, Uniparental|Uniparental Heterodisomies"
NEW08687,DISEASE,psychiatric behavior,psychiatric behaviors
NEW08688,CHEMICAL,mitochondrial acylcarnitine transport,mitochondrial acylcarnitine transport
NEW08689,DISEASE,hepatic glucose production secondary,hepatic glucose production secondary
NEW08690,CHEMICAL,glucose consumption secondary,glucose consumption secondary
NEW08692,BIOCHEMICAL,growth hormone release,growth hormone release
NEW08693,DISEASE,mild psychomotor delay,mild psychomotor delays
D053560,DISEASE,Ichthyosis Bullosa of Siemens,"Bullous Type of Ichthyosis|Bullous Type Ichthyosis|Ichthyosis, Bullous Type of Siemens|ichthyosis|Ichthyoses, Bullous Type|Siemens Ichthyosis Bullosa|Bullous Type Ichthyoses|Ichthyosis, Bullous Type|Ichthyosis Bullous Type"
NEW08696,DISEASE,depressive illness prediction,depressive illness prediction
NEW08697,DISEASE,unipolar affective disorder,unipolar affective disorder
NEW08698,CHEMICAL,serum cortisol,serum cortisol
NEW08701,MENTAL_HEALTH,bingeing-related eat disorder,bingeing-related eating disorders
D000073599,DISEASE,Health Risk Behaviors,"Behavior, Risky Health|Health Behaviors, Risky|Risky Health Behaviors|Risk Behaviors, Health|Risky Health Behavior|behaviors|Behavior, Health Risk|Health Behavior, Risky|Behaviors, Health Risk|Risk Behavior, Health|Health Risk Behavior|Behaviors, Risky Health"
NEW08703,CHEMICAL,iron metabolism due,iron metabolism due
NEW08704,DISEASE,impaired fertility due,impaired fertility due
NEW08706,DISEASE,human motivational dysfunction,humans motivational dysfunction
NEW08707,NUTRITION,strawberry plant,strawberry plants
NEW08709,CHEMICAL,gr dysfunction,GR dysfunctions
NEW08710,DISEASE,chronic stress-induced depression-like phenotype,chronic stress-induced depression-like phenotypes
NEW08712,CHEMICAL,morphine withdrawal,morphine withdrawal
NEW08714,CHEMICAL,morphine-dependent rat,morphine-dependent rats
NEW08715,DISEASE,anxiety/depressive-like behavior,anxiety/depressive-like behaviors
NEW08716,MENTAL_HEALTH,anxiety regulation,anxiety regulation
NEW08718,MENTAL_HEALTH,heterosexual pedophilia,heterosexual pedophilia
NEW08720,CHEMICAL,cortisol processing speed,cortisol processing speed
NEW08722,BIOCHEMICAL,drug injection,drug injection
NEW08725,DISEASE,second rs period,second RS period
http://purl.obolibrary.org/obo/SYMP_0000835,DISEASE,hypoalgesia,hypernociception
D004700,BIOCHEMICAL,Endocrine System Diseases,"Disease, Endocrine|System Diseases, Endocrine|Endocrine Diseases|Diseases, Endocrine System|Diseases of Endocrine System|Disease, Endocrine System|endocrine disease|Diseases, Endocrine|Endocrine Disease|Endocrine System Disease|System Disease, Endocrine"
C487045,MENTAL_HEALTH,"XRRA1 protein, human [Supplementary Concept]",radiation resistance|Proteins
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Psychiatric_Symptoms,DISEASE,psychiatric symptoms,psychiatric symptomatology
NEW08731,DISEASE,exacerbate hypercatabolism,exacerbated hypercatabolism
NEW08733,CHEMICAL,alcohol abstinence syndrome,alcohol abstinence syndrome
NEW08734,MENTAL_HEALTH,acute alcoholic psychosis,acute alcoholic psychoses
NEW08737,DISEASE,behavioral addiction,behavioral addiction
NEW08738,DISEASE,neuropsychiatric impairment,neuropsychiatric impairments
NEW08740,CHEMICAL,diameter low salivary cortisol level,diameter lower salivary cortisol levels
NEW08742,BIOCHEMICAL,different endocrine profile,different endocrine profiles
NEW08745,CHEMICAL,low relative cortisol amplitude,lower relative cortisol amplitude
NEW08747,MENTAL_HEALTH,objective binge eat,objective binge eating
NEW08748,CHEMICAL,neuroactive steroid hormone,neuroactive steroid hormones
NEW08750,DISEASE,acute mental stress test,acute mental stress test
NEW08751,DISEASE,chronic mental stress,chronic mental stress
NEW08754,DISEASE,factor acute mental stress,factor acute mental stress
NEW08755,MENTAL_HEALTH,anxiety value,anxiety values
NEW08756,MENTAL_HEALTH,chronic stress parameter,chronic stress parameters
NEW08757,DISEASE,chronic mental stress condition,chronic mental stress condition
NEW08758,CHEMICAL,acute acid,acute acid
NEW08759,DISEASE,acute mental stress,acute mental stress
NEW08760,MENTAL_HEALTH,great physical fatigue,greater physical fatigue
http://purl.obolibrary.org/obo/CHEBI_177381,BIOCHEMICAL,naxagolide hydrochloride,"agonist (±)-8-Hydroxy-2-dipropylaminotetralin hydrobromide|naxagolide HCl|MK-458|(+)-PHNO hydrochloride|MK 458|(4aR,10bR)-9-hydroxy-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-4-ium chloride|naxagolide monohydrochloride|L 647339|L 647,339|L-647,339|(4aR-trans)-3,4,4a,5,6,10b-hexahydro-4-propyl-2H-naphth[1,2-b]-1,4-oxazin-9-ol hydrochloride|(4aR,10bR)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol hydrochloride"
NEW08762,CHEMICAL,95%ci=-0.128,95%CI=-0.128
NEW08763,CHEMICAL,pool logor=0.208,pooled logOR=0.208
NEW08764,CHEMICAL,pool logor=-0.366,pooled logOR=-0.366
NEW08765,CHEMICAL,placebo antidepressant combination,placebo antidepressant combination
NEW08767,DISEASE,mandatory tyramine-restricted diet,mandatory tyramine-restricted diet
NEW08769,BIOCHEMICAL,indirect sympathomimetic drug,indirect sympathomimetic drugs
NEW08770,CHEMICAL,severe serotonin toxicity,severe serotonin toxicity
NEW08776,CHEMICAL,neonatal flx effect,neonatal FLX effect
NEW08779,DISEASE,hyperactivity deficit,hyperactivity deficits
NEW08780,BIOCHEMICAL,toxin stereotactic surgery,toxin stereotactic surgery
NEW08781,CHEMICAL,dopamine depletor,dopamine depletors
NEW08782,CHEMICAL,dopamine receptor blocker,dopamine receptor blockers
http://purl.obolibrary.org/obo/DOID_11257,MENTAL_HEALTH,social phobia,specific social phobias
NEW08784,CHEMICAL,dietary tyramine,dietary tyramine
NEW08789,DISEASE,ss occurrence,SS occurrence
NEW08792,CHEMICAL,mesolimbic tract,mesolimbic tract
http://purl.obolibrary.org/obo/SYMP_0000422,DISEASE,dyspepsia,dysmotility-like functional dyspepsia|indigestion
NEW08793,DISEASE,double eyelid spasm,double eyelid spasm
NEW08798,CHEMICAL,dopamine receptor located,dopamine receptors located
http://purl.obolibrary.org/obo/CHEBI_81580,CHEMICAL,prolactin,PRL|prolactine
NEW08801,DISEASE,avh,AVHs
NEW08803,MENTAL_HEALTH,deficit hyperactivity disorder patient,deficit hyperactivity disorder patients
NEW08806,MENTAL_HEALTH,ppi hyperactivity,PPI hyperactivity
NEW08808,DISEASE,schizophrenia-related ios,schizophrenia-related IOS
NEW08809,DISEASE,hyperammonemia cognitive function,hyperammonemia cognitive function
http://purl.obolibrary.org/obo/CHEBI_134742,CHEMICAL,delamanid,OPC-67683|40-mg|deltyba
NEW08811,DISEASE,motor fluctuation,motor fluctuations
D012137,DISEASE,Respiratory System,"Respiratory Tracts|System, Respiratory|Tracts, Respiratory|Respiratory Tract|Tract, Respiratory|respiratory systems|Respiratory Systems|Systems, Respiratory"
NEW08813,DISEASE,neuropsychological impairment,neuropsychological impairment
NEW08814,DISEASE,robust lordosis behavior,robust lordosis behavior
NEW08815,MENTAL_HEALTH,anxiety motor activity,anxiety motor activity
NEW08819,DISEASE,induce td,induced TD
NEW08822,CHEMICAL,selective bzd compound,selective BZD compounds
NEW08823,BIOCHEMICAL,5-ht moduline antagonist,5-HT moduline antagonists
NEW08824,MENTAL_HEALTH,daytime drowsiness,daytime drowsiness
NEW08826,CHEMICAL,mild aa,mild AA
NEW08827,DISEASE,nonresponsive psychosis,nonresponsive psychoses
NEW08828,MENTAL_HEALTH,pupillary fatigue,pupillary fatigue
NEW08830,CHEMICAL,estrogen receptor positive human cancer mcf-7 cell,estrogen receptor positive human cancer MCF-7 cells
NEW08831,CHEMICAL,striatal dopamine innervation,striatal dopamine innervation
NEW08835,CHEMICAL,age-matched ethanol abuser,age-matched ethanol abusers
NEW08837,DISEASE,bicuculline-induced seizure-like activity,bicuculline-induced seizure-like activity
NEW08838,MENTAL_HEALTH,state anxiety,state anxiety
NEW08840,DISEASE,classical nutritional deficiency model,classical nutritional deficiency models
NEW08842,BIOCHEMICAL,standard drug fluoxetine,standard drug fluoxetine
NEW01088,CHEMICAL,mg/kg,mg/kg
NEW08844,DISEASE,diabetes-associated ocd symptomatology,diabetes-associated OCD symptomatology
NEW08845,CHEMICAL,glucose parameter,glucose parameters
NEW08847,DISEASE,various hormone-dependent disorder,various hormone-dependent disorders
NEW08849,DISEASE,metabolic neurobehavioral disorder,metabolic neurobehavioral disorders
NEW08853,MENTAL_HEALTH,fetal restlessness,fetal restlessness
D006332,DISEASE,Cardiomegaly,"Cardiac Hypertrophies|Hypertrophy, Heart|Hypertrophy, Cardiac|Heart Hypertrophy|Heart Hypertrophies|Enlarged Heart|Hypertrophies, Heart|Heart Enlargement|Cardiac Hypertrophy|Hypertrophies, Cardiac|Heart, Enlarged|Enlargement, Heart|heart hypertrophy"
NEW08855,MENTAL_HEALTH,menopause-induced anxiety,menopause-induced anxiety
NEW08856,CHEMICAL,selective serotonin reuptake inhibitor/serotonin,selective serotonin reuptake inhibitor/serotonin
NEW08857,CHEMICAL,hrt norepinephrine reuptake inhibitor antidepressant therapy,HRT norepinephrine reuptake inhibitor antidepressant therapy
C090142,CHEMICAL,secoisolariciresinol diglucoside [Supplementary Concept],Butylene Glycols|secoisolariciresinol diglucoside|Glucosides
D017962,CHEMICAL,alpha-Linolenic Acid,"alpha-Linolenic Acid, (E,Z,E)-Isomer|alpha-Linolenic Acid, (Z,E,E)-Isomer|alpha-Linolenic Acid, (E,Z,Z)-Isomer|alpha Linolenic Acid, Magnesium Salt|alpha-Linolenic Acid, (Z,E,Z)-Isomer|alpha-Linolenic Acid, Magnesium Salt|alpha Linolenic Acid|alpha Linolenic Acid, Zinc Salt|alpha-Linolenic Acid, Calcium Salt|alpha-Linolenic Acid, Lithium Salt|alpha Linolenic Acid, Potassium Salt|alpha-Linolenic Acid, Sodium Salt|alpha-Linolenic Acid, (E,E,Z)-Isomer|alpha Linolenic Acid, Calcium Salt|Linolenic Acid|alpha-Linolenic Acid, Tin(2+) Salt|Linolenate|alpha-Linolenic Acid, Zinc Salt|alpha Linolenic Acid, Ammonium Salt|alpha-Linolenic Acid, Ammonium Salt|alpha-Linolenic Acid, (Z,Z,E)-Isomer|alpha Linolenic Acid, Sodium Salt|alpha-Linolenic Acid, (E,E,E)-Isomer|alpha-linolenic acid|alpha-Linolenic Acid, Potassium Salt|alpha Linolenic Acid, Lithium Salt"
NEW08859,BIOCHEMICAL,phytoestrogen precursor,phytoestrogen precursor
NEW08861,DISEASE,cholinergic-related alteration,cholinergic-related alterations
NEW08862,DISEASE,schizophrenia-like syndrome,schizophrenia-like syndrome
NEW08865,DISEASE,stroke-induced,stroke-induced
C082469,CHEMICAL,sodium-influx-stimulating peptide [Supplementary Concept],sodium influx|Neuropeptides
NEW08866,DISEASE,chronic stroke,chronic stroke
NEW08870,BIOCHEMICAL,suboptimal vitamin d,suboptimal vitamin D
NEW08872,DISEASE,its 's mitochondrial toxicity,mitochondrial toxicity
NEW08875,DISEASE,hiv/aids therapy neuropathy,HIV/AIDS therapy neuropathy
NEW08876,DISEASE,hiv-1 infection,HIV-1 infection
D005557,CHEMICAL,Formaldehyde,Formalin|Oxomethane|Formol|Methanal|formaldehyde
NEW08878,MENTAL_HEALTH,probable alzheimer disease,probable Alzheimer disease
NEW08881,MENTAL_HEALTH,long-term schizophrenia,long-term schizophrenia
D017968,CHEMICAL,Vanadium Compounds,"Compounds, Vanadium|vanadium"
C034554,CHEMICAL,16 alpha-bromo-17 beta-estradiol [Supplementary Concept],Estradiol/analogs  and  derivatives|beta-estradiol
NEW08885,DISEASE,hp toxicity,HP toxicity
NEW08893,DISEASE,severe respiratory infection,severe respiratory infections
NEW08894,DISEASE,vaccine-preventable infection,vaccine-preventable infections
D011087,DISEASE,Polycythemia Vera,"Osler-Vaquez Disease|Ruba Veras, Polycythemia|Veras, Polycythemia Ruba|Primary Polycythemia|polycythemia|Polycythemia Ruba Veras|Vera, Polycythemia Rubra|Erythremias|Polycythemia Rubra Veras|Osler Vaquez Disease|Polycythemia Ruba Vera|Vera, Polycythemia Ruba|Polycythemia, Primary|Ruba Vera, Polycythemia|Erythremia|Polycythemias, Primary|Veras, Polycythemia Rubra|Polycythemia Rubra Vera|Disease, Osler-Vaquez|Primary Polycythemias"
NEW08899,CHEMICAL,mitochondrial aspartate/glutamate antiporter,mitochondrial aspartate/glutamate antiporter
D029761,DISEASE,Garcinia cambogia,"Citrin Fruit|cambogia, Garcinia|Mangostana cambogias|cambogia, Mangostana|Fruits, Citrin|citrin|Garcinia cambogias|Fruit, Citrin|Citrin Fruits|Mangostana cambogia"
NEW08900,DISEASE,pandemic professional,pandemic professionals
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Death_Anxiety,MENTAL_HEALTH,death anxiety,death anxiety
D053722,DISEASE,"Receptors, Interleukin-17","Interleukin 17 Receptor E|Receptors, IL-17|Interleukin-17 Receptor B|Interleukin 17 Receptor B|IL-17|Interleukin-17 Receptor A|IL 17 Receptors|Interleukin 17 Receptor|Interleukin-17 Receptor E|Interleukin-17 Receptor C|Antigen, CDw217|Interleukin-17 Receptor D|Il 17 Receptor|Interleukin 17 Receptors|CDw217 Antigen|Interleukin-17 Receptors|IL-17 Receptors|Interleukin 17 Receptor C|Interleukin-17 Receptor|Interleukin 17 Receptor D|Receptor, Il-17|Receptor, Interleukin-17|Antigens, CDw217|Cdw217 Antigens|Receptors, Interleukin 17|Il-17 Receptor|Interleukin 17 Receptor A"
NEW08903,MENTAL_HEALTH,stress depression,stress depression
D013592,DISEASE,"Syphilis, Latent","Syphilis, Latent Stage|syphilis|Latent Stage Syphilis"
NEW08904,BIOCHEMICAL,supplementary vitamin =,supplementary vitamins =
NEW08905,DISEASE,ivig-dependent cidp patient,IVIg-dependent CIDP patients
NEW08908,CHEMICAL,chloride     mg/kg b.w,chloride    mg/kg b.w
C027157,CHEMICAL,uridine 5'-monophosphate synthase [Supplementary Concept],Orotidine-5'-Phosphate Decarboxylase|Multienzyme Complexes|Orotate Phosphoribosyltransferase|uridine-5'-monophosphate
NEW08909,CHEMICAL,mmadhc gene mutation,MMADHC gene mutations
NEW08912,CHEMICAL,multinutrient formula,multinutrient formulas
NEW08914,NUTRITION,physiologic folate transfer,physiologic folate transfer
NEW08916,DISEASE,premenstrual irritability,premenstrual irritability
NEW08917,CHEMICAL,gut-microbiota-brain axis dysfunction,gut-microbiota-brain axis dysfunction
NEW08918,CHEMICAL,b-vitamin intervention,B-vitamin intervention
NEW08920,DISEASE,ultra-high-risk stage,ultra-high-risk stage
NEW08921,BIOCHEMICAL,niacin deficiency,niacin deficiency
NEW08923,DISEASE,alcohol-induced fatty liver,alcohol-induced fatty liver
NEW08924,DISEASE,fetal morphological abnormality,fetal morphological abnormalities
NEW08925,BIOCHEMICAL,vitamin metabolism,vitamin metabolism
NEW08926,CHEMICAL,glutamate equilibrium,glutamate equilibrium
NEW08927,BIOCHEMICAL,vitamin action,vitamin action
NEW08928,CHEMICAL,abnormal calcium influx,abnormal calcium influx
NEW08931,BIOCHEMICAL,multiple vitamin therapy,multiple vitamin therapy
NEW08933,DISEASE,severe encephalopathy,severe encephalopathy
NEW08934,NUTRITION,parenteral thiamine,parenteral thiamine
NEW08935,BIOCHEMICAL,drug condition,drug conditions
NEW08938,DISEASE,result erythema,resulting erythema
NEW08940,BIOCHEMICAL,beta (aβ)-injected mouse,beta (Aβ)-injected mice
NEW08941,MENTAL_HEALTH,alzheimer disease (ad)-related gene expression,Alzheimer disease (AD)-related gene expression
NEW08943,CHEMICAL,lysergic acid diethylamine,lysergic acid diethylamine
NEW08944,CHEMICAL,psychedelic hallucinogen,psychedelic hallucinogens
NEW08946,BIOCHEMICAL,antipsychotic drug development,antipsychotic drug development
NEW08947,CHEMICAL,"1r,4r,5s,6r-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate","1R,4R,5S,6R-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate"
C113896,CHEMICAL,dimethoxy-4-indophenyl-2-aminopropane [Supplementary Concept],"1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane|Indophenol/analogs  and  derivatives"
NEW08948,CHEMICAL,doi mouse,DOI mice
NEW08949,BIOCHEMICAL,agonist doi,agonist DOI
NEW08951,CHEMICAL,presynaptic 5-ht synthesis,presynaptic 5-HT synthesis
NEW08953,DISEASE,context-dependent,context-dependent
NEW08955,BIOCHEMICAL,i.v 's antibiotic therapy,i.v's antibiotic therapy
NEW08956,CHEMICAL,intramuscular procaine penicillin administration,intramuscular procaine penicillin administration
NEW08958,BIOCHEMICAL,minocycline antibiotic,minocycline antibiotic
D000741,DISEASE,"Anemia, Aplastic","Anemia, Hypoplastic|aplastic anemia|Aplastic Anaemia|Hypoplastic Anemia|Aplastic Anemias|Aplastic Anemia|Hypoplastic Anemias|Anaemia, Aplastic|Aplastic Anaemias"
NEW08959,BIOCHEMICAL,antibiotic coverage,antibiotic coverage
NEW08960,DISEASE,nephrotoxic effect,nephrotoxic effects
D018461,DISEASE,Soft Tissue Infections,"Infections, Soft Tissue|soft tissue infections|Soft Tissue Infection|Infection, Soft Tissue"
NEW08963,MENTAL_HEALTH,early schizophrenia,early schizophrenia
NEW08964,DISEASE,stress-induced inflammation,stress-induced inflammation
NEW08966,CHEMICAL,lps plasma concentration,LPS plasma concentration
NEW08967,DISEASE,clostridium concentration,Clostridium concentration
D065507,CHEMICAL,Vancomycin-Resistant Enterococci,vancomycin|Vancomycin Resistant Enterococci
NEW08969,BIOCHEMICAL,broad spectrum antibiotic therapy,broad spectrum antibiotic therapy
http://purl.obolibrary.org/obo/SYMP_0000602,DISEASE,orthopnea,dyspnoea
NEW08971,DISEASE,persistent frontal lobe syndrome,persistent frontal lobe syndrome
NEW08972,DISEASE,intentional overdose,intentional overdose
NEW08975,DISEASE,resistant infection,resistant infections
NEW08978,DISEASE,brain abnormality,brain abnormalities
NEW08980,MENTAL_HEALTH,few hallucination,few hallucinations
NEW08982,DISEASE,activation-mediated endogenous inflammation,activation-mediated endogenous inflammation
NEW08983,MENTAL_HEALTH,stress-induced anxiety disorder,stress-induced anxiety disorders
NEW08986,DISEASE,central nervous system hypersomnia,central nervous system hypersomnias
NEW08987,DISEASE,disruptive mood dysregulation disorder,disruptive mood dysregulation disorder
NEW08990,DISEASE,consequent neurodegeneration,consequent neurodegeneration
http://purl.obolibrary.org/obo/DOID_9993,DISEASE,hypoglycemia,prediabetes-related hypoglycemia|Hypoglycaemia
NEW08993,DISEASE,acute symptomatic etiology,acute symptomatic etiologies
NEW08994,DISEASE,severe pain secondary,severe pain secondary
NEW08995,CHEMICAL,analgesic tramadol,analgesic tramadol
NEW08997,MENTAL_HEALTH,period minimize hallucination,period minimizing hallucinations
NEW08998,CHEMICAL,standard lidocaine spinal anesthetic,standard lidocaine spinal anesthetic
D010149,DISEASE,"Pain, Postoperative","Post-operative Pain, Chronic|Post-operative Pains|Pain, Acute Postoperative|Pain, Postsurgical|Postoperative Pain|Pain, Chronic Post-operative|Post surgical Pain|Chronic Postsurgical Pains|Acute Post-operative Pain|Pain, Chronic Postsurgical|Pain, Post operative|Pain, Acute Post-operative|Acute Post operative Pain|Pain, Chronic Post-surgical|Persistent Postsurgical Pain|Pain, Post-operative|Postoperative Pain, Chronic|Chronic Postsurgical Pain|Chronic Post-operative Pain|Pain, Chronic Postoperative|Post-operative Pain|Post-operative Pain, Acute|Chronic Post operative Pain|Chronic Post surgical Pain|postoperative pain|Post operative Pain, Chronic|Chronic Postoperative Pain|Chronic Post-surgical Pain|Post operative Pain, Acute|Postsurgical Pain, Chronic|Post-surgical Pain|Post operative Pain|Pain, Persistent Postsurgical|Postoperative Pain, Acute|Acute Postoperative Pain|Post-surgical Pain, Chronic|Pain, Post-surgical|Postsurgical Pain, Persistent|Postsurgical Pain"
NEW09000,DISEASE,ches-induced gastric motor maladaptation,CHeS-induced gastric motor maladaptation
NEW09002,DISEASE,stress-related gastric motility disorder,stress-related gastric motility disorders
NEW09004,CHEMICAL,vasopressin v1a receptor,vasopressin V1a receptors
NEW09005,DISEASE,stress-induced visceral hyperalgesia,stress-induced visceral hyperalgesia
NEW09006,DISEASE,chronic stress-related gastrointestinal disorder,chronic stress-related gastrointestinal disorders
NEW09009,DISEASE,stress-induced tachycardia,stress-induced tachycardia
NEW09011,CHEMICAL,vasopressin system,vasopressin system
NEW09013,CHEMICAL,tyr-avp,Tyr-AVP
NEW09015,DISEASE,focal cerebral ischemia,focal cerebral ischemia
NEW09016,DISEASE,secondary brain damage,secondary brain damage
NEW09017,DISEASE,cortex specific gravity,cortex edema|cortex specific gravity
NEW09020,DISEASE,focal cortex edema,focal cortex edema
NEW09023,DISEASE,ischemia-evoked cortex edema,ischemia-evoked cortex edema
NEW09025,CHEMICAL,ppads pre-treatment,PPADS pre-treatment
NEW09027,DISEASE,complicated influenza infection,complicated influenza infections
NEW09028,DISEASE,similar adverse neuropsychiatric reaction,similar adverse neuropsychiatric reactions
NEW09031,DISEASE,ischemic injury,ischemic injury
NEW09032,DISEASE,mood function,mood function
NEW09034,DISEASE,pyramidal neuron atrophy,pyramidal neuron atrophy
NEW09036,DISEASE,adrenal hypertrophy,adrenal hypertrophy
NEW09037,CHEMICAL,elevated plasma corticosterone level,elevated plasma corticosterone levels
http://purl.obolibrary.org/obo/DOID_0050782,DISEASE,zollinger-ellison syndrome,overt Cushing syndrome
NEW09040,CHEMICAL,glucose insulin resistance,glucose insulin resistance
NEW09042,CHEMICAL,concomitant abnormal glucose parameter,concomitant abnormal glucose parameters
NEW09044,CHEMICAL,acs due,ACS due
NEW09045,DISEASE,single stress-induced hyperalgesia,single stress-induced hyperalgesia
NEW09046,MENTAL_HEALTH,elevated anxiety,elevated anxiety
NEW09047,DISEASE,rac1-gtp fear memory,Rac1-GTP fear memory
http://purl.obolibrary.org/obo/GO_0008542,DISEASE,visual learning,visual learning
NEW09049,BIOCHEMICAL,bdnf bdnf receptor agonist,BDNF BDNF receptor agonist
http://purl.obolibrary.org/obo/CL_0002309,DISEASE,corticotroph,corticotroph pituitary tumor
C562732,DISEASE,Euthyroid Goiter [Supplementary Concept],"Goiter, Nodular|euthyroid goiter"
NEW09054,DISEASE,tachy- cardia,tachy- cardia
NEW09055,BIOCHEMICAL,thyroid hormone insufficiency,thyroid hormone insufficiency
NEW09056,BIOCHEMICAL,thyroid-stimulating hormone level,thyroid-stimulating hormone level
NEW09057,DISEASE,thyroiditis iodine deficiency,thyroiditis iodine deficiency
NEW09058,BIOCHEMICAL,thyroid hormone excess,thyroid hormone excess
NEW09061,DISEASE,extra-pyramidal side-effect,extra-pyramidal side-effects
NEW09063,DISEASE,bacterial septicaemia,bacterial septicaemia
D011015,DISEASE,"Pneumonia, Aspiration","Syndromes, Acid Aspiration|Aspiration Pneumonia|aspiration pneumonia|Syndrome, Acid Aspiration|Aspiration Pneumonias|Syndrome, Mendelson's|Syndrome, Mendelson|Mendelson's Syndrome|Mendelson Syndrome|Pneumonias, Aspiration|Acid Aspiration Syndromes|Gastric Acid Aspiration Syndrome|Mendelsons Syndrome|Acid Aspiration Syndrome"
NEW09064,DISEASE,ischaemic bowel disease,ischaemic bowel disease
D045823,DISEASE,Ileus,ileus|Intestinal Obstruction (1968-2003)
NEW09065,DISEASE,colon perforation,colon perforation
NEW03922,CHEMICAL,effective antidepressant,effective antidepressants
NEW09066,MENTAL_HEALTH,comorbid anxiety,comorbid anxiety
NEW09069,MENTAL_HEALTH,daily sleepiness,daily sleepiness
NEW09073,DISEASE,nausea sexual dysfunction,nausea sexual dysfunction
NEW09074,MENTAL_HEALTH,geriatric dementia population,geriatric dementia population
NEW09076,DISEASE,cognitive problem,cognitive problems
NEW09077,MENTAL_HEALTH,excessive daytime sleepiness due,excessive daytime sleepiness due
NEW09079,DISEASE,brain pathology,brain pathologies
NEW09082,DISEASE,allergic patient,allergic patients
NEW09088,MENTAL_HEALTH,adhd autism spectrum disorder symptom,ADHD autism spectrum disorder symptoms
http://purl.obolibrary.org/obo/MFOMD_0000145,DISEASE,hypomanic episode,manic/hypomanic episodes
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Hypomania,DISEASE,hypomania,mania/hypomania
NEW09090,DISEASE,postprandial distress syndrome,PDS|Postprandial Distress Syndrome
NEW09091,DISEASE,postprandial syndrome symptom,Postprandial Syndrome symptoms
NEW09095,NUTRITION,choline esterase inhibitor,choline esterase inhibitor
NEW09096,CHEMICAL,inhibitor donepezil,inhibitor donepezil
NEW09099,CHEMICAL,contraceptive strategy,contraceptive strategies
NEW09100,DISEASE,acute dependence model,acute dependence model
NEW09101,CHEMICAL,naloxone minimal withdrawal,naloxone minimal withdrawal
NEW09102,DISEASE,chronic dependence model,chronic dependence model
NEW09105,DISEASE,ischemia-induced delay neuronal death,ischemia-induced delayed neuronal death
NEW09106,DISEASE,cuprizone-induced demyelination,cuprizone-induced demyelination
NEW09108,DISEASE,als mouse,ALS mice
NEW09109,DISEASE,mn loss,MN loss
NEW09110,NUTRITION,phospholipid side chain,phospholipid side chains
NEW09112,DISEASE,untreated psychiatric patient,untreated psychiatric patients
http://purl.obolibrary.org/obo/DOID_0060164,DISEASE,pain disorder,pain disorders
NEW09114,NUTRITION,g-protein coupled-receptor fatty acid receptor,G-protein coupled-receptor fatty acid receptor
NEW09115,DISEASE,stress-evoked pain chronicity,stress-evoked pain chronicity
NEW09118,CHEMICAL,oral dha supplementation,oral DHA supplementation
NEW09119,DISEASE,stress-evoked chronic pain,stress-evoked chronic pain
D003930,DISEASE,Diabetic Retinopathy,"Retinopathy, Diabetic|Retinopathies, Diabetic|diabetic retinopathy|Diabetic Retinopathies"
NEW09124,DISEASE,congenital hyperammonemia,congenital hyperammonemia
NEW09126,DISEASE,hyperammonemic encephalopathy,hyperammonemic encephalopathies
D000067489,DISEASE,Metacognition,"Awareness, Meta-cognitive|Metacognitive Controls|Metamemory|Metaemotions|Monitoring, Metacognitive|Meta-cognitive Awarenesses|Metacognitive Awarenesses|Meta-cognitive Monitoring|Meta-cognition|Metaemotion|Meta-cognitive Awareness|Awareness, Metacognitive|Meta cognitive Control|Metacognitive Monitoring|Meta-memory|Metacognitive Knowledges|Meta cognitive Monitoring|Metacognitive Knowledge|Meta-cognitive Controls|Meta-cognitive Control|Meta cognitive Awareness|cognitive control|Metamemories|Meta memory|Metacognitive Awareness|Meta-emotion|Meta cognition|Knowledge, Metacognitive|Meta-memories|Metacognitive Control|Meta-cognitive Monitorings|Meta emotion"
NEW09129,MENTAL_HEALTH,great hyperactivity,greater hyperactivity
C532623,DISEASE,"Mirn155 microRNA, mouse [Supplementary Concept]",microRNA-155|MicroRNAs
NEW09133,DISEASE,hpa-axis abnormality,HPA-axis abnormalities
NEW09135,DISEASE,certain neurological disorder,certain neurological disorders
NEW09138,MENTAL_HEALTH,retardation plasma hdl concentration,retardation plasma HDL concentrations
NEW09141,CHEMICAL,epa supplementation,EPA supplementation
NEW09142,DISEASE,cardiometabolic disorder,cardiometabolic disorders
NEW09144,DISEASE,depressed peri-menopausal woman,depressed peri-menopausal women
NEW09146,BIOCHEMICAL,estrogen signalling,estrogen signalling
NEW09150,CHEMICAL,clozapine review,clozapine review
NEW09151,DISEASE,childhood bacterial skin infection,childhood bacterial skin infections
NEW09152,BIOCHEMICAL,topical antibiotic,topical antibiotics
NEW09153,CHEMICAL,topical permethrin,topical permethrin
NEW09157,CHEMICAL,p<0.01 alone,p<0.01 alone
NEW09158,CHEMICAL,concurrent glycine treatment,concurrent glycine treatment
NEW09161,DISEASE,ltd sensitivity,LTD sensitivity
NEW09163,DISEASE,abnormal anxiolytic-like behavior,abnormal anxiolytic-like behavior
NEW09165,DISEASE,nmdar-dependent ltd,NMDAR-dependent LTD
NEW09167,DISEASE,depression- behavior,depression- behaviors
NEW09169,DISEASE,hormone-simulated pregnancy,hormone-simulated pregnancy|HSP mice
NEW09173,CHEMICAL,metabotropic glutamate receptor located,metabotropic glutamate receptors located
C000629763,CHEMICAL,BCI-838 [Supplementary Concept],BCI-838|Bridged Bicyclo Compounds
NEW09181,CHEMICAL,striatal na release,striatal NA release
NEW09182,CHEMICAL,endogenous 5-ht,endogenous 5-HT
D051306,CHEMICAL,L-Lysine 6-Transaminase,"6-Aminotransferase, Lysine|2-Oxoglutarate 6-Aminotransferase, Lysine|Lysine 6-Aminotransferase|L Lysine 6 Transaminase|lysine|Lysine-6-Aminotransferase|Lysine epsilon Transaminase|Lysine epsilon-Transaminase|Lysine 6 Aminotransferase|6-Aminotransferase, Lysine 2-Oxoglutarate|epsilon-Transaminase, Lysine|6-Transaminase, L-Lysine|Lysine-epsilon Aminotransferase|Aminotransferase, Lysine-epsilon|Lysine 2 Oxoglutarate 6 Aminotransferase|Lysine 2-Oxoglutarate 6-Aminotransferase|Lysine epsilon Aminotransferase"
D006901,CHEMICAL,Hydroxylysine,"(2S,5R)-2,6-Diamino-5-hydroxyhexanoic Acid|5-Hydroxylysine|5 Hydroxylysine|Lysine, 5 Hydroxy|2,6-Diamino-5-hydroxyhexanoic Acid|Lysine, 5-Hydroxy-|hydroxylysine|2,6 Diamino 5 hydroxyhexanoic Acid"
D003680,DISEASE,Deglutition Disorders,"Deglutition Disorder|Swallowing Disorder|Swallowing Disorders|Dysphagia|Dysphagia, Esophageal|dysphagia|Disorders, Deglutition|Dysphagia, Oropharyngeal|Oropharyngeal Dysphagia|Esophageal Dysphagia"
NEW09185,DISEASE,severe dystonia,severe dystonia
NEW09192,DISEASE,axonal degeneration,axonal degeneration
NEW09193,DISEASE,neuromuscular dysfunction,neuromuscular dysfunction
D016013,DISEASE,Likelihood Functions,"Likelihood Function|Function, Likelihood|functions|Test, Likelihood Ratio|Maximum Likelihood Estimate|Estimates, Maximum Likelihood|Functions, Likelihood|Maximum Likelihood Estimates|Estimate, Maximum Likelihood|Likelihood Ratio Test"
C497467,CHEMICAL,"TPH1 protein, human [Supplementary Concept]",tryptophan hydroxylase-1|Tryptophan Hydroxylase|TPH-1
C041756,CHEMICAL,"alpha,beta-diacryloxypropionic acid [Supplementary Concept]",Acrylates|DAPS
NEW09199,DISEASE,chronic pain therapy,chronic pain therapy
NEW09200,CHEMICAL,kynurenine aminotransferase activity,kynurenine aminotransferase activity
NEW09202,DISEASE,enhance autonomic nervous system response,enhanced autonomic nervous system responses
NEW09204,CHEMICAL,ky ka acid,KY KA acid
NEW09208,DISEASE,high depressive symptom,higher depressive symptoms
NEW09210,MENTAL_HEALTH,chronic stress-induced depression,chronic stress-induced depression
NEW09215,MENTAL_HEALTH,minor depression,minor depression
NEW09219,CHEMICAL,efficacious antidepressant action,efficacious antidepressant action
NEW09224,MENTAL_HEALTH,age-related mood disorder,age-related mood disorders
NEW09226,DISEASE,affective disorder model,affective disorder models
NEW09230,DISEASE,excess hyperammonemia,excess hyperammonemia
NEW09232,NUTRITION,high tryptophan uptake,high tryptophan uptake
D054325,DISEASE,"vpr Gene Products, Human Immunodeficiency Virus","Viral Protein R, HIV|HIV vpr Gene Product|vpr Protein, Human Immunodeficiency Virus|human immunodeficiency virus"
http://purl.obolibrary.org/obo/DOID_0111146,DISEASE,acquired von willebrand syndrome,AVWS|von Willebrand syndrome
NEW09235,CHEMICAL,basal cortisol level,basal cortisol levels
NEW09236,CHEMICAL,neuronal serotonin transporter,neuronal serotonin transporters
NEW09237,DISEASE,neurotoxic release,neurotoxic release
NEW09242,DISEASE,adhd combined presentation,ADHD combined presentation|ADHD-C
NEW09246,CHEMICAL,5-ht receptor mrna,5-HT receptor mRNA
NEW09247,CHEMICAL,dl-fenfluramine mg/kg,dl-fenfluramine mg/kg
NEW09252,CHEMICAL,high postdexamethasone cortisol,higher postdexamethasone cortisol
NEW09253,CHEMICAL,low l-trp level,lower L-TRP levels
NEW09254,DISEASE,scid-ii interview,SCID-II interview
NEW09256,DISEASE,self-aggressive behavior,self-aggressive behavior
NEW09258,BIOCHEMICAL,selective serotonin reuptake inhibitor efficacy,selective serotonin reuptake inhibitor efficacy
NEW09260,CHEMICAL,selective serotonin reuptake inhibitor-remitted obsessive-compulsive disorder patient,selective serotonin reuptake inhibitor-remitted obsessive-compulsive disorder patients
NEW09262,CHEMICAL,serotonin over-,serotonin over-
NEW09267,DISEASE,age-related disease,age-related disease
NEW09268,CHEMICAL,brain neurotransmitter serotonin,brain neurotransmitter serotonin
NEW09269,DISEASE,sad treatment,SAD treatment
NEW09272,CHEMICAL,matter GM volume,matter GM volumes
NEW09274,CHEMICAL,to kynurenine,Kyn|to kynurenine
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Affective_Psychosis,MENTAL_HEALTH,affective psychosis,functional affective psychosis
D009473,DISEASE,Neuronal Plasticity,"Pruning, Neurite|Dendrite Prunings|Plasticity, Brain|Plasticities, Synaptic|Dendritic Remodelings|Pruning, Axon|Neuronal Network Remodeling|Pruning, Dendritic|Prunings, Neuronal|Arborizations, Dendrite|Synaptic Prunings|Dendritic Pruning|Prunings, Neurite|Prunings, Axon|Axonal Prunings|Brain Plasticities|Pruning, Axonal|Prunings, Dendrite|Prunings, Dendritic|Network Remodelings, Neuronal|Neuronal Remodelings|Dendritic Arborization|Dendritic Prunings|Neuronal Plasticities|Neuroplasticities|Plasticity, Neural|Remodelings, Neuronal|Remodeling, Dendritic|Arborizations, Dendritic|Arborizations, Neuronal|Brain Plasticity|Arborization, Dendrite|Neuronal Arborization|Neuronal Prunings|Pruning, Synaptic|Dendrite Pruning|Neural Plasticities|Axon Pruning|Pruning, Dendrite|Prunings, Synaptic|Synaptic Pruning|Pruning, Neuronal|Dendrite Arborizations|Plasticities, Neuronal|Neurite Prunings|Plasticities, Brain|Neuronal Network Remodelings|Axonal Pruning|Neurite Pruning|Remodelings, Neuronal Network|Plasticities, Neural|neuronal plasticity|Axon Prunings|Synaptic Plasticity|Plasticity, Synaptic|Dendritic Remodeling|Network Remodeling, Neuronal|Neuronal Pruning|Neuronal Arborizations|Plasticity, Neuronal|Arborization, Dendritic|Synaptic Plasticities|Prunings, Axonal|Neuronal Remodeling|Remodeling, Neuronal Network|Remodelings, Dendritic|Dendrite Arborization|Arborization, Neuronal|Remodeling, Neuronal|Neural Plasticity|Neuroplasticity|Dendritic Arborizations"
NEW09277,DISEASE,glun2b containing receptor,GluN2B containing receptors
NEW09278,CHEMICAL,wild-type nmdar,wild-type NMDARs
NEW09283,CHEMICAL,serotonin activity,serotonin activity
NEW09285,DISEASE,chronic physical disease =,chronic physical disease =
NEW09288,CHEMICAL,peripheral lipopolysaccharide injection,peripheral lipopolysaccharide injection
NEW09289,NUTRITION,phospholipid acid metabolism,phospholipid acid metabolism
D052283,CHEMICAL,"Creatine Kinase, MM Form","Kinase, M Creatine|creatine|Muscle Creatine Kinase|Kinase, MM Creatine|Creatine Kinase, MM|M Creatine Kinase|Kinase, Muscle Creatine|Creatine Kinase, M|MM Creatine Kinase|Creatine Kinase, Muscle"
NEW09292,DISEASE,receptor-mediated neurotoxicity,receptor-mediated neurotoxicity
NEW09294,DISEASE,long-term stressor,long-term stressors
NEW09296,MENTAL_HEALTH,behavioral anxiety,behavioral anxiety
NEW09298,DISEASE,pv loss,PV loss
D006111,DISEASE,Graves Disease,"Disease, Basedow|Exophthalmic Goiters|Goiter, Exophthalmic|Basedow Disease|Graves' Disease|Hyperthyroidism, Autoimmune|Basedows Disease|Disease, Graves|Disease, Graves'|Goiters, Exophthalmic|Graves disease|Disease, Basedow's|Exophthalmic Goiter|Basedow's Disease"
NEW09300,DISEASE,abuse potential,abuse potential
NEW09304,MENTAL_HEALTH,low dose potent analgesia,low dose potent analgesia
NEW09305,CHEMICAL,chronic l-dopa administration,chronic l-DOPA administration
NEW09307,CHEMICAL,nr2b-containing n-methyl-d-aspartate receptor,NR2B-containing N-methyl-D-aspartate receptors
NEW09309,CHEMICAL,"cp-101,606 selective blocker","CP-101,606 selective blocker"
NEW09310,BIOCHEMICAL,non-competitive modern-affinity strong voltage-dependent n-methyl-d-aspartate receptor antagonist,non-competitive modern-affinity strong voltage-dependent N-methyl-D-aspartate receptor antagonist
NEW09312,CHEMICAL,enlarged calcium ion current,enlarged calcium ion current
NEW09314,CHEMICAL,plasma elevated kyn/trp ratio,plasma elevated KYN/TRP ratio
NEW09315,CHEMICAL,potent antidepressant,potent antidepressant
NEW09316,CHEMICAL,hyperphosphorylate tau protein,hyperphosphorylated Tau protein
NEW09317,CHEMICAL,sucrose preference deficit,sucrose preference deficit
NEW09318,DISEASE,structural brain abnormality,structural brain abnormalities
NEW09319,DISEASE,hippocampal atrophy,hippocampal atrophy
NEW09324,MENTAL_HEALTH,first-episode psychosis,first-episode psychosis
NEW09328,CHEMICAL,cumulative morphine consumption,Cumulative morphine consumption
NEW09330,MENTAL_HEALTH,anxiety relative,anxiety relative
NEW09331,MENTAL_HEALTH,refractory anxiety disorder,refractory anxiety disorders
NEW09332,DISEASE,various psychiatric illness,various psychiatric illnesses
NEW09335,DISEASE,age-related cognitive impairment,age-related cognitive impairment
NEW09336,BIOCHEMICAL,investigational drug status,investigational drug status
NEW09338,CHEMICAL,mg/kg i.p,mg/kg i.p
NEW09341,BIOCHEMICAL,mitochondrial a beta toxicity,mitochondrial A beta toxicity
NEW09343,MENTAL_HEALTH,typical stress reaction,typical stress reactions
NEW09346,DISEASE,chronic pain patient,chronic pain patients
NEW09348,MENTAL_HEALTH,major chronic stress,major chronic stress
D056650,DISEASE,Vulvodynia,"Vulvodynia, Generalized|Generalized Vulvodynia|vulvodynia|Generalized Vulvodynias|Vestibulodynia|Vulvodynias, Generalized|Vestibulodynias|Vulvodynias"
NEW09349,DISEASE,chronic injury,chronic injuries
NEW09350,CHEMICAL,immoderate alcohol consumption,immoderate alcohol consumption
NEW09351,DISEASE,metabolic failure,metabolic failure
NEW09352,DISEASE,progressive degenerative dementia,progressive degenerative dementias
NEW09353,DISEASE,prion disorder,prion disorders
NEW09355,BIOCHEMICAL,antigen hla dqb1(*)0602,antigen HLA DQB1(*)0602
NEW09358,BIOCHEMICAL,certain environmental toxin,certain environmental toxins
NEW09360,DISEASE,deep cerebral venous thrombosis,deep cerebral venous thrombosis
D020526,DISEASE,Brain Stem Infarctions,"Foville Syndrome|Brainstem Infarctions|Brainstem Stroke|Claude Syndrome|Infarcts, Brain Stem|Infarction, Brainstem|Brain Stem Infarction|Syndrome, Millard-Gublar|Benedict Syndrome|basilar syndrome|Weber Syndrome|Millard Gublar Syndrome|Infarctions, Brainstem|Infarction, Brain Stem|Infarctions, Brain Stem|Brainstem Infarction|Millard-Gublar Syndrome|Stroke, Brainstem|Stem Infarct, Brain|Brain Stem Infarcts|Stem Infarcts, Brain|Top of the Basilar Syndrome|Infarct, Brain Stem|Brain Stem Infarct"
D064726,DISEASE,Triple Negative Breast Neoplasms,"neoplasms|Triple-Negative Breast Cancer|Breast Neoplasm, Triple-Negative|Triple-Negative Breast Neoplasm|Breast Cancers, Triple-Negative|ER Negative PR Negative HER2 Negative Breast Cancer|ER Negative PR Negative HER2 Negative Breast Neoplasms|Triple-Negative Breast Neoplasms|Breast Cancer, Triple-Negative|Triple Negative Breast Neoplasm|Breast Neoplasms, Triple-Negative|Triple Negative Breast Cancer|ER-Negative PR-Negative HER2-Negative Breast Neoplasms|ER-Negative PR-Negative HER2-Negative Breast Cancer|Triple-Negative Breast Cancers"
NEW09362,DISEASE,cognition retardation,cognition retardations
NEW09365,CHEMICAL,afb1-mediated toxicity,AFB1-mediated toxicity
NEW09368,DISEASE,multifocal lymphoplasmacellular hepatitis,multifocal lymphoplasmacellular hepatitis
NEW09369,DISEASE,periportal fibrosis,periportal fibrosis
http://purl.obolibrary.org/obo/DOID_0060040,MENTAL_HEALTH,pervasive developmental disorder,pervasive developmental disorders|pervasive development disorder|Pervasive Child Development Disorders
NEW09370,CHEMICAL,its 's major extraneuronal metabolite,major extraneuronal metabolite
D009647,CHEMICAL,Normetanephrine,Normetadrenaline|normetanephrine|3 Methoxynoradrenaline|3-Methoxynoradrenaline
NEW09372,CHEMICAL,exaggerated plasma ne,exaggerated plasma NE
D009245,CHEMICAL,NADH Dehydrogenase,"NADH Cytochrome c Oxidoreductase|Dehydrogenase, NADH|NADH dehydrogenase|Diaphorase (NADH Dehydrogenase)|NADH (Acceptor) Oxidoreductase|NADH Cytochrome c Reductase"
D051047,CHEMICAL,Dihydrolipoyllysine-Residue Acetyltransferase,"Dihydrolipoyl Acetyltransferase|Dihydrolipoyl Transacetylase|Acetyltransferase, Dihydrolipoyl|Acetyltransferase, Lipoate|Dihydrolipoamide Acetyltransferase|Dihydrolipoamide S-Acetyltransferase|Pyruvate Dehydrogenase Complex E2|S-Acetyltransferase, Dihydrolipoamide|Acetyltransferase, Dihydrolipoamide|Acetyltransferase, Dihydrolipoyllysine-Residue|Dihydrolipoamide S Acetyltransferase|Dihydrolipoyllysine Residue Acetyltransferase|Transacetylase, Dihydrolipoyl|dihydrolipoamide acetyltransferase|Acetyl-CoA-Dihydrolipoamide S-Acetyltransferase|S-Acetyltransferase, Acetyl-CoA-Dihydrolipoamide|Acetyl CoA Dihydrolipoamide S Acetyltransferase|Lipoate Acetyltransferase"
C494878,CHEMICAL,"Dlat protein, mouse [Supplementary Concept]",Mitochondrial Proteins|E2 component|Dihydrolipoyllysine-Residue Acetyltransferase
NEW09383,DISEASE,jump impairment,jumping impairment
NEW09384,DISEASE,significant memory impairment,significant memory impairment
NEW09385,CHEMICAL,morphine withdrawal jump,morphine withdrawal jumping
NEW09387,CHEMICAL,olanzapine exposure,olanzapine exposure
NEW09389,DISEASE,olanzapine-associated weight gain,olanzapine-associated weight gain
NEW09390,DISEASE,human psychogenic drinking behavior,human psychogenic drinking behavior
NEW09391,CHEMICAL,crh secretion,CRH secretions
NEW09395,MENTAL_HEALTH,context-related analgesia,context-related analgesia
NEW09399,BIOCHEMICAL,indirect sympathomimetic,indirect sympathomimetics
NEW09401,CHEMICAL,daily cocaine use,daily cocaine use
NEW09403,CHEMICAL,ephedrine racemic amphetamine,ephedrine racemic amphetamine
NEW09404,DISEASE,hyperkalaemia,hyperkalaemia
D064549,DISEASE,Myeloid Cell Leukemia Sequence 1 Protein,"leukemia|Myeloid Cell Factor-1|Cell Factor-1, Myeloid|Myeloid Cell Factor 1|Factor-1, Myeloid Cell|Myeloid Cell Leukemia Sequence 1|Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1|Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1"
NEW09405,DISEASE,chronic graft-versus-host disease,chronic graft-versus-host disease
NEW09406,MENTAL_HEALTH,schizophrenia field,schizophrenia field
NEW09408,DISEASE,non-24-hr sleep-wake disorder,non-24-hr sleep-wake disorder
NEW09409,DISEASE,seizure frequency,seizure frequency
NEW09411,DISEASE,ka-induced hyperlocomotion,KA-induced hyperlocomotion
NEW09413,DISEASE,vehicle accident,vehicle accidents
NEW09417,CHEMICAL,glucose homeostasis,glucose homeostasis
http://purl.obolibrary.org/obo/DOID_4195,DISEASE,hyperglycemia,CF-induced hyperglycemia
http://purl.obolibrary.org/obo/CHEBI_131790,CHEMICAL,melatonin receptor antagonist,melatonin receptor antagonists|mixed melatonin receptor agonist/5-HT(2C receptor antagonist
NEW09420,CHEMICAL,acute fluoxetine,acute fluoxetine
NEW09421,BIOCHEMICAL,neuroleptic drug sensitivity,neuroleptic drug sensitivity
NEW09422,DISEASE,dlb guideline,DLB guidelines
NEW09424,MENTAL_HEALTH,insomnia treatment,insomnia treatment
NEW09425,DISEASE,ham/tsp patient,HAM/TSP patients
D000073618,DISEASE,Varicella Zoster Virus Infection,virus infection|Congenital Varicella Syndrome
NEW09426,BIOCHEMICAL,possible antiviral activity,possible antiviral activity
NEW09428,DISEASE,c patient toxicity,C patients toxicity
NEW09429,DISEASE,chc patient,CHC patients
NEW09431,DISEASE,l-dopa-induced alteration,L-DOPA-induced alteration
NEW09434,DISEASE,experimental SDAT,experimental SDAT
NEW09436,DISEASE,hp-induced cataleptic symptom,HP-induced cataleptic symptoms
NEW09437,CHEMICAL,non-nmda glutamatergic receptor,non-NMDA glutamatergic receptors
NEW09438,BIOCHEMICAL,depression antagonist,depression antagonists
NEW09439,CHEMICAL,adenosine neuromodulation,adenosine neuromodulation
NEW09440,DISEASE,respiratory disease,respiratory diseases
NEW09441,MENTAL_HEALTH,different mental disorder,different mental disorders
http://purl.obolibrary.org/obo/CHEBI_52214,CHEMICAL,ligand,A2-receptor ligands|ligands
NEW09444,DISEASE,focal ischemia,focal ischemia
NEW09445,DISEASE,cerebral ischemic damage,cerebral ischemic damage
NEW09446,MENTAL_HEALTH,dyspareunia due menopause,dyspareunia due menopause
NEW09447,MENTAL_HEALTH,moderate-to-severe dyspareunia,moderate-to-severe dyspareunia
NEW09448,DISEASE,breast cancer drug,breast cancer drugs
NEW09449,BIOCHEMICAL,selective estrogen receptor modulator strong,selective estrogen receptor modulators strong
NEW09450,BIOCHEMICAL,full estrogen agonist effect,full estrogen agonist effect
NEW09452,DISEASE,intrauterine infection,intrauterine infection
D003733,DISEASE,Dental Caries Susceptibility,"Resistance, Dental Caries|Dental Caries Resistance|dental caries|Susceptibility, Dental Caries|Caries Resistance, Dental|Caries Susceptibility, Dental"
NEW09454,CHEMICAL,tooth-pain management prevention,tooth-pain management prevention
NEW09455,CHEMICAL,urinary urea,urinary urea
NEW09456,DISEASE,bacterial diarrhea,bacterial diarrhea
D020947,CHEMICAL,Tea Tree Oil,"Aetheroleum Melaleucae alternifoliae|tea|Melaleucae alternifoliae, Aetheroleum|Oil, Tea Tree|Melaleuca alternifolia Oil|Oil, Melaleuca alternifolia"
NEW09459,MENTAL_HEALTH,lethal caffeine intoxication,lethal caffeine intoxication
NEW09460,DISEASE,consequent reduction,consequent reduction
NEW09462,DISEASE,non-motor symptom slow,non-motor symptoms slowing
NEW09464,CHEMICAL,different antidepressant,different antidepressants
NEW09467,DISEASE,various central nervous disorder,various central nervous disorders
C026539,CHEMICAL,preclamol [Supplementary Concept],3-PPP|Piperidines
NEW09469,BIOCHEMICAL,d2 agonist,D2 agonist
NEW09470,CHEMICAL,norepinephrine-dopamine reuptake inhibitor,norepinephrine-dopamine reuptake inhibitors
http://purl.obolibrary.org/obo/CHEBI_44814,CHEMICAL,4-phenylbutylamine,4-phenylbutan-1-amine|d-threo-methylphenidate|1-amino-4-phenylbutane|4-amino-1-phenylbutane|benzenebutanamine
NEW09473,DISEASE,p. aeruginosa biofilm formation,P. aeruginosa biofilm formation
D018410,DISEASE,"Pneumonia, Bacterial","bacterial pneumonia|Pneumonias, Bacterial|Bacterial Pneumonias|Bacterial Pneumonia"
NEW09475,BIOCHEMICAL,bacterial virulence factor,bacterial virulence factors
NEW09477,MENTAL_HEALTH,drn projection region,DRN projection regions
NEW09479,DISEASE,bobs receptor,bobs receptors
NEW09481,DISEASE,head bob,head bobs
NEW09482,DISEASE,body shake,body shakes
NEW09484,CHEMICAL,doi-elicited head bob,DOI-elicited head bobs
NEW09487,DISEASE,emotional instability,emotional instability
NEW09488,DISEASE,crf crf antagonist,CRF CRF antagonist
NEW09491,CHEMICAL,n-acetyl aspartate/choline,N-acetyl aspartate/choline
NEW09492,CHEMICAL,naa/cr significant reduction,NAA/Cr significant reduction
NEW09493,NUTRITION,cortical choline acetyltransferase activity,cortical choline acetyltransferase activity
NEW09494,CHEMICAL,[(3)h]epibatidine binding,[(3)H]epibatidine binding
NEW09495,CHEMICAL,low [(125)i]alpha bungarotoxin binding,lower [(125)I]alpha bungarotoxin binding
NEW09499,DISEASE,cognitive performance,cognitive performance
NEW09500,DISEASE,ischaemic cell damage,ischaemic cell damage
NEW09504,CHEMICAL,choline-containing compound,choline-containing compounds|Cho
NEW09506,DISEASE,ms-induced cognitive deficit,MS-induced cognitive deficits
NEW09508,CHEMICAL,serum testosterone level,serum testosterone level
NEW09510,DISEASE,unilateral galactorrhea,unilateral galactorrhea
NEW09512,DISEASE,fas/pfas relative,FAS/PFAS relative
NEW09514,DISEASE,fas/pfas,FAS/PFAS
NEW09515,DISEASE,matter deficit,matter deficits
C016583,CHEMICAL,4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone [Supplementary Concept],NNK|Nitrosamines|4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
NEW09517,DISEASE,lithium-free bipolar patient,lithium-free bipolar patients
NEW09518,CHEMICAL,blood ammonium,blood ammonium
NEW09521,DISEASE,schizophrenia scz patient,schizophrenia SCZ patients
NEW09522,CHEMICAL,neurometabolite concentration,neurometabolite concentrations
NEW09524,DISEASE,rem- neurotransmitter acetylcholine,REM- neurotransmitter acetylcholine
NEW09525,MENTAL_HEALTH,idiopathic narcolepsy,idiopathic narcolepsy
NEW09526,CHEMICAL,adhd-pae prenatal alcohol exposure,ADHD-PAE prenatal alcohol exposure
NEW09530,MENTAL_HEALTH,ASD hyperactivity disorder,ASD hyperactivity disorder
NEW09531,DISEASE,dose-dependent social deficit,dose-dependent social deficits
NEW09532,DISEASE,asd-like feature,ASD-like features
NEW09533,MENTAL_HEALTH,adult adhd study,Adult ADHD Study
NEW09534,CHEMICAL,glucose value,glucose value
http://purl.org/sig/ont/fma/fma72971,DISEASE,right temporal lobe,right temporal lobe
NEW09539,CHEMICAL,cho level,Cho levels
NEW09541,CHEMICAL,altered mpl metabolism,altered MPL metabolism
D012178,DISEASE,Retinopathy of Prematurity,"Retrolental Fibroplasias|Fibroplasias, Retrolental|Fibroplasia, Retrolental|prematurity|Prematurity Retinopathies|Prematurity Retinopathy|Retrolental Fibroplasia"
NEW09543,DISEASE,neonatal wheezing prevention,neonatal wheezing prevention
NEW09546,CHEMICAL,spontaneous alternation behavior,spontaneous alternation behavior|scopolamine-SA
http://purl.obolibrary.org/obo/DOID_3328,DISEASE,temporal lobe epilepsy,"mesial temporal lobe epilepsy|epilepsy, temporal lobe"
NEW09550,DISEASE,hippocampal sclerosis,hippocampal sclerosis
NEW09552,CHEMICAL,serum norepinephrine level,serum norepinephrine levels
NEW09554,DISEASE,catecholamine receptor hypersensitivity,catecholamine receptor hypersensitivity
NEW09555,BIOCHEMICAL,growth hormone response,growth hormone responses
NEW09556,DISEASE,ethanol-induced behavioral deficit,ethanol-induced behavioral deficits
NEW09561,CHEMICAL,ntx mg/d,NTX mg/d
NEW09563,DISEASE,recurrent gambling behavior,recurrent gambling behaviors
C057287,CHEMICAL,3'-azido-3'-deoxythymidine 5'phosphate [Supplementary Concept],Thymine Nucleotides|3'-azido-3'-deoxythymidine|Zidovudine/analogs  and  derivatives|Dideoxynucleotides
NEW09565,CHEMICAL,low hdl-cholesterin,lower HDL-cholesterin
NEW09566,MENTAL_HEALTH,stepwise regression analysis,stepwise regression analysis
NEW09567,CHEMICAL,low uric acid,lower uric acid
NEW09568,NUTRITION,phospholipid metabolism,phospholipids metabolism
http://purl.obolibrary.org/obo/CHEBI_28355,CHEMICAL,"adenosine 2',5'-bisphosphate",adenosine tri-phosphate
NEW09570,CHEMICAL,energy inorganic phosphate,energy inorganic phosphate
http://purl.obolibrary.org/obo/PR_000010963,CHEMICAL,n-acetylglucosamine-1-phosphodiester alpha-n-acetylglucosaminidase,mannose 6-phosphate-uncovering enzyme|phosphodiester alpha-glcnacase|phosphodiesters|nagpa
http://purl.obolibrary.org/obo/CHEBI_138101,CHEMICAL,"2-[(9s,11r)-epidioxy-(15s)-hydroxy-(5z,13e)-prostadienoyl]-sn-glycero-3- phosphocholine","phosphomonoesters|(2R)-3-hydroxy-2-{[(5Z)-7-{(1R,4S,5R,6R)-6-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl}hept-5-enoyl]oxy}propyl 2-(trimethylazaniumyl)ethyl phosphate|2-(prostaglandin H2)-sn-glycero-3-phosphocholine|2-[(9S,11R)-epidioxy-15(S)-hydroxy-(5Z,13E)-prostadienoyl]-sn-glycero-3-phosphocholine"
NEW09571,MENTAL_HEALTH,specific up-front fragmentation,specific up-front fragmentation
NEW09573,BIOCHEMICAL,niacin skin flush response,niacin skin flush response
NEW09574,NUTRITION,cell membrane phospholipid,cell membrane phospholipids
NEW09576,NUTRITION,erythrocyte membrane phospholipid composition,erythrocyte membrane phospholipid composition
NEW09580,DISEASE,hyperammonemic crises-associated disorder,hyperammonemic crises-associated disorders
NEW09581,CHEMICAL,ammonia removal,ammonia removal
NEW09583,MENTAL_HEALTH,depression disease,depression disease
NEW09584,CHEMICAL,polyunsaturated lipid,polyunsaturated lipids
NEW09586,MENTAL_HEALTH,neuronal resistance,neuronal resistance
http://purl.obolibrary.org/obo/CL_0000127,CHEMICAL,astrocyte,DHA-enriched astrocytes
NEW09587,DISEASE,pain therapy,pain therapy
NEW09588,DISEASE,inflammatory pain test,inflammatory pain test
NEW09589,DISEASE,human pain therapy,human pain therapy
NEW09591,DISEASE,negative deficit,negative deficits
NEW09593,DISEASE,cognition dysfunction,cognition dysfunction
NEW09594,DISEASE,pain n-methyl-d-aspartate receptor antagonist,pain N-methyl-D-aspartate receptor antagonists
NEW09595,DISEASE,opioid-induced hyperalgesia,opioid-induced hyperalgesia
NEW09597,DISEASE,focal ischemia model,focal ischemia model
NEW09600,DISEASE,intestinal peristaltism,intestinal peristaltism
NEW09601,DISEASE,bacterial gastroenteritis,bacterial gastroenteritis
D005770,DISEASE,Gastrointestinal Neoplasms,"Gastrointestinal Neoplasm|Gastrointestinal Tract Cancers|Cancer of the Gastrointestinal Tract|Cancer of Gastrointestinal Tract|Neoplasm, Gastrointestinal|Cancer, Gastrointestinal|Gastrointestinal Tract Cancer|Neoplasms, Gastrointestinal|Gastrointestinal Cancer|Gastrointestinal Cancers|gastrointestinal cancer|Cancers, Gastrointestinal"
NEW09602,DISEASE,chronic gastritis,chronic gastritis
NEW09604,DISEASE,cardiovascular disease due,cardiovascular diseases due
NEW09606,CHEMICAL,extracellular noradrenaline level,extracellular noradrenaline level
NEW09609,MENTAL_HEALTH,anxiety reaction,anxiety reaction
NEW09610,CHEMICAL,6-hydroxydopamine lesion,6-hydroxydopamine lesions
NEW09611,CHEMICAL,forebrain dopamine system,forebrain dopamine system
NEW09612,CHEMICAL,neonatal 6-hydroxydopamine,neonatal 6-hydroxydopamine
NEW09615,CHEMICAL,iy yohimbine,IY yohimbine
NEW09616,DISEASE,visual reminder,visual reminders
NEW09617,CHEMICAL,24-hour urine catecholamine excretion,24-hour urine catecholamine excretion
NEW09618,CHEMICAL,platelet paroxetine,platelet paroxetine
NEW09620,CHEMICAL,l-dopa administration,L-DOPA administration
NEW09622,CHEMICAL,amphetamine challenge,amphetamine challenge
NEW09623,CHEMICAL,cp94253,CP94253
D020891,CHEMICAL,Raclopride,"FLB-472|C11, Raclopride|Raclopride C11|FLA 870|FLA870|raclopride|FLB472|FLB 472|FLA-870"
NEW09624,MENTAL_HEALTH,amphetamine-induced dyskinesia,amphetamine-induced dyskinesia
NEW09625,DISEASE,chemotherapy-induced axonal degeneration,chemotherapy-induced axonal degeneration
NEW09626,DISEASE,neuropathic control,neuropathic controls
NEW09627,CHEMICAL,functional dopamine antagonism,functional dopamine antagonism
NEW09629,DISEASE,antipsychotic-induced side effect,antipsychotic-induced side effects
NEW09630,CHEMICAL,butac mouse,BuTAC mice
NEW09631,CHEMICAL,m2/m4(-/- double-knockout mouse,M2/M4(-/- double-knockout mice
NEW09634,CHEMICAL,fenton reaction,Fenton reaction
NEW09635,CHEMICAL,hydroxyl radical,hydroxyl radicals
http://purl.obolibrary.org/obo/DOID_13269,DISEASE,hereditary coproporphyria,hereditary hemochromatosis|Coproporphyrinogen oxidase deficiency|Hereditary coproporphyria|hereditary coproporphyria porphyria
NEW09638,DISEASE,common liver disease,common liver diseases
NEW09639,CHEMICAL,hepatitis c virus iron accumulation,hepatitis C virus iron accumulation
NEW09641,MENTAL_HEALTH,computationally-defined psychosis biotype,computationally-defined psychosis biotypes
NEW09644,DISEASE,persistent iron dysfunction,persistent iron dysfunction
NEW09646,DISEASE,hippocampal neuronal ferroptosis,hippocampal neuronal ferroptosis
NEW09648,DISEASE,stimulant-naive attention-deficit/hyperactivity disorder,stimulant-naive attention-deficit/hyperactivity disorder
NEW09649,CHEMICAL,iron signal,iron signal
NEW09651,DISEASE,disease with/without metastasis weight loss,disease with/without metastases weight loss
NEW09652,DISEASE,acute diabete complication,acute diabetes complications
NEW09653,DISEASE,coagulopathy alcohol abuse,coagulopathy alcohol abuse
D058729,DISEASE,Peripheral Arterial Disease,"Arterial Diseases, Peripheral|peripheral artery disease|Disease, Peripheral Artery|Diseases, Peripheral Artery|Peripheral Arterial Diseases|Peripheral Artery Disease|Arterial Disease, Peripheral|Artery Disease, Peripheral|Peripheral Artery Diseases|Diseases, Peripheral Arterial|Disease, Peripheral Arterial|Artery Diseases, Peripheral"
NEW09654,CHEMICAL,baseline alcohol consumption,baseline alcohol consumption
NEW09655,DISEASE,channel structural disorder,channel structural disorder
NEW09657,MENTAL_HEALTH,hyperactivity domain,hyperactivity domain
NEW09658,MENTAL_HEALTH,adhd trait,ADHD traits
NEW09662,MENTAL_HEALTH,adhd pathophysiology,ADHD pathophysiology
NEW09663,CHEMICAL,short-term oxygen storage,short-term oxygen storage
NEW09664,CHEMICAL,body iron,body iron
NEW09665,CHEMICAL,oxygen transport,oxygen transport
NEW09666,CHEMICAL,iron absorption,iron absorption
NEW09667,MENTAL_HEALTH,cognitive learning disorder,cognitive learning disorders
D059907,DISEASE,Functional Neuroimaging,"functional|Functional Brain Imagings|Imagings, Functional Brain|Neuroimaging, Functional|Brain Imaging, Functional|Functional Brain Imaging|Imaging, Functional Brain|Brain Imagings, Functional"
NEW09669,CHEMICAL,typical antipsychotic haloperidol,typical antipsychotic haloperidol
NEW09670,BIOCHEMICAL,opioid agonist maintenance treatment,opioid agonist maintenance treatment
NEW09671,DISEASE,aggressive/hostile behaviour,aggressive/hostile behaviour
NEW09672,DISEASE,panic state,panic states
NEW09677,MENTAL_HEALTH,mouse analgesia test,mouse analgesia tests
NEW09678,BIOCHEMICAL,low efficacy agonist,lower efficacy agonist
NEW09679,CHEMICAL,fluorine substituent,fluorine substituent
NEW09680,CHEMICAL,tramadol label,tramadol label
NEW09682,DISEASE,cocaine-induced surge,cocaine-induced surges
NEW09685,CHEMICAL,impaired th uptake,impaired TH uptake
NEW09686,MENTAL_HEALTH,intellectual disability due,intellectual disability due
NEW09688,DISEASE,hepatic degeneration,hepatic degeneration
D006359,DISEASE,Heat Exhaustion,"Collapse, Heat|Exhaustion, Heat|prostration|Heat Collapse|Heat Prostration|Prostration, Heat"
NEW09689,DISEASE,splenic congestion,splenic congestion
D020300,DISEASE,Intracranial Hemorrhages,"Posterior Fossa Hemorrhage|Hemorrhage, Brain|Hemorrhages, Intracranial|hemorrhages|Hemorrhages, Brain|Hemorrhage, Intracranial|Hemorrhages, Posterior Fossa|Intracranial Hemorrhage|Hemorrhage, Posterior Fossa|Brain Hemorrhages|Posterior Fossa Hemorrhages|Brain Hemorrhage"
NEW09690,CHEMICAL,subepicardium,subepicardium
D006941,DISEASE,Hyperesthesia,"Oxyesthesia|Hyperesthesia, Thermal|Sensation, Hyperesthetic|Hyperesthesias, Thermal|hyperesthesia|Thermal Hyperesthesias|Tactile Hyperesthesias|Sensations, Hyperesthetic|Thermal Hyperesthesia|Hyperesthetic Sensations|Oxyesthesias|Hyperesthesia, Tactile|Hyperesthesias|Hyperesthetic Sensation|Hyperesthesias, Tactile|Tactile Hyperesthesia"
D056844,DISEASE,Renal Colic,"Renal Colics|Colic, Acute Renal|Colic, Ureteral|Colics, Acute Renal|Renal Colics, Acute|Colic, Renal|Ureteral Colics|Ureteral Colic|Renal Colic, Acute|colic|Colics, Renal|Colics, Ureteral|Acute Renal Colic|Acute Renal Colics"
D053490,DISEASE,Mink enteritis virus,"enteritis|Infectious Enteritis Virus of Mink|enteritis viruses, Mink|Mink enteritis viruses"
NEW09691,DISEASE,levamisole-induced tachyphylaxis,levamisole-induced tachyphylaxis
NEW09692,DISEASE,depletion-induced cognitive deficit,depletion-induced cognitive deficits
NEW09696,DISEASE,advanced non-small cell lung cancer patient,advanced non-small cell lung cancer patients
NEW09698,MENTAL_HEALTH,additional mental disorder,additional mental disorders
NEW09699,CHEMICAL,potassium-activated adenosine triphosphatase,potassium-activated adenosine triphosphatase
NEW09700,CHEMICAL,na membrane pump,Na membrane pump
NEW09703,NUTRITION,lithium efflux,lithium efflux
NEW09704,DISEASE,massive overdose,massive overdose
NEW09705,CHEMICAL,serum potassium,serum potassium
NEW09706,DISEASE,chronic thoracolumbar spinal cord injury,chronic thoracolumbar spinal cord injury
NEW09707,DISEASE,chronic SCI,chronic SCI
NEW09708,CHEMICAL,oxygen evolution,oxygen evolution
NEW09710,DISEASE,severe shock,severe shock
D051676,CHEMICAL,G Protein-Coupled Inwardly-Rectifying Potassium Channels,"potassium channels|GIRK4 Potassium Channel|G Protein-Activated Potassium Channels|G Protein-Coupled Inwardly-Rectifying Potassium Channel 1|Kir3.4 Potassium Channel|Potassium Channel, Kir3.4|G Protein Coupled Inwardly Rectifying Potassium Channel 3|GIRK2 Potassium Channel|Potassium Channels, GIRK|GIRK1 Potassium Channel|Potassium Channels, Kir3|Kir3 Potassium Channels|Kir3.3 Potassium Channel|G Protein-Coupled Inwardly-Rectifying Potassium Channel 2|Kir3.2 Potassium Channel|Potassium Channel, GIRK3|GIRK3 Potassium Channel|Potassium Channel, GIRK4|G Protein Coupled Inwardly Rectifying Potassium Channel 4|Potassium Channel, GIRK1|G Protein-Coupled Inwardly-Rectifying Potassium Channel 4|G Protein-Coupled Inwardly-Rectifying Potassium Channel 3|G Protein Coupled Inwardly Rectifying Potassium Channels|Kir3.1 Potassium Channel|Potassium Channel, Kir3.1|G Protein Coupled Inwardly Rectifying Potassium Channel 1|Potassium Channel, GIRK2|G Protein Activated Potassium Channels|GIRK Potassium Channels|G Protein Coupled Inwardly Rectifying Potassium Channel 2|Potassium Channel, Kir3.3|Potassium Channel, Kir3.2"
NEW09712,CHEMICAL,cyclic adenosine monophosphate response element binding protein,cyclic adenosine monophosphate response element binding protein
NEW09713,DISEASE,type Diabetes Mellitus,Type Diabetes Mellitus
NEW09715,DISEASE,despair cognitive dysfunction,despair cognitive dysfunction
NEW09716,CHEMICAL,continuous albuterol,continuous albuterol
D013181,MENTAL_HEALTH,Cortical Spreading Depression,"Depression, Spreading Cortical|Cortical Depressions, Spreading|Depression, Cortical Spreading|Spreading Depressions, Cortical|Spreading Cortical Depression|Depressions, Cortical Spreading|Spreading Depression, Cortical|Cortical Spreading Depressions|Cortical Depression, Spreading|Depressions, Spreading Cortical|Spreading Depression of Leao|Leao Spreading Depression|Spreading Cortical Depressions|Cortical Spreading Depression"
NEW09719,CHEMICAL,extracellular glutamate,extracellular glutamate
NEW09720,DISEASE,neuronal hyperexcitability,neuronal hyperexcitability
NEW09722,CHEMICAL,noradrenaline- contraction,noradrenaline- contractions
NEW09724,DISEASE,corticotropin-dependent hypercortisolemia,corticotropin-dependent hypercortisolemia
NEW09726,DISEASE,lithium-free bipolar affective disorder patient,lithium-free bipolar affective disorder patients
NEW09731,MENTAL_HEALTH,rebound mania,rebound mania
NEW09732,CHEMICAL,urea cycle pathway,urea cycle pathway
NEW09735,DISEASE,congenital disorder secondary,congenital disorders secondary
NEW09736,MENTAL_HEALTH,proxy syndrome,proxy syndrome
NEW09737,DISEASE,factitious hypoglycaemia,factitious hypoglycaemia
NEW09738,NUTRITION,fatty acid oxidation deficiency,fatty acid oxidation deficiency
NEW09739,DISEASE,srs score,SRS score
NEW09740,CHEMICAL,oral potassium supplement,oral potassium supplements
D019305,DISEASE,"Epilepsy, Rolandic","Epilepsy, Temporal-Central Focal|Epilepsy, Sylvian|Benign Childhood Epilepsy With Centro-Temporal Spikes|Centralopathic Epilepsy|Epilepsies, Centralopathic|Epilepsies, Rolandic|Focal Epilepsies, Temporal-Central|Focal Epilepsy, Temporal-Central|Benign Epilepsy With Centrotemporal Spikes|Centrotemporal Epilepsies|rolandic epilepsy|Centrotemporal Epilepsy|Temporal-Central Focal Epilepsy|Rolands Epilepsy|Epilepsies, Temporal-Central Focal|Epilepsies, Centrotemporal|Temporal Central Focal Epilepsy|Benign Epilepsy Of Childhood With Centrotemporal Spikes|Temporal-Central Focal Epilepsies|Epilepsy, Benign Rolandic|Epilepsy, Rolands|Benign Rolandic Epilepsy of Childhood|Sylvian Epilepsy|Epilepsy, Centralopathic|Rolandic Epilepsies|Benign Rolandic Epilepsy|Centralopathic Epilepsies|BCECTS|Benign Childhood Epilepsy With Centro Temporal Spikes|Rolandic Epilepsy|Epilepsy, Centrotemporal|BECTS|Rolandic Epilepsy, Benign"
C562694,DISEASE,"Epilepsy, Idiopathic Generalized [Supplementary Concept]","Epilepsy, Generalized|idiopathic generalized epilepsy|IGE"
NEW09742,CHEMICAL,rare snp,rare SNP
NEW09744,CHEMICAL,altered potassium homeostasis,altered potassium homeostasis
NEW09745,BIOCHEMICAL,elevated s100 beta,elevated S100 beta
NEW09746,CHEMICAL,na level,NA levels
http://purl.obolibrary.org/obo/CHEBI_63129,CHEMICAL,ile-alapsi[(e)-ch=ch]gly-phe-lys(5-galo)-gly-glu-gln-gly-pro-lys-gly-glu-thr,"± =|IleAlaPsi[(E)-CH=CH]GlyPheLys(5-GalO)GlyGluGlnGlyProLysGlyGluThr|L-isoleucyl-(3E,5S)-5-aminohex-3-enoyl-L-phenylalanyl-(5R)-5-(beta-D-galactopyranosyloxy)-L-lysylglycyl-L-alpha-glutamyl-L-glutaminylglycyl-L-prolyl-L-lysylglycyl-L-alpha-glutamyl-L-threonine"
NEW09748,DISEASE,chronic constriction injury,chronic constriction injury
NEW09750,DISEASE,acute leukemia cell,acute leukemia cells
NEW09751,MENTAL_HEALTH,subsequent primary disorder,subsequent primary disorder
NEW09752,DISEASE,matter abnormality,matter abnormalities
NEW09755,MENTAL_HEALTH,profound stress reaction,profound stress reactions
NEW09758,CHEMICAL,dopamine tone,dopamine tone
NEW09760,CHEMICAL,liberally-biased respond,liberally-biased responding
NEW09761,DISEASE,low severity ptsd subject,lower severity PTSD subjects
NEW09762,DISEASE,high severity ptsd subject,higher severity PTSD subjects
NEW09763,DISEASE,experimental sad model,experimental SAD model
NEW09766,DISEASE,treatment-resistant case,treatment-resistant cases
D000066891,DISEASE,Critical Care Outcomes,"Care Outcome, Critical|Outcome, Critical Care|outcomes|Care Outcomes, Critical|Outcomes, Critical Care|Critical Care Outcome"
NEW09771,MENTAL_HEALTH,idiopathic adhd,idiopathic ADHD
NEW09772,CHEMICAL,striatal dopamine level,striatal dopamine levels
NEW09777,MENTAL_HEALTH,schizophrenia risk,schizophrenia risk
NEW09779,MENTAL_HEALTH,first-episode schizophrenia spectrum disorder,first-episode schizophrenia spectrum disorder
NEW09783,DISEASE,impulsivity personality,impulsivity personality
NEW09787,MENTAL_HEALTH,Dementia questionnaire,Dementia Questionnaire
NEW09790,DISEASE,aβ42 aggregation,Aβ42 aggregation
NEW09791,DISEASE,infectious micro-organism,infectious micro-organisms
NEW09792,CHEMICAL,μg/dl. commonest symptom,μg/dL. commonest symptom
D009497,MENTAL_HEALTH,Neurotic Disorders,"Psychoneuroses|neurotic disorders|Neurotic Disorder|Disorders, Neurotic|Neuroses|Disorder, Neurotic"
NEW09793,DISEASE,significant toxicity,significant toxicity
C093267,CHEMICAL,"tau protein (389-402), synthetic [Supplementary Concept]","Genes, Synthetic|Tau Protein|tau Proteins|Peptide Fragments"
NEW09796,DISEASE,coexist infection,coexisting infections
C060564,CHEMICAL,"titanium dioxide, zinc peroxide, zinc oxide drug combination [Supplementary Concept]",Zinc Oxide|Titanium Dioxide|Peroxides|TiO2|Titanium|Drug Combinations
D017639,CHEMICAL,"Asbestos, Amosite",Amosite Asbestos|Asbestos|Cummingtonite Grunerite|Amosite|Cummingtonite-Grunerite
NEW09797,CHEMICAL,acetylcholine level,Acetylcholine levels
NEW09798,DISEASE,disease disturbance,Disease disturbances
NEW09799,MENTAL_HEALTH,dsm iiir schizoaffective disorder,DSM IIIR schizoaffective disorder
NEW09800,CHEMICAL,valproate treatment,valproate treatment
NEW09802,DISEASE,chronic virus infection,chronic virus infection
C041364,BIOCHEMICAL,nitrox [Supplementary Concept],gas mixture|Oxygen|Nitrogen
NEW09803,DISEASE,hypercarbia %,hypercarbia %
NEW09805,CHEMICAL,mm ammonium acetate,mM ammonium acetate
NEW09806,CHEMICAL,intravenous atropine,intravenous atropine
NEW09808,CHEMICAL,cortisol biosynthesis,cortisol biosynthesis
NEW09809,DISEASE,common autosomal recessive disorder,common autosomal recessive disorder
NEW09810,CHEMICAL,atomoxetine exposure,atomoxetine exposure
NEW09814,CHEMICAL,atomoxetine recipient,atomoxetine recipients
D059020,DISEASE,Suicidal Ideation,"suicidal ideation|Ideations, Suicidal|Ideation, Suicidal|Suicidal Ideations"
NEW09815,DISEASE,serious liver injury,serious liver injury
NEW09816,CHEMICAL,oral atomoxetine,oral atomoxetine
NEW09818,MENTAL_HEALTH,Conners 's adult adhd rating scale,Conners's Adult ADHD Rating Scale
NEW09820,DISEASE,chronic stroke patient,chronic stroke patients
NEW09822,CHEMICAL,share antidepressant action,shared antidepressant action
NEW09823,DISEASE,consequent cognitive dysfunction,consequent cognitive dysfunctions
NEW09824,CHEMICAL,serotonergic antidepressant,serotonergic antidepressants
NEW09825,CHEMICAL,reboxetine group,reboxetine group
NEW09827,MENTAL_HEALTH,hyperarousal depression,hyperarousal depression
NEW09828,MENTAL_HEALTH,classic melancholic depression,classic melancholic depression
NEW09830,DISEASE,toxicity episode,toxicity episodes
NEW09832,DISEASE,progressive neurodegeneration,progressive neurodegeneration
NEW09833,DISEASE,long-term neurotoxic effect,long-term neurotoxic effects
NEW09835,CHEMICAL,human serotonin 5-ht transporter,human serotonin 5-HT transporter
C493227,CHEMICAL,"SLC6A2 protein, human [Supplementary Concept]",human norepinephrine transporter|Norepinephrine Plasma Membrane Transport Proteins
NEW09839,DISEASE,contrast pain hypersensitivity,contrast pain hypersensitivity
NEW09840,DISEASE,affective pain dimension,affective pain dimension
NEW09841,DISEASE,unipolar disorder,unipolar disorders
NEW09843,CHEMICAL,its 's antidepressant action,antidepressant action
NEW09845,DISEASE,risk-taking behavior,risk-taking behaviors
NEW09846,DISEASE,psychotic symptom similar,psychotic symptoms similar
NEW09847,BIOCHEMICAL,stress hormone concentration,stress hormone concentrations
NEW09850,DISEASE,economic stressor,economic stressors
NEW09852,DISEASE,islet autoimmunity,islet autoimmunity
NEW09858,DISEASE,county psychiatric emergency service,county psychiatric emergency service
NEW09860,MENTAL_HEALTH,stress-induced anxiety behavior,stress-induced anxiety behaviors
NEW09862,DISEASE,sporadic als patient,sporadic ALS patients
NEW09867,BIOCHEMICAL,anxiolytic drug diazepam,anxiolytic drug diazepam
NEW09869,DISEASE,threat-induced increase,threat-induced increase
NEW09870,DISEASE,massive destruction,massive destruction
NEW09871,DISEASE,central function,central functions
NEW09874,MENTAL_HEALTH,condition anxiety,conditioned anxiety
NEW09875,DISEASE,neuropsychological disease,neuropsychological diseases
NEW09879,DISEASE,conclusion tactile hypersensitivity,conclusion tactile hypersensitivity
NEW09881,BIOCHEMICAL,antiviral resistance,antiviral resistance
D001048,DISEASE,Aplysia,Aplysias|Aplysia
NEW09883,MENTAL_HEALTH,alzheimer disease therapy,Alzheimer disease therapy
NEW09885,DISEASE,colon cancer cell,colon cancer cells
NEW09886,DISEASE,various toxicity marker,various toxicity markers
NEW09889,MENTAL_HEALTH,inter-nucleosomal dna fragmentation,inter-nucleosomal DNA fragmentation
NEW09891,DISEASE,sperm head abnormality,sperm head abnormality
NEW09892,DISEASE,toxicity biomarker,toxicity biomarkers
NEW09893,CHEMICAL,aspartate amino transferase,aspartate amino transferases
NEW09896,CHEMICAL,potent acetylcholinesterase inhibitory,AChEI|potent acetylcholinesterase inhibitory
D012909,DISEASE,Snake Bites,"Envenomation, Snakebite|Snakebite Envenomation|Snakebite Envenomations|Snake Envenomings|Bite, Snake|snakebite|Snake Envenoming|Snakebites|Snake Bite|Envenomings, Snake|Snakebite|Envenoming, Snake"
D003288,DISEASE,Contusions,contusions|Contusion|Bruise|Bruises
NEW09900,CHEMICAL,nm rotenone,nM rotenone
NEW09902,MENTAL_HEALTH,addition dissociation,addition dissociation
NEW09903,CHEMICAL,cd % up,Cd % up
NEW09904,CHEMICAL,cd up,Cd up
NEW09908,CHEMICAL,μg g(-1,μg g(-1
NEW09909,DISEASE,pollutant-induced stress syndrome,pollutant-induced stress syndrome
NEW09911,CHEMICAL,castor methyl ester,castor methyl ester
NEW09913,CHEMICAL,plant-based biodiesels-safflower methyl ester,plant-based biodiesels-safflower methyl ester
NEW09916,NUTRITION,wheat straw,wheat straw
NEW09918,DISEASE,a. caliginosa,A. caliginosa
NEW09921,DISEASE,s. feltiae,S. feltiae
NEW09924,MENTAL_HEALTH,more displacement,more displacement
http://purl.obolibrary.org/obo/CHEBI_67452,CHEMICAL,isogomisin o,o p'-DDT
NEW09926,CHEMICAL,p'-dde,p'-DDE
D064227,CHEMICAL,"Chlorofluorocarbons, Ethane",Ethane Chlorofluorocarbons|ethane|Chlorofluoroethanes
http://purl.obolibrary.org/obo/CHEBI_42266,CHEMICAL,ethane,"C2H6|dimethyl|bimethyl|R-170|Ethan|ethane|CH3-CH3|Aethan|1,1,1-trichloro-2-(p-chlorophenyl)-2-(o-chlorophenyl ethane|ETHANE|methylmethane|ethyl hydride"
NEW09927,CHEMICAL,ethylene ethane,ethylene ethane
NEW09928,NUTRITION,phosphatidylserine externalization,phosphatidylserine externalization
NEW09929,MENTAL_HEALTH,chromosomal dna fragmentation,chromosomal DNA fragmentation
D000072257,CHEMICAL,Oxygen Radical Absorbance Capacity,"ORAC Methods|ORAC Assays|Methods, ORAC|Assay, ORAC|ORAC Assay|Method, ORAC|Trolox Equivalence Antioxidant Capacity Assay|Assays, ORAC|oxygen radical absorbance capacity|ORAC Method|TEAC Assay"
NEW09931,CHEMICAL,PPO enzyme,PPO enzyme
NEW09933,BIOCHEMICAL,effective alternative anticoccidial agent,effective alternative anticoccidial agent
NEW09936,CHEMICAL,fin-feet,fin-feet
NEW09937,MENTAL_HEALTH,near displacement rotation,near displacement rotation
NEW09940,MENTAL_HEALTH,clinical insomnia,clinical insomnia
NEW09942,CHEMICAL,Carbon monoxide-oximetry,Carbon monoxide-oximetry
NEW09943,DISEASE,neurodegenerative disorder patient,neurodegenerative disorders patients
NEW09945,DISEASE,neuropsychiatric phenotype,neuropsychiatric phenotypes
NEW09946,BIOCHEMICAL,cerebral folate deficiency,cerebral folate deficiency
NEW09947,MENTAL_HEALTH,so-called deficiency cfd syndrome,so-called deficiency CFD syndromes
NEW09949,MENTAL_HEALTH,most cfd syndrome,most CFD syndromes
NEW09953,NUTRITION,pacific white shrimp,Pacific white shrimp
NEW09955,MENTAL_HEALTH,fragmentation pattern,fragmentation patterns
NEW09957,NUTRITION,common pheasant,common pheasant
NEW09958,MENTAL_HEALTH,two eurasian magpie,Pica pica|two Eurasian magpies
NEW09962,BIOCHEMICAL,topical estrogen therapy,topical estrogen therapy
NEW09964,DISEASE,large paraovarian cyst due,large paraovarian cyst due
NEW09967,CHEMICAL,galactose-1-phosphate uridyltransferase galt deficiency,galactose-1-phosphate uridyltransferase GALT deficiency
NEW09971,CHEMICAL,dopamine signaling,dopamine signaling
NEW09973,DISEASE,adolescent hypertensive rat,adolescent hypertensive rats
NEW09974,MENTAL_HEALTH,validate adhd animal model,validated ADHD animal model
NEW09975,DISEASE,alcoholic organic brain syndrome patient,alcoholic organic brain syndrome patients
NEW09977,CHEMICAL,csf 5hiaa,CSF 5HIAA
D004305,BIOCHEMICAL,"Dose-Response Relationship, Drug","Drug Dose-Response Relationships|drug dose|Dose Response Relationship, Drug|Drug Dose-Response Relationship|Relationships, Drug Dose-Response|Dose-Response Relationships, Drug|Relationship, Drug Dose-Response"
NEW09979,DISEASE,hyperoxic,hyperoxic
NEW09981,CHEMICAL,lactate dehydrogenase ldh leakage,lactate dehydrogenase LDH leakage
NEW09982,BIOCHEMICAL,vitamin e homolog,vitamin E homologs
NEW09983,DISEASE,hyperoxic apoptosis,hyperoxic apoptosis
NEW09984,DISEASE,m crf 10(-8 m,M CRF 10(-8 M
NEW09986,BIOCHEMICAL,specific crf antagonist alpha-h-crf,specific CRF antagonist alpha-h-CRF
NEW09992,DISEASE,breast cancer-related death,breast cancer-related deaths
NEW09993,CHEMICAL,estrogen receptor antagonist fulvestrant,estrogen receptor antagonist fulvestrant|Fulv
NEW09998,DISEASE,liver metastatic tumor,liver metastatic tumors
NEW10003,DISEASE,psychiatric side-effect,psychiatric side-effects
NEW10007,DISEASE,diet (hfd)-induced metabolic disorder,diet (HFD)-induced metabolic disorder
D054872,NUTRITION,Fatty Acid Synthesis Inhibitors,fatty acid synthesis|Fatty Acid Synthetase Complex (1971-2007)
NEW10009,NUTRITION,fatty acid uptake,fatty acid uptake
NEW10012,DISEASE,autoimmune rheumatic disease,autoimmune rheumatic diseases
NEW10015,DISEASE,systolic hypertension,systolic hypertension
NEW10016,DISEASE,impulse behavior,impulse behavior
NEW10018,CHEMICAL,dopamine therapy,dopamine therapy
NEW10020,CHEMICAL,thalamic gaba concentration,thalamic GABA concentrations
NEW10021,DISEASE,diet deficiency,diet deficiency
NEW10023,DISEASE,atypical psychiatric symptom,atypical psychiatric symptoms
NEW10025,DISEASE,parkinson 's disease-like neurodegenerative disorder,Parkinson's disease-like neurodegenerative disorders
NEW10026,MENTAL_HEALTH,neonatal abstinence syndrome refractory,neonatal abstinence syndrome refractory
NEW10028,DISEASE,various psychiatric symptom,various psychiatric symptoms
NEW10029,MENTAL_HEALTH,high suicide risk,higher suicide risk
C008692,CHEMICAL,nuciferine [Supplementary Concept],nuciferine|Aporphines
NEW10031,NUTRITION,low antral follicle count,lower antral follicle count
NEW10032,BIOCHEMICAL,fetal sex hormone,fetal sex hormones
NEW10034,MENTAL_HEALTH,autism pathophysiology,autism pathophysiology
NEW10037,MENTAL_HEALTH,same autism group,same autism group
NEW10040,CHEMICAL,prostanoid tp receptor,prostanoid TP receptor
D065091,BIOCHEMICAL,Amylin Receptor Agonists,"Receptor Agonist, Amylin|Agonists, Amylin|Agonists, Amylin Receptor|Amylin Mimetics|Amylin Receptor Agonist|Mimetics, Amylin|receptor agonists|Amylin Agonists|Receptor Agonists, Amylin|Agonist, Amylin Receptor"
NEW10042,CHEMICAL,serum quinolinic acid concentration,serum quinolinic acid concentrations
http://purl.obolibrary.org/obo/NCBITaxon_10379,DISEASE,rhadinovirus,SAIDS macaques
NEW10043,CHEMICAL,normal csf quinolinic acid,normal CSF quinolinic acid
NEW10044,CHEMICAL,kynurenic acid concentration,kynurenic acid concentrations
NEW10045,CHEMICAL,serum l-kynurenine concentration,serum L-kynurenine concentrations
NEW10046,CHEMICAL,reduce serum l-tryptophan,reduced serum L-tryptophan
NEW10048,DISEASE,deficiency explanation,deficiency explanation
NEW10049,CHEMICAL,Grijns dietary deficiency,Grijns dietary deficiency
C538618,DISEASE,Donath-Landsteiner hemolytic anemia [Supplementary Concept],"Donath|Anemia, Hemolytic, Autoimmune"
NEW10051,DISEASE,endemic pellagra,endemic pellagra
NEW10052,BIOCHEMICAL,inadequate niacin,inadequate niacin
NEW10053,NUTRITION,precursor tryptophan,precursor tryptophan
NEW10054,CHEMICAL,its 's amino acid precursor,amino acid precursor
NEW10055,DISEASE,deficiency disease due,deficiency disease due
NEW10058,DISEASE,li-induced anti-inflammatory effect,Li-induced anti-inflammatory effects
NEW10060,DISEASE,ich-induced anxiety-like behavior,ICH-induced anxiety-like behaviors
NEW10062,DISEASE,alzheimer patient,Alzheimer patients
NEW10065,DISEASE,hcv infection,HCV infections
NEW10067,DISEASE,moderate dlb,moderate DLB
http://purl.org/sig/ont/fma/fma271967,CHEMICAL,radlex term,nonperjorative term symbiophobia
NEW10068,DISEASE,in peptic digestion,in peptic digestion
NEW10069,CHEMICAL,n-dipropylaminotetralin,N-dipropylaminotetralin
NEW10070,MENTAL_HEALTH,dissociation constant =,dissociation constant =
NEW10071,CHEMICAL,± lower,± lower
NEW10072,CHEMICAL,∼1000 nm,∼1000 nm
NEW10073,CHEMICAL,[(3)h]btx-b,[(3)H]BTX-B
NEW10074,CHEMICAL,ipsc,IPSCs
C042403,CHEMICAL,vita K+B 93 [Supplementary Concept],Acrylic Resins|K(B
NEW10076,DISEASE,pain suppression,pain suppression
NEW10077,MENTAL_HEALTH,cue-induced craving,cue-induced craving
NEW10078,DISEASE,drug-induced hyponatremia,drug-induced hyponatremia
NEW10079,CHEMICAL,serum sodium concentration,serum sodium concentration
NEW10081,DISEASE,t2dm-related complication,T2DM-related complications
NEW10082,CHEMICAL,p-ir,p-IR
http://purl.obolibrary.org/obo/CHEBI_80875,CHEMICAL,nigakilactone k,p-PI3 K
NEW10083,DISEASE,treatment-resistant depressed patient,treatment-resistant depressed patients
NEW10085,MENTAL_HEALTH,kernel resistance,kernel resistance
NEW10086,BIOCHEMICAL,antifungal protein,antifungal proteins
NEW10090,CHEMICAL,tetrodotoxin bioassay,tetrodotoxin bioassay
NEW10091,CHEMICAL,ttx microg g(-1,TTX microg g(-1
NEW10096,DISEASE,primary depressive group,primary depressive group
NEW10102,DISEASE,general depressive syndrome,general depressive syndrome
D017970,DISEASE,Thorium Compounds,"Th-2|Compounds, Thorium|thorium"
NEW10104,DISEASE,th-1 neurotoxicity profile,Th-1 neurotoxicity profiles
NEW10105,CHEMICAL,increase pha th-1,increased PHA Th-1
NEW10106,DISEASE,th-1 neurotoxicity profile,Th-1 neurotoxicity profile
NEW10108,DISEASE,ouabain-induced bipolar disease model,ouabain-induced bipolar disease model
NEW10109,CHEMICAL,sucrose preference test,sucrose preference tests
NEW10110,DISEASE,drug-taking behavior,drug-taking behavior
NEW10111,DISEASE,comorbid physical disease,comorbid physical disease
NEW10113,MENTAL_HEALTH,depression treatment effect,depression treatment effects
NEW10115,DISEASE,idiopathic rbd,idiopathic RBD
NEW10116,BIOCHEMICAL,dietary carotenoid,dietary carotenoids
D000069467,DISEASE,Fecal Microbiota Transplantation,"Fecal Microbiota Transfer|Fecal Transplants|Fecal Transplantations|Transplantation, Fecal|Fecal Microbiome Transplantation|Microbiota Transplantation, Intestinal|Transplant, Intestinal Microbiome|Transplantation, Intestinal Microbiota|Microbiome Transplantation, Intestinal|Intestinal Microbiota Transplants|Transplants, Fecal Microbiota|Intestinal Microbiome Transfers|Microbiome Transplantations, Fecal|Microbiome Transplant, Intestinal|Microbiota Transfers, Fecal|Transfers, Fecal Microbiota|Transplantations, Fecal|Transplant, Intestinal Microbiota|Transplantations, Fecal Microbiome|Transplantation, Intestinal Microbiome|Transfers, Intestinal Microbiome|Microbiome Transfer, Intestinal|Intestinal Microbiota Transfer|Fecal Microbiota Transplant|Fecal Transplantation|Fecal Microbiota Transplantations|Transplantations, Intestinal Microbiota|Transplantation, Fecal Microbiome|Microbiome Transfers, Intestinal|Transplant, Fecal|Intestinal Microbiome Transplants|Transplantation, Fecal Microbiota|Microbiota Transfer, Intestinal|Fecal Transplant|Donor Feces Infusions|Microbiota Transfer, Fecal|Microbiome Transplantation, Fecal|Microbiota Transfers, Intestinal|Transfers, Intestinal Microbiota|Intestinal Microbiota Transfers|Transfer, Intestinal Microbiome|Microbiome Transplants, Intestinal|Transfer, Intestinal Microbiota|Intestinal Microbiome Transplantation|Infusions, Donor Feces|Microbiome Transplantations, Intestinal|Transplantations, Intestinal Microbiome|Intestinal Microbiota Transplantation|Fecal Microbiome Transplantations|Intestinal Microbiome Transplantations|Transfer, Fecal Microbiota|Transplantations, Fecal Microbiota|Microbiota Transplant, Intestinal|Microbiota Transplants, Intestinal|Donor Feces Infusion|Fecal Microbiota Transfers|intestinal microbiome|Infusion, Donor Feces|Microbiota Transplantations, Fecal|Intestinal Microbiome Transplant|Feces Infusions, Donor|Feces Infusion, Donor|Microbiota Transplantations, Intestinal|Intestinal Microbiota Transplantations|Microbiota Transplant, Fecal|Transplants, Intestinal Microbiota|Fecal Microbiota Transplants|Intestinal Microbiome Transfer|Microbiota Transplants, Fecal|Transplant, Fecal Microbiota|Transplants, Fecal|Transplants, Intestinal Microbiome|Intestinal Microbiota Transplant|Microbiota Transplantation, Fecal"
NEW10118,NUTRITION,short fatty acid,short fatty acids
NEW10119,DISEASE,human liver microsome,human liver microsomes
NEW10121,MENTAL_HEALTH,external resistance,external resistance
NEW10122,MENTAL_HEALTH,efficient resistance,efficient resistance
NEW10123,DISEASE,heightened distress,heightened distress
NEW10124,CHEMICAL,altered calcium release,altered calcium release
NEW10127,CHEMICAL,7tm n-terminal stalk,7TM N-terminal stalk
NEW10129,CHEMICAL,cpt-3 task,CPT-3 tasks
NEW10131,DISEASE,congenital cardiovascular malformation,congenital cardiovascular malformations
NEW10132,DISEASE,congenital limb deficiency,congenital limb deficiencies
NEW10133,DISEASE,tract 's defect,tract's defects
D017823,DISEASE,Furcation Defects,"Defects, Furcation|Furcation Defect|Defect, Furcation|defects"
D000013,DISEASE,Congenital Abnormalities,"Abnormalities, Congenital|Birth Defect|Fetal Malformation|Malformation, Fetal|Birth Defects|Fetal Malformations|Congenital Abnormality|Defect, Congenital|Congenital Defect|Defect, Birth|Fetal Anomaly|Deformities|Fetal Anomalies|Defects, Congenital|Abnormality, Congenital|Deformity|Anomaly, Fetal|Congenital Defects|congenital abnormalities"
NEW10135,DISEASE,hyperhomocysteinemia-related disorder,hyperhomocysteinemia-related disorders
NEW10138,DISEASE,manic mood swing,manic mood swings
NEW10139,MENTAL_HEALTH,multidrug resistance reversal,multidrug resistance reversal
NEW10140,DISEASE,tumor regression,tumor regression
NEW10141,MENTAL_HEALTH,severe respiratory depression,severe respiratory depression
NEW10144,NUTRITION,clinical yeast,clinical yeast
D019688,DISEASE,Gram-Negative Oxygenic Photosynthetic Bacteria,Gram Negative Oxygenic Photosynthetic Bacteria|Gram+
NEW10145,DISEASE,numerous brain abnormality,numerous brain abnormalities
NEW10146,CHEMICAL,amyloid pathway,amyloid pathways
NEW10148,CHEMICAL,low inorganic sulfate level,low inorganic sulfate levels
NEW10150,CHEMICAL,polyamine coproduct,polyamine coproduct
NEW10152,DISEASE,gastrointestinal bioavailability,gastrointestinal bioavailability
http://purl.obolibrary.org/obo/CHEBI_37853,CHEMICAL,phosphate salt,Phosphatsalze|Phosphatsalz|phosphate salt|phosphate salts
NEW10155,BIOCHEMICAL,vitamin d-resistant osteomalacia,vitamin D-resistant osteomalacia
NEW10158,CHEMICAL,al accumulation,Al accumulation
NEW10159,CHEMICAL,bone Al,bone Al
NEW10162,CHEMICAL,site-selective camp analog,site-selective cAMP analogs
NEW10163,DISEASE,ventricular enlargement,ventricular enlargement
http://purl.obolibrary.org/obo/DOID_0050453,DISEASE,lissencephaly,microencephaly
NEW10165,MENTAL_HEALTH,agitation time,agitation time
D018804,DISEASE,Hantavirus Pulmonary Syndrome,Hantavirus-Associated Respiratory Distress Syndrome|Hantavirus Associated Respiratory Distress Syndrome|HARDS|Hantavirus Pulmonary Syndromes|Hantavirus pulmonary syndrome
NEW10167,DISEASE,rare acquire infection,rare acquired infection
NEW10169,DISEASE,focal cerebral arteriopathy,focal cerebral arteriopathy
NEW10170,DISEASE,cardioembolic mechanism,cardioembolic mechanism
NEW10171,CHEMICAL,covid-19 patient,Covid-19 patients
NEW10172,DISEASE,underreported cerebrovascular injury mechanism,underreported cerebrovascular injury mechanism
NEW10174,BIOCHEMICAL,antimicrobial impact,antimicrobial impact
NEW10176,DISEASE,physiological impairment,physiological impairment
NEW10179,CHEMICAL,intravenous bpa administration,intravenous BPA administration
NEW10181,MENTAL_HEALTH,lgn projection,LGN projection
D017436,DISEASE,Kallmann Syndrome,"Anosmic Idiopathic Hypogonadotropic Hypogonadism|Syndrome, Kallmann|Dysplasia Olfactogenitalis of De Morsier|Anosmic Hypogonadism|Anosmic Hypogonadisms|Autosomal Dominant Form of Kallmann Syndrome|Kallmanns Syndrome|hypogonadotropic hypogonadism|Kallmann's Syndrome|Kallmann Syndrome, Type 3, Recessive|Kallmann Syndrome, Type 1, X-linked|Hypogonadotropic Hypogonadism-Anosmia Syndrome|Hypogonadisms, Anosmic|Autosomal Recessive Form of Kallmann Syndrome|Kallmann Syndrome 1|Syndrome, Kallmann's|Hypogonadism, Anosmic|Kallmann Syndrome 2|Kallmann Syndrome 3|Hypogonadotropic Hypogonadism and Anosmia|Hypogonadotropic Hypogonadism, Anosmia, and Midline Cranial Anomalies (Cleft Lip, Cleft Palate and Imperfect Fusion)"
C562492,DISEASE,Robinow Syndrome [Supplementary Concept],"Urogenital Abnormalities|Limb Deformities, Congenital|Dwarfism|Craniofacial Abnormalities|genital abnormalities"
NEW10182,DISEASE,precocious pubertal development,precocious pubertal development
NEW10185,DISEASE,testosterone deficiency,testosterone deficiency
NEW10190,MENTAL_HEALTH,pro analgesia,Pro analgesia
NEW10191,DISEASE,clinical pain situation,clinical pain situation
NEW10194,CHEMICAL,pyridaoxine,pyridaoxine
NEW10196,BIOCHEMICAL,interferon-based virus antiviral therapy,interferon-based virus antiviral therapy
NEW10197,DISEASE,hepatitis c. common side effect,hepatitis C. common side effect
http://purl.obolibrary.org/obo/DOID_9970,DISEASE,obesity,high-fat-diet-induced obesity
NEW10199,CHEMICAL,neuroactive progesterone metabolite allopregnanolone effect,neuroactive progesterone metabolite allopregnanolone effect
NEW10203,MENTAL_HEALTH,fluoxetine-induced sexual dysfunction,fluoxetine-induced sexual dysfunction
NEW10204,DISEASE,lordosis behavior,lordosis behavior
NEW10206,CHEMICAL,nitroethenediamine series,nitroethenediamine series
NEW10208,DISEASE,akinetic catatonia,akinetic catatonia
D012560,MENTAL_HEALTH,"Schizophrenia, Catatonic","catatonic schizophrenia|Schizophrenias, Catatonic|Catatonic Schizophrenia|Catatonic Schizophrenias"
http://purl.obolibrary.org/obo/CHEBI_9598,BIOCHEMICAL,tiludronic acid,Tiludronic acid|Tiludronate|folinic acid treatment|tiludronate disodium
D002588,CHEMICAL,Cesium Radioisotopes,"cesium|Cs+|Radioisotopes, Cesium"
NEW10213,MENTAL_HEALTH,hock fragmentation,Hock fragmentation
D012414,CHEMICAL,Rubidium Radioisotopes,"Rb+|Radioisotopes, Rubidium|rubidium"
NEW10215,DISEASE,advanced pd subject,advanced PD subjects
NEW10216,BIOCHEMICAL,muscarinic m4 cholinergic antagonist,muscarinic M4 cholinergic antagonists
NEW10221,CHEMICAL,high co2 sparging rate,higher CO2 sparging rates
NEW10222,MENTAL_HEALTH,increase agitation,increased agitation
D000082142,BIOCHEMICAL,Mast Cell Stabilizers,"Cell Stabilizer, Mast|Stabilizer, Mast Cell|Mast Cells Stabilizers|Mast Cells Degranulation Stabilizers|Mast Cell Stabilizing Compounds|Mast Cell Degranulation Stabilizer|Cells Stabilizer, Mast|Mast Cells Degranulation Stabilizer|Stabilizers, Mast Cell|Mast Cell Stabilizing Compound|Mast Cell Degranulation Stabilizers|Stabilizer, Mast Cells|Mast Cells Stabilizer|Mast Cell Stabilizer|stabilizer|Stabilizers, Mast Cells"
D005781,BIOCHEMICAL,"Gelatin Sponge, Absorbable","Gelfoam|Absorbable Gelatin Sponges|Gelaspon|Gelatin Sponges, Absorbable|gelatin|Sponge, Absorbable Gelatin|Absorbable Gelatin Sponge|Sponges, Absorbable Gelatin"
NEW10229,DISEASE,gram-positive bacillus subtilis,Gram-positive Bacillus subtilis
NEW10236,BIOCHEMICAL,act sympathomimetic,acting sympathomimetics
NEW10238,DISEASE,neuromuscular disorder,neuromuscular disorders
http://purl.obolibrary.org/obo/SYMP_0000369,DISEASE,ptosis,hyperlacrimation|droopiness
NEW10239,DISEASE,excessive drooling,excessive drooling
NEW10240,DISEASE,nasal hypersecretion,nasal hypersecretion
NEW10242,MENTAL_HEALTH,refractory tension headache,refractory tension headache
NEW10244,DISEASE,significant rv dysfunction,significant RV dysfunction
NEW10245,CHEMICAL,suhx pah model,SuHx PAH model
NEW10246,DISEASE,interventricular dependence,interventricular dependence
NEW10249,DISEASE,% less polymicrobial biofilm formation,% less polymicrobial biofilm formation
NEW10251,DISEASE,dual-specie biofilm formation,dual-species biofilm formation
D047928,DISEASE,Premature Birth,"Premature Births|PTB|Birth, Preterm|preterm birth|Preterm Births|Births, Preterm|Birth, Premature|Preterm Birth|Births, Premature"
NEW10254,DISEASE,high mdd,higher MDD
NEW10255,DISEASE,mdd rate,MDD rates
NEW10257,DISEASE,aging disease,aging diseases
NEW10260,CHEMICAL,silver grain localization,silver grain localization
NEW10261,MENTAL_HEALTH,significant dependent analgesia,significant dependent analgesia
NEW10267,DISEASE,mthfr c677 t mutation,MTHFR C677 T mutation
NEW10268,DISEASE,complex psychiatric phenomenon,complex psychiatric phenomenon
NEW10269,CHEMICAL,vka therapy,VKA therapy
NEW10270,DISEASE,organelle degeneration,organelle degeneration
C000620621,CHEMICAL,1-pentyfluoro-1H-indole-3-carboxylic acid 8-quinolinyl ester [Supplementary Concept],5F-PB-22|Quinolines|Indoles
C000625623,CHEMICAL,1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide [Supplementary Concept],Indazoles|Cumyl-4CN-BINACA
NEW10273,DISEASE,ald role,ALD role
NEW10274,DISEASE,dyspeptic patient,dyspeptic patients
NEW10276,DISEASE,v. agnus-castus L.,V. agnus-castus L.
NEW10278,MENTAL_HEALTH,pro-oxidant non-no-dependent cell defense mechanism,pro-oxidant non-NO-dependent cell defense mechanism
NEW10279,CHEMICAL,gemcitabine-based chemotherapy,gemcitabine-based chemotherapy
NEW10283,DISEASE,pemetrexed-induced toxicity,pemetrexed-induced toxicity
NEW10284,DISEASE,fear-like behavior,fear-like behavior
D014277,DISEASE,Trigeminal Neuralgia,"trigeminal neuralgia|Trigeminal Neuralgia, Idiopathic|Neuralgia, Trigeminal|Trigeminal Neuralgias|Trifacial Neuralgia|Tic Douloureux|Epileptiform Neuralgia|Neuralgia, Epileptiform|Neuralgia, Idiopathic Trigeminal|Neuralgia, Trifacial|Tic Doloureux|Neuralgia, Secondary Trigeminal|Trifacial Neuralgias|Trigeminal Neuralgia, Secondary|Idiopathic Trigeminal Neuralgias|Epileptiform Neuralgias|Secondary Trigeminal Neuralgia|Secondary Trigeminal Neuralgias|Fothergill Disease|Idiopathic Trigeminal Neuralgia|Disease, Fothergill"
NEW10289,CHEMICAL,tianeptine treatment,tianeptine treatment
NEW10293,CHEMICAL,alcohol exposure,alcohol exposure
NEW10295,CHEMICAL,antibody-antigen,antibody-antigen
http://purl.obolibrary.org/obo/DOID_9408,DISEASE,acute myocardial infarction,acute myocardial infarction
D005499,DISEASE,Folliculitis,Folliculitides|Sycoses|Sycosis|folliculitis
D003236,DISEASE,"Conjunctivitis, Viral","conjunctivitis|Viral Conjunctivitides|Conjunctivitides, Viral|Viral Conjunctivitis"
D007766,DISEASE,Lacrimal Apparatus Diseases,"Epiphoras|Epiphora|Apparatus Diseases, Lacrimal|Apparatus Disease, Lacrimal|Diseases, Lacrimal Apparatus|Disease, Lacrimal Apparatus|Lacrimal Apparatus Disease|epiphora"
D029780,DISEASE,Chamaecyparis,"nootkatenses, Chamaecyparis|Chamaecyparis lawsoniana|Cypress, Lawsons False|Atlantic White Cedar|Lawsons False Cypress|Lawson's False Cypress|Lawson's False Cypresses|Cypresses, Lawson's False|Yellow Cypress|Cypress, Lawson's False|Chamaecyparis thyoide|Chamaecyparis thyoides|Chamaecyparis nootkatenses|Chamaecyparis nootkatensis|Yellow Cedars|Chamaecyparis obtusa|lawsonianas, Chamaecyparis|Lawson False Cypress|Cypress, Yellow|False Cypress, Lawson's|thyoides, Chamaecyparis|Atlantic White Cedars|Chamaecyparis lawsonianas|White Cedar, Atlantic|White Cedars, Atlantic|Cypress, Hinoki|Chamaecyparis obtusas|Hinoki Cypress|Cypresses, Yellow|Cedars, Yellow|Cedar, Yellow|False Cypresses, Lawson's|Cedars, Atlantic White|Cypress, Lawson False|Yellow Cedar|Yellow Cypresses|obtusas, Chamaecyparis|white cedar|Chamaecypari|Cedar, Atlantic White"
NEW10299,NUTRITION,ornamental tree,ornamental tree
NEW10302,DISEASE,pd long-term cognitive decline,PD long-term cognitive decline
NEW10303,MENTAL_HEALTH,juvenile paraphilia,juvenile paraphilias
NEW10304,DISEASE,obesity-related neuropsychiatric comorbiditie,obesity-related neuropsychiatric comorbidities
NEW10305,BIOCHEMICAL,adjunct drug,adjunct drug
NEW10307,CHEMICAL,d1 dopamine receptor expression,D1 dopamine receptor expression
NEW10313,CHEMICAL,n-3 pufa level,n-3 PUFA levels
NEW10314,CHEMICAL,low dha level,lower DHA levels
NEW10316,DISEASE,acs patient,ACS patients
NEW10317,MENTAL_HEALTH,depression variable,depression variables
NEW10318,BIOCHEMICAL,selective serotonin reuptake inhibitor class,selective serotonin reuptake inhibitor class
NEW10328,CHEMICAL,caramboxin,caramboxin
NEW10330,DISEASE,primary cerebral folate deficiency,primary cerebral folate deficiency
D029181,DISEASE,Spirituality,Spiritualities|spirituality
http://purl.obolibrary.org/obo/CHEBI_35475,BIOCHEMICAL,non-steroidal anti-inflammatory drug,non-steroidal anti-inflammatory agent|NSAIDs|non-steroid anti-inflammatory drug|non-steroidal anti-inflammatory drugs|NSAID
D004374,DISEASE,"Ductus Arteriosus, Patent",Patency of the Ductus Arteriosus|Patent Ductus Arteriosus|Patent Ductus Arteriosus Familial|ductus arteriosus
NEW10338,BIOCHEMICAL,numerous virulence factor,numerous virulence factors
NEW10339,MENTAL_HEALTH,biofilm-mediated multidrug resistance,biofilm-mediated multidrug resistance
NEW10341,NUTRITION,phospholipid degrade enzyme,phospholipid degrading enzymes
NEW10342,DISEASE,p. aeruginosa biofilm,P. aeruginosa biofilms
D002772,DISEASE,Cholera Toxin,"Cholera Toxin A|Cholera Enterotoxin CT|Toxin, Cholera|Toxin A, Cholera|Enterotoxin CT, Cholera|Cholera Toxin Subunit B|Choleragenoid|Toxin B|Procholeragenoid|Cholera Toxin Protomer A|Cholera Toxin A Subunit|Cholera Exotoxin|Cholera Toxin B|Cholera Toxin Protomer B|Choleragen|Toxin B, Cholera|Cholera Toxin Subunit A|Cholera Toxin B Subunit|Exotoxin, Cholera|TcdB"
NEW10343,BIOCHEMICAL,major virulence factor,major virulence factors
NEW10344,CHEMICAL,abnormal dopamine signalling,abnormal dopamine signalling
NEW10345,CHEMICAL,cannabis oil,cannabis oil
NEW10346,DISEASE,test formalin pain assay,test formalin pain assay
NEW10348,MENTAL_HEALTH,maximal analgesia,maximal analgesia
NEW10350,CHEMICAL,high csf hva concentration,higher CSF HVA concentrations
NEW10352,DISEASE,psychotic-like schizotypal symptom,psychotic-like schizotypal symptoms
NEW10353,CHEMICAL,leucine degradation pathway,leucine degradation pathway
C536297,DISEASE,Male sterility due to Y-chromosome deletions [Supplementary Concept],"Chromosome Deletion|Sex Chromosome Disorders of Sex Development|Infertility, Male|Chromosomes, Human, Y|microdeletions|Sex Chromosome Aberrations"
NEW10360,DISEASE,violent antisocial personality,violent antisocial personality
NEW10363,NUTRITION,high phospholipid dgla value,high phospholipid DGLA values
NEW10365,DISEASE,male homicidal offender,male homicidal offenders
NEW10369,CHEMICAL,peak oxygen consumption,peak oxygen consumption|VO2
NEW10370,CHEMICAL,impaired glucose utilization,impaired glucose utilization
NEW10371,DISEASE,central anomaly,central anomalies
NEW10373,DISEASE,m. arenaria,M. arenaria
NEW10377,MENTAL_HEALTH,resistance reduction,resistance reduction
NEW10379,DISEASE,intense axial dyskinetic symptom,intense axial dyskinetic symptoms
NEW10381,BIOCHEMICAL,palliative androgen deprivation therapy,palliative androgen deprivation therapy
NEW10382,DISEASE,mood disturbance,mood disturbances
NEW10383,DISEASE,ejaculation disorder,ejaculation disorder
http://purl.obolibrary.org/obo/MFOMD_0000083,DISEASE,orgasmic disorder,orgasm disorders
NEW10385,DISEASE,hemorrhage shock,hemorrhage shock
D000069463,DISEASE,Olive Oil,"Oils, Olive|olive oil|Oil, Olive|ROO|Olive Oils"
NEW10388,CHEMICAL,high oleic- sunflower oil,high oleic- sunflower oil
D012715,CHEMICAL,Sesame Oil,"sesame oil|Oils, Sesame|Oil, Sesame|Sesame Oils"
NEW10390,DISEASE,seasonal allergy,seasonal allergies
NEW10391,MENTAL_HEALTH,hyperactivity inducing property,hyperactivity inducing properties
NEW10392,MENTAL_HEALTH,haloperidol-induced orofacial dyskinesia,haloperidol-induced orofacial dyskinesia
NEW10395,DISEASE,rtt pathology,RTT pathology
NEW10397,DISEASE,experimental glaucoma model,experimental glaucoma models
D058625,DISEASE,End Stage Liver Disease,"Chronic Liver Failure|Liver Failure, Chronic|end-stage liver disease|Failure, Chronic Liver|Failures, Chronic Liver|Liver Failures, Chronic|Chronic Liver Failures"
NEW10399,CHEMICAL,arginine vasopressin production,arginine vasopressin production
NEW10400,DISEASE,euvolemic hyponatremia due,euvolemic hyponatremia due
NEW10401,CHEMICAL,800-mg dose,800-mg dose
D009169,CHEMICAL,Mycobacterium tuberculosis,Mycobacterium tuberculosis|Mycobacterium tuberculosis H37Rv
NEW10405,CHEMICAL,err2510337-err2510445,ERR2510337-ERR2510445
NEW10406,CHEMICAL,BioSample prjeb32684,BioSample PRJEB32684
NEW10408,CHEMICAL,intravenous lorazepam,intravenous lorazepam
NEW10411,MENTAL_HEALTH,background anxiety,background anxiety
NEW10414,MENTAL_HEALTH,photoactivate defense mechanism,photoactivated defense mechanism
D002928,CHEMICAL,Cinanserin,"Cinanserin Monohydrochloride|SQ 16,167|cinanserin|SQ16,167|SQ10,643|Cinanserin Hydrochloride|Hydrochloride, Cinanserin|SQ-16,167|SQ-10,643|Monohydrochloride, Cinanserin|SQ 10,643"
NEW10415,CHEMICAL,serotonin synthesis inhibition,serotonin synthesis inhibition|PCPA
NEW10416,CHEMICAL,serotonin nerve terminal damage,"5,6-dihydroxytryptamine|serotonin nerve terminal damage"
D057645,DISEASE,Deltoid Muscle,"Deltoid Muscles|muscle|Muscles, Deltoid|Muscle, Deltoid"
D020159,DISEASE,Citrullinemia,"Citrullinemia, Type I|Late-Onset Citrullinemia|Deficiency, Argininosuccinic Acid Synthetase, Partial|ASS Deficiency|Classic Citrullinemia|Citrullinemia, Classical|Citrullinurias|Partial Argininosuccinic Acid Synthetase Deficiency Disease|Argininosuccinic Acid Synthetase Deficiency|Citrullinemia 1|Type I Citrullinemia|Citrullinemia, Late Onset|Argininosuccinic Acid Synthase Deficiency Disease|Complete Argininosuccinic Acid Synthetase Deficiency Disease|Deficiency Disease, Argininosuccinate Synthase|ASS Deficiencies|Deficiencies, Argininosuccinate Synthetase|Deficiency Disease, Argininosuccinic Acid Synthase|Citrullinemia, Late-Onset|Classical Citrullinemias|Argininosuccinic Acid Synthetase Deficiency, Complete|Argininosuccinate Synthetase Deficiencies|Argininosuccinate Synthase Deficiency Disease|Deficiency, Argininosuccinic Acid Synthetase, Complete|Argininosuccinic Acid Synthetase Deficiency Disease|Argininosuccinic Acid Synthetase Deficiency Disease, Partial|Citrullinemias|Deficiency, Argininosuccinate Synthetase|Type I Citrullinemias|Neonatal Citrullinemia|Citrullinemias, Classic|Citrullinuria|Argininosuccinate Synthetase Deficiency|Citrullinemia Type 1|Citrullinemia, Classic|Citrullinemia, Neonatal|Classical Citrullinemia|citrullinemia|Classic Citrullinemias|Late-Onset Citrullinemias|Neonatal Citrullinemias|Deficiency, ASS"
NEW10417,CHEMICAL,urea cycle balance,urea cycle balance
NEW10419,DISEASE,related leg movement,related leg movements
NEW10420,DISEASE,mild sleep improvement,mild sleep improvements
NEW10424,DISEASE,mcd reaction,MCD reactions
NEW10425,DISEASE,coronary vasodilation,coronary vasodilation|MCD
NEW10428,DISEASE,various stress-mediated disease,various stress-mediated diseases
NEW10430,CHEMICAL,excessive lactate formation,excessive lactate formation
NEW10431,NUTRITION,possible thiamine deficiency,possible thiamine deficiency
NEW10432,CHEMICAL,ethanol ingestion,ethanol ingestion
D019343,CHEMICAL,Citric Acid,"Citric Acid Monohydrate|Citrate|Uralyt U|Anhydrous Citric Acid|citric acid|Citric Acid, Anhydrous"
NEW10434,MENTAL_HEALTH,adhd development,ADHD development
NEW10437,MENTAL_HEALTH,supplement non-compliance precipitated psychosis,supplement non-compliance precipitated psychosis
NEW10438,CHEMICAL,calcium supplement,calcium supplement
NEW10439,DISEASE,postsurgical hypoparathyroidism,postsurgical hypoparathyroidism
NEW10440,NUTRITION,functional folate deficiency,functional folate deficiency
NEW10442,CHEMICAL,poor antidepressant response,poor antidepressant response
NEW10445,DISEASE,cholestatic liver insult,cholestatic liver insults
NEW10446,CHEMICAL,high cingulate myo-inositol/creatine-phosphocreatine measurement,higher cingulate myo-inositol/creatine-phosphocreatine measurements
NEW10448,MENTAL_HEALTH,amnesia treatment,amnesia treatment
NEW10450,CHEMICAL,no synthesis activity,NO synthesis activity
NEW10453,CHEMICAL,physiological no function,physiological NO functions
NEW10454,MENTAL_HEALTH,brain insulin resistance,brain insulin resistance
NEW10455,CHEMICAL,increase renal glucose reabsorption,increased renal glucose reabsorption
NEW10456,CHEMICAL,glucagon secretion,glucagon secretion
NEW10458,CHEMICAL,play-leisure,play-leisure
NEW10459,DISEASE,associate asd symptom,associated ASD symptoms
NEW10461,NUTRITION,displace native white-spotted charr salvelinus leucomaeni,displaced native white-spotted charr Salvelinus leucomaenis
NEW10462,CHEMICAL,erosion-control dam,erosion-control dam
NEW10463,MENTAL_HEALTH,habitat fragmentation,habitat fragmentation
NEW10465,CHEMICAL,a steroidal lactone,A steroidal lactone
http://purl.obolibrary.org/obo/DOID_1289,DISEASE,neurodegenerative disease,late-onset neurodegenerative disease|Neurodegenerative disease|degenerative disease
NEW10468,DISEASE,cardiovascular-related disease,cardiovascular-related diseases
NEW10470,DISEASE,loop gain,loop gain
D006410,DISEASE,Hematopoiesis,"Hematopoiesis, Medullary|haematopoiesis|Haematopoiesis|Medullary Hematopoiesis"
D012084,CHEMICAL,Renin-Angiotensin System,"System, Renin-Angiotensin-Aldosterone|Renin-Angiotensin-Aldosterone System|Renin Angiotensin Aldosterone System|renin-angiotensin aldosterone system|Renin Angiotensin System|System, Renin-Angiotensin"
NEW10471,MENTAL_HEALTH,alzheimer 's dementia,Alzheimer's dementia
D007252,CHEMICAL,Influenza Vaccines,"Universal Influenza Vaccine|Influenza Vaccines, Monovalent|Influenza Virus Vaccines|Vaccine, Influenza|High Dose Trivalent Influenza Vaccine|Universal Flu Vaccine|Vaccine, LAIV|Vaccine, Flu|high-dose|Influenza Virus Vaccine|Universal Influenza Vaccines|High-Dose Trivalent Influenza Vaccine|LAIV Vaccine|Flu Vaccines|Vaccines, Monovalent Influenza|Trivalent Live Attenuated Influenza Vaccine|Influenza Vaccine|Trivalent Influenza Vaccine|Flu Vaccine|Vaccine, Trivalent Influenza|Flu Vaccine, Universal|Influenza Vaccine, Monovalent|Vaccine, Universal Influenza|Vaccine, Influenza Virus|Universal Flu Vaccines|Influenzavirus Vaccines|Intranasal Live Attenuated Influenza Vaccine|Monovalent Influenza Vaccine|Influenza Vaccine, Trivalent|Influenza Vaccine, Universal|Virus Vaccine, Influenza|Influenzavirus Vaccine|Vaccine, Monovalent Influenza|Influenza Vaccine, Quadrivalent|Monovalent Influenza Vaccines|Quadrivalent Influenza Vaccine|Intranasal Live-Attenuated Influenza Vaccine|Vaccine, Quadrivalent Influenza|Vaccine, Influenzavirus|Vaccine, Universal Flu"
NEW10472,CHEMICAL,methotrexate mtx chemotherapy,methotrexate MTX chemotherapy
NEW10473,BIOCHEMICAL,leucovorin lv rescue,leucovorin LV rescue
http://purl.obolibrary.org/obo/DOID_10608,DISEASE,celiac disease,coeliac disease|idiopathic steatorrhea|celiac sprue
NEW10475,MENTAL_HEALTH,intestinal infantilism syndrome,intestinal infantilism syndrome
NEW10476,CHEMICAL,contextual fear conditioning,CFC|contextual fear conditioning
NEW10478,CHEMICAL,antidepressant effect subsequent,antidepressant effects subsequent
NEW10480,CHEMICAL,GlaxoSmithKline,GlaxoSmithKline
NEW10481,DISEASE,h1n1 vaccine manufactured,H1N1 vaccine manufactured
NEW10482,CHEMICAL,l-dopa treatment,L-DOPA treatment
NEW10485,DISEASE,mptp-induced parkinsonian monkey,MPTP-induced parkinsonian monkeys
C000719955,NUTRITION,Odocoileus virginianus [Supplementary Concept],white-tailed deer|Deer
NEW10488,DISEASE,lv mass,LV mass
NEW10492,NUTRITION,large yellow croaker,large yellow croaker
NEW10494,MENTAL_HEALTH,frog retinotectal projection role,frog retinotectal projection role
NEW10496,DISEASE,retinal arbor,retinal arbors
NEW10498,DISEASE,minimal toxicity,minimal toxicity
NEW10499,DISEASE,psychosis-like behaviour,psychosis-like behaviour
NEW10502,MENTAL_HEALTH,acute alcoholic psychosis,acute alcoholic psychosis
NEW10507,CHEMICAL,alternative to sodium oxybate,SXB|alternative to sodium oxybate
NEW10508,BIOCHEMICAL,dysfunctional beta fatty acid oxidation pathway,dysfunctional beta fatty acid oxidation pathway
NEW10515,DISEASE,bile acid resin,bile acid resins
NEW10517,DISEASE,cholestatic itch,cholestatic itch
NEW10519,CHEMICAL,pyrrolidine ring,pyrrolidine ring
NEW10521,BIOCHEMICAL,agonist radioligand,agonist radioligand
NEW10522,CHEMICAL,[(125)I]N(6)-(4-amino-3-iodobenzyl)-5'-N-methylcarboxamidoadenosine,[(125)I]N(6)-(4-amino-3-iodobenzyl)-5'-N-methylcarboxamidoadenosine
NEW10526,DISEASE,hypertensive postmenopausal woman,hypertensive postmenopausal women
NEW10527,CHEMICAL,levodopa medication,levodopa medications
NEW10530,CHEMICAL,phenibut consumption,phenibut consumption
NEW10531,DISEASE,oligomeric αsyn-induced damage,oligomeric αSyn-induced damage
NEW10532,DISEASE,pd/lbd,PD/LBD
NEW10533,DISEASE,αsyn-induced synaptic spine loss,αSyn-induced synaptic spine loss
NEW10535,MENTAL_HEALTH,chronic alcohol dependence,chronic alcohol dependence
NEW10536,DISEASE,adjuvant stroke treatment,adjuvant stroke treatment
NEW10537,DISEASE,rat ptsd model,rat PTSD model
NEW10539,DISEASE,48h memory retention,48h memory retention
NEW10540,DISEASE,traumatic memory enhancement,traumatic memory enhancement
NEW10541,BIOCHEMICAL,phase drug,Phase drug
C053387,DISEASE,endoplasmin [Supplementary Concept],tumor rejection|Membrane Glycoproteins
NEW10543,DISEASE,exquisite tumor specificity,exquisite tumor specificity
NEW10544,CHEMICAL,atp production,ATP production
NEW10545,DISEASE,mitochondrial damage,mitochondrial damage
NEW10547,DISEASE,post exertional malaise,post exertional malaise
D003072,DISEASE,Cognition Disorders,"cognition|Disorders, Cognition|Overinclusion|Disorder, Cognition"
NEW10549,DISEASE,acute gastrointestinal distress,acute gastrointestinal distress
NEW10551,DISEASE,autism-like behavior,autism-like behaviors
NEW10553,DISEASE,rapid bone loss,rapid bone loss
NEW10554,DISEASE,net bone loss,net bone loss
D001997,DISEASE,Bronchopulmonary Dysplasia,"Dysplasia, Bronchopulmonary|bronchopulmonary dysplasia"
NEW10557,MENTAL_HEALTH,dna fragmentation intensity,DNA fragmentation intensity
NEW10558,DISEASE,epilepsy bipolar disorder,epilepsy bipolar disorder
NEW10559,DISEASE,atherosclerosis model,atherosclerosis model
NEW10560,DISEASE,atherosclerosis in-stent restenosis,atherosclerosis in-stent restenosis
NEW10562,DISEASE,disorder risk,disorder risk
NEW10565,DISEASE,functional abnormality,functional abnormalities
NEW10568,CHEMICAL,abnormal d-serine metabolism,abnormal D-serine metabolism
NEW10571,CHEMICAL,tbi+ptsd,TBI+PTSD
NEW10572,DISEASE,tbi group,TBI groups
NEW10574,CHEMICAL,protein-pfas pair,protein-PFAS pairs
NEW10577,BIOCHEMICAL,ppar target gene,PPAR target genes
NEW10579,MENTAL_HEALTH,quantitative microcomplement fixation test,quantitative microcomplement fixation tests
NEW10582,CHEMICAL,pic/quin ratio,PIC/QUIN ratio
NEW10584,CHEMICAL,increase csf quin,increased CSF QUIN
NEW10585,DISEASE,tooth chatter,teeth chattering
NEW10586,DISEASE,penis lick,penis licking
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Acute_Schizophrenia,MENTAL_HEALTH,acute schizophrenia,acute schizophrenia
D005475,CHEMICAL,Flupenthixol,flupenthixol|cis-Flupenthixol|Flupentixol|Emergil|Fluanxol|alpha-Flupenthixol
NEW10588,DISEASE,acute schizophrenic illness,acute schizophrenic illnesses
NEW10590,MENTAL_HEALTH,crave time,craving time
NEW10593,DISEASE,hyperammonemic rat,hyperammonemic rats
NEW10594,MENTAL_HEALTH,cancer-related fatigue,cancer-related fatigue
D050900,CHEMICAL,Ferredoxin-Nitrite Reductase,"nitrite|Reductase, Ferredoxin-Nitrite|Ferredoxin Nitrite Reductase"
NEW10596,BIOCHEMICAL,specific drug treatment,specific drug treatment
NEW10597,MENTAL_HEALTH,temporary organic mental disorder,temporary organic mental disorder
NEW10598,MENTAL_HEALTH,alcohol dependence treatment,alcohol dependence treatment
NEW10602,MENTAL_HEALTH,dementia-related psychosis,dementia-related psychosis
NEW10603,DISEASE,ethanol developmental neurotoxicity,ethanol developmental neurotoxicity
NEW10604,NUTRITION,mitochondrial phospholipid cardiolipin,mitochondrial phospholipid cardiolipin
NEW10607,NUTRITION,alginate coat insulin-loaded yeast microcapsule,alginate coated insulin-loaded yeast microcapsule
NEW10609,DISEASE,overdose death,overdose death
NEW10610,DISEASE,criminal justice sample,criminal justice sample
NEW10611,CHEMICAL,reduce intracellular glutathione level,reduced intracellular glutathione levels
NEW10613,CHEMICAL,glutamate decarboxylase,glutamate decarboxylases
NEW10615,DISEASE,autistic cerebellum,autistic cerebellum
NEW10617,MENTAL_HEALTH,sleep-onset insomnia,sleep-onset insomnia
NEW10620,DISEASE,lorazepam-dependent rat,lorazepam-dependent rats
NEW10621,DISEASE,hyperaggression,hyperaggression
C485926,DISEASE,"COMMD5 protein, human [Supplementary Concept]","hypertension related|Nuclear Proteins|Adaptor Proteins, Signal Transducing"
NEW10625,DISEASE,jaw-opening dystonia,jaw-opening dystonia
NEW10626,CHEMICAL,persistent high methotrexate plasmatic level,persistent high methotrexate plasmatic levels
NEW10628,NUTRITION,anthocyanin biosynthesis,anthocyanin biosynthesis
NEW10633,CHEMICAL,intravenous cocaine,intravenous cocaine
NEW10634,CHEMICAL,ester nitric oxide synthase inhibitor,ester nitric oxide synthase inhibitor
NEW10635,CHEMICAL,"6-anilino-5,8-quinolinedione guanylate cyclase inhibitor","6-anilino-5,8-quinolinedione guanylate cyclase inhibitor"
NEW10636,CHEMICAL,thiopental/miconazole,thiopental/miconazole
NEW10637,CHEMICAL,indomethacin cyclo-oxygenase inhibitor,indomethacin cyclo-oxygenase inhibitor
D045462,CHEMICAL,Endothelium-Dependent Relaxing Factors,"Endothelium-Derived Relaxant Factor|Relaxant Factor, Neutrophil-Derived|Endothelium Dependent Vasodilators|Relaxing Factors, Endothelium-Dependent|Vasodilators, Endothelium-Dependent|Endothelium-Dependent Relaxing Factor|Endothelium-Derived Relaxing Factor|Endothelium Derived Relaxing Factor|Neutrophil Derived Relaxant Factor|Endothelium Dependent Relaxing Factor|Endothelium-Dependent Vasodilators|Neutrophil-Derived Relaxant Factor|Endothelium Derived Relaxant Factor|Endothelium Dependent Relaxing Factors|Factor, Neutrophil-Derived Relaxant|Relaxing Factor, Endothelium-Derived|Relaxant Factor, Endothelium-Derived|endothelium-dependent|Relaxing Factor, Endothelium-Dependent"
NEW10638,CHEMICAL,high n-6:n-3 fa ratio,higher n-6:n-3 FA ratios
NEW10639,CHEMICAL,low n-3 fa level,lower n-3 FA levels
NEW10641,DISEASE,secondary adrenal insufficiency,secondary adrenal insufficiency
NEW10642,DISEASE,cerebral insult,cerebral insults
C012509,CHEMICAL,propineb [Supplementary Concept],propineb|Zineb/analogs  and  derivatives
D008724,CHEMICAL,Methomyl,Lannate 20|Lannate|methomyl
D007559,CHEMICAL,Ivermectin,Ivomec|Mectizan|MK-933|MK 933|Eqvalan|Stromectol|MK933|ivermectin
NEW10644,CHEMICAL,ivermectin-diethylcarbamazine,ivermectin-diethylcarbamazine
D002235,CHEMICAL,Carbofuran,Bayer 70143|NIA 10242|NIA-10242|carbofuran|Furadan|NIA10242
D000072316,CHEMICAL,Dioxins and Dioxin-like Compounds,dioxin|Dioxins and Dioxin like Compounds
NEW10645,BIOCHEMICAL,fungicide combination,fungicide combination
NEW10649,DISEASE,acute bacterial sinusitis,acute bacterial sinusitis
NEW10651,CHEMICAL,alcohol withdrawal reaction,alcohol withdrawal reaction
NEW10653,CHEMICAL,heavy alcohol,heavy alcohol
NEW10654,DISEASE,disorder-related behavior,disorder-related behaviors
NEW10655,CHEMICAL,3.0 7.4,3.0 7.4
NEW10656,CHEMICAL,dmpc acyl chain,DMPC acyl chains
NEW10657,MENTAL_HEALTH,orientation order,orientation order
NEW10658,NUTRITION,phospholipid bilayer,phospholipid bilayer
NEW10662,BIOCHEMICAL,antifungal medicine,antifungal medicine
NEW10665,CHEMICAL,increase lactate dehydrogenase,increased lactate dehydrogenase
NEW10666,DISEASE,tumor necrosis factor (tnf)-alpha,tumor necrosis factor (TNF)-alpha
D053475,CHEMICAL,Receptor-Interacting Protein Serine-Threonine Kinase 2,RIPK2 Protein|CARD-containing Interleukin (IL)-1 beta Converting Enzyme|CARDIAK|interleukin (IL)-1|Receptor Interacting Serine Threonine Kinase 2|RICK Protein|Receptor Interacting Protein Serine Threonine Kinase 2|Receptor-Interacting Serine-Threonine Kinase 2
NEW10669,BIOCHEMICAL,drug craving,drug craving
C501919,DISEASE,"alpha-amylase, Bacillus licheniformis [Supplementary Concept]",B. licheniformis|alpha-Amylases
NEW10671,DISEASE,lactobacillus spp,Lactobacillus spp
NEW10674,CHEMICAL,mu mutagenesis,Mu mutagenesis
NEW10676,MENTAL_HEALTH,pica promoter,picA promoter
NEW10677,NUTRITION,cholesterol absorption inhibitor,cholesterol absorption inhibitors
NEW10679,DISEASE,lipid abnormality,lipid abnormalities
NEW10681,BIOCHEMICAL,orexigenic hormone ghrelin,orexigenic hormone ghrelin
D018376,DISEASE,Cardiovascular Abnormalities,"Cardiovascular Abnormality|Abnormalities, Cardiovascular|cardiovascular abnormalities|Abnormality, Cardiovascular"
NEW10683,MENTAL_HEALTH,opiate abstinence syndrome,opiates abstinence syndrome
NEW10684,NUTRITION,phospholipid efflux,phospholipid efflux
NEW10685,DISEASE,pathologic defect,pathologic defects
D047868,DISEASE,Pulmonary Sclerosing Hemangioma,"Sclerosing Hemangioma, Lung|Sclerosing Hemangioma, Pulmonary|Sclerosing Hemangiomas, Lung|Pulmonary Sclerosing Hemangiomas|Lung Sclerosing Hemangiomas|Sclerosing Hemangioma of the Lung|hemangioma|Sclerosing Hemangiomas, Pulmonary|Lung Sclerosing Hemangioma|Hemangioma, Sclerosing, Pulmonary"
NEW10691,DISEASE,corneal neo-vascularisation phenotype,corneal neo-vascularisation phenotype
NEW04809,DISEASE,impaired neurogenesis,impaired neurogenesis
NEW10694,DISEASE,transgenic ad mouse,transgenic AD mice
NEW10696,CHEMICAL,° c condition,° C conditions
NEW10699,DISEASE,migraine preventive,migraine preventives
D000550,DISEASE,Amblyopia,"Eyes, Lazy|Amblyopia, Anisometropic|Deprivation-Induced Amblyopias, Stimulus|Deprivation-Induced Amblyopia, Stimulus|Stimulus Deprivation Induced Amblyopia|Amblyopias|Stimulus Deprivation-Induced Amblyopias|Anisometropic Amblyopias|Amblyopia, Stimulus Deprivation-Induced|Developmental Amblyopia|Lazy Eye|Amblyopias, Anisometropic|Amblyopia, Developmental|Suppression Amblyopia|Amblyopias, Developmental|Lazy Eyes|Developmental Amblyopias|Amblyopias, Stimulus Deprivation-Induced|Eye, Lazy|Amblyopias, Suppression|Anisometropic Amblyopia|Amblyopia, Stimulus Deprivation Induced|amblyopia|Amblyopia, Suppression|Suppression Amblyopias|Stimulus Deprivation-Induced Amblyopia"
NEW10701,DISEASE,control paralysis,controlled paralysis
NEW10702,DISEASE,common strabismus syndrome,common strabismus syndromes
NEW10703,CHEMICAL,mg/d oral imipramine,mg/d oral Imipramine
NEW10704,MENTAL_HEALTH,21-item Hamilton Depression rating scale,21-item Hamilton Depression Rating Scale
NEW10705,CHEMICAL,150 mg/d oral imipramine,150 mg/d oral Imipramine|IMI
NEW10708,DISEASE,fatal overdose,fatal overdose
NEW10710,MENTAL_HEALTH,severe acquire respiratory syndrome,severe acquired respiratory syndromes
http://purl.org/sig/ont/fma/fma74643,BIOCHEMICAL,melanocyte-stimulating hormone,MSH|adrenocorticotropin hormone
NEW10712,CHEMICAL,supraphysiological steroid treatment,supraphysiological steroid treatment
NEW10715,DISEASE,cholangiopathy fibrosis,cholangiopathy fibrosis
D008105,DISEASE,"Liver Cirrhosis, Biliary","Liver Cirrhoses, Biliary|Primary Biliary Cholangitis|Biliary Cholangitides, Primary|Primary Biliary Cirrhosis|primary biliary cholangitis|Secondary Biliary Cholangitides|Cholangitis, Chronic Nonsuppurative Destructive|Biliary Cholangitis, Primary|Obstructive Liver Cirrhosis|Secondary Biliary Cirrhosis|Cholangitides, Primary Biliary|Biliary Cirrhosis, Secondary|Cirrhosis, Biliary|Cholangitis, Primary Biliary|Liver Cirrhosis, Obstructive|Biliary Cholangitis, Secondary|Primary Biliary Cholangitides|Secondary Biliary Cholangitis|Biliary Cirrhosis|Cirrhosis, Secondary Biliary|Biliary Cirrhosis, Primary, 1|Biliary Cirrhosis, Primary|Cholangitis, Secondary Biliary"
NEW10717,CHEMICAL,second-line treatment,second-line treatment
NEW10718,CHEMICAL,oral norepinephrine precursor droxidopa,oral norepinephrine precursor droxidopa
http://purl.obolibrary.org/obo/SYMP_0000030,DISEASE,paralysis,Aβ-induced paralysis
NEW10721,DISEASE,bioenergetic defect,bioenergetic defects
NEW10722,MENTAL_HEALTH,mitochondrial fragmentation,mitochondrial fragmentation
NEW10724,MENTAL_HEALTH,ms fragmentation spectrum,MS fragmentation spectra
NEW10725,CHEMICAL,gsh marker,GSH markers
NEW10726,DISEASE,target mitochondria dysfunction,targets mitochondria dysfunction
D005739,DISEASE,Gas Poisoning,"Poisoning, Gas|Poisonings, Gas|Gas Poisonings|gas poisoning"
NEW10727,DISEASE,androgen-mediated cutaneous disorder,androgen-mediated cutaneous disorders
NEW10728,CHEMICAL,optimum anticoccidial activity,optimum anticoccidial activity|POAA
NEW10729,CHEMICAL,his(55,His(55
NEW10730,CHEMICAL,thr(254,Thr(254
NEW10732,DISEASE,physical dependence,physical dependence
NEW10733,BIOCHEMICAL,adrenal androgen production,adrenal androgen production
NEW10734,CHEMICAL,zr development,ZR development
NEW10736,DISEASE,sexual pubic hair,sexual pubic hair|pubarche
NEW10738,DISEASE,associate behavioral disorder,associated behavioral disorders
NEW10741,NUTRITION,fish cell line,fish cell line
NEW10744,CHEMICAL,ryr2(p/s,RyR2(p/s
NEW10747,CHEMICAL,alveolar epithelial na,alveolar epithelial Na
NEW10751,CHEMICAL,n-methyl-d-aspartate nmda receptor activation,N-methyl-D-aspartate NMDA receptor activation
NEW10752,CHEMICAL,high-dose multivitamin,high-dose multivitamins
NEW10754,MENTAL_HEALTH,severe treatment-resistant depression,severe treatment-resistant depression
NEW10757,MENTAL_HEALTH,desiccation resistance,desiccation resistance
NEW10759,CHEMICAL,d2-like receptor antagonist sulpiride,D2-like receptor antagonist sulpiride
NEW10763,DISEASE,high toxicity,high toxicity
NEW10764,DISEASE,severe hypercortisolism,severe hypercortisolism
NEW10766,CHEMICAL,intracellular zn2,intracellular Zn2
NEW10768,DISEASE,lamotrigine sjs,lamotrigine SJS
NEW10769,CHEMICAL,phenyltriazine class,phenyltriazine class
D000067401,CHEMICAL,Blood Alcohol Content,"Blood Alcohol Concentration|Alcohol Concentration, Blood|Concentration, Blood Alcohol|Content, Blood Alcohol|Alcohol Content, Blood|% blood alcohol concentration|Level, Blood Alcohol|Blood Alcohol Level|Alcohol Level, Blood"
NEW10770,CHEMICAL,ethanol intoxication,ethanol intoxication
D007521,CHEMICAL,Isocitrate Dehydrogenase,"Dehydrogenase, Isocitrate|Isocitrate Dehydrogenase, NAD|Isocitrate Dehydrogenase (NAD+)|NAD Isocitrate Dehydrogenase|Dehydrogenase, NAD Isocitrate|isocitrate dehydrogenase|Isocitrate Dehydrogenase I|Isocitrate Dehydrogenase-I"
NEW10771,DISEASE,idh-mutant glioma,IDH-mutant gliomas
NEW10774,CHEMICAL,nalac response,NaLac response
NEW10776,DISEASE,panic-like state,panic-like state
NEW10777,CHEMICAL,nalac-induced panic-like behavior,NaLac-induced panic-like behaviors
NEW10779,DISEASE,cardiovascular tachycardia response,cardiovascular tachycardia responses
NEW10780,CHEMICAL,nalac-induced panic-like cardiovascular,NaLac-induced panic-like cardiovascular
NEW10784,CHEMICAL,serum nitrite level,serum nitrite levels
NEW10785,DISEASE,l-methionine-induced endothelial dysfunction,L-methionine-induced endothelial dysfunction
NEW10788,DISEASE,immune-mediated disorder,immune-mediated disorders
NEW10790,BIOCHEMICAL,parathyroid hormone deficiency,parathyroid hormone deficiency
NEW10792,DISEASE,affective disease,affective disease
NEW10793,CHEMICAL,thyrotropin (tsh)-releasing hormone test,thyrotropin (TSH)-releasing hormone test
NEW10798,BIOCHEMICAL,narcotic analgesic support,narcotic analgesic support
NEW10799,CHEMICAL,thyroxine level,thyroxine levels
NEW10800,DISEASE,muscle mass breakdown,muscle mass breakdown
NEW10801,DISEASE,depressed ambulatory outpatient,depressed ambulatory outpatients
D006502,DISEASE,Budd-Chiari Syndrome,"Hepatic Venous Outflow Obstruction|Chiaris Syndrome|Thrombosis, Hepatic Vein|Thromboses, Hepatic Vein|Budd-Chiari Syndrome|Hepatic Vein Thromboses|Vein Thromboses, Hepatic|Chiari Syndrome|Vein Thrombosis, Hepatic|Chiari's Syndrome|Budd Chiari Syndrome|Hepatic Vein Thrombosis"
NEW10802,DISEASE,formalin-induced nociceptive behavior,formalin-induced nociceptive behavior
NEW10804,DISEASE,vacc dysfunction,vACC dysfunction
NEW10806,BIOCHEMICAL,antipanic drug efficacy,antipanic drug efficacy
NEW10807,BIOCHEMICAL,human drug use,human drug use
NEW10813,CHEMICAL,calcium precipitation,calcium precipitation
NEW10817,DISEASE,vdbt patient,VDBT patients
NEW10818,DISEASE,binswanger type vascular dementia,VDBT|Binswanger type vascular dementia
NEW10821,DISEASE,high-modulus property,high-modulus properties
D000078789,BIOCHEMICAL,Polyacetylene Polymer,"polymer|Polymer, Polyacetylene|Polyacetylene Polymers|Polyacetylene|Polymers, Polyacetylene"
NEW10825,DISEASE,similar neurotoxicity profile,similar neurotoxicity profile
NEW10827,DISEASE,androgen-independent prostate cancer,androgen-independent prostate cancer
NEW10829,DISEASE,cums rat,CUMS rats
NEW10831,BIOCHEMICAL,corticotrophin-releasing hormone protein level,corticotrophin-releasing hormone protein level
NEW10832,CHEMICAL,reduce serum corticosterone level,reduced serum corticosterone level
NEW10833,DISEASE,hippocampal neuronal deficit,hippocampal neuronal deficits
NEW10834,DISEASE,dyskinesia-like abnormal involuntary movement,dyskinesia-like abnormal involuntary movements
NEW10836,CHEMICAL,l-dopa injection,L-DOPA injection
NEW10837,DISEASE,l-dopa-induced dyskinesia-model rat,L-DOPA-induced dyskinesia-model rats
NEW10838,CHEMICAL,l-dopa dosing,L-DOPA dosing
NEW10839,CHEMICAL,excessive gaba storage,excessive GABA storage
NEW10842,BIOCHEMICAL,nicotinic agonist drug,nicotinic agonist drugs
NEW10844,DISEASE,ar-positive prostate cancer cell line,AR-positive prostate cancer cell lines
NEW10845,CHEMICAL,atp content,ATP content
NEW10846,DISEASE,toxin-induced excruciate pain,toxin-induced excruciating pain
NEW10848,CHEMICAL,production profile,production profiles
D065851,DISEASE,Ovarian Reserve,"Ovarian Reserves|ovarian|Reserve, Ovarian|Reserves, Ovarian"
D001749,DISEASE,Urinary Bladder Neoplasms,"bladder cancer|Urinary Bladder Neoplasm|Bladder Neoplasm|Bladder Tumor|Tumors, Bladder|Bladder Cancer|Bladder Tumors|Cancer of the Bladder|Tumor, Bladder|Malignant Tumor of Urinary Bladder|Neoplasm, Urinary Bladder|Cancer, Urinary Bladder|Bladder Neoplasms|Cancer of Bladder|Urinary Bladder Cancer|Cancer, Bladder|Neoplasms, Bladder|Neoplasm, Bladder|Bladder Cancers"
D051794,DISEASE,Von Hippel-Lindau Tumor Suppressor Protein,Von Hippel Lindau Tumor Suppressor Protein|tumor suppressor|VHL Tumor Suppressor Protein
D019389,CHEMICAL,Cytochrome P-450 CYP2D6,"CYP2D6, Cytochrome P-450|Debrisoquine 4 Hydroxylase|Monooxygenase, Sparteine|4-Hydroxylase, Debrisoquine|Debrisoquine Hydroxylase|Debrisoquine 4 Monooxygenase|debrisoquine|Hydroxylase, Debrisoquine|Cytochrome P450 2D6|CYP 2D6|Cytochrome P 450 CYP2D6|Debrisoquine 4-Monooxygenase|Debrisoquine 4-Hydroxylase|P450 2D6, Cytochrome|2-Hydroxylase, Imipramine|4-Monooxygenase, Debrisoquine|Imipramine 2-Hydroxylase|CYP2D6|Imipramine 2 Hydroxylase|P-450 CYP2D6, Cytochrome|Sparteine Monooxygenase"
NEW10851,BIOCHEMICAL,genetic probe drug,genetic probe drug
C028653,CHEMICAL,2-hydroxydesipramine [Supplementary Concept],Desipramine/analogs  and  derivatives|2-hydroxydesipramine
NEW10852,DISEASE,sphincter spasm,sphincter spasm
NEW10854,MENTAL_HEALTH,hand amnesia,hand amnesia
NEW10857,DISEASE,anger level,anger levels
NEW10858,DISEASE,aggressive tendency,aggressive tendencies
NEW10862,DISEASE,silent pandemic,silent pandemic
NEW10864,MENTAL_HEALTH,somnolence risk,somnolence risk
NEW10867,CHEMICAL,camp signaling cascade,cAMP signaling cascades
NEW10868,MENTAL_HEALTH,local acupuncture analgesia,local acupuncture analgesia
NEW10870,CHEMICAL,adenosine a1 receptor activation,adenosine A1 receptor activation
NEW10873,NUTRITION,topical tocopherol,topical tocopherol
D064548,BIOCHEMICAL,Hand Sanitizers,"disinfectant|Hand Sanitizer|Sanitizer, Hand|Antiseptic, Hand|Disinfectant, Hand|Hand Antiseptic|Hand Disinfectant|Hand Antiseptics|Hand Disinfectants"
NEW10877,DISEASE,depressive process,depressive process
NEW10878,CHEMICAL,1l-1β,1L-1β
NEW10880,NUTRITION,insect pest,insect pests
NEW10881,DISEASE,impaired recognition memory,impaired recognition memory
NEW10882,BIOCHEMICAL,asymptomatic gene carrier,asymptomatic gene carriers
NEW10883,DISEASE,early cognitive deficit,early cognitive deficits
D019465,DISEASE,Craniofacial Abnormalities,"Abnormalities, Craniofacial|craniofacial abnormalities|Craniofacial Abnormality|Abnormality, Craniofacial"
NEW10891,CHEMICAL,ssri/snri,SSRI/SNRI
NEW10892,BIOCHEMICAL,c. jejuni drug resistance,C. jejuni drug resistance
NEW10893,BIOCHEMICAL,standard antibiotic,standard antibiotics
NEW10894,CHEMICAL,gaba type a receptor modulation,GABA type A receptor modulation
NEW10895,CHEMICAL,gtp gamma s great,GTP gamma S greater
D006165,CHEMICAL,Guanylyl Imidodiphosphate,"Guanyl 5' Imidodiphosphate|Guanosine 5'-(Beta,Gamma-Imido)Triphosphate|Imidodiphosphate, Guanylyl|Guanyl-5'-Imidodiphosphate|Gpp(NH)p|GPP(NH)P|GMP-PNP|GMP-P(NH)P|P(NH)PPG"
NEW10899,CHEMICAL,aflatoxin contamination,aflatoxin contamination
NEW10902,CHEMICAL,afb1 degradation,AFB1 degradation
NEW10904,CHEMICAL,crop aflatoxin contamination,crop aflatoxin contamination
NEW10906,DISEASE,peripheral nerve ending,peripheral nerve endings
NEW10907,DISEASE,erectile body,erectile bodies
NEW10910,MENTAL_HEALTH,persistent gender dysphoria,persistent gender dysphoria
NEW10914,MENTAL_HEALTH,moment orientation,moment orientation
NEW10918,DISEASE,facial tic,facial tics
NEW10920,BIOCHEMICAL,amyloid beta accumulation,amyloid beta accumulation
NEW10923,CHEMICAL,nitrate transport,nitrate transport
NEW10924,CHEMICAL,citrate cycle,citrate cycle
NEW10925,DISEASE,cerebrovascular inflammation,cerebrovascular inflammation
NEW10927,DISEASE,aneurysm dome,aneurysm dome
NEW10928,DISEASE,great stress/anxiety,greater stress/anxiety
NEW10929,MENTAL_HEALTH,less hyperarousal,less hyperarousal
NEW10930,CHEMICAL,wwh,WWH
NEW10932,MENTAL_HEALTH,crack cocaine dependence treatment,crack cocaine dependence treatment
NEW10934,CHEMICAL,low sphingomyelin level,low sphingomyelin levels
NEW10935,DISEASE,sporadic ad patient,sporadic AD patients
NEW10936,DISEASE,obesity risk factor,obesity risk factors
NEW10938,MENTAL_HEALTH,monoaminergic antidepressant-resistant mood disorder,monoaminergic antidepressant-resistant mood disorder
NEW10939,DISEASE,abdominal obesity lipid disorder,abdominal obesity lipids disorders
NEW10940,DISEASE,carbohydrate disorder,carbohydrates disorders
NEW10942,MENTAL_HEALTH,generalize acquire hypoactive sexual desire disorder,generalized acquired hypoactive sexual desire disorder
NEW10945,CHEMICAL,persistent alcohol imbibing,persistent alcohol imbibing
NEW10946,DISEASE,nerve damage,nerve damage
NEW10947,DISEASE,prolonged non-convulsive status epilepticus,prolonged non-convulsive status epilepticus|NCSE
NEW10949,MENTAL_HEALTH,patient-controlled analgesia device,patient-controlled analgesia device
D062788,DISEASE,Adenomyosis,Adenomyoses|adenomyosis
NEW10951,BIOCHEMICAL,endometrial estrogen agonist,endometrial estrogen agonist
NEW10953,DISEASE,hormone-sensitive diseaseand,hormone-sensitive diseaseand
NEW10955,CHEMICAL,impaired glucose metabolism,impaired glucose metabolism
NEW10957,MENTAL_HEALTH,meth-induced locomotor hyperactivity,METH-induced locomotor hyperactivity
D011969,CHEMICAL,"Receptors, Histamine H1","Receptors, H1|H1 receptors|H1 Receptors|Receptor, Histamine H1|Receptor, H1|H1 Receptor, Histamine|Histamine H1 Receptor|H1 Receptor|H1 Receptors, Histamine|Histamine H1 Receptors"
NEW10958,DISEASE,meth-induced abnormal behavior,METH-induced abnormal behaviors
NEW10959,DISEASE,asd-like behavioral change,ASD-like behavioral changes
http://purl.obolibrary.org/obo/DOID_8670,MENTAL_HEALTH,eating disorder,bulimic-spectrum eating disorders
NEW10963,MENTAL_HEALTH,pathological gambling severity,pathological gambling severity
NEW10965,DISEASE,key impulsivity function,key impulsivity function
NEW10969,NUTRITION,black raspberry,black raspberry
NEW10970,NUTRITION,red raspberry,red raspberry
D031985,NUTRITION,Fragaria,"Woodland Strawberries|Strawberries|Woodland Strawberry|Alpine Strawberry|Strawberries, Woodland|Strawberry|Strawberry, Alpine|Strawberry, Woodland|Fragaria vesca|Strawberries, Alpine|strawberry|Alpine Strawberries"
NEW10972,CHEMICAL,p225f,P225F
NEW10974,MENTAL_HEALTH,addition resistance,addition resistance
NEW10975,DISEASE,murine endotoxemia,murine endotoxemia
NEW10976,CHEMICAL,centrally-acting cholinergic drug galantamine,centrally-acting cholinergic drug galantamine
NEW10979,MENTAL_HEALTH,apparent drowsiness,apparent drowsiness
NEW10980,DISEASE,neck hyperextension,neck hyperextension
NEW10981,BIOCHEMICAL,a dose equivalent,A doses equivalent
NEW10983,MENTAL_HEALTH,related erectile dysfunction,related erectile dysfunction
NEW10984,DISEASE,select neurological disorder,selected neurological disorders
NEW10985,CHEMICAL,sativa plant,sativa plant
NEW10986,DISEASE,psychotic symptom due,psychotic symptoms due
D046730,DISEASE,"Colitis, Lymphocytic",colitis|Lymphocytic Colitis
NEW10988,BIOCHEMICAL,serotonin agonist medication,serotonin agonist medications
NEW10991,CHEMICAL,natural riboswitch regulatory ligand flavin mononucleotide,natural riboswitch regulatory ligand flavin mononucleotide
NEW10993,BIOCHEMICAL,riboflavin biosynthesis,riboflavin biosynthesis
NEW10994,MENTAL_HEALTH,efficient repression,efficient repression
NEW10996,CHEMICAL,norepinephrine stimulation,norepinephrine stimulation
NEW10998,DISEASE,cud patient,CUD patients
NEW10999,DISEASE,cjd patient,CJD patient
NEW11001,CHEMICAL,serial plasma cortisol,serial plasma cortisol
NEW11002,CHEMICAL,cortisol response,cortisol responses
NEW11004,CHEMICAL,altered cortisol response,altered cortisol responses
NEW11006,CHEMICAL,cortisol temperature response,cortisol temperature responses
NEW11011,CHEMICAL,d-palmitylcarnitine,D-Palmitylcarnitine
C008472,CHEMICAL,N-methylnicotinamide [Supplementary Concept],N-methylnicotinamide|Niacinamide/analogs  and  derivatives
C034516,CHEMICAL,dimethylamine [Supplementary Concept],dimethylamine|Dimethylamines
D006643,CHEMICAL,Histidine-tRNA Ligase,"Ligase, His-tRNA|Ligase, Histidine-tRNA|histidine|Histidyl tRNA Synthetase|His-tRNA Ligase|Jo-1 Antigen|Histidyl T RNA Synthetase|Synthetase, Histidyl-tRNA|Histidyl-tRNA Synthetase|Antigen, Jo-1|Histidine tRNA Ligase|His tRNA Ligase|Jo 1 Antigen"
C001505,CHEMICAL,alpha-ketoisovalerate [Supplementary Concept],alpha-ketoisovaleric acid|Hemiterpenes|Keto Acids
C475599,CHEMICAL,"3,7-dimethyl-1,6-octadien-3-yl isobutyrate [Supplementary Concept]",Butyrates|isobutyrate|Monoterpenes
C024840,CHEMICAL,ethyl acetoacetate [Supplementary Concept],Acetoacetates|acetoacetate
NEW11013,DISEASE,massive proteinuria,massive proteinuria
NEW11014,MENTAL_HEALTH,depression medication,depression medication
http://purl.obolibrary.org/obo/CHEBI_70707,CHEMICAL,vilazodone,vilazodonum|vilazodona|vilazodone|5-{4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl}-1-benzofuran-2-carboxamide|duloxetine milnacipran
NEW11015,CHEMICAL,atypical antidepressant group,atypical antidepressants group
http://purl.obolibrary.org/obo/CHEBI_3219,CHEMICAL,bupropion,bupropion nefazodone|Bupropion|2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one
http://purl.obolibrary.org/obo/CHEBI_50940,CHEMICAL,tetracyclic antidepressant,tetracyclic antidepressants|antidepresivos tetraciclicos|piperazinoazepine antidepressant|antidepresivo tetraciclico
D000657,CHEMICAL,Amoxapine,"Asendis|Demolox|CL-67,772|amoxapine|CL67,772|Asendin|Desmethylloxapine|CL 67,772|Défanyl|2-Chloro-11-(1-piperazinyl)dibenz(b,f)(1,4)oxazepine"
NEW11016,CHEMICAL,significant drug-appropriate,significant drug-appropriate
NEW11018,DISEASE,writhe,writhes
NEW11024,DISEASE,depressive behavior,depressive behavior
NEW11028,DISEASE,lung disease cardiovascular disease,lung disease cardiovascular disease
NEW11029,DISEASE,hyperemesis syndrome,hyperemesis syndrome
NEW11030,CHEMICAL,ergot alkaloid bromocriptine,ergot alkaloid bromocriptine
NEW11031,MENTAL_HEALTH,end-of-dose akinesia,end-of-dose akinesia
http://purl.obolibrary.org/obo/CHEBI_91184,CHEMICAL,dehydrodiconiferyl alcohol,"lignin cw compound-2004|dehydrodiconiferol|DA-metabolite homovanillyl alcohol|G(8-5)G|4-{3-(hydroxymethyl)-5-[(1E)-3-hydroxyprop-1-en-1-yl]-7-methoxy-2,3-dihydro-1-benzofuran-2-yl}-2-methoxyphenol"
D002742,CHEMICAL,Chlorphenamidine,chlordimeform|Chlordimeform
NEW11033,CHEMICAL,oar-antagonist,OAR-antagonist
NEW11036,NUTRITION,striped catfish,striped catfish
NEW11037,BIOCHEMICAL,drug label,drug label
http://purl.obolibrary.org/obo/DOID_0060060,DISEASE,non-hodgkin lymphoma,non-Hodgkin lymphomas
NEW11044,MENTAL_HEALTH,self-reported hallucination,self-reported hallucinations
NEW11045,MENTAL_HEALTH,reversible amnesia,reversible amnesia
NEW11046,MENTAL_HEALTH,amnesia development,amnesia development
NEW11048,MENTAL_HEALTH,repression condition,repression conditions
NEW11052,NUTRITION,liquid tissue marker sucrose acetate isobutyrate,liquid tissue marker sucrose acetate isobutyrate
NEW11053,CHEMICAL,radiopaque electron dense saib analogue,radiopaque electron dense SAIB analogue
NEW11055,DISEASE,autism-like behavior,autism-like behavior
D000033,DISEASE,"Abortion, Threatened","Threatened Miscarriages|Miscarriage, Threatened|Threatened Abortions|threatened abortion|Threatened Miscarriage|Threatened Abortion"
NEW11056,DISEASE,ASD development,ASD development
NEW11059,DISEASE,core ptsd symptom cluster,core PTSD symptom clusters
NEW11061,DISEASE,arthritis development,arthritis development
NEW11063,DISEASE,metabolic imbalance,metabolic imbalances
C467741,DISEASE,"STEAP2 protein, human [Supplementary Concept]",human prostate cancer|Oxidoreductases
NEW11068,DISEASE,human prostate cancer cell,human prostate cancer cells
NEW11070,CHEMICAL,h dqf nmr spectroscopy,H DQF NMR spectroscopy
NEW11072,MENTAL_HEALTH,robinson mental retardation syndrome,Robinson mental retardation syndrome
NEW11074,DISEASE,emotional function,emotional functioning
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Postpartum_Psychosis,CHEMICAL,postpartum psychosis,PPP|Postpartum psychosis
NEW11078,DISEASE,genus Clostridium,genus Clostridium
D018692,CHEMICAL,Antimanic Agents,"Drugs, Antimanic|Antimanic Effects|antimanic effects|Antimanic Effect|Antimanics|Antimanic Drugs|Agents, Antimanic|Effects, Antimanic|Effect, Antimanic"
C536106,DISEASE,Myostatin-related muscle hypertrophy [Supplementary Concept],muscle hypertrophy|Muscular Diseases|Hypertrophy
NEW11082,NUTRITION,red abalone,red abalone
NEW11083,NUTRITION,healthy red abalone,healthy red abalone
NEW11085,DISEASE,hepatic disorder,hepatic disorders
NEW11086,DISEASE,arterial hypotension,arterial hypotension
NEW11089,NUTRITION,spanish outpatient,Spanish outpatients
NEW11091,MENTAL_HEALTH,slow dissociation,slower dissociation
NEW04798,CHEMICAL,α9α10 subtype,α9α10 subtype
NEW11093,MENTAL_HEALTH,channelopathie pain syndrome,channelopathies pain syndromes
NEW11095,DISEASE,0.084 mg/L,inferior vena cava blood|0.084 mg/L
D017359,DISEASE,HELLP Syndrome,"Syndrome, HELLP|HELLP syndrome|Hemolysis, Elevated Liver Enzymes, Lowered Platelets"
NEW11097,DISEASE,hellp rat,HELLP rats
NEW11100,DISEASE,learn motor deficit,learned motor deficits
NEW11103,NUTRITION,phospholipid dysregulation,phospholipid dysregulation
NEW11105,CHEMICAL,"3'r)-2-(2,3-dicarboxyl-cyclopropyl)-glycine","3'R)-2-(2,3-dicarboxyl-cyclopropyl)-glycine"
C082313,CHEMICAL,"2-(2,3-dicarboxycyclopropyl)glycine [Supplementary Concept]",DCG-IV|Cyclopropanes|Glycine/analogs  and  derivatives
D017242,CHEMICAL,Complement Factor H,"Factor H|complement factor H|Factor H, Complement"
NEW11108,DISEASE,unsubstantiated parkinson disease diagnosis,unsubstantiated Parkinson disease diagnosis
NEW11109,MENTAL_HEALTH,pd psychosis,PD psychosis
NEW11110,BIOCHEMICAL,high-dose folic acid supplement use,high-dose folic acid supplement use
NEW11111,DISEASE,acute thymic atrophy,acute thymic atrophy
NEW11113,DISEASE,thymic atrophy,thymic atrophy
NEW11115,MENTAL_HEALTH,undifferentiated somatoform disorder,undifferentiated somatoform disorder
NEW11116,DISEASE,psychiatric indication,psychiatric indications
NEW11118,DISEASE,aggressive violent behavior,aggressive violent behavior
NEW11120,CHEMICAL,oxygen deprivation,oxygen deprivation
NEW11121,DISEASE,system inflammation,system inflammation
NEW11125,MENTAL_HEALTH,drug orientation,drug orientation
NEW11127,MENTAL_HEALTH,fragmentation scheme,fragmentation schemes
NEW11128,CHEMICAL,serotonin 5-ht1a receptor agonist,serotonin 5-HT1A receptor agonist
NEW11130,MENTAL_HEALTH,recurrent major depression,recurrent major depression
NEW11132,DISEASE,erbb family tumor,ERBB family tumors
NEW11134,NUTRITION,pyrene boric acid,pyrene boric acid
NEW11135,CHEMICAL,deposit ag nanoparticle,deposit Ag nanoparticles|AgNPs
NEW11136,CHEMICAL,dopamine nanoparticle,dopamine nanoparticles
NEW11139,MENTAL_HEALTH,same displacement test,same displacement test
NEW11141,CHEMICAL,specific n-methyl-d-aspartic acid nmda glutamatergic blockade,specific N-methyl-D-aspartic acid NMDA glutamatergic blockade
NEW11144,DISEASE,repeat urticaria,repeated urticaria
http://purl.obolibrary.org/obo/CHEBI_77182,BIOCHEMICAL,food colouring,food colorings|food colourings|food coloring
NEW11146,CHEMICAL,olanzapine initiation,olanzapine initiation
NEW11147,DISEASE,short-term memory deficit,short-term memory deficits
NEW11149,CHEMICAL,prenatal vpa exposure,prenatal VPA exposure
NEW11150,CHEMICAL,serum omega-3 concentration,serum omega-3 concentration
NEW11151,MENTAL_HEALTH,multidimensional Fatigue Symptom Inventory,Multidimensional Fatigue Symptom Inventory
NEW11152,CHEMICAL,anti-convulsive property,anti-convulsive properties
NEW11153,CHEMICAL,dapsone treatment,dapsone treatment
NEW11157,DISEASE,glucose-induced insulin secretion,glucose-induced insulin secretion
NEW11159,NUTRITION,methionine choline-deficient db/db mouse,methionine choline-deficient db/db mice
D063991,NUTRITION,Mitochondrial Trifunctional Protein,"Trifunctional Protein, Mitochondrial|fatty acid β-oxidation|Mitochondrial Fatty Acid beta-Oxidation Trifunctional Protein|FA beta-OMC|Mitochondrial Fatty Acid beta Oxidation Trifunctional Protein|Mitochondrial Long Chain Enoyl CoA Hydratase 3 Hydroxyacyl CoA Dehydrogenase 3 Ketoacyl CoA Thiolase Trifunctional Protein"
NEW11160,CHEMICAL,triglyceride metabolism,triglyceride metabolism
NEW11161,CHEMICAL,treatment glucolipid metabolism,treatment glucolipid metabolism
NEW11162,DISEASE,ccl4-induced liver fibrosis,CCl4-induced liver fibrosis
C513081,DISEASE,"Myo5a protein, rat [Supplementary Concept]",Myosin Type V|opisthotonus|Myosin Heavy Chains
NEW11165,DISEASE,neck torticollis alon,neck torticollis alons
C535516,DISEASE,Hereditary leiomyomatosis and renal cell cancer [Supplementary Concept],"Neoplastic Syndromes, Hereditary|Leiomyomatosis|renal cell cancer|Skin Neoplasms|Uterine Neoplasms"
NEW11166,DISEASE,toxicity equivalent,toxicity equivalents
NEW11167,DISEASE,teq value,TEQ values
NEW11170,MENTAL_HEALTH,unusual host-plant resistance mechanism,unusual host-plant resistance mechanism
NEW11171,DISEASE,male sexual disorder,male sexual disorders
NEW11173,DISEASE,direct neurotoxicity,direct neurotoxicity
NEW11175,DISEASE,VaD. Morris water-maze,VaD. Morris water-maze
NEW11177,CHEMICAL,serum nitrite/nitrate level,serum nitrite/nitrate levels
NEW11178,CHEMICAL,brain glutathione,brain glutathione
NEW11179,CHEMICAL,brain thiobarbituric acid reactive specie,brain thiobarbituric acid reactive species
NEW11180,CHEMICAL,hhcy-hl,HHcy-HL
http://purl.obolibrary.org/obo/CHEBI_73085,CHEMICAL,colterol,"colterolum|D4Ch|colterol|(+-)-N-t-butylnoradrenaline|(+-)-N-tert-butylarterenol|4-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,2-diol|(+/-)-N-tert-butylarterenol"
NEW11184,MENTAL_HEALTH,hyperactivity syndrome,hyperactivity syndrome
NEW11187,CHEMICAL,globus pallidus par interna,GPi|globus pallidus pars interna
NEW11189,DISEASE,choreiform dyskinesia,choreiform dyskinesias
NEW11192,NUTRITION,impaired primary root protophloem differentiation,impaired primary root protophloem differentiation
NEW11195,BIOCHEMICAL,selective mineralocorticoid receptor antagonist,selective mineralocorticoid receptor antagonist
NEW11196,DISEASE,dry tissue,dry tissue
NEW11199,BIOCHEMICAL,natural aldosterone antagonist,natural aldosterone antagonist
NEW11203,DISEASE,age-related brain damage,age-related brain damage
NEW11206,DISEASE,peripheral pain,peripheral pain
NEW11208,DISEASE,neuronal disease,neuronal diseases
NEW11209,DISEASE,scop-induced oxidative toxicity,SCOP-induced oxidative toxicity
D012048,DISEASE,Correction of Hearing Impairment,"Perception Correction, Auditory|Impairment Habilitations, Hearing|Hearing Impairment Corrections|Impairment Rehabilitations, Hearing|Hearing Impairment Habilitations|Aural Rehabilitations|Auditory Perception Corrections|Perception Corrections, Auditory|Hearing Impairment Habilitation|Aural Habilitations|Impaired Habilitations, Hearing|Hearing Impaired Rehabilitation|Habilitation of Hearing Impaired|Rehabilitations, Aural|Hearing Loss Corrections|Hearing Impairment Rehabilitations|Habilitations, Aural|Rehabilitation of Hearing Impaired|Aural Rehabilitation|Audiologic Habilitations|Rehabilitation, Aural|Auditory Perception Correction|Rehabilitation, Audiologic|Rehabilitation, Hearing Impaired|Impairment Habilitation, Hearing|Correction of Auditory Perception|Hearing Loss Correction|Impairment Corrections, Hearing|Hearing Impairment Rehabilitation|impairment|Audiologic Rehabilitation|Habilitation of Hearing Impairment|Habilitations, Audiologic|Loss Corrections, Hearing|Impairment Correction, Hearing|Correction of Hearing Loss|Rehabilitation of Hearing Impairment|Hearing Impairment Correction|Hearing Impaired Habilitations|Rehabilitations, Audiologic|Habilitation, Aural|Audiologic Rehabilitations|Audiologic Habilitation|Impairment Rehabilitation, Hearing|Aural Habilitation|Impaired Habilitation, Hearing|Loss Correction, Hearing|Habilitation, Audiologic|Hearing Impaired Habilitation"
NEW11212,DISEASE,pre-threshold stage,pre-threshold stage
NEW11213,DISEASE,pre-threshold,pre-threshold
NEW11215,CHEMICAL,sex steroid synthesis,sex steroid synthesis
NEW11221,CHEMICAL,high alcohol intake,higher alcohol intake
NEW11224,MENTAL_HEALTH,overall craving level,overall craving level
NEW11235,DISEASE,non-erosive reflux disease,NERD|non-erosive reflux disease
NEW11237,DISEASE,inflammatory bowel syndrome,inflammatory bowel syndrome
NEW11240,DISEASE,high-grade osteosarcoma,high-grade osteosarcoma
NEW11242,DISEASE,diagnose osteosarcoma,diagnosed osteosarcoma
D054778,DISEASE,NM23 Nucleoside Diphosphate Kinases,Tumor Metastatic Process-Associated Protein|Granzyme A activated DNase|Nucleoside Diphosphate Kinase B|NM23A Nucleoside Diphosphate Kinases|NM23-H3 Nucleoside Diphosphate Kinase|Nm23-H1 Nucleoside Diphosphate Kinase|DR-NM23 Nucleoside Diphosphate Kinase|NDP Kinase A|NM23B Nucleoside Diphosphate Kinase|Expressed in Non Metastatic Cells 2 Protein|Tumor Metastatic Process Associated Protein|Nucleoside Diphosphate Kinase 3|NME1 Nucleoside Diphosphate Kinase|DR NM23 Nucleoside Diphosphate Kinase|Granzyme A-activated DNase|NM23 H3 Nucleoside Diphosphate Kinase|NM23-H2 Nucleoside Diphosphate Kinase|non-metastatic|Nm23 H1 Nucleoside Diphosphate Kinase|NM23 H2 Nucleoside Diphosphate Kinase|Non Metastatic Cells 1 Protein|Nucleoside Diphosphate Kinase A|Non-Metastatic Cells 1 Protein|Expressed in Non-Metastatic Cells 2 Protein|Nucleoside Diphosphate Kinase C
http://purl.obolibrary.org/obo/DOID_3356,DISEASE,localized osteosarcoma,localised osteosarcoma|localized Osteogenic sarcoma|localised Osteogenic sarcoma|localized osteosarcoma
D018217,DISEASE,"Osteosarcoma, Juxtacortical","Osteosarcomas, Juxtacortical|Juxtacortical Osteosarcomas|osteosarcoma|Juxtacortical Osteosarcoma"
NEW11245,DISEASE,rare sarcoma,rare sarcoma
NEW11247,DISEASE,autistic spectrum disorder aged,autistic spectrum disorders aged
NEW11250,BIOCHEMICAL,c beta-carotene plasma value,C beta-carotene plasma values
NEW11252,DISEASE,old autistic group,older autistic group
NEW11253,DISEASE,epilepsy psychiatric disease,epilepsy psychiatric diseases
NEW11255,CHEMICAL,sucrose concentration,sucrose concentration
NEW11256,NUTRITION,vacuolar acid invertase activity,vacuolar acid invertase activity
C022699,CHEMICAL,sucrose synthase [Supplementary Concept],sucrose synthase|Glucosyltransferases
C494367,CHEMICAL,estroprogestin [Supplementary Concept],Norpregnenes|estroprogestin|Drug Combinations|Ethinyl Estradiol
NEW11260,BIOCHEMICAL,exogenous oestrogen,exogenous oestrogens
NEW11261,DISEASE,pediatric mdd,pediatric MDDs
NEW11262,DISEASE,convulsive stimulus,convulsive stimuli
NEW11264,MENTAL_HEALTH,hallucination related,hallucinations related
NEW11265,DISEASE,obese osahs patient,obese OSAHS patients
NEW11268,CHEMICAL,n-6/n-3,n-6/n-3
NEW11269,MENTAL_HEALTH,depression development,depression development
NEW11272,CHEMICAL,prostaglandin family,prostaglandins family
NEW11273,BIOCHEMICAL,conventional mood stabiliser,conventional mood stabilisers
NEW11274,CHEMICAL,rapid-acting antidepressant effect,rapid-acting antidepressant effects
D014796,DISEASE,Visual Perception,"visual processing|Processing, Visual|Visual Processing|Perception, Visual"
NEW11276,DISEASE,mild hypothyroidism,mild hypothyroidism
NEW11278,CHEMICAL,major th transport protein,major TH transport proteins
NEW11280,DISEASE,ttr binding,TTR binding
NEW11282,CHEMICAL,use benzodiazepine,used benzodiazepines
NEW11285,DISEASE,hemorrhage risk,hemorrhage risk
NEW11286,DISEASE,ich guideline,ICH guideline
D045169,DISEASE,Severe Acute Respiratory Syndrome,"severe acute respiratory syndrome|Respiratory Syndrome, Severe Acute|Respiratory Syndrome, Acute, Severe|SARS (Severe Acute Respiratory Syndrome)"
http://purl.obolibrary.org/obo/DOID_0081013,CHEMICAL,severe covid-19,severe COVID-19
C047057,CHEMICAL,isoniazid acetyltransferase [Supplementary Concept],Arylamine N-Acetyltransferase|isoniazide
NEW11289,MENTAL_HEALTH,heavy ethanol abuse,heavy ethanol abuse
NEW11290,BIOCHEMICAL,known hepatotoxic agent,known hepatotoxic agents
NEW11291,CHEMICAL,agent busulfan,agents busulfan
NEW11294,DISEASE,neuromuscular deficit,neuromuscular deficit
NEW11295,BIOCHEMICAL,prolonged vitamin e deficiency,prolonged vitamin E deficiency
NEW11297,DISEASE,cancer cell growth,cancer cell growth
http://purl.obolibrary.org/obo/CHEBI_7573,BIOCHEMICAL,nilutamide,"antiandrogen flutamide|nilutamida|nilutamidum|5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin|Nilutamide|Nilandron|nilutamide|5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione"
NEW11299,BIOCHEMICAL,lhrh agonist,LHRH agonist
NEW11300,DISEASE,severe deviant behaviour,severe deviant behaviour
NEW11301,BIOCHEMICAL,androgen blocking,androgen blocking
NEW11303,BIOCHEMICAL,anti-androgenic hormone,anti-androgenic hormone
NEW11305,DISEASE,ics-induced thermal hyperalgesia,ICS-induced thermal hyperalgesia
NEW11308,CHEMICAL,ics model mouse,ICS model mice
NEW11309,DISEASE,sleep abnormality,sleep abnormalities
NEW11311,MENTAL_HEALTH,dnmt hyperactivity,DNMT hyperactivity
C479058,CHEMICAL,"oxoguanine glycosylase 1, human [Supplementary Concept]",DNA Glycosylases|hOGG1
C497172,DISEASE,"MSH2 protein, human [Supplementary Concept]",MutS Homolog 2 Protein|hMSH2
NEW11313,DISEASE,human sclc,human SCLC
NEW11314,DISEASE,neuroendocrine lung carcinoma similar,neuroendocrine lung carcinomas similar
D055752,DISEASE,Small Cell Lung Carcinoma,"small cell lung carcinoma|Oat Cell Lung Cancer|SCLC|Small Cell Cancer Of The Lung|Oat Cell Carcinoma of Lung|Carcinoma, Small Cell Lung|Small Cell Lung Cancer"
http://purl.obolibrary.org/obo/CHEBI_81841,BIOCHEMICAL,cyazofamid,"oomycete-targeted fungicides|4-chloro-2-cyano-N,N-dimethyl-5-(4-methylphenyl)-1H-imidazole-1-sulfonamide|4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide"
NEW11324,DISEASE,renal interstitial fibrosis,renal interstitial fibrosis
D011339,CHEMICAL,Probenecid,Benecid|Probecid|Benemid|Benuryl|Pro-Cid|probenecid|Probenecid Weimer
NEW11325,DISEASE,adv-induced nephrotoxicity,ADV-induced nephrotoxicity
http://purl.obolibrary.org/obo/DOID_0050855,DISEASE,renal fibrosis,renal fibrosis
NEW11329,CHEMICAL,interstitial mc,interstitial MCs
NEW11330,DISEASE,adv-associated fibrosis,ADV-associated fibrosis
NEW11333,DISEASE,cancer relapse,cancer relapse
NEW11338,MENTAL_HEALTH,potent strand displacement inhibitor,potent strand displacement inhibitors
NEW11340,MENTAL_HEALTH,combined fatigue,combined fatigue
NEW11343,DISEASE,heat-capsaicin human pain model,heat-capsaicin human pain model
NEW11345,MENTAL_HEALTH,dlb dementia,DLB dementia
C028697,CHEMICAL,dexamethasone receptor [Supplementary Concept],"Receptors, Glucocorticoid|dexamethasone binding site"
NEW11349,MENTAL_HEALTH,response resistance,response resistance
NEW11351,MENTAL_HEALTH,mixed dementia,mixed dementia
NEW11353,CHEMICAL,cortical gaba concentration,cortical GABA concentrations
C000670042,CHEMICAL,Fusarium poae [Supplementary Concept],Fusarium poae|Fusarium
C409825,DISEASE,"PGX4 protein, Fusarium oxysporum [Supplementary Concept]",Glycoside Hydrolases|Fungal Proteins|Fusarium oxysporum
NEW11358,CHEMICAL,wheat- alternaria alternata,wheat- Alternaria alternata
C479959,DISEASE,"Bcchs1 protein, Botrytis cinerea [Supplementary Concept]",Chitin Synthase|Fungal Proteins|Botrytis cinerea
NEW11359,BIOCHEMICAL,antifungal activity,antifungal activities
NEW11363,DISEASE,breast cancer cell,breast cancer cells
NEW11366,CHEMICAL,cerebral serotonin transporter,cerebral serotonin transporter
NEW11368,DISEASE,tuberculosis control,tuberculosis control
NEW11369,DISEASE,intestinal protozoa,intestinal protozoa
NEW11370,CHEMICAL,srif receptor,SRIF receptors
NEW11371,DISEASE,human endometrial cancer cell line,human endometrial cancer cell line
NEW11372,CHEMICAL,mt2 melatonin receptor subtype,MT2 melatonin receptor subtype
NEW11373,DISEASE,endometrial cancer therapy,endometrial cancer therapy
D014917,DISEASE,Whooping Cough,"Cough, Whooping|Pertussis|Pertusses|Bordetella pertussis Infection, Respiratory|cough"
D023341,DISEASE,Chills,chills|Shivering (1977-2000)
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Restlessness,DISEASE,restlessness,tiredness/fatigue
NEW11377,DISEASE,cold sore throat,cold sore throat
C008450,CHEMICAL,7-methylguanine [Supplementary Concept],7-methylguanine|Guanine/analogs  and  derivatives
NEW11378,BIOCHEMICAL,ovarian hormone signal,ovarian hormone signals
NEW11379,MENTAL_HEALTH,projection site,projection sites
http://purl.org/sig/ont/fma/fma77609,CHEMICAL,sublenticular extended amygdala,CMA|centromedial amygdala
NEW11380,NUTRITION,manner steroid hormone information,manner steroid hormone information
D006964,BIOCHEMICAL,Hyperpituitarism,"TSH Hypersecretion, Pituitary|Luteinizing Hormone, Inappropriate Secretion|Inappropriate Luteinizing Hormone Secretion|LH Hypersecretion, Pituitary|hormone secretion|Inappropriate FSH Secretion Syndrome|Pituitary TSH Hypersecretion|Pituitary FSH Hypersecretion|Hypersecretion, Pituitary TSH|Hypersecretion, Pituitary LH|Inappropriate Thyroid Stimulating Hormone Secretion|FSH Hypersecretion, Pituitary|Inappropriate Follicle Stimulating Hormone Secretion|Thyroid Stimulating Hormone, Inappropriate Secretion|Pituitary LH Hypersecretion|Inappropriate TSH Secretion Syndrome|Inappropriate LH Secretion Syndrome|Follicle Stimulating Hormone, Inappropriate Secretion|Hypersecretion, Pituitary FSH"
D023681,CHEMICAL,Cichlids,"Cichlidae|Fish, Cichlid|Tilapia nilotica|Oreochromis nilotica|Nile Tilapia|Cichlid|Oreochromis niloticus|Nile tilapia|Cichlid Fish"
C571043,CHEMICAL,exposed proliferation antigen 210 [Supplementary Concept],exposed|Thymidine Kinase|Peptide Fragments
D004289,NUTRITION,Dolphins,"Pygmy Killer Whale|Langenorhynchus obliquiden|Franciscanas|Inia geoffrensis|Pygmy Killer Whales|Lissodelphis|Whale, Melon-Headed|Lagenorhynchus|Ocean Dolphins|Planista gangetica|Ganges River Dolphin|Rissos Dolphin|Fraser Dolphin|White-Beaked Dolphins|Amazon River Dolphins|Pontoporia blainvilleus|Whale, False Killer|Pacific White-Sided Dolphin|Sotalia fluviatilis|Grampus griseus|Whale, Pygmy Killer|Platanista|Peponocephala electra|Risso Dolphin|Sotalia fluviatili|Many Toothed Blackfish|Orcaella brevirostri|Pseudorca crassidens|Pseudorca crassiden|La Plata Dolphin|Gray Grampus|Rough-Toothed Dolphin|Dolphin|blackfish|Marine Dolphins|Cephalorhynchus|Right Whale Dolphin|Feresa attenuata|Humpback Dolphins|False Killer Whales|Lagenorhynchus albirostris|Franciscana|Susus|False Killer Whale|Pontoporia blainvillei|Lagenodelphis hosei|Baijus|Right Whale Dolphins|Tucuxi Dolphins|Fraser's Dolphin|Melon-Headed Whales|Lipotes vexillifer|Irrawaddy River Dolphin|Pacific White Sided Dolphins|Dolphin, Fraser's|Rough-Toothed Dolphins|Pacific White-Sided Dolphins|Sousa|Ocean Dolphin|Platanistas|White Beaked Dolphins|Risso's Dolphin|Lagenorhynchus albirostri|Atlantic White-Sided Dolphins|Yangtze River Dolphin|Melon-Headed Whale|Humpback Dolphin|Planista gangeticas|Langenorhynchus obliquidens|Chinese River Dolphin|Baiji|Ganges Dolphin|Melon Headed Whale|Lagenorhynchus acutus|Steno bredanensis|Piebald Dolphins|Orcaella brevirostris|White-Beaked Dolphin|Tucuxi Dolphin|Rough Toothed Dolphin|Many-Toothed Blackfish|Piebald Dolphin|Amazon Dolphins|Atlantic White Sided Dolphins|Atlantic White-Sided Dolphin|Marine Dolphin|Lissodelphi|Lagenodelphis hoseus|Frasers Dolphin|Delphinidae"
D029921,NUTRITION,Trifolium,"Trifolium repen|Trifolium pratense|red clover|Clover, Red|Red Clover|Trifoliums|repen, Trifolium|pratenses, Trifolium|Trifolium repens|Trifolium pratenses"
NEW11382,CHEMICAL,monoamine transporter-inhibiting antidepressant,monoamine transporter-inhibiting antidepressants
NEW11386,DISEASE,traumatic rib,traumatic rib
NEW11387,DISEASE,rib sternal fracture,rib sternal fractures
NEW11388,BIOCHEMICAL,antibiotic use,antibiotic use
NEW11389,NUTRITION,trout egg l-rhamnose-binding lectin,trout egg L-rhamnose-binding lectins
C099881,NUTRITION,"egg jelly ligand receptors, Strongylocentrotus purpuratus [Supplementary Concept]","Receptors, Cell Surface|sea urchin"
NEW11390,DISEASE,lacunar stroke patient,lacunar stroke patients
NEW11391,BIOCHEMICAL,brain antigen,brain antigens
NEW11392,MENTAL_HEALTH,dementia type,dementia types
NEW11395,CHEMICAL,bond dissociation,bond dissociation
NEW11396,MENTAL_HEALTH,phenolic dissociation energy,phenolic dissociation energies
NEW11400,DISEASE,reproductive disorder,reproductive disorders
NEW11401,BIOCHEMICAL,sympathomimetic symptom,sympathomimetic symptoms
NEW11404,DISEASE,aspd subject,ASPD subjects
NEW11406,DISEASE,aureus bacteria,aureus bacteria
D020388,DISEASE,"Muscular Dystrophy, Duchenne","Progressive Muscular Dystrophy, Duchenne Type|Pseudohypertrophic Muscular Dystrophy, Childhood|Becker Muscular Dystrophy|Muscular Dystrophy, Becker Type|Duchenne muscular dystrophy|Muscular Dystrophy, Duchenne Type|Cardiomyopathy, Dilated, X-Linked|Muscular Dystrophy, Pseudohypertrophic|Pseudohypertrophic Muscular Dystrophy|Duchenne-Type Progressive Muscular Dystrophy|Duchenne Becker Muscular Dystrophy|Muscular Dystrophy, Pseudohypertrophic, Childhood|Muscular Dystrophy Pseudohypertrophic Progressive, Becker Type|Childhood Muscular Dystrophy, Pseudohypertrophic|Muscular Dystrophy, Childhood, Pseudohypertrophic|Childhood Pseudohypertrophic Muscular Dystrophy|Duchenne Type Progressive Muscular Dystrophy|Muscular Dystrophy, Pseudohypertrophic Progressive, Duchenne Type|Muscular Dystrophy, Duchenne-Becker|Muscular Dystrophy, Pseudohypertrophic Progressive, Becker Type|Pseudohypertrophic Childhood Muscular Dystrophy|Duchenne-Becker Muscular Dystrophy|Muscular Dystrophy, Duchenne and Becker Types|Cardiomyopathy, Dilated, 3B|Muscular Dystrophy, Becker|Muscular Dystrophy, Becker's|Duchenne Muscular Dystrophy|Becker's Muscular Dystrophy|Duchenne and Becker Muscular Dystrophy"
NEW11409,DISEASE,severe sma,severe SMA
http://purl.obolibrary.org/obo/HP_0003202,DISEASE,skeletal muscle atrophy,skeletal muscle atrophy
NEW11414,DISEASE,rigid-compulsive behavior,rigid-compulsive behavior
NEW11417,CHEMICAL,nicotine craving,nicotine craving
NEW11421,DISEASE,high dis,high DIS
NEW11422,BIOCHEMICAL,da agonist lisuride,DA agonist lisuride
NEW11425,DISEASE,co-morbiditie,co-morbidities
D016491,DISEASE,Peripheral Vascular Diseases,"peripheral vascular disease|Peripheral Vascular Disease|Angiopathies, Peripheral|Diseases, Peripheral Vascular|Peripheral Angiopathies|Disease, Peripheral Vascular|Angiopathy, Peripheral|Peripheral Angiopathy|Vascular Disease, Peripheral|Vascular Diseases, Peripheral"
D054537,DISEASE,Atrioventricular Block,"AV Blocks|Blocks, AV|atrioventricular block|Atrioventricular Conduction Blocks|Conduction Block, Atrioventricular|Block, AV|AV Block|Atrioventricular Blocks|Atrioventricular Conduction Block|Conduction Blocks, Atrioventricular"
NEW11426,DISEASE,elderly migraine patient,elderly migraine patients
NEW11427,DISEASE,migraine attack,migraine attacks
NEW11429,DISEASE,rodent td model,rodent TD models
NEW11431,DISEASE,oral allergy syndrome,oral allergy syndrome
NEW11435,DISEASE,personality-disordered individual,personality-disordered individuals
NEW11436,DISEASE,assaultiveness Buss-Durkee Assault,assaultiveness Buss-Durkee Assault
NEW11437,CHEMICAL,5-ht index,5-HT indices
D014754,MENTAL_HEALTH,Violence,"Behavior, Assaultive|Violence, Structural|assaultive behavior|Atrocities|Assaultive Behavior|Structural Violence"
NEW11439,MENTAL_HEALTH,depression symptomatology,depression symptomatology
NEW11440,DISEASE,adulthood psychiatric condition,adulthood psychiatric conditions
D052878,DISEASE,Urolithiasis,"urolithiasis|Urinary Lithiasis|Lithiasis, Urinary"
NEW11441,MENTAL_HEALTH,hyperactivity score,hyperactivity scores
NEW11443,BIOCHEMICAL,buffer medium drug,buffer medium drug
C077509,DISEASE,"mim-1 protein, Gallus gallus [Supplementary Concept]",Acetyltransferases|OMIM # gene codes
NEW11451,BIOCHEMICAL,specific cns folate transporter,specific CNS folate transporter
D006610,DISEASE,High Pressure Neurological Syndrome,"HPNSs|High Pressure Neurological Syndrome, Experimental|neurological syndrome|Experimental High Pressure Neurological Syndrome|HPNS|High Pressure Nervous Syndrome|High Pressure Neural Syndrome"
NEW11454,DISEASE,csf 5mthf deficiency,CSF 5MTHF deficiency
NEW11455,NUTRITION,normal folate metabolism,normal folate metabolism
NEW11459,DISEASE,diabetic neuropathic patient,diabetic neuropathic patients
NEW11462,CHEMICAL,calcium concentration,calcium concentration
NEW11463,NUTRITION,control crayfish,control crayfish
NEW11464,MENTAL_HEALTH,associate cardiac depression,associated cardiac depression
NEW11465,DISEASE,respiratory effect,respiratory effects
http://purl.obolibrary.org/obo/DOID_2913,DISEASE,acute pancreatitis,severe acute pancreatitis|acute necrotizing pancreatitis|PANCREATITIS NECROTIZING
D018746,DISEASE,Systemic Inflammatory Response Syndrome,"Sepsis Syndromes|Syndromes, Sepsis|Sepsis Syndrome|Inflammatory Response Syndrome, Systemic|systemic inflammatory response syndrome|Syndrome, Sepsis|SIRS"
C565512,DISEASE,"Mthfr Deficiency, Thermolabile Type [Supplementary Concept]",MTHFR deficiency|Homocystinuria|Methylenetetrahydrofolate Reductase (NADPH2)/deficiency
NEW11471,CHEMICAL,steroid hormone-modulating enzyme,steroid hormone-modulating enzyme
NEW11472,CHEMICAL,enzyme steroid sulfatase,enzyme steroid sulfatase
NEW11474,MENTAL_HEALTH,regression function,Regression function
C018206,CHEMICAL,alternariol monomethyl ether [Supplementary Concept],alternariol|AOH|Lactones
NEW11477,DISEASE,loose dropping,loose droppings
NEW11478,NUTRITION,10-to-16-wk-old bobwhite quail,10-to-16-wk-old bobwhite quail
D003370,NUTRITION,Coturnix,"Coturnix japonica|Japanese quail|Quail, Japanese|Japanese Quails|Quails, Japanese|Japanese Quail"
D016219,DISEASE,"Immunotherapy, Adoptive","CAR T-cell therapy|CAR T-Cell Therapies|T-Cell Therapies, CAR|Adoptive Cellular Immunotherapy|Therapies, CAR T-Cell|Therapy, CAR T-Cell|Adoptive Cellular Immunotherapies|Immunotherapies, Adoptive|Chimeric Antigen Receptor Therapy|Adoptive Immunotherapies|CAR T Cell Therapy|Adoptive Immunotherapy|Immunotherapy, Adoptive Cellular|Immunotherapies, Adoptive Cellular|T-Cell Therapy, CAR|CAR T-Cell Therapy|Cellular Immunotherapies, Adoptive|Cellular Immunotherapy, Adoptive"
NEW11482,DISEASE,tumour cell surface,tumour cell surface
NEW11483,DISEASE,Coratina,Coratina
NEW11484,MENTAL_HEALTH,projection score,projection scores
NEW11485,DISEASE,clinical pain management,clinical pain management
D001663,CHEMICAL,Bilirubin,"Salt Bilirubin, Calcium|Bilirubinate, Calcium|Bilirubin, (4E,15E)-Isomer|Bilirubin, Monosodium Salt|delta Bilirubin|Calcium Salt Bilirubin|Bilirubin, Calcium Salt|Hematoidin|Bilirubin, Disodium Salt|Disodium Salt Bilirubin|Bilirubin, (15E)-Isomer|Bilirubin, (4E)-Isomer|Bilirubin IX alpha|Calcium Bilirubinate|bilirubin|delta-Bilirubin|Monosodium Salt Bilirubin"
NEW11490,CHEMICAL,low dissolve oxygen,low dissolved oxygen
NEW11491,BIOCHEMICAL,antibiotic development,antibiotic development
NEW11492,CHEMICAL,selective serotonin inhibitor-resistant ocd,selective serotonin inhibitor-resistant OCD
NEW11493,CHEMICAL,fast-acting antidepressant therapy,fast-acting antidepressant therapy
NEW11494,DISEASE,ideal hypotensive agent,ideal hypotensive agent
NEW11495,BIOCHEMICAL,anaesthetic drug,anaesthetic drug
NEW11496,DISEASE,hypotensive effect,hypotensive effect
http://purl.obolibrary.org/obo/CHEBI_74518,BIOCHEMICAL,anti-obesity agent,anti-obesity agents|anti-obestic agents|therapeutic anti-obesity agents|anti-obestic agent
NEW11499,DISEASE,craving-related eat behavior,craving-related eating behavior
NEW11504,DISEASE,ostreid herpesvirus type,Ostreid herpesvirus type
NEW11506,DISEASE,human virus,human viruses
NEW11508,BIOCHEMICAL,in antiviral activity,in antiviral activity
D022301,DISEASE,Herpes Simplex Virus Vaccines,"herpes simplex virus|Vaccines, HSV|HSV Vaccines|Simplexvirus Vaccines|Vaccines, Simplexvirus"
C000623855,DISEASE,Human mastadenovirus F [Supplementary Concept],"Adenoviruses, Human|human adenovirus"
http://purl.obolibrary.org/obo/NCBITaxon_11250,DISEASE,human orthopneumovirus,human coronaviruses
C531821,DISEASE,Stenotrophomonas maltophilia bacteremia [Supplementary Concept],Gram-Negative Bacterial Infections|Stenotrophomonas maltophilia/immunology|bacteraemia
C006624,CHEMICAL,arcaine [Supplementary Concept],arcaine|Biguanides
NEW11511,MENTAL_HEALTH,perioperative analgesia,perioperative analgesia
http://purl.obolibrary.org/obo/SYMP_0000686,DISEASE,chronic cough,chronic cough
http://purl.obolibrary.org/obo/HP_0003198,DISEASE,myopathy,myodegeneration
http://purl.obolibrary.org/obo/CHEBI_80945,CHEMICAL,octan-3-ol,ethyl amyl carbinol|3-octanol|N-methyl-N-propyl isomer|1-ethylhexanol|octan-3-ol|ethylhexyl alcohol|LAMPA|amyl ethyl carbinol
NEW11515,NUTRITION,don-treated wheat suspension cell,DON-treated wheat suspension cells
NEW11518,NUTRITION,fusarium intermediate susceptible wheat cultivar,Fusarium intermediate susceptible wheat cultivar
NEW11519,DISEASE,cultivar zhengmai9023 resistant cultivar sumai3,cultivar Zhengmai9023 resistant cultivar Sumai3
C000626918,CHEMICAL,"Vam7 protein, Fusarium graminearum [Supplementary Concept]",Fungal Proteins|Synaptosomal-Associated Protein 25|Fusarium graminearum
NEW11521,DISEASE,graminearum alternaria alternata,graminearum Alternaria alternata
NEW11522,CHEMICAL,± µm,± µM
http://purl.obolibrary.org/obo/CHEBI_168087,CHEMICAL,"11-acetoxy-3beta,6alpha-dihydroxy-24-methyl-27-nor-9,11-seco-5alpha-cholesta-7,22e-dien-9-one.","± µM.|2-[(1R,2R,5R)-2-[(4S,4aS,6S,8aS)-4,6-dihydroxy-8a-methyl-1-oxo-4,4a,5,6,7,8-hexahydronaphthalen-2-yl]-1-methyl-5-[(E,2R)-5-methylhept-3-en-2-yl]cyclopentyl]ethyl acetate"
NEW11523,CHEMICAL,don affinity,DON affinity
NEW11524,CHEMICAL,67HXXXG71,67HXXXG71
NEW11525,CHEMICAL,don binding motif,DON binding motif
NEW11526,CHEMICAL,fusarium resistance,Fusarium resistance
NEW11527,CHEMICAL,great don tolerance,greater DON tolerance
NEW11528,MENTAL_HEALTH,low dissociation constant,lower dissociation constants
NEW11531,MENTAL_HEALTH,perpendicular least-square regression,perpendicular least-square regression
NEW11532,CHEMICAL,morphine treatment period,morphine treatment periods
NEW11533,CHEMICAL,detectable prenatal urinary bpa,detectable prenatal urinary BPA
NEW11534,DISEASE,increase internalizing behavior,increased internalizing behaviors
NEW11535,DISEASE,withdrawn/depressed behavior,withdrawn/depressed behavior
NEW11536,DISEASE,disorder trait,Disorder traits
NEW11539,CHEMICAL,fast-acting sustained antidepressant,fast-acting sustained antidepressant
NEW11540,CHEMICAL,sulphur-4'-thionucleosides,sulphur-4'-thionucleosides
NEW11541,CHEMICAL,methylene group-carbocyclic nucleoside,methylene group-carbocyclic nucleosides
http://purl.obolibrary.org/obo/SYMP_0000002,DISEASE,abdominal distention,abdominal distension
NEW11545,CHEMICAL,dexmedetomidine use,dexmedetomidine use
NEW11546,MENTAL_HEALTH,mild agitation,mild agitation
NEW11547,BIOCHEMICAL,superb stabilizer,superb stabilizer
D001806,CHEMICAL,Blood Urea Nitrogen,"blood urea nitrogen|Nitrogen, Blood Urea|Urea Nitrogen, Blood|BUN"
NEW11549,CHEMICAL,increase serum creatinine,increased serum creatinine
NEW11551,CHEMICAL,lanthanum tracer distribution similar,lanthanum tracer distribution similar
http://purl.obolibrary.org/obo/CHEBI_35524,BIOCHEMICAL,sympathomimetic agent,sympathomimetic|sympathomimetics|cholinomimetic agents
C000705477,CHEMICAL,pemigatinib [Supplementary Concept],Pyrimidines|Pyrroles|Morpholines|pemigatinib
C000713257,CHEMICAL,futibatinib [Supplementary Concept],Pyrazoles|Pyrimidines|futibatinib|Pyrroles
C000604580,CHEMICAL,erdafitinib [Supplementary Concept],Pyrazoles|erdafitinib|Quinoxalines
C568950,CHEMICAL,infigratinib [Supplementary Concept],Pyrimidines|Phenylurea Compounds|infigratinib
NEW11552,BIOCHEMICAL,selective fgfr inhibitor,selective FGFR inhibitors
NEW11553,DISEASE,chronic heart failure,chronic heart failure
D011249,DISEASE,"Pregnancy Complications, Cardiovascular","cardiovascular complications|Pregnancy, Cardiovascular Complications|Complication, Cardiovascular Pregnancy|Pregnancies, Cardiovascular Complications|Cardiovascular Pregnancy Complication|Pregnancy Complication, Cardiovascular|Complications, Cardiovascular Pregnancy|Cardiovascular Pregnancy Complications"
NEW11554,DISEASE,pulmonary hypertensive crisis,pulmonary hypertensive crises
NEW11557,DISEASE,single-strain infection,single-strain infections
NEW11560,DISEASE,hypotensive action,hypotensive action
NEW11561,BIOCHEMICAL,relevant analgesic action,relevant analgesic action
NEW11562,CHEMICAL,6-hydroxydopamine mouse model,6-hydroxydopamine mouse model
NEW11563,CHEMICAL,levodopa off,levodopa OFF
NEW11564,DISEASE,hypersensibility,hypersensibility
NEW11566,CHEMICAL,morphine development,morphine development
NEW11569,BIOCHEMICAL,coeruleus antagonist precipitate opioid withdrawal,coeruleus antagonist precipitated opioid withdrawal
NEW11572,CHEMICAL,eaa receptor,EAA receptors
NEW11574,BIOCHEMICAL,cardioselective drug atenolol,cardioselective drug atenolol
NEW11575,DISEASE,severe pfj oa refractory,severe PFJ OA refractory
C043874,DISEASE,tumor migration inhibition factor [Supplementary Concept],Lymphokines|tumor migration
NEW11576,MENTAL_HEALTH,cell cycle apprehension,cell cycle apprehension
D008590,DISEASE,Meningoencephalitis,Cerebromeningitides|Encephalomeningitides|meningoencephalitis|Encephalomeningitis|Meningoencephalitides|Cerebromeningitis
NEW11578,CHEMICAL,endogenous κ-opioid receptor agonist dynorphin a,Dyn A|endogenous κ-opioid receptor agonist dynorphin A
NEW11583,DISEASE,aggravate b. graminis infection,aggravated B. graminis infection
D000601,CHEMICAL,"Amino Acids, Essential","Acids, Essential Amino|Amino Acid, Essential|essential amino acids|Essential Amino Acids|Acid, Essential Amino|Essential Amino Acid"
NEW11585,NUTRITION,wheat increase,wheat increase
NEW11586,DISEASE,disruptive behaviour,disruptive behaviour
NEW11588,DISEASE,breast tenderness,breast tenderness
NEW11589,DISEASE,abdominal bloating,abdominal bloating
NEW11591,CHEMICAL,morphine analgesic potency,morphine analgesic potency
NEW11594,MENTAL_HEALTH,detrusor hyperactivity,detrusor hyperactivity
NEW11596,DISEASE,powdery mildew infection,powdery mildew infection
D019800,CHEMICAL,Phenol,"Phenolate, Sodium|Carbolic Acid|Sodium Phenolate|phenol|Phenol, Sodium Salt|Phenolate Sodium|Hydroxybenzene|Carbol"
NEW11598,CHEMICAL,mda content,MDA content
NEW11599,DISEASE,biosafety gastrointestinal toxicity,biosafety gastrointestinal toxicity
NEW11601,CHEMICAL,lecithin-cholesterol acyltransferase activity,lecithin-cholesterol acyltransferase activity
NEW11602,NUTRITION,cholesterol efflux capacity,cholesterol efflux capacity
NEW11605,DISEASE,extensive intracerebral calcification,extensive intracerebral calcifications
NEW11610,BIOCHEMICAL,potent fxr agonist,potent FXR agonist
D000080874,CHEMICAL,Synucleinopathies,alpha Synuclein Pathology|a-Synucleinopathies|a-Synucleinopathy|Synucleinopathy|α-synucleinopathy|alpha Synucleinopathies|alpha Synuclein Pathologies|alpha-Synucleinopathy|alpha-Synucleinopathies
NEW11614,DISEASE,schizophrenia-like syndrome,schizophrenia-like syndromes
D015493,DISEASE,"Paraparesis, Tropical Spastic","HTLV I Associated Myelopathy Tropical Spastic Paraparesis|Myelopathy, HTLV-I-Associated|Myelopathies, Htlv-1-Associated|Tropical Spastic Paraplegia|Myelopathy, Human T Lymphotropic Virus Type 1 Associated|HTLV-I-Associated Myelopathy|Myelopathies, HTLV I Associated|Human T Lymphotropic Virus Type 1 Associated Myelopathy|Spastic Paraparesis, Tropical|Htlv-1-Associated Myelopathy|Familial Spastic Paraparesis, Htlv-1-Associated|Tropical Spastic Parapareses|Spastic Paraplegia, Tropical|Myelopathy, Human T-Lymphotropic Virus Type 1 Associated|HTLV-I-Associated Myelopathy-Tropical Spastic Paraparesis|myelopathy|Tropical Spastic Paraplegias|Parapareses, Tropical Spastic|Myelopathy, Htlv-1-Associated|Paraplegias, Tropical Spastic|Myelopathies, HTLV-I-Associated|HTLV I Associated Myelopathies|Human T-Lymphotropic Virus Type 1 Associated Myelopathy|Myelopathy, Htlv 1 Associated|Htlv-1-Associated Myelopathies|Familial Spastic Paraparesis, Htlv 1 Associated|Spastic Parapareses, Tropical|HTLV-I-Associated Myelopathies|Paraplegia, Tropical Spastic|Spastic Paraplegias, Tropical|Tropical Spastic Paraparesis|HTLV I Associated Myelopathy"
NEW11616,DISEASE,chronic prostatitis/chronic pelvic pain syndrome patient,chronic prostatitis/chronic pelvic pain syndrome patients
NEW11617,DISEASE,bph-related low urinary tract symptom,BPH-related lower urinary tract symptoms
NEW11618,DISEASE,wide-spread neuroapoptosis,wide-spread neuroapoptosis
NEW11620,DISEASE,alcohol-induced neuronal death,alcohol-induced neuronal death
NEW11621,DISEASE,ethanol-induced neuronal death,ethanol-induced neuronal death
NEW11624,DISEASE,skin pick disorder,Skin Picking Disorder
NEW11625,DISEASE,oxidative stress damage,oxidative stress damage
D005076,DISEASE,Exanthema,"Exanthem|Skin Rash|Rash, Skin|Rash|skin rash"
NEW11628,CHEMICAL,simple fixation anol compression,simple fixation anol compression
NEW11629,DISEASE,chronic prostatitis/chronic pelvic pain syndrome,chronic prostatitis/chronic pelvic pain syndrome
NEW11632,DISEASE,dysfunctional behaviour,dysfunctional behaviours
NEW11633,CHEMICAL,hypovitaminosis D.,hypovitaminosis D.
NEW11635,MENTAL_HEALTH,dsm-iv Autistic Disorder,DSM-IV Autistic Disorder
NEW11636,DISEASE,adult male high-functioning Autistic patient,Adult Male High-Functioning Autistic Patients
NEW11638,DISEASE,chronic psychosocial stress model,chronic psychosocial stress model
NEW11641,DISEASE,vaccine toxicity,vaccine toxicities
D054440,BIOCHEMICAL,"Receptors, Ghrelin","Receptor, Ghrelin|Growth Hormone Secretogogue Receptor 1B|GHSR Protein|GHS-R1B|GHS Receptor Type 1|Receptor, Growth Hormone Secretagogue 1A|GHS-R Type 1A|Growth Hormone Secretagogue Receptor|Growth Hormone Secretagogue Receptors|Growth Hormone Secretagogue Receptor Type 1B|Growth Hormone Secretagogue Receptor Type 1A|GHS R Type 1A|Ghrelin Receptor|Ghrelin Receptors|growth hormone secretagogue receptor|Growth Hormone Secretagogue Receptor Type 1|GHS-R1A"
D011966,BIOCHEMICAL,"Receptors, LHRH","Luteinizing Hormone Releasing Hormone Receptor|Gonadoliberin Receptors|Receptors, Luliberin|Luteinizing Hormone Releasing-Hormone Receptor|LHFSHRH Receptors|Gonadorelin Receptor|LHRH Receptor|Receptors, Gonadotropin Releasing-Hormone|Follicle Stimulating Hormone Releasing Hormone Receptors|Receptor, Gonadotropin-Releasing Hormone|Receptors, GnRH|Receptors, LHFSHRH|Hormone Receptor, Gonadotropin-Releasing|Gonadorelin Receptors|Releasing-Hormone Receptors, Gonadotropin|Luliberin Receptors|GnRH Receptor|Follicle Stimulating Hormone-Releasing Hormone Receptors|GnRH Receptors|Gonadotropin Releasing-Hormone Receptors|Receptor, Gonadorelin|LHRH Receptors|Gonadotropin Releasing Hormone Receptor|Receptor, LHRH|Gonadotropin Releasing Hormone Receptors|Receptor, GnRH|Receptors, Gonadotropin Releasing Hormone|Receptors, Gonadoliberin|Gonadotropin-Releasing Hormone Receptor|hormone-releasing hormone receptor|Receptors, Gonadorelin|Luteinizing Hormone Releasing Hormone Receptors"
NEW11643,NUTRITION,winter wheat field,winter wheat fields
NEW11644,DISEASE,in als catalytic activity assay,in ALS catalytic activity assays
NEW11647,DISEASE,galleria mellonella infection model,Galleria mellonella infection model
NEW11649,DISEASE,antibiotic-resistant a. baumannii infection due,antibiotic-resistant A. baumannii infections due
D058922,DISEASE,Inflammatory Breast Neoplasms,"Inflammatory Breast Cancers|Breast Cancer, Inflammatory|Inflammatory Breast Cancer (IBC)|Inflammatory Breast Carcinomas|Breast Carcinoma, Inflammatory|Inflammatory Breast Neoplasm|Inflammatory Breast Carcinoma|Breast Carcinomas, Inflammatory|Cancers, Inflammatory Breast|Breast Neoplasms, Inflammatory|Breast Cancers, Inflammatory|Carcinomas, Inflammatory Breast|Neoplasm, Inflammatory Breast|Neoplasms, Inflammatory Breast|Carcinoma, Inflammatory Breast|Cancer, Inflammatory Breast|Inflammatory Breast Cancer|Breast Neoplasm, Inflammatory|breast carcinomas"
NEW11652,DISEASE,progestin-regulated breast cancer cell proliferation,progestin-regulated breast cancer cell proliferation
NEW11654,DISEASE,nor-induced breast cancer cell proliferation,NOR-induced breast cancer cell proliferation
NEW11656,DISEASE,nor-stimulated breast cancer cell,NOR-stimulated breast cancer cells
NEW11657,CHEMICAL,nor-induced fas activation,NOR-induced FAS activation
NEW11659,CHEMICAL,fas activity,FAS activity
NEW11660,DISEASE,hormone-dependent breast cancer cell,hormone-dependent breast cancer cells
NEW11662,BIOCHEMICAL,botulinum toxin injection,botulinum toxin injection
D020821,DISEASE,Dystonic Disorders,"Dystonias, Hereditary|Adult Onset Idiopathic Torsion Dystonias|Secondary Dystonia|Pseudodystonias|Psychogenic Dystonia|Sporadic Dystonia|Focal Dystonia|Childhood Onset Dystonia|Adult-Onset Idiopathic Torsion Dystonias|Idiopathic Familial Dystonia|Dystonias, Familial|Dystonias, Primary|Dystonias, Secondary|Dystonia Disorder|Dystonia, Hereditary|Dystonia, Psychogenic|Familial Dystonias, Idiopathic|Hereditary Dystonia|Dystonia, Secondary|Writer's Cramp|Adult Onset Dystonias|Dystonia, Focal|Familial Dystonia, Autosomal Recessive|Focal Dystonias|Dystonia, Idiopathic Familial|Adult-Onset Idiopathic Focal Dystonias|Dystonias, Sporadic|Familial Dystonias|Familial Dystonia|Adult-Onset Dystonia|focal dystonia|Secondary Dystonias|Idiopathic Familial Dystonias|Autosomal Dominant Familial Dystonia|Childhood Onset Dystonias|Dystonias, Idiopathic Familial|Dystonia, Primary|Writers Cramp|Psychogenic Dystonias|Dystonia Disorders|Writer Cramp|Dystonias, Adult-Onset|Dystonia, Familial|Dystonias, Focal|Sporadic Dystonias|Familial Dystonia, Autosomal Dominant|Pseudodystonia|Dystonia, Childhood Onset|Dystonias, Childhood Onset|Hereditary Dystonias|Primary Dystonias|Dystonia, Adult-Onset|Primary Dystonia|Dystonia, Sporadic|Adult-Onset Dystonias|Familial Dystonia, Idiopathic|Dystonias, Psychogenic|Dystonic Disorder|Autosomal Recessive Familial Dystonia|Adult Onset Idiopathic Focal Dystonias"
NEW11665,DISEASE,HAMD psychotic symptom,HAMD psychotic symptoms
NEW11666,BIOCHEMICAL,high thyroid stimulating hormone tsh serum level,higher thyroid stimulating hormone TSH serum levels
NEW11668,MENTAL_HEALTH,suicide prevention,suicide prevention
NEW11669,MENTAL_HEALTH,suicide intervention,suicide intervention
NEW11670,DISEASE,impaired thyroid function,impaired thyroid function
NEW11671,CHEMICAL,blood glucose level,blood glucose level
NEW11672,MENTAL_HEALTH,lamina projection neuron,lamina projection neurons
NEW11673,DISEASE,gly-sipsc,gly-sIPSC
NEW11674,DISEASE,sni-induced dynamic,SNI-induced dynamic
NEW11676,NUTRITION,fatty acid metabolic disorder,fatty acid metabolic disorders
NEW11678,DISEASE,downstream impairment,downstream impairments
D016687,DISEASE,Polydioxanone,Absolok|PDS|PDS II (Ethicon)|Polydioxanones|Absoloks
NEW11680,DISEASE,bone calcification,bone calcification
NEW11682,BIOCHEMICAL,antifungal susceptibility,antifungal susceptibility
NEW11685,DISEASE,subsequent hypodopaminergia,subsequent hypodopaminergia
NEW11686,DISEASE,non-substance behavioral addiction,non-substance behavioral addictions
NEW11688,MENTAL_HEALTH,induce anhedonia,induced anhedonia
NEW11689,BIOCHEMICAL,long-acting beta-2 agonist,long-acting beta-2 agonists
D000069502,CHEMICAL,"Budesonide, Formoterol Fumarate Drug Combination","Symbicort|Drug Combination, Budesonide-Formoterol|Budesonide-Formoterol Drug Combination|Combination, Budesonide-Formoterol Drug|Budesonide Formoterol Fumarate Drug Combination|Budesonide Formoterol Drug Combination|formoterol|Budesonide-Formoterol Fumarate Drug Combination"
C554862,CHEMICAL,indacaterol-glycopyrronium combination [Supplementary Concept],indacaterol|Quinolones|Glycopyrrolate/analogs  and  derivatives|Indans|Drug Combinations
NEW11691,CHEMICAL,® device,® device
NEW11692,CHEMICAL,single-dose dry-powder inhaler,single-dose dry-powder inhaler
NEW11694,BIOCHEMICAL,menopausal hormone treatment,menopausal hormone treatment
http://purl.obolibrary.org/obo/PR_Q9QXS6,CHEMICAL,drebrin (mouse),dbn1|mdbn1|DRBA|drba|developmentally-regulated brain protein (mouse)
NEW11696,DISEASE,movement phenomenology,movement phenomenology
NEW11697,CHEMICAL,drba exposure,DRBA exposure
NEW11703,DISEASE,similar motor disorder,similar motor disorders
C084582,CHEMICAL,clemizole [Supplementary Concept],clemizole|Benzimidazoles
D014189,MENTAL_HEALTH,Transsexualism,transsexualism|Transgenderism
NEW11708,DISEASE,dyslipidaemia,dyslipidaemia
NEW11711,DISEASE,ra receptor,RA receptor
NEW11713,CHEMICAL,inhibitory system(s,inhibitory system(s
NEW11714,DISEASE,chronic bladder pain,chronic bladder pain
NEW11715,MENTAL_HEALTH,painful bladder syndrome,painful bladder syndromes
NEW11717,CHEMICAL,mid-dose range,mid-dose range
NEW11718,CHEMICAL,lipopolysaccharide administration,lipopolysaccharide administration
NEW11719,CHEMICAL,established systemic antidepressant,established systemic antidepressant
NEW11720,CHEMICAL,endogenous catecholamine,endogenous catecholamines
NEW11724,CHEMICAL,rnase h-competent complex,RNase H-competent complexes
NEW11725,MENTAL_HEALTH,selective dissociation,selective dissociation
NEW11727,CHEMICAL,non-nucleoside rt inhibitor,non-nucleoside RT inhibitor|NNRTI
NEW11729,CHEMICAL,nnrti susceptibility,NNRTI susceptibility
NEW11732,MENTAL_HEALTH,depression comorbid patient,depression comorbid patients
NEW11735,CHEMICAL,gamma-aminobutyric acid gaba pathway,gamma-aminobutyric acid GABA pathways
NEW11739,MENTAL_HEALTH,logistic regression analysis,logistic regression analysis
http://purl.obolibrary.org/obo/CHEBI_282234,CHEMICAL,dihydrodigitoxin,"20,22-Dihydrodigitoxin|10(-6)M|(3beta,5beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-14-hydroxycardanolide|dihydrodigitoxin"
D056824,DISEASE,Upper Extremity Deep Vein Thrombosis,"Exercise Induced Upper Extremity Deep Vein Thrombosis|Central Venous Catheter Thrombosis|Exercise-Induced Upper Extremity Deep Vein Thrombosis|Effort-Induced Upper Extremity Deep Vein Thrombosis|thrombosis|Effort Related Upper Extremity Deep Vein Thrombosis|Paget Schroetter Syndrome|Effort-Related Upper Extremity Deep Vein Thrombosis|Syndrome, Paget-Schroetter|Idiopathic Upper Extremity Deep Vein Thrombosis|Upper Extremity Deep Vein Thrombosis, Secondary|Paget-Schroetter Syndrome|Effort Induced Upper Extremity Deep Vein Thrombosis|Upper Extremity Deep Vein Thrombosis, Primary"
NEW11743,MENTAL_HEALTH,radial arm maze amnesia,radial arm maze amnesia
D003371,DISEASE,Cough,coughs|Coughs
NEW11745,CHEMICAL,ghb administration,GHB administration
NEW11746,DISEASE,cardio-cerebrovascular disease,CCVDs|cardio-cerebrovascular diseases
NEW11749,DISEASE,important cerebral lesion,important cerebral lesions
NEW11750,CHEMICAL,atropine toxicity,atropine toxicity
NEW11752,NUTRITION,reduce insect herbivory,reduced insect herbivory
NEW11756,BIOCHEMICAL,plasma hormone,plasma hormones
NEW11757,BIOCHEMICAL,pcb mixture,PCB mixture
NEW11759,MENTAL_HEALTH,first-episode major depressive disorder,first-episode Major Depressive Disorder
NEW11761,CHEMICAL,normal ornithine level,normal ornithine level
NEW11762,DISEASE,k suicidal death,K suicidal deaths
NEW11763,CHEMICAL,k people,K people
NEW11766,DISEASE,social-defeat stress,social-defeat stress
NEW11768,CHEMICAL,gad67 pathway,GAD67 pathways
NEW11769,DISEASE,sds-induced neurobehavioral deficit,SDS-induced neurobehavioral deficits
NEW11770,DISEASE,profound motor impairment,profound motor impairment
NEW11773,DISEASE,psychosis-like phenotype,psychosis-like phenotypes
D017397,CHEMICAL,Prefrontal Cortex,"Straight Gyrus|Medial Frontal Gyrus|Brodmanns Area 10|Orbitofrontal Gyrus|Cortex, Prefrontal|Superior Frontal Gyrus|Cortex, Orbitofrontal|Subcallosal Area|Prefrontal Cortices, Anterior|Gyrus Frontalis Inferior|Gyrus, Rectus|Orbitofrontal Region|Gyrus, Orbitofrontal|Prefrontal Cortex, Anterior|Area 11, Brodmann|Convolution, Superior Frontal|Gyrus, Superior Frontal|Gyrus, Inferior Frontal|Area 12, Brodmann's|Orbital Cortices|Pars Orbitalis|Ventromedial Prefrontal Cortex|Frontalis Superior, Gyrus|Inferior Frontal Gyrus|Area 47, Brodmann's|Area 47, Brodmann|Orbitofrontal Cortex|Anterior Prefrontal Cortices|Gyrus, Straight|Orbitofrontal Cortices, Lateral|Brodmann Area 11|Ventral Medial Prefrontal Cortex|Gyrus, Medial Frontal|Area 12, Brodmann|Orbital Areas|Orbitofrontal Cortices|Rectal Gyrus|Area 11, Brodmann's|Superior Frontal Convolution|Brodmann Area 47|Gyrus, Marginal|Region, Orbitofrontal|Area, Subcallosal|Frontal Gyrus, Superior|Cortex, Orbital|Olfactory Sulci|Orbitofrontal Cortex, Lateral|Brodmanns Area 11|medial prefrontal cortex|Orbital Area|Brodmann Area 12|Superior, Gyrus Frontalis|Convolutions, Superior Frontal|Cortex, Lateral Orbitofrontal|Subcallosal Areas|Frontal Gyrus, Medial|Orbital Gyrus|mPFC|Lateral Orbitofrontal Cortices|Gyrus Orbitalis|Cortex, Ventromedial Prefrontal|Rectus Gyrus|Brodmanns Area 12|Brodmann's Area 12|Gyrus, Rectal|Orbital Cortex|Brodmann's Area 10|Sulcus, Frontal|Frontal Sulcus|Area, Orbital|Cortices, Ventromedial Prefrontal|Area 10, Brodmann's|Marginal Gyrus|Orbital Gyri|Brodmanns Area 47|Brodmann's Area 47|Ventromedial Prefrontal Cortices|Orbitalis, Pars|Brodmann's Area 11|Brodmann Area 10|Area 10, Brodmann|Olfactory Sulcus|Gyrus Rectus|Cortex, Anterior Prefrontal|Frontal Convolution, Superior|Gyrus, Orbital|Orbitofrontal Regions|Inferior, Gyrus Frontalis|Lateral Orbitofrontal Cortex|Gyrus Frontalis Superior|Superior Frontal Convolutions|Frontal Gyrus, Inferior|Orbitofrontal Gyri|Anterior Prefrontal Cortex|Prefrontal Cortex, Ventromedial"
NEW11775,CHEMICAL,prenatal poly(i c exposure,prenatal poly(I C exposure
NEW11778,MENTAL_HEALTH,early onset psychosis,early onset psychosis
NEW11780,DISEASE,trace element toxicity,trace element toxicity
NEW11786,MENTAL_HEALTH,treatment-resistant depression patient,treatment-resistant depression patients
NEW11788,DISEASE,schizophrenic inpatient,schizophrenic inpatients
D044095,DISEASE,Proteus penneri,Proteus|Proteus (1982-2003)
C014481,BIOCHEMICAL,dihydrocodeine [Supplementary Concept],dihydrocodeine|Codeine/analogs  and  derivatives|opioid analgesic
NEW11790,CHEMICAL,inpatient surgery tramadol,inpatient surgery tramadol
NEW11791,CHEMICAL,premedicant,premedicant
D017321,CHEMICAL,"Clinical Trials, Phase I as Topic","Clinical Trials, Phase 1|Drug Evaluation, FDA Phase 1|FDA|Trial, Human Microdosing|Phase I Clinical Trial|Human Microdosing Trials|Human Microdosing Trial|Evaluation Studies, FDA Phase 1|Microdosing Trials, Human|Drug Evaluation, FDA Phase I|Phase 1 Clinical Trials|Microdosing Trial, Human|Clinical Trials, Phase I|Phase I Clinical Trials|Drug Evaluation, FDA Phase I as Topic|Phase 1 Clinical Trial|Evaluation Studies, FDA Phase I|Trials, Human Microdosing"
NEW11792,DISEASE,severe parkinsonism,severe parkinsonism
NEW11793,CHEMICAL,glutamate concentration,glutamate concentration
NEW11794,DISEASE,cerebrovascular insufficiency state,cerebrovascular insufficiency states
NEW11796,BIOCHEMICAL,antidiuretic hormone secretion,antidiuretic hormone secretion
NEW11797,DISEASE,intracranial mass,intracranial mass
NEW11798,DISEASE,cerebral edema due,cerebral edema due
NEW11799,MENTAL_HEALTH,crave risk,craving risk
NEW11802,CHEMICAL,ant-man,Ant-Man
NEW11804,CHEMICAL,m(1)-selective positive allosteric modulator,M(1)-selective positive allosteric modulator
NEW11805,CHEMICAL,brand name elavil,brand name Elavil
NEW11806,CHEMICAL,anti-convulsant drug,anti-convulsant drugs
NEW11808,MENTAL_HEALTH,global dementia,global dementia
NEW11809,MENTAL_HEALTH,maintenance insomnia,maintenance insomnia
NEW11811,DISEASE,robust dependence behavior,robust dependence behaviors
D009026,DISEASE,Mortality,"Case Fatality Rate|Rates, Case Fatality|Rate, Crude Mortality|Excess Mortality|Mortality Rate|Crude Mortality Rates|Mortality Rate, Crude|Death Rate, Age-Specific|Differential Mortalities|Death Rates|death rate|Mortality Rates|Rate, Age-Specific Death|Crude Death Rates|Mortalities|Differential Mortality|CFR Case Fatality Rate|Death Rate|Case Fatality Rates|Rate, Death|Rate, Mortality|Mortality, Excess|Determinant, Mortality|Mortality Determinants|Age-Specific Death Rates|Determinants, Mortality|Age Specific Death Rate|Mortality Declines|Rate, Crude Death|Mortality Decline|Rate, Case Fatality|Crude Death Rate|Decline, Mortality|Mortality Determinant|Excess Mortalities|Age-Specific Death Rate|Crude Mortality Rate|Death Rate, Crude|Mortality, Differential"
NEW11812,MENTAL_HEALTH,narcotic craving,narcotic craving
NEW11813,BIOCHEMICAL,opioid antagonist treatment,opioid antagonists treatment
NEW11815,DISEASE,impulsive behaviour,impulsive behaviours
http://purl.obolibrary.org/obo/CHEBI_27594,CHEMICAL,carbon atom,Kohlenstoff|6C|C|Carbon|carbono|carbon|carbon atoms|carbone|carbonium
NEW11817,CHEMICAL,ω-(furan-2-yl)alkane-1-thiol,ω-(furan-2-yl)alkane-1-thiols
http://purl.obolibrary.org/obo/CHEBI_52939,CHEMICAL,gamma-lactone ring,gamma-lactone rings|gamma-lactone|furan ring|gamma-lactone ring
NEW11818,CHEMICAL,antiparkinson medication,antiparkinson medication
NEW11819,DISEASE,hyperlipidemia alteration,hyperlipidemia alterations
NEW11820,DISEASE,epileptic episode,epileptic episodes
NEW11822,DISEASE,tg diet,TG diets
NEW11823,DISEASE,encephalopathic mechanism,encephalopathic mechanisms
http://purl.obolibrary.org/obo/CHEBI_33978,CHEMICAL,alkali metal hydroxide,alkali metal base|metal hydroxide|alkali metal hydroxides|alkali metal bases
NEW11826,CHEMICAL,carbon production,carbon production
NEW11828,NUTRITION,ldl cholesterol level,LDL cholesterol levels
NEW11833,DISEASE,respiratory anomaly,respiratory anomalies
NEW11837,DISEASE,endocrine-responsive breast cancer cell,endocrine-responsive breast cancer cells
NEW11839,DISEASE,non-endocrine er+/her2 breast cancer cell,non-endocrine ER+/HER2 breast cancer cells
NEW11841,DISEASE,er+ breast cancer,ER+ breast cancer
NEW11846,MENTAL_HEALTH,bipolar disorder diagnosis,bipolar disorder diagnosis
NEW11847,DISEASE,weight gain useful,weight gain useful
NEW11849,DISEASE,human oral cancer cell,human oral cancer cells
NEW11850,MENTAL_HEALTH,non-alcohol related delirium,non-alcohol related delirium
NEW11851,DISEASE,desmosomal dysfunction,desmosomal dysfunction
NEW11854,BIOCHEMICAL,uremic toxin accumulation,uremic toxin accumulation
D051784,CHEMICAL,Aryl Hydrocarbon Receptor Nuclear Translocator,"Nuclear Translocator, AhR|Aryl Hydrocarbon Nuclear Translocator|Dioxin Receptor, Nuclear Translocator|Hypoxia Inducible Factor 1, beta Subunit|aryl hydrocarbon receptor|Ah Receptor Nuclear Translocator Protein|AhR Nuclear Translocator|Hypoxia-Inducible Factor 1, beta Subunit"
NEW11858,DISEASE,blood pressure management,blood pressure management
NEW11859,CHEMICAL,nucleus accumbens/anterior limb,nucleus accumbens/anterior limb
NEW11867,CHEMICAL,soluble epoxide hydrolase(seh)-derived oxylipin breakdown product,soluble epoxide hydrolase(sEH)-derived oxylipin breakdown products
NEW11868,DISEASE,morphine psychic dependence,morphine psychic dependence
NEW11872,DISEASE,nausea hot bathing,nausea hot bathing
NEW11873,DISEASE,emesis response,emesis response
NEW11874,CHEMICAL,cannabis plant,cannabis plant
NEW11876,MENTAL_HEALTH,perceive fatigue,perceived fatigue
NEW11878,CHEMICAL,cgrp substance p immunoreactivity,CGRP substance P immunoreactivity
NEW11879,DISEASE,robust withdrawal syndrome,robust withdrawal syndrome
NEW11880,BIOCHEMICAL,dopamine agonist therapy,dopamine agonist therapy
D018785,DISEASE,Tricuspid Atresia,"Tricuspid Valve Atresia|atresia|Tricuspid Valve Atresias|Valve Atresias, Tricuspid|Valve Atresia, Tricuspid|Atresia, Tricuspid Valve|Atresias, Tricuspid|Atresias, Tricuspid Valve|Atresia, Tricuspid|Absent Right Atrioventricular Connection|Tricuspid Atresias"
NEW11882,MENTAL_HEALTH,gonadal regression,gonadal regression
NEW11883,DISEASE,tcm doctor,TCM doctors
NEW11884,DISEASE,over-consolidated traumatic memory,over-consolidated traumatic memories
NEW11885,DISEASE,low parasitemia,lower parasitemia
D000091246,DISEASE,Memory T Cells,"T Cell, Memory|Effector Memory T Cells|Lymphocyte, Memory T|Memory T Cell|Tissue Resident Memory T Cells|Lymphocytes, Memory T|T Lymphocytes, Memory|effector memory T cells|Central Memory T Cells|Memory T Lymphocytes|Memory T Lymphocyte|T Lymphocyte, Memory|Virtual Memory T Cells"
NEW11886,DISEASE,late acute disease,late acute disease
NEW11887,DISEASE,mood behavior,mood behavior
NEW11889,DISEASE,preexist pancreatic damage,preexisting pancreatic damage
NEW11891,DISEASE,disorder ptsd symptom,disorder PTSD symptoms
NEW11892,DISEASE,trauma other,trauma other
NEW11893,DISEASE,clinician-administered ptsd scale,Clinician-Administered PTSD Scale
NEW11895,DISEASE,ptsd scale,PTSD Scale
D054448,DISEASE,"Precursor Cells, B-Lymphoid","Transitional B-Lymphocyte|Pro B Cells|Lymphocyte, Pro-B|B Lymphoid Precursor Cells|Pro-B Cells|B-Lymphocytes, Precursor|Pre-B Cells|Pre B Lymphocyte|B-Cell, Precursor|Lymphocyte, Pre-B|Transitional B-Cell|Cells, Pro-B|Immature B-Cell|Pre-B-Cells|Transitional B Cell|Precursor Cells, B Lymphoid|Progenitor B-Cell|Progenitor B-Lymphocytes|B-Lymphocytes, Immature|B-Lymphocyte, Precursor|B-Lymphocyte, Transitional|Pro B Cell|B-Cells, Progenitor|B-Cell, Immature|SE|B-Lymphocyte, Immature|Pro-B Lymphocytes|Cells, Pre-B|Cell, Pro-B|B-Lymphoid Precursor Cells|Progenitor B Lymphocytes|Immature B Lymphocyte|Pro-B Lymphocyte|B-Lymphocyte, Progenitor|B-Lymphocytes, Progenitor|Immature B-Lymphocytes|Transitional B Cells|Immature B Cells|Cell, Immature B|Precursor B Lymphocytes|Cells, Immature B|Precursor B-Lymphocytes|Pre-B Lymphocytes|Precursor B Lymphocyte|B-Cells, Transitional|Immature B Lymphocytes|Precursor B Cells|B Lymphoid Precursor Cell|Precursor B-Cell|Pre B Cell|Precursor B Cell|Immature B-Cells|B-Cells, Immature|Pro B Lymphocytes|B|Transitional B Lymphocytes|B Cell, Immature|Pro-B-Cells|Progenitor B Cell|B-Lymphoid Precursor Cell|Cells, B-Lymphoid Precursor|Transitional B-Cells|Progenitor B Lymphocyte|Transitional B-Lymphocytes|Pre B Cells|Pre-B-Cell|B-Cell, Transitional|B Cells, Immature|Pre B Lymphocytes|Transitional B Lymphocyte|Progenitor B Cells|Precursor B-Lymphocyte|Immature B-Lymphocyte|Lymphocytes, Pro-B|Precursor Cell, B-Lymphoid|Cell, B-Lymphoid Precursor|B-Cell, Progenitor|Pre-B Lymphocyte|Pre-B Cell|Immature B Cell|B-Lymphocytes, Transitional|Progenitor B-Lymphocyte|Lymphocytes, Pre-B|Pro-B-Cell|Cell, Pre-B|B-Cells, Precursor|Pro B Lymphocyte|Precursor B-Cells|Pro-B Cell|Progenitor B-Cells"
NEW11896,DISEASE,acs-induced ptss,ACS-induced PTSS
NEW11898,CHEMICAL,phytopigment,phytopigments
NEW11900,DISEASE,diabetic cell,diabetic cells
NEW11901,DISEASE,least toxicity,least toxicity
NEW11903,MENTAL_HEALTH,resistance reversal capability,resistance reversal capability
NEW11904,BIOCHEMICAL,group allergen,Group allergen
NEW11905,BIOCHEMICAL,principal antigen,principal antigen
NEW11907,CHEMICAL,pl lipid,PL lipids
NEW11913,CHEMICAL,nitrate solution,nitrate solution
NEW11915,CHEMICAL,3'-deoxy-hanasanagin,3'-deoxy-hanasanagin
NEW11916,NUTRITION,insect portion,insect portions
NEW11918,CHEMICAL,severe covid-19 survivor,severe COVID-19 survivors
NEW11919,BIOCHEMICAL,steroid drug administration,steroid drug administration
NEW11920,CHEMICAL,covid-19 sequela,COVID-19 sequela
NEW11922,DISEASE,check behavior,checking behavior
NEW11924,DISEASE,pain research,pain research
NEW11925,DISEASE,so-called death,so-called deaths
NEW11926,DISEASE,punde,punding
NEW11929,DISEASE,lithium-induced spatial learning impairment,lithium-induced spatial learning impairment
NEW11930,DISEASE,non-dementia psychiatric disorder,non-dementia psychiatric disorders
NEW11933,DISEASE,menopause disorder,menopause disorders
NEW11934,DISEASE,s. castanea,S. castanea
D055051,CHEMICAL,Salt-Tolerant Plants,"Halophytes|Plant, Saline-Tolerant|Plants, Halophytic|Plants, Halophilic|Salt Tolerant Plants|Plants, Salt-Tolerant|Halophyte|Halophilic Plant|Plants, Saline-Tolerant|Saline-Tolerant Plants|Plant, Saline-Resistant|Saline Resistant Plants|salt|Salt-Resistant Plant|Salt-Tolerant Plant|Halophytic Plant|Salt Resistant Plants|Salt-Resistant Plants|Salt-Adapted Plant|Plants, Saline-Resistant|Halophytic Plants|Salt-Adapted Plants|Saline Tolerant Plants|Plant, Salt-Resistant|Halophilic Plants|Saline-Resistant Plants|Plant, Halophytic|Plant, Salt-Adapted|Plants, Salt Tolerant|Plants, Salt-Adapted|Plants, Salt-Resistant|Salt Adapted Plants|Plant, Salt-Tolerant|Plant, Halophilic|Saline-Resistant Plant|Saline-Tolerant Plant"
NEW11937,DISEASE,pregnancy-associated mammary gland ductal side-branching,pregnancy-associated mammary gland ductal side-branching
NEW11938,CHEMICAL,subacute scopolamine,subacute scopolamine
D054975,DISEASE,Pallister-Hall Syndrome,"Hypothalamic Hamartoblastoma Syndromes|Hypothalamic Hamartoblastoma Syndrome|CAVE Complices|Hypothalamic Hamartoblastoma, Hypopituitarism, Imperforate Anus, and Postaxial Polydactyly|Hall Pallister Syndrome|Syndromes, Hypothalamic Hamartoblastoma|Hall-Pallister Syndrome|Hamartoblastoma Syndromes, Hypothalamic|Syndrome, Hall-Pallister|Syndrome, Pallister-Hall|Complex, CAVE|Syndrome, Hypothalamic Hamartoblastoma|Cerebroacrovisceral Early Lethality Complex|Complices, CAVE|Pallister Hall Syndrome|Pallister-Hall syndrome|Hamartoblastoma Syndrome, Hypothalamic|CAVE Complex"
http://purl.obolibrary.org/obo/DOID_0110978,DISEASE,brachydactyly type a1d,postaxial polydactyly type A|BDA1D
C537300,DISEASE,Greig cephalopolysyndactyly syndrome [Supplementary Concept],Acrocephalosyndactylia|Greig cephalopolysyndactyly syndrome
NEW11941,MENTAL_HEALTH,severe bipolar depression,severe bipolar depression
NEW11944,MENTAL_HEALTH,high nicotine dependence,higher nicotine dependence
NEW11946,MENTAL_HEALTH,retinotectal projection,retinotectal projection
NEW11949,BIOCHEMICAL,short-acting beta-2-adrenoceptor agonist,short-acting beta-2-adrenoceptor agonists
NEW11951,DISEASE,copd recurrent exacerbation,COPD recurrent exacerbations
NEW11952,BIOCHEMICAL,long-acting beta-2-adrenoceptor agonist,long-acting beta-2-adrenoceptor agonists
NEW11954,DISEASE,intestinal flora disorder,intestinal flora disorders
NEW11955,DISEASE,enhance inflammation,enhanced inflammation
NEW11956,DISEASE,tumor necrosis factor-α     expression consistent,tumor necrosis factor-α    expression consistent
NEW11957,BIOCHEMICAL,beta conformation,beta conformation
NEW11959,DISEASE,disease experience weight gain,disease experience weight gain
NEW11960,CHEMICAL,cih animal,CIH animals
NEW11961,BIOCHEMICAL,Federal Carrier Safety Administration,Federal Carrier Safety Administration
NEW11963,BIOCHEMICAL,long-acting muscarinic antagonist,long-acting muscarinic antagonist
NEW11964,CHEMICAL,triple fixed-dose combination inhaler therapy,triple fixed-dose combination inhaler therapy
NEW11965,DISEASE,catalepsy intensity,catalepsy intensity
NEW11966,DISEASE,catalepsy onset,catalepsy onset
C084820,CHEMICAL,profenamine [Supplementary Concept],ethopropazine|Phenothiazines
NEW11967,DISEASE,catalepsy time,catalepsy time
NEW11968,BIOCHEMICAL,selective a(2a)r antagonist zm,selective A(2A)R antagonist ZM
NEW11973,DISEASE,bacterial pathogen pseudomonas syringae pv,bacterial pathogen Pseudomonas syringae pv
C514341,MENTAL_HEALTH,"RFO1 protein, Arabidopsis [Supplementary Concept]",Arabidopsis Proteins|Arabidopsis resistance|Protein Kinases
NEW11974,CHEMICAL,aberrant potassium regulation,aberrant potassium regulation
NEW11977,CHEMICAL,clenbuterol muscle hypertrophy,clenbuterol muscle hypertrophy
NEW11980,CHEMICAL,rhodamine accumulation,Rhodamine accumulation
C494366,NUTRITION,"calcium phosphate, dibasic, dihydrate [Supplementary Concept]",calcium phosphate|Calcium Phosphates
NEW11984,DISEASE,lps-induced lipidosis,LPS-induced lipidosis
NEW11985,DISEASE,inflammation pathway,inflammation pathway
NEW11987,DISEASE,lps-related nafld damage,LPS-related NAFLD damage
NEW11988,DISEASE,glucose disposal,glucose disposal
NEW11989,DISEASE,nonalcoholic fatty liver disease activity score,nonalcoholic fatty liver disease activity score
NEW11991,MENTAL_HEALTH,deep depression,deep depression
NEW11992,MENTAL_HEALTH,nervous bulimia,nervous bulimia
NEW11994,CHEMICAL,fluoxetine cytotoxicity,fluoxetine cytotoxicity
NEW11996,CHEMICAL,ovx+cums mouse,OVX+CUMS mice
NEW11998,CHEMICAL,comedication,comedication
NEW12001,CHEMICAL,normal creatine kinase level,normal creatine kinase levels
NEW12002,DISEASE,unexplained paravertebral myopathy,unexplained paravertebral myopathies
NEW12003,DISEASE,late onset camptocormia,late onset camptocormia
NEW12004,BIOCHEMICAL,neoantigen processing,neoantigen processing
NEW12005,CHEMICAL,damage brain serotonin neuron,damaged brain serotonin neurons
NEW12006,MENTAL_HEALTH,emergent impulse control disorder,emergent impulse control disorders
D013203,DISEASE,Staphylococcal Infections,"Staphylococcal Infection|aureus infections|Staphylococcus aureus Infection|Staphylococcus aureus Infections|Infections, Staphylococcal"
NEW12010,BIOCHEMICAL,cyclic lipopeptide antibiotic active,cyclic lipopeptide antibiotic active
NEW12012,DISEASE,oropharyngeal candidiasis,oropharyngeal candidiasis
NEW12013,CHEMICAL,antifungal drug fluconazole,antifungal drug fluconazole
C570512,MENTAL_HEALTH,"SARD1 protein, Arabidopsis [Supplementary Concept]",Arabidopsis Proteins|acquired resistance
C448722,DISEASE,"DISC2 gene product, human [Supplementary Concept]","RNA, Long Noncoding|Disrupted-In-Schizophrenia"
NEW12015,NUTRITION,increase dietary fibre,increased dietary fibre
C587462,CHEMICAL,sodium polyethylene glycol monododecyl ether sulfate [Supplementary Concept],Polyethylene Glycols|ether sulfate
NEW12018,CHEMICAL,hydroxyethylidene bisphosphonate,hydroxyethylidene bisphosphonate
NEW12019,NUTRITION,xp-endo Finisher instrument,XP-Endo Finisher instrument
NEW12020,CHEMICAL,central 5ht receptor sensitivity,central 5HT receptor sensitivity
NEW12022,MENTAL_HEALTH,animal anhedonia,animals anhedonia
NEW12023,BIOCHEMICAL,antitubercular therapy,antitubercular therapy
NEW12024,NUTRITION,whale polar bear,whale polar bear
NEW12025,BIOCHEMICAL,excessive vitamin a intake,excessive vitamin A intake
NEW12026,DISEASE,leprosy transmission,leprosy transmission
NEW12027,BIOCHEMICAL,androgen secretion,androgen secretion
NEW12029,BIOCHEMICAL,estrogen supplementation ± suppression,estrogen supplementation ± suppression
NEW12031,CHEMICAL,glycine response kinetic,glycine response kinetics
D011371,DISEASE,Progeria,"Hutchinson-Gilford Progeria Syndrome|Hutchinson-Gilford Syndrome|Hutchinson Gilford Syndrome|Progeria Syndromes, Hutchinson-Gilford|Hutchinson-Gilford Progeria Syndromes|progeria|Progeria Syndrome, Hutchinson-Gilford|Hutchinson Gilford Progeria Syndrome"
NEW12034,BIOCHEMICAL,pre- androgen level,pre- androgen levels
NEW12035,BIOCHEMICAL,elevated androgen,elevated androgens
NEW12037,DISEASE,parietal c white matter,parietal C white matter
http://purl.obolibrary.org/obo/UBERON_0004720,DISEASE,cerebellar vermis,cerebellar vermian
NEW12039,MENTAL_HEALTH,high intrinsic resistance,high intrinsic resistance
http://purl.obolibrary.org/obo/CHEBI_478164,CHEMICAL,cefepime,"(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(1-methylpyrrolidinium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate|piperacillin/tazobactam|CFPM|cefepima|Cefepime|cefepime|cefepimum|7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-[(1-methylpyrrolidinium-1-yl)methyl]-3,4-didehydrocepham-4-carboxylate"
http://purl.obolibrary.org/obo/CHEBI_29013,CHEMICAL,fusidic acid,"(2Z)-2-[(17Z)-16beta-acetoxy-3alpha,11alpha-dihydroxy-4alpha,8alpha,10,14beta-tetramethyl-5alpha,9beta,13alpha-gonan-17-ylidene]-6-methylhept-5-enoic acid|Ramycin|Fusidine|Fusidic acid|Fucidin acid|fucidic acid|amoxicillin/clavulanic acid"
NEW12042,DISEASE,acquire immunodeficiency syndrome patient,acquired immunodeficiency syndrome patients
D016470,DISEASE,Bacteremia,Bacteremias|bacteremia
NEW12044,DISEASE,perirenal fat mass,perirenal fat mass
NEW12045,DISEASE,dyslipidemia level,dyslipidemia levels
NEW12046,CHEMICAL,selective noradrenaline reuptake blocker atomoxetine,selective noradrenaline reuptake blocker atomoxetine
NEW12049,DISEASE,ethanol-induced brain injury,ethanol-induced brain injury
NEW12050,DISEASE,ethanol-mediated inflammation,ethanol-mediated inflammation
NEW12051,MENTAL_HEALTH,anti-oxidant defense mechanism,anti-oxidant defense mechanism
D020421,DISEASE,Vagus Nerve Diseases,"Pneumogastric Nerve Disorder|Vagus Nerve Motor Disorder|Cranial Nerve X Diseases|Neuropathies, Vagus|Vagus Neuropathies|Tenth Cranial Nerve Diseases|Vagus Nerve Disorders|Vagus Nerve Disorder|Vagus Neuropathy|Pneumogastric Nerve Disorders|Motor Disorder, Vagus Nerve|Neuropathy, Vagus|Disorder, Pneumogastric Nerve|Disorders, Pneumogastric Nerve|motor disorder|Sensory Disorder, Vagus Nerve|Vagus Nerve Sensory Disorder|Vagus Nerve Disease"
NEW12052,BIOCHEMICAL,drug disorder,drug disorders
NEW12053,BIOCHEMICAL,serum vitamin d level,serum vitamin D levels
NEW12055,DISEASE,sleep-disordered respiration,sleep-disordered respiration
NEW12056,DISEASE,upper airway muscle respiratory burst,upper airway muscle respiratory bursts
NEW12058,BIOCHEMICAL,sugar sweetener,sugar sweeteners
NEW12066,DISEASE,dm disorder,DM disorders
NEW12067,BIOCHEMICAL,endocrine presentation,endocrine presentations
D002554,CHEMICAL,Cerebrosides,cerebrosides
NEW12069,NUTRITION,ganglioside fatty acid,ganglioside fatty acids
D033781,CHEMICAL,Adenine Nucleotide Translocator 3,"Transport Protein, ANT-3|ADP, ATP Carrier Protein, Liver Isoform T2|Transport Protein, ANT3|Solute Carrier Family 25, Member 6|Solute Carrier Family 25 Member 6|SLC25A6 Protein|ANT3 Transport Protein|ANT-3 Transport Protein|ADP ATP Carrier Protein, Liver Isoform T2|adenine|Solute Carrier Family 25 (Mitochondrial Carrier - Adenine Nucleotide Translocator), Member 6|ANT 3 Transport Protein|ADP-ATP Carrier Protein, Liver Isoform T2"
NEW12072,CHEMICAL,fumigation test,fumigation tests
NEW12074,MENTAL_HEALTH,collision-induced dissociation ms2 datum,collision-induced dissociation MS2 data
NEW12077,BIOCHEMICAL,fungicide resistance,fungicide resistance
NEW12079,CHEMICAL,drug-induced stuttering,DIS|Drug-induced stuttering
NEW12083,MENTAL_HEALTH,drug-induced stuttering,drug-induced stuttering
NEW12087,CHEMICAL,low pge2 metabolite level,lower PGE2 metabolite levels
NEW12089,DISEASE,postoperative mi,postoperative MI
NEW12090,CHEMICAL,severe intractable ne,severe intractable NE
NEW12093,CHEMICAL,sucrose- medium,sucrose- media
NEW12095,DISEASE,anxious psychopathology,anxious psychopathology
NEW12097,MENTAL_HEALTH,self-reported anxiety symptom,self-reported anxiety symptoms
NEW12098,MENTAL_HEALTH,increase anxiety symptom count,increased anxiety symptom counts
NEW12100,CHEMICAL,salivary dhea concentration,salivary DHEA concentrations
NEW12105,DISEASE,spinal cord ischaemia-reperfusion injury,spinal cord ischaemia-reperfusion injury
NEW12106,DISEASE,temporary ischaemia,temporary ischaemia
NEW12109,BIOCHEMICAL,gabapentin agonist,gabapentin agonists
NEW12112,CHEMICAL,alcohol metabolism,alcohol metabolism
NEW12114,CHEMICAL,sweet lime,sweet lime
NEW12116,BIOCHEMICAL,hormone use,hormone use
NEW12118,CHEMICAL,smoking duration,smoking duration
NEW12119,DISEASE,diabete status,diabetes status
NEW12120,MENTAL_HEALTH,conditional logistic regression analysis,conditional logistic regression analysis
NEW12121,CHEMICAL,cotinine level,cotinine levels
NEW12122,DISEASE,colorectal cancer risk,colorectal cancer risk
NEW12123,DISEASE,rectal cancer case,rectal cancer cases
NEW12124,DISEASE,colon cancer case,colon cancer cases
NEW12125,BIOCHEMICAL,effective antiviral therapy,effective antiviral therapies
http://purl.obolibrary.org/obo/SYMP_0000018,DISEASE,darkening of skin,skin discoloration
NEW12129,DISEASE,alzheimer 's type,SDAT|Alzheimer 's type
NEW12130,DISEASE,human SDAT unclear,human SDAT unclear
D054312,DISEASE,Buruli Ulcer,"Mycobacterium ulcerans Infection|Buruli Ulcer Disease|Infections, Mycobacterium ulcerans|Mycobacterium ulcerans Infections|Ulcer Disease, Buruli|Infection, Mycobacterium ulcerans|ulcer|Ulcer Diseases, Buruli|Ulcer, Buruli|Diseases, Buruli Ulcer|Buruli Ulcer Diseases|Disease, Buruli Ulcer"
NEW12131,MENTAL_HEALTH,supraspinal descending projection fiber,supraspinal descending projection fibers
NEW12132,CHEMICAL,low serum testosterone concentration,lower serum testosterone concentration
NEW12134,DISEASE,endogenous depressed drug-free patient,endogenous depressed drug-free patients
NEW12137,CHEMICAL,sr receptor antagonist naltrexone,SR receptor antagonist naltrexone
NEW12139,BIOCHEMICAL,suboptimal drug level,suboptimal drug levels
D018253,DISEASE,"Adenoma, Villous","Adenomas, Villous|Villous Adenomas|villous adenomas|Villous Adenoma"
NEW12141,DISEASE,endotoxinemia,endotoxinemia
NEW12142,CHEMICAL,(3)h-pirenzepine binding,(3)H-pirenzepine binding
NEW12146,MENTAL_HEALTH,nonlinear regression,nonlinear regression
NEW12147,DISEASE,stroke breast cancer,stroke breast cancer
NEW12148,DISEASE,carbapenem-resistant acinetobacter baumannii,CRAB|carbapenem-resistant Acinetobacter baumannii
NEW12149,BIOCHEMICAL,conclusion antimicrobial activity,conclusion antimicrobial activity
NEW12150,BIOCHEMICAL,third-generation beta-adrenoceptor antagonist,third-generation beta-adrenoceptor antagonist
NEW12151,DISEASE,hypertension heart failure,hypertension heart failure
NEW12154,DISEASE,severe motor dysfunction,severe motor dysfunction
NEW12155,DISEASE,autistic behavior,autistic behavior
NEW12156,DISEASE,symptom vaginal dryness,symptoms vaginal dryness
NEW12157,MENTAL_HEALTH,management mood disorder,management mood disorders
D000072817,DISEASE,Eryptosis,"Apoptoses, Erythrocyte|suicidal erythrocyte death|Deaths, Suicidal Erythrocyte|Erythrocyte Deaths, Suicidal|Death, Suicidal Erythrocyte|Suicidal Erythrocyte Death|Erythrocyte Death, Suicidal|Erythrocyte Apoptoses|Erythrocyte Apoptosis|Suicidal Erythrocyte Deaths|Apoptosis, Erythrocyte"
NEW12162,NUTRITION,phosphatidylserine exposure,phosphatidylserine exposure
NEW12163,MENTAL_HEALTH,mania mood-stabilising agent,mania mood-stabilising agents
NEW12164,DISEASE,concurrent hypomanic symptom,concurrent hypomanic symptoms
NEW12165,MENTAL_HEALTH,depression recurrence,depression recurrences
NEW12169,DISEASE,related hyperammonemia,related hyperammonemia
NEW12170,MENTAL_HEALTH,system depression,system depression
NEW12172,DISEASE,aggression test,aggression tests
NEW12173,DISEASE,host inflammation,host inflammation
NEW12174,CHEMICAL,vf gene,VF genes
NEW12176,DISEASE,pre-existing coronary disease,pre-existing coronary disease
NEW12179,DISEASE,serious infectious disease,serious infectious diseases
NEW12180,DISEASE,mycobacterial infection,mycobacterial infections
NEW12183,BIOCHEMICAL,novel antimycobacterial drug,novel antimycobacterial drugs
NEW12185,MENTAL_HEALTH,riboswitch-mediated repression,riboswitch-mediated repression
NEW12187,CHEMICAL,infanrix hexa trade mark,Infanrix hexa trade mark
NEW12191,BIOCHEMICAL,potential drug resistance,potential drug resistance
NEW12193,MENTAL_HEALTH,open-field hyperactivity,open-field hyperactivity
NEW12196,NUTRITION,tree nursery,tree nurseries
NEW12199,BIOCHEMICAL,antifungal probiotic saccharomyces boulardii,antifungal probiotic Saccharomyces boulardii
http://purl.obolibrary.org/obo/CHEBI_50825,CHEMICAL,gold nanoparticle,gold nanoparticles|AuNP
NEW12201,MENTAL_HEALTH,excessive day-time sleepiness,excessive day-time sleepiness
NEW12204,CHEMICAL,mm nmda,mM NMDA
NEW12205,MENTAL_HEALTH,maximum depression,maximum depression
NEW12207,DISEASE,human obesity,human obesity
NEW12209,CHEMICAL,palmitate esterification,palmitate esterification
http://purl.obolibrary.org/obo/CHEBI_10362,BIOCHEMICAL,beta-cryptoxanthin,"lutein 3'-O-linoleate-3-O-palmitate|beta-cryptoxanthin|(3R)-beta,beta-caroten-3-ol|cryptoxanthin|beta-Cryptoxanthin"
NEW12211,BIOCHEMICAL,lutein 3-O-palmitate,lutein 3-O-palmitate
NEW12212,BIOCHEMICAL,lutein dilinoleate,lutein dilinoleate
NEW12213,BIOCHEMICAL,lutein dipalmitate,lutein dipalmitate
NEW12216,DISEASE,early psychiatric history,earlier psychiatric history
NEW12217,MENTAL_HEALTH,less neurosis,less neurosis
NEW12219,CHEMICAL,prostaglandin biosynthesis,prostaglandin biosynthesis
NEW12220,DISEASE,human blood coagulation factor xiiia,human blood coagulation factor XIIIa
NEW12222,DISEASE,fungal ipks,fungal iPKSs
NEW12223,DISEASE,pancreatic cancer tumorigenesis,pancreatic cancer tumorigenesis
NEW12224,CHEMICAL,effective gp130/stat3 signaling inhibitor,effective GP130/STAT3 signaling inhibitor
NEW12226,DISEASE,pancreatic cancer therapy safe,pancreatic cancer therapy safe
NEW12227,CHEMICAL,non-small/small cell bronchogenic/pulmonary type,non-small/small cell bronchogenic/pulmonary types
NEW12229,CHEMICAL,dha deficit,DHA deficits
NEW12231,CHEMICAL,erythrocyte plasmalogen,erythrocyte plasmalogen
http://purl.obolibrary.org/obo/CHEBI_35819,NUTRITION,branched-chain fatty acid,BCFA|branched fatty acids|branched fatty acid|BCFAs|Branched chain fatty acid|branched-chain fatty acids
C031345,CHEMICAL,pipecolic acid [Supplementary Concept],Pipecolic Acids|pipecolic acid
C000630968,CHEMICAL,"Elovl6 protein, mouse [Supplementary Concept]",Fatty Acid Elongases|long-chain fatty acids|VLCFA
NEW12233,DISEASE,first-episode bipolar group,first-episode bipolar groups
NEW12234,CHEMICAL,low dha,lower DHA
NEW12236,BIOCHEMICAL,competitive n-methyl-d-aspartate antagonist -3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonate,competitive N-methyl-D-aspartate antagonist -3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonate
http://purl.obolibrary.org/obo/CHEBI_139155,BIOCHEMICAL,melanin-concentrating hormone receptor antagonist,MCHR agonist|MCHR agonists|corticotrophin-releasing hormone receptors|melanin-concentrating hormone receptor antagonists
NEW12238,DISEASE,mets complication,MetS complications
NEW12240,MENTAL_HEALTH,unexplained global amnesia great,unexplained global amnesia greater
NEW12242,NUTRITION,Chlamys islandica,Chlamys islandica
NEW12244,MENTAL_HEALTH,down syndrome patient,Down syndrome patients
NEW12247,BIOCHEMICAL,pharmacological glutamate receptor antagonist,pharmacological glutamate receptor antagonists
NEW12249,DISEASE,reflection impulsivity,reflection impulsivity
NEW12252,DISEASE,cognitive impairment relevant,cognitive impairment relevant
D014816,DISEASE,Vitelline Duct,"Ducts, Omphalomesenteric|duct|Omphalomesenteric Ducts|Vitelline Ducts|Ducts, Vitelline|Duct, Vitelline|Duct, Omphalomesenteric|Omphalomesenteric Duct"
C501876,DISEASE,"Mps1 protein, Drosophila [Supplementary Concept]",ALD protein|Protein Serine-Threonine Kinases|Drosophila Proteins|Cell Cycle Proteins
C049811,CHEMICAL,erucic acid [Supplementary Concept],Erucic Acids|erucic acid
NEW12257,CHEMICAL,vlcfa accumulation similar,VLCFA accumulation similar
NEW12258,DISEASE,ald fibroblast,ALD fibroblasts
NEW12259,CHEMICAL,intracellular atp production,intracellular ATP production
NEW12262,BIOCHEMICAL,phosphaturic hormone fibroblast growth factor,phosphaturic hormone fibroblast growth factor
http://purl.obolibrary.org/obo/DOID_0080655,CHEMICAL,hypophosphatemic nephrolithiasis/osteoporosis,hypophosphataemia-associated rickets
NEW12264,DISEASE,leg deformity,leg deformities
NEW12266,DISEASE,describe hereditary alpha-synucleinopathie,described hereditary alpha-synucleinopathies
NEW12268,DISEASE,low toxicity effect profile,low toxicity effect profile
NEW12270,CHEMICAL,continue effort 3-morpholino arecoline derivative,continuing effort 3-morpholino arecoline derivatives
NEW12271,MENTAL_HEALTH,neurological syndrome,neurological syndromes
NEW12272,DISEASE,eg nystagmus,eg nystagmus
NEW12274,CHEMICAL,glutamate 5-ht 2a receptor,glutamate 5-HT 2A receptor
NEW12275,BIOCHEMICAL,potent opiate antagonist,potent opiate antagonist
NEW12277,MENTAL_HEALTH,adhd phenotype,ADHD phenotype
NEW12278,BIOCHEMICAL,gnrh-a therapy,GnRH-a therapy
D010523,DISEASE,Peripheral Nervous System Diseases,"Peripheral Nervous System Disease|Neuropathy, Peripheral|Peripheral Neuropathy|PNS Diseases|nervous system diseases|Peripheral Nerve Disease|PNS (Peripheral Nervous System) Diseases|Peripheral Nervous System Disorders|Nerve Diseases, Peripheral|PNS Disease|Peripheral Nerve Diseases|Nerve Disease, Peripheral|Peripheral Neuropathies"
NEW12280,DISEASE,ulcer effect,ulcer effects
D018697,CHEMICAL,Nootropic Agents,"Agent, Nootropic|Anti Dementia Agent|Nootropic|Agents, Antidementia|anti-dementia|Nootropic Drugs|Agents, Anti-Dementia|Anti-Dementia Agent|Enhancers, Cognitive|Agent, Anti-Dementia|Drugs, Nootropic|Drug, Nootropic|Agent, Antidementia|Enhancer, Cognitive|Agent, Procognitive|Anti Dementia Agents|Nootropics|Agents, Procognitive|Agents, Nootropic|Procognitive Agents|Cognitive Enhancer|Anti-Dementia Agents|Procognitive Agent|Antidementia Agent|Nootropic Agent|Nootropic Drug|Antidementia Agents|Cognitive Enhancers"
http://purl.obolibrary.org/obo/CHEBI_53233,CHEMICAL,"3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide","3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay|3-(4,5-Dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide|3-(4,5-Dimethylthiazolyl)-2,5-diphenyltetrazolium bromide|Thiazolyl blue|Thiazolyl blue tetrazolium bromide|2-(4,5-dimethyl-1,3-thiazol-2-yl)-3,5-diphenyl-2H-tetrazol-3-ium bromide|TMCHB|3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide|MTT|MMT Tetrazolium|3-(4,5-dimethyl-1,3-thiazol-2-yl)-2,5-diphenyl-2H-tetrazol-3-ium bromide|Thiazolyl Blue Monotetrazolium|Methylthiazoletetrazolium"
NEW12282,DISEASE,ethanol-induced ulcer model,ethanol-induced ulcer model
D015222,CHEMICAL,Sodium Channels,"Channels, Sodium|Channels, Sodium Ion|Sodium Ion Channels|Sodium Channel|sodium ion|Channel, Sodium|Ion Channel, Sodium|Ion Channels, Sodium|Sodium Ion Channel|Channel, Sodium Ion"
NEW12285,CHEMICAL,dietary sterol,dietary sterol
NEW12286,DISEASE,toxicity availability,toxicity availability
NEW12288,DISEASE,modest hypotensive effect,modest hypotensive effect
NEW12291,CHEMICAL,immediate-release preparation,immediate-release preparations
NEW12295,CHEMICAL,Koch- Institute,Koch- Institute
NEW12296,DISEASE,infection prevention,Infection Prevention
NEW12297,DISEASE,allergic risk,allergic risk
NEW12304,DISEASE,amygdala cea long-lasting hyperexcitability,amygdala CeA long-lasting hyperexcitability
NEW12306,BIOCHEMICAL,alpha-1 adrenergic receptor antagonist,alpha-1 adrenergic receptor antagonist
NEW12308,NUTRITION,ranch american bison,ranched American bison
NEW12310,DISEASE,disease status epilepticus,disease status epilepticus
http://purl.obolibrary.org/obo/CHEBI_50792,BIOCHEMICAL,estrogen receptor antagonist,"estrogen receptor antagonist ICI182,780|estrogen receptor antagonists"
D005458,CHEMICAL,Fluoride Poisoning,"fluoride poisoning|Poisoning, Fluoride|Fluoride Poisonings|Poisonings, Fluoride"
NEW12314,MENTAL_HEALTH,low n fixation,low N fixation
NEW12317,BIOCHEMICAL,anxiolytic analgesic property,anxiolytic analgesic properties
NEW12320,DISEASE,stress-induced social impairment,stress-induced social impairment
NEW12325,BIOCHEMICAL,vaginal oestrogen,vaginal oestrogen
NEW12327,CHEMICAL,pentachlorophenol dechlorinating anaerobic microbial culture,pentachlorophenol dechlorinating anaerobic microbial culture
NEW12328,CHEMICAL,co2 reduction,CO2 reduction
NEW12329,CHEMICAL,hippocampus ca1 region,hippocampus CA1 region
NEW12331,DISEASE,ischemic coronary disease,ischemic coronary disease
NEW12332,CHEMICAL,enzyme phenylalanine hydroxylase,enzyme phenylalanine hydroxylase
NEW12335,DISEASE,acute inflammatory lung injury,acute inflammatory lung injury
NEW12336,CHEMICAL,circulate cytokine,circulating cytokines
NEW12337,DISEASE,ards/inflammatory lung injury,ARDS/inflammatory lung injury
D057056,CHEMICAL,Cysteine Proteases,"Cysteine Proteinase|Proteases, Cysteine|Proteinase, Cysteine|Cysteine Proteinases|Cysteine Protease|Protease, Cysteine|cysteine proteases|Proteinases, Cysteine"
NEW12342,CHEMICAL,high shbg level,higher SHBG levels
D050760,CHEMICAL,Cyclin-Dependent Kinase Inhibitor p27,"Cyclin Dependent Kinase Inhibitor p27|CDK Inhibitor, p27|CDKN4 Protein|Kip1 Protein, p27|p27 Kip1 Protein|CDKN1B|Cyclin Dependent Kinase Inhibitor 1B|p27Kip1 Protein|p27, CDK Inhibitor|p27 CDK Inhibitor|CDK Inhibitor p27|CDKN1B Protein|Cyclin-Dependent Kinase Inhibitor 1B"
NEW12349,MENTAL_HEALTH,proteostasis derailment,proteostasis derailment
NEW12351,DISEASE,TCM database@taiwan,TCM Database@Taiwan
http://purl.obolibrary.org/obo/CHEBI_177286,CHEMICAL,o-fatty acyl-l-serine residue,residue Ala327|O-fatty acyl-L-serine residue
NEW12354,CHEMICAL,ng expression,Ng expression
NEW12355,BIOCHEMICAL,male gonadal hormone,male gonadal hormones
http://purl.obolibrary.org/obo/DOID_1307,MENTAL_HEALTH,dementia,HIV-associated dementia
NEW12357,MENTAL_HEALTH,Cocaine dependence Disorder,Cocaine Dependence Disorder
NEW12358,DISEASE,major depressive illness,major depressive illness
NEW12360,DISEASE,multiple invasive infection,multiple invasive infections
NEW12362,CHEMICAL,core tetracycline ring,core tetracycline rings
NEW12363,CHEMICAL,cannabis aor,cannabis AOR
NEW12364,MENTAL_HEALTH,methamphetamine-induced hyperactivity,methamphetamine-induced hyperactivity
NEW12366,MENTAL_HEALTH,drug-induced hyperactivity,drug-induced hyperactivity
NEW12367,BIOCHEMICAL,important standardized beta,important standardized beta
NEW12369,CHEMICAL,acid drink,acid drink
NEW12371,BIOCHEMICAL,inadequate vitamin e,inadequate vitamin E
D009306,DISEASE,Natal Teeth,"Teeth Present At Birth|Natal Tooth|Tooth, Natal|teeth|Teeth, Natal"
NEW12376,DISEASE,intense vomiting,intense vomiting
NEW12378,DISEASE,human gingival squamous cell carcinoma,human gingival squamous cell carcinoma
NEW12379,MENTAL_HEALTH,depression-related anxiety,depression-related anxiety
D040921,DISEASE,"Stress Disorders, Traumatic","Traumatic Stress Disorder|Stress Disorder, Traumatic|stress disorders|Traumatic Stress Disorders"
NEW12381,MENTAL_HEALTH,particular bipolar depression,particular bipolar depression
C516138,CHEMICAL,dorsomorphin [Supplementary Concept],Pyrazoles|Pyrimidines|dorsomorphin
NEW12383,CHEMICAL,"pyrazolo[1,5-a]pyrimidine scaffold","pyrazolo[1,5-a]pyrimidine scaffold"
NEW12384,CHEMICAL,l741626,L741626
NEW12386,CHEMICAL,acute levodopa challenge,acute levodopa challenge
NEW12388,DISEASE,hfpef patient,HFpEF patients
http://purl.obolibrary.org/obo/CHEBI_51060,BIOCHEMICAL,hormone agonist,hormone agonists
D019332,CHEMICAL,Endothelin-1,"endothelin-1|Precursor, Proendothelin-1|Endothelin 1|Proendothelin 1 Precursor|Preproendothelin|Endothelin Type 1|Proendothelin-1 Precursor|Endothelin-1, Big|Big Endothelin-1|Endothelin, Big|Proendothelin (1-38)|Big Endothelin|Preproendothelin-1|Big Endothelin 1|Preproendothelin 1"
D014663,CHEMICAL,Nasal Decongestants,"Agents, Nasal Vasoconstrictor|Decongestant, Nasal|Decongestant|Nasal Decongestant|Decongestants, Nasal|Nasal Vasoconstrictors|Vasoconstrictors, Nasal|Vasoconstrictor Agents, Nasal|Decongestants|Nasal Vasoconstrictor Agents|vasoconstrictors"
NEW12390,NUTRITION,alpha adrenergic neuroeffector,alpha adrenergic neuroeffector
NEW12392,BIOCHEMICAL,androgen supplementation,androgen supplementation
NEW12394,CHEMICAL,beta-peptide-induced apoptosis,beta-peptide-induced apoptosis
NEW12397,DISEASE,primary generalize tonic-clonic seizure,primary generalized tonic-clonic seizures
http://purl.obolibrary.org/obo/SYMP_0000268,DISEASE,tonic-clonic seizure,partial-onset seizures|grand mal seizure
NEW12400,MENTAL_HEALTH,long-term eat disorder,long-term eating disorders
D055552,DISEASE,Infectious Disease Medicine,"Specialty, Infectious Diseases|Specialties, Infectious Disease|Medicine, Infectious Disease|Disease Medicine, Infectious|Specialties, Infectious Diseases|Diseases Specialty, Infectious|Infectious Diseases Specialty|Infectious Diseases Specialties|Specialty, Infectious Disease|Infectious Disease Specialty|infectious|Infectious Disease Specialties"
NEW12401,BIOCHEMICAL,allied nutraceutical constituent,allied nutraceutical constituents
D036381,CHEMICAL,Diarylheptanoids,"Diarylheptanones|Curcuminoids|Diaryl Heptanoids|Diarylheptanoids, Cyclic|Diarylheptanoid, Cyclic|Diarylheptanoid Derivative|Cyclic Diarylheptanoids|Diarylheptanoid|Acyclic Diarylheptanoids|Diarylheptanoid Derivatives|Derivative, Diarylheptanoid|Heptanoids, Diaryl|Linear Diarylheptanoids|Diarylheptanoids, Linear|Diarylheptanoids, Acyclic|curcuminoids|Curcuminoid|Cyclic Diarylheptanoid"
NEW12406,CHEMICAL,patients-there,patients-there
NEW12410,NUTRITION,insect C. maculatus,insect C. maculatus
NEW12412,CHEMICAL,tnbc paclitaxel (pac)-resistant tnbc cell,TNBC paclitaxel (PAC)-resistant TNBC cells
NEW12413,DISEASE,significant depressive symptom,significant depressive symptoms
NEW12414,MENTAL_HEALTH,depression independent,depression independent
NEW12416,DISEASE,age-related olfactory deficit,age-related olfactory deficits
NEW12418,MENTAL_HEALTH,chaotic orientation,chaotic orientation
NEW12420,BIOCHEMICAL,dopamine agonist therapy intrinsic,dopamine agonist therapy intrinsic
NEW12421,CHEMICAL,ischaemic heart disease,ischaemic heart disease|IHD
NEW12423,CHEMICAL,classic ischaemic preconditioning,classic ischaemic preconditioning|IPC
NEW12425,CHEMICAL,decrease nitric oxide no production,decreased nitric oxide NO production
NEW12426,CHEMICAL,impaired endothelial no synthase activity,impaired endothelial NO synthase activity
D000625,CHEMICAL,Aminooxyacetic Acid,"Acid, Aminooxyacetic|Carboxymethoxyamine|aminooxyacetic acid|Aminooxyacetate"
NEW12431,CHEMICAL,"s-(1,2-dichlorovinyl)-l-homocysteine","S-(1,2-dichlorovinyl)-L-homocysteine"
NEW12433,CHEMICAL,"s-(1,2-dichlorovinyl)-dl-alpha-methylhomocysteine toxic","S-(1,2-dichlorovinyl)-DL-alpha-methylhomocysteine toxic"
NEW12434,CHEMICAL,alpha-methyl analogue,alpha-methyl analogue
NEW12437,CHEMICAL,cb2r,CB2r
http://purl.obolibrary.org/obo/NCBITaxon_136,DISEASE,spirochaetales,Flexispira spp
D013900,DISEASE,Thoracic Nerves,"Pectoral Nerve|Nerve, Pectoral|nerves|Nerve, Thoracic|Thoracic Nerve|Nerves, Pectoral|Pectoral Nerves|Nerves, Thoracic"
NEW12441,DISEASE,endothelial damage,endothelial damage
NEW12443,CHEMICAL,ed50     mg/kg,ED50    mg/kg
NEW12444,BIOCHEMICAL,potent analgesic efficacy,potent analgesic efficacy
NEW12445,DISEASE,pain mouse,pain mouse
NEW12446,DISEASE,superimpose hyponatraemic dehydration,superimposed hyponatraemic dehydration
NEW12448,DISEASE,peripheral age-related hearing loss,peripheral age-related hearing loss
D005157,DISEASE,Facial Pain,"Facial Pain, Neuralgic|Pain, Orofacial|Craniofacial Pain|Orofacial Pain|orofacial pain|Pain, Craniofacial|Pain, Facial|Pain, Face|Pain, Neuralgic Facial|Myofacial Pain|Pain, Myofacial|Neuralgic Facial Pain|Face Pain"
C566398,DISEASE,Huntington Disease-Like 1 [Supplementary Concept],neurodegenerative disorder|Huntington Disease
NEW12454,CHEMICAL,sham-it,Sham-IT
NEW12455,DISEASE,neurodegenerative disease model,neurodegenerative disease models
NEW12459,MENTAL_HEALTH,fatigue failure,fatigue failure
NEW12461,DISEASE,eimeria acervulina oocyst,Eimeria acervulina oocysts
NEW12462,BIOCHEMICAL,absorb carotenoid,absorbed carotenoids
NEW12464,MENTAL_HEALTH,combined dementia,combined dementia
NEW12465,MENTAL_HEALTH,dementia due,dementia due
NEW12468,BIOCHEMICAL,synaptic antigen,synaptic antigens
NEW12469,BIOCHEMICAL,intracellular neuronal antigen,intracellular neuronal antigens
NEW12470,DISEASE,classic paraneoplastic limbic encephalitis,classic paraneoplastic limbic encephalitis
NEW12473,DISEASE,different mineral fertilization level,different mineral fertilization levels
NEW12474,MENTAL_HEALTH,neuroleptic-induced dyskinesia,neuroleptic-induced dyskinesia
NEW12476,DISEASE,schizophrenia-spectrum memory impairment,schizophrenia-spectrum memory impairments
NEW12478,BIOCHEMICAL,fasii antibiotic adaptation,FASII antibiotic adaptation
NEW12480,DISEASE,human pathogen staphylococcus aureus,human pathogen Staphylococcus aureus
NEW12481,BIOCHEMICAL,antimicrobial drug development,antimicrobial drug development
NEW12483,MENTAL_HEALTH,juvenile depression,juvenile depression
NEW12485,CHEMICAL,[3h]bunazosin binding,[3H]bunazosin binding
NEW12486,MENTAL_HEALTH,human depression ability,human depression ability
C100722,CHEMICAL,4-(N-(4-azidobenzoyl)-2-aminoethyl)-deoxycytidine triphosphate [Supplementary Concept],dCTP|Deoxycytosine Nucleotides
NEW12490,BIOCHEMICAL,receptor ppar family,receptor PPAR family
NEW12492,MENTAL_HEALTH,first-episode depression,first-episode depression
NEW12493,CHEMICAL,glucose delivery,glucose delivery
C528449,CHEMICAL,carglumic acid [Supplementary Concept],Glutamates|carglumic acid
NEW12494,CHEMICAL,ammonia scavenger treatment,ammonia scavenger treatment
NEW12496,DISEASE,chronic hyperammonemia,chronic hyperammonemia
NEW12497,DISEASE,severe cardiac dysfunction,severe cardiac dysfunction
NEW12499,DISEASE,devastating pandemic,devastating pandemic
D024322,CHEMICAL,"Amino Acids, Aromatic","Amino Acid, Aromatic|Aromatic Amino Acid|Aromatic Amino Acids|aromatic amino acids"
http://purl.obolibrary.org/obo/CHEBI_25588,CHEMICAL,nonpolar amino acid,hydrophobic amino acids
NEW12504,CHEMICAL,scopolamine-induced spatial memory impairment,scopolamine-induced spatial memory impairment
NEW12506,CHEMICAL,heterogeneous gb inclination,heterogeneous GB inclination
NEW12507,MENTAL_HEALTH,disorientation misorientation,disorientation misorientation
NEW12508,MENTAL_HEALTH,airway hyperactivity,airway hyperactivity
C586769,CHEMICAL,"IAA29 protein, Arabidopsis [Supplementary Concept]",Arabidopsis Proteins|Transcription Factors|IAA|indole-3-acetic acid
NEW12511,CHEMICAL,phosphate solubilization,phosphate solubilization
NEW12513,DISEASE,excess death,excess deaths
NEW12514,DISEASE,exacerbation lung function,exacerbations lung function
NEW12515,DISEASE,copd history,COPD history
NEW12516,MENTAL_HEALTH,undifferentiated agitated delirium,undifferentiated agitated delirium
D028361,DISEASE,Mitochondrial Diseases,"Phosphorylation Deficiencies, Oxidative|Oxidative Phosphorylation Deficiency|Oxidative Phosphorylation Deficiencies|Mitochondrial Respiratory Chain Deficiencies|Disease, Mitochondrial|Mitochondrial Disease|mitochondrial disorders|Respiratory Chain Deficiency|Deficiencies, Respiratory Chain|Mitochondrial Disorders|Deficiency, Respiratory Chain|Respiratory Chain Deficiencies, Mitochondrial|Disorder, Mitochondrial|Mitochondrial Disorder|Deficiency, Oxidative Phosphorylation|Deficiencies, Oxidative Phosphorylation|Phosphorylation Deficiency, Oxidative|Mitochondrial Electron Transport Chain Deficiencies|Disorders, Mitochondrial|Electron Transport Chain Deficiencies, Mitochondrial"
NEW12519,MENTAL_HEALTH,st segment depression,ST segment depression
D000138,DISEASE,Acidosis,"Acidosis, Metabolic|Acidoses|Metabolic Acidosis|metabolic acidosis|Acidoses, Metabolic|Metabolic Acidoses"
NEW12520,MENTAL_HEALTH,numerous human syndrome,numerous human syndromes
D015470,DISEASE,"Leukemia, Myeloid, Acute","Acute Nonlymphocytic Leukemia|Leukemia, Myelogenous, Acute|Acute Nonlymphocytic Leukemias|Acute Nonlymphoblastic Leukemias|acute myeloid leukemia|Acute Myeloid Leukemia with Maturation|Leukemia, Myeloid, Acute, M2|Myeloid Leukemia, Acute, M2|Leukemia, Nonlymphoblastic, Acute|Acute Nonlymphoblastic Leukemia|Leukemias, Acute Nonlymphoblastic|Acute Myelogenous Leukemias|Leukemias, Acute Myelogenous|Leukemia, Myeloid, Acute, M1|Nonlymphoblastic Leukemias, Acute|Leukemia, Acute Nonlymphoblastic|Myeloid Leukemia, Acute, M1|Myeloid Leukemias, Acute|Leukemia, Acute Myelocytic|Leukemia, Myelocytic, Acute|Acute Myeloblastic Leukemia|Leukemia, Acute Myeloid|Leukemias, Acute Myeloblastic|Myelogenous Leukemia, Acute|Myeloid Leukemia, Acute|Nonlymphoblastic Leukemia, Acute|Leukemia, Acute Myelogenous|Myelocytic Leukemia, Acute|Leukemias, Acute Nonlymphocytic|Myelogenous Leukemias, Acute|Leukemia, Acute Myeloblastic|Leukemia, Myeloblastic, Acute|Myeloblastic Leukemia, Acute|Leukemias, Acute Myelocytic|Myelocytic Leukemias, Acute|Leukemia, Nonlymphocytic, Acute|Nonlymphocytic Leukemias, Acute|Acute Myeloblastic Leukemias|Acute Myeloid Leukemia without Maturation|Acute Myelocytic Leukemia|Acute Myeloid Leukemias|Nonlymphocytic Leukemia, Acute|Acute Myeloid Leukemia|ANLL|Myeloblastic Leukemias, Acute|Leukemias, Acute Myeloid|Leukemia, Acute Nonlymphocytic|Acute Myelocytic Leukemias|Acute Myelogenous Leukemia"
NEW12524,CHEMICAL,cellular alteration,FCA|cellular alteration
NEW12525,NUTRITION,white croaker,white croaker
NEW12528,DISEASE,nsclc process,NSCLC process
NEW12530,DISEASE,nsclc progression,NSCLC progression
NEW12532,CHEMICAL,pelamitoxin a-encoding mrna,pelamitoxin a-encoding mRNAs
NEW12534,DISEASE,blood coagulation factor xa,blood coagulation factor Xa
NEW12541,CHEMICAL,biopterin derivative,biopterin derivatives
NEW12543,BIOCHEMICAL,drug experience,drug experience
NEW12544,DISEASE,neuronal alteration,neuronal alterations
D050556,NUTRITION,Fatty Acid-Binding Proteins,"Plasma Membrane Fatty Acid Binding Protein|Fatty Acid-Binding Proteins, Intestinal-Specific|Fatty Acid Binding Protein|Fatty Acid-Binding Proteins, Liver-Specific|Fatty Acid Binding Proteins, Plasma Membrane Specific|Brain-Type Fatty Acid-Binding Protein|Fatty Acid Binding Protein, Cardiac Myocyte|Fatty Acid-Binding Proteins, Brain-Specific|Fatty Acid-Binding Proteins, Myocardial-Specific|Fatty Acid-Binding Protein, Cardiac Myocyte|Intestinal Fatty Acid Binding Protein|Lipid-Binding Proteins, Cytosolic|Fatty Acid Binding Proteins, Cytosolic Specific|Myocardial Fatty Acid Binding Protein|Protein, Fatty Acid-Binding|Plasma Membrane Fatty Acid-Binding Protein|specific fatty acid|Fatty Acid Binding Proteins, Intestinal Specific|Brain Type Fatty Acid Binding Protein|Adipocyte Specific Fatty Acid Binding Protein|Liver Fatty Acid Binding Protein|Fatty Acid-Binding Proteins, Cytosolic-Specific|Fatty Acid Binding Proteins, Adipocyte Specific|Fatty Acid-Binding Proteins, Plasma-Membrane Specific|Fatty Acid Binding Proteins, Myocardial Specific|Cytosolic Lipid-Binding Proteins|Fatty Acid-Binding Proteins, Adipocyte-Specific|Fatty Acid Binding Proteins, Brain Specific|Liver Fatty Acid-Binding Protein|Fatty Acid-Binding Protein|Fatty Acid Binding Protein, Myocardial|Fatty Acid Binding Proteins, Liver Specific|Adipocyte-Specific Fatty Acid-Binding Protein|Fatty Acid-Binding Protein, Myocardial|Cytosolic Lipid Binding Proteins|Intestinal Fatty Acid-Binding Protein|Adipocyte Lipid Binding Protein|Fatty Acid Binding Proteins|Acid-Binding Protein, Fatty|Myocardial Fatty Acid-Binding Protein"
NEW12548,MENTAL_HEALTH,central sleep apnea hypopnea syndrome,central sleep apnea hypopnea syndrome
D002639,DISEASE,Cheyne-Stokes Respiration,"Respiration, Cheyne-Stokes|Cheyne-Stokes respiration|Cheyne Stokes Respiration"
NEW12550,CHEMICAL,blood gas value,blood gas values
NEW12551,DISEASE,(neuro)muscular level,(neuro)muscular level
D008776,CHEMICAL,Methylprednisolone Hemisuccinate,"Sodium Succinate, Methylprednisolone|Succinate, Methylprednisolone|Hemisuccinate, Methylprednisolone|6 alpha-Methylprednisolone Sodium Hemisuccinate|Solu-Medrol|A-MethaPred|Methylprednisolone Hemisuccinate Monosodium Salt|methylprednisolone|Solumedrol|Urbason-Soluble|Methylprednisolone Sodium Hemisuccinate|Methylprednisolone Sodium Succinate|Sodium Hemisuccinate, Methylprednisolone|Methylprednisolone Succinate|UrbasonSoluble"
NEW12556,BIOCHEMICAL,paf antagonist,PAF antagonists
D000542,DISEASE,"Alveolitis, Extrinsic Allergic","Pneumonitides, Hypersensitivity|Hypersensitivity Pneumonitis|Hypersensitivity Pneumonitides|Allergic Alveolitis, Extrinsic|Extrinsic Allergic Alveolitides|Extrinsic Allergic Alveolitis|Pneumonitis, Hypersensitivity|Allergic Alveolitides, Extrinsic|Alveolitides, Extrinsic Allergic|allergic alveolitis"
NEW12559,CHEMICAL,antagonist bicucculline,antagonist bicucculline
NEW12562,CHEMICAL,muscimol injection,muscimol injections
NEW12565,DISEASE,neuropsychological disorder,neuropsychological disorders
NEW12567,BIOCHEMICAL,advanced hormone receptor-positive,advanced hormone receptor-positive
NEW12570,DISEASE,myocardial fibrosis,myocardial fibrosis
NEW12573,CHEMICAL,paliperidone er,paliperidone ER
NEW12575,CHEMICAL,ii/iii antagonist (rs)-alpha-cyclopropyl-4-phosphonophenylglycine,CPPG|II/III antagonist (RS)-alpha-cyclopropyl-4-phosphonophenylglycine
NEW12579,CHEMICAL,v-ki-ras protein p21,v-Ki-ras protein p21
NEW12581,BIOCHEMICAL,female x-ald carrier,female X-ALD carriers
NEW12584,CHEMICAL,bromocriptine-qr,bromocriptine-QR
NEW12588,CHEMICAL,circadian-timed bromocriptine-qr therapy,circadian-timed bromocriptine-QR therapy
D011236,DISEASE,Prediabetic State,"Prediabetic States|State, Prediabetic|Prediabetes|prediabetes|States, Prediabetic"
NEW12589,DISEASE,type diabete subject,type diabetes subjects
NEW12593,CHEMICAL,l-carnitine ketogenic diet,L-carnitine ketogenic diet
NEW12597,DISEASE,progressive micrographia,progressive micrographia
NEW12599,DISEASE,related hyponatremia,related hyponatremia
NEW12601,DISEASE,non-endocrine disorder,non-endocrine disorders
NEW12603,BIOCHEMICAL,accessory endocrine disorder,accessory endocrine disorder
NEW12604,CHEMICAL,gaba production,GABA production
NEW12606,DISEASE,small pulmonary artery vascular smooth muscle cell,small pulmonary artery vascular smooth muscle cells
NEW12608,DISEASE,monocrotaline-induced pulmonary hypertension,monocrotaline-induced pulmonary hypertension
NEW12609,MENTAL_HEALTH,therapy resistance,therapy resistance
NEW12611,CHEMICAL,colitis dextran sodium sulfate-,colitis dextran sodium sulfate-
NEW12612,CHEMICAL,"2,4,6-trinitrobenzene sulfonic acid-induced","2,4,6-trinitrobenzene sulfonic acid-induced"
http://purl.org/sig/ont/fma/fma14984,DISEASE,mucosa of colon,Colonic mucosa|colon mucosa|Colon mucosa|Colonic mucous membrane
NEW12615,CHEMICAL,overprotection-overcontrol,overprotection-overcontrol
NEW12616,DISEASE,ambivalence,ambivalence
NEW12618,DISEASE,aspd subject 's,ASPD subjects's
NEW12620,CHEMICAL,reduce hr-qol.,reduced HR-QoL.
NEW12622,CHEMICAL,optimize bt treatment,optimized BT treatment
NEW12624,CHEMICAL,acid nmda receptor,acid NMDA receptors
C106092,CHEMICAL,microsomal triglyceride transfer protein [Supplementary Concept],triglyceride|Carrier Proteins
NEW12627,NUTRITION,state-dependent low cholesterol relative,state-dependent lower cholesterol relative
NEW12629,CHEMICAL,plasma bhac level,plasma BHAC level
http://purl.obolibrary.org/obo/CHEBI_6954,CHEMICAL,mitotane,Mitotane|chloditan|lysodren|opeprim|mitotan|BHAC chemotherapy|chlodithane|Lysodren (TN)
NEW12631,DISEASE,tumor cell specie,tumor cell species
NEW12632,DISEASE,lethargy hyperactivity symptom,lethargy hyperactivity symptoms
D013433,CHEMICAL,Sulfoglycosphingolipids,Sulfatoglycosphingolipids|sulfatides|Sulfatides|Sulfatide
NEW12634,DISEASE,trichomoniasis case,trichomoniasis cases
NEW12636,CHEMICAL,percent hydroxide solution,percent hydroxide solution
NEW12637,DISEASE,irritation,irritation
NEW12638,NUTRITION,altered steroid hormone homeostasis,altered steroid hormone homeostasis
D002191,CHEMICAL,Canrenoic Acid,"SC-14266|SC14266|Soludactone|Potassium Canrenoate|17-Hydroxy-3-Oxo-17alpha-Pregna-4,6-Diene-21-Carboxylic Acid|Kalium-Can.-Ratiopharm|Acid, 17-Hydroxy-3-Oxo-17alpha-Pregna-4,6-Diene-21-Carboxylic|Acid, Canrenoic|Kalium Can. Ratiopharm|Canrenoate, Potassium|17 Hydroxy 3 Oxo 17alpha Pregna 4,6 Diene 21 Carboxylic Acid|Canrenoate Potassium|Soldactone|potassium canrenoate|SC 14266|Spiroctan"
NEW12640,MENTAL_HEALTH,habitual alcohol dependence,habitual alcohol dependence
NEW12643,DISEASE,gland swelling,gland swelling
NEW12648,MENTAL_HEALTH,gemcitabine resistance,gemcitabine resistance
NEW12652,DISEASE,neuronal ischemic injury,neuronal ischemic injury
C000618847,CHEMICAL,amyloid beta-protein (5-16) [Supplementary Concept],Amyloid beta-Peptides|Peptide Fragments|Abeta
NEW12654,CHEMICAL,tyrosine analogue,tyrosine analogue
NEW12655,DISEASE,synthetic low-molecular-weight compound,synthetic low-molecular-weight compound
NEW12665,DISEASE,repetitive interest,repetitive interests
NEW12666,DISEASE,abnormal motor movement,abnormal motor movements
NEW12668,DISEASE,vaginal stenosis,vaginal stenosis
C537371,DISEASE,Mullerian aplasia [Supplementary Concept],"Congenital Abnormalities|Mullerian Ducts/abnormalities|Mayer-Rokitansky-Küster-Hauser syndrome|46, XX Disorders of Sex Development"
http://purl.obolibrary.org/obo/DOID_12849,MENTAL_HEALTH,autistic disorder,infantile autism|Kanner's syndrome|autism disorder|autism|autistic disorder of childhood onset|childhood autism
NEW12673,CHEMICAL,risperidone mg/kg ip,risperidone mg/kg ip
NEW12674,DISEASE,sevoflurane-induced cognitive impairment,sevoflurane-induced cognitive impairment
NEW12675,DISEASE,anesthetic-induced cognitive impairment,anesthetic-induced cognitive impairment
NEW12677,DISEASE,calvitie,calvities
NEW12678,DISEASE,mechanical trauma,mechanical trauma
NEW12679,DISEASE,most breast cancer,most breast cancers
NEW12681,DISEASE,murine b16 melanoma cell,murine B16 melanoma cells
NEW12682,NUTRITION,skin whiting,skin whiting
NEW12683,DISEASE,hyperprolactinaemic state,hyperprolactinaemic states
NEW12684,BIOCHEMICAL,long-acting dopamine agonist,long-acting dopamine agonist
NEW12685,DISEASE,idiopathic hyperprolactinemia,idiopathic hyperprolactinemia
NEW12686,MENTAL_HEALTH,additional non-organic mental disorder,additional non-organic mental disorder
NEW12687,DISEASE,disorder due intake,disorders due intake
D055272,CHEMICAL,Mucin-6,Mucin 6|mucin
NEW12689,DISEASE,dysplasia marker,dysplasia markers
NEW12690,DISEASE,factitious lesion,factitious lesion
NEW12692,BIOCHEMICAL,transdermal estrogen,transdermal estrogens
NEW12694,CHEMICAL,norepinephrine release,norepinephrine release
NEW12696,CHEMICAL,fast-acting antidepressant response,fast-acting antidepressant responses
NEW12697,CHEMICAL,single low-dose intravenous infusion,single low-dose intravenous infusion
NEW12699,CHEMICAL,amyloid β Aβ deposition,amyloid β Aβ deposition
NEW12700,DISEASE,p-tau aggregation,p-Tau aggregation
NEW12701,CHEMICAL,brain iron overload,brain iron overload
NEW12703,MENTAL_HEALTH,moderate depression syndrome,moderate depression syndromes
NEW12704,DISEASE,advanced ad patient,advanced AD patients
NEW12706,CHEMICAL,serotonin production due,serotonin production due
http://purl.obolibrary.org/obo/CHEBI_37622,CHEMICAL,carboxamide,"N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide"
C083501,CHEMICAL,Elacridar [Supplementary Concept],GF120918|Acridines|Tetrahydroisoquinolines
NEW12707,CHEMICAL,morphine slow-release pellet,morphine slow-release pellets
NEW12709,CHEMICAL,high bcaa supplementation,high BCAA supplementation
NEW12710,DISEASE,diet-induced obese mouse,diet-induced obese mice
NEW12711,DISEASE,ptai lighting,PTAI lighting
NEW12713,MENTAL_HEALTH,univariate regression model,univariate regression models
NEW12715,DISEASE,respiratory inflammation,respiratory inflammation
NEW12716,MENTAL_HEALTH,internucleosomal dna fragmentation,internucleosomal DNA fragmentation
NEW12718,DISEASE,glu261-luneo xenograft tumor model,Glu261-LuNeo xenograft tumor model
NEW12720,DISEASE,tumor cell proliferation,tumor cell proliferation
NEW12723,CHEMICAL,Azstarys ®,Azstarys ®
NEW12725,CHEMICAL,% kcl solution,% KCl solution
NEW12726,CHEMICAL,ipsilateral/left hemisphere,ipsilateral/left hemisphere
NEW12729,MENTAL_HEALTH,strong water resistance,strongest water resistance
NEW12730,DISEASE,aggressive disorder,aggressive disorders
NEW12733,NUTRITION,raw starch,raw starch
NEW12734,CHEMICAL,count iron study,count iron studies
NEW12740,MENTAL_HEALTH,elegan resistance,elegans resistance
NEW12744,BIOCHEMICAL,antioxidant vitamin level,antioxidant vitamin levels
NEW12747,CHEMICAL,glutathione depletion,glutathione depletion
NEW12749,DISEASE,disorder pontocerebellar hypoplasia type,disorder pontocerebellar hypoplasia type
NEW12751,DISEASE,creutzfeldt-jakob disease differential diagnosis,Creutzfeldt-Jakob disease differential diagnosis
NEW12753,DISEASE,s. trifoliatus,S. trifoliatus
NEW12754,MENTAL_HEALTH,concomitant metabolic syndrome,concomitant metabolic syndromes
NEW12756,DISEASE,lifelong cognitive deficit,lifelong cognitive deficits
NEW12758,MENTAL_HEALTH,adult behavioral hyperactivity,adult behavioral hyperactivity
NEW12760,CHEMICAL,maternal ethanol exposure,maternal ethanol exposure
NEW12761,DISEASE,ethanol-induced neuroapoptosis,ethanol-induced neuroapoptosis
http://purl.obolibrary.org/obo/CHEBI_6719,CHEMICAL,mefloquine hydrochloride,proguanil HCl|Mefloquine hydrochloride|Lariam
NEW12764,MENTAL_HEALTH,erectile impotence,erectile impotence
NEW12766,CHEMICAL,oral terbutaline therapy,oral terbutaline therapy
NEW12768,DISEASE,severe methemoglobinemia,severe methemoglobinemia
NEW12769,NUTRITION,seal oil,seal oil
NEW12770,CHEMICAL,venlafaxine dosage,venlafaxine dosage
NEW12771,CHEMICAL,inhibit dopamine reuptake,inhibited dopamine reuptake
NEW12772,CHEMICAL,CAT-MH computerize adaptive test,CAT-MH computerized adaptive test
NEW12774,CHEMICAL,nitrous oxide sedation,nitrous oxide sedation
NEW12775,DISEASE,hippocampal neuronal injury,hippocampal neuronal injury
D010381,DISEASE,Pelger-Huet Anomaly,"Anomaly, Pelger-Huët Nuclear|Anomaly, Pseudo Pelger-Huet|Anomaly, Pelger-Huet|Pelger-Huët Nuclear Anomaly|Anomaly, Pseudo Pelger-Huët|Nuclear Anomaly, Pelger-Huët|Pelger Huet Nuclear Anomaly|Pelger-Huet Nuclear Anomaly|Pelger Huët Anomaly|Anomaly, Pelger-Huet Nuclear|Ovoid Neutrophil Nuclei, Developmental Delay, Epilepsy and Skeletal Abnormalities|anomaly|Pseudo Pelger Huet Nuclear Anomaly|Pseudo Pelger Huët Anomaly|Pelger-Huet Anomaly, Pseudo|Pelger Huët Nuclear Anomaly|Pseudo Pelger Huet Anomaly|Pseudo Pelger-Huët Anomaly|Pseudo Pelger-Huet Nuclear Anomaly|Pseudo Pelger-Huet Anomaly|Nuclear Anomaly, Pelger-Huet|Pelger-Huët Anomaly, Pseudo|Pelger-Huët Anomaly|Ovoid Neutrophil Nuclei, Developmental Delay, Epilepsy, and Skeletal Abnormalities|Anomaly, Pelger-Huët|Pelger Huet Anomaly"
NEW12777,CHEMICAL,menthol-only product,menthol-only products
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Attention_Deficit_Disorder,DISEASE,attention deficit disorder,attention deficit-hyperkinetic disorder|AD-HKD
NEW12778,DISEASE,attention Deficit Hyperactivity/Hyperkinetic Disorder,Attention Deficit Hyperactivity/Hyperkinetic Disorder
NEW12779,DISEASE,mdd treatment,MDD treatment
NEW12780,BIOCHEMICAL,polymer chain reaction,Polymer Chain Reaction
NEW12782,CHEMICAL,4-hydoxytamoxifen,4-hydoxytamoxifen
NEW12784,DISEASE,posthypoxic myoclonus,posthypoxic myoclonus
NEW12786,CHEMICAL,nanoparticle/bacterium interaction,nanoparticle/bacterium interaction
C081954,CHEMICAL,lipoteichoic acid receptor [Supplementary Concept],"Receptors, Cell Surface|lipoteichoic acid"
NEW12790,DISEASE,methicillin-resistant s. aureus,methicillin-resistant S. aureus
NEW12792,CHEMICAL,olanzapine interruption,olanzapine interruption
NEW12793,DISEASE,sequential proton loss electron transfer,sequential proton loss electron transfer
NEW12794,DISEASE,severe depressive symptom,severe depressive symptoms
NEW12797,DISEASE,cavernosal damage,cavernosal damage
NEW12799,MENTAL_HEALTH,southward displacement,southward displacement
NEW12800,MENTAL_HEALTH,low displacement,low displacement
C538521,MENTAL_HEALTH,Bilateral temporal lobe disorder [Supplementary Concept],Kluver-Bucy Syndrome|distractibility
NEW12802,DISEASE,human behavior,human behavior
NEW12806,CHEMICAL,attr amyloidosis,ATTR amyloidosis
NEW12808,CHEMICAL,hydrate dissociation,hydrate dissociation
NEW12810,DISEASE,copd exacerbation,COPD exacerbations
NEW12811,MENTAL_HEALTH,fragmentation mechanism,fragmentation mechanisms
http://purl.obolibrary.org/obo/CHEBI_22861,NUTRITION,betalain,nonglycosylated anthocyanins|anthocyanidins|betalains
NEW12813,MENTAL_HEALTH,general fragmentation mechanism,general fragmentation mechanism
NEW12814,CHEMICAL,hydroxyl proton,hydroxyl protons
NEW12815,CHEMICAL,h/d exchange,H/D exchange
NEW12817,CHEMICAL,apple fruitlet,apple fruitlets
NEW12818,DISEASE,allergic symptom,allergic symptoms
NEW12819,MENTAL_HEALTH,various pollen-food syndrome,various pollen-food syndromes
NEW12821,CHEMICAL,avpr1a antagonist relcovaptan,AVPR1a antagonist Relcovaptan|SR49059
NEW12822,DISEASE,bpd participant,BPD participants
NEW12824,DISEASE,amygdala dysfunction,amygdala dysfunction
NEW12826,DISEASE,cerebrovascular function,cerebrovascular functions
NEW12828,MENTAL_HEALTH,insulin resistance index,insulin resistance index
NEW12829,DISEASE,cvr hypercapnia,CVR hypercapnia
NEW12831,DISEASE,neutropenic patient,neutropenic patients
NEW12832,DISEASE,spastic pain,spastic pain
NEW12835,NUTRITION,multi-gene backbone constraint tree,multi-gene backbone constraint tree
NEW12836,DISEASE,il-1beta-induced mechanical allodynia,IL-1beta-induced mechanical allodynia
NEW12837,DISEASE,mirror-image mechanical allodynia,mirror-image mechanical allodynia
NEW12839,DISEASE,irritability related,irritability related
NEW12841,MENTAL_HEALTH,hyperactivity hyperactivity disorder-like symptom,hyperactivity hyperactivity disorder-like symptoms
D008173,DISEASE,"Lung Diseases, Obstructive","Obstructive Lung Disease|Obstructive Lung Diseases|Pulmonary Diseases, Obstructive|Pulmonary Disease, Obstructive|Lung Disease, Obstructive|Obstructive Pulmonary Disease|Obstructive Pulmonary Diseases|pulmonary diseases"
NEW12844,DISEASE,complex neurological disease,complex neurological diseases
NEW12845,CHEMICAL,reduce testosterone level,reduced testosterone levels
NEW12847,DISEASE,mild-to-moderate ad patient,mild-to-moderate AD patients
NEW12848,MENTAL_HEALTH,suicide tendency,suicide tendencies
http://purl.obolibrary.org/obo/CHEBI_146212,DISEASE,ilicicolin,ilicicolins|MAO-A inactivators
NEW12853,DISEASE,treatment-resistant depressive patient,treatment-resistant depressive patients
NEW12854,CHEMICAL,first successful ketamine application,first successful ketamine application
NEW12857,DISEASE,environmental toxicity,environmental toxicity
NEW12858,DISEASE,reduce abuse potential,reduced abuse potential
NEW12859,DISEASE,fpra14-induced toxicity,FPRa14-induced toxicity
NEW12861,DISEASE,unmedicate depressed patient,unmedicated depressed patients
NEW12862,NUTRITION,steroid hormone system,steroid hormone systems
NEW12865,BIOCHEMICAL,asymptomatic carrier,asymptomatic carriers
NEW12866,CHEMICAL,selective serotonin-norepinephrine reuptake inhibitor,selective serotonin-norepinephrine reuptake inhibitors
NEW12868,DISEASE,robust autism-like behavior,robust autism-like behaviors
NEW12869,DISEASE,autism-like behavioral phenotype,autism-like behavioral phenotypes
NEW12872,CHEMICAL,γ-aminobutyric acid gaba receptor function,γ-aminobutyric acid GABA receptor function
NEW12874,DISEASE,tissue hypoxia,tissue hypoxia
C472864,NUTRITION,"free fatty acid receptor R10, human [Supplementary Concept]","free fatty acid|Receptors, Cell Surface"
NEW12876,CHEMICAL,ffa uptake,FFA uptake
http://purl.org/sig/ont/fma/fma20335,CHEMICAL,l5 level,O2 levels
NEW12881,CHEMICAL,non-mitochondrial o2 consumption,non-mitochondrial O2 consumption
D011064,CHEMICAL,Poly Adenosine Diphosphate Ribose,"ADP|Poly ADPR|adenosine diphosphate|Diphosphate-Ribose, Poly-Adenosine|Poly ADP Ribose|ADP Ribose, Poly|Poly(ADP-Ribose)|Poly-ADPR|Poly-Adenosine Diphosphate-Ribose|Ribose, Poly ADP"
NEW12886,MENTAL_HEALTH,leaf resistance,leaf resistance
NEW12888,CHEMICAL,chlorophyll content,chlorophyll contents
NEW12892,DISEASE,multidrug-resistant a. baumannii infection due,multidrug-resistant A. baumannii infections due
NEW12894,CHEMICAL,cortical glucose metabolism,cortical glucose metabolism
NEW12896,DISEASE,atopic disease,atopic disease
NEW12897,CHEMICAL,cellular glutathione,cellular glutathione
NEW12899,DISEASE,amnestic variant,amnestic variants
NEW12900,DISEASE,aphasic,aphasic
NEW12902,CHEMICAL,non-tea flavonoid,non-tea flavonoids
NEW12903,CHEMICAL,2-hour post load plasma glucose,2-hour post load plasma glucose
NEW12906,CHEMICAL,dm patient,DM patients
D002769,DISEASE,Cholelithiasis,Cholelithiases|Gallstone Disease|cholelithiasis|Gallstone Diseases
NEW12908,DISEASE,liver portion,liver portions
NEW12910,MENTAL_HEALTH,transient hallucination,transient hallucination
NEW12911,DISEASE,withdrawal convulsion,withdrawal convulsion
NEW12913,MENTAL_HEALTH,autism risk,autism risk
NEW12915,DISEASE,human asd,human ASD
http://purl.obolibrary.org/obo/MFOMD_0000199,MENTAL_HEALTH,social dysfunction,social dysfunction
NEW12918,MENTAL_HEALTH,hyperestrogenic syndrome,hyperestrogenic syndromes
NEW12919,CHEMICAL,fusarium specie,Fusarium species
NEW12922,DISEASE,zen-contaminated meal medium,ZEN-contaminated meal medium
NEW12923,DISEASE,saline zen concentration,saline ZEN concentration
NEW12924,CHEMICAL,bile salt tolerance,bile salt tolerance
NEW12925,BIOCHEMICAL,hormone neuron,Hormone neurons
NEW12926,CHEMICAL,blunt corticosterone secretion,blunted corticosterone secretion
NEW12928,MENTAL_HEALTH,resistance trait,resistance traits
NEW12930,DISEASE,poststroke mood,poststroke mood
NEW12932,CHEMICAL,2-alkylcylcyclobutanone,2-alkylcylcyclobutanones
C079750,CHEMICAL,"VP23 protein, Human herpesvirus 1 [Supplementary Concept]",uL18|Capsid Proteins
NEW12934,DISEASE,pain reduction,pain reduction
NEW12936,BIOCHEMICAL,maternal ltra use,maternal LTRA use
NEW12940,DISEASE,resistant tumor cell,resistant tumor cells
NEW12941,CHEMICAL,target combinational ferroptosis/apoptosis therapy,targeted combinational ferroptosis/apoptosis therapy
NEW12943,CHEMICAL,atp supply,ATP supply
NEW12944,CHEMICAL,ros level,ROS levels
NEW12947,DISEASE,seizure severity,seizure severity
NEW12948,DISEASE,stress-induced damage,stress-induced damage
NEW12950,CHEMICAL,tissue nad+ level,tissue NAD+ levels
NEW12952,BIOCHEMICAL,nicotinamide intake,nicotinamide intake
NEW12953,CHEMICAL,nad+ level,NAD+ levels
NEW12955,CHEMICAL,-29.7,-29.7
NEW12956,BIOCHEMICAL,drug exposure,drug exposure
NEW12957,DISEASE,disorder scale,Disorders scales
NEW12958,DISEASE,axis Disorders,Axis Disorders
NEW12959,DISEASE,tropane hydrochloride,tropane hydrochloride|DUI
NEW12962,DISEASE,severe ss,severe SS
NEW12964,DISEASE,g361 malignant human melanoma cell line,G361 malignant human melanoma cell lines
NEW12966,DISEASE,future suicidal behavior,future suicidal behaviors
NEW12968,DISEASE,af vascular disease,AF vascular disease
NEW12970,DISEASE,familial lcat deficiency,familial LCAT deficiency
NEW12971,DISEASE,early corneal opacity,early corneal opacity
NEW12975,MENTAL_HEALTH,rapid tat2 dissociation,rapid Tat2 dissociation
NEW12976,MENTAL_HEALTH,persecutory delusion,persecutory delusions
NEW12977,CHEMICAL,low pufa patient,low PUFA patients
NEW12982,BIOCHEMICAL,antibiotic-guided systemic antibiotic,antibiotic-guided systemic antibiotics
NEW12983,BIOCHEMICAL,surgical antimicrobial prophylaxis,surgical antimicrobial prophylaxis
NEW12985,MENTAL_HEALTH,postoperative analgesia,postoperative analgesia
D064705,CHEMICAL,Racepinephrine,"Adrenaline Hydrochloride, Racemic Mixture|Epinephrine, Racemic Mixture|adrenaline|Racemic Mixture Adrenaline|Racemic Adrenaline|Racepinephrine Hydrochloride|Racemic Epinephrine|Micronefrin|Vaponefrin|Racemic Mixture Epinephrine|Micronephrine|Adrenaline, Racemic Mixture|Epinephrine, Racemic|Adrenaline, Racemic|Epinephrine Hydrochloride, Racemic Mixture"
NEW12987,DISEASE,pseudomonas aeruginosa atcc,Pseudomonas aeruginosa ATCC
NEW12988,CHEMICAL,Group LA,Group LA
D034761,CHEMICAL,Heterogeneous-Nuclear Ribonucleoprotein Group M,"Heterogeneous-Nuclear Ribonucleoprotein M|hnRNP M|Heterogeneous Nuclear Ribonucleoprotein Group M|Mupirocine|Ribonucleoprotein M, Heterogeneous-Nuclear|Group M|Heterogeneous Nuclear Ribonucleoprotein M"
NEW12989,DISEASE,staphylococcus aureus american type culture collection,Staphylococcus aureus American type culture collection
NEW12992,BIOCHEMICAL,antimicrobial effect,antimicrobial effects
D000085002,CHEMICAL,Glycemic Control,"Glucose Control, Blood|Control, Blood Glucose|Blood Glucose Control|Control, Glycemic|glucose control"
NEW12996,BIOCHEMICAL,classic kop-r full agonist,classic KOP-r full agonists
http://purl.obolibrary.org/obo/CHEBI_51246,CHEMICAL,propidium,"3,8-diamino-5-{3-[diethyl(methyl)ammonio]propyl}-6-phenylphenanthridinium|3,8-diamino-5-(3-(diethylmethylammonio)propyl)-6-phenylphenanthridinium|3,8-DIAMINO-5[3-(DIETHYLMETHYLAMMONIO)PROPYL]-6-PHENYLPHENANTHRIDINIUM|propidium iodide/""5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolyl"
NEW12998,CHEMICAL,"iodide/""5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolyl carbocyanine iodide","iodide/""5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolyl carbocyanine iodide"
NEW12999,CHEMICAL,neutral comet assay/acridine orange assay,neutral comet assay/acridine orange assay
D016388,DISEASE,Tooth Loss,"tooth loss|Loss, Tooth"
NEW13002,BIOCHEMICAL,hepatotoxin,hepatotoxins
C057816,DISEASE,"gene 5 protein, Enterobacteria phage M13 [Supplementary Concept]",DNA-Binding Proteins|Viral Proteins|enterobacteria
NEW13004,DISEASE,cholestatic dili,cholestatic DILI
NEW13006,BIOCHEMICAL,sex-steroid hormone level,sex-steroid hormone levels
NEW13008,CHEMICAL,ovarian sex steroid,ovarian sex steroids
NEW13011,DISEASE,chronic migraine,chronic migraine
NEW13012,CHEMICAL,nitroglycerin model,nitroglycerin model
NEW13014,CHEMICAL,moh/oih,MOH/OIH
D015217,CHEMICAL,Cholesterol Ester Storage Disease,cholesteryl ester storage|Cholesteryl Ester Storage Disease
D015312,DISEASE,Hemodialysis Solutions,"Solutions, Hemodialysis Dialysis|Hemodialyzates|HD|Hemodialysates|Solutions, Hemodialysis|hemodialysis|Hemodialysis Dialysis Solutions|Dialysis Solutions, Hemodialysis"
NEW13019,MENTAL_HEALTH,disorder research,disorder research
NEW13024,DISEASE,long-lasting memory-associated deficit,long-lasting memory-associated deficits
NEW13025,DISEASE,antiepileptic drug-induced skin rash,antiepileptic drug-induced skin rash
NEW13026,DISEASE,hus pathophysiology,HUS pathophysiology
NEW13028,DISEASE,distal nephron disorder,distal nephron disorders
NEW13031,BIOCHEMICAL,polar narcotic,polar narcotics
NEW13033,CHEMICAL,µg/ml,µg/mL
D016833,DISEASE,Trypanosoma brucei rhodesiense,"brucei rhodesienses, Trypanosoma|brucei rhodesiense, Trypanosoma|rhodesienses, Trypanosoma|Trypanosoma brucei rhodesienses|Trypanosoma rhodesiense|rhodesienses, Trypanosoma brucei|Trypanosoma rhodesienses|Trypanosoma brucei"
NEW13035,CHEMICAL,hallucination-psychosis spectrum,hallucination-psychosis spectrum
NEW13037,NUTRITION,alpha band activity,alpha band activity
NEW13038,BIOCHEMICAL,beta-selective antagonist,beta-selective antagonist
NEW13040,DISEASE,rat ventricular muscle membrane,rat ventricular muscle membranes
NEW13042,CHEMICAL,microm phenoxybenzamine,microM phenoxybenzamine
NEW13044,NUTRITION,alpha site,alpha sites
NEW13046,DISEASE,cognitive damage,cognitive damage
NEW13047,DISEASE,learn deficiency,learning deficiencies
NEW13048,CHEMICAL,amyloid-beta aβ protein expression,amyloid-beta Aβ protein expression
D010838,DISEASE,Phytophthora,"Phytophthora ramorum|Phytophthoras|Phytophthora parasitica|Phytophthora ramorums|Phytophthora sojae|ramorums, Phytophthora|Phytophthora cinnamomus|Phytophthora cinnamomi|cinnamomi, Phytophthora|parasitica, Phytophthora|Phytophthora parasiticas"
D049970,DISEASE,Graves Ophthalmopathy,"Infiltrative Ophthalmopathies|Infiltrative Ophthalmopathy|Thyroid Eye Disease|Eye Disease, Graves|Ophthalmopathy, Dysthyroid|Myopathic Ophthalmopathy|Eye Disease, Thyroid|Edematous Ophthalmopathies|Thyroid Associated Ophthalmopathies|Ophthalmopathy, Thyroid Associated|Congestive Ophthalmopathies|Dysthyroid Ophthalmopathies|Ophthalmopathy, Infiltrative|Disease, Graves Eye|Ophthalmopathy, Congestive|Orbitopathy, Graves|Thyroid Associated Ophthalmopathy|Ophthalmopathy, Thyroid-Associated|Congestive Ophthalmopathy|Ophthalmopathy, Graves|Ophthalmopathy, Edematous|Disease, Thyroid Eye|Graves Orbitopathy|Dysthyroid Ophthalmopathy|Myopathic Ophthalmopathies|Graves Eye Disease|Thyroid-Associated Ophthalmopathy|Graves|Ophthalmopathies, Thyroid-Associated|Edematous Ophthalmopathy|Thyroid Eye Diseases|Ophthalmopathy, Myopathic|Thyroid-Associated Ophthalmopathies"
NEW13055,DISEASE,p. cinnamomi infection,P. cinnamomi infection
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Spinal_Cord_Injuries,DISEASE,spinal cord injuries,e.g. spinal cord trauma
NEW13056,DISEASE,acute tissue injury state,acute tissue injury states
NEW13058,DISEASE,functional hypoparathyroidism,functional hypoparathyroidism
NEW13059,BIOCHEMICAL,"1,25-(oh)2 vitamin d consistent","1,25-(OH)2 vitamin D consistent"
D019789,CHEMICAL,Tetraethylammonium,"Tetraethylammonium Bromide|Bromide, Tetraethylammonium|Tetraethylammonium Chloride|Chloride, Tetraethylammonium|Tetraethylammonium Hydroxide|Hydroxide, Tetraethylammonium|Iodide, Tetraethylammonium|tetraethylammonium|Ion, Tetraethylammonium|Tetraethylammonium Ion|Tetraethylammonium Iodide"
NEW13062,CHEMICAL,cgmp increase,cGMP increase
NEW13063,CHEMICAL,h2s synthesizing enzyme,H2S synthesizing enzymes
D003541,CHEMICAL,Cystathionine beta-Synthase,"beta Thionase|Serine Sulfhydrase|beta-Thionase|Cystathionine beta Synthase|Sulfhydrase, Serine|Cystathionine Synthetase|Synthetase, Cystathionine|beta-Synthase, Cystathionine|cystathionine β-synthase"
D006157,CHEMICAL,Guanosine Monophosphate,"Guanosine 5' Monophosphate|5'-Guanylic Acid|Monophosphate, Guanosine|5'-Monophosphate, Guanosine|guanosine monophosphate|cGMP|Acid, 5'-Guanylic|5'-GMP|Acid, Guanylic|5' Guanylic Acid|Guanylic Acid|Guanosine 5'-Monophosphate"
NEW13065,CHEMICAL,cgmp accumulation,cGMP accumulation
NEW13067,CHEMICAL,plasma bicarbonate,plasma bicarbonate
NEW13068,MENTAL_HEALTH,define syndrome,defined syndromes
NEW13069,MENTAL_HEALTH,addition anterograde amnesia,addition anterograde amnesia
D000067399,DISEASE,Abnormal Involuntary Movement Scale,abnormal involuntary movement
NEW13074,DISEASE,parkinsonian monkey,parkinsonian monkeys
NEW13075,DISEASE,l-dopa-induced aim,L-dopa-induced AIMs
NEW13076,CHEMICAL,partial striatal dopamine lesion,partial striatal dopamine lesion
NEW13078,NUTRITION,european sea bass specimen,European sea bass specimens
NEW13080,DISEASE,bacillus subtilis cell,Bacillus subtilis cells
NEW13081,DISEASE,colic gastrointestinal disorder,colic gastrointestinal disorders
NEW13083,CHEMICAL,complex chromosome rearrangement,CCR|complex chromosome rearrangement
NEW13085,CHEMICAL,model anthraquinone compound,model anthraquinone compound
NEW13088,MENTAL_HEALTH,non-goal-directed nighttime hyperactivity,non-goal-directed nighttime hyperactivity
NEW13091,DISEASE,amyloid aggregation,amyloid aggregation
NEW13092,DISEASE,dsm-iii-r diagnostic criterion,DSM-III-R diagnostic criteria
D016163,CHEMICAL,"Genes, DCC","DCC|Gene, DCC|DCC Genes|DCC Gene"
D000073218,CHEMICAL,Wisconsin Card Sorting Test,M-WCST|Wisconsin Card Sorting Test|Modified Wisconsin Card Sorting Test
NEW13098,CHEMICAL,skin structure infection,skin structure infections|ABSSSI
NEW13101,DISEASE,mp degradation,MP degradation
NEW13102,DISEASE,different toxicity target,different toxicity targets
C511776,CHEMICAL,2'-((4'-trifluoromethanesulfonyloxy)phenyl)-N-methanesulfonylpropionamide [Supplementary Concept],Sulfonamides|Df
NEW13105,NUTRITION,insect herb,insect herbs
NEW13107,DISEASE,grave abnormality,grave abnormalities
NEW13108,DISEASE,long-lasting neurobehavioral dysfunction,long-lasting neurobehavioral dysfunction
NEW13111,DISEASE,systemic disease pellagra,systemic disease pellagra
D017495,DISEASE,Hyperpigmentation,hyperpigmentation|Hypermelanoses|Hypermelanosis
NEW13112,CHEMICAL,nad+ pool,NAD+ pool
NEW13113,DISEASE,reduce due stressor,reduced due stressors
NEW13116,DISEASE,fetal alcohol disorder,fetal alcohol disorders
NEW13117,DISEASE,structural damage,structural damage
D012410,MENTAL_HEALTH,"Rubella Syndrome, Congenital","congenital syndromes|Congenital Rubella Syndrome|Syndrome, Congenital Rubella|Syndromes, Congenital Rubella|Rubella Syndromes, Congenital|Congenital Rubella Syndromes"
D008831,DISEASE,Microcephaly,"Congenital Microcephalies, Severe|microcephaly|Severe Congenital Microcephaly|Microcephalies, Severe Congenital|Microlissencephalies|Microlissencephaly|Microcephalies|Severe Congenital Microcephalies|Microcephaly, Severe Congenital|Congenital Microcephaly, Severe"
NEW13118,DISEASE,speech difficulty,speech difficulties
D061085,DISEASE,Agenesis of Corpus Callosum,"Absence of Corpus Callosum|Hypogeneses, Corpus Callosum|Corpus Callosum Hypogenesis|Corpus Callosum, Agenesis Of|Corpus Callosum Absences|Corpus Callosum Agenesis|corpus callosum|Corpus Callosum Dysgenesis|Corpus Callosum Hypogeneses|Hypogenesis, Corpus Callosum|Corpus Callosum Absence|Corpus Callosum Malformation|Dysgeneses, Corpus Callosum|Dysgenesis, Corpus Callosum|Ageneses, Corpus Callosum|Corpus Callosum Ageneses|Corpus Callosum Dysgeneses|Agenesis, Corpus Callosum"
NEW13124,CHEMICAL,nucleotide pool,nucleotide pool
NEW13127,DISEASE,low tract infection,lower tract infection
NEW13129,BIOCHEMICAL,virulence factor gene,virulence factor gene
NEW13132,CHEMICAL,effective antidepressant treatment,effective antidepressant treatment
NEW13133,DISEASE,hyperreactivity lung mechanic,hyperreactivity lung mechanics
D002575,DISEASE,Uterine Cervicitis,"Cervicitides|Cervicitis|Uterine Cervicitides|Cervicitides, Uterine|cervicitis|Cervicitis, Uterine"
NEW13136,BIOCHEMICAL,vaginal estrogen,vaginal estrogen
NEW13141,MENTAL_HEALTH,unipolar depression support model,unipolar depression support models
NEW13144,CHEMICAL,low naa/cr,lower NAA/Cr
NEW13146,DISEASE,neuronal metabolic dysfunction,neuronal metabolic dysfunction
NEW13147,DISEASE,severe behavioural disorder,severe behavioural disorders
NEW13149,DISEASE,sensory deficit,sensory deficit
NEW13150,MENTAL_HEALTH,pregnancy depression,pregnancy depression
NEW13152,MENTAL_HEALTH,ion fragmentation pattern,ion fragmentation pattern
NEW13155,CHEMICAL,sodium balance,sodium balance
NEW13158,DISEASE,lean mass,lean mass
NEW13159,BIOCHEMICAL,major serum carotenoid,major serum carotenoids
NEW13161,DISEASE,chronic disease risk,chronic disease risk
NEW13162,DISEASE,seizure risk,seizure risk
NEW13163,BIOCHEMICAL,analgesic action,analgesic action
NEW13164,DISEASE,central centrifugal descend pain facilitatory system,central centrifugal descending pain facilitatory system
NEW13165,CHEMICAL,cortisol release,cortisol release
D006009,NUTRITION,Glycogen Storage Disease Type II,"Pompe's Disease|Acid Alpha-Glucosidase Deficiencies|Generalized Glycogenoses|Alpha-1,4-Glucosidase Deficiencies|Alpha-Glucosidase Deficiencies, Acid|GAA Deficiencies|Acid Maltase Deficiencies|GAA Deficiency|Pompe Disease|Alpha-Glucosidase Deficiencies|Maltase Deficiencies, Acid|Glycogenosis Type II|Alpha 1,4 Glucosidase Deficiency|Deficiencies, Alpha-1,4-Glucosidase|GSD2|Deficiency of Alpha-Glucosidase|GSD2s|Acid Alpha-Glucosidase Deficiency|Disease, Pompe's|Glycogenosis 2|Alpha-1,4-Glucosidase Deficiency|Deficiency, Acid Alpha-Glucosidase|Deficiency, Alpha-1,4-Glucosidase|Adult Glycogen Storage Disease Type II|Deficiency Disease, Acid Maltase|Disease, Pompe|Deficiency, Acid Maltase|Glycogen Storage Disease Type II, Infantile|Lysosomal alpha-1,4-Glucosidase Deficiency Disease|Glycogenoses, Generalized|Juvenile Glycogen Storage Disease Type II|Acid Maltase Deficiency Disease|Acid Maltase Deficiency|Infantile Glycogen Storage Disease Type II|Deficiency Disease, Lysosomal alpha-1,4-Glucosidase|Deficiencies, Acid Alpha-Glucosidase|Glycogen Storage Disease II|Deficiencies, GAA|Acid Alpha Glucosidase Deficiency|Type IIs, Glycogenosis|Alpha-Glucosidase Deficiency|alpha glucosidase|Alpha-Glucosidase Deficiency, Acid|Glycogen Storage Disease Type II, Adult|Glycogenosis, Generalized|Deficiency, GAA|Type II, Glycogenosis|Lysosomal alpha 1,4 Glucosidase Deficiency Disease|Pompes Disease|GSD II|Deficiency of Alpha Glucosidase|Generalized Glycogenosis|Glycogen Storage Disease Type 2|Glycogen Storage Disease Type II, Juvenile|Deficiencies, Acid Maltase"
C509951,CHEMICAL,"GAA protein, human [Supplementary Concept]",recombinant human acid alpha glucosidase|alpha-Glucosidases|rhGAA
NEW13167,CHEMICAL,platelet-released polyp. p. gingivalis,platelet-released polyP. P. gingivalis
NEW13168,DISEASE,tumour necrosis factor-alpha suppressive property,tumour necrosis factor-alpha suppressive properties
NEW13171,DISEASE,p. somniferum,P. somniferum
NEW13172,DISEASE,p. rhoea,P. rhoeas
NEW13175,DISEASE,dsd model,DSD model
NEW13177,BIOCHEMICAL,hormone neurotrasnmitter molecule,hormone neurotrasnmitter molecule
NEW13179,NUTRITION,great wax moth,greater wax moth
NEW13181,DISEASE,post infection time,post infection time
NEW13184,DISEASE,regional glucose hypometabolism,regional glucose hypometabolism
NEW13186,CHEMICAL,approve serotonin re-uptake inhibitory drug duloxetine,approved serotonin re-uptake inhibitory drug duloxetine
NEW13187,CHEMICAL,approve antidepressant duloxetine,approved antidepressant duloxetine
NEW13188,DISEASE,gynecological condition,gynecological condition
NEW13189,CHEMICAL,female oxytocin system,female oxytocin system
NEW13191,DISEASE,seizure control,seizure control
NEW13193,BIOCHEMICAL,antiviral immunity,antiviral immunity
NEW13195,CHEMICAL,chain-terminating nucleotide,chain-terminating nucleotide
NEW13197,CHEMICAL,azt activation,AZT activation
NEW13199,BIOCHEMICAL,sugar additive,sugar additives
NEW13200,DISEASE,social difficulty,social difficulties
NEW13201,CHEMICAL,low-quality friendship,low-quality friendships
NEW13202,NUTRITION,alpha 1-adrenoceptor,alpha 1-adrenoceptors
NEW13207,DISEASE,osas more,OSAS more
NEW13209,CHEMICAL,CPAP+LCKD,CPAP+LCKD
NEW13213,BIOCHEMICAL,vitamin b12 metabolism,vitamin B12 metabolism
http://purl.obolibrary.org/obo/DOID_1094,DISEASE,attention deficit hyperactivity disorder,ADHD|deficit hyperactivity disorder/attention deficit disorder|hyperkinetic disorder|attention deficit disorder
NEW13214,DISEASE,unfavorable neuronal illness,unfavorable neuronal illnesses
NEW13215,DISEASE,deficit disorder deficit disorder,deficit disorder deficit disorder
NEW13217,DISEASE,gram-negative bacterium vibrio harveyi,Gram-negative bacterium Vibrio harveyi
NEW13218,CHEMICAL,available serotonin,available serotonin
NEW13221,DISEASE,deleterious psychiatric condition,deleterious psychiatric conditions
NEW13224,MENTAL_HEALTH,cardiovascular depression,cardiovascular depression
NEW13225,BIOCHEMICAL,narcotic anesthetic,narcotic anesthetic
NEW13226,MENTAL_HEALTH,prodromal psychosis,prodromal psychosis
NEW13229,DISEASE,sps-induced anxiety-like behavior,SPS-induced anxiety-like behaviors
NEW13230,DISEASE,impaired fear extinction,impaired fear extinction
NEW13231,CHEMICAL,morphine effect,morphine effects
NEW13235,CHEMICAL,small molecular aflatoxin b1,small molecular aflatoxin B1|AFB1
NEW13237,CHEMICAL,intracolonic administration,intracolonic administration
NEW13238,DISEASE,descend pain inhibitory pathway,descending pain inhibitory pathways
NEW13239,DISEASE,spinal defecation center,spinal defecation center
NEW13240,DISEASE,thoracic spinal transection,thoracic spinal transection
NEW13242,MENTAL_HEALTH,square displacement,square displacement
NEW13243,MENTAL_HEALTH,bond dissociation enthalpy,bond dissociation enthalpy
NEW13244,MENTAL_HEALTH,self-reported Athens insomnia scale,self-reported Athens insomnia scale
NEW13245,CHEMICAL,AIS score ≥,AIS score ≥
NEW13246,MENTAL_HEALTH,moderate insomnia,moderate insomnia
NEW13248,CHEMICAL,tca overdose,TCA overdoses
NEW13251,BIOCHEMICAL,b2 vitamin E. Tobacco smoking,B2 vitamin E. Tobacco smoking
NEW13253,BIOCHEMICAL,anterior pituitary trophic hormone,anterior pituitary trophic hormones
NEW13254,DISEASE,tetanic tension,tetanic tension
NEW13256,CHEMICAL,partial tetanic fade,partial tetanic fade
NEW13257,CHEMICAL,clinically-tolerated mechanism,clinically-tolerated mechanism
NEW13259,CHEMICAL,n-methyl-d-aspartate (nmda)-type glutamate receptor,N-methyl-D-aspartate (NMDA)-type glutamate receptors
NEW13260,DISEASE,additional neurological disorder,additional neurological disorders
NEW13262,CHEMICAL,n-methyl-d-aspartate (nmda)-type glutamate receptor,N-methyl-d-aspartate (NMDA)-type glutamate receptors
NEW13264,DISEASE,human cancer,human cancers
NEW13269,DISEASE,simple snore group,simple snoring group
NEW13271,CHEMICAL,low testosterone concentration,low testosterone concentration
NEW13273,DISEASE,tumor tissue,tumor tissues
NEW13274,DISEASE,t-cell infiltration,T-cell infiltration
http://purl.obolibrary.org/obo/CHEBI_90620,CHEMICAL,vatalanib,vatalanib|PTK787|N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine|ZK-232934|N-(p-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine|axitinib AUCSS|PTK 787|CGP-79787|CGP79787|CGP 79787|PTK/ZK|PTK-787|N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine
NEW13278,DISEASE,mdd onset,MDD onset
NEW13279,MENTAL_HEALTH,nutrition mood disorder,nutrition mood disorders
NEW13282,CHEMICAL,dapoxetine treatment,dapoxetine treatment
http://purl.obolibrary.org/obo/SYMP_0000061,DISEASE,inflammation,DHAV-1-induced inflammation
NEW13285,DISEASE,breast muscle,breast muscle
NEW13287,CHEMICAL,tibial ca,tibial Ca
NEW13289,DISEASE,estrogen receptor (er)‑positive breast cancer,estrogen receptor (ER)‑positive breast cancer
NEW13290,CHEMICAL,tamoxifen resistance,tamoxifen resistance
NEW13292,DISEASE,advanced cholangiocarcinoma harboring fgfr2 fusion,advanced cholangiocarcinoma harboring FGFR2 fusions
NEW13293,CHEMICAL,lactate dehydrogenase efflux,lactate dehydrogenase efflux
NEW13295,DISEASE,oxidative astrocyte death,oxidative astrocyte death
NEW13299,BIOCHEMICAL,mm ascorbic acid,mM ascorbic acid
http://purl.obolibrary.org/obo/CHEBI_82625,CHEMICAL,trolox,"µM Trolox|Trolox|6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid|3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromene-2-carboxylic acid|Trolox C"
NEW13300,DISEASE,oxidative neuronal death,oxidative neuronal death
NEW13301,DISEASE,bmaa-induced death,BMAA-induced death
NEW13303,DISEASE,tumor recurrence,tumor recurrence
NEW13306,DISEASE,tumor immunocombination therapy due,tumor immunocombination therapy due
NEW13307,DISEASE,mx-1 human mammary tumor xenograft,MX-1 human mammary tumor xenograft
NEW13308,MENTAL_HEALTH,complete regression,complete regression
D008546,DISEASE,"Melanoma, Experimental","Experimental Melanoma|Melanomas, B16|Melanoma, Cloudman S91|Harding Passey Melanoma|Cloudman S91 Melanoma|B16 melanoma|B16 Melanomas|Melanoma, Harding Passey|Harding-Passey Melanoma|Experimental Melanomas|B16 Melanoma|Melanomas, Experimental|Melanoma, Harding-Passey|S91 Melanoma, Cloudman|Melanoma, B16"
NEW13309,DISEASE,cd8f1 mammary carcinoma,CD8F1 mammary carcinomas
NEW13310,DISEASE,hepatoma 3924a cell,hepatoma 3924A cells
NEW13311,CHEMICAL,purine nucleotide biosynthesis,purine nucleotide biosynthesis
C020828,CHEMICAL,GMP synthase (glutamine-hydrolyzing) [Supplementary Concept],GMP synthase|Carbon-Nitrogen Ligases
http://purl.obolibrary.org/obo/PR_P23897,CHEMICAL,heat-stable enterotoxin receptor (rat),intestinal guanylate cyclase (rat)|guc2c|rgucy2c|gucy2c|guanylates|sta receptor (rat)|guanylyl cyclase c (rat)|gc-c (rat)
http://purl.obolibrary.org/obo/CHEBI_137396,CHEMICAL,5-carboxy-1-(5-o-phosphono-beta-d-ribofuranosyl)pyridinium-3-carbonyl adenylate,"adenylates|pyridinium-3,5-biscarboxylate mononucleotide adenylate|P2CMN-adenylate"
http://purl.obolibrary.org/obo/PR_P56702,CHEMICAL,diazepam-binding inhibitor-like 5 (rat),endozepines|endozepine-like peptide (rat)|dbil5|elp (rat)|rdbil5
NEW13313,BIOCHEMICAL,secondary antibiotic prophylaxis,secondary antibiotic prophylaxis
NEW13316,MENTAL_HEALTH,anxiety symptomology,anxiety symptomology
NEW13317,MENTAL_HEALTH,fatigue group,fatigue group
NEW13319,MENTAL_HEALTH,experimental fatigue test,experimental fatigue tests
NEW13323,NUTRITION,hl- ultra-high strength sucker rod,HL- ultra-high strength sucker rods
NEW13326,CHEMICAL,win55,WIN55
NEW13328,BIOCHEMICAL,available antibiotic,available antibiotics
D011770,CHEMICAL,Pyruvate Kinase,"pyruvate kinase|L-Type Pyruvate Kinase|M1 Type Pyruvate Kinase|Pyruvate Kinase, M-Type|Pyruvate Kinase, R-Type|Pyruvate Kinase, L-Type|M2-Type Pyruvate Kinase|M2 Type Pyruvate Kinase|R-Type Pyruvate Kinase|M Type Pyruvate Kinase|R Type Pyruvate Kinase|L Type Pyruvate Kinase|Pyruvate Kinase, M2-Type|M-Type Pyruvate Kinase|M1-Type Pyruvate Kinase|Pyruvate Kinase L|Pyruvate Kinase, M1-Type"
NEW13330,CHEMICAL,phosphoenolpyruvate pep flux,phosphoenolpyruvate PEP flux
NEW13333,MENTAL_HEALTH,depression mouse model,depression mouse model
NEW13335,CHEMICAL,intra-mpfc infusion,intra-mPFC infusions
NEW13336,DISEASE,psl-induced depression-like behavior,PSL-induced depression-like behavior
NEW13338,CHEMICAL,lcpufa content,LCPUFA content
NEW13340,CHEMICAL,glucocorticoid cortisol concentration,glucocorticoid cortisol concentrations
NEW13341,CHEMICAL,glycine antagonist,glycine antagonist
C066192,CHEMICAL,"5,7-dichlorokynurenic acid [Supplementary Concept]","DCKA|5,7-dichlorokynurenic acid|Kynurenic Acid/analogs  and  derivatives"
C105319,CHEMICAL,"3-(2-((phenylamino)carbonyl)ethenyl)-4,6-dichloroindole-2-carboxylic acid [Supplementary Concept]",GV150526A|Indoles
NEW13343,DISEASE,campylobacter population,Campylobacter populations
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Cerebral_Ischemia,DISEASE,cerebral ischemia,cerebral ischemia injury
NEW13345,CHEMICAL,5-triphenyltetrazolium chloride staining,5-Triphenyltetrazolium chloride staining
NEW13347,DISEASE,comorbid ptsd,comorbid PTSD
NEW13349,DISEASE,transient mild hemiparesis,transient mild hemiparesis
http://purl.obolibrary.org/obo/SYMP_0000414,MENTAL_HEALTH,dysarthria,astereognosia
NEW13350,CHEMICAL,cd treatment,Cd treatment
NEW13351,DISEASE,juvenile P. trituberculatus,juvenile P. trituberculatus
NEW13352,DISEASE,juvenile f. chinensis,juvenile F. chinensis
NEW13355,MENTAL_HEALTH,adiposity resistance,adiposity resistance
NEW13356,DISEASE,ammonia-induced neurotoxicity,ammonia-induced neurotoxicity
D010908,BIOCHEMICAL,"Pituitary Hormones, Anterior","Adenohypophyseal Hormones|Hormones, Adenohypophyseal|anterior pituitary hormones|Anterior Pituitary Hormones|Hormones, Anterior Pituitary"
NEW13363,DISEASE,possible neurodegeneration,possible neurodegeneration
NEW13365,CHEMICAL,nicotine neurodevelopmental defect,nicotine neurodevelopmental defects
NEW13367,MENTAL_HEALTH,resistance class,resistance classes
NEW13369,DISEASE,% ger severity,% GER severity
NEW13370,BIOCHEMICAL,multiple mycotoxin,multiple mycotoxins
http://purl.obolibrary.org/obo/DOID_10584,DISEASE,retinitis pigmentosa,LRAT-related retinitis pigmentosa|pericentral pigmentary retinopathy
http://purl.obolibrary.org/obo/CHEBI_47775,NUTRITION,high-density lipoprotein cholesterol,alpha-lipoprotein cholesterol|low high-density lipoprotein cholesterol levels|HDL-C|HDL cholesterol
NEW13373,MENTAL_HEALTH,organic amnesia,organic amnesia
NEW13374,CHEMICAL,psl injury,PSL injury
NEW13375,DISEASE,reduce heat allodynia,reduced heat allodynia
NEW13376,DISEASE,concentration neuropathic pain,concentrations neuropathic pain
NEW13378,CHEMICAL,da activity,DA activity
NEW13382,DISEASE,common metabolic liver disease,common metabolic liver diseases
D049913,DISEASE,ACTH-Secreting Pituitary Adenoma,"Pituitary Adenoma, ACTH-Producing|Pituitary Adenoma, ACTH-Secreting|Pituitary Corticotropin Secreting Adenoma|pituitary adenoma|Pituitary Adenomas, ACTH-Secreting|Corticotroph Adenoma|ACTH Producing Pituitary Adenoma|Corticotropin-Secreting Adenoma, Pituitary|ACTH-Producing Pituitary Adenoma|Corticotropin-Secreting Adenomas, Pituitary|Pituitary Adenomas, ACTH-Producing|Corticotroph Adenomas|Pituitary Adenoma, ACTH Secreting|ACTH-Producing Pituitary Adenomas|Adenomas, Corticotroph|ACTH Secreting Pituitary Adenoma|Pituitary Corticotropin-Secreting Adenomas|Adenoma, Corticotroph|Pituitary Corticotropin-Secreting Adenoma|ACTH-Secreting Pituitary Adenomas"
NEW13384,NUTRITION,insect midgut,insect midgut
NEW13385,CHEMICAL,protoxin-toxin conversion,protoxin-toxin conversion
NEW13387,MENTAL_HEALTH,orbital agitation speed,orbital agitation speed
NEW13388,CHEMICAL,non-synergistic strain,non-synergistic strain|AB250
NEW13392,CHEMICAL,nicotine cocaine administration,nicotine cocaine administration
NEW13396,CHEMICAL,naloxone-induced morphine abstinence syndrome,naloxone-induced morphine abstinence syndrome
NEW13397,CHEMICAL,naloxone-elicited morphine abstinence syndrome,naloxone-elicited morphine abstinence syndrome
NEW13399,MENTAL_HEALTH,ionic dissociation,ionic dissociation
NEW13403,DISEASE,gastroenteritis diarrhea,gastroenteritis diarrhea
NEW13405,DISEASE,diarrhea case,diarrhea cases
NEW13411,CHEMICAL,damage atp depletion,damaging ATP depletion
NEW13412,DISEASE,damage dysfunction,damage dysfunction
NEW13413,MENTAL_HEALTH,early defense mechanism,early defense mechanism
NEW13415,MENTAL_HEALTH,pathogen resistance,pathogen resistance
NEW13419,NUTRITION,hepatic bullhead gst isoform,hepatic bullhead GST isoforms
NEW13421,DISEASE,pollutant-associated neoplasia,pollutant-associated neoplasia
NEW13423,CHEMICAL,fructose administration,fructose administration
NEW13424,CHEMICAL,increase lactate production,increased lactate production
NEW13426,DISEASE,tumor initiation,tumor initiation
NEW13428,CHEMICAL,deltapml-raralpha formation,deltaPML-RARalpha formation
NEW13429,DISEASE,nb4-ci arsenic-resistant nb4/as cell,NB4-CI arsenic-resistant NB4/As cells
C018279,NUTRITION,sodium phosphate [Supplementary Concept],Phosphates|phosphoric acid
D012972,CHEMICAL,Sodium Hydroxide,"sodium hydroxide|Caustic Soda|Soda, Caustic|Hydroxide, Sodium"
C071567,CHEMICAL,"general secretion pathway protein, Xanthomonas campestris [Supplementary Concept]",Membrane Transport Proteins|XPS|Bacterial Proteins
D002482,CHEMICAL,Cellulose,"Rayophane|Heweten|alpha-Cellulose|Avicel|Polyanhydroglucuronic Acid|alpha Cellulose|Alphacel|Sulfite Cellulose|alpha-cellulose|Acid, Polyanhydroglucuronic"
C488493,CHEMICAL,"galactan-galactan galactosyltransferase, Ajuga reptans [Supplementary Concept]",Galactosyltransferases|galactan
NEW13433,DISEASE,numerous skin lesion,numerous skin lesions
NEW13437,CHEMICAL,binding affinity,ΔG|binding affinities
NEW13438,DISEASE,human endometriosis,human endometriosis
NEW13439,DISEASE,endometriosis cell line,endometriosis cell lines
NEW13442,CHEMICAL,hexacarboxyporphyrin,hexacarboxyporphyrin
http://purl.obolibrary.org/obo/CHEBI_52188,NUTRITION,meso-substituted porphyrin,meso-substituted porphyrins|porphyrins pentacarboxyporphyrin
D014578,CHEMICAL,Uroporphyrins,uroporphyrins|Porphyrins (1968-1974)
NEW13444,MENTAL_HEALTH,autism severity,autism severity
NEW13445,DISEASE,concomitant alcoholism,concomitant alcoholism
NEW13446,DISEASE,acute deficiency,acute deficiency
D000052,DISEASE,Acanthosis Nigricans,"acanthosis nigricans|Nigricans, Acanthosis|Nigrican, Acanthosis|Acanthosis Nigrican"
NEW13449,DISEASE,complex post-stroke emotional disorder,complex post-stroke emotional disorders
NEW13451,DISEASE,infarct size,infarct size
NEW13452,DISEASE,acute stroke patient due,acute stroke patients due
http://purl.obolibrary.org/obo/CHEBI_87100,BIOCHEMICAL,triazole fungicide,triazole fungicides
NEW13455,DISEASE,multiple sclerosis patient,multiple sclerosis patients
C090413,CHEMICAL,N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide [Supplementary Concept],"Piperazines|Pyridines|WAY-100,635"
NEW13459,CHEMICAL,50-mg baseline dose,50-mg baseline dose
NEW13461,DISEASE,severe hypotension,severe hypotension
NEW13463,CHEMICAL,parvalbumin immunoreactivity,parvalbumin immunoreactivity
NEW13465,DISEASE,steatosis-related early-stage hepatocarcinogenesis,steatosis-related early-stage hepatocarcinogenesis
NEW13466,DISEASE,steatosis-related hepatocarcinogenesis,steatosis-related hepatocarcinogenesis
NEW13468,DISEASE,p. aeruginosa colony formation,P. aeruginosa colony formation
NEW13469,CHEMICAL,impaired brain glucose metabolism,impaired brain glucose metabolism
NEW13473,MENTAL_HEALTH,double resistance due,double resistance due
NEW13477,BIOCHEMICAL,multiple stabilizer,multiple stabilizers
NEW13479,DISEASE,significant tachycardia,significant tachycardia
NEW13481,CHEMICAL,excess catecholamine,excess catecholamines
D006323,DISEASE,Heart Arrest,"Arrest, Cardiac|Arrest, Heart|Asystoles|Asystole|Cardiac Arrest|Cardiopulmonary Arrest|asystole|Arrest, Cardiopulmonary"
NEW13482,DISEASE,coronary spasm,coronary spasm
NEW13483,CHEMICAL,calcium blocker nitrendipine,calcium blocker nitrendipine
NEW13485,DISEASE,various pediatric psychiatric disorder,various pediatric psychiatric disorders
NEW13486,BIOCHEMICAL,drug profile,drug profile
C029795,BIOCHEMICAL,diphtheria toxin fragment A [Supplementary Concept],Diphtheria Toxin|diphtheria toxin fragment A|Peptide Fragments
D048909,DISEASE,Diabetes Complications,Diabetic Complications|Diabetes Related Complications|Diabetes Complication|Diabetes-Related Complications|Complications of Diabetes Mellitus|Diabetes Mellitus Complication|Diabetes Mellitus Complications|Diabetic Complication|Diabetes-Related Complication|diabetes complications
NEW13488,DISEASE,cardiomyopathy dcm protection,cardiomyopathy DCM protection
NEW13491,DISEASE,melancholic patient,melancholic patients
NEW13492,DISEASE,microvesicular lipidosis,microvesicular lipidosis
NEW13493,CHEMICAL,long-acting β(2)-adrenoceptor agonist,long-acting β(2)-adrenoceptor agonists|LABAs
C564221,MENTAL_HEALTH,Glucocorticoid Receptor Deficiency [Supplementary Concept],"Receptors, Glucocorticoid/deficiency|Metabolism, Inborn Errors|glucocorticoid resistance"
NEW13496,DISEASE,mouse tumor growth,mice tumor growth
NEW13497,CHEMICAL,succinate deyhydrogenase 0.05,succinate deyhydrogenase 0.05
NEW13499,DISEASE,neurodevelopmental difficulty,neurodevelopmental difficulties
D020830,BIOCHEMICAL,rac1 GTP-Binding Protein,"ras Related C3 Botulinum Toxin Substrate 1|ras-Related C3 Botulinum Toxin Substrate 1|TC 25 GTP Binding Protein|Ras-related C3 botulinum toxin substrate|rac1 Protein|TC-25 GTP-Binding Protein|rac1 GTP Binding Protein|GTP-Binding Protein, TC-25|GTP-Binding Protein, rac1"
NEW13503,CHEMICAL,aztmp excision,AZTMP excision
NEW13504,CHEMICAL,zidovudine resistance,zidovudine resistance
D011014,DISEASE,Pneumonia,"Inflammations, Pulmonary|Pneumonias, Lobar|Lung Inflammations, Experimental|Pulmonary Inflammations|Pneumonitis|Inflammation, Lung|Pneumonitides|Lung Inflammations|Lung Inflammation, Experimental|Inflammations, Lung|Pneumonia, Lobar|Inflammation, Experimental Lung|Pulmonary Inflammation|Experimental Lung Inflammation|Pneumonias|Lobar Pneumonia|lung inflammation|Experimental Lung Inflammations|Inflammation, Pulmonary|Lung Inflammation|Lobar Pneumonias"
C510105,CHEMICAL,halotrichite [Supplementary Concept],Alum Compounds|Ferrous Compounds|FeSO4
NEW13507,DISEASE,sunflower plant,sunflower plants
NEW13509,DISEASE,aging-related cognitive deficit,aging-related cognitive deficits
NEW13511,MENTAL_HEALTH,ad syndrome,AD syndromes
NEW13512,DISEASE,animal parkinsonism,animal parkinsonism
NEW13513,DISEASE,extensive wml,extensive WMLs
NEW13514,DISEASE,ovarian cancer patient,ovarian cancer patients
NEW13516,CHEMICAL,triglycerol pocket,triglycerol pocket
NEW13518,BIOCHEMICAL,dopamine agonist withdrawal syndrome,dopamine agonist withdrawal syndrome
NEW13520,DISEASE,generalize pain craving,generalized pain cravings
NEW13523,BIOCHEMICAL,nutraceutical role,nutraceutical role
NEW13524,DISEASE,leave frontal lobe lesion,left frontal lobe lesion
NEW13525,CHEMICAL,urea cycle metabolism,urea cycle metabolism
NEW13527,MENTAL_HEALTH,psychomental regression,psychomental regression
NEW13528,CHEMICAL,creatine monohydrate,creatine monohydrate
NEW13530,CHEMICAL,urea retention,urea retention
NEW13532,DISEASE,acute mental deterioration,acute mental deterioration
NEW13533,DISEASE,preexist nephropathy,preexisting nephropathy
NEW13534,DISEASE,acute confusional state,acute confusional state
NEW13536,MENTAL_HEALTH,overlap syndrome,overlapping syndromes
NEW13537,DISEASE,depressive mood state,depressive mood states
NEW13539,MENTAL_HEALTH,small equivalent series resistance lower,small equivalent series resistance lower
NEW13540,CHEMICAL,venlafaxine,venlafaxine
NEW13541,DISEASE,pds dosage,PDS dosage
C567924,DISEASE,Infantile Epileptic-Dyskinetic Encephalopathy [Supplementary Concept],"epileptic encephalopathy|Spasms, Infantile"
D051246,CHEMICAL,"Glucose Transport Proteins, Facilitative",SLC2A Proteins|Glucose Transport Facilitators|Glucose Transporter|glucose transport|GLUT Proteins|Glucose Transport Protein
NEW13544,NUTRITION,mitochondrial long-chain fatty acid oxidation,mitochondrial long-chain fatty acid oxidation
NEW13547,DISEASE,neurobiological deficiency,neurobiological deficiencies
NEW13548,DISEASE,increase depression-related behavior,increased depression-related behaviors
NEW13549,DISEASE,digital ulceration,digital ulceration
D000090122,DISEASE,Livedoid Vasculopathy,"vasculopathy|Vasculitis, Livedoid|Livedoid Vasculitis|Livedoid Vasculopathies|Livedo Reticularis with Summer Ulceration|Vasculopathy, Livedoid"
NEW13550,BIOCHEMICAL,type at1 receptor antagonist losartan,type AT1 receptor antagonist losartan
NEW13552,DISEASE,anger attack,anger attack
NEW13553,CHEMICAL,protirelin test,protirelin test
NEW13554,CHEMICAL,assess thyroid status,assessing thyroid status
NEW13555,DISEASE,psychiatric medication,psychiatric medication
NEW13557,CHEMICAL,5ht system perturbation,5HT system perturbation
NEW13558,CHEMICAL,saccharin preference,saccharin preference
NEW13560,MENTAL_HEALTH,drn projection field,DRN projection fields
NEW13563,CHEMICAL,thiram poisoning,thiram poisoning
http://purl.obolibrary.org/obo/CHEBI_60311,BIOCHEMICAL,thyroid hormone,thyroid hormone α|thyroid hormones
NEW13564,BIOCHEMICAL,novel antiandrogen treatment,novel antiandrogen treatments
NEW13565,DISEASE,renal insufficiency confusion,renal insufficiency confusion
NEW13567,DISEASE,age-related learning impairment,age-related learning impairments
NEW13568,DISEASE,manner age-related deficit,manner age-related deficits
NEW13572,CHEMICAL,oxphosci-linked,OXPHOSCI-LINKED
NEW13573,CHEMICAL,α-tocophenol,α-tocophenol
NEW13581,MENTAL_HEALTH,rapid analgesia,rapid analgesia
NEW13582,CHEMICAL,pentagastrin pressor test,pentagastrin pressor test
NEW13583,DISEASE,comorbid medical illness,comorbid medical illnesses
NEW13585,DISEASE,tumour type,tumour types
NEW13586,DISEASE,splanchnic vein thrombosis,splanchnic vein thrombosis
NEW13587,DISEASE,non-cirrhotic patient,non-cirrhotic patients
NEW13591,CHEMICAL,non-triple positive taps,non-triple positive TAPS
C565018,DISEASE,Dysfibrinogenemia Causing Recurrent Thrombosis [Supplementary Concept],Thrombosis|Coagulation Protein Disorders/congenital|recurrent thrombosis
NEW13592,NUTRITION,rs resistant starch,RS resistant starch
NEW13595,MENTAL_HEALTH,non-specific neurological syndrome,non-specific neurological syndromes
NEW13597,DISEASE,wilt disease,wilt disease
NEW13599,DISEASE,early post- traumatic stress reaction,early post- traumatic stress reaction
NEW13602,BIOCHEMICAL,antiviral innate immune peptide characteristic,antiviral innate immune peptide characteristics
NEW13603,NUTRITION,strawberry field,strawberry fields
NEW13604,MENTAL_HEALTH,major g143a resistance mutation,major G143A resistance mutation
NEW13607,CHEMICAL,a1 a2a adenosine receptor,A1 A2a adenosine receptors
NEW13608,DISEASE,mitochondrial function,mitochondrial function
NEW13611,CHEMICAL,memantine effect,memantine effects
NEW13612,MENTAL_HEALTH,elderly bipolar disorder,elderly bipolar disorder
NEW13613,MENTAL_HEALTH,acute psychotic mania,acute psychotic mania
NEW13616,CHEMICAL,broad-spectrum resistance,broad-spectrum resistance
NEW13618,CHEMICAL,methylnaloxonium administration,methylnaloxonium administration
C518846,BIOCHEMICAL,N'-aminooxymethylcarbonylhydrazino D-biotin [Supplementary Concept],Hydrazines|Biotin/analogs  and  derivatives|d-biotin
NEW13619,BIOCHEMICAL,serum biotin level,serum biotin level
NEW13624,CHEMICAL,biogenic amine neurotransmitter,biogenic amine neurotransmitters
NEW13625,DISEASE,bone gain,bone gain
NEW13626,CHEMICAL,high h2-value,high h2-values
NEW13628,CHEMICAL,subanesthetic dose,subanesthetic doses
NEW13630,CHEMICAL,intranasal esketamine,intranasal esketamine
NEW13633,CHEMICAL,sub-inflammatory status,sub-inflammatory status
D008527,DISEASE,Medulloblastoma,"Medulloblastomas, Childhood|Medulloblastomas|Medulloblastomas, Desmoplastic|medulloblastoma|Desmoplastic Medulloblastoma|Sarcoma, Cerebellar, Circumscribed Arachnoidal|Childhood Medulloblastoma|Melanocytic Medulloblastoma|Medulloblastoma, Childhood|Medulloblastoma, Adult|Adult Medulloblastomas|Medulloblastomas, Adult|Medulloblastoma, Desmoplastic|Medullomyoblastoma|Adult Medulloblastoma|Medulloblastoma, Melanocytic|Medullomyoblastomas|Arachnoidal Cerebellar Sarcoma, Circumscribed|Desmoplastic Medulloblastomas|Childhood Medulloblastomas|Melanocytic Medulloblastomas|Medulloblastomas, Melanocytic"
http://purl.obolibrary.org/obo/DOID_2513,DISEASE,basal cell carcinoma,malignant basal cell tumor|malignant Basal cell neoplasm|Basal cell neoplasm|human basal cell carcinoma|Basal cell tumor|Rodent ulcer|Basal cell cancer|Epithelioma basal cell|Basal cell carcinoma of skin
NEW13637,MENTAL_HEALTH,pervasive developmental Disorder behavior Inventory-Screening Version,Pervasive Developmental Disorder Behavior Inventory-Screening Version
NEW13638,DISEASE,Clostridiaceae Clostridium,Clostridiaceae Clostridium
NEW13639,CHEMICAL,scfa concentration,SCFA concentrations
NEW13640,DISEASE,skin pain,skin pain
NEW13642,DISEASE,profound hypotension,profound hypotension
NEW13643,CHEMICAL,sodium channel blockade,sodium channel blockade
NEW13644,DISEASE,impaired myocardial automaticity,impaired myocardial automaticity
NEW13645,DISEASE,seizure refractory,seizures refractory
NEW13646,CHEMICAL,high-dose intravenous diazepam,high-dose intravenous diazepam
NEW13647,DISEASE,severe hypokalemia,severe hypokalemia
NEW13648,DISEASE,unstable hypotension,unstable hypotension
NEW13650,MENTAL_HEALTH,cellular opiate dependence,cellular opiate dependence
NEW13651,DISEASE,withdrawal hyperexcitation,withdrawal hyperexcitation
NEW13653,DISEASE,ocd pathology,OCD pathology
NEW13654,DISEASE,multiple autoimmune disease,multiple autoimmune diseases
NEW13655,DISEASE,non-autoimmune eye disease,non-autoimmune eye disease
http://purl.obolibrary.org/obo/DOID_7188,DISEASE,autoimmune thyroiditis,Chronic Lymphocytic Thyroiditis|Lymphocytic Thyroiditis|autoimmune dacryoadenitis|Hashimoto's syndrome|Hashimoto's thyroiditis|Hashimoto's Disease|Hashimoto thyroiditis
NEW13657,CHEMICAL,il-2 expression model,IL-2 expression model
NEW13662,MENTAL_HEALTH,catatonic posture,catatonic posturing
NEW13663,MENTAL_HEALTH,neurotic depressive state,neurotic depressive state
NEW13666,MENTAL_HEALTH,human premature ejaculation,human premature ejaculation
NEW13667,CHEMICAL,selective serotonin reuptake inhibitory,selective serotonin reuptake inhibitory
NEW13668,BIOCHEMICAL,ssri property,SSRI properties
D052497,DISEASE,"Lipodystrophy, Congenital Generalized","Berardinelli-Seip Congenital Lipodystrophy Type 2|Total Lipodystrophy and Acromegaloid Gigantism|Brunzell Syndrome (with Bone Cysts)|Syndrome, Brunzell|Congenital Generalized Lipodystrophy Type 1|Syndrome, Berardinelli|Brunzell Syndrome, AGPAT2 Related|Congenital Generalized Lipodystrophy Type 2|Lipodystrophy, Berardinelli-Seip Congenital|Lipodystrophy, Congenital Generalized, Type 1|Generalized Lipodystrophies, Congenital|Berardinelli-Seip Congenital Lipodystrophy Type 1|Lipoatrophic Diabetes, Congenital|Brunzell Syndrome, BSCL2 Related|Generalized Lipodystrophies|Total Lipodystrophy|Lipodystrophy, Berardinelli-Seip Congenital, Type 2|Congenital Generalized Lipodystrophy|Syndrome, Brunzell (with Bone Cysts)|Generalized Lipodystrophy|Lipodystrophy, Total|Brunzell Syndrome|Syndrome, BSCL2-Related Brunzell|Berardinelli-Seip Congenital Lipodystrophy|Berardinelli Seip Syndrome|Berardinelli Seip Congenital Lipodystrophy, Type 2|Lipodystrophies, Total|Diabete, Congenital Lipoatrophic|Lipodystrophy, Congenital Generalized, Type 2|BSCL2-Related Brunzell Syndrome|Lipodystrophies, Congenital Generalized|Lipodystrophy, Total, And Acromegaloid Gigantism|Syndrome, Seip|Congenital Lipodystrophy, Berardinelli-Seip|Congenital Lipoatrophic Diabete|Brunzell Syndrome, BSCL2-Related|Lipoatrophic Diabete, Congenital|Seip Syndrome|Total Lipodystrophies|Lipodystrophy, Generalized|Congenital Lipoatrophic Diabetes|Generalized Lipodystrophy, Congenital|Berardinelli Seip Congenital Lipodystrophy, Type 1|Lipodystrophies, Generalized|Berardinelli-Seip Congenital Lipodystrophy, Type 2|Berardinelli Seip Congenital Lipodystrophy Type 1|Berardinelli Syndrome|Berardinelli-Seip Syndrome|Berardinelli-Seip Congenital Lipodystrophy, Type 1|Brunzell Syndrome, AGPAT2-Related|AGPAT2-Related Brunzell Syndrome|Syndrome, AGPAT2-Related Brunzell|Lipodystrophy, Berardinelli-Seip Congenital, Type 1|Syndrome, Berardinelli-Seip|Congenital Generalized Lipodystrophies|Berardinelli Seip Congenital Lipodystrophy Type 2|lipodystrophy|Diabetes, Congenital Lipoatrophic|Berardinelli Seip Congenital Lipodystrophy"
NEW13672,MENTAL_HEALTH,pulmonary vessel resistance,pulmonary vessel resistance
NEW13674,MENTAL_HEALTH,free fatty acid ffa displacement,free fatty acid FFA displacement
NEW13676,CHEMICAL,bilirubin acid,bilirubin acids
NEW13682,MENTAL_HEALTH,infantile autism disease,infantile autism disease
NEW13683,MENTAL_HEALTH,agitation response,agitation response
NEW13684,CHEMICAL,skf10047,SKF10047
http://purl.obolibrary.org/obo/CHEBI_28973,CHEMICAL,strychnine,strychnidin-10-one|strychnine MK-801|Strychnin|Strychnine
NEW13685,MENTAL_HEALTH,dose-dependent depression,dose-dependent depression
NEW13686,CHEMICAL,strychnine hyperesthesia,strychnine hyperesthesia
NEW13687,BIOCHEMICAL,narcotic list,narcotic list
NEW01307,CHEMICAL,second-line agent,second-line agents
NEW13688,CHEMICAL,third-line agent,third-line agents
NEW13690,CHEMICAL,baclofen withdrawal,baclofen withdrawal
NEW13692,DISEASE,antecedent cancer,antecedent cancer
NEW13694,DISEASE,legionella co-infection,Legionella co-infection
D059413,DISEASE,Intraabdominal Infections,"Intraabdominal Infection|Infections, Intra-Abdominal|Intra Abdominal Infections|intra- abdominal infections|Intra-Abdominal Infection|Infections, Intraabdominal|Intra-Abdominal Infections|Infection, Intra-Abdominal|Infection, Intraabdominal"
NEW13695,MENTAL_HEALTH,opioid overuse headache,opioid overuse headache
NEW13696,BIOCHEMICAL,burden analgesic requirement,burden analgesic requirements
NEW13697,MENTAL_HEALTH,headache burden,headache burden
NEW13699,DISEASE,bipolar-related disorder,bipolar-related disorders
D020257,DISEASE,Ventricular Remodeling,"Left Ventricular Remodeling|Remodeling, Ventricular Cardiac|Remodeling, Ventricle|Ventricular Myocardial Remodeling|Ventricle Remodelings|Cardiac Remodeling, Ventricular|Ventricular Cardiac Remodeling|Left Ventricle Remodelings|Remodelings, Ventricular Myocardial|Myocardial Remodeling, Ventricular|Remodeling, Ventricular Myocardial|Remodeling, Ventricular|Left Ventricular Remodelings|Remodeling, Left Ventricular|Remodelings, Ventricular|Remodeling, Left Ventricle|Remodelings, Left Ventricle|Remodelings, Ventricle|cardiac remodeling|Ventricular Remodeling, Left|Remodelings, Left Ventricular|Ventricular Remodelings|Ventricle Remodelings, Left|Cardiac Remodelings, Ventricular|Myocardial Remodelings, Ventricular|Ventricular Remodelings, Left|Left Ventricle Remodeling|Remodelings, Ventricular Cardiac|Ventricular Myocardial Remodelings|Ventricle Remodeling, Left|Ventricle Remodeling|Ventricular Cardiac Remodelings"
NEW13702,DISEASE,doxo-induced cardiotoxicity model,DOXO-induced cardiotoxicity model
NEW13703,DISEASE,doxo-induced cardiac fibrosis,DOXO-induced cardiac fibrosis
NEW13704,DISEASE,af-associated ionic remodeling,AF-associated ionic remodeling
NEW13705,DISEASE,partial bladder outlet obstruction,Partial bladder outlet obstruction|BOO
NEW13706,CHEMICAL,ethanol reward,ethanol reward
NEW13709,DISEASE,sad pathogenesis,SAD pathogenesis
NEW13710,DISEASE,gp120-induced neurotoxicity,gp120-induced neurotoxicity
NEW13711,DISEASE,tau-mediated impairment,tau-mediated impairments
NEW13713,DISEASE,elevated blood glucose level,elevated blood glucose levels
NEW13715,DISEASE,peripheral edema,peripheral edema
NEW13716,DISEASE,cardiometabolic abnormality,cardiometabolic abnormalities
NEW13717,DISEASE,lps-induced acute lung damage,LPS-induced acute lung damage
NEW13718,DISEASE,rheumatic pain,rheumatic pains
NEW13720,DISEASE,psychic premenstrual symptom,psychic premenstrual symptoms
NEW13722,DISEASE,high-turnover osteoporosis,high-turnover osteoporosis
NEW13723,DISEASE,antagonist phencyclidine (pcp)-induced cognitive deficit,antagonist phencyclidine (PCP)-induced cognitive deficits
NEW13724,CHEMICAL,n-methyl-d-aspartate antagonist,N-methyl-D-aspartate antagonist
NEW13725,BIOCHEMICAL,alpha7 nachr antagonist,alpha7 nAChR antagonist
NEW13727,MENTAL_HEALTH,severe learning disability,severe learning disability
NEW13728,DISEASE,hyperactive locomotion,hyperactive locomotion
D001082,DISEASE,Aqueous Humor,"Fluid, Intraocular|Aqueous Humors|Aqueous Flares|Aqueous Flare|Intraocular Fluid|Humor, Aqueous|Humors, Aqueous|Flare, Aqueous|Fluids, Intraocular|aqueous humor|Intraocular Fluids"
NEW13734,CHEMICAL,% oxygen equivalent,% oxygen equivalent
NEW13735,CHEMICAL,fix gas combination,fixed gas combination
C423682,CHEMICAL,RXP03 [Supplementary Concept],Oligopeptides|PO2
NEW13737,CHEMICAL,original SCAARED,original SCAARED
NEW13738,DISEASE,male autistic child,male autistic children
NEW13740,CHEMICAL,folic-acid deficient medium,folic-acid deficient medium
NEW13741,MENTAL_HEALTH,various amnesia model,various amnesia models
NEW13742,DISEASE,motoneuron disease,motoneuron disease
NEW13744,DISEASE,forelimb contracture,forelimb contracture
NEW13746,DISEASE,itch cheesy vaginal discharge,itching cheesy vaginal discharge
NEW13748,DISEASE,amyloid-β toxicity,amyloid-β toxicity
NEW13749,DISEASE,undifferentiated nb,undifferentiated NB
C577430,CHEMICAL,"CDNF protein, rat [Supplementary Concept]",Nerve Growth Factors|cerebral dopamine
NEW13751,CHEMICAL,acetylcholine function,acetylcholine function
NEW13752,DISEASE,neuroleptic-induced dyskinesia,neuroleptic-induced dyskinesias
NEW13754,DISEASE,da deficiency,DA deficiency
NEW13755,DISEASE,haloperidol-induced acute dyskinesia,haloperidol-induced acute dyskinesias
http://purl.obolibrary.org/obo/CHEBI_32789,CHEMICAL,tyrosine residue,tyrosine residues|tyrosine residue|tyrosyl|tyrosine acid residue
NEW13756,CHEMICAL,functional cysteine,functional cysteine
C000706809,CHEMICAL,"CALHM2 protein, human [Supplementary Concept]",calcium homeostasis|Calcium Channels
NEW13757,CHEMICAL,aea level,AEA levels
NEW13759,DISEASE,human gastric cancer cell line,human gastric cancer cell line
NEW13760,DISEASE,prominent tumor inhibition effect,prominent tumor inhibition effects
D013274,DISEASE,Stomach Neoplasms,"Gastric Cancers|Cancers, Gastric|Stomach Neoplasm|Cancer of the Stomach|Stomach Cancers|Neoplasms, Stomach|gastric cancer|Gastric Neoplasms|Gastric Cancer, Familial Diffuse|Cancer of Stomach|Gastric Cancer|Gastric Neoplasm|Neoplasm, Gastric|Cancer, Stomach|Neoplasm, Stomach|Cancers, Stomach|Neoplasms, Gastric|Cancer, Gastric|Stomach Cancer"
NEW13765,DISEASE,advanced prostate cancer treatment,advanced prostate cancer treatment
NEW13767,DISEASE,diabetic woman,diabetic women
NEW13770,MENTAL_HEALTH,dementia-related agitation,dementia-related agitation
NEW13773,CHEMICAL,active comparator risperidone,active comparator risperidone
NEW13774,DISEASE,difficult-to-treat symptom,difficult-to-treat symptoms
NEW13775,DISEASE,mixed mania/depression,mixed mania/depression
NEW13776,CHEMICAL,antipsychotic aripiprazole due,antipsychotics aripiprazole due
NEW13777,BIOCHEMICAL,partial agonist antipsychotic,partial agonist antipsychotics
NEW13780,DISEASE,autistic individual,autistic individuals
NEW13782,DISEASE,increase astrogliosis,increased astrogliosis
NEW13784,BIOCHEMICAL,own venom,own venom
NEW13786,BIOCHEMICAL,purify toxin,purified toxins
NEW13787,CHEMICAL,ca2 k+ channel,Ca2 K+ channels
NEW13789,NUTRITION,crayfish giant axon,crayfish giant axon
D024681,CHEMICAL,"Potassium Channels, Calcium-Activated","Ca2+-Activated K+ Channels|Calcium-Activated Potassium Channel|Potassium Channels, Calcium Activated|K+ Channels, Ca2+-Activated|Calcium Activated Potassium Channel|Calcium-Activated Potassium Channels|K+ Channels, Calcium-Activated|Calcium Activated Potassium Channels|K+ Channels, Calcium Activated|Potassium Channel, Calcium Activated|K+ Channels, Ca2+ Activated|Potassium Channels, Calcium-Dependent|Potassium Channels, Calcium Dependent|Potassium Channel, Calcium-Activated|Channels, Calcium-Dependent Potassium|Calcium-Activated K+ Channels|Ca2+ Activated K+ Channels|K+ channels|Calcium Dependent Potassium Channels|Calcium-Dependent Potassium Channels"
D001412,DISEASE,Bacillus subtilis,Natto Bacteria|Bacillus subtilis (natto)|Bacillus subtilis|Bacillus subtilis var. natto
C027619,DISEASE,"uracil-DNA glycosylase inhibitor protein, B. subtilis bacteriophage [Supplementary Concept]",B. subtilis|Viral Proteins
NEW13793,BIOCHEMICAL,overall mixture,overall mixture
NEW13794,DISEASE,human ovarian carcinoma cell line,human ovarian carcinoma cell lines
NEW13797,DISEASE,higher-order human behaviour,higher-order human behaviour
http://purl.obolibrary.org/obo/DOID_2848,DISEASE,melancholia,non-melancholic
NEW13798,MENTAL_HEALTH,sub-typing depression,sub-typing depression
D003483,DISEASE,Cutis Laxa,Dermatolyses|Dermatomegaly|cutis laxa|Dermatolysis
NEW13801,DISEASE,pxe feature,PXE features
C564741,BIOCHEMICAL,"Vitamin K-Dependent Clotting Factors, Combined Deficiency Of, 1 [Supplementary Concept]","vitamin K-dependent clotting factors|Blood Coagulation Disorders, Inherited"
NEW13803,MENTAL_HEALTH,quench defense mechanism,quenching defense mechanism
NEW13804,DISEASE,rat pd model,rat PD model
D009750,DISEASE,Nutritional and Metabolic Diseases,metabolic diseases
NEW13806,MENTAL_HEALTH,rgc hyperactivity,RGC hyperactivity
NEW13807,DISEASE,naloxone-precipitated withdrawal behavior,naloxone-precipitated withdrawal behaviors
NEW13813,DISEASE,bipolar spindle,bipolar spindle
NEW13816,MENTAL_HEALTH,amphetamine-induced psychotic disorder patient,amphetamine-induced psychotic disorder patients
NEW13818,DISEASE,osa comorbiditie,OSA comorbidities
NEW13819,CHEMICAL,low-cost generic prozac,low-cost generic prozac
NEW13820,BIOCHEMICAL,effective estrogen therapy,effective estrogen therapy
NEW13821,MENTAL_HEALTH,noniatrogenic nocturnal bruxism,noniatrogenic nocturnal bruxism
NEW13823,DISEASE,hypothalamic hyperphagia,hypothalamic hyperphagia
NEW13825,DISEASE,death Caps,Death Caps
NEW13826,NUTRITION,horse mushroom,Horse mushroom
http://purl.obolibrary.org/obo/CHEBI_66854,CHEMICAL,phosphatidylcholine 34:5,phosphotidylcholine 3-octadecanoate|phosphatidylcholine(34:5)|GPCho(34:5)|PC 34:5|PC(34:5)
C064904,CHEMICAL,"poly(dG-dC)-benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide [Supplementary Concept]","7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide|DG|Polydeoxyribonucleotides"
C543520,CHEMICAL,nemonoxacin [Supplementary Concept],Quinolones|18:0/16:0/18:3|TG
D054800,CHEMICAL,Glycosylphosphatidylinositol Diacylglycerol-Lyase,"Phosphatidylinositol Glycan Specific Phospholipase C|Phospholipase C, Phosphatidylinositol-Glycan-Specific|diacylglycerol|Phosphatidylinositol-Glycan-Specific Phospholipase C|Phospholipase C, PtdIns-Glycan|Glycosylphosphatidylinositol Specific Phospholipase C|PtdIns-Glycan Phospholipase C|Diacylglycerol-Lyase, Glycosylphosphatidylinositol|GPI-PLC|PtdIns Glycan Phospholipase C|Phospholipase C, Glycosylphosphatidylinositol-Specific|Glycosylphosphatidylinositol Diacylglycerol Lyase|Glycosylphosphatidylinositol-Specific Phospholipase C"
NEW13828,CHEMICAL,ce 20:5,CE 20:5
NEW13830,MENTAL_HEALTH,square regression,squares regression
C074428,CHEMICAL,"atpB protein, E coli [Supplementary Concept]",Bacterial Proton-Translocating ATPases|Escherichia coli Proteins|ATP synthase
NEW13832,CHEMICAL,anti-akinetic effect,anti-akinetic effects
NEW13833,DISEASE,"(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced neuronal cell death","(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced neuronal cell death"
NEW13834,DISEASE,akinetic parkinsonian crisis,akinetic parkinsonian crisis
NEW13835,CHEMICAL,mao isoform,MAO isoforms
NEW13839,MENTAL_HEALTH,baseline personality disorder,baseline personality disorder
NEW13840,MENTAL_HEALTH,equilibrium dissociation constant,equilibrium dissociation constants
NEW13841,DISEASE,secondary fracture,secondary fractures
NEW13842,BIOCHEMICAL,androgen hormone,androgen hormones
NEW13843,DISEASE,adolescent ptsd patient,adolescent PTSD patients
NEW13845,DISEASE,motor skill impairment,motor skill impairment
NEW13846,BIOCHEMICAL,promising analgesic potency,promising analgesic potency
NEW13848,CHEMICAL,ne region,NE region
NEW13849,CHEMICAL,vitamin b1 thiamin deficiency,vitamin B1 thiamin deficiency
NEW13850,DISEASE,stress urinary incontinence,stress urinary incontinence
NEW13852,CHEMICAL,hydroxyl moiety,hydroxyl moieties
NEW13856,DISEASE,cynical personality,cynical personality
NEW13857,CHEMICAL,serum nitrogen,serum nitrogen
NEW13859,CHEMICAL,gas phase,gas phase
NEW13860,BIOCHEMICAL,agonist substitution therapy,agonist substitution therapy
NEW13862,MENTAL_HEALTH,high variable importance projection value,high variable importance projection values
NEW13864,MENTAL_HEALTH,syndrome disorder,syndrome disorder
NEW13866,DISEASE,rtt disease,RTT disease
D055513,DISEASE,Connective Tissue Growth Factor,IGFBP-rP2|IGF-Binding Protein-Related Protein-2|CCN2 Protein|Insulin-Like Growth Factor Binding Protein 8|connective tissue|Hypertrophic Chondrocyte-Specific Protein 24|Hypertrophic Chondrocyte Specific Protein 24|IGF Binding Protein Related Protein 2|Insulin Like Growth Factor Binding Protein 8|IGFBP-8
NEW13870,CHEMICAL,regular smoking dependence,regular smoking dependence
NEW13871,DISEASE,diabetes treatment,diabetes treatment
NEW13872,DISEASE,ucms-induced decrease,UCMS-induced decrease
NEW13873,DISEASE,admit psychiatric patient,admitted psychiatric patients
NEW13874,CHEMICAL,increase plasma cortisol concentration,increased plasma cortisol concentrations
NEW13877,DISEASE,psychotic subgroup,psychotic subgroups
NEW13879,CHEMICAL,cathepsin b. hfd aortae,cathepsin B. HFD aortae
NEW13880,DISEASE,pain disease,pain diseases
NEW13881,DISEASE,refractory partial epilepsy,refractory partial epilepsy
NEW13884,CHEMICAL,tnf-α expression,TNF-α expression
NEW13885,DISEASE,stz-induced rat model,STZ-induced rat model
NEW13888,DISEASE,spinal pain transmission,spinal pain transmission
NEW13890,CHEMICAL,intrathecal neostigmine,intrathecal neostigmine
C069599,DISEASE,"trypsin inhibitor protein, Brassica napus [Supplementary Concept]",Plant Proteins|kohlrabi
NEW13894,CHEMICAL,sweet potato,sweet potatoes
NEW13895,DISEASE,transient maternal hypothyroxinemia,transient maternal hypothyroxinemia
NEW13897,DISEASE,maternal depressive symptom,maternal depressive symptoms
NEW13898,CHEMICAL,omega-6/omega-3 ratio,omega-6/omega-3 ratio
NEW13899,NUTRITION,excessive fatty acid intake,excessive fatty acid intake
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Pathophysiology,DISEASE,pathophysiology,ASD-like pathophysiology
NEW13903,BIOCHEMICAL,retinal vitamin a,retinal vitamin A
NEW13905,CHEMICAL,diacetate assay,diacetate assay
http://purl.obolibrary.org/obo/PR_000015412,CHEMICAL,sortilin,gp95|nt3|glycoprotein 95|sort1|neurotensin receptor 3|ntr3|NT3|100 kda nt receptor
NEW13908,DISEASE,excitotoxic injury,excitotoxic injury
NEW13909,CHEMICAL,endogenous neurotrophin,endogenous neurotrophins
NEW13910,MENTAL_HEALTH,medium-sized spiny projection neuron,medium-sized spiny projection neurons
NEW13914,DISEASE,tmd patient,TMD patients
D002012,DISEASE,Bruxism,"Teeth Grinding Disorder|Teeth Grinding Disorders|Bruxomania|teeth-grinding|Disorder, Teeth Grinding|Grinding Disorder, Teeth"
NEW13916,DISEASE,post-inflammatory visceral hypersensitivity,post-inflammatory visceral hypersensitivity
NEW13917,DISEASE,ibs-c,IBS-C
NEW13918,DISEASE,fibromyalgia symptom,fibromyalgia symptoms
NEW13920,CHEMICAL,bicarbonate dialysis,bicarbonate dialysis
http://purl.obolibrary.org/obo/SYMP_0000302,DISEASE,hypothermia,Δ9-tetrahydrocannabinol hypothermia
http://purl.obolibrary.org/obo/CHEBI_59119,CHEMICAL,thiopropazate,1-(2-Acetoxyethyl)-4-(3-(2-chloro-10-phenothiazinyl)propyl)piperazine|tiopropazato|Thiopropazat|thiopropazatum|Dronabinol ®|2-Chloro-10-(3-(1-(2-acetoxyethyl)-4-piperazinyl)propyl)phenothiazine|10-(3-(1-(2-Acetoxyethyl)-4-piperazinyl)propyl)-2-chlorophenothiazine|thiopropazate|2-(4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl)ethyl acetate|2-{4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethyl acetate|N-(beta-Acetoxyethyl)-N'-(gamma-(2'-chloro-10'-phenothiazinyl)propyl)piperazine|4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol acetate
http://purl.obolibrary.org/obo/HP_0001336,DISEASE,myoclonus,myoclonia
NEW13922,BIOCHEMICAL,"selective cb1 receptor antagonist/inverse agonist 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-n-(piperidin-1-yl)-1h-pyrazole-3-carboxamide","selective CB1 receptor antagonist/inverse agonist 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide"
NEW13924,BIOCHEMICAL,study drug,study drug
NEW13925,MENTAL_HEALTH,attack severity,attack severity
NEW13926,CHEMICAL,continuous antidepressant therapy,continuous antidepressant therapy
C564809,DISEASE,"Spastic Paresis, Glaucoma, and Mental Retardation [Supplementary Concept]","spastic paresis|Paraparesis, Spastic|Intellectual Disability|Glaucoma"
NEW13927,DISEASE,spontaneous spasm,spontaneous spasms
NEW13929,MENTAL_HEALTH,joint angular displacement,joint angular displacement
NEW13930,MENTAL_HEALTH,suicide victim,suicide victims
NEW13931,MENTAL_HEALTH,adolescent suicide victim,adolescent suicide victims
NEW13933,CHEMICAL,0.5mm,0.5mM
NEW13935,BIOCHEMICAL,chemical carcinogen,chemical carcinogens
NEW13937,DISEASE,snail disorder,snails disorders
NEW13939,CHEMICAL,fenfluramine administration,fenfluramine administration
D015715,DISEASE,Corneal Edema,"Corneal Edemas|Edemas, Corneal|Edema, Corneal|edema"
http://purl.obolibrary.org/obo/SYMP_0000867,DISEASE,gastrointestinal bleeding,gastrointestinal bleeding
D002915,DISEASE,Chylous Ascites,"Ascites, Chylous|Chyloperitoneum|Peritonitis, Chylous|ascites|Chylous Peritonitis"
NEW13940,DISEASE,coagulation disturbance,coagulation disturbances
NEW13941,DISEASE,spontaneous bacterial peritonitis,spontaneous bacterial peritonitis
D006530,DISEASE,Hepatorenal Syndrome,"Syndrome, Hepatorenal|hepatorenal syndrome"
NEW13945,CHEMICAL,excessive hcy level,excessive Hcy level
NEW13947,BIOCHEMICAL,vitamin a. β-cryptoxanthin,vitamin A. β-Cryptoxanthin
NEW13949,MENTAL_HEALTH,improve insulin resistance,improved insulin resistance
NEW13950,BIOCHEMICAL,peroxiproliferator-activated receptor ppar family activation,peroxiproliferator-activated receptor PPAR family activation
NEW13952,DISEASE,dysphoric property,dysphoric properties
NEW13955,DISEASE,anti-caspr2 antibody-associated autoimmune encephalitis,anti-Caspr2 antibody-associated autoimmune encephalitis
NEW13957,CHEMICAL,cuprac,CUPRAC
NEW13958,NUTRITION,proanthocyanidin tpa content,proanthocyanidin TPA content
C049960,CHEMICAL,1-salicylate glucuronide [Supplementary Concept],Salicylates|Glucuronates|phenolic
D050154,DISEASE,Adiposity,adiposity|Obesity (1965-2005)
NEW13960,DISEASE,fungal cell death,fungal cell death
NEW13962,BIOCHEMICAL,sufficient drug concentration,sufficient drug concentrations
D014009,DISEASE,Onychomycosis,"Nail Fungus|onychomycosis|Fungus, Nail|Onychomycoses|Tinea Unguium"
NEW13965,CHEMICAL,PVA group,PVA group
NEW13967,CHEMICAL,fentanyl dose,fentanyl dose
NEW13968,DISEASE,similar pain score,similar pain scores
NEW13969,DISEASE,frequent transient global uterine ischemia,frequent transient global uterine ischemia
NEW13970,BIOCHEMICAL,rescue analgesic use,rescue analgesic use
NEW13971,DISEASE,mct-induced liver injury,MCT-induced liver injury
NEW13973,DISEASE,siod,SIOD
NEW13974,DISEASE,seizure model,seizure model
NEW13977,DISEASE,community-associated disease,community-associated diseases
NEW13979,DISEASE,severe disfiguring skin sore,severe disfiguring skin sores
NEW13981,MENTAL_HEALTH,single- resistance,single- resistance
NEW13985,CHEMICAL,pterostilbene treatment,pterostilbene treatment
NEW13987,DISEASE,vascular cognitive impairment,vascular cognitive impairment
NEW13989,MENTAL_HEALTH,depression subtype,depression subtypes
NEW13991,DISEASE,salt-sensitive hypertension,salt-sensitive hypertension
NEW13993,DISEASE,drug-resistant microbial keratitis,drug-resistant microbial keratitis
NEW13994,MENTAL_HEALTH,opioid abuse relapse,opioid abuse relapse
http://purl.obolibrary.org/obo/SYMP_0000358,DISEASE,premature labor,premature labour
C057215,NUTRITION,"8.2K CTP protein, Bos taurus [Supplementary Concept]",Cholesterol Transport|Membrane Transport Proteins
NEW14001,CHEMICAL,plasma histidine,plasma histidine
NEW14003,CHEMICAL,oprm1-ag/gg,OPRM1-AG/GG
NEW14004,DISEASE,recurrent hemoptysis,recurrent hemoptysis
http://purl.obolibrary.org/obo/MF_0000040,CHEMICAL,communication,digital/online communication
NEW14007,BIOCHEMICAL,robust analgesic activity,robust analgesic activity
http://purl.obolibrary.org/obo/DOID_845,DISEASE,cyclothymic disorder,Cycloid personality|Cyclothymia|Affective personality disorder|non-depressive psychiatric disorders|Cyclothymic personality
NEW14012,DISEASE,hypertonia episode,hypertonia episodes
NEW14018,BIOCHEMICAL,islet beta cell compensation,islet beta cell compensation
NEW14020,DISEASE,moderate-to-severe ocd,moderate-to-severe OCD
NEW14021,DISEASE,ocd treatment,OCD treatment
NEW14024,DISEASE,colonic dysmotility,colonic dysmotility
NEW14027,DISEASE,group constipation,Group constipation
NEW14028,DISEASE,failure-induced accumulation,failure-induced accumulation
NEW14032,CHEMICAL,opioid antagonist naloxone,opioid antagonist naloxone
NEW14036,CHEMICAL,dehydrogenase-mediated excessive hepatic generation,dehydrogenase-mediated excessive hepatic generation
NEW14039,DISEASE,osteosarcoma cell line,osteosarcoma cell line
NEW14041,DISEASE,cancer-induced bone pain,CIBP|Cancer-induced bone pain
NEW14042,DISEASE,mechanical allodynia test,mechanical allodynia test
NEW14044,DISEASE,primary lumber sdh neuron,primary lumber SDH neurons
NEW14045,CHEMICAL,intracellular calcium concentration,intracellular calcium concentration
D001950,CHEMICAL,Bretylium Tosylate,Bretylate|Bretylium Tosilate|Ornid|Bretylol|tosylate
NEW14046,MENTAL_HEALTH,hydride displacement,hydride displacement
NEW14047,DISEASE,high heat coma threshold,highest heat coma threshold
NEW14048,CHEMICAL,well heat tolerance ctmax1,better heat tolerance CTmax1
NEW14049,MENTAL_HEALTH,high heat stupor threshold,highest heat stupor threshold
NEW14054,DISEASE,reduce anaemia odd,reduced anaemia odds
D000077323,DISEASE,Salt Stress,"Reaction, Salt Stress|Stress, Salt|Salinity Stress Reponse|Salinity Stresses|Response, Salt Stress|salt stress|Salt Stress Responses|Stress Response, Salt|Stress Reaction, Salinity|Salt Stresses|Salinity Stress Reactions|Salt Stress Reactions|Stress Reponse, Salinity|Salt Stress Reaction|Salinity Stress|Salinity Stress Reponses|Stress Reaction, Salt|Reaction, Salinity Stress|Reponse, Salinity Stress|Stress, Salinity|Salinity Stress Reaction|Salt Stress Response"
NEW14055,CHEMICAL,cs treatment,Cs treatment
D062967,CHEMICAL,Cyclic GMP-Dependent Protein Kinase Type II,cGMP-Dependent Protein Kinase II|Cyclic GMP Dependent Protein Kinase Type II|cGMP-Dependent Protein Kinase 2|cGK II|cGMP Dependent Protein Kinase 2|GMP|cGMP Dependent Protein Kinase II
C564871,MENTAL_HEALTH,Progesterone Resistance [Supplementary Concept],Uterine Diseases|Endometrium/abnormalities|progesterone resistance
NEW14059,MENTAL_HEALTH,symptoms-like anxiety,symptoms-like anxiety
NEW14060,CHEMICAL,lidocaine ±     min,lidocaine ±    min
NEW14061,CHEMICAL,± min,± min
NEW14062,CHEMICAL,tramadol-lidocaine ±     min,tramadol-lidocaine ±    min
http://purl.obolibrary.org/obo/CHEBI_119915,CHEMICAL,fentanyl,1-phenethyl-4-N-propionylanilinopiperidine|fentanyl|N-(1-phenethyl-piperidin-4-yl)-N-phenyl-propionamide|tramadol-lidocaine|Duragesic|1-phenethyl-4-(N-phenylpropionamido)piperidine|N-(1-phenethyl-4-piperidyl)propionanilide|N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide|N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|N-phenethyl-4-(N-propionylanilino)piperidine|fentanylum|fentanilo|N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide|N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide|phentanyl
NEW14064,CHEMICAL,calcium accumulation,calcium accumulation
NEW14065,DISEASE,aluminum-related bone disease,aluminum-related bone disease
NEW14066,MENTAL_HEALTH,alcohol-related brain disease,alcohol-related brain disease|ARBD
NEW14067,DISEASE,hypercalcaemia,hypercalcaemia
NEW14069,DISEASE,neurobehavioral function,neurobehavioral functions
NEW14071,MENTAL_HEALTH,withdrawal dysphoria,withdrawal dysphoria
NEW14072,MENTAL_HEALTH,increase craving,increasing craving
NEW14074,CHEMICAL,hydrophobic drug,hydrophobic drugs
NEW14076,DISEASE,un-resolve,un-resolving
C044118,CHEMICAL,fructan beta-fructosidase [Supplementary Concept],Glycoside Hydrolases|fructan
NEW14079,DISEASE,severe motor deficit,severe motor deficits
NEW14081,MENTAL_HEALTH,initial perseveration,initial perseveration
NEW14083,DISEASE,nose block,nose block
NEW14086,DISEASE,heightened mood intensification,heightened mood intensification
NEW14089,DISEASE,human leukaemia cell,human leukaemia cells
D013384,CHEMICAL,Succinate Cytochrome c Oxidoreductase,succinate cytochrome c reductase|Succinate Cytochrome c Reductase
NEW14090,DISEASE,object detection memory deficit,object detection memory deficit
NEW14091,BIOCHEMICAL,d1 receptor antagonist,D1 receptor antagonists
D050998,CHEMICAL,bcl-2 Homologous Antagonist-Killer Protein,N-Bak Protein|Bak Protein|bcl 2 Homologous Antagonist Killer Protein|bcl2 Homologous Antagonist Killer Protein|bcl2 Homologous Antagonist-Killer Protein|% BAK
NEW14095,DISEASE,ocd pathophysiology,OCD pathophysiology
NEW14097,MENTAL_HEALTH,opiate analgesia,opiate analgesia
NEW14099,DISEASE,neuropathic pain refractory,neuropathic pain refractory
NEW14100,DISEASE,major cardiovascular dysfunction,major cardiovascular dysfunction
NEW14101,BIOCHEMICAL,suggestive drug history,suggestive drug history
NEW14102,DISEASE,metastatic pancreatic cancer,metastatic pancreatic cancer
D001973,CHEMICAL,Bromodeoxyuridine,"NSC-38297|5 Bromodeoxyuridine|Bromouracil Deoxyriboside|5-Bromo-2'-deoxyuridine|5-Bromodeoxyuridine|5 Bromo 2' deoxyuridine|BUdR|bromodeoxyuridine|Deoxyriboside, Bromouracil|BrdU|Broxuridine"
NEW14106,DISEASE,respiratory motor output,respiratory motor output
NEW14107,CHEMICAL,classic antidepressant antidepressant role,classic antidepressant antidepressant role
NEW14108,CHEMICAL,cyclin d1-cyclin dependent kinase,Cyclin D1-cyclin dependent kinase
NEW14109,DISEASE,various sleep disorder,various sleep disorders
NEW14110,DISEASE,atherosclerosis mouse model,atherosclerosis mouse model
NEW14112,MENTAL_HEALTH,vasomotor syndrome,vasomotor syndromes
NEW14113,DISEASE,intestinal immunity,intestinal immunity
NEW14114,MENTAL_HEALTH,cluster crc syndrome,clustering CRC syndromes
NEW14115,DISEASE,profound pain insensitivity,profound pain insensitivity
NEW14117,MENTAL_HEALTH,opioid analgesia,opioid analgesia
C516256,CHEMICAL,"(2,4-bis(2-pyridylmethylimino)pentane)bis(acetonitrile)iron(II) [Supplementary Concept]",Ferrous Compounds|pentane
NEW14122,MENTAL_HEALTH,vitamin e-deficiency syndrome,vitamin E-deficiency syndromes
NEW14123,MENTAL_HEALTH,intravenous analgesia,intravenous analgesia
NEW14124,DISEASE,inappropriate antidiuretic hormone release secondary,inappropriate antidiuretic hormone release secondary
D008551,DISEASE,Melena,Melenas|melena
NEW14126,BIOCHEMICAL,potential drug candidate,potential drug candidates
D054332,DISEASE,Leishmaniasis Vaccines,"Leishmaniasis Vaccine|Leishmania Vaccines|Leishmania Vaccine|Vaccines, Leishmania|leishmaniasis|Vaccine, Leishmania|Vaccine, Leishmaniasis|Vaccines, Leishmaniasis"
NEW14127,CHEMICAL,benzodiazepine group,benzodiazepine group
NEW14129,BIOCHEMICAL,endocrine basis,endocrine basis
NEW14131,DISEASE,poor prognosis tumor,poor prognosis tumors
NEW14132,DISEASE,core basal phenotype tumor,core basal phenotype tumors
NEW14133,CHEMICAL,synthetic methionine enkephaline analogue fk,synthetic methionine enkephaline analogue FK
D018754,DISEASE,Ventricular Dysfunction,"Dysfunction, Ventricular|Dysfunctions, Ventricular|Ventricular Dysfunctions|ventricular dysfunction"
NEW14134,CHEMICAL,k1 multiresistant,K1 multiresistant
NEW14135,DISEASE,p. falciparum nf54 sensitive,P. falciparum NF54 sensitive
NEW14137,DISEASE,second-onset ocs,second-onset OCS
NEW14138,CHEMICAL,methyl-esterified pectin,methyl-esterified pectins
NEW14139,CHEMICAL,cannabis withdrawal,cannabis withdrawal
NEW14142,CHEMICAL,cocaine craving,cocaine craving
D007746,DISEASE,Labor Presentation,"Presentation, Labor|Fetal Presentation|Malpresentation, Fetal|Fetal Malpresentation|Presentation, Fetal|malpresentation|Fetal Malpresentations"
NEW14144,DISEASE,third trimester bleed,third trimester bleeding
D008471,DISEASE,Meconium Aspiration Syndrome,"Aspiration Syndrome, Meconium|Meconium Aspiration|Meconium Inhalation|Aspiration, Meconium|Syndrome, Meconium Aspiration|meconium aspiration"
http://purl.obolibrary.org/obo/SYMP_0019149,DISEASE,toxemia,toxaemia
NEW14145,DISEASE,reversible hepatitis,reversible hepatitis
NEW14149,DISEASE,mixed depressive state,mixed depressive states
NEW14150,DISEASE,fulminant alpha-synucleinopathy,fulminant alpha-synucleinopathy
NEW14153,CHEMICAL,striatal dopamine synthesis,striatal dopamine synthesis
D002421,DISEASE,Caudate Nucleus,"Caudatus|Nucleus Caudatus|Caudatus, Nucleus|caudate|Nucleus, Caudate"
NEW14154,CHEMICAL,striatal dopamine,striatal dopamine
NEW14156,DISEASE,impairment marker,impairment markers
NEW14157,MENTAL_HEALTH,headache prophylaxis,headache prophylaxis
NEW14159,DISEASE,complicated spastic paraplegia,complicated spastic paraplegia|SPG35
NEW14160,BIOCHEMICAL,mycobacterial antigen,mycobacterial antigens
NEW14162,MENTAL_HEALTH,solid fixation,solid fixation
NEW14164,DISEASE,ncc viability,NCC viability
NEW14166,DISEASE,hyalinize fibrosis,hyalinized fibrosis
NEW14169,NUTRITION,cane toad,cane toad
NEW14171,BIOCHEMICAL,synthetic auxin binding kinetic,synthetic auxin binding kinetics
NEW14177,CHEMICAL,cih condition,CIH conditions
NEW14179,DISEASE,migraine pathophysiology,migraine pathophysiology
NEW14181,DISEASE,low disease activity index score,lower disease activity index score
NEW14182,DISEASE,less body weight loss,less body weight loss
NEW14185,MENTAL_HEALTH,obstructive syndrome,obstructive syndromes
NEW14187,CHEMICAL,glutaraldehyde fixation,glutaraldehyde fixation
NEW14190,CHEMICAL,unlabeled avp,unlabeled AVP
NEW14192,DISEASE,anxiety/dysphoria,anxiety/dysphoria
http://purl.obolibrary.org/obo/CHEBI_84030,NUTRITION,reynoutria sachalinensis extract,giant knotweed extract|cowberry extract
NEW14194,DISEASE,manganism,Manganism
NEW14196,DISEASE,scz patient,Scz patients
C117855,DISEASE,"MEP1 protein, Haemonchus contortus [Supplementary Concept]",Microsporum canis|Fungal Proteins|Metalloendopeptidases
C569516,DISEASE,Trichophyton infection [Supplementary Concept],Tinea|Trichophyton rubrum
C000686285,DISEASE,Epidermophyton floccosum [Supplementary Concept],Epidermophyton floccosum|Epidermophyton
NEW14198,DISEASE,day-case cataract surgery,day-case cataract surgery
NEW14201,CHEMICAL,bupivacaine-lidocaine mixture,bupivacaine-lidocaine mixture
NEW14203,DISEASE,intraoperative pain,intraoperative pain
D004172,DISEASE,Diplopia,"Refractive Diplopias|Diplopias, Monocular|Vertical Diplopias|Diplopias, Cortical|Polyopsia|Cortical Diplopia|Diplopias, Refractive|Diplopia, Cortical|Vertical Diplopia|Monocular Diplopias|Intermittent Diplopias|Diplopia, Horizontal|Refractive Diplopia|Diplopia, Intermittent|Horizontal Diplopia|Diplopia, Refractive|Diplopias|diplopia|Diplopias, Unilateral|Unilateral Diplopias|Double Vision|Diplopia, Vertical|Polyopsias|Monocular Diplopia|Intermittent Diplopia|Horizontal Diplopias|Diplopias, Intermittent|Diplopia, Unilateral|Diplopias, Vertical|Diplopias, Horizontal|Vision, Double|Cortical Diplopias|Unilateral Diplopia|Diplopia, Monocular"
NEW14207,DISEASE,acromegaly patient due,acromegaly patients due
NEW14208,BIOCHEMICAL,growth hormone (gh)-secreting tumor,growth hormone (GH)-secreting tumor
http://purl.obolibrary.org/obo/CHEBI_16113,NUTRITION,cholesterol,"Cholesterin|Cholesterol|cholest-5-en-3beta-ol|cholesterol cholesterol levels|Cholest-5-en-3beta-ol|CHOLESTEROL|cholesterol|(3beta,14beta,17alpha)-cholest-5-en-3-ol"
NEW14211,BIOCHEMICAL,important antigen,important antigen
NEW14213,BIOCHEMICAL,receptor agonist morphine,receptor agonist morphine
NEW14214,MENTAL_HEALTH,pain-related depression,pain-related depression
NEW14225,MENTAL_HEALTH,depression patient,depression patients
NEW14232,DISEASE,severe body weight loss,severe body weight loss
NEW14236,CHEMICAL,increase dopamine activity,increased dopamine activity
NEW14239,DISEASE,amenorrhea patient,amenorrhea patients
NEW14242,CHEMICAL,mptp injection,MPTP injections
NEW14244,MENTAL_HEALTH,thalamic projection territory,thalamic projection territory
NEW14246,CHEMICAL,cocaine reinforcement,cocaine reinforcement
NEW14248,BIOCHEMICAL,infective antigen,infective antigens
NEW14250,MENTAL_HEALTH,plant immune mechanism,plant immune mechanism
NEW14251,DISEASE,a. besseyi,A. besseyi
NEW14252,MENTAL_HEALTH,rice resistance,rice resistance
NEW14254,DISEASE,premature ageing,premature ageing
NEW14257,DISEASE,ampa-mediated toxicity,AMPA-mediated toxicity
C566573,DISEASE,"Nephropathy, Progressive Tubulointerstitial, with Cholestatic Liver Disease [Supplementary Concept]","Cholestasis, Intrahepatic|Nephritis, Interstitial|cholestatic liver disease"
NEW14258,DISEASE,major extra-hepatic manifestation,major extra-hepatic manifestations
NEW14259,DISEASE,seizure generation,seizure generation
NEW14263,BIOCHEMICAL,development due pharmaceutical innovation,development due pharmaceutical innovations
NEW14265,NUTRITION,hemorrhagic insect bite,hemorrhagic insect bites
NEW14266,NUTRITION,innumerable insect sting,innumerable insect stings
NEW14267,DISEASE,orthostatic tolerance,orthostatic tolerance
NEW14268,DISEASE,postprandial hypotension,postprandial hypotension
NEW14270,MENTAL_HEALTH,marked depression,marked depression
NEW14271,DISEASE,depressed o(2 consumption rate,depressed O(2 consumption rates
NEW14272,MENTAL_HEALTH,alp depression,ALP depression
NEW14273,DISEASE,androgen-dependent prostate cancer cell line,androgen-dependent prostate cancer cell line
NEW14275,CHEMICAL,midazolam injection,midazolam injection
http://purl.obolibrary.org/obo/MFOMD_0000134,MENTAL_HEALTH,conditioned response,conditioned response
NEW14276,DISEASE,psychosis-like behavior,psychosis-like behavior
NEW14277,CHEMICAL,aberrant dopamine system function,aberrant dopamine system function
C431566,CHEMICAL,acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide [Supplementary Concept],Oligopeptides|degarelix
NEW14279,DISEASE,severe cutaneous lupus,severe cutaneous lupus
NEW14281,CHEMICAL,ketamine group,ketamine group
NEW14283,DISEASE,antenatal depressive symptom,antenatal depressive symptom
NEW14286,MENTAL_HEALTH,head displacement,head displacement
NEW14291,CHEMICAL,glutathione peroxidise,glutathione peroxidise
NEW14294,DISEASE,recurrent ischemia,recurrent ischemia
NEW14295,DISEASE,frequent major adverse cardiac evenment,frequent major adverse cardiac evenment
NEW14297,DISEASE,intestinal illness,intestinal illnesses
NEW14300,CHEMICAL,cyb.patient,CYB.Patients
NEW14301,CHEMICAL,new oral anti-xa anticoagulant darexaban,new oral anti-Xa anticoagulant darexaban
NEW14302,CHEMICAL,non-vitamin k antagonist oral anticoagulant,non-vitamin K antagonist oral anticoagulants
NEW14303,BIOCHEMICAL,atp-sensitive k+ channel opener,ATP-sensitive K+ channel openers
NEW14305,CHEMICAL,bimakalim antiischemic effect,bimakalim antiischemic effects
NEW14306,CHEMICAL,myocardial oxygen consumption,myocardial oxygen consumption
D005711,CHEMICAL,Gallopamil,"Elgiprona|Gallobeta|Gallopamil Hydrochloride|D-600|D 600|gallopamil von ct|D600|Procorum|Methoxyverapamil|gallopamil|Hydrochloride, Gallopamil|Prebet"
NEW14308,MENTAL_HEALTH,segment depression,segment depression
NEW14309,CHEMICAL,iron chelation drug,Iron chelation drugs
NEW14313,BIOCHEMICAL,vitamin b5 deficiency,vitamin B5 deficiency
NEW14315,CHEMICAL,sodium solute symporter family,sodium solute symporter family
D012974,CHEMICAL,Sodium Iodide,Iodides (1966-1978)|iodide|Sodium (1966-1978)
NEW14316,CHEMICAL,vitamin-like substance α-lipoic acid,vitamin-like substance α-lipoic acid
C520789,CHEMICAL,"TSPAN16 protein, human [Supplementary Concept]",TM4|Tetraspanins
NEW14319,MENTAL_HEALTH,similar projection pattern,similar projection patterns
NEW14320,DISEASE,consumption gain,consumption gain
NEW14321,CHEMICAL,saccharin group,saccharin group
NEW14323,CHEMICAL,sucrose self-administration,sucrose self-administration
NEW14324,CHEMICAL,sucrose craving,sucrose craving
NEW14325,MENTAL_HEALTH,crave incubate,craving incubates
D044927,CHEMICAL,Electron-Transferring Flavoproteins,"Electron Transferring Flavoprotein|Electron Transfer Flavoprotein|Flavoproteins, Electron-Transferring|Flavoprotein, Electron Transfer|Flavoprotein, Electron-Transferring|Electron Transferring Flavoproteins|Transfer Flavoprotein, Electron|Electron-Transferring Flavoprotein|Flavoprotein, ET|ET Flavoprotein|flavoproteins"
NEW14328,MENTAL_HEALTH,suicide reagent,suicide reagent
C002479,CHEMICAL,2-hydroxy-3-butynoic acid [Supplementary Concept],Hydroxybutyrates|2-hydroxy-3-butynoate
D005432,NUTRITION,Flounder,Pseudopleuronectes|Plaice|flounders|Pleuronectes|Flounders|Platichthys flesus|Halibut|Platichthys|Pleuronectes platessa
NEW14331,CHEMICAL,ng g(-1,ng g(-1
NEW14332,DISEASE,liver tissue,liver tissues
http://purl.obolibrary.org/obo/CHEBI_34444,CHEMICAL,4-tert-butylphenol,4-tert-octylphenol kg(-1
NEW14333,CHEMICAL,4-tert-octylphenol kg(-1 bw,4-tert-octylphenol kg(-1 BW
D013737,DISEASE,Testis,Testicles|Testes|testis|Testicle
D009798,DISEASE,Ocular Hypertension,"Glaucomas, Suspect|Suspect Glaucoma|Suspect Glaucomas|Hypertension, Ocular|Ocular Hypertensions|Hypertensions, Ocular|ocular hypertension|Glaucoma, Suspect"
NEW14336,DISEASE,profound cognitive impairment,profound cognitive impairment
NEW14337,MENTAL_HEALTH,abuse problem,abuse problems
NEW14338,CHEMICAL,pyridoxal phosphate level,pyridoxal phosphate levels
NEW07002,DISEASE,comorbid disorder,comorbid disorders
NEW14342,DISEASE,non-cocaine-abusing depressed alcoholic,non-cocaine-abusing depressed alcoholics
NEW14344,MENTAL_HEALTH,bdi depression scale,BDI depression scales
NEW14345,CHEMICAL,non-cocaine abusing depressed alcoholic,non-cocaine abusing depressed alcoholics
NEW14346,MENTAL_HEALTH,common mental disorder,common mental disorders
NEW14349,BIOCHEMICAL,specific noradrenergic neurotoxin dsp-4,specific noradrenergic neurotoxin DSP-4
C005915,CHEMICAL,Allura Red AC Dye [Supplementary Concept],Azo Compounds|Allura Red AC|ARAC
NEW14354,DISEASE,nmdar glun2b,NMDAR GluN2B
NEW14355,CHEMICAL,increase plasma catecholamine level,increased plasma catecholamine levels
NEW14356,CHEMICAL,low plasma catecholamine level,lower plasma catecholamine levels
NEW14358,MENTAL_HEALTH,abnormal hypomania scale,abnormal hypomania scale
NEW14359,MENTAL_HEALTH,abnormal hysteria,abnormal hysteria
NEW14360,MENTAL_HEALTH,schizophrenia scale,schizophrenia scales
NEW14362,CHEMICAL,blood cortisol level,blood cortisol levels
NEW14363,DISEASE,know DOA,known DOA
NEW14364,DISEASE,potential liver toxicity,potential liver toxicity
NEW14365,MENTAL_HEALTH,elastin fragmentation,elastin fragmentation
D002341,DISEASE,Carotid Artery Thrombosis,"Thrombosis, Common Carotid Artery|External Carotid Artery Thrombosis|Thrombosis, Internal Carotid Artery|Thrombosis, External Carotid Artery|Carotid Thrombosis|Common Carotid Artery Thrombosis|Thrombosis, Carotid Artery|Internal Carotid Artery Thrombosis|Thrombosis, Carotid|carotid thrombosis|Carotid Artery Thromboses"
NEW14366,DISEASE,α-toxin-mediated platelet injury,α-toxin-mediated platelet injury
NEW14367,DISEASE,lethal sa infection,lethal SA infection
NEW14369,DISEASE,depressed man,depressed men
NEW14370,MENTAL_HEALTH,depression important role,depression important role
NEW14376,DISEASE,brief electric shock,brief electric shock
D015812,DISEASE,"Glaucoma, Angle-Closure","Glaucomas, Closed-Angle|Glaucoma, Closed-Angle|angle-closure glaucoma|Uncompensative Glaucomas|Glaucomas, Angle Closure|Glaucoma, Narrow Angle|Narrow-Angle Glaucomas|Glaucoma, Uncompensated|Glaucoma, Angle Closure|Angle-Closure Glaucoma|Glaucomas, Angle-Closure|Glaucomas, Uncompensative|Closed-Angle Glaucomas|Angle Closure Glaucoma|Glaucomas, Narrow-Angle|Angle-Closure Glaucomas|Glaucoma, Narrow-Angle|Uncompensated Glaucoma|Glaucoma, Uncompensative|Narrow-Angle Glaucoma|Uncompensative Glaucoma|Uncompensated Glaucomas|Glaucoma, Closed Angle|Angle Closure Glaucomas|Glaucomas, Uncompensated|Closed-Angle Glaucoma"
NEW14377,MENTAL_HEALTH,important displacement,important displacement
NEW14378,CHEMICAL,14c-choline,14C-choline
NEW14379,CHEMICAL,3h-m binding,3H-M binding
NEW14381,CHEMICAL,3h-morphine binding,3H-morphine binding
NEW14384,DISEASE,cognition dysfunction,cognition dysfunctions
NEW14385,CHEMICAL,min diethyl ether exposure,min diethyl ether exposure
NEW14386,NUTRITION,omega-3 polyunsaturated fatty acid (pufa)/100 g body,omega-3 polyunsaturated fatty acid (PUFA)/100 g body
NEW14387,CHEMICAL,body weight/day,body weight/day
http://purl.obolibrary.org/obo/DOID_7907,CHEMICAL,mixed astrocytoma-ependymoma,mixed μ-
NEW14389,BIOCHEMICAL,over-the-counter μ-opioid receptor agonist,over-the-counter μ-opioid receptor agonist
D020391,DISEASE,"Muscular Dystrophy, Facioscapulohumeral","Dystrophy, Facioscapulohumeral Muscular|Atrophies, Facioscapulohumeral|Facio-Scapulo-Humeral Dystrophy|facioscapulohumeral muscular dystrophy|Dystrophies, Landouzy-Dejerine|Facioscapulohumeral Muscular Dystrophy|Dystrophy, Landouzy-Dejerine|Dystrophies, Facioscapulohumeral Muscular|Facioscapulohumeral Atrophies|FSH Muscular Dystrophy|Progressive Muscular Dystrophy, Facioscapulohumeral Type|Landouzy-Dejerine Dystrophy|Muscular Dystrophies, Facioscapulohumeral|Facioscapuloperoneal Muscular Dystrophy|Landouzy Dejerine Dystrophy|Landouzy-Dejerine Dystrophies|Muscular Dystrophy, Landouzy Dejerine|Facioscapulohumeral Type Progressive Muscular Dystrophy|Facioscapulohumeral Muscular Dystrophies|Facioscapulohumeral Atrophy|Atrophy, Facioscapulohumeral"
NEW14392,CHEMICAL,β-secretase activity,β-secretase activity
NEW14394,MENTAL_HEALTH,chronic opiate dependence,chronic opiate dependence
NEW14396,CHEMICAL,impaired gamma-aminobutyric acid metabolism,impaired gamma-aminobutyric acid metabolism
NEW14401,BIOCHEMICAL,parenteral dopamine agonist,parenteral dopamine agonist
NEW14402,CHEMICAL,comt-inhibitor,COMT-inhibitors
C026710,CHEMICAL,budipine [Supplementary Concept],budipine|Piperidines
NEW14405,DISEASE,high grade tumor,high grade tumors
NEW14407,DISEASE,tumor immune surveillance,tumor immune surveillance
NEW14409,MENTAL_HEALTH,pakistani stuttering individual,Pakistani stuttering individuals
NEW14413,MENTAL_HEALTH,prolonged stupor,prolonged stupor
D012378,DISEASE,Rodenticides,rodenticide|Rodenticide
NEW14415,DISEASE,spindle coma,spindle coma
NEW14416,NUTRITION,alpha coma,alpha coma
NEW14417,MENTAL_HEALTH,late suicide attempt,later suicide attempt
NEW14420,DISEASE,chemical-induced acute liver injury,chemical-induced acute liver injury
NEW14421,DISEASE,inflammasome-mediated inflammation,inflammasome-mediated inflammation
NEW14423,CHEMICAL,alcohol intoxication,alcohol intoxication
NEW14426,MENTAL_HEALTH,resistance gemr biomarker,resistance GemR biomarker
NEW14427,CHEMICAL,fibroblast growth factor receptor inhibitor (fgfri)/gemcitabine,fibroblast growth factor receptor inhibitor (FGFRi)/gemcitabine|Gem
http://purl.obolibrary.org/obo/DOID_0080784,DISEASE,urinary tract infection,UTI|bacterial urinary tract infections
NEW14429,DISEASE,chronic human african trypanosomiasis,chronic human African trypanosomiasis
D014355,DISEASE,Chagas Disease,"Infections, Trypanosoma cruzi|Trypanosoma cruzi Infections|South American Trypanosomiasis|Trypanosomiasis, American|Chagas disease|American Trypanosomiasis|Trypanosomiasis, South American|Trypanosoma cruzi Infection|Infection, Trypanosoma cruzi|Chagas' Disease"
NEW14431,CHEMICAL,single-celle flagellate haemo-protozoan parasite,single-celled flagellated haemo-protozoan parasites
NEW14436,MENTAL_HEALTH,second-order polynomial regression model,second-order polynomial regression model
NEW14437,CHEMICAL,iu/kg dietary vd3,IU/Kg dietary VD3
NEW14443,DISEASE,first depressive episode,first depressive episode
NEW14444,MENTAL_HEALTH,oxygen evolution depression,Oxygen evolution depression
D007382,CHEMICAL,Intermediate Filaments,"neurofilaments|Neurofilament|Neurofilaments|Tonofilaments|Tonofilament|Filament, Intermediate|Intermediate Filament|Filaments, Intermediate"
D055956,DISEASE,Diffuse Neurofibrillary Tangles with Calcification,"NFT|Disease, Kosaka-Shibayama|Kosaka-Shibayama Disease|neurofibrillary tangles|Kosaka Shibayama Disease"
NEW14448,DISEASE,numerous sp,numerous SP
NEW14451,BIOCHEMICAL,ca2 -permeable ampa receptor antagonist,Ca2 -permeable AMPA receptor antagonist
C110702,CHEMICAL,IEM 1460 [Supplementary Concept],IEM-1460|Adamantane/analogs  and  derivatives
D001254,DISEASE,Astrocytoma,"Astrocytomas, Pilocytic|Astrocytic Glioma|Cerebral Astrocytomas, Childhood|Fibrillary Astrocytoma|Astrocytoma, Intracranial|Astrocytoma, Grade II|Astrocytomas|Protoplasmic Astrocytoma|Pilocytic Astrocytomas|Astrocytoma, Gemistocytic|Oligoastrocytoma, Mixed|Grade II Astrocytomas|Astrocytomas, Gemistocytic|Pilocytic Astrocytoma, Juvenile|Astrocytomas, Juvenile Pilocytic|Gliomas, Astrocytic|Glioma, Astrocytic|Intracranial Astrocytomas|Grade II Astrocytoma|Astrocytomas, Grade I|Astrocytoma, Grade I|Pilocytic Astrocytoma|Grade I Astrocytomas|Protoplasmic Astrocytomas|Astrocytoma, Anaplastic|Astrocytomas, Grade III|Cerebral Astrocytoma, Childhood|Astrocytoma, Childhood Cerebral|Juvenile Pilocytic Astrocytomas|Oligoastrocytomas, Mixed|Astrocytomas, Childhood Cerebral|Intracranial Astrocytoma|Juvenile Pilocytic Astrocytoma|Anaplastic Astrocytoma|Astrocytomas, Grade II|Astrocytoma, Fibrillary|Astrocytoma, Grade III|Astroglioma|Pilocytic Astrocytomas, Juvenile|Subependymal Giant Cell Astrocytoma|Astrocytomas, Protoplasmic|Mixed Oligoastrocytoma|Astrocytomas, Cerebral|Mixed Oligoastrocytomas|Astrocytoma, Pilocytic|Childhood Cerebral Astrocytomas|Astrocytoma, Juvenile Pilocytic|Grade I Astrocytoma|Cerebral Astrocytomas|Grade III Astrocytoma|Astrocytoma, Protoplasmic|Astrocytoma, Cerebral|Anaplastic Astrocytomas|Astrogliomas|Childhood Cerebral Astrocytoma|Astrocytoma, Subependymal Giant Cell|Grade III Astrocytomas|Gemistocytic Astrocytomas|Cerebral Astrocytoma|Astrocytic Gliomas|Astrocytomas, Anaplastic|astrocytoma|Astrocytomas, Fibrillary|Gemistocytic Astrocytoma|Fibrillary Astrocytomas|Astrocytomas, Intracranial"
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Senile_Dementia,MENTAL_HEALTH,senile dementia,disease senile dementia
NEW14453,MENTAL_HEALTH,limited respiratory depression,limited respiratory depression
NEW14454,BIOCHEMICAL,strong antagonist activity withdrawal syndrome,strong antagonist activity withdrawal syndrome
NEW14455,CHEMICAL,due nalbuphine,due nalbuphine
NEW14457,DISEASE,ih-induced mandibular growth retardation,IH-induced mandibular growth retardation
NEW14459,MENTAL_HEALTH,depression min,depression min
NEW14461,DISEASE,intermittent hypercapnia exposure,intermittent hypercapnia exposure
C490101,DISEASE,"FTSJ1 protein, human [Supplementary Concept]",Nuclear Proteins|FTSJ1|Methyltransferases
NEW14462,MENTAL_HEALTH,retardation gene,retardation genes
NEW14463,CHEMICAL,escherichia coli methyltransferase ftsj/rrmj gene,Escherichia coli methyltransferase FtsJ/RrmJ gene
NEW14465,DISEASE,sex-biased cognitive deficit,sex-biased cognitive deficits
NEW14467,DISEASE,risk bacterial infection,risks bacterial infections
NEW14470,DISEASE,adverse psychiatric event,adverse psychiatric events
NEW14474,CHEMICAL,iso rat,ISO rats
NEW14479,DISEASE,herpes virus,herpes viruses
NEW14480,DISEASE,antipsychotic-induced hyperprolactinemia,hyperPRL|antipsychotic-induced hyperprolactinemia
NEW14481,MENTAL_HEALTH,prl hyperactivity,PRL hyperactivity
NEW14484,MENTAL_HEALTH,resistance allele,resistance alleles
C082315,DISEASE,"GAG-BP protein, Streptococcus pyogenes [Supplementary Concept]",S. pyogenes|Carrier Proteins|Bacterial Proteins
NEW14487,CHEMICAL,indole phytoalexin family,indole phytoalexin family
NEW14488,DISEASE,microbial infection,microbial infection
NEW14491,MENTAL_HEALTH,EDS1/PAD4-independent lcb accumulation resistance,EDS1/PAD4-independent LCB accumulation resistance
NEW14492,CHEMICAL,oxide (NO)/cyclic guanosine pathway,oxide (NO)/cyclic guanosine pathway
NEW14496,CHEMICAL,nadh fluorescence,NADH fluorescence
NEW14499,CHEMICAL,gge subgroup,GGE subgroups
NEW14504,DISEASE,diet-induced obese animal,diet-induced obese animals
NEW14505,DISEASE,diet-induce obesity,diet-induce obesity
NEW14507,DISEASE,fms patient,FMS patients
NEW14508,DISEASE,fms control,FMS controls
NEW14511,CHEMICAL,estrogen-progestogen user,estrogen-progestogen users
NEW14512,CHEMICAL,estrogen-progestogen user less,estrogen-progestogen users less
C505096,DISEASE,"PCA-1 antigen, human [Supplementary Concept]","prostate carcinoma|Antigens, Neoplasm"
NEW14513,BIOCHEMICAL,novelty drug candidate,novelty drug candidate
NEW14515,CHEMICAL,key amino acid residue present,key amino acid residues present
NEW14517,BIOCHEMICAL,dual agonist activity,dual agonist activity
C537271,DISEASE,Fowler Christmas Chapple syndrome [Supplementary Concept],polycystic ovaries|Polycystic Ovary Syndrome|Urination Disorders
NEW14518,DISEASE,metabolic complication,metabolic complications
NEW14520,DISEASE,acute degeneration organ,acute degeneration organs
NEW14521,DISEASE,man acute syndrome,man acute syndrome
NEW14522,MENTAL_HEALTH,similar syndrome,similar syndromes
NEW14524,DISEASE,human neurodegenerative disorder,human neurodegenerative disorders
D003139,DISEASE,Common Cold,"Cold, Common|Common Colds|Coryza, Acute|Colds, Common|Catarrh|Acute Coryza|Catarrhs|colds"
NEW14526,DISEASE,ptsd rat model,PTSD rat model
NEW14527,DISEASE,sps-induced memory deficit,SPS-induced memory deficits
NEW14528,CHEMICAL,new antidepressant class,newer antidepressant classes
NEW14530,MENTAL_HEALTH,methamphetamine-induced psychosis,methamphetamine-induced psychosis
NEW14531,DISEASE,schizophrenia-like behavioral abnormality,schizophrenia-like behavioral abnormalities
http://purl.obolibrary.org/obo/CHEBI_134870,CHEMICAL,toloxatone,"toloxatonum|MD-69276|(5RS)-5-(hydroxymethyl)-3-(3-methylphenyl)-1,3-oxazolidin-2-one|Perenum|(RS)-toloxatone|rac-5-(hydroxymethyl)-3-(3-methylphenyl)-2-oxazolidinone|racemic toloxatone|rac-5-(hydroxymethyl)-3-(3-methylphenyl)-1,3-oxazolidin-2-one|rac-toloxatone|MD 69276|rac-5-hydroxymethyl-3-(m-tolyl)-2-oxazolidinone|MD69276|toloxatona|toloxatone|iproniazide|Humoryl|Delalande 69276"
NEW14535,BIOCHEMICAL,inadequate vitamine intake,inadequate vitamine intake
D056653,DISEASE,Rheumatoid Vasculitis,"Vasculitides, Rheumatoid|vasculitis|Vasculitis, Rheumatoid|Rheumatoid Vasculitides"
http://purl.obolibrary.org/obo/CHEBI_186644,CHEMICAL,zk 159222,"butyl 1-[(E,1R,4R)-4-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(3S,5R)-3,5-dihydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-1-hydroxypent-2-enyl]cyclopropane-1-carboxylate|VKs"
NEW14537,DISEASE,hypoxia stress,hypoxia stress
NEW14540,BIOCHEMICAL,exclusive pharmaceutical approach,exclusive pharmaceutical approaches
D064092,CHEMICAL,Calbindin 1,Calbindin D28K|Calbindin-D28K|calbindin|Calbindin D(28)K
NEW14543,CHEMICAL,protein tyrosine phosphorylation,protein tyrosine phosphorylation
NEW14544,MENTAL_HEALTH,extract analgesia,extract analgesia
NEW14547,MENTAL_HEALTH,fatigue questionnaire,fatigue questionnaires
NEW14549,DISEASE,body muscle mass,body muscle mass
NEW14551,CHEMICAL,serum malondialdehyde level,serum malondialdehyde level
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Restless_Leg_Syndrome,DISEASE,restless leg syndrome,idiopathic restless legs syndrome
NEW14555,CHEMICAL,mg/dl. intravenous zoledronic acid,mg/dL. Intravenous zoledronic acid
http://purl.obolibrary.org/obo/DOID_0080832,DISEASE,mild cognitive impairment,mild cognitive impairment patients
NEW14558,DISEASE,irreversible cognitive deficit,irreversible cognitive deficits
NEW14561,CHEMICAL,long-acting benzodiazepine,long-acting benzodiazepines
NEW14563,BIOCHEMICAL,photo-generated carrier,photo-generated carriers
NEW14567,MENTAL_HEALTH,anxiety severity,anxiety severity
NEW14571,BIOCHEMICAL,auxin cytokinin response,auxin cytokinin response
C538274,DISEASE,Autoimmune oophoritis [Supplementary Concept],"Polyendocrinopathies, Autoimmune|autoimmune oophoritis|Oophoritis"
NEW14572,MENTAL_HEALTH,dna fragmentation gel,DNA fragmentation gel
NEW14575,DISEASE,lung tissue,lung tissues
NEW14576,DISEASE,inflammation group,inflammation group
NEW14579,CHEMICAL,striatopallidal medium spiny neuron,striatopallidal medium spiny neurons|spMSNs
NEW14581,CHEMICAL,mitochondrial toxin 3-nitropropionic acid,mitochondrial toxin 3-nitropropionic acid|3NP
NEW14583,CHEMICAL,serum triglyceride,serum triglyceride
NEW14585,MENTAL_HEALTH,in-source fragmentation,in-source fragmentation
NEW14587,MENTAL_HEALTH,different dominant fragmentation channel,different dominant fragmentation channels
NEW14588,CHEMICAL,clomipramine treatment,clomipramine treatment
NEW14590,BIOCHEMICAL,pharmaceutical standpoint,pharmaceutical standpoint
NEW14591,BIOCHEMICAL,lowered pharmaceutical response,lowered pharmaceutical response
http://purl.obolibrary.org/obo/HP_0002157,DISEASE,azotemia,prerenal azotemia
NEW14596,MENTAL_HEALTH,35)-induced amnesia modulation,35)-induced amnesia modulation
NEW14600,MENTAL_HEALTH,increase resistance,increased resistance
http://purl.obolibrary.org/obo/NCBITaxon_5820,DISEASE,plasmodium,Plasmodium parasite
D056404,CHEMICAL,Chaperonin Containing TCP-1,"chaperonin|Chaperonin CCT|Chaperonin CCT, zeta2 Subunit|Chaperonin CCT, gamma Subunit|Chaperonin CCT, delta Subunit|Chaperonin, Cytosolic|Chaperonin CCT, zeta1 Subunit|Chaperonin Containing TCP1, Subunit 6A|t Complex Protein 1|CCT delta Subunit|t Complex Polypeptide 1|Testis Complex Polypeptide 1|Chaperonin CCT, eta Subunit|t-Complex Polypeptide 1|Chaperonin Containing t Complex Polypeptide|Chaperonin Containing TCP1, Subunit 1|Chaperonin Containing TCP1, Subunit 6B|Chaperonin CCT, epsilon Subunit|Chaperonin Containing T Complex Polypeptide 1|Chaperonin CCT, alpha Subunit|Cytosolic Chaperonin|Chaperonin Containing TCP 1|Chaperonin Containing TCP1, Subunit 2|Chaperonin Containing TCP1, Subunit 3|t-Complex Protein 1|Chaperonin-Containing T-Complex Polypeptide 1|Chaperonin Containing TCP1, Subunit 7|Chaperonin Containing TCP1, Subunit 5|Chaperonin Containing t-Complex Polypeptide|Chaperonin CCT, beta Subunit|Cytosolic Molecular Chaperone CCT|Chaperonin Containing TCP1, Subunit 4|Chaperonin Containing TCP1, Subunit 8|Chaperonin CCT, theta Subunit"
NEW14602,DISEASE,plasmodium falciparum tcp-1 ring complex,Plasmodium falciparum TCP-1 ring complex
NEW14603,DISEASE,p. falciparum tric subunit,P. falciparum TRiC subunits
NEW14604,DISEASE,p. falciparum parasite,P. falciparum parasites
NEW14605,CHEMICAL,major tric substrate tubulin,major TRiC substrate tubulin
NEW14607,DISEASE,vestibular illusion,vestibular illusions
NEW14608,DISEASE,menstrual disease,menstrual diseases
NEW14612,BIOCHEMICAL,hydrophilic cyanotoxin,hydrophilic cyanotoxins
NEW14613,DISEASE,parkinson syndrome,Parkinson syndrome
NEW14614,DISEASE,severe cognitive pathology,severe cognitive pathologies
NEW14615,DISEASE,endocrine aberration,endocrine aberrations
NEW14616,DISEASE,high tumour burden,high tumour burden
NEW14617,DISEASE,advanced medullary thyroid carcinoma,advanced medullary thyroid carcinoma
NEW14620,CHEMICAL,vandetanib treatment,vandetanib treatment
NEW14621,DISEASE,apnea-hypopnea index,apnea-hypopnea index
NEW14623,DISEASE,sleep-related breathing disorder,sleep-related breathing disorder
NEW14624,DISEASE,endogenous infection,endogenous infection
NEW14625,BIOCHEMICAL,"vitamin M""-deficient monkey","vitamin M""-deficient monkeys"
NEW14628,MENTAL_HEALTH,activate dissociation,activated dissociation
D002414,CHEMICAL,"Cations, Monovalent","cations|Cation, Monovalent|Monovalent Cation|Monovalent Cations"
NEW14631,NUTRITION,fatty acid group,fatty acid group
http://purl.obolibrary.org/obo/CHEBI_69188,CHEMICAL,methyl stearate,"n-Octadecanoic acid methyl ester|Methyl ester of octadecanoic acid|Kemester 4516|Octadecanoic acid,methyl ester|Methyl octadecanoate|Stearic acid methyl ester|Methyl (Z)-9-octadecenoate|methyl octadecanoate|Stearic acid, methyl ester|methyl stearate|Kemester 9018|Metholene 2218|Octadecanoic acid, methyl ester|N-Octadecanoic acid, methyl ester|Kemester 9718|Methyl N-octadecanoate"
NEW14632,MENTAL_HEALTH,dissociation mechanism,dissociation mechanism
NEW14634,DISEASE,disorder movement,disordered movements
NEW14635,NUTRITION,excessive starch accumulation,excessive starch accumulation
NEW14636,MENTAL_HEALTH,opioid abuse disorder,opioid abuse disorder
NEW14638,DISEASE,cb1r agonist-mediated hypothermia,CB1R agonist-mediated hypothermia
NEW14639,DISEASE,metabolic remodelling,metabolic remodelling
D006317,DISEASE,"Hearing Loss, Noise-Induced","noise-induced hearing loss|Acoustic Trauma|Hearing Loss, Noise Induced|Noise-Induced Hearing Loss"
NEW14642,DISEASE,neuro-axonal degeneration,neuro-axonal degeneration
NEW14643,DISEASE,severe abdominal pain,severe abdominal pain
NEW14644,DISEASE,skin gastrointestinal disorder,skin gastrointestinal disorder
NEW14646,DISEASE,bright-red birefringence,bright-red birefringence
C506115,DISEASE,"bacteriocin-like inhibitory substance, Vibrio harveyi [Supplementary Concept]",Bacteriocins|V. harveyi
NEW14648,DISEASE,lethal heat shock,lethal heat shock
NEW14649,MENTAL_HEALTH,mouse-specific anxiety continuum,mouse-specific anxiety continuum
NEW14653,DISEASE,invasive human oscc line,invasive human OSCC line
NEW14654,CHEMICAL,cetuximab treatment,cetuximab treatment
NEW14655,DISEASE,tumor invasiveness,tumor invasiveness
NEW14657,CHEMICAL,ketamine effective antidepressant,ketamine effective antidepressant
NEW14658,DISEASE,cirrhosis impairment,cirrhosis impairments
NEW14659,DISEASE,chronic toxicity,chronic toxicities
NEW14663,DISEASE,chronic respiratory disorder,chronic respiratory disorder
NEW14665,NUTRITION,fish rainbow trout,fish rainbow trout
http://purl.obolibrary.org/obo/HP_0100543,DISEASE,cognitive impairment,T2DM-induced cognitive impairment
NEW14667,DISEASE,severe illness,severe illness
NEW14668,DISEASE,breast cancer cell proliferation,breast cancer cell proliferation
C407042,CHEMICAL,plant stanol ester [Supplementary Concept],stanol|Sitosterols
NEW14671,MENTAL_HEALTH,recent suicide attempt,recent suicide attempt
NEW14673,DISEASE,major bleeding,major bleeding
NEW14679,MENTAL_HEALTH,late-onset psychosis,late-onset psychosis
NEW14680,DISEASE,psp case,PSP cases
NEW14681,CHEMICAL,agd case,AGD cases
NEW14686,DISEASE,am-induced pulmonary toxicity,AM-induced pulmonary toxicity
NEW14689,DISEASE,dose-dependent necrosis,dose-dependent necrosis
NEW14690,BIOCHEMICAL,deficit hyperactivity disorder drug,deficit hyperactivity disorder drug
D000086102,DISEASE,Akkermansia,Verrucomicrobia (2004-2020)|Akkermansia
D001644,CHEMICAL,Bifidobacterium,Bifidobacterium|Actinomycetaceae (1975-1983)|Actinomycetales (1967-1974)
NEW14691,NUTRITION,alpha diversity,alpha diversity
NEW14693,CHEMICAL,noradrenaline release,noradrenaline release
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Erectile_Dysfunction,MENTAL_HEALTH,erectile dysfunction,concomitant erectile dysfunction
NEW14699,DISEASE,i disorder,I disorder
D017288,DISEASE,Pain Threshold,"Pain Thresholds|Thresholds, Pain|Threshold, Pain|pain threshold"
http://purl.obolibrary.org/obo/CHEBI_52210,BIOCHEMICAL,pharmacological role,pharmacological role
NEW14703,DISEASE,shock resistance,shock resistance
NEW14706,MENTAL_HEALTH,inevitable viral resistance,inevitable viral resistance
NEW14707,BIOCHEMICAL,fat-soluble vitamin deficiency,fat-soluble vitamin deficiencies
NEW14708,BIOCHEMICAL,fat soluble vitamin deficiency,fat soluble vitamin deficiency
NEW14710,DISEASE,parasympathetic dysfunction,parasympathetic dysfunction
NEW14711,DISEASE,c. chinensis,C. chinensis
NEW14712,CHEMICAL,µl/ml,µL/mL
NEW14713,DISEASE,classical program cell death,classical programmed cell death
NEW14716,DISEASE,necrotic cell death,necrotic cell death
NEW14717,DISEASE,post-traumatic cell death,post-traumatic cell death
D007004,DISEASE,Hypoglycemic Agents,"Hypoglycemics|Drug, Hypoglycemic|Drugs, Hypoglycemic|Agent, Antidiabetic|Hypoglycemic Drug|Agents, Hypoglycemic|Hypoglycemic Drugs|Agent, Hypoglycemic|Antidiabetic Drug|Antidiabetic Drugs|Drugs, Antidiabetic|Antihyperglycemic Agents|Agents, Antidiabetic|Antihyperglycemic|Antidiabetic Agents|Hypoglycemic Effect|Antidiabetic Agent|Antihyperglycemic Agent|Hypoglycemic|Hypoglycemic Agent|Agents, Antihyperglycemic|Drug, Antidiabetic|hypoglycemic|Antihyperglycemics|Effect, Hypoglycemic|Antidiabetic|Hypoglycemic Effects|Antidiabetics|Effects, Hypoglycemic|Agent, Antihyperglycemic"
NEW14722,DISEASE,tumor treatment,tumor treatment
NEW14723,MENTAL_HEALTH,associate vascular dementia,associated vascular dementia
NEW14724,MENTAL_HEALTH,hyperhomocysteinemia-induced vascular dementia,hyperhomocysteinemia-induced vascular dementia
NEW14726,CHEMICAL,n-methyl-d-aspartate nmda glutamate receptor,N-methyl-d-aspartate NMDA glutamate receptor
D053206,MENTAL_HEALTH,Nocturnal Enuresis,"nocturnal enuresis|Incontinence, Nighttime Urinary|Nighttime Urinary Incontinence|Enuresis, Nocturnal|Urinary Incontinence, Nighttime|Bedwetting"
NEW14729,DISEASE,ejaculatory disorder,ejaculatory disorders
NEW14731,CHEMICAL,surround crystalline region,surrounding crystalline regions
NEW14732,CHEMICAL,waxy-gene dosage,Waxy-gene dosage
D006330,DISEASE,"Heart Defects, Congenital","Abnormality, Heart|Congenital Heart Disease|Heart, Malformation Of|Heart Abnormality|Defects, Congenital Heart|heart defects|Congenital Heart Diseases|Malformation Of Hearts|Heart Defect, Congenital|Heart Disease, Congenital|Congenital Heart Defects|Malformation Of Heart|Defect, Congenital Heart|Disease, Congenital Heart|Heart Abnormalities|Congenital Heart Defect"
NEW14734,DISEASE,anesthesia-induced cognitive dysfunction,anesthesia-induced cognitive dysfunction
NEW14735,DISEASE,isoflurane-induced cognitive impairment,isoflurane-induced cognitive impairment
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Recurrent_Depression,MENTAL_HEALTH,recurrent depression,recurrent depression
NEW14739,BIOCHEMICAL,various endocrine abnormality,various endocrine abnormalities
NEW14741,DISEASE,multiglandular hyperparathyroidism,multiglandular hyperparathyroidism
NEW14742,DISEASE,subclinical parathyroid adenoma,subclinical parathyroid adenoma
NEW14743,CHEMICAL,preserve oxygen extraction fraction,preserved oxygen extraction fraction
NEW14744,CHEMICAL,acetylcholine precursor,acetylcholine precursors
NEW14746,CHEMICAL,low serum ua level,lower serum UA levels
NEW14747,CHEMICAL,% v/v aqueous acetic acid,% v/v aqueous acetic acid
D009072,DISEASE,Moyamoya Disease,"Disease, Primary Moyamoya|Moyamoya Disease, Classic|Moya Moya Disease|Progressive Intracranial Occlusive Arteropathy (Moyamoya)|moyamoya disease|Classic Moyamoya Disease|Cerebrovascular Moyamoya Disease|Secondary Moyamoya Disease|Moyamoya Disease, Primary|Primary Moyamoya Disease|Moyamoya Disease, Secondary|Moyamoya Syndrome|Disease, Moya-Moya|Moyamoya Diseases, Primary|Primary Moyamoya Diseases|Disease, Classic Moyamoya|Moya-Moya Disease"
NEW14749,DISEASE,perioperative hypertension,perioperative hypertension
NEW14750,CHEMICAL,rapamycin inhibitor,rapamycin inhibitor
D054066,DISEASE,"Leukemia, Large Granular Lymphocytic","NK-Cell Large Granular Lymphocytic Leukemia|T-LGL leukemia|Lymphoproliferative Disease of Granular Lymphocytes|Large Granular Lymphocyte Leukemia|Leukemias, LGL|T Cell Large Granular Lymphocytic Leukemia|Leukemia, T-LGL|Large Granular Lymphocytosis|Leukemia, Natural Killer Cell Large Granular Lymphocytic|Leukemia, T Cell Large Granular Lymphocytic|Leukemia, Lymphocytic, Large Granular|Leukemia, LGL|T-Cell Large Granular Lymphocyte Leukemia|Aggressive NK Cell Leukemia|Leukemias, T-LGL|T-LGL Leukemia|T-Cell Large Granular Lymphocytic Leukemia|Aggressive Natural Killer Cell Leukemia|NK-LGL Leukemia|NK Cell Large Granular Lymphocytic Leukemia|T-LGL Leukemias|Leukemia, T-Cell Large Granular Lymphocytic|Lymphoproliferative Disease of Large Granular Lymphocytes|Natural Killer Cell Large Granular Lymphocytic Leukemia|NK-LGL Leukemias|Granular Lymphocytosis, Large|Large Granular Lymphocytoses|Lymphocytoses, Large Granular|Granular Lymphocytoses, Large|Leukemia, NK-LGL|LGL Leukemias|T Cell Large Granular Lymphocyte Leukemia|Leukemia, NK LGL|NK LGL Leukemia|LGL Leukemia|Leukemias, NK-LGL|Lymphocytosis, Large Granular|T LGL Leukemia|Leukemia, T LGL"
NEW14751,MENTAL_HEALTH,nucleophilic displacement,nucleophilic displacement
NEW14752,CHEMICAL,malondialdehyde level,malondialdehyde level
NEW14754,MENTAL_HEALTH,transient dementia,transient dementia
NEW14755,DISEASE,arrhythmia vulnerability,arrhythmia vulnerability
D000070379,DISEASE,Attentional Bias,"attentional bias|Attention, Biased|Biases, Attentional|Biased Attention|Bias, Attentional|Attentional Biases"
NEW14757,DISEASE,uhr individual,UHR individuals
NEW14759,DISEASE,subdural haematoma,subdural haematomas
NEW14762,DISEASE,chronic leg ulcer fluid,chronic leg ulcer fluids
NEW14763,DISEASE,chronic ulcer,chronic ulcers
D009165,DISEASE,"Mycobacterium Infections, Nontuberculous","Infections, Mycobacterium abscessus|Atypical Mycobacterial Infection, Familial Disseminated|Atypical Mycobacterium Infection|Infection, Mycobacterium abscessus|Mycobacteriosis, Familial Atypical|Familial Atypical Mycobacteriosis|Atypical Mycobacteriosis, Familial|Mycobacterium abscessus Infection|Nontuberculous Mycobacterium Infections|Atypical Mycobacterium Infections|Mycobacterium abscessus Infections|Mycobacterium Infections, Atypical|Mycobacterioses, Familial Atypical|Infections, Atypical Mycobacterium|Mycobacterium Infection, Atypical|Familial Atypical Mycobacterioses|Atypical Mycobacteriosis, Familial Disseminated|Nontuberculous Mycobacterium Infection|Mycobacterium Infection, Nontuberculous|Atypical Mycobacterial Infection, Disseminated|nontuberculous mycobacterium"
NEW14765,DISEASE,advanced melanoma patient,advanced melanoma patients
NEW14767,DISEASE,cteph patient,CTEPH patients
D020001,CHEMICAL,1-Butanol,"butanol|Alcohol, n-Butyl|Alcohol, Butyl|Butyl Alcohol|1 Butanol|n Butyl Alcohol|n-Butyl Alcohol|n-Butanol|n Butanol"
C027873,CHEMICAL,"2-butanone, ethyl acetate cavity cleaner [Supplementary Concept]",ethyl acetate|Butanones|Acetates
NEW14771,MENTAL_HEALTH,task complete amnesia,task complete amnesia
NEW14772,BIOCHEMICAL,Farsi,Dari|Farsi
C021520,CHEMICAL,lysine decarboxylase [Supplementary Concept],lysine decarboxylase|Carboxy-Lyases
NEW14774,CHEMICAL,increase indole-3-butyric acid,increased indole-3-butyric acid
NEW14776,DISEASE,flowering-related,flowering-related
NEW14779,DISEASE,future glaucoma surgery,future glaucoma surgery
NEW14780,CHEMICAL,mitochondria-targeted antioxidant skq1,mitochondria-targeted antioxidant SkQ1
NEW14782,MENTAL_HEALTH,multivariate regression analysis,multivariate regression analysis
NEW14784,BIOCHEMICAL,antiviral role,antiviral role
NEW14787,BIOCHEMICAL,c vitamin status,C vitamins status
D007898,DISEASE,"Leishmaniasis, Visceral","visceral leishmaniasis|Black Fever|Kala-Azar|Fever, Black|Kala Azar|Visceral Leishmaniasis"
NEW14789,DISEASE,acne arthritis,acne arthritis
D019309,BIOCHEMICAL,Epstein-Barr Virus Nuclear Antigens,"EBV Nuclear Antigen|Herpesvirus 4, Human Nuclear Antigens|nuclear antigens|Nuclear Antigens, Herpesvirus 4, Human|Epstein Barr Virus Nuclear Antigen|EBV Nuclear Antigens|Epstein Barr Virus Nuclear Antigens|Antigen, EBV Nuclear|Nuclear Antigens, EBV|Nuclear Antigen, EBV|Epstein-Barr Virus Nuclear Antigen"
NEW14794,DISEASE,novel alcohol addiction treatment strategy,novel alcohol addiction treatment strategy
NEW14797,CHEMICAL,inhibitory crhcea→vta input,inhibitory CRHCeA→VTA inputs
NEW14799,DISEASE,hypercortisolemia post-stress challenge,hypercortisolemia post-stress challenge
NEW14802,DISEASE,seizure-induced behavioral deficit,seizure-induced behavioral deficits
NEW14804,DISEASE,somatic symptom disturbance,somatic symptom disturbance
C499434,CHEMICAL,"corticotropin-releasing factor receptor type 2a, rat [Supplementary Concept]","CRF(2|Receptors, Corticotropin-Releasing Hormone"
NEW14806,DISEASE,tremor shake,tremor shake
NEW14810,DISEASE,excessive irritability,excessive irritability
NEW14811,DISEASE,anger outburst,anger outbursts
NEW14813,DISEASE,aggressive population,aggressive populations
http://purl.org/sig/ont/fma/fma60992,CHEMICAL,helix,Helix of pinna|TZDs helix|Helix of auricle of ear|Helix of ear|Helical part of pinna|Helix (Auricula)
http://purl.obolibrary.org/obo/CHEBI_70781,BIOCHEMICAL,ppar modulator,selective PPAR modulator|peroxisome proliferator-activated receptor modulators|peroxisome proliferator-activated receptor modulator
NEW14815,CHEMICAL,glucose lipid metabolism,glucose lipid metabolism
NEW14817,MENTAL_HEALTH,5ht fixation,5HT fixation
NEW14818,CHEMICAL,l-dihydroxyphenylalanine,l-dihydroxyphenylalanine
NEW14820,DISEASE,tardive dyskinetic symptomatology,tardive dyskinetic symptomatology
NEW14821,CHEMICAL,tardive dyskinetic symptomatology,TDS|tardive dyskinetic symptomatology
D061186,DISEASE,Breast Milk Expression,"Collections, Breast Milk|Expression, Breast Milk|Breast Pumping|Expressions, Breastmilk|Breastmilk Collections|Collection, Breastmilk|Milk Expression, Breast|Milk Collection, Breast|Breastmilk Expression|Expressions, Breast Milk|milk|Breast Milk Expressions|Expression, Breastmilk|Breast Milk Collections|Breast Pumpings|Milk Collections, Breast|Pumping, Breast|Milk Expressions, Breast|Breast Milk Collection|Collections, Breastmilk|Breastmilk Collection|Collection, Breast Milk|Pumpings, Breast|Breastmilk Expressions"
NEW14823,MENTAL_HEALTH,psychogenic amnesia,psychogenic amnesia
C536350,DISEASE,Visceral myopathy familial external ophthalmoplegia [Supplementary Concept],"Muscular Dystrophy, Oculopharyngeal|encephalopathy syndrome|Ophthalmoplegia/congenital|Intestinal Pseudo-Obstruction"
NEW14825,BIOCHEMICAL,parathyroid hormone withdrawal,parathyroid hormone withdrawal
NEW14826,DISEASE,uremia serum aluminum binding,uremia serum aluminum binding
NEW14829,DISEASE,chronic paracoccidioidomycosis,chronic paracoccidioidomycosis
D009182,DISEASE,Mycosis Fungoides,mycosis
NEW14830,DISEASE,chronic paracoccidioidomycosis group,chronic paracoccidioidomycosis group
NEW14833,CHEMICAL,(rs)-alpha-methyl-4-carboxyphenyglycine,(RS)-alpha-methyl-4-carboxyphenyglycine
NEW14834,BIOCHEMICAL,nonselective group i/ii metabotropic glutamate receptor antagonist,nonselective group I/II metabotropic glutamate receptor antagonist
NEW14838,DISEASE,parahaemolyticus infection,parahaemolyticus infection
D014735,DISEASE,Vibrio Infections,"Infections, Vibrio|Vibrio Illnesses|Vibriosis|Infection, Vibrio|Vibrio Infection|Vibrioses|Vibrio infection|Vibrio Illness"
NEW14841,MENTAL_HEALTH,good fatigue resistance,good fatigue resistance
NEW14843,MENTAL_HEALTH,myalgic encephalomyelitis/chronic fatigue syndrome,myalgic encephalomyelitis/chronic fatigue syndrome
NEW14845,DISEASE,dravet syndrome mouse,Dravet syndrome mice
NEW14848,DISEASE,gastric irritation,gastric irritation
NEW14850,DISEASE,refractory scd-related pain,refractory SCD-related pain
NEW14852,DISEASE,pain management safe,pain management safe
D003295,DISEASE,Convulsive Therapy,"Coma Therapy, Insulin|Therapies, Insulin Coma|Shock Therapy, Insulin|Therapy, Convulsive|Insulin Shock Therapy|Therapies, Shock|convulsive|Insulin Coma Therapies|Insulin Coma Therapy|Therapies, Convulsive|Therapy, Shock|Therapy, Insulin Shock|Therapy, Insulin Coma|Coma Therapies, Insulin|Convulsive Therapies|Shock Therapy|Shock Therapies"
NEW14855,MENTAL_HEALTH,anxiety manifestation,anxiety manifestations
NEW14857,CHEMICAL,dose-dependent cortisol release,dose-dependent cortisol release
NEW14859,DISEASE,manic/hypomanic patient,manic/hypomanic patients
NEW14860,MENTAL_HEALTH,event headache,events headache
http://purl.obolibrary.org/obo/DOID_0050426,DISEASE,stevens-johnson syndrome,mild Stevens-Johnson syndrome
NEW14863,DISEASE,symptomatic endometriosis,symptomatic endometriosis
NEW14864,CHEMICAL,subanalgesic dose,subanalgesic dose
C494581,CHEMICAL,"nac protein, Drosophila [Supplementary Concept]",Drosophila Proteins|GDP-fucose|Monosaccharide Transport Proteins
NEW14865,DISEASE,staphylococcal enterocolitis,staphylococcal enterocolitis
NEW14866,DISEASE,occasional anaphylactic reaction,occasional anaphylactic reactions
NEW14867,DISEASE,blood dyscrasia,blood dyscrasias
NEW14868,CHEMICAL,potassium depletion,potassium depletion
NEW14869,DISEASE,ventricular premature beat,ventricular premature beats
NEW14870,DISEASE,jaundice blood dyscrasia,jaundice blood dyscrasias
NEW14871,DISEASE,parkinsonian state,parkinsonian states
NEW14872,DISEASE,hepatic dna damage,hepatic DNA damage
NEW14874,BIOCHEMICAL,addition endocrine disruption,addition endocrine disruption
NEW14875,NUTRITION,female african catfish,female African catfish
NEW14876,CHEMICAL,subchronic cpf toxicity,subchronic CPF toxicity
NEW14878,NUTRITION,lithium antagonist,lithium antagonist
NEW14880,MENTAL_HEALTH,folate level,enuresis group
NEW14882,CHEMICAL,mean vitamin B(12,kavalactones
NEW14883,CHEMICAL,mean vitamin B(12,kava group
C035736,CHEMICAL,glutaric acid [Supplementary Concept],glutaric acid|Glutarates
NEW14886,BIOCHEMICAL,urinary organic acid analysis,D1 agonist features
NEW14889,DISEASE,histidine ligand,dose-limiting schedule-dependent CNS toxicity
NEW14892,DISEASE,recurrent malignant astrocytoma,malignant astrocytomas
NEW14893,NUTRITION,recurrent malignant astrocytoma,high-density lipoprotein HDL cholesterol
NEW14895,CHEMICAL,phase agitation,undecenoic acid
NEW14897,DISEASE,combined monophasic contraceptive,functional ovarian cysts
NEW14900,DISEASE,gamma-aminobutyric acid-a gabaa receptor agonist alprazolam,greatest weight gain
NEW14901,DISEASE,gamma-aminobutyric acid-a gabaa receptor agonist alprazolam,fatal poisoning
D004299,CHEMICAL,Dopamine beta-Hydroxylase,"Dopamine beta Monooxygenase|dopamine β-hydroxylase|beta-Hydroxylase, Dopamine|beta-Monooxygenase, Dopamine|Dopamine beta Hydroxylase|Dopamine beta-Monooxygenase"
NEW14906,CHEMICAL,cannabinoid hyperemesis syndrome,Tau oligomers
NEW14907,DISEASE,psychiatric problem,psychiatric problems
NEW14908,CHEMICAL,Nat Rev Drug Discov,Nat Rev Drug Discov
D013124,DISEASE,Spinal Injuries,"Injury, Spinal|Spinal Injury|spinal injury|Injuries, Spinal"
NEW14909,MENTAL_HEALTH,resistance bacteria,resistance bacteria
NEW14912,DISEASE,mibg imaging,various cardiac diseases
NEW14915,NUTRITION,rvmat2,yeast vacuole
NEW14916,CHEMICAL,rvmat2,parkinsonian toxin 1-methyl-4-phenylpyridinium
D000167,CHEMICAL,Acriflavine,"acriflavine|Xanthacridinum|2,8-Diamino-10-Methylacridinium Chloride Mixture With 2,8-Diaminoacridine"
NEW14919,DISEASE,bipolar disorder effect,leg abduction
NEW14920,DISEASE,bipolar disorder effect,spontaneous pain
NEW14922,DISEASE,mitochondrial lesion,mitochondrial lesions
NEW14924,DISEASE,dilinoleoyl specie,ethanol-induced septal fibrosis
NEW14925,DISEASE,significant depression,excretory calcinosis
NEW14926,CHEMICAL,significant depression,calcium storage disease
NEW14928,MENTAL_HEALTH,high-mg2,gm9 synaptic depression
NEW14933,BIOCHEMICAL,serum drug concentration,prophylactic drug therapy
NEW14935,NUTRITION,machine regression,urinary phenols
NEW14936,CHEMICAL,regression model,tertile(T2-T3)medium/high
NEW14938,DISEASE,lopinavir/ritonavir-based combination,transaminitis
NEW14939,DISEASE,lopinavir/ritonavir-based combination,more bradycardia
NEW14942,MENTAL_HEALTH,tumor necrosis factor tnf antagonist infliximab,treatment-resistant major depression
NEW14944,CHEMICAL,high inflammation,ethanol abstinence syndrome
NEW14946,MENTAL_HEALTH,ethanol dependence phase,progressive severity hyperactivity
NEW14947,DISEASE,ethanol dependence phase,spastic rigidity
NEW14949,CHEMICAL,acetyl-l-carnitine treatment,ethanol withdrawal syndrome
NEW14951,DISEASE,amenable,psychiatric inpatients
NEW14953,CHEMICAL,standardized coefficient=0.385 p=0.007,standardized coefficient=0.385 p=0.007
NEW14954,DISEASE,depressive patient,depressive men
NEW14955,DISEASE,direct oral anticoagulant,gas significant pulmonary irritant
NEW14958,BIOCHEMICAL,death scene,multiple drug ingestion
NEW14959,DISEASE,death scene,Alzheimer's type
NEW14961,DISEASE,msa case,sleep-wake rhythm disorders
C412383,CHEMICAL,R 121919 [Supplementary Concept],Pyrimidines|R121919
NEW14964,DISEASE,ssri-tca combination,disturbed schizophrenic patients
NEW14965,CHEMICAL,ssri-tca combination,K variants
D004325,MENTAL_HEALTH,Dreams,Nightmare|Nightmares|Dream|nightmare
NEW14968,DISEASE,alpha-linolenic acid pathway,multidrug-resistant P. aeruginosa
NEW14969,DISEASE,alpha-linolenic acid pathway,ESBL+ Enterobacteriaceae
NEW14971,DISEASE,methylprednisolone therapy,dysarthria urinary incontinence
D004286,CHEMICAL,Dolichols,"Eicosamethyl Octacontanonadecasen-1-ol|6,10,14,18,22,26,30,34,38,42,46,50,54,58,62,66,70,74,78-Octacontanonadecaen-1-ol, 3,7,11,15,19,23,27,31,35,39,43,47,51,55,59,63,67,71,75,79-eicosamethyl-|Eicosamethyl Octacontanonadecasen 1 ol|Dolichol|Octacontanonadecasen-1-ol, Eicosamethyl|dolichols"
D009207,DISEASE,Myoclonus,"Palatal Myoclonus|Upper Extremity Myoclonus|Jerks, Myoclonic|Jerking, Myoclonic|Action Myoclonus|Myoclonic Jerks|Myoclonus, Intention|Simplex, Myoclonus|Myoclonic Jerking|Polymyoclonus|Myoclonus, Sleep|Segmental Myoclonus|Sleep Myoclonus|Oculopalatal Myoclonus|Eyelid Myoclonus|Lower Extremity Myoclonus|Nocturnal Myoclonus|Extremity Myoclonus, Upper|Myoclonus, Nocturnal|Intention Myoclonus|Myoclonus Simplex|Myoclonus, Palatal|myoclonic jerks|Myoclonus, Action|Myoclonus, Lower Extremity|Myoclonus, Eyelid|Myoclonus, Upper Extremity|Myoclonus, Oculopalatal|Extremity Myoclonus, Lower|Jerk, Myoclonic|Myoclonic Jerk|Myoclonus, Segmental"
NEW14974,CHEMICAL,inhibitory neurotransmitter γ-aminobutyric acid,GABAuria
NEW14976,MENTAL_HEALTH,sucrose tolerance,food compulsion related
NEW14978,MENTAL_HEALTH,d3 agonist therapy,behavioral syndromes
NEW14980,CHEMICAL,reversible somnolence,arginine butyrate doses
NEW14983,DISEASE,tamarillo pvy isolate,naranjilla
NEW14985,DISEASE,tam17,systemic infection
NEW14986,MENTAL_HEALTH,tam17,mild mood disorders
NEW14989,CHEMICAL,lactobacillus level,HCY levels
NEW14991,DISEASE,classical androgen,differentiated Simpson-Golabi-Behmel Syndrome
NEW14993,DISEASE,11-oxygenated androgen,hyperandrogenic profile
NEW14994,DISEASE,11-oxygenated androgen,long-term diet-induced obesity
NEW14995,DISEASE,11-oxygenated androgen,short-term diet-induced weight gain
NEW14996,MENTAL_HEALTH,11-oxygenated androgen,conclusion resistance
NEW14998,DISEASE,pcstat isoform,WSSV infection
NEW15000,MENTAL_HEALTH,crayfish group,significant heat resistance
NEW15001,MENTAL_HEALTH,crayfish group,inherited intellectual disability
NEW15003,DISEASE,pathological pain state,pathological pain states
NEW15006,DISEASE,cannabinoid analgesic system,intractable pathological pain syndromes
NEW15008,CHEMICAL,c(50 beta-cyclic carotenoid synthesis gene cluster,C(50 epsilon-cyclic carotenoids
C011431,CHEMICAL,decaprenoxanthin [Supplementary Concept],Xanthophylls|decaprenoxanthin
C000647321,DISEASE,Agromyces mediolanus [Supplementary Concept],Agromyces mediolanus|Actinobacteria
D048230,DISEASE,Corynebacterium glutamicum,Corynebacterium (1969-2004)|Corynebacterium glutamicum
D026082,CHEMICAL,Singlet Oxygen,"Dioxygen, Singlet|Singlet Dioxygen|Oxygen, Singlet|singlet oxygen"
NEW15010,DISEASE,otological vertigo,bilateral vestibular paresis
D020338,DISEASE,Vestibular Neuronitis,"Vestibular Nerve Neuritides|Nerve Inflammations, Vestibular|Vestibular Neuritis, Recurrent|Inflammation, Vestibular Nerve|Recurrent Vestibular Neuritis|Epidemic Neurolabyrinthitis|Neurolabyrinthitis, Epidemic|Neuritis, Vestibular Nerve|Vestibular Neuropathy|Neuritides, Recurrent Vestibular|Neurolabyrinthitides, Epidemic|Vestibular Neuronitides|Peripheral Vestibulopathy, Acute|Peripheral Vestibulopathies, Acute|Neuritis, Acute Vestibular|Neuronitis, Vestibular|Inflammations, Vestibular Nerve|Neuritides, Subacute Vestibular|Vestibular Neuritides, Acute|Vestibular Neuritis, Acute|Acute Vestibular Neuritides|Vestibulopathies, Recurrent|Vestibular Neuritides, Recurrent|Subacute Vestibular Neuritis|Vestibulopathy, Acute Peripheral|Neuropathies, Vestibular|Recurrent Vestibulopathies|Vestibular Neuritides, Subacute|Vestibular Neuritides|Epidemic Neurolabyrinthitides|vestibular neuritis|Neuritides, Vestibular|Vestibular Nerve Inflammation|Neuritis, Subacute Vestibular|Nerve Inflammation, Vestibular|Nerve Neuritides, Vestibular|Subacute Vestibular Neuritides|Vestibular Nerve Neuritis|Acute Vestibular Neuritis|Vestibular Neuritis|Vestibular Neuritis, Subacute|Neuritides, Acute Vestibular|Recurrent Vertigo, Episodic|Vestibular Nerve Inflammations|Episodic Recurrent Vertigo|Recurrent Vertigos, Episodic|Neuropathy, Vestibular|Recurrent Vestibulopathy|Neuritis, Vestibular|Nerve Neuritis, Vestibular|Neuronitides, Vestibular|Acute Peripheral Vestibulopathy|Neuritides, Vestibular Nerve|Acute Peripheral Vestibulopathies|Vestibulopathies, Acute Peripheral|Vestibular Neuropathies|Episodic Recurrent Vertigos|Neuritis, Recurrent Vestibular|Vestibulopathy, Recurrent|Vertigos, Episodic Recurrent|Recurrent Vestibular Neuritides|Vertigo, Episodic Recurrent"
NEW15012,DISEASE,vestibular suppressant,migraine-associated vertigo
NEW15016,CHEMICAL,5-hydroxyindoleacetic acid,alpha-methyldopa hydrazine
NEW15017,DISEASE,5-hydroxyindoleacetic acid,Parkinsonian patients
NEW15021,DISEASE,primary vv virulence factor,permanent neurologic impairment
NEW15026,DISEASE,tumor vasculature,tumor accumulation
NEW15029,DISEASE,unintentional traumatic injury,unintentional traumatic injury
NEW15031,DISEASE,vitamin k2 deficiency,developmental malformations
NEW15032,DISEASE,vitamin k2 deficiency,neurobehavioral anomalies
NEW15034,DISEASE,er hydrocodone,non-cancer non-neuropathic chronic pain
NEW15036,CHEMICAL,coital dysfunction,endocrine/neuro-endocrine
NEW15037,DISEASE,coital dysfunction,ejaculatory dysfunction
NEW15039,MENTAL_HEALTH,intracorporeal fibrosis,permanent post-RRP erectile dysfunction
NEW15040,BIOCHEMICAL,intracorporeal fibrosis,primary sex hormone
NEW15044,MENTAL_HEALTH,mania group,schizophrenia group
NEW15048,CHEMICAL,spanish acronym,fortification
NEW15053,BIOCHEMICAL,21-gene expression assay,oestrogen receptor (ER)-positive
NEW15056,NUTRITION,ofin vitrotest,higher median cholesterol
NEW15058,CHEMICAL,cask gene,ethyl acetate fraction|EAF
D007593,DISEASE,Joint Instability,"Hypermobility, Joint|Joint Instabilities|Joint Hypermobilities|hypermobility|Instability, Joint|Laxity, Joint|Joint Laxity|Laxities, Joint|Hypermobilities, Joint|Joint Laxities|Instabilities, Joint|Joint Hypermobility"
D019224,DISEASE,Temporomandibular Joint Disc,"Temporomandibular Joint Discs|Temporomandibular Articular Disc|Disc, Temporomandibular Articular|Disk, Temporomandibular Articular|Temporomandibular Articular Disk|temporomandibular joint|Articular Disc, Temporomandibular|TMJ|Disk, Temporomandibular Joint|Temporomandibular Articular Disks|Articular Disk, Temporomandibular|Articular Disks, Temporomandibular|Disks, Temporomandibular Articular|Temporomandibular Joint Disks|Joint Disks, Temporomandibular|Temporomandibular Joint Disk|Joint Discs, Temporomandibular|Joint Disk, Temporomandibular|Joint Disc, Temporomandibular|Disc, Temporomandibular Joint|Articular Discs, Temporomandibular|Discs, Temporomandibular Joint|Discs, Temporomandibular Articular|Disks, Temporomandibular Joint|Temporomandibular Articular Discs"
NEW15064,MENTAL_HEALTH,dose fatigue,dosing fatigue
NEW15065,CHEMICAL,polyol pathway,polyol pathway
D013012,CHEMICAL,Sorbitol,Medevac|klysma Sorbit|Yal|Sorbilax|sorbitol|Glucitol
NEW15067,CHEMICAL,selenium vitamin e,SAM homeostasis
D019706,CHEMICAL,Excitatory Postsynaptic Potentials,"Current, Excitatory Postsynaptic|Plate Potential, End|Potential, Excitatory Postsynaptic|Currents, Excitatory Postsynaptic|Plate Potentials, End|EPSP|Postsynaptic Current, Excitatory|Postsynaptic Potentials, Excitatory|excitatory postsynaptic currents|Postsynaptic Currents, Excitatory|End Plate Potentials|EPSCs|End Plate Potential|Potentials, Excitatory Postsynaptic|Excitatory Postsynaptic Potential|Excitatory Postsynaptic Currents|Postsynaptic Potential, Excitatory|Excitatory Postsynaptic Current|Potentials, End Plate|Potential, End Plate"
NEW15071,MENTAL_HEALTH,intermediate etoh concentration,membrane resistance
NEW15073,DISEASE,high etoh concentration,greater depressive effects
NEW15075,MENTAL_HEALTH,elevated cortisol level,psychosis subsequent onset
NEW15077,MENTAL_HEALTH,cortisol alteration,psychosis expression
NEW15079,DISEASE,cortisol stress measure,Attention Deficit/Hyperactive Disorder
NEW15080,DISEASE,cortisol stress measure,ureteral calculi expulsion
NEW15082,DISEASE,chr mrna,primary hypertension
NEW15083,MENTAL_HEALTH,chr mrna,PVN-RVLM projection neurons
NEW15084,NUTRITION,spanish preschool child,Spanish preschool children
NEW15085,MENTAL_HEALTH,tea consumption,anxiety biomarkers
NEW15087,DISEASE,amino-acid analogue tracer,brain gliomas
NEW15090,DISEASE,fixed-dose formulation,difficult-to-treat patient group
NEW15091,MENTAL_HEALTH,serotonergic agent,long-standing bulimia nervosa
NEW15092,DISEASE,psychiatric comorbid condition,psychiatric comorbid conditions
NEW15095,BIOCHEMICAL,urinary organic acid profile,B1 thiamine deficiency
NEW15096,DISEASE,urinary organic acid profile,different neurological diseases
NEW15099,BIOCHEMICAL,accidental poisoning,Paris Poison Centre
NEW15101,CHEMICAL,ec inverse agonist,CB1/2 receptors
NEW15102,DISEASE,ec inverse agonist,necrotic melanocyte death
NEW15103,DISEASE,vitiligo patient,vitiligo patients
NEW15105,MENTAL_HEALTH,endocrine factor,female sexual arousal disorder
NEW15110,DISEASE,tnf-α antagonist therapy,severe disseminated tuberculosis
NEW15111,DISEASE,tnf-α antagonist therapy,medical co-morbidities
NEW15113,CHEMICAL,ethanol metabolism,antioxidant molecule glutathione
NEW15114,BIOCHEMICAL,ethanol metabolism,antioxidant folic acid
NEW15115,NUTRITION,ethanol metabolism,poor folate
NEW15116,DISEASE,ethanol metabolism,preventable birth defects
D005563,CHEMICAL,Formic Acid Esters,"Esters, Formic Acid|Esters, Formate|Formate Esters|formic acid|Acid Esters, Formic"
NEW15117,DISEASE,ethanol metabolism,craniofacial defects
NEW15119,DISEASE,ethanol exposure,retinal defects
NEW15120,DISEASE,ethanol exposure,nerve differentiation defects
NEW15121,DISEASE,ethanol exposure,ethanol-induced retinal defects
NEW15122,CHEMICAL,ethanol exposure,GABA system
NEW15123,DISEASE,mtf population,MtF populations
NEW15124,DISEASE,cerebral masculinization,cerebral masculinization
NEW15126,CHEMICAL,pattern daughter loss method,"cyanidin-3-O-(3″,6″-dimalonyl-glucoside"
NEW15128,DISEASE,ect-induced acute hypercortisolemia,ECT-induced acute hypercortisolemia
D000073932,DISEASE,Food Addiction,"Compulsive Eating|Eating, Compulsive|Food Addictions|compulsive eating"
NEW15129,BIOCHEMICAL,dopamine agonist withdrawal syndrome,drug cravings
NEW15130,DISEASE,dopamine agonist withdrawal syndrome,generalized pain
NEW15131,MENTAL_HEALTH,visceral analgesia,visceral analgesia
NEW15133,DISEASE,guanylate cyclase-c guanosine monophosphate agonist,chronic idiopathic constipation|CIC
D010528,DISEASE,Peristalsis,peristalsis|Peristalses
NEW15136,DISEASE,oral poison,nauseas
D003085,DISEASE,Colic,"abdominal cramps|Cramps, Abdominal|Abdominal Cramp|Colic, Infantile|Infantile Colic|Abdominal Cramps|Cramp, Abdominal"
NEW15137,DISEASE,oral poison,painful spasms
NEW15138,DISEASE,oral poison,hormone-sensitive breast cancer
NEW15139,MENTAL_HEALTH,breast cancer patient,undiagnosed bipolar disorder
NEW15140,CHEMICAL,breast cancer patient,p<0.009
NEW15141,DISEASE,breast cancer patient,dopaminergic/opioidergic dysregulation
NEW15144,CHEMICAL,relief craving,gamma-aminobutyric acid (GABA)ergic/glutamatergic dysregulation
NEW15146,DISEASE,glp-1 system,cognitive processing
NEW15148,DISEASE,glp-1r agonist liraglutide,working impairments
NEW15151,CHEMICAL,fo treatment,NAD exhaustion
NEW15152,CHEMICAL,fo treatment,glutamate accumulation
D051997,CHEMICAL,ADP-ribosyl Cyclase 1,"ADPR|Cyclase 1, ADP-ribosyl|T10 Antigen|Cyclase CD38, ADPR|ADP ribosyl Cyclase 1|Cyclase T10, ADPR|NIM R5 Antigen|NIM-R5 Antigen|ADPR Cyclase T10|ADPR Cyclase CD38|CD38, ADPR Cyclase|Acute Lymphoblastic Leukemia Cells Antigen CD38|Antigens, CD38|Antigen, T10|CD38 Antigen|Lymphocyte Differentiation Antigen CD38|CD38 Antigens|1, ADP-ribosyl Cyclase"
C012589,CHEMICAL,trichostatin A [Supplementary Concept],trichostatin A|Hydroxamic Acids
NEW15154,BIOCHEMICAL,specific antibiotic group,pure agonist
NEW15155,BIOCHEMICAL,specific antibiotic group,values antagonist [3H]glibenclamide
NEW15156,MENTAL_HEALTH,specific antibiotic group,low dissociation constant
NEW15163,DISEASE,single amino acid mutation,early-onset autosomal recessive Parkinson disease
NEW15165,CHEMICAL,histone deacetylase inhibitor phenylbutyrate,N27 dopamine cell line
NEW15167,CHEMICAL,phenylbutyrate treatment,"4-phenyl 1,2,3,6-tetrahydropyridine MPTP toxicity"
NEW15168,MENTAL_HEALTH,phenylbutyrate treatment,diffuse Lewy body disease α-synuclein aggregation
NEW15170,DISEASE,vmpfc brain dysfunction,VmPFC brain dysfunction
NEW15171,DISEASE,axonal protein,axonal proteins
NEW15175,DISEASE,penicillin injection,pain system
NEW15176,DISEASE,chronic alcohol consumption,certain rheumatic diseases
NEW15177,DISEASE,analgesic property,fibromyalgia pain
NEW15180,NUTRITION,maternal serum lycopene concentration,p cis-lycopene
NEW15181,MENTAL_HEALTH,maternal serum lycopene concentration,morphine- analgesia
NEW15185,BIOCHEMICAL,opiate agonist therapy,opiate agonist
D014898,DISEASE,Werner Syndrome,"Progeria, Adult|Syndrome, Werner|Werners Syndrome|Adult Progeria|Syndrome, Werner's|Adult Premature Aging Syndrome|Werner Syndrome|Syndrome, Werners|Werner's Syndrome"
NEW15186,DISEASE,opiate agonist therapy,familial lipodystrophy FPLD type
C507159,CHEMICAL,"WRN protein, Xenopus [Supplementary Concept]",Werner Syndrome Helicase|Xenopus Proteins|WRN
NEW15187,DISEASE,nucleoside reverse transcriptase inhibitor,HAART-associated lipodystrophy syndrome
NEW15188,DISEASE,nucleoside reverse transcriptase inhibitor,lipodystrophies lipodystrophy
NEW15190,CHEMICAL,co-administration,co-administrations
NEW15191,MENTAL_HEALTH,suicide substrate,suicide substrates
NEW15192,CHEMICAL,suicide substrate,"7,8,4'-trihydroxyisoflavone"
NEW15193,CHEMICAL,suicide substrate,"5,7,8,4'-tetrahydroxyisoflavone"
NEW15197,CHEMICAL,chronic social defeat exposure,VTA putative dopamine neurons
NEW15201,CHEMICAL,nonacetylated salicylate,nonacetylated salicylate
D020512,DISEASE,"Myopathy, Central Core","Central Core Myopathy|Central Core Myopathies|Central Core Diseases|Myopathies, Central Core|Central Core Disease of Muscle|Syndrome, Shy-Magee|Shy-Magee Syndrome|myopathy|Central Core Disease|Shy Magee Syndrome"
NEW15204,CHEMICAL,mifepristone treatment,oral potassium replacement
NEW15206,MENTAL_HEALTH,phenolic glycoside,unique fragmentation pattern
NEW15207,DISEASE,phenolic glycoside,chemo-therapeutics chronic disease
NEW15211,DISEASE,hh signaling,pancreatic neoplasia
NEW15212,CHEMICAL,hh signaling,Hh pathway activity
NEW15213,CHEMICAL,hh signaling,Ptc-1 mRNA expression
NEW15214,MENTAL_HEALTH,hh signaling,preoperative apprehension
NEW15216,MENTAL_HEALTH,suspect acute coronary syndrome,disorder symptoms
D013920,DISEASE,"Thrombocythemia, Essential","Essential Thrombocythemia|Thrombocythemia, Hemorrhagic|Hemorrhagic Thrombocythemias|Dominant Thrombocytoses, Autosomal|Primary Thrombocytoses|Dominant Thrombocytosis, Autosomal|Idiopathic Thrombocythemias|Thrombocytoses, Autosomal Dominant|Thrombocythemias, Essential|Hemorrhagic Thrombocythemia|Thrombocytosis, Primary|essential thrombocythemia|Essential Thrombocythemias|Thrombocytoses, Primary|Autosomal Dominant Thrombocytoses|Thrombocythemias, Primary|Thrombocytosis, Autosomal Dominant|Thrombocythemia, Idiopathic|Thrombocythemia, Primary|Primary Thrombocytosis|Primary Thrombocythemia|Primary Thrombocythemias|Idiopathic Thrombocythemia|Thrombocythemias, Idiopathic|Thrombocythemias, Hemorrhagic|Autosomal Dominant Thrombocytosis"
NEW15218,DISEASE,mood stabilizer,urgency incontinence
NEW15221,NUTRITION,brown alga Padina pavonica,yeast mutant
NEW15222,MENTAL_HEALTH,brown alga Padina pavonica,collision-induced dissociation ion
NEW15223,DISEASE,brown alga Padina pavonica,PTSD Symptom
NEW15224,CHEMICAL,often-potassium zinc deficiency,sevoflurane-anesthesia
NEW15226,DISEASE,maternal folate intake,childhood low prosocial behavior
NEW15228,MENTAL_HEALTH,maternal vitamin b6 intake,childhood hyperactivity problems
NEW15229,DISEASE,maternal vitamin b6 intake,low prosocial behavior
NEW15230,DISEASE,maternal vitamin b6 intake,gonorrheal infections
D034421,NUTRITION,Sus scrofa,"Wild Boars|Boar, Wild|Sus scrofa domestica|wild boar|Domestic Pigs|Pig, Domestic|Wild Boar|Pigs, Domestic|Domestic Pig|Boars, Wild"
D043583,CHEMICAL,Nucleoside-Triphosphatase,"Nucleosidetriphosphatase|Nucleoside Triphosphate Phosphohydrolase I|NTPase|nucleoside triphosphate|Triphosphatase, Nucleoside|Nucleoside Triphosphatase|Phosphohydrolase, Nucleoside Triphosphate|Triphosphate Phosphohydrolase, Nucleoside|Nucleoside Triphosphate Phosphohydrolase|Nucleoside Triphosphate Phosphohydrolase II"
NEW15234,CHEMICAL,catecholamine mobilization,RBC|NTP
NEW15235,MENTAL_HEALTH,catecholamine mobilization,flu-like syndromes
NEW15236,CHEMICAL,catecholamine mobilization,oseltamivir group
NEW15237,DISEASE,catecholamine mobilization,type A/H7N7 virus
NEW15238,DISEASE,catecholamine mobilization,life-threatening bronchospasm
NEW15240,CHEMICAL,document infection,S-nucleophiles
NEW15243,BIOCHEMICAL,insect hormone balance,insect hormone balance
NEW15244,DISEASE,hyperactive stage,hyperactive stage
NEW15248,MENTAL_HEALTH,akh hormone,starvation-induced hyperactivity
NEW15251,DISEASE,somatotropin secretion,reactive depressive patients
NEW15252,DISEASE,somatotropin secretion,endogenous depressive patients
NEW15254,MENTAL_HEALTH,somatotropin stimulation maximum,endogenous depression reactive form
NEW15258,DISEASE,cyp1a2-ko mouse,DLX hepatoxicity
NEW15259,CHEMICAL,cyp1a2-ko mouse,Cyp1a2-mediated metabolism
NEW15261,MENTAL_HEALTH,Delicious 's winter squash c. maximum,age-related resistance
NEW15263,DISEASE,hand-pollinated fruit,P. capsici
NEW15264,DISEASE,hand-pollinated fruit,physical abnormalities
NEW15266,BIOCHEMICAL,fasd spectrum,nutraceutical treatment
NEW15268,BIOCHEMICAL,current antifungal drug,new antifungal therapeutics
NEW15270,CHEMICAL,fungicide use,triazole resistance development
NEW15271,BIOCHEMICAL,fungicide use,potent antifungal agents
NEW15272,BIOCHEMICAL,optimal peptide polymer,optimal peptide polymer
NEW15273,CHEMICAL,partial zwitterion,partial zwitterions
NEW15275,MENTAL_HEALTH,microm cch,reversible depression
NEW15277,DISEASE,cholinergic antagonist scopolamine,oxotremorine-induced tremor
NEW15279,CHEMICAL,active cholinergic antagonist methscopolamine,chromocacryorrhea
NEW15282,BIOCHEMICAL,vascular dysfunction,normal sex hormone profiles
NEW15283,DISEASE,vascular dysfunction,female HD mice relative
NEW15284,DISEASE,vascular dysfunction,female HD mice
NEW15286,DISEASE,ERβ agonist diarylpropionitrile,direct neurotoxic effects
NEW15288,DISEASE,dilute pilocarpine test,anhidrosis denervation hypersensitivity
NEW15290,DISEASE,neuroprotective steroid,mood pain modulation
NEW15292,CHEMICAL,intratracheal i.t hydrochloric acid 0.1n hcl instillation,mg/kg i.t
NEW15293,CHEMICAL,intratracheal i.t hydrochloric acid 0.1n hcl instillation,selective serotonin reuptake blockers
NEW15294,CHEMICAL,intratracheal i.t hydrochloric acid 0.1n hcl instillation,β-catenin-activated HCA
NEW15296,MENTAL_HEALTH,intratracheal i.t hydrochloric acid 0.1n hcl instillation,anxious apprehension R(2 =
NEW15298,DISEASE,nmdar-dependent audiogenic seizure due,NMDAR-dependent audiogenic seizures due
NEW15299,DISEASE,glun2b disease-causing mutation,GluN2B disease-causing mutations
NEW15300,BIOCHEMICAL,broccoli c,broccoli C
NEW15302,CHEMICAL,brain infarct area,TNF-α mRNA
D023582,DISEASE,Alzheimer Vaccines,"Alzheimer|Vaccines, Alzheimer"
NEW15303,BIOCHEMICAL,brain infarct area,fewer drug interactions
NEW15304,MENTAL_HEALTH,brain infarct area,fatigue model
D000084882,DISEASE,Developmental Disability Nursing,"Developmental Disability Nursings|Disability Nursing, Developmental|Nursing, Developmental Disability|developmental disability"
NEW15306,DISEASE,dietary nitrate,severe cardiac diseases
NEW15307,BIOCHEMICAL,dietary nitrate,opioid drug
NEW15308,DISEASE,dietary nitrate,mixed-mechanism opioid
NEW15309,DISEASE,dietary nitrate,postoperative pain management
NEW15311,DISEASE,epidural local analgesia,perioperative pain management
NEW15312,MENTAL_HEALTH,traditional antidepressant,hyperactivity symptomatology
NEW15313,DISEASE,traditional antidepressant,(ECT)-induced memory impairment
NEW15316,CHEMICAL,clupisoma garua,sufentanil group
NEW15317,CHEMICAL,clupisoma garua,fentanyl group
NEW15318,CHEMICAL,toxin gene,ST CC isolates
NEW15319,CHEMICAL,toxin gene,human adapted ST CC
NEW15320,DISEASE,toxin gene,S. aureus lineages
NEW15321,DISEASE,toxin gene,hepatitis B virus (HBV)-infected hepatitis
NEW15324,CHEMICAL,c. australi,similar leaf gas exchange
NEW15326,DISEASE,β-adrenoreceptor blocking drug β-blocker prescription,knee hip osteoarthritis
NEW15328,DISEASE,central pain pathway,human mechanistic pain biomarkers
NEW15329,DISEASE,central pain pathway,chronic pain conditions
NEW15331,DISEASE,cuff pressure pain stimulation,pain detection
NEW15332,DISEASE,cuff pressure pain stimulation,pain tolerance
NEW15334,DISEASE,implication analgesic effect,clinical pain populations
C502407,CHEMICAL,SSR125543 [Supplementary Concept],"Hydrocarbons, Halogenated|Thiazines|SSR125543"
NEW15335,CHEMICAL,abnormal fatty acid metabolism,FADS1 C/C
NEW15337,NUTRITION,thermal resistance,seal neonates
C538669,DISEASE,Alcohol induced encephalopathy [Supplementary Concept],Alcohol Amnestic Disorder|amnesic syndrome
D019001,CHEMICAL,Nitric Oxide Synthase,"Nitric Oxide Synthetase|Nitric-Oxide Synthetase|NO Synthase|NO synthase|Nitric-Oxide Synthase|Oxide Synthase, Nitric|Synthase, Nitric Oxide"
NEW15339,DISEASE,intraseptal muscarinic agonist,contractile dysfunction characteristic
NEW15341,DISEASE,hip fracture,hip fracture
NEW15342,DISEASE,hip fracture,nonvertebral fractures
NEW15344,DISEASE,calcium supplement,high baseline fracture risk
NEW15345,DISEASE,calcium supplement,advanced colorectal cancer
NEW15346,CHEMICAL,calcium supplement,deoxyuridine triphosphatase
NEW15347,DISEASE,calcium supplement,p53-proficient colorectal cancer cell line HCT116 expression
NEW15349,CHEMICAL,children-between year,P-5'-P
C587667,DISEASE,"GHET1 transcript, human [Supplementary Concept]","RNA, Long Noncoding|gastric carcinoma"
NEW15352,DISEASE,ginger constituent,cell cycle/DNA damage
NEW15354,MENTAL_HEALTH,estrogenic terpene,menopausal syndromes
NEW15355,BIOCHEMICAL,estrogenic terpene,endocrine toxicity/reproductive dysfunction
NEW15356,DISEASE,depressive state state,depressive state state
NEW15357,DISEASE,manic mood neuronal excitability,manic mood neuronal excitability
C420132,CHEMICAL,potassium channel subfamily K member 3 [Supplementary Concept],"Nerve Tissue Proteins|K+ channel|Potassium Channels, Tandem Pore Domain"
D060831,DISEASE,Hand-Foot Syndrome,"hand-foot syndrome|Palmoplantar Erythrodysesthesias, Chemotherapy-Induced|Chemotherapy Induced Palmoplantar Erythrodysesthesia|Chemotherapy Induced Acral Erythema|Hand-Foot Syndromes|Acral Erythemas, Chemotherapy-Induced|Chemotherapy-Induced Acral Erythema|HFS|Acral Erythema, Chemotherapy-Induced|Hand Foot Syndrome|Palmoplantar Erythrodysesthesia, Chemotherapy-Induced|Syndrome, Hand-Foot|Chemotherapy-Induced Palmoplantar Erythrodysesthesia|Chemotherapy-Induced Palmoplantar Erythrodysesthesias|Chemotherapy-Induced Acral Erythemas|Syndromes, Hand-Foot"
NEW15359,DISEASE,cancer patient,palmar-plantar erythrodysesthesia
NEW15361,DISEASE,background cisplatin/5-fluorouracil therapy,unresectable esophageal cancer
C536164,DISEASE,Keratosis palmoplantaris with esophageal cancer [Supplementary Concept],"Keratoderma, Palmoplantar|esophageal cancer|Esophageal Neoplasms"
NEW15365,CHEMICAL,inadequate antidiuretic hormone secretion,colchicine exposure
NEW15367,MENTAL_HEALTH,lycopene administration,haloperidol-induced orofacial dyskinesia special therapeutic effects
NEW15368,DISEASE,lycopene administration,TBI individuals
NEW15370,DISEASE,purmorphamine treatment,TBI fish
C542465,CHEMICAL,3-keto-N-aminoethylaminoethylcaproyldihydrocinnamoyl cyclopamine [Supplementary Concept],Cinnamates|cyclopamine|Veratrum Alkaloids
C000433,CHEMICAL,3-chloroperbenzoic acid [Supplementary Concept],meta-chloroperoxybenzoic acid|Chlorobenzoates
NEW15373,NUTRITION,water-soluble diacyl arsenosugar phospholipid,extracellular fatty acids
NEW15375,DISEASE,high neuroticism,gaming addiction
NEW15376,CHEMICAL,high neuroticism,β=0.06
NEW15377,CHEMICAL,high neuroticism,p<0.05
NEW15380,CHEMICAL,higher-fat diet,low HDL-cholesterol concentration
NEW15382,CHEMICAL,red onion,highest AOA
NEW15384,CHEMICAL,carbon onion,isopropanol alcohol
NEW15385,MENTAL_HEALTH,carbon onion,ultrasonic agitation
NEW15386,DISEASE,carbon onion,cancer cell death
NEW15387,MENTAL_HEALTH,carbon onion,schizophrenia substance dependence
NEW15388,DISEASE,carbon onion,crustacean eye
NEW15390,DISEASE,serotonin reuptake blocker,paraphilic disturbances
NEW15394,DISEASE,androgen receptor blockade,tic symptoms
NEW15395,DISEASE,androgen receptor blockade,tic symptom severity
NEW15397,CHEMICAL,lid nasal gel,hydroxypropyl methyl cellulose|HPMC
D001408,DISEASE,Bacillus anthracis,Bacillus anthracis
NEW15398,MENTAL_HEALTH,lid nasal gel,greater craving
C514862,DISEASE,"Akt1 protein, mouse [Supplementary Concept]",Proto-Oncogene Proteins c-akt|thymoma viral proto-oncogene
NEW15404,BIOCHEMICAL,safe antimicrobial peptide,food preservative
NEW15406,CHEMICAL,IMPORTANCE Nisin,selective serotonin reuptake inhibitor fluoxetine
NEW15407,DISEASE,IMPORTANCE Nisin,tumor suppression
NEW15408,DISEASE,IMPORTANCE Nisin,hyperactive protein translation
NEW15409,MENTAL_HEALTH,IMPORTANCE Nisin,particular dissociation kinetics
NEW15411,BIOCHEMICAL,opioid-induced respiratory depression,opioid receptor antagonist naloxone
NEW15412,CHEMICAL,opioid-induced respiratory depression,continuous naloxone infusion
NEW15413,CHEMICAL,opioid-induced respiratory depression,single naloxone dose
NEW15415,CHEMICAL,diazeniumdiolate amidine,useful NO donor compounds
NEW15416,DISEASE,[3h]rauwolscine,peripheral nerve catheters
D006591,CHEMICAL,Hexobarbital,"Evipan|hexobarbitone|Sodium Hexobarbital|Hexobarbital, Sodium|Hexobarbitone|Hexenal"
NEW15417,DISEASE,[3h]rauwolscine,experimental catatonia
NEW15419,CHEMICAL,alcoholic liver injury,long-term excessive alcohol consumption
NEW15420,BIOCHEMICAL,mitochondrial dysfunction,riboflavin supplementation
D033461,DISEASE,Hyperuricemia,Uric Acid (1963-2002)|hyperuricemia
NEW15424,DISEASE,significant xanthine oxidase inhibition,visceral pain perception
NEW15425,DISEASE,significant xanthine oxidase inhibition,recurrent wheezing
NEW15427,MENTAL_HEALTH,5-ht network,interferon (IFN)-induced depression
NEW15433,DISEASE,drug-induced parkinsonism,akinetic rigid syndrome
NEW15434,DISEASE,drug-induced parkinsonism,psychiatric patients drugs
NEW15435,BIOCHEMICAL,drug-induced parkinsonism,causative drug
NEW15436,DISEASE,drug-induced parkinsonism,persistent parkinsonism
NEW15438,DISEASE,irreversible dip,presymptomatic parkinsonian deficit
D014190,MENTAL_HEALTH,Transvestism,"transvestism|Transvestisms|Transvestic Fetishisms|Fetishisms, Transvestic|Fetishism, Transvestic|Transvestic Fetishism"
NEW15440,BIOCHEMICAL,bona endometrial precancer,endogenous hormones
NEW15441,MENTAL_HEALTH,bona endometrial precancer,specimen fragmentation
NEW15446,MENTAL_HEALTH,escherichia coli mastitis,local host defense mechanism
NEW15449,CHEMICAL,gaseous antigen,oxygen contact
NEW15451,DISEASE,hyper-sensitivity,human nervous system diseases
NEW15453,MENTAL_HEALTH,alcohol abuser,anticipatory stable conditioned response
NEW15454,MENTAL_HEALTH,alcohol abuser,aversive conditioned response
NEW15456,DISEASE,alcohol abuser,bodyweight loss
NEW15457,CHEMICAL,alcohol abuser,glucose level
NEW15458,DISEASE,alcohol abuser,disorder level rise
NEW15459,MENTAL_HEALTH,alcohol abuser,cycle mechanism
NEW15462,DISEASE,moderate alcohol consumption,metabolic alterations
NEW15463,DISEASE,moderate alcohol consumption,aggravating parkinsonism
NEW15464,MENTAL_HEALTH,moderate alcohol consumption,agonist-induced psychosis
NEW15465,MENTAL_HEALTH,3 week,3 weeks|dyskinesia rats
NEW15466,DISEASE,l-dopa-induced excessive dopamine release,L-DOPA-induced excessive dopamine release
NEW15468,DISEASE,distal tracheobronchial tree,severe pulmonary complications
D000067562,MENTAL_HEALTH,Late Onset Disorders,"Late Onset Diseases|Later Onset Disorder|Disorders, Later Onset|Late Onset Disorder|Disease, Late Onset|Onset Disorders, Later|Onset Disorder, Later|Disorder, Late Onset|Disorders, Late Onset|Disorder, Late-Onset|Onset Diseases, Late|Onset Disorders, Late|Disorder, Later Onset|Late-Onset Disorders|disorder onset|Late-Onset Disorder|Onset Disease, Late|Diseases, Late Onset|Late Onset Disease|Onset Disorder, Late|Later Onset Disorders|Disorders, Late-Onset"
NEW15472,DISEASE,non-selective beta-blocker related,hyperandrogenemia
NEW15473,BIOCHEMICAL,non-selective beta-blocker related,reproductive endocrine abnormalities
NEW15474,CHEMICAL,non-selective beta-blocker related,nicotine abstinence-alleviating effects
C580075,DISEASE,Familial Acute Myeloid Leukemia with Mutated Cebpa [Supplementary Concept],"acute myeloid leukaemia|Leukemia, Myeloid, Acute"
NEW15478,CHEMICAL,2-year-old asthmatic boy,(AV)-reentry tachycardia
http://purl.obolibrary.org/obo/UPHENO_0001001,DISEASE,phenotype,LQT3 phenotype
NEW15479,DISEASE,abort cardiac arrest,aborted cardiac arrest
NEW15481,DISEASE,thyroid hormone alpha,tissue-specific hypothyroidism
NEW15482,DISEASE,different sarcoma cell line,different sarcoma cell lines
NEW15484,MENTAL_HEALTH,specific ppardelta agonist,subsequent DNA fragmentation
NEW15485,DISEASE,specific ppardelta agonist,transient focal cerebral ischemia
NEW15487,DISEASE,ppardelta-mediated mir-15a inhibition,stroke-related vascular dysfunction
C536503,DISEASE,Thakker Donnai syndrome [Supplementary Concept],"Facies|Abnormalities, Multiple|structural anomalies|Muscular Atrophy"
NEW15490,DISEASE,dopamine receptor activation,behavioral disabilities
NEW15491,CHEMICAL,dopamine receptor activation,tGnRH-A
NEW15492,CHEMICAL,dopamine receptor activation,excess unlabeled tGnRH
NEW15498,NUTRITION,alcohol-induced tissue damage,impaired fatty acid
NEW15505,DISEASE,excessive alcohol user,frequent lung infections
NEW15506,BIOCHEMICAL,excessive alcohol user,poor antibiotic response
NEW15507,CHEMICAL,excessive alcohol user,cAMP levels
NEW15509,CHEMICAL,e. amylovora,streptomycin resistance
NEW15510,MENTAL_HEALTH,e. amylovora,apprehension
NEW15514,DISEASE,brain kyna level,TAA-induced ALF
NEW15516,DISEASE,imipramine administration,liver necrosis
NEW15518,DISEASE,ccl4 ml,CCl4-induced liver necrosis
NEW15520,DISEASE,long-term ethanol treatment,dMMR adenomas
NEW15521,CHEMICAL,hair calcium,hair calcium
NEW15522,MENTAL_HEALTH,psychotic disorder secondary,psychotic disorder secondary
NEW15524,CHEMICAL,behavioral agitation,risperidone mg
NEW15526,DISEASE,psychotic thinking,adolescent's cardiac illnesses
NEW15527,DISEASE,psychotic thinking,psychotic disorders due
NEW15533,BIOCHEMICAL,hiv disease,multiple prolonged drug regimens
NEW15535,DISEASE,mek inhibitor pd184352,human tumor xenograft models
NEW15539,CHEMICAL,nonselective sri clomipramine,selective norepinephrine reuptake inhibitor desipramine
NEW15540,DISEASE,nonselective sri clomipramine,hyperandrogenemia elevated blood pressure
NEW15541,CHEMICAL,nonselective sri clomipramine,first maternal cousin
D050612,NUTRITION,Fatty Acid Transport Proteins,Fatty Acid Transport Protein|Fatty Acid-Transport Protein|fatty acid transport proteins
C408462,CHEMICAL,"ACBP protein, Trypanosoma brucei [Supplementary Concept]",Intracellular Signaling Peptides and Proteins|Protozoan Proteins|ACBP
NEW15546,CHEMICAL,nutritional alteration,SS-high group
NEW15548,DISEASE,natural actomyosin,associated tissue loss
NEW15550,BIOCHEMICAL,jellyfish stinging cell,contact complex venoms
NEW15551,CHEMICAL,jellyfish stinging cell,potent proteinaceous porins
NEW15552,DISEASE,jellyfish stinging cell,neurotoxic peptides
NEW15554,DISEASE,venom component,innate hypersensitivity reactions
NEW15555,BIOCHEMICAL,venom component,retinol concentration
NEW15556,DISEASE,venom component,morphological impairment
NEW15557,DISEASE,p. xylostella,P. xylostella
NEW15559,DISEASE,superoxide level,malnutrition group
D001275,CHEMICAL,ATP Citrate (pro-S)-Lyase,"ATP Citrate Lyase|Synthase, ATP Citrate|Citrate Synthase, ATP|ATP Citrate (pro-3S)-Lyase|Lyase, ATP Citrate|Citrate Cleavage Enzyme|Lyase, ATP-Dependent Citrate|citrate synthase|ATP-Dependent Citrate Lyase|ATP Citrate Synthase|Cleavage Enzyme, Citrate|Citrate Lyase, ATP-Dependent|Citrate Lyase, ATP|ATP Dependent Citrate Lyase"
NEW15560,BIOCHEMICAL,dopamine agonist therapy dysregulation,dopamine agonist therapy dysregulation
NEW15562,DISEASE,hiv drug regiment,syndrome therapy
NEW15563,BIOCHEMICAL,hiv drug regiment,new antiviral agents
NEW15565,CHEMICAL,extrasynaptic nmda receptor,extrasynaptic NMDA receptors
NEW15566,BIOCHEMICAL,ad drug development,AD drug development
NEW15568,BIOCHEMICAL,antimicrobial use,good antimicrobial stewardship practices
NEW15570,CHEMICAL,resistance phenotype,faecium E. hirae
NEW15572,CHEMICAL,craving response,HGH release
NEW15573,CHEMICAL,craving response,dopamine receptor sensitivity
NEW15574,DISEASE,craving response,PSP patients
NEW15575,DISEASE,craving response,ocular disturbances
NEW15578,DISEASE,α-1 receptor subtype,compulsive gnawing
NEW15580,CHEMICAL,infusion muscimol,apomorphine effects
NEW15581,DISEASE,infusion muscimol,head-to-tail ipsiversive circling
NEW15583,DISEASE,various eet product,cancer tumor growth
NEW15584,BIOCHEMICAL,various eet product,date first-line oral glucose-lowering drug
NEW15587,DISEASE,ppar-gamma agonist,hand myocardial infarct size
NEW15589,CHEMICAL,ppar-gamma agonist rosiglitazone,PTEN(+/)(-)murine model
NEW15599,CHEMICAL,indirectly-acting sympathomimetic amine,minimal tyramine potentiation
NEW15605,MENTAL_HEALTH,copper rockfish,changes hyperactivity
NEW15607,MENTAL_HEALTH,acute vx-745 application,resistance arteries
NEW15609,DISEASE,common chronic liver disease,hepatic steatosis due
NEW15610,DISEASE,androgen deprivation therapy,castration-resistant prostate cancer
NEW15613,CHEMICAL,pb(ac)2 exposure,interleukin (IL)-1β
C565157,DISEASE,"Corneal Degeneration, Ribbonlike, with Deafness [Supplementary Concept]","Deafness/congenital|keratopathy|Corneal Dystrophies, Hereditary"
D015352,DISEASE,Dry Eye Syndromes,"Dry Eyes|Dry Eye Syndrome|Evaporative Dry Eye Syndrome|Dry Eye Diseases|Dry Eye Disease|Evaporative Dry Eye Disease|Dry Eye, Evaporative|Evaporative Dry Eyes|Evaporative Dry Eye|dry eye|Dry Eye"
D000075363,DISEASE,Immunoglobulin Light-chain Amyloidosis,"Systemic Amyloidoses, Primary|Amyloidosis, Immunoglobulin Light chain|Amyloidosis, Primary Systemic|Primary Systemic Amyloidoses|Immunoglobulin Light-chain Amyloidoses|Primary Amyloidoses|Amyloidosis, Primary|Amyloidoses, Primary Systemic|Primary Systemic Amyloidosis|systemic amyloidoses|Immunoglobulin Light chain Amyloidosis|Amyloidoses, Primary|AL Amyloidosis|Primary Amyloidosis|Amyloidosis, Immunoglobulin Light-chain|AL Amyloidoses|Systemic Amyloidosis, Primary"
NEW15615,DISEASE,ape administration,human disorders
NEW15617,CHEMICAL,specie glycoursodeoxycholic acid,TNF-α production
NEW15618,DISEASE,specie glycoursodeoxycholic acid,tumour necrosis factor (TNF)-α production
NEW15619,CHEMICAL,specie glycoursodeoxycholic acid,glutathione production
NEW15621,MENTAL_HEALTH,bivalent cation,BPM resistance
NEW15623,CHEMICAL,lanthane,calcium conductivity
NEW15625,CHEMICAL,long chain polyunsaturated fatty acid level,magnesium sulphate infusion
NEW15626,DISEASE,long chain polyunsaturated fatty acid level,congenital long QT syndrome
NEW15629,DISEASE,functional single nucleotide polymorphism present,violent behavior
NEW15631,DISEASE,val allele,homicidal behavior
NEW15632,DISEASE,sex steroid,birth defects other
NEW15635,DISEASE,folic acid fortification,specific birth defects
NEW15636,DISEASE,folic acid fortification,atypical HLH transcriptional regulators
NEW15637,DISEASE,folic acid fortification,diabetic populations
NEW15638,CHEMICAL,adhd symptom,ATR|anterior thalamic radiation
NEW15639,BIOCHEMICAL,adhd symptom,beta modulation
NEW15642,DISEASE,iron supplementation,anemia cases
NEW15643,CHEMICAL,iron supplementation,serotonin synthesizing apparatus
NEW15644,CHEMICAL,iron supplementation,transsulfuration pathway abnormalities
NEW15645,MENTAL_HEALTH,iron supplementation,complex syndromes
C503840,CHEMICAL,dieckol [Supplementary Concept],dieckol|Benzofurans
NEW15647,DISEASE,phase-high performance chromatography method,Eisenia bicyclis
NEW15648,NUTRITION,phase-high performance chromatography method,major phlorotannins
C064093,CHEMICAL,phlorofucofuroeckol A [Supplementary Concept],phlorofucofuroeckol-A|Dioxins|Benzofurans
NEW15649,CHEMICAL,l-dopa reuptake inhibitor,l-DOPA reuptake inhibitors
NEW15650,BIOCHEMICAL,pxr agonist,PXR agonist
NEW15652,CHEMICAL,rifampicin-treate alcl3-rat,nitrite level
NEW15656,BIOCHEMICAL,extensive gut dysbiosis,neurotoxin levels
NEW15657,DISEASE,extensive gut dysbiosis,neurodevelopmental damage
NEW15660,DISEASE,dose mg/kg,typical motor syndrome
D020240,MENTAL_HEALTH,"Apraxia, Ideomotor","Apraxia, Classic|Limb Kinetic Apraxia|Ideomotor Apraxias|Dyspraxias, Ideomotor|Kinetic Apraxia, Limb|Classic Apraxia|Kinetic Apraxias, Limb|Ideomotor Dyspraxias|Apraxias, Classic|Limb Kinetic Apraxias|Transcortical Apraxia|Ideomotor Dyspraxia|Apraxia, Limb Kinetic|Ideokinetic Apraxia|apraxia|Transcortical Apraxias|Apraxias, Transcortical|Apraxia, Ideokinetic|Apraxias, Limb Kinetic|Dyspraxia, Ideomotor|Ideokinetic Apraxias|Classic Apraxias|Apraxias, Ideomotor|Apraxia, Transcortical|Ideomotor Apraxia|Apraxias, Ideokinetic"
NEW15662,CHEMICAL,low melatonin secretion,flumazenil group
NEW15663,BIOCHEMICAL,low melatonin secretion,main toxic substance
NEW15665,CHEMICAL,s. platensis,NO bioavailability
NEW15666,CHEMICAL,s. platensis,TAC|cavernous total antioxidant capacity
NEW15668,CHEMICAL,capsaicin-mediated bradycardia,± bpm
D050598,CHEMICAL,Vesicular Glutamate Transport Protein 1,Brain Specific Na Dependent Inorganic Phosphate Cotransporter|VGLUT1|Vesicular Glutamate Transporter 1|VGLUT1 Protein|BNPI Protein|Brain-Specific Na-Dependent Inorganic Phosphate Cotransporter|vesicular glutamate transporter 1
NEW15669,CHEMICAL,Fomosan,Fomosan
NEW15671,DISEASE,death due,alcohol-related traffic accident
NEW15673,CHEMICAL,alcohol liver disease,daily alcohol consumption
C050296,CHEMICAL,metsulfuron methyl [Supplementary Concept],tribenuron-methyl|Arylsulfonates
C037991,CHEMICAL,"2,4-D amine [Supplementary Concept]","2,4-D|Dimethylamines|2,4-Dichlorophenoxyacetic Acid"
C010974,CHEMICAL,glyphosate [Supplementary Concept],Glycine/analogs  and  derivatives|glyphosate
NEW15677,CHEMICAL,high-level resistance,RT deoxynucleoside-triphosphate
NEW15679,MENTAL_HEALTH,3'-azido-3'-deoxythymidine azt,disease psychosis
NEW15680,DISEASE,3'-azido-3'-deoxythymidine azt,Parkinson's disease psychosis
NEW15683,MENTAL_HEALTH,apoe4 carrier,Blessed Dementia Scale
NEW15692,DISEASE,antidepressant therapy,spontaneous intracerebral hemorrhage
NEW15694,DISEASE,high serum uric acid ua level,depressed inpatients
NEW15695,CHEMICAL,high serum uric acid ua level,losartan treatment
NEW15697,CHEMICAL,frailty score,serum losartan
C073600,CHEMICAL,"2-butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-carboxaldehyde [Supplementary Concept]",EXP3179|Losartan/analogs  and  derivatives
D053218,DISEASE,"Receptors, Death Domain","death receptors|Receptors, DR Family|Receptors, Death Domain Family|Death Receptor|Death Domain Receptors|DR Family Receptors|Receptor, Death|Death Receptors"
NEW15700,CHEMICAL,steroid phobia,immunosuppressed CD163high CD206high tumor-associated macrophages
D059016,DISEASE,Tumor Microenvironment,"Microenvironment, Cancer|tumor microenvironment|Cancer Microenvironment|Tumor Microenvironments|Microenvironments, Tumor|Microenvironment, Tumor|Cancer Microenvironments|Microenvironments, Cancer"
C000712172,BIOCHEMICAL,thiamine hydrochloride [Supplementary Concept],thiamine hydrochloride|Thiamine/analogs  and  derivatives
NEW15702,MENTAL_HEALTH,acid analysis,irritability mental retardation
NEW15706,DISEASE,uro-s,autosomal recessive disorder
D017092,DISEASE,"Porphyria, Erythropoietic","Erythropoietic Porphyria|Erythropoietic Porphyrias|Congenital Erythropoietic Porphyria|UROS Deficiency|Porphyrias, Congenital Erythropoietic|Deficiency of Uroporphyrinogen III Synthase|Gunthers Disease|Uroporphyrinogen III Synthase, Deficiency of|congenital erythropoietic porphyria|Porphyrias, Erythropoietic|Porphyria, Congenital Erythropoietic|Erythropoietic Porphyrias, Congenital|Gunther Disease|Congenital Erythropoietic Porphyrias|Erythropoietic Porphyria, Congenital|Porphyria, Erythropoietic, Congenital|Gunther's Disease"
NEW15709,NUTRITION,trna3lys,RT tryptophan fluorescence
NEW15712,DISEASE,plasma adrenaline,phobic patients
NEW15713,CHEMICAL,plasma adrenaline,diazapam mg/kg body weight
NEW15714,CHEMICAL,plasma adrenaline,prolonged NMDA receptor activation
NEW15716,DISEASE,increase plasma homocysteine,pathological disorders
D000026,DISEASE,"Abortion, Habitual","Abortion, Recurrent|Recurrent Miscarriage|Habitual Abortions|Habitual Abortion|Recurrent Abortion|Recurrent Early Pregnancy Loss|recurrent abortions|Miscarriage, Recurrent|Recurrent Miscarriages|Recurrent Abortions"
NEW15718,MENTAL_HEALTH,copper ammunition,minimal fragmentation
NEW15720,CHEMICAL,Tau amyloid-β generation,Tau Amyloid-β generation
NEW15722,DISEASE,a. indica,oil-induced diarrhea severity
NEW15724,MENTAL_HEALTH,alcohol amblyopia,tobacco abuse
NEW15728,DISEASE,aristata extract,testicular damage
NEW15729,DISEASE,aristata extract,TB|first-line anti-tuberculosis
NEW15730,DISEASE,aristata extract,tuberculosis treatment
NEW15731,DISEASE,vertebral mineralization,vertebral mineralization
NEW15733,DISEASE,bmp antagonist,numerous human connective tissue disorders
NEW15735,DISEASE,folie à double forme,folie circulaire
NEW15736,MENTAL_HEALTH,folie à double forme,higher resistance
D016736,DISEASE,Antiphospholipid Syndrome,"Anti Phospholipid Syndrome|APS|anti-phospholipid syndrome|Antiphospholipid Antibody Syndromes|Syndrome, Antiphospholipid Antibody|Syndrome, Anti-Phospholipid Antibody|Antibody Syndrome, Antiphospholipid|Antibody Syndrome, Anti-Phospholipid|Syndrome, Antiphospholipid|Hughes Syndrome|Syndrome, Anti-Phospholipid|Syndrome, Hughes|Anti-Phospholipid Syndrome|Antiphospholipid Antibody Syndrome|Anti Phospholipid Antibody Syndrome|Anti-Phospholipid Antibody Syndrome"
NEW15739,DISEASE,serotonin abnormality,syndrome patients
NEW15741,NUTRITION,least-square regression model,shikimic acid concentrations
NEW15742,MENTAL_HEALTH,least-square regression model,SPSS regression analysis
NEW15744,BIOCHEMICAL,homozygous sip1 mouse,respective receptor agonists
NEW15747,BIOCHEMICAL,vital endocrine organ,endocrine pathways
NEW15748,DISEASE,prenatal alcohol exposure,detrimental alcohol-induced defects
NEW15749,DISEASE,prenatal alcohol exposure,neurobehavioral deficits
NEW15750,CHEMICAL,prenatal alcohol exposure,oxidized phosphatidylcholines
NEW15751,NUTRITION,prenatal alcohol exposure,oxidized phospholipids
NEW15752,CHEMICAL,gut microbiota dysbiosis,serum 25(OH)D3 levels
NEW15753,BIOCHEMICAL,gut microbiota dysbiosis,vitamin D treatment
NEW15754,MENTAL_HEALTH,gut microbiota dysbiosis,moderate ADHD
NEW15756,MENTAL_HEALTH,bipolar adolescent,co-occurring alcohol dependence
NEW15758,CHEMICAL,selenium status,5HT2C receptor gene mutation
NEW15760,BIOCHEMICAL,correspond endocrine syndrome,multiple endocrine neoplasias
NEW15761,DISEASE,correspond endocrine syndrome,susceptibility to multiple endocrine neoplasias|MEN
NEW15763,CHEMICAL,other non-short-stature indication,cerebral Trp availability
NEW15766,DISEASE,levodopa-treated parkinson patient,psychotic mania symptoms
NEW15767,BIOCHEMICAL,"parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","Parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"
C011767,CHEMICAL,clopyralid [Supplementary Concept],clopyralid|Picolinic Acids
NEW15770,DISEASE,non-ischemic heart failure,sustained tachyarrhythmias
NEW15772,DISEASE,heart failure entity,impaired coronary blood flow
NEW15777,DISEASE,g-protein-activated inwardly rectifying potassium girk channel,cold pain
NEW15778,CHEMICAL,g-protein-activated inwardly rectifying potassium girk channel,milk-cereal drink|Horlicks
NEW15779,CHEMICAL,g-protein-activated inwardly rectifying potassium girk channel,ribonucleic acid levels
NEW15780,DISEASE,g-protein-activated inwardly rectifying potassium girk channel,histamine-induced catalepsy
NEW15785,MENTAL_HEALTH,α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid ampa receptor glua1 subunit-deficient glua1-/- mouse,novelty-induced hyperactivity
NEW15786,DISEASE,α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid ampa receptor glua1 subunit-deficient glua1-/- mouse,cognitive defects
NEW15788,DISEASE,cognition loss,resultant hypotension
NEW15790,DISEASE,combined nutraceutical supplement,early metabolic alterations
D004714,DISEASE,Endometrial Hyperplasia,"Simple Endometrial Hyperplasia|Hyperplasias, Simple Endometrial|Complex Endometrial Hyperplasias|Endometrial Hyperplasia, Atypical|Endometrial Hyperplasia, Simple|Hyperplasias, Atypical Endometrial|Simple Endometrial Hyperplasias|Hyperplasia, Endometrial|Endometrial Hyperplasias, Complex|Atypical Endometrial Hyperplasia|Hyperplasia, Simple Endometrial|Endometrial Hyperplasias, Atypical|Hyperplasias, Complex Endometrial|Hyperplasia, Complex Endometrial|Endometrial Hyperplasia, Complex|Hyperplasia, Atypical Endometrial|Hyperplasias, Endometrial|Complex Endometrial Hyperplasia|Atypical Endometrial Hyperplasias|Endometrial Hyperplasias|Endometrial Hyperplasias, Simple|endometrial hyperplasia"
NEW15791,DISEASE,breast cancer risk,influenza encephalopathy
NEW15794,DISEASE,significant quick-eze use,functional hepatic urea cycle
NEW15797,MENTAL_HEALTH,hypomethylating agent azacitidine,higher risk myelodysplastic syndromes
NEW15799,CHEMICAL,hypomethylating agent azacitidine,low-dose chemotherapy
NEW15801,DISEASE,aza-7,leukemia transformation
NEW15802,DISEASE,aza-7,excess blasts|RAEB
NEW15805,MENTAL_HEALTH,gaba alteration,hyperarousal symptoms
NEW15808,MENTAL_HEALTH,rsno,solvent displacement method
NEW15811,MENTAL_HEALTH,novel antibacterial agent,rapid displacement
NEW15813,CHEMICAL,elderly hypertensive male patient,[3H]N-methyl scopolamine-binding activity
NEW15815,DISEASE,serotonin synthesis production,neuropsychiatric disorders similar
NEW15817,CHEMICAL,aqueous nymphaea lotus extract,picrotoxin- seizures
NEW15818,DISEASE,aqueous nymphaea lotus extract,spontaneous recurrent seizures
NEW15819,DISEASE,aqueous nymphaea lotus extract,neurotoxins-induced seizures
NEW15820,DISEASE,aqueous nymphaea lotus extract,penile dysfunction
NEW15822,DISEASE,l-name chronic intake,male sexual behaviour
NEW15824,DISEASE,nymphea lotus,hypertensive male rats
D000077868,CHEMICAL,Atrasentan,"(11C)ABT-627|ABT627|2-(4-Methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(((dibutylamino)carbonyl)methyl)pyrrolidine-3-carboxylic acid|atrasentan|A127722.5|Atrasentan Hydrochloride|A 127722|A 127722.5|A-127722.5|A-147627|A147627|ABT 627|ABT-627|Xinlay|A-127722|A 147627|A127722"
http://purl.obolibrary.org/obo/DOID_11130,DISEASE,secondary hypertension,secondary hypertension
C073972,NUTRITION,dimethyl mercury [Supplementary Concept],Methylmercury Compounds|dimethyl mercury
NEW15829,BIOCHEMICAL,aid liver drug metabolism,AID liver drug metabolism
NEW15831,DISEASE,such pns sow,abnormal maternal behaviour
NEW15832,DISEASE,self-reported delusion,alcohol disorder
NEW15835,BIOCHEMICAL,excited delirium syndrome,sympathomimetic surge
NEW15836,MENTAL_HEALTH,excited delirium syndrome,marked agitation
NEW15839,MENTAL_HEALTH,prehospital ketamine,excited delirium
NEW15841,DISEASE,adrenocorticotrophic hormone rat model,cognitive senescence
NEW15845,CHEMICAL,lithium mood stabilizer,GD symptoms
NEW15846,CHEMICAL,lithium mood stabilizer,different DAA receptors
NEW15848,MENTAL_HEALTH,selective da-1 agonist,renal vascular resistance
C504483,DISEASE,"IQSEC1 protein, human [Supplementary Concept]",Guanine Nucleotide Exchange Factors|human ARF
NEW15850,BIOCHEMICAL,peripheral thyroid hormone action compatible,approved biased agonist oliceridine
NEW15851,BIOCHEMICAL,peripheral thyroid hormone action compatible,biased MOR agonists
NEW15853,DISEASE,respiration depression,single hepatotoxic dose
NEW15855,MENTAL_HEALTH,dibenzazepine mg/kg,greater repression
D013287,BIOCHEMICAL,Illicit Drugs,"Club Drugs|Illegal Drug|Drug, Illicit|Recreational Drugs|Drug, Illegal|Street Drug|Drugs, Street|Drugs, Illicit|Illegal Drugs|Drugs, Illegal|Drug, Recreational|Drugs, Club|Club Drug|Street Drugs|Drugs, Recreational|club drug|Recreational Drug|Illicit Drug|Drug, Club|Drug, Street"
D043586,CHEMICAL,Methylmalonyl-CoA Decarboxylase,"Decarboxylase, Methylmalonyl-CoA|Propionyl-Coenzyme A Carboxylase|Propionyl Coenzyme A Carboxylase|Methylmalonyl CoA Decarboxylase|Propionyl CoA Carboxylase|Carboxylase, Propionyl-Coenzyme A|propionyl coenzyme A|Propionyl-CoA Carboxylase"
NEW15856,CHEMICAL,dibenzazepine mg/kg,acetyl CoA. disorder
NEW15857,CHEMICAL,dibenzazepine mg/kg,carboxylases pyruvate
NEW15859,DISEASE,trinitrate ointment,chronic anal fissure
NEW15862,DISEASE,antibiotic resistant,early stage colon cancer
NEW15864,BIOCHEMICAL,5-fu resistance,drug transport
D054067,CHEMICAL,Dihydropyrimidine Dehydrogenase Deficiency,"Dehydrogenase Deficiency, Dihydropyrimidine|Deficiencies, Dihydropyrimidine Dehydrogenase|Dihydropyrimidinurias|Thymine Uraciluria, Hereditary|Familial Pyrimidemia|Deficiencies, DPD|Hereditary Thymine Uraciluria|Deficiency, Dihydropyrimidine Dehydrogenase|Dihydropyrimidinuria|Thymine-Uraciluria, Hereditary|Familial Pyrimidinemia|DPD Deficiencies|Familial Pyrimidinemias|Familial Pyrimidemias|Pyrimidemias, Familial|Pyrimidinemia, Familial|Pyrimidemia, Familial|Thymine-Uracilurias, Hereditary|dihydropyrimidine dehydrogenase|DPD Deficiency|Dehydrogenase Deficiencies, Dihydropyrimidine|Deficiency, DPD|Dihydropyrimidine Dehydrogenase Deficiencies|Hereditary Thymine-Uracilurias|Hereditary Thymine-Uraciluria|Pyrimidinemias, Familial"
NEW15868,DISEASE,thyrotoxic periodic paralysis,dose-dependent cardiotoxicity
NEW15869,DISEASE,thyrotoxic periodic paralysis,anthracycline-induced cardiotoxicity
NEW15871,DISEASE,class statin,neurotransmitter abnormalities
NEW15873,DISEASE,severe mood episode,naloxone-precipitated withdrawal syndrome
NEW15875,DISEASE,nicotinic acetylcholine receptor subtype inhibitor,acute dependence
NEW15876,DISEASE,nicotinic acetylcholine receptor subtype inhibitor,schizophrenic women
NEW15877,DISEASE,nicotinic acetylcholine receptor subtype inhibitor,toxic multinodular goiter
NEW15878,DISEASE,nicotinic acetylcholine receptor subtype inhibitor,toxic adenoma
NEW15880,CHEMICAL,overt hyperthyroidism,thyroxine values
NEW15882,CHEMICAL,subclinical hyperthyroidism,radioactive iodine ablation
NEW15884,MENTAL_HEALTH,ensue inflammation,mental confusion
NEW15885,BIOCHEMICAL,ensue inflammation,vitamin B3 deficiency
NEW15886,BIOCHEMICAL,ensue inflammation,vitamin B3 fortification programs
NEW15888,CHEMICAL,nad+ metabolism,NAD+ biosynthetic pathway
NEW15890,CHEMICAL,host 's nad+ salvage pathway,COVID-19 severity
D041221,DISEASE,Candida glabrata,Torulopsis glabrata|Candida
D003883,DISEASE,Arthrodermataceae,"Cutaneous Fungus|Arthrodermas|Arthroderma|Nannizzias|Dermatophytes|Dermatomyces|dermatophytes|Nannizzia|Fungus, Cutaneous|Keratinomyces|Cutaneous Fungi|Ctenomyce|Ctenomyces|Keratinomyce|Fungi, Cutaneous|Dermatophyte|Dermatomyce"
D001236,DISEASE,Aspergillus oryzae,Eurotium oryzae|Aspergillus
NEW15892,DISEASE,simple oxygenated xanthone,moderate-to-severe cognitive impairment related
NEW15896,BIOCHEMICAL,erythropoietin resistance index,agent responsiveness
NEW15898,DISEASE,hormone therapy,ASDs|to autism spectrum disorders
NEW15899,MENTAL_HEALTH,hormone therapy,Autism Genetic Resource Exchange
NEW15901,BIOCHEMICAL,low vitamin d,beta activity
NEW15902,MENTAL_HEALTH,low vitamin d,insomnia management
NEW15903,CHEMICAL,low vitamin d,glutamate molecule
NEW15905,MENTAL_HEALTH,Montmorency tart cherry juice,visual distractibility threshold
NEW15907,DISEASE,adjunctive tiagabine,aggressive outbursts
NEW15909,DISEASE,diet-induced obesity,pre-existing obesity
NEW15912,CHEMICAL,±6.42 %,±6.42 %
NEW15914,DISEASE,pancreatic cell damage,pancreatic cell damage
NEW15915,DISEASE,high-fat diet-induced obesity,high-fat diet-induced obesity
NEW15916,MENTAL_HEALTH,nonaddictive analgesia,nonaddictive analgesia
NEW15917,DISEASE,nutritional impairment,nutritional impairments
NEW15919,DISEASE,atypical vesicular glutamate transporter type 3,l-DOPA-induced phosphorylation
C431939,BIOCHEMICAL,carotenoid cleavage dioxygenase 1 [Supplementary Concept],Dioxygenases|carotenoid
NEW15920,MENTAL_HEALTH,atypical vesicular glutamate transporter type 3,Depression Inventory-II
C038678,CHEMICAL,N-methylpyrrolidone [Supplementary Concept],Pyrrolidinones|NMP|N-methylpyrrolidone
NEW15923,DISEASE,ampa-type glutamate receptor,alprazolam-induced spatial deficits
NEW15925,BIOCHEMICAL,endogenous acetylcholine,novel cholinomimetic agents
NEW15927,MENTAL_HEALTH,endogenous ach,regression equation
NEW15929,DISEASE,treatment-resistant depressive,treatment-resistant depressives
NEW15931,DISEASE,nmdar antagonist administration,models anxiety- behaviors
NEW15932,DISEASE,depressive phenotype,depressive phenotype
NEW15934,MENTAL_HEALTH,profound insomnia,profound insomnia
D010845,DISEASE,Obesity Hypoventilation Syndrome,"Obesity-Hypoventilation Syndromes|Pickwickian Syndrome|Obesity-Hypoventilation Syndrome|Hypoventilation Syndrome, Obesity|hypoventilation"
NEW15936,CHEMICAL,central neurogenic hypoventilation,anti-N-methyl-d-aspartate receptor antibody encephalitis
D012135,DISEASE,Respiratory Sounds,"Sounds, Breathing|Wheezings|Sound, Respiratory|Crackles|Breathing Sound|Wheezing|Breathing Sounds|Respiratory Sound|Rhonchi|Rhonchus|Stridor|Lung Sound|Rales|Lung Sounds|stridor|Rale|Stridors|Pleural Rub|Pleural Rubs|Sound, Breathing|Sound, Lung|Sounds, Lung|Rub, Pleural|Crackle"
NEW15938,DISEASE,combined serotonin,extrapyramidal motor symptoms
NEW15940,DISEASE,h(1)-histamine receptor blocker,supraventricular PB
NEW15942,DISEASE,Quifanidine,sinus node depression
NEW15944,CHEMICAL,low cholesterol,cholesterolemia
NEW15946,CHEMICAL,hematopathologic finding,unexplained cytopenia(s
NEW15950,CHEMICAL,prazosin addition,number ISRCTN61562706
NEW15953,MENTAL_HEALTH,acridinecarboxamide topoisomerase poison,molecular rationalization
NEW15957,CHEMICAL,nmdar-dependent bursting activity,rapid antidepressant actions
NEW15958,MENTAL_HEALTH,nmdar-dependent bursting activity,depression pathogenesis
NEW15960,CHEMICAL,functional fragile x mental retardation protein,synaptic metabotropic glutamate receptors
NEW15962,CHEMICAL,pi3 k signaling,hydrate chloral
NEW15963,NUTRITION,pi3 k signaling,omega-3 polyunsaturated fatty acids
NEW15965,CHEMICAL,pi3 k signaling,increased plasma norepinephrine
C534342,CHEMICAL,drospirenone and ethinyl estradiol combination [Supplementary Concept],Androstenes|drospirenone|Ethinyl Estradiol|DRSP
NEW15967,BIOCHEMICAL,to oseltamivir carboxylate,ruined carriers
NEW15969,CHEMICAL,androgenetic alopecia aga management,TGD|gender-diverse
NEW15970,CHEMICAL,androgenetic alopecia aga management,gas extraction
NEW15971,CHEMICAL,androgenetic alopecia aga management,silicone fiber-based membrane-dialyzer assembly
NEW15972,MENTAL_HEALTH,androgenetic alopecia aga management,direct purging
D014946,DISEASE,Wound Infection,"Infection, Wound|Infections, Wound|Wound Infections|wound infection"
NEW15974,DISEASE,gas sensor,tumor behaviors
NEW15976,DISEASE,transient receptor potential vanilloid type1 agonist,anaplastic thyroid cancer cells
D006334,DISEASE,Heart Function Tests,"Heart Function Test|Function Test, Cardiac|Tests, Cardiac Function|Test, Heart Function|Function Tests, Heart|Tests, Heart Function|Function Tests, Cardiac|Cardiac Function Tests|heart function|Function Test, Heart|Test, Cardiac Function|Cardiac Function Test"
NEW15980,CHEMICAL,erectile dysfunction present,protaglandins
NEW15982,DISEASE,frog wsc,passive-protective behavior
NEW15984,CHEMICAL,catalepsy homologue,high dopamine content
NEW15985,BIOCHEMICAL,catalepsy homologue,μ-opioid receptor agonist DAMGO
NEW15987,CHEMICAL,negative schizophrenia,gamma-aminobutyric acid GABAA receptor subunits
NEW15990,CHEMICAL,hallucinogen persist perception disorder,hallucinogen persisting perception disorder
NEW15991,DISEASE,partial onset seizure,partial onset seizures
D001913,DISEASE,Bowen's Disease,"Disease, Bowen's|Bowens Disease|Bowen's disease|Disease, Bowen|Bowen Disease"
NEW15994,CHEMICAL,organic skin disease,(ER)-mediated pathway activation
NEW15998,DISEASE,activity-based anorexia,advanced COPD stages
NEW15999,DISEASE,activity-based anorexia,COPD stages
NEW16000,DISEASE,activity-based anorexia,COPD pathogenesis
NEW16004,DISEASE,somatic anxiety,Postoperative pain scores
D006998,MENTAL_HEALTH,Hypochondriasis,"Neurosis, Hypochondriacal|Hypochondriacal Neurosis|hypochondriasis|Hypochondriacal Neuroses"
NEW16006,DISEASE,psychosocial dysadaptation,psychosocial dysadaptation
NEW16007,CHEMICAL,transepithelial electrical resistance,potassium ions
NEW16011,CHEMICAL,transmitter release,NO signalling pathway
NEW16014,DISEASE,gabaa agonist midazolam,devastating cerebral injuries
NEW16015,CHEMICAL,gabaa agonist midazolam,current second-line combination treatment
NEW16017,BIOCHEMICAL,nmdar antagonist s-ketamine,cytokinin receptor family
NEW16019,DISEASE,primary root growth promotion,arterial thromboembolism
NEW16020,CHEMICAL,primary root growth promotion,R-warfarin
NEW16022,DISEASE,ppar-γ agonist pioglitazone,Klebsiella pneumonia
NEW16024,DISEASE,14n nuclear quadrupole coupling hyperfine structure,DS pneumonias
NEW16026,DISEASE,14n nuclear quadrupole coupling hyperfine structure,delayed onset catatonia
NEW16027,MENTAL_HEALTH,14n nuclear quadrupole coupling hyperfine structure,COVID-induced brief psychotic disorder
NEW16028,DISEASE,14n nuclear quadrupole coupling hyperfine structure,AKI kidney injury
NEW16029,CHEMICAL,14n nuclear quadrupole coupling hyperfine structure,elevated dNTPs
NEW16033,DISEASE,schizophrenia abnormal gene,trauma memory
NEW16037,MENTAL_HEALTH,logistic regression model,logistic regression models
NEW16039,DISEASE,physician-confirmed food allergy,physician-confirmed food allergies
D009004,CHEMICAL,Monosaccharide Transport Proteins,"Glucose Transport Inducing Protein|Erythrocyte Band 4.5 Protein|Transport-Inducing Protein, Glucose|Preactin, Band 4.5|Band 4.5 Preactin|Hexose Transport Proteins|Transport Proteins, Monosaccharide|monosaccharide|4.5 Preactin, Band|Glucose Transport-Inducing Protein|Proteins, Monosaccharide Transport|Hexose Transporter|Transport Proteins, Hexose"
NEW16040,DISEASE,gut microbiota alteration,gut microbiota alterations
NEW16043,NUTRITION,intrauterine growth retardation iugr neonatus,lower cholesterol concentrations
NEW16045,NUTRITION,intrauterine growth retardation iugr neonatus,snow crab fishing industry
NEW16049,MENTAL_HEALTH,flexible 32-channel polymer microelectrode array,schizophrenia model
NEW16050,BIOCHEMICAL,polymer formation,polymer formation
NEW16052,MENTAL_HEALTH,testosterone supplementation,distressful low desire disorder
NEW16055,CHEMICAL,serum homocysteine,plasma Abeta levels
D065708,DISEASE,Porencephaly,"Type 1 Porencephaly|Brain Small-Vessel Disease with Hemorrhage|Porencephalies|Infantile Hemiplegia with Porencephaly|Post traumatic Porencephaly|Post-traumatic Porencephalies|Autosomal Dominant Porencephaly Type 1|Porencephaly, Posttraumatic|Familial Porencephalic White Matter Disease|Congenital Porencephaly|Posttraumatic Porencephaly|Porencephaly, Encephaloclastic|Encephaloclastic Porencephaly|Brain Small Vessel Disease With Axenfeld-Rieger Anomaly|Porencephaly, Post-traumatic|Porencephalies, Post-traumatic|Porencephaly, Type 1, Autosomal Dominant|Porencephaly, Familial|Leukoencephalopathy with Axenfeld-Rieger Anomaly|Porencephaly, Congenital|Familial Porencephaly|Porencephaly, Type 1|Developmental Porencephaly|Porencephaly, Developmental|Posttraumatic Porencephalies|small vessel disease|Porencephaly Type 1|Leukoencephalopathy with Axenfeld Rieger Anomaly|Post-traumatic Porencephaly|Brain Small Vessel Disease With Axenfeld Rieger Anomaly|Retinal Arteriolar Tortuosity, Infantile Hemiparesis, and Leukoencephalopathy, Autosomal Dominant|Col4a1 Related Brain Small Vessel Disease|Porencephalies, Posttraumatic|Brain Small Vessel Disease with Hemorrhage|Col4a1-Related Brain Small-Vessel Disease"
NEW16057,DISEASE,vitamin intervention,Stroke Prevention
D061985,DISEASE,Madin Darby Canine Kidney Cells,"MDCK Cell|Cell, MDCK|MDCK Cells|kidney|Cells, MDCK"
NEW16060,CHEMICAL,high-carbohydrate diet,triglyceride concentrations
NEW16062,NUTRITION,high carbohydrate level,cholesterol synthesis
NEW16064,BIOCHEMICAL,characterize virulence factor,AB-type toxin
NEW16066,NUTRITION,mda-mb-231 breast cancer cell,phosphatidylserine disruption
NEW16070,DISEASE,germ cell tumor risk,hemochromatosis gene|HFE
NEW16071,DISEASE,germ cell tumor risk,male breast cancer risk
NEW16074,CHEMICAL,estrogen molecule,hepatic glucose production
C052407,CHEMICAL,"HGP-30 peptide, Human immunodeficiency virus-1 [Supplementary Concept]","gag Gene Products, Human Immunodeficiency Virus|Peptides|HGP|HIV Antigens"
NEW16075,CHEMICAL,response to thyrotropin-releasing hormone,tetrodotoxin solution
NEW16077,DISEASE,4-(4-hydroxyphenyl)-2-butanone,weight loss supplement
NEW16078,DISEASE,severe hypersensitivity reaction,severe hypersensitivity reactions
NEW16079,DISEASE,oral hypoaesthesia,oral hypoaesthesia
NEW16081,DISEASE,phospholipid vesicle,intravascular clotting
NEW16082,DISEASE,phospholipid vesicle,hyperkinetic movement disorders
D006529,DISEASE,Hepatomegaly,"Liver, Enlarged|hepatomegaly|Enlarged Liver"
NEW16084,MENTAL_HEALTH,antibiotic-resistant iturin c,resistance potential
NEW16086,DISEASE,first rrr pattern,residual schizophrenic symptoms
NEW16088,CHEMICAL,various brain tumor,[18F]FDG PET
NEW16092,MENTAL_HEALTH,depression rating scale,depression rating scale
D000405,MENTAL_HEALTH,Akinetic Mutism,"Vigil, Coma|Coma Vigil|Akinetic Mutisms|Autism, Akinetic|Vigils, Coma|Mutism, Akinetic|akinetic mutism|Akinetic Autism|Coma Vigilans"
NEW16094,DISEASE,tacrolimus treatment,tacrolimus-induced neuropsychiatric symptoms
NEW16095,DISEASE,tacrolimus treatment,coronavirus pandemic
NEW16098,DISEASE,asai-mutant,maturing biofilm
NEW16102,CHEMICAL,deficit patient,"16,061"
NEW16104,DISEASE,antiviral drug toxicity,noninfectious organ diseases
D000077733,DISEASE,Immunoglobulin G4-Related Disease,"IgG4-Related Kidney Disease|Immunoglobulin G4 Related Kidney Disease|IgG4-Associated Autoimmune Diseases|Autoimmune Disease, IgG4-Associated|IgG4 Related Sclerosing Disease|systemic disease|IgG4-Related Kidney Diseases|Immunoglobulin G4-Related Kidney Disease|Sclerosing Disease, IgG4-Related|Immunoglobulin G4-Related Sclerosing Disease|Immunoglobulin G4-Related Diseases|IgG4-Related Diseases|IgG4-RD|IgG4-Related Disease|IgG4-Related Sclerosing Disease|IgG4 Associated Autoimmune Disease|IgG4 Related Systemic Disease|Kidney Disease, IgG4-Related|IgG4-Associated Autoimmune Disease|IgG4 Related Disease|Immunoglobulin G4 Related Sclerosing Disease|IgG4 Related Kidney Disease|IgG4-Related Sclerosing Diseases|Immunoglobulin G4 Related Disease"
NEW16110,DISEASE,serious extrapyramidal side effect,SC impairment
NEW16111,CHEMICAL,rat rotenone model muscle coordination,rat rotenone model muscle coordination
NEW16112,CHEMICAL,dopamine da replacement,dopamine DA replacement
NEW16113,CHEMICAL,retinoic acid/estradiol model,retinoic acid/estradiol model
NEW16115,MENTAL_HEALTH,prenatal folic acid supplementation,US autism diagnoses
D057927,DISEASE,Hydrophobic and Hydrophilic Interactions,"hydrophobicity|Interaction, Hydrophilic|Interactions, Hydrophilic|Hydrophilicity|Hydrophilic Interaction|Hydrophobicities|Hydrophobicity|Hydrophobic Interaction|Interaction, Hydrophobic|Hydrophilicities|Hydrophobic Interactions|Interactions, Hydrophobic|Hydrophilic Interactions|Hydrophilic and Hydrophobic Interactions"
NEW16122,CHEMICAL,dissociation energy,"benzoic acid-2,2,2-trideutero-1-trideuteromethyl-ethyl ester"
NEW16123,CHEMICAL,dissociation energy,benzoic acid-1-methyl-ethyl ester
NEW16124,CHEMICAL,dissociation energy,nicotinic acid-1-deutero-1-methyl-ethyl ester
NEW16125,CHEMICAL,dissociation energy,"nicotinic acid-2,2,2-trideutero-1-trideuteromethyl-ethyl ester"
NEW16126,CHEMICAL,dissociation energy,benzoic acid-1-deutero-1-methyl-ethyl ester
NEW16128,NUTRITION,largemouth bass ranavirus,cultured largemouth bass
NEW16129,DISEASE,largemouth bass ranavirus,infectious skin ulcerative syndrome
NEW16130,MENTAL_HEALTH,largemouth bass ranavirus,Marijuana Craving Questionnaire
NEW16132,DISEASE,gaba pathway,RTT neuropathology
NEW16133,MENTAL_HEALTH,second compound,lateral displacement
NEW16134,DISEASE,second compound,obstructive sleep apnea-hypopnea syndrome
NEW16136,CHEMICAL,severe hypoxia group,higher serum FT3 level
NEW16140,BIOCHEMICAL,ft3 level,thyroid hormone replacement therapy
NEW16141,BIOCHEMICAL,ft3 level,thyroid stimulating hormone concentration
NEW16144,CHEMICAL,population fragmentation,Wisconsin glaciation
NEW16145,DISEASE,population fragmentation,age-associated cardiovascular dysfunction
NEW16147,CHEMICAL,glucose response,H4CBD treatment
NEW16148,CHEMICAL,glucose response,glucose tolerance independent
NEW16149,DISEASE,glucose response,TG synthesis
NEW16154,CHEMICAL,cerebellar overactivity,abnormal glutamate signaling
NEW16155,CHEMICAL,po2 necessary,PO2 necessary
NEW16158,CHEMICAL,oxyhemoglobin dissociation curve,CO2 content
NEW16159,CHEMICAL,oxyhemoglobin dissociation curve,DPG|non diphosphoglycerate
NEW16160,CHEMICAL,oxyhemoglobin dissociation curve,Pi-0.09 Na+
NEW16162,DISEASE,dpg level,chronic neurocognitive deficits
NEW16163,DISEASE,dpg level,alcohol optic neuropathy
NEW16164,DISEASE,dpg level,TAON deficits
NEW16168,BIOCHEMICAL,low urinary tract symptom,agents alpha-adrenergic antagonists
NEW16169,DISEASE,low urinary tract symptom,LUTS secondary
NEW16170,DISEASE,low urinary tract symptom,benign prostate hyperplasia
NEW16173,DISEASE,chronic ethanol consumption,gender-dependent neuronal damage
NEW16174,DISEASE,ethanol consumption,ARN structure
NEW16175,MENTAL_HEALTH,ethanol consumption,heroin-induced ventilatory depression
NEW16176,DISEASE,overdose death,overdose deaths
NEW16177,CHEMICAL,naloxone possible explanation,naloxone possible explanation
NEW16179,BIOCHEMICAL,bio-based disease resistance inducer able,synthetic fungicides
NEW16184,DISEASE,numerous antidepressant,genetic derangements
NEW16185,DISEASE,numerous antidepressant,appetitive visual learning
NEW16186,DISEASE,numerous antidepressant,cell-mediated angioedema
NEW16188,CHEMICAL,urogenital infection,GEU
NEW16189,DISEASE,urogenital infection,possible infection
NEW16190,DISEASE,severe hepatic disorder,severe hepatic disorders
http://purl.obolibrary.org/obo/DOID_2497,DISEASE,enamel erosion,enamel erosion
NEW16192,CHEMICAL,gastric acid-neutralizing antacid rinse,calcium overload
NEW16193,CHEMICAL,gastric acid-neutralizing antacid rinse,acute ATP loss
NEW16195,DISEASE,polydatin treatment,infarction volume
NEW16199,DISEASE,adult coeliac disease,adult celiac disease
NEW16203,CHEMICAL,organophosphorus anticholinesterase,DFP treatment groups
NEW16205,DISEASE,abnormal sexual behavior,necrophilia
NEW16206,MENTAL_HEALTH,abnormal sexual behavior,bestiality
D014843,MENTAL_HEALTH,Voyeurism,Voyeurisms|voyeurism
NEW16207,DISEASE,abnormal sexual behavior,harassment sexual assault
NEW16208,DISEASE,abnormal sexual behavior,atherosclerotic cardiovascular disease
NEW16209,DISEASE,abnormal sexual behavior,GI disorder
NEW16215,CHEMICAL,permethrin susceptibility screening,dose % permethrin
D026023,CHEMICAL,Permethrin,"Cyclopropanecarboxylic Acid, 3-(2,2-dichloroethenyl)-2,2-dimethyl-, (3-phenoxyphenyl)methyl ester|NRDC147|NIA33297|S3151|Permethrin, trans-(1RS)-Isomer|Permethrin, (cis-(+-))-Isomer|Permethrin, (cis)-Isomer|NIA-33297|cis-permethrin|FMC33297|Permethrin, (1R-trans)-Isomer|Permethrin, (1S-trans)-Isomer|3-Phenoxybenzyl-cis,trans-(1RS)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate|trans-(1RS)-Permethrin|S 3151|permethrin|Ambush|PP-557|Permethrin, (1S-cis)-Isomer|FMC 33297|trans permethrin|3-Phenoxybenzyl-(+-)-cis,trans-2,2-dichlorovinyl-2,2-dimethyl-cyclopropylcarboxylic acid, ester|Nittifor|PP557|NRDC143|S-3151|cis-(1RS)-permethrin|NIA 33297|NRDC-147|trans-permethrin|Permethrin, (trans)-Isomer|NRDC-143|permethrin, cis-(1RS)-isomer|FMC-33297|PP 557|NRDC 143|NRDC 147|Permethrin, (1R-cis)-Isomer|Permethrin, (trans-(+-))-Isomer|(m-Phenoxybenzyl)-cis,trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate|cis permethrin|Elimite"
NEW16216,MENTAL_HEALTH,permethrin susceptibility screening,common fatigue
NEW16217,DISEASE,permethrin susceptibility screening,suicide-related behaviors
NEW16218,MENTAL_HEALTH,permethrin susceptibility screening,cocaine-induced paranoia
D017024,BIOCHEMICAL,"Chemotherapy, Adjuvant","Adjuvant Chemotherapy|Adjuvant Drug Therapy|adjuvant drug|Drug Therapy, Adjuvant"
NEW16220,BIOCHEMICAL,Federal Drug Administration,Federal Drug Administration
NEW16223,CHEMICAL,inhibitor tolcapone,prefrontal dopamine levels
NEW16224,MENTAL_HEALTH,inhibitor tolcapone,agitation behaviour
NEW16226,DISEASE,extracellular naag,neuropathic models
NEW16229,BIOCHEMICAL,class antagonist xv459,Class antagonist YZ211
C120234,CHEMICAL,orbofiban [Supplementary Concept],Alanine|orbofiban|Pyrrolidines
C100917,CHEMICAL,sibrafiban [Supplementary Concept],sibrafiban|Piperidines|Oximes
NEW16230,BIOCHEMICAL,class antagonist xv459,Class antagonist
NEW16231,CHEMICAL,class antagonist xv459,IC(50)=30 nM
NEW16232,CHEMICAL,class antagonist xv459,catecholamine synthesis
NEW16233,CHEMICAL,class antagonist xv459,gamma-linolenic acids
NEW16234,CHEMICAL,class antagonist xv459,n-6 PUFAs
NEW16235,CHEMICAL,class antagonist xv459,n-6/n-3 PUFAs
NEW16236,CHEMICAL,class antagonist xv459,monounsaturated nervonic acid
NEW16237,CHEMICAL,class antagonist xv459,acid ratio
NEW16238,NUTRITION,class antagonist xv459,altered fatty acid FA metabolism
NEW16240,DISEASE,auranofin af,pain narcotic usage
NEW16243,CHEMICAL,combined dama action,L-DOPA effect
D055413,CHEMICAL,Growth Differentiation Factor 10,GDF-10|BMP-3b|Bone Morphogenetic Protein 3B|10
NEW16249,CHEMICAL,winter depressive patient,excessive circulating melatonin
NEW16253,MENTAL_HEALTH,kynurenine metabolism,uterine hyperactivity
NEW16256,MENTAL_HEALTH,"2r,4r-apdc",similar equilibrium dissociation constants
NEW16257,CHEMICAL,"2r,4r-apdc",synaptic noradrenaline
NEW16259,CHEMICAL,depression score,oral salbutamol treatment
NEW16262,CHEMICAL,Pocock scorpion venom,Centro de Biotecnología
NEW16264,BIOCHEMICAL,venom poisoning,subcutaneous venom injection
D011455,CHEMICAL,"Prostaglandins A, Synthetic","Prostaglandin A Analogues|Synthetic, PGA|Analogues, Prostaglandin A|Analogs, Prostaglandin A|PGA Synthetic|Prostaglandin A Analogs|PGA|Synthetic Prostaglandins A"
NEW16267,BIOCHEMICAL,displacement average,free pteroylglutamic acid
NEW16269,CHEMICAL,complete dissociation,pteroyltriglutamate
NEW16270,NUTRITION,complete dissociation,biological folate activity
D007780,DISEASE,Lactobacillus casei,casei|Lactobacillus (1966-1971)
NEW16271,MENTAL_HEALTH,antidepressant fluoxetine,reverse depletion-induced anergia
NEW16273,MENTAL_HEALTH,depressed individual,anergia
NEW16274,DISEASE,depressed individual,effort-related motivational symptoms
NEW16277,DISEASE,agent tetrabenazine,motivational deficits
NEW16278,DISEASE,agent tetrabenazine,rare hereditary metabolic disorders
NEW16280,DISEASE,endogenous acetylcholine degradation,VaD patients
NEW16281,CHEMICAL,endogenous acetylcholine degradation,blood glucose levels
NEW16283,DISEASE,aspartame intake,impaired blood glucose tolerance
D019812,CHEMICAL,Heparan Sulfate Proteoglycans,"Heparan Sulfate Proteoglycan|Sulfate Proteoglycans, Heparan|Proteoglycans, Heparan Sulfate|Proteoheparan Sulfate|Proteoglycan, Heparan Sulfate|sulfate|HSPG"
NEW16286,DISEASE,basic oxygen furnace sludge,severe fecal retention unresponsive
NEW16288,DISEASE,group mglu receptor antagonist,epithelial ovarian cancer cells
NEW16290,CHEMICAL,fearful memory,SKF83959 pharmacotherapy training
NEW06696,CHEMICAL,fearful memory,mg/kg/day
NEW16292,DISEASE,impaired da transmission,effortful food-seeking behaviors
NEW16293,DISEASE,muscarinic agonist pilocarpine,effort-related choice behavior similar
NEW16294,DISEASE,da receptor,effort-related choice behavior
NEW16296,CHEMICAL,soft polymer nanoparticle,slow-release nanostars
NEW16298,BIOCHEMICAL,controlled release analgesic system,repeated drug dosing
NEW16299,BIOCHEMICAL,controlled release analgesic system,dosing drug dependency
NEW16301,DISEASE,bupivacaine/meloxicam pr,pain consumption relative
D000077239,CHEMICAL,Meloxicam,Movalis|Mobic|Mobec|Reumoxicam|meloxicam|Parocin|Movicox|Uticox|Miloxicam|Masflex|Mobicox
NEW16303,MENTAL_HEALTH,novel polymer technology,analgesia regimen
NEW16305,MENTAL_HEALTH,spanish cohort,Autism Sequencing Consortium
NEW16308,DISEASE,polygenic risk score,Psychiatric Consortium PGC repository
NEW16309,NUTRITION,polygenic risk score,Spanish trios's
NEW16312,NUTRITION,maternal pre-pregnancy obesity,Spanish children
NEW16314,NUTRITION,multivariate linear regression model,umbilical cord blood mercury
NEW16315,NUTRITION,multivariate linear regression model,long-chain polyunsaturated fatty acid concentrations
NEW16317,DISEASE,cch-induced neuronal degeneration,CCH-induced neuronal degeneration
NEW16318,DISEASE,ischemic neuronal damage,ischemic neuronal damage
NEW16319,CHEMICAL,common phenolic acid,common phenolic acids
NEW16321,DISEASE,alkyl catechol,multiple chronic diseases
C078893,CHEMICAL,indium In 113m sulfur colloid [Supplementary Concept],Sulfur|Indium|sulphur
D010273,DISEASE,"Parasitic Diseases, Animal","parasitic disease|Disease, Animal Parasitic|Parasitic Infections, Animal|Animal Parasitic Infection|Infection, Animal Parasitic|Parasitic Infection, Animal|Animal Parasitic Infections|Animal Parasitic Diseases|Parasitic Disease, Animal|Animal Parasitic Disease|Diseases, Animal Parasitic|Infections, Animal Parasitic"
NEW16323,DISEASE,artificial fever,different gastrointestinal symptoms
NEW16324,MENTAL_HEALTH,artificial fever,Alzheimer 's disease|presenile dementia
NEW16330,NUTRITION,single-nucleotide polymorphism snp diagnostic marker,bread wheat lines
NEW16331,CHEMICAL,single-nucleotide polymorphism snp diagnostic marker,FarmCPU algorithm
NEW16333,MENTAL_HEALTH,Q.Yr.bisa-2D,Pst resistance
D000647,DISEASE,Amnesia,"State, Amnestic|Amnesias, Temporary|Temporary Amnesia|Dissociative Amnesia|Global Amnesia|Amnesia, Temporary|States, Amnestic|Hysterical Amnesias|Amnesia-Memory Loss|Amnesias|Amnesia, Dissociative|Global Amnesias|amnesias|Amnesia, Tactile|Temporary Amnesias|Hysterical Amnesia|Amnestic States|Amnesia, Hysterical|Tactile Amnesias|Amnesia-Memory Losses|Amnesias, Global|Amnesias, Tactile|Amnesia Memory Loss|Tactile Amnesia|Amnestic State|Amnesias, Hysterical|Dissociative Amnesias|Amnesias, Dissociative|Amnesia, Global"
NEW16339,DISEASE,stress-induced corticosterone,pigmentary patches
NEW16340,DISEASE,stress-induced corticosterone,painful chemotherapy-induced peripheral neuropathy
NEW16342,DISEASE,naltrexone mg/kg,self-biting behavior
NEW16343,DISEASE,naltrexone mg/kg,pemoline-induced self-biting behavior
NEW16345,BIOCHEMICAL,fracture prevention,vitamine D.
NEW16346,DISEASE,fracture prevention,P. alkekengi|Makino
C472867,DISEASE,"RXFP2 protein, human [Supplementary Concept]","Receptors, G-Protein-Coupled|testis descent"
NEW16348,DISEASE,phthalate mixture risk assessment,male developmental toxicity
NEW16350,BIOCHEMICAL,antagonist protocol,antagonist protocol
NEW16351,CHEMICAL,gonadotrophin-releasing-hormone agonist,gonadotrophin-releasing-hormone agonist
NEW16352,CHEMICAL,alternate-day therapy,alternate-day therapy
NEW16353,DISEASE,cs-induced neuropsychiatric disorder,CS-induced neuropsychiatric disorders|CIPD
NEW16357,CHEMICAL,[³h]-domperidone,hypothalamic Nhlh2
NEW16359,BIOCHEMICAL,bifidobacterium longum strain,folic acid derivatives
NEW16361,CHEMICAL,high-dose intravenous vitamin c,harmful reactive oxygen species
NEW16363,DISEASE,supplementary vitamin c,post-cardiac arrest patients
NEW16364,BIOCHEMICAL,supplementary vitamin c,agonist dose-response curves
NEW16365,DISEASE,supplementary vitamin c,morula development
NEW16366,CHEMICAL,psychiatric symptom,trihexyphenidyl anti-cholinergic agent
NEW16368,DISEASE,traditional prescription kyung-ok-ko,age-associated disorders
NEW16369,CHEMICAL,traditional prescription kyung-ok-ko,dehydroepiandrosterone s.c.)-induced PCOS rat model
D005497,DISEASE,Follicular Cyst,"follicular cysts|Cyst, Follicular|Follicular Cysts|Cysts, Follicular"
NEW16371,CHEMICAL,pre-administration,DHEA injection
NEW16372,CHEMICAL,pre-administration,serum glucose
NEW07486,DISEASE,Lycium chinense Miller,induced toxicity
NEW16377,DISEASE,behavioural disturbance,antibiotic-related encephalopathy
NEW16378,DISEASE,behavioural disturbance,excluded organic encephalopathy
NEW16379,BIOCHEMICAL,behavioural disturbance,high dose vitamin
NEW16380,BIOCHEMICAL,behavioural disturbance,monoaminergic agonist properties
NEW16382,DISEASE,regal,regal|Pygoplites diacanthus
NEW16383,NUTRITION,angelfish regal,angelfish regal
NEW16384,NUTRITION,regal angelfish,regal angelfish
NEW16385,DISEASE,major biliary bile acid,major biliary bile acids
NEW16388,CHEMICAL,angelfish,N-methyltaurine conjugation
NEW16390,DISEASE,biliary bile acid,Proliferative Kidney Disease
NEW16392,DISEASE,hydropinic therapy,dispeptic patients
C536735,DISEASE,Winter Shortland Temple syndrome [Supplementary Concept],Skin Abnormalities|craniofacial malformations|Syndactyly|Craniofacial Abnormalities|Intestines/abnormalities
C536730,DISEASE,Zuska's Disease [Supplementary Concept],Breast Diseases|Abscess|squamous metaplasia|Fistula
NEW16395,MENTAL_HEALTH,suvorexant treatment,trauma-related insomnia
NEW16399,BIOCHEMICAL,hiv protease inhibitor saquinavir,p53-deficient hormone resistant prostate cancer PC-3 cells
NEW16400,DISEASE,hiv protease inhibitor saquinavir,prostate cancer cell growth
NEW16401,CHEMICAL,hiv protease inhibitor saquinavir,saquinavir TRAIL sensitivity
NEW16405,BIOCHEMICAL,specific antigen fixation,mentioned parasympatholytics
NEW16406,CHEMICAL,specific antigen fixation,M-cholinereceptors
D001442,CHEMICAL,Bacteroides Infections,"Infection, Bacteroides|Infections, Bacteroides|Bacteroides Infection|Bacteroides"
C000641481,CHEMICAL,Intestinimonas butyriciproducens [Supplementary Concept],Intestinimonas|Clostridiales
D057790,DISEASE,Staphylococcus saprophyticus,Staphylococcus (1976-2010)|Staphylococcus
NEW16407,DISEASE,specific antigen fixation,BA saprophyticus subsp
NEW16409,DISEASE,theophylline administration,glucocorticoid-induced hyperglycemia
NEW16410,CHEMICAL,theophylline administration,GR activity
NEW16413,DISEASE,sr agonist,opioid withdrawal behaviors
NEW16415,CHEMICAL,increase intracellular cyclic adenosine monophosphate camp level,10mg/kg day
NEW16418,CHEMICAL,precipitate opioid withdrawal syndrome,morphine dependent mice
NEW16420,DISEASE,acute inorganic arsenic,exacerbating infections
NEW16422,CHEMICAL,acute inorganic arsenic,cardiotonic steroid binding pocket
NEW16424,MENTAL_HEALTH,gl-iv-03,agonists agitation response
NEW16426,DISEASE,gaba agonist muscimol,severe oculomotor impairment
NEW16427,DISEASE,gaba agonist muscimol,abnormal mood
NEW16428,DISEASE,gaba agonist muscimol,cataleptic responses
NEW16429,DISEASE,gaba agonist muscimol,comorbid chronic pelvic pain syndromes
NEW16430,DISEASE,gaba agonist muscimol,chronic endometriosis-associated pain
NEW16431,BIOCHEMICAL,gaba agonist muscimol,selective V1 receptor antagonist radioligand
NEW16432,CHEMICAL,gaba agonist muscimol,mol/L kidney
NEW16433,CHEMICAL,gaba agonist muscimol,vasopressin V1 receptors
NEW16434,CHEMICAL,gaba agonist muscimol,sarcosine7]AVP
NEW16435,MENTAL_HEALTH,gaba agonist muscimol,concentration-dependent displacement
NEW16437,BIOCHEMICAL,gaba agonist muscimol,narcotic analgesic-induced emesis
NEW16439,DISEASE,immunosuppressant tacrolimus,human cancer models
C040946,DISEASE,uterine-derived cell growth factor [Supplementary Concept],tumor cell growth|Pregnancy Proteins
NEW16440,CHEMICAL,immunosuppressant tacrolimus,tubulin dissociation constant
NEW16441,BIOCHEMICAL,immunosuppressant tacrolimus,group agonist
NEW16442,CHEMICAL,immunosuppressant tacrolimus,metabotropic glutamate receptor group
NEW16443,BIOCHEMICAL,immunosuppressant tacrolimus,narcotic analgesics number
NEW16445,CHEMICAL,oxygen repression,DppsR/OprrA
NEW16446,BIOCHEMICAL,oxygen repression,efficient lycopene production
NEW16447,BIOCHEMICAL,native carotenoid pigment decaprenoxanthin,native carotenoid pigment decaprenoxanthin
NEW16449,CHEMICAL,carotenogenesis repressor gene,decaprenoxanthin production
D055371,DISEASE,Acute Lung Injury,"Lung Injury, Acute|Lung Injuries, Acute|acute lung injury|Acute Lung Injuries"
NEW16460,DISEASE,smoke exposure,columnar cells
NEW16461,CHEMICAL,smoke exposure,eg glutathione
NEW16462,CHEMICAL,smoke exposure,sulphur-containing groups
NEW16463,MENTAL_HEALTH,smoke exposure,due displacement
NEW16465,MENTAL_HEALTH,chronic lithium ingestion,fatigue substance
NEW16471,MENTAL_HEALTH,diacylglycerol kinase (dgkη)-knockout mouse,disorder remedy-sensitive mania-like behaviors
NEW16473,DISEASE,acid (pufa)-containe phosphatidic acid pa molecular specie,DGKη deficiency
NEW16474,DISEASE,acid (pufa)-containe phosphatidic acid pa molecular specie,oxaliplatin-induced neuropathic pain
NEW16479,MENTAL_HEALTH,idazoxan 5-ht₃ receptor antagonist bemesetron,VLX-induced analgesia
D033705,CHEMICAL,Equilibrative Nucleoside Transport Proteins,Equilibrative Nucleoside Transport Protein|nucleoside transport
D001595,CHEMICAL,Benzylamine Oxidase,"Clorgyline Resistant Amine Oxidase|Oxidase, Benzylamine|Clorgyline-Resistant Amine Oxidase|Amine Oxidase, Clorgyline-Resistant|Oxidase, Clorgyline-Resistant Amine|benzylamine"
NEW16482,MENTAL_HEALTH,7-deazapurine nucleoside antibiotic tubercidin,SN Ar displacement
NEW16483,CHEMICAL,7-deazapurine nucleoside antibiotic tubercidin,fluoro-diazotization
NEW16485,CHEMICAL,"2',3',5'-o-acetyladenosine",aryl isocyanates
NEW16487,CHEMICAL,nucleophillic displacement,tetra-n-butylammonium fluoride
NEW16489,DISEASE,toyocamycin analogue,human CMV
NEW16492,BIOCHEMICAL,leucine catabolite beta-hydroxy-beta-methylbutyrate,coccidiostat
NEW16494,MENTAL_HEALTH,maduramicin residue,childhood apraxia
NEW16495,CHEMICAL,maduramicin residue,topographically-parallel corticostriatal
NEW16496,DISEASE,ejaculatory behaviour,ejaculatory behaviour
D060327,CHEMICAL,Solid-Phase Synthesis Techniques,"Solid Phase Synthesis Techniques|Solid-Phase Nucleotide Synthesis Techniques|Syntheses, Solid-Phase Nucleotide|Peptide Syntheses, Solid-Phase|Solid Phase Peptide Synthesis Techniques|Solid-Phase Synthesis Method|Synthesis, Solid-Phase Nucleotide|Solid Phase Nucleotide Synthesis Techniques|Synthesis Method, Solid-Phase|Synthesis Methods, Solid-Phase|Peptide Synthesis, Solid Phase|Synthesis Technique, Solid-Phase|Solid-Phase Peptide Synthesis|Method, Solid-Phase Synthesis|Solid-Phase Nucleotide Syntheses|Solid-Phase Synthesis Technique|Solid-Phase Synthesis Methods|Synthesis Techniques, Solid-Phase|Solid-Phase Peptide Syntheses|Syntheses, Solid-Phase|Methods, Solid-Phase Synthesis|Techniques, Solid-Phase Synthesis|Solid Phase Synthesis|Solid-Phase Syntheses|Synthesis, Solid-Phase|Solid Phase Synthesis Methods|nucleotide synthesis|Solid-Phase Synthesis|Synthesis, Solid Phase|Technique, Solid-Phase Synthesis|Solid Phase Peptide Synthesis|Peptide Synthesis, Solid-Phase|Solid-Phase Peptide Synthesis Techniques|Synthesis, Solid-Phase Peptide|Nucleotide Synthesis, Solid-Phase|Syntheses, Solid-Phase Peptide|Solid Phase Nucleotide Synthesis|Nucleotide Syntheses, Solid-Phase|Solid-Phase Nucleotide Synthesis"
NEW16497,MENTAL_HEALTH,retinal projection growth,retinal projection growth
NEW16499,BIOCHEMICAL,stress-induced motivational anhedonia,fenofibrate agonist
NEW16501,DISEASE,improve luts,pelvic atherosclerosis
NEW16502,CHEMICAL,improve luts,nitric oxide levels
NEW16505,MENTAL_HEALTH,pde-5 inhibitor tadalafil,concomitant erectile dysfunction
NEW16507,DISEASE,β-adrenergic antagonist toxicity,cardiovascular collapse refractory
NEW16509,BIOCHEMICAL,high-dose insulin,β-adrenergic antagonist cardiotoxicity
NEW16511,CHEMICAL,suicide group,3H-imipramine
NEW16512,CHEMICAL,suicide group,presynaptic serotonin marker
NEW16515,BIOCHEMICAL,persistent hypotension,beta adrenergic blockade
NEW16517,DISEASE,serum propranolol level,ASD-like behavior
NEW16519,MENTAL_HEALTH,glutamate system,conditioned response
NEW16522,BIOCHEMICAL,da defect,orphan drug status
NEW16524,DISEASE,anesthetic drug agent,upper airway collapsibility
NEW16526,BIOCHEMICAL,repetitive sleep fragmentation,opioid analgesic potency
NEW16532,DISEASE,cysteinyl leukotriene,postinfectious cough
NEW16534,CHEMICAL,left-right orientation,ASP traits
NEW16535,DISEASE,left-right orientation,ASD-like behavioral symptoms
NEW16539,DISEASE,maternal ethanol consumption,metal toxicity
NEW16541,CHEMICAL,pbc patient,anti-mitochondrial antibodies|AMA
D019819,CHEMICAL,Budesonide,"Budesonide, (R)-Isomer|Rhinocort|Budesonide, (S)-Isomer|Horacort|Pulmicort|budesonide"
D002792,CHEMICAL,Cholestyramine Resin,"Cuemid|Cholestyramine|Colestyramines|Colestyramin|Colestyramine|MK135|Questrans|Cholestyramine Resins|Quantalan|cholestyramine|Questran|Colestyramins|Resin, Cholestyramine|Quantalans|MK 135|Cholestyramines|Cuemids|MK-135|Resins, Cholestyramine"
NEW16545,DISEASE,same common drug therapy,behavioral hypersensitivity
NEW16546,BIOCHEMICAL,same common drug therapy,glutamate transporter activator riluzole
D027341,CHEMICAL,Excitatory Amino Acid Transporter 1,"SLC1A3 Transporter|Glutamate Aspartate Transporter 1|GLAST|EAAT-1 Excitatory Amino Acid Transporter|glutamate-aspartate transporter|GLAST 1 Glutamate Aspartate Transporter|EAAT 1 Excitatory Amino Acid Transporter|GLAST-1 Glutamate Aspartate Transporter|Transporter, SLC1A3"
NEW16547,CHEMICAL,same common drug therapy,selective GLT-1 blocker dihydrokainic acid
NEW16549,CHEMICAL,six-herb medicine formula,BBTD AD
NEW16550,CHEMICAL,six-herb medicine formula,Baizhu Tianma decoction
D004932,DISEASE,Esophageal and Gastric Varices,"Gastric Varices|Varix, Esophageal|Varices, Esophageal|Esophageal Varix|esophageal varices|Varices, Gastric|Varix, Gastric|Esophageal Varices|Gastric Varix"
NEW16552,DISEASE,six-herb medicine formula,gastrointestinal bleeding
NEW16553,DISEASE,six-herb medicine formula,infantile hemangiomas
NEW16556,DISEASE,channel blocker phenytoin,acute liver cytolysis
NEW16562,MENTAL_HEALTH,cytoplasmic luminal mutation,derailment product
NEW16564,MENTAL_HEALTH,stnfr60 level,depression mania
NEW16565,MENTAL_HEALTH,pregnancy neonatal abstinence syndrome,pregnancy neonatal abstinence syndrome
NEW16567,DISEASE,uplc-qtofms-based metabolomic method,VaD. Experimental VaD model
NEW16570,CHEMICAL,vad rat,hematoxylin-eosin staining
NEW16572,CHEMICAL,2-vo-induced VaD,arachidonic acid metabolism
NEW16573,DISEASE,2-vo-induced VaD,protein fibrillation
NEW16576,CHEMICAL,toxicity acetaminophen,membrane calcium pumps
NEW16577,DISEASE,toxicity acetaminophen,severe hepatotoxicity
D016410,DISEASE,"Lymphoma, T-Cell, Cutaneous","Cutaneous T-Cell Lymphoma|Lymphomas, Cutaneous T-Cell|Cutaneous T Cell Lymphoma|Slack Skin, Granulomatous|T Cell Lymphoma, Cutaneous|Granulomatous Slack Skin|Cutaneous T-Cell Lymphomas|cutaneous T-cell lymphoma|Lymphoma, T Cell, Cutaneous|Lymphoma, Cutaneous T-Cell|T-Cell Lymphomas, Cutaneous|T-Cell Lymphoma, Cutaneous"
D011952,CHEMICAL,"Receptors, Concanavalin A","Concanavalin A Binding Sites|Concanavalin A Receptors|Concanavalin A Receptor|Receptor, Concanavalin A|concanavalin A"
C027774,CHEMICAL,concanavalin A-binding glycoproteins [Supplementary Concept],"Con A|Receptors, Concanavalin A"
NEW16581,CHEMICAL,il-2 % reduction,IL-2 % reduction
NEW16582,CHEMICAL,antitcr,antiTCR
NEW16583,DISEASE,splenic t cell proliferation,splenic T cell proliferation
NEW16584,CHEMICAL,tnf-alpha production,TNF-alpha production
NEW16585,BIOCHEMICAL,partial agonist property,partial agonist properties
NEW16586,CHEMICAL,% ±,% ±
NEW16587,CHEMICAL,% ±     iron acquisition,% ±    iron acquisition
NEW16588,CHEMICAL,ton/tol transport,ton/tol transport
NEW16589,MENTAL_HEALTH,post-schizophrenic depression,post-schizophrenic depression
NEW16591,DISEASE,δ-tocotrienol,diet-induced metabolic syndrome
D000820,DISEASE,Animal Diseases,"animal diseases|Diseases, Animal"
NEW16593,BIOCHEMICAL,antimicrobial protein,T-2/HT-2 toxins
NEW16594,MENTAL_HEALTH,antimicrobial protein,coronary vascular resistance
NEW16595,BIOCHEMICAL,antimicrobial protein,systemic endocrine events
NEW16597,BIOCHEMICAL,ischaemic priapism,cavernosal sympathomimetic injections
NEW16601,CHEMICAL,dl-alpha-tocopheryl acetate,conjugated diene formation
NEW16602,MENTAL_HEALTH,dl-alpha-tocopheryl acetate,lipoprotein resistance
NEW16603,CHEMICAL,dl-alpha-tocopheryl acetate,000+/-7129
NEW16604,DISEASE,dl-alpha-tocopheryl acetate,atherosclerotic vascular disease
NEW16608,DISEASE,ne-induced polycystic condition,PCO phenotype
NEW16610,NUTRITION,ss patient,Asian water buffalo
NEW16611,DISEASE,ss patient,two Asian water buffalo|Bubalus bubalis
NEW16612,CHEMICAL,ss patient,postnatal Copper
NEW16613,CHEMICAL,ss patient,Copper-to-Zinc ratio
NEW16614,CHEMICAL,ss patient,inhibitory adenosine receptors
NEW16615,CHEMICAL,ss patient,extracellular adenosine
NEW16616,MENTAL_HEALTH,ss patient,slower subsequent hypoxic depression
D052066,CHEMICAL,N-Ethylmaleimide-Sensitive Proteins,"N-Ethylmaleimide-Sensitive Protein|N Ethylmaleimide Sensitive Protein|N Ethylmaleimide Sensitive ATPase|NEM-Sensitive Fusion Proteins|N-Ethylmaleimide-Sensitive ATPase|N Ethylmaleimide Sensitive Factor|N Ethylmaleimide Sensitive Fusion Protein|N-Ethylmaleimide-Sensitive Fusion Protein|ATPase, NSF|NEM Sensitive Fusion Proteins|NSF ATPase|N-Ethylmaleimide-Sensitive Factors|ATPase, N-Ethylmaleimide-Sensitive|N Ethylmaleimide Sensitive Proteins|N-Ethylmaleimide-Sensitive Factor|N-ethylmaleimide|N Ethylmaleimide Sensitive Factors"
D017696,CHEMICAL,"Myopathies, Nemaline","Rod Myopathies|Adult Onset Nemaline Myopathy|Autosomal Recessive Nemaline Myopathy|Childhood Onset Nemaline Myopathy|Nemaline Myopathy, Late Onset|Nemaline Myopathies|Nemaline Myopathy, Autosomal Recessive|Nemaline Myopathy, Autosomal Dominant|Rod Myopathy|NEM|Nemaline myopathy|Late Onset Nemaline Myopathy|Nemaline Body Disease|Rod-Body Myopathies|Rod Body Myopathy|Myopathies, Rod|Myopathy, Rod Body|Myopathy, Rod|Rod Body Disease|Nemaline Rod Disease|Nemaline Myopathy|Rod-Body Myopathy|Myopathy, Rod-Body|Myopathies, Rod-Body|Autosomal Dominant Nemaline Myopathy|Myopathy, Nemaline|Nemaline Myopathy, Adult Onset|Nemaline Myopathy, Childhood Onset"
NEW16618,CHEMICAL,hypoxic depression,CB1 cannabinoid receptor antagonist AM251
NEW16619,BIOCHEMICAL,hypoxic depression,GI mGluR antagonist AIDA
NEW16621,DISEASE,elevated psychiatric morbidity,elevated psychiatric morbidity
C407905,BIOCHEMICAL,"virulence factor p28, Ectromelia virus [Supplementary Concept]",Viral Proteins|virulence factor
NEW16623,DISEASE,gut tryptamine increase,necrotizing ability
NEW16624,CHEMICAL,gut tryptamine increase,tryptamine cytotoxicity
NEW16628,MENTAL_HEALTH,ns structural arrangement,strong detergent resistance
NEW16629,CHEMICAL,ns structural arrangement,nm-width fibrils
NEW16632,DISEASE,multiple-voxel h-mrs,atypical schizophrenic patients
D017245,CHEMICAL,Foscarnet,Foscarnet Barium (2:3) Salt|Foscavir|Phosphonoformic Acid|Foscarnet Trilithium Salt|Foscarnet Trisodium Salt|Foscarnet Manganese (2+) (2:3) Salt|Foscarnet Calcium (2:3) Salt|Foscarnet Disodium Salt|Foscarnet Tripotassium Salt|Foscarnet Sodium|Foscarnet Magnesium (2:3) Salt|Phosphonoformate|foscarnet|Trisodium Phosphonoformate|Foscarnet Sodium Hexahydrate
NEW16637,DISEASE,high luteinizing hormone concentration,concomitant hyperinsulinemia
NEW16640,MENTAL_HEALTH,cyclic metaphosphate structure,final fragmentation product
NEW16641,DISEASE,cyclic metaphosphate structure,atherothrombotic cardiovascular disease
D021921,DISEASE,"Aortic Stenosis, Supravalvular","Aortic Supravalvular Stenosis|Supravalvular Stenoses, Aortic|Aortic Supravalvular Stenoses|aortic stenosis|Stenosis, Supravalvular Aortic|Stenosis, Aortic Supravalvular|Supravalvar Aortic Stenosis|Supravalvular Stenosis, Aortic|Supravalvular Aortic Stenosis|Stenoses, Aortic Supravalvular"
NEW16644,DISEASE,α1-adrenergic antagonist prazosin,posttraumatic stress disorder-related nightmares
NEW16646,CHEMICAL,patient allergic,GRPs|recombinant gibberellin-regulated proteins
C050807,CHEMICAL,"presurface protein 2, hepatitis B surface antigen [Supplementary Concept]",Protein Precursors|Hepatitis B Surface Antigens|HBsAg
NEW16651,DISEASE,down patient,Down patients
D000079404,DISEASE,Regulated Cell Death,"Cell Death, Regulated|regulated cell death"
NEW16655,CHEMICAL,arsenic resistance operon,hydroxyarsinothricin butanoate
NEW16657,BIOCHEMICAL,importance antimicrobial resistance,novel potent antibiotics
NEW16658,DISEASE,importance antimicrobial resistance,MODY families
D000077294,BIOCHEMICAL,"Receptor, Transforming Growth Factor-beta Type II","TGF-beta Type II Receptors|Transforming Growth Factor beta Type II Receptor|Transforming Growth Factor beta Type II Receptors|TGF beta Type II Receptor|transforming growth factor beta|Type II TGF-beta Receptor|Type II TGF-beta Receptors|Type II TGF beta Receptor|TGF-beta Type II Receptor|Transforming Growth Factor-beta Type II Receptor|TbetaR II Kinase|TGFBR2|TbetaR-II Kinase|Type II TGF beta Receptors|Receptor, Transforming Growth Factor beta Type II|Kinase, TbetaR-II|TGF beta Type II Receptors|Transforming Growth Factor-beta Type II Receptors"
NEW16660,DISEASE,bone metastasis,impaired coronary microvascular function
NEW16663,DISEASE,levodopa-induced lao aim,levodopa-induced LAO AIMs
NEW16664,DISEASE,lid model,LID model
NEW16665,DISEASE,parkinsonian sign,parkinsonian signs
NEW16669,CHEMICAL,oxidize β-cyclodextrin,tyramine functionalities
NEW16676,DISEASE,p97/vcp valosin,hyperactive alleles
NEW16680,CHEMICAL,recombinant pegylated human ifn alpha,inositol levels
NEW16682,BIOCHEMICAL,soya isoflavone,oestrogen receptors
NEW16684,BIOCHEMICAL,vitamin d skeleton,vitamin D receptor VDR binding affinity
NEW16685,DISEASE,vitamin d skeleton,glomerular inflammation
NEW16686,DISEASE,vitamin d skeleton,glomerulomegaly
NEW16687,DISEASE,tubulointerstitial fibrosis,tubulointerstitial fibrosis
NEW16688,MENTAL_HEALTH,addition insulin resistance,addition insulin resistance
D003928,DISEASE,Diabetic Nephropathies,"Diabetic Kidney Diseases|Diabetic Glomerulosclerosis|Kimmelstiel-Wilson Disease|Diabetic Kidney Disease|Nephropathies, Diabetic|Kimmelstiel Wilson Syndrome|Intracapillary Glomerulosclerosis|Glomerulosclerosis, Nodular|Nodular Glomerulosclerosis|Kidney Disease, Diabetic|Kimmelstiel Wilson Disease|Diabetic Nephropathy|diabetic nephropathy|Kimmelstiel-Wilson Syndrome|Syndrome, Kimmelstiel-Wilson|Glomerulosclerosis, Diabetic|Nephropathy, Diabetic|Kidney Diseases, Diabetic"
NEW16690,CHEMICAL,nicotine abstinence,smoking individuals
D065311,DISEASE,Adenocarcinoma in Situ,"Intraepithelial Adenocarcinoma|Preinvasive Adenocarcinoma|Adenocarcinoma, Preinvasive|Preinvasive Adenocarcinomas|adenocarcinoma|in Situ, Adenocarcinoma|Adenocarcinoma, Intraepithelial|Adenocarcinomas, Preinvasive|Situ, Adenocarcinoma in|Intraepithelial Adenocarcinomas|Adenocarcinoma in Situs|Adenocarcinomas, Intraepithelial"
NEW16695,MENTAL_HEALTH,unopposed estrogen use,childhood enuresis
NEW16697,DISEASE,oxcnh-cap-ibn composite nanoparticle,metastatic bone destruction
D002130,NUTRITION,Calcium Phosphates,"Phosphates, Calcium|calcium phosphates"
NEW16700,MENTAL_HEALTH,composite,engineering fixation applications
NEW16701,MENTAL_HEALTH,2-adrenergic receptor agonist,agoraphobia panic attacks
NEW16702,BIOCHEMICAL,2-adrenergic receptor agonist,growth hormone levels
NEW16703,MENTAL_HEALTH,2-adrenergic receptor agonist,self-rated drowsiness
NEW16704,BIOCHEMICAL,2-adrenergic receptor agonist,2-adrenergic receptor antagonist yohimbine
NEW16705,CHEMICAL,2-adrenergic receptor agonist,plasma MHPG levels
NEW16707,DISEASE,active alpha-2 adrenergic receptor agonist clonidine,problematic spasticity
NEW16708,DISEASE,active alpha-2 adrenergic receptor agonist clonidine,spinal cord injury patients
NEW16709,DISEASE,active alpha-2 adrenergic receptor agonist clonidine,primary diabetic ulcer DFU cells
NEW16710,CHEMICAL,active alpha-2 adrenergic receptor agonist clonidine,DFU therapy
NEW16713,BIOCHEMICAL,APEC strain,tested antimicrobials
NEW16715,DISEASE,pneumonia onset,nosocomial CRGNB pneumonia
D010926,BIOCHEMICAL,Placental Hormones,"Hormones, Placental|placental hormones"
NEW16716,CHEMICAL,pneumonia onset,decreased bicarbonate buffer
NEW16717,MENTAL_HEALTH,pneumonia onset,schizophrenia RCTs
NEW16719,MENTAL_HEALTH,addon administration,acute agitation
NEW16723,CHEMICAL,second partial agonist,α1B receptors
NEW16724,DISEASE,second partial agonist,extrapyramidal dysfunction
NEW16726,MENTAL_HEALTH,brexpiprazole target dosing,depression augmentation
NEW16728,CHEMICAL,57co-cyanocobalamin,phytohemagglutinin lymphocytes
C021557,CHEMICAL,"5,10-methenyltetrahydrofolate synthetase [Supplementary Concept]",Carbon-Nitrogen Ligases|5-formyltetrahydrofolate
NEW16730,CHEMICAL,uninterrupted folate cycle,Me-Cbl synthesis
NEW16733,MENTAL_HEALTH,depression antidepressant,perimenopausal depression
NEW16736,CHEMICAL,chronic ven treatment,acH3K9 level
NEW16737,CHEMICAL,chronic ven treatment,CUS rats
NEW16738,CHEMICAL,chronic ven treatment,TH protein expression
NEW16739,BIOCHEMICAL,synaptic serotonin availability,SSRI efficacy
NEW16741,CHEMICAL,female pd patient,hypersensitive serotonin receptors
D051703,DISEASE,Sp Transcription Factors,"Specificity Protein Transcription Factors|Transcription Factors, Sp|Sephacryl Phosphocellulose Transcription Factors|SP"
NEW16742,BIOCHEMICAL,freshwater fish,vitamin K. Menaquinone-7
D019959,MENTAL_HEALTH,Feeding and Eating Disorders of Childhood,eating disorders|Childhood Eating and Feeding Disorders
NEW16746,DISEASE,dopamine innervation,CKD-associated adverse cardiovascular events
NEW16747,DISEASE,young autistic child biological fluid,young autistic children biological fluids
NEW16749,DISEASE,p-cresol circulating concentration,postictal hypoxia
NEW16750,DISEASE,p-cresol circulating concentration,postictal cerebral hypoperfusion
NEW16751,CHEMICAL,p-cresol circulating concentration,Ca2 redox imbalance
NEW16752,MENTAL_HEALTH,p-cresol circulating concentration,AD-type dementia
D010899,DISEASE,Pituitary Apoplexy,"pituitary apoplexy|Apoplexy, Pituitary"
NEW16754,DISEASE,pkc-mediated mitochondrial dysfunction,psychiatric disturbance
NEW16755,DISEASE,pkc-mediated mitochondrial dysfunction,moderate manic episodes
NEW16756,NUTRITION,pkc-mediated mitochondrial dysfunction,lithium valproate
NEW16757,CHEMICAL,pkc-mediated mitochondrial dysfunction,firstpsychotropic drugs
NEW16759,DISEASE,ms-ms fragmentation pattern,programmed cell death signal transduction pathways
NEW16763,MENTAL_HEALTH,leave temporal lobe,schizophrenia spectrum disorders
NEW16765,CHEMICAL,membrane phospholipid abnormality,amyloid β25 peptide
NEW16769,MENTAL_HEALTH,high bpa level,experiment significant depression
NEW16771,DISEASE,lactate accumulation,gram-negative bacterium Vibrio campbellii
NEW16773,DISEASE,oxygen uptake,cocaine-induced myocardial ischemia
NEW16774,DISEASE,oxygen uptake,lethal arrhythmias
NEW16775,DISEASE,oxygen uptake,early afterdepolarizations
NEW16776,CHEMICAL,oxygen uptake,potassium current
NEW16779,BIOCHEMICAL,aids pandemic,available antiviral therapies
NEW16781,BIOCHEMICAL,vif-a3f,antiviral drug development
NEW16782,NUTRITION,vif-a3f,impaired intracellular cholesterol trafficking
NEW16784,CHEMICAL,tisafp8,isoform TisAFP6
NEW16785,MENTAL_HEALTH,great depression,greatest depression
D018690,BIOCHEMICAL,Excitatory Amino Acid Agonists,"Agonist, EAA|Amino Acid Agonist, Excitatory|Glutamate Agonists|Agonists, Glutamate|Amino Acids, Excitatory, Agonists|EAA Agonists|Glutamate Agonist|EAA Agonist|Amino Acid Agonists, Excitatory|EAA agonists|Agonists, Excitatory Amino Acid|Agonist, Glutamate|Agonists, EAA|Excitatory Amino Acid Agonist"
NEW16787,DISEASE,"5-ht2 agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane",dose-dependent behavioural syndrome similar
NEW16789,CHEMICAL,behavioral syndrome,gamma-D-glutamyl-amino-methylsulfonic acid
NEW16790,CHEMICAL,behavioral syndrome,DL-2-amino-5 phosphonovalerate
NEW16795,DISEASE,dietary soy isoflavone intervention,metabolic syndrome markers
NEW16796,DISEASE,dietary soy isoflavone intervention,RA homeostasis
NEW16797,DISEASE,dietary soy isoflavone intervention,local RA degradation
NEW16800,DISEASE,rar antagonist,MCMV infection
NEW16803,DISEASE,indolic antimicrobial metabolite,pathogen infection
NEW16804,CHEMICAL,indolic antimicrobial metabolite,camalexin biosynthesis
NEW16808,DISEASE,conclusion dexamethasone,moderate CTS cases
NEW16809,MENTAL_HEALTH,conclusion dexamethasone,proteolytic resistance
NEW16811,CHEMICAL,fty720 administration,sunitinib treatment
NEW16812,DISEASE,fty720 administration,tumor growth inhibition effect
NEW16816,BIOCHEMICAL,locomotion hyperactivity phenotype,mAChR antagonists
NEW16817,DISEASE,chronic intermittent hypoxia,hypoxia-induced hypertension
NEW16819,DISEASE,adipose-produce hormone leptin,upper airway obstruction
NEW16822,DISEASE,chronic epilepsy model,chronic epilepsy model
NEW16824,CHEMICAL,bile sequestrant,bile salt reabsorption
NEW16825,BIOCHEMICAL,bile sequestrant,sequestrant
NEW16827,CHEMICAL,chromosome autistic psychotic rett syndrome child,folic-acid-depleted medium
NEW16830,CHEMICAL,5-hydroxy-indoleacetic acid,standard urinary amino acid detection testing methods
NEW16831,CHEMICAL,5-hydroxy-indoleacetic acid,low-phenylalanine diets
NEW16832,MENTAL_HEALTH,5-hydroxy-indoleacetic acid,more perseveration
NEW16834,DISEASE,glucolipid metabolism disorder,metabolic liver disease
NEW16838,DISEASE,range phytotoxin,B. glumae
NEW16842,BIOCHEMICAL,Drug Commission,new antihistamines
NEW16843,CHEMICAL,Drug Commission,CNS-stimulation
NEW16846,NUTRITION,cadmium treatment,wheat cultivars
NEW16847,DISEASE,cadmium treatment,necrotic patches
NEW16851,DISEASE,clinical syndrome,HIT platelet count
NEW16852,DISEASE,clinical syndrome,associated disseminated intravascular coagulation
NEW16853,DISEASE,clinical syndrome,fondaparinux-associated HIT
NEW16854,DISEASE,clinical syndrome,heparin's flush'-induced HIT
NEW16856,DISEASE,nascent pf4-ahit-igg complex,additional heparin-dependent HIT antibodies
NEW16858,CHEMICAL,"new p(1),p(4)-di(adenosine-5 tetraphosphate ap4a derivative",platelet P2Y1
NEW16861,MENTAL_HEALTH,acid content,analyzer DNA fragmentation
NEW16862,CHEMICAL,acid content,amino acid analyzer
NEW16864,MENTAL_HEALTH,ralstonia spp,treatment-refractory schizophrenia
NEW16867,CHEMICAL,plasma homocysteine level,polymorphism SNP MTHFR C677 T
NEW16870,DISEASE,spot seal pup,mild hemolytic disorder due
NEW05266,BIOCHEMICAL,circadian disruption-induced metabolic syndrome,abused drug
NEW16872,CHEMICAL,circadian disruption-induced metabolic syndrome,alpha-tocopherol-enriched chow
NEW16875,DISEASE,serum thiobarbituric acid reactive substance,collagen-induced platelet aggregation responses
NEW16878,CHEMICAL,prenylflavonoid xanthohumol,[3H]EBOB binding
NEW16879,MENTAL_HEALTH,prenylflavonoid xanthohumol,GABA-induced displacement
NEW16881,DISEASE,subclinical vitamin deficiency other,cerebral impairment
NEW16882,DISEASE,subclinical vitamin deficiency other,vasomotor sympathetic activity
NEW16883,DISEASE,subclinical vitamin deficiency other,inflexibility
NEW16884,DISEASE,subclinical vitamin deficiency other,compulsivity
NEW16886,DISEASE,coumestrol binding,microglia-mediated inflammation
C108134,CHEMICAL,"TPS10 protein, Arabidopsis [Supplementary Concept]",Arabidopsis Proteins|(E)-β-ocimene|Intramolecular Lyases
NEW16887,CHEMICAL,coumestrol binding,lunatus (E)-β-ocimene synthase
NEW16888,NUTRITION,coumestrol binding,crayfish consumption
NEW16889,DISEASE,coumestrol binding,related Haff disease
NEW16890,DISEASE,coumestrol binding,mental sluggishness
NEW16892,DISEASE,crayfish muscle,rhabdomyolysis disease animal model
NEW16893,BIOCHEMICAL,crayfish muscle,potential toxin tool
NEW16896,BIOCHEMICAL,nivolumab immune checkpoint inhibitor,P2-purinoceptor antagonist
NEW16897,MENTAL_HEALTH,nivolumab immune checkpoint inhibitor,field-induced cathodal orientation
NEW16899,BIOCHEMICAL,promising drug molecule,drug molecules
NEW16900,MENTAL_HEALTH,promising drug molecule,protein orientation
NEW16902,DISEASE,morbid vasospasm,stomachache
NEW16903,DISEASE,morbid vasospasm,nervousness/restlessness
NEW16904,MENTAL_HEALTH,morbid vasospasm,mucosal immune depression
D000072230,DISEASE,Sustained Virologic Response,"viral suppression|Sustained Viral Suppressions|Virologic Response, Sustained|Sustained Virologic Responses|Suppression, Sustained Viral|Response, Sustained Virologic|Sustained Viral Suppression"
NEW16909,CHEMICAL,carotenoid standard,isoFOH
C483031,CHEMICAL,fucoxanthinol [Supplementary Concept],beta Carotene/analogs  and  derivatives|FOH|fucoxanthinol
NEW16910,CHEMICAL,carotenoid standard,mactraxanthin|MX
D018814,BIOCHEMICAL,Multiple Endocrine Neoplasia Type 2b,"Multiple Endocrine Neoplasms Type 2b|Syndrome, Wagenmann-Froboese|Multiple Endocrine Neoplasia, Type IIb|MEN 2b|Neuroma Syndrome, Mucosal|MEN III|MEA 2b|MEN2b|Mucosal Neuroma Syndrome|MEA IIb|Neuromata, Mucosal, With Endocrine Tumors|Wagenmann Froboese Syndrome|multiple endocrine neoplasia|MEN IIb|Mucosal Neuroma Syndromes|MEN 3|Neoplasia, Multiple Endocrine Type 2b|Neoplasms, Multiple Endocrine Type 2b|Wagenmann-Froboese Syndrome|Multiple Endocrine Neoplasia, Type 2b"
NEW16912,DISEASE,multiple linear regression,multiple endocrine neoplasia 2|MEN2
NEW16915,DISEASE,metastatic mtc,unilateral testis involvement
NEW16917,CHEMICAL,sodium nitrite intoxication,saponated cresol solution
NEW16919,DISEASE,Chilto powder,glucose adsorption
NEW16920,CHEMICAL,Chilto powder,glucose diffusion rate
NEW16922,CHEMICAL,human aggression,isotope cisternography
NEW16923,CHEMICAL,progesterone nucleus,progesterone nucleus
NEW16924,DISEASE,deficit hypersensitivity disorder,deficit hypersensitivity disorder
NEW16925,DISEASE,nasal decongestion,nasal decongestion
NEW16927,DISEASE,systemic antifungal drug,Cryptococcus neoformans meningitis
NEW16932,DISEASE,tyrosine analog,bone marrow B cells
NEW16934,BIOCHEMICAL,drug-induced delirium,opioid drug groups
NEW16936,DISEASE,anabolic androgen steroid user,more anger issues
NEW16939,CHEMICAL,n-9 user,N-9 users
D002305,DISEASE,Cardiac Tamponade,"Tamponades, Cardiac|Pericardial Tamponades|Tamponades, Pericardial|Cardiac Tamponades|Tamponade, Cardiac|cardiac tamponade|Tamponade, Pericardial|Pericardial Tamponade"
D006342,DISEASE,"Heart Rupture, Post-Infarction","Post-Infarction Heart Rupture|Post Infarction Heart Rupture|Heart Ruptures, Post-Infarction|heart rupture|Cardiac Ruptures, Post-Infarction|Ruptures, Post-Infarction Heart|Rupture, Post-Infarction Cardiac|Heart Rupture, Post Infarction|Post-Infarction Cardiac Rupture|Post-Infarction Cardiac Ruptures|Ruptures, Post-Infarction Cardiac|Rupture, Post-Infarction Heart|Cardiac Rupture, Post-Infarction|Cardiac Rupture, Post Infarction|Post-Infarction Heart Ruptures"
NEW16941,DISEASE,acute cocaine intoxication,massive myocardial infarction
NEW16944,CHEMICAL,similar death,cocaine abuser
D020921,DISEASE,Sleep Arousal Disorders,"arousal disorders|Confusional Arousal|Confusional Arousals|Arousal, Confusional|Arousals, Confusional|Sleep Arousal Disorder|Arousal Disorder, Sleep|Arousal Disorders, Sleep"
NEW16945,MENTAL_HEALTH,similar death,sexsomnia eating disorder
NEW16946,BIOCHEMICAL,similar death,drug consumption
NEW16947,MENTAL_HEALTH,similar death,lower insulin resistance
NEW16948,CHEMICAL,acid exposure,acid exposure
NEW16950,CHEMICAL,letrozole stimulation,calcium metabolism parameters
D018823,CHEMICAL,gamma-Endorphin,"gamma Endorphin|endorphin|Endorphin, gamma|beta-Endorphin (1-17)"
NEW16954,DISEASE,neurometabolic factor,spikelet degeneration phenotype
NEW16957,CHEMICAL,hippocampal-dependent behavior,PGC-1α+/+ mice
NEW16958,BIOCHEMICAL,hippocampal-dependent behavior,uppermost carotenoid tertile
NEW16959,BIOCHEMICAL,mixed-effects regression model,E individual carotenoids
NEW16960,DISEASE,mixed-effects regression model,PRV|previtellogenic
NEW16965,DISEASE,estrogen therapy,coronary heart disease oral
NEW16966,MENTAL_HEALTH,estrogen therapy,suicide vulnerability
NEW16967,NUTRITION,estrogen therapy,hemicellulose hydrolysates
NEW16968,CHEMICAL,estrogen therapy,phenolic compounds
NEW16969,DISEASE,estrogen therapy,hypertension dyslipdaemia
NEW16972,MENTAL_HEALTH,phthalate metabolite concentration,ADHD symptom traits
NEW16974,BIOCHEMICAL,xenobiotic agonist,hepatic drug metabolizing enzymes
NEW16976,BIOCHEMICAL,functional drug metabolism,functional drug metabolism
NEW16978,CHEMICAL,medium-sized projection neuron,striatum tonic GABA currents
NEW16979,DISEASE,medium-sized projection neuron,peripheral infection
D024221,DISEASE,Antineoplastic Protocols,"Cancer Treatment Protocol|Antineoplastic Protocol|Protocols, Antineoplastic|Protocol, Cancer Treatment|cancer treatment|Cancer Treatment Protocols|Protocol, Antineoplastic|Treatment Protocol, Cancer|Treatment Protocols, Cancer|Protocols, Cancer Treatment"
C536697,DISEASE,WHIM syndrome [Supplementary Concept],WHIM syndrome|Primary Immunodeficiency Diseases|Warts
D019529,DISEASE,Sexuality,sexuality|Sex Behavior (1974-1996)
NEW16985,DISEASE,female androgen insufficiency syndrome,psychiatric regimens
NEW16986,BIOCHEMICAL,female androgen insufficiency syndrome,serotonin 5HT1B receptor agonist
NEW16987,DISEASE,female androgen insufficiency syndrome,lethal hemorrhagic infection
NEW16988,DISEASE,female androgen insufficiency syndrome,human herpes viruses
NEW16989,BIOCHEMICAL,female androgen insufficiency syndrome,potent antiviral agent
NEW16990,DISEASE,female androgen insufficiency syndrome,various viral infections
NEW16991,BIOCHEMICAL,female androgen insufficiency syndrome,drug metabolites
NEW16994,CHEMICAL,tourette patient,urinary beta-phenylethylamine level
NEW16996,MENTAL_HEALTH,urinary beta-phenylethylamine level,Tourette Syndrome Global Scale
D014418,NUTRITION,Tupaiidae,"Tree Shrews|Tupaiinae|Tree Shrew|Shrews, Tree|Treeshrew|tree shrews|Ptilocercus|Treeshrews|Shrew, Tree"
NEW17001,CHEMICAL,regression equation,tailor-made pectins
NEW17002,CHEMICAL,regression equation,lower testosterone
NEW17003,CHEMICAL,regression equation,decreased plasma testosterone
NEW17004,DISEASE,regression equation,pioglitazone more weight loss
NEW17005,MENTAL_HEALTH,tnfα-induced insulin resistance,TNFα-induced insulin resistance
NEW17007,MENTAL_HEALTH,cytoplasmic human uterine progesterone receptor,monophasic first order dissociation curve
NEW17010,CHEMICAL,label steroid,dextran-coated charcoal treatment
NEW17012,DISEASE,80-gene molecular subtyping profile,cancer patient
NEW17014,CHEMICAL,mesolimbic dopamine da system,DA antagonism
NEW17015,DISEASE,mesolimbic dopamine da system,related hypersomnia
D000668,CHEMICAL,Ampicillin Resistance,"Resistance, Ampicillin|ampicillin|Resistances, Ampicillin|Ampicillin Resistances"
NEW17018,BIOCHEMICAL,strain e13 t (= dsm t,acquired antibiotic resistance genes
NEW17019,CHEMICAL,strain e13 t (= dsm t,tet(D tetracycline resistance genes
C057416,CHEMICAL,KT 5720 [Supplementary Concept],KT5720|Pyrroles|Carbazoles
NEW17020,CHEMICAL,strain e13 t (= dsm t,8-HO-DPAT
NEW17021,MENTAL_HEALTH,memory disorder due,memory disorders due
NEW17024,MENTAL_HEALTH,dha intake,current depressive disorder
NEW17027,BIOCHEMICAL,α5/5 conotoxin isomer,venom gland
NEW17028,DISEASE,gaba signaling,myoclonic seizure susceptibility
NEW17030,BIOCHEMICAL,erythroleukemia cell line,mM vitamin E
NEW17034,MENTAL_HEALTH,cherax destructor hemocyanin,alkaline dissociation product
D064286,CHEMICAL,ATP Binding Cassette Transporter 1,"Cholesterol-Efflux Regulatory Protein|dATP|ATP|Cholesterol Efflux Regulatory Protein|ATP-Binding Cassette Sub-Family A Member 1|ABCA1 Protein|CERP Protein|ATP Binding Cassette Transporter, Subfamily A, Member 1|ATP Binding Cassette Sub Family A Member 1"
NEW17039,DISEASE,glyceraldehyde-derived ages,strong neurotoxicity
NEW17041,DISEASE,peroxiproliferator-activated receptor alpha agonist,ocular ischemia
NEW17042,DISEASE,uccao-induced retinal dysfunction,UCCAO-induced retinal dysfunction
NEW17043,DISEASE,mixed dyslipidemia,mixed dyslipidemia
NEW17046,DISEASE,third-generation fibric acid derivative,experimental ischemia/reperfusion injury
NEW17048,MENTAL_HEALTH,fenofibrate therapy,myocardial insulin resistance
NEW17049,MENTAL_HEALTH,fenofibrate therapy,intrahepatic resistance
D011170,DISEASE,"Portasystemic Shunt, Surgical","Shunt, Portosystemic|Surgical Portosystemic Shunt|Shunt, Surgical Portosystemic|Surgical Portosystemic Shunts|portosystemic shunts|Surgical Portasystemic Shunt|Portasystemic Shunts, Surgical|Portosystemic Shunt, Surgical|Shunt, Surgical Portasystemic|Shunts, Surgical Portosystemic|Portosystemic Shunts|Shunts, Portasystemic|Portasystemic Shunts|Surgical Portasystemic Shunts|Shunts, Portosystemic|Portosystemic Shunt|Shunt, Portasystemic|Portosystemic Shunts, Surgical|Portasystemic Shunt|Shunts, Surgical Portasystemic"
NEW17050,DISEASE,fenofibrate therapy,extensive HPC damage
NEW17051,MENTAL_HEALTH,fenofibrate therapy,scopolamine-induced amnesia
NEW17054,CHEMICAL,pectin receptor,substrate-bound chemicals
NEW17056,MENTAL_HEALTH,somatotopic projection,chemosensory orientation
NEW17057,CHEMICAL,somatotopic projection,p-T305-CaMKII
NEW17059,CHEMICAL,rt inhibitor,NE children
NEW17062,MENTAL_HEALTH,mild-to-moderate erectile dysfunction,mild-to-moderate erectile dysfunction
D000040,CHEMICAL,Abscisic Acid,"Abscisic Acid, (+,-)-Isomer|Abscisic Acid, (E,Z)-(+,-)-Isomer|Abscisic Acid, (R)-Isomer|Abscissic Acid|Abscissins|2,4-Pentadienoic acid, 5-(1-hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-, (S-(Z,E))-|Abscisic Acid Monoammonium Salt, (R)-Isomer|abscisic acid|Abscisic Acid, (Z,E)-Isomer|Abscisic Acid, (E,E)-(+-)-Isomer"
NEW17065,DISEASE,ndma-induced toxicity,NDMA-induced toxicity
NEW17067,DISEASE,long-term liquorice ingestion,hypokalaemic periodic paralysis
NEW17068,DISEASE,long-term liquorice ingestion,ROT-induced cell death
NEW17070,DISEASE,nicotine administration,factor CRF systems
C090047,CHEMICAL,skin peptide tyrosine-tyrosine [Supplementary Concept],peptide tyrosine tyrosine|Pancreatic Polypeptide
D050418,CHEMICAL,Pancreatic Polypeptide-Secreting Cells,"Pancreatic PP Cell|Pancreatic Polypeptide Cells|Cells, Pancreatic Polypeptide-Secreting|PP Cell, Pancreatic|Pancreatic Polypeptide Cell|pancreatic polypeptide|Pancreatic PP Cells|Pancreatic Polypeptide Secreting Cells|PP Cells, Pancreatic|Pancreatic Polypeptide-Secreting Cell|Cell, Pancreatic Polypeptide-Secreting|PP"
NEW17074,DISEASE,ee/ln ee/drsp coc treatment,pancreatic β-cell dysfunction
NEW17075,DISEASE,ee/ln ee/drsp coc treatment,atherothrombosis
NEW17076,DISEASE,ee/ln ee/drsp coc treatment,cellular metabolic derangements
NEW17077,MENTAL_HEALTH,ee/ln ee/drsp coc treatment,Beck Depression
NEW17079,CHEMICAL,consecutive hypertensive patient,Irbesartan Treatment
NEW17081,CHEMICAL,gastrointestinal bacterial community,bacterial-derived metabolites
NEW17082,CHEMICAL,gastrointestinal bacterial community,PM-exposure
NEW17084,DISEASE,anti-gamma aminobutyric acid b receptor encephalitis,lung cancer patients
NEW17087,DISEASE,poison gland mucus,similar oral movements
C548518,CHEMICAL,"CEA X protein, human [Supplementary Concept]",Carcinoembryonic Antigen|CeA.
NEW17092,DISEASE,potent estrogen,psychic disorders related
NEW17093,DISEASE,endocrine therapy,advanced breast cancer
NEW17097,CHEMICAL,early breast cancer,non-hormonal modalities
NEW05586,DISEASE,new endocrine agent,advanced cancer
NEW17100,MENTAL_HEALTH,nbm ch neuron,indirect inhibitory projection
NEW17101,BIOCHEMICAL,nbm ch neuron,specific N-methyl-D-aspartate NMDA receptor antagonist 3-((+/-)-2-(carboxypiperazine-4-yl))-propyl-1-phosphonic acid
NEW17103,CHEMICAL,glutamatergic corticostriatal projection,KA neurotoxicity
D009812,DISEASE,Odorants,Aroma|Odorant|Aromas|aromas|Odor|Fragrance|Scents|Scent|Odors|Fragrances
D057093,CHEMICAL,Orphan Nuclear Receptors,"Nuclear Receptors, Orphan|NRs|Orphan Nuclear Receptor|Nuclear Receptor, Orphan|nuclear receptors|Receptor, Orphan Nuclear|Receptors, Orphan Nuclear"
NEW17106,MENTAL_HEALTH,pronamide administration,suicide inhibition
NEW17107,DISEASE,purine metabolism,Rett patients
NEW17108,DISEASE,purine metabolism,Rett children
NEW17111,CHEMICAL,photoadduct,peroxynitrite-modified biomolecules
D010282,DISEASE,Parathyroid Neoplasms,"Cancer of Parathyroid|Carcinoma, Parathyroid|Parathyroid Adenoma|Carcinomas, Parathyroid|Parathyroid Adenomas|Cancer of the Parathyroid|Parathyroid Carcinoma|Parathyroid Cancers|Cancer, Parathyroid|Parathyroid Cancer|Neoplasms, Parathyroid|Adenoma, Parathyroid|Parathyroid Neoplasm|Adenomas, Parathyroid|Parathyroid Carcinomas|parathyroid adenoma|Cancers, Parathyroid|Neoplasm, Parathyroid"
NEW17112,CHEMICAL,[(3)h]prazosin,[(3)H]prazosin
NEW17115,CHEMICAL,peroxiproliferator activate receptor γ agonist pioglitazone AK Scientific,rosiglitazone gamma agonist
NEW17116,CHEMICAL,peroxiproliferator activate receptor γ agonist pioglitazone AK Scientific,punctate calcium deposits
NEW17117,CHEMICAL,peroxiproliferator activate receptor γ agonist pioglitazone AK Scientific,mucopolysacharidosis type
NEW17118,CHEMICAL,peroxiproliferator activate receptor γ agonist pioglitazone AK Scientific,type GM1 gangliosidosis
D002869,DISEASE,Chromosome Aberrations,"Aberration, Cytogenetic|Abnormalities, Chromosomal|Cytogenetic Abnormalities|Chromosomal Aberrations|chromosomal abnormalities|Abnormality, Chromosomal|Autosome Abnormalities|Aberration, Chromosome|Abnormality, Chromosome|Aberrations, Chromosomal|Chromosomal Abnormality|Abnormality, Autosome|Abnormalities, Chromosome|Abnormality, Cytogenetic|Cytogenetic Abnormality|Chromosome Abnormalities|Chromosomal Abnormalities|Chromosome Abnormality|Aberrations, Cytogenetic|Chromosomal Aberration|Cytogenetic Aberration|Chromosome Aberration|Aberrations, Chromosome|Aberration, Chromosomal|Cytogenetic Aberrations|Autosome Abnormality|Abnormalities, Autosome|Abnormalities, Cytogenetic"
NEW17119,CHEMICAL,peroxiproliferator activate receptor γ agonist pioglitazone AK Scientific,maternal alcohol intoxication
NEW17121,BIOCHEMICAL,maternal hepatic lesion,estrogen receptor signaling
NEW17123,DISEASE,bpa exposure,migraine symptoms
NEW17125,DISEASE,bpa treatment,migraine-like behaviors
NEW17126,BIOCHEMICAL,bpa treatment,estrogen genes
NEW17128,DISEASE,pervasive xenoestrogen,migraine-like behavior
NEW17129,MENTAL_HEALTH,pervasive xenoestrogen,pseudopod projection
NEW17131,MENTAL_HEALTH,cholinergic projection,anxiety associated cardiovascular reactivity
NEW17135,DISEASE,iodine-rich drug,maternal tachyarrhythmias
NEW17136,DISEASE,iodine-rich drug,maternal/fetal tachyarrhythmias
NEW17137,DISEASE,iodine-rich drug,term toxemia
D058927,CHEMICAL,5-Lipoxygenase-Activating Proteins,zileuton|Arachidonate 5 Lipoxygenase Activating Protein|5 Lipoxygenase Activating Protein|Arachidonate 5-Lipoxygenase Activating Proteins|5-lipoxygenase|5 LO Activating Protein|5 Lipoxygenase Activating Proteins|Arachidonate 5-Lipoxygenase Activating Protein|5-LO-Activating Protein|Arachidonate 5 Lipoxygenase Activating Proteins|5-Lipoxygenase-Activating Protein
NEW17142,DISEASE,cynanchi atrati,acute urinary infection
NEW17143,DISEASE,skin inflammation process,skin inflammation process
NEW17144,DISEASE,rtt patient,RTT erythrocytes
NEW17148,DISEASE,in trolox treatment,complex Rett phenotype
NEW17149,BIOCHEMICAL,in trolox treatment,vitamin E-derivative based pharmacotherapy
NEW17150,DISEASE,in trolox treatment,hypoxia susceptibility
NEW17151,DISEASE,in trolox treatment,seizure-like discharges
NEW17153,BIOCHEMICAL,augmented mglur-induced long-term depression,mGluR1 antagonists
NEW17155,MENTAL_HEALTH,young-onset mouse,sleep-wake fragmentation
NEW17157,NUTRITION,dta-induced orexin neurodegeneration,steroid hormone biosynthesis metabolism
D057845,CHEMICAL,Pyrimidine Phosphorylases,"Phosphorylase, Pyrimidine Nucleoside|pyrimidine|Pyrimidine Nucleoside Phosphorylase|Phosphorylases, Pyrimidine|Nucleoside Phosphorylase, Pyrimidine"
NEW17158,CHEMICAL,dta-induced orexin neurodegeneration,purine metabolisms
NEW17159,CHEMICAL,dta-induced orexin neurodegeneration,carnitine acylation
NEW17160,NUTRITION,dta-induced orexin neurodegeneration,disturbed phospholipid metabolism
NEW17164,NUTRITION,diacylglycerol kinase dgk δ,acid (SFA)-
NEW17165,NUTRITION,diacylglycerol kinase dgk δ,monounsaturated fatty acid (MUFA)-containing phosphatidic acids
NEW17166,DISEASE,mood impairment,mood impairments
NEW17169,DISEASE,bacillus sp. b87,three-component non-hemolytic enterotoxin
D030262,NUTRITION,Soybean Proteins,"Protein, Soybean|Bean Protein, Soy|Soy Proteins|Soy Protein|Protein, Soy Bean|Dietary Soybean Protein|Soybean Proteins, Dietary|Soybean Protein, Dietary|Soy Bean Proteins|Proteins, Soy|Soy Bean Protein|Protein, Soy|Dietary Soybean Proteins|Protein, Dietary Soybean|Soybean Protein|soybean|Proteins, Dietary Soybean"
NEW17172,MENTAL_HEALTH,immunogenic neoantigen,regularized regression model
NEW17174,DISEASE,differential ion mobility spectrometry,optic nerve dysmorphogenesis
NEW17178,MENTAL_HEALTH,nonlinear regression analysis,nonlinear regression analysis
NEW17181,CHEMICAL,trauma anxiety disorder,bromdihydrochlorphenylbenzodiazepine
NEW17182,DISEASE,trauma anxiety disorder,PTHS.SIGNIFICANCE STATEMENT Pitt-Hopkins syndrome
NEW17184,MENTAL_HEALTH,serotonin metabolism,primary endogenous depression
NEW17186,CHEMICAL,strong antidepressant effect,strong antidepressant effect
D015473,DISEASE,"Leukemia, Promyelocytic, Acute","Leukemia, Progranulocytic|Acute Promyelocytic Leukemias|Leukemia, Myeloid, Acute, M3|Progranulocytic Leukemia|Myeloid Leukemia, Acute, M3|Leukemia, Acute Promyelocytic|acute promyelocytic leukemia|ANLL, M3|M3 ANLL|Promyelocytic Leukemia, Acute|AML M3|Acute Promyelocytic Leukemia"
NEW17188,CHEMICAL,opiate partial agonist buprenorphine,increased ATRA metabolism
NEW17189,DISEASE,opiate partial agonist buprenorphine,hematological abnormalities
NEW17193,DISEASE,combined blindness,AHDS patients
NEW17194,CHEMICAL,combined blindness,serum malonyl dialdehyde
NEW17196,DISEASE,atherosclerotic burden,atherosclerotic burden
NEW17197,DISEASE,rts group,RTS groups
NEW17198,BIOCHEMICAL,plasma lycopene isomer,plasma lycopene isomers
NEW17199,CHEMICAL,energetic kyn,energetic Kyn
NEW17201,DISEASE,tryptophan intervention,reactive aggression
NEW17208,DISEASE,neurotoxic pathway,fewer cognitive deficits
NEW17211,NUTRITION,continuous oligonol treatment,tree nuts
D055728,DISEASE,Primary Myelofibrosis,"Fibrosis, Bone Marrow|Metaplasias, Agnogenic Myeloid|Myelosis, Nonleukemic|Myelofibrosis|Myelofibroses, Primary|Metaplasia, Agnogenic Myeloid|Metaplasia, Myeloid|Nonleukemic Myelosis|Myeloid Metaplasia|Primary Myelofibroses|Myelofibroses|Nonleukemic Myeloses|Bone Marrow Fibrosis|Myeloses, Nonleukemic|Myeloid Metaplasias|Metaplasias, Myeloid|Myelofibrosis, Primary|Chronic Idiopathic Myelofibrosis|Idiopathic Myelofibrosis|myelofibrosis|Myelosclerosis|Myeloscleroses|Myeloid Metaplasia, Agnogenic|Myeloid Metaplasias, Agnogenic|Agnogenic Myeloid Metaplasias|Agnogenic Myeloid Metaplasia|Fibroses, Bone Marrow|Myelofibrosis With Myeloid Metaplasia|Bone Marrow Fibroses"
NEW17216,DISEASE,5-ht vomiting network,DAS-induced acute vomiting
NEW17217,DISEASE,5-ht vomiting network,relapsed multiple myeloma
NEW17219,CHEMICAL,p450c17 deficiency,steroid biosynthesis
NEW17221,CHEMICAL,cry1a toxin,Mg2 signaling pathway
NEW17222,DISEASE,cry1a toxin,6-OHDA-induced neurotoxicity
NEW17227,CHEMICAL,opposite neuroactivitie,standard anxiogens
NEW17228,CHEMICAL,opposite neuroactivitie,anxiogenic NEKY
NEW17231,DISEASE,don contamination level,harvested grain
NEW17234,CHEMICAL,bayesian logistic regression,×    NTX treatment
NEW17235,CHEMICAL,bayesian logistic regression,NTX treatment
D053779,CHEMICAL,Latent TGF-beta Binding Proteins,Latent TGF-beta Binding Protein|Latent TGF beta Binding Protein 3|Latent TGF-beta Binding Protein 4|TGF-β|Latent TGF beta Binding Protein|Latent TGF-beta Binding Protein 1|Latent TGF beta Binding Protein 1|Latent TGF beta Binding Protein 4|Latent TGF-beta Binding Protein 3|Latent TGF beta Binding Protein 2|Latent TGF beta Binding Proteins|Latent TGF-beta Binding Protein 2
NEW17238,MENTAL_HEALTH,soybean protoplast,transcriptional repression activities
NEW17239,DISEASE,soybean protoplast,memory defects
NEW17240,CHEMICAL,soybean protoplast,high 7-dehydrocholesterol
NEW17241,DISEASE,vitamin e supplementation,SLOS patients
D002819,DISEASE,Chorea,"Choreiform Movement|Chorea, Hereditary|Syndrome, Chorea|Chorea Syndrome|Choreatic Disorder|Chorea, Chronic Progressive|St. Vitus Dance|Movement, Choreic|Chorea Disorders|Choreic Movement|Chronic Progressive Chorea|Chorea, Benign Hereditary|Hereditary Chorea, Benign|Disorders, Chorea|Choreic Movements|Sydenham Choreas|Benign Hereditary Chorea|Progressive Choreas, Chronic|Chorea, Sydenham's|Hereditary Progressive Chorea Without Dementia|Senile Choreas|Chronic Progressive Choreas|Chorea, Senile|Paroxysmal Dyskinesias|Sydenham Chorea|Movements, Choreic|Choreas, Hereditary|Dyskinesias, Paroxysmal|Choreatic Syndromes|Choreas, Sydenham|Rheumatic Choreas|Choreas|Chorea, Sydenham|St. Vituss Dance|Dyskinesia, Paroxysmal|St. Vitus's Dances|Senile Chorea|Progressive Chorea, Chronic|Hereditary Chorea|Rheumatic Chorea|Movements, Choreiform|Choreas, Benign Hereditary|Choreatic Syndrome|St. Vitus's Dance|Paroxysmal Dyskinesia|Syndrome, Choreatic|Chorea, Rheumatic|Sydenhams Chorea|Choreas, Senile|Disorder, Chorea|Choreatic Disorders|Chorea Disorder|Choreas, Rheumatic|Syndromes, Choreatic|Disorder, Choreatic|Hereditary Choreas|Choreas, Chronic Progressive|Disorders, Choreatic|Movement, Choreiform|Hereditary Choreas, Benign|Chorea Syndromes|Syndromes, Chorea|Choreiform Movements|Sydenham's Chorea|choreiform movements|Benign Hereditary Choreas"
NEW17243,CHEMICAL,leucine incorporation,leucine/min/microgram
NEW17244,DISEASE,atherosclerotic cerebral infarction,atherosclerotic cerebral infarction
NEW17246,DISEASE,zinc deficiency,thyroid function disorders
NEW17248,DISEASE,glutamic acid decarboxylase isoform,chronic psychotic disorders
NEW17252,DISEASE,ala supplementation,mg/kg catalepsy dose
NEW17253,DISEASE,ala supplementation,HAL-induced TD
NEW17255,DISEASE,metabolite dihydro lipoic acid,obstetrical infections
NEW17257,DISEASE,myotoxic complication,myotoxic complication
NEW17258,BIOCHEMICAL,novel toxin,novel toxins
NEW17261,MENTAL_HEALTH,bite envenoming,appropriate analgesia
D000081030,DISEASE,Myotoxicity,"Myalgia-Arthralgia Syndrome|Drug Induced Myopathy|Induced Myopathy, Drug|Drug Related Myopathies|Myopathy, Toxic|Myopathy, Drug Associated|Drug Induced Myopathies|Drug Related Myopathy|Myopathy, Drug Induced|Related Myopathies, Drug|Drug Associated Myopathies|Myalgia Arthralgia Syndrome|myotoxicity|Toxic Myopathies|Toxic Myopathy|Myalgia-Arthralgia Syndromes|Related Myopathy, Drug|Myopathies, Drug Related|Myopathy, Drug Related|Drug Associated Myopathy|Myotoxicities"
C096915,MENTAL_HEALTH,"FXR2 protein, human [Supplementary Concept]",RNA-Binding Proteins|fragile X mental retardation gene
NEW17266,BIOCHEMICAL,schisandrae lignan,sympathomimetic vasoconstriction
NEW17269,NUTRITION,hepatotoxic metabolite,omega-3 fatty acid family
NEW17270,DISEASE,hepatotoxic metabolite,central deficits
NEW17274,NUTRITION,pufa composition,monounsaturated fatty acid composition
NEW17276,MENTAL_HEALTH,age-related reduction,petiole orientation
NEW17277,DISEASE,age-related reduction,human encephalitis
NEW17279,DISEASE,de adnp mutation,intractable autism/intellectual disability syndrome
NEW17280,DISEASE,de adnp mutation,exogenous hypercalcemia
NEW17282,DISEASE,calcium sulfate bead,postoperative hardware infections
NEW17283,CHEMICAL,calcium sulfate bead,recombinant human superoxide dismutase
NEW17284,CHEMICAL,calcium sulfate bead,L-citrulline
NEW17285,DISEASE,calcium sulfate bead,Parkinsonism syndrome
NEW17287,BIOCHEMICAL,lung mitochondrial dysfunction present,high dietary vitamin E.
NEW17288,MENTAL_HEALTH,histamine neuron,insomnia dual orexin receptor antagonists
NEW17290,DISEASE,proline content,stimulus shock termination
NEW17291,DISEASE,proline content,postprandial triglyceride-rich lipoproteins|TRLs
NEW17292,NUTRITION,proline content,small dense low-density lipoprotein LDL particles
NEW17293,NUTRITION,proline content,low-density lipoprotein particles
NEW17295,DISEASE,cucumber vascular wilt disease,cucumber vascular wilt disease
NEW17297,DISEASE,serum ua concentration,first-episode manic patients
NEW17299,CHEMICAL,first-episode bpd,serum UA
NEW17300,CHEMICAL,first-episode bpd,GSK3β phosphorylation
NEW17301,MENTAL_HEALTH,first-episode bpd,Akt repression
NEW17302,CHEMICAL,double-blind controlled trial progabide,double-blind controlled trial progabide
NEW17303,CHEMICAL,progabide treatment,progabide treatment
NEW17305,NUTRITION,% grje dietary supplementation,juvenile black rockfish
NEW17307,NUTRITION,SsCCL25,black rockfish
NEW17310,DISEASE,elagolix exposure,moderate/severe renal impairment
NEW17311,DISEASE,elagolix exposure,mild hepatic impairment
NEW17314,CHEMICAL,elagolix dose,A205
C536897,DISEASE,Tang Hsi Ryu syndrome [Supplementary Concept],Pigmentation Disorders|Nervous System Diseases|oedema|Splenomegaly|Hepatomegaly
NEW17317,BIOCHEMICAL,bite venom,bite venom
NEW17321,DISEASE,sanocrysin,tuberculosis animals
NEW17322,CHEMICAL,sanocrysin,myochrysine gold salts
NEW17328,MENTAL_HEALTH,resistance mdr1a/b knockout mouse,resistance mdr1a/b knockout mice
NEW17330,BIOCHEMICAL,constipation-induced reduction,peripheral mu-opioid receptor antagonist
NEW17333,CHEMICAL,pantoea ananatis brt175,arginine ABC transporter permease subunit gene
NEW17335,DISEASE,importance formylaminooxyvinylglycine,pathogen Erwinia amylovora
NEW17339,DISEASE,dietary proanthocyanidin,meticillin-resistant Staphylococcus aureus
D000077299,DISEASE,Healthcare-Associated Pneumonia,"Hospital Acquired Pneumonia|nosocomial pneumonia|Healthcare-Associated Pneumonias|Pneumonia, Hospital Acquired|Hospital Acquired Pneumonias|Nosocomial Pneumonias|Nosocomial Pneumonia|Healthcare Associated Pneumonia|Pneumonia, Nosocomial|Pneumonia, Healthcare-Associated"
NEW17341,DISEASE,linezolid therapy,difficile-related diarrhoea
D020314,DISEASE,Central Nervous System Fungal Infections,"Infections, CNS Fungal|fungal infections|CNS Fungal Infection|Fungal Infections, CNS|Infections, Fungal, Central Nervous System|Mycoses, Central Nervous System|CNS Fungal Infections|Infection, CNS Fungal|Central Nervous System Mycoses|Fungal Infection, CNS|Fungal Infections, Central Nervous System"
NEW17342,DISEASE,linezolid therapy,serotonin-like syndrome
D001066,DISEASE,Appetite,"Alteration, Appetite|Appetite Alterations|alterations|Alterations, Appetite|Appetites|Appetite Alteration"
NEW17343,DISEASE,linezolid therapy,multidrug-resistant infections
NEW17345,DISEASE,melatonin mt(1 receptor,particular RBD
NEW17346,DISEASE,primary herpes,primary herpes
NEW17347,DISEASE,orolabial,orolabial
NEW17350,DISEASE,recurrent hsv-i infection hsv-i,HSV-related folliculitis
D065310,DISEASE,Squamous Intraepithelial Lesions of the Cervix,Epithelial Cells (1996-2014)|lesions
NEW17352,DISEASE,antagonist muscle,primary ataxic syndromes
NEW17353,DISEASE,antagonist muscle,akinetic syndromes
NEW17355,DISEASE,neuro-transmitter serotonin,eating behaviour
D058907,BIOCHEMICAL,Adenosine A1 Receptor Agonists,"Receptor, Adenosine A1/agonists (2004-2010)|A1 receptor agonists"
NEW17357,MENTAL_HEALTH,nervosa serotonin agonist,pure dextral displacement
NEW17358,DISEASE,nervosa serotonin agonist,endotoxin-induced acute lung injury
NEW17360,BIOCHEMICAL,glitazone class,glitazones class
D017637,DISEASE,Clonal Deletion,"Clonal Deletions|Clonal Abortion|deletions|Deletions, Clonal|Abortions, Clonal|Deletion, Clonal|Abortion, Clonal|Clonal Abortions"
NEW17362,DISEASE,fly gd model,obstructive sleep apnea/hypopnea syndrome
C012526,CHEMICAL,quercitrin [Supplementary Concept],Quercetin/analogs  and  derivatives|quercetin-3-O-rhamnoside
NEW17364,DISEASE,dissociation constant,metabolic stroke
NEW17371,CHEMICAL,high-carbohydrate level,p-adenosine monophosphate (AMP)-activated protein kinase
NEW17372,DISEASE,high-carbohydrate level,weight gain rate
NEW17373,DISEASE,steroid-resistant chronic graft-versus-host disease,steroid-resistant chronic graft-versus-host disease
NEW17375,DISEASE,tn crt2,hemolytic assay
NEW17378,DISEASE,testosterone level,male VaD patients
NEW17379,DISEASE,estradiol level,female VaD patients
NEW17382,MENTAL_HEALTH,meningeal inflammation,trinitrate-induced delayed headache
NEW17384,DISEASE,conventional μ-opioid receptor agonist,IC/PBS pain
NEW17385,DISEASE,conventional μ-opioid receptor agonist,pain hypersensitivity
NEW17389,MENTAL_HEALTH,ethanol-induced analgesia,ethanol-induced analgesia
NEW17391,DISEASE,plp deficiency,hyperhomocysteinemia MTHFR gene mutation
NEW17392,BIOCHEMICAL,plp deficiency,antigen (HLA)-haploidentical mother
NEW17393,DISEASE,gsh concentration,neuroblastoma cell lines
NEW17395,NUTRITION,faah gene,Spanish population sample
NEW17398,DISEASE,selective a2a receptor antagonist,akathisia-like behavior
NEW17401,CHEMICAL,one parenteral dopamine agonist,sphingomyelin SM profiles
D051147,CHEMICAL,Ganglioside Galactosyltransferase,"Ganglioside Beta-1-3-Galactosyltransferase, UDP-Galactose-GM2|Ganglioside GM1 Synthase|GM1 Synthase, Ganglioside|UDP Galactose-Ceramide Galactosyltransferase|Synthase, Ganglioside GM1|Cer|Galactosyltransferase, UDP Galactose-Ceramide|Beta1-3-Galactosyltransferase, UDPGal-GM2|ceramide|Beta-1-3-Galactosyltransferase, UDP-Galactose-GM2 Ganglioside|UDP Galactose GM2 Ganglioside Beta 1 3 Galactosyltransferase|Galactose-GM2 Galactosyltransferase, UDP|Galactosyltransferase, Ganglioside|UDP Galactose GM2 Galactosyltransferase|Galactosyltransferase, UDP Galactose-GM2|Galactose-Ceramide Galactosyltransferase, UDP|UDP Galactose-GM2 Galactosyltransferase|UDPGal GM2 Beta1 3 Galactosyltransferase|UDPGalactose-N-Acetylgalactosaminyl-(N-Acetylneuraminyl)-Galactosyl-Glucosyl-Ceramide Galactosyltransferase|UDPGal-GM2 Beta1-3-Galactosyltransferase|UDP-Galactose-GM2 Ganglioside Beta-1-3-Galactosyltransferase|UDP Galactose Ceramide Galactosyltransferase"
NEW17402,DISEASE,one parenteral dopamine agonist,streptozotocin-induced hyperglycemia
NEW17404,DISEASE,avp action,volume overload conditions
NEW17405,DISEASE,avp action,hyponatremic states
NEW17406,DISEASE,avp action,failure HF syndrome
C104999,CHEMICAL,acetyl-E VEALEKK VAALESK VQALEKK VEALEHG-amide [Supplementary Concept],Recombinant Proteins|V₁(a
NEW17407,MENTAL_HEALTH,avp action,severe major depression
NEW17408,NUTRITION,avp action,HIV-inhibiting MIP-1 alpha
C515429,NUTRITION,"CCL3 protein, human [Supplementary Concept]",Chemokine CCL3|MIP-1 alpha
NEW17409,CHEMICAL,depressed individual,current antidepressant treatments
NEW17411,CHEMICAL,depressed participant,higher cortisol levels
NEW17412,DISEASE,depressed participant,negative psychotic symptoms
NEW17413,CHEMICAL,depressed participant,adjunctive raloxifene
NEW17417,DISEASE,mixed micro-/kappa-opioid analgesic,OCD 2012
NEW17420,MENTAL_HEALTH,ser-the aggression,locomotor hyperactivity
NEW17422,CHEMICAL,cocaine locomotor hyperactivity,cocaine locomotor hyperactivity
NEW17425,DISEASE,low-dose ttx,severe treatment-resistant cancer pain
NEW17427,MENTAL_HEALTH,Aviophobia,orientation responses
NEW17428,CHEMICAL,Aviophobia,stress-induced cortisol elevation
NEW17429,CHEMICAL,Aviophobia,antidepressant discontinuation
NEW17430,CHEMICAL,Aviophobia,antidepressant-associated mania|AAM
NEW17432,DISEASE,treatment-emergent mania,treatment-emergent manic episodes
D014994,CHEMICAL,Xylose,D-Xylose|xylose|D Xylose
D013013,CHEMICAL,Sorbose,D Sorbose|D-Sorbose|sorbose|L Sorbose|L-Sorbose
NEW17433,CHEMICAL,treatment-emergent mania,alpha-lactose
NEW17434,CHEMICAL,treatment-emergent mania,beta-lactose
NEW17435,CHEMICAL,treatment-emergent mania,% w/v glucose
NEW17436,DISEASE,treatment-emergent mania,hypoxia exposure
NEW17437,CHEMICAL,ua dilator muscle,UA dilator muscles
NEW17439,CHEMICAL,ERα level,ERα level
NEW17441,NUTRITION,resveratrol dimer,dietary food additive
D017365,CHEMICAL,Spices,spice|Spice
NEW17442,MENTAL_HEALTH,resveratrol dimer,nausea delirium
D006983,DISEASE,Hypertrichosis,hypertrichosis|Hypertrichoses
NEW17444,DISEASE,day minoxidil,mild OSAS
NEW17446,DISEASE,nasal steroid,diabetic hyperglycemia
NEW17447,CHEMICAL,nasal steroid,fasting plasma glucose levels
NEW17448,BIOCHEMICAL,nasal steroid,glucagon receptor antagonist administration
NEW17450,CHEMICAL,fatty liver disease secondary,impaired amino acid turnover
NEW17451,CHEMICAL,fatty liver disease secondary,certain glucagonotropic amino acids
NEW17452,CHEMICAL,fatty liver disease secondary,amino acid turnover
NEW17455,DISEASE,fernblock ® ifc,pigmentary disorders
NEW17457,DISEASE,Melasma quality,Melasma Area
NEW17458,CHEMICAL,Melasma quality,melanin indexes
NEW17460,CHEMICAL,oral PLE aqueous extract product,topical hydroquinone
D008548,DISEASE,Melanosis,melasma|Melanoses|Melanism|Melasmas|Chloasma|Freckles|Freckle|Chloasmas|Melasma
NEW17462,MENTAL_HEALTH,non-puerperal depression,non-puerperal depression
NEW17465,BIOCHEMICAL,syndrome ds trisomy cell,glycogen synthase kinase-3 beta (GSK3β)-transcription factor EB
NEW17466,CHEMICAL,syndrome ds trisomy cell,EB signaling
NEW17467,DISEASE,syndrome ds trisomy cell,dAGEs-induced neurotoxicity
C537301,DISEASE,Griscelli syndrome type 1 [Supplementary Concept],"Pigmentation Disorders|Piebaldism|neurologic impairment|Hearing Loss, Sensorineural"
D031941,DISEASE,"Hemorrhagic Septicemia, Viral","Septicaemia, Viral Haemorrhagic|Viral Haemorrhagic Septicaemia|Septicemia, Viral Hemorrhagic|Haemorrhagic Septicaemia, Viral|septicemia|Viral Hemorrhagic Septicemia"
NEW17470,DISEASE,kynurenine pathway metabolite,inflammatory neurologic diseases independent
NEW17472,DISEASE,neuroactive kynurenine pathway metabolite,inflammatory neurologic diseases
NEW17473,DISEASE,neuroactive kynurenine pathway metabolite,brain infection
NEW17476,CHEMICAL,nimodipine pre-treatment,NA content
NEW17478,CHEMICAL,alpha 2-adrenoceptor,alleviating alcohol abstinence syndrome
NEW17479,DISEASE,alpha 2-adrenoceptor,cognitive deficiencies
NEW17480,CHEMICAL,alpha 2-adrenoceptor,dim light melatonin onset
NEW17481,MENTAL_HEALTH,efficacious analgesia,efficacious analgesia
NEW17483,CHEMICAL,acetylcholinesterase inhibitor soman,combined oral contraceptive pills
D005867,CHEMICAL,Gestrinone,"Nemestran|18,19-Dinorpregna-4,9,11-trien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-|R2323|Dimetriose|R-2323|gestrinone|R 2323"
D005493,CHEMICAL,Folic Acid Antagonists,"Antifolates|Reductase Inhibitors, Dihydrofolate|Reductase Inhibitor, Dihydrofolate|Dihydrofolate Reductase Inhibitors|Inhibitor, Dihydrofolate Reductase|Antifolate|Antagonists, Folic Acid|Acid Antagonists, Folic|Antagonist, Folic Acid|Dihydrofolate Reductase Inhibitor|Acid Antagonist, Folic|Folic Acid Antagonist|Inhibitors, Dihydrofolate Reductase|antifolate|Folic Acid Metabolism Inhibitors"
NEW17485,DISEASE,[3h]mtx,sarcoma line
NEW17486,CHEMICAL,[3h]mtx,long-chain gamma-glutamyl derivatives
NEW17487,CHEMICAL,[3h]mtx,metachlorophenylpiperazine agonist
D044282,CHEMICAL,"Receptor, Serotonin, 5-HT1A","5-Hydroxytryptamine 1A Receptors|Receptor, 5 Hydroxytryptamine 1A|Receptor Serotonin, 5-HT1a|Serotonin 1A Receptor|5-HT(1A|Receptors, 5-Hydroxytryptamine 1A|5-HT1a Receptor Serotonin|Receptor, 5-HT1A|1A Receptor, 5-Hydroxytryptamine|Serotonin, 5-HT1a Receptor|5-HT(1A) Receptor|Receptor, Serotonin 1A|Receptor, 5-HT1A Serotonin|5 Hydroxytryptamine 1A Receptors|5-HT1A Serotonin Receptor|Receptor, 5-Hydroxytryptamine 1A|Serotonin Receptor, 5-HT1A|5-HT1A Receptor|Serotonin Receptor, 5 HT1A|5-Hydroxytryptamine 1A Receptor|Serotonin, 5 HT1a Receptor|5 HT1A Receptor|1A Receptors, 5-Hydroxytryptamine|5 Hydroxytryptamine 1A Receptor"
NEW17488,MENTAL_HEALTH,[3h]mtx,dysthymia patients
NEW17489,DISEASE,cortisol response,tenseness scores
NEW17491,MENTAL_HEALTH,nicotine replacement therapy,tobacco craving
NEW17492,MENTAL_HEALTH,nicotine replacement therapy,atypical withdrawal syndromes
NEW17494,BIOCHEMICAL,differentiated thyroid cancer,VEGF receptor inhibitors
NEW17496,DISEASE,vegf receptor inhibitor pazopanib,advanced solid tumors
NEW17498,CHEMICAL,mek inhibitor trametinib,Alz-heimer's disease
NEW17499,CHEMICAL,mek inhibitor trametinib,lipopolysaccharide (LPS)/D-galactosamine (D-Gal)-induced fulminant hepatitis
NEW17501,DISEASE,lethal inflammatory disorder,inflammation-based lethal inflammatory liver disorders
NEW17503,DISEASE,high plasma homocysteine,stroke survivors
NEW17504,MENTAL_HEALTH,high plasma homocysteine,poststroke depression
NEW17506,MENTAL_HEALTH,flc-like,flowering repression
NEW17508,CHEMICAL,formalin-induced inflammatory pain,P2X3 receptor antagonist A-317491
NEW17515,MENTAL_HEALTH,precede viral infection,new depression episode
NEW17518,BIOCHEMICAL,postoperative analgesia,analgesic acetaminophen/ibuprofen medication use
D014736,DISEASE,Vibrio parahaemolyticus,Beneckea parahaemolytica|Oceanomonas parahaemolytica|Vibrio parahaemolyticus|Pasteurella parahaemolytica
NEW17522,MENTAL_HEALTH,exocyclic b-o-n linkage,surprising hydrolytic resistance
NEW17523,DISEASE,exocyclic b-o-n linkage,addiction behaviors
NEW17527,CHEMICAL,ttx level,TTX ELISA
D003093,DISEASE,"Colitis, Ulcerative","Colitis Gravis|Inflammatory Bowel Disease, Ulcerative Colitis Type|Ulcerative Colitis|ulcerative colitis|Idiopathic Proctocolitis"
NEW17530,CHEMICAL,nmda receptor agonist quinolinic acid,kynurenine metabolite levels
NEW17531,DISEASE,nmda receptor agonist quinolinic acid,infantile neurometabolic disease
NEW17532,DISEASE,nmda receptor agonist quinolinic acid,fluctuating disease course
NEW17535,CHEMICAL,moderate accidental trauma,equine practice
NEW17536,DISEASE,moderate accidental trauma,colic cases
NEW17537,DISEASE,moderate accidental trauma,SNpc impairments
NEW17538,DISEASE,moderate accidental trauma,αSyn neurotoxicity
NEW17541,BIOCHEMICAL,electroacupuncture treatment,positive analgesic effects
NEW17543,CHEMICAL,maternal tobacco smoking,developmental nicotine exposure
NEW17545,DISEASE,alpha-5 nicotinic acetylcholine receptor subunit,DNE|developmental nicotine exposure
NEW17548,DISEASE,female central precocious puberty patient,female central precocious puberty patients
D008719,CHEMICAL,Methiothepin,"Metitepine|Methiothepine|methiothepin|Methiothepin Maleate|Maleate, Methiothepin"
NEW17549,CHEMICAL,dom nm. dissociation constant,DOM nM. dissociation constant
C045918,CHEMICAL,2-methyl-5-HT [Supplementary Concept],Serotonin/analogs  and  derivatives|2-methyl-5-HT
NEW17550,CHEMICAL,nm dopamine,nM dopamine
NEW17551,CHEMICAL,[3h]spiperone,[3H]spiperone
NEW17555,MENTAL_HEALTH,n-methyl-d-aspartate glutamate-receptor antagonist,bipolar disorder depression
NEW17559,BIOCHEMICAL,other endocrine abnormality,due growth hormone deficiency
NEW17561,DISEASE,hypothalamic-pituitary abnormality,severe neutropenia
NEW17562,DISEASE,hypothalamic-pituitary abnormality,delayed diarrhea cholinergic syndrome
NEW17564,CHEMICAL,peritoneal metastasis,levofolinate calcium|FOLFIRI
D000068818,CHEMICAL,Cetuximab,IMC-C225|IMC C225|cetuximab|MAb C225|Erbitux|C225
NEW17565,DISEASE,peritoneal metastasis,irinotecan-induced cholinergic syndrome
NEW17566,DISEASE,peritoneal metastasis,blurred vision
NEW17568,DISEASE,corrected calcium,ARF due rhabdomyolysis
NEW17569,MENTAL_HEALTH,myocardial resistance,myocardial resistance
D054059,DISEASE,Coronary Occlusion,"Occlusion, Coronary|Occlusions, Coronary|coronary occlusion|Coronary Occlusions"
NEW17570,MENTAL_HEALTH,heart resistance,heart resistance
NEW17572,DISEASE,accelerate liver fibrosis,chronic hepatitis C patients
NEW17577,DISEASE,(hypo)manic,(hypo)manic
NEW17578,DISEASE,moderate-to-severe psoriatic patient,moderate-to-severe psoriatic patients
D048568,DISEASE,Clostridium botulinum type G,Clostridium botulinum G|Clostridium botulinum
NEW17579,CHEMICAL,hypocapnic csa,hypocapnic CSA
NEW17580,DISEASE,chronic sci patient,chronic SCI patients
NEW17581,CHEMICAL,co2 reserve,CO2 reserve
NEW17583,DISEASE,mild metabolic acidosis,mild metabolic acidosis
NEW17584,DISEASE,spontaneous central apnea,spontaneous central apnea
NEW17585,DISEASE,plant gain,plant gain
NEW17586,DISEASE,hypocapnic central apnea due,hypocapnic central apnea due
NEW17587,CHEMICAL,nocturnal oxygen saturation,nocturnal oxygen saturation
NEW17589,DISEASE,high-dose acetazolamide,cervical spinal cord injury
D000426,CHEMICAL,Alcohol Dehydrogenase,"Oxidoreductase, Alcohol-NAD+|Alcohol NAD+ Oxidoreductase|Alcohol Dehydrogenase I|Alcohol Dehydrogenase II|Alcohol-NAD+ Oxidoreductase|Dehydrogenase, Yeast Alcohol|alcohol dehydrogenase|Alcohol Dehydrogenase (NAD+)|Dehydrogenase, Alcohol|Yeast Alcohol Dehydrogenase|Alcohol Dehydrogenase, Yeast"
NEW17594,NUTRITION,chronic alcohol abuse,fatty acid ethyl esters
NEW17595,CHEMICAL,chronic alcohol abuse,FAEEs|ethanol to fatty acid ethyl esters
NEW17596,DISEASE,chronic alcohol abuse,ethanol-induced pancreatic injury
NEW17598,DISEASE,repetitive ethanol intoxication,non-apoptotic neurodegenerative processes
NEW17599,DISEASE,repetitive ethanol intoxication,selective neurodegeneration
NEW17600,DISEASE,repetitive ethanol intoxication,trauma-like brain edema
NEW17601,CHEMICAL,repetitive ethanol intoxication,N-terminal truncated soluble 3kD
NEW17602,MENTAL_HEALTH,repetitive ethanol intoxication,Down Syndrome brain
C566531,MENTAL_HEALTH,Pseudoacromegaly with Severe Insulin Resistance [Supplementary Concept],Acromegaly|severe insulin resistance|Insulin Resistance
NEW17605,DISEASE,cognitive abnormality,cognitive abnormalities
NEW17606,DISEASE,hypersomnia due drug,hypersomnia due drug
http://purl.obolibrary.org/obo/DOID_9207,DISEASE,periodic limb movement disorder,periodic leg movement disorders|nocturnal myoclonus
NEW17608,CHEMICAL,exogenous atp,elevated intracellular calcium responses
NEW17609,CHEMICAL,exogenous atp,intracellular calcium elevations
NEW17610,DISEASE,exogenous atp,diverse cancers
NEW17611,DISEASE,exogenous atp,metastasis tumor growth
NEW17613,DISEASE,gonadotropin-releasing hormone analogue,premature luteinizing hormone
NEW17615,DISEASE,conventional gnrh antagonist protocol,controlled ovarian hyperstimulation
NEW17617,NUTRITION,p. plecoglossicida,Larimichthys crocea|large yellow croaker
D036441,NUTRITION,Osmeriformes,Plecoglossus altivelis|Osmeridae|Plecoglossinae|Smelts|Galaxiid|Galaxiids|Ayu|Galaxiidae|Plecoglossidae|Galaxias maculatus|ayu|Smelt|Plecoglossus altiveli
D005218,DISEASE,Fat Necrosis,"Fat Necroses|Steatonecrosis|Necrosis, Fat|fat necrosis|Steatonecroses"
NEW17619,DISEASE,spleen granuloma,days infection b liver steatosis
NEW17620,MENTAL_HEALTH,spleen granuloma,binary logistic regression analysis
NEW17621,MENTAL_HEALTH,spleen granuloma,impaired orientation
NEW17622,BIOCHEMICAL,spleen granuloma,vitamin K evaluation
NEW17623,NUTRITION,spleen granuloma,biliary cholesterol
NEW17625,DISEASE,hormone hypothalamic-pituitary-adrenal axis hormone,poorer cognitive functioning
NEW17631,CHEMICAL,estrogen metabolite,4-hydroxylation estrone|OHE1
D004970,CHEMICAL,Estrone,"estrone|Kestrone|Unigen|Estrone, (+-)-Isomer|Wehgen|Folliculin (Hormone)|Estrone, (8 alpha)-Isomer|Estrone, (9 beta)-Isomer|Estrovarin"
NEW17633,MENTAL_HEALTH,estrogen hydroxylation pathway,nociceptor hyperactivity
NEW17634,BIOCHEMICAL,endocrine hormone,axis hormones
NEW17636,DISEASE,ra derivative,RA dimer
C053099,NUTRITION,"allantoin, heparin, onion extract drug combination [Supplementary Concept]",Allantoin|onion|Plant Extracts|Heparin|Drug Combinations
NEW17641,DISEASE,asmsrb-rnai hairy root,infection threads
NEW17644,BIOCHEMICAL,premature adrenarche,exaggerated androgen synthesis
NEW17648,DISEASE,partial d5 receptor agonist,significant dyskinetic movements
NEW17649,DISEASE,partial d5 receptor agonist,dyskinetic behavior
NEW17652,DISEASE,resistance exercise,glutamate-induced memory impairment
NEW17655,DISEASE,excessive food additive monosodium glutamate,interspecific hybrid sterility
NEW17656,NUTRITION,excessive food additive monosodium glutamate,rice genotypes
C484246,CHEMICAL,"DTC1 protein, Oryza sativa [Supplementary Concept]",Plant Proteins|O. sativa|Isomerases
NEW17660,CHEMICAL,rs7713917 a g snp,1000-fold excess estradiol-17 beta
NEW17662,MENTAL_HEALTH,high-dose trimethoprim-sulfamethoxazole,hypothyroid-induced central nervous system depression
NEW17665,BIOCHEMICAL,endogenous amide n-oleoylglycine,antimicrobials active
NEW17666,DISEASE,anorexic patient,anorexic patients
NEW17668,CHEMICAL,excessive dietary leucine intake,progestogen/estrogen compound
NEW17670,MENTAL_HEALTH,dose thyroid hormone,polyneuropathy syndromes
D008324,DISEASE,"Mammary Tumor Virus, Mouse","Mammary Tumor Viruses, Mouse|Bittner Virus|Mouse mammary tumor virus|mammary cancer|Mammary Cancer Virus"
NEW17671,DISEASE,dose thyroid hormone,esophageal tumors
NEW17672,DISEASE,dose thyroid hormone,esophageal lesions
NEW17673,DISEASE,dose thyroid hormone,spontaneous thymic lymphomas
NEW17676,DISEASE,c3h-a(vy mouse,amnesic effect
NEW17677,DISEASE,c3h-a(vy mouse,amnesic effects
NEW17678,DISEASE,localized tumor,localized tumor
http://purl.obolibrary.org/obo/CHEBI_48525,CHEMICAL,calcimimetic,calcimimetics
NEW17679,DISEASE,phosphatidylinositol 3‑kinase/v‑akt murine thymoma viral oncogene homologue,phosphatidylinositol 3‑kinase/v‑akt murine thymoma viral oncogene homologue
NEW17680,DISEASE,contralateral limb,contralateral limbs
NEW17683,CHEMICAL,pufa ratio,erythrocyte sphingomyelin
NEW17684,NUTRITION,pufa ratio,erythrocyte phospholipid species
NEW17685,NUTRITION,pufa ratio,phosphatidylethanolamine concentrations
NEW17688,CHEMICAL,cel treatment,intracellular reactive oxygen species levels
NEW17689,MENTAL_HEALTH,cannabis use,vivid hallucinations
NEW17690,DISEASE,cdk4/6 inhibitor,oestrogen receptor-positive ER+ HER2-negative breast cancer
NEW17691,MENTAL_HEALTH,disease dependence,disease dependence
NEW17695,NUTRITION,low peripheral resistance,large bore capillaries
NEW17697,DISEASE,hypoglycemic activity,diabetic rat model
NEW17698,MENTAL_HEALTH,hypoglycemic activity,complete resistance
NEW17700,DISEASE,addition estrogen deficiency,frequency infection
NEW17701,DISEASE,addition estrogen deficiency,vaginal atrophy
NEW17702,DISEASE,androgen deficiency,diminished sexual desire
NEW17708,DISEASE,il-4 agonist administration,relevant mouse stroke model
NEW17709,DISEASE,il-4 agonist administration,ischemic stroke treatment
NEW17711,DISEASE,circulate lecithin,SDAT patients
NEW17712,DISEASE,circulate lecithin,late-stage LP female gametophytes
C068271,CHEMICAL,inositol hexakisphosphate receptor [Supplementary Concept],"inositol hexakisphosphate|Receptors, Cytoplasmic and Nuclear"
NEW17717,DISEASE,fibrosis rat,fibrosis rats
NEW17718,CHEMICAL,advanced pulmonary fibrosis stage,M21-M28|advanced pulmonary fibrosis stage
NEW17719,DISEASE,Shuangshen Pingfei Formula,SSPF|Shuangshen Pingfei Formula
NEW17721,NUTRITION,serine acid,familial lecithin cholesterol acyltransferase deficiency
NEW17722,DISEASE,serine acid,rare lipid disorder
NEW17726,DISEASE,dopaminergic d2 antagonist haloperidol,disease bradykinesia
NEW17727,NUTRITION,corresponding triphosphate,corresponding triphosphates
NEW17728,CHEMICAL,adrenal steroid synthesis pathway protein,adrenal steroid synthesis pathway proteins
NEW11870,BIOCHEMICAL,popular drug,popular drug
NEW17730,DISEASE,methionine positron emission tomography,tumor invasion
NEW17731,CHEMICAL,methionine positron emission tomography,unconjugated phenylethylamine
NEW17732,DISEASE,methionine positron emission tomography,mood behaviour
NEW17735,NUTRITION,kg-1 trehalose,trehalose transporter isoform X4
NEW17736,NUTRITION,kg-1 trehalose,trehalose transporter homolog isoform X2
NEW17737,NUTRITION,kg-1 trehalose,juvenile red claw crayfish
NEW17739,DISEASE,cqkpi,hwajinpoensis C. albicans
NEW17741,MENTAL_HEALTH,typha angustifolia,multi-linear regression model
NEW17743,DISEASE,typha angustifolia L.,stranguria
NEW17744,DISEASE,typha angustifolia L.,postmenopausal estrogen-receptor positive breast cancer
NEW17747,DISEASE,selective estrogen receptor er modulator,positive solid tumors
NEW17748,DISEASE,selective estrogen receptor er modulator,endocrine-refractory metastatic breast cancer
NEW17753,CHEMICAL,IMPORTANCE Heartland bandavirus,Dabie bandavirus
NEW17754,DISEASE,IMPORTANCE Heartland bandavirus,gastrointestinal discomfort
NEW17756,DISEASE,Acyclovir 's main metabolite 9-carboxymethoxymethylguanine,neurotoxic symptoms
NEW17757,DISEASE,Acyclovir 's main metabolite 9-carboxymethoxymethylguanine,impaired renal function
D006606,DISEASE,Hiccup,Hiccups|Hiccough|Hiccoughs|hiccups
NEW17759,CHEMICAL,schizophrenia pathophysiology,glutamate NMDA receptors
NEW17763,CHEMICAL,spleen t cell function,ethanol-exposed 6-day pups
NEW17765,CHEMICAL,long-acting beta2-agonist,serum potassium concentration
NEW17766,DISEASE,long-acting beta2-agonist,paradoxical bronchospasm
NEW17768,DISEASE,lysine methylation,multiple neurodevelopmental disorders
C504157,CHEMICAL,Met-enkephalin-glycyl-tyrosine [Supplementary Concept],"Met-enkephalin|Enkephalin, Methionine/analogs  and  derivatives"
NEW17770,DISEASE,lysine methylation,tumor incidence
NEW17773,DISEASE,mixture b. monnieri,heart failure mortality
NEW17776,MENTAL_HEALTH,nutritional dermatosis,population displacement
D000079685,CHEMICAL,Famine,famine|Starvation|Hunger
NEW17777,DISEASE,nutritional dermatosis,5-FU-induced injury
NEW17778,CHEMICAL,nutritional dermatosis,aspartate aminotransferase AST content
NEW17779,MENTAL_HEALTH,nutritional dermatosis,dissociation pathways
NEW17781,DISEASE,baseline neuroticism,aggression aggression scores
NEW17783,DISEASE,questionnaire neuroticism,OAS-M aggression scores
NEW17784,DISEASE,questionnaire neuroticism,catatonic youngsters
NEW17785,MENTAL_HEALTH,questionnaire neuroticism,baseline anxiety scores
NEW17786,MENTAL_HEALTH,questionnaire neuroticism,VAMS anxiety subscale
NEW17787,BIOCHEMICAL,questionnaire neuroticism,adrenal ascorbic acid
NEW17789,CHEMICAL,gal-3 gene deletion,hippocampal GABA-AR2S
NEW17792,DISEASE,n-ethyl-2-(1-ethyl-2-hydroxy-2-nitrosohydrazino)-ethanamine,human neuroblastoma SH-SY5Y cell cultures
NEW17793,DISEASE,n-ethyl-2-(1-ethyl-2-hydroxy-2-nitrosohydrazino)-ethanamine,peroxynitrite-induced cell death
NEW17794,NUTRITION,n-ethyl-2-(1-ethyl-2-hydroxy-2-nitrosohydrazino)-ethanamine,phosphatidylserine synthase gene
D014005,DISEASE,Tinea,"Epidermophytosis|Ringworm|Dermatophytoses|Dermatophytosis|Tinea Corporis|Infection, Trichophyton mentagrophytes|Trichophytoses|Epidermophytoses|Trichophyton mentagrophytes Infections|Trichophytosis|dermatophytosis|Tineas|Trichophyton mentagrophytes Infection"
NEW17795,BIOCHEMICAL,n-ethyl-2-(1-ethyl-2-hydroxy-2-nitrosohydrazino)-ethanamine,new promising systemic antifungal drug
NEW17796,DISEASE,n-ethyl-2-(1-ethyl-2-hydroxy-2-nitrosohydrazino)-ethanamine,deep fungal infections
NEW17798,CHEMICAL,dietary-induced binge,central norepinephrine
NEW17799,CHEMICAL,dietary-induced binge,brain norepinephrine system
NEW17800,DISEASE,parkinson patient,Parkinson patients
NEW17801,CHEMICAL,l-dopa treatment,l-DOPA treatment
NEW17802,MENTAL_HEALTH,striatal projection neuron,striatal projection neurons
NEW17804,CHEMICAL,tremulous jaw movement,acetylcholine agonist tacrine
NEW17805,BIOCHEMICAL,tremulous jaw movement,dopamine antagonist pimozide
NEW17806,DISEASE,tremulous jaw movement,pimozide-induced TJM activity
NEW17808,DISEASE,whole plant,maximal electroshock seizure model
NEW17809,CHEMICAL,t20 diet,T20 diet
NEW17810,CHEMICAL,dopamine receptor availability related,dopamine receptor availability related
NEW17811,DISEASE,preventable death,preventable death
NEW17813,MENTAL_HEALTH,aluminium dust,pre-clinical mild cognitive disorder
NEW17814,DISEASE,aluminium dust,reactive gliosis
NEW17815,CHEMICAL,aluminium dust,Aβ1 42
NEW17816,CHEMICAL,aluminium dust,oral contraceptive steroid preparations
NEW17817,BIOCHEMICAL,aluminium dust,oestrogen ethinyloestradiol
NEW17819,CHEMICAL,different progestogen,EE2 2-hydroxylation
NEW17820,DISEASE,different progestogen,multiple sclerosis symptoms
NEW17824,CHEMICAL,arnd characteristic,contortus ACR-26/ACR-27 nAChRs
NEW17825,DISEASE,arnd characteristic,Parascaris equorum
NEW17828,DISEASE,intraoral sucrose,subsequent weight gain
NEW17829,DISEASE,intraoral sucrose,obesity risk
NEW17832,MENTAL_HEALTH,chestnut hybrid,inherited partial resistance
D053379,CHEMICAL,Chromogranin A,"CHGA Protein|Secretory Protein, Parathyroid|Secretory Protein I, Parathyroid Gland|Parathyroid Secretory Protein|chromogranin"
NEW17835,CHEMICAL,androgen therapy,serum creatinine level
NEW17837,CHEMICAL,copper solution,urea creatinine levels
NEW17838,DISEASE,copper solution,intense gastrointestinal mild hemolysis
NEW17840,NUTRITION,thiourea group,thein binding affinity
NEW17842,DISEASE,focal bilateral amygdala damage,focal bilateral amygdala damage
NEW17846,DISEASE,ml417,movement scoring method
NEW17850,CHEMICAL,abnormal mental behavior,elevated blood cortisol levels
NEW17852,CHEMICAL,dysregulate depressed function,tyrosine metabolism pathway
NEW17853,DISEASE,dysregulate depressed function,migraine rats
NEW17856,MENTAL_HEALTH,sympathomimetic decongestant,nasal airway resistance
NEW17861,DISEASE,selective alpha(2)-adrenoceptor agonist,nasal congestion
NEW17862,DISEASE,selective alpha(2)-adrenoceptor agonist,infection-induced death
NEW17863,CHEMICAL,selective alpha(2)-adrenoceptor agonist,baseline binge-eating BE behavior
NEW17865,DISEASE,fatty acid class,diabetic VED
NEW17866,MENTAL_HEALTH,fatty acid class,lower hyperarousal
NEW17867,BIOCHEMICAL,fatty acid class,allele carriers
NEW17868,DISEASE,fatty acid class,PTSD better spatial processing
NEW17870,MENTAL_HEALTH,parkinson 's syndrome,depression susceptibility
NEW17871,MENTAL_HEALTH,parkinson 's syndrome,headache attack
NEW17872,DISEASE,parkinson 's syndrome,congestive failure
NEW17874,DISEASE,pimavanserin inverse agonist,maximum weight gain
NEW17875,DISEASE,pimavanserin inverse agonist,PIP syndrome
NEW17876,DISEASE,pimavanserin inverse agonist,premature apoptosis
NEW17878,CHEMICAL,combustion value,DF supplements
NEW17879,NUTRITION,combustion value,cholesterol content
NEW17881,DISEASE,lr cholesterol,FXS group
NEW17882,NUTRITION,lr cholesterol,plasma cholesterol
C078862,DISEASE,melanoma growth stimulating activity receptor [Supplementary Concept],"Receptors, Cytokine|melanoma growth"
NEW17884,CHEMICAL,lrs cholesterol,low ciglitazone concentrations
NEW17885,DISEASE,lrs cholesterol,human melanoma xenograft development
NEW17886,DISEASE,lrs cholesterol,melanoma treatment
NEW17889,DISEASE,due concomitant tonic pain,experimental pain model
NEW17891,CHEMICAL,phasic pain relief,narco-analgesic drug
NEW17893,DISEASE,da toxicosis,severe tardive EPS
NEW17895,DISEASE,Background lithium,neuropathic pain rat models
NEW17896,DISEASE,Background lithium,painful cluster headaches
NEW17897,DISEASE,Background lithium,neuropathic mice
NEW17898,MENTAL_HEALTH,Background lithium,long-lasting analgesia
NEW17901,MENTAL_HEALTH,allergen binding,preferred orientation
NEW17903,DISEASE,dolutegravir resistance,viral fitness
NEW17905,MENTAL_HEALTH,lithium administration,morphine-induced amnesia
NEW17909,CHEMICAL,carbachol-induced csd inhibition,preferential M1 muscarinic antagonist telenzepine
NEW17912,DISEASE,tree oil ρ-cymene,Gram-negative bacterium
NEW17913,DISEASE,tree oil ρ-cymene,SalmonellaTyphimurium
NEW08637,BIOCHEMICAL,severe hyperhomocysteinemia,neurotoxic agent
D016754,CHEMICAL,Boron Neutron Capture Therapy,"Therapy, Boron-Neutron Capture|boron|Boron-Neutron Capture Therapy|Neutron Capture Therapy, Boron|Therapy, Boron Neutron Capture|B12"
NEW17915,BIOCHEMICAL,severe hyperhomocysteinemia,B vitamin deficiency
D020774,DISEASE,Pick Disease of the Brain,"Pick Disease|Pick Disease Of Brain|Lobar Atrophy (Brain)|brain atrophy|Atrophies, Lobar (Brain)|Disease, Pick|Picks Disease|Dementia with Lobar Atrophy and Neuronal Cytoplasmic Inclusions|Lobar Atrophies (Brain)|Atrophy, Lobar (Brain)|Circumscribed Lobar Atrophy of the Brain|Lobar Atrophy of the Brain|Disease, Pick's|Lobar Atrophy Of Brain|Pick's Disease|Brain Atrophy, Circumscribed Lobar|Picks Disease of Brain"
NEW17918,CHEMICAL,vitamin supplementation,plasma Hcy
NEW17919,CHEMICAL,vitamin supplementation,anti-ischemic interventions
NEW17920,MENTAL_HEALTH,drug effect,cycloheximide-induced amnesia
NEW17924,DISEASE,n-methyl scaffold,LA structure angioedema
NEW17927,MENTAL_HEALTH,selective serotonergic drug,reactive species-mediated dissociation
NEW17928,CHEMICAL,selective serotonergic drug,GSH/ATP levels
NEW17930,DISEASE,novel cholinomimetic,cognitive endophenotypes
NEW17932,NUTRITION,resistance heritability,sheepshead minnow
NEW17933,CHEMICAL,resistance heritability,male Mecp2-null mice
NEW17935,CHEMICAL,neocortical projection neuron,Mecp2-null heterozygous mice
NEW17938,CHEMICAL,mdma challenge,5-hydroxyhyptamine
NEW17939,CHEMICAL,mdma challenge,hypothalamic serotonin
NEW17940,MENTAL_HEALTH,mdma challenge,hyperactivity levels
NEW17941,DISEASE,mdma challenge,hemorrhagic patch
D004620,DISEASE,"Embolism, Fat","Embolisms, Fat|fat embolism|Fat Embolism Syndrome|Fat Embolisms|Fat Embolism"
NEW17944,MENTAL_HEALTH,carotenoid degradation,one-step regression analysis
NEW17947,CHEMICAL,pah metabolite,ITC|isothermal titration calorimetry
NEW17950,DISEASE,croceine croaker,anepithymia
C522605,DISEASE,"Cd99 protein, mouse [Supplementary Concept]",Cancer Research|12E7 Antigen
NEW17952,CHEMICAL,swim bladder peptide fraction,excessive LA
NEW17953,BIOCHEMICAL,swim bladder peptide fraction,drug actions
NEW17954,DISEASE,swim bladder peptide fraction,current pandemic
NEW17956,DISEASE,low-level developmental mehg,sensory deficits
NEW17957,CHEMICAL,low-level developmental mehg,developmental MeHg
NEW17959,CHEMICAL,mean mercury ingestion,µg Hg/kg·day
NEW17960,CHEMICAL,mean mercury ingestion,Hg/kg·day
NEW17963,DISEASE,serum na level,hyponatremic patients
NEW17965,DISEASE,transient mutism,reversible bilateral symmetric hyperintensity
NEW17966,CHEMICAL,transient mutism,amphotericin B. Fluid-attenuated inversion recovery
NEW17967,BIOCHEMICAL,transient mutism,antifungal prophylaxis
NEW17969,CHEMICAL,relative toxicity,IN-JT333 >
NEW17970,CHEMICAL,relative toxicity,IN-MK638 IN-MF014
NEW17972,CHEMICAL,visual function loss,antiglaucomatous eye
NEW17974,CHEMICAL,b. aegyptiaca gall,moderate xanthine oxidase inhibitory activity
NEW17978,CHEMICAL,extracellular adenosine availability,AK inhibitors
NEW17979,DISEASE,extracellular adenosine availability,pain signalling
NEW17981,DISEASE,adenosine analog,human uterine progesterone receptors
NEW17983,CHEMICAL,tritium label cyproterone acetate,3H-progesterone
C486424,CHEMICAL,"Pgrmc1 protein, rat [Supplementary Concept]","progesterone receptor|Receptors, Progesterone|Membrane Proteins"
NEW17985,CHEMICAL,beta-estradiol oophorectomized animal,[3H]ORG binding moiety
NEW17987,DISEASE,tumor cytosol,human ovarian carcinoma
NEW17989,CHEMICAL,covid-19 outcome,COVID-19 outcome
NEW17990,CHEMICAL,neuroendocrine dopamine release,neuroendocrine dopamine release
NEW17992,CHEMICAL,transendothelial electrical resistance,myosin light chain phosphorylation
NEW17994,DISEASE,human pulmonary artery endothelial cell,early-onset cognitive impairment
NEW17996,DISEASE,selective gper agonist g-1,TBI rats
NEW17997,DISEASE,selective gper agonist g-1,hippocampal CA1 neuronal loss
NEW17998,CHEMICAL,selective gper agonist g-1,inhibitor LY294002
NEW17999,MENTAL_HEALTH,selective gper agonist g-1,postoperative amnesia
NEW18000,DISEASE,selective gper agonist g-1,Fas death receptor
NEW18001,MENTAL_HEALTH,vitamin d metabolite,characteristic spectrometric fragmentation patterns
NEW18002,MENTAL_HEALTH,vitamin d metabolite,same time resistance
NEW18003,DISEASE,vitamin d metabolite,HL-60 promyelocytic leukemia cells
NEW18006,CHEMICAL,non-competitive antagonist,[(3)H]-LY450295 potentiator binding
NEW18009,DISEASE,nhe rat,immunological abnormality
NEW18010,CHEMICAL,nhe rat,glutamatergic N-methyl-D-aspartate NMDA receptors
NEW18012,CHEMICAL,southeast asian tree,opium withdrawal
NEW18013,DISEASE,southeast asian tree,solid malignancies
NEW18017,DISEASE,fibro-scan,liver stiffness
NEW18018,DISEASE,fibro-scan,liver fibrosis biomarkers
D000080242,CHEMICAL,8-Hydroxy-2'-Deoxyguanosine,"2'-Deoxy-8-Oxoguanosine|8-Oxo-7-Hydrodeoxyguanosine|7 Hydro 8 Oxodeoxyguanosine|8-Hydroxydeoxyguanosine|8 Oxo 7,8 Dihydro 2' Deoxyguanosine|8-Oxo-2'-Deoxyguanosine|8-hydroxy-2'-deoxyguanosine|2' Deoxy 7,8 Dihydro 8 Oxoguanosine|2' Deoxy 8 Hydroxyguanosine|2'-Deoxy-8-Hydroxyguanosine|8-OHdG|2' Deoxy 8 Oxoguanosine|8 Oxo 2' Deoxyguanosine|8 Oxo 7 Hydrodeoxyguanosine|8OHdG|2'-Deoxy-7,8-Dihydro-8-Oxoguanosine|8-OH-dG|8-oxo-dGuo|8-Oxo-7,8-Dihydro-2'-Deoxyguanosine|2' Deoxy 8 Oxo 7,8 Dihydroguanosine|7,8-Dihydro-8-Oxo-2'-Deoxyguanosine|8-oxodG|8-Oxo-Deoxyguanosine|8-oxodGuo|8-oxo-dG|7,8 Dihydro 8 Oxo 2' Deoxyguanosine|7-Hydro-8-Oxodeoxyguanosine|8-Oxo-7,8-Dihydrodeoxyguanosine|8 Oxo 7,8 Dihydrodeoxyguanosine|8 Hydroxydeoxyguanosine|2'-Deoxy-8-Oxo-7,8-Dihydroguanosine|8 Hydroxy 2' Deoxyguanosine|8 Oxo Deoxyguanosine"
NEW18019,DISEASE,fibro-scan,non-alcoholic steatohepatitis secondary
NEW18023,CHEMICAL,ota level,mean OTA value
NEW18024,DISEASE,ota level,severe cognitive impairments
D029382,CHEMICAL,Dicarboxylic Acid Transporters,"Dicarboxylate Carrier|Dicarboxylate Transporter|Dicarboxylate-Binding Protein|Transporters, Dicarboxylic Acid|dicarboxylate|Dicarboxylic Acid Transport Proteins|Dicarboxylate Binding Protein|Dicarboxylate Transport Protein"
NEW18028,DISEASE,small-molecule selective gsk3β inhibitor,chemo-resistant PDX glioblastoma models
NEW18029,CHEMICAL,small-molecule selective gsk3β inhibitor,enhanced lomustine antitumor effect
NEW18030,CHEMICAL,small-molecule selective gsk3β inhibitor,wine fining
NEW18031,DISEASE,grape seed proanthocyanidin extract,myocardial reperfusion arrhythmias
D020559,CHEMICAL,Monomeric GTP-Binding Proteins,"Monomeric G-Proteins|ras-Related GTP-Binding Protein|Small GTPases|Monomeric G-Protein|GTPase, Small|GTP-Binding Proteins, Monomeric|Small G Protein|Small G-Protein|Small GTPase|ras Related G Proteins|Monomeric G Proteins|Small G Proteins|GTPases, Small|G-Proteins, Monomeric|GTPases, ras-Related|ras-Related G-Proteins|GTP-Binding Proteins, ras-Related|ras Related GTPases|G-Protein, Monomeric|ras-Related GTPase|G Proteins, Monomeric|ras-Related GTP-Binding Proteins|ras-Related GTPases|Monomeric G Protein|GTP Binding Proteins, Monomeric|G-Proteins, ras-Related|G-Protein, Small|ras Related GTP Binding Protein|ras Related GTPase|GTP-Binding Protein, ras-Related|Protein, ras-Related GTP-Binding|Small G-Proteins|G-proteins|Monomeric GTP Binding Proteins|G-Proteins, Small|GTPase, ras-Related|ras Related GTP Binding Proteins|Proteins, ras-Related GTP-Binding"
NEW18034,MENTAL_HEALTH,motor conversion disorder,medium spiny projection neurons
NEW18038,DISEASE,hand due gelatin embolism,hand due gelatin embolism
NEW18039,DISEASE,acute ischemic insult,acute ischemic insult
NEW18040,CHEMICAL,postsynaptic dopamine da receptor supersensitivity,postsynaptic dopamine DA receptor supersensitivity
NEW18042,CHEMICAL,postsynaptic da receptor supersensitivity,DA agonist
NEW18044,CHEMICAL,ginseng total saponin,postsynaptic DA receptor
NEW18045,CHEMICAL,ginseng total saponin,datumetine
NEW18046,BIOCHEMICAL,ginseng total saponin,precursor stabilizer
NEW18048,CHEMICAL,novel three-zone ionization source,sample gas
NEW18049,CHEMICAL,novel three-zone ionization source,RH gas samples
NEW18050,MENTAL_HEALTH,novel three-zone ionization source,microbubble purging process
NEW18051,BIOCHEMICAL,novel three-zone ionization source,A1R agonist
D004899,DISEASE,"Erythroblastosis, Fetal","Fetalis, Erythroblastosis|Hemolytic Disease of Newborn|Erythroblastosis Fetalis|Fetal Erythroblastosis|Newborn Hemolytic Disease|Erythroblastosis Fetali|Newborn Hemolytic Diseases|Fetali, Erythroblastosis|hemolytic disease|Fetal Erythroblastoses|Erythroblastoses, Fetal"
NEW18054,DISEASE,cholesterol stone,skin toxicity
NEW18055,DISEASE,cholesterol stone,mania/depression
D010673,DISEASE,Pheochromocytoma,"Pheochromocytoma, Extra Adrenal|Pheochromocytoma, Extra-Adrenal|Extra-Adrenal Pheochromocytoma|Pheochromocytomas, Extra-Adrenal|Extra-Adrenal Pheochromocytomas|Pheochromocytomas|pheochromocytoma"
D020640,DISEASE,Arcobacter,Arcobacter|Arcobacter butzleri
NEW18059,DISEASE,Pseudarcobacter,Arcobacter parvum comb
NEW18063,CHEMICAL,unexpected stroke,normal serum sterol
NEW18064,NUTRITION,unexpected stroke,fatty acid contents
NEW18065,MENTAL_HEALTH,unexpected stroke,planar orientation
NEW18067,MENTAL_HEALTH,catechin molecule,outlet resistance
NEW18069,CHEMICAL,systemic oestrogen replacement,Zn nutrition
NEW18071,CHEMICAL,novel antimicrobial agent,effective decolonization
NEW18072,DISEASE,novel antimicrobial agent,virus-associated pneumonia
NEW18073,MENTAL_HEALTH,novel antimicrobial agent,irreversible displacement
NEW18075,MENTAL_HEALTH,Chrysanthemum × grandiflora,strong salt resistance
NEW18077,CHEMICAL,c. grandiflora,mM NaCl solution
NEW18080,CHEMICAL,mg-3zn substrate,NA pretreatment film
NEW18081,BIOCHEMICAL,mg-3zn substrate,acid NA solution
NEW18084,NUTRITION,heat shock protein gene,miiuy croaker
D058642,DISEASE,Planococcus Bacteria,Aeromonas hydrophila|bacteria
NEW18087,CHEMICAL,nitrogen equilibrium,N/kg/day
NEW18089,DISEASE,selective npr agonist,apnea frequency
NEW18090,NUTRITION,sleep loss,low sex steroid hormone concentrations
NEW18092,BIOCHEMICAL,intact opioid drug product,oral drug addiction
NEW18095,DISEASE,raclopride bp,heightened mood
NEW18097,DISEASE,glutamatergic nmda receptor,psychotic symptom formation
NEW18099,DISEASE,circulate estrogen,night sweats
NEW18100,DISEASE,circulate estrogen,genito-urinary syndrome
NEW18103,DISEASE,premature neonate,persistent hyponatremia
NEW18104,DISEASE,premature neonate,asthma allergic rhinitis
NEW18107,CHEMICAL,publish soil-to-small mammal bioaccumulation regression model,arsenic body burdens
NEW18108,MENTAL_HEALTH,publish soil-to-small mammal bioaccumulation regression model,site orientation
NEW18111,NUTRITION,esbl strain,Christmas shearwater
C053268,CHEMICAL,cefpodoxime [Supplementary Concept],cefpodoxime|Ceftizoxime/analogs  and  derivatives
NEW18114,BIOCHEMICAL,cyclohexane-cyclohexane pair,polymer segments
NEW18115,MENTAL_HEALTH,cyclohexane-cyclohexane pair,special orientation
NEW18116,CHEMICAL,hyperexcitability,alpha(α)-synucleinopathies
NEW18117,DISEASE,hyperexcitability,vascular cognitive impairment|VCI
NEW18119,DISEASE,postpartum psychosis,postpartum psychoses
NEW18121,DISEASE,sodium pump activity,bipolar manic-depressive group
NEW18123,CHEMICAL,bipolar group,lower sodium pump activity
NEW18124,DISEASE,bipolar group,unipolar depressive group
NEW18125,MENTAL_HEALTH,bipolar group,chronic abuse group
C043958,NUTRITION,2-butanol [Supplementary Concept],Butanols|Lithium salt
NEW18126,CHEMICAL,bipolar group,ICS model
NEW18127,CHEMICAL,bipolar group,(R)-CPP
NEW18128,BIOCHEMICAL,bipolar group,NR2A antagonist
NEW18129,CHEMICAL,bipolar group,NR2A-NMDA receptor-knockout
NEW18133,BIOCHEMICAL,antiopioid n-methyl-d-aspartate receptor system,μ-opioid receptor-mediated analgesic mechanisms
NEW18134,MENTAL_HEALTH,antiopioid n-methyl-d-aspartate receptor system,favorable catalytic orientation
NEW18136,CHEMICAL,lesion orientation,O4-methylene group
NEW18137,DISEASE,lesion orientation,oxidative hepatic injury
NEW18140,MENTAL_HEALTH,urethral resistance,urethral resistance
http://purl.obolibrary.org/obo/CHEBI_28946,CHEMICAL,theobromine,"factors:1 caffeine|3,7-dihydro-3,7-dimethyl-1H-purine-2,6-dione|3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione|3,7-dimethylxanthine|Theobromin|3,7-dimethylpurine-2,6-dione|Theobromine|theobromine|THEOBROMINE|3,7-Dimethylxanthine"
NEW18143,NUTRITION,insomnia severity,key branched chain amino acid metabolites
NEW18145,DISEASE,eb diet,muscle incoordination
NEW18148,DISEASE,established 3d gelatin scaffold model,neuronal stem cell exposure
NEW18150,DISEASE,triac therapy,thyrotoxic cardiomyopathy
NEW18154,BIOCHEMICAL,serious ocular complication,estrogen dosage
NEW18155,BIOCHEMICAL,serious ocular complication,third-generation progestins
NEW18157,CHEMICAL,soy phytoestrogen,metabotropic glutamate receptor signaling
NEW18158,DISEASE,soy phytoestrogen,lower seizure threshold
NEW18160,BIOCHEMICAL,soy-based infant formula,adrenocorticotropic hormone (ACTH)-treated rats
NEW18161,DISEASE,soy-based infant formula,human gastrointestinal tract
NEW18163,CHEMICAL,saccharin/sucralose consumption,serum lipopolysaccharide
NEW18165,CHEMICAL,metformin supplementation,NAFLD.IMPORTANCE
NEW18166,DISEASE,metformin supplementation,NAFLD treatment
NEW18167,DISEASE,metformin supplementation,gingival inflammation
NEW18168,DISEASE,metformin supplementation,respiratory tract due
NEW18169,MENTAL_HEALTH,metformin supplementation,body syndromes
NEW18170,DISEASE,metformin supplementation,nephrotoxic
NEW18172,CHEMICAL,cauliflower waste extract,cauliflower waste extract
D038225,CHEMICAL,tau-Crystallins,"tau Crystallin|Crystallins, tau|tau-Crystallin|tau Crystallins|Tau"
C020193,CHEMICAL,"activated charcoal, colloidal silver, dimethicone, liquorice, silicone dioxide drug combination [Supplementary Concept]",Salicylates|activated charcoal|Drug Combinations|Silver Compounds
D056831,DISEASE,Coordination Complexes,"coordination|Complexes, Metal|Metal Complexes|Complexes, Coordination"
NEW18177,DISEASE,phyllanthus tenellus Roxb,intestinal infections
D012431,CHEMICAL,Rutin,"rutin|Quercetin, 3-Rhamnosyl-Glucosyl|Rutoside|Quercetin 3 Rutinoside|3-Rhamnosyl-Glucosyl Quercetin|Quercetin-3-Rutinoside"
NEW18178,DISEASE,phyllanthus tenellus Roxb,P. tenellus extract
NEW18180,DISEASE,% drug loading,chronic physical disorders
D010148,DISEASE,"Pain, Intractable","intractable pain|Pains, Refractory|Intractable Pains|Intractable Pain|Refractory Pains|Pains, Intractable|Pain, Refractory|Refractory Pain"
NEW18182,DISEASE,serum testosterone level,AO AGHD patients
NEW18183,DISEASE,serum testosterone level,AGHD patients
NEW18184,DISEASE,serum testosterone level,adult growth hormone deficiency|AGHD
NEW18186,MENTAL_HEALTH,testosterone level,equatorial projection
NEW18187,NUTRITION,testosterone level,angle alpha
D018738,CHEMICAL,Hexamethonium,"Diperchlorate, Hexamethonium|Dichloride Dihydrate, Hexamethonium|Dihydrate, Hexamethonium Dibromide|Dihydroxide, Hexamethonium|Monotartrate, Hexamethonium|Diiodide, Hexamethonium|Hexamethonium Dimethylsulfate|Hexonium|Depressin|Dibromide, Hexamethonium|Hexamethonium Bromide|Dibromide Dihydrate, Hexamethonium|Hexamethonium Monotartrate|Hexamethonium Chloride|Iodide, Hexamethonium|Hexamethonium Iodide|Hexamethonium Bitartrate|Hexamethonium Dibromide Dihydrate|Hexamethonium Diperchlorate|Bitartrate, Hexamethonium|Hexamethonium Diiodide|Dimethylsulfate, Hexamethonium|Hexamethonium Dichloride Dihydrate|Hexamethonium Dihydroxide|Hexamethonium Dibromide|Dihydrate, Hexamethonium Dichloride|Chloride, Hexamethonium|hexamethonium|Bromide, Hexamethonium"
NEW18192,CHEMICAL,scop amnesia,MECA 1 3
D008595,DISEASE,Menorrhagia,"Heavy Period|Heavy Menstrual Bleeding|menorrhagia|Menstrual Bleeding, Heavy|Hypermenorrhea|Heavy Periods"
NEW18193,DISEASE,scop amnesia,gonorrhea affections
NEW18194,CHEMICAL,% carbohydrate iron,% carbohydrate Iron
NEW18196,CHEMICAL,zeylanicus plant powder,new glitazone
NEW18197,BIOCHEMICAL,zeylanicus plant powder,full PPAR gamma agonists
NEW18198,BIOCHEMICAL,zeylanicus plant powder,marketed PPAR gamma agonists
NEW18199,DISEASE,zeylanicus plant powder,less heart enlargement
NEW18202,MENTAL_HEALTH,free drug level,PPAR-gamma corepressor displacement
D006218,CHEMICAL,Halofenate,halofenate|MK-185|MK185|MK 185
NEW18204,MENTAL_HEALTH,diabetic ob/ob mouse,addition hyperactivity response
NEW18207,DISEASE,glaucoma surgery,severe glaucoma
NEW18209,DISEASE,gelatin stent,gestational stage
NEW18210,CHEMICAL,gelatin stent,MAOI tranylcypromine
NEW18213,DISEASE,chronic cort exposure,anhedonia-like behaviors
NEW18214,DISEASE,chronic cort exposure,devastating neurodegenerative disease
NEW18215,DISEASE,chronic cort exposure,congenital neuronal ceroid-lipofuscinosis
D012725,MENTAL_HEALTH,Sexual Behavior,"Sexual Activity|Sex, Oral|Orientation, Sexual|Behavior, Sexual|Sex, Anal|Sexual Orientation|Anal Sex|Activities, Sexual|Behavior, Premarital Sex|Behavior, Sex|sexual orientation|Sex Behavior|Oral Sex|Sex Orientation|Premarital Sex Behavior|Activity, Sexual|Sexual Activities"
D020176,DISEASE,Tyrosinemias,"Tyrosinemias, Type III|4-Hydroxyphenylpyruvate Dioxygenase Deficiency|Type I Hypertyrosinemia|Deficiency Disease, 4 Hydroxyphenol Pyruvic Acid Oxidase|Tyrosinemia Type 1s|Keratosis Palmoplantaris with Corneal Dystrophy|Tyrosine Aminotransferase Deficiency|Fumarylacetoacetase Deficiencies|Type III Tyrosinemia|Tyrosine Transaminase Deficiency Disease|Hepatorenal Tyrosinemia|Tyrosinoses, Oculocutaneous Type|Richner Hanhart Syndrome|Hereditary Tyrosinemia, Type III|Type II Tyrosinemia|Dioxygenase Deficiencies, 4-Hydroxyphenylpyruvate|Richner-Hanhart Syndrome|Deficiency Diseases, Fumarylacetoacetase|Deficiencies, Tat|Oregon Type Tyrosinemia|Type I Tyrosinemias|Tyrosinemia, Type 2|Oculocutaneous Type Tyrosinoses|Tyrosinemia, Type III|Dioxygenase Deficiency, 4-Hydroxyphenylpyruvate|Tyrosinemia|Tat Deficiencies|Tyrosine Transaminase Deficiency|Richner-Hanhart Syndrome, Tyrosinosis, Oculocutaneous Type|Deficiency, 4-Hydroxyphenylpyruvate Dioxygenase|Tyrosinemia, Hereditary|Tyrosinemias, Hereditary|Hereditary Tyrosinemia|Disease, Fumarylacetoacetase Deficiency|Type 2 Tyrosinemias|Tyrosinosis, Oculocutaneous Type|hypertyrosinemia|4-Hydroxyphenylpyruvic Acid Oxidase Deficiency|Tyrosinemia Type 1|Deficiencies, 4-Hydroxyphenylpyruvate Dioxygenase|Type Tyrosinosis, Oculocutaneous|Tat Deficiency|Type II Tyrosinemias|Hereditary Tyrosinemia, Type II|Deficiency Disease, Tyrosine Transaminase|Hypertyrosinemia, Type I|Tyrosinemias, Type I|Tyrosinemias, Hepatorenal|Type 2 Tyrosinemia|Tyrosinemia, Hepatorenal|Syndromes, Richner-Hanhart|Deficiency Disease, 4-Hydroxyphenol Pyruvic Acid Oxidase|Hypertyrosinemias, Type I|4 Hydroxyphenylpyruvate Dioxygenase Deficiency Disease|Tyrosinemias, Type II|Fumarylacetoacetase Deficiency|Type III Tyrosinemias|Tyrosinemia, Type I|Diseases, Fumarylacetoacetase Deficiency|Deficiency, Tat|Fumarylacetoacetase Deficiency Disease|Richner-Hanhart Syndromes|Tyrosinemias, Type 2|4 Hydroxyphenol Pyruvic Acid Oxidase Deficiency Disease|Hereditary Tyrosinemia, Type I|2 Tyrosinemias, Type|Deficiency Disease, Fumarylacetoacetase|Type I Tyrosinemia|Type Tyrosinoses, Oculocutaneous|Type I Hypertyrosinemias|Tyrosinemia, Type II|4-Hydroxyphenol Pyruvic Acid Oxidase Deficiency Disease|Hypertyrosinemia|Deficiencies, Fumarylacetoacetase|Fumarylacetoacetase Deficiency Diseases|Hepatorenal Tyrosinemias|Hereditary Tyrosinemias|Oculocutaneous Type Tyrosinosis|Syndrome, Richner-Hanhart|Deficiency, Fumarylacetoacetase"
NEW18217,BIOCHEMICAL,ors structure,contrast drug response
NEW18218,DISEASE,ors structure,impaired working memory
NEW18219,DISEASE,ors structure,pentylenetetrazol-induced convulsion
http://purl.obolibrary.org/obo/CHEBI_45327,CHEMICAL,adenine arabinoside,"9H-adenin-9-yl beta-D-arabinofuranoside|9-beta-D-Arabinofuranosyladenine|9-beta-D-arabinofuranosyl-9H-purin-6-amine|9-(beta-D-arabinofuranosyl)-9H-adenine|Vidarabine|2-(6-AMINO-PURIN-9-YL)-5-HYDROXYMETHYL-TETRAHYDRO-FURAN-3,4-DIOL|adenine arabinoside (ara-A)/kg|Spongoadenosine"
NEW18223,DISEASE,norepinephrine biosynthesis,trigeminal neuropathic pain
NEW18225,DISEASE,capsaicin administration,infraorbital nerve
NEW18226,CHEMICAL,capsaicin administration,beta-adrenergics
NEW18227,DISEASE,serotonin hypothesis,depression-associated memory loss
NEW18229,DISEASE,associate memory loss,associated memory loss
NEW18231,MENTAL_HEALTH,lactobacillus family,subiculo-accumbens projection system
D045473,DISEASE,SARS Virus,"SARS|Coronavirus, SARS-Related|SARS Related Coronavirus|Coronavirus, SARS-Associated|Coronavirus, Urbani SARS-Associated|SARS-Associated Coronavirus, Urbani|Severe Acute Respiratory Syndrome Virus|Urbani SARS Associated Coronavirus|SARS Coronavirus|SARS-Associated Coronavirus|SARS-CoV|Severe acute respiratory syndrome related coronavirus|SARS Associated Coronavirus|Severe acute respiratory syndrome-related coronavirus|Coronavirus, SARS|SARS-Related Coronavirus|Urbani SARS-Associated Coronavirus"
NEW18237,BIOCHEMICAL,unaffected obligatory carrier,unaffected obligatory carriers
NEW18239,DISEASE,biperiden abuser,polytoxicomania
NEW18241,DISEASE,intra-articular ia hyaluronic acid injection,TMJ osteoarthritis
NEW18244,CHEMICAL,cholinergic projection system,dopamine nonresponsive features
NEW18245,BIOCHEMICAL,cholinergic projection system,targeted cholinergic drug treatment
NEW18246,CHEMICAL,cholinergic projection system,"BA|benzene-1,4-diboronic acid"
C070804,CHEMICAL,alizarin complexone [Supplementary Concept],ALC|Anthraquinones|alizarin complexone
NEW18247,CHEMICAL,cholinergic projection system,boronate ester
NEW18248,MENTAL_HEALTH,cholinergic projection system,competitive binding dissociation
NEW18250,DISEASE,gemfibrozil preincubation,P450 human liver microsomes
NEW18251,DISEASE,gemfibrozil preincubation,metabolic alkalosis
NEW18252,NUTRITION,gemfibrozil preincubation,low serum phosphorus concentrations
NEW18253,DISEASE,gemfibrozil preincubation,intestinal atony
NEW18255,DISEASE,mglu1 pam,concomitant cognitive deficits
NEW18256,MENTAL_HEALTH,mglu1 pam,cortical hyperactivity
NEW18258,MENTAL_HEALTH,depressive symptom,Epidemiologic Studies Depression Scale
NEW18259,CHEMICAL,depressive symptom,plasma F2-isoprostanes
NEW18260,BIOCHEMICAL,depressive symptom,serum carotenoids
NEW18261,CHEMICAL,depressive symptom,subsequent F2-isoprostane
NEW18262,MENTAL_HEALTH,depressive symptom,subsequent depression
NEW18263,CHEMICAL,depressive symptom,increased F2-isoprostanes
NEW18265,DISEASE,low carotenoid,Rabbit Syndrome
NEW18267,DISEASE,sigma agonist fluvoxamine,numerous movement disorders
NEW18268,CHEMICAL,sigma agonist fluvoxamine,intracellular magnesium
NEW18269,CHEMICAL,standard antidepressant,sucrose intake
D002112,CHEMICAL,Calcifediol,"25-Hydroxyvitamin D 3|Dedrogyl|25-Hydroxycholecalciferol Monohydrate|25 Hydroxyvitamin D 3|25 Hydroxycholecalciferol|Hidroferol|25-Hydroxyvitamin D3|Calcifediol Anhydrous|25-hydroxycholecalciferol|Calcifediol, (3 beta,5E,7E)-Isomer|Calderol|Monohydrate, 25-Hydroxycholecalciferol|Anhydrous, Calcifediol|25 Hydroxyvitamin D3|Calcidiol|25-Hydroxycholecalciferol|Calcifediol, (3 alpha,5Z,7E)-Isomer|25 Hydroxycholecalciferol Monohydrate"
C031424,CHEMICAL,"24,25-dihydroxycholecalciferol receptor [Supplementary Concept]","Receptors, Calcitriol|24,25-dihydroxycholecalciferol"
NEW18272,BIOCHEMICAL,postpartum depressive symptom,mixture modeling
NEW18273,DISEASE,postpartum depressive symptom,subcutaneous tumors
C566375,DISEASE,Expansile Bone Lesions [Supplementary Concept],bone lesions|Bone Diseases|Bone and Bones/abnormalities
NEW18274,DISEASE,postpartum depressive symptom,high-risk MM patients
NEW18276,CHEMICAL,5-ht neurotransmission,TRP liberation
NEW18278,BIOCHEMICAL,cognitive development,classical nuclear androgen receptor
NEW18279,BIOCHEMICAL,circulate androgen,excess androgen production
D006689,DISEASE,Hodgkin Disease,"Hodgkin Lymphoma|Malignant Granuloma|Nodular Lymphocyte Predominant Hodgkin's Lymphoma|Lymphoma, Hodgkin's|Disease, Hodgkins|Lymphoma, Hodgkin|Hodgkins Disease|Lymphogranuloma, Malignant|Lymphocyte-Rich Classical Hodgkin's Lymphoma|Hodgkin Granuloma|Granuloma, Hodgkin's|Mixed Cellularity Hodgkin's Lymphoma|Adult Hodgkin Lymphoma|Hodgkin Lymphoma, Adult|Nodular Lymphocyte-Predominant Hodgkin's Lymphoma|Disease, Hodgkin|Disease, Hodgkin's|Malignant Lymphogranulomas|Lymphocyte Rich Classical Hodgkin's Lymphoma|Nodular Sclerosing Hodgkin's Lymphoma|Granuloma, Hodgkin|Hodgkin's Disease|Lymphocyte Depletion Hodgkin's Lymphoma|Malignant Lymphogranuloma|Malignant Granulomas|Lymphogranulomas, Malignant|Granuloma, Hodgkins|Hodgkins Lymphoma|Hodgkins Granuloma|Hodgkin's disease|Granuloma, Malignant|Hodgkin's Granuloma|Hodgkin's Lymphoma"
NEW18285,DISEASE,mycoplasma gallisepticum infection,chronic respiratory disease
NEW18286,DISEASE,mycoplasma gallisepticum infection,infectious sinusitis
NEW18288,DISEASE,melatonin-receptor agonist,chronobiotic effet
NEW18289,CHEMICAL,melatonin-receptor agonist,melatonin agonist action
NEW18290,CHEMICAL,melatonin-receptor agonist,5HT2c antagonist
NEW18292,CHEMICAL,frequent CAE,TBA|tributyl aconitate
NEW18294,NUTRITION,polyposis registry clinician,high amylose maize starch
C551966,NUTRITION,octenyl succinic anhydride-modified starch [Supplementary Concept],Starch/analogs  and  derivatives|potato starch
D012811,DISEASE,Sigmoid Neoplasms,"Sigmoidal Cancer|Sigmoid Cancer|Sigmoid Colon Neoplasm|Cancer, Sigmoid Colon|Colon Cancer, Sigmoid|Sigmoid Neoplasm|Neoplasm, Sigmoid Colon|Cancer, Sigmoid|Neoplasms, Sigmoid Colon|Colon Neoplasms, Sigmoid|Sigmoid Colon Cancer|Cancer of Sigmoid|Neoplasms, Sigmoid|Cancer of the Sigmoid|sigmoid colon|Neoplasm, Sigmoid|Sigmoid Colon Neoplasms"
NEW18297,CHEMICAL,aspirin group,aspirin group
NEW18298,DISEASE,aspirin group,significant gastrointestinal bleeds
NEW18300,DISEASE,metabolise phytanic acid,peripheral dissociative polyneuropathy
D012174,DISEASE,Retinitis Pigmentosa,"Pigmentary Retinopathy|Tapetoretinal Degenerations|Retinopathies, Pigmentary|Retinopathy, Pigmentary|Pigmentary Retinopathies|retinitis pigmentosa|Tapetoretinal Degeneration"
NEW18303,BIOCHEMICAL,breast cancer tissue,neoantigen production due
NEW18305,DISEASE,natural coumarin,Alzheimer's disease inhibition
NEW18307,DISEASE,natural coumarin,dopamine-induced neurodegeneration
C537180,MENTAL_HEALTH,Familial paroxysmal dystonia [Supplementary Concept],Dystonia|paroxysmal kinesigenic dyskinesia
NEW18309,BIOCHEMICAL,increase prostate index,cell antigen PCNA index
NEW18310,DISEASE,increase prostate index,increased erection latency
NEW18312,BIOCHEMICAL,seahorse extract,candidate marine drug
D019574,DISEASE,Optic Nerve Neoplasms,"Benign Optic Nerve Sheath Neoplasms|Tumor, Optic Nerve, Benign|Malignant Optic Nerve Neoplasm|Benign Optic Nerve Tumor|benign tumor|Benign Optic Nerve Neoplasm|Optic Nerve Sheath Tumors|Malignant Optic Nerve Tumor|Tumor, Malignant, Optic Nerve|Malignant Optic Nerve Sheath Neoplasms|Optic Nerve Sheath Tumors, Malignant|Malignant Optic Nerve Sheath Tumors|Tumor, Optic Nerve, Malignant|Neoplasm, Optic Nerve|Neoplasm, Optic Nerve, Benign|Optic Nerve Neoplasm, Benign|Tumor, Benign, Optic Nerve|Optic Nerve Tumor, Malignant|Optic Nerve Sheath Neoplasm|Neoplasm, Benign, Optic Nerve|Optic Nerve Sheath Neoplasms, Malignant|Benign Optic Nerve Sheath Tumors|Neoplasms, Optic Nerve|Optic Nerve Sheath Tumors, Benign|Optic Nerve Neoplasm"
NEW18314,DISEASE,Suicidegene therapy,uterine leiomyoma
NEW18315,MENTAL_HEALTH,Suicidegene therapy,suicide gene therapy
NEW18317,BIOCHEMICAL,cationic peptide carrier,modular non-viral carriers
NEW18319,NUTRITION,cubic spline,lithium concentration
NEW18320,DISEASE,cubic spline,any mood episodes
NEW18323,CHEMICAL,sp. strain jdr-2,"beta-1,4-xylotriose"
NEW18324,CHEMICAL,sp. strain jdr-2,MeGAX(3
D013318,DISEASE,Stroke Volume,"Ejection Fraction, Ventricular|Volume, Stroke|Ventricular End Diastolic Volume|Volumes, Ventricular End-Systolic|Volumes, Ventricular End-Diastolic|Volume, Ventricular End-Diastolic|Fractions, Ventricular Ejection|Stroke Volumes|Fraction, Ventricular Ejection|End-Systolic Volume, Ventricular|Ventricular Ejection Fractions|stroke volume|Ventricular End-Diastolic Volumes|End-Diastolic Volume, Ventricular|Volumes, Stroke|Volume, Ventricular End-Systolic|Ejection Fractions, Ventricular|Ventricular Ejection Fraction|Ventricular End-Diastolic Volume|Ventricular End-Systolic Volume|End-Diastolic Volumes, Ventricular|Ventricular End-Systolic Volumes|End-Systolic Volumes, Ventricular|Ventricular End Systolic Volume"
NEW18325,CHEMICAL,sp. strain jdr-2,uric acid levels
NEW18326,BIOCHEMICAL,sp. strain jdr-2,high serum parathyroid hormone
NEW18327,DISEASE,sp. strain jdr-2,behavioral dysexecutive disorders
NEW18329,MENTAL_HEALTH,low serum glucose level,steroid psychosis
NEW18335,MENTAL_HEALTH,captive adult snow leopard,anxiety presence
NEW18337,MENTAL_HEALTH,oral fluoxetine,pharmacological dissociation
NEW18339,NUTRITION,e. ictaluri,yellow catfish
NEW18342,DISEASE,atypical antipsychotic ziprasidone,adverse motor events
D000071956,DISEASE,Myocardial Contusions,"Contusion, Heart|Cardiac Contusion|Heart Contusions|Contusions, Heart|Cordis, Contusio|Injury, Blunt Cardiac|Injuries, Blunt Cardiac|Cardiac Contusions|Contusion, Myocardial|Contusion, Cardiac|Myocardial Contusion|cardiac injuries|Cardiac Injuries, Blunt|Contusions, Cardiac|Blunt Cardiac Injury|Contusio Cordis|Cardiac Injury, Blunt|Heart Contusion|Contusions, Myocardial|Blunt Cardiac Injuries"
NEW18345,CHEMICAL,camp signaling pathway,ethanol sensitivity
NEW18346,BIOCHEMICAL,camp signaling pathway,postdischarge narcotic refills
NEW18347,BIOCHEMICAL,camp signaling pathway,narcotic refills
NEW18350,MENTAL_HEALTH,antiviral pf74,stress fatigue
NEW18351,DISEASE,nitrous oxide abuse,myeloneuropathy
NEW18353,CHEMICAL,g. sabinae,CUP-067943 aecia roestelioid
NEW18354,CHEMICAL,g. sabinae,periderium balanoid
NEW18355,DISEASE,g. sabinae,P. calleryana
NEW18357,CHEMICAL,fatigue resistance,FO independent
NEW18360,CHEMICAL,a. auriculiformis,coordinated gas exchange
NEW18362,CHEMICAL,aggregated cd toxicity,GA20ox
D054732,CHEMICAL,Calcium-Calmodulin-Dependent Protein Kinase Type 2,CaM KII|CaMKIIgamma|Calcium Calmodulin Dependent Protein Kinase Type 2 gamma Subunit|Calcium-Calmodulin Protein Kinase II|Calcium Calmodulin Dependent Protein Kinase Type 2 delta Subunit|CaM Kinase II beta|CaM-Kinase IIalpha|Calcium Calmodulin Dependent Protein Kinase II delta|Calcium Calmodulin Dependent PK Type II|Calmodulin Dependent Protein Kinase II|Calmodulin Kinase IIalpha|CaM Kinase II alpha|Calcium Calmodulin Dependent Protein Kinase II beta|Calcium Calmodulin Dependent Protein Kinase Type 2 beta Subunit|Calcium-Dependent CaM Kinase II|Calcium-Calmodulin-Dependent Protein Kinase Type 2 gamma Subunit|Calcium Calmodulin Dependent Protein Kinase Type 2|Calcium Calmodulin Dependent Protein Kinase II gamma|Calcium-Calmodulin Dependent Protein Kinase II beta|Calcium-Calmodulin-Dependent Protein Kinase Type 2 beta Subunit|CaM PK II|CaM KIIbeta|Calcium-Calmodulin-Dependent PK Type II|CaM|CaM Kinase IIalpha|CaM KIIalpha|CaM Kinase II|CaM-Kinase II|Calcium-Calmodulin Dependent Protein Kinase II delta|CaM Kinase II gamma|CaMKII|Calcium-Calmodulin-Dependent Protein Kinase Type 2 delta Subunit|CaM Kinase II delta|CaM KIIdelta|Calcium-Calmodulin-Dependent Protein Kinase Type 2 alpha Subunit|Calcium Calmodulin Dependent Protein Kinase Type 2 alpha Subunit|Calcium Dependent CaM Kinase II|Calmodulin-Dependent Protein Kinase II|Calcium-Calmodulin Dependent Protein Kinase II gamma|Calcium Calmodulin Protein Kinase II|Ca(2+)-Calmodulin Dependent Protein Kinase Type II|CaCMKII
NEW18363,DISEASE,functional bowel disease,functional bowel disease
NEW18364,DISEASE,central neuropathic pain,central neuropathic pain
NEW18367,DISEASE,plasma agrp elevation,homeostasis disturbance
NEW18368,MENTAL_HEALTH,plasma agrp elevation,anorexia nervosa patients
NEW18369,DISEASE,activity-based anorexia,anxiety- attack-like behaviours
NEW18371,DISEASE,mg741,hepatic steatosis score
NEW18372,DISEASE,mg741,HFD-induced deterioration
NEW18374,DISEASE,thyroid hormone signaling regulation,stroke outcome
NEW18377,DISEASE,potent serotonin reuptake inhibition,premenstrual complaints
NEW18380,DISEASE,high brain mk4 concentration,good seizure control attributable
NEW18381,CHEMICAL,high brain mk4 concentration,toxic intermediates α-aminoadipic semialdehyde|AASA
D050698,CHEMICAL,Glutamate-5-Semialdehyde Dehydrogenase,"Dehydrogenase, Glutamate-Semialdehyde|Reductase, Beta-Glutamylphosphate|Beta-Glutamylphosphate Reductase|Dehydrogenase, Glutamate-5-Semialdehyde|Beta Glutamylphosphate Reductase|Gamma-Glutamylphosphate Reductase|semialdehyde|Reductase, Gamma-Glutamylphosphate|Glutamate 5 Semialdehyde Dehydrogenase|Glutamate Semialdehyde Dehydrogenase|5-Semialdehyde Dehydrogenase, Glutamate|Gamma Glutamylphosphate Reductase|Dehydrogenase, Glutamate 5-Semialdehyde|Glutamate-Semialdehyde Dehydrogenase|Glutamate 5-Semialdehyde Dehydrogenase"
NEW18383,DISEASE,high brain mk4 concentration,good seizure control
NEW18385,DISEASE,folate transporter deficiency,non-epileptic manifestations
NEW18386,DISEASE,folate transporter deficiency,bipolar manic
NEW18388,MENTAL_HEALTH,pharmaceutical campaign,ADHD medication
NEW18389,MENTAL_HEALTH,pharmaceutical campaign,ADHD awareness
NEW18392,MENTAL_HEALTH,ovarian cancer 3d culture,mitotic spindle disorientation
NEW18396,DISEASE,estrogen pathway activation,white matter abnormality
NEW18397,CHEMICAL,free triiodothyronine,LT4 monotherapy
NEW18399,DISEASE,free thyroxine,summary cognitive deficits
NEW18402,CHEMICAL,total cholesterol,7-transmembrane receptor family
C528574,CHEMICAL,astressin-2B [Supplementary Concept],"Peptides, Cyclic|Peptide Fragments|astressin"
NEW18404,DISEASE,total cholesterol,ischemic cerebral infarction
NEW18406,CHEMICAL,finite-temperature k spectrum,potential energy surfaces|PES
NEW18407,DISEASE,finite-temperature k spectrum,behavior food consumption
NEW18409,DISEASE,catecholaminergic amp system,obesity-related metabolic syndrome
NEW18410,DISEASE,catecholaminergic amp system,hepatic inflammation
NEW18411,DISEASE,catecholaminergic amp system,chronic liver metabolic diseases
NEW18414,CHEMICAL,2=0.52,LF+ST
NEW18415,DISEASE,2=0.52,direct acute lung injury
NEW18416,DISEASE,2=0.52,direct ARDS
NEW18417,DISEASE,2=0.52,indirect ARDS
NEW18418,DISEASE,2=0.52,experimental acute lung injury lung injury
NEW18421,DISEASE,smooth muscle contraction,smooth muscle contraction
D011429,DISEASE,Propolis,"Glue, Bee|Bee Glue|Bee Bread|Bread, Bee|propolis"
NEW18422,MENTAL_HEALTH,parallel rightward displacement,parallel rightward displacement
NEW18423,DISEASE,panic attack-like defensive behaviour,panic attack-like defensive behaviours
NEW18424,DISEASE,sarcoidosis patient,sarcoidosis patients
NEW18425,DISEASE,suppression subtractive hybridization,VPAHPND infection
NEW18426,NUTRITION,suppression subtractive hybridization,white shrimp Litopenaeus
NEW18427,BIOCHEMICAL,suppression subtractive hybridization,anti-viral agent
NEW18429,DISEASE,oseltamivir resistance,H1N1 subtype neuraminidases
NEW18430,MENTAL_HEALTH,oseltamivir resistance,p11 consequent repression
NEW18431,DISEASE,oseltamivir resistance,insulin-dependent metabolic disorder
NEW18433,CHEMICAL,ccl exposure,glucagon levels
NEW18434,DISEASE,ccl exposure,liver cell damage
NEW18436,CHEMICAL,acute ccl exposure,chronic -exposed liver cells
NEW18438,CHEMICAL,anit feeding,hydrophobic BAs
NEW18439,DISEASE,anit feeding,significant cholestasis
NEW18440,CHEMICAL,serum alanine aminotransferase,serum alanine aminotransferase
NEW18441,DISEASE,minimal bile duct damage,minimal bile duct damage
NEW18442,CHEMICAL,direct bilirubin,direct bilirubin
NEW18446,DISEASE,pst27791,fibrosarcoma (Raf)-like kinase
NEW18448,MENTAL_HEALTH,TaRaf46,wheat resistance
NEW18451,DISEASE,5-ht(3 receptor antagonist ondansetron,treatment-resistant OCD patients
NEW18454,MENTAL_HEALTH,low-dose ondansetron,control disorder
NEW18455,CHEMICAL,low-dose ondansetron,midodrine therapy
NEW18457,CHEMICAL,melissa officinalis L.,memory-enhancing herb
NEW18458,CHEMICAL,melissa officinalis L.,inhibitor rivastigmine
NEW18459,CHEMICAL,low dose clonazepam,low dose clonazepam
NEW18460,BIOCHEMICAL,dopamine agonist due,dopamine agonists due
NEW18462,DISEASE,abnormal thyroid hormone system function,brain defects
NEW18463,BIOCHEMICAL,abnormal thyroid hormone system function,thyroid hormone system function
NEW18464,CHEMICAL,abnormal thyroid hormone system function,fetal alcohol exposure
NEW18469,DISEASE,serotonin 5-hydroxytryptamine type receptor,digestive dysfunction
NEW18471,CHEMICAL,otsuka Pharmaceutical Co. Ltd.,Abilify ®
NEW18472,BIOCHEMICAL,otsuka Pharmaceutical Co. Ltd.,first dopamine D2 receptor partial agonist antipsychotic aripiprazole
NEW18473,CHEMICAL,otsuka Pharmaceutical Co. Ltd.,mg ramelteon
NEW18477,DISEASE,human pxr agonist,conclusion postprandial hyperglycemia
NEW18478,CHEMICAL,-52‰,-52‰
NEW18479,BIOCHEMICAL,agonist dicarboxylic acid,agonist dicarboxylic acid
C036361,CHEMICAL,"1-amino-1,3-dicarboxycyclopentane [Supplementary Concept]","(1S,3R)-ACPD|Cycloleucine/analogs  and  derivatives"
NEW18481,DISEASE,group metabotropic glutamate receptor mglur agonist,major loss
NEW18483,CHEMICAL,synchronized 1a9 ovarian carcinoma cell,peloruside A. Co-immunoprecipitation
D050257,CHEMICAL,Tubulin Modulators,"Polymerization Inhibitor, Tubulin|Tubulin Modulator|Modulators, Microtubule|Inhibitors, Tubulin|Polymerization Promoters, Tubulin|Tubulin Inhibitors|Polymerization Promoter, Tubulin|Microtubule Modulator|Promoter, Tubulin Polymerization|Modulator, Tubulin|Polymerization Inhibitors, Tubulin|Tubulin Polymerization Inhibitors|Microtubule Modulators|Inhibitors, Tubulin Polymerization|Promoter, Tubulin|Modulator, Microtubule|Tubulin Promoter|Modulators, Tubulin|Inhibitor, Tubulin Polymerization|Promoters, Tubulin Polymerization|Tubulin Polymerization Promoters|Tubulin Polymerization Inhibitor|Tubulin Inhibitor|Inhibitor, Tubulin|Promoters, Tubulin|Tubulin Promoters|tubulin|Tubulin Polymerization Promoter"
NEW18485,DISEASE,microtubule stabilize agent,internal transformation
NEW18487,BIOCHEMICAL,stress-induced ibs,AV/GC mixture
NEW18490,DISEASE,brain degeneration,brain degeneration
NEW18492,CHEMICAL,beta gamma secretase,amyloid precursor protein(APP
NEW18494,DISEASE,retinoic acid signaling defect,cyclical nausea
NEW18496,MENTAL_HEALTH,pee group,unpredictable chronic stress
NEW18497,DISEASE,pee group,higher HCC
NEW18499,CHEMICAL,hypertension higher,anti-diarrheals
NEW18500,DISEASE,hypertension higher,tumor anti-proliferative agents
D017979,CHEMICAL,Gold Colloid,"Au|gold|Colloidal Gold|Gold, Colloidal|Colloid, Gold"
NEW18506,BIOCHEMICAL,nb atom,ovarian hormone levels
NEW18508,DISEASE,premenstrual depression,primary sleep disorders
NEW18509,CHEMICAL,premenstrual depression,increased GLU
NEW18510,DISEASE,premenstrual depression,skeletal deformities
NEW18512,BIOCHEMICAL,mtf ts,oestrogens antiandrogens application
NEW18514,DISEASE,endocrinopathy occurence,autoimmune thyreoiditis
D007713,DISEASE,Klinefelter Syndrome,"Syndromes, Klinefelter|XXY Syndromes|Klinefelter Syndromes, Variants|Xxyy Syndromes|Syndrome, Klinefelter|Trisomy, XXY|Klinefelter's Syndrome|Syndromes, Xxyy|Syndrome, XXY|Klinefelter Syndromes|Xxyy Syndrome|XXXY Males|Syndromes, XXY|Syndromes, Variants Klinefelter|49,XXXXY Syndrome|Klinefelters Syndrome|XXXY Male|Syndrome, Klinefelter's|Syndrome, Variants Klinefelter|Syndrome, Xxyy|XXY Trisomy|Trisomies, XXY|Klinefelter Syndrome, Variants|48,XXYY Syndrome|XXY Trisomies|Klinefelter syndrome|XXY Syndrome"
NEW18515,DISEASE,endocrinopathy occurence,nonfunctional pituitary adenoma
NEW18516,CHEMICAL,endocrinopathy occurence,DM type
NEW18519,DISEASE,progesterone increase,cerebellar degeneracy
NEW18520,MENTAL_HEALTH,progesterone increase,alcoholic dementia
NEW18521,CHEMICAL,progesterone increase,alcohol treatment
NEW18525,DISEASE,adipose inflammation,CSD mice
NEW18528,CHEMICAL,serotonergic antidepressant exposure,serotonergic antidepressant exposure
NEW18530,CHEMICAL,large-scale dm/q trial,PBA rating scale
NEW18535,CHEMICAL,nonselective opioid antagonist naltrexone,rapid antidepressant effect
NEW18537,CHEMICAL,cci-tbi,cocaine place
NEW18541,CHEMICAL,cannabinoid hyperemesis syndrome patient,topical capsaicin
NEW18543,CHEMICAL,cannabinoid hyperemesis syndrome patient,mg/12 h.
NEW18544,CHEMICAL,cannabinoid hyperemesis syndrome patient,B6 mg/12 h
NEW18545,CHEMICAL,cannabinoid hyperemesis syndrome patient,mg/12 h
NEW18549,MENTAL_HEALTH,cus exposure,fEPSP depression
C558329,DISEASE,"6-chloro-N-(3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)imidazo(2,1-b)thiazole-5-sulfonamide [Supplementary Concept]",Thiazoles|Sulfonamides|CDI|Indoles
NEW18551,DISEASE,widespread antibiotic resistance,fighting infections
NEW18553,CHEMICAL,chronic pbz exposure,glyceride metabolism
NEW18555,NUTRITION,lithium-treate excellent lithium responder,excellent lithium responders
NEW18561,DISEASE,Lithium Genetics,hormone positive breast cancer
NEW18562,BIOCHEMICAL,Lithium Genetics,oestrogen receptor (ER)-positive breast tumours
NEW18563,CHEMICAL,Lithium Genetics,tamoxifen-resistant tumours
NEW18565,DISEASE,stable mood stabilizer,self-reported depressive symptoms
NEW18567,DISEASE,selective beta-adrenoceptor agonist,bronchial obstruction
C518017,DISEASE,"BRCC3 protein, human [Supplementary Concept]",Deubiquitinating Enzymes|cancer cell
NEW18569,BIOCHEMICAL,red rice extract,antiviral signalling
NEW18570,MENTAL_HEALTH,insulin-resistant syndrome,insulin-resistant syndromes
NEW18571,DISEASE,control pain,control pain
NEW18572,CHEMICAL,iron retention,iron retention
NEW18577,NUTRITION,cyclase inhibitor tripropylamine,4-hydroxybenzoate choline
NEW18578,CHEMICAL,cyclase inhibitor tripropylamine,1-palmitoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine
NEW18579,BIOCHEMICAL,cyclase inhibitor tripropylamine,lycopene accumulation
NEW18580,DISEASE,cyclase inhibitor tripropylamine,TRMA syndrome
NEW18583,CHEMICAL,stress-induced cortisol secretion,brain 5-HT activity
NEW18584,BIOCHEMICAL,stress-induced cortisol secretion,5-HT-mediated growth hormone
NEW18585,BIOCHEMICAL,depressed patient,drug free
NEW18587,BIOCHEMICAL,hydrophobic property,weak polar mycotoxins
NEW18588,BIOCHEMICAL,hydrophobic property,multifunctional mycotoxin adsorbents
NEW18589,MENTAL_HEALTH,hydrophobic property,new orientation
NEW18592,BIOCHEMICAL,viral nervous necrosis,NNV-infected carriers
NEW18594,DISEASE,hormone regulation,EHP infection
NEW18596,BIOCHEMICAL,cue-induced craving,drug relapse
D056743,CHEMICAL,Cyclin D3,cyclin D3
NEW18597,CHEMICAL,cue-induced craving,naloxone treatment
NEW18598,MENTAL_HEALTH,chronic morphine treatment,withdrawal-induced hyperactivity
D011699,CHEMICAL,Putamen,"Nucleus Putamen|Put|putamen|Nucleus Putamens|Putamens, Nucleus|Putamen, Nucleus|Putamens"
NEW18600,MENTAL_HEALTH,gaba agonist 3-aminopropane sulphonic acid,dopamine-accumbens hyperactivity model
NEW18602,MENTAL_HEALTH,gaba uptake system,dopamine-dependent hyperactivity
NEW18603,MENTAL_HEALTH,gaba uptake system,dose-related depression
NEW18605,MENTAL_HEALTH,gaba uptake blockade,GABA-mediated depression
NEW18607,CHEMICAL,hyperactivity model,GABA uptake blocking compounds
NEW18609,DISEASE,drd1 antagonist,anorexia weight loss
NEW18610,BIOCHEMICAL,drd1 antagonist,antibacterial drug consumption
NEW18611,DISEASE,drd1 antagonist,common infections
NEW18612,CHEMICAL,drd1 antagonist,fluorescein leakage
NEW18616,CHEMICAL,syn orientation,3-indole acetic acid
NEW18617,BIOCHEMICAL,syn orientation,antibiotic resistance marker
NEW18618,CHEMICAL,syn orientation,chloramphenicol resistance gene
NEW18619,CHEMICAL,syn orientation,fenretinide acetate
NEW18620,DISEASE,syn orientation,induced enteritis
NEW18621,BIOCHEMICAL,syn orientation,enteritis drug
NEW18623,DISEASE,induce enteritis model,brain microsomes
NEW18624,DISEASE,non-aromatized androgene dihydrotestosterone,erection disorders
NEW18627,DISEASE,pyruvate dehydrogenase pdh deficiency,congenital lactic acidosis
NEW18629,DISEASE,sialic-acid dosage,central pain transmission
NEW18631,DISEASE,antagonist [11C]raclopride,neurometabolic disorder
NEW18632,CHEMICAL,antagonist [11C]raclopride,lysine metabolism
NEW18633,CHEMICAL,antagonist [11C]raclopride,α-aminoadipic semialdehyde dehydrogenase
NEW18635,DISEASE,antagonist [11C]raclopride,dopaminergic neuronal death
D004660,DISEASE,Encephalitis,"Inflammation, Brain|Rasmussen Encephalitis|Rasmussen's Syndrome|Brain Inflammation|Encephalitis, Rasmussen|Brain Inflammations|Rasmussen Syndrome|brain inflammation"
NEW18638,DISEASE,altered brain injury gene,various disorders deficit hyperactive disorder
NEW18641,DISEASE,tree algorithm,bipolar spectrum disorders|BPSD
NEW18643,DISEASE,srg suppression,death cues
D055113,DISEASE,Chronic Periodontitis,"periodontitis|Periodontitides, Adult|Periodontitis, Chronic|Chronic Periodontitides|Periodontitides, Chronic|Adult Periodontitis|Adult Periodontitides|Periodontitis, Adult"
NEW18644,DISEASE,srg suppression,thyroid follicular cell hyperplasia
NEW18645,BIOCHEMICAL,srg suppression,GI drug use
NEW18647,NUTRITION,ruminal lactic acidosis,lower volatile fatty acid concentrations
NEW18648,BIOCHEMICAL,ruminal lactic acidosis,normal serum vitamin B12
D007611,CHEMICAL,Aprotinin,"aprotinin|Bovine Kunitz Pancreatic Trypsin Inhibitor|Trypsin Inhibitor, Basic, Pancreatic|Bovine Pancreatic Trypsin Inhibitor|Contrykal|Contrical|Trasylol|Inactivator, Kallikrein-Trypsin|Trypsin Inhibitor, Kunitz, Pancreatic|Kontrykal|Iniprol|Kallikrein Trypsin Inactivator|Pulmin|Dilmintal|Kallikrein-Trypsin Inactivator|Traskolan|Basic Pancreatic Trypsin Inhibitor|Kunitz Pancreatic Trypsin Inhibitor|BPTI, Basic Pancreatic Trypsin Inhibitor|Antilysin|Kontrikal|Zymofren"
NEW18651,CHEMICAL,veris L.,oral diethylstilboestrol
D020360,CHEMICAL,Neoadjuvant Therapy,"Therapy, Neoadjuvant|Treatment, Neoadjuvant|Neoadjuvant Chemotherapy|Radiation, Neoadjuvant|Systemic Treatment, Neoadjuvant|Chemoradiation Therapy, Neoadjuvant|Neoadjuvant Radiotherapies|Neoadjuvant Chemoradiation Treatments|Neoadjuvant Chemoradiations|Neoadjuvant Radiation|Neoadjuvant Chemoradiation Treatment|Therapy, Neoadjuvant Systemic|Neoadjuvant Radiotherapy|Chemotherapy Treatment, Neoadjuvant|Neoadjuvant Chemoradiotherapies|Neoadjuvant Systemic Treatments|Radiotherapy, Neoadjuvant|Treatment, Neoadjuvant Chemoradiation|Therapy, Neoadjuvant Radiation|Neoadjuvant Chemoradiotherapy|Neoadjuvant Chemotherapy Treatments|Radiation Therapy, Neoadjuvant|Neoadjuvant Systemic Therapy|Radiation Treatment, Neoadjuvant|Treatment, Neoadjuvant Radiation|Systemic Therapy, Neoadjuvant|Neoadjuvant Chemotherapy Treatment|Neoadjuvant Chemoradiation|neoadjuvant therapy|Neoadjuvant Radiation Treatments|Neoadjuvant Radiation Therapy|Chemoradiation, Neoadjuvant|Neoadjuvant Chemoradiation Therapies|Neoadjuvant Treatments|Neoadjuvant Radiations|Neoadjuvant Treatment|Neoadjuvant Systemic Treatment|Neoadjuvant Radiation Treatment|Chemoradiotherapy, Neoadjuvant|Neoadjuvant Therapies|Neoadjuvant Chemoradiation Therapy|Therapy, Neoadjuvant Chemoradiation|Neoadjuvant Chemotherapies|Treatment, Neoadjuvant Systemic|Treatment, Neoadjuvant Chemotherapy|Chemoradiation Treatment, Neoadjuvant|Chemotherapy, Neoadjuvant|Neoadjuvant Systemic Therapies|Neoadjuvant Radiation Therapies"
NEW18652,DISEASE,veris L.,downstaging prostate tumours
NEW18653,DISEASE,veris L.,erythema nodosum leprosum
D003168,MENTAL_HEALTH,Complement Fixation Tests,"Conglutination Reactions|Complement Fixation Test|complement fixation|Fixation Tests, Complement|Tests, Complement Fixation|Test, Complement Fixation|Reaction, Conglutination|Reactions, Conglutination|Conglutinating Complement Absorption Test|Fixation Test, Complement|Conglutination Reaction|Complement Absorption Test, Conglutinating"
NEW18654,DISEASE,daa therapy,HCV-associated disease burden
NEW18656,CHEMICAL,astrovirus projection domain,amino acid compositions
NEW18658,DISEASE,dopamine da depletion,abnormal spontaneous motor behavior
NEW18659,DISEASE,dopamine da depletion,daily myoclonic jerks
NEW18660,DISEASE,dopamine da depletion,severe dystonias
NEW18662,DISEASE,exercise fatigue,fatigue-related decrements
NEW18665,MENTAL_HEALTH,brain infarct area,exercise fatigue
NEW18666,MENTAL_HEALTH,norepinephrine-dopamine reuptake inhibition,conditional logistic regression model
NEW18668,CHEMICAL,coal combustion emission,CCE relevant
C119064,DISEASE,"DLEC1 protein, human [Supplementary Concept]",Tumor Suppressor Proteins|lung cancer
NEW18670,DISEASE,bismuth-containing quadruple therapy,Helicobacter pylori infection
NEW18672,CHEMICAL,ip3 receptor antagonist heparin,acetylcholine current
NEW18676,CHEMICAL,"1,4,5-inositol trisphosphate-linked subtype",postsynaptic calcium concentration
D000378,DISEASE,Agonistic Behavior,"Behavior, Agonistic|Agonistic Behaviors|agonistic behaviors|Behaviors, Agonistic"
NEW18679,BIOCHEMICAL,migraine remission,stable oestrogen levels
NEW18681,CHEMICAL,herbicide paraquat,nigrostriatal dopamine system
NEW18682,DISEASE,herbicide paraquat,permanent toxicity
NEW18690,CHEMICAL,episodic memory failure,micrograms/kg/day
NEW18691,CHEMICAL,op poisoning,OP poisoning
NEW18692,DISEASE,miosis op poisoning,Miosis OP poisoning
NEW18694,BIOCHEMICAL,swainsonine concentration,fungicide treatment
NEW18698,MENTAL_HEALTH,Schizophrenia spectrum Disorders,early-onset schizophrenia
NEW18700,MENTAL_HEALTH,old generation dopamine antagonist medication,stuttering symptoms
NEW18701,BIOCHEMICAL,old generation dopamine antagonist medication,adrenergic agonist abuse
NEW18702,DISEASE,old generation dopamine antagonist medication,Psychiatric Clinic
NEW18703,BIOCHEMICAL,old generation dopamine antagonist medication,pharmaceutical opioid
NEW18707,CHEMICAL,subclinical atherosclerosis,medical metformin
NEW18710,MENTAL_HEALTH,gremlin-1-silenced mesothelioma cell,poor resistance profile
NEW18712,MENTAL_HEALTH,arctic charr,resistance profiles
NEW18714,MENTAL_HEALTH,most steroid metabolite,syndrome Asperger syndrome
NEW18716,CHEMICAL,oral montelukast,guggulipid group
D005638,CHEMICAL,Fruit,"Legume Pod|Plant Aril|Aril, Plant|Fruits|Plant Capsules|Pod, Legume|Plant Arils|Legume Pods|Arils, Plant|Pods, Legume|Plant Capsule|Capsule, Plant|Berry|Capsules, Plant|Berries|fruit-"
NEW18717,NUTRITION,oral montelukast,% cholesterol/high lipoprotein HDL cholesterol ratio
NEW18719,DISEASE,inflammatory t helper cell,psychiatric signs
NEW18720,DISEASE,inflammatory t helper cell,psychiatric outcomes
NEW18724,BIOCHEMICAL,microbial resistance,novel antimicrobials
NEW18726,BIOCHEMICAL,classical antimicrobial agent,androgen activity
NEW18727,DISEASE,classical antimicrobial agent,antisocial criminal behaviour
NEW18729,DISEASE,da symptom,non-betrayal trauma
NEW18730,MENTAL_HEALTH,da symptom,depression levels
NEW18731,DISEASE,da symptom,betrayal trauma
NEW18732,DISEASE,da symptom,morphine-induced memory recall
NEW18735,BIOCHEMICAL,low nicotine concentration,effective anti-viral drug
NEW18738,DISEASE,anxiety-like behavior,PWD-induced anxiety-like behavior
NEW18740,CHEMICAL,brainstem-acting drug cloperastine,Mecp2-null mice
NEW18741,DISEASE,brainstem-acting drug cloperastine,breathing dysfunction
NEW18743,CHEMICAL,sarcoma cell,chloroctyl amino-phenildioxan derivatives
NEW18745,DISEASE,liver-specific thyromimetic,G6pc-/--deficient|GSD Ia
NEW18746,DISEASE,liver-specific thyromimetic,PRRSV infection
NEW18749,CHEMICAL,cpt1a1 sirna knockdown,treated HBMECs
NEW18751,DISEASE,transcript variant 4,TL-induced brain microvascular inflammation
NEW18752,DISEASE,transcript variant 4,lipotoxic
NEW18755,DISEASE,program cell death signalling pathway,small-fibre peripheral neuropathies
NEW18757,MENTAL_HEALTH,gel sample,corrosion resistance
C000711728,CHEMICAL,spartalizumab [Supplementary Concept],"Antibodies, Monoclonal, Humanized|anti-PD1"
NEW18759,DISEASE,antitumor immunity,tumor PDL1
NEW18760,DISEASE,antitumor immunity,immunogenic tumor STING signals
NEW18761,DISEASE,antitumor immunity,due acute diverticulitis
NEW18763,BIOCHEMICAL,high alcohol intake,prototypic μ-opioid agonist remifentanil
NEW18767,DISEASE,smoking rate,abdominal adiposity
NEW18770,DISEASE,vitamin d deficiency serum,disease treatment guidelines
NEW18773,DISEASE,extended-release calcifediol,chronic kidney disease stages
NEW18775,DISEASE,nmdar antagonist apv,gp120-induced mechanical allodynia
NEW18776,DISEASE,nmdar antagonist apv,gp120-induced pain
NEW18777,MENTAL_HEALTH,nmdar antagonist apv,disorder children
NEW18779,DISEASE,Trp98Stop,dysphoric state
NEW18781,DISEASE,nicotine seek,intermittent footshock stress
NEW18783,DISEASE,rapid-acting antidepressant property,HCV-induced hepatic steatosis
D015428,DISEASE,Myocardial Reperfusion Injury,"myocardial injury|Myocardial Ischemic Reperfusion Injury|Injuries, Myocardial Reperfusion|Reperfusion Injuries, Myocardial|Injury, Myocardial Reperfusion|Reperfusion Injury, Myocardial|Myocardial Reperfusion Injuries"
NEW18786,CHEMICAL,cb(1 antagonist rimonabant,CCK(2
C000648218,DISEASE,Brachyspira pilosicoli [Supplementary Concept],Brachyspira|Serpulina pilosicoli
NEW18788,BIOCHEMICAL,beta-hemolytic spirochete,pharmaceutical intervention
NEW18790,DISEASE,beta-hemolytic spirochete,psychiatric unit
NEW18793,MENTAL_HEALTH,levodopa l-dopa therapy,L-dopa-induced dyskinesia
NEW18795,MENTAL_HEALTH,camp signaling cascade,#NAME?
NEW18797,CHEMICAL,"l-3,4-dihydroxyphenylalanine therapy","L-3,4-dihydroxyphenylalanine therapy"
NEW18800,DISEASE,± sd serum level,delirium non-delirium patients
NEW18803,MENTAL_HEALTH,facl4 gene mutation,non-specific mental retardation
D058892,CHEMICAL,Adenosine Deaminase Inhibitors,"Inhibitors, ADA|Inhibitors, Adenosine Deaminase|adenosine deaminase|ADA Inhibitors|Deaminase Inhibitors, Adenosine"
NEW18806,MENTAL_HEALTH,hair cortisol,multiple regression analysis r(2 = =
NEW18808,DISEASE,selective adrenergic blocker,hypertension standing diastolic blood pressure
NEW18810,MENTAL_HEALTH,oral labetalol,significant fatigue
D053448,DISEASE,Prostatism,Prostate (1950-1951)|Prostatic Hyperplasia (1951-2006)|prostatism
NEW18815,DISEASE,3-hydroxy-3-methylglutaryl coenzyme a hmg-coa reductase inhibitor,arrhythmogenesis
NEW18817,DISEASE,pravastatin administration,favorable ventricular remodeling
NEW18818,CHEMICAL,pravastatin administration,endothelin-1 pathway
NEW18819,BIOCHEMICAL,pravastatin administration,antagonist pretreatment
NEW18820,BIOCHEMICAL,dissociation rate,insurmountable antagonists
NEW18823,CHEMICAL,ischemia-induced retrograde amnesia,FO administration
NEW18824,DISEASE,ischemia-induced retrograde amnesia,transient global cerebral ischemia|TGCI
NEW18825,DISEASE,toxic aggregation,toxic aggregation
NEW18827,MENTAL_HEALTH,southern flounder,metabolic fatigue
NEW18828,MENTAL_HEALTH,southern flounder,major syndromes
NEW18830,BIOCHEMICAL,spanish first-grade,muscarinic receptor antagonist
NEW18832,NUTRITION,calculate antagonist dissociation constant,alpha 2-adrenoceptors
D014642,CHEMICAL,Vanilmandelic Acid,"Acid, Methoxyhydroxymandelic|4-Hydroxy-3-Methoxymandelic Acid|Acid, 4-Hydroxy-3-Methoxymandelic|vanillylmandelic acid|Acid, Vanilmandelic|4 Hydroxy 3 Methoxymandelic Acid|Acid, Vanillylmandelic|Methoxyhydroxymandelic Acid|Vanillylmandelic Acid"
NEW18833,CHEMICAL,calculate antagonist dissociation constant,urinary NE
NEW18835,DISEASE,mibg scintigraphy,catecholamine-producing tumor
NEW18837,MENTAL_HEALTH,low ascorbic acid level,senile dementia patients
NEW18838,DISEASE,low ascorbic acid level,self-injurious responses
NEW18840,NUTRITION,salmonella typhimurium cecal colonization,quail chicks
NEW18843,DISEASE,bobwhite quail,mynah pox virus
NEW18844,DISEASE,bobwhite quail,post-operative ileus
NEW18845,MENTAL_HEALTH,bobwhite quail,slower dissociation rate
NEW18846,CHEMICAL,bobwhite quail,t(1/2)=44 min
NEW18847,CHEMICAL,bobwhite quail,long acting partial agonist buprenorphine
NEW18848,MENTAL_HEALTH,bobwhite quail,slow dissociation rate
NEW18849,MENTAL_HEALTH,bobwhite quail,dissociation symptoms
NEW18851,DISEASE,one extra carbon,memory impairments-effects
NEW18852,DISEASE,one extra carbon,psychiatric events
NEW18854,DISEASE,o2 stimulus,respiratory instability
NEW18858,CHEMICAL,hyperglycaemia,C(60)HyFn
NEW18860,MENTAL_HEALTH,camp production,ligand dissociation
NEW18861,CHEMICAL,camp production,W124EL1
NEW18862,CHEMICAL,camp production,benzamide motif
NEW18863,CHEMICAL,camp production,immediate-release IR opioids
NEW18864,BIOCHEMICAL,camp production,μ-opioid-receptor agonists
NEW18865,MENTAL_HEALTH,camp production,slow dissociation profile
NEW18867,NUTRITION,mood disorder patient,lithium use
NEW18868,MENTAL_HEALTH,mood disorder patient,resistance index
NEW18869,CHEMICAL,mood disorder patient,BCAAs genotypes
NEW18870,CHEMICAL,mood disorder patient,bensulfuron-methyl inhibition
NEW18872,CHEMICAL,subpopulation bc1,ALS-inhibiting herbicides
NEW18873,DISEASE,subpopulation bc1,ALS enzyme
C549011,CHEMICAL,bispyribac [Supplementary Concept],Benzoates|Pyrimidines|bispyribac-sodium
NEW18875,MENTAL_HEALTH,bc1 population,resistance ratios
NEW18876,MENTAL_HEALTH,bc1 population,non-target-site resistance
NEW18877,DISEASE,bc1 population,minimal ALL disease
NEW18878,DISEASE,bc1 population,severe HPP types
NEW18879,BIOCHEMICAL,bc1 population,vitamin B6 metabolism
NEW18880,CHEMICAL,bc1 population,transmethylases
D014178,DISEASE,"Translocation, Genetic","translocations|Genetic Translocations|Chromosomal Translocations|Translocation, Chromosomal|Translocations, Chromosomal|Translocations, Genetic|Genetic Translocation|Chromosomal Translocation"
NEW18881,DISEASE,bc1 population,marked chromosomal aberrations
NEW18882,CHEMICAL,bc1 population,gonadotropin-induced cAMP generation
NEW18884,CHEMICAL,crf action,pertussis toxin-insensitive guanyl nucleotide regulatory unit
NEW18885,CHEMICAL,crf action,5HT2 receptors
NEW18886,BIOCHEMICAL,crf action,toxin insensitive G-protein
NEW18887,DISEASE,crf action,CRF secretion
NEW18889,MENTAL_HEALTH,high ps level,rate dissociation rate
NEW18890,DISEASE,endocrine change,breast cancer cell migration
NEW18892,MENTAL_HEALTH,norepinephrine ne transporter,depression research
NEW18893,MENTAL_HEALTH,norepinephrine ne transporter,resistance due
NEW18897,MENTAL_HEALTH,astrocytic hypertrophy,adult personality disorder
D019955,MENTAL_HEALTH,Conduct Disorder,Callous Unemotional Traits|conduct disorder|Conduct Disorders|Callous-Unemotional Traits|Callous-Unemotional Trait
NEW18898,MENTAL_HEALTH,astrocytic hypertrophy,late-onset ADHD
NEW18899,MENTAL_HEALTH,astrocytic hypertrophy,less insomnia
NEW18902,DISEASE,iron supplement,involuntary erection
NEW18903,DISEASE,iron supplement,interpersonal hypersensitivity
NEW18904,DISEASE,iron supplement,metabolic syndrome related
NEW18909,MENTAL_HEALTH,intravenous eptifibatide,elevation acute coronary syndromes
NEW18910,DISEASE,intravenous eptifibatide,non-ST-segment elevation|NSTE
D000789,DISEASE,"Angina, Unstable","Preinfarction Anginas|Angina Pectoris, Unstable|Preinfarction Syndromes, Myocardial|Angina at Rest|Anginas, Unstable|Unstable Anginas|Myocardial Preinfarction Syndrome|Unstable angina|Unstable Angina Pectoris|Syndrome, Myocardial Preinfarction|Myocardial Preinfarction Syndromes|Unstable Angina Pectori|Syndromes, Myocardial Preinfarction|Angina Pectori, Unstable|Preinfarction Angina|Anginas, Preinfarction|Preinfarction Syndrome, Myocardial|Angina, Preinfarction|Unstable Angina"
NEW18913,NUTRITION,acute untreated schizophrenia,prominent alpha activity
NEW18915,NUTRITION,disorganized type schizophrenia,alpha activity
NEW18917,CHEMICAL,central serotonin 5ht system,meta-chlorphenylpiprazine
NEW18918,BIOCHEMICAL,central serotonin 5ht system,central serotonin receptor agonist
NEW18920,CHEMICAL,primary bilateral macronodular adrenal hyperplasia,subclinical cortisol production
NEW18921,DISEASE,primary bilateral macronodular adrenal hyperplasia,bilateral adrenal incidentalomas
NEW18923,DISEASE,primary bilateral macronodular adrenal hyperplasia,Garcinia sp.
NEW18924,CHEMICAL,primary bilateral macronodular adrenal hyperplasia,MPTP mouse model
NEW18926,BIOCHEMICAL,toxicity,adrenergic agonist drugs
NEW18928,DISEASE,appropriate adrenergic agent,massive hepatocellular necrosis
NEW18930,BIOCHEMICAL,whose be hepatotoxicity,adrenergic antagonist drugs
NEW18931,BIOCHEMICAL,whose be hepatotoxicity,hepatotoxicant
NEW18932,CHEMICAL,whose be hepatotoxicity,endogenous catecholamine levels
NEW18935,DISEASE,elevated catecholamine,hepatotoxic effects
NEW18936,BIOCHEMICAL,ethanol extract,good analgesic activity
NEW18937,CHEMICAL,equianalgesic dose,equianalgesic doses
NEW18938,CHEMICAL,pethidine-tilidine combination,pethidine-tilidine combinations
NEW18940,DISEASE,lithium therapy,multiple neuropsychiatric disorders
NEW18941,DISEASE,lithium therapy,neurobehavioural impairments
NEW18943,MENTAL_HEALTH,lithium therapy,terminal projection areas
NEW18944,CHEMICAL,lithium therapy,cocaine-evoked DA overflow
NEW18946,DISEASE,adenosine A2AR,serious neuropathological damage
NEW18948,CHEMICAL,e3 adhd subunit,E2 AdhC.
NEW18949,CHEMICAL,e3 adhd subunit,most 2-oxoacid dehydrogenases
NEW18950,CHEMICAL,e3 adhd subunit,glucose medium
NEW18953,DISEASE,renin-angiotensin-aldosterone blockade,short-term loss
NEW18955,CHEMICAL,an-induced cognitive deficit,Astaxanthin pretreatment
NEW18956,CHEMICAL,an-induced cognitive deficit,intracellular glutathione
NEW18957,DISEASE,an-induced cognitive deficit,vascular EC dysfunction
NEW18960,CHEMICAL,cabergoline therapy,cabergoline therapy
NEW18962,BIOCHEMICAL,hyperprolactinemic serum,antifungals
NEW18964,MENTAL_HEALTH,specific egfr inhibitor osimertinib mesylate,azole resistance
NEW18965,MENTAL_HEALTH,specific egfr inhibitor osimertinib mesylate,fluconazole resistance
NEW18966,MENTAL_HEALTH,specific egfr inhibitor osimertinib mesylate,probable bruxism
NEW18968,CHEMICAL,bruxism episode,pramipexole episodes
NEW18969,CHEMICAL,bruxism episode,pramipexole conditions
NEW18971,CHEMICAL,post-partum mental illness,PlantVis
D000971,BIOCHEMICAL,Antineoplastic Combined Chemotherapy Protocols,"Agents, Combined Antineoplastic|Anticancer Drug Combination|Antineoplastic Drug Combination|Agent, Combined Antineoplastic|Drug Combination, Antineoplastic|Chemotherapy Protocols, Antineoplastic|Protocols, Cancer Chemotherapy|Chemotherapy Protocol, Antineoplastic|Anticancer Drug Combinations|Combined Antineoplastic Agent|Antineoplastic Chemotherapy Protocol|Antineoplastic Combined Chemotherapy Regimens|Combined Antineoplastic Agents|Cancer Chemotherapy Protocol|Cancer Chemotherapy Protocols|Antineoplastic Chemotherapy Protocols|Combinations, Antineoplastic Drug|Antineoplastic Agents, Combined|anticancer drug|Drug Combination, Anticancer|Drug Combinations, Antineoplastic|Protocol, Antineoplastic Chemotherapy|Protocols, Antineoplastic Chemotherapy|Chemotherapy Protocols, Cancer|Antineoplastic Drug Combinations|Drug Combinations, Anticancer|Chemotherapy Protocol, Cancer|Protocol, Cancer Chemotherapy|Antineoplastic Agent, Combined"
NEW18974,DISEASE,Psoralea corylifolia L. seed,kidney yang deficiency
NEW18975,MENTAL_HEALTH,long-term mental disorder,long-term mental disorders
NEW18977,DISEASE,prenatal vitamin d,postnatal months|PNM
C113300,CHEMICAL,TPH hybrid [Supplementary Concept],TPH|Composite Resins
NEW18979,MENTAL_HEALTH,prenatal dexamethasone,depression attention
NEW18983,CHEMICAL,refractory early onset schizophrenia,clozapine regimen
NEW18984,DISEASE,refractory early onset schizophrenia,sleep-related breathing difficulties
NEW18985,DISEASE,contrast antipsychotic-induced eps,contrast antipsychotic-induced EPS
NEW18986,DISEASE,eps induction,EPS induction
NEW18987,DISEASE,antipsychotic-induced eps,antipsychotic-induced EPS
NEW18989,CHEMICAL,multiple 5-ht receptor,ChEIs reuptake inhibitors
NEW18992,CHEMICAL,dopamine receptor antagonist haloperidol,glutamatergic AMPA/Kainate-
NEW18993,BIOCHEMICAL,dopamine receptor antagonist haloperidol,NMDA-receptor antagonists
NEW18995,MENTAL_HEALTH,new selective norepinephrine reuptake inhibitor,ADHD tic disorder
NEW18996,CHEMICAL,selective norepinephrine reuptake inhibitor,medication atomoxetine
D061270,DISEASE,Nasal Septal Perforation,"Septal Perforations, Nasal|perforation|Perforations, Nasal Septum|Septum Perforations, Nasal|Nasal Septum Perforations|Septum Perforation, Nasal|Perforation, Nasal Septal|Perforations, Nasal Septal|Septal Perforation, Nasal|Nasal Septal Perforations|Perforation, Nasal Septum|Nasal Septum Perforation"
NEW18997,DISEASE,selective norepinephrine reuptake inhibitor,metabolic derangement
NEW18998,CHEMICAL,selective norepinephrine reuptake inhibitor,hydroxy-carboxylic acid receptor
D009846,DISEASE,Oliguria,oliguria|Oligurias
NEW18999,DISEASE,selective norepinephrine reuptake inhibitor,central impairment
NEW19001,NUTRITION,aegerita lectin,fungi Agrocybe aegerita
NEW19002,CHEMICAL,aegerita lectin,purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase
D006467,DISEASE,Hemophilia A,"Autosomal Hemophilia As|Classic Hemophilias|Haemophilia|Deficiency, Factor VIII|Autosomal Hemophilia A|As, Autosomal Hemophilia|Hemophilias, Classic|Classic Hemophilia|Congenital Hemophilia A|Factor VIII Deficiency|Factor VIII Deficiency, Congenital|Hemophilia As, Congenital|Factor 8 Deficiency, Congenital|Congenital Hemophilia As|Hemophilia|Hemophilia As, Autosomal|Hemophilia, Classic|Hemophilia A, Congenital|congenital deficiency|Hemophilia As|Hemophilia A, Autosomal"
NEW19004,MENTAL_HEALTH,synthetic calcium phosphate,projection reconstruction technique
NEW19008,DISEASE,minimal thyroid abnormality,central thyroid disorders
NEW19009,CHEMICAL,minimal thyroid abnormality,exhausted TRH hypothalamic biodisponibility
NEW19011,BIOCHEMICAL,norepinephrine level,increased hormones biodisponibility
NEW19012,CHEMICAL,serotonin synthesis,5HIA catabolite
NEW19013,DISEASE,serotonin synthesis,acne treatment regimen
C116177,DISEASE,capsular polysaccharide 19F [Supplementary Concept],Bacterial Capsules|S. pneumoniae
NEW19016,MENTAL_HEALTH,antibiotic intervention mouse,peripartum depression
NEW19018,DISEASE,bovine mycotoxicosis,Clostridium botulinum bacteria
D008575,CHEMICAL,Meniere Disease,"Diseases, Ménière|Meniere's Syndrome|Ménière's Vertigo|Ménière's Diseases|Ménière Disease|Disease, Ménière|Ménières Vertigo|Vertigo, Ménière's|Ménière Diseases|Meniere's Disease|Syndrome, Meniere's|Vertigos, Auditory|Ménière's Disease|Otogenic Vertigos|Meniere Syndrome|Vertigos, Otogenic|Auditory Vertigo|Ménière's Vertigos|Otogenic Vertigo|Disease, Meniere's|Ménière Vertigo|Aural Vertigo|Vertigos, Ménière's|Diseases, Ménière's|Disease, Meniere|Disease, Ménière's|Auditory Vertigos|Menieres Syndrome|Ménière's disease|Vertigo, Aural|Vertigo, Otogenic|Menieres Disease|Ménières Disease|Vertigo, Auditory"
D002537,DISEASE,Intracranial Arteriosclerosis,"Arteriosclerosis, Cerebral|Atherosclerosis, Cerebral|Cerebral Arteriosclerosis|Arterioscleroses, Cerebral|Arterioscleroses, Intracranial|Cerebral Arterioscleroses|Intracranial Arterioscleroses|Cerebral Atheroscleroses|Cerebral Atherosclerosis|Intracranial Atheroscleroses|Intracranial Atherosclerosis|Atherosclerosis, Intracranial|Arteriosclerosis, Intracranial|arteriosclerosis|Atheroscleroses, Intracranial|Atheroscleroses, Cerebral"
D041781,DISEASE,"Jaundice, Obstructive","Jaundice, Cholestatic|Cholestatic Jaundice|Obstructive Jaundice|Mechanical Jaundice|Jaundice, Mechanical|obstructive jaundice"
NEW19022,MENTAL_HEALTH,standard cholesterol,regression coefficient
NEW19025,DISEASE,csa array,chronic bacterial sinusitis
NEW19027,DISEASE,iron deprivation,HPV-positive cancer cells
NEW19028,BIOCHEMICAL,iron deprivation,antiviral effects
D001232,DISEASE,Aspergillus fumigatus,Sartorya fumigata|Aspergillus fumigatus|Aspergillus fumigates|Neosartorya fumigata
NEW19032,CHEMICAL,inosine monophosphate dehydrogenase inhibitor,Amphotericin B susceptibility
NEW19034,DISEASE,different psychiatric disorder,behavior mood symptoms
NEW19037,DISEASE,aki mouse,cardiac hypertrophy phenotype
C004180,NUTRITION,dexamethasone 21-phosphate [Supplementary Concept],Dexamethasone/analogs  and  derivatives|dexamethasone sodium phosphate
NEW19041,CHEMICAL,tumor necrosis factor (tnf)-α,glucagon synthase kinase
C104723,CHEMICAL,"glutamate receptor ionotropic, AMPA 3 [Supplementary Concept]","glutamate receptor subunit|Receptors, AMPA"
NEW19042,CHEMICAL,modafinil/armodafinil cns stimulant,modafinil/armodafinil CNS stimulants
NEW19043,MENTAL_HEALTH,narcolepsy type,narcolepsy type
NEW19045,MENTAL_HEALTH,sympathomimetic stimulant,excessive sleepiness symptoms
NEW19047,CHEMICAL,xp-associated neoplasia,topical mitomycin C|MMC
NEW19050,CHEMICAL,transient mental depression,PEG-IFN-alpha-2b|pegylated interferon alpha 2b
NEW19052,DISEASE,renal inflammation,renal inflammation
NEW19054,MENTAL_HEALTH,peroxiproliferator-activated receptor gamma agonist ciglitazone,PPARgamma-independent transcriptional repression
NEW19056,CHEMICAL,brain omega-3 fatty acid concentration,eicospentaenoic acid
NEW19057,CHEMICAL,brain omega-3 fatty acid concentration,SRI treatment
NEW19059,DISEASE,ocd dominant patient,permanent cognitive disability
NEW19061,CHEMICAL,4-ethylphenylsulfate,4-ethylphenylsulfate oxindole
NEW19062,CHEMICAL,4-ethylphenylsulfate,indolepropionate
NEW19063,NUTRITION,4-ethylphenylsulfate,catechol sulfate
NEW19065,CHEMICAL,crf group,0:0/20:4
C093004,CHEMICAL,N-(5-dimethylaminonaphthalenesulfonyl)-1-palmitoyl-sn-glycero-3-phosphoethanolamine [Supplementary Concept],LysoPE|Phosphatidylethanolamines|Dansyl Compounds
C090324,CHEMICAL,docosahexaenoyl lysophosphatidylcholine [Supplementary Concept],Docosahexaenoic Acids|LysoPC|Lysophosphatidylcholines
C098569,CHEMICAL,ProSol PDX [Supplementary Concept],Polysorbates|Sodium Dodecyl Sulfate|22:04|Edetic Acid|Drug Combinations|Sodium Bicarbonate
D008243,CHEMICAL,1-Acylglycerophosphocholine O-Acyltransferase,"Acyltransferase, 1-Acylglycerophosphocholine|O-Acyltransferase, 1-Acylglycerophosphocholine|lysophosphatidylcholine|Acyltransferase, Lysophosphatidylcholine|Acyltransferase, Lysophosphatidylcholine-Palmitoyl CoA|Lysophosphatidylcholine Acyltransferase|Lysolecithin Acyltransferase|Acyl CoA Lysolecithin Acyltransferase|Lysophosphatidylcholine Palmitoyl CoA Acyltransferase|Acyl-CoA-1-Acylglycero-3-Phosphocholine-O-Acyltransferase|Acyltransferase, Lysolecithin|1-Acylglycerophosphocholine Acyltransferase|1 Acylglycerophosphocholine O Acyltransferase|1 Acylglycerophosphocholine Acyltransferase|Acyl CoA 1 Acylglycero 3 Phosphocholine O Acyltransferase|Lysophosphatidylcholine-Palmitoyl CoA Acyltransferase|Lysophospholipid Acyltransferase|Acyltransferase, Lysophospholipid|CoA Acyltransferase, Lysophosphatidylcholine-Palmitoyl"
NEW19066,CHEMICAL,crf group,N-docosahexaenoyl γ-aminobutyric acid
C576492,CHEMICAL,"20-(4-carboxyphenyl)-2,13-dimethyl-3,12-diethyl-(22pi)pentaphyrin [Supplementary Concept]",20:04|Porphyrins
NEW19067,CHEMICAL,crf group,PE 18:0/0:0
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Toxicomania,MENTAL_HEALTH,toxicomania,alcoholism tremens
NEW19068,MENTAL_HEALTH,delirium group,delirium group
NEW19069,DISEASE,longstanding malnutrition,longstanding malnutrition
NEW19070,CHEMICAL,glycerol backbone,glycerol backbone
D043263,CHEMICAL,Myosin-Light-Chain Phosphatase,"Muscle Phosphatase-II, Smooth|Myosin Light Chain Phosphatase|Phosphatase, Calponin|Smooth Muscle Myosin-bound Phosphatase|Phosphatase-II, Smooth Muscle|Smooth Muscle Myosin bound Phosphatase|Smooth Muscle Phosphatase-II|Smooth Muscle MBP|Calponin Phosphatase|Smooth Muscle Phosphatase I|Phosphatase, Myosin-Light-Chain|Phosphatase, Myosin|Smooth Muscle Phosphatase II|Smooth Muscle Phosphatase-I|myosin|Myosin Phosphatase"
NEW19071,MENTAL_HEALTH,antiviral treatment,dementia development
NEW19073,DISEASE,vitamin b6 supplementation,levetiracetam-associated irritability
C496334,DISEASE,"PCGF1 protein, human [Supplementary Concept]",Polycomb Repressive Complex 1|human nervous system
D012294,CHEMICAL,Rifamycins,Rifomycin|Rifamycin|Rifomycins|rifamycins
D003283,CHEMICAL,"Contraceptives, Postcoital, Synthetic","Contraceptives, Synthetic Postcoital|contraceptives|Postcoital Contraceptive Agents, Synthetic|Synthetic Postcoital Contraceptives|Contraceptive Agents, Postcoital, Synthetic|Postcoital Contraceptives, Synthetic|Synthetic Postcoital Contraceptive Agents"
NEW19078,DISEASE,drug group,sclerosis mice
NEW19079,MENTAL_HEALTH,drug group,biological nitrogen fixation
NEW19083,CHEMICAL,high intensity ultrasound,lower NaCl concentration
NEW19084,MENTAL_HEALTH,high intensity ultrasound,unfolding dissociation
NEW19085,BIOCHEMICAL,high intensity ultrasound,major narcotics
NEW19087,BIOCHEMICAL,hormone use status,hormone misuse
NEW19089,MENTAL_HEALTH,free amino acid level,dementia subgroups
NEW19090,CHEMICAL,free amino acid level,amino acid levels
NEW19093,MENTAL_HEALTH,high glycine level,dementia subgroup
NEW19094,CHEMICAL,high glycine level,higher phenylalanine levels
NEW19095,CHEMICAL,high glycine level,subgroup higher alanine
NEW19098,CHEMICAL,oseltamivir-susceptible b/brisbane/60/2008,common amino acid substitutions
NEW19100,DISEASE,new antimicrobial peptide,biofilm cells
NEW19102,CHEMICAL,etoh concomitant,serum estradiol
NEW19103,DISEASE,etoh concomitant,female puberty
NEW19105,BIOCHEMICAL,psychotic symptom,pyridoxine acid treatment
NEW19106,CHEMICAL,psychotic symptom,high-dose naloxone
NEW19107,DISEASE,psychotic symptom,P. savastanoi pv
NEW19110,MENTAL_HEALTH,metabolic acid lactic,pH depression
NEW19112,CHEMICAL,sleep dysfunction,Ri gamma-aminobutyric acid (GABA)-B-receptor
NEW19113,CHEMICAL,sleep dysfunction,N-methyl-D-aspartate (NMDA)-receptor Ma2 dipeptidyl-peptidase-like protein-6
NEW19116,BIOCHEMICAL,depressed mood-may,first antagonists
NEW19117,MENTAL_HEALTH,depressed mood-may,excessive daytime somnolence
NEW19118,MENTAL_HEALTH,depressed mood-may,nocturnal hyperarousal
NEW19120,DISEASE,telomerase inhibitor,esophageal adenocarcinoma
NEW19122,DISEASE,acetylcholinesterase inhibitor pyridostigmine,(LPS)-induced ARDS
NEW19124,DISEASE,cholinergic agent pyridostigmine,endotoxin-induced ARDS
NEW19125,CHEMICAL,cholinergic agent pyridostigmine,IL-12p70
NEW19126,CHEMICAL,cholinergic agent pyridostigmine,lipopolysaccharide BMDCs
NEW19127,CHEMICAL,cholinergic agent pyridostigmine,serotonin-dopamine activity
NEW19128,DISEASE,cholinergic agent pyridostigmine,adult bipolar patients
NEW19129,BIOCHEMICAL,nutraceutical use,nutraceutical uses
NEW19133,DISEASE,serum glucose level,candidal vulvovaginitis
D014848,DISEASE,Vulvovaginitis,Vulvovaginitides|vulvovaginitis
NEW19135,CHEMICAL,au year,membrane sialic acid content
NEW19137,MENTAL_HEALTH,16:1n7 t,clinical regression
NEW19138,MENTAL_HEALTH,16:1n7 t,early onset autism
NEW19140,DISEASE,abnormal fatty acid metabolism,fatty fish
NEW19141,CHEMICAL,abnormal fatty acid metabolism,omega-3 oils
NEW19145,DISEASE,fecal spermidine level,NASH phenotypes
NEW19148,DISEASE,spermidine supplementation,NASH mice
C501477,DISEASE,"Thrsp protein, mouse [Supplementary Concept]",thyroid hormone-responsive protein|Transcription Factors
NEW19149,DISEASE,spermidine supplementation,hepatic bile acids
NEW19150,CHEMICAL,spermidine supplementation,pets/cats
NEW19152,NUTRITION,Most infection,hypoxia inducible factor subunit alpha
NEW19154,MENTAL_HEALTH,l-carnitine supplementation,first-line host defense mechanism
NEW19156,CHEMICAL,l-carnitine supplementation,intravenous magnesium
NEW19157,DISEASE,l-carnitine supplementation,human osteosarcoma cell line
NEW19159,MENTAL_HEALTH,-3347,cell-specific repression
NEW19161,NUTRITION,such differential repression,ChAT component
NEW19162,NUTRITION,such differential repression,Arctic char
NEW19166,DISEASE,dha consumption,known coronary heart disease
NEW19168,MENTAL_HEALTH,hif1-α,DFO-induced NRP2 repression
NEW19169,DISEASE,hif1-α,mammary gland tissue
NEW19171,DISEASE,plasma agitation,hypercholesterolemia treatment
NEW19173,DISEASE,plasma agitation,neuro-inflammation glucose dysmetabolism
NEW19175,CHEMICAL,competitive displacement assay,oral anhydrous aluminum chloride
NEW19177,BIOCHEMICAL,alzheimer 's disease-like symptom,well-established neurotoxin
NEW19178,CHEMICAL,alzheimer 's disease-like symptom,skin-resident memory CD4
D030283,DISEASE,Epsilonretrovirus,"WDSV|epidermal hyperplasia|WEHV-1|Epidermal Hyperplasia Virus 2, Walleye|Epsilonretroviruses|Epidermal Hyperplasia Virus 1, Walleye|Walleye dermal sarcoma virus|Sarcoma Virus, Walleye Dermal|Walleye epidermal hyperplasia virus 2|WEHV-2|Walleye epidermal hyperplasia virus 1"
NEW19179,MENTAL_HEALTH,alzheimer 's disease-like symptom,pituicyte input resistance
NEW19181,DISEASE,antimicrobial activity,Rhizopus oligosporus
NEW19182,DISEASE,antimicrobial activity,Staphylococcus aureus ATCC 6538and fungi
NEW19183,DISEASE,antimicrobial activity,Asperillus niger
D001409,DISEASE,Bacillus cereus,Bacillus cereus
NEW19184,DISEASE,ptsd development,PTSD development
NEW19185,DISEASE,significant cognitive dysfunction,significant cognitive dysfunctions
D000072198,CHEMICAL,ADAM17 Protein,"TNF-alpha Convertase|Tumor Necrosis Factor-alpha Convertase|Tumor Necrosis Factor alpha Converting Enzyme|TNF- α|TNF-alpha Converting Enzyme|ADAM 17 Protein|Tumor Necrosis Factor-alpha Converting Enzyme|Disintegrin and Metalloproteinase Domain-Containing Protein 17|Convertase, TNF-alpha|CD156b Antigen|TNF alpha Converting Enzyme|TACE (Enzyme)|Tumor Necrosis Factor Alpha Convertase|TNF alpha Convertase|Antigen, CD156b|ADAM-17 Protein|TACA (Enzyme)|Disintegrin and Metalloproteinase Domain Containing Protein 17|ADAM-17"
D007150,CHEMICAL,Immunohistochemistry,"Immunolabeling Technics|Technic, Immunogold-Silver|immunohistochemistry|Technics, Immunogold|Technique, Immunogold-Silver|Immunohistocytochemistry|Immunogold-Silver Technic|Techniques, Immunogold|Techniques, Immunolabeling|Technic, Immunogold|Technic, Immunolabeling|Immunolabeling Technique|Immunolabeling Techniques|Immunogold Silver Technics|Technique, Immunogold|Technics, Immunolabeling|TH|Immunogold-Silver Techniques|Technique, Immunolabeling|Immunogold-Silver Technics|Techniques, Immunogold-Silver|Immunogold Techniques|Immunogold Silver Techniques|Immunogold Technique|Immunolabeling Technic|Immunogold Technics|Technics, Immunogold-Silver|Immunogold Technic|Immunogold-Silver Technique|Immunocytochemistry"
NEW19187,MENTAL_HEALTH,fenofibrate treatment,fragmentation studies
NEW19188,DISEASE,fenofibrate treatment,PD-induced cognitive impairment
NEW19190,CHEMICAL,long-term steroid use,steroid dependence
NEW19192,MENTAL_HEALTH,combined androgen blockade,libido dysfunction
NEW19195,DISEASE,dopamine type receptor,stress-induced premature senescence
NEW19196,DISEASE,dopamine type receptor,different cancer types
NEW19198,CHEMICAL,plasma triglyceride,plasma triglyceride
NEW19199,CHEMICAL,isotretionin treatment,isotretionin treatment
NEW19201,DISEASE,psychotic mania symptom,diabetic state
NEW19205,DISEASE,post-burst afterhyperpolarization,age-associated learning deficits
NEW19209,DISEASE,maintenance antidepressant,recurrent depressive episodes
NEW19210,CHEMICAL,maintenance antidepressant,lithium-intolerant
NEW19211,DISEASE,maintenance antidepressant,lithium-refractory patients
NEW19213,DISEASE,standard candida albicans strain,psychiatric medicine
NEW19215,DISEASE,partial μ-opioid receptor agonist buprenorphine,difficult-to-treat groups
NEW19216,DISEASE,partial μ-opioid receptor agonist buprenorphine,DSM-III major depressives
NEW19218,DISEASE,gastric motility,reward-seeking behaviour
NEW19220,CHEMICAL,dynamic cysteine s-acylation,intercellular LCFA transport
NEW19222,CHEMICAL,source dissociation,brain phosphatidylcholine
D013108,CHEMICAL,Sphingomyelin Phosphodiesterase,sphingomyelin|Sphingomyelinase C|Sphingomyelin Cleaving Enzyme|Sphingomyelinase|Sphingomyelin Cholinephosphohydrolase
NEW19224,DISEASE,unsaturated phosphatidyl choline,acute lung injury ALI oxidation
NEW19225,DISEASE,unsaturated phosphatidyl choline,ALI associated vascular leak
NEW19226,DISEASE,unsaturated phosphatidyl choline,methicillin-resistant Staphyloccocus aureus
NEW19228,DISEASE,glp-1 receptor agonist,disability scores
NEW19231,BIOCHEMICAL,nmdar antagonist memantine,androgen biosynthesis
NEW19233,DISEASE,graves 's disease,overt hyperfunction
NEW19235,DISEASE,acute global amnesia,cerebral tumours
D020236,MENTAL_HEALTH,"Amnesia, Transient Global","Transient Global Amnesia|Global Amnesia, Transient|TGA (Transient Global Amnesia)|transient global amnesia|TGAs (Transient Global Amnesia)"
NEW19236,DISEASE,acute global amnesia,drug-related confusional state
NEW19237,DISEASE,acute global amnesia,infective diseases
NEW19238,DISEASE,acute global amnesia,minor depressed
NEW19239,DISEASE,acute global amnesia,diurnal hypertension
NEW19240,DISEASE,chronic intermittent hypoxia,sustained hypertension
NEW19242,NUTRITION,5-mthf formulation,normal folate levels
NEW19243,MENTAL_HEALTH,5-mthf formulation,dementia folate deficiency
NEW19246,DISEASE,no production,diabetic wound healing
D020031,DISEASE,Epstein-Barr Virus Infections,"Human Herpesvirus 4 Infections|Infection, EBV|Virus Infections, Epstein-Barr|EBV Infections|Infection, Epstein-Barr Virus|Human Herpes Virus 4 Infections|Infections, EBV|Virus Infection, Epstein-Barr|Infections, Epstein-Barr Virus|Herpesvirus 4 Infections, Human|Epstein-Barr Virus Infection|Epstein Barr Virus Infections|EBV Infection|Virus infections|Epstein Barr Virus Infection"
NEW19252,CHEMICAL,se concentration,elevated Allo levels
NEW19255,BIOCHEMICAL,l. plantarum,antimicrobial drugs
NEW19257,MENTAL_HEALTH,correspond antimicrobial drug,solvent displacement strategy
NEW19259,CHEMICAL,ovarian membrane,specific 20beta-S binding
NEW19261,MENTAL_HEALTH,borate treatment,extensive tissue dissociation
NEW19262,DISEASE,antibiotic treatment,HFD-induced weight gain
NEW19263,DISEASE,antibiotic treatment,self-care reduction
NEW19264,DISEASE,antibiotic treatment,HFD-induced anhedonia-like behavior
NEW19265,NUTRITION,antibiotic treatment,alpha GLRA1 gene
NEW19266,CHEMICAL,antibiotic treatment,inhibitory glycine receptor subunit alpha
NEW19269,DISEASE,so-called parkinson-plus syndrome,vascular parkinsonism
NEW19270,DISEASE,so-called parkinson-plus syndrome,multiple systems atrophy
NEW19272,CHEMICAL,P. maximus,GluF|iGluR
NEW19274,DISEASE,lipid metabolic abnormality,human cataracts
NEW19276,CHEMICAL,plasma octanoate,highest trioctanoin infusion rate
NEW19277,CHEMICAL,plasma octanoate,mmol/liter
NEW19278,CHEMICAL,plasma octanoate,highest trioctanoin rates
NEW19280,MENTAL_HEALTH,α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor activation,fast mitochondrial fragmentation
NEW19281,CHEMICAL,tissue damage,N-methyl-d-aspartate-type glutamate receptors
NEW19284,DISEASE,melatonin/memantine combination,traumatic injury
NEW19285,CHEMICAL,pcp treatment,NR2A polypeptides
NEW19286,DISEASE,pcp treatment,Alzheimer's disease research
NEW19287,CHEMICAL,pcp treatment,scopolamine administration
NEW19290,CHEMICAL,proanthocyanidin b2,TASD-41 transgenic mice
D029903,NUTRITION,Melilotus,"Common Melilots|Yellow Sweet Clover|Sweetclover, Yellow|Sweet Clovers|Melilotus officinalis|Melilots, Common|Yellow Sweetclover|Melilots, Field|Common Melilot|Sweetclovers, Yellow|Clover, Sweet|Clover, Yellow Sweet|Field Melilots|Field Melilot|Yellow Sweetclovers|Melilot, Common|Yellow Sweet Clovers|Melilot, Field|Clovers, Yellow Sweet|Clovers, Sweet|Sweet Clover|Sweet Clovers, Yellow|Sweet Clover, Yellow"
NEW19293,MENTAL_HEALTH,intelligent premutation carrier,disorders DSM-III-R criteria
NEW19294,DISEASE,intelligent premutation carrier,remedy cough
NEW19295,CHEMICAL,intelligent premutation carrier,granulysin levels
NEW19297,CHEMICAL,serious rot disease,gas chromatographic analysis
D000068556,CHEMICAL,Interferon beta-1a,"beta 1a, Interferon|Avonex Pen|Interferon beta 1a|interferon beta-1a|beta-1a, Interferon|Avonex|Rebif"
NEW19298,DISEASE,drug regiman,pseudoparkinsonism
NEW19301,MENTAL_HEALTH,acei,dementia prevention
C405562,DISEASE,"TOMM7 protein, human [Supplementary Concept]",human AD|Mitochondrial Precursor Protein Import Complex Proteins
NEW19302,DISEASE,acei,non-responder aggressive pituitary adenoma management
NEW19303,DISEASE,acei,human leukemia Molt 4B cells
NEW19306,CHEMICAL,generalize insect herbivore,furanocoumarin content
C039410,CHEMICAL,sphondin [Supplementary Concept],Methoxsalen/analogs  and  derivatives|sphondin
NEW19308,CHEMICAL,wild parsnip plant,furanocoumarin characteristics-resistance amount
NEW19311,DISEASE,epidermal growth factor receptor egfr tyrosine kinase inhibitor osimertinib,EGFR-mutant lung cancer
NEW19312,DISEASE,brain metastasis,brain metastasis
NEW19315,DISEASE,genetic repression,human embryonal carcinoma cell line NTERA-2 clone D1
NEW19318,DISEASE,m1r/m4r agonist xanomeline,headaches treatment
D009355,CHEMICAL,Neomycin,Neomycin Palmitate|Neomycin Sulfate|Fradiomycin Sulfate|neomycin
D000077728,CHEMICAL,"Cilastatin, Imipenem Drug Combination","MK 0787 MK 0791 mixture|Imipenem-Cilastatin|Imipenem Cilastatin Sodium|Cilastatin, Imipenem|Imipenem Cilastatin, Sodium Salt|Imipenem - Cilastatin|Imipenem-Cilastatin Sodium|Primaxin|Tienam 500|Imipenem Cilastatin|Imipenem-Cilastatin, Sodium Salt|MK 787-MK 791 mixture|imipenem-cilastatin|Zienam|MK 787 MK 791 mixture|MK 0787-MK 0791 mixture|Imipenem - Cilastatin Sodium|Thienam"
NEW19323,DISEASE,serotonergic overstimulation,diabetic peripheral neuropathic pain
NEW19325,BIOCHEMICAL,sb exposure,breakthrough drug
NEW19327,DISEASE,rat poison,resistant tuberculosis treatment
D019297,CHEMICAL,"2,4-Dinitrophenol","2,4-DNP|2,4 Dinitrophenol|DNP|2,4-dinitrophenol"
NEW19330,CHEMICAL,[3h]batrachotoxin,mumol/l (+/-)-kavain
NEW19332,CHEMICAL,folic acid trial,folic acid-neuropathy
NEW19334,NUTRITION,increase cognitive impairment,high folate intake
NEW19336,MENTAL_HEALTH,v. cholerae o395,micromolar dissociation constants
C513735,CHEMICAL,dicyanocobinamide [Supplementary Concept],Nitriles|Organometallic Compounds|dicyanocobinamide
NEW19338,DISEASE,defensin gene cluster,adeno-tonsillar hypertrophy|ATH
NEW19339,DISEASE,defensin gene cluster,PCP intoxication
NEW19342,MENTAL_HEALTH,sterilized pei microparticle,gentle agitation
C525734,CHEMICAL,meta-phenylene ethynylene [Supplementary Concept],Alkynes|Phenethylamines|MPE
NEW19345,DISEASE,thalidomide gavage,neuropathic pain rats
NEW19346,DISEASE,thalidomide gavage,peripheral injury-induced proinflammatory cytokines
NEW19347,MENTAL_HEALTH,thalidomide gavage,natural orientation
NEW19351,DISEASE,ceramide metabolism,different synucleinopathies
NEW19353,DISEASE,unsolved amyloid fibril,distinct human neurodegenerative diseases
D002981,CHEMICAL,Clindamycin,"Clindamycin Hydrochloride|Chlorlincocin|Cleocin|Clindamycin Monohydrochloride, Monohydrate|Monohydrate Clindamycin Monohydrochloride|7-Chloro-7-deoxylincomycin|Monohydrochloride, Clindamycin|Dalacin C|Hydrochloride, Clindamycin|Clindamycin Monohydrochloride|clindamycin|Monohydrochloride, Monohydrate Clindamycin|7 Chloro 7 deoxylincomycin|Chlolincocin"
D017103,DISEASE,Bacillus Phages,"Bacillus Bacteriophage|Bacillus Bacteriophages|Bacillus Phage|Bacteriophage phi 105|Bacteriophages, Bacillus|Phage phi 105|Bacillus|Phage phi 29|Bacteriophage phi 29|Bacteriophage, Bacillus"
D000077422,CHEMICAL,Enrofloxacin,Endrofloxicin|enrofloxacin|Baytril|Bay-Vp-2674|Bay Vp 2674
NEW19356,MENTAL_HEALTH,important antimicrobial,antimuscarinic psychosis
NEW19361,MENTAL_HEALTH,antidepressant medication,morphine-and-bupivacaine-induced analgesia
NEW19362,DISEASE,n-diethyl-benzamide,% L5178Y-R tumor-bearing Balb/c mice death
NEW19363,DISEASE,n-diethyl-benzamide,severe nonmalignant pain
NEW19365,CHEMICAL,oxygen molecule,fluid phase DMPC membrane
NEW19367,CHEMICAL,all-trans isomer,polar terminal hydroxyl groups located
NEW19369,MENTAL_HEALTH,zeaxanthin similar,transmembrane orientation
D024341,BIOCHEMICAL,Xanthophylls,"xanthophylls|Xanthophyll Carotenoids|Carotenoids, Xanthophyll"
NEW19371,MENTAL_HEALTH,zeaxanthin-dppc monolayer,different orientation
NEW19373,DISEASE,repeat corticosterone injection,depressive behavioral
NEW19377,CHEMICAL,peripheral insulin resistance,steroid spectra
NEW19379,NUTRITION,transdermal estrogen,cholesterol cholesterol levels
NEW19380,DISEASE,transdermal estrogen,hormone-related decrease
NEW19382,MENTAL_HEALTH,b vitamin requirement,carbon fixation pathways
NEW19383,CHEMICAL,b vitamin requirement,acetogenesis
NEW19384,CHEMICAL,b vitamin requirement,sulfate reduction
NEW19385,CHEMICAL,b vitamin requirement,sulfur disproportionation
NEW19387,DISEASE,selenium only group,leprosy control
NEW19388,CHEMICAL,selenium only group,testosterone replacement therapy
NEW19389,BIOCHEMICAL,selenium only group,combination estrogen
NEW19390,CHEMICAL,selenium only group,progesterone replacement
C536317,DISEASE,PEHO syndrome [Supplementary Concept],"Spasms, Infantile|Neurodegenerative Diseases|Optic Atrophy|progressive encephalopathy|Brain Edema"
NEW19391,DISEASE,febrile illness,febrile illness
NEW19392,DISEASE,lung adenocarcinoma patient,lung adenocarcinoma patients
NEW19394,DISEASE,saccharin exposure,model motor impulsivity
NEW19396,DISEASE,stimulant drug methylphenidate,significant behavioral impairment
D000077237,CHEMICAL,Arsenic Trioxide,Arsenous Anhydride|Tetra-Arsenic Hexaoxide|Diarsenic Trioxide|Arsenic(III) Oxide|Arsenic Oxide (As4O6)|Arsenolite|Tetra-Arsenic Oxide|Trisenox|Tetraarsenic Hexaoxide|Naonobin|Tetraarsenic Oxide|Arsenic Oxide (As2O3)|Tetra Arsenic Oxide|Tetra Arsenic Hexaoxide|Trixenox|As4O6|As2O3|arsenic trioxide
NEW19401,CHEMICAL,cardiotoxic agent due,lidocain
NEW19402,CHEMICAL,cardiotoxic agent due,humans anthracyclines
D000087522,BIOCHEMICAL,Cyanobacteria Toxins,"Cyanobacterial Neurotoxin|Cyanotoxins|Cyanobacterial Toxins|cyanotoxins|Cyanobacterial Neurotoxins|Neurotoxin, Cyanobacterial"
D057889,CHEMICAL,Iridoid Glycosides,"Secoiridoid Glycosides|glycosides|Glycosides, Iridoid|Iridoidglycosides|Glycosides, Secoiridoid"
C005566,CHEMICAL,pivalic acid [Supplementary Concept],pivalic acid|Pentanoic Acids
NEW19403,DISEASE,cardiotoxic agent due,mitochondrial cardiotoxic effects
NEW19404,DISEASE,cardiotoxic agent due,involuntary movement disorders
NEW19405,MENTAL_HEALTH,da function,diabetic impotence
D009170,DISEASE,Nontuberculous Mycobacteria,"Mycobacterium gordonae|Mycobacterium duvalii|Atypical Mycobacterium|Mycobacterium szulgai|Mycobacterium terrae|Mycobacterium obuense|Mycolicibacter terrae|Mycobacteria, Atypical|Mycolicibacterium gilvum|Mycolicibacterium duvalii|Tuberculoid Bacillus|Nontuberculous Mycobacterium|Mycobacterium flavescens|Mycolicibacterium flavescens|Mycobacterium, Atypical|non-tuberculous mycobacteria|Mycobacterium gilvum|Non-Tuberculous Mycobacteria|Atypical Mycobacteria|Mycolicibacterium obuense"
NEW19406,DISEASE,da function,impaired lung function
NEW19408,CHEMICAL,epetraborole,LeuRSMabs
NEW19409,CHEMICAL,epetraborole,LeuRSMtb
NEW19410,DISEASE,epetraborole,EPT mutants
NEW19411,DISEASE,epetraborole,M. abscessus infection
NEW19414,DISEASE,cleavage-resistant d314e mutant,hippocampal neurodegeneration
NEW19417,CHEMICAL,focal neuronal lipofuscinosis,FNL tissue
NEW19418,DISEASE,focal neuronal lipofuscinosis,interictal-like activity
NEW19420,DISEASE,first paclitaxel injection,day mechanical allodynia
C558337,CHEMICAL,p-O-geranyl-7''-acetoxy coumaric acid [Supplementary Concept],Coumaric Acids|p.o
NEW19421,DISEASE,first paclitaxel injection,non organic major depressive episodes
NEW19422,DISEASE,first paclitaxel injection,non-valvular atrial fibrillation
NEW19424,DISEASE,dabigatran-induced anticoagulation,bleeding surgery
NEW19426,CHEMICAL,unlabeled conantokin-g,N-methyl-D-aspartate receptor-associated polyamine site
NEW19429,MENTAL_HEALTH,n-methyl-d-aspartate receptor agonist binding site,chromatin fragmentation
NEW19430,DISEASE,n-methyl-d-aspartate receptor agonist binding site,seizure exacerbation
NEW19433,CHEMICAL,compulsion zone,indirect dopamine receptor agonists
NEW19434,NUTRITION,compulsion zone,fatty acid supplementation
NEW19435,MENTAL_HEALTH,dyslexia disorder,dyslexia disorder
NEW19437,NUTRITION,membrane phospholipid metabolism,phospholipid spectrum
NEW19438,CHEMICAL,membrane phospholipid metabolism,Annexin V Apoptosis Detection Kit
NEW19439,CHEMICAL,membrane phospholipid metabolism,dichloro-dihydro-fluorescein diacetate
NEW19440,CHEMICAL,membrane phospholipid metabolism,kit-8|CCK-8
NEW19441,CHEMICAL,gamma-aminobutyric acid gaba antagonist,gamma-aminobutyric acid GABA antagonists
NEW19443,MENTAL_HEALTH,2-deoxyglucose metabolic mapping technique,active dyskinesia
NEW19445,DISEASE,escitalopram treatment,HIV-1-mediated synaptodendritic damage
NEW19446,BIOCHEMICAL,escitalopram treatment,antagonist SDA type
NEW19447,DISEASE,treatment-refractory symptom,treatment-refractory symptoms
NEW19448,MENTAL_HEALTH,medication-refractory schizophrenia,medication-refractory schizophrenia
NEW19450,BIOCHEMICAL,neurological complication,encephalopathy vitamin B1 deficiency
NEW19455,DISEASE,natural delta-tocotrienol,radiation-induced damage
NEW19456,CHEMICAL,natural delta-tocotrienol,total-body irradiated
NEW19457,DISEASE,natural delta-tocotrienol,human acquired immunodeficiency syndrome
NEW19458,BIOCHEMICAL,nutraceutical property,nutraceutical properties
NEW19459,DISEASE,grand mal seizure,grand mal seizures
http://purl.obolibrary.org/obo/DOID_3576,DISEASE,sagittal sinus thrombosis,Thrombosis of superior longitudinal sinus|Thrombosis of superior sagittal sinus|superior sagittal sinus thrombosis
NEW19461,DISEASE,imipramine treatment,chronic coronary syndromes
D015427,DISEASE,Reperfusion Injury,"Ischemia Reperfusion Injury|Reperfusion Damages|Injury, Ischemia-Reperfusion|Injury, Reperfusion|ischemia-reperfusion injury|Damage, Reperfusion|Reperfusion Damage|Reperfusion Injuries|Injury, Ischemia Reperfusion|Ischemia-Reperfusion Injuries|Ischemia-Reperfusion Injury"
NEW19462,CHEMICAL,imipramine treatment,metformin cotreatment
NEW19463,DISEASE,imipramine treatment,HFD-induced disorders
NEW19465,CHEMICAL,popular phytochemical-rich beverage,glucolipid metabolism
NEW19466,MENTAL_HEALTH,popular phytochemical-rich beverage,AD dementia
NEW19467,DISEASE,popular phytochemical-rich beverage,chronic liver diseases
D000072516,CHEMICAL,Retinoic Acid 4-Hydroxylase,"RA 4 Hydroxylase|Cytochrome P450 4 Hydroxylase|RA-4-Hydroxylase|CYP26B1, Cytochrome P-450|Cytochrome P 450 CYP26B1|CYP26B1|P450RAI|CYP450 4-Hydroxylase|Cytochrome P450 26A1 Enzyme|Enzyme, CYP26A1|Cytochrome P450 4-Hydroxylase|Cytochrome P-450 CYP26B1|Retinoic Acid-Metabolizing Enzyme, CYP26B1|Retinoic Acid Metabolizing Enzyme, CYP26B1|CYP26A1 Enzyme|Cytochrome P-450 26B1|Retinoic Acid 4 Hydroxylase|CYP26A1"
D018079,CHEMICAL,"Receptors, GABA","acid receptors|Receptor, gamma-Aminobutyric Acid|GABA Receptor|gamma-Aminobutyric Acid Receptor|Receptor, GABA|Receptors, gamma-Aminobutyric Acid|gamma Aminobutyric Acid Receptor|Receptors, gamma Aminobutyric Acid|gamma Aminobutyric Acid Receptors|GABA Receptors|gamma-Aminobutyric Acid Receptors"
NEW19469,DISEASE,5-fu-sensitive ht29 colorectal cancer cell,RA Response Elements
NEW19471,BIOCHEMICAL,yap/rar-rxr cross-talk,vitamin A metabolism
NEW19473,DISEASE,colorectal cancer cell,colon cancer cell growth
NEW19474,DISEASE,colorectal cancer cell,alpha-synuclein aggregation
NEW19477,NUTRITION,syndrome ds risk,choline metabolism
NEW19480,BIOCHEMICAL,maternal choline supplementation,wild-type androgen receptor
NEW19481,CHEMICAL,ERα state,ERα states
NEW19485,CHEMICAL,dopamine loss,DA replacement
NEW19486,CHEMICAL,dopamine loss,altered DA responses
NEW19488,MENTAL_HEALTH,da input,basal hyperactivity
NEW19492,CHEMICAL,cdg treatment,lipopolysaccharide (LPS)-stimulated
NEW19493,CHEMICAL,cdg treatment,mouse Kupffer cells|ImKCs
D004718,NUTRITION,Saccharomycetales,"Yeast, Budding|Yeasts, Budding|Budding Yeasts|Budding Yeast|Saccharomycetale|Endomycopses|Endomycopsis|Endomycetale|Endomycetales|budding yeast"
NEW19497,CHEMICAL,dxa/piximus,female TREM2R47H/+ animals
C074636,CHEMICAL,amyloid beta-protein (25-35) [Supplementary Concept],Amyloid beta-Peptides|Peptide Fragments|Aβ25
NEW19498,CHEMICAL,dxa/piximus,Aβ25 challenge
NEW19499,CHEMICAL,dxa/piximus,ERα pathway
NEW19500,DISEASE,dxa/piximus,35-induced brain injury
NEW19501,CHEMICAL,dxa/piximus,inducible nitric oxide NO synthase
NEW19505,BIOCHEMICAL,hypoxia group,non-xenon mixture
NEW19507,DISEASE,xenon treatment,hypoxia-induced seizures
NEW19508,CHEMICAL,memantine µm.,memantine µM.
NEW19510,DISEASE,memantine treatment model,moderate AD patients
NEW19511,DISEASE,memantine treatment model,preventable birth disorders
NEW19512,MENTAL_HEALTH,facile dissociation,facile dissociation
NEW19514,CHEMICAL,kappa opiate agonist,dysphoria psychotomimetic effects
NEW19516,DISEASE,sibulelo,grandparents trauma
NEW19518,CHEMICAL,mixed mania,valproate semisodium
C536858,DISEASE,"Spastic paraplegia 20, autosomal recessive [Supplementary Concept]","Spastic Paraplegia, Hereditary|muscle wasting"
NEW19520,DISEASE,act crf antagonist,bradycardia p<0.001
NEW19522,DISEASE,levodopa treatment,L-DOPA-induced gene regulation
D053713,DISEASE,Azoospermia,"azoospermia|Infertility, Male (1965-1976)|Oligospermia (1977-2006)"
D009845,DISEASE,Oligospermia,"Oligozoospermia|Hypospermatogeneses|Sperm Counts, Low|Low Sperm Counts|Oligoasthenoteratozoospermia|Low Sperm Count|Oligoasthenoteratozoospermias|Sperm Count, Low|Hypospermatogenesis|oligospermia"
NEW19524,DISEASE,azole antifungal,libido adrenal insufficiency
D000077277,DISEASE,Esophageal Squamous Cell Carcinoma,squamous cell carcinoma|Oesophageal Squamous Cell Carcinoma
NEW19525,DISEASE,azole antifungal,phototoxic reactions
D010522,DISEASE,Periostitis,periostitis|Periostitides
C046311,CHEMICAL,periodate-lysine-paraformaldehyde [Supplementary Concept],Lysine|Periodic Acid|% paraformaldehyde|Formaldehyde
NEW19527,CHEMICAL,folate supplement,Mn intoxication
NEW19531,MENTAL_HEALTH,SNP rs3776362,Clinical Dementia Rating Sum
NEW19532,BIOCHEMICAL,moderate depression,vitamin B6 intake
D020261,CHEMICAL,Arsenic Poisoning,"Arsenic Encephalopathies|Arsenic Encephalopathy|Polyneuropathy, Arsenic Induced|arsenic|Poisoning, Arsenic, Nervous System|Arsenic-Induced Polyneuropathies|Poisonings, Organic Arsenic|Poisoning, Inorganic Arsenic|Neurotoxicity Syndromes, Arsenical|Arsenic Poisonings, Organic|Organic Arsenic Poisoning|Arsenic Induced Polyneuropathy|Encephalopathy, Arsenic|Organic Arsenic Poisonings|Arsenical Neurotoxicity Syndrome|Syndrome, Arsenical Neurotoxicity|Inorganic Arsenic Poisoning|Arsenic Poisoning, Nervous System|Poisoning, Arsenic|Inorganic Arsenic Poisonings|Arsenic Poisonings|Nervous System Poisoning, Arsenic|Polyneuropathy, Arsenic-Induced|Arsenic Poisoning, Inorganic|Organic Arsenic Poisoning, Nervous System|Neurotoxicity Syndrome, Arsenical|Arsenic-Induced Polyneuropathy|Arsenical Neurotoxicity Syndromes|Poisonings, Arsenic|Arsenic Poisonings, Inorganic|Poisonings, Inorganic Arsenic|Nervous System, Organic Arsenic Poisoning|Arsenic Poisoning, Organic|Poisoning, Organic Arsenic|Syndromes, Arsenical Neurotoxicity|Encephalopathies, Arsenic"
NEW19534,CHEMICAL,marmoset wasting syndrome,dietary magnesium
NEW19536,CHEMICAL,dyt1 early-onset primary dystonia,glutamic acid residue
NEW19538,DISEASE,small molecule 4-phenylbutyrate,dystonia treatment
NEW19539,CHEMICAL,albendazole administration,albendazole administration
NEW19540,DISEASE,rapid deterioration,rapid deterioration
NEW19541,CHEMICAL,omega fatty acid,PGs|polyglucosan inclusions
NEW19542,DISEASE,omega fatty acid,generalized epileptic seizures
NEW19543,CHEMICAL,omega fatty acid,selective serotonin reuptake inhibitors Administration-indicated
NEW19544,DISEASE,omega fatty acid,somatoform symptoms
NEW19545,MENTAL_HEALTH,omega fatty acid,functional body syndromes
NEW19548,CHEMICAL,mild hypercortisolism,excessive cortisol secretion
NEW19550,BIOCHEMICAL,late-night salivary cortisol,basal morning plasma adrenocorticotroph hormone
NEW19553,DISEASE,24-h urinary free cortisol,person-to-person fast transmission global problem
NEW19554,DISEASE,24-h urinary free cortisol,pre-existing neurological disorders
NEW19559,DISEASE,postinfective IBS,irritable bowl syndrome
NEW19560,DISEASE,postinfective IBS,MDMA abuse
NEW19562,DISEASE,tph2 gene,5-HT dysfunction
NEW19563,DISEASE,tph2 gene,various neuropsychiatric disorders related
NEW19565,DISEASE,strawberry packaging,mechanical damage
NEW19568,DISEASE,moderate-to-severe dysmenorrhea,low-to-moderate pain symptoms
NEW19570,DISEASE,n-6:n-3 ratio,endometriosis group
NEW19571,NUTRITION,n-6:n-3 ratio,Spanish sample
NEW19573,DISEASE,general anxiety,painful musculoskeletal disorders
NEW19575,CHEMICAL,first modern antidepressant,drug MAO-inhibition
NEW19576,DISEASE,first modern antidepressant,reserpine-induced sedation
NEW19577,CHEMICAL,first modern antidepressant,MTX GVHD prophylaxis
NEW19579,CHEMICAL,dukes c colon carcinoma,adjuvant FOLFOX4
NEW19582,DISEASE,circulate gonadal steroid,bone mass
NEW19584,DISEASE,reduce gonadal steroid hormone concentration,athletic amenorrhea
C415771,CHEMICAL,metreleptin [Supplementary Concept],metreleptin|Leptin/analogs  and  derivatives
NEW19587,DISEASE,low dose morphine,sustained hyperalgesia
D006969,DISEASE,"Hypersensitivity, Immediate","Immediate Hypersensitivities|Type I Hypersensitivity|Hypersensitivity, Type I|Hypersensitivity, IgE-Mediated|Hypersensitivities, Atopic|Hypersensitivities, Immediate|IgE-Mediated Hypersensitivity|Hypersensitivity, Atopic|Hypersensitivities, IgE-Mediated|IgE Mediated Hypersensitivity|IgE-Mediated Hypersensitivities|Type I Hypersensitivities|Hypersensitivities, Type I|immediate hypersensitivity|Immediate Hypersensitivity|Atopic Hypersensitivity|Atopic Hypersensitivities"
NEW19589,CHEMICAL,headache pain,G14F peptide
NEW19591,CHEMICAL,g14f mutant peptide,Stavudine 2'-3'-didehydro-2'-3'-dideoxythymidine ® model
NEW19592,DISEASE,g14f mutant peptide,AIDS therapy-induced peripheral neuropathy
NEW19593,CHEMICAL,g14f mutant peptide,hyperosmolar sodium
C538113,DISEASE,Herrmann syndrome [Supplementary Concept],Deafness|Diabetes Mellitus|Myoclonus|Diabetic Neuropathies|cerebral dysfunction|Kidney Diseases|Cerebellar Ataxia
NEW19596,DISEASE,few opioid-related adverse event,ORAEs|fewer opioid-related adverse events
NEW19597,CHEMICAL,conventional opioid morphine,conventional opioid morphine
D000071560,CHEMICAL,beta-Arrestin 2,"Arrestin, beta 2|β-arrestin|beta Arrestin 2|Arrestin 3|beta 2 Arrestin|ARRB2 Protein|Arrestin-3"
NEW19604,NUTRITION,high progesterone level,yeast colonies
NEW19605,BIOCHEMICAL,high progesterone level,dextrose agar selection
NEW19607,DISEASE,previous oc,Candida spp
D006763,DISEASE,"Hospitals, Chronic Disease","Hospitals, Tuberculosis|Tuberculosis Hospitals|Sanitarias, Tuberculosis|Sanitaria, Tuberculosis|Tuberculosis Sanitarias|Tuberculosis Sanitorias|Tuberculosis Sanitoria|Chronic Disease Hospitals|Tuberculosis Sanitaria|chronic disease|Tuberculosis Hospital|Sanitorias, Tuberculosis|Hospital, Chronic Disease|Sanitoria, Tuberculosis|Hospital, Tuberculosis|Chronic Disease Hospital"
NEW19609,DISEASE,single mood episode effective,single mood episodes effective
NEW19611,CHEMICAL,phenolic hydroxyls,phenolic hydroxyls
NEW19612,DISEASE,fish death,fish deaths
NEW19614,CHEMICAL,chronic social defeat stress,subunit GluA2
NEW19616,DISEASE,complex disorder,complex disorders
NEW19617,DISEASE,painful hiv-related neuropathy,painful HIV-related neuropathy
NEW19621,CHEMICAL,npk fertilizer biochar manure,N concentrations
NEW19622,CHEMICAL,npk fertilizer biochar manure,exchangeable K
NEW19625,NUTRITION,biochar manure,fresh carrot root yield
D000082462,MENTAL_HEALTH,Plant Defense Against Herbivory,"Anti-Herbivore Defenses|Anti Herbivore Defenses|Tolerance, Host-Plant|Host-Plant Resistance|Plant Anti Xenosis|Plant Anti-Xenosis|Plant Antixenosis|Anti-Herbivore Defense|Antibiosis, Plant|Antixenosis, Plant|Anti Herbivore Defense|Plant Resistance to Herbivory|Anti-Xenosis, Plant|Resistance, Host-Plant|Plant Antibiosis|plant resistance|Host Plant Tolerance|Host-Plant Tolerance|Host Plant Resistance"
NEW19626,CHEMICAL,biochar manure,platinum chemotherapeutic agent
NEW19628,BIOCHEMICAL,oxaliplatin-induced mechanical allodynia,TCS-OX2 orexin type-2 receptor antagonist
C542397,BIOCHEMICAL,SB 408124 [Supplementary Concept],Phenylurea Compounds|SB-408124|orexin type-1 receptor antagonist
NEW19630,DISEASE,orexin type-1 receptor agonist,CIPN pain
NEW19631,CHEMICAL,morphine-dependent mouse,3mg/kg subcutaneous
NEW19632,CHEMICAL,morphine-dependent mouse,SB269970
NEW19633,MENTAL_HEALTH,morphine-dependent mouse,morphine withdrawal syndromes
D046150,MENTAL_HEALTH,Laron Syndrome,"Syndrome, Laron|Dwarfism II, Pituitary|Dwarfism IIs, Pituitary|growth hormone resistance|Laron Type Dwarfism I|Growth Hormone Insensitivity Syndrome|Primary Growth Hormone Resistance|Laron Dwarfism|Severe GH Insensitivity|Pituitary Dwarfism II|Growth Hormone Receptor Defect|Primary GH Resistance|Growth Hormone Receptor Deficiency|Pituitary Dwarfism IIs|Dwarfism, Laron|GH Resistance, Primary"
NEW19641,DISEASE,Cil/Val,hypertension hyperactivity
NEW19643,MENTAL_HEALTH,sympatholytic action,nor-adrenergic hyperactivity
NEW19649,DISEASE,high-dose pyridoxine,certain dysphoric mental states
NEW19651,CHEMICAL,vaginal progesterone,low progesterone concentrations
NEW19652,CHEMICAL,vaginal progesterone,[3H]strychnine binding
NEW19654,DISEASE,bacterial endotoxin lipopolysaccharide,chemical-induced tissue injury
D016789,DISEASE,Plasmodium cynomolgi,"Plasmodium cynomolgi|cynomolgus, Plasmodium|Plasmodium cynomolgus"
NEW19655,DISEASE,acute ethanol exposure,birth defects similar
NEW19657,DISEASE,embryonic ethanol exposure,later-life neurobehavioral impairments
NEW19659,DISEASE,sag treatment,anxiety risk-taking behavior
NEW19660,DISEASE,sag treatment,long-term neurodevelopmental impairments related
NEW19662,MENTAL_HEALTH,combined ethanol exposure,human fetal alcohol spectrum disorder
NEW19663,DISEASE,h3 receptor antagonist,PAE-induced deficits
NEW19665,DISEASE,target folic acid-conjugated oxidize mesoporous carbon nanosphere,targeted breast cancer therapy
NEW19666,CHEMICAL,target folic acid-conjugated oxidize mesoporous carbon nanosphere,antitumoral doxorubicin delivery
NEW19670,CHEMICAL,mouse 's chronic glu-excited str,Striatal GABA
NEW19671,DISEASE,mouse 's chronic glu-excited str,hyperactive striatal CSTC output
NEW19672,CHEMICAL,mouse 's chronic glu-excited str,d-serine inputs
NEW19674,DISEASE,ocd-like mouse,juvenile-onset tics
NEW19675,DISEASE,ocd-like mouse,comorbid TS-like behaviors
NEW19677,CHEMICAL,cortical-limbic Neuron neuronal circuit model,abnormal cortical-limbic processing
NEW19678,DISEASE,cortical-limbic Neuron neuronal circuit model,adequate pain relief
NEW19679,DISEASE,cortical-limbic Neuron neuronal circuit model,comorbid AD
NEW19680,MENTAL_HEALTH,cortical-limbic Neuron neuronal circuit model,complex regional pain disorder
NEW19683,MENTAL_HEALTH,antidepressant psychoactive drug,life-threatening neuropsychiatric syndromes
NEW19686,DISEASE,casein kinase i epsilon,human circadian rhythm sleep disorders
NEW19687,DISEASE,casein kinase i epsilon,non-24-h sleep-wake syndrome
NEW19688,BIOCHEMICAL,casein kinase i epsilon,new selective serotonin uptake inhibitor
D015031,CHEMICAL,Zimeldine,"Zelmid|Zimelidin|Zimeldine Hydrochloride|Zimelidine|Zimelidine Hydrochloride|H10209|Hydrochloride, Zimeldine|Hydrochloride, Zimelidine|H-102-09|H 102 09"
NEW19689,DISEASE,casein kinase i epsilon,ligand TRAIL death receptors
NEW19691,DISEASE,adenomatous polyposis coli apc gene,human colon polyps
NEW19692,DISEASE,adenomatous polyposis coli apc gene,colorectal cancer chemoprevention
NEW19693,MENTAL_HEALTH,adenomatous polyposis coli apc gene,fast dissociation
NEW19694,BIOCHEMICAL,adenomatous polyposis coli apc gene,passive antagonist
NEW19696,BIOCHEMICAL,fast dissociation,passive antagonists
NEW19697,MENTAL_HEALTH,fast dissociation,dissociation overall increasing complex affinity
C000721448,DISEASE,Loss of reflex tearing [Supplementary Concept],"Dry Eye Syndromes|tearing|Reflex, Abnormal"
NEW19698,DISEASE,fast dissociation,nasal irritation
NEW19699,DISEASE,fast dissociation,mild toxicity
NEW19700,DISEASE,prenatal ethanol exposure,abnormal cell death
NEW19702,CHEMICAL,nmdar memantine-as,NMDA glutamate receptors
NEW19704,CHEMICAL,red wheat bran,normal glucose homeostasis
NEW19705,NUTRITION,red wheat bran,white wheat variety
NEW19706,DISEASE,red wheat bran,variety Danby TaPHS1
NEW19708,NUTRITION,phs resistance,white wheat
NEW19709,MENTAL_HEALTH,phs resistance,ADHD participants
NEW19710,MENTAL_HEALTH,phs resistance,emotional dysfunction
NEW19712,MENTAL_HEALTH,entacapone addition,residual schizophrenia
NEW19714,DISEASE,plant-based food flavoring agent,neurological dysfunctions
NEW19717,DISEASE,reboxetine dose,narcoleptic episodes
NEW19718,CHEMICAL,reboxetine dose,NADH-TR staining
NEW19719,CHEMICAL,reboxetine dose,thiazolidinedione group
NEW19720,CHEMICAL,reboxetine dose,rosiglitazone use
NEW19723,CHEMICAL,glutamate modulation,riluzole augmentation
C116819,CHEMICAL,NGB 2849 [Supplementary Concept],NGB|Piperazines
NEW19725,MENTAL_HEALTH,functional impairment,paired-pulse depression
C000594150,CHEMICAL,3-hydroxy-17-aza-D-homo-5-androsten-17-one [Supplementary Concept],HAAO|Androstenols|Azasteroids
NEW19727,CHEMICAL,±        pg/mg protein,±       pg/mg protein
C565579,DISEASE,Facial Dysmorphism with Multiple Malformations [Supplementary Concept],"multiple malformations|Abnormalities, Multiple|Craniofacial Abnormalities|Muscular Atrophy"
NEW19731,DISEASE,decrease nad+ production,similar malformations
NEW19732,BIOCHEMICAL,decrease nad+ production,first-line drug treatment
NEW19733,MENTAL_HEALTH,decrease nad+ production,major recurrent depression
NEW19735,DISEASE,pharmaceutical dosage,diarrhea incidence
NEW19736,DISEASE,pharmaceutical dosage,endometriosis-associated pain
NEW19737,DISEASE,pharmaceutical dosage,nonmenstrual pelvic pain components
NEW19738,CHEMICAL,pharmaceutical dosage,subcutaneous depot medroxyprogesterone acetate|DMPA-SC
NEW19741,NUTRITION,elagolix treatment,domesticated dromedary camel
NEW19743,DISEASE,mp135,reward behavior
D002440,CHEMICAL,Cefoxitin,"MK-306|MK306|Mefoxitin|MK 306|Méfoxin|Cefoxitin Sodium|Sodium, Cefoxitin|cefoxitin|Mefoxin"
NEW19748,DISEASE,Methicillin-resistant s. aureus isolate,mecA gene
NEW19749,DISEASE,17β-oestradiol,ERS injury
NEW19751,CHEMICAL,cysteine uptake,hippocampal GSH synthesis
NEW19752,DISEASE,cysteine uptake,ischemia-induced neuronal death
NEW19755,BIOCHEMICAL,Shandong Quangang Pharmaceutical Co. Ltd.,Shandong Quangang Pharmaceutical Co. Ltd.
NEW19756,CHEMICAL,da reuptake,DA reuptake
NEW19757,DISEASE,male prepubescent lamb,male prepubescent lambs
NEW19759,BIOCHEMICAL,second degree burn,local antibacterial agents
D018129,CHEMICAL,Phosphatidylinositol Phosphates,"Polyphosphoinositides|Polyphosphoinositide|Phosphatidyl Inositol Phosphates|Phosphates, Phosphatidyl Inositol|phosphates|Phosphates, Phosphatidylinositol|Inositol Phosphates, Phosphatidyl"
D001639,CHEMICAL,Bicarbonates,"Bicarbonate Ion|Hydrogen Carbonates|Carbonate, Hydrogen|Carbonic Acid Ions|Ion, Bicarbonate|Ions, Carbonic Acid|Ions, Bicarbonate|bicarbonates|Carbonates, Hydrogen|Bicarbonate|Bicarbonate Ions|Hydrogen Carbonate"
NEW19763,BIOCHEMICAL,selective inhibitor ssri monotherapy,selective inhibitor SSRI monotherapy
NEW19764,CHEMICAL,venlafaxine-extended release,venlafaxine-extended release
NEW19765,CHEMICAL,bupropion-sustained release,bupropion-sustained release
NEW19766,CHEMICAL,antidepressant medication combination,antidepressant medication combinations
NEW19768,DISEASE,great baseline depressive severity,hypocondriasis
C584722,CHEMICAL,meso-zeaxanthin [Supplementary Concept],meso-zeaxanthin|MZ|Zeaxanthins
NEW19770,BIOCHEMICAL,t2dm patient,carotenoids lutein
NEW19772,CHEMICAL,drug Latrodectus,amino acid exchange
D046788,DISEASE,Patellofemoral Pain Syndrome,"pain syndrome|Pain, Patellofemoral|Patellofemoral Syndrome|Pain Syndrome, Patellofemoral|Patellofemoral Pain|Anterior Knee Pain Syndrome|Patellofemoral Pains"
NEW19773,CHEMICAL,drug Latrodectus,acute VNS treatment
NEW19774,DISEASE,drug Latrodectus,AD-like effect
NEW19775,CHEMICAL,drug Latrodectus,chronic VNS treatment
NEW19778,DISEASE,trpa1 endogenous agonist,trigeminal nociceptors
NEW19780,DISEASE,impaired sociability,impaired sociability
C011559,CHEMICAL,tributyltin [Supplementary Concept],Trialkyltin Compounds|tributyltin
NEW19782,CHEMICAL,aeromonas molluscorum av27,TBT|resistant to tributyltin
NEW19784,DISEASE,few virulence factor,strain Av27
NEW19785,DISEASE,few virulence factor,end-stage hepatic disease
NEW19786,DISEASE,few virulence factor,stomach pain
NEW19787,DISEASE,few virulence factor,increased Cardiovascular diseases
NEW19789,DISEASE,rat msg exposure,typical adult life MetS
NEW19790,CHEMICAL,rat msg exposure,MSG metabolic
NEW19795,CHEMICAL,otud7a/cezanne2,calcium-induced calcium release
NEW19797,DISEASE,colon rupture,colon rupture
D017609,CHEMICAL,Barium Compounds,"Ba|Compounds, Barium|barium"
D017971,CHEMICAL,Tin Compounds,"Compounds, Tin|tin"
NEW19798,NUTRITION,lithium level,lithium levels
NEW19799,CHEMICAL,vanadium concentration,vanadium concentrations
NEW19800,CHEMICAL,plasma chromium,plasma chromium
C092978,CHEMICAL,immunotoxin LMB-7 [Supplementary Concept],"Exotoxins|Antibodies, Monoclonal|LMB"
NEW19806,CHEMICAL,juvenile lmb,DM basis|30 % fishmeal CP
NEW19808,BIOCHEMICAL,rhinosinusitis,antibiotic prescriptions
NEW19809,DISEASE,rhinosinusitis,estrogenic syndrome
NEW19810,DISEASE,rhinosinusitis,strong toxicity
NEW19813,DISEASE,suitable carbon source,ZEN degradation
NEW19815,CHEMICAL,wheat ingestion,± times/2 h
NEW19816,DISEASE,wheat ingestion,frequent TLESR
NEW19819,DISEASE,wheat noodle,higher GERD
NEW19820,DISEASE,wheat noodle,SAHS patients
NEW19822,DISEASE,[2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine mesdopetam,psychiatric disabilities
NEW19825,CHEMICAL,retroculus,crenicichlines
NEW19826,CHEMICAL,retroculus,chaetobranchines
NEW19827,CHEMICAL,retroculus,cichlasomines
NEW19832,MENTAL_HEALTH,anti-histamine drug,adult bipolar depression
NEW19834,MENTAL_HEALTH,stimulant-like medication,odor-induced analgesia
NEW19836,BIOCHEMICAL,idiopathic premature ovarian failure,hormone agonist
NEW19838,CHEMICAL,daytime eat disorder,triazolam abuse
NEW19841,CHEMICAL,sleep-related eating,opiate/cocaine abuse
NEW19844,CHEMICAL,hybrid factor mixture model,recent cannabis users
NEW19845,DISEASE,hybrid factor mixture model,related neurodegenerative diseases
NEW19848,CHEMICAL,leucettine,Threonine-212-Tau phosphorylation
NEW19849,DISEASE,leucettine,glutamate-induced cell death
NEW19853,CHEMICAL,ongoing coronavirus disease pandemic,bat coronavirus strain RaTG13
NEW19854,DISEASE,ongoing coronavirus disease pandemic,pangolin coronavirus
NEW19856,DISEASE,novel 3-cyanopyridine derivative,human cancer cell lines
D006327,DISEASE,Heart Block,"Heart Blocks|Dissociations, Atrioventricular|Atrioventricular Dissociations|heart block|A-V Dissociation|Dissociation, Auriculo-Ventricular|Auriculo Ventricular Dissociation|Dissociations, Auriculo-Ventricular|A V Dissociation|Auriculo-Ventricular Dissociations|Atrioventricular Dissociation|A-V Dissociations|Dissociations, A-V|Dissociation, Atrioventricular|Auriculo-Ventricular Dissociation|Dissociation, A-V|Blocks, Heart|Block, Heart"
NEW19859,DISEASE,potent survivin modulator,symptomatic orthostasis
NEW19862,MENTAL_HEALTH,plasma acylcarnitine profile,MDD core depression
NEW19863,MENTAL_HEALTH,plasma acylcarnitine profile,anxious depression
NEW19865,MENTAL_HEALTH,mood stabilizer,bipolar disorder BD patients
NEW19866,CHEMICAL,mood stabilizer,serum LDL-cholesterol levels
C566544,DISEASE,"Short Stature, Auditory Canal Atresia, Mandibular Hypoplasia, Skeletal Abnormalities [Supplementary Concept]","SAMS|Ear Canal/abnormalities|Bone Diseases, Developmental|Mandible/abnormalities|statin-associated muscle symptoms"
NEW19868,DISEASE,statin use,fatal cardiovascular events
NEW19869,DISEASE,tumor cell death,tumor cell death
NEW19871,MENTAL_HEALTH,gts patient,exacerbated schizophrenia
D000071857,DISEASE,Tumor Suppressor p53-Binding Protein 1,"TP53BP1 Protein|tumor suppressor p53|Tumor Protein p53 Binding Protein, 1|53BP1 Protein|Tumor Suppressor p53 Binding Protein 1|Tumor Protein p53-Binding Protein, 1|p202 Protein"
NEW19873,DISEASE,cytochrome c oxidase 2,HCT116 colorectal cancer cells
NEW19875,DISEASE,dfz exposure,hepatic oxidative stress
NEW19876,DISEASE,dfz exposure,glycolipid metabolism disorder
D020238,MENTAL_HEALTH,Prosopagnosia,"Recognition Agnosias, Facial|Prosopagnosias, Acquired|Prosopagnosias, Developmental|Agnosias, Facial Recognition|Developmental Prosopagnosias|Acquired Prosopagnosia|Acquired Prosopagnosias|Prosopagnosia, Acquired|developmental prosopagnosia|Prosopagnosias|Recognition Agnosia, Facial|Agnosia for Faces|Prosopagnosia, Developmental|Facial Recognition Agnosia|Facial Recognition Agnosias|Developmental Prosopagnosia|Agnosia, Facial Recognition|Agnosia for Face"
NEW19878,DISEASE,developmental phonagnosia,inherent toxicity
D010525,DISEASE,Peripheral Nerves,"peripheral nerves|Nerves, Peripheral|Perineuriums|Endoneuriums|Nerve, Peripheral|Epineuriums|Epineurium|Endoneurium|Perineurium|Peripheral Nerve"
NEW19884,DISEASE,skin toxin,autoimmune damage
NEW19885,CHEMICAL,skin toxin,classical antidepressants
NEW19887,MENTAL_HEALTH,bee toxin,robust myofiber fragmentation
D007922,DISEASE,Leptospirosis,"Mud Fever|Swineherd's Diseases|Leptospiroses|Leptospira Infections|Stuttgart Disease|leptospirosis|Leptospira Canicola Infections|Infection, Leptospira|Rice-Field Fever|Infection, Leptospira Canicola|Fevers, Cane-Cutter|Rice Field Fever|Leptospirosis Canicola|Infections, Leptospira Canicola|Canicola Fever|Infections, Leptospira|Fever, Rice-Field|Leptospira Canicola Infection|Swineherd's Disease|Leptospira Infection|Leptospirosis Canicolas|Cane Cutter Fever|Cane-Cutter Fever|Fever, Canicola|Fever, Mud"
NEW19890,DISEASE,chronic unpredictable mild stress,anhedonic-like behaviors
D014435,DISEASE,Typhoid Fever,"Typhus, Abdominal|Typhoid Fevers|Abdominal Typhus|Fever, Enteric|Typhoid|Infection, Salmonella typhi|Typhoids|typhoid fever|Salmonella typhi Infection|Fever, Typhoid|Fevers, Enteric|Salmonella typhi Infections|Infections, Salmonella typhi|Enteric Fever|Enteric Fevers|Fevers, Typhoid"
NEW19894,DISEASE,kir6.2 mutant mouse,severe memory deficits
NEW19895,CHEMICAL,kir6.2 mutant mouse,Kir6.2 activity
NEW19897,BIOCHEMICAL,therapeutic impotence,familiar drug
NEW19898,CHEMICAL,therapeutic impotence,pharmacologic therapy stimulants
NEW19901,DISEASE,tobacco smoke toxin,alcohol-related brain disease
NEW19902,BIOCHEMICAL,tobacco smoke toxin,estrogen dominance
NEW19905,MENTAL_HEALTH,intravaginal dehydroepiandrosterone,dyspareunia secondary
NEW19907,CHEMICAL,bergenin derivative,NO generation
NEW19909,CHEMICAL,hyperketonemia,serum BHB concentrations
NEW19910,DISEASE,upper gastrointestinal bleeding,upper gastrointestinal bleeding
NEW19911,DISEASE,bleed prevention,bleeding prevention
NEW19912,CHEMICAL,cysteamine metabolism pathway,cysteamine metabolism pathway
NEW19914,BIOCHEMICAL,symptomatic propylthiouracil hepatic injury,adrenal androgen hyperresponsiveness
NEW19915,DISEASE,symptomatic propylthiouracil hepatic injury,syndrome adrenal enzyme dysfunction
NEW19916,MENTAL_HEALTH,symptomatic propylthiouracil hepatic injury,multivariable linear regression
NEW19919,DISEASE,platelet mao activity,free depressed patients
NEW19922,DISEASE,metastatic kidney cancer,metastatic kidney cancer
NEW19930,CHEMICAL,modify high amylopectin cornstarch,glucose transporter deficiency syndrome
NEW19931,CHEMICAL,modify high amylopectin cornstarch,steady-state glucose transport
NEW19934,BIOCHEMICAL,displacement hypothesis,estrogen sulfates
NEW19936,DISEASE,cxc chemokine receptor cxcr4 antagonist,mucosal damage
D011024,DISEASE,"Pneumonia, Viral","Viral Pneumonia|Pneumonias, Viral|Viral Pneumonias|viral pneumonia"
NEW19938,CHEMICAL,clostridium acetobutylicum cell,accumulated butanol
NEW19939,CHEMICAL,clostridium acetobutylicum cell,butanol stress
NEW19940,DISEASE,clostridium acetobutylicum cell,C. acetobutylicum metabolic response
NEW19941,DISEASE,clostridium acetobutylicum cell,C. acetobutylicum
NEW19942,CHEMICAL,clostridium acetobutylicum cell,addition butanol tolerance
NEW19943,DISEASE,contrast locomotor hyperactivity,contrast locomotor hyperactivity
NEW19945,NUTRITION,crustacean hyperglycemia hormone,American lobster Homarus americanus
NEW19946,CHEMICAL,crustacean hyperglycemia hormone,PGE2 activation
NEW19948,DISEASE,mef2-reporter mouse,ideators
NEW19949,DISEASE,mef2-reporter mouse,non-ideators
NEW19951,BIOCHEMICAL,herpes simplex virus thymidine kinase,agent ganciclovir
NEW19953,MENTAL_HEALTH,agent aciclovir,mutant suicide gene system
NEW19954,CHEMICAL,agent aciclovir,potent acetylcholine analogue
NEW19955,CHEMICAL,agent aciclovir,carbamylcholine chloride
NEW19956,NUTRITION,agent aciclovir,Spanish case
NEW19958,NUTRITION,mixed-effects regression model,free sugar
NEW19960,DISEASE,past-year nutrition,trans-diagnostic impulsivity
NEW19965,MENTAL_HEALTH,central insulin resistance,central insulin resistance
NEW19969,DISEASE,soybean root,altered infection thread
NEW19970,DISEASE,soybean root,aberrant rhizobia infection
D049368,CHEMICAL,"Receptors, Lysophosphatidic Acid","Receptor, LPA|Edg-7 Receptor|LPA3 Receptor|LPA1 Receptor|Lysophosphatidic Acid Receptors|Receptor, edg-2|vzg-1 Receptor|Edg 4 Receptor|vzg 1 Receptor|Receptor, Edg-4|Acid Receptors, Lysophosphatidic|Acid Receptor, Lysophosphatidic|Receptor, LPA3|Receptor, Lysophosphatidic Acid|Receptor, LPA1|Edg-4 Receptor|Receptors, LPA|LPA Receptor|LPA-1 Receptor|Edg4 Protein|lysophosphatidic acid|Receptor, vzg-1|edg 2 Receptor|LPA2 Receptor|EDG7 Protein|Edg2 Protein|edg-2 Receptor|LPA Receptors|Receptor, Edg-7|Lysophosphatidic Acid Receptor|Receptor, LPA2|LPA 1 Receptor|Edg 7 Receptor"
NEW19971,NUTRITION,soybean root,phospholipid growth factor
NEW19973,DISEASE,atx expression,obesity-associated metabolic diseases
NEW19976,CHEMICAL,stepwise regression analysis,grain Zn
C559490,CHEMICAL,"vasopressin, Phe(2)-Ile(3)-Hgn(4)-Orn(iPr)(8)- [Supplementary Concept]",IPR|Vasopressins
NEW19977,DISEASE,stepwise regression analysis,ZBR
NEW19983,MENTAL_HEALTH,cold sdf-1alpha,bimodal ligand displacement curve
NEW19984,CHEMICAL,cold sdf-1alpha,IC(50)=7.4 nM
D015498,DISEASE,HIV-2,"Human Immunodeficiency Virus Type 2|LAV-2|HIV-II|HTLV-IV|Human immunodeficiency virus 2|SBL-6669|Human T Lymphotropic Virus Type IV|Human T-Lymphotropic Virus Type IV|Immunodeficiency Virus Type 2, Human|HIV-2"
NEW19986,BIOCHEMICAL,bicyclam amd3100,strong antiviral activity
NEW19989,CHEMICAL,cxcr4-specific antibody,Asp(171
NEW19990,DISEASE,cxcr4-specific antibody,childhood neuropsychiatric disorders
NEW19991,MENTAL_HEALTH,cxcr4-specific antibody,childhood epileptic syndromes
NEW19993,CHEMICAL,plasmolysis process,representative micro-anisotropy experimental analysis
NEW19995,CHEMICAL,pi3 k inhibitor,PI3 K inhibitors
NEW19997,CHEMICAL,thirty-five lbw infant,daily LDX
NEW19998,DISEASE,thirty-five lbw infant,urinary bladder discomfort
NEW19999,DISEASE,cancer patient,pain administration
NEW20001,DISEASE,central sympathetic blocker clonidine hydrochloride,experimental subarachnoid haemorrhage
NEW20002,CHEMICAL,central sympathetic blocker clonidine hydrochloride,comparison dopamine beta-hydroxylase=1.214+/-0.313
NEW20003,CHEMICAL,cerebral dopamine beta-hydroxylase,cerebral dopamine beta-hydroxylase
NEW20005,BIOCHEMICAL,intact pth level,G carriers
NEW20009,DISEASE,target gpcr antagonist,superior pain relief
NEW20012,DISEASE,µ-opioid receptor,trauma memory formation
NEW20014,DISEASE,urinary homovanillic acid,rare metabolic disorders
NEW20015,CHEMICAL,urinary homovanillic acid,glutamate Glu receptors
NEW20017,DISEASE,histamine production,histaminergic dysfunction
NEW20019,DISEASE,histamine decarboxylase hdc gene,fetus disabilities
NEW20021,CHEMICAL,histamine decarboxylase hdc gene,chitosan sponge
C028033,NUTRITION,potassium ferricyanide [Supplementary Concept],Ferricyanides|potassium hexacyanoferrate
C466420,CHEMICAL,"5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinato iron(III) chloride [Supplementary Concept]",Metalloporphyrins|iron(III chloride
NEW20023,DISEASE,brain 5-ht,aberrant social behaviors
NEW20025,NUTRITION,[3h]5 alpha-androstane-3 beta,crayfish aquaculture industry
NEW20027,CHEMICAL,native crayfish population,higher tobacco smoking rates
NEW20030,DISEASE,induce hypocortisolism,IWP-induced pain
D004121,CHEMICAL,Dimethyl Sulfoxide,"Rheumabene|DMSO|Rimso-50|Sulfinylbis(methane)|dimethyl sulfoxide|Sulphoxide, Dimethyl|Rimso 100|Sclerosol|Rimso|Dimethyl Sulphoxide|Dimexide|Sulfoxide, Dimethyl|Dimethylsulphoxide|Rimso 50|Dimethylsulfoxide|Rimso50|Dimethylsulphinyl"
NEW20033,DISEASE,gut neurotoxin p-cresol,seizure reactions
NEW20034,CHEMICAL,gut neurotoxin p-cresol,adenosine regulation
NEW20035,DISEASE,gut neurotoxin p-cresol,human corpus cavernosum|HCC
NEW20038,CHEMICAL,HCC strip,CGS21680C-sensitive receptors
D043704,CHEMICAL,"Receptor, Adenosine A2B","A2B Receptors, Adenosine|A2B Receptor, Adenosine|Adenosine A(2B) Receptor|Adenosine A2B Receptor|Adenosine A2B Receptors|Receptors, Adenosine A2B|A(2B"
NEW20039,DISEASE,HCC strip,HCC smooth muscle tone
NEW20045,DISEASE,ubiquitous trimethylxanthine,ductus arteriousus
NEW20046,DISEASE,ubiquitous trimethylxanthine,post-operative apnea
NEW20048,CHEMICAL,Illumina Cotton SNP k,polymorphism SNP data
NEW20050,CHEMICAL,valine (val)66-to-methionine met variant located,PI3K/Akt nitric oxide signaling pathways
NEW20052,DISEASE,drug exposure,secondary disabilities
D042882,DISEASE,Gallstones,"Gall Stones, Common Bile Duct|Calculi, Biliary|Biliary Calculi|Common Bile Duct Gall Stone|gallstones|Gall Stone|Biliary Calculi, Common Bile Duct|Common Bile Duct Gallstone|Gallstone|Gall Stones|Common Bile Duct Gall Stones|Common Bile Duct Calculi|Gallstones, Common Bile Duct|Common Bile Duct Gallstones"
NEW20059,CHEMICAL,associate fibrogenesis,ZER treatment
NEW20060,DISEASE,associate fibrogenesis,primary hepatic stellate cells
NEW20061,MENTAL_HEALTH,d supplementation,pediatrics resistance development
NEW20062,DISEASE,d supplementation,N. parkeri
C093204,CHEMICAL,"unc-2 protein, C elegans [Supplementary Concept]",Caenorhabditis elegans Proteins|Membrane Proteins|UNC-2
NEW20072,CHEMICAL,in-tcpp surface-coordinated mof thin film,In(NO3)3
C503831,CHEMICAL,"5,10,15,20-tetrakis(4-carboxyphenyl)porphyrin cobalt [Supplementary Concept]",TCPP|Metalloporphyrins
NEW20074,DISEASE,porphyrinic mof thin film,infertility agent
NEW20075,CHEMICAL,antidepressant pharmacotherapy,DiScenna
NEW20076,MENTAL_HEALTH,antidepressant pharmacotherapy,cholinergic projection neurons
NEW20077,DISEASE,antidepressant pharmacotherapy,toxicity effects
NEW20078,CHEMICAL,antidepressant pharmacotherapy,acetic acid mice model
NEW20081,DISEASE,synthetic rxr agonist,despair behaviors
NEW20084,CHEMICAL,dapsone hypersensitivity syndrome,ABSSSI due
NEW20086,BIOCHEMICAL,camv 35s-driven rnai repression,carotenoid biosynthesis
NEW20088,MENTAL_HEALTH,Opioid dependency,social dysfunction
NEW20090,BIOCHEMICAL,deposition-induced loss,potent microtubule-stabilizing agent
NEW20092,MENTAL_HEALTH,prototypical beta blocker propranolol,sympathetic hyperactivity
NEW20093,DISEASE,prototypical beta blocker propranolol,aggravated mitochondrial dysfunction
NEW20094,DISEASE,prototypical beta blocker propranolol,cognitive skills
NEW20095,DISEASE,depressive,primary recurrent familial mood disorders
NEW20096,CHEMICAL,depressive,cloned dopamine D1
NEW20099,BIOCHEMICAL,mild small vessel disease phenotype,NOTCH3 variant carriers
NEW20100,CHEMICAL,narcolepsy patient,muscarinic agonist carbachol
NEW20102,MENTAL_HEALTH,nitric oxide no donor sodium nitroprusside,solvent displacement
NEW20103,DISEASE,nitric oxide no donor sodium nitroprusside,addiction-related behaviors
NEW20104,CHEMICAL,nitric oxide no donor sodium nitroprusside,postsynaptic dopamine receptor supersensitivity
NEW20105,MENTAL_HEALTH,smoke cannabis,uremic syndromes
NEW20106,BIOCHEMICAL,smoke cannabis,intravenous thiamine administrations
NEW20107,DISEASE,smoke cannabis,disturbance T2 MRI lesions
NEW20108,DISEASE,smoke cannabis,childhood acute lymphoblastic leukemia
NEW20109,MENTAL_HEALTH,smoke cannabis,acute neurotoxicity syndromes
NEW20111,DISEASE,subacute mtx neurotoxicity,hemisensory deficits
NEW20113,DISEASE,transient neurological dysfunction,possible ischemic infarct
D014749,CHEMICAL,Vincamine,Vincimax|Vincapront|Devincan|Cerebroxine|vincamine|Pervincamine
NEW20117,CHEMICAL,transduce tumor cell,ganciclovir treatment
NEW20118,DISEASE,transduce tumor cell,orthotopic glioblastoma xenograft model
NEW20119,BIOCHEMICAL,transduce tumor cell,retinol cell surface receptor
NEW20120,CHEMICAL,transduce tumor cell,AI animals
NEW20122,BIOCHEMICAL,transduce tumor cell,A prophylaxis program
NEW20124,CHEMICAL,elevated local e2 level,S162C
NEW20125,CHEMICAL,elevated local e2 level,L116C
D015179,DISEASE,Colorectal Neoplasms,"Colorectal Cancer|Neoplasms, Colorectal|Cancer, Colorectal|Colorectal Carcinomas|Carcinoma, Colorectal|colorectal carcinoma|Carcinomas, Colorectal|Colorectal Carcinoma|Colorectal Cancers|Neoplasm, Colorectal|Tumor, Colorectal|Cancers, Colorectal|Colorectal Tumors|Colorectal Tumor|Colorectal Neoplasm|Tumors, Colorectal"
NEW20133,DISEASE,tryptophan degrade enzyme,persistent penile erection
NEW20134,MENTAL_HEALTH,tryptophan degrade enzyme,transient apical dyskinesia
NEW20135,DISEASE,severe cm,severe CM
NEW20136,CHEMICAL,creatinine clearance,creatinine clearance
D017597,DISEASE,"Renal Blood Flow, Effective","renal blood flow|Effective Renal Blood Flow|Blood Flow, Renal, Effective|ERBF"
NEW20137,CHEMICAL,noradrenaline contraction,noradrenaline contraction
NEW20138,CHEMICAL,% .Q(sys,% .Q(sys
NEW20139,DISEASE,spontaneous non-convulsive seizure,spontaneous non-convulsive seizures
NEW20140,DISEASE,ad-relate abnormal neuronal hyperactivity,AD-related abnormal neuronal hyperactivity
C057682,CHEMICAL,panaxytriol [Supplementary Concept],Fatty Alcohols|panaxytriol|Enediynes
NEW20146,DISEASE,intraperitoneal ellagic acid,phasic pain models
NEW20148,CHEMICAL,p. fluorescens subgroup,polyketide antibiotic mupirocin
NEW20150,CHEMICAL,simple linear regression analysis,Cd concentration
C014024,CHEMICAL,"2,4,5,2',4',5'-hexachlorobiphenyl [Supplementary Concept]",CB-153|Polychlorinated Biphenyls
NEW20152,MENTAL_HEALTH,low trait anxiety,different regression slopes
NEW20154,DISEASE,growth hormone releasing hormone antagonist,LPS-induced lung endothelial hyperpermeability
NEW20155,DISEASE,severe human disease,severe human disease
NEW20157,DISEASE,μm. ziram,asthenozoospermia spermatozoa
D058492,BIOCHEMICAL,Drug Repositioning,"Drug Rescue|Rescue, Drug|Drug Repurposing|Repurposing, Drug|Repositioning, Drug"
NEW20158,DISEASE,μm. ziram,Effective Alzheimer Medicines
NEW20161,NUTRITION,bacillus siamensis strain b44v,catfish culture
NEW20162,DISEASE,bacillus siamensis strain b44v,hydrophila FW52
NEW20163,CHEMICAL,bacillus siamensis strain b44v,mucin binding
NEW20167,CHEMICAL,rtt hippocampus,repetitive glutamate transients
NEW20169,DISEASE,hyperarousal symptom,trauma memories
NEW20170,BIOCHEMICAL,hyperarousal symptom,future high-risk drug use
D053978,CHEMICAL,Pentacyclic Triterpenes,"Fernane Derivatives|Derivatives, Hopane|Adianane Derivatives|Hopenoid Derivatives|Hopanes|Triterpenes, Baccharane|Baccharane Triterpenes|Lupane Derivatives|Derivatives, Lupane|Gammacerane Derivatives|Hopane Derivatives|Triterpenes, Pentacyclic|Derivatives, Gammacerane|Gammaceranes|Derivatives, Adianane|Derivatives, Fernane|Derivatives, Hopenoid|Fernanes|Lupanes|Adiananes|pentacyclic triterpenes"
NEW20172,DISEASE,human hepatocellular carcinoma cell,human hepatocellular carcinoma cells
NEW20173,DISEASE,different psychiatric diagnosis,different psychiatric diagnosis
NEW20174,MENTAL_HEALTH,parkinson 's Fatigue scale,Parkinson's Fatigue Scale
NEW20175,DISEASE,Disease Rate,Disease Rate
NEW20176,DISEASE,parkinson 's Disease Sleep scale,Parkinson's Disease Sleep Scale
NEW20177,DISEASE,39-item Parkinson 's Disease questionnaire,39-item Parkinson's Disease Questionnaire
NEW20178,DISEASE,wearing-off,wearing-off
NEW20180,BIOCHEMICAL,locomotor-enhancing effect,selective mu-opioid receptor antagonist
C034643,CHEMICAL,naloxonazine [Supplementary Concept],Naloxone/analogs  and  derivatives|naloxonazine
NEW20181,CHEMICAL,locomotor-enhancing effect,naloxone challenge
NEW20184,DISEASE,serotonergic antagonist mirtazapine,CUD participants
NEW20185,CHEMICAL,serotonergic antagonist mirtazapine,product ions
NEW20186,MENTAL_HEALTH,serotonergic antagonist mirtazapine,collision-induced dissociation mass
NEW20189,BIOCHEMICAL,depressed pregnant woman,stress hormone levels
NEW20190,MENTAL_HEALTH,depressed pregnant woman,Major Depression N=54 groups
NEW20192,CHEMICAL,dysthymic group,higher prenatal cortisol levels
NEW20193,CHEMICAL,post-lumpectomy,post-lumpectomy
NEW20195,CHEMICAL,multifunctional silica bead,small molecular aflatoxin B1
D000069295,CHEMICAL,Mammary Analogue Secretory Carcinoma,dextran|analogue|Carcinoma (2010-2015)
NEW20198,CHEMICAL,competitive-type displacement reaction,A A binding sites
NEW20199,CHEMICAL,competitive-type displacement reaction,H2O2-thionine system
NEW20201,MENTAL_HEALTH,ige sensitization,pollen-food syndromes
NEW20202,MENTAL_HEALTH,ige sensitization,celery-mugwort-spice syndromes
NEW20203,CHEMICAL,ige sensitization,goosefoot-melon associations
NEW20205,DISEASE,cross-reactive allergen component,allergy practice
NEW20207,MENTAL_HEALTH,inhale allergen,disorder admissions
NEW20208,DISEASE,dopamine release,migraine triggers
NEW20210,BIOCHEMICAL,most candida albican,azole antifungals
NEW20212,CHEMICAL,acute alcohol hallucinosis,inhibitory amino acid neurotransmitter
NEW20213,BIOCHEMICAL,acute alcohol hallucinosis,current drug
D014337,NUTRITION,Trout,trout|Char|Chars|Salvelinus
NEW20215,CHEMICAL,S. nigriventris,diurnal Chiloglanis-like benthic ancestor
NEW20218,MENTAL_HEALTH,icu delirium,ICU delirium
NEW20220,MENTAL_HEALTH,dysthymia symptom,dysthymia symptoms
D002864,CHEMICAL,Chromogranins,Granin|Secretogranins|chromogranins|Chromogranin|Granins|Secretogranin
D016708,CHEMICAL,Synaptophysin,"synaptophysin|p38 Membrane Protein, Synaptic Vesicle"
NEW20224,CHEMICAL,non-epithelial neuroendocrine neoplasm,keratins tyrosine hydroxylase
NEW20225,DISEASE,non-epithelial neuroendocrine neoplasm,equina neuroendocrine tumor
NEW20226,DISEASE,inflammatory rheumatic disease,inflammatory rheumatic diseases
NEW20227,DISEASE,low extremity arterial disease,lower extremity arterial disease
NEW20229,CHEMICAL,jaundice syndrome,sea-pen-farmed Chinook Salmon
NEW20231,CHEMICAL,male daily cannabis smoker,frequent 20-mg oral Δ⁹-tetrahydrocannabinol
NEW20232,CHEMICAL,male daily cannabis smoker,Δ⁹-tetrahydrocannabinol dosages
NEW20234,CHEMICAL,vibrio cholerae neuraminidase,unmasked GM1
NEW20235,CHEMICAL,vibrio cholerae neuraminidase,sialic acid residues
NEW20236,DISEASE,fetal alcohol exposure,atrial defects
NEW20238,NUTRITION,american bullfrog,yellowfin tuna|Thunnus albacares
NEW20239,NUTRITION,american bullfrog,sandbar shark|Carcharhinus plumbeus
NEW20240,CHEMICAL,american bullfrog,elevated extracellular potassium
NEW20243,DISEASE,haliotis tuberculata mortality,pathogenic Vibrio harveyi
NEW20248,NUTRITION,isolate ovarian follicular cell dna,BKME-exposed white sucker
NEW20249,BIOCHEMICAL,isolate ovarian follicular cell dna,used antifungal agents
NEW20250,MENTAL_HEALTH,isolate ovarian follicular cell dna,intrinsic resistance
NEW20251,BIOCHEMICAL,isolate ovarian follicular cell dna,drug binding site
D000073216,MENTAL_HEALTH,Mental Status and Dementia Tests,"Cognitive Assessment Screening Instrument|Neurocognitive Test|Montreal Cognitive Assessment|Mini-Cog|Neurobehavioral Cognitive Status Examination|Mini Mental State Examination|MicroCog|Neurocognitive Tests|UPDRS Panel|Unified Parkinson's Disease Rating Scale|Mini Mental Status Examination|COGNISTAT|Mental Status and Dementia Test|Dementia Rating Scale|MMSE, Mini Mental State Examination|Clinical Dementia Rating Scale|General Practitioner Assessment of Cognition|Clinical Dementia Rating|Dementia Rating|Folstein Mini-Mental State Examination|GPCOG|Mental Status Tests|Mental Status Test"
NEW20253,BIOCHEMICAL,important antibacterial drug,important antibacterial drugs
NEW20255,BIOCHEMICAL,junctional disorder,cholinergic drugs useful
NEW20257,DISEASE,specific ar antagonist,CFA-induced mechanical hypersensitivity
NEW20258,BIOCHEMICAL,specific ar antagonist,specific MOR agonist
http://purl.obolibrary.org/obo/CHEBI_33234,BIOCHEMICAL,vitamin e,vitamin E vitamer|rancherosSome vitamin E|vitamin E|vitamins E|vitamin-E|vitamin E vitamers
NEW20260,CHEMICAL,cannabis medicine,cannabis medicines
NEW20263,DISEASE,functional deficiency,functional deficiencies
NEW20265,DISEASE,follow-up acromegaly,follow-up acromegaly
NEW20267,DISEASE,positive symptom,positive symptoms
NEW20268,CHEMICAL,heavy cannabis user,heavy cannabis users
NEW20270,DISEASE,rtt individual,RTT individuals
NEW20271,DISEASE,rtt pathophysiology,RTT pathophysiology
NEW20273,MENTAL_HEALTH,low alexithymia group,low alexithymia group
NEW20276,CHEMICAL,multiple aminoacidemia,multiple aminoacidemia
NEW20278,DISEASE,hyperammonemic coma,hyperammonemic coma
NEW20279,DISEASE,trd patient,TRD patients
NEW20280,NUTRITION,daily food intake,daily food intake
NEW20282,DISEASE,a. flavus,A. flavus
NEW20283,DISEASE,a. flavus infection/aflatoxin production,A. flavus infection/aflatoxin production
NEW20285,CHEMICAL,tramadol group,tramadol group
NEW20288,MENTAL_HEALTH,thymocyte dna fragmentation,thymocyte DNA fragmentation
NEW20290,DISEASE,dht-induced tec-secreted factor,DHT-induced TEC-secreted factor
NEW20291,CHEMICAL,propylthiouracil preconception,propylthiouracil preconception
NEW20292,CHEMICAL,original kut herb,original KUT herbs
NEW20293,DISEASE,chronic painful peripheral neuropathy,chronic painful peripheral neuropathy
NEW20295,DISEASE,primary lung cancer,primary lung cancer
NEW20304,DISEASE,behavioral difficulty,behavioral difficulties
NEW20306,CHEMICAL,spermine deficiency,spermine deficiency
NEW20307,CHEMICAL,spermidine toxicity,spermidine toxicity
NEW20310,BIOCHEMICAL,analgesic tolerance,analgesic tolerance
NEW20312,BIOCHEMICAL,concomitant oestrogen,concomitant oestrogen
NEW20313,DISEASE,healthy oophorectomised woman,healthy oophorectomised women
NEW20315,MENTAL_HEALTH,dissociative psychosis,dissociative psychosis
NEW20319,DISEASE,regional myocardial oxygen consumption,regional myocardial oxygen consumption
NEW20321,DISEASE,appswe/ps1de9 transgenic ad mouse,APPswe/PS1dE9 transgenic AD mice
NEW20323,CHEMICAL,more arachidonic acid,more arachidonic acid
NEW20327,CHEMICAL,endogenous cannabinoid anandamide,endogenous cannabinoid anandamide
NEW20328,DISEASE,persistent depressive symptom,persistent depressive symptoms
NEW20330,DISEASE,incipient diabetic nephropathy,incipient diabetic nephropathy
NEW20333,NUTRITION,hatchery-reared rainbow trout,hatchery-reared rainbow trout
NEW20336,CHEMICAL,galactose metabolism,galactose metabolism
NEW20337,CHEMICAL,glutamate-glutamine metabolic pathway,glutamate-glutamine metabolic pathway
NEW20339,DISEASE,stress damage,stress damage
NEW20341,CHEMICAL,gamma-aminobutyric acid release,gamma-aminobutyric acid release
NEW20343,DISEASE,Cannabis Use Disorder,Cannabis Use Disorder
NEW20346,DISEASE,arterial flutter,arterial flutter
NEW20347,BIOCHEMICAL,potent serotonin uptake inhibitor clomipramine hydrochloride,potent serotonin uptake inhibitor clomipramine hydrochloride
NEW20351,DISEASE,dendritic loss,dendritic loss
NEW20353,DISEASE,pws patient,PWS patients
NEW20355,MENTAL_HEALTH,imprint disorder prader-willi syndrome,imprinting disorder Prader-Willi syndrome
NEW20357,CHEMICAL,fast blood glucose level,fasting blood glucose level
NEW20361,CHEMICAL,receptor a(htr1 a,receptor A(HTR1 A
NEW20363,NUTRITION,unconjugated phenol,unconjugated phenols
NEW20365,DISEASE,overt hypothyroidism,overt hypothyroidism
NEW20367,DISEASE,euthymic lithium-treated bipolar patient,euthymic lithium-treated bipolar patients
NEW20369,DISEASE,tnt myopathy,TnT myopathies
NEW20371,CHEMICAL,nicotine biosynthetic gene,nicotine biosynthetic genes
NEW20373,BIOCHEMICAL,different hormone signaling pathway,different hormone signaling pathways
NEW20375,CHEMICAL,testosterone support,testosterone support
NEW20376,DISEASE,body mass gain,body mass gain
NEW20378,DISEASE,c9orf72 disease spectrum,C9orf72 disease spectrum
NEW20380,DISEASE,extensive small vessel disease severity,extensive small vessel disease severity
NEW20381,CHEMICAL,ap-5 50μm,AP-5 50μM
NEW20382,CHEMICAL,n-methyl-d-aspartic acid nmda receptor inhibitor dl-2-amino-5-phosphonopentanoic acid,N-methyl-d-aspartic acid NMDA receptor inhibitor DL-2-amino-5-phosphonopentanoic acid
NEW20385,BIOCHEMICAL,psychrophilum antimicrobial susceptibility,psychrophilum antimicrobial susceptibility
NEW20387,MENTAL_HEALTH,cns insulin resistance,CNS insulin resistance
NEW20389,DISEASE,generalize disorder-like behavior,generalized disorder-like behaviors
NEW20391,DISEASE,generalize anxiety-like behavior,generalized anxiety-like behavior
NEW20394,CHEMICAL,urinary sodium concentration,urinary sodium concentration
NEW20396,BIOCHEMICAL,cortisone hormone,cortisone hormones
NEW20398,CHEMICAL,(32)pi uptake,(32)Pi uptake
NEW20401,DISEASE,haematologic dysfunction,haematologic dysfunction
NEW20403,DISEASE,treatment volume reduction,treatment volume reduction
NEW20405,CHEMICAL,serum glutathione,serum glutathione|GSH
NEW20406,CHEMICAL,mda assay,MDA assay
NEW20410,CHEMICAL,"u69,593 dose","U69,593 dose"
NEW20412,DISEASE,pericardial edema,pericardial edemas
NEW20414,NUTRITION,mandarin fish fry cell,mandarin fish fry cells
NEW20416,DISEASE,pcos patient,PCOS patients
NEW20418,CHEMICAL,cardiac potassium channel,cardiac potassium channels
NEW20421,DISEASE,necrotic host cell damage,necrotic host cell damage
NEW20423,CHEMICAL,monochamus alternatus,Monochamus alternatus|Japanese pine sawyer
NEW20424,BIOCHEMICAL,neurotoxin entry,neurotoxin entry
NEW20426,BIOCHEMICAL,neurotoxin blood level,neurotoxin blood levels
NEW20428,DISEASE,neuroleptic-free schizophrenic patient,neuroleptic-free schizophrenic patients
NEW20432,DISEASE,genetic dystonic disorder,genetic dystonic disorders
NEW20434,CHEMICAL,dopamine signalling,dopamine signalling
NEW20436,DISEASE,drd mouse,DRD mice
NEW20438,NUTRITION,auditory discrimination,TOAD|Auditory Discrimination
NEW20440,DISEASE,paw edema volume,paw edema volume
NEW20443,DISEASE,anovular sterility,anovular sterility
NEW20444,MENTAL_HEALTH,splicing repression,splicing repression
NEW20445,DISEASE,asd-like,ASD-like
NEW20447,DISEASE,ovarian effect,ovarian effects
NEW20449,MENTAL_HEALTH,high depression score,higher depression scores
NEW20451,DISEASE,fish physiological disorder,fish physiological disorder
NEW20453,BIOCHEMICAL,certain drug withdrawal symptom,certain drug withdrawal symptoms
NEW20455,CHEMICAL,distinct nmda receptor subunit phenotype,distinct NMDA receptor subunit phenotypes
NEW20459,BIOCHEMICAL,sheep blood agar,sheep blood agar
NEW20460,BIOCHEMICAL,agar plate indicative,agar plates indicative
NEW20462,NUTRITION,walnut tree,walnut tree
NEW20465,NUTRITION,soybean phosphatidylcholine,soybean phosphatidylcholine
NEW20468,NUTRITION,bovine brain cortex-derived phosphatidylserine,bovine brain cortex-derived phosphatidylserine
NEW20469,NUTRITION,fatty acid significant activity,fatty acid significant activities
NEW20470,CHEMICAL,brain glucose concentration,brain glucose concentrations
NEW20472,BIOCHEMICAL,high-affinity choline carrier,high-affinity choline carriers
NEW20476,DISEASE,treatment-resistant BDD,treatment-resistant BDD
NEW20478,MENTAL_HEALTH,social phobia secondary,social phobia secondary
NEW20479,MENTAL_HEALTH,major psychiatric syndrome,major psychiatric syndromes
NEW20484,DISEASE,regular pulmonary arterial hypertension follow-up schedule,regular pulmonary arterial hypertension follow-up schedule
NEW20487,DISEASE,beta-amyloid-induced cognitive impairment,beta-amyloid-induced cognitive impairment
NEW20489,DISEASE,alcohol liver disease,alcohol liver diseases
NEW20490,DISEASE,cellular damage,cellular damage
NEW20492,DISEASE,acidic tumor microenvironment,acidic tumor microenvironment
NEW20494,DISEASE,severe throat pain,severe throat pain
NEW20497,CHEMICAL,benzodiazepine injection,benzodiazepine injections
NEW20498,DISEASE,autistic-like behavior,autistic-like behaviors
NEW20499,BIOCHEMICAL,nmdar antagonist model,NMDAR antagonist models
http://purl.obolibrary.org/obo/CHEBI_8552,CHEMICAL,"protein n6,n6-dimethyl-l-lysine","Protein N6,N6-dimethyl-L-lysine|NMDAR-associated proteins"
NEW20501,CHEMICAL,saturated anacardic acid,saturated anacardic acid
NEW20503,DISEASE,light slow-wave sleep,light slow-wave sleep|SWS
NEW20506,NUTRITION,bad cholesterol,bad cholesterol
NEW20508,MENTAL_HEALTH,opioid-induced respiratory depression,opioid-induced respiratory depression
NEW20510,DISEASE,varied encephalopathy,varied encephalopathies
NEW20511,DISEASE,peripheral hyperinsulinemia,peripheral hyperinsulinemia
NEW20513,DISEASE,metastatic melanoma,metastatic melanoma
NEW20516,MENTAL_HEALTH,resistant unipolar depression,resistant unipolar depression
NEW20522,CHEMICAL,specific l-(3h glutamate binding,specific L-(3H glutamate binding
NEW20523,MENTAL_HEALTH,dissociation equilibrium,dissociation equilibrium
NEW20524,DISEASE,rat forebrain,rat forebrain
NEW20525,DISEASE,chronic inflammatory disease,chronic inflammatory diseases
NEW20526,CHEMICAL,% serotonin-norepinephrine reuptake inhibitor,% serotonin-norepinephrine reuptake inhibitor
NEW20532,CHEMICAL,pg proband,PG probands
NEW20534,CHEMICAL,familial pg spectrum,familial PG spectrum
NEW20536,CHEMICAL,increase gamble-related cue reactivity,increased gamble-related cue reactivity
NEW20539,CHEMICAL,serum triglyceride concentration,serum triglyceride concentration
NEW20540,DISEASE,gout patient,gout patients
NEW20544,MENTAL_HEALTH,progressive neurological depression,progressive neurological depression
NEW20545,CHEMICAL,altered regional cerebral acetylcholine metabolism,altered regional cerebral acetylcholine metabolism
NEW20547,CHEMICAL,glucose concentration,glucose concentrations
NEW20549,CHEMICAL,2h2 2h2]choline incorporation,2H2 2H2]choline incorporation
NEW20550,CHEMICAL,acetylcholine concentration,acetylcholine concentrations
NEW20552,MENTAL_HEALTH,insulin stupor,insulin stupor
NEW20553,NUTRITION,reverse cholesterol transport,reverse cholesterol transport
NEW20555,DISEASE,marked hypertriglyceridemia,marked hypertriglyceridemia
NEW20557,DISEASE,Sorrel herb,Sorrel herb
NEW20559,NUTRITION,acid dietary supplementation,acids dietary supplementation
NEW20561,DISEASE,familial bipolar diathesis,familial bipolar diathesis
NEW20563,BIOCHEMICAL,licensed antagonist,licensed antagonists
NEW20567,DISEASE,prostate tumour,prostate tumours
NEW20570,MENTAL_HEALTH,depression Endpoints Research,Depression Endpoints Research
NEW20571,CHEMICAL,initial antidepressant choice,initial antidepressant choice
NEW20573,CHEMICAL,non-nmo-related indication,non-NMO-related indications
http://purl.obolibrary.org/obo/DOID_0050175,DISEASE,tick-borne encephalitis,Russian spring-summer encephalitis|Far Eastern TBE|Taiga encephalitis|tick-borne louping encephalitis|Central European encephalitis|west-Siberian encephalitis|Western European tick-borne encephalitis|Siberian tick-borne encephalitis
NEW20576,DISEASE,sandfly-borne,sandfly-borne
NEW20577,DISEASE,aino disease,Aino disease
NEW20578,DISEASE,midge-borne,midge-borne
NEW20579,DISEASE,thogoto fever,Thogoto fever
NEW20580,CHEMICAL,tembusu disease/duck egg-drop syndrome,Tembusu disease/duck egg-drop syndrome
http://purl.obolibrary.org/obo/SYMP_0000613,DISEASE,fever,Soldado fever|pyrexia
NEW20581,DISEASE,cocal disease,Cocal disease
NEW20582,DISEASE,kotonkan disease,Kotonkan disease
NEW20583,DISEASE,main drain disease,Main Drain disease
NEW20584,DISEASE,West Nile encephalitis,West Nile encephalitis
NEW20585,DISEASE,akabane disease,Akabane disease
http://purl.obolibrary.org/obo/DOID_0050171,DISEASE,obsolete snowshoe hare encephalitis,Snowshoe hare encephalitis
NEW20589,CHEMICAL,non-parenteral ketamine,non-parenteral ketamine
NEW20592,BIOCHEMICAL,antimicrobial susceptibility,antimicrobial susceptibilities
NEW20593,MENTAL_HEALTH,resistance determinant,resistance determinants
NEW20594,MENTAL_HEALTH,subjective ictal anxiety,subjective ictal anxiety
NEW20596,DISEASE,thrombotic event,thrombotic events
NEW20598,CHEMICAL,glutathione level antioxidant enzyme,glutathione levels antioxidant enzymes
NEW20599,BIOCHEMICAL,e level,E levels
http://purl.obolibrary.org/obo/CHEBI_4667,CHEMICAL,valproate semisodium,semisodium valproate|sodium divalproate|sodium hydrogen bis(2-propylpentanoate)|valproatum seminatricum|sodium hydrogen bis(2-propylvalerate)|sodium hydrogen divalproate|valproate semisodium|sodium 2-propylpentanoate--2-propylpentanoic acid (1:1)|valproato semisodico|divalproex sodium|valproate semisodique
NEW20602,MENTAL_HEALTH,increase binge eating symptom,increased binge eating symptoms
NEW20603,CHEMICAL,r(2)=0.086,R(2)=0.086
NEW20606,CHEMICAL,vulvar intraepithelial neoplasia,VIN|vulvar intraepithelial neoplasia
NEW20607,MENTAL_HEALTH,pdt resistance,PDT resistance
NEW20609,DISEASE,well-defined nephrotoxic effect,well-defined nephrotoxic effects
NEW20611,DISEASE,significant thermal hypersensitivity,significant thermal hypersensitivity
NEW20612,CHEMICAL,third epidural steroid injection,third epidural steroid injection
NEW20614,CHEMICAL,epidural steroid,epidural steroids
NEW20615,DISEASE,inflammatory pain model,inflammatory pain models
NEW20620,DISEASE,painful neuroma,painful neuromas
NEW20623,DISEASE,tap-harboring p. fluorescens,TAP-harboring P. fluorescens
NEW20626,MENTAL_HEALTH,behavioral stupor,behavioral stupor
NEW20628,CHEMICAL,pyruvate kinase activity,pyruvate kinase activity
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Central_Nervous_System_Disorders,MENTAL_HEALTH,central nervous system disorders,central nervous system depression
NEW20631,DISEASE,chronic abuse,chronic abuse
NEW20633,CHEMICAL,alloxan administration,alloxan administration
http://purl.obolibrary.org/obo/HP_0003674,DISEASE,onset,NCSE onset
NEW20637,DISEASE,primary pituitary gonadotrope,primary pituitary gonadotropes
NEW20639,BIOCHEMICAL,agonist ligand,agonist ligand
NEW20641,DISEASE,oral mucositis-related pain,oral mucositis-related pain
NEW20645,NUTRITION,spanish general population,Spanish general population
NEW20648,DISEASE,less wmh volume progression,less WMH volume progression
NEW20650,DISEASE,wmh progression,WMH progression
NEW20652,NUTRITION,tolerate trout,tolerated trout
NEW20653,NUTRITION,tolerate sea bass,tolerated sea bass
NEW20656,NUTRITION,technetium-99m-labeled diphosphate,technetium-99m-labeled diphosphates
NEW20657,DISEASE,acute trauma,acute trauma
NEW20658,CHEMICAL,body-first subtype,body-first subtype
NEW20659,CHEMICAL,striatal gln,striatal Gln
NEW20661,CHEMICAL,c. sativus L.,C. sativus L.
NEW20662,MENTAL_HEALTH,endorphinergic hyperactivity,endorphinergic hyperactivity
NEW20664,CHEMICAL,Li et 2013,Li et 2013
NEW20666,CHEMICAL,urea nitrogen suggestive,urea nitrogen suggestive
NEW20668,MENTAL_HEALTH,cocaine abuse therapy,cocaine abuse therapy
NEW20670,BIOCHEMICAL,masculinize hormone therapy,masculinizing hormone therapy
NEW20672,CHEMICAL,hippocampal adam10-notch-hes5 proliferative pathway,hippocampal ADAM10-Notch-Hes5 proliferative pathway
NEW20674,MENTAL_HEALTH,combat fatigue,combat fatigue
NEW20676,NUTRITION,fatty acid intake,fatty acid intakes
NEW20677,CHEMICAL,dietary pufa consumption,dietary PUFA consumption
NEW20679,NUTRITION,Whiting Bay,Whiting Bay
NEW20680,CHEMICAL,nitrotyrosine protein modification,nitrotyrosine protein modifications
NEW20682,MENTAL_HEALTH,appropriate fragmentation pattern,appropriate fragmentation patterns
NEW20684,CHEMICAL,testicular glutathione,testicular glutathione
NEW20685,CHEMICAL,peroxidation oxide production,peroxidation oxide production
NEW20687,DISEASE,p. peruviana,P. peruviana
NEW20688,CHEMICAL,dietary nucleotide,dietary nucleotides
NEW20692,MENTAL_HEALTH,acid dissociation constant,acid dissociation constants
NEW20694,DISEASE,m. tuberculosis h37rv strain,M. tuberculosis H37Rv strain
NEW20696,DISEASE,prostate gland alteration,prostate gland alterations
NEW20698,DISEASE,bladder derangement,bladder derangements
NEW20699,DISEASE,cerebral ischemia/reperfusion injury,cerebral ischemia/reperfusion injury
NEW20701,CHEMICAL,lc3-ii level,LC3-II levels
http://purl.obolibrary.org/obo/OGMS_0000102,CHEMICAL,injury,OGD/R injury
NEW20703,DISEASE,white vein disease,white vein disease
NEW20705,MENTAL_HEALTH,dpdpe-induced analgesia,DPDPE-induced analgesia
NEW20708,CHEMICAL,squalene content,squalene content
NEW20710,MENTAL_HEALTH,cancerophobia effect,cancerophobia effects
NEW20711,DISEASE,climacteric complaint,climacteric complaints
NEW20713,MENTAL_HEALTH,binary logistic regression,binary logistic regression
NEW20715,DISEASE,stress resemble diabete,stress resembling diabetes
NEW20717,NUTRITION,alpha pcc,alpha PCC
NEW20720,DISEASE,delay onset cardiogenic pulmonary edema,delayed onset cardiogenic pulmonary edema
NEW20722,CHEMICAL,release guanfacine ingestion,release Guanfacine ingestion
NEW20724,CHEMICAL,suicidogen,suicidogen
NEW20728,MENTAL_HEALTH,nts projection,NTS projection
NEW20731,DISEASE,vaginal atrophy itching,vaginal atrophy itching
NEW20733,DISEASE,various lung disease,various lung diseases
NEW20739,DISEASE,stress-induced cognitive decline,stress-induced cognitive decline
NEW20742,DISEASE,multi-episode patient,multi-episode patients
http://purl.obolibrary.org/obo/CHEBI_132144,CHEMICAL,bacteriohopanetetrol cyclitol ether,Tetrahydroxybacteriohopane cyclitol ether|bacteriohopanetetrol cyclitol ether
NEW20745,DISEASE,ra activity,RA activity
NEW20746,CHEMICAL,mg/l phe similar,mg/L PHE similar
NEW20749,DISEASE,restless leg syndrome/willis-ekbom disease,restless legs syndrome/Willis-Ekbom disease|RLS/WED
NEW20751,CHEMICAL,reverse salt flux,reverse salt flux
NEW20753,BIOCHEMICAL,specific antimalarial,specific antimalarials
NEW20755,DISEASE,bioluminescent model brain tumor growth,bioluminescent model brain tumor growth
NEW20757,DISEASE,paw tremor,paw tremor
NEW20759,BIOCHEMICAL,serotonergic drug use,serotonergic drug use
NEW20760,CHEMICAL,increase serotonin activity,increased serotonin activity
NEW20762,DISEASE,blood stasis,blood stasis
NEW20763,DISEASE,renew dislocation,renewed dislocation
NEW20764,DISEASE,delirious state,delirious state
NEW20765,CHEMICAL,anti-brain lysate,anti-brain lysate
NEW20767,CHEMICAL,adequate calcium intake,adequate calcium intake
NEW20769,CHEMICAL,radiocesium fixation,radiocesium fixation
NEW20770,CHEMICAL,k supply,K supply
NEW20771,CHEMICAL,radiocesium transfer,radiocesium transfer
NEW20773,CHEMICAL,amino acid nitrogen,amino acid nitrogen
NEW20777,DISEASE,inflammatory neuropathy,inflammatory neuropathies
NEW20780,DISEASE,neuronal mild mitochondrial dysfunction,neuronal mild mitochondrial dysfunction
NEW20783,CHEMICAL,positive anti-ro/ssa,positive anti-Ro/SSA
NEW20785,DISEASE,significant lymphoid atrophy,significant lymphoid atrophy
NEW20787,DISEASE,leishmanial disease,leishmanial disease
NEW20789,CHEMICAL,short-term iodide excess,short-term iodide excess
NEW20791,CHEMICAL,long-term dopamine replacement therapy,long-term dopamine replacement therapy
NEW20794,MENTAL_HEALTH,postreceptor resistance,postreceptor resistance
NEW20795,BIOCHEMICAL,endocrine influence,endocrine influences
NEW20797,DISEASE,fungal keratitis curable,fungal keratitis curable
NEW20799,BIOCHEMICAL,beta frequency range,beta frequency range
NEW20801,DISEASE,family Crassulaceae,family Crassulaceae
NEW20803,DISEASE,hagsto1-overexpressing FHM cell,HaGSTO1-overexpressing FHM cells
NEW20807,NUTRITION,croaker granulosa cell,croaker granulosa cells
NEW20808,DISEASE,human breast cancer skbr-3 cell,human breast cancer SKBR-3 cells
NEW20811,MENTAL_HEALTH,cultivar resistance,cultivar resistance
NEW20812,BIOCHEMICAL,foliar fungicide,foliar fungicides
NEW20814,MENTAL_HEALTH,displacement reaction,displacement reactions
NEW20816,CHEMICAL,cocaine cpp,cocaine CPP
NEW20819,DISEASE,sporadic ad,SAD|sporadic AD
NEW20820,DISEASE,familial ad,familial AD
NEW20822,CHEMICAL,proprietary dihydropyrimidone dhpm derivative,proprietary dihydropyrimidone DHPM derivatives
NEW20823,CHEMICAL,dhfr specificity,DHFR specificity
NEW20826,CHEMICAL,amyloid metabolism/catabolism,amyloid metabolism/catabolism
NEW20830,CHEMICAL,ige antibody,IgE antibodies
NEW20831,CHEMICAL,fentanyl intake,fentanyl intake
NEW20832,CHEMICAL,high circulate corticosterone level,high circulating corticosterone levels
NEW20834,CHEMICAL,glucose deprivation,glucose deprivation
NEW20835,CHEMICAL,dopamine depletion,dopamine depletions
NEW20838,DISEASE,myelination lesion,myelination lesions
NEW20839,DISEASE,aplysia medial pleural neuron,Aplysia medial pleural neurons
NEW20841,CHEMICAL,key viral cysteine enzymes/protease,key viral cysteine enzymes/proteases
NEW20843,MENTAL_HEALTH,hepatic glucagon resistance,hepatic glucagon resistance
NEW20846,DISEASE,physiological hypertrophy,physiological hypertrophy
NEW20847,CHEMICAL,benzylic hydroxyl group,benzylic hydroxyl group
NEW20848,CHEMICAL,sodium metabolism,sodium metabolism
NEW20850,CHEMICAL,stimulation-induced pr,stimulation-induced PRs
NEW20852,MENTAL_HEALTH,increase input resistance,increased input resistance
NEW20853,DISEASE,depressive disturbance,depressive disturbances
NEW20854,DISEASE,homozygote sickle-cell disease,homozygote sickle-cell disease
NEW20856,DISEASE,p. pastoris km71,P. pastoris KM71
NEW20857,CHEMICAL,methanol induction,methanol induction
NEW20859,MENTAL_HEALTH,corresponding displacement peak,corresponding displacement peaks
NEW20860,DISEASE,hormone-receptor-positive early-stage breast cancer,hormone-receptor-positive early-stage breast cancer
NEW20863,MENTAL_HEALTH,swell fragmentation,swelling fragmentation
http://purl.obolibrary.org/obo/CHEBI_28697,CHEMICAL,21-deoxycortisol,"pregn-4-ene-11beta,17alpha-diol-3,20-dione|(1R,3aS,3bS,9aR,9bS,10S,11aS)-1-acetyl-1,10-dihydroxy-9a,11a-dimethyl-1,2,3,3a,3b,4,5,8,9,9a,9b,10,11,11a-tetradecahydro-7H-cyclopenta[a]phenanthren-7-one|11beta,17-dihydroxypregn-4-ene-3,20-dione|21-deoxycortisol|11beta,17alpha-dihydroxypregn-4-ene-3,20-dione|4-pregnene-11beta,17alpha-diol-3,20-dione|11beta,17-dihydroxyprogesterone|11beta,17alpha-dihydroxyprogesterone|dehydroepiandrosterone-sulphate|11-beta,17-alpha-dihydroxypregn-4-ene-3,20-dione"
NEW20866,CHEMICAL,omega-6 pufa,omega-6 PUFA
NEW20868,CHEMICAL,[d-arg]-sp,[D-Arg]-SP
http://purl.obolibrary.org/obo/UBERON_0001871,DISEASE,temporal lobe,temporal lobe pathology
NEW20872,MENTAL_HEALTH,dementia syndrome,dementia syndromes
NEW20875,MENTAL_HEALTH,multiple resistance gene,multiple resistance genes
NEW20877,DISEASE,toxic injury mechanism,toxic injury mechanism
NEW20879,DISEASE,thrombus formation,thrombus formation
NEW20880,DISEASE,mild acute liver cell damage,mild acute liver cell damage
NEW20882,DISEASE,hs pain,HS pain
NEW20884,BIOCHEMICAL,compound mixture,compound mixture
NEW20885,DISEASE,topical pain control,topical pain control
NEW20888,DISEASE,self-reported sleep disturbance,self-reported sleep disturbances
NEW20889,NUTRITION,phlorotannin group,phlorotannin group
NEW20890,BIOCHEMICAL,general opioid antagonist,general opioid antagonist
NEW20892,MENTAL_HEALTH,peripheral pth resistance,peripheral PTH resistance
NEW20894,DISEASE,young biofilm,young biofilm
NEW20896,DISEASE,p. falciparum 3d7 strain,P. falciparum 3D7 strain
NEW20898,DISEASE,malaria treatment,malaria treatment
NEW20901,MENTAL_HEALTH,addiction-like craving,addiction-like craving
NEW20903,CHEMICAL,clonidine dose-response line,clonidine dose-response line
NEW20905,MENTAL_HEALTH,dose-dependent displacement,dose-dependent displacement
NEW20906,CHEMICAL,baclofen dose-response line,baclofen dose-response line
NEW20907,CHEMICAL,baclofen antinociception,baclofen antinociception
NEW20909,BIOCHEMICAL,progestin component,progestin component
NEW20911,CHEMICAL,camp hydrolysis,cAMP hydrolysis
NEW20912,DISEASE,chronic respiratory disease,chronic respiratory diseases
NEW20914,BIOCHEMICAL,environmental poison,environmental poisons
NEW20915,CHEMICAL,skin blood carotene level,skin blood carotene levels
NEW20917,MENTAL_HEALTH,anxiety harm avoidance,anxiety harm avoidance
NEW20918,DISEASE,type alcoholism,Type alcoholism
NEW20919,MENTAL_HEALTH,depression pathology,depression pathology
NEW20922,DISEASE,glun2b expression,GluN2B expression
NEW20923,DISEASE,chronic ih-induced anxiety-like behavior,chronic IH-induced anxiety-like behavior
NEW20925,DISEASE,solid draw shd technology,solid drawing SHD technology
NEW20929,DISEASE,oral tremor,oral tremor
NEW20930,CHEMICAL,da neurotransmission,DA neurotransmission
NEW20932,CHEMICAL,da depletion,DA depletions
NEW20934,DISEASE,low-intensity inflammation,low-intensity inflammation
NEW20936,CHEMICAL,various fat-soluble water-soluble vitamin,various fat-soluble water-soluble vitamins
NEW20937,DISEASE,metabolic syndrome concurrent,metabolic syndrome concurrent
NEW20939,DISEASE,murine meer hnscc model,murine MEER HNSCC model
NEW20942,DISEASE,neuromyelopathie,neuromyelopathies
NEW20943,DISEASE,malnutrition marasmus nutritional neuropathy,malnutrition marasmus nutritional neuropathies
NEW20945,DISEASE,memory function,memory functions
http://purl.obolibrary.org/obo/CHEBI_165545,NUTRITION,n-oleoyl methionine,(2S)-4-methylsulanyl-2-[[(Z)-octadec-9-enoyl]amino]butanoic acid|methionine (M)/valine
NEW20947,CHEMICAL,amphetamine mechanism,amphetamine mechanisms
NEW20949,DISEASE,intraocular inflammation,intraocular inflammation
NEW20950,DISEASE,recurrent multiple brao,recurrent multiple BRAO
NEW20952,MENTAL_HEALTH,reversible addition fragmentation chain transfer,reversible addition fragmentation chain transfer
NEW20954,CHEMICAL,pfos co-exposure,PFOS co-exposures
NEW20956,MENTAL_HEALTH,benzodiazepine-induced amnesia,benzodiazepine-induced amnesia
NEW20959,MENTAL_HEALTH,conclusion root trait syndrome,conclusion root trait syndromes
NEW20960,DISEASE,bile acid diarrhoea,bile acid diarrhoea
NEW20963,CHEMICAL,carbonic anhydrase inhibitor acetazolamide,carbonic anhydrase inhibitor acetazolamide
NEW20964,CHEMICAL,presynaptic p/n type calcium channel,presynaptic P/N type calcium channels
NEW20968,DISEASE,increase toxicity,increased toxicity
NEW20970,DISEASE,multiple poisoning event,multiple poisoning events
NEW20972,DISEASE,intermediate toxicity,intermediate toxicity
NEW20974,CHEMICAL,domoic acid molecule,domoic acid molecule
NEW20976,BIOCHEMICAL,chronic drug treatment,chronic drug treatment
NEW20978,DISEASE,l-dopa-induced phospho-erk1/2,L-DOPA-induced phospho-ERK1/2
NEW20979,DISEASE,l-dopa-induced improvement,L-DOPA-induced improvement
NEW20982,DISEASE,somatic damage,somatic damage
NEW20983,CHEMICAL,economy/business,economy/business
NEW20987,BIOCHEMICAL,broad antiviral activity,broad antiviral activity
NEW20988,DISEASE,little toxicity,little toxicity
NEW20989,BIOCHEMICAL,antiviral activity,antiviral activity
http://purl.obolibrary.org/obo/CHEBI_48219,BIOCHEMICAL,disinfectant,disinfecting agent|disinfectants|desinfectant|Desinfektionsmittel|QAC-containing disinfectants
NEW20994,CHEMICAL,aristolochic acid nephropathy,aristolochic acid nephropathy
NEW20995,DISEASE,associate urothelial malignancy,associated urothelial malignancy
NEW20996,DISEASE,tumor development,tumor development
NEW20998,DISEASE,human renal microsome,human renal microsomes
NEW21002,DISEASE,fibromyalgia fm patient,fibromyalgia FM patients
NEW21003,DISEASE,pain sleep,pain sleep
NEW21006,MENTAL_HEALTH,cold resistance,cold resistance
NEW21007,CHEMICAL,mycobacterium difficult nontuberculous mycobacterium,Mycobacterium difficult nontuberculous Mycobacterium
NEW21009,MENTAL_HEALTH,antibiotic resistance,antibiotics resistance
NEW21010,DISEASE,communal infection,communal infections
NEW21012,DISEASE,aids prophylaxis drug,AIDS prophylaxis drugs
NEW21014,DISEASE,purge t-cell immunity,purging T-cell immunity
NEW21015,DISEASE,breast tumor growth,breast tumor growth
NEW21017,CHEMICAL,psychic experience,CAPE|Psychic Experiences
NEW21018,CHEMICAL,deuterium isotope effect,deuterium isotope effects
NEW21022,DISEASE,aip patient,AIP patients
NEW21024,DISEASE,vertical oozing canker,vertical oozing canker
NEW21028,CHEMICAL,oocyte nmda receptor,oocyte NMDA receptor
NEW21029,CHEMICAL,"1 mm. 6-nitro-7-cyano-quinoxaline-2,3-dione","1 mM. 6-Nitro-7-cyano-quinoxaline-2,3-dione|CNQX"
NEW21031,MENTAL_HEALTH,atp-induced dna fragmentation,ATP-induced DNA fragmentation
NEW21033,DISEASE,gastric dysmotility,gastric dysmotility
NEW21035,MENTAL_HEALTH,fragmentation route,fragmentation routes
NEW21036,DISEASE,impaired cardiovascular reflex,impaired cardiovascular reflexes
NEW21038,DISEASE,campylobacter ureolyticus,Campylobacter ureolyticus
NEW21039,MENTAL_HEALTH,dna fragmentation assay,DNA fragmentation assay
NEW21043,DISEASE,heart reperfusion,heart reperfusion
NEW21046,CHEMICAL,aas user,AAS users
NEW21047,DISEASE,acute injury,acute injuries
NEW21049,CHEMICAL,90 min,dextran|90 min
NEW21051,DISEASE,tumor immunotherapy,tumor immunotherapy
NEW21055,DISEASE,sleep-related disorder,sleep-related disorders
NEW21056,DISEASE,acute manic,acute manic
NEW21057,DISEASE,bipolar adult,bipolar adults
NEW21059,NUTRITION,male gametophyte development,male gametophyte development
NEW21061,DISEASE,iah-induced brain injury,IAH-induced brain injury
NEW21062,DISEASE,renal nephropathy,renal nephropathy
NEW21065,DISEASE,persistent pain condition,persistent pain conditions
NEW21066,CHEMICAL,plant-derived biocide,plant-derived biocide
NEW21067,CHEMICAL,toxicity/cost ratio,toxicity/cost ratio
NEW21070,MENTAL_HEALTH,anaplerotic carboxylase fixation,anaplerotic carboxylase fixation
NEW21072,MENTAL_HEALTH,olfactory fatigue,olfactory fatigue
NEW21073,DISEASE,disorder alloy counterpart,disordered alloy counterparts
NEW21076,CHEMICAL,nalmefene group,nalmefene group
NEW21077,DISEASE,juvenile stage,juvenile stage
NEW21078,MENTAL_HEALTH,growth depression,growth depression
NEW21082,CHEMICAL,amph abuse,Amph abuse
NEW21083,CHEMICAL,upregulate metabotropic glutamate receptor,upregulated metabotropic glutamate receptor
NEW21086,DISEASE,carrageenan-induced inflammatory pain,carrageenan-induced inflammatory pain
NEW21088,DISEASE,refractory vasopressor-resistant shock,refractory vasopressor-resistant shock
NEW21089,CHEMICAL,ccb toxicity,CCB toxicity
NEW21091,DISEASE,substantial aids population,substantial AIDS population
NEW21093,DISEASE,multiple cortical/subcortical infarct-like lesion,multiple cortical/subcortical infarct-like lesions
NEW21094,DISEASE,central nerve demyelination,central nerve demyelination
NEW21095,CHEMICAL,% ）,% ）
NEW21096,DISEASE,white matter hyperintensitie,white matter hyperintensities
NEW21098,DISEASE,congenital tube defect,congenital tube defects
NEW21100,CHEMICAL,homocysteine metabolism,homocysteine metabolism
NEW21103,NUTRITION,weaner pig,weaner pig
NEW21104,DISEASE,daily weight gain,daily weight gain
NEW21105,DISEASE,pmws,PMWS
NEW21107,DISEASE,amyloid deposition,amyloid deposition
NEW21110,DISEASE,t7901,T7901
NEW21112,DISEASE,developmental hyperserotonemia,developmental hyperserotonemia
NEW21115,CHEMICAL,phytotoxic sesterterpenoid,phytotoxic sesterterpenoids
NEW21119,NUTRITION,cholesterol cleft,cholesterol clefts
NEW21120,DISEASE,atheromatous component,atheromatous components
NEW21121,DISEASE,necrotic core,necrotic core
NEW21122,DISEASE,stroke onset,stroke onset
NEW21124,CHEMICAL,hcl extractable cd concentration,HCl extractable Cd concentrations
NEW21126,MENTAL_HEALTH,dominant-negative repression,dominant-negative repression
NEW21128,CHEMICAL,pgr_tv3,pgr_tv3
NEW21129,CHEMICAL,pgr_tv4,pgr_tv4
NEW21132,MENTAL_HEALTH,adjunctive analgesia,adjunctive analgesia
NEW21133,DISEASE,mdd comorbidity,MDD comorbidity
NEW21135,CHEMICAL,noradrenergic-mask,noradrenergic-mask
NEW21138,NUTRITION,biological phosphorus removal,biological phosphorus removal
NEW21140,NUTRITION,biological phosphorus removal plant,biological phosphorus removal plants
NEW21141,BIOCHEMICAL,narcotic Commission,Narcotics Commission
NEW21145,CHEMICAL,cinnamon aqueous extract,cinnamon aqueous extract
NEW21151,CHEMICAL,isnomia,isnomia
NEW21156,DISEASE,myeloid malignancy,myeloid malignancies
NEW21158,DISEASE,melt-blending moulding,melt-blending moulding
NEW21160,CHEMICAL,glucose recovered group,glucose recovered group
NEW21161,CHEMICAL,group glucose recover group,groups glucose recovered group
NEW21163,NUTRITION,tryptophan trp metabolism,tryptophan Trp metabolism
NEW21164,CHEMICAL,5-ht level,5-HT level
http://purl.obolibrary.org/obo/DOID_0060894,DISEASE,early-onset parkinson's disease,early-onset Parkinson disease|early-onset Alzheimer's disease
NEW21167,MENTAL_HEALTH,pyramidal projection neuron,pyramidal projection neurons
NEW21169,CHEMICAL,unfractionate commercial heparin,unfractionated commercial heparin
NEW21172,CHEMICAL,glucose homeostasis definitive study,glucose homeostasis definitive studies
NEW21173,MENTAL_HEALTH,pp2a hyperactivity,PP2A hyperactivity
NEW21175,CHEMICAL,bilirubin displacement,bilirubin displacement
NEW21176,DISEASE,deformity lordosis,deformities lordosis
NEW21177,CHEMICAL,levamisole-adulterated cocaine use,levamisole-adulterated cocaine use
NEW21180,MENTAL_HEALTH,synclinal orientation,synclinal orientation
NEW21182,DISEASE,fatal ventricular tachyarrhythmia,fatal ventricular tachyarrhythmia
NEW21184,CHEMICAL,"lead compound 5'-chloro-2,2'-dihydroxychalcone","lead compound 5'-chloro-2,2'-dihydroxychalcone|Cl-DHC"
http://purl.obolibrary.org/obo/DOID_162,DISEASE,cancer,malignant neoplasm|malignant tumor|primary cancer|cancer DU145
NEW21186,DISEASE,sympathetic overactivity,sympathetic overactivity
NEW21187,DISEASE,multi-organ dysfunction,multi-organ dysfunction
NEW21189,DISEASE,septic patient,septic patients
NEW21191,DISEASE,pr-rich t47d human breast cancer cell line,PR-rich T47D human breast cancer cell line
NEW21193,DISEASE,conclusion potent cardiotoxic activity,conclusion potent cardiotoxic activity
NEW21195,DISEASE,delusional symptomatology,delusional symptomatology
NEW21197,CHEMICAL,abnormal local cell-energy demand,abnormal local cell-energy demand
NEW21198,CHEMICAL,elevated cho,elevated Cho
NEW21200,NUTRITION,phospholipid membrane disturbance,phospholipid membrane disturbances
NEW21202,NUTRITION,particular thiamine deficiency,particular thiamine deficiency
NEW21203,CHEMICAL,heavy alcohol use,heavy alcohol use
NEW21205,DISEASE,concomitant osteoporosis,concomitant osteoporosis
NEW21206,DISEASE,high fracture risk,high fracture risk
NEW21210,DISEASE,chronic peripheral burn pain,chronic peripheral burning pain
http://purl.obolibrary.org/obo/DOID_1205,DISEASE,allergic disease,allergic diseases|hypersensitivity reaction type I disease|hypersensitivity|allergic hypersensitivity disease
NEW21211,CHEMICAL,stacking-interaction energy,stacking-interaction energy
NEW21212,MENTAL_HEALTH,mutual displacement,mutual displacement
NEW21213,DISEASE,psychotic behavior,psychotic behaviors
NEW21215,MENTAL_HEALTH,psychosis due,psychosis due
NEW21217,CHEMICAL,≥ parturition,≥ parturitions
NEW21219,DISEASE,tuberculosis patient,tuberculosis patients
NEW21221,DISEASE,poison presence,poisoning presence
NEW21223,DISEASE,ischemia-induced neuronal nmdar hyperactivity,ischemia-induced neuronal NMDAR hyperactivity
NEW21224,CHEMICAL,high testosterone level,higher testosterone levels
NEW21225,CHEMICAL,acetaldehyde accumulation,acetaldehyde accumulation
NEW21227,MENTAL_HEALTH,mrna defense mechanism,mRNA defense mechanism
NEW21229,DISEASE,advanced chronic kidney disease,advanced chronic kidney disease
NEW21231,MENTAL_HEALTH,lambda-cyhalothrin resistance,lambda-cyhalothrin resistance
NEW21233,DISEASE,ptsd- individual,PTSD- individuals
NEW21234,DISEASE,great pain severity,greater pain severity
NEW21235,DISEASE,psychiatric use consequence,psychiatric use consequences
NEW21237,BIOCHEMICAL,deletion carrier,deletion carriers
NEW21239,CHEMICAL,serotonin concentration,serotonin concentrations
NEW21241,CHEMICAL,act+ssri condition,ACT+SSRI conditions
NEW21247,CHEMICAL,long-term l-dopa treatment,long-term l-DOPA treatment
NEW21248,CHEMICAL,excessive dopamine receptor transmission,excessive dopamine receptor transmission
NEW21249,CHEMICAL,d1- function,D1- function
NEW21251,DISEASE,carbamazepine-induced hyponatremia,carbamazepine-induced hyponatremia
NEW21253,NUTRITION,black white abalone,black white abalone
NEW21254,CHEMICAL,nightly caffeine,nightly caffeine
NEW21255,DISEASE,acute cerebrovascular disease,acute cerebrovascular disease
NEW21260,NUTRITION,mercury level,mercury level
NEW21262,MENTAL_HEALTH,alleviate fatigue,alleviating fatigue
NEW21263,DISEASE,ischemic deficit,ischemic deficits
NEW21264,CHEMICAL,four-liter fermentor,four-liter fermentor
NEW21266,BIOCHEMICAL,zeaxanthin production,zeaxanthin production
NEW21268,MENTAL_HEALTH,scopolamine-induced hyperactivity,scopolamine-induced hyperactivity
NEW21269,DISEASE,pd diagnosis,PD diagnosis
NEW21270,BIOCHEMICAL,fxs agonist,FXS agonist
NEW21273,NUTRITION,internal consistency coefficient alpha =,internal consistency coefficient alpha =
NEW21275,BIOCHEMICAL,microbial virulence factor,microbial virulence factors
NEW21277,CHEMICAL,madopar hbs,Madopar HBS
NEW21279,DISEASE,fructose-induced de hepatic lipogenesis,fructose-induced de hepatic lipogenesis
NEW21280,DISEASE,consequent hyperglycemia,consequent hyperglycemia
NEW21282,CHEMICAL,hla-20 series,HLA-20 series
NEW21284,DISEASE,depersonalization/derealization dissociative symptom,depersonalization/derealization dissociative symptoms
NEW21286,CHEMICAL,related to 5-hydroxytriptamine,5-HT|related to 5-hydroxytriptamine
NEW21287,DISEASE,depressed animal,depressed animals
http://cbmi.med.harvard.edu/asdphenotype#Class_168,DISEASE,involuntary behaviors,dyskinetic-like behavior
NEW21289,BIOCHEMICAL,neurotoxin injection,neurotoxin injection
NEW21290,CHEMICAL,injection l-dopa,injection L-DOPA
NEW21292,CHEMICAL,atypical ps,atypical PS
http://purl.obolibrary.org/obo/CHEBI_27007,NUTRITION,tin atom,50Sn|stannum|Sn|tin|tin atom|Zinn|etain|estano
NEW21297,DISEASE,cold/flu,cold/flu
http://purl.obolibrary.org/obo/SYMP_0000056,DISEASE,hyperpigmentation,leucoderma
NEW21299,MENTAL_HEALTH,menopause-associated dyspareunia,menopause-associated dyspareunia
NEW21300,MENTAL_HEALTH,heart-rate conditioned response,heart-rate conditioned response
NEW21304,DISEASE,depressed patient,depressed patient
NEW21305,CHEMICAL,conventional antidepressant treatment,conventional antidepressant treatment
NEW21307,DISEASE,model neurobehavioral deficit,models neurobehavioral deficits
NEW21309,DISEASE,rare inborn error,rare inborn errors
NEW21314,DISEASE,ischemic cardiovascular disease,ischemic cardiovascular disease
NEW21318,CHEMICAL,cellular glutamate,cellular glutamate
NEW21322,DISEASE,cancer selection criterion,cancer selection criteria
NEW21324,DISEASE,primary degenerative dementia,primary degenerative dementia
NEW21325,BIOCHEMICAL,pharmaceutical treatment,pharmaceutical treatment
NEW21327,DISEASE,childhood amblyopia,childhood amblyopia
NEW21328,DISEASE,overall psychotic,overall psychotic
NEW21330,CHEMICAL,high-concentration streptomycin,high-concentration streptomycin
NEW21332,MENTAL_HEALTH,akinesia skill,akinesia skills
NEW21333,DISEASE,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism apparent improvement","1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism apparent improvement"
NEW21334,CHEMICAL,dissolve oxygen,dissolved oxygen
NEW21336,CHEMICAL,high cho/cre,higher Cho/Cre
NEW21337,CHEMICAL,low naa/cho ratio,lower NAA/Cho ratios
NEW21340,MENTAL_HEALTH,h postpartum great analgesia,h postpartum greater analgesia
NEW21341,DISEASE,severe pruritus,severe pruritus
NEW21342,DISEASE,epidural nalbuphine,epidural nalbuphine|NB
NEW21344,MENTAL_HEALTH,well analgesia,better analgesia
NEW21347,NUTRITION,cranberry juice,cranberry juice
NEW21348,DISEASE,obvious depressive-like behavior,obvious depressive-like behaviors
NEW21350,CHEMICAL,maternal hair zinc content,maternal hair zinc content
NEW21352,DISEASE,craniofacial dysmorphology,craniofacial dysmorphology
NEW21355,CHEMICAL,standard antidepressant treatment,standard antidepressant treatment
NEW21357,DISEASE,wat dysfunction,WAT dysfunction
NEW21359,MENTAL_HEALTH,additional repression loop,additional repression loop
NEW21360,BIOCHEMICAL,circulate hormone,circulating hormones
NEW21361,DISEASE,murine hair follicle,murine Hair Follicles|HF
NEW21363,CHEMICAL,pathway ppp rate,Pathway PPP rate
http://purl.obolibrary.org/obo/CHEBI_183852,CHEMICAL,"13,14-dihydro-15-keto-tetranor prostaglandin f1beta","3-[(1R,2R,3R,5R)-3,5-dihydroxy-2-(3-oxooctyl)cyclopentyl]propanoic acid|Prostaglandins F2α"
NEW21364,CHEMICAL,pufa catabolite,PUFA catabolites
NEW21367,DISEASE,lsd abuse,LSD abuse
NEW21369,CHEMICAL,neurochemical/neuropeptide receptor expression,neurochemical/neuropeptide receptor expression
NEW21371,NUTRITION,elevated serum phosphorus concentration,elevated serum phosphorus concentration
NEW21373,MENTAL_HEALTH,ouabain-induced amnesia,ouabain-induced amnesia
NEW21374,MENTAL_HEALTH,regression log,regression log
NEW21375,CHEMICAL,(V)-0.10 log d,(V)-0.10 log D
NEW21376,CHEMICAL,e(2)(7,E(2)(7
NEW21378,NUTRITION,mackerel Scomber japonicus,mackerel Scomber japonicus
NEW21380,DISEASE,pain score,pain score
NEW21385,CHEMICAL,µm cdcl2,µM CdCl2
NEW21389,MENTAL_HEALTH,gene-for-gene resistance,gene-for-gene resistance
NEW21390,MENTAL_HEALTH,nonhost resistance,nonhost resistance
NEW21391,MENTAL_HEALTH,basal resistance,basal resistance
NEW21394,BIOCHEMICAL,extended-spectrum beta lactamase,extended-spectrum beta lactamases
NEW21396,BIOCHEMICAL,plasma lutein,plasma lutein
NEW21398,DISEASE,thromboembolic event,thromboembolic events
NEW21400,CHEMICAL,potent sulfonylurea agent glibenclamide,potent sulfonylurea agent glibenclamide
NEW21402,CHEMICAL,atp kinase activity,ATP kinase activity
NEW21404,CHEMICAL,lifestyle modification,GA group|lifestyle modification
NEW21407,DISEASE,spontaneously hypertension rat,spontaneously hypertension rats
NEW21408,DISEASE,increase chemoreflex hypersensitivity,increased chemoreflex hypersensitivity
NEW21410,DISEASE,idiosyncratic hepatotoxicity signature,idiosyncratic hepatotoxicity signatures
NEW21412,DISEASE,postapproval drug failure,postapproval drug failure
NEW21414,CHEMICAL,last amino acid,last amino acids
NEW21415,MENTAL_HEALTH,selective fixation,selective fixation
NEW21417,CHEMICAL,wine waste mixture,wine waste mixture
NEW21421,CHEMICAL,bind inosine,bound inosine
NEW21423,CHEMICAL,co2 gas,CO2 gas
NEW21426,DISEASE,structural lung disorder,structural lung disorders
NEW21428,MENTAL_HEALTH,oculomotor apraxia type,oculomotor apraxia type
NEW21431,DISEASE,chronic anal fissure comparable,chronic anal fissure comparable
NEW21433,NUTRITION,juvenile red sea bream,juvenile red sea bream
NEW21435,NUTRITION,red sea bream,red sea bream
NEW21436,CHEMICAL,mapk pi-3 k inhibitor,MAPK PI-3 K inhibitors
NEW21441,CHEMICAL,varenicline treatment,varenicline treatment
NEW21444,MENTAL_HEALTH,ethanol-mediated dissociation,ethanol-mediated dissociation
NEW21446,CHEMICAL,mets domain,MetS domains
NEW21448,CHEMICAL,glucose profile,glucose profiles
NEW21450,DISEASE,female ptsd group,female PTSD group
NEW21453,DISEASE,cc-nbs-lrr,CNL|CC-NBS-LRR
NEW21455,CHEMICAL,rs86,RS86
NEW21457,DISEASE,estrogen receptor positive breast cancer,estrogen receptor positive breast cancer
NEW21461,BIOCHEMICAL,lxr agonist,LXR agonist
NEW21463,DISEASE,malaria parasite,malaria parasites
NEW21464,CHEMICAL,n-3 incorporation,n-3 incorporation
NEW21466,CHEMICAL,nucleotide binding leucine-rich repeat nlr gene,nucleotide binding leucine-rich repeat NLR gene
NEW21468,DISEASE,p. arrhenomane infection,P. arrhenomanes infection
NEW21473,CHEMICAL,lignoresidue,lignoresidues
NEW21477,DISEASE,fatigue disturbance,fatigue disturbances
NEW21480,CHEMICAL,hepatic reduce glutathione content,hepatic reduced glutathione content
NEW21481,DISEASE,ichthyosis premature syndrome,ichthyosis premature syndrome
NEW21483,BIOCHEMICAL,anti-mullerian hormone accumulation,anti-mullerian hormone accumulation
NEW21484,DISEASE,pro-inflammatory advanced glycation end Products,pro-inflammatory Advanced Glycation End Products
NEW21485,DISEASE,abnormal folliculogenesis,abnormal folliculogenesis
NEW21486,DISEASE,hepatitis c infection,hepatitis C infection
NEW21488,BIOCHEMICAL,sr vasopressin-1a v1a receptor antagonist,SR vasopressin-1A V1A receptor antagonist
NEW21490,CHEMICAL,high dopamine turnover ratio,higher dopamine turnover ratio
NEW21492,DISEASE,mineral metabolism disorder,mineral metabolism disorder|CKD-MBD
NEW21494,DISEASE,edema phenotype due,edema phenotypes due
http://purl.obolibrary.org/obo/DOID_2590,DISEASE,familial nephrotic syndrome,familial steroid-sensitive nephrotic syndrome|Congenital nephrotic syndrome|SSNS
NEW21497,CHEMICAL,antiretroviral arv drug,antiretrovirals ARVs drugs
NEW21498,MENTAL_HEALTH,stepwise multiple regression analysis,stepwise multiple regression analysis
http://purl.obolibrary.org/obo/NCBITaxon_1783257,CHEMICAL,pvc group,PTZ group
NEW21501,DISEASE,inflow stenosis,inflow stenosis
NEW21503,DISEASE,renal venous congestion,renal venous congestion
NEW21504,CHEMICAL,ace-i/arb withdrawal,ACE-I/ARB withdrawal
NEW21506,MENTAL_HEALTH,sperm hyperactivity,sperm hyperactivity
NEW21508,CHEMICAL,nahco3,NaHCO3
NEW21510,MENTAL_HEALTH,"ptdins(3,5)p2-dependent vacuolar fragmentation","PtdIns(3,5)P2-dependent vacuolar fragmentation"
NEW21512,CHEMICAL,creatine metabolism,creatine metabolism
NEW21514,CHEMICAL,low creatine level,low creatine levels
NEW21515,BIOCHEMICAL,adjunctive drug treatment,adjunctive drug treatment
NEW21517,BIOCHEMICAL,male c-allele carrier,male C-allele carriers
NEW21520,CHEMICAL,gabra6 rs3219151 t allele,GABRA6 rs3219151 T allele
NEW21522,MENTAL_HEALTH,adhd score,ADHD scores
NEW21524,MENTAL_HEALTH,schizophrenia evolution,schizophrenia evolution
NEW21526,BIOCHEMICAL,synthetic pyridoxine,synthetic pyridoxine
NEW21528,MENTAL_HEALTH,augmentation control disorder,augmentation control disorders
NEW21530,BIOCHEMICAL,reproductive endocrine disorder,reproductive endocrine disorders
NEW21531,CHEMICAL,cpd trimester,CPD trimester
NEW21534,DISEASE,psychiatric association,psychiatric association
NEW21535,CHEMICAL,long-chain poly unsaturated Fatty Acids,long-chain Poly Unsaturated Fatty Acids
NEW21537,CHEMICAL,gvg,GVG
NEW21538,CHEMICAL,vigabatrin gamma vinyl gaba,Vigabatrin gamma vinyl GABA
NEW21539,MENTAL_HEALTH,suicide inhibitor,suicide inhibitor
NEW21540,CHEMICAL,epa effect,EPA effects
NEW21542,CHEMICAL,EPA supplement,EPA supplement
NEW21544,CHEMICAL,t3 g. fraction,T3 g. fraction
NEW21546,NUTRITION,' onion,' onion
NEW21548,DISEASE,fracture toughness,fracture toughness
NEW21550,CHEMICAL,residue leachate,residue leachate
NEW21552,CHEMICAL,sodium bentonite geosynthetic clay liner,sodium bentonite geosynthetic clay liner|GCL
NEW21554,DISEASE,amyloid-beta-peptide abeta neurotoxicity,amyloid-beta-peptide Abeta neurotoxicity
NEW21559,CHEMICAL,antidepressant user,antidepressant users
NEW21562,DISEASE,severe paraphilic subject,severe paraphilic subjects
NEW21563,CHEMICAL,ammonium cerium nitrate,ammonium cerium nitrate
NEW21565,CHEMICAL,long-acting antimuscarinic agent,long-acting antimuscarinic agents|LAMA
NEW21566,CHEMICAL,1:1-indacaterol,1:1-indacaterol
NEW21568,CHEMICAL,indacaterol group,indacaterol group
NEW21569,DISEASE,multiple neuropathologie,multiple neuropathologies
NEW21570,DISEASE,neurodegeneration dementia,neurodegeneration dementia
NEW21572,DISEASE,nanoparticle tumor exocancer vaccine,nanoparticle tumor exocancer vaccine
NEW21573,DISEASE,vaccine research,vaccine research
http://purl.obolibrary.org/obo/CHEBI_50804,CHEMICAL,nanoshell,nonhomeopathic nanoparticle
NEW21576,DISEASE,genotype infection,genotype infections
NEW21578,DISEASE,decompensated cirrhosis,decompensated cirrhosis
NEW21580,CHEMICAL,daa treatment,DAA treatment
NEW21581,DISEASE,disorder muscle strength,disorders muscle strength
NEW21583,CHEMICAL,enzyme glutathione synthase,enzyme glutathione synthase
NEW21586,MENTAL_HEALTH,mild anxiety,mild anxiety
NEW21587,DISEASE,osa management,OSA management
NEW21588,DISEASE,osa pathogenesis,OSA pathogenesis
NEW21589,DISEASE,itp care,ITP care
NEW21592,DISEASE,calcinosis treatment,calcinosis treatment
NEW21594,CHEMICAL,insp6 non-treated rat,InsP6 non-treated rats
NEW21599,CHEMICAL,"irreversible alpha-2 adrenoceptor antagonist n-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline","EEDQ|irreversible alpha-2 adrenoceptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline"
NEW21601,CHEMICAL,serotonin system integrity,serotonin system integrity
NEW21602,DISEASE,long-lasting deficit,long-lasting deficits
NEW21604,DISEASE,tg soil,TG soil
NEW21606,MENTAL_HEALTH,clubroot resistance,clubroot resistance
NEW21609,MENTAL_HEALTH,late-life depression,late-life depression
NEW21612,MENTAL_HEALTH,dark (14)co(2 fixation period,dark (14)CO(2 fixation periods
NEW21614,CHEMICAL,preillumination,preillumination
NEW21616,MENTAL_HEALTH,dark co(2 fixation,dark CO(2 fixation
NEW21619,CHEMICAL,ped user,PED users
http://purl.obolibrary.org/obo/CHEBI_135145,BIOCHEMICAL,neridronic acid,neridronate|± ascorbic acid
NEW21622,CHEMICAL,i.pl,i.pl
NEW21623,DISEASE,chronic constriction injury model,chronic constriction injury model
NEW21627,CHEMICAL,prostanoid synthesis,prostanoid synthesis
NEW21629,DISEASE,dok7 myasthenic mouse,DOK7 myasthenic mice
NEW21630,DISEASE,myasthenic patient,myasthenic patients
NEW21632,CHEMICAL,medication pyridostigmine,medication pyridostigmine
NEW21633,MENTAL_HEALTH,amnesia induction,amnesia induction
NEW21637,DISEASE,primary b,primary B
http://purl.obolibrary.org/obo/DOID_13359,DISEASE,ehlers-danlos syndrome,Cutis hyperelastica|TRPS1 tricho-rhino-phalangeal syndrome|elastic skin
http://purl.obolibrary.org/obo/DOID_4467,DISEASE,clear cell renal cell carcinoma,clear cell renal cell carcinomas|Clear cell carcinoma of kidney|conventional renal cell carcinoma|clear cell kidney carcinoma|conventional (Clear cell) renal cell carcinoma|renal clear cell carcinoma|Clear-cell metastatic renal cell carcinoma
NEW21640,DISEASE,cns hemangioblastoma,CNS hemangioblastomas
NEW21642,DISEASE,vhl-hb rcc viability,VHL-HB RCC viability
NEW21645,CHEMICAL,mda production,MDA production
NEW21646,CHEMICAL,elevated ros,elevated ROS
NEW21648,DISEASE,human virus-1-associated dementia,human virus-1-associated dementia
NEW21650,MENTAL_HEALTH,adhd outcome,ADHD outcomes
NEW21652,MENTAL_HEALTH,chronic dyspareunia,chronic dyspareunia
NEW21654,BIOCHEMICAL,narcotic substance,narcotic substances
NEW21656,DISEASE,mixed decompensated respiratory lactic acidosis,mixed decompensated respiratory lactic acidosis
NEW21657,DISEASE,nosocomial focal low lobe pneumonia,nosocomial focal lower lobe pneumonia
NEW21658,CHEMICAL,lactate mmol l,lactate mmol l
NEW21659,CHEMICAL,phenyl-2- -1-pentanone,phenyl-2- -1-pentanone
NEW21660,DISEASE,convulsive syndrome,convulsive syndrome
NEW21662,DISEASE,bone complication,bone complications
NEW21664,DISEASE,natural a. marginale infection,natural A. marginale infection
NEW21666,DISEASE,respiratory viral infection,respiratory viral infections
NEW21670,DISEASE,myopia development,myopia development
NEW21676,DISEASE,severe functional impairment,severe functional impairment
NEW21678,BIOCHEMICAL,insufficient analgesic effect,insufficient analgesic effects
NEW21680,BIOCHEMICAL,drug effect,Drug effect
NEW21682,DISEASE,swollen breast,swollen breasts
http://purl.obolibrary.org/obo/CHEBI_49325,CHEMICAL,oral contraceptive,oral contraceptive use|oral contraceptives
NEW21684,DISEASE,pre-existing mastodynia,pre-existing mastodynia
NEW21685,DISEASE,fibrocystic breast manifestation,fibrocystic breast manifestations
NEW21687,MENTAL_HEALTH,colon dyskinesia,colon dyskinesia
http://purl.obolibrary.org/obo/CHEBI_28304,CHEMICAL,heparin,Parnaparin|Reviparin|Fluxum|Sandoparin|Cy 222|Heparin|heparine|heparina|heparin heparins|Enoxaparin|heparinum|heparin|Bemiparin|Certoparin|Heparinic acid
NEW21690,DISEASE,potent platelet aggregation inhibitor,potent platelet aggregation inhibitors
NEW21692,DISEASE,painful dystonia,painful dystonia
NEW21693,CHEMICAL,mean ±,mean ±
NEW21695,DISEASE,cms-induced bone loss,CMS-induced bone loss
NEW21697,DISEASE,leprosy herpetiformis,leprosy herpetiformis
NEW21700,CHEMICAL,acetylcholine molecule,acetylcholine molecules
http://purl.obolibrary.org/obo/DOID_1059,MENTAL_HEALTH,intellectual disability,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15|severe intellectual disability|mental retardation"
NEW21702,CHEMICAL,growth-hormone response,growth-hormone response
NEW21704,DISEASE,male-based childhood-onset neuropsychiatric disorder,male-based childhood-onset neuropsychiatric disorders
NEW21706,MENTAL_HEALTH,irreversible erectile dysfunction,irreversible erectile dysfunction
NEW21710,CHEMICAL,ala-d activity,ALA-D activity
NEW21712,BIOCHEMICAL,adjunct analgesic agent,adjunct analgesic agent
NEW21714,DISEASE,adrenolytic heart defect,AHD|Adrenolytic heart defect
NEW21719,BIOCHEMICAL,agar diffusion,agar diffusion
NEW21721,MENTAL_HEALTH,dna fragmentation level,DNA fragmentation levels
NEW21723,DISEASE,leishmania amazonensis-infected macrophage,Leishmania amazonensis-infected macrophages
NEW21725,CHEMICAL,lactate clearance,lactate clearance
NEW21727,CHEMICAL,clonidine hormone release,clonidine hormone release
NEW21732,MENTAL_HEALTH,dementia marker,dementia markers
NEW21733,DISEASE,loss impairment,loss impairments
NEW21735,DISEASE,frequent headache,frequent headaches
NEW21737,DISEASE,dehydration tolerance,dehydration tolerance
NEW21739,NUTRITION,elevated erythrocyte choline,elevated erythrocyte choline
NEW21740,CHEMICAL,anti-dementia medication,anti-dementia medications
NEW21742,DISEASE,malignant disease,malignant diseases
NEW21745,DISEASE,benign esophageal stricture,benign esophageal stricture
NEW21749,CHEMICAL,chitosan nanoparticle due,chitosan nanoparticles due
NEW21752,DISEASE,human nonmelanoma skin carcinoma,human nonmelanoma skin carcinomas
NEW21754,DISEASE,cholestasis serum total,cholestasis serum total
NEW21755,CHEMICAL,nicotinic antagonist hexamethonium,nicotinic antagonist hexamethonium
NEW21757,DISEASE,thyroid hormone-dependent metamorphosis,thyroid hormone-dependent metamorphosis
NEW21758,DISEASE,pituitary expression,pituitary expression
NEW21759,MENTAL_HEALTH,strong repression,strong repression
NEW21763,DISEASE,fxs model,FXS model
NEW21764,DISEASE,numerous behavioral deficit,numerous behavioral deficits
NEW21766,MENTAL_HEALTH,syndrome autism spectrum Disorders,Syndrome Autism Spectrum Disorders
NEW21768,DISEASE,csf psychiatric patient,CSF psychiatric patients
NEW21769,CHEMICAL,mild antidepressant response,mild antidepressant response
NEW21771,DISEASE,necrotic epidermal tissue,necrotic epidermal tissue
NEW21772,NUTRITION,sea urchin disease,sea urchin disease
NEW21774,CHEMICAL,meq sodium intake,mEq sodium intake
NEW21776,DISEASE,orthostasis procedure,orthostasis procedures
NEW21777,BIOCHEMICAL,oestrogen stimulation,oestrogen stimulation
NEW21781,DISEASE,white spot syndrome virus immediate early gene,white spot syndrome virus immediate early gene
NEW21782,CHEMICAL,beta-actin promoter,TbaP|beta-actin promoter
NEW21784,DISEASE,large carnivorous fish liver,large carnivorous fish liver
NEW21785,BIOCHEMICAL,vitamin supplement,vitamin supplements
NEW21787,DISEASE,asd study,ASD studies
NEW21791,MENTAL_HEALTH,curve % dna fragmentation,curve % DNA fragmentation
NEW21794,MENTAL_HEALTH,hyphae fragmentation,hyphae fragmentation
NEW21796,MENTAL_HEALTH,lps-induced autism model,LPS-induced autism model
NEW21798,DISEASE,different liver disease,different liver diseases
NEW21799,DISEASE,postnecrotic cirrhosis,postnecrotic cirrhosis
NEW21801,DISEASE,obesity-related metabolic disorder,obesity-related metabolic disorders
NEW21803,MENTAL_HEALTH,neonatal neurobehavioral depression,neonatal neurobehavioral depression
NEW21805,DISEASE,distal twitch glycolytic fog muscle,distal twitch glycolytic FOG muscle
NEW21807,DISEASE,twitch tension,twitch tension
NEW21808,CHEMICAL,carbon balance,carbon balance
NEW21810,DISEASE,cap patient,CAP patients
NEW21813,DISEASE,marked edema,marked edema
NEW21814,MENTAL_HEALTH,cellular dissociation,cellular dissociation
NEW21817,CHEMICAL,[3h]norepinephrine,[3H]norepinephrine
NEW21819,CHEMICAL,gamma-aminobutyric acid gaba transmission,gamma-aminobutyric acid GABA transmission
NEW21821,MENTAL_HEALTH,similar different regression,similar different regression
NEW21823,MENTAL_HEALTH,regression algorithm,regression algorithm
NEW21825,BIOCHEMICAL,drug market,drug market
NEW21827,MENTAL_HEALTH,toxic psychosis,toxic psychosis
NEW21831,MENTAL_HEALTH,suicide case,suicide cases
NEW21832,CHEMICAL,selenium (se)-polymer,selenium (Se)-polymer
http://purl.obolibrary.org/obo/CHEBI_26915,CHEMICAL,tetrahydronicotinamide adenine dinucleotide phosphate,tetrahydronicotinamide adenine dinucleotide phosphates|nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase activation
NEW21835,CHEMICAL,congenic fvb129 wild-type control,congenic FVB129 wild-type controls
NEW21838,DISEASE,rvo patient,RVO patients
NEW21841,CHEMICAL,significant erythrocyte mda,significant erythrocyte MDA
NEW21843,DISEASE,constant severe pain,constant severe pain
NEW21845,BIOCHEMICAL,testosterone extra-gonadal estrogen,testosterone extra-gonadal estrogens
NEW21846,CHEMICAL,letrozole treatment,letrozole treatment
NEW21848,DISEASE,p. damselae subsp,P. damselae subsp
NEW21850,MENTAL_HEALTH,affinity fixation,affinity fixation
NEW21851,CHEMICAL,magnetic chitosan microsphere,magnetic chitosan microspheres|MCS-NTA-Ni
NEW21853,CHEMICAL,tumor-overexpressed glutathione,tumor-overexpressed glutathione
http://purl.obolibrary.org/obo/SYMP_0019145,DISEASE,vomiting,stomachache|emesis
NEW21856,CHEMICAL,new disulfide bridge,new disulfide bridge
NEW21858,DISEASE,epileptic patient,epileptic patient
NEW21861,CHEMICAL,cd reduction,Cd reductions
NEW21864,CHEMICAL,h2o2 accumulation,H2O2 accumulation
NEW21866,CHEMICAL,cd oxidative damage,Cd oxidative damage
NEW21868,MENTAL_HEALTH,foliar resistance control agent,foliar resistance control agent
NEW21869,CHEMICAL,cd accumulation,Cd accumulation
NEW21870,CHEMICAL,cd toxicity,Cd toxicity
NEW21873,CHEMICAL,gaba mimetic drug,GABA mimetic drugs
NEW21876,MENTAL_HEALTH,kinase hsv-tk suicide gene,kinase HSV-tk suicide gene
NEW21877,CHEMICAL,herpes simplex virus thymidine kinase,herpes simplex virus thymidine kinase
NEW21879,DISEASE,trail‑resistant a549 lung cancer cell,TRAIL‑resistant A549 lung cancer cells
NEW21881,DISEASE,subsequent alcohol-drinking behavior,subsequent alcohol-drinking behaviors
NEW21883,DISEASE,abnormal low tsh level,abnormal low TSH level
NEW21885,DISEASE,neurogenic dural vasodilation,neurogenic dural vasodilation
NEW21887,CHEMICAL,l pigment,L pigments
NEW21888,NUTRITION,colored anthocyanin,colored anthocyanins
NEW21892,DISEASE,chronic severe malnutrition,chronic severe malnutrition
NEW21894,DISEASE,hypertension disease,hypertension disease
NEW21897,CHEMICAL,sv-chd,SV-CHD
NEW21899,MENTAL_HEALTH,recurrent priapism,recurrent priapism|stuttering
NEW21900,DISEASE,sickle-cell priapism,sickle-cell priapism
NEW21902,MENTAL_HEALTH,experimental stress anxiety derivative,experimental stress anxiety derivatives
NEW21904,CHEMICAL,injectable contraceptive norethisterone enanthate,NET-EN|injectable contraceptive norethisterone enanthate
NEW21905,DISEASE,autistic-like behaviour,autistic-like behaviour
NEW21906,DISEASE,variable behavioural impairment,variable behavioural impairments
NEW21907,DISEASE,subcortical neural mechanism,subcortical neural mechanisms
NEW21909,DISEASE,cocaine-induced leukoencephalopathy,cocaine-induced leukoencephalopathy
NEW21911,DISEASE,neuroanesthesia,neuroanesthesia
NEW21913,DISEASE,neuronal abnormality,neuronal abnormalities
NEW21914,CHEMICAL,lac preferential effect,LAC preferential effect
NEW21915,DISEASE,hyperactive behaviour,hyperactive behaviour
NEW21917,BIOCHEMICAL,acute sympathomimetic toxicity,acute sympathomimetic toxicity
NEW21920,MENTAL_HEALTH,high cyclic fatigue resistance,higher cyclic fatigue resistance
http://purl.obolibrary.org/obo/HP_0100035,DISEASE,phonic tics,coprolalia
NEW21921,DISEASE,motor phonic tic,motor phonic tics
NEW21923,CHEMICAL,carbon skeleton,carbon skeleton
NEW21926,DISEASE,migraine pain,migraine pain
NEW21931,DISEASE,eating-disordered patient,eating-disordered patients
NEW21933,MENTAL_HEALTH,electroacupuncture-induced analgesia,electroacupuncture-induced analgesia
NEW21937,MENTAL_HEALTH,antidepressant-resistant major depression,antidepressant-resistant major depression
http://purl.obolibrary.org/obo/SYMP_0000051,DISEASE,hydrocephalus,PHH|Posthemorrhagic hydrocephalus
NEW21940,CHEMICAL,co-substrate,co-substrate
NEW21942,DISEASE,obsessional thinking,obsessional thinking
NEW21944,CHEMICAL,ammonia ion,ammonia ion
http://purl.obolibrary.org/obo/CHEBI_67450,CHEMICAL,ananolignan m,"(5R,6S,7R,8R)-8-(isobutyryloxy)-1,2,3,13-tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-5-yl (2Z)-2-methylbut-2-enoate|M SCN-"
NEW21945,CHEMICAL,tris-citrate buffer,Tris-citrate buffer
NEW21948,CHEMICAL,f.c.how,F.C.How
NEW21950,DISEASE,atp1a3 gene,ATP1A3 gene
NEW21952,CHEMICAL,low hodes level,lower HODEs levels
NEW21955,CHEMICAL,mg./ml,mg./ml
NEW21956,DISEASE,drug-induced erection,drug-induced erections
NEW21958,CHEMICAL,δg efficiency,ΔG efficiency
NEW21960,DISEASE,systolic dysfunction,systolic dysfunction
NEW21963,DISEASE,importence,importence
NEW21965,DISEASE,nocturnal hypoglycemia,nocturnal hypoglycemia
NEW21968,DISEASE,psychogenic illness,psychogenic illness
NEW21971,DISEASE,resistant ocd,resistant OCD
NEW21975,DISEASE,septal deviation,SD|septal deviation
NEW21979,MENTAL_HEALTH,81297-induced acute oral dyskinesia,81297-induced acute oral dyskinesia
NEW21980,CHEMICAL,skf 81297-induced grooming,SKF 81297-induced grooming
NEW21982,CHEMICAL,ca2 current,Ca2 current
NEW21983,CHEMICAL,strong cd2 inhibition,strong Cd2 inhibition
NEW21985,DISEASE,ptsd group,PTSD group
NEW21987,CHEMICAL,naloxone distribution program,naloxone distribution programs
NEW21990,DISEASE,morphine-induced attention dysfunction,morphine-induced attention dysfunction
NEW21993,DISEASE,movement-evoked pain,movement-evoked pain
NEW21995,DISEASE,obstructive airway disease,obstructive airways diseases
NEW21998,CHEMICAL,(53.7±3.2)%,(53.7±3.2)%
NEW21999,CHEMICAL,(23.2±1.1)%,(23.2±1.1)%
NEW22000,CHEMICAL,276±4,276±4
NEW22004,CHEMICAL,mirtazapine treatment,mirtazapine treatment
NEW22006,NUTRITION,smooth bore weapon,smooth bore weapon
NEW22008,MENTAL_HEALTH,bacterial drug resistance,bacterial drug resistance
NEW22012,CHEMICAL,technical lignin,technical lignins
NEW22015,CHEMICAL,rhenium carbonyl complex,rhenium carbonyl complexes
NEW22016,DISEASE,pcos insulin resistance,PCOS insulin resistance
NEW22021,DISEASE,micronutrient deficiency,micronutrient deficiencies
NEW22023,DISEASE,obsessive compulsive spectrum,obsessive compulsive spectrum
NEW22025,DISEASE,depressive change,depressive change
NEW22027,DISEASE,human african trypanosomiasis,human African trypanosomiasis
NEW22029,DISEASE,underlie autoimmune encephalopathy,underlying autoimmune encephalopathy
NEW22030,DISEASE,newborn withdrawal syndrome,newborn withdrawal syndrome
NEW22034,BIOCHEMICAL,fxr agonist potency,FXR agonist potency
NEW22035,MENTAL_HEALTH,optimal orientation,optimal orientation
NEW22037,MENTAL_HEALTH,vigilance mood disorder,vigilance mood disorders
NEW22041,MENTAL_HEALTH,smv resistance germplasm,SMV resistance germplasm
NEW22043,MENTAL_HEALTH,reserpine-induced akinesia,reserpine-induced akinesia
NEW22045,BIOCHEMICAL,narcotic dissolution,narcotic dissolution
NEW22051,CHEMICAL,ayurvedic syrup shankhapushpi,Ayurvedic syrup shankhapushpi
NEW22052,DISEASE,hypertension xaio chai hu tang,hypertension xaio chai hu tang
NEW22054,CHEMICAL,3'-alkyl aba,3'-alkyl ABAs
NEW22056,DISEASE,postmenopausal syndrome,postmenopausal syndrome
NEW22058,DISEASE,uvb-induced damage,UVB-induced damage
NEW22060,DISEASE,primary structural brain disease,primary structural brain disease
NEW22061,DISEASE,global cerebral dysfunction,global cerebral dysfunction
NEW22062,DISEASE,high ptsd prevalence,higher PTSD prevalence
NEW22064,BIOCHEMICAL,female c allele carrier,female C allele carriers
NEW22065,CHEMICAL,cc homozygote,CC homozygotes
NEW22067,CHEMICAL,female cc homozygote,female CC homozygotes
NEW22068,DISEASE,high tg,higher TG
NEW22070,MENTAL_HEALTH,adaptability resistance,adaptability resistance
NEW22071,CHEMICAL,bt product,Bt products
NEW22073,MENTAL_HEALTH,pediatric enuresis,pediatric enuresis
NEW22076,DISEASE,syndrome allergy,syndrome allergies
NEW22083,BIOCHEMICAL,fetal hormone system,fetal hormone systems
NEW22085,BIOCHEMICAL,pharmaceutical market,pharmaceutical market
NEW22088,NUTRITION,tree pollen,tree pollen
NEW22090,DISEASE,life failure,life failure
NEW22091,DISEASE,apoptotic neuronal death,apoptotic neuronal death
NEW22094,DISEASE,example atherosclerosis,example atherosclerosis
NEW22096,CHEMICAL,ica bifurcation,ICA bifurcation
NEW22097,MENTAL_HEALTH,depression group,depression groups
NEW22099,MENTAL_HEALTH,geriatric depression,geriatric depression
NEW22100,DISEASE,certain depressive subtype,certain depressive subtypes
NEW22103,MENTAL_HEALTH,leaf rust resistance,leaf rust resistance
NEW22105,NUTRITION,durum wheat genotype,durum wheat genotype
NEW22107,NUTRITION,wheat breeding,wheat breeding
http://purl.obolibrary.org/obo/MFOMD_0000129,MENTAL_HEALTH,fixation,CoR. Fixation
NEW22110,CHEMICAL,iolg,IolG
NEW22112,MENTAL_HEALTH,Health Anxiety Group,Health Anxiety Group
NEW22113,DISEASE,infection Obsessions Group,Infection Obsessions Group
NEW22115,DISEASE,habitually violent antisocial male alcoholic offender,habitually violent antisocial male alcoholic offenders
NEW22117,CHEMICAL,sideropaenia,sideropaenia
NEW22120,CHEMICAL,altered dopamine concentration,altered dopamine concentrations
NEW22124,DISEASE,mdd relief,MDD relief
NEW22126,CHEMICAL,neurotransmitter glutamate,neurotransmitter glutamate
NEW22127,MENTAL_HEALTH,opioid resistance due,opioid resistance due
NEW22131,BIOCHEMICAL,know nephrotoxin,known nephrotoxin
NEW22132,MENTAL_HEALTH,disorder syndrome related,disorder syndrome related
NEW22134,BIOCHEMICAL,in antimicrobial activity,in antimicrobial activities
NEW22135,DISEASE,a. hydrophila,A. hydrophila
NEW22136,CHEMICAL,serotonin uptake inhibitor fluoxetine,serotonin uptake inhibitor fluoxetine
NEW22138,CHEMICAL,biosynthetic precursor fasamycin,biosynthetic precursors fasamycins
NEW22139,CHEMICAL,formicamycin,formicamycins
NEW22140,BIOCHEMICAL,type polyketide antibiotic,type polyketide antibiotics
NEW22142,CHEMICAL,5-hydroxytriptamine deficiency,5-hydroxytriptamine deficiency
NEW22143,DISEASE,concomitant memory impairment,concomitant memory impairment
NEW22144,DISEASE,spine loss,spine loss
NEW22145,DISEASE,inflammation-related brain disorder,inflammation-related brain disorders
NEW22147,DISEASE,relapsed hematologic malignancy,relapsed hematologic malignancies
NEW22149,DISEASE,amygdala-kindled seizure,amygdala-kindled seizures
NEW22151,DISEASE,anxio-depressive symptom,anxio-depressive symptoms
NEW22153,DISEASE,depressive clinical manifestation,depressive clinical manifestations
NEW22154,CHEMICAL,long-term mph treatment,long-term MPH treatment
NEW22158,MENTAL_HEALTH,impotence infertility,impotence infertility
NEW22159,BIOCHEMICAL,kidney-tonifying drug,kidney-tonifying drug
NEW22161,DISEASE,diabetic model group,diabetic model group
NEW22163,CHEMICAL,equilibrative nucleoside transporter,equilibrative nucleoside transporters
NEW22165,DISEASE,liver ischemia,liver ischemia
NEW22166,CHEMICAL,hepatic adenosine level,hepatic adenosine levels
NEW22169,DISEASE,febrile disease,febrile disease
NEW22170,DISEASE,consumptive disease,consumptive disease
NEW22171,DISEASE,thoracic obstruction,thoracic obstruction
NEW22172,DISEASE,bellyache due spleen qi deficiency,bellyache due spleen Qi deficiency
NEW22173,BIOCHEMICAL,yin-yang toxin syndrome,Yin-Yang toxin syndrome
NEW22177,CHEMICAL,antidepressant non-responder,antidepressant non-responders
NEW22180,BIOCHEMICAL,antibiotic residue,antibiotic residues
NEW22183,DISEASE,aortic inflammation,aortic inflammation
NEW22185,DISEASE,ethanol-induced steatohepatitis,ethanol-induced steatohepatitis
NEW22188,MENTAL_HEALTH,scopolamine (sco)-induced amnesia,scopolamine (Sco)-induced amnesia
NEW22189,NUTRITION,anthocyanin biosynthetic gene,anthocyanin biosynthetic genes
NEW22190,CHEMICAL,anthocyanin lignin content,anthocyanin lignin content
NEW22193,MENTAL_HEALTH,local infiltration analgesia,local infiltration analgesia
NEW22195,CHEMICAL,individual naa,individual NAA
NEW22196,CHEMICAL,acid brain uptake,acids brain uptake
NEW22198,CHEMICAL,hg level,Hg levels
NEW22200,DISEASE,dlb abnormality,DLB abnormalities
NEW22201,DISEASE,marked olfactory loss,marked olfactory loss
NEW22203,CHEMICAL,enr concentration,ENR concentration
NEW22205,DISEASE,bone marrow depression,bone marrow depression
http://purl.obolibrary.org/obo/DOID_1556,DISEASE,arthus reaction,Arthus phenomenon|hypersensitivity reaction|Arthus reaction|Arthus type urticaria|Arthus Phenomenon
NEW22207,CHEMICAL,co-trimoxazole toxicity,co-trimoxazole toxicity
NEW22209,MENTAL_HEALTH,hand depression,hand depression
NEW22210,CHEMICAL,pge2 synthesis,PGE2 synthesis
NEW22212,CHEMICAL,30.1+/-5.4,30.1+/-5.4
NEW22213,DISEASE,addition migraine,addition migraine
NEW22216,BIOCHEMICAL,endogenous estrogen,endogenous estrogens
NEW22218,DISEASE,manic- behavior,manic- behaviors
http://purl.org/sig/ont/fma/fma50583,DISEASE,posterior cerebral artery,posterior cerebral artery injury
NEW22222,DISEASE,cardiovascular disease due,cardiovascular disease due
NEW22224,CHEMICAL,elevated testosterone level,elevated testosterone levels
http://purl.org/sig/ont/fma/fma14342,DISEASE,right ovarian vein,right ovarian vein
NEW22226,CHEMICAL,hexobarbitone sleep time,hexobarbitone sleep time
NEW22227,MENTAL_HEALTH,cns depression,CNS depression
NEW22229,MENTAL_HEALTH,open circuit potential difference,open circuit potential difference|OCPD
NEW22231,DISEASE,anti-gastric ulcer,anti-gastric ulcer
NEW22232,DISEASE,anti-hyperlipidemia,anti-hyperlipidemia
http://purl.obolibrary.org/obo/CHEBI_73336,DISEASE,vulnerary,wound-healing drug|wound-healing agent|vulneraries|wound-healing agents|wound-healing drugs|anti-hyperglycemia
NEW13440,CHEMICAL,selective serotonin re-uptake inhibitor,selective serotonin re-uptake inhibitor
NEW22240,DISEASE,organ damage,organ damage
NEW22242,BIOCHEMICAL,Food Drug Administration,Food Drug Administration
NEW22244,DISEASE,multiple cancer cell,multiple cancer cells
NEW22246,CHEMICAL,400mm,400mM
NEW22247,CHEMICAL,increase chronic cortisol exposure,increased chronic cortisol exposure
NEW22250,DISEASE,neuromuscular nature,neuromuscular nature
http://purl.obolibrary.org/obo/CHEBI_35820,BIOCHEMICAL,antiprotozoal drug,antiprotozoal agent|antiprotozoal drugs|antiprotozoal agents
NEW22254,NUTRITION,hybrid yellow catfish,hybrid yellow catfish
NEW22257,DISEASE,blunt trunk injury,blunt trunk injury
NEW22258,CHEMICAL,xylene oxide component,xylene oxide components
NEW22259,NUTRITION,cholesterol serum concentration,cholesterol serum concentrations
NEW22261,CHEMICAL,low esterify cholesterol ratio,lower esterified cholesterol ratio
NEW22263,BIOCHEMICAL,thromboxane-receptor antagonist,thromboxane-receptor antagonist
NEW22264,BIOCHEMICAL,platelet-activating factor-receptor antagonist,platelet-activating factor-receptor antagonist
NEW22267,MENTAL_HEALTH,anhedonia detailed deconstruction,anhedonia detailed deconstruction
NEW22268,BIOCHEMICAL,stabilizer antipsychotic treatment,stabilizer antipsychotic treatment
NEW22271,CHEMICAL,high-maltose synthetic medium,high-maltose synthetic medium
NEW22273,CHEMICAL,% v/v ethanol lager beer,% v/v ethanol lager beer
NEW22275,CHEMICAL,alcoholic beer,alcoholic beer
NEW22276,MENTAL_HEALTH,low thermal resistance,lower thermal resistance
NEW22278,CHEMICAL,lactulose hydrogen breath test,lactulose hydrogen breath test
NEW22279,MENTAL_HEALTH,dramatic tumor regression,dramatic tumor regression
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Speech_Anxiety,MENTAL_HEALTH,speech anxiety,speech anxiety
NEW22283,NUTRITION,chicory intybus 1-feh iia,chicory intybus 1-FEH IIa
http://purl.obolibrary.org/obo/DOID_9975,CHEMICAL,cocaine dependence,methamphetamine dependence
NEW22285,MENTAL_HEALTH,cortical dementia syndrome,cortical dementia syndromes
NEW22287,CHEMICAL,potassium concentration,potassium concentration
NEW22293,CHEMICAL,time-based PM task,TBPM|time-based PM tasks
NEW22295,DISEASE,hyperadrenergic symptom,hyperadrenergic symptoms
NEW22297,BIOCHEMICAL,antileishmanial drug target,antileishmanial drug target
NEW22300,MENTAL_HEALTH,orientation similar,orientation similar
NEW22302,CHEMICAL,2'-terminal purine,2'-terminal purines
NEW22304,DISEASE,age-onset cognitive deficit,age-onset cognitive deficits
NEW22306,CHEMICAL,altered membrane pufa content,altered membrane PUFA content
NEW22309,DISEASE,chemotherapy-induced emesis,chemotherapy-induced emesis
NEW22311,DISEASE,pain reliever,pain relievers
NEW22313,DISEASE,hypoxia protocol,hypoxia protocol
NEW22314,DISEASE,hypomanic symptom,hypomanic symptoms
NEW22316,DISEASE,p. maculicauda,P. maculicauda
NEW22321,CHEMICAL,itraconazole pulse therapy,itraconazole pulse therapy
NEW22324,DISEASE,acute heart failure,AHF|acute heart failure
NEW22326,MENTAL_HEALTH,presynaptic n-methyl-d-aspartate receptor hyperactivity,presynaptic N-methyl-D-aspartate receptor hyperactivity
NEW22329,CHEMICAL,serum selenium,serum selenium
NEW22331,DISEASE,ghb-deficiency-related dysphoric syndrome,GHB-deficiency-related dysphoric syndrome
NEW22333,MENTAL_HEALTH,subsequent regression analysis,subsequent regression analyses
NEW22335,CHEMICAL,circulate glycerolipid,circulating glycerolipids
NEW22341,NUTRITION,altered membrane phospholipid metabolism,altered membrane phospholipid metabolism
http://ontology.apa.org/apaonto/termsonlyOUT%20(5).owl#Panic_Attack,DISEASE,panic attack,anxiety panic attacks
NEW22343,CHEMICAL,oral prednisolone,oral prednisolone
NEW22344,DISEASE,ethanol-induced toxicity,ethanol-induced toxicity
NEW22346,DISEASE,hypoxia condition,hypoxia conditions
NEW22348,CHEMICAL,purine metabolic disorder,purine metabolic disorder
NEW22350,CHEMICAL,hypocretin ligand-hypocretin receptor pathway,hypocretin ligand-hypocretin receptor pathway
NEW22353,DISEASE,suspect humoral immunodeficiency,suspected humoral immunodeficiencies
NEW22354,DISEASE,bacterial nematode,bacterial nematodes
http://purl.obolibrary.org/obo/CHEBI_132281,DISEASE,4-methyltridecane,4-methyltridecane|resistance/tolerance
NEW22355,DISEASE,old depressed patient,older depressed patients
NEW22358,DISEASE,vascular remodelling,vascular remodelling
NEW22359,CHEMICAL,endogenous prostacyclin inhibition,endogenous prostacyclin inhibition
NEW22362,CHEMICAL,gtpɣs binding,GTPɣS binding
NEW22364,BIOCHEMICAL,mor agonist effect,MOR agonist effects
NEW22366,BIOCHEMICAL,mor agonist efficacy,MOR agonist efficacy
NEW22368,BIOCHEMICAL,high drug safety,high drug safety
NEW22372,DISEASE,more dizziness,more dizziness
NEW22373,CHEMICAL,40-mg group,40-mg group
NEW22374,DISEASE,more nausea,more nausea
NEW22376,CHEMICAL,cefazolin g,cefazolin g
NEW22377,CHEMICAL,g q12h,g q12h
NEW22379,DISEASE,cancer type,cancer types
NEW22381,DISEASE,gastrointestinal reflux disease,gastrointestinal reflux disease
NEW22386,DISEASE,cold damage,cold damage
NEW22388,MENTAL_HEALTH,dual resistance specificity,dual resistance specificity
NEW22390,DISEASE,colonic hyperpermeability,colonic hyperpermeability
NEW22392,DISEASE,intestinal hyperpermeability,intestinal hyperpermeability
NEW22394,DISEASE,stz-induced memory impairment,STZ-induced memory impairment
NEW22396,BIOCHEMICAL,low-dose niacin,low-dose niacin
NEW22398,DISEASE,chronic skin infection,chronic skin infections
NEW22399,CHEMICAL,acidergic neurosteroid,acidergic neurosteroid
NEW22400,CHEMICAL,cerebral oxygen metabolism,cerebral oxygen metabolism
NEW22401,CHEMICAL,l fenfluramine,FEN|l fenfluramine
NEW22403,CHEMICAL,blood Sec,blood Sec
NEW22405,CHEMICAL,se metabolite,Se metabolites
NEW22406,DISEASE,liver semet ratio,liver SeMet ratios
NEW22410,CHEMICAL,HR=0.201,HR=0.201
NEW22413,DISEASE,biliary excretion disorder,biliary excretion disorders
NEW22414,MENTAL_HEALTH,subsequent insomnia symptom,subsequent insomnia symptoms
NEW22416,DISEASE,rtt mouse model,RTT mouse model
NEW22418,CHEMICAL,cortex mitochondrial atp content,cortex mitochondrial ATP content
NEW22419,DISEASE,seizure phenotype,seizure phenotype
NEW22421,CHEMICAL,new generation antidepressant,newer generation antidepressants
NEW22422,CHEMICAL,well-recognized antidepressant drug,well-recognized antidepressant drugs
NEW22424,MENTAL_HEALTH,central analgesia,central analgesia
NEW04976,DISEASE,psychiatric practice,psychiatric practice
NEW22429,DISEASE,iatrogenic dyskinesia,iatrogenic dyskinesias
NEW22431,DISEASE,increase tumor t cell infiltrate,increased tumor T cell infiltrates
NEW22432,BIOCHEMICAL,vegf receptor inhibitor SUGEN,VEGF receptor inhibitor SUGEN
NEW22435,DISEASE,ocular allergic reaction,ocular allergic reactions
NEW22436,DISEASE,glaucoma patient,glaucoma patients
NEW22439,MENTAL_HEALTH,nitrogen fixation process,nitrogen fixation processes
NEW22442,DISEASE,vertebrate neuronal somatic cell hybrid tcx11,vertebrate neuronal somatic cell hybrid TCX11
NEW22444,MENTAL_HEALTH,narcolepsy excessive daytime sleepiness,narcolepsy excessive daytime sleepiness
NEW22445,NUTRITION,choline present,choline present
NEW22446,DISEASE,ischemia-induced cell death,ischemia-induced cell death
NEW22448,DISEASE,acute health effect,acute health effects
NEW22450,DISEASE,spontaneous locomotor behavior,spontaneous locomotor behaviors
NEW22453,MENTAL_HEALTH,ans displacement assay,ANS displacement assay
NEW22454,BIOCHEMICAL,cough mixture use,cough mixture use
NEW22460,DISEASE,parkinsonian brain,parkinsonian brains
NEW22462,CHEMICAL,atp hydrolysis,ATP hydrolysis
NEW22464,DISEASE,abnormal gut microbiota,abnormal gut microbiota
NEW22466,DISEASE,cognitive impaired mouse,cognitive impaired mice
NEW22468,DISEASE,mild traumatic brain injury model,mild traumatic brain injury model
NEW22469,DISEASE,mild cognitive impairment model mouse,mild cognitive impairment model mice
NEW22471,CHEMICAL,low sucrose consumption,lower sucrose consumption
NEW22473,CHEMICAL,dibenzoyl-atp,Bz-ATP|dibenzoyl-ATP
NEW22474,DISEASE,pain model,pain models
NEW22477,CHEMICAL,fine-tuning flavonoid synthesis,fine-tuning flavonoids synthesis
NEW22478,NUTRITION,ammonia b2:0.4 g potassium dihydrogen phosphate,ammonia B2:0.4 g potassium dihydrogen phosphate
NEW22479,CHEMICAL,g potassium chloride,g potassium chloride
NEW22480,NUTRITION,g urea b3:0.4 g potassium dihydrogen phosphate,g urea B3:0.4 g potassium dihydrogen phosphate
C540010,DISEASE,biochar [Supplementary Concept],Charcoal|biochar
NEW22485,BIOCHEMICAL,antifungal treatment,antifungal treatments
NEW22486,MENTAL_HEALTH,profound dementia,profound dementia
NEW22488,BIOCHEMICAL,partial opiate agonist tramadol,partial opiate agonist tramadol
http://purl.obolibrary.org/obo/CHEBI_134728,CHEMICAL,mebanazine,ICI-31397|actomol|mebanazine monohydrochloride|mebanazine sulfate|mebanazine oxalate|desimipramine|mebanazine monooxalate|mebanazine monosulfate|mebanazine hydrochloride
NEW22490,DISEASE,spontaneous epileptic activity,spontaneous epileptic activity
NEW22492,DISEASE,receptor-mediated hyperexcitability,receptor-mediated hyperexcitability
NEW22493,CHEMICAL,defective histamine metabolism,defective histamine metabolism
NEW22496,BIOCHEMICAL,novel antibacterial agent,novel antibacterial agents
NEW22497,BIOCHEMICAL,obvious endocrine disturbance,obvious endocrine disturbances
NEW22498,CHEMICAL,midnight serum cortisol concentration,midnight serum cortisol concentrations
C536148,DISEASE,Meier Blumberg Imahorn syndrome [Supplementary Concept],Oculocerebrorenal Syndrome|idiopathic hypercalciuria|Calcium Metabolism Disorders
C431914,DISEASE,"SstT protein, Porphyromonas gingivalis [Supplementary Concept]","P. gingivalis|Amino Acid Transport Systems, Neutral|Bacterial Proteins"
NEW22503,DISEASE,chronic combat-related nightmare,chronic combat-related nightmares
NEW22505,DISEASE,hypercholesterolemia disease,hypercholesterolemia disease
NEW22506,MENTAL_HEALTH,mixed regression model,mixed regression model
D009999,DISEASE,"Ossification, Heterotopic","Ossification, Pathologic|Pathological Ossification|heterotopic ossification|Ossification, Ectopic|Ectopic Ossification|Ossification, Pathological|Heterotopic Ossification|Pathologic Ossification"
NEW22510,DISEASE,low-grade chondrosarcoma,low-grade chondrosarcomas
NEW22512,DISEASE,environmental enteric disorder,environmental enteric disorder
NEW22514,DISEASE,epithelial injury,epithelial injuries
NEW22515,DISEASE,primary trimethylaminuria,primary trimethylaminuria
NEW22517,CHEMICAL,acetaminophen metabolite,acetaminophen metabolite
NEW22519,MENTAL_HEALTH,cannabinoid-mediated analgesia,cannabinoid-mediated analgesia
NEW22522,DISEASE,severe anaphylactic reaction,severe anaphylactic reactions
NEW22525,MENTAL_HEALTH,schizophrenia pathogenesis,schizophrenia pathogenesis
NEW22526,DISEASE,paediatric psychiatric patient,paediatric psychiatric patients
NEW22529,CHEMICAL,mev. loss,meV. loss
NEW22534,MENTAL_HEALTH,cannabinoid-induced anxiety,cannabinoid-induced anxiety
NEW22536,CHEMICAL,midbrain da system,midbrain DA system
NEW22538,CHEMICAL,non-echinocandin,non-echinocandins
D054970,DISEASE,Pure Autonomic Failure,"Syndrome, Bradbury-Eggleston|Bradbury Eggleston Syndrome|autonomic failure|Autonomic Failure, Pure|Bradbury-Eggleston Syndrome"
http://purl.obolibrary.org/obo/DOID_0080855,DISEASE,parkinsonism,levodopa-unresponsive parkinsonism
NEW22540,DISEASE,neurodegeneration formation,neurodegeneration formation
NEW22543,DISEASE,specific learning disability,specific learning disabilities
NEW22546,DISEASE,hippocampal neuronal degeneration,hippocampal neuronal degeneration
D007022,DISEASE,hyper- or hypotension,hyper- or hypotension
D006973,DISEASE,hyper- or hypotension,hyper- or hypotension
D009325,DISEASE,nausea,nausea
D009203,DISEASE,myocardial infarction,myocardial infarction
D002037,DISEASE,bundle branch block,bundle branch block
D004421,DISEASE,tardive dystonia,tardive dystonia
D012164,DISEASE,pigmentary retinal deposits,pigmentary retinal deposits
D014786,DISEASE,audiovisual toxicity,audiovisual toxicity
D006319,DISEASE,neurosensorial hearing loss,neurosensorial hearing loss
D009157,DISEASE,Myasthenia gravis,Myasthenia gravis
D003556,DISEASE,HC,HC
D006470,DISEASE,HC,HC
D016534,DISEASE,increase in heart rate and cardiac output,increase in heart rate and cardiac output
D007681,DISEASE,renal papillary necrosis,renal papillary necrosis
D007680,DISEASE,renal cancer,renal cancer
D000743,DISEASE,hemolytic anemia,hemolytic anemia
D005355,DISEASE,fibrous myopathy,fibrous myopathy
D009135,DISEASE,fibrous myopathy,fibrous myopathy
D020425,DISEASE,neuropathy of the radial nerve,neuropathy of the radial nerve
D009408,DISEASE,compression neuropathy,compression neuropathy
D010490,DISEASE,haemopericardium,haemopericardium
D009468,DISEASE,neuromuscular disease,neuromuscular disease
D010996,DISEASE,pleural effusions,pleural effusions
D001201,DISEASE,ascites,ascites
D011660,DISEASE,cor pulmonale,cor pulmonale
D014987,DISEASE,dry mouth,dry mouth
D010911,DISEASE,adenohypophyseal tumors,adenohypophyseal tumors
D003638,DISEASE,deafness,deafness
D005921,DISEASE,glomerulosclerosis,glomerulosclerosis
D007674,DISEASE,nephropathy,nephropathy
D000799,DISEASE,Angioedema,Angioedema
D001176,DISEASE,arthrogryposis,arthrogryposis
D002543,DISEASE,cranial hemorrhage,cranial hemorrhage
D013927,DISEASE,HITT,HITT
D013921,DISEASE,HITT,HITT
D009503,DISEASE,neutropenia,neutropenia
D061205,DISEASE,artery calcification,artery calcification
D001745,DISEASE,bladder damage,bladder damage
D009202,DISEASE,myocardial injury,myocardial injury
D007565,DISEASE,jaundice,jaundice
D002779,DISEASE,cholestasis,cholestasis
D020326,DISEASE,migraineurs (without aura),migraineurs (without aura)
D003323,DISEASE,Coronary aneurysm,Coronary aneurysm
D010409,DISEASE,penile erection,penile erection
D055154,DISEASE,dysphonia,dysphonia
D005221,DISEASE,tiredness,tiredness
D001259,DISEASE,ataxia,ataxia
D014826,DISEASE,vocal fold palsy,vocal fold palsy
D012170,DISEASE,retinal vein occlusion,retinal vein occlusion
D009759,DISEASE,nystagmus,nystagmus
D006471,DISEASE,gastric hemorrhagic,gastric hemorrhagic
D014456,DISEASE,ulcers,ulcers
D016063,DISEASE,intraoperative bleeding,intraoperative bleeding
D019106,DISEASE,postoperative bleeding,postoperative bleeding
D002493,DISEASE,Central nervous system complications,Central nervous system complications
D013280,DISEASE,stomatitis,stomatitis
D014839,DISEASE,vomiting,vomiting
D003967,DISEASE,diarrhea,diarrhea
D013345,DISEASE,subarachnoid hemorrhage,subarachnoid hemorrhage
D013035,DISEASE,spasm,spasm
D012848,DISEASE,sinoatrial block,sinoatrial block
D003025,DISEASE,talipes equinovarus,talipes equinovarus
D001017,DISEASE,coarctation of the aorta,coarctation of the aorta
D006345,DISEASE,ventricular septal defect,ventricular septal defect
D007690,DISEASE,Potter-type IIa polycystic kidney,Potter-type IIa polycystic kidney
D006504,DISEASE,Veno-occlusive liver disease,Veno-occlusive liver disease
D001855,DISEASE,myelosuppression,myelosuppression
D003128,DISEASE,coma,coma
D004892,DISEASE,Erythema multiforme,Erythema multiforme
D004342,DISEASE,allergic reactions,allergic reactions
D000707,DISEASE,anaphylaxis,anaphylaxis
D010243,DISEASE,paralysis,paralysis
D001049,DISEASE,desaturation,desaturation
D014549,DISEASE,incontinence,incontinence
D009410,DISEASE,neuronal death,neuronal death
D000740,DISEASE,anemia,anemia
D002311,DISEASE,dilated cardiomyopathy,dilated cardiomyopathy
D001660,DISEASE,biliary pseudolithiasis,biliary pseudolithiasis
D011128,DISEASE,Cauda equina syndrome,Cauda equina syndrome
D009336,DISEASE,necrosis,necrosis
D034381,DISEASE,hearing loss,hearing loss
D013923,DISEASE,thromboembolic,thromboembolic
D001763,DISEASE,ptosis on the right upper lid,ptosis on the right upper lid
D015835,DISEASE,restricted right eye movement,restricted right eye movement
D002303,DISEASE,decreased cardiac output,decreased cardiac output
D002534,DISEASE,reduces frontal lobe oxygenation,reduces frontal lobe oxygenation
D060845,DISEASE,hoarding,hoarding
D012817,DISEASE,gastrointestinal symptoms,gastrointestinal symptoms
D001068,DISEASE,decreased appetite,decreased appetite
D006940,DISEASE,venous congestion,venous congestion
D000787,DISEASE,Angina,Angina
D006316,DISEASE,"abnormal audiograms with deficits mostly in the high frequency range of 4,000 to 8,000 Hz","abnormal audiograms with deficits mostly in the high frequency range of 4,000 to 8,000 Hz"
D006261,DISEASE,headache,headache
D013118,DISEASE,cord damage,cord damage
D004437,DISEASE,Ebstein's anomaly,Ebstein's anomaly
D031300,DISEASE,retinal vasculitis,retinal vasculitis
D003704,DISEASE,dementia,dementia
D014625,DISEASE,adenocarcinoma of the vagina,adenocarcinoma of the vagina
D018262,DISEASE,clear cell adenocarcinoma,clear cell adenocarcinoma
D003919,DISEASE,diabetes insipidus,diabetes insipidus
D004775,DISEASE,enuresis,enuresis
D041881,DISEASE,acute cholecystitis,acute cholecystitis
D007511,DISEASE,ischemia,ischemia
D013611,DISEASE,atrioventricular reentrant tachycardia,atrioventricular reentrant tachycardia
D012678,DISEASE,loss of pinprick sensation,loss of pinprick sensation
D006976,DISEASE,primary pulmonary hypertension,primary pulmonary hypertension
D013610,DISEASE,tachy- or bradycardia,tachy- or bradycardia
D057049,DISEASE,thrombotic microangiopathy,thrombotic microangiopathy
D001002,DISEASE,anuria,anuria
D008171,DISEASE,lung toxicity,lung toxicity
D005128,DISEASE,visual field defects,visual field defects
D006406,DISEASE,hematoma,hematoma
D020293,DISEASE,cerebral vasculitis,cerebral vasculitis
D006509,DISEASE,hepatitis B virus (HBV) infected,hepatitis B virus (HBV) infected
D009422,DISEASE,neuropathy,neuropathy
D020968,DISEASE,brachial neuritis,brachial neuritis
D001022,DISEASE,aortic regurgitation,aortic regurgitation
D008944,DISEASE,mitral regurgitation,mitral regurgitation
D000160,DISEASE,adverse effect on the proximal eighth nerve,adverse effect on the proximal eighth nerve
D006949,DISEASE,hyperlipidemia,hyperlipidemia
D009401,DISEASE,nephrosis,nephrosis
D008113,DISEASE,liver tumors,liver tumors
D006394,DISEASE,Angiosarcoma,Angiosarcoma
D003731,DISEASE,caries,caries
D005334,DISEASE,hyperthermia,hyperthermia
D000860,DISEASE,hypoxia,hypoxia
D005483,DISEASE,flushing of the face,flushing of the face
D004417,DISEASE,dyspnea,dyspnea
D007035,DISEASE,hypothermia,hypothermia
D006456,DISEASE,hemoglobinuria,hemoglobinuria
D009212,DISEASE,Myoglobinuria,Myoglobinuria
D017180,DISEASE,ventricular tachycardia,ventricular tachycardia
D011693,DISEASE,petechiae,petechiae
D003161,DISEASE,compartment syndrome,compartment syndrome
D001650,DISEASE,Bile duct hamartoma,Bile duct hamartoma
D006222,DISEASE,hamartoma,hamartoma
D006099,DISEASE,granulomas,granulomas
D017542,DISEASE,ruptured aneurysms,ruptured aneurysms
D004832,DISEASE,absence seizures,absence seizures
D011230,DISEASE,initiation induced by carcinogens,initiation induced by carcinogens
D010291,DISEASE,transient hemiparesis,transient hemiparesis
D052016,DISEASE,mucositis,mucositis
D003873,DISEASE,erythroderma,erythroderma
D007955,DISEASE,leukemoid reaction,leukemoid reaction
D017093,DISEASE,hepatic failure,hepatic failure
D015814,DISEASE,ocular hypotensive,ocular hypotensive
D004774,DISEASE,entropion,entropion
D003316,DISEASE,corneal abrasion,corneal abrasion
D003229,DISEASE,Conjunctival blanching,Conjunctival blanching
D014581,DISEASE,urticaria,urticaria
D003231,DISEASE,conjunctivitis,conjunctivitis
D010195,DISEASE,pancreatitis,pancreatitis
D003244,DISEASE,impaired consciousness,impaired consciousness
D018879,DISEASE,premature ventricular contractions,premature ventricular contractions
D004487,DISEASE,swelling,swelling
D009896,DISEASE,optic atrophy,optic atrophy
D001018,DISEASE,angiopathy,angiopathy
D006548,DISEASE,diaphragmatic hernia,diaphragmatic hernia
D018636,DISEASE,hypoplastic left heart syndrome,hypoplastic left heart syndrome
D017880,DISEASE,transverse limb deficiency,transverse limb deficiency
D006344,DISEASE,atrial septal defects,atrial septal defects
D002972,DISEASE,cleft palate,cleft palate
D000853,DISEASE,anophthalmia,anophthalmia
D000014,DISEASE,birth defects,birth defects
D002754,DISEASE,choanal atresia,choanal atresia
D008850,DISEASE,microphthalmos,microphthalmos
D000757,DISEASE,anencephaly,anencephaly
D002277,DISEASE,carcinoma,carcinoma
D000855,DISEASE,anorexia,anorexia
D010689,DISEASE,phlebitis,phlebitis
D010211,DISEASE,papilledema,papilledema
D012163,DISEASE,retinal detachment,retinal detachment
D058447,DISEASE,ocular pain,ocular pain
D009916,DISEASE,orbital toxicity,orbital toxicity
D007239,DISEASE,infection,infection
D006932,DISEASE,hyperbilirubinemia,hyperbilirubinemia
D002653,DISEASE,behavioral disorder,behavioral disorder
D004802,DISEASE,eosinophilia,eosinophilia
D008180,DISEASE,lupus erythematosus,lupus erythematosus
D020447,DISEASE,parasomnias,parasomnias
D053608,DISEASE,stuporous,stuporous
D003490,DISEASE,cyanosis,cyanosis
D006311,DISEASE,audiovisual toxicity,audiovisual toxicity
D020428,DISEASE,femoral nerve palsy,femoral nerve palsy
D007683,DISEASE,acute tubular necrosis,acute tubular necrosis
D005317,DISEASE,intrauterine growth retardation,intrauterine growth retardation
D009139,DISEASE,increase of external and skeletal variations,increase of external and skeletal variations
D020141,DISEASE,impaired blood clotting,impaired blood clotting
D004827,DISEASE,epileptic,epileptic
D054138,DISEASE,Sinus arrest,Sinus arrest
D009133,DISEASE,muscle wastage,muscle wastage
D012140,DISEASE,respiratory upset,respiratory upset
D017682,DISEASE,myocardial stunning,myocardial stunning
D006528,DISEASE,hepatocellular carcinomas,hepatocellular carcinomas
D012798,DISEASE,hypersalivation,hypersalivation
D011697,DISEASE,thrombotic thrombocytopenic purpura,thrombotic thrombocytopenic purpura
D006402,DISEASE,hematotoxicity,hematotoxicity
D008206,DISEASE,lymphadenopathy,lymphadenopathy
D018805,DISEASE,sepsis,sepsis
D009393,DISEASE,nephritis,nephritis
D003872,DISEASE,dermatitis,dermatitis
D012769,DISEASE,shock,shock
D006417,DISEASE,hematuria,hematuria
D010493,DISEASE,pericarditis,pericarditis
D009400,DISEASE,nephrosclerosis,nephrosclerosis
D014717,DISEASE,vertigo,vertigo
D006965,DISEASE,hyperplasia,hyperplasia
D020225,DISEASE,sagittal sinus thrombosis,sagittal sinus thrombosis
D020518,DISEASE,focal nodular hyperplasia,focal nodular hyperplasia
D000236,DISEASE,adenoma,adenoma
D001157,DISEASE,arterial occlusion,arterial occlusion
D020246,DISEASE,venous thrombosis,venous thrombosis
D014652,DISEASE,renovascular disease,renovascular disease
D005705,DISEASE,gallbladder disease,gallbladder disease
D019586,DISEASE,elevated ICP,elevated ICP
D005414,DISEASE,flatulence,flatulence
D001308,DISEASE,impairment in auditory location discrimination,impairment in auditory location discrimination
D001264,DISEASE,choreoathetosis,choreoathetosis
D009901,DISEASE,optic neuropathy,optic neuropathy
D004831,DISEASE,Myoclonic seizures,Myoclonic seizures
D009765,DISEASE,obese,obese
D012804,DISEASE,sinus bradycardia,sinus bradycardia
D011681,DISEASE,pupillary oscillation,pupillary oscillation
D018366,DISEASE,LV Cutaneous lesions,LV Cutaneous lesions
D020336,DISEASE,spastic paraparesis,spastic paraparesis
D009220,DISEASE,inflammatory myopathy,inflammatory myopathy
D008232,DISEASE,post-transplant lmphoproliferate disease,post-transplant lmphoproliferate disease
D007410,DISEASE,intestinal,intestinal
D006073,DISEASE,gout,gout
D013651,DISEASE,altered taste perception,altered taste perception
D013617,DISEASE,supraventricular tachyarrhythmias,supraventricular tachyarrhythmias
D011183,DISEASE,postoperative delirium,postoperative delirium
D001167,DISEASE,arteritis,arteritis
D005759,DISEASE,gastroenteritis,gastroenteritis
D013746,DISEASE,tetanic,tetanic
D014657,DISEASE,vasculitis,vasculitis
D018658,DISEASE,ventricular septal defect,ventricular septal defect
D012851,DISEASE,Cerebral sinus thrombosis,Cerebral sinus thrombosis
D013575,DISEASE,syncope,syncope
D001766,DISEASE,blindness,blindness
D011115,DISEASE,polyneuropathy,polyneuropathy
D017285,DISEASE,polymyositis,polymyositis
D007662,DISEASE,ketosis,ketosis
D000140,DISEASE,lactic acidosis,lactic acidosis
D003875,DISEASE,eruptions,eruptions
D013684,DISEASE,telangiectasis,telangiectasis
D012607,DISEASE,scotomata,scotomata
D020879,DISEASE,neuromuscular blockade,neuromuscular blockade
D002761,DISEASE,cholangitis,cholangitis
D000748,DISEASE,macrocytic anemia,macrocytic anemia
D006130,DISEASE,growth impairment,growth impairment
C537296,DISEASE,Granulosa cell tumor of the ovary,Granulosa cell tumor of the ovary
D011471,DISEASE,prostate cancer,prostate cancer
D001416,DISEASE,Leg and back pain,Leg and back pain
D001778,DISEASE,blood coagulation,blood coagulation
D013924,DISEASE,thrombophlebitis,thrombophlebitis
D007177,DISEASE,inappropriate antidiuretic hormone secretion,inappropriate antidiuretic hormone secretion
D005315,DISEASE,fetal anomalies,fetal anomalies
D001791,DISEASE,platelet aggregation,platelet aggregation
D003920,DISEASE,Diabetes mellitus,Diabetes mellitus
D003389,DISEASE,cranial neuropathy,cranial neuropathy
D021501,DISEASE,flank pain,flank pain
D011702,DISEASE,pyeloureteritis cystica,pyeloureteritis cystica
D004893,DISEASE,erythema nodosum,erythema nodosum
D009230,DISEASE,myxedemic,myxedemic
D065630,DISEASE,diaphragmatic hernia,diaphragmatic hernia
D003645,DISEASE,sudden death,sudden death
D015837,DISEASE,vestibulotoxicity,vestibulotoxicity
D019559,DISEASE,capillary leak syndrome,capillary leak syndrome
D010468,DISEASE,visual disturbances,visual disturbances
D014869,DISEASE,Water intoxication,Water intoxication
D012595,DISEASE,systemic sclerosis,systemic sclerosis
D000686,DISEASE,AL,AL
C531767,DISEASE,optic disc edema,optic disc edema
D007249,DISEASE,inflammation,inflammation
D006505,DISEASE,acute hepatitis,acute hepatitis
D019115,DISEASE,Necrotising fasciitis,Necrotising fasciitis
D018487,DISEASE,left ventricular systolic and diastolic dysfunction,left ventricular systolic and diastolic dysfunction
D005901,DISEASE,glaucomatous,glaucomatous
D064793,DISEASE,teratogenicity,teratogenicity
D020964,DISEASE,embryolethality,embryolethality
D011041,DISEASE,poisoning,poisoning
D002386,DISEASE,cataracts,cataracts
D004408,DISEASE,Dysguesia,Dysguesia
C537417,DISEASE,Butyrylcholinesterase deficiency,Butyrylcholinesterase deficiency
D008175,DISEASE,lung cancer,lung cancer
D010677,DISEASE,Philadelphia chromosome,Philadelphia chromosome
D008224,DISEASE,follicular cell lymphoma,follicular cell lymphoma
D009369,DISEASE,tumor,tumor
D009136,DISEASE,muscular dystrophy,muscular dystrophy
D002806,DISEASE,stippled epiphyses,stippled epiphyses
D018457,DISEASE,retained placenta,retained placenta
D006473,DISEASE,blood loss,blood loss
D003320,DISEASE,Corneal ulcers,Corneal ulcers
D020520,DISEASE,globus pallidus infarctions,globus pallidus infarctions
D012010,DISEASE,Pure red cell aplasia,Pure red cell aplasia
D053099,DISEASE,Azotemia,Azotemia
D020767,DISEASE,intracranial vascular thrombosis,intracranial vascular thrombosis
D015356,DISEASE,retinal artery and choriocapillaris occlusion,retinal artery and choriocapillaris occlusion
D007049,DISEASE,sensory and motor dysfunction,sensory and motor dysfunction
D020758,DISEASE,Thoracic hematomyelia,Thoracic hematomyelia
D010382,DISEASE,peliosis,peliosis
D008413,DISEASE,mastitis,mastitis
D009120,DISEASE,muscle cramps,muscle cramps
D003318,DISEASE,corneal opacities,corneal opacities
D011559,DISEASE,pseudotumor cerebri,pseudotumor cerebri
D014985,DISEASE,dry eyes,dry eyes
D010787,DISEASE,photodermatitis,photodermatitis
D006994,DISEASE,hypoaldosteronism,hypoaldosteronism
D002180,DISEASE,oral candidiasis,oral candidiasis
D006685,DISEASE,hoarseness,hoarseness
D003328,DISEASE,coronary thrombosis,coronary thrombosis
D001146,DISEASE,Alternating sinus rhythm,Alternating sinus rhythm
D006876,DISEASE,hydrothorax,hydrothorax
D000784,DISEASE,dissecting aneurysm,dissecting aneurysm
D000141,DISEASE,renal tubular acidosis,renal tubular acidosis
D015845,DISEASE,tonic pupillary,tonic pupillary
D007964,DISEASE,Leukocytosis,Leukocytosis
D000471,DISEASE,metabolic alkalosis,metabolic alkalosis
D012871,DISEASE,skin eruptions,skin eruptions
D014514,DISEASE,ureteric calculi,ureteric calculi
D017091,DISEASE,Ischemic colitis,Ischemic colitis
D005885,DISEASE,gingival hyperplasia,gingival hyperplasia
D014474,DISEASE,loss of consciousness,loss of consciousness
D004310,DISEASE,Taussig-Bing malformation,Taussig-Bing malformation
D065817,DISEASE,anotia,anotia
D019226,DISEASE,oral ulcers,oral ulcers
D003560,DISEASE,cysts,cysts
D007235,DISEASE,preterm infants,preterm infants
D008415,DISEASE,mastocytosis,mastocytosis
D018856,DISEASE,interstitial cystitis,interstitial cystitis
D012393,DISEASE,rosacea,rosacea
D001943,DISEASE,breast cancer,breast cancer
D010488,DISEASE,polyarteritis nodosa,polyarteritis nodosa
D017512,DISEASE,lichenoid dermatitis,lichenoid dermatitis
D054220,DISEASE,cortical dysplasia,cortical dysplasia
D055370,DISEASE,pulmonary mass,pulmonary mass
D015433,DISEASE,membranoproliferative glomerulopathy,membranoproliferative glomerulopathy
D006486,DISEASE,hemosiderosis,hemosiderosis
D006961,DISEASE,hyperparathyroidism,hyperparathyroidism
D010309,DISEASE,parotiditis,parotiditis
D056648,DISEASE,ANCA positive vasculitis,ANCA positive vasculitis
D001168,DISEASE,arthritis,arthritis
D006679,DISEASE,HIV seroconversion,HIV seroconversion
D012770,DISEASE,cardiogenic shock,cardiogenic shock
http://purl.obolibrary.org/obo/CHEBI_82448,NUTRITION,"N,N'-diethylthiourea","N,N'-diethylthiourea"
http://purl.obolibrary.org/obo/CHEBI_30879,NUTRITION,alcohol,alcohol
http://purl.obolibrary.org/obo/CHEBI_6759,NUTRITION,mepivacaine,mepivacaine
http://purl.obolibrary.org/obo/CHEBI_355510,NUTRITION,cefotiam,cefotiam
http://purl.obolibrary.org/obo/CHEBI_53018,NUTRITION,"2,4-dinitrophenyl group","2,4-dinitrophenyl group"
http://purl.obolibrary.org/obo/FOODON_00001615,NUTRITION,apricot food product,apricot food product
http://purl.obolibrary.org/obo/CHEBI_204928,NUTRITION,cefotaxime,cefotaxime
http://purl.obolibrary.org/obo/CHEBI_8069,NUTRITION,phenobarbital,phenobarbital
http://purl.obolibrary.org/obo/FOODON_00001274,NUTRITION,egg food product,egg food product
http://purl.obolibrary.org/obo/FOODON_00002239,NUTRITION,shrimp food product,shrimp food product
http://purl.obolibrary.org/obo/CHEBI_15365,NUTRITION,acetylsalicylic acid,acetylsalicylic acid
http://purl.obolibrary.org/obo/FOODON_00001293,NUTRITION,shellfish food product,shellfish food product
http://purl.obolibrary.org/obo/FOODON_00001717,NUTRITION,cherry food product,cherry food product
http://purl.obolibrary.org/obo/FOODON_00002044,NUTRITION,mollusc food product,mollusc food product
http://purl.obolibrary.org/obo/CHEBI_8232,NUTRITION,piperacillin,piperacillin
http://purl.obolibrary.org/obo/CHEBI_9332,NUTRITION,sulfamethoxazole,sulfamethoxazole
http://purl.obolibrary.org/obo/FOODON_00002095,NUTRITION,peach food product,peach food product
http://purl.obolibrary.org/obo/CHEBI_3387,NUTRITION,carbamazepine,carbamazepine
http://purl.obolibrary.org/obo/CHEBI_3508,NUTRITION,ceftazidime,ceftazidime
http://purl.obolibrary.org/obo/CHEBI_53555,NUTRITION,toluene meta-diisocyanate,toluene meta-diisocyanate
http://purl.obolibrary.org/obo/CHEBI_3614,NUTRITION,chlorhexidine,chlorhexidine
http://purl.obolibrary.org/obo/CHEBI_8884,NUTRITION,rocuronium,rocuronium
http://purl.obolibrary.org/obo/CHEBI_103210,NUTRITION,hexahydrophthalic anhydride,hexahydrophthalic anhydride
http://purl.obolibrary.org/obo/CHEBI_53218,NUTRITION,"diphenylmethane-4,4'-diisocyanate","diphenylmethane-4,4'-diisocyanate"
http://purl.obolibrary.org/obo/CHEBI_3515,NUTRITION,cefuroxime,cefuroxime
http://purl.obolibrary.org/obo/FOODON_00001792,NUTRITION,crustacean food product,crustacean food product
http://purl.obolibrary.org/obo/CHEBI_421707,NUTRITION,abacavir,abacavir
http://purl.obolibrary.org/obo/FOODON_00001623,NUTRITION,atlantic salmon food product,atlantic salmon food product
http://purl.obolibrary.org/obo/CHEBI_35358,NUTRITION,sulfonamide,sulfonamide
http://purl.obolibrary.org/obo/CHEBI_9334,NUTRITION,sulfasalazine,sulfasalazine
http://purl.obolibrary.org/obo/CHEBI_35627,NUTRITION,beta-lactam,beta-lactam
http://purl.obolibrary.org/obo/CHEBI_53050,NUTRITION,trimellitic anhydride,trimellitic anhydride
http://purl.obolibrary.org/obo/FOODON_00001684,NUTRITION,carp food product,carp food product
http://purl.obolibrary.org/obo/CHEBI_3770,NUTRITION,co-trimoxazole,co-trimoxazole
http://purl.obolibrary.org/obo/CHEBI_27638,NUTRITION,cobalt atom,cobalt atom
http://purl.obolibrary.org/obo/CHEBI_30746,NUTRITION,benzoic acid,benzoic acid
http://purl.obolibrary.org/obo/FOODON_00001261,NUTRITION,vegetable food product,vegetable food product
http://purl.obolibrary.org/obo/CHEBI_59601,NUTRITION,patent blue V,patent blue V
http://purl.obolibrary.org/obo/CHEBI_36605,NUTRITION,phthalic anhydride,phthalic anhydride
http://purl.obolibrary.org/obo/CHEBI_43968,NUTRITION,meropenem,meropenem
http://purl.obolibrary.org/obo/CHEBI_5516,NUTRITION,sodium aurothiomalate,sodium aurothiomalate
http://purl.obolibrary.org/obo/CHEBI_45924,NUTRITION,trimethoprim,trimethoprim
http://purl.obolibrary.org/obo/CHEBI_53731,NUTRITION,remazole black-GR,remazole black-GR
http://purl.obolibrary.org/obo/CHEBI_474859,NUTRITION,maleic anhydride,maleic anhydride
http://purl.obolibrary.org/obo/CHEBI_53767,NUTRITION,chloramine T,chloramine T
http://purl.obolibrary.org/obo/CHEBI_26096,NUTRITION,phthalyl group,phthalyl group
http://purl.obolibrary.org/obo/CHEBI_28876,NUTRITION,melphalan,melphalan
http://purl.obolibrary.org/obo/FOODON_00001705,NUTRITION,celery vegetable food product,celery vegetable food product
http://purl.obolibrary.org/obo/CHEBI_51403,NUTRITION,"1,4-phenylenediamine","1,4-phenylenediamine"
http://purl.obolibrary.org/obo/CHEBI_167099,NUTRITION,benzo[d]isothiazol-3-one,benzo[d]isothiazol-3-one
http://purl.obolibrary.org/obo/CHEBI_18208,NUTRITION,benzylpenicillin,benzylpenicillin
http://purl.obolibrary.org/obo/CHEBI_472657,NUTRITION,cefixime,cefixime
http://purl.obolibrary.org/obo/CHEBI_8776,NUTRITION,ranitidine,ranitidine
http://purl.obolibrary.org/obo/FOODON_00001611,NUTRITION,apple food product,apple food product
http://purl.obolibrary.org/obo/CHEBI_2676,NUTRITION,amoxicillin,amoxicillin
http://purl.obolibrary.org/obo/CHEBI_23066,NUTRITION,cephalosporin,cephalosporin
http://purl.obolibrary.org/obo/CHEBI_8107,NUTRITION,phenytoin,phenytoin
http://purl.obolibrary.org/obo/CHEBI_53556,NUTRITION,"toluene 2,4-diisocyanate","toluene 2,4-diisocyanate"
http://purl.obolibrary.org/obo/FOODON_00002161,NUTRITION,plum fruit food product,plum fruit food product
http://purl.obolibrary.org/obo/CHEBI_2674,NUTRITION,amodiaquine,amodiaquine
http://purl.obolibrary.org/obo/CHEBI_29007,NUTRITION,ceftriaxone,ceftriaxone
http://purl.obolibrary.org/obo/FOODON_00001164,NUTRITION,tomato food product,tomato food product
http://purl.obolibrary.org/obo/FOODON_00002244,NUTRITION,snail food product,snail food product
http://purl.obolibrary.org/obo/FOODON_00001248,NUTRITION,fish food product,fish food product
http://purl.obolibrary.org/obo/CHEBI_9362,NUTRITION,suprofen,suprofen
http://purl.obolibrary.org/obo/FOODON_00001057,NUTRITION,plant fruit food product,plant fruit food product
http://purl.obolibrary.org/obo/CHEBI_17334,NUTRITION,penicillin,penicillin
http://purl.obolibrary.org/obo/FOODON_00001275,NUTRITION,hen egg food product,hen egg food product
http://purl.obolibrary.org/obo/CHEBI_3478,NUTRITION,cefaclor,cefaclor
http://purl.obolibrary.org/obo/CHEBI_53578,NUTRITION,hexamethylene diisocyanate,hexamethylene diisocyanate
http://purl.obolibrary.org/obo/FOODON_00001257,NUTRITION,milk or milk based food product,milk or milk based food product
http://purl.obolibrary.org/obo/CHEBI_4027,NUTRITION,cyclophosphamide,cyclophosphamide
http://purl.obolibrary.org/obo/CHEBI_102166,NUTRITION,thiopental,thiopental
http://purl.obolibrary.org/obo/CHEBI_59097,NUTRITION,tetrachlorophthalic anhydride,tetrachlorophthalic anhydride
http://purl.obolibrary.org/obo/CHEBI_53212,NUTRITION,isocyanates,isocyanates
http://purl.obolibrary.org/obo/CHEBI_6030,NUTRITION,isoniazide,isoniazide
http://purl.obolibrary.org/obo/FOODON_00002071,NUTRITION,orange food product,orange food product
http://purl.obolibrary.org/obo/CHEBI_50858,NUTRITION,corticosteroid,corticosteroid
http://purl.obolibrary.org/obo/CHEBI_47381,NUTRITION,diclofenac,diclofenac
http://purl.obolibrary.org/obo/CHEBI_46633,NUTRITION,carbapenems,carbapenems
http://purl.obolibrary.org/obo/FOODON_00002185,NUTRITION,rainbow trout food product,rainbow trout food product
http://purl.obolibrary.org/obo/CHEBI_16899,NUTRITION,D-mannitol,D-mannitol
http://purl.obolibrary.org/obo/FOODON_00002029,NUTRITION,melon food product,melon food product
http://purl.obolibrary.org/obo/CHEBI_6456,NUTRITION,lidocaine,lidocaine
http://purl.obolibrary.org/obo/CHEBI_59001,NUTRITION,4-vinylcyclohexene dioxide,4-vinylcyclohexene dioxide
http://purl.obolibrary.org/obo/CHEBI_28112,NUTRITION,nickel atom,nickel atom
http://purl.obolibrary.org/obo/CHEBI_9774,NUTRITION,tubocurarine,tubocurarine
http://purl.obolibrary.org/obo/CHEBI_128458,NUTRITION,disodium cromoglycate,disodium cromoglycate
http://purl.obolibrary.org/obo/CHEBI_28073,NUTRITION,chromium atom,chromium atom
http://purl.obolibrary.org/obo/FOODON_00001264,NUTRITION,legume food product,legume food product
http://purl.obolibrary.org/obo/CHEBI_36606,NUTRITION,acid anhydride,acid anhydride
http://purl.obolibrary.org/obo/CHEBI_15400,NUTRITION,(-)-carvone,(-)-carvone
http://purl.obolibrary.org/obo/CHEBI_33363,NUTRITION,palladium,palladium
http://purl.obolibrary.org/obo/CHEBI_7939,NUTRITION,parthenolide,parthenolide
http://purl.obolibrary.org/obo/CHEBI_161680,NUTRITION,aztreonam,aztreonam
http://purl.obolibrary.org/obo/CHEBI_45652,NUTRITION,succinylcholine,succinylcholine
http://purl.obolibrary.org/obo/CHEBI_28593,NUTRITION,quinidine,quinidine
http://purl.obolibrary.org/obo/CHEBI_27561,NUTRITION,oxirane,oxirane
http://purl.obolibrary.org/obo/CHEBI_34718,NUTRITION,"1-chloro-2,4-dinitrobenzene","1-chloro-2,4-dinitrobenzene"
http://purl.obolibrary.org/obo/CHEBI_488385,NUTRITION,alcuronium bromide,alcuronium bromide
http://purl.obolibrary.org/obo/CHEBI_138412,NUTRITION,"N,N'-diphenylthiourea","N,N'-diphenylthiourea"
http://purl.obolibrary.org/obo/CHEBI_503442,NUTRITION,gallamine,gallamine
http://purl.obolibrary.org/obo/CHEBI_53444,NUTRITION,potassium dichromate,potassium dichromate
http://purl.obolibrary.org/obo/CHEBI_16842,NUTRITION,formaldehyde,formaldehyde
